Citrus Sinensis ID: 007680

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590---
Protein Sequence
MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKLEGEIPVKGSFKNFSTESFFGNYALCGPPKLRVPPCKPDNSKRTKKVPLIVLKYILPPIVSTVLVVITIIMYIRCRNRNTKKSDHEDFLPLAIWRRTSYLDIQRATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKFLDDAAATNWRNFHCVSLLTLCVLFLVCACGIRAIVFSRT
Secondary Structure (PSIPRED)
ccEEEcccccccccccHHHHHccccccEEEcccccccccccccccccccccEEEcccccccccccHHHHccccccccccccccEEcccccccccccccccccEEEcccccccccccHHHHccccccccccccccccccccHHHHccccccEEEcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEEEEHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccHHHHHHHHcccccccEEEcccccEEEEEEcccccEEEEEEEEcccccccccHHHHHHHHHcccccccccEEEEEEcccccEEEEccccccccccccccccccccHHHHHHHHHHHHHHHHHHccccccccEEEccccccccccccccEEEEccccccccccccccccccEEccccccccccccccccccccccccccHHHHHHHHHHccccccccccccccHHHHHHHHcccccccEEccccccHHcccccHHHHHHHHHHHHHHcccccccccccHHHHHHHHHHHHHHHHHcHHcccccccEEEcccHHHHHHHHHccccEEEEEEcc
Secondary Structure Prediction (SSPRO)
ccEEEEccccccccccHHHHHHcccccEEEcccccccccccHHHccccccEEEEcccccccccccHHHcccccccEEEccccEEEcccccccccccccccEEEEEcccccccccccHHHcccccccEEEcccccccccccHHHccccccEEEEEccccccccccHHHcccccccEEEEcccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccHHHHHHHHccccHccEEEcccccEEEEEEcccccEEEEEEcccccccccHHHHHHHHHHHHHHHHcHHHHHcEccccccEEEEEEccccccHHHHHccccccccHHHHHHHHHHHHHHHHHHHcccccccEEcccccHHHEEEcccccEEEccccccEEccccccccEEEEEccccccccHHHHcEcEEcccccHHHHHHHHHHHHcccccccccccccccHHHHHHHHHHccccEEEcHHHccccccccccHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHccccccccccccccccccccEEEcccccccccccccEEEEEEcc
Coil and Loop (DISEMBL)
mriltlegnqlsgrlpstighslpNIEYLLLTAnnltgtipnsitNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLMFGIRLTgnklygrippclVLTVLDVsrnqlsgdipstiggrvdletlslasnqfqgpipesvgslislesldlsgnnlsgkipklegeipvkgsfknfstesffgnyalcgppklrvppckpdnskrtkkvPLIVLKYILPPIVSTVLVVITIIMYIRcrnrntkksdhedflpLAIWRRTSYLDIQRATDefnecnllgtssfgsvykgtisdgtDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILssysnpdfKALVLefmpngslekwLYSHNYFLDILERLNIMIDVGSALEYLhnghssvhiihcdlkptnilldenmvahvsDFGIYkllgegedsvRQTMTMATIgymapeyglegivsakcDVYSYGVLLMEtftrkrptdemfigEMSLRRWVKeslphgltevvdanLVREEQAFSAKMDCILSIMDFALdccmespdmrINMTDAAAKLKKIKVKFLDDaaatnwrnfHCVSLLTLCVLFLVCACGIRAIVFSRT
Flexible Loop (DISEMBL)
mriltlegnqlsgrlpstigHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKLEGEIPVKGSFKNFSTESFFGNYALCGPPKLrvppckpdnskrtkkvplivlkyilppivsTVLVVITIIMYIRcrnrntkksdhedflplAIWRRTSYLDIQRATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMEtftrkrptdemfigEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKFLDDAAATNWRNFHCVSLLTLCVLFLVCACGIRAIVFSRT
Low Complexity Region (SEG)
MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKLEGEIPVKGSFKNFSTESFFGNYALCGPPKLRVPPCKPDNSKRTKKVPLIVLKYilppivstvlvvitiiMYIRCRNRNTKKSDHEDFLPLAIWRRTSYLDIQRATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKFLDDAAATNWRNFHCVSLLTLCVLFLVCACGIRAIVFSRT
Disordered region (IsUnstruct)
*****************TIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLA**************LI********************GEIPVKGSFKNFSTESFFGNYALCGPPKLRV***********KKVPLIVLKYILPPIVSTVLVVITIIMYIRCRNRNTKKSDHEDFLPLAIWRRTSYLDIQRATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKFLDDAAATNWRNFHCVSLLTLCVLFLVCACGIRAIVF***
Disordered Region (DISOPRED)
MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKLEGEIPVKGSFKNFSTESFFGNYALCGPPKL********************LKYILPPIVSTVLVVITIIMYI*********************RRTSYLDIQRATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGE***RQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKF*************CVSLLTLCVLFLVCACGIRAIVFSR*
Disordered Region (DISEMBL)
MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKLEGEIPVKGSFKNFSTESFFGNYALCGPPKLRVPPCKPDNSKRTKKVPLIVLKYILPPIVSTVLVVITIIMYIRCRNRNTKKSDHEDFLPLAIWRRTSYLDIQRATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKFLDDAAATNWRNFHCVSLLTLCVLFLVCACGIRAIVFSRT
Disordered Region (DISPRO)
MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKLEGEIPVKGSFKNFSTESFFGNYALCGPPKLRVPP**********KVPLIVLKYILPPIVSTVLVVITIIMYIRCRNR**********LPLAIWRRTSYLDIQRATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIK***************************LVCACGIRAIVFSR*
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHiiiiiiii
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHoooo
TM Helix, Signal Peptide (Phobius)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKLEGEIPVKGSFKNFSTESFFGNYALCGPPKLRVPPCKPDNSKRTKKVPLIVLKYILPPIVSTVLVVITIIMYIRCRNRNTKKSDHEDFLPLAIWRRTSYLDIQRATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKFLDDAAATNWRNFHCVSLLTLCVLFLVCACGIRAIVFSRT
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	593	2.2.26 [Sep-21-2011]
C0LGP4	1010	Probable LRR receptor-lik	yes	no	0.930	0.546	0.371	8e-99
C0LGT6	1031	LRR receptor-like serine/	no	no	0.908	0.522	0.359	7e-90
Q9SD62	1025	Putative receptor-like pr	no	no	0.927	0.536	0.371	8e-90
Q9ZUI0	980	Putative leucine-rich rep	no	no	0.905	0.547	0.349	3e-84
Q9FL28	1173	LRR receptor-like serine/	no	no	0.898	0.454	0.340	3e-76
C0LGQ5	1249	LRR receptor-like serine/	no	no	0.892	0.423	0.320	7e-70
Q9LYN8	1192	Leucine-rich repeat recep	no	no	0.893	0.444	0.332	7e-66
Q9SYQ8	980	Receptor protein kinase C	no	no	0.873	0.528	0.315	7e-65
Q9FIZ3	1252	LRR receptor-like serine/	no	no	0.875	0.414	0.318	1e-63
Q9M2Z1	1002	Leucine-rich repeat recep	no	no	0.802	0.475	0.338	6e-63

>sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1

 Score =  361 bits (927), Expect = 8e-99,   Method: Compositional matrix adjust.
 Identities = 236/636 (37%), Positives = 355/636 (55%), Gaps = 84/636 (13%)

Query: 1    MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSF 60
            ++ L L+ N LSG LP+++G  L N+ YL L +N L+G IP  I N T L  LDL  N F
Sbjct: 387  LQKLILDQNMLSGPLPTSLGKLL-NLRYLSLFSNRLSGGIPAFIGNMTMLETLDLSNNGF 445

Query: 61   SGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLV----LTVLDVSRNQLSGDIP 116
             G +  + GN  HL         + +  NKL G IP  ++    L  LD+S N L G +P
Sbjct: 446  EGIVPTSLGNCSHL-------LELWIGDNKLNGTIPLEIMKIQQLLRLDMSGNSLIGSLP 498

Query: 117  STIGGRVDLETLSLASNQFQGPIPESVGSLISLESL-----------------------D 153
              IG   +L TLSL  N+  G +P+++G+ +++ESL                       D
Sbjct: 499  QDIGALQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLEGNLFYGDIPDLKGLVGVKEVD 558

Query: 154  LSGNNLSGKIPK-----------------LEGEIPVKGSFKNFSTESFFGNYALCG---- 192
            LS N+LSG IP+                 LEG++PVKG F+N +T S  GN  LCG    
Sbjct: 559  LSNNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPVKGIFENATTVSIVGNNDLCGGIMG 618

Query: 193  ----PPKLRVPPCKPDNSKRTKKVPLIVLKYILPPIVSTVLVVITIIMYIRCRNRNTKKS 248
                P   + P     +S R KKV +I +   +  ++   +  +T+I ++R R +N + +
Sbjct: 619  FQLKPCLSQAPSVVKKHSSRLKKV-VIGVSVGITLLLLLFMASVTLI-WLRKRKKNKETN 676

Query: 249  DHEDFLPLAIWRRTSYLDIQRATDEFNECNLLGTSSFGSVYKGTI-SDGTDVAIKVFNLQ 307
            +        +  + SY D++ AT+ F+  N++G+ SFG+VYK  + ++   VA+KV N+Q
Sbjct: 677  NPTPSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVKVLNMQ 736

Query: 308  LERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDF-----KALVLEFMPNGSLEKWLYSH 362
               A +SF +ECE L+++RHRNL+K+L++ S+ DF     +AL+ EFMPNGSL+ WL+  
Sbjct: 737  RRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSLDMWLHPE 796

Query: 363  --------NYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHV 414
                    +  L +LERLNI IDV S L+YLH  H    I HCDLKP+N+LLD+++ AHV
Sbjct: 797  EVEEIHRPSRTLTLLERLNIAIDVASVLDYLHV-HCHEPIAHCDLKPSNVLLDDDLTAHV 855

Query: 415  SDFGIYKLLGE-GEDSVRQTMTMA----TIGYMAPEYGLEGIVSAKCDVYSYGVLLMETF 469
            SDFG+ +LL +  E+S    ++ A    TIGY APEYG+ G  S   DVYS+G+LL+E F
Sbjct: 856  SDFGLARLLLKFDEESFFNQLSSAGVRGTIGYAAPEYGVGGQPSINGDVYSFGILLLEMF 915

Query: 470  TRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVR-EEQAFSAKMDCILSIMDFALD 528
            T KRPT+E+F G  +L  + K +LP  + ++VD +++    +     ++C+  + +  L 
Sbjct: 916  TGKRPTNELFGGNFTLNSYTKSALPERILDIVDESILHIGLRVGFPVVECLTMVFEVGLR 975

Query: 529  CCMESPDMRINMTDAAAKLKKIKVKFLDDAAATNWR 564
            CC ESP  R+  +    +L  I+ +F   A+ T WR
Sbjct: 976  CCEESPMNRLATSIVVKELISIRERFF-KASRTTWR 1010

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1

 Score =  332 bits (850), Expect = 7e-90,   Method: Compositional matrix adjust.
 Identities = 224/623 (35%), Positives = 330/623 (52%), Gaps = 84/623 (13%)

Query: 1    MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSF 60
            ++ L+LE N LSG LP + G  L N++ + L +N ++G IP+   N T+L  L L  NSF
Sbjct: 395  LQELSLETNMLSGELPVSFGK-LLNLQVVDLYSNAISGEIPSYFGNMTRLQKLHLNSNSF 453

Query: 61   SGHILNTFGNLRHLSVLSLLMFGIRLTG-------------------NKLYGRIPPCL-- 99
             G I  + G  R+L  L L M   RL G                   N L G  P  +  
Sbjct: 454  HGRIPQSLGRCRYL--LDLWMDTNRLNGTIPQEILQIPSLAYIDLSNNFLTGHFPEEVGK 511

Query: 100  --VLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGN 157
              +L  L  S N+LSG +P  IGG + +E L +  N F G IP+ +  L+SL+++D S N
Sbjct: 512  LELLVGLGASYNKLSGKMPQAIGGCLSMEFLFMQGNSFDGAIPD-ISRLVSLKNVDFSNN 570

Query: 158  NLSGKIP-----------------KLEGEIPVKGSFKNFSTESFFGNYALCGPPK-LRVP 199
            NLSG+IP                 K EG +P  G F+N +  S FGN  +CG  + +++ 
Sbjct: 571  NLSGRIPRYLASLPSLRNLNLSMNKFEGRVPTTGVFRNATAVSVFGNTNICGGVREMQLK 630

Query: 200  PCKPDNSKRTKKVPLIVLKYILPPI---VSTVLVVITII----MYIRCRNRNTKKSDHED 252
            PC    S R +K PL V K ++  I   ++++L++I +        R +  N    +  D
Sbjct: 631  PCIVQASPRKRK-PLSVRKKVVSGICIGIASLLLIIIVASLCWFMKRKKKNNASDGNPSD 689

Query: 253  FLPLAIW-RRTSYLDIQRATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLER 310
               L ++  + SY ++  AT  F+  NL+G+ +FG+V+KG +  +   VA+KV NL    
Sbjct: 690  STTLGMFHEKVSYEELHSATSRFSSTNLIGSGNFGNVFKGLLGPENKLVAVKVLNLLKHG 749

Query: 311  AFRSFDSECEVLRNVRHRNLIKILSSYSN-----PDFKALVLEFMPNGSLEKWLY----- 360
            A +SF +ECE  + +RHRNL+K+++  S+      DF+ALV EFMP GSL+ WL      
Sbjct: 750  ATKSFMAECETFKGIRHRNLVKLITVCSSLDSEGNDFRALVYEFMPKGSLDMWLQLEDLE 809

Query: 361  ---SHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDF 417
                H+  L   E+LNI IDV SALEYLH  H    + HCD+KP+NILLD+++ AHVSDF
Sbjct: 810  RVNDHSRSLTPAEKLNIAIDVASALEYLHV-HCHDPVAHCDIKPSNILLDDDLTAHVSDF 868

Query: 418  GIYKLLGEGE-----DSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRK 472
            G+ +LL + +     +         TIGY APEYG+ G  S + DVYS+G+LL+E F+ K
Sbjct: 869  GLAQLLYKYDRESFLNQFSSAGVRGTIGYAAPEYGMGGQPSIQGDVYSFGILLLEMFSGK 928

Query: 473  RPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCME 532
            +PTDE F G+ +L  + K S+  G T    +N + E             ++   + C  E
Sbjct: 929  KPTDESFAGDYNLHSYTK-SILSGCTSSGGSNAIDEGLRL---------VLQVGIKCSEE 978

Query: 533  SPDMRINMTDAAAKLKKIKVKFL 555
             P  R+   +A  +L  I+ KF 
Sbjct: 979  YPRDRMRTDEAVRELISIRSKFF 1001

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1

 Score =  331 bits (849), Expect = 8e-90,   Method: Compositional matrix adjust.
 Identities = 224/603 (37%), Positives = 337/603 (55%), Gaps = 53/603 (8%)

Query: 1    MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSF 60
            +R + L  N LSG +PS++G+ +  + YL L  N+  G+IP+S+ + + L+ L+LG N  
Sbjct: 427  LRKVLLYSNGLSGEIPSSLGN-ISGLTYLYLLNNSFEGSIPSSLGSCSYLLDLNLGTNKL 485

Query: 61   SGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLVLTVLDVSRNQLSGDIPSTIG 120
            +G I +    L  L VL++      L    L   I     L  LDVS N+LSG IP T+ 
Sbjct: 486  NGSIPHELMELPSLVVLNV---SFNLLVGPLRQDIGKLKFLLALDVSYNKLSGQIPQTLA 542

Query: 121  GRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPK--------------- 165
              + LE L L  N F GPIP+  G L  L  LDLS NNLSG IP+               
Sbjct: 543  NCLSLEFLLLQGNSFVGPIPDIRG-LTGLRFLDLSKNNLSGTIPEYMANFSKLQNLNLSL 601

Query: 166  --LEGEIPVKGSFKNFSTESFFGNYALCGP-PKLRVPPCK---PDNSKRTKKVPLIVLKY 219
               +G +P +G F+N S  S FGN  LCG  P L++ PC    P      +K+  I +  
Sbjct: 602  NNFDGAVPTEGVFRNTSAMSVFGNINLCGGIPSLQLQPCSVELPRRHSSVRKIITICVSA 661

Query: 220  ILPPIVSTVLVVITIIMYIRCRNRNTKKSDHED---FLPL-AIWRRTSYLDIQRATDEFN 275
            ++  ++   L V+ +  Y + R ++ + +++E+   F P+ + + + SY ++ + T  F+
Sbjct: 662  VMAALLLLCLCVVYLCWY-KLRVKSVRANNNENDRSFSPVKSFYEKISYDELYKTTGGFS 720

Query: 276  ECNLLGTSSFGSVYKGTI-SDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKIL 334
              NL+G+ +FG+V+KG + S    VAIKV NL    A +SF +ECE L  +RHRNL+K++
Sbjct: 721  SSNLIGSGNFGAVFKGFLGSKNKAVAIKVLNLCKRGAAKSFIAECEALGGIRHRNLVKLV 780

Query: 335  -----SSYSNPDFKALVLEFMPNGSLEKWLY--------SHNYFLDILERLNIMIDVGSA 381
                 S +   DF+ALV EFMPNG+L+ WL+        + +  L +  RLNI IDV SA
Sbjct: 781  TICSSSDFEGNDFRALVYEFMPNGNLDMWLHPDEIEETGNPSRTLGLFARLNIAIDVASA 840

Query: 382  LEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGE-DSVRQTMTMA--- 437
            L YLH  +    I HCD+KP+NILLD+++ AHVSDFG+ +LL + + D+     + A   
Sbjct: 841  LVYLHT-YCHNPIAHCDIKPSNILLDKDLTAHVSDFGLAQLLLKFDRDTFHIQFSSAGVR 899

Query: 438  -TIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESL-PH 495
             TIGY APEYG+ G  S   DVYS+G++L+E FT KRPT+++F+  ++L  + K +L   
Sbjct: 900  GTIGYAAPEYGMGGHPSIMGDVYSFGIVLLEIFTGKRPTNKLFVDGLTLHSFTKSALQKR 959

Query: 496  GLTEVVDANLVREEQAFSAKM-DCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKF 554
               ++ D  ++R   A    M +C+  +    + C  ESP  RI+M +A +KL  I+  F
Sbjct: 960  QALDITDETILRGAYAQHFNMVECLTLVFRVGVSCSEESPVNRISMAEAISKLVSIRESF 1019

Query: 555  LDD 557
              D
Sbjct: 1020 FRD 1022

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1

 Score =  313 bits (802), Expect = 3e-84,   Method: Compositional matrix adjust.
 Identities = 210/601 (34%), Positives = 320/601 (53%), Gaps = 64/601 (10%)

Query: 1   MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSF 60
           + +L +  N LSG +P + G+ L  +  LLL  N+L+GT+P S+     L +LDL  N+ 
Sbjct: 371 LGLLDVSRNNLSGSIPDSFGN-LSQLRRLLLYGNHLSGTVPQSLGKCINLEILDLSHNNL 429

Query: 61  SGHI-LNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCL-----VLTVLDVSRNQLSGD 114
           +G I +    NLR+L +       + L+ N L G IP  L     VL+V D+S N+LSG 
Sbjct: 430 TGTIPVEVVSNLRNLKLY------LNLSSNHLSGPIPLELSKMDMVLSV-DLSSNELSGK 482

Query: 115 IPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPK--------- 165
           IP  +G  + LE L+L+ N F   +P S+G L  L+ LD+S N L+G IP          
Sbjct: 483 IPPQLGSCIALEHLNLSRNGFSSTLPSSLGQLPYLKELDVSFNRLTGAIPPSFQQSSTLK 542

Query: 166 --------LEGEIPVKGSFKNFSTESFFGNYALCGPPKLRVPPCKPDNSKRTKKVPLIVL 217
                   L G +  KGSF   + ESF G+  LCG  K  +  CK  +   +  +P+++ 
Sbjct: 543 HLNFSFNLLSGNVSDKGSFSKLTIESFLGDSLLCGSIK-GMQACKKKHKYPSVLLPVLLS 601

Query: 218 KYILP-------PIVSTVLVVITIIMYIRCRNRNTKKSDHEDFLPLAIWRRTSYLDIQRA 270
               P       P+V        + +Y +    + +K +  D      + R SY  +  A
Sbjct: 602 LIATPVLCVFGYPLVQRSRFGKNLTVYAKEEVEDEEKQNQND----PKYPRISYQQLIAA 657

Query: 271 TDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFR-SFDSECEVLRNVRHRN 329
           T  FN  +L+G+  FG VYKG + + T VA+KV + +    F  SF  EC++L+  RHRN
Sbjct: 658 TGGFNASSLIGSGRFGHVYKGVLRNNTKVAVKVLDPKTALEFSGSFKRECQILKRTRHRN 717

Query: 330 LIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYF---LDILERLNIMIDVGSALEYLH 386
           LI+I+++ S P F ALVL  MPNGSLE+ LY   Y    LD+++ +NI  DV   + YLH
Sbjct: 718 LIRIITTCSKPGFNALVLPLMPNGSLERHLYPGEYSSKNLDLIQLVNICSDVAEGIAYLH 777

Query: 387 NGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMA--------- 437
           + +S V ++HCDLKP+NILLD+ M A V+DFGI +L+   E++V    +++         
Sbjct: 778 H-YSPVKVVHCDLKPSNILLDDEMTALVTDFGISRLVQGVEETVSTDDSVSFGSTDGLLC 836

Query: 438 -TIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHG 496
            ++GY+APEYG+    S   DVYS+GVLL+E  + +RPTD +     SL  ++K   P  
Sbjct: 837 GSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVSGRRPTDVLVNEGSSLHEFMKSHYPDS 896

Query: 497 LTEVVDANLVR------EEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKI 550
           L  +++  L R       E+      + IL +++  L C   +P  R +M D A ++ ++
Sbjct: 897 LEGIIEQALSRWKPQGKPEKCEKLWREVILEMIELGLVCTQYNPSTRPDMLDVAHEMGRL 956

Query: 551 K 551
           K
Sbjct: 957 K 957

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1

 Score =  286 bits (732), Expect = 3e-76,   Method: Compositional matrix adjust.
 Identities = 203/597 (34%), Positives = 324/597 (54%), Gaps = 64/597 (10%)

Query: 4    LTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGF--NSFS 61
            L+L+GN+ +G +P+++  SL  +    ++ N LTGTIP  +  + K + L L F  N  +
Sbjct: 580  LSLQGNKFNGSIPASL-KSLSLLNTFDISDNLLTGTIPGELLASLKNMQLYLNFSNNLLT 638

Query: 62   GHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIP----PCLVLTVLDVSRNQLSGDIPS 117
            G I    G L        ++  I L+ N   G IP     C  +  LD S+N LSG IP 
Sbjct: 639  GTIPKELGKLE-------MVQEIDLSNNLFSGSIPRSLQACKNVFTLDFSQNNLSGHIPD 691

Query: 118  TIGGRVDLE-TLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPK----------- 165
             +   +D+  +L+L+ N F G IP+S G++  L SLDLS NNL+G+IP+           
Sbjct: 692  EVFQGMDMIISLNLSRNSFSGEIPQSFGNMTHLVSLDLSSNNLTGEIPESLANLSTLKHL 751

Query: 166  ------LEGEIPVKGSFKNFSTESFFGNYALCGPPKLRVPPCKPDN-----SKRTKKVPL 214
                  L+G +P  G FKN +     GN  LCG  K  + PC         SKRT+ + +
Sbjct: 752  KLASNNLKGHVPESGVFKNINASDLMGNTDLCGSKK-PLKPCTIKQKSSHFSKRTRVILI 810

Query: 215  IVLKYILPPIVSTVLVVITIIMYIRCRNRNTKKSDHEDFLPLAIWRRTSYLDIQRATDEF 274
            I+       +V  +++++T       +  N+ +S   D       +R    ++++ATD F
Sbjct: 811  ILGSAAALLLVLLLVLILTCCKKKEKKIENSSESSLPDLDSALKLKRFEPKELEQATDSF 870

Query: 275  NECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQ--LERAFRSFDSECEVLRNVRHRNLIK 332
            N  N++G+SS  +VYKG + DGT +A+KV NL+     + + F +E + L  ++HRNL+K
Sbjct: 871  NSANIIGSSSLSTVYKGQLEDGTVIAVKVLNLKEFSAESDKWFYTEAKTLSQLKHRNLVK 930

Query: 333  ILS-SYSNPDFKALVLEFMPNGSLEKWLY-SHNYFLDILERLNIMIDVGSALEYLHNGHS 390
            IL  ++ +   KALVL FM NG+LE  ++ S      +LE++++ + + S ++YLH+G+ 
Sbjct: 931  ILGFAWESGKTKALVLPFMENGNLEDTIHGSAAPIGSLLEKIDLCVHIASGIDYLHSGY- 989

Query: 391  SVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMA---TIGYMAPEYG 447
               I+HCDLKP NILLD + VAHVSDFG  ++LG  ED      T A   TIGY+APE+ 
Sbjct: 990  GFPIVHCDLKPANILLDSDRVAHVSDFGTARILGFREDGSTTASTSAFEGTIGYLAPEFA 1049

Query: 448  LEGIVSAKCDVYSYGVLLMETFTRKRPT--DEMFIGEMSLRRWVKESLPH---GLTEVVD 502
                V+ K DV+S+G+++ME  T++RPT  ++    +M+LR+ V++S+ +   G+  V+D
Sbjct: 1050 YMRKVTTKADVFSFGIIMMELMTKQRPTSLNDEDSQDMTLRQLVEKSIGNGRKGMVRVLD 1109

Query: 503  ANL------VREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVK 553
              L      +++E+A       I   +   L C    P+ R +M +    L K++ K
Sbjct: 1110 MELGDSIVSLKQEEA-------IEDFLKLCLFCTSSRPEDRPDMNEILTHLMKLRGK 1159

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1

 Score =  265 bits (677), Expect = 7e-70,   Method: Compositional matrix adjust.
 Identities = 192/599 (32%), Positives = 290/599 (48%), Gaps = 70/599 (11%)

Query: 4    LTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGH 63
            + L  N LSG +P  +G  L  +  L L++N    ++P  + N TKL+VL L  NS +G 
Sbjct: 652  IDLNNNFLSGPIPPWLG-KLSQLGELKLSSNQFVESLPTELFNCTKLLVLSLDGNSLNGS 710

Query: 64   ILNTFGNLRHLSVLSL-----------------LMFGIRLTGNKLYGRIPPCL-----VL 101
            I    GNL  L+VL+L                  ++ +RL+ N L G IP  +     + 
Sbjct: 711  IPQEIGNLGALNVLNLDKNQFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQLQDLQ 770

Query: 102  TVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSG 161
            + LD+S N  +GDIPSTIG    LETL L+ NQ  G +P SVG + SL  L++S NNL G
Sbjct: 771  SALDLSYNNFTGDIPSTIGTLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSFNNLGG 830

Query: 162  KIPKLEGEIPVKGSFKNFSTESFFGNYALCGPPKLRVPPCKPDNSKRTKKVPLIVLKYIL 221
            K+ K          F  +  +SF GN  LCG P  R    + +N ++      +V+   +
Sbjct: 831  KLKK---------QFSRWPADSFLGNTGLCGSPLSRCNRVRSNNKQQGLSARSVVIISAI 881

Query: 222  PPIVSTVLVVITIIMYIRCRNRNTKKSDHED-----------------FLPLAIWRRTSY 264
              + +  L+++ I ++ + R+   KK  H                   F   A      +
Sbjct: 882  SALTAIGLMILVIALFFKQRHDFFKKVGHGSTAYTSSSSSSQATHKPLFRNGASKSDIRW 941

Query: 265  LDIQRATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLE-RAFRSFDSECEVLR 323
             DI  AT   +E  ++G+   G VYK  + +G  VA+K    + +  + +SF  E + L 
Sbjct: 942  EDIMEATHNLSEEFMIGSGGSGKVYKAELENGETVAVKKILWKDDLMSNKSFSREVKTLG 1001

Query: 324  NVRHRNLIKILS--SYSNPDFKALVLEFMPNGSLEKWLYS-------HNYFLDILERLNI 374
             +RHR+L+K++   S  +     L+ E+M NGS+  WL+            LD   RL I
Sbjct: 1002 RIRHRHLVKLMGYCSSKSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKKLLDWEARLRI 1061

Query: 375  MIDVGSALEYLHNGHSSVH-IIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQT 433
             + +   +EYLH  H  V  I+H D+K +N+LLD NM AH+ DFG+ K+L E  D+   +
Sbjct: 1062 AVGLAQGVEYLH--HDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTENCDTNTDS 1119

Query: 434  MTM--ATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKE 491
             T    + GY+APEY      + K DVYS G++LME  T K PTD +F  EM + RWV+ 
Sbjct: 1120 NTWFACSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTDSVFGAEMDMVRWVET 1179

Query: 492  SLP---HGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKL 547
             L        +++D  L   +     + D    +++ AL C   SP  R +   A   L
Sbjct: 1180 HLEVAGSARDKLIDPKL---KPLLPFEEDAACQVLEIALQCTKTSPQERPSSRQACDSL 1235

Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LYN8|EXS_ARATH Leucine-rich repeat receptor protein kinase EXS OS=Arabidopsis thaliana GN=EXS PE=1 SV=1

 Score =  252 bits (643), Expect = 7e-66,   Method: Compositional matrix adjust.
 Identities = 200/601 (33%), Positives = 288/601 (47%), Gaps = 71/601 (11%)

Query: 4    LTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGH 63
            ++L  N LSG +P+++   L N+  L L+ N LTG+IP  + N+ KL  L+L  N  +GH
Sbjct: 609  ISLSNNHLSGEIPASLSR-LTNLTILDLSGNALTGSIPKEMGNSLKLQGLNLANNQLNGH 667

Query: 64   ILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCL----VLTVLDVSRNQLSGDIPSTI 119
            I  +FG L  L  L+L       T NKL G +P  L     LT +D+S N LSG++ S +
Sbjct: 668  IPESFGLLGSLVKLNL-------TKNKLDGPVPASLGNLKELTHMDLSFNNLSGELSSEL 720

Query: 120  GGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIP--------------- 164
                 L  L +  N+F G IP  +G+L  LE LD+S N LSG+IP               
Sbjct: 721  STMEKLVGLYIEQNKFTGEIPSELGNLTQLEYLDVSENLLSGEIPTKICGLPNLEFLNLA 780

Query: 165  --KLEGEIPVKGSFKNFSTESFFGNYALCGPPKLRVPPCKPDNSKRTKKVPLIVLKYILP 222
               L GE+P  G  ++ S     GN  LCG  ++    CK + +K      +  L     
Sbjct: 781  KNNLRGEVPSDGVCQDPSKALLSGNKELCG--RVVGSDCKIEGTKLRSAWGIAGLMLGFT 838

Query: 223  PIVST-VLVVITIIMYIRCRNRNTKKSDHEDFL------------------PLAI----- 258
             IV   V  +    M  R + R+  +   E  L                  PL+I     
Sbjct: 839  IIVFVFVFSLRRWAMTKRVKQRDDPERMEESRLKGFVDQNLYFLSGSRSREPLSINIAMF 898

Query: 259  ---WRRTSYLDIQRATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSF 315
                 +    DI  ATD F++ N++G   FG+VYK  +     VA+K  +    +  R F
Sbjct: 899  EQPLLKVRLGDIVEATDHFSKKNIIGDGGFGTVYKACLPGEKTVAVKKLSEAKTQGNREF 958

Query: 316  DSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILE---RL 372
             +E E L  V+H NL+ +L   S  + K LV E+M NGSL+ WL +    L++L+   RL
Sbjct: 959  MAEMETLGKVKHPNLVSLLGYCSFSEEKLLVYEYMVNGSLDHWLRNQTGMLEVLDWSKRL 1018

Query: 373  NIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQ 432
             I +     L +LH+G    HIIH D+K +NILLD +    V+DFG+ +L+   E  V  
Sbjct: 1019 KIAVGAARGLAFLHHGFIP-HIIHRDIKASNILLDGDFEPKVADFGLARLISACESHV-S 1076

Query: 433  TMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEM--SLRRWVK 490
            T+   T GY+ PEYG     + K DVYS+GV+L+E  T K PT   F      +L  W  
Sbjct: 1077 TVIAGTFGYIPPEYGQSARATTKGDVYSFGVILLELVTGKEPTGPDFKESEGGNLVGWAI 1136

Query: 491  ESLPHG-LTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKK 549
            + +  G   +V+D  LV       A  +  L ++  A+ C  E+P  R NM D    LK+
Sbjct: 1137 QKINQGKAVDVIDPLLVS-----VALKNSQLRLLQIAMLCLAETPAKRPNMLDVLKALKE 1191

Query: 550  I 550
            I
Sbjct: 1192 I 1192

Receptor with a serine/threonine-protein kinase activity required for the specification of the correct number of male archesporial initials and for the subsequent specification of tapetal and middle cell layer identities. In seeds, required for enhancing cell size and the rate of embryonic development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SYQ8|CLV1_ARATH Receptor protein kinase CLAVATA1 OS=Arabidopsis thaliana GN=CLV1 PE=1 SV=3

 Score =  248 bits (634), Expect = 7e-65,   Method: Compositional matrix adjust.
 Identities = 176/558 (31%), Positives = 282/558 (50%), Gaps = 40/558 (7%)

Query: 3   ILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSG 62
           I+ L  N  SG LP T+   +  ++ + L+ N  +G IP +I N   L  L L  N F G
Sbjct: 437 IIELTDNFFSGELPVTMSGDV--LDQIYLSNNWFSGEIPPAIGNFPNLQTLFLDRNRFRG 494

Query: 63  HILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPP----CLVLTVLDVSRNQLSGDIPST 118
           +I      L+HLS        I  + N + G IP     C  L  +D+SRN+++G+IP  
Sbjct: 495 NIPREIFELKHLSR-------INTSANNITGGIPDSISRCSTLISVDLSRNRINGEIPKG 547

Query: 119 IGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKLEGEIPVKGSFKN 178
           I    +L TL+++ NQ  G IP  +G++ SL +LDLS N+LSG++P       + G F  
Sbjct: 548 INNVKNLGTLNISGNQLTGSIPTGIGNMTSLTTLDLSFNDLSGRVP-------LGGQFLV 600

Query: 179 FSTESFFGNYALCGPPKLRVPPCKPDNSKRTKKVPLIVLKYILPPIVSTVLVVITIIMYI 238
           F+  SF GN  LC P ++  P  +P  +       L     I+  +++ +  +I I + I
Sbjct: 601 FNETSFAGNTYLCLPHRVSCP-TRPGQTSDHNHTALFSPSRIVITVIAAITGLILISVAI 659

Query: 239 RCRNRNTKKSDHEDFLPLAIWRRTSYLDIQRATDEFNEC----NLLGTSSFGSVYKGTIS 294
           R  N   KK + +       W+ T++  +   +++  EC    N++G    G VY+G++ 
Sbjct: 660 RQMN---KKKNQKSL----AWKLTAFQKLDFKSEDVLECLKEENIIGKGGAGIVYRGSMP 712

Query: 295 DGTDVAIK-VFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNG 353
           +  DVAIK +      R+   F +E + L  +RHR+++++L   +N D   L+ E+MPNG
Sbjct: 713 NNVDVAIKRLVGRGTGRSDHGFTAEIQTLGRIRHRHIVRLLGYVANKDTNLLLYEYMPNG 772

Query: 354 SLEKWLY-SHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVA 412
           SL + L+ S    L    R  + ++    L YLH+  S + I+H D+K  NILLD +  A
Sbjct: 773 SLGELLHGSKGGHLQWETRHRVAVEAAKGLCYLHHDCSPL-ILHRDVKSNNILLDSDFEA 831

Query: 413 HVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRK 472
           HV+DFG+ K L +G  S   +    + GY+APEY     V  K DVYS+GV+L+E    K
Sbjct: 832 HVADFGLAKFLVDGAASECMSSIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGK 891

Query: 473 RPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLV---REEQAFSAKMDCILSIMDFALDC 529
           +P  E   G + + RWV+ +    +T+  DA +V    + +     +  ++ +   A+ C
Sbjct: 892 KPVGEFGEG-VDIVRWVRNT-EEEITQPSDAAIVVAIVDPRLTGYPLTSVIHVFKIAMMC 949

Query: 530 CMESPDMRINMTDAAAKL 547
             E    R  M +    L
Sbjct: 950 VEEEAAARPTMREVVHML 967

Involved in the detection of CLV3 and CLV3-like peptides, that act as extracellular signals regulating meristem maintenance. Acts with CLV3 as a ligand-receptor pair in a signal transduction pathway coordinating growth between adjacent meristematic regions and controlling the balance between meristem cell proliferation and differentiation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2

 Score =  244 bits (623), Expect = 1e-63,   Method: Compositional matrix adjust.
 Identities = 185/581 (31%), Positives = 284/581 (48%), Gaps = 62/581 (10%)

Query: 4    LTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGH 63
            L L  N+  G LP+ I  SL NI  L L  N+L G+IP  I N   L  L+L  N  SG 
Sbjct: 677  LKLSSNKFVGSLPTEI-FSLTNILTLFLDGNSLNGSIPQEIGNLQALNALNLEENQLSGP 735

Query: 64   ILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCL-----VLTVLDVSRNQLSGDIPST 118
            + +T G L  L       F +RL+ N L G IP  +     + + LD+S N  +G IPST
Sbjct: 736  LPSTIGKLSKL-------FELRLSRNALTGEIPVEIGQLQDLQSALDLSYNNFTGRIPST 788

Query: 119  IGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKLEGEIPVKGSFKN 178
            I     LE+L L+ NQ  G +P  +G + SL  L+LS NNL GK+ K          F  
Sbjct: 789  ISTLPKLESLDLSHNQLVGEVPGQIGDMKSLGYLNLSYNNLEGKLKK---------QFSR 839

Query: 179  FSTESFFGNYALCGPPKLRVPPCKPDNSKRTKKV--PLIVLKYILPPIVSTVLVVITIIM 236
            +  ++F GN  LCG P   +  C    SK  + +    +V+   +  + +  L+V+ II+
Sbjct: 840  WQADAFVGNAGLCGSP---LSHCNRAGSKNQRSLSPKTVVIISAISSLAAIALMVLVIIL 896

Query: 237  YIRCRNRNTKK----------SDHEDFLPL----AIWRRTSYLDIQRATDEFNECNLLGT 282
            + +  +   KK          +      PL           + DI  AT   NE  ++G+
Sbjct: 897  FFKQNHDLFKKVRGGNSAFSSNSSSSQAPLFSNGGAKSDIKWDDIMEATHYLNEEFMIGS 956

Query: 283  SSFGSVYKGTISDGTDVAIKVFNLQLE-RAFRSFDSECEVLRNVRHRNLIKILS--SYSN 339
               G VYK  + +G  +A+K    + +  + +SF+ E + L  +RHR+L+K++   S   
Sbjct: 957  GGSGKVYKAELKNGETIAVKKILWKDDLMSNKSFNREVKTLGTIRHRHLVKLMGYCSSKA 1016

Query: 340  PDFKALVLEFMPNGSLEKWLYSH-----NYFLDILERLNIMIDVGSALEYLHNGHSSV-H 393
                 L+ E+M NGS+  WL+++        L    RL I + +   +EYLH  +  V  
Sbjct: 1017 DGLNLLIYEYMANGSVWDWLHANENTKKKEVLGWETRLKIALGLAQGVEYLH--YDCVPP 1074

Query: 394  IIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTM--ATIGYMAPEYGLEGI 451
            I+H D+K +N+LLD N+ AH+ DFG+ K+L    D+  ++ TM   + GY+APEY     
Sbjct: 1075 IVHRDIKSSNVLLDSNIEAHLGDFGLAKILTGNYDTNTESNTMFAGSYGYIAPEYAYSLK 1134

Query: 452  VSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESL--PHG---LTEVVDANLV 506
             + K DVYS G++LME  T K PT+ MF  E  + RWV+  L  P G     +++D+ L 
Sbjct: 1135 ATEKSDVYSMGIVLMEIVTGKMPTEAMFDEETDMVRWVETVLDTPPGSEAREKLIDSEL- 1193

Query: 507  REEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKL 547
              +     + +    +++ AL C    P  R +   A+  L
Sbjct: 1194 --KSLLPCEEEAAYQVLEIALQCTKSYPQERPSSRQASEYL 1232

Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9M2Z1|BAME2_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM2 OS=Arabidopsis thaliana GN=BAM2 PE=1 SV=1

 Score =  242 bits (618), Expect = 6e-63,   Method: Compositional matrix adjust.
 Identities = 181/534 (33%), Positives = 265/534 (49%), Gaps = 58/534 (10%)

Query: 6   LEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHIL 65
           L+ N L+G LP + G    ++  + L+ N L+G++P +I N + +  L L  N FSG I 
Sbjct: 438 LQDNYLTGELPISGGGVSGDLGQISLSNNQLSGSLPAAIGNLSGVQKLLLDGNKFSGSIP 497

Query: 66  NTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPP----CLVLTVLDVSRNQLSGDIPSTIGG 121
              G L+ LS L         + N   GRI P    C +LT +D+SRN+LSGDIP+ + G
Sbjct: 498 PEIGRLQQLSKLDF-------SHNLFSGRIAPEISRCKLLTFVDLSRNELSGDIPNELTG 550

Query: 122 RVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKLEGEIPVKGSFKNFST 181
              L  L+L+ N   G IP ++ S+ SL S+D S NNLSG +P         G F  F+ 
Sbjct: 551 MKILNYLNLSRNHLVGSIPVTIASMQSLTSVDFSYNNLSGLVPS-------TGQFSYFNY 603

Query: 182 ESFFGNYALCGPPKLRVPPCKPDNSKRTKKVPLIVLKYILPPIVSTVLVVITIIMYIRCR 241
            SF GN  LCGP    + PC     +   K      K +L   +    +V  I+  I+ R
Sbjct: 604 TSFVGNSHLCGP---YLGPCGKGTHQSHVKPLSATTKLLLVLGLLFCSMVFAIVAIIKAR 660

Query: 242 N-RNTKKSDHEDFLPLAIWRRTSY--LDI--QRATDEFNECNLLGTSSFGSVYKGTISDG 296
           + RN  ++          WR T++  LD       D   E N++G    G VYKGT+  G
Sbjct: 661 SLRNASEAK--------AWRLTAFQRLDFTCDDVLDSLKEDNIIGKGGAGIVYKGTMPKG 712

Query: 297 TDVAIKVFNLQLERAFR--SFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGS 354
             VA+K        +     F++E + L  +RHR+++++L   SN +   LV E+MPNGS
Sbjct: 713 DLVAVKRLATMSHGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGS 772

Query: 355 LEKWLYSH-NYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAH 413
           L + L+      L    R  I ++    L YLH+  S + I+H D+K  NILLD N  AH
Sbjct: 773 LGEVLHGKKGGHLHWNTRYKIALEAAKGLCYLHHDCSPL-IVHRDVKSNNILLDSNFEAH 831

Query: 414 VSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKR 473
           V+DFG+ K L +   S   +    + GY+APEY     V  K DVYS+GV+L+E  T K+
Sbjct: 832 VADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGKK 891

Query: 474 PTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFAL 527
           P  E   G + + +WV+         + D+N            DC+L ++D  L
Sbjct: 892 PVGEFGDG-VDIVQWVR--------SMTDSN-----------KDCVLKVIDLRL 925

Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	593
224116832	1061	predicted protein [Populus trichocarpa]	0.920	0.514	0.544	1e-165
255572272	1089	serine-threonine protein kinase, plant-t	0.929	0.505	0.533	1e-164
224139658	1019	predicted protein [Populus trichocarpa]	0.930	0.541	0.522	1e-161
359483198	1087	PREDICTED: probable LRR receptor-like se	0.912	0.497	0.527	1e-153
255578886	1043	serine-threonine protein kinase, plant-t	0.913	0.519	0.505	1e-153
359497186	1140	PREDICTED: LRR receptor-like serine/thre	0.922	0.479	0.497	1e-149
359483677	1229	PREDICTED: LRR receptor-like serine/thre	0.922	0.445	0.492	1e-149
255585401	843	serine-threonine protein kinase, plant-t	0.927	0.652	0.489	1e-148
359485451	1454	PREDICTED: LRR receptor-like serine/thre	0.915	0.373	0.493	1e-147
255583725	973	serine-threonine protein kinase, plant-t	0.913	0.557	0.500	1e-146

>gi|224116832|ref|XP_002317405.1| predicted protein [Populus trichocarpa] gi|222860470|gb|EEE98017.1| predicted protein [Populus trichocarpa]

 Score =  587 bits (1513), Expect = e-165,   Method: Compositional matrix adjust.
 Identities = 316/580 (54%), Positives = 402/580 (69%), Gaps = 34/580 (5%)

Query: 1    MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSF 60
            ++  +L  N+L G +P+ I H L  + YL L  N  +G++P  ++N T L  L LG N F
Sbjct: 486  LQDFSLASNKLQGHIPNEICH-LERLSYLYLLENGFSGSLPACLSNITSLRELYLGSNRF 544

Query: 61   SGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCL----VLTVLDVSRNQLSGDIP 116
            +  I  TF +L+ L         I L+ N L G +P  +    V+TV+D S NQLSGDIP
Sbjct: 545  TS-IPTTFWSLKDL-------LQINLSFNSLTGTLPLEIGNLKVVTVIDFSSNQLSGDIP 596

Query: 117  STIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPK----------- 165
            ++I    +L   SL+ N+ QGPIP S G L+SLE LDLS N+LSG IPK           
Sbjct: 597  TSIADLQNLAHFSLSDNRMQGPIPSSFGDLVSLEFLDLSRNSLSGAIPKSLEKLVHLKTF 656

Query: 166  ------LEGEIPVKGSFKNFSTESFFGNYALCGPPKLRVPPCKPDNSKRTKKVPL-IVLK 218
                  L+GEI   G F NFS  SF  N ALCGP +++VPPCK  ++ R  K P   V++
Sbjct: 657  NVSFNRLQGEILDGGPFANFSFRSFMDNEALCGPIRMQVPPCKSISTHRQSKRPREFVIR 716

Query: 219  YILPPIVSTVLVVITIIMYIRCRNRNTKKSDHEDFLPLAIWRRTSYLDIQRATDEFNECN 278
            YI+P I   +LV+   ++  R R+   K S  ED LP A WR+ SY ++ RAT+ FNE N
Sbjct: 717  YIVPAIAFIILVLALAVIIFR-RSHKRKLSTQEDPLPPATWRKISYHELYRATEGFNETN 775

Query: 279  LLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYS 338
            LLGT S GSVYKGT+SDG  +A+KVF+LQLE     FDSECEVLR +RHRNL+KI+SS  
Sbjct: 776  LLGTGSCGSVYKGTLSDGLCIAVKVFHLQLEGELMRFDSECEVLRMLRHRNLVKIISSCC 835

Query: 339  NPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCD 398
            N DFKAL+LEF+P+GSLEKWLYSHNY+LDIL+RLNIMIDV SALEYLH+G  +  ++HCD
Sbjct: 836  NLDFKALILEFIPHGSLEKWLYSHNYYLDILQRLNIMIDVASALEYLHHG-CTRPVVHCD 894

Query: 399  LKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDV 458
            LKP+N+L++E+MVAHVSDFGI +LLGEG D+V QT+T+ATIGYMAPEYGLEGIVS K DV
Sbjct: 895  LKPSNVLINEDMVAHVSDFGISRLLGEG-DAVTQTLTLATIGYMAPEYGLEGIVSVKGDV 953

Query: 459  YSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDC 518
            YSYG+ LMETFTRK+PTD+MF GEMSL+ WVK+SLP  +TEV+DANL+ EE+ F AK DC
Sbjct: 954  YSYGIFLMETFTRKKPTDDMFGGEMSLKNWVKQSLPKAITEVIDANLLIEEEHFVAKKDC 1013

Query: 519  ILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKFLDDA 558
            I SI++ AL+C  + P  RI M D    L+KIK+K+  D 
Sbjct: 1014 ITSILNLALECSADLPGERICMRDVLPALEKIKLKYKKDV 1053

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255572272|ref|XP_002527075.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223533580|gb|EEF35319.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score =  585 bits (1508), Expect = e-164,   Method: Compositional matrix adjust.
 Identities = 317/594 (53%), Positives = 409/594 (68%), Gaps = 43/594 (7%)

Query: 4    LTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGH 63
            L L  N L+GR+P+TIG +L +++ L L  N+L G+IP+ + +   L  L+L  N  SG 
Sbjct: 494  LNLGNNDLTGRIPTTIG-TLKHLQGLYLHGNDLDGSIPSELCDLRTLYNLELTGNKLSGS 552

Query: 64   ILNTFGNL-----------RHLSVLSLLMFGIR------LTGNKLYGRIPPCL----VLT 102
            I   F NL           R +S +S  ++ ++      L  N L G +P  +     + 
Sbjct: 553  IPTCFSNLTSLRNLFLASNRFVSTISSTLWTLKDILQVNLASNYLTGSLPSEIENLRAVY 612

Query: 103  VLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGK 162
            ++++S+NQLSG+IP +IGG  DL  L L+ N+ QGPIP+SVG + SLE LDLS NNLSG 
Sbjct: 613  MINISKNQLSGEIPISIGGLQDLAQLYLSGNKLQGPIPQSVGDIKSLEFLDLSSNNLSGM 672

Query: 163  IPK-----------------LEGEIPVKGSFKNFSTESFFGNYALCGPPKLRVPPCKPDN 205
            IPK                 L+GEIP  GSF NFS +SF GN ALCG  +L+V PCK DN
Sbjct: 673  IPKSLDNLLYLKYFNVSFNYLQGEIPEGGSFSNFSAQSFIGNEALCGSARLQVSPCKDDN 732

Query: 206  SKRTKKV-PLIVLKYILPPIVSTVLVVITIIMYIRCRNRNTKKSDHEDFLPLAIWRRTSY 264
            S+ T+     IVL+Y+LP IV  V V+  +IM  R   R  K S  +DFL L   RR SY
Sbjct: 733  SRATETPGSKIVLRYVLPAIVFAVFVLAFVIMLKRYCERKAKFSIEDDFLALTTIRRISY 792

Query: 265  LDIQRATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRN 324
             ++Q AT+ F E N LG  SFGSVYKGT+SDGT +A KVFNLQLERAF+SFD+ECEVLRN
Sbjct: 793  HELQLATNGFQESNFLGMGSFGSVYKGTLSDGTVIAAKVFNLQLERAFKSFDTECEVLRN 852

Query: 325  VRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEY 384
            +RHRNL+KI++S S P+FKALVLEFMPN SLEKWLYS +YFL+ L+RLNIM+DV S LEY
Sbjct: 853  LRHRNLVKIITSCSGPNFKALVLEFMPNWSLEKWLYSDDYFLNNLQRLNIMLDVASVLEY 912

Query: 385  LHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAP 444
            LH+G+ ++ + HCD+KP+N+LL+E+MVA ++DFGI KLLGE E SV QTMT+ATIGYMAP
Sbjct: 913  LHHGY-TIPMAHCDIKPSNVLLNEDMVAFLADFGISKLLGE-EGSVMQTMTLATIGYMAP 970

Query: 445  EYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDAN 504
            EYG EGIVS + DVYSYGVLLMETFT+K+PTD+MF  ++SL+ WV++SL   +T+V+DAN
Sbjct: 971  EYGSEGIVSVRGDVYSYGVLLMETFTQKKPTDKMFTEQLSLKSWVEQSLSCEVTQVIDAN 1030

Query: 505  LVR-EEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKFLDD 557
            L+  EE   +AK DCI+SI+  AL C  + P  RI+M      L+KIK KFL D
Sbjct: 1031 LLGIEEDHLAAKKDCIVSILKLALQCSADLPHDRIDMKHVVTTLQKIKTKFLRD 1084

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224139658|ref|XP_002323215.1| predicted protein [Populus trichocarpa] gi|222867845|gb|EEF04976.1| predicted protein [Populus trichocarpa]

 Score =  576 bits (1485), Expect = e-161,   Method: Compositional matrix adjust.
 Identities = 311/595 (52%), Positives = 403/595 (67%), Gaps = 43/595 (7%)

Query: 3    ILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSG 62
            +L+LE N L G +P+T+G  L  I+ L L  NNL G+IP+ I  A +L+ + L  N  SG
Sbjct: 424  VLSLEENSLMGPIPTTVG-GLRKIQVLYLHKNNLNGSIPSDICLARRLVDITLNNNVLSG 482

Query: 63   HILNTFGNLR-------HLSVLS----LLMFGIR------LTGNKLYGRIPPCL----VL 101
             I +  GNL        H ++LS    + ++ ++      L  N LYG +P  +      
Sbjct: 483  EIPSCIGNLTSLRNLYLHFNILSSTIPMALWSLKDLLILNLHSNFLYGSLPSQVGEMEAA 542

Query: 102  TVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSG 161
              + +S NQLSG+IPSTIG   +L   SL+ N FQG IPE+ G L+SLE LDLS NNLSG
Sbjct: 543  IGIRLSSNQLSGNIPSTIGSLQNLIRFSLSKNSFQGSIPEAFGGLVSLELLDLSQNNLSG 602

Query: 162  KIPK-----------------LEGEIPVKGSFKNFSTESFFGNYALCGPPKLRVPPCKPD 204
            +IPK                 L+GEIP  G F NF+  SF  N  LCGP +L+VPPC  +
Sbjct: 603  EIPKSLEALRYLEFFSVSFNGLQGEIPRGGPFANFTARSFIMNKGLCGPSRLQVPPCSIE 662

Query: 205  NSKRTKKVPLIVLKYILPPIVSTVLVVITIIMYIRCRNRNTKKSDHEDFLPLAIWRRTSY 264
             S++  K    +L++ LP + S +LVV  I + + CR R  K    E     AI RR SY
Sbjct: 663  -SRKDSKTKSRLLRFSLPTVASILLVVAFIFLVMGCRRRYRKDPIPEALPVTAIQRRISY 721

Query: 265  LDIQRATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRN 324
            L++  AT+EF+E NLLG  SFGSVY+G + DG +VA+K+FNLQL+RAFRSFD+ECE++RN
Sbjct: 722  LELLHATNEFHESNLLGIGSFGSVYQGRLRDGLNVAVKIFNLQLQRAFRSFDTECEIMRN 781

Query: 325  VRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEY 384
            +RHRNL+KI+ S SN DFKALVLE+MP GSLEKWLYSHNY LDI++R+NIMIDV SALEY
Sbjct: 782  IRHRNLVKIICSCSNLDFKALVLEYMPKGSLEKWLYSHNYCLDIIQRVNIMIDVASALEY 841

Query: 385  LHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAP 444
            LH+G+ S  ++HCDLKP+N+LLDE+MVAHV DFGI KLLGE E S  QT T+ATIGYMAP
Sbjct: 842  LHHGYPS-PVVHCDLKPSNVLLDEDMVAHVCDFGIAKLLGENE-SFAQTRTLATIGYMAP 899

Query: 445  EYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDAN 504
            EYGL+G+VS K DVYS+G++LME  TRKRPTDEMF GEMSL+R VKESLP  + ++VD+N
Sbjct: 900  EYGLDGLVSTKIDVYSFGIMLMEMLTRKRPTDEMFEGEMSLKRLVKESLPDSVIDIVDSN 959

Query: 505  LVREEQAFSAKMD-CILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKFLDDA 558
            ++     +S K + C+ SIM+ AL C  ESP  R+ M +  A+LK IK +FL D+
Sbjct: 960  MLNRGDGYSVKKEHCVTSIMELALQCVNESPGERMAMVEILARLKNIKAEFLRDS 1014

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359483198|ref|XP_002271405.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera]

 Score =  549 bits (1414), Expect = e-153,   Method: Compositional matrix adjust.
 Identities = 304/576 (52%), Positives = 390/576 (67%), Gaps = 35/576 (6%)

Query: 1    MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSF 60
            ++ L L  N+L G +P+ I   L N+  L LT N L+G+IP  +   T L  L LG N  
Sbjct: 519  LQGLYLPSNKLQGSIPNDICQ-LRNLGELFLTNNQLSGSIPACLGELTFLRHLYLGSNKL 577

Query: 61   SGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCL----VLTVLDVSRNQLSGDIP 116
            +  I +T  +L H  +LSL M     + N L G +P  +    VL  +D+SRNQLSG+IP
Sbjct: 578  NSTIPSTLWSLIH--ILSLDM-----SSNFLVGYLPSDMGNLKVLVKIDLSRNQLSGEIP 630

Query: 117  STIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPK----------- 165
            S IGG  DL +LSLA N+F+GPI  S  +L SLE +DLS N L G+IPK           
Sbjct: 631  SNIGGLQDLTSLSLAHNRFEGPILHSFSNLKSLEFMDLSDNALFGEIPKSLEGLVYLKYL 690

Query: 166  ------LEGEIPVKGSFKNFSTESFFGNYALCGPPKLRVPPCKPDNSKRTKKVPLIVLKY 219
                  L GEIP +G F NFS ESF  N ALCG P+L++PPC+   ++ +  +  ++LKY
Sbjct: 691  DVSFNGLYGEIPPEGPFANFSAESFMMNKALCGSPRLKLPPCR-TGTRWSTTISWLLLKY 749

Query: 220  ILPPIVSTVLVVITIIMYIRCRNRNTKKSDHEDFLPLAIWRRTSYLDIQRATDEFNECNL 279
            ILP I+ST+L +  I ++ RCR RN       + L  A WRR SY +I +AT+ F+  NL
Sbjct: 750  ILPAILSTLLFLALIFVWTRCRKRNAVLPTQSESLLTATWRRISYQEIFQATNGFSAGNL 809

Query: 280  LGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSN 339
            LG  S GSVY+GT+SDG + AIKVFNLQ E AF+SFD+ECEV+ ++RHRNLIKI+SS SN
Sbjct: 810  LGRGSLGSVYRGTLSDGKNAAIKVFNLQEEAAFKSFDAECEVMHHIRHRNLIKIVSSCSN 869

Query: 340  P--DFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHC 397
               DFKALVLE++PNGSLE+WLYSHNY LDIL+RLNIMIDV  A+EYLH+G  S  ++HC
Sbjct: 870  SYIDFKALVLEYVPNGSLERWLYSHNYCLDILQRLNIMIDVALAMEYLHHG-CSTPVVHC 928

Query: 398  DLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCD 457
            DLKP+NILLDE+   HV DFGI KLL E E+S+R+T T+ATIGYMAP+Y   GIV+   D
Sbjct: 929  DLKPSNILLDEDFGGHVGDFGIAKLLRE-EESIRETQTLATIGYMAPKYVSNGIVTTSGD 987

Query: 458  VYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVR-EEQAFSAKM 516
            VYSYG++LMETFTR+RPTDE+F  EMS++ WV + L   +TEVVDANL+R E++ F AK 
Sbjct: 988  VYSYGIVLMETFTRRRPTDEIFSEEMSMKNWVWDWLCGSITEVVDANLLRGEDEQFMAKK 1047

Query: 517  DCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKV 552
             CI  I+  A+DC  +SP+ RI M D    LKKIK 
Sbjct: 1048 QCISLILGLAMDCVADSPEERIKMKDVVTTLKKIKT 1083

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255578886|ref|XP_002530297.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223530195|gb|EEF32104.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score =  546 bits (1408), Expect = e-153,   Method: Compositional matrix adjust.
 Identities = 305/603 (50%), Positives = 392/603 (65%), Gaps = 61/603 (10%)

Query: 4    LTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGH 63
            L L  N L G +P+TI   L  ++ L L  N L G+ P  + +   L  L L  N+ SG 
Sbjct: 451  LDLGANDLRGTIPTTI-RKLGKLQELKLHYNRLEGSFPYELCDLQSLAYLYLEVNALSGQ 509

Query: 64   ILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCL------------------------ 99
            I +  GN+  L  LS+ M       NK    IP  L                        
Sbjct: 510  IPSCLGNVNSLRTLSMGM-------NKFSSTIPSTLWRLADILELNLSSNSLSGSLAVDI 562

Query: 100  ----VLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLS 155
                 +T++D+S NQLSG IPS+IGG   L  LSLA N+ +G IP+  G  ISL+ LDLS
Sbjct: 563  GNLKAVTLIDLSGNQLSGHIPSSIGGLKTLLNLSLAVNRLEGSIPQLFGDAISLQLLDLS 622

Query: 156  GNNLSGKIPK-----------------LEGEIPVKGSFKNFSTESFFGNYALCGPPKLRV 198
             NNLSG+IPK                 L+GEIP   +F N S +SF GN  LCG  KL+V
Sbjct: 623  NNNLSGEIPKSLEELRYLTYFNVSFNELQGEIPNGRAFINLSAKSFMGNKGLCGAAKLQV 682

Query: 199  PPCKPDNSKRTKKVPLIVLKYILPPIVSTVLVVITI-IMYIRCRNRNTKKSDHEDFLPLA 257
             PC+    + +K    + L+Y L     T+L V  + I++IR R RN + +  E  LPLA
Sbjct: 683  QPCETSTHQGSKAASKLALRYGLMATGLTILAVAAVAIIFIRSRKRNMRIT--EGLLPLA 740

Query: 258  IWRRTSYLDIQRATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDS 317
              +R SY ++++ATD+FNE NLLG  SFGSVYKGT SDG+ VA+KVFNLQ+E AF+SFD 
Sbjct: 741  TLKRISYRELEQATDKFNEMNLLGRGSFGSVYKGTFSDGSSVAVKVFNLQVEGAFKSFDV 800

Query: 318  ECEVLRNVRHRNLIKILSSYS--NPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIM 375
            ECEVLR +RHRNL+KI++S S  N DFKALVLEFMPN SLEKWL S  +FL++LERLNIM
Sbjct: 801  ECEVLRMIRHRNLVKIITSCSDINIDFKALVLEFMPNYSLEKWLCSPKHFLELLERLNIM 860

Query: 376  IDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMT 435
            +DV SA+EYLH+G+ ++ I+HCDLKP+NILLDENMVAHV+DFGI KLLG+ E S  QT+T
Sbjct: 861  LDVASAVEYLHHGY-AMPIVHCDLKPSNILLDENMVAHVTDFGIAKLLGD-EHSFIQTIT 918

Query: 436  MATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPH 495
            +AT+GYMAPEYG EG+VS   D+YS+G+LLMETFTRK+PTD+MF  E+S+++WV+ES+P 
Sbjct: 919  LATVGYMAPEYGSEGVVSTGGDIYSFGILLMETFTRKKPTDDMFNEEISMKQWVQESVPG 978

Query: 496  GLTEVVDANLVR-EEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKF 554
            G+T++ D +L+R EEQ FSAK DCILS+M  AL C  + P+ R N+ D    L   KVKF
Sbjct: 979  GVTQITDPDLLRIEEQHFSAKKDCILSVMQVALQCSADLPEERPNIRDVLNTLNHTKVKF 1038

Query: 555  LDD 557
            L D
Sbjct: 1039 LKD 1041

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359497186|ref|XP_003635448.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO1-like [Vitis vinifera]

 Score =  535 bits (1377), Expect = e-149,   Method: Compositional matrix adjust.
 Identities = 294/591 (49%), Positives = 390/591 (65%), Gaps = 44/591 (7%)

Query: 4    LTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGH 63
            L L  N L+G +P+T+G  L  +++L +  N + G+IPN + +   L  L L  N  SG 
Sbjct: 554  LDLGANDLTGSIPTTLGQ-LQKLQWLYIAGNRIRGSIPNDLCHLKDLGYLFLSSNKLSGS 612

Query: 64   ILNTFGNLRHLSVLSL----LMFGI-------------RLTGNKLYGRIPPCL----VLT 102
            I + FG+L  L  L L    L F I              L+ N L G +PP +     +T
Sbjct: 613  IPSCFGDLLALQELFLDSNVLAFNIPTSLWSLRDLLALNLSSNFLTGNLPPEVGNMKSIT 672

Query: 103  VLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGK 162
             LD+S+N +SG IPS +G    L TLSL+ N+ QGPIP   G L+SLESLDLS NNLSG 
Sbjct: 673  TLDLSKNLVSGYIPSKMGKLQSLITLSLSQNRLQGPIPIEFGDLVSLESLDLSQNNLSGT 732

Query: 163  IPK-----------------LEGEIPVKGSFKNFSTESFFGNYALCGPPKLRVPPCKPDN 205
            IPK                 L+GEIP  G F NF+ ESF  N ALCG P  +V  C  +N
Sbjct: 733  IPKSLEALIYLKYLNVSLNKLQGEIPNGGPFINFTAESFMFNEALCGAPHFQVMACDKNN 792

Query: 206  SKRTKKVPLIVLKYILPPIVSTVLVVITIIMYIRCRNRNTKKSDHEDFLPLAIWRRTSYL 265
              ++ K    +LKYIL P+ S V +V+ I+++IR R+     +  + +LP     + S+ 
Sbjct: 793  RTQSWKTKSFILKYILLPVGSIVTLVVFIVLWIRRRDNMEIPTPIDSWLP-GTHEKISHQ 851

Query: 266  DIQRATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNV 325
             +  AT++F E NL+G  S G VYKG +S+G  VAIKVFNL+ + A RSFDSECEV++ +
Sbjct: 852  QLLYATNDFGEDNLIGKGSQGMVYKGVLSNGLTVAIKVFNLEFQGALRSFDSECEVMQGI 911

Query: 326  RHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYL 385
            RHRNL++I++  SN DFKALVLE+MPNGSLEKWLYSHNYFLD+++RLNIMIDV SALEYL
Sbjct: 912  RHRNLVRIITCCSNLDFKALVLEYMPNGSLEKWLYSHNYFLDLIQRLNIMIDVASALEYL 971

Query: 386  HNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPE 445
            H+  SS+ ++HCDLKP N+LLD++MVAHV+DFGI KLL + E S++QT T+ TIGYMAPE
Sbjct: 972  HHDCSSL-VVHCDLKPNNVLLDDDMVAHVADFGITKLLTKTE-SMQQTKTLGTIGYMAPE 1029

Query: 446  YGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANL 505
            +G +GIVS K DVYSYG+LLME F+RK+P DEMF G ++L+ WV ESL + + +VVDANL
Sbjct: 1030 HGSDGIVSTKSDVYSYGILLMEVFSRKKPMDEMFTGGLTLKTWV-ESLSNSVIQVVDANL 1088

Query: 506  V-REEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKFL 555
            + RE++  + K+ C+ SIM  AL C   SP+ R+NM DA  +LKK K+K L
Sbjct: 1089 LRREDEDLATKLSCLSSIMALALACTTNSPEKRLNMKDAVVELKKSKMKLL 1139

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359483677|ref|XP_003633000.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO2-like [Vitis vinifera]

 Score =  534 bits (1375), Expect = e-149,   Method: Compositional matrix adjust.
 Identities = 291/591 (49%), Positives = 392/591 (66%), Gaps = 44/591 (7%)

Query: 4    LTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGH 63
            L L  N L+G +P+T+G  L  ++ L +  N L G+IPN + +   L  L L  N  SG 
Sbjct: 643  LDLGANDLTGSIPTTLGR-LKKLQKLHIVGNRLRGSIPNDLCHLKNLGYLHLSSNKLSGS 701

Query: 64   ILNTFGNLRHLSVL----SLLMFGI-------------RLTGNKLYGRIPPCL----VLT 102
            I + FG+L  L  L    ++L F I              L+ N L G +PP +     +T
Sbjct: 702  IPSCFGDLPALQELFLDSNVLAFNIPTSLWSLRDLLVLNLSSNFLTGNLPPEVGNMKSIT 761

Query: 103  VLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGK 162
             LD+S+N +SG IP  +G + +L  LSL+ N+ QGPIP   G L+SLESLDLS NNLSG 
Sbjct: 762  TLDLSKNLVSGHIPRKMGEQQNLAKLSLSQNKLQGPIPIEFGDLVSLESLDLSQNNLSGT 821

Query: 163  IPK-----------------LEGEIPVKGSFKNFSTESFFGNYALCGPPKLRVPPCKPDN 205
            IPK                 L+GEIP  G F NF+ ESF  N ALCG P  +V  C  +N
Sbjct: 822  IPKSLEALIYLKYLNVSLNKLQGEIPNGGPFINFTAESFMFNEALCGAPHFQVMACDKNN 881

Query: 206  SKRTKKVPLIVLKYILPPIVSTVLVVITIIMYIRCRNRNTKKSDHEDFLPLAIWRRTSYL 265
              ++ K    +LKYIL P+ S V +V+ I+++IR R+     +  + +LP     + S+ 
Sbjct: 882  RTQSWKTKSFILKYILLPVGSIVTLVVFIVLWIRRRDNMEIPTPIDSWLP-GTHEKISHQ 940

Query: 266  DIQRATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNV 325
             +  AT++F E NL+G  S G VYKG +S+G  VAIKVFNL+ + A RSFDSECEV++ +
Sbjct: 941  QLLYATNDFGEDNLIGKGSQGMVYKGVLSNGLTVAIKVFNLEFQGALRSFDSECEVMQGI 1000

Query: 326  RHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYL 385
            RHRNL++I++  SN DFKALVLE+MPNGSLEKWLYSHNYFLD+++RLNIMIDV SALEYL
Sbjct: 1001 RHRNLVRIITCCSNLDFKALVLEYMPNGSLEKWLYSHNYFLDLIQRLNIMIDVASALEYL 1060

Query: 386  HNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPE 445
            H+  SS+ ++HCDLKP N+LLD++MVAHV+DFGI KLL + E S++QT T+ TIGYMAPE
Sbjct: 1061 HHDCSSL-VVHCDLKPNNVLLDDDMVAHVADFGITKLLTKTE-SMQQTKTLGTIGYMAPE 1118

Query: 446  YGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANL 505
            +G +GIVS K DVYSYG+LLME F+RK+P DEMF G+++L+ WV ESL + + +VVDANL
Sbjct: 1119 HGSDGIVSTKSDVYSYGILLMEVFSRKKPMDEMFTGDLTLKTWV-ESLSNSVIQVVDANL 1177

Query: 506  V-REEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKFL 555
            + RE++  + K+ C+ SIM  AL C  +SP+ R+NM DA  +LKK ++K L
Sbjct: 1178 LRREDEDLATKLSCLSSIMALALACTTDSPEERLNMKDAVVELKKSRMKLL 1228

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255585401|ref|XP_002533396.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223526770|gb|EEF28996.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score =  532 bits (1371), Expect = e-148,   Method: Compositional matrix adjust.
 Identities = 293/599 (48%), Positives = 395/599 (65%), Gaps = 49/599 (8%)

Query: 4   LTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGH 63
           L L+ N+L G +P TIG  L  ++ L L  N L G+IP  I + + L  L L  NS  G 
Sbjct: 251 LHLQNNELVGSIPVTIG-GLQKLQRLYLHGNLLYGSIPTDICHLSNLGELFLSNNSLFGP 309

Query: 64  ILNTFGNLRHLSVLSLL-----------------MFGIRLTGNKLYGRIPPCL----VLT 102
           +   FG+L  L +L L                  +  + L+ N L G IP  +    VLT
Sbjct: 310 LPACFGDLISLRILHLHSNNFTSGIPFSLWSLKDVLELNLSSNSLSGHIPLSIGNLKVLT 369

Query: 103 VLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGK 162
            +D S N LSG IP+ IG   +L +LSL  N+F+GPIPE  G LISLESLDLS NNLSGK
Sbjct: 370 QVDFSYNSLSGIIPNAIGSLRNLMSLSLTHNRFEGPIPEPFGELISLESLDLSSNNLSGK 429

Query: 163 IPK-----------------LEGEIPVKGSFKNFSTESFFGNYALCGPPKLRVPPCKPDN 205
           IPK                 L+GE+P KG+F NFS  SF GN ALCG   L + PCK + 
Sbjct: 430 IPKSLEQLKYLKYLNVSFNNLDGEVPNKGAFANFSASSFLGNLALCGSRLLPLMPCKNNT 489

Query: 206 SKRTKKVPLIVLKYILPPIVSTVLVVITIIMYIRCRNRNTKKSDHEDFLPLAIWRRTSYL 265
              +K    ++L Y+LP   +++L +  I++++RC+    +  +  D + +  WRR S+ 
Sbjct: 490 HGGSKTSTKLLLIYVLP---ASILTIAFILVFLRCQKVKLELENVMDIITVGTWRRISFQ 546

Query: 266 DIQRATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNV 325
           ++++ATD F   NLLG   +GSVYKG + DGT+VAIKVFNL +E AF+ FD+ECEV+ ++
Sbjct: 547 ELEQATDGFCASNLLGAGGYGSVYKGRLEDGTNVAIKVFNLGVEGAFKIFDTECEVMSSI 606

Query: 326 RHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYL 385
           RHRNL+KI+S  SN DFKA+VLE+MPNGSLEKWLYSHNY L+I +RL +MIDV SALEYL
Sbjct: 607 RHRNLVKIISCCSNQDFKAIVLEYMPNGSLEKWLYSHNYCLNIQQRLEVMIDVASALEYL 666

Query: 386 HNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPE 445
           H+G S+  I+HCDLKP+N+LLD++MV HV+DFG+ KLLGEG D + QT T+ATIGYMAPE
Sbjct: 667 HHGFSA-PIVHCDLKPSNVLLDQDMVGHVADFGMAKLLGEG-DLITQTKTLATIGYMAPE 724

Query: 446 YGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGE--MSLRRWVKESLPH-GLTEVVD 502
           YG +GIVS   DVYS+G+LLMETFTR +PTD+MF GE  +SL+++++++L H  ++E+ D
Sbjct: 725 YGSKGIVSISGDVYSFGILLMETFTRMKPTDDMF-GERVLSLKQYIEDALLHNAVSEIAD 783

Query: 503 ANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKFLDDAAAT 561
           AN + +E+  S K DC+ SI+  ALDC +E P  RI+M+   A L+ IK + L  +A T
Sbjct: 784 ANFLIDEKNLSTK-DCVSSILGLALDCSVELPHGRIDMSQVLAALRSIKAQLLASSART 841

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359485451|ref|XP_002276944.2| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO2-like [Vitis vinifera]

 Score =  528 bits (1360), Expect = e-147,   Method: Compositional matrix adjust.
 Identities = 285/577 (49%), Positives = 387/577 (67%), Gaps = 34/577 (5%)

Query: 1    MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSF 60
            ++ L + GN+L G +P+ +   L N+ YL L++N LTG+IP+ +     L  L L  N+ 
Sbjct: 889  LQELGIAGNRLRGSIPNDLCR-LKNLGYLFLSSNQLTGSIPSCLGYLPPLRELYLHSNAL 947

Query: 61   SGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCL----VLTVLDVSRNQLSGDIP 116
            + +I  +   LR L VL+L       + N L G +PP +     +  LD+S+NQ+SG IP
Sbjct: 948  ASNIPPSLWTLRGLLVLNL-------SSNFLTGHLPPEVGNIKSIRTLDLSKNQVSGHIP 1000

Query: 117  STIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPK----------- 165
             T+G   +LE LSL+ N+ QGPIP   G L+SL+ LDLS NNLSG IPK           
Sbjct: 1001 RTLGELQNLEDLSLSQNRLQGPIPLEFGDLLSLKFLDLSQNNLSGVIPKSLKALTYLKYL 1060

Query: 166  ------LEGEIPVKGSFKNFSTESFFGNYALCGPPKLRVPPCKPDNSKRTKKVPLIVLKY 219
                  L+GEIP  G F NF+ ESF  N ALCG P  +V  C      R+ +  L +LKY
Sbjct: 1061 NVSFNKLQGEIPDGGPFMNFTAESFIFNEALCGAPHFQVIACDKSTRSRSWRTKLFILKY 1120

Query: 220  ILPPIVSTVLVVITIIMYIRCRNRNTKKSDHEDFLPLAIWRRTSYLDIQRATDEFNECNL 279
            ILPP++S + +V+ ++++IR R      +  + +LP     + S+  +  AT+ F E NL
Sbjct: 1121 ILPPVISIITLVVFLVLWIRRRKNLEVPTPIDSWLP-GSHEKISHQQLLYATNYFGEDNL 1179

Query: 280  LGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSN 339
            +G  S   VYKG +S+G  VA+KVFNL+ + AFRSFDSECEV++++RHRNL+KI++  SN
Sbjct: 1180 IGKGSLSMVYKGVLSNGLTVAVKVFNLEFQGAFRSFDSECEVMQSIRHRNLVKIITCCSN 1239

Query: 340  PDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDL 399
             DFKALVLE+MP GSL+KWLYSHNYFLD+++RLNIMIDV SALEYLH+   S+ ++HCDL
Sbjct: 1240 LDFKALVLEYMPKGSLDKWLYSHNYFLDLIQRLNIMIDVASALEYLHHDCPSL-VVHCDL 1298

Query: 400  KPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVY 459
            KP NILLD++MVAHV DFGI +LL E E S++QT T+ TIGYMAPEYG +GIVS K DV+
Sbjct: 1299 KPNNILLDDDMVAHVGDFGIARLLTETE-SMQQTKTLGTIGYMAPEYGSDGIVSTKGDVF 1357

Query: 460  SYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLV-REEQAFSAKMDC 518
            SYG++LME F RK+P DEMF G+++L+ WV ESL   + EVVDANL+ RE++ F+ K+ C
Sbjct: 1358 SYGIMLMEVFARKKPMDEMFNGDLTLKSWV-ESLADSMIEVVDANLLRREDEDFATKLSC 1416

Query: 519  ILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKFL 555
            + SIM  AL C  +SP+ RI+M D    LKKIK++ L
Sbjct: 1417 LSSIMALALACTTDSPEERIDMKDVVVGLKKIKIELL 1453

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255583725|ref|XP_002532616.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223527672|gb|EEF29782.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score =  526 bits (1355), Expect = e-146,   Method: Compositional matrix adjust.
 Identities = 295/589 (50%), Positives = 387/589 (65%), Gaps = 47/589 (7%)

Query: 9   NQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTF 68
           N L G +P+TIG  L  ++ LLL  N L G  P  + +   L +L LG N+ SG I +  
Sbjct: 386 NDLRGTIPATIGK-LRKLQALLLDHNKLEGVFPPELCDLQSLAILSLGVNTLSGSIPSCL 444

Query: 69  GNLRHLSVLSLLM-----------------FGIRLTGNKLYGRIPPCL----VLTVLDVS 107
           GN+  L  LS+ M                   + L+ N L G +   +    V T++D+S
Sbjct: 445 GNVDSLRNLSMQMNKFNSTIPSTLWRLENILIVNLSFNSLSGALAVDIGNLKVATIIDLS 504

Query: 108 RNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPK-- 165
            NQLSG IP  +G   DL +LSLA N+F+G IP+S G  ISL+ LDLS N LSG+IPK  
Sbjct: 505 GNQLSGQIPPGLGSLKDLSSLSLADNRFEGSIPQSFGDAISLQFLDLSNNTLSGEIPKYL 564

Query: 166 ---------------LEGEIPVKGSFKNFSTESFFGNYALCGPPKLRVPPCKPDNSKRTK 210
                          L+GEIP  G+F N S +SF GN   CG  K +V PCK    + +K
Sbjct: 565 EILRYLTYFNVSFNELQGEIPNGGAFTNLSAQSFMGNKGFCGAAKFQVQPCKTRTDQGSK 624

Query: 211 KVPLIVLKYILPPIVSTVLVVITI-IMYIRCRNRNTKKSDHEDFLPLAIWRRTSYLDIQR 269
               + L+Y L     T+L V  + I++IR R RN + +  E  LPLA   R SY ++++
Sbjct: 625 AGSKLALRYGLMATGLTILAVAAVVIIFIRSRKRNRRTT--EGLLPLATLERISYRELEQ 682

Query: 270 ATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRN 329
           ATD+FNE NLLG  SFGSVYKG  SDG  VA+KVFNLQ E AF+SFD E EVLR +RHRN
Sbjct: 683 ATDKFNEINLLGKGSFGSVYKGIFSDGRSVAVKVFNLQAEGAFKSFDVESEVLRMIRHRN 742

Query: 330 LIKILSSYS--NPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
           L+KI++S S  N +FKALVLEFMPN SLEKWLYS N+FL+ L+RLNIM+DV SA+EYLH+
Sbjct: 743 LVKIITSCSSVNIEFKALVLEFMPNHSLEKWLYSPNHFLEFLQRLNIMLDVASAVEYLHH 802

Query: 388 GHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYG 447
           G+++  I+HCDLKP NILLDENM AHV+DFGI KLLG+ E S  +T+T+AT+GYMAPEYG
Sbjct: 803 GYTT-PIVHCDLKPNNILLDENMAAHVTDFGIAKLLGD-ERSFIRTITLATVGYMAPEYG 860

Query: 448 LEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVR 507
            EG+VS   DVYS+G+L++ETFT ++PTD+MF  EM++++WV+ESL  G+T++ D NL+R
Sbjct: 861 SEGVVSTGGDVYSFGILMIETFTSRKPTDDMFNEEMNMKQWVQESLAGGVTQIADPNLLR 920

Query: 508 -EEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKFL 555
            E++  SAK DCI+S+M  AL C  + P+ R N+ D  + L  IKVKFL
Sbjct: 921 IEDEHLSAKKDCIISMMQLALQCSADLPEERPNIRDVLSTLNHIKVKFL 969

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	593
UNIPROTKB|Q40640	1025	Xa21 "Receptor kinase-like pro	0.831	0.480	0.388	6.4e-83
TAIR|locus:2170483	1173	FLS2 "FLAGELLIN-SENSITIVE 2" [	0.887	0.448	0.342	5.4e-74
TAIR|locus:2047525	980	AT2G24130 [Arabidopsis thalian	0.819	0.495	0.370	3.6e-73
TAIR|locus:2079142	1010	AT3G47570 [Arabidopsis thalian	0.681	0.4	0.380	2.9e-63
TAIR|locus:2075631	1009	AT3G47090 [Arabidopsis thalian	0.686	0.403	0.365	1e-61
TAIR|locus:2079157	1011	AT3G47580 [Arabidopsis thalian	0.676	0.396	0.358	1.2e-59
TAIR|locus:2075661	1025	AT3G47110 [Arabidopsis thalian	0.677	0.392	0.363	3.7e-59
TAIR|locus:2182870	1192	EMS1 "EXCESS MICROSPOROCYTES1"	0.468	0.233	0.367	5.1e-63
TAIR|locus:2169975	993	HSL2 "HAESA-like 2" [Arabidops	0.755	0.451	0.332	5.8e-63
TAIR|locus:2204350	980	CLV1 "AT1G75820" [Arabidopsis	0.880	0.532	0.312	4.8e-60

UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)]

 Score = 831 (297.6 bits), Expect = 6.4e-83, P = 6.4e-83
 Identities = 212/546 (38%), Positives = 298/546 (54%)

Query:     3 ILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSG 62
             IL    N LSG +P  IG+ L  +  LLL  N  +G IP +++N T L+ L L  N+ SG
Sbjct:   428 ILLAYENNLSGSIPLAIGN-LTELNILLLGTNKFSGWIPYTLSNLTNLLSLGLSTNNLSG 486

Query:    63 HILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLV----LTVLDVSRNQLSGDIPST 118
              I +   N++ LS++      I ++ N L G IP  +     L       N+LSG IP+T
Sbjct:   487 PIPSELFNIQTLSIM------INVSKNNLEGSIPQEIGHLKNLVEFHAESNRLSGKIPNT 540

Query:   119 IGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIP-------------- 164
             +G    L  L L +N   G IP ++G L  LE+LDLS NNLSG+IP              
Sbjct:   541 LGDCQLLRYLYLQNNLLSGSIPSALGQLKGLETLDLSSNNLSGQIPTSLADITMLHSLNL 600

Query:   165 ---KLEGEIPVKGSFKNFSTESFFGNYALCGP-PKLRVPPCKPDNSKRTKKVPLIVLKYX 220
                   GE+P  G+F   S  S  GN  LCG  P L +P C P    R K  P++ +   
Sbjct:   601 SFNSFVGEVPTIGAFAAASGISIQGNAKLCGGIPDLHLPRCCPLLENR-KHFPVLPISVS 659

Query:   221 XXXXXXXXXXXXXXXMYIRCRNRNTKKSDHEDFLPLAIWRRTSYLDIQRATDEFNECNLL 280
                             + +   +           PL      SY  + +ATD F   NLL
Sbjct:   660 LAAALAILSSLYLLITWHKRTKKGAPSRTSMKGHPLV-----SYSQLVKATDGFAPTNLL 714

Query:   281 GTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKIL---SSY 337
             G+ SFGSVYKG ++    VA+KV  L+  +A +SF +ECE LRN+RHRNL+KI+   SS 
Sbjct:   715 GSGSFGSVYKGKLNIQDHVAVKVLKLENPKALKSFTAECEALRNMRHRNLVKIVTICSSI 774

Query:   338 SNP--DFKALVLEFMPNGSLEKWLY------SHNYFLDILERLNIMIDVGSALEYLHNGH 389
              N   DFKA+V +FMPNGSLE W++      +    L++  R+ I++DV  AL+YLH  H
Sbjct:   775 DNRGNDFKAIVYDFMPNGSLEDWIHPETNDQADQRHLNLHRRVTILLDVACALDYLHR-H 833

Query:   390 SSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQ-TMTMA---TIGYMAPE 445
                 ++HCD+K +N+LLD +MVAHV DFG+ ++L +G   ++Q T +M    TIGY APE
Sbjct:   834 GPEPVVHCDIKSSNVLLDSDMVAHVGDFGLARILVDGTSLIQQSTSSMGFIGTIGYAAPE 893

Query:   446 YGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHG-LTEVVDAN 504
             YG+  I S   D+YSYG+L++E  T KRPTD  F  ++ LR++V+  L HG +T+VVD  
Sbjct:   894 YGVGLIASTHGDIYSYGILVLEIVTGKRPTDSTFRPDLGLRQYVELGL-HGRVTDVVDTK 952

Query:   505 LVREEQ 510
             L+ + +
Sbjct:   953 LILDSE 958

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2170483 FLS2 "FLAGELLIN-SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 753 (270.1 bits), Expect = 5.4e-74, P = 5.4e-74
 Identities = 197/576 (34%), Positives = 313/576 (54%)

Query:     6 LEGNQLSGRLPSTIGHSLPNIEYLLLTANNL-TGTIPNSITNATKLIVLDLGFNSFSGHI 64
             +  N L+G +P  +  SL N++  L  +NNL TGTIP  +     +  +DL  N FSG I
Sbjct:   606 ISDNLLTGTIPGELLASLKNMQLYLNFSNNLLTGTIPKELGKLEMVQEIDLSNNLFSGSI 665

Query:    65 LNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCL-----VLTVLDVSRNQLSGDIPSTI 119
               +    +++       F +  + N L G IP  +     ++  L++SRN  SG+IP + 
Sbjct:   666 PRSLQACKNV-------FTLDFSQNNLSGHIPDEVFQGMDMIISLNLSRNSFSGEIPQSF 718

Query:   120 GGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKLEGEIPVKGSFKNF 179
             G    L +L L+SN   G IPES+ +L +L+ L L+ NNL G +P+        G FKN 
Sbjct:   719 GNMTHLVSLDLSSNNLTGEIPESLANLSTLKHLKLASNNLKGHVPE-------SGVFKNI 771

Query:   180 STESFFGNYALCGPPKLRVPPC--KPDNSKRTKKVPLIVLKYXXXXXXXXXXXXXXXXMY 237
             +     GN  LCG  K  + PC  K  +S  +K+  +I++                  + 
Sbjct:   772 NASDLMGNTDLCGSKK-PLKPCTIKQKSSHFSKRTRVILI---ILGSAAALLLVLLLVLI 827

Query:   238 IRCRNRNTKKSDH--EDFLP---LAI-WRRTSYLDIQRATDEFNECNLLGTSSFGSVYKG 291
             + C  +  KK ++  E  LP    A+  +R    ++++ATD FN  N++G+SS  +VYKG
Sbjct:   828 LTCCKKKEKKIENSSESSLPDLDSALKLKRFEPKELEQATDSFNSANIIGSSSLSTVYKG 887

Query:   292 TISDGTDVAIKVFNLQLERAFRS---FDSECEVLRNVRHRNLIKILS-SYSNPDFKALVL 347
              + DGT +A+KV NL+ E +  S   F +E + L  ++HRNL+KIL  ++ +   KALVL
Sbjct:   888 QLEDGTVIAVKVLNLK-EFSAESDKWFYTEAKTLSQLKHRNLVKILGFAWESGKTKALVL 946

Query:   348 EFMPNGSLEKWLYSHNYFL-DILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILL 406
              FM NG+LE  ++     +  +LE++++ + + S ++YLH+G+    I+HCDLKP NILL
Sbjct:   947 PFMENGNLEDTIHGSAAPIGSLLEKIDLCVHIASGIDYLHSGYG-FPIVHCDLKPANILL 1005

Query:   407 DENMVAHVSDFGIYKLLGEGEDSVRQTMTMA---TIGYMAPEYGLEGIVSAKCDVYSYGV 463
             D + VAHVSDFG  ++LG  ED      T A   TIGY+APE+     V+ K DV+S+G+
Sbjct:  1006 DSDRVAHVSDFGTARILGFREDGSTTASTSAFEGTIGYLAPEFAYMRKVTTKADVFSFGI 1065

Query:   464 LLMETFTRKRPT--DEMFIGEMSLRRWVKESLPHG---LTEVVDANLVREEQAFSAKMD- 517
             ++ME  T++RPT  ++    +M+LR+ V++S+ +G   +  V+D  L   +   S K + 
Sbjct:  1066 IMMELMTKQRPTSLNDEDSQDMTLRQLVEKSIGNGRKGMVRVLDMEL--GDSIVSLKQEE 1123

Query:   518 CILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVK 553
              I   +   L C    P+ R +M +    L K++ K
Sbjct:  1124 AIEDFLKLCLFCTSSRPEDRPDMNEILTHLMKLRGK 1159

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0016020 "membrane" evidence=ISS;IDA

GO:0016045 "detection of bacterium" evidence=IMP

GO:0005886 "plasma membrane" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0042742 "defense response to bacterium" evidence=RCA;IMP

GO:0052544 "defense response by callose deposition in cell wall" evidence=IMP

GO:0010359 "regulation of anion channel activity" evidence=IMP

GO:0016310 "phosphorylation" evidence=RCA

GO:0005768 "endosome" evidence=IDA

GO:0006898 "receptor-mediated endocytosis" evidence=IDA

TAIR|locus:2047525 AT2G24130 [Arabidopsis thaliana (taxid:3702)]

 Score = 739 (265.2 bits), Expect = 3.6e-73, P = 3.6e-73
 Identities = 198/534 (37%), Positives = 290/534 (54%)

Query:     1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIP-NSITNATKL-IVLDLGFN 58
             +R L L GN LSG +P ++G  + N+E L L+ NNLTGTIP   ++N   L + L+L  N
Sbjct:   395 LRRLLLYGNHLSGTVPQSLGKCI-NLEILDLSHNNLTGTIPVEVVSNLRNLKLYLNLSSN 453

Query:    59 SFSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPP----CLVLTVLDVSRNQLSGD 114
               SG I         LS + +++  + L+ N+L G+IPP    C+ L  L++SRN  S  
Sbjct:   454 HLSGPIP------LELSKMDMVL-SVDLSSNELSGKIPPQLGSCIALEHLNLSRNGFSST 506

Query:   115 IPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKLEGEIPVKG 174
             +PS++G    L+ L ++ N+  G IP S     +L+ L+ S N LSG +         KG
Sbjct:   507 LPSSLGQLPYLKELDVSFNRLTGAIPPSFQQSSTLKHLNFSFNLLSGNVSD-------KG 559

Query:   175 SFKNFSTESFFGNYALCGPPKLRVPPCKPDNSKRTKKVPLI-------VLKYXXXXXXXX 227
             SF   + ESF G+  LCG  K  +  CK  +   +  +P++       VL          
Sbjct:   560 SFSKLTIESFLGDSLLCGSIK-GMQACKKKHKYPSVLLPVLLSLIATPVLCVFGYPLVQR 618

Query:   228 XXXXXXXXMYIRCRNRNTKKSDHEDFLPLAIWRRTSYLDIQRATDEFNECNLLGTSSFGS 287
                     +Y +    + +K +  D  P   + R SY  +  AT  FN  +L+G+  FG 
Sbjct:   619 SRFGKNLTVYAKEEVEDEEKQNQND--PK--YPRISYQQLIAATGGFNASSLIGSGRFGH 674

Query:   288 VYKGTISDGTDVAIKVFNLQLERAFR-SFDSECEVLRNVRHRNLIKILSSYSNPDFKALV 346
             VYKG + + T VA+KV + +    F  SF  EC++L+  RHRNLI+I+++ S P F ALV
Sbjct:   675 VYKGVLRNNTKVAVKVLDPKTALEFSGSFKRECQILKRTRHRNLIRIITTCSKPGFNALV 734

Query:   347 LEFMPNGSLEKWLYSHNYF---LDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTN 403
             L  MPNGSLE+ LY   Y    LD+++ +NI  DV   + YLH+ +S V ++HCDLKP+N
Sbjct:   735 LPLMPNGSLERHLYPGEYSSKNLDLIQLVNICSDVAEGIAYLHH-YSPVKVVHCDLKPSN 793

Query:   404 ILLDENMVAHVSDFGIYKLL-GEGE-----DSVRQTMT----MATIGYMAPEYGLEGIVS 453
             ILLD+ M A V+DFGI +L+ G  E     DSV    T      ++GY+APEYG+    S
Sbjct:   794 ILLDDEMTALVTDFGISRLVQGVEETVSTDDSVSFGSTDGLLCGSVGYIAPEYGMGKRAS 853

Query:   454 AKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVR 507
                DVYS+GVLL+E  + +RPTD +     SL  ++K   P  L  +++  L R
Sbjct:   854 THGDVYSFGVLLLEIVSGRRPTDVLVNEGSSLHEFMKSHYPDSLEGIIEQALSR 907

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)]

 Score = 651 (234.2 bits), Expect = 2.9e-63, P = 2.9e-63
 Identities = 171/449 (38%), Positives = 250/449 (55%)

Query:     1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSF 60
             +  L L  N   G +P+++G+    +E L +  N L GTIP  I    +L+ LD+  NS 
Sbjct:   435 LETLDLSNNGFEGIVPTSLGNCSHLLE-LWIGDNKLNGTIPLEIMKIQQLLRLDMSGNSL 493

Query:    61 SGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPP----CLVLTVLDVSRNQLSGDIP 116
              G +    G L++L  LSL   G     NKL G++P     CL +  L +  N   GDIP
Sbjct:   494 IGSLPQDIGALQNLGTLSL---G----DNKLSGKLPQTLGNCLTMESLFLEGNLFYGDIP 546

Query:   117 STIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKLEGEIPVKGSF 176
               + G V ++ + L++N   G IPE   S   LE L+LS NNL       EG++PVKG F
Sbjct:   547 D-LKGLVGVKEVDLSNNDLSGSIPEYFASFSKLEYLNLSFNNL-------EGKVPVKGIF 598

Query:   177 KNFSTESFFGNYALCGPPK-LRVPPC---KPD----NSKRTKKVPLIVLKYXXXXXXXXX 228
             +N +T S  GN  LCG     ++ PC    P     +S R KKV + V            
Sbjct:   599 ENATTVSIVGNNDLCGGIMGFQLKPCLSQAPSVVKKHSSRLKKVVIGVS--VGITLLLLL 656

Query:   229 XXXXXXXMYIRCRNRNTKKSDHEDFLPLAIWRRTSYLDIQRATDEFNECNLLGTSSFGSV 288
                    +++R R +N + ++        +  + SY D++ AT+ F+  N++G+ SFG+V
Sbjct:   657 FMASVTLIWLRKRKKNKETNNPTPSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSFGTV 716

Query:   289 YKGTI-SDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDF----- 342
             YK  + ++   VA+KV N+Q   A +SF +ECE L+++RHRNL+K+L++ S+ DF     
Sbjct:   717 YKALLLTEKKVVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEF 776

Query:   343 KALVLEFMPNGSLEKWLYS------H--NYFLDILERLNIMIDVGSALEYLHNGHSSVHI 394
             +AL+ EFMPNGSL+ WL+       H  +  L +LERLNI IDV S L+YLH  H    I
Sbjct:   777 RALIYEFMPNGSLDMWLHPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHV-HCHEPI 835

Query:   395 IHCDLKPTNILLDENMVAHVSDFGIYKLL 423
              HCDLKP+N+LLD+++ AHVSDFG+ +LL
Sbjct:   836 AHCDLKPSNVLLDDDLTAHVSDFGLARLL 864

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)]

 Score = 637 (229.3 bits), Expect = 1.0e-61, P = 1.0e-61
 Identities = 160/438 (36%), Positives = 240/438 (54%)

Query:     4 LTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGH 63
             L L  N   G +P ++G     ++ L +  N L GTIP  I     L+ L++  NS SG 
Sbjct:   439 LYLSNNSFEGIVPPSLGDCSHMLD-LQIGYNKLNGTIPKEIMQIPTLVHLNMESNSLSGS 497

Query:    64 ILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLVLTVLDVSRNQLSGDIPSTIGGRV 123
             + N  G L++L  + LL+    L+G+ L   +  CL + V+ +  N   G IP  I G +
Sbjct:   498 LPNDIGRLQNL--VELLLGNNNLSGH-LPQTLGKCLSMEVIYLQENHFDGTIPD-IKGLM 553

Query:   124 DLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKLEGEIPVKGSFKNFSTES 183
              ++ + L++N   G I E   +   LE L+LS NN        EG +P +G F+N +  S
Sbjct:   554 GVKNVDLSNNNLSGSISEYFENFSKLEYLNLSDNNF-------EGRVPTEGIFQNATLVS 606

Query:   184 FFGNYALCGPPK-LRVPPCKPDNSKRTKKVPLIVLKYXXXXXXXXXXXXXXXXM---YIR 239
              FGN  LCG  K L++ PC         + P ++ K                 +   + +
Sbjct:   607 VFGNKNLCGSIKELKLKPCIAQAPPVETRHPSLLKKVAIGVSVGIALLLLLFIVSLSWFK 666

Query:   240 CRNRNTKKSDHEDFLPLAIWRRTSYLDIQRATDEFNECNLLGTSSFGSVYKGTI-SDGTD 298
              R  N K ++   F       + SY D++ ATD F+  N++G+ SFG+V+K  + ++   
Sbjct:   667 KRKNNQKINNSAPFTLEIFHEKLSYGDLRNATDGFSSSNIVGSGSFGTVFKALLQTENKI 726

Query:   299 VAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDF-----KALVLEFMPNG 353
             VA+KV N+Q   A +SF +ECE L+++RHRNL+K+L++ ++ DF     +AL+ EFMPNG
Sbjct:   727 VAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACASIDFQGNEFRALIYEFMPNG 786

Query:   354 SLEKWLYS------H--NYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNIL 405
             SL+KWL+       H  +  L +LERLNI IDV S L+YLH  H    I HCDLKP+NIL
Sbjct:   787 SLDKWLHPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHV-HCHEPIAHCDLKPSNIL 845

Query:   406 LDENMVAHVSDFGIYKLL 423
             LD+++ AHVSDFG+ +LL
Sbjct:   846 LDDDLTAHVSDFGLARLL 863

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009507 "chloroplast" evidence=IDA

TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)]

 Score = 618 (222.6 bits), Expect = 1.2e-59, P = 1.2e-59
 Identities = 162/452 (35%), Positives = 247/452 (54%)

Query:     1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSF 60
             + IL L  N   G +P ++G     ++ L +  N L GTIP  I     L+ L +  NS 
Sbjct:   436 LEILYLSNNSFEGIVPPSLGKCSHMLD-LRIGYNKLNGTIPKEIMQIPTLVNLSMEGNSL 494

Query:    61 SGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPP----CLVLTVLDVSRNQLSGDIP 116
             SG + N  G+L++L  LSL         NK  G +P     CL +  L +  N   G IP
Sbjct:   495 SGSLPNDIGSLQNLVKLSL-------ENNKFSGHLPQTLGNCLAMEQLFLQGNSFDGAIP 547

Query:   117 STIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKLEGEIPVKGSF 176
             + I G + +  + L++N   G IPE   +   LE L+LS NN +GK+P        KG+F
Sbjct:   548 N-IRGLMGVRRVDLSNNDLSGSIPEYFANFSKLEYLNLSINNFTGKVPS-------KGNF 599

Query:   177 KNFSTESFFGNYALCGPPK-LRVPPC---KPD----NSKRTKKVPLIVLKYXXXXXXXXX 228
             +N +    FGN  LCG  K L++ PC   +P     +S   KKV ++V            
Sbjct:   600 QNSTIVFVFGNKNLCGGIKDLKLKPCLAQEPPVETKHSSHLKKVAILVS--IGIALLLLL 657

Query:   229 XXXXXXXMYIRCRNRNTKKSDHEDFLP--LAIWR-RTSYLDIQRATDEFNECNLLGTSSF 285
                     + R R +N + ++    +P  L I+  + SY D++ AT+ F+  N++G+ SF
Sbjct:   658 VIASMVLCWFRKRRKNQQTNN---LVPSKLEIFHEKISYGDLRNATNGFSSSNMVGSGSF 714

Query:   286 GSVYKGTI-SDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDF-- 342
             G+V+K  + ++   VA+KV N+Q   A +SF +ECE L++ RHRNL+K+L++ ++ DF  
Sbjct:   715 GTVFKALLPTESKIVAVKVLNMQRRGAMKSFMAECESLKDTRHRNLVKLLTACASTDFQG 774

Query:   343 ---KALVLEFMPNGSLEKWLYSHNY--------FLDILERLNIMIDVGSALEYLHNGHSS 391
                +AL+ E++PNGS++ WL+             L +LERLNI+IDV S L+YLH  H  
Sbjct:   775 NEFRALIYEYLPNGSVDMWLHPEEVEEIRRPPRTLTLLERLNIVIDVASVLDYLHV-HCH 833

Query:   392 VHIIHCDLKPTNILLDENMVAHVSDFGIYKLL 423
               I HCDLKP+N+LL++++ AHVSDFG+ +LL
Sbjct:   834 EPIAHCDLKPSNVLLEDDLTAHVSDFGLARLL 865

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)]

 Score = 614 (221.2 bits), Expect = 3.7e-59, P = 3.7e-59
 Identities = 162/446 (36%), Positives = 239/446 (53%)

Query:     4 LTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGH 63
             L L  N   G +PS++G S   +  L L  N L G+IP+ +     L+VL++ FN   G 
Sbjct:   454 LYLLNNSFEGSIPSSLG-SCSYLLDLNLGTNKLNGSIPHELMELPSLVVLNVSFNLLVGP 512

Query:    64 ILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPP----CLVLTVLDVSRNQLSGDIPSTI 119
             +    G L+ L  L +       + NKL G+IP     CL L  L +  N   G IP  I
Sbjct:   513 LRQDIGKLKFLLALDV-------SYNKLSGQIPQTLANCLSLEFLLLQGNSFVGPIPD-I 564

Query:   120 GGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKLEGEIPVKGSFKNF 179
              G   L  L L+ N   G IPE + +   L++L+LS NN        +G +P +G F+N 
Sbjct:   565 RGLTGLRFLDLSKNNLSGTIPEYMANFSKLQNLNLSLNNF-------DGAVPTEGVFRNT 617

Query:   180 STESFFGNYALCGP-PKLRVPPCKPDNSKRTKKVPLIVLKYXXXXXXXXXXXXXXXXMYI 238
             S  S FGN  LCG  P L++ PC  +  +R   V  I+                   +Y+
Sbjct:   618 SAMSVFGNINLCGGIPSLQLQPCSVELPRRHSSVRKIIT-ICVSAVMAALLLLCLCVVYL 676

Query:   239 ---RCRNRNTKKSDHED---FLPL-AIWRRTSYLDIQRATDEFNECNLLGTSSFGSVYKG 291
                + R ++ + +++E+   F P+ + + + SY ++ + T  F+  NL+G+ +FG+V+KG
Sbjct:   677 CWYKLRVKSVRANNNENDRSFSPVKSFYEKISYDELYKTTGGFSSSNLIGSGNFGAVFKG 736

Query:   292 TI-SDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKIL-----SSYSNPDFKAL 345
              + S    VAIKV NL    A +SF +ECE L  +RHRNL+K++     S +   DF+AL
Sbjct:   737 FLGSKNKAVAIKVLNLCKRGAAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRAL 796

Query:   346 VLEFMPNGSLEKWLY--------SHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHC 397
             V EFMPNG+L+ WL+        + +  L +  RLNI IDV SAL YLH  +    I HC
Sbjct:   797 VYEFMPNGNLDMWLHPDEIEETGNPSRTLGLFARLNIAIDVASALVYLHT-YCHNPIAHC 855

Query:   398 DLKPTNILLDENMVAHVSDFGIYKLL 423
             D+KP+NILLD+++ AHVSDFG+ +LL
Sbjct:   856 DIKPSNILLDKDLTAHVSDFGLAQLL 881

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2182870 EMS1 "EXCESS MICROSPOROCYTES1" [Arabidopsis thaliana (taxid:3702)]

 Score = 430 (156.4 bits), Expect = 5.1e-63, Sum P(2) = 5.1e-63
 Identities = 107/291 (36%), Positives = 154/291 (52%)

Query:   266 DIQRATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNV 325
             DI  ATD F++ N++G   FG+VYK  +     VA+K  +    +  R F +E E L  V
Sbjct:   909 DIVEATDHFSKKNIIGDGGFGTVYKACLPGEKTVAVKKLSEAKTQGNREFMAEMETLGKV 968

Query:   326 RHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILE---RLNIMIDVGSAL 382
             +H NL+ +L   S  + K LV E+M NGSL+ WL +    L++L+   RL I +     L
Sbjct:   969 KHPNLVSLLGYCSFSEEKLLVYEYMVNGSLDHWLRNQTGMLEVLDWSKRLKIAVGAARGL 1028

Query:   383 EYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYM 442
              +LH+G    HIIH D+K +NILLD +    V+DFG+ +L+   E  V  T+   T GY+
Sbjct:  1029 AFLHHGFIP-HIIHRDIKASNILLDGDFEPKVADFGLARLISACESHV-STVIAGTFGYI 1086

Query:   443 APEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEM--SLRRWVKESLPHG-LTE 499
              PEYG     + K DVYS+GV+L+E  T K PT   F      +L  W  + +  G   +
Sbjct:  1087 PPEYGQSARATTKGDVYSFGVILLELVTGKEPTGPDFKESEGGNLVGWAIQKINQGKAVD 1146

Query:   500 VVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKI 550
             V+D  LV       A  +  L ++  A+ C  E+P  R NM D    LK+I
Sbjct:  1147 VIDPLLVSV-----ALKNSQLRLLQIAMLCLAETPAKRPNMLDVLKALKEI 1192

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009556 "microsporogenesis" evidence=IMP

GO:0010234 "tapetal cell fate specification" evidence=IMP

GO:0016020 "membrane" evidence=IDA

GO:0019199 "transmembrane receptor protein kinase activity" evidence=ISS

GO:0005515 "protein binding" evidence=IPI

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2169975 HSL2 "HAESA-like 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 552 (199.4 bits), Expect = 5.8e-63, Sum P(2) = 5.8e-63
 Identities = 166/500 (33%), Positives = 239/500 (47%)

Query:     2 RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFS 61
             R+     NQL G +P +I  +  ++  L ++ANN +G IP  + +   L V+DL  NSF 
Sbjct:   438 RLELANNNQLQGSIPPSISKAR-HLSQLEISANNFSGVIPVKLCDLRDLRVIDLSRNSFL 496

Query:    62 GHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPP----CLVLTVLDVSRNQLSGDIPS 117
             G I +    L++L         + +  N L G IP     C  LT L++S N+L G IP 
Sbjct:   497 GSIPSCINKLKNLE-------RVEMQENMLDGEIPSSVSSCTELTELNLSNNRLRGGIPP 549

Query:   118 TIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKLEGEIPVKGSFK 177
              +G    L  L L++NQ  G IP  +  L  L   ++S N L GKIP         G  +
Sbjct:   550 ELGDLPVLNYLDLSNNQLTGEIPAELLRL-KLNQFNVSDNKLYGKIPS--------GFQQ 600

Query:   178 NFSTESFFGNYALCGPPKLRVPPCKPDNSKRTKK--VPLIVLKYXXXXXXXXXXXXXXXX 235
             +    SF GN  LC P    + P +P  SKR  +  +P+ +L                  
Sbjct:   601 DIFRPSFLGNPNLCAP---NLDPIRPCRSKRETRYILPISILCIVALTGALVWLFIKTKP 657

Query:   236 MYIRCRNRNTKKSDHEDFLPLAIWRRTSYLDIQRATDEFNECNLLGTSSFGSVYKGTISD 295
             ++ R   R  K         + I++R  + + +    +  E N++G+   G VY+  +  
Sbjct:   658 LFKRKPKRTNK---------ITIFQRVGFTE-EDIYPQLTEDNIIGSGGSGLVYRVKLKS 707

Query:   296 GTDVAIKVFNLQLERAFRS---FDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPN 352
             G  +A+K    +  +   S   F SE E L  VRH N++K+L   +  +F+ LV EFM N
Sbjct:   708 GQTLAVKKLWGETGQKTESESVFRSEVETLGRVRHGNIVKLLMCCNGEEFRFLVYEFMEN 767

Query:   353 GSLEKWLYS---HNYF--LDILERLNIMIDVGSALEYLHNGHSSVH-IIHCDLKPTNILL 406
             GSL   L+S   H     LD   R +I +     L YLH  H SV  I+H D+K  NILL
Sbjct:   768 GSLGDVLHSEKEHRAVSPLDWTTRFSIAVGAAQGLSYLH--HDSVPPIVHRDVKSNNILL 825

Query:   407 DENMVAHVSDFGIYKLL----GEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYG 462
             D  M   V+DFG+ K L     +G   V  +    + GY+APEYG    V+ K DVYS+G
Sbjct:   826 DHEMKPRVADFGLAKPLKREDNDGVSDVSMSCVAGSYGYIAPEYGYTSKVNEKSDVYSFG 885

Query:   463 VLLMETFTRKRPTDEMFIGE 482
             V+L+E  T KRP D  F GE
Sbjct:   886 VVLLELITGKRPNDSSF-GE 904

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2204350 CLV1 "AT1G75820" [Arabidopsis thaliana (taxid:3702)]

 Score = 621 (223.7 bits), Expect = 4.8e-60, P = 4.8e-60
 Identities = 173/554 (31%), Positives = 274/554 (49%)

Query:     3 ILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSG 62
             I+ L  N  SG LP T+   +  ++ + L+ N  +G IP +I N   L  L L  N F G
Sbjct:   437 IIELTDNFFSGELPVTMSGDV--LDQIYLSNNWFSGEIPPAIGNFPNLQTLFLDRNRFRG 494

Query:    63 HILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLVLTVLDVSRNQLSGDIPSTIGGR 122
             +I      L+HLS ++     I  TG  +   I  C  L  +D+SRN+++G+IP  I   
Sbjct:   495 NIPREIFELKHLSRINTSANNI--TGG-IPDSISRCSTLISVDLSRNRINGEIPKGINNV 551

Query:   123 VDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKLEGEIPVKGSFKNFSTE 182
              +L TL+++ NQ  G IP  +G++ SL +LDLS N+LSG++P       + G F  F+  
Sbjct:   552 KNLGTLNISGNQLTGSIPTGIGNMTSLTTLDLSFNDLSGRVP-------LGGQFLVFNET 604

Query:   183 SFFGNYALCGPPKLRVPPCKPDNSKRTKKVPLIVLKYXXXXXXXXXXXXXXXXMYIRCRN 242
             SF GN  LC P ++  P  +P  +       L                     + +  R 
Sbjct:   605 SFAGNTYLCLPHRVSCPT-RPGQTSDHNHTALF--SPSRIVITVIAAITGLILISVAIRQ 661

Query:   243 RNTKKSDHEDFLPLAIWRRTSYLDIQRATDEFNEC----NLLGTSSFGSVYKGTISDGTD 298
              N KK+       LA W+ T++  +   +++  EC    N++G    G VY+G++ +  D
Sbjct:   662 MNKKKNQKS----LA-WKLTAFQKLDFKSEDVLECLKEENIIGKGGAGIVYRGSMPNNVD 716

Query:   299 VAIK-VFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEK 357
             VAIK +      R+   F +E + L  +RHR+++++L   +N D   L+ E+MPNGSL +
Sbjct:   717 VAIKRLVGRGTGRSDHGFTAEIQTLGRIRHRHIVRLLGYVANKDTNLLLYEYMPNGSLGE 776

Query:   358 WLY-SHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSD 416
              L+ S    L    R  + ++    L YLH+  S + I+H D+K  NILLD +  AHV+D
Sbjct:   777 LLHGSKGGHLQWETRHRVAVEAAKGLCYLHHDCSPL-ILHRDVKSNNILLDSDFEAHVAD 835

Query:   417 FGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTD 476
             FG+ K L +G  S   +    + GY+APEY     V  K DVYS+GV+L+E    K+P  
Sbjct:   836 FGLAKFLVDGAASECMSSIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVG 895

Query:   477 EMFIGEMSLRRWVKESLPHGLTEVVDANLVR---EEQAFSAKMDCILSIMDFALDCCMES 533
             E   G + + RWV+ +    +T+  DA +V    + +     +  ++ +   A+ C  E 
Sbjct:   896 EFGEG-VDIVRWVRNT-EEEITQPSDAAIVVAIVDPRLTGYPLTSVIHVFKIAMMCVEEE 953

Query:   534 PDMRINMTDAAAKL 547
                R  M +    L
Sbjct:   954 AAARPTMREVVHML 967

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0005524 "ATP binding" evidence=ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0007172 "signal complex assembly" evidence=IDA

GO:0016021 "integral to membrane" evidence=TAS

GO:0030154 "cell differentiation" evidence=IMP

GO:0005515 "protein binding" evidence=IPI

GO:0033612 "receptor serine/threonine kinase binding" evidence=IPI

GO:0043621 "protein self-association" evidence=IDA

GO:0004702 "receptor signaling protein serine/threonine kinase activity" evidence=ISS

GO:0009934 "regulation of meristem structural organization" evidence=IMP

GO:0016020 "membrane" evidence=ISS

GO:0042802 "identical protein binding" evidence=IPI

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: GSVIVG00025215001 SubName- Full=Chromosome chr9 scaffold_33, whole genome shotgun sequence; (691 aa) (Vitis vinifera)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	593
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	7e-46
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-43
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-43
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	4e-41
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	4e-38
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-37
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-36
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	4e-36
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	7e-33
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	9e-30
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-27
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	4e-27
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	7e-27
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-26
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	7e-26
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	8e-26
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-25
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-25
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-25
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	4e-25
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	4e-25
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	9e-25
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-24
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-24
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	4e-24
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-23
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	3e-23
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	6e-23
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	3e-22
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	3e-22
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	4e-22
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	1e-21
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-21
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	3e-21
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	4e-21
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-20
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-20
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	1e-20
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-20
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	4e-20
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	1e-19
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	1e-19
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-19
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-19
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	5e-19
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	6e-19
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	7e-19
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	8e-19
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	8e-19
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-18
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-18
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	1e-18
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-18
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-18
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-18
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-18
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-18
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	4e-18
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	4e-18
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	6e-18
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	7e-18
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	7e-18
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	9e-18
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-17
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-17
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-17
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-17
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	3e-17
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	3e-17
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	4e-17
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	4e-17
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	5e-17
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	5e-17
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	5e-17
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	7e-17
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	9e-17
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-16
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-16
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-16
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	4e-16
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	7e-16
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	7e-16
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	8e-16
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	1e-15
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-15
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-15
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-15
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	2e-15
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-15
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	3e-15
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	5e-15
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	5e-15
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	5e-15
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	5e-15
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	5e-15
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	7e-15
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	9e-15
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-14
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	1e-14
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	3e-14
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	3e-14
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	3e-14
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-14
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	7e-14
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	7e-14
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	8e-14
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	9e-14
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	9e-14
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-13
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-13
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-13
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-13
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-13
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-13
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-13
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	3e-13
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	4e-13
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	8e-13
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	8e-13
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	8e-13
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-12
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-12
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	1e-12
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	1e-12
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	1e-12
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	1e-12
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-12
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-12
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	1e-12
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-12
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-12
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-12
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-12
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-12
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	3e-12
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	3e-12
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	4e-12
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	4e-12
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	4e-12
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	4e-12
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	5e-12
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	5e-12
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	7e-12
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	7e-12
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	8e-12
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	8e-12
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	9e-12
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	9e-12
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	9e-12
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-11
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-11
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-11
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-11
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	1e-11
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-11
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	1e-11
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-11
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-11
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	3e-11
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	3e-11
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	3e-11
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	3e-11
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	3e-11
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	3e-11
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	4e-11
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	5e-11
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	5e-11
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	7e-11
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	8e-11
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-10
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-10
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-10
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-10
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-10
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-10
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-10
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-10
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-10
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-10
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-10
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	3e-10
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	3e-10
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	3e-10
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	5e-10
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	5e-10
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	7e-10
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-09
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	1e-09
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	1e-09
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-09
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-09
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-09
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-09
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-09
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-09
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	3e-09
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	3e-09
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	3e-09
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	3e-09
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	5e-09
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	5e-09
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	6e-09
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	6e-09
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	6e-09
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	6e-09
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	7e-09
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	7e-09
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	7e-09
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	7e-09
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	7e-09
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	7e-09
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	8e-09
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	8e-09
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-08
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	1e-08
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-08
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	1e-08
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	1e-08
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-08
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	2e-08
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-08
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-08
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	2e-08
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	2e-08
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-08
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-08
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-08
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	3e-08
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	3e-08
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	3e-08
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	3e-08
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	4e-08
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	4e-08
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	5e-08
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	5e-08
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	5e-08
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	5e-08
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	6e-08
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	6e-08
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	7e-08
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	7e-08
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	9e-08
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	9e-08
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-07
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	1e-07
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	1e-07
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-07
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	2e-07
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-07
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	2e-07
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-07
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	3e-07
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	3e-07
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	3e-07
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	3e-07
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	3e-07
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	4e-07
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	4e-07
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	6e-07
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	6e-07
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	8e-07
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	8e-07
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	8e-07
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-06
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-06
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	1e-06
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	1e-06
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	1e-06
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-06
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-06
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-06
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-06
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	2e-06
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	3e-06
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	3e-06
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	4e-06
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	4e-06
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	4e-06
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	5e-06
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	6e-06
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	6e-06
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	6e-06
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	6e-06
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	9e-06
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	1e-05
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	1e-05
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	1e-05
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	1e-05
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	2e-05
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-05
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-05
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	2e-05
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	2e-05
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-05
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	3e-05
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	4e-05
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	4e-05
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	6e-05
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	7e-05
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	7e-05
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	7e-05
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	8e-05
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-04
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	2e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	2e-04
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	2e-04
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	4e-04
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	4e-04
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	0.001
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	0.001
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	0.002
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	0.004

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  160 bits (408), Expect = 7e-46
 Identities = 69/192 (35%), Positives = 99/192 (51%), Gaps = 10/192 (5%)

Query: 280 LGTSSFGSVYKGT-ISDGTDVAIKVFNLQLE-RAFRSFDSECEVLRNVRHRNLIKILSSY 337
           LG   FG+VY       G  VAIK+   +           E E+L+ + H N++K+   +
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 338 SNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHC 397
            + +   LV+E+   GSL+  L  +   L   E L I++ +   LEYLH    S  IIH 
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLH----SNGIIHR 116

Query: 398 DLKPTNILLDE-NMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGL-EGIVSAK 455
           DLKP NILLD  N    ++DFG+ KLL   +  ++    + T  YMAPE  L +G  S K
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT--IVGTPAYMAPEVLLGKGYYSEK 174

Query: 456 CDVYSYGVLLME 467
            D++S GV+L E
Sbjct: 175 SDIWSLGVILYE 186

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  155 bits (395), Expect = 2e-43
 Identities = 74/199 (37%), Positives = 102/199 (51%), Gaps = 11/199 (5%)

Query: 280 LGTSSFGSVYKGT-ISDGTDVAIKVFNLQLER--AFRSFDSECEVLRNVRHRNLIKILSS 336
           LG+ SFG+VYK      G  VA+K+   + E+    ++   E  +LR + H N+++++ +
Sbjct: 7   LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66

Query: 337 YSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIH 396
           + + D   LV+E+   G L  +L          E   I + +   LEYLH    S  IIH
Sbjct: 67  FEDKDHLYLVMEYCEGGDLFDYLSRGGPL-SEDEAKKIALQILRGLEYLH----SNGIIH 121

Query: 397 CDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGI-VSAK 455
            DLKP NILLDEN V  ++DFG+ K L     S   T    T  YMAPE  L G     K
Sbjct: 122 RDLKPENILLDENGVVKIADFGLAKKL-LKSSSSLTTFV-GTPWYMAPEVLLGGNGYGPK 179

Query: 456 CDVYSYGVLLMETFTRKRP 474
            DV+S GV+L E  T K P
Sbjct: 180 VDVWSLGVILYELLTGKPP 198

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  155 bits (394), Expect = 2e-43
 Identities = 69/199 (34%), Positives = 97/199 (48%), Gaps = 10/199 (5%)

Query: 278 NLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFR-SFDSECEVLRNVRHRNLIKILS 335
             LG  SFG VY       G  VAIKV   +  +  R     E ++L+ ++H N++++  
Sbjct: 5   EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64

Query: 336 SYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHII 395
            + + D   LV+E+   G L   L          E    +  + SALEYLH    S  I+
Sbjct: 65  VFEDEDKLYLVMEYCEGGDLFDLLKKRGRL-SEDEARFYLRQILSALEYLH----SKGIV 119

Query: 396 HCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAK 455
           H DLKP NILLDE+    ++DFG+ + L  GE   + T  + T  YMAPE  L       
Sbjct: 120 HRDLKPENILLDEDGHVKLADFGLARQLDPGE---KLTTFVGTPEYMAPEVLLGKGYGKA 176

Query: 456 CDVYSYGVLLMETFTRKRP 474
            D++S GV+L E  T K P
Sbjct: 177 VDIWSLGVILYELLTGKPP 195

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  159 bits (404), Expect = 4e-41
 Identities = 148/572 (25%), Positives = 238/572 (41%), Gaps = 74/572 (12%)

Query: 1   MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSF 60
           +R + L+ N  SG LPS     LP + +L ++ NNL G I +   +   L +L L  N F
Sbjct: 406 LRRVRLQDNSFSGELPSEF-TKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKF 464

Query: 61  SGHILNTFG--NLRHLSVLSLLMFGIRLTGNKLYGRIPPCLV----LTVLDVSRNQLSGD 114
            G + ++FG   L +L           L+ N+  G +P  L     L  L +S N+LSG+
Sbjct: 465 FGGLPDSFGSKRLENLD----------LSRNQFSGAVPRKLGSLSELMQLKLSENKLSGE 514

Query: 115 IPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPK--------- 165
           IP  +     L +L L+ NQ  G IP S   +  L  LDLS N LSG+IPK         
Sbjct: 515 IPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLV 574

Query: 166 --------LEGEIPVKGSFKNFSTESFFGNYALCGPPKLR-VPPCKPDNSKRTKKVPL-- 214
                   L G +P  G+F   +  +  GN  LCG      +PPC     KR +K P   
Sbjct: 575 QVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPC-----KRVRKTPSWW 629

Query: 215 IVLKYILPPIVSTVLVVITIIMYIRCRNRNTKKSDHEDFLPLAIW-------RRTSYLDI 267
             +   L   +   LV    +      N   K+ ++ED      W       + +  + I
Sbjct: 630 FYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENED----GTWELQFFDSKVSKSITI 685

Query: 268 QRATDEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVR 326
                   E N++     G+ YKG +I +G    +K  N  +     S  ++   +  ++
Sbjct: 686 NDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEIN-DVNSIPSSEIAD---MGKLQ 741

Query: 327 HRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH 386
           H N++K++    +     L+ E++   +L + L +    L    R  I I +  AL +LH
Sbjct: 742 HPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLH 797

Query: 387 NGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEY 446
               S  ++  +L P  I++D     H+        L         T    +  Y+APE 
Sbjct: 798 -CRCSPAVVVGNLSPEKIIIDGKDEPHL-------RLSLPGLLCTDTKCFISSAYVAPET 849

Query: 447 GLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPH-GLTEVVDANL 505
                ++ K D+Y +G++L+E  T K P D  F    S+  W +       L   +D ++
Sbjct: 850 RETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSI 909

Query: 506 VREEQAFSAKMDCILSIMDFALDCCMESPDMR 537
             +    S   + I+ +M+ AL C    P  R
Sbjct: 910 RGD---VSVNQNEIVEVMNLALHCTATDPTAR 938

Length = 968

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  140 bits (356), Expect = 4e-38
 Identities = 74/275 (26%), Positives = 124/275 (45%), Gaps = 30/275 (10%)

Query: 280 LGTSSFGSVYKGTI-----SDGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKI 333
           LG  +FG VYKGT+        T VA+K       E     F  E  +++ + H N++++
Sbjct: 7   LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66

Query: 334 LSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVH 393
           L   +  +   +V E+MP G L  +L  H   L + + L + + +   +EYL     S +
Sbjct: 67  LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE----SKN 122

Query: 394 IIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVS 453
            +H DL   N L+ EN+V  +SDFG+ + + E +   ++      I +MAPE   +G  +
Sbjct: 123 FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFT 182

Query: 454 AKCDVYSYGVLLMETFTR-KRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQAF 512
           +K DV+S+GVLL E FT  ++P   M                    EV+   L+ +    
Sbjct: 183 SKSDVWSFGVLLWEIFTLGEQPYPGM-----------------SNEEVL--ELLEDGYRL 223

Query: 513 SAKMDCILSIMDFALDCCMESPDMRINMTDAAAKL 547
               +C   + +  L C    P+ R   ++    L
Sbjct: 224 PRPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  139 bits (352), Expect = 2e-37
 Identities = 77/275 (28%), Positives = 124/275 (45%), Gaps = 31/275 (11%)

Query: 280 LGTSSFGSVYKGTISD-----GTDVAIKVFNL-QLERAFRSFDSECEVLRNVRHRNLIKI 333
           LG  +FG VYKG +         +VA+K       E+    F  E  ++R + H N++K+
Sbjct: 7   LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66

Query: 334 LSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVH 393
           L   +  +   +V+E+M  G L  +L  +   L + + L+  + +   +EYL     S +
Sbjct: 67  LGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE----SKN 122

Query: 394 IIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVS 453
            IH DL   N L+ EN+V  +SDFG+ + L +  D  R+      I +MAPE   EG  +
Sbjct: 123 FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD-DYYRKRGGKLPIRWMAPESLKEGKFT 181

Query: 454 AKCDVYSYGVLLMETFTR-KRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQAF 512
           +K DV+S+GVLL E FT  ++P   M                    EV+    ++     
Sbjct: 182 SKSDVWSFGVLLWEIFTLGEQPYPGM-----------------SNEEVL--EYLKNGYRL 222

Query: 513 SAKMDCILSIMDFALDCCMESPDMRINMTDAAAKL 547
               +C   + D  L C  E P+ R   ++    L
Sbjct: 223 PQPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  136 bits (344), Expect = 2e-36
 Identities = 77/276 (27%), Positives = 124/276 (44%), Gaps = 32/276 (11%)

Query: 280 LGTSSFGSVYKGTISDG-----TDVAIKVFNL-QLERAFRSFDSECEVLRNVRHRNLIKI 333
           LG  +FG VYKGT+         +VA+K       E+    F  E  ++R + H N++K+
Sbjct: 7   LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66

Query: 334 LSSYSNPDFKALVLEFMPNGSLEKWL-YSHNYFLDILERLNIMIDVGSALEYLHNGHSSV 392
           L   +  +   +V+E+MP G L  +L  +    L + + L+  + +   +EYL     S 
Sbjct: 67  LGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE----SK 122

Query: 393 HIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIV 452
           + IH DL   N L+ EN+V  +SDFG+ + L +  D  +       I +MAPE   EG  
Sbjct: 123 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD-DYYKVKGGKLPIRWMAPESLKEGKF 181

Query: 453 SAKCDVYSYGVLLMETFTR-KRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQA 511
           ++K DV+S+GVLL E FT  + P   M                    EV+    +++   
Sbjct: 182 TSKSDVWSFGVLLWEIFTLGEEPYPGM-----------------SNAEVL--EYLKKGYR 222

Query: 512 FSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKL 547
                +C   +    L C  E P+ R   ++    L
Sbjct: 223 LPKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  135 bits (342), Expect = 4e-36
 Identities = 65/209 (31%), Positives = 103/209 (49%), Gaps = 21/209 (10%)

Query: 278 NLLGTSSFGSVYKGTISDG----TDVAIKVFNLQLERAFRS-FDSECEVLRNVRHRNLIK 332
             LG  +FG VYKG +       T+VA+K          R  F  E  V++ + H N+++
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 333 IL--SSYSNPDFKALVLEFMPNGSLEKWLYSH--------NYFLDILERLNIMIDVGSAL 382
           +L   +   P +  LVLE+M  G L  +L              L + + L+  I +   +
Sbjct: 61  LLGVCTEEEPLY--LVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118

Query: 383 EYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYM 442
           EYL     S   +H DL   N L+ E++V  +SDFG+ + + + +   ++T     I +M
Sbjct: 119 EYLA----SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWM 174

Query: 443 APEYGLEGIVSAKCDVYSYGVLLMETFTR 471
           APE   +GI ++K DV+S+GVLL E FT 
Sbjct: 175 APESLKDGIFTSKSDVWSFGVLLWEIFTL 203

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  126 bits (319), Expect = 7e-33
 Identities = 64/211 (30%), Positives = 91/211 (43%), Gaps = 28/211 (13%)

Query: 278 NLLGTSSFGSVYKGTISD-GTDVAIKVFNLQ--LERAFRSFDSECEVLRNVRHRNLIKIL 334
            LLG  SFGSVY     D G  +A+K   L    E    + + E  +L +++H N+++  
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 335 SSYSNPDFKAL--VLEFMPNGSLEKWLYS---------HNYFLDILERLNIMIDVGSALE 383
            S  + +   L   LE++  GSL   L             Y   ILE           L 
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILE----------GLA 115

Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           YLH    S  I+H D+K  NIL+D + V  ++DFG  K LG+ E          T  +MA
Sbjct: 116 YLH----SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMA 171

Query: 444 PEYGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
           PE           D++S G  ++E  T K P
Sbjct: 172 PEVIRGEEYGRAADIWSLGCTVIEMATGKPP 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  117 bits (296), Expect = 9e-30
 Identities = 64/196 (32%), Positives = 95/196 (48%), Gaps = 8/196 (4%)

Query: 280 LGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYS 338
           +G   FG VYK      G +VAIKV  L+ +       +E ++L+  +H N++K   SY 
Sbjct: 8   IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67

Query: 339 NPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCD 398
             D   +V+EF   GSL+  L S N  L   +   +  ++   LEYLH+      IIH D
Sbjct: 68  KKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS----NGIIHRD 123

Query: 399 LKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDV 458
           +K  NILL  +    + DFG+   L + +   R TM + T  +MAPE         K D+
Sbjct: 124 IKAANILLTSDGEVKLIDFGLSAQLSDTKA--RNTM-VGTPYWMAPEVINGKPYDYKADI 180

Query: 459 YSYGVLLMETFTRKRP 474
           +S G+  +E    K P
Sbjct: 181 WSLGITAIELAEGKPP 196

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  117 bits (294), Expect = 3e-27
 Identities = 69/169 (40%), Positives = 96/169 (56%), Gaps = 12/169 (7%)

Query: 1   MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSF 60
           +  LTL  NQL G++P  +G  + +++++ L  NNL+G IP  I   T L  LDL +N+ 
Sbjct: 190 LEFLTLASNQLVGQIPRELGQ-MKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNL 248

Query: 61  SGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLV----LTVLDVSRNQLSGDIP 116
           +G I ++ GNL++L  L L         NKL G IPP +     L  LD+S N LSG+IP
Sbjct: 249 TGPIPSSLGNLKNLQYLFLYQ-------NKLSGPIPPSIFSLQKLISLDLSDNSLSGEIP 301

Query: 117 STIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPK 165
             +    +LE L L SN F G IP ++ SL  L+ L L  N  SG+IPK
Sbjct: 302 ELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPK 350

Length = 968

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  113 bits (282), Expect = 4e-27
 Identities = 78/285 (27%), Positives = 117/285 (41%), Gaps = 27/285 (9%)

Query: 273 EFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLER---AFRSFDSECEVLRNVRH-R 328
            +     LG  SFG VY     D   VA+KV   +LE        F  E ++L ++ H  
Sbjct: 1   SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 329 NLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLN--IMIDVGSALEYLH 386
           N++K+   + +     LV+E++  GSLE  L        + E     I+  + SALEYLH
Sbjct: 59  NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118

Query: 387 NGHSSVHIIHCDLKPTNILLDEN-MVAHVSDFGIYKLLGEGEDSVRQTMTMA----TIGY 441
               S  IIH D+KP NILLD +  V  + DFG+ KLL +   +       +    T GY
Sbjct: 119 ----SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174

Query: 442 MAPEY---GLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLT 498
           MAPE          S+  D++S G+ L E  T   P +       S      + +    T
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFE--GEKNSSATSQTLKIILELPT 232

Query: 499 EVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDA 543
             + + L       S       +  D       + P  R++ +  
Sbjct: 233 PSLASPLSP-----SNPELISKAASDLLKKLLAKDPKNRLSSSSD 272

Length = 384

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  109 bits (274), Expect = 7e-27
 Identities = 63/205 (30%), Positives = 100/205 (48%), Gaps = 7/205 (3%)

Query: 268 QRATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRH 327
           +R  +EF     LG+  FG V++G   +   VAIK+         + F  E + L+ +RH
Sbjct: 2   ERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRH 61

Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYS-HNYFLDILERLNIMIDVGSALEYLH 386
           ++LI + +  S  +   ++ E M  GSL  +L S     L +   +++   V   + YL 
Sbjct: 62  KHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE 121

Query: 387 NGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEY 446
                 + IH DL   NIL+ E++V  V+DFG+ +L+   ED    +       + APE 
Sbjct: 122 ----EQNSIHRDLAARNILVGEDLVCKVADFGLARLI--KEDVYLSSDKKIPYKWTAPEA 175

Query: 447 GLEGIVSAKCDVYSYGVLLMETFTR 471
              G  S K DV+S+G+LL E FT 
Sbjct: 176 ASHGTFSTKSDVWSFGILLYEMFTY 200

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  114 bits (287), Expect = 2e-26
 Identities = 84/226 (37%), Positives = 113/226 (50%), Gaps = 37/226 (16%)

Query: 1   MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSF 60
           +R L L  N  +G +P     S+PN+E L L+ N L+G IPN I + + L VLDLG N  
Sbjct: 120 LRYLNLSNNNFTGSIP---RGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVL 176

Query: 61  SGHILNTFGNLRHLSVLSLL---MFG--------------IRLTGNKLYGRIPPCL---- 99
            G I N+  NL  L  L+L    + G              I L  N L G IP  +    
Sbjct: 177 VGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLT 236

Query: 100 VLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNL 159
            L  LD+  N L+G IPS++G   +L+ L L  N+  GPIP S+ SL  L SLDLS N+L
Sbjct: 237 SLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSL 296

Query: 160 SGKIPKLEGEIPVKGSFKNFSTESFFGNY-------ALCGPPKLRV 198
           SG+IP+L  ++      +N      F N        AL   P+L+V
Sbjct: 297 SGEIPELVIQL------QNLEILHLFSNNFTGKIPVALTSLPRLQV 336

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  112 bits (282), Expect = 7e-26
 Identities = 76/207 (36%), Positives = 106/207 (51%), Gaps = 27/207 (13%)

Query: 4   LTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGH 63
           L L  N L+G +PS++G +L N++YL L  N L+G IP SI +  KLI LDL  NS SG 
Sbjct: 241 LDLVYNNLTGPIPSSLG-NLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGE 299

Query: 64  ILNTFGNLRHLSVLSLLMFGIRLTG-------------------NKLYGRIPPCL----V 100
           I      L++L +L L  F    TG                   NK  G IP  L     
Sbjct: 300 IPELVIQLQNLEILHL--FSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNN 357

Query: 101 LTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLS 160
           LTVLD+S N L+G+IP  +    +L  L L SN  +G IP+S+G+  SL  + L  N+ S
Sbjct: 358 LTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFS 417

Query: 161 GKIPKLEGEIPVKGSFKNFSTESFFGN 187
           G++P    ++P+   F + S  +  G 
Sbjct: 418 GELPSEFTKLPLV-YFLDISNNNLQGR 443

Length = 968

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  106 bits (267), Expect = 8e-26
 Identities = 62/218 (28%), Positives = 96/218 (44%), Gaps = 42/218 (19%)

Query: 278 NLLGTSSFGSVYKGT-ISDGTDVAIKVFNL------QLERAFRSFDSECEVLRNVRHRNL 330
             +G  SFG VY     SDG    +K  +L      + E A      E ++L+ + H N+
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALN----EVKILKKLNHPNI 61

Query: 331 IKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDIL---ERLNIMIDVGSALEYLHN 387
           IK   S+       +V+E+   G L + +             + L+  + +  AL+YLH 
Sbjct: 62  IKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH- 120

Query: 388 GHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMAT--IG---YM 442
              S  I+H D+KP NI L  N +  + DFGI K+L         T+ +A   +G   Y+
Sbjct: 121 ---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS-------TVDLAKTVVGTPYYL 170

Query: 443 APE------YGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
           +PE      Y      + K D++S G +L E  T K P
Sbjct: 171 SPELCQNKPY------NYKSDIWSLGCVLYELCTLKHP 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  106 bits (266), Expect = 1e-25
 Identities = 63/205 (30%), Positives = 98/205 (47%), Gaps = 24/205 (11%)

Query: 280 LGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRS-FDSECEVLRNVRHRNLIKILSSY 337
           LG  S G VYK      G   A+K  ++  +  FR     E + LR+     ++K   ++
Sbjct: 9   LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68

Query: 338 SNPDFKALVLEFMPNGSLEKWLYSHNYFLD-ILERLNIMIDVGSALEYLHNGHSSVHIIH 396
                 ++VLE+M  GSL   L       + +L  +   I  G  L+YLH      HIIH
Sbjct: 69  YKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKG--LDYLHTKR---HIIH 123

Query: 397 CDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMT-MATIGYMAPE------YGLE 449
            D+KP+N+L++      ++DFGI K+L   E+++ Q  T + T+ YM+PE      Y   
Sbjct: 124 RDIKPSNLLINSKGEVKIADFGISKVL---ENTLDQCNTFVGTVTYMSPERIQGESY--- 177

Query: 450 GIVSAKCDVYSYGVLLMETFTRKRP 474
              S   D++S G+ L+E    K P
Sbjct: 178 ---SYAADIWSLGLTLLECALGKFP 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  104 bits (263), Expect = 2e-25
 Identities = 66/210 (31%), Positives = 94/210 (44%), Gaps = 18/210 (8%)

Query: 280 LGTSSFGSVYKGTI-SDGTDVAIKVFNLQLERAFRSFD---SECEVLRNVRHRNLIKILS 335
           LG  SFG V        G   A+KV   +     +  +   +E  +L  + H  ++K+  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60

Query: 336 SYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHII 395
           ++   +   LVLE+ P G L   L     F +   R     ++  ALEYLH    S+ II
Sbjct: 61  AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARF-YAAEIVLALEYLH----SLGII 115

Query: 396 HCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMA-TIGYMAPEYGLEGIVSA 454
           + DLKP NILLD +    ++DFG+ K L        +T T   T  Y+APE  L      
Sbjct: 116 YRDLKPENILLDADGHIKLTDFGLAKELSSEGS---RTNTFCGTPEYLAPEVLLGKGYGK 172

Query: 455 KCDVYSYGVLLMETFTRKRP-----TDEMF 479
             D +S GVLL E  T K P       E++
Sbjct: 173 AVDWWSLGVLLYEMLTGKPPFYAEDRKEIY 202

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  105 bits (264), Expect = 2e-25
 Identities = 79/300 (26%), Positives = 122/300 (40%), Gaps = 62/300 (20%)

Query: 280 LGTSSFGSVYKGTIS------DGTDVAIKVF-NLQLERAFRSFDSECEVLRNVRHRNLIK 332
           LG  +FG V+ G         D   VA+K         A + F+ E E+L N +H N++K
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDIL-------------ERLNIMIDVG 379
                +  D   +V E+M +G L K+L SH      L             + L I + + 
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132

Query: 380 SALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGI---------YKLLGEGEDSV 430
           S + YL    +S H +H DL   N L+  ++V  + DFG+         Y++ G      
Sbjct: 133 SGMVYL----ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGH----- 183

Query: 431 RQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTR-KRPTDEMFIGEMSLRRWV 489
               TM  I +M PE  +    + + DV+S+GV+L E FT  K+P             W 
Sbjct: 184 ----TMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP-------------WY 226

Query: 490 KESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKK 549
             S    + E +    + +         C   + D  L C    P  RIN+ D   +L+K
Sbjct: 227 GLS-NEEVIECITQGRLLQRPR-----TCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  110 bits (276), Expect = 4e-25
 Identities = 69/169 (40%), Positives = 87/169 (51%), Gaps = 15/169 (8%)

Query: 1   MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPN-SITNATKLIVLDLGFNS 59
           ++ + L  NQLSG +P  I  +  ++ YL L+ NN TG+IP  SI N   L  LDL  N 
Sbjct: 95  IQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPN---LETLDLSNNM 151

Query: 60  FSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLV----LTVLDVSRNQLSGDI 115
            SG I N  G+   L VL        L GN L G+IP  L     L  L ++ NQL G I
Sbjct: 152 LSGEIPNDIGSFSSLKVLD-------LGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQI 204

Query: 116 PSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIP 164
           P  +G    L+ + L  N   G IP  +G L SL  LDL  NNL+G IP
Sbjct: 205 PRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIP 253

Length = 968

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  104 bits (262), Expect = 4e-25
 Identities = 61/198 (30%), Positives = 102/198 (51%), Gaps = 13/198 (6%)

Query: 280 LGTSSFGSVYKGTISDGTDVAIKVF---NLQLERAFRSFDSECEVLRNVRHRNLIKILSS 336
           LG   FG V+ GT +  T VA+K      +  E    +F  E ++++ +RH  L+++ + 
Sbjct: 14  LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPE----AFLQEAQIMKKLRHDKLVQLYAV 69

Query: 337 YSNPDFKALVLEFMPNGSLEKWLYS-HNYFLDILERLNIMIDVGSALEYLHNGHSSVHII 395
            S  +   +V E+M  GSL  +L S     L + + +++   +   + YL     S + I
Sbjct: 70  CSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE----SRNYI 125

Query: 396 HCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAK 455
           H DL   NIL+ EN+V  ++DFG+ +L+ + E + R+      I + APE    G  + K
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFP-IKWTAPEAANYGRFTIK 184

Query: 456 CDVYSYGVLLMETFTRKR 473
            DV+S+G+LL E  T  R
Sbjct: 185 SDVWSFGILLTEIVTYGR 202

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  103 bits (258), Expect = 9e-25
 Identities = 63/193 (32%), Positives = 99/193 (51%), Gaps = 5/193 (2%)

Query: 279 LLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFR-SFDSECEVLRNVRHRNLIKILSSY 337
            +G  +FG VYKG +   T+VA+K     L    +  F  E E+L+   H N++K++   
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61

Query: 338 SNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHC 397
                  +V+E +P GSL  +L      L + + L + +D  + +EYL     S + IH 
Sbjct: 62  VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE----SKNCIHR 117

Query: 398 DLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCD 457
           DL   N L+ EN V  +SDFG+ +    G  +V   +    I + APE    G  +++ D
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESD 177

Query: 458 VYSYGVLLMETFT 470
           V+SYG+LL ETF+
Sbjct: 178 VWSYGILLWETFS 190

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  102 bits (257), Expect = 1e-24
 Identities = 65/198 (32%), Positives = 99/198 (50%), Gaps = 16/198 (8%)

Query: 279 LLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKIL--SS 336
            +G   FG V  G    G  VA+K        A ++F +E  V+  +RH NL+++L    
Sbjct: 13  TIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAA-QAFLAEASVMTTLRHPNLVQLLGVVL 70

Query: 337 YSNPDFKALVLEFMPNGSLEKWLYSH-NYFLDILERLNIMIDVGSALEYLHNGHSSVHII 395
             NP +  +V E+M  GSL  +L S     + + ++L   +DV   +EYL       + +
Sbjct: 71  QGNPLY--IVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE----EKNFV 124

Query: 396 HCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAK 455
           H DL   N+L+ E++VA VSDFG+ K     E S  Q      + + APE   E   S K
Sbjct: 125 HRDLAARNVLVSEDLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAPEALREKKFSTK 179

Query: 456 CDVYSYGVLLMETFTRKR 473
            DV+S+G+LL E ++  R
Sbjct: 180 SDVWSFGILLWEIYSFGR 197

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  102 bits (257), Expect = 2e-24
 Identities = 64/203 (31%), Positives = 99/203 (48%), Gaps = 16/203 (7%)

Query: 278 NLLGTSSFGSVYKG-TISDGTDVAIKVFNLQ--LERAFRSFDSECEVLRNVRHRNLIKIL 334
           +L+G  +FG VYKG  +  G  VAIK  +L+   E A +S   E ++L+N++H N++K +
Sbjct: 6   DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65

Query: 335 SSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNI--MIDVGSALEYLHN-GHSS 391
            S    D   ++LE+  NGSL + +     F    E L    +  V   L YLH  G   
Sbjct: 66  GSIETSDSLYIILEYAENGSLRQIIKKFGPF---PESLVAVYVYQVLQGLAYLHEQG--- 119

Query: 392 VHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGI 451
             +IH D+K  NIL  ++ V  ++DFG+   L +          + T  +MAPE      
Sbjct: 120 --VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGTPYWMAPEVIEMSG 175

Query: 452 VSAKCDVYSYGVLLMETFTRKRP 474
            S   D++S G  ++E  T   P
Sbjct: 176 ASTASDIWSLGCTVIELLTGNPP 198

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score =  101 bits (252), Expect = 4e-24
 Identities = 70/219 (31%), Positives = 114/219 (52%), Gaps = 21/219 (9%)

Query: 280 LGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSN 339
           +G   FG+V +G  + G  VA+K  N++ +   ++F  E  V+  + H+NL+++L    +
Sbjct: 14  IGEGEFGAVLQGEYT-GQKVAVK--NIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILH 70

Query: 340 PDFKALVLEFMPNGSLEKWLYSHNYFL-DILERLNIMIDVGSALEYLHNGHSSVHIIHCD 398
                +V+E M  G+L  +L +    L  +++ L   +DV   +EYL     S  ++H D
Sbjct: 71  NGLY-IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE----SKKLVHRD 125

Query: 399 LKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDV 458
           L   NIL+ E+ VA VSDFG+ ++   G D+     +   + + APE       S+K DV
Sbjct: 126 LAARNILVSEDGVAKVSDFGLARVGSMGVDN-----SKLPVKWTAPEALKHKKFSSKSDV 180

Query: 459 YSYGVLLMETFTRKR-PTDEMFIGEMSLRRWVKESLPHG 496
           +SYGVLL E F+  R P  +M + E      VKE +  G
Sbjct: 181 WSYGVLLWEVFSYGRAPYPKMSLKE------VKECVEKG 213

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 99.8 bits (249), Expect = 2e-23
 Identities = 60/211 (28%), Positives = 98/211 (46%), Gaps = 12/211 (5%)

Query: 273 EFNECNLLGTSSFGSVYKGT-ISDG----TDVAIKVFNLQLER-AFRSFDSECEVLRNVR 326
           E  +  +LG+ +FG+VYKG  I +G      VAIKV   +    A +    E  V+ +V 
Sbjct: 8   ELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVD 67

Query: 327 HRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH 386
           H +++++L    +     L+ + MP G L  ++ +H   +     LN  + +   + YL 
Sbjct: 68  HPHVVRLLGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYL- 125

Query: 387 NGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEY 446
                  ++H DL   N+L+       ++DFG+ KLL   E           I +MA E 
Sbjct: 126 ---EEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALES 182

Query: 447 GLEGIVSAKCDVYSYGVLLMETFT-RKRPTD 476
            L  I + K DV+SYGV + E  T   +P +
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWELMTFGAKPYE 213

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 99.0 bits (246), Expect = 3e-23
 Identities = 63/196 (32%), Positives = 106/196 (54%), Gaps = 10/196 (5%)

Query: 280 LGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSN 339
           LG   FG V+ GT +  T VAIK        +  +F  E +V++ +RH  L+++ +  S 
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 72

Query: 340 -PDFKALVLEFMPNGSLEKWLY-SHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHC 397
            P +  +V E+M  GSL  +L      +L + + +++   + S + Y+      ++ +H 
Sbjct: 73  EPIY--IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER----MNYVHR 126

Query: 398 DLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCD 457
           DL+  NIL+ EN+V  V+DFG+ +L+ + E + RQ      I + APE  L G  + K D
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSD 185

Query: 458 VYSYGVLLMETFTRKR 473
           V+S+G+LL E  T+ R
Sbjct: 186 VWSFGILLTELTTKGR 201

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 98.6 bits (246), Expect = 6e-23
 Identities = 64/207 (30%), Positives = 100/207 (48%), Gaps = 13/207 (6%)

Query: 278 NLLGTSSFGSVYKGT---ISDGT--DVAIKVFNLQLERAFRS-FDSECEVLRNVRHRNLI 331
             LG   FG V       + D T   VA+K  N   E   RS F+ E E+LR + H N++
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 332 KILSSYSNPDFKA--LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGH 389
           K       P  ++  L++E++P+GSL  +L  H   +++   L     +   ++YL +  
Sbjct: 70  KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS-- 127

Query: 390 SSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVR-QTMTMATIGYMAPEYGL 448
                IH DL   NIL++   +  +SDFG+ K+L E +D    +    + I + APE   
Sbjct: 128 --QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLR 185

Query: 449 EGIVSAKCDVYSYGVLLMETFTRKRPT 475
               S+  DV+S+GV L E FT   P+
Sbjct: 186 TSKFSSASDVWSFGVTLYELFTYGDPS 212

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 96.4 bits (240), Expect = 3e-22
 Identities = 72/299 (24%), Positives = 127/299 (42%), Gaps = 60/299 (20%)

Query: 280 LGTSSFGSVYKGTI------SDGTDVAIKVFNLQLERAFRS-FDSECEVLRNVRHRNLIK 332
           LG  +FG VYKG +         T VAIK      E   +  F  E E++ +++H N++ 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWLYSHN---------------YFLDILERLNIMID 377
           +L   +      ++ E++ +G L ++L  ++                 LD  + L+I I 
Sbjct: 73  LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132

Query: 378 VGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMA 437
           + + +EYL    SS H +H DL   N L+ E +   +SDFG+ + +   +    Q+ ++ 
Sbjct: 133 IAAGMEYL----SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLL 188

Query: 438 TIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGL 497
            + +M PE  L G  + + D++S+GV+L E F+                        +GL
Sbjct: 189 PVRWMPPEAILYGKFTTESDIWSFGVVLWEIFS------------------------YGL 224

Query: 498 --------TEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLK 548
                    EV+   ++R  Q      DC   +    ++C  E P  R    D   +L+
Sbjct: 225 QPYYGFSNQEVI--EMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLR 281

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 95.8 bits (238), Expect = 3e-22
 Identities = 63/193 (32%), Positives = 98/193 (50%), Gaps = 6/193 (3%)

Query: 279 LLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFR-SFDSECEVLRNVRHRNLIKILSSY 337
           LLG  +FG V+KGT+ D T VA+K     L +  +  F SE  +L+   H N++K++   
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61

Query: 338 SNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHC 397
           +      +V+E +P G    +L      L   + +   +D  + + YL     S + IH 
Sbjct: 62  TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLE----SKNCIHR 117

Query: 398 DLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCD 457
           DL   N L+ EN V  +SDFG+ +   +G  S    +    I + APE    G  S++ D
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLKQIPIKWTAPEALNYGRYSSESD 176

Query: 458 VYSYGVLLMETFT 470
           V+SYG+LL ETF+
Sbjct: 177 VWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 96.5 bits (241), Expect = 4e-22
 Identities = 63/226 (27%), Positives = 97/226 (42%), Gaps = 28/226 (12%)

Query: 272 DEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFN---LQLERAFRSFDSECEVL-RNVR 326
           D+F    ++G  SF +V          + AIK+ +   L  E+  +    E EVL R   
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60

Query: 327 HRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH 386
           H  +IK+  ++ + +    VLE+ PNG L +++      LD         ++  ALEYLH
Sbjct: 61  HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYI-RKYGSLDEKCTRFYAAEILLALEYLH 119

Query: 387 NGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIG------ 440
               S  IIH DLKP NILLD++M   ++DFG  K+L               I       
Sbjct: 120 ----SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKN 175

Query: 441 ------------YMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
                       Y++PE   E       D+++ G ++ +  T K P
Sbjct: 176 RRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 94.3 bits (235), Expect = 1e-21
 Identities = 62/211 (29%), Positives = 97/211 (45%), Gaps = 17/211 (8%)

Query: 278 NLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLER--AFRSFDSECEVLRNVRHRNLIKIL 334
           N +G  +FG VY    +  G  +A+K   +Q       +    E +VL  ++H NL+K  
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65

Query: 335 SSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLD--ILERLNIMIDVGSALEYLHNGHSSV 392
               + +   + +E+   G+LE+ L  H   LD  ++    + +  G  L YLH    S 
Sbjct: 66  GVEVHREKVYIFMEYCSGGTLEELL-EHGRILDEHVIRVYTLQLLEG--LAYLH----SH 118

Query: 393 HIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTM--TMATIGYMAPEYGLEG 450
            I+H D+KP NI LD N V  + DFG    L     ++ + +     T  YMAPE    G
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGG 178

Query: 451 IVSAK---CDVYSYGVLLMETFTRKRPTDEM 478
                    D++S G +++E  T KRP  E+
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKRPWSEL 209

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 94.5 bits (235), Expect = 2e-21
 Identities = 61/211 (28%), Positives = 104/211 (49%), Gaps = 23/211 (10%)

Query: 279 LLGTSSFGSVYKGTIS--DGTDVAIKVFNLQLE----RAFRSFDSECEVLRNVRHRNLIK 332
           +LG   FGSV +G +S  DG+ + + V  ++L+         F SE   +++  H N++K
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65

Query: 333 IL------SSYSNPDFKALVLEFMPNGSLEKWLYSHN-----YFLDILERLNIMIDVGSA 381
           ++      SS        ++L FM +G L  +L           L +   L  M+D+   
Sbjct: 66  LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125

Query: 382 LEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQT-MTMATIG 440
           +EYL    S+ + IH DL   N +L E+M   V+DFG+ K +  G D  RQ  +    + 
Sbjct: 126 MEYL----SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSG-DYYRQGRIAKMPVK 180

Query: 441 YMAPEYGLEGIVSAKCDVYSYGVLLMETFTR 471
           ++A E   + + ++K DV+++GV + E  TR
Sbjct: 181 WIAIESLADRVYTSKSDVWAFGVTMWEIATR 211

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 93.2 bits (231), Expect = 3e-21
 Identities = 60/195 (30%), Positives = 102/195 (52%), Gaps = 8/195 (4%)

Query: 280 LGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSN 339
           LG   FG V+ GT +  T VAIK           +F  E ++++ +RH  L+ + +  S 
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMP-EAFLQEAQIMKKLRHDKLVPLYAVVSE 72

Query: 340 PDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCD 398
                +V EFM  GSL  +L   +  +L + + +++   +   + Y+      ++ IH D
Sbjct: 73  EPI-YIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER----MNYIHRD 127

Query: 399 LKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDV 458
           L+  NIL+ +N+V  ++DFG+ +L+ + E + RQ      I + APE  L G  + K DV
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSDV 186

Query: 459 YSYGVLLMETFTRKR 473
           +S+G+LL E  T+ R
Sbjct: 187 WSFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 93.1 bits (231), Expect = 4e-21
 Identities = 73/261 (27%), Positives = 122/261 (46%), Gaps = 30/261 (11%)

Query: 280 LGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSN 339
           LG   FG V+ GT +  T VA+K        +  SF  E ++++ +RH  L+++ +  S 
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKTLKPG-TMSPESFLEEAQIMKKLRHDKLVQLYAVVSE 72

Query: 340 -PDFKALVLEFMPNGSLEKWLYS-HNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHC 397
            P +  +V E+M  GSL  +L       L +   +++   V + + Y+      ++ IH 
Sbjct: 73  EPIY--IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER----MNYIHR 126

Query: 398 DLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCD 457
           DL+  NIL+ + +V  ++DFG+ +L+ + E + RQ      I + APE  L G  + K D
Sbjct: 127 DLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSD 185

Query: 458 VYSYGVLLMETFTRKR-PTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKM 516
           V+S+G+LL E  T+ R P   M        R V E +  G                    
Sbjct: 186 VWSFGILLTELVTKGRVPYPGMN------NREVLEQVERGYR-------------MPCPQ 226

Query: 517 DCILSIMDFALDCCMESPDMR 537
           DC +S+ +  L C  + P+ R
Sbjct: 227 DCPISLHELMLQCWKKDPEER 247

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 96.1 bits (239), Expect = 1e-20
 Identities = 66/188 (35%), Positives = 91/188 (48%), Gaps = 13/188 (6%)

Query: 4   LTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGH 63
           L L  N LSG +P  +   L N+E L L +NN TG IP ++T+  +L VL L  N FSG 
Sbjct: 289 LDLSDNSLSGEIPELVIQ-LQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGE 347

Query: 64  ILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLV----LTVLDVSRNQLSGDIPSTI 119
           I    G   +L+VL L       + N L G IP  L     L  L +  N L G+IP ++
Sbjct: 348 IPKNLGKHNNLTVLDL-------STNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSL 400

Query: 120 GGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKLEGEIPVKGSFKNF 179
           G    L  + L  N F G +P     L  +  LD+S NNL G+I   + ++P      + 
Sbjct: 401 GACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMP-SLQMLSL 459

Query: 180 STESFFGN 187
           +   FFG 
Sbjct: 460 ARNKFFGG 467

Length = 968

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 92.2 bits (229), Expect = 1e-20
 Identities = 69/220 (31%), Positives = 114/220 (51%), Gaps = 21/220 (9%)

Query: 279 LLGTSSFGSVYKG-TISDGTDVAIKVFNLQLERAFR----------SFDSECEVLRNVRH 327
           L+G  ++G VY    ++ G  +A+K   L    A R          +  SE E L+++ H
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
            N+++ L   +  ++ ++ LE++P GS+   L ++  F + L R      V   L YLH 
Sbjct: 68  LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVR-FFTEQVLEGLAYLH- 125

Query: 388 GHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTM-ATIGYMAPE- 445
              S  I+H DLK  N+L+D + +  +SDFGI K   +  D+  Q M+M  ++ +MAPE 
Sbjct: 126 ---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDND-QNMSMQGSVFWMAPEV 181

Query: 446 -YGLEGIVSAKCDVYSYGVLLMETFTRKRP-TDEMFIGEM 483
            +      SAK D++S G +++E F  +RP +DE  I  M
Sbjct: 182 IHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAM 221

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 91.9 bits (229), Expect = 1e-20
 Identities = 55/195 (28%), Positives = 98/195 (50%), Gaps = 20/195 (10%)

Query: 280 LGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYS 338
           +G  + G VYK T  + G +VAIK   L+ +      + E  ++++ +H N++    SY 
Sbjct: 27  IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIIN-EILIMKDCKHPNIVDYYDSYL 85

Query: 339 NPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCD 398
             D   +V+E+M  GSL   +  +   ++  +   +  +V   LEYLH+ +    +IH D
Sbjct: 86  VGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN----VIHRD 141

Query: 399 LKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPE------YGLEGIV 452
           +K  NILL ++    ++DFG    L + +   R ++ + T  +MAPE      YG     
Sbjct: 142 IKSDNILLSKDGSVKLADFGFAAQLTKEKSK-RNSV-VGTPYWMAPEVIKRKDYG----- 194

Query: 453 SAKCDVYSYGVLLME 467
             K D++S G++ +E
Sbjct: 195 -PKVDIWSLGIMCIE 208

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 91.1 bits (226), Expect = 2e-20
 Identities = 68/211 (32%), Positives = 105/211 (49%), Gaps = 21/211 (9%)

Query: 279 LLGTSSFGSVYKG-TISDGTDVAIKVFNL-----QLERAFRS----FDSECEVLRNVRHR 328
           L+G+ SFGSVY G   S G  +A+K   L       +   RS       E  +L+ ++H 
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 329 NLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNG 388
           N+++ L S  + D   + LE++P GS+   L ++  F + L R N +  +   L YLHN 
Sbjct: 67  NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR-NFVRQILKGLNYLHNR 125

Query: 389 HSSVHIIHCDLKPTNILLDENMVAHVSDFGIYK-----LLGEGEDSVRQTMTMATIGYMA 443
                IIH D+K  NIL+D      +SDFGI K      L    +  R ++   ++ +MA
Sbjct: 126 ----GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSL-QGSVFWMA 180

Query: 444 PEYGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
           PE   +   + K D++S G L++E  T K P
Sbjct: 181 PEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 90.6 bits (225), Expect = 4e-20
 Identities = 76/286 (26%), Positives = 128/286 (44%), Gaps = 25/286 (8%)

Query: 279 LLGTSSFGSVYK---GTISDGTD--VAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIK- 332
            LG  +FGSV       + D T   VA+K          R F+ E E+L++++H N++K 
Sbjct: 11  QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKY 70

Query: 333 --ILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHS 390
             +  S    + + LV+E++P GSL  +L  H   LD  + L     +   +EYL     
Sbjct: 71  KGVCYSAGRRNLR-LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYL----G 125

Query: 391 SVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGED--SVRQTMTMATIGYMAPEYGL 448
           S   +H DL   NIL++      + DFG+ K+L + ++   VR+    + I + APE   
Sbjct: 126 SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREP-GESPIFWYAPESLT 184

Query: 449 EGIVSAKCDVYSYGVLLMETFT---RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANL 505
           E   S   DV+S+GV+L E FT   +       F+  M   +  +  + H +       L
Sbjct: 185 ESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLI------EL 238

Query: 506 VREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIK 551
           ++      A   C   I     +C    P  R + ++ A +++ I+
Sbjct: 239 LKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 88.1 bits (219), Expect = 1e-19
 Identities = 65/216 (30%), Positives = 95/216 (43%), Gaps = 37/216 (17%)

Query: 273 EFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLI 331
           +  E   LG  S+GSVYK      G  VAIKV  +  E   +    E  +L+      ++
Sbjct: 6   DILEK--LGEGSYGSVYKAIHKETGQVVAIKVVPV--EEDLQEIIKEISILKQCDSPYIV 61

Query: 332 KILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLN----------IMIDVGSA 381
           K   SY       +V+E+   GS            DI++  N          I+      
Sbjct: 62  KYYGSYFKNTDLWIVMEYCGAGS----------VSDIMKITNKTLTEEEIAAILYQTLKG 111

Query: 382 LEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIG- 440
           LEYLH    S   IH D+K  NILL+E   A ++DFG+    G+  D++ +  T+  IG 
Sbjct: 112 LEYLH----SNKKIHRDIKAGNILLNEEGQAKLADFGVS---GQLTDTMAKRNTV--IGT 162

Query: 441 --YMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
             +MAPE   E   + K D++S G+  +E    K P
Sbjct: 163 PFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPP 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 88.5 bits (219), Expect = 1e-19
 Identities = 68/282 (24%), Positives = 128/282 (45%), Gaps = 36/282 (12%)

Query: 279 LLGTSSFGSVYKGTI--SDGTDVAIKVFNLQ---LERAFRSFDSECEVLRNVRHRNLIKI 333
           ++G   FG V++G +      +VA+ +  L+    E+  + F SE  ++    H N+I++
Sbjct: 12  VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71

Query: 334 LSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVH 393
               +      ++ E+M NG+L+K+L  H+      + + ++  + + ++YL    S ++
Sbjct: 72  EGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYL----SDMN 127

Query: 394 IIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMA----TIGYMAPEYGLE 449
            +H DL   NIL++ N+   VSDFG+ ++L   ED    T T +     I + APE    
Sbjct: 128 YVHRDLAARNILVNSNLECKVSDFGLSRVL---EDDPEGTYTTSGGKIPIRWTAPEAIAY 184

Query: 450 GIVSAKCDVYSYGVLLMETFTR-KRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVRE 508
              ++  DV+S+G+++ E  +  +RP  +M                    EV+ A  + +
Sbjct: 185 RKFTSASDVWSFGIVMWEVMSFGERPYWDM-----------------SNHEVMKA--IND 225

Query: 509 EQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKI 550
                A MDC  ++    L C  +    R    D    L K+
Sbjct: 226 GFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 88.3 bits (219), Expect = 1e-19
 Identities = 58/195 (29%), Positives = 98/195 (50%), Gaps = 7/195 (3%)

Query: 280 LGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSN 339
           LG   FG V++G  ++ T VA+K          + F +E ++++ +RH  LI++ +  + 
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDP-KDFLAEAQIMKKLRHPKLIQLYAVCTL 72

Query: 340 PDFKALVLEFMPNGSLEKWLY-SHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCD 398
            +   +V E M  GSL ++L       L + + +++   V S + YL     + + IH D
Sbjct: 73  EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE----AQNYIHRD 128

Query: 399 LKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDV 458
           L   N+L+ EN +  V+DFG+ +++ E     R       I + APE  L    S K DV
Sbjct: 129 LAARNVLVGENNICKVADFGLARVIKEDIYEAR-EGAKFPIKWTAPEAALYNRFSIKSDV 187

Query: 459 YSYGVLLMETFTRKR 473
           +S+G+LL E  T  R
Sbjct: 188 WSFGILLTEIVTYGR 202

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 88.1 bits (218), Expect = 2e-19
 Identities = 71/227 (31%), Positives = 108/227 (47%), Gaps = 17/227 (7%)

Query: 280 LGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSN 339
           +G   FG V  G    G  VA+K   ++ +   ++F +E  V+  +RH NL+++L     
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70

Query: 340 PDFKA-LVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHC 397
                 +V E+M  GSL  +L S     L     L   +DV  A+EYL     + + +H 
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE----ANNFVHR 126

Query: 398 DLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCD 457
           DL   N+L+ E+ VA VSDFG+ K     E S  Q      + + APE   E   S K D
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKSD 181

Query: 458 VYSYGVLLMETFTRKR-PTDEMFIGEMSLR--RWVKESLPHGLTEVV 501
           V+S+G+LL E ++  R P   + + ++  R  +  K   P G   VV
Sbjct: 182 VWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVV 228

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 86.7 bits (215), Expect = 5e-19
 Identities = 68/215 (31%), Positives = 104/215 (48%), Gaps = 39/215 (18%)

Query: 279 LLGTSSFGSVYKG-TISDGTDVAIKVFNL-----QLERAFRSFDSECEVLRNVRHRNLIK 332
           LLG+ SFGSVY+G  + DG   A+K  +L       + A +  + E  +L  ++H N+++
Sbjct: 7   LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66

Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERL---NIMIDVGSALEYLHNGH 389
            L +    D   + LE +P GSL K L  +  F + + RL    I+      LEYLH+ +
Sbjct: 67  YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQIL----LGLEYLHDRN 122

Query: 390 SSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIG---YMAPE- 445
                +H D+K  NIL+D N V  ++DFG+ K        V  +   +  G   +MAPE 
Sbjct: 123 ----TVHRDIKGANILVDTNGVVKLADFGMAK------QVVEFSFAKSFKGSPYWMAPEV 172

Query: 446 ------YGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
                 YGL        D++S G  ++E  T K P
Sbjct: 173 IAQQGGYGLA------ADIWSLGCTVLEMATGKPP 201

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 86.6 bits (215), Expect = 6e-19
 Identities = 62/207 (29%), Positives = 92/207 (44%), Gaps = 24/207 (11%)

Query: 278 NLLGTSSFGSVYKGTISDGTDV-AIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLIKI 333
            ++G  +FG V      D   + A+K  N Q    + + R+  +E  +L+ + H  L+ +
Sbjct: 6   RVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNL 65

Query: 334 LSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLN------IMIDVGSALEYLHN 387
             S+ + +   LV++ +  G L        Y L    + +       + ++  ALEYLH 
Sbjct: 66  WYSFQDEENMYLVVDLLLGGDLR-------YHLSQKVKFSEEQVKFWICEIVLALEYLH- 117

Query: 388 GHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYG 447
              S  IIH D+KP NILLDE    H++DF I   +         T T  T GYMAPE  
Sbjct: 118 ---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKV---TPDTLTTSTSGTPGYMAPEVL 171

Query: 448 LEGIVSAKCDVYSYGVLLMETFTRKRP 474
                S   D +S GV   E    KRP
Sbjct: 172 CRQGYSVAVDWWSLGVTAYECLRGKRP 198

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 86.5 bits (214), Expect = 7e-19
 Identities = 72/279 (25%), Positives = 124/279 (44%), Gaps = 30/279 (10%)

Query: 279 LLGTSSFGSVYKGTIS----DGTDVAIKVFNL-QLERAFRSFDSECEVLRNVRHRNLIKI 333
           ++G   FG V  G +         VAIK       E+  R F SE  ++    H N+I +
Sbjct: 11  VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 334 LSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVH 393
               +      +V E+M NGSL+ +L  H+    +++ + ++  + S ++YL    S + 
Sbjct: 71  EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYL----SDMG 126

Query: 394 IIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTM-TMATIGYMAPEYGLEGIV 452
            +H DL   NIL++ N+V  VSDFG+ ++L +  ++   T      I + APE       
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 186

Query: 453 SAKCDVYSYGVLLMETFTR-KRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQA 511
           ++  DV+SYG+++ E  +  +RP       EMS +  +K               + E   
Sbjct: 187 TSASDVWSYGIVMWEVMSYGERP-----YWEMSNQDVIKA--------------IEEGYR 227

Query: 512 FSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKI 550
             A MDC  ++    LDC  +  + R       + L K+
Sbjct: 228 LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 86.6 bits (214), Expect = 8e-19
 Identities = 59/216 (27%), Positives = 98/216 (45%), Gaps = 25/216 (11%)

Query: 280 LGTSSFGSVYKGTIS------DGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKI 333
           LG  +FG V+           D   VA+K      E A + F  E E+L  ++H+++++ 
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 334 LSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILER--------------LNIMIDVG 379
               +      +V E+M +G L ++L SH     IL                L I   + 
Sbjct: 73  YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132

Query: 380 SALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATI 439
           S + YL    +S+H +H DL   N L+ + +V  + DFG+ + +   +       TM  I
Sbjct: 133 SGMVYL----ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188

Query: 440 GYMAPEYGLEGIVSAKCDVYSYGVLLMETFTR-KRP 474
            +M PE  L    + + D++S+GV+L E FT  K+P
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 86.2 bits (213), Expect = 8e-19
 Identities = 58/205 (28%), Positives = 93/205 (45%), Gaps = 12/205 (5%)

Query: 272 DEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRS---FDSECEVLRNVRHR 328
            E      +G+  FG V+ G   +   VAIK     +     S   F  E +V+  + H 
Sbjct: 4   SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKT----IREGAMSEEDFIEEAQVMMKLSHP 59

Query: 329 NLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNG 388
            L+++    +      LV EFM +G L  +L +          L + +DV   + YL   
Sbjct: 60  KLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE-- 117

Query: 389 HSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGL 448
             S ++IH DL   N L+ EN V  VSDFG+ + + + +     T T   + + +PE   
Sbjct: 118 --SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLD-DQYTSSTGTKFPVKWSSPEVFS 174

Query: 449 EGIVSAKCDVYSYGVLLMETFTRKR 473
               S+K DV+S+GVL+ E F+  +
Sbjct: 175 FSKYSSKSDVWSFGVLMWEVFSEGK 199

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 86.1 bits (214), Expect = 1e-18
 Identities = 56/217 (25%), Positives = 91/217 (41%), Gaps = 23/217 (10%)

Query: 273 EFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRSFD--------SECEVLR 323
           ++     +G  SFG+V K    SDG  +  K  +      + +          SE  +LR
Sbjct: 1   DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEID------YGNMTEKEKQQLVSEVNILR 54

Query: 324 NVRHRNLIKILSSYSNPDFKAL--VLEFMPNGSLEKWL---YSHNYFLDILERLNIMIDV 378
            ++H N+++      +   + L  V+E+   G L + +        +++      I+  +
Sbjct: 55  ELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQL 114

Query: 379 GSALEYLHNG-HSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMA 437
             AL   HN       ++H DLKP NI LD N    + DFG+ K+L  G DS      + 
Sbjct: 115 LLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL--GHDSSFAKTYVG 172

Query: 438 TIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
           T  YM+PE         K D++S G L+ E      P
Sbjct: 173 TPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 85.5 bits (211), Expect = 1e-18
 Identities = 54/193 (27%), Positives = 96/193 (49%), Gaps = 6/193 (3%)

Query: 280 LGTSSFGSVYKGTI-SDGTDVAIKVFNLQLERAFRS-FDSECEVLRNVRHRNLIKILSSY 337
           +G  +FG V+ G + +D T VA+K     L    ++ F  E  +L+   H N+++++   
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 338 SNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHC 397
           +      +V+E +  G    +L +    L + E + ++ +  + +EYL     S H IH 
Sbjct: 63  TQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLE----SKHCIHR 118

Query: 398 DLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCD 457
           DL   N L+ E  V  +SDFG+ +   +G  +    M    + + APE    G  S++ D
Sbjct: 119 DLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESD 178

Query: 458 VYSYGVLLMETFT 470
           V+S+G+LL E F+
Sbjct: 179 VWSFGILLWEAFS 191

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 85.9 bits (213), Expect = 1e-18
 Identities = 54/207 (26%), Positives = 103/207 (49%), Gaps = 10/207 (4%)

Query: 278 NLLGTSSFGSVYKGTIS----DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIK 332
            ++G   FG V +G +        DVAIK       ++    F +E  ++    H N+I+
Sbjct: 10  KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69

Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSV 392
           +    +      ++ E+M NGSL+K+L  ++    + + + ++  + S ++YL    S +
Sbjct: 70  LEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYL----SEM 125

Query: 393 HIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIV 452
           + +H DL   NIL++ N+V  VSDFG+ + L + E +         I + APE       
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKF 185

Query: 453 SAKCDVYSYGVLLMETFTR-KRPTDEM 478
           ++  DV+S+G+++ E  +  +RP  +M
Sbjct: 186 TSASDVWSFGIVMWEVMSYGERPYWDM 212

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 85.6 bits (212), Expect = 1e-18
 Identities = 77/264 (29%), Positives = 118/264 (44%), Gaps = 36/264 (13%)

Query: 280 LGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRS--FDSECEVLRNVRHRNLIKI--LS 335
           LG+  FG V+ G      DVAIK+     E A     F  E +V+  + H NL+++  + 
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIR---EGAMSEDDFIEEAKVMMKLSHPNLVQLYGVC 68

Query: 336 SYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHII 395
           +   P F  +V E+M NG L  +L      L     L++  DV  A+EYL     S   I
Sbjct: 69  TKQRPIF--IVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE----SNGFI 122

Query: 396 HCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAK 455
           H DL   N L+ E+ V  VSDFG+ + + + +       T   + +  PE       S+K
Sbjct: 123 HRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ-YTSSQGTKFPVKWAPPEVFDYSRFSSK 181

Query: 456 CDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANL--VREEQAFS 513
            DV+S+GVL+ E F+          G+M   R+         +EVV++     R  +   
Sbjct: 182 SDVWSFGVLMWEVFSE---------GKMPYERFSN-------SEVVESVSAGYRLYRPKL 225

Query: 514 AKMDCILSIMDFALDCCMESPDMR 537
           A  + + +IM     C  E P+ R
Sbjct: 226 APTE-VYTIMY---SCWHEKPEDR 245

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 85.3 bits (211), Expect = 1e-18
 Identities = 62/202 (30%), Positives = 94/202 (46%), Gaps = 15/202 (7%)

Query: 280 LGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKI--LSSY 337
           LGT  FG V  G      DVAIK+   +   +   F  E +V+  + H  L+++  + + 
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70

Query: 338 SNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHC 397
             P +  +V E+M NG L  +L  H       + L +  DV   + YL     S   IH 
Sbjct: 71  QRPIY--IVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE----SKQFIHR 124

Query: 398 DLKPTNILLDENMVAHVSDFGI--YKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAK 455
           DL   N L+D+     VSDFG+  Y L  E   SV    +   + +  PE  L    S+K
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVG---SKFPVRWSPPEVLLYSKFSSK 181

Query: 456 CDVYSYGVLLMETFTR-KRPTD 476
            DV+++GVL+ E ++  K P +
Sbjct: 182 SDVWAFGVLMWEVYSLGKMPYE 203

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 86.1 bits (214), Expect = 1e-18
 Identities = 59/207 (28%), Positives = 92/207 (44%), Gaps = 24/207 (11%)

Query: 278 NLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQLER---------AFRSFDSECEVLRNVRH 327
             LG  ++  VYK      G  VAIK   L   +         A R    E ++L+ ++H
Sbjct: 6   KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALR----EIKLLQELKH 61

Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
            N+I +L  + +     LV EFM    LEK +   +  L   +  + M+     LEYLH+
Sbjct: 62  PNIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHS 120

Query: 388 GHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPE-- 445
                 I+H DLKP N+L+  + V  ++DFG+ +    G  + + T  + T  Y APE  
Sbjct: 121 NW----ILHRDLKPNNLLIASDGVLKLADFGLARSF--GSPNRKMTHQVVTRWYRAPELL 174

Query: 446 YGLEGIVSAKCDVYSYGVLLMETFTRK 472
           +G         D++S G +  E   R 
Sbjct: 175 FGARHYGVG-VDMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 85.8 bits (212), Expect = 2e-18
 Identities = 71/285 (24%), Positives = 120/285 (42%), Gaps = 45/285 (15%)

Query: 280 LGTSSFGSVYKGT------ISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKI 333
           LG  +FG V+           D   VA+K        A + F  E E+L N++H +++K 
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72

Query: 334 LSSYSNPDFKALVLEFMPNGSLEKWLYSH---------------NYFLDILERLNIMIDV 378
                + D   +V E+M +G L K+L +H                  L + + L+I   +
Sbjct: 73  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132

Query: 379 GSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMAT 438
            S + YL    +S H +H DL   N L+  N++  + DFG+ + +   +       TM  
Sbjct: 133 ASGMVYL----ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 188

Query: 439 IGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTR-KRPTDEMFIGEMSLRRWVKESLPHGL 497
           I +M PE  +    + + DV+S+GV+L E FT  K+P             W +       
Sbjct: 189 IRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP-------------WFQ----LSN 231

Query: 498 TEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTD 542
           TEV++   + + +       C   + D  L C    P  R+N+ +
Sbjct: 232 TEVIEC--ITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKE 274

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 86.0 bits (214), Expect = 2e-18
 Identities = 63/213 (29%), Positives = 97/213 (45%), Gaps = 32/213 (15%)

Query: 278 NLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQLE------RAFRSFDSECEVLRNVRHRNL 330
             +G+ ++G V        G  VAIK  +   +      R  R    E ++LR++RH N+
Sbjct: 6   KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILR----EIKLLRHLRHENI 61

Query: 331 IKILS---SYSNPDFKAL--VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYL 385
           I +L      S  DF  +  V E M    L K + S     D   +   +  +   L+YL
Sbjct: 62  IGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQY-FLYQILRGLKYL 119

Query: 386 HNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMT--MATIGYMA 443
           H    S ++IH DLKP+NIL++ N    + DFG+ + +   ED     +T  + T  Y A
Sbjct: 120 H----SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGF-LTEYVVTRWYRA 174

Query: 444 PEYGLEGIVSAKC----DVYSYGVLLMETFTRK 472
           PE  L    S++     D++S G +  E  TRK
Sbjct: 175 PELLL---SSSRYTKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 83.9 bits (208), Expect = 4e-18
 Identities = 64/206 (31%), Positives = 93/206 (45%), Gaps = 13/206 (6%)

Query: 280 LGTSSFGSVYKGT--ISDGT--DVAIKVF-NLQLERAFRSFDSECEVLRNVRHRNLIKIL 334
           LG  +FGSV KG   +  G   +VA+K      +    + F  E  V+  + H  +++++
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 335 SSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHI 394
                     LV+E  P G L K+L          +   +   V   + YL     S H 
Sbjct: 63  GVCKGEPL-MLVMELAPLGPLLKYLKKRREIPVS-DLKELAHQVAMGMAYLE----SKHF 116

Query: 395 IHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVR-QTMTMATIGYMAPEYGLEGIVS 453
           +H DL   N+LL     A +SDFG+ + LG G D  R  T     + + APE    G  S
Sbjct: 117 VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFS 176

Query: 454 AKCDVYSYGVLLMETFTR-KRPTDEM 478
           +K DV+SYGV L E F+   +P  EM
Sbjct: 177 SKSDVWSYGVTLWEAFSYGAKPYGEM 202

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 84.2 bits (208), Expect = 4e-18
 Identities = 66/281 (23%), Positives = 126/281 (44%), Gaps = 32/281 (11%)

Query: 279 LLGTSSFGSVYKGTIS----DGTDVAIKVFNL-QLERAFRSFDSECEVLRNVRHRNLIKI 333
           ++G   FG V +G +         VAIK       E+  R F SE  ++    H N+I +
Sbjct: 11  VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 334 LSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVH 393
               +      ++ EFM NG+L+ +L  ++    +++ + ++  + + ++YL    S ++
Sbjct: 71  EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL----SEMN 126

Query: 394 IIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMA---TIGYMAPEYGLEG 450
            +H DL   NIL++ N+V  VSDFG+ + L +       T ++     I + APE     
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYR 186

Query: 451 IVSAKCDVYSYGVLLMETFTR-KRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREE 509
             ++  DV+SYG+++ E  +  +RP  +M                    +V++A  + ++
Sbjct: 187 KFTSASDVWSYGIVMWEVMSYGERPYWDM-----------------SNQDVINA--IEQD 227

Query: 510 QAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKI 550
                 MDC  ++    LDC  +  + R       + L K+
Sbjct: 228 YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 83.8 bits (207), Expect = 6e-18
 Identities = 66/221 (29%), Positives = 102/221 (46%), Gaps = 41/221 (18%)

Query: 278 NLLGTSSFGSVYKGTISD----GTD---VAIKVFNL-QLERAFRSFDSECEVLRNVRHRN 329
           N LG+ +FG VY+GT +D    G+    VA+K       ++  + F  E  ++ N  H N
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60

Query: 330 LIKILSSYSNPDFKALVLEFMPNGSLEKWLYS------HNYFLDILERLNIMIDVGSALE 383
           ++K+L      + + +++E M  G L  +L            L + E L+I +DV     
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 384 YLHNGHSSVHIIHCDLKPTNILLDE-----NMVAHVSDFGI---------YKLLGEGEDS 429
           YL      +H IH DL   N L+ E     + V  + DFG+         Y+  GEG   
Sbjct: 121 YLEQ----MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLP 176

Query: 430 VRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
           VR         +MAPE  L+G  + + DV+S+GVL+ E  T
Sbjct: 177 VR---------WMAPESLLDGKFTTQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 83.3 bits (206), Expect = 7e-18
 Identities = 64/217 (29%), Positives = 97/217 (44%), Gaps = 20/217 (9%)

Query: 279 LLGTSSFGSVYK-GTISDGTDVAIKVFNLQLERAFRSFDS--ECEVLRNVRHRNLIKILS 335
            LG  S+GSVYK   +SD    A+K  +L         D+  E  +L +V H N+I    
Sbjct: 7   KLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKE 66

Query: 336 SYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILER---LNIMIDVGSALEYLHNGHSSV 392
           ++ + +   +V+E+ P G L K +        ++       I I +   L+ LH      
Sbjct: 67  AFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH----EQ 122

Query: 393 HIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIG---YMAPEYGLE 449
            I+H DLK  NILL  N +  + D GI K+L       ++ M    IG   YMAPE    
Sbjct: 123 KILHRDLKSANILLVANDLVKIGDLGISKVL-------KKNMAKTQIGTPHYMAPEVWKG 175

Query: 450 GIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLR 486
              S K D++S G LL E  T   P +   + ++  +
Sbjct: 176 RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYK 212

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 84.1 bits (209), Expect = 7e-18
 Identities = 57/210 (27%), Positives = 96/210 (45%), Gaps = 34/210 (16%)

Query: 280 LGTSSFGSVYKG-TISDGTDVAIKVFNLQLER------AFRSFDSECEVLRNVRHRNLIK 332
           +G  ++G VYK      G  VA+K   ++ E+      A R    E ++L+ +RH N+++
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIR----EIKLLQKLRHPNIVR 62

Query: 333 ---ILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGH 389
              I++S        +V E+M +  L   L S        +    M  +   L+YLH+  
Sbjct: 63  LKEIVTSKGKGSI-YMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG 120

Query: 390 SSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPE---- 445
               I+H D+K +NIL++ + V  ++DFG+ +      +S   T  + T+ Y  PE    
Sbjct: 121 ----ILHRDIKGSNILINNDGVLKLADFGLARPY-TKRNSADYTNRVITLWYRPPELLLG 175

Query: 446 ---YGLEGIVSAKCDVYSYGVLLMETFTRK 472
              YG E       D++S G +L E F  K
Sbjct: 176 ATRYGPE------VDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 83.0 bits (205), Expect = 9e-18
 Identities = 60/199 (30%), Positives = 97/199 (48%), Gaps = 16/199 (8%)

Query: 278 NLLGTSSFGSVYKGTISD-GTDVAIKVF---NLQLERAFRSFDSECEVLRNVRHRNLIKI 333
           + LG   +G VY+G        VA+K      +++E     F  E  V++ ++H NL+++
Sbjct: 12  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE----EFLKEAAVMKEIKHPNLVQL 67

Query: 334 LSSYS-NPDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHNGHSS 391
           L   +  P F  ++ EFM  G+L  +L   N   ++ +  L +   + SA+EYL      
Sbjct: 68  LGVCTREPPF-YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE----K 122

Query: 392 VHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGI 451
            + IH DL   N L+ EN +  V+DFG+ +L+  G+           I + APE      
Sbjct: 123 KNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNK 181

Query: 452 VSAKCDVYSYGVLLMETFT 470
            S K DV+++GVLL E  T
Sbjct: 182 FSIKSDVWAFGVLLWEIAT 200

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 82.2 bits (203), Expect = 1e-17
 Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 14/210 (6%)

Query: 273 EFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQ-LERAFRSFD-SECEVLRNVRHRN 329
           +F   N +G  SFG V+K    +D    A+K  +L  + R  R     E  VL  +    
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60

Query: 330 LIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHN---YFLDILERLNIMIDVGSALEYLH 386
           +I+   S+ +     +V+E+  NG L K L          D + R  I I +G  L +LH
Sbjct: 61  IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLG--LAHLH 118

Query: 387 NGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEY 446
               S  I+H D+K  N+ LD      + D G+ KLL +   +   T+ + T  Y++PE 
Sbjct: 119 ----SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD-NTNFANTI-VGTPYYLSPEL 172

Query: 447 GLEGIVSAKCDVYSYGVLLMETFTRKRPTD 476
             +   + K DV++ GV+L E  T K P D
Sbjct: 173 CEDKPYNEKSDVWALGVVLYECCTGKHPFD 202

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 82.7 bits (204), Expect = 2e-17
 Identities = 69/291 (23%), Positives = 123/291 (42%), Gaps = 44/291 (15%)

Query: 280 LGTSSFGSVYKGTIS-DGTD----VAIKVF-NLQLERAFRSFDSECEVLRNVRHRNLIKI 333
           LG  +FG +YKG +   G D    VAIK   ++   + +  F  E  ++  + H N++ +
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72

Query: 334 LSSYSNPDFKALVLEFMPNGSLEKWLYSHN----------------YFLDILERLNIMID 377
           L   +      ++ E++  G L ++L   +                  LD  + L+I I 
Sbjct: 73  LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132

Query: 378 VGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMA 437
           + + +EYL    SS   +H DL   NIL+ E +   +SD G+ + +   +    Q  ++ 
Sbjct: 133 IAAGMEYL----SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188

Query: 438 TIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGL 497
            I +M PE  + G  S+  D++S+GV+L E F+              L+ +      +G 
Sbjct: 189 PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS------------FGLQPY------YGF 230

Query: 498 TEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLK 548
           +      +VR+ Q      DC   +     +C  E P  R    D   +L+
Sbjct: 231 SNQEVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR 281

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 81.9 bits (203), Expect = 2e-17
 Identities = 55/196 (28%), Positives = 88/196 (44%), Gaps = 15/196 (7%)

Query: 285 FGSVYKG-TISDGTDVAIKVFN---LQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNP 340
           +G V+     S G   AIKV     +  +       +E ++L   +   ++K+  S+   
Sbjct: 6   YGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGK 65

Query: 341 DFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLK 400
               LV+E++P G L   L +     + + R   + ++  ALEYLH+      IIH DLK
Sbjct: 66  KNLYLVMEYLPGGDLASLLENVGSLDEDVAR-IYIAEIVLALEYLHS----NGIIHRDLK 120

Query: 401 PTNILLDENMVAHVSDFGIYKL------LGEGEDSVRQTMTMATIGYMAPEYGLEGIVSA 454
           P NIL+D N    ++DFG+ K+      +   +D       + T  Y+APE  L    S 
Sbjct: 121 PDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSK 180

Query: 455 KCDVYSYGVLLMETFT 470
             D +S G +L E   
Sbjct: 181 TVDWWSLGCILYEFLV 196

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 83.7 bits (207), Expect = 2e-17
 Identities = 65/220 (29%), Positives = 102/220 (46%), Gaps = 40/220 (18%)

Query: 273 EFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFR-SFDSECEVLRNVRHRNL 330
           E    N +G+ + G+VYK      G   A+KV     E   R     E E+LR+V H N+
Sbjct: 75  ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNV 134

Query: 331 IKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHS 390
           +K    + +     ++LEFM  GSLE    +   FL  + R      + S + YLH    
Sbjct: 135 VKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR-----QILSGIAYLH---- 185

Query: 391 SVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTM-----TMATIGYMAPE 445
             HI+H D+KP+N+L++      ++DFG+ ++L        QTM     ++ TI YM+PE
Sbjct: 186 RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILA-------QTMDPCNSSVGTIAYMSPE 238

Query: 446 Y-----------GLEGIVSAKCDVYSYGVLLMETFTRKRP 474
                       G  G      D++S GV ++E +  + P
Sbjct: 239 RINTDLNHGAYDGYAG------DIWSLGVSILEFYLGRFP 272

Length = 353

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 81.5 bits (202), Expect = 3e-17
 Identities = 61/210 (29%), Positives = 89/210 (42%), Gaps = 34/210 (16%)

Query: 280 LGTSSFGSVYK-GTISDGTDVAIK------VFNLQLERAFRSFDSECEVLRNVRHRNLIK 332
           LG   FG V      S     A+K      +     +    S   E E+L    H  ++K
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFS---EKEILEECNHPFIVK 57

Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNI--MIDVGSALEYLHNGHS 390
           +  ++ +  +  +++E+   G L   L     F +   R  I  ++    A EYLHN   
Sbjct: 58  LYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVV---LAFEYLHN--- 111

Query: 391 SVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTM-ATIGYMAPEYGLE 449
              II+ DLKP N+LLD N    + DFG  K L  G    ++T T   T  Y+APE    
Sbjct: 112 -RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG----QKTWTFCGTPEYVAPE---- 162

Query: 450 GIVSAK-----CDVYSYGVLLMETFTRKRP 474
            I+  K      D +S G+LL E  T + P
Sbjct: 163 -IILNKGYDFSVDYWSLGILLYELLTGRPP 191

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 81.6 bits (202), Expect = 3e-17
 Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 24/209 (11%)

Query: 280 LGTSSFGSVYKG---TISDG---TDVAIK-VFNLQLERAFRSFDSECEVLRNVRHRNLIK 332
           LG  SFG VY+G    +  G   T VAIK V      R    F +E  V++     ++++
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 333 ILS--SYSNPDFKALVLEFMPNGSLEKWLYSH------NYFLDILERLNIM---IDVGSA 381
           +L   S   P    +V+E M  G L+ +L S       N  L        +    ++   
Sbjct: 74  LLGVVSTGQPTL--VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131

Query: 382 LEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGY 441
           + YL     +   +H DL   N ++ E++   + DFG+ + + E +   +    +  + +
Sbjct: 132 MAYLA----AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 187

Query: 442 MAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
           MAPE   +G+ + K DV+S+GV+L E  T
Sbjct: 188 MAPESLKDGVFTTKSDVWSFGVVLWEMAT 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 84.5 bits (209), Expect = 4e-17
 Identities = 61/193 (31%), Positives = 87/193 (45%), Gaps = 18/193 (9%)

Query: 83  GIRLTGNKLYGRIPPCLV----LTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGP 138
           G+ L    L G IP  +     L  +++S N + G+IP ++G    LE L L+ N F G 
Sbjct: 422 GLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481

Query: 139 IPESVGSLISLESLDLSGNNLSGKIPKLEGEIPVKGSFKNFSTESFFGNYALCGPPKLRV 198
           IPES+G L SL  L+L+GN+LSG++P   G   +  +  NF+      N  LCG P LR 
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTD-----NAGLCGIPGLR- 535

Query: 199 PPCKPDNSKRTK-KVPLIVLKYILPPIVSTVLVVITIIMYIRCRNRNTKKSDHEDFLPLA 257
             C P  S   K  +   V    L       LV+  +  + R +N    +       P A
Sbjct: 536 -ACGPHLSVGAKIGIAFGVSVAFL------FLVICAMCWWKRRQNILRAQRIAAREAPYA 588

Query: 258 IWRRTSYLDIQRA 270
             R     D+Q  
Sbjct: 589 KARTHFSRDVQMT 601

Length = 623

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 81.4 bits (201), Expect = 4e-17
 Identities = 58/220 (26%), Positives = 96/220 (43%), Gaps = 46/220 (20%)

Query: 279 LLGTSSFGSVYKGTISD-GTDVAIKVFNL-----QLERAFRSFDSECEVLRNVRHRNLIK 332
           LLG  +FG VY     D G ++A+K         + ++   + + E ++L+N++H  +++
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68

Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWLYSH---------NYFLDILERLNIMIDVGSALE 383
                 + +  ++ +E+MP GS++  L ++          Y   ILE           +E
Sbjct: 69  YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILE----------GVE 118

Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIG--- 440
           YLH    S  I+H D+K  NIL D      + DFG  K L        QT+  +  G   
Sbjct: 119 YLH----SNMIVHRDIKGANILRDSAGNVKLGDFGASKRL--------QTICSSGTGMKS 166

Query: 441 ------YMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
                 +M+PE         K DV+S G  ++E  T K P
Sbjct: 167 VTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 81.4 bits (202), Expect = 5e-17
 Identities = 63/226 (27%), Positives = 100/226 (44%), Gaps = 66/226 (29%)

Query: 272 DEFNECNLLGTSSFGSV----YKGTISDGTDVAIKVFNL-------QLERAFRSFDSECE 320
           D+F     LGT SFG V    +KG+   G   A+K+ +        Q+E       +E  
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGS---GKYYALKILSKAKIVKLKQVEHVL----NEKR 53

Query: 321 VLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWL-------------YSHNYFLD 367
           +L+++RH  L+ +  S+ +     LV+E++P G L   L             Y+    L 
Sbjct: 54  ILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVL- 112

Query: 368 ILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGE 427
                        ALEYLH+    + I++ DLKP N+LLD +    ++DFG  K +    
Sbjct: 113 -------------ALEYLHS----LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR- 154

Query: 428 DSVRQTMTM-ATIGYMAPEYGLEGIVSAK-----CDVYSYGVLLME 467
                T T+  T  Y+APE     I+ +K      D ++ G+L+ E
Sbjct: 155 -----TYTLCGTPEYLAPE-----IILSKGYGKAVDWWALGILIYE 190

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 81.0 bits (200), Expect = 5e-17
 Identities = 71/231 (30%), Positives = 107/231 (46%), Gaps = 34/231 (14%)

Query: 265 LDIQRATDEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLERAFRSFDSECEVLR 323
           L+ +   DE  E  +LG  ++G VY    +S    +AIK    +  R  +    E  +  
Sbjct: 1   LEYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHS 60

Query: 324 NVRHRNLIKILSSYSNPDFKALVLEFMPNGSLE-----KW--LYSHN-----YFLDILER 371
            ++HRN+++ L S S   F  + +E +P GSL      KW  L  +      Y   ILE 
Sbjct: 61  YLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILE- 119

Query: 372 LNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDE-NMVAHVSDFGIYKLLGEGEDSV 430
                     L+YLH+      I+H D+K  N+L++  + V  +SDFG  K L  G +  
Sbjct: 120 ---------GLKYLHDN----QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA-GINPC 165

Query: 431 RQTMTMATIGYMAPE---YGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEM 478
            +T T  T+ YMAPE    G  G   A  D++S G  ++E  T K P  E+
Sbjct: 166 TETFT-GTLQYMAPEVIDKGPRG-YGAPADIWSLGCTIVEMATGKPPFIEL 214

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 80.8 bits (200), Expect = 5e-17
 Identities = 63/210 (30%), Positives = 95/210 (45%), Gaps = 30/210 (14%)

Query: 272 DEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNL 330
           +++     +G+ ++G VYK   I+ G  VAIKV  L+    F     E  +L+  RH N+
Sbjct: 3   EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNI 62

Query: 331 IKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMI---DVGSALEYLHN 387
           +    SY   D   +V+E+   GSL+  +Y        L  L I     +    L YLH 
Sbjct: 63  VAYFGSYLRRDKLWIVMEYCGGGSLQD-IY--QVTRGPLSELQIAYVCRETLKGLAYLH- 118

Query: 388 GHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMAT----IG--- 440
                  IH D+K  NILL E+    ++DFG+         S + T T+A     IG   
Sbjct: 119 ---ETGKIHRDIKGANILLTEDGDVKLADFGV---------SAQLTATIAKRKSFIGTPY 166

Query: 441 YMAPEYGLE---GIVSAKCDVYSYGVLLME 467
           +MAPE       G    KCD+++ G+  +E
Sbjct: 167 WMAPEVAAVERKGGYDGKCDIWALGITAIE 196

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 80.5 bits (199), Expect = 7e-17
 Identities = 68/271 (25%), Positives = 101/271 (37%), Gaps = 39/271 (14%)

Query: 279 LLGTSSFGSVYKGTISDGT----DVAIKVF-NLQLERAFRSFDSECEVLRNVRHRNLIKI 333
            LG  SFG V +G  S        VA+K   + +L      F  E  ++ ++ H NLI++
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 334 LSSYSNPDFKALVLEFMPNGSL-EKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSV 392
                      +V E  P GSL ++          I    +  + + + + YL     S 
Sbjct: 62  YGVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE----SK 116

Query: 393 HIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMAT-IGYMAPEYGLEGI 451
             IH DL   NILL  +    + DFG+ + L + ED       +     + APE      
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRT 176

Query: 452 VSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLT-----EVVDANLV 506
            S   DV+ +GV L E FT          GE     W       GL+     + +D    
Sbjct: 177 FSHASDVWMFGVTLWEMFT---------YGEEP---WA------GLSGSQILKKIDKEGE 218

Query: 507 REEQAFSAKMDCILSIMDFALDCCMESPDMR 537
           R E+       C   I +  L C   +P  R
Sbjct: 219 RLERP----EACPQDIYNVMLQCWAHNPADR 245

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 80.5 bits (198), Expect = 9e-17
 Identities = 72/280 (25%), Positives = 119/280 (42%), Gaps = 42/280 (15%)

Query: 280 LGTSSFGSVYKGTI------SDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKI 333
           LG  +FG V+           D   VA+K      + A + F  E E+L N++H +++K 
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72

Query: 334 LSSYSNPDFKALVLEFMPNGSLEKWLYSHN------------YFLDILERLNIMIDVGSA 381
                  D   +V E+M +G L K+L +H               L   + L+I   + + 
Sbjct: 73  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132

Query: 382 LEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGY 441
           + YL    +S H +H DL   N L+ EN++  + DFG+ + +   +       TM  I +
Sbjct: 133 MVYL----ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 188

Query: 442 MAPEYGLEGIVSAKCDVYSYGVLLMETFTR-KRPTDEMFIGEMSLRRWVKESLPHGLTEV 500
           M PE  +    + + DV+S GV+L E FT  K+P             W + S      EV
Sbjct: 189 MPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP-------------WYQLS----NNEV 231

Query: 501 VDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINM 540
           ++   + + +       C   + D  L C    P MR+N+
Sbjct: 232 IEC--ITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNI 269

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 80.1 bits (198), Expect = 1e-16
 Identities = 59/199 (29%), Positives = 93/199 (46%), Gaps = 13/199 (6%)

Query: 280 LGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERA-FRSFDSECEVLRNVRHRNLIKILSSY 337
           LG  + G V K      G  +A+K   L++  A  +    E ++L       ++    ++
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68

Query: 338 SNPDFKALVLEFMPNGSLEKWL--YSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHII 395
            N    ++ +E+M  GSL+K L          IL +  I + V   L YLH  H    II
Sbjct: 69  YNNGDISICMEYMDGGSLDKILKEVQGRIPERILGK--IAVAVLKGLTYLHEKH---KII 123

Query: 396 HCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAK 455
           H D+KP+NIL++      + DFG+    G+  +S+ +T    T  YMAPE       S K
Sbjct: 124 HRDVKPSNILVNSRGQIKLCDFGVS---GQLVNSLAKTFV-GTSSYMAPERIQGNDYSVK 179

Query: 456 CDVYSYGVLLMETFTRKRP 474
            D++S G+ L+E  T + P
Sbjct: 180 SDIWSLGLSLIELATGRFP 198

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 79.9 bits (197), Expect = 1e-16
 Identities = 64/203 (31%), Positives = 94/203 (46%), Gaps = 19/203 (9%)

Query: 280 LGTSSFGSV----YKGTISDGTD--VAIKVFNLQLERAFRS-FDSECEVLRNVRHRNLIK 332
           LG   FG V    Y    +DGT   VA+K    +  +   S +  E  +L+ + H N++K
Sbjct: 12  LGEGHFGKVSLYCYDPA-NDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVK 70

Query: 333 ILSSYSNPDFKA--LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHS 390
                S    K   L++E++P GSL  +L  H   L++ + L     +   + YLH    
Sbjct: 71  YKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK--LNLAQLLLFAQQICEGMAYLH---- 124

Query: 391 SVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGED--SVRQTMTMATIGYMAPEYGL 448
           S H IH DL   N+LLD + +  + DFG+ K + EG +   VR+        Y A E   
Sbjct: 125 SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-AVECLK 183

Query: 449 EGIVSAKCDVYSYGVLLMETFTR 471
           E   S   DV+S+GV L E  T 
Sbjct: 184 ENKFSYASDVWSFGVTLYELLTH 206

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 79.7 bits (196), Expect = 2e-16
 Identities = 63/210 (30%), Positives = 100/210 (47%), Gaps = 27/210 (12%)

Query: 278 NLLGTSSFGSVYKGTIS-DGT--DVAIKVFN-LQLERAFRSFDSECEVLRNV-RHRNLIK 332
           +++G  +FG V +  I  DG   + AIK+      E   R F  E EVL  +  H N+I 
Sbjct: 8   DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67

Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYF---------------LDILERLNIMID 377
           +L +  N  +  + +E+ P G+L  +L                     L   + L    D
Sbjct: 68  LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127

Query: 378 VGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMA 437
           V + ++YL    S    IH DL   N+L+ EN+ + ++DFG+ +  GE E  V++TM   
Sbjct: 128 VATGMQYL----SEKQFIHRDLAARNVLVGENLASKIADFGLSR--GE-EVYVKKTMGRL 180

Query: 438 TIGYMAPEYGLEGIVSAKCDVYSYGVLLME 467
            + +MA E     + + K DV+S+GVLL E
Sbjct: 181 PVRWMAIESLNYSVYTTKSDVWSFGVLLWE 210

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 78.1 bits (192), Expect = 4e-16
 Identities = 50/192 (26%), Positives = 99/192 (51%), Gaps = 7/192 (3%)

Query: 280 LGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSN 339
           LG   FG V+ G  ++ T VA+K        + ++F  E  +++ ++H  L+++ +  + 
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72

Query: 340 PDFKALVLEFMPNGSLEKWLYSHNYFLDILERL-NIMIDVGSALEYLHNGHSSVHIIHCD 398
            +   ++ E+M  GSL  +L S      +L +L +    +   + Y+   +     IH D
Sbjct: 73  EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN----YIHRD 128

Query: 399 LKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDV 458
           L+  N+L+ E+++  ++DFG+ +++ + E + R+      I + APE    G  + K DV
Sbjct: 129 LRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFP-IKWTAPEAINFGSFTIKSDV 187

Query: 459 YSYGVLLMETFT 470
           +S+G+LL E  T
Sbjct: 188 WSFGILLYEIVT 199

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 78.0 bits (192), Expect = 7e-16
 Identities = 63/208 (30%), Positives = 101/208 (48%), Gaps = 13/208 (6%)

Query: 280 LGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYS 338
           +G  + G+VY    ++ G +VAIK  NLQ +       +E  V+R  +H N++  L SY 
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86

Query: 339 NPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCD 398
             D   +V+E++  GSL   +      +D  +   +  +   ALE+LH    S  +IH D
Sbjct: 87  VGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLH----SNQVIHRD 140

Query: 399 LKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDV 458
           +K  NILL  +    ++DFG    +   E S R TM + T  +MAPE         K D+
Sbjct: 141 IKSDNILLGMDGSVKLTDFGFCAQITP-EQSKRSTM-VGTPYWMAPEVVTRKAYGPKVDI 198

Query: 459 YSYGVLLMETFTRKRPTDEMFIGEMSLR 486
           +S G++ +E    + P    ++ E  LR
Sbjct: 199 WSLGIMAIEMVEGEPP----YLNENPLR 222

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 77.6 bits (191), Expect = 7e-16
 Identities = 55/196 (28%), Positives = 100/196 (51%), Gaps = 10/196 (5%)

Query: 280 LGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSN 339
           LG   FG V+ G  +  T VAIK    Q   +  +F +E  +++ ++H  L+++ +  + 
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIKSLK-QGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQ 72

Query: 340 -PDFKALVLEFMPNGSLEKWL-YSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHC 397
            P +  ++ E+M NGSL  +L       L I + +++   +   + ++   +     IH 
Sbjct: 73  EPIY--IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNY----IHR 126

Query: 398 DLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCD 457
           DL+  NIL+ E +   ++DFG+ +L+ + E + R+      I + APE    G  + K D
Sbjct: 127 DLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFP-IKWTAPEAINYGTFTIKSD 185

Query: 458 VYSYGVLLMETFTRKR 473
           V+S+G+LL E  T  R
Sbjct: 186 VWSFGILLTEIVTYGR 201

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 78.1 bits (192), Expect = 8e-16
 Identities = 66/210 (31%), Positives = 100/210 (47%), Gaps = 27/210 (12%)

Query: 278 NLLGTSSFGSVYKGTI-SDG--TDVAIK-VFNLQLERAFRSFDSECEVL-RNVRHRNLIK 332
           +++G  +FG V K  I  DG   D AIK +     +   R F  E EVL +   H N+I 
Sbjct: 13  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72

Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYF---------------LDILERLNIMID 377
           +L +  +  +  L +E+ P+G+L  +L                     L   + L+   D
Sbjct: 73  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132

Query: 378 VGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMA 437
           V   ++YL    S    IH DL   NIL+ EN VA ++DFG+ +  G+ E  V++TM   
Sbjct: 133 VARGMDYL----SQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQ-EVYVKKTMGRL 185

Query: 438 TIGYMAPEYGLEGIVSAKCDVYSYGVLLME 467
            + +MA E     + +   DV+SYGVLL E
Sbjct: 186 PVRWMAIESLNYSVYTTNSDVWSYGVLLWE 215

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 77.2 bits (190), Expect = 1e-15
 Identities = 58/204 (28%), Positives = 104/204 (50%), Gaps = 14/204 (6%)

Query: 279 LLGTSSFGSVY--KGTISDGTDVAIKVFNL-QLERAFR-SFDSECEVLRNVRHRNLIKIL 334
           ++G  +FG V+  +   +D   V IK   + Q+ +  R +  +EC+VL+ + H N+I+  
Sbjct: 7   VVGRGAFGIVHLCRRK-ADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYY 65

Query: 335 SSYSNPDFKALVLEFMPNGSLEKWLYSH-NYFLDILERLNIMIDVGSALEYLHNGHSSVH 393
            ++       +V+E+ P G+L +++    N  LD    L+  + +  AL ++H       
Sbjct: 66  ENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK----L 121

Query: 394 IIHCDLKPTNILLDEN-MVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIV 452
           I+H DLK  NILLD++ MV  + DFGI K+L       +    + T  Y++PE       
Sbjct: 122 ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS---KAYTVVGTPCYISPELCEGKPY 178

Query: 453 SAKCDVYSYGVLLMETFTRKRPTD 476
           + K D+++ G +L E  + KR  +
Sbjct: 179 NQKSDIWALGCVLYELASLKRAFE 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 77.1 bits (190), Expect = 1e-15
 Identities = 60/211 (28%), Positives = 95/211 (45%), Gaps = 24/211 (11%)

Query: 278 NLLGTSSFGSVYKGTIS----DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNVRHRNL 330
             LG  +FG VY+G       D  ++ + V  L     E+    F  E  ++    H+N+
Sbjct: 12  RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71

Query: 331 IKI--LSSYSNPDFKALVLEFMPNGSLEKWLY------SHNYFLDILERLNIMIDVGSAL 382
           +++  +S    P F  ++LE M  G L+ +L            L + + L    DV    
Sbjct: 72  VRLIGVSFERLPRF--ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGC 129

Query: 383 EYLHNGHSSVHIIHCDLKPTNILLD---ENMVAHVSDFGIYKLLGEGEDSVRQTMTMATI 439
           +YL       H IH D+   N LL       VA ++DFG+ + +       +    M  I
Sbjct: 130 KYLE----ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPI 185

Query: 440 GYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
            +M PE  L+GI ++K DV+S+GVLL E F+
Sbjct: 186 KWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 77.4 bits (191), Expect = 1e-15
 Identities = 58/201 (28%), Positives = 91/201 (45%), Gaps = 19/201 (9%)

Query: 280 LGTSSFGSVYKG-TISDGTDVAIKVFNLQLE------RAFRSFDSECEVLRNVRHRNLIK 332
           +G  ++G VYK      G  VAIK   L+ E       A R    E ++L+ + H N+IK
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALR----EIKLLKELNHPNIIK 62

Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSV 392
           +L  + +     LV EFM +  L K +      L      + +  +   L + H    S 
Sbjct: 63  LLDVFRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH----SH 117

Query: 393 HIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGL-EGI 451
            I+H DLKP N+L++   V  ++DFG+ +    G      T  + T  Y APE  L +  
Sbjct: 118 GILHRDLKPENLLINTEGVLKLADFGLARSF--GSPVRPYTHYVVTRWYRAPELLLGDKG 175

Query: 452 VSAKCDVYSYGVLLMETFTRK 472
            S   D++S G +  E  +R+
Sbjct: 176 YSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 79.9 bits (197), Expect = 2e-15
 Identities = 63/186 (33%), Positives = 86/186 (46%), Gaps = 48/186 (25%)

Query: 4   LTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSI-TNATKLIVLDLGFNSFSG 62
           + L G  +SG++ S I   LP I+ + L+ N L+G IP+ I T ++ L  L+L  N+F+G
Sbjct: 74  IDLSGKNISGKISSAIFR-LPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTG 132

Query: 63  HILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLVLTVLDVSRNQLSGDIPSTIGGR 122
            I                            G IP    L  LD+S N LSG+IP+ IG  
Sbjct: 133 SIPR--------------------------GSIP---NLETLDLSNNMLSGEIPNDIGSF 163

Query: 123 VDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPK----------------- 165
             L+ L L  N   G IP S+ +L SLE L L+ N L G+IP+                 
Sbjct: 164 SSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNN 223

Query: 166 LEGEIP 171
           L GEIP
Sbjct: 224 LSGEIP 229

Length = 968

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 76.6 bits (188), Expect = 2e-15
 Identities = 68/300 (22%), Positives = 124/300 (41%), Gaps = 62/300 (20%)

Query: 280 LGTSSFGSVYKGTISDGTD------VAIKVFNLQLERAFRS-FDSECEVLRNVRHRNLIK 332
           LG   FG VYKG +           VAIK    + E   R  F  E  +   ++H N++ 
Sbjct: 13  LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72

Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDI------------LER---LNIMID 377
           +L   +     +++  +  +  L ++L   +   D+            LE    ++I+  
Sbjct: 73  LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQ 132

Query: 378 VGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGI---------YKLLGEGED 428
           + + +E+L    SS H++H DL   N+L+ + +   +SD G+         YKL+G    
Sbjct: 133 IAAGMEFL----SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGN--- 185

Query: 429 SVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRW 488
                 ++  I +M+PE  + G  S   D++SYGV+L E F+                  
Sbjct: 186 ------SLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYG---------------- 223

Query: 489 VKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLK 548
           ++    +   +V++  ++R  Q      DC   +    L+C  E P  R    D  ++L+
Sbjct: 224 LQPYCGYSNQDVIE--MIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR 281

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 76.3 bits (188), Expect = 2e-15
 Identities = 78/291 (26%), Positives = 123/291 (42%), Gaps = 47/291 (16%)

Query: 274 FNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRSFD-----SECEVLRNVRH 327
           +    L+G  ++G+VY+G  +  G  VA+K+ NL         D      E  +L  +R 
Sbjct: 3   YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP----DDDVSDIQREVALLSQLRQ 58

Query: 328 ---RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLN--IMIDVGSAL 382
               N+ K   SY       +++E+   GS+   + +      I E+    I+ +V  AL
Sbjct: 59  SQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGP----IAEKYISVIIREVLVAL 114

Query: 383 EYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYM 442
           +Y+H     V +IH D+K  NIL+       + DFG+  LL +   S R T    T  +M
Sbjct: 115 KYIH----KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS-SKRSTFV-GTPYWM 168

Query: 443 APEYGLEGIV-SAKCDVYSYGVLLMETFTRKRP-TDEMFIGEMSLRRWVKESLPHGLTEV 500
           APE   EG     K D++S G+ + E  T   P +D      M L   + +S P  L   
Sbjct: 169 APEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMML---IPKSKPPRL--- 222

Query: 501 VDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIK 551
                  E+  +S  +       +F   C  E P  R++  +   K K IK
Sbjct: 223 -------EDNGYSKLLR------EFVAACLDEEPKERLS-AEELLKSKWIK 259

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 75.8 bits (186), Expect = 3e-15
 Identities = 60/211 (28%), Positives = 99/211 (46%), Gaps = 26/211 (12%)

Query: 280 LGTSSFGSVYKGTISDGT---DVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKIL 334
           LG   FGSV +G ++       VA+K   + +        F SE   ++   H N+++++
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 335 ---------SSYSNPDFKALVLEFMPNGSLEKWL-YSH----NYFLDILERLNIMIDVGS 380
                      Y +P    ++L FM +G L  +L YS       +L     +  M D+ S
Sbjct: 67  GVCLQTVESEGYPSP---VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIAS 123

Query: 381 ALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIG 440
            +EYL    SS   IH DL   N +L+ENM   V+DFG+ K +  G+   +  +    + 
Sbjct: 124 GMEYL----SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVK 179

Query: 441 YMAPEYGLEGIVSAKCDVYSYGVLLMETFTR 471
           ++A E   + + + K DV+S+GV + E  TR
Sbjct: 180 WIAIESLADRVYTTKSDVWSFGVTMWEIATR 210

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 76.2 bits (187), Expect = 5e-15
 Identities = 65/230 (28%), Positives = 105/230 (45%), Gaps = 12/230 (5%)

Query: 273 EFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQLE-----RAFRSFDSECEVLRNVR 326
           EF +  +LG+ +FG+VYKG  I +G  V I V   +L      +A +    E  V+ +V 
Sbjct: 8   EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 67

Query: 327 HRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH 386
           + ++ ++L        + L+ + MP G L  ++  H   +     LN  + +   + YL 
Sbjct: 68  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 126

Query: 387 NGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEY 446
                  ++H DL   N+L+       ++DFG+ KLLG  E           I +MA E 
Sbjct: 127 ERR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALES 182

Query: 447 GLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPH 495
            L  I + + DV+SYGV + E  T   +P D +   E+S      E LP 
Sbjct: 183 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ 232

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 75.1 bits (184), Expect = 5e-15
 Identities = 66/210 (31%), Positives = 99/210 (47%), Gaps = 27/210 (12%)

Query: 278 NLLGTSSFGSVYKGTIS-DG--TDVAIKVFN-LQLERAFRSFDSECEVLRNV-RHRNLIK 332
           +++G  +FG V K  I  DG   D AIK       +   R F  E EVL  +  H N+I 
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60

Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYF---------------LDILERLNIMID 377
           +L +  +  +  L +E+ P+G+L  +L                     L   + L+   D
Sbjct: 61  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120

Query: 378 VGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMA 437
           V   ++YL    S    IH DL   NIL+ EN VA ++DFG+ +  G+ E  V++TM   
Sbjct: 121 VARGMDYL----SQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQ-EVYVKKTMGRL 173

Query: 438 TIGYMAPEYGLEGIVSAKCDVYSYGVLLME 467
            + +MA E     + +   DV+SYGVLL E
Sbjct: 174 PVRWMAIESLNYSVYTTNSDVWSYGVLLWE 203

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 74.9 bits (184), Expect = 5e-15
 Identities = 57/217 (26%), Positives = 100/217 (46%), Gaps = 17/217 (7%)

Query: 273 EFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQ------LERAFRSFDSECEVLRNVR 326
           E+ +  +LG  ++G+VY G  + G  +A+K   L        E+ +     E ++L++++
Sbjct: 1   EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK 60

Query: 327 HRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDI-LERLNIMIDVGSALEYL 385
           H N+++ L +  + +  ++ +EF+P GS+   L       +    +    I  G A  YL
Sbjct: 61  HVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVA--YL 118

Query: 386 HNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG-EGEDSVRQTMTMATIG---Y 441
           HN      ++H D+K  N++L  N +  + DFG  + L   G       M  +  G   +
Sbjct: 119 HNN----CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYW 174

Query: 442 MAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEM 478
           MAPE   E     K D++S G  + E  T K P   M
Sbjct: 175 MAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASM 211

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 75.3 bits (186), Expect = 5e-15
 Identities = 62/218 (28%), Positives = 93/218 (42%), Gaps = 36/218 (16%)

Query: 272 DEFNECNLLGTSSFGSVYKGTI-SDGTDVAIKVFNLQLERAFRSFD---SECEVLRNVRH 327
           + F     +G  SFG VYK         VAIKV +L  E A    +    E + L   R 
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDL--EEAEDEIEDIQQEIQFLSQCRS 58

Query: 328 RNLIKILSSYSNPDFK-ALVLEFMPNGSLEKWLYSHNYFLDILE--RLN------IMIDV 378
             + K   S+     K  +++E+   GS           LD+L+  +L+      I+ +V
Sbjct: 59  PYITKYYGSFLK-GSKLWIIMEYCGGGSC----------LDLLKPGKLDETYIAFILREV 107

Query: 379 GSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSV--RQTMTM 436
              LEYLH        IH D+K  NILL E     ++DFG+    G+   ++  R T   
Sbjct: 108 LLGLEYLHEEGK----IHRDIKAANILLSEEGDVKLADFGVS---GQLTSTMSKRNTFV- 159

Query: 437 ATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
            T  +MAPE   +     K D++S G+  +E    + P
Sbjct: 160 GTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPP 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 75.4 bits (185), Expect = 5e-15
 Identities = 71/305 (23%), Positives = 122/305 (40%), Gaps = 54/305 (17%)

Query: 280 LGTSSFGSVYKGT------ISDGTDVAIKVFNLQLERA-FRSFDSECEVLRNVRHRNLIK 332
           LG   FG V K T       +  T VA+K+       +  R   SE  +L+ V H ++IK
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67

Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWL-----------------YSHNYFLDILERLNIM 375
           +  + S      L++E+   GSL  +L                  S          L + 
Sbjct: 68  LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127

Query: 376 I------DVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDS 429
                   +   ++YL    + + ++H DL   N+L+ E     +SDFG+ + + E +  
Sbjct: 128 DLISFAWQISRGMQYL----AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY 183

Query: 430 VRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTR-KRPTDEMFIGEMSLRRW 488
           V+++     + +MA E   + I + + DV+S+GVLL E  T    P    + G    R +
Sbjct: 184 VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP----YPGIAPERLF 239

Query: 489 VKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLK 548
                          NL++         +C   + +  L C  + PD R    D + +L+
Sbjct: 240 ---------------NLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELE 284

Query: 549 KIKVK 553
           K+ VK
Sbjct: 285 KMMVK 289

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 74.7 bits (184), Expect = 7e-15
 Identities = 64/213 (30%), Positives = 98/213 (46%), Gaps = 33/213 (15%)

Query: 280 LGTSSFGSVYKG-TISDGTDVAIKVFNLQLERAFRSFDS---ECEVLRNVRHRNLIKILS 335
           +G  +   VY    + +   VAIK  +L  E+   S D    E + +    H N++K  +
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRIDL--EKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66

Query: 336 SYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNI---MIDVGSALEYLH-NGHSS 391
           S+   D   LV+ ++  GSL   +   +Y    L+   I   + +V   LEYLH NG   
Sbjct: 67  SFVVGDELWLVMPYLSGGSLLD-IMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ-- 123

Query: 392 VHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDS---VRQTMTMATIGYMAPE--- 445
              IH D+K  NILL E+    ++DFG+   L +G D    VR+T  + T  +MAPE   
Sbjct: 124 ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTF-VGTPCWMAPEVME 179

Query: 446 ----YGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
               Y        K D++S+G+  +E  T   P
Sbjct: 180 QVHGYD------FKADIWSFGITAIELATGAAP 206

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 74.4 bits (183), Expect = 9e-15
 Identities = 54/206 (26%), Positives = 92/206 (44%), Gaps = 14/206 (6%)

Query: 280 LGTSSFGSVYKGTISDGTDV--AIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSY 337
           LG  +FG VYK      T +  A K+  ++ E     F  E ++L   +H N++ +  +Y
Sbjct: 13  LGDGAFGKVYK-AQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAY 71

Query: 338 SNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHC 397
              +   +++EF   G+L+  +      L   +   +   +  AL +LH+      +IH 
Sbjct: 72  FYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH----KVIHR 127

Query: 398 DLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGL-EGIVSA-- 454
           DLK  NILL  +    ++DFG+     +     R T  + T  +MAPE    E       
Sbjct: 128 DLKAGNILLTLDGDVKLADFGV-SAKNKSTLQKRDTF-IGTPYWMAPEVVACETFKDNPY 185

Query: 455 --KCDVYSYGVLLMETFTRKRPTDEM 478
             K D++S G+ L+E    + P  E+
Sbjct: 186 DYKADIWSLGITLIELAQMEPPHHEL 211

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 73.8 bits (181), Expect = 1e-14
 Identities = 57/206 (27%), Positives = 99/206 (48%), Gaps = 13/206 (6%)

Query: 280 LGTSSFGSVYKGTI---SDGTDVAIKVFNLQLERAFR-SFDSECEVLRNVRHRNLIKILS 335
           LG+ +FG V KG         DVAIKV   + E++ R     E E++  + +  +++++ 
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 336 SYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHII 395
                +   LV+E    G L K+L      + +   + +M  V   ++YL   +     +
Sbjct: 63  -VCEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN----FV 117

Query: 396 HCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMAT--IGYMAPEYGLEGIVS 453
           H DL   N+LL     A +SDFG+ K LG  +DS  +  +     + + APE       S
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSKALG-ADDSYYKARSAGKWPLKWYAPECINFRKFS 176

Query: 454 AKCDVYSYGVLLMETFTR-KRPTDEM 478
           ++ DV+SYG+ + E F+  ++P  +M
Sbjct: 177 SRSDVWSYGITMWEAFSYGQKPYKKM 202

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 77.2 bits (190), Expect = 1e-14
 Identities = 60/191 (31%), Positives = 90/191 (47%), Gaps = 19/191 (9%)

Query: 296 GTDVAIKVF---NLQLERAFRSFDSECEVLRNVRHRNLIKILSS-YSNPDFKALVLEFMP 351
           G +VAIK+      + E     F  E  +   + H N++ +L S  + P     V E++P
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62

Query: 352 NGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILL---DE 408
             +L + L +    L   E   +M+ V  AL   HN      I+H DLKP NI++     
Sbjct: 63  GRTLREVLAADGA-LPAGETGRLMLQVLDALACAHNQG----IVHRDLKPQNIMVSQTGV 117

Query: 409 NMVAHVSDFGIYKLLGEGEDSVRQTMTMAT--IG---YMAPEYGLEG-IVSAKCDVYSYG 462
              A V DFGI  LL    D+   T+T  T  +G   Y APE  L G  V+   D+Y++G
Sbjct: 118 RPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQ-LRGEPVTPNSDLYAWG 176

Query: 463 VLLMETFTRKR 473
           ++ +E  T +R
Sbjct: 177 LIFLECLTGQR 187

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 73.3 bits (180), Expect = 3e-14
 Identities = 69/228 (30%), Positives = 110/228 (48%), Gaps = 38/228 (16%)

Query: 268 QRATDEFNECNLLGTSSFGSVYKGTISD-GTDVAIKVFNLQLER------AFRSFDSECE 320
           +R  D+F+    +G  ++G VYK    D G  VA+K   L  E+      A R    E +
Sbjct: 3   KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR----EIK 58

Query: 321 VLRNVRHRNLIK---ILSSYSNP-DFKA------LVLEFMPN---GSLEKWL--YSHNYF 365
           +LR + HRN++    I++   +  DFK       LV E+M +   G LE  L  +S ++ 
Sbjct: 59  ILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHI 118

Query: 366 LDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGE 425
              +++L   ++    L Y H  +     +H D+K +NILL+      ++DFG+ +L   
Sbjct: 119 KSFMKQL---LE---GLNYCHKKN----FLHRDIKCSNILLNNKGQIKLADFGLARLY-N 167

Query: 426 GEDSVRQTMTMATIGYMAPEYGL-EGIVSAKCDVYSYGVLLMETFTRK 472
            E+S   T  + T+ Y  PE  L E       DV+S G +L E FT+K
Sbjct: 168 SEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 72.4 bits (177), Expect = 3e-14
 Identities = 64/230 (27%), Positives = 111/230 (48%), Gaps = 15/230 (6%)

Query: 280 LGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSN 339
           LG   FG V+  T +  T VA+K        +  +F +E  V++ ++H  L+K L +   
Sbjct: 14  LGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVK-LHAVVT 71

Query: 340 PDFKALVLEFMPNGSLEKWLYSHNYFLDILERL-NIMIDVGSALEYLHNGHSSVHIIHCD 398
            +   ++ EFM  GSL  +L S       L +L +    +   + ++   +     IH D
Sbjct: 72  KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN----YIHRD 127

Query: 399 LKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDV 458
           L+  NIL+  ++V  ++DFG+ +++ + E + R+      I + APE    G  + K DV
Sbjct: 128 LRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFP-IKWTAPEAINFGSFTIKSDV 186

Query: 459 YSYGVLLMETFTRKR-PTDEMFIGEM--SLRRWVK----ESLPHGLTEVV 501
           +S+G+LLME  T  R P   M   E+  +L R  +    E+ P  L  ++
Sbjct: 187 WSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIM 236

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 72.9 bits (179), Expect = 3e-14
 Identities = 60/201 (29%), Positives = 99/201 (49%), Gaps = 12/201 (5%)

Query: 280 LGTSSFGSVYK-GTISDGTDVAIKVFNLQLERAFR-SFDSECEVLRNVRHRNLIKILSSY 337
           LG  + GSV K   I  GT +A KV ++  + + R     E +++   R   ++    ++
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72

Query: 338 SNPDFKALVLEFMPNGSLEKWLYSHNYF-LDILERLNIMIDVGSALEYLHNGHSSVHIIH 396
            N +   + +EFM  GSL++         ++IL +  I + V   L YL+N H    I+H
Sbjct: 73  LNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGK--IAVAVVEGLTYLYNVH---RIMH 127

Query: 397 CDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKC 456
            D+KP+NIL++      + DFG+    GE  +S+  T  + T  YM+PE    G  + K 
Sbjct: 128 RDIKPSNILVNSRGQIKLCDFGVS---GELINSIADTF-VGTSTYMSPERIQGGKYTVKS 183

Query: 457 DVYSYGVLLMETFTRKRPTDE 477
           DV+S G+ ++E    K P   
Sbjct: 184 DVWSLGISIIELALGKFPFAF 204

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 72.9 bits (179), Expect = 3e-14
 Identities = 60/218 (27%), Positives = 100/218 (45%), Gaps = 36/218 (16%)

Query: 272 DEFNECNLLGTSSFGSVY--KGTISDGTDVAIKVFNL-------QLERAFRSFDSECEVL 322
           D+      +GT +FG V+  +  IS     A+KV  +       Q +       +E  VL
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRIS-EHYYALKVMAIPEVIRLKQEQHV----HNEKRVL 55

Query: 323 RNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSAL 382
           + V H  +I++  +  +  F  +++E++P G L  +L +   F +         ++  AL
Sbjct: 56  KEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLF-YASEIVCAL 114

Query: 383 EYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTM-ATIGY 441
           EYLH    S  I++ DLKP NILLD+     ++DFG  K L        +T T+  T  Y
Sbjct: 115 EYLH----SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKL------RDRTWTLCGTPEY 164

Query: 442 MAPEYGLEGIVSAK-----CDVYSYGVLLMETFTRKRP 474
           +APE     ++ +K      D ++ G+L+ E      P
Sbjct: 165 LAPE-----VIQSKGHNKAVDWWALGILIYEMLVGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 71.9 bits (176), Expect = 7e-14
 Identities = 62/211 (29%), Positives = 102/211 (48%), Gaps = 23/211 (10%)

Query: 279 LLGTSSFGSVYKGTI--SDGT--DVAIKVFNLQLERA--FRSFDSECEVLRNVRHRNLIK 332
           +LG   FGSV +  +   DG+   VA+K+    +  +     F  E   ++   H N+IK
Sbjct: 6   MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65

Query: 333 IL--SSYSNPDFK----ALVLEFMPNGSLEKWLYSHN-----YFLDILERLNIMIDVGSA 381
           ++  S  S    +     ++L FM +G L  +L         + L +   +  MID+ S 
Sbjct: 66  LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125

Query: 382 LEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQ-TMTMATIG 440
           +EYL    SS + IH DL   N +L+ENM   V+DFG+ K +  G D  RQ   +   + 
Sbjct: 126 MEYL----SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSG-DYYRQGCASKLPVK 180

Query: 441 YMAPEYGLEGIVSAKCDVYSYGVLLMETFTR 471
           ++A E   + + +   DV+++GV + E  TR
Sbjct: 181 WLALESLADNVYTTHSDVWAFGVTMWEIMTR 211

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 72.0 bits (177), Expect = 7e-14
 Identities = 45/177 (25%), Positives = 80/177 (45%), Gaps = 16/177 (9%)

Query: 314 SFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILER-- 371
            F  E ++L  +   N+ ++L   +      +++E+M NG L ++L  H      L    
Sbjct: 65  DFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNS 124

Query: 372 --------LNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLL 423
                   L +   + S + YL     S++ +H DL   N L+ +N    ++DFG+ + L
Sbjct: 125 KSLSFSTLLYMATQIASGMRYL----ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNL 180

Query: 424 GEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT--RKRPTDEM 478
              +    Q      I +MA E  L G  + K DV+++GV L E  T  R++P + +
Sbjct: 181 YSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL 237

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 72.5 bits (178), Expect = 8e-14
 Identities = 71/234 (30%), Positives = 112/234 (47%), Gaps = 28/234 (11%)

Query: 279 LLGTSSFGSVY---KGTISD-GTDVAIKVF---NLQLERAFRSFDSECEVLRNVRHRNLI 331
           +LG  SFG V+   K T  D G   A+KV     L++    R+   E ++L  V H  ++
Sbjct: 3   VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRT-KMERDILAEVNHPFIV 61

Query: 332 KILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNI-MIDVGSALEYLHNGHS 390
           K+  ++       L+L+F+  G L   L     F +  E +   + ++  AL++LH    
Sbjct: 62  KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTE--EDVKFYLAELALALDHLH---- 115

Query: 391 SVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTM-ATIGYMAPEYGLE 449
           S+ II+ DLKP NILLDE     ++DFG+ K   E  D  ++  +   T+ YMAPE    
Sbjct: 116 SLGIIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCGTVEYMAPEVVNR 172

Query: 450 GIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGE-----MSLRRWVKESLPHGLT 498
              +   D +S+GVL+ E  T   P    F G+     M++    K  +P  L+
Sbjct: 173 RGHTQSADWWSFGVLMFEMLTGSLP----FQGKDRKETMTMILKAKLGMPQFLS 222

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 72.0 bits (176), Expect = 9e-14
 Identities = 64/241 (26%), Positives = 109/241 (45%), Gaps = 12/241 (4%)

Query: 273 EFNECNLLGTSSFGSVYKGT-ISDGTDV----AIKVFNLQL-ERAFRSFDSECEVLRNVR 326
           E     +LG+ +FG+VYKG  + +G  V    AIK+ N     +A   F  E  ++ ++ 
Sbjct: 8   ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMD 67

Query: 327 HRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH 386
           H +L+++L    +P  + LV + MP+G L  +++ H   +     LN  + +   + YL 
Sbjct: 68  HPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE 126

Query: 387 NGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEY 446
                  ++H DL   N+L+       ++DFG+ +LL   E           I +MA E 
Sbjct: 127 ERR----LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALEC 182

Query: 447 GLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANL 505
                 + + DV+SYGV + E  T   +P D +   E+       E LP      +D  +
Sbjct: 183 IHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVYM 242

Query: 506 V 506
           V
Sbjct: 243 V 243

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 71.4 bits (175), Expect = 9e-14
 Identities = 61/239 (25%), Positives = 106/239 (44%), Gaps = 28/239 (11%)

Query: 279 LLGTSSFGSVYK--GTISDGTDVAIKVFNL----------QLERAFRSFDSECEVLR-NV 325
            LG+ +FG VYK     +    +A+K  N+          + +++     SE  +++  +
Sbjct: 7   HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66

Query: 326 RHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYS----HNYFLDILERL-NIMIDVGS 380
           RH N+++   ++   D   +V++ +    L +   S       F +  ER+ NI + +  
Sbjct: 67  RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTE--ERIWNIFVQMVL 124

Query: 381 ALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIG 440
           AL YLH       I+H DL P NI+L E+    ++DFG+ K         + T  + TI 
Sbjct: 125 ALRYLHK---EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES---KLTSVVGTIL 178

Query: 441 YMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRP--TDEMFIGEMSLRRWVKESLPHGL 497
           Y  PE         K DV+++G +L +  T + P  +  M      +   V E LP G+
Sbjct: 179 YSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGM 237

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 71.2 bits (174), Expect = 1e-13
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 19/205 (9%)

Query: 280 LGTSSFGSVYKGT-ISDGTDVAIK---VFNLQLERAFRSFDSECEVLRNVRHRNLIKILS 335
           +G   F  VY+ T + DG  VA+K   +F+L   +A      E ++L+ + H N+IK  +
Sbjct: 10  IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69

Query: 336 SYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNI---MIDVGSALEYLHNGHSSV 392
           S+   +   +VLE    G L + +        ++    +    + + SALE++H    S 
Sbjct: 70  SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH----SR 125

Query: 393 HIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIG---YMAPEYGLE 449
            ++H D+KP N+ +    V  + D G+ +       S + T   + +G   YM+PE   E
Sbjct: 126 RVMHRDIKPANVFITATGVVKLGDLGLGRFF-----SSKTTAAHSLVGTPYYMSPERIHE 180

Query: 450 GIVSAKCDVYSYGVLLMETFTRKRP 474
              + K D++S G LL E    + P
Sbjct: 181 NGYNFKSDIWSLGCLLYEMAALQSP 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 71.3 bits (175), Expect = 1e-13
 Identities = 59/216 (27%), Positives = 92/216 (42%), Gaps = 41/216 (18%)

Query: 272 DEFNECNLLGTSSFGSVYKGTI-SDGTDVAIKVFNL--------QLERAFRSFDSECEVL 322
           ++  E + LG  + GSV K  + + G   A+K            Q+ R       E E+ 
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILR-------ELEIN 53

Query: 323 RNVRHRNLIKILSSYSNPDFK--ALVLEFMPNGSLEKWLYSHNYFLDILER--------- 371
           ++ +   ++K   ++ +       + +E+   GSL+  +Y       + +R         
Sbjct: 54  KSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDS-IYK-----KVKKRGGRIGEKVL 107

Query: 372 LNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVR 431
             I   V   L YLH    S  IIH D+KP+NILL       + DFG+    GE  +S+ 
Sbjct: 108 GKIAESVLKGLSYLH----SRKIIHRDIKPSNILLTRKGQVKLCDFGVS---GELVNSLA 160

Query: 432 QTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLME 467
            T T  T  YMAPE       S   DV+S G+ L+E
Sbjct: 161 GTFT-GTSFYMAPERIQGKPYSITSDVWSLGLTLLE 195

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 71.1 bits (174), Expect = 1e-13
 Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 11/206 (5%)

Query: 271 TDEFNECNLLGTSSFGSVYKGT-ISDGTD----VAIKVF-NLQLERAFRSFDSECEVLRN 324
             E  +  LLG+  FG+V+KG  I +G      VAIK   +    + F+        + +
Sbjct: 6   ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGS 65

Query: 325 VRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEY 384
           + H  ++++L        + LV +  P GSL   +  H   LD    LN  + +   + Y
Sbjct: 66  LDHAYIVRLLGICPGASLQ-LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYY 124

Query: 385 LHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAP 444
           L        ++H +L   NILL  + +  ++DFG+  LL   +     +     I +MA 
Sbjct: 125 LEEHR----MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMAL 180

Query: 445 EYGLEGIVSAKCDVYSYGVLLMETFT 470
           E  L G  + + DV+SYGV + E  +
Sbjct: 181 ESILFGRYTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 70.5 bits (173), Expect = 2e-13
 Identities = 56/215 (26%), Positives = 95/215 (44%), Gaps = 16/215 (7%)

Query: 267 IQRATDEFNECNLLGTSSFGSVYKGT----ISDGTDVAIKVFNLQLERAFRS-FDSECEV 321
           IQR       C  +G   FG VY+G      ++   VA+K        + R  F  E  +
Sbjct: 3   IQREDITLGRC--IGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYI 60

Query: 322 LRNVRHRNLIKILSSYS-NPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGS 380
           +R   H +++K++   + NP +  +V+E  P G L  +L  + Y LD+   +     + +
Sbjct: 61  MRQFDHPHIVKLIGVITENPVW--IVMELAPLGELRSYLQVNKYSLDLASLILYSYQLST 118

Query: 381 ALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIG 440
           AL YL     S   +H D+   N+L+       + DFG+ + L E E   + +     I 
Sbjct: 119 ALAYLE----SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL-EDESYYKASKGKLPIK 173

Query: 441 YMAPEYGLEGIVSAKCDVYSYGVLLMETFTR-KRP 474
           +MAPE       ++  DV+ +GV + E      +P
Sbjct: 174 WMAPESINFRRFTSASDVWMFGVCMWEILMLGVKP 208

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 70.6 bits (174), Expect = 2e-13
 Identities = 44/150 (29%), Positives = 70/150 (46%), Gaps = 12/150 (8%)

Query: 274 FNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRSFDSEC--EV--LRNVRHR 328
           + +   LG  ++G VYK      G  VA+K   ++L+       S    E+  L+ ++H 
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKK--IRLDNEEEGIPSTALREISLLKELKHP 58

Query: 329 NLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNG 388
           N++K+L          LV E+     L+K+L      L      +IM  +   L Y H  
Sbjct: 59  NIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH-- 115

Query: 389 HSSVHIIHCDLKPTNILLDENMVAHVSDFG 418
             S  I+H DLKP NIL++ + V  ++DFG
Sbjct: 116 --SHRILHRDLKPQNILINRDGVLKLADFG 143

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 71.0 bits (174), Expect = 2e-13
 Identities = 65/206 (31%), Positives = 85/206 (41%), Gaps = 18/206 (8%)

Query: 280 LGTSSFGSVYKGT-ISDGTDVAIKVFNL---QLERAFRSFDSECEVLRNVRHRNLIKILS 335
           +G  SFG+VY    +     VAIK  +    Q    ++    E   L+ +RH N I+   
Sbjct: 23  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82

Query: 336 SYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHII 395
            Y       LV+E+   GS    L  H   L  +E   I       L YLH    S   I
Sbjct: 83  CYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLH----SHERI 137

Query: 396 HCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGL---EGIV 452
           H D+K  NILL E     ++DFG   L+      V       T  +MAPE  L   EG  
Sbjct: 138 HRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV------GTPYWMAPEVILAMDEGQY 191

Query: 453 SAKCDVYSYGVLLMETFTRKRPTDEM 478
             K DV+S G+  +E   RK P   M
Sbjct: 192 DGKVDVWSLGITCIELAERKPPLFNM 217

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 70.5 bits (172), Expect = 2e-13
 Identities = 62/208 (29%), Positives = 101/208 (48%), Gaps = 13/208 (6%)

Query: 280 LGTSSFGSVYKG-TISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYS 338
           +G  + G+VY    I+ G +VAIK  NLQ +       +E  V+R  ++ N++  L SY 
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86

Query: 339 NPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCD 398
             D   +V+E++  GSL   +      +D  +   +  +   AL++LH    S  +IH D
Sbjct: 87  VGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLH----SNQVIHRD 140

Query: 399 LKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDV 458
           +K  NILL  +    ++DFG    +   E S R TM + T  +MAPE         K D+
Sbjct: 141 IKSDNILLGMDGSVKLTDFGFCAQITP-EQSKRSTM-VGTPYWMAPEVVTRKAYGPKVDI 198

Query: 459 YSYGVLLMETFTRKRPTDEMFIGEMSLR 486
           +S G++ +E    + P    ++ E  LR
Sbjct: 199 WSLGIMAIEMVEGEPP----YLNENPLR 222

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 70.1 bits (171), Expect = 3e-13
 Identities = 57/208 (27%), Positives = 102/208 (49%), Gaps = 13/208 (6%)

Query: 280 LGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYS 338
           +G  + G+V+    ++ G +VAIK  NLQ +       +E  V++ +++ N++  L S+ 
Sbjct: 27  IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86

Query: 339 NPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCD 398
             D   +V+E++  GSL   +      +D  +   +  +   ALE+LH    +  +IH D
Sbjct: 87  VGDELFVVMEYLAGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLH----ANQVIHRD 140

Query: 399 LKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDV 458
           +K  N+LL  +    ++DFG    +   E S R TM + T  +MAPE         K D+
Sbjct: 141 IKSDNVLLGMDGSVKLTDFGFCAQITP-EQSKRSTM-VGTPYWMAPEVVTRKAYGPKVDI 198

Query: 459 YSYGVLLMETFTRKRPTDEMFIGEMSLR 486
           +S G++ +E    + P    ++ E  LR
Sbjct: 199 WSLGIMAIEMVEGEPP----YLNENPLR 222

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 72.2 bits (177), Expect = 4e-13
 Identities = 45/125 (36%), Positives = 65/125 (52%), Gaps = 14/125 (11%)

Query: 45  TNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIP-----PCL 99
            N+++++ +DL   + SG I +    L ++         I L+ N+L G IP        
Sbjct: 66  NNSSRVVSIDLSGKNISGKISSAIFRLPYIQT-------INLSNNQLSGPIPDDIFTTSS 118

Query: 100 VLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNL 159
            L  L++S N  +G IP   G   +LETL L++N   G IP  +GS  SL+ LDL GN L
Sbjct: 119 SLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVL 176

Query: 160 SGKIP 164
            GKIP
Sbjct: 177 VGKIP 181

Length = 968

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 68.7 bits (168), Expect = 8e-13
 Identities = 60/215 (27%), Positives = 93/215 (43%), Gaps = 33/215 (15%)

Query: 279 LLGTSSFGSVYKGT-ISDGTDVAIKVFNLQ------LERAFRSFDSECEVLRNVRHRNLI 331
            LGT +F S Y+   +  GT +A+K            E    +   E  ++  + H ++I
Sbjct: 7   QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66

Query: 332 KILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSS 391
           ++L +        L +E+M  GS+   L  +  F + +  +N    +   L YLH     
Sbjct: 67  RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVI-INYTEQLLRGLSYLHEN--- 122

Query: 392 VHIIHCDLKPTNILLDEN-MVAHVSDFGI-----YKLLGEGEDSVRQTMTMATIGYMAPE 445
             IIH D+K  N+L+D       ++DFG       K  G GE    Q   + TI +MAPE
Sbjct: 123 -QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGE---FQGQLLGTIAFMAPE 178

Query: 446 ------YGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
                 YG        CDV+S G +++E  T K P
Sbjct: 179 VLRGEQYG------RSCDVWSVGCVIIEMATAKPP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 69.0 bits (168), Expect = 8e-13
 Identities = 61/208 (29%), Positives = 101/208 (48%), Gaps = 13/208 (6%)

Query: 280 LGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYS 338
           +G  + G+VY    ++ G +VAI+  NLQ +       +E  V+R  ++ N++  L SY 
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87

Query: 339 NPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCD 398
             D   +V+E++  GSL   +      +D  +   +  +   ALE+LH    S  +IH D
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLH----SNQVIHRD 141

Query: 399 LKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDV 458
           +K  NILL  +    ++DFG    +   E S R TM + T  +MAPE         K D+
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQITP-EQSKRSTM-VGTPYWMAPEVVTRKAYGPKVDI 199

Query: 459 YSYGVLLMETFTRKRPTDEMFIGEMSLR 486
           +S G++ +E    + P    ++ E  LR
Sbjct: 200 WSLGIMAIEMIEGEPP----YLNENPLR 223

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 68.3 bits (167), Expect = 8e-13
 Identities = 59/196 (30%), Positives = 89/196 (45%), Gaps = 10/196 (5%)

Query: 280 LGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSN 339
           LG+  FG V+ G       VAIK  N +   +   F  E +V+  + H  L+++    + 
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKAIN-EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ 70

Query: 340 PDFKALVLEFMPNGSLEKWLYSHNYFL--DILERLNIMIDVGSALEYLHNGHSSVHIIHC 397
                +V EFM NG L  +L      L  D+L  L++  DV   +EYL         IH 
Sbjct: 71  QKPLYIVTEFMENGCLLNYLRQRQGKLSKDML--LSMCQDVCEGMEYLERNS----FIHR 124

Query: 398 DLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCD 457
           DL   N L+    V  VSDFG+ + + + E     +     + +  PE       S+K D
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLDDE-YTSSSGAKFPVKWSPPEVFNFSKYSSKSD 183

Query: 458 VYSYGVLLMETFTRKR 473
           V+S+GVL+ E FT  +
Sbjct: 184 VWSFGVLMWEVFTEGK 199

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 68.5 bits (167), Expect = 1e-12
 Identities = 56/208 (26%), Positives = 97/208 (46%), Gaps = 12/208 (5%)

Query: 274 FNECNLLGTSSFGSVYKGTISDGTD--VAIKVFNLQ-LERAFRSFDSECEVLRNVRHRNL 330
           F +   +G  SFG V+KG I + T   VAIK+ +L+  E        E  VL       +
Sbjct: 6   FTKLERIGKGSFGEVFKG-IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 64

Query: 331 IKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHS 390
            K   SY       +++E++  GS    L +  +  D  +   ++ ++   L+YLH    
Sbjct: 65  TKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPF--DEFQIATMLKEILKGLDYLH---- 118

Query: 391 SVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEG 450
           S   IH D+K  N+LL E     ++DFG+   L + +  +++   + T  +MAPE   + 
Sbjct: 119 SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IKRNTFVGTPFWMAPEVIQQS 176

Query: 451 IVSAKCDVYSYGVLLMETFTRKRPTDEM 478
              +K D++S G+  +E    + P  +M
Sbjct: 177 AYDSKADIWSLGITAIELAKGEPPNSDM 204

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 68.2 bits (166), Expect = 1e-12
 Identities = 56/207 (27%), Positives = 96/207 (46%), Gaps = 25/207 (12%)

Query: 272 DEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNL 330
           ++F     +G+ ++G VYK   ++ G   AIKV  L+    F     E  ++++ +H N+
Sbjct: 9   EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNI 68

Query: 331 IKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHS 390
           +    SY   D   + +EF   GSL+  +Y     L   +   +  +    L YLH+   
Sbjct: 69  VAYFGSYLRRDKLWICMEFCGGGSLQD-IYHVTGPLSESQIAYVSRETLQGLYYLHSKGK 127

Query: 391 SVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMAT----IG---YMA 443
               +H D+K  NILL +N    ++DFG+         S + T T+A     IG   +MA
Sbjct: 128 ----MHRDIKGANILLTDNGHVKLADFGV---------SAQITATIAKRKSFIGTPYWMA 174

Query: 444 PEYGL---EGIVSAKCDVYSYGVLLME 467
           PE      +G  +  CD+++ G+  +E
Sbjct: 175 PEVAAVERKGGYNQLCDIWAVGITAIE 201

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 68.1 bits (166), Expect = 1e-12
 Identities = 59/233 (25%), Positives = 102/233 (43%), Gaps = 20/233 (8%)

Query: 270 ATDEFNECNLLGTSSFGSVY----KGTISDG--TDVAIKVFNLQLERAFR-SFDSECEVL 322
           A ++      LG  SFG VY    KG + D   T VAIK  N       R  F +E  V+
Sbjct: 4   AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 63

Query: 323 RNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYS-----HNYFLDILERLNIMI- 376
           +     +++++L   S      +++E M  G L+ +L S      N  +     L  MI 
Sbjct: 64  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQ 123

Query: 377 ---DVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQT 433
              ++   + YL    ++   +H DL   N ++ E+    + DFG+ + + E +   +  
Sbjct: 124 MAGEIADGMAYL----NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 179

Query: 434 MTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLR 486
             +  + +M+PE   +G+ +   DV+S+GV+L E  T      +    E  LR
Sbjct: 180 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLR 232

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 68.3 bits (167), Expect = 1e-12
 Identities = 57/249 (22%), Positives = 105/249 (42%), Gaps = 30/249 (12%)

Query: 276 ECNLLGTSSFGSVY----KGTISDGTD--VAIKVFN-LQLERAFRSFDSECEVLRNVRHR 328
           E   LG   FG V+    KG   +G +  V +K     + E     F  E ++ R + H+
Sbjct: 9   EITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHK 68

Query: 329 NLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDIL--------ERLNIMIDVGS 380
           N++++L      +   ++LE+   G L+++L +     + L        +++ +   +  
Sbjct: 69  NVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIAL 128

Query: 381 ALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGE-DSVRQTMTMATI 439
            +++L N       +H DL   N L+       VS   + K +   E   +R  +    +
Sbjct: 129 GMDHLSNAR----FVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNAL--IPL 182

Query: 440 GYMAPEYGLEGIVSAKCDVYSYGVLLMETFTR------KRPTDEMF--IGEMSLRRWVKE 491
            ++APE   E   S K DV+S+GVL+ E FT+          +E+   +    L   V E
Sbjct: 183 RWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPE 242

Query: 492 SLPHGLTEV 500
             P  L ++
Sbjct: 243 GCPSRLYKL 251

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 68.5 bits (167), Expect = 1e-12
 Identities = 57/216 (26%), Positives = 101/216 (46%), Gaps = 29/216 (13%)

Query: 280 LGTSSFGSVY--------KGTISDGTDVAIKVFNLQL-ERAFRSFDSECEVLRNV-RHRN 329
           LG   FG V         K   +  T VA+K+      E+      SE E+++ + +H+N
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 330 LIKILSSYSNPDFKALVLEFMPNGSLEKWL---------YSHN------YFLDILERLNI 374
           +I +L + +      +++E+   G+L ++L         Y +N        L   + ++ 
Sbjct: 86  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145

Query: 375 MIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTM 434
              V   +EYL    +S   IH DL   N+L+ E+ V  ++DFG+ + +   +   + T 
Sbjct: 146 AYQVARGMEYL----ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 201

Query: 435 TMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
               + +MAPE   + I + + DV+S+GVLL E FT
Sbjct: 202 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 68.3 bits (167), Expect = 1e-12
 Identities = 63/207 (30%), Positives = 91/207 (43%), Gaps = 19/207 (9%)

Query: 280 LGTSSFGSVY----KGTISDGTDVAIKVFN----LQLERAFRSFDSECEVLRNVRHRNLI 331
           LGT ++G V+     G    G   A+KV      +Q  +      +E +VL  VR    +
Sbjct: 8   LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67

Query: 332 KILSSYSNPDFKA-LVLEFMPNGSLEKWLYSHNYFLDILERLNIMI-DVGSALEYLHNGH 389
             L      D K  L+L+++  G L   LY   +F      + + I ++  AL++LH   
Sbjct: 68  VTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHF--TESEVRVYIAEIVLALDHLHQ-- 123

Query: 390 SSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEY--G 447
             + II+ D+K  NILLD      ++DFG+ K     E+  R      TI YMAPE   G
Sbjct: 124 --LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE-RAYSFCGTIEYMAPEVIRG 180

Query: 448 LEGIVSAKCDVYSYGVLLMETFTRKRP 474
             G      D +S GVL  E  T   P
Sbjct: 181 GSGGHDKAVDWWSLGVLTFELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 68.9 bits (169), Expect = 1e-12
 Identities = 60/197 (30%), Positives = 89/197 (45%), Gaps = 39/197 (19%)

Query: 296 GTDVAIKV---FNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKA-----L 345
           G  VAIK    F  Q   +R  R    E ++LR  +H N+I IL     P F++     +
Sbjct: 30  GVKVAIKKISPFEHQTFCQRTLR----EIKILRRFKHENIIGILDIIRPPSFESFNDVYI 85

Query: 346 VLEFMPNGSLEKWLYSHN-------YFL-DILERLNIMIDVGSALEYLHNGHSSVHIIHC 397
           V E M    L K + + +       YFL  IL            L+Y+H    S +++H 
Sbjct: 86  VQELMET-DLYKLIKTQHLSNDHIQYFLYQILR----------GLKYIH----SANVLHR 130

Query: 398 DLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQ-TMTMATIGYMAPEYGLEGIVSAKC 456
           DLKP+N+LL+ N    + DFG+ ++     D     T  +AT  Y APE  L      K 
Sbjct: 131 DLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKA 190

Query: 457 -DVYSYGVLLMETFTRK 472
            D++S G +L E  + +
Sbjct: 191 IDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 67.9 bits (166), Expect = 1e-12
 Identities = 50/200 (25%), Positives = 83/200 (41%), Gaps = 12/200 (6%)

Query: 280 LGTSSFGSVYKGTISD-GTDVAIKVFN---LQLERAFRSFDSECEVLRNVRHRNLIKILS 335
           LG   FG V    +   G   A K  +   L+  +  +   +E ++L  V  R ++ +  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 336 SYSNPDFKALVLEFMPNGSLEKWLYSHNYF-LDILERLNIMIDVGSALEYLHNGHSSVHI 394
           ++   D   LV+  M  G L+  +Y+           +     +   LE+LH       I
Sbjct: 61  AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQ----RRI 116

Query: 395 IHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSA 454
           ++ DLKP N+LLD++    +SD G+   L  G+   +      T GYMAPE     +   
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKGRAGTPGYMAPEVLQGEVYDF 173

Query: 455 KCDVYSYGVLLMETFTRKRP 474
             D ++ G  L E    + P
Sbjct: 174 SVDWFALGCTLYEMIAGRSP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 68.3 bits (167), Expect = 1e-12
 Identities = 55/213 (25%), Positives = 99/213 (46%), Gaps = 20/213 (9%)

Query: 273 EFNECNL-----LGTSSFGSVYKGT---ISDGTDVAIKVFNLQLERAFRSFD-----SEC 319
           EF   NL     LG  +FG V + T   +S  +D  +KV    L+    S +     SE 
Sbjct: 31  EFPRNNLSFGKTLGAGAFGKVVEATAYGLSK-SDAVMKVAVKMLKPTAHSSEREALMSEL 89

Query: 320 EVLRNV-RHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNY-FLDILERLNIMID 377
           +++ ++  H N++ +L + +      ++ E+   G L  +L      FL + + L+    
Sbjct: 90  KIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQ 149

Query: 378 VGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMA 437
           V   + +L    +S + IH DL   N+LL    +  + DFG+ + +    + V +     
Sbjct: 150 VAKGMAFL----ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARL 205

Query: 438 TIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
            + +MAPE     + + + DV+SYG+LL E F+
Sbjct: 206 PVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 67.9 bits (167), Expect = 2e-12
 Identities = 45/150 (30%), Positives = 71/150 (47%), Gaps = 23/150 (15%)

Query: 280 LGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVR-------HRNLI 331
           LG  +FGSVY       G  VAIK    ++++ F S++ EC  LR V+       H N++
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIK----KMKKKFYSWE-ECMNLREVKSLRKLNEHPNIV 61

Query: 332 KILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERL--NIMIDVGSALEYLH-NG 388
           K+   +   D    V E+M  G+L + L          E +  +I+  +   L ++H +G
Sbjct: 62  KLKEVFRENDELYFVFEYM-EGNLYQ-LMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG 119

Query: 389 HSSVHIIHCDLKPTNILLDENMVAHVSDFG 418
                  H DLKP N+L+    V  ++DFG
Sbjct: 120 F-----FHRDLKPENLLVSGPEVVKIADFG 144

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 68.3 bits (167), Expect = 2e-12
 Identities = 56/175 (32%), Positives = 83/175 (47%), Gaps = 20/175 (11%)

Query: 280 LGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRSFDSECEV-------LRNVRHRNLI 331
           +G  SFG V      +DG   A+KV     ++A      +  +       L+NV+H  L+
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQ---KKAILKKKEQKHIMAERNVLLKNVKHPFLV 59

Query: 332 KILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSS 391
            +  S+   D    VL+++  G L   L     F +   R     ++ SAL YLH    S
Sbjct: 60  GLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARF-YAAEIASALGYLH----S 114

Query: 392 VHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTM-ATIGYMAPE 445
           ++II+ DLKP NILLD      ++DFG+ K   EG +  + T T   T  Y+APE
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCK---EGIEHSKTTSTFCGTPEYLAPE 166

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 67.7 bits (166), Expect = 2e-12
 Identities = 59/206 (28%), Positives = 89/206 (43%), Gaps = 30/206 (14%)

Query: 279 LLGTSSFGSVYKGTISD-GTDVAIKVF------NLQLERAFRSFDSECEVLRNVRHRNLI 331
           ++G  ++G V K      G  VAIK F          + A R    E +VLR +RH N++
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALR----EVKVLRQLRHENIV 63

Query: 332 KILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSS 391
            +  ++       LV E++    LE  L +    L      + +  +  A+ Y H    S
Sbjct: 64  NLKEAFRRKGRLYLVFEYVERTLLEL-LEASPGGLPPDAVRSYIWQLLQAIAYCH----S 118

Query: 392 VHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPE------ 445
            +IIH D+KP NIL+ E+ V  + DFG  + L     S   T  +AT  Y APE      
Sbjct: 119 HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS-PLTDYVATRWYRAPELLVGDT 177

Query: 446 -YGLEGIVSAKCDVYSYGVLLMETFT 470
            YG         DV++ G ++ E   
Sbjct: 178 NYG------KPVDVWAIGCIMAELLD 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 67.4 bits (164), Expect = 2e-12
 Identities = 58/208 (27%), Positives = 97/208 (46%), Gaps = 12/208 (5%)

Query: 274 FNECNLLGTSSFGSVYKGTISDGTD--VAIKVFNLQ-LERAFRSFDSECEVLRNVRHRNL 330
           F +   +G  SFG V+KG I + T   VAIK+ +L+  E        E  VL       +
Sbjct: 6   FTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 64

Query: 331 IKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHS 390
            K   SY       +++E++  GS    L      LD  +   I+ ++   L+YLH    
Sbjct: 65  TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLH---- 118

Query: 391 SVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEG 450
           S   IH D+K  N+LL E+    ++DFG+   L + +  +++   + T  +MAPE   + 
Sbjct: 119 SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--IKRNTFVGTPFWMAPEVIKQS 176

Query: 451 IVSAKCDVYSYGVLLMETFTRKRPTDEM 478
              +K D++S G+  +E    + P  E+
Sbjct: 177 AYDSKADIWSLGITAIELAKGEPPHSEL 204

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 67.4 bits (165), Expect = 2e-12
 Identities = 58/203 (28%), Positives = 92/203 (45%), Gaps = 25/203 (12%)

Query: 279 LLGTSSFGSVYKGTISD-GTDVAIKVFNLQLER---------AFRSFDSECEVLRNVRHR 328
           L+G  S+G V K    + G  VAIK F   LE          A R    E  +L+ +RH 
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKF---LESEDDKMVKKIAMR----EIRMLKQLRHE 60

Query: 329 NLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNG 388
           NL+ ++  +       LV EF+ +  L+  L  +   LD       +  +   +E+ H+ 
Sbjct: 61  NLVNLIEVFRRKKRLYLVFEFVDHTVLDD-LEKYPNGLDESRVRKYLFQILRGIEFCHSH 119

Query: 389 HSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGL 448
           +    IIH D+KP NIL+ ++ V  + DFG  + L    +    T  +AT  Y APE  +
Sbjct: 120 N----IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY--TDYVATRWYRAPELLV 173

Query: 449 EGIVSAK-CDVYSYGVLLMETFT 470
                 +  D+++ G L+ E  T
Sbjct: 174 GDTKYGRAVDIWAVGCLVTEMLT 196

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 67.0 bits (163), Expect = 3e-12
 Identities = 60/214 (28%), Positives = 100/214 (46%), Gaps = 27/214 (12%)

Query: 280 LGTSSFGSVYKGT-ISDGTDVAIK---VFNLQLERAFRSFDSECEVLRNVRHRNLIKILS 335
           +G   F  VY+ T + D   VA+K   +F +   +A +    E ++L+ + H N+IK L 
Sbjct: 10  IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69

Query: 336 SYSNPDFKALVLEFMPNGSLEKWLYSHNYFLD----ILERL--NIMIDVGSALEYLHNGH 389
           S+   +   +VLE    G L + +    YF      I ER      + + SA+E++H   
Sbjct: 70  SFIEDNELNIVLELADAGDLSQMI---KYFKKQKRLIPERTVWKYFVQLCSAVEHMH--- 123

Query: 390 SSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIG---YMAPEY 446
            S  ++H D+KP N+ +    V  + D G+ +       S + T   + +G   YM+PE 
Sbjct: 124 -SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF-----SSKTTAAHSLVGTPYYMSPER 177

Query: 447 GLEGIVSAKCDVYSYGVLLMETFTRKRP--TDEM 478
             E   + K D++S G LL E    + P   D+M
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM 211

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 67.3 bits (164), Expect = 3e-12
 Identities = 51/200 (25%), Positives = 102/200 (51%), Gaps = 22/200 (11%)

Query: 299 VAIKVFNLQLERAFRS-FDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEK 357
           VA+K+    + +  R+ F  E +++  +++ N+I++L    + D   ++ E+M NG L +
Sbjct: 47  VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQ 106

Query: 358 WL--------YSHNYFLDILERLNIM---IDVGSALEYLHNGHSSVHIIHCDLKPTNILL 406
           +L        ++H   +  +   N++   + + S ++YL    +S++ +H DL   N L+
Sbjct: 107 FLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL----ASLNFVHRDLATRNCLV 162

Query: 407 DENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLM 466
             +    ++DFG+ + L  G+    Q   +  I +MA E  L G  +   DV+++GV L 
Sbjct: 163 GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLW 222

Query: 467 ETFT--RKRP----TDEMFI 480
           E FT  +++P    +DE  I
Sbjct: 223 EMFTLCKEQPYSLLSDEQVI 242

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 67.2 bits (164), Expect = 4e-12
 Identities = 50/199 (25%), Positives = 95/199 (47%), Gaps = 21/199 (10%)

Query: 299 VAIKVFNLQLERAFRS-FDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEK 357
           VA+K+      +  R+ F  E +++  ++  N+I++L+     D   ++ E+M NG L +
Sbjct: 49  VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQ 108

Query: 358 WLYSHNY----------FLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLD 407
           +L  H             +     + +   + S ++YL    SS++ +H DL   N L+ 
Sbjct: 109 FLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL----SSLNFVHRDLATRNCLVG 164

Query: 408 ENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLME 467
           +N    ++DFG+ + L  G+    Q   +  I +M+ E  L G  +   DV+++GV L E
Sbjct: 165 KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWE 224

Query: 468 TFT--RKRP----TDEMFI 480
             T  +++P    +DE  I
Sbjct: 225 ILTLCKEQPYSQLSDEQVI 243

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 66.3 bits (162), Expect = 4e-12
 Identities = 58/205 (28%), Positives = 95/205 (46%), Gaps = 12/205 (5%)

Query: 278 NLLGTSSFGSVYKGTISDG----TDVAIKVFNLQLE-RAFRSFDSECEVLRNVRHRNLIK 332
            ++G   FG VY GT+ D        A+K  N   +      F  E  ++++  H N++ 
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 333 ILSSYSNPDFKALV-LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSS 391
           +L      +   LV L +M +G L  ++ S  +   + + +   + V   +EYL    +S
Sbjct: 61  LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYL----AS 116

Query: 392 VHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGE-DSVRQ-TMTMATIGYMAPEYGLE 449
              +H DL   N +LDE+    V+DFG+ + + + E  SV   T     + +MA E    
Sbjct: 117 KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQT 176

Query: 450 GIVSAKCDVYSYGVLLMETFTRKRP 474
              + K DV+S+GVLL E  TR  P
Sbjct: 177 QKFTTKSDVWSFGVLLWELMTRGAP 201

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 67.0 bits (163), Expect = 4e-12
 Identities = 58/212 (27%), Positives = 97/212 (45%), Gaps = 26/212 (12%)

Query: 280 LGTSSFGSVYKGTISD-GTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYS 338
           LG  +FG VYK    + G   A KV   + E     +  E E+L    H  ++K+L ++ 
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79

Query: 339 NPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCD 398
                 +++EF P G+++  +   +  L   +   I   +  AL+YLH    S+ IIH D
Sbjct: 80  WDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH----SMKIIHRD 135

Query: 399 LKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTM----ATIG---YMAPEYGL--- 448
           LK  N+LL  +    ++DFG+         S +   T+    + IG   +MAPE  +   
Sbjct: 136 LKAGNVLLTLDGDIKLADFGV---------SAKNVKTLQRRDSFIGTPYWMAPEVVMCET 186

Query: 449 --EGIVSAKCDVYSYGVLLMETFTRKRPTDEM 478
             +     K D++S G+ L+E    + P  E+
Sbjct: 187 MKDTPYDYKADIWSLGITLIEMAQIEPPHHEL 218

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 66.3 bits (162), Expect = 4e-12
 Identities = 62/221 (28%), Positives = 102/221 (46%), Gaps = 32/221 (14%)

Query: 280 LGTSSFGSVYKGT-ISDGTDVA---IKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILS 335
           +G   F  VYK   + DG  VA   +++F +   +A +    E ++L+ + H N+IK L+
Sbjct: 10  IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69

Query: 336 SYSNPDFKALVLEFMPNGSLEKWLYSHNYFLD----ILERL--NIMIDVGSALEYLHNGH 389
           S+   +   +VLE    G L + +    +F      I ER      + + SALE++H   
Sbjct: 70  SFIENNELNIVLELADAGDLSRMI---KHFKKQKRLIPERTIWKYFVQLCSALEHMH--- 123

Query: 390 SSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMT----MATIGYMAPE 445
            S  I+H D+KP N+ +    V  + D G+ +          +T      + T  YM+PE
Sbjct: 124 -SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS------KTTAAHSLVGTPYYMSPE 176

Query: 446 YGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGE-MSL 485
              E   + K D++S G LL E    + P    F G+ M+L
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSP----FYGDKMNL 213

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 67.0 bits (163), Expect = 5e-12
 Identities = 58/231 (25%), Positives = 106/231 (45%), Gaps = 35/231 (15%)

Query: 280 LGTSSFGSVY--------KGTISDGTDVAIKVF-NLQLERAFRSFDSECEVLRNV-RHRN 329
           LG   FG V         K    +   VA+K+  +   E+      SE E+++ + +H+N
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 330 LIKILSSYSNPDFKALVLEFMPNGSLEKWLYSH-----NYFLDIL----------ERLNI 374
           +I +L + +      +++E+   G+L ++L +       Y  DI           + ++ 
Sbjct: 83  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142

Query: 375 MIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTM 434
              V   +EYL    +S   IH DL   N+L+ EN V  ++DFG+ + +   +   + T 
Sbjct: 143 TYQVARGMEYL----ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTN 198

Query: 435 TMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKR------PTDEMF 479
               + +MAPE   + + + + DV+S+GVL+ E FT         P +E+F
Sbjct: 199 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 249

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 67.0 bits (164), Expect = 5e-12
 Identities = 61/208 (29%), Positives = 96/208 (46%), Gaps = 45/208 (21%)

Query: 296 GTDVAIKVFNLQLERAF-------RSFDSECEVLRNVRHRNLIKILSSYSNP--DFKA-- 344
           G  VAIK    ++  AF       R+   E ++LR+ +H N+I I      P  DFK   
Sbjct: 30  GKKVAIK----KIPHAFDVPTLAKRTL-RELKILRHFKHDNIIAIRDILRPPGADFKDVY 84

Query: 345 LVLEFMPNGSLEKWLYSH--------NYFLDILERLNIMIDVGSALEYLHNGHSSVHIIH 396
           +V++ M +  L   ++S          YFL  L R          L+Y+H    S ++IH
Sbjct: 85  VVMDLMES-DLHHIIHSDQPLTEEHIRYFLYQLLR---------GLKYIH----SANVIH 130

Query: 397 CDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMT--MATIGYMAPEYGLE-GIVS 453
            DLKP+N+L++E+    + DFG+ + L       +  MT  +AT  Y APE  L     +
Sbjct: 131 RDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYT 190

Query: 454 AKCDVYSYGVLLMETFTRKRPTDEMFIG 481
              D++S G +  E   R+    ++F G
Sbjct: 191 TAIDMWSVGCIFAEMLGRR----QLFPG 214

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 66.3 bits (162), Expect = 7e-12
 Identities = 56/225 (24%), Positives = 97/225 (43%), Gaps = 47/225 (20%)

Query: 279 LLGTSSFGSVYKGTISDGTD-------VAIKVFNLQ-LERAFRSFDSECEVLRNV-RHRN 329
            LG  +FG V K   + G D       VA+K+      E+      SE E+++ + +H+N
Sbjct: 19  PLGEGAFGQVVKAE-AVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 77

Query: 330 LIKILSSYSNPDFKALVLEFMPNGSLEKWLYSH-------NYFLDILERLNIMI------ 376
           +I +L   +      +V+E+  +G+L  +L +        +          +        
Sbjct: 78  IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSF 137

Query: 377 --DVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGI---------YKLLGE 425
              V   +E+L    +S   IH DL   N+L+ E+ V  ++DFG+         Y+    
Sbjct: 138 AYQVARGMEFL----ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTN 193

Query: 426 GEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
           G   V+         +MAPE   + + + + DV+S+GVLL E FT
Sbjct: 194 GRLPVK---------WMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 65.5 bits (160), Expect = 7e-12
 Identities = 59/206 (28%), Positives = 101/206 (49%), Gaps = 26/206 (12%)

Query: 280 LGTSSFGS--VYKGTISDGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILS 335
           LG  +FG   +Y+ T  D + V  K  NL    E+  R   +E  +L  ++H N+I   +
Sbjct: 8   LGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66

Query: 336 SYSNPDFKALVLEFMPNGSL-------EKWLYSHNYFLDILERLNIMIDVGSALEYLHNG 388
            + + +   + +E+   G+L       +  L+     L  L +      + SA+ Y+H  
Sbjct: 67  HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQ------IVSAVSYIH-- 118

Query: 389 HSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGL 448
                I+H D+K  NI L +  +  + DFGI K+LG  E S+ +T+ + T  YM+PE   
Sbjct: 119 --KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGS-EYSMAETV-VGTPYYMSPEL-C 173

Query: 449 EGI-VSAKCDVYSYGVLLMETFTRKR 473
           +G+  + K D+++ G +L E  T KR
Sbjct: 174 QGVKYNFKSDIWALGCVLYELLTLKR 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 65.9 bits (161), Expect = 8e-12
 Identities = 52/157 (33%), Positives = 80/157 (50%), Gaps = 18/157 (11%)

Query: 347 LEFMPNGSLEKW---LYSHNYFL--DILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKP 401
           +E M + SL+K+   +Y     +  DIL +  I + +  ALEYLH   S + +IH D+KP
Sbjct: 79  MEVM-DTSLDKFYKKVYDKGLTIPEDILGK--IAVSIVKALEYLH---SKLSVIHRDVKP 132

Query: 402 TNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEY----GLEGIVSAKCD 457
           +N+L++ N    + DFGI    G   DSV +T+      YMAPE       +     K D
Sbjct: 133 SNVLINRNGQVKLCDFGIS---GYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSD 189

Query: 458 VYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLP 494
           V+S G+ ++E  T + P D        L++ V+E  P
Sbjct: 190 VWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSP 226

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 65.7 bits (160), Expect = 8e-12
 Identities = 56/249 (22%), Positives = 107/249 (42%), Gaps = 37/249 (14%)

Query: 318 ECEVLRNVRHRNLIK---ILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNI 374
           E E+LRN+ H N++K   I +       K L++EF+P+GSL+++L  +   +++ ++L  
Sbjct: 56  EIEILRNLYHENIVKYKGICTEDGGNGIK-LIMEFLPSGSLKEYLPRNKNKINLKQQLKY 114

Query: 375 MIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGED--SVRQ 432
            + +   ++YL     S   +H DL   N+L++      + DFG+ K +   ++  +V+ 
Sbjct: 115 AVQICKGMDYL----GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKD 170

Query: 433 TMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT----RKRPTDEMFI-------G 481
            +      Y APE  ++       DV+S+GV L E  T       P   +F+       G
Sbjct: 171 DLDSPVFWY-APECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPM-TLFLKMIGPTHG 228

Query: 482 EMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMT 541
           +M++ R V+              ++ E +      +C   +      C    P  R    
Sbjct: 229 QMTVTRLVR--------------VLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQ 274

Query: 542 DAAAKLKKI 550
           +     + I
Sbjct: 275 NLIEGFEAI 283

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 65.8 bits (160), Expect = 9e-12
 Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 11/204 (5%)

Query: 273 EFNECNLLGTSSFGSVYKGT-ISDGTD----VAIKVFNLQLE-RAFRSFDSECEVLRNVR 326
           E  +  +LG+ +FG+VYKG  I DG +    VAIKV       +A +    E  V+  V 
Sbjct: 8   ELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVG 67

Query: 327 HRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH 386
              + ++L        + LV + MP G L  ++  +   +   + LN  + +   + YL 
Sbjct: 68  SPYVCRLLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE 126

Query: 387 NGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEY 446
                V ++H DL   N+L+       ++DFG+ +LL   E           I +MA E 
Sbjct: 127 E----VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALES 182

Query: 447 GLEGIVSAKCDVYSYGVLLMETFT 470
            L    + + DV+SYGV + E  T
Sbjct: 183 ILHRRFTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 65.6 bits (160), Expect = 9e-12
 Identities = 61/212 (28%), Positives = 95/212 (44%), Gaps = 28/212 (13%)

Query: 274 FNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLER------AFRSFDSECEVLRNVR 326
           F +   +G  ++G VYK      G  VA+K   L  E       A R    E  +L+ + 
Sbjct: 2   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR----EISLLKELN 57

Query: 327 HRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMID-VGSALEYL 385
           H N++K+L      +   LV EF+ +  L+K       F+D      I +  + S L  L
Sbjct: 58  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKK-------FMDASPLSGIPLPLIKSYLFQL 109

Query: 386 HNGHSSVH---IIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQ-TMTMATIGY 441
             G +  H   ++H DLKP N+L++      ++DFG+ +  G     VR  T  + T+ Y
Sbjct: 110 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV---PVRTYTHEVVTLWY 166

Query: 442 MAPEYGL-EGIVSAKCDVYSYGVLLMETFTRK 472
            APE  L     S   D++S G +  E  TR+
Sbjct: 167 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 65.2 bits (159), Expect = 9e-12
 Identities = 54/206 (26%), Positives = 87/206 (42%), Gaps = 36/206 (17%)

Query: 284 SFGSVYKG-TISDGTDVAIKVF------------NLQLERAFRSFDSECEVLRNVRHRNL 330
           +FGSVY     S G   AIKV             N++ ERA      E           +
Sbjct: 8   AFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESP--------YV 59

Query: 331 IKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH-NGH 389
            K+  S+ + D+  LV+E++  G     + +     +   +   + +V   +E LH  G 
Sbjct: 60  AKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAK-QYIAEVVLGVEDLHQRG- 117

Query: 390 SSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLE 449
               IIH D+KP N+L+D+     ++DFG+ +   E +  V       T  Y+APE  + 
Sbjct: 118 ----IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFV------GTPDYLAPET-IL 166

Query: 450 GIVSAK-CDVYSYGVLLMETFTRKRP 474
           G+   K  D +S G ++ E      P
Sbjct: 167 GVGDDKMSDWWSLGCVIFEFLFGYPP 192

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 65.8 bits (160), Expect = 1e-11
 Identities = 63/212 (29%), Positives = 91/212 (42%), Gaps = 18/212 (8%)

Query: 274 FNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNL---QLERAFRSFDSECEVLRNVRHRN 329
           F++   +G  SFG+VY    + +   VAIK  +    Q    ++    E   L+ +RH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 330 LIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGH 389
            I+    Y       LV+E+   GS    L  H   L  +E   +       L YLH+ +
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN 135

Query: 390 SSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGL- 448
               +IH D+K  NILL E  +  + DFG   ++      V       T  +MAPE  L 
Sbjct: 136 ----MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV------GTPYWMAPEVILA 185

Query: 449 --EGIVSAKCDVYSYGVLLMETFTRKRPTDEM 478
             EG    K DV+S G+  +E   RK P   M
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 65.5 bits (160), Expect = 1e-11
 Identities = 39/101 (38%), Positives = 50/101 (49%), Gaps = 11/101 (10%)

Query: 381 ALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIG 440
           AL YL        IIH D+KP+NILLD N    + DFGI    G+  DS+ +T       
Sbjct: 119 ALNYLKEEL---KIIHRDVKPSNILLDRNGNIKLCDFGIS---GQLVDSIAKTRDAGCRP 172

Query: 441 YMAPE----YGLEGIVSAKCDVYSYGVLLMETFTRKRPTDE 477
           YMAPE       +G    + DV+S G+ L E  T K P  +
Sbjct: 173 YMAPERIDPSARDG-YDVRSDVWSLGITLYEVATGKFPYPK 212

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 66.2 bits (162), Expect = 1e-11
 Identities = 63/228 (27%), Positives = 97/228 (42%), Gaps = 56/228 (24%)

Query: 272 DEFNECNLLGTSSFGSVYKGTISD-GTDVAIKVFNLQLE------RAFRSFDSECEVLRN 324
           D +   + +G+ ++G V     +  G  VAIK  +   +      R +R    E  +L++
Sbjct: 15  DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYR----ELRLLKH 70

Query: 325 VRHRNLIKILSSY----SNPDFKA--LVLEFMPNGSLEKWLYS------HNYFL--DILE 370
           + H N+I +L  +    S  DF+   LV   M    L   +        H  FL   IL 
Sbjct: 71  MDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKCQKLSDDHIQFLVYQILR 129

Query: 371 RLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSV 430
                      L+Y+H    S  IIH DLKP+NI ++E+    + DFG+           
Sbjct: 130 ----------GLKYIH----SAGIIHRDLKPSNIAVNEDCELKILDFGL----------A 165

Query: 431 RQT---MT--MATIGYMAPEYGLEGI-VSAKCDVYSYGVLLMETFTRK 472
           R T   MT  +AT  Y APE  L  +  +   D++S G ++ E  T K
Sbjct: 166 RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 65.0 bits (158), Expect = 1e-11
 Identities = 61/216 (28%), Positives = 100/216 (46%), Gaps = 30/216 (13%)

Query: 279 LLGTSSFGSVYKGTISD-GTDVAIKV--FNLQLERAFRSFDS-ECEV--LRNVRHRNLIK 332
           LLG  +FG VY    +D G ++A+K   F+   +   +  ++ ECE+  L+N+RH  +++
Sbjct: 9   LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68

Query: 333 ILSSYSNPDFKALVL--EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHS 390
                 +P+ K L +  E+MP GS++  L ++    + + R      +   + YLH    
Sbjct: 69  YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTR-RYTRQILQGVSYLH---- 123

Query: 391 SVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIG---------Y 441
           S  I+H D+K  NIL D      + DFG  K +        QT+ M+  G         +
Sbjct: 124 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRI--------QTICMSGTGIKSVTGTPYW 175

Query: 442 MAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDE 477
           M+PE         K DV+S    ++E  T K P  E
Sbjct: 176 MSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAE 211

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 66.0 bits (161), Expect = 1e-11
 Identities = 34/93 (36%), Positives = 52/93 (55%), Gaps = 4/93 (4%)

Query: 378 VGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMA 437
           V   +E+L    +S   IH DL   NILL EN V  + DFG+ + + +  D VR+     
Sbjct: 182 VARGMEFL----ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 237

Query: 438 TIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
            + +MAPE   + + + + DV+S+GVLL E F+
Sbjct: 238 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 65.4 bits (160), Expect = 1e-11
 Identities = 50/177 (28%), Positives = 84/177 (47%), Gaps = 19/177 (10%)

Query: 280 LGTSSFGSVYKGT-ISDGTDVAIKVFNLQL------ERAFRSFDSECEVLRNVRHRNLIK 332
           +G  + G V+K      G  VA+K   L+        +A R    E + L+  +H  ++K
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALR----EIKALQACQHPYVVK 63

Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSV 392
           +L  + +     LV+E+MP   L + L      L   +  + M  +   + Y+H    + 
Sbjct: 64  LLDVFPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH----AN 118

Query: 393 HIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPE--YG 447
            I+H DLKP N+L+  + V  ++DFG+ +L  E E  +  +  +AT  Y APE  YG
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL-YSHQVATRWYRAPELLYG 174

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 66.4 bits (162), Expect = 1e-11
 Identities = 68/215 (31%), Positives = 98/215 (45%), Gaps = 24/215 (11%)

Query: 279 LLGTSSFGSV-YKGTISDGTDVAIKVFNLQ------LERAFRSFDS--ECEVLRNVR-HR 328
           +LG+ + G+V     +SDG   A+KV +++        RA         C+    V+ H 
Sbjct: 39  VLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHE 98

Query: 329 NLIKILSSYSNPD---FKALVLEFMPNGSLEKWLYSH---NYFLDILERLNIMIDVGSAL 382
           +  K      NP+     ALVL++   G L + + S    N      E   + I V  A+
Sbjct: 99  DFAK--KDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAV 156

Query: 383 EYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG-EDSVRQTMTMATIGY 441
            ++H    S H+IH D+K  NILL  N +  + DFG  K+      D V +T    T  Y
Sbjct: 157 HHVH----SKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFC-GTPYY 211

Query: 442 MAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTD 476
           +APE       S K D++S GVLL E  T KRP D
Sbjct: 212 VAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246

Length = 496

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 64.8 bits (158), Expect = 2e-11
 Identities = 57/203 (28%), Positives = 99/203 (48%), Gaps = 37/203 (18%)

Query: 280 LGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYS 338
           +G  S G V   T  S G  VA+K  +L+ ++      +E  ++R+ +H N++++ SSY 
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL 86

Query: 339 NPDFKALVLEFMPNGSLEKWLYSHNYFLDILE--RLN------IMIDVGSALEYLHNGHS 390
             D   +V+EF+  G+L           DI+   R+N      + + V  AL +LH    
Sbjct: 87  VGDELWVVMEFLEGGALT----------DIVTHTRMNEEQIATVCLAVLKALSFLH---- 132

Query: 391 SVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPE----- 445
           +  +IH D+K  +ILL  +    +SDFG    +   ++  R+   + T  +MAPE     
Sbjct: 133 AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQV--SKEVPRRKSLVGTPYWMAPEVISRL 190

Query: 446 -YGLEGIVSAKCDVYSYGVLLME 467
            YG E       D++S G++++E
Sbjct: 191 PYGTE------VDIWSLGIMVIE 207

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 65.4 bits (160), Expect = 2e-11
 Identities = 65/237 (27%), Positives = 103/237 (43%), Gaps = 56/237 (23%)

Query: 272 DEFNECNLLGTSSFGSVYKGTISDGTDV-AIKVFN--LQLERAFRSFD-SECEVLRNVRH 327
           D+F    ++G  +FG V+     D   V A+KV      ++R   +   +E ++L +   
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60

Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNI--MIDVGSALEYL 385
             ++K+  S+ + +   LV+E+MP G L   L   + F +   R  I  ++    AL+ +
Sbjct: 61  PWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELV---LALDSV 117

Query: 386 HNGHSSVHIIHCDLKPTNILLDENMVAHV--SDFGI-----------YKLLGEGEDSVR- 431
           H     +  IH D+KP NIL+D +   H+  +DFG+           Y L        R 
Sbjct: 118 H----KLGFIHRDIKPDNILIDAD--GHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRD 171

Query: 432 ----------QTMTMA--TIG---YMAPE------YGLEGIVSAKCDVYSYGVLLME 467
                     Q    A  T+G   Y+APE      YGLE      CD +S GV+L E
Sbjct: 172 NVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLE------CDWWSLGVILYE 222

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 64.7 bits (157), Expect = 3e-11
 Identities = 64/206 (31%), Positives = 88/206 (42%), Gaps = 18/206 (8%)

Query: 280 LGTSSFGSVYKGTISDGTD-VAIKVFNL---QLERAFRSFDSECEVLRNVRHRNLIKILS 335
           +G  SFG+VY  T S   + VA+K  +    Q    ++    E + L+ ++H N I+   
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88

Query: 336 SYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHII 395
            Y       LV+E+   GS    L  H   L  +E   I       L YLH    S ++I
Sbjct: 89  CYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH----SHNMI 143

Query: 396 HCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGL---EGIV 452
           H D+K  NILL E     ++DFG           V       T  +MAPE  L   EG  
Sbjct: 144 HRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV------GTPYWMAPEVILAMDEGQY 197

Query: 453 SAKCDVYSYGVLLMETFTRKRPTDEM 478
             K DV+S G+  +E   RK P   M
Sbjct: 198 DGKVDVWSLGITCIELAERKPPLFNM 223

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 63.8 bits (155), Expect = 3e-11
 Identities = 52/184 (28%), Positives = 85/184 (46%), Gaps = 12/184 (6%)

Query: 294 SDGTDVAIKVFNLQ--LERAFRSFDSECEVLRNVRHRNLIKILSSYSNPD-FKALVLEFM 350
           +DG    IK  NL+    R  ++ + E ++L  ++H N++    S+   D    +V+ F 
Sbjct: 23  TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFC 82

Query: 351 PNGSLEKWLYSHNYFLDILER--LNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDE 408
             G L   L      L + E   +   + +  AL+YLH  H    I+H DLK  N+ L  
Sbjct: 83  EGGDLYHKLKEQKGKL-LPENQVVEWFVQIAMALQYLHEKH----ILHRDLKTQNVFLTR 137

Query: 409 NMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMET 468
             +  V D GI ++L E +  +  T+ + T  YM+PE       + K DV++ G  + E 
Sbjct: 138 TNIIKVGDLGIARVL-ENQCDMASTL-IGTPYYMSPELFSNKPYNYKSDVWALGCCVYEM 195

Query: 469 FTRK 472
            T K
Sbjct: 196 ATLK 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 63.9 bits (155), Expect = 3e-11
 Identities = 58/216 (26%), Positives = 94/216 (43%), Gaps = 30/216 (13%)

Query: 279 LLGTSSFGSVYKG-TISDGTDVAIKVFNLQLE-----RAFRSFDSECEVLRNVRHRNLIK 332
           LLG  +FG VY    +  G ++A K      E     +   + + E ++L+N++H  +++
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68

Query: 333 ILSSYSNPDFKALV--LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHS 390
                 +   K L   +E+MP GS++  L ++    + + R      +   + YLH    
Sbjct: 69  YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTR-KYTRQILEGMSYLH---- 123

Query: 391 SVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIG---------Y 441
           S  I+H D+K  NIL D      + DFG  K L        QT+ M+  G         +
Sbjct: 124 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRL--------QTICMSGTGIRSVTGTPYW 175

Query: 442 MAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDE 477
           M+PE         K DV+S G  ++E  T K P  E
Sbjct: 176 MSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAE 211

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 63.9 bits (155), Expect = 3e-11
 Identities = 55/211 (26%), Positives = 93/211 (44%), Gaps = 18/211 (8%)

Query: 274 FNECNLLGTSSFGSVYKGTISDGTDV-AIKVFNLQ-LERAFRSFDSECEVLRNVRHRNLI 331
           F +   +G  SFG VYKG  +   +V AIK+ +L+  E        E  VL       + 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65

Query: 332 KILSSYSNPDFKALVLEFMPNGS----LEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
           +   SY       +++E++  GS    L+       Y   IL       ++   L+YLH 
Sbjct: 66  RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILR------EILKGLDYLH- 118

Query: 388 GHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYG 447
              S   IH D+K  N+LL E     ++DFG+   L + +  +++   + T  +MAPE  
Sbjct: 119 ---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IKRNTFVGTPFWMAPEVI 173

Query: 448 LEGIVSAKCDVYSYGVLLMETFTRKRPTDEM 478
            +     K D++S G+  +E    + P  ++
Sbjct: 174 KQSAYDFKADIWSLGITAIELAKGEPPNSDL 204

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 64.8 bits (158), Expect = 3e-11
 Identities = 55/225 (24%), Positives = 94/225 (41%), Gaps = 38/225 (16%)

Query: 278 NLLGTSSFGSVYKG--TISDGTDVAIKVFNLQLERAFRSFDS--------------ECEV 321
             LG  ++G V K   T+  G  VAIK   +       + D               E ++
Sbjct: 15  AHLGEGTYGKVEKAYDTL-TGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKI 73

Query: 322 LRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSA 381
           +  ++H N++ ++  Y   DF  LV++ M    L+K +      L   +   I++ + + 
Sbjct: 74  MNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKK-VVDRKIRLTESQVKCILLQILNG 131

Query: 382 LEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG----------EGEDSVR 431
           L  LH      + +H DL P NI ++   +  ++DFG+ +  G          +     R
Sbjct: 132 LNVLHK----WYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRR 187

Query: 432 QTMT--MATIGYMAPE--YGLEGIVSAKCDVYSYGVLLMETFTRK 472
           + MT  + T+ Y APE   G E    A  D++S G +  E  T K
Sbjct: 188 EEMTSKVVTLWYRAPELLMGAEKYHFA-VDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 64.6 bits (157), Expect = 3e-11
 Identities = 60/213 (28%), Positives = 93/213 (43%), Gaps = 39/213 (18%)

Query: 272 DEFNECNLLGTSSFGSVYKGTISDGT--DVAIKVF-------NLQLERAFRSFDSECEVL 322
           ++FN    LGT SFG V   T  +     VAIK F         Q++  F    SE ++L
Sbjct: 30  EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVF----SERKIL 85

Query: 323 RNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGS-- 380
             + H   + +  S+ +  +  LVLEF+  G    +L  +  F +         DVG   
Sbjct: 86  NYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPN---------DVGCFY 136

Query: 381 ------ALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTM 434
                   EYL     S++I++ DLKP N+LLD++    ++DFG  K++       R   
Sbjct: 137 AAQIVLIFEYLQ----SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV-----DTRTYT 187

Query: 435 TMATIGYMAPEYGLEGIVSAKCDVYSYGVLLME 467
              T  Y+APE  L        D ++ G+ + E
Sbjct: 188 LCGTPEYIAPEILLNVGHGKAADWWTLGIFIYE 220

Length = 340

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 63.9 bits (155), Expect = 4e-11
 Identities = 60/225 (26%), Positives = 113/225 (50%), Gaps = 24/225 (10%)

Query: 296 GTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSL 355
           G  VA+K  +L+ ++      +E  ++R+  H N++ + +SY   D   +V+EF+  G+L
Sbjct: 47  GKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106

Query: 356 EKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVS 415
              + +H   ++  +   + + V  AL YLHN      +IH D+K  +ILL  +    +S
Sbjct: 107 TD-IVTHTR-MNEEQIATVCLSVLRALSYLHNQ----GVIHRDIKSDSILLTSDGRIKLS 160

Query: 416 DFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPT 475
           DFG    + + E   R+++ + T  +MAPE         + D++S G++++E    + P 
Sbjct: 161 DFGFCAQVSK-EVPKRKSL-VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPP- 217

Query: 476 DEMFIGEMSLR--RWVKESLP------HGLTEV----VDANLVRE 508
              +  E  L+  R ++++LP      H ++ V    +D  LVRE
Sbjct: 218 ---YFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVRE 259

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 63.1 bits (153), Expect = 5e-11
 Identities = 60/213 (28%), Positives = 94/213 (44%), Gaps = 24/213 (11%)

Query: 279 LLGTSSFGSVYKGTISD-GTDVAIKVFNLQLE-----RAFRSFDSECEVLRNVRHRNLIK 332
           LLG  +FG VY    +D G ++A+K      E     +   + + E ++L+N+ H  +++
Sbjct: 9   LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68

Query: 333 ILSSYSNPDFKAL--VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHS 390
                 +P  + L   +E MP GS++  L S+    + + R      +   + YLH    
Sbjct: 69  YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTR-KYTRQILEGVSYLH---- 123

Query: 391 SVHIIHCDLKPTNILLDENMVAHVSDFGIYKLL------GEGEDSVRQTMTMATIGYMAP 444
           S  I+H D+K  NIL D      + DFG  K L      G G  SV       T  +M+P
Sbjct: 124 SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSV-----TGTPYWMSP 178

Query: 445 EYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDE 477
           E         K D++S G  ++E  T K P  E
Sbjct: 179 EVISGEGYGRKADIWSVGCTVVEMLTEKPPWAE 211

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 63.8 bits (155), Expect = 5e-11
 Identities = 56/173 (32%), Positives = 84/173 (48%), Gaps = 14/173 (8%)

Query: 279 LLGTSSFGSVYKGT-ISDGTDVAIKVFN----LQLERAFRSFDSECEVLRNVRHRNLIKI 333
           ++G  SFG V      SDG+  A+KV      L+ +           +L+N++H  L+ +
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61

Query: 334 LSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVH 393
             S+   +    VL+++  G L   L     FL+   R     +V SA+ YLH    S++
Sbjct: 62  HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF-YAAEVASAIGYLH----SLN 116

Query: 394 IIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTM-ATIGYMAPE 445
           II+ DLKP NILLD      ++DFG+ K   EG +    T T   T  Y+APE
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCK---EGVEPEETTSTFCGTPEYLAPE 166

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 63.4 bits (154), Expect = 7e-11
 Identities = 56/208 (26%), Positives = 100/208 (48%), Gaps = 31/208 (14%)

Query: 299 VAIKVFNLQLERAFRS-FDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEK 357
           VA+K+      +  R+ F  E ++L  ++  N+I++L    + D   ++ E+M NG L +
Sbjct: 49  VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108

Query: 358 WLYSHNYFLDILER-------------------LNIMIDVGSALEYLHNGHSSVHIIHCD 398
           +L S ++  D  E                    L++ + + S ++YL    SS++ +H D
Sbjct: 109 FL-SSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL----SSLNFVHRD 163

Query: 399 LKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDV 458
           L   N L+ EN+   ++DFG+ + L  G+    Q   +  I +MA E  L G  +   DV
Sbjct: 164 LATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDV 223

Query: 459 YSYGVLLMETFT--RKRP----TDEMFI 480
           +++GV L E     +++P    TDE  I
Sbjct: 224 WAFGVTLWEILMLCKEQPYGELTDEQVI 251

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 63.1 bits (153), Expect = 8e-11
 Identities = 52/207 (25%), Positives = 93/207 (44%), Gaps = 20/207 (9%)

Query: 280 LGTSSFGSVYKGTISD------GTDVAIKVFNLQLE-RAFRSFDSECEVLRNVRHRNLIK 332
           LG  SFG VY+G   D       T VA+K  N     R    F +E  V++     ++++
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73

Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWLYS-----HNYFLDILERLNIMI----DVGSALE 383
           +L   S      +V+E M +G L+ +L S      N        L  MI    ++   + 
Sbjct: 74  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133

Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           YL    ++   +H DL   N ++  +    + DFG+ + + E +   +    +  + +MA
Sbjct: 134 YL----NAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 189

Query: 444 PEYGLEGIVSAKCDVYSYGVLLMETFT 470
           PE   +G+ +   D++S+GV+L E  +
Sbjct: 190 PESLKDGVFTTSSDMWSFGVVLWEITS 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 62.9 bits (153), Expect = 1e-10
 Identities = 63/236 (26%), Positives = 100/236 (42%), Gaps = 41/236 (17%)

Query: 278 NLLGTSSFGSV----YKGTISDGTDVAIKVFNLQLERAFRSFD---SECEVLRNVRHRNL 330
             LGT SFG V    +KGT   G   AIK    +     +       E  +L  + H  +
Sbjct: 24  ETLGTGSFGRVRIAKHKGT---GEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFI 80

Query: 331 IKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHS 390
           + ++ S+ + +    +LEF+  G L   L     F + + +     ++  A EYLH+   
Sbjct: 81  VNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKF-YHAELVLAFEYLHS--- 136

Query: 391 SVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTM-ATIGYMAPEYGLE 449
              II+ DLKP N+LLD      V+DFG  K + +      +T T+  T  Y+APE    
Sbjct: 137 -KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD------RTFTLCGTPEYLAPE---- 185

Query: 450 GIVSAK-----CDVYSYGVLLMETF---------TRKRPTDEMFIGEMSLRRWVKE 491
            ++ +K      D ++ GVLL E           T  R  +++  G +    W   
Sbjct: 186 -VIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDG 240

Length = 329

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 62.7 bits (152), Expect = 1e-10
 Identities = 56/231 (24%), Positives = 106/231 (45%), Gaps = 35/231 (15%)

Query: 280 LGTSSFGSVY--------KGTISDGTDVAIKVF-NLQLERAFRSFDSECEVLRNV-RHRN 329
           LG   FG V         K   +    VA+K+  +   ++      SE E+++ + +H+N
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 330 LIKILSSYSNPDFKALVLEFMPNGSLEKWLYSH-----NYFLDIL----------ERLNI 374
           +I +L + +      +++E+   G+L ++L +      +Y  D            + ++ 
Sbjct: 80  IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139

Query: 375 MIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTM 434
              V   +EYL    +S   IH DL   N+L+ E+ V  ++DFG+ + +   +   + T 
Sbjct: 140 AYQVARGMEYL----ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTN 195

Query: 435 TMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKR------PTDEMF 479
               + +MAPE   + + + + DV+S+GVLL E FT         P +E+F
Sbjct: 196 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF 246

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 62.5 bits (152), Expect = 1e-10
 Identities = 67/235 (28%), Positives = 103/235 (43%), Gaps = 46/235 (19%)

Query: 279 LLGTSSFGSVYKGTISDGTD----VAIKVFNLQLERAFRS------FDSECEVLRNVRHR 328
           +LG   +G V++     G D     A+KV  L+     R+        +E  +L  V+H 
Sbjct: 3   VLGKGGYGKVFQVRKVTGADTGKIFAMKV--LKKATIVRNQKDTAHTKAERNILEAVKHP 60

Query: 329 NLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNI-MIDVGS------- 380
            ++ ++ ++       L+LE++  G L    + H      LER  I M D          
Sbjct: 61  FIVDLIYAFQTGGKLYLILEYLSGGEL----FMH------LEREGIFMEDTACFYLSEIS 110

Query: 381 -ALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATI 439
            ALE+LH       II+ DLKP NILLD      ++DFG+ K     E +V  T    TI
Sbjct: 111 LALEHLH----QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIH-EGTVTHTFC-GTI 164

Query: 440 GYMAPEYGLEGIVSAKCDVYSYGVLLMETFT---------RKRPTDEMFIGEMSL 485
            YMAPE  +        D +S G L+ +  T         RK+  D++  G+++L
Sbjct: 165 EYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNL 219

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 61.5 bits (149), Expect = 1e-10
 Identities = 58/202 (28%), Positives = 92/202 (45%), Gaps = 15/202 (7%)

Query: 280 LGTSSFGSVY--KGTISDGTDVAIKVFNLQLERAFRSFDSECEV--LRNVRHRNLIKILS 335
           +G  SFG +Y  K   SD     IK  +L          S+ EV  L  ++H N++   +
Sbjct: 8   IGEGSFGKIYLAKAK-SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66

Query: 336 SYSNPDFKALVLEFMPNGSLEKWL-YSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHI 394
           S+       +V+E+   G L K +           + L+  + +   L+++H+      I
Sbjct: 67  SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK----I 122

Query: 395 IHCDLKPTNILLDEN-MVAHVSDFGIYKLLGEGEDSVRQTMTMA-TIGYMAPEYGLEGIV 452
           +H D+K  NI L +N MVA + DFGI + L    DS+    T   T  Y++PE       
Sbjct: 123 LHRDIKSQNIFLSKNGMVAKLGDFGIARQL---NDSMELAYTCVGTPYYLSPEICQNRPY 179

Query: 453 SAKCDVYSYGVLLMETFTRKRP 474
           + K D++S G +L E  T K P
Sbjct: 180 NNKTDIWSLGCVLYELCTLKHP 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 63.7 bits (155), Expect = 2e-10
 Identities = 37/98 (37%), Positives = 52/98 (53%), Gaps = 12/98 (12%)

Query: 4   LTLEGNQLSGRLPSTIG--HSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFS 61
           L L+   L G +P+ I     L +I    L+ N++ G IP S+ + T L VLDL +NSF+
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSIN---LSGNSIRGNIPPSLGSITSLEVLDLSYNSFN 479

Query: 62  GHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCL 99
           G I  + G L  L +L+       L GN L GR+P  L
Sbjct: 480 GSIPESLGQLTSLRILN-------LNGNSLSGRVPAAL 510

Length = 623

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 62.3 bits (151), Expect = 2e-10
 Identities = 61/217 (28%), Positives = 94/217 (43%), Gaps = 26/217 (11%)

Query: 273 EFNECNLLGTSSFGSVYKGTISDGTDV----AIKVFN----LQLERAFRSFDSECEVLRN 324
            F    +LGT ++G V+      G D     A+KV      +Q  +      +E  VL +
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 325 VRHRNLIKILSSYSNPDFKA-LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALE 383
           VR    +  L      + K  L+L+++  G +   LY  + F +   R     ++  ALE
Sbjct: 61  VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSG-EIILALE 119

Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           +LH     + I++ D+K  NILLD      ++DFG+ K     E+  R      TI YMA
Sbjct: 120 HLHK----LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLS-EEKERTYSFCGTIEYMA 174

Query: 444 PEYGLEGIVSAK------CDVYSYGVLLMETFTRKRP 474
           PE     I+  K       D +S G+L+ E  T   P
Sbjct: 175 PE-----IIRGKGGHGKAVDWWSLGILIFELLTGASP 206

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 61.9 bits (151), Expect = 2e-10
 Identities = 52/225 (23%), Positives = 92/225 (40%), Gaps = 48/225 (21%)

Query: 274 FNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERA------FRSFDSECEVLRNVR 326
           + E   +G  ++G+VYK   ++ G  VA+K   + L          R    E  +L+ + 
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLR----EIALLKQLE 56

Query: 327 ---HRNLIKILSSYSNPDFK-----ALVLEFM-----------PNGSLEKWLYSHNYFLD 367
              H N++++L     P         LV E +           P   L            
Sbjct: 57  SFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETI------- 109

Query: 368 ILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGE 427
                ++M  +   +++LH    S  I+H DLKP NIL+  +    ++DFG+ ++     
Sbjct: 110 ----KDLMRQLLRGVDFLH----SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSF-- 159

Query: 428 DSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRK 472
             +  T  + T+ Y APE  L+   +   D++S G +  E F R+
Sbjct: 160 -EMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRR 203

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 62.3 bits (151), Expect = 2e-10
 Identities = 34/93 (36%), Positives = 52/93 (55%), Gaps = 4/93 (4%)

Query: 378 VGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMA 437
           V   +E+L    +S   IH DL   NILL EN V  + DFG+ + + +  D VR+     
Sbjct: 183 VARGMEFL----ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238

Query: 438 TIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
            + +MAPE   + + + + DV+S+GVLL E F+
Sbjct: 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 61.6 bits (149), Expect = 2e-10
 Identities = 64/212 (30%), Positives = 89/212 (41%), Gaps = 18/212 (8%)

Query: 274 FNECNLLGTSSFGSVYKGTISDGTDV-AIKVFNL---QLERAFRSFDSECEVLRNVRHRN 329
           F +   +G  SFG+VY        +V AIK  +    Q    ++    E + L+ ++H N
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 330 LIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGH 389
            I+    Y       LV+E+   GS    L  H   L  +E   I       L YLH   
Sbjct: 87  SIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH--- 142

Query: 390 SSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGL- 448
            S ++IH D+K  NILL E     ++DFG   +       V       T  +MAPE  L 
Sbjct: 143 -SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV------GTPYWMAPEVILA 195

Query: 449 --EGIVSAKCDVYSYGVLLMETFTRKRPTDEM 478
             EG    K DV+S G+  +E   RK P   M
Sbjct: 196 MDEGQYDGKVDVWSLGITCIELAERKPPLFNM 227

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 61.9 bits (150), Expect = 2e-10
 Identities = 56/173 (32%), Positives = 83/173 (47%), Gaps = 14/173 (8%)

Query: 279 LLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVL-RNVRHRNLIKI 333
           ++G  SFG V       DG   A+KV   ++    +  +   +E  VL +NV+H  L+ +
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61

Query: 334 LSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVH 393
             S+   +    VL+F+  G L   L     F +   R     ++ SAL YLH    S++
Sbjct: 62  HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAA-EIASALGYLH----SIN 116

Query: 394 IIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTM-ATIGYMAPE 445
           I++ DLKP NILLD      ++DFG+ K   EG      T T   T  Y+APE
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCK---EGIAQSDTTTTFCGTPEYLAPE 166

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 61.5 bits (149), Expect = 2e-10
 Identities = 56/200 (28%), Positives = 90/200 (45%), Gaps = 22/200 (11%)

Query: 317 SECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSH-NYFLDILERLNIM 375
           +E ++L  V  + ++ +  +Y   D   LVL  M  G L+  +Y+  N   +    L   
Sbjct: 49  NEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYA 108

Query: 376 IDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMT 435
            ++   LE LH  +     ++ DLKP NILLD+     +SD G+   + EG +S+R    
Sbjct: 109 AEILCGLEDLHREN----TVYRDLKPENILLDDYGHIRISDLGLAVKIPEG-ESIRG--R 161

Query: 436 MATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPH 495
           + T+GYMAPE       +   D +  G L+ E    + P            R  KE +  
Sbjct: 162 VGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPF-----------RGRKEKVKR 210

Query: 496 GLTEVVDANLVREEQAFSAK 515
              E VD  ++  E+ +SAK
Sbjct: 211 ---EEVDRRVLETEEVYSAK 227

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 61.4 bits (149), Expect = 3e-10
 Identities = 56/231 (24%), Positives = 92/231 (39%), Gaps = 56/231 (24%)

Query: 280 LGTSSFGSVYKGTI------SDGTDVAIKVF----NLQLERAFRSFDSECEVLRNVRHRN 329
           +G  +FG V++            T VA+K+     +  ++     F  E  ++    H N
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQA---DFQREAALMAEFDHPN 69

Query: 330 LIKILSSYSNPDFKALVLEFMPNGSLEKWL--------------------YSHNYF-LDI 368
           ++K+L   +      L+ E+M  G L ++L                       N   L  
Sbjct: 70  IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSC 129

Query: 369 LERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGI--------- 419
            E+L I   V + + YL    S    +H DL   N L+ ENMV  ++DFG+         
Sbjct: 130 TEQLCIAKQVAAGMAYL----SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 185

Query: 420 YKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
           YK      D++        I +M PE       + + DV++YGV+L E F+
Sbjct: 186 YK--ASENDAI-------PIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 61.2 bits (148), Expect = 3e-10
 Identities = 57/224 (25%), Positives = 110/224 (49%), Gaps = 27/224 (12%)

Query: 280 LGTSSFGSVYKGTI-SDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYS 338
           +G  S G V   T+ S G  VA+K  +L+ ++      +E  ++R+ +H N++++ +SY 
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87

Query: 339 NPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLN------IMIDVGSALEYLHNGHSSV 392
             D   +V+EF+  G+L   + +H        R+N      + + V  AL  LH    + 
Sbjct: 88  VGDELWVVMEFLEGGALTD-IVTHT-------RMNEEQIAAVCLAVLKALSVLH----AQ 135

Query: 393 HIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIV 452
            +IH D+K  +ILL  +    +SDFG    +   ++  R+   + T  +MAPE       
Sbjct: 136 GVIHRDIKSDSILLTHDGRVKLSDFGFCAQV--SKEVPRRKSLVGTPYWMAPELISRLPY 193

Query: 453 SAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLR--RWVKESLP 494
             + D++S G++++E    + P    +  E  L+  + ++++LP
Sbjct: 194 GPEVDIWSLGIMVIEMVDGEPP----YFNEPPLKAMKMIRDNLP 233

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 61.1 bits (149), Expect = 3e-10
 Identities = 63/233 (27%), Positives = 92/233 (39%), Gaps = 39/233 (16%)

Query: 270 ATDEFNECNLLGTSSFGSVYKGTISD-GTDVAIKVFNLQLERAFRSFDSECEVLRNV-RH 327
            T  F    ++G  ++G VYK      G  VAIK+ ++  +        E  +LR    H
Sbjct: 4   PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEE-EEIKEEYNILRKYSNH 62

Query: 328 RNLIKILSSYSNPDFKA------LVLEFMPNGS---LEKWLYSHNYFLDILERLN----- 373
            N+     ++   +         LV+E    GS   L K L          +RL      
Sbjct: 63  PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKG------KRLKEEWIA 116

Query: 374 -IMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVS--DFGIYKLLGEGEDSV 430
            I+ +    L YLH       +IH D+K  NILL +N  A V   DFG+   L +     
Sbjct: 117 YILRETLRGLAYLHENK----VIHRDIKGQNILLTKN--AEVKLVDFGVSAQL-DSTLGR 169

Query: 431 RQTMTMATIGYMAPE-----YGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEM 478
           R T    T  +MAPE        +    A+ DV+S G+  +E    K P  +M
Sbjct: 170 RNTFI-GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDM 221

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 60.4 bits (146), Expect = 5e-10
 Identities = 64/213 (30%), Positives = 96/213 (45%), Gaps = 19/213 (8%)

Query: 274 FNECNLLGTSSFGSVYKGTISDGTDV----AIKVFN----LQLERAFRSFDSECEVLRNV 325
           F    +LGT ++G V+      G D     A+KV      +Q  +      +E +VL ++
Sbjct: 2   FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61

Query: 326 RHRNLIKILSSYSNPDFKA-LVLEFMPNGSLEKWLYSHNYFLDILERLNIMI-DVGSALE 383
           R    +  L      D K  L+L+++  G L   L     F +  + + I   ++  ALE
Sbjct: 62  RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKE--QEVQIYSGEIVLALE 119

Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           +LH     + II+ D+K  NILLD N    ++DFG+ K   E E   R      TI YMA
Sbjct: 120 HLHK----LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE-RAYSFCGTIEYMA 174

Query: 444 PEY--GLEGIVSAKCDVYSYGVLLMETFTRKRP 474
           P+   G +G      D +S GVL+ E  T   P
Sbjct: 175 PDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 60.8 bits (147), Expect = 5e-10
 Identities = 34/93 (36%), Positives = 52/93 (55%), Gaps = 4/93 (4%)

Query: 378 VGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMA 437
           V   +E+L    +S   IH DL   NILL EN V  + DFG+ + + +  D VR+     
Sbjct: 188 VAKGMEFL----ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243

Query: 438 TIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
            + +MAPE   + + + + DV+S+GVLL E F+
Sbjct: 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 59.7 bits (144), Expect = 7e-10
 Identities = 55/215 (25%), Positives = 97/215 (45%), Gaps = 27/215 (12%)

Query: 266 DIQRAT--DEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLERAFRSFDSECEVL 322
           DI R     ++     +G+ ++G VYK   +  G   A+K+  L+    F     E  ++
Sbjct: 1   DILRRNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMV 60

Query: 323 RNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSAL 382
           +  +H N++    SY + +   + +E+   GSL+  +Y     L  L+   +  +    L
Sbjct: 61  KECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQD-IYHVTGPLSELQIAYVCRETLQGL 119

Query: 383 EYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMAT---- 438
            YLH    S   +H D+K  NILL +N    ++DFG+         + + T T+A     
Sbjct: 120 AYLH----SKGKMHRDIKGANILLTDNGDVKLADFGV---------AAKITATIAKRKSF 166

Query: 439 IG---YMAPEYGL---EGIVSAKCDVYSYGVLLME 467
           IG   +MAPE       G  +  CD+++ G+  +E
Sbjct: 167 IGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIE 201

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 60.1 bits (145), Expect = 1e-09
 Identities = 57/201 (28%), Positives = 91/201 (45%), Gaps = 13/201 (6%)

Query: 279 LLGTSSFGSV-YKGTISDGTDVAIKVFNLQLERAFRSFD---SECEVLRNVRHRNLIKIL 334
           LLG  +FG V      + G   A+K+   ++  A        +E  VL+N RH  L  + 
Sbjct: 2   LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61

Query: 335 SSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHI 394
            S+   D    V+E++  G L   L     F +   R     ++ SAL+YLH+G     I
Sbjct: 62  YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRF-YGAEIVSALDYLHSG----KI 116

Query: 395 IHCDLKPTNILLDENMVAHVSDFGIYKLLGEG-EDSVRQTMTMATIGYMAPEYGLEGIVS 453
           ++ DLK  N++LD++    ++DFG+ K   EG  D+        T  Y+APE   +    
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCK---EGITDAATMKTFCGTPEYLAPEVLEDNDYG 173

Query: 454 AKCDVYSYGVLLMETFTRKRP 474
              D +  GV++ E    + P
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 59.5 bits (144), Expect = 1e-09
 Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 29/212 (13%)

Query: 272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERA-FRSFDSECEVLRNVRHRN 329
           DE    + LG  ++GSVYK      G  +A+K   L+L+ + F     E ++L       
Sbjct: 1   DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPY 60

Query: 330 LIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFL-----DILERLNIMIDVGSALEY 384
           ++    ++       + +E+M  GSL+K LY+          D+L R+   +  G  L++
Sbjct: 61  IVDFYGAFFIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKG--LKF 117

Query: 385 LHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIG---Y 441
           L   H   +IIH D+KPTN+L++ N    + DFG+    G    S+ +T     IG   Y
Sbjct: 118 LKEEH---NIIHRDVKPTNVLVNGNGQVKLCDFGVS---GNLVASLAKT----NIGCQSY 167

Query: 442 MAPEY------GLEGIVSAKCDVYSYGVLLME 467
           MAPE             + + DV+S G+ ++E
Sbjct: 168 MAPERIKSGGPNQNPTYTVQSDVWSLGLSILE 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 60.2 bits (146), Expect = 1e-09
 Identities = 47/170 (27%), Positives = 71/170 (41%), Gaps = 22/170 (12%)

Query: 313 RSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYF--LDILE 370
           ++   E ++L+ + HR +I ++ +Y     K+ V   MP        Y  + F  +D   
Sbjct: 131 KTPGREIDILKTISHRAIINLIHAYRW---KSTVCMVMPK-------YKCDLFTYVDRSG 180

Query: 371 RLN----IMIDVG--SALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG 424
            L     I I      AL YLH       IIH D+K  NI LDE   A + DFG    L 
Sbjct: 181 PLPLEQAITIQRRLLEALAYLHGRG----IIHRDVKTENIFLDEPENAVLGDFGAACKLD 236

Query: 425 EGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
              D+ +      T+   +PE        AK D++S G++L E   +   
Sbjct: 237 AHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286

Length = 392

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 58.8 bits (142), Expect = 2e-09
 Identities = 49/207 (23%), Positives = 100/207 (48%), Gaps = 13/207 (6%)

Query: 279 LLGTSSFGSVYKGTISDGTD----VAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKI 333
           +LGT  FG + +G +   +     VAI        ++  R F +E   L    H N++++
Sbjct: 12  ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71

Query: 334 LSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVH 393
               +  +   +V E+M NG+L+ +L  H   L   + + ++  + S ++YL    S + 
Sbjct: 72  EGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYL----SEMG 127

Query: 394 IIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIG-YMAPEYGLEGIV 452
            +H  L    +L++ ++V  +S F   +L  +  +++  TM+  +   + APE       
Sbjct: 128 YVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHF 185

Query: 453 SAKCDVYSYGVLLMETFTR-KRPTDEM 478
           S+  DV+S+G+++ E  +  +RP  +M
Sbjct: 186 SSASDVWSFGIVMWEVMSYGERPYWDM 212

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 58.9 bits (142), Expect = 2e-09
 Identities = 56/212 (26%), Positives = 93/212 (43%), Gaps = 26/212 (12%)

Query: 280 LGTSSFGSVYKGTISD-GTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYS 338
           LG  +FG VYK    + G   A KV + + E     +  E ++L +  H N++K+L ++ 
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72

Query: 339 NPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCD 398
             +   +++EF   G+++  +      L   +   +      AL YLH       IIH D
Sbjct: 73  YENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN----KIIHRD 128

Query: 399 LKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTM-------ATIGYMAPEYGL--- 448
           LK  NIL   +    ++DFG+         S + T T+        T  +MAPE  +   
Sbjct: 129 LKAGNILFTLDGDIKLADFGV---------SAKNTRTIQRRDSFIGTPYWMAPEVVMCET 179

Query: 449 --EGIVSAKCDVYSYGVLLMETFTRKRPTDEM 478
             +     K DV+S G+ L+E    + P  E+
Sbjct: 180 SKDRPYDYKADVWSLGITLIEMAQIEPPHHEL 211

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 59.3 bits (144), Expect = 2e-09
 Identities = 64/238 (26%), Positives = 98/238 (41%), Gaps = 54/238 (22%)

Query: 270 ATDEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLER------AFRSFDSECEVL 322
              ++     LG  +FG VYK   I  G  VA+K   +  E+      A R    E ++L
Sbjct: 6   KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR----EIKIL 61

Query: 323 RNVRHRNLIKILS-SYSNPDFKA-------LVLEFMP---NGSLE----KWLYSH--NYF 365
           + ++H N++ ++  +   PD          +V  +M    +G LE    K   S    Y 
Sbjct: 62  KKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYM 121

Query: 366 LDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFG------- 418
           L +LE +N          YLH      HI+H D+K  NIL+D   +  ++DFG       
Sbjct: 122 LQLLEGIN----------YLH----ENHILHRDIKAANILIDNQGILKIADFGLARPYDG 167

Query: 419 -IYKLLGEGEDSVRQ-TMTMATIGYMAPEY--GLEGIVSAKCDVYSYGVLLMETFTRK 472
                 G G    R+ T  + T  Y  PE   G     +A  D++  G +  E FTR+
Sbjct: 168 PPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTA-VDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 58.9 bits (142), Expect = 2e-09
 Identities = 64/227 (28%), Positives = 93/227 (40%), Gaps = 30/227 (13%)

Query: 271 TDEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRSFDSECEVLRNV---- 325
           TD +     +G  ++G VYK T   DG+  A+K+ +          D E E   N+    
Sbjct: 21  TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILD-----PISDVDEEIEAEYNILQSL 75

Query: 326 -RHRNLIKILSSYSNPDFKA-----LVLEFMPNGS---LEKWLYSHNYFLDILERLNIMI 376
             H N++K    +   D        LVLE    GS   L K L      LD      I+ 
Sbjct: 76  PNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILY 135

Query: 377 DVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTM 436
                L++LHN      IIH D+K  NILL       + DFG+   L      +R+  ++
Sbjct: 136 GALLGLQHLHNNR----IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR--LRRNTSV 189

Query: 437 ATIGYMAPEY-----GLEGIVSAKCDVYSYGVLLMETFTRKRPTDEM 478
            T  +MAPE        +    A+CDV+S G+  +E      P  +M
Sbjct: 190 GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDM 236

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 58.8 bits (142), Expect = 2e-09
 Identities = 42/170 (24%), Positives = 86/170 (50%), Gaps = 20/170 (11%)

Query: 317 SECEVLRNV-RHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSH-----NYFLDILE 370
           SE E+++ + +H+N+I +L   +      +++E+   G+L ++L +      +Y  DI +
Sbjct: 66  SEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITK 125

Query: 371 R----------LNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIY 420
                      ++    V   +EYL     S   IH DL   N+L+ E+ V  ++DFG+ 
Sbjct: 126 VPEEQLSFKDLVSCAYQVARGMEYL----ESRRCIHRDLAARNVLVTEDNVMKIADFGLA 181

Query: 421 KLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
           + + + +   + +     + +MAPE   + + + + DV+S+G+L+ E FT
Sbjct: 182 RGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 59.0 bits (143), Expect = 2e-09
 Identities = 62/253 (24%), Positives = 109/253 (43%), Gaps = 37/253 (14%)

Query: 280 LGTSSFGSVYKGTISDGTD-VAIKVFNLQL-----ERAFRSFDSECEVLRNVRHRNLIKI 333
           +G   +G V+     D  + VA+K     L     E   R   +E ++L   +   L+K+
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEV--RHVLTERDILTTTKSEWLVKL 66

Query: 334 LSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVH 393
           L ++ + ++  L +E++P G     L ++   L        M ++  A++ LH     + 
Sbjct: 67  LYAFQDDEYLYLAMEYVPGGDFRTLL-NNLGVLSEDHARFYMAEMFEAVDALHE----LG 121

Query: 394 IIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVS 453
            IH DLKP N L+D +    ++DFG+ K +    +SV     + +  YMAPE     ++ 
Sbjct: 122 YIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSV-----VGSPDYMAPE-----VLR 171

Query: 454 AK-----CDVYSYGVLLMETFTRKRP-----TDEMFIGEMSLRRWVKESLPHGLTEVVDA 503
            K      D +S G +L E      P      +E +    +L+ W KE+L   + +    
Sbjct: 172 GKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWE---NLKYW-KETLQRPVYDDPRF 227

Query: 504 NLVREEQAFSAKM 516
           NL  E      K+
Sbjct: 228 NLSDEAWDLITKL 240

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 58.4 bits (142), Expect = 3e-09
 Identities = 56/214 (26%), Positives = 102/214 (47%), Gaps = 21/214 (9%)

Query: 269 RATDEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRSFD----SECEVLR 323
           R+ DE+ + N +   ++G VY+      G  VA+K   L++E+    F      E  +L 
Sbjct: 2   RSVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALK--KLKMEKEKEGFPITSLREINILL 59

Query: 324 NVRHRNLIKI--LSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSA 381
            ++H N++ +  +   SN D   +V+E++ +  L+  + +        E   +M+ + S 
Sbjct: 60  KLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSG 118

Query: 382 LEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMT--MATI 439
           + +LH       I+H DLK +N+LL+   +  + DFG+ +  G    S  +  T  + T+
Sbjct: 119 VAHLH----DNWILHRDLKTSNLLLNNRGILKICDFGLAREYG----SPLKPYTQLVVTL 170

Query: 440 GYMAPEYGL-EGIVSAKCDVYSYGVLLMETFTRK 472
            Y APE  L     S   D++S G +  E  T+K
Sbjct: 171 WYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 58.0 bits (140), Expect = 3e-09
 Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 15/208 (7%)

Query: 280 LGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAF-RSFDSECEVLRNVRHRNLIKILSSY 337
           LG  + G+VYK   +     +A+KV  L +     +   SE E+L       +I    ++
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68

Query: 338 SNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHC 397
              +  ++  EFM  GSL+ +     + L       I + V   L YL     S+ I+H 
Sbjct: 69  FVENRISICTEFMDGGSLDVYRKIPEHVLG-----RIAVAVVKGLTYLW----SLKILHR 119

Query: 398 DLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCD 457
           D+KP+N+L++      + DFG+   L    +S+ +T  + T  YMAPE           D
Sbjct: 120 DVKPSNMLVNTRGQVKLCDFGVSTQL---VNSIAKTY-VGTNAYMAPERISGEQYGIHSD 175

Query: 458 VYSYGVLLMETFTRKRPTDEMFIGEMSL 485
           V+S G+  ME    + P  ++   + SL
Sbjct: 176 VWSLGISFMELALGRFPYPQIQKNQGSL 203

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 58.1 bits (140), Expect = 3e-09
 Identities = 54/181 (29%), Positives = 82/181 (45%), Gaps = 16/181 (8%)

Query: 317 SECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIM- 375
           +E ++L  V  R ++ +  +Y   D   LVL  M  G L+  +Y H       E   +  
Sbjct: 49  NEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIY-HMGEAGFEEGRAVFY 107

Query: 376 -IDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTM 434
             ++   LE LH       I++ DLKP NILLD++    +SD G+   + EG     QT+
Sbjct: 108 AAEICCGLEDLHQER----IVYRDLKPENILLDDHGHIRISDLGLAVHVPEG-----QTI 158

Query: 435 T--MATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDE--MFIGEMSLRRWVK 490
              + T+GYMAPE       +   D ++ G LL E    + P  +    I    + R VK
Sbjct: 159 KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK 218

Query: 491 E 491
           E
Sbjct: 219 E 219

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 58.2 bits (141), Expect = 3e-09
 Identities = 57/204 (27%), Positives = 95/204 (46%), Gaps = 23/204 (11%)

Query: 280 LGTSSFGSVYKG-TISDGTDVAIKVFNLQLER------AFRSFDSECEVLRNVRHRNLIK 332
           +G  ++G VYKG     G  VA+K   L+ E       A R    E  +L+ ++H N++ 
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIR----EISLLKELQHPNIVC 63

Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWLYS--HNYFLDILERLNIMIDVGSALEYLHNGHS 390
           +           L+ EF+ +  L+K+L S     ++D     + +  +   + + H    
Sbjct: 64  LQDVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---- 118

Query: 391 SVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVR-QTMTMATIGYMAPEYGLE 449
           S  ++H DLKP N+L+D   V  ++DFG+ +  G     VR  T  + T+ Y APE  L 
Sbjct: 119 SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGI---PVRVYTHEVVTLWYRAPEVLLG 175

Query: 450 GI-VSAKCDVYSYGVLLMETFTRK 472
               S   D++S G +  E  T+K
Sbjct: 176 SPRYSTPVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 57.8 bits (140), Expect = 5e-09
 Identities = 55/216 (25%), Positives = 97/216 (44%), Gaps = 39/216 (18%)

Query: 280 LGTSSFGSVYKG-TISDGTDVAIKVFNLQLER------AFRSFDSECEVLRNVRHRN--- 329
           +G  +FG V+K         VA+K   ++ E+      A R    E ++L+ ++H N   
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALR----EIKILQLLKHENVVN 75

Query: 330 LIKILSSYSNP--DFKA---LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEY 384
           LI+I  + + P   +K    LV EF  +  L   L + N    + E   +M  + + L Y
Sbjct: 76  LIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYY 134

Query: 385 LHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMT--MATIGYM 442
           +H       I+H D+K  NIL+ ++ +  ++DFG+ +     ++S     T  + T+ Y 
Sbjct: 135 IH----RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYR 190

Query: 443 APE-------YGLEGIVSAKCDVYSYGVLLMETFTR 471
            PE       YG         D++  G ++ E +TR
Sbjct: 191 PPELLLGERDYG------PPIDMWGAGCIMAEMWTR 220

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 57.7 bits (139), Expect = 5e-09
 Identities = 58/207 (28%), Positives = 106/207 (51%), Gaps = 14/207 (6%)

Query: 272 DEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRS-FDSECEVLRNVRHRN 329
           D+F + + LG  + G V+K +    G  +A K+ +L+++ A R+    E +VL       
Sbjct: 5   DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64

Query: 330 LIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLD-ILERLNIMIDVGSALEYLHNG 388
           ++    ++ +    ++ +E M  GSL++ L       + IL +++I +  G  L YL   
Sbjct: 65  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG--LTYLREK 122

Query: 389 HSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGL 448
           H    I+H D+KP+NIL++      + DFG+    G+  DS+  +  + T  YM+PE  L
Sbjct: 123 HK---IMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSF-VGTRSYMSPER-L 174

Query: 449 EGI-VSAKCDVYSYGVLLMETFTRKRP 474
           +G   S + D++S G+ L+E    + P
Sbjct: 175 QGTHYSVQSDIWSMGLSLVEMAIGRYP 201

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 57.3 bits (138), Expect = 6e-09
 Identities = 49/187 (26%), Positives = 92/187 (49%), Gaps = 24/187 (12%)

Query: 296 GTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSL 355
           G  VA+K+ +L+ ++      +E  ++R+ +H+N++++  SY   +   +++EF+  G+L
Sbjct: 46  GRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105

Query: 356 EKWLYSHNYFLDILE--RLN------IMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLD 407
                      DI+   RLN      +   V  AL YLH    S  +IH D+K  +ILL 
Sbjct: 106 T----------DIVSQTRLNEEQIATVCESVLQALCYLH----SQGVIHRDIKSDSILLT 151

Query: 408 ENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLME 467
            +    +SDFG    +   +D  ++   + T  +MAPE         + D++S G++++E
Sbjct: 152 LDGRVKLSDFGFCAQI--SKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIE 209

Query: 468 TFTRKRP 474
               + P
Sbjct: 210 MVDGEPP 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 57.3 bits (138), Expect = 6e-09
 Identities = 57/200 (28%), Positives = 89/200 (44%), Gaps = 22/200 (11%)

Query: 317 SECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSH-NYFLDILERLNIM 375
           +E  +L  V  R ++ +  +Y   D   LVL  M  G L+  +Y+  N   D    +   
Sbjct: 49  NEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYA 108

Query: 376 IDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMT 435
            ++   LE L        I++ DLKP NILLD+     +SD G+   + EGE +VR    
Sbjct: 109 AELCCGLEDLQRER----IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-TVRG--R 161

Query: 436 MATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPH 495
           + T+GYMAPE       +   D +  G L+           EM  G+   R+  KE +  
Sbjct: 162 VGTVGYMAPEVINNEKYTFSPDWWGLGCLIY----------EMIQGQSPFRKR-KERVKR 210

Query: 496 GLTEVVDANLVREEQAFSAK 515
              E VD  +  +++ +S K
Sbjct: 211 ---EEVDRRVKEDQEEYSEK 227

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 57.4 bits (139), Expect = 6e-09
 Identities = 37/138 (26%), Positives = 61/138 (44%), Gaps = 12/138 (8%)

Query: 285 FGSVYKGTISDGTDVAIKVFNL--QLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDF 342
              + K   +  T VA+K  NL    +   +    E    R ++H N++  ++S+     
Sbjct: 15  IVHLAKHKPT-NTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSE 73

Query: 343 KALVLEFMPNGSLEKWLYSHNYFLDILERL---NIMIDVGSALEYLHNGHSSVHIIHCDL 399
             +V   M  GS E  L +H  F + L  L    I+ DV +AL+Y+H    S   IH  +
Sbjct: 74  LYVVSPLMAYGSCEDLLKTH--FPEGLPELAIAFILKDVLNALDYIH----SKGFIHRSV 127

Query: 400 KPTNILLDENMVAHVSDF 417
           K ++ILL  +    +S  
Sbjct: 128 KASHILLSGDGKVVLSGL 145

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 57.4 bits (139), Expect = 6e-09
 Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 19/213 (8%)

Query: 269 RATDEFNECNLLGTSSFGSVYKGTISD-GTDVAIKVFNLQLERAFRSFDS--ECEVLRNV 325
           R+  EF + N +G  ++G VY+   +  G  VA+K   +  ER      S  E  +L N+
Sbjct: 4   RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNL 63

Query: 326 RHRNLIKILSSY--SNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALE 383
           RH N++++       + D   LV+E+     L   L +        +   +M+ +   L+
Sbjct: 64  RHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQ 122

Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMT--MATIGY 441
           YLH       IIH DLK +N+LL +     ++DFG+ +  G       + MT  + T+ Y
Sbjct: 123 YLHENF----IIHRDLKVSNLLLTDKGCLKIADFGLARTYG----LPAKPMTPKVVTLWY 174

Query: 442 MAPE--YGLEGIVSAKCDVYSYGVLLMETFTRK 472
            APE   G     +A  D+++ G +L E    K
Sbjct: 175 RAPELLLGCTTYTTA-IDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 57.7 bits (139), Expect = 7e-09
 Identities = 59/227 (25%), Positives = 106/227 (46%), Gaps = 35/227 (15%)

Query: 266 DIQRATDEFNECNLLGTSSFGSV----YKGTISDGTDVAIKVFNLQLERAF----RS--- 314
           D++   +++    ++G  +FG V    +K T         KV+ ++L   F    RS   
Sbjct: 37  DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTR--------KVYAMKLLSKFEMIKRSDSA 88

Query: 315 -FDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLN 373
            F  E +++       ++++  ++ +  +  +V+E+MP G L   +   NY  D+ E+  
Sbjct: 89  FFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM--SNY--DVPEKWA 144

Query: 374 --IMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVR 431
                +V  AL+ +H    S+  IH D+KP N+LLD++    ++DFG    + + E  VR
Sbjct: 145 RFYTAEVVLALDAIH----SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK-EGMVR 199

Query: 432 QTMTMATIGYMAPEY----GLEGIVSAKCDVYSYGVLLMETFTRKRP 474
               + T  Y++PE     G +G    +CD +S GV L E      P
Sbjct: 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 56.9 bits (137), Expect = 7e-09
 Identities = 45/157 (28%), Positives = 71/157 (45%), Gaps = 16/157 (10%)

Query: 336 SYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHII 395
           ++  PD    +L+ M  G L   L  H  F +   R     ++   LE++HN      ++
Sbjct: 65  AFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRF-YATEIILGLEHMHNRF----VV 119

Query: 396 HCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIV-SA 454
           + DLKP NILLDE+    +SD G    L       +   ++ T GYMAPE   +G    +
Sbjct: 120 YRDLKPANILLDEHGHVRISDLG----LACDFSKKKPHASVGTHGYMAPEVLQKGTAYDS 175

Query: 455 KCDVYSYGVLLME------TFTRKRPTDEMFIGEMSL 485
             D +S G +L +       F + +  D+  I  M+L
Sbjct: 176 SADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL 212

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 57.7 bits (139), Expect = 7e-09
 Identities = 52/162 (32%), Positives = 87/162 (53%), Gaps = 17/162 (10%)

Query: 3   ILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSG 62
            L L+ N ++  +P  IG    N++ L L+ N +  ++P+ + N   L  LDL FN  S 
Sbjct: 120 SLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS- 176

Query: 63  HILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPP----CLVLTVLDVSRNQLSGDIPST 118
            +     NL +L+ L L       +GNK+   +PP       L  LD+S N +  ++ S+
Sbjct: 177 DLPKLLSNLSNLNNLDL-------SGNKI-SDLPPEIELLSALEELDLSNNSII-ELLSS 227

Query: 119 IGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLS 160
           +    +L  L L++N+ +  +PES+G+L +LE+LDLS N +S
Sbjct: 228 LSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS 268

Length = 394

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 57.7 bits (139), Expect = 7e-09
 Identities = 57/219 (26%), Positives = 104/219 (47%), Gaps = 21/219 (9%)

Query: 267 IQRATDEFNECNLLGTSSFGSVYKGTISDGTDV-AIKVFNLQLERAFRS----FDSECEV 321
           +Q   ++++   ++G  +FG V          V A+K+ + + E   RS    F  E ++
Sbjct: 38  LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLS-KFEMIKRSDSAFFWEERDI 96

Query: 322 LRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLN--IMIDVG 379
           +       ++++  ++ +  +  +V+E+MP G L   +   NY  D+ E+       +V 
Sbjct: 97  MAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLM--SNY--DVPEKWAKFYTAEVV 152

Query: 380 SALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATI 439
            AL+ +H    S+ +IH D+KP N+LLD++    ++DFG    + E    VR    + T 
Sbjct: 153 LALDAIH----SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE-TGMVRCDTAVGTP 207

Query: 440 GYMAPEY----GLEGIVSAKCDVYSYGVLLMETFTRKRP 474
            Y++PE     G +G    +CD +S GV L E      P
Sbjct: 208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 57.0 bits (138), Expect = 7e-09
 Identities = 36/99 (36%), Positives = 48/99 (48%), Gaps = 10/99 (10%)

Query: 380 SALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATI 439
            AL YL   H    +IH D+KP+NILLD +    + DFGI    G   DS  +T +    
Sbjct: 125 KALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGIS---GRLVDSKAKTRSAGCA 178

Query: 440 GYMAPEY----GLEGIVSAKCDVYSYGVLLMETFTRKRP 474
            YMAPE             + DV+S G+ L+E  T + P
Sbjct: 179 AYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 57.3 bits (138), Expect = 7e-09
 Identities = 63/212 (29%), Positives = 96/212 (45%), Gaps = 19/212 (8%)

Query: 279 LLGTSSFGSVYKGT-ISDGTDVAIKVFNLQL---ERAFRSFDSECEVL-RNVRHRNLIKI 333
           ++G  SFG V      ++    A+KV   +    ++  +   SE  VL +NV+H  L+ +
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61

Query: 334 LSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVH 393
             S+   D    VL+++  G L   L     FL+   R     ++ SAL YLH    S++
Sbjct: 62  HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYLH----SLN 116

Query: 394 IIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTM-ATIGYMAPEYGLEGIV 452
           I++ DLKP NILLD      ++DFG+ K   E  +    T T   T  Y+APE   +   
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLCK---ENIEHNGTTSTFCGTPEYLAPEVLHKQPY 173

Query: 453 SAKCDVYSYGVLLMETFT-----RKRPTDEMF 479
               D +  G +L E          R T EM+
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY 205

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 57.2 bits (139), Expect = 8e-09
 Identities = 59/183 (32%), Positives = 95/183 (51%), Gaps = 32/183 (17%)

Query: 280 LGTSSFGSVYKGT-ISDGTDVAIK-VF----NLQ-LERAFRSFDSECEVLRNVR-HRNLI 331
           LG  ++G V+K         VA+K +F    N    +R FR    E   L+ +  H N++
Sbjct: 15  LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFR----EIMFLQELGDHPNIV 70

Query: 332 KILSSY---SNPDFKALVLEFMPNGSLEKWLYS---HNYFLDILERLNIMIDVGSALEYL 385
           K+L+     ++ D   LV E+M     E  L++    N   D+ +R  IM  +  AL+Y+
Sbjct: 71  KLLNVIKAENDKDI-YLVFEYM-----ETDLHAVIRANILEDVHKRY-IMYQLLKALKYI 123

Query: 386 HNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSV-RQTMT--MATIGYM 442
           H+G+    +IH DLKP+NILL+ +    ++DFG+ + L E E++     +T  +AT  Y 
Sbjct: 124 HSGN----VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYR 179

Query: 443 APE 445
           APE
Sbjct: 180 APE 182

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 57.5 bits (139), Expect = 8e-09
 Identities = 56/213 (26%), Positives = 102/213 (47%), Gaps = 21/213 (9%)

Query: 266 DIQRATDEFNECNLLGTSSFGSVYKGTISDGTDV-AIKVFNLQLERAFRS----FDSECE 320
            ++   ++F+   ++G  +FG V          V A+K+ + + E   RS    F  E +
Sbjct: 37  KLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLS-KFEMIKRSDSAFFWEERD 95

Query: 321 VLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIM--IDV 378
           ++ +     ++++  ++ +  +  +V+E+MP G L   +   NY  DI E+       +V
Sbjct: 96  IMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLM--SNY--DIPEKWARFYTAEV 151

Query: 379 GSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMAT 438
             AL+ +H    S+  IH D+KP N+LLD++    ++DFG    +      VR    + T
Sbjct: 152 VLALDAIH----SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA-NGMVRCDTAVGT 206

Query: 439 IGYMAPEY----GLEGIVSAKCDVYSYGVLLME 467
             Y++PE     G +G    +CD +S GV L E
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYE 239

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 56.6 bits (136), Expect = 1e-08
 Identities = 58/219 (26%), Positives = 93/219 (42%), Gaps = 36/219 (16%)

Query: 271 TDEFNECNLLGTSSFGSVYK-GTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNV---- 325
           +D +     +G  ++G V+K     +G+  A+K+ +          D E E   N+    
Sbjct: 17  SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILD-----PIHDIDEEIEAEYNILKAL 71

Query: 326 -RHRNLIKILSSYSNPDFKA-----LVLEFMPNGSLEKWLYSHNYFLDILERLN------ 373
             H N++K    Y   D K      LVLE    GS+   +     FL   ER+       
Sbjct: 72  SDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKG---FLKRGERMEEPIIAY 128

Query: 374 IMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQT 433
           I+ +    L++LH   +    IH D+K  NILL       + DFG+   L      +R+ 
Sbjct: 129 ILHEALMGLQHLHVNKT----IHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR--LRRN 182

Query: 434 MTMATIGYMAPEY-----GLEGIVSAKCDVYSYGVLLME 467
            ++ T  +MAPE       L+    A+CDV+S G+  +E
Sbjct: 183 TSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIE 221

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 55.7 bits (134), Expect = 1e-08
 Identities = 55/199 (27%), Positives = 96/199 (48%), Gaps = 16/199 (8%)

Query: 280 LGTSSFGSVYKG---TISDGTDVAIKVF-NLQLERAFR-SFDSECEVLRNVRHRNLIKIL 334
           LG+ +FG+V KG          VA+K+  N   + A +     E  V++ + +  +++++
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 335 SSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLD--ILERLNIMIDVGSALEYLHNGHSSV 392
                  +  LV+E    G L K+L  + +  +  I E ++    V   ++YL   +   
Sbjct: 63  GICEAESW-MLVMELAELGPLNKFLQKNKHVTEKNITELVH---QVSMGMKYLEETN--- 115

Query: 393 HIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVR-QTMTMATIGYMAPEYGLEGI 451
             +H DL   N+LL     A +SDFG+ K LG  E+  + +T     + + APE      
Sbjct: 116 -FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYK 174

Query: 452 VSAKCDVYSYGVLLMETFT 470
            S+K DV+S+GVL+ E F+
Sbjct: 175 FSSKSDVWSFGVLMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 56.4 bits (136), Expect = 1e-08
 Identities = 62/216 (28%), Positives = 93/216 (43%), Gaps = 27/216 (12%)

Query: 279 LLGTSSFGSVYKGTISDGTD--VAIKVFNLQLERAFRSFDSECEVLRN------VRHRNL 330
           +LG  SFG V    +  GTD   AIKV  L+ +   +  D +C +          +H  L
Sbjct: 2   VLGKGSFGKVMLAELK-GTDEVYAIKV--LKKDVILQDDDVDCTMTEKRILALAAKHPFL 58

Query: 331 IKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH-NGH 389
             +   +   D    V+E++  G L   +     F +   R     +V  AL +LH +G 
Sbjct: 59  TALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRF-YAAEVTLALMFLHRHG- 116

Query: 390 SSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTM-ATIGYMAPEYGL 448
               +I+ DLK  NILLD      ++DFG+ K   EG  +   T T   T  Y+APE   
Sbjct: 117 ----VIYRDLKLDNILLDAEGHCKLADFGMCK---EGILNGVTTTTFCGTPDYIAPEILQ 169

Query: 449 EGIVSAKCDVYSYGVLLMETFTRKRP-----TDEMF 479
           E       D ++ GVL+ E    + P      D++F
Sbjct: 170 ELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLF 205

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 56.5 bits (136), Expect = 1e-08
 Identities = 60/217 (27%), Positives = 101/217 (46%), Gaps = 34/217 (15%)

Query: 272 DEFNECNLLGTSSFGSV-YKGTISDGTDVAIKVF------NLQLERAFRSFDSECEVLRN 324
           D + +   +G+ ++G+V        G  VAIK         L  +RA+R    E  +L++
Sbjct: 15  DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR----ELRLLKH 70

Query: 325 VRHRNLIKILSSYSNPDFKA-------LVLEFMPNGSLEKWLYSHNYFLDILERLNIMI- 376
           ++H N+I +L  ++ PD          LV+ FM  G+    L  H    +  +R+  ++ 
Sbjct: 71  MKHENVIGLLDVFT-PDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSE--DRIQFLVY 125

Query: 377 DVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTM 436
            +   L+Y+H    +  IIH DLKP N+ ++E+    + DFG    L    DS   T  +
Sbjct: 126 QMLKGLKYIH----AAGIIHRDLKPGNLAVNEDCELKILDFG----LARQTDS-EMTGYV 176

Query: 437 ATIGYMAPEYGLEGI-VSAKCDVYSYGVLLMETFTRK 472
            T  Y APE  L  +  +   D++S G ++ E  T K
Sbjct: 177 VTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 56.1 bits (135), Expect = 1e-08
 Identities = 57/215 (26%), Positives = 99/215 (46%), Gaps = 28/215 (13%)

Query: 262 TSYLDIQRATDEFNECNLLGTSSFGSVYKGTIS--DGTDVAIKVFNLQLERA--FRSFDS 317
           TSYL++++          LG  S+ +VYKG IS  +G  VA+KV +++ E    F +   
Sbjct: 5   TSYLNLEK----------LGEGSYATVYKG-ISRINGQLVALKVISMKTEEGVPFTAI-R 52

Query: 318 ECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMID 377
           E  +L+ ++H N++ +       +    V E+M +  L +++  H   L        M  
Sbjct: 53  EASLLKGLKHANIVLLHDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQ 111

Query: 378 VGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMT-- 435
           +   L Y+H  H    I+H DLKP N+L+       ++DFG    L   +    QT +  
Sbjct: 112 LLRGLAYIHGQH----ILHRDLKPQNLLISYLGELKLADFG----LARAKSIPSQTYSSE 163

Query: 436 MATIGYMAPEYGLEGI-VSAKCDVYSYGVLLMETF 469
           + T+ Y  P+  L     S+  D++  G + +E  
Sbjct: 164 VVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEML 198

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 56.2 bits (136), Expect = 1e-08
 Identities = 71/267 (26%), Positives = 105/267 (39%), Gaps = 80/267 (29%)

Query: 280 LGTSSFGSVYKGTISD-GTDVAIK----VFNLQLE--RAFRSFDSECEVLRNVRHRNLIK 332
           +G  ++G V     S+    VAIK     F+ +++  R  R    E ++LR++ H N+I 
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLR----EIKLLRHLDHENVIA 68

Query: 333 ILSSYSNPDFKA-----LVLEFMPNGSLEKWLYS-------H-NYFLDILERLNIMIDVG 379
           I      P  +A     +V E M +  L + + S       H  YFL  L R        
Sbjct: 69  IKDIMPPPHREAFNDVYIVYELM-DTDLHQIIRSSQTLSDDHCQYFLYQLLR-------- 119

Query: 380 SALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMT--MA 437
             L+Y+H    S +++H DLKP+N+LL+ N    + DFG    L          MT  + 
Sbjct: 120 -GLKYIH----SANVLHRDLKPSNLLLNANCDLKICDFG----LARTTSEKGDFMTEYVV 170

Query: 438 TIGYMAPE-------YGLEGIVSAKCDVYSYGVLLMETFTRK------------------ 472
           T  Y APE       Y          DV+S G +  E   RK                  
Sbjct: 171 TRWYRAPELLLNCSEYT------TAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITEL 224

Query: 473 ----RPTDEMFIGEMSLRRWVKESLPH 495
                  D  FI     RR+++ SLP+
Sbjct: 225 LGSPSEEDLGFIRNEKARRYIR-SLPY 250

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 56.6 bits (136), Expect = 2e-08
 Identities = 31/105 (29%), Positives = 55/105 (52%), Gaps = 4/105 (3%)

Query: 366 LDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGE 425
           L  L+ L+    V   +E+L    +S + +H DL   N+LL +  +  + DFG+ + +  
Sbjct: 234 LTTLDLLSFTYQVARGMEFL----ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMH 289

Query: 426 GEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
             + V +  T   + +MAPE   + + +   DV+SYG+LL E F+
Sbjct: 290 DSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 55.7 bits (134), Expect = 2e-08
 Identities = 45/157 (28%), Positives = 73/157 (46%), Gaps = 16/157 (10%)

Query: 336 SYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHII 395
           ++  PD  + +L+ M  G L   L  H  F +   R     ++   LE++HN      ++
Sbjct: 65  AFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRF-YAAEIILGLEHMHNRF----VV 119

Query: 396 HCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIV-SA 454
           + DLKP NILLDE+    +SD G    L       +   ++ T GYMAPE   +G+   +
Sbjct: 120 YRDLKPANILLDEHGHVRISDLG----LACDFSKKKPHASVGTHGYMAPEVLQKGVAYDS 175

Query: 455 KCDVYSYGVLLME------TFTRKRPTDEMFIGEMSL 485
             D +S G +L +       F + +  D+  I  M+L
Sbjct: 176 SADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL 212

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 55.8 bits (135), Expect = 2e-08
 Identities = 46/173 (26%), Positives = 78/173 (45%), Gaps = 18/173 (10%)

Query: 280 LGTSSFGSVYKGTISD-GTDVAIKVF-----NLQLER-AFRSFDSECEVLRNVRHRNLIK 332
           +G  S+G V+K    + G  VAIK F     +  +++ A R    E  +L+ ++H NL+ 
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALR----EIRMLKQLKHPNLVN 64

Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSV 392
           ++  +       LV E+  +  L + L  +   +       I+     A+ + H      
Sbjct: 65  LIEVFRRKRKLHLVFEYCDHTVLNE-LEKNPRGVPEHLIKKIIWQTLQAVNFCH----KH 119

Query: 393 HIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPE 445
           + IH D+KP NIL+ +     + DFG  ++L    D    T  +AT  Y APE
Sbjct: 120 NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY--TDYVATRWYRAPE 170

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 56.1 bits (136), Expect = 2e-08
 Identities = 49/162 (30%), Positives = 74/162 (45%), Gaps = 31/162 (19%)

Query: 272 DEFNECNLLGTSSFGSVY----KGTISDGTDVAIKVFNLQ-------LERAFRSFDSECE 320
             F +  LLG    G V+    KGT   G   A+KV + +       ++R      +E E
Sbjct: 1   KHFKKIKLLGKGDVGRVFLVRLKGT---GKLFALKVLDKKEMIKRNKVKRVL----TEQE 53

Query: 321 VLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWL--YSHNYFLDILERLNIMIDV 378
           +L  + H  L  + +S+    +  LV+++ P G L + L         + + R     +V
Sbjct: 54  ILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAA-EV 112

Query: 379 GSALEYLH-NGHSSVHIIHCDLKPTNILLDENMVAHV--SDF 417
             ALEYLH  G     I++ DLKP NILL E+   H+  SDF
Sbjct: 113 LLALEYLHLLG-----IVYRDLKPENILLHES--GHIMLSDF 147

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 55.5 bits (134), Expect = 2e-08
 Identities = 49/215 (22%), Positives = 92/215 (42%), Gaps = 34/215 (15%)

Query: 278 NLLGTSSFGSVYKGTISDGT-----DVAIK-VFNLQLERAFRSFDSECEVLRNVRHRNLI 331
           +LL   +FG ++ G + D       +V +K V +   E        E  +L  + H+N++
Sbjct: 12  DLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNIL 71

Query: 332 KILS-SYSNPDFKALVLEFMPNGSLEKWLYSHNYF-------LDILERLNIMIDVGSALE 383
            IL     + +   ++  +M  G+L+ +L             L   + +++ I +   + 
Sbjct: 72  PILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMS 131

Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGI--------YKLLGEGEDSVRQTMT 435
           YLH       +IH D+   N ++DE +   ++D  +        Y  LG+ E+       
Sbjct: 132 YLH----KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENR------ 181

Query: 436 MATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
              + +MA E  +    S+  DV+S+GVLL E  T
Sbjct: 182 --PVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 56.3 bits (136), Expect = 2e-08
 Identities = 66/230 (28%), Positives = 99/230 (43%), Gaps = 51/230 (22%)

Query: 280 LGTSSFGSV----YKGTISDGTDVAIK----VFN--LQLERAFRSFDSECEVLRNVR-HR 328
           LG  ++G V       T S+   VAIK    VF+  +  +RA R    E ++LR+ R H+
Sbjct: 8   LGQGAYGIVCSARNAET-SEEETVAIKKITNVFSKKILAKRALR----ELKLLRHFRGHK 62

Query: 329 NLIKILS----SYSNPDFKALVLEFMPNGSLEKWLYS-------H-NYFL-DILERLNIM 375
           N+  +         N +   L  E M    L + + S       H   F+  IL      
Sbjct: 63  NITCLYDMDIVFPGNFNELYLYEELM-EADLHQIIRSGQPLTDAHFQSFIYQIL------ 115

Query: 376 IDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMT 435
                 L+Y+H    S +++H DLKP N+L++ +    + DFG+ +   E        MT
Sbjct: 116 ----CGLKYIH----SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMT 167

Query: 436 --MATIGYMAPEYGLEGIVSAKC-DVYSYGVLLMETFTRKRPTDEMFIGE 482
             +AT  Y APE  L      K  DV+S G +L E   RK     +F G+
Sbjct: 168 EYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK----PVFKGK 213

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 55.8 bits (134), Expect = 2e-08
 Identities = 58/207 (28%), Positives = 103/207 (49%), Gaps = 14/207 (6%)

Query: 272 DEFNECNLLGTSSFGSVYK-GTISDGTDVAIKVFNLQLERAFRS-FDSECEVLRNVRHRN 329
           D+F   + LG  + G V K      G  +A K+ +L+++ A R+    E +VL       
Sbjct: 5   DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64

Query: 330 LIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYF-LDILERLNIMIDVGSALEYLHNG 388
           ++    ++ +    ++ +E M  GSL++ L        +IL +++I +  G  L YL   
Sbjct: 65  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRG--LAYLREK 122

Query: 389 HSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGL 448
           H    I+H D+KP+NIL++      + DFG+    G+  DS+  +  + T  YM+PE  L
Sbjct: 123 H---QIMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSF-VGTRSYMSPER-L 174

Query: 449 EGI-VSAKCDVYSYGVLLMETFTRKRP 474
           +G   S + D++S G+ L+E    + P
Sbjct: 175 QGTHYSVQSDIWSMGLSLVELAIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 55.2 bits (133), Expect = 2e-08
 Identities = 49/159 (30%), Positives = 75/159 (47%), Gaps = 8/159 (5%)

Query: 317 SECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYS-HNYFLDILERLNIM 375
           +E ++L  V  R ++ +  +Y   D   LVL  M  G L+  +Y+  N   D    +   
Sbjct: 49  NEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYA 108

Query: 376 IDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMT 435
            ++   LE LH       I++ DLKP NILLD+     +SD G+   + EGE ++R    
Sbjct: 109 AEITCGLEDLH----RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE-TIRG--R 161

Query: 436 MATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
           + T+GYMAPE       +   D +  G L+ E    K P
Sbjct: 162 VGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 55.6 bits (134), Expect = 3e-08
 Identities = 59/225 (26%), Positives = 100/225 (44%), Gaps = 53/225 (23%)

Query: 271 TDEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVF------NLQLERAFRSFDSECEVLR 323
           T+ + +   +G  +FG V        G +VAIK         +  +R +R    E ++L+
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYR----ELKLLK 64

Query: 324 NVRHRNLIKILSSYSNP-DFKALVLEFM--------PNGSLEKWLYSHNYFLDILERLNI 374
           ++RH N+I +   + +P +    V E +         +  LEK      YFL  + R   
Sbjct: 65  HLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFI--QYFLYQILR--- 119

Query: 375 MIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTM 434
                  L+Y+H    S  ++H DLKP+NIL++EN    + DFG+ ++    +D  + T 
Sbjct: 120 ------GLKYVH----SAGVVHRDLKPSNILINENCDLKICDFGLARI----QDP-QMTG 164

Query: 435 TMATIGYMAPE-------YGLEGIVSAKCDVYSYGVLLMETFTRK 472
            ++T  Y APE       Y +E       D++S G +  E    K
Sbjct: 165 YVSTRYYRAPEIMLTWQKYDVE------VDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 55.4 bits (133), Expect = 3e-08
 Identities = 56/213 (26%), Positives = 102/213 (47%), Gaps = 16/213 (7%)

Query: 272 DEFNECNLLGTSSFGSVYKGTISDGTDV-AIKVFNL--QLERAFRS-FDSECEVLRNVRH 327
           D+F    ++G  +FG V    +     + A+K+ N    L+RA  + F  E  VL N   
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60

Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
           + +  +  ++ + ++  LV+++   G L   L   + F D L        +   +  +H+
Sbjct: 61  QWITTLHYAFQDENYLYLVMDYYVGGDLLTLL---SKFEDRLPEDMARFYIAEMVLAIHS 117

Query: 388 GHSSVHIIHCDLKPTNILLDENMVAHVSDFG-IYKLLGEGEDSVRQTMTMATIGYMAPEY 446
            H  +H +H D+KP N+LLD N    ++DFG   K+  +G  +V+ ++ + T  Y++PE 
Sbjct: 118 IHQ-LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG--TVQSSVAVGTPDYISPEI 174

Query: 447 --GLE---GIVSAKCDVYSYGVLLMETFTRKRP 474
              +E   G    +CD +S GV + E    + P
Sbjct: 175 LQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 55.3 bits (133), Expect = 3e-08
 Identities = 64/214 (29%), Positives = 94/214 (43%), Gaps = 23/214 (10%)

Query: 279 LLGTSSFGSVYKGTI-SDGTDVAIKVFNLQLERAFRSFDSEC-----EVLRNVR-HRNLI 331
           +LG  SFG V    +   G   A+KV  L+ +   +  D EC      +L   R H  L 
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKV--LKKDVILQDDDVECTMTEKRILSLARNHPFLT 59

Query: 332 KILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSS 391
           ++   +  PD    V+EF+  G L   +     F +   R     ++ SAL +LH     
Sbjct: 60  QLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF-YAAEITSALMFLH----D 114

Query: 392 VHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTM-ATIGYMAPEYGLEG 450
             II+ DLK  N+LLD      ++DFG+ K   EG  + + T T   T  Y+APE   E 
Sbjct: 115 KGIIYRDLKLDNVLLDHEGHCKLADFGMCK---EGIFNGKTTSTFCGTPDYIAPEILQEM 171

Query: 451 IVSAKCDVYSYGVLLMETFTRKRP-----TDEMF 479
           +     D ++ GVLL E      P      D++F
Sbjct: 172 LYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLF 205

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 55.3 bits (133), Expect = 3e-08
 Identities = 59/186 (31%), Positives = 84/186 (45%), Gaps = 12/186 (6%)

Query: 317 SECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMI 376
           +E  VL  V    ++ +  S+ +P+   LVL F+  G L   L     F     R     
Sbjct: 42  AERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTA- 100

Query: 377 DVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTM 436
           ++  ALE LH      ++I+ DLKP NILLD      + DFG+ KL    +D  +     
Sbjct: 101 ELLCALENLH----KFNVIYRDLKPENILLDYQGHIALCDFGLCKL--NMKDDDKTNTFC 154

Query: 437 ATIGYMAPEYGLEGIVSAKC-DVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESL-- 493
            T  Y+APE  L G    K  D ++ GVLL E  T   P  +  + EM  R+ ++E L  
Sbjct: 155 GTPEYLAPEL-LLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEM-YRKILQEPLRF 212

Query: 494 PHGLTE 499
           P G   
Sbjct: 213 PDGFDR 218

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 55.3 bits (133), Expect = 4e-08
 Identities = 31/105 (29%), Positives = 52/105 (49%), Gaps = 4/105 (3%)

Query: 366 LDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGE 425
           LD  + L+    V   + +L    +S + IH DL   NILL    +  + DFG+ + +  
Sbjct: 211 LDTEDLLSFSYQVAKGMSFL----ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRN 266

Query: 426 GEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
             + V +      + +MAPE     + + + DV+SYG+LL E F+
Sbjct: 267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 54.6 bits (131), Expect = 4e-08
 Identities = 54/210 (25%), Positives = 96/210 (45%), Gaps = 31/210 (14%)

Query: 272 DEFNECNLLGTSSFGSVYKGTISDGTD-VAIKVF--NLQLERAFRSFDSECEVLRNVRHR 328
           ++F    ++G  ++G V K    +  + VAIK F  + + E    +   E ++LR ++  
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60

Query: 329 NLIKILSSYSNPDFKALVLEF-----------MPNGSLEKWLYSHNYFLDILERLNIMID 377
           N++++  ++       LV E+           MPNG   + + S+ Y L           
Sbjct: 61  NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQL----------- 109

Query: 378 VGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMA 437
               ++ +H  H +  I+H D+KP N+L+  N V  + DFG  + L EG ++   T  +A
Sbjct: 110 ----IKAIHWCHKN-DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA-NYTEYVA 163

Query: 438 TIGYMAPEYGLEGIVSAKCDVYSYGVLLME 467
           T  Y +PE  L        D++S G +L E
Sbjct: 164 TRWYRSPELLLGAPYGKAVDMWSVGCILGE 193

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 54.7 bits (131), Expect = 5e-08
 Identities = 55/214 (25%), Positives = 107/214 (50%), Gaps = 18/214 (8%)

Query: 272 DEFNECNLLGTSSFGSVYKGTISDGTDV-AIKVFNL--QLERAFRS-FDSECEVLRNVRH 327
           ++F    ++G  +FG V    + +   V A+K+ N    L+RA  + F  E +VL N  +
Sbjct: 1   EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60

Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYS-HNYFLDILERLNIMIDVGSALEYLH 386
           + +  +  ++ + +   LV+++   G L   L    +   + + R   + ++  A++ +H
Sbjct: 61  QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARF-YLAEMVIAIDSVH 119

Query: 387 NGHSSVHIIHCDLKPTNILLDENMVAHVSDFG-IYKLLGEGEDSVRQTMTMATIGYMAPE 445
                +H +H D+KP NIL+D N    ++DFG   KL+ +G  +V+ ++ + T  Y++PE
Sbjct: 120 Q----LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG--TVQSSVAVGTPDYISPE 173

Query: 446 Y--GLE---GIVSAKCDVYSYGVLLMETFTRKRP 474
               +E   G    +CD +S GV + E    + P
Sbjct: 174 ILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 54.6 bits (132), Expect = 5e-08
 Identities = 52/208 (25%), Positives = 96/208 (46%), Gaps = 37/208 (17%)

Query: 280 LGTSSFGSVYKG-TISDGTDVAIKVFNLQLERAFRSFD-----SECEVLRNVR-HRNLIK 332
           +G  +F  V K  +   G   AIK     +++ F+S +      E + LR +  H N+++
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIK----CMKKHFKSLEQVNNLREIQALRRLSPHPNILR 62

Query: 333 ILSS-YSNPDFK-ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH-NGH 389
           ++   +     + ALV E M + +L + +      L      + M  +  +L+++H NG 
Sbjct: 63  LIEVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG- 120

Query: 390 SSVHIIHCDLKPTNILLDENMVAHVSDFG----IYKLLGEGEDSVRQTMT--MATIGYMA 443
               I H D+KP NIL+ ++++  ++DFG    IY          +   T  ++T  Y A
Sbjct: 121 ----IFHRDIKPENILIKDDIL-KLADFGSCRGIY---------SKPPYTEYISTRWYRA 166

Query: 444 PEYGL-EGIVSAKCDVYSYGVLLMETFT 470
           PE  L +G    K D+++ G +  E  +
Sbjct: 167 PECLLTDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 55.4 bits (133), Expect = 5e-08
 Identities = 63/217 (29%), Positives = 107/217 (49%), Gaps = 27/217 (12%)

Query: 266 DIQRATDE-FNECNLLGTSSFGSVYKGTISDGTD-VAIKVFNLQLERAFRSFDSECEVLR 323
           DI R+ ++ +   N++G  SFG VY+    D ++ VAIK    ++ +  +  + E  +++
Sbjct: 59  DINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIK----KVLQDPQYKNRELLIMK 114

Query: 324 NVRHRNLIKILSSYSNPDFKA--------LVLEFMPNGSLEKWL--YS-HNYFLDILERL 372
           N+ H N+I +   Y    FK         +V+EF+P  ++ K++  Y+ +N+ L +    
Sbjct: 115 NLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVK 173

Query: 373 NIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENM-VAHVSDFGIYKLLGEGEDSVR 431
                +  AL Y+H    S  I H DLKP N+L+D N     + DFG  K L  G+ SV 
Sbjct: 174 LYSYQLCRALAYIH----SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVS 229

Query: 432 QTMTMATIGYMAPEYGLEGI-VSAKCDVYSYGVLLME 467
               + +  Y APE  L     +   D++S G ++ E
Sbjct: 230 Y---ICSRFYRAPELMLGATNYTTHIDLWSLGCIIAE 263

Length = 440

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 54.7 bits (131), Expect = 5e-08
 Identities = 50/200 (25%), Positives = 94/200 (47%), Gaps = 12/200 (6%)

Query: 272 DEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLERA--FRSFDSECEVLRNVRHR 328
           D + +   LG  S+ +VYKG +  +G  VA+KV  LQ E    F +   E  +L+ ++H 
Sbjct: 5   DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAI-REASLLKGLKHA 63

Query: 329 NLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNG 388
           N++ +       +   LV E++ +  L +++  H   L        +  +   L Y+H  
Sbjct: 64  NIVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR 122

Query: 389 HSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGL 448
           +    I+H DLKP N+L+ +     ++DFG+ +   +   S   +  + T+ Y  P+  L
Sbjct: 123 Y----ILHRDLKPQNLLISDTGELKLADFGLAR--AKSVPSHTYSNEVVTLWYRPPDVLL 176

Query: 449 EGIVSAKC-DVYSYGVLLME 467
                + C D++  G + +E
Sbjct: 177 GSTEYSTCLDMWGVGCIFVE 196

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 54.2 bits (131), Expect = 6e-08
 Identities = 58/205 (28%), Positives = 95/205 (46%), Gaps = 26/205 (12%)

Query: 280 LGTSSFGSVYKG-TISDGTDVAIKVFNLQLER------AFRSFDSECEVLRNVRHRNLIK 332
           +G  ++G VYK      G  VA+K   L+ E       A R    E  +L+ + H N+++
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIR----EISLLKELNHPNIVR 62

Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNI---MIDVGSALEYLHNGH 389
           +L    + +   LV EF+ +  L+K++ S    L  L+   I   +  +   + Y H   
Sbjct: 63  LLDVVHSENKLYLVFEFL-DLDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCH--- 116

Query: 390 SSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQ-TMTMATIGYMAPEYGL 448
            S  ++H DLKP N+L+D      ++DFG+ +  G     VR  T  + T+ Y APE  L
Sbjct: 117 -SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGV---PVRTYTHEVVTLWYRAPEILL 172

Query: 449 EG-IVSAKCDVYSYGVLLMETFTRK 472
                S   D++S G +  E   R+
Sbjct: 173 GSRQYSTPVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 53.8 bits (129), Expect = 6e-08
 Identities = 41/158 (25%), Positives = 73/158 (46%), Gaps = 8/158 (5%)

Query: 318 ECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYS-HNYFLDILERLNIMI 376
           E E+L  V    ++ +  ++ +     LV+  M  G L+  +Y+     L++   ++   
Sbjct: 43  EKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSA 102

Query: 377 DVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTM 436
            +   + +LH    S+ I++ D+KP N+LLD+     +SD G+   L +G+     T   
Sbjct: 103 QITCGILHLH----SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI---TQRA 155

Query: 437 ATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
            T GYMAPE   E   S   D ++ G  + E    + P
Sbjct: 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 54.2 bits (130), Expect = 7e-08
 Identities = 60/208 (28%), Positives = 93/208 (44%), Gaps = 26/208 (12%)

Query: 279 LLGTSSFGSVY----KGTISDGTDVAIKVFNLQLERAFRSFDSECE-VLRNV-----RHR 328
           +LG  SFG V+    KGT       AIK   L+ +      D EC  V + V      H 
Sbjct: 2   MLGKGSFGKVFLAELKGT---NQFFAIKA--LKKDVVLMDDDVECTMVEKRVLSLAWEHP 56

Query: 329 NLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNG 388
            L  +  ++   +    V+E++  G L   + S + F D+        ++   L++LH  
Sbjct: 57  FLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKF-DLPRATFYAAEIICGLQFLH-- 113

Query: 389 HSSVHIIHCDLKPTNILLDENMVAHVSDFGIYK--LLGEGEDSVRQTMTMATIGYMAPEY 446
             S  I++ DLK  NILLD +    ++DFG+ K  +LG+     +      T  Y+APE 
Sbjct: 114 --SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA----KTCTFCGTPDYIAPEI 167

Query: 447 GLEGIVSAKCDVYSYGVLLMETFTRKRP 474
            L    +   D +S+GVLL E    + P
Sbjct: 168 LLGQKYNTSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 53.7 bits (129), Expect = 7e-08
 Identities = 53/202 (26%), Positives = 81/202 (40%), Gaps = 13/202 (6%)

Query: 280 LGTSSFGSVYKGTI-SDGTDVAIKVFN---LQLERAFRSFDSECEVLRNVRHRNLIKILS 335
           LG   FG V    + + G   A K  N   L+  + +     E  +L  V  R ++ +  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 336 SYSNPDFKALVLEFMPNGSLEKWLYS---HNYFLDILERLNIMIDVGSALEYLHNGHSSV 392
           ++       LV+  M  G L   +Y+    N              + S LE+LH      
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR--- 117

Query: 393 HIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIV 452
            II+ DLKP N+LLD +    +SD G+   L +G+   +      T G+MAPE       
Sbjct: 118 -IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKG--YAGTPGFMAPELLQGEEY 174

Query: 453 SAKCDVYSYGVLLMETFTRKRP 474
               D ++ GV L E    + P
Sbjct: 175 DFSVDYFALGVTLYEMIAARGP 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 54.0 bits (130), Expect = 9e-08
 Identities = 60/207 (28%), Positives = 97/207 (46%), Gaps = 26/207 (12%)

Query: 280 LGTSSFGSVYKGT-ISDGTDVAIK----VFN--LQLERAFRSFDSECEVLRNVRHRNLIK 332
           +G  +FG V+  T   DG  VA+K    VF   +  +R FR    E ++L   +H N++ 
Sbjct: 8   IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFR----ELKMLCFFKHDNVLS 63

Query: 333 ILSSYSNPD---FKAL--VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
            L     P    F+ +  V E M    L K + S         ++  +  +   L+YLH 
Sbjct: 64  ALDILQPPHIDPFEEIYVVTELM-QSDLHKIIVSPQPLSSDHVKV-FLYQILRGLKYLH- 120

Query: 388 GHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYG 447
              S  I+H D+KP N+L++ N V  + DFG+ + + E ++S   T  + T  Y APE  
Sbjct: 121 ---SAGILHRDIKPGNLLVNSNCVLKICDFGLAR-VEEPDESKHMTQEVVTQYYRAPEI- 175

Query: 448 LEGI--VSAKCDVYSYGVLLMETFTRK 472
           L G    ++  D++S G +  E   R+
Sbjct: 176 LMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 54.1 bits (130), Expect = 9e-08
 Identities = 56/225 (24%), Positives = 93/225 (41%), Gaps = 33/225 (14%)

Query: 272 DEFNECNLLGTSSFGSVY----KGTISDGTDVAIKVFN---LQLERAFRSFDSECEVLRN 324
            +F+  +L+G   FG V     K T   G   A+KV     L  +     F+ E ++L  
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKAT---GDIYAMKVMKKSVLLAQETVSFFEEERDILSI 57

Query: 325 VRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEY 384
                + ++  ++ + D   LV+E+ P G L   L   N + D  +       +   +  
Sbjct: 58  SNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLL---NRYEDQFDEDMAQFYLAELVLA 114

Query: 385 LHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAP 444
           +H+ H  +  +H D+KP N+L+D      ++DFG    L      V   + + T  Y+AP
Sbjct: 115 IHSVHQ-MGYVHRDIKPENVLIDRTGHIKLADFGSAARL-TANKMVNSKLPVGTPDYIAP 172

Query: 445 E------------YGLEGIVSAKCDVYSYGVLLMETFTRKRPTDE 477
           E            YG+E      CD +S GV+  E    + P  E
Sbjct: 173 EVLTTMNGDGKGTYGVE------CDWWSLGVIAYEMIYGRSPFHE 211

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 53.9 bits (129), Expect = 1e-07
 Identities = 58/204 (28%), Positives = 91/204 (44%), Gaps = 18/204 (8%)

Query: 279 LLGTSSFGSVY----KGTISDGTDVAIKVFNLQLERAFRSFD---SECEVLRNVRHRNLI 331
           LLG  +FG V     K T   G   A+K+   ++  A        +E  VL+N RH  L 
Sbjct: 2   LLGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT 58

Query: 332 KILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSS 391
            +  S+   D    V+E+   G L   L     F +   R     ++ SAL+YLH   S 
Sbjct: 59  ALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDYLH---SE 114

Query: 392 VHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG-EDSVRQTMTMATIGYMAPEYGLEG 450
            ++++ DLK  N++LD++    ++DFG+ K   EG +D         T  Y+APE   + 
Sbjct: 115 KNVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKTFCGTPEYLAPEVLEDN 171

Query: 451 IVSAKCDVYSYGVLLMETFTRKRP 474
                 D +  GV++ E    + P
Sbjct: 172 DYGRAVDWWGLGVVMYEMMCGRLP 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 53.5 bits (128), Expect = 1e-07
 Identities = 45/159 (28%), Positives = 72/159 (45%), Gaps = 9/159 (5%)

Query: 317 SECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMI 376
           +E  VL+N RH  L  +  ++   D    V+E+   G L   L     F +   R     
Sbjct: 44  TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGA 102

Query: 377 DVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG-EDSVRQTMT 435
           ++ SALEYLH    S  +++ D+K  N++LD++    ++DFG+ K   EG  D       
Sbjct: 103 EIVSALEYLH----SRDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTF 155

Query: 436 MATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
             T  Y+APE   +       D +  GV++ E    + P
Sbjct: 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 53.2 bits (128), Expect = 1e-07
 Identities = 64/267 (23%), Positives = 114/267 (42%), Gaps = 52/267 (19%)

Query: 280 LGTSSFGSVYKGTISD-GTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKIL---- 334
           LG  S G V+    SD    VA+K   L   ++ +    E +++R + H N++K+     
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72

Query: 335 --SSYSNPDFKAL--------VLEFMPNG---SLEKWLYSHNYFLDILERLNIMIDVGSA 381
              S    D  +L        V E+M       LE+   S  +      RL  M  +   
Sbjct: 73  PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHA-----RL-FMYQLLRG 126

Query: 382 LEYLHNGHSSVHIIHCDLKPTNILLD-ENMVAHVSDFGIYKLLG-EGEDSVRQTMTMATI 439
           L+Y+H    S +++H DLKP N+ ++ E++V  + DFG+ +++          +  + T 
Sbjct: 127 LKYIH----SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTK 182

Query: 440 GYMAPEYGLEGIVSAKC-DVYSYGVLLMETFTRKRPTDEMFIG--EMSLRRWVKESLPHG 496
            Y +P   L      K  D+++ G +  E  T K     +F G  E+   + + ES+P  
Sbjct: 183 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK----PLFAGAHELEQMQLILESVP-- 236

Query: 497 LTEVVDANLVREEQAFSAKMDCILSIM 523
                   +VREE       + +L+++
Sbjct: 237 --------VVREED-----RNELLNVI 250

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 53.7 bits (129), Expect = 2e-07
 Identities = 35/104 (33%), Positives = 52/104 (50%), Gaps = 17/104 (16%)

Query: 101 LTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLI-SLESLDLSGNNL 159
           +  +D+S   +SG I S I     ++T++L++NQ  GPIP+ + +   SL  L+LS NN 
Sbjct: 71  VVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNF 130

Query: 160 SGKIPK---------------LEGEIPVK-GSFKNFSTESFFGN 187
           +G IP+               L GEIP   GSF +       GN
Sbjct: 131 TGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGN 174

Length = 968

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 53.5 bits (128), Expect = 2e-07
 Identities = 37/159 (23%), Positives = 75/159 (47%), Gaps = 13/159 (8%)

Query: 351 PNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENM 410
           P  +    L + +  L  ++ +     V + +E+L    +S + +H DL   N+L+ E  
Sbjct: 221 PERTRRDTLINESPALSYMDLVGFSYQVANGMEFL----ASKNCVHRDLAARNVLICEGK 276

Query: 411 VAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
           +  + DFG+ + +    + + +  T   + +MAPE     + +   DV+S+G+LL E FT
Sbjct: 277 LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336

Query: 471 ------RKRPTDEMFIGEMSLRRWVKESLP-HGLTEVVD 502
                  + P +E F    +++R  + + P H   E+ +
Sbjct: 337 LGGTPYPELPMNEQFYN--AIKRGYRMAKPAHASDEIYE 373

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 52.7 bits (126), Expect = 2e-07
 Identities = 53/221 (23%), Positives = 101/221 (45%), Gaps = 46/221 (20%)

Query: 272 DEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSF------DSECEVLRNV 325
           + +   + +G+ ++GSV     +  T   ++V   +L R F+S         E  +L+++
Sbjct: 17  ERYQNLSPVGSGAYGSVCA---AFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 73

Query: 326 RHRNLIKILSSYSNPDFKALVLEFMPNGSLEK----WLYSHNYFLDI-----LERLN--- 373
           +H N+I +L  ++            P  SLE+    +L +H    D+      ++L    
Sbjct: 74  KHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH 121

Query: 374 ---IMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSV 430
              ++  +   L+Y+H    S  IIH DLKP+N+ ++E+    + DFG+ +   +     
Sbjct: 122 VQFLIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----- 172

Query: 431 RQTMTMATIGYMAPEYGLEGI-VSAKCDVYSYGVLLMETFT 470
             T  +AT  Y APE  L  +  +   D++S G ++ E  T
Sbjct: 173 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 213

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 52.4 bits (126), Expect = 2e-07
 Identities = 50/202 (24%), Positives = 87/202 (43%), Gaps = 21/202 (10%)

Query: 287 SVYKGTISDGTDVAIKVF---NLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPD-- 341
           S+YKG I +  +V I+ F   +   +      ++E + LR +   N++KI     +    
Sbjct: 35  SIYKG-IFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93

Query: 342 --FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDL 399
               +L+LE+   G L + L      L    +L++ ID    L    N +   +  + +L
Sbjct: 94  LPRLSLILEYCTRGYLREVLD-KEKDLSFKTKLDMAIDCCKGLY---NLYKYTNKPYKNL 149

Query: 400 KPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSA---KC 456
              + L+ EN    +   G+ K+L     S      +  + Y + +  L  I S    K 
Sbjct: 150 TSVSFLVTENYKLKIICHGLEKIL-----SSPPFKNVNFMVYFSYKM-LNDIFSEYTIKD 203

Query: 457 DVYSYGVLLMETFTRKRPTDEM 478
           D+YS GV+L E FT K P + +
Sbjct: 204 DIYSLGVVLWEIFTGKIPFENL 225

Length = 283

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 52.5 bits (126), Expect = 2e-07
 Identities = 58/216 (26%), Positives = 91/216 (42%), Gaps = 27/216 (12%)

Query: 279 LLGTSSFGSVYKGTISDGTDV-AIKVFNLQLERAFRSFDSECE-VLRNV-----RHRNLI 331
           +LG  SFG V    +    +  AIK   L+ +      D EC  V R V      H  L 
Sbjct: 2   VLGKGSFGKVMLAELKGTNEFFAIKA--LKKDVVLEDDDVECTMVERRVLALAWEHPFLT 59

Query: 332 KILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSS 391
            +  ++   +    V+E++  G L   + S   F +   R     ++   L++LH     
Sbjct: 60  HLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARF-YAAEIICGLQFLH----K 114

Query: 392 VHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIG---YMAPEYGL 448
             II+ DLK  N+LLD++    ++DFG+ K     E+   +       G   Y+APE   
Sbjct: 115 KGIIYRDLKLDNVLLDKDGHIKIADFGMCK-----ENMNGEGKASTFCGTPDYIAPEILK 169

Query: 449 EGIVSAKCDVYSYGVLLMETFTRKRP-----TDEMF 479
               +   D +S+GVLL E    + P      DE+F
Sbjct: 170 GQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELF 205

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 52.7 bits (126), Expect = 3e-07
 Identities = 57/167 (34%), Positives = 86/167 (51%), Gaps = 19/167 (11%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFS 61
           + L L  N++   LPS + + LPN++ L L+ N+L+  +P  ++N + L  LDL  N  S
Sbjct: 143 KELDLSDNKIE-SLPSPLRN-LPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS 199

Query: 62  GHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCL----VLTVLDVSRNQLSGDIPS 117
             +      L  L  L L         N     +   L     L+ L++S N+L  D+P 
Sbjct: 200 -DLPPEIELLSALEELDL--------SNNSIIELLSSLSNLKNLSGLELSNNKLE-DLPE 249

Query: 118 TIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIP 164
           +IG   +LETL L++NQ       S+GSL +L  LDLSGN+LS  +P
Sbjct: 250 SIGNLSNLETLDLSNNQIS--SISSLGSLTNLRELDLSGNSLSNALP 294

Length = 394

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 51.9 bits (124), Expect = 3e-07
 Identities = 50/205 (24%), Positives = 88/205 (42%), Gaps = 19/205 (9%)

Query: 280 LGTSSFGSVYKGTI-SDGTDVAIKVFNLQLERAF---RSFDSECEVLRNVRHRNLIKILS 335
           +G   FG V  G + S  T   + V  L++  +      F  E +  R+++H NL++ L 
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 336 SYSNPDFKALVLEFMPNGSLEKWLYS----HNYFLDILERLNIMIDVGSALEYLHNGHSS 391
             +      LV+EF P G L+ +L S         D      +  ++   L +LH  +  
Sbjct: 63  QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN-- 120

Query: 392 VHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPE-----Y 446
              IH DL   N LL  ++   + D+G+     + +  V        + ++APE     +
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVH 178

Query: 447 GLEGIV--SAKCDVYSYGVLLMETF 469
           G   +V  + + +V+S GV + E F
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWELF 203

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 52.5 bits (126), Expect = 3e-07
 Identities = 31/105 (29%), Positives = 56/105 (53%), Gaps = 4/105 (3%)

Query: 366 LDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGE 425
           LD+ + L     V   +++L    +S + IH D+   N+LL +  VA + DFG+ + +  
Sbjct: 209 LDLDDLLRFSSQVAQGMDFL----ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMN 264

Query: 426 GEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
             + V +      + +MAPE   + + + + DV+SYG+LL E F+
Sbjct: 265 DSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 53.2 bits (127), Expect = 3e-07
 Identities = 62/245 (25%), Positives = 105/245 (42%), Gaps = 41/245 (16%)

Query: 264 YLDIQRATDEFNECNLLGTSSFGSVY----KGTISDGTDVAIKVFNLQLERAFRSFDSEC 319
           Y D +   +E+     +G   FG V+    K T       AI    L+ ER       E 
Sbjct: 5   YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK-EREKSQLVIEV 63

Query: 320 EVLRNVRHRNLIKILSSYSNPDFKAL--VLEFMPNGSLEKWLYS-HNYFLDILER--LNI 374
            V+R ++H+N+++ +  + N   + L  ++EF   G L + +   +  F  I E   ++I
Sbjct: 64  NVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDI 123

Query: 375 MIDVGSALEYLHN---GHSSVHIIHCDLKPTNILLDENM-----------------VAHV 414
              +  AL Y HN   G +   ++H DLKP NI L   +                 +A +
Sbjct: 124 TRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKI 183

Query: 415 SDFGIYKLLGEGEDSVRQTMTMATIG---YMAPEYGLEGIVS--AKCDVYSYGVLLMETF 469
            DFG+ K +G       ++M  + +G   Y +PE  L    S   K D+++ G ++ E  
Sbjct: 184 GDFGLSKNIG------IESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELC 237

Query: 470 TRKRP 474
           + K P
Sbjct: 238 SGKTP 242

Length = 1021

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 51.4 bits (124), Expect = 3e-07
 Identities = 48/170 (28%), Positives = 72/170 (42%), Gaps = 24/170 (14%)

Query: 327 HRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH 386
           + N IK+  S +      L+++++ +G L   L      L   E   I+  +  AL  LH
Sbjct: 68  NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGK-LSEAEVKKIIRQLVEALNDLH 126

Query: 387 NGHSSVHIIHCDLKPTNILLDENMV-AHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPE 445
             H   +IIH D+K  N+L D      ++ D+G+ K+   G  S        T+ Y +P 
Sbjct: 127 K-H---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKI--IGTPSCYD----GTLDYFSP- 175

Query: 446 YGLEGIVSAKCDV----YSYGVLLMETFTRKRP----TDEMFIGEMSLRR 487
              E I     DV    ++ GVL  E  T K P     DE    E  L+R
Sbjct: 176 ---EKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKR 222

Length = 267

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 52.1 bits (125), Expect = 4e-07
 Identities = 48/160 (30%), Positives = 73/160 (45%), Gaps = 11/160 (6%)

Query: 317 SECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMI 376
           +E  VL+N RH  L  +  S+   D    V+E+   G L   L     F +   R     
Sbjct: 44  TESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGA 102

Query: 377 DVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTM 436
           ++ SAL YLH    S  +++ DLK  N++LD++    ++DFG+ K   EG        T 
Sbjct: 103 EIVSALGYLH----SCDVVYRDLKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTF 155

Query: 437 -ATIGYMAPEYGLEGIVSAKC-DVYSYGVLLMETFTRKRP 474
             T  Y+APE  LE     +  D +  GV++ E    + P
Sbjct: 156 CGTPEYLAPEV-LEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 52.2 bits (125), Expect = 4e-07
 Identities = 46/183 (25%), Positives = 80/183 (43%), Gaps = 50/183 (27%)

Query: 330 LIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGH 389
           ++ +  S+ +  +  L++EF+P G L   L  ++ F + + R   M +   A+E +H   
Sbjct: 63  VVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRF-YMAECVLAIEAVHK-- 119

Query: 390 SSVHIIHCDLKPTNILLDENMVAHVSDFGI------------YKLLGEGE---------- 427
             +  IH D+KP NIL+D      +SDFG+            Y+ L +G+          
Sbjct: 120 --LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRN 177

Query: 428 ----DSV----------------RQTMTMATIG---YMAPEYGLEGIVSAKCDVYSYGVL 464
               DS+                R+ M  +T+G   Y+APE  L+     +CD +S G +
Sbjct: 178 SVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI 237

Query: 465 LME 467
           + E
Sbjct: 238 MFE 240

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 50.9 bits (122), Expect = 6e-07
 Identities = 49/200 (24%), Positives = 95/200 (47%), Gaps = 20/200 (10%)

Query: 280 LGTSSFGSVYKG-TISDGTDVAIKVFNLQLER-----AFRSFDSECEVLRNVRHRNLIKI 333
           LG  ++ +VYKG   + G  VA+K  +L  E      A R    E  +++ ++H N++++
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIR----EISLMKELKHENIVRL 63

Query: 334 LSSYSNPDFKALVLEFMPNGSLEKWLYSHNYF--LDILERLNIMIDVGSALEYLHNGHSS 391
                  +   LV E+M +  L+K++ +H     LD     +    +   + + H     
Sbjct: 64  HDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR-- 120

Query: 392 VHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGI 451
             ++H DLKP N+L+++     ++DFG+ +  G   ++   +  + T+ Y AP+  L   
Sbjct: 121 --VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTF--SNEVVTLWYRAPDVLLGSR 176

Query: 452 V-SAKCDVYSYGVLLMETFT 470
             S   D++S G ++ E  T
Sbjct: 177 TYSTSIDIWSVGCIMAEMIT 196

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 51.5 bits (123), Expect = 6e-07
 Identities = 63/234 (26%), Positives = 102/234 (43%), Gaps = 32/234 (13%)

Query: 279 LLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRN------VRHRNLIK 332
           +LG  SFG V    +  G      V  L+ +      D EC ++          +  L  
Sbjct: 2   VLGKGSFGKVLLAELK-GKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60

Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSV 392
           +  ++   +    V+EF+  G L   +     F D+        ++   L++LH    S 
Sbjct: 61  LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRF-DLYRATFYAAEIVCGLQFLH----SK 115

Query: 393 HIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGI- 451
            II+ DLK  N++LD +    ++DFG+ K    G++  R +    T  Y+APE  L+G+ 
Sbjct: 116 GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN--RASTFCGTPDYIAPEI-LQGLK 172

Query: 452 VSAKCDVYSYGVLLMETFTRKRP-----TDEMFIGEMSLR-------RWV-KES 492
            +   D +S+GVLL E    + P      DE+F    S+R       RW+ KES
Sbjct: 173 YTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELF---ESIRVDTPHYPRWITKES 223

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 50.7 bits (121), Expect = 8e-07
 Identities = 55/214 (25%), Positives = 88/214 (41%), Gaps = 35/214 (16%)

Query: 280 LGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFR-----SFDSECEVLRNVRHRNLIKIL 334
           +G   FG V  G    G   A +V   +L  +        F  E +  R + H N+++ L
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKA-RVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61

Query: 335 SSYSNPDFKALVLEFMPNGSLEKWLYSHNYFL------DILERLNIMIDVGSALEYLHNG 388
                     LVLEF P G L+ +L S+   +      D+L+R+    +V S L +LH  
Sbjct: 62  GQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRM--ACEVASGLLWLHQ- 118

Query: 389 HSSVHIIHCDLKPTNILLDENMVAHVSDFGI----YKLLGEGEDS-VRQTMTMATIGYMA 443
                 IH DL   N  L  ++   + D+G+    Y      ED  + +      + ++A
Sbjct: 119 ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYP-----EDYYITKDCHAVPLRWLA 170

Query: 444 PEYG-------LEGIVSAKCDVYSYGVLLMETFT 470
           PE         L    + K +++S GV + E FT
Sbjct: 171 PELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 50.7 bits (121), Expect = 8e-07
 Identities = 54/207 (26%), Positives = 94/207 (45%), Gaps = 24/207 (11%)

Query: 280 LGTSSFGSVYKGTISD-GTDVAIKVFNLQLERAFRSFDSECEV-----LRNVRHRNLIKI 333
           +G  ++G+VYK      G  VA+K   +Q         +  EV     L    H N++++
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 334 L----SSYSNPDFK-ALVLEFMPNGSLEKWLYSHNYFLDILERL-NIMIDVGSALEYLHN 387
           +    +S ++ + K  LV E + +  L  +L          E + ++M      L++LH 
Sbjct: 68  MDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA 126

Query: 388 GHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMT--MATIGYMAPE 445
                 I+H DLKP NIL+       ++DFG+ ++      S +  +T  + T+ Y APE
Sbjct: 127 NC----IVHRDLKPENILVTSGGQVKLADFGLARIY-----SCQMALTPVVVTLWYRAPE 177

Query: 446 YGLEGIVSAKCDVYSYGVLLMETFTRK 472
             L+   +   D++S G +  E F RK
Sbjct: 178 VLLQSTYATPVDMWSVGCIFAEMFRRK 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 50.9 bits (122), Expect = 8e-07
 Identities = 53/187 (28%), Positives = 91/187 (48%), Gaps = 33/187 (17%)

Query: 296 GTDVAIKV----FNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSY----SNPDFKA- 344
           G +VAIK     F      +RA+R       +++ V H+N+I +L+ +    S  +F+  
Sbjct: 41  GQNVAIKKLSRPFQNVTHAKRAYREL----VLMKLVNHKNIIGLLNVFTPQKSLEEFQDV 96

Query: 345 -LVLEFMPNGSLEKWLYSHNYFLDILERLNIMI-DVGSALEYLHNGHSSVHIIHCDLKPT 402
            LV+E M + +L + +      LD  ER++ ++  +   +++LH    S  IIH DLKP+
Sbjct: 97  YLVMELM-DANLCQVI---QMDLD-HERMSYLLYQMLCGIKHLH----SAGIIHRDLKPS 147

Query: 403 NILLDENMVAHVSDFGIYKLLGEGEDSVRQTMT--MATIGYMAPEYGLEGIVSAKCDVYS 460
           NI++  +    + DFG+ +  G         MT  + T  Y APE  L        D++S
Sbjct: 148 NIVVKSDCTLKILDFGLARTAGTS-----FMMTPYVVTRYYRAPEVILGMGYKENVDIWS 202

Query: 461 YGVLLME 467
            G ++ E
Sbjct: 203 VGCIMGE 209

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 50.4 bits (120), Expect = 1e-06
 Identities = 30/102 (29%), Positives = 54/102 (52%), Gaps = 8/102 (7%)

Query: 373 NIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQ 432
           ++M  +   L++LH    S  ++H DLKP NIL+  +    ++DFG+ ++       +  
Sbjct: 114 DMMFQLLRGLDFLH----SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMAL 166

Query: 433 TMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
           T  + T+ Y APE  L+   +   D++S G +  E F R++P
Sbjct: 167 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF-RRKP 207

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 50.7 bits (121), Expect = 1e-06
 Identities = 63/208 (30%), Positives = 101/208 (48%), Gaps = 31/208 (14%)

Query: 279 LLGTSSFGSVYKGT-ISDGTDVAIKVFN--LQLE----RAFRSFDSECEVLRNVRHRNLI 331
            +G+ ++GSV        G  VAIK  +   Q E    RA+R    E  +L++++H N+I
Sbjct: 22  QVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYR----ELTLLKHMQHENVI 77

Query: 332 KIL----SSYSNPDFKA--LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYL 385
            +L    S+ S  +F+   LV+ +M    L+K +  H    D ++ L   +  G  L+Y+
Sbjct: 78  GLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQK-IMGHPLSEDKVQYLVYQMLCG--LKYI 133

Query: 386 HNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPE 445
           H    S  IIH DLKP N+ ++E+    + DFG    L    D+   T  + T  Y APE
Sbjct: 134 H----SAGIIHRDLKPGNLAVNEDCELKILDFG----LARHADA-EMTGYVVTRWYRAPE 184

Query: 446 YGLEGI-VSAKCDVYSYGVLLMETFTRK 472
             L  +  +   D++S G ++ E  T K
Sbjct: 185 VILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 49.8 bits (119), Expect = 1e-06
 Identities = 50/201 (24%), Positives = 95/201 (47%), Gaps = 18/201 (8%)

Query: 280 LGTSSFG-SVYKGTISDGTDVAIKVFNL------QLERAFRSFDSECEVLRNVRHRNLIK 332
           +G  SFG ++   +  DG    IK  N+      + E + +    E  VL N++H N+++
Sbjct: 8   IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRK----EVAVLSNMKHPNIVQ 63

Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILER-LNIMIDVGSALEYLHNGHSS 391
              S+       +V+++   G L K + +    L   ++ L+  + +  AL+++H+    
Sbjct: 64  YQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK-- 121

Query: 392 VHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGI 451
             I+H D+K  NI L ++    + DFGI ++L    +  R    + T  Y++PE      
Sbjct: 122 --ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELAR--TCIGTPYYLSPEICENRP 177

Query: 452 VSAKCDVYSYGVLLMETFTRK 472
            + K D+++ G +L E  T K
Sbjct: 178 YNNKSDIWALGCVLYEMCTLK 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 51.2 bits (122), Expect = 1e-06
 Identities = 54/183 (29%), Positives = 77/183 (42%), Gaps = 15/183 (8%)

Query: 299 VAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKW 358
           V  K   L  ER      SE   L    H  ++K    + + D   L++E+   G L K 
Sbjct: 96  VVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQ 155

Query: 359 ----LYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHV 414
               L  H  F +    L +   +  AL+ +H    S  ++H DLK  NI L    +  +
Sbjct: 156 IKQRLKEHLPFQEYEVGL-LFYQIVLALDEVH----SRKMMHRDLKSANIFLMPTGIIKL 210

Query: 415 SDFGIYKLLGEGEDSVRQTMTMATIG---YMAPEYGLEGIVSAKCDVYSYGVLLMETFTR 471
            DFG  K   +  DSV   +  +  G   Y+APE       S K D++S GV+L E  T 
Sbjct: 211 GDFGFSK---QYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTL 267

Query: 472 KRP 474
            RP
Sbjct: 268 HRP 270

Length = 478

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 50.5 bits (121), Expect = 1e-06
 Identities = 63/234 (26%), Positives = 88/234 (37%), Gaps = 61/234 (26%)

Query: 274 FNECNLLGTSSFGSV----YKGTISDGTDVAIKVFNLQ--LER-AFRSFDSE---CEVLR 323
           F    +LG   FG V    YK T   G   AIK       + R    S   E    E   
Sbjct: 1   FRCLAVLGRGHFGKVLLAEYKKT---GELYAIKALKKGDIIARDEVESLMCEKRIFETAN 57

Query: 324 NVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGS--- 380
           + RH  L+ + + +   D    V+E+   G L                ++I  DV S   
Sbjct: 58  SERHPFLVNLFACFQTEDHVCFVMEYAAGGDL---------------MMHIHTDVFSEPR 102

Query: 381 ----------ALEYLH-NGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDS 429
                      L+YLH N      I++ DLK  N+LLD      ++DFG+ K   EG   
Sbjct: 103 AVFYAACVVLGLQYLHENK-----IVYRDLKLDNLLLDTEGFVKIADFGLCK---EGMGF 154

Query: 430 VRQTMTM-ATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGE 482
             +T T   T  ++APE   E   +   D +  GVL+           EM +GE
Sbjct: 155 GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIY----------EMLVGE 198

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 50.1 bits (119), Expect = 1e-06
 Identities = 61/222 (27%), Positives = 97/222 (43%), Gaps = 27/222 (12%)

Query: 274 FNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRSFDSECEVLRNV-RHRNLI 331
           F    L+G  ++G VYKG  +  G   AIKV ++  +        E  +L+    HRN+ 
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-EEIKQEINMLKKYSHHRNIA 66

Query: 332 KILSSY--SNP----DFKALVLEFMPNGSLEKWLYSHNYFLDILER---LNIMIDVGSAL 382
               ++   NP    D   LV+EF   GS+   +   N   + L+      I  ++   L
Sbjct: 67  TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI--KNTKGNTLKEEWIAYICREILRGL 124

Query: 383 EYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSV-RQTMTMATIGY 441
            +LH  H    +IH D+K  N+LL EN    + DFG+   L   + +V R+   + T  +
Sbjct: 125 SHLHQ-HK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQL---DRTVGRRNTFIGTPYW 177

Query: 442 MAPEY-----GLEGIVSAKCDVYSYGVLLMETFTRKRPTDEM 478
           MAPE        +     K D++S G+  +E      P  +M
Sbjct: 178 MAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 219

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 50.9 bits (122), Expect = 1e-06
 Identities = 36/119 (30%), Positives = 52/119 (43%), Gaps = 20/119 (16%)

Query: 372 LNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGED--- 428
           L+I   + + +EY+H    S  ++H DLKP NILL       + D+G        E+   
Sbjct: 116 LSIFHKICATIEYVH----SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLL 171

Query: 429 --SVRQT------MT-----MATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
              V +       MT     + T  YMAPE  L    S   D+Y+ GV+L +  T   P
Sbjct: 172 DIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230

Length = 932

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 49.6 bits (118), Expect = 2e-06
 Identities = 58/222 (26%), Positives = 95/222 (42%), Gaps = 27/222 (12%)

Query: 274 FNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRSFDSECEVLRNV-RHRNLI 331
           F    ++G  ++G VYKG  +  G   AIKV ++  E        E  +L+    HRN+ 
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-EDEEEEIKLEINMLKKYSHHRNIA 76

Query: 332 KILSSY------SNPDFKALVLEFMPNGS---LEKWLYSHNYFLDILERLNIMIDVGSAL 382
               ++       + D   LV+EF   GS   L K    +    D +    I  ++   L
Sbjct: 77  TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILRGL 134

Query: 383 EYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSV-RQTMTMATIGY 441
            +LH    +  +IH D+K  N+LL EN    + DFG+   L   + +V R+   + T  +
Sbjct: 135 AHLH----AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL---DRTVGRRNTFIGTPYW 187

Query: 442 MAPEY-----GLEGIVSAKCDVYSYGVLLMETFTRKRPTDEM 478
           MAPE        +     + D++S G+  +E      P  +M
Sbjct: 188 MAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDM 229

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 49.7 bits (119), Expect = 2e-06
 Identities = 58/200 (29%), Positives = 85/200 (42%), Gaps = 24/200 (12%)

Query: 279 LLGTSSFGSV----YKGTISDGTDVAIKVFNLQLERAFRSFDSEC-----EVLRNV-RHR 328
           +LG  SFG V     KGT       A+KV  L+ +   +  D EC      VL    +H 
Sbjct: 2   VLGKGSFGKVLLAELKGT---DELYAVKV--LKKDVILQDDDVECTMTEKRVLALAGKHP 56

Query: 329 NLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNG 388
            L ++ S +   D    V+E++  G L   +     F +   R     ++   L++LH  
Sbjct: 57  FLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARF-YAAEIVLGLQFLH-- 113

Query: 389 HSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG-EDSVRQTMTMATIGYMAPEYG 447
                II+ DLK  N+LLD      ++DFG+ K   EG    V  +    T  Y+APE  
Sbjct: 114 --ERGIIYRDLKLDNVLLDSEGHIKIADFGMCK---EGILGGVTTSTFCGTPDYIAPEIL 168

Query: 448 LEGIVSAKCDVYSYGVLLME 467
                    D ++ GVLL E
Sbjct: 169 SYQPYGPAVDWWALGVLLYE 188

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 49.4 bits (118), Expect = 2e-06
 Identities = 58/219 (26%), Positives = 101/219 (46%), Gaps = 28/219 (12%)

Query: 272 DEFNECNLLGTSSFGSVYKGTISDGTDV-AIKVFNL--QLERAFRS-FDSECEVLRNVRH 327
           D+F    ++G  +FG V    + +   V A+K+ N    L+RA  + F  E +VL N   
Sbjct: 1   DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60

Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
           R +  +  ++ + +   LV+++   G L   L   + F D L        +   +  + +
Sbjct: 61  RWITNLHYAFQDENNLYLVMDYYVGGDLLTLL---SKFEDRLPEDMARFYLAEMVLAIDS 117

Query: 388 GHSSVHIIHCDLKPTNILLDENMVAHVSDFG-IYKLLGEGEDSVRQTMTMATIGYMAPE- 445
            H  +  +H D+KP N+LLD+N    ++DFG   +LL +G  +V+  + + T  Y++PE 
Sbjct: 118 VHQ-LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG--TVQSNVAVGTPDYISPEI 174

Query: 446 ----------YGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
                     YG E      CD +S GV + E    + P
Sbjct: 175 LQAMEDGKGRYGPE------CDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 49.4 bits (118), Expect = 3e-06
 Identities = 45/179 (25%), Positives = 74/179 (41%), Gaps = 46/179 (25%)

Query: 330 LIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGH 389
           ++K+  S+ + D    V++++P G +   L     F + L R  I  ++  A+E +H   
Sbjct: 63  VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIA-ELTCAIESVHK-- 119

Query: 390 SSVHIIHCDLKPTNILLDENMVAHVSDFGI---------YKLLGEG----EDS------- 429
             +  IH D+KP NIL+D +    ++DFG+          K   +G    +DS       
Sbjct: 120 --MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEW 177

Query: 430 ---------------VRQTMT------MATIGYMAPEYGLEGIVSAKCDVYSYGVLLME 467
                           RQ         + T  Y+APE  L    +  CD +S GV+L E
Sbjct: 178 SEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 48.7 bits (116), Expect = 3e-06
 Identities = 55/213 (25%), Positives = 99/213 (46%), Gaps = 25/213 (11%)

Query: 272 DEFNECNLLGTSSFGSVYKGT--ISDGTDVAIKVFNLQLE------RAFRSFDSECEVLR 323
           D++ +   +G  ++G VYK    +++ T +A+K   L+ E       A R    E  +L+
Sbjct: 2   DQYEKVEKIGEGTYGVVYKARDRVTNET-IALKKIRLEQEDEGVPSTAIR----EISLLK 56

Query: 324 NVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNI-MIDVGSAL 382
            ++H N++++     +     LV E++ +  L+K + S   F      +   +  +   +
Sbjct: 57  EMQHGNIVRLQDVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGI 115

Query: 383 EYLHNGHSSVHIIHCDLKPTNILLDENMVA-HVSDFGIYKLLGEGEDSVRQ-TMTMATIG 440
            Y H    S  ++H DLKP N+L+D    A  ++DFG+ +  G     VR  T  + T+ 
Sbjct: 116 AYCH----SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFG---IPVRTFTHEVVTLW 168

Query: 441 YMAPEYGLEG-IVSAKCDVYSYGVLLMETFTRK 472
           Y APE  L     S   D++S G +  E   +K
Sbjct: 169 YRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 48.9 bits (117), Expect = 4e-06
 Identities = 44/187 (23%), Positives = 83/187 (44%), Gaps = 41/187 (21%)

Query: 317 SECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMI 376
           +E ++L    +  ++K+  S+ + ++  L++E++P G +   L   + F +   R  I  
Sbjct: 50  AERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAE 109

Query: 377 DVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGI------------YKLLG 424
            +  A++ +H     +  IH D+KP N+LLD      +SDFG+            Y++L 
Sbjct: 110 TI-LAIDSIH----KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILS 164

Query: 425 EGE-----DSVRQTM-------------------TMATIGYMAPEYGLEGIVSAKCDVYS 460
                   D + + M                   T+ T  Y+APE  L+   + +CD +S
Sbjct: 165 HALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWS 224

Query: 461 YGVLLME 467
            GV++ E
Sbjct: 225 LGVIMYE 231

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 48.6 bits (116), Expect = 4e-06
 Identities = 63/220 (28%), Positives = 95/220 (43%), Gaps = 47/220 (21%)

Query: 279 LLGTSSFGSVYKGT-ISDGTDVAIKVFNLQLE------RAFRSFDSECEVLRNVRHRNLI 331
           ++G  S+G V        G  VAIK  N   E      R  R    E ++LR +RH +++
Sbjct: 7   VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILR----EIKLLRLLRHPDIV 62

Query: 332 KILSSYSNP---DFKAL--VLEFM---------PNGSLEKWLYSHNYFLDILERLNIMID 377
           +I      P   +FK +  V E M          N  L      H +FL  L R      
Sbjct: 63  EIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTP--EHHQFFLYQLLR------ 114

Query: 378 VGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKL-LGEGEDSVRQTMTM 436
              AL+Y+H    + ++ H DLKP NIL + +    + DFG+ ++   +   ++  T  +
Sbjct: 115 ---ALKYIH----TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV 167

Query: 437 ATIGYMAPEYGLEGIVSAK----CDVYSYGVLLMETFTRK 472
           AT  Y APE  L G   +K     D++S G +  E  T K
Sbjct: 168 ATRWYRAPE--LCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 48.6 bits (116), Expect = 4e-06
 Identities = 42/133 (31%), Positives = 73/133 (54%), Gaps = 13/133 (9%)

Query: 337 YSNPDFKALVLEFMPNGSLEKWLYSHNYF-LDILERLNIMIDVGSALEYLHNGHSSVHII 395
           YS+ +  ++ +E M  GSL++ L        +IL +++I +  G  L YL   H    I+
Sbjct: 69  YSDGEI-SICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRG--LTYLREKHK---IM 122

Query: 396 HCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGI-VSA 454
           H D+KP+NIL++      + DFG+    G+  DS+  +  + T  YM+PE  L+G   + 
Sbjct: 123 HRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSF-VGTRSYMSPER-LQGTHYTV 177

Query: 455 KCDVYSYGVLLME 467
           + D++S G+ L+E
Sbjct: 178 QSDIWSLGLSLVE 190

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 48.0 bits (114), Expect = 5e-06
 Identities = 54/200 (27%), Positives = 87/200 (43%), Gaps = 22/200 (11%)

Query: 280 LGTSSFGSVYKGTISDGTDVA---------IKVFNLQLERAFRSFDSECEVLRNVRHRNL 330
           LG  SFG+VY   + D   VA         I V  L      ++ + E ++L  + H  +
Sbjct: 8   LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQA-NQEAQLLSKLDHPAI 64

Query: 331 IKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNI---MIDVGSALEYLHN 387
           +K  +S+   D   ++ E+     L+  L    +    L    +    I +   + Y+H 
Sbjct: 65  VKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH- 123

Query: 388 GHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYG 447
                 I+H DLK  NI L  N++  + DFG+ +LL  G   +  T T  T  YM+PE  
Sbjct: 124 ---QRRILHRDLKAKNIFLKNNLL-KIGDFGVSRLL-MGSCDLATTFT-GTPYYMSPEAL 177

Query: 448 LEGIVSAKCDVYSYGVLLME 467
                 +K D++S G +L E
Sbjct: 178 KHQGYDSKSDIWSLGCILYE 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 48.2 bits (115), Expect = 6e-06
 Identities = 50/204 (24%), Positives = 95/204 (46%), Gaps = 21/204 (10%)

Query: 280 LGTSSFGSVYKGTISD-GTDVAIKVFNLQLE------RAFRSFDSECEVLRNVRHRNLIK 332
           +G  ++G+V+K    +    VA+K   L  +       A R    E  +L+ ++H+N+++
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR----EICLLKELKHKNIVR 63

Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSV 392
           +     +     LV E+  +  L+K+  S N  +D     + M  +   L + H    S 
Sbjct: 64  LYDVLHSDKKLTLVFEYC-DQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH----SH 118

Query: 393 HIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQ-TMTMATIGYMAPEYGLEG- 450
           +++H DLKP N+L+++N    ++DFG+ +  G     VR  +  + T+ Y  P+      
Sbjct: 119 NVLHRDLKPQNLLINKNGELKLADFGLARAFGI---PVRCYSAEVVTLWYRPPDVLFGAK 175

Query: 451 IVSAKCDVYSYGVLLMETFTRKRP 474
           + S   D++S G +  E     RP
Sbjct: 176 LYSTSIDMWSAGCIFAELANAGRP 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 48.3 bits (115), Expect = 6e-06
 Identities = 56/238 (23%), Positives = 104/238 (43%), Gaps = 40/238 (16%)

Query: 272 DEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLER------AFRSFDSECEVLRN 324
           D + +   +G  ++G VYK    + G  VA+K   L+++       A R    E  +L+ 
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALR----EISLLQM 56

Query: 325 VRHRNLIKILSSYSNPDFKA------LVLEFMPNGSLEKWLYSH----NYFLDILERLNI 374
           +     I  L    + + K       LV E++ +  L+K++ S+       L      + 
Sbjct: 57  LSESIYIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSF 115

Query: 375 MIDVGSALEYLHNGHSSVHIIHCDLKPTNILLD-ENMVAHVSDFGIYKLLGEGEDSV--- 430
           M  +   + + H       ++H DLKP N+L+D +  +  ++D G+ +       S+   
Sbjct: 116 MYQLLKGVAHCH----KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAF-----SIPVK 166

Query: 431 RQTMTMATIGYMAPEYGLEGI-VSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRR 487
             T  + T+ Y APE  L     S   D++S G +  E  +RK+P   +F G+  L++
Sbjct: 167 SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAE-MSRKQP---LFPGDSELQQ 220

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 48.2 bits (115), Expect = 6e-06
 Identities = 61/220 (27%), Positives = 93/220 (42%), Gaps = 34/220 (15%)

Query: 273 EFNECNLLGTSSFGSVYKGTISDGTD--VAIKVFNLQLERAFRSFDSECEVL-RNV---- 325
           +FN   +LG  SFG V       GTD   AIK+  L+ +   +  D EC ++ + V    
Sbjct: 1   DFNFLMVLGKGSFGKVMLAE-RKGTDELYAIKI--LKKDVIIQDDDVECTMVEKRVLALP 57

Query: 326 -RHRNLIKILSSYSNPDFKALVLEFMPNGSLE-------KWLYSHNYFLDILERLNIMID 377
            +   L ++ S +   D    V+E++  G L        K+   H  F           +
Sbjct: 58  GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFY--------AAE 109

Query: 378 VGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTM- 436
           +   L +LH    S  II+ DLK  N++LD      ++DFG+ K   E     + T T  
Sbjct: 110 IAIGLFFLH----SKGIIYRDLKLDNVMLDAEGHIKIADFGMCK---ENIFGGKTTRTFC 162

Query: 437 ATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTD 476
            T  Y+APE           D +++GVLL E    + P D
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 48.0 bits (114), Expect = 6e-06
 Identities = 56/202 (27%), Positives = 85/202 (42%), Gaps = 27/202 (13%)

Query: 280 LGTSSFGSVYKGTISDGTDV-AIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILS--- 335
           +G  +FG VY+    D   + A+KV + +   A +      EV   +  RN++       
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKK------EVAHTIGERNILVRTLLDE 54

Query: 336 ---------SYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH 386
                    S+       LV ++M  G L   L     F +   +  I  ++  ALE+LH
Sbjct: 55  SPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIA-ELVLALEHLH 113

Query: 387 NGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEY 446
                  I++ DLKP NILLD      + DFG+ K     ++    T    T  Y+APE 
Sbjct: 114 KYD----IVYRDLKPENILLDATGHIALCDFGLSK-ANLTDNKTTNTFC-GTTEYLAPEV 167

Query: 447 GLEGIVSAK-CDVYSYGVLLME 467
            L+     K  D +S GVL+ E
Sbjct: 168 LLDEKGYTKHVDFWSLGVLVFE 189

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 47.4 bits (113), Expect = 9e-06
 Identities = 39/147 (26%), Positives = 68/147 (46%), Gaps = 17/147 (11%)

Query: 280 LGTSSFGSVYKGTISDGTD--VAIKVFNLQLER-----AFRSFDSECEVLRNVRHRNLIK 332
           LG  S+ +VYKG  S  T   VA+K   L+ E      A R    E  +L++++H N++ 
Sbjct: 13  LGEGSYATVYKG-RSKLTGQLVALKEIRLEHEEGAPFTAIR----EASLLKDLKHANIVT 67

Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSV 392
           +           LV E++ +  L++++      L +      +  +   L Y H      
Sbjct: 68  LHDIIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCH----QR 122

Query: 393 HIIHCDLKPTNILLDENMVAHVSDFGI 419
            ++H DLKP N+L+ E     ++DFG+
Sbjct: 123 RVLHRDLKPQNLLISERGELKLADFGL 149

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 47.4 bits (112), Expect = 1e-05
 Identities = 49/189 (25%), Positives = 89/189 (47%), Gaps = 27/189 (14%)

Query: 309 ERAFRSFDSECEVLRNVRHRNLIKILSSYSN----PDFKA--LVLEFMPNGSLEKWLYSH 362
           +RA+R    E  +++ V H+N+I +L+ ++      +F+   LV+E M     +      
Sbjct: 61  KRAYR----ELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMEL 116

Query: 363 NYFLDILERLNIMI-DVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYK 421
           ++     ER++ ++  +   +++LH    S  IIH DLKP+NI++  +    + DFG+ +
Sbjct: 117 DH-----ERMSYLLYQMLCGIKHLH----SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 167

Query: 422 LLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIG 481
             G    S   T  + T  Y APE  L        D++S G ++ E    K     +F G
Sbjct: 168 TAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI----LFPG 220

Query: 482 EMSLRRWVK 490
              + +W K
Sbjct: 221 RDYIDQWNK 229

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 45.5 bits (108), Expect = 1e-05
 Identities = 27/127 (21%), Positives = 59/127 (46%), Gaps = 13/127 (10%)

Query: 294 SDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLI--KILSSYSNPDFKALVLEFMP 351
           +   D  +K+   + + A R  + E  +L+ +  + L   K+L+S  +  +  L++E++ 
Sbjct: 19  TKDEDYVLKINPSREKGADR--EREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIE 76

Query: 352 NGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMV 411
             +L++        +   E+ +I   +   L  LH     + + H DL P NIL+D+  +
Sbjct: 77  GETLDE--------VSEEEKEDIAEQLAELLAKLHQ-LPLLVLCHGDLHPGNILVDDGKI 127

Query: 412 AHVSDFG 418
             + D+ 
Sbjct: 128 LGIIDWE 134

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 47.3 bits (112), Expect = 1e-05
 Identities = 53/233 (22%), Positives = 97/233 (41%), Gaps = 42/233 (18%)

Query: 272 DEFNECNLLGTSSFGSVYKGTISD-GTDVAIKVF---NLQLERAFRSFDSECEVLRNVRH 327
           D+F    ++G  +FG V      D G   A+K+    ++  +       +E ++L     
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60

Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
             ++K+  S+ +     L++EF+P G +   L   +   +   +  I   V  A++ +H 
Sbjct: 61  AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETV-LAIDAIHQ 119

Query: 388 GHSSVHIIHCDLKPTNILLDENMVAHVSDFGI------------YKLL------------ 423
               +  IH D+KP N+LLD      +SDFG+            Y+ L            
Sbjct: 120 ----LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQN 175

Query: 424 ------GEGEDSVRQTMTMATIG---YMAPEYGLEGIVSAKCDVYSYGVLLME 467
                  E     R+ +  +T+G   Y+APE  ++   +  CD +S GV++ E
Sbjct: 176 MNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYE 228

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 46.9 bits (112), Expect = 1e-05
 Identities = 54/199 (27%), Positives = 80/199 (40%), Gaps = 56/199 (28%)

Query: 281 GTSSFGSVYKG---TISDGTDVAIKVFNLQLER-------AFRSFDSECEVLRNVRHRNL 330
           G  ++G VYK       DG + AIK F    E+       A R    E  +LR ++H N+
Sbjct: 9   GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACR----EIALLRELKHENV 64

Query: 331 IKILSSYSNPDFKALVLEFMPNGSLEKWL---YSHNYFLDIL----ERLNIMID---VGS 380
           +             LV  F+ +     +L   Y+ +    I+    +   + I    V S
Sbjct: 65  VS------------LVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKS 112

Query: 381 ALEYLHNG----HSSVHIIHCDLKPTNILL----DENMVAHVSDFGIYKLLGE------G 426
            L  + NG    HS+  ++H DLKP NIL+     E  V  + D G+ +L          
Sbjct: 113 LLWQILNGVHYLHSN-WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLAD 171

Query: 427 EDSVRQTMTMATIGYMAPE 445
            D V     + TI Y APE
Sbjct: 172 LDPV-----VVTIWYRAPE 185

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 46.9 bits (111), Expect = 2e-05
 Identities = 39/155 (25%), Positives = 68/155 (43%), Gaps = 9/155 (5%)

Query: 317 SECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLY-SHNYFLDILERLNIM 375
           +E  +LR + H ++I++  +++   F  L+L   P    + + Y +    + I + L I 
Sbjct: 132 TEAHILRAINHPSIIQLKGTFTYNKFTCLIL---PRYKTDLYCYLAAKRNIAICDILAIE 188

Query: 376 IDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMT 435
             V  A++YLH       IIH D+K  NI ++      + DFG         ++ +    
Sbjct: 189 RSVLRAIQYLHEN----RIIHRDIKAENIFINHPGDVCLGDFGA-ACFPVDINANKYYGW 243

Query: 436 MATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
             TI   APE           D++S G++L E  T
Sbjct: 244 AGTIATNAPELLARDPYGPAVDIWSAGIVLFEMAT 278

Length = 391

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 46.8 bits (111), Expect = 2e-05
 Identities = 38/151 (25%), Positives = 67/151 (44%), Gaps = 8/151 (5%)

Query: 318 ECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMID 377
           E  +L+NV H ++I++  +  +     +VL    +  L  +L   +  L I + L I   
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYLTKRSRPLPIDQALIIEKQ 165

Query: 378 VGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMA 437
           +   L YLH    +  IIH D+K  NI +++     + D G  +        +    T+ 
Sbjct: 166 ILEGLRYLH----AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVE 221

Query: 438 TIGYMAPEYGLEGIVSAKCDVYSYGVLLMET 468
           T    APE       ++K D++S G++L E 
Sbjct: 222 T---NAPEVLARDKYNSKADIWSAGIVLFEM 249

Length = 357

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 46.6 bits (110), Expect = 2e-05
 Identities = 55/219 (25%), Positives = 96/219 (43%), Gaps = 54/219 (24%)

Query: 280 LGTSSFGSVYKGTISDGTDVAI--KVFNLQLERAFRSF------DSECEVLRNVRHRNLI 331
           +G+ ++GSV         D  +  KV   +L R F+S         E  +L++++H N+I
Sbjct: 23  VGSGAYGSV-----CSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVI 77

Query: 332 KILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDIL----------------ERLNIM 375
            +L              F P  S+E   ++  Y +  L                E +  +
Sbjct: 78  GLLDV------------FTPATSIEN--FNEVYLVTNLMGADLNNIVKCQKLSDEHVQFL 123

Query: 376 I-DVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTM 434
           I  +   L+Y+H    S  IIH DLKP+N+ ++E+    + DFG+ +   + +D +  T 
Sbjct: 124 IYQLLRGLKYIH----SAGIIHRDLKPSNVAVNEDCELRILDFGLAR---QADDEM--TG 174

Query: 435 TMATIGYMAPEYGLEGI-VSAKCDVYSYGVLLMETFTRK 472
            +AT  Y APE  L  +  +   D++S G ++ E    K
Sbjct: 175 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 46.6 bits (110), Expect = 2e-05
 Identities = 52/233 (22%), Positives = 97/233 (41%), Gaps = 42/233 (18%)

Query: 272 DEFNECNLLGTSSFGSVYKGTISDGTDV-AIKVF---NLQLERAFRSFDSECEVLRNVRH 327
           ++F    ++G  +FG V      D   V A+K+    ++  +       +E ++L     
Sbjct: 1   EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60

Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
             ++K+  S+ +     L++EF+P G +   L   +   +   +  I   V  A++ +H 
Sbjct: 61  LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETV-LAIDSIHQ 119

Query: 388 GHSSVHIIHCDLKPTNILLDENMVAHVSDFGI------------YKLL------------ 423
               +  IH D+KP N+LLD      +SDFG+            Y+ L            
Sbjct: 120 ----LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQN 175

Query: 424 ------GEGEDSVRQTMTMATIG---YMAPEYGLEGIVSAKCDVYSYGVLLME 467
                  E     R+ +  +T+G   Y+APE  ++   +  CD +S GV++ E
Sbjct: 176 MNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYE 228

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 46.6 bits (110), Expect = 2e-05
 Identities = 50/196 (25%), Positives = 86/196 (43%), Gaps = 41/196 (20%)

Query: 309 ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKW--LYSHNYFL 366
           +RA+R    E  +++ V H+N+I +L+             F P  SLE++  +Y     +
Sbjct: 68  KRAYR----ELVLMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELM 111

Query: 367 DI-----------LERLNIMI-DVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHV 414
           D             ER++ ++  +   +++LH    S  IIH DLKP+NI++  +    +
Sbjct: 112 DANLCQVIQMELDHERMSYLLYQMLCGIKHLH----SAGIIHRDLKPSNIVVKSDCTLKI 167

Query: 415 SDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
            DFG+ +  G    S   T  + T  Y APE  L        D++S G ++ E       
Sbjct: 168 LDFGLARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGV- 223

Query: 475 TDEMFIGEMSLRRWVK 490
              +F G   + +W K
Sbjct: 224 ---LFPGTDHIDQWNK 236

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 46.8 bits (111), Expect = 2e-05
 Identities = 28/78 (35%), Positives = 45/78 (57%), Gaps = 5/78 (6%)

Query: 345 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNI 404
           LV+E++  G ++  L+ + YF + +    I  +V  AL+YLH  H    IIH DLKP N+
Sbjct: 81  LVMEYLIGGDVKSLLHIYGYFDEEMAVKYIS-EVALALDYLHR-HG---IIHRDLKPDNM 135

Query: 405 LLDENMVAHVSDFGIYKL 422
           L+       ++DFG+ K+
Sbjct: 136 LISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 46.5 bits (110), Expect = 3e-05
 Identities = 60/229 (26%), Positives = 101/229 (44%), Gaps = 31/229 (13%)

Query: 266 DIQRATDEFNECNLLGTSSFGSVYKGTISDGTD-VAIKVFNLQLERAFRSFDSECEVLRN 324
           DI  +T  F   +LLG  +FG V +       +  A+K+    + +  R    E + +  
Sbjct: 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVR-NVPKYTRDAKIEIQFMEK 181

Query: 325 VRHRN------LIKILSSYSNPDFKALVLEFMPN--GSLEKWLYSHNYFLDILERLNIMI 376
           VR  +      L+KI   + N      ++  MP     L  W+  H  F        I+ 
Sbjct: 182 VRQADPADRFPLMKIQRYFQNETGHMCIV--MPKYGPCLLDWIMKHGPF-SHRHLAQIIF 238

Query: 377 DVGSALEYLHNGHSSVHIIHCDLKPTNILLD--ENMVAHVSD---------FGIYKLLGE 425
             G AL+Y H   + +H++H DLKP NIL++  + +V  V++           I  L G 
Sbjct: 239 QTGVALDYFH---TELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGC 295

Query: 426 GEDSVRQTMTMATIGYMAPE--YGLEGIVSAKCDVYSYGVLLMETFTRK 472
            ++   +T  ++T  Y +PE   GL  + S   D++S G ++ E +T K
Sbjct: 296 CDERHSRTAIVSTRHYRSPEVVLGLGWMYST--DMWSMGCIIYELYTGK 342

Length = 467

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 45.7 bits (108), Expect = 4e-05
 Identities = 42/165 (25%), Positives = 66/165 (40%), Gaps = 35/165 (21%)

Query: 279 LLGTSSFGSVY----KGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKIL 334
           L+G   FG VY                K+ NL+ E    +   E  V  N+   + I + 
Sbjct: 19  LIGCGGFGCVYETQCASDHCINNQAVAKIENLENE----TIVMETLVYNNIYDIDKIALW 74

Query: 335 SSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERL--------------------NI 374
            +  N D   +   +   GS ++    + + L  LE+L                    NI
Sbjct: 75  KNIHNIDHLGIPK-YYGCGSFKRCRMYYRFIL--LEKLVENTKEIFKRIKCKNKKLIKNI 131

Query: 375 MIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGI 419
           M D+ + LEY+H       I H D+KP NI++D N   ++ D+GI
Sbjct: 132 MKDMLTTLEYIH----EHGISHGDIKPENIMVDGNNRGYIIDYGI 172

Length = 294

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 46.2 bits (109), Expect = 4e-05
 Identities = 57/251 (22%), Positives = 95/251 (37%), Gaps = 56/251 (22%)

Query: 274 FNECNLLGTSSFGSVYKGTISD-GTDVAIKVF---NLQLERAFRSFDSECEVLRNVRHRN 329
           F +   LG  +FG V      D     A+K     ++ L        +E ++L    +  
Sbjct: 3   FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62

Query: 330 LIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGH 389
           ++++  S+ + D    V++++P G +   L     F + L R  I  ++  A+E +H   
Sbjct: 63  VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIA-ELTCAVESVHK-- 119

Query: 390 SSVHIIHCDLKPTNILLDENMVAHVSDFGI---------YKLLGEGEDSVRQTMT----- 435
             +  IH D+KP NIL+D +    ++DFG+          K    G D VRQ        
Sbjct: 120 --MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSG-DHVRQDSMDFSNE 176

Query: 436 --------------------------------MATIGYMAPEYGLEGIVSAKCDVYSYGV 463
                                           + T  Y+APE  L    +  CD +S GV
Sbjct: 177 WGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236

Query: 464 LLMETFTRKRP 474
           +L E    + P
Sbjct: 237 ILYEMLVGQPP 247

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 45.6 bits (108), Expect = 6e-05
 Identities = 24/66 (36%), Positives = 39/66 (59%), Gaps = 1/66 (1%)

Query: 4   LTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGH 63
           + L GN + G +P ++G S+ ++E L L+ N+  G+IP S+   T L +L+L  NS SG 
Sbjct: 447 INLSGNSIRGNIPPSLG-SITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGR 505

Query: 64  ILNTFG 69
           +    G
Sbjct: 506 VPAALG 511

Length = 623

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 44.6 bits (105), Expect = 7e-05
 Identities = 57/221 (25%), Positives = 97/221 (43%), Gaps = 27/221 (12%)

Query: 280 LGTSSFGSVYKGTIS-DGTDVAIKVFNLQLER-----AFRSFDSECEVLRNVRHRNLIKI 333
           LG  ++ +V+KG        VA+K   L+ E      A R    E  +L+N++H N++ +
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR----EVSLLKNLKHANIVTL 68

Query: 334 LSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVH 393
                      LV E++ +  L+++L +    + +      M  +   L Y H       
Sbjct: 69  HDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK---- 123

Query: 394 IIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGI-V 452
           I+H DLKP N+L++E     ++DFG+ +   +   +   +  + T+ Y  P+  L     
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLAR--AKSVPTKTYSNEVVTLWYRPPDVLLGSTEY 181

Query: 453 SAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESL 493
           S   D++  G +L E  T  RP   MF G       VKE L
Sbjct: 182 STPIDMWGVGCILYEMAT-GRP---MFPGST-----VKEEL 213

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 45.0 bits (106), Expect = 7e-05
 Identities = 47/203 (23%), Positives = 84/203 (41%), Gaps = 50/203 (24%)

Query: 317 SECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMI 376
           +E ++L    +  ++K+  S+ + D    V++++P G +   L     F ++L R  I  
Sbjct: 50  AERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIA- 108

Query: 377 DVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGI---------YKLLGEG- 426
           ++  A+E +H     +  IH D+KP NIL+D +    ++DFG+          K   +G 
Sbjct: 109 ELTLAIESVHK----MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGS 164

Query: 427 ---EDSVRQT---------------MTM-----------------ATIGYMAPEYGLEGI 451
              +DS+  +                T+                  T  Y+APE  L   
Sbjct: 165 HIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKG 224

Query: 452 VSAKCDVYSYGVLLMETFTRKRP 474
            +  CD +S GV+L E    + P
Sbjct: 225 YTQLCDWWSVGVILFEMLVGQPP 247

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 45.0 bits (106), Expect = 7e-05
 Identities = 51/185 (27%), Positives = 91/185 (49%), Gaps = 29/185 (15%)

Query: 296 GTDVAIKVF------NLQLERAFRSFDSECEVLRNVRHRNLIKILSSY----SNPDFKA- 344
           G +VA+K            +RA+R    E  +L+ V H+N+I +L+ +    S  +F+  
Sbjct: 46  GINVAVKKLSRPFQNQTHAKRAYR----ELVLLKCVNHKNIISLLNVFTPQKSLEEFQDV 101

Query: 345 -LVLEFMPNGSLEKWLYSHNYFLDILERLNIMI-DVGSALEYLHNGHSSVHIIHCDLKPT 402
            LV+E M + +L + ++     LD  ER++ ++  +   +++LH    S  IIH DLKP+
Sbjct: 102 YLVMELM-DANLCQVIHME---LD-HERMSYLLYQMLCGIKHLH----SAGIIHRDLKPS 152

Query: 403 NILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYG 462
           NI++  +    + DFG+ +       +   T  + T  Y APE  L        D++S G
Sbjct: 153 NIVVKSDCTLKILDFGLAR---TACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVG 209

Query: 463 VLLME 467
            ++ E
Sbjct: 210 CIMGE 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 44.4 bits (105), Expect = 8e-05
 Identities = 34/100 (34%), Positives = 48/100 (48%), Gaps = 17/100 (17%)

Query: 381 ALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKL--------LGEG--EDSV 430
           ALEYLHN      I+H DLKP N+L+       ++DFG+ K+        L EG  E   
Sbjct: 113 ALEYLHN----YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDT 168

Query: 431 RQTMTMATIG---YMAPEYGLEGIVSAKCDVYSYGVLLME 467
           R+ +     G   Y+APE  L        D ++ G++L E
Sbjct: 169 REFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYE 208

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 43.8 bits (103), Expect = 1e-04
 Identities = 56/218 (25%), Positives = 89/218 (40%), Gaps = 19/218 (8%)

Query: 273 EFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNV------R 326
           +FN   +LG  SFG V       GTD    +  L+ +   +  D EC ++         +
Sbjct: 1   DFNFLMVLGKGSFGKVMLAE-RKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGK 59

Query: 327 HRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH 386
              L ++ S +   D    V+E++  G L   +     F +    +    ++   L +LH
Sbjct: 60  PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEP-HAVFYAAEIAIGLFFLH 118

Query: 387 NGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEY 446
               S  II+ DLK  N++LD      ++DFG+ K      D V       T  Y+APE 
Sbjct: 119 ----SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENMWDGVTTKTFCGTPDYIAPEI 172

Query: 447 GLEGIVSAKCDVYSYGVLLMETFTRKRP-----TDEMF 479
                     D +++GVLL E    + P      DE+F
Sbjct: 173 IAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF 210

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 43.4 bits (102), Expect = 2e-04
 Identities = 60/220 (27%), Positives = 95/220 (43%), Gaps = 23/220 (10%)

Query: 273 EFNECNLLGTSSFGSVYKGTISDGTD--VAIKVFNLQLERAFRSFDSECEVL--RNVRHR 328
           +FN   +LG  SFG V       GTD   AIK+  L+ +   +  D EC ++  R +  +
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERK-GTDELYAIKI--LKKDVVIQDDDVECTMVEKRVLALQ 57

Query: 329 N----LIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEY 384
           +    L ++ S +   D    V+E++  G L   +     F +  + +    ++   L +
Sbjct: 58  DKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEP-QAVFYAAEISVGLFF 116

Query: 385 LHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAP 444
           LH       II+ DLK  N++LD      ++DFG+ K      D V       T  Y+AP
Sbjct: 117 LHRRG----IIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGTPDYIAP 170

Query: 445 EYGLEGIVSAKCDVYSYGVLLMETFTRKRP-----TDEMF 479
           E           D ++YGVLL E    + P      DE+F
Sbjct: 171 EIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELF 210

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 39.1 bits (92), Expect = 2e-04
 Identities = 25/59 (42%), Positives = 32/59 (54%)

Query: 101 LTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNL 159
           L  LD+S N+L+        G  +L+ L L+ N      PE+   L SL SLDLSGNNL
Sbjct: 2   LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 43.0 bits (101), Expect = 2e-04
 Identities = 50/206 (24%), Positives = 97/206 (47%), Gaps = 22/206 (10%)

Query: 296 GTDVAIKVFNLQ--LERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNG 353
           GT V +++ +L+   E   ++  +E  +    RH N++   + ++   +  ++  FM  G
Sbjct: 25  GTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84

Query: 354 SLEKWLYSHNYFLD-ILERL--NIMIDVGSALEYLH-NGHSSVHIIHCDLKPTNILLDEN 409
           S    L    YF + + E L  NI+      L YLH NG+     IH ++K ++IL+  +
Sbjct: 85  SANSLL--KTYFPEGMSEALIGNILFGALRGLNYLHQNGY-----IHRNIKASHILISGD 137

Query: 410 MVAHVSDFG-IYKLLGEGEDSVR----QTMTMATIGYMAPEY---GLEGIVSAKCDVYSY 461
            +  +S    +Y L+  G+ +         + + + +++PE     L G  + K D+YS 
Sbjct: 138 GLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYG-YNVKSDIYSV 196

Query: 462 GVLLMETFTRKRPTDEMFIGEMSLRR 487
           G+   E  T + P  +M   +M L++
Sbjct: 197 GITACELATGRVPFQDMLRTQMLLQK 222

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 42.3 bits (99), Expect = 4e-04
 Identities = 54/210 (25%), Positives = 94/210 (44%), Gaps = 35/210 (16%)

Query: 280 LGTSSFGSVYKGTISDGTD--VAIKVFNLQLER-----AFRSFDSECEVLRNVRHRNLIK 332
           LG  ++ +VYKG  S  TD  VA+K   L+ E      A R    E  +L++++H N++ 
Sbjct: 14  LGEGTYATVYKGR-SKLTDNLVALKEIRLEHEEGAPCTAIR----EVSLLKDLKHANIVT 68

Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWL-------YSHNYFLDILERLNIMIDVGSALEYL 385
           +           LV E++ +  L+++L         HN  L + + L         L Y 
Sbjct: 69  LHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQLLR-------GLNYC 120

Query: 386 HNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPE 445
           H       ++H DLKP N+L++E     ++DFG+ +   +   +   +  + T+ Y  P+
Sbjct: 121 HRRK----VLHRDLKPQNLLINERGELKLADFGLAR--AKSIPTKTYSNEVVTLWYRPPD 174

Query: 446 YGLEGI-VSAKCDVYSYGVLLMETFTRKRP 474
             L     S + D++  G +  E  T  RP
Sbjct: 175 ILLGSTDYSTQIDMWGVGCIFYEMST-GRP 203

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 42.3 bits (100), Expect = 4e-04
 Identities = 48/214 (22%), Positives = 75/214 (35%), Gaps = 58/214 (27%)

Query: 1   MRILTLEGNQLSGRLPSTIGHSL---PNIEYLLLTANNL------TGTIPNSITNATKLI 51
           +++L LEGN L       +  +L   P+++ L L+ N          ++   +T    L 
Sbjct: 25  LQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQ 84

Query: 52  VLDLGFNSFSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRI---------PPCLVLT 102
            LDL  N+          +L   S L  L    +L  N L  R               L 
Sbjct: 85  ELDLSDNALGPDGCGVLESLLRSSSLQEL----KLNNNGLGDRGLRLLAKGLKDLPPALE 140

Query: 103 VLDVSRNQLSG----DIPSTIGGRVDLETLSLASNQFQGP-------------------- 138
            L + RN+L G     +   +    DL+ L+LA+N                         
Sbjct: 141 KLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDL 200

Query: 139 ------------IPESVGSLISLESLDLSGNNLS 160
                       + E++ SL SLE L+L  NNL+
Sbjct: 201 NNNGLTDEGASALAETLASLKSLEVLNLGDNNLT 234

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 41.1 bits (96), Expect = 0.001
 Identities = 43/192 (22%), Positives = 89/192 (46%), Gaps = 12/192 (6%)

Query: 280 LGTSSFGSVYKGTISDGTD--VAIKVFNLQLER-AFRSFDSECEVLRNVRHRNLIKILSS 336
           LG  ++ +V+KG  S  T+  VA+K   L+ E  A  +   E  +L++++H N++ +   
Sbjct: 14  LGEGTYATVFKGR-SKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 337 YSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIH 396
                   LV E++ +  L++++      + +      +  +   L Y H       ++H
Sbjct: 73  VHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK----VLH 127

Query: 397 CDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGL-EGIVSAK 455
            DLKP N+L++E     ++DFG+ +   +   +   +  + T+ Y  P+  L     S +
Sbjct: 128 RDLKPQNLLINERGELKLADFGLAR--AKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQ 185

Query: 456 CDVYSYGVLLME 467
            D++  G +  E
Sbjct: 186 IDMWGVGCIFFE 197

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 40.6 bits (95), Expect = 0.001
 Identities = 49/211 (23%), Positives = 89/211 (42%), Gaps = 32/211 (15%)

Query: 280 LGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRN------VRHRNLIKI 333
           +G   FG V    I   T VA  V  ++  +A  S   + E L+       ++H N+++ 
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVV--VKELKANASSKEQNEFLQQGDPYRILQHPNILQC 60

Query: 334 LSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFL---DILERLNIMIDVGSALEYLHNGHS 390
           L          LV E+   G L+ +L    +      +L    +  ++ + + ++H    
Sbjct: 61  LGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK--- 117

Query: 391 SVHIIHCDLKPTNILLDENMVAHVSDFGI----YKLLGEGEDSVR-QTMTMATIGYMAPE 445
             + +H DL   N  L  ++   V D+GI    YK     ED +  +      + ++APE
Sbjct: 118 -HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYK-----EDYIETEDDKCVPLRWLAPE 171

Query: 446 YGLE---GIVSAK----CDVYSYGVLLMETF 469
              E   G+++A+     +V++ GV L E F
Sbjct: 172 LVGEFHGGLITAEQTKPSNVWALGVTLWELF 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 36.8 bits (86), Expect = 0.002
 Identities = 17/55 (30%), Positives = 23/55 (41%)

Query: 25 NIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSL 79
          N++ L L+ N LT     +      L VLDL  N+ +      F  L  L  L L
Sbjct: 1  NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDL 55

Length = 60

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 39.6 bits (92), Expect = 0.004
 Identities = 38/141 (26%), Positives = 67/141 (47%), Gaps = 9/141 (6%)

Query: 36  LTGTIPNSITNATK-LIVLDLGFNSFSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGR 94
           L   + ++        +   L  +  S   +++     +L  L  L   + L  N+L   
Sbjct: 50  LALNLSSNTLLLLPSSLSRLLSLDLLSPSGISSLDGSENLLNLLPLPS-LDLNLNRLRSN 108

Query: 95  IPPCL---VLTVLDVSRNQLSGDIPSTIG-GRVDLETLSLASNQFQGPIPESVGSLISLE 150
           I   L    LT LD+  N ++ DIP  IG  + +L+ L L+ N+ +  +P  + +L +L+
Sbjct: 109 ISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLK 166

Query: 151 SLDLSGNNLSGKIPKLEGEIP 171
           +LDLS N+LS  +PKL   + 
Sbjct: 167 NLDLSFNDLS-DLPKLLSNLS 186

Length = 394

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	593
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
PTZ00284	467	protein kinase; Provisional	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.98
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.98
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.98
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.98
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.97
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.97
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.97
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.97
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.97
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.97
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.97
KOG1152	772	consensus Signal transduction serine/threonine kin	99.96
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.96
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.96
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.96
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.95
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.95
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.95
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.94
PLN00181	793	protein SPA1-RELATED; Provisional	99.94
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.91
PRK09188	365	serine/threonine protein kinase; Provisional	99.91
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.9
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.9
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.89
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.89
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.89
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.86
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.86
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.85
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.84
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.84
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.83
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.83
PRK12274	218	serine/threonine protein kinase; Provisional	99.82
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.82
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.81
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.81
PRK10345	210	hypothetical protein; Provisional	99.79
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.78
smart00090	237	RIO RIO-like kinase.	99.75
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.75
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.74
PRK14879	211	serine/threonine protein kinase; Provisional	99.73
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	99.73
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	99.73
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.72
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	99.72
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.71
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.7
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.66
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.64
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.62
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.62
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.62
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	99.61
KOG0472	565	consensus Leucine-rich repeat protein [Function un	99.59
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.59
KOG0472	565	consensus Leucine-rich repeat protein [Function un	99.5
PLN03150	623	hypothetical protein; Provisional	99.49
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.49
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.46
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.43
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.41
KOG1243	690	consensus Protein kinase [General function predict	99.39
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.39
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	99.37
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.36
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.35
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.35
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.32
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.32
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	99.31
PLN03150	623	hypothetical protein; Provisional	99.27
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.26
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.25
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.21
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.18
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.18
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.17
KOG3087	229	consensus Serine/threonine protein kinase [General	99.16
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.16
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.15
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.15
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.15
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.15
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.14
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.12
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.12
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.11
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.08
COG4248	637	Uncharacterized protein with protein kinase and he	99.02
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.99
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.99
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	98.97
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.91
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.89
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.85
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	98.83
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.79
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.76
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.66
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.6
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	98.55
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	98.54
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	98.53
PRK09902	216	hypothetical protein; Provisional	98.51
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.48
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.42
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.41
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.4
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	98.4
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.39
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.34
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.32

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=6.3e-64  Score=586.63  Aligned_cols=524  Identities=27%  Similarity=0.429  Sum_probs=371.8

Q ss_pred             cEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhhc
Q 007680            2 RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLM   81 (593)
Q Consensus         2 ~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~   81 (593)
                      +.|+|++|.+.+.+|..+.. +++|+.|+|++|++++.+|..|.++++|+.|+|++|++++.+|..+..+++|+.|+|++
T Consensus       383 ~~L~l~~n~l~~~~p~~~~~-~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~  461 (968)
T PLN00113        383 FKLILFSNSLEGEIPKSLGA-CRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLAR  461 (968)
T ss_pred             CEEECcCCEecccCCHHHhC-CCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcC
Confidence            45555555555555555553 67777777777777777777777777777777777777777777777777777777776


Q ss_pred             ce----------------eeccCCcccccCCC----cccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCc
Q 007680           82 FG----------------IRLTGNKLYGRIPP----CLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPE  141 (593)
Q Consensus        82 n~----------------l~l~~n~l~~~~~~----~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~  141 (593)
                      |.                +++++|++.+.+|.    +..|++|+|++|++.+.+|..+.++++|+.|+|++|++++.+|.
T Consensus       462 n~~~~~~p~~~~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~  541 (968)
T PLN00113        462 NKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPA  541 (968)
T ss_pred             ceeeeecCcccccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCCh
Confidence            54                56778888766554    33588888888888888888888888899999999999888888


Q ss_pred             cccCCccccccccccccccCCCCCCCC-----------------CCCCCCCccCCCcccccCCccCCCCC-CCCCCCCCC
Q 007680          142 SVGSLISLESLDLSGNNLSGKIPKLEG-----------------EIPVKGSFKNFSTESFFGNYALCGPP-KLRVPPCKP  203 (593)
Q Consensus       142 ~l~~~~~L~~L~l~~N~l~~~~p~~~~-----------------~~~~~~~~~~~~~~~~~~n~~~c~~~-~~~~~~~~~  203 (593)
                      .+..+++|+.|||++|++++.+|..+.                 .+|..+.+..+...++.+|+.+|+++ ....++|..
T Consensus       542 ~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~  621 (968)
T PLN00113        542 SFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKR  621 (968)
T ss_pred             hHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCcc
Confidence            888888999999999999888876433                 33444555566677889999999854 334566643


Q ss_pred             CCCccccccceeeEEEecccchhhhHHHHHHhhhhheeccCCC---CCCCCCCc-cc-----hhcccCCHHHHHHhhhcc
Q 007680          204 DNSKRTKKVPLIVLKYILPPIVSTVLVVITIIMYIRCRNRNTK---KSDHEDFL-PL-----AIWRRTSYLDIQRATDEF  274 (593)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~-~~-----~~~~~~~~~~~~~~~~~~  274 (593)
                      ..    +...+.  .++++++++.+++++++++++++|+++..   +...++.. ..     ......++   ......|
T Consensus       622 ~~----~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~  692 (968)
T PLN00113        622 VR----KTPSWW--FYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITI---NDILSSL  692 (968)
T ss_pred             cc----ccceee--eehhHHHHHHHHHHHHHHHHHHHHhhhcccccccccccccccccccccccchhhhH---HHHHhhC
Confidence            21    111121  11111111111212222222222222211   11111100 00     00111222   3334567


Q ss_pred             ccccccCccCcccEEEEEe-CCCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEeccCCC
Q 007680          275 NECNLLGTSSFGSVYKGTI-SDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNG  353 (593)
Q Consensus       275 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  353 (593)
                      ...+.||+|+||.||+|+. .++..||+|.++....    ....|++.+++++||||+++++++.+++..++||||+++|
T Consensus       693 ~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g  768 (968)
T PLN00113        693 KEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGK  768 (968)
T ss_pred             CcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCC
Confidence            7888999999999999997 4789999999864322    1234688999999999999999999999999999999999


Q ss_pred             CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCccccc
Q 007680          354 SLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQT  433 (593)
Q Consensus       354 sL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~  433 (593)
                      +|.++++.    ++|.++.+++.|+++||+|||.++ +.+|+||||||+||+++.++.+++. ||.......      ..
T Consensus       769 ~L~~~l~~----l~~~~~~~i~~~ia~~L~yLH~~~-~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~------~~  836 (968)
T PLN00113        769 NLSEVLRN----LSWERRRKIAIGIAKALRFLHCRC-SPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT------DT  836 (968)
T ss_pred             cHHHHHhc----CCHHHHHHHHHHHHHHHHHhccCC-CCCeecCCCCHHhEEECCCCceEEE-ecccccccc------CC
Confidence            99999963    889999999999999999999765 5679999999999999999888875 665443211      12


Q ss_pred             cccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCc-hhhhhhhhhhhhhhhh
Q 007680          434 MTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHG-LTEVVDANLVREEQAF  512 (593)
Q Consensus       434 ~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  512 (593)
                      ...+++.|+|||++.+..++.++|||||||++|||+||+.||+..........+|........ ....+|+.+....   
T Consensus       837 ~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  913 (968)
T PLN00113        837 KCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDV---  913 (968)
T ss_pred             CccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCC---
Confidence            235789999999999999999999999999999999999999765555556677765544332 3334444332211   


Q ss_pred             hhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhhh
Q 007680          513 SAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKF  554 (593)
Q Consensus       513 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  554 (593)
                      ....+...++.+++.+||+.||++||||.|+++.|+++...-
T Consensus       914 ~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~  955 (968)
T PLN00113        914 SVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSS  955 (968)
T ss_pred             CccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccc
Confidence            111233557889999999999999999999999999886543

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-50  Score=411.81  Aligned_cols=289  Identities=41%  Similarity=0.642  Sum_probs=246.9

Q ss_pred             hcccCCHHHHHHhhhccccccccCccCcccEEEEEeCCCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeee
Q 007680          258 IWRRTSYLDIQRATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSY  337 (593)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  337 (593)
                      ..+.+++.++..+|++|...+.||+|+||.||+|...+|+.||||++.........+|.+|++++.+++|||+|+++|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            46779999999999999999999999999999999998899999988765432145599999999999999999999999


Q ss_pred             ecCC-ceEEEEeccCCCCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEE
Q 007680          338 SNPD-FKALVLEFMPNGSLEKWLYSHNY-FLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVS  415 (593)
Q Consensus       338 ~~~~-~~~lv~e~~~~gsL~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~  415 (593)
                      .+.+ +.++|+|||++|+|.+++..... .++|..+++||.++|+||+|||+.. ...|+||||||+|||+|+++++||+
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~-~~~iiHrDiKssNILLD~~~~aKls  219 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGC-PPPIIHRDIKSSNILLDEDFNAKLS  219 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCC-CCCEecCCCCHHHeeECCCCCEEcc
Confidence            9998 59999999999999999998776 7999999999999999999999876 5679999999999999999999999


Q ss_pred             eeccceecCCCCCccccccc-cCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccc-cccchHHHHHHHhc
Q 007680          416 DFGIYKLLGEGEDSVRQTMT-MATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMF-IGEMSLRRWVKESL  493 (593)
Q Consensus       416 Dfg~a~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~-~~~~~~~~~~~~~~  493 (593)
                      |||+|+.......  ..... .||.+|+|||+...+..+.|+|||||||++.|++||+.|.+... .++..+..|....+
T Consensus       220 DFGLa~~~~~~~~--~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~  297 (361)
T KOG1187|consen  220 DFGLAKLGPEGDT--SVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL  297 (361)
T ss_pred             CccCcccCCcccc--ceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence            9999976543111  11111 79999999999999999999999999999999999999887643 34456888887776


Q ss_pred             CCc-hhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhh
Q 007680          494 PHG-LTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKV  552 (593)
Q Consensus       494 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~  552 (593)
                      .+. +.+++|+.+........   .....+..++.+|++.+|.+||+|.||++.|+.+..
T Consensus       298 ~~~~~~eiiD~~l~~~~~~~~---~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~  354 (361)
T KOG1187|consen  298 EEGKLREIVDPRLKEGEYPDE---KEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS  354 (361)
T ss_pred             HCcchhheeCCCccCCCCChH---HHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence            664 88999998863211110   334568999999999999999999999999966543

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-49  Score=385.74  Aligned_cols=255  Identities=23%  Similarity=0.305  Sum_probs=213.4

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCc-eEEEE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDF-KALVL  347 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lv~  347 (593)
                      .++.+..+.||+|..|+||+++++ +++.+|+|++.... ....+++.+|+++++..+||+||.+||.|...+. .+++|
T Consensus        78 ~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~m  157 (364)
T KOG0581|consen   78 LSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICM  157 (364)
T ss_pred             HHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeeh
Confidence            456677789999999999999987 78999999996543 4556789999999999999999999999999994 99999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCC
Q 007680          348 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGE  427 (593)
Q Consensus       348 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~  427 (593)
                      |||++|+|.+++...+. +++...-+|+.++++||.|||+   +.+|+||||||+|||++..|++||+|||.+..+... 
T Consensus       158 EYMDgGSLd~~~k~~g~-i~E~~L~~ia~~VL~GL~YLh~---~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-  232 (364)
T KOG0581|consen  158 EYMDGGSLDDILKRVGR-IPEPVLGKIARAVLRGLSYLHE---ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-  232 (364)
T ss_pred             hhcCCCCHHHHHhhcCC-CCHHHHHHHHHHHHHHHHHHhh---ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence            99999999999987654 9999999999999999999996   346999999999999999999999999999887544 


Q ss_pred             CccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhh
Q 007680          428 DSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVR  507 (593)
Q Consensus       428 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  507 (593)
                         .....+||..|||||.+.+..|+.++||||||++++|+.+|+.||.........            ..+.++.-...
T Consensus       233 ---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~------------~~~Ll~~Iv~~  297 (364)
T KOG0581|consen  233 ---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLD------------IFELLCAIVDE  297 (364)
T ss_pred             ---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCC------------HHHHHHHHhcC
Confidence               335578999999999999999999999999999999999999999763111111            22222222211


Q ss_pred             hhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          508 EEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       508 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      .....+. ..+++++.+|+..||++||.+||+++|+++|
T Consensus       298 ppP~lP~-~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H  335 (364)
T KOG0581|consen  298 PPPRLPE-GEFSPEFRSFVSCCLRKDPSERPSAKQLLQH  335 (364)
T ss_pred             CCCCCCc-ccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            2222211 1478899999999999999999999999987

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-47  Score=387.68  Aligned_cols=263  Identities=28%  Similarity=0.429  Sum_probs=215.7

Q ss_pred             hhccccccccCccCcccEEEEEeCCCCeEEEEEeehhhH--HHHHHHHHHHHHHhhcCCCCcceeeeeeecCC-ceEEEE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLE--RAFRSFDSECEVLRNVRHRNLIKILSSYSNPD-FKALVL  347 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~  347 (593)
                      .++....+.+|+|+||+||+|.+.....||||++.....  ...+.|.+|+.+|.+++|||||+++|++.++. ..++||
T Consensus        40 ~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVt  119 (362)
T KOG0192|consen   40 PDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVT  119 (362)
T ss_pred             hHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEE
Confidence            344555667999999999999997444499999986532  22568999999999999999999999999987 799999


Q ss_pred             eccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC-cEEEEeeccceecCC
Q 007680          348 EFMPNGSLEKWLYSH-NYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENM-VAHVSDFGIYKLLGE  425 (593)
Q Consensus       348 e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~-~~kL~Dfg~a~~~~~  425 (593)
                      ||+++|+|.+++... +..+++..++.++.|||+||.|||++++   ||||||||+|||++.++ ++||+|||+++....
T Consensus       120 Ey~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~---iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~  196 (362)
T KOG0192|consen  120 EYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP---IIHRDLKSDNILVDLKGKTLKIADFGLSREKVI  196 (362)
T ss_pred             EeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC---eeecccChhhEEEcCCCCEEEECCCccceeecc
Confidence            999999999999883 5579999999999999999999995441   99999999999999997 999999999987654


Q ss_pred             CCCccccccccCCccccCccccC--CCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhh
Q 007680          426 GEDSVRQTMTMATIGYMAPEYGL--EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDA  503 (593)
Q Consensus       426 ~~~~~~~~~~~gt~~y~aPE~~~--~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  503 (593)
                      ..  ...+...||+.|||||++.  ...|+.|+||||||+++|||+||+.||......  .....+.             
T Consensus       197 ~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~--~~~~~v~-------------  259 (362)
T KOG0192|consen  197 SK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV--QVASAVV-------------  259 (362)
T ss_pred             cc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH--HHHHHHH-------------
Confidence            32  2233467999999999999  568999999999999999999999999885431  1111110             


Q ss_pred             hhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhhhcc
Q 007680          504 NLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKFLD  556 (593)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~  556 (593)
                         ....+...+..+++.+..++.+||..||+.||++.+++..|+.+......
T Consensus       260 ---~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~  309 (362)
T KOG0192|consen  260 ---VGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS  309 (362)
T ss_pred             ---hcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence               11111122233678899999999999999999999999999999876543

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.8e-47  Score=389.59  Aligned_cols=248  Identities=24%  Similarity=0.349  Sum_probs=213.7

Q ss_pred             hccccccccCccCcccEEEEEe-CCCCeEEEEEeehhh---HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEE
Q 007680          272 DEFNECNLLGTSSFGSVYKGTI-SDGTDVAIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVL  347 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  347 (593)
                      ..|...+.||+|||+.||.++. .+|+.||+|++.+..   ....+.+.+|++|.++++|||||+++++|++.++.|+|.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            5799999999999999999997 789999999998743   456678999999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCC
Q 007680          348 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGE  427 (593)
Q Consensus       348 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~  427 (593)
                      |+|+.++|..+++. ++.+++.+++.+++||+.||.|||++    +|+|||||..|+|++++.++||+|||+|..+..++
T Consensus        98 ELC~~~sL~el~Kr-rk~ltEpEary~l~QIv~GlkYLH~~----~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~  172 (592)
T KOG0575|consen   98 ELCHRGSLMELLKR-RKPLTEPEARYFLRQIVEGLKYLHSL----GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG  172 (592)
T ss_pred             EecCCccHHHHHHh-cCCCCcHHHHHHHHHHHHHHHHHHhc----CceecccchhheeecCcCcEEecccceeeeecCcc
Confidence            99999999999984 44699999999999999999999954    59999999999999999999999999999887543


Q ss_pred             CccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhh
Q 007680          428 DSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVR  507 (593)
Q Consensus       428 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  507 (593)
                      .  +....+|||.|.|||++.....+..+||||+||++|.|+.|++||+...-                 .+..+ ++..
T Consensus       173 E--rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~v-----------------kety~-~Ik~  232 (592)
T KOG0575|consen  173 E--RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTV-----------------KETYN-KIKL  232 (592)
T ss_pred             c--ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchH-----------------HHHHH-HHHh
Confidence            2  34567899999999999999999999999999999999999999987311                 11111 1111


Q ss_pred             hhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          508 EEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       508 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      ...  ..+...+.+..+||.++|+.||.+|||+++|+.|
T Consensus       233 ~~Y--~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h  269 (592)
T KOG0575|consen  233 NEY--SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH  269 (592)
T ss_pred             cCc--ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            111  2223456788999999999999999999999976

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-47  Score=371.94  Aligned_cols=201  Identities=32%  Similarity=0.538  Sum_probs=183.8

Q ss_pred             hhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehh--hHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEE
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQ--LERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALV  346 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  346 (593)
                      ...+|...+.||+|+||+||+|+++ ++..||||.+.+.  ..+..+.+..|+++|+.++|||||++++++..++..|+|
T Consensus         8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV   87 (429)
T KOG0595|consen    8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV   87 (429)
T ss_pred             ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence            3568999999999999999999976 6899999999876  466677889999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCC------CcEEEEeeccc
Q 007680          347 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDEN------MVAHVSDFGIY  420 (593)
Q Consensus       347 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~------~~~kL~Dfg~a  420 (593)
                      ||||.||||.++++.++. +++..+..++.|++.||++||+++    ||||||||+|||++..      -.+||+|||+|
T Consensus        88 MEyC~gGDLs~yi~~~~~-l~e~t~r~Fm~QLA~alq~L~~~~----IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA  162 (429)
T KOG0595|consen   88 MEYCNGGDLSDYIRRRGR-LPEATARHFMQQLASALQFLHENN----IIHRDLKPQNILLSTTARNDTSPVLKIADFGFA  162 (429)
T ss_pred             EEeCCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHCC----eeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence            999999999999999875 999999999999999999999655    9999999999999864      46899999999


Q ss_pred             eecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCcc
Q 007680          421 KLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEM  478 (593)
Q Consensus       421 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~  478 (593)
                      +.+....   .....+|++.|||||++..++|+.|+|+||+|+++|++++|+.||+..
T Consensus       163 R~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~  217 (429)
T KOG0595|consen  163 RFLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE  217 (429)
T ss_pred             hhCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence            9987543   345678999999999999999999999999999999999999999864

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-47  Score=373.87  Aligned_cols=254  Identities=26%  Similarity=0.365  Sum_probs=209.0

Q ss_pred             hhhccccccccCccCcccEEEEEe-CCCCeEEEEEeehhhHH-------HHHHHHHHHHHHhhcCCCCcceeeeeeecCC
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTI-SDGTDVAIKVFNLQLER-------AFRSFDSECEVLRNVRHRNLIKILSSYSNPD  341 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  341 (593)
                      ..+.|.+.+.||+|+||.|-+|.. ++|+.||||++++....       .....++|+++|++++|||||+++++|+.++
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            456788999999999999999985 48999999999875311       2234679999999999999999999999999


Q ss_pred             ceEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCC---CcEEEEeec
Q 007680          342 FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDEN---MVAHVSDFG  418 (593)
Q Consensus       342 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~---~~~kL~Dfg  418 (593)
                      ..|+||||++||+|.+.+-.++. +.+..-..+++|++.|+.|||++    ||+||||||+|||+..+   ..+||+|||
T Consensus       250 s~YmVlE~v~GGeLfd~vv~nk~-l~ed~~K~~f~Qll~avkYLH~~----GI~HRDiKPeNILl~~~~e~~llKItDFG  324 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVANKY-LREDLGKLLFKQLLTAVKYLHSQ----GIIHRDIKPENILLSNDAEDCLLKITDFG  324 (475)
T ss_pred             ceEEEEEEecCccHHHHHHhccc-cccchhHHHHHHHHHHHHHHHHc----CcccccCCcceEEeccCCcceEEEecccc
Confidence            99999999999999999988776 88888899999999999999955    59999999999999766   789999999


Q ss_pred             cceecCCCCCccccccccCCccccCccccCCCC---CCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCC
Q 007680          419 IYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGI---VSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPH  495 (593)
Q Consensus       419 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~  495 (593)
                      +|+..++..   .....+||+.|.|||++.+..   +..++|+||+||++|-+++|.+||.+....... .+.+      
T Consensus       325 lAK~~g~~s---fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl-~eQI------  394 (475)
T KOG0615|consen  325 LAKVSGEGS---FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSL-KEQI------  394 (475)
T ss_pred             hhhccccce---ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccH-HHHH------
Confidence            999876433   345678999999999988654   344889999999999999999999874332211 1111      


Q ss_pred             chhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          496 GLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       496 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                           ....+.   ...+.+..++++..++|.+||..||++|||+.|+++|
T Consensus       395 -----~~G~y~---f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h  437 (475)
T KOG0615|consen  395 -----LKGRYA---FGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH  437 (475)
T ss_pred             -----hcCccc---ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence                 111111   1123445667889999999999999999999999986

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.9e-47  Score=353.74  Aligned_cols=260  Identities=22%  Similarity=0.324  Sum_probs=209.4

Q ss_pred             hhhccccccccCccCcccEEEEE-eCCCCeEEEEEeehh--hHHHHHHHHHHHHHHhhcCCCCcceeee-eeecCC-ceE
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQ--LERAFRSFDSECEVLRNVRHRNLIKILS-SYSNPD-FKA  344 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~-~~~  344 (593)
                      ...+|++.++||+|+||+||++. ..+|..||.|.++..  +....+....|+.+|++++|||||++++ .+.+.. ..+
T Consensus        17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evln   96 (375)
T KOG0591|consen   17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLN   96 (375)
T ss_pred             cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhH
Confidence            35679999999999999999998 458999999998754  3566778999999999999999999998 444444 489


Q ss_pred             EEEeccCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccce
Q 007680          345 LVLEFMPNGSLEKWLYS---HNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYK  421 (593)
Q Consensus       345 lv~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~  421 (593)
                      ||||||.+|||.++++.   .++.+++..+++++.|++.||.++|...+...|+||||||.|||++.+|.+||+|||+++
T Consensus        97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r  176 (375)
T KOG0591|consen   97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGR  176 (375)
T ss_pred             HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHh
Confidence            99999999999998864   344799999999999999999999974433349999999999999999999999999999


Q ss_pred             ecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhh
Q 007680          422 LLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVV  501 (593)
Q Consensus       422 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  501 (593)
                      .+.....  .....+|||.||+||.+.+..|+.+|||||+||++|||+.-++||.+.     ++.....           
T Consensus       177 ~l~s~~t--fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-----n~~~L~~-----------  238 (375)
T KOG0591|consen  177 FLSSKTT--FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-----NLLSLCK-----------  238 (375)
T ss_pred             HhcchhH--HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-----cHHHHHH-----------
Confidence            8865432  345568999999999999999999999999999999999999999873     1111111           


Q ss_pred             hhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHH
Q 007680          502 DANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKK  549 (593)
Q Consensus       502 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  549 (593)
                        ++.......-+..-++.++.+++..|+..||+.||+...++..+..
T Consensus       239 --KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~  284 (375)
T KOG0591|consen  239 --KIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS  284 (375)
T ss_pred             --HHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence              1111111111123457789999999999999999986555554443

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-46  Score=379.69  Aligned_cols=259  Identities=29%  Similarity=0.468  Sum_probs=219.1

Q ss_pred             HhhhccccccccCccCcccEEEEEeCCCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEe
Q 007680          269 RATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLE  348 (593)
Q Consensus       269 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  348 (593)
                      ...+.+..++.||+|.||.||.|.+....+||+|.++... -..+.|.+|+++|.+++|+|||+++++|..++..+||||
T Consensus       203 i~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE  281 (468)
T KOG0197|consen  203 IPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTE  281 (468)
T ss_pred             ecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEE
Confidence            3445567788999999999999999877799999998752 233678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCC
Q 007680          349 FMPNGSLEKWLYS-HNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGE  427 (593)
Q Consensus       349 ~~~~gsL~~~l~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~  427 (593)
                      ||+.|+|.++++. .+..+...+.+.++.|||+|++||+++    ++|||||.+.||||+++..+||+|||+|+...++.
T Consensus       282 ~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~----~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~  357 (468)
T KOG0197|consen  282 YMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK----NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDE  357 (468)
T ss_pred             ecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC----CccchhhhhhheeeccCceEEEcccccccccCCCc
Confidence            9999999999997 445799999999999999999999954    59999999999999999999999999999655443


Q ss_pred             CccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhhhhhhh
Q 007680          428 DSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLV  506 (593)
Q Consensus       428 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  506 (593)
                      .. ......-...|.|||.+..+.++.|||||||||+|||++| |+.||..+...+                 ++  ...
T Consensus       358 Y~-~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e-----------------v~--~~l  417 (468)
T KOG0197|consen  358 YT-ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE-----------------VL--ELL  417 (468)
T ss_pred             ee-ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH-----------------HH--HHH
Confidence            22 2223334677999999999999999999999999999999 999987753221                 11  112


Q ss_pred             hhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhh
Q 007680          507 REEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKV  552 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~  552 (593)
                      ....+.+.+..||+++.++|..||+.+|++|||++.+...|+++..
T Consensus       418 e~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~  463 (468)
T KOG0197|consen  418 ERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT  463 (468)
T ss_pred             hccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence            3345566777899999999999999999999999999888888743

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.6e-45  Score=345.38  Aligned_cols=266  Identities=21%  Similarity=0.258  Sum_probs=210.6

Q ss_pred             hccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh--HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEe
Q 007680          272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLE  348 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  348 (593)
                      +.|+.+.++|+|+||+||+++++ +|+.||||.+....  ....+...+|+++|++++|||+|.++++|......++|+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            56889999999999999999976 79999999997543  3445667899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCC
Q 007680          349 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGED  428 (593)
Q Consensus       349 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  428 (593)
                      ||+. ++.+-+.......+...+.++++|++.|+.|+|.++    ++||||||+|||++.+|.+||||||+|+.+.....
T Consensus        82 ~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n----~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd  156 (396)
T KOG0593|consen   82 YCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNN----CIHRDIKPENILITQNGVVKLCDFGFARTLSAPGD  156 (396)
T ss_pred             ecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcC----eecccCChhheEEecCCcEEeccchhhHhhcCCcc
Confidence            9976 666667776666999999999999999999999655    99999999999999999999999999998875333


Q ss_pred             ccccccccCCccccCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHh---cCCchhhhhhhh
Q 007680          429 SVRQTMTMATIGYMAPEYGLE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKES---LPHGLTEVVDAN  504 (593)
Q Consensus       429 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~  504 (593)
                        ..+..+.|.+|+|||.+.+ .+|++.+||||+||++.||++|.+.|.+.+  +.+....+...   +......++..+
T Consensus       157 --~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~S--DiDQLy~I~ktLG~L~prhq~iF~~N  232 (396)
T KOG0593|consen  157 --NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRS--DIDQLYLIRKTLGNLIPRHQSIFSSN  232 (396)
T ss_pred             --hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcc--hHHHHHHHHHHHcccCHHHHHHhccC
Confidence              3455678999999999887 679999999999999999999999987743  33322222221   111122222211


Q ss_pred             hhhhh----------hhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          505 LVREE----------QAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       505 ~~~~~----------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      -....          .........+.-+.++++.||+.||++|++.+|++.|
T Consensus       233 ~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H  284 (396)
T KOG0593|consen  233 PFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH  284 (396)
T ss_pred             CceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence            11000          0011112344578999999999999999999999876

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-45  Score=354.33  Aligned_cols=243  Identities=27%  Similarity=0.338  Sum_probs=204.0

Q ss_pred             hhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEE
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKAL  345 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  345 (593)
                      ..++|++++.||+|+||.||+++.+ +++.+|+|++++..   ....+....|..+|.+++||+||+++..|++++..|+
T Consensus        23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl  102 (357)
T KOG0598|consen   23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL  102 (357)
T ss_pred             ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence            3678999999999999999999965 78999999998763   3456788999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCC
Q 007680          346 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGE  425 (593)
Q Consensus       346 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~  425 (593)
                      |+||+.||.|..++++++. +++..+.-++..|+.||.|||+    .||+||||||+|||+|.+|+++|+|||+++..-.
T Consensus       103 Vld~~~GGeLf~hL~~eg~-F~E~~arfYlaEi~lAL~~LH~----~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~  177 (357)
T KOG0598|consen  103 VLDYLNGGELFYHLQREGR-FSEDRARFYLAEIVLALGYLHS----KGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK  177 (357)
T ss_pred             EEeccCCccHHHHHHhcCC-cchhHHHHHHHHHHHHHHHHHh----CCeeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence            9999999999999998776 9999999999999999999995    4599999999999999999999999999986443


Q ss_pred             CCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhh
Q 007680          426 GEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANL  505 (593)
Q Consensus       426 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  505 (593)
                      ...  .....+||+.|||||++.+..|+.++|.||+|+++|||++|.+||....     ..+++.....           
T Consensus       178 ~~~--~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~-----~~~~~~~I~~-----------  239 (357)
T KOG0598|consen  178 DGD--ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED-----VKKMYDKILK-----------  239 (357)
T ss_pred             CCC--ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc-----HHHHHHHHhc-----------
Confidence            322  3344789999999999999999999999999999999999999997732     1111111111           


Q ss_pred             hhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCC
Q 007680          506 VREEQAFSAKMDCILSIMDFALDCCMESPDMRI  538 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP  538 (593)
                        .. ....+.-.+.+..+++.+.|+.||++|.
T Consensus       240 --~k-~~~~p~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  240 --GK-LPLPPGYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             --Cc-CCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence              10 0011111345789999999999999996

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-44  Score=361.61  Aligned_cols=254  Identities=24%  Similarity=0.376  Sum_probs=213.8

Q ss_pred             HHhhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhc-CCCCcceeeeeeecCCc
Q 007680          268 QRATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNV-RHRNLIKILSSYSNPDF  342 (593)
Q Consensus       268 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  342 (593)
                      ++...+|...+.||+|+|++|++|+.+ +++.||||++.+.-   +...+.+..|-.+|.+| .||.|++++-.|.+...
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            456789999999999999999999954 79999999997652   33455677899999999 89999999999999999


Q ss_pred             eEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeecccee
Q 007680          343 KALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKL  422 (593)
Q Consensus       343 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~  422 (593)
                      .|+|+||+++|+|.++|.+.+. +++...+.++.+|+.||+|||    +.|||||||||+|||+|.++++||+|||.|+.
T Consensus       149 LYFvLe~A~nGdll~~i~K~Gs-fde~caR~YAAeIldAleylH----~~GIIHRDlKPENILLd~dmhikITDFGsAK~  223 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKKYGS-FDETCARFYAAEILDALEYLH----SNGIIHRDLKPENILLDKDGHIKITDFGSAKI  223 (604)
T ss_pred             eEEEEEecCCCcHHHHHHHhCc-chHHHHHHHHHHHHHHHHHHH----hcCceeccCChhheeEcCCCcEEEeecccccc
Confidence            9999999999999999998876 999999999999999999999    45599999999999999999999999999998


Q ss_pred             cCCCCCc---------ccc--ccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHH
Q 007680          423 LGEGEDS---------VRQ--TMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKE  491 (593)
Q Consensus       423 ~~~~~~~---------~~~--~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~  491 (593)
                      +......         ...  ...+||..|.+||++.++..++.+|+|+|||++|+|+.|.+||.+..+ ...+.     
T Consensus       224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne-yliFq-----  297 (604)
T KOG0592|consen  224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE-YLIFQ-----  297 (604)
T ss_pred             CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH-HHHHH-----
Confidence            8653322         111  447899999999999999999999999999999999999999977321 11111     


Q ss_pred             hcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          492 SLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       492 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                             .++     .-  .++.+..+++.+.+|+++.|..||++|+|++||.+|
T Consensus       298 -------kI~-----~l--~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H  338 (604)
T KOG0592|consen  298 -------KIQ-----AL--DYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH  338 (604)
T ss_pred             -------HHH-----Hh--cccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence                   111     11  122233456788999999999999999999988887

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=2e-44  Score=382.37  Aligned_cols=263  Identities=28%  Similarity=0.455  Sum_probs=221.5

Q ss_pred             HhhhccccccccCccCcccEEEEEeC------CCCeEEEEEeehhhHH-HHHHHHHHHHHHhhcCCCCcceeeeeeecCC
Q 007680          269 RATDEFNECNLLGTSSFGSVYKGTIS------DGTDVAIKVFNLQLER-AFRSFDSECEVLRNVRHRNLIKILSSYSNPD  341 (593)
Q Consensus       269 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  341 (593)
                      ....+....+.||+|.||.||+|+..      +...||||.++...+. ...+|++|++++..++|||||+++|+|.+++
T Consensus       483 i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~  562 (774)
T KOG1026|consen  483 IPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGD  562 (774)
T ss_pred             echhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC
Confidence            34456677889999999999999842      3567999999987655 7889999999999999999999999999999


Q ss_pred             ceEEEEeccCCCCHHHHHhhCCC-------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC
Q 007680          342 FKALVLEFMPNGSLEKWLYSHNY-------------FLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDE  408 (593)
Q Consensus       342 ~~~lv~e~~~~gsL~~~l~~~~~-------------~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~  408 (593)
                      ..|+|+|||..|||.+++.....             +++..+.+.||.|||.||+||-+++    +|||||..+|+||.+
T Consensus       563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~----FVHRDLATRNCLVge  638 (774)
T KOG1026|consen  563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH----FVHRDLATRNCLVGE  638 (774)
T ss_pred             eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc----ccccchhhhhceecc
Confidence            99999999999999999976432             3889999999999999999999554    999999999999999


Q ss_pred             CCcEEEEeeccceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHH
Q 007680          409 NMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRR  487 (593)
Q Consensus       409 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~  487 (593)
                      +..|||+|||+++..-..+.........-..+|||||.+..+++|.+||||||||+|||+++ |+.||.+...++     
T Consensus       639 ~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E-----  713 (774)
T KOG1026|consen  639 NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE-----  713 (774)
T ss_pred             ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH-----
Confidence            99999999999987654433222223445788999999999999999999999999999999 999998854432     


Q ss_pred             HHHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhhh
Q 007680          488 WVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKF  554 (593)
Q Consensus       488 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  554 (593)
                                  +++  ........+.+.+||.++++||..||+.+|.+||+++||-..|+.....-
T Consensus       714 ------------VIe--~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s  766 (774)
T KOG1026|consen  714 ------------VIE--CIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS  766 (774)
T ss_pred             ------------HHH--HHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence                        111  11222335667789999999999999999999999999999999875543

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-44  Score=353.30  Aligned_cols=258  Identities=28%  Similarity=0.379  Sum_probs=206.6

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCC--ceEEEE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPD--FKALVL  347 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~  347 (593)
                      ..+|...+.||+|+||+||++... +|...|||.+........+.+.+|+.+|.+++|||||+++|......  .+++.|
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m   95 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM   95 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence            346788899999999999999976 48999999998764334677899999999999999999999855554  689999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC-CCcEEEEeeccceecCCC
Q 007680          348 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDE-NMVAHVSDFGIYKLLGEG  426 (593)
Q Consensus       348 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~-~~~~kL~Dfg~a~~~~~~  426 (593)
                      ||+++|+|.+++...+..+++..+...++||++||+|||++    ||+||||||+|||++. ++.+||+|||++......
T Consensus        96 Ey~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~----g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~  171 (313)
T KOG0198|consen   96 EYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSK----GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESK  171 (313)
T ss_pred             eccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC----CEeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence            99999999999998775699999999999999999999954    5999999999999999 799999999999876641


Q ss_pred             -CCccccccccCCccccCccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhh
Q 007680          427 -EDSVRQTMTMATIGYMAPEYGLEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDAN  504 (593)
Q Consensus       427 -~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  504 (593)
                       ..........||+.|||||++.++ ...+++||||+||++.||+||++||.+...............            
T Consensus       172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~------------  239 (313)
T KOG0198|consen  172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRED------------  239 (313)
T ss_pred             cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccC------------
Confidence             111223446799999999999854 344699999999999999999999987411111111110000            


Q ss_pred             hhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHH
Q 007680          505 LVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKK  549 (593)
Q Consensus       505 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  549 (593)
                           .....+...+.+..+|+.+|++.||++||||.++++|---
T Consensus       240 -----~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~  279 (313)
T KOG0198|consen  240 -----SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL  279 (313)
T ss_pred             -----CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence                 0001122356688999999999999999999999998543

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-44  Score=363.66  Aligned_cols=270  Identities=24%  Similarity=0.397  Sum_probs=221.1

Q ss_pred             CHHHHHHhhhccccccccCccCcccEEEEEeCCCCeEEEEEeehhh--HHHHHHHHHHHHHHhhcCCCCcceeeeeeecC
Q 007680          263 SYLDIQRATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSYSNP  340 (593)
Q Consensus       263 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  340 (593)
                      +..++.+..+++.+.+.||+|+||+||+|+|.  ..||||+++...  ....+.|++|+..+++-+|.||+-+.|+|..+
T Consensus       383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p  460 (678)
T KOG0193|consen  383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP  460 (678)
T ss_pred             cccccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence            34667777788889999999999999999985  369999998753  45678999999999999999999999999998


Q ss_pred             CceEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccc
Q 007680          341 DFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIY  420 (593)
Q Consensus       341 ~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a  420 (593)
                      .. .||+.+|+|.+|+.+++..+..++....+.|++||++|+.|||.++    |+|||||..|||+.+++.|||+|||++
T Consensus       461 ~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~----IIHrDLKSnNIFl~~~~kVkIgDFGLa  535 (678)
T KOG0193|consen  461 PL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKN----IIHRDLKSNNIFLHEDLKVKIGDFGLA  535 (678)
T ss_pred             ce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhh----hhhhhccccceEEccCCcEEEecccce
Confidence            87 9999999999999999988878999999999999999999999655    999999999999999999999999998


Q ss_pred             eecCCCCCccccccccCCccccCccccCC---CCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCch
Q 007680          421 KLLGEGEDSVRQTMTMATIGYMAPEYGLE---GIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGL  497 (593)
Q Consensus       421 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  497 (593)
                      ..-..-..........|...|||||++..   .+|++.+||||||+|+|||+||..||.....+..              
T Consensus       536 tvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqI--------------  601 (678)
T KOG0193|consen  536 TVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQI--------------  601 (678)
T ss_pred             eeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhhe--------------
Confidence            76443222223344568888999998764   4699999999999999999999999974221111              


Q ss_pred             hhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhhh
Q 007680          498 TEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKF  554 (593)
Q Consensus       498 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  554 (593)
                      .-++-..... ........+|++++++|+..||+.++++||.+.+|+..|+++....
T Consensus       602 ifmVGrG~l~-pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~  657 (678)
T KOG0193|consen  602 IFMVGRGYLM-PDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSL  657 (678)
T ss_pred             EEEecccccC-ccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcc
Confidence            0001111000 1112233467889999999999999999999999999998887754

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.2e-43  Score=327.53  Aligned_cols=266  Identities=24%  Similarity=0.346  Sum_probs=213.0

Q ss_pred             hccccccccCccCcccEEEEEe-CCCCeEEEEEeehhhH--HHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEe
Q 007680          272 DEFNECNLLGTSSFGSVYKGTI-SDGTDVAIKVFNLQLE--RAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLE  348 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  348 (593)
                      ++|...+++|+|.||.||+|++ ++|+.||||.++....  .......+|++.|+.++|+||+.++++|.+.+...+|+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            4688899999999999999995 5899999999987532  224567899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCC
Q 007680          349 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGED  428 (593)
Q Consensus       349 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  428 (593)
                      |++. +|...++.....++..++..++.++++|++|||.+.    |+||||||.|+|++++|.+||+|||+|+.+.....
T Consensus        82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~----IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~  156 (318)
T KOG0659|consen   82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW----ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR  156 (318)
T ss_pred             eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh----hhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence            9965 999999998889999999999999999999999655    99999999999999999999999999999876554


Q ss_pred             ccccccccCCccccCccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHH--------hcCCc--h
Q 007680          429 SVRQTMTMATIGYMAPEYGLEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKE--------SLPHG--L  497 (593)
Q Consensus       429 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~--------~~~~~--~  497 (593)
                      ..  +..+-|.+|+|||.+.|. .|+...||||.|||+.||+.|.+-|.+.  ++.+....+-+        .+|+.  +
T Consensus       157 ~~--~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~--sDidQL~~If~~LGTP~~~~WP~~~~l  232 (318)
T KOG0659|consen  157 IQ--THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGD--SDIDQLSKIFRALGTPTPDQWPEMTSL  232 (318)
T ss_pred             cc--ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCC--chHHHHHHHHHHcCCCCcccCcccccc
Confidence            32  334789999999998875 5999999999999999999999887663  22222222221        12221  2


Q ss_pred             hhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          498 TEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       498 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      .+...-...+..........++.+..+|+.+|+..||.+|+|++|+++|
T Consensus       233 pdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  233 PDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             ccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            2222221111111111223456678999999999999999999999976

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-43  Score=346.19  Aligned_cols=262  Identities=23%  Similarity=0.307  Sum_probs=213.3

Q ss_pred             hhccccccccCccCcccEEEEE-eCCCCeEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEe
Q 007680          271 TDEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLE  348 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  348 (593)
                      .++|+..+.||.|..++||+|+ .+.+..||||++..+. ....+.+++|+..|+.++||||++++..|..+...|+||.
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp  104 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP  104 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence            5689999999999999999998 4578999999998764 3446889999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCC
Q 007680          349 FMPNGSLEKWLYSHNY-FLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGE  427 (593)
Q Consensus       349 ~~~~gsL~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~  427 (593)
                      ||.+|++.+.+...-. .+++..+..|++++++||.|||++|    .||||||+.||||+++|.|||+|||.+..+....
T Consensus       105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G----~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G  180 (516)
T KOG0582|consen  105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG----HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG  180 (516)
T ss_pred             hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC----ceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence            9999999999986433 5999999999999999999999665    9999999999999999999999999877765543


Q ss_pred             Ccc-cc-ccccCCccccCccccCC--CCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhh
Q 007680          428 DSV-RQ-TMTMATIGYMAPEYGLE--GIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDA  503 (593)
Q Consensus       428 ~~~-~~-~~~~gt~~y~aPE~~~~--~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  503 (593)
                      ... .. ....||++|||||++..  ..|+.|+||||||++..|+.+|..||.....-.+-+.. +....|.....    
T Consensus       181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~t-Lqn~pp~~~t~----  255 (516)
T KOG0582|consen  181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLT-LQNDPPTLLTS----  255 (516)
T ss_pred             ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHH-hcCCCCCcccc----
Confidence            221 11 45689999999999654  35999999999999999999999999875433222211 11111111100    


Q ss_pred             hhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          504 NLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                           ....+....++..+.+++..||.+||.+|||++++++|
T Consensus       256 -----~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh  293 (516)
T KOG0582|consen  256 -----GLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH  293 (516)
T ss_pred             -----cCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence                 11122333456689999999999999999999999986

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2e-43  Score=352.58  Aligned_cols=268  Identities=24%  Similarity=0.299  Sum_probs=213.6

Q ss_pred             hhccccccccCccCcccEEEEEe-CCCCeEEEEEeehhh--HHHHHHHHHHHHHHhhcCCCCcceeeeeeecC--CceEE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTI-SDGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSYSNP--DFKAL  345 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  345 (593)
                      .+.|+.+++||+|.||.||+|+. .+|+.||+|.++...  +.......+|+.||++++||||+++.+...+.  +.+|+
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl  195 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL  195 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence            56799999999999999999995 589999999998764  34456678999999999999999999988776  68999


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCC
Q 007680          346 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGE  425 (593)
Q Consensus       346 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~  425 (593)
                      |+|||+. ||..++....-.+++.++..+++|++.||+|+|.+    ||+|||||.+|||||.+|.+||+|||+|+++..
T Consensus       196 VFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~----gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~  270 (560)
T KOG0600|consen  196 VFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSR----GVLHRDIKGSNILIDNNGVLKIADFGLARFYTP  270 (560)
T ss_pred             EEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhc----CeeeccccccceEEcCCCCEEeccccceeeccC
Confidence            9999976 99999988777799999999999999999999954    599999999999999999999999999998866


Q ss_pred             CCCccccccccCCccccCccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHh--cC-Cch-h--
Q 007680          426 GEDSVRQTMTMATIGYMAPEYGLEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKES--LP-HGL-T--  498 (593)
Q Consensus       426 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~--~~-~~~-~--  498 (593)
                      .... ..+..+.|.+|+|||++.|. .|+.+.|+||.|||+.||++|++.|.+..  +......+...  .| +.. .  
T Consensus       271 ~~~~-~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~t--EveQl~kIfklcGSP~e~~W~~~  347 (560)
T KOG0600|consen  271 SGSA-PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRT--EVEQLHKIFKLCGSPTEDYWPVS  347 (560)
T ss_pred             CCCc-ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCcc--HHHHHHHHHHHhCCCChhccccc
Confidence            5432 35667889999999998876 59999999999999999999999998742  22222211111  01 111 1  


Q ss_pred             -----hhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          499 -----EVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       499 -----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                           ..+.+.......-.+....++....+|+..+|..||.+|.|+.+++++
T Consensus       348 kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s  400 (560)
T KOG0600|consen  348 KLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS  400 (560)
T ss_pred             cCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence                 111111110111122344567788999999999999999999999864

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-44  Score=354.28  Aligned_cols=267  Identities=24%  Similarity=0.295  Sum_probs=210.9

Q ss_pred             hhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHH-HHHHHHHHHHHHhhcC-CCCcceeeeeeecCC-ceEE
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLER-AFRSFDSECEVLRNVR-HRNLIKILSSYSNPD-FKAL  345 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~~l  345 (593)
                      ..++|..+++||.|.||.||+|+.. +|..||||.++..... +.-.-.+|++.|++++ ||||+++.+++.+.+ ..++
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f   87 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF   87 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence            4578999999999999999999954 7999999999876432 2223468999999998 999999999999888 9999


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCC
Q 007680          346 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGE  425 (593)
Q Consensus       346 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~  425 (593)
                      |||||+ .+|.+++..+++.+++..++.|+.||++||+|+|++|    +.|||+||+|||+.....+||+|||+|+.+..
T Consensus        88 VfE~Md-~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~G----fFHRDlKPENiLi~~~~~iKiaDFGLARev~S  162 (538)
T KOG0661|consen   88 VFEFMD-CNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHG----FFHRDLKPENILISGNDVIKIADFGLAREVRS  162 (538)
T ss_pred             eHHhhh-hhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcC----cccccCChhheEecccceeEeccccccccccc
Confidence            999995 5999999999889999999999999999999999766    99999999999999999999999999998765


Q ss_pred             CCCccccccccCCccccCccccC-CCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhc--CCc--hhh-
Q 007680          426 GEDSVRQTMTMATIGYMAPEYGL-EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESL--PHG--LTE-  499 (593)
Q Consensus       426 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~--~~~--~~~-  499 (593)
                      ..   ..+..+.|.+|+|||++. .+.|+.+.||||+|||++|+.+-++.|-+..+  .+..-.+.+.+  |..  +.+ 
T Consensus       163 kp---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE--~Dqi~KIc~VLGtP~~~~~~eg  237 (538)
T KOG0661|consen  163 KP---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASE--IDQIYKICEVLGTPDKDSWPEG  237 (538)
T ss_pred             CC---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcH--HHHHHHHHHHhCCCccccchhH
Confidence            44   345677999999999865 56799999999999999999999999877432  22222222111  111  111 


Q ss_pred             -----hhhhhhhhhhh-h-hhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          500 -----VVDANLVREEQ-A-FSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       500 -----~~~~~~~~~~~-~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                           .+.-.+..... . ..-...++.+..+++.+|+++||++||||+|+++|
T Consensus       238 ~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  238 YNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             HHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence                 11111100000 0 00112367789999999999999999999999987

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-43  Score=360.12  Aligned_cols=251  Identities=23%  Similarity=0.338  Sum_probs=213.2

Q ss_pred             hhccccccccCccCcccEEEEEe-CCCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEec
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTI-SDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEF  349 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  349 (593)
                      ...|...++||+|+.|.||.|.. .+++.||||++........+-+.+|+.+|+..+|+|||++++.|...+..++||||
T Consensus       272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy  351 (550)
T KOG0578|consen  272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY  351 (550)
T ss_pred             hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence            34688888999999999999984 47899999999887666667889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCc
Q 007680          350 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDS  429 (593)
Q Consensus       350 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~  429 (593)
                      |+||+|.+.+....  +++.++..|++++++||+|||.++    |+|||||.+|||++.+|.+||+|||++..+..... 
T Consensus       352 m~ggsLTDvVt~~~--~~E~qIA~Icre~l~aL~fLH~~g----IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-  424 (550)
T KOG0578|consen  352 MEGGSLTDVVTKTR--MTEGQIAAICREILQGLKFLHARG----IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-  424 (550)
T ss_pred             cCCCchhhhhhccc--ccHHHHHHHHHHHHHHHHHHHhcc----eeeeccccceeEeccCCcEEEeeeeeeeccccccC-
Confidence            99999999998766  899999999999999999999655    99999999999999999999999999998766543 


Q ss_pred             cccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhh
Q 007680          430 VRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREE  509 (593)
Q Consensus       430 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  509 (593)
                       .....+||++|||||+.....|+++.||||||++++||+-|++||-..   ....+-|....              ...
T Consensus       425 -KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE---~PlrAlyLIa~--------------ng~  486 (550)
T KOG0578|consen  425 -KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNE---NPLRALYLIAT--------------NGT  486 (550)
T ss_pred             -ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCC---ChHHHHHHHhh--------------cCC
Confidence             445568999999999999999999999999999999999999998641   11111111100              011


Q ss_pred             hhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          510 QAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       510 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      .....+...++.+.+|+.+||..||++|+++.|+|+|
T Consensus       487 P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  487 PKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             CCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence            1222334557789999999999999999999999987

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=3e-44  Score=373.42  Aligned_cols=257  Identities=25%  Similarity=0.467  Sum_probs=224.2

Q ss_pred             ccccccccCccCcccEEEEEeC----CCCeEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEE
Q 007680          273 EFNECNLLGTSSFGSVYKGTIS----DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVL  347 (593)
Q Consensus       273 ~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  347 (593)
                      ...+.++||.|.||.||+|+++    ....||||.++... ++...+|..|+.||.+++||||+++.|+.......+||+
T Consensus       630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT  709 (996)
T KOG0196|consen  630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT  709 (996)
T ss_pred             heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence            4567889999999999999975    24579999998763 567789999999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCC
Q 007680          348 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGE  427 (593)
Q Consensus       348 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~  427 (593)
                      |||++|+|+.+++.+.+.+++.+...++++|+.|++||-    ++++|||||.++||||+.+..+|++|||+++.+.++.
T Consensus       710 EyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLs----dm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~  785 (996)
T KOG0196|consen  710 EYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLS----DMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP  785 (996)
T ss_pred             hhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHh----hcCchhhhhhhhheeeccceEEEeccccceeecccCC
Confidence            999999999999999888999999999999999999999    5669999999999999999999999999999886655


Q ss_pred             Cccccccc--cCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhhhhh
Q 007680          428 DSVRQTMT--MATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDAN  504 (593)
Q Consensus       428 ~~~~~~~~--~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  504 (593)
                      .. ..+..  .-...|.|||.+...+++.++||||||++|||.++ |..||-++...+                 ++  +
T Consensus       786 ~~-~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd-----------------VI--k  845 (996)
T KOG0196|consen  786 EA-AYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD-----------------VI--K  845 (996)
T ss_pred             Cc-cccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH-----------------HH--H
Confidence            22 22222  23577999999999999999999999999999887 999998754332                 11  1


Q ss_pred             hhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhh
Q 007680          505 LVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVK  553 (593)
Q Consensus       505 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  553 (593)
                      -..+..+.+.+++||..+.+||..||++|-++||.+.||+..|.++...
T Consensus       846 aIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn  894 (996)
T KOG0196|consen  846 AIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN  894 (996)
T ss_pred             HHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence            1244567788999999999999999999999999999999999998754

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-43  Score=357.02  Aligned_cols=257  Identities=24%  Similarity=0.373  Sum_probs=215.2

Q ss_pred             hhhccccccccCccCcccEEEEEeCCCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEec
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEF  349 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  349 (593)
                      ..+....++-||+|+.|.||+|+++ ++.||||.++.-       -..+++-|++|+||||+.+.|+|.....+||||||
T Consensus       122 PFe~IsELeWlGSGaQGAVF~Grl~-netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEf  193 (904)
T KOG4721|consen  122 PFEEISELEWLGSGAQGAVFLGRLH-NETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEF  193 (904)
T ss_pred             CHHHhhhhhhhccCcccceeeeecc-CceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeec
Confidence            3445566789999999999999986 789999987533       23478889999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCc
Q 007680          350 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDS  429 (593)
Q Consensus       350 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~  429 (593)
                      |..|-|.+.++..+. ++......|..+||.|+.|||.+.    |||||||.-||||+.+..+||+|||.++...+..  
T Consensus       194 Ca~GqL~~VLka~~~-itp~llv~Wsk~IA~GM~YLH~hK----IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S--  266 (904)
T KOG4721|consen  194 CAQGQLYEVLKAGRP-ITPSLLVDWSKGIAGGMNYLHLHK----IIHRDLKSPNILISYDDVVKISDFGTSKELSDKS--  266 (904)
T ss_pred             cccccHHHHHhccCc-cCHHHHHHHHHHhhhhhHHHHHhh----HhhhccCCCceEeeccceEEeccccchHhhhhhh--
Confidence            999999999988775 888889999999999999999655    9999999999999999999999999998765432  


Q ss_pred             cccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhh
Q 007680          430 VRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREE  509 (593)
Q Consensus       430 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  509 (593)
                       ....+.||..|||||++.+.+.++|+||||||||||||+||..||.+.......   |               .+-...
T Consensus       267 -TkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAII---w---------------GVGsNs  327 (904)
T KOG4721|consen  267 -TKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAII---W---------------GVGSNS  327 (904)
T ss_pred             -hhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeE---E---------------eccCCc
Confidence             234468999999999999999999999999999999999999999774221110   0               000111


Q ss_pred             hhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhhhcchhhc
Q 007680          510 QAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKFLDDAAA  560 (593)
Q Consensus       510 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~~  560 (593)
                      ...+.+..|++.++-|+++||+..|..||++.+++.||+-...++.+...+
T Consensus       328 L~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pell~~tee  378 (904)
T KOG4721|consen  328 LHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPELLSTTEE  378 (904)
T ss_pred             ccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHHhcccHH
Confidence            234456678999999999999999999999999999999888776554443

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-42  Score=354.63  Aligned_cols=251  Identities=26%  Similarity=0.354  Sum_probs=206.6

Q ss_pred             HhhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehh----hH-HHHHHHHHHHHHHhhcC-CCCcceeeeeeecCC
Q 007680          269 RATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQ----LE-RAFRSFDSECEVLRNVR-HRNLIKILSSYSNPD  341 (593)
Q Consensus       269 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~  341 (593)
                      ...+.|.+.+.||+|+||.|+.|.+. +++.||+|++...    .. ...+.+.+|+.+++.++ ||||+++++++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            34568999999999999999999854 7899999987654    12 23456778999999998 999999999999999


Q ss_pred             ceEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCC-CcEEEEeeccc
Q 007680          342 FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDEN-MVAHVSDFGIY  420 (593)
Q Consensus       342 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~-~~~kL~Dfg~a  420 (593)
                      ..++||||+.||+|.+++.+ .+.+.+.++..+++|++.|++|+|.    .||+||||||+||+++.+ +.+||+|||++
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~----~gi~HRDLK~ENilld~~~~~~Kl~DFG~s  168 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHS----RGIVHRDLKPENILLDGNEGNLKLSDFGLS  168 (370)
T ss_pred             eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHh----CCEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence            99999999999999999999 4459999999999999999999995    459999999999999999 99999999999


Q ss_pred             eecCCCCCccccccccCCccccCccccCCCC-CC-ccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchh
Q 007680          421 KLLGEGEDSVRQTMTMATIGYMAPEYGLEGI-VS-AKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLT  498 (593)
Q Consensus       421 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  498 (593)
                      .....  ........+||+.|+|||++.+.. |+ .++||||+||++|.|++|+.||++....  .+...          
T Consensus       169 ~~~~~--~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~--~l~~k----------  234 (370)
T KOG0583|consen  169 AISPG--EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP--NLYRK----------  234 (370)
T ss_pred             cccCC--CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH--HHHHH----------
Confidence            98741  112345578999999999999877 75 7899999999999999999999872111  11110          


Q ss_pred             hhhhhhhhhhhhhhhhhHHH-HHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          499 EVVDANLVREEQAFSAKMDC-ILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       499 ~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                            +....  +..+..+ +.++..++.+||..||.+|+++.+++++
T Consensus       235 ------i~~~~--~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h  275 (370)
T KOG0583|consen  235 ------IRKGE--FKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEH  275 (370)
T ss_pred             ------HhcCC--ccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhC
Confidence                  11111  1111222 5688999999999999999999999954

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=3.7e-42  Score=355.57  Aligned_cols=261  Identities=26%  Similarity=0.427  Sum_probs=206.2

Q ss_pred             hhhccccccccCccCcccEEEEEe------CCCCeEEEEEeehhh-HHHHHHHHHHHHHHhhc-CCCCcceeeeeeecCC
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTI------SDGTDVAIKVFNLQL-ERAFRSFDSECEVLRNV-RHRNLIKILSSYSNPD  341 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  341 (593)
                      ..++|++.++||+|+||.||+|.+      .+++.||+|+++... ......+.+|+.++.++ +||||+++++++...+
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (338)
T cd05102           5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN   84 (338)
T ss_pred             chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence            457899999999999999999974      235689999987542 33456789999999999 8999999999887654


Q ss_pred             -ceEEEEeccCCCCHHHHHhhCC---------------------------------------------------------
Q 007680          342 -FKALVLEFMPNGSLEKWLYSHN---------------------------------------------------------  363 (593)
Q Consensus       342 -~~~lv~e~~~~gsL~~~l~~~~---------------------------------------------------------  363 (593)
                       ..++||||+++|+|.+++....                                                         
T Consensus        85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (338)
T cd05102          85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD  164 (338)
T ss_pred             CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence             5889999999999999987532                                                         


Q ss_pred             ----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCccccccccCCc
Q 007680          364 ----YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATI  439 (593)
Q Consensus       364 ----~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~  439 (593)
                          ..+++.++..++.|+++||+|||++    +|+||||||+||+++.++.+||+|||+++...............++.
T Consensus       165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~----~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~  240 (338)
T cd05102         165 DLWKSPLTMEDLICYSFQVARGMEFLASR----KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL  240 (338)
T ss_pred             ccccCCCCHHHHHHHHHHHHHHHHHHHHC----CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence                1377888999999999999999954    59999999999999999999999999998764433222223344677


Q ss_pred             cccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhhhhhhhhHHH
Q 007680          440 GYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDC  518 (593)
Q Consensus       440 ~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  518 (593)
                      .|+|||++.+..++.++|||||||++|||++ |..||......+ .+........                 ....+..+
T Consensus       241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~-~~~~~~~~~~-----------------~~~~~~~~  302 (338)
T cd05102         241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE-EFCQRLKDGT-----------------RMRAPENA  302 (338)
T ss_pred             cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH-HHHHHHhcCC-----------------CCCCCCCC
Confidence            8999999999999999999999999999997 999997632211 1111111000                 00011234


Q ss_pred             HHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhh
Q 007680          519 ILSIMDFALDCCMESPDMRINMTDAAAKLKKIKV  552 (593)
Q Consensus       519 ~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~  552 (593)
                      ++++.+++.+||+.||++|||+.|+++.|+++..
T Consensus       303 ~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         303 TPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            5678999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.4e-42  Score=349.25  Aligned_cols=247  Identities=27%  Similarity=0.418  Sum_probs=211.0

Q ss_pred             hccccccccCccCcccEEEEEeC-CCCeEEEEEeehh--hHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEe
Q 007680          272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQ--LERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLE  348 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  348 (593)
                      ++|.+.+.||+|+||.||+|+.+ +.+.||+|.+.+.  .+++.+.+.+|++|++.++||||+.++++|+...+.++|+|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            57889999999999999999966 7899999999765  35567789999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCC
Q 007680          349 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGED  428 (593)
Q Consensus       349 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  428 (593)
                      |+.| +|..++...+. ++++.+..++.|++.||.|||.    .+|.|||+||.||+++..+.+|++|||+|+.+..+. 
T Consensus        82 ~a~g-~L~~il~~d~~-lpEe~v~~~a~~LVsaL~yLhs----~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t-  154 (808)
T KOG0597|consen   82 YAVG-DLFTILEQDGK-LPEEQVRAIAYDLVSALYYLHS----NRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT-  154 (808)
T ss_pred             hhhh-hHHHHHHhccC-CCHHHHHHHHHHHHHHHHHHHh----cCcccccCCcceeeecCCCceeechhhhhhhcccCc-
Confidence            9976 99999988776 9999999999999999999995    559999999999999999999999999999876543 


Q ss_pred             ccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhh
Q 007680          429 SVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVRE  508 (593)
Q Consensus       429 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  508 (593)
                       ...+...||+.|||||+..+++|+..+|+||+||++||+++|++||....     +...+..             +..+
T Consensus       155 -~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s-----i~~Lv~~-------------I~~d  215 (808)
T KOG0597|consen  155 -SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS-----ITQLVKS-------------ILKD  215 (808)
T ss_pred             -eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH-----HHHHHHH-------------HhcC
Confidence             23455679999999999999999999999999999999999999996521     1111111             1111


Q ss_pred             hhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          509 EQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       509 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      ..  ..+...+..+..++...|.+||..|.+..+++.|
T Consensus       216 ~v--~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H  251 (808)
T KOG0597|consen  216 PV--KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH  251 (808)
T ss_pred             CC--CCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence            11  1122456688999999999999999999999976

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.8e-42  Score=352.93  Aligned_cols=248  Identities=24%  Similarity=0.332  Sum_probs=211.9

Q ss_pred             hccccccccCccCcccEEEEEe-CCCCeEEEEEeehhh---HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEE
Q 007680          272 DEFNECNLLGTSSFGSVYKGTI-SDGTDVAIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVL  347 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  347 (593)
                      .-|+..+.||.|+.|.|-+|++ .+|+.+|||++.+..   ......+.+|+-+|+-+.|||+++++++|++..++|+|.
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            4578889999999999999996 489999999998762   233456889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCC
Q 007680          348 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGE  427 (593)
Q Consensus       348 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~  427 (593)
                      ||+++|.|.+++-.++. +++.++.++++||+.|+.|+|.    .+|+|||+||+|+|+|..+.+||+|||+|..-.++.
T Consensus        92 Eyv~gGELFdylv~kG~-l~e~eaa~ff~QIi~gv~yCH~----~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk  166 (786)
T KOG0588|consen   92 EYVPGGELFDYLVRKGP-LPEREAAHFFRQILDGVSYCHA----FNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK  166 (786)
T ss_pred             EecCCchhHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHhh----hcceeccCCchhhhhhcccCEeeeccceeecccCCc
Confidence            99999999999988876 9999999999999999999995    459999999999999999999999999998654433


Q ss_pred             CccccccccCCccccCccccCCCCC-CccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhh
Q 007680          428 DSVRQTMTMATIGYMAPEYGLEGIV-SAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLV  506 (593)
Q Consensus       428 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  506 (593)
                         --...+|++.|.|||++.|.+| +.++||||.|||+|.|+||+.||++.     ++...            +.   +
T Consensus       167 ---lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd-----Nir~L------------Ll---K  223 (786)
T KOG0588|consen  167 ---LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD-----NIRVL------------LL---K  223 (786)
T ss_pred             ---cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc-----cHHHH------------HH---H
Confidence               2345689999999999999987 57899999999999999999999862     11111            11   1


Q ss_pred             hhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 007680          507 REEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKL  547 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  547 (593)
                      -....++.+..++.+..+|+++|+..||++|.|++||++|-
T Consensus       224 V~~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP  264 (786)
T KOG0588|consen  224 VQRGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHP  264 (786)
T ss_pred             HHcCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence            11223445566788999999999999999999999999984

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.3e-41  Score=342.74  Aligned_cols=254  Identities=22%  Similarity=0.337  Sum_probs=207.3

Q ss_pred             HhhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceE
Q 007680          269 RATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKA  344 (593)
Q Consensus       269 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  344 (593)
                      ...++|+.++.||+|+||.||+|+.+ +|..+|+|++++..   ....+.++.|-.+|...++|+||+++..|++.+..|
T Consensus       138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY  217 (550)
T KOG0605|consen  138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY  217 (550)
T ss_pred             CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence            35789999999999999999999965 79999999998764   445677889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecC
Q 007680          345 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG  424 (593)
Q Consensus       345 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~  424 (593)
                      |||||++|||+..+|...+. +++..+...+.+++.|++.+|+.    |++||||||+|+|||..|++||+|||++.-+.
T Consensus       218 LiMEylPGGD~mTLL~~~~~-L~e~~arfYiaE~vlAI~~iH~~----gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~  292 (550)
T KOG0605|consen  218 LIMEYLPGGDMMTLLMRKDT-LTEDWARFYIAETVLAIESIHQL----GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD  292 (550)
T ss_pred             EEEEecCCccHHHHHHhcCc-CchHHHHHHHHHHHHHHHHHHHc----CcccccCChhheeecCCCCEeeccccccchhh
Confidence            99999999999999988776 99999999999999999999965    49999999999999999999999999986432


Q ss_pred             CC----------------------CCc----c-------------------ccccccCCccccCccccCCCCCCccchHH
Q 007680          425 EG----------------------EDS----V-------------------RQTMTMATIGYMAPEYGLEGIVSAKCDVY  459 (593)
Q Consensus       425 ~~----------------------~~~----~-------------------~~~~~~gt~~y~aPE~~~~~~~s~~~Dvw  459 (593)
                      ..                      ...    .                   .....+|||.|+|||++.+..|+..+|.|
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW  372 (550)
T KOG0605|consen  293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW  372 (550)
T ss_pred             hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence            10                      000    0                   01123699999999999999999999999


Q ss_pred             HHHHHHHHHHhCCCCCCccccccc--hHHHHHHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCC
Q 007680          460 SYGVLLMETFTRKRPTDEMFIGEM--SLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMR  537 (593)
Q Consensus       460 SlGvvl~elltg~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R  537 (593)
                      |+|||+|||+.|.+||......+.  .+..|..                  .-.++....++.+..+||.+|+. ||++|
T Consensus       373 SLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~------------------~l~fP~~~~~s~eA~DLI~rll~-d~~~R  433 (550)
T KOG0605|consen  373 SLGCIMYEMLVGYPPFCSETPQETYRKIVNWRE------------------TLKFPEEVDLSDEAKDLITRLLC-DPENR  433 (550)
T ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhh------------------hccCCCcCcccHHHHHHHHHHhc-CHHHh
Confidence            999999999999999977432211  1111211                  11122223345688999999999 99999


Q ss_pred             CC---HHHHHHH
Q 007680          538 IN---MTDAAAK  546 (593)
Q Consensus       538 Ps---~~evl~~  546 (593)
                      ..   ++||.+|
T Consensus       434 LG~~G~~EIK~H  445 (550)
T KOG0605|consen  434 LGSKGAEEIKKH  445 (550)
T ss_pred             cCcccHHHHhcC
Confidence            85   5666543

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=9e-42  Score=324.36  Aligned_cols=267  Identities=23%  Similarity=0.318  Sum_probs=210.4

Q ss_pred             hhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHH--HHHHHHHHHHHHhhcCCCCcceeeeeeecC--CceE
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLER--AFRSFDSECEVLRNVRHRNLIKILSSYSNP--DFKA  344 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~  344 (593)
                      ..++|+.+++|++|.||.||+|+++ +++.||+|+++...+.  ..-...+|+.+|.+++|||||.+.++....  +..|
T Consensus        74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy  153 (419)
T KOG0663|consen   74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY  153 (419)
T ss_pred             cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence            4678999999999999999999975 7899999999876432  223467899999999999999999977543  5799


Q ss_pred             EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecC
Q 007680          345 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG  424 (593)
Q Consensus       345 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~  424 (593)
                      +|||||+. ||...+...+.++...++..++.|+++|++|||.+.    |+||||||+|+|+++.|.+||+|||+|+.++
T Consensus       154 ~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~w----ilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg  228 (419)
T KOG0663|consen  154 IVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNW----ILHRDLKTSNLLLSHKGILKIADFGLAREYG  228 (419)
T ss_pred             eeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhce----eEecccchhheeeccCCcEEecccchhhhhc
Confidence            99999976 999999999888999999999999999999999665    9999999999999999999999999999987


Q ss_pred             CCCCccccccccCCccccCccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhc--C-----Cc
Q 007680          425 EGEDSVRQTMTMATIGYMAPEYGLEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESL--P-----HG  496 (593)
Q Consensus       425 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~--~-----~~  496 (593)
                      ....  ..+..+-|.+|+|||.+.+. .|+++.|+||+|||+.||+++++.|.+.  ++.+....+-..+  |     +.
T Consensus       229 sp~k--~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~--sE~dQl~~If~llGtPte~iwpg  304 (419)
T KOG0663|consen  229 SPLK--PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGK--SEIDQLDKIFKLLGTPSEAIWPG  304 (419)
T ss_pred             CCcc--cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCC--chHHHHHHHHHHhCCCccccCCC
Confidence            6533  34556789999999998876 5999999999999999999999999874  3333332221111  1     11


Q ss_pred             hhhhhh---hhhhhhh-----hhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          497 LTEVVD---ANLVREE-----QAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       497 ~~~~~~---~~~~~~~-----~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      ..+.-.   .......     ..+... ..+..-.+|+..+|..||.+|.|++|.++|
T Consensus       305 ~~~lp~~k~~~f~~~pyn~lr~kF~~~-~lse~g~~Lln~llt~dP~kR~tA~~~L~h  361 (419)
T KOG0663|consen  305 YSELPAVKKMTFSEHPYNNLRKKFGAL-SLSEQGFDLLNKLLTYDPGKRITAEDGLKH  361 (419)
T ss_pred             ccccchhhccccCCCCchhhhhhcccc-ccchhHHHHHHHHhccCccccccHHHhhcc
Confidence            111000   0000000     011111 134677899999999999999999999986

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.9e-43  Score=343.01  Aligned_cols=250  Identities=27%  Similarity=0.376  Sum_probs=210.4

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEe
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLE  348 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  348 (593)
                      ...|+..+.||+|+||.||+|.+. +++.||+|++.... +...+.+++|+.++.+++++||.++|+.+..+...+++||
T Consensus        12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe   91 (467)
T KOG0201|consen   12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME   91 (467)
T ss_pred             ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence            345778899999999999999954 78999999998764 4557789999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCC
Q 007680          349 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGED  428 (593)
Q Consensus       349 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  428 (593)
                      ||.||++.+.+..... +.+.++.-++++++.|+.|||.++    .+|||||+.||++..+|.+||+|||.+..+.....
T Consensus        92 y~~gGsv~~lL~~~~~-~~E~~i~~ilre~l~~l~ylH~~~----kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~  166 (467)
T KOG0201|consen   92 YCGGGSVLDLLKSGNI-LDEFEIAVILREVLKGLDYLHSEK----KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK  166 (467)
T ss_pred             HhcCcchhhhhccCCC-CccceeeeehHHHHHHhhhhhhcc----eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence            9999999999987663 588888899999999999999654    99999999999999999999999999988765433


Q ss_pred             ccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhh
Q 007680          429 SVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVRE  508 (593)
Q Consensus       429 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  508 (593)
                        +....+||+.|||||++.+..|+.|+||||||++.+||.+|.+|+....+..  +.-.+....|              
T Consensus       167 --rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr--vlflIpk~~P--------------  228 (467)
T KOG0201|consen  167 --RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR--VLFLIPKSAP--------------  228 (467)
T ss_pred             --ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce--EEEeccCCCC--------------
Confidence              3356789999999999998899999999999999999999999998743211  0000111111              


Q ss_pred             hhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          509 EQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       509 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                       +..+  ..+++.+++|+..||++||+.||+|.++++|
T Consensus       229 -P~L~--~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  229 -PRLD--GDFSPPFKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             -Cccc--cccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence             1111  1456789999999999999999999999986

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=4.3e-41  Score=338.53  Aligned_cols=247  Identities=22%  Similarity=0.297  Sum_probs=201.0

Q ss_pred             cccCccCcccEEEEEeCCCCeEEEEEeehhhH---HHHHHHHHHHHHHhhcCCCCcceeeeeeec----CCceEEEEecc
Q 007680          278 NLLGTSSFGSVYKGTISDGTDVAIKVFNLQLE---RAFRSFDSECEVLRNVRHRNLIKILSSYSN----PDFKALVLEFM  350 (593)
Q Consensus       278 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~  350 (593)
                      ..||+|++|.||+|.+ +|+.||||+++....   ...+.+.+|+.++.+++||||+++++++.+    ....++||||+
T Consensus        26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~  104 (283)
T PHA02988         26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC  104 (283)
T ss_pred             eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence            6799999999999998 689999999976432   225678899999999999999999999876    34689999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCcc
Q 007680          351 PNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSV  430 (593)
Q Consensus       351 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~  430 (593)
                      ++|+|.+++.+.. .+++.....++.|++.||+|||+.   .+++||||||+||++++++.+||+|||+++.+....   
T Consensus       105 ~~g~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lH~~---~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~---  177 (283)
T PHA02988        105 TRGYLREVLDKEK-DLSFKTKLDMAIDCCKGLYNLYKY---TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP---  177 (283)
T ss_pred             CCCcHHHHHhhCC-CCChhHHHHHHHHHHHHHHHHHhc---CCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc---
Confidence            9999999998765 489999999999999999999963   258899999999999999999999999988654321   


Q ss_pred             ccccccCCccccCccccCC--CCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhh
Q 007680          431 RQTMTMATIGYMAPEYGLE--GIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVRE  508 (593)
Q Consensus       431 ~~~~~~gt~~y~aPE~~~~--~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  508 (593)
                        ....++..|+|||++.+  ..++.++|||||||++|||++|+.||......  .....+...                
T Consensus       178 --~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~--~~~~~i~~~----------------  237 (283)
T PHA02988        178 --FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK--EIYDLIINK----------------  237 (283)
T ss_pred             --ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHhc----------------
Confidence              23457889999999876  67999999999999999999999999764211  111111000                


Q ss_pred             hhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhh
Q 007680          509 EQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKV  552 (593)
Q Consensus       509 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~  552 (593)
                      ......+..++..+.+++.+||+.||++|||++|+++.|+.++.
T Consensus       238 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~  281 (283)
T PHA02988        238 NNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF  281 (283)
T ss_pred             CCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence            00111112356789999999999999999999999999998754

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-41  Score=315.45  Aligned_cols=237  Identities=26%  Similarity=0.310  Sum_probs=202.1

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALV  346 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  346 (593)
                      .++|++++.||.|+||.|.+++.+ +|..+|+|++++..   -+..+...+|..+|+.+.||+++++++.|.+.+..++|
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv  122 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV  122 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence            468999999999999999999976 78999999998764   34556778999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCC
Q 007680          347 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG  426 (593)
Q Consensus       347 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  426 (593)
                      |||++||.|..++++.+. +++..++-++.||+.||+|||    +.+|++||+||+|||+|.+|.+||+|||+|+.....
T Consensus       123 meyv~GGElFS~Lrk~~r-F~e~~arFYAAeivlAleylH----~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r  197 (355)
T KOG0616|consen  123 MEYVPGGELFSYLRKSGR-FSEPHARFYAAEIVLALEYLH----SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR  197 (355)
T ss_pred             EeccCCccHHHHHHhcCC-CCchhHHHHHHHHHHHHHHHH----hcCeeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence            999999999999998776 999999999999999999999    455999999999999999999999999999987532


Q ss_pred             CCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhh
Q 007680          427 EDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLV  506 (593)
Q Consensus       427 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  506 (593)
                           ....+||+.|+|||++....|+.++|.|||||++|||+.|.+||..... ...+.+.+.            ..+ 
T Consensus       198 -----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~-~~iY~KI~~------------~~v-  258 (355)
T KOG0616|consen  198 -----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP-IQIYEKILE------------GKV-  258 (355)
T ss_pred             -----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh-HHHHHHHHh------------Ccc-
Confidence                 3557899999999999999999999999999999999999999977432 111111111            111 


Q ss_pred             hhhhhhhhhHHHHHHHHHHHhhcccCCCCCC
Q 007680          507 REEQAFSAKMDCILSIMDFALDCCMESPDMR  537 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R  537 (593)
                            ..+.-++.++.+|+++.|+.|-.+|
T Consensus       259 ------~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  259 ------KFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             ------cCCcccCHHHHHHHHHHHhhhhHhh
Confidence                  1122335678999999999999988

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.6e-41  Score=343.23  Aligned_cols=251  Identities=22%  Similarity=0.290  Sum_probs=214.4

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh--HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCc-eEEE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDF-KALV  346 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lv  346 (593)
                      .++|..++++|+|+||.++.++++ +++.+|+|.+....  ....+...+|+.++++++|||||.+.+.|..++. .+||
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv   82 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV   82 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence            367999999999999999999976 68899999997653  4455678899999999999999999999999888 9999


Q ss_pred             EeccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCC
Q 007680          347 LEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGE  425 (593)
Q Consensus       347 ~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~  425 (593)
                      |+||+||++.+.+.+.+ ..+++..+..|+.|++.|+.|||++.    |+|||||+.|||++.++.|||+|||+|+.+..
T Consensus        83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~----iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~  158 (426)
T KOG0589|consen   83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR----VLHRDLKCANIFLTKDKKVKLGDFGLAKILNP  158 (426)
T ss_pred             EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh----hhcccchhhhhhccccCceeecchhhhhhcCC
Confidence            99999999999998876 47999999999999999999999554    99999999999999999999999999999876


Q ss_pred             CCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhh
Q 007680          426 GEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANL  505 (593)
Q Consensus       426 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  505 (593)
                      ...  ......||+.||+||++.+.+|+.|+|||||||++|||++-+++|....                 +...+....
T Consensus       159 ~~~--~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~-----------------m~~Li~ki~  219 (426)
T KOG0589|consen  159 EDS--LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASN-----------------MSELILKIN  219 (426)
T ss_pred             chh--hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccc-----------------hHHHHHHHh
Confidence            542  3455789999999999999999999999999999999999999997732                 111111111


Q ss_pred             hhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          506 VREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      ...  ..+.+..++.++..+++.|++.+|..||++.+++.+
T Consensus       220 ~~~--~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  220 RGL--YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             hcc--CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            111  122334557789999999999999999999999987

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=2.3e-40  Score=340.97  Aligned_cols=266  Identities=22%  Similarity=0.291  Sum_probs=208.2

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEe
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLE  348 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  348 (593)
                      .++|++.+.||+|+||.||+++.+ ++..||+|.+.... ......+.+|++++++++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            468999999999999999999976 68899999987653 3345678999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCC
Q 007680          349 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGED  428 (593)
Q Consensus       349 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  428 (593)
                      |+++++|.+++..... +++..+..++.|++.||.|||+++   +|+||||||+||+++.++.+||+|||++....... 
T Consensus        84 ~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~l~~lH~~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  158 (331)
T cd06649          84 HMDGGSLDQVLKEAKR-IPEEILGKVSIAVLRGLAYLREKH---QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-  158 (331)
T ss_pred             cCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHhhcC---CEEcCCCChhhEEEcCCCcEEEccCcccccccccc-
Confidence            9999999999987654 899999999999999999999632   59999999999999999999999999987654322 


Q ss_pred             ccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCc------------
Q 007680          429 SVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHG------------  496 (593)
Q Consensus       429 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~------------  496 (593)
                         .....|+..|+|||++.+..++.++|||||||++|||++|+.||......  .+...........            
T Consensus       159 ---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  233 (331)
T cd06649         159 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAK--ELEAIFGRPVVDGEEGEPHSISPRP  233 (331)
T ss_pred             ---cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHhcccccccccCCccccCccc
Confidence               23346899999999999989999999999999999999999999653221  1111111100000            


Q ss_pred             -------------------hhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 007680          497 -------------------LTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKL  547 (593)
Q Consensus       497 -------------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  547 (593)
                                         ..+..+... ...........++.++.+|+.+||+.||++|||+.|+++|-
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~  302 (331)
T cd06649         234 RPPGRPVSGHGMDSRPAMAIFELLDYIV-NEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT  302 (331)
T ss_pred             ccccccccccccccccchhHHHHHHHHH-hCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence                               000000000 00000000113456899999999999999999999999874

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-41  Score=369.97  Aligned_cols=261  Identities=27%  Similarity=0.432  Sum_probs=218.4

Q ss_pred             hhccccccccCccCcccEEEEEeC--CCC----eEEEEEeehh-hHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCce
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS--DGT----DVAIKVFNLQ-LERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFK  343 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  343 (593)
                      .+..+..+.||+|.||.||.|+..  +|.    .||+|.++.. +.....+|.+|..+|++++|||||+++|++.+....
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~  770 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP  770 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence            455677889999999999999965  343    3899998765 456678999999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEee
Q 007680          344 ALVLEFMPNGSLEKWLYSH------NYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDF  417 (593)
Q Consensus       344 ~lv~e~~~~gsL~~~l~~~------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df  417 (593)
                      ++++|||++|||..+|++.      ...++..+.+.++.|||+|+.||+++    ++|||||..+|+|++....|||+||
T Consensus       771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~----~fvHRDLAaRNCLL~~~r~VKIaDF  846 (1025)
T KOG1095|consen  771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK----HFVHRDLAARNCLLDERRVVKIADF  846 (1025)
T ss_pred             EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC----CCcCcchhhhheeecccCcEEEccc
Confidence            9999999999999999987      45799999999999999999999954    5999999999999999999999999


Q ss_pred             ccceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCc
Q 007680          418 GIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHG  496 (593)
Q Consensus       418 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~  496 (593)
                      |+|+.+...+.........-...|||||.+..+.++.|+|||||||++||++| |..||.+....+              
T Consensus       847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~--------------  912 (1025)
T KOG1095|consen  847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE--------------  912 (1025)
T ss_pred             chhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH--------------
Confidence            99995543332222222234578999999999999999999999999999999 999997743211              


Q ss_pred             hhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhhh
Q 007680          497 LTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKF  554 (593)
Q Consensus       497 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  554 (593)
                         ++..  ..+..+.+++..|+..+.++|.+||+.+|++||++..+++.+..+....
T Consensus       913 ---v~~~--~~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~  965 (1025)
T KOG1095|consen  913 ---VLLD--VLEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA  965 (1025)
T ss_pred             ---HHHH--HHhCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence               1111  1122256677789999999999999999999999999999998887664

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.7e-41  Score=326.55  Aligned_cols=248  Identities=24%  Similarity=0.334  Sum_probs=210.4

Q ss_pred             hhccccccccCccCcccEEEEEe-CCCCeEEEEEeehhh---HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTI-SDGTDVAIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALV  346 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  346 (593)
                      ..+|++.+.||+|.||.|-+|.. ..|+.||||.+++..   +.+.-.+.+|++||+.++||||+.++++|+..+...+|
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv  131 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV  131 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence            45799999999999999999984 689999999998763   44556789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCC
Q 007680          347 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG  426 (593)
Q Consensus       347 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  426 (593)
                      |||..+|.|.+|+...+. +++.++..+++||.+|+.|+|+++    ++|||||.+|||+|.++++||+|||++..+...
T Consensus       132 MEYaS~GeLYDYiSer~~-LsErEaRhfFRQIvSAVhYCHknr----VvHRDLKLENILLD~N~NiKIADFGLSNly~~~  206 (668)
T KOG0611|consen  132 MEYASGGELYDYISERGS-LSEREARHFFRQIVSAVHYCHKNR----VVHRDLKLENILLDQNNNIKIADFGLSNLYADK  206 (668)
T ss_pred             EEecCCccHHHHHHHhcc-ccHHHHHHHHHHHHHHHHHHhhcc----ceecccchhheeecCCCCeeeeccchhhhhccc
Confidence            999999999999998776 999999999999999999999655    999999999999999999999999999887654


Q ss_pred             CCccccccccCCccccCccccCCCCC-CccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhh
Q 007680          427 EDSVRQTMTMATIGYMAPEYGLEGIV-SAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANL  505 (593)
Q Consensus       427 ~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  505 (593)
                      .   ....++|++-|.+||+..+.+| ++.+|-|||||++|.++.|..||++..  ...+.+.+..              
T Consensus       207 k---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D--hk~lvrQIs~--------------  267 (668)
T KOG0611|consen  207 K---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD--HKRLVRQISR--------------  267 (668)
T ss_pred             c---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch--HHHHHHHhhc--------------
Confidence            3   3456789999999999999887 678999999999999999999998832  1111111111              


Q ss_pred             hhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 007680          506 VREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKL  547 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  547 (593)
                       +.....+.    +....-||+.||..+|++|-|+.+|..|-
T Consensus       268 -GaYrEP~~----PSdA~gLIRwmLmVNP~RRATieDiAsHW  304 (668)
T KOG0611|consen  268 -GAYREPET----PSDASGLIRWMLMVNPERRATIEDIASHW  304 (668)
T ss_pred             -ccccCCCC----CchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence             11111111    33567899999999999999999999874

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-41  Score=311.53  Aligned_cols=263  Identities=20%  Similarity=0.241  Sum_probs=213.2

Q ss_pred             hhhccccccccCccCcccEEEEE-eCCCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCC-----ce
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPD-----FK  343 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~  343 (593)
                      ..++|.+.+.||+|||+-||+++ ..+++.+|+|++.....+..+..++|++..++++|||+++++++...+.     ..
T Consensus        19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~   98 (302)
T KOG2345|consen   19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA   98 (302)
T ss_pred             cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence            45789999999999999999999 5589999999999887778889999999999999999999999875443     58


Q ss_pred             EEEEeccCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccc
Q 007680          344 ALVLEFMPNGSLEKWLYSH---NYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIY  420 (593)
Q Consensus       344 ~lv~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a  420 (593)
                      |++++|+..|+|.+.+...   +..+++.+++.|+.++++||++||+..  .+++||||||.||++++++.++|.|||.+
T Consensus        99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~--~~yAH~DiKP~NILls~~~~~vl~D~GS~  176 (302)
T KOG2345|consen   99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE--PPYAHRDIKPANILLSDSGLPVLMDLGSA  176 (302)
T ss_pred             EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC--CcccccCCCcceeEecCCCceEEEeccCc
Confidence            9999999999999998753   337999999999999999999999764  35999999999999999999999999998


Q ss_pred             eecCCCCCc-------cccccccCCccccCccccC---CCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHH
Q 007680          421 KLLGEGEDS-------VRQTMTMATIGYMAPEYGL---EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVK  490 (593)
Q Consensus       421 ~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~---~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~  490 (593)
                      ....-.-..       ........|..|+|||.+.   +...++++|||||||++|+|+.|..||+.....+.++.-.  
T Consensus       177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLA--  254 (302)
T KOG2345|consen  177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALA--  254 (302)
T ss_pred             cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEe--
Confidence            765321110       1112235789999999875   4567899999999999999999999998754433222111  


Q ss_pred             HhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHh
Q 007680          491 ESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKI  550 (593)
Q Consensus       491 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  550 (593)
                               +.     .....++....++..+.++++.|++.||.+||++.+++.+++.+
T Consensus       255 ---------v~-----n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L  300 (302)
T KOG2345|consen  255 ---------VQ-----NAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL  300 (302)
T ss_pred             ---------ee-----ccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence                     11     11112222233567899999999999999999999999999875

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8e-41  Score=338.09  Aligned_cols=245  Identities=24%  Similarity=0.296  Sum_probs=202.4

Q ss_pred             hccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEE
Q 007680          272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVL  347 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  347 (593)
                      ++|++.+.||+|+||.||+|..+ +++.||+|++....   ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            47889999999999999999975 78999999997643   234456889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCC
Q 007680          348 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGE  427 (593)
Q Consensus       348 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~  427 (593)
                      ||+++|+|.+++...+. +++..+..++.|++.||+|||++    +|+||||||+||++++++.+||+|||++.......
T Consensus        81 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~  155 (291)
T cd05612          81 EYVPGGELFSYLRNSGR-FSNSTGLFYASEIVCALEYLHSK----EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT  155 (291)
T ss_pred             eCCCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHC----CeeecCCCHHHeEECCCCCEEEEecCcchhccCCc
Confidence            99999999999987654 89999999999999999999965    59999999999999999999999999988654321


Q ss_pred             CccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhh
Q 007680          428 DSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVR  507 (593)
Q Consensus       428 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  507 (593)
                           ....|++.|+|||++.+..++.++|||||||++|||++|+.||......  .....+...           ..  
T Consensus       156 -----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~--~~~~~i~~~-----------~~--  215 (291)
T cd05612         156 -----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF--GIYEKILAG-----------KL--  215 (291)
T ss_pred             -----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhC-----------Cc--
Confidence                 2346899999999999888999999999999999999999999763211  111111100           00  


Q ss_pred             hhhhhhhhHHHHHHHHHHHhhcccCCCCCCCC-----HHHHHHH
Q 007680          508 EEQAFSAKMDCILSIMDFALDCCMESPDMRIN-----MTDAAAK  546 (593)
Q Consensus       508 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~  546 (593)
                           ..+...+..+.+++.+||+.||.+||+     ++|+++|
T Consensus       216 -----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         216 -----EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             -----CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence                 001122457899999999999999995     8888877

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.8e-40  Score=334.44  Aligned_cols=250  Identities=24%  Similarity=0.296  Sum_probs=201.5

Q ss_pred             cccccccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEec
Q 007680          274 FNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEF  349 (593)
Q Consensus       274 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  349 (593)
                      |+..+.||+|+||.||+|... +|+.||+|.+....   ......+.+|+.++++++|+||+++++++.+.+..++||||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            677889999999999999864 79999999987643   22334678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCC
Q 007680          350 MPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGED  428 (593)
Q Consensus       350 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  428 (593)
                      +++|+|.+++.... ..+++..+..++.|++.||+|||++    +|+||||||+||++++++.+||+|||++........
T Consensus        82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~----~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~  157 (285)
T cd05631          82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE----RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET  157 (285)
T ss_pred             cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC----CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe
Confidence            99999998886543 2589999999999999999999954    599999999999999999999999999987543221


Q ss_pred             ccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhh
Q 007680          429 SVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVRE  508 (593)
Q Consensus       429 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  508 (593)
                         .....|+..|+|||++.+..++.++|||||||++|||++|+.||........  ...+            +..+...
T Consensus       158 ---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~--~~~~------------~~~~~~~  220 (285)
T cd05631         158 ---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK--REEV------------DRRVKED  220 (285)
T ss_pred             ---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh--HHHH------------HHHhhcc
Confidence               2334689999999999999999999999999999999999999976322110  0000            0011000


Q ss_pred             hhhhhhhHHHHHHHHHHHhhcccCCCCCCCC-----HHHHHHH
Q 007680          509 EQAFSAKMDCILSIMDFALDCCMESPDMRIN-----MTDAAAK  546 (593)
Q Consensus       509 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~  546 (593)
                      .  .......+.++.+++.+||+.||++||+     ++++++|
T Consensus       221 ~--~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  261 (285)
T cd05631         221 Q--EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH  261 (285)
T ss_pred             c--ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence            0  0111234567899999999999999997     8888876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.8e-40  Score=347.23  Aligned_cols=259  Identities=22%  Similarity=0.350  Sum_probs=205.7

Q ss_pred             hhhccccccccCccCcccEEEEEe------CCCCeEEEEEeehhh-HHHHHHHHHHHHHHhhc-CCCCcceeeeeeecCC
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTI------SDGTDVAIKVFNLQL-ERAFRSFDSECEVLRNV-RHRNLIKILSSYSNPD  341 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  341 (593)
                      ..++|++.+.||+|+||.||+|++      .++..||+|+++... ....+.+.+|+.++..+ +||||+++++++...+
T Consensus        33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~  112 (375)
T cd05104          33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGG  112 (375)
T ss_pred             chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence            356799999999999999999973      246689999987542 33456788999999999 8999999999999999


Q ss_pred             ceEEEEeccCCCCHHHHHhhCC----------------------------------------------------------
Q 007680          342 FKALVLEFMPNGSLEKWLYSHN----------------------------------------------------------  363 (593)
Q Consensus       342 ~~~lv~e~~~~gsL~~~l~~~~----------------------------------------------------------  363 (593)
                      ..++||||+++|+|.+++....                                                          
T Consensus       113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (375)
T cd05104         113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG  192 (375)
T ss_pred             cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence            9999999999999999986532                                                          


Q ss_pred             ----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCC
Q 007680          364 ----------------YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGE  427 (593)
Q Consensus       364 ----------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~  427 (593)
                                      ..+++..+..++.|+++||+|||++    +|+||||||+||+++.++.+||+|||+++......
T Consensus       193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~  268 (375)
T cd05104         193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK----NCIHRDLAARNILLTHGRITKICDFGLARDIRNDS  268 (375)
T ss_pred             eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence                            1367888999999999999999964    59999999999999999999999999998765433


Q ss_pred             CccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhhhhhhh
Q 007680          428 DSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLV  506 (593)
Q Consensus       428 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  506 (593)
                      .........++..|+|||++.+..++.++|||||||++|||++ |..||...... ....+.+.....            
T Consensus       269 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~-~~~~~~~~~~~~------------  335 (375)
T cd05104         269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD-SKFYKMIKEGYR------------  335 (375)
T ss_pred             cccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch-HHHHHHHHhCcc------------
Confidence            2222222335677999999999999999999999999999998 88998764221 122222221110            


Q ss_pred             hhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHh
Q 007680          507 REEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKI  550 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  550 (593)
                           ...+...+.++.+++.+||+.||++||++.|+++.|++.
T Consensus       336 -----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         336 -----MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             -----CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence                 000112345789999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-41  Score=332.18  Aligned_cols=260  Identities=25%  Similarity=0.365  Sum_probs=204.6

Q ss_pred             HhhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhH--------------HHHHHHHHHHHHHhhcCCCCccee
Q 007680          269 RATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLE--------------RAFRSFDSECEVLRNVRHRNLIKI  333 (593)
Q Consensus       269 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~h~niv~l  333 (593)
                      +..++|++.+.||+|.||.|-+|+.. +++.||||++.+...              ...+...+|+.+|++++|||||++
T Consensus        94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L  173 (576)
T KOG0585|consen   94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL  173 (576)
T ss_pred             eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence            44678999999999999999999965 799999999976421              123578999999999999999999


Q ss_pred             eeeeecC--CceEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCc
Q 007680          334 LSSYSNP--DFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMV  411 (593)
Q Consensus       334 ~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~  411 (593)
                      +++..++  +..|||+|||..|.+...-.... .+++.++++++++++.||+|||.++    |+||||||+|+|++++|+
T Consensus       174 iEvLDDP~s~~~YlVley~s~G~v~w~p~d~~-els~~~Ar~ylrDvv~GLEYLH~Qg----iiHRDIKPsNLLl~~~g~  248 (576)
T KOG0585|consen  174 IEVLDDPESDKLYLVLEYCSKGEVKWCPPDKP-ELSEQQARKYLRDVVLGLEYLHYQG----IIHRDIKPSNLLLSSDGT  248 (576)
T ss_pred             EEeecCcccCceEEEEEeccCCccccCCCCcc-cccHHHHHHHHHHHHHHHHHHHhcC----eeccccchhheEEcCCCc
Confidence            9999876  58999999999887755332222 2899999999999999999999655    999999999999999999


Q ss_pred             EEEEeeccceecCCCCCc---cccccccCCccccCccccCCCC----CCccchHHHHHHHHHHHHhCCCCCCccccccch
Q 007680          412 AHVSDFGIYKLLGEGEDS---VRQTMTMATIGYMAPEYGLEGI----VSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMS  484 (593)
Q Consensus       412 ~kL~Dfg~a~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~----~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~  484 (593)
                      +||+|||.+.....+...   ......+||+.|+|||...++.    .+.+.||||+||+||.|+.|+.||.+.+.-   
T Consensus       249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~---  325 (576)
T KOG0585|consen  249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL---  325 (576)
T ss_pred             EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH---
Confidence            999999998876433211   1123368999999999876632    467899999999999999999999763211   


Q ss_pred             HHHHHHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhh
Q 007680          485 LRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIK  551 (593)
Q Consensus       485 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~  551 (593)
                                    +..+ ++..+...++...+....+.++|.++|.+||+.|.+..+|..|.---.
T Consensus       326 --------------~l~~-KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~  377 (576)
T KOG0585|consen  326 --------------ELFD-KIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTR  377 (576)
T ss_pred             --------------HHHH-HHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceecc
Confidence                          1111 122222223333345668899999999999999999999998865443

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.7e-40  Score=347.21  Aligned_cols=260  Identities=23%  Similarity=0.377  Sum_probs=206.1

Q ss_pred             HhhhccccccccCccCcccEEEEEeC------CCCeEEEEEeehhh-HHHHHHHHHHHHHHhhc-CCCCcceeeeeeecC
Q 007680          269 RATDEFNECNLLGTSSFGSVYKGTIS------DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNV-RHRNLIKILSSYSNP  340 (593)
Q Consensus       269 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  340 (593)
                      ...++|++.+.||+|+||.||+|...      ++..||+|.++... ......+.+|+.+++.+ +|+||+++++++...
T Consensus        35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~  114 (374)
T cd05106          35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG  114 (374)
T ss_pred             ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence            34568999999999999999999742      34579999997543 33456788999999999 899999999999999


Q ss_pred             CceEEEEeccCCCCHHHHHhhCC---------------------------------------------------------
Q 007680          341 DFKALVLEFMPNGSLEKWLYSHN---------------------------------------------------------  363 (593)
Q Consensus       341 ~~~~lv~e~~~~gsL~~~l~~~~---------------------------------------------------------  363 (593)
                      +..++||||+++|+|.+++....                                                         
T Consensus       115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (374)
T cd05106         115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS  194 (374)
T ss_pred             CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence            99999999999999999986421                                                         


Q ss_pred             ------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCccc
Q 007680          364 ------------YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVR  431 (593)
Q Consensus       364 ------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~  431 (593)
                                  ..+++.++.+++.|+++||+|||++    +|+||||||+||++++++.+||+|||+++..........
T Consensus       195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~----giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~  270 (374)
T cd05106         195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK----NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV  270 (374)
T ss_pred             ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC----CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceee
Confidence                        1367888999999999999999954    599999999999999999999999999987644332222


Q ss_pred             cccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhhh
Q 007680          432 QTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQ  510 (593)
Q Consensus       432 ~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  510 (593)
                      .....++..|+|||++.+..++.++|||||||++|||++ |+.||....... ...........                
T Consensus       271 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-~~~~~~~~~~~----------------  333 (374)
T cd05106         271 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-KFYKMVKRGYQ----------------  333 (374)
T ss_pred             ccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH-HHHHHHHcccC----------------
Confidence            222335678999999988899999999999999999997 999997642221 11111111000                


Q ss_pred             hhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHh
Q 007680          511 AFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKI  550 (593)
Q Consensus       511 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  550 (593)
                       ...+...++++.+++.+||+.||++|||+.++++.|+++
T Consensus       334 -~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~  372 (374)
T cd05106         334 -MSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ  372 (374)
T ss_pred             -ccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence             000111356789999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.4e-41  Score=306.37  Aligned_cols=249  Identities=23%  Similarity=0.307  Sum_probs=210.4

Q ss_pred             hhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEE
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKAL  345 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  345 (593)
                      +.++|++.+.||+|.||.||.|+.+ ++-.||+|++.+..   .....++.+|++|-+.++||||+++|++|.+....|+
T Consensus        20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL   99 (281)
T KOG0580|consen   20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL   99 (281)
T ss_pred             chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence            3578999999999999999999954 78889999997653   3445689999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecC
Q 007680          346 VLEFMPNGSLEKWLYSHNY-FLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG  424 (593)
Q Consensus       346 v~e~~~~gsL~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~  424 (593)
                      ++||..+|++...+...+. .+++.....+..|+|.||.|+|.    .+|+||||||+|+|++.++..|++|||.+..-.
T Consensus       100 ilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~----k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p  175 (281)
T KOG0580|consen  100 ILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHL----KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP  175 (281)
T ss_pred             EEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhcc----CCcccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence            9999999999999985443 58999999999999999999995    459999999999999999999999999987644


Q ss_pred             CCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhh
Q 007680          425 EGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDAN  504 (593)
Q Consensus       425 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  504 (593)
                      .    .+....+||..|.+||+..+..++..+|+|++|++.||++.|.+||+... .+..+.+...-             
T Consensus       176 ~----~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-~~etYkrI~k~-------------  237 (281)
T KOG0580|consen  176 S----NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS-HSETYKRIRKV-------------  237 (281)
T ss_pred             C----CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh-hHHHHHHHHHc-------------
Confidence            2    23455689999999999999999999999999999999999999998754 22122221110             


Q ss_pred             hhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          505 LVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       505 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                          .  ...+..++.+..++|.+|+.++|.+|.+..|+++|
T Consensus       238 ----~--~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  238 ----D--LKFPSTISGGAADLISRLLVKNPIERLALTEVMDH  273 (281)
T ss_pred             ----c--ccCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence                0  11113346678999999999999999999999987

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=3.7e-40  Score=335.44  Aligned_cols=263  Identities=24%  Similarity=0.357  Sum_probs=203.5

Q ss_pred             hhccccccccCccCcccEEEEEeCC-----------------CCeEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcce
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTISD-----------------GTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIK  332 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~  332 (593)
                      .++|.+.++||+|+||.||+|.+++                 +..||+|++.... ......+.+|++++.+++||||++
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            4678899999999999999997532                 3469999987643 334567899999999999999999


Q ss_pred             eeeeeecCCceEEEEeccCCCCHHHHHhhCC------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 007680          333 ILSSYSNPDFKALVLEFMPNGSLEKWLYSHN------------------YFLDILERLNIMIDVGSALEYLHNGHSSVHI  394 (593)
Q Consensus       333 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~------------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~i  394 (593)
                      +++++.+.+..++||||+++++|.+++....                  ..+++..+..++.|++.||+|||++    +|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~----~i  159 (304)
T cd05096          84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL----NF  159 (304)
T ss_pred             EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC----Cc
Confidence            9999999999999999999999999986532                  1367888999999999999999965    49


Q ss_pred             EecCCCCCCeeeCCCCcEEEEeeccceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh--CC
Q 007680          395 IHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT--RK  472 (593)
Q Consensus       395 vH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt--g~  472 (593)
                      +||||||+||+++.++.+||+|||+++.+.............++..|+|||++.++.++.++||||||+++|||++  +.
T Consensus       160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~  239 (304)
T cd05096         160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE  239 (304)
T ss_pred             cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCC
Confidence            9999999999999999999999999986644332222233445788999999988899999999999999999987  56


Q ss_pred             CCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHH
Q 007680          473 RPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKK  549 (593)
Q Consensus       473 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  549 (593)
                      .||......  ................          .....+..++..+.+++.+||+.||++|||+.|+.+.|++
T Consensus       240 ~p~~~~~~~--~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         240 QPYGELTDE--QVIENAGEFFRDQGRQ----------VYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             CCCCcCCHH--HHHHHHHHHhhhcccc----------ccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence            777653221  1111111110000000          0000112346688999999999999999999999988763

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-40  Score=321.40  Aligned_cols=272  Identities=25%  Similarity=0.282  Sum_probs=210.6

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeeh--hhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-----CCc
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNL--QLERAFRSFDSECEVLRNVRHRNLIKILSSYSN-----PDF  342 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~~  342 (593)
                      ...|...+.||+|+||.|+.|..+ +|+.||||.+..  ......++..+|+++++.++|+||+.+.+.+..     -..
T Consensus        21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D  100 (359)
T KOG0660|consen   21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND  100 (359)
T ss_pred             cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence            455666899999999999999965 799999999873  344566778899999999999999999998865     347


Q ss_pred             eEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeecccee
Q 007680          343 KALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKL  422 (593)
Q Consensus       343 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~  422 (593)
                      .|+|+|+| +.+|.+.++.... ++...+..++.|+++||+|+|    +.+|+|||+||+|++++.+...||+|||+|+.
T Consensus       101 vYiV~elM-etDL~~iik~~~~-L~d~H~q~f~YQiLrgLKyiH----SAnViHRDLKPsNll~n~~c~lKI~DFGLAR~  174 (359)
T KOG0660|consen  101 VYLVFELM-ETDLHQIIKSQQD-LTDDHAQYFLYQILRGLKYIH----SANVIHRDLKPSNLLLNADCDLKICDFGLARY  174 (359)
T ss_pred             eEEehhHH-hhHHHHHHHcCcc-ccHHHHHHHHHHHHHhcchhh----cccccccccchhheeeccCCCEEeccccceee
Confidence            89999999 6699999987765 899999999999999999999    45599999999999999999999999999998


Q ss_pred             cCCCCCccccccccCCccccCccccC-CCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCc----h
Q 007680          423 LGEGEDSVRQTMTMATIGYMAPEYGL-EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHG----L  497 (593)
Q Consensus       423 ~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~----~  497 (593)
                      ..........+..+.|.+|+|||++. ...|+.+.||||.|||+.||++|++-|.+.  +.......+....+..    +
T Consensus       175 ~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~--d~v~Ql~lI~~~lGtP~~e~l  252 (359)
T KOG0660|consen  175 LDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGK--DYVHQLQLILELLGTPSEEDL  252 (359)
T ss_pred             ccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCC--chHHHHHHHHHhcCCCCHHHH
Confidence            86543333446678999999999764 567999999999999999999999998763  2222222222222211    1


Q ss_pred             hhhhhhhhhh--------hhhh-hhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH--HHHh
Q 007680          498 TEVVDANLVR--------EEQA-FSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK--LKKI  550 (593)
Q Consensus       498 ~~~~~~~~~~--------~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~i  550 (593)
                      ..+-......        .... ........+...+|+.+||..||.+|+|++|+++|  |...
T Consensus       253 ~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~  316 (359)
T KOG0660|consen  253 QKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPY  316 (359)
T ss_pred             HHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhh
Confidence            1111111100        0000 01112445778999999999999999999999988  4444

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=2.4e-40  Score=336.70  Aligned_cols=269  Identities=22%  Similarity=0.289  Sum_probs=202.8

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhH-HHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEe
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLE-RAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLE  348 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  348 (593)
                      .++|++.+.||+|+||.||+|+.. +++.||+|+++.... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            478999999999999999999976 789999999875432 223457789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCC
Q 007680          349 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGED  428 (593)
Q Consensus       349 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  428 (593)
                      |++ ++|.+++......+++..+..++.|++.||+|||++    +|+||||||+||++++++.+||+|||++........
T Consensus        84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~----~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  158 (303)
T cd07869          84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR----YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH  158 (303)
T ss_pred             CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEECCCCCEEECCCCcceeccCCCc
Confidence            995 688888877666689999999999999999999955    499999999999999999999999999875432221


Q ss_pred             ccccccccCCccccCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHh-cCCc--hhhh----
Q 007680          429 SVRQTMTMATIGYMAPEYGLE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKES-LPHG--LTEV----  500 (593)
Q Consensus       429 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~-~~~~--~~~~----  500 (593)
                        ......+++.|+|||++.+ ..++.++||||+||++|||++|+.||.+.......+....... .+..  ....    
T Consensus       159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (303)
T cd07869         159 --TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLP  236 (303)
T ss_pred             --cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcc
Confidence              2233467899999998765 4588999999999999999999999976432222221111100 0000  0000    


Q ss_pred             -hhh-hhh---h-hhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          501 -VDA-NLV---R-EEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       501 -~~~-~~~---~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                       .++ ...   . ...........+..+.+++.+||+.||++|||+.|+++|
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h  288 (303)
T cd07869         237 HFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH  288 (303)
T ss_pred             ccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence             000 000   0 000000011124568899999999999999999999975

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.1e-40  Score=343.01  Aligned_cols=246  Identities=24%  Similarity=0.252  Sum_probs=203.0

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALV  346 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  346 (593)
                      .++|++.+.||+|+||.||+|+.+ +++.||+|+++...   ....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   96 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL   96 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence            467999999999999999999975 68999999998653   23446788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCC
Q 007680          347 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG  426 (593)
Q Consensus       347 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  426 (593)
                      |||+++|+|.+++..... +++..+..++.|++.||+|||++    +|+||||||+||+++.++.+||+|||+++.....
T Consensus        97 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~qi~~aL~~LH~~----~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  171 (329)
T PTZ00263         97 LEFVVGGELFTHLRKAGR-FPNDVAKFYHAELVLAFEYLHSK----DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR  171 (329)
T ss_pred             EcCCCCChHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHC----CeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence            999999999999987654 88999999999999999999965    4999999999999999999999999999876432


Q ss_pred             CCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhh
Q 007680          427 EDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLV  506 (593)
Q Consensus       427 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  506 (593)
                      .     ....|++.|+|||++.+..++.++|||||||++|||++|+.||......  ...+.+...           .. 
T Consensus       172 ~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~--~~~~~i~~~-----------~~-  232 (329)
T PTZ00263        172 T-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF--RIYEKILAG-----------RL-  232 (329)
T ss_pred             c-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH--HHHHHHhcC-----------Cc-
Confidence            2     2346899999999999999999999999999999999999999653211  111111100           00 


Q ss_pred             hhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCC-----HHHHHHH
Q 007680          507 REEQAFSAKMDCILSIMDFALDCCMESPDMRIN-----MTDAAAK  546 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~  546 (593)
                            ..+..++..+.+++.+||+.||++||+     ++++++|
T Consensus       233 ------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  271 (329)
T PTZ00263        233 ------KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH  271 (329)
T ss_pred             ------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence                  001113456789999999999999997     6888766

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=3.5e-40  Score=328.95  Aligned_cols=256  Identities=21%  Similarity=0.336  Sum_probs=206.5

Q ss_pred             hhccccccccCccCcccEEEEEeC----CCCeEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS----DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKAL  345 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  345 (593)
                      .++|++.+.||+|+||.||+|.++    .+..||+|.++... ......+.+|+.++.+++||||+++++++..++..++
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   83 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI   83 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence            467899999999999999999753    46789999987653 3344678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCC
Q 007680          346 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGE  425 (593)
Q Consensus       346 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~  425 (593)
                      ||||+++|+|.+++......+++.+++.++.|++.||+|||+++    ++||||||+||+++.++.++++|||.+.....
T Consensus        84 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~----iiH~dikp~nili~~~~~~~l~dfg~~~~~~~  159 (266)
T cd05064          84 VTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG----YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS  159 (266)
T ss_pred             EEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC----EeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence            99999999999999876556899999999999999999999654    99999999999999999999999998765322


Q ss_pred             CCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhhhhh
Q 007680          426 GEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDAN  504 (593)
Q Consensus       426 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  504 (593)
                      ... .......++..|+|||.+.+..++.++|||||||++||+++ |+.||......  ...+.+...            
T Consensus       160 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~--~~~~~~~~~------------  224 (266)
T cd05064         160 EAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ--DVIKAVEDG------------  224 (266)
T ss_pred             cch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--HHHHHHHCC------------
Confidence            111 11112235678999999999999999999999999999875 99999764221  111111110            


Q ss_pred             hhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHh
Q 007680          505 LVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKI  550 (593)
Q Consensus       505 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  550 (593)
                           ...+.+..++..+.+++.+||+.+|++||++.|+.+.|+++
T Consensus       225 -----~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         225 -----FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             -----CCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence                 00111234567889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=3.4e-40  Score=333.06  Aligned_cols=266  Identities=20%  Similarity=0.280  Sum_probs=202.7

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEe
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLE  348 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  348 (593)
                      .++|++.+.||+|+||.||+|..+ +++.||+|+++... ......+.+|++++++++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE   83 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence            357999999999999999999865 78999999987543 2233467789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCC
Q 007680          349 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGED  428 (593)
Q Consensus       349 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  428 (593)
                      |+++ +|.+++......+++..+..++.|++.||+|||++    +|+||||||+||++++++.+||+|||+++.......
T Consensus        84 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~----~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~  158 (288)
T cd07871          84 YLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR----KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK  158 (288)
T ss_pred             CCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence            9974 99999887666689999999999999999999954    599999999999999999999999999876543221


Q ss_pred             ccccccccCCccccCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCc----hhhhhh-
Q 007680          429 SVRQTMTMATIGYMAPEYGLE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHG----LTEVVD-  502 (593)
Q Consensus       429 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~-  502 (593)
                        ......+++.|+|||++.+ ..++.++||||+||++|||++|+.||......+.  ...........    +....+ 
T Consensus       159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T cd07871         159 --TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEE--LHLIFRLLGTPTEETWPGITSN  234 (288)
T ss_pred             --cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCChHHhhccccc
Confidence              1233467899999998765 5689999999999999999999999976422211  11111111100    111000 


Q ss_pred             --------hhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          503 --------ANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       503 --------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                              +..... .........+.+..+++.+||..||.+|||++|+++|
T Consensus       235 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h  285 (288)
T cd07871         235 EEFRSYLFPQYRAQ-PLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH  285 (288)
T ss_pred             hhhhccccCccCCC-chHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence                    000000 0000111234678999999999999999999999865

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.7e-40  Score=340.73  Aligned_cols=242  Identities=22%  Similarity=0.258  Sum_probs=197.7

Q ss_pred             cccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEeccCCC
Q 007680          278 NLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNG  353 (593)
Q Consensus       278 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  353 (593)
                      +.||+|+||.||+|+.+ +|+.||+|+++...   ......+.+|+.++++++||||+++++++...+..++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999865 78999999998653   234456788999999999999999999999999999999999999


Q ss_pred             CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCccccc
Q 007680          354 SLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQT  433 (593)
Q Consensus       354 sL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~  433 (593)
                      +|.+++...+. +++..+..++.|++.||+|||++    +|+||||||+||+++.++.+||+|||+++.......  ...
T Consensus        81 ~L~~~l~~~~~-~~~~~~~~~~~qi~~~L~~lH~~----~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~  153 (323)
T cd05571          81 ELFFHLSRERV-FSEDRARFYGAEIVSALGYLHSC----DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA--TMK  153 (323)
T ss_pred             cHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHhC----CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC--ccc
Confidence            99999987654 89999999999999999999955    599999999999999999999999999875322211  123


Q ss_pred             cccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhhhhhh
Q 007680          434 MTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQAFS  513 (593)
Q Consensus       434 ~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  513 (593)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||......  ........                ..  ..
T Consensus       154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~--~~~~~~~~----------------~~--~~  213 (323)
T cd05571         154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KLFELILM----------------EE--IR  213 (323)
T ss_pred             ceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH--HHHHHHHc----------------CC--CC
Confidence            356899999999999999999999999999999999999999653211  11111100                00  00


Q ss_pred             hhHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHHH
Q 007680          514 AKMDCILSIMDFALDCCMESPDMRI-----NMTDAAAK  546 (593)
Q Consensus       514 ~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  546 (593)
                      .+...+.++.+++.+||+.||++||     ++.++++|
T Consensus       214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  251 (323)
T cd05571         214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH  251 (323)
T ss_pred             CCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence            1122456789999999999999999     79999875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=5.4e-40  Score=330.51  Aligned_cols=257  Identities=25%  Similarity=0.475  Sum_probs=208.0

Q ss_pred             hhccccccccCccCcccEEEEEeCC------CCeEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCce
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTISD------GTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFK  343 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  343 (593)
                      .++|++.+.||+|+||.||+|...+      ...||+|.++... ......+.+|++++.+++||||+++++++...+..
T Consensus         4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T cd05048           4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT   83 (283)
T ss_pred             hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence            3578999999999999999998642      2579999987543 33456789999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC
Q 007680          344 ALVLEFMPNGSLEKWLYSHN---------------YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDE  408 (593)
Q Consensus       344 ~lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~  408 (593)
                      +++|||+++++|.+++....               ..+++.++..++.|++.||+|||++    +++|+||||+||++++
T Consensus        84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~----~i~H~dlkp~Nil~~~  159 (283)
T cd05048          84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH----HFVHRDLAARNCLVGE  159 (283)
T ss_pred             EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC----CeeccccccceEEEcC
Confidence            99999999999999997642               2478889999999999999999965    4999999999999999


Q ss_pred             CCcEEEEeeccceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHH
Q 007680          409 NMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRR  487 (593)
Q Consensus       409 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~  487 (593)
                      ++.++|+|||++................+++.|+|||++.+..++.++|||||||++|||++ |..||......  ....
T Consensus       160 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~--~~~~  237 (283)
T cd05048         160 GLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ--EVIE  237 (283)
T ss_pred             CCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHH
Confidence            99999999999886543332222233456788999999988899999999999999999998 99998764321  1111


Q ss_pred             HHHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHh
Q 007680          488 WVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKI  550 (593)
Q Consensus       488 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  550 (593)
                      .+...                 .....+..++.++.+++.+||+.||++||+++|++++|+++
T Consensus       238 ~i~~~-----------------~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~  283 (283)
T cd05048         238 MIRSR-----------------QLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW  283 (283)
T ss_pred             HHHcC-----------------CcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence            11110                 00111234677899999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=2.4e-40  Score=333.89  Aligned_cols=269  Identities=20%  Similarity=0.225  Sum_probs=202.9

Q ss_pred             hccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh--HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEe
Q 007680          272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLE  348 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  348 (593)
                      ++|++.+.||+|+||.||+|+.+ +++.||+|+++...  ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            46899999999999999999976 68899999987542  2334567889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCC
Q 007680          349 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGED  428 (593)
Q Consensus       349 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  428 (593)
                      |++++.+..+.. ....+++..+..++.|++.||+|||+.    +|+||||||+||+++.++.+||+|||++........
T Consensus        81 ~~~~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~----~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  155 (287)
T cd07848          81 YVEKNMLELLEE-MPNGVPPEKVRSYIYQLIKAIHWCHKN----DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN  155 (287)
T ss_pred             cCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence            998876665543 334589999999999999999999954    599999999999999999999999999987643322


Q ss_pred             ccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchH-HHHHHHhcCCchhhhh--hhh-
Q 007680          429 SVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSL-RRWVKESLPHGLTEVV--DAN-  504 (593)
Q Consensus       429 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~--~~~-  504 (593)
                      . ......+++.|+|||++.+..++.++|||||||++|||++|+.||......+... ........+.......  +.. 
T Consensus       156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (287)
T cd07848         156 A-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRF  234 (287)
T ss_pred             c-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchh
Confidence            1 1233468999999999988889999999999999999999999997642211100 0000000110000000  000 


Q ss_pred             -------hh-hhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          505 -------LV-REEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       505 -------~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                             .. ...........++.++.+++.+||+.||++|||++|+++|
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h  284 (287)
T cd07848         235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH  284 (287)
T ss_pred             cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                   00 0000001112346679999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-40  Score=340.87  Aligned_cols=253  Identities=21%  Similarity=0.264  Sum_probs=204.9

Q ss_pred             hccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEE
Q 007680          272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVL  347 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  347 (593)
                      ++|++.+.||+|+||.||+|+.. +++.||+|+++...   ......+.+|++++..++||||+++++++..++..++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            36899999999999999999976 68999999998653   234467889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCC
Q 007680          348 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGE  427 (593)
Q Consensus       348 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~  427 (593)
                      ||+++++|.+++..... +++..+..++.|++.||+|||++    +|+||||||+||+++.++.+||+|||++.....  
T Consensus        81 e~~~g~~L~~~l~~~~~-l~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--  153 (333)
T cd05600          81 EYVPGGDFRTLLNNLGV-LSEDHARFYMAEMFEAVDALHEL----GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--  153 (333)
T ss_pred             eCCCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHC----CccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence            99999999999976654 89999999999999999999965    499999999999999999999999999876543  


Q ss_pred             CccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhh
Q 007680          428 DSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVR  507 (593)
Q Consensus       428 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  507 (593)
                         ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+  ....+... ...    ...    
T Consensus       154 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~--~~~~i~~~-~~~----~~~----  219 (333)
T cd05600         154 ---YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE--TWENLKYW-KET----LQR----  219 (333)
T ss_pred             ---ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH--HHHHHHhc-ccc----ccC----
Confidence               1233568999999999999999999999999999999999999997632211  11111100 000    000    


Q ss_pred             hhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          508 EEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       508 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                       .........++.++.+++.+||..+|++||++.|+++|
T Consensus       220 -~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         220 -PVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             -CCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence             00000001345678999999999999999999999987

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-41  Score=345.27  Aligned_cols=265  Identities=27%  Similarity=0.406  Sum_probs=215.5

Q ss_pred             HHHhhhccccccccCccCcccEEEEEeCC--C---CeEEEEEeehh---hHHHHHHHHHHHHHHhhcCCCCcceeeeeee
Q 007680          267 IQRATDEFNECNLLGTSSFGSVYKGTISD--G---TDVAIKVFNLQ---LERAFRSFDSECEVLRNVRHRNLIKILSSYS  338 (593)
Q Consensus       267 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~--~---~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  338 (593)
                      ++...++....++||+|+||.||+|+.+.  +   ..||+|..+..   ......++.+|+++|++++|||||+++|+..
T Consensus       152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~  231 (474)
T KOG0194|consen  152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV  231 (474)
T ss_pred             cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence            34455666777999999999999998652  2   23899998852   3566788999999999999999999999999


Q ss_pred             cCCceEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeec
Q 007680          339 NPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFG  418 (593)
Q Consensus       339 ~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg  418 (593)
                      .....++|||+|.||+|.+++.+.+..++..+...++.++|.||+|||.+    +++||||..+|+|++.++.+||+|||
T Consensus       232 ~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k----~~IHRDIAARNcL~~~~~~vKISDFG  307 (474)
T KOG0194|consen  232 LEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSK----NCIHRDIAARNCLYSKKGVVKISDFG  307 (474)
T ss_pred             CCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHC----CCcchhHhHHHheecCCCeEEeCccc
Confidence            99999999999999999999999887799999999999999999999955    49999999999999999999999999


Q ss_pred             cceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCch
Q 007680          419 IYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGL  497 (593)
Q Consensus       419 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  497 (593)
                      +++.-..  .........-...|+|||.+..+.|++++|||||||++||+++ |..||.+....  ....++        
T Consensus       308 Ls~~~~~--~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~--~v~~kI--------  375 (474)
T KOG0194|consen  308 LSRAGSQ--YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY--EVKAKI--------  375 (474)
T ss_pred             cccCCcc--eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH--HHHHHH--------
Confidence            9875321  1111112235678999999999999999999999999999999 88899774322  112222        


Q ss_pred             hhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhhhc
Q 007680          498 TEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKFL  555 (593)
Q Consensus       498 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~  555 (593)
                              .....+...+...+..+..++.+||..+|++||+|.++.+.++.+.....
T Consensus       376 --------~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~  425 (474)
T KOG0194|consen  376 --------VKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE  425 (474)
T ss_pred             --------HhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence                    11112222222446788999999999999999999999999999876654

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-39  Score=324.89  Aligned_cols=257  Identities=25%  Similarity=0.434  Sum_probs=209.4

Q ss_pred             hhccccccccCccCcccEEEEEeC----CCCeEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS----DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKAL  345 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  345 (593)
                      .++|++.+.||+|+||.||+|.++    +...||+|.++... ......+.+|+.++++++||||+++++++...+..++
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   82 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI   82 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence            467999999999999999999874    24579999987543 3345678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCC
Q 007680          346 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGE  425 (593)
Q Consensus       346 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~  425 (593)
                      ||||+++++|.+++......+++..+..++.|++.||+|||++    +|+|+||||+||++++++.++|+|||+++....
T Consensus        83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~----~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  158 (266)
T cd05033          83 ITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEM----NYVHRDLAARNILVNSNLVCKVSDFGLSRRLED  158 (266)
T ss_pred             EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence            9999999999999987666789999999999999999999964    599999999999999999999999999987753


Q ss_pred             CCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhhhhh
Q 007680          426 GEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDAN  504 (593)
Q Consensus       426 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  504 (593)
                      ...........++..|+|||...+..++.++||||||+++|+|++ |..||......  ...+......           
T Consensus       159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~--~~~~~~~~~~-----------  225 (266)
T cd05033         159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ--DVIKAVEDGY-----------  225 (266)
T ss_pred             cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH--HHHHHHHcCC-----------
Confidence            222222222345678999999998899999999999999999998 99998653211  1111111100           


Q ss_pred             hhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHh
Q 007680          505 LVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKI  550 (593)
Q Consensus       505 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  550 (593)
                            ..+...+++..+.+++.+||+.+|++||++.|++++|+++
T Consensus       226 ------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         226 ------RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             ------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                  0011123456789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-42  Score=311.92  Aligned_cols=253  Identities=23%  Similarity=0.346  Sum_probs=208.1

Q ss_pred             hhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh--HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEE
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALV  346 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  346 (593)
                      ..+.|++.+.||+|.|+.||++.+. +|+.+|+|+++...  ....+.+.+|++|.+.++||||+++.+.+.+.+..|+|
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv   88 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   88 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence            4678999999999999999999854 89999999987542  34667899999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCC---CcEEEEeeccceec
Q 007680          347 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDEN---MVAHVSDFGIYKLL  423 (593)
Q Consensus       347 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~---~~~kL~Dfg~a~~~  423 (593)
                      +|+|+|++|..-|-.+. ..++..+-..++||+++|.|+|.++    |||||+||+|+++.+.   --+||+|||+|..+
T Consensus        89 Fe~m~G~dl~~eIV~R~-~ySEa~aSH~~rQiLeal~yCH~n~----IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l  163 (355)
T KOG0033|consen   89 FDLVTGGELFEDIVARE-FYSEADASHCIQQILEALAYCHSNG----IVHRDLKPENLLLASKAKGAAVKLADFGLAIEV  163 (355)
T ss_pred             EecccchHHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHhcC----ceeccCChhheeeeeccCCCceeecccceEEEe
Confidence            99999999977665543 3788899999999999999999655    9999999999999543   46999999999988


Q ss_pred             CCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhh
Q 007680          424 GEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDA  503 (593)
Q Consensus       424 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  503 (593)
                      +.+.   ......|||.|||||++...+|+..+|||+.||++|-++.|.+||.+...+  .+.+.+..           .
T Consensus       164 ~~g~---~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~--rlye~I~~-----------g  227 (355)
T KOG0033|consen  164 NDGE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH--RLYEQIKA-----------G  227 (355)
T ss_pred             CCcc---ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH--HHHHHHhc-----------c
Confidence            7332   345678999999999999999999999999999999999999999773211  11111111           0


Q ss_pred             hhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          504 NLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      ..   ....+++..++++..+|+++||..||++|.|+.|+++|
T Consensus       228 ~y---d~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H  267 (355)
T KOG0033|consen  228 AY---DYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKH  267 (355)
T ss_pred             cc---CCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence            11   11112344556788999999999999999999999875

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-40  Score=343.72  Aligned_cols=246  Identities=24%  Similarity=0.293  Sum_probs=205.3

Q ss_pred             HHHhhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhc-CCCCcceeeeeeecCC
Q 007680          267 IQRATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNV-RHRNLIKILSSYSNPD  341 (593)
Q Consensus       267 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  341 (593)
                      .....++|..+++||+|+||.|+++..+ +++.+|||++++..   .++.+....|.+|+... +||.+++++.+|+.++
T Consensus       363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~  442 (694)
T KOG0694|consen  363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE  442 (694)
T ss_pred             CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence            3445689999999999999999999976 78899999999864   45677888899998888 5999999999999999


Q ss_pred             ceEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccce
Q 007680          342 FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYK  421 (593)
Q Consensus       342 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~  421 (593)
                      +.|+||||+.||++..+.+..  .+++..+.-++..++.||+|||+++    ||+||||.+|||+|.+|.+||+|||+++
T Consensus       443 ~l~fvmey~~Ggdm~~~~~~~--~F~e~rarfyaAev~l~L~fLH~~~----IIYRDlKLdNiLLD~eGh~kiADFGlcK  516 (694)
T KOG0694|consen  443 HLFFVMEYVAGGDLMHHIHTD--VFSEPRARFYAAEVVLGLQFLHENG----IIYRDLKLDNLLLDTEGHVKIADFGLCK  516 (694)
T ss_pred             eEEEEEEecCCCcEEEEEecc--cccHHHHHHHHHHHHHHHHHHHhcC----ceeeecchhheEEcccCcEEeccccccc
Confidence            999999999999955444333  4999999999999999999999765    9999999999999999999999999998


Q ss_pred             ecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhh
Q 007680          422 LLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVV  501 (593)
Q Consensus       422 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  501 (593)
                      .--...  ...+..+||+.|||||++.+..|+.++|.|||||+||||+.|..||.+..++                 ++.
T Consensus       517 e~m~~g--~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe-----------------e~F  577 (694)
T KOG0694|consen  517 EGMGQG--DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE-----------------EVF  577 (694)
T ss_pred             ccCCCC--CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH-----------------HHH
Confidence            643222  2456789999999999999999999999999999999999999999873221                 222


Q ss_pred             hhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCH
Q 007680          502 DANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINM  540 (593)
Q Consensus       502 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  540 (593)
                      |.-+ .++..+  +..++.+..++++++|.++|++|-.+
T Consensus       578 dsI~-~d~~~y--P~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  578 DSIV-NDEVRY--PRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             HHHh-cCCCCC--CCcccHHHHHHHHHHhccCcccccCC
Confidence            2211 222222  23456788999999999999999855

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-40  Score=324.86  Aligned_cols=279  Identities=23%  Similarity=0.323  Sum_probs=209.0

Q ss_pred             hhccccccccCccCcccEEEEEeCCCCeEEEEEeehhhHHHHHHHHHHHHHHhhc--CCCCcceeeeeeecCC----ceE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNV--RHRNLIKILSSYSNPD----FKA  344 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~~----~~~  344 (593)
                      ....+..+.+|+|.||.||+|.+. ++.||||++...   ..+.|++|-+|.+..  +|+||++++++-....    .++
T Consensus       209 l~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw  284 (534)
T KOG3653|consen  209 LDPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW  284 (534)
T ss_pred             CCchhhHHHhhcCccceeehhhcc-CceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence            445667789999999999999985 699999999865   446788888888765  8999999999876655    889


Q ss_pred             EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCCeEecCCCCCCeeeCCCCcEEEEeecc
Q 007680          345 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGH-----SSVHIIHCDLKPTNILLDENMVAHVSDFGI  419 (593)
Q Consensus       345 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-----~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~  419 (593)
                      ||+||.+.|+|.+++..+-  ++|.+..+++..+++||+|||+..     ++++|+|||||+.||||.+|+++.|+|||+
T Consensus       285 LVt~fh~kGsL~dyL~~nt--isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL  362 (534)
T KOG3653|consen  285 LVTEFHPKGSLCDYLKANT--ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL  362 (534)
T ss_pred             EEeeeccCCcHHHHHHhcc--ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence            9999999999999998876  899999999999999999999743     256799999999999999999999999999


Q ss_pred             ceecCCCCCccccccccCCccccCccccCCCC-CC-----ccchHHHHHHHHHHHHhCCCCCCc--cccccchHHHHHHH
Q 007680          420 YKLLGEGEDSVRQTMTMATIGYMAPEYGLEGI-VS-----AKCDVYSYGVLLMETFTRKRPTDE--MFIGEMSLRRWVKE  491 (593)
Q Consensus       420 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-----~~~DvwSlGvvl~elltg~~pf~~--~~~~~~~~~~~~~~  491 (593)
                      |..+..+.........+||.+|||||++.+.. ..     .+.||||+|.|+|||+++-.-+..  ..+=...+..-+..
T Consensus       363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~  442 (534)
T KOG3653|consen  363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN  442 (534)
T ss_pred             eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence            99998766555555578999999999987643 12     369999999999999986543321  00001111111111


Q ss_pred             hcC-Cchhhhh-hhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhhhc
Q 007680          492 SLP-HGLTEVV-DANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKFL  555 (593)
Q Consensus       492 ~~~-~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~  555 (593)
                      +.. +++.+.+ ..+..+.-...-..-.....+.+.+..||..||+.|.|+.=+.+++.++..-.+
T Consensus       443 hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~  508 (534)
T KOG3653|consen  443 HPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE  508 (534)
T ss_pred             CCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence            100 0011111 111111111110111234578999999999999999999999999988876554

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=9.8e-40  Score=334.21  Aligned_cols=259  Identities=25%  Similarity=0.423  Sum_probs=207.5

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCC----eEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGT----DVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKA  344 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  344 (593)
                      ..+|+..+.||+|+||.||+|.+. +++    .||+|.++... ....+.+.+|+.+++.++||||+++++++... ..+
T Consensus         6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~   84 (316)
T cd05108           6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ   84 (316)
T ss_pred             hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence            357999999999999999999864 333    48999987543 34456788999999999999999999998765 567


Q ss_pred             EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecC
Q 007680          345 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG  424 (593)
Q Consensus       345 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~  424 (593)
                      +++||+++|+|.+++......+++..+..++.|++.||+|||++    +|+||||||+||++++++.+||+|||+++...
T Consensus        85 ~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~----~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~  160 (316)
T cd05108          85 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEER----RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  160 (316)
T ss_pred             eeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhc----CeeccccchhheEecCCCcEEEcccccccccc
Confidence            99999999999999988766689999999999999999999954    59999999999999999999999999998775


Q ss_pred             CCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhhhh
Q 007680          425 EGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDA  503 (593)
Q Consensus       425 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  503 (593)
                      ............++..|+|||++.+..++.++|||||||++|||++ |+.||.+....  .........           
T Consensus       161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~--~~~~~~~~~-----------  227 (316)
T cd05108         161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSILEKG-----------  227 (316)
T ss_pred             CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHhCC-----------
Confidence            4433222222334678999999999999999999999999999998 99999763211  111111110           


Q ss_pred             hhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhh
Q 007680          504 NLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVK  553 (593)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  553 (593)
                            ...+.+..++.++.+++.+||+.+|++||++.+++.++..+..+
T Consensus       228 ------~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~  271 (316)
T cd05108         228 ------ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  271 (316)
T ss_pred             ------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence                  00011122345789999999999999999999999999888654

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=2e-40  Score=329.41  Aligned_cols=249  Identities=31%  Similarity=0.504  Sum_probs=196.5

Q ss_pred             cccccCccCcccEEEEEeC-----CCCeEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEec
Q 007680          276 ECNLLGTSSFGSVYKGTIS-----DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEF  349 (593)
Q Consensus       276 ~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  349 (593)
                      +.+.||.|.||.||+|.+.     .+..|+||.++... ....+.+.+|++.+++++||||++++|++...+..++||||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            4578999999999999976     36779999996643 34478899999999999999999999999988889999999


Q ss_pred             cCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCC
Q 007680          350 MPNGSLEKWLYSH-NYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGED  428 (593)
Q Consensus       350 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  428 (593)
                      +++|+|.+++... ...+++..+..|+.|+++||+|||+++    ++|+||+++||++++++.+||+|||++........
T Consensus        83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~----iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~  158 (259)
T PF07714_consen   83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN----IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK  158 (259)
T ss_dssp             -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT----EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred             ccccccccccccccccccccccccccccccccccccccccc----ccccccccccccccccccccccccccccccccccc
Confidence            9999999999987 446999999999999999999999654    99999999999999999999999999987743332


Q ss_pred             ccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhh
Q 007680          429 SVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVR  507 (593)
Q Consensus       429 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  507 (593)
                      ............|+|||.+.+..++.++||||||+++||+++ |+.||.+....  .....+.                 
T Consensus       159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~--~~~~~~~-----------------  219 (259)
T PF07714_consen  159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNE--EIIEKLK-----------------  219 (259)
T ss_dssp             EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHH--HHHHHHH-----------------
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccc--ccccccc-----------------
Confidence            222333457788999999988889999999999999999999 78998664211  1111111                 


Q ss_pred             hhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 007680          508 EEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKL  547 (593)
Q Consensus       508 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  547 (593)
                      .......+..++..+.+++.+||+.||++|||+.++++.|
T Consensus       220 ~~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  220 QGQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             TTEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             ccccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            1111112233566889999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=2.2e-39  Score=321.13  Aligned_cols=252  Identities=25%  Similarity=0.344  Sum_probs=203.8

Q ss_pred             hhccccccccCccCcccEEEEEeCCCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEecc
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFM  350 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  350 (593)
                      .++|++.+.||+|+||.||++.++++..+|+|.+.... ...+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus         3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~   81 (256)
T cd05114           3 PSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM   81 (256)
T ss_pred             HHHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence            35788999999999999999998888899999886432 22357888999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCcc
Q 007680          351 PNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSV  430 (593)
Q Consensus       351 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~  430 (593)
                      ++|+|.+++......+++..+..++.|++.||+|||+++    ++||||||+||++++++.+||+|||.++........ 
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~----i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~-  156 (256)
T cd05114          82 ENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS----FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT-  156 (256)
T ss_pred             CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC----ccccccCcceEEEcCCCeEEECCCCCccccCCCcee-
Confidence            999999999865556899999999999999999999654    999999999999999999999999998765432211 


Q ss_pred             ccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhh
Q 007680          431 RQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREE  509 (593)
Q Consensus       431 ~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  509 (593)
                      ......++..|+|||+..+..++.++||||||+++|||++ |+.||.....  ......+......              
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~--~~~~~~i~~~~~~--------------  220 (256)
T cd05114         157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN--YEVVEMISRGFRL--------------  220 (256)
T ss_pred             ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHCCCCC--------------
Confidence            1122235668999999988889999999999999999999 8999966321  1111111111000              


Q ss_pred             hhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 007680          510 QAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKL  547 (593)
Q Consensus       510 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  547 (593)
                         ..+...+.++.+++.+||+.+|++||++.++++.|
T Consensus       221 ---~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         221 ---YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             ---CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence               00111245789999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=9.1e-40  Score=324.75  Aligned_cols=257  Identities=28%  Similarity=0.456  Sum_probs=212.3

Q ss_pred             HhhhccccccccCccCcccEEEEEeCCCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEe
Q 007680          269 RATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLE  348 (593)
Q Consensus       269 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  348 (593)
                      +...+|++.+.||+|+||.||+|..++++.+|+|++..........+.+|+.+++.++||||+++++++...+..++|||
T Consensus         3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   82 (261)
T cd05148           3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE   82 (261)
T ss_pred             CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence            34678999999999999999999988899999999987765556788999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCC
Q 007680          349 FMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGE  427 (593)
Q Consensus       349 ~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~  427 (593)
                      |+++++|.+++.... ..+++..+..++.|++.||+|||+++    ++|+||||+||++++++.+||+|||.+.......
T Consensus        83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~----i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~  158 (261)
T cd05148          83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN----SIHRDLAARNILVGEDLVCKVADFGLARLIKEDV  158 (261)
T ss_pred             ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC----eeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence            999999999998643 35899999999999999999999654    9999999999999999999999999988764332


Q ss_pred             CccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhhhhhhh
Q 007680          428 DSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLV  506 (593)
Q Consensus       428 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  506 (593)
                      ..  .....++..|+|||...+..++.++||||||+++|+|++ |+.||......  ...+......             
T Consensus       159 ~~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~--~~~~~~~~~~-------------  221 (261)
T cd05148         159 YL--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH--EVYDQITAGY-------------  221 (261)
T ss_pred             cc--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH--HHHHHHHhCC-------------
Confidence            11  123345678999999988899999999999999999998 89999663211  1111111100             


Q ss_pred             hhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHh
Q 007680          507 REEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKI  550 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  550 (593)
                          ..+.+..+++.+.+++.+||+.||.+|||+.++++.|+.+
T Consensus       222 ----~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         222 ----RMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             ----cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence                0111123456789999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=8.2e-40  Score=335.63  Aligned_cols=242  Identities=21%  Similarity=0.254  Sum_probs=197.1

Q ss_pred             cccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEeccCCC
Q 007680          278 NLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNG  353 (593)
Q Consensus       278 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  353 (593)
                      +.||+|+||.||+++.. +|+.||+|+++...   ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            46999999999999965 78999999998653   234456778999999999999999999999999999999999999


Q ss_pred             CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCccccc
Q 007680          354 SLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQT  433 (593)
Q Consensus       354 sL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~  433 (593)
                      +|.+++.... .+++..+..++.|++.||+|||++    +|+||||||+||+++.++.+||+|||++........  ...
T Consensus        81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~  153 (323)
T cd05595          81 ELFFHLSRER-VFTEERARFYGAEIVSALEYLHSR----DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMK  153 (323)
T ss_pred             cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC--ccc
Confidence            9999887665 489999999999999999999955    599999999999999999999999999875322221  123


Q ss_pred             cccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhhhhhh
Q 007680          434 MTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQAFS  513 (593)
Q Consensus       434 ~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  513 (593)
                      ...|++.|+|||++.+..++.++|||||||++|||++|+.||.......  ......   ..        .     .  .
T Consensus       154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~--~~~~~~---~~--------~-----~--~  213 (323)
T cd05595         154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER--LFELIL---ME--------E-----I--R  213 (323)
T ss_pred             cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH--HHHHHh---cC--------C-----C--C
Confidence            3468999999999999999999999999999999999999996532111  111000   00        0     0  0


Q ss_pred             hhHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHHH
Q 007680          514 AKMDCILSIMDFALDCCMESPDMRI-----NMTDAAAK  546 (593)
Q Consensus       514 ~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  546 (593)
                      .+..+++++.+++.+||+.||++||     ++.++++|
T Consensus       214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h  251 (323)
T cd05595         214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  251 (323)
T ss_pred             CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence            1123456789999999999999998     88888876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.3e-39  Score=342.14  Aligned_cols=260  Identities=22%  Similarity=0.390  Sum_probs=206.6

Q ss_pred             hhhccccccccCccCcccEEEEEeC------CCCeEEEEEeehhh-HHHHHHHHHHHHHHhhcC-CCCcceeeeeeecCC
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTIS------DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVR-HRNLIKILSSYSNPD  341 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~  341 (593)
                      ..++|.+.+.||+|+||.||+|.+.      .+..||||+++... ....+.+.+|+++++++. ||||+++++++.+.+
T Consensus        35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~  114 (400)
T cd05105          35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG  114 (400)
T ss_pred             cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence            3568999999999999999999853      23469999997543 334567899999999996 999999999999999


Q ss_pred             ceEEEEeccCCCCHHHHHhhCC----------------------------------------------------------
Q 007680          342 FKALVLEFMPNGSLEKWLYSHN----------------------------------------------------------  363 (593)
Q Consensus       342 ~~~lv~e~~~~gsL~~~l~~~~----------------------------------------------------------  363 (593)
                      ..++||||+++|+|.+++....                                                          
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (400)
T cd05105         115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI  194 (400)
T ss_pred             ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence            9999999999999999886531                                                          


Q ss_pred             -------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeee
Q 007680          364 -------------------------------------YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILL  406 (593)
Q Consensus       364 -------------------------------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll  406 (593)
                                                           ..+++.++..++.|+++||+|||++    +|+||||||+||++
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~----~ivH~dikp~Nill  270 (400)
T cd05105         195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK----NCVHRDLAARNVLL  270 (400)
T ss_pred             hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCChHhEEE
Confidence                                                 1367888899999999999999954    59999999999999


Q ss_pred             CCCCcEEEEeeccceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchH
Q 007680          407 DENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSL  485 (593)
Q Consensus       407 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~  485 (593)
                      ++++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||........ .
T Consensus       271 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~-~  349 (400)
T cd05105         271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST-F  349 (400)
T ss_pred             eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH-H
Confidence            9999999999999987644332222233456788999999988899999999999999999997 9999876322111 1


Q ss_pred             HHHHHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhh
Q 007680          486 RRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIK  551 (593)
Q Consensus       486 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~  551 (593)
                      ...+...                 ........++.++.+++.+||+.||++||++.++.+.|+++.
T Consensus       350 ~~~~~~~-----------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~  398 (400)
T cd05105         350 YNKIKSG-----------------YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL  398 (400)
T ss_pred             HHHHhcC-----------------CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence            1111100                 001112234668899999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.8e-39  Score=334.50  Aligned_cols=265  Identities=22%  Similarity=0.290  Sum_probs=205.1

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEe
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLE  348 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  348 (593)
                      .++|++.++||+|+||.||++.+. ++..+|+|.++... ......+.+|++++++++||||+++++++.+.+..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            478999999999999999999976 68889999887642 3345678999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCC
Q 007680          349 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGED  428 (593)
Q Consensus       349 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  428 (593)
                      |+++++|.+++...+. +++..+..++.|++.||+|||+.   .+++||||||+||++++++.+||+|||++....... 
T Consensus        84 ~~~~~~L~~~l~~~~~-~~~~~~~~~~~~l~~~l~~lH~~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-  158 (333)
T cd06650          84 HMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLREK---HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-  158 (333)
T ss_pred             cCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHhc---CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc-
Confidence            9999999999987554 88999999999999999999963   259999999999999999999999999987653321 


Q ss_pred             ccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCc------------
Q 007680          429 SVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHG------------  496 (593)
Q Consensus       429 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~------------  496 (593)
                         .....++..|+|||++.+..++.++|||||||++|||++|+.||.......  ............            
T Consensus       159 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  233 (333)
T cd06650         159 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKE--LELMFGCPVEGDPAESETSPRPRP  233 (333)
T ss_pred             ---cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhH--HHHHhcCcccCCccccccCcccCC
Confidence               123468899999999998889999999999999999999999997532211  111100000000            


Q ss_pred             -----------------hhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          497 -----------------LTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       497 -----------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                                       .....+.......... .....+.++.+++.+||+.||++|||+.|+++|
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h  299 (333)
T cd06650         234 PGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKL-PSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH  299 (333)
T ss_pred             ccchhhhhcccccccccHHHHHHHHhcCCCccC-CCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence                             0000000000000000 001134678999999999999999999999876

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=3.2e-39  Score=324.30  Aligned_cols=256  Identities=29%  Similarity=0.461  Sum_probs=206.2

Q ss_pred             hhccccccccCccCcccEEEEEeC------CCCeEEEEEeehhhHH-HHHHHHHHHHHHhhcCCCCcceeeeeeecCCce
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS------DGTDVAIKVFNLQLER-AFRSFDSECEVLRNVRHRNLIKILSSYSNPDFK  343 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  343 (593)
                      .++|.+.+.||+|+||.||+|...      +++.||+|.++..... ..+.+.+|+++++.++||||+++++++...+..
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   83 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP   83 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence            457889999999999999999863      3478999998765433 457899999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhCC-------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC
Q 007680          344 ALVLEFMPNGSLEKWLYSHN-------------YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENM  410 (593)
Q Consensus       344 ~lv~e~~~~gsL~~~l~~~~-------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~  410 (593)
                      ++||||+++++|.+++...+             ..+++.++..++.|++.|++|||++    +++||||||+||+++.++
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~----~i~h~dlkp~nili~~~~  159 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ----HFVHRDLATRNCLVGYDL  159 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC----CeeccccccceEEEcCCC
Confidence            99999999999999997643             2478889999999999999999955    599999999999999999


Q ss_pred             cEEEEeeccceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHH
Q 007680          411 VAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWV  489 (593)
Q Consensus       411 ~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~  489 (593)
                      .+||+|||.+................++..|+|||++.+..++.++|||||||++|||++ |+.||......+  .....
T Consensus       160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~--~~~~~  237 (280)
T cd05049         160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE--VIECI  237 (280)
T ss_pred             eEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH--HHHHH
Confidence            999999999876543322112223345788999999999999999999999999999998 999986532211  11111


Q ss_pred             HHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHH
Q 007680          490 KESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKK  549 (593)
Q Consensus       490 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  549 (593)
                      .....                 ......++..+.+++.+||+.||++||++.|+++.|++
T Consensus       238 ~~~~~-----------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         238 TQGRL-----------------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             HcCCc-----------------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence            11000                 00112345678999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=4.7e-39  Score=324.71  Aligned_cols=260  Identities=27%  Similarity=0.424  Sum_probs=210.3

Q ss_pred             hhccccccccCccCcccEEEEEeC------CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS------DGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKA  344 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  344 (593)
                      .++|.+.+.||+|+||.||++...      ++..+|+|.+........+.+.+|++++++++||||+++++++...+..+
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   83 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence            467899999999999999999742      34568999987665556678999999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhhCC------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcE
Q 007680          345 LVLEFMPNGSLEKWLYSHN------------YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVA  412 (593)
Q Consensus       345 lv~e~~~~gsL~~~l~~~~------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~  412 (593)
                      +||||+++++|.+++....            ..+++..+..++.|++.||+|||++    +++||||||+||++++++.+
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~----~i~H~dlkp~Nili~~~~~~  159 (288)
T cd05093          84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ----HFVHRDLATRNCLVGENLLV  159 (288)
T ss_pred             EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC----CeeecccCcceEEEccCCcE
Confidence            9999999999999997543            1489999999999999999999965    49999999999999999999


Q ss_pred             EEEeeccceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHH
Q 007680          413 HVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKE  491 (593)
Q Consensus       413 kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~  491 (593)
                      ||+|||++................++..|+|||++.+..++.++|||||||++|||++ |..||......+  ....+..
T Consensus       160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~--~~~~i~~  237 (288)
T cd05093         160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE--VIECITQ  237 (288)
T ss_pred             EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHc
Confidence            9999999886543322222233345778999999988899999999999999999998 999986642211  1111111


Q ss_pred             hcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhh
Q 007680          492 SLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVK  553 (593)
Q Consensus       492 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  553 (593)
                      ...                 ......++.++.+++.+||+.||.+|||+.|+.+.|+++...
T Consensus       238 ~~~-----------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~  282 (288)
T cd05093         238 GRV-----------------LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA  282 (288)
T ss_pred             CCc-----------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence            000                 000112345789999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-39  Score=333.29  Aligned_cols=240  Identities=25%  Similarity=0.292  Sum_probs=195.0

Q ss_pred             cCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEeccCCCCH
Q 007680          280 LGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSL  355 (593)
Q Consensus       280 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  355 (593)
                      ||+|+||.||+|+.. +++.||+|+++...   ......+.+|+.++.+++||||+++++++...+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            799999999999975 68899999997642   33456778899999999999999999999999999999999999999


Q ss_pred             HHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCccccccc
Q 007680          356 EKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMT  435 (593)
Q Consensus       356 ~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~  435 (593)
                      .+++..... +++..+..++.|++.||+|||++    +|+||||||+||+++.++.+||+|||+++.......  .....
T Consensus        81 ~~~l~~~~~-~~~~~~~~~~~qi~~~l~~lH~~----~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~~~  153 (312)
T cd05585          81 FHHLQREGR-FDLSRARFYTAELLCALENLHKF----NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--KTNTF  153 (312)
T ss_pred             HHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhC----CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC--ccccc
Confidence            999977654 89999999999999999999954    599999999999999999999999999875432221  22345


Q ss_pred             cCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhhhhhhhh
Q 007680          436 MATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAK  515 (593)
Q Consensus       436 ~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  515 (593)
                      .||+.|+|||++.+..++.++|||||||++|||++|+.||......     .........             .  ...+
T Consensus       154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~-----~~~~~~~~~-------------~--~~~~  213 (312)
T cd05585         154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN-----EMYRKILQE-------------P--LRFP  213 (312)
T ss_pred             cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH-----HHHHHHHcC-------------C--CCCC
Confidence            6899999999999999999999999999999999999999753211     111111000             0  0111


Q ss_pred             HHHHHHHHHHHhhcccCCCCCCCC---HHHHHHH
Q 007680          516 MDCILSIMDFALDCCMESPDMRIN---MTDAAAK  546 (593)
Q Consensus       516 ~~~~~~l~~li~~cl~~dP~~RPs---~~evl~~  546 (593)
                      ..+++++.+++.+||+.||++||+   +.|++.|
T Consensus       214 ~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h  247 (312)
T cd05585         214 DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH  247 (312)
T ss_pred             CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence            234567899999999999999985   6677665

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.5e-39  Score=334.42  Aligned_cols=271  Identities=21%  Similarity=0.258  Sum_probs=200.4

Q ss_pred             ccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh--HHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-----CceE
Q 007680          273 EFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSYSNP-----DFKA  344 (593)
Q Consensus       273 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~  344 (593)
                      +|++.+.||+|+||.||+|+.. +++.||+|.++...  ......+.+|++++++++||||+++++++...     ...+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            4888999999999999999965 78999999987532  23345688999999999999999999987543     2479


Q ss_pred             EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecC
Q 007680          345 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG  424 (593)
Q Consensus       345 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~  424 (593)
                      +||||++ ++|.+++..... +++..+..++.|+++||+|||++    +|+||||||+||+++.++.+||+|||+++...
T Consensus        81 lv~e~~~-~~L~~~l~~~~~-~~~~~~~~i~~qi~~aL~~LH~~----~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~  154 (338)
T cd07859          81 VVFELME-SDLHQVIKANDD-LTPEHHQFFLYQLLRALKYIHTA----NVFHRDLKPKNILANADCKLKICDFGLARVAF  154 (338)
T ss_pred             EEEecCC-CCHHHHHHhccc-CCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeEECCCCcEEEccCccccccc
Confidence            9999995 699999876654 89999999999999999999965    59999999999999999999999999988653


Q ss_pred             CCCCc-cccccccCCccccCccccCC--CCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCc----h
Q 007680          425 EGEDS-VRQTMTMATIGYMAPEYGLE--GIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHG----L  497 (593)
Q Consensus       425 ~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~----~  497 (593)
                      ..... .......|++.|+|||++.+  ..++.++|||||||++|||++|+.||.....  ......+.......    .
T Consensus       155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~--~~~~~~~~~~~~~~~~~~~  232 (338)
T cd07859         155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV--VHQLDLITDLLGTPSPETI  232 (338)
T ss_pred             cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCCh--HHHHHHHHHHhCCCCHHHH
Confidence            32211 11234568999999998765  6789999999999999999999999965321  11111111111000    0


Q ss_pred             hh--------hhhhhhhhhhhh-hhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH--HHHhh
Q 007680          498 TE--------VVDANLVREEQA-FSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK--LKKIK  551 (593)
Q Consensus       498 ~~--------~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~i~  551 (593)
                      ..        ............ .......++.+.+++.+||+.||++|||++|+++|  ++.+.
T Consensus       233 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~  297 (338)
T cd07859         233 SRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLA  297 (338)
T ss_pred             HHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcC
Confidence            00        000000000000 00011235678999999999999999999999987  44433

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=3e-39  Score=319.34  Aligned_cols=248  Identities=24%  Similarity=0.412  Sum_probs=198.7

Q ss_pred             cccCccCcccEEEEEeC-CCCeEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEeccCCCCH
Q 007680          278 NLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSL  355 (593)
Q Consensus       278 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  355 (593)
                      +.||+|+||.||+|+.. +++.||+|.+.... ......+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            47999999999999965 78999999876542 33456789999999999999999999999999999999999999999


Q ss_pred             HHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCccccccc
Q 007680          356 EKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMT  435 (593)
Q Consensus       356 ~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~  435 (593)
                      .+++......+++..+..++.|++.||+|||++    +++||||||+||+++.++.+||+|||.+...............
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~----~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  156 (252)
T cd05084          81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLESK----HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK  156 (252)
T ss_pred             HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC----CccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence            999987665689999999999999999999955    4999999999999999999999999998765432211111112


Q ss_pred             cCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhhhhhhh
Q 007680          436 MATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSA  514 (593)
Q Consensus       436 ~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  514 (593)
                      ..+..|+|||.+.++.++.++||||||+++|||++ |..||.......  .........+                 ...
T Consensus       157 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~--~~~~~~~~~~-----------------~~~  217 (252)
T cd05084         157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ--TREAIEQGVR-----------------LPC  217 (252)
T ss_pred             CCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH--HHHHHHcCCC-----------------CCC
Confidence            23467999999998899999999999999999998 888986532211  1111111000                 011


Q ss_pred             hHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHH
Q 007680          515 KMDCILSIMDFALDCCMESPDMRINMTDAAAKLK  548 (593)
Q Consensus       515 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  548 (593)
                      +..++..+.+++.+||..+|++|||+.++++.|+
T Consensus       218 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         218 PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            1233567899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-42  Score=320.22  Aligned_cols=250  Identities=24%  Similarity=0.364  Sum_probs=214.4

Q ss_pred             hccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEecc
Q 007680          272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFM  350 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  350 (593)
                      +-|.++++||+|+||.||+|.++ +|+.+|||.+...  ...+++.+|+.++++++.|++|++||.|......++|||||
T Consensus        33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC  110 (502)
T KOG0574|consen   33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC  110 (502)
T ss_pred             HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence            34778899999999999999865 7999999998755  45678899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCcc
Q 007680          351 PNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSV  430 (593)
Q Consensus       351 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~  430 (593)
                      ..|+..+.++.+++.+++.++..++++.++||+|||.    +.-+|||||..|||++.+|.+||+|||.|..+.+..  .
T Consensus       111 GAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~----~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM--A  184 (502)
T KOG0574|consen  111 GAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHD----LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM--A  184 (502)
T ss_pred             CCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHH----HHHHHhhcccccEEEcccchhhhhhccccchhhhhH--H
Confidence            9999999999999999999999999999999999994    458999999999999999999999999998765432  2


Q ss_pred             ccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhhh
Q 007680          431 RQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQ  510 (593)
Q Consensus       431 ~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  510 (593)
                      ......||+.|||||++..-.|+.++||||+|++..||..|++||.+...-...+      .+|           ...+.
T Consensus       185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF------MIP-----------T~PPP  247 (502)
T KOG0574|consen  185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF------MIP-----------TKPPP  247 (502)
T ss_pred             hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE------ecc-----------CCCCC
Confidence            3456789999999999999999999999999999999999999998742111000      000           11233


Q ss_pred             hhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          511 AFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       511 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      .+..+...+.++.+++++||-+.|++|-|+.++++|
T Consensus       248 TF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  248 TFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             CCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence            445566778899999999999999999999999987

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=2.1e-39  Score=322.24  Aligned_cols=256  Identities=22%  Similarity=0.396  Sum_probs=208.3

Q ss_pred             hhhccccccccCccCcccEEEEEeCCCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEec
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEF  349 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  349 (593)
                      ..++|++.++||+|+||.||+|...++..||+|.+.... ...+.+.+|+.++++++|+||+++++.+...+..+++|||
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05072           4 PRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY   82 (261)
T ss_pred             chHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence            357899999999999999999998888899999986543 2346789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCC
Q 007680          350 MPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGED  428 (593)
Q Consensus       350 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  428 (593)
                      +++++|.+++.... ..+++..+..++.|++.||+|||+.    +++||||||+||++++++.++|+|||.+........
T Consensus        83 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~----~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05072          83 MAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK----NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY  158 (261)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC----CeeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence            99999999997643 3588999999999999999999965    499999999999999999999999999987654322


Q ss_pred             ccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhh
Q 007680          429 SVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVR  507 (593)
Q Consensus       429 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  507 (593)
                      . ......++..|+|||+..+..++.++|||||||++|+|+| |+.||......  .....+....+             
T Consensus       159 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~~~~~~~~~-------------  222 (261)
T cd05072         159 T-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS--DVMSALQRGYR-------------  222 (261)
T ss_pred             e-ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH--HHHHHHHcCCC-------------
Confidence            1 1122345678999999988889999999999999999998 99999653211  11111111100             


Q ss_pred             hhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHh
Q 007680          508 EEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKI  550 (593)
Q Consensus       508 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  550 (593)
                          .+....++.++.+++.+||..+|++||+++++.+.|+++
T Consensus       223 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         223 ----MPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             ----CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence                011122456789999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=9.7e-40  Score=336.95  Aligned_cols=247  Identities=22%  Similarity=0.248  Sum_probs=202.4

Q ss_pred             hhhccccccccCccCcccEEEEEeC-C-CCeEEEEEeehhh---HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceE
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTIS-D-GTDVAIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKA  344 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  344 (593)
                      ..++|++.+.||+|+||.||+|.++ + +..||+|++....   ....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus        28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~  107 (340)
T PTZ00426         28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY  107 (340)
T ss_pred             ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence            3567999999999999999999854 2 3689999997643   234567889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecC
Q 007680          345 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG  424 (593)
Q Consensus       345 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~  424 (593)
                      +||||+++|+|.+++..... +++..+..++.|++.||+|||++    +|+||||||+||+++.++.+||+|||++....
T Consensus       108 lv~Ey~~~g~L~~~i~~~~~-~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~  182 (340)
T PTZ00426        108 LVLEFVIGGEFFTFLRRNKR-FPNDVGCFYAAQIVLIFEYLQSL----NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD  182 (340)
T ss_pred             EEEeCCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHC----CeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence            99999999999999987654 89999999999999999999954    59999999999999999999999999998754


Q ss_pred             CCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhh
Q 007680          425 EGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDAN  504 (593)
Q Consensus       425 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  504 (593)
                      ..     .....||+.|+|||++.+..++.++|||||||++|||++|+.||......  .....+..           ..
T Consensus       183 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~--~~~~~i~~-----------~~  244 (340)
T PTZ00426        183 TR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL--LIYQKILE-----------GI  244 (340)
T ss_pred             CC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH--HHHHHHhc-----------CC
Confidence            32     12346899999999999888999999999999999999999999763211  11111100           00


Q ss_pred             hhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHHH
Q 007680          505 LVREEQAFSAKMDCILSIMDFALDCCMESPDMRI-----NMTDAAAK  546 (593)
Q Consensus       505 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  546 (593)
                      .       ..+...+..+.+++++||+.||++|+     +++++++|
T Consensus       245 ~-------~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        245 I-------YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             C-------CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence            0       00112345678999999999999995     88988876

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.2e-39  Score=334.96  Aligned_cols=242  Identities=23%  Similarity=0.296  Sum_probs=197.4

Q ss_pred             cccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEeccCCC
Q 007680          278 NLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNG  353 (593)
Q Consensus       278 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  353 (593)
                      +.||+|+||.||+++.. +|+.||+|++....   ......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46899999999999965 78999999998653   334567788999999999999999999999999999999999999


Q ss_pred             CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCccccc
Q 007680          354 SLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQT  433 (593)
Q Consensus       354 sL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~  433 (593)
                      +|.+++.... .+++.++..++.|++.||+|||++    +|+||||||+||+++.++.+||+|||+++.......  ...
T Consensus        81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH~~----~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~~  153 (328)
T cd05593          81 ELFFHLSRER-VFSEDRTRFYGAEIVSALDYLHSG----KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA--TMK  153 (328)
T ss_pred             CHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC----CeEecccCHHHeEECCCCcEEEecCcCCccCCCccc--ccc
Confidence            9999987655 489999999999999999999955    599999999999999999999999999875332211  123


Q ss_pred             cccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhhhhhh
Q 007680          434 MTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQAFS  513 (593)
Q Consensus       434 ~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  513 (593)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||......  ......   ..             ...  .
T Consensus       154 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~--~~~~~~---~~-------------~~~--~  213 (328)
T cd05593         154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KLFELI---LM-------------EDI--K  213 (328)
T ss_pred             cccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH--HHHHHh---cc-------------CCc--c
Confidence            356899999999999889999999999999999999999999653211  111100   00             000  0


Q ss_pred             hhHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHHH
Q 007680          514 AKMDCILSIMDFALDCCMESPDMRI-----NMTDAAAK  546 (593)
Q Consensus       514 ~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  546 (593)
                      .+..++.++.+++.+||+.||++||     ++.|+++|
T Consensus       214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         214 FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            1112356789999999999999997     89999876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.9e-39  Score=349.64  Aligned_cols=251  Identities=22%  Similarity=0.236  Sum_probs=203.8

Q ss_pred             ccccccccCccCcccEEEEEeC-C-CCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEecc
Q 007680          273 EFNECNLLGTSSFGSVYKGTIS-D-GTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFM  350 (593)
Q Consensus       273 ~~~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  350 (593)
                      .|.+.+.||+|++|.||+|... + ++.||+|.+..........+..|+.+++.++||||+++++++...+..++||||+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            4899999999999999999854 4 6789999876655555567888999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCC
Q 007680          351 PNGSLEKWLYSH---NYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGE  427 (593)
Q Consensus       351 ~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~  427 (593)
                      ++|+|.+++...   ...+++.++..++.|++.||+|||++    +|+||||||+||+++.++.+||+|||+++.+....
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~----~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~  223 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR----KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV  223 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC----CEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence            999999988642   23588999999999999999999954    59999999999999999999999999998765433


Q ss_pred             CccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhh
Q 007680          428 DSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVR  507 (593)
Q Consensus       428 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  507 (593)
                      .........||+.|+|||++.+..++.++|||||||++|||++|+.||......  ........               .
T Consensus       224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~--~~~~~~~~---------------~  286 (478)
T PTZ00267        224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR--EIMQQVLY---------------G  286 (478)
T ss_pred             ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHh---------------C
Confidence            222233456899999999999999999999999999999999999999653211  11111000               0


Q ss_pred             hhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          508 EEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       508 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      ...  +.+..++.++.+++.+||..||++||++.+++.+
T Consensus       287 ~~~--~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~  323 (478)
T PTZ00267        287 KYD--PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT  323 (478)
T ss_pred             CCC--CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence            000  0111245678999999999999999999999764

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=4.3e-39  Score=323.43  Aligned_cols=259  Identities=24%  Similarity=0.386  Sum_probs=205.3

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCC----eEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGT----DVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKA  344 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  344 (593)
                      .++|++.+.||+|+||.||+|.+. +++    .+++|.+.... ......+..|+..+++++||||+++++++.. ...+
T Consensus         6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~   84 (279)
T cd05111           6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQ   84 (279)
T ss_pred             HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccE
Confidence            357888999999999999999864 444    47778775432 2344677888889999999999999998754 4578


Q ss_pred             EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecC
Q 007680          345 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG  424 (593)
Q Consensus       345 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~  424 (593)
                      +++||+++|+|.+++......+++..+..++.|++.||+|||++    +++||||||+||++++++.+||+|||.++...
T Consensus        85 ~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~----~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~  160 (279)
T cd05111          85 LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEH----RMVHRNLAARNILLKSDSIVQIADFGVADLLY  160 (279)
T ss_pred             EEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC----CEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence            89999999999999987766799999999999999999999965    49999999999999999999999999998765


Q ss_pred             CCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhhhh
Q 007680          425 EGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDA  503 (593)
Q Consensus       425 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  503 (593)
                      ............++..|+|||+..++.++.++||||||+++||+++ |+.||.+....  ...+.+....          
T Consensus       161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~--~~~~~~~~~~----------  228 (279)
T cd05111         161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH--EVPDLLEKGE----------  228 (279)
T ss_pred             CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHCCC----------
Confidence            4433222334457778999999988899999999999999999998 99999764221  1111111110          


Q ss_pred             hhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhh
Q 007680          504 NLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVK  553 (593)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  553 (593)
                             ....+..++.++.+++.+||..||++|||+.|+++.|..+..+
T Consensus       229 -------~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~  271 (279)
T cd05111         229 -------RLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD  271 (279)
T ss_pred             -------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence                   0001112345678999999999999999999999999887653

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=3.6e-39  Score=326.03  Aligned_cols=260  Identities=26%  Similarity=0.409  Sum_probs=210.5

Q ss_pred             hhccccccccCccCcccEEEEEeC------CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS------DGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKA  344 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  344 (593)
                      ..+|.+.+.||+|+||.||+|...      ++..+++|.++.......+.+.+|++++++++||||+++++++...+..+
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (291)
T cd05094           4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI   83 (291)
T ss_pred             hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence            356888999999999999999742      35569999987665555678899999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCC
Q 007680          345 LVLEFMPNGSLEKWLYSHN---------------YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDEN  409 (593)
Q Consensus       345 lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~  409 (593)
                      +||||+++++|.+++....               ..+++..++.++.|++.|++|||+++    ++||||||+||+++++
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~----i~H~dlkp~Nil~~~~  159 (291)
T cd05094          84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH----FVHRDLATRNCLVGAN  159 (291)
T ss_pred             EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC----eeecccCcceEEEccC
Confidence            9999999999999997543               24789999999999999999999654    9999999999999999


Q ss_pred             CcEEEEeeccceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHH
Q 007680          410 MVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRW  488 (593)
Q Consensus       410 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~  488 (593)
                      +.++|+|||++................++..|+|||++.+..++.++||||||+++|||+| |+.||......+  ..+.
T Consensus       160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~~~~  237 (291)
T cd05094         160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE--VIEC  237 (291)
T ss_pred             CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHH
Confidence            9999999999876544332222233456788999999998999999999999999999999 999986632211  1111


Q ss_pred             HHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhh
Q 007680          489 VKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVK  553 (593)
Q Consensus       489 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  553 (593)
                      ......                 ......++..+.+++.+||+.||++||++.++++.|+++...
T Consensus       238 ~~~~~~-----------------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~  285 (291)
T cd05094         238 ITQGRV-----------------LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA  285 (291)
T ss_pred             HhCCCC-----------------CCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence            111000                 001112356789999999999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.8e-40  Score=340.98  Aligned_cols=253  Identities=22%  Similarity=0.334  Sum_probs=202.0

Q ss_pred             hccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEE
Q 007680          272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVL  347 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  347 (593)
                      ++|++.+.||+|+||.||+|+.. +++.||||+++...   ......+.+|+.++..++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            47899999999999999999975 68999999998653   234456788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCC
Q 007680          348 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGE  427 (593)
Q Consensus       348 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~  427 (593)
                      ||+++|+|.+++..... +++..+..++.|++.||+|||++    +|+||||||+||+++.++.+||+|||++..+....
T Consensus        81 E~~~~g~L~~~l~~~~~-l~~~~~~~~~~qi~~aL~~lH~~----~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  155 (364)
T cd05599          81 EYLPGGDMMTLLMKKDT-FTEEETRFYIAETILAIDSIHKL----GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH  155 (364)
T ss_pred             CCCCCcHHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHC----CeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence            99999999999987654 89999999999999999999965    49999999999999999999999999987653221


Q ss_pred             Ccc------------------------------------ccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhC
Q 007680          428 DSV------------------------------------RQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTR  471 (593)
Q Consensus       428 ~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg  471 (593)
                      ...                                    ......||+.|+|||++.+..++.++|||||||++|||++|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G  235 (364)
T cd05599         156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG  235 (364)
T ss_pred             cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence            100                                    01123589999999999998999999999999999999999


Q ss_pred             CCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCC---HHHHHHH
Q 007680          472 KRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRIN---MTDAAAK  546 (593)
Q Consensus       472 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~~  546 (593)
                      ..||......+  ....+... ..             ....+....+++++.+++.+|+. +|.+|++   +.|+++|
T Consensus       236 ~~Pf~~~~~~~--~~~~i~~~-~~-------------~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h  296 (364)
T cd05599         236 YPPFCSDNPQE--TYRKIINW-KE-------------TLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH  296 (364)
T ss_pred             CCCCCCCCHHH--HHHHHHcC-CC-------------ccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence            99997632211  11111000 00             00001111235578899999996 9999998   9998876

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.7e-39  Score=340.98  Aligned_cols=253  Identities=21%  Similarity=0.291  Sum_probs=199.2

Q ss_pred             ccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEe
Q 007680          273 EFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLE  348 (593)
Q Consensus       273 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  348 (593)
                      .|+.++.||+|+||.||+|+.. +++.||+|+++...   ......+.+|++++++++||||+++++++.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            5888999999999999999865 68899999997643   3345678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCC
Q 007680          349 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGED  428 (593)
Q Consensus       349 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  428 (593)
                      |+++|+|.+++..... +++..+..++.|++.||+|||+.    +|+||||||+||+++.++.+||+|||+++.+.....
T Consensus        82 ~~~gg~L~~~l~~~~~-~~e~~~~~~~~qi~~aL~~LH~~----givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~  156 (381)
T cd05626          82 YIPGGDMMSLLIRMEV-FPEVLARFYIAELTLAIESVHKM----GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN  156 (381)
T ss_pred             cCCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhC----CeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence            9999999999987654 88999999999999999999954    599999999999999999999999999764321100


Q ss_pred             c---------------------------------------------cccccccCCccccCccccCCCCCCccchHHHHHH
Q 007680          429 S---------------------------------------------VRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGV  463 (593)
Q Consensus       429 ~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGv  463 (593)
                      .                                             .......||+.|+|||++.+..++.++|||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~  236 (381)
T cd05626         157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV  236 (381)
T ss_pred             cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence            0                                             0011246899999999999888999999999999


Q ss_pred             HHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhh--cccCCCCCCCCHH
Q 007680          464 LLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALD--CCMESPDMRINMT  541 (593)
Q Consensus       464 vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~--cl~~dP~~RPs~~  541 (593)
                      ++|||++|+.||......+. ......  ..             .....+....+++++.+++.+  |+..+|..||++.
T Consensus       237 il~elltG~~Pf~~~~~~~~-~~~i~~--~~-------------~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~  300 (381)
T cd05626         237 ILFEMLVGQPPFLAPTPTET-QLKVIN--WE-------------NTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGAD  300 (381)
T ss_pred             HHHHHHhCCCCCcCCCHHHH-HHHHHc--cc-------------cccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHH
Confidence            99999999999976322111 000000  00             000011111235577889988  5566677799999


Q ss_pred             HHHHH
Q 007680          542 DAAAK  546 (593)
Q Consensus       542 evl~~  546 (593)
                      |+++|
T Consensus       301 ~~l~h  305 (381)
T cd05626         301 DIKAH  305 (381)
T ss_pred             HHhcC
Confidence            99987

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=4.8e-39  Score=323.85  Aligned_cols=271  Identities=25%  Similarity=0.398  Sum_probs=206.9

Q ss_pred             hccccccccCccCcccEEEEEeC-----CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC--CceE
Q 007680          272 DEFNECNLLGTSSFGSVYKGTIS-----DGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNP--DFKA  344 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~  344 (593)
                      .+|++.+.||+|+||.||++..+     +++.||+|.++.......+.+.+|++++++++||||+++++++...  ...+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            47889999999999999999742     5789999999876666667899999999999999999999987543  4688


Q ss_pred             EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecC
Q 007680          345 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG  424 (593)
Q Consensus       345 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~  424 (593)
                      +||||+++++|.+++......+++..+..++.|++.||+|||+++    ++||||||+||++++++.+||+|||++....
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~----i~H~dlkp~nili~~~~~~~l~dfg~~~~~~  159 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR----YVHRDLATRNILVESENRVKIGDFGLTKVLP  159 (284)
T ss_pred             EEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC----ceeccCCHhhEEECCCCeEEECCCccccccc
Confidence            999999999999999876556899999999999999999999654    9999999999999999999999999998765


Q ss_pred             CCCCccc-cccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCC--chhhhh
Q 007680          425 EGEDSVR-QTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPH--GLTEVV  501 (593)
Q Consensus       425 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~  501 (593)
                      ....... .....++..|+|||+..+..++.++|||||||++|||++|..|+.....   ...+........  ......
T Consensus       160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd05081         160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPA---EFMRMMGNDKQGQMIVYHLI  236 (284)
T ss_pred             CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcch---hhhhhcccccccccchHHHH
Confidence            4332111 1112244569999999888899999999999999999998877643211   111111110000  000000


Q ss_pred             hhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhh
Q 007680          502 DANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIK  551 (593)
Q Consensus       502 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~  551 (593)
                      +  ........+....++.++.+++.+||+.+|++|||+.|+++.|+.++
T Consensus       237 ~--~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~  284 (284)
T cd05081         237 E--LLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR  284 (284)
T ss_pred             H--HHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence            0  00111111122345668999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=2.6e-39  Score=333.66  Aligned_cols=261  Identities=26%  Similarity=0.431  Sum_probs=205.4

Q ss_pred             hhhccccccccCccCcccEEEEEeC------CCCeEEEEEeehhh-HHHHHHHHHHHHHHhhc-CCCCcceeeeeeecC-
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTIS------DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNV-RHRNLIKILSSYSNP-  340 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-  340 (593)
                      ..++|++.+.||+|+||.||+|...      +++.||+|+++... ....+.+.+|+.++.++ +|+||+++++++... 
T Consensus         5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~   84 (337)
T cd05054           5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG   84 (337)
T ss_pred             CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence            3568999999999999999999632      35789999987542 23345678899999999 899999999987654 


Q ss_pred             CceEEEEeccCCCCHHHHHhhCC---------------------------------------------------------
Q 007680          341 DFKALVLEFMPNGSLEKWLYSHN---------------------------------------------------------  363 (593)
Q Consensus       341 ~~~~lv~e~~~~gsL~~~l~~~~---------------------------------------------------------  363 (593)
                      ...+++|||+++++|.+++....                                                         
T Consensus        85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (337)
T cd05054          85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE  164 (337)
T ss_pred             CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence            56889999999999999986432                                                         


Q ss_pred             ---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCccccccccCCcc
Q 007680          364 ---YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIG  440 (593)
Q Consensus       364 ---~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~  440 (593)
                         ..+++..+..++.|++.||+|||++    +|+||||||+||++++++.++|+|||++..+.............++..
T Consensus       165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~----~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~  240 (337)
T cd05054         165 LYKEPLTLEDLISYSFQVARGMEFLASR----KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK  240 (337)
T ss_pred             HhhcCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence               1478999999999999999999955    599999999999999999999999999987654333222333456778


Q ss_pred             ccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhhhhhhhhHHHH
Q 007680          441 YMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCI  519 (593)
Q Consensus       441 y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  519 (593)
                      |+|||++.+..++.++|||||||++|||++ |..||......+ .+.........                 ...+...+
T Consensus       241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~-~~~~~~~~~~~-----------------~~~~~~~~  302 (337)
T cd05054         241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-EFCRRLKEGTR-----------------MRAPEYAT  302 (337)
T ss_pred             ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH-HHHHHHhccCC-----------------CCCCccCC
Confidence            999999999999999999999999999998 999996532111 11111111000                 00011234


Q ss_pred             HHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhh
Q 007680          520 LSIMDFALDCCMESPDMRINMTDAAAKLKKIKV  552 (593)
Q Consensus       520 ~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~  552 (593)
                      .++.+++.+||+.+|++||++.|++++|+++..
T Consensus       303 ~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         303 PEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            578999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.4e-40  Score=340.51  Aligned_cols=253  Identities=24%  Similarity=0.383  Sum_probs=205.5

Q ss_pred             hccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEE
Q 007680          272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVL  347 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  347 (593)
                      ++|++.+.||+|+||.||+|+.. +++.||+|+++...   ......+..|++++..++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            47899999999999999999976 78999999998653   234567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCC
Q 007680          348 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGE  427 (593)
Q Consensus       348 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~  427 (593)
                      ||+++++|.+++.... .+++..+..++.|++.||+|||++    ||+||||||+||+++.++.+||+|||++.......
T Consensus        81 e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~----giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~  155 (350)
T cd05573          81 EYMPGGDLMNLLIRKD-VFPEETARFYIAELVLALDSVHKL----GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK  155 (350)
T ss_pred             cCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence            9999999999998774 489999999999999999999954    59999999999999999999999999988765432


Q ss_pred             C---------------------------ccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCcccc
Q 007680          428 D---------------------------SVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFI  480 (593)
Q Consensus       428 ~---------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~  480 (593)
                      .                           ........||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~  235 (350)
T cd05573         156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL  235 (350)
T ss_pred             cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence            0                           0112335689999999999999999999999999999999999999976431


Q ss_pred             ccchHHHHHHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCC-HHHHHHH
Q 007680          481 GEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRIN-MTDAAAK  546 (593)
Q Consensus       481 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~  546 (593)
                      .. .... +.. ..             .....+....+++++.+++.+|+. ||.+||+ +.|+++|
T Consensus       236 ~~-~~~~-i~~-~~-------------~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         236 QE-TYNK-IIN-WK-------------ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             HH-HHHH-Hhc-cC-------------CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            11 0000 000 00             000011111145688999999997 9999999 9999987

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-39  Score=348.08  Aligned_cols=259  Identities=22%  Similarity=0.257  Sum_probs=212.4

Q ss_pred             hccccccccCccCcccEEEEEeCCC-CeEEEEEeehhhHHHHHHHHHHHHHHhhcC-CCCcceeee-eeecC------Cc
Q 007680          272 DEFNECNLLGTSSFGSVYKGTISDG-TDVAIKVFNLQLERAFRSFDSECEVLRNVR-HRNLIKILS-SYSNP------DF  342 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~-~~~~~------~~  342 (593)
                      .++++.+.|.+|||+.||+|+...+ ..||+|++-..++...+.+.+|+++|++|. |+|||.+++ .....      -+
T Consensus        37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E  116 (738)
T KOG1989|consen   37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE  116 (738)
T ss_pred             EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence            4678889999999999999997655 999999998888888899999999999996 999999999 33221      26


Q ss_pred             eEEEEeccCCCCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccce
Q 007680          343 KALVLEFMPNGSLEKWLYSHNY-FLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYK  421 (593)
Q Consensus       343 ~~lv~e~~~~gsL~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~  421 (593)
                      ++|.||||.||.|-+++..+-. .+++.++++|+.|+++|+++||..  +.+|||||||-+||||+.++..||||||.+.
T Consensus       117 vllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~--~pPiIHRDLKiENvLls~~g~~KLCDFGSat  194 (738)
T KOG1989|consen  117 VLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL--KPPIIHRDLKIENVLLSADGNYKLCDFGSAT  194 (738)
T ss_pred             EEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC--CCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence            7899999999999999985432 499999999999999999999975  4679999999999999999999999999987


Q ss_pred             ecCCCCCcc-------ccccccCCccccCcccc---CCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHH
Q 007680          422 LLGEGEDSV-------RQTMTMATIGYMAPEYG---LEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKE  491 (593)
Q Consensus       422 ~~~~~~~~~-------~~~~~~gt~~y~aPE~~---~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~  491 (593)
                      -.-......       ..-....|+.|+|||++   .+...++|+|||||||+||.|+....||++...           
T Consensus       195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~-----------  263 (738)
T KOG1989|consen  195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK-----------  263 (738)
T ss_pred             cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-----------
Confidence            433222110       11123479999999975   467899999999999999999999999987311           


Q ss_pred             hcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhhh
Q 007680          492 SLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKF  554 (593)
Q Consensus       492 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  554 (593)
                            .     .+......++....++..+.+||+.||+.||++||++.+++.++.++...-
T Consensus       264 ------l-----aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~  315 (738)
T KOG1989|consen  264 ------L-----AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP  315 (738)
T ss_pred             ------e-----eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence                  1     112222334444567789999999999999999999999999999987654

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.4e-39  Score=319.35  Aligned_cols=256  Identities=27%  Similarity=0.425  Sum_probs=207.1

Q ss_pred             hhhccccccccCccCcccEEEEEeCCCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEec
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEF  349 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  349 (593)
                      ..++|++.+.||+|++|.||+|...+++.||+|.++... ...+.+.+|++++++++||||+++++++...+..++||||
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05068           4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL   82 (261)
T ss_pred             chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence            356799999999999999999998778889999987543 2345688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCC
Q 007680          350 MPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGED  428 (593)
Q Consensus       350 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  428 (593)
                      +++++|.+++.... ..+++..+..++.|++.|+.|||+.    +++||||||+||++++++.+||+|||+++.......
T Consensus        83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05068          83 MKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ----NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY  158 (261)
T ss_pred             ccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC----CeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence            99999999997654 3589999999999999999999965    499999999999999999999999999987753221


Q ss_pred             ccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhh
Q 007680          429 SVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVR  507 (593)
Q Consensus       429 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  507 (593)
                      . .......+..|+|||+..+..++.++||||||+++|||++ |+.||......  .....+.....             
T Consensus       159 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~~~~~~~-------------  222 (261)
T cd05068         159 E-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA--EVLQQVDQGYR-------------  222 (261)
T ss_pred             c-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHHcCCC-------------
Confidence            1 1111223457999999988899999999999999999999 99999663211  11111111000             


Q ss_pred             hhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHh
Q 007680          508 EEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKI  550 (593)
Q Consensus       508 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  550 (593)
                          .+....++..+.+++.+||+.+|++||++.++.+.|+++
T Consensus       223 ----~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         223 ----MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             ----CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence                011123456789999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=4.8e-39  Score=323.73  Aligned_cols=255  Identities=24%  Similarity=0.437  Sum_probs=204.2

Q ss_pred             hccccccccCccCcccEEEEEe-----CCCCeEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEE
Q 007680          272 DEFNECNLLGTSSFGSVYKGTI-----SDGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKAL  345 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  345 (593)
                      ++|++.+.||+|+||.||+|..     .++..||+|.++... ......+.+|++++++++||||+++++++..++..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            5788899999999999999984     256789999997533 3344678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhCC----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCC
Q 007680          346 VLEFMPNGSLEKWLYSHN----------------YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDEN  409 (593)
Q Consensus       346 v~e~~~~gsL~~~l~~~~----------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~  409 (593)
                      ||||+++++|.+++....                ..+++.++..++.|++.||+|||++    +++||||||+||+++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~----~i~H~dlkp~nili~~~  160 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH----FFVHKDLAARNILIGEQ  160 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc----CeehhccccceEEEcCC
Confidence            999999999999985322                1478889999999999999999965    49999999999999999


Q ss_pred             CcEEEEeeccceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHH
Q 007680          410 MVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRW  488 (593)
Q Consensus       410 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~  488 (593)
                      +.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||.....  ......
T Consensus       161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~--~~~~~~  238 (283)
T cd05090         161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN--QEVIEM  238 (283)
T ss_pred             CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--HHHHHH
Confidence            9999999999987644332222233445678999999988889999999999999999998 9999865321  111111


Q ss_pred             HHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHH
Q 007680          489 VKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKK  549 (593)
Q Consensus       489 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  549 (593)
                      +....                 ..+.+..++.++.+++.+||+.||++||++.++.++|+.
T Consensus       239 ~~~~~-----------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         239 VRKRQ-----------------LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HHcCC-----------------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            11110                 001112345678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=3.1e-39  Score=336.87  Aligned_cols=254  Identities=22%  Similarity=0.305  Sum_probs=198.1

Q ss_pred             hccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEE
Q 007680          272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVL  347 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  347 (593)
                      ++|++.+.||+|+||.||+|... +++.||+|+++...   ......+..|+.++.+++||||+++++.+.+.+..++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            47899999999999999999865 68999999998643   233456888999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCC
Q 007680          348 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGE  427 (593)
Q Consensus       348 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~  427 (593)
                      ||+++|+|.+++...+. +++.++..++.|++.||+|||++    +|+||||||+||+++.++.+||+|||+++.+....
T Consensus        81 E~~~gg~L~~~l~~~~~-l~~~~~~~~~~qi~~aL~~lH~~----givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~  155 (363)
T cd05628          81 EFLPGGDMMTLLMKKDT-LTEEETQFYIAETVLAIDSIHQL----GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH  155 (363)
T ss_pred             cCCCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhC----CeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence            99999999999987654 89999999999999999999954    59999999999999999999999999987653211


Q ss_pred             Cc---------------------------------cccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCC
Q 007680          428 DS---------------------------------VRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRP  474 (593)
Q Consensus       428 ~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~p  474 (593)
                      ..                                 .......||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P  235 (363)
T cd05628         156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP  235 (363)
T ss_pred             cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence            00                                 001234699999999999999999999999999999999999999


Q ss_pred             CCccccccchHHHHHHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhccc--CCCCCCCCHHHHHHH
Q 007680          475 TDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCM--ESPDMRINMTDAAAK  546 (593)
Q Consensus       475 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~--~dP~~RPs~~evl~~  546 (593)
                      |......+  ....+... ..             ....+.....++++.+++.+++.  .++..||++.|+++|
T Consensus       236 f~~~~~~~--~~~~i~~~-~~-------------~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         236 FCSETPQE--TYKKVMNW-KE-------------TLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             CCCCCHHH--HHHHHHcC-cC-------------cccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence            97632111  11111000 00             00011111234567788887554  233456899999987

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=7.4e-40  Score=337.21  Aligned_cols=253  Identities=21%  Similarity=0.297  Sum_probs=204.0

Q ss_pred             hccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEE
Q 007680          272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVL  347 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  347 (593)
                      ++|++.+.||+|+||.||++... +|+.||+|+++...   ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            46899999999999999999965 78999999998653   234567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCC
Q 007680          348 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGE  427 (593)
Q Consensus       348 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~  427 (593)
                      ||+++|+|.+++......+++..+..++.|++.||+|||++    +|+||||||+||+++.++.+||+|||++..+....
T Consensus        81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~----~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~  156 (330)
T cd05601          81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQM----GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK  156 (330)
T ss_pred             CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC----CeEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence            99999999999988755699999999999999999999955    59999999999999999999999999998765433


Q ss_pred             CccccccccCCccccCccccC------CCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhh
Q 007680          428 DSVRQTMTMATIGYMAPEYGL------EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVV  501 (593)
Q Consensus       428 ~~~~~~~~~gt~~y~aPE~~~------~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  501 (593)
                      .. ......||+.|+|||++.      +..++.++|||||||++|||++|+.||....... .+..... .         
T Consensus       157 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~-~~~~i~~-~---------  224 (330)
T cd05601         157 MV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK-TYNNIMN-F---------  224 (330)
T ss_pred             ce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH-HHHHHHc-C---------
Confidence            22 223346899999999876      4567899999999999999999999997632111 1111000 0         


Q ss_pred             hhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          502 DANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       502 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                        .   .....+.....+.++.+++.+|+. +|++||++.++++|
T Consensus       225 --~---~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h  263 (330)
T cd05601         225 --Q---RFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH  263 (330)
T ss_pred             --C---CccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence              0   000011111235678999999998 99999999999876

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=6.6e-39  Score=317.87  Aligned_cols=253  Identities=24%  Similarity=0.345  Sum_probs=204.4

Q ss_pred             hhccccccccCccCcccEEEEEeCCCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEecc
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFM  350 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  350 (593)
                      .++|++.+.||+|+||.||.|.+.++..+|+|.++... ...+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus         3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd05113           3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM   81 (256)
T ss_pred             hHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence            35788999999999999999998777789999987543 22357889999999999999999999999989999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCcc
Q 007680          351 PNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSV  430 (593)
Q Consensus       351 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~  430 (593)
                      ++++|.+++......+++..++.++.|++.||+|||+.    +++|+||||+||++++++.+||+|||.++....... .
T Consensus        82 ~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~  156 (256)
T cd05113          82 SNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK----QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-T  156 (256)
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC----CeeccccCcceEEEcCCCCEEECCCccceecCCCce-e
Confidence            99999999987655689999999999999999999955    599999999999999999999999999886543321 1


Q ss_pred             ccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhh
Q 007680          431 RQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREE  509 (593)
Q Consensus       431 ~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  509 (593)
                      ......++..|+|||+..+..++.++|||||||++|+|++ |+.||......  ............              
T Consensus       157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--~~~~~~~~~~~~--------------  220 (256)
T cd05113         157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS--ETVEKVSQGLRL--------------  220 (256)
T ss_pred             ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--HHHHHHhcCCCC--------------
Confidence            1122345678999999988889999999999999999999 99998753221  111111111000              


Q ss_pred             hhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHH
Q 007680          510 QAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLK  548 (593)
Q Consensus       510 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  548 (593)
                         ......+..+.+++.+||+.+|++||++.++++.|+
T Consensus       221 ---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         221 ---YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             ---CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence               001112457899999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.7e-39  Score=335.89  Aligned_cols=263  Identities=19%  Similarity=0.212  Sum_probs=199.9

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEec
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEF  349 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  349 (593)
                      ..+|++.+.||+|+||.||++... +++.||+|...      ...+.+|++++++++||||+++++++...+..++|+|+
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~  164 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR  164 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence            357999999999999999999965 78999999743      23567899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCc
Q 007680          350 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDS  429 (593)
Q Consensus       350 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~  429 (593)
                      +. ++|.+++..... +++.++..++.|++.||+|||++    +|+||||||+||+++.++.+||+|||+++....... 
T Consensus       165 ~~-~~L~~~l~~~~~-l~~~~~~~i~~qi~~aL~ylH~~----~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~-  237 (391)
T PHA03212        165 YK-TDLYCYLAAKRN-IAICDILAIERSVLRAIQYLHEN----RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA-  237 (391)
T ss_pred             CC-CCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhC----CcccCCCChHhEEEcCCCCEEEEeCCcccccccccc-
Confidence            94 689988876554 89999999999999999999965    599999999999999999999999999875432211 


Q ss_pred             cccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCcccc------ccchHHHHHHHh------cCCch
Q 007680          430 VRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFI------GEMSLRRWVKES------LPHGL  497 (593)
Q Consensus       430 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~------~~~~~~~~~~~~------~~~~~  497 (593)
                      .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....      ....+...+...      .+...
T Consensus       238 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~  317 (391)
T PHA03212        238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA  317 (391)
T ss_pred             cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcch
Confidence            122335699999999999999999999999999999999999988644211      111111111110      00000


Q ss_pred             hhhhhhhh----h---h---hhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          498 TEVVDANL----V---R---EEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       498 ~~~~~~~~----~---~---~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      ....+...    .   .   ...........+.++.+++.+||+.||++|||++|+++|
T Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h  376 (391)
T PHA03212        318 QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF  376 (391)
T ss_pred             hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence            00011000    0   0   000111122456789999999999999999999999975

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=2.5e-39  Score=332.26  Aligned_cols=245  Identities=22%  Similarity=0.275  Sum_probs=195.0

Q ss_pred             cccccccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHH---hhcCCCCcceeeeeeecCCceEEE
Q 007680          274 FNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVL---RNVRHRNLIKILSSYSNPDFKALV  346 (593)
Q Consensus       274 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lv  346 (593)
                      |++.+.||+|+||.||+|... +++.||||+++...   ....+.+..|++++   +.++||||+++++++...+..|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            677899999999999999865 68999999998653   23345566676655   466899999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCC
Q 007680          347 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG  426 (593)
Q Consensus       347 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  426 (593)
                      |||+++++|..++...  .+++..+..++.|++.||+|||++    +|+||||||+||+++.++.+||+|||+++.....
T Consensus        81 ~E~~~~~~L~~~~~~~--~l~~~~~~~~~~qi~~al~~lH~~----~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~  154 (324)
T cd05589          81 MEYAAGGDLMMHIHTD--VFSEPRAVFYAACVVLGLQYLHEN----KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF  154 (324)
T ss_pred             EcCCCCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhC----CeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence            9999999999988654  489999999999999999999955    5999999999999999999999999998753322


Q ss_pred             CCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhh
Q 007680          427 EDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLV  506 (593)
Q Consensus       427 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  506 (593)
                      ..  ......|++.|+|||++.+..++.++|||||||++|||++|+.||......  .....+...           .  
T Consensus       155 ~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~--~~~~~i~~~-----------~--  217 (324)
T cd05589         155 GD--RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE--EVFDSIVND-----------E--  217 (324)
T ss_pred             CC--cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhC-----------C--
Confidence            11  223456899999999999999999999999999999999999999763211  111111000           0  


Q ss_pred             hhhhhhhhhHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHHH
Q 007680          507 REEQAFSAKMDCILSIMDFALDCCMESPDMRI-----NMTDAAAK  546 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  546 (593)
                           ...+..++..+.+++.+||+.||++||     ++.+++++
T Consensus       218 -----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~  257 (324)
T cd05589         218 -----VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ  257 (324)
T ss_pred             -----CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence                 001122456789999999999999999     56677665

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.8e-39  Score=331.79  Aligned_cols=243  Identities=22%  Similarity=0.301  Sum_probs=196.0

Q ss_pred             ccccCccCcccEEEEEe----CCCCeEEEEEeehhh----HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEe
Q 007680          277 CNLLGTSSFGSVYKGTI----SDGTDVAIKVFNLQL----ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLE  348 (593)
Q Consensus       277 ~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  348 (593)
                      ++.||+|+||.||+++.    .+++.||+|+++...    ......+.+|+.+++.++||||+++++++..++..++|||
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e   80 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE   80 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence            36899999999999985    257899999998642    2334567889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCC
Q 007680          349 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGED  428 (593)
Q Consensus       349 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  428 (593)
                      |+++++|.+++..... +++..+..++.|++.||+|||++    +|+||||||+||+++.++.+||+|||+++.......
T Consensus        81 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  155 (323)
T cd05584          81 YLSGGELFMHLEREGI-FMEDTACFYLSEISLALEHLHQQ----GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT  155 (323)
T ss_pred             CCCCchHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence            9999999999977654 78889999999999999999955    599999999999999999999999999875432221


Q ss_pred             ccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhh
Q 007680          429 SVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVRE  508 (593)
Q Consensus       429 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  508 (593)
                        ......|++.|+|||++.+..++.++|||||||++|||++|+.||......     ......        ....    
T Consensus       156 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~-----~~~~~~--------~~~~----  216 (323)
T cd05584         156 --VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK-----KTIDKI--------LKGK----  216 (323)
T ss_pred             --cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH-----HHHHHH--------HcCC----
Confidence              123346899999999999888999999999999999999999999763211     111110        0000    


Q ss_pred             hhhhhhhHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHHH
Q 007680          509 EQAFSAKMDCILSIMDFALDCCMESPDMRI-----NMTDAAAK  546 (593)
Q Consensus       509 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  546 (593)
                         ...+..+++++.+++.+||+.||++||     ++.++++|
T Consensus       217 ---~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h  256 (323)
T cd05584         217 ---LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH  256 (323)
T ss_pred             ---CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence               001112355789999999999999999     78888775

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=5.2e-39  Score=324.59  Aligned_cols=266  Identities=24%  Similarity=0.305  Sum_probs=196.2

Q ss_pred             hccccccccCccCcccEEEEEeC--CCCeEEEEEeehhh--HHHHHHHHHHHHHHhhc---CCCCcceeeeeee-----c
Q 007680          272 DEFNECNLLGTSSFGSVYKGTIS--DGTDVAIKVFNLQL--ERAFRSFDSECEVLRNV---RHRNLIKILSSYS-----N  339 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~-----~  339 (593)
                      ++|++.+.||+|+||.||+|+..  +++.||+|+++...  ......+.+|+.+++.+   +||||+++++++.     .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            36889999999999999999863  46889999987542  22233456677777665   6999999999875     2


Q ss_pred             CCceEEEEeccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeec
Q 007680          340 PDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFG  418 (593)
Q Consensus       340 ~~~~~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg  418 (593)
                      ....++||||++ ++|.+++.... ..+++..+..++.|++.||+|||++    +|+||||||+||+++.++.+||+|||
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~----~iiH~dlkp~Nil~~~~~~~kl~Dfg  155 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH----RVVHRDLKPQNILVTSSGQIKLADFG  155 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC----CeeeCCCCHHHEEEcCCCCEEEcccc
Confidence            456899999996 69999987643 3589999999999999999999965    49999999999999999999999999


Q ss_pred             cceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHh-cC--C
Q 007680          419 IYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKES-LP--H  495 (593)
Q Consensus       419 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~-~~--~  495 (593)
                      +++......   ......+++.|+|||++.+..++.++|||||||++|||++|++||......+ .+....... .+  .
T Consensus       156 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~-~~~~i~~~~~~~~~~  231 (290)
T cd07862         156 LARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILDVIGLPGEE  231 (290)
T ss_pred             ceEeccCCc---ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH-HHHHHHHHhCCCChh
Confidence            998764331   2234568999999999988899999999999999999999999997642211 111111110 00  0


Q ss_pred             chhhhh---hhhhhhhh--hhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          496 GLTEVV---DANLVREE--QAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       496 ~~~~~~---~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      ......   ........  .......+++..+.+++.+||+.||++|||+.|+++|
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h  287 (290)
T cd07862         232 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  287 (290)
T ss_pred             hchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence            000000   00000000  0000111345678999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=8.8e-39  Score=318.78  Aligned_cols=258  Identities=22%  Similarity=0.317  Sum_probs=208.0

Q ss_pred             hccccccccCccCcccEEEEEeC-CCCeEEEEEeehh---hHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEE
Q 007680          272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQ---LERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVL  347 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  347 (593)
                      ++|++.+.||+|+||.||+|+.. +++.||+|.++..   .......+.+|+++++.++||||+++++++...+..++|+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            57999999999999999999965 7899999987642   2344567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecC
Q 007680          348 EFMPNGSLEKWLYS---HNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG  424 (593)
Q Consensus       348 e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~  424 (593)
                      ||+++++|.+++..   ....+++..+..++.|++.||+|||++    +++|+||||+||+++.++.++|+|||.+....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~----~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~  157 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR----RVMHRDIKPANVFITATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC----CeeCCCCCHHHEEEcCCCCEEECccccceecc
Confidence            99999999998854   223578999999999999999999965    49999999999999999999999999988765


Q ss_pred             CCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhh
Q 007680          425 EGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDAN  504 (593)
Q Consensus       425 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  504 (593)
                      ....  ......++..|+|||.+.+..++.++|+||||+++|||++|+.||.............+....           
T Consensus       158 ~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~-----------  224 (267)
T cd08228         158 SKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCD-----------  224 (267)
T ss_pred             chhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCC-----------
Confidence            3321  112345788999999998888999999999999999999999998653221111111111100           


Q ss_pred             hhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhh
Q 007680          505 LVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIK  551 (593)
Q Consensus       505 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~  551 (593)
                           .........+..+.+++.+||+.+|++||++.++++.++.++
T Consensus       225 -----~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         225 -----YPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             -----CCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence                 000011234567899999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=3.3e-39  Score=323.87  Aligned_cols=257  Identities=24%  Similarity=0.407  Sum_probs=203.9

Q ss_pred             hhhccccccccCccCcccEEEEEeC------CCCeEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCc
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTIS------DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDF  342 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  342 (593)
                      ..++|++.+.||+|+||.||+|.+.      ++..||+|+++... ......+.+|+.+++.++||||+++++++..++.
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            5678999999999999999999753      35679999986432 2344568899999999999999999999999999


Q ss_pred             eEEEEeccCCCCHHHHHhhCCC---------CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEE
Q 007680          343 KALVLEFMPNGSLEKWLYSHNY---------FLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAH  413 (593)
Q Consensus       343 ~~lv~e~~~~gsL~~~l~~~~~---------~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~k  413 (593)
                      .++||||+++++|.+++.....         .+++..+..++.|++.||+|||+.    +++||||||+||++++++.++
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~----~~vH~dlkp~Nil~~~~~~~~  159 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN----KFVHRDLAARNCMVAEDFTVK  159 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCcchheEEEcCCCCEE
Confidence            9999999999999999876322         357788999999999999999964    599999999999999999999


Q ss_pred             EEeeccceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHh
Q 007680          414 VSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKES  492 (593)
Q Consensus       414 L~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~  492 (593)
                      |+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||......  ...+.....
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~--~~~~~~~~~  237 (277)
T cd05062         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE--QVLRFVMEG  237 (277)
T ss_pred             ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHcC
Confidence            999999876543322222222345778999999988899999999999999999999 78898653211  111111110


Q ss_pred             cCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHH
Q 007680          493 LPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKK  549 (593)
Q Consensus       493 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  549 (593)
                      .           .      ......++..+.+++.+||+.||++|||+.|++++|++
T Consensus       238 ~-----------~------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         238 G-----------L------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             C-----------c------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence            0           0      00111235678999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.6e-39  Score=315.27  Aligned_cols=254  Identities=23%  Similarity=0.313  Sum_probs=208.9

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALV  346 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  346 (593)
                      .+.|+.++.||+|.-|+||+++.. ++..+|+|++.+..   .+...+.+.|.+||+.++||.+..+|+.|+.++..|++
T Consensus        76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~  155 (459)
T KOG0610|consen   76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV  155 (459)
T ss_pred             HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence            467888999999999999999976 46899999998764   34556788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCC
Q 007680          347 LEFMPNGSLEKWLYSHNY-FLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGE  425 (593)
Q Consensus       347 ~e~~~~gsL~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~  425 (593)
                      ||||+||+|..+++++.. .+++..++-++..++-||+|||-    +|||.|||||+||||.++|++.|+||.++.....
T Consensus       156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHm----lGivYRDLKPENILvredGHIMLsDFDLS~~~~~  231 (459)
T KOG0610|consen  156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHM----LGIVYRDLKPENILVREDGHIMLSDFDLSLRCPV  231 (459)
T ss_pred             EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHh----hceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence            999999999999987655 79999999999999999999994    5699999999999999999999999998654321


Q ss_pred             C----------------------------------C--------------------CccccccccCCccccCccccCCCC
Q 007680          426 G----------------------------------E--------------------DSVRQTMTMATIGYMAPEYGLEGI  451 (593)
Q Consensus       426 ~----------------------------------~--------------------~~~~~~~~~gt~~y~aPE~~~~~~  451 (593)
                      .                                  .                    ...+....+||-.|.|||++.+..
T Consensus       232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G  311 (459)
T KOG0610|consen  232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG  311 (459)
T ss_pred             CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence            0                                  0                    001223346899999999999999


Q ss_pred             CCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhccc
Q 007680          452 VSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCM  531 (593)
Q Consensus       452 ~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~  531 (593)
                      .+.++|.|+|||++|||+.|..||.+....+.             +..++     .....++.....+..+.+||++.|.
T Consensus       312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~T-------------l~NIv-----~~~l~Fp~~~~vs~~akDLIr~LLv  373 (459)
T KOG0610|consen  312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKET-------------LRNIV-----GQPLKFPEEPEVSSAAKDLIRKLLV  373 (459)
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCcCCCCchhh-------------HHHHh-----cCCCcCCCCCcchhHHHHHHHHHhc
Confidence            99999999999999999999999988533221             11111     2222233333456688999999999


Q ss_pred             CCCCCCCC----HHHHHHH
Q 007680          532 ESPDMRIN----MTDAAAK  546 (593)
Q Consensus       532 ~dP~~RPs----~~evl~~  546 (593)
                      +||.+|..    +.||-+|
T Consensus       374 KdP~kRlg~~rGA~eIK~H  392 (459)
T KOG0610|consen  374 KDPSKRLGSKRGAAEIKRH  392 (459)
T ss_pred             cChhhhhccccchHHhhcC
Confidence            99999998    7777665

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=8.3e-39  Score=321.30  Aligned_cols=260  Identities=23%  Similarity=0.385  Sum_probs=207.2

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCC----eEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGT----DVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKA  344 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  344 (593)
                      .++|++.+.||+|+||+||+|++. +++    +||+|+++... ......+.+|+.+++.++||||+++++++... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~   84 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ   84 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence            467899999999999999999853 444    48999987543 33456788999999999999999999998754 568


Q ss_pred             EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecC
Q 007680          345 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG  424 (593)
Q Consensus       345 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~  424 (593)
                      +++||+++|+|.+++......+++..+..++.|++.||+|||++    +++||||||+||++++++.+||+|||+++...
T Consensus        85 l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~----~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~  160 (279)
T cd05109          85 LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEV----RLVHRDLAARNVLVKSPNHVKITDFGLARLLD  160 (279)
T ss_pred             EEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC----CeeccccccceEEEcCCCcEEECCCCceeecc
Confidence            99999999999999987666689999999999999999999955    49999999999999999999999999998775


Q ss_pred             CCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhhhh
Q 007680          425 EGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDA  503 (593)
Q Consensus       425 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  503 (593)
                      ............++..|+|||...+..++.++|||||||++|||++ |..||.....  .....++....          
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~~~~~~----------  228 (279)
T cd05109         161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA--REIPDLLEKGE----------  228 (279)
T ss_pred             cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHCCC----------
Confidence            4332222222345678999999988899999999999999999998 9999865321  11112211110          


Q ss_pred             hhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhhh
Q 007680          504 NLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKF  554 (593)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  554 (593)
                             ..+.+..++.++.+++.+||+.||++||++.++++.|+++..+.
T Consensus       229 -------~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~  272 (279)
T cd05109         229 -------RLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP  272 (279)
T ss_pred             -------cCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence                   01111234567899999999999999999999999998875443

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=3.3e-39  Score=335.44  Aligned_cols=249  Identities=26%  Similarity=0.365  Sum_probs=195.5

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEe
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLE  348 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  348 (593)
                      .++|+..+.||+|+||.||+|++. +++.||+|++.... ......+.+|+++++.++|+||+++++++...+..++|||
T Consensus        73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  152 (353)
T PLN00034         73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE  152 (353)
T ss_pred             HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence            356777889999999999999965 68999999986543 3345678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCC
Q 007680          349 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGED  428 (593)
Q Consensus       349 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  428 (593)
                      |+++++|.+..     ..++..+..++.||+.||+|||++    +|+||||||+||++++++.+||+|||+++.+.....
T Consensus       153 ~~~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~  223 (353)
T PLN00034        153 FMDGGSLEGTH-----IADEQFLADVARQILSGIAYLHRR----HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD  223 (353)
T ss_pred             cCCCCcccccc-----cCCHHHHHHHHHHHHHHHHHHHHC----CEeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence            99999986532     256778889999999999999965    499999999999999999999999999987643321


Q ss_pred             ccccccccCCccccCccccCC-----CCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhh
Q 007680          429 SVRQTMTMATIGYMAPEYGLE-----GIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDA  503 (593)
Q Consensus       429 ~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  503 (593)
                        ......||..|+|||++..     ...+.++|||||||++|||++|+.||......+  ........           
T Consensus       224 --~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~--~~~~~~~~-----------  288 (353)
T PLN00034        224 --PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD--WASLMCAI-----------  288 (353)
T ss_pred             --cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc--HHHHHHHH-----------
Confidence              1233468999999998743     234578999999999999999999997422111  11111000           


Q ss_pred             hhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          504 NLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                       ...  ........++.++.+++.+||+.||++||++.|+++|
T Consensus       289 -~~~--~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        289 -CMS--QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             -hcc--CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             000  0001112345678999999999999999999999987

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3.8e-40  Score=318.87  Aligned_cols=266  Identities=24%  Similarity=0.335  Sum_probs=200.6

Q ss_pred             hccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCC-----ceEE
Q 007680          272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPD-----FKAL  345 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~l  345 (593)
                      -.|+..+.+|.|+||.||+|... +++.||||.+-.+..    .-.+|+++|+.++|||||++.-+|....     ...+
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl   99 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL   99 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence            35778899999999999999954 679999998854422    2246999999999999999998885432     3458


Q ss_pred             EEeccCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCC-CcEEEEeeccce
Q 007680          346 VLEFMPNGSLEKWLYSH---NYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDEN-MVAHVSDFGIYK  421 (593)
Q Consensus       346 v~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~-~~~kL~Dfg~a~  421 (593)
                      |||||+. +|.+.++..   +..++...+.-+++||.+||.|||.    .+|+||||||.|+|+|.+ |.+||+|||.|+
T Consensus       100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~----~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK  174 (364)
T KOG0658|consen  100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS----HGICHRDIKPQNLLVDPDTGVLKICDFGSAK  174 (364)
T ss_pred             HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh----cCcccCCCChheEEEcCCCCeEEeccCCcce
Confidence            9999976 999998752   3458888999999999999999995    559999999999999976 899999999999


Q ss_pred             ecCCCCCccccccccCCccccCccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhh
Q 007680          422 LLGEGEDSVRQTMTMATIGYMAPEYGLEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEV  500 (593)
Q Consensus       422 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  500 (593)
                      .+..++..   .....|..|+|||.+.+. .|+.+.||||.|||+.||+-|++-|.+.. +...+...+. .+.-...+-
T Consensus       175 ~L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s-~~dQL~eIik-~lG~Pt~e~  249 (364)
T KOG0658|consen  175 VLVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDS-SVDQLVEIIK-VLGTPTRED  249 (364)
T ss_pred             eeccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCC-HHHHHHHHHH-HhCCCCHHH
Confidence            98776643   335678999999998875 59999999999999999999999998732 2222222221 111111111


Q ss_pred             h-----------hhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH--HHHhh
Q 007680          501 V-----------DANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK--LKKIK  551 (593)
Q Consensus       501 ~-----------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~i~  551 (593)
                      +           .+.+.......-.....+++..+|+.++|..+|.+|.++.|++.|  ..+++
T Consensus       250 I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr  313 (364)
T KOG0658|consen  250 IKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELR  313 (364)
T ss_pred             HhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhh
Confidence            1           111111111011122456789999999999999999999999976  44443

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=2.1e-39  Score=338.56  Aligned_cols=255  Identities=19%  Similarity=0.287  Sum_probs=203.6

Q ss_pred             HhhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceE
Q 007680          269 RATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKA  344 (593)
Q Consensus       269 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  344 (593)
                      ...++|++.+.||+|+||.||+++.. +++.||+|+++...   ......+.+|+.+++.++||||+++++++.+++..+
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~  119 (370)
T cd05596          40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY  119 (370)
T ss_pred             CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence            34678999999999999999999975 68899999997642   223455788999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecC
Q 007680          345 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG  424 (593)
Q Consensus       345 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~  424 (593)
                      +||||+++|+|.+++....  +++..+..++.|++.||+|||++    +|+||||||+||+++.++.+||+|||++....
T Consensus       120 lv~Ey~~gg~L~~~l~~~~--l~~~~~~~~~~qi~~aL~~LH~~----~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~  193 (370)
T cd05596         120 MVMEYMPGGDLVNLMSNYD--IPEKWARFYTAEVVLALDAIHSM----GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMD  193 (370)
T ss_pred             EEEcCCCCCcHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence            9999999999999987653  88889999999999999999954    59999999999999999999999999998764


Q ss_pred             CCCCccccccccCCccccCccccCCC----CCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhh
Q 007680          425 EGEDSVRQTMTMATIGYMAPEYGLEG----IVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEV  500 (593)
Q Consensus       425 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  500 (593)
                      .... .......||+.|+|||++.+.    .++.++|||||||++|||++|+.||....... .+..... .        
T Consensus       194 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-~~~~i~~-~--------  262 (370)
T cd05596         194 ANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-TYSKIMD-H--------  262 (370)
T ss_pred             CCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH-HHHHHHc-C--------
Confidence            3321 122345699999999987653    47899999999999999999999997632110 1111100 0        


Q ss_pred             hhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCC--CCCHHHHHHH
Q 007680          501 VDANLVREEQAFSAKMDCILSIMDFALDCCMESPDM--RINMTDAAAK  546 (593)
Q Consensus       501 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~  546 (593)
                         .   .....+....++.++.+++.+||+.+|++  ||++.|+++|
T Consensus       263 ---~---~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         263 ---K---NSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             ---C---CcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence               0   00011111124567899999999999988  9999999887

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.7e-39  Score=313.71  Aligned_cols=272  Identities=23%  Similarity=0.284  Sum_probs=209.8

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhH--HHHHHHHHHHHHHhhcCCCC-cceeeeeeecCC-----
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLE--RAFRSFDSECEVLRNVRHRN-LIKILSSYSNPD-----  341 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~-----  341 (593)
                      ...|+.+++||+|.||+||+|+.+ +|+.||+|.++...+  .......+|+.+++.++|+| |+++++++...+     
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            556888899999999999999965 799999999987643  24456789999999999999 999999998776     


Q ss_pred             -ceEEEEeccCCCCHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEee
Q 007680          342 -FKALVLEFMPNGSLEKWLYSHN---YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDF  417 (593)
Q Consensus       342 -~~~lv~e~~~~gsL~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df  417 (593)
                       ..++|+||++ -+|.+++....   ..++...+..+++||+.||+|||+++    |+||||||.||+|+++|.+||+||
T Consensus        90 ~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~----IlHRDLKPQNlLi~~~G~lKlaDF  164 (323)
T KOG0594|consen   90 GKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG----ILHRDLKPQNLLISSSGVLKLADF  164 (323)
T ss_pred             ceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC----eecccCCcceEEECCCCcEeeecc
Confidence             7899999994 59999998866   35777899999999999999999554    999999999999999999999999


Q ss_pred             ccceecCCCCCccccccccCCccccCccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHh--cC
Q 007680          418 GIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKES--LP  494 (593)
Q Consensus       418 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~--~~  494 (593)
                      |+|+...-+...  .+..++|..|+|||++.+. .|+...||||+||++.||+++++-|.+..+  .+....+.+.  .|
T Consensus       165 GlAra~~ip~~~--yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se--~~ql~~If~~lGtP  240 (323)
T KOG0594|consen  165 GLARAFSIPMRT--YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE--IDQLFRIFRLLGTP  240 (323)
T ss_pred             chHHHhcCCccc--ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH--HHHHHHHHHHcCCC
Confidence            999976544332  4556789999999998887 699999999999999999999999877543  2221111111  11


Q ss_pred             C--chhhhh---hhhhhh-hhh-h---hhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH--HHHhh
Q 007680          495 H--GLTEVV---DANLVR-EEQ-A---FSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK--LKKIK  551 (593)
Q Consensus       495 ~--~~~~~~---~~~~~~-~~~-~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~i~  551 (593)
                      .  .+..+.   +.+... ... .   ........+...+++.+|++.+|.+|.|++.+++|  +..+.
T Consensus       241 ~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~  309 (323)
T KOG0594|consen  241 NEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELP  309 (323)
T ss_pred             CccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccc
Confidence            1  111111   111100 000 0   00011112478999999999999999999999998  66654

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=8.5e-40  Score=302.48  Aligned_cols=256  Identities=28%  Similarity=0.366  Sum_probs=212.3

Q ss_pred             HHHhhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh--------HHHHHHHHHHHHHHhhc-CCCCcceeeee
Q 007680          267 IQRATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL--------ERAFRSFDSECEVLRNV-RHRNLIKILSS  336 (593)
Q Consensus       267 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l-~h~niv~l~~~  336 (593)
                      -+..-+.|+..+.+|+|..++|-++.++ +|+.+|+|++....        ....+.-.+|+.||+++ .||+|+.+.++
T Consensus        12 a~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~   91 (411)
T KOG0599|consen   12 AKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDV   91 (411)
T ss_pred             HhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeee
Confidence            3445567888899999999999998765 78999999986432        23445667899999999 69999999999


Q ss_pred             eecCCceEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEe
Q 007680          337 YSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSD  416 (593)
Q Consensus       337 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~D  416 (593)
                      |+.+...++|+|.|+.|.|.|++.+.-. +++.+..+|++|+.+|++|||.++    ||||||||+|||++++.++||+|
T Consensus        92 yes~sF~FlVFdl~prGELFDyLts~Vt-lSEK~tR~iMrqlfegVeylHa~~----IVHRDLKpENILlddn~~i~isD  166 (411)
T KOG0599|consen   92 YESDAFVFLVFDLMPRGELFDYLTSKVT-LSEKETRRIMRQLFEGVEYLHARN----IVHRDLKPENILLDDNMNIKISD  166 (411)
T ss_pred             ccCcchhhhhhhhcccchHHHHhhhhee-ecHHHHHHHHHHHHHHHHHHHHhh----hhhcccChhheeeccccceEEec
Confidence            9999999999999999999999988765 999999999999999999999765    99999999999999999999999


Q ss_pred             eccceecCCCCCccccccccCCccccCccccC------CCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHH
Q 007680          417 FGIYKLLGEGEDSVRQTMTMATIGYMAPEYGL------EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVK  490 (593)
Q Consensus       417 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~  490 (593)
                      ||+++.+..++.   -...+||++|.|||.+.      ...|+...|+||.||++|.++.|.+||....  .+-+.+.+.
T Consensus       167 FGFa~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk--QmlMLR~Im  241 (411)
T KOG0599|consen  167 FGFACQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK--QMLMLRMIM  241 (411)
T ss_pred             cceeeccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH--HHHHHHHHH
Confidence            999999877653   34568999999999764      2358899999999999999999999996521  111111111


Q ss_pred             HhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          491 ESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       491 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      +.           +   .....+++.+.+...++||.+||+.||.+|.|++|+++|
T Consensus       242 eG-----------k---yqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH  283 (411)
T KOG0599|consen  242 EG-----------K---YQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH  283 (411)
T ss_pred             hc-----------c---cccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence            10           1   112345567788899999999999999999999999987

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=7.4e-39  Score=321.89  Aligned_cols=256  Identities=25%  Similarity=0.396  Sum_probs=205.8

Q ss_pred             hhccccccccCccCcccEEEEEeC------CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS------DGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKA  344 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  344 (593)
                      ..+|...++||+|+||.||++...      ++..+|+|.+..........+.+|+++++.++|+||+++++++...+..+
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (280)
T cd05092           4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL   83 (280)
T ss_pred             hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence            457888999999999999999632      46689999988766666678999999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhhCC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC
Q 007680          345 LVLEFMPNGSLEKWLYSHN--------------YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENM  410 (593)
Q Consensus       345 lv~e~~~~gsL~~~l~~~~--------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~  410 (593)
                      ++|||+++++|.+++....              ..+++..+..++.|++.|++|||++    +++||||||+||++++++
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~----~i~H~dlkp~nil~~~~~  159 (280)
T cd05092          84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL----HFVHRDLATRNCLVGQGL  159 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC----CeecccccHhhEEEcCCC
Confidence            9999999999999997643              2478899999999999999999955    499999999999999999


Q ss_pred             cEEEEeeccceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHH
Q 007680          411 VAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWV  489 (593)
Q Consensus       411 ~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~  489 (593)
                      .+||+|||++................+++.|+|||+..+..++.++|||||||++|||++ |..||......+  .....
T Consensus       160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~~~~  237 (280)
T cd05092         160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE--AIECI  237 (280)
T ss_pred             CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH--HHHHH
Confidence            999999999876543322111222345678999999998999999999999999999998 999986532211  11111


Q ss_pred             HHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHH
Q 007680          490 KESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKK  549 (593)
Q Consensus       490 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  549 (593)
                      ....                 ....+..+++.+.+++.+||+.||++||++.|+.+.|++
T Consensus       238 ~~~~-----------------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~  280 (280)
T cd05092         238 TQGR-----------------ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA  280 (280)
T ss_pred             HcCc-----------------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence            1000                 001112345678999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-39  Score=339.26  Aligned_cols=253  Identities=22%  Similarity=0.312  Sum_probs=198.9

Q ss_pred             hccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEE
Q 007680          272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVL  347 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  347 (593)
                      ++|++.+.||+|+||.||++... +++.||+|++....   ....+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            47899999999999999999865 78999999987642   234567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCC
Q 007680          348 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGE  427 (593)
Q Consensus       348 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~  427 (593)
                      ||+++|+|.+++...+. +++..+..++.|++.||+|||+.    +|+||||||+||+++.++.+||+|||+++.+....
T Consensus        81 E~~~gg~L~~~l~~~~~-~~~~~~~~~~~ql~~aL~~LH~~----givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~  155 (377)
T cd05629          81 EFLPGGDLMTMLIKYDT-FSEDVTRFYMAECVLAIEAVHKL----GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH  155 (377)
T ss_pred             eCCCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence            99999999999976554 89999999999999999999954    59999999999999999999999999986432110


Q ss_pred             Cc-----------c----------------------------------ccccccCCccccCccccCCCCCCccchHHHHH
Q 007680          428 DS-----------V----------------------------------RQTMTMATIGYMAPEYGLEGIVSAKCDVYSYG  462 (593)
Q Consensus       428 ~~-----------~----------------------------------~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG  462 (593)
                      ..           .                                  ......||+.|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG  235 (377)
T cd05629         156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG  235 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence            00           0                                  00124689999999999998999999999999


Q ss_pred             HHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCC---CC
Q 007680          463 VLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMR---IN  539 (593)
Q Consensus       463 vvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps  539 (593)
                      |++|||++|..||......+ .+.....  ....             ...+....++.++.+++.+|+. +|.+|   ++
T Consensus       236 vil~elltG~~Pf~~~~~~~-~~~~i~~--~~~~-------------~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~  298 (377)
T cd05629         236 AIMFECLIGWPPFCSENSHE-TYRKIIN--WRET-------------LYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGG  298 (377)
T ss_pred             hhhhhhhcCCCCCCCCCHHH-HHHHHHc--cCCc-------------cCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCC
Confidence            99999999999997632111 1111100  0000             0001111234578999999997 77765   59


Q ss_pred             HHHHHHH
Q 007680          540 MTDAAAK  546 (593)
Q Consensus       540 ~~evl~~  546 (593)
                      +.|+++|
T Consensus       299 ~~~~l~h  305 (377)
T cd05629         299 AHEIKSH  305 (377)
T ss_pred             HHHHhcC
Confidence            9999987

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=9.9e-39  Score=317.86  Aligned_cols=255  Identities=24%  Similarity=0.388  Sum_probs=206.0

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEec
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEF  349 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  349 (593)
                      ..+|++.+.||+|+||.||+|..+ +++.||+|.+.... .....+.+|++++++++||||+++++++...+..+++|||
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (263)
T cd05052           5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   83 (263)
T ss_pred             hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence            456888999999999999999865 58899999987543 3346788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCC
Q 007680          350 MPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGED  428 (593)
Q Consensus       350 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  428 (593)
                      +++++|.+++.... ..+++..+..++.|+++||+|||++    +++||||||+||++++++.+||+|||.+........
T Consensus        84 ~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~----~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~  159 (263)
T cd05052          84 MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK----NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  159 (263)
T ss_pred             CCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC----CEeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence            99999999997644 3589999999999999999999965    599999999999999999999999999887654321


Q ss_pred             ccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhh
Q 007680          429 SVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVR  507 (593)
Q Consensus       429 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  507 (593)
                      . .......+..|+|||...+..++.++|||||||++|||++ |..||......  ..........              
T Consensus       160 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~--~~~~~~~~~~--------------  222 (263)
T cd05052         160 T-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVYELLEKGY--------------  222 (263)
T ss_pred             e-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHCCC--------------
Confidence            1 1112234567999999988899999999999999999998 99998653211  1111111100              


Q ss_pred             hhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHh
Q 007680          508 EEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKI  550 (593)
Q Consensus       508 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  550 (593)
                         ....+..++.++.+++.+||+.||++||++.++++.|+.+
T Consensus       223 ---~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         223 ---RMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             ---CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence               0011123456889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=3.7e-39  Score=347.77  Aligned_cols=257  Identities=25%  Similarity=0.293  Sum_probs=205.1

Q ss_pred             HHHhhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehh--hHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCC--
Q 007680          267 IQRATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQ--LERAFRSFDSECEVLRNVRHRNLIKILSSYSNPD--  341 (593)
Q Consensus       267 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--  341 (593)
                      .....++|++.+.||+|+||.||+|+.. +|+.||||++...  .......+.+|+.++..++|+||+++++.+...+  
T Consensus        27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~  106 (496)
T PTZ00283         27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR  106 (496)
T ss_pred             ccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence            3344679999999999999999999854 7999999998754  2344567889999999999999999988765432  


Q ss_pred             ------ceEEEEeccCCCCHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcE
Q 007680          342 ------FKALVLEFMPNGSLEKWLYSHN---YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVA  412 (593)
Q Consensus       342 ------~~~lv~e~~~~gsL~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~  412 (593)
                            ..++||||+++|+|.+++....   ..+++..+..++.|++.||+|||++    +|+||||||+||+++.++.+
T Consensus       107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~----~IiHrDLKP~NILl~~~~~v  182 (496)
T PTZ00283        107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK----HMIHRDIKSANILLCSNGLV  182 (496)
T ss_pred             CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC----CEecCCCCHHHEEEeCCCCE
Confidence                  3689999999999999987532   3589999999999999999999954    59999999999999999999


Q ss_pred             EEEeeccceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHh
Q 007680          413 HVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKES  492 (593)
Q Consensus       413 kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~  492 (593)
                      ||+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||.....     ...+...
T Consensus       183 kL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~-----~~~~~~~  257 (496)
T PTZ00283        183 KLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM-----EEVMHKT  257 (496)
T ss_pred             EEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHH
Confidence            99999999876543222223345689999999999999999999999999999999999999975321     1111111


Q ss_pred             cCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          493 LPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       493 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      ..            ...  .+.+..+++++.+++.+||+.||++||++.+++++
T Consensus       258 ~~------------~~~--~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        258 LA------------GRY--DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             hc------------CCC--CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            00            000  00112345678999999999999999999999876

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=4.8e-39  Score=330.25  Aligned_cols=247  Identities=23%  Similarity=0.246  Sum_probs=197.9

Q ss_pred             ccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhcCCC-CcceeeeeeecCCceEEEE
Q 007680          273 EFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNVRHR-NLIKILSSYSNPDFKALVL  347 (593)
Q Consensus       273 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~  347 (593)
                      +|++.+.||+|+||.||+|+.+ +++.||+|+++...   ....+.+..|.+++..++|+ +|+++++++...+..++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            5888999999999999999965 67899999998653   23456678899999999764 6888999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCC
Q 007680          348 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGE  427 (593)
Q Consensus       348 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~  427 (593)
                      ||+++|+|.+++..... +++..+..++.|++.||+|||++    +|+||||||+||+++.++.+||+|||++.......
T Consensus        81 E~~~~g~L~~~~~~~~~-~~~~~~~~~~~qi~~al~~lH~~----~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  155 (324)
T cd05587          81 EYVNGGDLMYHIQQVGK-FKEPHAVFYAAEIAIGLFFLHSK----GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG  155 (324)
T ss_pred             cCCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence            99999999999977654 89999999999999999999965    59999999999999999999999999987532221


Q ss_pred             CccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhh
Q 007680          428 DSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVR  507 (593)
Q Consensus       428 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  507 (593)
                      .  ......||+.|+|||++.+..++.++||||+||++|||+||+.||......  .....+....              
T Consensus       156 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~--~~~~~i~~~~--------------  217 (324)
T cd05587         156 K--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED--ELFQSIMEHN--------------  217 (324)
T ss_pred             C--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--HHHHHHHcCC--------------
Confidence            1  123356899999999999999999999999999999999999999763211  1111111000              


Q ss_pred             hhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCH-----HHHHHH
Q 007680          508 EEQAFSAKMDCILSIMDFALDCCMESPDMRINM-----TDAAAK  546 (593)
Q Consensus       508 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~~  546 (593)
                          ...+...+.++.+++.+||..||.+|++.     .++++|
T Consensus       218 ----~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  257 (324)
T cd05587         218 ----VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH  257 (324)
T ss_pred             ----CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence                00011235578999999999999999976     566654

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=2.1e-39  Score=333.04  Aligned_cols=243  Identities=22%  Similarity=0.253  Sum_probs=197.1

Q ss_pred             cccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEeccCCC
Q 007680          278 NLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNG  353 (593)
Q Consensus       278 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  353 (593)
                      +.||+|+||.||++... +|+.||+|+++...   ......+..|++++..++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999864 78999999998653   234456788999999999999999999999999999999999999


Q ss_pred             CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCccccc
Q 007680          354 SLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQT  433 (593)
Q Consensus       354 sL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~  433 (593)
                      +|.+++..... +++..+..++.|++.||+|||+.   .+|+||||||+||+++.++.+||+|||+++.......  ...
T Consensus        81 ~L~~~l~~~~~-l~~~~~~~~~~qi~~aL~~lH~~---~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~  154 (325)
T cd05594          81 ELFFHLSRERV-FSEDRARFYGAEIVSALDYLHSE---KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMK  154 (325)
T ss_pred             cHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhc---CCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--ccc
Confidence            99998876654 89999999999999999999951   3599999999999999999999999999875432221  122


Q ss_pred             cccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhhhhhh
Q 007680          434 MTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQAFS  513 (593)
Q Consensus       434 ~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  513 (593)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||......  .........                .  ..
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~--~~~~~i~~~----------------~--~~  214 (325)
T cd05594         155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KLFELILME----------------E--IR  214 (325)
T ss_pred             cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH--HHHHHHhcC----------------C--CC
Confidence            346899999999999999999999999999999999999999653211  111111000                0  00


Q ss_pred             hhHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHHH
Q 007680          514 AKMDCILSIMDFALDCCMESPDMRI-----NMTDAAAK  546 (593)
Q Consensus       514 ~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  546 (593)
                      .+...++++.+++.+||+.||++|+     ++.++++|
T Consensus       215 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         215 FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             CCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence            0112356789999999999999997     89999876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=5.5e-39  Score=324.91  Aligned_cols=261  Identities=25%  Similarity=0.432  Sum_probs=207.7

Q ss_pred             HHhhhccccccccCccCcccEEEEEeC------CCCeEEEEEeehhh-HHHHHHHHHHHHHHhhc-CCCCcceeeeeeec
Q 007680          268 QRATDEFNECNLLGTSSFGSVYKGTIS------DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNV-RHRNLIKILSSYSN  339 (593)
Q Consensus       268 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  339 (593)
                      ....++|++.+.||+|+||.||++...      +...+|+|.+.... ......+.+|++++.++ +|+||+++++++..
T Consensus         8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   87 (293)
T cd05053           8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ   87 (293)
T ss_pred             ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence            345678999999999999999999864      23679999987542 33446788999999999 89999999999999


Q ss_pred             CCceEEEEeccCCCCHHHHHhhC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCe
Q 007680          340 PDFKALVLEFMPNGSLEKWLYSH---------------NYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNI  404 (593)
Q Consensus       340 ~~~~~lv~e~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NI  404 (593)
                      ++..+++|||+++|+|.+++...               ...+++..++.++.|++.||+|||++    +|+||||||+||
T Consensus        88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~----~ivH~dlkp~Ni  163 (293)
T cd05053          88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK----KCIHRDLAARNV  163 (293)
T ss_pred             CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC----CccccccceeeE
Confidence            99999999999999999998643               23588999999999999999999965    499999999999


Q ss_pred             eeCCCCcEEEEeeccceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccc
Q 007680          405 LLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEM  483 (593)
Q Consensus       405 ll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~  483 (593)
                      ++++++.+||+|||.++.+.............++..|+|||++.+..++.++|||||||++||+++ |..||......+ 
T Consensus       164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-  242 (293)
T cd05053         164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE-  242 (293)
T ss_pred             EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH-
Confidence            999999999999999987654332222222335678999999988899999999999999999998 999986532111 


Q ss_pred             hHHHHHHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhh
Q 007680          484 SLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIK  551 (593)
Q Consensus       484 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~  551 (593)
                       ..+.....                 .....+..++..+.+++.+||+.||++|||+.|+++.|+++.
T Consensus       243 -~~~~~~~~-----------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         243 -LFKLLKEG-----------------YRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             -HHHHHHcC-----------------CcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence             11111100                 000111233567899999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.5e-39  Score=317.41  Aligned_cols=251  Identities=27%  Similarity=0.355  Sum_probs=202.9

Q ss_pred             hccccccccCccCcccEEEEEeCCCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEeccC
Q 007680          272 DEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMP  351 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  351 (593)
                      .+|++.+.||+|+||.||+|.++++..+|+|.+..... ....+.+|++++++++||||+++++++...+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA   82 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence            46889999999999999999988778899999864322 23467889999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCccc
Q 007680          352 NGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVR  431 (593)
Q Consensus       352 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~  431 (593)
                      +++|.+++......+++..+..++.|++.||+|||+++    ++||||||+||++++++.+||+|||.++........ .
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~----i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~-~  157 (256)
T cd05059          83 NGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG----FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-S  157 (256)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC----cccccccHhhEEECCCCcEEECCcccceeccccccc-c
Confidence            99999999876656899999999999999999999654    999999999999999999999999998865432211 1


Q ss_pred             cccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhhh
Q 007680          432 QTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQ  510 (593)
Q Consensus       432 ~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  510 (593)
                      .....++..|+|||...+..++.++||||||+++||+++ |+.||......  ..........                 
T Consensus       158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~~~~~-----------------  218 (256)
T cd05059         158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS--EVVESVSAGY-----------------  218 (256)
T ss_pred             cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH--HHHHHHHcCC-----------------
Confidence            112224457999999998899999999999999999999 89998753221  1111111100                 


Q ss_pred             hhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 007680          511 AFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKL  547 (593)
Q Consensus       511 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  547 (593)
                      ....+..++.++.+++.+||..+|++|||+.|+++.|
T Consensus       219 ~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         219 RLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence            0011112466889999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.9e-39  Score=340.18  Aligned_cols=253  Identities=21%  Similarity=0.286  Sum_probs=199.4

Q ss_pred             hccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEE
Q 007680          272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVL  347 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  347 (593)
                      .+|++.+.||+|+||.||+|+.. +++.||+|++....   ......+.+|++++++++||||+++++.+.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            36899999999999999999965 68999999997643   233456889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCC
Q 007680          348 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGE  427 (593)
Q Consensus       348 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~  427 (593)
                      ||+++|+|.+++...+. +++..+..++.||+.||+|||++    +|+||||||+||+++.++.+||+|||++..+....
T Consensus        81 E~~~~g~L~~~i~~~~~-~~~~~~~~~~~qi~~al~~lH~~----~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~  155 (376)
T cd05598          81 DYIPGGDMMSLLIRLGI-FEEDLARFYIAELTCAIESVHKM----GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (376)
T ss_pred             eCCCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHC----CeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence            99999999999987654 88999999999999999999955    59999999999999999999999999975331100


Q ss_pred             C-----------------------------------------ccccccccCCccccCccccCCCCCCccchHHHHHHHHH
Q 007680          428 D-----------------------------------------SVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLM  466 (593)
Q Consensus       428 ~-----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~  466 (593)
                      .                                         ........||+.|+|||++.+..++.++|||||||++|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily  235 (376)
T cd05598         156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY  235 (376)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence            0                                         00011246899999999999999999999999999999


Q ss_pred             HHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCC---CHHHH
Q 007680          467 ETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRI---NMTDA  543 (593)
Q Consensus       467 elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP---s~~ev  543 (593)
                      ||++|+.||......+.  ...+.. ...             ....+....+++++.+++.+|+ .+|.+|+   ++.|+
T Consensus       236 ell~G~~Pf~~~~~~~~--~~~i~~-~~~-------------~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~el  298 (376)
T cd05598         236 EMLVGQPPFLADTPAET--QLKVIN-WET-------------TLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEI  298 (376)
T ss_pred             ehhhCCCCCCCCCHHHH--HHHHhc-cCc-------------cccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHH
Confidence            99999999976422111  000000 000             0000111123556788888876 5999999   89999


Q ss_pred             HHH
Q 007680          544 AAK  546 (593)
Q Consensus       544 l~~  546 (593)
                      ++|
T Consensus       299 l~h  301 (376)
T cd05598         299 KAH  301 (376)
T ss_pred             hCC
Confidence            987

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=3.9e-39  Score=338.53  Aligned_cols=252  Identities=21%  Similarity=0.306  Sum_probs=197.9

Q ss_pred             ccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEe
Q 007680          273 EFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLE  348 (593)
Q Consensus       273 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  348 (593)
                      .|++++.||+|+||.||+|+.. +++.||+|++....   ......+.+|+.++++++||||+++++.+.+++..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            5889999999999999999965 68899999998653   3345678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCC
Q 007680          349 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGED  428 (593)
Q Consensus       349 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  428 (593)
                      |+++|+|.+++...+ .+++..+..++.|++.||+|||++    +|+||||||+|||++.++.+||+|||++..+.....
T Consensus        82 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~al~~lH~~----~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~  156 (382)
T cd05625          82 YIPGGDMMSLLIRMG-IFPEDLARFYIAELTCAVESVHKM----GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD  156 (382)
T ss_pred             CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence            999999999997765 388999999999999999999954    599999999999999999999999999753321000


Q ss_pred             ---------------------------------------------ccccccccCCccccCccccCCCCCCccchHHHHHH
Q 007680          429 ---------------------------------------------SVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGV  463 (593)
Q Consensus       429 ---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGv  463 (593)
                                                                   ........||+.|+|||++.+..++.++||||+||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv  236 (382)
T cd05625         157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV  236 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence                                                         00011236899999999999999999999999999


Q ss_pred             HHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCC---H
Q 007680          464 LLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRIN---M  540 (593)
Q Consensus       464 vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~  540 (593)
                      ++|||++|+.||......+. ......  ..             .....+.....++++.+++.+|+ .+|++|++   +
T Consensus       237 il~elltG~~Pf~~~~~~~~-~~~i~~--~~-------------~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~  299 (382)
T cd05625         237 ILYEMLVGQPPFLAQTPLET-QMKVIN--WQ-------------TSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGA  299 (382)
T ss_pred             HHHHHHhCCCCCCCCCHHHH-HHHHHc--cC-------------CCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCH
Confidence            99999999999976322110 111000  00             00001111223456788888876 49999997   8


Q ss_pred             HHHHHH
Q 007680          541 TDAAAK  546 (593)
Q Consensus       541 ~evl~~  546 (593)
                      .|+++|
T Consensus       300 ~ei~~h  305 (382)
T cd05625         300 DEIKAH  305 (382)
T ss_pred             HHHhcC
Confidence            888775

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=4.6e-39  Score=329.63  Aligned_cols=242  Identities=24%  Similarity=0.300  Sum_probs=194.5

Q ss_pred             cccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhc-CCCCcceeeeeeecCCceEEEEeccCC
Q 007680          278 NLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNV-RHRNLIKILSSYSNPDFKALVLEFMPN  352 (593)
Q Consensus       278 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  352 (593)
                      +.||+|+||.||+|+.+ +++.||+|+++...   ....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999975 68899999998643   23445677888888877 699999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCcccc
Q 007680          353 GSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQ  432 (593)
Q Consensus       353 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~  432 (593)
                      |+|.+++..... +++..+..++.|++.||+|||++    +|+||||||+||++++++.+||+|||+++.......  ..
T Consensus        81 g~L~~~i~~~~~-l~~~~~~~~~~ql~~~L~~lH~~----~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~--~~  153 (320)
T cd05590          81 GDLMFHIQKSRR-FDEARARFYAAEITSALMFLHDK----GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK--TT  153 (320)
T ss_pred             chHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHC----CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC--cc
Confidence            999999877654 89999999999999999999965    499999999999999999999999999875432221  22


Q ss_pred             ccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhhhhh
Q 007680          433 TMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQAF  512 (593)
Q Consensus       433 ~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  512 (593)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||......  .....+...           ..       
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~--~~~~~i~~~-----------~~-------  213 (320)
T cd05590         154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED--DLFEAILND-----------EV-------  213 (320)
T ss_pred             cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH--HHHHHHhcC-----------CC-------
Confidence            3356899999999999889999999999999999999999999763211  111111100           00       


Q ss_pred             hhhHHHHHHHHHHHhhcccCCCCCCCCH------HHHHHH
Q 007680          513 SAKMDCILSIMDFALDCCMESPDMRINM------TDAAAK  546 (593)
Q Consensus       513 ~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~~  546 (593)
                      ..+...+.++.+++.+||+.||++||++      +++++|
T Consensus       214 ~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h  253 (320)
T cd05590         214 VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH  253 (320)
T ss_pred             CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence            0011235578999999999999999998      556554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-39  Score=329.02  Aligned_cols=264  Identities=23%  Similarity=0.375  Sum_probs=217.8

Q ss_pred             hhccccccccCccCcccEEEEEeCCCCeEEEEEeehhhH-HHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEec
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLE-RAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEF  349 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  349 (593)
                      .+...+.++||+|.||.|.++....+.+||||.++.... .....|.+|+++|.+++||||++++|+|..++..++|+||
T Consensus       537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY  616 (807)
T KOG1094|consen  537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY  616 (807)
T ss_pred             hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence            345677899999999999999988789999999998753 4458999999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCC-CHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCC
Q 007680          350 MPNGSLEKWLYSHNYFL-DILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGED  428 (593)
Q Consensus       350 ~~~gsL~~~l~~~~~~l-~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  428 (593)
                      |++|+|.+++.++..+. ......+|+.||+.|++||.    +.++||||+.+.|+|++.++++||+|||+++-+-.++.
T Consensus       617 mEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLe----s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y  692 (807)
T KOG1094|consen  617 MENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLE----SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY  692 (807)
T ss_pred             HhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHH----hhchhhccccccceeecCcccEEecCcccccccccCCc
Confidence            99999999999885433 55667789999999999999    67799999999999999999999999999997766554


Q ss_pred             ccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh--CCCCCCccccccchHHHHHHHhcCCchhhhhhhhhh
Q 007680          429 SVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT--RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLV  506 (593)
Q Consensus       429 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  506 (593)
                      .......+-...|||||.+..++++.++|||+||+++||+++  ...||++..++.  ..+-....++..          
T Consensus       693 y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~--vven~~~~~~~~----------  760 (807)
T KOG1094|consen  693 YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ--VVENAGEFFRDQ----------  760 (807)
T ss_pred             eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH--HHHhhhhhcCCC----------
Confidence            444444566789999999999999999999999999999876  788998754322  111111111111          


Q ss_pred             hhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHh
Q 007680          507 REEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKI  550 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  550 (593)
                      ........+.-|+.++.+++.+||+.|-++||+++++..+|++.
T Consensus       761 ~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  761 GRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             CcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            11112234456788999999999999999999999999998764

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=4.2e-39  Score=331.87  Aligned_cols=252  Identities=23%  Similarity=0.256  Sum_probs=199.3

Q ss_pred             ccccccccCccCcccEEEEEeC----CCCeEEEEEeehhh----HHHHHHHHHHHHHHhhc-CCCCcceeeeeeecCCce
Q 007680          273 EFNECNLLGTSSFGSVYKGTIS----DGTDVAIKVFNLQL----ERAFRSFDSECEVLRNV-RHRNLIKILSSYSNPDFK  343 (593)
Q Consensus       273 ~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  343 (593)
                      +|++.+.||+|+||.||+++..    +++.||+|+++...    ....+.+..|+.++..+ +||||+++++++...+..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            4888999999999999999752    58899999997642    23345678899999999 599999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceec
Q 007680          344 ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLL  423 (593)
Q Consensus       344 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~  423 (593)
                      ++||||+++|+|.+++..... +++.++..++.|++.||+|||++    +|+||||||+|||++.++.+||+|||+++..
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~qi~~~l~~lH~~----~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~  155 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRDN-FSEDEVRFYSGEIILALEHLHKL----GIVYRDIKLENILLDSEGHVVLTDFGLSKEF  155 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHC----CcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence            999999999999999977654 89999999999999999999955    5999999999999999999999999998865


Q ss_pred             CCCCCccccccccCCccccCccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhh
Q 007680          424 GEGEDSVRQTMTMATIGYMAPEYGLEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVD  502 (593)
Q Consensus       424 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  502 (593)
                      ...... ......||..|+|||++.+. .++.++|||||||++|||+||+.||........ .......           
T Consensus       156 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-~~~~~~~-----------  222 (332)
T cd05614         156 LSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT-QSEVSRR-----------  222 (332)
T ss_pred             cccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC-HHHHHHH-----------
Confidence            433221 12235689999999998765 478999999999999999999999965321110 0000000           


Q ss_pred             hhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHHH
Q 007680          503 ANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRI-----NMTDAAAK  546 (593)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  546 (593)
                        +....  ...+...+..+.+++.+||+.||++||     +++++++|
T Consensus       223 --~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  267 (332)
T cd05614         223 --ILKCD--PPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH  267 (332)
T ss_pred             --HhcCC--CCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence              00000  001112356789999999999999999     77788876

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=8.6e-39  Score=320.89  Aligned_cols=257  Identities=26%  Similarity=0.398  Sum_probs=203.5

Q ss_pred             hhhccccccccCccCcccEEEEEeC------CCCeEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCc
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTIS------DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDF  342 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  342 (593)
                      ..++|++.+.||+|++|.||+|.+.      .+..||+|.+.... ......+.+|+.++++++|+||+++++++.+.+.
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP   83 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            4578999999999999999999875      35679999886543 3334578899999999999999999999999999


Q ss_pred             eEEEEeccCCCCHHHHHhhCCC------CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC---cEE
Q 007680          343 KALVLEFMPNGSLEKWLYSHNY------FLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENM---VAH  413 (593)
Q Consensus       343 ~~lv~e~~~~gsL~~~l~~~~~------~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~---~~k  413 (593)
                      .++||||+++++|.+++...+.      .+++..+..++.||+.||+|||++    +++||||||+||+++.++   .+|
T Consensus        84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~----~ivH~dlkp~nil~~~~~~~~~~k  159 (277)
T cd05036          84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN----HFIHRDIAARNCLLTCKGPGRVAK  159 (277)
T ss_pred             cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC----CEeecccchheEEEeccCCCcceE
Confidence            9999999999999999976542      488999999999999999999965    499999999999998654   699


Q ss_pred             EEeeccceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHh
Q 007680          414 VSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKES  492 (593)
Q Consensus       414 L~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~  492 (593)
                      |+|||+++................+..|+|||++.+..++.++|||||||++|||++ |..||......+  ....+...
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~--~~~~~~~~  237 (277)
T cd05036         160 IADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE--VMEFVTGG  237 (277)
T ss_pred             eccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHHcC
Confidence            999999987633221111122234567999999988899999999999999999997 999997632211  11111110


Q ss_pred             cCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHH
Q 007680          493 LPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKK  549 (593)
Q Consensus       493 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  549 (593)
                      .                 ....+..++..+.+++.+||+.+|++||++.+++++|++
T Consensus       238 ~-----------------~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~  277 (277)
T cd05036         238 G-----------------RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY  277 (277)
T ss_pred             C-----------------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence            0                 001112345678999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=9.3e-39  Score=321.62  Aligned_cols=268  Identities=24%  Similarity=0.377  Sum_probs=204.6

Q ss_pred             cc-ccccccCccCcccEEEEEe-----CCCCeEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceeeeeeecC--Cce
Q 007680          273 EF-NECNLLGTSSFGSVYKGTI-----SDGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSYSNP--DFK  343 (593)
Q Consensus       273 ~~-~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  343 (593)
                      +| ++.+.||+|+||.||++..     .+++.||+|.++... ......+.+|++++++++||||+++++++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (283)
T cd05080           4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL   83 (283)
T ss_pred             hhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence            44 8889999999999988653     357889999997643 23456788999999999999999999987654  357


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceec
Q 007680          344 ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLL  423 (593)
Q Consensus       344 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~  423 (593)
                      ++||||+++++|.+++....  +++.++..++.|++.||+|||++    +|+||||||+||++++++.++|+|||++...
T Consensus        84 ~lv~e~~~~~~l~~~~~~~~--l~~~~~~~i~~~l~~~l~~lH~~----~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~  157 (283)
T cd05080          84 QLIMEYVPLGSLRDYLPKHK--LNLAQLLLFAQQICEGMAYLHSQ----HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV  157 (283)
T ss_pred             EEEecCCCCCCHHHHHHHcC--CCHHHHHHHHHHHHHHHHHHHHC----CeeccccChheEEEcCCCcEEEeeccccccc
Confidence            89999999999999997654  89999999999999999999965    4999999999999999999999999999876


Q ss_pred             CCCCCccc-cccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcC-Cchhhhh
Q 007680          424 GEGEDSVR-QTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLP-HGLTEVV  501 (593)
Q Consensus       424 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~  501 (593)
                      ........ .....++..|+|||...+..++.++||||||+++|||+||..||................... ....+.+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (283)
T cd05080         158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELL  237 (283)
T ss_pred             CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhh
Confidence            54332111 122345667999999988889999999999999999999999986532211111111000000 0011111


Q ss_pred             hhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhh
Q 007680          502 DANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIK  551 (593)
Q Consensus       502 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~  551 (593)
                      +...     ..+.+..++.++.+++.+||+.+|++|||++++++.|+++.
T Consensus       238 ~~~~-----~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         238 ERGM-----RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             hcCC-----CCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            1111     11112245678999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=2.2e-38  Score=321.35  Aligned_cols=268  Identities=25%  Similarity=0.406  Sum_probs=211.0

Q ss_pred             hccccccccCccCcccEEEEEeC-CCC--eEEEEEeehh-hHHHHHHHHHHHHHHhhc-CCCCcceeeeeeecCCceEEE
Q 007680          272 DEFNECNLLGTSSFGSVYKGTIS-DGT--DVAIKVFNLQ-LERAFRSFDSECEVLRNV-RHRNLIKILSSYSNPDFKALV  346 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  346 (593)
                      ++|++.+.||+|+||.||+|..+ ++.  .+++|.++.. .....+.+.+|++++.++ +||||+++++++...+..++|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            67999999999999999999875 333  4788888743 233456788999999999 799999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCc
Q 007680          347 LEFMPNGSLEKWLYSHN---------------YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMV  411 (593)
Q Consensus       347 ~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~  411 (593)
                      |||+++++|.+++....               ..+++..+..++.|++.||+|||++    +|+||||||+||++++++.
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~----~ivH~dlkp~Nill~~~~~  157 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK----QFIHRDLAARNVLVGENLA  157 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCcCCcceEEECCCCe
Confidence            99999999999997542               2478899999999999999999965    4999999999999999999


Q ss_pred             EEEEeeccceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHH
Q 007680          412 AHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVK  490 (593)
Q Consensus       412 ~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~  490 (593)
                      +||+|||++.......   .......+..|+|||+..+..++.++|||||||++|||++ |..||.......  ......
T Consensus       158 ~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~--~~~~~~  232 (297)
T cd05089         158 SKIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE--LYEKLP  232 (297)
T ss_pred             EEECCcCCCcccccee---ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHh
Confidence            9999999986432111   1111223557999999988889999999999999999997 999996632111  111100


Q ss_pred             HhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhhhcchhhccCCcc
Q 007680          491 ESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKFLDDAAATNWRN  565 (593)
Q Consensus       491 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~~~~~~~  565 (593)
                      .            ..     ....+..++..+.+++.+||+.+|.+||++.++++.|+.+.......-....|++
T Consensus       233 ~------------~~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~~~~~~~~~~  290 (297)
T cd05089         233 Q------------GY-----RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKAYVNMALFEN  290 (297)
T ss_pred             c------------CC-----CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcccccchhhhh
Confidence            0            00     0011123456789999999999999999999999999999988766666666655

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.3e-38  Score=320.22  Aligned_cols=245  Identities=23%  Similarity=0.287  Sum_probs=194.9

Q ss_pred             cCccCcccEEEEEeC-CCCeEEEEEeehhhH---HHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEeccCCCCH
Q 007680          280 LGTSSFGSVYKGTIS-DGTDVAIKVFNLQLE---RAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSL  355 (593)
Q Consensus       280 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  355 (593)
                      ||+|+||+||++... +++.||+|.+.....   ...+.+..|++++++++||||+++.+++...+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            799999999999865 789999999976432   2335677899999999999999999999999999999999999999


Q ss_pred             HHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCcccc
Q 007680          356 EKWLYS---HNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQ  432 (593)
Q Consensus       356 ~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~  432 (593)
                      .+++..   ....+++..+..++.|++.||+|||++    +|+||||||+||++++++.++|+|||.+..+.....  ..
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~  154 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR----RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KT  154 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--cc
Confidence            988754   223589999999999999999999954    599999999999999999999999999987654332  12


Q ss_pred             ccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhhhhh
Q 007680          433 TMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQAF  512 (593)
Q Consensus       433 ~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  512 (593)
                      ....|++.|+|||++.+..++.++|||||||++|||++|+.||........ .........             ...  .
T Consensus       155 ~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~-------------~~~--~  218 (280)
T cd05608         155 KGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE-NKELKQRIL-------------NDS--V  218 (280)
T ss_pred             cccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh-HHHHHHhhc-------------ccC--C
Confidence            234689999999999999999999999999999999999999975321110 000000000             000  0


Q ss_pred             hhhHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHHH
Q 007680          513 SAKMDCILSIMDFALDCCMESPDMRI-----NMTDAAAK  546 (593)
Q Consensus       513 ~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  546 (593)
                      ..+..++..+.+++.+||+.||++||     +++++++|
T Consensus       219 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h  257 (280)
T cd05608         219 TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH  257 (280)
T ss_pred             CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence            11123466789999999999999999     67777765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=5.7e-39  Score=329.23  Aligned_cols=242  Identities=22%  Similarity=0.239  Sum_probs=195.6

Q ss_pred             cccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhc-CCCCcceeeeeeecCCceEEEEeccCC
Q 007680          278 NLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNV-RHRNLIKILSSYSNPDFKALVLEFMPN  352 (593)
Q Consensus       278 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  352 (593)
                      +.||+|+||.||+|+.. +++.||+|+++...   ....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999975 68899999998653   23445677888888876 799999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCcccc
Q 007680          353 GSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQ  432 (593)
Q Consensus       353 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~  432 (593)
                      ++|.+++..... +++..+..++.|++.||+|||++    +|+||||||+||+++.++.+||+|||++........  ..
T Consensus        81 ~~L~~~l~~~~~-~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~~  153 (321)
T cd05591          81 GDLMFQIQRSRK-FDEPRSRFYAAEVTLALMFLHRH----GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--TT  153 (321)
T ss_pred             CcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHeEECCCCCEEEeecccceecccCCc--cc
Confidence            999999876654 89999999999999999999965    499999999999999999999999999875432221  12


Q ss_pred             ccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhhhhh
Q 007680          433 TMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQAF  512 (593)
Q Consensus       433 ~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  512 (593)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||......  .....+...           .     .  
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~--~~~~~i~~~-----------~-----~--  213 (321)
T cd05591         154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED--DLFESILHD-----------D-----V--  213 (321)
T ss_pred             cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH--HHHHHHHcC-----------C-----C--
Confidence            3346899999999999889999999999999999999999999763211  111111100           0     0  


Q ss_pred             hhhHHHHHHHHHHHhhcccCCCCCCC-------CHHHHHHH
Q 007680          513 SAKMDCILSIMDFALDCCMESPDMRI-------NMTDAAAK  546 (593)
Q Consensus       513 ~~~~~~~~~l~~li~~cl~~dP~~RP-------s~~evl~~  546 (593)
                      ..+..++.++.+++.+||+.||++||       ++.++++|
T Consensus       214 ~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         214 LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence            00112345789999999999999999       78888866

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=7.2e-39  Score=327.61  Aligned_cols=242  Identities=23%  Similarity=0.281  Sum_probs=192.1

Q ss_pred             cccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhc-CCCCcceeeeeeecCCceEEEEeccCC
Q 007680          278 NLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNV-RHRNLIKILSSYSNPDFKALVLEFMPN  352 (593)
Q Consensus       278 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  352 (593)
                      +.||+|+||.||+|+.. +++.||+|+++...   ....+.+..|..++... +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999965 68899999998653   22334556677777654 899999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCcccc
Q 007680          353 GSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQ  432 (593)
Q Consensus       353 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~  432 (593)
                      |+|.+++..... +++..+..++.|++.||+|||++    +|+||||||+||+++.++.+||+|||+++......  ...
T Consensus        81 g~L~~~~~~~~~-~~~~~~~~~~~qi~~al~~LH~~----~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~  153 (316)
T cd05592          81 GDLMFHIQSSGR-FDEARARFYAAEIICGLQFLHKK----GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKA  153 (316)
T ss_pred             CcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHC----CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Ccc
Confidence            999999977654 89999999999999999999965    59999999999999999999999999988643322  122


Q ss_pred             ccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhhhhh
Q 007680          433 TMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQAF  512 (593)
Q Consensus       433 ~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  512 (593)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||......  .....+....                .  
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~--~~~~~i~~~~----------------~--  213 (316)
T cd05592         154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED--ELFDSILNDR----------------P--  213 (316)
T ss_pred             ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH--HHHHHHHcCC----------------C--
Confidence            3456899999999999989999999999999999999999999763211  1111111000                0  


Q ss_pred             hhhHHHHHHHHHHHhhcccCCCCCCCCHH-HHHHH
Q 007680          513 SAKMDCILSIMDFALDCCMESPDMRINMT-DAAAK  546 (593)
Q Consensus       513 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~~  546 (593)
                      ..+..++.++.+++.+||+.||++||++. ++++|
T Consensus       214 ~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h  248 (316)
T cd05592         214 HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQH  248 (316)
T ss_pred             CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence            00112345778999999999999999875 55543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1e-38  Score=335.07  Aligned_cols=263  Identities=21%  Similarity=0.361  Sum_probs=207.0

Q ss_pred             HHHhhhccccccccCccCcccEEEEEeC------CCCeEEEEEeehhh-HHHHHHHHHHHHHHhhcC-CCCcceeeeeee
Q 007680          267 IQRATDEFNECNLLGTSSFGSVYKGTIS------DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVR-HRNLIKILSSYS  338 (593)
Q Consensus       267 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~  338 (593)
                      .....++|.+.++||+|+||.||+|++.      .++.||+|+++... ....+.+.+|++++.++. ||||+++++++.
T Consensus        32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~  111 (401)
T cd05107          32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT  111 (401)
T ss_pred             ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence            4445678999999999999999999853      34679999997643 233457889999999997 999999999999


Q ss_pred             cCCceEEEEeccCCCCHHHHHhhCC-------------------------------------------------------
Q 007680          339 NPDFKALVLEFMPNGSLEKWLYSHN-------------------------------------------------------  363 (593)
Q Consensus       339 ~~~~~~lv~e~~~~gsL~~~l~~~~-------------------------------------------------------  363 (593)
                      ..+..++||||+++|+|.++++..+                                                       
T Consensus       112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (401)
T cd05107         112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP  191 (401)
T ss_pred             cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence            9999999999999999999986532                                                       


Q ss_pred             ------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCC
Q 007680          364 ------------------------------------------YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKP  401 (593)
Q Consensus       364 ------------------------------------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp  401 (593)
                                                                ..+++..+..++.|++.||+|||+    .+++||||||
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~----~~ivHrdlkp  267 (401)
T cd05107         192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS----KNCVHRDLAA  267 (401)
T ss_pred             hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc----CCcCcccCCc
Confidence                                                      135677888999999999999995    4599999999


Q ss_pred             CCeeeCCCCcEEEEeeccceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCcccc
Q 007680          402 TNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFI  480 (593)
Q Consensus       402 ~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~  480 (593)
                      +||++++++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus       268 ~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~  347 (401)
T cd05107         268 RNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM  347 (401)
T ss_pred             ceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence            999999999999999999986543322112222346788999999988889999999999999999998 8999865321


Q ss_pred             ccchHHHHHHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhh
Q 007680          481 GEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIK  551 (593)
Q Consensus       481 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~  551 (593)
                      .+. ....+....                 ....+..++.++.+++.+||..+|++||+++|+++.|+++.
T Consensus       348 ~~~-~~~~~~~~~-----------------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         348 NEQ-FYNAIKRGY-----------------RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             hHH-HHHHHHcCC-----------------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            111 111111000                 00111224568899999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=5.4e-39  Score=335.15  Aligned_cols=256  Identities=19%  Similarity=0.283  Sum_probs=202.2

Q ss_pred             HHhhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCce
Q 007680          268 QRATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFK  343 (593)
Q Consensus       268 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  343 (593)
                      ....++|++.+.||+|+||.||+++.. +++.||+|++....   ......+.+|+.+++.++||||+++++++.+++..
T Consensus        39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~  118 (370)
T cd05621          39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL  118 (370)
T ss_pred             CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence            344678999999999999999999976 68899999997532   22345678899999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceec
Q 007680          344 ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLL  423 (593)
Q Consensus       344 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~  423 (593)
                      ++||||+++|+|.+++....  +++..+..++.|++.||+|||++    +|+||||||+||++++++.+||+|||++...
T Consensus       119 ~lv~Ey~~gg~L~~~l~~~~--~~~~~~~~~~~qil~aL~~LH~~----~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~  192 (370)
T cd05621         119 YMVMEYMPGGDLVNLMSNYD--VPEKWAKFYTAEVVLALDAIHSM----GLIHRDVKPDNMLLDKHGHLKLADFGTCMKM  192 (370)
T ss_pred             EEEEcCCCCCcHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCHHHEEECCCCCEEEEecccceec
Confidence            99999999999999997653  88999999999999999999954    5999999999999999999999999999876


Q ss_pred             CCCCCccccccccCCccccCccccCCC----CCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhh
Q 007680          424 GEGEDSVRQTMTMATIGYMAPEYGLEG----IVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTE  499 (593)
Q Consensus       424 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  499 (593)
                      ..... .......||+.|+|||++.+.    .++.++||||+||++|||++|+.||...... ..+....          
T Consensus       193 ~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~-~~~~~i~----------  260 (370)
T cd05621         193 DETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV-GTYSKIM----------  260 (370)
T ss_pred             ccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH-HHHHHHH----------
Confidence            43321 122345699999999988654    3789999999999999999999999763211 1111111          


Q ss_pred             hhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCC--CCCHHHHHHH
Q 007680          500 VVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDM--RINMTDAAAK  546 (593)
Q Consensus       500 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~  546 (593)
                        +...   ....+.....+..+.+++.+|+..+|.+  ||++.|+++|
T Consensus       261 --~~~~---~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         261 --DHKN---SLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             --hCCc---ccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence              0000   0011111234567889999999855543  8999999987

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-38  Score=321.11  Aligned_cols=251  Identities=24%  Similarity=0.309  Sum_probs=201.3

Q ss_pred             ccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEe
Q 007680          273 EFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLE  348 (593)
Q Consensus       273 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  348 (593)
                      .|++.+.||+|+||.||++... +++.||+|++....   ......+.+|+.+++.++||||+++++.+..++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            4788899999999999999965 78999999997643   2223457789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCC
Q 007680          349 FMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGE  427 (593)
Q Consensus       349 ~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~  427 (593)
                      |+++|+|.+++.... ..+++..+..++.|++.||+|||+.    +++||||||+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE----RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE  156 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC----CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence            999999999886543 3589999999999999999999955    59999999999999999999999999988754322


Q ss_pred             CccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhh
Q 007680          428 DSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVR  507 (593)
Q Consensus       428 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  507 (593)
                      .   .....|+..|+|||++.+..++.++||||+||++|||++|+.||....... .. +.+...            +..
T Consensus       157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~-~~-~~~~~~------------~~~  219 (285)
T cd05605         157 T---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV-KR-EEVERR------------VKE  219 (285)
T ss_pred             c---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh-HH-HHHHHH------------hhh
Confidence            1   123468999999999988899999999999999999999999997632111 00 001100            000


Q ss_pred             hhhhhhhhHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHHH
Q 007680          508 EEQAFSAKMDCILSIMDFALDCCMESPDMRI-----NMTDAAAK  546 (593)
Q Consensus       508 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  546 (593)
                      ..  ...+..++..+.+++.+||..||++||     ++.++++|
T Consensus       220 ~~--~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         220 DQ--EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             cc--cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence            00  011123456789999999999999999     88888776

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=9.2e-39  Score=321.63  Aligned_cols=255  Identities=22%  Similarity=0.404  Sum_probs=203.8

Q ss_pred             hccccccccCccCcccEEEEEeC------CCCeEEEEEeehhhH-HHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceE
Q 007680          272 DEFNECNLLGTSSFGSVYKGTIS------DGTDVAIKVFNLQLE-RAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKA  344 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  344 (593)
                      .+|++.+.||+|+||.||+|...      +++.||+|+++.... ...+.+.+|+.++.+++||||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~   84 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS   84 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence            46888899999999999999853      357899999975532 33467889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhhC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCC
Q 007680          345 LVLEFMPNGSLEKWLYSH---------------NYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDEN  409 (593)
Q Consensus       345 lv~e~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~  409 (593)
                      +++||+.+++|.+++...               ...+++..+..++.|++.||+|||++    +|+||||||+||+++++
T Consensus        85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~----gi~H~dlkp~Nil~~~~  160 (283)
T cd05091          85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH----HVVHKDLATRNVLVFDK  160 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc----CccccccchhheEecCC
Confidence            999999999999998532               12478888999999999999999954    59999999999999999


Q ss_pred             CcEEEEeeccceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHH
Q 007680          410 MVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRW  488 (593)
Q Consensus       410 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~  488 (593)
                      +.+||+|||+++...............+++.|+|||++.++.++.++|||||||++|||++ |..||......  .....
T Consensus       161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--~~~~~  238 (283)
T cd05091         161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ--DVIEM  238 (283)
T ss_pred             CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHH
Confidence            9999999999886644332222233446788999999988889999999999999999998 88888653211  11111


Q ss_pred             HHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHH
Q 007680          489 VKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKK  549 (593)
Q Consensus       489 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  549 (593)
                      +....                 ....+.+++..+.+++.+||+.+|++||+++++++.|+.
T Consensus       239 i~~~~-----------------~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         239 IRNRQ-----------------VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             HHcCC-----------------cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            11100                 001123456788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.4e-38  Score=324.41  Aligned_cols=261  Identities=25%  Similarity=0.406  Sum_probs=207.2

Q ss_pred             hhccccccccCccCcccEEEEEeC--------CCCeEEEEEeehhh-HHHHHHHHHHHHHHhhc-CCCCcceeeeeeecC
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS--------DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNV-RHRNLIKILSSYSNP  340 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  340 (593)
                      .++|.+.+.||+|+||.||+++..        ++..+|+|.++... ......+..|+.+++.+ +||||+++++++...
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            468999999999999999999752        23569999997642 34456788899999999 799999999999999


Q ss_pred             CceEEEEeccCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCee
Q 007680          341 DFKALVLEFMPNGSLEKWLYSHN---------------YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNIL  405 (593)
Q Consensus       341 ~~~~lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIl  405 (593)
                      +..++||||+++++|.+++....               ..+++.++..++.|++.||+|||++    +++||||||+||+
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~----gi~H~dlkp~Nil  172 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK----KCIHRDLAARNVL  172 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC----CcccccccHHheE
Confidence            99999999999999999997642               1478899999999999999999954    5999999999999


Q ss_pred             eCCCCcEEEEeeccceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccch
Q 007680          406 LDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMS  484 (593)
Q Consensus       406 l~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~  484 (593)
                      ++.++.+||+|||.+................++..|+|||++.+..++.++|||||||++|||++ |..||.....  ..
T Consensus       173 l~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~--~~  250 (307)
T cd05098         173 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--EE  250 (307)
T ss_pred             EcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH--HH
Confidence            99999999999999876543221111122234568999999988889999999999999999998 8888865321  11


Q ss_pred             HHHHHHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhhh
Q 007680          485 LRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKF  554 (593)
Q Consensus       485 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  554 (593)
                      ..+.....                 ...+.+..++.++.+++.+||..+|++||++.++++.|+++....
T Consensus       251 ~~~~~~~~-----------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~  303 (307)
T cd05098         251 LFKLLKEG-----------------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT  303 (307)
T ss_pred             HHHHHHcC-----------------CCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence            11111110                 001112234568899999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.9e-38  Score=323.61  Aligned_cols=266  Identities=17%  Similarity=0.271  Sum_probs=202.2

Q ss_pred             hccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEec
Q 007680          272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEF  349 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  349 (593)
                      ++|.+.+.||+|+||.||+|+.+ +++.||+|.++... ......+.+|++++++++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            67999999999999999999865 68889999987543 22334577899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCc
Q 007680          350 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDS  429 (593)
Q Consensus       350 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~  429 (593)
                      +++ +|.+++...+..+++..+..++.|++.||+|||++    +|+||||||+||+++.++.+||+|||++........ 
T Consensus        86 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~----~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-  159 (309)
T cd07872          86 LDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR----KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK-  159 (309)
T ss_pred             CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEECCCCCEEECccccceecCCCcc-
Confidence            965 89998877666689999999999999999999965    499999999999999999999999999876543221 


Q ss_pred             cccccccCCccccCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCc----hhhhhh--
Q 007680          430 VRQTMTMATIGYMAPEYGLE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHG----LTEVVD--  502 (593)
Q Consensus       430 ~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~--  502 (593)
                       ......++..|+|||++.+ ..++.++|||||||++|||+||+.||......+.  ...........    +.....  
T Consensus       160 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  236 (309)
T cd07872         160 -TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDE--LHLIFRLLGTPTEETWPGISSND  236 (309)
T ss_pred             -ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHhCCCCHHHHhhhcchh
Confidence             1223457899999998765 4689999999999999999999999976422211  11111111000    000000  


Q ss_pred             ----hhhhhh--hhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          503 ----ANLVRE--EQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       503 ----~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                          ......  .........++.++.+++.+||..||.+|||+.|+++|
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  286 (309)
T cd07872         237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH  286 (309)
T ss_pred             hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence                000000  00001112345678999999999999999999999975

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.8e-38  Score=320.75  Aligned_cols=257  Identities=26%  Similarity=0.410  Sum_probs=204.8

Q ss_pred             ccccccccCccCcccEEEEEeC------CCCeEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEE
Q 007680          273 EFNECNLLGTSSFGSVYKGTIS------DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKAL  345 (593)
Q Consensus       273 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  345 (593)
                      +|++.+.||+|+||.||+|...      ....+++|.+.... ......+.+|+.+++.++||||+++++.+...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            4778899999999999999853      23568999886543 3345678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCC
Q 007680          346 VLEFMPNGSLEKWLYSHN-----------------------YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPT  402 (593)
Q Consensus       346 v~e~~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~  402 (593)
                      ++||+.+++|.+++....                       ..+++..+..++.|++.||+|||++    +++||||||+
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~----~ivH~dikp~  156 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM----KLVHRDLAAR  156 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC----Ceehhhhhhh
Confidence            999999999999986531                       2478899999999999999999965    4999999999


Q ss_pred             CeeeCCCCcEEEEeeccceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccc
Q 007680          403 NILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIG  481 (593)
Q Consensus       403 NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~  481 (593)
                      ||++++++.+||+|||+++...............++..|+|||+..+..++.++||||||+++|||++ |..||......
T Consensus       157 nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~  236 (290)
T cd05045         157 NVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE  236 (290)
T ss_pred             eEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence            99999999999999999886543332222233345678999999888889999999999999999998 99999653211


Q ss_pred             cchHHHHHHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhh
Q 007680          482 EMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKV  552 (593)
Q Consensus       482 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~  552 (593)
                        .........            .     ....+..++.++.+++.+||+.+|++||++.|+++.|+++-.
T Consensus       237 --~~~~~~~~~------------~-----~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         237 --RLFNLLKTG------------Y-----RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV  288 (290)
T ss_pred             --HHHHHHhCC------------C-----CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence              111111111            0     001112345678999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1e-38  Score=318.39  Aligned_cols=255  Identities=21%  Similarity=0.316  Sum_probs=202.7

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEec
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEF  349 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  349 (593)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++..........+.+|+.++++++||||+++++++...+..++||||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~   87 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY   87 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence            457999999999999999999964 7889999999765444456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCc
Q 007680          350 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDS  429 (593)
Q Consensus       350 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~  429 (593)
                      +++++|.+++.... .+++..+..++.|++.||+|||++    +|+||||||+||++++++.++|+|||++........ 
T Consensus        88 ~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-  161 (267)
T cd06646          88 CGGGSLQDIYHVTG-PLSELQIAYVCRETLQGLAYLHSK----GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-  161 (267)
T ss_pred             CCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC----CccccCCCHHHEEECCCCCEEECcCccceeeccccc-
Confidence            99999999987654 489999999999999999999965    599999999999999999999999999987643221 


Q ss_pred             cccccccCCccccCccccC---CCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhh
Q 007680          430 VRQTMTMATIGYMAPEYGL---EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLV  506 (593)
Q Consensus       430 ~~~~~~~gt~~y~aPE~~~---~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  506 (593)
                       ......++..|+|||.+.   ...++.++|||||||++|||++|+.||......+.. ..+...            ...
T Consensus       162 -~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~-~~~~~~------------~~~  227 (267)
T cd06646         162 -KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL-FLMSKS------------NFQ  227 (267)
T ss_pred             -ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh-eeeecC------------CCC
Confidence             122345788999999874   345788999999999999999999998653211100 000000            000


Q ss_pred             hhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 007680          507 REEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKL  547 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  547 (593)
                      .  .........+..+.+++.+||..+|++||+++++++++
T Consensus       228 ~--~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         228 P--PKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             C--CCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            0  00000112356789999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=2.4e-38  Score=322.07  Aligned_cols=262  Identities=24%  Similarity=0.414  Sum_probs=208.9

Q ss_pred             HhhhccccccccCccCcccEEEEEeC--------CCCeEEEEEeehhh-HHHHHHHHHHHHHHhhc-CCCCcceeeeeee
Q 007680          269 RATDEFNECNLLGTSSFGSVYKGTIS--------DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNV-RHRNLIKILSSYS  338 (593)
Q Consensus       269 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  338 (593)
                      ...++|++.+.||+|+||.||+|+..        ++..||+|.+.... ....+.+.+|+.+++.+ +||||+++++++.
T Consensus        12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   91 (304)
T cd05101          12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT   91 (304)
T ss_pred             ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence            34678999999999999999999741        34579999987542 34456789999999999 8999999999999


Q ss_pred             cCCceEEEEeccCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCC
Q 007680          339 NPDFKALVLEFMPNGSLEKWLYSHN---------------YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTN  403 (593)
Q Consensus       339 ~~~~~~lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~N  403 (593)
                      ..+..++||||+++++|.+++....               ..+++.++..++.|+++||+|||++    +++||||||+|
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~----givH~dlkp~N  167 (304)
T cd05101          92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ----KCIHRDLAARN  167 (304)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC----Ceeecccccce
Confidence            9999999999999999999997642               2478888999999999999999965    59999999999


Q ss_pred             eeeCCCCcEEEEeeccceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCcccccc
Q 007680          404 ILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGE  482 (593)
Q Consensus       404 Ill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~  482 (593)
                      |++++++.+||+|||.++...............++..|+|||++.+..++.++||||||+++||+++ |..||...... 
T Consensus       168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-  246 (304)
T cd05101         168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE-  246 (304)
T ss_pred             EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH-
Confidence            9999999999999999987654333222233345678999999988889999999999999999998 78888653211 


Q ss_pred             chHHHHHHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhh
Q 007680          483 MSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVK  553 (593)
Q Consensus       483 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  553 (593)
                       .....+...                 .....+..++..+.+++.+||+.+|++||++.|+++.|+++...
T Consensus       247 -~~~~~~~~~-----------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~  299 (304)
T cd05101         247 -ELFKLLKEG-----------------HRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL  299 (304)
T ss_pred             -HHHHHHHcC-----------------CcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence             111111100                 00011123456889999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=2.5e-38  Score=315.79  Aligned_cols=257  Identities=24%  Similarity=0.456  Sum_probs=207.0

Q ss_pred             hhccccccccCccCcccEEEEEeC-CC---CeEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DG---TDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKAL  345 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  345 (593)
                      .++|+..+.||+|+||.||+|..+ ++   ..+|+|.++... ....+.+..|++++++++||||+++.+++...+..++
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            457888999999999999999865 33   369999987542 3445678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCC
Q 007680          346 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGE  425 (593)
Q Consensus       346 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~  425 (593)
                      ||||+++++|.+++......+++.++..++.|++.|++|||+.    +++|+||||+||++++++.+||+|||++.....
T Consensus        84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~----~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  159 (268)
T cd05063          84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDM----NYVHRDLAARNILVNSNLECKVSDFGLSRVLED  159 (268)
T ss_pred             EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC----CeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence            9999999999999987666689999999999999999999965    499999999999999999999999999887654


Q ss_pred             CCCcccc-ccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhhhh
Q 007680          426 GEDSVRQ-TMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDA  503 (593)
Q Consensus       426 ~~~~~~~-~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  503 (593)
                      ....... .....+..|+|||++.+..++.++|||||||++||+++ |+.||......  .....+...           
T Consensus       160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~--~~~~~i~~~-----------  226 (268)
T cd05063         160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH--EVMKAINDG-----------  226 (268)
T ss_pred             ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH--HHHHHHhcC-----------
Confidence            3221111 11223457999999988889999999999999999998 99999653211  111111100           


Q ss_pred             hhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHh
Q 007680          504 NLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKI  550 (593)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  550 (593)
                            ...+...+++.++.+++.+||+.+|++||++.++++.|+++
T Consensus       227 ------~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         227 ------FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             ------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                  01111223456789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-38  Score=327.15  Aligned_cols=251  Identities=25%  Similarity=0.338  Sum_probs=212.7

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhH---HHHHHHHHHHHHHhhcC-CCCcceeeeeeecCCceEE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLE---RAFRSFDSECEVLRNVR-HRNLIKILSSYSNPDFKAL  345 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l  345 (593)
                      .+.|++.+.||+|.||.||+++.+ +|+.+|+|++.+...   .....+.+|+++|+++. ||||+.++++|++....++
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l  113 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL  113 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence            457888899999999999999976 599999999987643   24468999999999998 9999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCC----CcEEEEeeccce
Q 007680          346 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDEN----MVAHVSDFGIYK  421 (593)
Q Consensus       346 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~----~~~kL~Dfg~a~  421 (593)
                      |||++.||.|.+.+... . +++..+..++.|++.+++|||.    .||+|||+||+|+|+...    +.+|++|||++.
T Consensus       114 vmEL~~GGeLfd~i~~~-~-~sE~da~~~~~~il~av~~lH~----~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~  187 (382)
T KOG0032|consen  114 VMELCEGGELFDRIVKK-H-YSERDAAGIIRQILEAVKYLHS----LGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK  187 (382)
T ss_pred             EEEecCCchHHHHHHHc-c-CCHHHHHHHHHHHHHHHHHHHh----CCceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence            99999999999999887 3 9999999999999999999994    569999999999999643    479999999999


Q ss_pred             ecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhh
Q 007680          422 LLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVV  501 (593)
Q Consensus       422 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  501 (593)
                      .....   ......+||+.|+|||++....|+..+||||+||++|.|++|.+||.......... .            +.
T Consensus       188 ~~~~~---~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-~------------i~  251 (382)
T KOG0032|consen  188 FIKPG---ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-A------------IL  251 (382)
T ss_pred             EccCC---ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-H------------HH
Confidence            87652   23456789999999999999999999999999999999999999998743222111 1            11


Q ss_pred             hhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          502 DANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       502 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      ....   ....+.+...+..+.+++++|+..||.+|+|+.++++|
T Consensus       252 ~~~~---~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  252 RGDF---DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             cCCC---CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence            1111   11233445567789999999999999999999999997

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=2.4e-38  Score=316.08  Aligned_cols=256  Identities=25%  Similarity=0.457  Sum_probs=206.1

Q ss_pred             hccccccccCccCcccEEEEEeC-CC---CeEEEEEeehh-hHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEE
Q 007680          272 DEFNECNLLGTSSFGSVYKGTIS-DG---TDVAIKVFNLQ-LERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALV  346 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  346 (593)
                      .+|++.+.||+|+||.||+|... ++   ..||+|.++.. .......+..|+.++++++||||+++++++..++..++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            46888999999999999999865 33   36999998764 344567899999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCC
Q 007680          347 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG  426 (593)
Q Consensus       347 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  426 (593)
                      |||+++++|.+++......+++.++..++.|++.||+|||++    +++|+||||+||+++.++.+||+|||++......
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~----g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  159 (269)
T cd05065          84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEM----NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD  159 (269)
T ss_pred             EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC----CEeecccChheEEEcCCCcEEECCCccccccccC
Confidence            999999999999987666689999999999999999999965    4999999999999999999999999998766443


Q ss_pred             CCcccccccc---CCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhhh
Q 007680          427 EDSVRQTMTM---ATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVD  502 (593)
Q Consensus       427 ~~~~~~~~~~---gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  502 (593)
                      ..........   .+..|+|||++.+..++.++|||||||++||+++ |..||......  ....++....         
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~--~~~~~i~~~~---------  228 (269)
T cd05065         160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ--DVINAIEQDY---------  228 (269)
T ss_pred             ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH--HHHHHHHcCC---------
Confidence            2211111111   2457999999998899999999999999999887 99999763211  1222221110         


Q ss_pred             hhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHh
Q 007680          503 ANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKI  550 (593)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  550 (593)
                              ..+.+.+++..+.+++.+||+.+|++||++.++++.|+++
T Consensus       229 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         229 --------RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             --------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                    1111224566789999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.8e-38  Score=318.99  Aligned_cols=261  Identities=21%  Similarity=0.335  Sum_probs=209.5

Q ss_pred             hhhccccccccCccCcccEEEEEeCC-----CCeEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CCc
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTISD-----GTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSYSN-PDF  342 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~  342 (593)
                      ..++|++.+.||+|+||.||+|.+.+     +..|++|++.... ......+.+|+.++++++||||+++++++.. +..
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   83 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP   83 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            45789999999999999999999765     6889999987542 3445678899999999999999999998766 567


Q ss_pred             eEEEEeccCCCCHHHHHhhCC-------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEE
Q 007680          343 KALVLEFMPNGSLEKWLYSHN-------YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVS  415 (593)
Q Consensus       343 ~~lv~e~~~~gsL~~~l~~~~-------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~  415 (593)
                      .++++||+++++|.+++....       ..+++..+..++.|++.||+|||++    +++||||||+||++++++.+||+
T Consensus        84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~----~i~H~di~p~nil~~~~~~~kl~  159 (280)
T cd05043          84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR----GVIHKDIAARNCVIDEELQVKIT  159 (280)
T ss_pred             CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC----CEeecccCHhhEEEcCCCcEEEC
Confidence            899999999999999987642       3488999999999999999999965    49999999999999999999999


Q ss_pred             eeccceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcC
Q 007680          416 DFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLP  494 (593)
Q Consensus       416 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~  494 (593)
                      |||+++.+.............++..|+|||++.+..++.++||||||+++||+++ |+.||.....  .....+..... 
T Consensus       160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~~~~-  236 (280)
T cd05043         160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP--FEMAAYLKDGY-  236 (280)
T ss_pred             CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH--HHHHHHHHcCC-
Confidence            9999986644332212222345778999999988889999999999999999999 9999976321  11222211110 


Q ss_pred             CchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhh
Q 007680          495 HGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVK  553 (593)
Q Consensus       495 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  553 (593)
                                      .......+++++.+++.+||..||++|||+.++++.|+.+..+
T Consensus       237 ----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~  279 (280)
T cd05043         237 ----------------RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ  279 (280)
T ss_pred             ----------------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence                            0011123456789999999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.4e-38  Score=325.51  Aligned_cols=242  Identities=22%  Similarity=0.297  Sum_probs=192.9

Q ss_pred             cccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhc-CCCCcceeeeeeecCCceEEEEeccCC
Q 007680          278 NLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNV-RHRNLIKILSSYSNPDFKALVLEFMPN  352 (593)
Q Consensus       278 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  352 (593)
                      +.||+|+||.||+|+.+ +|+.||+|+++...   .........|..++... +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999976 68899999998653   23345567788888765 899999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCcccc
Q 007680          353 GSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQ  432 (593)
Q Consensus       353 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~  432 (593)
                      |+|.+++..... +++.++..++.|++.||+|||++    +|+||||||+||+++.++.+||+|||+++.......  ..
T Consensus        81 g~L~~~i~~~~~-~~~~~~~~~~~qi~~~l~~lH~~----~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~  153 (316)
T cd05620          81 GDLMFHIQDKGR-FDLYRATFYAAEIVCGLQFLHSK----GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN--RA  153 (316)
T ss_pred             CcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC--ce
Confidence            999999877544 89999999999999999999965    599999999999999999999999999875322211  22


Q ss_pred             ccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhhhhh
Q 007680          433 TMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQAF  512 (593)
Q Consensus       433 ~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  512 (593)
                      ....||+.|+|||++.+..++.++||||+||++|||++|+.||.....  ....+.+....+                . 
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~--~~~~~~~~~~~~----------------~-  214 (316)
T cd05620         154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE--DELFESIRVDTP----------------H-  214 (316)
T ss_pred             eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--HHHHHHHHhCCC----------------C-
Confidence            345689999999999999999999999999999999999999975321  111111110000                0 


Q ss_pred             hhhHHHHHHHHHHHhhcccCCCCCCCCHH-HHHHH
Q 007680          513 SAKMDCILSIMDFALDCCMESPDMRINMT-DAAAK  546 (593)
Q Consensus       513 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~~  546 (593)
                       .+..++.++.+++.+||+.||++||++. ++++|
T Consensus       215 -~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h  248 (316)
T cd05620         215 -YPRWITKESKDILEKLFERDPTRRLGVVGNIRGH  248 (316)
T ss_pred             -CCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence             0112345789999999999999999984 66543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-38  Score=314.03  Aligned_cols=252  Identities=22%  Similarity=0.306  Sum_probs=202.8

Q ss_pred             hccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh-----HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEE
Q 007680          272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL-----ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKAL  345 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  345 (593)
                      ++|++.+.||+|++|.||+|... ++++||+|.+....     ....+.+.+|++++++++||||+++++++...+..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            56899999999999999999864 68999999986532     2234578899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCC
Q 007680          346 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGE  425 (593)
Q Consensus       346 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~  425 (593)
                      |+||+++++|.+++..... +++..+..++.|++.||+|||+.    +++||||+|+||++++++.++|+|||.++....
T Consensus        82 v~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lH~~----~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~  156 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYGA-LTETVTRKYTRQILEGVEYLHSN----MIVHRDIKGANILRDSAGNVKLGDFGASKRLQT  156 (263)
T ss_pred             EEEECCCCcHHHHHHHhCC-CCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence            9999999999999977654 88999999999999999999965    599999999999999999999999999886543


Q ss_pred             CCCccc-cccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhh
Q 007680          426 GEDSVR-QTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDAN  504 (593)
Q Consensus       426 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  504 (593)
                      ...... .....++..|+|||++.+..++.++||||+|+++||+++|+.||....... .........            
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~~~~------------  223 (263)
T cd06625         157 ICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA-AIFKIATQP------------  223 (263)
T ss_pred             cccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH-HHHHHhccC------------
Confidence            221111 123457889999999999889999999999999999999999996532111 000000000            


Q ss_pred             hhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          505 LVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       505 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                           .....+..++..+.+++.+||..+|++|||+.|++++
T Consensus       224 -----~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         224 -----TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             -----CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence                 0001112345678999999999999999999999876

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.4e-38  Score=327.46  Aligned_cols=248  Identities=20%  Similarity=0.272  Sum_probs=196.1

Q ss_pred             cccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhc-CCCCcceeeeeeecCCceEEEEeccCC
Q 007680          278 NLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNV-RHRNLIKILSSYSNPDFKALVLEFMPN  352 (593)
Q Consensus       278 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  352 (593)
                      +.||+|+||.||+|+.. +++.||+|+++...   ....+.+..|..++.++ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46899999999999965 68999999998653   23445688899999998 799999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCcccc
Q 007680          353 GSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQ  432 (593)
Q Consensus       353 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~  432 (593)
                      |+|.+++...+. +++..+..++.|++.||+|||++    +|+||||||+||+++.++.+||+|||+++.......  ..
T Consensus        81 g~L~~~~~~~~~-l~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~--~~  153 (329)
T cd05588          81 GDLMFHMQRQRK-LPEEHARFYSAEISLALNFLHER----GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD--TT  153 (329)
T ss_pred             CCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCHHHeEECCCCCEEECcCccccccccCCC--cc
Confidence            999999876654 99999999999999999999965    599999999999999999999999999874322111  22


Q ss_pred             ccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCcccccc---chHHHHHHHhcCCchhhhhhhhhhhhh
Q 007680          433 TMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGE---MSLRRWVKESLPHGLTEVVDANLVREE  509 (593)
Q Consensus       433 ~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~  509 (593)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||+.....+   .....+....            +....
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~------------~~~~~  221 (329)
T cd05588         154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQV------------ILEKQ  221 (329)
T ss_pred             ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHH------------HHcCC
Confidence            34568999999999999999999999999999999999999996421111   1111111111            00000


Q ss_pred             hhhhhhHHHHHHHHHHHhhcccCCCCCCCC------HHHHHHH
Q 007680          510 QAFSAKMDCILSIMDFALDCCMESPDMRIN------MTDAAAK  546 (593)
Q Consensus       510 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs------~~evl~~  546 (593)
                      .  ..+..++.++.+++.+||+.||.+||+      +.++++|
T Consensus       222 ~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05588         222 I--RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH  262 (329)
T ss_pred             C--CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence            0  011123567899999999999999997      5677765

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1e-38  Score=327.66  Aligned_cols=247  Identities=22%  Similarity=0.243  Sum_probs=197.8

Q ss_pred             ccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhc-CCCCcceeeeeeecCCceEEEE
Q 007680          273 EFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNV-RHRNLIKILSSYSNPDFKALVL  347 (593)
Q Consensus       273 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  347 (593)
                      +|++.+.||+|+||.||+|+.. +++.||+|+++...   ....+.+..|..++..+ +|++|+++++++...+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            5788999999999999999876 67899999998653   22334567788888777 5899999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCC
Q 007680          348 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGE  427 (593)
Q Consensus       348 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~  427 (593)
                      ||+++|+|.+++..... +++.++..++.|++.||+|||++    +|+||||||+||++++++.+||+|||+++......
T Consensus        81 E~~~~g~L~~~~~~~~~-~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~  155 (323)
T cd05616          81 EYVNGGDLMYQIQQVGR-FKEPHAVFYAAEIAIGLFFLHSK----GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG  155 (323)
T ss_pred             cCCCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHC----CEEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence            99999999999877654 89999999999999999999955    59999999999999999999999999987543222


Q ss_pred             CccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhh
Q 007680          428 DSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVR  507 (593)
Q Consensus       428 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  507 (593)
                      .  ......||+.|+|||++.+..++.++|||||||++|||+||+.||......  .....+...           .   
T Consensus       156 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~--~~~~~i~~~-----------~---  217 (323)
T cd05616         156 V--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--ELFQSIMEH-----------N---  217 (323)
T ss_pred             C--ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH--HHHHHHHhC-----------C---
Confidence            1  223456899999999999999999999999999999999999999763211  111111110           0   


Q ss_pred             hhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCH-----HHHHHH
Q 007680          508 EEQAFSAKMDCILSIMDFALDCCMESPDMRINM-----TDAAAK  546 (593)
Q Consensus       508 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~~  546 (593)
                          ...+...+.++.+++.+||+.||++|++.     .++.+|
T Consensus       218 ----~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h  257 (323)
T cd05616         218 ----VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  257 (323)
T ss_pred             ----CCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence                00111235678999999999999999985     566544

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.8e-38  Score=313.25  Aligned_cols=254  Identities=26%  Similarity=0.450  Sum_probs=201.3

Q ss_pred             cccccccCccCcccEEEEEeC-C---CCeEEEEEeehhh--HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCc-----
Q 007680          274 FNECNLLGTSSFGSVYKGTIS-D---GTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDF-----  342 (593)
Q Consensus       274 ~~~~~~lg~G~~g~Vy~~~~~-~---~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  342 (593)
                      |.+.+.||+|+||.||+|... +   +..||+|.++...  ......+.+|++.++.++||||+++++++...+.     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            567889999999999999864 2   4679999987542  3445678999999999999999999998866554     


Q ss_pred             -eEEEEeccCCCCHHHHHhhCC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEe
Q 007680          343 -KALVLEFMPNGSLEKWLYSHN-----YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSD  416 (593)
Q Consensus       343 -~~lv~e~~~~gsL~~~l~~~~-----~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~D  416 (593)
                       .+++|||+++++|.+++....     ..+++..+..++.|++.||+|||++    +++||||||+||++++++.+||+|
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~----~i~H~dlkp~Nil~~~~~~~kl~d  156 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR----NFIHRDLAARNCMLREDMTVCVAD  156 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC----CeeccccchheEEECCCCeEEECC
Confidence             799999999999999985432     2589999999999999999999965    499999999999999999999999


Q ss_pred             eccceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCC
Q 007680          417 FGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPH  495 (593)
Q Consensus       417 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~  495 (593)
                      ||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.+....  ...++...... 
T Consensus       157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~--~~~~~~~~~~~-  233 (273)
T cd05035         157 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH--EIYDYLRHGNR-  233 (273)
T ss_pred             ccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCC-
Confidence            999987654332222222335678999999988899999999999999999999 88998663221  11122111100 


Q ss_pred             chhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHh
Q 007680          496 GLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKI  550 (593)
Q Consensus       496 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  550 (593)
                                      ...+..++.++.+++.+||+.||++||++.|++++|+++
T Consensus       234 ----------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         234 ----------------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             ----------------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                            011123456889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-38  Score=319.47  Aligned_cols=253  Identities=25%  Similarity=0.358  Sum_probs=206.1

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEec
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEF  349 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  349 (593)
                      .++|++.+.||+|+||.||++... ++..+|+|++........+.+..|++++++++||||+++++.+..++..++||||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            467999999999999999999975 6899999999876666667889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCc
Q 007680          350 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDS  429 (593)
Q Consensus       350 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~  429 (593)
                      +++++|.+++......+++..+..++.|++.||.|||+++    |+|+||||+||+++.++.++|+|||.+........ 
T Consensus        84 ~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~----i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-  158 (280)
T cd06611          84 CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK----VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ-  158 (280)
T ss_pred             cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC----cccCCCChhhEEECCCCCEEEccCccchhhccccc-
Confidence            9999999999876666999999999999999999999654    99999999999999999999999998876533221 


Q ss_pred             cccccccCCccccCccccC-----CCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhh
Q 007680          430 VRQTMTMATIGYMAPEYGL-----EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDAN  504 (593)
Q Consensus       430 ~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  504 (593)
                       ......++..|+|||++.     +..++.++||||||+++|||++|+.||....... ....+.. .            
T Consensus       159 -~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~-~------------  223 (280)
T cd06611         159 -KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR-VLLKILK-S------------  223 (280)
T ss_pred             -ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH-HHHHHhc-C------------
Confidence             223345888999999864     3457889999999999999999999997632111 1111100 0            


Q ss_pred             hhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          505 LVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       505 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                         .......+..++.++.+++.+||+.+|++||++.+++++
T Consensus       224 ---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         224 ---EPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             ---CCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence               000011112345578999999999999999999999886

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.3e-38  Score=326.12  Aligned_cols=242  Identities=23%  Similarity=0.253  Sum_probs=195.8

Q ss_pred             cccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhc-CCCCcceeeeeeecCCceEEEEeccCC
Q 007680          278 NLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNV-RHRNLIKILSSYSNPDFKALVLEFMPN  352 (593)
Q Consensus       278 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  352 (593)
                      +.||+|+||.||+|+.+ +++.||+|+++...   ......+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999976 68899999998653   23445677888999888 799999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCcccc
Q 007680          353 GSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQ  432 (593)
Q Consensus       353 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~  432 (593)
                      |+|.+++..... +++.++..++.|++.||+|||++    +|+||||||+||++++++.+||+|||++........  ..
T Consensus        81 ~~L~~~~~~~~~-l~~~~~~~~~~qi~~~l~~LH~~----~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~  153 (318)
T cd05570          81 GDLMFHIQRSGR-FDEPRARFYAAEIVLGLQFLHER----GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV--TT  153 (318)
T ss_pred             CCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHhC----CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC--cc
Confidence            999999877654 89999999999999999999954    599999999999999999999999999875322211  12


Q ss_pred             ccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhhhhh
Q 007680          433 TMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQAF  512 (593)
Q Consensus       433 ~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  512 (593)
                      ....|++.|+|||++.+..++.++|||||||++|+|++|+.||.....  ..........           .     .  
T Consensus       154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~--~~~~~~i~~~-----------~-----~--  213 (318)
T cd05570         154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE--DELFQSILED-----------E-----V--  213 (318)
T ss_pred             cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH--HHHHHHHHcC-----------C-----C--
Confidence            234689999999999999999999999999999999999999975321  1111111100           0     0  


Q ss_pred             hhhHHHHHHHHHHHhhcccCCCCCCCCH-----HHHHHH
Q 007680          513 SAKMDCILSIMDFALDCCMESPDMRINM-----TDAAAK  546 (593)
Q Consensus       513 ~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~~  546 (593)
                      ..+..++.++.+++.+||..||++||++     .+++++
T Consensus       214 ~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~  252 (318)
T cd05570         214 RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH  252 (318)
T ss_pred             CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence            0011235678999999999999999999     888765

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=3.3e-38  Score=315.50  Aligned_cols=254  Identities=24%  Similarity=0.428  Sum_probs=197.9

Q ss_pred             cccccccCccCcccEEEEEeCC-CC--eEEEEEeehh--hHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC------Cc
Q 007680          274 FNECNLLGTSSFGSVYKGTISD-GT--DVAIKVFNLQ--LERAFRSFDSECEVLRNVRHRNLIKILSSYSNP------DF  342 (593)
Q Consensus       274 ~~~~~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~  342 (593)
                      |.+.+.||+|+||.||+|++.+ ++  .||+|.++..  .....+.+..|+++++.++||||+++++++...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            3467899999999999999753 33  6899988654  234457788999999999999999999977432      25


Q ss_pred             eEEEEeccCCCCHHHHHhhC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEee
Q 007680          343 KALVLEFMPNGSLEKWLYSH-----NYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDF  417 (593)
Q Consensus       343 ~~lv~e~~~~gsL~~~l~~~-----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df  417 (593)
                      .+++|||+++|+|.+++...     ...+++..+..++.|++.||+|||++    +|+||||||+||++++++.+||+||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~kl~Df  156 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK----SFIHRDLAARNCMLNENMNVCVADF  156 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC----CeeccccchhheEEcCCCCEEECCC
Confidence            68999999999999987432     22478999999999999999999965    4999999999999999999999999


Q ss_pred             ccceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCc
Q 007680          418 GIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHG  496 (593)
Q Consensus       418 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~  496 (593)
                      |+++...............+++.|+|||+..+..++.++||||||+++|||++ |+.||.....  ...........   
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~~~~~~~~~~~---  231 (272)
T cd05075         157 GLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN--SEIYDYLRQGN---  231 (272)
T ss_pred             CcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHcCC---
Confidence            99987654332112223346678999999998899999999999999999999 8899865321  11111111100   


Q ss_pred             hhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHh
Q 007680          497 LTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKI  550 (593)
Q Consensus       497 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  550 (593)
                                    .......++..+.+++.+||+.||++|||+.+++++|+++
T Consensus       232 --------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         232 --------------RLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             --------------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                          0011123456789999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=2.7e-38  Score=318.08  Aligned_cols=252  Identities=25%  Similarity=0.347  Sum_probs=202.3

Q ss_pred             hccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEecc
Q 007680          272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFM  350 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  350 (593)
                      +.|++.+.||+|+||.||+|... ++..+++|.+........+.+.+|+++++.++||||+++++++...+..++||||+
T Consensus         5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~   84 (282)
T cd06643           5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   84 (282)
T ss_pred             HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence            34688899999999999999976 57889999987665556678899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCcc
Q 007680          351 PNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSV  430 (593)
Q Consensus       351 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~  430 (593)
                      ++++|..++......+++..+..++.|+++||+|||+.    +++||||||+||+++.++.+||+|||++........  
T Consensus        85 ~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~----~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--  158 (282)
T cd06643          85 AGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN----KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--  158 (282)
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCCcccEEEccCCCEEEcccccccccccccc--
Confidence            99999998876555689999999999999999999954    599999999999999999999999999876533221  


Q ss_pred             ccccccCCccccCccccC-----CCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhh
Q 007680          431 RQTMTMATIGYMAPEYGL-----EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANL  505 (593)
Q Consensus       431 ~~~~~~gt~~y~aPE~~~-----~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  505 (593)
                      ......++..|+|||++.     +..++.++|||||||++|||++|+.||......+ ......... +.          
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-~~~~~~~~~-~~----------  226 (282)
T cd06643         159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR-VLLKIAKSE-PP----------  226 (282)
T ss_pred             ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH-HHHHHhhcC-CC----------
Confidence            223346889999999873     3457889999999999999999999987632111 111111100 00          


Q ss_pred             hhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          506 VREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                           ....+..++.++.+++.+||+.||++||++.+++++
T Consensus       227 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  262 (282)
T cd06643         227 -----TLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH  262 (282)
T ss_pred             -----CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                 001112235578999999999999999999999865

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=5.6e-38  Score=310.73  Aligned_cols=249  Identities=24%  Similarity=0.302  Sum_probs=204.6

Q ss_pred             ccccccccCccCcccEEEEEeC-CCCeEEEEEeehh--hHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEec
Q 007680          273 EFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQ--LERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEF  349 (593)
Q Consensus       273 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  349 (593)
                      +|++.+.||+|++|.||+|..+ +++.|++|.+...  .......+.+|++++++++||||+++++++...+..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4788899999999999999975 6899999998754  234566788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCC
Q 007680          350 MPNGSLEKWLYSH-NYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGED  428 (593)
Q Consensus       350 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  428 (593)
                      +++++|.+++... ...+++..+..++.|++.||.|||+.    +++|+||||+||++++++.++|+|||++........
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~----~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~  156 (256)
T cd08529          81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK----KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN  156 (256)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence            9999999999875 34689999999999999999999954    599999999999999999999999999887654322


Q ss_pred             ccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhh
Q 007680          429 SVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVRE  508 (593)
Q Consensus       429 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  508 (593)
                        ......++..|+|||+..+..++.++||||||+++|+|++|+.||.....  .............             
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~~-------------  219 (256)
T cd08529         157 --FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ--GALILKIIRGVFP-------------  219 (256)
T ss_pred             --hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHcCCCC-------------
Confidence              12234578899999999998999999999999999999999999976421  1111111110000             


Q ss_pred             hhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          509 EQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       509 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                          .....++.++.+++.+||+.+|++||++.+++++
T Consensus       220 ----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         220 ----PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             ----CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence                0011345678999999999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=9.4e-39  Score=328.56  Aligned_cols=248  Identities=20%  Similarity=0.267  Sum_probs=195.0

Q ss_pred             cccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhc-CCCCcceeeeeeecCCceEEEEeccCC
Q 007680          278 NLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNV-RHRNLIKILSSYSNPDFKALVLEFMPN  352 (593)
Q Consensus       278 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  352 (593)
                      +.||+|+||.||+|+.+ +++.||+|+++...   ......+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999965 68899999998652   23445678899988877 899999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCcccc
Q 007680          353 GSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQ  432 (593)
Q Consensus       353 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~  432 (593)
                      |+|.+++..... +++..+..++.|++.||+|||++    +|+||||||+||+++.++.+||+|||+++.......  ..
T Consensus        81 ~~L~~~~~~~~~-l~~~~~~~i~~qi~~~l~~lH~~----~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~--~~  153 (329)
T cd05618          81 GDLMFHMQRQRK-LPEEHARFYSAEISLALNYLHER----GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TT  153 (329)
T ss_pred             CCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHC----CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC--cc
Confidence            999998876654 89999999999999999999965    499999999999999999999999999875322211  12


Q ss_pred             ccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCcccccc---chHHHHHHHhcCCchhhhhhhhhhhhh
Q 007680          433 TMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGE---MSLRRWVKESLPHGLTEVVDANLVREE  509 (593)
Q Consensus       433 ~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~  509 (593)
                      ....||..|+|||++.+..++.++|||||||++|||++|+.||.......   .....+....            +....
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~------------i~~~~  221 (329)
T cd05618         154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV------------ILEKQ  221 (329)
T ss_pred             ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHH------------HhcCC
Confidence            33568999999999999999999999999999999999999996421111   1111111110            00000


Q ss_pred             hhhhhhHHHHHHHHHHHhhcccCCCCCCCC------HHHHHHH
Q 007680          510 QAFSAKMDCILSIMDFALDCCMESPDMRIN------MTDAAAK  546 (593)
Q Consensus       510 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs------~~evl~~  546 (593)
                      .  ..+...+.++.+++.+||+.||++||+      +.++++|
T Consensus       222 ~--~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05618         222 I--RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  262 (329)
T ss_pred             C--CCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence            0  011223557889999999999999998      4677665

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1.8e-38  Score=324.61  Aligned_cols=242  Identities=23%  Similarity=0.314  Sum_probs=192.9

Q ss_pred             cccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhc-CCCCcceeeeeeecCCceEEEEeccCC
Q 007680          278 NLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNV-RHRNLIKILSSYSNPDFKALVLEFMPN  352 (593)
Q Consensus       278 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  352 (593)
                      +.||+|+||.||+|+.. +++.||+|+++...   .........|..++... +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999975 57899999998753   23345566788888765 899999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCcccc
Q 007680          353 GSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQ  432 (593)
Q Consensus       353 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~  432 (593)
                      |+|.+++..... +++.++..++.|++.||+|||++    +|+||||||+||+++.++.+||+|||++........  ..
T Consensus        81 g~L~~~l~~~~~-~~~~~~~~~~~qi~~al~~LH~~----~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~  153 (316)
T cd05619          81 GDLMFHIQSCHK-FDLPRATFYAAEIICGLQFLHSK----GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA--KT  153 (316)
T ss_pred             CcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHhC----CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC--ce
Confidence            999999976543 89999999999999999999965    599999999999999999999999999875432221  12


Q ss_pred             ccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhhhhh
Q 007680          433 TMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQAF  512 (593)
Q Consensus       433 ~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  512 (593)
                      ....||..|+|||++.+..++.++|||||||++|||++|+.||......  ...+.+....                .. 
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~--~~~~~i~~~~----------------~~-  214 (316)
T cd05619         154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE--ELFQSIRMDN----------------PC-  214 (316)
T ss_pred             eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhCC----------------CC-
Confidence            3346899999999999989999999999999999999999999763211  1111111000                00 


Q ss_pred             hhhHHHHHHHHHHHhhcccCCCCCCCCHH-HHHHH
Q 007680          513 SAKMDCILSIMDFALDCCMESPDMRINMT-DAAAK  546 (593)
Q Consensus       513 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~~  546 (593)
                       .+..++.++.+++.+||+.||++||++. ++.+|
T Consensus       215 -~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h  248 (316)
T cd05619         215 -YPRWLTREAKDILVKLFVREPERRLGVKGDIRQH  248 (316)
T ss_pred             -CCccCCHHHHHHHHHHhccCHhhcCCChHHHHcC
Confidence             0112345679999999999999999997 66553

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=3.5e-38  Score=319.01  Aligned_cols=253  Identities=25%  Similarity=0.327  Sum_probs=204.1

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEec
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEF  349 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  349 (593)
                      .+.|++.+.||+|+||.||+|+.. +++.|++|.+........+.+.+|+.++++++||||+++++.+...+..++||||
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   90 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF   90 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence            367999999999999999999975 5899999999877666677889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCc
Q 007680          350 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDS  429 (593)
Q Consensus       350 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~  429 (593)
                      +++++|..++.+....+++..+..++.|++.||+|||++    +++||||||+||+++.++.++|+|||.+.......  
T Consensus        91 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~----~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~--  164 (292)
T cd06644          91 CPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSM----KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL--  164 (292)
T ss_pred             CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcC----CeeecCCCcceEEEcCCCCEEEccCccceeccccc--
Confidence            999999998876655689999999999999999999954    59999999999999999999999999887543221  


Q ss_pred             cccccccCCccccCccccC-----CCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhh
Q 007680          430 VRQTMTMATIGYMAPEYGL-----EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDAN  504 (593)
Q Consensus       430 ~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  504 (593)
                      .......++..|+|||++.     ...++.++|||||||++|||++|+.||...... ..........            
T Consensus       165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-~~~~~~~~~~------------  231 (292)
T cd06644         165 QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-RVLLKIAKSE------------  231 (292)
T ss_pred             cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH-HHHHHHhcCC------------
Confidence            1223345788999999874     345788999999999999999999998663211 1111110000            


Q ss_pred             hhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          505 LVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       505 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                          .........++.++.+++.+||+.+|++||++.|++++
T Consensus       232 ----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  269 (292)
T cd06644         232 ----PPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH  269 (292)
T ss_pred             ----CccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence                00001112334578999999999999999999999875

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=2.8e-38  Score=323.12  Aligned_cols=264  Identities=22%  Similarity=0.403  Sum_probs=208.6

Q ss_pred             hhhccccccccCccCcccEEEEEeC--------CCCeEEEEEeehhh-HHHHHHHHHHHHHHhhc-CCCCcceeeeeeec
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTIS--------DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNV-RHRNLIKILSSYSN  339 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  339 (593)
                      ..++|.+.+.||+|+||.||+|+..        ....+|+|.++... ......+.+|+.+++++ +||||+++++++..
T Consensus        10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~   89 (314)
T cd05099          10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ   89 (314)
T ss_pred             cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence            4578999999999999999999742        24569999987542 34456788999999999 69999999999999


Q ss_pred             CCceEEEEeccCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCe
Q 007680          340 PDFKALVLEFMPNGSLEKWLYSHN---------------YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNI  404 (593)
Q Consensus       340 ~~~~~lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NI  404 (593)
                      .+..+++|||+++|+|.+++....               ..+++.++..++.|++.||+|||++    |++||||||+||
T Consensus        90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~----gi~H~dlkp~Ni  165 (314)
T cd05099          90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR----RCIHRDLAARNV  165 (314)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC----CeeeccccceeE
Confidence            999999999999999999997632               2478899999999999999999965    499999999999


Q ss_pred             eeCCCCcEEEEeeccceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccc
Q 007680          405 LLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEM  483 (593)
Q Consensus       405 ll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~  483 (593)
                      ++++++.+||+|||.++...............++..|+|||++.+..++.++||||||+++|||++ |..||......  
T Consensus       166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~--  243 (314)
T cd05099         166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE--  243 (314)
T ss_pred             EEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH--
Confidence            999999999999999986643221111122234567999999988899999999999999999999 88998653211  


Q ss_pred             hHHHHHHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhhhcc
Q 007680          484 SLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKFLD  556 (593)
Q Consensus       484 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~  556 (593)
                      .........                 .....+..++.++.+++.+||+.+|++||++.|+++.|+++.....+
T Consensus       244 ~~~~~~~~~-----------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~  299 (314)
T cd05099         244 ELFKLLREG-----------------HRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSE  299 (314)
T ss_pred             HHHHHHHcC-----------------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhcC
Confidence            111111110                 00011123456789999999999999999999999999999876644

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-39  Score=326.84  Aligned_cols=260  Identities=22%  Similarity=0.375  Sum_probs=218.8

Q ss_pred             HhhhccccccccCccCcccEEEEEeC---CCC--eEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCc
Q 007680          269 RATDEFNECNLLGTSSFGSVYKGTIS---DGT--DVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDF  342 (593)
Q Consensus       269 ~~~~~~~~~~~lg~G~~g~Vy~~~~~---~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  342 (593)
                      ...+..+..+.||+|-||.||+|.+.   .|+  -||||..+.+. ....+.|..|..+|++++||||++++|+|.+. .
T Consensus       386 l~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P  464 (974)
T KOG4257|consen  386 LRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-P  464 (974)
T ss_pred             eehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-c
Confidence            33444556678999999999999853   233  48899988743 44578899999999999999999999999774 5


Q ss_pred             eEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeecccee
Q 007680          343 KALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKL  422 (593)
Q Consensus       343 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~  422 (593)
                      .++|||.++-|.|..+++.++..++......++.||+.||+|||    +..+|||||..+|||+.+...+||+|||+++.
T Consensus       465 ~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLe----SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~  540 (974)
T KOG4257|consen  465 MWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLE----SKRFVHRDIAARNILVSSPQCVKLADFGLSRY  540 (974)
T ss_pred             eeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHH----hhchhhhhhhhhheeecCcceeeecccchhhh
Confidence            79999999999999999999888999999999999999999999    56699999999999999999999999999998


Q ss_pred             cCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhh
Q 007680          423 LGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVV  501 (593)
Q Consensus       423 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  501 (593)
                      +.+... ...+...-...|||||-+.-.+++.++|||-|||++||++. |..||.+....+.                 +
T Consensus       541 ~ed~~y-YkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV-----------------I  602 (974)
T KOG4257|consen  541 LEDDAY-YKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV-----------------I  602 (974)
T ss_pred             ccccch-hhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccce-----------------E
Confidence            865443 33344445678999999999999999999999999999987 9999987533221                 1


Q ss_pred             hhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhh
Q 007680          502 DANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVK  553 (593)
Q Consensus       502 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  553 (593)
                        .....+.+.+.+..||+.+..++.+||+.||.+||++.|+.+.|.++...
T Consensus       603 --~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qe  652 (974)
T KOG4257|consen  603 --GHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQE  652 (974)
T ss_pred             --EEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHH
Confidence              11133455677788999999999999999999999999999999998764

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=3.4e-38  Score=320.61  Aligned_cols=259  Identities=22%  Similarity=0.362  Sum_probs=206.9

Q ss_pred             hhhccccccccCccCcccEEEEEeC------CCCeEEEEEeehhh-HHHHHHHHHHHHHHhhc-CCCCcceeeeeeecCC
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTIS------DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNV-RHRNLIKILSSYSNPD  341 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  341 (593)
                      ..++|.+.+.||+|+||.||++...      ++..||+|.++... ....+.+.+|+.+++++ +||||+++++++...+
T Consensus        33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  112 (302)
T cd05055          33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG  112 (302)
T ss_pred             cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence            4568999999999999999999742      35579999987543 33456789999999999 7999999999999999


Q ss_pred             ceEEEEeccCCCCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccc
Q 007680          342 FKALVLEFMPNGSLEKWLYSHNY-FLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIY  420 (593)
Q Consensus       342 ~~~lv~e~~~~gsL~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a  420 (593)
                      ..++||||+++++|.+++..... .+++.++..++.|++.||+|||++    +++|+||||+||+++.++.++++|||++
T Consensus       113 ~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~~l~dfg~~  188 (302)
T cd05055         113 PILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK----NCIHRDLAARNVLLTHGKIVKICDFGLA  188 (302)
T ss_pred             ceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC----CeehhhhccceEEEcCCCeEEECCCccc
Confidence            99999999999999999976443 489999999999999999999965    4999999999999999999999999998


Q ss_pred             eecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhh
Q 007680          421 KLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTE  499 (593)
Q Consensus       421 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  499 (593)
                      ................++..|+|||++.+..++.++||||+||++|||++ |..||......+ .+.+......+     
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~-~~~~~~~~~~~-----  262 (302)
T cd05055         189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS-KFYKLIKEGYR-----  262 (302)
T ss_pred             ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH-HHHHHHHcCCc-----
Confidence            86644332212222345778999999998999999999999999999998 999987642211 11111111100     


Q ss_pred             hhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHh
Q 007680          500 VVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKI  550 (593)
Q Consensus       500 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  550 (593)
                                  ...+...+.++.+++.+||..+|++|||+.|+++.|+++
T Consensus       263 ------------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         263 ------------MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             ------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence                        000112245789999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=4.3e-38  Score=314.03  Aligned_cols=257  Identities=26%  Similarity=0.454  Sum_probs=207.0

Q ss_pred             hhccccccccCccCcccEEEEEeC-C---CCeEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-D---GTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKAL  345 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  345 (593)
                      .++|++.+.||+|+||.||+|... +   +..+|+|.++... ....+.+.+|+.++++++||||+++++++...+..++
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI   82 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            357889999999999999999864 2   3479999987542 3345678999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCC
Q 007680          346 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGE  425 (593)
Q Consensus       346 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~  425 (593)
                      ||||+++++|.+++......+++.++..++.|++.||+|||+.    +++||||||+||+++.++.++|+|||.+..+..
T Consensus        83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~----~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd05066          83 VTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDM----GYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  158 (267)
T ss_pred             EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC----CEeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence            9999999999999987766689999999999999999999955    499999999999999999999999999987654


Q ss_pred             CCCccc-cccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhhhh
Q 007680          426 GEDSVR-QTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDA  503 (593)
Q Consensus       426 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  503 (593)
                      ...... .....++..|+|||++.+..++.++||||||+++||+++ |..||......  ..........          
T Consensus       159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~--~~~~~~~~~~----------  226 (267)
T cd05066         159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ--DVIKAIEEGY----------  226 (267)
T ss_pred             ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH--HHHHHHhCCC----------
Confidence            332111 111223567999999998899999999999999999887 99999763221  1111111100          


Q ss_pred             hhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHh
Q 007680          504 NLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKI  550 (593)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  550 (593)
                             ..+....++..+.+++.+||+.+|.+||++.++++.|+++
T Consensus       227 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         227 -------RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             -------cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence                   0111123456789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.5e-38  Score=332.10  Aligned_cols=261  Identities=19%  Similarity=0.270  Sum_probs=204.8

Q ss_pred             HHHHHHhhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhcCCCCcceeeeeeec
Q 007680          264 YLDIQRATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSYSN  339 (593)
Q Consensus       264 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  339 (593)
                      ..++....++|++.+.||+|+||.||+++.+ +++.||+|++....   ......+.+|+.+++.++||||+++++++.+
T Consensus        35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~  114 (371)
T cd05622          35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  114 (371)
T ss_pred             HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence            4455666789999999999999999999976 68899999997532   2334567889999999999999999999999


Q ss_pred             CCceEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeecc
Q 007680          340 PDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGI  419 (593)
Q Consensus       340 ~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~  419 (593)
                      ++..++||||+++|+|.+++....  +++..+..++.|++.||+|||++    +|+||||||+||+++.++.+||+|||+
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~~~~~~--~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDLkp~NIll~~~~~ikL~DfG~  188 (371)
T cd05622         115 DRYLYMVMEYMPGGDLVNLMSNYD--VPEKWARFYTAEVVLALDAIHSM----GFIHRDVKPDNMLLDKSGHLKLADFGT  188 (371)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHHHC----CEEeCCCCHHHEEECCCCCEEEEeCCc
Confidence            999999999999999999987654  88899999999999999999955    599999999999999999999999999


Q ss_pred             ceecCCCCCccccccccCCccccCccccCCC----CCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCC
Q 007680          420 YKLLGEGEDSVRQTMTMATIGYMAPEYGLEG----IVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPH  495 (593)
Q Consensus       420 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~  495 (593)
                      +........ .......||+.|+|||++.+.    .++.++|||||||++|||++|+.||...... ..+..... ..  
T Consensus       189 a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-~~~~~i~~-~~--  263 (371)
T cd05622         189 CMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-GTYSKIMN-HK--  263 (371)
T ss_pred             eeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH-HHHHHHHc-CC--
Confidence            987643321 122345699999999998653    3789999999999999999999999763211 01111100 00  


Q ss_pred             chhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCC--CCCHHHHHHHH
Q 007680          496 GLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDM--RINMTDAAAKL  547 (593)
Q Consensus       496 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~L  547 (593)
                                  .....+....++..+.+++.+|+..++.+  ||++.|+++|.
T Consensus       264 ------------~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         264 ------------NSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             ------------CcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence                        00011112234567899999999844433  78999999874

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=4e-38  Score=316.09  Aligned_cols=247  Identities=21%  Similarity=0.295  Sum_probs=194.5

Q ss_pred             cCccCcccEEEEEeC-CCCeEEEEEeehhhH---HHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEeccCCCCH
Q 007680          280 LGTSSFGSVYKGTIS-DGTDVAIKVFNLQLE---RAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSL  355 (593)
Q Consensus       280 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  355 (593)
                      ||+|+||.||+++.+ +|+.||+|.+.....   .....+..|++++++++||||+++++++..+...++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            799999999999865 689999999975421   2234456799999999999999999999999999999999999999


Q ss_pred             HHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCcccccc
Q 007680          356 EKWLYSHNY-FLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTM  434 (593)
Q Consensus       356 ~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~  434 (593)
                      .+++..... .+++..+..++.|++.||+|||+.    +|+||||||+||++++++.++|+|||++........   ...
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~----~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~---~~~  153 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSM----DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQ  153 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC----CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce---eec
Confidence            998865443 588999999999999999999954    599999999999999999999999999887654321   223


Q ss_pred             ccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhhhhhhh
Q 007680          435 TMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSA  514 (593)
Q Consensus       435 ~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  514 (593)
                      ..++..|+|||++.+..++.++||||+||++|||++|+.||....... ............        ...     . .
T Consensus       154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~-~~~~~~~~~~~~--------~~~-----~-~  218 (277)
T cd05607         154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV-AKEELKRRTLED--------EVK-----F-E  218 (277)
T ss_pred             cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh-hHHHHHHHhhcc--------ccc-----c-c
Confidence            468899999999988889999999999999999999999997532111 111111111000        000     0 0


Q ss_pred             hHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHH
Q 007680          515 KMDCILSIMDFALDCCMESPDMRINMTDAAAKLK  548 (593)
Q Consensus       515 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  548 (593)
                      ...++.++.+++.+||+.||++||+++|+++.+.
T Consensus       219 ~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~  252 (277)
T cd05607         219 HQNFTEESKDICRLFLAKKPEDRLGSREKNDDPR  252 (277)
T ss_pred             cccCCHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence            1124567899999999999999999977664443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=4.1e-38  Score=313.98  Aligned_cols=258  Identities=22%  Similarity=0.318  Sum_probs=207.6

Q ss_pred             hccccccccCccCcccEEEEEe-CCCCeEEEEEeehh---hHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEE
Q 007680          272 DEFNECNLLGTSSFGSVYKGTI-SDGTDVAIKVFNLQ---LERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVL  347 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  347 (593)
                      ++|++.+.||+|++|.||+|.. .+++.+|+|.+...   .......+.+|+.+++.++||||+++++++..++..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            4788899999999999999995 47899999988653   2334567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecC
Q 007680          348 EFMPNGSLEKWLYS---HNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG  424 (593)
Q Consensus       348 e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~  424 (593)
                      ||+++++|.+++..   ....+++..+..++.|++.||+|||++    +++|+||||+||+++.++.++|+|||.+....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~----~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~  157 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR----RVMHRDIKPANVFITATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEEcCCCCEEECcchhhhccc
Confidence            99999999998864   223589999999999999999999965    49999999999999999999999999987664


Q ss_pred             CCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhh
Q 007680          425 EGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDAN  504 (593)
Q Consensus       425 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  504 (593)
                      ....  ......++..|+|||++.+..++.++||||||+++|+|++|..||.....+.....+......           
T Consensus       158 ~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----------  224 (267)
T cd08229         158 SKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD-----------  224 (267)
T ss_pred             cCCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCC-----------
Confidence            3322  112345888999999998888999999999999999999999998653221111111111000           


Q ss_pred             hhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhh
Q 007680          505 LVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIK  551 (593)
Q Consensus       505 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~  551 (593)
                           ........++.++.+++.+||+.||++|||+.+|++.++++.
T Consensus       225 -----~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         225 -----YPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             -----CCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence                 000011234568899999999999999999999999998864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=2.5e-38  Score=320.68  Aligned_cols=251  Identities=23%  Similarity=0.322  Sum_probs=204.0

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEec
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEF  349 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  349 (593)
                      ..+|++.+.||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++||||+++++.+...+..++||||
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~   98 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence            357899999999999999999864 7899999999876545557788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCc
Q 007680          350 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDS  429 (593)
Q Consensus       350 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~  429 (593)
                      +++++|.+++...  .+++.++..++.|++.||+|||+.    +|+||||||+||+++.++.+||+|||.+........ 
T Consensus        99 ~~~~~L~~~~~~~--~~~~~~~~~i~~ql~~aL~~LH~~----gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-  171 (296)
T cd06654          99 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSN----QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-  171 (296)
T ss_pred             cCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEEcCCCCEEECccccchhcccccc-
Confidence            9999999998654  378999999999999999999954    599999999999999999999999999876543221 


Q ss_pred             cccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhh
Q 007680          430 VRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREE  509 (593)
Q Consensus       430 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  509 (593)
                       ......+++.|+|||.+.+..++.++|||||||++|+|++|+.||........ ......    ...            
T Consensus       172 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~-~~~~~~----~~~------------  233 (296)
T cd06654         172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-LYLIAT----NGT------------  233 (296)
T ss_pred             -ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh-HHHHhc----CCC------------
Confidence             12234688899999999888899999999999999999999999965322111 000000    000            


Q ss_pred             hhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          510 QAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       510 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      .....+...+..+.+++.+||..||++||++.|++++
T Consensus       234 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         234 PELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             CCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence            0000112345678999999999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.4e-38  Score=329.42  Aligned_cols=195  Identities=29%  Similarity=0.392  Sum_probs=171.4

Q ss_pred             ccccccccCccCcccEEEEEe-CCCCeEEEEEeehhhHHHHHHHHHHHHHHhhcC-C-----CCcceeeeeeecCCceEE
Q 007680          273 EFNECNLLGTSSFGSVYKGTI-SDGTDVAIKVFNLQLERAFRSFDSECEVLRNVR-H-----RNLIKILSSYSNPDFKAL  345 (593)
Q Consensus       273 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~~~l  345 (593)
                      +|++.+.||+|+||.|-+|.+ ++++.||||+++... ....+...|+.+|..++ |     -|+|+++++|...++.||
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci  265 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI  265 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence            899999999999999999985 479999999998764 34466788999999996 4     489999999999999999


Q ss_pred             EEeccCCCCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCC--CcEEEEeecccee
Q 007680          346 VLEFMPNGSLEKWLYSHNY-FLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDEN--MVAHVSDFGIYKL  422 (593)
Q Consensus       346 v~e~~~~gsL~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~--~~~kL~Dfg~a~~  422 (593)
                      |+|.+ .-+|.+++..++. .++...++.++.||+.||.+||+    .+|||+||||+|||+.+.  ..+||+|||.|..
T Consensus       266 VfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~----l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~  340 (586)
T KOG0667|consen  266 VFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHE----LGIIHCDLKPENILLKDPKRSRIKVIDFGSSCF  340 (586)
T ss_pred             eehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh----CCeeeccCChhheeeccCCcCceeEEecccccc
Confidence            99999 5599999988664 68999999999999999999995    459999999999999754  3799999999987


Q ss_pred             cCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCcc
Q 007680          423 LGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEM  478 (593)
Q Consensus       423 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~  478 (593)
                      .....     .....+..|+|||++.+.+|+.+.||||||||+.||++|.+.|.+.
T Consensus       341 ~~q~v-----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~  391 (586)
T KOG0667|consen  341 ESQRV-----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGD  391 (586)
T ss_pred             cCCcc-----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCC
Confidence            54322     2456789999999999999999999999999999999998888663

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=4.8e-38  Score=312.83  Aligned_cols=254  Identities=28%  Similarity=0.450  Sum_probs=203.4

Q ss_pred             hhccccccccCccCcccEEEEEeCCCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEecc
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFM  350 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  350 (593)
                      .++|++.++||+|+||.||+|++.++..||+|.++.... ..+.+.+|++++++++||||+++++.+.. +..++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~   82 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM   82 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence            467999999999999999999987767899999875322 23578899999999999999999998754 5679999999


Q ss_pred             CCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCc
Q 007680          351 PNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDS  429 (593)
Q Consensus       351 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~  429 (593)
                      ++++|.+++.... ..+++..+..++.|++.||+|||+.    +++||||||+||++++++.++|+|||.+..+......
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~----~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~  158 (262)
T cd05071          83 SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM----NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT  158 (262)
T ss_pred             CCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC----CccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence            9999999998643 3578999999999999999999954    5999999999999999999999999999876543321


Q ss_pred             cccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhh
Q 007680          430 VRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVRE  508 (593)
Q Consensus       430 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  508 (593)
                       ......++..|+|||+..+..++.++||||||+++|||+| |..||......+  .......            ..   
T Consensus       159 -~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~--~~~~~~~------------~~---  220 (262)
T cd05071         159 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLDQVER------------GY---  220 (262)
T ss_pred             -cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH--HHHHHhc------------CC---
Confidence             1122346678999999888899999999999999999999 888986632111  0000000            00   


Q ss_pred             hhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHh
Q 007680          509 EQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKI  550 (593)
Q Consensus       509 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  550 (593)
                        ..+...+++..+.+++.+||+.||++||++.++++.|++.
T Consensus       221 --~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         221 --RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             --CCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence              0011123466789999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=5.1e-39  Score=329.19  Aligned_cols=238  Identities=25%  Similarity=0.289  Sum_probs=192.7

Q ss_pred             cccCccCcccEEEEEe----CCCCeEEEEEeehhhH--HHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEeccC
Q 007680          278 NLLGTSSFGSVYKGTI----SDGTDVAIKVFNLQLE--RAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMP  351 (593)
Q Consensus       278 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  351 (593)
                      +.||+|+||.||+++.    .+|+.||+|+++....  .....+..|++++++++||||+++++++..++..++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999975    3688999999986532  234567789999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCccc
Q 007680          352 NGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVR  431 (593)
Q Consensus       352 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~  431 (593)
                      +|+|.+++.+.. .+++..+..++.|+++||+|||++    +|+||||||+||++++++.+||+|||++........  .
T Consensus        82 ~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~--~  154 (318)
T cd05582          82 GGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLHSL----GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--K  154 (318)
T ss_pred             CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC----CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC--c
Confidence            999999997655 489999999999999999999954    599999999999999999999999999876543321  2


Q ss_pred             cccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhhhh
Q 007680          432 QTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQA  511 (593)
Q Consensus       432 ~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  511 (593)
                      .....|++.|+|||++.+..++.++|||||||++|||++|+.||......  .....+...           .       
T Consensus       155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~--~~~~~i~~~-----------~-------  214 (318)
T cd05582         155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK--ETMTMILKA-----------K-------  214 (318)
T ss_pred             eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH--HHHHHHHcC-----------C-------
Confidence            23356899999999998888999999999999999999999999763211  111111000           0       


Q ss_pred             hhhhHHHHHHHHHHHhhcccCCCCCCCCHHH
Q 007680          512 FSAKMDCILSIMDFALDCCMESPDMRINMTD  542 (593)
Q Consensus       512 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e  542 (593)
                      ...+..+++++.+++.+||+.||++||++.+
T Consensus       215 ~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         215 LGMPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            0011123567899999999999999999544

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=3.3e-38  Score=313.53  Aligned_cols=253  Identities=26%  Similarity=0.461  Sum_probs=203.4

Q ss_pred             hhccccccccCccCcccEEEEEeCCCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEecc
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFM  350 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  350 (593)
                      .++|++.++||+|+||.||+|..+++..+|+|.++.... ..+.+.+|+.++++++|+|++++++++. .+..+++|||+
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~   82 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM   82 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence            468999999999999999999988888899999876432 2356889999999999999999999875 45678999999


Q ss_pred             CCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCc
Q 007680          351 PNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDS  429 (593)
Q Consensus       351 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~  429 (593)
                      ++++|.+++.... ..+++.++..++.|++.||+|||+++    ++||||||+||++++++.++|+|||.+..+......
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~----i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05070          83 SKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN----YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC----cccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence            9999999997643 35899999999999999999999654    999999999999999999999999999876543221


Q ss_pred             cccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhh
Q 007680          430 VRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVRE  508 (593)
Q Consensus       430 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  508 (593)
                      . .....++..|+|||+..+..++.++||||||+++|||++ |..||......  ..........               
T Consensus       159 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--~~~~~~~~~~---------------  220 (260)
T cd05070         159 A-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR--EVLEQVERGY---------------  220 (260)
T ss_pred             c-ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHHcCC---------------
Confidence            1 112235667999999888889999999999999999999 89998653211  1111111000               


Q ss_pred             hhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHH
Q 007680          509 EQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKK  549 (593)
Q Consensus       509 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  549 (593)
                        ..+.+.+.+..+.+++.+||..+|++|||+.++.+.|++
T Consensus       221 --~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         221 --RMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             --CCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence              001122345678999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=4.4e-38  Score=318.71  Aligned_cols=262  Identities=23%  Similarity=0.340  Sum_probs=205.4

Q ss_pred             hhccccccccCccCcccEEEEEeCC-----------------CCeEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcce
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTISD-----------------GTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIK  332 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~  332 (593)
                      ..+|++.+.||+|+||.||+|...+                 +..||+|.+.... ....+.+.+|++++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            4679999999999999999998542                 2458999987653 345567899999999999999999


Q ss_pred             eeeeeecCCceEEEEeccCCCCHHHHHhhCC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCC
Q 007680          333 ILSSYSNPDFKALVLEFMPNGSLEKWLYSHN----------YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPT  402 (593)
Q Consensus       333 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~  402 (593)
                      +++++...+..+++|||+++++|.+++....          ..+++..++.++.|++.||+|||++    +++||||||+
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~----~i~H~dlkp~  159 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL----NFVHRDLATR  159 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc----Cccccccchh
Confidence            9999999999999999999999999997654          1489999999999999999999965    4999999999


Q ss_pred             CeeeCCCCcEEEEeeccceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh--CCCCCCcccc
Q 007680          403 NILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT--RKRPTDEMFI  480 (593)
Q Consensus       403 NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt--g~~pf~~~~~  480 (593)
                      ||++++++.++|+|||.++...............++..|+|||+..+..++.++|||||||++|||++  |..||.....
T Consensus       160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~  239 (296)
T cd05051         160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD  239 (296)
T ss_pred             ceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence            99999999999999999886544332222233456778999999888889999999999999999998  7788865321


Q ss_pred             ccchHHHHHHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHH
Q 007680          481 GEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLK  548 (593)
Q Consensus       481 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  548 (593)
                      ..  .............          .....+.+..++.++.+++.+||+.||++|||+.|+++.|+
T Consensus       240 ~~--~~~~~~~~~~~~~----------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         240 QQ--VIENAGHFFRDDG----------RQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             HH--HHHHHHhcccccc----------ccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            11  1111111100000          00000111223568899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=6e-38  Score=317.76  Aligned_cols=263  Identities=22%  Similarity=0.340  Sum_probs=201.9

Q ss_pred             hhccccccccCccCcccEEEEEeCC---------------CCeEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceee
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTISD---------------GTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKIL  334 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~  334 (593)
                      .++|++.+.||+|+||.||+++.++               ...||+|.++... ......+.+|++++++++|||+++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            4679999999999999999987532               2348999987642 33456789999999999999999999


Q ss_pred             eeeecCCceEEEEeccCCCCHHHHHhhCC-----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCC
Q 007680          335 SSYSNPDFKALVLEFMPNGSLEKWLYSHN-----------YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTN  403 (593)
Q Consensus       335 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~N  403 (593)
                      +++...+..++||||+++++|.+++....           ..+++..+..++.|++.||+|||++    +++||||||+|
T Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~----~i~H~dlkp~N  159 (295)
T cd05097          84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL----NFVHRDLATRN  159 (295)
T ss_pred             EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc----CeeccccChhh
Confidence            99999999999999999999999986532           1368889999999999999999955    59999999999


Q ss_pred             eeeCCCCcEEEEeeccceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh--CCCCCCccccc
Q 007680          404 ILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT--RKRPTDEMFIG  481 (593)
Q Consensus       404 Ill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt--g~~pf~~~~~~  481 (593)
                      |++++++.+||+|||++................++..|+|||+..++.++.++|||||||++|+|++  |..||......
T Consensus       160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~  239 (295)
T cd05097         160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE  239 (295)
T ss_pred             EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH
Confidence            9999999999999999876543322212223345678999999988899999999999999999998  66787653221


Q ss_pred             cchHHHHHHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHH
Q 007680          482 EMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKK  549 (593)
Q Consensus       482 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  549 (593)
                      .  ..............     ..     .......++..+.+++.+||+.||++||++.++++.|++
T Consensus       240 ~--~~~~~~~~~~~~~~-----~~-----~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~  295 (295)
T cd05097         240 Q--VIENTGEFFRNQGR-----QI-----YLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE  295 (295)
T ss_pred             H--HHHHHHHhhhhccc-----cc-----cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence            1  11111100000000     00     000011235689999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=4.6e-38  Score=327.65  Aligned_cols=264  Identities=21%  Similarity=0.229  Sum_probs=197.4

Q ss_pred             hhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehh--hHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCC-----
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQ--LERAFRSFDSECEVLRNVRHRNLIKILSSYSNPD-----  341 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  341 (593)
                      ..++|++.+.||+|+||.||++... +|+.||+|++...  .......+.+|+.+++.++||||+++++++...+     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            3578999999999999999999865 6899999998653  2334466789999999999999999999886543     


Q ss_pred             -ceEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccc
Q 007680          342 -FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIY  420 (593)
Q Consensus       342 -~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a  420 (593)
                       ..++||||+++ +|.+.+..   .+++..+..++.|++.||+|||++    +|+||||||+||+++.++.+||+|||++
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~----~ivHrDlkp~NIl~~~~~~~kl~Dfg~a  170 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIHM---ELDHERMSYLLYQMLCGIKHLHSA----GIIHRDLKPSNIVVKSDCTLKILDFGLA  170 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHhc---cCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEECCCCCEEEecCCCc
Confidence             47999999965 67666643   278899999999999999999965    4999999999999999999999999998


Q ss_pred             eecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhh
Q 007680          421 KLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEV  500 (593)
Q Consensus       421 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  500 (593)
                      +......   ......+|+.|+|||++.+..++.++|||||||++|+|++|+.||....... .... ..........+.
T Consensus       171 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~-~~~~-~~~~~~~~~~~~  245 (359)
T cd07876         171 RTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHID-QWNK-VIEQLGTPSAEF  245 (359)
T ss_pred             cccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHH-HHHhcCCCcHHH
Confidence            7543221   1233468999999999999999999999999999999999999997642111 1111 111111000000


Q ss_pred             hhhh---hh---hh-----hhh-------------hhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          501 VDAN---LV---RE-----EQA-------------FSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       501 ~~~~---~~---~~-----~~~-------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      .+..   ..   ..     ...             .......+..+.+++.+||..||++|||+.|+++|
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  315 (359)
T cd07876         246 MNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH  315 (359)
T ss_pred             HHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence            0000   00   00     000             00001124568999999999999999999999987

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=5e-38  Score=311.76  Aligned_cols=248  Identities=23%  Similarity=0.419  Sum_probs=197.5

Q ss_pred             ccCccCcccEEEEEeC---CCCeEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEeccCCCC
Q 007680          279 LLGTSSFGSVYKGTIS---DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGS  354 (593)
Q Consensus       279 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  354 (593)
                      .||+|+||.||+|.+.   ++..||+|++.... ....+.+.+|+.++++++||||+++++++.. +..++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence            4899999999999764   35579999987653 3344678999999999999999999998754 57899999999999


Q ss_pred             HHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCccc-cc
Q 007680          355 LEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVR-QT  433 (593)
Q Consensus       355 L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~-~~  433 (593)
                      |.+++......+++..+..++.|++.||+|||++    +++||||||+||+++.++.+||+|||++........... ..
T Consensus        81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05115          81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGK----NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS  156 (257)
T ss_pred             HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhc----CeeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence            9999987666699999999999999999999965    499999999999999999999999999886544332211 11


Q ss_pred             cccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhhhhh
Q 007680          434 MTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQAF  512 (593)
Q Consensus       434 ~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  512 (593)
                      ...++..|+|||++.+..++.++|||||||++||+++ |..||......  .....+....+                 .
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~~~-----------------~  217 (257)
T cd05115         157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP--EVMSFIEQGKR-----------------L  217 (257)
T ss_pred             CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH--HHHHHHHCCCC-----------------C
Confidence            1223578999999888889999999999999999996 99999764221  11111111100                 0


Q ss_pred             hhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHh
Q 007680          513 SAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKI  550 (593)
Q Consensus       513 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  550 (593)
                      ..+..++.++.+++.+||..+|++||++.++.+.|+.+
T Consensus       218 ~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         218 DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            11123456889999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=3.4e-38  Score=314.60  Aligned_cols=254  Identities=23%  Similarity=0.337  Sum_probs=202.9

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEec
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEF  349 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  349 (593)
                      .++|++.+.||+|+||.||+|+.. +++.||+|+++.........+.+|+.+++.++||||+++++.+...+..++||||
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~   87 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF   87 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence            457899999999999999999864 6899999999876555556788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCc
Q 007680          350 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDS  429 (593)
Q Consensus       350 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~  429 (593)
                      +++++|.+++...+ .+++.++..++.|++.|++|||++    +++|+||||+||+++.++.++|+|||.+........ 
T Consensus        88 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~-  161 (267)
T cd06645          88 CGGGSLQDIYHVTG-PLSESQIAYVSRETLQGLYYLHSK----GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA-  161 (267)
T ss_pred             cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEECCCCCEEECcceeeeEccCccc-
Confidence            99999999987665 489999999999999999999965    499999999999999999999999999876543221 


Q ss_pred             cccccccCCccccCccccC---CCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhh
Q 007680          430 VRQTMTMATIGYMAPEYGL---EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLV  506 (593)
Q Consensus       430 ~~~~~~~gt~~y~aPE~~~---~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  506 (593)
                       ......|+..|+|||++.   ...++.++|||||||++|+|++|+.||........ ...........           
T Consensus       162 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~-~~~~~~~~~~~-----------  228 (267)
T cd06645         162 -KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-LFLMTKSNFQP-----------  228 (267)
T ss_pred             -ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh-HHhhhccCCCC-----------
Confidence             223346889999999874   45688999999999999999999999865321111 00000000000           


Q ss_pred             hhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          507 REEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                         ........++..+.+++.+||+.+|++||+++++++|
T Consensus       229 ---~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~  265 (267)
T cd06645         229 ---PKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH  265 (267)
T ss_pred             ---CcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence               0000011234567899999999999999999999865

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=4.5e-38  Score=311.43  Aligned_cols=251  Identities=26%  Similarity=0.350  Sum_probs=206.4

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEec
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEF  349 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  349 (593)
                      .++|++.+.||+|+||.||+|... +++.+++|.+.....  .+.+.+|++++++++||||+++++++......++++||
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~   79 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY   79 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence            367999999999999999999976 488999999976543  57899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCc
Q 007680          350 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDS  429 (593)
Q Consensus       350 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~  429 (593)
                      +++++|.+++......+++..+..++.|++.||.|||+.    +++|+||+|+||++++++.++|+|||.+........ 
T Consensus        80 ~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~----~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-  154 (256)
T cd06612          80 CGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSN----KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-  154 (256)
T ss_pred             CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence            999999999987666789999999999999999999965    499999999999999999999999999887654321 


Q ss_pred             cccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhh
Q 007680          430 VRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREE  509 (593)
Q Consensus       430 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  509 (593)
                       ......++..|+|||++.+..++.++||||||+++|+|++|+.||.........  ......               ..
T Consensus       155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~--~~~~~~---------------~~  216 (256)
T cd06612         155 -KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI--FMIPNK---------------PP  216 (256)
T ss_pred             -ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh--hhhccC---------------CC
Confidence             223345788999999998889999999999999999999999999763221100  000000               00


Q ss_pred             hhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          510 QAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       510 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      ........++..+.+++.+||+.||++|||+.|++++
T Consensus       217 ~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~  253 (256)
T cd06612         217 PTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH  253 (256)
T ss_pred             CCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence            0011112345678999999999999999999999864

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=3.6e-38  Score=330.00  Aligned_cols=265  Identities=23%  Similarity=0.304  Sum_probs=199.6

Q ss_pred             ccccccccCccCcccEEEEEeC-CCCeEEEEEeehh--hHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCC-----ceE
Q 007680          273 EFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQ--LERAFRSFDSECEVLRNVRHRNLIKILSSYSNPD-----FKA  344 (593)
Q Consensus       273 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~  344 (593)
                      +|++.+.||+|+||.||++... +|+.||+|.+...  .....+.+.+|+++++.++||||+++++++...+     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            4788999999999999999964 7899999998653  2234467889999999999999999999998776     789


Q ss_pred             EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecC
Q 007680          345 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG  424 (593)
Q Consensus       345 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~  424 (593)
                      +||||+. ++|.+++.... .+++..+..++.|++.||+|||++    +|+||||||+||+++.++.+||+|||+++...
T Consensus        81 lv~e~~~-~~l~~~~~~~~-~l~~~~~~~~~~qi~~aL~~LH~~----~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~  154 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSPQ-PLSSDHVKVFLYQILRGLKYLHSA----GILHRDIKPGNLLVNSNCVLKICDFGLARVEE  154 (372)
T ss_pred             EEeeccc-cCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCChHHEEECCCCCEEeccccceeecc
Confidence            9999995 58888886654 489999999999999999999955    59999999999999999999999999998654


Q ss_pred             CCCCccccccccCCccccCccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCc-hhhhhh
Q 007680          425 EGEDSVRQTMTMATIGYMAPEYGLEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHG-LTEVVD  502 (593)
Q Consensus       425 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~  502 (593)
                      .... .......++..|+|||++.+. .++.++||||+||++|||++|+.||......  .....+....... ..+...
T Consensus       155 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~i~~~~g~~~~~~~~~  231 (372)
T cd07853         155 PDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPI--QQLDLITDLLGTPSLEAMRS  231 (372)
T ss_pred             cCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHH--HHHHHHHHHcCCCCHHHHHH
Confidence            3321 122334578999999998764 4799999999999999999999999764221  1111111111100 000000


Q ss_pred             ------hhhhhhhh-------hhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          503 ------ANLVREEQ-------AFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       503 ------~~~~~~~~-------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                            ..+.....       ........++++.+++.+||+.||++|||+.|+++|
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         232 ACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             hhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence                  00000000       000111235678999999999999999999999986

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.4e-38  Score=311.45  Aligned_cols=255  Identities=25%  Similarity=0.368  Sum_probs=206.9

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEec
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEF  349 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  349 (593)
                      .++|++.+.||+|+||.||+|... +++.+++|++........+.+.+|++++++++||||+++++++.+.+..+++|||
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~   81 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY   81 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence            367999999999999999999965 6788999999876555667899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCc
Q 007680          350 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDS  429 (593)
Q Consensus       350 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~  429 (593)
                      +++++|.+++......+++.++..++.|++.||+|||++    +++|+||+|+||++++++.+||+|||.+........ 
T Consensus        82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~----~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-  156 (262)
T cd06613          82 CGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHET----GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-  156 (262)
T ss_pred             CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC----CceecCCChhhEEECCCCCEEECccccchhhhhhhh-
Confidence            999999999987745699999999999999999999965    499999999999999999999999999876543221 


Q ss_pred             cccccccCCccccCccccCCC---CCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhh
Q 007680          430 VRQTMTMATIGYMAPEYGLEG---IVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLV  506 (593)
Q Consensus       430 ~~~~~~~gt~~y~aPE~~~~~---~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  506 (593)
                       ......++..|+|||...+.   .++.++||||||+++|||++|+.||.......... .......+.           
T Consensus       157 -~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~-~~~~~~~~~-----------  223 (262)
T cd06613         157 -KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALF-LISKSNFPP-----------  223 (262)
T ss_pred             -ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhccCCC-----------
Confidence             12334578899999998776   78999999999999999999999997643211111 000000000           


Q ss_pred             hhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          507 REEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                         .........+.++.+++.+||..+|.+|||+.+++.+
T Consensus       224 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  260 (262)
T cd06613         224 ---PKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH  260 (262)
T ss_pred             ---ccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence               0001112345678999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=5.7e-38  Score=311.28  Aligned_cols=246  Identities=24%  Similarity=0.382  Sum_probs=196.7

Q ss_pred             ccCccCcccEEEEEeC---CCCeEEEEEeehhh--HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEeccCCC
Q 007680          279 LLGTSSFGSVYKGTIS---DGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNG  353 (593)
Q Consensus       279 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  353 (593)
                      .||+|+||.||+|.++   ++..+|+|+++...  ....+.+..|+.+++.++||||+++++++. .+..++||||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            6899999999999753   57889999986543  334567899999999999999999999875 45678999999999


Q ss_pred             CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCccc-c
Q 007680          354 SLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVR-Q  432 (593)
Q Consensus       354 sL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~-~  432 (593)
                      +|.+++.... .+++..+..++.|++.||+|||++    +++||||||+||++++++.+||+|||.+........... .
T Consensus        81 ~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~~----~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  155 (257)
T cd05116          81 PLNKFLQKNK-HVTEKNITELVHQVSMGMKYLEET----NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK  155 (257)
T ss_pred             cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC----CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence            9999997655 489999999999999999999965    499999999999999999999999999987654332111 1


Q ss_pred             ccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhhhh
Q 007680          433 TMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQA  511 (593)
Q Consensus       433 ~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  511 (593)
                      ....++..|+|||.+....++.++|||||||++|||++ |+.||......  .....+....                 .
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~i~~~~-----------------~  216 (257)
T cd05116         156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN--EVTQMIESGE-----------------R  216 (257)
T ss_pred             CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHCCC-----------------C
Confidence            22234578999999888889999999999999999998 99999763221  1111111110                 0


Q ss_pred             hhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHH
Q 007680          512 FSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKK  549 (593)
Q Consensus       512 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  549 (593)
                      .+.+..++.++.+++.+||+.||++||++.+|.+.|++
T Consensus       217 ~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         217 MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence            11112346688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-39  Score=318.03  Aligned_cols=249  Identities=22%  Similarity=0.341  Sum_probs=212.0

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh--HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVL  347 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  347 (593)
                      ..-|...+.||+|.|++|-+|++- +|.+||||++.+..  .-....+.+|++.|+.++|||||++|++.......|+|+
T Consensus        17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL   96 (864)
T KOG4717|consen   17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL   96 (864)
T ss_pred             eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence            345788899999999999999865 89999999998753  334457889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeee-CCCCcEEEEeeccceecCCC
Q 007680          348 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILL-DENMVAHVSDFGIYKLLGEG  426 (593)
Q Consensus       348 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll-~~~~~~kL~Dfg~a~~~~~~  426 (593)
                      |.-++|+|.+||-++...+.+..+.+++.||+.|+.|+|+    .++|||||||+||.+ ..-|-|||.|||++..+..+
T Consensus        97 ELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHq----LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG  172 (864)
T KOG4717|consen   97 ELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQ----LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG  172 (864)
T ss_pred             EecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhh----hhhhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence            9999999999999988889999999999999999999995    559999999999866 46689999999999888765


Q ss_pred             CCccccccccCCccccCccccCCCCCC-ccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhh
Q 007680          427 EDSVRQTMTMATIGYMAPEYGLEGIVS-AKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANL  505 (593)
Q Consensus       427 ~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  505 (593)
                      .   ..+..+|+..|.|||++.+..|+ +++||||||||+|.++.|++||....+.+.             +.-++|-+.
T Consensus       173 ~---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET-------------LTmImDCKY  236 (864)
T KOG4717|consen  173 K---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET-------------LTMIMDCKY  236 (864)
T ss_pred             c---hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh-------------hhhhhcccc
Confidence            5   34567899999999999999875 679999999999999999999988644331             222333222


Q ss_pred             hhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          506 VREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                             ..+.-.+.++.+||.+||..||.+|-+.+||..+
T Consensus       237 -------tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~  270 (864)
T KOG4717|consen  237 -------TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST  270 (864)
T ss_pred             -------cCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence                   2233456788999999999999999999999865

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=2.2e-38  Score=325.16  Aligned_cols=237  Identities=25%  Similarity=0.294  Sum_probs=188.2

Q ss_pred             cccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHH-HHhhcCCCCcceeeeeeecCCceEEEEeccCC
Q 007680          278 NLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECE-VLRNVRHRNLIKILSSYSNPDFKALVLEFMPN  352 (593)
Q Consensus       278 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  352 (593)
                      +.||+|+||.||+|+.. +|+.||+|++....   ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46999999999999975 78999999997643   222334445544 56778999999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCcccc
Q 007680          353 GSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQ  432 (593)
Q Consensus       353 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~  432 (593)
                      |+|.+++.... .+++..+..++.||+.||+|||++    +|+||||||+||+++.++.+||+|||++........  ..
T Consensus        81 g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~----givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~  153 (323)
T cd05575          81 GELFFHLQRER-SFPEPRARFYAAEIASALGYLHSL----NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK--TT  153 (323)
T ss_pred             CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC----CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC--cc
Confidence            99999987755 489999999999999999999965    499999999999999999999999999875322211  22


Q ss_pred             ccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhhhhh
Q 007680          433 TMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQAF  512 (593)
Q Consensus       433 ~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  512 (593)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||......     ......        .....       
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~-----~~~~~i--------~~~~~-------  213 (323)
T cd05575         154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA-----EMYDNI--------LNKPL-------  213 (323)
T ss_pred             ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH-----HHHHHH--------HcCCC-------
Confidence            3456899999999999999999999999999999999999999763211     111110        00000       


Q ss_pred             hhhHHHHHHHHHHHhhcccCCCCCCCCHH
Q 007680          513 SAKMDCILSIMDFALDCCMESPDMRINMT  541 (593)
Q Consensus       513 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~  541 (593)
                      ......+..+.+++.+||+.||++||++.
T Consensus       214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         214 RLKPNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             CCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence            00112356789999999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=4.1e-38  Score=317.17  Aligned_cols=269  Identities=21%  Similarity=0.354  Sum_probs=204.8

Q ss_pred             ccccccccCccCcccEEEEEe-----CCCCeEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceeeeeeecC--CceE
Q 007680          273 EFNECNLLGTSSFGSVYKGTI-----SDGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSYSNP--DFKA  344 (593)
Q Consensus       273 ~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~  344 (593)
                      -|++.+.||+|+||.||+++.     .++..||+|.++... ......+.+|++++++++||||+++.+++...  ...+
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK   84 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence            478899999999999999974     257889999987543 33456789999999999999999999988775  5689


Q ss_pred             EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecC
Q 007680          345 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG  424 (593)
Q Consensus       345 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~  424 (593)
                      +||||+++++|.+++.+....+++.++..++.|++.||+|||++    |++||||||+||+++.++.++|+|||+++.+.
T Consensus        85 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~----gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05079          85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSR----QYVHRDLAARNVLVESEHQVKIGDFGLTKAIE  160 (284)
T ss_pred             EEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC----CeeecccchheEEEcCCCCEEECCCccccccc
Confidence            99999999999999977655689999999999999999999965    49999999999999999999999999988765


Q ss_pred             CCCCcc-ccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCc-hhhhhh
Q 007680          425 EGEDSV-RQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHG-LTEVVD  502 (593)
Q Consensus       425 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~  502 (593)
                      ...... ......++..|+|||++.+..++.++||||||+++|||+|+..|+.......   .+.......+. ....+.
T Consensus       161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~  237 (284)
T cd05079         161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLF---LKMIGPTHGQMTVTRLVR  237 (284)
T ss_pred             cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchh---hhhcccccccccHHHHHH
Confidence            433211 1123456778999999888889999999999999999999887653321100   00000000000 000000


Q ss_pred             hhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHh
Q 007680          503 ANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKI  550 (593)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  550 (593)
                       .+ ......+....++.++.+++.+||+.+|++||++.++++.++++
T Consensus       238 -~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         238 -VL-EEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             -HH-HcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence             00 00011111223567899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=2.7e-38  Score=319.16  Aligned_cols=259  Identities=22%  Similarity=0.389  Sum_probs=204.0

Q ss_pred             HhhhccccccccCccCcccEEEEEeC------CCCeEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCC
Q 007680          269 RATDEFNECNLLGTSSFGSVYKGTIS------DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPD  341 (593)
Q Consensus       269 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  341 (593)
                      ...++|++.+.||+|+||.||+|..+      .+..||+|.++... ......+.+|+.+++.++||||+++++++...+
T Consensus         3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (288)
T cd05061           3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ   82 (288)
T ss_pred             ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            35678999999999999999999753      24579999886443 233446788999999999999999999999999


Q ss_pred             ceEEEEeccCCCCHHHHHhhCC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcE
Q 007680          342 FKALVLEFMPNGSLEKWLYSHN---------YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVA  412 (593)
Q Consensus       342 ~~~lv~e~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~  412 (593)
                      ..++||||+++|+|.+++....         ...++..+..++.|++.||+|||++    +|+||||||+||++++++.+
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~----~i~H~dikp~nili~~~~~~  158 (288)
T cd05061          83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK----KFVHRDLAARNCMVAHDFTV  158 (288)
T ss_pred             CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC----CCcCCCCChheEEEcCCCcE
Confidence            9999999999999999997532         1356778899999999999999965    49999999999999999999


Q ss_pred             EEEeeccceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHH
Q 007680          413 HVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKE  491 (593)
Q Consensus       413 kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~  491 (593)
                      +|+|||+++...............++..|+|||.+.++.++.++|||||||++|||++ |..||......  ...+....
T Consensus       159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~--~~~~~~~~  236 (288)
T cd05061         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE--QVLKFVMD  236 (288)
T ss_pred             EECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHc
Confidence            9999999886543322222222345678999999988899999999999999999998 78898653221  11111110


Q ss_pred             hcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHh
Q 007680          492 SLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKI  550 (593)
Q Consensus       492 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  550 (593)
                      .           ..      ...+..++..+.+++.+||+.||++|||+.++++.|++.
T Consensus       237 ~-----------~~------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~  278 (288)
T cd05061         237 G-----------GY------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD  278 (288)
T ss_pred             C-----------CC------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence            0           00      001112356789999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.3e-37  Score=310.11  Aligned_cols=258  Identities=23%  Similarity=0.327  Sum_probs=208.0

Q ss_pred             hccccccccCccCcccEEEEEeC-CCCeEEEEEeehh---hHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEE
Q 007680          272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQ---LERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVL  347 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  347 (593)
                      ++|++.+.||+|+||.||+|... +|+.||+|.++..   .....+.+.+|++++++++|+|++++++++...+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57999999999999999999976 7999999988643   2334567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecC
Q 007680          348 EFMPNGSLEKWLYSH---NYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG  424 (593)
Q Consensus       348 e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~  424 (593)
                      ||+++++|.+++...   ...+++.++..++.|++.||.|||+.    +++||||+|+||+++.++.++|+|||.+....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~----~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~  157 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK----RIMHRDIKPANVFITATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC----CEecCCcChhhEEECCCCcEEEeccceeeecc
Confidence            999999999998642   23589999999999999999999954    59999999999999999999999999987654


Q ss_pred             CCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhh
Q 007680          425 EGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDAN  504 (593)
Q Consensus       425 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  504 (593)
                      ....  ......++..|+|||.+.+..++.++|||||||++|+|++|+.||.....   ...+......         ..
T Consensus       158 ~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~---------~~  223 (267)
T cd08224         158 SKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM---NLYSLCKKIE---------KC  223 (267)
T ss_pred             CCCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc---cHHHHHhhhh---------cC
Confidence            3221  12234578889999999888899999999999999999999999865321   1111111000         00


Q ss_pred             hhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhh
Q 007680          505 LVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIK  551 (593)
Q Consensus       505 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~  551 (593)
                         .... .....++..+.+++.+||..+|++|||+.++++.|+++.
T Consensus       224 ---~~~~-~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         224 ---DYPP-LPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             ---CCCC-CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence               0000 001134567899999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.5e-38  Score=309.55  Aligned_cols=248  Identities=30%  Similarity=0.476  Sum_probs=200.4

Q ss_pred             cccCccCcccEEEEEeCCCCeEEEEEeehhhH-HHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEeccCCCCHH
Q 007680          278 NLLGTSSFGSVYKGTISDGTDVAIKVFNLQLE-RAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLE  356 (593)
Q Consensus       278 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~  356 (593)
                      ++||+|+||.||++...+++.||+|.+..... .....+.+|++++++++|+||+++++++...+..++||||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            47999999999999987799999999876533 34567899999999999999999999999999999999999999999


Q ss_pred             HHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCcccccccc
Q 007680          357 KWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTM  436 (593)
Q Consensus       357 ~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~  436 (593)
                      +++......+++..+..++.+++.||+|||+++    ++||||||+||+++.++.+||+|||.+................
T Consensus        81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~----i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~  156 (251)
T cd05041          81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN----CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ  156 (251)
T ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC----EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence            999776556889999999999999999999654    9999999999999999999999999987654322111112223


Q ss_pred             CCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhhhhhhhh
Q 007680          437 ATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAK  515 (593)
Q Consensus       437 gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  515 (593)
                      .+..|+|||++.++.++.++||||||+++|||+| |..||......  ..........                 ....+
T Consensus       157 ~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~--~~~~~~~~~~-----------------~~~~~  217 (251)
T cd05041         157 IPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ--QTRERIESGY-----------------RMPAP  217 (251)
T ss_pred             ceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH--HHHHHHhcCC-----------------CCCCC
Confidence            4567999999988899999999999999999999 88888663221  1111111000                 01112


Q ss_pred             HHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHH
Q 007680          516 MDCILSIMDFALDCCMESPDMRINMTDAAAKLK  548 (593)
Q Consensus       516 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  548 (593)
                      ..++.++.+++.+||..+|++|||+.|+++.|+
T Consensus       218 ~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         218 QLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             ccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            234568899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=5.8e-38  Score=311.19  Aligned_cols=248  Identities=28%  Similarity=0.493  Sum_probs=204.3

Q ss_pred             cccCccCcccEEEEEeCC----CCeEEEEEeehhhHH-HHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEeccCC
Q 007680          278 NLLGTSSFGSVYKGTISD----GTDVAIKVFNLQLER-AFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPN  352 (593)
Q Consensus       278 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  352 (593)
                      +.||+|+||.||+|....    +..|++|.++..... ..+.+.+|++.++.++|+||+++++++...+..++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            479999999999999753    888999999875433 367889999999999999999999999999999999999999


Q ss_pred             CCHHHHHhhC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecC
Q 007680          353 GSLEKWLYSH--------NYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG  424 (593)
Q Consensus       353 gsL~~~l~~~--------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~  424 (593)
                      ++|.+++...        ...+++.++..++.|++.||+|||++    +++|+||||+||++++++.+||+|||.+....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~----~i~H~di~p~nili~~~~~~~l~dfg~~~~~~  156 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK----KFVHRDLAARNCLVGEDLVVKISDFGLSRDVY  156 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC----CcccCccCcceEEECCCCcEEEcccccccccc
Confidence            9999999886        35699999999999999999999954    59999999999999999999999999998776


Q ss_pred             CCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhhhh
Q 007680          425 EGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDA  503 (593)
Q Consensus       425 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  503 (593)
                      ............++..|+|||.+.+..++.++||||+|+++|||++ |..||.....  ..........           
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~~~~~~~-----------  223 (262)
T cd00192         157 DDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN--EEVLEYLRKG-----------  223 (262)
T ss_pred             cccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHHcC-----------
Confidence            5432222334557889999999988899999999999999999999 6999977421  1111111110           


Q ss_pred             hhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHH
Q 007680          504 NLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLK  548 (593)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  548 (593)
                            .....+..++.++.+++.+||+.+|++|||+.|++++|+
T Consensus       224 ------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         224 ------YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             ------CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                  011112234668899999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-39  Score=332.26  Aligned_cols=244  Identities=25%  Similarity=0.345  Sum_probs=204.6

Q ss_pred             ccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEeccCCCCHHH
Q 007680          279 LLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEK  357 (593)
Q Consensus       279 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~  357 (593)
                      +||+|.||+||.|++. +...+|||-+.....+..+.+..|+.+.++++|.|||+++|.+.+++..-|.||-++||+|.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            7999999999999965 567899999988888888889999999999999999999999999999999999999999999


Q ss_pred             HHhhCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeC-CCCcEEEEeeccceecCCCCCcccccc
Q 007680          358 WLYSHNYFL--DILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLD-ENMVAHVSDFGIYKLLGEGEDSVRQTM  434 (593)
Q Consensus       358 ~l~~~~~~l--~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~-~~~~~kL~Dfg~a~~~~~~~~~~~~~~  434 (593)
                      +++..=+++  .+..+--..+||++||.|||++.    |||||||-+||||+ -.|.+||+|||.++.+..-.  .-...
T Consensus       662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHen~----IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin--P~TET  735 (1226)
T KOG4279|consen  662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK----IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN--PCTET  735 (1226)
T ss_pred             HHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc----eeeccccCCcEEEeeccceEEecccccchhhccCC--ccccc
Confidence            998866556  77888889999999999999765    99999999999996 68999999999998875322  22345


Q ss_pred             ccCCccccCccccCCCC--CCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhhhhh
Q 007680          435 TMATIGYMAPEYGLEGI--VSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQAF  512 (593)
Q Consensus       435 ~~gt~~y~aPE~~~~~~--~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  512 (593)
                      ..||..|||||++..++  |++++|||||||++.||.||++||.+.......+-+               -.+  ...-.
T Consensus       736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFk---------------VGm--yKvHP  798 (1226)
T KOG4279|consen  736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFK---------------VGM--YKVHP  798 (1226)
T ss_pred             cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhh---------------hcc--eecCC
Confidence            67999999999998765  899999999999999999999999875332211111               011  01112


Q ss_pred             hhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007680          513 SAKMDCILSIMDFALDCCMESPDMRINMTDAAA  545 (593)
Q Consensus       513 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  545 (593)
                      +.+.+.+.+...+|.+|+.+||.+||+++++++
T Consensus       799 ~iPeelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  799 PIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             CCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            234456778899999999999999999999985

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=4.5e-38  Score=325.54  Aligned_cols=260  Identities=27%  Similarity=0.427  Sum_probs=202.7

Q ss_pred             hhccccccccCccCcccEEEEEe------CCCCeEEEEEeehhh-HHHHHHHHHHHHHHhhc-CCCCcceeeeeeecC-C
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTI------SDGTDVAIKVFNLQL-ERAFRSFDSECEVLRNV-RHRNLIKILSSYSNP-D  341 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~  341 (593)
                      .++|++.+.||+|+||.||+|.+      .+++.||||+++... ......+.+|+.++.++ +||||+++++++... .
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            56899999999999999999973      257889999997543 33456788999999999 689999999987654 4


Q ss_pred             ceEEEEeccCCCCHHHHHhhCC----------------------------------------------------------
Q 007680          342 FKALVLEFMPNGSLEKWLYSHN----------------------------------------------------------  363 (593)
Q Consensus       342 ~~~lv~e~~~~gsL~~~l~~~~----------------------------------------------------------  363 (593)
                      ..++||||+++|+|.+++....                                                          
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            6789999999999999986532                                                          


Q ss_pred             --------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCccccccc
Q 007680          364 --------YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMT  435 (593)
Q Consensus       364 --------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~  435 (593)
                              ..+++..+..++.|+++||+|||++    +|+||||||+||+++.++.+||+|||++...............
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~----~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  241 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR----KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA  241 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence                    1367788899999999999999954    5999999999999999999999999998865433222222223


Q ss_pred             cCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhhhhhhh
Q 007680          436 MATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSA  514 (593)
Q Consensus       436 ~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  514 (593)
                      .++..|+|||++.+..++.++||||||+++|+|++ |..||....... .....+.....                 ...
T Consensus       242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-~~~~~~~~~~~-----------------~~~  303 (343)
T cd05103         242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-EFCRRLKEGTR-----------------MRA  303 (343)
T ss_pred             CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH-HHHHHHhccCC-----------------CCC
Confidence            45678999999988899999999999999999997 999986532211 11111110000                 000


Q ss_pred             hHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhh
Q 007680          515 KMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKV  552 (593)
Q Consensus       515 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~  552 (593)
                      +...++++.+++.+||+.||++|||+.|++++|+.+..
T Consensus       304 ~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         304 PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            11124578999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4e-38  Score=315.81  Aligned_cols=255  Identities=24%  Similarity=0.408  Sum_probs=204.8

Q ss_pred             hhccccccccCccCcccEEEEEeC------CCCeEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCce
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS------DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFK  343 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  343 (593)
                      .++|++.+.||+|+||.||+|...      ++..||+|.+.... ......+.+|+.++..++||||+++++++...+..
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            568999999999999999999864      24689999986543 23445788999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhCC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEE
Q 007680          344 ALVLEFMPNGSLEKWLYSHN---------YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHV  414 (593)
Q Consensus       344 ~lv~e~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL  414 (593)
                      ++||||+++++|.+++....         ..+++..+..++.|++.||.|||+.    +++||||||+||+++.++.+||
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~di~p~nill~~~~~~kl  160 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK----KFVHRDLAARNCMVAEDLTVKI  160 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC----CccccccChheEEEcCCCCEEE
Confidence            99999999999999987532         1368889999999999999999954    5999999999999999999999


Q ss_pred             EeeccceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhc
Q 007680          415 SDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESL  493 (593)
Q Consensus       415 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~  493 (593)
                      +|||+++...............++..|+|||.+.++.++.++|||||||++||+++ |..||......  ...+......
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--~~~~~~~~~~  238 (277)
T cd05032         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE--EVLKFVIDGG  238 (277)
T ss_pred             CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH--HHHHHHhcCC
Confidence            99999886644332222233456788999999988889999999999999999998 99998653211  1111111100


Q ss_pred             CCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHH
Q 007680          494 PHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLK  548 (593)
Q Consensus       494 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  548 (593)
                                       ....+..++.++.+++.+||+.+|++|||+.++++.|+
T Consensus       239 -----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         239 -----------------HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             -----------------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence                             00111223568899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=6.9e-38  Score=319.32  Aligned_cols=265  Identities=22%  Similarity=0.280  Sum_probs=205.1

Q ss_pred             hccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEec
Q 007680          272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEF  349 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  349 (593)
                      ++|++.+.||+|+||.||++... ++..+|+|.++... ......+.+|++++++++||||+++++++..++..++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            46899999999999999999865 68889999987542 33456688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCc
Q 007680          350 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDS  429 (593)
Q Consensus       350 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~  429 (593)
                      +++++|.+++.... .+++..+..++.|+++||+|||+.   .+++|+||||+||++++++.+||+|||++.......  
T Consensus        81 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--  154 (308)
T cd06615          81 MDGGSLDQVLKKAG-RIPENILGKISIAVLRGLTYLREK---HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--  154 (308)
T ss_pred             cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhh---CCEEECCCChHHEEEecCCcEEEccCCCcccccccc--
Confidence            99999999998764 489999999999999999999962   359999999999999999999999999987553321  


Q ss_pred             cccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCc-------------
Q 007680          430 VRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHG-------------  496 (593)
Q Consensus       430 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-------------  496 (593)
                        .....++..|+|||.+.+..++.++||||||+++|+|++|+.||....  ......+........             
T Consensus       155 --~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (308)
T cd06615         155 --ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPD--AKELEAMFGRPVSEGEAKESHRPVSGHP  230 (308)
T ss_pred             --cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcc--hhhHHHhhcCccccccccCCcccccCCC
Confidence              223468899999999888889999999999999999999999986532  111111111100000             


Q ss_pred             --------hhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 007680          497 --------LTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKL  547 (593)
Q Consensus       497 --------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  547 (593)
                              ..+..+......... .....++.++.+++.+||..+|++||++.|++++-
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~  288 (308)
T cd06615         231 PDSPRPMAIFELLDYIVNEPPPK-LPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP  288 (308)
T ss_pred             CCccchhhHHHHHHHHhcCCCcc-CcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence                    000010000000000 00112456789999999999999999999999873

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=8.2e-38  Score=308.63  Aligned_cols=247  Identities=29%  Similarity=0.454  Sum_probs=199.3

Q ss_pred             cccCccCcccEEEEEeCCCCeEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEeccCCCCHH
Q 007680          278 NLLGTSSFGSVYKGTISDGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLE  356 (593)
Q Consensus       278 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~  356 (593)
                      +.||+|+||.||+|...+++.+|+|.++... ......+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            4799999999999998888999999987543 233456889999999999999999999999999999999999999999


Q ss_pred             HHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCcccccccc
Q 007680          357 KWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTM  436 (593)
Q Consensus       357 ~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~  436 (593)
                      +++......+++..+..++.|++.||.|+|++    +++||||||+||++++++.+||+|||++......... ......
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~----~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~  155 (250)
T cd05085          81 SFLRKKKDELKTKQLVKFALDAAAGMAYLESK----NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLKQ  155 (250)
T ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC----CeeecccChheEEEcCCCeEEECCCccceeccccccc-cCCCCC
Confidence            99977665689999999999999999999965    4999999999999999999999999998754332211 111223


Q ss_pred             CCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhhhhhhhh
Q 007680          437 ATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAK  515 (593)
Q Consensus       437 gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  515 (593)
                      ++..|+|||+..+..++.++||||||+++|++++ |..||.......  .........                 ....+
T Consensus       156 ~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~--~~~~~~~~~-----------------~~~~~  216 (250)
T cd05085         156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ--AREQVEKGY-----------------RMSCP  216 (250)
T ss_pred             CcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH--HHHHHHcCC-----------------CCCCC
Confidence            4667999999988899999999999999999998 999996642211  111111100                 00011


Q ss_pred             HHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHH
Q 007680          516 MDCILSIMDFALDCCMESPDMRINMTDAAAKLK  548 (593)
Q Consensus       516 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  548 (593)
                      ..++..+.+++.+||+.+|++||++.|+++.|.
T Consensus       217 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         217 QKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            124568899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-38  Score=309.70  Aligned_cols=268  Identities=25%  Similarity=0.388  Sum_probs=209.6

Q ss_pred             hhhccccccccCccCcccEEEEEeCCCCeEEEEEeehhhHHHHHHHHHHHHHHhhc--CCCCcceeeeeeecCC----ce
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNV--RHRNLIKILSSYSNPD----FK  343 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~~----~~  343 (593)
                      ...+....+.||+|.||.||+|+|. |+.||||++...++   +.+.+|.+|++.+  +|+||+.+++.-..+.    ..
T Consensus       209 iarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL  284 (513)
T KOG2052|consen  209 IARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL  284 (513)
T ss_pred             hhheeEEEEEecCccccceeecccc-CCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence            3467888999999999999999996 89999999976543   4678888888876  9999999998765443    67


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh-----cCCCCCeEecCCCCCCeeeCCCCcEEEEeec
Q 007680          344 ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN-----GHSSVHIIHCDLKPTNILLDENMVAHVSDFG  418 (593)
Q Consensus       344 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~-----~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg  418 (593)
                      ++|++|.+.|+|.|++....  ++....++++..+|.||+|||.     +| ++.|+|||||+.||||..++.+-|+|+|
T Consensus       285 wLvTdYHe~GSL~DyL~r~t--v~~~~ml~LalS~AsGLaHLH~eI~GTqg-KPaIAHRDlKSKNILVKkn~~C~IADLG  361 (513)
T KOG2052|consen  285 WLVTDYHEHGSLYDYLNRNT--VTTEGMLKLALSIASGLAHLHMEIVGTQG-KPAIAHRDLKSKNILVKKNGTCCIADLG  361 (513)
T ss_pred             EEeeecccCCcHHHHHhhcc--CCHHHHHHHHHHHhhhHHHHHHHHhcCCC-CchhhccccccccEEEccCCcEEEeece
Confidence            99999999999999998854  8999999999999999999995     44 6789999999999999999999999999


Q ss_pred             cceecCCCCCc--cccccccCCccccCccccCCCC----C-C-ccchHHHHHHHHHHHHhC----------CCCCCcccc
Q 007680          419 IYKLLGEGEDS--VRQTMTMATIGYMAPEYGLEGI----V-S-AKCDVYSYGVLLMETFTR----------KRPTDEMFI  480 (593)
Q Consensus       419 ~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~----~-s-~~~DvwSlGvvl~elltg----------~~pf~~~~~  480 (593)
                      +|.......+.  ......+||..|||||++...-    + + ..+||||||.|+||+.-+          +.||.+..+
T Consensus       362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp  441 (513)
T KOG2052|consen  362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP  441 (513)
T ss_pred             eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC
Confidence            99987765332  2345678999999999986542    1 2 359999999999998752          367766555


Q ss_pred             ccchHHHHHHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhh
Q 007680          481 GEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKV  552 (593)
Q Consensus       481 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~  552 (593)
                      .+.++.+...-        +-..++.+.....-...++...+.++|+.||..+|..|-|+--+-+.|.++..
T Consensus       442 ~DPs~eeMrkV--------VCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~  505 (513)
T KOG2052|consen  442 SDPSFEEMRKV--------VCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN  505 (513)
T ss_pred             CCCCHHHHhcc--------eeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence            54444332110        00111111112222233455678999999999999999999999999988864

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.6e-38  Score=310.08  Aligned_cols=250  Identities=29%  Similarity=0.473  Sum_probs=206.2

Q ss_pred             hhccccccccCccCcccEEEEEeCCCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEecc
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFM  350 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  350 (593)
                      .++|++.+.||+|+||.||+|... |+.||+|.++.... ..+.+.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   82 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM   82 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence            467899999999999999999875 78999999976644 4577899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCc
Q 007680          351 PNGSLEKWLYSHNY-FLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDS  429 (593)
Q Consensus       351 ~~gsL~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~  429 (593)
                      ++++|.+++..... .+++..+..++.|++.||.|||+++    ++|+||||+||+++.++.+||+|||.++....... 
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~----i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-  157 (256)
T cd05039          83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN----FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-  157 (256)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC----ccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence            99999999976553 5899999999999999999999654    99999999999999999999999999887633221 


Q ss_pred             cccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhh
Q 007680          430 VRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVRE  508 (593)
Q Consensus       430 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  508 (593)
                          ....+..|+|||++.++.++.++||||||+++||+++ |+.||......  ...........              
T Consensus       158 ----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~~~~~~--------------  217 (256)
T cd05039         158 ----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPHVEKGYR--------------  217 (256)
T ss_pred             ----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHhcCCC--------------
Confidence                2234567999999988889999999999999999997 99998653211  11111111000              


Q ss_pred             hhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHh
Q 007680          509 EQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKI  550 (593)
Q Consensus       509 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  550 (593)
                         ...+..+++.+.+++.+||..+|++||++.|+++.|+.+
T Consensus       218 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         218 ---MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             ---CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence               001123456889999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=5.6e-38  Score=347.66  Aligned_cols=261  Identities=21%  Similarity=0.259  Sum_probs=205.1

Q ss_pred             hccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEE
Q 007680          272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVL  347 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  347 (593)
                      ++|++.++||+|+||.||+|... +|+.||+|+++...   ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            57999999999999999999975 68999999997542   234567899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEee
Q 007680          348 EFMPNGSLEKWLYSHN----------YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDF  417 (593)
Q Consensus       348 e~~~~gsL~~~l~~~~----------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df  417 (593)
                      ||++|++|.+++....          ...++..+..++.|+++||+|||++    +|+||||||+||+++.++.+||+||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~----GIIHRDLKPeNILLd~dg~vKLiDF  157 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK----GVLHRDLKPDNILLGLFGEVVILDW  157 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC----CccccCCchheEEEcCCCCEEEEec
Confidence            9999999999986421          1356778899999999999999954    5999999999999999999999999


Q ss_pred             ccceecCCCCCc----------------cccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccc
Q 007680          418 GIYKLLGEGEDS----------------VRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIG  481 (593)
Q Consensus       418 g~a~~~~~~~~~----------------~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~  481 (593)
                      |+++........                .......||+.|+|||++.+..++.++|||||||++|||+||+.||......
T Consensus       158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~  237 (932)
T PRK13184        158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR  237 (932)
T ss_pred             CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence            999876221100                0112246899999999999999999999999999999999999999763211


Q ss_pred             cchHHHHHHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCC-CHHHHHHHHHHhhhh
Q 007680          482 EMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRI-NMTDAAAKLKKIKVK  553 (593)
Q Consensus       482 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~i~~~  553 (593)
                      .....    ...             ..........++++.+.+++.+||+.||++|| +++++.+.|+.....
T Consensus       238 ki~~~----~~i-------------~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~  293 (932)
T PRK13184        238 KISYR----DVI-------------LSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG  293 (932)
T ss_pred             hhhhh----hhc-------------cChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence            11000    000             00001111124466789999999999999997 567777777776543

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=3.8e-38  Score=313.05  Aligned_cols=254  Identities=23%  Similarity=0.405  Sum_probs=204.7

Q ss_pred             hhhccccccccCccCcccEEEEEeCCCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEec
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEF  349 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  349 (593)
                      ..++|++.++||+|+||.||+|..++++.||+|.+..... ....+.+|+.++++++|+||+++++++. .+..+++|||
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~   81 (260)
T cd05067           4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY   81 (260)
T ss_pred             chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence            3568999999999999999999988899999999875432 2357889999999999999999999864 4578999999


Q ss_pred             cCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCC
Q 007680          350 MPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGED  428 (593)
Q Consensus       350 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  428 (593)
                      +++++|.+++.... ..+++.++..++.|++.||+|||+    .+++||||||+||++++++.++|+|||.+........
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~----~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05067          82 MENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER----KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY  157 (260)
T ss_pred             CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhc----CCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence            99999999987643 368999999999999999999995    4599999999999999999999999999887653221


Q ss_pred             ccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhh
Q 007680          429 SVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVR  507 (593)
Q Consensus       429 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  507 (593)
                      . ......++..|+|||++.+..++.++||||||+++||+++ |+.||......  ...........             
T Consensus       158 ~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~~~-------------  221 (260)
T cd05067         158 T-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP--EVIQNLERGYR-------------  221 (260)
T ss_pred             c-cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH--HHHHHHHcCCC-------------
Confidence            1 1122345678999999988889999999999999999999 99999763211  11111111100             


Q ss_pred             hhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHH
Q 007680          508 EEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKK  549 (593)
Q Consensus       508 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  549 (593)
                          .+.+...+.++.+++.+||+.+|++||+++++.+.|+.
T Consensus       222 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         222 ----MPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             ----CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence                01112235578999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=6.7e-38  Score=310.60  Aligned_cols=248  Identities=25%  Similarity=0.372  Sum_probs=200.4

Q ss_pred             cccCccCcccEEEEEeCC--C--CeEEEEEeehhhH-HHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEeccCC
Q 007680          278 NLLGTSSFGSVYKGTISD--G--TDVAIKVFNLQLE-RAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPN  352 (593)
Q Consensus       278 ~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  352 (593)
                      +.||+|++|.||+|.+.+  +  ..||+|.+..... ...+.+.+|+.++++++||||+++++.+.. ...++||||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            478999999999998643  3  3699999987654 566789999999999999999999999988 889999999999


Q ss_pred             CCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCccc
Q 007680          353 GSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVR  431 (593)
Q Consensus       353 gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~  431 (593)
                      ++|.+++.... ..+++..+..++.|++.||+|||++    +++|+||||+||+++.++.+||+|||++..+........
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~----~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  155 (257)
T cd05040          80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK----RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV  155 (257)
T ss_pred             CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC----CccccccCcccEEEecCCEEEecccccccccccccccee
Confidence            99999998765 4689999999999999999999955    599999999999999999999999999987754332211


Q ss_pred             -cccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhh
Q 007680          432 -QTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREE  509 (593)
Q Consensus       432 -~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  509 (593)
                       .....++..|+|||+..+..++.++|||||||++|||++ |+.||......+  ..+......                
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~~~~~~----------------  217 (257)
T cd05040         156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ--ILKKIDKEG----------------  217 (257)
T ss_pred             cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHhcC----------------
Confidence             123456788999999988899999999999999999999 999996532211  111111000                


Q ss_pred             hhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHH
Q 007680          510 QAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLK  548 (593)
Q Consensus       510 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  548 (593)
                      .........+..+.+++.+||+.+|++||++.++++.|.
T Consensus       218 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         218 ERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             CcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            000111234567899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=5e-38  Score=317.16  Aligned_cols=256  Identities=25%  Similarity=0.414  Sum_probs=204.0

Q ss_pred             hhccccccccCccCcccEEEEEeC------CCCeEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCce
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS------DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFK  343 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  343 (593)
                      .++|++.+.||+|+||.||+|...      ++..||+|.+.... ......+.+|+.++++++||||+++++++.+++..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            568999999999999999999863      46789999987543 33456788999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCC
Q 007680          344 ALVLEFMPNGSLEKWLYSHN---------------------YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPT  402 (593)
Q Consensus       344 ~lv~e~~~~gsL~~~l~~~~---------------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~  402 (593)
                      ++||||+++++|.+++....                     ..+++.+++.++.|++.||+|||++    +++||||||+
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~----~i~H~dl~p~  159 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER----KFVHRDLATR  159 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC----CeecccccHh
Confidence            99999999999999997532                     1367888999999999999999965    4999999999


Q ss_pred             CeeeCCCCcEEEEeeccceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccc
Q 007680          403 NILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIG  481 (593)
Q Consensus       403 NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~  481 (593)
                      ||++++++.++|+|||.+.................+..|+|||...+..++.++|||||||++|||++ |..||......
T Consensus       160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~  239 (288)
T cd05050         160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE  239 (288)
T ss_pred             heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999876543322111222335667999999888899999999999999999998 88888653221


Q ss_pred             cchHHHHHHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHH
Q 007680          482 EMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKK  549 (593)
Q Consensus       482 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  549 (593)
                      +  ....+..           ...      ...+..++.++.+++.+||+.||++|||+.|+++.|++
T Consensus       240 ~--~~~~~~~-----------~~~------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         240 E--VIYYVRD-----------GNV------LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             H--HHHHHhc-----------CCC------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence            1  1111110           000      01112345678999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.4e-38  Score=331.73  Aligned_cols=253  Identities=23%  Similarity=0.359  Sum_probs=199.0

Q ss_pred             hccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEE
Q 007680          272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVL  347 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  347 (593)
                      ++|+..+.||+|+||.||++..+ +++.||+|+++...   ......+..|+.++.+++||||+++++.+.+.+..++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46889999999999999999865 68999999998643   234567888999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCC
Q 007680          348 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGE  427 (593)
Q Consensus       348 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~  427 (593)
                      ||+++|+|.+++.+... +++..+..++.|++.||+|||++    +|+||||||+||+++.++.+||+|||++..+....
T Consensus        81 E~~~gg~L~~~l~~~~~-l~~~~~~~~~~qi~~~L~~lH~~----givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~  155 (360)
T cd05627          81 EFLPGGDMMTLLMKKDT-LSEEATQFYIAETVLAIDAIHQL----GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH  155 (360)
T ss_pred             eCCCCccHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHC----CeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence            99999999999977654 89999999999999999999954    59999999999999999999999999987543211


Q ss_pred             Cc---------------------------------cccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCC
Q 007680          428 DS---------------------------------VRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRP  474 (593)
Q Consensus       428 ~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~p  474 (593)
                      ..                                 .......||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P  235 (360)
T cd05627         156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP  235 (360)
T ss_pred             ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence            00                                 001134689999999999999999999999999999999999999


Q ss_pred             CCccccccchHHHHHHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCC---HHHHHHH
Q 007680          475 TDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRIN---MTDAAAK  546 (593)
Q Consensus       475 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~~  546 (593)
                      |....... .... +.. ..             .....+.....+.++.+++.+|+. ||.+|++   +.|+++|
T Consensus       236 f~~~~~~~-~~~~-i~~-~~-------------~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h  293 (360)
T cd05627         236 FCSETPQE-TYRK-VMN-WK-------------ETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSH  293 (360)
T ss_pred             CCCCCHHH-HHHH-HHc-CC-------------CceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence            97632211 0000 000 00             000011111234577889988774 9999985   6777766

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=4.7e-38  Score=319.49  Aligned_cols=267  Identities=18%  Similarity=0.252  Sum_probs=203.2

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEe
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLE  348 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  348 (593)
                      .++|++.+.||+|+||.||+|+.. +++.||+|.++... ......+.+|+.++++++||||+++++++..++..++|||
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e   84 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE   84 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence            357999999999999999999865 68899999987543 2233467789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCC
Q 007680          349 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGED  428 (593)
Q Consensus       349 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  428 (593)
                      |++ ++|.+++......+++..+..++.|+++||+|||++    +|+|+||||+||++++++.+||+|||++........
T Consensus        85 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~----~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  159 (301)
T cd07873          85 YLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR----KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK  159 (301)
T ss_pred             ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence            996 599999887666689999999999999999999954    599999999999999999999999999876443221


Q ss_pred             ccccccccCCccccCccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCc----hhhhhhh
Q 007680          429 SVRQTMTMATIGYMAPEYGLEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHG----LTEVVDA  503 (593)
Q Consensus       429 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~~  503 (593)
                        ......+++.|+|||++.+. .++.++|||||||++|||++|+.||......  .............    +....+.
T Consensus       160 --~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  235 (301)
T cd07873         160 --TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE--EQLHFIFRILGTPTEETWPGILSN  235 (301)
T ss_pred             --cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHcCCCChhhchhhhcc
Confidence              12233568899999987654 5888999999999999999999999764221  1111111111110    1111110


Q ss_pred             hh------hhhh--hhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          504 NL------VREE--QAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       504 ~~------~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      ..      ....  ........+++.+.+++.+||+.||.+|||++|+++|
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h  286 (301)
T cd07873         236 EEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH  286 (301)
T ss_pred             ccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            00      0000  0001112345678999999999999999999999985

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=9.2e-38  Score=312.10  Aligned_cols=257  Identities=21%  Similarity=0.367  Sum_probs=206.0

Q ss_pred             hhccccccccCccCcccEEEEEeCC----CCeEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTISD----GTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKAL  345 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  345 (593)
                      .++|.+.+.||+|+||.||+|.+.+    ...||+|...... ....+.+.+|+.++++++||||+++++++.+ +..++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l   83 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI   83 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence            4568889999999999999998643    3468999887654 4456688999999999999999999998875 45789


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCC
Q 007680          346 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGE  425 (593)
Q Consensus       346 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~  425 (593)
                      ||||+++++|.+++......+++..+..++.|++.||+|||+.    +++|+||||+||+++.++.+||+|||+++....
T Consensus        84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~----~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  159 (270)
T cd05056          84 VMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESK----RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED  159 (270)
T ss_pred             EEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC----CeeccccChheEEEecCCCeEEccCceeeeccc
Confidence            9999999999999987665689999999999999999999955    499999999999999999999999999887644


Q ss_pred             CCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhhhhh
Q 007680          426 GEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDAN  504 (593)
Q Consensus       426 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  504 (593)
                      ... .......++..|+|||.+....++.++||||||+++||+++ |..||......+  .........           
T Consensus       160 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~--~~~~~~~~~-----------  225 (270)
T cd05056         160 ESY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND--VIGRIENGE-----------  225 (270)
T ss_pred             ccc-eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHHcCC-----------
Confidence            321 11222334567999999888889999999999999999996 999997643211  111111000           


Q ss_pred             hhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhh
Q 007680          505 LVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKV  552 (593)
Q Consensus       505 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~  552 (593)
                            ....+..++..+.+++.+|+..+|++|||+.++++.|+++..
T Consensus       226 ------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~  267 (270)
T cd05056         226 ------RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ  267 (270)
T ss_pred             ------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence                  001122346688999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=7.4e-38  Score=317.25  Aligned_cols=263  Identities=22%  Similarity=0.330  Sum_probs=202.7

Q ss_pred             hhccccccccCccCcccEEEEEeC-----------------CCCeEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcce
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-----------------DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIK  332 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~  332 (593)
                      .++|++.+.||+|+||.||++...                 ++..||+|+++... ......+.+|+.+++.++|+||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            357999999999999999998532                 23468999987543 344568899999999999999999


Q ss_pred             eeeeeecCCceEEEEeccCCCCHHHHHhhCCC----------CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCC
Q 007680          333 ILSSYSNPDFKALVLEFMPNGSLEKWLYSHNY----------FLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPT  402 (593)
Q Consensus       333 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~----------~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~  402 (593)
                      +++++...+..++||||+++++|.+++.....          .+++.++..++.|++.||+|||+.    +++|+||||+
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~----~i~H~dlkp~  159 (296)
T cd05095          84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL----NFVHRDLATR  159 (296)
T ss_pred             EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC----CeecccCChh
Confidence            99999999999999999999999999876431          367788999999999999999965    4999999999


Q ss_pred             CeeeCCCCcEEEEeeccceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh--CCCCCCcccc
Q 007680          403 NILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT--RKRPTDEMFI  480 (593)
Q Consensus       403 NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt--g~~pf~~~~~  480 (593)
                      ||++++++.++|+|||+++.+.............++..|+|||...++.++.++|||||||++|||++  |..||.....
T Consensus       160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~  239 (296)
T cd05095         160 NCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD  239 (296)
T ss_pred             eEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence            99999999999999999886543322111222334678999998888889999999999999999998  7788865322


Q ss_pred             ccchHHHHHHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHH
Q 007680          481 GEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKK  549 (593)
Q Consensus       481 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  549 (593)
                      .+  ........        .....  .....+.+..++..+.+++.+||+.||++||++.|+.+.|++
T Consensus       240 ~~--~~~~~~~~--------~~~~~--~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         240 EQ--VIENTGEF--------FRDQG--RQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             HH--HHHHHHHH--------Hhhcc--ccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            11  11100000        00000  000011112345688999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=5.3e-38  Score=319.39  Aligned_cols=258  Identities=29%  Similarity=0.442  Sum_probs=202.9

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCC--eEEEEEeehh-hHHHHHHHHHHHHHHhhc-CCCCcceeeeeeecCCceEE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGT--DVAIKVFNLQ-LERAFRSFDSECEVLRNV-RHRNLIKILSSYSNPDFKAL  345 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  345 (593)
                      .++|++.+.||+|+||.||+|.++ ++.  .+|+|.++.. .......+.+|++++.++ +||||+++++++...+..++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l   85 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   85 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence            568899999999999999999965 454  4577776643 234456788999999999 89999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC
Q 007680          346 VLEFMPNGSLEKWLYSHN---------------YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENM  410 (593)
Q Consensus       346 v~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~  410 (593)
                      ||||+++++|.+++....               ..+++.+++.++.|++.|++|||++    +++||||||+||++++++
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~----gi~H~dlkp~Nili~~~~  161 (303)
T cd05088          86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK----QFIHRDLAARNILVGENY  161 (303)
T ss_pred             EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC----CccccccchheEEecCCC
Confidence            999999999999997543               2478999999999999999999954    599999999999999999


Q ss_pred             cEEEEeeccceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHH
Q 007680          411 VAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWV  489 (593)
Q Consensus       411 ~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~  489 (593)
                      .+||+|||++......   ........+..|+|||+..+..++.++|||||||++|||+| |..||......  ......
T Consensus       162 ~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~~  236 (303)
T cd05088         162 VAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--ELYEKL  236 (303)
T ss_pred             cEEeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH--HHHHHH
Confidence            9999999998632211   11112234567999999888889999999999999999998 99999653211  111111


Q ss_pred             HHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhhh
Q 007680          490 KESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKF  554 (593)
Q Consensus       490 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  554 (593)
                      .    ..             .....+..++.++.+++.+||+.+|++||++.++++.|+.+....
T Consensus       237 ~----~~-------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~  284 (303)
T cd05088         237 P----QG-------------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  284 (303)
T ss_pred             h----cC-------------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence            0    00             000011123557899999999999999999999999998876554

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=7.1e-38  Score=314.60  Aligned_cols=249  Identities=23%  Similarity=0.302  Sum_probs=198.7

Q ss_pred             hccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEec
Q 007680          272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEF  349 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  349 (593)
                      ++|++.+.||+|+||.||+|... +++.||+|.+.... ......+.+|++++++++||||+++++++...+..++||||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            36888999999999999999864 78999999987542 33446788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCc
Q 007680          350 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDS  429 (593)
Q Consensus       350 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~  429 (593)
                      +++++|..+.     .+++..+..++.|++.||+|||+.    +|+|+||||+||+++.++.++|+|||++.......  
T Consensus        81 ~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~--  149 (279)
T cd06619          81 MDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLWSL----KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI--  149 (279)
T ss_pred             CCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHHHC----CEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc--
Confidence            9999997652     278888999999999999999954    59999999999999999999999999988654322  


Q ss_pred             cccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchH--HHHHHHhcCCchhhhhhhhhhh
Q 007680          430 VRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSL--RRWVKESLPHGLTEVVDANLVR  507 (593)
Q Consensus       430 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  507 (593)
                        .....++..|+|||++.+..++.++||||||+++|+|++|+.||..........  ......        ..+..   
T Consensus       150 --~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~--------~~~~~---  216 (279)
T cd06619         150 --AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQC--------IVDED---  216 (279)
T ss_pred             --ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHH--------HhccC---
Confidence              233468899999999998899999999999999999999999997633221110  000000        00000   


Q ss_pred             hhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          508 EEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       508 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                       .. .......++++.+++.+||+.+|++||+++|++++
T Consensus       217 -~~-~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         217 -PP-VLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             -CC-CCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence             00 00011234578999999999999999999999987

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1e-37  Score=311.38  Aligned_cols=256  Identities=27%  Similarity=0.339  Sum_probs=202.5

Q ss_pred             HHhhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEE
Q 007680          268 QRATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALV  346 (593)
Q Consensus       268 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  346 (593)
                      +.+++++.....||+|+||.||+|... ++..||+|.+........+.+.+|+.++++++|+||+++++++..++..++|
T Consensus         4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   83 (268)
T cd06624           4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF   83 (268)
T ss_pred             ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence            345566666779999999999999865 6788999998776555667899999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC-CCcEEEEeeccceec
Q 007680          347 LEFMPNGSLEKWLYSHNYFL--DILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDE-NMVAHVSDFGIYKLL  423 (593)
Q Consensus       347 ~e~~~~gsL~~~l~~~~~~l--~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~-~~~~kL~Dfg~a~~~  423 (593)
                      +||+++++|.+++......+  ++..+..++.|++.||+|||++    +|+||||||+||+++. ++.++|+|||.+...
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~----~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~  159 (268)
T cd06624          84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN----QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL  159 (268)
T ss_pred             EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC----CEeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence            99999999999998754435  8888999999999999999954    5999999999999976 679999999998765


Q ss_pred             CCCCCccccccccCCccccCccccCCCC--CCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhh
Q 007680          424 GEGEDSVRQTMTMATIGYMAPEYGLEGI--VSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVV  501 (593)
Q Consensus       424 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  501 (593)
                      .....  ......++..|+|||++.+..  ++.++||||||+++|+|++|+.||.........  .+...          
T Consensus       160 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~--~~~~~----------  225 (268)
T cd06624         160 AGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA--MFKVG----------  225 (268)
T ss_pred             ccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh--Hhhhh----------
Confidence            43221  122335788999999986643  789999999999999999999999653211111  00000          


Q ss_pred             hhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          502 DANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       502 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                         .....  ...+..+++++.+++.+||+.+|++|||+.|+++|
T Consensus       226 ---~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  265 (268)
T cd06624         226 ---MFKIH--PEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD  265 (268)
T ss_pred             ---hhccC--CCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence               00000  00112345678999999999999999999999875

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=4.3e-38  Score=323.45  Aligned_cols=248  Identities=20%  Similarity=0.256  Sum_probs=195.6

Q ss_pred             cccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhc-CCCCcceeeeeeecCCceEEEEeccCC
Q 007680          278 NLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNV-RHRNLIKILSSYSNPDFKALVLEFMPN  352 (593)
Q Consensus       278 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  352 (593)
                      +.||+|+||.||+|+.. +++.||+|+++...   ....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999965 67899999998653   23456688999999888 699999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCcccc
Q 007680          353 GSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQ  432 (593)
Q Consensus       353 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~  432 (593)
                      |+|.+++...+. +++..+..++.|++.||+|||++    +|+||||||+||+++.++.+||+|||+++.......  ..
T Consensus        81 ~~L~~~~~~~~~-l~~~~~~~~~~qi~~al~~lH~~----~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~  153 (327)
T cd05617          81 GDLMFHMQRQRK-LPEEHARFYAAEICIALNFLHER----GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD--TT  153 (327)
T ss_pred             CcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC--ce
Confidence            999998876554 99999999999999999999965    599999999999999999999999999875322211  12


Q ss_pred             ccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCcccccc-chHHHHHHHhcCCchhhhhhhhhhhhhhh
Q 007680          433 TMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGE-MSLRRWVKESLPHGLTEVVDANLVREEQA  511 (593)
Q Consensus       433 ~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  511 (593)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||....... .....+....            +..... 
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~------------~~~~~~-  220 (327)
T cd05617         154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQV------------ILEKPI-  220 (327)
T ss_pred             ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHH------------HHhCCC-
Confidence            34568999999999999999999999999999999999999996532111 1111111110            000000 


Q ss_pred             hhhhHHHHHHHHHHHhhcccCCCCCCCCH------HHHHHH
Q 007680          512 FSAKMDCILSIMDFALDCCMESPDMRINM------TDAAAK  546 (593)
Q Consensus       512 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~~  546 (593)
                       ..+...+..+.+++.+||+.||++|+++      .++.+|
T Consensus       221 -~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  260 (327)
T cd05617         221 -RIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH  260 (327)
T ss_pred             -CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence             0111234577999999999999999985      566655

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.6e-37  Score=310.49  Aligned_cols=259  Identities=25%  Similarity=0.414  Sum_probs=208.0

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCC----eEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGT----DVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKA  344 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  344 (593)
                      ..+|++.+.||+|+||.||+|..+ +|+    .+|+|.+.... ......+.+|+.++++++||||+++++++.. ...+
T Consensus         6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~   84 (279)
T cd05057           6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ   84 (279)
T ss_pred             HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence            467899999999999999999864 333    58999887553 3345678899999999999999999999887 7889


Q ss_pred             EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecC
Q 007680          345 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG  424 (593)
Q Consensus       345 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~  424 (593)
                      +||||+++|+|.+++......+++..+..++.|++.||+|||++    +++||||||+||++++++.+||+|||.++...
T Consensus        85 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~----~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~  160 (279)
T cd05057          85 LITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEK----RLVHRDLAARNVLVKTPQHVKITDFGLAKLLD  160 (279)
T ss_pred             EEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC----CEEecccCcceEEEcCCCeEEECCCccccccc
Confidence            99999999999999988766699999999999999999999964    59999999999999999999999999998765


Q ss_pred             CCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhhhh
Q 007680          425 EGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDA  503 (593)
Q Consensus       425 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  503 (593)
                      ............++..|+|||...+..++.++||||||+++||+++ |+.||......  .....+....          
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~~----------  228 (279)
T cd05057         161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV--EIPDLLEKGE----------  228 (279)
T ss_pred             CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH--HHHHHHhCCC----------
Confidence            4333222222234568999999888889999999999999999999 99999763211  1111111100          


Q ss_pred             hhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhh
Q 007680          504 NLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVK  553 (593)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  553 (593)
                             ....+..++..+.+++.+||..||++||++.++++.|+++..+
T Consensus       229 -------~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~  271 (279)
T cd05057         229 -------RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD  271 (279)
T ss_pred             -------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence                   0111112345689999999999999999999999999998543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=4.6e-38  Score=322.64  Aligned_cols=241  Identities=23%  Similarity=0.257  Sum_probs=193.8

Q ss_pred             ccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhcC-CCCcceeeeeeecCCceEEEE
Q 007680          273 EFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNVR-HRNLIKILSSYSNPDFKALVL  347 (593)
Q Consensus       273 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  347 (593)
                      +|+..+.||+|+||.||+|... +|+.||+|+++...   ....+.+..|..++..+. |++|+++++++...+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            4778899999999999999865 68999999998653   233456778888988885 577888999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCC
Q 007680          348 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGE  427 (593)
Q Consensus       348 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~  427 (593)
                      ||+++|+|.+++..... +++.++..++.|++.||+|||++    +|+||||||+||++++++.+||+|||+++......
T Consensus        81 Ey~~~g~L~~~i~~~~~-l~~~~~~~i~~qi~~al~~lH~~----~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~  155 (323)
T cd05615          81 EYVNGGDLMYHIQQVGK-FKEPQAVFYAAEISVGLFFLHRR----GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG  155 (323)
T ss_pred             cCCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence            99999999999977654 89999999999999999999965    49999999999999999999999999987543222


Q ss_pred             CccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhh
Q 007680          428 DSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVR  507 (593)
Q Consensus       428 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  507 (593)
                      .  ......||+.|+|||++.+..++.++||||+||++|||++|+.||......  .....+...           .   
T Consensus       156 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~--~~~~~i~~~-----------~---  217 (323)
T cd05615         156 V--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED--ELFQSIMEH-----------N---  217 (323)
T ss_pred             c--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH--HHHHHHHhC-----------C---
Confidence            1  123346899999999999889999999999999999999999999763211  111111100           0   


Q ss_pred             hhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCH
Q 007680          508 EEQAFSAKMDCILSIMDFALDCCMESPDMRINM  540 (593)
Q Consensus       508 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  540 (593)
                          ...+..++.++.+++.+||+.+|++|++.
T Consensus       218 ----~~~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         218 ----VSYPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             ----CCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence                00111234578999999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=3.1e-38  Score=324.32  Aligned_cols=240  Identities=24%  Similarity=0.270  Sum_probs=189.1

Q ss_pred             cccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHH-HHHhhcCCCCcceeeeeeecCCceEEEEeccCC
Q 007680          278 NLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSEC-EVLRNVRHRNLIKILSSYSNPDFKALVLEFMPN  352 (593)
Q Consensus       278 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~-~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  352 (593)
                      +.||+|+||.||+|+.. +++.||+|++....   ......+..|. .+++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46999999999999976 67889999997643   12223344444 456778999999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCcccc
Q 007680          353 GSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQ  432 (593)
Q Consensus       353 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~  432 (593)
                      ++|.+++..... +++..+..++.|+++||+|||++    ||+||||||+||+++.++.+||+|||+++.......  ..
T Consensus        81 ~~L~~~~~~~~~-~~~~~~~~~~~qi~~~L~~lH~~----giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~--~~  153 (325)
T cd05602          81 GELFYHLQRERC-FLEPRARFYAAEIASALGYLHSL----NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--TT  153 (325)
T ss_pred             CcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC--Cc
Confidence            999999987554 78889999999999999999954    599999999999999999999999999875432221  22


Q ss_pred             ccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhhhhh
Q 007680          433 TMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQAF  512 (593)
Q Consensus       433 ~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  512 (593)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||......  .....+..           ...       
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~i~~-----------~~~-------  213 (325)
T cd05602         154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA--EMYDNILN-----------KPL-------  213 (325)
T ss_pred             ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH--HHHHHHHh-----------CCc-------
Confidence            3456899999999999999999999999999999999999999753211  11111110           000       


Q ss_pred             hhhHHHHHHHHHHHhhcccCCCCCCCCHHHHH
Q 007680          513 SAKMDCILSIMDFALDCCMESPDMRINMTDAA  544 (593)
Q Consensus       513 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl  544 (593)
                      ......+..+.+++.+||+.||.+||++.+.+
T Consensus       214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~  245 (325)
T cd05602         214 QLKPNITNSARHLLEGLLQKDRTKRLGAKDDF  245 (325)
T ss_pred             CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence            01113356789999999999999999987443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=5.4e-38  Score=316.25  Aligned_cols=278  Identities=23%  Similarity=0.298  Sum_probs=213.3

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEe
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLE  348 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  348 (593)
                      .++|++.+.||+|+||.||++... +|+.||+|++.... ....+.+.+|+++++.++||||+++++++...+..++|||
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME   83 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence            467899999999999999999965 68899999887543 3445678999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCC
Q 007680          349 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGED  428 (593)
Q Consensus       349 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  428 (593)
                      |+++++|.+++...+ .+++..+..++.+++.||.|||+.   .+++||||||+||++++++.++|+|||++....... 
T Consensus        84 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~---~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~-  158 (284)
T cd06620          84 FMDCGSLDRIYKKGG-PIPVEILGKIAVAVVEGLTYLYNV---HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI-  158 (284)
T ss_pred             cCCCCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHh---cCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc-
Confidence            999999999987754 489999999999999999999962   359999999999999999999999999886543221 


Q ss_pred             ccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhh
Q 007680          429 SVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVRE  508 (593)
Q Consensus       429 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  508 (593)
                         .....++..|+|||++.+..++.++|||||||++|++++|+.||......+...      ..+....+.........
T Consensus       159 ---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~------~~~~~~~~~~~~~~~~~  229 (284)
T cd06620         159 ---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQ------DDPMGILDLLQQIVQEP  229 (284)
T ss_pred             ---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhh------hhhhHHHHHHHHHhhcc
Confidence               123468899999999888899999999999999999999999997643221100      00000011111111000


Q ss_pred             hhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhhhcchhhccCC
Q 007680          509 EQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKFLDDAAATNW  563 (593)
Q Consensus       509 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~~~~~  563 (593)
                      .. ......++.++.+++.+||+.||++|||+.|++++.--++........-..|
T Consensus       230 ~~-~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~~~~~~~~~~~  283 (284)
T cd06620         230 PP-RLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRASNVDLQAW  283 (284)
T ss_pred             CC-CCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccccccCCcccc
Confidence            00 0111235667899999999999999999999999855444433333333444

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=6.1e-38  Score=334.21  Aligned_cols=263  Identities=24%  Similarity=0.308  Sum_probs=193.2

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC--------C
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNP--------D  341 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------~  341 (593)
                      ..+|++.+.||+|+||.||+|... +++.||||.+....    ....+|+.+++.++||||+++++++...        .
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~  140 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI  140 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence            467999999999999999999965 68999999886432    2345799999999999999999876432        2


Q ss_pred             ceEEEEeccCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC-cEEEEee
Q 007680          342 FKALVLEFMPNGSLEKWLYS---HNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENM-VAHVSDF  417 (593)
Q Consensus       342 ~~~lv~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~-~~kL~Df  417 (593)
                      ..++||||+++ +|.+++..   ....+++..+..++.|++.||+|||++    +|+||||||+||+++.++ .+||+||
T Consensus       141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~----~IiHrDLKp~NILl~~~~~~vkL~DF  215 (440)
T PTZ00036        141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK----FICHRDLKPQNLLIDPNTHTLKLCDF  215 (440)
T ss_pred             EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC----CEecCCcCHHHEEEcCCCCceeeecc
Confidence            46789999964 78777653   234589999999999999999999954    599999999999999665 7999999


Q ss_pred             ccceecCCCCCccccccccCCccccCccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCc
Q 007680          418 GIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHG  496 (593)
Q Consensus       418 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  496 (593)
                      |+++.+.....   .....+|+.|+|||++.+. .++.++|||||||++|||++|.+||.+....+ .+.+.....-...
T Consensus       216 Gla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~-~~~~i~~~~~~p~  291 (440)
T PTZ00036        216 GSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD-QLVRIIQVLGTPT  291 (440)
T ss_pred             ccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCC
Confidence            99987644322   2234689999999987654 68999999999999999999999997642211 1111111100000


Q ss_pred             hhh--hhhhh--------hhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          497 LTE--VVDAN--------LVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       497 ~~~--~~~~~--------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      ...  ...+.        ..........+...+.++.+|+.+||..||.+|||+.|+++|
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h  351 (440)
T PTZ00036        292 EDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD  351 (440)
T ss_pred             HHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence            000  00000        000000011112245688999999999999999999999977

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=8.8e-38  Score=314.89  Aligned_cols=250  Identities=23%  Similarity=0.306  Sum_probs=200.1

Q ss_pred             cccccccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEec
Q 007680          274 FNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEF  349 (593)
Q Consensus       274 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  349 (593)
                      |+..+.||+|+||.||++... +++.||+|.+....   ......+.+|+.++++++|++|+++++.+.+.+..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            677889999999999999865 78999999987643   22234577899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCC
Q 007680          350 MPNGSLEKWLYSHNY-FLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGED  428 (593)
Q Consensus       350 ~~~gsL~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  428 (593)
                      +++++|.+++..... .+++..+..++.|++.||.|||+    .+|+||||||+||++++++.++|+|||++........
T Consensus        82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~----~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  157 (285)
T cd05630          82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQ----ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT  157 (285)
T ss_pred             cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh----CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence            999999999865432 58999999999999999999995    4599999999999999999999999999876543221


Q ss_pred             ccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhh
Q 007680          429 SVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVRE  508 (593)
Q Consensus       429 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  508 (593)
                         .....|+..|+|||++.+..++.++||||+|+++|+|++|+.||........ ... ...        ..+ ..   
T Consensus       158 ---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~-~~~-~~~--------~~~-~~---  220 (285)
T cd05630         158 ---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK-REE-VER--------LVK-EV---  220 (285)
T ss_pred             ---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccch-HHH-HHh--------hhh-hh---
Confidence               1234689999999999999999999999999999999999999976321110 000 000        000 00   


Q ss_pred             hhhhhhhHHHHHHHHHHHhhcccCCCCCCCC-----HHHHHHH
Q 007680          509 EQAFSAKMDCILSIMDFALDCCMESPDMRIN-----MTDAAAK  546 (593)
Q Consensus       509 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~  546 (593)
                        .......+++++.+++.+||+.||++|||     ++|+++|
T Consensus       221 --~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h  261 (285)
T cd05630         221 --QEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH  261 (285)
T ss_pred             --hhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence              00011234567899999999999999999     8898875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.1e-37  Score=310.34  Aligned_cols=239  Identities=20%  Similarity=0.298  Sum_probs=190.3

Q ss_pred             cccCccCcccEEEEEeCC-------------CCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceE
Q 007680          278 NLLGTSSFGSVYKGTISD-------------GTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKA  344 (593)
Q Consensus       278 ~~lg~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  344 (593)
                      +.||+|+||.||+|...+             ...|++|++..........+.+|+.+++.++||||+++++++......+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            468999999999998532             2358999987665555667889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCc-------EEEEee
Q 007680          345 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMV-------AHVSDF  417 (593)
Q Consensus       345 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~-------~kL~Df  417 (593)
                      +||||+++++|..++......+++..+..++.|+++||+|||++    +|+||||||+||+++.++.       ++++||
T Consensus        81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~  156 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDK----DLVHGNVCTKNILLAREGIDGECGPFIKLSDP  156 (262)
T ss_pred             EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhC----CeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence            99999999999999887666689999999999999999999954    5999999999999987654       899999


Q ss_pred             ccceecCCCCCccccccccCCccccCccccC-CCCCCccchHHHHHHHHHHHH-hCCCCCCccccccchHHHHHHHhcCC
Q 007680          418 GIYKLLGEGEDSVRQTMTMATIGYMAPEYGL-EGIVSAKCDVYSYGVLLMETF-TRKRPTDEMFIGEMSLRRWVKESLPH  495 (593)
Q Consensus       418 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~~DvwSlGvvl~ell-tg~~pf~~~~~~~~~~~~~~~~~~~~  495 (593)
                      |.+......      ....++..|+|||.+. +..++.++|||||||++|||+ +|..||......+  ........   
T Consensus       157 g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~--~~~~~~~~---  225 (262)
T cd05077         157 GIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE--KERFYEGQ---  225 (262)
T ss_pred             CCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH--HHHHHhcC---
Confidence            988654322      2235788899999876 466899999999999999997 5888886532111  00000000   


Q ss_pred             chhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 007680          496 GLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKL  547 (593)
Q Consensus       496 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  547 (593)
                               .       ......+.++.+++.+||+.||++||++.++++++
T Consensus       226 ---------~-------~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         226 ---------C-------MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             ---------c-------cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence                     0       00011235789999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=4.4e-38  Score=312.14  Aligned_cols=253  Identities=28%  Similarity=0.422  Sum_probs=199.9

Q ss_pred             cccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHHH--HHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEecc
Q 007680          274 FNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERA--FRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFM  350 (593)
Q Consensus       274 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  350 (593)
                      |++.+.||+|+||+||+++.. +++.||+|++.......  .....+|+.++++++||||+++++++.+.+..++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            678899999999999999976 56789999998764332  223456999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCcc
Q 007680          351 PNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSV  430 (593)
Q Consensus       351 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~  430 (593)
                      ++++|.+++.... .+++.++..++.|+++||++||+++    ++|+||||+||++++++.++|+|||.+......  ..
T Consensus        81 ~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~Lh~~~----i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~--~~  153 (260)
T PF00069_consen   81 PGGSLQDYLQKNK-PLSEEEILKIAYQILEALAYLHSKG----IVHRDIKPENILLDENGEVKLIDFGSSVKLSEN--NE  153 (260)
T ss_dssp             TTEBHHHHHHHHS-SBBHHHHHHHHHHHHHHHHHHHHTT----EEESSBSGGGEEESTTSEEEESSGTTTEESTST--TS
T ss_pred             ccccccccccccc-ccccccccccccccccccccccccc----ccccccccccccccccccccccccccccccccc--cc
Confidence            9999999998443 3899999999999999999999654    999999999999999999999999998865221  12


Q ss_pred             ccccccCCccccCccccC-CCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhh
Q 007680          431 RQTMTMATIGYMAPEYGL-EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREE  509 (593)
Q Consensus       431 ~~~~~~gt~~y~aPE~~~-~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  509 (593)
                      ......++..|+|||+.. +..++.++||||+|+++|+|++|..||......  .........        .....   .
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~--~~~~~~~~~--------~~~~~---~  220 (260)
T PF00069_consen  154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSD--DQLEIIEKI--------LKRPL---P  220 (260)
T ss_dssp             EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHH--HHHHHHHHH--------HHTHH---H
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccch--hhhhhhhhc--------ccccc---c
Confidence            334456899999999988 788999999999999999999999999874110  111111000        00000   0


Q ss_pred             hhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          510 QAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       510 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      ............+.+++.+||+.||++||++.+++++
T Consensus       221 ~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~  257 (260)
T PF00069_consen  221 SSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH  257 (260)
T ss_dssp             HHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred             ccccccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0000000112688999999999999999999999864

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-38  Score=322.59  Aligned_cols=255  Identities=22%  Similarity=0.273  Sum_probs=199.1

Q ss_pred             hccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEE
Q 007680          272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVL  347 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  347 (593)
                      ++|++.+.||+|+||.||+++.. +++.||+|++....   ....+.+.+|..++..++|+||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            47899999999999999999965 68999999997632   233456888999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCC
Q 007680          348 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGE  427 (593)
Q Consensus       348 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~  427 (593)
                      ||+++|+|.+++.+....+++..+..++.|++.||+|||++    +|+||||||+||+++.++.+||+|||++..+....
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  156 (331)
T cd05597          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQL----GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG  156 (331)
T ss_pred             ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC----CeEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence            99999999999987555689999999999999999999955    59999999999999999999999999987654432


Q ss_pred             CccccccccCCccccCccccCC-----CCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhh
Q 007680          428 DSVRQTMTMATIGYMAPEYGLE-----GIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVD  502 (593)
Q Consensus       428 ~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  502 (593)
                      . .......||+.|+|||++.+     ..++.++|||||||++|||++|+.||......     ..........      
T Consensus       157 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~-----~~~~~i~~~~------  224 (331)
T cd05597         157 T-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV-----ETYGKIMNHK------  224 (331)
T ss_pred             C-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH-----HHHHHHHcCC------
Confidence            2 12233468999999998763     45788999999999999999999999653211     1111000000      


Q ss_pred             hhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCC--CCCCHHHHHHH
Q 007680          503 ANLVREEQAFSAKMDCILSIMDFALDCCMESPD--MRINMTDAAAK  546 (593)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~--~RPs~~evl~~  546 (593)
                      ...    ........++.++.+++.+|+..+++  .||++.++++|
T Consensus       225 ~~~----~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         225 EHF----QFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             Ccc----cCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            000    00000112456788999998865443  47899999988

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1e-37  Score=331.61  Aligned_cols=265  Identities=18%  Similarity=0.178  Sum_probs=199.9

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEec
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEF  349 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  349 (593)
                      ..+|.+.+.||+|+||.||+|.+. +++.||||....      ..+.+|++++++++|+||+++++++...+..++|||+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            447999999999999999999976 588899996432      3456899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCc
Q 007680          350 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDS  429 (593)
Q Consensus       350 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~  429 (593)
                      + .++|.+++......+++.++..++.|++.||+|||++    +|+||||||+|||++.++.+||+|||+++........
T Consensus       242 ~-~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~----gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~  316 (461)
T PHA03211        242 Y-RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGE----GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST  316 (461)
T ss_pred             c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC----CEEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence            9 4799998877655699999999999999999999955    5999999999999999999999999999876443222


Q ss_pred             cccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccc------cchHHHHHHHhc------CCch
Q 007680          430 VRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIG------EMSLRRWVKESL------PHGL  497 (593)
Q Consensus       430 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~------~~~~~~~~~~~~------~~~~  497 (593)
                      .......||..|+|||++.+..++.++|||||||++|||++|..|+......      ...+.+.+....      +...
T Consensus       317 ~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~  396 (461)
T PHA03211        317 PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA  396 (461)
T ss_pred             ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence            2223456899999999999999999999999999999999988765332111      111222222110      1000


Q ss_pred             hhhhhhhhhhh----------hhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          498 TEVVDANLVRE----------EQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       498 ~~~~~~~~~~~----------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      ...+.......          .............+.+|+.+||+.||++|||+.|+++|
T Consensus       397 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        397 GSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             chHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence            00000000000          00001111233578899999999999999999999986

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.4e-37  Score=309.13  Aligned_cols=253  Identities=27%  Similarity=0.443  Sum_probs=202.6

Q ss_pred             hhccccccccCccCcccEEEEEeCCCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEecc
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFM  350 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  350 (593)
                      .++|.+.+.||+|++|.||+|..+++..+|+|.+.... ...+.+.+|++++++++|||++++++++. .+..+++|||+
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05069           5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM   82 (260)
T ss_pred             hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence            35688999999999999999998777789999886543 23456888999999999999999999875 45678999999


Q ss_pred             CCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCc
Q 007680          351 PNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDS  429 (593)
Q Consensus       351 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~  429 (593)
                      ++++|.+++.... ..+++..+..++.|++.||+|||+.    +++|+||||+||++++++.++|+|||.+.........
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~----~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05069          83 GKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM----NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC----CEeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence            9999999997643 3578999999999999999999965    4999999999999999999999999999876433221


Q ss_pred             cccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhh
Q 007680          430 VRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVRE  508 (593)
Q Consensus       430 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  508 (593)
                       ......++..|+|||+..+..++.++||||||+++|||+| |+.||.+....+  ...+......              
T Consensus       159 -~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~~~~~~~--------------  221 (260)
T cd05069         159 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE--VLEQVERGYR--------------  221 (260)
T ss_pred             -ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCCC--------------
Confidence             1122345678999999988899999999999999999999 999997632211  1111111100              


Q ss_pred             hhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHH
Q 007680          509 EQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKK  549 (593)
Q Consensus       509 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  549 (593)
                         .+.+...+..+.+++.+||+.||++||+++++.+.|++
T Consensus       222 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         222 ---MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             ---CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence               01112345678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=2.1e-37  Score=306.96  Aligned_cols=249  Identities=28%  Similarity=0.423  Sum_probs=201.0

Q ss_pred             hhccccccccCccCcccEEEEEeCCCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeee-cCCceEEEEec
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYS-NPDFKALVLEF  349 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~  349 (593)
                      .++|++.+.||+|+||.||++... |..||+|.++...  ..+.+.+|+.++++++|+|++++++++. .++..+++|||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~   81 (256)
T cd05082           5 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   81 (256)
T ss_pred             HHhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence            457899999999999999999875 7889999986543  3457889999999999999999999754 55678999999


Q ss_pred             cCCCCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCC
Q 007680          350 MPNGSLEKWLYSHNY-FLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGED  428 (593)
Q Consensus       350 ~~~gsL~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  428 (593)
                      +++++|.+++..... .+++..+..++.|++.||+|||++    +++||||||+||++++++.+||+|||++....... 
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-  156 (256)
T cd05082          82 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN----NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-  156 (256)
T ss_pred             CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC----CEeccccchheEEEcCCCcEEecCCccceeccccC-
Confidence            999999999976544 488999999999999999999965    49999999999999999999999999987654322 


Q ss_pred             ccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhh
Q 007680          429 SVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVR  507 (593)
Q Consensus       429 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  507 (593)
                          ....++..|+|||+..+..++.++|||||||++|||++ |+.||.....  ......+....+             
T Consensus       157 ----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~--~~~~~~~~~~~~-------------  217 (256)
T cd05082         157 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPRVEKGYK-------------  217 (256)
T ss_pred             ----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHhcCCC-------------
Confidence                12234567999999988889999999999999999998 9999865211  111111111100             


Q ss_pred             hhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHh
Q 007680          508 EEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKI  550 (593)
Q Consensus       508 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  550 (593)
                          ......+++.+.+++.+||+.+|++|||+.+++++|+++
T Consensus       218 ----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         218 ----MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             ----CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence                011123466889999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=7.6e-38  Score=317.11  Aligned_cols=250  Identities=21%  Similarity=0.310  Sum_probs=204.5

Q ss_pred             hccccccccCccCcccEEEEEe-CCCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEecc
Q 007680          272 DEFNECNLLGTSSFGSVYKGTI-SDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFM  350 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  350 (593)
                      .+|+..+.||.|++|.||+|.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++...+..++|+||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            4699999999999999999985 478999999997655445567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCcc
Q 007680          351 PNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSV  430 (593)
Q Consensus       351 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~  430 (593)
                      ++++|.+++....  +++.++..++.|++.|++|||++    +++||||||+||+++.++.+||+|||++........  
T Consensus        99 ~~~~L~~~~~~~~--l~~~~~~~i~~~l~~al~~LH~~----~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~--  170 (296)
T cd06655          99 AGGSLTDVVTETC--MDEAQIAAVCRECLQALEFLHAN----QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS--  170 (296)
T ss_pred             CCCcHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEEccCccchhcccccc--
Confidence            9999999987643  89999999999999999999954    599999999999999999999999999876543322  


Q ss_pred             ccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhhh
Q 007680          431 RQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQ  510 (593)
Q Consensus       431 ~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  510 (593)
                      ......++..|+|||.+.+..++.++|||||||++|++++|+.||........  .........               .
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~--~~~~~~~~~---------------~  233 (296)
T cd06655         171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--LYLIATNGT---------------P  233 (296)
T ss_pred             cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhcCC---------------c
Confidence            12234588899999999888899999999999999999999999976322111  011100000               0


Q ss_pred             hhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          511 AFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       511 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      ....+..+++.+.+++.+||..||++||++.+++++
T Consensus       234 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~  269 (296)
T cd06655         234 ELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH  269 (296)
T ss_pred             ccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence            011122345678999999999999999999999865

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.3e-37  Score=308.27  Aligned_cols=249  Identities=20%  Similarity=0.255  Sum_probs=202.1

Q ss_pred             ccccccccCccCcccEEEEEeC-CCCeEEEEEeehh-hHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEecc
Q 007680          273 EFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQ-LERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFM  350 (593)
Q Consensus       273 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  350 (593)
                      +|++.+.||+|+||.||++... +++.+|+|.++.. .....+.+.+|+.+++.++||||+++++.+...+..+++|||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            4788999999999999999965 7899999998653 2345567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCc
Q 007680          351 PNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDS  429 (593)
Q Consensus       351 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~  429 (593)
                      ++++|.+++.... ..+++..+..++.|++.||.|||++    +++|+||||+||++++++.++++|||.+........ 
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~----~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-  155 (255)
T cd08219          81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK----RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-  155 (255)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC----CcccCCCCcceEEECCCCcEEEcccCcceeeccccc-
Confidence            9999999887543 3578999999999999999999965    499999999999999999999999999886643322 


Q ss_pred             cccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhh
Q 007680          430 VRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREE  509 (593)
Q Consensus       430 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  509 (593)
                       ......++..|+|||++.+..++.++|+||||+++|+|++|+.||......  ...........               
T Consensus       156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~--~~~~~~~~~~~---------------  217 (255)
T cd08219         156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK--NLILKVCQGSY---------------  217 (255)
T ss_pred             -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH--HHHHHHhcCCC---------------
Confidence             122346888999999998888999999999999999999999999753211  11000100000               


Q ss_pred             hhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          510 QAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       510 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                        .+.+..++..+.+++.+||+.||++||++.+++..
T Consensus       218 --~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         218 --KPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             --CCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence              00011234568999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=6.4e-38  Score=317.86  Aligned_cols=251  Identities=23%  Similarity=0.301  Sum_probs=204.7

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEec
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEF  349 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  349 (593)
                      ..+|++.+.||+|+||.||++... +++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   97 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   97 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence            467999999999999999999964 7999999999765545556788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCc
Q 007680          350 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDS  429 (593)
Q Consensus       350 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~  429 (593)
                      +++++|.+++.+..  +++.++..++.|++.||.|||+.    +++||||||+||+++.++.++|+|||.+........ 
T Consensus        98 ~~~~~L~~~~~~~~--~~~~~~~~~~~~l~~~L~~LH~~----~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~-  170 (297)
T cd06656          98 LAGGSLTDVVTETC--MDEGQIAAVCRECLQALDFLHSN----QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-  170 (297)
T ss_pred             cCCCCHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEECcCccceEccCCcc-
Confidence            99999999987643  78999999999999999999954    599999999999999999999999999876543322 


Q ss_pred             cccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhh
Q 007680          430 VRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREE  509 (593)
Q Consensus       430 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  509 (593)
                       ......+++.|+|||...+..++.++|||||||++|++++|+.||............+ .                ...
T Consensus       171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~-~----------------~~~  232 (297)
T cd06656         171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-T----------------NGT  232 (297)
T ss_pred             -CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeec-c----------------CCC
Confidence             1223457889999999988889999999999999999999999996532111000000 0                000


Q ss_pred             hhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          510 QAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       510 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      .....+...+..+.+++.+||..+|++||++.+++++
T Consensus       233 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (297)
T cd06656         233 PELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH  269 (297)
T ss_pred             CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0001112335578899999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.6e-37  Score=321.67  Aligned_cols=266  Identities=22%  Similarity=0.278  Sum_probs=198.9

Q ss_pred             HHHhhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh--HHHHHHHHHHHHHHhhcCCCCcceeeeeeecC---
Q 007680          267 IQRATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSYSNP---  340 (593)
Q Consensus       267 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---  340 (593)
                      .....++|++.+.||+|+||.||+|... +++.||+|.+....  ......+.+|+.++++++||||+++++++...   
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (343)
T cd07878          10 VWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSI   89 (343)
T ss_pred             HhhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccc
Confidence            3445688999999999999999999864 78899999987542  23345677899999999999999999987543   


Q ss_pred             ---CceEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEee
Q 007680          341 ---DFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDF  417 (593)
Q Consensus       341 ---~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df  417 (593)
                         ...++++|++ +++|.+++...  .+++..+..++.|++.||+|||++    +|+||||||+||++++++.+||+||
T Consensus        90 ~~~~~~~~~~~~~-~~~l~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~----~ivHrdikp~Nil~~~~~~~kl~Df  162 (343)
T cd07878          90 ENFNEVYLVTNLM-GADLNNIVKCQ--KLSDEHVQFLIYQLLRGLKYIHSA----GIIHRDLKPSNVAVNEDCELRILDF  162 (343)
T ss_pred             cccCcEEEEeecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC----CeecccCChhhEEECCCCCEEEcCC
Confidence               3578999998 78999887654  389999999999999999999965    4999999999999999999999999


Q ss_pred             ccceecCCCCCccccccccCCccccCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCc
Q 007680          418 GIYKLLGEGEDSVRQTMTMATIGYMAPEYGLE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHG  496 (593)
Q Consensus       418 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  496 (593)
                      |+++.....     .....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||...... ..+..+.. .....
T Consensus       163 g~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~~~~-~~~~~  235 (343)
T cd07878         163 GLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI-DQLKRIME-VVGTP  235 (343)
T ss_pred             ccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHH-HhCCC
Confidence            999865432     223468999999999876 56899999999999999999999999653211 11111111 00000


Q ss_pred             hhhhhh---hhhhh----h------hhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          497 LTEVVD---ANLVR----E------EQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       497 ~~~~~~---~~~~~----~------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      ..+...   .....    .      ...........+.+.+++.+||..||++|||+.|+++|
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         236 SPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             CHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            000000   00000    0      00000001223467899999999999999999999987

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.1e-37  Score=317.15  Aligned_cols=259  Identities=25%  Similarity=0.426  Sum_probs=205.3

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCC----eEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGT----DVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKA  344 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  344 (593)
                      .++|+..+.||+|+||.||+|.+. +|.    .||+|.+.... ......+.+|+.+++.++||||+++++++... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~   84 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ   84 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence            467888999999999999999864 444    47888886543 23344688999999999999999999988764 467


Q ss_pred             EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecC
Q 007680          345 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG  424 (593)
Q Consensus       345 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~  424 (593)
                      +++||+++|+|.+++......+++..+..++.|++.||+|||++    +|+||||||+||++++++.+||+|||+++...
T Consensus        85 ~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~----~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~  160 (303)
T cd05110          85 LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER----RLVHRDLAARNVLVKSPNHVKITDFGLARLLE  160 (303)
T ss_pred             eeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhc----CeeccccccceeeecCCCceEEcccccccccc
Confidence            99999999999999987766689999999999999999999965    49999999999999999999999999998765


Q ss_pred             CCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhhhh
Q 007680          425 EGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDA  503 (593)
Q Consensus       425 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  503 (593)
                      ............++..|+|||++.+..++.++||||||+++||+++ |..||.+...  .....+.....          
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~--~~~~~~~~~~~----------  228 (303)
T cd05110         161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT--REIPDLLEKGE----------  228 (303)
T ss_pred             CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHCCC----------
Confidence            4332222233445778999999988899999999999999999997 8999866321  11122211110          


Q ss_pred             hhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhh
Q 007680          504 NLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVK  553 (593)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  553 (593)
                             ..+....++..+.+++.+||..+|++||++.++++.|+++..+
T Consensus       229 -------~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~  271 (303)
T cd05110         229 -------RLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD  271 (303)
T ss_pred             -------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence                   0011112345789999999999999999999999999987544

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=7.1e-38  Score=315.00  Aligned_cols=271  Identities=25%  Similarity=0.364  Sum_probs=209.0

Q ss_pred             hccccccccCccCcccEEEEEeC-----CCCeEEEEEeehhhHH-HHHHHHHHHHHHhhcCCCCcceeeeeeec--CCce
Q 007680          272 DEFNECNLLGTSSFGSVYKGTIS-----DGTDVAIKVFNLQLER-AFRSFDSECEVLRNVRHRNLIKILSSYSN--PDFK  343 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~  343 (593)
                      ++|++.+.||+|+||.||+|++.     ++..||+|+++..... ..+.+.+|+++++.++||||+++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            46788899999999999999853     4688999999865433 46789999999999999999999999877  5578


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceec
Q 007680          344 ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLL  423 (593)
Q Consensus       344 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~  423 (593)
                      ++||||+++++|.+++......+++..+..++.|++.||+|||+.    +++|+||||+||+++.++.++|+|||.+...
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~----~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  159 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQ----RYIHRDLAARNILVESEDLVKISDFGLAKVL  159 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence            999999999999999987765699999999999999999999954    5999999999999999999999999999877


Q ss_pred             CCCCCccc-cccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhh
Q 007680          424 GEGEDSVR-QTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVD  502 (593)
Q Consensus       424 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  502 (593)
                      ........ .....++..|+|||...+..++.++||||||+++|||++|..|+.........   +............+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~---~~~~~~~~~~~~~~~  236 (284)
T cd05038         160 PEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR---MIGIAQGQMIVTRLL  236 (284)
T ss_pred             ccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcc---ccccccccccHHHHH
Confidence            53322211 11233556799999998889999999999999999999999998653221110   000000000000000


Q ss_pred             hhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHh
Q 007680          503 ANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKI  550 (593)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  550 (593)
                      ..+. .......+..++.++.+++.+||+.+|++|||+.|+++.|+++
T Consensus       237 ~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         237 ELLK-EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHHH-cCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            0110 0111112234557899999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=4.7e-38  Score=323.01  Aligned_cols=240  Identities=25%  Similarity=0.308  Sum_probs=189.1

Q ss_pred             cccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHH-HHhhcCCCCcceeeeeeecCCceEEEEeccCC
Q 007680          278 NLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECE-VLRNVRHRNLIKILSSYSNPDFKALVLEFMPN  352 (593)
Q Consensus       278 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  352 (593)
                      +.||+|+||.||+|+.. +|+.||+|++....   ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46999999999999865 78999999997652   223344555554 56778999999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCcccc
Q 007680          353 GSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQ  432 (593)
Q Consensus       353 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~  432 (593)
                      |+|..++.... .+++..+..++.||+.||+|||++    ||+||||||+||++++++.+||+|||+++.......  ..
T Consensus        81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~----givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~  153 (325)
T cd05604          81 GELFFHLQRER-SFPEPRARFYAAEIASALGYLHSI----NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD--TT  153 (325)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC--Cc
Confidence            99999887655 489999999999999999999954    599999999999999999999999999875322211  22


Q ss_pred             ccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhhhhh
Q 007680          433 TMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQAF  512 (593)
Q Consensus       433 ~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  512 (593)
                      ....|++.|+|||++.+..++.++|||||||++|||++|+.||......+  .   ....        .....       
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~--~---~~~~--------~~~~~-------  213 (325)
T cd05604         154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE--M---YDNI--------LHKPL-------  213 (325)
T ss_pred             ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH--H---HHHH--------HcCCc-------
Confidence            34568999999999999999999999999999999999999997632111  1   1100        00000       


Q ss_pred             hhhHHHHHHHHHHHhhcccCCCCCCCCHHHHH
Q 007680          513 SAKMDCILSIMDFALDCCMESPDMRINMTDAA  544 (593)
Q Consensus       513 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl  544 (593)
                      ......+..+.+++.+|++.+|.+||++.+.+
T Consensus       214 ~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~  245 (325)
T cd05604         214 VLRPGASLTAWSILEELLEKDRQRRLGAKEDF  245 (325)
T ss_pred             cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence            00012345678999999999999999886433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=4.6e-38  Score=322.56  Aligned_cols=237  Identities=24%  Similarity=0.296  Sum_probs=187.1

Q ss_pred             cccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHH-HHhhcCCCCcceeeeeeecCCceEEEEeccCC
Q 007680          278 NLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECE-VLRNVRHRNLIKILSSYSNPDFKALVLEFMPN  352 (593)
Q Consensus       278 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  352 (593)
                      +.||+|+||.||+|+.. +++.||+|++....   ......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999975 68899999997643   222334555544 67888999999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCcccc
Q 007680          353 GSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQ  432 (593)
Q Consensus       353 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~  432 (593)
                      ++|.+++.... .+++..+..++.||+.||+|||++    +|+||||||+||+++.++.+||+|||+++.......  ..
T Consensus        81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH~~----~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~  153 (321)
T cd05603          81 GELFFHLQRER-CFLEPRARFYAAEVASAIGYLHSL----NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE--TT  153 (321)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC----CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC--cc
Confidence            99999887654 388999999999999999999954    599999999999999999999999999875322221  22


Q ss_pred             ccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhhhhh
Q 007680          433 TMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQAF  512 (593)
Q Consensus       433 ~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  512 (593)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||......  .....+.           ....       
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~i~-----------~~~~-------  213 (321)
T cd05603         154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS--QMYDNIL-----------HKPL-------  213 (321)
T ss_pred             ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH--HHHHHHh-----------cCCC-------
Confidence            3456899999999999889999999999999999999999999763211  1111100           0000       


Q ss_pred             hhhHHHHHHHHHHHhhcccCCCCCCCCHH
Q 007680          513 SAKMDCILSIMDFALDCCMESPDMRINMT  541 (593)
Q Consensus       513 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~  541 (593)
                      ..+...+.++.+++.+||+.||++||++.
T Consensus       214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         214 QLPGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence            00112345789999999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.7e-38  Score=310.17  Aligned_cols=255  Identities=26%  Similarity=0.435  Sum_probs=206.9

Q ss_pred             hhhccccccccCccCcccEEEEEeCCCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEec
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEF  349 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  349 (593)
                      ..++|++.+.||+|+||.||+|..++++.||+|.+..... ..+.+.+|+.++++++|+||+++++++......++||||
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   82 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY   82 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence            3578999999999999999999988788999999875432 345788999999999999999999999998999999999


Q ss_pred             cCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCC
Q 007680          350 MPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGED  428 (593)
Q Consensus       350 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  428 (593)
                      +++++|.+++.... ..+++..+..++.|++.|++|||+++    ++|+||||+||++++++.+||+|||.+........
T Consensus        83 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~----i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~  158 (261)
T cd05034          83 MSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN----YIHRDLAARNILVGENLVCKIADFGLARLIEDDEY  158 (261)
T ss_pred             cCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC----cccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence            99999999997754 35899999999999999999999654    99999999999999999999999999887654221


Q ss_pred             ccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhh
Q 007680          429 SVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVR  507 (593)
Q Consensus       429 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  507 (593)
                      . .......+..|+|||...+..++.++||||+|+++|++++ |+.||......  ...........             
T Consensus       159 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--~~~~~~~~~~~-------------  222 (261)
T cd05034         159 T-AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR--EVLEQVERGYR-------------  222 (261)
T ss_pred             h-hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCC-------------
Confidence            1 1122234568999999988889999999999999999998 99999653211  11111111000             


Q ss_pred             hhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHH
Q 007680          508 EEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKK  549 (593)
Q Consensus       508 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  549 (593)
                          ...+.+.+.++.+++.+||..+|++||+++++.+.|+.
T Consensus       223 ----~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         223 ----MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             ----CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence                01111235578999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.9e-37  Score=305.27  Aligned_cols=249  Identities=27%  Similarity=0.433  Sum_probs=199.2

Q ss_pred             cccCccCcccEEEEEeC-C---CCeEEEEEeehhhH-HHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEeccCC
Q 007680          278 NLLGTSSFGSVYKGTIS-D---GTDVAIKVFNLQLE-RAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPN  352 (593)
Q Consensus       278 ~~lg~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  352 (593)
                      ++||+|+||.||+|.+. .   +..+|+|.+..... ...+.+.+|++++++++||||+++++++. .+..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            47999999999999753 2   36899999876543 34567889999999999999999999876 4568999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCcccc
Q 007680          353 GSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQ  432 (593)
Q Consensus       353 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~  432 (593)
                      ++|.+++.... .+++..+..++.|++.||+|||+++    ++|+||||+||++++++.+||+|||.++...........
T Consensus        80 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh~~~----i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~  154 (257)
T cd05060          80 GPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLESKH----FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA  154 (257)
T ss_pred             CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcC----eeccCcccceEEEcCCCcEEeccccccceeecCCccccc
Confidence            99999998766 4899999999999999999999654    999999999999999999999999998876543322111


Q ss_pred             -ccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhhh
Q 007680          433 -TMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQ  510 (593)
Q Consensus       433 -~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  510 (593)
                       ....++..|+|||...+..++.++||||||+++||+++ |..||.....  .....+.....+                
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~--~~~~~~~~~~~~----------------  216 (257)
T cd05060         155 TTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--AEVIAMLESGER----------------  216 (257)
T ss_pred             ccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH--HHHHHHHHcCCc----------------
Confidence             11223467999999988899999999999999999998 9999976422  122222221110                


Q ss_pred             hhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhh
Q 007680          511 AFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIK  551 (593)
Q Consensus       511 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~  551 (593)
                       .+.+..++..+.+++.+||..+|++||++.++++.|+++.
T Consensus       217 -~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         217 -LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             -CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence             0111234567899999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=2.3e-37  Score=308.33  Aligned_cols=252  Identities=24%  Similarity=0.344  Sum_probs=201.5

Q ss_pred             ccccccccCccCcccEEEEEeCCCCeEEEEEeehhh------HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEE
Q 007680          273 EFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQL------ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALV  346 (593)
Q Consensus       273 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  346 (593)
                      +|++.+.||+|+||.||+|...+++.+|+|.++...      ......+.+|++++++++|+||+++++++.+.+..++|
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            478889999999999999998889999999886432      23345688999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCC
Q 007680          347 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG  426 (593)
Q Consensus       347 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  426 (593)
                      |||+++++|.+++.+... +++..+..++.|++.||+|||+.    +++|+||+|+||++++++.++|+|||.+......
T Consensus        81 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  155 (265)
T cd06631          81 MEFVPGGSISSILNRFGP-LPEPVFCKYTKQILDGVAYLHNN----CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV  155 (265)
T ss_pred             EecCCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhC----CcccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence            999999999999977553 88999999999999999999965    4999999999999999999999999998765321


Q ss_pred             CC----ccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhh
Q 007680          427 ED----SVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVD  502 (593)
Q Consensus       427 ~~----~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  502 (593)
                      ..    ........++..|+|||+..+..++.++||||||+++|+|++|+.||........ ... ....  ...     
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~-~~~-~~~~--~~~-----  226 (265)
T cd06631         156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA-MFY-IGAH--RGL-----  226 (265)
T ss_pred             cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH-HHH-hhhc--cCC-----
Confidence            11    1111234588899999999888899999999999999999999999975321110 000 0000  000     


Q ss_pred             hhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          503 ANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                              ....+..++.++.+++++||+.+|++||++.|++++
T Consensus       227 --------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  262 (265)
T cd06631         227 --------MPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH  262 (265)
T ss_pred             --------CCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence                    000111235678999999999999999999999864

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.1e-37  Score=328.41  Aligned_cols=265  Identities=21%  Similarity=0.229  Sum_probs=201.0

Q ss_pred             hhccccccccCccCcccEEEEEeC---CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS---DGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVL  347 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  347 (593)
                      ..+|++.+.||+|+||.||++...   +++.||+|.+...     ....+|++++++++||||+++++++...+..++||
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~  165 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM  165 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence            357999999999999999999753   4678999987643     23567999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCC
Q 007680          348 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGE  427 (593)
Q Consensus       348 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~  427 (593)
                      |++. ++|.+++.... .+++.++..++.|++.||+|||++    +|+||||||+||+++.++.+||+|||++.......
T Consensus       166 e~~~-~~l~~~l~~~~-~l~~~~~~~i~~ql~~aL~~LH~~----givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~  239 (392)
T PHA03207        166 PKYK-CDLFTYVDRSG-PLPLEQAITIQRRLLEALAYLHGR----GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP  239 (392)
T ss_pred             hhcC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC----CccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence            9995 68999885443 599999999999999999999965    59999999999999999999999999998765543


Q ss_pred             CccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCcccccc--chHHHHHHHh--cCCchhh----
Q 007680          428 DSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGE--MSLRRWVKES--LPHGLTE----  499 (593)
Q Consensus       428 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~--~~~~~~~~~~--~~~~~~~----  499 (593)
                      .........||+.|+|||++.+..++.++|||||||++|||++|+.||.......  ..+.......  .+.....    
T Consensus       240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~  319 (392)
T PHA03207        240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGST  319 (392)
T ss_pred             ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccch
Confidence            3333334579999999999999999999999999999999999999996642211  1111111100  0000000    


Q ss_pred             hhhhhhhhh----hh--h---hhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          500 VVDANLVRE----EQ--A---FSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       500 ~~~~~~~~~----~~--~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      .+.......    ..  .   .......+.++.+++.+||..||++|||+.|++.|
T Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        320 NLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             hHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence            000000000    00  0   00011234578899999999999999999999987

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1.9e-37  Score=312.56  Aligned_cols=250  Identities=23%  Similarity=0.290  Sum_probs=199.1

Q ss_pred             cccccccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEec
Q 007680          274 FNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEF  349 (593)
Q Consensus       274 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  349 (593)
                      |+..+.||+|+||.||+|... +++.||+|.+....   ......+.+|++++++++|+||+++.+++..++..++||||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            667789999999999999865 78999999987643   22334578899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCC
Q 007680          350 MPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGED  428 (593)
Q Consensus       350 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  428 (593)
                      +++++|.+++.... ..+++..+..++.|++.||.|||+.    +|+||||||+||++++++.++|+|||++........
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~----~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~  157 (285)
T cd05632          82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE----NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES  157 (285)
T ss_pred             ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC----CeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence            99999999887543 2589999999999999999999954    599999999999999999999999999876543221


Q ss_pred             ccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhh
Q 007680          429 SVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVRE  508 (593)
Q Consensus       429 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  508 (593)
                         .....|+..|+|||++.+..++.++|+||||+++|||++|..||........ ... .......            .
T Consensus       158 ---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~-~~~-~~~~~~~------------~  220 (285)
T cd05632         158 ---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK-REE-VDRRVLE------------T  220 (285)
T ss_pred             ---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH-HHH-HHHhhhc------------c
Confidence               2234689999999999888999999999999999999999999976321110 001 1100000            0


Q ss_pred             hhhhhhhHHHHHHHHHHHhhcccCCCCCCCC-----HHHHHHH
Q 007680          509 EQAFSAKMDCILSIMDFALDCCMESPDMRIN-----MTDAAAK  546 (593)
Q Consensus       509 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~  546 (593)
                      ..  .....++.++.+++.+||+.||++||+     +.+++++
T Consensus       221 ~~--~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05632         221 EE--VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH  261 (285)
T ss_pred             cc--ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence            00  011123557899999999999999999     6677765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.5e-37  Score=323.43  Aligned_cols=264  Identities=20%  Similarity=0.230  Sum_probs=197.7

Q ss_pred             hhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehh--hHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC------
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQ--LERAFRSFDSECEVLRNVRHRNLIKILSSYSNP------  340 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  340 (593)
                      ..++|++.+.||+|+||.||++... +++.||+|++...  .......+.+|+.+++.++||||+++++++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            4578999999999999999999865 6889999998753  233446778899999999999999999988643      


Q ss_pred             CceEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccc
Q 007680          341 DFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIY  420 (593)
Q Consensus       341 ~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a  420 (593)
                      ...++||||+++ ++.+.+..   .+++..+..++.|++.||+|||++    +|+||||||+||+++.++.+||+|||++
T Consensus        95 ~~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~----givHrDikp~Nill~~~~~~kl~Dfg~~  166 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSA----GIIHRDLKPSNIVVKSDCTLKILDFGLA  166 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCChHHEEECCCCCEEEeeCccc
Confidence            357999999965 67776653   378899999999999999999965    4999999999999999999999999999


Q ss_pred             eecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCc----
Q 007680          421 KLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHG----  496 (593)
Q Consensus       421 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~----  496 (593)
                      +......   ......+|..|+|||++.+..++.++|||||||++|+|++|+.||......+ .....+. .....    
T Consensus       167 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~-~~~~~~~~~  241 (355)
T cd07874         167 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID-QWNKVIE-QLGTPCPEF  241 (355)
T ss_pred             ccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHH-HhCCCCHHH
Confidence            8654322   1233468999999999998899999999999999999999999997632111 1111111 00000    


Q ss_pred             -------hhhhhhhhhh----------hhh---hhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          497 -------LTEVVDANLV----------REE---QAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       497 -------~~~~~~~~~~----------~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                             ....++....          ...   .........+.++.+++.+||+.||++|||+.|+++|
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             HHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence                   0000000000          000   0000011124567999999999999999999999987

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=7.6e-38  Score=312.90  Aligned_cols=252  Identities=23%  Similarity=0.317  Sum_probs=198.8

Q ss_pred             hhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhc-CCCCcceeeeeeecC------C
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNV-RHRNLIKILSSYSNP------D  341 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~------~  341 (593)
                      +.+.|++.+.||+|+||.||+|... +++.||+|.+.... .....+..|+.++.++ +||||+++++++...      .
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD   82 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence            5678999999999999999999865 68899999987543 2335678899999998 799999999988653      4


Q ss_pred             ceEEEEeccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccc
Q 007680          342 FKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIY  420 (593)
Q Consensus       342 ~~~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a  420 (593)
                      ..++||||+++++|.+++.... ..+++..+..++.|++.|++|||++    +|+|+||||+||++++++.++|+|||++
T Consensus        83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~----~ivh~dl~~~nili~~~~~~~l~Dfg~~  158 (272)
T cd06637          83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH----KVIHRDIKGQNVLLTENAEVKLVDFGVS  158 (272)
T ss_pred             EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC----CCccCCCCHHHEEECCCCCEEEccCCCc
Confidence            5789999999999999998743 3589999999999999999999965    4999999999999999999999999998


Q ss_pred             eecCCCCCccccccccCCccccCccccC-----CCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCC
Q 007680          421 KLLGEGEDSVRQTMTMATIGYMAPEYGL-----EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPH  495 (593)
Q Consensus       421 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~  495 (593)
                      ........  ......|+..|+|||++.     +..++.++|||||||++|||++|+.||..........  ....   .
T Consensus       159 ~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~--~~~~---~  231 (272)
T cd06637         159 AQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF--LIPR---N  231 (272)
T ss_pred             eecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHH--HHhc---C
Confidence            86543221  223456889999999875     3458889999999999999999999996532111000  0000   0


Q ss_pred             chhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          496 GLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       496 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                                   .........++.++.+++.+||..||.+|||+.|+++|
T Consensus       232 -------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  269 (272)
T cd06637         232 -------------PAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH  269 (272)
T ss_pred             -------------CCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence                         00000011234578999999999999999999999864

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=2.5e-37  Score=307.41  Aligned_cols=251  Identities=24%  Similarity=0.404  Sum_probs=194.6

Q ss_pred             cccCccCcccEEEEEeC----CCCeEEEEEeehh-hHHHHHHHHHHHHHHhhcCCCCcceeeeeee-cCCceEEEEeccC
Q 007680          278 NLLGTSSFGSVYKGTIS----DGTDVAIKVFNLQ-LERAFRSFDSECEVLRNVRHRNLIKILSSYS-NPDFKALVLEFMP  351 (593)
Q Consensus       278 ~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~~  351 (593)
                      +.||+|+||.||+|...    ++..||+|.+... .....+.+.+|+.+++.++||||+++++++. .++..+++|||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            46899999999999853    2457999988543 2344567889999999999999999999765 4556899999999


Q ss_pred             CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCc--
Q 007680          352 NGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDS--  429 (593)
Q Consensus       352 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~--  429 (593)
                      +++|.+++.......++..+..++.|+++||+|||+.    +++||||||+||++++++.+||+|||+++........  
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~  156 (262)
T cd05058          81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASK----KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV  156 (262)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC----CccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence            9999999987665578888999999999999999964    5999999999999999999999999998765432111  


Q ss_pred             cccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhC-CCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhh
Q 007680          430 VRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTR-KRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVRE  508 (593)
Q Consensus       430 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  508 (593)
                      .......++..|+|||++.+..++.++|||||||++|||++| .+||.....  ...........               
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~--~~~~~~~~~~~---------------  219 (262)
T cd05058         157 HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS--FDITVYLLQGR---------------  219 (262)
T ss_pred             cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHhcCC---------------
Confidence            111223456789999999888999999999999999999995 556654211  11111111100               


Q ss_pred             hhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhh
Q 007680          509 EQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIK  551 (593)
Q Consensus       509 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~  551 (593)
                        .......++..+.+++.+||..+|++||++.|+++.|+++.
T Consensus       220 --~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~  260 (262)
T cd05058         220 --RLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF  260 (262)
T ss_pred             --CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence              00011123557899999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.4e-37  Score=334.99  Aligned_cols=268  Identities=22%  Similarity=0.271  Sum_probs=195.1

Q ss_pred             HHHHhhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCC------CCcceeeeeee
Q 007680          266 DIQRATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNVRH------RNLIKILSSYS  338 (593)
Q Consensus       266 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~~~~  338 (593)
                      ++....++|++.+.||+|+||.||+|... +++.||||+++... ...+....|+++++.++|      .+++++++++.
T Consensus       123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~  201 (467)
T PTZ00284        123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ  201 (467)
T ss_pred             ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence            34445788999999999999999999865 68899999997532 223445667777777754      45888888887


Q ss_pred             cC-CceEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC-------
Q 007680          339 NP-DFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENM-------  410 (593)
Q Consensus       339 ~~-~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~-------  410 (593)
                      .. ++.|+|||++ +++|.+++.+.+ .+++..+..++.||+.||+|||.+   .+|+||||||+|||++.++       
T Consensus       202 ~~~~~~~iv~~~~-g~~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH~~---~gIiHrDlKP~NILl~~~~~~~~~~~  276 (467)
T PTZ00284        202 NETGHMCIVMPKY-GPCLLDWIMKHG-PFSHRHLAQIIFQTGVALDYFHTE---LHLMHTDLKPENILMETSDTVVDPVT  276 (467)
T ss_pred             cCCceEEEEEecc-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhc---CCeecCCCCHHHEEEecCCccccccc
Confidence            64 5789999998 779999887765 489999999999999999999952   3599999999999998765       


Q ss_pred             ---------cEEEEeeccceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccc
Q 007680          411 ---------VAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIG  481 (593)
Q Consensus       411 ---------~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~  481 (593)
                               .+||+|||.+.....     ......||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus       277 ~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~  351 (467)
T PTZ00284        277 NRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNL  351 (467)
T ss_pred             ccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence                     499999998754221     123457899999999999999999999999999999999999999763221


Q ss_pred             cchHHHHHHHh---cCCchh---------hhhhhhh------hhh-----hh-hhhhhHHHHHHHHHHHhhcccCCCCCC
Q 007680          482 EMSLRRWVKES---LPHGLT---------EVVDANL------VRE-----EQ-AFSAKMDCILSIMDFALDCCMESPDMR  537 (593)
Q Consensus       482 ~~~~~~~~~~~---~~~~~~---------~~~~~~~------~~~-----~~-~~~~~~~~~~~l~~li~~cl~~dP~~R  537 (593)
                        .....+...   .+..+.         ++.+...      ...     .. .........+.+.+|+.+||..||++|
T Consensus       352 --~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R  429 (467)
T PTZ00284        352 --EHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKR  429 (467)
T ss_pred             --HHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhC
Confidence              111111111   111000         0000000      000     00 000000113467899999999999999


Q ss_pred             CCHHHHHHH
Q 007680          538 INMTDAAAK  546 (593)
Q Consensus       538 Ps~~evl~~  546 (593)
                      ||++|+++|
T Consensus       430 ~ta~e~L~H  438 (467)
T PTZ00284        430 LNARQMTTH  438 (467)
T ss_pred             CCHHHHhcC
Confidence            999999986

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-39  Score=326.39  Aligned_cols=253  Identities=25%  Similarity=0.325  Sum_probs=211.8

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEec
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEF  349 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  349 (593)
                      .+.|+++..||.|+||.||+|..+ ++-..|.|++........++|.-|++||..++||+||++++.|...+..++..||
T Consensus        31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF  110 (1187)
T KOG0579|consen   31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF  110 (1187)
T ss_pred             HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence            345788899999999999999976 4556778999888888889999999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCc
Q 007680          350 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDS  429 (593)
Q Consensus       350 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~  429 (593)
                      |.||-....+-.-+..+++.++..+++|++.||.|||.+    .|+|||||+.|||++-+|.++|+|||.+.....  ..
T Consensus       111 C~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~----~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t~  184 (1187)
T KOG0579|consen  111 CGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQ----NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--TR  184 (1187)
T ss_pred             cCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhc----chhhhhccccceEEEecCcEeeecccccccchh--HH
Confidence            999999999888777899999999999999999999955    499999999999999999999999998765322  12


Q ss_pred             cccccccCCccccCccccC-----CCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhh
Q 007680          430 VRQTMTMATIGYMAPEYGL-----EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDAN  504 (593)
Q Consensus       430 ~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  504 (593)
                      .....+.||++|||||+..     ..+|+.++||||||++|.||..+.+|-.+...                 ..++-.-
T Consensus       185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp-----------------MRVllKi  247 (1187)
T KOG0579|consen  185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP-----------------MRVLLKI  247 (1187)
T ss_pred             hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch-----------------HHHHHHH
Confidence            2345578999999999754     57899999999999999999999999765321                 1111111


Q ss_pred             hhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          505 LVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       505 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      ...+++....+...+..+.+++.+||.+||..||++.++++|
T Consensus       248 aKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H  289 (1187)
T KOG0579|consen  248 AKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH  289 (1187)
T ss_pred             hhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence            122333344455567789999999999999999999999975

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-38  Score=320.94  Aligned_cols=262  Identities=24%  Similarity=0.374  Sum_probs=218.0

Q ss_pred             HHHHHhhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCce
Q 007680          265 LDIQRATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFK  343 (593)
Q Consensus       265 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  343 (593)
                      ++++....+.....+||.|.||.||.|.|+ -.-.||||.++.+ ....++|..|+.+|+.++|||+|+++|+|......
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF  338 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF  338 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence            334444456777789999999999999987 3667999999765 34568999999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeecccee
Q 007680          344 ALVLEFMPNGSLEKWLYSHNY-FLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKL  422 (593)
Q Consensus       344 ~lv~e~~~~gsL~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~  422 (593)
                      |||+|||..|+|.+|+++... .++.-..+.++.||+.|++||..++    +|||||...|+||.++..+|++|||+++.
T Consensus       339 YIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn----FIHRDLAARNCLVgEnhiVKvADFGLsRl  414 (1157)
T KOG4278|consen  339 YIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN----FIHRDLAARNCLVGENHIVKVADFGLSRL  414 (1157)
T ss_pred             EEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh----hhhhhhhhhhccccccceEEeeccchhhh
Confidence            999999999999999987654 5666677899999999999999655    99999999999999999999999999999


Q ss_pred             cCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhh
Q 007680          423 LGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVV  501 (593)
Q Consensus       423 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  501 (593)
                      +..+..+. +....-...|.|||-+....++.|+|||+|||+|||+.| |..||-+...+                 ++.
T Consensus       415 MtgDTYTA-HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlS-----------------qVY  476 (1157)
T KOG4278|consen  415 MTGDTYTA-HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-----------------QVY  476 (1157)
T ss_pred             hcCCceec-ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHH-----------------HHH
Confidence            87554322 122223567999999999999999999999999999998 89998763211                 111


Q ss_pred             hhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhh
Q 007680          502 DANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIK  551 (593)
Q Consensus       502 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~  551 (593)
                        .+.....+.+.+..|++.+++||+.||++.|.+||++.|+-+.++.+-
T Consensus       477 --~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf  524 (1157)
T KOG4278|consen  477 --GLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF  524 (1157)
T ss_pred             --HHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence              122333455566789999999999999999999999999999998875

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-39  Score=324.29  Aligned_cols=245  Identities=28%  Similarity=0.345  Sum_probs=203.0

Q ss_pred             ccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEe
Q 007680          273 EFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLE  348 (593)
Q Consensus       273 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  348 (593)
                      -|+-++.||.|+||.||-|++. +.+.||||.+....   .....++.+|+..|++++|||++.+.|+|......|+|||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence            4666788999999999999964 78899999987542   3345678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCC
Q 007680          349 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGED  428 (593)
Q Consensus       349 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  428 (593)
                      || -|+-.|++.-+++++-+.++..|+.+.+.||+|||    +.+.||||||..|||+++.|.|||+|||.|....+   
T Consensus       107 YC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLH----S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P---  178 (948)
T KOG0577|consen  107 YC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH----SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP---  178 (948)
T ss_pred             HH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHH----HhhHHhhhccccceEecCCCeeeeccccchhhcCc---
Confidence            99 56999999988888999999999999999999999    45599999999999999999999999999876543   


Q ss_pred             ccccccccCCccccCccccC---CCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhh
Q 007680          429 SVRQTMTMATIGYMAPEYGL---EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANL  505 (593)
Q Consensus       429 ~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  505 (593)
                         ...++|||+|||||++.   .+.|+-++||||||++..|+.-.++|...+.. ...+.......             
T Consensus       179 ---AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA-MSALYHIAQNe-------------  241 (948)
T KOG0577|consen  179 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-MSALYHIAQNE-------------  241 (948)
T ss_pred             ---hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH-HHHHHHHHhcC-------------
Confidence               23467999999999864   57899999999999999999999999765321 11111111111             


Q ss_pred             hhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          506 VREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                          .......+.+..+.+|+..||++-|.+|||..+++.|
T Consensus       242 ----sPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H  278 (948)
T KOG0577|consen  242 ----SPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH  278 (948)
T ss_pred             ----CCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence                1111123456788999999999999999999999986

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=3.1e-37  Score=305.65  Aligned_cols=252  Identities=25%  Similarity=0.379  Sum_probs=203.1

Q ss_pred             hhccccccccCccCcccEEEEEeCCCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEecc
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFM  350 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  350 (593)
                      ..+|++.+.||+|+||.||+|.+.+++.+|+|.++.... ....+.+|++++++++|||++++++++......++||||+
T Consensus         3 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   81 (256)
T cd05112           3 PSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM   81 (256)
T ss_pred             hhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence            357888999999999999999987788999998875422 2356889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCcc
Q 007680          351 PNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSV  430 (593)
Q Consensus       351 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~  430 (593)
                      ++++|.+++......+++..+..++.|++.|++|||+++    ++|+||||+||+++.++.++|+|||.+......... 
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~----i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~-  156 (256)
T cd05112          82 EHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN----VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT-  156 (256)
T ss_pred             CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC----ccccccccceEEEcCCCeEEECCCcceeecccCccc-
Confidence            999999999876666899999999999999999999654    999999999999999999999999998865432211 


Q ss_pred             ccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhh
Q 007680          431 RQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREE  509 (593)
Q Consensus       431 ~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  509 (593)
                      ......++..|+|||+..++.++.++||||||+++|||++ |+.||......  ..........                
T Consensus       157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~~----------------  218 (256)
T cd05112         157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS--EVVETINAGF----------------  218 (256)
T ss_pred             ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH--HHHHHHhCCC----------------
Confidence            1122235678999999988899999999999999999998 99998753211  1111111000                


Q ss_pred             hhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 007680          510 QAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKL  547 (593)
Q Consensus       510 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  547 (593)
                       ....+...+..+.+++.+||+.+|++||++.|++++|
T Consensus       219 -~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         219 -RLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             -CCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence             0000111245789999999999999999999999887

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=2.1e-37  Score=319.47  Aligned_cols=260  Identities=23%  Similarity=0.398  Sum_probs=205.9

Q ss_pred             hhccccccccCccCcccEEEEEeC--------CCCeEEEEEeehhh-HHHHHHHHHHHHHHhhc-CCCCcceeeeeeecC
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS--------DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNV-RHRNLIKILSSYSNP  340 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  340 (593)
                      ..+|++.+.||+|+||.||+|+..        ++..||+|.++... ....+.+.+|+++++++ +||||+++++++...
T Consensus        11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (334)
T cd05100          11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   90 (334)
T ss_pred             HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence            357899999999999999999742        12368999887542 33456789999999999 899999999999999


Q ss_pred             CceEEEEeccCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCee
Q 007680          341 DFKALVLEFMPNGSLEKWLYSHN---------------YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNIL  405 (593)
Q Consensus       341 ~~~~lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIl  405 (593)
                      +..+++|||+++|+|.+++....               ..+++.++..++.|++.||+|||++    +++||||||+||+
T Consensus        91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~----givH~dlkp~Nil  166 (334)
T cd05100          91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ----KCIHRDLAARNVL  166 (334)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC----CeeccccccceEE
Confidence            99999999999999999987532               2478889999999999999999965    5999999999999


Q ss_pred             eCCCCcEEEEeeccceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccch
Q 007680          406 LDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMS  484 (593)
Q Consensus       406 l~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~  484 (593)
                      ++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||......  .
T Consensus       167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~  244 (334)
T cd05100         167 VTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE--E  244 (334)
T ss_pred             EcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH--H
Confidence            99999999999999987654322222222334567999999999999999999999999999998 88888653211  1


Q ss_pred             HHHHHHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhh
Q 007680          485 LRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVK  553 (593)
Q Consensus       485 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  553 (593)
                      ....+....                 ....+..++.++.+++.+||+.+|++||++.|++++|+++...
T Consensus       245 ~~~~~~~~~-----------------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~  296 (334)
T cd05100         245 LFKLLKEGH-----------------RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV  296 (334)
T ss_pred             HHHHHHcCC-----------------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhh
Confidence            111111000                 0011123356789999999999999999999999999998743

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=3.6e-37  Score=308.60  Aligned_cols=239  Identities=20%  Similarity=0.275  Sum_probs=189.2

Q ss_pred             ccCccCcccEEEEEeCC-------------------------CCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCccee
Q 007680          279 LLGTSSFGSVYKGTISD-------------------------GTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKI  333 (593)
Q Consensus       279 ~lg~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  333 (593)
                      .||+|+||.||+|....                         ...|++|++..........+.+|+.++++++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            69999999999997421                         23589999876655555678889999999999999999


Q ss_pred             eeeeecCCceEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC---
Q 007680          334 LSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENM---  410 (593)
Q Consensus       334 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~---  410 (593)
                      ++++...+..++||||+++|+|.+++......+++..+..++.|+++||+|||++    +|+||||||+||+++..+   
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~----~iiH~dlkp~Nill~~~~~~~  157 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDK----NLVHGNVCAKNILLARLGLAE  157 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcC----CccCCCCCcccEEEeccCccc
Confidence            9999999999999999999999999987666689999999999999999999954    599999999999997543   


Q ss_pred             ----cEEEEeeccceecCCCCCccccccccCCccccCccccCC-CCCCccchHHHHHHHHHHHH-hCCCCCCccccccch
Q 007680          411 ----VAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLE-GIVSAKCDVYSYGVLLMETF-TRKRPTDEMFIGEMS  484 (593)
Q Consensus       411 ----~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlGvvl~ell-tg~~pf~~~~~~~~~  484 (593)
                          .+|++|||.+......      ....++..|+|||.+.+ ..++.++||||||+++||++ +|+.||......+  
T Consensus       158 ~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--  229 (274)
T cd05076         158 GTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE--  229 (274)
T ss_pred             CccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH--
Confidence                4899999987643221      22346788999998765 56899999999999999985 6999987632211  


Q ss_pred             HHHHHHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHH
Q 007680          485 LRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLK  548 (593)
Q Consensus       485 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  548 (593)
                      ...+.....                 ..  +....+.+.+++.+||+.+|++|||+.++++.|+
T Consensus       230 ~~~~~~~~~-----------------~~--~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         230 KERFYEKKH-----------------RL--PEPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             HHHHHHhcc-----------------CC--CCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            111111000                 00  0011346899999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.4e-37  Score=313.67  Aligned_cols=265  Identities=23%  Similarity=0.300  Sum_probs=194.5

Q ss_pred             ccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh--HHHHHHHHHHHHHHhhc---CCCCcceeeeeeec-----CC
Q 007680          273 EFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL--ERAFRSFDSECEVLRNV---RHRNLIKILSSYSN-----PD  341 (593)
Q Consensus       273 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----~~  341 (593)
                      +|++.+.||+|+||.||+|+.. +++.||+|.++...  ......+.+|+.+++.+   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4888999999999999999865 68999999987542  11223455677777665   79999999998764     24


Q ss_pred             ceEEEEeccCCCCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccc
Q 007680          342 FKALVLEFMPNGSLEKWLYSHNY-FLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIY  420 (593)
Q Consensus       342 ~~~lv~e~~~~gsL~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a  420 (593)
                      ..++||||++ ++|.+++..... .+++.++..++.|++.||+|||++    +|+||||||+||+++.++.+||+|||++
T Consensus        81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~----~ivH~dikp~Nili~~~~~~kl~dfg~~  155 (288)
T cd07863          81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN----CIVHRDLKPENILVTSGGQVKLADFGLA  155 (288)
T ss_pred             eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEECCCCCEEECccCcc
Confidence            5799999997 489998876433 489999999999999999999955    5999999999999999999999999998


Q ss_pred             eecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHh-cCC--ch
Q 007680          421 KLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKES-LPH--GL  497 (593)
Q Consensus       421 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~-~~~--~~  497 (593)
                      .......   ......++..|+|||++.+..++.++||||+||++|||++|++||......+ .+.+..... .+.  .+
T Consensus       156 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~-~~~~~~~~~~~~~~~~~  231 (288)
T cd07863         156 RIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD-QLGKIFDLIGLPPEDDW  231 (288)
T ss_pred             ccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH-HHHHHHHHhCCCChhhC
Confidence            8664322   1223457899999999988899999999999999999999999996532211 111111100 000  00


Q ss_pred             hhhh---hhhhhhh--hhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          498 TEVV---DANLVRE--EQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       498 ~~~~---~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      ....   .......  .........++..+.+++.+||+.||++|||+.|++.|
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h  285 (288)
T cd07863         232 PRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH  285 (288)
T ss_pred             cccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            0000   0000000  00001111345678999999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=2e-37  Score=312.05  Aligned_cols=266  Identities=24%  Similarity=0.331  Sum_probs=199.4

Q ss_pred             ccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh--HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEec
Q 007680          273 EFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEF  349 (593)
Q Consensus       273 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  349 (593)
                      +|++.+.||+|++|.||+|+.. +++.||+|.++...  ......+.+|+.++++++||||+++++++.+++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            5788899999999999999975 78999999987542  22345678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCC
Q 007680          350 MPNGSLEKWLYSHN--YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGE  427 (593)
Q Consensus       350 ~~~gsL~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~  427 (593)
                      ++ ++|.+++....  ..+++..+..++.|+++||+|||++    +++|+||||+||++++++.+||+|||++.......
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~----~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  155 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR----RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV  155 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC----CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence            97 68988886543  3589999999999999999999955    59999999999999999999999999987654332


Q ss_pred             CccccccccCCccccCccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhc-C-C----chhhh
Q 007680          428 DSVRQTMTMATIGYMAPEYGLEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESL-P-H----GLTEV  500 (593)
Q Consensus       428 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~-~-~----~~~~~  500 (593)
                      .  ......+++.|+|||++.+. .++.++|||||||++|+|+||+.||........ ......... + .    .....
T Consensus       156 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  232 (285)
T cd07861         156 R--VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ-LFRIFRILGTPTEDVWPGVTSL  232 (285)
T ss_pred             c--cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHHhCCCChhhhhcchhh
Confidence            1  12233568899999987654 578999999999999999999999976322111 111111000 0 0    00000


Q ss_pred             hhhh--hhh--hhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          501 VDAN--LVR--EEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       501 ~~~~--~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      .+..  ...  ..........+++++.+++.+||..||++|||+.+++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~  282 (285)
T cd07861         233 PDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH  282 (285)
T ss_pred             HHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence            0000  000  000001112346788999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=2.6e-37  Score=322.65  Aligned_cols=264  Identities=20%  Similarity=0.208  Sum_probs=198.0

Q ss_pred             hhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehh--hHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC------
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQ--LERAFRSFDSECEVLRNVRHRNLIKILSSYSNP------  340 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  340 (593)
                      ..++|++.+.||+|+||.||++... +++.||||++...  .......+.+|+.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            3578999999999999999999865 6889999998753  233446678899999999999999999987543      


Q ss_pred             CceEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccc
Q 007680          341 DFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIY  420 (593)
Q Consensus       341 ~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a  420 (593)
                      ...++||||+++ +|.+.+..   .+++..+..++.|++.||+|||++    +|+||||||+||+++.++.+||+|||++
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~kL~DfG~a  173 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSA----GIIHRDLKPSNIVVKSDCTLKILDFGLA  173 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhC----CeecCCCCHHHEEECCCCcEEEEeCCCc
Confidence            357999999964 78777753   278899999999999999999955    5999999999999999999999999999


Q ss_pred             eecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhh-
Q 007680          421 KLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTE-  499 (593)
Q Consensus       421 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~-  499 (593)
                      +......   ......+|..|+|||++.+..++.++|||||||++|||++|+.||......+ ...... ........+ 
T Consensus       174 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~~~~~-~~~~~~~~~~  248 (364)
T cd07875         174 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID-QWNKVI-EQLGTPCPEF  248 (364)
T ss_pred             cccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHH-HhcCCCCHHH
Confidence            8654322   1233468999999999999999999999999999999999999997642211 111111 111100000 


Q ss_pred             --hhhhhhhhh--------h-------------hhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          500 --VVDANLVRE--------E-------------QAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       500 --~~~~~~~~~--------~-------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                        .+.......        .             ...........++.+++.+||+.||++|||+.|+++|
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         249 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             HHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence              000000000        0             0000001123468899999999999999999999987

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=5.3e-37  Score=307.91  Aligned_cols=248  Identities=23%  Similarity=0.359  Sum_probs=203.5

Q ss_pred             hccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEec
Q 007680          272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEF  349 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  349 (593)
                      ..|+..+.||+|+||.||+|.+. +++.||+|.+.... ......+.+|+.++++++||||+++++++.++...++||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            45788899999999999999975 68899999987543 34557789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCc
Q 007680          350 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDS  429 (593)
Q Consensus       350 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~  429 (593)
                      +++++|.+++...  .+++.++..++.|++.||+|||+.    +++|+||+|+||+++.++.++|+|||.+........ 
T Consensus        84 ~~~~~L~~~i~~~--~l~~~~~~~~~~~l~~~l~~lh~~----~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-  156 (277)
T cd06640          84 LGGGSALDLLRAG--PFDEFQIATMLKEILKGLDYLHSE----KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-  156 (277)
T ss_pred             CCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC----CccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-
Confidence            9999999998754  388999999999999999999954    599999999999999999999999999876643321 


Q ss_pred             cccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhh
Q 007680          430 VRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREE  509 (593)
Q Consensus       430 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  509 (593)
                       ......++..|+|||++.+..++.++|+|||||++|||++|..||.........  .......+               
T Consensus       157 -~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~--~~~~~~~~---------------  218 (277)
T cd06640         157 -KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL--FLIPKNNP---------------  218 (277)
T ss_pred             -ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh--hhhhcCCC---------------
Confidence             122345788899999998888999999999999999999999999763221100  00000000               


Q ss_pred             hhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          510 QAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       510 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                        ......++..+.+++.+||+.+|++||++.+++++
T Consensus       219 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         219 --PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             --CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence              01112346678999999999999999999999887

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-37  Score=309.90  Aligned_cols=249  Identities=25%  Similarity=0.323  Sum_probs=204.1

Q ss_pred             hccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEec
Q 007680          272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEF  349 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  349 (593)
                      ++|++.+.||.|++|.||+|... +++.||+|.+.... ......+.+|+++++.++|+||+++++++.++...++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            46888999999999999999965 68999999987653 34456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCc
Q 007680          350 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDS  429 (593)
Q Consensus       350 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~  429 (593)
                      +++++|.+++...  .+++..+..++.|++.|+.|||++    +++|+||+|+||++++++.++|+|||.++....... 
T Consensus        81 ~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~----~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-  153 (274)
T cd06609          81 CGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEE----GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS-  153 (274)
T ss_pred             eCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEECCCCCEEEcccccceeeccccc-
Confidence            9999999999876  489999999999999999999954    499999999999999999999999999987754321 


Q ss_pred             cccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhh
Q 007680          430 VRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREE  509 (593)
Q Consensus       430 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  509 (593)
                       ......++..|+|||++.+..++.++||||||+++|+|+||+.||.......  .........+..             
T Consensus       154 -~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~-------------  217 (274)
T cd06609         154 -KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR--VLFLIPKNNPPS-------------  217 (274)
T ss_pred             -ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH--HHHHhhhcCCCC-------------
Confidence             2233467888999999998889999999999999999999999997532111  111111110000             


Q ss_pred             hhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          510 QAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       510 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                        ... ..++.++.+++.+||..+|++|||+++++++
T Consensus       218 --~~~-~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~  251 (274)
T cd06609         218 --LEG-NKFSKPFKDFVSLCLNKDPKERPSAKELLKH  251 (274)
T ss_pred             --Ccc-cccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence              000 0135578999999999999999999999875

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.9e-37  Score=322.40  Aligned_cols=263  Identities=19%  Similarity=0.215  Sum_probs=196.2

Q ss_pred             hhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEe
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLE  348 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  348 (593)
                      ...+|++.+.||+|+||.||+|+.. +++.||+|+....      ....|+.++++++||||+++++++...+..++|||
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  137 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP  137 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence            4457999999999999999999975 5788999975432      23568999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCC
Q 007680          349 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGED  428 (593)
Q Consensus       349 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  428 (593)
                      ++ .++|.+++......+++..+..++.|++.||+|||++    +|+||||||+||+++.++.+||+|||.++...... 
T Consensus       138 ~~-~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-  211 (357)
T PHA03209        138 HY-SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQ----RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP-  211 (357)
T ss_pred             cc-CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEECCCCCEEEecCccccccccCc-
Confidence            99 4689999877666799999999999999999999965    49999999999999999999999999987533221 


Q ss_pred             ccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCC-Cccccccc--------hHHHHHHHh--cCCch
Q 007680          429 SVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPT-DEMFIGEM--------SLRRWVKES--LPHGL  497 (593)
Q Consensus       429 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf-~~~~~~~~--------~~~~~~~~~--~~~~~  497 (593)
                        ......||..|+|||++.+..++.++|||||||++|||+++..|+ ........        .+.+.....  .+...
T Consensus       212 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  289 (357)
T PHA03209        212 --AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEF  289 (357)
T ss_pred             --ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhc
Confidence              123346899999999999999999999999999999999865554 33211100        111111100  00000


Q ss_pred             h---------hhhhhh-hhhh---hhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          498 T---------EVVDAN-LVRE---EQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       498 ~---------~~~~~~-~~~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      .         ..++.. ....   .........++.++.+++.+||+.||++|||+.|+++|
T Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h  351 (357)
T PHA03209        290 PRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY  351 (357)
T ss_pred             CCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence            0         000000 0000   00001111334567789999999999999999999986

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.2e-37  Score=320.61  Aligned_cols=255  Identities=21%  Similarity=0.282  Sum_probs=199.6

Q ss_pred             hccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEE
Q 007680          272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVL  347 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  347 (593)
                      ++|++.+.||+|+||.||+++.. +++.||+|++....   ......+.+|..++..++|+||+++++++.+.+..++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47899999999999999999975 68899999997632   233456788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCC
Q 007680          348 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGE  427 (593)
Q Consensus       348 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~  427 (593)
                      ||+++|+|.+++......+++..+..++.|++.||+|||++    +|+||||||+||+++.++.+||+|||++.......
T Consensus        81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~----~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  156 (331)
T cd05624          81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQL----HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG  156 (331)
T ss_pred             eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC----CeeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence            99999999999987555689999999999999999999954    59999999999999999999999999998765432


Q ss_pred             CccccccccCCccccCccccCC-----CCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhh
Q 007680          428 DSVRQTMTMATIGYMAPEYGLE-----GIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVD  502 (593)
Q Consensus       428 ~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  502 (593)
                      . .......|++.|+|||++.+     +.++.++|||||||++|||++|+.||......+ .+.......  .       
T Consensus       157 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~-~~~~i~~~~--~-------  225 (331)
T cd05624         157 T-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE-TYGKIMNHE--E-------  225 (331)
T ss_pred             c-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH-HHHHHHcCC--C-------
Confidence            2 12233568999999998765     468899999999999999999999996532111 011100000  0       


Q ss_pred             hhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCC--CCCHHHHHHH
Q 007680          503 ANLVREEQAFSAKMDCILSIMDFALDCCMESPDM--RINMTDAAAK  546 (593)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~  546 (593)
                       ..    .......+++.++.+++.+|+..++++  |++++++++|
T Consensus       226 -~~----~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         226 -RF----QFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             -cc----cCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence             00    000001123567899999999866544  4688888876

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=5.1e-37  Score=306.58  Aligned_cols=252  Identities=21%  Similarity=0.302  Sum_probs=190.2

Q ss_pred             cccCccCcccEEEEEeC---CCCeEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEeccCCC
Q 007680          278 NLLGTSSFGSVYKGTIS---DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNG  353 (593)
Q Consensus       278 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  353 (593)
                      +.||+|+||.||+|...   ++..+|+|.++... ......+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            36899999999999864   34679999887643 233457888999999999999999999999999999999999999


Q ss_pred             CHHHHHhhCCC----CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCc
Q 007680          354 SLEKWLYSHNY----FLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDS  429 (593)
Q Consensus       354 sL~~~l~~~~~----~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~  429 (593)
                      +|.+++.....    ..++..+..++.|++.|++|||+.    +++|+||||+||+++.++.+||+|||.+.........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~----~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~  156 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN----NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY  156 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC----CEeccccCcceEEEcCCCcEEECCccccccccCccee
Confidence            99999975332    456778889999999999999954    5999999999999999999999999998754332221


Q ss_pred             cccccccCCccccCccccCCC-------CCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhh
Q 007680          430 VRQTMTMATIGYMAPEYGLEG-------IVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVV  501 (593)
Q Consensus       430 ~~~~~~~gt~~y~aPE~~~~~-------~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  501 (593)
                      .......++..|+|||++.+.       .++.++||||||+++|||++ |+.||......+.  .......   ......
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~--~~~~~~~---~~~~~~  231 (269)
T cd05087         157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV--LTYTVRE---QQLKLP  231 (269)
T ss_pred             ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH--HHHHhhc---ccCCCC
Confidence            222334567889999987542       35789999999999999996 9999976432211  1110000   000000


Q ss_pred             hhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHH
Q 007680          502 DANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLK  548 (593)
Q Consensus       502 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  548 (593)
                      ++.+         ....+..+.+++.+|| .+|++|||++||+..|+
T Consensus       232 ~~~~---------~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         232 KPRL---------KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCcc---------CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            0000         0112446788999999 68999999999998764

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=5.2e-37  Score=304.97  Aligned_cols=254  Identities=23%  Similarity=0.407  Sum_probs=204.9

Q ss_pred             hhhccccccccCccCcccEEEEEeCCCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEec
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEF  349 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  349 (593)
                      ..++|++.+.||+|+||.||++...++..+|+|.+.... ...+.+.+|++++++++|+||+++++.+.. ...+++|||
T Consensus         4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~   81 (260)
T cd05073           4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF   81 (260)
T ss_pred             cccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence            356799999999999999999998778889999887543 234678899999999999999999999887 778999999


Q ss_pred             cCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCC
Q 007680          350 MPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGED  428 (593)
Q Consensus       350 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  428 (593)
                      +++++|.+++.... ..+++..+..++.|++.||.|||+.    +++|+||||+||+++.++.+||+|||.+........
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~----~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  157 (260)
T cd05073          82 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR----NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY  157 (260)
T ss_pred             CCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC----CccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence            99999999997643 3578899999999999999999965    499999999999999999999999999886643322


Q ss_pred             ccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhh
Q 007680          429 SVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVR  507 (593)
Q Consensus       429 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  507 (593)
                      . ......++..|+|||++.+..++.++|+|||||++|+++| |+.||......  ...........             
T Consensus       158 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~~~~~~~~~-------------  221 (260)
T cd05073         158 T-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--EVIRALERGYR-------------  221 (260)
T ss_pred             c-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHhCCCC-------------
Confidence            1 1122345677999999988889999999999999999999 99999763211  11111111110             


Q ss_pred             hhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHH
Q 007680          508 EEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKK  549 (593)
Q Consensus       508 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  549 (593)
                          .+.....+.++.+++.+||+.+|++||++.++.+.|+.
T Consensus       222 ----~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         222 ----MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             ----CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                00112235578999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.8e-38  Score=317.26  Aligned_cols=255  Identities=22%  Similarity=0.274  Sum_probs=206.2

Q ss_pred             hhhccccccccCccCcccEEEEEeCCCCeEEEEEeehh--hHHHHHHHHHHHHHHhhc-CCCCcceeeeeeecCCceEEE
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQ--LERAFRSFDSECEVLRNV-RHRNLIKILSSYSNPDFKALV  346 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  346 (593)
                      .-..|+++++||+||.+.||++...+.+.+|+|.+...  +......|.+|+..|.++ .|.+|+++++|-..++..|+|
T Consensus       359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv  438 (677)
T KOG0596|consen  359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV  438 (677)
T ss_pred             CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence            34579999999999999999999888888888877543  456678899999999999 589999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCC
Q 007680          347 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG  426 (593)
Q Consensus       347 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  426 (593)
                      |||- ..+|..++.+....++...++.+..|++.++.++|++|    |||.||||.|+++- .|.+||+|||+|..+..+
T Consensus       439 mE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~g----IVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~D  512 (677)
T KOG0596|consen  439 MECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHG----IVHSDLKPANFLLV-KGRLKLIDFGIANAIQPD  512 (677)
T ss_pred             eecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhc----eeecCCCcccEEEE-eeeEEeeeechhcccCcc
Confidence            9987 55999999988765554488889999999999999766    99999999999885 468999999999999887


Q ss_pred             CCccccccccCCccccCccccCCC-----------CCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCC
Q 007680          427 EDSVRQTMTMATIGYMAPEYGLEG-----------IVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPH  495 (593)
Q Consensus       427 ~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~  495 (593)
                      .........+||+.||+||.+...           +.++++||||+|||+|+|+.|+.||......      |.      
T Consensus       513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~------~a------  580 (677)
T KOG0596|consen  513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQ------IA------  580 (677)
T ss_pred             ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHH------HH------
Confidence            777667778899999999976432           2578999999999999999999999763110      10      


Q ss_pred             chhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          496 GLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       496 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      .+..+.++.-.-+....+.    ..++.++++.||+.||++||++.|+++|
T Consensus       581 Kl~aI~~P~~~Iefp~~~~----~~~li~~mK~CL~rdPkkR~si~eLLqh  627 (677)
T KOG0596|consen  581 KLHAITDPNHEIEFPDIPE----NDELIDVMKCCLARDPKKRWSIPELLQH  627 (677)
T ss_pred             HHHhhcCCCccccccCCCC----chHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence            1222333322111111111    1238999999999999999999999986

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.5e-37  Score=320.09  Aligned_cols=255  Identities=21%  Similarity=0.265  Sum_probs=199.2

Q ss_pred             hccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEE
Q 007680          272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVL  347 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  347 (593)
                      ++|++.++||+|+||.||+++.+ +++.+|+|++....   ......+.+|+.++..++|++|+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            47899999999999999999976 57889999997532   223445788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCC
Q 007680          348 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGE  427 (593)
Q Consensus       348 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~  427 (593)
                      ||+++|+|.+++.+....+++..+..++.|++.||+|||++    +|+||||||+||+++.++.+||+|||++.......
T Consensus        81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~----~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~  156 (332)
T cd05623          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL----HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG  156 (332)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence            99999999999987655689999999999999999999954    59999999999999999999999999987654322


Q ss_pred             CccccccccCCccccCccccC-----CCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhh
Q 007680          428 DSVRQTMTMATIGYMAPEYGL-----EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVD  502 (593)
Q Consensus       428 ~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  502 (593)
                      . .......||+.|+|||++.     ...++.++|||||||++|||++|+.||.....     ..........       
T Consensus       157 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~-----~~~~~~i~~~-------  223 (332)
T cd05623         157 T-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL-----VETYGKIMNH-------  223 (332)
T ss_pred             c-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH-----HHHHHHHhCC-------
Confidence            2 1223356899999999875     34688999999999999999999999975321     1111110000       


Q ss_pred             hhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCC--CCCHHHHHHH
Q 007680          503 ANLVREEQAFSAKMDCILSIMDFALDCCMESPDM--RINMTDAAAK  546 (593)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~  546 (593)
                       ..  ..........++.++.+++.+|+..+|++  |+++.|+++|
T Consensus       224 -~~--~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         224 -KE--RFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             -Cc--cccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence             00  00000011234567899999988654444  7899999988

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=5.7e-37  Score=308.86  Aligned_cols=266  Identities=21%  Similarity=0.254  Sum_probs=204.2

Q ss_pred             ccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh--HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEec
Q 007680          273 EFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEF  349 (593)
Q Consensus       273 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  349 (593)
                      +|++.+.||+|++|.||+|... +|+.||+|++....  ......+.+|+.++++++||||+++++++..++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            4788999999999999999965 78999999997653  33456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCc
Q 007680          350 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDS  429 (593)
Q Consensus       350 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~  429 (593)
                      + +++|.+++......+++.++..++.|+++||+|||++    +++|+||||+||++++++.++|+|||.+........ 
T Consensus        81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-  154 (286)
T cd07832          81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN----GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-  154 (286)
T ss_pred             c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-
Confidence            9 9999999987666699999999999999999999954    599999999999999999999999999887654332 


Q ss_pred             cccccccCCccccCccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCc----hhhhhh--
Q 007680          430 VRQTMTMATIGYMAPEYGLEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHG----LTEVVD--  502 (593)
Q Consensus       430 ~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~--  502 (593)
                      .......++..|+|||++.+. .++.++||||+|+++|||++|.+||.....  ..............    ..+..+  
T Consensus       155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07832         155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND--IEQLAIVFRTLGTPNEETWPGLTSLP  232 (286)
T ss_pred             CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH--HHHHHHHHHHcCCCChHHHhhccCcc
Confidence            112334688999999987654 468999999999999999999888865321  11111111111100    000000  


Q ss_pred             -h-h--hhhh-h-hhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          503 -A-N--LVRE-E-QAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       503 -~-~--~~~~-~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                       . .  .... . .......+.+..+.+++.+||..+|++||+++++++|
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence             0 0  0000 0 0001112335788999999999999999999999876

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=3.5e-37  Score=316.85  Aligned_cols=266  Identities=19%  Similarity=0.246  Sum_probs=196.4

Q ss_pred             cccccCcc--CcccEEEEEeC-CCCeEEEEEeehhh--HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEecc
Q 007680          276 ECNLLGTS--SFGSVYKGTIS-DGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFM  350 (593)
Q Consensus       276 ~~~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  350 (593)
                      ++++||+|  +|++||++..+ +|+.||+|+++...  ....+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            46789999  67899999864 78999999997642  334456788999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCc
Q 007680          351 PNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDS  429 (593)
Q Consensus       351 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~  429 (593)
                      ++|+|.+++.... ..+++..+..++.|++.||+|||++    +|+||||||+||+++.++.++++||+.+.........
T Consensus        82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~----~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~  157 (327)
T cd08227          82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM----GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR  157 (327)
T ss_pred             CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC----CEecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence            9999999997643 3489999999999999999999965    4999999999999999999999999865443211110


Q ss_pred             c-----ccccccCCccccCccccCC--CCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchh----
Q 007680          430 V-----RQTMTMATIGYMAPEYGLE--GIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLT----  498 (593)
Q Consensus       430 ~-----~~~~~~gt~~y~aPE~~~~--~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~----  498 (593)
                      .     ......++..|+|||++.+  ..++.++|||||||++|||++|+.||........ .........+....    
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~  236 (327)
T cd08227         158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM-LLEKLNGTVPCLLDTTTI  236 (327)
T ss_pred             ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH-HHHHhcCCccccccccch
Confidence            0     1122346778999999876  4589999999999999999999999976432211 11111111110000    


Q ss_pred             --hh---------hhhhhh---------h---hhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          499 --EV---------VDANLV---------R---EEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       499 --~~---------~~~~~~---------~---~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                        +.         .+....         .   .....+....+++.+.+++.+||+.||++|||++|+++|
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~  307 (327)
T cd08227         237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  307 (327)
T ss_pred             hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence              00         000000         0   000001112345688999999999999999999999976

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=5.4e-37  Score=303.88  Aligned_cols=250  Identities=22%  Similarity=0.299  Sum_probs=204.1

Q ss_pred             ccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh--HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEec
Q 007680          273 EFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEF  349 (593)
Q Consensus       273 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  349 (593)
                      +|+..+.||+|+||.||.++.. +++.+++|.+....  ....+.+.+|++++++++|+||+++++++.+.+..+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            4888999999999999999854 68999999987542  44556788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCC
Q 007680          350 MPNGSLEKWLYSH-NYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGED  428 (593)
Q Consensus       350 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  428 (593)
                      +++++|.+++... ...+++.++..++.|++.||.|||+.    +++|+||+|+||++++++.+||+|||.+........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~----~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~  156 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA----GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS  156 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC----CccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence            9999999999875 33589999999999999999999954    599999999999999999999999999887644331


Q ss_pred             ccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhh
Q 007680          429 SVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVRE  508 (593)
Q Consensus       429 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  508 (593)
                        ......+++.|+|||+..+..++.++||||||+++|||++|+.||......     .........        ...  
T Consensus       157 --~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-----~~~~~~~~~--------~~~--  219 (256)
T cd08221         157 --MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL-----NLVVKIVQG--------NYT--  219 (256)
T ss_pred             --cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH-----HHHHHHHcC--------CCC--
Confidence              223346889999999998888999999999999999999999999653211     111110000        000  


Q ss_pred             hhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 007680          509 EQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKL  547 (593)
Q Consensus       509 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  547 (593)
                          .....++.++.+++.+||..+|++||++.|+++++
T Consensus       220 ----~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         220 ----PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             ----CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence                00123356789999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.6e-37  Score=311.64  Aligned_cols=248  Identities=23%  Similarity=0.351  Sum_probs=201.9

Q ss_pred             hccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEec
Q 007680          272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEF  349 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  349 (593)
                      +.|+..+.||+|+||.||+|... +++.||+|.++... ....+.+.+|++++++++||||+++++++..++..++||||
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence            45777889999999999999865 68899999987543 34456789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCc
Q 007680          350 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDS  429 (593)
Q Consensus       350 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~  429 (593)
                      +++++|.+++...  .+++..+..++.|+++|+.|||++    +++|+||+|+||++++++.++|+|||++..+..... 
T Consensus        84 ~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~----~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-  156 (277)
T cd06642          84 LGGGSALDLLKPG--PLEETYIATILREILKGLDYLHSE----RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-  156 (277)
T ss_pred             cCCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhcC----CeeccCCChheEEEeCCCCEEEccccccccccCcch-
Confidence            9999999998654  389999999999999999999954    599999999999999999999999999876543221 


Q ss_pred             cccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhh
Q 007680          430 VRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREE  509 (593)
Q Consensus       430 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  509 (593)
                       ......++..|+|||++.+..++.++|||||||++|||++|+.||.......  .........+.              
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~--------------  219 (277)
T cd06642         157 -KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR--VLFLIPKNSPP--------------  219 (277)
T ss_pred             -hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh--HHhhhhcCCCC--------------
Confidence             1223457889999999998889999999999999999999999987532211  01111100000              


Q ss_pred             hhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          510 QAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       510 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                         .....++.++.+++.+||+.+|++||++.+++++
T Consensus       220 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         220 ---TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             ---CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence               0011235578999999999999999999999986

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=2.5e-37  Score=308.68  Aligned_cols=249  Identities=27%  Similarity=0.463  Sum_probs=197.2

Q ss_pred             cccCccCcccEEEEEeCC-------CCeEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEec
Q 007680          278 NLLGTSSFGSVYKGTISD-------GTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEF  349 (593)
Q Consensus       278 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  349 (593)
                      +.||+|+||.||+|+..+       ++.+|+|.+.... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            368999999999998642       2579999886543 23456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC-----cEEEEeec
Q 007680          350 MPNGSLEKWLYSHN------YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENM-----VAHVSDFG  418 (593)
Q Consensus       350 ~~~gsL~~~l~~~~------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~-----~~kL~Dfg  418 (593)
                      +++++|.+++....      ..+++.++..++.|++.||+|||+.    +++|+||||+||+++.++     .++|+|||
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~----~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg  156 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM----HFIHRDLAARNCLVSEKGYDADRVVKIGDFG  156 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC----CcccCCCChheEEEecCCCCCCcceEECCcc
Confidence            99999999997532      2478899999999999999999954    599999999999999887     89999999


Q ss_pred             cceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCch
Q 007680          419 IYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGL  497 (593)
Q Consensus       419 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  497 (593)
                      ++................++..|+|||++.++.++.++|||||||++|||++ |+.||......  .....+...     
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~--~~~~~~~~~-----  229 (269)
T cd05044         157 LARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ--EVLQHVTAG-----  229 (269)
T ss_pred             cccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH--HHHHHHhcC-----
Confidence            9876543322222223345678999999999999999999999999999998 99998653211  111111100     


Q ss_pred             hhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHH
Q 007680          498 TEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKK  549 (593)
Q Consensus       498 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  549 (593)
                                  ........++..+.+++.+||+.+|.+||++.++++.|++
T Consensus       230 ------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         230 ------------GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             ------------CccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence                        0011122345678999999999999999999999998863

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=5e-37  Score=306.86  Aligned_cols=248  Identities=29%  Similarity=0.464  Sum_probs=194.8

Q ss_pred             cccCccCcccEEEEEeC-CCC--eEEEEEeehh-hHHHHHHHHHHHHHHhhc-CCCCcceeeeeeecCCceEEEEeccCC
Q 007680          278 NLLGTSSFGSVYKGTIS-DGT--DVAIKVFNLQ-LERAFRSFDSECEVLRNV-RHRNLIKILSSYSNPDFKALVLEFMPN  352 (593)
Q Consensus       278 ~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  352 (593)
                      +.||+|+||.||+|+.+ ++.  .+++|.++.. .....+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            46899999999999975 343  4688888743 234456788999999999 799999999999999999999999999


Q ss_pred             CCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEee
Q 007680          353 GSLEKWLYSHN---------------YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDF  417 (593)
Q Consensus       353 gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df  417 (593)
                      ++|.+++....               ..+++.++..++.|++.||+|||++    +++||||||+||++++++.+||+||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~----~i~H~dikp~nili~~~~~~kl~df  156 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK----QFIHRDLAARNILVGENYVAKIADF  156 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC----CEeecccccceEEEcCCCeEEECCC
Confidence            99999997543               1478899999999999999999964    5999999999999999999999999


Q ss_pred             ccceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCc
Q 007680          418 GIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHG  496 (593)
Q Consensus       418 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~  496 (593)
                      |++......   ........+..|+|||++.+..++.++|||||||++|||++ |..||......  ..........   
T Consensus       157 gl~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~--~~~~~~~~~~---  228 (270)
T cd05047         157 GLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--ELYEKLPQGY---  228 (270)
T ss_pred             CCccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH--HHHHHHhCCC---
Confidence            997532211   11112234567999999988889999999999999999997 99999653211  1111111000   


Q ss_pred             hhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhh
Q 007680          497 LTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIK  551 (593)
Q Consensus       497 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~  551 (593)
                                    ..+.+..++.++.+++.+||+.+|.+|||+.++++.|+++.
T Consensus       229 --------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         229 --------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             --------------CCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence                          00111123457899999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=2.5e-37  Score=307.79  Aligned_cols=255  Identities=24%  Similarity=0.289  Sum_probs=205.5

Q ss_pred             hccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEec
Q 007680          272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEF  349 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  349 (593)
                      ++|+..+.||+|++|.||++..+ +++.+|+|.+.... ......+.+|++++++++||||+++++.+...+..++++||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            46888899999999999999976 68999999987653 34456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCc
Q 007680          350 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDS  429 (593)
Q Consensus       350 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~  429 (593)
                      +++++|.+++......+++..+..++.|++.|++|||+   ..+++|+||||+||++++++.++|+|||.+........ 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-  156 (265)
T cd06605          81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHE---KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA-  156 (265)
T ss_pred             cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcC---CCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh-
Confidence            99999999998765568999999999999999999995   15699999999999999999999999999876532211 


Q ss_pred             cccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhh
Q 007680          430 VRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREE  509 (593)
Q Consensus       430 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  509 (593)
                         ....++..|+|||++.+..++.++||||||+++|+|++|+.||...................            ...
T Consensus       157 ---~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------------~~~  221 (265)
T cd06605         157 ---KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN------------EPP  221 (265)
T ss_pred             ---hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhc------------CCC
Confidence               11567889999999988899999999999999999999999997642211111111111100            000


Q ss_pred             hhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          510 QAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       510 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      ... ....++.++.+++.+||..||++|||+.+++.+
T Consensus       222 ~~~-~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  257 (265)
T cd06605         222 PRL-PSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH  257 (265)
T ss_pred             CCC-ChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence            000 001145678999999999999999999999865

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=2.6e-37  Score=309.68  Aligned_cols=255  Identities=21%  Similarity=0.358  Sum_probs=203.5

Q ss_pred             hccccccccCccCcccEEEEEeC------CCCeEEEEEeehhhHH-HHHHHHHHHHHHhhcCCCCcceeeeeeecCCceE
Q 007680          272 DEFNECNLLGTSSFGSVYKGTIS------DGTDVAIKVFNLQLER-AFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKA  344 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  344 (593)
                      ++|++.+.||+|+||.||+|+.+      +.+.|++|.+...... ..+.+.+|++++++++|+||+++++++.+.+..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            67899999999999999999864      3467999988664433 4567899999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhhCCC--------CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEe
Q 007680          345 LVLEFMPNGSLEKWLYSHNY--------FLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSD  416 (593)
Q Consensus       345 lv~e~~~~gsL~~~l~~~~~--------~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~D  416 (593)
                      +||||+++++|.+++.....        .+++..+..++.|++.||+|||++    +|+||||||+||+++.++.++++|
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~----~i~H~dlkp~Nili~~~~~~~l~~  160 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA----RFVHRDLAARNCLVSSQREVKVSL  160 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc----CcccCcCccceEEEeCCCcEEEcc
Confidence            99999999999999976551        489999999999999999999965    499999999999999999999999


Q ss_pred             eccceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCC
Q 007680          417 FGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPH  495 (593)
Q Consensus       417 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~  495 (593)
                      ||++....... ........++..|+|||.+.+..++.++||||||+++|++++ |..||......  ..........  
T Consensus       161 ~~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~--~~~~~~~~~~--  235 (275)
T cd05046         161 LSLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE--EVLNRLQAGK--  235 (275)
T ss_pred             cccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH--HHHHHHHcCC--
Confidence            99987543221 112223346778999999888889999999999999999999 88898653211  1111111000  


Q ss_pred             chhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHH
Q 007680          496 GLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKK  549 (593)
Q Consensus       496 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  549 (593)
                               .     .......++..+.+++.+||+.+|++||++.|+++.|++
T Consensus       236 ---------~-----~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~  275 (275)
T cd05046         236 ---------L-----ELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE  275 (275)
T ss_pred             ---------c-----CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence                     0     000112345678999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.7e-37  Score=310.42  Aligned_cols=252  Identities=24%  Similarity=0.323  Sum_probs=201.0

Q ss_pred             hccccccccCccCcccEEEEEeC-CCCeEEEEEeehh-hHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEec
Q 007680          272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQ-LERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEF  349 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  349 (593)
                      ++|++.+.||+|+||.||++... +++.||+|.++.. .......+.+|+.++++++||||+++++.+...+..++||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            47899999999999999999976 7899999998754 233456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCC
Q 007680          350 MPNGSLEKWLYSHN--YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGE  427 (593)
Q Consensus       350 ~~~gsL~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~  427 (593)
                      +++++|.+++....  ..+++..+..++.|++.||.|||++   .+++|+||||+||+++.++.+||+|||.+..+....
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  157 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE---HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL  157 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhc---CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence            99999999987642  2589999999999999999999952   359999999999999999999999999987653322


Q ss_pred             CccccccccCCccccCccccCCC------CCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhh
Q 007680          428 DSVRQTMTMATIGYMAPEYGLEG------IVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVV  501 (593)
Q Consensus       428 ~~~~~~~~~gt~~y~aPE~~~~~------~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  501 (593)
                          .....++..|+|||++.+.      .++.++|||||||++|+|++|+.||.......  .......        ..
T Consensus       158 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~~--------~~  223 (286)
T cd06622         158 ----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN--IFAQLSA--------IV  223 (286)
T ss_pred             ----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh--HHHHHHH--------Hh
Confidence                1234578899999987554      35889999999999999999999996531111  0000000        00


Q ss_pred             hhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          502 DANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       502 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      +    ...  ...+.+++.++.+++.+||..+|++||++.+++++
T Consensus       224 ~----~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~  262 (286)
T cd06622         224 D----GDP--PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH  262 (286)
T ss_pred             h----cCC--CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence            0    000  01112346678999999999999999999999985

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.8e-37  Score=307.93  Aligned_cols=250  Identities=26%  Similarity=0.374  Sum_probs=200.1

Q ss_pred             ccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh---------HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCc
Q 007680          273 EFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---------ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDF  342 (593)
Q Consensus       273 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  342 (593)
                      +|.+.+.||+|++|.||+|... +++.+|+|.+....         ....+.+.+|+.++++++||||+++++++...+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            3677889999999999999864 68899999886432         1233568899999999999999999999999999


Q ss_pred             eEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeecccee
Q 007680          343 KALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKL  422 (593)
Q Consensus       343 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~  422 (593)
                      .++||||+++++|.+++..... +++..+..++.|++.||+|||+.    +++||||+|+||++++++.++|+|||.++.
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~-l~~~~~~~~~~~l~~~l~~lH~~----~ivH~di~p~nil~~~~~~~~l~dfg~~~~  155 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYGA-FEETLVRNFVRQILKGLNYLHNR----GIIHRDIKGANILVDNKGGIKISDFGISKK  155 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhccC-ccHHHHHHHHHHHHHHHHHHHhc----CcccccCCHHHEEEcCCCCEEecccCCCcc
Confidence            9999999999999999987643 88999999999999999999965    499999999999999999999999999887


Q ss_pred             cCCCCCcc----ccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchh
Q 007680          423 LGEGEDSV----RQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLT  498 (593)
Q Consensus       423 ~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  498 (593)
                      ........    ......++..|+|||.+.+..++.++||||+||++|+|++|+.||....... .. .......     
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~-~~~~~~~-----  228 (267)
T cd06628         156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ-AI-FKIGENA-----  228 (267)
T ss_pred             cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH-HH-HHHhccC-----
Confidence            65321111    1122357889999999988889999999999999999999999997632111 00 0000000     


Q ss_pred             hhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          499 EVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       499 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                                  ....+...+..+.+++.+||+.||++||++.|++++
T Consensus       229 ------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  264 (267)
T cd06628         229 ------------SPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH  264 (267)
T ss_pred             ------------CCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence                        000112235678999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.8e-37  Score=313.74  Aligned_cols=250  Identities=22%  Similarity=0.311  Sum_probs=200.9

Q ss_pred             hccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEecc
Q 007680          272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFM  350 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  350 (593)
                      +.|.....||+|+||.||++... ++..||||.+........+.+.+|+.+++.++||||+++++.+..++..++||||+
T Consensus        22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~  101 (292)
T cd06658          22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL  101 (292)
T ss_pred             HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence            34444578999999999999865 68899999987665555677899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCcc
Q 007680          351 PNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSV  430 (593)
Q Consensus       351 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~  430 (593)
                      ++++|.+++...  .+++.++..++.|++.||+|||++    +|+||||||+||++++++.++|+|||++........  
T Consensus       102 ~~~~L~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~~----~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--  173 (292)
T cd06658         102 EGGALTDIVTHT--RMNEEQIATVCLSVLRALSYLHNQ----GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--  173 (292)
T ss_pred             CCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC----CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--
Confidence            999999988654  389999999999999999999965    599999999999999999999999999876543221  


Q ss_pred             ccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhhh
Q 007680          431 RQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQ  510 (593)
Q Consensus       431 ~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  510 (593)
                      ......++..|+|||+..+..++.++||||||+++|||++|+.||......  ..........+..              
T Consensus       174 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--~~~~~~~~~~~~~--------------  237 (292)
T cd06658         174 KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL--QAMRRIRDNLPPR--------------  237 (292)
T ss_pred             cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhcCCCc--------------
Confidence            122345889999999998888999999999999999999999998653211  1111111111100              


Q ss_pred             hhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          511 AFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       511 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                       .......+..+.+++.+||..||++|||+.|++++
T Consensus       238 -~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         238 -VKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             -cccccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence             00111234578899999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=3.3e-37  Score=311.66  Aligned_cols=270  Identities=22%  Similarity=0.283  Sum_probs=200.0

Q ss_pred             hhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhH-HHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEE
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLE-RAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVL  347 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  347 (593)
                      ++++|.+.+.||+|+||.||+|... +|+.||+|++..... .....+.+|+.+++.++|+||+++++++..++..++||
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            3578999999999999999999864 689999999875432 22345678999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCC
Q 007680          348 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGE  427 (593)
Q Consensus       348 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~  427 (593)
                      ||+. +++.+++......+++..+..++.|++.||+|||++    +|+|+||||+||+++.++.+||+|||+++......
T Consensus        83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~----~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  157 (291)
T cd07870          83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQ----HILHRDLKPQNLLISYLGELKLADFGLARAKSIPS  157 (291)
T ss_pred             eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence            9995 688877766555578889999999999999999965    49999999999999999999999999987643322


Q ss_pred             CccccccccCCccccCccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHH-HhcCC----------
Q 007680          428 DSVRQTMTMATIGYMAPEYGLEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVK-ESLPH----------  495 (593)
Q Consensus       428 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~-~~~~~----------  495 (593)
                      .  ......++..|+|||++.+. .++.++||||||+++|||++|+.||.........+.+... ...+.          
T Consensus       158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (291)
T cd07870         158 Q--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKL  235 (291)
T ss_pred             C--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhc
Confidence            1  12233578899999998754 5788999999999999999999999764332221111110 00000          


Q ss_pred             --chhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          496 --GLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       496 --~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                        ...+...................+..+.+++.+|+..||++|||+.|++.|
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h  288 (291)
T cd07870         236 PNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH  288 (291)
T ss_pred             ccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence              000000000000000000001124578899999999999999999999864

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.7e-37  Score=312.52  Aligned_cols=267  Identities=21%  Similarity=0.272  Sum_probs=199.7

Q ss_pred             ccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh--HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEec
Q 007680          273 EFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEF  349 (593)
Q Consensus       273 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  349 (593)
                      +|++.+.||+|+||.||+|... +|+.||+|.++...  ......+.+|++++++++||||+++++++.+.+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4788899999999999999975 68999999987542  22234677899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCc
Q 007680          350 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDS  429 (593)
Q Consensus       350 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~  429 (593)
                      ++ ++|.+++......+++..+..++.||++||+|||++    +++||||||+||+++.++.+||+|||+++........
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~----~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~  155 (284)
T cd07839          81 CD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH----NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC  155 (284)
T ss_pred             CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC----CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCC
Confidence            96 588888876555699999999999999999999965    5999999999999999999999999998865433221


Q ss_pred             cccccccCCccccCccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCc---hh---hhhh
Q 007680          430 VRQTMTMATIGYMAPEYGLEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHG---LT---EVVD  502 (593)
Q Consensus       430 ~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~---~~---~~~~  502 (593)
                        .....++..|+|||++.+. .++.++|||||||++|||+||..|+.........+...........   ..   +..+
T Consensus       156 --~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07839         156 --YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPD  233 (284)
T ss_pred             --cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccc
Confidence              1234578899999987764 4799999999999999999999886443222211111111000000   00   0000


Q ss_pred             hhhh----hhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          503 ANLV----REEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       503 ~~~~----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      ....    ...........++.++.+++.+||+.||.+|||++|+++|
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h  281 (284)
T cd07839         234 YKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH  281 (284)
T ss_pred             ccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence            0000    0000001112345688999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=8.3e-37  Score=312.69  Aligned_cols=195  Identities=23%  Similarity=0.312  Sum_probs=159.6

Q ss_pred             ccccCccCcccEEEEEeC---CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec--CCceEEEEeccC
Q 007680          277 CNLLGTSSFGSVYKGTIS---DGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSN--PDFKALVLEFMP  351 (593)
Q Consensus       277 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~  351 (593)
                      .++||+|+||.||+|+.+   +++.||+|.+....  ....+.+|++++++++||||+++++++..  ....+++|||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            468999999999999864   56789999986542  22456789999999999999999998854  456889999995


Q ss_pred             CCCHHHHHhhCC--------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeee----CCCCcEEEEeecc
Q 007680          352 NGSLEKWLYSHN--------YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILL----DENMVAHVSDFGI  419 (593)
Q Consensus       352 ~gsL~~~l~~~~--------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll----~~~~~~kL~Dfg~  419 (593)
                       ++|.+++....        ..+++..+..++.|++.||+|||++    +|+||||||+||++    +.++.+||+|||+
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~----~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~  158 (317)
T cd07868          84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN----WVLHRDLKPANILVMGEGPERGRVKIADMGF  158 (317)
T ss_pred             -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC----CEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence             58888875321        2488999999999999999999955    49999999999999    4567999999999


Q ss_pred             ceecCCCCCc-cccccccCCccccCccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCcc
Q 007680          420 YKLLGEGEDS-VRQTMTMATIGYMAPEYGLEG-IVSAKCDVYSYGVLLMETFTRKRPTDEM  478 (593)
Q Consensus       420 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlGvvl~elltg~~pf~~~  478 (593)
                      ++........ .......+|+.|+|||++.+. .++.++||||+||++|||++|++||...
T Consensus       159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~  219 (317)
T cd07868         159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence            9876543221 122345689999999988764 5899999999999999999999999653

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.9e-37  Score=312.44  Aligned_cols=260  Identities=23%  Similarity=0.321  Sum_probs=201.2

Q ss_pred             HHHHHHhhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhc-CCCCcceeeeeee---
Q 007680          264 YLDIQRATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNV-RHRNLIKILSSYS---  338 (593)
Q Consensus       264 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~---  338 (593)
                      +..+....++|++.+.||+|+||.||+|... +++.+|+|++.... .....+..|+.+++++ +||||+++++++.   
T Consensus        10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   88 (286)
T cd06638          10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD   88 (286)
T ss_pred             eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence            3455567889999999999999999999865 68899999886532 2235678899999999 6999999999874   


Q ss_pred             --cCCceEEEEeccCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEE
Q 007680          339 --NPDFKALVLEFMPNGSLEKWLYS---HNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAH  413 (593)
Q Consensus       339 --~~~~~~lv~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~k  413 (593)
                        .++..++||||+++++|.+++..   ....+++..+..++.|+++||.|||++    +++||||||+||++++++.+|
T Consensus        89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~nili~~~~~~k  164 (286)
T cd06638          89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN----KTIHRDVKGNNILLTTEGGVK  164 (286)
T ss_pred             cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC----CccccCCCHHhEEECCCCCEE
Confidence              34578999999999999998763   223588999999999999999999954    599999999999999999999


Q ss_pred             EEeeccceecCCCCCccccccccCCccccCccccCC-----CCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHH
Q 007680          414 VSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLE-----GIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRW  488 (593)
Q Consensus       414 L~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~  488 (593)
                      |+|||++........  ......|+..|+|||++..     ..++.++||||+||++|||++|+.||....... .....
T Consensus       165 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~-~~~~~  241 (286)
T cd06638         165 LVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR-ALFKI  241 (286)
T ss_pred             EccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH-HHhhc
Confidence            999999887643221  2233468899999998753     457899999999999999999999987532111 00000


Q ss_pred             HHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 007680          489 VKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKL  547 (593)
Q Consensus       489 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  547 (593)
                       ....+   .            ....+..++.++.+++.+||+.||++|||+.|++++.
T Consensus       242 -~~~~~---~------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~  284 (286)
T cd06638         242 -PRNPP---P------------TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV  284 (286)
T ss_pred             -cccCC---C------------cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence             00000   0            0000111245689999999999999999999999874

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=7.4e-37  Score=305.39  Aligned_cols=252  Identities=21%  Similarity=0.296  Sum_probs=188.7

Q ss_pred             cccCccCcccEEEEEeCC---CCeEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEeccCCC
Q 007680          278 NLLGTSSFGSVYKGTISD---GTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNG  353 (593)
Q Consensus       278 ~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  353 (593)
                      +.||+|+||.||+|...+   ...+|+|.+.... ......+.+|+.+++.++||||+++++.+...+..++||||+++|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            369999999999997543   4568888776442 334467889999999999999999999999999999999999999


Q ss_pred             CHHHHHhhCCC----CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCc
Q 007680          354 SLEKWLYSHNY----FLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDS  429 (593)
Q Consensus       354 sL~~~l~~~~~----~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~  429 (593)
                      +|.+++.....    ..++.....++.|++.||+|||++    +|+||||||+||++++++.+||+|||++.........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~  156 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA----DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY  156 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc----CEecccccHhheEecCCCcEEEeccccccccccchhe
Confidence            99999977543    246778899999999999999954    5999999999999999999999999998754332211


Q ss_pred             cccccccCCccccCccccC-------CCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhh
Q 007680          430 VRQTMTMATIGYMAPEYGL-------EGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVV  501 (593)
Q Consensus       430 ~~~~~~~gt~~y~aPE~~~-------~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  501 (593)
                      .......++..|+|||+..       ...++.++|||||||++|||++ |..||......+ ...........    ...
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-~~~~~~~~~~~----~~~  231 (269)
T cd05042         157 ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ-VLKQVVREQDI----KLP  231 (269)
T ss_pred             eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH-HHHHHhhccCc----cCC
Confidence            1122334567899999864       3457889999999999999999 788886532211 11111111100    000


Q ss_pred             hhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHH
Q 007680          502 DANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLK  548 (593)
Q Consensus       502 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  548 (593)
                      .+.         ....++..+.+++..|| .||++|||++||++.|.
T Consensus       232 ~~~---------~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         232 KPQ---------LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             CCc---------ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            000         01123456788899998 59999999999998763

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.5e-37  Score=306.90  Aligned_cols=240  Identities=20%  Similarity=0.314  Sum_probs=190.1

Q ss_pred             cccCccCcccEEEEEeC-C-------CCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEec
Q 007680          278 NLLGTSSFGSVYKGTIS-D-------GTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEF  349 (593)
Q Consensus       278 ~~lg~G~~g~Vy~~~~~-~-------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  349 (593)
                      +.||+|+||.||+|... .       ...+|+|.+........+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            47999999999999864 2       234888888766555567888999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCc--------EEEEeeccce
Q 007680          350 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMV--------AHVSDFGIYK  421 (593)
Q Consensus       350 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~--------~kL~Dfg~a~  421 (593)
                      +++|+|.+++...+..+++..+..++.|++.||+|||++    +|+||||||+||+++.++.        ++++|||.+.
T Consensus        81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~----~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~  156 (258)
T cd05078          81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDK----GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI  156 (258)
T ss_pred             CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence            999999999987666689999999999999999999955    5999999999999987765        6999999876


Q ss_pred             ecCCCCCccccccccCCccccCccccCCC-CCCccchHHHHHHHHHHHHhCC-CCCCccccccchHHHHHHHhcCCchhh
Q 007680          422 LLGEGEDSVRQTMTMATIGYMAPEYGLEG-IVSAKCDVYSYGVLLMETFTRK-RPTDEMFIGEMSLRRWVKESLPHGLTE  499 (593)
Q Consensus       422 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlGvvl~elltg~-~pf~~~~~~~~~~~~~~~~~~~~~~~~  499 (593)
                      ....      .....++..|+|||++.+. .++.++||||||+++|||++|. .||.......  .......        
T Consensus       157 ~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~--~~~~~~~--------  220 (258)
T cd05078         157 TVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK--KLQFYED--------  220 (258)
T ss_pred             ccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH--HHHHHHc--------
Confidence            5432      1224578889999998764 5899999999999999999985 5554421110  0000000        


Q ss_pred             hhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHH
Q 007680          500 VVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLK  548 (593)
Q Consensus       500 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  548 (593)
                               ..  ..+.....++.+++.+||+.||++|||++++++.|+
T Consensus       221 ---------~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         221 ---------RH--QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             ---------cc--cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                     00  001112356899999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=6.1e-37  Score=311.90  Aligned_cols=256  Identities=20%  Similarity=0.243  Sum_probs=199.8

Q ss_pred             hccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEE
Q 007680          272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVL  347 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  347 (593)
                      ++|++.+.||+|+||.||++... +++.||+|.+....   ......+.+|+++++.++||||+++++.+..++..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            46889999999999999999975 67899999987653   234457889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCC
Q 007680          348 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGE  427 (593)
Q Consensus       348 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~  427 (593)
                      ||+++++|.+++...+ .+++..+..++.|++.||+|||++    +++||||||+||+++.++.+||+|||.++......
T Consensus        81 e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~  155 (305)
T cd05609          81 EYVEGGDCATLLKNIG-ALPVDMARMYFAETVLALEYLHNY----GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL  155 (305)
T ss_pred             ecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC----CccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence            9999999999997765 489999999999999999999965    59999999999999999999999999886421110


Q ss_pred             C-------------ccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcC
Q 007680          428 D-------------SVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLP  494 (593)
Q Consensus       428 ~-------------~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~  494 (593)
                      .             ........++..|+|||++.+..++.++|+||||+++||+++|..||.+....+ ...........
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~-~~~~~~~~~~~  234 (305)
T cd05609         156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE-LFGQVISDDIE  234 (305)
T ss_pred             cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhcccC
Confidence            0             001112357888999999988889999999999999999999999996532111 00010000000


Q ss_pred             CchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHH
Q 007680          495 HGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKK  549 (593)
Q Consensus       495 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  549 (593)
                                      .......++.++.+++.+||+.||++||++.++.+.|+.
T Consensus       235 ----------------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         235 ----------------WPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             ----------------CCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence                            000001245678999999999999999996555554443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=5.8e-37  Score=308.79  Aligned_cols=266  Identities=22%  Similarity=0.265  Sum_probs=201.8

Q ss_pred             hccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh--HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEe
Q 007680          272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLE  348 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  348 (593)
                      ++|+..+.||+|++|.||+|..+ +|+.||+|++....  ....+.+.+|+.++++++|||++++++++......++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            46889999999999999999976 68999999986542  2233567899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCC
Q 007680          349 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGED  428 (593)
Q Consensus       349 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  428 (593)
                      |+++++|..++.... .+++..+..++.|++.||+|||+.    +++||||||+||+++.++.++|+|||++........
T Consensus        81 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~ql~~~l~~LH~~----~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  155 (286)
T cd07847          81 YCDHTVLNELEKNPR-GVPEHLIKKIIWQTLQAVNFCHKH----NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD  155 (286)
T ss_pred             ccCccHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHHC----CceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence            999988888776544 489999999999999999999964    599999999999999999999999999987654332


Q ss_pred             ccccccccCCccccCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCc---hhhhhhhh
Q 007680          429 SVRQTMTMATIGYMAPEYGLE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHG---LTEVVDAN  504 (593)
Q Consensus       429 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~  504 (593)
                        ......++..|+|||++.+ ..++.++||||||+++|||++|+.||.+....+. .... .......   .....+..
T Consensus       156 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~  231 (286)
T cd07847         156 --DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQ-LYLI-RKTLGDLIPRHQQIFSTN  231 (286)
T ss_pred             --cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHH-HHHH-HHHhCCCChHHhhhcccc
Confidence              1223357888999998766 4588999999999999999999999976432211 1111 1100000   00000000


Q ss_pred             ------hhhh----hhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          505 ------LVRE----EQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       505 ------~~~~----~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                            ....    ..........+..+.+++.+||+.+|++||++.|++.|
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~  283 (286)
T cd07847         232 QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH  283 (286)
T ss_pred             cccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence                  0000    00001112345678999999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1.7e-36  Score=300.44  Aligned_cols=249  Identities=23%  Similarity=0.338  Sum_probs=200.2

Q ss_pred             ccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh--HHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-CceEEEEe
Q 007680          273 EFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSYSNP-DFKALVLE  348 (593)
Q Consensus       273 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e  348 (593)
                      +|++.+.||+|++|.||++..+ +++.||+|.+....  ....+.+.+|++++++++|+|++++++.+... ...+++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4889999999999999999965 67899999987543  34456788999999999999999999987644 46789999


Q ss_pred             ccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCC
Q 007680          349 FMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGE  427 (593)
Q Consensus       349 ~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~  427 (593)
                      |+++++|.+++.... ..+++.++..++.|++.|+++||++    +++||||||+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~----~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~  156 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK----HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC  156 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence            999999999997643 3589999999999999999999965    49999999999999999999999999988764322


Q ss_pred             CccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhh
Q 007680          428 DSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVR  507 (593)
Q Consensus       428 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  507 (593)
                      .  ......+++.|+|||+..+..++.++||||||+++|++++|+.||......     ...........          
T Consensus       157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~-----~~~~~~~~~~~----------  219 (257)
T cd08223         157 D--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN-----SLVYRIIEGKL----------  219 (257)
T ss_pred             C--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH-----HHHHHHHhcCC----------
Confidence            2  123345788999999999999999999999999999999999998753211     11111000000          


Q ss_pred             hhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          508 EEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       508 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                          .......++.+.+++.+||+.+|++||++.+++++
T Consensus       220 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         220 ----PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             ----CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence                00112345678999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=7.5e-37  Score=302.86  Aligned_cols=249  Identities=20%  Similarity=0.314  Sum_probs=202.8

Q ss_pred             ccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh--HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEec
Q 007680          273 EFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEF  349 (593)
Q Consensus       273 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  349 (593)
                      +|++.+.||+|+||.||++... +|+.||+|.+....  ....+.+.+|+.++++++||||+++++++...+..++||||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            4888999999999999999865 68999999987542  33456789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCC
Q 007680          350 MPNGSLEKWLYSHNY-FLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGED  428 (593)
Q Consensus       350 ~~~gsL~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  428 (593)
                      +++++|.+++..... .+++.++..++.|++.|+.|||++    +++|+||+|+||+++.++.++|+|||.+........
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~----~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~  156 (256)
T cd08218          81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR----KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE  156 (256)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC----CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence            999999999876443 578999999999999999999965    599999999999999999999999999886644321


Q ss_pred             ccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhh
Q 007680          429 SVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVRE  508 (593)
Q Consensus       429 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  508 (593)
                        ......++..|+|||+..+..++.++|+|||||++|+|++|+.||.....     ...+.....            ..
T Consensus       157 --~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-----~~~~~~~~~------------~~  217 (256)
T cd08218         157 --LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM-----KNLVLKIIR------------GS  217 (256)
T ss_pred             --hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH-----HHHHHHHhc------------CC
Confidence              11234578889999999888999999999999999999999999865211     111111100            00


Q ss_pred             hhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          509 EQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       509 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      .  ...+..++.++.+++.+||+.+|++||++.|+++|
T Consensus       218 ~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         218 Y--PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             C--CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence            0  00112345678999999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=8.3e-37  Score=304.53  Aligned_cols=251  Identities=22%  Similarity=0.279  Sum_probs=196.2

Q ss_pred             hccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh-----HHHHHHHHHHHHHHhhcCCCCcceeeeeeec--CCce
Q 007680          272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL-----ERAFRSFDSECEVLRNVRHRNLIKILSSYSN--PDFK  343 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~  343 (593)
                      .+|+..+.||+|+||.||+|... +++.||+|.+....     ......+.+|+.++++++||||+++++++.+  .+..
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            46889999999999999999865 68999999986432     2344678899999999999999999998865  3567


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceec
Q 007680          344 ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLL  423 (593)
Q Consensus       344 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~  423 (593)
                      ++++||+++++|.+++..... +++..+..++.|++.||+|||+.    +++||||||+||++++++.+||+|||++...
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~~-l~~~~~~~~~~qi~~~l~~LH~~----~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~  156 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYGA-LTESVTRKYTRQILEGMSYLHSN----MIVHRDIKGANILRDSAGNVKLGDFGASKRL  156 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHhC----CeeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence            899999999999999977554 88999999999999999999954    5999999999999999999999999998765


Q ss_pred             CCCCCcc-ccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhh
Q 007680          424 GEGEDSV-RQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVD  502 (593)
Q Consensus       424 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  502 (593)
                      ....... ......++..|+|||++.+..++.++|||||||++||+++|+.||.......     .........      
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~-----~~~~~~~~~------  225 (266)
T cd06651         157 QTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA-----AIFKIATQP------  225 (266)
T ss_pred             ccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH-----HHHHHhcCC------
Confidence            4321111 1122457889999999998889999999999999999999999997632111     011000000      


Q ss_pred             hhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          503 ANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                             .....+...++.+.+++ +||..+|++||+++|+++|
T Consensus       226 -------~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h  261 (266)
T cd06651         226 -------TNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH  261 (266)
T ss_pred             -------CCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence                   00000112344567777 6888999999999999865

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-37  Score=319.16  Aligned_cols=241  Identities=23%  Similarity=0.241  Sum_probs=187.3

Q ss_pred             cCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhc---CCCCcceeeeeeecCCceEEEEeccCC
Q 007680          280 LGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNV---RHRNLIKILSSYSNPDFKALVLEFMPN  352 (593)
Q Consensus       280 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~  352 (593)
                      ||+|+||.||+|+.. +++.||+|++....   .........|..++...   +||||+++++++...+..++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999965 68999999997643   22233455666777665   699999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCcccc
Q 007680          353 GSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQ  432 (593)
Q Consensus       353 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~  432 (593)
                      |+|.+++..... +++..+..++.||++||+|||++    +|+||||||+||+++.++.+||+|||++........  ..
T Consensus        81 g~L~~~l~~~~~-~~~~~~~~~~~qil~al~~LH~~----~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~--~~  153 (330)
T cd05586          81 GELFWHLQKEGR-FSEDRAKFYIAELVLALEHLHKY----DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK--TT  153 (330)
T ss_pred             ChHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHC----CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC--Cc
Confidence            999999876554 89999999999999999999965    499999999999999999999999999875432221  12


Q ss_pred             ccccCCccccCccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhhhh
Q 007680          433 TMTMATIGYMAPEYGLEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQA  511 (593)
Q Consensus       433 ~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  511 (593)
                      ....||..|+|||++.+. .++.++|||||||++|||++|+.||......+  ..+.+..   .        .     ..
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~--~~~~i~~---~--------~-----~~  215 (330)
T cd05586         154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ--MYRNIAF---G--------K-----VR  215 (330)
T ss_pred             cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH--HHHHHHc---C--------C-----CC
Confidence            345689999999988765 48999999999999999999999996632111  1110000   0        0     00


Q ss_pred             hhhhHHHHHHHHHHHhhcccCCCCCCC----CHHHHHHH
Q 007680          512 FSAKMDCILSIMDFALDCCMESPDMRI----NMTDAAAK  546 (593)
Q Consensus       512 ~~~~~~~~~~l~~li~~cl~~dP~~RP----s~~evl~~  546 (593)
                      . ....++.++.+++.+||+.||++||    ++.++++|
T Consensus       216 ~-~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h  253 (330)
T cd05586         216 F-PKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH  253 (330)
T ss_pred             C-CCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence            0 0012345778999999999999998    46666654

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=6.9e-37  Score=306.04  Aligned_cols=255  Identities=25%  Similarity=0.369  Sum_probs=199.5

Q ss_pred             ccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh----------HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCC
Q 007680          273 EFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL----------ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPD  341 (593)
Q Consensus       273 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  341 (593)
                      +|...+.||+|+||.||+|... +|+.||+|.++...          ....+.+..|+.++++++|||++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            4777889999999999999864 68999999886421          112346788999999999999999999999999


Q ss_pred             ceEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccce
Q 007680          342 FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYK  421 (593)
Q Consensus       342 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~  421 (593)
                      ..++||||+++++|.+++.... .+++..+..++.|++.||.|||++    +++||||+|+||+++.++.++|+|||.+.
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~~~nil~~~~~~~~l~d~~~~~  156 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYG-RFEEQLVRFFTEQVLEGLAYLHSK----GILHRDLKADNLLVDADGICKISDFGISK  156 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhC----CeeecCCChhhEEEcCCCeEEEeeccccc
Confidence            9999999999999999998764 489999999999999999999964    59999999999999999999999999987


Q ss_pred             ecCCCCCccccccccCCccccCccccCCCC--CCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhh
Q 007680          422 LLGEGEDSVRQTMTMATIGYMAPEYGLEGI--VSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTE  499 (593)
Q Consensus       422 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  499 (593)
                      ...............++..|+|||.+....  ++.++|+||||+++|++++|..||......    ..... ........
T Consensus       157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~----~~~~~-~~~~~~~~  231 (272)
T cd06629         157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI----AAMFK-LGNKRSAP  231 (272)
T ss_pred             cccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH----HHHHH-hhccccCC
Confidence            654322222223345788999999877654  889999999999999999999998642211    11100 00000000


Q ss_pred             hhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          500 VVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       500 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      .+..         ....+++.++.+++.+||..+|++||++.++++|
T Consensus       232 ~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         232 PIPP---------DVSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             cCCc---------cccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence            0000         0111345688999999999999999999999876

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=7.2e-37  Score=304.67  Aligned_cols=257  Identities=25%  Similarity=0.321  Sum_probs=205.6

Q ss_pred             hccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEec
Q 007680          272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEF  349 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  349 (593)
                      ++|++.+.||.|+||+||+|... ++..+|+|++.... ....+.+.+|+++++.++|+||+++++.+..++..++|||+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            47899999999999999999965 68899999986542 23557889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCC
Q 007680          350 MPNGSLEKWLYSHN--YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGE  427 (593)
Q Consensus       350 ~~~gsL~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~  427 (593)
                      +++++|.+++....  ..+++..+..++.|++.||+|||++    +++||||+|+||++++++.++|+|||++..+....
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~----~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~  156 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN----GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG  156 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence            99999999997642  3589999999999999999999955    59999999999999999999999999988765543


Q ss_pred             Ccc--ccccccCCccccCccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhh
Q 007680          428 DSV--RQTMTMATIGYMAPEYGLEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDAN  504 (593)
Q Consensus       428 ~~~--~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  504 (593)
                      ...  ......++..|+|||++... .++.++|+||||+++|+|++|+.||...... ..+.+..... +.....     
T Consensus       157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~-~~~~~~~~~~-~~~~~~-----  229 (267)
T cd06610         157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM-KVLMLTLQND-PPSLET-----  229 (267)
T ss_pred             cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh-hhHHHHhcCC-CCCcCC-----
Confidence            321  12334588899999998776 7899999999999999999999999764221 1111111110 000000     


Q ss_pred             hhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          505 LVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       505 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                             ......++..+.+++.+||..||++||++.++++|
T Consensus       230 -------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~  264 (267)
T cd06610         230 -------GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH  264 (267)
T ss_pred             -------ccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence                   00012345678999999999999999999999875

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.9e-38  Score=321.78  Aligned_cols=245  Identities=24%  Similarity=0.379  Sum_probs=199.4

Q ss_pred             cccccCccCcccEEEEEeC-CCCeEEEEEeeh----hhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCc--eEEEEe
Q 007680          276 ECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNL----QLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDF--KALVLE  348 (593)
Q Consensus       276 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~----~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~lv~e  348 (593)
                      ...+||+|+|-+||+|.+. +|..||=-.++.    ......++|..|+.+|+.|+||||++++++|.+...  .-+|+|
T Consensus        44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE  123 (632)
T KOG0584|consen   44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE  123 (632)
T ss_pred             hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence            3468999999999999875 577776322222    124556889999999999999999999999987765  778999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC-CCcEEEEeeccceecCCCC
Q 007680          349 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDE-NMVAHVSDFGIYKLLGEGE  427 (593)
Q Consensus       349 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~-~~~~kL~Dfg~a~~~~~~~  427 (593)
                      .+..|+|..|+.+.+. .+...+..|++||++||.|||.+.  ++|+|||||-+||||+. -|.|||+|+|+|..+....
T Consensus       124 L~TSGtLr~Y~kk~~~-vn~kaik~W~RQILkGL~yLHs~~--PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~  200 (632)
T KOG0584|consen  124 LFTSGTLREYRKKHRR-VNIKAIKSWCRQILKGLVYLHSQD--PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH  200 (632)
T ss_pred             cccCCcHHHHHHHhcc-CCHHHHHHHHHHHHHHhhhhhcCC--CCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence            9999999999999886 899999999999999999999875  68999999999999984 5899999999999875433


Q ss_pred             CccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhh
Q 007680          428 DSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVR  507 (593)
Q Consensus       428 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  507 (593)
                          .....|||.|||||+.. ..|++.+||||||++++||+|+..||.+.......+.+-.....|..+..+-|     
T Consensus       201 ----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~d-----  270 (632)
T KOG0584|consen  201 ----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKD-----  270 (632)
T ss_pred             ----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCC-----
Confidence                23378999999999866 78999999999999999999999999886444333333222222222332222     


Q ss_pred             hhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          508 EEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       508 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                                  +++.+||.+|+.. .++|||+.|++++
T Consensus       271 ------------Pevr~fIekCl~~-~~~R~sa~eLL~d  296 (632)
T KOG0584|consen  271 ------------PEVREFIEKCLAT-KSERLSAKELLKD  296 (632)
T ss_pred             ------------HHHHHHHHHHhcC-chhccCHHHHhhC
Confidence                        4679999999999 9999999999975

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2e-37  Score=344.47  Aligned_cols=259  Identities=21%  Similarity=0.281  Sum_probs=201.0

Q ss_pred             HHHHhhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehh--hHHHHHHHHHHHHHHhhcCCCCcceeeeeeec--C
Q 007680          266 DIQRATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQ--LERAFRSFDSECEVLRNVRHRNLIKILSSYSN--P  340 (593)
Q Consensus       266 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~  340 (593)
                      +.....++|++.+.||+|+||.||+|+.. ++..||+|++...  .......+..|+.++++++||||++++++|..  .
T Consensus         7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~   86 (1021)
T PTZ00266          7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN   86 (1021)
T ss_pred             CCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC
Confidence            34445678999999999999999999975 6788999998753  23445678899999999999999999998854  3


Q ss_pred             CceEEEEeccCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHhcCC---CCCeEecCCCCCCeeeCC------
Q 007680          341 DFKALVLEFMPNGSLEKWLYSH---NYFLDILERLNIMIDVGSALEYLHNGHS---SVHIIHCDLKPTNILLDE------  408 (593)
Q Consensus       341 ~~~~lv~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~~~---~~~ivH~Dlkp~NIll~~------  408 (593)
                      ...++||||+++++|.+++...   ...+++..++.|+.||+.||+|||+.+.   ..+|+||||||+|||++.      
T Consensus        87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg  166 (1021)
T PTZ00266         87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG  166 (1021)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence            5689999999999999998753   2358999999999999999999996431   145999999999999964      


Q ss_pred             -----------CCcEEEEeeccceecCCCCCccccccccCCccccCccccCC--CCCCccchHHHHHHHHHHHHhCCCCC
Q 007680          409 -----------NMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLE--GIVSAKCDVYSYGVLLMETFTRKRPT  475 (593)
Q Consensus       409 -----------~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~~DvwSlGvvl~elltg~~pf  475 (593)
                                 .+.+||+|||++..+....   ......||+.|+|||++.+  ..++.++|||||||++|||+||+.||
T Consensus       167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF  243 (1021)
T PTZ00266        167 KITAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF  243 (1021)
T ss_pred             cccccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCC
Confidence                       2358999999998664322   1233468999999998854  45899999999999999999999999


Q ss_pred             CccccccchHHHHHHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          476 DEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       476 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      .....    ....+....             .. .. ......+.++.+||.+||..+|.+||++.|++.+
T Consensus       244 ~~~~~----~~qli~~lk-------------~~-p~-lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h  295 (1021)
T PTZ00266        244 HKANN----FSQLISELK-------------RG-PD-LPIKGKSKELNILIKNLLNLSAKERPSALQCLGY  295 (1021)
T ss_pred             CcCCc----HHHHHHHHh-------------cC-CC-CCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence            65321    111111000             00 00 0011235678999999999999999999999964

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=8.4e-37  Score=302.29  Aligned_cols=246  Identities=28%  Similarity=0.498  Sum_probs=198.7

Q ss_pred             hccccccccCccCcccEEEEEeCCCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEeccC
Q 007680          272 DEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMP  351 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  351 (593)
                      ++|++.+.||+|+||.||++.. +++.||+|.++...  ..+.+.+|+.++++++|||++++++++... ..++||||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence            5789999999999999999975 57889999987543  235788999999999999999999998664 4799999999


Q ss_pred             CCCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCcc
Q 007680          352 NGSLEKWLYSHNY-FLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSV  430 (593)
Q Consensus       352 ~gsL~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~  430 (593)
                      +++|.+++..... .+++..+..++.|++.||.|||++    +++||||||+||+++.++.+||+|||.+.......   
T Consensus        82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~----~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~---  154 (254)
T cd05083          82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK----KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV---  154 (254)
T ss_pred             CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC----CeeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence            9999999976543 588999999999999999999965    59999999999999999999999999987643221   


Q ss_pred             ccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhh
Q 007680          431 RQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREE  509 (593)
Q Consensus       431 ~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  509 (593)
                        .....+..|+|||++.+..++.++|+||||+++|||++ |+.||......+  .......            ..    
T Consensus       155 --~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~------------~~----  214 (254)
T cd05083         155 --DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE--VKECVEK------------GY----  214 (254)
T ss_pred             --CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH--HHHHHhC------------CC----
Confidence              11234567999999988899999999999999999998 999987632211  1111110            00    


Q ss_pred             hhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHH
Q 007680          510 QAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKK  549 (593)
Q Consensus       510 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  549 (593)
                       .......++..+.+++.+||+.+|++||+++++++.|++
T Consensus       215 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         215 -RMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             -CCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence             001112345678999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1e-36  Score=302.18  Aligned_cols=237  Identities=22%  Similarity=0.368  Sum_probs=189.6

Q ss_pred             cccCccCcccEEEEEeCC-C----------CeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEE
Q 007680          278 NLLGTSSFGSVYKGTISD-G----------TDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALV  346 (593)
Q Consensus       278 ~~lg~G~~g~Vy~~~~~~-~----------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  346 (593)
                      +.||+|+||.||+|.+.+ +          ..+++|.+...... ...+.+|+.++++++||||+++++++.. +..++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            469999999999999763 3          25788887655433 5788899999999999999999999888 778999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC-------cEEEEeecc
Q 007680          347 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENM-------VAHVSDFGI  419 (593)
Q Consensus       347 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~-------~~kL~Dfg~  419 (593)
                      |||+++|+|.+++......+++..+..++.|++.||+|||++    +|+||||||+||+++.++       .+||+|||+
T Consensus        79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~----~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~  154 (259)
T cd05037          79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDK----KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI  154 (259)
T ss_pred             EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhC----CeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence            999999999999987665689999999999999999999954    599999999999999887       799999999


Q ss_pred             ceecCCCCCccccccccCCccccCccccCCC--CCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCc
Q 007680          420 YKLLGEGEDSVRQTMTMATIGYMAPEYGLEG--IVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHG  496 (593)
Q Consensus       420 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~  496 (593)
                      +.....      .....++..|+|||++.+.  .++.++||||||+++||+++ |..||......  ....+....  ..
T Consensus       155 a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~--~~~~~~~~~--~~  224 (259)
T cd05037         155 PITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS--EKERFYQDQ--HR  224 (259)
T ss_pred             cccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch--hHHHHHhcC--CC
Confidence            886543      1223467789999998776  78999999999999999999 57777664211  111111100  00


Q ss_pred             hhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 007680          497 LTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKL  547 (593)
Q Consensus       497 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  547 (593)
                               ..        ......+.+++.+||..+|.+|||+.|+++.|
T Consensus       225 ---------~~--------~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l  258 (259)
T cd05037         225 ---------LP--------MPDCAELANLINQCWTYDPTKRPSFRAILRDL  258 (259)
T ss_pred             ---------CC--------CCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence                     00        00014789999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-38  Score=322.29  Aligned_cols=252  Identities=25%  Similarity=0.388  Sum_probs=210.4

Q ss_pred             hccccccccCccCcccEEEEEeC--CC--CeEEEEEeehhhHH-HHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEE
Q 007680          272 DEFNECNLLGTSSFGSVYKGTIS--DG--TDVAIKVFNLQLER-AFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALV  346 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  346 (593)
                      ++....+.||+|.||+|++|.|.  .|  ..||||.++..... ...+|.+|+.+|.+++|||++++||+..+ ....+|
T Consensus       110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV  188 (1039)
T KOG0199|consen  110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV  188 (1039)
T ss_pred             HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence            34556789999999999999985  33  45899999876533 67899999999999999999999999887 667899


Q ss_pred             EeccCCCCHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCC
Q 007680          347 LEFMPNGSLEKWLYS-HNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGE  425 (593)
Q Consensus       347 ~e~~~~gsL~~~l~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~  425 (593)
                      ||.++.|+|.+.+++ ....+-......++.|||.||+||..    .++|||||...|+++-....+||+|||+.+.++.
T Consensus       189 ~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLes----krlvHRDLAARNlllasprtVKI~DFGLmRaLg~  264 (1039)
T KOG0199|consen  189 FELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLES----KRLVHRDLAARNLLLASPRTVKICDFGLMRALGE  264 (1039)
T ss_pred             hhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhh----hhhhhhhhhhhhheecccceeeeecccceeccCC
Confidence            999999999999998 34467888889999999999999994    5599999999999999999999999999999987


Q ss_pred             CCCcccc-ccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhhhh
Q 007680          426 GEDSVRQ-TMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDA  503 (593)
Q Consensus       426 ~~~~~~~-~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  503 (593)
                      +++.... ....-...|+|||.+....++.++|||+|||++|||+| |+.||.+....  .            +.+.+| 
T Consensus       265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~--q------------IL~~iD-  329 (1039)
T KOG0199|consen  265 NEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI--Q------------ILKNID-  329 (1039)
T ss_pred             CCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH--H------------HHHhcc-
Confidence            7665432 23345678999999999999999999999999999999 88999773211  1            111122 


Q ss_pred             hhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 007680          504 NLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKL  547 (593)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  547 (593)
                          +..+.+.+..|++++++++.+||..+|++|||+..+.+.+
T Consensus       330 ----~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~  369 (1039)
T KOG0199|consen  330 ----AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL  369 (1039)
T ss_pred             ----ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence                2334556678899999999999999999999999997554

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=4e-37  Score=312.00  Aligned_cols=249  Identities=21%  Similarity=0.296  Sum_probs=200.1

Q ss_pred             ccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEeccC
Q 007680          273 EFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMP  351 (593)
Q Consensus       273 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  351 (593)
                      .|+....||+|+||.||+|... +++.||+|.+........+.+.+|+.++..++||||+++++++..++..++||||++
T Consensus        22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~  101 (297)
T cd06659          22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQ  101 (297)
T ss_pred             hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCC
Confidence            3444568999999999999865 689999999976544455678899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCccc
Q 007680          352 NGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVR  431 (593)
Q Consensus       352 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~  431 (593)
                      +++|.+++...  .+++..+..++.|++.||+|||++    +++||||||+||+++.++.+||+|||++........  .
T Consensus       102 ~~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~----~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~  173 (297)
T cd06659         102 GGALTDIVSQT--RLNEEQIATVCESVLQALCYLHSQ----GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--K  173 (297)
T ss_pred             CCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHeEEccCCcEEEeechhHhhcccccc--c
Confidence            99999987653  389999999999999999999955    499999999999999999999999999875543221  1


Q ss_pred             cccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhhhh
Q 007680          432 QTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQA  511 (593)
Q Consensus       432 ~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  511 (593)
                      .....++..|+|||++.+..++.++|||||||++|||++|+.||......  ..........+..               
T Consensus       174 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--~~~~~~~~~~~~~---------------  236 (297)
T cd06659         174 RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV--QAMKRLRDSPPPK---------------  236 (297)
T ss_pred             ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHhccCCCC---------------
Confidence            23346889999999998888999999999999999999999999653211  1111111110000               


Q ss_pred             hhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          512 FSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       512 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      .......+..+.+++.+||+.+|++||++.+++++
T Consensus       237 ~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         237 LKNAHKISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             ccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            00011234568999999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=5.4e-37  Score=308.56  Aligned_cols=260  Identities=22%  Similarity=0.301  Sum_probs=203.5

Q ss_pred             CCHHHHHHhhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhc-CCCCcceeeeeeec
Q 007680          262 TSYLDIQRATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNV-RHRNLIKILSSYSN  339 (593)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  339 (593)
                      .+..++....+.|++.+.||+|+||.||+|... +++.+|+|++..... ....+..|+.++.++ +|+||+++++++..
T Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   84 (282)
T cd06636           6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED-EEEEIKLEINMLKKYSHHRNIATYYGAFIK   84 (282)
T ss_pred             hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH-HHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence            355666667889999999999999999999974 688999999876532 345688899999998 79999999998853


Q ss_pred             ------CCceEEEEeccCCCCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcE
Q 007680          340 ------PDFKALVLEFMPNGSLEKWLYSHNY-FLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVA  412 (593)
Q Consensus       340 ------~~~~~lv~e~~~~gsL~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~  412 (593)
                            .+..+++|||+++|+|.+++..... .+++..+..++.|++.||+|||++    +++|+||||+||++++++.+
T Consensus        85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~----~ivH~dl~~~nili~~~~~~  160 (282)
T cd06636          85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH----KVIHRDIKGQNVLLTENAEV  160 (282)
T ss_pred             ccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCE
Confidence                  4578999999999999999976443 578888999999999999999965    49999999999999999999


Q ss_pred             EEEeeccceecCCCCCccccccccCCccccCccccC-----CCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHH
Q 007680          413 HVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGL-----EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRR  487 (593)
Q Consensus       413 kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~  487 (593)
                      +|+|||++........  ......++..|+|||.+.     +..++.++|||||||++|||++|+.||.......... .
T Consensus       161 ~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~-~  237 (282)
T cd06636         161 KLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF-L  237 (282)
T ss_pred             EEeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh-h
Confidence            9999999876532211  123346888999999875     3468889999999999999999999996532111000 0


Q ss_pred             HHHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          488 WVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       488 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                       ....                .........++.++.+++.+||..||.+||++.|++++
T Consensus       238 -~~~~----------------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~  279 (282)
T cd06636         238 -IPRN----------------PPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH  279 (282)
T ss_pred             -HhhC----------------CCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence             0000                00000111345688999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.9e-37  Score=306.54  Aligned_cols=253  Identities=25%  Similarity=0.353  Sum_probs=200.3

Q ss_pred             hhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhc-CCCCcceeeeeeecCC------
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNV-RHRNLIKILSSYSNPD------  341 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~------  341 (593)
                      .+++|++.+.||+|++|.||+|..+ +++.+++|++..... ..+.+.+|+.+++++ +|+||+++++++....      
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD   82 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence            4689999999999999999999975 678999999876543 346789999999999 7999999999987644      


Q ss_pred             ceEEEEeccCCCCHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeec
Q 007680          342 FKALVLEFMPNGSLEKWLYSHN---YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFG  418 (593)
Q Consensus       342 ~~~lv~e~~~~gsL~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg  418 (593)
                      ..++||||+++++|.+++....   ..+++..+..++.|++.||+|||++    +++|+||+|+||++++++.++|+|||
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~----~i~H~~l~p~ni~~~~~~~~~l~d~~  158 (275)
T cd06608          83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN----KVIHRDIKGQNILLTKNAEVKLVDFG  158 (275)
T ss_pred             EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC----CcccCCCCHHHEEEccCCeEEECCCc
Confidence            4899999999999999887533   4689999999999999999999954    59999999999999999999999999


Q ss_pred             cceecCCCCCccccccccCCccccCccccCC-----CCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhc
Q 007680          419 IYKLLGEGEDSVRQTMTMATIGYMAPEYGLE-----GIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESL  493 (593)
Q Consensus       419 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~  493 (593)
                      .+........  ......++..|+|||++..     ..++.++|||||||++|+|++|+.||....... ....... ..
T Consensus       159 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~-~~  234 (275)
T cd06608         159 VSAQLDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR-ALFKIPR-NP  234 (275)
T ss_pred             cceecccchh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH-HHHHhhc-cC
Confidence            9876543221  2233458889999998753     347889999999999999999999996532111 1111100 00


Q ss_pred             CCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          494 PHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       494 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      +               ........++.++.+++.+||..||++|||+.|++++
T Consensus       235 ~---------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~  272 (275)
T cd06608         235 P---------------PTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH  272 (275)
T ss_pred             C---------------CCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            0               0011112345678999999999999999999999864

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.4e-36  Score=303.27  Aligned_cols=252  Identities=24%  Similarity=0.369  Sum_probs=200.4

Q ss_pred             ccccccccCccCcccEEEEEeCC--CCeEEEEEeehh----------hHHHHHHHHHHHHHHhh-cCCCCcceeeeeeec
Q 007680          273 EFNECNLLGTSSFGSVYKGTISD--GTDVAIKVFNLQ----------LERAFRSFDSECEVLRN-VRHRNLIKILSSYSN  339 (593)
Q Consensus       273 ~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~  339 (593)
                      +|++.+.||+|+||.||+|..+.  ++.+|+|.+...          .......+..|+.++.+ ++||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47888999999999999999764  688999988632          12334567788888875 699999999999999


Q ss_pred             CCceEEEEeccCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEe
Q 007680          340 PDFKALVLEFMPNGSLEKWLYS---HNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSD  416 (593)
Q Consensus       340 ~~~~~lv~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~D  416 (593)
                      .+..+++|||+++++|.+++..   ....+++..++.++.|++.||.|||+.   .+++|+||+|+||++++++.+||+|
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~~i~H~dl~~~nil~~~~~~~~l~d  157 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE---KRIVHRDLTPNNIMLGEDDKVTITD  157 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC---CceeecCCCHHHEEECCCCcEEEec
Confidence            9999999999999999998754   333589999999999999999999952   3599999999999999999999999


Q ss_pred             eccceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCc
Q 007680          417 FGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHG  496 (593)
Q Consensus       417 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  496 (593)
                      ||.+.......   ......++..|+|||...+..++.++||||||+++|+|++|+.||......  .........    
T Consensus       158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~--~~~~~~~~~----  228 (269)
T cd08528         158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML--SLATKIVEA----  228 (269)
T ss_pred             ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH--HHHHHHhhc----
Confidence            99988754432   223456888999999999888999999999999999999999998652111  111111100    


Q ss_pred             hhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHH
Q 007680          497 LTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLK  548 (593)
Q Consensus       497 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  548 (593)
                             ....     .....+++.+.+++.+||+.||++||++.|+.++++
T Consensus       229 -------~~~~-----~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         229 -------VYEP-----LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             -------cCCc-----CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence                   0000     001123467899999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.5e-36  Score=300.72  Aligned_cols=248  Identities=27%  Similarity=0.345  Sum_probs=200.9

Q ss_pred             ccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh-----HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEE
Q 007680          273 EFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL-----ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALV  346 (593)
Q Consensus       273 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  346 (593)
                      +|+..+.||+|++|.||+|... +++.|++|.+....     ....+.+.+|+++++.++|+||+++++++...+..+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4677889999999999999976 78999999987543     23456789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCC
Q 007680          347 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG  426 (593)
Q Consensus       347 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  426 (593)
                      +||+++++|.+++.... .+++..+..++.|++.|++|||+.    +++|+||+|+||+++.++.+||+|||.+......
T Consensus        81 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~  155 (258)
T cd06632          81 LELVPGGSLAKLLKKYG-SFPEPVIRLYTRQILLGLEYLHDR----NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF  155 (258)
T ss_pred             EEecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence            99999999999998765 388999999999999999999965    4999999999999999999999999998865433


Q ss_pred             CCccccccccCCccccCccccCCCC-CCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhh
Q 007680          427 EDSVRQTMTMATIGYMAPEYGLEGI-VSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANL  505 (593)
Q Consensus       427 ~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  505 (593)
                      .   ......++..|+|||...... ++.++|+||||+++|+|++|+.||....... .........             
T Consensus       156 ~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~-------------  218 (258)
T cd06632         156 S---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA-AVFKIGRSK-------------  218 (258)
T ss_pred             c---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH-HHHHHHhcc-------------
Confidence            2   123345888999999887766 8999999999999999999999997642110 000000000             


Q ss_pred             hhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          506 VREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                          .....+..++..+.+++.+||+.+|++||++.+++.+
T Consensus       219 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  255 (258)
T cd06632         219 ----ELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH  255 (258)
T ss_pred             ----cCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence                0000111234678999999999999999999999864

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.4e-36  Score=300.78  Aligned_cols=250  Identities=29%  Similarity=0.501  Sum_probs=201.7

Q ss_pred             cccccccCccCcccEEEEEeCC-----CCeEEEEEeehhhHH-HHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEE
Q 007680          274 FNECNLLGTSSFGSVYKGTISD-----GTDVAIKVFNLQLER-AFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVL  347 (593)
Q Consensus       274 ~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  347 (593)
                      +++.+.||+|+||.||+++..+     +..||+|+++..... ..+.+..|+.++..++|+||+++++++.+.+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            3567899999999999999753     388999999765432 5678899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCC
Q 007680          348 EFMPNGSLEKWLYSHNYF-LDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG  426 (593)
Q Consensus       348 e~~~~gsL~~~l~~~~~~-l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  426 (593)
                      ||+++++|.+++...... +++..+..++.|++.||+|||+.    +++|+||||+||++++++.++|+|||.+......
T Consensus        81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~----~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  156 (258)
T smart00219       81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK----NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD  156 (258)
T ss_pred             eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC----CeeecccccceEEEccCCeEEEcccCCceecccc
Confidence            999999999999876544 89999999999999999999954    5999999999999999999999999999876554


Q ss_pred             CCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhhhhhh
Q 007680          427 EDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANL  505 (593)
Q Consensus       427 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  505 (593)
                      .... .....++..|+|||...+..++.++||||+|+++|+|++ |..||.....  ....+.......           
T Consensus       157 ~~~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~--~~~~~~~~~~~~-----------  222 (258)
T smart00219      157 DYYK-KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN--EEVLEYLKKGYR-----------  222 (258)
T ss_pred             cccc-cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHhcCCC-----------
Confidence            2211 112336788999999888889999999999999999998 8888865211  111111111100           


Q ss_pred             hhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 007680          506 VREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKL  547 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  547 (593)
                            ......++.++.+++.+||..||++|||+.|+++.|
T Consensus       223 ------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      223 ------LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             ------CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence                  001112456789999999999999999999998764

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1e-36  Score=307.88  Aligned_cols=245  Identities=24%  Similarity=0.295  Sum_probs=201.2

Q ss_pred             hccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEE
Q 007680          272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVL  347 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  347 (593)
                      ++|++.+.||+|++|.||++... +++.||+|++....   ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            46899999999999999999965 68999999997643   234567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCC
Q 007680          348 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGE  427 (593)
Q Consensus       348 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~  427 (593)
                      ||+++++|.+++.... .+++..+..++.|++.||.|||+.    +++|+||+|+||+++.++.+||+|||++...... 
T Consensus        81 e~~~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~l~~lH~~----~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-  154 (290)
T cd05580          81 EYVPGGELFSHLRKSG-RFPEPVARFYAAQVVLALEYLHSL----DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-  154 (290)
T ss_pred             ecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC----CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence            9999999999998765 489999999999999999999964    5999999999999999999999999998876443 


Q ss_pred             CccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhh
Q 007680          428 DSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVR  507 (593)
Q Consensus       428 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  507 (593)
                          .....+++.|+|||.+.+...+.++||||||+++|+|++|+.||.....  ....+.....           .   
T Consensus       155 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~-----------~---  214 (290)
T cd05580         155 ----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP--IQIYEKILEG-----------K---  214 (290)
T ss_pred             ----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHhcC-----------C---
Confidence                2234588999999999888899999999999999999999999976321  1111111000           0   


Q ss_pred             hhhhhhhhHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHHH
Q 007680          508 EEQAFSAKMDCILSIMDFALDCCMESPDMRI-----NMTDAAAK  546 (593)
Q Consensus       508 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  546 (593)
                          ...+...+..+.+++.+||..||.+||     +++|+++|
T Consensus       215 ----~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~  254 (290)
T cd05580         215 ----VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH  254 (290)
T ss_pred             ----ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence                000112245789999999999999999     77777655

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=7.1e-37  Score=309.57  Aligned_cols=251  Identities=23%  Similarity=0.318  Sum_probs=204.2

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEec
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEF  349 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  349 (593)
                      .++|.+.+.||+|+||.||++... +++.||+|.+........+.+.+|+.++++++||||+++++.+...+..++|+||
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~   97 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY   97 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence            468999999999999999999864 6889999998765545557788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCc
Q 007680          350 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDS  429 (593)
Q Consensus       350 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~  429 (593)
                      +++++|.+++.+..  +++.++..++.|++.||.|||++    +++|+||||+||+++.++.++|+|||++........ 
T Consensus        98 ~~~~~L~~~~~~~~--l~~~~~~~i~~~l~~al~~LH~~----gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-  170 (293)
T cd06647          98 LAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLHSN----QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-  170 (293)
T ss_pred             CCCCcHHHHHhhcC--CCHHHHHHHHHHHHHHHHHHHhC----CEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-
Confidence            99999999987653  78999999999999999999955    599999999999999999999999998876543322 


Q ss_pred             cccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhh
Q 007680          430 VRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREE  509 (593)
Q Consensus       430 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  509 (593)
                       ......+++.|+|||.+.+..++.++||||||+++|++++|+.||......... . ....               ...
T Consensus       171 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~-~-~~~~---------------~~~  232 (293)
T cd06647         171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-Y-LIAT---------------NGT  232 (293)
T ss_pred             -ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhe-e-ehhc---------------CCC
Confidence             122345888999999998888999999999999999999999999753211100 0 0000               000


Q ss_pred             hhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          510 QAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       510 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      .........+..+.+++.+||..+|++||++.+++.|
T Consensus       233 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         233 PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0111122335578999999999999999999999977

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1.4e-36  Score=302.78  Aligned_cols=251  Identities=22%  Similarity=0.279  Sum_probs=197.4

Q ss_pred             hccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh-----HHHHHHHHHHHHHHhhcCCCCcceeeeeeecC--Cce
Q 007680          272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL-----ERAFRSFDSECEVLRNVRHRNLIKILSSYSNP--DFK  343 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  343 (593)
                      ++|++.+.||+|+||.||+|... +++.||+|.+....     ....+.+.+|+.++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            47889999999999999999865 68999999886431     23456788999999999999999999988764  467


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceec
Q 007680          344 ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLL  423 (593)
Q Consensus       344 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~  423 (593)
                      +++|||+++++|.+++..... +++..+..++.|++.||+|||++    +++|+||||+||+++.++.++|+|||.+...
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~l~~~l~~lH~~----~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~  156 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYGA-LTENVTRKYTRQILEGVSYLHSN----MIVHRDIKGANILRDSVGNVKLGDFGASKRL  156 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHhC----CEecCCCCHHHEEecCCCCEEECcCcccccc
Confidence            899999999999999976644 78899999999999999999965    4999999999999999999999999998865


Q ss_pred             CCCCCcc-ccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhh
Q 007680          424 GEGEDSV-RQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVD  502 (593)
Q Consensus       424 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  502 (593)
                      ....... ......++..|+|||++.+..++.++|||||||++|||++|+.||....... ...+    .....      
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-~~~~----~~~~~------  225 (265)
T cd06652         157 QTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA-AIFK----IATQP------  225 (265)
T ss_pred             ccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH-HHHH----HhcCC------
Confidence            4321111 1223458889999999988889999999999999999999999997531111 1100    00000      


Q ss_pred             hhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          503 ANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                             .....+...+..+.+++.+|+. +|++||+++|++++
T Consensus       226 -------~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~  261 (265)
T cd06652         226 -------TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH  261 (265)
T ss_pred             -------CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence                   0000112234567899999995 99999999999865

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=6.9e-37  Score=309.29  Aligned_cols=259  Identities=25%  Similarity=0.327  Sum_probs=201.4

Q ss_pred             HHHHHHhhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhc-CCCCcceeeeeeecC-
Q 007680          264 YLDIQRATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNV-RHRNLIKILSSYSNP-  340 (593)
Q Consensus       264 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-  340 (593)
                      ..++....++|++.+.||+|+||.||++..+ +++.+|+|++.... .....+.+|+.+++++ +|||++++++++... 
T Consensus        14 ~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~   92 (291)
T cd06639          14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKAD   92 (291)
T ss_pred             cccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecc
Confidence            3455566889999999999999999999974 68899999986542 2235677899999999 899999999988653 


Q ss_pred             ----CceEEEEeccCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEE
Q 007680          341 ----DFKALVLEFMPNGSLEKWLYS---HNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAH  413 (593)
Q Consensus       341 ----~~~~lv~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~k  413 (593)
                          +..++||||+++++|.+++..   ....+++..+..++.|++.||+|||++    +++||||||+||++++++.+|
T Consensus        93 ~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~----~ivH~dlkp~nili~~~~~~k  168 (291)
T cd06639          93 KLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN----RIIHRDVKGNNILLTTEGGVK  168 (291)
T ss_pred             ccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHEEEcCCCCEE
Confidence                358999999999999998864   233589999999999999999999965    599999999999999999999


Q ss_pred             EEeeccceecCCCCCccccccccCCccccCccccCCC-----CCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHH
Q 007680          414 VSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEG-----IVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRW  488 (593)
Q Consensus       414 L~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~  488 (593)
                      |+|||.+........  ......++..|+|||++...     .++.++|||||||++|||++|+.||....... ...++
T Consensus       169 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~-~~~~~  245 (291)
T cd06639         169 LVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK-TLFKI  245 (291)
T ss_pred             Eeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH-HHHHH
Confidence            999999886543221  12234578899999987543     36889999999999999999999997632211 11111


Q ss_pred             HHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          489 VKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       489 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      .. ..+.   .            ..........+.+++.+||+.+|++||++.|+++|
T Consensus       246 ~~-~~~~---~------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         246 PR-NPPP---T------------LLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             hc-CCCC---C------------CCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            10 0000   0            00011234568999999999999999999999876

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1.5e-36  Score=303.76  Aligned_cols=254  Identities=24%  Similarity=0.435  Sum_probs=199.0

Q ss_pred             cccccccCccCcccEEEEEeC----CCCeEEEEEeehh--hHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCC------
Q 007680          274 FNECNLLGTSSFGSVYKGTIS----DGTDVAIKVFNLQ--LERAFRSFDSECEVLRNVRHRNLIKILSSYSNPD------  341 (593)
Q Consensus       274 ~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  341 (593)
                      |.+.+.||+|+||.||+|.+.    +++.||+|++...  .....+.+.+|++++++++||||+++++++...+      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            567789999999999999853    4688999998754  2344567889999999999999999999886542      


Q ss_pred             ceEEEEeccCCCCHHHHHhhCC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEe
Q 007680          342 FKALVLEFMPNGSLEKWLYSHN-----YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSD  416 (593)
Q Consensus       342 ~~~lv~e~~~~gsL~~~l~~~~-----~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~D  416 (593)
                      ..++++||+.+|+|.+++....     ..+++..+..++.|++.||+|||+.    +|+||||||+||++++++.+||+|
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~----~i~H~dikp~nili~~~~~~kl~d  156 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK----NFIHRDLAARNCMLNENMTVCVAD  156 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC----CEeecccchhhEEEcCCCCEEECc
Confidence            2478899999999998875321     2478899999999999999999954    599999999999999999999999


Q ss_pred             eccceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCC
Q 007680          417 FGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPH  495 (593)
Q Consensus       417 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~  495 (593)
                      ||.++...............++..|++||.+.+..++.++||||||+++|||++ |+.||.....  .....+...... 
T Consensus       157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~--~~~~~~~~~~~~-  233 (273)
T cd05074         157 FGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN--SEIYNYLIKGNR-  233 (273)
T ss_pred             ccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH--HHHHHHHHcCCc-
Confidence            999887644332222223345678999999988889999999999999999999 8899865322  111111111000 


Q ss_pred             chhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHh
Q 007680          496 GLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKI  550 (593)
Q Consensus       496 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  550 (593)
                                      ......++..+.+++.+||+.+|++||++.|+++.|+++
T Consensus       234 ----------------~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         234 ----------------LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             ----------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                            001112356789999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=3.4e-36  Score=300.54  Aligned_cols=252  Identities=19%  Similarity=0.291  Sum_probs=186.4

Q ss_pred             cccCccCcccEEEEEeCCC---CeEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEeccCCC
Q 007680          278 NLLGTSSFGSVYKGTISDG---TDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNG  353 (593)
Q Consensus       278 ~~lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  353 (593)
                      +.||+|+||.||++...++   ..+++|.++... ....+.+.+|+.+++.++||||+++++.+......++||||+++|
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            3699999999999975433   345667665432 334568899999999999999999999999999999999999999


Q ss_pred             CHHHHHhhCCC---CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCcc
Q 007680          354 SLEKWLYSHNY---FLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSV  430 (593)
Q Consensus       354 sL~~~l~~~~~---~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~  430 (593)
                      +|.+++.+...   ..++..+..++.|+++||+|||+.    +++||||||+||+++.++.++|+|||++..........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~----~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~  156 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH----NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE  156 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC----CeeccCCccceEEEcCCccEEecccccccccCcchhhh
Confidence            99999976432   356777889999999999999965    49999999999999999999999999876432211111


Q ss_pred             ccccccCCccccCccccCC-------CCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhhh
Q 007680          431 RQTMTMATIGYMAPEYGLE-------GIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVD  502 (593)
Q Consensus       431 ~~~~~~gt~~y~aPE~~~~-------~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  502 (593)
                      ......++..|+|||++..       ..++.++||||||+++|||++ |..||...... ..+........    ....+
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-~~~~~~~~~~~----~~~~~  231 (268)
T cd05086         157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR-EVLNHVIKDQQ----VKLFK  231 (268)
T ss_pred             cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHhhcc----cccCC
Confidence            1233457889999998743       245789999999999999997 56787653211 11111111110    01111


Q ss_pred             hhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHH
Q 007680          503 ANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLK  548 (593)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  548 (593)
                      +.+         .....+.+.+++..|| .+|++||+++++++.|.
T Consensus       232 ~~~---------~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         232 PQL---------ELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             Ccc---------CCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            111         0113456788999999 67999999999998774

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=7.8e-37  Score=307.91  Aligned_cols=267  Identities=24%  Similarity=0.292  Sum_probs=201.7

Q ss_pred             hccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh--HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEe
Q 007680          272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLE  348 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  348 (593)
                      ++|++.+.||+|+||.||+|.++ +++.||+|++....  ....+.+.+|+++++.++||||+++++++..++..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            46889999999999999999976 68999999886542  2234568889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCC
Q 007680          349 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGED  428 (593)
Q Consensus       349 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  428 (593)
                      |+++++|.++...... +++.++..++.|++.||+|||+.    +++|+||+|+||++++++.++|+|||++........
T Consensus        81 ~~~~~~l~~~~~~~~~-~~~~~~~~~~~~i~~~l~~LH~~----~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~  155 (286)
T cd07846          81 FVDHTVLDDLEKYPNG-LDESRVRKYLFQILRGIEFCHSH----NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE  155 (286)
T ss_pred             cCCccHHHHHHhccCC-CCHHHHHHHHHHHHHHHHHHHHC----CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc
Confidence            9999989887765443 89999999999999999999965    599999999999999999999999999887644322


Q ss_pred             ccccccccCCccccCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHH--HHhcCCchhhhhhhh-
Q 007680          429 SVRQTMTMATIGYMAPEYGLE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWV--KESLPHGLTEVVDAN-  504 (593)
Q Consensus       429 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~-  504 (593)
                        ......++..|+|||+..+ ..++.++||||||+++|||++|++||......+ ...+..  ............+.. 
T Consensus       156 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07846         156 --VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDID-QLYHIIKCLGNLIPRHQEIFQKNP  232 (286)
T ss_pred             --ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHH-HHHHHHHHhCCCchhhHHHhccch
Confidence              1223457889999998765 457889999999999999999999986532111 111100  001111111111000 


Q ss_pred             ---------hhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          505 ---------LVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       505 ---------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                               .............++..+.+++.+||..+|++||++.+++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  283 (286)
T cd07846         233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH  283 (286)
T ss_pred             HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence                     000000011112346789999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7e-38  Score=327.01  Aligned_cols=258  Identities=26%  Similarity=0.403  Sum_probs=220.3

Q ss_pred             ccccccccCccCcccEEEEEe-CCC----CeEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEE
Q 007680          273 EFNECNLLGTSSFGSVYKGTI-SDG----TDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALV  346 (593)
Q Consensus       273 ~~~~~~~lg~G~~g~Vy~~~~-~~~----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  346 (593)
                      .....++||+|+||+||+|.+ ..|    -+||+|++.... .+...++.+|+-+|.+++|||++++++++.... ..||
T Consensus       697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv  775 (1177)
T KOG1025|consen  697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV  775 (1177)
T ss_pred             hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence            345568999999999999985 333    468999987643 445678999999999999999999999998876 7899


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCC
Q 007680          347 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG  426 (593)
Q Consensus       347 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  426 (593)
                      ++|++.|+|.++++.++..+.....+.|..|||+||.|||++.    ++||||..+||||.+-..+|+.|||+++.+..+
T Consensus       776 tq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qr----lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d  851 (1177)
T KOG1025|consen  776 TQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQR----LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD  851 (1177)
T ss_pred             HHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcc----hhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence            9999999999999999988999999999999999999999654    999999999999999999999999999998877


Q ss_pred             CCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhhhhhh
Q 007680          427 EDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANL  505 (593)
Q Consensus       427 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  505 (593)
                      ..........-.+.|||-|.+....|+.++|||||||++||++| |..|+++....+.              .     .+
T Consensus       852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI--------------~-----dl  912 (1177)
T KOG1025|consen  852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEI--------------P-----DL  912 (1177)
T ss_pred             cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHh--------------h-----HH
Confidence            76555444455778999999999999999999999999999999 9999987532221              1     12


Q ss_pred             hhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhhh
Q 007680          506 VREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKF  554 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  554 (593)
                      .+...+.+++..|+.++..++.+||..|++.||+++++.+.+.++..+.
T Consensus       913 le~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardp  961 (1177)
T KOG1025|consen  913 LEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDP  961 (1177)
T ss_pred             HhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCc
Confidence            2333446667778899999999999999999999999999999887654

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.5e-36  Score=307.89  Aligned_cols=265  Identities=24%  Similarity=0.296  Sum_probs=200.8

Q ss_pred             ccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhH-----HHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEE
Q 007680          273 EFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLE-----RAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALV  346 (593)
Q Consensus       273 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  346 (593)
                      +|++.+.||+|++|.||+|... +++.||+|.++....     .....+..|++++++++|+||+++++++.+.+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4778899999999999999965 689999999976532     2344577899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCC
Q 007680          347 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG  426 (593)
Q Consensus       347 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  426 (593)
                      |||+ +++|.+++......+++..+..++.|+++||+|||++    +++|+||||+||+++.++.++|+|||++......
T Consensus        81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~----~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~  155 (298)
T cd07841          81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSN----WILHRDLKPNNLLIASDGVLKLADFGLARSFGSP  155 (298)
T ss_pred             Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC----CeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence            9999 8999999987654599999999999999999999955    5999999999999999999999999999876543


Q ss_pred             CCccccccccCCccccCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCc----hh---
Q 007680          427 EDSVRQTMTMATIGYMAPEYGLE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHG----LT---  498 (593)
Q Consensus       427 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~----~~---  498 (593)
                      ...  .....++..|+|||.+.+ ..++.++|||||||++|||++|.+||...... ..+.+... .....    ..   
T Consensus       156 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~  231 (298)
T cd07841         156 NRK--MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI-DQLGKIFE-ALGTPTEENWPGVT  231 (298)
T ss_pred             Ccc--ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH-HHHHHHHH-HcCCCchhhhhhcc
Confidence            221  122346788999998754 45789999999999999999998877653221 11111111 11000    00   


Q ss_pred             ---hhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          499 ---EVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       499 ---~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                         ....................+.++.+++.+||+.||++|||+.|++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             cccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence               000000000000001112335678999999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=2.1e-36  Score=298.04  Aligned_cols=250  Identities=28%  Similarity=0.373  Sum_probs=205.6

Q ss_pred             ccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEeccC
Q 007680          273 EFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMP  351 (593)
Q Consensus       273 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  351 (593)
                      +|+..+.||+|++|.||++... +++.+++|++..........+.+|++++++++|+|++++++++...+..++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            4778899999999999999975 689999999987655566789999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCccc
Q 007680          352 NGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVR  431 (593)
Q Consensus       352 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~  431 (593)
                      +++|.+++......+++..+..++.|+++||++||++    +++||||+|+||++++++.++|+|||.+........   
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~----~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---  153 (253)
T cd05122          81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN----GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---  153 (253)
T ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcC----CEecCCCCHHHEEEccCCeEEEeecccccccccccc---
Confidence            9999999988755689999999999999999999954    599999999999999999999999999887654331   


Q ss_pred             cccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhhhh
Q 007680          432 QTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQA  511 (593)
Q Consensus       432 ~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  511 (593)
                      .....++..|+|||++.+..++.++||||||+++|+|++|+.||.......  ..........               ..
T Consensus       154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~---------------~~  216 (253)
T cd05122         154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMK--ALFKIATNGP---------------PG  216 (253)
T ss_pred             ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHH--HHHHHHhcCC---------------CC
Confidence            233468889999999988889999999999999999999999987632111  0000000000               00


Q ss_pred             hhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          512 FSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       512 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      ......++..+.+++.+||+.||++|||+.|+++|
T Consensus       217 ~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         217 LRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             cCcccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            01111124578999999999999999999999875

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-37  Score=288.06  Aligned_cols=252  Identities=22%  Similarity=0.271  Sum_probs=204.7

Q ss_pred             hccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh-HHHHHHHHHHHHHHhhc-CCCCcceeeeeeecCCceEEEEe
Q 007680          272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNV-RHRNLIKILSSYSNPDFKALVLE  348 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  348 (593)
                      ++.+.+..||.|..|.|++++.. +|...|||.+.... .+..+++...+.++.+- ++|.||+.+|+|......++.||
T Consensus        92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe  171 (391)
T KOG0983|consen   92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME  171 (391)
T ss_pred             HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence            44566778999999999999965 68999999997653 44556777778777666 48999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCC
Q 007680          349 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGED  428 (593)
Q Consensus       349 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  428 (593)
                      .| .-.+..++..-..++++.-+-++...+++||.||-+++   +|+|||+||+|||+|+.|++|+||||++.++.+...
T Consensus       172 lM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH---~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA  247 (391)
T KOG0983|consen  172 LM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA  247 (391)
T ss_pred             HH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc---ceeecccCccceEEccCCCEEeecccccceeecccc
Confidence            98 44677777776667899888899999999999999854   799999999999999999999999999988765543


Q ss_pred             ccccccccCCccccCccccCC---CCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhh
Q 007680          429 SVRQTMTMATIGYMAPEYGLE---GIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANL  505 (593)
Q Consensus       429 ~~~~~~~~gt~~y~aPE~~~~---~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  505 (593)
                         .+...|.+.|||||.+..   ..|+.++||||||++++|+.||+.||.....+...+.+.+. ..            
T Consensus       248 ---htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln-~e------------  311 (391)
T KOG0983|consen  248 ---HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN-EE------------  311 (391)
T ss_pred             ---cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh-cC------------
Confidence               455679999999998764   46899999999999999999999999875433332222222 11            


Q ss_pred             hhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          506 VREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                         ....+..+.+++.+.+++..||.+|+.+||...++++|
T Consensus       312 ---PP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  312 ---PPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             ---CCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence               12222223367789999999999999999999999986

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=3.3e-36  Score=298.06  Aligned_cols=248  Identities=24%  Similarity=0.362  Sum_probs=201.3

Q ss_pred             ccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh--HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEec
Q 007680          273 EFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEF  349 (593)
Q Consensus       273 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  349 (593)
                      +|+..+.||+|+||.||++... +++.+|+|.+....  ......+.+|++++++++|||++++++.+..++..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            4888999999999999999864 78899999987542  33456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCC-CcEEEEeeccceecCCCC
Q 007680          350 MPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDEN-MVAHVSDFGIYKLLGEGE  427 (593)
Q Consensus       350 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~-~~~kL~Dfg~a~~~~~~~  427 (593)
                      +++++|.+++.... ..+++..+..++.|++.||+|||++    +++|+||+|+||+++++ +.+||+|||.+.......
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~----~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (256)
T cd08220          81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK----LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS  156 (256)
T ss_pred             CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence            99999999998754 3589999999999999999999965    49999999999999855 468999999998765432


Q ss_pred             CccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhh
Q 007680          428 DSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVR  507 (593)
Q Consensus       428 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  507 (593)
                      .   .....++..|+|||.+.+..++.++||||||+++|+|++|+.||......  ...........             
T Consensus       157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~--~~~~~~~~~~~-------------  218 (256)
T cd08220         157 K---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP--ALVLKIMSGTF-------------  218 (256)
T ss_pred             c---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH--HHHHHHHhcCC-------------
Confidence            2   22345788999999998888999999999999999999999999663211  11111110000             


Q ss_pred             hhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          508 EEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       508 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                          ......++.++.+++.+||+.+|++|||+.|++++
T Consensus       219 ----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         219 ----APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             ----CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence                00111245678999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.4e-36  Score=301.29  Aligned_cols=254  Identities=24%  Similarity=0.327  Sum_probs=201.3

Q ss_pred             ccccccccCccCcccEEEEEe-CCCCeEEEEEeehhh------HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEE
Q 007680          273 EFNECNLLGTSSFGSVYKGTI-SDGTDVAIKVFNLQL------ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKAL  345 (593)
Q Consensus       273 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  345 (593)
                      +|+..+.||+|++|.||++.. .+++.||+|++....      ....+.+.+|++++++++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            477889999999999999985 478999999987532      2245678999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC-cEEEEeeccceecC
Q 007680          346 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENM-VAHVSDFGIYKLLG  424 (593)
Q Consensus       346 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~-~~kL~Dfg~a~~~~  424 (593)
                      ||||+++++|.+++.... .+++..+..++.|++.||.|||++    +++|+||+|+||+++.++ .+||+|||.+..+.
T Consensus        81 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~ql~~al~~LH~~----~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~  155 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYG-AFKEAVIINYTEQLLRGLSYLHEN----QIIHRDVKGANLLIDSTGQRLRIADFGAAARLA  155 (268)
T ss_pred             EEeccCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence            999999999999997655 489999999999999999999965    599999999999998776 69999999988765


Q ss_pred             CCCCcc--ccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhh
Q 007680          425 EGEDSV--RQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVD  502 (593)
Q Consensus       425 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  502 (593)
                      ......  ......++..|+|||++.+..++.++||||+|+++|++++|..||.......  ..........        
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~--~~~~~~~~~~--------  225 (268)
T cd06630         156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN--HLALIFKIAS--------  225 (268)
T ss_pred             cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcc--hHHHHHHHhc--------
Confidence            432111  1123457889999999988889999999999999999999999996432111  1111110000        


Q ss_pred             hhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          503 ANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                           .......+...++++.+++.+||..+|++||++.|++++
T Consensus       226 -----~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~  264 (268)
T cd06630         226 -----ATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH  264 (268)
T ss_pred             -----cCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence                 000011112345678999999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.6e-36  Score=305.39  Aligned_cols=266  Identities=23%  Similarity=0.310  Sum_probs=198.7

Q ss_pred             ccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh--HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEec
Q 007680          273 EFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEF  349 (593)
Q Consensus       273 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  349 (593)
                      +|+..+.||+|++|.||+|+.+ +|+.||+|.++...  ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4888999999999999999875 68999999987543  22335688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCC
Q 007680          350 MPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGED  428 (593)
Q Consensus       350 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  428 (593)
                      +. ++|.+++.... ..+++..+..++.|++.||+|||+.    +++|+||+|+||++++++.+||+|||++........
T Consensus        81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~----~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~  155 (284)
T cd07860          81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH----RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR  155 (284)
T ss_pred             cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence            95 68999887643 3589999999999999999999965    499999999999999999999999999876543321


Q ss_pred             ccccccccCCccccCccccCCCC-CCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHh-cCCc-hhhhhhh--
Q 007680          429 SVRQTMTMATIGYMAPEYGLEGI-VSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKES-LPHG-LTEVVDA--  503 (593)
Q Consensus       429 ~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~-~~~~-~~~~~~~--  503 (593)
                        ......++..|+|||+..+.. ++.++||||||+++|||+||+.||....... ...+..... .+.. .......  
T Consensus       156 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd07860         156 --TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID-QLFRIFRTLGTPDEVVWPGVTSLP  232 (284)
T ss_pred             --ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHhCCCChhhhhhhhHHH
Confidence              122334678899999876644 6889999999999999999999996532211 111111111 0100 0000000  


Q ss_pred             --h--hhh-hhhh-hhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          504 --N--LVR-EEQA-FSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       504 --~--~~~-~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                        .  ... .... .......+.++.+++.+||+.||++|||++|+++|
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  281 (284)
T cd07860         233 DYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH  281 (284)
T ss_pred             HHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence              0  000 0000 00011234678899999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=2.1e-36  Score=304.81  Aligned_cols=249  Identities=22%  Similarity=0.308  Sum_probs=200.7

Q ss_pred             ccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEeccC
Q 007680          273 EFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMP  351 (593)
Q Consensus       273 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  351 (593)
                      +|...+.||+|++|.||++... +++.+++|+++.......+.+.+|+.+++.++||||+++++++...+..++++||++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            4555679999999999999864 789999999876554555678899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCccc
Q 007680          352 NGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVR  431 (593)
Q Consensus       352 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~  431 (593)
                      +++|.+++...  .+++.++..++.|++.||+|||++    +++||||+|+||+++.++.++|+|||.+........  .
T Consensus       100 ~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--~  171 (285)
T cd06648         100 GGALTDIVTHT--RMNEEQIATVCLAVLKALSFLHAQ----GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--R  171 (285)
T ss_pred             CCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc--c
Confidence            99999999873  389999999999999999999955    599999999999999999999999998775543221  1


Q ss_pred             cccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhhhh
Q 007680          432 QTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQA  511 (593)
Q Consensus       432 ~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  511 (593)
                      .....++..|+|||...+..++.++||||||+++|||++|+.||......  ..........+..               
T Consensus       172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~--~~~~~~~~~~~~~---------------  234 (285)
T cd06648         172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL--QAMKRIRDNLPPK---------------  234 (285)
T ss_pred             cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH--HHHHHHHhcCCCC---------------
Confidence            22345889999999998888999999999999999999999998652111  1111111110000               


Q ss_pred             hhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          512 FSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       512 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      ......++..+.+++.+||+.+|++||++.+++++
T Consensus       235 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  269 (285)
T cd06648         235 LKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH  269 (285)
T ss_pred             CcccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence            00111235678999999999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-36  Score=306.38  Aligned_cols=268  Identities=22%  Similarity=0.307  Sum_probs=199.5

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhH-HHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEe
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLE-RAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLE  348 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  348 (593)
                      .++|++.+.||+|++|.||+|..+ +++.||+|.+..... .....+.+|++++++++||||+++++++.+.+..++|||
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE   83 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence            367999999999999999999976 689999999875432 223456789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCC
Q 007680          349 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGED  428 (593)
Q Consensus       349 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  428 (593)
                      |+++ +|.+++......+++..+..++.|+++||.|||++    +++||||||+||++++++.+||+|||+++.......
T Consensus        84 ~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~----~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~  158 (291)
T cd07844          84 YLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR----RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK  158 (291)
T ss_pred             cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC----CeecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence            9974 99999887665689999999999999999999954    599999999999999999999999999875432221


Q ss_pred             ccccccccCCccccCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCC---c-hhhhhhh
Q 007680          429 SVRQTMTMATIGYMAPEYGLE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPH---G-LTEVVDA  503 (593)
Q Consensus       429 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~---~-~~~~~~~  503 (593)
                        ......++..|+|||+..+ ..++.++||||+|+++|+|++|+.||.............. .....   . .......
T Consensus       159 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  235 (291)
T cd07844         159 --TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIF-RVLGTPTEETWPGVSSN  235 (291)
T ss_pred             --cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHH-HhcCCCChhhhhhhhhc
Confidence              1122346788999998765 4588999999999999999999999965432111111111 10000   0 0000000


Q ss_pred             ------h--hhhhhhhhhh--hHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          504 ------N--LVREEQAFSA--KMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       504 ------~--~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                            .  ..........  ......++.+++.+||+.+|++|||+.|++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~  288 (291)
T cd07844         236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH  288 (291)
T ss_pred             cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence                  0  0000000000  01112577899999999999999999998864

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-36  Score=310.65  Aligned_cols=253  Identities=25%  Similarity=0.329  Sum_probs=202.2

Q ss_pred             hccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEE
Q 007680          272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVL  347 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  347 (593)
                      ++|+..+.||+|++|.||+|... +++.||+|.+....   ....+.+..|+++++.++||||+++++.+...+..++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            36889999999999999999976 58999999997643   234567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCC
Q 007680          348 EFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG  426 (593)
Q Consensus       348 e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  426 (593)
                      ||+.+++|.+++.... ..+++..+..++.|+++||+|||+.    +++|+||||+||+++.++.++|+|||++......
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  156 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL----GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVE  156 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC----CeeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence            9999999999987643 3589999999999999999999954    5999999999999999999999999998765332


Q ss_pred             CCcc---------------------------ccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccc
Q 007680          427 EDSV---------------------------RQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMF  479 (593)
Q Consensus       427 ~~~~---------------------------~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~  479 (593)
                      ....                           ......|+..|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~  236 (316)
T cd05574         157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN  236 (316)
T ss_pred             ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence            1110                           1112357889999999998889999999999999999999999997632


Q ss_pred             cccchHHHHHHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCC----HHHHHHH
Q 007680          480 IGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRIN----MTDAAAK  546 (593)
Q Consensus       480 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs----~~evl~~  546 (593)
                      ... .+....            +...     ........+..+.+++.+||..||++||+    +.|++++
T Consensus       237 ~~~-~~~~~~------------~~~~-----~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~  289 (316)
T cd05574         237 RDE-TFSNIL------------KKEV-----TFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH  289 (316)
T ss_pred             hHH-HHHHHh------------cCCc-----cCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence            211 111110            0000     01111114568899999999999999999    7777664

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=2.5e-36  Score=300.33  Aligned_cols=253  Identities=26%  Similarity=0.361  Sum_probs=203.2

Q ss_pred             ccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhH--HHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEec
Q 007680          273 EFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLE--RAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEF  349 (593)
Q Consensus       273 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  349 (593)
                      +|+..+.||+|+||.||+|... +++.|++|.++....  ...+.+..|+++++.++|+||+++++.+...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            4788899999999999999865 789999999986543  3667899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCc
Q 007680          350 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDS  429 (593)
Q Consensus       350 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~  429 (593)
                      +++++|.+++..... +++..+..++.|++.||+|||+.    +++|+||+|+||++++++.+||+|||.+.........
T Consensus        81 ~~~~~L~~~~~~~~~-~~~~~~~~i~~~i~~~l~~lh~~----~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~  155 (264)
T cd06626          81 CSGGTLEELLEHGRI-LDEHVIRVYTLQLLEGLAYLHSH----GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT  155 (264)
T ss_pred             CCCCcHHHHHhhcCC-CChHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence            999999999987643 88999999999999999999955    4999999999999999999999999998876543321


Q ss_pred             cc--cccccCCccccCccccCCCC---CCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhh
Q 007680          430 VR--QTMTMATIGYMAPEYGLEGI---VSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDAN  504 (593)
Q Consensus       430 ~~--~~~~~gt~~y~aPE~~~~~~---~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  504 (593)
                      ..  .....++..|+|||++.+..   ++.++||||||+++|++++|+.||....... .........            
T Consensus       156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~-~~~~~~~~~------------  222 (264)
T cd06626         156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF-QIMFHVGAG------------  222 (264)
T ss_pred             ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH-HHHHHHhcC------------
Confidence            11  11245788999999988766   8899999999999999999999997532111 111111100            


Q ss_pred             hhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          505 LVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       505 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                         .....+....++..+.+++.+||+.+|++||++.|++.+
T Consensus       223 ---~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~  261 (264)
T cd06626         223 ---HKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQH  261 (264)
T ss_pred             ---CCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence               000111112235677899999999999999999998764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=2.4e-36  Score=303.93  Aligned_cols=251  Identities=25%  Similarity=0.322  Sum_probs=194.1

Q ss_pred             hccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh-HHHHHHHHHHHHH-HhhcCCCCcceeeeeeecCCceEEEEe
Q 007680          272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL-ERAFRSFDSECEV-LRNVRHRNLIKILSSYSNPDFKALVLE  348 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e  348 (593)
                      ++|++.+.||+|+||.||+|..+ +|+.||+|+++... ......+..|+.+ ++..+||||+++++++..++..+++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            47899999999999999999975 69999999987643 2223445556665 556689999999999999999999999


Q ss_pred             ccCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCC
Q 007680          349 FMPNGSLEKWLYSH---NYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGE  425 (593)
Q Consensus       349 ~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~  425 (593)
                      |++ ++|.+++...   ...+++..+..++.|++.||+|||++   .+++||||||+||+++.++.+||+|||.+.....
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK---LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD  156 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc---CCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            996 6888877642   23589999999999999999999964   2599999999999999999999999999886543


Q ss_pred             CCCccccccccCCccccCccccCC----CCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhh
Q 007680          426 GEDSVRQTMTMATIGYMAPEYGLE----GIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVV  501 (593)
Q Consensus       426 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  501 (593)
                      ..   ......++..|+|||++.+    ..++.++|+|||||++|+|++|+.||..................+       
T Consensus       157 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-------  226 (283)
T cd06617         157 SV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSP-------  226 (283)
T ss_pred             cc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCC-------
Confidence            21   1233457889999998765    456889999999999999999999996532211111111110000       


Q ss_pred             hhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          502 DANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       502 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                        .+        ....++.++.+++.+||..+|++||++.+++++
T Consensus       227 --~~--------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  261 (283)
T cd06617         227 --QL--------PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH  261 (283)
T ss_pred             --CC--------CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              00        011245678999999999999999999999875

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=2.9e-36  Score=308.63  Aligned_cols=194  Identities=23%  Similarity=0.316  Sum_probs=158.3

Q ss_pred             cccCccCcccEEEEEeC---CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec--CCceEEEEeccCC
Q 007680          278 NLLGTSSFGSVYKGTIS---DGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSN--PDFKALVLEFMPN  352 (593)
Q Consensus       278 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~  352 (593)
                      .+||+|+||.||+|+.+   ++..||+|.+....  ....+.+|++++++++||||+++++++..  ....++||||++ 
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-   83 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE-   83 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-
Confidence            58999999999999864   45789999986542  22457789999999999999999998854  457899999986 


Q ss_pred             CCHHHHHhhC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeee----CCCCcEEEEeeccc
Q 007680          353 GSLEKWLYSH--------NYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILL----DENMVAHVSDFGIY  420 (593)
Q Consensus       353 gsL~~~l~~~--------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll----~~~~~~kL~Dfg~a  420 (593)
                      ++|.+++...        ...+++..+..++.|++.||+|||++    +|+||||||+||++    +.++.+||+|||++
T Consensus        84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~----~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          84 HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN----WVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC----CEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence            5888877532        12478899999999999999999954    59999999999999    56679999999999


Q ss_pred             eecCCCCCcc-ccccccCCccccCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCcc
Q 007680          421 KLLGEGEDSV-RQTMTMATIGYMAPEYGLE-GIVSAKCDVYSYGVLLMETFTRKRPTDEM  478 (593)
Q Consensus       421 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlGvvl~elltg~~pf~~~  478 (593)
                      +......... ......+|+.|+|||++.+ ..++.++|||||||++|||+||++||...
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            8765432211 1233468899999998876 45899999999999999999999999753

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=3.8e-36  Score=306.33  Aligned_cols=247  Identities=28%  Similarity=0.321  Sum_probs=198.4

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALV  346 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  346 (593)
                      ...|+..+.||+|+||.||+|... +++.||+|.+....   ....+.+.+|+++++.++||||+++.+++.+.+..++|
T Consensus        14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv   93 (307)
T cd06607          14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV   93 (307)
T ss_pred             chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence            356888999999999999999965 68999999986432   23445788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCC
Q 007680          347 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG  426 (593)
Q Consensus       347 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  426 (593)
                      |||++ |++.+++......+++..+..++.|++.||.|||+.    +++||||+|+||++++++.++|+|||++......
T Consensus        94 ~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~----~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~  168 (307)
T cd06607          94 MEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSH----ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA  168 (307)
T ss_pred             HHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHC----CceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence            99996 588888776555689999999999999999999954    5999999999999999999999999998765322


Q ss_pred             CCccccccccCCccccCccccC---CCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhh
Q 007680          427 EDSVRQTMTMATIGYMAPEYGL---EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDA  503 (593)
Q Consensus       427 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  503 (593)
                            ....++..|+|||++.   ...++.++||||||+++|||+||+.||.......  .........+         
T Consensus       169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~--~~~~~~~~~~---------  231 (307)
T cd06607         169 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--ALYHIAQNDS---------  231 (307)
T ss_pred             ------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH--HHHHHhcCCC---------
Confidence                  2235788899999874   4568899999999999999999999986532111  0000000000         


Q ss_pred             hhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          504 NLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                             .......++..+.+++.+||..+|++||++.+++.+
T Consensus       232 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         232 -------PTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             -------CCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence                   000112245678999999999999999999999986

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=3.1e-36  Score=303.73  Aligned_cols=253  Identities=23%  Similarity=0.329  Sum_probs=206.6

Q ss_pred             hhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEe
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLE  348 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  348 (593)
                      .++.|+..+.||+|++|.||+|.+. +++.|++|++..... ....+.+|++++++++|+|++++++.+...+..++++|
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   95 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME   95 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence            4667899999999999999999976 689999999986544 45678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCC
Q 007680          349 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGED  428 (593)
Q Consensus       349 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  428 (593)
                      |+++++|.+++......+++..+..++.|++.||+|||+    .|++|+||+|+||+++.++.++|+|||.+........
T Consensus        96 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~----~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  171 (286)
T cd06614          96 YMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHS----QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS  171 (286)
T ss_pred             ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHh----CCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh
Confidence            999999999998876459999999999999999999995    4599999999999999999999999998876543221


Q ss_pred             ccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhh
Q 007680          429 SVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVRE  508 (593)
Q Consensus       429 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  508 (593)
                        ......++..|+|||++.+..++.++||||||+++|+|++|+.||....... .........                
T Consensus       172 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~-~~~~~~~~~----------------  232 (286)
T cd06614         172 --KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR-ALFLITTKG----------------  232 (286)
T ss_pred             --hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhcC----------------
Confidence              1123347788999999988889999999999999999999999987532111 111110000                


Q ss_pred             hhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          509 EQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       509 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      .........++..+.+++.+||+.+|.+||++.+++++
T Consensus       233 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  270 (286)
T cd06614         233 IPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH  270 (286)
T ss_pred             CCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence            00011112245678999999999999999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=5.2e-36  Score=297.86  Aligned_cols=253  Identities=23%  Similarity=0.315  Sum_probs=201.4

Q ss_pred             ccccccccCccCcccEEEEEeC-CCCeEEEEEeehh--hHHHHHHHHHHHHHHhhcCCCCcceeeeeeec--CCceEEEE
Q 007680          273 EFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQ--LERAFRSFDSECEVLRNVRHRNLIKILSSYSN--PDFKALVL  347 (593)
Q Consensus       273 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~  347 (593)
                      +|++.+.||.|+||.||++... +++.||+|.+...  .....+.+..|++++++++||||+++++++..  ....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            4788899999999999999864 7889999998753  23445678899999999999999999997754  45679999


Q ss_pred             eccCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHhcC-CCCCeEecCCCCCCeeeCCCCcEEEEeeccceec
Q 007680          348 EFMPNGSLEKWLYSH---NYFLDILERLNIMIDVGSALEYLHNGH-SSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLL  423 (593)
Q Consensus       348 e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~~-~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~  423 (593)
                      ||+++++|.+++...   ...+++..++.++.|++.||+|||..+ .+.+++|+||||+||++++++.+||+|||.+...
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            999999999998764   336899999999999999999999221 0234999999999999999999999999998876


Q ss_pred             CCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhh
Q 007680          424 GEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDA  503 (593)
Q Consensus       424 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  503 (593)
                      .....  ......++..|+|||++.+..++.++|+||||+++|+|++|+.||....  .....+.+.....         
T Consensus       161 ~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~~---------  227 (265)
T cd08217         161 GHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN--QLQLASKIKEGKF---------  227 (265)
T ss_pred             cCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC--HHHHHHHHhcCCC---------
Confidence            54332  1223458899999999998889999999999999999999999997632  1111111111100         


Q ss_pred             hhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          504 NLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                              ...+...+.++.+++.+||+.+|++||++.+++++
T Consensus       228 --------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         228 --------RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             --------CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                    00111335678999999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=3.6e-36  Score=301.83  Aligned_cols=248  Identities=24%  Similarity=0.367  Sum_probs=201.3

Q ss_pred             hccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEec
Q 007680          272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEF  349 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  349 (593)
                      +-|++.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.++.+++||||+++++++..++..++||||
T Consensus         4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   83 (277)
T cd06641           4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY   83 (277)
T ss_pred             HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence            34778889999999999999864 68899999986432 33456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCc
Q 007680          350 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDS  429 (593)
Q Consensus       350 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~  429 (593)
                      +++++|.+++...  .+++..+..++.|++.|++|||++    +++|+||+|+||+++.++.++|+|||++..+..... 
T Consensus        84 ~~~~~l~~~i~~~--~~~~~~~~~~~~~l~~~l~~lh~~----~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-  156 (277)
T cd06641          84 LGGGSALDLLEPG--PLDETQIATILREILKGLDYLHSE----KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-  156 (277)
T ss_pred             CCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHccC----CeecCCCCHHhEEECCCCCEEEeecccceecccchh-
Confidence            9999999998754  389999999999999999999954    599999999999999999999999999876543221 


Q ss_pred             cccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhh
Q 007680          430 VRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREE  509 (593)
Q Consensus       430 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  509 (593)
                       ......++..|+|||++.+..++.++|+|||||++|+|++|..||......  .....+....+.              
T Consensus       157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~--------------  219 (277)
T cd06641         157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM--KVLFLIPKNNPP--------------  219 (277)
T ss_pred             -hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH--HHHHHHhcCCCC--------------
Confidence             122345788899999998888999999999999999999999999653211  111111100000              


Q ss_pred             hhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          510 QAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       510 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                         .....++.++.+++.+||+.+|++||++.++++|
T Consensus       220 ---~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         220 ---TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             ---CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence               0011235678999999999999999999999996

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-36  Score=304.35  Aligned_cols=267  Identities=24%  Similarity=0.287  Sum_probs=202.0

Q ss_pred             hccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh--HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEe
Q 007680          272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLE  348 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  348 (593)
                      ++|++.+.||+|++|.||+|..+ +++.||+|.++...  ....+.+.+|++++++++|+||+++++++..++..++|||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            36889999999999999999976 68899999987542  2334678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCC
Q 007680          349 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGED  428 (593)
Q Consensus       349 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  428 (593)
                      |++++.+..+.... ..+++.++..++.|++.||+|||+++    ++|+||+|+||++++++.+||+|||.+........
T Consensus        81 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~----i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~  155 (288)
T cd07833          81 YVERTLLELLEASP-GGLPPDAVRSYIWQLLQAIAYCHSHN----IIHRDIKPENILVSESGVLKLCDFGFARALRARPA  155 (288)
T ss_pred             cCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC----eecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence            99887666655443 34899999999999999999999654    99999999999999999999999999887654432


Q ss_pred             ccccccccCCccccCccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHH---hcCCchhhhhh--
Q 007680          429 SVRQTMTMATIGYMAPEYGLEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKE---SLPHGLTEVVD--  502 (593)
Q Consensus       429 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~---~~~~~~~~~~~--  502 (593)
                      . ......++..|+|||++.+. .++.++||||||+++|+|++|+.||......+  .......   ..+........  
T Consensus       156 ~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  232 (288)
T cd07833         156 S-PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID--QLYLIQKCLGPLPPSHQELFSSN  232 (288)
T ss_pred             c-cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCHHHhhhcccC
Confidence            1 12234578889999998887 78999999999999999999999997532211  1111110   00100000000  


Q ss_pred             hhhhh---------hhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          503 ANLVR---------EEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       503 ~~~~~---------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      .....         ..........++.++.+++++||..+|++||++++++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  285 (288)
T cd07833         233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH  285 (288)
T ss_pred             ccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence            00000         000000111236789999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6e-36  Score=301.87  Aligned_cols=256  Identities=23%  Similarity=0.271  Sum_probs=200.3

Q ss_pred             hccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceeeeeeecC--CceEEEE
Q 007680          272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSYSNP--DFKALVL  347 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~  347 (593)
                      ++|+..+.||.|++|.||++... +++.+|+|.+.... ......+.+|++++++++||||+++++++.+.  +..++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            46888999999999999999975 68999999987543 23456788999999999999999999988653  4789999


Q ss_pred             eccCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecC
Q 007680          348 EFMPNGSLEKWLYS---HNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG  424 (593)
Q Consensus       348 e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~  424 (593)
                      ||+++++|.+++..   ....+++..+..++.|++.||+|||+.    +++|+||+|+||++++++.++|+|||++....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~----~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~  156 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR----KIIHRDIKPSNILLTRKGQVKLCDFGVSGELV  156 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEEecCCeEEEeecccccccc
Confidence            99999999988653   233588999999999999999999965    49999999999999999999999999987654


Q ss_pred             CCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCcccc---ccchHHHHHHHhcCCchhhhh
Q 007680          425 EGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFI---GEMSLRRWVKESLPHGLTEVV  501 (593)
Q Consensus       425 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~  501 (593)
                      ....    ....++..|+|||.+.+..++.++||||+|+++|+|++|+.||.....   .......+...........  
T Consensus       157 ~~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  230 (287)
T cd06621         157 NSLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKD--  230 (287)
T ss_pred             cccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhcc--
Confidence            3221    223478889999999888999999999999999999999999976422   1111222211110000000  


Q ss_pred             hhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          502 DANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       502 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                               ........++.+.+++.+||+.+|++|||+.|++++
T Consensus       231 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~  266 (287)
T cd06621         231 ---------EPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH  266 (287)
T ss_pred             ---------CCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence                     000001234578999999999999999999999985

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=6.1e-36  Score=297.45  Aligned_cols=252  Identities=25%  Similarity=0.335  Sum_probs=206.9

Q ss_pred             hccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhH-HHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEec
Q 007680          272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLE-RAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEF  349 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  349 (593)
                      ++|++.+.||+|++|.||+|+.. +++.|++|++..... .....+.+|++.+.+++|+|++++++++...+..++||||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            46889999999999999999976 599999999876643 4457889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCc
Q 007680          350 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDS  429 (593)
Q Consensus       350 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~  429 (593)
                      +++++|.+++.... .+++..+..++.|+++|++|||+   +.+++|+||+|+||+++.++.++|+|||.+.........
T Consensus        81 ~~~~~L~~~l~~~~-~l~~~~~~~~~~~l~~~l~~lh~---~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~  156 (264)
T cd06623          81 MDGGSLADLLKKVG-KIPEPVLAYIARQILKGLDYLHT---KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ  156 (264)
T ss_pred             cCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhc---cCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence            99999999998764 48999999999999999999995   045999999999999999999999999998876543321


Q ss_pred             cccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCcccc-ccchHHHHHHHhcCCchhhhhhhhhhhh
Q 007680          430 VRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFI-GEMSLRRWVKESLPHGLTEVVDANLVRE  508 (593)
Q Consensus       430 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  508 (593)
                        .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||..... ..............              
T Consensus       157 --~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~--------------  220 (264)
T cd06623         157 --CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPP--------------  220 (264)
T ss_pred             --ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCC--------------
Confidence              1234578899999999988999999999999999999999999977432 11111111110000              


Q ss_pred             hhhhhhhHH-HHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          509 EQAFSAKMD-CILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       509 ~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                         ...... ++..+.+++.+||..+|++||++.|++++
T Consensus       221 ---~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         221 ---PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             ---CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence               001112 45688999999999999999999999985

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=4.8e-36  Score=303.43  Aligned_cols=267  Identities=22%  Similarity=0.268  Sum_probs=201.0

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhH--HHHHHHHHHHHHHhhcCCCCcceeeeeeecC--CceEE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLE--RAFRSFDSECEVLRNVRHRNLIKILSSYSNP--DFKAL  345 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  345 (593)
                      .++|++.+.||+|+||.||+|..+ +++.+|+|.++....  .....+.+|+.++.+++||||+++++++...  +..++
T Consensus         4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l   83 (293)
T cd07843           4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM   83 (293)
T ss_pred             hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence            357999999999999999999976 688999999975432  2233567899999999999999999998877  88999


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCC
Q 007680          346 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGE  425 (593)
Q Consensus       346 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~  425 (593)
                      ||||++ ++|.+++......+++.++..++.|++.||+|||++    +++|+||||+||++++++.++|+|||.+.....
T Consensus        84 v~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~----~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  158 (293)
T cd07843          84 VMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDN----WILHRDLKTSNLLLNNRGILKICDFGLAREYGS  158 (293)
T ss_pred             EehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC----CeeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence            999996 599999887665689999999999999999999965    499999999999999999999999999887654


Q ss_pred             CCCccccccccCCccccCccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCc----hhhh
Q 007680          426 GEDSVRQTMTMATIGYMAPEYGLEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHG----LTEV  500 (593)
Q Consensus       426 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~----~~~~  500 (593)
                      ...  ......++..|+|||.+.+. .++.++|+||+|+++|+|++|..||....... ...+ +.......    +...
T Consensus       159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~-~~~~-~~~~~~~~~~~~~~~~  234 (293)
T cd07843         159 PLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEID-QLNK-IFKLLGTPTEKIWPGF  234 (293)
T ss_pred             Ccc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHH-HHHH-HHHHhCCCchHHHHHh
Confidence            322  12234578889999987654 46899999999999999999999997642211 1111 11111000    0000


Q ss_pred             hh------hhhhhhh--hhhhhhHH--HHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          501 VD------ANLVREE--QAFSAKMD--CILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       501 ~~------~~~~~~~--~~~~~~~~--~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      .+      .......  ........  .++.+.+++.+||+.||++|||+.|++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~  290 (293)
T cd07843         235 SELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH  290 (293)
T ss_pred             hccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence            00      0000000  00000001  35678999999999999999999999875

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=7.4e-36  Score=300.10  Aligned_cols=261  Identities=21%  Similarity=0.246  Sum_probs=195.9

Q ss_pred             cccccccCccCcccEEEEEeC-CCCeEEEEEeehhh-HHHHHHHHHHHHHHhhcC-CCCcceeeeeeecC--CceEEEEe
Q 007680          274 FNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVR-HRNLIKILSSYSNP--DFKALVLE  348 (593)
Q Consensus       274 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e  348 (593)
                      |++.+.||+|+||.||+|... +++.||+|.++... ........+|+.++.++. |+|++++++++.+.  +..++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            667889999999999999965 68999999987642 122233457888898885 99999999999887  88999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCC
Q 007680          349 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGED  428 (593)
Q Consensus       349 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  428 (593)
                      |++ ++|.+++......+++.++..++.|++.||+|||+.    +++||||+|+||+++. +.+||+|||.+........
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~----~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~  154 (282)
T cd07831          81 LMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN----GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP  154 (282)
T ss_pred             cCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC----CceecccCHHHEEEcC-CCeEEEecccccccccCCC
Confidence            996 588888877655689999999999999999999965    4999999999999999 9999999999987643322


Q ss_pred             ccccccccCCccccCccccC-CCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhh
Q 007680          429 SVRQTMTMATIGYMAPEYGL-EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVR  507 (593)
Q Consensus       429 ~~~~~~~~gt~~y~aPE~~~-~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  507 (593)
                         .....++..|+|||++. +..++.++||||+||++|||++|..||.....  .....+............ ......
T Consensus       155 ---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~--~~~~~~~~~~~~~~~~~~-~~~~~~  228 (282)
T cd07831         155 ---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE--LDQIAKIHDVLGTPDAEV-LKKFRK  228 (282)
T ss_pred             ---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH--HHHHHHHHHHcCCCCHHH-HHhhcc
Confidence               12245788999999764 45678999999999999999999999966322  112222222111111100 000000


Q ss_pred             hh------------hhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          508 EE------------QAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       508 ~~------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      ..            ........++.++.+++.+||+.+|++||++.+++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  279 (282)
T cd07831         229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH  279 (282)
T ss_pred             cccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence            00            0001112346789999999999999999999999875

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.5e-36  Score=301.13  Aligned_cols=248  Identities=26%  Similarity=0.306  Sum_probs=202.2

Q ss_pred             ccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEe
Q 007680          273 EFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLE  348 (593)
Q Consensus       273 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  348 (593)
                      +|++.+.||.|+||.||+|... +++.||+|.+....   ....+.+.+|++++++++||||+++++.+..++..++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4888999999999999999976 68999999997643   2446788999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCC
Q 007680          349 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGED  428 (593)
Q Consensus       349 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  428 (593)
                      |+++++|.+++.... .+++..+..++.|+++||.|||++    +++|+||+|+||++++++.++|+|||.+....... 
T Consensus        81 ~~~~~~L~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lh~~----~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-  154 (258)
T cd05578          81 LLLGGDLRYHLSQKV-KFSEEQVKFWICEIVLALEYLHSK----GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-  154 (258)
T ss_pred             CCCCCCHHHHHHhcC-CcCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence            999999999998763 489999999999999999999965    49999999999999999999999999988664432 


Q ss_pred             ccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhh
Q 007680          429 SVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVRE  508 (593)
Q Consensus       429 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  508 (593)
                        ......++..|+|||+..+..++.++|+||||+++|+|++|+.||.......   ..........             
T Consensus       155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~-------------  216 (258)
T cd05578         155 --LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI---RDQIRAKQET-------------  216 (258)
T ss_pred             --cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH---HHHHHHHhcc-------------
Confidence              1233457889999999988889999999999999999999999997643210   1111100000             


Q ss_pred             hhhhhhhHHHHHHHHHHHhhcccCCCCCCCCH--HHHHH
Q 007680          509 EQAFSAKMDCILSIMDFALDCCMESPDMRINM--TDAAA  545 (593)
Q Consensus       509 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~--~evl~  545 (593)
                       .....+...+..+.+++.+||+.||.+||++  +|+++
T Consensus       217 -~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~  254 (258)
T cd05578         217 -ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN  254 (258)
T ss_pred             -ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence             0001112235688999999999999999999  66553

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-36  Score=301.92  Aligned_cols=248  Identities=25%  Similarity=0.391  Sum_probs=199.3

Q ss_pred             ccccccccCccCcccEEEEEe-CCCCeEEEEEeehhh-HHHHHHHHHHHHHHhhcC---CCCcceeeeeeecCCceEEEE
Q 007680          273 EFNECNLLGTSSFGSVYKGTI-SDGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVR---HRNLIKILSSYSNPDFKALVL  347 (593)
Q Consensus       273 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~  347 (593)
                      .|+..+.||+|+||.||+|.+ .+++.||+|.++... ......+.+|+.++++++   |||++++++++......++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            477889999999999999996 478999999987542 344567889999999996   999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCC
Q 007680          348 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGE  427 (593)
Q Consensus       348 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~  427 (593)
                      ||+++++|.+++...  .+++..+..++.|++.||.|||+.    +++|+||+|+||++++++.++|+|||.+.......
T Consensus        82 e~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh~~----~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06917          82 EYAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIHKV----GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS  155 (277)
T ss_pred             ecCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHhC----CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence            999999999998764  489999999999999999999955    59999999999999999999999999998765433


Q ss_pred             CccccccccCCccccCccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhh
Q 007680          428 DSVRQTMTMATIGYMAPEYGLEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLV  506 (593)
Q Consensus       428 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  506 (593)
                      .  ......|+..|+|||.+.++ .++.++||||||+++|+|++|..||......     ...... ...    ..+.+.
T Consensus       156 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-----~~~~~~-~~~----~~~~~~  223 (277)
T cd06917         156 S--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF-----RAMMLI-PKS----KPPRLE  223 (277)
T ss_pred             c--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh-----hhhhcc-ccC----CCCCCC
Confidence            2  22334688899999987654 4789999999999999999999999763211     111000 000    000000


Q ss_pred             hhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          507 REEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                              ....+.++.+++.+||+.||++||++.|++++
T Consensus       224 --------~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~  255 (277)
T cd06917         224 --------DNGYSKLLREFVAACLDEEPKERLSAEELLKS  255 (277)
T ss_pred             --------cccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence                    01135578999999999999999999999874

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=6.3e-36  Score=308.72  Aligned_cols=271  Identities=23%  Similarity=0.303  Sum_probs=200.6

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-----Cce
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSYSNP-----DFK  343 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~  343 (593)
                      .++|++.+.||+|+||.||+|... +|+.||+|.+.... ......+.+|+.++++++||||+++++++...     ...
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            468999999999999999999864 78999999986432 23445678899999999999999999876544     357


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceec
Q 007680          344 ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLL  423 (593)
Q Consensus       344 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~  423 (593)
                      ++|+||++ ++|.+++...  .+++..+..++.|++.||+|||++    +|+||||||+||+++.++.+||+|||++...
T Consensus        84 ~lv~e~~~-~~l~~~~~~~--~l~~~~~~~i~~ql~~aL~~LH~~----~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~  156 (336)
T cd07849          84 YIVQELME-TDLYKLIKTQ--HLSNDHIQYFLYQILRGLKYIHSA----NVLHRDLKPSNLLLNTNCDLKICDFGLARIA  156 (336)
T ss_pred             EEEehhcc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHEEECCCCCEEECcccceeec
Confidence            99999996 5888887654  389999999999999999999965    5999999999999999999999999998876


Q ss_pred             CCCCCcc-ccccccCCccccCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCc----h
Q 007680          424 GEGEDSV-RQTMTMATIGYMAPEYGLE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHG----L  497 (593)
Q Consensus       424 ~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~----~  497 (593)
                      ....... ......++..|+|||.+.+ ..++.++||||+||++|+|++|+.||.....  ..............    .
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~--~~~~~~~~~~~~~~~~~~~  234 (336)
T cd07849         157 DPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY--LHQLNLILGVLGTPSQEDL  234 (336)
T ss_pred             cccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHcCCCCHHHH
Confidence            4332211 1123467899999998654 5689999999999999999999999965321  11111111111111    1


Q ss_pred             hhhhhhhhhhh------hhh--h-hhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH--HHHh
Q 007680          498 TEVVDANLVRE------EQA--F-SAKMDCILSIMDFALDCCMESPDMRINMTDAAAK--LKKI  550 (593)
Q Consensus       498 ~~~~~~~~~~~------~~~--~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~i  550 (593)
                      ....+......      ...  . ......+.++.+++.+||+.||++|||+.|+++|  ++..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~  298 (336)
T cd07849         235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY  298 (336)
T ss_pred             HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence            11111110000      000  0 0011235678999999999999999999999998  5544

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=6.6e-36  Score=304.90  Aligned_cols=268  Identities=23%  Similarity=0.273  Sum_probs=200.0

Q ss_pred             hhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhH--HHHHHHHHHHHHHhhcCCCCcceeeeeeecC--CceE
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLE--RAFRSFDSECEVLRNVRHRNLIKILSSYSNP--DFKA  344 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~  344 (593)
                      ..++|++.+.||+|+||.||+|... +|+.||+|.++....  .....+.+|+.++++++|+||+++++++...  +..+
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF   84 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence            3578999999999999999999975 689999999875432  1223456799999999999999999998755  4689


Q ss_pred             EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecC
Q 007680          345 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG  424 (593)
Q Consensus       345 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~  424 (593)
                      +||||++ ++|.+++......+++.++..++.|++.||+|||+.    +++||||||+||++++++.+||+|||.+....
T Consensus        85 lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~  159 (309)
T cd07845          85 LVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHEN----FIIHRDLKVSNLLLTDKGCLKIADFGLARTYG  159 (309)
T ss_pred             EEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEECCCCCEEECccceeeecC
Confidence            9999996 589998887656689999999999999999999965    49999999999999999999999999998765


Q ss_pred             CCCCccccccccCCccccCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhh---
Q 007680          425 EGEDSVRQTMTMATIGYMAPEYGLE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEV---  500 (593)
Q Consensus       425 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---  500 (593)
                      .....  .....++..|+|||.+.+ ..++.++||||+||++|||++|+.||.....  ......+...........   
T Consensus       160 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~--~~~~~~~~~~~~~~~~~~~~~  235 (309)
T cd07845         160 LPAKP--MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE--IEQLDLIIQLLGTPNESIWPG  235 (309)
T ss_pred             CccCC--CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHhcCCCChhhchh
Confidence            43211  122345788999998765 4578999999999999999999999975321  111111111111100000   


Q ss_pred             h-hh------hhhhh--hhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          501 V-DA------NLVRE--EQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       501 ~-~~------~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      . +.      .....  ..........++++.+++.+||..||++|||+.|+++|
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h  290 (309)
T cd07845         236 FSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES  290 (309)
T ss_pred             hhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            0 00      00000  00000011235678999999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-36  Score=287.45  Aligned_cols=271  Identities=21%  Similarity=0.319  Sum_probs=209.3

Q ss_pred             CHHHHHHhhhccccccccCccCcccEEEEE-eCCCCeEEEEEeehhhHHHHHHHHHHHHHHhhc-CCCCcceeeeeeecC
Q 007680          263 SYLDIQRATDEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRSFDSECEVLRNV-RHRNLIKILSSYSNP  340 (593)
Q Consensus       263 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  340 (593)
                      .+.|+-+-++     +.||+|+|+.|--+. ..+|..+|||++.+.......++.+|++++.+. .|+||++++++|+++
T Consensus        74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd  148 (463)
T KOG0607|consen   74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD  148 (463)
T ss_pred             hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence            3566655554     489999999999887 568999999999988777788899999999999 599999999999999


Q ss_pred             CceEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC---cEEEEee
Q 007680          341 DFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENM---VAHVSDF  417 (593)
Q Consensus       341 ~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~---~~kL~Df  417 (593)
                      ...|+|||-|.||+|.++|.++.. +++.++.++.++|+.||++||.+|    |.|||+||+|||..+..   -+||+||
T Consensus       149 ~~FYLVfEKm~GGplLshI~~~~~-F~E~EAs~vvkdia~aLdFlH~kg----IAHRDlKPENiLC~~pn~vsPvKiCDf  223 (463)
T KOG0607|consen  149 TRFYLVFEKMRGGPLLSHIQKRKH-FNEREASRVVKDIASALDFLHTKG----IAHRDLKPENILCESPNKVSPVKICDF  223 (463)
T ss_pred             ceEEEEEecccCchHHHHHHHhhh-ccHHHHHHHHHHHHHHHHHHhhcC----cccccCCccceeecCCCCcCceeeecc
Confidence            999999999999999999998876 999999999999999999999654    99999999999997544   5899999


Q ss_pred             ccceecCCCCC-----ccccccccCCccccCccccC---C--CCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHH
Q 007680          418 GIYKLLGEGED-----SVRQTMTMATIGYMAPEYGL---E--GIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRR  487 (593)
Q Consensus       418 g~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~---~--~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~  487 (593)
                      .+..-+....+     +..-...+|+..|||||+..   +  ..|+.++|.||||||+|-|+.|.+||.+....+..   
T Consensus       224 DLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCG---  300 (463)
T KOG0607|consen  224 DLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCG---  300 (463)
T ss_pred             ccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCC---
Confidence            88654332211     12234567899999999643   2  35899999999999999999999999876432211   


Q ss_pred             HHHHhcCCchhhhhhhhhhhhhhhh--hhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          488 WVKESLPHGLTEVVDANLVREEQAF--SAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       488 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      |-+...-....+.+-..++.....+  ..+..++.+..+++...+..||.+|-++.+++.|
T Consensus       301 WdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnh  361 (463)
T KOG0607|consen  301 WDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNH  361 (463)
T ss_pred             ccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence            1000000001111111222222222  2334667788999999999999999999999884

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.6e-35  Score=303.25  Aligned_cols=248  Identities=27%  Similarity=0.332  Sum_probs=198.6

Q ss_pred             ccccccccCccCcccEEEEEeC-CCCeEEEEEeehh---hHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEe
Q 007680          273 EFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQ---LERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLE  348 (593)
Q Consensus       273 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  348 (593)
                      .|+..+.||+|+||.||+|+.. ++..||+|.+...   .......+.+|++++++++|||++++++++.+++..++|||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            3777889999999999999965 6889999998743   23344678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCC
Q 007680          349 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGED  428 (593)
Q Consensus       349 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  428 (593)
                      |+. |+|.+.+......+++.++..++.|++.|+.|||++    +++||||+|+||+++.++.++|+|||++......  
T Consensus       106 ~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~----~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~--  178 (317)
T cd06635         106 YCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH----NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA--  178 (317)
T ss_pred             CCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCcccEEECCCCCEEEecCCCccccCCc--
Confidence            996 588888876666689999999999999999999965    4999999999999999999999999988754322  


Q ss_pred             ccccccccCCccccCccccC---CCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhh
Q 007680          429 SVRQTMTMATIGYMAPEYGL---EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANL  505 (593)
Q Consensus       429 ~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  505 (593)
                          ....++..|+|||++.   ++.++.++|||||||++|||++|+.||...... .....+.....+           
T Consensus       179 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-~~~~~~~~~~~~-----------  242 (317)
T cd06635         179 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIAQNESP-----------  242 (317)
T ss_pred             ----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH-HHHHHHHhccCC-----------
Confidence                2245788999999873   456899999999999999999999998653111 111111111000           


Q ss_pred             hhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHH
Q 007680          506 VREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKK  549 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  549 (593)
                            ......++..+.+++.+||+.+|.+||++.+++++.-.
T Consensus       243 ------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~  280 (317)
T cd06635         243 ------TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV  280 (317)
T ss_pred             ------CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence                  01112335578999999999999999999999987643

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.6e-35  Score=295.56  Aligned_cols=252  Identities=22%  Similarity=0.244  Sum_probs=197.5

Q ss_pred             CHHHHHHhhhcccccccc--CccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhc-CCCCcceeeeeee
Q 007680          263 SYLDIQRATDEFNECNLL--GTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNV-RHRNLIKILSSYS  338 (593)
Q Consensus       263 ~~~~~~~~~~~~~~~~~l--g~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  338 (593)
                      +..+.....++|++.+.+  |+|+||.||++..+ +++.+|+|.+.......     .|+.....+ +||||+++++.+.
T Consensus         5 ~~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~   79 (267)
T PHA03390          5 SLSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVT   79 (267)
T ss_pred             HHHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEe
Confidence            345556667788888887  99999999999964 78899999987542211     122222222 7999999999999


Q ss_pred             cCCceEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC-cEEEEee
Q 007680          339 NPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENM-VAHVSDF  417 (593)
Q Consensus       339 ~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~-~~kL~Df  417 (593)
                      ..+..++||||+++++|.+++.... .+++.++..++.|+++||+|||+.    +++||||||+||+++.++ .++|+||
T Consensus        80 ~~~~~~iv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~nil~~~~~~~~~l~df  154 (267)
T PHA03390         80 TLKGHVLIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLHKH----NIIHNDIKLENVLYDRAKDRIYLCDY  154 (267)
T ss_pred             cCCeeEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC----CeeeCCCCHHHEEEeCCCCeEEEecC
Confidence            9999999999999999999998765 589999999999999999999954    599999999999999998 9999999


Q ss_pred             ccceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCch
Q 007680          418 GIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGL  497 (593)
Q Consensus       418 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  497 (593)
                      |.+......      ....++..|+|||++.+..++.++||||+|+++|||++|+.||............+.... ..  
T Consensus       155 g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~--  225 (267)
T PHA03390        155 GLCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QK--  225 (267)
T ss_pred             ccceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-cc--
Confidence            998765432      123578899999999988999999999999999999999999975433332222222111 00  


Q ss_pred             hhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCC-HHHHHHH
Q 007680          498 TEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRIN-MTDAAAK  546 (593)
Q Consensus       498 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~  546 (593)
                                   ........++.+.+++.+||+.+|.+||+ ++|+++|
T Consensus       226 -------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h  262 (267)
T PHA03390        226 -------------KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH  262 (267)
T ss_pred             -------------cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence                         00111134567899999999999999996 5888864

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-35  Score=297.98  Aligned_cols=264  Identities=23%  Similarity=0.284  Sum_probs=202.4

Q ss_pred             cccccccCccCcccEEEEEeC-CCCeEEEEEeehhhH--HHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEecc
Q 007680          274 FNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLE--RAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFM  350 (593)
Q Consensus       274 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  350 (593)
                      |++.+.||+|++|.||+|... +++.+++|.++....  .....+.+|++++++++|+||+++++++..++..++|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            567789999999999999865 789999999875432  24567888999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCcc
Q 007680          351 PNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSV  430 (593)
Q Consensus       351 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~  430 (593)
                      ++ ++.+++......+++..+..++.|++.||.|||+++    ++|+||||+||++++++.++|+|||.+........  
T Consensus        81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~----i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~--  153 (283)
T cd05118          81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG----ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR--  153 (283)
T ss_pred             CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCC----eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc--
Confidence            65 899888776556899999999999999999999654    99999999999999999999999999887654431  


Q ss_pred             ccccccCCccccCccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCc----hhhhhh---
Q 007680          431 RQTMTMATIGYMAPEYGLEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHG----LTEVVD---  502 (593)
Q Consensus       431 ~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~---  502 (593)
                      ......++..|+|||.+.+. .++.++||||+|+++|+|+||+.||......+  ............    .....+   
T Consensus       154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  231 (283)
T cd05118         154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID--QLFKIFRTLGTPDPEVWPKFTSLAR  231 (283)
T ss_pred             cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHcCCCchHhcccchhhhh
Confidence            12234578889999998776 78999999999999999999999996532211  111111111110    000000   


Q ss_pred             hh---hhh--hhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          503 AN---LVR--EEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       503 ~~---~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      ..   ...  ..........++.++.+++.+||+.||.+||++.+++.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~  280 (283)
T cd05118         232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH  280 (283)
T ss_pred             hhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            00   000  000011123456789999999999999999999999864

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=5.8e-36  Score=302.05  Aligned_cols=254  Identities=24%  Similarity=0.290  Sum_probs=195.6

Q ss_pred             hccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh-HHHHHHHHHHHHHHhhcC-CCCcceeeeeeecCCceEEEEe
Q 007680          272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVR-HRNLIKILSSYSNPDFKALVLE  348 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e  348 (593)
                      ++|+..+.||+|+||.||++... +++.||+|.+.... ......+.+|+.++.++. ||||+++++++..++..+++||
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e   83 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME   83 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence            46777889999999999999965 68999999987543 334567889999999996 9999999999999999999999


Q ss_pred             ccCCCCHHHHH---hh-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecC
Q 007680          349 FMPNGSLEKWL---YS-HNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG  424 (593)
Q Consensus       349 ~~~~gsL~~~l---~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~  424 (593)
                      |+. +++.++.   .. ....+++..+..++.|++.||+|||+.   .+++||||||+||+++.++.+||+|||++....
T Consensus        84 ~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  159 (288)
T cd06616          84 LMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE---LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV  159 (288)
T ss_pred             ccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc---CCeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence            985 4655543   22 224589999999999999999999963   369999999999999999999999999987654


Q ss_pred             CCCCccccccccCCccccCccccCCC---CCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhh
Q 007680          425 EGEDSVRQTMTMATIGYMAPEYGLEG---IVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVV  501 (593)
Q Consensus       425 ~~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  501 (593)
                      ....   .....++..|+|||++.+.   .++.++|||||||++|||++|+.||.....    .............    
T Consensus       160 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----~~~~~~~~~~~~~----  228 (288)
T cd06616         160 DSIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS----VFDQLTQVVKGDP----  228 (288)
T ss_pred             cCCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch----HHHHHhhhcCCCC----
Confidence            3221   1233578899999998766   689999999999999999999999965321    1111111110000    


Q ss_pred             hhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          502 DANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       502 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                       +.+.     ......++.++.+++.+||+.||++|||+.+++++
T Consensus       229 -~~~~-----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         229 -PILS-----NSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             -CcCC-----CcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             0000     00112346688999999999999999999999986

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8e-38  Score=341.59  Aligned_cols=253  Identities=25%  Similarity=0.336  Sum_probs=205.4

Q ss_pred             hhccccccccCccCcccEEEEEe-CCCCeEEEEEeehhh--HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTI-SDGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVL  347 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  347 (593)
                      +-+|+...+||.|.||.||-|.. .+|...|+|-++...  .+....+.+|..++..++|||+|+++|+-.+++..+|.|
T Consensus      1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred             eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence            44677788999999999999984 579999999987654  344567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCC
Q 007680          348 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGE  427 (593)
Q Consensus       348 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~  427 (593)
                      |||++|+|.+.+...+. .++.....+..|++.|++|||++|    ||||||||.||+++.+|.+|++|||.|..+....
T Consensus      1314 EyC~~GsLa~ll~~gri-~dE~vt~vyt~qll~gla~LH~~g----IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~ 1388 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGRI-EDEMVTRVYTKQLLEGLAYLHEHG----IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNA 1388 (1509)
T ss_pred             HHhccCcHHHHHHhcch-hhhhHHHHHHHHHHHHHHHHHhcC----ceecCCCccceeeecCCcEEeecccceeEecCch
Confidence            99999999999876653 666677778899999999999765    9999999999999999999999999999886553


Q ss_pred             Ccc--ccccccCCccccCccccCCCC---CCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhh
Q 007680          428 DSV--RQTMTMATIGYMAPEYGLEGI---VSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVD  502 (593)
Q Consensus       428 ~~~--~~~~~~gt~~y~aPE~~~~~~---~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  502 (593)
                      ...  .-....||+.|||||++.+..   ...++||||+|||+.||+||+.||.....+-..+.+-..            
T Consensus      1389 ~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~------------ 1456 (1509)
T KOG4645|consen 1389 QTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAA------------ 1456 (1509)
T ss_pred             hcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhc------------
Confidence            221  123457999999999987643   567899999999999999999999875332211111111            


Q ss_pred             hhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          503 ANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                          +..+.  .+...+.+-.+++.+||..||++|+++.|++++
T Consensus      1457 ----gh~Pq--~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1457 ----GHKPQ--IPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             ----cCCCC--CchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence                11111  122356778999999999999999999988876

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.7e-35  Score=307.62  Aligned_cols=264  Identities=21%  Similarity=0.235  Sum_probs=198.4

Q ss_pred             hhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehh--hHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC------
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQ--LERAFRSFDSECEVLRNVRHRNLIKILSSYSNP------  340 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  340 (593)
                      ..++|++.+.||+|+||.||+|... +++.||+|.+...  .......+.+|+.++++++||||+++++++...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            3578999999999999999999965 7899999998643  223345677899999999999999999988643      


Q ss_pred             CceEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccc
Q 007680          341 DFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIY  420 (593)
Q Consensus       341 ~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a  420 (593)
                      ...++||||+. ++|.+.+...   ++...+..++.|++.||+|||++    +|+||||||+||+++.++.+||+|||.+
T Consensus        94 ~~~~lv~e~~~-~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~~----gi~H~dlkp~Nil~~~~~~~kL~Dfg~~  165 (353)
T cd07850          94 QDVYLVMELMD-ANLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSA----GIIHRDLKPSNIVVKSDCTLKILDFGLA  165 (353)
T ss_pred             CcEEEEEeccC-CCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHhC----CeeeCCCCHHHEEECCCCCEEEccCccc
Confidence            35799999995 5888887643   88899999999999999999965    5999999999999999999999999999


Q ss_pred             eecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCC---ch
Q 007680          421 KLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPH---GL  497 (593)
Q Consensus       421 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~---~~  497 (593)
                      ........   .....++..|+|||++.+..++.++|||||||++|+|++|+.||...... ..... +......   .+
T Consensus       166 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~-~~~~~-~~~~~~~~~~~~  240 (353)
T cd07850         166 RTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHI-DQWNK-IIEQLGTPSDEF  240 (353)
T ss_pred             eeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHH-HHHhcCCCCHHH
Confidence            87643321   22345788999999999999999999999999999999999999653211 11111 1110000   00


Q ss_pred             hhhhhhhhh--------hhhh--------------hhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          498 TEVVDANLV--------REEQ--------------AFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       498 ~~~~~~~~~--------~~~~--------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      .+.++....        ....              ........+..+.+++.+||+.||++|||+.|++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         241 MSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             HHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            000000000        0000              000011235678999999999999999999999987

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=8.1e-36  Score=301.62  Aligned_cols=246  Identities=23%  Similarity=0.318  Sum_probs=198.7

Q ss_pred             cccccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEeccCCCC
Q 007680          276 ECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGS  354 (593)
Q Consensus       276 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  354 (593)
                      ...+||+|+||.||++..+ +++.||+|.+..........+.+|+.+++.++|+||+++++.+...+..++||||+++++
T Consensus        24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~  103 (292)
T cd06657          24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA  103 (292)
T ss_pred             hHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCc
Confidence            3468999999999999874 789999999865544556678999999999999999999999999999999999999999


Q ss_pred             HHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCcccccc
Q 007680          355 LEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTM  434 (593)
Q Consensus       355 L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~  434 (593)
                      |.+++...  .+++..+..++.|++.|++|||++    |++||||+|+||+++.++.++|+|||.+........  ....
T Consensus       104 L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~----givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~  175 (292)
T cd06657         104 LTDIVTHT--RMNEEQIAAVCLAVLKALSVLHAQ----GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKS  175 (292)
T ss_pred             HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEECCCCCEEEcccccceecccccc--cccc
Confidence            99987654  389999999999999999999964    599999999999999999999999999876543221  1223


Q ss_pred             ccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhhhhhhh
Q 007680          435 TMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSA  514 (593)
Q Consensus       435 ~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  514 (593)
                      ..++..|+|||+..+..++.++|+||+|+++|+|++|..||.....  ...........+...               ..
T Consensus       176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~--~~~~~~~~~~~~~~~---------------~~  238 (292)
T cd06657         176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--LKAMKMIRDNLPPKL---------------KN  238 (292)
T ss_pred             cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhhCCccc---------------CC
Confidence            4578899999998888899999999999999999999999865211  111111111111110               01


Q ss_pred             hHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          515 KMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       515 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      ...++..+.+++.+||+.+|.+||++.+++++
T Consensus       239 ~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~  270 (292)
T cd06657         239 LHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  270 (292)
T ss_pred             cccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence            11234567899999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.7e-35  Score=292.82  Aligned_cols=252  Identities=26%  Similarity=0.335  Sum_probs=206.0

Q ss_pred             ccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh--HHHHHHHHHHHHHHhhcCCCCcceeeeeeecC--CceEEEE
Q 007680          273 EFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSYSNP--DFKALVL  347 (593)
Q Consensus       273 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~  347 (593)
                      +|...+.||+|++|.||+|... +++.|++|++....  ....+.+.+|+.++++++||||+++++.+...  +..++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4778899999999999999976 78999999987654  24567889999999999999999999999988  8899999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCC
Q 007680          348 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGE  427 (593)
Q Consensus       348 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~  427 (593)
                      ||+++++|.+++.... .+++..+..++.|++.||+|||+.    +++|+||+|+||+++.++.++|+|||.+.......
T Consensus        81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~----~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  155 (260)
T cd06606          81 EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSN----GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE  155 (260)
T ss_pred             EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC----CccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence            9999999999998776 599999999999999999999964    49999999999999999999999999988776543


Q ss_pred             CccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhh
Q 007680          428 DSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVR  507 (593)
Q Consensus       428 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  507 (593)
                      .........++..|+|||...+...+.++||||||+++|+|++|..||..............                 .
T Consensus       156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-----------------~  218 (260)
T cd06606         156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIG-----------------S  218 (260)
T ss_pred             ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhcc-----------------c
Confidence            21112345688899999999888899999999999999999999999976431110000000                 0


Q ss_pred             hhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          508 EEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       508 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      .......+...+..+.+++.+|++.+|++||++.|++.+
T Consensus       219 ~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~  257 (260)
T cd06606         219 SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH  257 (260)
T ss_pred             cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence            000001112235688999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.5e-35  Score=298.28  Aligned_cols=266  Identities=21%  Similarity=0.329  Sum_probs=200.2

Q ss_pred             ccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhH-HHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEecc
Q 007680          273 EFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLE-RAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFM  350 (593)
Q Consensus       273 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  350 (593)
                      +|++.+.||+|++|.||+|+.. +|+.||+|.++.... .....+.+|++++++++||||+++++++.+.+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            5888999999999999999975 689999999876532 23456778999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCC
Q 007680          351 PNGSLEKWLYSHN--YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGED  428 (593)
Q Consensus       351 ~~gsL~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  428 (593)
                      ++ +|.+++....  ..+++..+..++.|++.||+|||+.    +++||||||+||++++++.++|+|||.+........
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~  155 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN----RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN  155 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC----CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence            75 8999887654  3589999999999999999999954    599999999999999999999999999876543221


Q ss_pred             ccccccccCCccccCccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhc-CC--chhhhhh--
Q 007680          429 SVRQTMTMATIGYMAPEYGLEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESL-PH--GLTEVVD--  502 (593)
Q Consensus       429 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~-~~--~~~~~~~--  502 (593)
                        ......++..|+|||++.+. .++.++||||||+++|+|++|+.||......+ ...+...... +.  .+....+  
T Consensus       156 --~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd07836         156 --TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED-QLLKIFRIMGTPTESTWPGISQLP  232 (284)
T ss_pred             --ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCCCChhhHHHHhcCc
Confidence              11233568889999987654 57899999999999999999999997643221 1111111100 00  0000000  


Q ss_pred             ---hhhhh--hhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          503 ---ANLVR--EEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       503 ---~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                         .....  ...........+..+.+++.+||+.||++||++.|++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  281 (284)
T cd07836         233 EYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH  281 (284)
T ss_pred             hhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence               00000  000001112345678999999999999999999999864

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-35  Score=299.24  Aligned_cols=264  Identities=23%  Similarity=0.308  Sum_probs=198.9

Q ss_pred             cccccccCccCcccEEEEEeC-CCCeEEEEEeehhh--HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEecc
Q 007680          274 FNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFM  350 (593)
Q Consensus       274 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  350 (593)
                      |++.+.||+|++|.||+|... +|+.||+|++....  ......+.+|++++++++|||++++++++.+++..+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            677889999999999999865 79999999987553  223356788999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCc
Q 007680          351 PNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDS  429 (593)
Q Consensus       351 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~  429 (593)
                      + ++|.+++.... ..+++..+..++.|+++||+|||++    +++||||+|+||++++++.++|+|||.+.........
T Consensus        81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~----~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~  155 (283)
T cd07835          81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH----RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT  155 (283)
T ss_pred             C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC----CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence            5 69999987755 2589999999999999999999964    5999999999999999999999999998765432221


Q ss_pred             cccccccCCccccCccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhc-CCc-h-------hh
Q 007680          430 VRQTMTMATIGYMAPEYGLEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESL-PHG-L-------TE  499 (593)
Q Consensus       430 ~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~-~~~-~-------~~  499 (593)
                        .....++..|+|||++.+. .++.++||||||+++|+|++|+.||....... ...+...... +.. .       .+
T Consensus       156 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd07835         156 --YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID-QLFRIFRTLGTPDEDVWPGVTSLPD  232 (283)
T ss_pred             --cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCChHHhhhhhhchh
Confidence              1223468889999987664 57899999999999999999999997532211 1111111100 000 0       00


Q ss_pred             hhhhhhhhh--hhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          500 VVDANLVRE--EQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       500 ~~~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      ... .....  ..........+..+.+++.+||+.||++|||++|++++
T Consensus       233 ~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  280 (283)
T cd07835         233 YKP-TFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH  280 (283)
T ss_pred             hhh-hcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            000 00000  00001112334678999999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=8.1e-36  Score=295.44  Aligned_cols=249  Identities=22%  Similarity=0.340  Sum_probs=201.0

Q ss_pred             ccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh--HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEec
Q 007680          273 EFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEF  349 (593)
Q Consensus       273 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  349 (593)
                      +|++.+.||+|+||.||+|..+ +|..+|+|.+....  ....+.+.+|+++++.++|+||+++++.+...+..++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4788899999999999999975 68899999987642  23445788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC-cEEEEeeccceecCCCC
Q 007680          350 MPNGSLEKWLYSHNY-FLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENM-VAHVSDFGIYKLLGEGE  427 (593)
Q Consensus       350 ~~~gsL~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~-~~kL~Dfg~a~~~~~~~  427 (593)
                      +++++|.+++..... .+++..+..++.|+++||+|||+.    +++|+||||+||++++++ .+||+|||.+.......
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~----~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (257)
T cd08225          81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR----KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM  156 (257)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC----CcccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence            999999999976543 579999999999999999999955    499999999999999885 56999999988765432


Q ss_pred             CccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhh
Q 007680          428 DSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVR  507 (593)
Q Consensus       428 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  507 (593)
                      .  ......|++.|+|||+..+..++.++|+||||+++|||++|..||....     ..++...........        
T Consensus       157 ~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~--------  221 (257)
T cd08225         157 E--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-----LHQLVLKICQGYFAP--------  221 (257)
T ss_pred             c--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HHHHHHHHhcccCCC--------
Confidence            2  1223458889999999888889999999999999999999999986532     111221111111000        


Q ss_pred             hhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          508 EEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       508 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                            .....+.++.+++.+||..+|++|||+.|++++
T Consensus       222 ------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         222 ------ISPNFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             ------CCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence                  011234578999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-35  Score=303.53  Aligned_cols=269  Identities=20%  Similarity=0.255  Sum_probs=197.6

Q ss_pred             ccccccccCccCcccEEEEEeC---CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhcCCCCcceeeeeeecC--CceE
Q 007680          273 EFNECNLLGTSSFGSVYKGTIS---DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSYSNP--DFKA  344 (593)
Q Consensus       273 ~~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~  344 (593)
                      +|++.+.||+|++|.||+|...   +++.||+|.+....   ......+.+|+.++++++||||+++++++.+.  +..+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            4788899999999999999965   47899999998632   33345678899999999999999999999888  7899


Q ss_pred             EEEeccCCCCHHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC----CCcEEEEe
Q 007680          345 LVLEFMPNGSLEKWLYSHN----YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDE----NMVAHVSD  416 (593)
Q Consensus       345 lv~e~~~~gsL~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~----~~~~kL~D  416 (593)
                      +||||+++ ++.+++....    ..+++..+..++.|++.||+|||+.    +|+||||||+||+++.    ++.+||+|
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~----~i~h~dlkp~Nil~~~~~~~~~~~kl~D  155 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN----WVLHRDLKPANILVMGEGPERGVVKIGD  155 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC----CEeeCCCCHHHEEEcCCCCccceEEECC
Confidence            99999964 7777765332    2588999999999999999999954    5999999999999999    99999999


Q ss_pred             eccceecCCCCC-ccccccccCCccccCccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCcccccc--------chHH
Q 007680          417 FGIYKLLGEGED-SVRQTMTMATIGYMAPEYGLEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFIGE--------MSLR  486 (593)
Q Consensus       417 fg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~--------~~~~  486 (593)
                      ||++........ ........++..|+|||++.+. .++.++||||||+++|+|++|+.||.......        ..+.
T Consensus       156 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (316)
T cd07842         156 LGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLE  235 (316)
T ss_pred             CccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHH
Confidence            999887644332 1122334678899999987664 58999999999999999999999997643322        0111


Q ss_pred             HHHHHhcCC------------chhhhhhhhh---hh-h--hhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          487 RWVKESLPH------------GLTEVVDANL---VR-E--EQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       487 ~~~~~~~~~------------~~~~~~~~~~---~~-~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      ..+......            ......+...   .. .  ....+.....+.++.+++.+||+.||++|||+.|+++|
T Consensus       236 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~  313 (316)
T cd07842         236 RIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH  313 (316)
T ss_pred             HHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            111000000            0000000000   00 0  00000001334578999999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.6e-35  Score=294.44  Aligned_cols=242  Identities=26%  Similarity=0.328  Sum_probs=195.0

Q ss_pred             cCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEeccCCCCH
Q 007680          280 LGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSL  355 (593)
Q Consensus       280 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  355 (593)
                      ||.|++|.||+|+.. +++.||+|++....   ....+.+.+|+.++++++||||+++++.+.+++..+++|||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            699999999999975 58999999997542   23456789999999999999999999999999999999999999999


Q ss_pred             HHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCccccccc
Q 007680          356 EKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMT  435 (593)
Q Consensus       356 ~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~  435 (593)
                      .+++.+... +++..+..++.|+++||+|||++    +++|+||+|+||+++.++.++|+|||.+.......   .....
T Consensus        81 ~~~l~~~~~-l~~~~~~~~~~~i~~~l~~lH~~----~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~  152 (262)
T cd05572          81 WTILRDRGL-FDEYTARFYIACVVLAFEYLHNR----GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTF  152 (262)
T ss_pred             HHHHhhcCC-CCHHHHHHHHHHHHHHHHHHhhC----CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccc
Confidence            999987654 89999999999999999999964    49999999999999999999999999988765432   12234


Q ss_pred             cCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhhhhhhhh
Q 007680          436 MATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAK  515 (593)
Q Consensus       436 ~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  515 (593)
                      .++..|+|||.+.+..++.++|+||+|+++|+|++|..||.........   ......        +     .......+
T Consensus       153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~~~~~--------~-----~~~~~~~~  216 (262)
T cd05572         153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPME---IYNDIL--------K-----GNGKLEFP  216 (262)
T ss_pred             cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHH---HHHHHh--------c-----cCCCCCCC
Confidence            5788999999988888999999999999999999999999764321111   111100        0     00000111


Q ss_pred             HHHHHHHHHHHhhcccCCCCCCCC-----HHHHHH
Q 007680          516 MDCILSIMDFALDCCMESPDMRIN-----MTDAAA  545 (593)
Q Consensus       516 ~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  545 (593)
                      ...+.++.+++.+||..+|++||+     ++|+++
T Consensus       217 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         217 NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             cccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            122567899999999999999999     666665

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.7e-35  Score=292.81  Aligned_cols=249  Identities=24%  Similarity=0.355  Sum_probs=204.4

Q ss_pred             ccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh--HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEec
Q 007680          273 EFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEF  349 (593)
Q Consensus       273 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  349 (593)
                      +|++.+.||+|+||.||++... +++.||+|++....  ......+.+|++++++++|||++++.+.+...+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            4788899999999999999975 68999999997653  24566788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCC
Q 007680          350 MPNGSLEKWLYSHN---YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG  426 (593)
Q Consensus       350 ~~~gsL~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  426 (593)
                      +++++|.+++....   ..+++..+..++.+++.||.|||++    +++|+||+|+||++++++.++|+|||.+......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~----~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  156 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR----KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST  156 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC----CEecccCChHHeEEcCCCcEEECCccceeecccC
Confidence            99999999998753   4699999999999999999999965    5999999999999999999999999998876543


Q ss_pred             CCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhh
Q 007680          427 EDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLV  506 (593)
Q Consensus       427 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  506 (593)
                      ..  ......+++.|+|||...+..++.++|+||+|+++|+|++|+.||......  ............           
T Consensus       157 ~~--~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~--~~~~~~~~~~~~-----------  221 (258)
T cd08215         157 VD--LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL--ELALKILKGQYP-----------  221 (258)
T ss_pred             cc--eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH--HHHHHHhcCCCC-----------
Confidence            31  223346788999999988888999999999999999999999998663211  111111000000           


Q ss_pred             hhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          507 REEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                            ..+..++.++.+++.+||..+|++||++.|++++
T Consensus       222 ------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         222 ------PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             ------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                  0011335678999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.5e-35  Score=301.09  Aligned_cols=271  Identities=24%  Similarity=0.277  Sum_probs=201.5

Q ss_pred             HhhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh--HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCC----
Q 007680          269 RATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPD----  341 (593)
Q Consensus       269 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----  341 (593)
                      ...++|++.+.||+|+||.||+|..+ +|+.||+|+++...  ......+.+|++++++++||||+++++++.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            45678999999999999999999976 68999999997643  223346778999999999999999999887654    


Q ss_pred             ------ceEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEE
Q 007680          342 ------FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVS  415 (593)
Q Consensus       342 ------~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~  415 (593)
                            ..++|+||+++ ++.+.+......+++..+..++.|++.||+|||+.    +|+|+||||+||++++++.+||+
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~----~i~H~dl~p~nili~~~~~~kl~  158 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKK----NFLHRDIKCSNILLNNKGQIKLA  158 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEECCCCcEEeC
Confidence                  78999999975 78887776555689999999999999999999965    49999999999999999999999


Q ss_pred             eeccceecCCCCCccccccccCCccccCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHH---
Q 007680          416 DFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKE---  491 (593)
Q Consensus       416 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~---  491 (593)
                      |||.+......... ......++..|+|||.+.+ ..++.++|||||||++|||++|++||..... ...+......   
T Consensus       159 dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~-~~~~~~~~~~~~~  236 (302)
T cd07864         159 DFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE-LAQLELISRLCGS  236 (302)
T ss_pred             cccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCC
Confidence            99998876543321 1122345778999998765 4578999999999999999999999975321 1111111111   


Q ss_pred             hcCCchhhhhhhhh--------hhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          492 SLPHGLTEVVDANL--------VREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       492 ~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      ..+.....+.....        .............+..+.+++.+||..||++||++.+++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  299 (302)
T cd07864         237 PCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS  299 (302)
T ss_pred             CChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            00000111100000        00000011112246788999999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-35  Score=296.81  Aligned_cols=265  Identities=22%  Similarity=0.255  Sum_probs=200.5

Q ss_pred             cccccccCccCcccEEEEEeC-CCCeEEEEEeehhh--HHHHHHHHHHHHHHhhcCCCCcceeeeeeecC--CceEEEEe
Q 007680          274 FNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSYSNP--DFKALVLE  348 (593)
Q Consensus       274 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e  348 (593)
                      |++.+.||+|++|.||+|... +++.+|+|++....  ......+.+|++++++++|||++++++++...  +..++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            677889999999999999976 58899999998763  33445688899999999999999999999888  88999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCC
Q 007680          349 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGED  428 (593)
Q Consensus       349 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  428 (593)
                      |+++ +|.+++......+++..+..++.|+++||+|||++    +++|+||+|+||++++++.+||+|||.+........
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~----~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~  155 (287)
T cd07840          81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSN----GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS  155 (287)
T ss_pred             cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC----CceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence            9974 89999877655699999999999999999999965    499999999999999999999999999987654432


Q ss_pred             ccccccccCCccccCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcC----Cchhhhhh-
Q 007680          429 SVRQTMTMATIGYMAPEYGLE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLP----HGLTEVVD-  502 (593)
Q Consensus       429 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~----~~~~~~~~-  502 (593)
                      . ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......  ...........    .......+ 
T Consensus       156 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07840         156 A-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTEL--EQLEKIFELCGSPTDENWPGVSKL  232 (287)
T ss_pred             c-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCchhhccccccc
Confidence            1 1233456788999997664 45789999999999999999999999764321  11111111100    00000000 


Q ss_pred             -------hhhhhhhhhhhhhHH-HHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          503 -------ANLVREEQAFSAKMD-CILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       503 -------~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                             ............... ++.++.+++.+||..+|.+||++.+++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  284 (287)
T cd07840         233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH  284 (287)
T ss_pred             hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence                   000000000001111 36788999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=1.7e-35  Score=301.65  Aligned_cols=271  Identities=21%  Similarity=0.282  Sum_probs=197.4

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh--HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCC------
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPD------  341 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  341 (593)
                      .++|++.+.||+|+||.||+|... +++.||+|.+....  ......+.+|++++++++||||+++++++...+      
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            457999999999999999999975 68999999986542  222335678999999999999999999886654      


Q ss_pred             --ceEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeecc
Q 007680          342 --FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGI  419 (593)
Q Consensus       342 --~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~  419 (593)
                        ..++||||+. ++|.+++......+++.++..++.|++.||+|||++    +++|+||||+||+++.++.+||+|||.
T Consensus        91 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~----~i~H~dl~p~nil~~~~~~~kl~dfg~  165 (310)
T cd07865          91 KGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRN----KILHRDMKAANILITKDGILKLADFGL  165 (310)
T ss_pred             CceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHEEECCCCcEEECcCCC
Confidence              4599999995 589888877655689999999999999999999965    499999999999999999999999999


Q ss_pred             ceecCCCCCc--cccccccCCccccCccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCcccccc-chHHHHHHHhcCC
Q 007680          420 YKLLGEGEDS--VRQTMTMATIGYMAPEYGLEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFIGE-MSLRRWVKESLPH  495 (593)
Q Consensus       420 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~-~~~~~~~~~~~~~  495 (593)
                      +.........  .......++..|+|||++.+. .++.++||||||+++|||++|+.||....... ...........+.
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (310)
T cd07865         166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP  245 (310)
T ss_pred             cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence            9876443221  111234578889999987664 47889999999999999999999997632211 0111111111111


Q ss_pred             ch-hhh-----hhh-hhhhhhh-hhh---hhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          496 GL-TEV-----VDA-NLVREEQ-AFS---AKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       496 ~~-~~~-----~~~-~~~~~~~-~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      .. ...     .+. ....... ...   ........+.+++.+||..||++|||++|+++|
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h  307 (310)
T cd07865         246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH  307 (310)
T ss_pred             hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence            10 000     000 0000000 000   000123467899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.6e-35  Score=297.16  Aligned_cols=244  Identities=22%  Similarity=0.290  Sum_probs=192.6

Q ss_pred             cCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEeccCCCCH
Q 007680          280 LGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSL  355 (593)
Q Consensus       280 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  355 (593)
                      ||+|+||+||++... +|+.||+|.+....   ......+..|++++++++||||+++++.+...+..|+||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            699999999999865 68999999987542   22344567899999999999999999999999999999999999999


Q ss_pred             HHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCcccccc
Q 007680          356 EKWLYSHNY-FLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTM  434 (593)
Q Consensus       356 ~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~  434 (593)
                      .+++..... .+++.++..++.|++.||.|||+.    +++||||+|+||++++++.++|+|||.+.......   ....
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~----~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~  153 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR----RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKG  153 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEECCCCCEEEccCcchhhhccCC---cccc
Confidence            999977553 589999999999999999999965    59999999999999999999999999987654321   1223


Q ss_pred             ccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhhhhhhh
Q 007680          435 TMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSA  514 (593)
Q Consensus       435 ~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  514 (593)
                      ..++..|+|||++.+..++.++||||||+++|+|++|+.||....... ..... ...            ....  ....
T Consensus       154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~-~~~------------~~~~--~~~~  217 (277)
T cd05577         154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKV-EKEEL-KRR------------TLEM--AVEY  217 (277)
T ss_pred             ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccc-cHHHH-Hhc------------cccc--cccC
Confidence            457889999999888889999999999999999999999996632210 00000 000            0000  0011


Q ss_pred             hHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHHH
Q 007680          515 KMDCILSIMDFALDCCMESPDMRI-----NMTDAAAK  546 (593)
Q Consensus       515 ~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  546 (593)
                      +...++.+.+++.+||+.||++||     ++.++++|
T Consensus       218 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h  254 (277)
T cd05577         218 PDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREH  254 (277)
T ss_pred             CccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence            122356789999999999999999     55556553

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=3.1e-35  Score=295.35  Aligned_cols=242  Identities=20%  Similarity=0.267  Sum_probs=186.7

Q ss_pred             ccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHh---hcCCCCcceeeeeeecCCceEEEEeccC
Q 007680          279 LLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLR---NVRHRNLIKILSSYSNPDFKALVLEFMP  351 (593)
Q Consensus       279 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~---~l~h~niv~l~~~~~~~~~~~lv~e~~~  351 (593)
                      .||+|+||.||++... +++.+|+|.+....   ......+.+|..+++   ..+||||+.+++++...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999975 68999999986542   111223344443333   3479999999999999999999999999


Q ss_pred             CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCccc
Q 007680          352 NGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVR  431 (593)
Q Consensus       352 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~  431 (593)
                      +++|.+++..... +++..+..++.|++.||+|||++    +|+||||||+||++++++.++|+|||++.......    
T Consensus        81 ~~~L~~~i~~~~~-l~~~~~~~i~~qi~~al~~lH~~----~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~----  151 (279)
T cd05633          81 GGDLHYHLSQHGV-FSEKEMRFYATEIILGLEHMHNR----FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----  151 (279)
T ss_pred             CCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHC----CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC----
Confidence            9999999876654 89999999999999999999954    49999999999999999999999999987554322    


Q ss_pred             cccccCCccccCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhhh
Q 007680          432 QTMTMATIGYMAPEYGLE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQ  510 (593)
Q Consensus       432 ~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  510 (593)
                      .....++..|+|||...+ ..++.++||||+||++|+|++|..||.................                 .
T Consensus       152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-----------------~  214 (279)
T cd05633         152 PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT-----------------V  214 (279)
T ss_pred             ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhc-----------------C
Confidence            123468999999998764 5689999999999999999999999976322111110000000                 0


Q ss_pred             hhhhhHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHHH
Q 007680          511 AFSAKMDCILSIMDFALDCCMESPDMRI-----NMTDAAAK  546 (593)
Q Consensus       511 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  546 (593)
                      ....+..++.++.+++.+||..||++||     +++|+++|
T Consensus       215 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         215 NVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             CcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence            0011123456889999999999999999     59988876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=2.1e-35  Score=299.03  Aligned_cols=267  Identities=21%  Similarity=0.246  Sum_probs=196.4

Q ss_pred             hccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhH--HHHHHHHHHHHHHhhcC-CCCcceeeeeeecCCc-----
Q 007680          272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLE--RAFRSFDSECEVLRNVR-HRNLIKILSSYSNPDF-----  342 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~-----  342 (593)
                      ++|++.+.||+|+||.||+|... +++.||+|.++....  .....+.+|+.++++++ ||||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            46889999999999999999965 689999999865432  22356788999999995 6999999999877665     


Q ss_pred             eEEEEeccCCCCHHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC-CCcEEEEee
Q 007680          343 KALVLEFMPNGSLEKWLYSHN----YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDE-NMVAHVSDF  417 (593)
Q Consensus       343 ~~lv~e~~~~gsL~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~-~~~~kL~Df  417 (593)
                      .++||||+++ +|.+++....    ..+++..+..++.||+.||+|||++    +|+||||||+||+++. ++.+||+||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~----~i~H~dl~~~nil~~~~~~~~kl~df  155 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH----GVMHRDLKPQNLLVDKQKGLLKIADL  155 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCChHHEEEecCCCeEEEeec
Confidence            8999999975 8988886532    2479999999999999999999954    5999999999999998 889999999


Q ss_pred             ccceecCCCCCccccccccCCccccCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHh-cCC
Q 007680          418 GIYKLLGEGEDSVRQTMTMATIGYMAPEYGLE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKES-LPH  495 (593)
Q Consensus       418 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~-~~~  495 (593)
                      |.+..+.....  ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||....... ...+..... .+.
T Consensus       156 g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~  232 (295)
T cd07837         156 GLGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ-QLLHIFKLLGTPT  232 (295)
T ss_pred             ccceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHHHhCCCC
Confidence            99886543221  1122346788999998765 457999999999999999999999997532111 111111100 000


Q ss_pred             c--hhhhhhhhhh------hhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          496 G--LTEVVDANLV------REEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       496 ~--~~~~~~~~~~------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      .  ..........      ............+.++.+++.+||..||++||++.|++.|
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~  291 (295)
T cd07837         233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH  291 (295)
T ss_pred             hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            0  0000000000      0000001112356788999999999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.5e-35  Score=320.57  Aligned_cols=271  Identities=16%  Similarity=0.177  Sum_probs=191.6

Q ss_pred             hhhccccccccCccCcccEEEEEeC--CCCeEEEEE--------------eeh---hhHHHHHHHHHHHHHHhhcCCCCc
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTIS--DGTDVAIKV--------------FNL---QLERAFRSFDSECEVLRNVRHRNL  330 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~--------------~~~---~~~~~~~~~~~E~~~l~~l~h~ni  330 (593)
                      ..++|++++.||+|+||.||++..+  ++...+.|.              +.+   ........+.+|+.++++++||||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence            4578999999999999999998753  222222221              111   112234568899999999999999


Q ss_pred             ceeeeeeecCCceEEEEeccCCCCHHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeee
Q 007680          331 IKILSSYSNPDFKALVLEFMPNGSLEKWLYSHN----YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILL  406 (593)
Q Consensus       331 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll  406 (593)
                      +++++++...+..++|+|++ +++|.+++....    ......++..++.|++.||+|||++    +|+||||||+|||+
T Consensus       226 v~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~----gIiHrDLKP~NILl  300 (501)
T PHA03210        226 LKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK----KLIHRDIKLENIFL  300 (501)
T ss_pred             CcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEE
Confidence            99999999999999999999 457887775432    1234567888999999999999954    59999999999999


Q ss_pred             CCCCcEEEEeeccceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCC-CCccccc-cch
Q 007680          407 DENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRP-TDEMFIG-EMS  484 (593)
Q Consensus       407 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~p-f~~~~~~-~~~  484 (593)
                      +.++.+||+|||+++.+...... ......||..|+|||++.+..++.++|||||||++|||++|..+ +...... ...
T Consensus       301 ~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~  379 (501)
T PHA03210        301 NCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ  379 (501)
T ss_pred             CCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence            99999999999999876543221 22335689999999999999999999999999999999998754 4332111 112


Q ss_pred             HHHHHH------HhcCCchh---hhhhhh-hhhhh---hhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          485 LRRWVK------ESLPHGLT---EVVDAN-LVREE---QAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       485 ~~~~~~------~~~~~~~~---~~~~~~-~~~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      +.+.+.      ..+++...   +.++.. +....   ...-.....+.++.+++.+||+.||++|||+.|+++|
T Consensus       380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h  454 (501)
T PHA03210        380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL  454 (501)
T ss_pred             HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            222111      11111111   111100 00000   0000111234567889999999999999999999975

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-36  Score=298.90  Aligned_cols=248  Identities=24%  Similarity=0.331  Sum_probs=207.6

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALV  346 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  346 (593)
                      .+.|...++||+|+||.||-++.+ +|+.+|.|.+.+..   ........+|-.++++++.+.||.+-..|+..+..|+|
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV  263 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV  263 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence            456888899999999999999854 89999999886643   33445678899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCC
Q 007680          347 LEFMPNGSLEKWLYSHNY-FLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGE  425 (593)
Q Consensus       347 ~e~~~~gsL~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~  425 (593)
                      +..|.||+|.-+|.+.+. .+++..+.-.+.+|+.||++||+..    ||.||+||+|||+|+.|+++|+|+|+|..+..
T Consensus       264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~----iVYRDLKPeNILLDd~GhvRISDLGLAvei~~  339 (591)
T KOG0986|consen  264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR----IVYRDLKPENILLDDHGHVRISDLGLAVEIPE  339 (591)
T ss_pred             EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc----eeeccCChhheeeccCCCeEeeccceEEecCC
Confidence            999999999999988764 5999999999999999999999654    99999999999999999999999999999877


Q ss_pred             CCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhh
Q 007680          426 GEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANL  505 (593)
Q Consensus       426 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  505 (593)
                      +..   ....+||.+|||||++.++.|+...|.||+||++|||+.|+.||......              .-.+-+|...
T Consensus       340 g~~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK--------------vk~eEvdrr~  402 (591)
T KOG0986|consen  340 GKP---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK--------------VKREEVDRRT  402 (591)
T ss_pred             CCc---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhh--------------hhHHHHHHHH
Confidence            654   23458999999999999999999999999999999999999999663110              0112333333


Q ss_pred             hhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHH
Q 007680          506 VREEQAFSAKMDCILSIMDFALDCCMESPDMRINMT  541 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  541 (593)
                      ......+  +..++++..++.+..|.+||++|....
T Consensus       403 ~~~~~ey--~~kFS~eakslc~~LL~Kdp~~RLGcr  436 (591)
T KOG0986|consen  403 LEDPEEY--SDKFSEEAKSLCEGLLTKDPEKRLGCR  436 (591)
T ss_pred             hcchhhc--ccccCHHHHHHHHHHHccCHHHhccCC
Confidence            3333322  245678899999999999999997543

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.3e-36  Score=307.86  Aligned_cols=249  Identities=25%  Similarity=0.336  Sum_probs=208.6

Q ss_pred             hhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh--HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEE
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALV  346 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  346 (593)
                      ....|.+.+.||+|.|+.|.+|++. ++..||||.+.+..  ....+.+.+|+++|..++|||||+++.+.+.....|+|
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV  133 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV  133 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence            3567999999999999999999965 79999999998753  33445688999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCC
Q 007680          347 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG  426 (593)
Q Consensus       347 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  426 (593)
                      |||+.+|.+.+++.+++. ..+.++..++.|+.+|++|||+++    |+|||||++||+++.+.++||+|||++..+...
T Consensus       134 ~eya~~ge~~~yl~~~gr-~~e~~ar~~F~q~vsaveYcH~k~----ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~  208 (596)
T KOG0586|consen  134 MEYASGGELFDYLVKHGR-MKEKEARAKFRQIVSAVEYCHSKN----IVHRDLKAENILLDENMNIKIADFGFSTFFDYG  208 (596)
T ss_pred             EEeccCchhHHHHHhccc-chhhhhhhhhHHHHHHHHHHhhcc----eeccccchhhcccccccceeeeccccceeeccc
Confidence            999999999999999886 666899999999999999999655    999999999999999999999999999988744


Q ss_pred             CCccccccccCCccccCccccCCCCC-CccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhh
Q 007680          427 EDSVRQTMTMATIGYMAPEYGLEGIV-SAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANL  505 (593)
Q Consensus       427 ~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  505 (593)
                      .   .....+|++.|.|||++.+..| ++++|+||+|+++|-|+.|..||++..-.                 +.-++.+
T Consensus       209 ~---~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk-----------------~Lr~rvl  268 (596)
T KOG0586|consen  209 L---MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK-----------------ELRPRVL  268 (596)
T ss_pred             c---cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc-----------------cccchhe
Confidence            3   3345689999999999998775 68999999999999999999999873211                 1111111


Q ss_pred             hhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          506 VREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                       ....+.+..+  +.+..+++++++..+|.+|++++++.++
T Consensus       269 -~gk~rIp~~m--s~dce~lLrk~lvl~Pskr~~~dqim~~  306 (596)
T KOG0586|consen  269 -RGKYRIPFYM--SCDCEDLLRKFLVLNPSKRGPCDQIMKD  306 (596)
T ss_pred             -eeeeccccee--echhHHHHHHhhccCccccCCHHHhhhh
Confidence             1111122222  3467899999999999999999999886

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=2.7e-35  Score=303.02  Aligned_cols=270  Identities=20%  Similarity=0.293  Sum_probs=196.7

Q ss_pred             cccCcc--CcccEEEEEeC-CCCeEEEEEeehhh--HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEeccCC
Q 007680          278 NLLGTS--SFGSVYKGTIS-DGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPN  352 (593)
Q Consensus       278 ~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  352 (593)
                      ..||+|  +||+||++++. +|+.||+|++....  ....+.+.+|+.+++.++||||+++++++..++..++||||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            456776  88999999975 79999999987532  33457789999999999999999999999999999999999999


Q ss_pred             CCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCcc-
Q 007680          353 GSLEKWLYSHNY-FLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSV-  430 (593)
Q Consensus       353 gsL~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~-  430 (593)
                      ++|.+++..... .+++..+..++.|++.||+|||++    +++||||||+||+++.++.++++||+.+.......... 
T Consensus        84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~----~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~  159 (328)
T cd08226          84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN----GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK  159 (328)
T ss_pred             CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence            999999876532 588999999999999999999954    59999999999999999999999998654332211110 


Q ss_pred             ----ccccccCCccccCccccCCC--CCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhc---------CC
Q 007680          431 ----RQTMTMATIGYMAPEYGLEG--IVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESL---------PH  495 (593)
Q Consensus       431 ----~~~~~~gt~~y~aPE~~~~~--~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~---------~~  495 (593)
                          ......++..|+|||++.+.  .++.++|||||||++|||++|+.||........ .........         +.
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  238 (328)
T cd08226         160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM-LLQKLKGPPYSPLDITTFPC  238 (328)
T ss_pred             ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH-HHHHhcCCCCCCccccccch
Confidence                01112346679999998764  478999999999999999999999976432211 111110000         00


Q ss_pred             chhh---------------hhhh----hhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH--HHHhhh
Q 007680          496 GLTE---------------VVDA----NLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK--LKKIKV  552 (593)
Q Consensus       496 ~~~~---------------~~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~i~~  552 (593)
                      ....               ....    .........+....++..+.+++++||+.||++|||+.|+++|  +..++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~  316 (328)
T cd08226         239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE  316 (328)
T ss_pred             hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence            0000               0000    0000001112233466789999999999999999999999976  444433

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.3e-35  Score=294.98  Aligned_cols=245  Identities=24%  Similarity=0.314  Sum_probs=195.0

Q ss_pred             cCccCcccEEEEEeC-CCCeEEEEEeehhhH---HHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEeccCCCCH
Q 007680          280 LGTSSFGSVYKGTIS-DGTDVAIKVFNLQLE---RAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSL  355 (593)
Q Consensus       280 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  355 (593)
                      ||+|+||.||++... +|+.+++|++.....   ...+.+.+|++++++++||||+++++.+..++..+++|||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999976 599999999876532   4556788999999999999999999999999999999999999999


Q ss_pred             HHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCC------c
Q 007680          356 EKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGED------S  429 (593)
Q Consensus       356 ~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~------~  429 (593)
                      .+++.+.+ .+++..+..++.|+++||+|||+.+    ++|+||+|+||++++++.++|+|||++........      .
T Consensus        81 ~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH~~~----i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  155 (265)
T cd05579          81 ASLLENVG-SLDEDVARIYIAEIVLALEYLHSNG----IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE  155 (265)
T ss_pred             HHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcC----eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence            99998765 4899999999999999999999654    99999999999999999999999999876443321      1


Q ss_pred             cccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhh
Q 007680          430 VRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREE  509 (593)
Q Consensus       430 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  509 (593)
                      .......++..|+|||...+...+.++||||||+++|++++|..||......+  .......                ..
T Consensus       156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~--~~~~~~~----------------~~  217 (265)
T cd05579         156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE--IFQNILN----------------GK  217 (265)
T ss_pred             ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHhc----------------CC
Confidence            12233457888999999888889999999999999999999999997532111  1111000                00


Q ss_pred             hhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 007680          510 QAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKL  547 (593)
Q Consensus       510 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  547 (593)
                      ...+.....+..+.+++.+||+.+|++|||+.++.+.|
T Consensus       218 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l  255 (265)
T cd05579         218 IEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK  255 (265)
T ss_pred             cCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence            00111111256789999999999999999995554443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=3.4e-35  Score=303.43  Aligned_cols=275  Identities=23%  Similarity=0.272  Sum_probs=203.1

Q ss_pred             hhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehh--hHHHHHHHHHHHHHHhhc-CCCCcceeeeeeecC--Cce
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQ--LERAFRSFDSECEVLRNV-RHRNLIKILSSYSNP--DFK  343 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--~~~  343 (593)
                      ..++|++.+.||+|+||.||+|... +++.+|+|.+...  .......+.+|+.+++++ +||||+++++++...  ...
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            4578999999999999999999975 6889999988542  223345677899999999 999999999988654  368


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceec
Q 007680          344 ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLL  423 (593)
Q Consensus       344 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~  423 (593)
                      ++||||++ ++|.+++...  .+++..+..++.|++.||+|||++    +|+||||||+||+++.++.+||+|||.+...
T Consensus        85 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~----~i~H~dl~p~nill~~~~~~kl~d~g~~~~~  157 (337)
T cd07852          85 YLVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSG----NVIHRDLKPSNILLNSDCRVKLADFGLARSL  157 (337)
T ss_pred             EEEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence            99999996 5999998765  488999999999999999999954    5999999999999999999999999998876


Q ss_pred             CCCCCc---cccccccCCccccCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchh-
Q 007680          424 GEGEDS---VRQTMTMATIGYMAPEYGLE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLT-  498 (593)
Q Consensus       424 ~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~-  498 (593)
                      ......   .......++..|+|||++.+ ..++.++||||||+++|+|++|+.||.......  .............. 
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~--~~~~~~~~~~~~~~~  235 (337)
T cd07852         158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLN--QLEKIIEVIGPPSAE  235 (337)
T ss_pred             ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCCHH
Confidence            543221   12233457889999998754 457899999999999999999999996532211  11111111110000 


Q ss_pred             -----------hhhhhhhhhhhhh-hhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH--HHHhhhh
Q 007680          499 -----------EVVDANLVREEQA-FSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK--LKKIKVK  553 (593)
Q Consensus       499 -----------~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~i~~~  553 (593)
                                 ...+......... ......++.++.+++.+||+.||++|||+.+++++  ++.....
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~  304 (337)
T cd07852         236 DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNP  304 (337)
T ss_pred             HHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccC
Confidence                       0000000000000 00011246788999999999999999999999987  5555433

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.8e-35  Score=305.04  Aligned_cols=268  Identities=21%  Similarity=0.274  Sum_probs=200.6

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh--HHHHHHHHHHHHHHhhcCCCCcceeeeeeec----CCce
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSYSN----PDFK  343 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~  343 (593)
                      .++|++.+.||+|++|.||+|... +|+.||+|++....  ......+.+|+.++++++||||+++++++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            368999999999999999999965 69999999987542  2334567789999999999999999998753    3468


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceec
Q 007680          344 ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLL  423 (593)
Q Consensus       344 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~  423 (593)
                      ++||||+. ++|.+++..... +++..+..++.|++.||+|||++    +|+||||||+||++++++.+||+|||.+...
T Consensus        84 ~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~i~~qi~~aL~~LH~~----~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~  157 (334)
T cd07855          84 YVVMDLME-SDLHHIIHSDQP-LTEEHIRYFLYQLLRGLKYIHSA----NVIHRDLKPSNLLVNEDCELRIGDFGMARGL  157 (334)
T ss_pred             EEEEehhh-hhHHHHhccCCC-CCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEEcCCCcEEecccccceee
Confidence            99999995 689999876554 89999999999999999999965    4999999999999999999999999998866


Q ss_pred             CCCCCcc--ccccccCCccccCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhh
Q 007680          424 GEGEDSV--RQTMTMATIGYMAPEYGLE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEV  500 (593)
Q Consensus       424 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  500 (593)
                      .......  ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||.......  ..............+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~--~~~~~~~~~g~~~~~~  235 (334)
T cd07855         158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVH--QLKLILSVLGSPSEEV  235 (334)
T ss_pred             cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHH--HHHHHHHHhCCChhHh
Confidence            4332211  1123468889999998765 468999999999999999999999996632111  1111111110000000


Q ss_pred             h----hhhhhh--------hhhh-hhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          501 V----DANLVR--------EEQA-FSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       501 ~----~~~~~~--------~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      .    ...+..        .... .......+.++.+++.+||+.+|++||++.+++.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  294 (334)
T cd07855         236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH  294 (334)
T ss_pred             hhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            0    000000        0000 00112346789999999999999999999999986

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.6e-35  Score=300.11  Aligned_cols=253  Identities=21%  Similarity=0.263  Sum_probs=197.3

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh-HHHHHHHHHHHHHHhhc-CCCCcceeeeeeecCCceEEEE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNV-RHRNLIKILSSYSNPDFKALVL  347 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  347 (593)
                      .++|++.+.||+|++|.||+|.++ +++.||||.++... ......+..|+.++.+. .||||+++++++......+++|
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   93 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM   93 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence            467899999999999999999986 48999999997542 23344566677777666 4999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCC
Q 007680          348 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGE  427 (593)
Q Consensus       348 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~  427 (593)
                      ||++ +++.+++......+++..+..++.|++.||+|||+.   .+|+||||+|+||++++++.+||+|||.+..+....
T Consensus        94 e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~  169 (296)
T cd06618          94 ELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEK---HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK  169 (296)
T ss_pred             eccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhh---CCEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence            9984 578887776555689999999999999999999952   359999999999999999999999999987654322


Q ss_pred             CccccccccCCccccCccccCCCC----CCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhh
Q 007680          428 DSVRQTMTMATIGYMAPEYGLEGI----VSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDA  503 (593)
Q Consensus       428 ~~~~~~~~~gt~~y~aPE~~~~~~----~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  503 (593)
                      .   .....++..|+|||++.+..    ++.++||||||+++|+|++|+.||.........+........+         
T Consensus       170 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~---------  237 (296)
T cd06618         170 A---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPP---------  237 (296)
T ss_pred             c---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCC---------
Confidence            1   12235778899999987553    7889999999999999999999996532211111111111000         


Q ss_pred             hhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          504 NLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                             ..+....++.++.+++.+||..||++||++.+++++
T Consensus       238 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         238 -------SLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             -------CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                   000111235678999999999999999999999977

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=3.2e-35  Score=290.91  Aligned_cols=247  Identities=28%  Similarity=0.348  Sum_probs=202.0

Q ss_pred             ccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh--HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEec
Q 007680          273 EFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEF  349 (593)
Q Consensus       273 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  349 (593)
                      +|++.+.||+|++|.||++..+ +++.+|+|.+....  ......+.+|++++++++|+||+++.+++......++||||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            4788999999999999999865 78899999987642  33456778899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCC
Q 007680          350 MPNGSLEKWLYSH---NYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG  426 (593)
Q Consensus       350 ~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  426 (593)
                      +++++|.+++...   ...+++..+..++.|++.||+|||+.    +++|+||+|+||++++++.+||+|||++......
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~----~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ----KILHRDLKSANILLVANDLVKIGDLGISKVLKKN  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC----CcccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence            9999999998762   23589999999999999999999954    5999999999999999999999999998876543


Q ss_pred             CCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhh
Q 007680          427 EDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLV  506 (593)
Q Consensus       427 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  506 (593)
                      .    .....++..|+|||.+.+..++.++|+||+|+++|+|++|+.||......  .+.........            
T Consensus       157 ~----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~--~~~~~~~~~~~------------  218 (256)
T cd08530         157 M----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ--DLRYKVQRGKY------------  218 (256)
T ss_pred             C----cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHhcCCC------------
Confidence            1    12245788999999999989999999999999999999999999763211  11111111000            


Q ss_pred             hhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          507 REEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                           ......++.++.+++.+||..+|++||++.|++++
T Consensus       219 -----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         219 -----PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             -----CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence                 00111345678999999999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-36  Score=284.30  Aligned_cols=250  Identities=23%  Similarity=0.282  Sum_probs=201.2

Q ss_pred             hhccccc-cccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhc-CCCCcceeeeeeecC----Cce
Q 007680          271 TDEFNEC-NLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNV-RHRNLIKILSSYSNP----DFK  343 (593)
Q Consensus       271 ~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----~~~  343 (593)
                      +++|++. ++||-|-.|.|-.+.++ +|+++|+|++...     ...++|+++.-.. .|||||.++++|++.    ...
T Consensus        60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL  134 (400)
T KOG0604|consen   60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL  134 (400)
T ss_pred             hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence            5566654 58999999999999865 8999999998532     4567788877666 699999999988653    467


Q ss_pred             EEEEeccCCCCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC---CCcEEEEeecc
Q 007680          344 ALVLEFMPNGSLEKWLYSHNY-FLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDE---NMVAHVSDFGI  419 (593)
Q Consensus       344 ~lv~e~~~~gsL~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~---~~~~kL~Dfg~  419 (593)
                      .+|||.|+||.|.+.++.++. .+++.++..|++||+.|++|||    +++|.||||||+|+|.+.   +-.+||+|||+
T Consensus       135 LiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH----~~nIAHRDlKpENLLyt~t~~na~lKLtDfGF  210 (400)
T KOG0604|consen  135 LIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLH----SMNIAHRDLKPENLLYTTTSPNAPLKLTDFGF  210 (400)
T ss_pred             EeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHH----hcchhhccCChhheeeecCCCCcceEeccccc
Confidence            789999999999999988765 7999999999999999999999    556999999999999974   45799999999


Q ss_pred             ceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhh
Q 007680          420 YKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTE  499 (593)
Q Consensus       420 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  499 (593)
                      |+.-...   ......+-|+.|.|||++...+|+..+|+||+||++|-|+.|.+||.......          ++..+  
T Consensus       211 AK~t~~~---~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a----------ispgM--  275 (400)
T KOG0604|consen  211 AKETQEP---GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA----------ISPGM--  275 (400)
T ss_pred             ccccCCC---ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc----------CChhH--
Confidence            9865432   23345678999999999999999999999999999999999999997642211          01111  


Q ss_pred             hhhhhhhhhhh--hhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          500 VVDANLVREEQ--AFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       500 ~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                        ..++.....  ..+++..++++.+++|+.+|+.+|.+|.|+.|+++|
T Consensus       276 --k~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h  322 (400)
T KOG0604|consen  276 --KRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH  322 (400)
T ss_pred             --HhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence              111222222  234566788899999999999999999999999986

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=3.8e-35  Score=299.96  Aligned_cols=264  Identities=21%  Similarity=0.222  Sum_probs=193.5

Q ss_pred             cccccCccCcccEEEEEeCCCCeEEEEEeehh--hHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEeccCCC
Q 007680          276 ECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQ--LERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNG  353 (593)
Q Consensus       276 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  353 (593)
                      +.+.+|.|+++.||++.. +++.||+|+++..  .....+.+.+|++++++++||||+++++++...+..+++|||++++
T Consensus         6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~   84 (314)
T cd08216           6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG   84 (314)
T ss_pred             hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence            334445555554555444 6899999999765  3445678999999999999999999999999999999999999999


Q ss_pred             CHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCc---
Q 007680          354 SLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDS---  429 (593)
Q Consensus       354 sL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~---  429 (593)
                      +|.+++.... ..+++..+..++.|+++||+|||++    +|+||||||+||+++.++.+||+|||.+.........   
T Consensus        85 ~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~----~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~  160 (314)
T cd08216          85 SCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK----GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV  160 (314)
T ss_pred             CHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence            9999998643 3588999999999999999999965    4999999999999999999999999988765432211   


Q ss_pred             --cccccccCCccccCccccCC--CCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCch--------
Q 007680          430 --VRQTMTMATIGYMAPEYGLE--GIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGL--------  497 (593)
Q Consensus       430 --~~~~~~~gt~~y~aPE~~~~--~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~--------  497 (593)
                        .......++..|+|||++.+  ..++.++|||||||++|||++|+.||.......... +......+..+        
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  239 (314)
T cd08216         161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLL-EKVRGTVPCLLDKSTYPLY  239 (314)
T ss_pred             cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhccCccccccCchhhh
Confidence              11123346778999999866  358899999999999999999999997643222111 11111111000        


Q ss_pred             ----hh----hhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          498 ----TE----VVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       498 ----~~----~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                          ..    ..+... ..............++.+++.+||..||++|||++|+++|
T Consensus       240 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  295 (314)
T cd08216         240 EDSMSQSRSSNEHPNN-RDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH  295 (314)
T ss_pred             cCCcCcccccccccch-hhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence                00    000000 0011111222345678999999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.8e-35  Score=303.94  Aligned_cols=273  Identities=23%  Similarity=0.275  Sum_probs=203.7

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehh--hHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-----Cc
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQ--LERAFRSFDSECEVLRNVRHRNLIKILSSYSNP-----DF  342 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~  342 (593)
                      .++|.+.+.||+|+||.||+|... +++.||+|.++..  .......+.+|+.+++.++|+||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            457999999999999999999864 7899999998753  223345677899999999999999999987644     35


Q ss_pred             eEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeecccee
Q 007680          343 KALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKL  422 (593)
Q Consensus       343 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~  422 (593)
                      .++|+||+. ++|.+++.... .+++..+..++.|++.||.|||++    +++||||||+||+++.++.+||+|||++..
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~----~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~  157 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRSSQ-TLSDDHCQYFLYQLLRGLKYIHSA----NVLHRDLKPSNLLLNANCDLKICDFGLART  157 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhC----CEecCCCCHHHEEEcCCCCEEECcCccccc
Confidence            799999995 68999887654 489999999999999999999955    599999999999999999999999999886


Q ss_pred             cCCCCCccccccccCCccccCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhc---C-Cch
Q 007680          423 LGEGEDSVRQTMTMATIGYMAPEYGLE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESL---P-HGL  497 (593)
Q Consensus       423 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~---~-~~~  497 (593)
                      ......  ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||......  ..........   + +..
T Consensus       158 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~  233 (337)
T cd07858         158 TSEKGD--FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYV--HQLKLITELLGSPSEEDL  233 (337)
T ss_pred             cCCCcc--cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChH--HHHHHHHHHhCCCChHHh
Confidence            643321  1223457889999998765 46899999999999999999999999653211  1111111000   0 001


Q ss_pred             hhhhhhhhhh---------hhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH--HHHhhhh
Q 007680          498 TEVVDANLVR---------EEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK--LKKIKVK  553 (593)
Q Consensus       498 ~~~~~~~~~~---------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~i~~~  553 (593)
                      ....+.....         .........++++++.+++++||+.+|++|||++|+++|  ++.+...
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~  300 (337)
T cd07858         234 GFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDP  300 (337)
T ss_pred             hhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCc
Confidence            0000000000         000001112456788999999999999999999999998  7665444

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.9e-35  Score=291.45  Aligned_cols=251  Identities=22%  Similarity=0.271  Sum_probs=198.4

Q ss_pred             hccccccccCccCcccEEEEEeC-CCCeEEEEEeehh-----hHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC--Cce
Q 007680          272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQ-----LERAFRSFDSECEVLRNVRHRNLIKILSSYSNP--DFK  343 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  343 (593)
                      .+|++.+.||+|+||.||+|... +++.||+|.+...     .......+.+|++++++++|+||+++++++.+.  +..
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            47899999999999999999964 6899999987542     233456788999999999999999999998764  457


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceec
Q 007680          344 ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLL  423 (593)
Q Consensus       344 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~  423 (593)
                      ++++||+++++|.+++..... +++..+..++.|++.||.|||++    +++|+||||+||+++.++.++|+|||.++..
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~~-l~~~~~~~~~~~i~~al~~LH~~----~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~  156 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYGA-LTENVTRRYTRQILQGVSYLHSN----MIVHRDIKGANILRDSAGNVKLGDFGASKRI  156 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHhC----CEecCCCCHHHEEEcCCCCEEECcccccccc
Confidence            899999999999999976554 88999999999999999999965    4999999999999999999999999998865


Q ss_pred             CCCCCc-cccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhh
Q 007680          424 GEGEDS-VRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVD  502 (593)
Q Consensus       424 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  502 (593)
                      ...... .......++..|+|||++.+..++.++|+|||||++|++++|+.||....... ...+.....          
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~----------  225 (264)
T cd06653         157 QTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA-AIFKIATQP----------  225 (264)
T ss_pred             ccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH-HHHHHHcCC----------
Confidence            332111 11123458889999999988889999999999999999999999997632111 111110000          


Q ss_pred             hhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          503 ANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                             .....+...++.+.+++.+||. +|..||++.+++.|
T Consensus       226 -------~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~  261 (264)
T cd06653         226 -------TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH  261 (264)
T ss_pred             -------CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence                   0001112335678999999999 57999999998865

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-35  Score=289.77  Aligned_cols=248  Identities=26%  Similarity=0.388  Sum_probs=202.9

Q ss_pred             ccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhH--HHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEec
Q 007680          273 EFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLE--RAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEF  349 (593)
Q Consensus       273 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  349 (593)
                      +|++.+.||+|++|.||++... +++.|++|.+.....  ...+.+.+|++++++++|||++++++++.+.+..+++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4788899999999999999865 688999999976643  4567899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCc
Q 007680          350 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDS  429 (593)
Q Consensus       350 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~  429 (593)
                      +++++|.+++.... .+++..+..++.|++.||.|||+.    |++||||+|+||+++.++.++|+|||.+.........
T Consensus        81 ~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  155 (254)
T cd06627          81 AENGSLRQIIKKFG-PFPESLVAVYVYQVLQGLAYLHEQ----GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD  155 (254)
T ss_pred             CCCCcHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHhhC----CcccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence            99999999998764 489999999999999999999954    5999999999999999999999999999876543321


Q ss_pred             cccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhh
Q 007680          430 VRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREE  509 (593)
Q Consensus       430 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  509 (593)
                        .....++..|+|||...+..++.++||||+|+++|+|++|..||.....    ........ ..            ..
T Consensus       156 --~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~----~~~~~~~~-~~------------~~  216 (254)
T cd06627         156 --DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP----MAALFRIV-QD------------DH  216 (254)
T ss_pred             --ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH----HHHHHHHh-cc------------CC
Confidence              2234578899999998888889999999999999999999999875321    11100000 00            00


Q ss_pred             hhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          510 QAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       510 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                        ...+...+..+.+++.+||..+|++||++.|++.+
T Consensus       217 --~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  251 (254)
T cd06627         217 --PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH  251 (254)
T ss_pred             --CCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence              00111234578999999999999999999999854

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-35  Score=290.94  Aligned_cols=241  Identities=22%  Similarity=0.253  Sum_probs=186.7

Q ss_pred             cccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHH-hhcCCCCcceeeeeeecCCceEEEEeccCC
Q 007680          278 NLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVL-RNVRHRNLIKILSSYSNPDFKALVLEFMPN  352 (593)
Q Consensus       278 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  352 (593)
                      +.||+|+||.||+|... +++.||+|+++...   ......+..|..++ ...+|+|++++++++..++..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            57999999999999865 68999999987542   12223344555444 445899999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCcccc
Q 007680          353 GSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQ  432 (593)
Q Consensus       353 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~  432 (593)
                      ++|.+++..... +++..+..++.|++.||.|||+.    +++||||+|+||++++++.++|+|||++.....      .
T Consensus        82 ~~L~~~l~~~~~-~~~~~~~~i~~qi~~aL~~lH~~----~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~  150 (260)
T cd05611          82 GDCASLIKTLGG-LPEDWAKQYIAEVVLGVEDLHQR----GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------N  150 (260)
T ss_pred             CCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeEECCCCcEEEeecccceeccc------c
Confidence            999999977554 89999999999999999999964    599999999999999999999999998875432      1


Q ss_pred             ccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhhhhh
Q 007680          433 TMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQAF  512 (593)
Q Consensus       433 ~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  512 (593)
                      ....++..|+|||...+..++.++||||||+++|+|++|..||.......  ........           ....   ..
T Consensus       151 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~-----------~~~~---~~  214 (260)
T cd05611         151 KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA--VFDNILSR-----------RINW---PE  214 (260)
T ss_pred             ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHhc-----------ccCC---CC
Confidence            22357888999999888889999999999999999999999996532211  11100000           0000   00


Q ss_pred             hhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007680          513 SAKMDCILSIMDFALDCCMESPDMRINMTDAAA  545 (593)
Q Consensus       513 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  545 (593)
                      .....+++.+.+++.+||+.+|++||++.++.+
T Consensus       215 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~  247 (260)
T cd05611         215 EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQE  247 (260)
T ss_pred             cccccCCHHHHHHHHHHccCCHHHccCCCcHHH
Confidence            011134668899999999999999997754433

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=4.3e-36  Score=326.67  Aligned_cols=257  Identities=26%  Similarity=0.371  Sum_probs=192.6

Q ss_pred             HHhhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceeeeeeec------
Q 007680          268 QRATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSYSN------  339 (593)
Q Consensus       268 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------  339 (593)
                      .+-..+|++++.||+||||.||+++.+ ||+.||||++.... ......+.+|+..+++++|||||+++..|.+      
T Consensus       475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~  554 (1351)
T KOG1035|consen  475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT  554 (1351)
T ss_pred             hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence            456788999999999999999999987 99999999997663 4455678899999999999999999843310      


Q ss_pred             ------------------------------------------------------------------------C-------
Q 007680          340 ------------------------------------------------------------------------P-------  340 (593)
Q Consensus       340 ------------------------------------------------------------------------~-------  340 (593)
                                                                                              +       
T Consensus       555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS  634 (1351)
T KOG1035|consen  555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS  634 (1351)
T ss_pred             cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence                                                                                    0       


Q ss_pred             ----------------------------------CceEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH
Q 007680          341 ----------------------------------DFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH  386 (593)
Q Consensus       341 ----------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH  386 (593)
                                                        -..||-||||+..++.+++..+...-.....++++++|++||+|+|
T Consensus       635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH  714 (1351)
T KOG1035|consen  635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH  714 (1351)
T ss_pred             ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH
Confidence                                              1246889999998888888766532257789999999999999999


Q ss_pred             hcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecC----------------CCCCccccccccCCccccCccccCCC
Q 007680          387 NGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG----------------EGEDSVRQTMTMATIGYMAPEYGLEG  450 (593)
Q Consensus       387 ~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~----------------~~~~~~~~~~~~gt~~y~aPE~~~~~  450 (593)
                      ++    |||||||||.|||++++..|||+|||+|+...                .+......+..+||.-|+|||++.+.
T Consensus       715 ~~----giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~  790 (1351)
T KOG1035|consen  715 DQ----GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT  790 (1351)
T ss_pred             hC----ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence            55    49999999999999999999999999998722                01112234567899999999998765


Q ss_pred             ---CCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHh
Q 007680          451 ---IVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFAL  527 (593)
Q Consensus       451 ---~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  527 (593)
                         .|+.|+|+||+|||++||+.   ||....+....+...-...+|.. ....++              ..+.-..+|+
T Consensus       791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~-~~f~~~--------------~~~~e~slI~  852 (1351)
T KOG1035|consen  791 SSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEP-ADFFDP--------------EHPEEASLIR  852 (1351)
T ss_pred             ccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCC-cccccc--------------cchHHHHHHH
Confidence               49999999999999999986   45442111000000001111111 111111              1234478999


Q ss_pred             hcccCCCCCCCCHHHHHHH
Q 007680          528 DCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       528 ~cl~~dP~~RPs~~evl~~  546 (593)
                      .|+++||++||||.|++..
T Consensus       853 ~Ll~hdP~kRPtA~eLL~s  871 (1351)
T KOG1035|consen  853 WLLSHDPSKRPTATELLNS  871 (1351)
T ss_pred             HHhcCCCccCCCHHHHhhc
Confidence            9999999999999999863

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-36  Score=327.70  Aligned_cols=261  Identities=21%  Similarity=0.328  Sum_probs=215.7

Q ss_pred             CHHHHHHhhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhcCCCCcceeeeeee
Q 007680          263 SYLDIQRATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSYS  338 (593)
Q Consensus       263 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  338 (593)
                      ...++....++|++++.||+|+||.|..++++ +++.||+|++++..   ......|..|-.+|..-+.+-|+.++-.|.
T Consensus        66 ~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ  145 (1317)
T KOG0612|consen   66 KVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQ  145 (1317)
T ss_pred             HHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc
Confidence            34566777899999999999999999999975 78999999998742   334567899999999999999999999999


Q ss_pred             cCCceEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeec
Q 007680          339 NPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFG  418 (593)
Q Consensus       339 ~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg  418 (593)
                      +..+.|+|||||+||||-.++.+.. .+++..+.-++..|+.||.-+|    ++|+|||||||+|||+|..|++||+|||
T Consensus       146 D~~~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH----~mgyVHRDiKPDNvLld~~GHikLADFG  220 (1317)
T KOG0612|consen  146 DERYLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLH----SMGYVHRDIKPDNVLLDKSGHIKLADFG  220 (1317)
T ss_pred             CccceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHH----hccceeccCCcceeEecccCcEeeccch
Confidence            9999999999999999999999988 6999999999999999999999    6779999999999999999999999999


Q ss_pred             cceecCCCCCccccccccCCccccCccccC----C-CCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhc
Q 007680          419 IYKLLGEGEDSVRQTMTMATIGYMAPEYGL----E-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESL  493 (593)
Q Consensus       419 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~  493 (593)
                      .+-.+..++ .......+|||.|.+||++.    + +.|++.+|.||+||++|||+.|..||....     +..-+..  
T Consensus       221 sClkm~~dG-~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads-----lveTY~K--  292 (1317)
T KOG0612|consen  221 SCLKMDADG-TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS-----LVETYGK--  292 (1317)
T ss_pred             hHHhcCCCC-cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH-----HHHHHHH--
Confidence            998887554 34567788999999999875    3 569999999999999999999999997621     1111111  


Q ss_pred             CCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCC---HHHHHHH
Q 007680          494 PHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRIN---MTDAAAK  546 (593)
Q Consensus       494 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~~  546 (593)
                            +++-   .+...++...+++.+..+||.+.+. +|+.|..   +.++..|
T Consensus       293 ------Im~h---k~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H  338 (1317)
T KOG0612|consen  293 ------IMNH---KESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH  338 (1317)
T ss_pred             ------Hhch---hhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence                  1110   1112223233467788999988876 7888887   8888876

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=5.2e-35  Score=296.07  Aligned_cols=259  Identities=20%  Similarity=0.199  Sum_probs=186.1

Q ss_pred             hhccccccccCccCcccEEEEEeCC----CCeEEEEEeehhhHHH-----------HHHHHHHHHHHhhcCCCCcceeee
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTISD----GTDVAIKVFNLQLERA-----------FRSFDSECEVLRNVRHRNLIKILS  335 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~l~~  335 (593)
                      .++|.+.+.||+|+||.||+|...+    +..+|+|+........           ......+...+..++|++++++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            4689999999999999999999653    4567777643221110           011223344556678999999998


Q ss_pred             eeecCC----ceEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCc
Q 007680          336 SYSNPD----FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMV  411 (593)
Q Consensus       336 ~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~  411 (593)
                      ++....    ..++++|++. .++.+.+.... ..++..+..++.|++.||+|||++    +|+||||||+||+++.++.
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~----~iiHrDiKp~Nill~~~~~  164 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKRIK-CKNKKLIKNIMKDMLTTLEYIHEH----GISHGDIKPENIMVDGNNR  164 (294)
T ss_pred             eeeEecCCceEEEEEEehhc-cCHHHHHHhhc-cCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCc
Confidence            765543    3467888873 46777665543 267888999999999999999954    5999999999999999999


Q ss_pred             EEEEeeccceecCCCCCcc-----ccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHH
Q 007680          412 AHVSDFGIYKLLGEGEDSV-----RQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLR  486 (593)
Q Consensus       412 ~kL~Dfg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~  486 (593)
                      ++|+|||+++.+.......     ......||+.|+|||+..+..++.++|||||||++|||++|+.||........ ..
T Consensus       165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~-~~  243 (294)
T PHA02882        165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN-LI  243 (294)
T ss_pred             EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH-HH
Confidence            9999999998764322111     11234699999999999999999999999999999999999999987522211 11


Q ss_pred             HHHHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 007680          487 RWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKL  547 (593)
Q Consensus       487 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  547 (593)
                      .....       +.+. .+....   .....+++.+.+++..|++.+|++||++.++.+.+
T Consensus       244 ~~~~~-------~~~~-~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        244 HAAKC-------DFIK-RLHEGK---IKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             HHhHH-------HHHH-Hhhhhh---hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            11000       0000 000000   01123467889999999999999999999999865

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=5.4e-35  Score=298.02  Aligned_cols=249  Identities=27%  Similarity=0.329  Sum_probs=198.1

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehh---hHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQ---LERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALV  346 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  346 (593)
                      .+.|+..+.||+|+||.||+|+.. +++.+|+|.+...   .......+.+|+++++.++|+|++++++++...+..++|
T Consensus        14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   93 (308)
T cd06634          14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV   93 (308)
T ss_pred             HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence            345778889999999999999965 6788999998642   233445678899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCC
Q 007680          347 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG  426 (593)
Q Consensus       347 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  426 (593)
                      |||+. |++.+.+......+++.++..++.|++.|+.|||++    +++||||+|+||+++.++.++|+|||++......
T Consensus        94 ~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~----~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  168 (308)
T cd06634          94 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH----NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  168 (308)
T ss_pred             EEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence            99996 688888766555689999999999999999999965    4999999999999999999999999998765432


Q ss_pred             CCccccccccCCccccCccccC---CCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhh
Q 007680          427 EDSVRQTMTMATIGYMAPEYGL---EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDA  503 (593)
Q Consensus       427 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  503 (593)
                            ....++..|+|||++.   ...++.++|||||||++|+|++|..||....... ....+.....+         
T Consensus       169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~~~~~~---------  232 (308)
T cd06634         169 ------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQNESP---------  232 (308)
T ss_pred             ------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH-HHHHHhhcCCC---------
Confidence                  2235788999999864   3568889999999999999999999986532111 01111110000         


Q ss_pred             hhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHH
Q 007680          504 NLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLK  548 (593)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  548 (593)
                              ......++..+.+++.+||+.+|++||++.+++++--
T Consensus       233 --------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~  269 (308)
T cd06634         233 --------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF  269 (308)
T ss_pred             --------CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence                    0011234567899999999999999999999998744

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=5.4e-35  Score=295.89  Aligned_cols=266  Identities=21%  Similarity=0.265  Sum_probs=197.0

Q ss_pred             hccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh--HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEe
Q 007680          272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLE  348 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  348 (593)
                      ++|++.+.||+|++|.||+|..+ +|+.||+|.+....  ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            57899999999999999999975 78999999986542  2234567889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC-CCcEEEEeeccceecCCC
Q 007680          349 FMPNGSLEKWLYSHNY-FLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDE-NMVAHVSDFGIYKLLGEG  426 (593)
Q Consensus       349 ~~~~gsL~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~-~~~~kL~Dfg~a~~~~~~  426 (593)
                      |++ ++|.+++..... .+++..+..++.|++.||+|||++    +++|+||+|+||+++. ++.+||+|||++......
T Consensus        82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~----~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~  156 (294)
T PLN00009         82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH----RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP  156 (294)
T ss_pred             ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence            995 588888765443 367888899999999999999965    4999999999999985 567999999999765432


Q ss_pred             CCccccccccCCccccCccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhh-----
Q 007680          427 EDSVRQTMTMATIGYMAPEYGLEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEV-----  500 (593)
Q Consensus       427 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-----  500 (593)
                      ..  ......+++.|+|||++.+. .++.++||||+|+++|+|+||+.||......+. ..+.. ..........     
T Consensus       157 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~  232 (294)
T PLN00009        157 VR--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE-LFKIF-RILGTPNEETWPGVT  232 (294)
T ss_pred             cc--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHH-HHhCCCChhhccccc
Confidence            21  11233568899999987664 578999999999999999999999976322111 11111 0000000000     


Q ss_pred             --hhhh--hh--hhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          501 --VDAN--LV--REEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       501 --~~~~--~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                        .+..  ..  ............++++.+++.+||+.+|++||++.+++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~  284 (294)
T PLN00009        233 SLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH  284 (294)
T ss_pred             cchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              0000  00  0000000112235678999999999999999999999975

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=2.3e-35  Score=295.96  Aligned_cols=250  Identities=26%  Similarity=0.380  Sum_probs=203.0

Q ss_pred             hccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhcC-CCCcceeeeeeecCCceEEE
Q 007680          272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNVR-HRNLIKILSSYSNPDFKALV  346 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv  346 (593)
                      ++|.+.+.||+|++|.||+|... +++.||+|++....   ....+.+.+|++++++++ ||||+++++++...+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            46889999999999999999965 79999999987632   233467889999999998 99999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCC
Q 007680          347 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG  426 (593)
Q Consensus       347 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  426 (593)
                      |||+++++|.+++.+.+. +++..+..++.|++.||.|||+.    +++|+||+|+||+++.++.++|+|||.+......
T Consensus        81 ~e~~~~~~L~~~l~~~~~-l~~~~~~~i~~ql~~~l~~Lh~~----~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~  155 (280)
T cd05581          81 LEYAPNGELLQYIRKYGS-LDEKCTRFYAAEILLALEYLHSK----GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN  155 (280)
T ss_pred             EcCCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHC----CeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence            999999999999987654 99999999999999999999965    4999999999999999999999999998876543


Q ss_pred             CCc------------------cccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHH
Q 007680          427 EDS------------------VRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRW  488 (593)
Q Consensus       427 ~~~------------------~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~  488 (593)
                      ...                  .......++..|+|||...+..++.++||||||++++++++|+.||.....  ......
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~~~  233 (280)
T cd05581         156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE--YLTFQK  233 (280)
T ss_pred             cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH--HHHHHH
Confidence            211                  122234578899999998888899999999999999999999999976321  000000


Q ss_pred             HHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCH----HHHHHH
Q 007680          489 VKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINM----TDAAAK  546 (593)
Q Consensus       489 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~----~evl~~  546 (593)
                      ...                  .....+...++.+.+++.+||+.+|++||++    .++++|
T Consensus       234 ~~~------------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~  277 (280)
T cd05581         234 ILK------------------LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH  277 (280)
T ss_pred             HHh------------------cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence            000                  0001111235678999999999999999999    777754

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=1.6e-36  Score=285.60  Aligned_cols=272  Identities=22%  Similarity=0.257  Sum_probs=201.5

Q ss_pred             hhccccccccCccCcccEEEEEeC---C--CCeEEEEEeehhhH--HHHHHHHHHHHHHhhcCCCCcceeeeeeec-CCc
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS---D--GTDVAIKVFNLQLE--RAFRSFDSECEVLRNVRHRNLIKILSSYSN-PDF  342 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~---~--~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~  342 (593)
                      ...|+.+..||+|.||.||+|..+   +  ...+|+|.++...+  .......+|+.+++.++|||++.+..+|.. +..
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~  102 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK  102 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence            457999999999999999999643   2  33799999876532  233467889999999999999999998877 778


Q ss_pred             eEEEEeccCCCCHHHHHhhCCC----CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCC----CcEEE
Q 007680          343 KALVLEFMPNGSLEKWLYSHNY----FLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDEN----MVAHV  414 (593)
Q Consensus       343 ~~lv~e~~~~gsL~~~l~~~~~----~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~----~~~kL  414 (593)
                      .++++||.+. +|.+.|+-++.    .++...+..|+.||+.|+.|||++.    |+||||||.||+|..+    |.|||
T Consensus       103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW----vlHRDLKPaNIlvmgdgperG~VKI  177 (438)
T KOG0666|consen  103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW----VLHRDLKPANILVMGDGPERGRVKI  177 (438)
T ss_pred             EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh----eeeccCCcceEEEeccCCccCeeEe
Confidence            9999999976 99998865432    5888899999999999999999765    9999999999999877    89999


Q ss_pred             EeeccceecCCCCCcc-ccccccCCccccCccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCcccccc-------chH
Q 007680          415 SDFGIYKLLGEGEDSV-RQTMTMATIGYMAPEYGLEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFIGE-------MSL  485 (593)
Q Consensus       415 ~Dfg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~-------~~~  485 (593)
                      +|||+++.+...-... .....+-|..|+|||.+.+. .|+++.||||.|||+.||+|-++.|.+....-       .+.
T Consensus       178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQ  257 (438)
T KOG0666|consen  178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQ  257 (438)
T ss_pred             ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHH
Confidence            9999999887654333 34456789999999998876 49999999999999999999998886532110       011


Q ss_pred             HHHHHH--------------hcCCchhhhhhhhhhh-hh----hhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          486 RRWVKE--------------SLPHGLTEVVDANLVR-EE----QAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       486 ~~~~~~--------------~~~~~~~~~~~~~~~~-~~----~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      .+.+-+              ..|+....+-+..... ..    .-......-++...+|+.++|..||.+|.|+++++++
T Consensus       258 l~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh  337 (438)
T KOG0666|consen  258 LDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH  337 (438)
T ss_pred             HHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence            111110              0111101111110000 00    0000111123347899999999999999999999987


Q ss_pred             H
Q 007680          547 L  547 (593)
Q Consensus       547 L  547 (593)
                      .
T Consensus       338 ~  338 (438)
T KOG0666|consen  338 P  338 (438)
T ss_pred             c
Confidence            4

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=1.3e-34  Score=295.87  Aligned_cols=244  Identities=28%  Similarity=0.320  Sum_probs=194.6

Q ss_pred             cccccccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEec
Q 007680          274 FNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEF  349 (593)
Q Consensus       274 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  349 (593)
                      |...+.||+|+||.||+|+.. +++.|++|.+....   ......+.+|+++++.++|||++++++++.+.+..++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            666788999999999999865 68899999987532   23445788899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCc
Q 007680          350 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDS  429 (593)
Q Consensus       350 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~  429 (593)
                      +. +++.+++......+++.++..++.|++.|++|||++    +++|+||+|+||++++++.+||+|||.+.....    
T Consensus       103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~----gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~----  173 (313)
T cd06633         103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH----NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP----  173 (313)
T ss_pred             CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCChhhEEECCCCCEEEeecCCCcccCC----
Confidence            95 588888876666689999999999999999999965    499999999999999999999999998764321    


Q ss_pred             cccccccCCccccCccccC---CCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhh
Q 007680          430 VRQTMTMATIGYMAPEYGL---EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLV  506 (593)
Q Consensus       430 ~~~~~~~gt~~y~aPE~~~---~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  506 (593)
                        .....++..|+|||++.   +..++.++|||||||++|+|++|..||......  ...........   .        
T Consensus       174 --~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~--~~~~~~~~~~~---~--------  238 (313)
T cd06633         174 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SALYHIAQNDS---P--------  238 (313)
T ss_pred             --CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHhcCC---C--------
Confidence              12345788999999874   456889999999999999999999998663211  11111110000   0        


Q ss_pred             hhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          507 REEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                           ......++..+.+++.+||+.+|++||++.+++.+
T Consensus       239 -----~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         239 -----TLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             -----CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                 00011234468999999999999999999999976

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-34  Score=291.02  Aligned_cols=264  Identities=23%  Similarity=0.274  Sum_probs=197.2

Q ss_pred             cccccccCccCcccEEEEEeC-CCCeEEEEEeehhh--HHHHHHHHHHHHHHhhc---CCCCcceeeeeeecCCc-----
Q 007680          274 FNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL--ERAFRSFDSECEVLRNV---RHRNLIKILSSYSNPDF-----  342 (593)
Q Consensus       274 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~-----  342 (593)
                      |++.+.||+|+||.||+|+.+ +++.||+|+++...  ......+.+|+.+++++   +|||++++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            567889999999999999976 58999999997542  22234566787777666   59999999999988776     


Q ss_pred             eEEEEeccCCCCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccce
Q 007680          343 KALVLEFMPNGSLEKWLYSHNY-FLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYK  421 (593)
Q Consensus       343 ~~lv~e~~~~gsL~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~  421 (593)
                      .+++|||+. ++|.+++..... .+++..+..++.|+++||+|||+.    +++|+||+|+||++++++.+||+|||.+.
T Consensus        81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~----~i~h~~l~~~nili~~~~~~~l~dfg~~~  155 (287)
T cd07838          81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH----RIVHRDLKPQNILVTSDGQVKIADFGLAR  155 (287)
T ss_pred             eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC----CeeeccCChhhEEEccCCCEEEeccCcce
Confidence            899999996 489998876443 589999999999999999999965    49999999999999999999999999988


Q ss_pred             ecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCc-hhhh
Q 007680          422 LLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHG-LTEV  500 (593)
Q Consensus       422 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~  500 (593)
                      .......   .....++..|+|||++.+..++.++|||||||++|||++|.+||..... .....++........ ....
T Consensus       156 ~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  231 (287)
T cd07838         156 IYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE-ADQLDKIFDVIGLPSEEEWP  231 (287)
T ss_pred             eccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh-HHHHHHHHHHcCCCChHhcC
Confidence            7644322   1223478889999999988999999999999999999999999876332 122222222111100 0000


Q ss_pred             hhh-----hhhhh--hhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          501 VDA-----NLVRE--EQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       501 ~~~-----~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      ...     .....  ........+.+..+.+++.+||+.||++||++.|++.|
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~  284 (287)
T cd07838         232 RNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH  284 (287)
T ss_pred             CCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence            000     00000  00011112345778999999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.5e-35  Score=300.39  Aligned_cols=273  Identities=24%  Similarity=0.283  Sum_probs=207.4

Q ss_pred             ccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh--HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCC-----ceE
Q 007680          273 EFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPD-----FKA  344 (593)
Q Consensus       273 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~  344 (593)
                      +|++.+.||+|++|.||+|+.. +++.||+|.+....  ....+.+.+|+.+++.++||||+++.+++...+     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            4788999999999999999975 58999999987643  344567889999999999999999999988775     789


Q ss_pred             EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecC
Q 007680          345 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG  424 (593)
Q Consensus       345 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~  424 (593)
                      ++|||++ ++|.+++.... .+++..+..++.|++.||+|||++    ||+||||||+||+++.++.++|+|||.+....
T Consensus        81 lv~e~~~-~~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~----gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~  154 (330)
T cd07834          81 IVTELME-TDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLHSA----NVIHRDLKPSNILVNSNCDLKICDFGLARGVD  154 (330)
T ss_pred             EEecchh-hhHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence            9999997 58999887655 599999999999999999999954    59999999999999999999999999998765


Q ss_pred             CCCCc-cccccccCCccccCccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCc------
Q 007680          425 EGEDS-VRQTMTMATIGYMAPEYGLEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHG------  496 (593)
Q Consensus       425 ~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~------  496 (593)
                      ..... .......++..|+|||++.+. .++.++||||||+++|+|++|+.||......+  ....+.......      
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~--~~~~i~~~~~~~~~~~~~  232 (330)
T cd07834         155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYID--QLNLIVEVLGTPSEEDLK  232 (330)
T ss_pred             ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHH--HHHHHHHhcCCCChhHhh
Confidence            44311 112334578899999998887 79999999999999999999999997643211  111111111100      


Q ss_pred             ------hhhhhhhhhhh-hhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH--HHHhhhh
Q 007680          497 ------LTEVVDANLVR-EEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK--LKKIKVK  553 (593)
Q Consensus       497 ------~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~i~~~  553 (593)
                            ....+...... ...........+..+.+++.+||+.+|++||++.+++++  ++.++..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~  298 (330)
T cd07834         233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP  298 (330)
T ss_pred             hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence                  00000000000 000000112246788999999999999999999999987  6665543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.8e-34  Score=298.77  Aligned_cols=273  Identities=21%  Similarity=0.275  Sum_probs=202.6

Q ss_pred             cCCHHHHHHhhhccccccccCccCcccEEEEEe-CCCCeEEEEEeehhh--HHHHHHHHHHHHHHhhcCCCCcceeeeee
Q 007680          261 RTSYLDIQRATDEFNECNLLGTSSFGSVYKGTI-SDGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSY  337 (593)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~  337 (593)
                      +....++....++|++.+.||+|+||.||+|.. .+++.||+|+++...  ....+.+.+|+.++++++||||+++++++
T Consensus         6 ~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~   85 (345)
T cd07877           6 QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVF   85 (345)
T ss_pred             hhHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeee
Confidence            344566777889999999999999999999985 478999999987532  22345678899999999999999999987


Q ss_pred             ecC------CceEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCc
Q 007680          338 SNP------DFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMV  411 (593)
Q Consensus       338 ~~~------~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~  411 (593)
                      ...      ...+++++++ +++|.+++....  +++..+..++.|+++||+|||++    +|+||||||+||++++++.
T Consensus        86 ~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~~--l~~~~~~~i~~qi~~aL~~LH~~----~ivH~dlkp~NIll~~~~~  158 (345)
T cd07877          86 TPARSLEEFNDVYLVTHLM-GADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIHSA----DIIHRDLKPSNLAVNEDCE  158 (345)
T ss_pred             eecccccccccEEEEehhc-ccCHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC----CeeecCCChHHEEEcCCCC
Confidence            543      3467888887 789998886543  89999999999999999999965    4999999999999999999


Q ss_pred             EEEEeeccceecCCCCCccccccccCCccccCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHH
Q 007680          412 AHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVK  490 (593)
Q Consensus       412 ~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~  490 (593)
                      +||+|||++......     .....++..|+|||...+ ..++.++|||||||++|||++|+.||...... ..+.....
T Consensus       159 ~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~-~~~~~~~~  232 (345)
T cd07877         159 LKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILR  232 (345)
T ss_pred             EEEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHH
Confidence            999999998764321     223457889999998766 56889999999999999999999999653211 11111111


Q ss_pred             Hh--cCCchhhhhhhhhhhhh----h-----hh-hhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          491 ES--LPHGLTEVVDANLVREE----Q-----AF-SAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       491 ~~--~~~~~~~~~~~~~~~~~----~-----~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      ..  .+......+........    .     .. ......++++.+++.+|++.||.+||++.++++|
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         233 LVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             HhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence            00  00001000000000000    0     00 0001235678999999999999999999999987

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=2e-34  Score=289.34  Aligned_cols=242  Identities=21%  Similarity=0.278  Sum_probs=186.1

Q ss_pred             ccCccCcccEEEEEeC-CCCeEEEEEeehhhH---HHHHHHHHHH---HHHhhcCCCCcceeeeeeecCCceEEEEeccC
Q 007680          279 LLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLE---RAFRSFDSEC---EVLRNVRHRNLIKILSSYSNPDFKALVLEFMP  351 (593)
Q Consensus       279 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~---~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  351 (593)
                      .||+|+||.||+|... +++.||+|.+.....   .....+..|.   ..++...||+|+++++++...+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999864 688999999875421   1112233343   34444579999999999999999999999999


Q ss_pred             CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCccc
Q 007680          352 NGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVR  431 (593)
Q Consensus       352 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~  431 (593)
                      +++|.+++.... .+++..+..++.|+++|+.|||++    +++||||||+||+++.++.+||+|||++.......    
T Consensus        81 g~~L~~~l~~~~-~l~~~~~~~~~~ql~~~l~~lH~~----~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~----  151 (278)
T cd05606          81 GGDLHYHLSQHG-VFSEAEMRFYAAEIILGLEHMHNR----FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----  151 (278)
T ss_pred             CCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC----CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC----
Confidence            999999987654 489999999999999999999965    49999999999999999999999999987653322    


Q ss_pred             cccccCCccccCccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhhh
Q 007680          432 QTMTMATIGYMAPEYGLEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQ  510 (593)
Q Consensus       432 ~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  510 (593)
                      .....|+..|+|||++.++ .++.++||||+|+++|||++|+.||................               ..  
T Consensus       152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~---------------~~--  214 (278)
T cd05606         152 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL---------------TM--  214 (278)
T ss_pred             CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhh---------------cc--
Confidence            1234689999999998754 68999999999999999999999997632111100000000               00  


Q ss_pred             hhhhhHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHHH
Q 007680          511 AFSAKMDCILSIMDFALDCCMESPDMRI-----NMTDAAAK  546 (593)
Q Consensus       511 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  546 (593)
                      ....+..++.++.+++.+||..+|.+||     ++.+++++
T Consensus       215 ~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~  255 (278)
T cd05606         215 AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH  255 (278)
T ss_pred             CCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence            0011112356789999999999999999     99999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=1e-34  Score=298.43  Aligned_cols=267  Identities=24%  Similarity=0.305  Sum_probs=199.8

Q ss_pred             HHHHhhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh--HHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CC
Q 007680          266 DIQRATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSYSN-PD  341 (593)
Q Consensus       266 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~  341 (593)
                      ++...+++|++.+.||+|+||.||+|... +++.||+|.+....  ....+.+.+|++++++++||||+++.+++.. ..
T Consensus         4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   83 (328)
T cd07856           4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE   83 (328)
T ss_pred             ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence            34456889999999999999999999865 78999999886432  2334667889999999999999999998865 56


Q ss_pred             ceEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccce
Q 007680          342 FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYK  421 (593)
Q Consensus       342 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~  421 (593)
                      ..++++||+ +++|.+++....  +++..+..++.|+++||+|||+.    +++||||+|+||++++++.++|+|||.+.
T Consensus        84 ~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~ql~~aL~~LH~~----~iiH~dl~p~Nili~~~~~~~l~dfg~~~  156 (328)
T cd07856          84 DIYFVTELL-GTDLHRLLTSRP--LEKQFIQYFLYQILRGLKYVHSA----GVVHRDLKPSNILINENCDLKICDFGLAR  156 (328)
T ss_pred             cEEEEeehh-ccCHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEeECCCCCEEeCcccccc
Confidence            789999998 668998886543  78888999999999999999954    59999999999999999999999999987


Q ss_pred             ecCCCCCccccccccCCccccCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhh
Q 007680          422 LLGEGEDSVRQTMTMATIGYMAPEYGLE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEV  500 (593)
Q Consensus       422 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  500 (593)
                      .....     .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||......  ...............+.
T Consensus       157 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~--~~~~~~~~~~~~~~~~~  229 (328)
T cd07856         157 IQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHV--NQFSIITDLLGTPPDDV  229 (328)
T ss_pred             ccCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCCHHH
Confidence            54321     122356788999998765 56899999999999999999999999653211  11111111110000011


Q ss_pred             hh----hh-------hh-hhh-hhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          501 VD----AN-------LV-REE-QAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       501 ~~----~~-------~~-~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      ..    ..       .. ... ........++.++.+++.+||+.+|++||++.+++.+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         230 INTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             HHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00    00       00 000 0000111245688999999999999999999999887

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1.3e-34  Score=292.58  Aligned_cols=252  Identities=25%  Similarity=0.286  Sum_probs=197.0

Q ss_pred             ccccccccCccCcccEEEEEe----CCCCeEEEEEeehhh----HHHHHHHHHHHHHHhhc-CCCCcceeeeeeecCCce
Q 007680          273 EFNECNLLGTSSFGSVYKGTI----SDGTDVAIKVFNLQL----ERAFRSFDSECEVLRNV-RHRNLIKILSSYSNPDFK  343 (593)
Q Consensus       273 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  343 (593)
                      +|++.+.||+|+||.||+|..    .+|+.||+|+++...    ....+.+.+|+++++++ +|+||+++++++..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            478889999999999999986    368999999997642    22345678899999999 599999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceec
Q 007680          344 ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLL  423 (593)
Q Consensus       344 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~  423 (593)
                      ++||||+++++|.+++..... +++..+..++.|+++||.|||+.    +++||||+|+||+++.++.+||+|||++...
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~-l~~~~~~~~~~qi~~al~~lH~~----~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  155 (290)
T cd05613          81 HLILDYINGGELFTHLSQRER-FKEQEVQIYSGEIVLALEHLHKL----GIIYRDIKLENILLDSNGHVVLTDFGLSKEF  155 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence            999999999999999987654 88999999999999999999954    5999999999999999999999999998865


Q ss_pred             CCCCCccccccccCCccccCccccCCC--CCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhh
Q 007680          424 GEGEDSVRQTMTMATIGYMAPEYGLEG--IVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVV  501 (593)
Q Consensus       424 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  501 (593)
                      ...... ......++..|+|||...+.  .++.++||||||+++|+|++|+.||..... .............       
T Consensus       156 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-~~~~~~~~~~~~~-------  226 (290)
T cd05613         156 HEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE-KNSQAEISRRILK-------  226 (290)
T ss_pred             cccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc-cccHHHHHHHhhc-------
Confidence            433211 12234588899999987653  478899999999999999999999864211 1111111111000       


Q ss_pred             hhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHHH
Q 007680          502 DANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRI-----NMTDAAAK  546 (593)
Q Consensus       502 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  546 (593)
                           ..   .+.+..+++.+.+++.+||+.||++||     ++.+++++
T Consensus       227 -----~~---~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~  268 (290)
T cd05613         227 -----SE---PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH  268 (290)
T ss_pred             -----cC---CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence                 00   001122356789999999999999997     67777765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=9.9e-35  Score=293.08  Aligned_cols=255  Identities=25%  Similarity=0.285  Sum_probs=198.8

Q ss_pred             ccccccccCccCcccEEEEEeC----CCCeEEEEEeehhh----HHHHHHHHHHHHHHhhc-CCCCcceeeeeeecCCce
Q 007680          273 EFNECNLLGTSSFGSVYKGTIS----DGTDVAIKVFNLQL----ERAFRSFDSECEVLRNV-RHRNLIKILSSYSNPDFK  343 (593)
Q Consensus       273 ~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  343 (593)
                      +|++.+.||+|++|.||+++..    +++.||+|+++...    ....+.+.+|++++.++ +||||+++++.+..++..
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            4788899999999999999742    57889999997542    23345688999999999 599999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceec
Q 007680          344 ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLL  423 (593)
Q Consensus       344 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~  423 (593)
                      ++||||+++++|.+++.... .+++..+..++.|+++||+|||+.    +++||||+|+||+++.++.++|+|||++...
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH~~----~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~  155 (288)
T cd05583          81 HLILDYVNGGELFTHLYQRE-HFTESEVRVYIAEIVLALDHLHQL----GIIYRDIKLENILLDSEGHVVLTDFGLSKEF  155 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcC-CcCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence            99999999999999987654 388999999999999999999954    5999999999999999999999999998765


Q ss_pred             CCCCCccccccccCCccccCccccCCCC--CCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhh
Q 007680          424 GEGEDSVRQTMTMATIGYMAPEYGLEGI--VSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVV  501 (593)
Q Consensus       424 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  501 (593)
                      ...... ......++..|+|||...+..  .+.++||||||+++|||++|..||...... ..........         
T Consensus       156 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-~~~~~~~~~~---------  224 (288)
T cd05583         156 LAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ-NSQSEISRRI---------  224 (288)
T ss_pred             cccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc-chHHHHHHHH---------
Confidence            433221 122345788999999987655  788999999999999999999998642110 0111111100         


Q ss_pred             hhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHH
Q 007680          502 DANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKK  549 (593)
Q Consensus       502 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  549 (593)
                          ....  .+.+..++..+.+++.+||+.||++|||+.++.+.|+.
T Consensus       225 ----~~~~--~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         225 ----LKSK--PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             ----HccC--CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence                0000  01112235678999999999999999998877766554

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=8.7e-35  Score=296.60  Aligned_cols=268  Identities=22%  Similarity=0.249  Sum_probs=196.4

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhH--HHHHHHHHHHHHHhhcCCCCcceeeeeeecCC------
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLE--RAFRSFDSECEVLRNVRHRNLIKILSSYSNPD------  341 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  341 (593)
                      .++|++.+.||+|+||.||+|... +++.+|+|.+.....  .....+.+|++++++++||||+++++++....      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            578999999999999999999965 689999999865432  12345678999999999999999999875433      


Q ss_pred             --ceEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeecc
Q 007680          342 --FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGI  419 (593)
Q Consensus       342 --~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~  419 (593)
                        ..++||||+. +++.+.+......+++.++..++.|+++||+|||.+    +++|+||||+||++++++.++|+|||+
T Consensus        87 ~~~~~lv~~~~~-~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~----~i~H~dl~p~nil~~~~~~~~l~dfg~  161 (311)
T cd07866          87 RGSVYMVTPYMD-HDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHEN----HILHRDIKAANILIDNQGILKIADFGL  161 (311)
T ss_pred             CceEEEEEecCC-cCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEECCCCCEEECcCcc
Confidence              4699999996 478887776555699999999999999999999954    599999999999999999999999999


Q ss_pred             ceecCCCCCcc---------ccccccCCccccCccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHH
Q 007680          420 YKLLGEGEDSV---------RQTMTMATIGYMAPEYGLEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWV  489 (593)
Q Consensus       420 a~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~  489 (593)
                      +..........         ......+++.|+|||+..+. .++.++|||||||++|||++|++||....... ......
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~-~~~~~~  240 (311)
T cd07866         162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDID-QLHLIF  240 (311)
T ss_pred             chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHH
Confidence            88654332211         11223567889999987654 58999999999999999999999997532211 111111


Q ss_pred             HHh--cCC-ch------hhhh----hhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          490 KES--LPH-GL------TEVV----DANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       490 ~~~--~~~-~~------~~~~----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      ...  .++ ..      ....    .......  .........+.+.+++.+||..||++|||+.|++.+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~  308 (311)
T cd07866         241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRT--LEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH  308 (311)
T ss_pred             HHhCCCChhhchhhhhcccccccccCCCCCcc--HHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence            100  000 00      0000    0000000  000111233578999999999999999999999864

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-35  Score=306.99  Aligned_cols=274  Identities=26%  Similarity=0.332  Sum_probs=204.3

Q ss_pred             ccccccccCccCcccEEEEEe-CCCCeEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceeeeeeecC------CceE
Q 007680          273 EFNECNLLGTSSFGSVYKGTI-SDGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSYSNP------DFKA  344 (593)
Q Consensus       273 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~  344 (593)
                      .|...+.||+|+||.||++++ ++|+.||||.++... ....+...+|++++++++|||||++.+.-+..      ....
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v   93 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV   93 (732)
T ss_pred             ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence            355668999999999999995 489999999998753 34556788999999999999999999876554      3678


Q ss_pred             EEEeccCCCCHHHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeC--CCC--cEEEEeec
Q 007680          345 LVLEFMPNGSLEKWLYSHNY--FLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLD--ENM--VAHVSDFG  418 (593)
Q Consensus       345 lv~e~~~~gsL~~~l~~~~~--~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~--~~~--~~kL~Dfg  418 (593)
                      +|||||.||||...+.+...  .+++.+.+.+..+++.||.|||+++    |+||||||.||++-  .+|  ..||+|||
T Consensus        94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~----IvHRDlKP~NIvl~~Gedgq~IyKLtDfG  169 (732)
T KOG4250|consen   94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG----IVHRDLKPGNIVLQIGEDGQSIYKLTDFG  169 (732)
T ss_pred             EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC----ceeccCCCCcEEEeecCCCceEEeeeccc
Confidence            99999999999999986433  6999999999999999999999766    99999999999984  333  57999999


Q ss_pred             cceecCCCCCccccccccCCccccCccccC-CCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHH-HHH-HHhcCC
Q 007680          419 IYKLLGEGEDSVRQTMTMATIGYMAPEYGL-EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLR-RWV-KESLPH  495 (593)
Q Consensus       419 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~-~~~-~~~~~~  495 (593)
                      .|+.+.++.   .....+||..|.+||+.. .+.|+..+|.|||||++|+..||..||........... .|. ....+.
T Consensus       170 ~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~  246 (732)
T KOG4250|consen  170 AARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPS  246 (732)
T ss_pred             ccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCC
Confidence            999887655   345578999999999988 48899999999999999999999999976533322111 111 111111


Q ss_pred             chhhhhhhhhh---hhhhhhhhh----HHHHHHHHHHHhhcccCCCCCCC--CHHHHHHHHHHhhhh
Q 007680          496 GLTEVVDANLV---REEQAFSAK----MDCILSIMDFALDCCMESPDMRI--NMTDAAAKLKKIKVK  553 (593)
Q Consensus       496 ~~~~~~~~~~~---~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RP--s~~evl~~L~~i~~~  553 (593)
                      ...-.......   .-....+.+    ......+-..+..+|..+|++|.  ...+..+.+..|...
T Consensus       247 ~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~  313 (732)
T KOG4250|consen  247 GVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNL  313 (732)
T ss_pred             ceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhh
Confidence            11111111000   000011111    12234566778888899999999  777777777766543

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=9.7e-35  Score=300.53  Aligned_cols=266  Identities=21%  Similarity=0.273  Sum_probs=196.0

Q ss_pred             hccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC----------
Q 007680          272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNP----------  340 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----------  340 (593)
                      .+|++.+.||+|+||.||+|... +|+.||+|.+........+.+.+|++++++++||||+++++++...          
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            67999999999999999999865 6899999998776555567788999999999999999999876544          


Q ss_pred             ----CceEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeC-CCCcEEEE
Q 007680          341 ----DFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLD-ENMVAHVS  415 (593)
Q Consensus       341 ----~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~-~~~~~kL~  415 (593)
                          ...++||||++ ++|.+++...  .+++..+..++.|+++||+|||+.    +++||||||+||+++ +++.+||+
T Consensus        85 ~~~~~~~~lv~e~~~-~~L~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~----givH~dikp~Nili~~~~~~~kl~  157 (342)
T cd07854          85 LTELNSVYIVQEYME-TDLANVLEQG--PLSEEHARLFMYQLLRGLKYIHSA----NVLHRDLKPANVFINTEDLVLKIG  157 (342)
T ss_pred             ccccceEEEEeeccc-ccHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEEcCCCceEEEC
Confidence                35789999996 5999888654  388999999999999999999965    499999999999997 45678999


Q ss_pred             eeccceecCCCCCcc-ccccccCCccccCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhc
Q 007680          416 DFGIYKLLGEGEDSV-RQTMTMATIGYMAPEYGLE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESL  493 (593)
Q Consensus       416 Dfg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~  493 (593)
                      |||.+.......... ......++..|+|||++.+ ..++.++|||||||++|+|++|+.||....... ..... ....
T Consensus       158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~-~~~~~-~~~~  235 (342)
T cd07854         158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELE-QMQLI-LESV  235 (342)
T ss_pred             CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHH-HHhc
Confidence            999988654321111 1122357889999997654 568899999999999999999999997542211 11111 1111


Q ss_pred             CCchh----h---hhhhhhh----hh-hhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          494 PHGLT----E---VVDANLV----RE-EQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       494 ~~~~~----~---~~~~~~~----~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      +....    .   .......    .. ..........+.++.+++.+||..||++|||+.|+++|
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  300 (342)
T cd07854         236 PVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH  300 (342)
T ss_pred             CCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence            10000    0   0000000    00 00000011245678999999999999999999999976

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1.8e-34  Score=297.86  Aligned_cols=268  Identities=21%  Similarity=0.262  Sum_probs=197.0

Q ss_pred             hhcccc-ccccCccCcccEEEEEeC-CCCeEEEEEeehhhHHH--------------HHHHHHHHHHHhhcCCCCcceee
Q 007680          271 TDEFNE-CNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERA--------------FRSFDSECEVLRNVRHRNLIKIL  334 (593)
Q Consensus       271 ~~~~~~-~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~l~  334 (593)
                      .++|.. .+.||+|+||.||+|..+ +++.||+|.++......              ...+.+|++++++++||||++++
T Consensus         7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   86 (335)
T PTZ00024          7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV   86 (335)
T ss_pred             ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence            345654 467999999999999965 68999999987542211              12467899999999999999999


Q ss_pred             eeeecCCceEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEE
Q 007680          335 SSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHV  414 (593)
Q Consensus       335 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL  414 (593)
                      +++...+..++||||+. ++|.+++.... .+++.....++.|++.||+|||+.    +++|+||+|+||+++.++.++|
T Consensus        87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH~~----~i~H~dl~~~nill~~~~~~kl  160 (335)
T PTZ00024         87 DVYVEGDFINLVMDIMA-SDLKKVVDRKI-RLTESQVKCILLQILNGLNVLHKW----YFMHRDLSPANIFINSKGICKI  160 (335)
T ss_pred             EEEecCCcEEEEEeccc-cCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC----CeecccccHHHeEECCCCCEEE
Confidence            99999999999999996 69999987654 389999999999999999999954    5999999999999999999999


Q ss_pred             EeeccceecCCCCC------------ccccccccCCccccCccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCccccc
Q 007680          415 SDFGIYKLLGEGED------------SVRQTMTMATIGYMAPEYGLEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFIG  481 (593)
Q Consensus       415 ~Dfg~a~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlGvvl~elltg~~pf~~~~~~  481 (593)
                      +|||.+........            ........++..|+|||++.+. .++.++|||||||++|||++|+.||......
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~  240 (335)
T PTZ00024        161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI  240 (335)
T ss_pred             CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            99999887652110            0111223467889999988764 4789999999999999999999999764321


Q ss_pred             cchHHHHHHHhcC----Cchhhhhhhh-h----hhh-hhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          482 EMSLRRWVKESLP----HGLTEVVDAN-L----VRE-EQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       482 ~~~~~~~~~~~~~----~~~~~~~~~~-~----~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      +  ....+.....    ..+.+..+.. .    ... .........++.++.+++.+||+.+|++||+++|++.+
T Consensus       241 ~--~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~  313 (335)
T PTZ00024        241 D--QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH  313 (335)
T ss_pred             H--HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence            1  1111111100    0000000000 0    000 00001112235678999999999999999999999974

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.4e-34  Score=297.67  Aligned_cols=267  Identities=23%  Similarity=0.262  Sum_probs=199.2

Q ss_pred             HHHhhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehh--hHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCC--
Q 007680          267 IQRATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQ--LERAFRSFDSECEVLRNVRHRNLIKILSSYSNPD--  341 (593)
Q Consensus       267 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--  341 (593)
                      +....++|++.+.||+|+||.||+|... +++.||+|++...  .......+.+|+.++++++||||+++++++....  
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (343)
T cd07880          10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL   89 (343)
T ss_pred             hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence            3345778999999999999999999854 7899999998643  2333456889999999999999999999887653  


Q ss_pred             ----ceEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEee
Q 007680          342 ----FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDF  417 (593)
Q Consensus       342 ----~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df  417 (593)
                          ..++||||+ +++|.+++...  .+++..+..++.|+++||+|||+.    +|+||||||+||++++++.++|+||
T Consensus        90 ~~~~~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~i~~qi~~al~~LH~~----gi~H~dlkp~Nill~~~~~~kl~df  162 (343)
T cd07880          90 DRFHDFYLVMPFM-GTDLGKLMKHE--KLSEDRIQFLVYQMLKGLKYIHAA----GIIHRDLKPGNLAVNEDCELKILDF  162 (343)
T ss_pred             cccceEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEeec
Confidence                458999999 77999888654  389999999999999999999954    5999999999999999999999999


Q ss_pred             ccceecCCCCCccccccccCCccccCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHh--cC
Q 007680          418 GIYKLLGEGEDSVRQTMTMATIGYMAPEYGLE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKES--LP  494 (593)
Q Consensus       418 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~--~~  494 (593)
                      |.+.......     ....+++.|+|||.+.+ ..++.++|+||+|+++|++++|+.||...... ..+.......  .+
T Consensus       163 g~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~  236 (343)
T cd07880         163 GLARQTDSEM-----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL-DQLMEIMKVTGTPS  236 (343)
T ss_pred             ccccccccCc-----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCC
Confidence            9987653321     22357889999998766 45889999999999999999999999753211 1111111100  00


Q ss_pred             Cchhhhhhhh--------hhhh--hhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          495 HGLTEVVDAN--------LVRE--EQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       495 ~~~~~~~~~~--------~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      ..+...+...        +...  .........++.++.+++.+|+..||++|||+.+++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~  298 (343)
T cd07880         237 KEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH  298 (343)
T ss_pred             HHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            0000000000        0000  00001112345678999999999999999999999965

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-35  Score=286.31  Aligned_cols=265  Identities=22%  Similarity=0.290  Sum_probs=204.5

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcC-C-C----CcceeeeeeecCCce
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNVR-H-R----NLIKILSSYSNPDFK  343 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-~----niv~l~~~~~~~~~~  343 (593)
                      +++|.+...+|+|.||.|-.+.+. .+..||+|+++.- ....+...-|+++++++. + |    -++.+.++|...++.
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi  166 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI  166 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence            778999999999999999999854 5789999998754 344566778999999993 2 2    378888999999999


Q ss_pred             EEEEeccCCCCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC--------------
Q 007680          344 ALVLEFMPNGSLEKWLYSHNY-FLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDE--------------  408 (593)
Q Consensus       344 ~lv~e~~~~gsL~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~--------------  408 (593)
                      |+|+|.+ |.++.+++..++. +++...+..+++|+++++++||+    .+++|.||||+||++.+              
T Consensus       167 Civfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~----~kl~HTDLKPENILfvss~~~~~~~~k~~~~  241 (415)
T KOG0671|consen  167 CIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHD----LKLTHTDLKPENILFVSSEYFKTYNPKKKVC  241 (415)
T ss_pred             EEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHh----cceeecCCChheEEEeccceEEEeccCCccc
Confidence            9999999 7799999988665 79999999999999999999995    55999999999999832              


Q ss_pred             ------CCcEEEEeeccceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCcccccc
Q 007680          409 ------NMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGE  482 (593)
Q Consensus       409 ------~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~  482 (593)
                            +..++++|||.|+.-.+.     .+..+.|..|+|||++.+-.++.++||||+||||+|+.||...|....+.+
T Consensus       242 ~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E  316 (415)
T KOG0671|consen  242 FIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLE  316 (415)
T ss_pred             eeccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHH
Confidence                  346899999999874433     255678999999999999999999999999999999999999987643222


Q ss_pred             -chHHHHHHHhcCCchhhhh-----------h-------h-------hhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCC
Q 007680          483 -MSLRRWVKESLPHGLTEVV-----------D-------A-------NLVREEQAFSAKMDCILSIMDFALDCCMESPDM  536 (593)
Q Consensus       483 -~~~~~~~~~~~~~~~~~~~-----------~-------~-------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~  536 (593)
                       ..+.+.+...+|..+..-.           |       .       .................++.+|+++||..||.+
T Consensus       317 HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~  396 (415)
T KOG0671|consen  317 HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR  396 (415)
T ss_pred             HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence             2222222222332211111           0       0       000001111122334567999999999999999


Q ss_pred             CCCHHHHHHH
Q 007680          537 RINMTDAAAK  546 (593)
Q Consensus       537 RPs~~evl~~  546 (593)
                      |+|+.|++.|
T Consensus       397 RiTl~EAL~H  406 (415)
T KOG0671|consen  397 RITLREALSH  406 (415)
T ss_pred             cccHHHHhcC
Confidence            9999999876

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2e-34  Score=289.59  Aligned_cols=264  Identities=25%  Similarity=0.271  Sum_probs=200.6

Q ss_pred             cccccccCccCcccEEEEEeC-CCCeEEEEEeehhh--HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEecc
Q 007680          274 FNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFM  350 (593)
Q Consensus       274 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  350 (593)
                      |+..+.||+|++|.||+|+.. +++.||+|++....  ....+.+..|+.++++++|+|++++++++.+.+..++||||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            566789999999999999976 58999999998753  333456788999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCcc
Q 007680          351 PNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSV  430 (593)
Q Consensus       351 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~  430 (593)
                      + ++|.+++......+++..+..++.|++.||+|||+++    |+||||+|+||++++++.++|+|||.+........  
T Consensus        81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~----i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--  153 (282)
T cd07829          81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR----ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--  153 (282)
T ss_pred             C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC----cccCCCChheEEEcCCCCEEEecCCcccccCCCcc--
Confidence            7 5999999887445999999999999999999999654    99999999999999999999999999887644322  


Q ss_pred             ccccccCCccccCccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCc----hhhhhhh--
Q 007680          431 RQTMTMATIGYMAPEYGLEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHG----LTEVVDA--  503 (593)
Q Consensus       431 ~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~~--  503 (593)
                      ......++..|+|||.+.+. .++.++||||||+++||+++|+.||......+  ............    .....+.  
T Consensus       154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  231 (282)
T cd07829         154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEID--QLFKIFQILGTPTEESWPGVTKLPD  231 (282)
T ss_pred             ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHH--HHHHHHHHhCCCcHHHHHhhccccc
Confidence            12233457789999998766 78999999999999999999999996632211  111111110000    0000000  


Q ss_pred             ---hhhhh--hhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          504 ---NLVRE--EQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       504 ---~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                         .....  ..........+..+.+++.+||..||++||++.+++.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  279 (282)
T cd07829         232 YKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH  279 (282)
T ss_pred             ccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence               00000  00001111235679999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-34  Score=288.17  Aligned_cols=263  Identities=22%  Similarity=0.248  Sum_probs=196.2

Q ss_pred             cccccccCccCcccEEEEEeC-CCCeEEEEEeehhhH-HHHHHHHHHHHHHhhcC-CCCcceeeeeeecCCceEEEEecc
Q 007680          274 FNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLE-RAFRSFDSECEVLRNVR-HRNLIKILSSYSNPDFKALVLEFM  350 (593)
Q Consensus       274 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~  350 (593)
                      |++.+.||+|++|.||+|... +++.|++|.+..... .......+|+..+.+++ |||++++++++...+..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            677889999999999999976 578999999875432 22234557899999998 999999999999999999999999


Q ss_pred             CCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCc
Q 007680          351 PNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDS  429 (593)
Q Consensus       351 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~  429 (593)
                       +++|.+++.... ..+++.++..++.|++.+|.|||++    +++|+||+|+||++++++.++|+|||.+........ 
T Consensus        81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~----~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~-  154 (283)
T cd07830          81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH----GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-  154 (283)
T ss_pred             -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC-
Confidence             789999887765 3589999999999999999999965    499999999999999999999999999886643322 


Q ss_pred             cccccccCCccccCccccC-CCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCc----hhh-----
Q 007680          430 VRQTMTMATIGYMAPEYGL-EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHG----LTE-----  499 (593)
Q Consensus       430 ~~~~~~~gt~~y~aPE~~~-~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~----~~~-----  499 (593)
                        .....++..|+|||++. +..++.++|+||||+++|||++|+.||......+  ............    ..+     
T Consensus       155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  230 (283)
T cd07830         155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEID--QLYKICSVLGTPTKQDWPEGYKLA  230 (283)
T ss_pred             --cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHH--HHHHHHHhcCCCChhhhhhHhhhh
Confidence              22345788999999875 4558999999999999999999999986532211  111111100000    000     


Q ss_pred             -hhhhhhhhhh--hhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          500 -VVDANLVREE--QAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       500 -~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                       ..+..+....  .........+..+.+++++||+.||++|||++|++.+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         231 SKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             ccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence             0000000000  0000011124678999999999999999999999865

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2e-34  Score=298.13  Aligned_cols=268  Identities=21%  Similarity=0.252  Sum_probs=198.1

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh--HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCC------
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPD------  341 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  341 (593)
                      .++|.+.+.||+|+||.||+|... +|+.||+|++....  ......+.+|+.++++++||||+++++++....      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            478999999999999999999964 78999999986532  223456788999999999999999999886543      


Q ss_pred             ceEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccce
Q 007680          342 FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYK  421 (593)
Q Consensus       342 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~  421 (593)
                      ..++|+||+. .+|.++..   ..+++..+..++.|++.||+|||++    +++||||||+||+++.++.+||+|||+++
T Consensus        94 ~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~----~i~H~dlkp~NIll~~~~~~kL~dfg~~~  165 (342)
T cd07879          94 DFYLVMPYMQ-TDLQKIMG---HPLSEDKVQYLVYQMLCGLKYIHSA----GIIHRDLKPGNLAVNEDCELKILDFGLAR  165 (342)
T ss_pred             eEEEEecccc-cCHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence            4689999995 47777653   2389999999999999999999965    49999999999999999999999999987


Q ss_pred             ecCCCCCccccccccCCccccCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCc---h
Q 007680          422 LLGEGEDSVRQTMTMATIGYMAPEYGLE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHG---L  497 (593)
Q Consensus       422 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~---~  497 (593)
                      .....     .....++..|+|||++.+ ..++.++|||||||++|||++|+.||......  ..........+..   .
T Consensus       166 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~  238 (342)
T cd07879         166 HADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL--DQLTQILKVTGVPGPEF  238 (342)
T ss_pred             CCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHhcCCCCHHH
Confidence            54321     123356888999998766 46899999999999999999999999763211  1111111110000   0


Q ss_pred             hhhhhhhhhh----------hhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH--HHHhhhh
Q 007680          498 TEVVDANLVR----------EEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK--LKKIKVK  553 (593)
Q Consensus       498 ~~~~~~~~~~----------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~i~~~  553 (593)
                      .+........          ...........+.++.+++.+||+.||++||+++|++.|  ++..+..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~  306 (342)
T cd07879         239 VQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA  306 (342)
T ss_pred             HHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence            0100000000          000000011234678999999999999999999999987  7776543

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.3e-34  Score=299.74  Aligned_cols=263  Identities=22%  Similarity=0.278  Sum_probs=198.7

Q ss_pred             hhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehh--hHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCc----
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQ--LERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDF----  342 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----  342 (593)
                      ..++|++.+.||+|++|.||+|+.. +++.||+|++...  .......+.+|+.++++++|||++++.+++...+.    
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            4678999999999999999999975 6889999998653  22334567789999999999999999998876554    


Q ss_pred             --eEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccc
Q 007680          343 --KALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIY  420 (593)
Q Consensus       343 --~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a  420 (593)
                        .++|+||+ +++|.+++...  .+++..+..++.|+++||+|||+.    +|+||||||+||++++++.++|+|||++
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~ql~~aL~~LH~~----gi~H~dlkp~Nill~~~~~~kL~dfg~~  165 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKCQ--KLSDDHIQFLVYQILRGLKYIHSA----GIIHRDLKPSNIAVNEDCELKILDFGLA  165 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeEECCCCCEEEcccccc
Confidence              89999999 67999998764  389999999999999999999954    5999999999999999999999999998


Q ss_pred             eecCCCCCccccccccCCccccCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhh
Q 007680          421 KLLGEGEDSVRQTMTMATIGYMAPEYGLE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTE  499 (593)
Q Consensus       421 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  499 (593)
                      ......     .....++..|+|||...+ ..++.++|||||||++||+++|+.||......  .....+..........
T Consensus       166 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~--~~~~~i~~~~~~~~~~  238 (343)
T cd07851         166 RHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI--DQLKRIMNLVGTPDEE  238 (343)
T ss_pred             cccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHhcCCCCHH
Confidence            865432     123357888999998765 36789999999999999999999999653211  1111111111100000


Q ss_pred             hhh------------hhhhhhhhhh-hhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          500 VVD------------ANLVREEQAF-SAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       500 ~~~------------~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      ...            .......... ......++++.+++.+||..||++|||+.|+++|
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h  298 (343)
T cd07851         239 LLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH  298 (343)
T ss_pred             HHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence            000            0000000000 0011236789999999999999999999999876

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-35  Score=280.30  Aligned_cols=250  Identities=23%  Similarity=0.280  Sum_probs=205.0

Q ss_pred             hhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEE
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKAL  345 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  345 (593)
                      ..++|..++.||+|.||.|-+++-+ +|+.+|+|++++..   ..+...-..|-++|+..+||.+..+...|+..++.|+
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF  245 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF  245 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence            4578999999999999999999855 89999999998864   4445566789999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCC
Q 007680          346 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGE  425 (593)
Q Consensus       346 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~  425 (593)
                      ||||..||.|.-++...+. +++....-....|+.||.|||++    +||.||+|.+|.++|.+|++||+|||+++.--.
T Consensus       246 VMeyanGGeLf~HLsrer~-FsE~RtRFYGaEIvsAL~YLHs~----~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~  320 (516)
T KOG0690|consen  246 VMEYANGGELFFHLSRERV-FSEDRTRFYGAEIVSALGYLHSR----NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK  320 (516)
T ss_pred             EEEEccCceEeeehhhhhc-ccchhhhhhhHHHHHHhhhhhhC----CeeeeechhhhheeccCCceEeeecccchhccc
Confidence            9999999999999887665 88888888999999999999954    499999999999999999999999999885322


Q ss_pred             CCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhh
Q 007680          426 GEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANL  505 (593)
Q Consensus       426 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  505 (593)
                      ..  ......+||+.|.|||++....|+.++|.|.+||++|||+.|+.||.....+.  +            -+++    
T Consensus       321 ~g--~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k--L------------FeLI----  380 (516)
T KOG0690|consen  321 YG--DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK--L------------FELI----  380 (516)
T ss_pred             cc--ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhH--H------------HHHH----
Confidence            22  23456789999999999999999999999999999999999999997632211  1            1111    


Q ss_pred             hhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHHH
Q 007680          506 VREEQAFSAKMDCILSIMDFALDCCMESPDMRI-----NMTDAAAK  546 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  546 (593)
                      ..+...+  +...+++...|+...|.+||.+|.     .+.||.+|
T Consensus       381 l~ed~kF--Pr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h  424 (516)
T KOG0690|consen  381 LMEDLKF--PRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH  424 (516)
T ss_pred             HhhhccC--CccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence            1111111  223456789999999999999996     34555543

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-36  Score=279.74  Aligned_cols=255  Identities=25%  Similarity=0.285  Sum_probs=196.5

Q ss_pred             hccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh-HHHHHHHHHHHHHHhhc-CCCCcceeeeeeecCCceEEEEe
Q 007680          272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNV-RHRNLIKILSSYSNPDFKALVLE  348 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  348 (593)
                      ++.+-+..||.|+||+|++..++ .|+..|||+++... +.+.+++..|.+...+- +.||||+++|.+..++..++-||
T Consensus        64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME  143 (361)
T KOG1006|consen   64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME  143 (361)
T ss_pred             chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence            34455678999999999999875 79999999998764 46677888888876655 78999999999999999999999


Q ss_pred             ccCCCCHHHHHh---h-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecC
Q 007680          349 FMPNGSLEKWLY---S-HNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG  424 (593)
Q Consensus       349 ~~~~gsL~~~l~---~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~  424 (593)
                      .| .-++..+-.   . ....+++.-.-+|+...+.||.||-+   ...|+|||+||+|||++..|.+||||||++..+.
T Consensus       144 LM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~---~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv  219 (361)
T KOG1006|consen  144 LM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE---ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLV  219 (361)
T ss_pred             HH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH---HhhhhhccCChhheEEecCCCEeeecccchHhHH
Confidence            99 446655432   1 22258888888999999999999987   4579999999999999999999999999987664


Q ss_pred             CCCCccccccccCCccccCccccCCC--CCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhh
Q 007680          425 EGEDSVRQTMTMATIGYMAPEYGLEG--IVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVD  502 (593)
Q Consensus       425 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  502 (593)
                      .   +...+...|...|||||.+...  .|+.+|||||||+++||+.||+.|+.....-...+...+....|.       
T Consensus       220 ~---SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~-------  289 (361)
T KOG1006|consen  220 D---SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPI-------  289 (361)
T ss_pred             H---HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCe-------
Confidence            3   2334556789999999987643  489999999999999999999999976432211221111111111       


Q ss_pred             hhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          503 ANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                        +..    ......++..+..++.-|+.+|-++||...++.++
T Consensus       290 --l~~----~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  290 --LLF----DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             --ecC----cccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence              000    01112356688999999999999999999998764

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=6.9e-34  Score=293.04  Aligned_cols=266  Identities=21%  Similarity=0.237  Sum_probs=193.6

Q ss_pred             ccccccccCccCcccEEEEEeC-C--CCeEEEEEeehhh--HHHHHHHHHHHHHHhhc-CCCCcceeeeeeecC----Cc
Q 007680          273 EFNECNLLGTSSFGSVYKGTIS-D--GTDVAIKVFNLQL--ERAFRSFDSECEVLRNV-RHRNLIKILSSYSNP----DF  342 (593)
Q Consensus       273 ~~~~~~~lg~G~~g~Vy~~~~~-~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----~~  342 (593)
                      +|++.+.||+|+||.||+++.. +  +..||+|.+....  ....+.+.+|+++++++ +||||+++++.+...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4788899999999999999965 4  7889999987532  22345678899999999 599999999875432    45


Q ss_pred             eEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeecccee
Q 007680          343 KALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKL  422 (593)
Q Consensus       343 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~  422 (593)
                      .++++||+. ++|.+++.... .+++..+..++.|++.||+|||++    +++||||||+||++++++.+||+|||.++.
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~----givH~dlkp~Nili~~~~~~kl~Dfg~a~~  154 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSGQ-PLTDAHFQSFIYQILCGLKYIHSA----NVLHRDLKPGNLLVNADCELKICDFGLARG  154 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence            788999985 69999987654 489999999999999999999965    499999999999999999999999999987


Q ss_pred             cCCCCCcc--ccccccCCccccCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCc---
Q 007680          423 LGEGEDSV--RQTMTMATIGYMAPEYGLE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHG---  496 (593)
Q Consensus       423 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~---  496 (593)
                      ........  ......|+..|+|||+..+ ..++.++||||+|+++|++++|+.||......  .............   
T Consensus       155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~  232 (332)
T cd07857         155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYV--DQLNQILQVLGTPDEE  232 (332)
T ss_pred             cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHH--HHHHHHHHHhCCCCHH
Confidence            65432211  1223468899999998765 46899999999999999999999999763211  1111111110000   


Q ss_pred             -hhhhhhhhhh--------hhhhhhh-hhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          497 -LTEVVDANLV--------REEQAFS-AKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       497 -~~~~~~~~~~--------~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                       ..........        ....... .....+..+.+++.+||+.||++|||+.|++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~  292 (332)
T cd07857         233 TLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH  292 (332)
T ss_pred             HHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence             0000000000        0000000 001234678999999999999999999999865

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=4.7e-34  Score=318.39  Aligned_cols=146  Identities=27%  Similarity=0.426  Sum_probs=131.7

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALV  346 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  346 (593)
                      .++|.+.++||+|+||.||+|.+. +++.||+|+++...   ......+..|+.++..++||||+++++++...+..|+|
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            367999999999999999999976 68999999997542   33456788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccce
Q 007680          347 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYK  421 (593)
Q Consensus       347 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~  421 (593)
                      |||+.+++|.+++...+. +++..++.++.||+.||+|||.+    +|+||||||+|||++.++.+||+|||+++
T Consensus        83 mEy~~g~~L~~li~~~~~-l~~~~~~~i~~qil~aL~yLH~~----gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          83 MEYLIGGDVKSLLHIYGY-FDEEMAVKYISEVALALDYLHRH----GIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EeCCCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhC----CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            999999999999976554 88999999999999999999964    59999999999999999999999999876

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.8e-34  Score=280.92  Aligned_cols=236  Identities=27%  Similarity=0.301  Sum_probs=192.6

Q ss_pred             cCccCcccEEEEEeC-CCCeEEEEEeehhhH---HHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEeccCCCCH
Q 007680          280 LGTSSFGSVYKGTIS-DGTDVAIKVFNLQLE---RAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSL  355 (593)
Q Consensus       280 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  355 (593)
                      ||+|+||.||++... +++.+|+|+++....   .....+..|++++++++||||+++++.+..++..++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            699999999999975 589999999876532   2456788999999999999999999999999999999999999999


Q ss_pred             HHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCccccccc
Q 007680          356 EKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMT  435 (593)
Q Consensus       356 ~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~  435 (593)
                      .+++..... +++..+..++.|+++|+.|||+.    +++|+||+|+||++++++.++|+|||.+........  .....
T Consensus        81 ~~~l~~~~~-l~~~~~~~~~~qi~~~l~~lh~~----~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~  153 (250)
T cd05123          81 FSHLSKEGR-FSEERARFYAAEIVLALEYLHSL----GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--RTNTF  153 (250)
T ss_pred             HHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHC----CceecCCCcceEEEcCCCcEEEeecCcceecccCCC--cccCC
Confidence            999987654 89999999999999999999965    499999999999999999999999999887644321  12334


Q ss_pred             cCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhhhhhhhh
Q 007680          436 MATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAK  515 (593)
Q Consensus       436 ~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  515 (593)
                      .++..|+|||...+...+.++|+||||+++|++++|..||.....  ......+..                  .....+
T Consensus       154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--~~~~~~~~~------------------~~~~~~  213 (250)
T cd05123         154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR--KEIYEKILK------------------DPLRFP  213 (250)
T ss_pred             cCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHhc------------------CCCCCC
Confidence            578899999999888899999999999999999999999965321  111111110                  000111


Q ss_pred             HHHHHHHHHHHhhcccCCCCCCCCHHH
Q 007680          516 MDCILSIMDFALDCCMESPDMRINMTD  542 (593)
Q Consensus       516 ~~~~~~l~~li~~cl~~dP~~RPs~~e  542 (593)
                      ...+..+.+++.+||..||++||++.+
T Consensus       214 ~~~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         214 EFLSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             CCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence            122567899999999999999999943

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=3.3e-34  Score=284.72  Aligned_cols=248  Identities=21%  Similarity=0.246  Sum_probs=193.6

Q ss_pred             ccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh-----HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEE
Q 007680          273 EFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL-----ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALV  346 (593)
Q Consensus       273 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  346 (593)
                      +|.+.+.||+|+||.||++... .+..+++|+++...     ......+..|+.++++++||||+++++++.+.+..++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            4788899999999999999865 34556666665321     12334567899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceec
Q 007680          347 LEFMPNGSLEKWLYS---HNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLL  423 (593)
Q Consensus       347 ~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~  423 (593)
                      |||+++++|.+++..   ....+++.++..++.|+++||+|||+.    +++|+||||+||++++ +.++|+|||.+...
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~----~i~h~~l~~~nili~~-~~~~l~d~g~~~~~  155 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR----RILHRDLKAKNIFLKN-NLLKIGDFGVSRLL  155 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc----CccccCCChhheEeec-CCEeecccCceeec
Confidence            999999999998864   233589999999999999999999954    5999999999999975 56999999998876


Q ss_pred             CCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhh
Q 007680          424 GEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDA  503 (593)
Q Consensus       424 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  503 (593)
                      .....  ......++..|+|||...+..++.++|+||||+++|+|++|..||.....     ..........        
T Consensus       156 ~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~-----~~~~~~~~~~--------  220 (260)
T cd08222         156 MGSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF-----LSVVLRIVEG--------  220 (260)
T ss_pred             CCCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-----HHHHHHHHcC--------
Confidence            44322  12234578899999998888889999999999999999999999865211     1111110000        


Q ss_pred             hhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          504 NLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                          .  ....+..++.++.+++.+||..+|++||++.|++++
T Consensus       221 ----~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  257 (260)
T cd08222         221 ----P--TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN  257 (260)
T ss_pred             ----C--CCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence                0  000112345688999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-35  Score=295.93  Aligned_cols=245  Identities=24%  Similarity=0.363  Sum_probs=201.2

Q ss_pred             ccccCccCcccEEEEEeC-CCCeEEEEEeehhh--HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEeccCCC
Q 007680          277 CNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNG  353 (593)
Q Consensus       277 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  353 (593)
                      .+.||+|.||+||-|+++ +|+.||||++.+..  .+...++++|+.||++++||.||.+...|+.++..++|||-+.|.
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            479999999999999864 89999999997642  334478899999999999999999999999999999999999654


Q ss_pred             CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCC---CcEEEEeeccceecCCCCCcc
Q 007680          354 SLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDEN---MVAHVSDFGIYKLLGEGEDSV  430 (593)
Q Consensus       354 sL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~---~~~kL~Dfg~a~~~~~~~~~~  430 (593)
                      =|.-.+....+.+++....-+..||+.||.|||.++    |+|+||||+|||+.+.   -++||+|||+|+++++..   
T Consensus       649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn----IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks---  721 (888)
T KOG4236|consen  649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN----IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS---  721 (888)
T ss_pred             HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc----eeeccCCchheeeccCCCCCceeeccccceeecchhh---
Confidence            455556666667999888899999999999999655    9999999999999754   379999999999987643   


Q ss_pred             ccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhhh
Q 007680          431 RQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQ  510 (593)
Q Consensus       431 ~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  510 (593)
                      .....+||+.|.|||++.+..|...-|+||.||++|--++|..||.+..    +..+.++           ....   ..
T Consensus       722 FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE----dIndQIQ-----------NAaF---My  783 (888)
T KOG4236|consen  722 FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE----DINDQIQ-----------NAAF---MY  783 (888)
T ss_pred             hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc----chhHHhh-----------cccc---cc
Confidence            2344689999999999999999999999999999999999999997631    1111111           0011   11


Q ss_pred             hhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          511 AFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       511 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      ...++.+++....+||...|+..-++|.|..+.+.|
T Consensus       784 Pp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh  819 (888)
T KOG4236|consen  784 PPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSH  819 (888)
T ss_pred             CCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence            123455667788999999999999999999888765

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-34  Score=252.54  Aligned_cols=267  Identities=22%  Similarity=0.286  Sum_probs=203.8

Q ss_pred             hccccccccCccCcccEEEEEe-CCCCeEEEEEeehhh--HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEe
Q 007680          272 DEFNECNLLGTSSFGSVYKGTI-SDGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLE  348 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  348 (593)
                      .+|...++||+|.||+||+|+. .+++.||+|.++.++  +.......+|+.+++.++|.|||+++++...+....+|+|
T Consensus         2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe   81 (292)
T KOG0662|consen    2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_pred             cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence            3577889999999999999995 478999999998764  3344578899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCC
Q 007680          349 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGED  428 (593)
Q Consensus       349 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  428 (593)
                      ||. .+|..+..+-.+.++.+.+..++.|+++||.++|.++    +.|||+||.|.+|+.+|..|++|||+++.++-...
T Consensus        82 ~cd-qdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn----vlhrdlkpqnllin~ngelkladfglarafgipvr  156 (292)
T KOG0662|consen   82 FCD-QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN----VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR  156 (292)
T ss_pred             Hhh-HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh----hhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence            994 5999999888778999999999999999999999655    99999999999999999999999999998765432


Q ss_pred             ccccccccCCccccCccccCCCC-CCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHH-hcC-----Cchhhh
Q 007680          429 SVRQTMTMATIGYMAPEYGLEGI-VSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKE-SLP-----HGLTEV  500 (593)
Q Consensus       429 ~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~-~~~-----~~~~~~  500 (593)
                      .  .+..+-|..|.+|.++.+.+ |+...|+||.||++.|+.. |++.|.+... +..+.+..+. ..+     ..+...
T Consensus       157 c--ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dv-ddqlkrif~~lg~p~ed~wps~t~l  233 (292)
T KOG0662|consen  157 C--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV-DDQLKRIFRLLGTPTEDQWPSMTKL  233 (292)
T ss_pred             e--eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcH-HHHHHHHHHHhCCCccccCCccccC
Confidence            2  23456799999999998865 8999999999999999987 6666655322 2222222111 001     111122


Q ss_pred             hhhhhhhhhhhhhhhHH----HHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          501 VDANLVREEQAFSAKMD----CILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       501 ~~~~~~~~~~~~~~~~~----~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      -|...-+.........+    ....-.+++++.+.-+|..|.++++.++|
T Consensus       234 pdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh  283 (292)
T KOG0662|consen  234 PDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH  283 (292)
T ss_pred             CCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence            22211111111111111    22334688899999999999999998875

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-34  Score=313.02  Aligned_cols=262  Identities=23%  Similarity=0.391  Sum_probs=213.7

Q ss_pred             HHHhhhccccccccCccCcccEEEEEeC----C----CCeEEEEEeehhh-HHHHHHHHHHHHHHhhc-CCCCcceeeee
Q 007680          267 IQRATDEFNECNLLGTSSFGSVYKGTIS----D----GTDVAIKVFNLQL-ERAFRSFDSECEVLRNV-RHRNLIKILSS  336 (593)
Q Consensus       267 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~  336 (593)
                      ++...++..+.+.+|+|.||.|++|...    .    ...||||.++... ....+.+..|+++|..+ +|+||+.++|+
T Consensus       291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~  370 (609)
T KOG0200|consen  291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA  370 (609)
T ss_pred             eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence            3444555567779999999999999743    1    4569999998653 35667899999999999 69999999999


Q ss_pred             eecCCceEEEEeccCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCC
Q 007680          337 YSNPDFKALVLEFMPNGSLEKWLYSHN---------------YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKP  401 (593)
Q Consensus       337 ~~~~~~~~lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp  401 (593)
                      +..++..++|+||++.|+|.++++..+               ..++..+.+.++.|||.|++||+    +.+++||||..
T Consensus       371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~----~~~~vHRDLAa  446 (609)
T KOG0200|consen  371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA----SVPCVHRDLAA  446 (609)
T ss_pred             eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh----hCCccchhhhh
Confidence            999999999999999999999999887               23889999999999999999999    45599999999


Q ss_pred             CCeeeCCCCcEEEEeeccceecCCCCCcccccccc--CCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCcc
Q 007680          402 TNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTM--ATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEM  478 (593)
Q Consensus       402 ~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~  478 (593)
                      +|||++.+..+||+|||+|+.......... ....  -...|||||.+....|+.++|||||||++||++| |..||.+.
T Consensus       447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~-~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~  525 (609)
T KOG0200|consen  447 RNVLITKNKVIKIADFGLARDHYNKDYYRT-KSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGI  525 (609)
T ss_pred             hhEEecCCCEEEEccccceeccCCCCceEe-cCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCC
Confidence            999999999999999999996554433221 1112  2455999999999999999999999999999999 89999762


Q ss_pred             ccccchHHHHHHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhh
Q 007680          479 FIGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIK  551 (593)
Q Consensus       479 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~  551 (593)
                      ... ..+.++                 .+...+.+.+..|+.++.++|+.||+.+|++||++.|+.+.++...
T Consensus       526 ~~~-~~l~~~-----------------l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l  580 (609)
T KOG0200|consen  526 PPT-EELLEF-----------------LKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL  580 (609)
T ss_pred             CcH-HHHHHH-----------------HhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence            211 111112                 2333444556677889999999999999999999999999999853

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-35  Score=272.48  Aligned_cols=271  Identities=20%  Similarity=0.289  Sum_probs=203.2

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh--HHHHHHHHHHHHHHhhcCCCCcceeeeeeec--------
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSYSN--------  339 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------  339 (593)
                      ...|+...+||+|.||.||+|+.+ +|+.||+|++-...  ........+|++++..++|+|++.+++.|..        
T Consensus        16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~   95 (376)
T KOG0669|consen   16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD   95 (376)
T ss_pred             chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence            456778889999999999999965 68889998765432  2233466889999999999999999988753        


Q ss_pred             CCceEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeecc
Q 007680          340 PDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGI  419 (593)
Q Consensus       340 ~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~  419 (593)
                      ....|+||++|+. +|..++......++..++.+++.++..||.|+|..    .|+|||+||.|+||+.+|.+||+|||+
T Consensus        96 r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~----kilHRDmKaaNvLIt~dgilklADFGl  170 (376)
T KOG0669|consen   96 RATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRN----KILHRDMKAANVLITKDGILKLADFGL  170 (376)
T ss_pred             cceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHh----hHHhhcccHhhEEEcCCceEEeecccc
Confidence            2358999999976 99999988767799999999999999999999954    499999999999999999999999999


Q ss_pred             ceecCCCCC--ccccccccCCccccCccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCcccccc-chHHHHHHHhcCC
Q 007680          420 YKLLGEGED--SVRQTMTMATIGYMAPEYGLEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFIGE-MSLRRWVKESLPH  495 (593)
Q Consensus       420 a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~-~~~~~~~~~~~~~  495 (593)
                      ++.+.....  ..+.+.++-|..|++||.+.+. .|+++.|||+.||++.||+||.+-+.+..... ..+...+......
T Consensus       171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk  250 (376)
T KOG0669|consen  171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK  250 (376)
T ss_pred             ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence            987654433  2234566779999999988765 59999999999999999999999987743221 1122222211111


Q ss_pred             c-hhhhhhhhhh--------hhhhhhhhhHH------HHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 007680          496 G-LTEVVDANLV--------REEQAFSAKMD------CILSIMDFALDCCMESPDMRINMTDAAAKL  547 (593)
Q Consensus       496 ~-~~~~~~~~~~--------~~~~~~~~~~~------~~~~l~~li~~cl~~dP~~RPs~~evl~~L  547 (593)
                      + +..+..-.+.        ... .+....+      -.++..+++.+++..||.+|+++++++.|-
T Consensus       251 evWP~~d~lpL~~sie~ePl~~~-~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~  316 (376)
T KOG0669|consen  251 EVWPNVDNLPLYQSIELEPLPKG-QKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD  316 (376)
T ss_pred             ccCCCcccchHHHhccCCCCCcc-hhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence            1 1111111110        000 0000011      123678999999999999999999999873

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-34  Score=297.92  Aligned_cols=242  Identities=24%  Similarity=0.298  Sum_probs=197.9

Q ss_pred             hhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhc-CCCCcceeeeeeecCCceEEEE
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNV-RHRNLIKILSSYSNPDFKALVL  347 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  347 (593)
                      .++.|+....+|.|+|+.|-.+... +++..++|++....    .+..+|+.++... +||||+++.+.+.+..+.|+||
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~  395 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM  395 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence            3678889999999999999998854 78999999997652    2345677666666 7999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeee-CCCCcEEEEeeccceecCCC
Q 007680          348 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILL-DENMVAHVSDFGIYKLLGEG  426 (593)
Q Consensus       348 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll-~~~~~~kL~Dfg~a~~~~~~  426 (593)
                      |.+.|+-+.+.+...+. +. .++..|+.+|+.|+.|||++|    ++|||+||+|||+ ++.++++|+|||.++.....
T Consensus       396 e~l~g~ell~ri~~~~~-~~-~e~~~w~~~lv~Av~~LH~~g----vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~  469 (612)
T KOG0603|consen  396 ELLDGGELLRRIRSKPE-FC-SEASQWAAELVSAVDYLHEQG----VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS  469 (612)
T ss_pred             hhccccHHHHHHHhcch-hH-HHHHHHHHHHHHHHHHHHhcC----eeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence            99999998888877664 33 788889999999999999655    9999999999999 69999999999999876543


Q ss_pred             CCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhh
Q 007680          427 EDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLV  506 (593)
Q Consensus       427 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  506 (593)
                           ....+-|..|.|||++....|++++|+||||++||+|++|+.||.....+ ..+...+.                
T Consensus       470 -----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-~ei~~~i~----------------  527 (612)
T KOG0603|consen  470 -----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-IEIHTRIQ----------------  527 (612)
T ss_pred             -----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-HHHHHhhc----------------
Confidence                 22345688899999999999999999999999999999999999875333 11111100                


Q ss_pred             hhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 007680          507 REEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKL  547 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  547 (593)
                      .    ......++...++|+.+||+.||.+||++.++..|=
T Consensus       528 ~----~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~  564 (612)
T KOG0603|consen  528 M----PKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHP  564 (612)
T ss_pred             C----CccccccCHHHHHHHHHhccCChhhCcChhhhccCc
Confidence            0    001134567889999999999999999999998873

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-34  Score=276.62  Aligned_cols=268  Identities=20%  Similarity=0.283  Sum_probs=219.2

Q ss_pred             HHHHHHhhhccccccccCccCcccEEEEEeC------CCCeEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceeeee
Q 007680          264 YLDIQRATDEFNECNLLGTSSFGSVYKGTIS------DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSS  336 (593)
Q Consensus       264 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~  336 (593)
                      ..++.....+++....+.+|.||.||+|.+.      +.+.|-+|.++... .-....+..|...+..+.|||+.++.++
T Consensus       276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V  355 (563)
T KOG1024|consen  276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV  355 (563)
T ss_pred             HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence            4456666777888889999999999999654      34557778776543 3345678889999999999999999997


Q ss_pred             ee-cCCceEEEEeccCCCCHHHHHhhCC-------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC
Q 007680          337 YS-NPDFKALVLEFMPNGSLEKWLYSHN-------YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDE  408 (593)
Q Consensus       337 ~~-~~~~~~lv~e~~~~gsL~~~l~~~~-------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~  408 (593)
                      +. +.+..+..+.++.-|+|..++...+       ..++..+...++.|++.|++|||.++    |+|.||..+|.+||+
T Consensus       356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~----ViHkDiAaRNCvIdd  431 (563)
T KOG1024|consen  356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG----VIHKDIAARNCVIDD  431 (563)
T ss_pred             EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC----cccchhhhhcceehh
Confidence            75 4567888999999999999998321       25777888999999999999999654    999999999999999


Q ss_pred             CCcEEEEeeccceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHH
Q 007680          409 NMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRR  487 (593)
Q Consensus       409 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~  487 (593)
                      ..++||+|=.+++.+-+.+.+.-.........||+||.+.+..|+.++|||||||++|||+| |+.|+.+..+.++  . 
T Consensus       432 ~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm--~-  508 (563)
T KOG1024|consen  432 QLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEM--E-  508 (563)
T ss_pred             heeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHH--H-
Confidence            99999999999987766554444444456788999999999999999999999999999999 9999987433221  1 


Q ss_pred             HHHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhhh
Q 007680          488 WVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKF  554 (593)
Q Consensus       488 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  554 (593)
                                      .+..++.+..++.+||+++..+|.-||+.+|++||+++|+..-|.+.....
T Consensus       509 ----------------~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ql  559 (563)
T KOG1024|consen  509 ----------------HYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQL  559 (563)
T ss_pred             ----------------HHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHH
Confidence                            222344566677889999999999999999999999999999999876543

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=9.2e-34  Score=277.63  Aligned_cols=219  Identities=18%  Similarity=0.145  Sum_probs=175.7

Q ss_pred             cCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEeccCCCCHHHHHhh
Q 007680          283 SSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYS  361 (593)
Q Consensus       283 G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~  361 (593)
                      |.+|.||+++.. +++.||+|.++...     .+..|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            899999999965 78999999997653     233455555566799999999999999999999999999999999876


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCccccccccCCccc
Q 007680          362 HNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGY  441 (593)
Q Consensus       362 ~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y  441 (593)
                      ... +++..+..++.|+++||+|||+.    +++||||||+||+++.++.++++|||.+.......     ....++..|
T Consensus        79 ~~~-l~~~~~~~~~~ql~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~y  148 (237)
T cd05576          79 FLN-IPEECVKRWAAEMVVALDALHRE----GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENMY  148 (237)
T ss_pred             hcC-CCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCccc
Confidence            654 89999999999999999999954    59999999999999999999999999876554321     223456779


Q ss_pred             cCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHH
Q 007680          442 MAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILS  521 (593)
Q Consensus       442 ~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  521 (593)
                      +|||...+..++.++||||+|+++|||++|+.|+.......               ....         ....+..++..
T Consensus       149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~---------------~~~~---------~~~~~~~~~~~  204 (237)
T cd05576         149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI---------------NTHT---------TLNIPEWVSEE  204 (237)
T ss_pred             cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc---------------cccc---------ccCCcccCCHH
Confidence            99999988889999999999999999999998875421100               0000         00011123457


Q ss_pred             HHHHHhhcccCCCCCCCCH
Q 007680          522 IMDFALDCCMESPDMRINM  540 (593)
Q Consensus       522 l~~li~~cl~~dP~~RPs~  540 (593)
                      +.+++.+||+.||++||++
T Consensus       205 ~~~li~~~l~~dp~~R~~~  223 (237)
T cd05576         205 ARSLLQQLLQFNPTERLGA  223 (237)
T ss_pred             HHHHHHHHccCCHHHhcCC
Confidence            8999999999999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-34  Score=279.07  Aligned_cols=259  Identities=26%  Similarity=0.380  Sum_probs=205.5

Q ss_pred             hhccccccccCccCcccEEEEEe-CCCCeEEEEEeehhh-------HHHHHHHHHHHHHHhhcCCCCcceeeeeee-cCC
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTI-SDGTDVAIKVFNLQL-------ERAFRSFDSECEVLRNVRHRNLIKILSSYS-NPD  341 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~  341 (593)
                      .++|-.+..||+|||+.||+|.+ ...+.||||+-..+.       +...+...+|.+|.+.++||.||++|++|. +.+
T Consensus       462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd  541 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD  541 (775)
T ss_pred             HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence            46788899999999999999984 468899999875432       223445678999999999999999999986 456


Q ss_pred             ceEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeC---CCCcEEEEeec
Q 007680          342 FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLD---ENMVAHVSDFG  418 (593)
Q Consensus       342 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~---~~~~~kL~Dfg  418 (593)
                      .+|-|+|||+|.+|.-++..++. +++.++..|+.||+.||.||.+.  +.+|+|-||||.|||+.   ..|.+||+|||
T Consensus       542 sFCTVLEYceGNDLDFYLKQhkl-mSEKEARSIiMQiVnAL~YLNEi--kpPIIHYDLKPgNILLv~GtacGeIKITDFG  618 (775)
T KOG1151|consen  542 SFCTVLEYCEGNDLDFYLKQHKL-MSEKEARSIIMQIVNALKYLNEI--KPPIIHYDLKPGNILLVNGTACGEIKITDFG  618 (775)
T ss_pred             cceeeeeecCCCchhHHHHhhhh-hhHHHHHHHHHHHHHHHHHHhcc--CCCeeeeccCCccEEEecCcccceeEeeecc
Confidence            78999999999999999988775 99999999999999999999976  46899999999999995   45789999999


Q ss_pred             cceecCCCCCcc-----ccccccCCccccCccccCC----CCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHH
Q 007680          419 IYKLLGEGEDSV-----RQTMTMATIGYMAPEYGLE----GIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWV  489 (593)
Q Consensus       419 ~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~----~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~  489 (593)
                      +++.+..+....     -.+...||.+|++||.+.-    ...+.++||||.||++|..+.|+.||+......    +.+
T Consensus       619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ----dIL  694 (775)
T KOG1151|consen  619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ----DIL  694 (775)
T ss_pred             hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH----HHH
Confidence            999987654321     2345679999999997643    347889999999999999999999998742111    111


Q ss_pred             HHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          490 KESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       490 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      ...          ..+...+..++....++.+..++|++||++.-++|....++..+
T Consensus       695 qeN----------TIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~d  741 (775)
T KOG1151|consen  695 QEN----------TILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACD  741 (775)
T ss_pred             hhh----------chhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccC
Confidence            110          01112233444445566788999999999999999998887653

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-34  Score=283.35  Aligned_cols=250  Identities=22%  Similarity=0.317  Sum_probs=205.1

Q ss_pred             hhccccccccCccCcccEEEEEeCCC-CeEEEEEeehh---hHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTISDG-TDVAIKVFNLQ---LERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALV  346 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  346 (593)
                      ..+++++..||-|+||.|-++..+.. ..+|+|.+++.   +.+..+.+..|-.+|...+.|.||++|..|.+....|+.
T Consensus       419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL  498 (732)
T KOG0614|consen  419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML  498 (732)
T ss_pred             hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence            34667778999999999999987533 34899988765   344556788899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCC
Q 007680          347 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG  426 (593)
Q Consensus       347 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  426 (593)
                      ||-|-||.|+..++.++. ++.....-++..+++|++|||.    .+||.|||||+|.+++.+|.+||.|||+|+.++.+
T Consensus       499 mEaClGGElWTiLrdRg~-Fdd~tarF~~acv~EAfeYLH~----k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g  573 (732)
T KOG0614|consen  499 MEACLGGELWTILRDRGS-FDDYTARFYVACVLEAFEYLHR----KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG  573 (732)
T ss_pred             HHhhcCchhhhhhhhcCC-cccchhhhhHHHHHHHHHHHHh----cCceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence            999999999999998776 8888999999999999999995    45999999999999999999999999999998876


Q ss_pred             CCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhh
Q 007680          427 EDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLV  506 (593)
Q Consensus       427 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  506 (593)
                      ..   ....+||+.|.|||++.+...+.++|.||||+++||+++|++||.+..  .+.....+...              
T Consensus       574 ~K---TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~d--pmktYn~ILkG--------------  634 (732)
T KOG0614|consen  574 RK---TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVD--PMKTYNLILKG--------------  634 (732)
T ss_pred             Cc---eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCc--hHHHHHHHHhh--------------
Confidence            53   455789999999999999999999999999999999999999998732  11111111111              


Q ss_pred             hhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCC-----HHHHHHH
Q 007680          507 REEQAFSAKMDCILSIMDFALDCCMESPDMRIN-----MTDAAAK  546 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~  546 (593)
                        -.....+..++....+++++.++.+|.+|..     +.|+-+|
T Consensus       635 --id~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH  677 (732)
T KOG0614|consen  635 --IDKIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH  677 (732)
T ss_pred             --hhhhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence              0111122334556789999999999999985     5566555

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-33  Score=292.61  Aligned_cols=254  Identities=23%  Similarity=0.316  Sum_probs=205.8

Q ss_pred             HhhhccccccccCccCcccEEEEEe-CCCCeEEEEEeehhhHHHHHHHHHHHHHHhhc-CCCCcceeeeeeec-----CC
Q 007680          269 RATDEFNECNLLGTSSFGSVYKGTI-SDGTDVAIKVFNLQLERAFRSFDSECEVLRNV-RHRNLIKILSSYSN-----PD  341 (593)
Q Consensus       269 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-----~~  341 (593)
                      .-++-|++.+.||.|.+|.||+++. ++++.+|+|+.....+ ..++++.|.++++.. .|||++.++|+|..     ++
T Consensus        16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~D   94 (953)
T KOG0587|consen   16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGD   94 (953)
T ss_pred             CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCC
Confidence            3467799999999999999999995 4789999999876643 335677899999988 69999999998853     56


Q ss_pred             ceEEEEeccCCCCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccc
Q 007680          342 FKALVLEFMPNGSLEKWLYSHNY-FLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIY  420 (593)
Q Consensus       342 ~~~lv~e~~~~gsL~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a  420 (593)
                      ..++|||||.+|+..|++..-.+ .+.|..+..|++.++.|+.+||++.    ++|||||-.|||++.++.|||+|||.+
T Consensus        95 qLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk----viHRDikG~NiLLT~e~~VKLvDFGvS  170 (953)
T KOG0587|consen   95 QLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK----VIHRDIKGQNVLLTENAEVKLVDFGVS  170 (953)
T ss_pred             eEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc----eeeecccCceEEEeccCcEEEeeeeee
Confidence            89999999999999999876433 6899999999999999999999655    999999999999999999999999998


Q ss_pred             eecCCCCCccccccccCCccccCccccCCC-----CCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCC
Q 007680          421 KLLGEGEDSVRQTMTMATIGYMAPEYGLEG-----IVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPH  495 (593)
Q Consensus       421 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~  495 (593)
                      ..+...  ..+.....||+.|||||++.-.     .|+.++|+||||++..||.-|.+|+.++..-.     .+-. ++ 
T Consensus       171 aQldsT--~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr-----aLF~-Ip-  241 (953)
T KOG0587|consen  171 AQLDST--VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR-----ALFL-IP-  241 (953)
T ss_pred             eeeecc--cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh-----hhcc-CC-
Confidence            876542  2344567899999999987643     37789999999999999999999987743211     0000 00 


Q ss_pred             chhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          496 GLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       496 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                                .........+...++++.++|..||.+|-+.||++.++++|
T Consensus       242 ----------RNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h  282 (953)
T KOG0587|consen  242 ----------RNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH  282 (953)
T ss_pred             ----------CCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence                      01112222344567789999999999999999999999875

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-33  Score=274.11  Aligned_cols=244  Identities=23%  Similarity=0.255  Sum_probs=196.6

Q ss_pred             HhhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhc-CCCCcceeeeeeecCCce
Q 007680          269 RATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNV-RHRNLIKILSSYSNPDFK  343 (593)
Q Consensus       269 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  343 (593)
                      ....+|..+.+||+|+||.|.+|..+ +.+.+|||+++++.   ....+--..|-++|..- +-|.+++++.+|+..+..
T Consensus       346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRL  425 (683)
T KOG0696|consen  346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL  425 (683)
T ss_pred             eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence            34457999999999999999999865 57889999998763   22333345566777665 578999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceec
Q 007680          344 ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLL  423 (593)
Q Consensus       344 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~  423 (593)
                      |+||||+.||+|--++++-++ +.+..+.-.+..||-||-+||+    .||+.||||.+||++|.+|++||+|||+++.-
T Consensus       426 yFVMEyvnGGDLMyhiQQ~Gk-FKEp~AvFYAaEiaigLFFLh~----kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn  500 (683)
T KOG0696|consen  426 YFVMEYVNGGDLMYHIQQVGK-FKEPVAVFYAAEIAIGLFFLHS----KGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN  500 (683)
T ss_pred             eeEEEEecCchhhhHHHHhcc-cCCchhhhhhHHHHHHhhhhhc----CCeeeeeccccceEeccCCceEeeeccccccc
Confidence            999999999999999988776 8888999999999999999995    55999999999999999999999999998753


Q ss_pred             CCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhh
Q 007680          424 GEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDA  503 (593)
Q Consensus       424 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  503 (593)
                      --+.  ......+||+.|+|||++..++|+.++|.|||||+||||+.|++||++..++  .+-+.+           .+.
T Consensus       501 i~~~--~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~--elF~aI-----------~eh  565 (683)
T KOG0696|consen  501 IFDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED--ELFQAI-----------MEH  565 (683)
T ss_pred             ccCC--cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHH--HHHHHH-----------HHc
Confidence            2222  2334578999999999999999999999999999999999999999884222  111111           111


Q ss_pred             hhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCC
Q 007680          504 NLVREEQAFSAKMDCILSIMDFALDCCMESPDMRIN  539 (593)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs  539 (593)
                      +.       ..+...+.+..++++..+.+.|.+|..
T Consensus       566 nv-------syPKslSkEAv~ickg~ltK~P~kRLG  594 (683)
T KOG0696|consen  566 NV-------SYPKSLSKEAVAICKGLLTKHPGKRLG  594 (683)
T ss_pred             cC-------cCcccccHHHHHHHHHHhhcCCccccC
Confidence            11       112234567789999999999999964

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.98  E-value=7.3e-32  Score=263.73  Aligned_cols=238  Identities=31%  Similarity=0.384  Sum_probs=193.0

Q ss_pred             CcccEEEEEeC-CCCeEEEEEeehhhHHH-HHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEeccCCCCHHHHHhh
Q 007680          284 SFGSVYKGTIS-DGTDVAIKVFNLQLERA-FRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYS  361 (593)
Q Consensus       284 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~  361 (593)
                      +||.||+|... +|+.+|+|++....... .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999976 58999999997664433 67899999999999999999999999999999999999999999999987


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCccccccccCCccc
Q 007680          362 HNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGY  441 (593)
Q Consensus       362 ~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y  441 (593)
                      ... +++..+..++.++++++.+||+.    +++|+||+|+||++++++.++|+|||.+.......   ......++..|
T Consensus        81 ~~~-~~~~~~~~~~~~l~~~l~~lh~~----~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~  152 (244)
T smart00220       81 RGR-LSEDEARFYARQILSALEYLHSN----GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEY  152 (244)
T ss_pred             ccC-CCHHHHHHHHHHHHHHHHHHHHc----CeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCC
Confidence            654 89999999999999999999965    49999999999999999999999999998765432   22334578889


Q ss_pred             cCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHH
Q 007680          442 MAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILS  521 (593)
Q Consensus       442 ~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  521 (593)
                      ++||...+..++.++||||||++++++++|..||...... ....+........               .......++.+
T Consensus       153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~-~~~~~~~~~~~~~---------------~~~~~~~~~~~  216 (244)
T smart00220      153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL-LELFKKIGKPKPP---------------FPPPEWKISPE  216 (244)
T ss_pred             CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHhccCCC---------------CccccccCCHH
Confidence            9999998888999999999999999999999998663111 1111111110000               00000004567


Q ss_pred             HHHHHhhcccCCCCCCCCHHHHHH
Q 007680          522 IMDFALDCCMESPDMRINMTDAAA  545 (593)
Q Consensus       522 l~~li~~cl~~dP~~RPs~~evl~  545 (593)
                      +.+++.+||..+|++||++.++++
T Consensus       217 ~~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      217 AKDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHHHHHHccCCchhccCHHHHhh
Confidence            899999999999999999999987

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.98  E-value=1.3e-32  Score=245.47  Aligned_cols=212  Identities=24%  Similarity=0.296  Sum_probs=174.0

Q ss_pred             HhhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh-HHHHHHHHHHHHHHhhc-CCCCcceeeeeeecCCceEE
Q 007680          269 RATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNV-RHRNLIKILSSYSNPDFKAL  345 (593)
Q Consensus       269 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  345 (593)
                      ...++...+..||+|++|.|-+.++. +|+..|+|.++... .+..++...|+.+..+. .+|.+|+++|.+...+..++
T Consensus        43 V~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwI  122 (282)
T KOG0984|consen   43 VPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWI  122 (282)
T ss_pred             cchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEE
Confidence            34556667789999999999888864 79999999998753 44556778888876665 79999999999999999999


Q ss_pred             EEeccCCCCHHHHHh---hCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeecccee
Q 007680          346 VLEFMPNGSLEKWLY---SHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKL  422 (593)
Q Consensus       346 v~e~~~~gsL~~~l~---~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~  422 (593)
                      .||.|. -+|..+-.   ..+..+++..+-+|+..+.+||.|||+   ...++|||+||+|||++.+|++|+||||++-.
T Consensus       123 cME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~---kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~  198 (282)
T KOG0984|consen  123 CMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS---KLSVIHRDVKPSNILINYDGQVKICDFGISGY  198 (282)
T ss_pred             eHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH---HhhhhhccCCcceEEEccCCcEEEccccccee
Confidence            999994 47766543   344568999999999999999999998   45799999999999999999999999999988


Q ss_pred             cCCCCCccccccccCCccccCccccCC----CCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHH
Q 007680          423 LGEGEDSVRQTMTMATIGYMAPEYGLE----GIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRR  487 (593)
Q Consensus       423 ~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~  487 (593)
                      +.+.-   ..+...|...|||||.+..    ..|+.++||||||+++.||.+++.||+........+.+
T Consensus       199 L~dSi---Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkq  264 (282)
T KOG0984|consen  199 LVDSI---AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQ  264 (282)
T ss_pred             ehhhh---HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHH
Confidence            75432   3344568889999998653    36899999999999999999999999875444433333

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.98  E-value=1.8e-32  Score=298.34  Aligned_cols=265  Identities=20%  Similarity=0.204  Sum_probs=171.2

Q ss_pred             hhhccccccccCccCcccEEEEEeC-C----CCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeee------ee
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTIS-D----GTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSS------YS  338 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~------~~  338 (593)
                      ..++|++.+.||+|+||.||+|++. +    +..||+|.+......  +....|  .+....+.++..+...      ..
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            5678999999999999999999975 4    689999987643221  111111  1112222233322221      23


Q ss_pred             cCCceEEEEeccCCCCHHHHHhhCCCC-------------------CCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCC
Q 007680          339 NPDFKALVLEFMPNGSLEKWLYSHNYF-------------------LDILERLNIMIDVGSALEYLHNGHSSVHIIHCDL  399 (593)
Q Consensus       339 ~~~~~~lv~e~~~~gsL~~~l~~~~~~-------------------l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dl  399 (593)
                      .....++||||+++++|.+++......                   .....+..++.|++.||+|||++    +|+||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~----gIiHRDL  281 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST----GIVHRDV  281 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC----CEEeCcC
Confidence            556789999999999999998754321                   11234567999999999999965    5999999


Q ss_pred             CCCCeeeCC-CCcEEEEeeccceecCCCCCccccccccCCccccCccccCCC----------------------CCCccc
Q 007680          400 KPTNILLDE-NMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEG----------------------IVSAKC  456 (593)
Q Consensus       400 kp~NIll~~-~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~s~~~  456 (593)
                      ||+|||+++ ++.+||+|||+++.+...... ......+++.|+|||.+...                      .++.++
T Consensus       282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~  360 (566)
T PLN03225        282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF  360 (566)
T ss_pred             CHHHEEEeCCCCcEEEEeCCCcccccccccc-CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence            999999985 579999999999865433222 22345688999999964322                      234567


Q ss_pred             hHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCC--chhhhhhhhhhhh-hhhhhhhHHHHHHHHHHHhhcccCC
Q 007680          457 DVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPH--GLTEVVDANLVRE-EQAFSAKMDCILSIMDFALDCCMES  533 (593)
Q Consensus       457 DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~d  533 (593)
                      |||||||++|||+++..|++...   ..+...+...-.+  .+..........+ ...++..........+|+.+||+.|
T Consensus       361 DVwSlGviL~el~~~~~~~~~~~---~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~d  437 (566)
T PLN03225        361 DIYSAGLIFLQMAFPNLRSDSNL---IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFK  437 (566)
T ss_pred             ccHHHHHHHHHHHhCcCCCchHH---HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCC
Confidence            99999999999999877754321   1111111110000  0011111110000 0001111111234568999999999


Q ss_pred             CCCCCCHHHHHHH
Q 007680          534 PDMRINMTDAAAK  546 (593)
Q Consensus       534 P~~RPs~~evl~~  546 (593)
                      |++|||+.|+++|
T Consensus       438 P~kR~ta~e~L~H  450 (566)
T PLN03225        438 GRQRISAKAALAH  450 (566)
T ss_pred             cccCCCHHHHhCC
Confidence            9999999999987

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.98  E-value=1.9e-31  Score=283.29  Aligned_cols=265  Identities=21%  Similarity=0.242  Sum_probs=182.2

Q ss_pred             hhhccccccccCccCcccEEEEEe-----------------CCCCeEEEEEeehhhHHHHH--------------HHHHH
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTI-----------------SDGTDVAIKVFNLQLERAFR--------------SFDSE  318 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~--------------~~~~E  318 (593)
                      ..++|++.++||+|+||+||+|..                 .+++.||||.++.......+              ....|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            467899999999999999999963                 23567999998754322222              23447


Q ss_pred             HHHHhhcCCCCc-----ceeeeeeec--------CCceEEEEeccCCCCHHHHHhhCCC---------------------
Q 007680          319 CEVLRNVRHRNL-----IKILSSYSN--------PDFKALVLEFMPNGSLEKWLYSHNY---------------------  364 (593)
Q Consensus       319 ~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~---------------------  364 (593)
                      +.++.+++|.++     ++++++|..        .+..++||||+++++|.++++....                     
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            777777766554     667777653        3568999999999999999864311                     


Q ss_pred             --CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCccccccccCCcccc
Q 007680          365 --FLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYM  442 (593)
Q Consensus       365 --~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~  442 (593)
                        .+++..+..++.|++.||.|||++    +|+||||||+||+++.++.+||+|||++......... ......+++.|+
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~----~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~  377 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRI----GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYS  377 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCccee
Confidence              245677889999999999999965    4999999999999999999999999998765433211 112233578999


Q ss_pred             CccccCCCC--------------------C--CccchHHHHHHHHHHHHhCCC-CCCccccccchHHHHHHHhcCCchhh
Q 007680          443 APEYGLEGI--------------------V--SAKCDVYSYGVLLMETFTRKR-PTDEMFIGEMSLRRWVKESLPHGLTE  499 (593)
Q Consensus       443 aPE~~~~~~--------------------~--s~~~DvwSlGvvl~elltg~~-pf~~~~~~~~~~~~~~~~~~~~~~~~  499 (593)
                      |||.+....                    +  ..+.||||+||++++|++|.. ||.....-......+     ......
T Consensus       378 aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~-----~~~~~~  452 (507)
T PLN03224        378 PPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQY-----DNDLNR  452 (507)
T ss_pred             ChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhc-----cchHHH
Confidence            999875432                    1  124799999999999999885 665421100000000     000000


Q ss_pred             hhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCC---CCCCCHHHHHHH
Q 007680          500 VVDANLVREEQAFSAKMDCILSIMDFALDCCMESP---DMRINMTDAAAK  546 (593)
Q Consensus       500 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP---~~RPs~~evl~~  546 (593)
                      .  .........++.....+....+++.++|..+|   .+|+|++|+++|
T Consensus       453 ~--r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H  500 (507)
T PLN03224        453 W--RMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH  500 (507)
T ss_pred             H--HhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence            0  00011111122223345678999999999866   789999999987

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.97  E-value=2.4e-32  Score=247.22  Aligned_cols=264  Identities=20%  Similarity=0.343  Sum_probs=202.9

Q ss_pred             HhhhccccccccCccCcccEEEEE-eCCCCeEEEEEeehhhHHHHHHHHHHHHHHhhcC-CCCcceeeeeeecCC--ceE
Q 007680          269 RATDEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVR-HRNLIKILSSYSNPD--FKA  344 (593)
Q Consensus       269 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~~~  344 (593)
                      ...++|++.+++|+|.|+.||.|. ..+.++++||++++-.   .+.+.+|+.||+.++ ||||+++++...++.  ...
T Consensus        35 g~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa  111 (338)
T KOG0668|consen   35 GNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS  111 (338)
T ss_pred             cccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence            356889999999999999999998 4578899999998653   357889999999997 999999999988764  678


Q ss_pred             EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCC-CcEEEEeeccceec
Q 007680          345 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDEN-MVAHVSDFGIYKLL  423 (593)
Q Consensus       345 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~-~~~kL~Dfg~a~~~  423 (593)
                      +|+||+.+.+...+...    ++..++...+.+++.||.|+|    |+||+|||+||.|+++|.. -..+|+|+|+|.++
T Consensus       112 LiFE~v~n~Dfk~ly~t----l~d~dIryY~~elLkALdyCH----S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY  183 (338)
T KOG0668|consen  112 LIFEYVNNTDFKQLYPT----LTDYDIRYYIYELLKALDYCH----SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  183 (338)
T ss_pred             hHhhhhccccHHHHhhh----hchhhHHHHHHHHHHHHhHHH----hcCcccccCCcceeeechhhceeeeeecchHhhc
Confidence            99999998887776543    777889999999999999999    6779999999999999954 57999999999987


Q ss_pred             CCCCCccccccccCCccccCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHH------------
Q 007680          424 GEGEDSVRQTMTMATIGYMAPEYGLE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVK------------  490 (593)
Q Consensus       424 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~------------  490 (593)
                      -.+.   ....++.+..|.-||.+-. +.|+..-|+|||||++..|+..+.||........++.+.+.            
T Consensus       184 Hp~~---eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~  260 (338)
T KOG0668|consen  184 HPGK---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLN  260 (338)
T ss_pred             CCCc---eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHH
Confidence            6544   3455677888999998765 45899999999999999999999998654333333333211            


Q ss_pred             H---hcCCchhhhhhhhhhhhhhhh---hhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          491 E---SLPHGLTEVVDANLVREEQAF---SAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       491 ~---~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      .   .++....+++.......-..+   +...-..++..+++.+.|..|-.+|+|++|+++|
T Consensus       261 KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H  322 (338)
T KOG0668|consen  261 KYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH  322 (338)
T ss_pred             HHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence            1   112222222222111111111   1111234688999999999999999999999987

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.9e-32  Score=259.01  Aligned_cols=249  Identities=20%  Similarity=0.255  Sum_probs=201.9

Q ss_pred             hhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhc-CCCCcceeeeeeecCCceE
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNV-RHRNLIKILSSYSNPDFKA  344 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  344 (593)
                      ..++|..+.+||+|+|+.|.+++++ +.+.+|+|++++..   .+..+-.+.|-.+..+. +||.+|.+..+|......+
T Consensus       248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf  327 (593)
T KOG0695|consen  248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF  327 (593)
T ss_pred             ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence            3568999999999999999999965 78999999998763   44556678888888887 7999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecC
Q 007680          345 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG  424 (593)
Q Consensus       345 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~  424 (593)
                      +|.||++||+|--+++..++ ++++.+.-....|..||.|||++|    |+.||+|.+||++|..|++||+|+|.++.--
T Consensus       328 fvieyv~ggdlmfhmqrqrk-lpeeharfys~ei~lal~flh~rg----iiyrdlkldnvlldaeghikltdygmcke~l  402 (593)
T KOG0695|consen  328 FVIEYVNGGDLMFHMQRQRK-LPEEHARFYSAEICLALNFLHERG----IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL  402 (593)
T ss_pred             EEEEEecCcceeeehhhhhc-CcHHHhhhhhHHHHHHHHHHhhcC----eeeeeccccceEEccCCceeecccchhhcCC
Confidence            99999999999888887776 999999999999999999999655    9999999999999999999999999988543


Q ss_pred             CCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCcc--ccccchHHHHHHHhcCCchhhhhh
Q 007680          425 EGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEM--FIGEMSLRRWVKESLPHGLTEVVD  502 (593)
Q Consensus       425 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~--~~~~~~~~~~~~~~~~~~~~~~~~  502 (593)
                      .+.+  ..+..+||+.|.|||++.+..|+..+|.|++||+++||+.|+.||+-.  ...+.+..+++-+.+-        
T Consensus       403 ~~gd--~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvil--------  472 (593)
T KOG0695|consen  403 GPGD--TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVIL--------  472 (593)
T ss_pred             CCCc--ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHh--------
Confidence            3222  346678999999999999999999999999999999999999999753  3333333333322211        


Q ss_pred             hhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCC
Q 007680          503 ANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRIN  539 (593)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs  539 (593)
                          ....+.+  ...+.....+++.-|.+||.+|..
T Consensus       473 ----ekqirip--rslsvkas~vlkgflnkdp~erlg  503 (593)
T KOG0695|consen  473 ----EKQIRIP--RSLSVKASHVLKGFLNKDPKERLG  503 (593)
T ss_pred             ----hhccccc--ceeehhhHHHHHHhhcCCcHHhcC
Confidence                1111111  112335577888899999999863

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=8.2e-32  Score=274.41  Aligned_cols=217  Identities=23%  Similarity=0.380  Sum_probs=181.5

Q ss_pred             CCHHHHHHhh---hccccccccCccCcccEEEEEe-CCCCeEEEEEeehhh---HHHHHHHHHHHHHHhhcCCCCcceee
Q 007680          262 TSYLDIQRAT---DEFNECNLLGTSSFGSVYKGTI-SDGTDVAIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLIKIL  334 (593)
Q Consensus       262 ~~~~~~~~~~---~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~  334 (593)
                      ..|..++++.   .-|..++.||-|+||.|.+++. .+...+|.|.+++.+   .......+.|-.||...+.+-||++|
T Consensus       616 SnYiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLy  695 (1034)
T KOG0608|consen  616 SNYIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLY  695 (1034)
T ss_pred             hhHHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEE
Confidence            3455555443   4588899999999999999984 357789999998764   34456678899999999999999999


Q ss_pred             eeeecCCceEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEE
Q 007680          335 SSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHV  414 (593)
Q Consensus       335 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL  414 (593)
                      -.|.+.+.+|+||||++||++-.++.+.+- +++..++-++..+..|+++.|    .+|+|||||||+|||||.+|++||
T Consensus       696 ySFQDkdnLYFVMdYIPGGDmMSLLIrmgI-FeE~LARFYIAEltcAiesVH----kmGFIHRDiKPDNILIDrdGHIKL  770 (1034)
T KOG0608|consen  696 YSFQDKDNLYFVMDYIPGGDMMSLLIRMGI-FEEDLARFYIAELTCAIESVH----KMGFIHRDIKPDNILIDRDGHIKL  770 (1034)
T ss_pred             EEeccCCceEEEEeccCCccHHHHHHHhcc-CHHHHHHHHHHHHHHHHHHHH----hccceecccCccceEEccCCceee
Confidence            999999999999999999999999988775 888888888899999999999    567999999999999999999999


Q ss_pred             EeeccceecC---------CCCCc-------------------------------cccccccCCccccCccccCCCCCCc
Q 007680          415 SDFGIYKLLG---------EGEDS-------------------------------VRQTMTMATIGYMAPEYGLEGIVSA  454 (593)
Q Consensus       415 ~Dfg~a~~~~---------~~~~~-------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~  454 (593)
                      +|||++.-+.         ++...                               ......+||+.|+|||++....|+.
T Consensus       771 TDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q  850 (1034)
T KOG0608|consen  771 TDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQ  850 (1034)
T ss_pred             eeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccc
Confidence            9999976432         11000                               0011235999999999999999999


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCccccccc
Q 007680          455 KCDVYSYGVLLMETFTRKRPTDEMFIGEM  483 (593)
Q Consensus       455 ~~DvwSlGvvl~elltg~~pf~~~~~~~~  483 (593)
                      .+|.||.|||||||+.|++||......+.
T Consensus       851 ~cdwws~gvil~em~~g~~pf~~~tp~~t  879 (1034)
T KOG0608|consen  851 LCDWWSVGVILYEMLVGQPPFLADTPGET  879 (1034)
T ss_pred             cchhhHhhHHHHHHhhCCCCccCCCCCcc
Confidence            99999999999999999999987655443

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.97  E-value=2.7e-32  Score=287.42  Aligned_cols=245  Identities=27%  Similarity=0.411  Sum_probs=191.2

Q ss_pred             cccccccCccCccc-EEEEEeCCCCeEEEEEeehhhHHHHHHHHHHHHHHhhc-CCCCcceeeeeeecCCceEEEEeccC
Q 007680          274 FNECNLLGTSSFGS-VYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNV-RHRNLIKILSSYSNPDFKALVLEFMP  351 (593)
Q Consensus       274 ~~~~~~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~  351 (593)
                      |.-.+.+|.|+.|+ ||+|..+ |+.||||++-..   .....++|+..++.- +|||||++++.-.++...||..|.| 
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-  585 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-  585 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence            33346789999885 7999985 899999987543   334678899999988 6999999999999999999999999 


Q ss_pred             CCCHHHHHhhCCC---CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC---C--CcEEEEeeccceec
Q 007680          352 NGSLEKWLYSHNY---FLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDE---N--MVAHVSDFGIYKLL  423 (593)
Q Consensus       352 ~gsL~~~l~~~~~---~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~---~--~~~kL~Dfg~a~~~  423 (593)
                      ..+|.+++.....   .......+.+..|+++||++||    +.+||||||||.||||+.   +  .+++|+|||+++.+
T Consensus       586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH----sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl  661 (903)
T KOG1027|consen  586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH----SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL  661 (903)
T ss_pred             hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH----hcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence            4599999988521   1111455788999999999999    677999999999999975   2  47999999999998


Q ss_pred             CCCCCccc-cccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhC-CCCCCccccccchHHHHHHHhcCCchhhhh
Q 007680          424 GEGEDSVR-QTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTR-KRPTDEMFIGEMSLRRWVKESLPHGLTEVV  501 (593)
Q Consensus       424 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  501 (593)
                      ..+..... .....||-+|+|||++....-+.++||||+||++|+.++| .+||++....+.+...-.        ..+ 
T Consensus       662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~--------~~L-  732 (903)
T KOG1027|consen  662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGN--------YTL-  732 (903)
T ss_pred             CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCc--------cce-
Confidence            87665433 3556799999999999999889999999999999999995 999987432221111000        000 


Q ss_pred             hhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          502 DANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       502 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                              .......++  +..+||.+|+.+||..||++.+|+.|
T Consensus       733 --------~~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H  767 (903)
T KOG1027|consen  733 --------VHLEPLPDC--EAKDLISRMLNPDPQLRPSATDVLNH  767 (903)
T ss_pred             --------eeeccCchH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence                    000111122  67899999999999999999999975

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.4e-30  Score=257.60  Aligned_cols=130  Identities=28%  Similarity=0.409  Sum_probs=112.4

Q ss_pred             hccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcC-----C---CCcceeeeeeecC--
Q 007680          272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNVR-----H---RNLIKILSSYSNP--  340 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~~~~~~~--  340 (593)
                      .+|.+.++||-|.|++||++.+. +.+.||+|+.+.. ....+....|+++|++++     |   .+||++++.|...  
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp  156 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP  156 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence            68999999999999999999864 6788999998865 334566788999999994     3   4799999999754  


Q ss_pred             --CceEEEEeccCCCCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeee
Q 007680          341 --DFKALVLEFMPNGSLEKWLYSHNY-FLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILL  406 (593)
Q Consensus       341 --~~~~lv~e~~~~gsL~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll  406 (593)
                        .++|+|+|++ |.+|..+|..... .++...+.+|++||+.||.|||..   .||+|.||||+|||+
T Consensus       157 NG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~e---cgIIHTDlKPENvLl  221 (590)
T KOG1290|consen  157 NGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRE---CGIIHTDLKPENVLL  221 (590)
T ss_pred             CCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHh---cCccccCCCcceeee
Confidence              5899999999 7799999876544 699999999999999999999985   489999999999996

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4.3e-32  Score=251.33  Aligned_cols=267  Identities=22%  Similarity=0.300  Sum_probs=197.6

Q ss_pred             ccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh--HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCC-----ceE
Q 007680          273 EFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPD-----FKA  344 (593)
Q Consensus       273 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~  344 (593)
                      +.+..+.||.|+||.||.+++. +|+.||+|.+....  -...+.+-+|++++..++|.|++..++...-..     +.|
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY  133 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY  133 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence            3455679999999999999975 89999999886542  234567889999999999999999988775543     567


Q ss_pred             EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecC
Q 007680          345 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG  424 (593)
Q Consensus       345 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~  424 (593)
                      +++|.| ..+|...+-+.. .++...+.-+..||++||+|||.    .+|.||||||.|.+++++...||+|||+++...
T Consensus       134 V~TELm-QSDLHKIIVSPQ-~Ls~DHvKVFlYQILRGLKYLHs----A~ILHRDIKPGNLLVNSNCvLKICDFGLARvee  207 (449)
T KOG0664|consen  134 VLTELM-QSDLHKIIVSPQ-ALTPDHVKVFVYQILRGLKYLHT----ANILHRDIKPGNLLVNSNCILKICDFGLARTWD  207 (449)
T ss_pred             HHHHHH-HhhhhheeccCC-CCCcchhhhhHHHHHhhhHHHhh----cchhhccCCCccEEeccCceEEecccccccccc
Confidence            889988 558888876654 48889999999999999999994    559999999999999999999999999999755


Q ss_pred             CCCCccccccccCCccccCccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhh
Q 007680          425 EGEDSVRQTMTMATIGYMAPEYGLEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDA  503 (593)
Q Consensus       425 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  503 (593)
                      .++. ...+..+-|..|+|||++.+. .|+.+.||||.||++.|++..+..|....  .....+.+.+.+.....+.+..
T Consensus       208 ~d~~-~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~--PiqQL~lItdLLGTPs~EaMr~  284 (449)
T KOG0664|consen  208 QRDR-LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAG--PIEQLQMIIDLLGTPSQEAMKY  284 (449)
T ss_pred             hhhh-hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccC--hHHHHHHHHHHhCCCcHHHHHH
Confidence            4332 234555678999999999886 59999999999999999999998886632  2222222222211111111100


Q ss_pred             h-------hhhhhh---------hhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHH
Q 007680          504 N-------LVREEQ---------AFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLK  548 (593)
Q Consensus       504 ~-------~~~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  548 (593)
                      .       +.+...         ..........+...+...++..||++|.+..+.+.++-
T Consensus       285 ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~  345 (449)
T KOG0664|consen  285 ACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY  345 (449)
T ss_pred             HhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence            0       000000         00111122345678889999999999999999998753

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.97  E-value=8.2e-31  Score=262.06  Aligned_cols=268  Identities=21%  Similarity=0.261  Sum_probs=204.8

Q ss_pred             HhhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcC------CCCcceeeeeeecCC
Q 007680          269 RATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNVR------HRNLIKILSSYSNPD  341 (593)
Q Consensus       269 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~~~~~~~~  341 (593)
                      .--.+|.+....|+|-|++|.+|.+. .|+.||||++..+. ...+.=+.|+++|.+|+      --|+++++..|...+
T Consensus       429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hkn  507 (752)
T KOG0670|consen  429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKN  507 (752)
T ss_pred             hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcc
Confidence            34568999999999999999999865 57899999998763 33445578999999995      358999999999999


Q ss_pred             ceEEEEeccCCCCHHHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCC-CcEEEEeec
Q 007680          342 FKALVLEFMPNGSLEKWLYSHNY--FLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDEN-MVAHVSDFG  418 (593)
Q Consensus       342 ~~~lv~e~~~~gsL~~~l~~~~~--~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~-~~~kL~Dfg  418 (593)
                      ++|||+|-+ ..+|.+.+.+.+.  .+....+..++.|+.-||..|-    ..+|+|.||||+||||++. ..+||||||
T Consensus       508 HLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK----~c~vlHaDIKPDNiLVNE~k~iLKLCDfG  582 (752)
T KOG0670|consen  508 HLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK----KCGVLHADIKPDNILVNESKNILKLCDFG  582 (752)
T ss_pred             eeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH----hcCeeecccCccceEeccCcceeeeccCc
Confidence            999999998 5699999988765  5788899999999999999999    4569999999999999865 578999999


Q ss_pred             cceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccch-HH-----------
Q 007680          419 IYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMS-LR-----------  486 (593)
Q Consensus       419 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~-~~-----------  486 (593)
                      .|....+.+.+    ....+..|.|||++.|-+|+...|+||.||+|||+.||+..|.+.....+- +.           
T Consensus       583 SA~~~~eneit----PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~Km  658 (752)
T KOG0670|consen  583 SASFASENEIT----PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKM  658 (752)
T ss_pred             ccccccccccc----HHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHH
Confidence            99887665432    234567899999999999999999999999999999999998775433221 00           


Q ss_pred             ----HHHHHhcCCch---hhhhh---------------------hhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCC
Q 007680          487 ----RWVKESLPHGL---TEVVD---------------------ANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRI  538 (593)
Q Consensus       487 ----~~~~~~~~~~~---~~~~~---------------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP  538 (593)
                          .+..+++...+   ..-+|                     ..+................+.+|+.+|+..||++|.
T Consensus       659 lRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRi  738 (752)
T KOG0670|consen  659 LRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRI  738 (752)
T ss_pred             hhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcC
Confidence                01111111100   00000                     000000011112234567899999999999999999


Q ss_pred             CHHHHHHH
Q 007680          539 NMTDAAAK  546 (593)
Q Consensus       539 s~~evl~~  546 (593)
                      |..++++|
T Consensus       739 t~nqAL~H  746 (752)
T KOG0670|consen  739 TVNQALKH  746 (752)
T ss_pred             CHHHHhcC
Confidence            99999876

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.96  E-value=1.4e-30  Score=263.50  Aligned_cols=197  Identities=23%  Similarity=0.359  Sum_probs=171.1

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh--------HHHHHHHHHHHHHHhhcC---CCCcceeeeeee
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL--------ERAFRSFDSECEVLRNVR---HRNLIKILSSYS  338 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~  338 (593)
                      ..+|+.++.+|+|+||.|+.|.++ +...|+||.+.+..        .+....+..|++||..++   |+||++++++|+
T Consensus       560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE  639 (772)
T KOG1152|consen  560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE  639 (772)
T ss_pred             cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence            356999999999999999999976 56779999987653        112234667999999997   999999999999


Q ss_pred             cCCceEEEEecc-CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEee
Q 007680          339 NPDFKALVLEFM-PNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDF  417 (593)
Q Consensus       339 ~~~~~~lv~e~~-~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df  417 (593)
                      +.+.+|++||-. ++-+|.++|..+.. +++.++..|++|++.|+++||++    ||+|||||-+||.++.+|.+||+||
T Consensus       640 ddd~yyl~te~hg~gIDLFd~IE~kp~-m~E~eAk~IFkQV~agi~hlh~~----~ivhrdikdenvivd~~g~~klidf  714 (772)
T KOG1152|consen  640 DDDYYYLETEVHGEGIDLFDFIEFKPR-MDEPEAKLIFKQVVAGIKHLHDQ----GIVHRDIKDENVIVDSNGFVKLIDF  714 (772)
T ss_pred             cCCeeEEEecCCCCCcchhhhhhccCc-cchHHHHHHHHHHHhcccccccc----CceecccccccEEEecCCeEEEeec
Confidence            999999999974 56699999987775 99999999999999999999955    5999999999999999999999999


Q ss_pred             ccceecCCCCCccccccccCCccccCccccCCCCC-CccchHHHHHHHHHHHHhCCCCCC
Q 007680          418 GIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIV-SAKCDVYSYGVLLMETFTRKRPTD  476 (593)
Q Consensus       418 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DvwSlGvvl~elltg~~pf~  476 (593)
                      |.|.....+.    ....+||..|.|||++.+.+| +..-|||++|+++|.++....||.
T Consensus       715 gsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  715 GSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             cchhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            9988765443    345679999999999998886 667999999999999999998875

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.96  E-value=1.5e-28  Score=234.27  Aligned_cols=211  Identities=34%  Similarity=0.512  Sum_probs=183.7

Q ss_pred             cCccCcccEEEEEeC-CCCeEEEEEeehhhHH-HHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEeccCCCCHHH
Q 007680          280 LGTSSFGSVYKGTIS-DGTDVAIKVFNLQLER-AFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEK  357 (593)
Q Consensus       280 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~  357 (593)
                      ||+|++|.||++... +++.+++|++...... ..+.+.+|++.++.++|++++++++++......++++|++++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            689999999999975 4899999999866432 34678999999999999999999999999999999999999999999


Q ss_pred             HHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC-CCcEEEEeeccceecCCCCCcccccccc
Q 007680          358 WLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDE-NMVAHVSDFGIYKLLGEGEDSVRQTMTM  436 (593)
Q Consensus       358 ~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~-~~~~kL~Dfg~a~~~~~~~~~~~~~~~~  436 (593)
                      ++......+++..+..++.++++++++||+.    +++|+||+|.||+++. ++.++|+|||.+........  ......
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~----~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~  154 (215)
T cd00180          81 LLKENEGKLSEDEILRILLQILEGLEYLHSN----GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIV  154 (215)
T ss_pred             HHHhccCCCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhccc
Confidence            9987644589999999999999999999965    5999999999999999 89999999999887654321  122345


Q ss_pred             CCccccCccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhhhhhhhh
Q 007680          437 ATIGYMAPEYGLEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAK  515 (593)
Q Consensus       437 gt~~y~aPE~~~~~-~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  515 (593)
                      +...|++||..... .++.++|+|++|++++++                                               
T Consensus       155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-----------------------------------------------  187 (215)
T cd00180         155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-----------------------------------------------  187 (215)
T ss_pred             CCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------------------
Confidence            78889999998877 888999999999999998                                               


Q ss_pred             HHHHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 007680          516 MDCILSIMDFALDCCMESPDMRINMTDAAAKL  547 (593)
Q Consensus       516 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  547 (593)
                          ..+.+++.+|++.+|++||++.++++++
T Consensus       188 ----~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 ----PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             ----HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence                2568999999999999999999998753

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.96  E-value=2.4e-29  Score=238.85  Aligned_cols=259  Identities=24%  Similarity=0.294  Sum_probs=192.4

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehh--hHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC------C
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQ--LERAFRSFDSECEVLRNVRHRNLIKILSSYSNP------D  341 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~  341 (593)
                      ..+|.-++.+|.|.- .|..|.+. .+++||+|.....  .....++..+|...+..++|+||++++.+|.-.      .
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~   94 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ   94 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence            346777888999988 66666543 6899999987543  223445678899999999999999999988643      3


Q ss_pred             ceEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccce
Q 007680          342 FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYK  421 (593)
Q Consensus       342 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~  421 (593)
                      ..|+|||+| ..+|.+.+...   ++-..+..+..|++.|++|||    +.||+||||||+||++..+..+||.|||+|+
T Consensus        95 e~y~v~e~m-~~nl~~vi~~e---lDH~tis~i~yq~~~~ik~lh----s~~IihRdLkPsnivv~~~~~lKi~dfg~ar  166 (369)
T KOG0665|consen   95 EVYLVMELM-DANLCQVILME---LDHETISYILYQMLCGIKHLH----SAGIIHRDLKPSNIVVNSDCTLKILDFGLAR  166 (369)
T ss_pred             hHHHHHHhh-hhHHHHHHHHh---cchHHHHHHHHHHHHHHHHHH----hcceeecccCcccceecchhheeeccchhhc
Confidence            679999999 56999988732   677889999999999999999    5569999999999999999999999999998


Q ss_pred             ecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHH--HhcCCchhh
Q 007680          422 LLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVK--ESLPHGLTE  499 (593)
Q Consensus       422 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~--~~~~~~~~~  499 (593)
                      .-+..   ...+..+.|..|.|||++.+..+.+.+||||.||++.||++|+.-|.+.    ....+|.+  +.....-..
T Consensus       167 ~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~----d~idQ~~ki~~~lgtpd~~  239 (369)
T KOG0665|consen  167 TEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGK----DHIDQWNKIIEQLGTPDPS  239 (369)
T ss_pred             ccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCc----hHHHHHHHHHHHhcCCCHH
Confidence            64433   3456678899999999999988999999999999999999999887642    22222211  000000000


Q ss_pred             hhhh---h------hhhhhhh-----------h----hh-hHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          500 VVDA---N------LVREEQA-----------F----SA-KMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       500 ~~~~---~------~~~~~~~-----------~----~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      ..+.   .      ...+...           +    +. +.+ .....+++.+||..||++|.+++++++|
T Consensus       240 F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~-~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  240 FMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLD-CSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             HHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccc-hHHHHHHHHHhhccChhhcccHHHHhcC
Confidence            0000   0      0000000           0    00 111 2457899999999999999999999987

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.96  E-value=1.3e-30  Score=268.03  Aligned_cols=254  Identities=23%  Similarity=0.333  Sum_probs=205.4

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEec
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEF  349 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  349 (593)
                      .++|+.+.++|+|.||.||+++++ +++..|+|+++..........++|+-+++..+||||+.+++.+...+..++.|||
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy   93 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY   93 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence            468999999999999999999965 7999999999988777778889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCc
Q 007680          350 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDS  429 (593)
Q Consensus       350 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~  429 (593)
                      |.+|+|.+.-+-.+ ++++.++...++..++||+|||    ++|-+|||||-.||++++.|.+|++|||.+..++..-  
T Consensus        94 cgggslQdiy~~Tg-plselqiayvcRetl~gl~ylh----s~gk~hRdiKGanilltd~gDvklaDfgvsaqitati--  166 (829)
T KOG0576|consen   94 CGGGSLQDIYHVTG-PLSELQIAYVCRETLQGLKYLH----SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATI--  166 (829)
T ss_pred             cCCCcccceeeecc-cchhHHHHHHHhhhhccchhhh----cCCcccccccccceeecccCceeecccCchhhhhhhh--
Confidence            99999999766554 4999999999999999999999    5568999999999999999999999999987665322  


Q ss_pred             cccccccCCccccCccccC---CCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhh
Q 007680          430 VRQTMTMATIGYMAPEYGL---EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLV  506 (593)
Q Consensus       430 ~~~~~~~gt~~y~aPE~~~---~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  506 (593)
                      .+.....||+.|||||+..   .+.|...+|||+.|++..|+-.-.+|..+...-..  ........             
T Consensus       167 ~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~--l~LmTkS~-------------  231 (829)
T KOG0576|consen  167 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRA--LFLMTKSG-------------  231 (829)
T ss_pred             hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHH--HHHhhccC-------------
Confidence            2334567999999999753   56689999999999999999887777544211110  00000000             


Q ss_pred             hhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          507 REEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      ........+....+.+.+|++.|+.++|++||+++.++.|
T Consensus       232 ~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h  271 (829)
T KOG0576|consen  232 FQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQH  271 (829)
T ss_pred             CCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence            0111112222345678999999999999999999888764

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1e-28  Score=229.07  Aligned_cols=254  Identities=19%  Similarity=0.267  Sum_probs=194.0

Q ss_pred             hhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhc-CCCCcceeee-eeecCCceEEE
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNV-RHRNLIKILS-SYSNPDFKALV  346 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~-~~~~~~~~~lv  346 (593)
                      ..+.|.+.+.+|+|.||.+-+++++ +.+.+|+|.+.... ...++|.+|...--.| .|.||+.-|+ .|+..+.+.++
T Consensus        22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~  100 (378)
T KOG1345|consen   22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV  100 (378)
T ss_pred             hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence            4678999999999999999999976 67889999987653 3456788888776666 5899999887 56777888899


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeC--CCCcEEEEeeccceecC
Q 007680          347 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLD--ENMVAHVSDFGIYKLLG  424 (593)
Q Consensus       347 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~--~~~~~kL~Dfg~a~~~~  424 (593)
                      +||++.|+|.+-+...+  +.+....+++.|+++|+.|+|+    ..+||||||.+||||-  +..++||+|||..+..+
T Consensus       101 qE~aP~gdL~snv~~~G--igE~~~K~v~~ql~SAi~fMHs----knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g  174 (378)
T KOG1345|consen  101 QEFAPRGDLRSNVEAAG--IGEANTKKVFAQLLSAIEFMHS----KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG  174 (378)
T ss_pred             eccCccchhhhhcCccc--ccHHHHHHHHHHHHHHHHHhhc----cchhhcccccceEEEecCCccEEEeeecccccccC
Confidence            99999999999887755  8888899999999999999995    4599999999999994  34589999999987654


Q ss_pred             CCCCccccccccCCccccCccccCC---C--CCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhh
Q 007680          425 EGEDSVRQTMTMATIGYMAPEYGLE---G--IVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTE  499 (593)
Q Consensus       425 ~~~~~~~~~~~~gt~~y~aPE~~~~---~--~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  499 (593)
                      ...     .....+..|.+||....   +  ...+.+|||.||+++|.++||.+||......+..+.+|..-......  
T Consensus       175 ~tV-----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~--  247 (378)
T KOG1345|consen  175 TTV-----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNP--  247 (378)
T ss_pred             cee-----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCc--
Confidence            321     12234667999996442   2  35788999999999999999999998766666666665432111100  


Q ss_pred             hhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 007680          500 VVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKL  547 (593)
Q Consensus       500 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  547 (593)
                          .+.+.      ...+++.+.++.++-+..+|++|-...++.+..
T Consensus       248 ----~~P~~------F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~r  285 (378)
T KOG1345|consen  248 ----ALPKK------FNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMR  285 (378)
T ss_pred             ----cCchh------hcccCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence                11111      112345678899999999999996665555544

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.95  E-value=2.1e-27  Score=229.70  Aligned_cols=199  Identities=29%  Similarity=0.414  Sum_probs=172.8

Q ss_pred             cccccccCccCcccEEEEEeCC-CCeEEEEEeehhhHH-HHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEeccC
Q 007680          274 FNECNLLGTSSFGSVYKGTISD-GTDVAIKVFNLQLER-AFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMP  351 (593)
Q Consensus       274 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  351 (593)
                      |.+.+.||+|++|.||++...+ ++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++...+..++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            5667899999999999999764 899999999876444 56788999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCccc
Q 007680          352 NGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVR  431 (593)
Q Consensus       352 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~  431 (593)
                      +++|.+++......+++..+..++.+++.++.+||++    +++|+|++|+||+++.++.++|+|||.+......... .
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~----~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~-~  155 (225)
T smart00221       81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSL----GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA-L  155 (225)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-c
Confidence            9999999987654378999999999999999999965    5999999999999999999999999998877544211 1


Q ss_pred             cccccCCccccCcccc-CCCCCCccchHHHHHHHHHHHHhCCCCCCc
Q 007680          432 QTMTMATIGYMAPEYG-LEGIVSAKCDVYSYGVLLMETFTRKRPTDE  477 (593)
Q Consensus       432 ~~~~~gt~~y~aPE~~-~~~~~s~~~DvwSlGvvl~elltg~~pf~~  477 (593)
                      .....++..|++||.. ....++.++|||+||+++++|++|+.||..
T Consensus       156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            2234577889999998 666788899999999999999999999965

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.95  E-value=9.1e-28  Score=236.50  Aligned_cols=270  Identities=24%  Similarity=0.322  Sum_probs=200.8

Q ss_pred             HHHhhhccccccccCccCcccEEEEEeC----CCCeEEEEEeehhhHHHHHHHHHHHHHHhhc-CCCCcceeeeeeecCC
Q 007680          267 IQRATDEFNECNLLGTSSFGSVYKGTIS----DGTDVAIKVFNLQLERAFRSFDSECEVLRNV-RHRNLIKILSSYSNPD  341 (593)
Q Consensus       267 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  341 (593)
                      +....+.|..+++||+|.|++||++...    .++.||+|.+.....  ...+..|+++|..+ -+.||+++.+++...+
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd  108 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNND  108 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence            4445678999999999999999999843    478899999876543  35688999999999 5899999999999999


Q ss_pred             ceEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC-CCcEEEEeeccc
Q 007680          342 FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDE-NMVAHVSDFGIY  420 (593)
Q Consensus       342 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~-~~~~kL~Dfg~a  420 (593)
                      ...+|+||++..+..++...    ++..++...++.++.||+++|.+    |||||||||+|++.+. .+.-.|+|||+|
T Consensus       109 ~v~ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h~~----GIvHRDiKpsNFL~n~~t~rg~LvDFgLA  180 (418)
T KOG1167|consen  109 QVAIVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLHKN----GIVHRDIKPSNFLYNRRTQRGVLVDFGLA  180 (418)
T ss_pred             eeEEEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhhcc----CccccCCCccccccccccCCceEEechhH
Confidence            99999999999999998876    67889999999999999999955    5999999999999985 457789999998


Q ss_pred             eecCCCC------------------------------------------CccccccccCCccccCccccCCC-CCCccch
Q 007680          421 KLLGEGE------------------------------------------DSVRQTMTMATIGYMAPEYGLEG-IVSAKCD  457 (593)
Q Consensus       421 ~~~~~~~------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~D  457 (593)
                      .......                                          .......+.||++|.|||++... ..++++|
T Consensus       181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD  260 (418)
T KOG1167|consen  181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID  260 (418)
T ss_pred             HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence            8211000                                          00011224699999999987654 5789999


Q ss_pred             HHHHHHHHHHHHhCCCCCCccccccchHHHHHHH----------hcCCc--hhh---------h------hh-hhhhh-h
Q 007680          458 VYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKE----------SLPHG--LTE---------V------VD-ANLVR-E  508 (593)
Q Consensus       458 vwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~----------~~~~~--~~~---------~------~~-~~~~~-~  508 (593)
                      |||.||++.-+++++.||.....+-..+.+.+.-          ..+..  +.+         .      ++ ..+.. +
T Consensus       261 iws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~  340 (418)
T KOG1167|consen  261 IWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSR  340 (418)
T ss_pred             eeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccc
Confidence            9999999999999999997654444333332110          01111  000         0      00 00000 0


Q ss_pred             h--hhhhhhHH-HHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          509 E--QAFSAKMD-CILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       509 ~--~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      .  .......+ .+..+.+++.+|+..||.+|.|++|+++|
T Consensus       341 q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH  381 (418)
T KOG1167|consen  341 QPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH  381 (418)
T ss_pred             ccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence            0  01111222 34478999999999999999999999987

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.94  E-value=3.7e-26  Score=212.88  Aligned_cols=170  Identities=22%  Similarity=0.170  Sum_probs=129.8

Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCcccc
Q 007680          353 GSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQ  432 (593)
Q Consensus       353 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~  432 (593)
                      |+|.+++...+..+++.++..++.|+++||+|||++    +      ||+||+++.++.+|+  ||.+.......     
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~----~------kp~Nil~~~~~~~~~--fG~~~~~~~~~-----   63 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQ----A------KSGNILLTWDGLLKL--DGSVAFKTPEQ-----   63 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc----C------CcccEeEcCccceee--ccceEeecccc-----
Confidence            689999987666799999999999999999999953    2      999999999999999  99988754322     


Q ss_pred             ccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhhhhh
Q 007680          433 TMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQAF  512 (593)
Q Consensus       433 ~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  512 (593)
                        ..|++.|+|||++.+..++.++|||||||++|||+||+.||.........+..+.....+..            ....
T Consensus        64 --~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------------~~~~  129 (176)
T smart00750       64 --SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADD------------PRDR  129 (176)
T ss_pred             --CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCC------------cccc
Confidence              25789999999999999999999999999999999999999764322222222221111100            0000


Q ss_pred             hhhHHHHH--HHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhh
Q 007680          513 SAKMDCIL--SIMDFALDCCMESPDMRINMTDAAAKLKKIKVK  553 (593)
Q Consensus       513 ~~~~~~~~--~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  553 (593)
                      ........  ++.+++.+||..+|++||++.|+++++..+...
T Consensus       130 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~  172 (176)
T smart00750      130 SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAE  172 (176)
T ss_pred             ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence            01112222  689999999999999999999999999876543

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.94  E-value=7.2e-27  Score=267.02  Aligned_cols=197  Identities=19%  Similarity=0.257  Sum_probs=139.4

Q ss_pred             hcCC-CCcceeeeee-------ecCCceEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeE
Q 007680          324 NVRH-RNLIKILSSY-------SNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHII  395 (593)
Q Consensus       324 ~l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~iv  395 (593)
                      .++| +||++++++|       ...+..+.++|++ +++|.+++......+++.++..++.||++||+|||++    ||+
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~----gIv  102 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQ----GIV  102 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhC----Cee
Confidence            3455 5888888877       2334567788987 6699999986555699999999999999999999954    599


Q ss_pred             ecCCCCCCeeeCCCC-------------------cEEEEeeccceecCCCCC--------------ccccccccCCcccc
Q 007680          396 HCDLKPTNILLDENM-------------------VAHVSDFGIYKLLGEGED--------------SVRQTMTMATIGYM  442 (593)
Q Consensus       396 H~Dlkp~NIll~~~~-------------------~~kL~Dfg~a~~~~~~~~--------------~~~~~~~~gt~~y~  442 (593)
                      ||||||+|||++..+                   .+|++|||+++.......              ........||+.||
T Consensus       103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~  182 (793)
T PLN00181        103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT  182 (793)
T ss_pred             eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence            999999999996544                   455566665543211000              00011235788999


Q ss_pred             CccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHH
Q 007680          443 APEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSI  522 (593)
Q Consensus       443 aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  522 (593)
                      |||++.+..++.++|||||||++|||++|..|+.....   ..........+             .     .........
T Consensus       183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~---~~~~~~~~~~~-------------~-----~~~~~~~~~  241 (793)
T PLN00181        183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR---TMSSLRHRVLP-------------P-----QILLNWPKE  241 (793)
T ss_pred             ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH---HHHHHHHhhcC-------------h-----hhhhcCHHH
Confidence            99999999999999999999999999999988754210   00011000000             0     000112345


Q ss_pred             HHHHhhcccCCCCCCCCHHHHHHH
Q 007680          523 MDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       523 ~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      .+++.+||.++|.+||++.|+++|
T Consensus       242 ~~~~~~~L~~~P~~Rps~~eil~h  265 (793)
T PLN00181        242 ASFCLWLLHPEPSCRPSMSELLQS  265 (793)
T ss_pred             HHHHHHhCCCChhhCcChHHHhhc
Confidence            688899999999999999999876

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.91  E-value=3.2e-23  Score=211.95  Aligned_cols=273  Identities=19%  Similarity=0.199  Sum_probs=203.2

Q ss_pred             ccccccccCccCcccEEEEEeCCC--CeEEEEEeehhhHHHHHHHHHHHHHHhhcCC----CCcceeeeee-ecCCceEE
Q 007680          273 EFNECNLLGTSSFGSVYKGTISDG--TDVAIKVFNLQLERAFRSFDSECEVLRNVRH----RNLIKILSSY-SNPDFKAL  345 (593)
Q Consensus       273 ~~~~~~~lg~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~~~l  345 (593)
                      +|.+.+.||+|+||.||.+...+.  ..+|+|............+..|..++..+..    +++..+++.. ..+...++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            799999999999999999997543  4789998776533322367889999998863    6899999988 47778899


Q ss_pred             EEeccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCC-----CcEEEEeecc
Q 007680          346 VLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDEN-----MVAHVSDFGI  419 (593)
Q Consensus       346 v~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~-----~~~kL~Dfg~  419 (593)
                      ||+.+ |.+|.++..... ..++..++..|+.|++.+|+++|+    .|++||||||+|+.+...     ..+.|.|||+
T Consensus        99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~----~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl  173 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHS----KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGL  173 (322)
T ss_pred             EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHh----cCcccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence            99998 889999886555 579999999999999999999995    559999999999999865     4699999999


Q ss_pred             ce--ecCCCCC----ccc--cccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHH
Q 007680          420 YK--LLGEGED----SVR--QTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKE  491 (593)
Q Consensus       420 a~--~~~~~~~----~~~--~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~  491 (593)
                      ++  .+.....    ..+  .....||..|+++....+...+.+.|+||++.++.|+..|..||........ ..+....
T Consensus       174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-~~~~~~~  252 (322)
T KOG1164|consen  174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-KSKFEKD  252 (322)
T ss_pred             CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-HHHHHHH
Confidence            98  3322221    111  1234599999999999999999999999999999999999999966432111 1110000


Q ss_pred             hcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhhh-cchhhccCCcc
Q 007680          492 SLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKF-LDDAAATNWRN  565 (593)
Q Consensus       492 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~-~~~~~~~~~~~  565 (593)
                      ...         .....     .....+.++.++...+-..+..++|....+...+++..... .....+.+|..
T Consensus       253 ~~~---------~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~~~~~~~~dw~~  313 (322)
T KOG1164|consen  253 PRK---------LLTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSEGSKEDSPFDWEV  313 (322)
T ss_pred             hhh---------hcccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhcCCCCCCCCcccc
Confidence            000         00000     01112345666666666689999999999999988876654 34446677765

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.91  E-value=8.5e-24  Score=215.72  Aligned_cols=174  Identities=22%  Similarity=0.211  Sum_probs=133.7

Q ss_pred             hhhccccccccCccCcccEEEEEeC--CCCeEEEEEeehh-----hHHHHHHHHHHHHHHhhcCCCCcce-eeeeeecCC
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTIS--DGTDVAIKVFNLQ-----LERAFRSFDSECEVLRNVRHRNLIK-ILSSYSNPD  341 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~~~  341 (593)
                      ..++|++.+.||+|+||.||+|.+.  +++.||||++...     .....+.+.+|++++++++|+|+++ ++++    +
T Consensus        16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~   91 (365)
T PRK09188         16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----G   91 (365)
T ss_pred             ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----C
Confidence            4678999999999999999999864  5777899986533     1234567899999999999999985 4432    4


Q ss_pred             ceEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCC-CCCCeeeCCCCcEEEEeeccc
Q 007680          342 FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDL-KPTNILLDENMVAHVSDFGIY  420 (593)
Q Consensus       342 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dl-kp~NIll~~~~~~kL~Dfg~a  420 (593)
                      ..++||||++|++|... ..    ..   ...++.|+++||+|||++    ||+|||| ||+||+++.++.+||+|||+|
T Consensus        92 ~~~LVmE~~~G~~L~~~-~~----~~---~~~~~~~i~~aL~~lH~~----gIiHrDL~KP~NILv~~~~~ikLiDFGlA  159 (365)
T PRK09188         92 KDGLVRGWTEGVPLHLA-RP----HG---DPAWFRSAHRALRDLHRA----GITHNDLAKPQNWLMGPDGEAAVIDFQLA  159 (365)
T ss_pred             CcEEEEEccCCCCHHHh-Cc----cc---hHHHHHHHHHHHHHHHHC----CCeeCCCCCcceEEEcCCCCEEEEECccc
Confidence            57999999999999732 11    11   146789999999999965    5999999 999999999999999999999


Q ss_pred             eecCCCCCccc------cccccCCccccCccccCCCC------CCccchHH
Q 007680          421 KLLGEGEDSVR------QTMTMATIGYMAPEYGLEGI------VSAKCDVY  459 (593)
Q Consensus       421 ~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~------~s~~~Dvw  459 (593)
                      +.+........      -....+++.|+|||++...+      .+..+|-|
T Consensus       160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW  210 (365)
T PRK09188        160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW  210 (365)
T ss_pred             eecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence            98765432111      13456788899999876543      33456666

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.90  E-value=1.5e-24  Score=201.34  Aligned_cols=250  Identities=22%  Similarity=0.340  Sum_probs=191.6

Q ss_pred             cccccccCccCcccEEEEEeCCCCeEEEEEeehhh--HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEeccC
Q 007680          274 FNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMP  351 (593)
Q Consensus       274 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  351 (593)
                      .....+|.+...|..|+|+++ |..+++|+++...  .+..++|..|.-.++-+.||||..+++.|..+.+..++..||+
T Consensus       192 lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp  270 (448)
T KOG0195|consen  192 LNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMP  270 (448)
T ss_pred             hhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeecc
Confidence            344568899999999999996 6677788887653  4455789999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCcc
Q 007680          352 NGSLEKWLYSHNY-FLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSV  430 (593)
Q Consensus       352 ~gsL~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~  430 (593)
                      .|+|...++.... ..+..++.+++.++++|++|||.-.  .-|----+.+..+++|++.+++|.-=. .++      +.
T Consensus       271 ~gslynvlhe~t~vvvd~sqav~faldiargmaflhsle--p~ipr~~lns~hvmidedltarismad-~kf------sf  341 (448)
T KOG0195|consen  271 FGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLE--PMIPRFYLNSKHVMIDEDLTARISMAD-TKF------SF  341 (448)
T ss_pred             chHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcc--hhhhhhhcccceEEecchhhhheeccc-cee------ee
Confidence            9999999988765 5778899999999999999999643  224444688899999999888764211 111      11


Q ss_pred             ccccccCCccccCccccCCCCC---CccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhh
Q 007680          431 RQTMTMATIGYMAPEYGLEGIV---SAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVR  507 (593)
Q Consensus       431 ~~~~~~gt~~y~aPE~~~~~~~---s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  507 (593)
                      ......-.+.||+||.+...+-   -.++|+|||++++||+.|...||.+...-+... +                 +.-
T Consensus       342 qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm-k-----------------ial  403 (448)
T KOG0195|consen  342 QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM-K-----------------IAL  403 (448)
T ss_pred             eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh-h-----------------hhh
Confidence            1222345788999998876653   357999999999999999999998854333211 1                 111


Q ss_pred             hhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhh
Q 007680          508 EEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIK  551 (593)
Q Consensus       508 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~  551 (593)
                      +..+...+...+..+.+++.-|+..||.+||.+..++--|+++.
T Consensus       404 eglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  404 EGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             ccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence            11112222334567899999999999999999999999988864

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.90  E-value=1.1e-22  Score=186.20  Aligned_cols=264  Identities=19%  Similarity=0.190  Sum_probs=198.3

Q ss_pred             hhhccccccccCccCcccEEEEE-eCCCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCC-CCcceeeeeeecCCceEEEE
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRH-RNLIKILSSYSNPDFKALVL  347 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~  347 (593)
                      ....|..+++||+|+||.+|.|. ..+|..||||+-......  .++..|..+...+++ ..|.++..+..+...-.+||
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM   90 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM   90 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence            34679999999999999999998 457999999997655332  357789999999975 67777778888888899999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC---CCcEEEEeeccceecC
Q 007680          348 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDE---NMVAHVSDFGIYKLLG  424 (593)
Q Consensus       348 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~---~~~~kL~Dfg~a~~~~  424 (593)
                      |.+ |.+|.++..-....++..+++-++-|++.-++|+|.++    ++||||||+|+|..-   ...+.++|||+|+.+.
T Consensus        91 dLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~----fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~  165 (341)
T KOG1163|consen   91 DLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRN----FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR  165 (341)
T ss_pred             ecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhc----cccccCCccceeeccccccceEEEEeccchhhhc
Confidence            999 88999998776667999999999999999999999766    999999999999863   4578999999999876


Q ss_pred             CCCCcc-----ccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccc-hHHHHHHHhcCCchh
Q 007680          425 EGEDSV-----RQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEM-SLRRWVKESLPHGLT  498 (593)
Q Consensus       425 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~-~~~~~~~~~~~~~~~  498 (593)
                      +.....     ......||..|.+--...+..-+.+.|+-|+|.++..+--|..||.+...... .-.+.+.+..-....
T Consensus       166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~i  245 (341)
T KOG1163|consen  166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPI  245 (341)
T ss_pred             cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCH
Confidence            543221     12334689999998877777888999999999999999999999988532111 101111111000001


Q ss_pred             hhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhh
Q 007680          499 EVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVK  553 (593)
Q Consensus       499 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  553 (593)
                      +             .-...+|.++.-.+.-|-..--++-|...-+.+...-+...
T Consensus       246 e-------------~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~  287 (341)
T KOG1163|consen  246 E-------------VLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRT  287 (341)
T ss_pred             H-------------HHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhh
Confidence            1             11123456777777778777778888877666665555443

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.89  E-value=4.8e-22  Score=189.94  Aligned_cols=272  Identities=16%  Similarity=0.190  Sum_probs=208.6

Q ss_pred             ccccccccCccCcccEEEEE-eCCCCeEEEEEeehhhHHHHHHHHHHHHHHhhcC-CCCcceeeeeeecCCceEEEEecc
Q 007680          273 EFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVR-HRNLIKILSSYSNPDFKALVLEFM  350 (593)
Q Consensus       273 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~  350 (593)
                      .|.+.++||+|+||+++.|+ .-++++||||.-....  ...++..|.+..+.|. .+.|..++-+-.++.+-.+|+|.+
T Consensus        29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL  106 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL  106 (449)
T ss_pred             cceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence            68899999999999999998 4479999999865443  2346778888888884 689999998888888889999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCC-----CcEEEEeeccceecCC
Q 007680          351 PNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDEN-----MVAHVSDFGIYKLLGE  425 (593)
Q Consensus       351 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~-----~~~kL~Dfg~a~~~~~  425 (593)
                       |.+|.|+..-.+..++...+..+|.|++.-++|+|+++    +|.|||||+|+||...     ..+.++|||+|+.+.+
T Consensus       107 -GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~----LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD  181 (449)
T KOG1165|consen  107 -GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKD----LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD  181 (449)
T ss_pred             -CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcc----eeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence             88999999887778999999999999999999999665    9999999999999743     3689999999998876


Q ss_pred             CCCcc-----ccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHH--HHHhcCCchh
Q 007680          426 GEDSV-----RQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRW--VKESLPHGLT  498 (593)
Q Consensus       426 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~--~~~~~~~~~~  498 (593)
                      .....     ......||..||+-....+..-+.+.|+-|+|-++...+-|..||.+....... .++  +.+.....  
T Consensus       182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK-~kYeKIGe~Kr~T--  258 (449)
T KOG1165|consen  182 PKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNK-EKYEKIGETKRST--  258 (449)
T ss_pred             ccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchH-HHHHHhccccccC--
Confidence            54321     123346999999999989999999999999999999999999999885322211 111  11110000  


Q ss_pred             hhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhhhcc-hhhccCCcc
Q 007680          499 EVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKFLD-DAAATNWRN  565 (593)
Q Consensus       499 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~-~~~~~~~~~  565 (593)
                                 ....-...+|.++...++-.-..+-.+-|..+-+...+..+.....+ +....+|.-
T Consensus       259 -----------~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~Dg~yDW~~  315 (449)
T KOG1165|consen  259 -----------PIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETDDGEYDWMG  315 (449)
T ss_pred             -----------CHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCcccccccccc
Confidence                       00111223456667766666677888999998888888887766533 334455543

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.89  E-value=9.7e-24  Score=229.25  Aligned_cols=254  Identities=20%  Similarity=0.187  Sum_probs=190.5

Q ss_pred             ccccccCccCcccEEEEEeC-CCCeEEEEEee----h-hhH-HHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEE
Q 007680          275 NECNLLGTSSFGSVYKGTIS-DGTDVAIKVFN----L-QLE-RAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVL  347 (593)
Q Consensus       275 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~----~-~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  347 (593)
                      .....+|.|++|.|+.+... ....++.|.++    . ... .....+..|+.+-..+.|||++..+..+.+.....-+|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            34568999999988877643 33334444332    1 111 12223667888888899999998888777766655669


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCC
Q 007680          348 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGE  427 (593)
Q Consensus       348 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~  427 (593)
                      |||++ +|..++.... .++..++..+++|++.|++|+|.    .||.|||+|++|++++.+|.+||+|||.+..+..+.
T Consensus       401 E~~~~-Dlf~~~~~~~-~~~~~e~~c~fKqL~~Gv~y~h~----~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~  474 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSNG-KLTPLEADCFFKQLLRGVKYLHS----MGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW  474 (601)
T ss_pred             hcccH-HHHHHHhccc-ccchhhhhHHHHHHHHHHHHHHh----cCceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence            99999 9999998763 38889999999999999999995    559999999999999999999999999988766544


Q ss_pred             Cc--cccccccCCccccCccccCCCCCCc-cchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhh
Q 007680          428 DS--VRQTMTMATIGYMAPEYGLEGIVSA-KCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDAN  504 (593)
Q Consensus       428 ~~--~~~~~~~gt~~y~aPE~~~~~~~s~-~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  504 (593)
                      ..  .......|+..|+|||++.+..|.+ ..||||.|+++..|.+|+.||......+..+....           -...
T Consensus       475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~-----------~~~~  543 (601)
T KOG0590|consen  475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNN-----------YSDQ  543 (601)
T ss_pred             chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhc-----------cccc
Confidence            33  4456678999999999999999876 58999999999999999999977544433320000           0000


Q ss_pred             hhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007680          505 LVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAA  545 (593)
Q Consensus       505 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  545 (593)
                      ..............+.....++.+||+.||.+|.|+++|++
T Consensus       544 ~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  544 RNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             cccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            00111122233456778899999999999999999999985

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.89  E-value=1.4e-21  Score=199.39  Aligned_cols=258  Identities=30%  Similarity=0.398  Sum_probs=198.9

Q ss_pred             cccccccCccCcccEEEEEeCCCCeEEEEEeehhhHH---HHHHHHHHHHHHhhcCCC-CcceeeeeeecCCceEEEEec
Q 007680          274 FNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLER---AFRSFDSECEVLRNVRHR-NLIKILSSYSNPDFKALVLEF  349 (593)
Q Consensus       274 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~  349 (593)
                      |...+.||.|+||.||++...  ..+++|.+......   ....+.+|+.+++.+.|+ +++++.+.+......++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            677889999999999999976  78999999876432   467899999999999988 799999999777778999999


Q ss_pred             cCCCCHHHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC-cEEEEeeccceecCCC
Q 007680          350 MPNGSLEKWLYSHNY--FLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENM-VAHVSDFGIYKLLGEG  426 (593)
Q Consensus       350 ~~~gsL~~~l~~~~~--~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~-~~kL~Dfg~a~~~~~~  426 (593)
                      +.++++.+++.....  .++......++.|++.+++|+|..+    ++|||+||+||+++..+ .++++|||.+......
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~----~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~  155 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG----IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP  155 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC----eeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence            999999977776542  4899999999999999999999654    99999999999999988 7999999999866544


Q ss_pred             CCcc----ccccccCCccccCccccCC---CCCCccchHHHHHHHHHHHHhCCCCCCccccc--cchHHHHHHHhcCCch
Q 007680          427 EDSV----RQTMTMATIGYMAPEYGLE---GIVSAKCDVYSYGVLLMETFTRKRPTDEMFIG--EMSLRRWVKESLPHGL  497 (593)
Q Consensus       427 ~~~~----~~~~~~gt~~y~aPE~~~~---~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~--~~~~~~~~~~~~~~~~  497 (593)
                      ....    ......++..|+|||...+   ..++...|+||+|++++++++|..||......  .......+........
T Consensus       156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  235 (384)
T COG0515         156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL  235 (384)
T ss_pred             CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCccc
Confidence            3221    2355679999999999887   57899999999999999999999997654321  1111121111111100


Q ss_pred             hhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          498 TEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       498 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      ........    .     ......+.+++.+|+..+|..|.+..+...+
T Consensus       236 ~~~~~~~~----~-----~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         236 ASPLSPSN----P-----ELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             ccccCccc----c-----chhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            00000000    0     1123467899999999999999999888776

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.86  E-value=2.5e-22  Score=217.60  Aligned_cols=251  Identities=21%  Similarity=0.254  Sum_probs=182.9

Q ss_pred             ccccccccCccCcccEEEEEeCCCCeEEEEEeehhh-HHHHHHH---HHHHHHHhhcCCCCcceeeeeeecCCceEEEEe
Q 007680          273 EFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQL-ERAFRSF---DSECEVLRNVRHRNLIKILSSYSNPDFKALVLE  348 (593)
Q Consensus       273 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~---~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  348 (593)
                      +|...+.||++.|=.|.+|++..|. |+||++-+.. .-..+.+   ..|++ ....+|||++++.-+.......|+|-+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq  101 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ  101 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence            6777889999999999999988776 9999997654 2222333   33444 445589999999988878888889999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCC
Q 007680          349 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGED  428 (593)
Q Consensus       349 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  428 (593)
                      |+. -+|.|.+..+.. +...+.+-|+.|++.||..+|+.    ||+|||||.+||||++-..+.|+||...+..--.++
T Consensus       102 yvk-hnLyDRlSTRPF-L~~iEKkWiaFQLL~al~qcH~~----gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD  175 (1431)
T KOG1240|consen  102 YVK-HNLYDRLSTRPF-LVLIEKKWIAFQLLKALSQCHKL----GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPED  175 (1431)
T ss_pred             HHh-hhhhhhhccchH-HHHHHHHHHHHHHHHHHHHHHHc----CccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence            984 499999987654 88889999999999999999954    599999999999999999999999987654322222


Q ss_pred             cc-----ccccccCCccccCccccCC----------CC-CCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHH
Q 007680          429 SV-----RQTMTMATIGYMAPEYGLE----------GI-VSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKE  491 (593)
Q Consensus       429 ~~-----~~~~~~gt~~y~aPE~~~~----------~~-~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~  491 (593)
                      ..     ..........|.|||.+..          .. .+++.||||+||++.|+++ |++||.-.     ++..+ +.
T Consensus       176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS-----QL~aY-r~  249 (1431)
T KOG1240|consen  176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS-----QLLAY-RS  249 (1431)
T ss_pred             CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH-----HHHhH-hc
Confidence            11     1122334567999996543          11 5789999999999999998 78888541     11111 11


Q ss_pred             hcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHh
Q 007680          492 SLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKI  550 (593)
Q Consensus       492 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  550 (593)
                      .-.......+           +...  ...+.+++..|++.||++|.++++.++.-.++
T Consensus       250 ~~~~~~e~~L-----------e~Ie--d~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~  295 (1431)
T KOG1240|consen  250 GNADDPEQLL-----------EKIE--DVSLRNLILSMIQRDPSKRLSAEDYLQKYRGL  295 (1431)
T ss_pred             cCccCHHHHH-----------HhCc--CccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence            1000000000           0001  12578999999999999999999999886554

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.86  E-value=5.5e-22  Score=188.29  Aligned_cols=171  Identities=14%  Similarity=0.172  Sum_probs=133.2

Q ss_pred             hhhccccccccCccCcccEEEEEeCCCCeEEEEEeehhhHH---HHH------HHHHHHHHHhhcCCCCcceeeeeeecC
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLER---AFR------SFDSECEVLRNVRHRNLIKILSSYSNP  340 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~------~~~~E~~~l~~l~h~niv~l~~~~~~~  340 (593)
                      ..++|...+.+|.|+||.||++.. ++..+|+|+++.....   ...      .+.+|+..+.+++||+|..+.+++...
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            467899999999999999999766 5778999999765322   112      268999999999999999999886543


Q ss_pred             --------CceEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcE
Q 007680          341 --------DFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVA  412 (593)
Q Consensus       341 --------~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~  412 (593)
                              +..++||||++|.+|.++..     ++.    ....+++.++..+|+++    ++|||+||+||++++++ +
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH~~g----i~H~Dikp~Nili~~~g-i  173 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLHQHG----MVSGDPHKGNFIVSKNG-L  173 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHHHcC----CccCCCChHHEEEeCCC-E
Confidence                    35789999999999988732     232    24669999999999655    99999999999999988 9


Q ss_pred             EEEeeccceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHH
Q 007680          413 HVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETF  469 (593)
Q Consensus       413 kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ell  469 (593)
                      +|+|||......+....              ..+.....+..++|+||||+++....
T Consensus       174 ~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        174 RIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence            99999987654322110              11334455678999999999987653

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.85  E-value=3.2e-21  Score=181.01  Aligned_cols=139  Identities=17%  Similarity=0.172  Sum_probs=108.2

Q ss_pred             ccccCccCcccEEEEEeCCCCeEEEEEeehhhHH--H------------------------HHHHHHHHHHHhhcCCCCc
Q 007680          277 CNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLER--A------------------------FRSFDSECEVLRNVRHRNL  330 (593)
Q Consensus       277 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~E~~~l~~l~h~ni  330 (593)
                      .+.||+|++|.||+|...+|+.||+|+++.....  .                        ......|++.+.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            4689999999999999888999999999754210  0                        1123459999999988776


Q ss_pred             ceeeeeeecCCceEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCCeEecCCCCCCeeeCCC
Q 007680          331 IKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYL-HNGHSSVHIIHCDLKPTNILLDEN  409 (593)
Q Consensus       331 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~L-H~~~~~~~ivH~Dlkp~NIll~~~  409 (593)
                      .....+..  ...++||||++++++....... ..++..++..++.|++.+|+++ |+.    ||+||||||+||+++ +
T Consensus        82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~-~~~~~~~~~~i~~qi~~~L~~l~H~~----giiHrDlkP~NIli~-~  153 (190)
T cd05147          82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKD-APLSESKARELYLQVIQIMRILYQDC----RLVHADLSEYNLLYH-D  153 (190)
T ss_pred             CCCcEEEe--cCCEEEEEEeCCCCCcchhhhc-CCCCHHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEEE-C
Confidence            44333222  2238999999988776553333 3488999999999999999999 644    599999999999998 4


Q ss_pred             CcEEEEeeccceec
Q 007680          410 MVAHVSDFGIYKLL  423 (593)
Q Consensus       410 ~~~kL~Dfg~a~~~  423 (593)
                      +.++|+|||+|...
T Consensus       154 ~~v~LiDFG~a~~~  167 (190)
T cd05147         154 GKLYIIDVSQSVEH  167 (190)
T ss_pred             CcEEEEEccccccC
Confidence            78999999998754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.84  E-value=1.3e-20  Score=184.05  Aligned_cols=198  Identities=23%  Similarity=0.266  Sum_probs=141.6

Q ss_pred             CCCCcceeeeeeec---------------------------CCceEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHH
Q 007680          326 RHRNLIKILSSYSN---------------------------PDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDV  378 (593)
Q Consensus       326 ~h~niv~l~~~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i  378 (593)
                      +|||||++.++|.+                           +...|+||..++. +|.+++..+.  .+.....-++.|+
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~--~s~r~~~~~laQl  350 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH--RSYRTGRVILAQL  350 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC--CchHHHHHHHHHH
Confidence            59999999987743                           2367899998854 9999998765  5677788899999


Q ss_pred             HHHHHHHHhcCCCCCeEecCCCCCCeee--CCCC--cEEEEeeccceecCCCCC----ccccccccCCccccCccccCCC
Q 007680          379 GSALEYLHNGHSSVHIIHCDLKPTNILL--DENM--VAHVSDFGIYKLLGEGED----SVRQTMTMATIGYMAPEYGLEG  450 (593)
Q Consensus       379 ~~~L~~LH~~~~~~~ivH~Dlkp~NIll--~~~~--~~kL~Dfg~a~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~  450 (593)
                      ++|+.|||+++    |.|||+|++||++  |+|+  ...++|||++---....-    ....-...|....||||+....
T Consensus       351 LEav~hL~~hg----vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~  426 (598)
T KOG4158|consen  351 LEAVTHLHKHG----VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV  426 (598)
T ss_pred             HHHHHHHHHcc----chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence            99999999765    9999999999998  3444  578999998643211000    0011223577889999986543


Q ss_pred             C------CCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHH
Q 007680          451 I------VSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMD  524 (593)
Q Consensus       451 ~------~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  524 (593)
                      +      .-.|+|.|+.|.+.||+++...||....+-..+...+-                  +.+-...++.+++.+.+
T Consensus       427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yq------------------e~qLPalp~~vpp~~rq  488 (598)
T KOG4158|consen  427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQ------------------ESQLPALPSRVPPVARQ  488 (598)
T ss_pred             CCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhh------------------hhhCCCCcccCChHHHH
Confidence            2      12489999999999999999999976211111111111                  11112233456778899


Q ss_pred             HHhhcccCCCCCCCCHHHHHHHHH
Q 007680          525 FALDCCMESPDMRINMTDAAAKLK  548 (593)
Q Consensus       525 li~~cl~~dP~~RPs~~evl~~L~  548 (593)
                      ++...|+.||++|++..-....|.
T Consensus       489 lV~~lL~r~pskRvsp~iAANvl~  512 (598)
T KOG4158|consen  489 LVFDLLKRDPSKRVSPNIAANVLN  512 (598)
T ss_pred             HHHHHhcCCccccCCccHHHhHHH
Confidence            999999999999999876666554

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.84  E-value=1.3e-20  Score=195.65  Aligned_cols=218  Identities=26%  Similarity=0.353  Sum_probs=165.9

Q ss_pred             HhhcCCCCcceeeeeeecCCceEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCC
Q 007680          322 LRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKP  401 (593)
Q Consensus       322 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp  401 (593)
                      |+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+......+++.....+.++++.||+|+|.   +..-.|+.+++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~---s~i~~hg~l~s   77 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHN---SPIGYHGALKS   77 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhc---Ccceeeeeecc
Confidence            457899999999999999999999999999999999999877779999999999999999999996   34449999999


Q ss_pred             CCeeeCCCCcEEEEeeccceecCCCCCccccccccCCccccCccccCCCC-------CCccchHHHHHHHHHHHHhCCCC
Q 007680          402 TNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGI-------VSAKCDVYSYGVLLMETFTRKRP  474 (593)
Q Consensus       402 ~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~s~~~DvwSlGvvl~elltg~~p  474 (593)
                      .|.++|....+||+|||+....................-|.|||.+.+..       .+.++||||||++++|+++.+.|
T Consensus        78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~  157 (484)
T KOG1023|consen   78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP  157 (484)
T ss_pred             ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence            99999999999999999987764311111122223456699999877631       46789999999999999999999


Q ss_pred             CCccccccch--HHHHHHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhh
Q 007680          475 TDEMFIGEMS--LRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKV  552 (593)
Q Consensus       475 f~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~  552 (593)
                      |+........  ...++.....    ....+.+.       ...+.++++..++.+||..+|++||+++++-..++.+..
T Consensus       158 ~~~~~~~~~~~eii~~~~~~~~----~~~rP~i~-------~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~  226 (484)
T KOG1023|consen  158 FDLRNLVEDPDEIILRVKKGGS----NPFRPSIE-------LLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK  226 (484)
T ss_pred             cccccccCChHHHHHHHHhcCC----CCcCcchh-------hhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence            9875333322  2222222000    01111110       011334578999999999999999999999988877755


Q ss_pred             h
Q 007680          553 K  553 (593)
Q Consensus       553 ~  553 (593)
                      .
T Consensus       227 ~  227 (484)
T KOG1023|consen  227 G  227 (484)
T ss_pred             c
Confidence            3

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.83  E-value=5.1e-20  Score=173.53  Aligned_cols=141  Identities=19%  Similarity=0.204  Sum_probs=111.1

Q ss_pred             ccccCccCcccEEEEEeCCCCeEEEEEeehhhHH--------------------------HHHHHHHHHHHHhhcCCCCc
Q 007680          277 CNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLER--------------------------AFRSFDSECEVLRNVRHRNL  330 (593)
Q Consensus       277 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~~l~h~ni  330 (593)
                      .+.||+|++|.||+|...+|+.||||+++.....                          ....+..|.+.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            5689999999999999878999999999864210                          01234678999999999987


Q ss_pred             ceeeeeeecCCceEEEEeccCCCCHHHH-HhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCC
Q 007680          331 IKILSSYSNPDFKALVLEFMPNGSLEKW-LYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDEN  409 (593)
Q Consensus       331 v~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~  409 (593)
                      .....+...  ..++||||++|+++... +..  ..++..+...++.|++.++.++|+   ..||+||||||+||+++ +
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH~---~~givHrDlkP~NIll~-~  153 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLYQ---EAGLVHGDLSEYNILYH-D  153 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHHH---hCCEecCCCChhhEEEE-C
Confidence            554444333  24899999998865443 332  237888999999999999999996   14599999999999999 7


Q ss_pred             CcEEEEeeccceecCC
Q 007680          410 MVAHVSDFGIYKLLGE  425 (593)
Q Consensus       410 ~~~kL~Dfg~a~~~~~  425 (593)
                      +.++|+|||++.....
T Consensus       154 ~~~~liDFG~a~~~~~  169 (190)
T cd05145         154 GKPYIIDVSQAVELDH  169 (190)
T ss_pred             CCEEEEEcccceecCC
Confidence            8999999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.83  E-value=2.2e-20  Score=219.43  Aligned_cols=172  Identities=37%  Similarity=0.579  Sum_probs=127.9

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLL   80 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~   80 (593)
                      |+.|+|++|++++.+|..+.. +++|+.|++++|++++.+|..+..+++|+.|+|++|++++.+|..|..+++|+.|+|+
T Consensus       358 L~~L~Ls~n~l~~~~p~~~~~-~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls  436 (968)
T PLN00113        358 LTVLDLSTNNLTGEIPEGLCS-SGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDIS  436 (968)
T ss_pred             CcEEECCCCeeEeeCChhHhC-cCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECc
Confidence            344555555555555555543 5555555555555555666666666777777777777776777777777777777666


Q ss_pred             cce-----------------eeccCCcccccCCCcc---cccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCC
Q 007680           81 MFG-----------------IRLTGNKLYGRIPPCL---VLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIP  140 (593)
Q Consensus        81 ~n~-----------------l~l~~n~l~~~~~~~~---~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p  140 (593)
                      +|.                 +++++|++.+.+|...   .|+.|++++|++++.+|..|.++++|+.|+|++|++++.+|
T Consensus       437 ~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p  516 (968)
T PLN00113        437 NNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIP  516 (968)
T ss_pred             CCcccCccChhhccCCCCcEEECcCceeeeecCcccccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCC
Confidence            543                 4466666666665533   48899999999999999999999999999999999999999


Q ss_pred             ccccCCccccccccccccccCCCCCCCCCCCCC
Q 007680          141 ESVGSLISLESLDLSGNNLSGKIPKLEGEIPVK  173 (593)
Q Consensus       141 ~~l~~~~~L~~L~l~~N~l~~~~p~~~~~~~~~  173 (593)
                      ..+.++++|+.|++++|++++.+|..+..++.+
T Consensus       517 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  549 (968)
T PLN00113        517 DELSSCKKLVSLDLSHNQLSGQIPASFSEMPVL  549 (968)
T ss_pred             hHHcCccCCCEEECCCCcccccCChhHhCcccC
Confidence            999999999999999999999999877666654

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.82  E-value=1.6e-19  Score=167.70  Aligned_cols=187  Identities=17%  Similarity=0.079  Sum_probs=140.2

Q ss_pred             ccccccCccCcccEEEEEeCCCCeEEEEEeehhhHH----HHHHHHHHHHHHhhcC-CCCcceeeeeeecCCceEEEEec
Q 007680          275 NECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLER----AFRSFDSECEVLRNVR-HRNLIKILSSYSNPDFKALVLEF  349 (593)
Q Consensus       275 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~  349 (593)
                      .+...|++|+||+||.+.. .+.+++.+.+......    ....+.+|+++|+++. |+++.+++++    +..+++|||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            3567899999999998876 6888888877655321    1235789999999995 5889999886    446999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCC-CCCCeeeCCCCcEEEEeeccceecCCCCC
Q 007680          350 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDL-KPTNILLDENMVAHVSDFGIYKLLGEGED  428 (593)
Q Consensus       350 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dl-kp~NIll~~~~~~kL~Dfg~a~~~~~~~~  428 (593)
                      ++|.+|.+....        ....++.|++++|+++|++|    |+|||| ||+||+++.++.++|+|||++........
T Consensus        80 I~G~~L~~~~~~--------~~~~~~~qi~~~L~~lH~~G----IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~  147 (218)
T PRK12274         80 LAGAAMYQRPPR--------GDLAYFRAARRLLQQLHRCG----VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR  147 (218)
T ss_pred             ecCccHHhhhhh--------hhHHHHHHHHHHHHHHHHCc----CccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence            999999764321        12357889999999999655    999999 79999999999999999999986543321


Q ss_pred             c----c-------ccccccCCccccCccccCCC-CCC-ccchHHHHHHHHHHHHhCCCCCCcc
Q 007680          429 S----V-------RQTMTMATIGYMAPEYGLEG-IVS-AKCDVYSYGVLLMETFTRKRPTDEM  478 (593)
Q Consensus       429 ~----~-------~~~~~~gt~~y~aPE~~~~~-~~s-~~~DvwSlGvvl~elltg~~pf~~~  478 (593)
                      .    .       .......++.|++|+...-. ..+ .+.+.++-|.-+|.++|+..|.-+.
T Consensus       148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~  210 (218)
T PRK12274        148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED  210 (218)
T ss_pred             HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence            1    0       01122357777888743221 233 5678889999999999999886553

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.82  E-value=8.2e-20  Score=178.64  Aligned_cols=231  Identities=18%  Similarity=0.234  Sum_probs=148.2

Q ss_pred             ccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhcCC----------CCcceeeeeee
Q 007680          273 EFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNVRH----------RNLIKILSSYS  338 (593)
Q Consensus       273 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h----------~niv~l~~~~~  338 (593)
                      .+...+.||.|+++.||.+++. +|+++|+|++....   ....+.+++|.-....+.+          -.++-.++...
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            3456679999999999999986 69999999986432   3345667777655555322          12222222221


Q ss_pred             ---------cC---C-----ceEEEEeccCCCCHHHHHhh---CCC---CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeE
Q 007680          339 ---------NP---D-----FKALVLEFMPNGSLEKWLYS---HNY---FLDILERLNIMIDVGSALEYLHNGHSSVHII  395 (593)
Q Consensus       339 ---------~~---~-----~~~lv~e~~~~gsL~~~l~~---~~~---~l~~~~~~~i~~~i~~~L~~LH~~~~~~~iv  395 (593)
                               ..   .     ..+++|+-+ .+||.+++..   ...   .+....+..+..|+++.+++||..|    ++
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G----lV  167 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG----LV  167 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT----EE
T ss_pred             EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc----eE
Confidence                     11   1     236778877 5688887543   221   2334455677899999999999654    99


Q ss_pred             ecCCCCCCeeeCCCCcEEEEeeccceecCCCCCccccccccCCccccCccccCC--------CCCCccchHHHHHHHHHH
Q 007680          396 HCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLE--------GIVSAKCDVYSYGVLLME  467 (593)
Q Consensus       396 H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~~~DvwSlGvvl~e  467 (593)
                      |+||+|+|++++.+|.++|+||+.....+....    . ...+..|.+||....        -.++.+.|.|++|+++|.
T Consensus       168 Hgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~----~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~  242 (288)
T PF14531_consen  168 HGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYR----C-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYS  242 (288)
T ss_dssp             EST-SGGGEEE-TTS-EEE--GGGEEETTEEEE----G-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHH
T ss_pred             ecccceeeEEEcCCCCEEEcChHHHeecCceee----c-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHH
Confidence            999999999999999999999998776543211    1 334577999996533        247889999999999999


Q ss_pred             HHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCC
Q 007680          468 TFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMR  537 (593)
Q Consensus       468 lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R  537 (593)
                      |++|+.||+.........                        ..+....+.|+.+..||..+|+.+|++|
T Consensus       243 lWC~~lPf~~~~~~~~~~------------------------~~f~~C~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  243 LWCGRLPFGLSSPEADPE------------------------WDFSRCRDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHHSS-STCCCGGGSTSG------------------------GGGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred             HHHccCCCCCCCcccccc------------------------ccchhcCCcCHHHHHHHHHHccCCcccC
Confidence            999999998642221100                        0112222567789999999999999988

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.81  E-value=1.2e-19  Score=200.95  Aligned_cols=202  Identities=22%  Similarity=0.229  Sum_probs=163.3

Q ss_pred             HHHHHHhhhccccccccCccCcccEEEEEeCCCCeEEEEEeehhhHHHHHHHHHHHHHHhhcC---CCCcceeeeeeecC
Q 007680          264 YLDIQRATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVR---HRNLIKILSSYSNP  340 (593)
Q Consensus       264 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~  340 (593)
                      ..+.+...+.|.+.+.||+|+||.||+|...+|+.||+|+-+.....+.   ---.+++.+|+   -+.|.++..++...
T Consensus       690 ~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEf---YI~~q~~~RLk~~~~~~~~~~~~a~~~~  766 (974)
T KOG1166|consen  690 NTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEF---YICLQVMERLKPQMLPSIMHISSAHVFQ  766 (974)
T ss_pred             cceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceee---eehHHHHHhhchhhhcchHHHHHHHccC
Confidence            3445556678999999999999999999988899999999876543211   11112233333   35566677777777


Q ss_pred             CceEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeC-------CCCcEE
Q 007680          341 DFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLD-------ENMVAH  413 (593)
Q Consensus       341 ~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~-------~~~~~k  413 (593)
                      +..++|+||.+.|+|.+++...+ .+++..++.++.|++..+++||+.+    ||||||||+|+++.       +..-++
T Consensus       767 ~~S~lv~ey~~~Gtlld~~N~~~-~m~e~lv~~~~~qml~ive~lH~~~----IIHgDiKPDNfll~~~~~~~~~~~~l~  841 (974)
T KOG1166|consen  767 NASVLVSEYSPYGTLLDLINTNK-VMDEYLVMFFSCQMLRIVEHLHAMG----IIHGDIKPDNFLLRREICADSDSKGLY  841 (974)
T ss_pred             CcceeeeeccccccHHHhhccCC-CCCchhhhHHHHHHHHHHHHHHhcc----eecccCCcceeEeecccCCCCcccceE
Confidence            88899999999999999998554 4999999999999999999999654    99999999999994       234689


Q ss_pred             EEeeccceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCC
Q 007680          414 VSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKR  473 (593)
Q Consensus       414 L~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~  473 (593)
                      |+|||.+..+..-.+.......++|-.+-.+|+..|.++++++|.|.++.+++-|+.|+.
T Consensus       842 lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  842 LIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             EEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            999999887665444445566788999999999999999999999999999999999975

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.81  E-value=4.7e-21  Score=198.59  Aligned_cols=225  Identities=23%  Similarity=0.263  Sum_probs=178.0

Q ss_pred             ccCccCcccEEEEEe----CCCCeEEEEEeehhhH--HHHHHHHHHHHHHhhcC-CCCcceeeeeeecCCceEEEEeccC
Q 007680          279 LLGTSSFGSVYKGTI----SDGTDVAIKVFNLQLE--RAFRSFDSECEVLRNVR-HRNLIKILSSYSNPDFKALVLEFMP  351 (593)
Q Consensus       279 ~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~  351 (593)
                      .+|+|+||.|++++.    ..|..+|+|+.++...  ........|..++..++ ||.++++...++.+...+++++|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            379999999998862    2477899999876531  11225567888888886 9999999999999999999999999


Q ss_pred             CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCccc
Q 007680          352 NGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVR  431 (593)
Q Consensus       352 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~  431 (593)
                      +|+|...+.+... ++..........++-+++++|+    .+++|||+|++||+++.+|++++.|||.++..-+.+.   
T Consensus        81 gg~lft~l~~~~~-f~~~~~~~~~aelaLald~lh~----l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~---  152 (612)
T KOG0603|consen   81 GGDLFTRLSKEVM-FDELDVAFYLAELALALDHLHK----LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI---  152 (612)
T ss_pred             cchhhhccccCCc-hHHHHHHHHHHHHHHHHhhcch----hHHHHhcccccceeecccCccccCCchhhhHhHhhhh---
Confidence            9999998887765 6777777788889999999994    5599999999999999999999999999887644332   


Q ss_pred             cccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhhhh
Q 007680          432 QTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQA  511 (593)
Q Consensus       432 ~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  511 (593)
                         .+||..|||||+..  ....++|.||||++++||+||..||..      .....+.                ..  .
T Consensus       153 ---~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~------~~~~~Il----------------~~--~  203 (612)
T KOG0603|consen  153 ---ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG------DTMKRIL----------------KA--E  203 (612)
T ss_pred             ---cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch------HHHHHHh----------------hh--c
Confidence               27899999999987  667889999999999999999999976      1111110                00  1


Q ss_pred             hhhhHHHHHHHHHHHhhcccCCCCCCCCH
Q 007680          512 FSAKMDCILSIMDFALDCCMESPDMRINM  540 (593)
Q Consensus       512 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~  540 (593)
                      ...+.+......+++..++..+|..|--.
T Consensus       204 ~~~p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  204 LEMPRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             cCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence            11223345567888888888999888754

>PRK10345 hypothetical protein; Provisional

Probab=99.79  E-value=8.4e-19  Score=166.19  Aligned_cols=135  Identities=18%  Similarity=0.262  Sum_probs=105.8

Q ss_pred             cccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhc-----CCCCcceeeeeeecCC---c-e
Q 007680          274 FNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNV-----RHRNLIKILSSYSNPD---F-K  343 (593)
Q Consensus       274 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~-~  343 (593)
                      +.-.+.||+|+||.||.  ++ ++.. +||++........+.+.+|+++++.+     +||||++++|+++++.   . .
T Consensus         4 L~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~   80 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY   80 (210)
T ss_pred             cCCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence            34457899999999996  44 4444 79998765444456789999999999     5799999999998863   3 3


Q ss_pred             EEEEec--cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCCCeEecCCCCCCeeeCC----CCcEEEEe
Q 007680          344 ALVLEF--MPNGSLEKWLYSHNYFLDILERLNIMIDVGSAL-EYLHNGHSSVHIIHCDLKPTNILLDE----NMVAHVSD  416 (593)
Q Consensus       344 ~lv~e~--~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L-~~LH~~~~~~~ivH~Dlkp~NIll~~----~~~~kL~D  416 (593)
                      .+|+||  +.+++|.+++.+..  +++.  ..++.+++.++ +|||+++    |+||||||+||+++.    ++.++|+|
T Consensus        81 ~~I~e~~G~~~~tL~~~l~~~~--~~e~--~~~~~~~L~~l~~yLh~~~----IvhrDlKp~NILl~~~~~~~~~~~LiD  152 (210)
T PRK10345         81 DVIADFDGKPSITLTEFAEQCR--YEED--VAQLRQLLKKLKRYLLDNR----IVTMELKPQNILCQRISESEVIPVVCD  152 (210)
T ss_pred             EEEecCCCCcchhHHHHHHccc--ccHh--HHHHHHHHHHHHHHHHHCC----EeecCCCHHHEEEeccCCCCCcEEEEE
Confidence            378999  55799999997643  5555  35678888888 9999655    999999999999974    34899999


Q ss_pred             ecc
Q 007680          417 FGI  419 (593)
Q Consensus       417 fg~  419 (593)
                      |+-
T Consensus       153 g~G  155 (210)
T PRK10345        153 NIG  155 (210)
T ss_pred             CCC
Confidence            543

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.78  E-value=8.4e-21  Score=165.18  Aligned_cols=152  Identities=34%  Similarity=0.555  Sum_probs=137.3

Q ss_pred             cEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhhc
Q 007680            2 RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLM   81 (593)
Q Consensus         2 ~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~   81 (593)
                      +.|-||+|.++ .+|+++.. |.+|+.|++++|+|+ .+|..++.|++|+.|+++-|++. .+|..|++++.|+.|    
T Consensus        36 TrLtLSHNKl~-~vppnia~-l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levl----  107 (264)
T KOG0617|consen   36 TRLTLSHNKLT-VVPPNIAE-LKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVL----  107 (264)
T ss_pred             hhhhcccCcee-ecCCcHHH-hhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhh----
Confidence            46789999999 89999997 999999999999999 89999999999999999999999 899999999999999    


Q ss_pred             ceeeccCCcccc-cCCC----cccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCccccCCcccccccccc
Q 007680           82 FGIRLTGNKLYG-RIPP----CLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSG  156 (593)
Q Consensus        82 n~l~l~~n~l~~-~~~~----~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~~  156 (593)
                         ||.+|++.. .+|.    +..|+.|+|+.|.+. .+|..++.+++|+.|.+..|.+- .+|..++.+..|++|.+++
T Consensus       108 ---dltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqg  182 (264)
T KOG0617|consen  108 ---DLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQG  182 (264)
T ss_pred             ---hccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhccc
Confidence               666666552 3444    345999999999998 89999999999999999999998 7999999999999999999


Q ss_pred             ccccCCCCCC
Q 007680          157 NNLSGKIPKL  166 (593)
Q Consensus       157 N~l~~~~p~~  166 (593)
                      |+++-.+|++
T Consensus       183 nrl~vlppel  192 (264)
T KOG0617|consen  183 NRLTVLPPEL  192 (264)
T ss_pred             ceeeecChhh
Confidence            9999777764

>smart00090 RIO RIO-like kinase

Probab=99.75  E-value=5.8e-18  Score=164.45  Aligned_cols=141  Identities=18%  Similarity=0.134  Sum_probs=110.6

Q ss_pred             ccccccccCccCcccEEEEE--eCCCCeEEEEEeehhhH------------------------HHHHHHHHHHHHHhhcC
Q 007680          273 EFNECNLLGTSSFGSVYKGT--ISDGTDVAIKVFNLQLE------------------------RAFRSFDSECEVLRNVR  326 (593)
Q Consensus       273 ~~~~~~~lg~G~~g~Vy~~~--~~~~~~vavK~~~~~~~------------------------~~~~~~~~E~~~l~~l~  326 (593)
                      .|.+.+.||+|++|.||+|.  ..+|+.||+|+++....                        .....+..|+..+.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            57888999999999999998  45899999999875321                        01134578999999997


Q ss_pred             CC--CcceeeeeeecCCceEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCC-eEecCCCCCC
Q 007680          327 HR--NLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVH-IIHCDLKPTN  403 (593)
Q Consensus       327 h~--niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~-ivH~Dlkp~N  403 (593)
                      +.  .+.+++++    ...++||||+++++|........ .....+...++.|++.++++||    +.+ ++||||||+|
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~LH----~~g~iiH~Dikp~N  179 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV-EPEEEEEFELYDDILEEMRKLY----KEGELVHGDLSEYN  179 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCcccccccccC-CcchHHHHHHHHHHHHHHHHHH----hcCCEEeCCCChhh
Confidence            53  33444442    23589999999988877653332 3566677899999999999999    456 9999999999


Q ss_pred             eeeCCCCcEEEEeeccceec
Q 007680          404 ILLDENMVAHVSDFGIYKLL  423 (593)
Q Consensus       404 Ill~~~~~~kL~Dfg~a~~~  423 (593)
                      |+++ ++.++|+|||.+...
T Consensus       180 Ili~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      180 ILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             EEEE-CCCEEEEEChhhhcc
Confidence            9999 889999999988754

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.75  E-value=7.8e-19  Score=190.69  Aligned_cols=210  Identities=22%  Similarity=0.258  Sum_probs=144.7

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEec
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEF  349 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  349 (593)
                      ..+|+.++.|..|+||.||.++++ +.+.+|+|+ +++.-     +.+-  ++.....|.+|                  
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~l-----ilRn--ilt~a~npfvv------------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL-----ILRN--ILTFAGNPFVV------------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhcc-cccch-----hhhc--cccccCCccee------------------
Confidence            468999999999999999999976 577888854 32211     1110  22222333333                  


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCC-
Q 007680          350 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGED-  428 (593)
Q Consensus       350 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~-  428 (593)
                         ||-...+...+. ++..        ++.+++|||    +.||+|||+||+|.+|+.-|++|++|||+++....... 
T Consensus       136 ---gDc~tllk~~g~-lPvd--------mvla~Eylh----~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at  199 (1205)
T KOG0606|consen  136 ---GDCATLLKNIGP-LPVD--------MVLAVEYLH----SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT  199 (1205)
T ss_pred             ---chhhhhcccCCC-Ccch--------hhHHhHhhc----cCCeecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence               344444444332 3322        277899999    56699999999999999999999999999875321110 


Q ss_pred             ------------ccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCc
Q 007680          429 ------------SVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHG  496 (593)
Q Consensus       429 ------------~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  496 (593)
                                  .......+||+.|.|||++..+.|+..+|.|++|+++||.+.|..||.+...++ -+...+..     
T Consensus       200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee-lfg~visd-----  273 (1205)
T KOG0606|consen  200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE-LFGQVISD-----  273 (1205)
T ss_pred             hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH-HHhhhhhh-----
Confidence                        112234589999999999999999999999999999999999999998743221 11111111     


Q ss_pred             hhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCC
Q 007680          497 LTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRIN  539 (593)
Q Consensus       497 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs  539 (593)
                             .+    ...+.....+++..+++.+.|+.+|..|--
T Consensus       274 -------~i----~wpE~dea~p~Ea~dli~~LL~qnp~~Rlg  305 (1205)
T KOG0606|consen  274 -------DI----EWPEEDEALPPEAQDLIEQLLRQNPLCRLG  305 (1205)
T ss_pred             -------hc----cccccCcCCCHHHHHHHHHHHHhChHhhcc
Confidence                   11    111112234668899999999999999963

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.74  E-value=9.4e-19  Score=178.26  Aligned_cols=173  Identities=24%  Similarity=0.383  Sum_probs=130.3

Q ss_pred             ceEEEEeccCCCCHHHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeecc
Q 007680          342 FKALVLEFMPNGSLEKWLYSHNY--FLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGI  419 (593)
Q Consensus       342 ~~~lv~e~~~~gsL~~~l~~~~~--~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~  419 (593)
                      ..|+.|++|+..+|.+|+...+.  ..++.....++.|++.|++|   ++    .+|+|+||.||+...+..+||+|||+
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~----~ihrdlkp~nif~~~d~q~kIgDFgl  402 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG----LIHRDLKPSNIFFSDDDQLKIGDFGL  402 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc----chhhhccccccccccchhhhhhhhhh
Confidence            57899999999999999975433  57888999999999999999   44    89999999999999999999999999


Q ss_pred             ceecCCCC----CccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcC
Q 007680          420 YKLLGEGE----DSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLP  494 (593)
Q Consensus       420 a~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~  494 (593)
                      ........    .....+...||..||+||.+.+..|+.++||||||++++|+++ =..+++..    ..          
T Consensus       403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~----~t----------  468 (516)
T KOG1033|consen  403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI----AT----------  468 (516)
T ss_pred             eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH----Hh----------
Confidence            88776554    2334566789999999999999999999999999999999998 33333221    00          


Q ss_pred             CchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHH
Q 007680          495 HGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDA  543 (593)
Q Consensus       495 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev  543 (593)
                        +.++-|..+ +...    ..+. +.-..|+.+++...|.+||++.+.
T Consensus       469 --~~d~r~g~i-p~~~----~~d~-p~e~~ll~~lls~~p~~RP~~~~~  509 (516)
T KOG1033|consen  469 --LTDIRDGII-PPEF----LQDY-PEEYTLLQQLLSPSPEERPSAIEV  509 (516)
T ss_pred             --hhhhhcCCC-ChHH----hhcC-cHHHHHHHHhcCCCcccCchHHHH
Confidence              011111111 1000    0111 233689999999999999955444

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.73  E-value=4e-17  Score=156.70  Aligned_cols=134  Identities=21%  Similarity=0.343  Sum_probs=113.2

Q ss_pred             cccCccCcccEEEEEeCCCCeEEEEEeehhh--------HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEec
Q 007680          278 NLLGTSSFGSVYKGTISDGTDVAIKVFNLQL--------ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEF  349 (593)
Q Consensus       278 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  349 (593)
                      +.||+|++|.||+|.+ +|..+++|+.....        ......+.+|++++..++|+++.....++...+..+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5799999999999987 67889999865321        11234678899999999999988877777777888999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeecccee
Q 007680          350 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKL  422 (593)
Q Consensus       350 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~  422 (593)
                      ++|++|.+++....    . ....++.+++.+|.++|+.    +++|+|++|+||+++ ++.++++|||.+..
T Consensus        81 ~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~----~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSNG----M-EELELSREIGRLVGKLHSA----GIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhC----CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            99999999986543    2 7889999999999999965    499999999999999 78899999998764

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=99.73  E-value=3.7e-19  Score=182.30  Aligned_cols=153  Identities=35%  Similarity=0.486  Sum_probs=100.9

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCcc-CCCCCCCcEEEccCCcccccccccccCCCCchhhhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNS-ITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSL   79 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l   79 (593)
                      |++||||+|+|. ++|.++-. -+++-.|+||+|+|. ++|.. |.+|+.|-.||||+|+|. .+|..+..|..|++|.|
T Consensus       105 Lt~lDLShNqL~-EvP~~LE~-AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~L  180 (1255)
T KOG0444|consen  105 LTILDLSHNQLR-EVPTNLEY-AKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKL  180 (1255)
T ss_pred             ceeeecchhhhh-hcchhhhh-hcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhc
Confidence            678899999998 89988875 788899999999998 56654 668888999999999998 66666777777777777


Q ss_pred             hcce------------------------------------------eeccCCcccccCCCcc----cccEEEccCCcccC
Q 007680           80 LMFG------------------------------------------IRLTGNKLYGRIPPCL----VLTVLDVSRNQLSG  113 (593)
Q Consensus        80 ~~n~------------------------------------------l~l~~n~l~~~~~~~~----~L~~L~l~~N~l~~  113 (593)
                      ++|.                                          +|++.|+|+ .+|.|.    +|+.|+||+|+|+ 
T Consensus       181 s~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-  258 (1255)
T KOG0444|consen  181 SNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-  258 (1255)
T ss_pred             CCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-
Confidence            6555                                          345555554 333332    2455555555554 


Q ss_pred             cCCCCCCCCCCCCEecCCCccCCCCCCccccCCcccccccccccccc
Q 007680          114 DIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLS  160 (593)
Q Consensus       114 ~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~~N~l~  160 (593)
                      .+....+...+|++|+|+.|+++ .+|+++..+++|+.|.+.+|+++
T Consensus       259 eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~  304 (1255)
T KOG0444|consen  259 ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLT  304 (1255)
T ss_pred             eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCccc
Confidence            34433334444555555555554 45555555555555555555543

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=99.73  E-value=4e-19  Score=181.11  Aligned_cols=162  Identities=28%  Similarity=0.295  Sum_probs=142.9

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLL   80 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~   80 (593)
                      +++|+|+.|+++ .+.++..-+|+.|+.|+||+|.|....+++....++|++|+|++|+|+...+++|..|.+|++|   
T Consensus       271 me~l~L~~N~l~-~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~L---  346 (873)
T KOG4194|consen  271 MEHLNLETNRLQ-AVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEEL---  346 (873)
T ss_pred             cceeecccchhh-hhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhh---
Confidence            478999999999 6665433369999999999999999999999999999999999999998888899999999999   


Q ss_pred             cceeeccCCccc----ccCCCcccccEEEccCCcccCcCCC---CCCCCCCCCEecCCCccCCCCCCccccCCccccccc
Q 007680           81 MFGIRLTGNKLY----GRIPPCLVLTVLDVSRNQLSGDIPS---TIGGRVDLETLSLASNQFQGPIPESVGSLISLESLD  153 (593)
Q Consensus        81 ~n~l~l~~n~l~----~~~~~~~~L~~L~l~~N~l~~~~p~---~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~  153 (593)
                          +|++|++.    +++-.+.+|+.|||++|.|+..+.+   .|.+|+.|+.|.+.+|+|....-.+|.++.+|+.||
T Consensus       347 ----nLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~Ld  422 (873)
T KOG4194|consen  347 ----NLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLD  422 (873)
T ss_pred             ----cccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceec
Confidence                77777776    4566667799999999999977754   478899999999999999966667899999999999


Q ss_pred             cccccccCCCCCCCCCC
Q 007680          154 LSGNNLSGKIPKLEGEI  170 (593)
Q Consensus       154 l~~N~l~~~~p~~~~~~  170 (593)
                      |.+|.+..+-|+.|..+
T Consensus       423 L~~NaiaSIq~nAFe~m  439 (873)
T KOG4194|consen  423 LGDNAIASIQPNAFEPM  439 (873)
T ss_pred             CCCCcceeecccccccc
Confidence            99999999999998876

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.72  E-value=5.7e-17  Score=153.96  Aligned_cols=144  Identities=19%  Similarity=0.168  Sum_probs=111.7

Q ss_pred             HHHHhhhccccccccCccCcccEEEEEeCCCCeEEEEEeehhhH----------------------HHHHHHHHHHHHHh
Q 007680          266 DIQRATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLE----------------------RAFRSFDSECEVLR  323 (593)
Q Consensus       266 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~  323 (593)
                      ++.....-|.+.+.||+|+||.||++..++|+.||||+++....                      ........|..++.
T Consensus         9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   88 (198)
T cd05144           9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK   88 (198)
T ss_pred             HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence            33333444888899999999999999988899999998764310                      01123677899999


Q ss_pred             hcCCC--CcceeeeeeecCCceEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCC
Q 007680          324 NVRHR--NLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKP  401 (593)
Q Consensus       324 ~l~h~--niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp  401 (593)
                      ++.|+  .+.+.++    ....++||||++|++|.+....       .....++.+++.++.++|+.    +++||||||
T Consensus        89 ~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~~----gi~H~Dl~p  153 (198)
T cd05144          89 ALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYKH----GIIHGDLSE  153 (198)
T ss_pred             HHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHHC----CCCcCCCCc
Confidence            99777  4444444    2445899999999999775431       34567889999999999964    599999999


Q ss_pred             CCeeeCCCCcEEEEeeccceecC
Q 007680          402 TNILLDENMVAHVSDFGIYKLLG  424 (593)
Q Consensus       402 ~NIll~~~~~~kL~Dfg~a~~~~  424 (593)
                      +||++++++.++|+|||.+....
T Consensus       154 ~Nill~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         154 FNILVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             ccEEEcCCCcEEEEECCccccCC
Confidence            99999999999999999986544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=99.72  E-value=1.3e-18  Score=177.51  Aligned_cols=164  Identities=26%  Similarity=0.250  Sum_probs=110.7

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLL   80 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~   80 (593)
                      |+.||||.|.|+ ++|...|..=.++++|+|++|+|+..-.+.|.++.+|.+|.|++|+|+..++..|..|++|+.|+|.
T Consensus       151 lrslDLSrN~is-~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLn  229 (873)
T KOG4194|consen  151 LRSLDLSRNLIS-EIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLN  229 (873)
T ss_pred             hhhhhhhhchhh-cccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhcc
Confidence            578899999998 8888776545789999999999998778889999999999999999997777788889999999887


Q ss_pred             cceee-----------------ccCCccc----ccCCCcccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCC
Q 007680           81 MFGIR-----------------LTGNKLY----GRIPPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPI  139 (593)
Q Consensus        81 ~n~l~-----------------l~~n~l~----~~~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~  139 (593)
                      .|.|.                 |..|++.    |.+-.+-.+++|+|+.|+++..-.+++-++..|+.|+|++|.|...-
T Consensus       230 rN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih  309 (873)
T KOG4194|consen  230 RNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIH  309 (873)
T ss_pred             ccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheee
Confidence            66543                 2333332    22222223555555555555444444555555555555555555555


Q ss_pred             CccccCCccccccccccccccCCCCC
Q 007680          140 PESVGSLISLESLDLSGNNLSGKIPK  165 (593)
Q Consensus       140 p~~l~~~~~L~~L~l~~N~l~~~~p~  165 (593)
                      ++.+.-+.+|++|||++|+++...+.
T Consensus       310 ~d~WsftqkL~~LdLs~N~i~~l~~~  335 (873)
T KOG4194|consen  310 IDSWSFTQKLKELDLSSNRITRLDEG  335 (873)
T ss_pred             cchhhhcccceeEeccccccccCChh
Confidence            55555555555555555555554444

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.71  E-value=1.4e-16  Score=173.97  Aligned_cols=138  Identities=21%  Similarity=0.278  Sum_probs=111.4

Q ss_pred             hhhccccccccCccCcccEEEEEeCCCCeEEEEEeehh--------hHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCC
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQ--------LERAFRSFDSECEVLRNVRHRNLIKILSSYSNPD  341 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--------~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  341 (593)
                      ....|...+.||+|+||.||++.+.+ ..+++|+....        .....+.+.+|++++++++|++++....++...+
T Consensus       331 ~~~~~~~~~~iG~G~~g~Vy~~~~~~-~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~  409 (535)
T PRK09605        331 VKRRKIPDHLIGKGAEADIKKGEYLG-RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE  409 (535)
T ss_pred             cccccCccceeccCCcEEEEEEeecC-ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence            34455667899999999999998754 34444432211        1122356889999999999999998888777777


Q ss_pred             ceEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccce
Q 007680          342 FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYK  421 (593)
Q Consensus       342 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~  421 (593)
                      ..++||||+++++|.+++.         ....++.+++++|.+||+.    +++|||+||+||++ +++.++|+|||+++
T Consensus       410 ~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~----giiHrDlkp~NILl-~~~~~~liDFGla~  475 (535)
T PRK09605        410 EKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKA----GIVHGDLTTSNFIV-RDDRLYLIDFGLGK  475 (535)
T ss_pred             CCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhC----CCccCCCChHHEEE-ECCcEEEEeCcccc
Confidence            8899999999999999875         3567899999999999965    49999999999999 67799999999987


Q ss_pred             e
Q 007680          422 L  422 (593)
Q Consensus       422 ~  422 (593)
                      .
T Consensus       476 ~  476 (535)
T PRK09605        476 Y  476 (535)
T ss_pred             c
Confidence            5

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.70  E-value=1.5e-16  Score=151.18  Aligned_cols=130  Identities=22%  Similarity=0.331  Sum_probs=106.2

Q ss_pred             ccCccCcccEEEEEeCCCCeEEEEEeehhh--------HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEecc
Q 007680          279 LLGTSSFGSVYKGTISDGTDVAIKVFNLQL--------ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFM  350 (593)
Q Consensus       279 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  350 (593)
                      .||+|++|.||+|.+ +|..|++|+.....        ......+.+|++++..++|+++.....++...+..++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            489999999999996 57889999864321        112356788999999999887666555556667779999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeecccee
Q 007680          351 PNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKL  422 (593)
Q Consensus       351 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~  422 (593)
                      +|++|.+++.....        .++.+++.+|.++|+.    +++|||++|+||+++ ++.++++|||.+..
T Consensus        80 ~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH~~----gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEGND--------ELLREIGRLVGKLHKA----GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhcHH--------HHHHHHHHHHHHHHHC----CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            99999998755321        7899999999999954    599999999999999 78999999998764

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.66  E-value=1e-17  Score=163.96  Aligned_cols=183  Identities=23%  Similarity=0.257  Sum_probs=146.3

Q ss_pred             cEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccC-CcccccccccccCCCCchhhhhh
Q 007680            2 RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGF-NSFSGHILNTFGNLRHLSVLSLL   80 (593)
Q Consensus         2 ~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~l~   80 (593)
                      ..|+|..|+|+ .||++.|+.+++|+.|+||+|.|+.+-|++|.+|.+|..|-+.+ |+|+....+.|++|.+|+.|.+.
T Consensus        70 veirLdqN~I~-~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllN  148 (498)
T KOG4237|consen   70 VEIRLDQNQIS-SIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLLN  148 (498)
T ss_pred             eEEEeccCCcc-cCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhcC
Confidence            35899999999 99999999999999999999999999999999999998888876 99996666678888888877664


Q ss_pred             cce-----------------------------------------eeccCCcc----------------------------
Q 007680           81 MFG-----------------------------------------IRLTGNKL----------------------------   91 (593)
Q Consensus        81 ~n~-----------------------------------------l~l~~n~l----------------------------   91 (593)
                      -|.                                         +.+..|.+                            
T Consensus       149 an~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~p  228 (498)
T KOG4237|consen  149 ANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVSP  228 (498)
T ss_pred             hhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecch
Confidence            111                                         11111210                            


Q ss_pred             --------------------------------c-c-----cCCCcccccEEEccCCcccCcCCCCCCCCCCCCEecCCCc
Q 007680           92 --------------------------------Y-G-----RIPPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASN  133 (593)
Q Consensus        92 --------------------------------~-~-----~~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N  133 (593)
                                                      . +     .+..+..|+.|+|++|+|+.+-+++|.++..+++|+|..|
T Consensus       229 ~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N  308 (498)
T KOG4237|consen  229 YRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRN  308 (498)
T ss_pred             HHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcc
Confidence                                            0 0     0111223899999999999888999999999999999999


Q ss_pred             cCCCCCCccccCCccccccccccccccCCCCCCCCCCCCCCCccCCCcccccCCccCC
Q 007680          134 QFQGPIPESVGSLISLESLDLSGNNLSGKIPKLEGEIPVKGSFKNFSTESFFGNYALC  191 (593)
Q Consensus       134 ~l~~~~p~~l~~~~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~n~~~c  191 (593)
                      +|...-...|.++..|++|+|.+|+|+.+.|..|..+-      .+.+....+||+.|
T Consensus       309 ~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~------~l~~l~l~~Np~~C  360 (498)
T KOG4237|consen  309 KLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLF------SLSTLNLLSNPFNC  360 (498)
T ss_pred             hHHHHHHHhhhccccceeeeecCCeeEEEecccccccc------eeeeeehccCcccC
Confidence            99977778899999999999999999999998876543      44556788899887

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.64  E-value=1.6e-17  Score=180.76  Aligned_cols=257  Identities=21%  Similarity=0.252  Sum_probs=198.0

Q ss_pred             hhccccccccCccCcccEEEEEeC--CCCeEEEEEeehhh--HHHHHHHHHHHHHHhhcC-CCCcceeeeeeecCCceEE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS--DGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVR-HRNLIKILSSYSNPDFKAL  345 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l  345 (593)
                      ...|...+.||+|+|+.|-.....  ....+|+|.+....  .........|..+-..+. |+|++++++...+++..++
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~   98 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL   98 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence            346777888999999999888753  34456666655432  333445556777777776 9999999999999999999


Q ss_pred             EEeccCCCCHHHHH-hhCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCCeEecCCCCCCeeeCCCC-cEEEEeecccee
Q 007680          346 VLEFMPNGSLEKWL-YSHNYFLDILERLNIMIDVGSALEYLH-NGHSSVHIIHCDLKPTNILLDENM-VAHVSDFGIYKL  422 (593)
Q Consensus       346 v~e~~~~gsL~~~l-~~~~~~l~~~~~~~i~~~i~~~L~~LH-~~~~~~~ivH~Dlkp~NIll~~~~-~~kL~Dfg~a~~  422 (593)
                      ++||..++++.+-+ .......+.......+.|+..++.|+| ..+    +.|+|+||+|.+++..+ ..++.|||+|..
T Consensus        99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~----~~h~~ikP~n~~l~~s~~~l~~~df~~At~  174 (601)
T KOG0590|consen   99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG----VTHRDIKPSNSLLDESGSALKIADFGLATA  174 (601)
T ss_pred             ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc----cccCCCCCccchhccCCCcccCCCchhhcc
Confidence            99999999999988 444424677788889999999999999 554    99999999999999999 999999999998


Q ss_pred             cCC-CCCccccccccC-CccccCccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhh
Q 007680          423 LGE-GEDSVRQTMTMA-TIGYMAPEYGLEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTE  499 (593)
Q Consensus       423 ~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  499 (593)
                      +.. ...........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++........+..|......     
T Consensus       175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~-----  249 (601)
T KOG0590|consen  175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGR-----  249 (601)
T ss_pred             ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccc-----
Confidence            876 444444455678 9999999998874 56788999999999999999999998865555444444332210     


Q ss_pred             hhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          500 VVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       500 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                                .....+........+++.+++..+|+.|.+.+++...
T Consensus       250 ----------~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d  286 (601)
T KOG0590|consen  250 ----------FTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLD  286 (601)
T ss_pred             ----------cccCccccCChhhhhcccccccCCchhcccccccccc
Confidence                      0011112223456889999999999999999887653

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.62  E-value=2.3e-15  Score=141.52  Aligned_cols=137  Identities=20%  Similarity=0.226  Sum_probs=97.8

Q ss_pred             ccccCccCcccEEEEEeCCCCeEEEEEeehhhHH--HHHH----------------------HHHHHHHHhhcCCC--Cc
Q 007680          277 CNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLER--AFRS----------------------FDSECEVLRNVRHR--NL  330 (593)
Q Consensus       277 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~E~~~l~~l~h~--ni  330 (593)
                      .+.||+|+||.||+|...+|+.||||+++.....  ....                      ...|...+.++.+.  .+
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            4689999999999999888999999998753211  1111                      13566666666443  24


Q ss_pred             ceeeeeeecCCceEEEEeccCCCCHHH-HHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCC
Q 007680          331 IKILSSYSNPDFKALVLEFMPNGSLEK-WLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDEN  409 (593)
Q Consensus       331 v~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~  409 (593)
                      .+.+++    ...++||||++++++.. .+....  .. .+...++.+++.++.++|.   +.+|+|+||||+||+++ +
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh~---~~~ivH~Dl~p~Nili~-~  150 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLYR---EAGLVHGDLSEYNILVD-D  150 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHhh---ccCcCcCCCChhhEEEE-C
Confidence            444443    24589999999854321 111111  11 5678899999999999995   14599999999999999 8


Q ss_pred             CcEEEEeeccceecC
Q 007680          410 MVAHVSDFGIYKLLG  424 (593)
Q Consensus       410 ~~~kL~Dfg~a~~~~  424 (593)
                      +.++++|||.+....
T Consensus       151 ~~~~liDfg~a~~~~  165 (187)
T cd05119         151 GKVYIIDVPQAVEID  165 (187)
T ss_pred             CcEEEEECccccccc
Confidence            899999999987543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.62  E-value=1.4e-17  Score=145.24  Aligned_cols=153  Identities=25%  Similarity=0.423  Sum_probs=132.1

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCccc-ccccccccCCCCchhhhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFS-GHILNTFGNLRHLSVLSL   79 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~l   79 (593)
                      |++|+|++|+|. ++|..+.+ +++|+.|+++-|++. .+|.+|+.++.|+.|||..|+++ ..+|+.|..|+.|+.|  
T Consensus        58 levln~~nnqie-~lp~~iss-l~klr~lnvgmnrl~-~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlral--  132 (264)
T KOG0617|consen   58 LEVLNLSNNQIE-ELPTSISS-LPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRAL--  132 (264)
T ss_pred             hhhhhcccchhh-hcChhhhh-chhhhheecchhhhh-cCccccCCCchhhhhhccccccccccCCcchhHHHHHHHH--
Confidence            678999999999 99999986 999999999999999 89999999999999999999995 4779999999999999  


Q ss_pred             hcceeeccCCccc---ccCCCcccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCccccCCcc---ccccc
Q 007680           80 LMFGIRLTGNKLY---GRIPPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLIS---LESLD  153 (593)
Q Consensus        80 ~~n~l~l~~n~l~---~~~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~---L~~L~  153 (593)
                           +|++|.+.   +.+..+..|+.|.+..|.+- .+|.+++.+..|++|++.+|+++ .+|..++++.-   =+.+.
T Consensus       133 -----yl~dndfe~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~-vlppel~~l~l~~~k~v~r  205 (264)
T KOG0617|consen  133 -----YLGDNDFEILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLT-VLPPELANLDLVGNKQVMR  205 (264)
T ss_pred             -----HhcCCCcccCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceee-ecChhhhhhhhhhhHHHHh
Confidence                 77888876   33344567999999999998 89999999999999999999998 78888887643   34567


Q ss_pred             cccccccCCCCC
Q 007680          154 LSGNNLSGKIPK  165 (593)
Q Consensus       154 l~~N~l~~~~p~  165 (593)
                      +.+|++-..+.+
T Consensus       206 ~E~NPwv~pIae  217 (264)
T KOG0617|consen  206 MEENPWVNPIAE  217 (264)
T ss_pred             hhhCCCCChHHH
Confidence            778887654443

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.62  E-value=3.5e-15  Score=134.52  Aligned_cols=135  Identities=21%  Similarity=0.269  Sum_probs=114.2

Q ss_pred             cccccCccCcccEEEEEeCCCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCC--CCcceeeeeeecCCceEEEEeccCCC
Q 007680          276 ECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRH--RNLIKILSSYSNPDFKALVLEFMPNG  353 (593)
Q Consensus       276 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g  353 (593)
                      +.+.||+|.++.||++...+ ..+++|.......  ...+.+|+.++..++|  .++.+++++....+..+++|||++++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            45789999999999999854 7899999866533  4578899999999976  58999999888888899999999887


Q ss_pred             CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeecccee
Q 007680          354 SLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKL  422 (593)
Q Consensus       354 sL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~  422 (593)
                      ++..+        +......++.+++++++++|... ..+++|+|++|+||+++..+.++++|||.+..
T Consensus        79 ~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~-~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          79 TLDEV--------SEEEKEDIAEQLAELLAKLHQLP-LLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ecccC--------CHHHHHHHHHHHHHHHHHHhCCC-ceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            77654        45667788999999999999643 35699999999999999989999999998764

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=99.61  E-value=6.4e-17  Score=166.11  Aligned_cols=157  Identities=25%  Similarity=0.326  Sum_probs=131.6

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLL   80 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~   80 (593)
                      |..+|||.|+|. .+|+-+.. +++|+.|+||+|+|+ .+.-+.+.-.+|++|+||+|+|+ .+|+.++.|+.|+.|++.
T Consensus       224 L~dvDlS~N~Lp-~vPecly~-l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n  299 (1255)
T KOG0444|consen  224 LRDVDLSENNLP-IVPECLYK-LRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYAN  299 (1255)
T ss_pred             hhhccccccCCC-cchHHHhh-hhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhc
Confidence            456899999998 89998886 999999999999999 66767777788999999999999 899999999999999444


Q ss_pred             cceeeccCCcccccCCCcccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCccccCCcccccccccccccc
Q 007680           81 MFGIRLTGNKLYGRIPPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLS  160 (593)
Q Consensus        81 ~n~l~l~~n~l~~~~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~~N~l~  160 (593)
                      +|.++..+  +...|..+..|+.++.++|.|. .+|..++.|..|+.|.|++|++. .+|+++.-++.|+.||+..|+-.
T Consensus       300 ~NkL~FeG--iPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnL  375 (1255)
T KOG0444|consen  300 NNKLTFEG--IPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNL  375 (1255)
T ss_pred             cCcccccC--CccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCc
Confidence            44433322  1234455667999999999998 89999999999999999999998 79999999999999999999987


Q ss_pred             CCCCC
Q 007680          161 GKIPK  165 (593)
Q Consensus       161 ~~~p~  165 (593)
                      -.+|+
T Consensus       376 VMPPK  380 (1255)
T KOG0444|consen  376 VMPPK  380 (1255)
T ss_pred             cCCCC
Confidence            76766

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=99.59  E-value=2.7e-17  Score=161.13  Aligned_cols=167  Identities=30%  Similarity=0.412  Sum_probs=128.5

Q ss_pred             cEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhhc
Q 007680            2 RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLM   81 (593)
Q Consensus         2 ~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~   81 (593)
                      +.|+..+|+++ .+|++++. +.+|..|++.+|+++ .+|++.-+++.|+.||..+|.++ .+|..+++|.+|..|    
T Consensus       140 ~dl~~~~N~i~-slp~~~~~-~~~l~~l~~~~n~l~-~l~~~~i~m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~L----  211 (565)
T KOG0472|consen  140 EDLDATNNQIS-SLPEDMVN-LSKLSKLDLEGNKLK-ALPENHIAMKRLKHLDCNSNLLE-TLPPELGGLESLELL----  211 (565)
T ss_pred             hhhhccccccc-cCchHHHH-HHHHHHhhccccchh-hCCHHHHHHHHHHhcccchhhhh-cCChhhcchhhhHHH----
Confidence            44566677776 67777765 677777777777777 34444444788888888888888 777788888888888    


Q ss_pred             ceeeccCCccc--ccCCCcccccEEEccCCcccCcCCCCCC-CCCCCCEecCCCccCCCCCCccccCCcccccccccccc
Q 007680           82 FGIRLTGNKLY--GRIPPCLVLTVLDVSRNQLSGDIPSTIG-GRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNN  158 (593)
Q Consensus        82 n~l~l~~n~l~--~~~~~~~~L~~L~l~~N~l~~~~p~~~~-~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~~N~  158 (593)
                         ++..|++.  -+||.|..|.+|+++.|+|. .+|.+.+ ++++|..|||.+|+++ ..|+.+.-+.+|+.||+|+|.
T Consensus       212 ---yL~~Nki~~lPef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~  286 (565)
T KOG0472|consen  212 ---YLRRNKIRFLPEFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNND  286 (565)
T ss_pred             ---HhhhcccccCCCCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCc
Confidence               67777776  35677777999999999998 7887776 8999999999999998 789999999999999999999


Q ss_pred             ccCCCCCCCCCCCCCCCccCCCcccccCCcc
Q 007680          159 LSGKIPKLEGEIPVKGSFKNFSTESFFGNYA  189 (593)
Q Consensus       159 l~~~~p~~~~~~~~~~~~~~~~~~~~~~n~~  189 (593)
                      +++.++.+       +.+ .+......|||-
T Consensus       287 is~Lp~sL-------gnl-hL~~L~leGNPl  309 (565)
T KOG0472|consen  287 ISSLPYSL-------GNL-HLKFLALEGNPL  309 (565)
T ss_pred             cccCCccc-------ccc-eeeehhhcCCch
Confidence            99866552       233 444556777765

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.59  E-value=1.7e-14  Score=140.44  Aligned_cols=134  Identities=17%  Similarity=0.208  Sum_probs=103.9

Q ss_pred             cccC-ccCcccEEEEEeCCCCeEEEEEeehhh-------------HHHHHHHHHHHHHHhhcCCCCc--ceeeeeeecCC
Q 007680          278 NLLG-TSSFGSVYKGTISDGTDVAIKVFNLQL-------------ERAFRSFDSECEVLRNVRHRNL--IKILSSYSNPD  341 (593)
Q Consensus       278 ~~lg-~G~~g~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~~  341 (593)
                      ..|| .|+.|+||.+... +..+++|.+....             ......+.+|++++.+++|+++  ++.+++.....
T Consensus        37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~  115 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH  115 (239)
T ss_pred             ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence            4687 8999999999875 7789999885311             1223467889999999988775  66776644322


Q ss_pred             ----ceEEEEeccCC-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEe
Q 007680          342 ----FKALVLEFMPN-GSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSD  416 (593)
Q Consensus       342 ----~~~lv~e~~~~-gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~D  416 (593)
                          ..++|||+++| .+|.+++....  ++..    .+.+++.++.+||++|    |+||||||+|||++.++.++|+|
T Consensus       116 ~~~~~~~lV~e~l~G~~~L~~~l~~~~--l~~~----~~~~i~~~l~~lH~~G----I~HrDlkp~NILv~~~~~v~LID  185 (239)
T PRK01723        116 GLFYRADILIERIEGARDLVALLQEAP--LSEE----QWQAIGQLIARFHDAG----VYHADLNAHNILLDPDGKFWLID  185 (239)
T ss_pred             CcceeeeEEEEecCCCCCHHHHHhcCC--CCHH----HHHHHHHHHHHHHHCC----CCCCCCCchhEEEcCCCCEEEEE
Confidence                23599999997 69999886532  4443    3578999999999655    99999999999999999999999


Q ss_pred             ecccee
Q 007680          417 FGIYKL  422 (593)
Q Consensus       417 fg~a~~  422 (593)
                      ||.+..
T Consensus       186 fg~~~~  191 (239)
T PRK01723        186 FDRGEL  191 (239)
T ss_pred             CCCccc
Confidence            998764

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=99.50  E-value=8e-16  Score=150.93  Aligned_cols=150  Identities=31%  Similarity=0.491  Sum_probs=126.4

Q ss_pred             cEEEeeCccccccCChhhhhCCCCCc-EEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhh
Q 007680            2 RILTLEGNQLSGRLPSTIGHSLPNIE-YLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLL   80 (593)
Q Consensus         2 ~~L~Ls~n~l~~~lp~~~~~~l~~L~-~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~   80 (593)
                      +..+++.|+|. ++|..+.. ++.++ .+.+++|+++ .+|..++.+++|..|+|++|.+. .+|..++++..||.|   
T Consensus       391 t~VnfskNqL~-elPk~L~~-lkelvT~l~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~L---  463 (565)
T KOG0472|consen  391 TSVNFSKNQLC-ELPKRLVE-LKELVTDLVLSNNKIS-FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTL---  463 (565)
T ss_pred             EEEecccchHh-hhhhhhHH-HHHHHHHHHhhcCccc-cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhhee---
Confidence            46788889998 88888775 55544 4567777776 88999999999999999999999 899999999999999   


Q ss_pred             cceeeccCCcccccCCCcc----cccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCccccCCcccccccccc
Q 007680           81 MFGIRLTGNKLYGRIPPCL----VLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSG  156 (593)
Q Consensus        81 ~n~l~l~~n~l~~~~~~~~----~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~~  156 (593)
                          +++.|++. .+|.+.    .|+.+-.++|++....|..+.++.+|..|||.+|.|. .+|..+++|.+|++|++++
T Consensus       464 ----nlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~g  537 (565)
T KOG0472|consen  464 ----NLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDG  537 (565)
T ss_pred             ----cccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecC
Confidence                77888776 666654    3788888889998655666999999999999999998 7899999999999999999


Q ss_pred             ccccCCCCC
Q 007680          157 NNLSGKIPK  165 (593)
Q Consensus       157 N~l~~~~p~  165 (593)
                      |+|+ .++.
T Consensus       538 Npfr-~Pr~  545 (565)
T KOG0472|consen  538 NPFR-QPRH  545 (565)
T ss_pred             CccC-CCHH
Confidence            9999 4443

>PLN03150 hypothetical protein; Provisional

Probab=99.49  E-value=4.7e-14  Score=155.97  Aligned_cols=112  Identities=39%  Similarity=0.663  Sum_probs=86.2

Q ss_pred             eccCCcccccCCC----cccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCccccCCcccccccccccccc
Q 007680           85 RLTGNKLYGRIPP----CLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLS  160 (593)
Q Consensus        85 ~l~~n~l~~~~~~----~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~~N~l~  160 (593)
                      +|++|.+.|.+|.    +..|+.|+|++|.++|.+|..++.+++|+.|+|++|+|+|.+|+.++++++|+.|+|++|+++
T Consensus       424 ~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~  503 (623)
T PLN03150        424 GLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLS  503 (623)
T ss_pred             ECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCccc
Confidence            4445555444432    233677788888898899999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCCCCCCccCCCcccccCCccCCCCCCCCCCCCCC
Q 007680          161 GKIPKLEGEIPVKGSFKNFSTESFFGNYALCGPPKLRVPPCKP  203 (593)
Q Consensus       161 ~~~p~~~~~~~~~~~~~~~~~~~~~~n~~~c~~~~~~~~~~~~  203 (593)
                      |.+|..+..+.     .......+.+|+.+|+.|.  .++|..
T Consensus       504 g~iP~~l~~~~-----~~~~~l~~~~N~~lc~~p~--l~~C~~  539 (623)
T PLN03150        504 GRVPAALGGRL-----LHRASFNFTDNAGLCGIPG--LRACGP  539 (623)
T ss_pred             ccCChHHhhcc-----ccCceEEecCCccccCCCC--CCCCcc
Confidence            99988665332     2234567889999998663  356753

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.49  E-value=1.6e-13  Score=145.18  Aligned_cols=140  Identities=21%  Similarity=0.297  Sum_probs=99.2

Q ss_pred             cccCccCcccEEEEEeCCCCeEEEEEeehhhHHHH----------------------------------------HHHHH
Q 007680          278 NLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAF----------------------------------------RSFDS  317 (593)
Q Consensus       278 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~~~  317 (593)
                      +.||.|++|.||+|+.++|+.||||+.+.......                                        -++.+
T Consensus       123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~  202 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR  202 (437)
T ss_pred             cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence            68999999999999999999999999865421100                                        02445


Q ss_pred             HHHHHhhcC----CCCcceeeeee-ecCCceEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHH-HHHHHHhcCCC
Q 007680          318 ECEVLRNVR----HRNLIKILSSY-SNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGS-ALEYLHNGHSS  391 (593)
Q Consensus       318 E~~~l~~l~----h~niv~l~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~-~L~~LH~~~~~  391 (593)
                      |+..+.+++    |.+-+.+-.++ ......++||||++|++|.++........   ....++.+++. .+..+|..   
T Consensus       203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~---  276 (437)
T TIGR01982       203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRD---  276 (437)
T ss_pred             HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhC---
Confidence            665555552    32223322222 23445799999999999988765432112   23456666665 46788854   


Q ss_pred             CCeEecCCCCCCeeeCCCCcEEEEeeccceecC
Q 007680          392 VHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG  424 (593)
Q Consensus       392 ~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~  424 (593)
                       |++|+|++|.||++++++.++++|||++..+.
T Consensus       277 -g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       277 -GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             -CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence             59999999999999999999999999987664

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.46  E-value=5.5e-14  Score=135.02  Aligned_cols=203  Identities=19%  Similarity=0.228  Sum_probs=141.7

Q ss_pred             HHhhcCCCCcceeeeeeecCC-----ceEEEEeccCCCCHHHHHhhCCC---CCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 007680          321 VLRNVRHRNLIKILSSYSNPD-----FKALVLEFMPNGSLEKWLYSHNY---FLDILERLNIMIDVGSALEYLHNGHSSV  392 (593)
Q Consensus       321 ~l~~l~h~niv~l~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~---~l~~~~~~~i~~~i~~~L~~LH~~~~~~  392 (593)
                      -+-++.|.||++++.|+.+..     +..+++|||..|++.+++++.++   .+......+|+.||+.||.|||.-  ..
T Consensus       120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~--~P  197 (458)
T KOG1266|consen  120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC--DP  197 (458)
T ss_pred             HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc--CC
Confidence            344567999999999986543     57889999999999999987543   577788889999999999999975  46


Q ss_pred             CeEecCCCCCCeeeCCCCcEEEEeecccee--cCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh
Q 007680          393 HIIHCDLKPTNILLDENMVAHVSDFGIYKL--LGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT  470 (593)
Q Consensus       393 ~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~--~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt  470 (593)
                      .|+|+++..+-|++..+|-+|++--.-...  ..........+...+-++|.|||+-.....+.++|||+||+...||..
T Consensus       198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai  277 (458)
T KOG1266|consen  198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI  277 (458)
T ss_pred             ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence            799999999999999999888753211110  000011112223346788999998777778889999999999999988


Q ss_pred             CCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 007680          471 RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKL  547 (593)
Q Consensus       471 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  547 (593)
                      +..--........             ..+.+...+......         .-..++..|++..|..||+|.+++.|.
T Consensus       278 lEiq~tnseS~~~-------------~ee~ia~~i~~len~---------lqr~~i~kcl~~eP~~rp~ar~llfHp  332 (458)
T KOG1266|consen  278 LEIQSTNSESKVE-------------VEENIANVIIGLENG---------LQRGSITKCLEGEPNGRPDARLLLFHP  332 (458)
T ss_pred             heeccCCCcceee-------------hhhhhhhheeeccCc---------cccCcCcccccCCCCCCcchhhhhcCc
Confidence            7754221100000             001111111111000         125788999999999999999998774

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.43  E-value=2e-13  Score=150.97  Aligned_cols=88  Identities=26%  Similarity=0.318  Sum_probs=54.4

Q ss_pred             ccCCcccccCCCcc-cccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCccccCCccccccccccccccCCCC
Q 007680           86 LTGNKLYGRIPPCL-VLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIP  164 (593)
Q Consensus        86 l~~n~l~~~~~~~~-~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~~N~l~~~~p  164 (593)
                      +++|+|. .+|... +|+.|++++|+|+ .+|..   .++|+.|++++|+|+ .+|..   ..+|+.|++++|+++. +|
T Consensus       369 Ls~N~L~-~LP~l~~~L~~LdLs~N~Lt-~LP~l---~s~L~~LdLS~N~Ls-sIP~l---~~~L~~L~Ls~NqLt~-LP  438 (788)
T PRK15387        369 AYNNRLT-SLPALPSGLKELIVSGNRLT-SLPVL---PSELKELMVSGNRLT-SLPML---PSGLLSLSVYRNQLTR-LP  438 (788)
T ss_pred             hhccccc-cCcccccccceEEecCCccc-CCCCc---ccCCCEEEccCCcCC-CCCcc---hhhhhhhhhccCcccc-cC
Confidence            4555555 344433 4778888888887 45543   256788888888887 46643   2467778888888874 45


Q ss_pred             CCCCCCCCCCCccCCCcccccCCcc
Q 007680          165 KLEGEIPVKGSFKNFSTESFFGNYA  189 (593)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~n~~  189 (593)
                      ..+..++      .+..+.+.+|+.
T Consensus       439 ~sl~~L~------~L~~LdLs~N~L  457 (788)
T PRK15387        439 ESLIHLS------SETTVNLEGNPL  457 (788)
T ss_pred             hHHhhcc------CCCeEECCCCCC
Confidence            5444333      333455666654

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.41  E-value=4.6e-13  Score=148.98  Aligned_cols=147  Identities=27%  Similarity=0.443  Sum_probs=79.7

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLL   80 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~   80 (593)
                      |+.|+|++|+|+ .+|..++   ++|+.|+|++|+|+ .+|..+.  ++|+.|+|++|+|+ .+|+.+.  ++|+.|+|+
T Consensus       222 L~~L~Ls~N~Lt-sLP~~l~---~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls  291 (754)
T PRK15370        222 IKTLYANSNQLT-SIPATLP---DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVY  291 (754)
T ss_pred             CCEEECCCCccc-cCChhhh---ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECC
Confidence            456677777776 6665543   24555666666655 4454442  34555555555555 3444332  245555333


Q ss_pred             ccee--------------eccCCcccccCCCc--ccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCcccc
Q 007680           81 MFGI--------------RLTGNKLYGRIPPC--LVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVG  144 (593)
Q Consensus        81 ~n~l--------------~l~~n~l~~~~~~~--~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~  144 (593)
                      +|.+              ++++|++.. +|..  .+|+.|++++|.++ .+|..+.  ++|+.|++++|+|+ .+|..+.
T Consensus       292 ~N~Lt~LP~~lp~sL~~L~Ls~N~Lt~-LP~~l~~sL~~L~Ls~N~Lt-~LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp  366 (754)
T PRK15370        292 DNSIRTLPAHLPSGITHLNVQSNSLTA-LPETLPPGLKTLEAGENALT-SLPASLP--PELQVLDVSKNQIT-VLPETLP  366 (754)
T ss_pred             CCccccCcccchhhHHHHHhcCCcccc-CCccccccceeccccCCccc-cCChhhc--CcccEEECCCCCCC-cCChhhc
Confidence            2221              344555542 2221  23666666666666 3554442  56777777777776 4555442


Q ss_pred             CCccccccccccccccCCCC
Q 007680          145 SLISLESLDLSGNNLSGKIP  164 (593)
Q Consensus       145 ~~~~L~~L~l~~N~l~~~~p  164 (593)
                        ++|+.|++++|+|+.+++
T Consensus       367 --~~L~~LdLs~N~Lt~LP~  384 (754)
T PRK15370        367 --PTITTLDVSRNALTNLPE  384 (754)
T ss_pred             --CCcCEEECCCCcCCCCCH
Confidence              467777777777765433

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.39  E-value=7.4e-12  Score=131.80  Aligned_cols=233  Identities=18%  Similarity=0.197  Sum_probs=154.1

Q ss_pred             eCCCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEeccCCCCHHHHHhhCCCCCCHHHHH
Q 007680          293 ISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERL  372 (593)
Q Consensus       293 ~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~  372 (593)
                      ..++.+|.|...+...........+-++.++.++||||+++++.++..+..|+|+|.+.  .|..++.+.    ....+.
T Consensus        34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l----~~~~v~  107 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL----GKEEVC  107 (690)
T ss_pred             eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh----HHHHHH
Confidence            44788999988876655445667888999999999999999999999999999999983  677777663    356677


Q ss_pred             HHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCccccccccCCccccCccccCCCCC
Q 007680          373 NIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIV  452 (593)
Q Consensus       373 ~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  452 (593)
                      -.+.||+.||.|||+.+   +++|++|.-+.|+|+..|..||++|.++........  ......--..|..|+.+.... 
T Consensus       108 ~Gl~qIl~AL~FL~~d~---~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~-  181 (690)
T KOG1243|consen  108 LGLFQILAALSFLNDDC---NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE-  181 (690)
T ss_pred             HHHHHHHHHHHHHhccC---CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc-
Confidence            78899999999999744   699999999999999999999999998765432211  011111222355565432222 


Q ss_pred             CccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccC
Q 007680          453 SAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCME  532 (593)
Q Consensus       453 s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~  532 (593)
                       -..|.|-||++++|++.|..+-......        ...+|....+.....+.....       ..+...+++..|...
T Consensus       182 -~s~D~~~Lg~li~el~ng~~~~~~~~~~--------~~~ipk~~~~~~~k~~~~~~~-------~r~n~~~~~~~~~~~  245 (690)
T KOG1243|consen  182 -WSIDSWGLGCLIEELFNGSLLTKTDLSN--------TGKIPKALIELYCKKLGATEL-------KRPNKLRFILECRLL  245 (690)
T ss_pred             -cchhhhhHHHHHHHHhCcccCcchhhhc--------cCccchhHHHHHHHHhccccc-------cccchhhHHHHHHhc
Confidence             3569999999999999994332211000        000110000000000000000       001145667777776


Q ss_pred             CCCCCCCHHHHHHHHHHhhhh
Q 007680          533 SPDMRINMTDAAAKLKKIKVK  553 (593)
Q Consensus       533 dP~~RPs~~evl~~L~~i~~~  553 (593)
                      -+--|=.+-+++..|++++-+
T Consensus       246 ~gff~n~fvd~~~fLeel~lk  266 (690)
T KOG1243|consen  246 GGFFRNDFVDTLLFLEELRLK  266 (690)
T ss_pred             cccccchHHHHHHHHHhcccC
Confidence            677777777777777776643

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.39  E-value=3.8e-13  Score=140.29  Aligned_cols=250  Identities=21%  Similarity=0.253  Sum_probs=182.6

Q ss_pred             hccccccccCc--cCcccEEEEEe---CCCCeEEEEEeehhhH--HHHHHHHHHHHHHhhc-CCCCcceeeeeeecCCce
Q 007680          272 DEFNECNLLGT--SSFGSVYKGTI---SDGTDVAIKVFNLQLE--RAFRSFDSECEVLRNV-RHRNLIKILSSYSNPDFK  343 (593)
Q Consensus       272 ~~~~~~~~lg~--G~~g~Vy~~~~---~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  343 (593)
                      ..+.+.+.+|.  |.+|.||.+..   .++..+|+|.-+....  .....=.+|+....++ .|+|.++.+..++.++..
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l  193 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL  193 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence            34667789999  99999999985   3688899998443221  2222234566666666 499999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCCCeEecCCCCCCeeeCCC-CcEEEEeec
Q 007680          344 ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGS----ALEYLHNGHSSVHIIHCDLKPTNILLDEN-MVAHVSDFG  418 (593)
Q Consensus       344 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~----~L~~LH~~~~~~~ivH~Dlkp~NIll~~~-~~~kL~Dfg  418 (593)
                      ++-+|++ +.+|.++.......++....+....+..+    |+.++|.    .+++|-|+||.||+...+ ...+++|||
T Consensus       194 fiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs----~~~~~~~~kp~~i~~~~~~~s~~~~df~  268 (524)
T KOG0601|consen  194 FIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHS----NNIVHDDLKPANIFTTSDWTSCKLTDFG  268 (524)
T ss_pred             eeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCC----CcccccccchhheecccccceeecCCcc
Confidence            9999999 57999988877666888889999999999    9999994    459999999999999999 899999999


Q ss_pred             cceecCCCCCccc---cccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCC
Q 007680          419 IYKLLGEGEDSVR---QTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPH  495 (593)
Q Consensus       419 ~a~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~  495 (593)
                      +...+.+......   .....+...|++||. ..+.++.++|+|++|.++.+..++..+.......     .|..     
T Consensus       269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~-~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~-----~W~~-----  337 (524)
T KOG0601|consen  269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKEL-LNGLATFASDIFSLGEVILEAILGSHLPSVGKNS-----SWSQ-----  337 (524)
T ss_pred             eeEEccCCccccceeeeecCCCCceEeChhh-hccccchHhhhcchhhhhHhhHhhcccccCCCCC-----Cccc-----
Confidence            9998876542211   112257788999997 4567889999999999999999987765431100     1110     


Q ss_pred             chhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          496 GLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       496 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                           ++......    +.......++...+.+|++.+|..|++.+.+.++
T Consensus       338 -----~r~~~ip~----e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l  379 (524)
T KOG0601|consen  338 -----LRQGYIPL----EFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL  379 (524)
T ss_pred             -----cccccCch----hhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence                 00000000    0011112345558899999999999998877653

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=99.37  E-value=2e-14  Score=154.57  Aligned_cols=155  Identities=30%  Similarity=0.415  Sum_probs=81.9

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLL   80 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~   80 (593)
                      |+++|+|+|+++ .+|+++.. +++|+.|...+|+|+ .+|..+...++|+.|++.+|.++ .+|....++.+|++|+|.
T Consensus       243 l~~~dis~n~l~-~lp~wi~~-~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~  318 (1081)
T KOG0618|consen  243 LQYLDISHNNLS-NLPEWIGA-CANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQ  318 (1081)
T ss_pred             ceeeecchhhhh-cchHHHHh-cccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeeh
Confidence            578888999988 78877775 888888888888886 44444444444444444444444 233333333333333332


Q ss_pred             cce------------------------------------------eeccCCccccc-CCCc---ccccEEEccCCcccCc
Q 007680           81 MFG------------------------------------------IRLTGNKLYGR-IPPC---LVLTVLDVSRNQLSGD  114 (593)
Q Consensus        81 ~n~------------------------------------------l~l~~n~l~~~-~~~~---~~L~~L~l~~N~l~~~  114 (593)
                      .|.                                          +++.+|.|+.. +|-+   ..|+.|+|++|+|...
T Consensus       319 ~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~f  398 (1081)
T KOG0618|consen  319 SNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSF  398 (1081)
T ss_pred             hccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccC
Confidence            111                                          23445554432 2222   1266666666666522


Q ss_pred             CCCCCCCCCCCCEecCCCccCCCCCCccccCCcccccccccccccc
Q 007680          115 IPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLS  160 (593)
Q Consensus       115 ~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~~N~l~  160 (593)
                      +...+.++..|++|+|++|+|+ .+|..+..++.|++|...+|++.
T Consensus       399 pas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~  443 (1081)
T KOG0618|consen  399 PASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL  443 (1081)
T ss_pred             CHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee
Confidence            2233455555556666666555 44444444444444444444443

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.36  E-value=8.5e-13  Score=146.85  Aligned_cols=137  Identities=26%  Similarity=0.453  Sum_probs=96.2

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLL   80 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~   80 (593)
                      |+.|+|++|+|+ .+|..++   ++|+.|+|++|+|+ .+|..+.  .+|+.|+|++|++. .+|..+.  .+|+.|   
T Consensus       201 L~~L~Ls~N~Lt-sLP~~l~---~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L---  267 (754)
T PRK15370        201 ITTLILDNNELK-SLPENLQ---GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSL---  267 (754)
T ss_pred             CcEEEecCCCCC-cCChhhc---cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEE---
Confidence            578999999999 8998775   49999999999999 6787664  47999999999999 6777665  478888   


Q ss_pred             cceeeccCCcccccCCCc--ccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCccccCCcccccccccccc
Q 007680           81 MFGIRLTGNKLYGRIPPC--LVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNN  158 (593)
Q Consensus        81 ~n~l~l~~n~l~~~~~~~--~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~~N~  158 (593)
                          ++++|+|. .+|..  .+|+.|++++|+|+ .+|..+.  .+|+.|++++|+++ .+|..+.  ++|+.|++++|+
T Consensus       268 ----~Ls~N~L~-~LP~~l~~sL~~L~Ls~N~Lt-~LP~~lp--~sL~~L~Ls~N~Lt-~LP~~l~--~sL~~L~Ls~N~  336 (754)
T PRK15370        268 ----DLFHNKIS-CLPENLPEELRYLSVYDNSIR-TLPAHLP--SGITHLNVQSNSLT-ALPETLP--PGLKTLEAGENA  336 (754)
T ss_pred             ----ECcCCccC-ccccccCCCCcEEECCCCccc-cCcccch--hhHHHHHhcCCccc-cCCcccc--ccceeccccCCc
Confidence                66666666 34432  24888888888887 4554432  34555666666665 3443322  345555555555


Q ss_pred             ccC
Q 007680          159 LSG  161 (593)
Q Consensus       159 l~~  161 (593)
                      +++
T Consensus       337 Lt~  339 (754)
T PRK15370        337 LTS  339 (754)
T ss_pred             ccc
Confidence            554

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.35  E-value=3.2e-12  Score=136.76  Aligned_cols=144  Identities=19%  Similarity=0.233  Sum_probs=94.3

Q ss_pred             hhccccccccCccCcccEEEEEeCC-CCeEEEEEeehhhHH----------------------------------HHH--
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTISD-GTDVAIKVFNLQLER----------------------------------AFR--  313 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~----------------------------------~~~--  313 (593)
                      -.+|+. +.||+|++|.||+|+.++ |+.||||+.++....                                  ..+  
T Consensus       119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l  197 (537)
T PRK04750        119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL  197 (537)
T ss_pred             HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence            445776 799999999999999886 999999999754210                                  011  


Q ss_pred             ----HHHHHHHHHhhcC----CCCcceeeeeee-cCCceEEEEeccCCCCHHHHH--hhCCC---CCCHHHHHHHHHHHH
Q 007680          314 ----SFDSECEVLRNVR----HRNLIKILSSYS-NPDFKALVLEFMPNGSLEKWL--YSHNY---FLDILERLNIMIDVG  379 (593)
Q Consensus       314 ----~~~~E~~~l~~l~----h~niv~l~~~~~-~~~~~~lv~e~~~~gsL~~~l--~~~~~---~l~~~~~~~i~~~i~  379 (593)
                          ++.+|+..+.+++    +.+.+.+-.++. .....++||||++|+++.++-  ...+.   .+....+..++.|+ 
T Consensus       198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-  276 (537)
T PRK04750        198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-  276 (537)
T ss_pred             HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-
Confidence                1334444444442    333333333332 234568999999999998753  22221   12222223333333 


Q ss_pred             HHHHHHHhcCCCCCeEecCCCCCCeeeCCCC----cEEEEeeccceecCCC
Q 007680          380 SALEYLHNGHSSVHIIHCDLKPTNILLDENM----VAHVSDFGIYKLLGEG  426 (593)
Q Consensus       380 ~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~----~~kL~Dfg~a~~~~~~  426 (593)
                            +.    .|++|+|+||.||+++.++    .++++|||++..+...
T Consensus       277 ------f~----~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~  317 (537)
T PRK04750        277 ------FR----DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE  317 (537)
T ss_pred             ------Hh----CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence                  32    3599999999999999888    9999999999887543

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.35  E-value=2.6e-12  Score=142.29  Aligned_cols=139  Identities=28%  Similarity=0.384  Sum_probs=92.2

Q ss_pred             cEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhhc
Q 007680            2 RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLM   81 (593)
Q Consensus         2 ~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~   81 (593)
                      ..|||++|+|+ .+|..+.   ++|+.|+|++|+|+ .+|..   +++|++|+|++|+|+ .+|..   .++|+.|+|++
T Consensus       204 ~~LdLs~~~Lt-sLP~~l~---~~L~~L~L~~N~Lt-~LP~l---p~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~Ls~  271 (788)
T PRK15387        204 AVLNVGESGLT-TLPDCLP---AHITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQLT-SLPVL---PPGLLELSIFS  271 (788)
T ss_pred             cEEEcCCCCCC-cCCcchh---cCCCEEEccCCcCC-CCCCC---CCCCcEEEecCCccC-cccCc---ccccceeeccC
Confidence            46899999998 8998775   37899999999999 56753   578999999999998 45543   34677776655


Q ss_pred             ce-------------eeccCCcccccCCCc-ccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCccccCCc
Q 007680           82 FG-------------IRLTGNKLYGRIPPC-LVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLI  147 (593)
Q Consensus        82 n~-------------l~l~~n~l~~~~~~~-~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~  147 (593)
                      |.             +++++|++. .+|.. .+|+.|+|++|+|++ +|...   .+|+.|++++|+|+ .+|..   ..
T Consensus       272 N~L~~Lp~lp~~L~~L~Ls~N~Lt-~LP~~p~~L~~LdLS~N~L~~-Lp~lp---~~L~~L~Ls~N~L~-~LP~l---p~  342 (788)
T PRK15387        272 NPLTHLPALPSGLCKLWIFGNQLT-SLPVLPPGLQELSVSDNQLAS-LPALP---SELCKLWAYNNQLT-SLPTL---PS  342 (788)
T ss_pred             CchhhhhhchhhcCEEECcCCccc-cccccccccceeECCCCcccc-CCCCc---ccccccccccCccc-ccccc---cc
Confidence            53             356677766 33332 347788888887774 44321   23555556666655 34431   13


Q ss_pred             cccccccccccccC
Q 007680          148 SLESLDLSGNNLSG  161 (593)
Q Consensus       148 ~L~~L~l~~N~l~~  161 (593)
                      +|+.|+|++|+|++
T Consensus       343 ~Lq~LdLS~N~Ls~  356 (788)
T PRK15387        343 GLQELSVSDNQLAS  356 (788)
T ss_pred             ccceEecCCCccCC
Confidence            56667777777665

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.32  E-value=8.7e-14  Score=142.44  Aligned_cols=144  Identities=26%  Similarity=0.397  Sum_probs=98.4

Q ss_pred             EEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhhcc
Q 007680            3 ILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLMF   82 (593)
Q Consensus         3 ~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n   82 (593)
                      .|.|++|.+. .+|..+.+ |..|+.|||+.|+++ .+|..++.|+ |+.|-+++|+++ .+|+.++.+..|..|     
T Consensus       102 ~liLy~n~~r-~ip~~i~~-L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~l-----  171 (722)
T KOG0532|consen  102 SLILYHNCIR-TIPEAICN-LEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHL-----  171 (722)
T ss_pred             HHHHHhccce-ecchhhhh-hhHHHHhhhccchhh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHh-----
Confidence            3445555555 55555554 666667777777776 6666666665 667777777776 666667766667766     


Q ss_pred             eeeccCCcccccCCC---cccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCccccCCccccccccccccc
Q 007680           83 GIRLTGNKLYGRIPP---CLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNL  159 (593)
Q Consensus        83 ~l~l~~n~l~~~~~~---~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~~N~l  159 (593)
                        |.+.|.+....+.   +.+|+.|.+..|++. .+|.+++.| .|..||++.|+++ .+|-.|..|..|++|.|.+|++
T Consensus       172 --d~s~nei~slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPL  246 (722)
T KOG0532|consen  172 --DVSKNEIQSLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPL  246 (722)
T ss_pred             --hhhhhhhhhchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCcee-ecchhhhhhhhheeeeeccCCC
Confidence              6666666533332   334677777777777 567677754 4788888888887 7888888888888888888888


Q ss_pred             cC
Q 007680          160 SG  161 (593)
Q Consensus       160 ~~  161 (593)
                      +.
T Consensus       247 qS  248 (722)
T KOG0532|consen  247 QS  248 (722)
T ss_pred             CC
Confidence            74

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.32  E-value=5.9e-12  Score=116.25  Aligned_cols=131  Identities=18%  Similarity=0.196  Sum_probs=96.7

Q ss_pred             ccccCccCcccEEEEEeCCCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcc-eeeeeeecCCceEEEEeccCCCCH
Q 007680          277 CNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLI-KILSSYSNPDFKALVLEFMPNGSL  355 (593)
Q Consensus       277 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~gsL  355 (593)
                      ++.++.|.++.||+++.. ++.|++|+...... ....+..|+.+++.+.+.+++ +++.+.  .+..++||||++|.++
T Consensus         3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l   78 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL   78 (170)
T ss_pred             eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence            467899999999999875 77899999765432 123467899999998655544 455443  2345899999999887


Q ss_pred             HHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCCeEecCCCCCCeeeCCCCcEEEEeeccce
Q 007680          356 EKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHS-SVHIIHCDLKPTNILLDENMVAHVSDFGIYK  421 (593)
Q Consensus       356 ~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~  421 (593)
                      .+.    .     .....++.+++++|+.||+.+. ..+++|+|++|.||+++ ++.++++|||.+.
T Consensus        79 ~~~----~-----~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          79 LTE----D-----FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             ccc----c-----ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            653    0     1123456789999999996541 22369999999999999 6689999999865

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=99.31  E-value=2.2e-13  Score=146.69  Aligned_cols=147  Identities=31%  Similarity=0.442  Sum_probs=111.2

Q ss_pred             CcEEEeeCccccccCChhhhhC-------------------------CCCCcEEECCCCcCcccCCccCCCCCCCcEEEc
Q 007680            1 MRILTLEGNQLSGRLPSTIGHS-------------------------LPNIEYLLLTANNLTGTIPNSITNATKLIVLDL   55 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~-------------------------l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L   55 (593)
                      |++|||..|+|. .+|+.++.-                         ++.|+.|+|.+|.|+...=+.|.+.++|+.|+|
T Consensus       312 L~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhL  390 (1081)
T KOG0618|consen  312 LRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHL  390 (1081)
T ss_pred             eeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeee
Confidence            578899999997 788766531                         233677888888888665566788888999999


Q ss_pred             cCCcccccccccccCCCCchhhhhhcceeeccCCcccccCC----CcccccEEEccCCcccCcCCCCCCCCCCCCEecCC
Q 007680           56 GFNSFSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIP----PCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLA  131 (593)
Q Consensus        56 ~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~l~~n~l~~~~~----~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~  131 (593)
                      ++|+|...+...+.++..|++|       +|++|+|+ .+|    .+..|++|...+|+|. ..| .+..++.|+.+|++
T Consensus       391 syNrL~~fpas~~~kle~LeeL-------~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS  460 (1081)
T KOG0618|consen  391 SYNRLNSFPASKLRKLEELEEL-------NLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLS  460 (1081)
T ss_pred             cccccccCCHHHHhchHHhHHH-------hcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecc
Confidence            9999884444468888888888       77888877 333    3445888888999888 677 78888889999999


Q ss_pred             CccCCCC-CCccccCCccccccccccccc
Q 007680          132 SNQFQGP-IPESVGSLISLESLDLSGNNL  159 (593)
Q Consensus       132 ~N~l~~~-~p~~l~~~~~L~~L~l~~N~l  159 (593)
                      .|+|+.. +|... .-++|++||+++|..
T Consensus       461 ~N~L~~~~l~~~~-p~p~LkyLdlSGN~~  488 (1081)
T KOG0618|consen  461 CNNLSEVTLPEAL-PSPNLKYLDLSGNTR  488 (1081)
T ss_pred             cchhhhhhhhhhC-CCcccceeeccCCcc
Confidence            9988743 34333 337889999998885

>PLN03150 hypothetical protein; Provisional

Probab=99.27  E-value=6.9e-12  Score=138.85  Aligned_cols=105  Identities=33%  Similarity=0.570  Sum_probs=79.7

Q ss_pred             CcEEEccCCcccccccccccCCCCchhhhhhcceeeccCCcccccCCC----cccccEEEccCCcccCcCCCCCCCCCCC
Q 007680           50 LIVLDLGFNSFSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPP----CLVLTVLDVSRNQLSGDIPSTIGGRVDL  125 (593)
Q Consensus        50 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~l~~n~l~~~~~~----~~~L~~L~l~~N~l~~~~p~~~~~l~~L  125 (593)
                      ++.|+|++|.+++.+|..++.|++|+.|       +|++|++.|.+|.    +..|+.|+|++|+++|.+|..++++++|
T Consensus       420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L-------~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L  492 (623)
T PLN03150        420 IDGLGLDNQGLRGFIPNDISKLRHLQSI-------NLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSL  492 (623)
T ss_pred             EEEEECCCCCccccCCHHHhCCCCCCEE-------ECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCC
Confidence            5566666666666666666666666666       5556666555443    3347788999999999999999999999


Q ss_pred             CEecCCCccCCCCCCccccCC-ccccccccccccccC
Q 007680          126 ETLSLASNQFQGPIPESVGSL-ISLESLDLSGNNLSG  161 (593)
Q Consensus       126 ~~L~l~~N~l~~~~p~~l~~~-~~L~~L~l~~N~l~~  161 (593)
                      +.|+|++|+++|.+|..+... .++..+++++|+...
T Consensus       493 ~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc  529 (623)
T PLN03150        493 RILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLC  529 (623)
T ss_pred             CEEECcCCcccccCChHHhhccccCceEEecCCcccc
Confidence            999999999999999988764 467788999997543

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.26  E-value=1.2e-12  Score=134.10  Aligned_cols=144  Identities=28%  Similarity=0.370  Sum_probs=123.5

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLL   80 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~   80 (593)
                      |+.|||+.|+++ .+|..++. | -|+.|-+++|+++ .+|+.++.+..|..||.+.|.+. .+|..++.+.+|+.|   
T Consensus       123 lt~l~ls~NqlS-~lp~~lC~-l-pLkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l---  194 (722)
T KOG0532|consen  123 LTFLDLSSNQLS-HLPDGLCD-L-PLKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDL---  194 (722)
T ss_pred             HHHhhhccchhh-cCChhhhc-C-cceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHH---
Confidence            567899999999 99999995 5 7999999999999 89999999999999999999999 788899999999999   


Q ss_pred             cceeeccCCcccccCCCc--ccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCccccCCcc---ccccccc
Q 007680           81 MFGIRLTGNKLYGRIPPC--LVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLIS---LESLDLS  155 (593)
Q Consensus        81 ~n~l~l~~n~l~~~~~~~--~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~---L~~L~l~  155 (593)
                          .+..|.+....+.+  ..|..||+|.|+++ .+|-.|..|+.|++|-|.+|.|. .+|..+.-..+   .++|+.+
T Consensus       195 ----~vrRn~l~~lp~El~~LpLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC~kGkVHIFKyL~~q  268 (722)
T KOG0532|consen  195 ----NVRRNHLEDLPEELCSLPLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQICEKGKVHIFKYLSTQ  268 (722)
T ss_pred             ----HHhhhhhhhCCHHHhCCceeeeecccCcee-ecchhhhhhhhheeeeeccCCCC-CChHHHHhccceeeeeeecch
Confidence                66677776333332  23899999999999 89999999999999999999998 77877654433   5777777


Q ss_pred             ccc
Q 007680          156 GNN  158 (593)
Q Consensus       156 ~N~  158 (593)
                      -.+
T Consensus       269 A~q  271 (722)
T KOG0532|consen  269 ACQ  271 (722)
T ss_pred             hcc
Confidence            665

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.25  E-value=1.2e-10  Score=108.61  Aligned_cols=137  Identities=20%  Similarity=0.193  Sum_probs=99.1

Q ss_pred             ccccCccCcccEEEEEeCC-------CCeEEEEEeehhh------------H----------HHHHHH----HHHHHHHh
Q 007680          277 CNLLGTSSFGSVYKGTISD-------GTDVAIKVFNLQL------------E----------RAFRSF----DSECEVLR  323 (593)
Q Consensus       277 ~~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~------------~----------~~~~~~----~~E~~~l~  323 (593)
                      ...||.|--+.||.|...+       +..+|||+.+...            +          ...+.+    ++|.+.|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            3578999999999998543       4799999886421            0          011223    38999999


Q ss_pred             hcC--CCCcceeeeeeecCCceEEEEeccCCCCHHH-HHhhCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCCeEecCC
Q 007680          324 NVR--HRNLIKILSSYSNPDFKALVLEFMPNGSLEK-WLYSHNYFLDILERLNIMIDVGSALEYL-HNGHSSVHIIHCDL  399 (593)
Q Consensus       324 ~l~--h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~l~~~~~~~i~~~i~~~L~~L-H~~~~~~~ivH~Dl  399 (593)
                      ++.  .-++.+++++    ...++||||+.+..+.. .+...  .++..+...+..+++.+|..+ |+.    +++|||+
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~--~~~~~~~~~i~~~i~~~l~~l~H~~----glVHGDL  151 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA--KLNDEEMKNAYYQVLSMMKQLYKEC----NLVHADL  151 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc--ccCHHHHHHHHHHHHHHHHHHHHhC----CeecCCC
Confidence            994  3566667764    45689999997653322 22221  255566778889999999999 744    5999999


Q ss_pred             CCCCeeeCCCCcEEEEeeccceecC
Q 007680          400 KPTNILLDENMVAHVSDFGIYKLLG  424 (593)
Q Consensus       400 kp~NIll~~~~~~kL~Dfg~a~~~~  424 (593)
                      ++.||+++ ++.++++|||.+....
T Consensus       152 s~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         152 SEYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             CHHHEEEE-CCcEEEEECCCceeCC
Confidence            99999997 4679999999887653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.21  E-value=1.1e-12  Score=128.99  Aligned_cols=145  Identities=24%  Similarity=0.303  Sum_probs=96.9

Q ss_pred             EEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhhcc
Q 007680            3 ILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLMF   82 (593)
Q Consensus         3 ~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n   82 (593)
                      ..|.++-+|+ ++|.++.   +..+.++|..|+|+.+.|.+|..+++|+.||||+|+|+.+-|++|.++++|..|-    
T Consensus        50 ~VdCr~~GL~-eVP~~LP---~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lv----  121 (498)
T KOG4237|consen   50 IVDCRGKGLT-EVPANLP---PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLV----  121 (498)
T ss_pred             eEEccCCCcc-cCcccCC---CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHH----
Confidence            4677888898 8998875   4899999999999977777899999999999999999988899999999998772    


Q ss_pred             eeeccCCccc----ccCCCcccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCc-cccCCccccccccccc
Q 007680           83 GIRLTGNKLY----GRIPPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPE-SVGSLISLESLDLSGN  157 (593)
Q Consensus        83 ~l~l~~n~l~----~~~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~l~~~~~L~~L~l~~N  157 (593)
                        ..++|+|+    +.+..+.+|+.|.+.-|++.-+..++|..+++|..|.+-+|.+. .++. .|..+.+++.+.+..|
T Consensus       122 --lyg~NkI~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q-~i~~~tf~~l~~i~tlhlA~n  198 (498)
T KOG4237|consen  122 --LYGNNKITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQ-SICKGTFQGLAAIKTLHLAQN  198 (498)
T ss_pred             --hhcCCchhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhh-hhccccccchhccchHhhhcC
Confidence              12235544    22223333445555555554444444445555555555555554 2332 4444555555555444


Q ss_pred             c
Q 007680          158 N  158 (593)
Q Consensus       158 ~  158 (593)
                      +
T Consensus       199 p  199 (498)
T KOG4237|consen  199 P  199 (498)
T ss_pred             c
Confidence            4

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.18  E-value=2.8e-10  Score=102.32  Aligned_cols=131  Identities=21%  Similarity=0.303  Sum_probs=101.1

Q ss_pred             cccCccCcccEEEEEeCCCCeEEEEEeehhh--------HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEec
Q 007680          278 NLLGTSSFGSVYKGTISDGTDVAIKVFNLQL--------ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEF  349 (593)
Q Consensus       278 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  349 (593)
                      ..+++|+-+.+|.+.+. |.++++|.=.++.        .-....-.+|+.++.+++--.|...+=+..+++...|+|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            46789999999999875 5556776432211        11234567899999999766666655566788888999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeecccee
Q 007680          350 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKL  422 (593)
Q Consensus       350 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~  422 (593)
                      ++|..|.+.+...        ...++..+-.-+.-||.++    |+|+||.++||++..+. +.++|||++..
T Consensus        81 I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~g----ivHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          81 IEGELLKDALEEA--------RPDLLREVGRLVGKLHKAG----IVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             eCChhHHHHHHhc--------chHHHHHHHHHHHHHHhcC----eecCCCccceEEEeCCc-EEEEECCcccc
Confidence            9999999998765        2456777888888999655    99999999999998775 89999999764

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.18  E-value=1.4e-11  Score=128.74  Aligned_cols=252  Identities=19%  Similarity=0.159  Sum_probs=175.9

Q ss_pred             HHHhhhccccccccCccCcccEEEEEe--CCCCeEEEEEeehhhHHHH--HHHHHHHHHHhhc-CCCCcceeeeeeecCC
Q 007680          267 IQRATDEFNECNLLGTSSFGSVYKGTI--SDGTDVAIKVFNLQLERAF--RSFDSECEVLRNV-RHRNLIKILSSYSNPD  341 (593)
Q Consensus       267 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  341 (593)
                      ......+|..+..||.|.|+.|+....  .++..|++|.+........  ..-..|+.+...+ .|.++++....|..-.
T Consensus       260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r  339 (524)
T KOG0601|consen  260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR  339 (524)
T ss_pred             ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence            344566899999999999999999874  3688899998765432211  1223456555555 5899999888887777


Q ss_pred             ceEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCC-CcEEEEeeccc
Q 007680          342 FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDEN-MVAHVSDFGIY  420 (593)
Q Consensus       342 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~-~~~kL~Dfg~a  420 (593)
                      ..++--|||+++++...+.... .+++..++++..|++.++.++|    ++.++|+|+||+||++..+ +..+++|||.+
T Consensus       340 ~~~ip~e~~~~~s~~l~~~~~~-~~d~~~~~~~~~q~~~~l~~i~----s~~~~~~d~~psni~i~~~~~~~~~~~~~~~  414 (524)
T KOG0601|consen  340 QGYIPLEFCEGGSSSLRSVTSQ-MLDEDPRLRLTAQILTALNVIH----SKLFVHLDVKPSNILISNDGFFSKLGDFGCW  414 (524)
T ss_pred             cccCchhhhcCcchhhhhHHHH-hcCcchhhhhHHHHHhcccccc----chhhhcccccccceeeccchhhhhccccccc
Confidence            7889999999998877663322 3778889999999999999999    5669999999999999886 78899999998


Q ss_pred             eecCCCCCccccccccCCccc-cCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhh
Q 007680          421 KLLGEGEDSVRQTMTMATIGY-MAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTE  499 (593)
Q Consensus       421 ~~~~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  499 (593)
                      ..+.-..    ......+..| .+|+......+..++|+||||..+.+..++..--....       .|.         .
T Consensus       415 t~~~~~~----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~-------~~~---------~  474 (524)
T KOG0601|consen  415 TRLAFSS----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV-------QSL---------T  474 (524)
T ss_pred             cccceec----ccccccccccccchhhccccccccccccccccccccccccCcccCcccc-------cce---------e
Confidence            7532111    1111233334 35555566678899999999999999999875422210       000         0


Q ss_pred             hhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHh
Q 007680          500 VVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKI  550 (593)
Q Consensus       500 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  550 (593)
                      +. ..      ..+........+..+.+.+...++..||.+.++..+....
T Consensus       475 i~-~~------~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~  518 (524)
T KOG0601|consen  475 IR-SG------DTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY  518 (524)
T ss_pred             ee-cc------cccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence            00 00      0000111124567788888899999999998887665443

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.17  E-value=1.8e-10  Score=111.24  Aligned_cols=144  Identities=21%  Similarity=0.204  Sum_probs=111.1

Q ss_pred             ccccCccCcccEEEEEeCCCCeEEEEEeehhhH-HHHHHHHHHHHHHhhcCC--CCcceeeeeeecC---CceEEEEecc
Q 007680          277 CNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLE-RAFRSFDSECEVLRNVRH--RNLIKILSSYSNP---DFKALVLEFM  350 (593)
Q Consensus       277 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~---~~~~lv~e~~  350 (593)
                      .+.|+.|.++.||++...+|+.+++|....... .....+..|+++++.+++  .++.+++.+....   +..++||||+
T Consensus         3 ~~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i   82 (223)
T cd05154           3 VRQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV   82 (223)
T ss_pred             ceecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence            357899999999999987678999999765422 134578899999999965  4456777776654   3668999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------------
Q 007680          351 PNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGH-----------------------------------------  389 (593)
Q Consensus       351 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-----------------------------------------  389 (593)
                      +|.++.+.+..  ..++..+...++.+++++|..||+..                                         
T Consensus        83 ~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (223)
T cd05154          83 DGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL  160 (223)
T ss_pred             CCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence            99888776532  23677788888889999998888521                                         


Q ss_pred             -----------CCCCeEecCCCCCCeeeCC--CCcEEEEeecccee
Q 007680          390 -----------SSVHIIHCDLKPTNILLDE--NMVAHVSDFGIYKL  422 (593)
Q Consensus       390 -----------~~~~ivH~Dlkp~NIll~~--~~~~kL~Dfg~a~~  422 (593)
                                 ....++|+|++|.||+++.  ++.+.++||+.+..
T Consensus       161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                       0245799999999999998  66789999997753

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.16  E-value=3.9e-10  Score=100.76  Aligned_cols=142  Identities=20%  Similarity=0.267  Sum_probs=107.2

Q ss_pred             cccccCccCcccEEEEEeCCCCeEEEEEe-ehh-------hHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEE
Q 007680          276 ECNLLGTSSFGSVYKGTISDGTDVAIKVF-NLQ-------LERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVL  347 (593)
Q Consensus       276 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~-~~~-------~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  347 (593)
                      .+..+-+|+-+.|+++.+. |+..+||.= .+.       ..-..++..+|++++.+++--.|.-..=++.+...-.++|
T Consensus        11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            4678899999999999985 777777642 221       1223456788999999997555555555666777778999


Q ss_pred             eccCC-CCHHHHHhhCCCCCCHHHH-HHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC---cEEEEeecccee
Q 007680          348 EFMPN-GSLEKWLYSHNYFLDILER-LNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENM---VAHVSDFGIYKL  422 (593)
Q Consensus       348 e~~~~-gsL~~~l~~~~~~l~~~~~-~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~---~~kL~Dfg~a~~  422 (593)
                      ||++| .++.+++......-...+. ..++.+|-+.+.-||.++    |+||||..+||++.+++   .+.++|||++..
T Consensus        90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd----iiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND----IIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC----eecccccccceEEecCCCcCceEEEeecchhc
Confidence            99977 4788888775543333333 788999999999999665    99999999999997655   458999998764

>PLN03210 Resistant to P

Probab=99.16  E-value=1.1e-10  Score=138.61  Aligned_cols=161  Identities=21%  Similarity=0.269  Sum_probs=94.8

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLL   80 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~   80 (593)
                      |+.|+|++|+|. .+|.++.. +++|+.|+|++|...+.+|+ ++.+++|+.|+|++|.....+|..++.+++|+.|+++
T Consensus       613 L~~L~L~~s~l~-~L~~~~~~-l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~  689 (1153)
T PLN03210        613 LVKLQMQGSKLE-KLWDGVHS-LTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMS  689 (1153)
T ss_pred             CcEEECcCcccc-cccccccc-CCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCC
Confidence            456677777776 66666653 77777777776543335553 6667777777777665444667777777777777554


Q ss_pred             cce----------------eeccCCcccccCCCcc-cccEEEccCCcccCcCCCCC------------------------
Q 007680           81 MFG----------------IRLTGNKLYGRIPPCL-VLTVLDVSRNQLSGDIPSTI------------------------  119 (593)
Q Consensus        81 ~n~----------------l~l~~n~l~~~~~~~~-~L~~L~l~~N~l~~~~p~~~------------------------  119 (593)
                      ++.                +++++|...+.+|... +|++|++++|.+. .+|..+                        
T Consensus       690 ~c~~L~~Lp~~i~l~sL~~L~Lsgc~~L~~~p~~~~nL~~L~L~~n~i~-~lP~~~~l~~L~~L~l~~~~~~~l~~~~~~  768 (1153)
T PLN03210        690 RCENLEILPTGINLKSLYRLNLSGCSRLKSFPDISTNISWLDLDETAIE-EFPSNLRLENLDELILCEMKSEKLWERVQP  768 (1153)
T ss_pred             CCCCcCccCCcCCCCCCCEEeCCCCCCccccccccCCcCeeecCCCccc-cccccccccccccccccccchhhccccccc
Confidence            321                2333333223333222 3666666666655 344321                        


Q ss_pred             ------CCCCCCCEecCCCccCCCCCCccccCCccccccccccccccCCCCC
Q 007680          120 ------GGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPK  165 (593)
Q Consensus       120 ------~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~~N~l~~~~p~  165 (593)
                            ...++|+.|+|++|+..+.+|..++++++|+.|++++|+..+.+|.
T Consensus       769 l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~  820 (1153)
T PLN03210        769 LTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPT  820 (1153)
T ss_pred             cchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCC
Confidence                  0123566677777765556777777777777777777654444444

syringae 6; Provisional

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.15  E-value=1.9e-11  Score=128.98  Aligned_cols=150  Identities=36%  Similarity=0.613  Sum_probs=119.1

Q ss_pred             CcEEEeeCccccccCChhhhhCCC-CCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLP-NIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSL   79 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l   79 (593)
                      ++.|++.+|.++ .+|..... ++ +|+.|++++|+|. .+|..+..+++|+.|++++|+++ .+|...+.+++|+.|  
T Consensus       118 l~~L~l~~n~i~-~i~~~~~~-~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L--  191 (394)
T COG4886         118 LTSLDLDNNNIT-DIPPLIGL-LKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNL--  191 (394)
T ss_pred             eeEEecCCcccc-cCcccccc-chhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhhe--
Confidence            467899999999 89987764 64 8999999999999 77788899999999999999999 666666678888888  


Q ss_pred             hcceeeccCCcccccCCC---ccc-ccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCccccCCccccccccc
Q 007680           80 LMFGIRLTGNKLYGRIPP---CLV-LTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLS  155 (593)
Q Consensus        80 ~~n~l~l~~n~l~~~~~~---~~~-L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~  155 (593)
                           ++++|++. .+|.   ..+ |++|++++|.+. ..+..+..+.++..+.+.+|++. .++..++.++.++.|+++
T Consensus       192 -----~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s  263 (394)
T COG4886         192 -----DLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLS  263 (394)
T ss_pred             -----eccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-eccchhccccccceeccc
Confidence                 77888877 4444   233 888888888654 46667788888888888888887 457777888888888888


Q ss_pred             cccccCCCC
Q 007680          156 GNNLSGKIP  164 (593)
Q Consensus       156 ~N~l~~~~p  164 (593)
                      +|.++.+.+
T Consensus       264 ~n~i~~i~~  272 (394)
T COG4886         264 NNQISSISS  272 (394)
T ss_pred             ccccccccc
Confidence            888886543

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.15  E-value=4.5e-12  Score=120.41  Aligned_cols=129  Identities=29%  Similarity=0.386  Sum_probs=92.9

Q ss_pred             CCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhhcceeeccCCcccccC---CCcc
Q 007680           23 LPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRI---PPCL   99 (593)
Q Consensus        23 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~l~~n~l~~~~---~~~~   99 (593)
                      .+.|++|+||+|.|+ .+.+...=++.++.|++|+|.|. .+.. +..|++|+.|       ||++|.++..-   -.+.
T Consensus       283 Wq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~n-La~L~~L~~L-------DLS~N~Ls~~~Gwh~KLG  352 (490)
T KOG1259|consen  283 WQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQN-LAELPQLQLL-------DLSGNLLAECVGWHLKLG  352 (490)
T ss_pred             Hhhhhhccccccchh-hhhhhhhhccceeEEecccccee-eehh-hhhcccceEe-------ecccchhHhhhhhHhhhc
Confidence            456777788888877 66666667777888888888877 3433 7777777777       67777766221   1233


Q ss_pred             cccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCC-CCccccCCccccccccccccccCCC
Q 007680          100 VLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGP-IPESVGSLISLESLDLSGNNLSGKI  163 (593)
Q Consensus       100 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~-~p~~l~~~~~L~~L~l~~N~l~~~~  163 (593)
                      +.+.|.|++|.|. .+. .++.+-+|..||+.+|+|... .-..+++++-|+.+.|.+|++++++
T Consensus       353 NIKtL~La~N~iE-~LS-GL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~v  415 (490)
T KOG1259|consen  353 NIKTLKLAQNKIE-TLS-GLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSV  415 (490)
T ss_pred             CEeeeehhhhhHh-hhh-hhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccc
Confidence            4788899999886 454 477778899999999998732 1234788888999999999998744

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.15  E-value=1.4e-11  Score=112.54  Aligned_cols=134  Identities=25%  Similarity=0.286  Sum_probs=45.7

Q ss_pred             EeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCC-CCCCCcEEEccCCcccccccccccCCCCchhhhhhcce
Q 007680            5 TLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSIT-NATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLMFG   83 (593)
Q Consensus         5 ~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~   83 (593)
                      .|..+.|. .+|....  ..++++|+|++|+|+ .+. .++ .+.+|+.|+|++|.|+. ++ .|..+++|++|      
T Consensus         3 ~lt~~~i~-~~~~~~n--~~~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~~-l~-~l~~L~~L~~L------   69 (175)
T PF14580_consen    3 RLTANMIE-QIAQYNN--PVKLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQITK-LE-GLPGLPRLKTL------   69 (175)
T ss_dssp             --------------------------------------S--TT-TT--EEE-TTS--S---T-T----TT--EE------
T ss_pred             cccccccc-ccccccc--ccccccccccccccc-ccc-chhhhhcCCCEEECCCCCCcc-cc-CccChhhhhhc------
Confidence            45566666 5665432  457788888888888 343 455 57888888888888884 43 47778888888      


Q ss_pred             eeccCCccccc---C-CCcccccEEEccCCcccCcCC--CCCCCCCCCCEecCCCccCCCCCCcc----ccCCccccccc
Q 007680           84 IRLTGNKLYGR---I-PPCLVLTVLDVSRNQLSGDIP--STIGGRVDLETLSLASNQFQGPIPES----VGSLISLESLD  153 (593)
Q Consensus        84 l~l~~n~l~~~---~-~~~~~L~~L~l~~N~l~~~~p--~~~~~l~~L~~L~l~~N~l~~~~p~~----l~~~~~L~~L~  153 (593)
                       ++++|+++..   + ..+.+|++|++++|+|.. +.  ..+..+++|+.|+|.+|+++ ..+..    +..+++|+.||
T Consensus        70 -~L~~N~I~~i~~~l~~~lp~L~~L~L~~N~I~~-l~~l~~L~~l~~L~~L~L~~NPv~-~~~~YR~~vi~~lP~Lk~LD  146 (175)
T PF14580_consen   70 -DLSNNRISSISEGLDKNLPNLQELYLSNNKISD-LNELEPLSSLPKLRVLSLEGNPVC-EKKNYRLFVIYKLPSLKVLD  146 (175)
T ss_dssp             -E--SS---S-CHHHHHH-TT--EEE-TTS---S-CCCCGGGGG-TT--EEE-TT-GGG-GSTTHHHHHHHH-TT-SEET
T ss_pred             -ccCCCCCCccccchHHhCCcCCEEECcCCcCCC-hHHhHHHHcCCCcceeeccCCccc-chhhHHHHHHHHcChhheeC
Confidence             6777777632   1 124568899999999873 33  23567899999999999998 34432    66789999998


Q ss_pred             c
Q 007680          154 L  154 (593)
Q Consensus       154 l  154 (593)
                      -
T Consensus       147 ~  147 (175)
T PF14580_consen  147 G  147 (175)
T ss_dssp             T
T ss_pred             C
Confidence            3

>PLN03210 Resistant to P

Probab=99.15  E-value=1.2e-10  Score=138.17  Aligned_cols=159  Identities=28%  Similarity=0.313  Sum_probs=105.8

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLL   80 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~   80 (593)
                      |+.|+|++|.....+|. +. .+++|+.|+|++|.....+|..+.++++|+.|+|++|..-..+|..+ ++++|+.|+++
T Consensus       636 Lk~L~Ls~~~~l~~ip~-ls-~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Ls  712 (1153)
T PLN03210        636 LRNIDLRGSKNLKEIPD-LS-MATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYRLNLS  712 (1153)
T ss_pred             CCEEECCCCCCcCcCCc-cc-cCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCCEEeCC
Confidence            56777877653336764 43 37778888887766555777777777778888877754333555544 56666666665


Q ss_pred             cce--------------eeccCCcccccCCC----------------------------------cccccEEEccCCccc
Q 007680           81 MFG--------------IRLTGNKLYGRIPP----------------------------------CLVLTVLDVSRNQLS  112 (593)
Q Consensus        81 ~n~--------------l~l~~n~l~~~~~~----------------------------------~~~L~~L~l~~N~l~  112 (593)
                      ++.              +++++|.+. .+|.                                  ..+|+.|+|++|...
T Consensus       713 gc~~L~~~p~~~~nL~~L~L~~n~i~-~lP~~~~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l  791 (1153)
T PLN03210        713 GCSRLKSFPDISTNISWLDLDETAIE-EFPSNLRLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSL  791 (1153)
T ss_pred             CCCCccccccccCCcCeeecCCCccc-cccccccccccccccccccchhhccccccccchhhhhccccchheeCCCCCCc
Confidence            432              455556543 2221                                  124888999999877


Q ss_pred             CcCCCCCCCCCCCCEecCCCccCCCCCCccccCCccccccccccccccCCCC
Q 007680          113 GDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIP  164 (593)
Q Consensus       113 ~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~~N~l~~~~p  164 (593)
                      +.+|..++++++|+.|++++|..-+.+|..+ ++++|+.|++++|......|
T Consensus       792 ~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p  842 (1153)
T PLN03210        792 VELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFP  842 (1153)
T ss_pred             cccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccc
Confidence            7899999999999999999875434677665 67777777777765444443

syringae 6; Provisional

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.14  E-value=2.4e-11  Score=128.34  Aligned_cols=145  Identities=34%  Similarity=0.364  Sum_probs=82.3

Q ss_pred             EEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCC-CCcEEEccCCcccccccccccCCCCchhhhhhcc
Q 007680            4 LTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNAT-KLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLMF   82 (593)
Q Consensus         4 L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n   82 (593)
                      |+++.|.+. .-+..+.. ++.++.|++.+|.++ .+|.....+. +|+.|++++|++. .+|..++.+++|+.|     
T Consensus        98 l~~~~~~~~-~~~~~~~~-~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L-----  168 (394)
T COG4886          98 LDLNLNRLR-SNISELLE-LTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNL-----  168 (394)
T ss_pred             eeccccccc-cCchhhhc-ccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhcccccccc-----
Confidence            555555553 22333332 456666666666666 4555555553 6666666666666 454556666666666     


Q ss_pred             eeeccCCcccccCC---CcccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCccccCCccccccccccccc
Q 007680           83 GIRLTGNKLYGRIP---PCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNL  159 (593)
Q Consensus        83 ~l~l~~n~l~~~~~---~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~~N~l  159 (593)
                        +++.|++...-+   ....|+.|++++|+++ .+|.....+..|++|++++|++. ..+..+.++.++..+.+++|++
T Consensus       169 --~l~~N~l~~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~  244 (394)
T COG4886         169 --DLSFNDLSDLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKL  244 (394)
T ss_pred             --ccCCchhhhhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCcee
Confidence              555555552222   2234666666666666 55554444555666666666443 3555566666666666666666


Q ss_pred             cC
Q 007680          160 SG  161 (593)
Q Consensus       160 ~~  161 (593)
                      ..
T Consensus       245 ~~  246 (394)
T COG4886         245 ED  246 (394)
T ss_pred             ee
Confidence            54

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.12  E-value=7.6e-12  Score=128.03  Aligned_cols=152  Identities=26%  Similarity=0.339  Sum_probs=109.4

Q ss_pred             CcEEEeeCccccccCChhhhhCCCC---CcEEECCCCcCcc----cCCccCCCC-CCCcEEEccCCccccc----ccccc
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPN---IEYLLLTANNLTG----TIPNSITNA-TKLIVLDLGFNSFSGH----ILNTF   68 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~---L~~L~L~~N~l~~----~~p~~~~~l-~~L~~L~L~~N~l~~~----~p~~~   68 (593)
                      |+.|+|++|.+.+..+..+.. +.+   |++|++++|++++    .+...+..+ ++|+.|+|++|.+++.    ++..+
T Consensus        83 L~~L~l~~~~~~~~~~~~~~~-l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~  161 (319)
T cd00116          83 LQELDLSDNALGPDGCGVLES-LLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKAL  161 (319)
T ss_pred             eeEEEccCCCCChhHHHHHHH-HhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHH
Confidence            578999999998555555543 555   9999999999883    333456667 8899999999999843    34457


Q ss_pred             cCCCCchhhhhhcceeeccCCcccc--------cCCCcccccEEEccCCcccCc----CCCCCCCCCCCCEecCCCccCC
Q 007680           69 GNLRHLSVLSLLMFGIRLTGNKLYG--------RIPPCLVLTVLDVSRNQLSGD----IPSTIGGRVDLETLSLASNQFQ  136 (593)
Q Consensus        69 ~~l~~L~~L~l~~n~l~l~~n~l~~--------~~~~~~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~  136 (593)
                      ..+++|+.|       ++++|.+.+        .++....|++|++++|.+++.    ++..+..+++|+.|++++|+++
T Consensus       162 ~~~~~L~~L-------~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~  234 (319)
T cd00116         162 RANRDLKEL-------NLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLT  234 (319)
T ss_pred             HhCCCcCEE-------ECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCc
Confidence            777889988       666776662        123344699999999988633    3345667888999999999987


Q ss_pred             CCCCcccc-----CCcccccccccccccc
Q 007680          137 GPIPESVG-----SLISLESLDLSGNNLS  160 (593)
Q Consensus       137 ~~~p~~l~-----~~~~L~~L~l~~N~l~  160 (593)
                      +.....+.     ..+.|+.|++++|.++
T Consensus       235 ~~~~~~l~~~~~~~~~~L~~L~l~~n~i~  263 (319)
T cd00116         235 DAGAAALASALLSPNISLLTLSLSCNDIT  263 (319)
T ss_pred             hHHHHHHHHHHhccCCCceEEEccCCCCC
Confidence            53222222     2368999999999887

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.12  E-value=1.4e-11  Score=135.00  Aligned_cols=252  Identities=22%  Similarity=0.261  Sum_probs=173.4

Q ss_pred             HHhhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCce
Q 007680          268 QRATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFK  343 (593)
Q Consensus       268 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  343 (593)
                      ....+++.+.+.+.+|+++.++.+.-. .|...+.|+.....   ....+....+-.++-..++|.+++...-+......
T Consensus       800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~  879 (1205)
T KOG0606|consen  800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPL  879 (1205)
T ss_pred             cCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCc
Confidence            346678889999999999999988743 45455555543321   11122223333333334567777666556667788


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceec
Q 007680          344 ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLL  423 (593)
Q Consensus       344 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~  423 (593)
                      +++++|+.+++|...++..+. .+..-.......+..++++||.    ..+.|+|++|.|.+...++..++.|||.....
T Consensus       880 ~L~~~~~~~~~~~Skl~~~~~-~saepaRs~i~~~vqs~e~L~s----~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v  954 (1205)
T KOG0606|consen  880 PLVGHYLNGGDLPSKLHNSGC-LSAEPARSPILERVQSLESLHS----SLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKV  954 (1205)
T ss_pred             chhhHHhccCCchhhhhcCCC-cccccccchhHHHHhhhhcccc----chhhcccccccchhhcccCCcccCcccccccc
Confidence            999999999999999887664 5555556666778889999995    34899999999999999999999999843322


Q ss_pred             CCC---------------------CC--------ccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCC
Q 007680          424 GEG---------------------ED--------SVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRP  474 (593)
Q Consensus       424 ~~~---------------------~~--------~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~p  474 (593)
                      +..                     ..        ........+|+.|.+||...+......+|.|+.|++++|.++|.+|
T Consensus       955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen  955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred             ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence            110                     00        0112334689999999999999999999999999999999999999


Q ss_pred             CCccccccchHHHHHHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHH
Q 007680          475 TDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMT  541 (593)
Q Consensus       475 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  541 (593)
                      |.......                 +++..+.+...-.......+....+++.+.+..+|.+|-.+.
T Consensus      1035 ~na~tpq~-----------------~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1035 FNAETPQQ-----------------IFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             CCCcchhh-----------------hhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            97743221                 111111111111111223345678888889999999998775

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.11  E-value=8e-12  Score=127.85  Aligned_cols=153  Identities=25%  Similarity=0.303  Sum_probs=116.4

Q ss_pred             CcEEEeeCccccc------cCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCC---CcEEEccCCcccc----ccccc
Q 007680            1 MRILTLEGNQLSG------RLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATK---LIVLDLGFNSFSG----HILNT   67 (593)
Q Consensus         1 L~~L~Ls~n~l~~------~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~---L~~L~L~~N~l~~----~~p~~   67 (593)
                      |+.|++++|.+.+      .++..+.. +++|+.|+|++|.+.+..+..+..+.+   |+.|++++|++++    .+...
T Consensus        53 l~~l~l~~~~~~~~~~~~~~~~~~l~~-~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~  131 (319)
T cd00116          53 LKELCLSLNETGRIPRGLQSLLQGLTK-GCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKG  131 (319)
T ss_pred             ceEEeccccccCCcchHHHHHHHHHHh-cCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHH
Confidence            5788999998872      23444554 889999999999998766666666655   9999999999983    33345


Q ss_pred             ccCC-CCchhhhhhcceeeccCCcccc--------cCCCcccccEEEccCCcccCc----CCCCCCCCCCCCEecCCCcc
Q 007680           68 FGNL-RHLSVLSLLMFGIRLTGNKLYG--------RIPPCLVLTVLDVSRNQLSGD----IPSTIGGRVDLETLSLASNQ  134 (593)
Q Consensus        68 ~~~l-~~L~~L~l~~n~l~l~~n~l~~--------~~~~~~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~  134 (593)
                      +..+ ++|+.|       ++++|.+++        .+..+..|++|++++|.+++.    ++..+..+++|+.|++++|.
T Consensus       132 l~~~~~~L~~L-------~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~  204 (319)
T cd00116         132 LKDLPPALEKL-------VLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNG  204 (319)
T ss_pred             HHhCCCCceEE-------EcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCc
Confidence            6677 899999       777777762        233445699999999999842    33445566799999999999


Q ss_pred             CCCC----CCccccCCccccccccccccccC
Q 007680          135 FQGP----IPESVGSLISLESLDLSGNNLSG  161 (593)
Q Consensus       135 l~~~----~p~~l~~~~~L~~L~l~~N~l~~  161 (593)
                      +++.    ++..+..+++|+.|++++|++++
T Consensus       205 i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~  235 (319)
T cd00116         205 LTDEGASALAETLASLKSLEVLNLGDNNLTD  235 (319)
T ss_pred             cChHHHHHHHHHhcccCCCCEEecCCCcCch
Confidence            9743    34456778899999999999986

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.08  E-value=4.7e-11  Score=109.07  Aligned_cols=121  Identities=34%  Similarity=0.425  Sum_probs=41.4

Q ss_pred             ECCCCcCcccCCccCCCCCCCcEEEccCCccccccccccc-CCCCchhhhhhcceeeccCCccc--ccCCCcccccEEEc
Q 007680           30 LLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFG-NLRHLSVLSLLMFGIRLTGNKLY--GRIPPCLVLTVLDV  106 (593)
Q Consensus        30 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~l~~n~l~l~~n~l~--~~~~~~~~L~~L~l  106 (593)
                      .|..|.|. ..|. +.+..+++.|+|++|+|+ .+. .++ .+.+|+.|       ++++|.+.  ..++.+..|++|++
T Consensus         3 ~lt~~~i~-~~~~-~~n~~~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L-------~Ls~N~I~~l~~l~~L~~L~~L~L   71 (175)
T PF14580_consen    3 RLTANMIE-QIAQ-YNNPVKLRELNLRGNQIS-TIE-NLGATLDKLEVL-------DLSNNQITKLEGLPGLPRLKTLDL   71 (175)
T ss_dssp             -------------------------------------S--TT-TT--EE-------E-TTS--S--TT----TT--EEE-
T ss_pred             cccccccc-cccc-cccccccccccccccccc-ccc-chhhhhcCCCEE-------ECCCCCCccccCccChhhhhhccc
Confidence            35566666 3443 556668999999999999 443 466 57889988       78888877  24566677999999


Q ss_pred             cCCcccCcCCCCC-CCCCCCCEecCCCccCCCCC-CccccCCccccccccccccccCC
Q 007680          107 SRNQLSGDIPSTI-GGRVDLETLSLASNQFQGPI-PESVGSLISLESLDLSGNNLSGK  162 (593)
Q Consensus       107 ~~N~l~~~~p~~~-~~l~~L~~L~l~~N~l~~~~-p~~l~~~~~L~~L~l~~N~l~~~  162 (593)
                      ++|+|+ .++..+ ..+++|++|++++|+|...- =..+..+++|+.|+|.+|+++..
T Consensus        72 ~~N~I~-~i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~  128 (175)
T PF14580_consen   72 SNNRIS-SISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEK  128 (175)
T ss_dssp             -SS----S-CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGS
T ss_pred             CCCCCC-ccccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccch
Confidence            999998 455444 36899999999999997421 14577889999999999999853

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.02  E-value=1.2e-08  Score=102.11  Aligned_cols=262  Identities=12%  Similarity=0.084  Sum_probs=164.1

Q ss_pred             cccccCccCcccEEEEEeCCCCeEEEEEeehhhHHHHHHHHHHHHHHhhc-CCCCcceeeeee------ecC-CceEEEE
Q 007680          276 ECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNV-RHRNLIKILSSY------SNP-DFKALVL  347 (593)
Q Consensus       276 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~------~~~-~~~~lv~  347 (593)
                      ....||+|+-+.+|-.---  ...+.|+..........+   .+..|... .||-+..-+.+=      -++ ....+.|
T Consensus        15 ~gr~LgqGgea~ly~l~e~--~d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm   89 (637)
T COG4248          15 PGRPLGQGGEADLYTLGEV--RDQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM   89 (637)
T ss_pred             CCccccCCccceeeecchh--hchhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence            4568999999999965321  223457776543222111   22333343 566544312111      112 2366788


Q ss_pred             eccCCCC-HHHHHhh-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccce
Q 007680          348 EFMPNGS-LEKWLYS-----HNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYK  421 (593)
Q Consensus       348 e~~~~gs-L~~~l~~-----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~  421 (593)
                      +.+.+.- ...+...     .-....|...++.++.++.+.+.||++|    .+-+|+.++|+|+++++.+.|.|-....
T Consensus        90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G----h~vGDVn~~~~lVsd~~~V~LVdsDsfq  165 (637)
T COG4248          90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG----HVVGDVNQNSFLVSDDSKVVLVDSDSFQ  165 (637)
T ss_pred             ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC----CcccccCccceeeecCceEEEEccccee
Confidence            8876642 2222221     1125789999999999999999999766    7889999999999999999999966544


Q ss_pred             ecCCCCCccccccccCCccccCccccC-----CCCCCccchHHHHHHHHHHHHhC-CCCCCcccccc---chHH-HHHHH
Q 007680          422 LLGEGEDSVRQTMTMATIGYMAPEYGL-----EGIVSAKCDVYSYGVLLMETFTR-KRPTDEMFIGE---MSLR-RWVKE  491 (593)
Q Consensus       422 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DvwSlGvvl~elltg-~~pf~~~~~~~---~~~~-~~~~~  491 (593)
                      ....+   ...-..+|...|.+||.-.     +...+...|-|.+|+++++++.| ++||.+.....   ..+. +....
T Consensus       166 i~~ng---~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g  242 (637)
T COG4248         166 INANG---TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHG  242 (637)
T ss_pred             eccCC---ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcc
Confidence            33221   2234457899999999643     34567789999999999999886 99998752211   1111 11000


Q ss_pred             hcCCchhhhhhh--hhhhhhhhhhhhHHHHHHHHHHHhhcccC--CCCCCCCHHHHHHHHHHhhhhh
Q 007680          492 SLPHGLTEVVDA--NLVREEQAFSAKMDCILSIMDFALDCCME--SPDMRINMTDAAAKLKKIKVKF  554 (593)
Q Consensus       492 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~li~~cl~~--dP~~RPs~~evl~~L~~i~~~~  554 (593)
                      .+    ...-+.  .... ........-.++++..+..+|+..  .|.-|||++..+..|.++...+
T Consensus       243 ~f----~ya~~~~~g~~p-~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L  304 (637)
T COG4248         243 RF----AYASDQRRGLKP-PPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQL  304 (637)
T ss_pred             ee----eechhccCCCCC-CCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhh
Confidence            00    000000  0000 111122334567888899999975  3668999999999999988775

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.99  E-value=4.5e-09  Score=97.63  Aligned_cols=126  Identities=22%  Similarity=0.261  Sum_probs=83.3

Q ss_pred             cEEEEEeCCCCeEEEEEeehhh--------------------------HHHHHHHHHHHHHHhhcCCC--Ccceeeeeee
Q 007680          287 SVYKGTISDGTDVAIKVFNLQL--------------------------ERAFRSFDSECEVLRNVRHR--NLIKILSSYS  338 (593)
Q Consensus       287 ~Vy~~~~~~~~~vavK~~~~~~--------------------------~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~  338 (593)
                      .||.|...+|..+|+|+.+...                          .......++|.+.|.++...  ++.+++++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            3899998889999999886421                          01123567899999999755  566666542 


Q ss_pred             cCCceEEEEeccC--CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHH-HHhcCCCCCeEecCCCCCCeeeCCCCcEEEE
Q 007680          339 NPDFKALVLEFMP--NGSLEKWLYSHNYFLDILERLNIMIDVGSALEY-LHNGHSSVHIIHCDLKPTNILLDENMVAHVS  415 (593)
Q Consensus       339 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~-LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~  415 (593)
                         ..++||||++  |..+..+....   ++......++.+++..+.. +|    ..||+|||+++.||+++++ .+.++
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~----~~givHGDLs~~NIlv~~~-~~~iI  148 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLH----KAGIVHGDLSEYNILVDDG-KVYII  148 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHH----CTTEEESS-STTSEEEETT-CEEE-
T ss_pred             ---CCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHH----hcCceecCCChhhEEeecc-eEEEE
Confidence               3479999998  54554433322   1234556677888886665 46    4469999999999999988 99999


Q ss_pred             eeccceecC
Q 007680          416 DFGIYKLLG  424 (593)
Q Consensus       416 Dfg~a~~~~  424 (593)
                      |||.+....
T Consensus       149 Df~qav~~~  157 (188)
T PF01163_consen  149 DFGQAVDSS  157 (188)
T ss_dssp             -GTTEEETT
T ss_pred             ecCcceecC
Confidence            999887543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.99  E-value=2.6e-10  Score=85.69  Aligned_cols=53  Identities=38%  Similarity=0.481  Sum_probs=25.9

Q ss_pred             CCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhh
Q 007680           25 NIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVL   77 (593)
Q Consensus        25 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L   77 (593)
                      +|++|+|++|+|+...++.|.++++|++|+|++|.++...|+.|.++++|++|
T Consensus         2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L   54 (61)
T PF13855_consen    2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYL   54 (61)
T ss_dssp             TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEE
T ss_pred             cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEE
Confidence            44455555555553333444455555555555555554444445555555555

...

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=98.97  E-value=6e-11  Score=112.86  Aligned_cols=127  Identities=27%  Similarity=0.279  Sum_probs=66.7

Q ss_pred             CCCCcEEEccCCcccccccccccCCCCchhhhhhcceeeccCCccc--ccCCCcccccEEEccCCcccCcCCCCCCCCCC
Q 007680           47 ATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLY--GRIPPCLVLTVLDVSRNQLSGDIPSTIGGRVD  124 (593)
Q Consensus        47 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~l~~n~l~--~~~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~  124 (593)
                      -+.|+.||||+|.|+ .+.++..-++.++.|       ++++|.+.  +.+..+.+|+.||||+|.++ .+.+.=..+.+
T Consensus       283 Wq~LtelDLS~N~I~-~iDESvKL~Pkir~L-------~lS~N~i~~v~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGN  353 (490)
T KOG1259|consen  283 WQELTELDLSGNLIT-QIDESVKLAPKLRRL-------ILSQNRIRTVQNLAELPQLQLLDLSGNLLA-ECVGWHLKLGN  353 (490)
T ss_pred             Hhhhhhccccccchh-hhhhhhhhccceeEE-------eccccceeeehhhhhcccceEeecccchhH-hhhhhHhhhcC
Confidence            345666666666666 455555555666666       44444444  22333444666666666665 44444345555


Q ss_pred             CCEecCCCccCCCCCCccccCCccccccccccccccCCCCCCCCCCCCCCCccCCCcccccCCcc
Q 007680          125 LETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKLEGEIPVKGSFKNFSTESFFGNYA  189 (593)
Q Consensus       125 L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~n~~  189 (593)
                      .+.|.|+.|.|. .+ +.+..+.+|..||+++|++..     +..+..-++++.+..+.+.+||.
T Consensus       354 IKtL~La~N~iE-~L-SGL~KLYSLvnLDl~~N~Ie~-----ldeV~~IG~LPCLE~l~L~~NPl  411 (490)
T KOG1259|consen  354 IKTLKLAQNKIE-TL-SGLRKLYSLVNLDLSSNQIEE-----LDEVNHIGNLPCLETLRLTGNPL  411 (490)
T ss_pred             EeeeehhhhhHh-hh-hhhHhhhhheeccccccchhh-----HHHhcccccccHHHHHhhcCCCc
Confidence            666666666665 22 234555566666666666653     11222234444455555555543

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.91  E-value=8.3e-10  Score=82.93  Aligned_cols=59  Identities=37%  Similarity=0.544  Sum_probs=55.6

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcc
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSF   60 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l   60 (593)
                      |++|+|++|+|+ .+|...+.++++|++|+|++|+|+...|++|.++++|+.|+|++|+|
T Consensus         3 L~~L~l~~n~l~-~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    3 LESLDLSNNKLT-EIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             ESEEEETSSTES-EECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             CcEEECCCCCCC-ccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            689999999999 89998888899999999999999988888999999999999999986

...

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.89  E-value=3.7e-08  Score=97.14  Aligned_cols=139  Identities=14%  Similarity=0.075  Sum_probs=98.4

Q ss_pred             ccCccCcccEEEEEeCCCCeEEEEEeehhhHH-HH----------HHHHHHHHHHhhcCCC--Ccceeeeeeec-----C
Q 007680          279 LLGTSSFGSVYKGTISDGTDVAIKVFNLQLER-AF----------RSFDSECEVLRNVRHR--NLIKILSSYSN-----P  340 (593)
Q Consensus       279 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~----------~~~~~E~~~l~~l~h~--niv~l~~~~~~-----~  340 (593)
                      .+-......|++... +|+.|.||........ ..          ..+.+|...+.++...  ...+.+++.+.     .
T Consensus        29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~  107 (268)
T PRK15123         29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT  107 (268)
T ss_pred             EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence            333333445667766 5788999977543211 11          1377899999888433  33344555543     2


Q ss_pred             CceEEEEeccCCC-CHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC-------CCc
Q 007680          341 DFKALVLEFMPNG-SLEKWLYSH-NYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDE-------NMV  411 (593)
Q Consensus       341 ~~~~lv~e~~~~g-sL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~-------~~~  411 (593)
                      ...++|||++++. +|.+++... ....+......++.+++..+.-||++|    |+|+|++++|||++.       ++.
T Consensus       108 ~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G----i~HgDL~~~NiLl~~~~~~~~~~~~  183 (268)
T PRK15123        108 RTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG----INHRDCYICHFLLHLPFPGREEDLK  183 (268)
T ss_pred             ceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc----CccCCCChhhEEEeccccCCCCCce
Confidence            3578999999876 899988642 223566778899999999999999655    999999999999975       468


Q ss_pred             EEEEeecccee
Q 007680          412 AHVSDFGIYKL  422 (593)
Q Consensus       412 ~kL~Dfg~a~~  422 (593)
                      +.++||+.+..
T Consensus       184 ~~LIDl~r~~~  194 (268)
T PRK15123        184 LSVIDLHRAQI  194 (268)
T ss_pred             EEEEECCcccc
Confidence            99999997753

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.85  E-value=1.2e-07  Score=97.58  Aligned_cols=167  Identities=20%  Similarity=0.232  Sum_probs=126.3

Q ss_pred             cccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec----CCceEEEEeccCC-CCHHHH
Q 007680          285 FGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSN----PDFKALVLEFMPN-GSLEKW  358 (593)
Q Consensus       285 ~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~~~-gsL~~~  358 (593)
                      ..+.|++... ||..|++|+++............-+++++++.|+|+|++.++|..    +...++|++|+++ ++|.+.
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~  368 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL  368 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence            3578999854 899999999954432222233456788999999999999998863    3478999999986 467775


Q ss_pred             HhhC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecC
Q 007680          359 LYSH--------------NYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG  424 (593)
Q Consensus       359 l~~~--------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~  424 (593)
                      -...              +...++...+.++.|+..||.++|+.    |+..+-|.|.+|+++.+.+++|...|+...+.
T Consensus       369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss----GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS----GLACKTLDLKKILVTGKMRIRISGCGIMDVLQ  444 (655)
T ss_pred             HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc----CceeecccHhHeEeeCcceEEEecccceeeec
Confidence            4321              12467889999999999999999955    49999999999999999999999888877665


Q ss_pred             CCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCC
Q 007680          425 EGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRP  474 (593)
Q Consensus       425 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~p  474 (593)
                      .+..                |-+.+   -.+-|.=.||.++..|.||..-
T Consensus       445 ~d~~----------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  445 EDPT----------------EPLES---QQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             CCCC----------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence            4431                00111   1356888999999999999643

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=98.83  E-value=1.6e-09  Score=108.53  Aligned_cols=153  Identities=27%  Similarity=0.334  Sum_probs=101.7

Q ss_pred             CcEEEeeCccccccCC-hhhhhCCCCCcEEECCCCcCcccCCcc-CCCCCCCcEEEccCCcccc-cccccccCCCCchhh
Q 007680            1 MRILTLEGNQLSGRLP-STIGHSLPNIEYLLLTANNLTGTIPNS-ITNATKLIVLDLGFNSFSG-HILNTFGNLRHLSVL   77 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp-~~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L   77 (593)
                      ++.||||+|-+..--| -.+.+.||+|+.|+|+.|++.-..... -..+++|+.|.|+.+.|+- .+-.-+..+|+|+.|
T Consensus       148 v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L  227 (505)
T KOG3207|consen  148 VRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVL  227 (505)
T ss_pred             ceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhCCcHHHh
Confidence            3578888887772211 123345888888888888886332222 2257788888888888872 122235567888888


Q ss_pred             hhhcceeeccCCccc--ccCCC--cccccEEEccCCcccCcCC--CCCCCCCCCCEecCCCccCCCC-CCcc-----ccC
Q 007680           78 SLLMFGIRLTGNKLY--GRIPP--CLVLTVLDVSRNQLSGDIP--STIGGRVDLETLSLASNQFQGP-IPES-----VGS  145 (593)
Q Consensus        78 ~l~~n~l~l~~n~l~--~~~~~--~~~L~~L~l~~N~l~~~~p--~~~~~l~~L~~L~l~~N~l~~~-~p~~-----l~~  145 (593)
                             +|.+|...  ...+.  +..|++|||++|++- ..+  ...+.+++|..|+++.+.+... .|+.     ...
T Consensus       228 -------~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li-~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~  299 (505)
T KOG3207|consen  228 -------YLEANEIILIKATSTKILQTLQELDLSNNNLI-DFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHT  299 (505)
T ss_pred             -------hhhcccccceecchhhhhhHHhhccccCCccc-ccccccccccccchhhhhccccCcchhcCCCccchhhhcc
Confidence                   66666311  11111  123999999999987 455  4567889999999999998742 3433     455


Q ss_pred             CccccccccccccccC
Q 007680          146 LISLESLDLSGNNLSG  161 (593)
Q Consensus       146 ~~~L~~L~l~~N~l~~  161 (593)
                      +++|+.|+++.|++..
T Consensus       300 f~kL~~L~i~~N~I~~  315 (505)
T KOG3207|consen  300 FPKLEYLNISENNIRD  315 (505)
T ss_pred             cccceeeecccCcccc
Confidence            7889999999999975

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.79  E-value=4.5e-08  Score=93.46  Aligned_cols=134  Identities=22%  Similarity=0.202  Sum_probs=98.6

Q ss_pred             ccccccCccCcccEEEEEeCCCCeEEEEEeehhh----------------------HHHHHHHHHHHHHHhhcCCC--Cc
Q 007680          275 NECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQL----------------------ERAFRSFDSECEVLRNVRHR--NL  330 (593)
Q Consensus       275 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----------------------~~~~~~~~~E~~~l~~l~h~--ni  330 (593)
                      .+..+||-|--+.||.|..+.|.++|||.-+...                      .-.....++|.++|+++...  .+
T Consensus        94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V  173 (304)
T COG0478          94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV  173 (304)
T ss_pred             hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence            4567999999999999999999999999754321                      11234567899999999644  67


Q ss_pred             ceeeeeeecCCceEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC
Q 007680          331 IKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENM  410 (593)
Q Consensus       331 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~  410 (593)
                      .+.+++    +...+||||++|-.|...-      ++....-.++..|++-+.-+-.    .||+|+|+++-||+++++|
T Consensus       174 P~P~~~----nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~~----~GiVHGDlSefNIlV~~dg  239 (304)
T COG0478         174 PKPIAW----NRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAYR----RGIVHGDLSEFNILVTEDG  239 (304)
T ss_pred             CCcccc----ccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHHH----cCccccCCchheEEEecCC
Confidence            776664    5568999999886665532      1233444455555555554443    3599999999999999999


Q ss_pred             cEEEEeecccee
Q 007680          411 VAHVSDFGIYKL  422 (593)
Q Consensus       411 ~~kL~Dfg~a~~  422 (593)
                      .+.++||--+..
T Consensus       240 ~~~vIDwPQ~v~  251 (304)
T COG0478         240 DIVVIDWPQAVP  251 (304)
T ss_pred             CEEEEeCccccc
Confidence            999999976654

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.76  E-value=2.9e-09  Score=112.95  Aligned_cols=152  Identities=18%  Similarity=0.256  Sum_probs=104.5

Q ss_pred             HHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCccc-------cccccCCccccCcccc
Q 007680          375 MIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVR-------QTMTMATIGYMAPEYG  447 (593)
Q Consensus       375 ~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~-------~~~~~gt~~y~aPE~~  447 (593)
                      +.+++.|+.|+|.   +.++||++|.|++|.++..+..||+.|+++...........       .........|.|||++
T Consensus       105 l~~v~dgl~flh~---sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~  181 (700)
T KOG2137|consen  105 LGNVADGLAFLHR---SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYL  181 (700)
T ss_pred             hhcccchhhhhcc---CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhh
Confidence            3455599999996   67899999999999999999999999998776544221111       1112345679999999


Q ss_pred             CCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHH
Q 007680          448 LEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFA  526 (593)
Q Consensus       448 ~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  526 (593)
                      .+...+.++|+||+|+.+|.+.. |+.-+... ..... .....              ...+...+......+.++.+=+
T Consensus       182 ~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~-~~~~~-~~~~~--------------~~~~~~~~~~s~~~p~el~~~l  245 (700)
T KOG2137|consen  182 LGTTNTPASDVFSLGVLIYTIYNGGKSIIAAN-GGLLS-YSFSR--------------NLLNAGAFGYSNNLPSELRESL  245 (700)
T ss_pred             ccccccccccceeeeeEEEEEecCCcchhhcc-CCcch-hhhhh--------------cccccccccccccCcHHHHHHH
Confidence            99889999999999999999995 55444331 11100 00000              0001111122245677889999


Q ss_pred             hhcccCCCCCCCCHHHHHH
Q 007680          527 LDCCMESPDMRINMTDAAA  545 (593)
Q Consensus       527 ~~cl~~dP~~RPs~~evl~  545 (593)
                      .+++..++.-||++.++..
T Consensus       246 ~k~l~~~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  246 KKLLNGDSAVRPTLDLLLS  264 (700)
T ss_pred             HHHhcCCcccCcchhhhhc
Confidence            9999999999997776653

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.66  E-value=1.5e-07  Score=100.49  Aligned_cols=143  Identities=18%  Similarity=0.226  Sum_probs=95.4

Q ss_pred             cccCccCcccEEEEEeCCCCeEEEEEeehhhHH----------------------------------------HHHHHHH
Q 007680          278 NLLGTSSFGSVYKGTISDGTDVAIKVFNLQLER----------------------------------------AFRSFDS  317 (593)
Q Consensus       278 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------------------------------~~~~~~~  317 (593)
                      +.|+.++-|.||+|++++|+.||||+.++....                                        ..-++.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            689999999999999999999999998754210                                        0012445


Q ss_pred             HHHHHhhcC-----CCCcceeeeeeecCCceEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 007680          318 ECEVLRNVR-----HRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSV  392 (593)
Q Consensus       318 E~~~l~~l~-----h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~  392 (593)
                      |+.-+.+++     .+++.-..=+++-.+...++|||++|-.+.+.........+...+.....++.  +..+-.    .
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~~~----d  284 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQLLR----D  284 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHHHh----c
Confidence            555555552     34433222233445667899999999988887433223355333332222221  222221    2


Q ss_pred             CeEecCCCCCCeeeCCCCcEEEEeeccceecCCC
Q 007680          393 HIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG  426 (593)
Q Consensus       393 ~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  426 (593)
                      |++|.|..|.||+++.+|.+.+.|||+...+.+.
T Consensus       285 gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~  318 (517)
T COG0661         285 GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK  318 (517)
T ss_pred             CccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence            5999999999999999999999999998877543

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.60  E-value=4e-07  Score=86.77  Aligned_cols=105  Identities=22%  Similarity=0.277  Sum_probs=83.2

Q ss_pred             HHHHHHHHHHhhcC--CCCcceeeeeeecCC----ceEEEEeccCCC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHH
Q 007680          313 RSFDSECEVLRNVR--HRNLIKILSSYSNPD----FKALVLEFMPNG-SLEKWLYSHNYFLDILERLNIMIDVGSALEYL  385 (593)
Q Consensus       313 ~~~~~E~~~l~~l~--h~niv~l~~~~~~~~----~~~lv~e~~~~g-sL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~L  385 (593)
                      ....+|...+..+.  .=.+.+.+++.+...    ..++|+|++++. +|.+++..... .+......++.+++..++-|
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~l  134 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAKL  134 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHHH
Confidence            45778888888874  334555666655432    458999999874 79999887443 66677889999999999999


Q ss_pred             HhcCCCCCeEecCCCCCCeeeCCCC---cEEEEeecccee
Q 007680          386 HNGHSSVHIIHCDLKPTNILLDENM---VAHVSDFGIYKL  422 (593)
Q Consensus       386 H~~~~~~~ivH~Dlkp~NIll~~~~---~~kL~Dfg~a~~  422 (593)
                      |++|    |+|+|+++.|||++.+.   .+.++||+-++.
T Consensus       135 H~~g----i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  135 HDAG----IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHCc----CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            9665    99999999999999887   899999997765

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=98.55  E-value=1.4e-08  Score=107.76  Aligned_cols=103  Identities=30%  Similarity=0.417  Sum_probs=43.1

Q ss_pred             CCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhhcceeeccCCcccc--cCCCccc
Q 007680           23 LPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYG--RIPPCLV  100 (593)
Q Consensus        23 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~l~~n~l~~--~~~~~~~  100 (593)
                      +++|+.|++.+|+|. .+...+..+++|+.|+|++|+|+.+.+  +..++.|+.|       ++++|.+..  .+..+..
T Consensus        94 ~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls~N~I~~i~~--l~~l~~L~~L-------~l~~N~i~~~~~~~~l~~  163 (414)
T KOG0531|consen   94 LKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLSFNKITKLEG--LSTLTLLKEL-------NLSGNLISDISGLESLKS  163 (414)
T ss_pred             ccceeeeeccccchh-hcccchhhhhcchheeccccccccccc--hhhccchhhh-------eeccCcchhccCCccchh
Confidence            444555555555554 222224444455555555555543222  3334444444       444444431  1222233


Q ss_pred             ccEEEccCCcccCcCCCC-CCCCCCCCEecCCCccCC
Q 007680          101 LTVLDVSRNQLSGDIPST-IGGRVDLETLSLASNQFQ  136 (593)
Q Consensus       101 L~~L~l~~N~l~~~~p~~-~~~l~~L~~L~l~~N~l~  136 (593)
                      |+.+++++|++.. +... ...+..|+.+++++|.+.
T Consensus       164 L~~l~l~~n~i~~-ie~~~~~~~~~l~~l~l~~n~i~  199 (414)
T KOG0531|consen  164 LKLLDLSYNRIVD-IENDELSELISLEELDLGGNSIR  199 (414)
T ss_pred             hhcccCCcchhhh-hhhhhhhhccchHHHhccCCchh
Confidence            4444444444442 2221 234444444444444443

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=98.54  E-value=4e-08  Score=104.21  Aligned_cols=150  Identities=28%  Similarity=0.357  Sum_probs=95.6

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLL   80 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~   80 (593)
                      |+.|+|..|+|. .+...+.. +++|++|+|++|+|+.+.  .+..++.|+.|++++|.|+ .+. .|..+++|+.|+++
T Consensus        97 l~~l~l~~n~i~-~i~~~l~~-~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L~l~~N~i~-~~~-~~~~l~~L~~l~l~  170 (414)
T KOG0531|consen   97 LEALDLYDNKIE-KIENLLSS-LVNLQVLDLSFNKITKLE--GLSTLTLLKELNLSGNLIS-DIS-GLESLKSLKLLDLS  170 (414)
T ss_pred             eeeeeccccchh-hcccchhh-hhcchheecccccccccc--chhhccchhhheeccCcch-hcc-CCccchhhhcccCC
Confidence            467888888887 66654443 788888888888888443  3566677888888888888 333 36667777777444


Q ss_pred             cceeeccCCcccccCCCcccccEEEccCC----------------------cccCcCCCCCCCCCC--CCEecCCCccCC
Q 007680           81 MFGIRLTGNKLYGRIPPCLVLTVLDVSRN----------------------QLSGDIPSTIGGRVD--LETLSLASNQFQ  136 (593)
Q Consensus        81 ~n~l~l~~n~l~~~~~~~~~L~~L~l~~N----------------------~l~~~~p~~~~~l~~--L~~L~l~~N~l~  136 (593)
                      +|.+.-..+.  . +..+..|+.+++.+|                      .++ .+-+ +..+..  |+.+++++|++.
T Consensus       171 ~n~i~~ie~~--~-~~~~~~l~~l~l~~n~i~~i~~~~~~~~l~~~~l~~n~i~-~~~~-l~~~~~~~L~~l~l~~n~i~  245 (414)
T KOG0531|consen  171 YNRIVDIEND--E-LSELISLEELDLGGNSIREIEGLDLLKKLVLLSLLDNKIS-KLEG-LNELVMLHLRELYLSGNRIS  245 (414)
T ss_pred             cchhhhhhhh--h-hhhccchHHHhccCCchhcccchHHHHHHHHhhcccccce-eccC-cccchhHHHHHHhcccCccc
Confidence            3333322220  0 112223444444444                      444 1111 222222  789999999998


Q ss_pred             CCCCccccCCccccccccccccccCC
Q 007680          137 GPIPESVGSLISLESLDLSGNNLSGK  162 (593)
Q Consensus       137 ~~~p~~l~~~~~L~~L~l~~N~l~~~  162 (593)
                       ..+..+..+..+..|++.+|++...
T Consensus       246 -~~~~~~~~~~~l~~l~~~~n~~~~~  270 (414)
T KOG0531|consen  246 -RSPEGLENLKNLPVLDLSSNRISNL  270 (414)
T ss_pred             -cccccccccccccccchhhcccccc
Confidence             5657778888999999999999863

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=98.53  E-value=1.9e-08  Score=100.91  Aligned_cols=152  Identities=24%  Similarity=0.242  Sum_probs=83.2

Q ss_pred             CcEEEeeCccccccCCh-hhhhCCCCCcEEECCCCcCcccCC--ccCCCCCCCcEEEccCCccccccccc-ccCCCCchh
Q 007680            1 MRILTLEGNQLSGRLPS-TIGHSLPNIEYLLLTANNLTGTIP--NSITNATKLIVLDLGFNSFSGHILNT-FGNLRHLSV   76 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~-~~~~~l~~L~~L~L~~N~l~~~~p--~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~   76 (593)
                      |+.+.|.+..+. ..+. +....+++++.|+||+|-+...-|  .-...|++|+.|+|+.|++.-..... -..+++|+.
T Consensus       123 L~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~  201 (505)
T KOG3207|consen  123 LREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQ  201 (505)
T ss_pred             hhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhhe
Confidence            445556666665 4442 222236777777777777663322  22345677777777777765222111 113445555


Q ss_pred             hhhhcceeeccCCccc-----ccCCCcccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCC--ccccCCccc
Q 007680           77 LSLLMFGIRLTGNKLY-----GRIPPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIP--ESVGSLISL  149 (593)
Q Consensus        77 L~l~~n~l~l~~n~l~-----~~~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p--~~l~~~~~L  149 (593)
                      |       .++++.|+     ..+-.+.+|+.|+|..|...+.-......+..|++|+|++|++. ..+  ...+.++.|
T Consensus       202 L-------~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li-~~~~~~~~~~l~~L  273 (505)
T KOG3207|consen  202 L-------VLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLI-DFDQGYKVGTLPGL  273 (505)
T ss_pred             E-------EeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCccc-ccccccccccccch
Confidence            5       55555554     12223344777777777432233333445666777777777776 344  345666677


Q ss_pred             cccccccccccC
Q 007680          150 ESLDLSGNNLSG  161 (593)
Q Consensus       150 ~~L~l~~N~l~~  161 (593)
                      +.|+++.+.++.
T Consensus       274 ~~Lnls~tgi~s  285 (505)
T KOG3207|consen  274 NQLNLSSTGIAS  285 (505)
T ss_pred             hhhhccccCcch
Confidence            777777766654

>PRK09902 hypothetical protein; Provisional

Probab=98.51  E-value=2.1e-06  Score=80.35  Aligned_cols=138  Identities=17%  Similarity=0.080  Sum_probs=101.5

Q ss_pred             ccCccCcccEEEEEeCCCCeEEEEEeehhh------HHHHHHHHHHHHHHhhcCC--CCcceeeeeee---cC--CceEE
Q 007680          279 LLGTSSFGSVYKGTISDGTDVAIKVFNLQL------ERAFRSFDSECEVLRNVRH--RNLIKILSSYS---NP--DFKAL  345 (593)
Q Consensus       279 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~---~~--~~~~l  345 (593)
                      --|+||-+.|++.... |+.+-+|.-....      +-....|.+|...+.++..  -.+.+.. ++.   .+  -..+|
T Consensus        25 N~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L  102 (216)
T PRK09902         25 NYRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL  102 (216)
T ss_pred             CcCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence            3477899999998875 4568888764221      2234678999999999953  2344444 222   11  24679


Q ss_pred             EEeccCC-CCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCc--EEEEeeccce
Q 007680          346 VLEFMPN-GSLEKWLYSHNY-FLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMV--AHVSDFGIYK  421 (593)
Q Consensus       346 v~e~~~~-gsL~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~--~kL~Dfg~a~  421 (593)
                      |+|-+++ .||.+++.+... ..+......+..+++..+.-||+.+    +.|+|+.+.||+++.++.  ++++||.-++
T Consensus       103 VTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G----v~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        103 VTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN----RQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             EEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC----CcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            9997753 589998866432 4677888899999999999999655    999999999999986666  9999998655


Q ss_pred             e
Q 007680          422 L  422 (593)
Q Consensus       422 ~  422 (593)
                      .
T Consensus       179 ~  179 (216)
T PRK09902        179 R  179 (216)
T ss_pred             h
Confidence            3

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.48  E-value=1.1e-08  Score=86.90  Aligned_cols=72  Identities=19%  Similarity=0.263  Sum_probs=35.4

Q ss_pred             EEEeeCccccccCChhhhh--CCCCCcEEECCCCcCcccCCccCC-CCCCCcEEEccCCcccccccccccCCCCchhh
Q 007680            3 ILTLEGNQLSGRLPSTIGH--SLPNIEYLLLTANNLTGTIPNSIT-NATKLIVLDLGFNSFSGHILNTFGNLRHLSVL   77 (593)
Q Consensus         3 ~L~Ls~n~l~~~lp~~~~~--~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L   77 (593)
                      .+|||+++|- .++..+..  ....|+..+|++|.+. ..|+.|. ..+.+++|+|++|.|+ .+|..+..++.|+.|
T Consensus        31 ~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~l  105 (177)
T KOG4579|consen   31 FLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSL  105 (177)
T ss_pred             hcccccchhh-HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhc
Confidence            3455555554 45444332  1223444456666655 3444443 2335555555555555 455555555555444

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.42  E-value=3.3e-08  Score=83.99  Aligned_cols=74  Identities=22%  Similarity=0.411  Sum_probs=66.8

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVL   77 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L   77 (593)
                      |...+|++|.+. ..|+.+....+.++.|+|++|+|+ .+|.++..++.|+.|+++.|.|. ..|..+..|.+|-.|
T Consensus        55 l~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~L  128 (177)
T KOG4579|consen   55 LTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDML  128 (177)
T ss_pred             EEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHh
Confidence            456899999999 899999877789999999999999 79999999999999999999999 788888777777777

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.41  E-value=1.9e-06  Score=80.97  Aligned_cols=137  Identities=16%  Similarity=0.173  Sum_probs=91.7

Q ss_pred             hhhccccccccCccCcccEEEEEeCCCCeEEEEEeehhhHHHHHH---------HHHHHHHHhhcCC---CCcceeeeee
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRS---------FDSECEVLRNVRH---RNLIKILSSY  337 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~h---~niv~l~~~~  337 (593)
                      ...+|.+.+.+-......|.+... +|+.+++|..+.......+.         ..+++..+.+++.   .....++.+.
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            456788888888888777777766 57899999987654322222         2344444444432   2222322222


Q ss_pred             e-----cCCceEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcE
Q 007680          338 S-----NPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVA  412 (593)
Q Consensus       338 ~-----~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~  412 (593)
                      +     -....+++|||++|..|.+...     ++.    .++..+.+++.-+|+.|    ++|+|..|.|+++++++ +
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~G----~~HGD~hpgNFlv~~~~-i  173 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKHG----FYHGDPHPGNFLVSNNG-I  173 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHcC----CccCCCCcCcEEEECCc-E
Confidence            2     2234568999999988876532     222    24566778899999654    99999999999998665 8


Q ss_pred             EEEeeccce
Q 007680          413 HVSDFGIYK  421 (593)
Q Consensus       413 kL~Dfg~a~  421 (593)
                      +++||+..+
T Consensus       174 ~iID~~~k~  182 (229)
T PF06176_consen  174 RIIDTQGKR  182 (229)
T ss_pred             EEEECcccc
Confidence            999998644

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.40  E-value=4.3e-06  Score=80.77  Aligned_cols=138  Identities=14%  Similarity=0.147  Sum_probs=85.7

Q ss_pred             cccCccCcccEEEEEeCCCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCC--CcceeeeeeecCCceEEEEeccCCCC-
Q 007680          278 NLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHR--NLIKILSSYSNPDFKALVLEFMPNGS-  354 (593)
Q Consensus       278 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~~~~~lv~e~~~~gs-  354 (593)
                      ..||+|..+.||+.   .|..+++|......  ......+|.++++.+..-  .+.+.+++....+...+|||+++|.+ 
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~   81 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS   81 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence            57899999999984   25568889876543  224568899999998643  35677888777778889999998863 


Q ss_pred             HHHHH---------------------hhCC-CCCCHHHHHH-HHH----------HHHH-HHHHHHhcCCCCCeEecCCC
Q 007680          355 LEKWL---------------------YSHN-YFLDILERLN-IMI----------DVGS-ALEYLHNGHSSVHIIHCDLK  400 (593)
Q Consensus       355 L~~~l---------------------~~~~-~~l~~~~~~~-i~~----------~i~~-~L~~LH~~~~~~~ivH~Dlk  400 (593)
                      +...+                     +.-. .......... +..          .+.+ ..++|........++|+|+.
T Consensus        82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~  161 (226)
T TIGR02172        82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ  161 (226)
T ss_pred             hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence            22111                     1100 0011111000 000          0111 12222211113457899999


Q ss_pred             CCCeeeCCCCcEEEEeeccce
Q 007680          401 PTNILLDENMVAHVSDFGIYK  421 (593)
Q Consensus       401 p~NIll~~~~~~kL~Dfg~a~  421 (593)
                      |.||++++++ +.++||+.+.
T Consensus       162 ~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       162 IGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CCcEEEcCCC-cEEEechhcC
Confidence            9999999888 9999999765

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=98.40  E-value=3e-08  Score=96.93  Aligned_cols=160  Identities=24%  Similarity=0.283  Sum_probs=81.7

Q ss_pred             CcEEEeeCccccccCChhhh---hCCCCCcEEECCCCcCcccC-------------CccCCCCCCCcEEEccCCcccccc
Q 007680            1 MRILTLEGNQLSGRLPSTIG---HSLPNIEYLLLTANNLTGTI-------------PNSITNATKLIVLDLGFNSFSGHI   64 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~---~~l~~L~~L~L~~N~l~~~~-------------p~~~~~l~~L~~L~L~~N~l~~~~   64 (593)
                      |++||||.|.+...-+..+.   ++..+|++|+|++|-|...-             .....+-++|+++..++|++....
T Consensus        94 L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~g  173 (382)
T KOG1909|consen   94 LQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENGG  173 (382)
T ss_pred             eeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeecccccccc
Confidence            56677777777644444333   23566777777777665211             111234456777777777775322


Q ss_pred             ----cccccCCCCchhhhhhcceeeccCC-cccccCCCcccccEEEccCCcccCc----CCCCCCCCCCCCEecCCCccC
Q 007680           65 ----LNTFGNLRHLSVLSLLMFGIRLTGN-KLYGRIPPCLVLTVLDVSRNQLSGD----IPSTIGGRVDLETLSLASNQF  135 (593)
Q Consensus        65 ----p~~~~~l~~L~~L~l~~n~l~l~~n-~l~~~~~~~~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l  135 (593)
                          ...|...+.|+.+.+..|.|.-.+- -+...+..|..|+.|||..|.++..    +..++..+++|++|+++++.+
T Consensus       174 a~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll  253 (382)
T KOG1909|consen  174 ATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLL  253 (382)
T ss_pred             HHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeeccccccc
Confidence                2345556666666222222221111 1112233444566666666665421    223444555666666666666


Q ss_pred             CCCCCccc-----cCCcccccccccccccc
Q 007680          136 QGPIPESV-----GSLISLESLDLSGNNLS  160 (593)
Q Consensus       136 ~~~~p~~l-----~~~~~L~~L~l~~N~l~  160 (593)
                      +..-..+|     ...++|+.|.|.+|.++
T Consensus       254 ~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt  283 (382)
T KOG1909|consen  254 ENEGAIAFVDALKESAPSLEVLELAGNEIT  283 (382)
T ss_pred             ccccHHHHHHHHhccCCCCceeccCcchhH
Confidence            53322221     12456666666666665

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.39  E-value=1.1e-08  Score=108.30  Aligned_cols=122  Identities=28%  Similarity=0.287  Sum_probs=61.2

Q ss_pred             CcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhhcceeeccCCcccccCCCcc----cc
Q 007680           26 IEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCL----VL  101 (593)
Q Consensus        26 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~l~~n~l~~~~~~~~----~L  101 (593)
                      |...+.+.|.|. ....++.-++.|+.|||++|+++..-  .+..|+.|.+|       |++.|.|. .+|.+.    .|
T Consensus       166 L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhL-------DlsyN~L~-~vp~l~~~gc~L  234 (1096)
T KOG1859|consen  166 LATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHL-------DLSYNCLR-HVPQLSMVGCKL  234 (1096)
T ss_pred             HhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH--HHHhccccccc-------ccccchhc-cccccchhhhhh
Confidence            344455555555 45555555555666666666655322  45555555555       55555554 333221    15


Q ss_pred             cEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCC-ccccCCcccccccccccccc
Q 007680          102 TVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIP-ESVGSLISLESLDLSGNNLS  160 (593)
Q Consensus       102 ~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p-~~l~~~~~L~~L~l~~N~l~  160 (593)
                      +.|.+++|.++ .+- .+.+|.+|+.||+++|-|.+.-- .-+..+..|..|+|.+|++.
T Consensus       235 ~~L~lrnN~l~-tL~-gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~  292 (1096)
T KOG1859|consen  235 QLLNLRNNALT-TLR-GIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC  292 (1096)
T ss_pred             eeeeecccHHH-hhh-hHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence            55666666555 333 24555556666666665553210 11233444555566666554

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.34  E-value=5.3e-06  Score=78.74  Aligned_cols=153  Identities=19%  Similarity=0.194  Sum_probs=99.2

Q ss_pred             CCHHHHHHhhhcccccc---ccCccCcccEEEEEeCCCCeEEEEEeehhhHHH------------------------HHH
Q 007680          262 TSYLDIQRATDEFNECN---LLGTSSFGSVYKGTISDGTDVAIKVFNLQLERA------------------------FRS  314 (593)
Q Consensus       262 ~~~~~~~~~~~~~~~~~---~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~------------------------~~~  314 (593)
                      .+...+....++..+..   .|+.|.-+.||+|...++..+|+|+++......                        ..-
T Consensus        35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W  114 (268)
T COG1718          35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW  114 (268)
T ss_pred             HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence            34444555555555544   455566678999998889999999997542100                        011


Q ss_pred             HHHHHHHHhhcC--CCCcceeeeeeecCCceEEEEeccCCCC-HHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 007680          315 FDSECEVLRNVR--HRNLIKILSSYSNPDFKALVLEFMPNGS-LEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSS  391 (593)
Q Consensus       315 ~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~gs-L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~  391 (593)
                      ..+|..-|.++.  +-.+.+.+++.    .-.+||||+.... -.-.+..-  .+...+...+..++++.+.-|-.   .
T Consensus       115 ~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv--~~e~~e~~~~~~~~v~~~~~l~~---~  185 (268)
T COG1718         115 ARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKDV--PLELEEAEGLYEDVVEYMRRLYK---E  185 (268)
T ss_pred             HHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcccC--CcCchhHHHHHHHHHHHHHHHHH---h
Confidence            345666666663  33444444443    3369999985431 00011111  23344677888888888888875   2


Q ss_pred             CCeEecCCCCCCeeeCCCCcEEEEeeccceecC
Q 007680          392 VHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG  424 (593)
Q Consensus       392 ~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~  424 (593)
                      .++||+||+.=|||+. ++.+.++|||-|....
T Consensus       186 a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         186 AGLVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             cCcccccchhhheEEE-CCeEEEEECccccccC
Confidence            4699999999999999 8899999999887654

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.32  E-value=1.2e-08  Score=107.89  Aligned_cols=122  Identities=27%  Similarity=0.316  Sum_probs=78.0

Q ss_pred             cEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccc-cccCCCCchhhhhh
Q 007680            2 RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILN-TFGNLRHLSVLSLL   80 (593)
Q Consensus         2 ~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~l~   80 (593)
                      .+.++++|+|. .+-..+- -++.|+.|+|++|+++. .. .+..+++|+.|||+.|+|+ .+|. ...++. |+.|   
T Consensus       167 ~~a~fsyN~L~-~mD~SLq-ll~ale~LnLshNk~~~-v~-~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L---  237 (1096)
T KOG1859|consen  167 ATASFSYNRLV-LMDESLQ-LLPALESLNLSHNKFTK-VD-NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLL---  237 (1096)
T ss_pred             hhhhcchhhHH-hHHHHHH-HHHHhhhhccchhhhhh-hH-HHHhcccccccccccchhc-cccccchhhhh-heee---
Confidence            34567777776 5665554 37778888888888773 33 6777778888888888887 4443 233333 6666   


Q ss_pred             cceeeccCCcccc--cCCCcccccEEEccCCcccCcCC-CCCCCCCCCCEecCCCccCC
Q 007680           81 MFGIRLTGNKLYG--RIPPCLVLTVLDVSRNQLSGDIP-STIGGRVDLETLSLASNQFQ  136 (593)
Q Consensus        81 ~n~l~l~~n~l~~--~~~~~~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~  136 (593)
                          .+.+|.++.  .+-++.+|+.||+++|-|.+.-- ..+..|..|..|+|.+|.+-
T Consensus       238 ----~lrnN~l~tL~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~  292 (1096)
T KOG1859|consen  238 ----NLRNNALTTLRGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC  292 (1096)
T ss_pred             ----eecccHHHhhhhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence                666676663  23445567778888887763221 11345566777788888775

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	593
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		2e-33
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		5e-32
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		5e-32
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-31
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-25
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		3e-25
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		5e-25
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		3e-23
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-21
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-21
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-21
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		4e-21
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		5e-21
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		7e-21
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		7e-21
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		7e-21
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		7e-21
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		7e-21
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		8e-21
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		8e-21
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		9e-21
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		9e-21
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-20
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		1e-20
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-20
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		1e-20
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		2e-20
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-20
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		3e-20
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		3e-19
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		1e-18
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-18
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-18
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-18
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		3e-18
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		3e-18
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-18
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		5e-18
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		5e-18
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		5e-18
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		5e-18
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		6e-18
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		6e-18
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		6e-18
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		6e-18
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-18
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-18
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		7e-18
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		7e-18
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		7e-18
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		7e-18
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		8e-18
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		8e-18
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		8e-18
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		8e-18
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		8e-18
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		8e-18
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		8e-18
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		8e-18
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		8e-18
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		9e-18
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		9e-18
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		1e-17
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		1e-17
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		1e-17
4h58_A	275	Braf In Complex With Compound 3 Length = 275		1e-17
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-17
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-17
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-17
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-17
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-17
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		3e-17
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		3e-17
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		3e-17
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		4e-17
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		4e-17
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		4e-17
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		5e-17
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		7e-17
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		7e-17
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-16
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		1e-16
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-16
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		3e-16
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		3e-16
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		4e-16
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		4e-16
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		7e-16
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		8e-16
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		9e-16
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		1e-15
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		1e-15
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		1e-15
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-15
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-15
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		1e-15
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		1e-15
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		1e-15
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		7e-14
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		1e-15
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		1e-15
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		6e-14
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-15
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-15
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-15
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-15
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-15
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		2e-15
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-15
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		2e-15
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-15
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-15
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-15
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-15
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		3e-15
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		3e-15
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		3e-15
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		3e-15
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		3e-15
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		3e-15
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		3e-15
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		3e-15
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		3e-15
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		3e-15
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		3e-15
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		3e-15
2pl0_A	289	Lck Bound To Imatinib Length = 289		3e-15
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		3e-15
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		3e-15
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		3e-15
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-15
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-15
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		4e-15
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		4e-15
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		4e-15
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		4e-15
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		4e-15
3a4o_X	286	Lyn Kinase Domain Length = 286		4e-15
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		4e-15
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		5e-15
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		6e-15
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		7e-15
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		7e-15
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		7e-15
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		7e-15
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		8e-15
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		1e-14
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		1e-14
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		1e-14
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		1e-14
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		1e-14
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-14
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		1e-14
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-14
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-14
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-14
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-14
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-14
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		2e-14
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		2e-14
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-14
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		2e-14
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		2e-14
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-14
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-14
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-14
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		2e-14
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		3e-14
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		3e-14
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-14
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		3e-14
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-14
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		3e-14
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		3e-14
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		3e-14
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		3e-14
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		4e-14
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		4e-14
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		4e-14
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		4e-14
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		4e-14
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		4e-14
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		4e-14
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		4e-14
1fvr_A	327	Tie2 Kinase Domain Length = 327		4e-14
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		4e-14
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		4e-14
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		4e-14
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		4e-14
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		5e-14
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		5e-14
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		5e-14
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		5e-14
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		5e-14
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		5e-14
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		5e-14
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		5e-14
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		5e-14
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		5e-14
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		5e-14
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		5e-14
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		5e-14
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		6e-14
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		6e-14
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		6e-14
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		6e-14
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		6e-14
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		7e-14
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		7e-14
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		7e-14
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		8e-14
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		8e-14
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		8e-14
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		8e-14
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		9e-14
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		9e-14
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		9e-14
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		9e-14
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		9e-14
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		9e-14
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		9e-14
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		9e-14
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-13
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-13
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		1e-13
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-13
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-13
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-13
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-13
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-13
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-13
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-13
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-13
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-13
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-13
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-13
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-13
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-13
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-13
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-13
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-13
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-13
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-13
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-13
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-13
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-13
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-13
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		3e-13
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		3e-13
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		3e-13
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		3e-13
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		3e-13
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		3e-13
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		3e-13
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		3e-13
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-13
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		3e-13
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		3e-13
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		3e-13
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		4e-13
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-13
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		4e-13
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		4e-13
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		4e-13
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		4e-13
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-13
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		4e-13
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		4e-13
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		4e-13
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		4e-13
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		5e-13
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		5e-13
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		5e-13
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		5e-13
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		5e-13
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		5e-13
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-13
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		5e-13
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-13
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		5e-13
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		6e-13
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		6e-13
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		6e-13
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		6e-13
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-13
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		6e-13
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		6e-13
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		6e-13
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		7e-13
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		7e-13
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		7e-13
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		8e-13
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		8e-13
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		8e-13
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		8e-13
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		8e-13
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		8e-13
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		9e-13
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		9e-13
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		9e-13
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		9e-13
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		1e-12
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-12
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-12
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		1e-12
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-12
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-12
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		1e-12
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		1e-12
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		1e-12
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-12
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-12
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-12
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-12
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		1e-12
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-12
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-12
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		1e-12
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-12
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-12
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-12
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-12
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-12
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-12
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-12
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-12
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-12
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-12
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-12
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-12
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-12
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-12
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-12
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-12
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-12
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		2e-12
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-12
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-12
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-12
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		2e-12
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-12
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-12
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		2e-12
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		3e-12
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-12
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		3e-12
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		3e-12
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		3e-12
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		3e-12
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		3e-12
3g51_A	325	Structural Diversity Of The Active Conformation Of		3e-12
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		3e-12
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		4e-12
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		4e-12
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		4e-12
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		5e-12
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-12
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		5e-12
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		5e-12
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-12
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		5e-12
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		5e-12
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		6e-12
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-12
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		7e-12
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		8e-12
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		8e-12
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-12
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-12
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		9e-12
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		9e-12
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-12
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-11
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-11
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-11
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-11
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		1e-11
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-11
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-11
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-11
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-11
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-11
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		1e-11
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		1e-11
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-11
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-11
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-11
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-11
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-11
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-11
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-11
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-11
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-11
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-11
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		3e-11
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		3e-11
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		3e-11
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		3e-11
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		3e-11
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		3e-11
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		3e-11
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		3e-11
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-11
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		4e-11
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		4e-11
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-11
4ae9_A	343	Structure And Function Of The Human Sperm-specific		4e-11
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-11
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		4e-11
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-11
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		5e-11
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		5e-11
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		5e-11
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		5e-11
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-11
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		6e-11
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		6e-11
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		6e-11
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		6e-11
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		6e-11
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		6e-11
4ae6_A	343	Structure And Function Of The Human Sperm-specific		6e-11
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		6e-11
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-11
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		6e-11
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		6e-11
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		6e-11
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		6e-11
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		7e-11
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		8e-11
3a7f_A	303	Human Mst3 Kinase Length = 303		8e-11
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		9e-11
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		9e-11
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		9e-11
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		9e-11
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		9e-11
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-10
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-10
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-10
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		1e-10
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		1e-10
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-10
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-10
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-10
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		1e-10
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-10
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-10
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-10
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		2e-10
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		2e-10
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-10
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-10
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		2e-10
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-10
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-10
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		2e-10
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-10
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-10
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-10
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-10
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		2e-10
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-10
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-10
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-10
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		3e-10
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		3e-10
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		3e-10
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		3e-10
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		3e-10
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-10
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		3e-10
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		3e-10
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		3e-10
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-10
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		3e-10
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		3e-10
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		3e-10
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		3e-10
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		3e-10
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		3e-10
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		3e-10
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		3e-10
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-10
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		3e-10
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		3e-10
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		3e-10
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		4e-10
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		4e-10
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		4e-10
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		4e-10
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		5e-10
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		5e-10
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		5e-10
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		5e-10
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		5e-10
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		5e-10
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		5e-10
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		5e-10
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		5e-10
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		5e-10
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		5e-10
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		5e-10
4fie_A	423	Full-Length Human Pak4 Length = 423		5e-10
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		5e-10
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		5e-10
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		6e-10
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		6e-10
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		6e-10
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		6e-10
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		6e-10
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		6e-10
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		6e-10
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		6e-10
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		6e-10
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		7e-10
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		7e-10
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		8e-10
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		8e-10
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		9e-10
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		9e-10
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-09
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		1e-09
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		1e-09
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		1e-09
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		1e-09
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		1e-09
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		1e-09
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		1e-09
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-09
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-09
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		1e-09
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-09
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		1e-09
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-09
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-09
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		1e-09
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-09
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-09
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		2e-09
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		2e-09
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		2e-09
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-09
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		2e-09
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		2e-09
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-09
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-09
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		2e-09
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-09
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-09
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-09
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-09
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-09
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-09
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-09
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-09
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-09
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-09
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-09
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-09
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-09
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-09
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-09
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-09
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-09
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-09
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-09
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-09
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-09
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-09
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-09
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-09
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-09
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-09
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-09
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-09
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-09
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		2e-09
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-09
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-09
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-09
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-09
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		2e-09
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		3e-09
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		3e-09
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		3e-09
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		3e-09
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		3e-09
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-09
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		3e-09
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-09
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		3e-09
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		3e-09
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-09
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		4e-09
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-09
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		4e-09
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		4e-09
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		4e-09
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		4e-09
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		4e-09
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-09
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		5e-09
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		5e-09
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		5e-09
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		5e-09
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		5e-09
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		5e-09
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		5e-09
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		5e-09
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-09
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		5e-09
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		5e-09
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		5e-09
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		5e-09
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		6e-09
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		6e-09
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		6e-09
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		6e-09
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		6e-09
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		6e-09
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		6e-09
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		6e-09
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		6e-09
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		6e-09
3kk9_A	282	Camkii Substrate Complex B Length = 282		7e-09
3kk8_A	284	Camkii Substrate Complex A Length = 284		7e-09
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		8e-09
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		8e-09
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		8e-09
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		9e-09
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		9e-09
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		9e-09
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		9e-09
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		9e-09
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		9e-09
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		9e-09
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		1e-08
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-08
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		1e-08
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		1e-08
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-08
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		1e-08
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		1e-08
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-08
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		1e-08
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-08
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		1e-08
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-08
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-08
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		2e-08
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-08
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-08
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-08
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		2e-08
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-08
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-08
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-08
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-08
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-08
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-08
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-08
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-08
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-08
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-08
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-08
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-08
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-08
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-08
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-08
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-08
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-08
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-08
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-08
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		2e-08
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-08
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-08
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-08
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		2e-08
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-08
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		3e-08
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		3e-08
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-08
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		3e-08
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-08
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		3e-08
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		3e-08
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-08
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		3e-08
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		3e-08
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-08
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		3e-08
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		3e-08
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-08
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		3e-08
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		4e-08
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		4e-08
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		4e-08
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		4e-08
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		4e-08
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		4e-08
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		4e-08
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		4e-08
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		4e-08
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		4e-08
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-08
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		4e-08
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-08
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		5e-08
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		5e-08
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		5e-08
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		5e-08
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		5e-08
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		5e-08
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		5e-08
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		5e-08
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		5e-08
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		5e-08
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		6e-08
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		6e-08
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		6e-08
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		6e-08
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		6e-08
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		7e-08
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		7e-08
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		7e-08
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		7e-08
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		7e-08
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		8e-08
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		9e-08
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-07
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-07
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-07
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		1e-07
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		1e-07
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		1e-07
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		1e-07
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-07
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-07
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		1e-07
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-07
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-07
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-07
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		2e-07
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-07
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		2e-07
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-07
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-07
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		3e-07
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-07
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		3e-07
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-07
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		3e-07
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		3e-07
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		4e-07
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		4e-07
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		4e-07
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		5e-07
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		5e-07
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		6e-07
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		6e-07
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		7e-07
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		7e-07
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		7e-07
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		8e-07
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		8e-07
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		8e-07
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		8e-07
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		8e-07
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		8e-07
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-07
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		8e-07
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		8e-07
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		9e-07
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		9e-07
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		9e-07
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-06
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		1e-06
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		1e-06
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		1e-06
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-06
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-06
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-06
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		1e-06
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-06
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		1e-06
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-06
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-06
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-06
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-06
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-06
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		1e-06
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-06
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		1e-06
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-06
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-06
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		1e-06
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-06
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		1e-06
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-06
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-06
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		1e-06
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		1e-06
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		1e-06
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		1e-06
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-06
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-06
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		1e-06
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-06
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		1e-06
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		1e-06
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		1e-06
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		1e-06
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-06
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		1e-06
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		1e-06
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		1e-06
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		1e-06
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-06
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		1e-06
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-06
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-06
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-06
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		1e-06
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		1e-06
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		1e-06
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-06
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-06
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		1e-06
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-06
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		1e-06
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		1e-06
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		1e-06
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-06
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		2e-06
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-06
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-06
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		2e-06
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		2e-06
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-06
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-06
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		2e-06
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		2e-06
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-06
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-06
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-06
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		2e-06
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		2e-06
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		2e-06
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-06
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		3e-06
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		3e-06
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		3e-06
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		3e-06
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		3e-06
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-06
3soa_A	444	Full-Length Human Camkii Length = 444		3e-06
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-06
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		4e-06
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		4e-06
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-06
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		4e-06
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		4e-06
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		5e-06
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		5e-06
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-06
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		6e-06
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		6e-06
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		6e-06
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		6e-06
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		7e-06
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		7e-06
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		7e-06
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		8e-06
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		8e-06
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		8e-06
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		9e-06
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		9e-06
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-05
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		1e-05
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		1e-05
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		1e-05
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		1e-05
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-05
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-05
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-05
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		2e-05
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		2e-05
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-05
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		2e-05
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-05
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		2e-05
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		2e-05
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		2e-05
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		2e-05
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		2e-05
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-05
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		2e-05
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		2e-05
2oza_A	356	Structure Of P38alpha Complex Length = 356		2e-05
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		2e-05
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		2e-05
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		3e-05
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		3e-05
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		3e-05
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		3e-05
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		3e-05
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		3e-05
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		3e-05
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		3e-05
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		3e-05
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		3e-05
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		3e-05
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		3e-05
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		3e-05
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		3e-05
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		3e-05
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-05
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		4e-05
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		4e-05
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		4e-05
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		4e-05
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		4e-05
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		4e-05
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		4e-05
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		4e-05
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		4e-05
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		4e-05
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		4e-05
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		4e-05
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		4e-05
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		4e-05
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		5e-05
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-05
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		5e-05
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		5e-05
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-05
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		5e-05
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		5e-05
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		5e-05
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		5e-05
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		5e-05
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		5e-05
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		5e-05
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		6e-05
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		6e-05
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		6e-05
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		6e-05
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		7e-05
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		7e-05
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		7e-05
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		7e-05
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		9e-05
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		9e-05
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		9e-05
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		9e-05
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		9e-05
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		9e-05
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		9e-05
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		9e-05
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		9e-05
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		1e-04
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		1e-04
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		1e-04
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-04
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		1e-04
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		1e-04
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		1e-04
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		1e-04
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		1e-04
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		1e-04
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		1e-04
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		1e-04
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-04
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-04
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		1e-04
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-04
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		2e-04
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-04
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		2e-04
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		2e-04
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		2e-04
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		2e-04
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		2e-04
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-04
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		2e-04
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		2e-04
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-04
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		3e-04
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		3e-04
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		4e-04
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		5e-04
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		5e-04
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		5e-04
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		5e-04
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		5e-04
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		5e-04
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		5e-04
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		6e-04
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		6e-04
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		6e-04
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		6e-04
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		6e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  140 bits (353), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 111/341 (32%), Positives = 160/341 (46%), Gaps = 30/341 (8%)
Query: 243 RNTKKSDHEDFLP--------LAIWRRTSYLDIQRATDEFNECNLLGTSSFGSVYKGTIS 294
           R  K  DH   +P        L   +R S  ++Q A+D F+  N+LG   FG VYKG ++
Sbjct: 1   RRKKPQDHFFDVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA 60
Query: 295 DGTDVAIKVFNLQLERAFR-SFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNG 353
           DGT VA+K    +  +     F +E E++    HRNL+++      P  + LV  +M NG
Sbjct: 61  DGTLVAVKRLKEERXQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANG 120
Query: 354 SLEKWLYSH---NYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENM 410
           S+   L         LD  +R  I +     L YLH+ H    IIH D+K  NILLDE  
Sbjct: 121 SVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHD-HCDPKIIHRDVKAANILLDEEF 179
Query: 411 VAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
            A V DFG+ KL+   +  V   +   TIG++APEY   G  S K DV+ YGV+L+E  T
Sbjct: 180 EAVVGDFGLAKLMDYKDXHVXXAVR-GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 238
Query: 471 RKRPTDEMFIG---EMSLRRWVKESLPH-GLTEVVDANLVREEQAFSAKMDCILSIMDFA 526
            +R  D   +    ++ L  WVK  L    L  +VD +L       + K + +  ++  A
Sbjct: 239 GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDL-----QGNYKDEEVEQLIQVA 293
Query: 527 LDCCMESPDMRINMTDAAAKLKKIKVKFLDDAAATNWRNFH 567
           L C   SP  R  M++    L+        D  A  W  + 
Sbjct: 294 LLCTQSSPMERPKMSEVVRMLE-------GDGLAERWEEWQ 327

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  135 bits (341), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 106/318 (33%), Positives = 152/318 (47%), Gaps = 26/318 (8%)
Query: 260 RRTSYLDIQRATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLER---AFRSFD 316
           +R S  ++Q A+D F   N+LG   FG VYKG ++DG  VA+K   L+ ER       F 
Sbjct: 18  KRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVK--RLKEERTQGGELQFQ 75
Query: 317 SECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSH---NYFLDILERLN 373
           +E E++    HRNL+++      P  + LV  +M NGS+   L         LD  +R  
Sbjct: 76  TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 135
Query: 374 IMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQT 433
           I +     L YLH+ H    IIH D+K  NILLDE   A V DFG+ KL+   +  V   
Sbjct: 136 IALGSARGLAYLHD-HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXA 194
Query: 434 MTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIG---EMSLRRWVK 490
           +    IG++APEY   G  S K DV+ YGV+L+E  T +R  D   +    ++ L  WVK
Sbjct: 195 VR-GXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253
Query: 491 ESLPH-GLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKK 549
             L    L  +VD +L       + K + +  ++  AL C   SP  R  M++    L+ 
Sbjct: 254 GLLKEKKLEALVDVDL-----QGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE- 307
Query: 550 IKVKFLDDAAATNWRNFH 567
                  D  A  W  + 
Sbjct: 308 ------GDGLAERWEEWQ 319

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  135 bits (341), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 97/293 (33%), Positives = 151/293 (51%), Gaps = 14/293 (4%)
Query: 261 RTSYLDIQRATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECE 320
           R   +D++ AT+ F+   L+G   FG VYKG + DG  VA+K    +  +    F++E E
Sbjct: 28  RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIE 87
Query: 321 VLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHN---YFLDILERLNIMID 377
            L   RH +L+ ++      +   L+ ++M NG+L++ LY  +     +   +RL I I 
Sbjct: 88  TLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIG 147
Query: 378 VGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMA 437
               L YLH    +  IIH D+K  NILLDEN V  ++DFGI K   E + +    +   
Sbjct: 148 AARGLHYLH----TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKG 203
Query: 438 TIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEM-SLRRWVKESLPHG 496
           T+GY+ PEY ++G ++ K DVYS+GV+L E    +    +    EM +L  W  ES  +G
Sbjct: 204 TLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNG 263
Query: 497 -LTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLK 548
            L ++VD NL     A   + + +    D A+ C   S + R +M D   KL+
Sbjct: 264 QLEQIVDPNL-----ADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  134 bits (337), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 97/293 (33%), Positives = 150/293 (51%), Gaps = 14/293 (4%)
Query: 261 RTSYLDIQRATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECE 320
           R   +D++ AT+ F+   L+G   FG VYKG + DG  VA+K    +  +    F++E E
Sbjct: 28  RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIE 87
Query: 321 VLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHN---YFLDILERLNIMID 377
            L   RH +L+ ++      +   L+ ++M NG+L++ LY  +     +   +RL I I 
Sbjct: 88  TLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIG 147
Query: 378 VGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMA 437
               L YLH    +  IIH D+K  NILLDEN V  ++DFGI K   E   +    +   
Sbjct: 148 AARGLHYLH----TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKG 203
Query: 438 TIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEM-SLRRWVKESLPHG 496
           T+GY+ PEY ++G ++ K DVYS+GV+L E    +    +    EM +L  W  ES  +G
Sbjct: 204 TLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNG 263
Query: 497 -LTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLK 548
            L ++VD NL     A   + + +    D A+ C   S + R +M D   KL+
Sbjct: 264 QLEQIVDPNL-----ADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 77/227 (33%), Positives = 120/227 (52%), Gaps = 18/227 (7%)
Query: 263 SYLDIQRATDEFNE------CNLLGTSSFGSVYKGTISDGTDVAIK----VFNLQLERAF 312
           S+ +++  T+ F+E       N +G   FG VYKG +++ T VA+K    + ++  E   
Sbjct: 16  SFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTT-VAVKKLAAMVDITTEELK 74
Query: 313 RSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERL 372
           + FD E +V+   +H NL+++L   S+ D   LV  +MPNGSL   L   +    +   +
Sbjct: 75  QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHM 134
Query: 373 NIMIDVGSA--LEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSV 430
              I  G+A  + +LH  H     IH D+K  NILLDE   A +SDFG+ +   +   +V
Sbjct: 135 RCKIAQGAANGINFLHENHH----IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190
Query: 431 RQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDE 477
             +  + T  YMAPE  L G ++ K D+YS+GV+L+E  T     DE
Sbjct: 191 MXSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDE 236

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  113 bits (282), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 77/227 (33%), Positives = 119/227 (52%), Gaps = 18/227 (7%)
Query: 263 SYLDIQRATDEFNE------CNLLGTSSFGSVYKGTISDGTDVAIK----VFNLQLERAF 312
           S+ +++  T+ F+E       N +G   FG VYKG +++ T VA+K    + ++  E   
Sbjct: 16  SFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTT-VAVKKLAAMVDITTEELK 74
Query: 313 RSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERL 372
           + FD E +V+   +H NL+++L   S+ D   LV  +MPNGSL   L   +    +   +
Sbjct: 75  QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHM 134
Query: 373 NIMIDVGSA--LEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSV 430
              I  G+A  + +LH  H     IH D+K  NILLDE   A +SDFG+ +   +   +V
Sbjct: 135 RCKIAQGAANGINFLHENHH----IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190
Query: 431 RQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDE 477
                + T  YMAPE  L G ++ K D+YS+GV+L+E  T     DE
Sbjct: 191 MXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDE 236

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  112 bits (280), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 77/227 (33%), Positives = 118/227 (51%), Gaps = 18/227 (7%)
Query: 263 SYLDIQRATDEFNE------CNLLGTSSFGSVYKGTISDGTDVAIK----VFNLQLERAF 312
           S+ +++  T+ F+E       N +G   FG VYKG +++ T VA+K    + ++  E   
Sbjct: 10  SFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEELK 68
Query: 313 RSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERL 372
           + FD E +V+   +H NL+++L   S+ D   LV  +MPNGSL   L   +    +   +
Sbjct: 69  QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHM 128
Query: 373 NIMIDVGSA--LEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSV 430
              I  G+A  + +LH  H     IH D+K  NILLDE   A +SDFG+ +   +    V
Sbjct: 129 RCKIAQGAANGINFLHENHH----IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXV 184
Query: 431 RQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDE 477
                + T  YMAPE  L G ++ K D+YS+GV+L+E  T     DE
Sbjct: 185 MXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDE 230

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  106 bits (265), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 75/227 (33%), Positives = 113/227 (49%), Gaps = 18/227 (7%)
Query: 263 SYLDIQRATDEFNE------CNLLGTSSFGSVYKGTISDGTDVAIK----VFNLQLERAF 312
           S+ +++  T+ F+E       N  G   FG VYKG +++ T VA+K    + ++  E   
Sbjct: 7   SFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEELK 65
Query: 313 RSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYF--LDILE 370
           + FD E +V    +H NL+++L   S+ D   LV  + PNGSL   L   +    L    
Sbjct: 66  QQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHX 125
Query: 371 RLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSV 430
           R  I     + + +LH  H     IH D+K  NILLDE   A +SDFG+ +   +    V
Sbjct: 126 RCKIAQGAANGINFLHENHH----IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXV 181
Query: 431 RQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDE 477
             +  + T  Y APE  L G ++ K D+YS+GV+L+E  T     DE
Sbjct: 182 XXSRIVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDE 227

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 64/199 (32%), Positives = 105/199 (52%), Gaps = 9/199 (4%)
Query: 280 LGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFR--SFDSECEVLRNVRHRNLIKILSSY 337
           +G  SFG+V++     G+DVA+K+   Q   A R   F  E  +++ +RH N++  + + 
Sbjct: 45  IGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 338 SNPDFKALVLEFMPNGSLEKWLYSHNYF--LDILERLNIMIDVGSALEYLHNGHSSVHII 395
           + P   ++V E++  GSL + L+       LD   RL++  DV   + YLHN +    I+
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPP--IV 161
Query: 396 HCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAK 455
           H DLK  N+L+D+     V DFG+ +L  +    +       T  +MAPE   +   + K
Sbjct: 162 HRDLKSPNLLVDKKYTVKVCDFGLSRL--KASXFLXSKXAAGTPEWMAPEVLRDEPSNEK 219
Query: 456 CDVYSYGVLLMETFTRKRP 474
            DVYS+GV+L E  T ++P
Sbjct: 220 SDVYSFGVILWELATLQQP 238

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 62/195 (31%), Positives = 105/195 (53%), Gaps = 8/195 (4%)
Query: 280 LGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSN 339
           LG   FG V+ GT +  T VAIK        +  +F  E +V++ +RH  L+++ +  S 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 340 PDFKALVLEFMPNGSLEKWLYSH-NYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCD 398
                +V+E+M  GSL  +L      +L + + +++   + S + Y+      ++ +H D
Sbjct: 85  EPI-YIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER----MNYVHRD 139
Query: 399 LKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDV 458
           L+  NIL+ EN+V  V+DFG+ +L+ + E + RQ      I + APE  L G  + K DV
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFP-IKWTAPEAALYGRFTIKSDV 198
Query: 459 YSYGVLLMETFTRKR 473
           +S+G+LL E  T+ R
Sbjct: 199 WSFGILLTELTTKGR 213

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 62/195 (31%), Positives = 104/195 (53%), Gaps = 8/195 (4%)
Query: 280 LGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSN 339
           LG   FG V+ GT +  T VAIK        +  +F  E +V++ +RH  L+++ +  S 
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 74
Query: 340 PDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCD 398
                +V E+M  GSL  +L      +L + + +++   + S + Y+      ++ +H D
Sbjct: 75  EPI-XIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER----MNYVHRD 129
Query: 399 LKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDV 458
           L+  NIL+ EN+V  V+DFG+ +L+ + E + RQ      I + APE  L G  + K DV
Sbjct: 130 LRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFP-IKWTAPEAALYGRFTIKSDV 188
Query: 459 YSYGVLLMETFTRKR 473
           +S+G+LL E  T+ R
Sbjct: 189 WSFGILLTELTTKGR 203

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 62/195 (31%), Positives = 105/195 (53%), Gaps = 8/195 (4%)
Query: 280 LGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSN 339
           LG   FG V+ GT +  T VAIK        +  +F  E +V++ +RH  L+++ +  S 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 340 PDFKALVLEFMPNGSLEKWLYSH-NYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCD 398
                +V+E+M  GSL  +L      +L + + +++   + S + Y+      ++ +H D
Sbjct: 85  EPI-YIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER----MNYVHRD 139
Query: 399 LKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDV 458
           L+  NIL+ EN+V  V+DFG+ +L+ + E + RQ      I + APE  L G  + K DV
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSDV 198
Query: 459 YSYGVLLMETFTRKR 473
           +S+G+LL E  T+ R
Sbjct: 199 WSFGILLTELTTKGR 213

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 62/195 (31%), Positives = 104/195 (53%), Gaps = 8/195 (4%)
Query: 280 LGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSN 339
           LG   FG V+ GT +  T VAIK        +  +F  E +V++ +RH  L+++ +  S 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKIRHEKLVQLYAVVSE 84
Query: 340 PDFKALVLEFMPNGSLEKWLYSH-NYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCD 398
                +V E+M  GSL  +L      +L + + +++   + S + Y+      ++ +H D
Sbjct: 85  EPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER----MNYVHRD 139
Query: 399 LKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDV 458
           L+  NIL+ EN+V  V+DFG+ +L+ + E + RQ      I + APE  L G  + K DV
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSDV 198
Query: 459 YSYGVLLMETFTRKR 473
           +S+G+LL E  T+ R
Sbjct: 199 WSFGILLTELTTKGR 213

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 99.0 bits (245), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 105/199 (52%), Gaps = 9/199 (4%)
Query: 280 LGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFR--SFDSECEVLRNVRHRNLIKILSSY 337
           +G  SFG+V++     G+DVA+K+   Q   A R   F  E  +++ +RH N++  + + 
Sbjct: 45  IGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 338 SNPDFKALVLEFMPNGSLEKWLYSHNYF--LDILERLNIMIDVGSALEYLHNGHSSVHII 395
           + P   ++V E++  GSL + L+       LD   RL++  DV   + YLHN +    I+
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPP--IV 161
Query: 396 HCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAK 455
           H +LK  N+L+D+     V DFG+ +L  +    +       T  +MAPE   +   + K
Sbjct: 162 HRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLRDEPSNEK 219
Query: 456 CDVYSYGVLLMETFTRKRP 474
            DVYS+GV+L E  T ++P
Sbjct: 220 SDVYSFGVILWELATLQQP 238

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 99.0 bits (245), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 62/195 (31%), Positives = 104/195 (53%), Gaps = 8/195 (4%)
Query: 280 LGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSN 339
           LG   FG V+ GT +  T VAIK        +  +F  E +V++ +RH  L+++ +  S 
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 77
Query: 340 PDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCD 398
                +V E+M  GSL  +L      +L + + +++   + S + Y+      ++ +H D
Sbjct: 78  EPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER----MNYVHRD 132
Query: 399 LKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDV 458
           L+  NIL+ EN+V  V+DFG+ +L+ + E + RQ      I + APE  L G  + K DV
Sbjct: 133 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSDV 191
Query: 459 YSYGVLLMETFTRKR 473
           +S+G+LL E  T+ R
Sbjct: 192 WSFGILLTELTTKGR 206

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 99.0 bits (245), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 62/195 (31%), Positives = 104/195 (53%), Gaps = 8/195 (4%)
Query: 280 LGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSN 339
           LG   FG V+ GT +  T VAIK        +  +F  E +V++ +RH  L+++ +  S 
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 333
Query: 340 PDFKALVLEFMPNGSLEKWLYSH-NYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCD 398
                +V E+M  GSL  +L      +L + + +++   + S + Y+      ++ +H D
Sbjct: 334 EPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER----MNYVHRD 388
Query: 399 LKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDV 458
           L+  NIL+ EN+V  V+DFG+ +L+ + E + RQ      I + APE  L G  + K DV
Sbjct: 389 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSDV 447
Query: 459 YSYGVLLMETFTRKR 473
           +S+G+LL E  T+ R
Sbjct: 448 WSFGILLTELTTKGR 462

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 99.0 bits (245), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 64/198 (32%), Positives = 106/198 (53%), Gaps = 14/198 (7%)
Query: 280 LGTSSFGSVYKGTISDGTDVAIKVF---NLQLERAFRSFDSECEVLRNVRHRNLIKILSS 336
           LG   FG V+ GT +  T VAIK     N+  E    +F  E +V++ +RH  L+++ + 
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSPE----AFLQEAQVMKKLRHEKLVQLYAV 248
Query: 337 YSNPDFKALVLEFMPNGSLEKWLYSH-NYFLDILERLNIMIDVGSALEYLHNGHSSVHII 395
            S      +V E+M  GSL  +L      +L + + +++   + S + Y+      ++ +
Sbjct: 249 VSEEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER----MNYV 303
Query: 396 HCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAK 455
           H DL+  NIL+ EN+V  V+DFG+ +L+ + E + RQ      I + APE  L G  + K
Sbjct: 304 HRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIK 362
Query: 456 CDVYSYGVLLMETFTRKR 473
            DV+S+G+LL E  T+ R
Sbjct: 363 SDVWSFGILLTELTTKGR 380

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 99.0 bits (245), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 62/195 (31%), Positives = 104/195 (53%), Gaps = 8/195 (4%)
Query: 280 LGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSN 339
           LG   FG V+ GT +  T VAIK        +  +F  E +V++ +RH  L+++ +  S 
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 73
Query: 340 PDFKALVLEFMPNGSLEKWLYSH-NYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCD 398
                +V E+M  GSL  +L      +L + + +++   + S + Y+      ++ +H D
Sbjct: 74  EPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER----MNYVHRD 128
Query: 399 LKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDV 458
           L+  NIL+ EN+V  V+DFG+ +L+ + E + RQ      I + APE  L G  + K DV
Sbjct: 129 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSDV 187
Query: 459 YSYGVLLMETFTRKR 473
           +S+G+LL E  T+ R
Sbjct: 188 WSFGILLTELTTKGR 202

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 98.6 bits (244), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 62/195 (31%), Positives = 104/195 (53%), Gaps = 8/195 (4%)
Query: 280 LGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSN 339
           LG   FG V+ GT +  T VAIK        +  +F  E +V++ +RH  L+++ +  S 
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 75
Query: 340 PDFKALVLEFMPNGSLEKWLYSH-NYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCD 398
                +V E+M  GSL  +L      +L + + +++   + S + Y+      ++ +H D
Sbjct: 76  EPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER----MNYVHRD 130
Query: 399 LKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDV 458
           L+  NIL+ EN+V  V+DFG+ +L+ + E + RQ      I + APE  L G  + K DV
Sbjct: 131 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSDV 189
Query: 459 YSYGVLLMETFTRKR 473
           +S+G+LL E  T+ R
Sbjct: 190 WSFGILLTELTTKGR 204

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 98.6 bits (244), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 62/195 (31%), Positives = 104/195 (53%), Gaps = 8/195 (4%)
Query: 280 LGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSN 339
           LG   FG V+ GT +  T VAIK        +  +F  E +V++ +RH  L+++ +  S 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 340 PDFKALVLEFMPNGSLEKWLYSH-NYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCD 398
                +V E+M  GSL  +L      +L + + +++   + S + Y+      ++ +H D
Sbjct: 85  EPI-YIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER----MNYVHRD 139
Query: 399 LKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDV 458
           L+  NIL+ EN+V  V+DFG+ +L+ + E + RQ      I + APE  L G  + K DV
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSDV 198
Query: 459 YSYGVLLMETFTRKR 473
           +S+G+LL E  T+ R
Sbjct: 199 WSFGILLTELTTKGR 213

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 98.6 bits (244), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 62/195 (31%), Positives = 104/195 (53%), Gaps = 8/195 (4%)
Query: 280 LGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSN 339
           LG   FG V+ GT +  T VAIK        +  +F  E +V++ +RH  L+++ +  S 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 340 PDFKALVLEFMPNGSLEKWLYSH-NYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCD 398
                +V E+M  GSL  +L      +L + + +++   + S + Y+      ++ +H D
Sbjct: 85  EPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER----MNYVHRD 139
Query: 399 LKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDV 458
           L+  NIL+ EN+V  V+DFG+ +L+ + E + RQ      I + APE  L G  + K DV
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSDV 198
Query: 459 YSYGVLLMETFTRKR 473
           +S+G+LL E  T+ R
Sbjct: 199 WSFGILLTELTTKGR 213

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 98.6 bits (244), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 62/195 (31%), Positives = 104/195 (53%), Gaps = 8/195 (4%)
Query: 280 LGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSN 339
           LG   FG V+ GT +  T VAIK        +  +F  E +V++ +RH  L+++ +  S 
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 340 PDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCD 398
                +V E+M  GSL  +L      +L + + +++   + S + Y+      ++ +H D
Sbjct: 251 EPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER----MNYVHRD 305
Query: 399 LKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDV 458
           L+  NIL+ EN+V  V+DFG+ +L+ + E + RQ      I + APE  L G  + K DV
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSDV 364
Query: 459 YSYGVLLMETFTRKR 473
           +S+G+LL E  T+ R
Sbjct: 365 WSFGILLTELTTKGR 379

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 62/195 (31%), Positives = 104/195 (53%), Gaps = 8/195 (4%)
Query: 280 LGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSN 339
           LG   FG V+ GT +  T VAIK        +  +F  E +V++ +RH  L+++ +  S 
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 340 PDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCD 398
                +V E+M  GSL  +L      +L + + +++   + S + Y+      ++ +H D
Sbjct: 251 EPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER----MNYVHRD 305
Query: 399 LKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDV 458
           L+  NIL+ EN+V  V+DFG+ +L+ + E + RQ      I + APE  L G  + K DV
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSDV 364
Query: 459 YSYGVLLMETFTRKR 473
           +S+G+LL E  T+ R
Sbjct: 365 WSFGILLTELTTKGR 379

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 62/195 (31%), Positives = 104/195 (53%), Gaps = 8/195 (4%)
Query: 280 LGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSN 339
           LG   FG V+ GT +  T VAIK        +  +F  E +V++ +RH  L+++ +  S 
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 81
Query: 340 PDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCD 398
                +V E+M  GSL  +L      +L + + +++   + S + Y+      ++ +H D
Sbjct: 82  EPI-YIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVER----MNYVHRD 136
Query: 399 LKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDV 458
           L+  NIL+ EN+V  V+DFG+ +L+ + E + RQ      I + APE  L G  + K DV
Sbjct: 137 LRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFP-IKWTAPEAALYGRFTIKSDV 195
Query: 459 YSYGVLLMETFTRKR 473
           +S+G+LL E  T+ R
Sbjct: 196 WSFGILLTELTTKGR 210

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 61/195 (31%), Positives = 104/195 (53%), Gaps = 8/195 (4%)
Query: 280 LGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSN 339
           LG   FG V+ GT +  T VAIK        +  +F  E +V++ +RH  L+++ +  S 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 340 PDFKALVLEFMPNGSLEKWLYSH-NYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCD 398
                +V+E+M  G L  +L      +L + + +++   + S + Y+      ++ +H D
Sbjct: 85  EPI-YIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER----MNYVHRD 139
Query: 399 LKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDV 458
           L+  NIL+ EN+V  V+DFG+ +L+ + E + RQ      I + APE  L G  + K DV
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSDV 198
Query: 459 YSYGVLLMETFTRKR 473
           +S+G+LL E  T+ R
Sbjct: 199 WSFGILLTELTTKGR 213

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 62/195 (31%), Positives = 104/195 (53%), Gaps = 8/195 (4%)
Query: 280 LGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSN 339
           LG   FG V+ GT +  T VAIK        +  +F  E +V++ +RH  L+++ +  S 
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 81
Query: 340 PDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCD 398
                +V E+M  GSL  +L      +L + + +++   + S + Y+      ++ +H D
Sbjct: 82  EPI-YIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVER----MNYVHRD 136
Query: 399 LKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDV 458
           L+  NIL+ EN+V  V+DFG+ +L+ + E + RQ      I + APE  L G  + K DV
Sbjct: 137 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSDV 195
Query: 459 YSYGVLLMETFTRKR 473
           +S+G+LL E  T+ R
Sbjct: 196 WSFGILLTELTTKGR 210

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 62/195 (31%), Positives = 104/195 (53%), Gaps = 8/195 (4%)
Query: 280 LGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSN 339
           LG   FG V+ GT +  T VAIK        +  +F  E +V++ +RH  L+++ +  S 
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 340 PDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCD 398
                +V E+M  GSL  +L      +L + + +++   + S + Y+      ++ +H D
Sbjct: 251 EPI-YIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER----MNYVHRD 305
Query: 399 LKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDV 458
           L+  NIL+ EN+V  V+DFG+ +L+ + E + RQ      I + APE  L G  + K DV
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSDV 364
Query: 459 YSYGVLLMETFTRKR 473
           +S+G+LL E  T+ R
Sbjct: 365 WSFGILLTELTTKGR 379

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 62/195 (31%), Positives = 103/195 (52%), Gaps = 8/195 (4%)
Query: 280 LGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSN 339
           LG   FG V+ GT +  T VAIK        +  +F  E +V++ +RH  L+++ +  S 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 340 PDFKALVLEFMPNGSLEKWLYSH-NYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCD 398
                +V E+M  GSL  +L      +L + + +++   + S + Y+      ++ +H D
Sbjct: 85  EPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER----MNYVHRD 139
Query: 399 LKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDV 458
           L   NIL+ EN+V  V+DFG+ +L+ + E + RQ      I + APE  L G  + K DV
Sbjct: 140 LAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSDV 198
Query: 459 YSYGVLLMETFTRKR 473
           +S+G+LL E  T+ R
Sbjct: 199 WSFGILLTELTTKGR 213

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 61/195 (31%), Positives = 103/195 (52%), Gaps = 8/195 (4%)
Query: 280 LGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSN 339
           LG   FG V+ GT +  T VAIK        +  +F  E +V++ +RH  L+++ +  S 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 340 PDFKALVLEFMPNGSLEKWLYSH-NYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCD 398
                +V E+M  G L  +L      +L + + +++   + S + Y+      ++ +H D
Sbjct: 85  EPI-YIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER----MNYVHRD 139
Query: 399 LKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDV 458
           L+  NIL+ EN+V  V+DFG+ +L+ + E + RQ      I + APE  L G  + K DV
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSDV 198
Query: 459 YSYGVLLMETFTRKR 473
           +S+G+LL E  T+ R
Sbjct: 199 WSFGILLTELTTKGR 213

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 98/200 (49%), Gaps = 12/200 (6%)
Query: 280 LGTSSFGSVYKGTISDGTDVAIKVFNL--QLERAFRSFDSECEVLRNVRHRNLIKILSSY 337
           +G+ SFG+VYKG      DVA+K+  +       F++F +E  VLR  RH N++ +   Y
Sbjct: 44  IGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNIL-LFMGY 100
Query: 338 SNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHC 397
              D  A+V ++    SL K L+       + + ++I       ++YLH    + +IIH 
Sbjct: 101 MTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLH----AKNIIHR 156
Query: 398 DLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPE---YGLEGIVSA 454
           D+K  NI L E +   + DFG+  +      S +      ++ +MAPE          S 
Sbjct: 157 DMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSF 216
Query: 455 KCDVYSYGVLLMETFTRKRP 474
           + DVYSYG++L E  T + P
Sbjct: 217 QSDVYSYGIVLYELMTGELP 236

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/260 (25%), Positives = 118/260 (45%), Gaps = 28/260 (10%)
Query: 280 LGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSN 339
           LG   FG V+ GT +  T VAIK        +  SF  E ++++ ++H  L+++ +  S 
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKTLKPGT-MSPESFLEEAQIMKKLKHDKLVQLYAVVSE 75
Query: 340 PDFKALVLEFMPNGSLEKWLY-SHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCD 398
                +V E+M  GSL  +L       L +   +++   V + + Y+      ++ IH D
Sbjct: 76  EPI-YIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER----MNYIHRD 130
Query: 399 LKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDV 458
           L+  NIL+   ++  ++DFG+ +L+ + E + RQ      I + APE  L G  + K DV
Sbjct: 131 LRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFP-IKWTAPEAALYGRFTIKSDV 189
Query: 459 YSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPH-GLTEVVDANLVREEQAFSAKMD 517
           +S+G+LL E  T+ R                   +P+ G+        V          D
Sbjct: 190 WSFGILLTELVTKGR-------------------VPYPGMNNREVLEQVERGYRMPCPQD 230
Query: 518 CILSIMDFALDCCMESPDMR 537
           C +S+ +  + C  + P+ R
Sbjct: 231 CPISLHELMIHCWKKDPEER 250

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 108/216 (50%), Gaps = 19/216 (8%)
Query: 269 RATDEFNECNL-----LGTSSFGSV---YKGTISDGTD--VAIKVFNLQLERAFRSFDSE 318
           R   +F E +L     LG  +FGSV       + D T   VA+K      E   R F+ E
Sbjct: 5   RDPTQFEERHLKFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 64
Query: 319 CEVLRNVRHRNLIK---ILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIM 375
            E+L++++H N++K   +  S    + K L++EF+P GSL ++L  H   +D ++ L   
Sbjct: 65  IEILKSLQHDNIVKYKGVCYSAGRRNLK-LIMEFLPYGSLREYLQKHKERIDHIKLLQYT 123
Query: 376 IDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVR-QTM 434
             +   +EYL     +   IH DL   NIL++      + DFG+ K+L + ++  + +  
Sbjct: 124 SQICKGMEYL----GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEP 179
Query: 435 TMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
             + I + APE   E   S   DV+S+GV+L E FT
Sbjct: 180 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 129/271 (47%), Gaps = 22/271 (8%)
Query: 278 NLLGTSSFGSVYKGT--ISDGTDVAIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLIK 332
            ++G+   G V  G   +    DV + +  L+    ER  R F SE  ++    H N+I+
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSV 392
           +    +      +V E+M NGSL+ +L +H+    I++ + ++  VG+ + YL    S +
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYL----SDL 170
Query: 393 HIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTM-TMATIGYMAPEYGLEGI 451
             +H DL   N+L+D N+V  VSDFG+ ++L +  D+   T      I + APE      
Sbjct: 171 GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEAIAFRT 230
Query: 452 VSAKCDVYSYGVLLMETFTR-KRP------TDEMFIGEMSLRRWVKESLPHGLTEVVDAN 504
            S+  DV+S+GV++ E     +RP       D +   E   R       PH L +++  +
Sbjct: 231 FSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHALHQLM-LD 289
Query: 505 LVREEQAFSAKMDCILSIMDFALDCCMESPD 535
              +++A   +   I+S+    LD  + SP+
Sbjct: 290 CWHKDRAQRPRFSQIVSV----LDALIRSPE 316

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 129/271 (47%), Gaps = 22/271 (8%)
Query: 278 NLLGTSSFGSVYKGT--ISDGTDVAIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLIK 332
            ++G+   G V  G   +    DV + +  L+    ER  R F SE  ++    H N+I+
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSV 392
           +    +      +V E+M NGSL+ +L +H+    I++ + ++  VG+ + YL    S +
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYL----SDL 170
Query: 393 HIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTM-TMATIGYMAPEYGLEGI 451
             +H DL   N+L+D N+V  VSDFG+ ++L +  D+   T      I + APE      
Sbjct: 171 GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRT 230
Query: 452 VSAKCDVYSYGVLLMETFTR-KRP------TDEMFIGEMSLRRWVKESLPHGLTEVVDAN 504
            S+  DV+S+GV++ E     +RP       D +   E   R       PH L +++  +
Sbjct: 231 FSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHALHQLM-LD 289
Query: 505 LVREEQAFSAKMDCILSIMDFALDCCMESPD 535
              +++A   +   I+S+    LD  + SP+
Sbjct: 290 CWHKDRAQRPRFSQIVSV----LDALIRSPE 316

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 107/220 (48%), Gaps = 12/220 (5%)
Query: 260 RRTSYLDIQRATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLE--RAFRSFDS 317
           RR S  D +    +      +G+ SFG+VYKG      DVA+K+ N+     +  ++F +
Sbjct: 24  RRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKN 81
Query: 318 ECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMID 377
           E  VLR  RH N++  +   + P   A+V ++    SL   L+      ++++ ++I   
Sbjct: 82  EVGVLRKTRHVNILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQ 140
Query: 378 VGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMA 437
               ++YLH    +  IIH DLK  NI L E++   + DFG+  +      S +      
Sbjct: 141 TAQGMDYLH----AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSG 196
Query: 438 TIGYMAPE---YGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
           +I +MAPE      +   S + DVY++G++L E  T + P
Sbjct: 197 SILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 236

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 107/220 (48%), Gaps = 12/220 (5%)
Query: 260 RRTSYLDIQRATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLE--RAFRSFDS 317
           RR S  D +    +      +G+ SFG+VYKG      DVA+K+ N+     +  ++F +
Sbjct: 23  RRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKN 80
Query: 318 ECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMID 377
           E  VLR  RH N++  +   + P   A+V ++    SL   L+      ++++ ++I   
Sbjct: 81  EVGVLRKTRHVNILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQ 139
Query: 378 VGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMA 437
               ++YLH    +  IIH DLK  NI L E++   + DFG+  +      S +      
Sbjct: 140 TAQGMDYLH----AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSG 195
Query: 438 TIGYMAPE---YGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
           +I +MAPE      +   S + DVY++G++L E  T + P
Sbjct: 196 SILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 235

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 75/295 (25%), Positives = 130/295 (44%), Gaps = 35/295 (11%)
Query: 278 NLLGTSSFGSVYKGTIS----DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIK 332
            ++G   FG V  G +         VAIK   +   E+  R F  E  ++    H N+I+
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSV 392
           +    +      +V E+M NGSL+ +L  H+    +++ + ++  + S ++YL    S +
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL----SDM 166
Query: 393 HIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTM-TMATIGYMAPEYGLEGI 451
             +H DL   NIL++ N+V  VSDFG+ ++L +  ++   T      I + +PE      
Sbjct: 167 GFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 452 VSAKCDVYSYGVLLMETFTR-KRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQ 510
            ++  DV+SYG++L E  +  +RP  EM                    +V+ A  V E  
Sbjct: 227 FTSASDVWSYGIVLWEVMSYGERPYWEM-----------------SNQDVIKA--VDEGY 267
Query: 511 AFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKI-----KVKFLDDAAA 560
                MDC  ++    LDC  +  + R       + L K+      +K +  AAA
Sbjct: 268 RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAA 322

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 107/216 (49%), Gaps = 19/216 (8%)
Query: 269 RATDEFNECNL-----LGTSSFGSV---YKGTISDGTD--VAIKVFNLQLERAFRSFDSE 318
           R   +F E +L     LG  +FGSV       + D T   VA+K      E   R F+ E
Sbjct: 1   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 60
Query: 319 CEVLRNVRHRNLIK---ILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIM 375
            E+L++++H N++K   +  S    + K L++E++P GSL  +L  H   +D ++ L   
Sbjct: 61  IEILKSLQHDNIVKYKGVCYSAGRRNLK-LIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 119
Query: 376 IDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVR-QTM 434
             +   +EYL     +   IH DL   NIL++      + DFG+ K+L + ++  + +  
Sbjct: 120 SQICKGMEYL----GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEP 175
Query: 435 TMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
             + I + APE   E   S   DV+S+GV+L E FT
Sbjct: 176 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 211

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 107/216 (49%), Gaps = 19/216 (8%)
Query: 269 RATDEFNECNL-----LGTSSFGSV---YKGTISDGTD--VAIKVFNLQLERAFRSFDSE 318
           R   +F E +L     LG  +FGSV       + D T   VA+K      E   R F+ E
Sbjct: 5   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 64
Query: 319 CEVLRNVRHRNLIK---ILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIM 375
            E+L++++H N++K   +  S    + K L++E++P GSL  +L  H   +D ++ L   
Sbjct: 65  IEILKSLQHDNIVKYKGVCYSAGRRNLK-LIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 123
Query: 376 IDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVR-QTM 434
             +   +EYL     +   IH DL   NIL++      + DFG+ K+L + ++  + +  
Sbjct: 124 SQICKGMEYL----GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEP 179
Query: 435 TMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
             + I + APE   E   S   DV+S+GV+L E FT
Sbjct: 180 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 107/216 (49%), Gaps = 19/216 (8%)
Query: 269 RATDEFNECNL-----LGTSSFGSV---YKGTISDGTD--VAIKVFNLQLERAFRSFDSE 318
           R   +F E +L     LG  +FGSV       + D T   VA+K      E   R F+ E
Sbjct: 2   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 61
Query: 319 CEVLRNVRHRNLIK---ILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIM 375
            E+L++++H N++K   +  S    + K L++E++P GSL  +L  H   +D ++ L   
Sbjct: 62  IEILKSLQHDNIVKYKGVCYSAGRRNLK-LIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 120
Query: 376 IDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVR-QTM 434
             +   +EYL     +   IH DL   NIL++      + DFG+ K+L + ++  + +  
Sbjct: 121 SQICKGMEYL----GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEP 176
Query: 435 TMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
             + I + APE   E   S   DV+S+GV+L E FT
Sbjct: 177 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 107/216 (49%), Gaps = 19/216 (8%)
Query: 269 RATDEFNECNL-----LGTSSFGSV---YKGTISDGTD--VAIKVFNLQLERAFRSFDSE 318
           R   +F E +L     LG  +FGSV       + D T   VA+K      E   R F+ E
Sbjct: 6   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 65
Query: 319 CEVLRNVRHRNLIK---ILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIM 375
            E+L++++H N++K   +  S    + K L++E++P GSL  +L  H   +D ++ L   
Sbjct: 66  IEILKSLQHDNIVKYKGVCYSAGRRNLK-LIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 124
Query: 376 IDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVR-QTM 434
             +   +EYL     +   IH DL   NIL++      + DFG+ K+L + ++  + +  
Sbjct: 125 SQICKGMEYL----GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEP 180
Query: 435 TMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
             + I + APE   E   S   DV+S+GV+L E FT
Sbjct: 181 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 216

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 107/216 (49%), Gaps = 19/216 (8%)
Query: 269 RATDEFNECNL-----LGTSSFGSV---YKGTISDGTD--VAIKVFNLQLERAFRSFDSE 318
           R   +F E +L     LG  +FGSV       + D T   VA+K      E   R F+ E
Sbjct: 9   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 68
Query: 319 CEVLRNVRHRNLIK---ILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIM 375
            E+L++++H N++K   +  S    + K L++E++P GSL  +L  H   +D ++ L   
Sbjct: 69  IEILKSLQHDNIVKYKGVCYSAGRRNLK-LIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 127
Query: 376 IDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVR-QTM 434
             +   +EYL     +   IH DL   NIL++      + DFG+ K+L + ++  + +  
Sbjct: 128 SQICKGMEYL----GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEP 183
Query: 435 TMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
             + I + APE   E   S   DV+S+GV+L E FT
Sbjct: 184 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 107/216 (49%), Gaps = 19/216 (8%)
Query: 269 RATDEFNECNL-----LGTSSFGSV---YKGTISDGTD--VAIKVFNLQLERAFRSFDSE 318
           R   +F E +L     LG  +FGSV       + D T   VA+K      E   R F+ E
Sbjct: 7   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 66
Query: 319 CEVLRNVRHRNLIK---ILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIM 375
            E+L++++H N++K   +  S    + K L++E++P GSL  +L  H   +D ++ L   
Sbjct: 67  IEILKSLQHDNIVKYKGVCYSAGRRNLK-LIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 125
Query: 376 IDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVR-QTM 434
             +   +EYL     +   IH DL   NIL++      + DFG+ K+L + ++  + +  
Sbjct: 126 SQICKGMEYL----GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEP 181
Query: 435 TMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
             + I + APE   E   S   DV+S+GV+L E FT
Sbjct: 182 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 217

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 107/216 (49%), Gaps = 19/216 (8%)
Query: 269 RATDEFNECNL-----LGTSSFGSV---YKGTISDGTD--VAIKVFNLQLERAFRSFDSE 318
           R   +F E +L     LG  +FGSV       + D T   VA+K      E   R F+ E
Sbjct: 8   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 67
Query: 319 CEVLRNVRHRNLIK---ILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIM 375
            E+L++++H N++K   +  S    + K L++E++P GSL  +L  H   +D ++ L   
Sbjct: 68  IEILKSLQHDNIVKYKGVCYSAGRRNLK-LIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 126
Query: 376 IDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVR-QTM 434
             +   +EYL     +   IH DL   NIL++      + DFG+ K+L + ++  + +  
Sbjct: 127 SQICKGMEYL----GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEP 182
Query: 435 TMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
             + I + APE   E   S   DV+S+GV+L E FT
Sbjct: 183 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 107/216 (49%), Gaps = 19/216 (8%)
Query: 269 RATDEFNECNL-----LGTSSFGSV---YKGTISDGTD--VAIKVFNLQLERAFRSFDSE 318
           R   +F E +L     LG  +FGSV       + D T   VA+K      E   R F+ E
Sbjct: 33  RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 92
Query: 319 CEVLRNVRHRNLIK---ILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIM 375
            E+L++++H N++K   +  S    + K L++E++P GSL  +L  H   +D ++ L   
Sbjct: 93  IEILKSLQHDNIVKYKGVCYSAGRRNLK-LIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 151
Query: 376 IDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVR-QTM 434
             +   +EYL     +   IH DL   NIL++      + DFG+ K+L + ++  + +  
Sbjct: 152 SQICKGMEYL----GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEP 207
Query: 435 TMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
             + I + APE   E   S   DV+S+GV+L E FT
Sbjct: 208 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 75/295 (25%), Positives = 130/295 (44%), Gaps = 35/295 (11%)
Query: 278 NLLGTSSFGSVYKGTIS----DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIK 332
            ++G   FG V  G +         VAIK   +   E+  R F  E  ++    H N+I+
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSV 392
           +    +      +V E+M NGSL+ +L  H+    +++ + ++  + S ++YL    S +
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL----SDM 166
Query: 393 HIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTM-TMATIGYMAPEYGLEGI 451
             +H DL   NIL++ N+V  VSDFG+ ++L +  ++   T      I + +PE      
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 452 VSAKCDVYSYGVLLMETFTR-KRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQ 510
            ++  DV+SYG++L E  +  +RP  EM                    +V+ A  V E  
Sbjct: 227 FTSASDVWSYGIVLWEVMSYGERPYWEM-----------------SNQDVIKA--VDEGY 267
Query: 511 AFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKI-----KVKFLDDAAA 560
                MDC  ++    LDC  +  + R       + L K+      +K +  AAA
Sbjct: 268 RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAA 322

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 75/295 (25%), Positives = 130/295 (44%), Gaps = 35/295 (11%)
Query: 278 NLLGTSSFGSVYKGTIS----DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIK 332
            ++G   FG V  G +         VAIK   +   E+  R F  E  ++    H N+I+
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSV 392
           +    +      +V E+M NGSL+ +L  H+    +++ + ++  + S ++YL    S +
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL----SDM 166
Query: 393 HIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTM-TMATIGYMAPEYGLEGI 451
             +H DL   NIL++ N+V  VSDFG+ ++L +  ++   T      I + +PE      
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 452 VSAKCDVYSYGVLLMETFTR-KRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQ 510
            ++  DV+SYG++L E  +  +RP  EM                    +V+ A  V E  
Sbjct: 227 FTSASDVWSYGIVLWEVMSYGERPYWEM-----------------SNQDVIKA--VDEGY 267
Query: 511 AFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKI-----KVKFLDDAAA 560
                MDC  ++    LDC  +  + R       + L K+      +K +  AAA
Sbjct: 268 RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAA 322

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 75/295 (25%), Positives = 130/295 (44%), Gaps = 35/295 (11%)
Query: 278 NLLGTSSFGSVYKGTIS----DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIK 332
            ++G   FG V  G +         VAIK   +   E+  R F  E  ++    H N+I+
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSV 392
           +    +      +V E+M NGSL+ +L  H+    +++ + ++  + S ++YL    S +
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL----SDM 166
Query: 393 HIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTM-TMATIGYMAPEYGLEGI 451
             +H DL   NIL++ N+V  VSDFG+ ++L +  ++   T      I + +PE      
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 452 VSAKCDVYSYGVLLMETFTR-KRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQ 510
            ++  DV+SYG++L E  +  +RP  EM                    +V+ A  V E  
Sbjct: 227 FTSASDVWSYGIVLWEVMSYGERPYWEM-----------------SNQDVIKA--VDEGY 267
Query: 511 AFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKI-----KVKFLDDAAA 560
                MDC  ++    LDC  +  + R       + L K+      +K +  AAA
Sbjct: 268 RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAA 322

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 75/295 (25%), Positives = 130/295 (44%), Gaps = 35/295 (11%)
Query: 278 NLLGTSSFGSVYKGTIS----DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIK 332
            ++G   FG V  G +         VAIK   +   E+  R F  E  ++    H N+I+
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSV 392
           +    +      +V E+M NGSL+ +L  H+    +++ + ++  + S ++YL    S +
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL----SDM 166
Query: 393 HIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTM-TMATIGYMAPEYGLEGI 451
             +H DL   NIL++ N+V  VSDFG+ ++L +  ++   T      I + +PE      
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 452 VSAKCDVYSYGVLLMETFTR-KRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQ 510
            ++  DV+SYG++L E  +  +RP  EM                    +V+ A  V E  
Sbjct: 227 FTSASDVWSYGIVLWEVMSYGERPYWEM-----------------SNQDVIKA--VDEGY 267
Query: 511 AFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKI-----KVKFLDDAAA 560
                MDC  ++    LDC  +  + R       + L K+      +K +  AAA
Sbjct: 268 RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAA 322

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 75/295 (25%), Positives = 130/295 (44%), Gaps = 35/295 (11%)
Query: 278 NLLGTSSFGSVYKGTIS----DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIK 332
            ++G   FG V  G +         VAIK   +   E+  R F  E  ++    H N+I+
Sbjct: 49  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 108
Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSV 392
           +    +      +V E+M NGSL+ +L  H+    +++ + ++  + S ++YL    S +
Sbjct: 109 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL----SDM 164
Query: 393 HIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTM-TMATIGYMAPEYGLEGI 451
             +H DL   NIL++ N+V  VSDFG+ ++L +  ++   T      I + +PE      
Sbjct: 165 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 224
Query: 452 VSAKCDVYSYGVLLMETFTR-KRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQ 510
            ++  DV+SYG++L E  +  +RP  EM                    +V+ A  V E  
Sbjct: 225 FTSASDVWSYGIVLWEVMSYGERPYWEM-----------------SNQDVIKA--VDEGY 265
Query: 511 AFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKI-----KVKFLDDAAA 560
                MDC  ++    LDC  +  + R       + L K+      +K +  AAA
Sbjct: 266 RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAA 320

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 75/295 (25%), Positives = 130/295 (44%), Gaps = 35/295 (11%)
Query: 278 NLLGTSSFGSVYKGTIS----DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIK 332
            ++G   FG V  G +         VAIK   +   E+  R F  E  ++    H N+I+
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSV 392
           +    +      +V E+M NGSL+ +L  H+    +++ + ++  + S ++YL    S +
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL----SDM 166
Query: 393 HIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTM-TMATIGYMAPEYGLEGI 451
             +H DL   NIL++ N+V  VSDFG+ ++L +  ++   T      I + +PE      
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 452 VSAKCDVYSYGVLLMETFTR-KRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQ 510
            ++  DV+SYG++L E  +  +RP  EM                    +V+ A  V E  
Sbjct: 227 FTSASDVWSYGIVLWEVMSYGERPYWEM-----------------SNQDVIKA--VDEGY 267
Query: 511 AFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKI-----KVKFLDDAAA 560
                MDC  ++    LDC  +  + R       + L K+      +K +  AAA
Sbjct: 268 RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAA 322

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 108/216 (50%), Gaps = 19/216 (8%)
Query: 269 RATDEFNECNL-----LGTSSFGSV---YKGTISDGTD--VAIKVFNLQLERAFRSFDSE 318
           R   +F E +L     LG  +FGSV       + D T   VA+K      E   R F+ E
Sbjct: 5   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 64
Query: 319 CEVLRNVRHRNLIK---ILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIM 375
            E+L++++H N++K   +  S    + K L++E++P GSL  +L +H   +D ++ L   
Sbjct: 65  IEILKSLQHDNIVKYKGVCYSAGRRNLK-LIMEYLPYGSLRDYLQAHAERIDHIKLLQYT 123
Query: 376 IDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVR-QTM 434
             +   +EYL     +   IH DL   NIL++      + DFG+ K+L + ++  + +  
Sbjct: 124 SQICKGMEYL----GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEP 179
Query: 435 TMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
             + I + APE   E   S   DV+S+GV+L E FT
Sbjct: 180 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 101/200 (50%), Gaps = 14/200 (7%)
Query: 280 LGTSSFGSV---YKGTISDGTD--VAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIK-- 332
           LG  +FGSV       + D T   VA+K      E   R F+ E E+L++++H N++K  
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 333 -ILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSS 391
            +  S    + K L++E++P GSL  +L  H   +D ++ L     +   +EYL     +
Sbjct: 96  GVCYSAGRRNLK-LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL----GT 150
Query: 392 VHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVR-QTMTMATIGYMAPEYGLEG 450
              IH DL   NIL++      + DFG+ K+L + ++  + +    + I + APE   E 
Sbjct: 151 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 210
Query: 451 IVSAKCDVYSYGVLLMETFT 470
             S   DV+S+GV+L E FT
Sbjct: 211 KFSVASDVWSFGVVLYELFT 230

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 101/200 (50%), Gaps = 14/200 (7%)
Query: 280 LGTSSFGSV---YKGTISDGTD--VAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIK-- 332
           LG  +FGSV       + D T   VA+K      E   R F+ E E+L++++H N++K  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 333 -ILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSS 391
            +  S    + K L++E++P GSL  +L  H   +D ++ L     +   +EYL     +
Sbjct: 78  GVCYSAGRRNLK-LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL----GT 132
Query: 392 VHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVR-QTMTMATIGYMAPEYGLEG 450
              IH DL   NIL++      + DFG+ K+L + ++  + +    + I + APE   E 
Sbjct: 133 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 192
Query: 451 IVSAKCDVYSYGVLLMETFT 470
             S   DV+S+GV+L E FT
Sbjct: 193 KFSVASDVWSFGVVLYELFT 212

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 75/295 (25%), Positives = 130/295 (44%), Gaps = 35/295 (11%)
Query: 278 NLLGTSSFGSVYKGTIS----DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIK 332
            ++G   FG V  G +         VAIK   +   E+  R F  E  ++    H N+I+
Sbjct: 39  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 98
Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSV 392
           +    +      +V E+M NGSL+ +L  H+    +++ + ++  + S ++YL    S +
Sbjct: 99  LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL----SDM 154
Query: 393 HIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTM-TMATIGYMAPEYGLEGI 451
             +H DL   NIL++ N+V  VSDFG+ ++L +  ++   T      I + +PE      
Sbjct: 155 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 214
Query: 452 VSAKCDVYSYGVLLMETFTR-KRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQ 510
            ++  DV+SYG++L E  +  +RP  EM                    +V+ A  V E  
Sbjct: 215 FTSASDVWSYGIVLWEVMSYGERPYWEM-----------------SNQDVIKA--VDEGY 255
Query: 511 AFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKI-----KVKFLDDAAA 560
                MDC  ++    LDC  +  + R       + L K+      +K +  AAA
Sbjct: 256 RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAA 310

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 101/200 (50%), Gaps = 14/200 (7%)
Query: 280 LGTSSFGSV---YKGTISDGTD--VAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIK-- 332
           LG  +FGSV       + D T   VA+K      E   R F+ E E+L++++H N++K  
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 333 -ILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSS 391
            +  S    + K L++E++P GSL  +L  H   +D ++ L     +   +EYL     +
Sbjct: 96  GVCYSAGRRNLK-LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL----GT 150
Query: 392 VHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVR-QTMTMATIGYMAPEYGLEG 450
              IH DL   NIL++      + DFG+ K+L + ++  + +    + I + APE   E 
Sbjct: 151 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 210
Query: 451 IVSAKCDVYSYGVLLMETFT 470
             S   DV+S+GV+L E FT
Sbjct: 211 KFSVASDVWSFGVVLYELFT 230

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 106/220 (48%), Gaps = 12/220 (5%)
Query: 260 RRTSYLDIQRATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQL--ERAFRSFDS 317
           RR S  D +    +      +G+ SFG+VYKG      DVA+K+ N+     +  ++F +
Sbjct: 24  RRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKN 81
Query: 318 ECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMID 377
           E  VLR  RH N++  +   + P   A+V ++    SL   L+      ++++ ++I   
Sbjct: 82  EVGVLRKTRHVNILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQ 140
Query: 378 VGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMA 437
               ++YLH    +  IIH DLK  NI L E++   + DFG+         S +      
Sbjct: 141 TAQGMDYLH----AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSG 196
Query: 438 TIGYMAPE---YGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
           +I +MAPE      +   S + DVY++G++L E  T + P
Sbjct: 197 SILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 236

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 106/220 (48%), Gaps = 12/220 (5%)
Query: 260 RRTSYLDIQRATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQL--ERAFRSFDS 317
           RR S  D +    +      +G+ SFG+VYKG      DVA+K+ N+     +  ++F +
Sbjct: 16  RRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKN 73
Query: 318 ECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMID 377
           E  VLR  RH N++  +   + P   A+V ++    SL   L+      ++++ ++I   
Sbjct: 74  EVGVLRKTRHVNILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQ 132
Query: 378 VGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMA 437
               ++YLH    +  IIH DLK  NI L E++   + DFG+         S +      
Sbjct: 133 TAQGMDYLH----AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSG 188
Query: 438 TIGYMAPE---YGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
           +I +MAPE      +   S + DVY++G++L E  T + P
Sbjct: 189 SILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 228

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 75/295 (25%), Positives = 130/295 (44%), Gaps = 35/295 (11%)
Query: 278 NLLGTSSFGSVYKGTIS----DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIK 332
            ++G   FG V  G +         VAIK   +   E+  R F  E  ++    H N+I+
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSV 392
           +    +      +V E+M NGSL+ +L  H+    +++ + ++  + S ++YL    S +
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL----SDM 166
Query: 393 HIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTM-TMATIGYMAPEYGLEGI 451
             +H DL   NIL++ N+V  VSDFG+ ++L +  ++   T      I + +PE      
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 452 VSAKCDVYSYGVLLMETFTR-KRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQ 510
            ++  DV+SYG++L E  +  +RP  EM                    +V+ A  V E  
Sbjct: 227 FTSASDVWSYGIVLWEVMSYGERPYWEM-----------------SNQDVIKA--VDEGY 267
Query: 511 AFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKI-----KVKFLDDAAA 560
                MDC  ++    LDC  +  + R       + L K+      +K +  AAA
Sbjct: 268 RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAA 322

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 101/200 (50%), Gaps = 14/200 (7%)
Query: 280 LGTSSFGSV---YKGTISDGTD--VAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIK-- 332
           LG  +FGSV       + D T   VA+K      E   R F+ E E+L++++H N++K  
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 75
Query: 333 -ILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSS 391
            +  S    + K L++E++P GSL  +L  H   +D ++ L     +   +EYL     +
Sbjct: 76  GVCYSAGRRNLK-LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL----GT 130
Query: 392 VHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVR-QTMTMATIGYMAPEYGLEG 450
              IH DL   NIL++      + DFG+ K+L + ++  + +    + I + APE   E 
Sbjct: 131 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 190
Query: 451 IVSAKCDVYSYGVLLMETFT 470
             S   DV+S+GV+L E FT
Sbjct: 191 KFSVASDVWSFGVVLYELFT 210

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 101/200 (50%), Gaps = 12/200 (6%)
Query: 280 LGTSSFGSVYKGTISDGTDVAIKVFNLQLE--RAFRSFDSECEVLRNVRHRNLIKILSSY 337
           +G+ SFG+VYKG      DVA+K+ N+     +  ++F +E  VLR  RH N++  +   
Sbjct: 21  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 338 SNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHC 397
           + P   A+V ++    SL   L+      ++++ ++I       ++YLH    +  IIH 
Sbjct: 79  TKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH----AKSIIHR 133
Query: 398 DLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPE---YGLEGIVSA 454
           DLK  NI L E++   + DFG+  +      S +      +I +MAPE      +   S 
Sbjct: 134 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 193
Query: 455 KCDVYSYGVLLMETFTRKRP 474
           + DVY++G++L E  T + P
Sbjct: 194 QSDVYAFGIVLYELMTGQLP 213

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 75/295 (25%), Positives = 130/295 (44%), Gaps = 35/295 (11%)
Query: 278 NLLGTSSFGSVYKGTIS----DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIK 332
            ++G   FG V  G +         VAIK   +   E+  R F  E  ++    H N+I+
Sbjct: 22  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 81
Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSV 392
           +    +      +V E+M NGSL+ +L  H+    +++ + ++  + S ++YL    S +
Sbjct: 82  LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL----SDM 137
Query: 393 HIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTM-TMATIGYMAPEYGLEGI 451
             +H DL   NIL++ N+V  VSDFG+ ++L +  ++   T      I + +PE      
Sbjct: 138 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 197
Query: 452 VSAKCDVYSYGVLLMETFTR-KRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQ 510
            ++  DV+SYG++L E  +  +RP  EM                    +V+ A  V E  
Sbjct: 198 FTSASDVWSYGIVLWEVMSYGERPYWEM-----------------SNQDVIKA--VDEGY 238
Query: 511 AFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKI-----KVKFLDDAAA 560
                MDC  ++    LDC  +  + R       + L K+      +K +  AAA
Sbjct: 239 RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAA 293

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 101/200 (50%), Gaps = 12/200 (6%)
Query: 280 LGTSSFGSVYKGTISDGTDVAIKVFNLQLE--RAFRSFDSECEVLRNVRHRNLIKILSSY 337
           +G+ SFG+VYKG      DVA+K+ N+     +  ++F +E  VLR  RH N++  +   
Sbjct: 21  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 338 SNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHC 397
           + P   A+V ++    SL   L+      ++++ ++I       ++YLH    +  IIH 
Sbjct: 79  TKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH----AKSIIHR 133
Query: 398 DLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPE---YGLEGIVSA 454
           DLK  NI L E++   + DFG+  +      S +      +I +MAPE      +   S 
Sbjct: 134 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 193
Query: 455 KCDVYSYGVLLMETFTRKRP 474
           + DVY++G++L E  T + P
Sbjct: 194 QSDVYAFGIVLYELMTGQLP 213

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 101/200 (50%), Gaps = 12/200 (6%)
Query: 280 LGTSSFGSVYKGTISDGTDVAIKVFNLQLE--RAFRSFDSECEVLRNVRHRNLIKILSSY 337
           +G+ SFG+VYKG      DVA+K+ N+     +  ++F +E  VLR  RH N++  +   
Sbjct: 18  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 75
Query: 338 SNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHC 397
           + P   A+V ++    SL   L+      ++++ ++I       ++YLH    +  IIH 
Sbjct: 76  TKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH----AKSIIHR 130
Query: 398 DLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPE---YGLEGIVSA 454
           DLK  NI L E++   + DFG+  +      S +      +I +MAPE      +   S 
Sbjct: 131 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 190
Query: 455 KCDVYSYGVLLMETFTRKRP 474
           + DVY++G++L E  T + P
Sbjct: 191 QSDVYAFGIVLYELMTGQLP 210

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 72/284 (25%), Positives = 128/284 (45%), Gaps = 37/284 (13%)
Query: 278 NLLGTSSFGSVYKG---TISDGTDVAIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLI 331
            ++G   FG VYKG   T S   +V + +  L+    E+    F  E  ++    H N+I
Sbjct: 50  KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 109
Query: 332 KILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSS 391
           ++    S      ++ E+M NG+L+K+L   +    +L+ + ++  + + ++YL N    
Sbjct: 110 RLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN---- 165
Query: 392 VHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMA----TIGYMAPEYG 447
           ++ +H DL   NIL++ N+V  VSDFG+ ++L   ED    T T +     I + APE  
Sbjct: 166 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVL---EDDPEATYTTSGGKIPIRWTAPEAI 222
Query: 448 LEGIVSAKCDVYSYGVLLMETFTR-KRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLV 506
                ++  DV+S+G+++ E  T  +RP  E+   E      V +++  G          
Sbjct: 223 SYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE------VMKAINDGFR-------- 268
Query: 507 REEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKI 550
                    MDC  +I    + C  +    R    D  + L K+
Sbjct: 269 -----LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 101/200 (50%), Gaps = 12/200 (6%)
Query: 280 LGTSSFGSVYKGTISDGTDVAIKVFNLQLE--RAFRSFDSECEVLRNVRHRNLIKILSSY 337
           +G+ SFG+VYKG      DVA+K+ N+     +  ++F +E  VLR  RH N++  +   
Sbjct: 16  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 338 SNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHC 397
           + P   A+V ++    SL   L+      ++++ ++I       ++YLH    +  IIH 
Sbjct: 74  TKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH----AKSIIHR 128
Query: 398 DLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPE---YGLEGIVSA 454
           DLK  NI L E++   + DFG+  +      S +      +I +MAPE      +   S 
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 188
Query: 455 KCDVYSYGVLLMETFTRKRP 474
           + DVY++G++L E  T + P
Sbjct: 189 QSDVYAFGIVLYELMTGQLP 208

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 101/200 (50%), Gaps = 14/200 (7%)
Query: 280 LGTSSFGSV---YKGTISDGTD--VAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIK-- 332
           LG  +FGSV       + D T   VA+K      E   R F+ E E+L++++H N++K  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 333 -ILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSS 391
            +  S    + K L++E++P GSL  +L  H   +D ++ L     +   +EYL     +
Sbjct: 78  GVCYSAGRRNLK-LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL----GT 132
Query: 392 VHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVR-QTMTMATIGYMAPEYGLEG 450
              IH DL   NIL++      + DFG+ K+L + ++  + +    + I + APE   E 
Sbjct: 133 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTES 192
Query: 451 IVSAKCDVYSYGVLLMETFT 470
             S   DV+S+GV+L E FT
Sbjct: 193 KFSVASDVWSFGVVLYELFT 212

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 101/200 (50%), Gaps = 12/200 (6%)
Query: 280 LGTSSFGSVYKGTISDGTDVAIKVFNLQLE--RAFRSFDSECEVLRNVRHRNLIKILSSY 337
           +G+ SFG+VYKG      DVA+K+ N+     +  ++F +E  VLR  RH N++  +   
Sbjct: 16  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 338 SNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHC 397
           + P   A+V ++    SL   L+      ++++ ++I       ++YLH    +  IIH 
Sbjct: 74  TAPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH----AKSIIHR 128
Query: 398 DLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPE---YGLEGIVSA 454
           DLK  NI L E++   + DFG+  +      S +      +I +MAPE      +   S 
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 188
Query: 455 KCDVYSYGVLLMETFTRKRP 474
           + DVY++G++L E  T + P
Sbjct: 189 QSDVYAFGIVLYELMTGQLP 208

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 75/258 (29%), Positives = 118/258 (45%), Gaps = 35/258 (13%)
Query: 270 ATDEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNL-------QLERAFRSFDSECEV 321
           A +E      +G   FG V+KG  + D + VAIK   L       ++   F+ F  E  +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 322 LRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSA 381
           + N+ H N++K+     NP    +V+EF+P G L   L    + +    +L +M+D+   
Sbjct: 77  MSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 382 LEYLHNGHSSVHIIHCDLKPTNIL---LDEN--MVAHVSDFGIYKLLGEGEDSVRQ-TMT 435
           +EY+ N +    I+H DL+  NI    LDEN  + A V+DFG+       + SV   +  
Sbjct: 135 IEYMQNQNPP--IVHRDLRSPNIFLQSLDENAPVCAKVADFGL------SQQSVHSVSGL 186
Query: 436 MATIGYMAPEY--GLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIG---------EMS 484
           +    +MAPE     E   + K D YS+ ++L    T + P DE   G         E  
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEG 246
Query: 485 LRRWVKESLPHGLTEVVD 502
           LR  + E  P  L  V++
Sbjct: 247 LRPTIPEDCPPRLRNVIE 264

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 75/295 (25%), Positives = 129/295 (43%), Gaps = 35/295 (11%)
Query: 278 NLLGTSSFGSVYKGTIS----DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIK 332
            ++G   FG V  G +         VAIK   +   E+  R F  E  ++    H N+I+
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSV 392
           +    +      +V E M NGSL+ +L  H+    +++ + ++  + S ++YL    S +
Sbjct: 111 LEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL----SDM 166
Query: 393 HIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTM-TMATIGYMAPEYGLEGI 451
             +H DL   NIL++ N+V  VSDFG+ ++L +  ++   T      I + +PE      
Sbjct: 167 GAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 452 VSAKCDVYSYGVLLMETFTR-KRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQ 510
            ++  DV+SYG++L E  +  +RP  EM                    +V+ A  V E  
Sbjct: 227 FTSASDVWSYGIVLWEVMSYGERPYWEM-----------------SNQDVIKA--VDEGY 267
Query: 511 AFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKI-----KVKFLDDAAA 560
                MDC  ++    LDC  +  + R       + L K+      +K +  AAA
Sbjct: 268 RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAA 322

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 75/295 (25%), Positives = 129/295 (43%), Gaps = 35/295 (11%)
Query: 278 NLLGTSSFGSVYKGTIS----DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIK 332
            ++G   FG V  G +         VAIK   +   E+  R F  E  ++    H N+I+
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSV 392
           +    +      +V E M NGSL+ +L  H+    +++ + ++  + S ++YL    S +
Sbjct: 111 LEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL----SDM 166
Query: 393 HIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTM-TMATIGYMAPEYGLEGI 451
             +H DL   NIL++ N+V  VSDFG+ ++L +  ++   T      I + +PE      
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 452 VSAKCDVYSYGVLLMETFTR-KRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQ 510
            ++  DV+SYG++L E  +  +RP  EM                    +V+ A  V E  
Sbjct: 227 FTSASDVWSYGIVLWEVMSYGERPYWEM-----------------SNQDVIKA--VDEGY 267
Query: 511 AFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKI-----KVKFLDDAAA 560
                MDC  ++    LDC  +  + R       + L K+      +K +  AAA
Sbjct: 268 RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAA 322

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 100/200 (50%), Gaps = 12/200 (6%)
Query: 280 LGTSSFGSVYKGTISDGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSY 337
           +G+ SFG+VYKG      DVA+K+ N+     +  ++F +E  VLR  RH N++  +   
Sbjct: 16  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 338 SNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHC 397
           + P   A+V ++    SL   L+      ++++ ++I       ++YLH    +  IIH 
Sbjct: 74  TKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH----AKSIIHR 128
Query: 398 DLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPE---YGLEGIVSA 454
           DLK  NI L E++   + DFG+         S +      +I +MAPE      +   S 
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 188
Query: 455 KCDVYSYGVLLMETFTRKRP 474
           + DVY++G++L E  T + P
Sbjct: 189 QSDVYAFGIVLYELMTGQLP 208

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 99/200 (49%), Gaps = 12/200 (6%)
Query: 280 LGTSSFGSVYKGTISDGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSY 337
           +G+ SFG+VYKG      DVA+K+ N+     +  ++F +E  VLR  RH N++  +   
Sbjct: 20  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 77
Query: 338 SNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHC 397
           + P   A+V ++    SL   L++     ++ + ++I       ++YLH    +  IIH 
Sbjct: 78  TKPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH----AKSIIHR 132
Query: 398 DLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPE---YGLEGIVSA 454
           DLK  NI L E+    + DFG+  +      S +      +I +MAPE          S 
Sbjct: 133 DLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 192
Query: 455 KCDVYSYGVLLMETFTRKRP 474
           + DVY++G++L E  T + P
Sbjct: 193 QSDVYAFGIVLYELMTGQLP 212

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 75/295 (25%), Positives = 129/295 (43%), Gaps = 35/295 (11%)
Query: 278 NLLGTSSFGSVYKGTIS----DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIK 332
            ++G   FG V  G +         VAIK   +   E+  R F  E  ++    H N+I+
Sbjct: 22  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 81
Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSV 392
           +    +      +V E M NGSL+ +L  H+    +++ + ++  + S ++YL    S +
Sbjct: 82  LEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL----SDM 137
Query: 393 HIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTM-TMATIGYMAPEYGLEGI 451
             +H DL   NIL++ N+V  VSDFG+ ++L +  ++   T      I + +PE      
Sbjct: 138 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 197
Query: 452 VSAKCDVYSYGVLLMETFTR-KRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQ 510
            ++  DV+SYG++L E  +  +RP  EM                    +V+ A  V E  
Sbjct: 198 FTSASDVWSYGIVLWEVMSYGERPYWEM-----------------SNQDVIKA--VDEGY 238
Query: 511 AFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKI-----KVKFLDDAAA 560
                MDC  ++    LDC  +  + R       + L K+      +K +  AAA
Sbjct: 239 RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAA 293

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 107/216 (49%), Gaps = 19/216 (8%)
Query: 269 RATDEFNECNL-----LGTSSFGSV---YKGTISDGTD--VAIKVFNLQLERAFRSFDSE 318
           R   +F E +L     LG  +FGSV       + D T   VA+K      E   R F+ E
Sbjct: 3   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 62
Query: 319 CEVLRNVRHRNLIK---ILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIM 375
            E+L++++H N++K   +  S    + K L++E++P GSL  +L  H   +D ++ L   
Sbjct: 63  IEILKSLQHDNIVKYKGVCYSAGRRNLK-LIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 121
Query: 376 IDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVR-QTM 434
             +   +EYL     +   IH +L   NIL++      + DFG+ K+L + ++  + +  
Sbjct: 122 SQICKGMEYL----GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEP 177
Query: 435 TMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
             + I + APE   E   S   DV+S+GV+L E FT
Sbjct: 178 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 213

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 75/258 (29%), Positives = 117/258 (45%), Gaps = 35/258 (13%)
Query: 270 ATDEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNL-------QLERAFRSFDSECEV 321
           A +E      +G   FG V+KG  + D + VAIK   L       ++   F+ F  E  +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 322 LRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSA 381
           + N+ H N++K+     NP    +V+EF+P G L   L    + +    +L +M+D+   
Sbjct: 77  MSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 382 LEYLHNGHSSVHIIHCDLKPTNIL---LDEN--MVAHVSDFGIYKLLGEGEDSVRQ-TMT 435
           +EY+ N +    I+H DL+  NI    LDEN  + A V+DFG        + SV   +  
Sbjct: 135 IEYMQNQNPP--IVHRDLRSPNIFLQSLDENAPVCAKVADFGT------SQQSVHSVSGL 186
Query: 436 MATIGYMAPEY--GLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIG---------EMS 484
           +    +MAPE     E   + K D YS+ ++L    T + P DE   G         E  
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEG 246
Query: 485 LRRWVKESLPHGLTEVVD 502
           LR  + E  P  L  V++
Sbjct: 247 LRPTIPEDCPPRLRNVIE 264

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 72/304 (23%), Positives = 134/304 (44%), Gaps = 39/304 (12%)
Query: 263 SYLDIQRATDEFNE-----C----NLLGTSSFGSVYKGTIS--DGTDVAIKVFNLQL--- 308
           +Y D  RA  +F +     C     ++G   FG V  G +      DVA+ +  L++   
Sbjct: 25  TYEDPNRAVHQFAKELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYT 84
Query: 309 ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDI 368
           E+  R F  E  ++    H N++ +    +      +V+EFM NG+L+ +L  H+    +
Sbjct: 85  EKQRRDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTV 144
Query: 369 LERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGED 428
           ++ + ++  + + + YL    + +  +H DL   NIL++ N+V  VSDFG+ +++ +  +
Sbjct: 145 IQLVGMLRGIAAGMRYL----ADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPE 200
Query: 429 SVRQTM-TMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTR-KRPTDEMFIGEMSLR 486
           +V  T      + + APE       ++  DV+SYG+++ E  +  +RP  +M        
Sbjct: 201 AVYTTTGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM-------- 252
Query: 487 RWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK 546
                       +V+ A  + E     A MDC   +    LDC  +    R         
Sbjct: 253 ---------SNQDVIKA--IEEGYRLPAPMDCPAGLHQLMLDCWQKERAERPKFEQIVGI 301
Query: 547 LKKI 550
           L K+
Sbjct: 302 LDKM 305

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 68/281 (24%), Positives = 126/281 (44%), Gaps = 32/281 (11%)
Query: 279 LLGTSSFGSVYKGTIS----DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKI 333
           ++G   FG V +G +       + VAIK       ER  R F SE  ++    H N+I++
Sbjct: 23  VIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRL 82
Query: 334 LSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVH 393
               +N     ++ EFM NG+L+ +L  ++    +++ + ++  + S + YL    + + 
Sbjct: 83  EGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYL----AEMS 138
Query: 394 IIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMA---TIGYMAPEYGLEG 450
            +H DL   NIL++ N+V  VSDFG+ + L E      +T ++     I + APE     
Sbjct: 139 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAFR 198
Query: 451 IVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREE 509
             ++  D +SYG+++ E  +  +RP  +M                    +V++A  + ++
Sbjct: 199 KFTSASDAWSYGIVMWEVMSFGERPYWDM-----------------SNQDVINA--IEQD 239
Query: 510 QAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKI 550
                  DC  S+    LDC  +  + R       + L K+
Sbjct: 240 YRLPPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKM 280

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 73/285 (25%), Positives = 121/285 (42%), Gaps = 45/285 (15%)
Query: 280 LGTSSFGSVYKGT------ISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKI 333
           LG  +FG V+           D   VA+K        A + F  E E+L N++H +++K 
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 334 LSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDIL---------------ERLNIMIDV 378
                + D   +V E+M +G L K+L +H     IL               + L+I   +
Sbjct: 83  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 379 GSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMAT 438
            S + YL    +S H +H DL   N L+  N++  + DFG+ + +   +       TM  
Sbjct: 143 ASGMVYL----ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 198
Query: 439 IGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTR-KRPTDEMFIGEMSLRRWVKESLPHGL 497
           I +M PE  +    + + DV+S+GV+L E FT  K+P             W + S     
Sbjct: 199 IRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP-------------WFQLS----N 241
Query: 498 TEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTD 542
           TEV++   + + +       C   + D  L C    P  R+N+ +
Sbjct: 242 TEVIEC--ITQGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKE 284

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 98/200 (49%), Gaps = 12/200 (6%)
Query: 280 LGTSSFGSVYKGTISDGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSY 337
           +G+ SFG+VYKG      DVA+K+ N+     +  ++F +E  VLR  RH N++  +   
Sbjct: 32  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 338 SNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHC 397
           + P   A+V ++    SL   L++     ++ + ++I       ++YLH    +  IIH 
Sbjct: 90  TKPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH----AKSIIHR 144
Query: 398 DLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPE---YGLEGIVSA 454
           DLK  NI L E+    + DFG+         S +      +I +MAPE          S 
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 204
Query: 455 KCDVYSYGVLLMETFTRKRP 474
           + DVY++G++L E  T + P
Sbjct: 205 QSDVYAFGIVLYELMTGQLP 224

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 98/200 (49%), Gaps = 12/200 (6%)
Query: 280 LGTSSFGSVYKGTISDGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSY 337
           +G+ SFG+VYKG      DVA+K+ N+     +  ++F +E  VLR  RH N++  +   
Sbjct: 32  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 338 SNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHC 397
           + P   A+V ++    SL   L++     ++ + ++I       ++YLH    +  IIH 
Sbjct: 90  TAPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH----AKSIIHR 144
Query: 398 DLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPE---YGLEGIVSA 454
           DLK  NI L E+    + DFG+         S +      +I +MAPE          S 
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 204
Query: 455 KCDVYSYGVLLMETFTRKRP 474
           + DVY++G++L E  T + P
Sbjct: 205 QSDVYAFGIVLYELMTGQLP 224

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/258 (28%), Positives = 117/258 (45%), Gaps = 35/258 (13%)
Query: 270 ATDEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNL-------QLERAFRSFDSECEV 321
           A +E      +G   FG V+KG  + D + VAIK   L       ++   F+ F  E  +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 322 LRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSA 381
           + N+ H N++K+     NP    +V+EF+P G L   L    + +    +L +M+D+   
Sbjct: 77  MSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 382 LEYLHNGHSSVHIIHCDLKPTNIL---LDEN--MVAHVSDFGIYKLLGEGEDSVRQ-TMT 435
           +EY+ N +    I+H DL+  NI    LDEN  + A V+DF +       + SV   +  
Sbjct: 135 IEYMQNQNPP--IVHRDLRSPNIFLQSLDENAPVCAKVADFSL------SQQSVHSVSGL 186
Query: 436 MATIGYMAPEY--GLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIG---------EMS 484
           +    +MAPE     E   + K D YS+ ++L    T + P DE   G         E  
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEG 246
Query: 485 LRRWVKESLPHGLTEVVD 502
           LR  + E  P  L  V++
Sbjct: 247 LRPTIPEDCPPRLRNVIE 264

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/282 (24%), Positives = 125/282 (44%), Gaps = 32/282 (11%)
Query: 278 NLLGTSSFGSVYKGTIS----DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIK 332
            ++G   FG V +G +       + VAIK       ER  R F SE  ++    H N+I+
Sbjct: 20  EVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIR 79
Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSV 392
           +    +N     ++ EFM NG+L+ +L  ++    +++ + ++  + S + YL    + +
Sbjct: 80  LEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYL----AEM 135
Query: 393 HIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMA---TIGYMAPEYGLE 449
             +H DL   NIL++ N+V  VSDFG+ + L E       T ++     I + APE    
Sbjct: 136 SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIAF 195
Query: 450 GIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVRE 508
              ++  D +SYG+++ E  +  +RP  +M                    +V++A  + +
Sbjct: 196 RKFTSASDAWSYGIVMWEVMSFGERPYWDM-----------------SNQDVINA--IEQ 236
Query: 509 EQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKI 550
           +       DC  S+    LDC  +  + R       + L K+
Sbjct: 237 DYRLPPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKM 278

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 95/204 (46%), Gaps = 14/204 (6%)
Query: 278 NLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSY 337
            ++G  +FG V K       DVAIK    + ER  ++F  E   L  V H N++K+  + 
Sbjct: 15  EVVGRGAFGVVCKAKWR-AKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGAC 71
Query: 338 SNPDFKALVLEFMPNGSLEKWLYSHNY--FLDILERLNIMIDVGSALEYLHNGHSSVHII 395
            NP    LV+E+   GSL   L+      +      ++  +     + YLH+      +I
Sbjct: 72  LNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA-LI 128
Query: 396 HCDLKPTNILL-DENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSA 454
           H DLKP N+LL     V  + DFG        +     T    +  +MAPE       S 
Sbjct: 129 HRDLKPPNLLLVAGGTVLKICDFGT-----ACDIQTHMTNNKGSAAWMAPEVFEGSNYSE 183
Query: 455 KCDVYSYGVLLMETFTRKRPTDEM 478
           KCDV+S+G++L E  TR++P DE+
Sbjct: 184 KCDVFSWGIILWEVITRRKPFDEI 207

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 95/204 (46%), Gaps = 14/204 (6%)
Query: 278 NLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSY 337
            ++G  +FG V K       DVAIK    + ER  ++F  E   L  V H N++K+  + 
Sbjct: 14  EVVGRGAFGVVCKAKWR-AKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 338 SNPDFKALVLEFMPNGSLEKWLYSHNY--FLDILERLNIMIDVGSALEYLHNGHSSVHII 395
            NP    LV+E+   GSL   L+      +      ++  +     + YLH+      +I
Sbjct: 71  LNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA-LI 127
Query: 396 HCDLKPTNILL-DENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSA 454
           H DLKP N+LL     V  + DFG        +     T    +  +MAPE       S 
Sbjct: 128 HRDLKPPNLLLVAGGTVLKICDFGT-----ACDIQTHMTNNKGSAAWMAPEVFEGSNYSE 182
Query: 455 KCDVYSYGVLLMETFTRKRPTDEM 478
           KCDV+S+G++L E  TR++P DE+
Sbjct: 183 KCDVFSWGIILWEVITRRKPFDEI 206

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 98/205 (47%), Gaps = 18/205 (8%)
Query: 273 EFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIK 332
           E      +G   FG V  G    G  VA+K   ++ +   ++F +E  V+  +RH NL++
Sbjct: 13  ELKLLQTIGKGEFGDVMLGDYR-GNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQ 69
Query: 333 ILSS-YSNPDFKALVLEFMPNGSLEKWLYSHNYFL---DILERLNIMIDVGSALEYLHNG 388
           +L           +V E+M  GSL  +L S    +   D L  L   +DV  A+EYL   
Sbjct: 70  LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL--LKFSLDVCEAMEYLEGN 127
Query: 389 HSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGL 448
               + +H DL   N+L+ E+ VA VSDFG+ K     E S  Q      + + APE   
Sbjct: 128 ----NFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALR 178
Query: 449 EGIVSAKCDVYSYGVLLMETFTRKR 473
           E   S K DV+S+G+LL E ++  R
Sbjct: 179 EAAFSTKSDVWSFGILLWEIYSFGR 203

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 75/304 (24%), Positives = 133/304 (43%), Gaps = 39/304 (12%)
Query: 263 SYLDIQRATDEFNE-----C----NLLGTSSFGSVYKGTIS----DGTDVAIKVFNLQL- 308
           +Y D  +A  EF +     C     ++G   FG V  G +         VAIK   +   
Sbjct: 4   TYEDPNQAVHEFAKEIEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYT 63
Query: 309 ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDI 368
           E+  R F  E  ++    H N+I +    +      +V E+M NGSL+ +L  ++    +
Sbjct: 64  EKQRRDFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTV 123
Query: 369 LERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGED 428
           ++ + ++  + + ++YL    S +  +H DL   NIL++ N+V  VSDFG+ ++L +  +
Sbjct: 124 IQLVGMLRGISAGMKYL----SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPE 179
Query: 429 SVRQTM-TMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTR-KRPTDEMFIGEMSLR 486
           +   T      I + APE       ++  DV+SYG+++ E  +  +RP  EM        
Sbjct: 180 AAYTTRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERPYWEM-------- 231
Query: 487 RWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK 546
                       +V+ A  V E     + MDC  ++    LDC  +  + R    +    
Sbjct: 232 ---------TNQDVIKA--VEEGYRLPSPMDCPAALYQLMLDCWQKERNSRPKFDEIVNM 280
Query: 547 LKKI 550
           L K+
Sbjct: 281 LDKL 284

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 118/280 (42%), Gaps = 42/280 (15%)
Query: 280 LGTSSFGSVYKGTI------SDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKI 333
           LG  +FG V+           D   VA+K      + A + F  E E+L N++H +++K 
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 80
Query: 334 LSSYSNPDFKALVLEFMPNGSLEKWLYSHN------------YFLDILERLNIMIDVGSA 381
                  D   +V E+M +G L K+L +H               L   + L+I   + + 
Sbjct: 81  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAG 140
Query: 382 LEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGY 441
           + YL    +S H +H DL   N L+ EN++  + DFG+ + +   +       TM  I +
Sbjct: 141 MVYL----ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 196
Query: 442 MAPEYGLEGIVSAKCDVYSYGVLLMETFTR-KRPTDEMFIGEMSLRRWVKESLPHGLTEV 500
           M PE  +    + + DV+S GV+L E FT  K+P             W + S      EV
Sbjct: 197 MPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP-------------WYQLS----NNEV 239
Query: 501 VDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINM 540
           ++   + + +       C   + +  L C    P MR N+
Sbjct: 240 IEC--ITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNI 277

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 66/278 (23%), Positives = 126/278 (45%), Gaps = 36/278 (12%)
Query: 278 NLLGTSSFGSVYKG--TISDGTDVAIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLIK 332
            ++G   FG V  G   +    ++ + +  L+    ++  R F SE  ++    H N+I 
Sbjct: 35  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIH 94
Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSV 392
           +    +      ++ E+M NGSL+ +L  ++    +++ + ++  +GS ++YL    S +
Sbjct: 95  LEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYL----SDM 150
Query: 393 HIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTM-TMATIGYMAPEYGLEGI 451
             +H DL   NIL++ N+V  VSDFG+ ++L +  ++   T      I + APE      
Sbjct: 151 SAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 210
Query: 452 VSAKCDVYSYGVLLMETFTR-KRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQ 510
            ++  DV+SYG+++ E  +  +RP  +M                    +V+ A  + E  
Sbjct: 211 FTSASDVWSYGIVMWEVMSYGERPYWDM-----------------SNQDVIKA--IEEGY 251
Query: 511 AFSAKMDCILSIMDFALDCCMESPDMR------INMTD 542
                MDC +++    LDC  +    R      +NM D
Sbjct: 252 RLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNMLD 289

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 66/278 (23%), Positives = 126/278 (45%), Gaps = 36/278 (12%)
Query: 278 NLLGTSSFGSVYKG--TISDGTDVAIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLIK 332
            ++G   FG V  G   +    ++ + +  L+    ++  R F SE  ++    H N+I 
Sbjct: 14  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIH 73
Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSV 392
           +    +      ++ E+M NGSL+ +L  ++    +++ + ++  +GS ++YL    S +
Sbjct: 74  LEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYL----SDM 129
Query: 393 HIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTM-TMATIGYMAPEYGLEGI 451
             +H DL   NIL++ N+V  VSDFG+ ++L +  ++   T      I + APE      
Sbjct: 130 SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 189
Query: 452 VSAKCDVYSYGVLLMETFTR-KRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQ 510
            ++  DV+SYG+++ E  +  +RP  +M                    +V+ A  + E  
Sbjct: 190 FTSASDVWSYGIVMWEVMSYGERPYWDM-----------------SNQDVIKA--IEEGY 230
Query: 511 AFSAKMDCILSIMDFALDCCMESPDMR------INMTD 542
                MDC +++    LDC  +    R      +NM D
Sbjct: 231 RLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNMLD 268

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/278 (23%), Positives = 126/278 (45%), Gaps = 36/278 (12%)
Query: 278 NLLGTSSFGSVYKG--TISDGTDVAIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLIK 332
            ++G   FG V  G   +    ++ + +  L+    ++  R F SE  ++    H N+I 
Sbjct: 20  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIH 79
Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSV 392
           +    +      ++ E+M NGSL+ +L  ++    +++ + ++  +GS ++YL    S +
Sbjct: 80  LEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYL----SDM 135
Query: 393 HIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTM-TMATIGYMAPEYGLEGI 451
             +H DL   NIL++ N+V  VSDFG+ ++L +  ++   T      I + APE      
Sbjct: 136 SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 195
Query: 452 VSAKCDVYSYGVLLMETFTR-KRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQ 510
            ++  DV+SYG+++ E  +  +RP  +M                    +V+ A  + E  
Sbjct: 196 FTSASDVWSYGIVMWEVMSYGERPYWDM-----------------SNQDVIKA--IEEGY 236
Query: 511 AFSAKMDCILSIMDFALDCCMESPDMR------INMTD 542
                MDC +++    LDC  +    R      +NM D
Sbjct: 237 RLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNMLD 274

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/241 (27%), Positives = 111/241 (46%), Gaps = 12/241 (4%)
Query: 273 EFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLE-----RAFRSFDSECEVLRNVR 326
           EF +  +LG+ +FG+VYKG  I +G  V I V  ++L      +A +    E  V+ +V 
Sbjct: 50  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVD 109
Query: 327 HRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH 386
           + ++ ++L        + L+ + MP G L  ++  H   +     LN  + +   + YL 
Sbjct: 110 NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 168
Query: 387 NGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEY 446
           +      ++H DL   N+L+       ++DFG+ KLLG  E           I +MA E 
Sbjct: 169 DRR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 224
Query: 447 GLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANL 505
            L  I + + DV+SYGV + E  T   +P D +   E+S      E LP      +D  +
Sbjct: 225 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM 284
Query: 506 V 506
           +
Sbjct: 285 I 285

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 98/205 (47%), Gaps = 18/205 (8%)
Query: 273 EFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIK 332
           E      +G   FG V  G    G  VA+K   ++ +   ++F +E  V+  +RH NL++
Sbjct: 7   ELKLLQTIGKGEFGDVMLGDYR-GNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQ 63
Query: 333 ILSSYSNPDFK-ALVLEFMPNGSLEKWLYSHNYFL---DILERLNIMIDVGSALEYLHNG 388
           +L           +V E+M  GSL  +L S    +   D L  L   +DV  A+EYL   
Sbjct: 64  LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL--LKFSLDVCEAMEYLEGN 121
Query: 389 HSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGL 448
               + +H DL   N+L+ E+ VA VSDFG+ K     E S  Q      + + APE   
Sbjct: 122 ----NFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALR 172
Query: 449 EGIVSAKCDVYSYGVLLMETFTRKR 473
           E   S K DV+S+G+LL E ++  R
Sbjct: 173 EKKFSTKSDVWSFGILLWEIYSFGR 197

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 95/193 (49%), Gaps = 6/193 (3%)
Query: 280 LGTSSFGSVYKGTI-SDGTDVAIKVFNLQLERAFRS-FDSECEVLRNVRHRNLIKILSSY 337
           +G  +FG V+ G + +D T VA+K     L    ++ F  E  +L+   H N+++++   
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 338 SNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHC 397
           +      +V+E +  G    +L +    L +   L ++ D  + +EYL     S   IH 
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYL----ESKCCIHR 237
Query: 398 DLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCD 457
           DL   N L+ E  V  +SDFG+ +   +G  +    +    + + APE    G  S++ D
Sbjct: 238 DLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYGRYSSESD 297
Query: 458 VYSYGVLLMETFT 470
           V+S+G+LL ETF+
Sbjct: 298 VWSFGILLWETFS 310

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 98/205 (47%), Gaps = 18/205 (8%)
Query: 273 EFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIK 332
           E      +G   FG V  G    G  VA+K   ++ +   ++F +E  V+  +RH NL++
Sbjct: 22  ELKLLQTIGKGEFGDVMLGDYR-GNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQ 78
Query: 333 ILSS-YSNPDFKALVLEFMPNGSLEKWLYSHNYFL---DILERLNIMIDVGSALEYLHNG 388
           +L           +V E+M  GSL  +L S    +   D L  L   +DV  A+EYL   
Sbjct: 79  LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL--LKFSLDVCEAMEYLEGN 136
Query: 389 HSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGL 448
               + +H DL   N+L+ E+ VA VSDFG+ K     E S  Q      + + APE   
Sbjct: 137 ----NFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALR 187
Query: 449 EGIVSAKCDVYSYGVLLMETFTRKR 473
           E   S K DV+S+G+LL E ++  R
Sbjct: 188 EKKFSTKSDVWSFGILLWEIYSFGR 212

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/241 (27%), Positives = 111/241 (46%), Gaps = 12/241 (4%)
Query: 273 EFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLE-----RAFRSFDSECEVLRNVR 326
           EF +  +LG+ +FG+VYKG  I +G  V I V   +L      +A +    E  V+ +V 
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 79
Query: 327 HRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH 386
           + ++ ++L        + L+++ MP G L  ++  H   +     LN  + +   + YL 
Sbjct: 80  NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 138
Query: 387 NGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEY 446
           +      ++H DL   N+L+       ++DFG+ KLLG  E           I +MA E 
Sbjct: 139 DRR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 194
Query: 447 GLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANL 505
            L  I + + DV+SYGV + E  T   +P D +   E+S      E LP      +D  +
Sbjct: 195 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM 254
Query: 506 V 506
           +
Sbjct: 255 I 255

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/241 (27%), Positives = 111/241 (46%), Gaps = 12/241 (4%)
Query: 273 EFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLE-----RAFRSFDSECEVLRNVR 326
           EF +  +LG+ +FG+VYKG  I +G  V I V   +L      +A +    E  V+ +V 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 327 HRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH 386
           + ++ ++L        + L+++ MP G L  ++  H   +     LN  + +   + YL 
Sbjct: 79  NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 137
Query: 387 NGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEY 446
           +      ++H DL   N+L+       ++DFG+ KLLG  E           I +MA E 
Sbjct: 138 DRR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 193
Query: 447 GLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANL 505
            L  I + + DV+SYGV + E  T   +P D +   E+S      E LP      +D  +
Sbjct: 194 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM 253
Query: 506 V 506
           +
Sbjct: 254 I 254

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/199 (32%), Positives = 98/199 (49%), Gaps = 37/199 (18%)
Query: 1   MRILTLEGNQLSGRLPSTI------------------GHSLPNI--------EYLLLTAN 34
           +++L L  N+ SG LP ++                  G  LPN+        + L L  N
Sbjct: 345 LKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNN 404
Query: 35  NLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGR 94
             TG IP +++N ++L+ L L FN  SG I ++ G+L  L  L L +       N L G 
Sbjct: 405 GFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWL-------NMLEGE 457
Query: 95  IPPCLV----LTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLE 150
           IP  L+    L  L +  N L+G+IPS +    +L  +SL++N+  G IP+ +G L +L 
Sbjct: 458 IPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLA 517
Query: 151 SLDLSGNNLSGKIPKLEGE 169
            L LS N+ SG IP   G+
Sbjct: 518 ILKLSNNSFSGNIPAELGD 536

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 53/151 (35%), Positives = 76/151 (50%), Gaps = 21/151 (13%)
Query: 60  FSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCL----VLTVLDVSRNQLSGDI 115
           + GH   TF N   +      MF + ++ N L G IP  +     L +L++  N +SG I
Sbjct: 620 YGGHTSPTFDNNGSM------MF-LDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSI 672
Query: 116 PSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKLEGEIPVKGS 175
           P  +G    L  L L+SN+  G IP+++ +L  L  +DLS NNLSG IP++       G 
Sbjct: 673 PDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEM-------GQ 725
Query: 176 FKNFSTESFFGNYALCGPPKLRVPPCKPDNS 206
           F+ F    F  N  LCG P   +P C P N+
Sbjct: 726 FETFPPAKFLNNPGLCGYP---LPRCDPSNA 753

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/241 (27%), Positives = 111/241 (46%), Gaps = 12/241 (4%)
Query: 273 EFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLE-----RAFRSFDSECEVLRNVR 326
           EF +  +LG+ +FG+VYKG  I +G  V I V   +L      +A +    E  V+ +V 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 327 HRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH 386
           + ++ ++L        + L+++ MP G L  ++  H   +     LN  + +   + YL 
Sbjct: 78  NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 136
Query: 387 NGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEY 446
           +      ++H DL   N+L+       ++DFG+ KLLG  E           I +MA E 
Sbjct: 137 DRR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 192
Query: 447 GLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANL 505
            L  I + + DV+SYGV + E  T   +P D +   E+S      E LP      +D  +
Sbjct: 193 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM 252
Query: 506 V 506
           +
Sbjct: 253 I 253

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/199 (32%), Positives = 98/199 (49%), Gaps = 37/199 (18%)
Query: 1   MRILTLEGNQLSGRLPSTI------------------GHSLPNI--------EYLLLTAN 34
           +++L L  N+ SG LP ++                  G  LPN+        + L L  N
Sbjct: 342 LKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNN 401
Query: 35  NLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGR 94
             TG IP +++N ++L+ L L FN  SG I ++ G+L  L  L L +       N L G 
Sbjct: 402 GFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWL-------NMLEGE 454
Query: 95  IPPCLV----LTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLE 150
           IP  L+    L  L +  N L+G+IPS +    +L  +SL++N+  G IP+ +G L +L 
Sbjct: 455 IPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLA 514
Query: 151 SLDLSGNNLSGKIPKLEGE 169
            L LS N+ SG IP   G+
Sbjct: 515 ILKLSNNSFSGNIPAELGD 533

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 53/151 (35%), Positives = 76/151 (50%), Gaps = 21/151 (13%)
Query: 60  FSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCL----VLTVLDVSRNQLSGDI 115
           + GH   TF N   +      MF + ++ N L G IP  +     L +L++  N +SG I
Sbjct: 617 YGGHTSPTFDNNGSM------MF-LDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSI 669
Query: 116 PSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKLEGEIPVKGS 175
           P  +G    L  L L+SN+  G IP+++ +L  L  +DLS NNLSG IP++       G 
Sbjct: 670 PDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEM-------GQ 722
Query: 176 FKNFSTESFFGNYALCGPPKLRVPPCKPDNS 206
           F+ F    F  N  LCG P   +P C P N+
Sbjct: 723 FETFPPAKFLNNPGLCGYP---LPRCDPSNA 750

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/241 (27%), Positives = 111/241 (46%), Gaps = 12/241 (4%)
Query: 273 EFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLE-----RAFRSFDSECEVLRNVR 326
           EF +  +LG+ +FG+VYKG  I +G  V I V   +L      +A +    E  V+ +V 
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 76
Query: 327 HRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH 386
           + ++ ++L        + L+++ MP G L  ++  H   +     LN  + +   + YL 
Sbjct: 77  NPHVCRLLGICLTSTVQ-LIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 135
Query: 387 NGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEY 446
           +      ++H DL   N+L+       ++DFG+ KLLG  E           I +MA E 
Sbjct: 136 DRR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 191
Query: 447 GLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANL 505
            L  I + + DV+SYGV + E  T   +P D +   E+S      E LP      +D  +
Sbjct: 192 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM 251
Query: 506 V 506
           +
Sbjct: 252 I 252

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/241 (27%), Positives = 111/241 (46%), Gaps = 12/241 (4%)
Query: 273 EFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLE-----RAFRSFDSECEVLRNVR 326
           EF +  +LG+ +FG+VYKG  I +G  V I V   +L      +A +    E  V+ +V 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 327 HRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH 386
           + ++ ++L        + L+++ MP G L  ++  H   +     LN  + +   + YL 
Sbjct: 76  NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 387 NGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEY 446
           +      ++H DL   N+L+       ++DFG+ KLLG  E           I +MA E 
Sbjct: 135 DRR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 190
Query: 447 GLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANL 505
            L  I + + DV+SYGV + E  T   +P D +   E+S      E LP      +D  +
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM 250
Query: 506 V 506
           +
Sbjct: 251 I 251

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/241 (27%), Positives = 111/241 (46%), Gaps = 12/241 (4%)
Query: 273 EFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLE-----RAFRSFDSECEVLRNVR 326
           EF +  +LG+ +FG+VYKG  I +G  V I V   +L      +A +    E  V+ +V 
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 76
Query: 327 HRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH 386
           + ++ ++L        + L+++ MP G L  ++  H   +     LN  + +   + YL 
Sbjct: 77  NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 135
Query: 387 NGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEY 446
           +      ++H DL   N+L+       ++DFG+ KLLG  E           I +MA E 
Sbjct: 136 DRR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 191
Query: 447 GLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANL 505
            L  I + + DV+SYGV + E  T   +P D +   E+S      E LP      +D  +
Sbjct: 192 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM 251
Query: 506 V 506
           +
Sbjct: 252 I 252

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 101/195 (51%), Gaps = 8/195 (4%)
Query: 280 LGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSN 339
           LG   FG V+ G  +  T VA+K    Q   +  +F +E  +++ ++H+ L+++ +  + 
Sbjct: 30  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 88
Query: 340 PDFKALVLEFMPNGSLEKWLYSHNYF-LDILERLNIMIDVGSALEYLHNGHSSVHIIHCD 398
                ++ E+M NGSL  +L + +   L I + L++   +   + ++   +     IH D
Sbjct: 89  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN----YIHRD 143
Query: 399 LKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDV 458
           L+  NIL+ + +   ++DFG+ +L+ + E + R+      I + APE    G  + K DV
Sbjct: 144 LRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFP-IKWTAPEAINYGTFTIKSDV 202
Query: 459 YSYGVLLMETFTRKR 473
           +S+G+LL E  T  R
Sbjct: 203 WSFGILLTEIVTHGR 217

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 101/195 (51%), Gaps = 8/195 (4%)
Query: 280 LGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSN 339
           LG   FG V+ G  +  T VA+K    Q   +  +F +E  +++ ++H+ L+++ +  + 
Sbjct: 29  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 87
Query: 340 PDFKALVLEFMPNGSLEKWLYSHNYF-LDILERLNIMIDVGSALEYLHNGHSSVHIIHCD 398
                ++ E+M NGSL  +L + +   L I + L++   +   + ++   +     IH D
Sbjct: 88  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN----YIHRD 142
Query: 399 LKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDV 458
           L+  NIL+ + +   ++DFG+ +L+ + E + R+      I + APE    G  + K DV
Sbjct: 143 LRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFP-IKWTAPEAINYGTFTIKSDV 201
Query: 459 YSYGVLLMETFTRKR 473
           +S+G+LL E  T  R
Sbjct: 202 WSFGILLTEIVTHGR 216

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/198 (32%), Positives = 97/198 (48%), Gaps = 18/198 (9%)
Query: 280 LGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSS-YS 338
           +G   FG V  G    G  VA+K   ++ +   ++F +E  V+  +RH NL+++L     
Sbjct: 201 IGKGEFGDVMLGDYR-GNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 339 NPDFKALVLEFMPNGSLEKWLYSHNYFL---DILERLNIMIDVGSALEYLHNGHSSVHII 395
                 +V E+M  GSL  +L S    +   D L  L   +DV  A+EYL       + +
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL--LKFSLDVCEAMEYLEGN----NFV 311
Query: 396 HCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAK 455
           H DL   N+L+ E+ VA VSDFG+ K     E S  Q      + + APE   E   S K
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTK 366
Query: 456 CDVYSYGVLLMETFTRKR 473
            DV+S+G+LL E ++  R
Sbjct: 367 SDVWSFGILLWEIYSFGR 384

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 101/195 (51%), Gaps = 8/195 (4%)
Query: 280 LGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSN 339
           LG   FG V+ G  +  T VA+K    Q   +  +F +E  +++ ++H+ L+++ +  + 
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 85
Query: 340 PDFKALVLEFMPNGSLEKWLYSHNYF-LDILERLNIMIDVGSALEYLHNGHSSVHIIHCD 398
                ++ E+M NGSL  +L + +   L I + L++   +   + ++   +     IH D
Sbjct: 86  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN----YIHRD 140
Query: 399 LKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDV 458
           L+  NIL+ + +   ++DFG+ +L+ + E + R+      I + APE    G  + K DV
Sbjct: 141 LRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFP-IKWTAPEAINYGTFTIKSDV 199
Query: 459 YSYGVLLMETFTRKR 473
           +S+G+LL E  T  R
Sbjct: 200 WSFGILLTEIVTHGR 214

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 95/193 (49%), Gaps = 6/193 (3%)
Query: 280 LGTSSFGSVYKGTI-SDGTDVAIKVFNLQLERAFRS-FDSECEVLRNVRHRNLIKILSSY 337
           +G  +FG V+ G + +D T VA+K     L    ++ F  E  +L+   H N+++++   
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 338 SNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHC 397
           +      +V+E +  G    +L +    L +   L ++ D  + +EYL     S   IH 
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYL----ESKCCIHR 237
Query: 398 DLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCD 457
           DL   N L+ E  V  +SDFG+ +   +G  +    +    + + APE    G  S++ D
Sbjct: 238 DLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESD 297
Query: 458 VYSYGVLLMETFT 470
           V+S+G+LL ETF+
Sbjct: 298 VWSFGILLWETFS 310

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 101/195 (51%), Gaps = 8/195 (4%)
Query: 280 LGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSN 339
           LG   FG V+ G  +  T VA+K    Q   +  +F +E  +++ ++H+ L+++ +  + 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 340 PDFKALVLEFMPNGSLEKWLYSHNYF-LDILERLNIMIDVGSALEYLHNGHSSVHIIHCD 398
                ++ E+M NGSL  +L + +   L I + L++   +   + ++   +     IH D
Sbjct: 80  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN----YIHRD 134
Query: 399 LKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDV 458
           L+  NIL+ + +   ++DFG+ +L+ + E + R+      I + APE    G  + K DV
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFP-IKWTAPEAINYGTFTIKSDV 193
Query: 459 YSYGVLLMETFTRKR 473
           +S+G+LL E  T  R
Sbjct: 194 WSFGILLTEIVTHGR 208

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 101/195 (51%), Gaps = 8/195 (4%)
Query: 280 LGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSN 339
           LG   FG V+ G  +  T VA+K    Q   +  +F +E  +++ ++H+ L+++ +  + 
Sbjct: 23  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 81
Query: 340 PDFKALVLEFMPNGSLEKWLYSHNYF-LDILERLNIMIDVGSALEYLHNGHSSVHIIHCD 398
                ++ E+M NGSL  +L + +   L I + L++   +   + ++   +     IH D
Sbjct: 82  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN----YIHRD 136
Query: 399 LKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDV 458
           L+  NIL+ + +   ++DFG+ +L+ + E + R+      I + APE    G  + K DV
Sbjct: 137 LRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFP-IKWTAPEAINYGTFTIKSDV 195
Query: 459 YSYGVLLMETFTRKR 473
           +S+G+LL E  T  R
Sbjct: 196 WSFGILLTEIVTHGR 210

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 101/195 (51%), Gaps = 8/195 (4%)
Query: 280 LGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSN 339
           LG   FG V+ G  +  T VA+K    Q   +  +F +E  +++ ++H+ L+++ +  + 
Sbjct: 22  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 80
Query: 340 PDFKALVLEFMPNGSLEKWLYSHNYF-LDILERLNIMIDVGSALEYLHNGHSSVHIIHCD 398
                ++ E+M NGSL  +L + +   L I + L++   +   + ++   +     IH D
Sbjct: 81  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN----YIHRD 135
Query: 399 LKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDV 458
           L+  NIL+ + +   ++DFG+ +L+ + E + R+      I + APE    G  + K DV
Sbjct: 136 LRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFP-IKWTAPEAINYGTFTIKSDV 194
Query: 459 YSYGVLLMETFTRKR 473
           +S+G+LL E  T  R
Sbjct: 195 WSFGILLTEIVTHGR 209

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 101/195 (51%), Gaps = 8/195 (4%)
Query: 280 LGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSN 339
           LG   FG V+ G  +  T VA+K    Q   +  +F +E  +++ ++H+ L+++ +  + 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 340 PDFKALVLEFMPNGSLEKWLYSHNYF-LDILERLNIMIDVGSALEYLHNGHSSVHIIHCD 398
                ++ E+M NGSL  +L + +   L I + L++   +   + ++   +     IH D
Sbjct: 80  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN----YIHRD 134
Query: 399 LKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDV 458
           L+  NIL+ + +   ++DFG+ +L+ + E + R+      I + APE    G  + K DV
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFP-IKWTAPEAINYGTFTIKSDV 193
Query: 459 YSYGVLLMETFTRKR 473
           +S+G+LL E  T  R
Sbjct: 194 WSFGILLTEIVTHGR 208

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 108/210 (51%), Gaps = 20/210 (9%)
Query: 299 VAIKVFNL---QLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSL 355
           VAIK   +   + E   + F+ E      + H+N++ ++      D   LV+E++   +L
Sbjct: 39  VAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTL 98
Query: 356 EKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVS 415
            +++ SH   L +   +N    +   +++ H+    + I+H D+KP NIL+D N    + 
Sbjct: 99  SEYIESHGP-LSVDTAINFTNQILDGIKHAHD----MRIVHRDIKPQNILIDSNKTLKIF 153
Query: 416 DFGIYKLLGEGEDSVRQT-MTMATIGYMAPEYGLEGIVSAKC-DVYSYGVLLMETFTRKR 473
           DFGI K L E   S+ QT   + T+ Y +PE   +G  + +C D+YS G++L E    + 
Sbjct: 154 DFGIAKALSET--SLTQTNHVLGTVQYFSPEQA-KGEATDECTDIYSIGIVLYEMLVGEP 210
Query: 474 PTDEMFIGEMSLR---RWVKESLPHGLTEV 500
           P    F GE ++    + +++S+P+  T+V
Sbjct: 211 P----FNGETAVSIAIKHIQDSVPNVTTDV 236

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/284 (23%), Positives = 125/284 (44%), Gaps = 36/284 (12%)
Query: 278 NLLGTSSFGSVYKG--TISDGTDVAIKVFNLQ---LERAFRSFDSECEVLRNVRHRNLIK 332
            ++G   FG V  G   +    ++ + +  L+    E+  R F SE  ++    H N+I 
Sbjct: 39  QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIH 98
Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSV 392
           +    +      ++ EFM NGSL+ +L  ++    +++ + ++  + + ++YL    + +
Sbjct: 99  LEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL----ADM 154
Query: 393 HIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMA-----TIGYMAPEYG 447
           + +H DL   NIL++ N+V  VSDFG+ + L   +D+   T T A      I + APE  
Sbjct: 155 NYVHRDLAARNILVNSNLVCKVSDFGLSRFL--EDDTSDPTYTSALGGKIPIRWTAPEAI 212
Query: 448 LEGIVSAKCDVYSYGVLLMETFTR-KRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLV 506
                ++  DV+SYG+++ E  +  +RP  +M                   T     N +
Sbjct: 213 QYRKFTSASDVWSYGIVMWEVMSYGERPYWDM-------------------TNQDVINAI 253
Query: 507 REEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKI 550
            ++      MDC  ++    LDC  +  + R         L K+
Sbjct: 254 EQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 297

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/241 (27%), Positives = 110/241 (45%), Gaps = 12/241 (4%)
Query: 273 EFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLE-----RAFRSFDSECEVLRNVR 326
           EF +  +LG+ +FG+VYKG  I +G  V I V   +L      +A +    E  V+ +V 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 327 HRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH 386
           + ++ ++L        + L+ + MP G L  ++  H   +     LN  + +   + YL 
Sbjct: 79  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 137
Query: 387 NGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEY 446
           +      ++H DL   N+L+       ++DFG+ KLLG  E           I +MA E 
Sbjct: 138 DRR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 193
Query: 447 GLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANL 505
            L  I + + DV+SYGV + E  T   +P D +   E+S      E LP      +D  +
Sbjct: 194 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM 253
Query: 506 V 506
           +
Sbjct: 254 I 254

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 101/195 (51%), Gaps = 8/195 (4%)
Query: 280 LGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSN 339
           LG   FG V+ G  +  T VA+K    Q   +  +F +E  +++ ++H+ L+++ +  + 
Sbjct: 26  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 84
Query: 340 PDFKALVLEFMPNGSLEKWLYSHNYF-LDILERLNIMIDVGSALEYLHNGHSSVHIIHCD 398
                ++ E+M NGSL  +L + +   L I + L++   +   + ++   +     IH D
Sbjct: 85  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN----YIHRD 139
Query: 399 LKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDV 458
           L+  NIL+ + +   ++DFG+ +L+ + E + R+      I + APE    G  + K DV
Sbjct: 140 LRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP-IKWTAPEAINYGTFTIKSDV 198
Query: 459 YSYGVLLMETFTRKR 473
           +S+G+LL E  T  R
Sbjct: 199 WSFGILLTEIVTHGR 213

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 101/195 (51%), Gaps = 8/195 (4%)
Query: 280 LGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSN 339
           LG   FG V+ G  +  T VA+K    Q   +  +F +E  +++ ++H+ L+++ +  + 
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 85
Query: 340 PDFKALVLEFMPNGSLEKWLYSHNYF-LDILERLNIMIDVGSALEYLHNGHSSVHIIHCD 398
                ++ E+M NGSL  +L + +   L I + L++   +   + ++   +     IH D
Sbjct: 86  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN----YIHRD 140
Query: 399 LKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDV 458
           L+  NIL+ + +   ++DFG+ +L+ + E + R+      I + APE    G  + K DV
Sbjct: 141 LRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP-IKWTAPEAINYGTFTIKSDV 199
Query: 459 YSYGVLLMETFTRKR 473
           +S+G+LL E  T  R
Sbjct: 200 WSFGILLTEIVTHGR 214

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 96/194 (49%), Gaps = 6/194 (3%)
Query: 280 LGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSN 339
           LG   FG V+  T +  T VA+K        +  +F +E  V++ ++H  L+K+ +  + 
Sbjct: 23  LGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 81
Query: 340 PDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDL 399
                ++ EFM  GSL  +L S       L +L   ID  + +          + IH DL
Sbjct: 82  EPI-YIITEFMAKGSLLDFLKSDEGSKQPLPKL---IDFSAQIAEGMAFIEQRNYIHRDL 137
Query: 400 KPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVY 459
           +  NIL+  ++V  ++DFG+ +++ + E + R+      I + APE    G  + K DV+
Sbjct: 138 RAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINFGSFTIKSDVW 196
Query: 460 SYGVLLMETFTRKR 473
           S+G+LLME  T  R
Sbjct: 197 SFGILLMEIVTYGR 210

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/241 (27%), Positives = 110/241 (45%), Gaps = 12/241 (4%)
Query: 273 EFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLE-----RAFRSFDSECEVLRNVR 326
           EF +  +LG+ +FG+VYKG  I +G  V I V   +L      +A +    E  V+ +V 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 327 HRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH 386
           + ++ ++L        + L+ + MP G L  ++  H   +     LN  + +   + YL 
Sbjct: 76  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 387 NGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEY 446
           +      ++H DL   N+L+       ++DFG+ KLLG  E           I +MA E 
Sbjct: 135 DRR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 190
Query: 447 GLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANL 505
            L  I + + DV+SYGV + E  T   +P D +   E+S      E LP      +D  +
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM 250
Query: 506 V 506
           +
Sbjct: 251 I 251

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/241 (27%), Positives = 110/241 (45%), Gaps = 12/241 (4%)
Query: 273 EFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLE-----RAFRSFDSECEVLRNVR 326
           EF +  +LG+ +FG+VYKG  I +G  V I V   +L      +A +    E  V+ +V 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 327 HRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH 386
           + ++ ++L        + L+ + MP G L  ++  H   +     LN  + +   + YL 
Sbjct: 79  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 137
Query: 387 NGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEY 446
           +      ++H DL   N+L+       ++DFG+ KLLG  E           I +MA E 
Sbjct: 138 DRR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 193
Query: 447 GLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANL 505
            L  I + + DV+SYGV + E  T   +P D +   E+S      E LP      +D  +
Sbjct: 194 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM 253
Query: 506 V 506
           +
Sbjct: 254 I 254

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/241 (27%), Positives = 110/241 (45%), Gaps = 12/241 (4%)
Query: 273 EFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLE-----RAFRSFDSECEVLRNVR 326
           EF +  +LG+ +FG+VYKG  I +G  V I V   +L      +A +    E  V+ +V 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 327 HRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH 386
           + ++ ++L        + L+ + MP G L  ++  H   +     LN  + +   + YL 
Sbjct: 78  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 136
Query: 387 NGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEY 446
           +      ++H DL   N+L+       ++DFG+ KLLG  E           I +MA E 
Sbjct: 137 DRR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 192
Query: 447 GLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANL 505
            L  I + + DV+SYGV + E  T   +P D +   E+S      E LP      +D  +
Sbjct: 193 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM 252
Query: 506 V 506
           +
Sbjct: 253 I 253

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 101/195 (51%), Gaps = 8/195 (4%)
Query: 280 LGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSN 339
           LG   FG V+ G  +  T VA+K    Q   +  +F +E  +++ ++H+ L+++ +  + 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 340 PDFKALVLEFMPNGSLEKWLYSHNYF-LDILERLNIMIDVGSALEYLHNGHSSVHIIHCD 398
                ++ E+M NGSL  +L + +   L I + L++   +   + ++   +     IH D
Sbjct: 80  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN----YIHRD 134
Query: 399 LKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDV 458
           L+  NIL+ + +   ++DFG+ +L+ + E + R+      I + APE    G  + K DV
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP-IKWTAPEAINYGTFTIKSDV 193
Query: 459 YSYGVLLMETFTRKR 473
           +S+G+LL E  T  R
Sbjct: 194 WSFGILLTEIVTHGR 208

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 101/195 (51%), Gaps = 8/195 (4%)
Query: 280 LGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSN 339
           LG   FG V+ G  +  T VA+K    Q   +  +F +E  +++ ++H+ L+++ +  + 
Sbjct: 16  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 74
Query: 340 PDFKALVLEFMPNGSLEKWLYSHNYF-LDILERLNIMIDVGSALEYLHNGHSSVHIIHCD 398
                ++ E+M NGSL  +L + +   L I + L++   +   + ++   +     IH D
Sbjct: 75  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN----YIHRD 129
Query: 399 LKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDV 458
           L+  NIL+ + +   ++DFG+ +L+ + E + R+      I + APE    G  + K DV
Sbjct: 130 LRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP-IKWTAPEAINYGTFTIKSDV 188
Query: 459 YSYGVLLMETFTRKR 473
           +S+G+LL E  T  R
Sbjct: 189 WSFGILLTEIVTHGR 203

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/241 (27%), Positives = 110/241 (45%), Gaps = 12/241 (4%)
Query: 273 EFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLE-----RAFRSFDSECEVLRNVR 326
           EF +  +LG+ +FG+VYKG  I +G  V I V   +L      +A +    E  V+ +V 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 327 HRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH 386
           + ++ ++L        + L+ + MP G L  ++  H   +     LN  + +   + YL 
Sbjct: 79  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 137
Query: 387 NGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEY 446
           +      ++H DL   N+L+       ++DFG+ KLLG  E           I +MA E 
Sbjct: 138 DRR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 193
Query: 447 GLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANL 505
            L  I + + DV+SYGV + E  T   +P D +   E+S      E LP      +D  +
Sbjct: 194 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM 253
Query: 506 V 506
           +
Sbjct: 254 I 254

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 101/195 (51%), Gaps = 8/195 (4%)
Query: 280 LGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSN 339
           LG   FG V+ G  +  T VA+K    Q   +  +F +E  +++ ++H+ L+++ +  + 
Sbjct: 31  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 89
Query: 340 PDFKALVLEFMPNGSLEKWLYSHNYF-LDILERLNIMIDVGSALEYLHNGHSSVHIIHCD 398
                ++ E+M NGSL  +L + +   L I + L++   +   + ++   +     IH D
Sbjct: 90  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN----YIHRD 144
Query: 399 LKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDV 458
           L+  NIL+ + +   ++DFG+ +L+ + E + R+      I + APE    G  + K DV
Sbjct: 145 LRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP-IKWTAPEAINYGTFTIKSDV 203
Query: 459 YSYGVLLMETFTRKR 473
           +S+G+LL E  T  R
Sbjct: 204 WSFGILLTEIVTHGR 218

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/241 (27%), Positives = 110/241 (45%), Gaps = 12/241 (4%)
Query: 273 EFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLE-----RAFRSFDSECEVLRNVR 326
           EF +  +LG+ +FG+VYKG  I +G  V I V   +L      +A +    E  V+ +V 
Sbjct: 22  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 81
Query: 327 HRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH 386
           + ++ ++L        + L+ + MP G L  ++  H   +     LN  + +   + YL 
Sbjct: 82  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 140
Query: 387 NGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEY 446
           +      ++H DL   N+L+       ++DFG+ KLLG  E           I +MA E 
Sbjct: 141 DRR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 196
Query: 447 GLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANL 505
            L  I + + DV+SYGV + E  T   +P D +   E+S      E LP      +D  +
Sbjct: 197 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM 256
Query: 506 V 506
           +
Sbjct: 257 I 257

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/241 (27%), Positives = 110/241 (45%), Gaps = 12/241 (4%)
Query: 273 EFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLE-----RAFRSFDSECEVLRNVR 326
           EF +  +LG+ +FG+VYKG  I +G  V I V   +L      +A +    E  V+ +V 
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 327 HRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH 386
           + ++ ++L        + L+ + MP G L  ++  H   +     LN  + +   + YL 
Sbjct: 83  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 141
Query: 387 NGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEY 446
           +      ++H DL   N+L+       ++DFG+ KLLG  E           I +MA E 
Sbjct: 142 DRR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 197
Query: 447 GLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANL 505
            L  I + + DV+SYGV + E  T   +P D +   E+S      E LP      +D  +
Sbjct: 198 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM 257
Query: 506 V 506
           +
Sbjct: 258 I 258

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/241 (27%), Positives = 110/241 (45%), Gaps = 12/241 (4%)
Query: 273 EFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLE-----RAFRSFDSECEVLRNVR 326
           EF +  +LG+ +FG+VYKG  I +G  V I V   +L      +A +    E  V+ +V 
Sbjct: 26  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 85
Query: 327 HRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH 386
           + ++ ++L        + L+ + MP G L  ++  H   +     LN  + +   + YL 
Sbjct: 86  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 144
Query: 387 NGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEY 446
           +      ++H DL   N+L+       ++DFG+ KLLG  E           I +MA E 
Sbjct: 145 DRR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 200
Query: 447 GLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANL 505
            L  I + + DV+SYGV + E  T   +P D +   E+S      E LP      +D  +
Sbjct: 201 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM 260
Query: 506 V 506
           +
Sbjct: 261 I 261

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/241 (27%), Positives = 110/241 (45%), Gaps = 12/241 (4%)
Query: 273 EFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLE-----RAFRSFDSECEVLRNVR 326
           EF +  +LG+ +FG+VYKG  I +G  V I V   +L      +A +    E  V+ +V 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 327 HRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH 386
           + ++ ++L        + L+ + MP G L  ++  H   +     LN  + +   + YL 
Sbjct: 76  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 387 NGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEY 446
           +      ++H DL   N+L+       ++DFG+ KLLG  E           I +MA E 
Sbjct: 135 DRR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 190
Query: 447 GLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANL 505
            L  I + + DV+SYGV + E  T   +P D +   E+S      E LP      +D  +
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM 250
Query: 506 V 506
           +
Sbjct: 251 I 251

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 66/241 (27%), Positives = 110/241 (45%), Gaps = 12/241 (4%)
Query: 273 EFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLE-----RAFRSFDSECEVLRNVR 326
           EF +  +LG+ +FG+VYKG  I +G  V I V   +L      +A +    E  V+ +V 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 327 HRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH 386
           + ++ ++L        + L+ + MP G L  ++  H   +     LN  + +   + YL 
Sbjct: 76  NPHVCRLLGICLTSTVQ-LITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 387 NGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEY 446
           +      ++H DL   N+L+       ++DFG+ KLLG  E           I +MA E 
Sbjct: 135 DRR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 190
Query: 447 GLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANL 505
            L  I + + DV+SYGV + E  T   +P D +   E+S      E LP      +D  +
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM 250
Query: 506 V 506
           +
Sbjct: 251 I 251

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 66/241 (27%), Positives = 110/241 (45%), Gaps = 12/241 (4%)
Query: 273 EFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLE-----RAFRSFDSECEVLRNVR 326
           EF +  +LG+ +FG+VYKG  I +G  V I V   +L      +A +    E  V+ +V 
Sbjct: 13  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 72
Query: 327 HRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH 386
           + ++ ++L        + L+ + MP G L  ++  H   +     LN  + +   + YL 
Sbjct: 73  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAEGMNYLE 131
Query: 387 NGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEY 446
           +      ++H DL   N+L+       ++DFG+ KLLG  E           I +MA E 
Sbjct: 132 DRR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 187
Query: 447 GLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANL 505
            L  I + + DV+SYGV + E  T   +P D +   E+S      E LP      +D  +
Sbjct: 188 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM 247
Query: 506 V 506
           +
Sbjct: 248 I 248

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 66/241 (27%), Positives = 110/241 (45%), Gaps = 12/241 (4%)
Query: 273 EFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLE-----RAFRSFDSECEVLRNVR 326
           EF +  +LG+ +FG+VYKG  I +G  V I V   +L      +A +    E  V+ +V 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 327 HRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH 386
           + ++ ++L        + L+++ MP G L  ++  H   +     LN  + +   + YL 
Sbjct: 78  NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 136
Query: 387 NGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEY 446
           +      ++H DL   N+L+       ++DFG  KLLG  E           I +MA E 
Sbjct: 137 DRR----LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALES 192
Query: 447 GLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANL 505
            L  I + + DV+SYGV + E  T   +P D +   E+S      E LP      +D  +
Sbjct: 193 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM 252
Query: 506 V 506
           +
Sbjct: 253 I 253

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 66/241 (27%), Positives = 110/241 (45%), Gaps = 12/241 (4%)
Query: 273 EFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLE-----RAFRSFDSECEVLRNVR 326
           EF +  +LG+ +FG+VYKG  I +G  V I V   +L      +A +    E  V+ +V 
Sbjct: 41  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 100
Query: 327 HRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH 386
           + ++ ++L        + L+ + MP G L  ++  H   +     LN  + +   + YL 
Sbjct: 101 NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 159
Query: 387 NGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEY 446
           +      ++H DL   N+L+       ++DFG+ KLLG  E           I +MA E 
Sbjct: 160 DRR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 215
Query: 447 GLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANL 505
            L  I + + DV+SYGV + E  T   +P D +   E+S      E LP      +D  +
Sbjct: 216 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM 275
Query: 506 V 506
           +
Sbjct: 276 I 276

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 66/241 (27%), Positives = 110/241 (45%), Gaps = 12/241 (4%)
Query: 273 EFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLE-----RAFRSFDSECEVLRNVR 326
           EF +  +LG+ +FG+VYKG  I +G  V I V   +L      +A +    E  V+ +V 
Sbjct: 10  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 69
Query: 327 HRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH 386
           + ++ ++L        + L+ + MP G L  ++  H   +     LN  + +   + YL 
Sbjct: 70  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 128
Query: 387 NGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEY 446
           +      ++H DL   N+L+       ++DFG+ KLLG  E           I +MA E 
Sbjct: 129 DRR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184
Query: 447 GLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANL 505
            L  I + + DV+SYGV + E  T   +P D +   E+S      E LP      +D  +
Sbjct: 185 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM 244
Query: 506 V 506
           +
Sbjct: 245 I 245

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 66/241 (27%), Positives = 110/241 (45%), Gaps = 12/241 (4%)
Query: 273 EFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLE-----RAFRSFDSECEVLRNVR 326
           EF +  +LG+ +FG+VYKG  I +G  V I V   +L      +A +    E  V+ +V 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 327 HRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH 386
           + ++ ++L        + L+++ MP G L  ++  H   +     LN  + +   + YL 
Sbjct: 78  NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 136
Query: 387 NGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEY 446
           +      ++H DL   N+L+       ++DFG  KLLG  E           I +MA E 
Sbjct: 137 DRR----LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALES 192
Query: 447 GLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANL 505
            L  I + + DV+SYGV + E  T   +P D +   E+S      E LP      +D  +
Sbjct: 193 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM 252
Query: 506 V 506
           +
Sbjct: 253 I 253

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 99/192 (51%), Gaps = 7/192 (3%)
Query: 280 LGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSN 339
           LG   FG V+ G  ++ T VA+K        + ++F  E  +++ ++H  L+++ +  + 
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTR 79
Query: 340 PDFKALVLEFMPNGSLEKWLYSHNYFLDILERL-NIMIDVGSALEYLHNGHSSVHIIHCD 398
            +   ++ E+M  GSL  +L S      +L +L +    +   + Y+   +     IH D
Sbjct: 80  EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN----YIHRD 135
Query: 399 LKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDV 458
           L+  N+L+ E+++  ++DFG+ +++ + E + R+      I + APE    G  + K DV
Sbjct: 136 LRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFP-IKWTAPEAINFGCFTIKSDV 194
Query: 459 YSYGVLLMETFT 470
           +S+G+LL E  T
Sbjct: 195 WSFGILLYEIVT 206

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 108/220 (49%), Gaps = 11/220 (5%)
Query: 255 PLAIWRRTSYLDIQRATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRS 314
           P   W + ++ +I R + +  +   LG   FG V+  T +  T VA+K        +  +
Sbjct: 174 PQKPWEKDAW-EIPRESLKLEKK--LGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEA 229
Query: 315 FDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERL-N 373
           F +E  V++ ++H  L+K+ +  +      ++ EFM  GSL  +L S       L +L +
Sbjct: 230 FLAEANVMKTLQHDKLVKLHAVVTKEPI-YIITEFMAKGSLLDFLKSDEGSKQPLPKLID 288
Query: 374 IMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQT 433
               +   + ++   +     IH DL+  NIL+  ++V  ++DFG+ +++ + E + R+ 
Sbjct: 289 FSAQIAEGMAFIEQRN----YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREG 344
Query: 434 MTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKR 473
                I + APE    G  + K DV+S+G+LLME  T  R
Sbjct: 345 AKFP-IKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGR 383

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 66/241 (27%), Positives = 110/241 (45%), Gaps = 12/241 (4%)
Query: 273 EFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLE-----RAFRSFDSECEVLRNVR 326
           EF +  +LG+ +FG+VYKG  I +G  V I V   +L      +A +    E  V+ +V 
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 79
Query: 327 HRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH 386
           + ++ ++L        + L+++ MP G L  ++  H   +     LN  + +   + YL 
Sbjct: 80  NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 138
Query: 387 NGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEY 446
           +      ++H DL   N+L+       ++DFG  KLLG  E           I +MA E 
Sbjct: 139 DRR----LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALES 194
Query: 447 GLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANL 505
            L  I + + DV+SYGV + E  T   +P D +   E+S      E LP      +D  +
Sbjct: 195 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM 254
Query: 506 V 506
           +
Sbjct: 255 I 255

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 69/292 (23%), Positives = 121/292 (41%), Gaps = 44/292 (15%)
Query: 280 LGTSSFGSVYKGTI------SDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKI 333
           LG  +FG V+           D   VA+K      E A + F  E E+L  ++H+++++ 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 334 LSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDIL--------------ERLNIMIDVG 379
               +      +V E+M +G L ++L SH     +L              + L +   V 
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 380 SALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATI 439
           + + YL    + +H +H DL   N L+ + +V  + DFG+ + +   +       TM  I
Sbjct: 169 AGMVYL----AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 224
Query: 440 GYMAPEYGLEGIVSAKCDVYSYGVLLMETFTR-KRPTDEMFIGEMSLRRWVKESLPHGLT 498
            +M PE  L    + + DV+S+GV+L E FT  K+P             W + S     T
Sbjct: 225 RWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP-------------WYQLS----NT 267
Query: 499 EVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKI 550
           E +D   + + +       C   +      C    P  R ++ D  A+L+ +
Sbjct: 268 EAIDC--ITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQAL 317

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 69/292 (23%), Positives = 121/292 (41%), Gaps = 44/292 (15%)
Query: 280 LGTSSFGSVYKGTI------SDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKI 333
           LG  +FG V+           D   VA+K      E A + F  E E+L  ++H+++++ 
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 334 LSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDIL--------------ERLNIMIDVG 379
               +      +V E+M +G L ++L SH     +L              + L +   V 
Sbjct: 80  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 139
Query: 380 SALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATI 439
           + + YL    + +H +H DL   N L+ + +V  + DFG+ + +   +       TM  I
Sbjct: 140 AGMVYL----AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 195
Query: 440 GYMAPEYGLEGIVSAKCDVYSYGVLLMETFTR-KRPTDEMFIGEMSLRRWVKESLPHGLT 498
            +M PE  L    + + DV+S+GV+L E FT  K+P             W + S     T
Sbjct: 196 RWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP-------------WYQLS----NT 238
Query: 499 EVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKI 550
           E +D   + + +       C   +      C    P  R ++ D  A+L+ +
Sbjct: 239 EAIDC--ITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQAL 288

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 99/192 (51%), Gaps = 7/192 (3%)
Query: 280 LGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSN 339
           LG   FG V+ G  ++ T VA+K        + ++F  E  +++ ++H  L+++ +  + 
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTK 78
Query: 340 PDFKALVLEFMPNGSLEKWLYSHNYFLDILERL-NIMIDVGSALEYLHNGHSSVHIIHCD 398
            +   ++ EFM  GSL  +L S      +L +L +    +   + Y+   +     IH D
Sbjct: 79  EEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN----YIHRD 134
Query: 399 LKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDV 458
           L+  N+L+ E+++  ++DFG+ +++ + E + R+      I + APE    G  + K +V
Sbjct: 135 LRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFP-IKWTAPEAINFGCFTIKSNV 193
Query: 459 YSYGVLLMETFT 470
           +S+G+LL E  T
Sbjct: 194 WSFGILLYEIVT 205

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 69/292 (23%), Positives = 121/292 (41%), Gaps = 44/292 (15%)
Query: 280 LGTSSFGSVYKGTI------SDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKI 333
           LG  +FG V+           D   VA+K      E A + F  E E+L  ++H+++++ 
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 334 LSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDIL--------------ERLNIMIDVG 379
               +      +V E+M +G L ++L SH     +L              + L +   V 
Sbjct: 86  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 145
Query: 380 SALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATI 439
           + + YL    + +H +H DL   N L+ + +V  + DFG+ + +   +       TM  I
Sbjct: 146 AGMVYL----AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 201
Query: 440 GYMAPEYGLEGIVSAKCDVYSYGVLLMETFTR-KRPTDEMFIGEMSLRRWVKESLPHGLT 498
            +M PE  L    + + DV+S+GV+L E FT  K+P             W + S     T
Sbjct: 202 RWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP-------------WYQLS----NT 244
Query: 499 EVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKI 550
           E +D   + + +       C   +      C    P  R ++ D  A+L+ +
Sbjct: 245 EAIDC--ITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQAL 294

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 110/241 (45%), Gaps = 12/241 (4%)
Query: 273 EFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLE-----RAFRSFDSECEVLRNVR 326
           EF +  +L + +FG+VYKG  I +G  V I V   +L      +A +    E  V+ +V 
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 327 HRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH 386
           + ++ ++L        + L+++ MP G L  ++  H   +     LN  + +   + YL 
Sbjct: 83  NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 141
Query: 387 NGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEY 446
           +      ++H DL   N+L+       ++DFG+ KLLG  E           I +MA E 
Sbjct: 142 DRR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 197
Query: 447 GLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANL 505
            L  I + + DV+SYGV + E  T   +P D +   E+S      E LP      +D  +
Sbjct: 198 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM 257
Query: 506 V 506
           +
Sbjct: 258 I 258

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 104/211 (49%), Gaps = 22/211 (10%)
Query: 278 NLLGTSSFGSVYKGTI--SDGTDVAIKVFNLQL----ERAFRSFDSECEVLRNVRHRNLI 331
            +LG   FGSV +G +   DGT + + V  ++L    +R    F SE   +++  H N+I
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 332 KIL------SSYSNPDFKALVLEFMPNGSLEKWL-YSH----NYFLDILERLNIMIDVGS 380
           ++L      SS   P    ++L FM  G L  +L YS        + +   L  M+D+  
Sbjct: 100 RLLGVCIEMSSQGIPK-PMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 381 ALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIG 440
            +EYL N +     +H DL   N +L ++M   V+DFG+ K +  G+   +  +    + 
Sbjct: 159 GMEYLSNRN----FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK 214
Query: 441 YMAPEYGLEGIVSAKCDVYSYGVLLMETFTR 471
           ++A E   + + ++K DV+++GV + E  TR
Sbjct: 215 WIAIESLADRVYTSKSDVWAFGVTMWEIATR 245

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/241 (27%), Positives = 109/241 (45%), Gaps = 12/241 (4%)
Query: 273 EFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLE-----RAFRSFDSECEVLRNVR 326
           EF +  +LG+ +FG+VYKG  I +G  V I V   +L      +A +    E  V+ +V 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 327 HRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH 386
           + ++ ++L        + L+ + MP G L  ++  H   +     LN  + +   + YL 
Sbjct: 78  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 136
Query: 387 NGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEY 446
           +      ++H DL   N+L+       ++DFG  KLLG  E           I +MA E 
Sbjct: 137 DRR----LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALES 192
Query: 447 GLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANL 505
            L  I + + DV+SYGV + E  T   +P D +   E+S      E LP      +D  +
Sbjct: 193 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM 252
Query: 506 V 506
           +
Sbjct: 253 I 253

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/241 (27%), Positives = 109/241 (45%), Gaps = 12/241 (4%)
Query: 273 EFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLE-----RAFRSFDSECEVLRNVR 326
           EF +  +LG+ +FG+VYKG  I +G  V I V   +L      +A +    E  V+ +V 
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 327 HRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH 386
           + ++ ++L        + L+ + MP G L  ++  H   +     LN  + +   + YL 
Sbjct: 83  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 141
Query: 387 NGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEY 446
           +      ++H DL   N+L+       ++DFG  KLLG  E           I +MA E 
Sbjct: 142 DRR----LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALES 197
Query: 447 GLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANL 505
            L  I + + DV+SYGV + E  T   +P D +   E+S      E LP      +D  +
Sbjct: 198 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM 257
Query: 506 V 506
           +
Sbjct: 258 I 258

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 101/195 (51%), Gaps = 8/195 (4%)
Query: 280 LGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSN 339
           LG   FG V+ G  +  T VA+K    Q   +  +F +E  +++ ++H+ L+++ +  + 
Sbjct: 17  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 75
Query: 340 PDFKALVLEFMPNGSLEKWLYSHNYF-LDILERLNIMIDVGSALEYLHNGHSSVHIIHCD 398
                ++ E+M NGSL  +L + +   L I + L++   +   + ++   +     IH +
Sbjct: 76  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN----YIHRN 130
Query: 399 LKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDV 458
           L+  NIL+ + +   ++DFG+ +L+ + E + R+      I + APE    G  + K DV
Sbjct: 131 LRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP-IKWTAPEAINYGTFTIKSDV 189
Query: 459 YSYGVLLMETFTRKR 473
           +S+G+LL E  T  R
Sbjct: 190 WSFGILLTEIVTHGR 204

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 100/195 (51%), Gaps = 8/195 (4%)
Query: 280 LGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSN 339
           LG    G V+ G  +  T VA+K    Q   +  +F +E  +++ ++H+ L+++ +  + 
Sbjct: 21  LGAGQAGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 340 PDFKALVLEFMPNGSLEKWLYSHNYF-LDILERLNIMIDVGSALEYLHNGHSSVHIIHCD 398
                ++ E+M NGSL  +L + +   L I + L++   +   + ++   +     IH D
Sbjct: 80  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN----YIHRD 134
Query: 399 LKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDV 458
           L+  NIL+ + +   ++DFG+ +L+ + E + R+      I + APE    G  + K DV
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFP-IKWTAPEAINYGTFTIKSDV 193
Query: 459 YSYGVLLMETFTRKR 473
           +S+G+LL E  T  R
Sbjct: 194 WSFGILLTEIVTHGR 208

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/241 (27%), Positives = 109/241 (45%), Gaps = 12/241 (4%)
Query: 273 EFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLE-----RAFRSFDSECEVLRNVR 326
           EF +  +LG+ +FG+VYKG  I +G  V I V   +L      +A +    E  V+ +V 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 327 HRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH 386
           + ++ ++L        + L+ + MP G L  ++  H   +     LN  + +   + YL 
Sbjct: 76  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 387 NGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEY 446
           +      ++H DL   N+L+       ++DFG  KLLG  E           I +MA E 
Sbjct: 135 DRR----LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALES 190
Query: 447 GLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANL 505
            L  I + + DV+SYGV + E  T   +P D +   E+S      E LP      +D  +
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM 250
Query: 506 V 506
           +
Sbjct: 251 I 251

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 100/212 (47%), Gaps = 15/212 (7%)
Query: 268 QRATDEFNECNLLGTSSFGSVYKGTISDGTDV-AIKV-FNLQLERA--FRSFDSECEVLR 323
           Q A ++F     LG   FG+VY         + A+KV F  QLE+A        E E+  
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 324 NVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALE 383
           ++RH N++++   + +     L+LE+ P G + K L   + F D       + ++ +AL 
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKF-DEQRTATYITELANALS 127
Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           Y H    S  +IH D+KP N+LL       ++DFG          S R+T    T+ Y+ 
Sbjct: 128 YCH----SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLP 179
Query: 444 PEYGLEG-IVSAKCDVYSYGVLLMETFTRKRP 474
           PE  +EG +   K D++S GVL  E    K P
Sbjct: 180 PEM-IEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/237 (28%), Positives = 104/237 (43%), Gaps = 55/237 (23%)
Query: 9   NQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTF 68
           N L G +P  I   L  + YL +T  N++G IP+ ++    L+ LD  +N+ SG +  + 
Sbjct: 87  NNLVGPIPPAIAK-LTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSI 145
Query: 69  GNLRHL------------------SVLSLLMFGIRLTGNKLYGRIPPC---LVLTVLDVS 107
            +L +L                     S L   + ++ N+L G+IPP    L L  +D+S
Sbjct: 146 SSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLS 205
Query: 108 RNQLSGDIPSTIG-------------------GRV----DLETLSLASNQFQGPIPESVG 144
           RN L GD     G                   G+V    +L  L L +N+  G +P+ + 
Sbjct: 206 RNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLT 265
Query: 145 SLISLESLDLSGNNLSGKIPKLEGEIPVKGSFKNFSTESFFGNYALCGPPKLRVPPC 201
            L  L SL++S NNL        GEIP  G+ + F   ++  N  LCG P   +P C
Sbjct: 266 QLKFLHSLNVSFNNLC-------GEIPQGGNLQRFDVSAYANNKCLCGSP---LPAC 312

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 24/209 (11%)
Query: 280 LGTSSFGSVYKGTIS----DGTDVAIKVFNLQ---LERAFRSFDSECEVLRNVRHRNLIK 332
           LG  +FG VY+G +S    D + + + V  L     E+    F  E  ++  + H+N+++
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 333 IL--SSYSNPDFKALVLEFMPNGSLEKWLY------SHNYFLDILERLNIMIDVGSALEY 384
            +  S  S P F  ++LE M  G L+ +L       S    L +L+ L++  D+    +Y
Sbjct: 99  CIGVSLQSLPRF--ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 156
Query: 385 LHNGHSSVHIIHCDLKPTNILL---DENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGY 441
           L   H     IH D+   N LL       VA + DFG+ + +       +    M  + +
Sbjct: 157 LEENH----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 212
Query: 442 MAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
           M PE  +EGI ++K D +S+GVLL E F+
Sbjct: 213 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 102/206 (49%), Gaps = 15/206 (7%)
Query: 278 NLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFR---SFDSECEVLRNVRHRNLIKI 333
           + LG  +FG V  G     G  VA+K+ N Q  R+         E + L+  RH ++IK+
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 334 LSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVH 393
               S P    +V+E++  G L  ++  H   ++ +E   +   + SA++Y H       
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYICKHGR-VEEMEARRLFQQILSAVDYCHRHM---- 131
Query: 394 IIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVS 453
           ++H DLKP N+LLD +M A ++DFG+  ++ +GE       +  +  Y APE  + G + 
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE---FLRTSCGSPNYAAPEV-ISGRLY 187
Query: 454 A--KCDVYSYGVLLMETFTRKRPTDE 477
           A  + D++S GV+L        P D+
Sbjct: 188 AGPEVDIWSCGVILYALLCGTLPFDD 213

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 109/241 (45%), Gaps = 12/241 (4%)
Query: 273 EFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLE-----RAFRSFDSECEVLRNVR 326
           EF +  +L + +FG+VYKG  I +G  V I V   +L      +A +    E  V+ +V 
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 327 HRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH 386
           + ++ ++L        + L+ + MP G L  ++  H   +     LN  + +   + YL 
Sbjct: 83  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 141
Query: 387 NGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEY 446
           +      ++H DL   N+L+       ++DFG+ KLLG  E           I +MA E 
Sbjct: 142 DRR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 197
Query: 447 GLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANL 505
            L  I + + DV+SYGV + E  T   +P D +   E+S      E LP      +D  +
Sbjct: 198 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM 257
Query: 506 V 506
           +
Sbjct: 258 I 258

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 104/206 (50%), Gaps = 15/206 (7%)
Query: 278 NLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFR---SFDSECEVLRNVRHRNLIKI 333
           + LG  +FG V  G     G  VA+K+ N Q  R+         E + L+  RH ++IK+
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 334 LSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVH 393
               S P    +V+E++  G L  ++  H   ++ +E   +   + SA++Y H       
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYICKHGR-VEEMEARRLFQQILSAVDYCHRHM---- 131
Query: 394 IIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVS 453
           ++H DLKP N+LLD +M A ++DFG+  ++ +GE  +R   +  +  Y APE  + G + 
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-FLRD--SCGSPNYAAPEV-ISGRLY 187
Query: 454 A--KCDVYSYGVLLMETFTRKRPTDE 477
           A  + D++S GV+L        P D+
Sbjct: 188 AGPEVDIWSCGVILYALLCGTLPFDD 213

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 99/202 (49%), Gaps = 10/202 (4%)
Query: 280 LGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKI--LSSY 337
           LGT  FG V  G      DVAIK+   +   +   F  E +V+ N+ H  L+++  + + 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 338 SNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHC 397
             P F  ++ E+M NG L  +L    +     + L +  DV  A+EYL     S   +H 
Sbjct: 91  QRPIF--IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE----SKQFLHR 144
Query: 398 DLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCD 457
           DL   N L+++  V  VSDFG+ + + + E++     +   + +  PE  +    S+K D
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEET-SSVGSKFPVRWSPPEVLMYSKFSSKSD 203
Query: 458 VYSYGVLLMETFTRKRPTDEMF 479
           ++++GVL+ E ++  +   E F
Sbjct: 204 IWAFGVLMWEIYSLGKMPYERF 225

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 24/209 (11%)
Query: 280 LGTSSFGSVYKGTIS----DGTDVAIKVFNLQ---LERAFRSFDSECEVLRNVRHRNLIK 332
           LG  +FG VY+G +S    D + + + V  L     E+    F  E  ++  + H+N+++
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 333 IL--SSYSNPDFKALVLEFMPNGSLEKWLY------SHNYFLDILERLNIMIDVGSALEY 384
            +  S  S P F  ++LE M  G L+ +L       S    L +L+ L++  D+    +Y
Sbjct: 113 CIGVSLQSLPRF--ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 170
Query: 385 LHNGHSSVHIIHCDLKPTNILL---DENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGY 441
           L   H     IH D+   N LL       VA + DFG+ + +       +    M  + +
Sbjct: 171 LEENH----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 226
Query: 442 MAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
           M PE  +EGI ++K D +S+GVLL E F+
Sbjct: 227 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 109/241 (45%), Gaps = 12/241 (4%)
Query: 273 EFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLE-----RAFRSFDSECEVLRNVR 326
           EF +  +L + +FG+VYKG  I +G  V I V   +L      +A +    E  V+ +V 
Sbjct: 16  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 327 HRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH 386
           + ++ ++L        + L+ + MP G L  ++  H   +     LN  + +   + YL 
Sbjct: 76  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 387 NGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEY 446
           +      ++H DL   N+L+       ++DFG+ KLLG  E           I +MA E 
Sbjct: 135 DRR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 190
Query: 447 GLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANL 505
            L  I + + DV+SYGV + E  T   +P D +   E+S      E LP      +D  +
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM 250
Query: 506 V 506
           +
Sbjct: 251 I 251

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 96/200 (48%), Gaps = 14/200 (7%)
Query: 280 LGTSSFGSV---YKGTISDGTDVAIKVFNLQLE--RAFRSFDSECEVLRNVRHRNLIKIL 334
           LG  +FGSV       + D T   + V  LQ       R F  E ++L+ +    ++K  
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 74
Query: 335 S-SYS--NPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSS 391
             SY    P+ + LV+E++P+G L  +L  H   LD    L     +   +EYL     S
Sbjct: 75  GVSYGPGRPELR-LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYL----GS 129
Query: 392 VHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDS-VRQTMTMATIGYMAPEYGLEG 450
              +H DL   NIL++      ++DFG+ KLL   +D  V +    + I + APE   + 
Sbjct: 130 RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSDN 189
Query: 451 IVSAKCDVYSYGVLLMETFT 470
           I S + DV+S+GV+L E FT
Sbjct: 190 IFSRQSDVWSFGVVLYELFT 209

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 99/209 (47%), Gaps = 24/209 (11%)
Query: 280 LGTSSFGSVYKGTIS----DGTDVAIKVFNLQ---LERAFRSFDSECEVLRNVRHRNLIK 332
           LG  +FG VY+G +S    D + + + V  L     E+    F  E  ++    H+N+++
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 333 IL--SSYSNPDFKALVLEFMPNGSLEKWLY------SHNYFLDILERLNIMIDVGSALEY 384
            +  S  S P F  ++LE M  G L+ +L       S    L +L+ L++  D+    +Y
Sbjct: 90  CIGVSLQSLPRF--ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 147
Query: 385 LHNGHSSVHIIHCDLKPTNILL---DENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGY 441
           L   H     IH D+   N LL       VA + DFG+ + +       +    M  + +
Sbjct: 148 LEENH----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 203
Query: 442 MAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
           M PE  +EGI ++K D +S+GVLL E F+
Sbjct: 204 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 99/209 (47%), Gaps = 24/209 (11%)
Query: 280 LGTSSFGSVYKGTIS----DGTDVAIKVFNLQ---LERAFRSFDSECEVLRNVRHRNLIK 332
           LG  +FG VY+G +S    D + + + V  L     E+    F  E  ++    H+N+++
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 333 IL--SSYSNPDFKALVLEFMPNGSLEKWLY------SHNYFLDILERLNIMIDVGSALEY 384
            +  S  S P F  ++LE M  G L+ +L       S    L +L+ L++  D+    +Y
Sbjct: 98  CIGVSLQSLPRF--ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 385 LHNGHSSVHIIHCDLKPTNILL---DENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGY 441
           L   H     IH D+   N LL       VA + DFG+ + +       +    M  + +
Sbjct: 156 LEENH----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 211
Query: 442 MAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
           M PE  +EGI ++K D +S+GVLL E F+
Sbjct: 212 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/284 (22%), Positives = 124/284 (43%), Gaps = 36/284 (12%)
Query: 278 NLLGTSSFGSVYKG--TISDGTDVAIKVFNLQ---LERAFRSFDSECEVLRNVRHRNLIK 332
            ++G   FG V  G   +    ++ + +  L+    E+  R F SE  ++    H N+I 
Sbjct: 13  QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIH 72
Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSV 392
           +    +      ++ EFM NGSL+ +L  ++    +++ + ++  + + ++YL    + +
Sbjct: 73  LEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL----ADM 128
Query: 393 HIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMA-----TIGYMAPEYG 447
           + +H  L   NIL++ N+V  VSDFG+ + L   +D+   T T A      I + APE  
Sbjct: 129 NYVHRALAARNILVNSNLVCKVSDFGLSRFL--EDDTSDPTYTSALGGKIPIRWTAPEAI 186
Query: 448 LEGIVSAKCDVYSYGVLLMETFTR-KRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLV 506
                ++  DV+SYG+++ E  +  +RP  +M                   T     N +
Sbjct: 187 QYRKFTSASDVWSYGIVMWEVMSYGERPYWDM-------------------TNQDVINAI 227
Query: 507 REEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKI 550
            ++      MDC  ++    LDC  +  + R         L K+
Sbjct: 228 EQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 271

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 99/209 (47%), Gaps = 24/209 (11%)
Query: 280 LGTSSFGSVYKGTIS----DGTDVAIKVFNLQ---LERAFRSFDSECEVLRNVRHRNLIK 332
           LG  +FG VY+G +S    D + + + V  L     E+    F  E  ++    H+N+++
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 333 IL--SSYSNPDFKALVLEFMPNGSLEKWLY------SHNYFLDILERLNIMIDVGSALEY 384
            +  S  S P F  ++LE M  G L+ +L       S    L +L+ L++  D+    +Y
Sbjct: 99  CIGVSLQSLPRF--ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 156
Query: 385 LHNGHSSVHIIHCDLKPTNILL---DENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGY 441
           L   H     IH D+   N LL       VA + DFG+ + +       +    M  + +
Sbjct: 157 LEENH----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 212
Query: 442 MAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
           M PE  +EGI ++K D +S+GVLL E F+
Sbjct: 213 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 99/209 (47%), Gaps = 24/209 (11%)
Query: 280 LGTSSFGSVYKGTISDGTD------VAIKVF-NLQLERAFRSFDSECEVLRNVRHRNLIK 332
           LG  +FG VY+G +S   +      VA+K    +  E+    F  E  ++    H+N+++
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 333 IL--SSYSNPDFKALVLEFMPNGSLEKWLY------SHNYFLDILERLNIMIDVGSALEY 384
            +  S  S P F  ++LE M  G L+ +L       S    L +L+ L++  D+    +Y
Sbjct: 113 CIGVSLQSLPRF--ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 170
Query: 385 LHNGHSSVHIIHCDLKPTNILL---DENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGY 441
           L   H     IH D+   N LL       VA + DFG+ + +       +    M  + +
Sbjct: 171 LEENH----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 226
Query: 442 MAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
           M PE  +EGI ++K D +S+GVLL E F+
Sbjct: 227 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 94/199 (47%), Gaps = 12/199 (6%)
Query: 280 LGTSSFGSV---YKGTISDGTDVAIKVFNLQLE--RAFRSFDSECEVLRNVRHRNLIKIL 334
           LG  +FGSV       + D T   + V  LQ       R F  E ++L+ +    ++K  
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 77
Query: 335 SSYSNPDFKAL--VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSV 392
                P  ++L  V+E++P+G L  +L  H   LD    L     +   +EYL     S 
Sbjct: 78  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYL----GSR 133
Query: 393 HIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDS-VRQTMTMATIGYMAPEYGLEGI 451
             +H DL   NIL++      ++DFG+ KLL   +D  V +    + I + APE   + I
Sbjct: 134 RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI 193
Query: 452 VSAKCDVYSYGVLLMETFT 470
            S + DV+S+GV+L E FT
Sbjct: 194 FSRQSDVWSFGVVLYELFT 212

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 85/331 (25%), Positives = 128/331 (38%), Gaps = 61/331 (18%)
Query: 242 NRNTKKSDHEDFLPLAIWRRTSYLDIQRATDEFNECNLLGTSSFGSVYKGTIS-DG--TD 298
           NR  K +      P+  W    + D+            +G  +FG V K  I  DG   D
Sbjct: 4   NRKVKNNPDPTIYPVLDWNDIKFQDV------------IGEGNFGQVLKARIKKDGLRMD 51
Query: 299 VAIKVFNLQLERA-FRSFDSECEVLRNVRHR-NLIKILSSYSNPDFKALVLEFMPNGSLE 356
            AIK       +   R F  E EVL  + H  N+I +L +  +  +  L +E+ P+G+L 
Sbjct: 52  AAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLL 111
Query: 357 KWLYSHNYF---------------LDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKP 401
            +L                     L   + L+   DV   ++YL    S    IH +L  
Sbjct: 112 DFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL----SQKQFIHRNLAA 167
Query: 402 TNILLDENMVAHVSDFGIYKLLGEGED-SVRQTMTMATIGYMAPEYGLEGIVSAKCDVYS 460
            NIL+ EN VA ++DFG    L  G++  V++TM    + +MA E     + +   DV+S
Sbjct: 168 RNILVGENYVAKIADFG----LSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWS 223
Query: 461 YGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCI 519
           YGVLL E  +    P   M   E+       E LP G                   ++C 
Sbjct: 224 YGVLLWEIVSLGGTPYCGMTCAELY------EKLPQGYR-------------LEKPLNCD 264
Query: 520 LSIMDFALDCCMESPDMRINMTDAAAKLKKI 550
             + D    C  E P  R +       L ++
Sbjct: 265 DEVYDLMRQCWREKPYERPSFAQILVSLNRM 295

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 99/209 (47%), Gaps = 24/209 (11%)
Query: 280 LGTSSFGSVYKGTIS----DGTDVAIKVFNLQ---LERAFRSFDSECEVLRNVRHRNLIK 332
           LG  +FG VY+G +S    D + + + V  L     E+    F  E  ++    H+N+++
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 333 IL--SSYSNPDFKALVLEFMPNGSLEKWLY------SHNYFLDILERLNIMIDVGSALEY 384
            +  S  S P F  ++LE M  G L+ +L       S    L +L+ L++  D+    +Y
Sbjct: 115 CIGVSLQSLPRF--ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 172
Query: 385 LHNGHSSVHIIHCDLKPTNILL---DENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGY 441
           L   H     IH D+   N LL       VA + DFG+ + +       +    M  + +
Sbjct: 173 LEENH----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 228
Query: 442 MAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
           M PE  +EGI ++K D +S+GVLL E F+
Sbjct: 229 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 257

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 99/209 (47%), Gaps = 24/209 (11%)
Query: 280 LGTSSFGSVYKGTIS----DGTDVAIKVFNLQ---LERAFRSFDSECEVLRNVRHRNLIK 332
           LG  +FG VY+G +S    D + + + V  L     E+    F  E  ++    H+N+++
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 333 IL--SSYSNPDFKALVLEFMPNGSLEKWLY------SHNYFLDILERLNIMIDVGSALEY 384
            +  S  S P F  ++LE M  G L+ +L       S    L +L+ L++  D+    +Y
Sbjct: 105 CIGVSLQSLPRF--ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 162
Query: 385 LHNGHSSVHIIHCDLKPTNILL---DENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGY 441
           L   H     IH D+   N LL       VA + DFG+ + +       +    M  + +
Sbjct: 163 LEENH----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 218
Query: 442 MAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
           M PE  +EGI ++K D +S+GVLL E F+
Sbjct: 219 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 247

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 94/199 (47%), Gaps = 12/199 (6%)
Query: 280 LGTSSFGSV---YKGTISDGTDVAIKVFNLQLE--RAFRSFDSECEVLRNVRHRNLIKIL 334
           LG  +FGSV       + D T   + V  LQ       R F  E ++L+ +    ++K  
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 78
Query: 335 SSYSNPDFKAL--VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSV 392
                P  ++L  V+E++P+G L  +L  H   LD    L     +   +EYL     S 
Sbjct: 79  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYL----GSR 134
Query: 393 HIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDS-VRQTMTMATIGYMAPEYGLEGI 451
             +H DL   NIL++      ++DFG+ KLL   +D  V +    + I + APE   + I
Sbjct: 135 RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI 194
Query: 452 VSAKCDVYSYGVLLMETFT 470
            S + DV+S+GV+L E FT
Sbjct: 195 FSRQSDVWSFGVVLYELFT 213

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 99/209 (47%), Gaps = 24/209 (11%)
Query: 280 LGTSSFGSVYKGTIS----DGTDVAIKVFNLQ---LERAFRSFDSECEVLRNVRHRNLIK 332
           LG  +FG VY+G +S    D + + + V  L     E+    F  E  ++    H+N+++
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 333 IL--SSYSNPDFKALVLEFMPNGSLEKWLY------SHNYFLDILERLNIMIDVGSALEY 384
            +  S  S P F  ++LE M  G L+ +L       S    L +L+ L++  D+    +Y
Sbjct: 125 CIGVSLQSLPRF--ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 182
Query: 385 LHNGHSSVHIIHCDLKPTNILL---DENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGY 441
           L   H     IH D+   N LL       VA + DFG+ + +       +    M  + +
Sbjct: 183 LEENH----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 238
Query: 442 MAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
           M PE  +EGI ++K D +S+GVLL E F+
Sbjct: 239 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 56/194 (28%), Positives = 89/194 (45%), Gaps = 6/194 (3%)
Query: 280 LGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSN 339
           +G+  FG V+ G   +   VAIK    +   +   F  E EV+  + H  L+++      
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 340 PDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDL 399
                LV EFM +G L  +L +          L + +DV   + YL        +IH DL
Sbjct: 74  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAS----VIHRDL 129
Query: 400 KPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVY 459
              N L+ EN V  VSDFG+ + + + +     T T   + + +PE       S+K DV+
Sbjct: 130 AARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 188
Query: 460 SYGVLLMETFTRKR 473
           S+GVL+ E F+  +
Sbjct: 189 SFGVLMWEVFSEGK 202

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 94/199 (47%), Gaps = 12/199 (6%)
Query: 280 LGTSSFGSV---YKGTISDGTDVAIKVFNLQLE--RAFRSFDSECEVLRNVRHRNLIKIL 334
           LG  +FGSV       + D T   + V  LQ       R F  E ++L+ +    ++K  
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 335 SSYSNPDFKAL--VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSV 392
                P  ++L  V+E++P+G L  +L  H   LD    L     +   +EYL     S 
Sbjct: 91  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYL----GSR 146
Query: 393 HIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDS-VRQTMTMATIGYMAPEYGLEGI 451
             +H DL   NIL++      ++DFG+ KLL   +D  V +    + I + APE   + I
Sbjct: 147 RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI 206
Query: 452 VSAKCDVYSYGVLLMETFT 470
            S + DV+S+GV+L E FT
Sbjct: 207 FSRQSDVWSFGVVLYELFT 225

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 99/209 (47%), Gaps = 24/209 (11%)
Query: 280 LGTSSFGSVYKGTIS----DGTDVAIKVFNLQ---LERAFRSFDSECEVLRNVRHRNLIK 332
           LG  +FG VY+G +S    D + + + V  L     E+    F  E  ++    H+N+++
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 333 IL--SSYSNPDFKALVLEFMPNGSLEKWLY------SHNYFLDILERLNIMIDVGSALEY 384
            +  S  S P F  ++LE M  G L+ +L       S    L +L+ L++  D+    +Y
Sbjct: 99  CIGVSLQSLPRF--ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 156
Query: 385 LHNGHSSVHIIHCDLKPTNILL---DENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGY 441
           L   H     IH D+   N LL       VA + DFG+ + +       +    M  + +
Sbjct: 157 LEENH----FIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKW 212
Query: 442 MAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
           M PE  +EGI ++K D +S+GVLL E F+
Sbjct: 213 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 101/209 (48%), Gaps = 21/209 (10%)
Query: 278 NLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFD------SECEVLRNVRHRNL 330
           + LG  +FG V  G     G  VA+K+ N Q     RS D       E + L+  RH ++
Sbjct: 22  DTLGVGTFGKVKVGKHELTGHKVAVKILNRQ---KIRSLDVVGKIRREIQNLKLFRHPHI 78
Query: 331 IKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHS 390
           IK+    S P    +V+E++  G L  ++   N  LD  E   +   + S ++Y H    
Sbjct: 79  IKLYQVISTPSDIFMVMEYVSGGELFDYI-CKNGRLDEKESRRLFQQILSGVDYCHRHM- 136
Query: 391 SVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEG 450
              ++H DLKP N+LLD +M A ++DFG+  ++ +GE       +  +  Y APE  + G
Sbjct: 137 ---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE---FLRXSCGSPNYAAPEV-ISG 189
Query: 451 IVSA--KCDVYSYGVLLMETFTRKRPTDE 477
            + A  + D++S GV+L        P D+
Sbjct: 190 RLYAGPEVDIWSSGVILYALLCGTLPFDD 218

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 24/209 (11%)
Query: 280 LGTSSFGSVYKGTIS----DGTDVAIKVFNLQ---LERAFRSFDSECEVLRNVRHRNLIK 332
           LG  +FG VY+G +S    D + + + V  L     E+    F  E  ++    H+N+++
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 333 IL--SSYSNPDFKALVLEFMPNGSLEKWLY------SHNYFLDILERLNIMIDVGSALEY 384
            +  S  S P F  +++E M  G L+ +L       S    L +L+ L++  D+    +Y
Sbjct: 98  CIGVSLQSLPRF--ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 385 LHNGHSSVHIIHCDLKPTNILL---DENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGY 441
           L   H     IH D+   N LL       VA + DFG+ + +       +    M  + +
Sbjct: 156 LEENH----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 211
Query: 442 MAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
           M PE  +EGI ++K D +S+GVLL E F+
Sbjct: 212 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 99/212 (46%), Gaps = 15/212 (7%)
Query: 268 QRATDEFNECNLLGTSSFGSVYKGTISDGTDV-AIKV-FNLQLERA--FRSFDSECEVLR 323
           Q A ++F     LG   FG+VY         + A+KV F  QLE+A        E E+  
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 324 NVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALE 383
           ++RH N++++   + +     L+LE+ P G + K L   + F D       + ++ +AL 
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKF-DEQRTATYITELANALS 127
Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           Y H    S  +IH D+KP N+LL       ++DFG          S R+     T+ Y+ 
Sbjct: 128 YCH----SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLXGTLDYLP 179
Query: 444 PEYGLEG-IVSAKCDVYSYGVLLMETFTRKRP 474
           PE  +EG +   K D++S GVL  E    K P
Sbjct: 180 PEM-IEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 80/295 (27%), Positives = 120/295 (40%), Gaps = 49/295 (16%)
Query: 278 NLLGTSSFGSVYKGTIS-DG--TDVAIKVFNLQLERA-FRSFDSECEVLRNVRHR-NLIK 332
           +++G  +FG V K  I  DG   D AIK       +   R F  E EVL  + H  N+I 
Sbjct: 21  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 80
Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYF---------------LDILERLNIMID 377
           +L +  +  +  L +E+ P+G+L  +L                     L   + L+   D
Sbjct: 81  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 140
Query: 378 VGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGED-SVRQTMTM 436
           V   ++YL    S    IH DL   NIL+ EN VA ++DFG    L  G++  V++TM  
Sbjct: 141 VARGMDYL----SQKQFIHRDLAARNILVGENYVAKIADFG----LSRGQEVYVKKTMGR 192
Query: 437 ATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPH 495
             + +MA E     + +   DV+SYGVLL E  +    P   M   E+       E LP 
Sbjct: 193 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY------EKLPQ 246
Query: 496 GLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKI 550
           G                   ++C   + D    C  E P  R +       L ++
Sbjct: 247 GYR-------------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 288

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 92/209 (44%), Gaps = 13/209 (6%)
Query: 272 DEFNECNLLGTSSFGSVYKGTISDGTDV-AIKV-FNLQLER--AFRSFDSECEVLRNVRH 327
           D+F+    LG   FG+VY         + A+KV F  QLE+         E E+  ++RH
Sbjct: 14  DDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
            N++++ + + +     L+LEF P G L K L  H  F D       M ++  AL Y H 
Sbjct: 74  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRF-DEQRSATFMEELADALHYCHE 132
Query: 388 GHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYG 447
                 +IH D+KP N+L+       ++DFG          S+R+     T+ Y+ PE  
Sbjct: 133 R----KVIHRDIKPENLLMGYKGELKIADFG----WSVHAPSLRRRXMCGTLDYLPPEMI 184
Query: 448 LEGIVSAKCDVYSYGVLLMETFTRKRPTD 476
                  K D++  GVL  E      P D
Sbjct: 185 EGKTHDEKVDLWCAGVLCYEFLVGMPPFD 213

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 56/194 (28%), Positives = 89/194 (45%), Gaps = 6/194 (3%)
Query: 280 LGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSN 339
           +G+  FG V+ G   +   VAIK    +   +   F  E EV+  + H  L+++      
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 76
Query: 340 PDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDL 399
                LV EFM +G L  +L +          L + +DV   + YL        +IH DL
Sbjct: 77  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC----VIHRDL 132
Query: 400 KPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVY 459
              N L+ EN V  VSDFG+ + + + +     T T   + + +PE       S+K DV+
Sbjct: 133 AARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 191
Query: 460 SYGVLLMETFTRKR 473
           S+GVL+ E F+  +
Sbjct: 192 SFGVLMWEVFSEGK 205

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 94/208 (45%), Gaps = 20/208 (9%)
Query: 280 LGTSSFGSVYKGTISD-GTDVAIKVFNLQLERAFRS-FDSECEVLRNVRHRNLIKI---- 333
           LGT  FG V +    D G  VAIK    +L    R  +  E ++++ + H N++      
Sbjct: 23  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 82
Query: 334 --LSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILER--LNIMIDVGSALEYLHNGH 389
             L   +  D   L +E+   G L K+L        + E     ++ D+ SAL YLH   
Sbjct: 83  DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR 142
Query: 390 SSVHIIHCDLKPTNILLD---ENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEY 446
               IIH DLKP NI+L    + ++  + D G  K L +GE     T  + T+ Y+APE 
Sbjct: 143 ----IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELC---TEFVGTLQYLAPEL 195
Query: 447 GLEGIVSAKCDVYSYGVLLMETFTRKRP 474
             +   +   D +S+G L  E  T  RP
Sbjct: 196 LEQKKYTVTVDYWSFGTLAFECITGFRP 223

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 101/212 (47%), Gaps = 15/212 (7%)
Query: 268 QRATDEFNECNLLGTSSFGSVYKGTISDGTDV-AIKV-FNLQLERA--FRSFDSECEVLR 323
           Q A ++F     LG   FG+VY         + A+KV F  QLE+A        E E+  
Sbjct: 8   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 67
Query: 324 NVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALE 383
           ++RH N++++   + +     L+LE+ P G++ + L   + F D       + ++ +AL 
Sbjct: 68  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALS 126
Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           Y H    S  +IH D+KP N+LL       ++DFG          S R+T    T+ Y+ 
Sbjct: 127 YCH----SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLP 178
Query: 444 PEYGLEG-IVSAKCDVYSYGVLLMETFTRKRP 474
           PE  +EG +   K D++S GVL  E    K P
Sbjct: 179 PEM-IEGRMHDEKVDLWSLGVLCYEFLVGKPP 209

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 99/209 (47%), Gaps = 24/209 (11%)
Query: 280 LGTSSFGSVYKGTIS----DGTDVAIKVFNLQ---LERAFRSFDSECEVLRNVRHRNLIK 332
           LG  +FG VY+G +S    D + + + V  L     E+    F  E  ++    H+N+++
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 333 IL--SSYSNPDFKALVLEFMPNGSLEKWLY------SHNYFLDILERLNIMIDVGSALEY 384
            +  S  S P F  ++LE M  G L+ +L       S    L +L+ L++  D+    +Y
Sbjct: 116 CIGVSLQSLPRF--ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 173
Query: 385 LHNGHSSVHIIHCDLKPTNILL---DENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGY 441
           L   H     IH D+   N LL       VA + DFG+ + +       +    M  + +
Sbjct: 174 LEENH----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKW 229
Query: 442 MAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
           M PE  +EGI ++K D +S+GVLL E F+
Sbjct: 230 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 258

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 80/295 (27%), Positives = 120/295 (40%), Gaps = 49/295 (16%)
Query: 278 NLLGTSSFGSVYKGTIS-DG--TDVAIKVFNLQLERA-FRSFDSECEVLRNVRHR-NLIK 332
           +++G  +FG V K  I  DG   D AIK       +   R F  E EVL  + H  N+I 
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYF---------------LDILERLNIMID 377
           +L +  +  +  L +E+ P+G+L  +L                     L   + L+   D
Sbjct: 91  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 378 VGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGED-SVRQTMTM 436
           V   ++YL    S    IH DL   NIL+ EN VA ++DFG    L  G++  V++TM  
Sbjct: 151 VARGMDYL----SQKQFIHRDLAARNILVGENYVAKIADFG----LSRGQEVYVKKTMGR 202
Query: 437 ATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPH 495
             + +MA E     + +   DV+SYGVLL E  +    P   M   E+       E LP 
Sbjct: 203 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY------EKLPQ 256
Query: 496 GLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKI 550
           G                   ++C   + D    C  E P  R +       L ++
Sbjct: 257 GYR-------------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 298

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 101/212 (47%), Gaps = 15/212 (7%)
Query: 268 QRATDEFNECNLLGTSSFGSVYKGTISDGTDV-AIKV-FNLQLERA--FRSFDSECEVLR 323
           Q A ++F     LG   FG+VY         + A+KV F  QLE+A        E E+  
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 324 NVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALE 383
           ++RH N++++   + +     L+LE+ P G++ + L   + F D       + ++ +AL 
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALS 122
Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           Y H    S  +IH D+KP N+LL       ++DFG          S R+T    T+ Y+ 
Sbjct: 123 YCH----SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLP 174
Query: 444 PEYGLEG-IVSAKCDVYSYGVLLMETFTRKRP 474
           PE  +EG +   K D++S GVL  E    K P
Sbjct: 175 PEM-IEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 56/194 (28%), Positives = 89/194 (45%), Gaps = 6/194 (3%)
Query: 280 LGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSN 339
           +G+  FG V+ G   +   VAIK    +   +   F  E EV+  + H  L+++      
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 340 PDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDL 399
                LV EFM +G L  +L +          L + +DV   + YL        +IH DL
Sbjct: 74  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC----VIHRDL 129
Query: 400 KPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVY 459
              N L+ EN V  VSDFG+ + + + +     T T   + + +PE       S+K DV+
Sbjct: 130 AARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 188
Query: 460 SYGVLLMETFTRKR 473
           S+GVL+ E F+  +
Sbjct: 189 SFGVLMWEVFSEGK 202

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 101/212 (47%), Gaps = 15/212 (7%)
Query: 268 QRATDEFNECNLLGTSSFGSVYKGTISDGTDV-AIKV-FNLQLERA--FRSFDSECEVLR 323
           Q A ++F     LG   FG+VY         + A+KV F  QLE+A        E E+  
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 324 NVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALE 383
           ++RH N++++   + +     L+LE+ P G++ + L   + F D       + ++ +AL 
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALS 122
Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           Y H    S  +IH D+KP N+LL       ++DFG          S R+T    T+ Y+ 
Sbjct: 123 YCH----SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTXLCGTLDYLP 174
Query: 444 PEYGLEG-IVSAKCDVYSYGVLLMETFTRKRP 474
           PE  +EG +   K D++S GVL  E    K P
Sbjct: 175 PEM-IEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 94/208 (45%), Gaps = 20/208 (9%)
Query: 280 LGTSSFGSVYKGTISD-GTDVAIKVFNLQLERAFRS-FDSECEVLRNVRHRNLIKI---- 333
           LGT  FG V +    D G  VAIK    +L    R  +  E ++++ + H N++      
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81
Query: 334 --LSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILER--LNIMIDVGSALEYLHNGH 389
             L   +  D   L +E+   G L K+L        + E     ++ D+ SAL YLH   
Sbjct: 82  DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR 141
Query: 390 SSVHIIHCDLKPTNILLD---ENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEY 446
               IIH DLKP NI+L    + ++  + D G  K L +GE     T  + T+ Y+APE 
Sbjct: 142 ----IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELC---TEFVGTLQYLAPEL 194
Query: 447 GLEGIVSAKCDVYSYGVLLMETFTRKRP 474
             +   +   D +S+G L  E  T  RP
Sbjct: 195 LEQKKYTVTVDYWSFGTLAFECITGFRP 222

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/291 (22%), Positives = 124/291 (42%), Gaps = 44/291 (15%)
Query: 280 LGTSSFGSVYKGTI------SDGTDVAIKVFNLQLERAFRS-FDSECEVLRNVRHRNLIK 332
           LG   FG VYKG +           VAIK    + E   R  F  E  +   ++H N++ 
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDI------------LER---LNIMID 377
           +L   +     +++  +  +G L ++L   +   D+            LE    ++++  
Sbjct: 77  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 378 VGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMA 437
           + + +EYL    SS H++H DL   N+L+ + +   +SD G+++ +   +       ++ 
Sbjct: 137 IAAGMEYL----SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLL 192
Query: 438 TIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGL 497
            I +MAPE  + G  S   D++SYGV+L E F+                  ++    +  
Sbjct: 193 PIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYG----------------LQPYCGYSN 236
Query: 498 TEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLK 548
            +VV+  ++R  Q      DC   +    ++C  E P  R    D  ++L+
Sbjct: 237 QDVVE--MIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLR 285

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 56/194 (28%), Positives = 89/194 (45%), Gaps = 6/194 (3%)
Query: 280 LGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSN 339
           +G+  FG V+ G   +   VAIK    +   +   F  E EV+  + H  L+++      
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 71
Query: 340 PDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDL 399
                LV EFM +G L  +L +          L + +DV   + YL        +IH DL
Sbjct: 72  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC----VIHRDL 127
Query: 400 KPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVY 459
              N L+ EN V  VSDFG+ + + + +     T T   + + +PE       S+K DV+
Sbjct: 128 AARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 186
Query: 460 SYGVLLMETFTRKR 473
           S+GVL+ E F+  +
Sbjct: 187 SFGVLMWEVFSEGK 200

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/291 (22%), Positives = 124/291 (42%), Gaps = 44/291 (15%)
Query: 280 LGTSSFGSVYKGTI------SDGTDVAIKVFNLQLERAFRS-FDSECEVLRNVRHRNLIK 332
           LG   FG VYKG +           VAIK    + E   R  F  E  +   ++H N++ 
Sbjct: 34  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 93
Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDI------------LER---LNIMID 377
           +L   +     +++  +  +G L ++L   +   D+            LE    ++++  
Sbjct: 94  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 153
Query: 378 VGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMA 437
           + + +EYL    SS H++H DL   N+L+ + +   +SD G+++ +   +       ++ 
Sbjct: 154 IAAGMEYL----SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLL 209
Query: 438 TIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGL 497
            I +MAPE  + G  S   D++SYGV+L E F+                  ++    +  
Sbjct: 210 PIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYG----------------LQPYCGYSN 253
Query: 498 TEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLK 548
            +VV+  ++R  Q      DC   +    ++C  E P  R    D  ++L+
Sbjct: 254 QDVVE--MIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLR 302

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 13/211 (6%)
Query: 268 QRATDEFNECNLLGTSSFGSVYKGTISDGTDV-AIKV-FNLQLERA--FRSFDSECEVLR 323
           Q A ++F     LG   FG+VY         + A+KV F  QLE+A        E E+  
Sbjct: 3   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 62
Query: 324 NVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALE 383
           ++RH N++++   + +     L+LE+ P G++ + L   + F D       + ++ +AL 
Sbjct: 63  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALS 121
Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           Y H    S  +IH D+KP N+LL       ++DFG          S R+T    T+ Y+ 
Sbjct: 122 YCH----SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLP 173
Query: 444 PEYGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
           PE     +   K D++S GVL  E    K P
Sbjct: 174 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 204

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 24/209 (11%)
Query: 280 LGTSSFGSVYKGTIS----DGTDVAIKVFNLQ---LERAFRSFDSECEVLRNVRHRNLIK 332
           LG  +FG VY+G +S    D + + + V  L     E+    F  E  ++    H+N+++
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 333 IL--SSYSNPDFKALVLEFMPNGSLEKWLY------SHNYFLDILERLNIMIDVGSALEY 384
            +  S  S P F  +++E M  G L+ +L       S    L +L+ L++  D+    +Y
Sbjct: 113 CIGVSLQSLPRF--ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 170
Query: 385 LHNGHSSVHIIHCDLKPTNILL---DENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGY 441
           L   H     IH D+   N LL       VA + DFG+ + +       +    M  + +
Sbjct: 171 LEENH----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 226
Query: 442 MAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
           M PE  +EGI ++K D +S+GVLL E F+
Sbjct: 227 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 84/317 (26%), Positives = 138/317 (43%), Gaps = 51/317 (16%)
Query: 272 DEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRN--VRHRN 329
           D      L+G   +G+VYKG++ D   VA+KVF+    +   +F +E  + R   + H N
Sbjct: 13  DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNIYRVPLMEHDN 68
Query: 330 LIKIL--SSYSNPDFKA---LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEY 384
           + + +        D +    LV+E+ PNGSL K+L  H    D +    +   V   L Y
Sbjct: 69  IARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS--DWVSSCRLAHSVTRGLAY 126
Query: 385 LHN-----GHSSVHIIHCDLKPTNILLDENMVAHVSDFGIY------KLLGEGEDSVRQT 433
           LH       H    I H DL   N+L+  +    +SDFG+       +L+  GE+     
Sbjct: 127 LHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAI 186
Query: 434 MTMATIGYMAPEYGLEGIVS--------AKCDVYSYGVLLMETFTRKRPTDEMFIGE--- 482
             + TI YMAPE  LEG V+         + D+Y+ G++  E F R     ++F GE   
Sbjct: 187 SEVGTIRYMAPEV-LEGAVNLRDXESALKQVDMYALGLIYWEIFMR---CTDLFPGESVP 242
Query: 483 ---MSLRRWVKESLPHGLTEVVDANLVREEQ------AFSAKMDCILSIMDFALDCCMES 533
              M+ +  V     H   E +   + RE+Q      A+      + S+ +   DC  + 
Sbjct: 243 EYQMAFQTEVGN---HPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQD 299
Query: 534 PDMRINMTDAAAKLKKI 550
            + R+    A  ++ ++
Sbjct: 300 AEARLTAQXAEERMAEL 316

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 101/212 (47%), Gaps = 15/212 (7%)
Query: 268 QRATDEFNECNLLGTSSFGSVYKGTISDGTDV-AIKV-FNLQLERA--FRSFDSECEVLR 323
           Q A ++F     LG   FG+VY         + A+KV F  QLE+A        E E+  
Sbjct: 30  QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 89
Query: 324 NVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALE 383
           ++RH N++++   + +     L+LE+ P G++ + L   + F D       + ++ +AL 
Sbjct: 90  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALS 148
Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           Y H    S  +IH D+KP N+LL       ++DFG          S R+T    T+ Y+ 
Sbjct: 149 YCH----SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLP 200
Query: 444 PEYGLEG-IVSAKCDVYSYGVLLMETFTRKRP 474
           PE  +EG +   K D++S GVL  E    K P
Sbjct: 201 PEM-IEGRMHDEKVDLWSLGVLCYEFLVGKPP 231

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 99/209 (47%), Gaps = 24/209 (11%)
Query: 280 LGTSSFGSVYKGTIS----DGTDVAIKVFNLQ---LERAFRSFDSECEVLRNVRHRNLIK 332
           LG  +FG VY+G +S    D + + + V  L     E+    F  E  ++    H+N+++
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 333 IL--SSYSNPDFKALVLEFMPNGSLEKWLY------SHNYFLDILERLNIMIDVGSALEY 384
            +  S  S P F  ++LE M  G L+ +L       S    L +L+ L++  D+    +Y
Sbjct: 139 CIGVSLQSLPRF--ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 385 LHNGHSSVHIIHCDLKPTNILL---DENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGY 441
           L   H     IH D+   N LL       VA + DFG+ + +       +    M  + +
Sbjct: 197 LEENH----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKW 252
Query: 442 MAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
           M PE  +EGI ++K D +S+GVLL E F+
Sbjct: 253 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 101/212 (47%), Gaps = 15/212 (7%)
Query: 268 QRATDEFNECNLLGTSSFGSVYKGTISDGTDV-AIKV-FNLQLERA--FRSFDSECEVLR 323
           Q A ++F     LG   FG+VY         + A+KV F  QLE+A        E E+  
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 324 NVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALE 383
           ++RH N++++   + +     L+LE+ P G++ + L   + F D       + ++ +AL 
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALS 127
Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           Y H    S  +IH D+KP N+LL       ++DFG          S R+T    T+ Y+ 
Sbjct: 128 YCH----SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLP 179
Query: 444 PEYGLEG-IVSAKCDVYSYGVLLMETFTRKRP 474
           PE  +EG +   K D++S GVL  E    K P
Sbjct: 180 PEM-IEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 13/211 (6%)
Query: 268 QRATDEFNECNLLGTSSFGSVYKGTISDGTDV-AIKV-FNLQLERA--FRSFDSECEVLR 323
           Q A ++F     LG   FG+VY         + A+KV F  QLE+A        E E+  
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 324 NVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALE 383
           ++RH N++++   + +     L+LE+ P G++ + L   + F D       + ++ +AL 
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALS 125
Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           Y H    S  +IH D+KP N+LL       ++DFG          S R+T    T+ Y+ 
Sbjct: 126 YCH----SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLP 177
Query: 444 PEYGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
           PE     +   K D++S GVL  E    K P
Sbjct: 178 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 56/194 (28%), Positives = 89/194 (45%), Gaps = 6/194 (3%)
Query: 280 LGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSN 339
           +G+  FG V+ G   +   VAIK    +   +   F  E EV+  + H  L+++      
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTIK-EGSMSEDDFIEEAEVMMKLSHPKLVQLYGVCLE 93
Query: 340 PDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDL 399
                LV EFM +G L  +L +          L + +DV   + YL        +IH DL
Sbjct: 94  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC----VIHRDL 149
Query: 400 KPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVY 459
              N L+ EN V  VSDFG+ + + + +     T T   + + +PE       S+K DV+
Sbjct: 150 AARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 208
Query: 460 SYGVLLMETFTRKR 473
           S+GVL+ E F+  +
Sbjct: 209 SFGVLMWEVFSEGK 222

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 13/211 (6%)
Query: 268 QRATDEFNECNLLGTSSFGSVYKGTISDGTDV-AIKV-FNLQLERA--FRSFDSECEVLR 323
           Q A ++F     LG   FG+VY         + A+KV F  QLE+A        E E+  
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 324 NVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALE 383
           ++RH N++++   + +     L+LE+ P G++ + L   + F D       + ++ +AL 
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALS 125
Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           Y H    S  +IH D+KP N+LL       ++DFG          S R+T    T+ Y+ 
Sbjct: 126 YCH----SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLP 177
Query: 444 PEYGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
           PE     +   K D++S GVL  E    K P
Sbjct: 178 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 107/225 (47%), Gaps = 16/225 (7%)
Query: 268 QRATDEFNECNLLGTSSFGSVYKGTISDGTDV-AIKV-FNLQLERA--FRSFDSECEVLR 323
           Q   ++F+    LG   FG+VY         + A+KV F  QLE+A        E E+  
Sbjct: 8   QWTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQS 67
Query: 324 NVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALE 383
           ++RH N++++   + +     L+LE+ P G++ + L   + F D       + ++ +AL 
Sbjct: 68  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRF-DEQRTATYITELANALS 126
Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           Y H    S  +IH D+KP N+LL  N    ++DFG          S R+T    T+ Y+ 
Sbjct: 127 YCH----SKRVIHRDIKPENLLLGSNGELKIADFG----WSVHAPSSRRTTLCGTLDYLP 178
Query: 444 PEYGLEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRR 487
           PE  +EG +   K D++S GVL  E F    P  E    + + RR
Sbjct: 179 PEM-IEGRMHDEKVDLWSLGVLCYE-FLVGMPPFEAHTYQETYRR 221

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 13/211 (6%)
Query: 268 QRATDEFNECNLLGTSSFGSVYKGTISDGTDV-AIKV-FNLQLERA--FRSFDSECEVLR 323
           Q A ++F     LG   FG+VY         + A+KV F  QLE+A        E E+  
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 324 NVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALE 383
           ++RH N++++   + +     L+LE+ P G++ + L   + F D       + ++ +AL 
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALS 122
Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           Y H    S  +IH D+KP N+LL       ++DFG          S R+T    T+ Y+ 
Sbjct: 123 YCH----SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTELCGTLDYLP 174
Query: 444 PEYGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
           PE     +   K D++S GVL  E    K P
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 97/204 (47%), Gaps = 14/204 (6%)
Query: 280 LGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKI--LSSY 337
           LGT  FG V  G      DVAIK+   +   +   F  E +V+ N+ H  L+++  + + 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 338 SNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHC 397
             P F  ++ E+M NG L  +L    +     + L +  DV  A+EYL     S   +H 
Sbjct: 91  QRPIF--IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE----SKQFLHR 144
Query: 398 DLKPTNILLDENMVAHVSDFGI--YKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAK 455
           DL   N L+++  V  VSDFG+  Y L  E   SV        + +  PE  +    S+K
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKF---PVRWSPPEVLMYSKFSSK 201
Query: 456 CDVYSYGVLLMETFTRKRPTDEMF 479
            D++++GVL+ E ++  +   E F
Sbjct: 202 SDIWAFGVLMWEIYSLGKMPYERF 225

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 92/209 (44%), Gaps = 13/209 (6%)
Query: 272 DEFNECNLLGTSSFGSVYKGTISDGTDV-AIKV-FNLQLER--AFRSFDSECEVLRNVRH 327
           D+F+    LG   FG+VY         + A+KV F  QLE+         E E+  ++RH
Sbjct: 15  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 74
Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
            N++++ + + +     L+LEF P G L K L  H  F D       M ++  AL Y H 
Sbjct: 75  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRF-DEQRSATFMEELADALHYCHE 133
Query: 388 GHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYG 447
                 +IH D+KP N+L+       ++DFG          S+R+     T+ Y+ PE  
Sbjct: 134 R----KVIHRDIKPENLLMGYKGELKIADFG----WSVHAPSLRRRXMCGTLDYLPPEMI 185
Query: 448 LEGIVSAKCDVYSYGVLLMETFTRKRPTD 476
                  K D++  GVL  E      P D
Sbjct: 186 EGKTHDEKVDLWCAGVLCYEFLVGMPPFD 214

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 109/221 (49%), Gaps = 14/221 (6%)
Query: 265 LDIQRATDEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLERAFRSFDSECEVLR 323
           L+     DE  +  +LG  ++G VY G  +S+   +AIK    +  R  +    E  + +
Sbjct: 15  LEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHK 74
Query: 324 NVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERL--NIMIDVGSA 381
           +++H+N+++ L S+S   F  + +E +P GSL   L S    L   E+        +   
Sbjct: 75  HLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEG 134
Query: 382 LEYLHNGHSSVHIIHCDLKPTNILLDE-NMVAHVSDFGIYKLLGEGEDSVRQTMTMATIG 440
           L+YLH+      I+H D+K  N+L++  + V  +SDFG  K L  G +   +T T  T+ 
Sbjct: 135 LKYLHDN----QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA-GINPCTETFT-GTLQ 188
Query: 441 YMAPE---YGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEM 478
           YMAPE    G  G   A  D++S G  ++E  T K P  E+
Sbjct: 189 YMAPEIIDKGPRGYGKA-ADIWSLGCTIIEMATGKPPFYEL 228

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 99/202 (49%), Gaps = 10/202 (4%)
Query: 280 LGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKI--LSSY 337
           LGT  FG V  G      DVAIK+   +   +   F  E +V+ N+ H  L+++  + + 
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 338 SNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHC 397
             P F  ++ E+M NG L  +L    +     + L +  DV  A+EYL     S   +H 
Sbjct: 76  QRPIF--IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL----ESKQFLHR 129
Query: 398 DLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCD 457
           DL   N L+++  V  VSDFG+ + + + E +  +  +   + +  PE  +    S+K D
Sbjct: 130 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRG-SKFPVRWSPPEVLMYSKFSSKSD 188
Query: 458 VYSYGVLLMETFTRKRPTDEMF 479
           ++++GVL+ E ++  +   E F
Sbjct: 189 IWAFGVLMWEIYSLGKMPYERF 210

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 101/212 (47%), Gaps = 15/212 (7%)
Query: 268 QRATDEFNECNLLGTSSFGSVYKGTISDGTDV-AIKV-FNLQLERA--FRSFDSECEVLR 323
           Q A ++F     LG   FG+VY         + A+KV F  QLE+A        E E+  
Sbjct: 21  QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 80
Query: 324 NVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALE 383
           ++RH N++++   + +     L+LE+ P G++ + L   + F D       + ++ +AL 
Sbjct: 81  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALS 139
Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           Y H    S  +IH D+KP N+LL       ++DFG          S R+T    T+ Y+ 
Sbjct: 140 YCH----SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLP 191
Query: 444 PEYGLEG-IVSAKCDVYSYGVLLMETFTRKRP 474
           PE  +EG +   K D++S GVL  E    K P
Sbjct: 192 PEM-IEGRMHDEKVDLWSLGVLCYEFLVGKPP 222

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 109/221 (49%), Gaps = 14/221 (6%)
Query: 265 LDIQRATDEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLERAFRSFDSECEVLR 323
           L+     DE  +  +LG  ++G VY G  +S+   +AIK    +  R  +    E  + +
Sbjct: 1   LEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHK 60
Query: 324 NVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERL--NIMIDVGSA 381
           +++H+N+++ L S+S   F  + +E +P GSL   L S    L   E+        +   
Sbjct: 61  HLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEG 120
Query: 382 LEYLHNGHSSVHIIHCDLKPTNILLDE-NMVAHVSDFGIYKLLGEGEDSVRQTMTMATIG 440
           L+YLH+      I+H D+K  N+L++  + V  +SDFG  K L  G +   +T T  T+ 
Sbjct: 121 LKYLHDN----QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA-GINPCTETFT-GTLQ 174
Query: 441 YMAPEY---GLEGIVSAKCDVYSYGVLLMETFTRKRPTDEM 478
           YMAPE    G  G   A  D++S G  ++E  T K P  E+
Sbjct: 175 YMAPEIIDKGPRGYGKA-ADIWSLGCTIIEMATGKPPFYEL 214

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 56/194 (28%), Positives = 89/194 (45%), Gaps = 6/194 (3%)
Query: 280 LGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSN 339
           +G+  FG V+ G   +   VAIK    +   +   F  E EV+  + H  L+++      
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 74
Query: 340 PDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDL 399
                LV EFM +G L  +L +          L + +DV   + YL        +IH DL
Sbjct: 75  QAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC----VIHRDL 130
Query: 400 KPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVY 459
              N L+ EN V  VSDFG+ + + + +     T T   + + +PE       S+K DV+
Sbjct: 131 AARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 189
Query: 460 SYGVLLMETFTRKR 473
           S+GVL+ E F+  +
Sbjct: 190 SFGVLMWEVFSEGK 203

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 13/211 (6%)
Query: 268 QRATDEFNECNLLGTSSFGSVYKGTISDGTDV-AIKV-FNLQLERA--FRSFDSECEVLR 323
           Q A ++F     LG   FG+VY         + A+KV F  QLE+A        E E+  
Sbjct: 1   QWALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQS 60
Query: 324 NVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALE 383
           ++RH N++++   + +     L+LE+ P G++ + L   + F D       + ++ +AL 
Sbjct: 61  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALS 119
Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           Y H    S  +IH D+KP N+LL       ++DFG          S R+T    T+ Y+ 
Sbjct: 120 YCH----SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLP 171
Query: 444 PEYGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
           PE     +   K D++S GVL  E    K P
Sbjct: 172 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 202

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 101/212 (47%), Gaps = 15/212 (7%)
Query: 268 QRATDEFNECNLLGTSSFGSVYKGTISDGTDV-AIKV-FNLQLERA--FRSFDSECEVLR 323
           Q A ++F     LG   FG+VY         + A+KV F  QLE+A        E E+  
Sbjct: 5   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 64
Query: 324 NVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALE 383
           ++RH N++++   + +     L+LE+ P G++ + L   + F D       + ++ +AL 
Sbjct: 65  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALS 123
Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           Y H    S  +IH D+KP N+LL       ++DFG          S R+T    T+ Y+ 
Sbjct: 124 YCH----SKRVIHRDIKPENLLLGSAGELKIADFG----WSCHAPSSRRTTLSGTLDYLP 175
Query: 444 PEYGLEG-IVSAKCDVYSYGVLLMETFTRKRP 474
           PE  +EG +   K D++S GVL  E    K P
Sbjct: 176 PEM-IEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 97/204 (47%), Gaps = 14/204 (6%)
Query: 280 LGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKI--LSSY 337
           LGT  FG V  G      DVAIK+   +   +   F  E +V+ N+ H  L+++  + + 
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 81
Query: 338 SNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHC 397
             P F  ++ E+M NG L  +L    +     + L +  DV  A+EYL     S   +H 
Sbjct: 82  QRPIF--IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE----SKQFLHR 135
Query: 398 DLKPTNILLDENMVAHVSDFGI--YKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAK 455
           DL   N L+++  V  VSDFG+  Y L  E   SV        + +  PE  +    S+K
Sbjct: 136 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKF---PVRWSPPEVLMYSKFSSK 192
Query: 456 CDVYSYGVLLMETFTRKRPTDEMF 479
            D++++GVL+ E ++  +   E F
Sbjct: 193 SDIWAFGVLMWEIYSLGKMPYERF 216

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 97/204 (47%), Gaps = 14/204 (6%)
Query: 280 LGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKI--LSSY 337
           LGT  FG V  G      DVAIK+   +   +   F  E +V+ N+ H  L+++  + + 
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 70
Query: 338 SNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHC 397
             P F  ++ E+M NG L  +L    +     + L +  DV  A+EYL     S   +H 
Sbjct: 71  QRPIF--IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL----ESKQFLHR 124
Query: 398 DLKPTNILLDENMVAHVSDFGI--YKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAK 455
           DL   N L+++  V  VSDFG+  Y L  E   SV        + +  PE  +    S+K
Sbjct: 125 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKF---PVRWSPPEVLMYSKFSSK 181
Query: 456 CDVYSYGVLLMETFTRKRPTDEMF 479
            D++++GVL+ E ++  +   E F
Sbjct: 182 SDIWAFGVLMWEIYSLGKMPYERF 205

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 13/211 (6%)
Query: 268 QRATDEFNECNLLGTSSFGSVYKGTISDGTDV-AIKV-FNLQLERA--FRSFDSECEVLR 323
           Q A ++F     LG   FG+VY         + A+KV F  QLE+A        E E+  
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 324 NVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALE 383
           ++RH N++++   + +     L+LE+ P G++ + L   + F D       + ++ +AL 
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALS 122
Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           Y H    S  +IH D+KP N+LL       ++DFG          S R+T    T+ Y+ 
Sbjct: 123 YCH----SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDYLP 174
Query: 444 PEYGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
           PE     +   K D++S GVL  E    K P
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 97/204 (47%), Gaps = 14/204 (6%)
Query: 280 LGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKI--LSSY 337
           LGT  FG V  G      DVAIK+   +   +   F  E +V+ N+ H  L+++  + + 
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 74
Query: 338 SNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHC 397
             P F  ++ E+M NG L  +L    +     + L +  DV  A+EYL     S   +H 
Sbjct: 75  QRPIF--IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL----ESKQFLHR 128
Query: 398 DLKPTNILLDENMVAHVSDFGI--YKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAK 455
           DL   N L+++  V  VSDFG+  Y L  E   SV        + +  PE  +    S+K
Sbjct: 129 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKF---PVRWSPPEVLMYSKFSSK 185
Query: 456 CDVYSYGVLLMETFTRKRPTDEMF 479
            D++++GVL+ E ++  +   E F
Sbjct: 186 SDIWAFGVLMWEIYSLGKMPYERF 209

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 100/212 (47%), Gaps = 15/212 (7%)
Query: 268 QRATDEFNECNLLGTSSFGSVYKGTISDGTDV-AIKV-FNLQLERA--FRSFDSECEVLR 323
           Q A ++F     LG   FG+VY         + A+KV F  QLE+A        E E+  
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 324 NVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALE 383
           ++RH N++++   + +     L+LE+ P G++ + L   + F D       + ++ +AL 
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALS 127
Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           Y H    S  +IH D+KP N+LL       ++DFG          S R+T    T+ Y+ 
Sbjct: 128 YCH----SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLP 179
Query: 444 PEYGLEGIV-SAKCDVYSYGVLLMETFTRKRP 474
           PE  +EG     K D++S GVL  E    K P
Sbjct: 180 PE-XIEGRXHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 13/211 (6%)
Query: 268 QRATDEFNECNLLGTSSFGSVYKGTISDGTDV-AIKV-FNLQLERA--FRSFDSECEVLR 323
           Q A ++F     LG   FG+VY         + A+KV F  QLE+A        E E+  
Sbjct: 5   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 64
Query: 324 NVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALE 383
           ++RH N++++   + +     L+LE+ P G++ + L   + F D       + ++ +AL 
Sbjct: 65  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALS 123
Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           Y H    S  +IH D+KP N+LL       ++DFG          S R+T    T+ Y+ 
Sbjct: 124 YCH----SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDYLP 175
Query: 444 PEYGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
           PE     +   K D++S GVL  E    K P
Sbjct: 176 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 13/211 (6%)
Query: 268 QRATDEFNECNLLGTSSFGSVYKGTISDGTDV-AIKV-FNLQLERA--FRSFDSECEVLR 323
           Q A ++F     LG   FG+VY         + A+KV F  QLE+A        E E+  
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 324 NVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALE 383
           ++RH N++++   + +     L+LE+ P G++ + L   + F D       + ++ +AL 
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALS 122
Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           Y H    S  +IH D+KP N+LL       ++DFG          S R+T    T+ Y+ 
Sbjct: 123 YCH----SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDYLP 174
Query: 444 PEYGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
           PE     +   K D++S GVL  E    K P
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 97/204 (47%), Gaps = 14/204 (6%)
Query: 280 LGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKI--LSSY 337
           LGT  FG V  G      DVAIK+   +   +   F  E +V+ N+ H  L+++  + + 
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 338 SNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHC 397
             P F  ++ E+M NG L  +L    +     + L +  DV  A+EYL     S   +H 
Sbjct: 76  QRPIF--IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL----ESKQFLHR 129
Query: 398 DLKPTNILLDENMVAHVSDFGI--YKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAK 455
           DL   N L+++  V  VSDFG+  Y L  E   SV        + +  PE  +    S+K
Sbjct: 130 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKF---PVRWSPPEVLMYSKFSSK 186
Query: 456 CDVYSYGVLLMETFTRKRPTDEMF 479
            D++++GVL+ E ++  +   E F
Sbjct: 187 SDIWAFGVLMWEIYSLGKMPYERF 210

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 13/211 (6%)
Query: 268 QRATDEFNECNLLGTSSFGSVYKGTISDGTDV-AIKV-FNLQLERA--FRSFDSECEVLR 323
           Q A ++F     LG   FG+VY         + A+KV F  QLE+A        E E+  
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 324 NVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALE 383
           ++RH N++++   + +     L+LE+ P G++ + L   + F D       + ++ +AL 
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALS 127
Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           Y H    S  +IH D+KP N+LL       ++DFG          S R+T    T+ Y+ 
Sbjct: 128 YCH----SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDYLP 179
Query: 444 PEYGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
           PE     +   K D++S GVL  E    K P
Sbjct: 180 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/285 (23%), Positives = 122/285 (42%), Gaps = 31/285 (10%)
Query: 273 EFNECNLLGTSSFGSVYKGT-ISDGT----DVAIKVFNLQL-ERAFRSFDSECEVLRNVR 326
           E     +LG+ +FG+VYKG  + +G      VAIK+ N     +A   F  E  ++ ++ 
Sbjct: 39  ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMD 98
Query: 327 HRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH 386
           H +L+++L    +P  + LV + MP+G L ++++ H   +     LN  + +   + YL 
Sbjct: 99  HPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYL- 156
Query: 387 NGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEY 446
                  ++H DL   N+L+       ++DFG+ +LL   E           I +MA E 
Sbjct: 157 ---EERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALEC 213
Query: 447 GLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANL 505
                 + + DV+SYGV + E  T   +P D +   E+                    +L
Sbjct: 214 IHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIP-------------------DL 254
Query: 506 VREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKI 550
           + + +       C + +    + C M   D R    + AA+  ++
Sbjct: 255 LEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM 299

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/194 (31%), Positives = 93/194 (47%), Gaps = 10/194 (5%)
Query: 280 LGTSSFGSVYKGTISDGT-DVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYS 338
           LG   +G VY G     +  VA+K    +       F  E  V++ ++H NL+++L   +
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 98
Query: 339 -NPDFKALVLEFMPNGSLEKWLYSHNYF-LDILERLNIMIDVGSALEYLHNGHSSVHIIH 396
             P F  +V E+MP G+L  +L   N   +  +  L +   + SA+EYL   +     IH
Sbjct: 99  LEPPF-YIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLEKKN----FIH 153
Query: 397 CDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKC 456
            DL   N L+ EN V  V+DFG+ +L+  G+           I + APE       S K 
Sbjct: 154 RDLAARNCLVGENHVVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNTFSIKS 212
Query: 457 DVYSYGVLLMETFT 470
           DV+++GVLL E  T
Sbjct: 213 DVWAFGVLLWEIAT 226

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 26/211 (12%)
Query: 279 LLGTSSFGSVYKGTISDGTDVAIKVF----NLQLERAFRSFDSECEVLRNVRHRNLIKIL 334
           ++G   FG VY+     G +VA+K      +  + +   +   E ++   ++H N+I + 
Sbjct: 14  IIGIGGFGKVYRA-FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72
Query: 335 SSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHI 394
                     LV+EF   G L + L       DIL  +N  + +   + YLH+  + V I
Sbjct: 73  GVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDIL--VNWAVQIARGMNYLHD-EAIVPI 129
Query: 395 IHCDLKPTNILLDE--------NMVAHVSDFGIYKLLGEGEDSVRQTMTMATIG---YMA 443
           IH DLK +NIL+ +        N +  ++DFG+ +          +T  M+  G   +MA
Sbjct: 130 IHRDLKSSNILILQKVENGDLSNKILKITDFGLAR-------EWHRTTKMSAAGAYAWMA 182
Query: 444 PEYGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
           PE     + S   DV+SYGVLL E  T + P
Sbjct: 183 PEVIRASMFSKGSDVWSYGVLLWELLTGEVP 213

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 94/200 (47%), Gaps = 9/200 (4%)
Query: 272 DEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVF---NLQLERAFRSFDSECEVLRNVRH 327
           ++F    +LG  SF +V     ++   + AIK+    ++  E        E +V+  + H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
              +K+  ++ + +     L +  NG L K++     F +   R     ++ SALEYLH 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRF-YTAEIVSALEYLHG 150
Query: 388 GHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYG 447
                 IIH DLKP NILL+E+M   ++DFG  K+L       R    + T  Y++PE  
Sbjct: 151 KG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 206
Query: 448 LEGIVSAKCDVYSYGVLLME 467
            E   S   D+++ G ++ +
Sbjct: 207 TEKSASKSSDLWALGCIIYQ 226

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 101/214 (47%), Gaps = 15/214 (7%)
Query: 268 QRATDEFNECNLLGTSSFGSVYKGTISDGTDV-AIKV-FNLQLERA--FRSFDSECEVLR 323
           Q A ++F     LG   FG+VY         + A+KV F  QLE+A        E E+  
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 324 NVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALE 383
           ++RH N++++   + +     L+LE+ P G++ + L   + F D       + ++ +AL 
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALS 122
Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           Y H    S  +IH D+KP N+LL       ++DFG          S R+     T+ Y+ 
Sbjct: 123 YCH----SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRAALCGTLDYLP 174
Query: 444 PEYGLEG-IVSAKCDVYSYGVLLMETFTRKRPTD 476
           PE  +EG +   K D++S GVL  E    K P +
Sbjct: 175 PEM-IEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 98/211 (46%), Gaps = 13/211 (6%)
Query: 268 QRATDEFNECNLLGTSSFGSVYKGTISDGTDV-AIKV-FNLQLERA--FRSFDSECEVLR 323
           Q A ++F     LG   FG+VY     +   + A+KV F  QLE+A        E E+  
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 324 NVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALE 383
           ++RH N++++   + +     L+LE+ P G++ + L   + F D       + ++ +AL 
Sbjct: 64  HLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALS 122
Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           Y H    S  +IH D+KP N+LL       ++DFG          S R+     T+ Y+ 
Sbjct: 123 YCH----SKKVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRAALCGTLDYLP 174
Query: 444 PEYGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
           PE     +   K D++S GVL  E    K P
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 93/198 (46%), Gaps = 7/198 (3%)
Query: 280 LGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSN 339
           LG+  FG V  G      DVA+K+   +   +   F  E + +  + H  L+K     S 
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIK-EGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 340 PDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDL 399
                +V E++ NG L  +L SH   L+  + L +  DV   + +L     S   IH DL
Sbjct: 75  EYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFL----ESHQFIHRDL 130
Query: 400 KPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVY 459
              N L+D ++   VSDFG+ + + + +  V    T   + + APE       S+K DV+
Sbjct: 131 AARNCLVDRDLCVKVSDFGMTRYVLD-DQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVW 189
Query: 460 SYGVLLMETFT-RKRPTD 476
           ++G+L+ E F+  K P D
Sbjct: 190 AFGILMWEVFSLGKMPYD 207

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 100/212 (47%), Gaps = 15/212 (7%)
Query: 268 QRATDEFNECNLLGTSSFGSVYKGTISDGTDV-AIKV-FNLQLERA--FRSFDSECEVLR 323
           Q A ++F     LG   FG+VY         + A+KV F  QLE+A        E E+  
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 324 NVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALE 383
           ++RH N++++   + +     L+LE+ P G++ + L   + F D       + ++ +AL 
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALS 125
Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           Y H    S  +IH D+KP N+LL       ++DFG          S R+     T+ Y+ 
Sbjct: 126 YCH----SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRAALCGTLDYLP 177
Query: 444 PEYGLEG-IVSAKCDVYSYGVLLMETFTRKRP 474
           PE  +EG +   K D++S GVL  E    K P
Sbjct: 178 PEM-IEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 93/193 (48%), Gaps = 8/193 (4%)
Query: 280 LGTSSFGSVYKGTISDGT-DVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYS 338
           LG   +G VY+G     +  VA+K    +       F  E  V++ ++H NL+++L   +
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 339 NPDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHC 397
                 +++EFM  G+L  +L   N   ++ +  L +   + SA+EYL   +     IH 
Sbjct: 81  REPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN----FIHR 136
Query: 398 DLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCD 457
           DL   N L+ EN +  V+DFG+ +L+  G+           I + APE       S K D
Sbjct: 137 DLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTAPESLAYNKFSIKSD 195
Query: 458 VYSYGVLLMETFT 470
           V+++GVLL E  T
Sbjct: 196 VWAFGVLLWEIAT 208

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 9/204 (4%)
Query: 268 QRATDEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVF---NLQLERAFRSFDSECEVLR 323
           ++  ++F    +LG  SF +V     ++   + AIK+    ++  E        E +V+ 
Sbjct: 6   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 65
Query: 324 NVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALE 383
            + H   +K+  ++ + +     L +  NG L K++     F +   R     ++ SALE
Sbjct: 66  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALE 124
Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           YLH       IIH DLKP NILL+E+M   ++DFG  K+L       R    + T  Y++
Sbjct: 125 YLHGKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 180
Query: 444 PEYGLEGIVSAKCDVYSYGVLLME 467
           PE   E       D+++ G ++ +
Sbjct: 181 PELLTEKSACKSSDLWALGCIIYQ 204

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 97/201 (48%), Gaps = 17/201 (8%)
Query: 280 LGTSSFGSV----YKGTISDGTD--VAIKVFNLQLERAFRS-FDSECEVLRNVRHRNLIK 332
           LG   FG V    Y  T +DGT   VA+K          RS +  E ++LR + H ++IK
Sbjct: 22  LGEGHFGKVSLYCYDPT-NDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIK 80
Query: 333 ILSSYSNPDFKAL--VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHS 390
                 +   K+L  V+E++P GSL  +L  H+  + + + L     +   + YLH    
Sbjct: 81  YKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLH---- 134
Query: 391 SVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVR-QTMTMATIGYMAPEYGLE 449
           S H IH +L   N+LLD + +  + DFG+ K + EG +  R +    + + + APE   E
Sbjct: 135 SQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKE 194
Query: 450 GIVSAKCDVYSYGVLLMETFT 470
                  DV+S+GV L E  T
Sbjct: 195 YKFYYASDVWSFGVTLYELLT 215

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 9/204 (4%)
Query: 268 QRATDEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVF---NLQLERAFRSFDSECEVLR 323
           ++  ++F    +LG  SF +V     ++   + AIK+    ++  E        E +V+ 
Sbjct: 5   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 64
Query: 324 NVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALE 383
            + H   +K+  ++ + +     L +  NG L K++     F +   R     ++ SALE
Sbjct: 65  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALE 123
Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           YLH       IIH DLKP NILL+E+M   ++DFG  K+L       R    + T  Y++
Sbjct: 124 YLHGKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 179
Query: 444 PEYGLEGIVSAKCDVYSYGVLLME 467
           PE   E       D+++ G ++ +
Sbjct: 180 PELLTEKSACKSSDLWALGCIIYQ 203

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 99/213 (46%), Gaps = 13/213 (6%)
Query: 268 QRATDEFNECNLLGTSSFGSVYKGTISDGTDV-AIKV-FNLQLERA--FRSFDSECEVLR 323
           Q A ++F     LG   FG+VY         + A+KV F  QLE+A        E E+  
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 324 NVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALE 383
           ++RH N++++   + +     L+LE+ P G++ + L   + F D       + ++ +AL 
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALS 125
Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           Y H    S  +IH D+KP N+LL       +++FG          S R+T    T+ Y+ 
Sbjct: 126 YCH----SKRVIHRDIKPENLLLGSAGELKIANFG----WSVHAPSSRRTTLCGTLDYLP 177
Query: 444 PEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTD 476
           PE     +   K D++S GVL  E    K P +
Sbjct: 178 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 97/204 (47%), Gaps = 11/204 (5%)
Query: 273 EFNECNLLGTSSFGSVYKGT-ISDGT----DVAIKVFNLQL-ERAFRSFDSECEVLRNVR 326
           E     +LG+ +FG+VYKG  + +G      VAIK+ N     +A   F  E  ++ ++ 
Sbjct: 16  ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMD 75
Query: 327 HRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH 386
           H +L+++L    +P  + LV + MP+G L ++++ H   +     LN  + +   + YL 
Sbjct: 76  HPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYL- 133
Query: 387 NGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEY 446
                  ++H DL   N+L+       ++DFG+ +LL   E           I +MA E 
Sbjct: 134 ---EERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALEC 190
Query: 447 GLEGIVSAKCDVYSYGVLLMETFT 470
                 + + DV+SYGV + E  T
Sbjct: 191 IHYRKFTHQSDVWSYGVTIWELMT 214

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 96/202 (47%), Gaps = 17/202 (8%)
Query: 280 LGTSSFGSV----YKGTISDGTD--VAIKVFNLQLERAFRS-FDSECEVLRNVRHRNLIK 332
           LG   FG V    Y  T +DGT   VA+K          RS +  E ++LR + H ++IK
Sbjct: 39  LGEGHFGKVSLYCYDPT-NDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIK 97
Query: 333 ILSSYSNPDFKAL--VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHS 390
                 +    +L  V+E++P GSL  +L  H+  + + + L     +   + YLH    
Sbjct: 98  YKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLH---- 151
Query: 391 SVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVR-QTMTMATIGYMAPEYGLE 449
           + H IH DL   N+LLD + +  + DFG+ K + EG +  R +    + + + APE   E
Sbjct: 152 AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLKE 211
Query: 450 GIVSAKCDVYSYGVLLMETFTR 471
                  DV+S+GV L E  T 
Sbjct: 212 YKFYYASDVWSFGVTLYELLTH 233

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/193 (30%), Positives = 91/193 (47%), Gaps = 8/193 (4%)
Query: 280 LGTSSFGSVYKGTISDGT-DVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYS 338
           LG   FG VY+G     +  VA+K    +       F  E  V++ ++H NL+++L   +
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 339 NPDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHC 397
                 ++ EFM  G+L  +L   N   +  +  L +   + SA+EYL   +     IH 
Sbjct: 78  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN----FIHR 133
Query: 398 DLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCD 457
           DL   N L+ EN +  V+DFG+ +L+  G+           I + APE       S K D
Sbjct: 134 DLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTAPESLAYNKFSIKSD 192
Query: 458 VYSYGVLLMETFT 470
           V+++GVLL E  T
Sbjct: 193 VWAFGVLLWEIAT 205

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 9/204 (4%)
Query: 268 QRATDEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVF---NLQLERAFRSFDSECEVLR 323
           ++  ++F    +LG  SF +V     ++   + AIK+    ++  E        E +V+ 
Sbjct: 4   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 324 NVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALE 383
            + H   +K+  ++ + +     L +  NG L K++     F +   R     ++ SALE
Sbjct: 64  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALE 122
Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           YLH       IIH DLKP NILL+E+M   ++DFG  K+L       R    + T  Y++
Sbjct: 123 YLHGKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 178
Query: 444 PEYGLEGIVSAKCDVYSYGVLLME 467
           PE   E       D+++ G ++ +
Sbjct: 179 PELLTEKSACKSSDLWALGCIIYQ 202

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 101/214 (47%), Gaps = 15/214 (7%)
Query: 268 QRATDEFNECNLLGTSSFGSVYKGTISDGTDV-AIKV-FNLQLERA--FRSFDSECEVLR 323
           Q A ++F     LG   FG+VY         + A+KV F  QLE+A        E E+  
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 324 NVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALE 383
           ++RH N++++   + +     L+LE+ P G++ + L   + F D       + ++ +AL 
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALS 122
Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           Y H    S  +IH D+KP N+LL       ++DFG          S R+     T+ Y+ 
Sbjct: 123 YCH----SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLCGTLDYLP 174
Query: 444 PEYGLEG-IVSAKCDVYSYGVLLMETFTRKRPTD 476
           PE  +EG +   K D++S GVL  E    K P +
Sbjct: 175 PEM-IEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 9/204 (4%)
Query: 268 QRATDEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVF---NLQLERAFRSFDSECEVLR 323
           ++  ++F    +LG  SF +V     ++   + AIK+    ++  E        E +V+ 
Sbjct: 3   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 62
Query: 324 NVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALE 383
            + H   +K+  ++ + +     L +  NG L K++     F +   R     ++ SALE
Sbjct: 63  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALE 121
Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           YLH       IIH DLKP NILL+E+M   ++DFG  K+L       R    + T  Y++
Sbjct: 122 YLHGKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 177
Query: 444 PEYGLEGIVSAKCDVYSYGVLLME 467
           PE   E       D+++ G ++ +
Sbjct: 178 PELLTEKSACKSSDLWALGCIIYQ 201

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 13/211 (6%)
Query: 268 QRATDEFNECNLLGTSSFGSVYKGTISDGTDV-AIKV-FNLQLERA--FRSFDSECEVLR 323
           Q A ++F     LG   FG+VY         + A+KV F  QLE+A        E E+  
Sbjct: 6   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 65
Query: 324 NVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALE 383
           ++RH N++++   + +     L+LE+ P G++ + L   + F D       + ++ +AL 
Sbjct: 66  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALS 124
Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           Y H    S  +IH D+KP N+LL       ++DFG          S R+     T+ Y+ 
Sbjct: 125 YCH----SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLCGTLDYLP 176
Query: 444 PEYGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
           PE     +   K D++S GVL  E    K P
Sbjct: 177 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 207

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 98/211 (46%), Gaps = 13/211 (6%)
Query: 268 QRATDEFNECNLLGTSSFGSVYKGTISDGTDV-AIKV-FNLQLERA--FRSFDSECEVLR 323
           Q A ++F     LG   FG+VY         + A+KV F  QLE+A        E E+  
Sbjct: 6   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 65
Query: 324 NVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALE 383
           ++RH N++++   + +     L+LE+ P G++ + L   + F D       + ++ +AL 
Sbjct: 66  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALS 124
Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           Y H    S  +IH D+KP N+LL       +++FG          S R+T    T+ Y+ 
Sbjct: 125 YCH----SKRVIHRDIKPENLLLGSAGELKIANFG----WSVHAPSSRRTTLCGTLDYLP 176
Query: 444 PEYGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
           PE     +   K D++S GVL  E    K P
Sbjct: 177 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 207

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 92/193 (47%), Gaps = 8/193 (4%)
Query: 280 LGTSSFGSVYKGTISDGT-DVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYS 338
           LG   +G VY+G     +  VA+K    +       F  E  V++ ++H NL+++L   +
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 339 NPDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHC 397
                 +++EFM  G+L  +L   N   +  +  L +   + SA+EYL   +     IH 
Sbjct: 78  REPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN----FIHR 133
Query: 398 DLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCD 457
           DL   N L+ EN +  V+DFG+ +L+  G+           I + APE       S K D
Sbjct: 134 DLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTAPESLAYNKFSIKSD 192
Query: 458 VYSYGVLLMETFT 470
           V+++GVLL E  T
Sbjct: 193 VWAFGVLLWEIAT 205

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 93/193 (48%), Gaps = 8/193 (4%)
Query: 280 LGTSSFGSVYKGTISDGT-DVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYS 338
           LG   +G VY+G     +  VA+K    +       F  E  V++ ++H NL+++L   +
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 339 NPDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHC 397
                 +++EFM  G+L  +L   N   ++ +  L +   + SA+EYL   +     IH 
Sbjct: 85  REPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN----FIHR 140
Query: 398 DLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCD 457
           DL   N L+ EN +  V+DFG+ +L+  G+           I + APE       S K D
Sbjct: 141 DLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 199
Query: 458 VYSYGVLLMETFT 470
           V+++GVLL E  T
Sbjct: 200 VWAFGVLLWEIAT 212

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 98/213 (46%), Gaps = 13/213 (6%)
Query: 268 QRATDEFNECNLLGTSSFGSVYKGTISDGTDV-AIKV-FNLQLERA--FRSFDSECEVLR 323
           Q A ++F     LG   FG+VY         + A+KV F  QLE+A        E E+  
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 324 NVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALE 383
           ++RH N++++   + +     L+LE+ P G++ + L   + F D       + ++ +AL 
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALS 125
Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           Y H    S  +IH D+KP N+LL       ++DFG          S R+     T+ Y+ 
Sbjct: 126 YCH----SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLCGTLDYLP 177
Query: 444 PEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTD 476
           PE     +   K D++S GVL  E    K P +
Sbjct: 178 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 13/211 (6%)
Query: 268 QRATDEFNECNLLGTSSFGSVYKGTISDGTDV-AIKV-FNLQLERA--FRSFDSECEVLR 323
           Q A ++F     LG   FG+VY         + A+KV F  QLE+A        E E+  
Sbjct: 5   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 64
Query: 324 NVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALE 383
           ++RH N++++   + +     L+LE+ P G++ + L   + F D       + ++ +AL 
Sbjct: 65  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALS 123
Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           Y H    S  +IH D+KP N+LL       ++DFG          S R+     T+ Y+ 
Sbjct: 124 YCH----SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRDTLCGTLDYLP 175
Query: 444 PEYGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
           PE     +   K D++S GVL  E    K P
Sbjct: 176 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 101/208 (48%), Gaps = 13/208 (6%)
Query: 280 LGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYS 338
           +G  + G+VY    ++ G +VAI+  NLQ +       +E  V+R  ++ N++  L SY 
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 339 NPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCD 398
             D   +V+E++  GSL   +      +D  +   +  +   ALE+LH    S  +IH D
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH----SNQVIHRD 141
Query: 399 LKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDV 458
           +K  NILL  +    ++DFG    +   E S R TM + T  +MAPE         K D+
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQITP-EQSKRSTM-VGTPYWMAPEVVTRKAYGPKVDI 199
Query: 459 YSYGVLLMETFTRKRPTDEMFIGEMSLR 486
           +S G++ +E    + P    ++ E  LR
Sbjct: 200 WSLGIMAIEMIEGEPP----YLNENPLR 223

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 93/200 (46%), Gaps = 9/200 (4%)
Query: 272 DEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVF---NLQLERAFRSFDSECEVLRNVRH 327
           ++F    +LG  SF +V     ++   + AIK+    ++  E        E +V+  + H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
              +K+  ++ + +     L +  NG L K++     F +   R     ++ SALEYLH 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLHG 150
Query: 388 GHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYG 447
                 IIH DLKP NILL+E+M   ++DFG  K+L       R    + T  Y++PE  
Sbjct: 151 KG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 206
Query: 448 LEGIVSAKCDVYSYGVLLME 467
            E       D+++ G ++ +
Sbjct: 207 TEKSAXKSSDLWALGCIIYQ 226

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 98/215 (45%), Gaps = 16/215 (7%)
Query: 265 LDIQRATDEFNECNLLGTSSFGSVYKGTISDGTD-VAIKVFNLQLERAF-----RSFDSE 318
           LD++     + + + LG   F +VYK    +    VAIK   L           R+   E
Sbjct: 3   LDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALRE 62
Query: 319 CEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDV 378
            ++L+ + H N+I +L ++ +    +LV +FM    LE  +  ++  L        M+  
Sbjct: 63  IKLLQELSHPNIIGLLDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLMT 121
Query: 379 GSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMAT 438
              LEYLH       I+H DLKP N+LLDEN V  ++DFG+ K  G    +    +   T
Sbjct: 122 LQGLEYLHQHW----ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVV--T 175
Query: 439 IGYMAPE--YGLEGIVSAKCDVYSYGVLLMETFTR 471
             Y APE  +G   +     D+++ G +L E   R
Sbjct: 176 RWYRAPELLFGAR-MYGVGVDMWAVGCILAELLLR 209

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 106/225 (47%), Gaps = 16/225 (7%)
Query: 268 QRATDEFNECNLLGTSSFGSVYKGTISDGTDV-AIKV-FNLQLERA--FRSFDSECEVLR 323
           Q   ++F+    LG   FG+VY         + A+KV F  QLE+A        E E+  
Sbjct: 8   QWTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQS 67
Query: 324 NVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALE 383
           ++RH N++++   + +     L+LE+ P G++ + L   + F D       + ++ +AL 
Sbjct: 68  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRF-DEQRTATYITELANALS 126
Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           Y H    S  +IH D+KP N+LL  N    ++DFG          S R+     T+ Y+ 
Sbjct: 127 YCH----SKRVIHRDIKPENLLLGSNGELKIADFG----WSVHAPSSRRDTLCGTLDYLP 178
Query: 444 PEYGLEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRR 487
           PE  +EG +   K D++S GVL  E F    P  E    + + RR
Sbjct: 179 PEM-IEGRMHDEKVDLWSLGVLCYE-FLVGMPPFEAHTYQETYRR 221

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/273 (24%), Positives = 123/273 (45%), Gaps = 27/273 (9%)
Query: 273 EFNECNLL---GTSSFGSVYKGTISDGTDVAIKVFNLQ--LERAFRSFDSECEVLRNVRH 327
           +F + N L     +  G ++KG    G D+ +KV  ++    R  R F+ EC  LR   H
Sbjct: 8   DFKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSH 66
Query: 328 RNLIKILSSYSNP--DFKALVLEFMPNGSLEKWLYS-HNYFLDILERLNIMIDVGSALEY 384
            N++ +L +  +P      L+  +MP GSL   L+   N+ +D  + +   +D+   + +
Sbjct: 67  PNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAF 126
Query: 385 LHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAP 444
           LH       I    L   ++++DE+M A +S       + + + S +    M    ++AP
Sbjct: 127 LHTLEPL--IPRHALNSRSVMIDEDMTARIS-------MADVKFSFQSPGRMYAPAWVAP 177
Query: 445 EY---GLEGIVSAKCDVYSYGVLLMETFTRKRPTDE---MFIGEMSLRRWVKESLPHGLT 498
           E      E       D++S+ VLL E  TR+ P  +   M IG       ++ ++P G++
Sbjct: 178 EALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGIS 237
Query: 499 EVVDANL---VREEQAFSAKMDCILSIMDFALD 528
             V   +   + E+ A   K D I+ I++   D
Sbjct: 238 PHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 97/201 (48%), Gaps = 17/201 (8%)
Query: 280 LGTSSFGSV----YKGTISDGTD--VAIKVFNLQLERAFRS-FDSECEVLRNVRHRNLIK 332
           LG   FG V    Y  T +DGT   VA+K          RS +  E ++LR + H ++IK
Sbjct: 22  LGEGHFGKVSLYCYDPT-NDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIK 80
Query: 333 ILSSYSNPDFKAL--VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHS 390
                 +   K+L  V+E++P GSL  +L  H+  + + + L     +   + YLH    
Sbjct: 81  YKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLH---- 134
Query: 391 SVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVR-QTMTMATIGYMAPEYGLE 449
           + H IH +L   N+LLD + +  + DFG+ K + EG +  R +    + + + APE   E
Sbjct: 135 AQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKE 194
Query: 450 GIVSAKCDVYSYGVLLMETFT 470
                  DV+S+GV L E  T
Sbjct: 195 YKFYYASDVWSFGVTLYELLT 215

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 92/193 (47%), Gaps = 8/193 (4%)
Query: 280 LGTSSFGSVYKGTISDGT-DVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYS 338
           LG   +G VY+G     +  VA+K    +       F  E  V++ ++H NL+++L   +
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 339 NPDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHC 397
                 ++ EFM  G+L  +L   N   ++ +  L +   + SA+EYL   +     IH 
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN----FIHR 140
Query: 398 DLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCD 457
           DL   N L+ EN +  V+DFG+ +L+  G+           I + APE       S K D
Sbjct: 141 DLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTAPESLAYNKFSIKSD 199
Query: 458 VYSYGVLLMETFT 470
           V+++GVLL E  T
Sbjct: 200 VWAFGVLLWEIAT 212

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 93/200 (46%), Gaps = 9/200 (4%)
Query: 272 DEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVF---NLQLERAFRSFDSECEVLRNVRH 327
           ++F    +LG  SF +V     ++   + AIK+    ++  E        E +V+  + H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
              +K+  ++ + +     L +  NG L K++     F +   R     ++ SALEYLH 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLHG 150
Query: 388 GHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYG 447
                 IIH DLKP NILL+E+M   ++DFG  K+L       R    + T  Y++PE  
Sbjct: 151 KG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 206
Query: 448 LEGIVSAKCDVYSYGVLLME 467
            E       D+++ G ++ +
Sbjct: 207 TEKSACKSSDLWALGCIIYQ 226

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 93/200 (46%), Gaps = 9/200 (4%)
Query: 272 DEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVF---NLQLERAFRSFDSECEVLRNVRH 327
           ++F    +LG  SF +V     ++   + AIK+    ++  E        E +V+  + H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
              +K+  ++ + +     L +  NG L K++     F +   R     ++ SALEYLH 
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLHG 148
Query: 388 GHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYG 447
                 IIH DLKP NILL+E+M   ++DFG  K+L       R    + T  Y++PE  
Sbjct: 149 KG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 204
Query: 448 LEGIVSAKCDVYSYGVLLME 467
            E       D+++ G ++ +
Sbjct: 205 TEKSACKSSDLWALGCIIYQ 224

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 93/200 (46%), Gaps = 9/200 (4%)
Query: 272 DEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVF---NLQLERAFRSFDSECEVLRNVRH 327
           ++F    +LG  SF +V     ++   + AIK+    ++  E        E +V+  + H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
              +K+  ++ + +     L +  NG L K++     F +   R     ++ SALEYLH 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLHG 150
Query: 388 GHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYG 447
                 IIH DLKP NILL+E+M   ++DFG  K+L       R    + T  Y++PE  
Sbjct: 151 KG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 206
Query: 448 LEGIVSAKCDVYSYGVLLME 467
            E       D+++ G ++ +
Sbjct: 207 TEKSACKSSDLWALGCIIYQ 226

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 93/200 (46%), Gaps = 9/200 (4%)
Query: 272 DEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVF---NLQLERAFRSFDSECEVLRNVRH 327
           ++F    +LG  SF +V     ++   + AIK+    ++  E        E +V+  + H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
              +K+  ++ + +     L +  NG L K++     F +   R     ++ SALEYLH 
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLHG 151
Query: 388 GHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYG 447
                 IIH DLKP NILL+E+M   ++DFG  K+L       R    + T  Y++PE  
Sbjct: 152 KG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 207
Query: 448 LEGIVSAKCDVYSYGVLLME 467
            E       D+++ G ++ +
Sbjct: 208 TEKSACKSSDLWALGCIIYQ 227

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 93/200 (46%), Gaps = 9/200 (4%)
Query: 272 DEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVF---NLQLERAFRSFDSECEVLRNVRH 327
           ++F    +LG  SF +V     ++   + AIK+    ++  E        E +V+  + H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
              +K+  ++ + +     L +  NG L K++     F +   R     ++ SALEYLH 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLHG 150
Query: 388 GHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYG 447
                 IIH DLKP NILL+E+M   ++DFG  K+L       R    + T  Y++PE  
Sbjct: 151 KG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 206
Query: 448 LEGIVSAKCDVYSYGVLLME 467
            E       D+++ G ++ +
Sbjct: 207 TEKSACKSSDLWALGCIIYQ 226

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 93/200 (46%), Gaps = 9/200 (4%)
Query: 272 DEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVF---NLQLERAFRSFDSECEVLRNVRH 327
           ++F    +LG  SF +V     ++   + AIK+    ++  E        E +V+  + H
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 94
Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
              +K+  ++ + +     L +  NG L K++     F +   R     ++ SALEYLH 
Sbjct: 95  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLHG 153
Query: 388 GHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYG 447
                 IIH DLKP NILL+E+M   ++DFG  K+L       R    + T  Y++PE  
Sbjct: 154 KG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 209
Query: 448 LEGIVSAKCDVYSYGVLLME 467
            E       D+++ G ++ +
Sbjct: 210 TEKSACKSSDLWALGCIIYQ 229

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 93/200 (46%), Gaps = 9/200 (4%)
Query: 272 DEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVF---NLQLERAFRSFDSECEVLRNVRH 327
           ++F    +LG  SF +V     ++   + AIK+    ++  E        E +V+  + H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
              +K+  ++ + +     L +  NG L K++     F +   R     ++ SALEYLH 
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLHG 148
Query: 388 GHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYG 447
                 IIH DLKP NILL+E+M   ++DFG  K+L       R    + T  Y++PE  
Sbjct: 149 KG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 204
Query: 448 LEGIVSAKCDVYSYGVLLME 467
            E       D+++ G ++ +
Sbjct: 205 TEKSACKSSDLWALGCIIYQ 224

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 92/193 (47%), Gaps = 8/193 (4%)
Query: 280 LGTSSFGSVYKGTISDGT-DVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYS 338
           LG   +G VY+G     +  VA+K    +       F  E  V++ ++H NL+++L   +
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 339 NPDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHC 397
                 +++EFM  G+L  +L   N   +  +  L +   + SA+EYL   +     IH 
Sbjct: 80  REPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN----FIHR 135
Query: 398 DLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCD 457
           DL   N L+ EN +  V+DFG+ +L+  G+           I + APE       S K D
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 194
Query: 458 VYSYGVLLMETFT 470
           V+++GVLL E  T
Sbjct: 195 VWAFGVLLWEIAT 207

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 93/200 (46%), Gaps = 9/200 (4%)
Query: 272 DEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVF---NLQLERAFRSFDSECEVLRNVRH 327
           ++F    +LG  SF +V     ++   + AIK+    ++  E        E +V+  + H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
              +K+  ++ + +     L +  NG L K++     F +   R     ++ SALEYLH 
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLHG 148
Query: 388 GHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYG 447
                 IIH DLKP NILL+E+M   ++DFG  K+L       R    + T  Y++PE  
Sbjct: 149 KG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELL 204
Query: 448 LEGIVSAKCDVYSYGVLLME 467
            E       D+++ G ++ +
Sbjct: 205 TEKSACKSSDLWALGCIIYQ 224

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 100/212 (47%), Gaps = 15/212 (7%)
Query: 268 QRATDEFNECNLLGTSSFGSVYKGTISDGTDV-AIKV-FNLQLERA--FRSFDSECEVLR 323
           Q A ++F     LG   FG+VY         + A+KV F  QLE+A        E E+  
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 324 NVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALE 383
           ++RH N++++   + +     L+LE+ P G++ + L   + F D       + ++ +AL 
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALS 125
Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           Y H    S  +IH D+KP N+LL       ++DFG          S R+     T+ Y+ 
Sbjct: 126 YCH----SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRDDLCGTLDYLP 177
Query: 444 PEYGLEG-IVSAKCDVYSYGVLLMETFTRKRP 474
           PE  +EG +   K D++S GVL  E    K P
Sbjct: 178 PEM-IEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 93/200 (46%), Gaps = 9/200 (4%)
Query: 272 DEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVF---NLQLERAFRSFDSECEVLRNVRH 327
           ++F    +LG  SF +V     ++   + AIK+    ++  E        E +V+  + H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
              +K+  ++ + +     L +  NG L K++     F +   R     ++ SALEYLH 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLHG 150
Query: 388 GHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYG 447
                 IIH DLKP NILL+E+M   ++DFG  K+L       R    + T  Y++PE  
Sbjct: 151 KG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 206
Query: 448 LEGIVSAKCDVYSYGVLLME 467
            E       D+++ G ++ +
Sbjct: 207 TEKSACKSSDLWALGCIIYQ 226

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 93/200 (46%), Gaps = 9/200 (4%)
Query: 272 DEFNECNLLGTSSFGS-VYKGTISDGTDVAIKVF---NLQLERAFRSFDSECEVLRNVRH 327
           ++F    +LG  SF + V    ++   + AIK+    ++  E        E +V+  + H
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
              +K+  ++ + +     L +  NG L K++     F +   R     ++ SALEYLH 
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLHG 148
Query: 388 GHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYG 447
                 IIH DLKP NILL+E+M   ++DFG  K+L       R    + T  Y++PE  
Sbjct: 149 KG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 204
Query: 448 LEGIVSAKCDVYSYGVLLME 467
            E       D+++ G ++ +
Sbjct: 205 TEKSACKSSDLWALGCIIYQ 224

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 92/193 (47%), Gaps = 8/193 (4%)
Query: 280 LGTSSFGSVYKGTISDGT-DVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYS 338
           LG   +G VY+G     +  VA+K    +       F  E  V++ ++H NL+++L   +
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 339 NPDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHC 397
                 +++EFM  G+L  +L   N   +  +  L +   + SA+EYL   +     IH 
Sbjct: 80  REPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN----FIHR 135
Query: 398 DLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCD 457
           DL   N L+ EN +  V+DFG+ +L+  G+           I + APE       S K D
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 194
Query: 458 VYSYGVLLMETFT 470
           V+++GVLL E  T
Sbjct: 195 VWAFGVLLWEIAT 207

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 92/193 (47%), Gaps = 8/193 (4%)
Query: 280 LGTSSFGSVYKGTISDGT-DVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYS 338
           LG   +G VY+G     +  VA+K    +       F  E  V++ ++H NL+++L   +
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 339 NPDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHC 397
                 ++ EFM  G+L  +L   N   ++ +  L +   + SA+EYL   +     IH 
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN----FIHR 140
Query: 398 DLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCD 457
           DL   N L+ EN +  V+DFG+ +L+  G+           I + APE       S K D
Sbjct: 141 DLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 199
Query: 458 VYSYGVLLMETFT 470
           V+++GVLL E  T
Sbjct: 200 VWAFGVLLWEIAT 212

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 93/200 (46%), Gaps = 9/200 (4%)
Query: 272 DEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVF---NLQLERAFRSFDSECEVLRNVRH 327
           ++F    +LG  SF +V     ++   + AIK+    ++  E        E +V+  + H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
              +K+  ++ + +     L +  NG L K++     F +   R     ++ SALEYLH 
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLHG 151
Query: 388 GHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYG 447
                 IIH DLKP NILL+E+M   ++DFG  K+L       R    + T  Y++PE  
Sbjct: 152 KG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 207
Query: 448 LEGIVSAKCDVYSYGVLLME 467
            E       D+++ G ++ +
Sbjct: 208 TEKSACKSSDLWALGCIIYQ 227

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 92/193 (47%), Gaps = 8/193 (4%)
Query: 280 LGTSSFGSVYKGTISDGT-DVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYS 338
           LG   +G VY+G     +  VA+K    +       F  E  V++ ++H NL+++L   +
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 83
Query: 339 NPDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHC 397
                 ++ EFM  G+L  +L   N   ++ +  L +   + SA+EYL   +     IH 
Sbjct: 84  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN----FIHR 139
Query: 398 DLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCD 457
           DL   N L+ EN +  V+DFG+ +L+  G+           I + APE       S K D
Sbjct: 140 DLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 198
Query: 458 VYSYGVLLMETFT 470
           V+++GVLL E  T
Sbjct: 199 VWAFGVLLWEIAT 211

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 97/213 (45%), Gaps = 20/213 (9%)
Query: 273 EFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLER-----AFRSFDSECEVLRNVRH 327
            FNE  ++G   FG VY GT+ D     I      L R         F +E  ++++  H
Sbjct: 32  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 89
Query: 328 RNLIKILS----SYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALE 383
            N++ +L     S  +P    +VL +M +G L  ++ +  +   + + +   + V   ++
Sbjct: 90  PNVLSLLGICLRSEGSP---LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 146
Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMAT--IGY 441
           YL    +S   +H DL   N +LDE     V+DFG+ + + + E       T A   + +
Sbjct: 147 YL----ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKW 202
Query: 442 MAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
           MA E       + K DV+S+GVLL E  TR  P
Sbjct: 203 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 93/200 (46%), Gaps = 9/200 (4%)
Query: 272 DEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVF---NLQLERAFRSFDSECEVLRNVRH 327
           ++F    +LG  SF +V     ++   + AIK+    ++  E        E +V+  + H
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 73
Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
              +K+  ++ + +     L +  NG L K++     F +   R     ++ SALEYLH 
Sbjct: 74  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLHG 132
Query: 388 GHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYG 447
                 IIH DLKP NILL+E+M   ++DFG  K+L       R    + T  Y++PE  
Sbjct: 133 KG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 188
Query: 448 LEGIVSAKCDVYSYGVLLME 467
            E       D+++ G ++ +
Sbjct: 189 TEKSACKSSDLWALGCIIYQ 208

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 100/212 (47%), Gaps = 15/212 (7%)
Query: 268 QRATDEFNECNLLGTSSFGSVYKGTISDGTDV-AIKV-FNLQLERA--FRSFDSECEVLR 323
           Q A ++F     LG   FG+VY         + A+KV F  QLE+A        E E+  
Sbjct: 30  QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 89
Query: 324 NVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALE 383
           ++RH N++++   + +     L+LE+ P G++ + L   + F D       + ++ +AL 
Sbjct: 90  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALS 148
Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           Y H    S  +IH D+KP N+LL       ++DFG          S R+     T+ Y+ 
Sbjct: 149 YCH----SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRDDLCGTLDYLP 200
Query: 444 PEYGLEG-IVSAKCDVYSYGVLLMETFTRKRP 474
           PE  +EG +   K D++S GVL  E    K P
Sbjct: 201 PEM-IEGRMHDEKVDLWSLGVLCYEFLVGKPP 231

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 92/193 (47%), Gaps = 8/193 (4%)
Query: 280 LGTSSFGSVYKGTISDGT-DVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYS 338
           LG   +G VY+G     +  VA+K    +       F  E  V++ ++H NL+++L   +
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 339 NPDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHC 397
                 ++ EFM  G+L  +L   N   ++ +  L +   + SA+EYL   +     IH 
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN----FIHR 135
Query: 398 DLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCD 457
           DL   N L+ EN +  V+DFG+ +L+  G+           I + APE       S K D
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 194
Query: 458 VYSYGVLLMETFT 470
           V+++GVLL E  T
Sbjct: 195 VWAFGVLLWEIAT 207

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 75/322 (23%), Positives = 126/322 (39%), Gaps = 69/322 (21%)
Query: 273 EFNECNL-----LGTSSFGSVYKGTI------SDGTDVAIKVFNLQLERA-FRSFDSECE 320
           EF   NL     LG   FG V K T       +  T VA+K+       +  R   SE  
Sbjct: 19  EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFN 78
Query: 321 VLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWL--------------------- 359
           VL+ V H ++IK+  + S      L++E+   GSL  +L                     
Sbjct: 79  VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138
Query: 360 --YSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDF 417
             +     L + + ++    +   ++YL    + + ++H DL   NIL+ E     +SDF
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYL----AEMKLVHRDLAARNILVAEGRKMKISDF 194
Query: 418 GIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKR---- 473
           G+ + + E +  V+++     + +MA E   + I + + DV+S+GVLL E  T       
Sbjct: 195 GLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 254
Query: 474 --PTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCM 531
             P + +F                        NL++         +C   +    L C  
Sbjct: 255 GIPPERLF------------------------NLLKTGHRMERPDNCSEEMYRLMLQCWK 290
Query: 532 ESPDMRINMTDAAAKLKKIKVK 553
           + PD R    D +  L+K+ VK
Sbjct: 291 QEPDKRPVFADISKDLEKMMVK 312

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 100/213 (46%), Gaps = 20/213 (9%)
Query: 273 EFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLER-----AFRSFDSECEVLRNVRH 327
            FNE  ++G   FG VY GT+ D     I      L R         F +E  ++++  H
Sbjct: 38  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 95
Query: 328 RNLIKILS----SYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALE 383
            N++ +L     S  +P    +VL +M +G L  ++ +  +   + + +   + V   ++
Sbjct: 96  PNVLSLLGICLRSEGSP---LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 152
Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGE-DSVR-QTMTMATIGY 441
           +L    +S   +H DL   N +LDE     V+DFG+ + + + E DSV  +T     + +
Sbjct: 153 FL----ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW 208
Query: 442 MAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
           MA E       + K DV+S+GVLL E  TR  P
Sbjct: 209 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 241

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 100/213 (46%), Gaps = 20/213 (9%)
Query: 273 EFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLER-----AFRSFDSECEVLRNVRH 327
            FNE  ++G   FG VY GT+ D     I      L R         F +E  ++++  H
Sbjct: 92  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 149
Query: 328 RNLIKILS----SYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALE 383
            N++ +L     S  +P    +VL +M +G L  ++ +  +   + + +   + V   ++
Sbjct: 150 PNVLSLLGICLRSEGSP---LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 206
Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGE-DSVR-QTMTMATIGY 441
           +L    +S   +H DL   N +LDE     V+DFG+ + + + E DSV  +T     + +
Sbjct: 207 FL----ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW 262
Query: 442 MAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
           MA E       + K DV+S+GVLL E  TR  P
Sbjct: 263 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 295

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 92/193 (47%), Gaps = 8/193 (4%)
Query: 280 LGTSSFGSVYKGTISDGT-DVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYS 338
           LG   +G VY+G     +  VA+K    +       F  E  V++ ++H NL+++L   +
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 339 NPDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHC 397
                 ++ EFM  G+L  +L   N   ++ +  L +   + SA+EYL   +     IH 
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN----FIHR 140
Query: 398 DLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCD 457
           DL   N L+ EN +  V+DFG+ +L+  G+           I + APE       S K D
Sbjct: 141 DLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 199
Query: 458 VYSYGVLLMETFT 470
           V+++GVLL E  T
Sbjct: 200 VWAFGVLLWEIAT 212

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 100/213 (46%), Gaps = 20/213 (9%)
Query: 273 EFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLER-----AFRSFDSECEVLRNVRH 327
            FNE  ++G   FG VY GT+ D     I      L R         F +E  ++++  H
Sbjct: 31  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 88
Query: 328 RNLIKILS----SYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALE 383
            N++ +L     S  +P    +VL +M +G L  ++ +  +   + + +   + V   ++
Sbjct: 89  PNVLSLLGICLRSEGSP---LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 145
Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGE-DSVR-QTMTMATIGY 441
           +L    +S   +H DL   N +LDE     V+DFG+ + + + E DSV  +T     + +
Sbjct: 146 FL----ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW 201
Query: 442 MAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
           MA E       + K DV+S+GVLL E  TR  P
Sbjct: 202 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 92/193 (47%), Gaps = 8/193 (4%)
Query: 280 LGTSSFGSVYKGTISDGT-DVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYS 338
           LG   +G VY+G     +  VA+K    +       F  E  V++ ++H NL+++L   +
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 339 NPDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHC 397
                 ++ EFM  G+L  +L   N   ++ +  L +   + SA+EYL   +     IH 
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN----FIHR 137
Query: 398 DLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCD 457
           DL   N L+ EN +  V+DFG+ +L+  G+           I + APE       S K D
Sbjct: 138 DLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 196
Query: 458 VYSYGVLLMETFT 470
           V+++GVLL E  T
Sbjct: 197 VWAFGVLLWEIAT 209

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 92/193 (47%), Gaps = 8/193 (4%)
Query: 280 LGTSSFGSVYKGTISDGT-DVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYS 338
           LG   +G VY+G     +  VA+K    +       F  E  V++ ++H NL+++L   +
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 339 NPDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHC 397
                 ++ EFM  G+L  +L   N   ++ +  L +   + SA+EYL   +     IH 
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN----FIHR 135
Query: 398 DLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCD 457
           DL   N L+ EN +  V+DFG+ +L+  G+           I + APE       S K D
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 194
Query: 458 VYSYGVLLMETFT 470
           V+++GVLL E  T
Sbjct: 195 VWAFGVLLWEIAT 207

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 93/200 (46%), Gaps = 9/200 (4%)
Query: 272 DEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVF---NLQLERAFRSFDSECEVLRNVRH 327
           ++F    +LG  SF +V     ++   + AIK+    ++  E        E +V+  + H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
              +K+  ++ + +     L +  NG L K++     F +   R     ++ SALEYLH 
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLHG 147
Query: 388 GHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYG 447
                 IIH DLKP NILL+E+M   ++DFG  K+L       R    + T  Y++PE  
Sbjct: 148 KG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 203
Query: 448 LEGIVSAKCDVYSYGVLLME 467
            E       D+++ G ++ +
Sbjct: 204 TEKSACKSSDLWALGCIIYQ 223

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 75/322 (23%), Positives = 126/322 (39%), Gaps = 69/322 (21%)
Query: 273 EFNECNL-----LGTSSFGSVYKGTI------SDGTDVAIKVFNLQLERA-FRSFDSECE 320
           EF   NL     LG   FG V K T       +  T VA+K+       +  R   SE  
Sbjct: 19  EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFN 78
Query: 321 VLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWL--------------------- 359
           VL+ V H ++IK+  + S      L++E+   GSL  +L                     
Sbjct: 79  VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138
Query: 360 --YSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDF 417
             +     L + + ++    +   ++YL    + + ++H DL   NIL+ E     +SDF
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYL----AEMSLVHRDLAARNILVAEGRKMKISDF 194
Query: 418 GIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKR---- 473
           G+ + + E +  V+++     + +MA E   + I + + DV+S+GVLL E  T       
Sbjct: 195 GLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 254
Query: 474 --PTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCM 531
             P + +F                        NL++         +C   +    L C  
Sbjct: 255 GIPPERLF------------------------NLLKTGHRMERPDNCSEEMYRLMLQCWK 290
Query: 532 ESPDMRINMTDAAAKLKKIKVK 553
           + PD R    D +  L+K+ VK
Sbjct: 291 QEPDKRPVFADISKDLEKMMVK 312

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 100/213 (46%), Gaps = 20/213 (9%)
Query: 273 EFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLER-----AFRSFDSECEVLRNVRH 327
            FNE  ++G   FG VY GT+ D     I      L R         F +E  ++++  H
Sbjct: 33  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 90
Query: 328 RNLIKILS----SYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALE 383
            N++ +L     S  +P    +VL +M +G L  ++ +  +   + + +   + V   ++
Sbjct: 91  PNVLSLLGICLRSEGSP---LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 147
Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGE-DSVR-QTMTMATIGY 441
           +L    +S   +H DL   N +LDE     V+DFG+ + + + E DSV  +T     + +
Sbjct: 148 FL----ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW 203
Query: 442 MAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
           MA E       + K DV+S+GVLL E  TR  P
Sbjct: 204 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 100/213 (46%), Gaps = 20/213 (9%)
Query: 273 EFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLER-----AFRSFDSECEVLRNVRH 327
            FNE  ++G   FG VY GT+ D     I      L R         F +E  ++++  H
Sbjct: 33  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 90
Query: 328 RNLIKILS----SYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALE 383
            N++ +L     S  +P    +VL +M +G L  ++ +  +   + + +   + V   ++
Sbjct: 91  PNVLSLLGICLRSEGSP---LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 147
Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGE-DSVR-QTMTMATIGY 441
           +L    +S   +H DL   N +LDE     V+DFG+ + + + E DSV  +T     + +
Sbjct: 148 FL----ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW 203
Query: 442 MAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
           MA E       + K DV+S+GVLL E  TR  P
Sbjct: 204 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 92/193 (47%), Gaps = 8/193 (4%)
Query: 280 LGTSSFGSVYKGTISDGT-DVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYS 338
           LG   +G VY+G     +  VA+K    +       F  E  V++ ++H NL+++L   +
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 339 NPDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHC 397
                 ++ EFM  G+L  +L   N   ++ +  L +   + SA+EYL   +     IH 
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN----FIHR 137
Query: 398 DLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCD 457
           DL   N L+ EN +  V+DFG+ +L+  G+           I + APE       S K D
Sbjct: 138 DLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 196
Query: 458 VYSYGVLLMETFT 470
           V+++GVLL E  T
Sbjct: 197 VWAFGVLLWEIAT 209

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 92/193 (47%), Gaps = 8/193 (4%)
Query: 280 LGTSSFGSVYKGTISDGT-DVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYS 338
           LG   +G VY+G     +  VA+K    +       F  E  V++ ++H NL+++L   +
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 92
Query: 339 NPDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHC 397
                 ++ EFM  G+L  +L   N   ++ +  L +   + SA+EYL   +     IH 
Sbjct: 93  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN----FIHR 148
Query: 398 DLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCD 457
           DL   N L+ EN +  V+DFG+ +L+  G+           I + APE       S K D
Sbjct: 149 DLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 207
Query: 458 VYSYGVLLMETFT 470
           V+++GVLL E  T
Sbjct: 208 VWAFGVLLWEIAT 220

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 100/213 (46%), Gaps = 20/213 (9%)
Query: 273 EFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLER-----AFRSFDSECEVLRNVRH 327
            FNE  ++G   FG VY GT+ D     I      L R         F +E  ++++  H
Sbjct: 34  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 91
Query: 328 RNLIKILS----SYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALE 383
            N++ +L     S  +P    +VL +M +G L  ++ +  +   + + +   + V   ++
Sbjct: 92  PNVLSLLGICLRSEGSP---LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 148
Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGE-DSVR-QTMTMATIGY 441
           +L    +S   +H DL   N +LDE     V+DFG+ + + + E DSV  +T     + +
Sbjct: 149 FL----ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW 204
Query: 442 MAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
           MA E       + K DV+S+GVLL E  TR  P
Sbjct: 205 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 60/194 (30%), Positives = 93/194 (47%), Gaps = 16/194 (8%)
Query: 280 LGTSSFGSVY-KGTISDGTDVAIKVFNLQLERA-FRSFDSECEVLRNVRHRNLIKILSSY 337
           LG+ +FG V+     S G +  IK  N    +      ++E EVL+++ H N+IKI   +
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 338 SNPDFKALVLEFMPNGSLEKWLYSHNYFLDILER---LNIMIDVGSALEYLHNGHSSVHI 394
            +     +V+E    G L + + S       L       +M  + +AL Y H    S H+
Sbjct: 90  EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH----SQHV 145
Query: 395 IHCDLKPTNILLDE---NMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGI 451
           +H DLKP NIL  +   +    + DFG+ +L    E S   T    T  YMAPE   +  
Sbjct: 146 VHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS---TNAAGTALYMAPEV-FKRD 201
Query: 452 VSAKCDVYSYGVLL 465
           V+ KCD++S GV++
Sbjct: 202 VTFKCDIWSAGVVM 215

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 100/213 (46%), Gaps = 20/213 (9%)
Query: 273 EFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLER-----AFRSFDSECEVLRNVRH 327
            FNE  ++G   FG VY GT+ D     I      L R         F +E  ++++  H
Sbjct: 34  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 91
Query: 328 RNLIKILS----SYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALE 383
            N++ +L     S  +P    +VL +M +G L  ++ +  +   + + +   + V   ++
Sbjct: 92  PNVLSLLGICLRSEGSP---LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 148
Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYK-LLGEGEDSVR-QTMTMATIGY 441
           +L    +S   +H DL   N +LDE     V+DFG+ + +L +  DSV  +T     + +
Sbjct: 149 FL----ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKW 204
Query: 442 MAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
           MA E       + K DV+S+GVLL E  TR  P
Sbjct: 205 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 75/322 (23%), Positives = 126/322 (39%), Gaps = 69/322 (21%)
Query: 273 EFNECNL-----LGTSSFGSVYKGTI------SDGTDVAIKVFNLQLERA-FRSFDSECE 320
           EF   NL     LG   FG V K T       +  T VA+K+       +  R   SE  
Sbjct: 19  EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFN 78
Query: 321 VLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWL--------------------- 359
           VL+ V H ++IK+  + S      L++E+   GSL  +L                     
Sbjct: 79  VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138
Query: 360 --YSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDF 417
             +     L + + ++    +   ++YL    + + ++H DL   NIL+ E     +SDF
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYL----AEMKLVHRDLAARNILVAEGRKMKISDF 194
Query: 418 GIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKR---- 473
           G+ + + E +  V+++     + +MA E   + I + + DV+S+GVLL E  T       
Sbjct: 195 GLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 254
Query: 474 --PTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCM 531
             P + +F                        NL++         +C   +    L C  
Sbjct: 255 GIPPERLF------------------------NLLKTGHRMERPDNCSEEMYRLMLQCWK 290
Query: 532 ESPDMRINMTDAAAKLKKIKVK 553
           + PD R    D +  L+K+ VK
Sbjct: 291 QEPDKRPVFADISKDLEKMMVK 312

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 92/193 (47%), Gaps = 8/193 (4%)
Query: 280 LGTSSFGSVYKGTISDGT-DVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYS 338
           LG   +G VY+G     +  VA+K    +       F  E  V++ ++H NL+++L   +
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 339 NPDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHC 397
                 ++ EFM  G+L  +L   N   ++ +  L +   + SA+EYL   +     IH 
Sbjct: 81  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN----FIHR 136
Query: 398 DLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCD 457
           DL   N L+ EN +  V+DFG+ +L+  G+           I + APE       S K D
Sbjct: 137 DLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAPAGAKFPIKWTAPESLAYNKFSIKSD 195
Query: 458 VYSYGVLLMETFT 470
           V+++GVLL E  T
Sbjct: 196 VWAFGVLLWEIAT 208

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 92/193 (47%), Gaps = 8/193 (4%)
Query: 280 LGTSSFGSVYKGTISDGT-DVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYS 338
           LG   +G VY+G     +  VA+K    +       F  E  V++ ++H NL+++L   +
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 339 NPDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHC 397
                 ++ EFM  G+L  +L   N   ++ +  L +   + SA+EYL   +     IH 
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN----FIHR 137
Query: 398 DLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCD 457
           DL   N L+ EN +  V+DFG+ +L+  G+           I + APE       S K D
Sbjct: 138 DLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAPAGAKFPIKWTAPESLAYNKFSIKSD 196
Query: 458 VYSYGVLLMETFT 470
           V+++GVLL E  T
Sbjct: 197 VWAFGVLLWEIAT 209

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 92/200 (46%), Gaps = 9/200 (4%)
Query: 272 DEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVF---NLQLERAFRSFDSECEVLRNVRH 327
           ++F    +LG  SF +V     ++   + AIK+    ++  E        E +V+  + H
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
              +K+   + + +     L +  NG L K++     F +   R     ++ SALEYLH 
Sbjct: 97  PFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLHG 155
Query: 388 GHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYG 447
                 IIH DLKP NILL+E+M   ++DFG  K+L       R    + T  Y++PE  
Sbjct: 156 KG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 211
Query: 448 LEGIVSAKCDVYSYGVLLME 467
            E       D+++ G ++ +
Sbjct: 212 TEKSACKSSDLWALGCIIYQ 231

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 93/200 (46%), Gaps = 9/200 (4%)
Query: 272 DEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVF---NLQLERAFRSFDSECEVLRNVRH 327
           ++F    +LG  SF +V     ++   + AIK+    ++  E        E +V+  + H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
              +K+  ++ + +     L +  NG L K++     F +   R     ++ SALEYLH 
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLHG 147
Query: 388 GHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYG 447
                 IIH DLKP NILL+E+M   ++DFG  K+L       R    + T  Y++PE  
Sbjct: 148 KG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 203
Query: 448 LEGIVSAKCDVYSYGVLLME 467
            E       D+++ G ++ +
Sbjct: 204 TEKSACKSSDLWALGCIIYQ 223

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 91/193 (47%), Gaps = 8/193 (4%)
Query: 280 LGTSSFGSVYKGTISDGT-DVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYS 338
           LG   +G VY+G     +  VA+K    +       F  E  V++ ++H NL+++L   +
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 339 NPDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHC 397
                 ++ EFM  G+L  +L   N   +  +  L +   + SA+EYL   +     IH 
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN----FIHR 140
Query: 398 DLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCD 457
           DL   N L+ EN +  V+DFG+ +L+  G+           I + APE       S K D
Sbjct: 141 DLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 199
Query: 458 VYSYGVLLMETFT 470
           V+++GVLL E  T
Sbjct: 200 VWAFGVLLWEIAT 212

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 91/193 (47%), Gaps = 8/193 (4%)
Query: 280 LGTSSFGSVYKGTISDGT-DVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYS 338
           LG   +G VY+G     +  VA+K    +       F  E  V++ ++H NL+++L   +
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 339 NPDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHC 397
                 ++ EFM  G+L  +L   N   +  +  L +   + SA+EYL   +     IH 
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN----FIHR 135
Query: 398 DLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCD 457
           DL   N L+ EN +  V+DFG+ +L+  G+           I + APE       S K D
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 194
Query: 458 VYSYGVLLMETFT 470
           V+++GVLL E  T
Sbjct: 195 VWAFGVLLWEIAT 207

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 97/215 (45%), Gaps = 18/215 (8%)
Query: 271 TDEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLERA---FRSFDSECEVLRNVR 326
           +D +    +LG      V+    + D  DVA+KV    L R    +  F  E +    + 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 327 HRNLIKI-----LSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSA 381
           H  ++ +       + + P    +V+E++   +L   +++    +     + ++ D   A
Sbjct: 71  HPAIVAVYDTGEAETPAGP-LPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQA 128
Query: 382 LEYLH-NGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMT-MATI 439
           L + H NG     IIH D+KP NIL+       V DFGI + + +  +SV QT   + T 
Sbjct: 129 LNFSHQNG-----IIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTA 183
Query: 440 GYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
            Y++PE      V A+ DVYS G +L E  T + P
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 91/193 (47%), Gaps = 8/193 (4%)
Query: 280 LGTSSFGSVYKGTISDGT-DVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYS 338
           LG   +G VY+G     +  VA+K    +       F  E  V++ ++H NL+++L   +
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 339 NPDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHC 397
                 ++ EFM  G+L  +L   N   +  +  L +   + SA+EYL   +     IH 
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN----FIHR 135
Query: 398 DLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCD 457
           DL   N L+ EN +  V+DFG+ +L+  G+           I + APE       S K D
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 194
Query: 458 VYSYGVLLMETFT 470
           V+++GVLL E  T
Sbjct: 195 VWAFGVLLWEIAT 207

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 91/193 (47%), Gaps = 8/193 (4%)
Query: 280 LGTSSFGSVYKGTISDGT-DVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYS 338
           LG   +G VY+G     +  VA+K    +       F  E  V++ ++H NL+++L   +
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 339 NPDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHC 397
                 ++ EFM  G+L  +L   N   +  +  L +   + SA+EYL   +     IH 
Sbjct: 78  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN----FIHR 133
Query: 398 DLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCD 457
           DL   N L+ EN +  V+DFG+ +L+  G+           I + APE       S K D
Sbjct: 134 DLAARNCLVGENHLVKVADFGLSRLMT-GDTFTAHAGAKFPIKWTAPESLAYNKFSIKSD 192
Query: 458 VYSYGVLLMETFT 470
           V+++GVLL E  T
Sbjct: 193 VWAFGVLLWEIAT 205

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 103/220 (46%), Gaps = 26/220 (11%)
Query: 272 DEFNECNLLGTSSFGSVYKGTISDGTD-------VAIKVFNLQLERA-FRSFDSECEVLR 323
           D  N    LG  +FG V +   + G D       VA+K+       +  R+  SE ++L 
Sbjct: 27  DRLNLGKPLGRGAFGQVIEAD-AFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILI 85
Query: 324 NVRHR-NLIKILSSYSNPDFKALVL-EFMPNGSLEKWLYS-----------HNYFLDILE 370
           ++ H  N++ +L + + P    +V+ EF   G+L  +L S           +  FL +  
Sbjct: 86  HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEH 145
Query: 371 RLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSV 430
            +     V   +E+L    +S   IH DL   NILL E  V  + DFG+ + + +  D V
Sbjct: 146 LIXYSFQVAKGMEFL----ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYV 201
Query: 431 RQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
           R+      + +MAPE   + + + + DV+S+GVLL E F+
Sbjct: 202 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 97/213 (45%), Gaps = 20/213 (9%)
Query: 273 EFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLER-----AFRSFDSECEVLRNVRH 327
            FNE  ++G   FG VY GT+ D     I      L R         F +E  ++++  H
Sbjct: 25  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 82
Query: 328 RNLIKILS----SYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALE 383
            N++ +L     S  +P    +VL +M +G L  ++ +  +   + + +   + V   ++
Sbjct: 83  PNVLSLLGICLRSEGSP---LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 139
Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMAT--IGY 441
           YL    +S   +H DL   N +LDE     V+DFG+ + + + E       T A   + +
Sbjct: 140 YL----ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 195
Query: 442 MAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
           MA E       + K DV+S+GVLL E  TR  P
Sbjct: 196 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 228

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 100/208 (48%), Gaps = 13/208 (6%)
Query: 280 LGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYS 338
           +G  + G+VY    ++ G +VAI+  NLQ +       +E  V+R  ++ N++  L SY 
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 339 NPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCD 398
             D   +V+E++  GSL   +      +D  +   +  +   ALE+LH    S  +IH D
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH----SNQVIHRD 141
Query: 399 LKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDV 458
           +K  NILL  +    ++DFG    +   E S R  M + T  +MAPE         K D+
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQITP-EQSKRSXM-VGTPYWMAPEVVTRKAYGPKVDI 199
Query: 459 YSYGVLLMETFTRKRPTDEMFIGEMSLR 486
           +S G++ +E    + P    ++ E  LR
Sbjct: 200 WSLGIMAIEMIEGEPP----YLNENPLR 223

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 101/208 (48%), Gaps = 13/208 (6%)
Query: 280 LGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYS 338
           +G  + G+VY    ++ G +VAI+  NLQ +       +E  V+R  ++ N++  L SY 
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 339 NPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCD 398
             D   +V+E++  GSL   +      +D  +   +  +   ALE+LH    S  +IH +
Sbjct: 89  VGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH----SNQVIHRN 142
Query: 399 LKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDV 458
           +K  NILL  +    ++DFG    +   E S R TM + T  +MAPE         K D+
Sbjct: 143 IKSDNILLGMDGSVKLTDFGFCAQITP-EQSKRSTM-VGTPYWMAPEVVTRKAYGPKVDI 200
Query: 459 YSYGVLLMETFTRKRPTDEMFIGEMSLR 486
           +S G++ +E    + P    ++ E  LR
Sbjct: 201 WSLGIMAIEMIEGEPP----YLNENPLR 224

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/199 (32%), Positives = 95/199 (47%), Gaps = 38/199 (19%)
Query: 288 VYKGTISDGTDVAIKVFNL--------QLERAFRSFDSECEVLRNVR-HRNLIKILSSYS 338
           V++ T   G + A+K+  +        QLE    +   E  +LR V  H ++I ++ SY 
Sbjct: 114 VHRAT---GHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE 170
Query: 339 NPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCD 398
           +  F  LV + M  G L  +L +    L   E  +IM  +  A+ +LH  +    I+H D
Sbjct: 171 SSSFMFLVFDLMRKGELFDYL-TEKVALSEKETRSIMRSLLEAVSFLHANN----IVHRD 225
Query: 399 LKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPE------------Y 446
           LKP NILLD+NM   +SDFG    L  GE  +R+     T GY+APE            Y
Sbjct: 226 LKPENILLDDNMQIRLSDFGFSCHLEPGE-KLRE--LCGTPGYLAPEILKCSMDETHPGY 282
Query: 447 GLEGIVSAKCDVYSYGVLL 465
           G E       D+++ GV+L
Sbjct: 283 GKE------VDLWACGVIL 295

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 103/214 (48%), Gaps = 10/214 (4%)
Query: 267 IQRATDEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQ-LERA--FRSFDSECEVL 322
           I    ++F   NLLG  SF  VY+  +I  G +VAIK+ + + + +A   +   +E ++ 
Sbjct: 6   IGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIH 65
Query: 323 RNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSAL 382
             ++H +++++ + + + ++  LVLE   NG + ++L +        E  + M  + + +
Sbjct: 66  CQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGM 125
Query: 383 EYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYM 442
            YLH    S  I+H DL  +N+LL  NM   ++DFG+   L    +  +      T  Y+
Sbjct: 126 LYLH----SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE--KHYTLCGTPNYI 179
Query: 443 APEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTD 476
           +PE         + DV+S G +       + P D
Sbjct: 180 SPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFD 213

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 100/208 (48%), Gaps = 13/208 (6%)
Query: 280 LGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYS 338
           +G  + G+VY    ++ G +VAI+  NLQ +       +E  V+R  ++ N++  L SY 
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 339 NPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCD 398
             D   +V+E++  GSL   +      +D  +   +  +   ALE+LH    S  +IH D
Sbjct: 89  VGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH----SNQVIHRD 142
Query: 399 LKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDV 458
           +K  NILL  +    ++DFG    +   E S R  M + T  +MAPE         K D+
Sbjct: 143 IKSDNILLGMDGSVKLTDFGFCAQITP-EQSKRSXM-VGTPYWMAPEVVTRKAYGPKVDI 200
Query: 459 YSYGVLLMETFTRKRPTDEMFIGEMSLR 486
           +S G++ +E    + P    ++ E  LR
Sbjct: 201 WSLGIMAIEMIEGEPP----YLNENPLR 224

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 97/213 (45%), Gaps = 20/213 (9%)
Query: 273 EFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLER-----AFRSFDSECEVLRNVRH 327
            FNE  ++G   FG VY GT+ D     I      L R         F +E  ++++  H
Sbjct: 52  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 109
Query: 328 RNLIKILS----SYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALE 383
            N++ +L     S  +P    +VL +M +G L  ++ +  +   + + +   + V   ++
Sbjct: 110 PNVLSLLGICLRSEGSP---LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 166
Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMAT--IGY 441
           YL    +S   +H DL   N +LDE     V+DFG+ + + + E       T A   + +
Sbjct: 167 YL----ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 222
Query: 442 MAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
           MA E       + K DV+S+GVLL E  TR  P
Sbjct: 223 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 255

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 97/213 (45%), Gaps = 20/213 (9%)
Query: 273 EFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLER-----AFRSFDSECEVLRNVRH 327
            FNE  ++G   FG VY GT+ D     I      L R         F +E  ++++  H
Sbjct: 33  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 90
Query: 328 RNLIKILS----SYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALE 383
            N++ +L     S  +P    +VL +M +G L  ++ +  +   + + +   + V   ++
Sbjct: 91  PNVLSLLGICLRSEGSP---LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 147
Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMAT--IGY 441
           YL    +S   +H DL   N +LDE     V+DFG+ + + + E       T A   + +
Sbjct: 148 YL----ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 203
Query: 442 MAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
           MA E       + K DV+S+GVLL E  TR  P
Sbjct: 204 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 97/213 (45%), Gaps = 20/213 (9%)
Query: 273 EFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLER-----AFRSFDSECEVLRNVRH 327
            FNE  ++G   FG VY GT+ D     I      L R         F +E  ++++  H
Sbjct: 51  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 108
Query: 328 RNLIKILS----SYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALE 383
            N++ +L     S  +P    +VL +M +G L  ++ +  +   + + +   + V   ++
Sbjct: 109 PNVLSLLGICLRSEGSP---LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 165
Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMAT--IGY 441
           YL    +S   +H DL   N +LDE     V+DFG+ + + + E       T A   + +
Sbjct: 166 YL----ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 221
Query: 442 MAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
           MA E       + K DV+S+GVLL E  TR  P
Sbjct: 222 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 254

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 95/207 (45%), Gaps = 17/207 (8%)
Query: 278 NLLGTSSFGSVYKGTISDGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSS 336
            +LG   FG   K T  +  +V +    ++  E   R+F  E +V+R + H N++K +  
Sbjct: 16  EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 337 YSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIH 396
                    + E++  G+L   + S +      +R++   D+ S + YLH    S++IIH
Sbjct: 76  LYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH----SMNIIH 131
Query: 397 CDLKPTNILLDENMVAHVSDFGIYKLL------GEG------EDSVRQTMTMATIGYMAP 444
            DL   N L+ EN    V+DFG+ +L+       EG       D  ++   +    +MAP
Sbjct: 132 RDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP 191
Query: 445 EYGLEGIVSAKCDVYSYGVLLMETFTR 471
           E         K DV+S+G++L E   R
Sbjct: 192 EMINGRSYDEKVDVFSFGIVLCEIIGR 218

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 100/208 (48%), Gaps = 13/208 (6%)
Query: 280 LGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYS 338
           +G  + G+VY    ++ G +VAI+  NLQ +       +E  V+R  ++ N++  L SY 
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 339 NPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCD 398
             D   +V+E++  GSL   +      +D  +   +  +   ALE+LH    S  +IH D
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH----SNQVIHRD 141
Query: 399 LKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDV 458
           +K  NILL  +    ++DFG    +   E S R  M + T  +MAPE         K D+
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQITP-EQSKRSEM-VGTPYWMAPEVVTRKAYGPKVDI 199
Query: 459 YSYGVLLMETFTRKRPTDEMFIGEMSLR 486
           +S G++ +E    + P    ++ E  LR
Sbjct: 200 WSLGIMAIEMIEGEPP----YLNENPLR 223

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 95/201 (47%), Gaps = 17/201 (8%)
Query: 280 LGTSSFGSV----YKGTISDGTD--VAIKVFNLQLERAFRS-FDSECEVLRNVRHRNLIK 332
           LG   FG V    Y  T +DGT   VA+K          RS +  E E+LR + H +++K
Sbjct: 16  LGEGHFGKVSLYCYDPT-NDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVK 74
Query: 333 ILSSYSNPDFKA--LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHS 390
                 +   K+  LV+E++P GSL  +L  H   + + + L     +   + YLH    
Sbjct: 75  YKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHC--VGLAQLLLFAQQICEGMAYLH---- 128
Query: 391 SVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVR-QTMTMATIGYMAPEYGLE 449
           + H IH  L   N+LLD + +  + DFG+ K + EG +  R +    + + + APE   E
Sbjct: 129 AQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKE 188
Query: 450 GIVSAKCDVYSYGVLLMETFT 470
                  DV+S+GV L E  T
Sbjct: 189 CKFYYASDVWSFGVTLYELLT 209

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 95/201 (47%), Gaps = 17/201 (8%)
Query: 280 LGTSSFGSV----YKGTISDGTD--VAIKVFNLQLERAFRS-FDSECEVLRNVRHRNLIK 332
           LG   FG V    Y  T +DGT   VA+K          RS +  E E+LR + H +++K
Sbjct: 17  LGEGHFGKVSLYCYDPT-NDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVK 75
Query: 333 ILSSYSNPDFKA--LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHS 390
                 +   K+  LV+E++P GSL  +L  H   + + + L     +   + YLH    
Sbjct: 76  YKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHC--VGLAQLLLFAQQICEGMAYLH---- 129
Query: 391 SVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVR-QTMTMATIGYMAPEYGLE 449
           + H IH  L   N+LLD + +  + DFG+ K + EG +  R +    + + + APE   E
Sbjct: 130 AQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKE 189
Query: 450 GIVSAKCDVYSYGVLLMETFT 470
                  DV+S+GV L E  T
Sbjct: 190 CKFYYASDVWSFGVTLYELLT 210

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 97/213 (45%), Gaps = 20/213 (9%)
Query: 273 EFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLER-----AFRSFDSECEVLRNVRH 327
            FNE  ++G   FG VY GT+ D     I      L R         F +E  ++++  H
Sbjct: 30  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 328 RNLIKILS----SYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALE 383
            N++ +L     S  +P    +VL +M +G L  ++ +  +   + + +   + V   ++
Sbjct: 88  PNVLSLLGICLRSEGSP---LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 144
Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMAT--IGY 441
           YL    +S   +H DL   N +LDE     V+DFG+ + + + E       T A   + +
Sbjct: 145 YL----ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 200
Query: 442 MAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
           MA E       + K DV+S+GVLL E  TR  P
Sbjct: 201 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 233

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 97/215 (45%), Gaps = 18/215 (8%)
Query: 271 TDEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLERA---FRSFDSECEVLRNVR 326
           +D +    +LG      V+    + D  DVA+KV    L R    +  F  E +    + 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 327 HRNLIKI-----LSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSA 381
           H  ++ +       + + P    +V+E++   +L   +++    +     + ++ D   A
Sbjct: 71  HPAIVAVYDTGEAETPAGP-LPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQA 128
Query: 382 LEYLH-NGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMT-MATI 439
           L + H NG     IIH D+KP NI++       V DFGI + + +  +SV QT   + T 
Sbjct: 129 LNFSHQNG-----IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 440 GYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
            Y++PE      V A+ DVYS G +L E  T + P
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 104/216 (48%), Gaps = 29/216 (13%)
Query: 280 LGTSSFGSVY--------KGTISDGTDVAIKVFNLQL-ERAFRSFDSECEVLRNV-RHRN 329
           LG  +FG V         K   +  T VA+K+      E+      SE E+++ + +H+N
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 330 LIKILSSYSNPDFKALVLEFMPNGSLEKWL---------YSHNYFLDILERLN------I 374
           +I +L + +      +++E+   G+L ++L         YS+N   +  E+L+       
Sbjct: 85  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 144
Query: 375 MIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTM 434
              V   +EYL    +S   IH DL   N+L+ E+ V  ++DFG+ + +   +   + T 
Sbjct: 145 AYQVARGMEYL----ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 200
Query: 435 TMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
               + +MAPE   + I + + DV+S+GVLL E FT
Sbjct: 201 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 236

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 97/213 (45%), Gaps = 20/213 (9%)
Query: 273 EFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLER-----AFRSFDSECEVLRNVRH 327
            FNE  ++G   FG VY GT+ D     I      L R         F +E  ++++  H
Sbjct: 31  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 88
Query: 328 RNLIKILS----SYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALE 383
            N++ +L     S  +P    +VL +M +G L  ++ +  +   + + +   + V   ++
Sbjct: 89  PNVLSLLGICLRSEGSP---LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 145
Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMAT--IGY 441
           YL    +S   +H DL   N +LDE     V+DFG+ + + + E       T A   + +
Sbjct: 146 YL----ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 201
Query: 442 MAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
           MA E       + K DV+S+GVLL E  TR  P
Sbjct: 202 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 104/216 (48%), Gaps = 29/216 (13%)
Query: 280 LGTSSFGSVY--------KGTISDGTDVAIKVFNLQL-ERAFRSFDSECEVLRNV-RHRN 329
           LG  +FG V         K   +  T VA+K+      E+      SE E+++ + +H+N
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 330 LIKILSSYSNPDFKALVLEFMPNGSLEKWL---------YSHNYFLDILERLN------I 374
           +I +L + +      +++E+   G+L ++L         YS+N   +  E+L+       
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 147
Query: 375 MIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTM 434
              V   +EYL    +S   IH DL   N+L+ E+ V  ++DFG+ + +   +   + T 
Sbjct: 148 AYQVARGMEYL----ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 203
Query: 435 TMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
               + +MAPE   + I + + DV+S+GVLL E FT
Sbjct: 204 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 239

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 106/213 (49%), Gaps = 21/213 (9%)
Query: 259 WRRTSYLDIQRATDEFNECNLLGTSSFGSVY-KGTISDGTDVAIK-VFNLQLERAFRSFD 316
           W++ +  DI++   EF E   LGT +F  V      + G   A+K +    L+    S +
Sbjct: 13  WKKQAE-DIKKIF-EFKET--LGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIE 68
Query: 317 SECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMI 376
           +E  VLR ++H N++ +   Y +P+   LV++ +  G L   +    ++ +  +   ++ 
Sbjct: 69  NEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTE-KDASTLIR 127
Query: 377 DVGSALEYLHNGHSSVHIIHCDLKPTNILL---DENMVAHVSDFGIYKLLGEGEDSVRQT 433
            V  A+ YLH     + I+H DLKP N+L    DE     +SDFG+ K+ G+G+      
Sbjct: 128 QVLDAVYYLHR----MGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGD-----V 178
Query: 434 MTMA--TIGYMAPEYGLEGIVSAKCDVYSYGVL 464
           M+ A  T GY+APE   +   S   D +S GV+
Sbjct: 179 MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 211

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 97/215 (45%), Gaps = 18/215 (8%)
Query: 271 TDEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLERA---FRSFDSECEVLRNVR 326
           +D +    +LG      V+    + D  DVA+KV    L R    +  F  E +    + 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 327 HRNLIKI-----LSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSA 381
           H  ++ +       + + P    +V+E++   +L   +++    +     + ++ D   A
Sbjct: 71  HPAIVAVYDTGEAETPAGP-LPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQA 128
Query: 382 LEYLH-NGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMT-MATI 439
           L + H NG     IIH D+KP NI++       V DFGI + + +  +SV QT   + T 
Sbjct: 129 LNFSHQNG-----IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 440 GYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
            Y++PE      V A+ DVYS G +L E  T + P
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 97/213 (45%), Gaps = 20/213 (9%)
Query: 273 EFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLER-----AFRSFDSECEVLRNVRH 327
            FNE  ++G   FG VY GT+ D     I      L R         F +E  ++++  H
Sbjct: 28  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 85
Query: 328 RNLIKILS----SYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALE 383
            N++ +L     S  +P    +VL +M +G L  ++ +  +   + + +   + V   ++
Sbjct: 86  PNVLSLLGICLRSEGSP---LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 142
Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMAT--IGY 441
           YL    +S   +H DL   N +LDE     V+DFG+ + + + E       T A   + +
Sbjct: 143 YL----ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 198
Query: 442 MAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
           MA E       + K DV+S+GVLL E  TR  P
Sbjct: 199 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 231

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 104/216 (48%), Gaps = 29/216 (13%)
Query: 280 LGTSSFGSVY--------KGTISDGTDVAIKVFNLQL-ERAFRSFDSECEVLRNV-RHRN 329
           LG  +FG V         K   +  T VA+K+      E+      SE E+++ + +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 330 LIKILSSYSNPDFKALVLEFMPNGSLEKWL---------YSHNYFLDILERLN------I 374
           +I +L + +      +++E+   G+L ++L         YS+N   +  E+L+       
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 375 MIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTM 434
              V   +EYL    +S   IH DL   N+L+ E+ V  ++DFG+ + +   +   + T 
Sbjct: 156 AYQVARGMEYL----ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 211
Query: 435 TMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
               + +MAPE   + I + + DV+S+GVLL E FT
Sbjct: 212 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 99/203 (48%), Gaps = 18/203 (8%)
Query: 271 TDEFNECNLLGTSSFGSVY--KGTISDGTDVAIKVFNLQLERAFRSFDS---ECEVLRNV 325
           +D +    +LG  SFG V   K  I+ G + A+KV + +  +     +S   E ++L+ +
Sbjct: 31  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 89
Query: 326 RHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYL 385
            H N++K+   + +  +  LV E    G L   + S   F ++ +   I+  V S + Y+
Sbjct: 90  DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-DAARIIRQVLSGITYM 148
Query: 386 HNGHSSVHIIHCDLKPTNILLD---ENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYM 442
           H       I+H DLKP N+LL+   ++    + DFG   L    E S +    + T  Y+
Sbjct: 149 HKNK----IVHRDLKPENLLLESKSKDANIRIIDFG---LSTHFEASKKMKDKIGTAYYI 201
Query: 443 APEYGLEGIVSAKCDVYSYGVLL 465
           APE  L G    KCDV+S GV+L
Sbjct: 202 APEV-LHGTYDEKCDVWSTGVIL 223

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 97/213 (45%), Gaps = 20/213 (9%)
Query: 273 EFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLER-----AFRSFDSECEVLRNVRH 327
            FNE  ++G   FG VY GT+ D     I      L R         F +E  ++++  H
Sbjct: 32  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 89
Query: 328 RNLIKILS----SYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALE 383
            N++ +L     S  +P    +VL +M +G L  ++ +  +   + + +   + V   ++
Sbjct: 90  PNVLSLLGICLRSEGSP---LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 146
Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMAT--IGY 441
           YL    +S   +H DL   N +LDE     V+DFG+ + + + E       T A   + +
Sbjct: 147 YL----ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 202
Query: 442 MAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
           MA E       + K DV+S+GVLL E  TR  P
Sbjct: 203 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 103/223 (46%), Gaps = 29/223 (13%)
Query: 272 DEFNECNLLGTSSFGSVYKGTISDGTD-------VAIKVFNLQLERA-FRSFDSECEVLR 323
           D  N    LG  +FG V +   + G D       VA+K+       +  R+  SE ++L 
Sbjct: 28  DRLNLGKPLGRGAFGQVIEAD-AFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILI 86
Query: 324 NVRHR-NLIKILSSYSNPDFKALVL-EFMPNGSLEKWLYS--------------HNYFLD 367
           ++ H  N++ +L + + P    +V+ EF   G+L  +L S              +  FL 
Sbjct: 87  HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLT 146
Query: 368 ILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGE 427
           +   +     V   +E+L    +S   IH DL   NILL E  V  + DFG+ + + +  
Sbjct: 147 LEHLICYSFQVAKGMEFL----ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDP 202
Query: 428 DSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
           D VR+      + +MAPE   + + + + DV+S+GVLL E F+
Sbjct: 203 DXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 103/220 (46%), Gaps = 26/220 (11%)
Query: 272 DEFNECNLLGTSSFGSVYKGTISDGTD-------VAIKVFNLQLERA-FRSFDSECEVLR 323
           D  N    LG  +FG V +   + G D       VA+K+       +  R+  SE ++L 
Sbjct: 27  DRLNLGKPLGRGAFGQVIEAD-AFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILI 85
Query: 324 NVRHR-NLIKILSSYSNPDFKALVL-EFMPNGSLEKWLYS-----------HNYFLDILE 370
           ++ H  N++ +L + + P    +V+ EF   G+L  +L S           +  FL +  
Sbjct: 86  HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEH 145
Query: 371 RLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSV 430
            +     V   +E+L    +S   IH DL   NILL E  V  + DFG+ + + +  D V
Sbjct: 146 LICYSFQVAKGMEFL----ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 201
Query: 431 RQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
           R+      + +MAPE   + + + + DV+S+GVLL E F+
Sbjct: 202 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 104/216 (48%), Gaps = 29/216 (13%)
Query: 280 LGTSSFGSVY--------KGTISDGTDVAIKVFNLQL-ERAFRSFDSECEVLRNV-RHRN 329
           LG  +FG V         K   +  T VA+K+      E+      SE E+++ + +H+N
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 330 LIKILSSYSNPDFKALVLEFMPNGSLEKWL---------YSHNYFLDILERLN------I 374
           +I +L + +      +++E+   G+L ++L         YS+N   +  E+L+       
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 148
Query: 375 MIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTM 434
              V   +EYL    +S   IH DL   N+L+ E+ V  ++DFG+ + +   +   + T 
Sbjct: 149 AYQVARGMEYL----ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 204
Query: 435 TMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
               + +MAPE   + I + + DV+S+GVLL E FT
Sbjct: 205 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 102/211 (48%), Gaps = 17/211 (8%)
Query: 272 DEFNECNLLGTSSFGSVYKGTISDGTDV-AIKVFNLQ--LER-AFRSFDSECEVLRNVRH 327
           D F     +G  SFG V     +D   + A+K  N Q  +ER   R+   E ++++ + H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
             L+ +  S+ + +   +V++ +  G L   L  + +F +   +L  + ++  AL+YL N
Sbjct: 75  PFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKL-FICELVMALDYLQN 133
Query: 388 GHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMA-TIGYMAPEY 446
                 IIH D+KP NILLDE+   H++DF I  +L        Q  TMA T  YMAPE 
Sbjct: 134 QR----IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE----TQITTMAGTKPYMAPEM 185
Query: 447 --GLEGI-VSAKCDVYSYGVLLMETFTRKRP 474
               +G   S   D +S GV   E    +RP
Sbjct: 186 FSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 97/213 (45%), Gaps = 20/213 (9%)
Query: 273 EFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLER-----AFRSFDSECEVLRNVRH 327
            FNE  ++G   FG VY GT+ D     I      L R         F +E  ++++  H
Sbjct: 33  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 90
Query: 328 RNLIKILS----SYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALE 383
            N++ +L     S  +P    +VL +M +G L  ++ +  +   + + +   + V   ++
Sbjct: 91  PNVLSLLGICLRSEGSP---LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 147
Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMAT--IGY 441
           YL    +S   +H DL   N +LDE     V+DFG+ + + + E       T A   + +
Sbjct: 148 YL----ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 203
Query: 442 MAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
           MA E       + K DV+S+GVLL E  TR  P
Sbjct: 204 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 18/203 (8%)
Query: 271 TDEFNECNLLGTSSFGSVY--KGTISDGTDVAIKVFNLQLERAFRSFDS---ECEVLRNV 325
           +D +    +LG  SFG V   K  I+ G + A+KV + +  +     +S   E ++L+ +
Sbjct: 48  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 106
Query: 326 RHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYL 385
            H N++K+   + +  +  LV E    G L   + S   F ++ +   I+  V S + Y+
Sbjct: 107 DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-DAARIIRQVLSGITYM 165
Query: 386 HNGHSSVHIIHCDLKPTNILLD---ENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYM 442
           H       I+H DLKP N+LL+   ++    + DFG+       E S +    + T  Y+
Sbjct: 166 HKNK----IVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKKMKDKIGTAYYI 218
Query: 443 APEYGLEGIVSAKCDVYSYGVLL 465
           APE  L G    KCDV+S GV+L
Sbjct: 219 APEV-LHGTYDEKCDVWSTGVIL 240

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 18/203 (8%)
Query: 271 TDEFNECNLLGTSSFGSVY--KGTISDGTDVAIKVFNLQLERAFRSFDS---ECEVLRNV 325
           +D +    +LG  SFG V   K  I+ G + A+KV + +  +     +S   E ++L+ +
Sbjct: 49  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 107
Query: 326 RHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYL 385
            H N++K+   + +  +  LV E    G L   + S   F ++ +   I+  V S + Y+
Sbjct: 108 DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-DAARIIRQVLSGITYM 166
Query: 386 HNGHSSVHIIHCDLKPTNILLD---ENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYM 442
           H       I+H DLKP N+LL+   ++    + DFG+       E S +    + T  Y+
Sbjct: 167 HKNK----IVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKKMKDKIGTAYYI 219
Query: 443 APEYGLEGIVSAKCDVYSYGVLL 465
           APE  L G    KCDV+S GV+L
Sbjct: 220 APEV-LHGTYDEKCDVWSTGVIL 241

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 104/216 (48%), Gaps = 29/216 (13%)
Query: 280 LGTSSFGSVY--------KGTISDGTDVAIKVFNLQL-ERAFRSFDSECEVLRNV-RHRN 329
           LG  +FG V         K   +  T VA+K+      E+      SE E+++ + +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 330 LIKILSSYSNPDFKALVLEFMPNGSLEKWL---------YSHNYFLDILERLN------I 374
           +I +L + +      +++E+   G+L ++L         YS+N   +  E+L+       
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 375 MIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTM 434
              V   +EYL    +S   IH DL   N+L+ E+ V  ++DFG+ + +   +   + T 
Sbjct: 156 AYQVARGMEYL----ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 211
Query: 435 TMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
               + +MAPE   + I + + DV+S+GVLL E FT
Sbjct: 212 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 104/216 (48%), Gaps = 29/216 (13%)
Query: 280 LGTSSFGSVY--------KGTISDGTDVAIKVFNLQL-ERAFRSFDSECEVLRNV-RHRN 329
           LG  +FG V         K   +  T VA+K+      E+      SE E+++ + +H+N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 330 LIKILSSYSNPDFKALVLEFMPNGSLEKWL---------YSHNYFLDILERLN------I 374
           +I +L + +      +++E+   G+L ++L         YS+N   +  E+L+       
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 375 MIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTM 434
              V   +EYL    +S   IH DL   N+L+ E+ V  ++DFG+ + +   +   + T 
Sbjct: 197 AYQVARGMEYL----ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 252
Query: 435 TMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
               + +MAPE   + I + + DV+S+GVLL E FT
Sbjct: 253 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 18/203 (8%)
Query: 271 TDEFNECNLLGTSSFGSVY--KGTISDGTDVAIKVFNLQLERAFRSFDS---ECEVLRNV 325
           +D +    +LG  SFG V   K  I+ G + A+KV + +  +     +S   E ++L+ +
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 83
Query: 326 RHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYL 385
            H N++K+   + +  +  LV E    G L   + S   F ++ +   I+  V S + Y+
Sbjct: 84  DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-DAARIIRQVLSGITYM 142
Query: 386 HNGHSSVHIIHCDLKPTNILLD---ENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYM 442
           H       I+H DLKP N+LL+   ++    + DFG+       E S +    + T  Y+
Sbjct: 143 HKNK----IVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKKMKDKIGTAYYI 195
Query: 443 APEYGLEGIVSAKCDVYSYGVLL 465
           APE  L G    KCDV+S GV+L
Sbjct: 196 APEV-LHGTYDEKCDVWSTGVIL 217

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 86/201 (42%), Gaps = 17/201 (8%)
Query: 280 LGTSSFGSVYKGTIS--DGTDVAIKVFNLQLE-----RAFRSFDSECEVLRNVRHRNLIK 332
           LG  SFG V +G      G  V++ V  L+ +      A   F  E   + ++ HRNLI+
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWLYSH--NYFLDILERLNIMIDVGSALEYLHNGHS 390
           +      P  K +V E  P GSL   L  H  ++ L  L R    + V   + YL     
Sbjct: 86  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYL----E 138
Query: 391 SVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGED-SVRQTMTMATIGYMAPEYGLE 449
           S   IH DL   N+LL    +  + DFG+ + L + +D  V Q        + APE    
Sbjct: 139 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKT 198
Query: 450 GIVSAKCDVYSYGVLLMETFT 470
              S   D + +GV L E FT
Sbjct: 199 RTFSHASDTWMFGVTLWEMFT 219

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 92/193 (47%), Gaps = 8/193 (4%)
Query: 280 LGTSSFGSVYKGTISDGT-DVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYS 338
           LG   +G VY+G     +  VA+K    +       F  E  V++ ++H NL+++L   +
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 325
Query: 339 NPDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHC 397
                 ++ EFM  G+L  +L   N   ++ +  L +   + SA+EYL       + IH 
Sbjct: 326 REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL----EKKNFIHR 381
Query: 398 DLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCD 457
           +L   N L+ EN +  V+DFG+ +L+  G+           I + APE       S K D
Sbjct: 382 NLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 440
Query: 458 VYSYGVLLMETFT 470
           V+++GVLL E  T
Sbjct: 441 VWAFGVLLWEIAT 453

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 101/210 (48%), Gaps = 17/210 (8%)
Query: 273 EFNECNLLGTSSFGSVYKGTISDGTDV----AIKVFN---LQLERAFRSFDSECEVLRNV 325
           +F    +LG  SFG V+      G+D     A+KV     L++    R+   E ++L  V
Sbjct: 26  QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT-KMERDILVEV 84
Query: 326 RHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYL 385
            H  ++K+  ++       L+L+F+  G L   L     F +   +   + ++  AL++L
Sbjct: 85  NHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKF-YLAELALALDHL 143
Query: 386 HNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTM-ATIGYMAP 444
           H    S+ II+ DLKP NILLDE     ++DFG+ K   E  D  ++  +   T+ YMAP
Sbjct: 144 H----SLGIIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCGTVEYMAP 196
Query: 445 EYGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
           E       +   D +S+GVL+ E  T   P
Sbjct: 197 EVVNRRGHTQSADWWSFGVLMFEMLTGTLP 226

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 101/210 (48%), Gaps = 17/210 (8%)
Query: 273 EFNECNLLGTSSFGSVYKGTISDGTDV----AIKVFN---LQLERAFRSFDSECEVLRNV 325
           +F    +LG  SFG V+      G+D     A+KV     L++    R+   E ++L  V
Sbjct: 25  QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT-KMERDILVEV 83
Query: 326 RHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYL 385
            H  ++K+  ++       L+L+F+  G L   L     F +   +   + ++  AL++L
Sbjct: 84  NHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKF-YLAELALALDHL 142
Query: 386 HNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTM-ATIGYMAP 444
           H    S+ II+ DLKP NILLDE     ++DFG+ K   E  D  ++  +   T+ YMAP
Sbjct: 143 H----SLGIIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCGTVEYMAP 195
Query: 445 EYGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
           E       +   D +S+GVL+ E  T   P
Sbjct: 196 EVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 86/201 (42%), Gaps = 17/201 (8%)
Query: 280 LGTSSFGSVYKGTIS--DGTDVAIKVFNLQLE-----RAFRSFDSECEVLRNVRHRNLIK 332
           LG  SFG V +G      G  V++ V  L+ +      A   F  E   + ++ HRNLI+
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWLYSH--NYFLDILERLNIMIDVGSALEYLHNGHS 390
           +      P  K +V E  P GSL   L  H  ++ L  L R    + V   + YL     
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYL----E 128
Query: 391 SVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGED-SVRQTMTMATIGYMAPEYGLE 449
           S   IH DL   N+LL    +  + DFG+ + L + +D  V Q        + APE    
Sbjct: 129 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKT 188
Query: 450 GIVSAKCDVYSYGVLLMETFT 470
              S   D + +GV L E FT
Sbjct: 189 RTFSHASDTWMFGVTLWEMFT 209

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 99/213 (46%), Gaps = 26/213 (12%)
Query: 280 LGTSSFGSVYKG------TISDGTDVAIKVFNLQLERA-FRSFDSECEVLRNVRHR-NLI 331
           LG  +FG V +         +    VA+K+       +  R+  SE ++L ++ H  N++
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 332 KILSSYSNPDFKALVL-EFMPNGSLEKWLYS-------------HNYFLDILERLNIMID 377
            +L + + P    +V+ EF   G+L  +L S             +  FL +   +     
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQ 156
Query: 378 VGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMA 437
           V   +E+L    +S   IH DL   NILL E  V  + DFG+ + + +  D VR+     
Sbjct: 157 VAKGMEFL----ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 212
Query: 438 TIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
            + +MAPE   + + + + DV+S+GVLL E F+
Sbjct: 213 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 103/220 (46%), Gaps = 21/220 (9%)
Query: 255 PLAIWRRTSYLDIQRATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRS 314
           P   W + ++ +I R + +  +   LG   FG V+  T +  T VA+K        +  +
Sbjct: 168 PQKPWEKDAW-EIPRESLKLEKK--LGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEA 223
Query: 315 FDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERL-N 373
           F +E  V++ ++H  L+K+ +  +      ++ EFM  GSL  +L S       L +L +
Sbjct: 224 FLAEANVMKTLQHDKLVKLHAVVTKEPI-YIITEFMAKGSLLDFLKSDEGSKQPLPKLID 282
Query: 374 IMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQT 433
               +   + ++   +     IH DL+  NIL+  ++V  ++DFG+ ++  +        
Sbjct: 283 FSAQIAEGMAFIEQRN----YIHRDLRAANILVSASLVCKIADFGLARVGAK-------- 330
Query: 434 MTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKR 473
                I + APE    G  + K DV+S+G+LLME  T  R
Sbjct: 331 ---FPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGR 367

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 86/201 (42%), Gaps = 17/201 (8%)
Query: 280 LGTSSFGSVYKGTIS--DGTDVAIKVFNLQLE-----RAFRSFDSECEVLRNVRHRNLIK 332
           LG  SFG V +G      G  V++ V  L+ +      A   F  E   + ++ HRNLI+
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWLYSH--NYFLDILERLNIMIDVGSALEYLHNGHS 390
           +      P  K +V E  P GSL   L  H  ++ L  L R    + V   + YL     
Sbjct: 80  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYL----E 132
Query: 391 SVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDS-VRQTMTMATIGYMAPEYGLE 449
           S   IH DL   N+LL    +  + DFG+ + L + +D  V Q        + APE    
Sbjct: 133 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 192
Query: 450 GIVSAKCDVYSYGVLLMETFT 470
              S   D + +GV L E FT
Sbjct: 193 RTFSHASDTWMFGVTLWEMFT 213

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 86/201 (42%), Gaps = 17/201 (8%)
Query: 280 LGTSSFGSVYKGTIS--DGTDVAIKVFNLQLE-----RAFRSFDSECEVLRNVRHRNLIK 332
           LG  SFG V +G      G  V++ V  L+ +      A   F  E   + ++ HRNLI+
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWLYSH--NYFLDILERLNIMIDVGSALEYLHNGHS 390
           +      P  K +V E  P GSL   L  H  ++ L  L R    + V   + YL     
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYL----E 128
Query: 391 SVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDS-VRQTMTMATIGYMAPEYGLE 449
           S   IH DL   N+LL    +  + DFG+ + L + +D  V Q        + APE    
Sbjct: 129 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 450 GIVSAKCDVYSYGVLLMETFT 470
              S   D + +GV L E FT
Sbjct: 189 RTFSHASDTWMFGVTLWEMFT 209

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 102/216 (47%), Gaps = 29/216 (13%)
Query: 280 LGTSSFGSVY--------KGTISDGTDVAIKVFNLQL-ERAFRSFDSECEVLRNV-RHRN 329
           LG  +FG V         K   +  T VA+K+      E+      SE E+++ + +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 330 LIKILSSYSNPDFKALVLEFMPNGSLEKWLY-------------SHN--YFLDILERLNI 374
           +I +L + +      +++E+   G+L ++L              SHN    L   + ++ 
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 375 MIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTM 434
              V   +EYL    +S   IH DL   N+L+ E+ V  ++DFG+ + +   +   + T 
Sbjct: 156 AYQVARGMEYL----ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTN 211
Query: 435 TMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
               + +MAPE   + I + + DV+S+GVLL E FT
Sbjct: 212 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 102/216 (47%), Gaps = 29/216 (13%)
Query: 280 LGTSSFGSVY--------KGTISDGTDVAIKVF-NLQLERAFRSFDSECEVLRNV-RHRN 329
           LG  +FG V         K    +   VA+K+  +   E+      SE E+++ + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 330 LIKILSSYSNPDFKALVLEFMPNGSLEKWLYSH-----NYFLDI----------LERLNI 374
           +I +L + +      +++E+   G+L ++L +       Y  DI           + ++ 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 375 MIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTM 434
              +   +EYL    +S   IH DL   N+L+ EN V  ++DFG+ + +   +   + T 
Sbjct: 163 TYQLARGMEYL----ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTN 218
Query: 435 TMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
               + +MAPE   + + + + DV+S+GVL+ E FT
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 86/201 (42%), Gaps = 17/201 (8%)
Query: 280 LGTSSFGSVYKGTIS--DGTDVAIKVFNLQLE-----RAFRSFDSECEVLRNVRHRNLIK 332
           LG  SFG V +G      G  V++ V  L+ +      A   F  E   + ++ HRNLI+
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWLYSH--NYFLDILERLNIMIDVGSALEYLHNGHS 390
           +      P  K +V E  P GSL   L  H  ++ L  L R    + V   + YL     
Sbjct: 86  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYL----E 138
Query: 391 SVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDS-VRQTMTMATIGYMAPEYGLE 449
           S   IH DL   N+LL    +  + DFG+ + L + +D  V Q        + APE    
Sbjct: 139 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 198
Query: 450 GIVSAKCDVYSYGVLLMETFT 470
              S   D + +GV L E FT
Sbjct: 199 RTFSHASDTWMFGVTLWEMFT 219

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 101/209 (48%), Gaps = 17/209 (8%)
Query: 274 FNECNLLGTSSFGSVY---KGTISD-GTDVAIKVFN---LQLERAFRSFDSECEVLRNVR 326
           F    +LG  SFG V+   K T  D G   A+KV     L++    R+   E ++L +V 
Sbjct: 30  FELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRT-KMERDILADVN 88
Query: 327 HRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH 386
           H  ++K+  ++       L+L+F+  G L   L     F +   +   + ++   L++LH
Sbjct: 89  HPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKF-YLAELALGLDHLH 147
Query: 387 NGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTM-ATIGYMAPE 445
               S+ II+ DLKP NILLDE     ++DFG+ K   E  D  ++  +   T+ YMAPE
Sbjct: 148 ----SLGIIYRDLKPENILLDEEGHIKLTDFGLSK---EAIDHEKKAYSFCGTVEYMAPE 200
Query: 446 YGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
                  S   D +SYGVL+ E  T   P
Sbjct: 201 VVNRQGHSHSADWWSYGVLMFEMLTGSLP 229

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 86/201 (42%), Gaps = 17/201 (8%)
Query: 280 LGTSSFGSVYKGTIS--DGTDVAIKVFNLQLE-----RAFRSFDSECEVLRNVRHRNLIK 332
           LG  SFG V +G      G  V++ V  L+ +      A   F  E   + ++ HRNLI+
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWLYSH--NYFLDILERLNIMIDVGSALEYLHNGHS 390
           +      P  K +V E  P GSL   L  H  ++ L  L R    + V   + YL     
Sbjct: 80  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYL----E 132
Query: 391 SVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDS-VRQTMTMATIGYMAPEYGLE 449
           S   IH DL   N+LL    +  + DFG+ + L + +D  V Q        + APE    
Sbjct: 133 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 192
Query: 450 GIVSAKCDVYSYGVLLMETFT 470
              S   D + +GV L E FT
Sbjct: 193 RTFSHASDTWMFGVTLWEMFT 213

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 101/210 (48%), Gaps = 17/210 (8%)
Query: 273 EFNECNLLGTSSFGSVYKGTISDGTDV----AIKVFN---LQLERAFRSFDSECEVLRNV 325
           +F    +LG  SFG V+      G+D     A+KV     L++    R+   E ++L  V
Sbjct: 25  QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT-KMERDILVEV 83
Query: 326 RHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYL 385
            H  ++K+  ++       L+L+F+  G L   L     F +   +   + ++  AL++L
Sbjct: 84  NHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKF-YLAELALALDHL 142
Query: 386 HNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTM-ATIGYMAP 444
           H    S+ II+ DLKP NILLDE     ++DFG+ K   E  D  ++  +   T+ YMAP
Sbjct: 143 H----SLGIIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCGTVEYMAP 195
Query: 445 EYGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
           E       +   D +S+GVL+ E  T   P
Sbjct: 196 EVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 86/201 (42%), Gaps = 17/201 (8%)
Query: 280 LGTSSFGSVYKGTIS--DGTDVAIKVFNLQLE-----RAFRSFDSECEVLRNVRHRNLIK 332
           LG  SFG V +G      G  V++ V  L+ +      A   F  E   + ++ HRNLI+
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWLYSH--NYFLDILERLNIMIDVGSALEYLHNGHS 390
           +      P  K +V E  P GSL   L  H  ++ L  L R    + V   + YL     
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYL----E 128
Query: 391 SVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDS-VRQTMTMATIGYMAPEYGLE 449
           S   IH DL   N+LL    +  + DFG+ + L + +D  V Q        + APE    
Sbjct: 129 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 450 GIVSAKCDVYSYGVLLMETFT 470
              S   D + +GV L E FT
Sbjct: 189 RTFSHASDTWMFGVTLWEMFT 209

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 91/193 (47%), Gaps = 8/193 (4%)
Query: 280 LGTSSFGSVYKGTISDGT-DVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYS 338
           LG   +G VY+G     +  VA+K    +       F  E  V++ ++H NL+++L   +
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 286
Query: 339 NPDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHC 397
                 ++ EFM  G+L  +L   N   +  +  L +   + SA+EYL       + IH 
Sbjct: 287 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK----NFIHR 342
Query: 398 DLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCD 457
           +L   N L+ EN +  V+DFG+ +L+  G+           I + APE       S K D
Sbjct: 343 NLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 401
Query: 458 VYSYGVLLMETFT 470
           V+++GVLL E  T
Sbjct: 402 VWAFGVLLWEIAT 414

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 94/213 (44%), Gaps = 29/213 (13%)
Query: 273 EFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLI 331
           +F E  L+G+  FG V+K     DG    IK      E+A R    E + L  + H N++
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLDHVNIV 67
Query: 332 KILSSYSNPDFKA----------------LVLEFMPNGSLEKWLYSHN-YFLDILERLNI 374
                +   D+                  + +EF   G+LE+W+       LD +  L +
Sbjct: 68  HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALEL 127
Query: 375 MIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTM 434
              +   ++Y+H    S  +I+ DLKP+NI L +     + DFG+   L   ++  ++  
Sbjct: 128 FEQITKGVDYIH----SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSL---KNDGKRXR 180
Query: 435 TMATIGYMAPEYGLEGIVSAKCDVYSYGVLLME 467
           +  T+ YM+PE         + D+Y+ G++L E
Sbjct: 181 SKGTLRYMSPEQISSQDYGKEVDLYALGLILAE 213

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 103/216 (47%), Gaps = 29/216 (13%)
Query: 280 LGTSSFGSVY--------KGTISDGTDVAIKVFNLQL-ERAFRSFDSECEVLRNV-RHRN 329
           LG  +FG V         K   +  T VA+K+      E+      SE E+++ + +H+N
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 330 LIKILSSYSNPDFKALVLEFMPNGSLEKWL---------YSHNYFLDILERLN------I 374
           +I +L + +      +++E+   G+L ++L         Y +N   +  E+L+       
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 140
Query: 375 MIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTM 434
              V   +EYL    +S   IH DL   N+L+ E+ V  ++DFG+ + +   +   + T 
Sbjct: 141 AYQVARGMEYL----ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 196
Query: 435 TMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
               + +MAPE   + I + + DV+S+GVLL E FT
Sbjct: 197 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 94/200 (47%), Gaps = 13/200 (6%)
Query: 280 LGTSSFGSV---YKGTISDGTDVAIKVFNLQLERA---FRSFDSECEVLRNVRHRNLIKI 333
           LG   FG V         D T   + V +L+ E           E E+LRN+ H N++K 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 334 --LSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSS 391
             + +    +   L++EF+P+GSL+++L  +   +++ ++L   + +   ++YL     S
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYL----GS 144
Query: 392 VHIIHCDLKPTNILLDENMVAHVSDFGIYKLL-GEGEDSVRQTMTMATIGYMAPEYGLEG 450
              +H DL   N+L++      + DFG+ K +  + E    +    + + + APE  ++ 
Sbjct: 145 RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQS 204
Query: 451 IVSAKCDVYSYGVLLMETFT 470
                 DV+S+GV L E  T
Sbjct: 205 KFYIASDVWSFGVTLHELLT 224

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 101/216 (46%), Gaps = 30/216 (13%)
Query: 280 LGTSSFGSVYKGTISDGTD-------VAIKVFNLQLERA-FRSFDSECEVLRNVRHR-NL 330
           LG  +FG V +   + G D       VA+K+       +  R+  SE ++L ++ H  N+
Sbjct: 26  LGRGAFGQVIEAD-AFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 84
Query: 331 IKILSSYSNPDFKALVL-EFMPNGSLEKWLYS---------------HNYFLDILERLNI 374
           + +L + + P    +V+ EF   G+L  +L S               +  FL +   +  
Sbjct: 85  VNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 144
Query: 375 MIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTM 434
              V   +E+L    +S   IH DL   NILL E  V  + DFG+ + + +  D VR+  
Sbjct: 145 SFQVAKGMEFL----ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 200
Query: 435 TMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
               + +MAPE   + + + + DV+S+GVLL E F+
Sbjct: 201 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 94/200 (47%), Gaps = 13/200 (6%)
Query: 280 LGTSSFGSV---YKGTISDGTDVAIKVFNLQLERA---FRSFDSECEVLRNVRHRNLIKI 333
           LG   FG V         D T   + V +L+ E           E E+LRN+ H N++K 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 334 --LSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSS 391
             + +    +   L++EF+P+GSL+++L  +   +++ ++L   + +   ++YL     S
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYL----GS 132
Query: 392 VHIIHCDLKPTNILLDENMVAHVSDFGIYKLL-GEGEDSVRQTMTMATIGYMAPEYGLEG 450
              +H DL   N+L++      + DFG+ K +  + E    +    + + + APE  ++ 
Sbjct: 133 RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQS 192
Query: 451 IVSAKCDVYSYGVLLMETFT 470
                 DV+S+GV L E  T
Sbjct: 193 KFYIASDVWSFGVTLHELLT 212

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 101/216 (46%), Gaps = 30/216 (13%)
Query: 280 LGTSSFGSVYKGTISDGTD-------VAIKVFNLQLERA-FRSFDSECEVLRNVRHR-NL 330
           LG  +FG V +   + G D       VA+K+       +  R+  SE ++L ++ H  N+
Sbjct: 35  LGRGAFGQVIEAD-AFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 93
Query: 331 IKILSSYSNPDFKALVL-EFMPNGSLEKWLYS---------------HNYFLDILERLNI 374
           + +L + + P    +V+ EF   G+L  +L S               +  FL +   +  
Sbjct: 94  VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 153
Query: 375 MIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTM 434
              V   +E+L    +S   IH DL   NILL E  V  + DFG+ + + +  D VR+  
Sbjct: 154 SFQVAKGMEFL----ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 209
Query: 435 TMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
               + +MAPE   + + + + DV+S+GVLL E F+
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 101/216 (46%), Gaps = 30/216 (13%)
Query: 280 LGTSSFGSVYKGTISDGTD-------VAIKVFNLQLERA-FRSFDSECEVLRNVRHR-NL 330
           LG  +FG V +   + G D       VA+K+       +  R+  SE ++L ++ H  N+
Sbjct: 26  LGRGAFGQVIEAD-AFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 84
Query: 331 IKILSSYSNPDFKALVL-EFMPNGSLEKWLYS---------------HNYFLDILERLNI 374
           + +L + + P    +V+ EF   G+L  +L S               +  FL +   +  
Sbjct: 85  VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 144
Query: 375 MIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTM 434
              V   +E+L    +S   IH DL   NILL E  V  + DFG+ + + +  D VR+  
Sbjct: 145 SFQVAKGMEFL----ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 200
Query: 435 TMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
               + +MAPE   + + + + DV+S+GVLL E F+
Sbjct: 201 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 40/99 (40%), Positives = 55/99 (55%), Gaps = 4/99 (4%)
Query: 372 LNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVR 431
           ++    V   +E+L    SS   IH DL   NILL EN V  + DFG+ + + +  D VR
Sbjct: 202 ISYSFQVARGMEFL----SSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVR 257
Query: 432 QTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
           +  T   + +MAPE   + I S K DV+SYGVLL E F+
Sbjct: 258 KGDTRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFS 296

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 99/237 (41%), Gaps = 42/237 (17%)
Query: 262 TSYLDIQRATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECE 320
           T Y   +R   +F E  L+G+  FG V+K     DG    I+      E+A R    E +
Sbjct: 2   TKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAER----EVK 57
Query: 321 VLRNVRHRNLIKILSSYSNPDFKA-----------------------------LVLEFMP 351
            L  + H N++     +   D+                               + +EF  
Sbjct: 58  ALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCD 117
Query: 352 NGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENM 410
            G+LE+W+       LD +  L +   +   ++Y+H    S  +IH DLKP+NI L +  
Sbjct: 118 KGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH----SKKLIHRDLKPSNIFLVDTK 173
Query: 411 VAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLME 467
              + DFG+   L   ++  ++T +  T+ YM+PE         + D+Y+ G++L E
Sbjct: 174 QVKIGDFGLVTSL---KNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAE 227

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 103/216 (47%), Gaps = 29/216 (13%)
Query: 280 LGTSSFGSVY--------KGTISDGTDVAIKVFNLQL-ERAFRSFDSECEVLRNV-RHRN 329
           LG  +FG V         K   +  T VA+K+      E+      SE E+++ + +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 330 LIKILSSYSNPDFKALVLEFMPNGSLEKWL---------YSHNYFLDILERLN------I 374
           +I +L + +      +++E+   G+L ++L         Y +N   +  E+L+       
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 155
Query: 375 MIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTM 434
              V   +EYL    +S   IH DL   N+L+ E+ V  ++DFG+ + +   +   + T 
Sbjct: 156 AYQVARGMEYL----ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 211
Query: 435 TMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
               + +MAPE   + I + + DV+S+GVLL E FT
Sbjct: 212 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 102/216 (47%), Gaps = 29/216 (13%)
Query: 280 LGTSSFGSVY--------KGTISDGTDVAIKVF-NLQLERAFRSFDSECEVLRNV-RHRN 329
           LG  +FG V         K    +   VA+K+  +   E+      SE E+++ + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 330 LIKILSSYSNPDFKALVLEFMPNGSLEKWLYSH-----NYFLDI----------LERLNI 374
           +I +L + +      +++E+   G+L ++L +       Y  DI           + ++ 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 375 MIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTM 434
              +   +EYL    +S   IH DL   N+L+ EN V  ++DFG+ + +   +   + T 
Sbjct: 163 TYQLARGMEYL----ASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTN 218
Query: 435 TMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
               + +MAPE   + + + + DV+S+GVL+ E FT
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 52/186 (27%), Positives = 87/186 (46%), Gaps = 15/186 (8%)
Query: 298 DVAIKVFNLQLERA---FRSFDSECEVLRNVRHRNLIKILSS--YSNP--DFKALVLEFM 350
           DVA+KV    L R    +  F  E +    + H  ++ + ++     P      +V+E++
Sbjct: 39  DVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYATGEAETPAGPLPYIVMEYV 98
Query: 351 PNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH-NGHSSVHIIHCDLKPTNILLDEN 409
              +L   +++    +     + ++ D   AL + H NG     IIH D+KP NI++   
Sbjct: 99  DGVTLRDIVHTEGP-MTPKRAIEVIADACQALNFSHQNG-----IIHRDVKPANIMISAT 152
Query: 410 MVAHVSDFGIYKLLGEGEDSVRQTMT-MATIGYMAPEYGLEGIVSAKCDVYSYGVLLMET 468
               V DFGI + + +  +SV QT   + T  Y++PE      V A+ DVYS G +L E 
Sbjct: 153 NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEV 212
Query: 469 FTRKRP 474
            T + P
Sbjct: 213 LTGEPP 218

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 95/205 (46%), Gaps = 19/205 (9%)
Query: 280 LGTSSFGSVYKGT-ISDGTDVAIK---VFNLQLERAFRSFDSECEVLRNVRHRNLIKILS 335
           +G   F  VY+   + DG  VA+K   +F+L   +A      E ++L+ + H N+IK  +
Sbjct: 40  IGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 99
Query: 336 SYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNI---MIDVGSALEYLHNGHSSV 392
           S+   +   +VLE    G L + +        ++    +    + + SALE++H    S 
Sbjct: 100 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH----SR 155
Query: 393 HIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIG---YMAPEYGLE 449
            ++H D+KP N+ +    V  + D G+ +       S + T   + +G   YM+PE   E
Sbjct: 156 RVMHRDIKPANVFITATGVVKLGDLGLGRFF-----SSKTTAAHSLVGTPYYMSPERIHE 210
Query: 450 GIVSAKCDVYSYGVLLMETFTRKRP 474
              + K D++S G LL E    + P
Sbjct: 211 NGYNFKSDIWSLGCLLYEMAALQSP 235

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 101/216 (46%), Gaps = 30/216 (13%)
Query: 280 LGTSSFGSVYKGTISDGTD-------VAIKVFNLQLERA-FRSFDSECEVLRNVRHR-NL 330
           LG  +FG V +   + G D       VA+K+       +  R+  SE ++L ++ H  N+
Sbjct: 35  LGRGAFGQVIEAD-AFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 93
Query: 331 IKILSSYSNPDFKALVL-EFMPNGSLEKWLYS---------------HNYFLDILERLNI 374
           + +L + + P    +V+ EF   G+L  +L S               +  FL +   +  
Sbjct: 94  VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 153
Query: 375 MIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTM 434
              V   +E+L    +S   IH DL   NILL E  V  + DFG+ + + +  D VR+  
Sbjct: 154 SFQVAKGMEFL----ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGD 209
Query: 435 TMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
               + +MAPE   + + + + DV+S+GVLL E F+
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 102/216 (47%), Gaps = 29/216 (13%)
Query: 280 LGTSSFGSVY--------KGTISDGTDVAIKVF-NLQLERAFRSFDSECEVLRNV-RHRN 329
           LG  +FG V         K    +   VA+K+  +   E+      SE E+++ + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 330 LIKILSSYSNPDFKALVLEFMPNGSLEKWLYSH-----NYFLDI----------LERLNI 374
           +I +L + +      +++E+   G+L ++L +       Y  DI           + ++ 
Sbjct: 103 IIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 375 MIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTM 434
              +   +EYL    +S   IH DL   N+L+ EN V  ++DFG+ + +   +   + T 
Sbjct: 163 TYQLARGMEYL----ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 435 TMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
               + +MAPE   + + + + DV+S+GVL+ E FT
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 102/216 (47%), Gaps = 29/216 (13%)
Query: 280 LGTSSFGSVY--------KGTISDGTDVAIKVF-NLQLERAFRSFDSECEVLRNV-RHRN 329
           LG  +FG V         K    +   VA+K+  +   E+      SE E+++ + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 330 LIKILSSYSNPDFKALVLEFMPNGSLEKWLYSH-----NYFLDI----------LERLNI 374
           +I +L + +      +++E+   G+L ++L +       Y  DI           + ++ 
Sbjct: 103 IITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 375 MIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTM 434
              +   +EYL    +S   IH DL   N+L+ EN V  ++DFG+ + +   +   + T 
Sbjct: 163 TYQLARGMEYL----ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 435 TMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
               + +MAPE   + + + + DV+S+GVL+ E FT
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 101/216 (46%), Gaps = 29/216 (13%)
Query: 280 LGTSSFGSVY--------KGTISDGTDVAIKVF-NLQLERAFRSFDSECEVLRNV-RHRN 329
           LG   FG V         K    +   VA+K+  +   E+      SE E+++ + +H+N
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 330 LIKILSSYSNPDFKALVLEFMPNGSLEKWLYSH-----NYFLDI----------LERLNI 374
           +I +L + +      +++E+   G+L ++L +       Y  DI           + ++ 
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 375 MIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTM 434
              +   +EYL    +S   IH DL   N+L+ EN V  ++DFG+ + +   +   + T 
Sbjct: 209 TYQLARGMEYL----ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 264
Query: 435 TMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
               + +MAPE   + + + + DV+S+GVL+ E FT
Sbjct: 265 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 97/203 (47%), Gaps = 18/203 (8%)
Query: 271 TDEFNECNLLGTSSFGSVY--KGTISDGTDVAIKVFNLQLERAFRSFDS---ECEVLRNV 325
           +D +    +LG  SFG V   K  I+ G + A+KV + +  +     +S   E ++L+ +
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 83
Query: 326 RHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYL 385
            H N+ K+   + +  +  LV E    G L   + S   F ++ +   I+  V S + Y 
Sbjct: 84  DHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-DAARIIRQVLSGITYX 142
Query: 386 HNGHSSVHIIHCDLKPTNILLD---ENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYM 442
           H       I+H DLKP N+LL+   ++    + DFG+       E S +    + T  Y+
Sbjct: 143 HKNK----IVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKKXKDKIGTAYYI 195
Query: 443 APEYGLEGIVSAKCDVYSYGVLL 465
           APE  L G    KCDV+S GV+L
Sbjct: 196 APEV-LHGTYDEKCDVWSTGVIL 217

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 101/216 (46%), Gaps = 30/216 (13%)
Query: 280 LGTSSFGSVYKGTISDGTD-------VAIKVFNLQLERA-FRSFDSECEVLRNVRHR-NL 330
           LG  +FG V +   + G D       VA+K+       +  R+  SE ++L ++ H  N+
Sbjct: 26  LGRGAFGQVIEAD-AFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 84
Query: 331 IKILSSYSNPDFKALVL-EFMPNGSLEKWLYS---------------HNYFLDILERLNI 374
           + +L + + P    +V+ EF   G+L  +L S               +  FL +   +  
Sbjct: 85  VNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 144
Query: 375 MIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTM 434
              V   +E+L    +S   IH DL   NILL E  V  + DFG+ + + +  D VR+  
Sbjct: 145 SFQVAKGMEFL----ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 200
Query: 435 TMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
               + +MAPE   + + + + DV+S+GVLL E F+
Sbjct: 201 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 116/232 (50%), Gaps = 35/232 (15%)
Query: 274 FNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKI 333
           +  C ++G  SFG V++  + +  +VAIK   +  ++ F+  + E +++R V+H N++ +
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDEVAIK--KVLQDKRFK--NRELQIMRIVKHPNVVDL 97
Query: 334 LS-SYSNPD-----FKALVLEFMPNGSLEKWLYSHNYFLDILERLNI------MIDVGSA 381
            +  YSN D     F  LVLE++P    E    +  ++  + + + +      M  +  +
Sbjct: 98  KAFFYSNGDKKDEVFLNLVLEYVP----ETVYRASRHYAKLKQTMPMLLIKLYMYQLLRS 153
Query: 382 LEYLHNGHSSVHIIHCDLKPTNILLD-ENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIG 440
           L Y+H    S+ I H D+KP N+LLD  + V  + DFG  K+L  GE +V     + +  
Sbjct: 154 LAYIH----SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVS---XICSRY 206
Query: 441 YMAPE--YGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVK 490
           Y APE  +G     +   D++S G ++ E    +     +F GE  + + V+
Sbjct: 207 YRAPELIFGATN-YTTNIDIWSTGCVMAELMQGQ----PLFPGESGIDQLVE 253

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 101/216 (46%), Gaps = 30/216 (13%)
Query: 280 LGTSSFGSVYKGTISDGTD-------VAIKVFNLQLERA-FRSFDSECEVLRNVRHR-NL 330
           LG  +FG V +   + G D       VA+K+       +  R+  SE ++L ++ H  N+
Sbjct: 26  LGRGAFGQVIEAD-AFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 84
Query: 331 IKILSSYSNPDFKALVL-EFMPNGSLEKWLYS---------------HNYFLDILERLNI 374
           + +L + + P    +V+ EF   G+L  +L S               +  FL +   +  
Sbjct: 85  VNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 144
Query: 375 MIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTM 434
              V   +E+L    +S   IH DL   NILL E  V  + DFG+ + + +  D VR+  
Sbjct: 145 SFQVAKGMEFL----ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 200
Query: 435 TMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
               + +MAPE   + + + + DV+S+GVLL E F+
Sbjct: 201 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 101/216 (46%), Gaps = 30/216 (13%)
Query: 280 LGTSSFGSVYKGTISDGTD-------VAIKVFNLQLERA-FRSFDSECEVLRNVRHR-NL 330
           LG  +FG V +   + G D       VA+K+       +  R+  SE ++L ++ H  N+
Sbjct: 35  LGRGAFGQVIEAD-AFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 93
Query: 331 IKILSSYSNPDFKALVL-EFMPNGSLEKWLYS---------------HNYFLDILERLNI 374
           + +L + + P    +V+ EF   G+L  +L S               +  FL +   +  
Sbjct: 94  VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 153
Query: 375 MIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTM 434
              V   +E+L    +S   IH DL   NILL E  V  + DFG+ + + +  D VR+  
Sbjct: 154 SFQVAKGMEFL----ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 209
Query: 435 TMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
               + +MAPE   + + + + DV+S+GVLL E F+
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 87/187 (46%), Gaps = 17/187 (9%)
Query: 298 DVAIKVFNLQLERA---FRSFDSECEVLRNVRHRNLIKI-----LSSYSNPDFKALVLEF 349
           DVA+KV    L R    +  F  E +    + H  ++ +       + + P    +V+E+
Sbjct: 39  DVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP-LPYIVMEY 97
Query: 350 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH-NGHSSVHIIHCDLKPTNILLDE 408
           +   +L   +++    +     + ++ D   AL + H NG     IIH D+KP NI++  
Sbjct: 98  VDGVTLRDIVHTEGP-MTPKRAIEVIADACQALNFSHQNG-----IIHRDVKPANIMISA 151
Query: 409 NMVAHVSDFGIYKLLGEGEDSVRQTMT-MATIGYMAPEYGLEGIVSAKCDVYSYGVLLME 467
                V DFGI + + +  +SV QT   + T  Y++PE      V A+ DVYS G +L E
Sbjct: 152 TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYE 211
Query: 468 TFTRKRP 474
             T + P
Sbjct: 212 VLTGEPP 218

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 101/216 (46%), Gaps = 30/216 (13%)
Query: 280 LGTSSFGSVYKGTISDGTD-------VAIKVFNLQLERA-FRSFDSECEVLRNVRHR-NL 330
           LG  +FG V +   + G D       VA+K+       +  R+  SE ++L ++ H  N+
Sbjct: 72  LGRGAFGQVIEAD-AFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 130
Query: 331 IKILSSYSNPDFKALVL-EFMPNGSLEKWLYS---------------HNYFLDILERLNI 374
           + +L + + P    +V+ EF   G+L  +L S               +  FL +   +  
Sbjct: 131 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 190
Query: 375 MIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTM 434
              V   +E+L    +S   IH DL   NILL E  V  + DFG+ + + +  D VR+  
Sbjct: 191 SFQVAKGMEFL----ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 246
Query: 435 TMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
               + +MAPE   + + + + DV+S+GVLL E F+
Sbjct: 247 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 282

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 102/212 (48%), Gaps = 21/212 (9%)
Query: 280 LGTSSFGSVY--------KGTISDGTDVAIKVF-NLQLERAFRSFDSECEVLRNV-RHRN 329
           LG  +FG V         K    +   VA+K+  +   E+      SE E+++ + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 330 LIKILSSYSNPDFKALVLEFMPNGSLEKWLYSH-------NYFLD-ILERLNIMIDVGSA 381
           +I +L + +      +++E+   G+L ++L +        +Y ++ + E      D+ S 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSC 162
Query: 382 LEYLHNGH---SSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMAT 438
              L  G    +S   IH DL   N+L+ EN V  ++DFG+ + +   +   + T     
Sbjct: 163 TYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLP 222
Query: 439 IGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
           + +MAPE   + + + + DV+S+GVL+ E FT
Sbjct: 223 VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 93/204 (45%), Gaps = 20/204 (9%)
Query: 280 LGTSSFGSVYKGTISD------GTDVAIKVFNLQLE-RAFRSFDSECEVLRNVRHRNLIK 332
           LG  SFG VY+G   D       T VA+K  N     R    F +E  V++     ++++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLD---------ILERLNIMIDVGSALE 383
           +L   S      +V+E M +G L+ +L S     +         + E + +  ++   + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           YL+    +   +H DL   N ++  +    + DFG+ + + E +   +    +  + +MA
Sbjct: 145 YLN----AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMA 200
Query: 444 PEYGLEGIVSAKCDVYSYGVLLME 467
           PE   +G+ +   D++S+GV+L E
Sbjct: 201 PESLKDGVFTTSSDMWSFGVVLWE 224

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 93/204 (45%), Gaps = 20/204 (9%)
Query: 280 LGTSSFGSVYKGTISD------GTDVAIKVFNLQLE-RAFRSFDSECEVLRNVRHRNLIK 332
           LG  SFG VY+G   D       T VA+K  N     R    F +E  V++     ++++
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLD---------ILERLNIMIDVGSALE 383
           +L   S      +V+E M +G L+ +L S     +         + E + +  ++   + 
Sbjct: 82  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 141
Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           YL+    +   +H DL   N ++  +    + DFG+ + + E +   +    +  + +MA
Sbjct: 142 YLN----AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMA 197
Query: 444 PEYGLEGIVSAKCDVYSYGVLLME 467
           PE   +G+ +   D++S+GV+L E
Sbjct: 198 PESLKDGVFTTSSDMWSFGVVLWE 221

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 101/216 (46%), Gaps = 29/216 (13%)
Query: 280 LGTSSFGSVY--------KGTISDGTDVAIKVF-NLQLERAFRSFDSECEVLRNV-RHRN 329
           LG   FG V         K    +   VA+K+  +   E+      SE E+++ + +H+N
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 330 LIKILSSYSNPDFKALVLEFMPNGSLEKWLYSH-----NYFLDI----------LERLNI 374
           +I +L + +      +++E+   G+L ++L +       Y  DI           + ++ 
Sbjct: 95  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 154
Query: 375 MIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTM 434
              +   +EYL    +S   IH DL   N+L+ EN V  ++DFG+ + +   +   + T 
Sbjct: 155 TYQLARGMEYL----ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 210
Query: 435 TMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
               + +MAPE   + + + + DV+S+GVL+ E FT
Sbjct: 211 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 101/216 (46%), Gaps = 29/216 (13%)
Query: 280 LGTSSFGSVY--------KGTISDGTDVAIKVF-NLQLERAFRSFDSECEVLRNV-RHRN 329
           LG   FG V         K    +   VA+K+  +   E+      SE E+++ + +H+N
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 330 LIKILSSYSNPDFKALVLEFMPNGSLEKWLYSH-----NYFLDI----------LERLNI 374
           +I +L + +      +++E+   G+L ++L +       Y  DI           + ++ 
Sbjct: 90  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 149
Query: 375 MIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTM 434
              +   +EYL    +S   IH DL   N+L+ EN V  ++DFG+ + +   +   + T 
Sbjct: 150 TYQLARGMEYL----ASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 205
Query: 435 TMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
               + +MAPE   + + + + DV+S+GVL+ E FT
Sbjct: 206 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 93/204 (45%), Gaps = 20/204 (9%)
Query: 280 LGTSSFGSVYKGTISD------GTDVAIKVFNLQLE-RAFRSFDSECEVLRNVRHRNLIK 332
           LG  SFG VY+G   D       T VA+K  N     R    F +E  V++     ++++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLD---------ILERLNIMIDVGSALE 383
           +L   S      +V+E M +G L+ +L S     +         + E + +  ++   + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           YL+    +   +H DL   N ++  +    + DFG+ + + E +   +    +  + +MA
Sbjct: 145 YLN----AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMA 200
Query: 444 PEYGLEGIVSAKCDVYSYGVLLME 467
           PE   +G+ +   D++S+GV+L E
Sbjct: 201 PESLKDGVFTTSSDMWSFGVVLWE 224

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 101/216 (46%), Gaps = 30/216 (13%)
Query: 280 LGTSSFGSVYKGTISDGTD-------VAIKVFNLQLERA-FRSFDSECEVLRNVRHR-NL 330
           LG  +FG V +   + G D       VA+K+       +  R+  SE ++L ++ H  N+
Sbjct: 37  LGRGAFGQVIEAD-AFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 95
Query: 331 IKILSSYSNPDFKALVL-EFMPNGSLEKWLYS---------------HNYFLDILERLNI 374
           + +L + + P    +V+ EF   G+L  +L S               +  FL +   +  
Sbjct: 96  VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICY 155
Query: 375 MIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTM 434
              V   +E+L    +S   IH DL   NILL E  V  + DFG+ + + +  D VR+  
Sbjct: 156 SFQVAKGMEFL----ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 211
Query: 435 TMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
               + +MAPE   + + + + DV+S+GVLL E F+
Sbjct: 212 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 247

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 101/216 (46%), Gaps = 29/216 (13%)
Query: 280 LGTSSFGSVY--------KGTISDGTDVAIKVF-NLQLERAFRSFDSECEVLRNV-RHRN 329
           LG   FG V         K    +   VA+K+  +   E+      SE E+++ + +H+N
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 330 LIKILSSYSNPDFKALVLEFMPNGSLEKWLYSH-----NYFLDI----------LERLNI 374
           +I +L + +      +++E+   G+L ++L +       Y  DI           + ++ 
Sbjct: 92  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 151
Query: 375 MIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTM 434
              +   +EYL    +S   IH DL   N+L+ EN V  ++DFG+ + +   +   + T 
Sbjct: 152 TYQLARGMEYL----ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 207
Query: 435 TMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
               + +MAPE   + + + + DV+S+GVL+ E FT
Sbjct: 208 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 243

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 101/216 (46%), Gaps = 29/216 (13%)
Query: 280 LGTSSFGSVY--------KGTISDGTDVAIKVF-NLQLERAFRSFDSECEVLRNV-RHRN 329
           LG  +FG V         K    +   VA+K+  +   E       SE E+++ + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 330 LIKILSSYSNPDFKALVLEFMPNGSLEKWLYSH-----NYFLDI----------LERLNI 374
           +I +L + +      +++E+   G+L ++L +       Y  DI           + ++ 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 375 MIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTM 434
              +   +EYL    +S   IH DL   N+L+ EN V  ++DFG+ + +   +   + T 
Sbjct: 163 TYQLARGMEYL----ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 435 TMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
               + +MAPE   + + + + DV+S+GVL+ E FT
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 87/187 (46%), Gaps = 17/187 (9%)
Query: 298 DVAIKVFNLQLERA---FRSFDSECEVLRNVRHRNLIKIL-----SSYSNPDFKALVLEF 349
           DVA+KV    L R    +  F  E +    + H  ++ +       + + P    +V+E+
Sbjct: 56  DVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP-LPYIVMEY 114
Query: 350 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH-NGHSSVHIIHCDLKPTNILLDE 408
           +   +L   +++    +     + ++ D   AL + H NG     IIH D+KP NI++  
Sbjct: 115 VDGVTLRDIVHTEGP-MTPKRAIEVIADACQALNFSHQNG-----IIHRDVKPANIMISA 168
Query: 409 NMVAHVSDFGIYKLLGEGEDSVRQTMT-MATIGYMAPEYGLEGIVSAKCDVYSYGVLLME 467
                V DFGI + + +  +SV QT   + T  Y++PE      V A+ DVYS G +L E
Sbjct: 169 TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYE 228
Query: 468 TFTRKRP 474
             T + P
Sbjct: 229 VLTGEPP 235

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 101/216 (46%), Gaps = 29/216 (13%)
Query: 280 LGTSSFGSVY--------KGTISDGTDVAIKVF-NLQLERAFRSFDSECEVLRNV-RHRN 329
           LG  +FG V         K    +   VA+K+  +   E+      SE E+++ + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 330 LIKILSSYSNPDFKALVLEFMPNGSLEKWLYSH-----NYFLDI----------LERLNI 374
           +I +L + +      +++E+   G+L ++L +       Y  DI           + ++ 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 375 MIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTM 434
              +   +EYL    +S   IH DL   N+L+ EN V  ++DFG+ + +   +     T 
Sbjct: 163 TYQLARGMEYL----ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTN 218
Query: 435 TMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
               + +MAPE   + + + + DV+S+GVL+ E FT
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 98/203 (48%), Gaps = 26/203 (12%)
Query: 280 LGTSSFGSVYKGTISDG-TDVAIKVF-------------NLQLERAFRSFDSECEVLRNV 325
           LG+ ++G V      +G ++ AIKV              N  +E+      +E  +L+++
Sbjct: 44  LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 326 RHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYL 385
            H N+IK+   + +  +  LV EF   G L + + + + F D  +  NIM  + S + YL
Sbjct: 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKF-DECDAANIMKQILSGICYL 162
Query: 386 HNGHSSVHIIHCDLKPTNILLDEN---MVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYM 442
           H      +I+H D+KP NILL+     +   + DFG+     +     +    + T  Y+
Sbjct: 163 HKH----NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSK---DYKLRDRLGTAYYI 215
Query: 443 APEYGLEGIVSAKCDVYSYGVLL 465
           APE  L+   + KCDV+S GV++
Sbjct: 216 APEV-LKKKYNEKCDVWSCGVIM 237

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 90/208 (43%), Gaps = 18/208 (8%)
Query: 274 FNECNLLGTSSFGSVY-KGTISDGTDVAIKVFNL---QLERAFRSFDSECEVLRNVRHRN 329
           F++   +G  SFG+VY    + +   VAIK  +    Q    ++    E   L+ +RH N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 330 LIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGH 389
            I+    Y       LV+E+   GS    L  H   L  +E   +       L YLH   
Sbjct: 116 TIQYRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH--- 171
Query: 390 SSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGL- 448
            S ++IH D+K  NILL E  +  + DFG   ++      V       T  +MAPE  L 
Sbjct: 172 -SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV------GTPYWMAPEVILA 224
Query: 449 --EGIVSAKCDVYSYGVLLMETFTRKRP 474
             EG    K DV+S G+  +E   RK P
Sbjct: 225 MDEGQYDGKVDVWSLGITCIELAERKPP 252

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 98/206 (47%), Gaps = 20/206 (9%)
Query: 280 LGTSSFGSV---YKGTISDGTDVAIKVFN---LQLERAFRSFDSECEVLRNVRHRNLIKI 333
           LG  SFG V   Y  T   G  VA+K+ N   L         + E   LR +RH ++IK+
Sbjct: 16  LGEGSFGKVKLAYHTTT--GQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKL 73
Query: 334 LSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVH 393
                + D   +V+E+  N  L  ++   +   +  E       + SA+EY H       
Sbjct: 74  YDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSE-QEARRFFQQIISAVEYCHRHK---- 127
Query: 394 IIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVS 453
           I+H DLKP N+LLDE++   ++DFG+  ++ +G        +  +  Y APE  + G + 
Sbjct: 128 IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN---FLKTSCGSPNYAAPEV-ISGKLY 183
Query: 454 A--KCDVYSYGVLLMETFTRKRPTDE 477
           A  + DV+S GV+L     R+ P D+
Sbjct: 184 AGPEVDVWSCGVILYVMLCRRLPFDD 209

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 98/206 (47%), Gaps = 20/206 (9%)
Query: 280 LGTSSFGSV---YKGTISDGTDVAIKVFN---LQLERAFRSFDSECEVLRNVRHRNLIKI 333
           LG  SFG V   Y  T   G  VA+K+ N   L         + E   LR +RH ++IK+
Sbjct: 21  LGEGSFGKVKLAYHTTT--GQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKL 78
Query: 334 LSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVH 393
                + D   +V+E+  N  L  ++   +   +  E       + SA+EY H       
Sbjct: 79  YDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSE-QEARRFFQQIISAVEYCHRHK---- 132
Query: 394 IIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVS 453
           I+H DLKP N+LLDE++   ++DFG+  ++ +G        +  +  Y APE  + G + 
Sbjct: 133 IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN---FLKTSCGSPNYAAPEV-ISGKLY 188
Query: 454 A--KCDVYSYGVLLMETFTRKRPTDE 477
           A  + DV+S GV+L     R+ P D+
Sbjct: 189 AGPEVDVWSCGVILYVMLCRRLPFDD 214

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 95/204 (46%), Gaps = 11/204 (5%)
Query: 273 EFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQLE-----RAFRSFDSECEVLRNVR 326
           E  +  +LG+  FG+V+KG  I +G  + I V    +E     ++F++       + ++ 
Sbjct: 14  ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLD 73
Query: 327 HRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH 386
           H +++++L        + LV +++P GSL   +  H   L     LN  + +   + YL 
Sbjct: 74  HAHIVRLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE 132
Query: 387 NGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEY 446
             H    ++H +L   N+LL       V+DFG+  LL   +  +  +     I +MA E 
Sbjct: 133 E-HG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALES 188
Query: 447 GLEGIVSAKCDVYSYGVLLMETFT 470
              G  + + DV+SYGV + E  T
Sbjct: 189 IHFGKYTHQSDVWSYGVTVWELMT 212

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 98/206 (47%), Gaps = 20/206 (9%)
Query: 280 LGTSSFGSV---YKGTISDGTDVAIKVFN---LQLERAFRSFDSECEVLRNVRHRNLIKI 333
           LG  SFG V   Y  T   G  VA+K+ N   L         + E   LR +RH ++IK+
Sbjct: 22  LGEGSFGKVKLAYHTTT--GQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKL 79
Query: 334 LSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVH 393
                + D   +V+E+  N  L  ++   +   +  E       + SA+EY H       
Sbjct: 80  YDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSE-QEARRFFQQIISAVEYCHRHK---- 133
Query: 394 IIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVS 453
           I+H DLKP N+LLDE++   ++DFG+  ++ +G        +  +  Y APE  + G + 
Sbjct: 134 IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN---FLKTSCGSPNYAAPEV-ISGKLY 189
Query: 454 A--KCDVYSYGVLLMETFTRKRPTDE 477
           A  + DV+S GV+L     R+ P D+
Sbjct: 190 AGPEVDVWSCGVILYVMLCRRLPFDD 215

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 98/206 (47%), Gaps = 20/206 (9%)
Query: 280 LGTSSFGSV---YKGTISDGTDVAIKVFN---LQLERAFRSFDSECEVLRNVRHRNLIKI 333
           LG  SFG V   Y  T   G  VA+K+ N   L         + E   LR +RH ++IK+
Sbjct: 12  LGEGSFGKVKLAYHTTT--GQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKL 69
Query: 334 LSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVH 393
                + D   +V+E+  N  L  ++   +   +  E       + SA+EY H       
Sbjct: 70  YDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSE-QEARRFFQQIISAVEYCHRHK---- 123
Query: 394 IIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVS 453
           I+H DLKP N+LLDE++   ++DFG+  ++ +G        +  +  Y APE  + G + 
Sbjct: 124 IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN---FLKTSCGSPNYAAPEV-ISGKLY 179
Query: 454 A--KCDVYSYGVLLMETFTRKRPTDE 477
           A  + DV+S GV+L     R+ P D+
Sbjct: 180 AGPEVDVWSCGVILYVMLCRRLPFDD 205

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 100/223 (44%), Gaps = 21/223 (9%)
Query: 266 DIQRATDEFNECNLLGTSSFGSVYKGTI--SDGTDVAIKVFNLQLE----RAFRSFDSEC 319
           D+     +F    +LG   FGSV +  +   DG+ V + V  L+ +         F  E 
Sbjct: 17  DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREA 76
Query: 320 EVLRNVRHRNLIKILSSYSNPDFKA------LVLEFMPNGSLEKWLYSHN-----YFLDI 368
             ++   H ++ K++        K       ++L FM +G L  +L +       + L +
Sbjct: 77  ACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPL 136
Query: 369 LERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGED 428
              +  M+D+   +EYL    SS + IH DL   N +L E+M   V+DFG+ + +  G+ 
Sbjct: 137 QTLVRFMVDIACGMEYL----SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDY 192
Query: 429 SVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTR 471
             +   +   + ++A E   + + +   DV+++GV + E  TR
Sbjct: 193 YRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTR 235

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 96/208 (46%), Gaps = 12/208 (5%)
Query: 274 FNECNLLGTSSFGSVYKGTISDGTD--VAIKVFNLQLERAFRSF-DSECEVLRNVRHRNL 330
           F +   +G  SFG V+KG I + T   VAIK+ +L+           E  VL       +
Sbjct: 25  FTKLERIGKGSFGEVFKG-IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYV 83
Query: 331 IKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHS 390
            K   SY       +++E++  GS    L +  +  D  +   ++ ++   L+YLH    
Sbjct: 84  TKYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPF--DEFQIATMLKEILKGLDYLH---- 137
Query: 391 SVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEG 450
           S   IH D+K  N+LL E     ++DFG+   L + +  +++   + T  +MAPE   + 
Sbjct: 138 SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IKRNTFVGTPFWMAPEVIQQS 195
Query: 451 IVSAKCDVYSYGVLLMETFTRKRPTDEM 478
              +K D++S G+  +E    + P  +M
Sbjct: 196 AYDSKADIWSLGITAIELAKGEPPNSDM 223

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 95/204 (46%), Gaps = 11/204 (5%)
Query: 273 EFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQLE-----RAFRSFDSECEVLRNVR 326
           E  +  +LG+  FG+V+KG  I +G  + I V    +E     ++F++       + ++ 
Sbjct: 32  ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLD 91
Query: 327 HRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH 386
           H +++++L        + LV +++P GSL   +  H   L     LN  + +   + YL 
Sbjct: 92  HAHIVRLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE 150
Query: 387 NGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEY 446
             H    ++H +L   N+LL       V+DFG+  LL   +  +  +     I +MA E 
Sbjct: 151 E-HG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALES 206
Query: 447 GLEGIVSAKCDVYSYGVLLMETFT 470
              G  + + DV+SYGV + E  T
Sbjct: 207 IHFGKYTHQSDVWSYGVTVWELMT 230

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 97/207 (46%), Gaps = 20/207 (9%)
Query: 280 LGTSSFGSVY----KGTISDG--TDVAIKVFNLQLERAFR-SFDSECEVLRNVRHRNLIK 332
           LG  SFG VY    KG + D   T VAIK  N       R  F +E  V++     ++++
Sbjct: 18  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 77
Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWLYS------HNYFL---DILERLNIMIDVGSALE 383
           +L   S      +++E M  G L+ +L S      +N  L    + + + +  ++   + 
Sbjct: 78  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 137
Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           YL+    +   +H DL   N ++ E+    + DFG+ + + E +   +    +  + +M+
Sbjct: 138 YLN----ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMS 193
Query: 444 PEYGLEGIVSAKCDVYSYGVLLMETFT 470
           PE   +G+ +   DV+S+GV+L E  T
Sbjct: 194 PESLKDGVFTTYSDVWSFGVVLWEIAT 220

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 92/204 (45%), Gaps = 11/204 (5%)
Query: 273 EFNECNLLGTSSFGSVYKGT-ISDGTDV----AIKVFNLQLE-RAFRSFDSECEVLRNVR 326
           E  +  +LG+ +FG+VYKG  I DG +V    AIKV       +A +    E  V+  V 
Sbjct: 18  ELRKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVG 77
Query: 327 HRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH 386
              + ++L        + LV + MP G L   +  +   L   + LN  + +   + YL 
Sbjct: 78  SPYVSRLLGICLTSTVQ-LVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKGMSYLE 136
Query: 387 NGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEY 446
           +    V ++H DL   N+L+       ++DFG+ +LL   E           I +MA E 
Sbjct: 137 D----VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALES 192
Query: 447 GLEGIVSAKCDVYSYGVLLMETFT 470
            L    + + DV+SYGV + E  T
Sbjct: 193 ILRRRFTHQSDVWSYGVTVWELMT 216

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 90/208 (43%), Gaps = 18/208 (8%)
Query: 274 FNECNLLGTSSFGSVY-KGTISDGTDVAIKVFNL---QLERAFRSFDSECEVLRNVRHRN 329
           F++   +G  SFG+VY    + +   VAIK  +    Q    ++    E   L+ +RH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 330 LIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGH 389
            I+    Y       LV+E+   GS    L  H   L  +E   +       L YLH   
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH--- 132
Query: 390 SSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGL- 448
            S ++IH D+K  NILL E  +  + DFG   ++      V       T  +MAPE  L 
Sbjct: 133 -SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV------GTPYWMAPEVILA 185
Query: 449 --EGIVSAKCDVYSYGVLLMETFTRKRP 474
             EG    K DV+S G+  +E   RK P
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKPP 213

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 97/207 (46%), Gaps = 20/207 (9%)
Query: 280 LGTSSFGSVY----KGTISDG--TDVAIKVFNLQLERAFR-SFDSECEVLRNVRHRNLIK 332
           LG  SFG VY    KG + D   T VAIK  N       R  F +E  V++     ++++
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 86
Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWLYS------HNYFL---DILERLNIMIDVGSALE 383
           +L   S      +++E M  G L+ +L S      +N  L    + + + +  ++   + 
Sbjct: 87  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 146
Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           YL+    +   +H DL   N ++ E+    + DFG+ + + E +   +    +  + +M+
Sbjct: 147 YLN----ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMS 202
Query: 444 PEYGLEGIVSAKCDVYSYGVLLMETFT 470
           PE   +G+ +   DV+S+GV+L E  T
Sbjct: 203 PESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 90/200 (45%), Gaps = 14/200 (7%)
Query: 272 DEFNECNLLGTSSFGSVY-KGTISDGTDVAIKVFNLQLERAFRSFD---SECEVLRNVRH 327
           D+F     LGT SFG V     +  G   A+K+ + Q     +  +   +E  +L+ V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
             L+K+  S+ +     +V+E++P G +   L     F +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 158
Query: 388 GHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYG 447
              S+ +I+ DLKP N+L+D+     V+DFG  K +       R      T  Y+APE  
Sbjct: 159 ---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEII 210
Query: 448 LEGIVSAKCDVYSYGVLLME 467
           L    +   D ++ GVL+ E
Sbjct: 211 LSKGYNKAVDWWALGVLIYE 230

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 90/200 (45%), Gaps = 14/200 (7%)
Query: 272 DEFNECNLLGTSSFGSVY-KGTISDGTDVAIKVFNLQLERAFRSFD---SECEVLRNVRH 327
           D+F     LGT SFG V     +  G   A+K+ + Q     +  +   +E  +L+ V  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
             L+K+  S+ +     +V+E++P G +   L     F +   R      +    EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 159
Query: 388 GHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYG 447
              S+ +I+ DLKP N+L+D+     V+DFG  K +       R      T  Y+APE  
Sbjct: 160 ---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEII 211
Query: 448 LEGIVSAKCDVYSYGVLLME 467
           L    +   D ++ GVL+ E
Sbjct: 212 LSKGYNKAVDWWALGVLIYE 231

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 90/200 (45%), Gaps = 14/200 (7%)
Query: 272 DEFNECNLLGTSSFGSVY-KGTISDGTDVAIKVFNLQLERAFRSFD---SECEVLRNVRH 327
           D+F     LGT SFG V     +  G   A+K+ + Q     +  +   +E  +L+ V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
             L+K+  S+ +     +V+E++P G +   L     F +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 158
Query: 388 GHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYG 447
              S+ +I+ DLKP N+L+D+     V+DFG  K +       R      T  Y+APE  
Sbjct: 159 ---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEII 210
Query: 448 LEGIVSAKCDVYSYGVLLME 467
           L    +   D ++ GVL+ E
Sbjct: 211 LSKGYNKAVDWWALGVLIYE 230

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 101/216 (46%), Gaps = 29/216 (13%)
Query: 280 LGTSSFGSVY--------KGTISDGTDVAIKVF-NLQLERAFRSFDSECEVLRNV-RHRN 329
           LG  +FG V         K    +   VA+K+  +   E+      SE E+++ + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 330 LIKILSSYSNPDFKALVLEFMPNGSLEKWLYSH-----NYFLDI----------LERLNI 374
           +I +L + +      +++ +   G+L ++L +       Y  DI           + ++ 
Sbjct: 103 IINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 375 MIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTM 434
              +   +EYL    +S   IH DL   N+L+ EN V  ++DFG+ + +   +   + T 
Sbjct: 163 TYQLARGMEYL----ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 435 TMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
               + +MAPE   + + + + DV+S+GVL+ E FT
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 92/203 (45%), Gaps = 20/203 (9%)
Query: 272 DEFNECNLLGTSSFGSV----YKGTISDGTDVAIKVFNLQLERAFRSFD---SECEVLRN 324
           D+F     LGT SFG V    +K T   G   A+K+ + Q     +  +   +E  +L+ 
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKET---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 90
Query: 325 VRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEY 384
           V    L+K+  S+ +     +V+E++P G +   L     F +   R      +    EY
Sbjct: 91  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEY 149
Query: 385 LHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAP 444
           LH    S+ +I+ DLKP N+L+D+     V+DFG  K +       R      T  Y+AP
Sbjct: 150 LH----SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAP 200
Query: 445 EYGLEGIVSAKCDVYSYGVLLME 467
           E  L    +   D ++ GVL+ E
Sbjct: 201 EIILSKGYNKAVDWWALGVLIYE 223

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 90/200 (45%), Gaps = 14/200 (7%)
Query: 272 DEFNECNLLGTSSFGSVY-KGTISDGTDVAIKVFNLQLERAFRSFD---SECEVLRNVRH 327
           D+F     +GT SFG V     +  G   A+K+ + Q     +  +   +E  +L+ V  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
             L+K+  S+ +     +V+E+MP G +   L     F +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 388 GHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYG 447
              S+ +I+ DLKP N+L+D+     V+DFG  K +       R      T  Y+APE  
Sbjct: 159 ---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRV-----KGRTWXLCGTPEYLAPEII 210
Query: 448 LEGIVSAKCDVYSYGVLLME 467
           L    +   D ++ GVL+ E
Sbjct: 211 LSKGYNKAVDWWALGVLIYE 230

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 92/203 (45%), Gaps = 20/203 (9%)
Query: 272 DEFNECNLLGTSSFGSV----YKGTISDGTDVAIKVFNLQLERAFRSFD---SECEVLRN 324
           D+F     LGT SFG V    +K T   G   A+K+ + Q     +  +   +E  +L+ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKET---GNHFAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 325 VRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEY 384
           V    L+K+  S+ +     +V+E++P G +   L     F +   R      +    EY
Sbjct: 98  VNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEY 156
Query: 385 LHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAP 444
           LH    S+ +I+ DLKP N+L+D+     V+DFG  K +       R      T  Y+AP
Sbjct: 157 LH----SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAP 207
Query: 445 EYGLEGIVSAKCDVYSYGVLLME 467
           E  L    +   D ++ GVL+ E
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYE 230

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 90/200 (45%), Gaps = 14/200 (7%)
Query: 272 DEFNECNLLGTSSFGSVY-KGTISDGTDVAIKVFNLQLERAFRSFD---SECEVLRNVRH 327
           D+F     +GT SFG V     +  G   A+K+ + Q     +  +   +E  +L+ V  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
             L+K+  S+ +     +V+E+MP G +   L     F +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 388 GHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYG 447
              S+ +I+ DLKP N+L+D+     V+DFG  K +       R      T  Y+APE  
Sbjct: 159 ---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRV-----KGRTWXLCGTPEYLAPEII 210
Query: 448 LEGIVSAKCDVYSYGVLLME 467
           L    +   D ++ GVL+ E
Sbjct: 211 LSKGYNKAVDWWALGVLIYE 230

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 92/203 (45%), Gaps = 20/203 (9%)
Query: 272 DEFNECNLLGTSSFGSV----YKGTISDGTDVAIKVFNLQLERAFRSFD---SECEVLRN 324
           D+F     LGT SFG V    +K T   G   A+K+ + Q     +  +   +E  +L+ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKET---GNHFAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 325 VRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEY 384
           V    L+K+  S+ +     +V+E++P G +   L     F +   R      +    EY
Sbjct: 98  VNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEY 156
Query: 385 LHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAP 444
           LH    S+ +I+ DLKP N+L+D+     V+DFG  K +       R      T  Y+AP
Sbjct: 157 LH----SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAP 207
Query: 445 EYGLEGIVSAKCDVYSYGVLLME 467
           E  L    +   D ++ GVL+ E
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYE 230

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 92/203 (45%), Gaps = 20/203 (9%)
Query: 272 DEFNECNLLGTSSFGSV----YKGTISDGTDVAIKVFNLQLERAFRSFD---SECEVLRN 324
           D+F     LGT SFG V    +K T   G   A+K+ + Q     +  +   +E  +L+ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKET---GNHFAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 325 VRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEY 384
           V    L+K+  S+ +     +V+E++P G +   L     F +   R      +    EY
Sbjct: 98  VNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEY 156
Query: 385 LHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAP 444
           LH    S+ +I+ DLKP N+L+D+     V+DFG  K +       R      T  Y+AP
Sbjct: 157 LH----SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAP 207
Query: 445 EYGLEGIVSAKCDVYSYGVLLME 467
           E  L    +   D ++ GVL+ E
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYE 230

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 67/240 (27%), Positives = 105/240 (43%), Gaps = 20/240 (8%)
Query: 272 DEFNECNLLGTSSFGSVYKGTISDGT-DVAIKV-FNLQLER--AFRSFDSECEVLRNVRH 327
           D+F     LG   FG+VY          VA+KV F  Q+E+         E E+  ++ H
Sbjct: 23  DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHH 82
Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
            N++++ + + +     L+LE+ P G L K L     F D      IM ++  AL Y H 
Sbjct: 83  PNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTF-DEQRTATIMEELADALMYCHG 141
Query: 388 GHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYG 447
                 +IH D+KP N+LL       ++DFG          S+R+     T+ Y+ PE  
Sbjct: 142 K----KVIHRDIKPENLLLGLKGELKIADFG----WSVHAPSLRRKTMCGTLDYLPPEMI 193
Query: 448 LEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVK------ESLPHGLTEVV 501
              + + K D++  GVL  E      P +     E + RR VK       S+P G  +++
Sbjct: 194 EGRMHNEKVDLWCIGVLCYELLVGNPPFESASHNE-TYRRIVKVDLKFPASVPTGAQDLI 252

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 92/203 (45%), Gaps = 20/203 (9%)
Query: 272 DEFNECNLLGTSSFGSV----YKGTISDGTDVAIKVFNLQLERAFRSFD---SECEVLRN 324
           D+F     LGT SFG V    +K T   G   A+K+ + Q     +  +   +E  +L+ 
Sbjct: 62  DQFERIKTLGTGSFGRVMLVKHKET---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 118
Query: 325 VRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEY 384
           V    L+K+  S+ +     +V+E++P G +   L     F +   R      +    EY
Sbjct: 119 VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEY 177
Query: 385 LHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAP 444
           LH    S+ +I+ DLKP N+L+D+     V+DFG  K +       R      T  Y+AP
Sbjct: 178 LH----SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAP 228
Query: 445 EYGLEGIVSAKCDVYSYGVLLME 467
           E  L    +   D ++ GVL+ E
Sbjct: 229 EIILSKGYNKAVDWWALGVLIYE 251

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 101/216 (46%), Gaps = 29/216 (13%)
Query: 280 LGTSSFGSVY--------KGTISDGTDVAIKVF-NLQLERAFRSFDSECEVLRNV-RHRN 329
           LG  +FG V         K    +   VA+K+  +   E+      SE E+++ + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 330 LIKILSSYSNPDFKALVLEFMPNGSLEKWLYSH-----NYFLDI----------LERLNI 374
           +I +L + +      +++ +   G+L ++L +       Y  DI           + ++ 
Sbjct: 103 IINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 375 MIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTM 434
              +   +EYL    +S   IH DL   N+L+ EN V  ++DFG+ + +   +   + T 
Sbjct: 163 TYQLARGMEYL----ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 435 TMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
               + +MAPE   + + + + DV+S+GVL+ E FT
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 93/204 (45%), Gaps = 20/204 (9%)
Query: 280 LGTSSFGSVYKGTISD------GTDVAIKVFNLQLE-RAFRSFDSECEVLRNVRHRNLIK 332
           LG  SFG VY+G   D       T VA+K  N     R    F +E  V++     ++++
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLD---------ILERLNIMIDVGSALE 383
           +L   S      +V+E M +G L+ +L S     +         + E + +  ++   + 
Sbjct: 84  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 143
Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           YL+    +   +H DL   N ++  +    + DFG+ + + E +   +    +  + +MA
Sbjct: 144 YLN----AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 199
Query: 444 PEYGLEGIVSAKCDVYSYGVLLME 467
           PE   +G+ +   D++S+GV+L E
Sbjct: 200 PESLKDGVFTTSSDMWSFGVVLWE 223

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 101/230 (43%), Gaps = 45/230 (19%)
Query: 272 DEFNECNLLGTSSFGSVYKGTISDGTD-VAIKVFNLQLERAFRSFDS---ECEVLRNVRH 327
           D++    ++G+ +   V     +   + VAIK  NL  E+   S D    E + +    H
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINL--EKCQTSMDELLKEIQAMSQCHH 67
Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERL--------------- 372
            N++   +S+   D   LV++ +  GS+          LDI++ +               
Sbjct: 68  PNIVSYYTSFVVKDELWLVMKLLSGGSV----------LDIIKHIVAKGEHKSGVLDEST 117
Query: 373 --NIMIDVGSALEYLH-NGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDS 429
              I+ +V   LEYLH NG      IH D+K  NILL E+    ++DFG+   L  G D 
Sbjct: 118 IATILREVLEGLEYLHKNGQ-----IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDI 172
Query: 430 VRQTMTMATIG---YMAPEYGLEGI--VSAKCDVYSYGVLLMETFTRKRP 474
            R  +    +G   +MAPE  +E +     K D++S+G+  +E  T   P
Sbjct: 173 TRNKVRKTFVGTPCWMAPEV-MEQVRGYDFKADIWSFGITAIELATGAAP 221

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 90/200 (45%), Gaps = 14/200 (7%)
Query: 272 DEFNECNLLGTSSFGSVY-KGTISDGTDVAIKVFNLQLERAFRSFD---SECEVLRNVRH 327
           D+F     LGT SFG V     +  G   A+K+ + Q     +  +   +E  +L+ V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
             L+K+  S+ +     +V+E++P G +   L     F +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 388 GHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYG 447
              S+ +I+ DLKP N+L+D+     V+DFG  K +       R      T  Y+APE  
Sbjct: 159 ---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEII 210
Query: 448 LEGIVSAKCDVYSYGVLLME 467
           L    +   D ++ GVL+ E
Sbjct: 211 LSKGYNKAVDWWALGVLIYE 230

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 90/200 (45%), Gaps = 14/200 (7%)
Query: 272 DEFNECNLLGTSSFGSVY-KGTISDGTDVAIKVFNLQLERAFRSFD---SECEVLRNVRH 327
           D+F     LGT SFG V     +  G   A+K+ + Q     +  +   +E  +L+ V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
             L+K+  S+ +     +V+E++P G +   L     F +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 388 GHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYG 447
              S+ +I+ DLKP N+L+D+     V+DFG  K +       R      T  Y+APE  
Sbjct: 159 ---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEII 210
Query: 448 LEGIVSAKCDVYSYGVLLME 467
           L    +   D ++ GVL+ E
Sbjct: 211 LSKGYNKAVDWWALGVLIYE 230

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 90/200 (45%), Gaps = 14/200 (7%)
Query: 272 DEFNECNLLGTSSFGSVY-KGTISDGTDVAIKVFNLQLERAFRSFD---SECEVLRNVRH 327
           D+F     LGT SFG V     +  G   A+K+ + Q     +  +   +E  +L+ V  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
             L+K+  S+ +     +V+E++P G +   L     F +   R      +    EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 388 GHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYG 447
              S+ +I+ DLKP N+L+D+     V+DFG  K +       R      T  Y+APE  
Sbjct: 160 ---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEII 211
Query: 448 LEGIVSAKCDVYSYGVLLME 467
           L    +   D ++ GVL+ E
Sbjct: 212 LSKGYNKAVDWWALGVLIYE 231

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 90/200 (45%), Gaps = 14/200 (7%)
Query: 272 DEFNECNLLGTSSFGSVY-KGTISDGTDVAIKVFNLQLERAFRSFD---SECEVLRNVRH 327
           D+F     LGT SFG V     +  G   A+K+ + Q     +  +   +E  +L+ V  
Sbjct: 27  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 86
Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
             L+K+  S+ +     +V+E++P G +   L     F +   R      +    EYLH 
Sbjct: 87  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 144
Query: 388 GHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYG 447
              S+ +I+ DLKP N+L+D+     V+DFG  K +       R      T  Y+APE  
Sbjct: 145 ---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWTLCGTPEYLAPEII 196
Query: 448 LEGIVSAKCDVYSYGVLLME 467
           L    +   D ++ GVL+ E
Sbjct: 197 LSKGYNKAVDWWALGVLIYE 216

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 92/203 (45%), Gaps = 20/203 (9%)
Query: 272 DEFNECNLLGTSSFGSV----YKGTISDGTDVAIKVFNLQLERAFRSFD---SECEVLRN 324
           D+F     LGT SFG V    +K T   G   A+K+ + Q     +  +   +E  +L+ 
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKET---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 90
Query: 325 VRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEY 384
           V    L+K+  S+ +     +V+E++P G +   L     F +   R      +    EY
Sbjct: 91  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEY 149
Query: 385 LHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAP 444
           LH    S+ +I+ DLKP N+L+D+     V+DFG  K +       R      T  Y+AP
Sbjct: 150 LH----SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAP 200
Query: 445 EYGLEGIVSAKCDVYSYGVLLME 467
           E  L    +   D ++ GVL+ E
Sbjct: 201 EIILSKGYNKAVDWWALGVLIYE 223

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 90/200 (45%), Gaps = 14/200 (7%)
Query: 272 DEFNECNLLGTSSFGSVY-KGTISDGTDVAIKVFNLQLERAFRSFD---SECEVLRNVRH 327
           D+F     LGT SFG V     +  G   A+K+ + Q     +  +   +E  +L+ V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
             L+K+  S+ +     +V+E++P G +   L     F +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 388 GHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYG 447
              S+ +I+ DLKP N+L+D+     V+DFG  K +       R      T  Y+APE  
Sbjct: 159 ---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEII 210
Query: 448 LEGIVSAKCDVYSYGVLLME 467
           L    +   D ++ GVL+ E
Sbjct: 211 LSKGYNKAVDWWALGVLIYE 230

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 93/204 (45%), Gaps = 20/204 (9%)
Query: 280 LGTSSFGSVYKGTISD------GTDVAIKVFNLQLE-RAFRSFDSECEVLRNVRHRNLIK 332
           LG  SFG VY+G   D       T VA+K  N     R    F +E  V++     ++++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLD---------ILERLNIMIDVGSALE 383
           +L   S      +V+E M +G L+ +L S     +         + E + +  ++   + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           YL+    +   +H DL   N ++  +    + DFG+ + + E +   +    +  + +MA
Sbjct: 145 YLN----AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 200
Query: 444 PEYGLEGIVSAKCDVYSYGVLLME 467
           PE   +G+ +   D++S+GV+L E
Sbjct: 201 PESLKDGVFTTSSDMWSFGVVLWE 224

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 92/203 (45%), Gaps = 20/203 (9%)
Query: 272 DEFNECNLLGTSSFGSV----YKGTISDGTDVAIKVFNLQLERAFRSFD---SECEVLRN 324
           D+F     LGT SFG V    +K T   G   A+K+ + Q     +  +   +E  +L+ 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKET---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 325 VRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEY 384
           V    L+K+  S+ +     +V+E++P G +   L     F +   R      +    EY
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEY 157
Query: 385 LHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAP 444
           LH    S+ +I+ DLKP N+L+D+     V+DFG  K +       R      T  Y+AP
Sbjct: 158 LH----SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAP 208
Query: 445 EYGLEGIVSAKCDVYSYGVLLME 467
           E  L    +   D ++ GVL+ E
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYE 231

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 90/200 (45%), Gaps = 14/200 (7%)
Query: 272 DEFNECNLLGTSSFGSVY-KGTISDGTDVAIKVFNLQLERAFRSFD---SECEVLRNVRH 327
           D+F     LGT SFG V     +  G   A+K+ + Q     +  +   +E  +L+ V  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
             L+K+  S+ +     +V+E++P G +   L     F +   R      +    EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 388 GHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYG 447
              S+ +I+ DLKP N+L+D+     V+DFG  K +       R      T  Y+APE  
Sbjct: 160 ---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWTLCGTPEYLAPEII 211
Query: 448 LEGIVSAKCDVYSYGVLLME 467
           L    +   D ++ GVL+ E
Sbjct: 212 LSKGYNKAVDWWALGVLIYE 231

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 92/203 (45%), Gaps = 20/203 (9%)
Query: 272 DEFNECNLLGTSSFGSV----YKGTISDGTDVAIKVFNLQLERAFRSFD---SECEVLRN 324
           D+F     LGT SFG V    +K T   G   A+K+ + Q     +  +   +E  +L+ 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKET---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 325 VRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEY 384
           V    L+K+  S+ +     +V+E++P G +   L     F +   R      +    EY
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEY 157
Query: 385 LHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAP 444
           LH    S+ +I+ DLKP N+L+D+     V+DFG  K +       R      T  Y+AP
Sbjct: 158 LH----SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAP 208
Query: 445 EYGLEGIVSAKCDVYSYGVLLME 467
           E  L    +   D ++ GVL+ E
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYE 231

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 101/230 (43%), Gaps = 45/230 (19%)
Query: 272 DEFNECNLLGTSSFGSVYKGTISDGTD-VAIKVFNLQLERAFRSFDS---ECEVLRNVRH 327
           D++    ++G+ +   V     +   + VAIK  NL  E+   S D    E + +    H
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINL--EKCQTSMDELLKEIQAMSQCHH 72
Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERL--------------- 372
            N++   +S+   D   LV++ +  GS+          LDI++ +               
Sbjct: 73  PNIVSYYTSFVVKDELWLVMKLLSGGSV----------LDIIKHIVAKGEHKSGVLDEST 122
Query: 373 --NIMIDVGSALEYLH-NGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDS 429
              I+ +V   LEYLH NG      IH D+K  NILL E+    ++DFG+   L  G D 
Sbjct: 123 IATILREVLEGLEYLHKNGQ-----IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDI 177
Query: 430 VRQTMTMATIG---YMAPEYGLEGI--VSAKCDVYSYGVLLMETFTRKRP 474
            R  +    +G   +MAPE  +E +     K D++S+G+  +E  T   P
Sbjct: 178 TRNKVRKTFVGTPCWMAPEV-MEQVRGYDFKADIWSFGITAIELATGAAP 226

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 92/203 (45%), Gaps = 20/203 (9%)
Query: 272 DEFNECNLLGTSSFGSV----YKGTISDGTDVAIKVFNLQLERAFRSFD---SECEVLRN 324
           D+F     LGT SFG V    +K T   G   A+K+ + Q     +  +   +E  +L+ 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKET---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 325 VRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEY 384
           V    L+K+  S+ +     +V+E++P G +   L     F +   R      +    EY
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEY 157
Query: 385 LHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAP 444
           LH    S+ +I+ DLKP N+L+D+     V+DFG  K +       R      T  Y+AP
Sbjct: 158 LH----SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAP 208
Query: 445 EYGLEGIVSAKCDVYSYGVLLME 467
           E  L    +   D ++ GVL+ E
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYE 231

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 103/211 (48%), Gaps = 18/211 (8%)
Query: 259 WRRTSYLDIQRATDEFNECNLLGTSSFGSVYKGTISDGTD-VAIK-VFNLQLERAFRSFD 316
           W++    DI+   D ++  ++LGT +F  V           VAIK +    LE    S +
Sbjct: 10  WKQAE--DIR---DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSME 64
Query: 317 SECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMI 376
           +E  VL  ++H N++ +   Y +     L+++ +  G L   +    ++ +  +   ++ 
Sbjct: 65  NEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTE-RDASRLIF 123
Query: 377 DVGSALEYLHNGHSSVHIIHCDLKPTNIL---LDENMVAHVSDFGIYKLLGEGEDSVRQT 433
            V  A++YLH+    + I+H DLKP N+L   LDE+    +SDFG+ K+   G  SV  T
Sbjct: 124 QVLDAVKYLHD----LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG--SVLST 177
Query: 434 MTMATIGYMAPEYGLEGIVSAKCDVYSYGVL 464
               T GY+APE   +   S   D +S GV+
Sbjct: 178 -ACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 207

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 12/208 (5%)
Query: 274 FNECNLLGTSSFGSVYKGTISDGTD--VAIKVFNLQLERAFRSF-DSECEVLRNVRHRNL 330
           F +   +G  SFG V+KG I + T   VAIK+ +L+           E  VL       +
Sbjct: 24  FTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 82
Query: 331 IKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHS 390
            K   SY       +++E++  GS    L      LD  +   I+ ++   L+YLH    
Sbjct: 83  TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLH---- 136
Query: 391 SVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEG 450
           S   IH D+K  N+LL E+    ++DFG+   L + +  +++   + T  +MAPE   + 
Sbjct: 137 SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--IKRNXFVGTPFWMAPEVIKQS 194
Query: 451 IVSAKCDVYSYGVLLMETFTRKRPTDEM 478
              +K D++S G+  +E    + P  E+
Sbjct: 195 AYDSKADIWSLGITAIELARGEPPHSEL 222

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 12/208 (5%)
Query: 274 FNECNLLGTSSFGSVYKGTISDGTD--VAIKVFNLQLERAFRSF-DSECEVLRNVRHRNL 330
           F +   +G  SFG V+KG I + T   VAIK+ +L+           E  VL       +
Sbjct: 29  FTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 87
Query: 331 IKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHS 390
            K   SY       +++E++  GS    L      LD  +   I+ ++   L+YLH    
Sbjct: 88  TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLH---- 141
Query: 391 SVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEG 450
           S   IH D+K  N+LL E+    ++DFG+   L + +  +++   + T  +MAPE   + 
Sbjct: 142 SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--IKRNTFVGTPFWMAPEVIKQS 199
Query: 451 IVSAKCDVYSYGVLLMETFTRKRPTDEM 478
              +K D++S G+  +E    + P  E+
Sbjct: 200 AYDSKADIWSLGITAIELARGEPPHSEL 227

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 101/204 (49%), Gaps = 30/204 (14%)
Query: 278 NLLGTSSFGS-VYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNV-RHRNLIKILS 335
           ++LG  + G+ VY+G   D  DVA+K     L   F   D E ++LR    H N+I+   
Sbjct: 30  DVLGHGAEGTIVYRGMF-DNRDVAVKRI---LPECFSFADREVQLLRESDEHPNVIRYFC 85
Query: 336 SYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHII 395
           +  +  F+ + +E     +L++++   ++    LE + ++    S L +LH    S++I+
Sbjct: 86  TEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH----SLNIV 140
Query: 396 HCDLKPTNILLD-----ENMVAHVSDFGIYKLLGEGEDSV-RQTMTMATIGYMAPEYGLE 449
           H DLKP NIL+        + A +SDFG+ K L  G  S  R++    T G++APE    
Sbjct: 141 HRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE---- 196
Query: 450 GIVSAKC--------DVYSYGVLL 465
            ++S  C        D++S G + 
Sbjct: 197 -MLSEDCKENPTYTVDIFSAGCVF 219

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 12/208 (5%)
Query: 274 FNECNLLGTSSFGSVYKGTISDGTD--VAIKVFNLQLERAFRSF-DSECEVLRNVRHRNL 330
           F +   +G  SFG V+KG I + T   VAIK+ +L+           E  VL       +
Sbjct: 9   FTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 67
Query: 331 IKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHS 390
            K   SY       +++E++  GS    L      LD  +   I+ ++   L+YLH    
Sbjct: 68  TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLH---- 121
Query: 391 SVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEG 450
           S   IH D+K  N+LL E+    ++DFG+   L + +  +++   + T  +MAPE   + 
Sbjct: 122 SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--IKRNTFVGTPFWMAPEVIKQS 179
Query: 451 IVSAKCDVYSYGVLLMETFTRKRPTDEM 478
              +K D++S G+  +E    + P  E+
Sbjct: 180 AYDSKADIWSLGITAIELARGEPPHSEL 207

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 12/208 (5%)
Query: 274 FNECNLLGTSSFGSVYKGTISDGTD--VAIKVFNLQLERAFRSF-DSECEVLRNVRHRNL 330
           F +   +G  SFG V+KG I + T   VAIK+ +L+           E  VL       +
Sbjct: 9   FTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 67
Query: 331 IKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHS 390
            K   SY       +++E++  GS    L      LD  +   I+ ++   L+YLH    
Sbjct: 68  TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLH---- 121
Query: 391 SVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEG 450
           S   IH D+K  N+LL E+    ++DFG+   L + +  +++   + T  +MAPE   + 
Sbjct: 122 SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--IKRNXFVGTPFWMAPEVIKQS 179
Query: 451 IVSAKCDVYSYGVLLMETFTRKRPTDEM 478
              +K D++S G+  +E    + P  E+
Sbjct: 180 AYDSKADIWSLGITAIELARGEPPHSEL 207

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 90/200 (45%), Gaps = 14/200 (7%)
Query: 272 DEFNECNLLGTSSFGSVY-KGTISDGTDVAIKVFNLQLERAFRSFD---SECEVLRNVRH 327
           D+F     LGT SFG V     +  G   A+K+ + Q     +  +   +E  +L+ V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
             L+K+  S+ +     +V+E+ P G +   L     F +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 388 GHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYG 447
              S+ +I+ DLKP N+++D+     V+DFG+ K +       R      T  Y+APE  
Sbjct: 159 ---SLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRV-----KGRTWXLCGTPEYLAPEII 210
Query: 448 LEGIVSAKCDVYSYGVLLME 467
           L    +   D ++ GVL+ E
Sbjct: 211 LSKGYNKAVDWWALGVLIYE 230

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 97/227 (42%), Gaps = 34/227 (14%)
Query: 269 RATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNVRH 327
           R   +F E  +LG  +FG V K   + D    AIK      E    +  SE  +L ++ H
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNH 61
Query: 328 -------------RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNI 374
                        RN +K +++        + +E+  NG+L   ++S N      E   +
Sbjct: 62  QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121
Query: 375 MIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVR--- 431
              +  AL Y+H    S  IIH DLKP NI +DE+    + DFG+ K +    D ++   
Sbjct: 122 FRQILEALSYIH----SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 432 ---------QTMTMATIGYMAPEYGLEGI--VSAKCDVYSYGVLLME 467
                     T  + T  Y+A E  L+G    + K D+YS G++  E
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEV-LDGTGHYNEKIDMYSLGIIFFE 223

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 117/242 (48%), Gaps = 25/242 (10%)
Query: 280 LGTSSFGSVYKGTISD-GTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYS 338
           +G  S G V   T    G  VA+K  +L+ ++      +E  ++R+  H N++ + SSY 
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYL 112
Query: 339 NPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCD 398
             D   +V+EF+  G+L   + +H   ++  +   + + V  AL YLHN      +IH D
Sbjct: 113 VGDELWVVMEFLEGGALTD-IVTHTR-MNEEQIATVCLSVLRALSYLHNQ----GVIHRD 166
Query: 399 LKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDV 458
           +K  +ILL  +    +SDFG    +   ++  ++   + T  +MAPE         + D+
Sbjct: 167 IKSDSILLTSDGRIKLSDFGFCAQV--SKEVPKRKXLVGTPYWMAPEVISRLPYGTEVDI 224
Query: 459 YSYGVLLMETFTRKRPTDEMFIGEMSLR--RWVKESLP------HGLTEV----VDANLV 506
           +S G++++E    + P    +  E  L+  R +++SLP      H ++ V    +D  LV
Sbjct: 225 WSLGIMVIEMIDGEPP----YFNEPPLQAMRRIRDSLPPRVKDLHKVSSVLRGFLDLMLV 280
Query: 507 RE 508
           RE
Sbjct: 281 RE 282

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 103/211 (48%), Gaps = 18/211 (8%)
Query: 259 WRRTSYLDIQRATDEFNECNLLGTSSFGSVYKGTISDGTD-VAIK-VFNLQLERAFRSFD 316
           W++    DI+   D ++  ++LGT +F  V           VAIK +    LE    S +
Sbjct: 10  WKQAE--DIR---DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSME 64
Query: 317 SECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMI 376
           +E  VL  ++H N++ +   Y +     L+++ +  G L   +    ++ +  +   ++ 
Sbjct: 65  NEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTE-RDASRLIF 123
Query: 377 DVGSALEYLHNGHSSVHIIHCDLKPTNIL---LDENMVAHVSDFGIYKLLGEGEDSVRQT 433
            V  A++YLH+    + I+H DLKP N+L   LDE+    +SDFG+ K+   G  SV  T
Sbjct: 124 QVLDAVKYLHD----LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG--SVLST 177
Query: 434 MTMATIGYMAPEYGLEGIVSAKCDVYSYGVL 464
               T GY+APE   +   S   D +S GV+
Sbjct: 178 -ACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 207

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 92/204 (45%), Gaps = 20/204 (9%)
Query: 280 LGTSSFGSVYKGTISD------GTDVAIKVFNLQLE-RAFRSFDSECEVLRNVRHRNLIK 332
           LG  SFG VY+G   D       T VA+K  N     R    F +E  V++     ++++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLD---------ILERLNIMIDVGSALE 383
           +L   S      +V+E M +G L+ +L S     +         + E + +  ++   + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           YL+    +   +H DL   N ++  +    + DFG+ + + E     +    +  + +MA
Sbjct: 145 YLN----AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWMA 200
Query: 444 PEYGLEGIVSAKCDVYSYGVLLME 467
           PE   +G+ +   D++S+GV+L E
Sbjct: 201 PESLKDGVFTTSSDMWSFGVVLWE 224

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 93/203 (45%), Gaps = 11/203 (5%)
Query: 274 FNECNLLGTSSFGSVYKGTISD-GTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIK 332
           F+    LG  S+GSVYK    + G  VAIK   + +E   +    E  +++     +++K
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIK--QVPVESDLQEIIKEISIMQQCDSPHVVK 88
Query: 333 ILSSY-SNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSS 391
              SY  N D   +V+E+   GS+   +   N  L   E   I+      LEYLH     
Sbjct: 89  YYGSYFKNTDL-WIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH----F 143
Query: 392 VHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGI 451
           +  IH D+K  NILL+    A ++DFG+   L   +   ++   + T  +MAPE   E  
Sbjct: 144 MRKIHRDIKAGNILLNTEGHAKLADFGVAGQL--TDXMAKRNXVIGTPFWMAPEVIQEIG 201
Query: 452 VSAKCDVYSYGVLLMETFTRKRP 474
            +   D++S G+  +E    K P
Sbjct: 202 YNCVADIWSLGITAIEMAEGKPP 224

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 103/211 (48%), Gaps = 18/211 (8%)
Query: 259 WRRTSYLDIQRATDEFNECNLLGTSSFGSVYKGTISDGTD-VAIK-VFNLQLERAFRSFD 316
           W++    DI+   D ++  ++LGT +F  V           VAIK +    LE    S +
Sbjct: 10  WKQAE--DIR---DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSME 64
Query: 317 SECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMI 376
           +E  VL  ++H N++ +   Y +     L+++ +  G L   +    ++ +  +   ++ 
Sbjct: 65  NEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTE-RDASRLIF 123
Query: 377 DVGSALEYLHNGHSSVHIIHCDLKPTNIL---LDENMVAHVSDFGIYKLLGEGEDSVRQT 433
            V  A++YLH+    + I+H DLKP N+L   LDE+    +SDFG+ K+   G  SV  T
Sbjct: 124 QVLDAVKYLHD----LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG--SVLST 177
Query: 434 MTMATIGYMAPEYGLEGIVSAKCDVYSYGVL 464
               T GY+APE   +   S   D +S GV+
Sbjct: 178 -ACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 207

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 103/211 (48%), Gaps = 18/211 (8%)
Query: 259 WRRTSYLDIQRATDEFNECNLLGTSSFGSVYKGTISDGTD-VAIK-VFNLQLERAFRSFD 316
           W++    DI+   D ++  ++LGT +F  V           VAIK +    LE    S +
Sbjct: 10  WKQAE--DIR---DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSME 64
Query: 317 SECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMI 376
           +E  VL  ++H N++ +   Y +     L+++ +  G L   +    ++ +  +   ++ 
Sbjct: 65  NEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTE-RDASRLIF 123
Query: 377 DVGSALEYLHNGHSSVHIIHCDLKPTNIL---LDENMVAHVSDFGIYKLLGEGEDSVRQT 433
            V  A++YLH+    + I+H DLKP N+L   LDE+    +SDFG+ K+   G  SV  T
Sbjct: 124 QVLDAVKYLHD----LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG--SVLST 177
Query: 434 MTMATIGYMAPEYGLEGIVSAKCDVYSYGVL 464
               T GY+APE   +   S   D +S GV+
Sbjct: 178 -ACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 207

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 89/200 (44%), Gaps = 14/200 (7%)
Query: 272 DEFNECNLLGTSSFGSVY-KGTISDGTDVAIKVFNLQLERAFRSFD---SECEVLRNVRH 327
           D+F     LGT SFG V     +  G   A+K+ + Q     +  +   +E  +L+ V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
             L+K+  S+ +     +V+E+ P G +   L     F +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 158
Query: 388 GHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYG 447
              S+ +I+ DLKP N+++D+     V+DFG  K +       R      T  Y+APE  
Sbjct: 159 ---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV-----KGRTWXLCGTPEYLAPEII 210
Query: 448 LEGIVSAKCDVYSYGVLLME 467
           L    +   D ++ GVL+ E
Sbjct: 211 LSKGYNKAVDWWALGVLIYE 230

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 89/200 (44%), Gaps = 14/200 (7%)
Query: 272 DEFNECNLLGTSSFGSVY-KGTISDGTDVAIKVFNLQLERAFRSFD---SECEVLRNVRH 327
           D+F     LGT SFG V     +  G   A+K+ + Q     +  +   +E  +L+ V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
             L+K+  S+ +     +V+E+ P G +   L     F +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 388 GHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYG 447
              S+ +I+ DLKP N+++D+     V+DFG  K +       R      T  Y+APE  
Sbjct: 159 ---SLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEII 210
Query: 448 LEGIVSAKCDVYSYGVLLME 467
           L    +   D ++ GVL+ E
Sbjct: 211 LSKGYNKAVDWWALGVLIYE 230

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 90/200 (45%), Gaps = 14/200 (7%)
Query: 272 DEFNECNLLGTSSFGSVY-KGTISDGTDVAIKVFNLQLERAFRSFD---SECEVLRNVRH 327
           D+F     LGT SFG V     +  G   A+K+ + Q     +  +   +E  +L+ V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
             L+K+  S+ +     +V+E+ P G +   L     F +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 388 GHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYG 447
              S+ +I+ DLKP N+++D+     V+DFG+ K +       R      T  Y+APE  
Sbjct: 159 ---SLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRV-----KGRTWXLCGTPEYLAPEII 210
Query: 448 LEGIVSAKCDVYSYGVLLME 467
           L    +   D ++ GVL+ E
Sbjct: 211 LSKGYNKAVDWWALGVLIYE 230

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 102/215 (47%), Gaps = 32/215 (14%)
Query: 280 LGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERA---FRSFDSECEVLRNVRHRNLIKILS 335
           LG  SFG V   T       VA+K  + QL +        + E   L+ +RH ++IK+  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 336 SYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGS--------ALEYLHN 387
             + P    +V+E+   G L         F  I+E+  +  D G         A+EY H 
Sbjct: 77  VITTPTDIVMVIEY-AGGEL---------FDYIVEKKRMTEDEGRRFFQQIICAIEYCHR 126
Query: 388 GHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYG 447
                 I+H DLKP N+LLD+N+   ++DFG+  ++ +G  +  +T +  +  Y APE  
Sbjct: 127 HK----IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG--NFLKT-SCGSPNYAAPEV- 178
Query: 448 LEGIVSA--KCDVYSYGVLLMETFTRKRPTDEMFI 480
           + G + A  + DV+S G++L      + P D+ FI
Sbjct: 179 INGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFI 213

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 90/200 (45%), Gaps = 14/200 (7%)
Query: 272 DEFNECNLLGTSSFGSVY-KGTISDGTDVAIKVFNLQLERAFRSFD---SECEVLRNVRH 327
           D+F     +GT SFG V     +  G   A+K+ + Q     +  +   +E  +L+ V  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
             L+K+  S+ +     +V+E++P G +   L     F +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 388 GHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYG 447
              S+ +I+ DLKP N+L+D+     V+DFG  K +       R      T  Y+APE  
Sbjct: 159 ---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRV-----KGRTWXLCGTPEYLAPEII 210
Query: 448 LEGIVSAKCDVYSYGVLLME 467
           L    +   D ++ GVL+ E
Sbjct: 211 LSKGYNKAVDWWALGVLIYE 230

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 97/207 (46%), Gaps = 20/207 (9%)
Query: 280 LGTSSFGSVY----KGTISDG--TDVAIKVFNLQLERAFR-SFDSECEVLRNVRHRNLIK 332
           LG  SFG VY    KG + D   T VAIK  N       R  F +E  V++     ++++
Sbjct: 23  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 82
Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWLYS------HNYFL---DILERLNIMIDVGSALE 383
           +L   S      +++E M  G L+ +L S      +N  L    + + + +  ++   + 
Sbjct: 83  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 142
Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           YL+    +   +H DL   N ++ E+    + DFG+ + + E +   +    +  + +M+
Sbjct: 143 YLN----ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 198
Query: 444 PEYGLEGIVSAKCDVYSYGVLLMETFT 470
           PE   +G+ +   DV+S+GV+L E  T
Sbjct: 199 PESLKDGVFTTYSDVWSFGVVLWEIAT 225

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 97/207 (46%), Gaps = 20/207 (9%)
Query: 280 LGTSSFGSVY----KGTISDG--TDVAIKVFNLQLERAFR-SFDSECEVLRNVRHRNLIK 332
           LG  SFG VY    KG + D   T VAIK  N       R  F +E  V++     ++++
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 79
Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWLYS------HNYFL---DILERLNIMIDVGSALE 383
           +L   S      +++E M  G L+ +L S      +N  L    + + + +  ++   + 
Sbjct: 80  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 139
Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           YL+    +   +H DL   N ++ E+    + DFG+ + + E +   +    +  + +M+
Sbjct: 140 YLN----ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 195
Query: 444 PEYGLEGIVSAKCDVYSYGVLLMETFT 470
           PE   +G+ +   DV+S+GV+L E  T
Sbjct: 196 PESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/193 (24%), Positives = 90/193 (46%), Gaps = 10/193 (5%)
Query: 275 NECNLLGTSSFGSVYK-GTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKI 333
           ++  +LG   FG V+K    + G  +A K+   +  +      +E  V+  + H NLI++
Sbjct: 92  SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQL 151
Query: 334 LSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVH 393
             ++ + +   LV+E++  G L   +   +Y L  L+ +  M  +   + ++H     ++
Sbjct: 152 YDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQ----MY 207
Query: 394 IIHCDLKPTNILLDENMVAHVS--DFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGI 451
           I+H DLKP NIL        +   DFG+ +     E   +  +   T  ++APE      
Sbjct: 208 ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---KLKVNFGTPEFLAPEVVNYDF 264
Query: 452 VSAKCDVYSYGVL 464
           VS   D++S GV+
Sbjct: 265 VSFPTDMWSVGVI 277

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 97/207 (46%), Gaps = 20/207 (9%)
Query: 280 LGTSSFGSVY----KGTISDG--TDVAIKVFNLQLERAFR-SFDSECEVLRNVRHRNLIK 332
           LG  SFG VY    KG + D   T VAIK  N       R  F +E  V++     ++++
Sbjct: 24  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 83
Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWLYS------HNYFL---DILERLNIMIDVGSALE 383
           +L   S      +++E M  G L+ +L S      +N  L    + + + +  ++   + 
Sbjct: 84  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 143
Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           YL+    +   +H DL   N ++ E+    + DFG+ + + E +   +    +  + +M+
Sbjct: 144 YLN----ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 199
Query: 444 PEYGLEGIVSAKCDVYSYGVLLMETFT 470
           PE   +G+ +   DV+S+GV+L E  T
Sbjct: 200 PESLKDGVFTTYSDVWSFGVVLWEIAT 226

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 97/207 (46%), Gaps = 20/207 (9%)
Query: 280 LGTSSFGSVY----KGTISDG--TDVAIKVFNLQLERAFR-SFDSECEVLRNVRHRNLIK 332
           LG  SFG VY    KG + D   T VAIK  N       R  F +E  V++     ++++
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 85
Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWLYS------HNYFL---DILERLNIMIDVGSALE 383
           +L   S      +++E M  G L+ +L S      +N  L    + + + +  ++   + 
Sbjct: 86  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 145
Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           YL+    +   +H DL   N ++ E+    + DFG+ + + E +   +    +  + +M+
Sbjct: 146 YLN----ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 201
Query: 444 PEYGLEGIVSAKCDVYSYGVLLMETFT 470
           PE   +G+ +   DV+S+GV+L E  T
Sbjct: 202 PESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 97/207 (46%), Gaps = 20/207 (9%)
Query: 280 LGTSSFGSVY----KGTISDG--TDVAIKVFNLQLERAFR-SFDSECEVLRNVRHRNLIK 332
           LG  SFG VY    KG + D   T VAIK  N       R  F +E  V++     ++++
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 86
Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWLYS------HNYFL---DILERLNIMIDVGSALE 383
           +L   S      +++E M  G L+ +L S      +N  L    + + + +  ++   + 
Sbjct: 87  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 146
Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           YL+    +   +H DL   N ++ E+    + DFG+ + + E +   +    +  + +M+
Sbjct: 147 YLN----ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 202
Query: 444 PEYGLEGIVSAKCDVYSYGVLLMETFT 470
           PE   +G+ +   DV+S+GV+L E  T
Sbjct: 203 PESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 97/207 (46%), Gaps = 20/207 (9%)
Query: 280 LGTSSFGSVY----KGTISDG--TDVAIKVFNLQLERAFR-SFDSECEVLRNVRHRNLIK 332
           LG  SFG VY    KG + D   T VAIK  N       R  F +E  V++     ++++
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWLYS------HNYFL---DILERLNIMIDVGSALE 383
           +L   S      +++E M  G L+ +L S      +N  L    + + + +  ++   + 
Sbjct: 93  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           YL+    +   +H DL   N ++ E+    + DFG+ + + E +   +    +  + +M+
Sbjct: 153 YLN----ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 208
Query: 444 PEYGLEGIVSAKCDVYSYGVLLMETFT 470
           PE   +G+ +   DV+S+GV+L E  T
Sbjct: 209 PESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 96/207 (46%), Gaps = 20/207 (9%)
Query: 280 LGTSSFGSVY----KGTISDG--TDVAIKVFNLQLERAFR-SFDSECEVLRNVRHRNLIK 332
           LG  SFG VY    KG + D   T VAIK  N       R  F +E  V++     ++++
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 85
Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWLYS------HNYFL---DILERLNIMIDVGSALE 383
           +L   S      +++E M  G L+ +L S      +N  L    + + + +  ++   + 
Sbjct: 86  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 145
Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           YL+        +H DL   N ++ E+    + DFG+ + + E +   +    +  + +M+
Sbjct: 146 YLNANK----FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 201
Query: 444 PEYGLEGIVSAKCDVYSYGVLLMETFT 470
           PE   +G+ +   DV+S+GV+L E  T
Sbjct: 202 PESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 89/200 (44%), Gaps = 14/200 (7%)
Query: 272 DEFNECNLLGTSSFGSVY-KGTISDGTDVAIKVFNLQLERAFRSFD---SECEVLRNVRH 327
           D+F     LGT SFG V     +  G   A+K+ + Q     +  +   +E  +L+ V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
             L+K+  S+ +     +V+E+ P G +   L     F +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 388 GHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYG 447
              S+ +I+ DLKP N+++D+     V+DFG  K +       R      T  Y+APE  
Sbjct: 159 ---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV-----KGRTWXLCGTPEYLAPEII 210
Query: 448 LEGIVSAKCDVYSYGVLLME 467
           L    +   D ++ GVL+ E
Sbjct: 211 LSKGYNKAVDWWALGVLIYE 230

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 91/203 (44%), Gaps = 20/203 (9%)
Query: 272 DEFNECNLLGTSSFGSV----YKGTISDGTDVAIKVFNLQLERAFRSFD---SECEVLRN 324
           D+F     LGT SFG V    +K T   G   A+K+ + Q     +  +   +E  +L+ 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKET---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 325 VRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEY 384
           V    L+K+  S+ +     +V+E+ P G +   L     F +   R      +    EY
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEY 157
Query: 385 LHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAP 444
           LH    S+ +I+ DLKP N+++D+     V+DFG  K +       R      T  Y+AP
Sbjct: 158 LH----SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV-----KGRTWXLCGTPEYLAP 208
Query: 445 EYGLEGIVSAKCDVYSYGVLLME 467
           E  L    +   D ++ GVL+ E
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYE 231

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 95/207 (45%), Gaps = 20/207 (9%)
Query: 280 LGTSSFGSVY----KGTISDG--TDVAIKVFNLQLERAFR-SFDSECEVLRNVRHRNLIK 332
           LG  SFG VY    KG + D   T VAIK  N       R  F +E  V++     ++++
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWLYS-----HNYFLDILERLNIMI----DVGSALE 383
           +L   S      +++E M  G L+ +L S      N  +     L+ MI    ++   + 
Sbjct: 93  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           YL+        +H DL   N ++ E+    + DFG+ + + E +   +    +  + +M+
Sbjct: 153 YLNANK----FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 208
Query: 444 PEYGLEGIVSAKCDVYSYGVLLMETFT 470
           PE   +G+ +   DV+S+GV+L E  T
Sbjct: 209 PESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 97/207 (46%), Gaps = 20/207 (9%)
Query: 280 LGTSSFGSVY----KGTISDG--TDVAIKVFNLQLERAFR-SFDSECEVLRNVRHRNLIK 332
           LG  SFG VY    KG + D   T VAIK  N       R  F +E  V++     ++++
Sbjct: 55  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 114
Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWLYS------HNYFL---DILERLNIMIDVGSALE 383
           +L   S      +++E M  G L+ +L S      +N  L    + + + +  ++   + 
Sbjct: 115 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 174
Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           YL+    +   +H DL   N ++ E+    + DFG+ + + E +   +    +  + +M+
Sbjct: 175 YLN----ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 230
Query: 444 PEYGLEGIVSAKCDVYSYGVLLMETFT 470
           PE   +G+ +   DV+S+GV+L E  T
Sbjct: 231 PESLKDGVFTTYSDVWSFGVVLWEIAT 257

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 97/221 (43%), Gaps = 18/221 (8%)
Query: 251 EDFLPLAIWRRTSYLDIQRATDEFNECNLLGTSSFGSVYKGTISD-GTDVAIKVFNLQLE 309
           EDFL    W   S    Q   D+F+    LGT SFG V      + G   A+K+ + Q  
Sbjct: 45  EDFL--KKWETPSQNTAQ--LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV 100
Query: 310 RAFRSFD---SECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFL 366
              +  +   +E  +L+ V    L+K+  S+ +     +V+E++  G +   L     F 
Sbjct: 101 VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFX 160
Query: 367 DILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG 426
           +   R      +    EYLH    S+ +I+ DLKP N+L+D+     V+DFG  K +   
Sbjct: 161 EPHARF-YAAQIVLTFEYLH----SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--- 212
Query: 427 EDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLME 467
               R      T  Y+APE  L    +   D ++ GVL+ E
Sbjct: 213 --KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 251

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 19/211 (9%)
Query: 271 TDEFNECNLLGTSSFGSVYKGTISDGTDV--AIKVFNLQLERAFRSFDSECEVL-RNVRH 327
           TD +     +G  S+ SV K  I   T++  A+K+    ++++ R    E E+L R  +H
Sbjct: 21  TDGYEVKEDIGVGSY-SVCKRCIHKATNMEFAVKI----IDKSKRDPTEEIEILLRYGQH 75
Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
            N+I +   Y +  +  +V E M  G L   +    +F +  E   ++  +   +EYLH 
Sbjct: 76  PNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSE-REASAVLFTITKTVEYLH- 133
Query: 388 GHSSVHIIHCDLKPTNIL-LDEN---MVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
              +  ++H DLKP+NIL +DE+       + DFG  K L   E+ +  T    T  ++A
Sbjct: 134 ---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL-RAENGLLMTPCY-TANFVA 188
Query: 444 PEYGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
           PE        A CD++S GVLL    T   P
Sbjct: 189 PEVLERQGYDAACDIWSLGVLLYTMLTGYTP 219

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 97/221 (43%), Gaps = 18/221 (8%)
Query: 251 EDFLPLAIWRRTSYLDIQRATDEFNECNLLGTSSFGSVYKGTISD-GTDVAIKVFNLQLE 309
           EDFL    W   S    Q   D+F+    LGT SFG V      + G   A+K+ + Q  
Sbjct: 11  EDFL--KKWETPSQNTAQ--LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV 66
Query: 310 RAFRSFD---SECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFL 366
              +  +   +E  +L+ V    L+K+  S+ +     +V+E++  G +   L     F 
Sbjct: 67  VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS 126
Query: 367 DILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG 426
           +   R      +    EYLH    S+ +I+ DLKP N+L+DE     V+DFG  K +   
Sbjct: 127 EPHARF-YAAQIVLTFEYLH----SLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRV--- 178
Query: 427 EDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLME 467
               R      T  Y+APE  L    +   D ++ GVL+ E
Sbjct: 179 --KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 217

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 12/205 (5%)
Query: 278 NLLGTSSFGSVYKGTISDGTDVAIKVFNLQLER-----AFRSFDSECEVLRNVRHRNLIK 332
            ++G   FG VY G   D     I+     L R        +F  E  ++R + H N++ 
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 333 ILSSYSNPD-FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSS 391
           ++     P+    ++L +M +G L +++ S      + + ++  + V   +EYL    + 
Sbjct: 87  LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYL----AE 142
Query: 392 VHIIHCDLKPTNILLDENMVAHVSDFGIYK-LLGEGEDSVRQ-TMTMATIGYMAPEYGLE 449
              +H DL   N +LDE+    V+DFG+ + +L     SV+Q       + + A E    
Sbjct: 143 QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQT 202
Query: 450 GIVSAKCDVYSYGVLLMETFTRKRP 474
              + K DV+S+GVLL E  TR  P
Sbjct: 203 YRFTTKSDVWSFGVLLWELLTRGAP 227

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 93/204 (45%), Gaps = 20/204 (9%)
Query: 280 LGTSSFGSVYKGTISD------GTDVAIKVFNLQLE-RAFRSFDSECEVLRNVRHRNLIK 332
           LG  SFG VY+G   D       T VA+K  N     R    F +E  V++     ++++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLD---------ILERLNIMIDVGSALE 383
           +L   S      +V+E M +G L+ +L S     +         + E + +  ++   + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           YL+    +   +H +L   N ++  +    + DFG+ + + E +   +    +  + +MA
Sbjct: 145 YLN----AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 200
Query: 444 PEYGLEGIVSAKCDVYSYGVLLME 467
           PE   +G+ +   D++S+GV+L E
Sbjct: 201 PESLKDGVFTTSSDMWSFGVVLWE 224

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 93/204 (45%), Gaps = 20/204 (9%)
Query: 280 LGTSSFGSVYKGTISD------GTDVAIKVFNLQLE-RAFRSFDSECEVLRNVRHRNLIK 332
           LG  SFG VY+G   D       T VA+K  N     R    F +E  V++     ++++
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 85
Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLD---------ILERLNIMIDVGSALE 383
           +L   S      +V+E M +G L+ +L S     +         + E + +  ++   + 
Sbjct: 86  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 145
Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           YL+    +   +H +L   N ++  +    + DFG+ + + E +   +    +  + +MA
Sbjct: 146 YLN----AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 201
Query: 444 PEYGLEGIVSAKCDVYSYGVLLME 467
           PE   +G+ +   D++S+GV+L E
Sbjct: 202 PESLKDGVFTTSSDMWSFGVVLWE 225

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 97/221 (43%), Gaps = 18/221 (8%)
Query: 251 EDFLPLAIWRRTSYLDIQRATDEFNECNLLGTSSFGSVYKGTISD-GTDVAIKVFNLQLE 309
           EDFL    W   S    Q   D+F+    LGT SFG V      + G   A+K+ + Q  
Sbjct: 24  EDFL--KKWETPSQNTAQ--LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV 79
Query: 310 RAFRSFD---SECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFL 366
              +  +   +E  +L+ V    L+K+  S+ +     +V+E++  G +   L     F 
Sbjct: 80  VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFX 139
Query: 367 DILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG 426
           +   R      +    EYLH    S+ +I+ DLKP N+L+D+     V+DFG  K +   
Sbjct: 140 EPHARF-YAAQIVLTFEYLH----SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--- 191
Query: 427 EDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLME 467
               R      T  Y+APE  L    +   D ++ GVL+ E
Sbjct: 192 --KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 230

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 100/215 (46%), Gaps = 28/215 (13%)
Query: 276 ECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNV--RHRNLIKI 333
           EC  +G   +G V++G+   G +VA+K+F+    R  +S+  E E+   V  RH N++  
Sbjct: 43  EC--VGKGRYGEVWRGSWQ-GENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGF 96
Query: 334 LSSYSNPDFKA----LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH--- 386
           ++S       +    L+  +   GSL  +L      LD +  L I++ + S L +LH   
Sbjct: 97  IASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRIVLSIASGLAHLHIEI 154
Query: 387 -NGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDS--VRQTMTMATIGYMA 443
                   I H DLK  NIL+ +N    ++D G+  +  +  +   V     + T  YMA
Sbjct: 155 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 214
Query: 444 PEYGLEGIVSAKC-------DVYSYGVLLMETFTR 471
           PE  L+  +   C       D++++G++L E   R
Sbjct: 215 PEV-LDETIQVDCFDSYKRVDIWAFGLVLWEVARR 248

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 98/195 (50%), Gaps = 21/195 (10%)
Query: 278 NLLGTSSFGSVY--KGTISDGTDVAIKVFNLQLERAFR--SFDSECEVLRNVRHRNLIKI 333
            +LG+ +F  V+  K  ++ G   A+K   ++   AFR  S ++E  VL+ ++H N++ +
Sbjct: 15  EVLGSGAFSEVFLVKQRLT-GKLFALKC--IKKSPAFRDSSLENEIAVLKKIKHENIVTL 71
Query: 334 LSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH-NGHSSV 392
              Y +     LV++ +  G L   +     + +    L ++  V SA++YLH NG    
Sbjct: 72  EDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASL-VIQQVLSAVKYLHENG---- 126
Query: 393 HIIHCDLKPTNILL---DENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLE 449
            I+H DLKP N+L    +EN    ++DFG+ K+    E +   +    T GY+APE   +
Sbjct: 127 -IVHRDLKPENLLYLTPEENSKIMITDFGLSKM----EQNGIMSTACGTPGYVAPEVLAQ 181
Query: 450 GIVSAKCDVYSYGVL 464
              S   D +S GV+
Sbjct: 182 KPYSKAVDCWSIGVI 196

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 97/221 (43%), Gaps = 18/221 (8%)
Query: 251 EDFLPLAIWRRTSYLDIQRATDEFNECNLLGTSSFGSVYKGTISD-GTDVAIKVFNLQLE 309
           EDFL    W   S    Q   D+F+    LGT SFG V      + G   A+K+ + Q  
Sbjct: 24  EDFL--KKWETPSQNTAQ--LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV 79
Query: 310 RAFRSFD---SECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFL 366
              +  +   +E  +L+ V    L+K+  S+ +     +V+E++  G +   L     F 
Sbjct: 80  VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS 139
Query: 367 DILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG 426
           +   R      +    EYLH    S+ +I+ DLKP N+L+D+     V+DFG  K +   
Sbjct: 140 EPHARF-YAAQIVLTFEYLH----SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--- 191
Query: 427 EDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLME 467
               R      T  Y+APE  L    +   D ++ GVL+ E
Sbjct: 192 --KGRTWXLAGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 230

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 97/221 (43%), Gaps = 18/221 (8%)
Query: 251 EDFLPLAIWRRTSYLDIQRATDEFNECNLLGTSSFGSVYKGTISD-GTDVAIKVFNLQLE 309
           EDFL    W   S    Q   D+F+    LGT SFG V      + G   A+K+ + Q  
Sbjct: 24  EDFL--KKWETPSQNTAQ--LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV 79
Query: 310 RAFRSFD---SECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFL 366
              +  +   +E  +L+ V    L+K+  S+ +     +V+E++  G +   L     F 
Sbjct: 80  VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS 139
Query: 367 DILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG 426
           +   R      +    EYLH    S+ +I+ DLKP N+L+D+     V+DFG  K +   
Sbjct: 140 EPHARF-YAAQIVLTFEYLH----SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--- 191
Query: 427 EDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLME 467
               R      T  Y+APE  L    +   D ++ GVL+ E
Sbjct: 192 --KGRTWXLXGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 230

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 97/221 (43%), Gaps = 18/221 (8%)
Query: 251 EDFLPLAIWRRTSYLDIQRATDEFNECNLLGTSSFGSVYKGTISD-GTDVAIKVFNLQLE 309
           EDFL    W   S    Q   D+F+    LGT SFG V      + G   A+K+ + Q  
Sbjct: 19  EDFL--KKWETPSQNTAQ--LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV 74
Query: 310 RAFRSFD---SECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFL 366
              +  +   +E  +L+ V    L+K+  S+ +     +V+E++  G +   L     F 
Sbjct: 75  VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFX 134
Query: 367 DILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG 426
           +   R      +    EYLH    S+ +I+ DLKP N+L+D+     V+DFG  K +   
Sbjct: 135 EPHARF-YAAQIVLTFEYLH----SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--- 186
Query: 427 EDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLME 467
               R      T  Y+APE  L    +   D ++ GVL+ E
Sbjct: 187 --KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 225

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 93/208 (44%), Gaps = 19/208 (9%)
Query: 268 QRATDEFNECNLLGTSSFGSVYK-GTISDGTDVAIKVFNLQLERAFR------SFDSECE 320
           Q+  D ++    LG+  F  V K    S G + A K    +  RA R        + E  
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 321 VLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGS 380
           +LR V H N+I +   Y N     L+LE +  G L  +L +    L   E  + +  +  
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILD 126
Query: 381 ALEYLHNGHSSVHIIHCDLKPTNI-LLDENM-VAHVS--DFGIYKLLGEGEDSVRQTMTM 436
            + YLH    +  I H DLKP NI LLD+N+ + H+   DFG   L  E ED V      
Sbjct: 127 GVNYLH----TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFG---LAHEIEDGVEFKNIF 179
Query: 437 ATIGYMAPEYGLEGIVSAKCDVYSYGVL 464
            T  ++APE      +  + D++S GV+
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVI 207

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 97/221 (43%), Gaps = 18/221 (8%)
Query: 251 EDFLPLAIWRRTSYLDIQRATDEFNECNLLGTSSFGSVYKGTISD-GTDVAIKVFNLQLE 309
           EDFL    W   S    Q   D+F+    LGT SFG V      + G   A+K+ + Q  
Sbjct: 24  EDFL--KKWETPSQNTAQ--LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV 79
Query: 310 RAFRSFD---SECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFL 366
              +  +   +E  +L+ V    L+K+  S+ +     +V+E++  G +   L     F 
Sbjct: 80  VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFX 139
Query: 367 DILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG 426
           +   R      +    EYLH    S+ +I+ DLKP N+L+D+     V+DFG  K +   
Sbjct: 140 EPHARF-YAAQIVLTFEYLH----SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--- 191
Query: 427 EDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLME 467
               R      T  Y+APE  L    +   D ++ GVL+ E
Sbjct: 192 --KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 230

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 97/221 (43%), Gaps = 18/221 (8%)
Query: 251 EDFLPLAIWRRTSYLDIQRATDEFNECNLLGTSSFGSVYKGTISD-GTDVAIKVFNLQLE 309
           EDFL    W   S    Q   D+F+    LGT SFG V      + G   A+K+ + Q  
Sbjct: 24  EDFL--KKWETPSQNTAQ--LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV 79
Query: 310 RAFRSFD---SECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFL 366
              +  +   +E  +L+ V    L+K+  S+ +     +V+E++  G +   L     F 
Sbjct: 80  VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFX 139
Query: 367 DILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG 426
           +   R      +    EYLH    S+ +I+ DLKP N+L+D+     V+DFG  K +   
Sbjct: 140 EPHARF-YAAQIVLTFEYLH----SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--- 191
Query: 427 EDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLME 467
               R      T  Y+APE  L    +   D ++ GVL+ E
Sbjct: 192 --KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 230

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 93/208 (44%), Gaps = 19/208 (9%)
Query: 268 QRATDEFNECNLLGTSSFGSVYK-GTISDGTDVAIKVFNLQLERAFR------SFDSECE 320
           Q+  D ++    LG+  F  V K    S G + A K    +  RA R        + E  
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 321 VLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGS 380
           +LR V H N+I +   Y N     L+LE +  G L  +L +    L   E  + +  +  
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILD 126
Query: 381 ALEYLHNGHSSVHIIHCDLKPTNI-LLDENM-VAHVS--DFGIYKLLGEGEDSVRQTMTM 436
            + YLH    +  I H DLKP NI LLD+N+ + H+   DFG   L  E ED V      
Sbjct: 127 GVNYLH----TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFG---LAHEIEDGVEFKNIF 179
Query: 437 ATIGYMAPEYGLEGIVSAKCDVYSYGVL 464
            T  ++APE      +  + D++S GV+
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVI 207

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 93/208 (44%), Gaps = 19/208 (9%)
Query: 268 QRATDEFNECNLLGTSSFGSVYK-GTISDGTDVAIKVFNLQLERAFR------SFDSECE 320
           Q+  D ++    LG+  F  V K    S G + A K    +  RA R        + E  
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 321 VLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGS 380
           +LR V H N+I +   Y N     L+LE +  G L  +L +    L   E  + +  +  
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILD 126
Query: 381 ALEYLHNGHSSVHIIHCDLKPTNI-LLDENM-VAHVS--DFGIYKLLGEGEDSVRQTMTM 436
            + YLH    +  I H DLKP NI LLD+N+ + H+   DFG   L  E ED V      
Sbjct: 127 GVNYLH----TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFG---LAHEIEDGVEFKNIF 179
Query: 437 ATIGYMAPEYGLEGIVSAKCDVYSYGVL 464
            T  ++APE      +  + D++S GV+
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVI 207

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 100/215 (46%), Gaps = 28/215 (13%)
Query: 276 ECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNV--RHRNLIKI 333
           EC  +G   +G V++G+   G +VA+K+F+    R  +S+  E E+   V  RH N++  
Sbjct: 14  EC--VGKGRYGEVWRGSWQ-GENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGF 67
Query: 334 LSSYSNPDFKA----LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH--- 386
           ++S       +    L+  +   GSL  +L      LD +  L I++ + S L +LH   
Sbjct: 68  IASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRIVLSIASGLAHLHIEI 125
Query: 387 -NGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDS--VRQTMTMATIGYMA 443
                   I H DLK  NIL+ +N    ++D G+  +  +  +   V     + T  YMA
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 444 PEYGLEGIVSAKC-------DVYSYGVLLMETFTR 471
           PE  L+  +   C       D++++G++L E   R
Sbjct: 186 PEV-LDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 74/313 (23%), Positives = 132/313 (42%), Gaps = 31/313 (9%)
Query: 238 IRCRNRNTKKSDHEDFLPLAIWRR--TSYLDIQRAT--DEFNECNLLGTSSFGSVYKGT- 292
           +R +    K +D++ F    IW++     +++++ +  D ++    LG+ +FG V++   
Sbjct: 14  VRGKYDGPKINDYDKFYE-DIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVE 72
Query: 293 ISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPN 352
            + G     K  N        +  +E  ++  + H  LI +  ++ +     L+LEF+  
Sbjct: 73  KATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG 132
Query: 353 GSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVA 412
           G L   + + +Y +   E +N M      L+++H  HS   I+H D+KP NI+ +    +
Sbjct: 133 GELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE-HS---IVHLDIKPENIMCETKKAS 188
Query: 413 HVS--DFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
            V   DFG+   L   E      +T AT  + APE      V    D+++ GVL     +
Sbjct: 189 SVKIIDFGLATKLNPDEIV---KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLS 245
Query: 471 RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCC 530
              P    F GE  L           L  V   +   +E AFS+         DF  +  
Sbjct: 246 GLSP----FAGEDDLE---------TLQNVKRCDWEFDEDAFSS---VSPEAKDFIKNLL 289
Query: 531 MESPDMRINMTDA 543
            + P  R+ + DA
Sbjct: 290 QKEPRKRLTVHDA 302

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 93/208 (44%), Gaps = 19/208 (9%)
Query: 268 QRATDEFNECNLLGTSSFGSVYK-GTISDGTDVAIKVFNLQLERAFR------SFDSECE 320
           Q+  D ++    LG+  F  V K    S G + A K    +  RA R        + E  
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 321 VLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGS 380
           +LR V H N+I +   Y N     L+LE +  G L  +L +    L   E  + +  +  
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILD 126
Query: 381 ALEYLHNGHSSVHIIHCDLKPTNI-LLDENM-VAHVS--DFGIYKLLGEGEDSVRQTMTM 436
            + YLH    +  I H DLKP NI LLD+N+ + H+   DFG   L  E ED V      
Sbjct: 127 GVNYLH----TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFG---LAHEIEDGVEFKNIF 179
Query: 437 ATIGYMAPEYGLEGIVSAKCDVYSYGVL 464
            T  ++APE      +  + D++S GV+
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVI 207

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 97/221 (43%), Gaps = 18/221 (8%)
Query: 251 EDFLPLAIWRRTSYLDIQRATDEFNECNLLGTSSFGSVYKGTISD-GTDVAIKVFNLQLE 309
           EDFL    W   S    Q   D+F+    LGT SFG V      + G   A+K+ + Q  
Sbjct: 24  EDFL--KKWETPSQNTAQ--LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV 79
Query: 310 RAFRSFD---SECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFL 366
              +  +   +E  +L+ V    L+K+  S+ +     +V+E++  G +   L     F 
Sbjct: 80  VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFA 139
Query: 367 DILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG 426
           +   R      +    EYLH    S+ +I+ DLKP N+L+D+     V+DFG  K +   
Sbjct: 140 EPHARF-YAAQIVLTFEYLH----SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--- 191
Query: 427 EDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLME 467
               R      T  Y+APE  L    +   D ++ GVL+ E
Sbjct: 192 --KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 230

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 93/208 (44%), Gaps = 19/208 (9%)
Query: 268 QRATDEFNECNLLGTSSFGSVYK-GTISDGTDVAIKVFNLQLERAFR------SFDSECE 320
           Q+  D ++    LG+  F  V K    S G + A K    +  RA R        + E  
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 321 VLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGS 380
           +LR V H N+I +   Y N     L+LE +  G L  +L +    L   E  + +  +  
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILD 126
Query: 381 ALEYLHNGHSSVHIIHCDLKPTNI-LLDENM-VAHVS--DFGIYKLLGEGEDSVRQTMTM 436
            + YLH    +  I H DLKP NI LLD+N+ + H+   DFG   L  E ED V      
Sbjct: 127 GVNYLH----TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFG---LAHEIEDGVEFKNIF 179
Query: 437 ATIGYMAPEYGLEGIVSAKCDVYSYGVL 464
            T  ++APE      +  + D++S GV+
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVI 207

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/259 (24%), Positives = 124/259 (47%), Gaps = 19/259 (7%)
Query: 239 RCRNRNTKKSDHEDFLPLAIWRRTSYLDIQRATDEFNECNLLGTSSFGSVYKGTI-SDGT 297
           R   R  ++  HE F   A+       D +   D F +   +G  S G V   T+ S G 
Sbjct: 45  RSPQREPQRVSHEQFR-AALQLVVDPGDPRSYLDNFIK---IGEGSTGIVCIATVRSSGK 100
Query: 298 DVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEK 357
            VA+K  +L+ ++      +E  ++R+ +H N++++ +SY   D   +V+EF+  G+L  
Sbjct: 101 LVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTD 160
Query: 358 WLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDF 417
            + +H   ++  +   + + V  AL  LH    +  +IH D+K  +ILL  +    +SDF
Sbjct: 161 -IVTHTR-MNEEQIAAVCLAVLQALSVLH----AQGVIHRDIKSDSILLTHDGRVKLSDF 214
Query: 418 GIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDE 477
           G    +   ++  R+   + T  +MAPE         + D++S G++++E    + P   
Sbjct: 215 GFCAQV--SKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP--- 269
Query: 478 MFIGEMSLR--RWVKESLP 494
            +  E  L+  + ++++LP
Sbjct: 270 -YFNEPPLKAMKMIRDNLP 287

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 100/215 (46%), Gaps = 28/215 (13%)
Query: 276 ECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNV--RHRNLIKI 333
           EC  +G   +G V++G+   G +VA+K+F+    R  +S+  E E+   V  RH N++  
Sbjct: 14  EC--VGKGRYGEVWRGSWQ-GENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGF 67
Query: 334 LSSYSNPDFKA----LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH--- 386
           ++S       +    L+  +   GSL  +L      LD +  L I++ + S L +LH   
Sbjct: 68  IASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRIVLSIASGLAHLHIEI 125
Query: 387 -NGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDS--VRQTMTMATIGYMA 443
                   I H DLK  NIL+ +N    ++D G+  +  +  +   V     + T  YMA
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 444 PEYGLEGIVSAKC-------DVYSYGVLLMETFTR 471
           PE  L+  +   C       D++++G++L E   R
Sbjct: 186 PEV-LDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 90/203 (44%), Gaps = 20/203 (9%)
Query: 272 DEFNECNLLGTSSFGSV----YKGTISDGTDVAIKVFNLQLERAFRSFD---SECEVLRN 324
           D+F     LGT SFG V    +K T   G   A+K+ + Q     +  +   +E  + + 
Sbjct: 42  DQFERIRTLGTGSFGRVMLVKHKET---GNHYAMKILDKQKVVKLKQIEHTLNEKRIQQA 98
Query: 325 VRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEY 384
           V    L+K+  S+ +     +VLE+ P G +   L     F +   R      +    EY
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEY 157
Query: 385 LHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAP 444
           LH    S+ +I+ DLKP N+L+D+     V+DFG  K +       R      T  Y+AP
Sbjct: 158 LH----SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRV-----KGRTWXLCGTPEYLAP 208
Query: 445 EYGLEGIVSAKCDVYSYGVLLME 467
           E  L    +   D ++ GVL+ E
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYE 231

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 107/217 (49%), Gaps = 27/217 (12%)
Query: 285 FGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSY---SNPD 341
           FG V+K  + +   VA+K+F +Q ++++++ + E   L  ++H N+++ + +    ++ D
Sbjct: 37  FGCVWKAQLLNEY-VAVKIFPIQDKQSWQN-EYEVYSLPGMKHENILQFIGAEKRGTSVD 94
Query: 342 FK-ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH-------NGHSSVH 393
               L+  F   GSL  +L ++   +   E  +I   +   L YLH       +GH    
Sbjct: 95  VDLWLITAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA- 151
Query: 394 IIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVS 453
           I H D+K  N+LL  N+ A ++DFG+      G+ +      + T  YMAPE  LEG ++
Sbjct: 152 ISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEV-LEGAIN 210
Query: 454 ------AKCDVYSYGVLLMETFTR----KRPTDEMFI 480
                  + D+Y+ G++L E  +R      P DE  +
Sbjct: 211 FQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 96/207 (46%), Gaps = 20/207 (9%)
Query: 280 LGTSSFGSVY----KGTISDG--TDVAIKVFNLQLERAFR-SFDSECEVLRNVRHRNLIK 332
           LG  SFG VY    KG + D   T VAIK  N       R  F +E  V++     ++++
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 79
Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWLYS------HNYFL---DILERLNIMIDVGSALE 383
           +L   S      +++E M  G L+ +L S      +N  L    + + + +  ++   + 
Sbjct: 80  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 139
Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           YL+    +   +H DL   N  + E+    + DFG+ + + E +   +    +  + +M+
Sbjct: 140 YLN----ANKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 195
Query: 444 PEYGLEGIVSAKCDVYSYGVLLMETFT 470
           PE   +G+ +   DV+S+GV+L E  T
Sbjct: 196 PESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 88/200 (44%), Gaps = 14/200 (7%)
Query: 272 DEFNECNLLGTSSFGSVY-KGTISDGTDVAIKVFNLQLERAFRSFD---SECEVLRNVRH 327
           D+F     LGT SFG V     +  G   A+K+ + Q     +  +   +E  +L+ V  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
             L K+  S+ +     +V+E+ P G +   L     F +   R      +    EYLH 
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 159
Query: 388 GHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYG 447
              S+ +I+ DLKP N+++D+     V+DFG  K +       R      T  Y+APE  
Sbjct: 160 ---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV-----KGRTWXLCGTPEYLAPEII 211
Query: 448 LEGIVSAKCDVYSYGVLLME 467
           L    +   D ++ GVL+ E
Sbjct: 212 LSKGYNKAVDWWALGVLIYE 231

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 97/221 (43%), Gaps = 18/221 (8%)
Query: 251 EDFLPLAIWRRTSYLDIQRATDEFNECNLLGTSSFGSVYKGTISD-GTDVAIKVFNLQLE 309
           EDFL    W   S    Q   D+F+    LGT SFG V      + G   A+K+ + Q  
Sbjct: 24  EDFL--KKWETPSQNTAQ--LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV 79
Query: 310 RAFRSFD---SECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFL 366
              +  +   +E  +L+ V    L+K+  S+ +     +V+E++  G +   L     F 
Sbjct: 80  VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS 139
Query: 367 DILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG 426
           +   R      +    EYLH    S+ +I+ DLKP N+L+D+     V+DFG  K +   
Sbjct: 140 EPHARF-YAAQIVLTFEYLH----SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--- 191
Query: 427 EDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLME 467
               R      T  Y+APE  L    +   D ++ GVL+ E
Sbjct: 192 --KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 230

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 98/228 (42%), Gaps = 36/228 (15%)
Query: 269 RATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNL-QLERAFRSFDSECEVLRNVR 326
           R   +F     LG   FG V++     D  + AIK   L   E A      E + L  + 
Sbjct: 2   RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 61
Query: 327 HRNLIKILSSY-----------SNPD-FKALVLEFMPNGSLEKWLYSHNYFLDILER--- 371
           H  +++  +++           S+P  +  + ++     +L+ W+   N    I ER   
Sbjct: 62  HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWM---NGRCTIEERERS 118
Query: 372 --LNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDS 429
             L+I + +  A+E+LH    S  ++H DLKP+NI    + V  V DFG+   + + E+ 
Sbjct: 119 VCLHIFLQIAEAVEFLH----SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEE 174
Query: 430 ----------VRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLME 467
                      R T  + T  YM+PE       S K D++S G++L E
Sbjct: 175 QTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFE 222

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 93/208 (44%), Gaps = 19/208 (9%)
Query: 268 QRATDEFNECNLLGTSSFGSVYK-GTISDGTDVAIKVFNLQLERAFR------SFDSECE 320
           Q+  D ++    LG+  F  V K    S G + A K    +  RA R        + E  
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVS 67
Query: 321 VLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGS 380
           +LR V H N+I +   Y N     L+LE +  G L  +L +    L   E  + +  +  
Sbjct: 68  ILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILD 126
Query: 381 ALEYLHNGHSSVHIIHCDLKPTNI-LLDENM-VAHVS--DFGIYKLLGEGEDSVRQTMTM 436
            + YLH    +  I H DLKP NI LLD+N+ + H+   DFG   L  E ED V      
Sbjct: 127 GVNYLH----TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFG---LAHEIEDGVEFKNIF 179
Query: 437 ATIGYMAPEYGLEGIVSAKCDVYSYGVL 464
            T  ++APE      +  + D++S GV+
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVI 207

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 18/211 (8%)
Query: 274 FNECNLLGTSSFGSVYKGTISDGTDV-AIKVFNLQLERAFRSF-DSECEVLRNVRHRNLI 331
           F + + +G  SFG VYKG  +   +V AIK+ +L+           E  VL       + 
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 332 KILSSYSNPDFKALVLEFMPNGS----LEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
           +   SY       +++E++  GS    L+       Y   IL       ++   L+YLH 
Sbjct: 81  RYFGSYLKSTKLWIIMEYLGGGSALDLLKPGPLEETYIATILR------EILKGLDYLH- 133
Query: 388 GHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYG 447
              S   IH D+K  N+LL E     ++DFG+   L + +  +++   + T  +MAPE  
Sbjct: 134 ---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IKRNXFVGTPFWMAPEVI 188
Query: 448 LEGIVSAKCDVYSYGVLLMETFTRKRPTDEM 478
            +     K D++S G+  +E    + P  ++
Sbjct: 189 KQSAYDFKADIWSLGITAIELAKGEPPNSDL 219

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 97/221 (43%), Gaps = 18/221 (8%)
Query: 251 EDFLPLAIWRRTSYLDIQRATDEFNECNLLGTSSFGSVYKGTISD-GTDVAIKVFNLQLE 309
           EDFL    W   S    Q   D+F+    LGT SFG V      + G   A+K+ + Q  
Sbjct: 24  EDFL--KKWETPSQNTAQ--LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV 79
Query: 310 RAFRSFD---SECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFL 366
              +  +   +E  +L+ V    L+K+  S+ +     +V+E++  G +   L     F 
Sbjct: 80  VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS 139
Query: 367 DILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG 426
           +   R      +    EYLH    S+ +I+ DLKP N+L+D+     V+DFG  K +   
Sbjct: 140 EPHARF-YAAQIVLTFEYLH----SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--- 191
Query: 427 EDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLME 467
               R      T  Y+APE  L    +   D ++ GVL+ E
Sbjct: 192 --KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 230

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 97/221 (43%), Gaps = 18/221 (8%)
Query: 251 EDFLPLAIWRRTSYLDIQRATDEFNECNLLGTSSFGSVYKGTISD-GTDVAIKVFNLQLE 309
           EDFL    W   S    Q   D+F+    LGT SFG V      + G   A+K+ + Q  
Sbjct: 24  EDFL--KKWETPSQNTAQ--LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV 79
Query: 310 RAFRSFD---SECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFL 366
              +  +   +E  +L+ V    L+K+  S+ +     +V+E++  G +   L     F 
Sbjct: 80  VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS 139
Query: 367 DILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG 426
           +   R      +    EYLH    S+ +I+ DLKP N+L+D+     V+DFG  K +   
Sbjct: 140 EPHARF-YAAQIVLTFEYLH----SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--- 191
Query: 427 EDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLME 467
               R      T  Y+APE  L    +   D ++ GVL+ E
Sbjct: 192 --KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 230

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 88/200 (44%), Gaps = 14/200 (7%)
Query: 272 DEFNECNLLGTSSFGSVY-KGTISDGTDVAIKVFNLQLERAFRSFD---SECEVLRNVRH 327
           D+F     LGT SFG V     +  G   A+K+ + Q     +  +   +E  +L+ V  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
             L K+  S+ +     +V+E+ P G +   L     F +   R      +    EYLH 
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 388 GHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYG 447
              S+ +I+ DLKP N+++D+     V+DFG  K +       R      T  Y+APE  
Sbjct: 160 ---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV-----KGRTWXLCGTPEYLAPEII 211
Query: 448 LEGIVSAKCDVYSYGVLLME 467
           L    +   D ++ GVL+ E
Sbjct: 212 LSKGYNKAVDWWALGVLIYE 231

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 97/221 (43%), Gaps = 18/221 (8%)
Query: 251 EDFLPLAIWRRTSYLDIQRATDEFNECNLLGTSSFGSVYKGTISD-GTDVAIKVFNLQLE 309
           EDFL    W   S    Q   D+F+    LGT SFG V      + G   A+K+ + Q  
Sbjct: 24  EDFL--KKWETPSQNTAQ--LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV 79
Query: 310 RAFRSFD---SECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFL 366
              +  +   +E  +L+ V    L+K+  S+ +     +V+E++  G +   L     F 
Sbjct: 80  VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS 139
Query: 367 DILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG 426
           +   R      +    EYLH    S+ +I+ DLKP N+L+D+     V+DFG  K +   
Sbjct: 140 EPHARF-YAAQIVLTFEYLH----SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--- 191
Query: 427 EDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLME 467
               R      T  Y+APE  L    +   D ++ GVL+ E
Sbjct: 192 --KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 230

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 99/213 (46%), Gaps = 27/213 (12%)
Query: 269 RATDEFNECNLLGTSSFGSVYKGTISD-GTDVAIKVF------NLQLERAFRSFDSECEV 321
           ++ +++    L+G  S+G V K    D G  VAIK F       +  + A R    E ++
Sbjct: 22  QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR----EIKL 77
Query: 322 LRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKW-LYSHNYFLDILERLNIMIDVGS 380
           L+ +RH NL+ +L          LV EF+ +  L+   L+ +     ++++    I  G 
Sbjct: 78  LKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGI 137
Query: 381 ALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLL---GEGEDSVRQTMTMA 437
              + HN      IIH D+KP NIL+ ++ V  + DFG  + L   GE  D       +A
Sbjct: 138 GFCHSHN------IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDD-----EVA 186
Query: 438 TIGYMAPEYGLEGIVSAKC-DVYSYGVLLMETF 469
           T  Y APE  +  +   K  DV++ G L+ E F
Sbjct: 187 TRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMF 219

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 95/209 (45%), Gaps = 20/209 (9%)
Query: 280 LGTSSFGSVYKGTISD-GTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYS 338
           LG  +FG VYK    + G   A KV   + E     +  E E+L    H  ++K+L +Y 
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 339 NPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCD 398
           +     +++EF P G+++  +   +  L   +   +   +  AL +LH    S  IIH D
Sbjct: 79  HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH----SKRIIHRD 134
Query: 399 LKPTNILLDENMVAHVSDFGI----YKLLGEGEDSVRQTMTMATIGYMAPEYGL-----E 449
           LK  N+L+       ++DFG+     K L +  DS      + T  +MAPE  +     +
Sbjct: 135 LKAGNVLMTLEGDIRLADFGVSAKNLKTL-QKRDSF-----IGTPYWMAPEVVMCETMKD 188
Query: 450 GIVSAKCDVYSYGVLLMETFTRKRPTDEM 478
                K D++S G+ L+E    + P  E+
Sbjct: 189 TPYDYKADIWSLGITLIEMAQIEPPHHEL 217

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 97/221 (43%), Gaps = 18/221 (8%)
Query: 251 EDFLPLAIWRRTSYLDIQRATDEFNECNLLGTSSFGSVYKGTISD-GTDVAIKVFNLQLE 309
           EDFL    W   S    Q   D+F+    LGT SFG V      + G   A+K+ + Q  
Sbjct: 24  EDFL--KKWETPSQNTAQ--LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV 79
Query: 310 RAFRSFD---SECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFL 366
              +  +   +E  +L+ V    L+K+  S+ +     +V+E++  G +   L     F 
Sbjct: 80  VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS 139
Query: 367 DILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG 426
           +   R      +    EYLH    S+ +I+ DLKP N+L+D+     V+DFG  K +   
Sbjct: 140 EPHARF-YAAQIVLTFEYLH----SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--- 191
Query: 427 EDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLME 467
               R      T  Y+APE  L    +   D ++ GVL+ E
Sbjct: 192 --KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 230

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 99/222 (44%), Gaps = 20/222 (9%)
Query: 251 EDFLPLAIWRRTSYLDIQRATDEFNECNLLGTSSFGSVYKGTISD-GTDVAIKVFNLQLE 309
           EDFL    W   S    Q   D+F+    LGT SFG V      + G   A+K+ + Q  
Sbjct: 45  EDFL--KKWETPSQNTAQ--LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV 100
Query: 310 RAFRSFD---SECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFL 366
              +  +   +E  +L+ V    L+K+  S+ +     +V+E++  G +   L     F 
Sbjct: 101 VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS 160
Query: 367 DILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG 426
           +   R      +    EYLH    S+ +I+ DLKP N+L+D+     V+DFG  K +   
Sbjct: 161 EPHARF-YAAQIVLTFEYLH----SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGA 215
Query: 427 EDSVRQTMTM-ATIGYMAPEYGLEGIVSAKCDVYSYGVLLME 467
                 T T+  T  Y+APE  L    +   D ++ GVL+ E
Sbjct: 216 ------TWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 251

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 97/221 (43%), Gaps = 18/221 (8%)
Query: 251 EDFLPLAIWRRTSYLDIQRATDEFNECNLLGTSSFGSVYKGTISD-GTDVAIKVFNLQLE 309
           EDFL    W   S    Q   D+F+    LGT SFG V      + G   A+K+ + Q  
Sbjct: 25  EDFL--KKWETPSQNTAQ--LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV 80
Query: 310 RAFRSFD---SECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFL 366
              +  +   +E  +L+ V    L+K+  S+ +     +V+E++  G +   L     F 
Sbjct: 81  VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS 140
Query: 367 DILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG 426
           +   R      +    EYLH    S+ +I+ DLKP N+L+D+     V+DFG  K +   
Sbjct: 141 EPHARF-YAAQIVLTFEYLH----SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--- 192
Query: 427 EDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLME 467
               R      T  Y+APE  L    +   D ++ GVL+ E
Sbjct: 193 --KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 231

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 65/262 (24%), Positives = 125/262 (47%), Gaps = 19/262 (7%)
Query: 239 RCRNRNTKKSDHEDFLPLAIWRRTSYLDIQRATDEFNECNLLGTSSFGSVYKGTI-SDGT 297
           R   R  ++  HE F   A+       D +   D F +   +G  S G V   T+ S G 
Sbjct: 122 RSPQREPQRVSHEQFR-AALQLVVDPGDPRSYLDNFIK---IGEGSTGIVCIATVRSSGK 177
Query: 298 DVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEK 357
            VA+K  +L+ ++      +E  ++R+ +H N++++ +SY   D   +V+EF+  G+L  
Sbjct: 178 LVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTD 237
Query: 358 WLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDF 417
            + +H   ++  +   + + V  AL  LH    +  +IH D+K  +ILL  +    +SDF
Sbjct: 238 -IVTHTR-MNEEQIAAVCLAVLQALSVLH----AQGVIHRDIKSDSILLTHDGRVKLSDF 291
Query: 418 GIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDE 477
           G    +   ++  R+   + T  +MAPE         + D++S G++++E    + P   
Sbjct: 292 GFCAQV--SKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP--- 346
Query: 478 MFIGEMSLR--RWVKESLPHGL 497
            +  E  L+  + ++++LP  L
Sbjct: 347 -YFNEPPLKAMKMIRDNLPPRL 367

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 102/212 (48%), Gaps = 28/212 (13%)
Query: 285 FGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLR--NVRHRNLIKILSSY---SN 339
           FG V+K  + +   VA+K+F LQ ++   S+ SE E+     ++H NL++ +++    SN
Sbjct: 28  FGCVWKAQLMNDF-VAVKIFPLQDKQ---SWQSEREIFSTPGMKHENLLQFIAAEKRGSN 83
Query: 340 PDFK-ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN--------GHS 390
            + +  L+  F   GSL  +L  +   +   E  ++   +   L YLH         GH 
Sbjct: 84  LEVELWLITAFHDKGSLTDYLKGN--IITWNELCHVAETMSRGLSYLHEDVPWCRGEGHK 141
Query: 391 SVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEG 450
              I H D K  N+LL  ++ A ++DFG+      G+        + T  YMAPE  LEG
Sbjct: 142 P-SIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPEV-LEG 199
Query: 451 IVS------AKCDVYSYGVLLMETFTRKRPTD 476
            ++       + D+Y+ G++L E  +R +  D
Sbjct: 200 AINFQRDAFLRIDMYAMGLVLWELVSRCKAAD 231

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 100/216 (46%), Gaps = 36/216 (16%)
Query: 280 LGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNV--RHRNLIKILSSY 337
           +G   FG V++G    G +VA+K+F+    R  RS+  E E+ + V  RH N++  +++ 
Sbjct: 50  IGKGRFGEVWRGKWR-GEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAA- 104
Query: 338 SNPDFKA-----LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH----NG 388
            N D        LV ++  +GSL  +L  + Y + +   + + +   S L +LH      
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 162
Query: 389 HSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMA------TIGYM 442
                I H DLK  NIL+ +N    ++D G    L    DS   T+ +A      T  YM
Sbjct: 163 QGKPAIAHRDLKSKNILVKKNGTCCIADLG----LAVRHDSATDTIDIAPNHRVGTKRYM 218
Query: 443 APEYGLEGIVSAK-------CDVYSYGVLLMETFTR 471
           APE  L+  ++ K        D+Y+ G++  E   R
Sbjct: 219 APEV-LDDSINMKHFESFKRADIYAMGLVFWEIARR 253

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 94/206 (45%), Gaps = 13/206 (6%)
Query: 280 LGTSSFGSVYKGTI---SDGTDVAIKVFNLQLERA-FRSFDSECEVLRNVRHRNLIKILS 335
           LG  +FGSV +G         DVAIKV     E+A       E +++  + +  +++++ 
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 336 SYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHII 395
                +   LV+E    G L K+L      + +     ++  V   ++YL   +     +
Sbjct: 78  V-CQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN----FV 132
Query: 396 HCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMAT--IGYMAPEYGLEGIVS 453
           H DL   N+LL     A +SDFG+ K LG  +DS     +     + + APE       S
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGLSKALG-ADDSYYTARSAGKWPLKWYAPECINFRKFS 191
Query: 454 AKCDVYSYGVLLMETFTR-KRPTDEM 478
           ++ DV+SYGV + E  +  ++P  +M
Sbjct: 192 SRSDVWSYGVTMWEALSYGQKPYKKM 217

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 92/211 (43%), Gaps = 21/211 (9%)
Query: 278 NLLGTSSFGSVYKGTISDGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILS 335
            L+G   FG VY G      +VAI++ +++   E   ++F  E    R  RH N++  + 
Sbjct: 39  ELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 336 SYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHII 395
           +  +P   A++       +L   +      LD+ +   I  ++   + YLH    +  I+
Sbjct: 97  ACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH----AKGIL 152
Query: 396 HCDLKPTNILLDENMVAHVSDFGIYKL-----LGEGEDSVRQT------MTMATIGYMAP 444
           H DLK  N+  D   V  ++DFG++ +      G  ED +R        +    I  ++P
Sbjct: 153 HKDLKSKNVFYDNGKVV-ITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSP 211
Query: 445 EYGLEGI-VSAKCDVYSYGVLLMETFTRKRP 474
           +   + +  S   DV++ G +  E   R+ P
Sbjct: 212 DTEEDKLPFSKHSDVFALGTIWYELHAREWP 242

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 100/216 (46%), Gaps = 36/216 (16%)
Query: 280 LGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNV--RHRNLIKILSSY 337
           +G   FG V++G    G +VA+K+F+    R  RS+  E E+ + V  RH N++  +++ 
Sbjct: 37  IGKGRFGEVWRGKWR-GEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAA- 91
Query: 338 SNPDFKA-----LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH----NG 388
            N D        LV ++  +GSL  +L  + Y + +   + + +   S L +LH      
Sbjct: 92  DNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 149
Query: 389 HSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMA------TIGYM 442
                I H DLK  NIL+ +N    ++D G    L    DS   T+ +A      T  YM
Sbjct: 150 QGKPAIAHRDLKSKNILVKKNGTCCIADLG----LAVRHDSATDTIDIAPNHRVGTKRYM 205
Query: 443 APEYGLEGIVSAK-------CDVYSYGVLLMETFTR 471
           APE  L+  ++ K        D+Y+ G++  E   R
Sbjct: 206 APEV-LDDSINMKHFESFKRADIYAMGLVFWEIARR 240

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 88/200 (44%), Gaps = 14/200 (7%)
Query: 272 DEFNECNLLGTSSFGSVY-KGTISDGTDVAIKVFNLQLERAFRSFD---SECEVLRNVRH 327
           D+F     LGT SFG V     +  G   A+K+ + Q     +  +   +E  +L+ V  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
             L K+  S+ +     +V+E+ P G +   L     F +   R      +    EYLH 
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 388 GHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYG 447
              S+ +I+ DLKP N+++D+     V+DFG  K +       R      T  Y+APE  
Sbjct: 160 ---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV-----KGRTWXLCGTPEYLAPEII 211
Query: 448 LEGIVSAKCDVYSYGVLLME 467
           L    +   D ++ GVL+ E
Sbjct: 212 LSKGYNKAVDWWALGVLIYE 231

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 79/308 (25%), Positives = 139/308 (45%), Gaps = 44/308 (14%)
Query: 272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRS-FDSECEVLRNVRHRN 329
           D+F + + LG  + G V+K +    G  +A K+ +L+++ A R+    E +VL       
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 68
Query: 330 LIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLD-ILERLNIMIDVGSALEYLHNG 388
           ++    ++ +    ++ +E M  GSL++ L       + IL +++I +  G  L YL   
Sbjct: 69  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG--LTYLREK 126
Query: 389 HSSVHIIHCDLKPTNILLDENMVAHVSDFGIY-KLLGEGEDSVRQTMTMATIGYMAPEYG 447
           H    I+H D+KP+NIL++      + DFG+  +L+ E  +       + T  YM+PE  
Sbjct: 127 HK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMANEF-----VGTRSYMSPER- 177
Query: 448 LEGI-VSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLV 506
           L+G   S + D++S G+ L+E    + P   M I E  L  ++    P  L   V     
Sbjct: 178 LQGTHYSVQSDIWSMGLSLVEMAVGRYPRPPMAIFE--LLDYIVNEPPPKLPSAV----- 230
Query: 507 REEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKFL---DDAAATNW 563
                FS      L   DF   C +++P  R       A LK++ V       DA   ++
Sbjct: 231 -----FS------LEFQDFVNKCLIKNPAER-------ADLKQLMVHAFIKRSDAEEVDF 272
Query: 564 RNFHCVSL 571
             + C ++
Sbjct: 273 AGWLCSTI 280

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 100/216 (46%), Gaps = 36/216 (16%)
Query: 280 LGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNV--RHRNLIKILSSY 337
           +G   FG V++G    G +VA+K+F+    R  RS+  E E+ + V  RH N++  +++ 
Sbjct: 11  IGKGRFGEVWRGKWR-GEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAA- 65
Query: 338 SNPDFKA-----LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH----NG 388
            N D        LV ++  +GSL  +L  + Y + +   + + +   S L +LH      
Sbjct: 66  DNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 123
Query: 389 HSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMA------TIGYM 442
                I H DLK  NIL+ +N    ++D G    L    DS   T+ +A      T  YM
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLG----LAVRHDSATDTIDIAPNHRVGTKRYM 179
Query: 443 APEYGLEGIVSAK-------CDVYSYGVLLMETFTR 471
           APE  L+  ++ K        D+Y+ G++  E   R
Sbjct: 180 APEV-LDDSINMKHFESFKRADIYAMGLVFWEIARR 214

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 95/209 (45%), Gaps = 20/209 (9%)
Query: 280 LGTSSFGSVYKGTISD-GTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYS 338
           LG  +FG VYK    + G   A KV   + E     +  E E+L    H  ++K+L +Y 
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 339 NPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCD 398
           +     +++EF P G+++  +   +  L   +   +   +  AL +LH    S  IIH D
Sbjct: 87  HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH----SKRIIHRD 142
Query: 399 LKPTNILLDENMVAHVSDFGI----YKLLGEGEDSVRQTMTMATIGYMAPEYGL-----E 449
           LK  N+L+       ++DFG+     K L +  DS      + T  +MAPE  +     +
Sbjct: 143 LKAGNVLMTLEGDIRLADFGVSAKNLKTL-QKRDSF-----IGTPYWMAPEVVMCETMKD 196
Query: 450 GIVSAKCDVYSYGVLLMETFTRKRPTDEM 478
                K D++S G+ L+E    + P  E+
Sbjct: 197 TPYDYKADIWSLGITLIEMAQIEPPHHEL 225

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 100/216 (46%), Gaps = 36/216 (16%)
Query: 280 LGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNV--RHRNLIKILSSY 337
           +G   FG V++G    G +VA+K+F+    R  RS+  E E+ + V  RH N++  +++ 
Sbjct: 17  IGKGRFGEVWRGKWR-GEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAA- 71
Query: 338 SNPDFKA-----LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH----NG 388
            N D        LV ++  +GSL  +L  + Y + +   + + +   S L +LH      
Sbjct: 72  DNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 129
Query: 389 HSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMA------TIGYM 442
                I H DLK  NIL+ +N    ++D G    L    DS   T+ +A      T  YM
Sbjct: 130 QGKPAIAHRDLKSKNILVKKNGTCCIADLG----LAVRHDSATDTIDIAPNHRVGTKRYM 185
Query: 443 APEYGLEGIVSAK-------CDVYSYGVLLMETFTR 471
           APE  L+  ++ K        D+Y+ G++  E   R
Sbjct: 186 APEV-LDDSINMKHFESFKRADIYAMGLVFWEIARR 220

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 100/216 (46%), Gaps = 36/216 (16%)
Query: 280 LGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNV--RHRNLIKILSSY 337
           +G   FG V++G    G +VA+K+F+    R  RS+  E E+ + V  RH N++  +++ 
Sbjct: 14  IGKGRFGEVWRGKWR-GEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAA- 68
Query: 338 SNPDFKA-----LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH----NG 388
            N D        LV ++  +GSL  +L  + Y + +   + + +   S L +LH      
Sbjct: 69  DNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 126
Query: 389 HSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMA------TIGYM 442
                I H DLK  NIL+ +N    ++D G    L    DS   T+ +A      T  YM
Sbjct: 127 QGKPAIAHRDLKSKNILVKKNGTCCIADLG----LAVRHDSATDTIDIAPNHRVGTKRYM 182
Query: 443 APEYGLEGIVSAK-------CDVYSYGVLLMETFTR 471
           APE  L+  ++ K        D+Y+ G++  E   R
Sbjct: 183 APEV-LDDSINMKHFESFKRADIYAMGLVFWEIARR 217

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 89/200 (44%), Gaps = 14/200 (7%)
Query: 272 DEFNECNLLGTSSFGSVY-KGTISDGTDVAIKVFNLQLERAFRSFD---SECEVLRNVRH 327
           D+F     LGT SFG V     +  G   A+K+ + Q     +  +   +E  +L+ V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
             L+K+  S+ +     +V+E++  G +   L     F +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 388 GHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYG 447
              S+ +I+ DLKP N+L+D+     V+DFG  K +       R      T  Y+APE  
Sbjct: 159 ---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEII 210
Query: 448 LEGIVSAKCDVYSYGVLLME 467
           L    +   D ++ GVL+ E
Sbjct: 211 LSKGYNKAVDWWALGVLIYE 230

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 100/216 (46%), Gaps = 36/216 (16%)
Query: 280 LGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNV--RHRNLIKILSSY 337
           +G   FG V++G    G +VA+K+F+    R  RS+  E E+ + V  RH N++  +++ 
Sbjct: 12  IGKGRFGEVWRGKWR-GEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAA- 66
Query: 338 SNPDFKA-----LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH----NG 388
            N D        LV ++  +GSL  +L  + Y + +   + + +   S L +LH      
Sbjct: 67  DNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 124
Query: 389 HSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMA------TIGYM 442
                I H DLK  NIL+ +N    ++D G    L    DS   T+ +A      T  YM
Sbjct: 125 QGKPAIAHRDLKSKNILVKKNGTCCIADLG----LAVRHDSATDTIDIAPNHRVGTKRYM 180
Query: 443 APEYGLEGIVSAK-------CDVYSYGVLLMETFTR 471
           APE  L+  ++ K        D+Y+ G++  E   R
Sbjct: 181 APEV-LDDSINMKHFESFKRADIYAMGLVFWEIARR 215

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 88/197 (44%), Gaps = 11/197 (5%)
Query: 280 LGTSSFGSVYK-GTISDGTDVAIKVFNL--QLERAFRSFDSECEVLRNVRHRNLIKILSS 336
           +GT S+G   K    SDG  +  K  +     E   +   SE  +LR ++H N+++    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 337 YSNPDFKAL--VLEFMPNGSLEKWLYS---HNYFLDILERLNIMIDVGSALEYLHNGHSS 391
             +     L  V+E+   G L   +        +LD    L +M  +  AL+  H     
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 392 VH-IIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEG 450
            H ++H DLKP N+ LD      + DFG+ ++L   ED  ++   + T  YM+PE     
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKE--FVGTPYYMSPEQMNRM 191
Query: 451 IVSAKCDVYSYGVLLME 467
             + K D++S G LL E
Sbjct: 192 SYNEKSDIWSLGCLLYE 208

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 93/194 (47%), Gaps = 17/194 (8%)
Query: 278 NLLGTSSFGSVYKGTISDGTDV---AIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKIL 334
           N +G  S+G V K  +  GT +   A K+    +E   R F  E E+++++ H N+I++ 
Sbjct: 15  NTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDR-FKQEIEIMKSLDHPNIIRLY 72
Query: 335 SSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHI 394
            ++ +     LV+E    G L + +     F +  +   IM DV SA+ Y H     +++
Sbjct: 73  ETFEDNTDIYLVMELCTGGELFERVVHKRVFRES-DAARIMKDVLSAVAYCHK----LNV 127
Query: 395 IHCDLKPTNILL---DENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGI 451
            H DLKP N L      +    + DFG+      G+        + T  Y++P+  LEG+
Sbjct: 128 AHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK---MMRTKVGTPYYVSPQV-LEGL 183
Query: 452 VSAKCDVYSYGVLL 465
              +CD +S GV++
Sbjct: 184 YGPECDEWSAGVMM 197

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 110/218 (50%), Gaps = 15/218 (6%)
Query: 280 LGTSSFGSVYKGTI-SDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYS 338
           +G  S G V   T+ S G  VA+K  +L+ ++      +E  ++R+ +H N++++ +SY 
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 339 NPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCD 398
             D   +V+EF+  G+L   + +H   ++  +   + + V  AL  LH    +  +IH D
Sbjct: 88  VGDELWVVMEFLEGGALTD-IVTHTR-MNEEQIAAVCLAVLQALSVLH----AQGVIHRD 141
Query: 399 LKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDV 458
           +K  +ILL  +    +SDFG    +   ++  R+   + T  +MAPE         + D+
Sbjct: 142 IKSDSILLTHDGRVKLSDFGFCAQV--SKEVPRRKXLVGTPYWMAPELISRLPYGPEVDI 199
Query: 459 YSYGVLLMETFTRKRPTDEMFIGEMSLR--RWVKESLP 494
           +S G++++E    + P    +  E  L+  + ++++LP
Sbjct: 200 WSLGIMVIEMVDGEPP----YFNEPPLKAMKMIRDNLP 233

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 63/256 (24%), Positives = 123/256 (48%), Gaps = 19/256 (7%)
Query: 242 NRNTKKSDHEDFLPLAIWRRTSYLDIQRATDEFNECNLLGTSSFGSVYKGTI-SDGTDVA 300
            R  ++  HE F   A+       D +   D F +   +G  S G V   T+ S G  VA
Sbjct: 5   QREPQRVSHEQFR-AALQLVVDPGDPRSYLDNFIK---IGEGSTGIVCIATVRSSGKLVA 60
Query: 301 IKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLY 360
           +K  +L+ ++      +E  ++R+ +H N++++ +SY   D   +V+EF+  G+L   + 
Sbjct: 61  VKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTD-IV 119
Query: 361 SHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIY 420
           +H   ++  +   + + V  AL  LH    +  +IH D+K  +ILL  +    +SDFG  
Sbjct: 120 THTR-MNEEQIAAVCLAVLQALSVLH----AQGVIHRDIKSDSILLTHDGRVKLSDFGFC 174
Query: 421 KLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFI 480
             +   ++  R+   + T  +MAPE         + D++S G++++E    + P    + 
Sbjct: 175 AQV--SKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP----YF 228
Query: 481 GEMSLR--RWVKESLP 494
            E  L+  + ++++LP
Sbjct: 229 NEPPLKAMKMIRDNLP 244

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 96/227 (42%), Gaps = 34/227 (14%)
Query: 269 RATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNVRH 327
           R   +F E  +LG  +FG V K   + D    AIK      E    +  SE  +L ++ H
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNH 61
Query: 328 -------------RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNI 374
                        RN +K +++        + +E+  N +L   ++S N      E   +
Sbjct: 62  QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRL 121
Query: 375 MIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVR--- 431
              +  AL Y+H    S  IIH DLKP NI +DE+    + DFG+ K +    D ++   
Sbjct: 122 FRQILEALSYIH----SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 432 ---------QTMTMATIGYMAPEYGLEGI--VSAKCDVYSYGVLLME 467
                     T  + T  Y+A E  L+G    + K D+YS G++  E
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEV-LDGTGHYNEKIDMYSLGIIFFE 223

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/256 (24%), Positives = 123/256 (48%), Gaps = 19/256 (7%)
Query: 242 NRNTKKSDHEDFLPLAIWRRTSYLDIQRATDEFNECNLLGTSSFGSVYKGTI-SDGTDVA 300
            R  ++  HE F   A+       D +   D F +   +G  S G V   T+ S G  VA
Sbjct: 3   QREPQRVSHEQFR-AALQLVVDPGDPRSYLDNFIK---IGEGSTGIVCIATVRSSGKLVA 58
Query: 301 IKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLY 360
           +K  +L+ ++      +E  ++R+ +H N++++ +SY   D   +V+EF+  G+L   + 
Sbjct: 59  VKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTD-IV 117
Query: 361 SHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIY 420
           +H   ++  +   + + V  AL  LH    +  +IH D+K  +ILL  +    +SDFG  
Sbjct: 118 THTR-MNEEQIAAVCLAVLQALSVLH----AQGVIHRDIKSDSILLTHDGRVKLSDFGFC 172
Query: 421 KLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFI 480
             +   ++  R+   + T  +MAPE         + D++S G++++E    + P    + 
Sbjct: 173 AQV--SKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP----YF 226
Query: 481 GEMSLR--RWVKESLP 494
            E  L+  + ++++LP
Sbjct: 227 NEPPLKAMKMIRDNLP 242

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 93/194 (47%), Gaps = 17/194 (8%)
Query: 278 NLLGTSSFGSVYKGTISDGTDV---AIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKIL 334
           N +G  S+G V K  +  GT +   A K+    +E   R F  E E+++++ H N+I++ 
Sbjct: 32  NTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDR-FKQEIEIMKSLDHPNIIRLY 89
Query: 335 SSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHI 394
            ++ +     LV+E    G L + +     F +  +   IM DV SA+ Y H     +++
Sbjct: 90  ETFEDNTDIYLVMELCTGGELFERVVHKRVFRES-DAARIMKDVLSAVAYCHK----LNV 144
Query: 395 IHCDLKPTNILL---DENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGI 451
            H DLKP N L      +    + DFG+      G+        + T  Y++P+  LEG+
Sbjct: 145 AHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK---MMRTKVGTPYYVSPQV-LEGL 200
Query: 452 VSAKCDVYSYGVLL 465
              +CD +S GV++
Sbjct: 201 YGPECDEWSAGVMM 214

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 110/218 (50%), Gaps = 15/218 (6%)
Query: 280 LGTSSFGSVYKGTI-SDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYS 338
           +G  S G V   T+ S G  VA+K  +L+ ++      +E  ++R+ +H N++++ +SY 
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 91
Query: 339 NPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCD 398
             D   +V+EF+  G+L   + +H   ++  +   + + V  AL  LH    +  +IH D
Sbjct: 92  VGDELWVVMEFLEGGALTD-IVTHTR-MNEEQIAAVCLAVLQALSVLH----AQGVIHRD 145
Query: 399 LKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDV 458
           +K  +ILL  +    +SDFG    +   ++  R+   + T  +MAPE         + D+
Sbjct: 146 IKSDSILLTHDGRVKLSDFGFCAQV--SKEVPRRKXLVGTPYWMAPELISRLPYGPEVDI 203
Query: 459 YSYGVLLMETFTRKRPTDEMFIGEMSLR--RWVKESLP 494
           +S G++++E    + P    +  E  L+  + ++++LP
Sbjct: 204 WSLGIMVIEMVDGEPP----YFNEPPLKAMKMIRDNLP 237

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 78/307 (25%), Positives = 139/307 (45%), Gaps = 32/307 (10%)
Query: 272 DEFNECNLLGTSSFGSVYK-GTISDGTDVAIKVFNLQLERAFRS-FDSECEVLRNVRHRN 329
           D+F + + LG  + G V+K      G  +A K+ +L+++ A R+    E +VL       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 330 LIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLD-ILERLNIMIDVGSALEYLHNG 388
           ++    ++ +    ++ +E M  GSL++ L       + IL +++I +  G  L YL   
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG--LTYLREK 123
Query: 389 HSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGL 448
           H    I+H D+KP+NIL++      + DFG+    G+  DS+  +  + T  YM+PE  L
Sbjct: 124 HK---IMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSF-VGTRSYMSPER-L 175
Query: 449 EGI-VSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVR 507
           +G   S + D++S G+ L+E    + P       E S         P  + E++D  +V 
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEDS-------RPPMAIFELLDY-IVN 227
Query: 508 EEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKFL---DDAAATNWR 564
           E           L   DF   C +++P  R       A LK++ V       DA   ++ 
Sbjct: 228 EPPPKLPSGVFSLEFQDFVNKCLIKNPAER-------ADLKQLMVHAFIKRSDAEEVDFA 280
Query: 565 NFHCVSL 571
            + C ++
Sbjct: 281 GWLCSTI 287

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 94/211 (44%), Gaps = 18/211 (8%)
Query: 272 DEFNECNLLGTSSFGSVYKGTISDGTDV-AIKVFNLQLERAFRSFDSEC-----EVLRNV 325
           D F    +LG  SFG V    + +  D+ A+KV  L+ +   +  D EC      +L   
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKV--LKKDVILQDDDVECTMTEKRILSLA 80
Query: 326 R-HRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEY 384
           R H  L ++   +  PD    V+EF+  G L   +     F +   R     ++ SAL +
Sbjct: 81  RNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF-YAAEIISALMF 139
Query: 385 LHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTM-ATIGYMA 443
           LH+      II+ DLK  N+LLD      ++DFG+ K   EG  +   T T   T  Y+A
Sbjct: 140 LHDKG----IIYRDLKLDNVLLDHEGHCKLADFGMCK---EGICNGVTTATFCGTPDYIA 192
Query: 444 PEYGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
           PE   E +     D ++ GVLL E      P
Sbjct: 193 PEILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 97/221 (43%), Gaps = 18/221 (8%)
Query: 251 EDFLPLAIWRRTSYLDIQRATDEFNECNLLGTSSFGSVYKGTISD-GTDVAIKVFNLQLE 309
           EDFL    W   S    Q   D+F+    LGT SFG V      + G   A+K+ + Q  
Sbjct: 24  EDFL--KKWETPSQNTAQ--LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV 79
Query: 310 RAFRSFD---SECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFL 366
              +  +   +E  +L+ V    L+K+  S+ +     +V+E++  G +   L     F 
Sbjct: 80  VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS 139
Query: 367 DILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG 426
           +   R      +    EYLH    S+ +I+ DLKP N+L+D+     V+DFG  K +   
Sbjct: 140 EPHARF-YAAQIVLTFEYLH----SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--- 191
Query: 427 EDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLME 467
               R      T  Y+APE  L    +   D ++ GVL+ +
Sbjct: 192 --KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYQ 230

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 98/211 (46%), Gaps = 19/211 (9%)
Query: 271 TDEFNECNLLGTSSFGSVYKGTISDGT--DVAIKVFNLQLERAFRSFDSECEVL-RNVRH 327
           TD +     +G  S+ SV K  I   T  + A+K+    ++++ R    E E+L R  +H
Sbjct: 21  TDGYEVKEDIGVGSY-SVCKRCIHKATNXEFAVKI----IDKSKRDPTEEIEILLRYGQH 75
Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
            N+I +   Y +  +  +V E    G L   +    +F +  E   ++  +   +EYLH 
Sbjct: 76  PNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQKFFSE-REASAVLFTITKTVEYLH- 133
Query: 388 GHSSVHIIHCDLKPTNIL-LDEN---MVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
              +  ++H DLKP+NIL +DE+       + DFG  K L   E+ +  T    T  ++A
Sbjct: 134 ---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL-RAENGLLXTPCY-TANFVA 188
Query: 444 PEYGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
           PE        A CD++S GVLL    T   P
Sbjct: 189 PEVLERQGYDAACDIWSLGVLLYTXLTGYTP 219

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 95/206 (46%), Gaps = 14/206 (6%)
Query: 273 EFNECNLLGTSSFGSVYK-GTISDGTDVAIKVFNLQLERAFRSFD---SECEVLRNVRHR 328
           +F     LGT SFG V+   +  +G   A+KV   ++    +  +    E  +L  V H 
Sbjct: 7   DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHP 66
Query: 329 NLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNG 388
            +I++  ++ +     ++++++  G L   L     F + + +     +V  ALEYLH  
Sbjct: 67  FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKF-YAAEVCLALEYLH-- 123
Query: 389 HSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGL 448
             S  II+ DLKP NILLD+N    ++DFG  K + +    +       T  Y+APE   
Sbjct: 124 --SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYXL-----CGTPDYIAPEVVS 176
Query: 449 EGIVSAKCDVYSYGVLLMETFTRKRP 474
               +   D +S+G+L+ E      P
Sbjct: 177 TKPYNKSIDWWSFGILIYEMLAGYTP 202

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 92/210 (43%), Gaps = 19/210 (9%)
Query: 266 DIQRATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVF-----NLQLERAFRSFDSECE 320
           +IQR   E   C  +G   FG V++G      + A+ V      N   +     F  E  
Sbjct: 11  EIQRERIELGRC--IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 68
Query: 321 VLRNVRHRNLIKILSSYS-NPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVG 379
            +R   H +++K++   + NP +  +++E    G L  +L    Y LD+   +     + 
Sbjct: 69  TMRQFDHPHIVKLIGVITENPVW--IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLS 126
Query: 380 SALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSV--RQTMTMA 437
           +AL YL     S   +H D+   N+L+  N    + DFG+ + +   EDS   + +    
Sbjct: 127 TALAYLE----SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM---EDSTYYKASKGKL 179
Query: 438 TIGYMAPEYGLEGIVSAKCDVYSYGVLLME 467
            I +MAPE       ++  DV+ +GV + E
Sbjct: 180 PIKWMAPESINFRRFTSASDVWMFGVCMWE 209

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 105/207 (50%), Gaps = 14/207 (6%)
Query: 272 DEFNECNLLGTSSFGSVYK-GTISDGTDVAIKVFNLQLERAFRS-FDSECEVLRNVRHRN 329
           D+F + + LG  + G V+K      G  +A K+ +L+++ A R+    E +VL       
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 127
Query: 330 LIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLD-ILERLNIMIDVGSALEYLHNG 388
           ++    ++ +    ++ +E M  GSL++ L       + IL +++I +  G  L YL   
Sbjct: 128 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG--LTYLREK 185
Query: 389 HSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGL 448
           H    I+H D+KP+NIL++      + DFG+    G+  DS+  +  + T  YM+PE  L
Sbjct: 186 HK---IMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSF-VGTRSYMSPER-L 237
Query: 449 EGI-VSAKCDVYSYGVLLMETFTRKRP 474
           +G   S + D++S G+ L+E    + P
Sbjct: 238 QGTHYSVQSDIWSMGLSLVEMAVGRYP 264

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 68/307 (22%), Positives = 130/307 (42%), Gaps = 51/307 (16%)
Query: 270 ATDEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLERAFRSFD-SECEVLRNVRH 327
           ++ +F +   LG  ++ +VYKG   + G  VA+K   L  E    S    E  +++ ++H
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62
Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYF-------LDILERLNIMIDVGS 380
            N++++       +   LV EFM N  L+K++ S           L++++     +  G 
Sbjct: 63  ENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQG- 120
Query: 381 ALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIG 440
            L + H       I+H DLKP N+L+++     + DFG+ +  G   ++   +  + T+ 
Sbjct: 121 -LAFCHENK----ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF--SSEVVTLW 173
Query: 441 YMAPEYGLEG-IVSAKCDVYSYGVLLMETFTRK--------------------RPTDEMF 479
           Y AP+  +     S   D++S G +L E  T K                     P + ++
Sbjct: 174 YRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLW 233
Query: 480 IGEMSLRRW---VKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDM 536
                L ++   +++  P  L +V+  +          K     ++MDF       +PDM
Sbjct: 234 PSVTKLPKYNPNIQQRPPRDLRQVLQPH---------TKEPLDGNLMDFLHGLLQLNPDM 284
Query: 537 RINMTDA 543
           R++   A
Sbjct: 285 RLSAKQA 291

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 92/210 (43%), Gaps = 19/210 (9%)
Query: 266 DIQRATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVF-----NLQLERAFRSFDSECE 320
           +IQR   E   C  +G   FG V++G      + A+ V      N   +     F  E  
Sbjct: 34  EIQRERIELGRC--IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 91
Query: 321 VLRNVRHRNLIKILSSYS-NPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVG 379
            +R   H +++K++   + NP +  +++E    G L  +L    Y LD+   +     + 
Sbjct: 92  TMRQFDHPHIVKLIGVITENPVW--IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLS 149
Query: 380 SALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSV--RQTMTMA 437
           +AL YL     S   +H D+   N+L+  N    + DFG+ + +   EDS   + +    
Sbjct: 150 TALAYLE----SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM---EDSTYYKASKGKL 202
Query: 438 TIGYMAPEYGLEGIVSAKCDVYSYGVLLME 467
            I +MAPE       ++  DV+ +GV + E
Sbjct: 203 PIKWMAPESINFRRFTSASDVWMFGVCMWE 232

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 92/210 (43%), Gaps = 19/210 (9%)
Query: 266 DIQRATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVF-----NLQLERAFRSFDSECE 320
           +IQR   E   C  +G   FG V++G      + A+ V      N   +     F  E  
Sbjct: 9   EIQRERIELGRC--IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 66
Query: 321 VLRNVRHRNLIKILSSYS-NPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVG 379
            +R   H +++K++   + NP +  +++E    G L  +L    Y LD+   +     + 
Sbjct: 67  TMRQFDHPHIVKLIGVITENPVW--IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLS 124
Query: 380 SALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSV--RQTMTMA 437
           +AL YL     S   +H D+   N+L+  N    + DFG+ + +   EDS   + +    
Sbjct: 125 TALAYLE----SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM---EDSTYYKASKGKL 177
Query: 438 TIGYMAPEYGLEGIVSAKCDVYSYGVLLME 467
            I +MAPE       ++  DV+ +GV + E
Sbjct: 178 PIKWMAPESINFRRFTSASDVWMFGVCMWE 207

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 102/206 (49%), Gaps = 24/206 (11%)
Query: 274 FNECNLLGTSSFGSVYKGTISD-GTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIK 332
           + +  ++G  SFG VY+  + D G  VAIK   LQ +R F+  + E +++R + H N+++
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FK--NRELQIMRKLDHCNIVR 111
Query: 333 I----LSSYSNPD--FKALVLEFMPNG--SLEKWLYSHNYFLDILERLNIMIDVGSALEY 384
           +     SS    D  +  LVL+++P     + +        L ++     M  +  +L Y
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 171
Query: 385 LHNGHSSVHIIHCDLKPTNILLD-ENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           +H    S  I H D+KP N+LLD +  V  + DFG  K L  GE +V     + +  Y A
Sbjct: 172 IH----SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV---SXICSRYYRA 224
Query: 444 PE--YGLEGIVSAKCDVYSYGVLLME 467
           PE  +G     S+  DV+S G +L E
Sbjct: 225 PELIFGATDYTSS-IDVWSAGCVLAE 249

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 92/210 (43%), Gaps = 19/210 (9%)
Query: 266 DIQRATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVF-----NLQLERAFRSFDSECE 320
           +IQR   E   C  +G   FG V++G      + A+ V      N   +     F  E  
Sbjct: 6   EIQRERIELGRC--IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 63
Query: 321 VLRNVRHRNLIKILSSYS-NPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVG 379
            +R   H +++K++   + NP +  +++E    G L  +L    Y LD+   +     + 
Sbjct: 64  TMRQFDHPHIVKLIGVITENPVW--IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLS 121
Query: 380 SALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSV--RQTMTMA 437
           +AL YL     S   +H D+   N+L+  N    + DFG+ + +   EDS   + +    
Sbjct: 122 TALAYLE----SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM---EDSTYYKASKGKL 174
Query: 438 TIGYMAPEYGLEGIVSAKCDVYSYGVLLME 467
            I +MAPE       ++  DV+ +GV + E
Sbjct: 175 PIKWMAPESINFRRFTSASDVWMFGVCMWE 204

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 92/210 (43%), Gaps = 19/210 (9%)
Query: 266 DIQRATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVF-----NLQLERAFRSFDSECE 320
           +IQR   E   C  +G   FG V++G      + A+ V      N   +     F  E  
Sbjct: 8   EIQRERIELGRC--IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 65
Query: 321 VLRNVRHRNLIKILSSYS-NPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVG 379
            +R   H +++K++   + NP +  +++E    G L  +L    Y LD+   +     + 
Sbjct: 66  TMRQFDHPHIVKLIGVITENPVW--IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLS 123
Query: 380 SALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSV--RQTMTMA 437
           +AL YL     S   +H D+   N+L+  N    + DFG+ + +   EDS   + +    
Sbjct: 124 TALAYLE----SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM---EDSTYYKASKGKL 176
Query: 438 TIGYMAPEYGLEGIVSAKCDVYSYGVLLME 467
            I +MAPE       ++  DV+ +GV + E
Sbjct: 177 PIKWMAPESINFRRFTSASDVWMFGVCMWE 206

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 93/210 (44%), Gaps = 19/210 (9%)
Query: 266 DIQRATDEFNECNLLGTSSFGSVYKGTI----SDGTDVAIKVF-NLQLERAFRSFDSECE 320
           +IQR   E   C  +G   FG V++G      +    VAIK   N   +     F  E  
Sbjct: 6   EIQRERIELGRC--IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEAL 63
Query: 321 VLRNVRHRNLIKILSSYS-NPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVG 379
            +R   H +++K++   + NP +  +++E    G L  +L    Y LD+   +     + 
Sbjct: 64  TMRQFDHPHIVKLIGVITENPVW--IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLS 121
Query: 380 SALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSV--RQTMTMA 437
           +AL YL     S   +H D+   N+L+  N    + DFG+ + +   EDS   + +    
Sbjct: 122 TALAYLE----SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM---EDSTYYKASKGKL 174
Query: 438 TIGYMAPEYGLEGIVSAKCDVYSYGVLLME 467
            I +MAPE       ++  DV+ +GV + E
Sbjct: 175 PIKWMAPESINFRRFTSASDVWMFGVCMWE 204

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 97/221 (43%), Gaps = 18/221 (8%)
Query: 251 EDFLPLAIWRRTSYLDIQRATDEFNECNLLGTSSFGSVYKGTISD-GTDVAIKVFNLQLE 309
           EDFL    W   S    Q   D+F+    LGT SFG V      + G   A+K+ + Q  
Sbjct: 24  EDFL--KKWETPSQNTAQ--LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV 79
Query: 310 RAFRSFD---SECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFL 366
              +  +   +E  +L+ V    L+K+  S+ +     +V+E++  G +   L     F 
Sbjct: 80  VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS 139
Query: 367 DILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG 426
           +   R      +    EYLH    S+ +I+ DLKP N+++D+     V+DFG  K +   
Sbjct: 140 EPHARF-YAAQIVLTFEYLH----SLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRV--- 191
Query: 427 EDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLME 467
               R      T  Y+APE  +    +   D ++ GVL+ E
Sbjct: 192 --KGRTWXLCGTPEYLAPEIIISKGYNKAVDWWALGVLIYE 230

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 98/223 (43%), Gaps = 44/223 (19%)
Query: 276 ECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNV--RHRNLIKI 333
           EC  +G   +G V++G +  G  VA+K+F+    R  +S+  E E+   V  RH N++  
Sbjct: 14  EC--VGKGRYGEVWRG-LWHGESVAVKIFS---SRDEQSWFRETEIYNTVLLRHDNILGF 67
Query: 334 LSSYSNPDFKALVLEFMPNGSLEKWLYSHNY----FLDILER--------LNIMIDVGSA 381
           ++S    D  +       N S + WL +H +      D L+R        L + +     
Sbjct: 68  IAS----DMTSR------NSSTQLWLITHYHEHGSLYDFLQRQTLEPHLALRLAVSAACG 117
Query: 382 LEYLH----NGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGED--SVRQTMT 435
           L +LH           I H D K  N+L+  N+   ++D G+  +  +G D   +     
Sbjct: 118 LAHLHVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPR 177
Query: 436 MATIGYMAPEYGLEGIVSAKC-------DVYSYGVLLMETFTR 471
           + T  YMAPE  L+  +   C       D++++G++L E   R
Sbjct: 178 VGTKRYMAPEV-LDEQIRTDCFESYKWTDIWAFGLVLWEIARR 219

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/274 (23%), Positives = 117/274 (42%), Gaps = 29/274 (10%)
Query: 273 EFNECNLL---GTSSFGSVYKGTISDGTDVAIKVFNLQ--LERAFRSFDSECEVLRNVRH 327
           +F + N L     +  G ++KG    G D+ +KV  ++    R  R F+ EC  LR   H
Sbjct: 8   DFKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSH 66
Query: 328 RNLIKILSSYSNP--DFKALVLEFMPNGSLEKWLYS-HNYFLDILERLNIMIDVGSALEY 384
            N++ +L +  +P      L+  + P GSL   L+   N+ +D  + +   +D      +
Sbjct: 67  PNVLPVLGACQSPPAPHPTLITHWXPYGSLYNVLHEGTNFVVDQSQAVKFALDXARGXAF 126
Query: 385 LHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAP 444
           LH       I    L   ++ +DE+  A +S   +       + S +         ++AP
Sbjct: 127 LHTLEPL--IPRHALNSRSVXIDEDXTARISXADV-------KFSFQSPGRXYAPAWVAP 177
Query: 445 E---YGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLR---RWVKESLPHGLT 498
           E      E       D +S+ VLL E  TR+ P  ++   E+  +     ++ ++P G++
Sbjct: 178 EALQKKPEDTNRRSADXWSFAVLLWELVTREVPFADLSNXEIGXKVALEGLRPTIPPGIS 237
Query: 499 EVVDANLVR----EEQAFSAKMDCILSIMDFALD 528
             V + L +    E+ A   K D I+ I++   D
Sbjct: 238 PHV-SKLXKICXNEDPAKRPKFDXIVPILEKXQD 270

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 94/206 (45%), Gaps = 13/206 (6%)
Query: 280 LGTSSFGSVYKGTI---SDGTDVAIKVFNLQLERA-FRSFDSECEVLRNVRHRNLIKILS 335
           LG  +FGSV +G         DVAIKV     E+A       E +++  + +  +++++ 
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 336 SYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHII 395
                +   LV+E    G L K+L      + +     ++  V   ++YL   +     +
Sbjct: 404 -VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN----FV 458
Query: 396 HCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMAT--IGYMAPEYGLEGIVS 453
           H +L   N+LL     A +SDFG+ K LG  +DS     +     + + APE       S
Sbjct: 459 HRNLAARNVLLVNRHYAKISDFGLSKALG-ADDSYYTARSAGKWPLKWYAPECINFRKFS 517
Query: 454 AKCDVYSYGVLLMETFTR-KRPTDEM 478
           ++ DV+SYGV + E  +  ++P  +M
Sbjct: 518 SRSDVWSYGVTMWEALSYGQKPYKKM 543

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 107/228 (46%), Gaps = 37/228 (16%)
Query: 266 DIQRATDEFNECNLLGTSSFGSV----YKGTISDGTDVAIKVFNLQLERAF----RS--- 314
           D++   +++    ++G  +FG V    +K T         KV+ ++L   F    RS   
Sbjct: 68  DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTR--------KVYAMKLLSKFEMIKRSDSA 119
Query: 315 -FDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLN 373
            F  E +++       ++++  ++ +  +  +V+E+MP G L   +   NY  D+ E+  
Sbjct: 120 FFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM--SNY--DVPEKWA 175
Query: 374 --IMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGI-YKLLGEGEDSV 430
                +V  AL+ +H    S+  IH D+KP N+LLD++    ++DFG   K+  EG   V
Sbjct: 176 RFYTAEVVLALDAIH----SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG--MV 229
Query: 431 RQTMTMATIGYMAPE----YGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
           R    + T  Y++PE     G +G    +CD +S GV L E      P
Sbjct: 230 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 277

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 107/228 (46%), Gaps = 37/228 (16%)
Query: 266 DIQRATDEFNECNLLGTSSFGSV----YKGTISDGTDVAIKVFNLQLERAF----RS--- 314
           D++   +++    ++G  +FG V    +K T         KV+ ++L   F    RS   
Sbjct: 63  DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTR--------KVYAMKLLSKFEMIKRSDSA 114
Query: 315 -FDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLN 373
            F  E +++       ++++  ++ +  +  +V+E+MP G L   +   NY  D+ E+  
Sbjct: 115 FFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM--SNY--DVPEKWA 170
Query: 374 --IMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGI-YKLLGEGEDSV 430
                +V  AL+ +H    S+  IH D+KP N+LLD++    ++DFG   K+  EG   V
Sbjct: 171 RFYTAEVVLALDAIH----SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG--MV 224
Query: 431 RQTMTMATIGYMAPE----YGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
           R    + T  Y++PE     G +G    +CD +S GV L E      P
Sbjct: 225 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 95/204 (46%), Gaps = 21/204 (10%)
Query: 271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDS-----ECEVLRN 324
            + +N   +LG  SFG V K        + A+KV N   + + ++ D+     E E+L+ 
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVIN---KASAKNKDTSTILREVELLKK 77
Query: 325 VRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEY 384
           + H N++K+     +     +V E    G L   +     F +  +   I+  V S + Y
Sbjct: 78  LDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSE-HDAARIIKQVFSGITY 136
Query: 385 LHNGHSSVHIIHCDLKPTNILL---DENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGY 441
           +H  +    I+H DLKP NILL   +++    + DFG+       + + +    + T  Y
Sbjct: 137 MHKHN----IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF---QQNTKMKDRIGTAYY 189
Query: 442 MAPEYGLEGIVSAKCDVYSYGVLL 465
           +APE  L G    KCDV+S GV+L
Sbjct: 190 IAPEV-LRGTYDEKCDVWSAGVIL 212

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 95/204 (46%), Gaps = 21/204 (10%)
Query: 271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDS-----ECEVLRN 324
            + +N   +LG  SFG V K        + A+KV N   + + ++ D+     E E+L+ 
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVIN---KASAKNKDTSTILREVELLKK 77
Query: 325 VRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEY 384
           + H N++K+     +     +V E    G L   +     F +  +   I+  V S + Y
Sbjct: 78  LDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSE-HDAARIIKQVFSGITY 136
Query: 385 LHNGHSSVHIIHCDLKPTNILL---DENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGY 441
           +H  +    I+H DLKP NILL   +++    + DFG+       + + +    + T  Y
Sbjct: 137 MHKHN----IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF---QQNTKMKDRIGTAYY 189
Query: 442 MAPEYGLEGIVSAKCDVYSYGVLL 465
           +APE  L G    KCDV+S GV+L
Sbjct: 190 IAPEV-LRGTYDEKCDVWSAGVIL 212

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 92/210 (43%), Gaps = 19/210 (9%)
Query: 266 DIQRATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVF-----NLQLERAFRSFDSECE 320
           +IQR   E   C  +G   FG V++G      + A+ V      N   +     F  E  
Sbjct: 3   EIQRERIELGRC--IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 60
Query: 321 VLRNVRHRNLIKILSSYS-NPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVG 379
            +R   H +++K++   + NP +  +++E    G L  +L    Y LD+   +     + 
Sbjct: 61  TMRQFDHPHIVKLIGVITENPVW--IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLS 118
Query: 380 SALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSV--RQTMTMA 437
           +AL YL     S   +H D+   N+L+  N    + DFG+ + +   EDS   + +    
Sbjct: 119 TALAYLE----SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM---EDSTYYKASKGKL 171
Query: 438 TIGYMAPEYGLEGIVSAKCDVYSYGVLLME 467
            I +MAPE       ++  DV+ +GV + E
Sbjct: 172 PIKWMAPESINFRRFTSASDVWMFGVCMWE 201

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 106/207 (51%), Gaps = 14/207 (6%)
Query: 272 DEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRS-FDSECEVLRNVRHRN 329
           D+F + + LG  + G V+K +    G  +A K+ +L+++ A R+    E +VL       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 330 LIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLD-ILERLNIMIDVGSALEYLHNG 388
           ++    ++ +    ++ +E M  GSL++ L       + IL +++I +  G  L YL   
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG--LTYLREK 123
Query: 389 HSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGL 448
           H    I+H D+KP+NIL++      + DFG+    G+  DS+  +  + T  YM+PE  L
Sbjct: 124 HK---IMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSF-VGTRSYMSPER-L 175
Query: 449 EGI-VSAKCDVYSYGVLLMETFTRKRP 474
           +G   S + D++S G+ L+E    + P
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 107/228 (46%), Gaps = 37/228 (16%)
Query: 266 DIQRATDEFNECNLLGTSSFGSV----YKGTISDGTDVAIKVFNLQLERAF----RS--- 314
           D++   +++    ++G  +FG V    +K T         KV+ ++L   F    RS   
Sbjct: 68  DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTR--------KVYAMKLLSKFEMIKRSDSA 119
Query: 315 -FDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLN 373
            F  E +++       ++++  ++ +  +  +V+E+MP G L   +   NY  D+ E+  
Sbjct: 120 FFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM--SNY--DVPEKWA 175
Query: 374 --IMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGI-YKLLGEGEDSV 430
                +V  AL+ +H    S+  IH D+KP N+LLD++    ++DFG   K+  EG   V
Sbjct: 176 RFYTAEVVLALDAIH----SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG--MV 229
Query: 431 RQTMTMATIGYMAPE----YGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
           R    + T  Y++PE     G +G    +CD +S GV L E      P
Sbjct: 230 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 277

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 102/206 (49%), Gaps = 24/206 (11%)
Query: 274 FNECNLLGTSSFGSVYKGTISD-GTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIK 332
           + +  ++G  SFG VY+  + D G  VAIK   LQ +R F+  + E +++R + H N+++
Sbjct: 58  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FK--NRELQIMRKLDHCNIVR 113
Query: 333 I----LSSYSNPD--FKALVLEFMPNG--SLEKWLYSHNYFLDILERLNIMIDVGSALEY 384
           +     SS    D  +  LVL+++P     + +        L ++     M  +  +L Y
Sbjct: 114 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 173
Query: 385 LHNGHSSVHIIHCDLKPTNILLD-ENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           +H    S  I H D+KP N+LLD +  V  + DFG  K L  GE +V     + +  Y A
Sbjct: 174 IH----SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRA 226
Query: 444 PE--YGLEGIVSAKCDVYSYGVLLME 467
           PE  +G     S+  DV+S G +L E
Sbjct: 227 PELIFGATDYTSS-IDVWSAGCVLAE 251

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 105/207 (50%), Gaps = 14/207 (6%)
Query: 272 DEFNECNLLGTSSFGSVYK-GTISDGTDVAIKVFNLQLERAFRS-FDSECEVLRNVRHRN 329
           D+F + + LG  + G V+K      G  +A K+ +L+++ A R+    E +VL       
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 330 LIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLD-ILERLNIMIDVGSALEYLHNG 388
           ++    ++ +    ++ +E M  GSL++ L       + IL +++I +  G  L YL   
Sbjct: 93  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG--LTYLREK 150
Query: 389 HSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGL 448
           H    I+H D+KP+NIL++      + DFG+    G+  DS+  +  + T  YM+PE  L
Sbjct: 151 HK---IMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSF-VGTRSYMSPER-L 202
Query: 449 EGI-VSAKCDVYSYGVLLMETFTRKRP 474
           +G   S + D++S G+ L+E    + P
Sbjct: 203 QGTHYSVQSDIWSMGLSLVEMAVGRYP 229

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 101/206 (49%), Gaps = 24/206 (11%)
Query: 274 FNECNLLGTSSFGSVYKGTISD-GTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIK 332
           + +  ++G  SFG VY+  + D G  VAIK   +   +AF+  + E +++R + H N+++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQGKAFK--NRELQIMRKLDHCNIVR 77
Query: 333 I----LSSYSNPD--FKALVLEFMPNG--SLEKWLYSHNYFLDILERLNIMIDVGSALEY 384
           +     SS    D  +  LVL+++P     + +        L ++     M  +  +L Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 385 LHNGHSSVHIIHCDLKPTNILLD-ENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           +H    S  I H D+KP N+LLD +  V  + DFG  K L  GE +V     + +  Y A
Sbjct: 138 IH----SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYRA 190
Query: 444 PE--YGLEGIVSAKCDVYSYGVLLME 467
           PE  +G     S+  DV+S G +L E
Sbjct: 191 PELIFGATDYTSS-IDVWSAGCVLAE 215

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 106/207 (51%), Gaps = 14/207 (6%)
Query: 272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRS-FDSECEVLRNVRHRN 329
           D+F + + LG  + G V+K +    G  +A K+ +L+++ A R+    E +VL       
Sbjct: 25  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 84
Query: 330 LIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLD-ILERLNIMIDVGSALEYLHNG 388
           ++    ++ +    ++ +E M  GSL++ L       + IL +++I +  G  L YL   
Sbjct: 85  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG--LTYLREK 142
Query: 389 HSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGL 448
           H    I+H D+KP+NIL++      + DFG+    G+  DS+  +  + T  YM+PE  L
Sbjct: 143 HK---IMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSF-VGTRSYMSPER-L 194
Query: 449 EGI-VSAKCDVYSYGVLLMETFTRKRP 474
           +G   S + D++S G+ L+E    + P
Sbjct: 195 QGTHYSVQSDIWSMGLSLVEMAVGRYP 221

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 101/206 (49%), Gaps = 24/206 (11%)
Query: 274 FNECNLLGTSSFGSVYKGTISD-GTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIK 332
           + +  ++G  SFG VY+  + D G  VAIK   +   +AF+  + E +++R + H N+++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQGKAFK--NRELQIMRKLDHCNIVR 77
Query: 333 I----LSSYSNPD--FKALVLEFMPNG--SLEKWLYSHNYFLDILERLNIMIDVGSALEY 384
           +     SS    D  +  LVL+++P     + +        L ++     M  +  +L Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 385 LHNGHSSVHIIHCDLKPTNILLD-ENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           +H    S  I H D+KP N+LLD +  V  + DFG  K L  GE +V     + +  Y A
Sbjct: 138 IH----SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRA 190
Query: 444 PE--YGLEGIVSAKCDVYSYGVLLME 467
           PE  +G     S+  DV+S G +L E
Sbjct: 191 PELIFGATDYTSS-IDVWSAGCVLAE 215

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 101/206 (49%), Gaps = 24/206 (11%)
Query: 274 FNECNLLGTSSFGSVYKGTISD-GTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIK 332
           + +  ++G  SFG VY+  + D G  VAIK   +  ++ F+  + E +++R + H N+++
Sbjct: 41  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFK--NRELQIMRKLDHCNIVR 96
Query: 333 I----LSSYSNPD--FKALVLEFMPNG--SLEKWLYSHNYFLDILERLNIMIDVGSALEY 384
           +     SS    D  +  LVL+++P     + +        L ++     M  +  +L Y
Sbjct: 97  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 156
Query: 385 LHNGHSSVHIIHCDLKPTNILLD-ENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           +H    S  I H D+KP N+LLD +  V  + DFG  K L  GE +V     + +  Y A
Sbjct: 157 IH----SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYRA 209
Query: 444 PE--YGLEGIVSAKCDVYSYGVLLME 467
           PE  +G     S+  DV+S G +L E
Sbjct: 210 PELIFGATDYTSS-IDVWSAGCVLAE 234

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 101/206 (49%), Gaps = 24/206 (11%)
Query: 274 FNECNLLGTSSFGSVYKGTISD-GTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIK 332
           + +  ++G  SFG VY+  + D G  VAIK   +  ++ F+  + E +++R + H N+++
Sbjct: 30  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFK--NRELQIMRKLDHCNIVR 85
Query: 333 I----LSSYSNPD--FKALVLEFMPNG--SLEKWLYSHNYFLDILERLNIMIDVGSALEY 384
           +     SS    D  +  LVL+++P     + +        L ++     M  +  +L Y
Sbjct: 86  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 145
Query: 385 LHNGHSSVHIIHCDLKPTNILLD-ENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           +H    S  I H D+KP N+LLD +  V  + DFG  K L  GE +V     + +  Y A
Sbjct: 146 IH----SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYRA 198
Query: 444 PE--YGLEGIVSAKCDVYSYGVLLME 467
           PE  +G     S+  DV+S G +L E
Sbjct: 199 PELIFGATDYTSS-IDVWSAGCVLAE 223

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 101/206 (49%), Gaps = 24/206 (11%)
Query: 274 FNECNLLGTSSFGSVYKGTISD-GTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIK 332
           + +  ++G  SFG VY+  + D G  VAIK   +  ++ F+  + E +++R + H N+++
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFK--NRELQIMRKLDHCNIVR 89
Query: 333 I----LSSYSNPD--FKALVLEFMPNG--SLEKWLYSHNYFLDILERLNIMIDVGSALEY 384
           +     SS    D  +  LVL+++P     + +        L ++     M  +  +L Y
Sbjct: 90  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 149
Query: 385 LHNGHSSVHIIHCDLKPTNILLD-ENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           +H    S  I H D+KP N+LLD +  V  + DFG  K L  GE +V     + +  Y A
Sbjct: 150 IH----SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYRA 202
Query: 444 PE--YGLEGIVSAKCDVYSYGVLLME 467
           PE  +G     S+  DV+S G +L E
Sbjct: 203 PELIFGATDYTSS-IDVWSAGCVLAE 227

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/257 (24%), Positives = 112/257 (43%), Gaps = 36/257 (14%)
Query: 249 DHEDFLPLAIWRRTSYLDIQRATDEFNECNLLGTSSFGSVYKGTISD-GTDVAIKVFNLQ 307
           + + F     W+    L+I    ++F+   ++G   FG VY    +D G   A+K  + +
Sbjct: 167 ESDKFTRFCQWKNVE-LNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKK 225
Query: 308 LERAFRSFDSECEVLRNVRHRNLIKILS------------SYSNPDFKALVLEFMPNGSL 355
                R    + E L  +  R ++ ++S            ++  PD  + +L+ M  G L
Sbjct: 226 -----RIKMKQGETL-ALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDL 279
Query: 356 EKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVS 415
              L  H  F +   R     ++   LE++HN      +++ DLKP NILLDE+    +S
Sbjct: 280 HYHLSQHGVFSEADMRF-YAAEIILGLEHMHNRF----VVYRDLKPANILLDEHGHVRIS 334
Query: 416 DFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIV-SAKCDVYSYGVLLME------T 468
           D G+     + +       ++ T GYMAPE   +G+   +  D +S G +L +       
Sbjct: 335 DLGLACDFSKKKPHA----SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
Query: 469 FTRKRPTDEMFIGEMSL 485
           F + +  D+  I  M+L
Sbjct: 391 FRQHKTKDKHEIDRMTL 407

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 23/205 (11%)
Query: 271 TDEFNECNLLGTSSFGSVYK--GTISDGTDVAIKVFNLQLERAFRSFDS-----ECEVLR 323
            + +N   +LG  SFG V K    I+   + A+KV N   + + ++ D+     E E+L+
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQ-QEYAVKVIN---KASAKNKDTSTILREVELLK 76
Query: 324 NVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALE 383
            + H N++K+     +     +V E    G L   +     F +  +   I+  V S + 
Sbjct: 77  KLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSE-HDAARIIKQVFSGIT 135
Query: 384 YLHNGHSSVHIIHCDLKPTNILL---DENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIG 440
           Y+H  +    I+H DLKP NILL   +++    + DFG+       + + +    + T  
Sbjct: 136 YMHKHN----IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF---QQNTKMKDRIGTAY 188
Query: 441 YMAPEYGLEGIVSAKCDVYSYGVLL 465
           Y+APE  L G    KCDV+S GV+L
Sbjct: 189 YIAPEV-LRGTYDEKCDVWSAGVIL 212

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 102/206 (49%), Gaps = 24/206 (11%)
Query: 274 FNECNLLGTSSFGSVYKGTISD-GTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIK 332
           + +  ++G  SFG VY+  + D G  VAIK   LQ +R F+  + E +++R + H N+++
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FK--NRELQIMRKLDHCNIVR 111
Query: 333 I----LSSYSNPD--FKALVLEFMPNG--SLEKWLYSHNYFLDILERLNIMIDVGSALEY 384
           +     SS    D  +  LVL+++P     + +        L ++     M  +  +L Y
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 171
Query: 385 LHNGHSSVHIIHCDLKPTNILLD-ENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           +H    S  I H D+KP N+LLD +  V  + DFG  K L  GE +V     + +  Y A
Sbjct: 172 IH----SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRA 224
Query: 444 PE--YGLEGIVSAKCDVYSYGVLLME 467
           PE  +G     S+  DV+S G +L E
Sbjct: 225 PELIFGATDYTSS-IDVWSAGCVLAE 249

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 101/206 (49%), Gaps = 24/206 (11%)
Query: 274 FNECNLLGTSSFGSVYKGTISD-GTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIK 332
           + +  ++G  SFG VY+  + D G  VAIK   +  ++ F+  + E +++R + H N+++
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFK--NRELQIMRKLDHCNIVR 89
Query: 333 I----LSSYSNPD--FKALVLEFMPNG--SLEKWLYSHNYFLDILERLNIMIDVGSALEY 384
           +     SS    D  +  LVL+++P     + +        L ++     M  +  +L Y
Sbjct: 90  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 149
Query: 385 LHNGHSSVHIIHCDLKPTNILLD-ENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           +H    S  I H D+KP N+LLD +  V  + DFG  K L  GE +V     + +  Y A
Sbjct: 150 IH----SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYRA 202
Query: 444 PE--YGLEGIVSAKCDVYSYGVLLME 467
           PE  +G     S+  DV+S G +L E
Sbjct: 203 PELIFGATDYTSS-IDVWSAGCVLAE 227

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 101/206 (49%), Gaps = 24/206 (11%)
Query: 274 FNECNLLGTSSFGSVYKGTISD-GTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIK 332
           + +  ++G  SFG VY+  + D G  VAIK   +   +AF+  + E +++R + H N+++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQGKAFK--NRELQIMRKLDHCNIVR 77
Query: 333 I----LSSYSNPD--FKALVLEFMPNG--SLEKWLYSHNYFLDILERLNIMIDVGSALEY 384
           +     SS    D  +  LVL+++P     + +        L ++     M  +  +L Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 385 LHNGHSSVHIIHCDLKPTNILLD-ENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           +H    S  I H D+KP N+LLD +  V  + DFG  K L  GE +V     + +  Y A
Sbjct: 138 IH----SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRA 190
Query: 444 PE--YGLEGIVSAKCDVYSYGVLLME 467
           PE  +G     S+  DV+S G +L E
Sbjct: 191 PELIFGATDYTSS-IDVWSAGCVLAE 215

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/197 (23%), Positives = 93/197 (47%), Gaps = 11/197 (5%)
Query: 279 LLGTSSFGSVYKGTISD--GTDVAIKVFNLQLERAF---RSFDSECEVLRNVRHRNLIKI 333
           +LG   FG VY+G  ++  G  + + V   + +        F SE  +++N+ H +++K+
Sbjct: 31  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 90
Query: 334 LSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVH 393
           +      +   +++E  P G L  +L  +   L +L  +   + +  A+ YL     S++
Sbjct: 91  IGIIEE-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE----SIN 145
Query: 394 IIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVS 453
            +H D+   NIL+       + DFG+ + + E ED  + ++T   I +M+PE       +
Sbjct: 146 CVHRDIAVRNILVASPECVKLGDFGLSRYI-EDEDYYKASVTRLPIKWMSPESINFRRFT 204
Query: 454 AKCDVYSYGVLLMETFT 470
              DV+ + V + E  +
Sbjct: 205 TASDVWMFAVCMWEILS 221

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/257 (24%), Positives = 112/257 (43%), Gaps = 36/257 (14%)
Query: 249 DHEDFLPLAIWRRTSYLDIQRATDEFNECNLLGTSSFGSVYKGTISD-GTDVAIKVFNLQ 307
           + + F     W+    L+I    ++F+   ++G   FG VY    +D G   A+K  + +
Sbjct: 166 ESDKFTRFCQWKNVE-LNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKK 224
Query: 308 LERAFRSFDSECEVLRNVRHRNLIKILS------------SYSNPDFKALVLEFMPNGSL 355
                R    + E L  +  R ++ ++S            ++  PD  + +L+ M  G L
Sbjct: 225 -----RIKMKQGETL-ALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDL 278
Query: 356 EKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVS 415
              L  H  F +   R     ++   LE++HN      +++ DLKP NILLDE+    +S
Sbjct: 279 HYHLSQHGVFSEADMRF-YAAEIILGLEHMHNRF----VVYRDLKPANILLDEHGHVRIS 333
Query: 416 DFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIV-SAKCDVYSYGVLLME------T 468
           D G+     + +       ++ T GYMAPE   +G+   +  D +S G +L +       
Sbjct: 334 DLGLACDFSKKKPHA----SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 389
Query: 469 FTRKRPTDEMFIGEMSL 485
           F + +  D+  I  M+L
Sbjct: 390 FRQHKTKDKHEIDRMTL 406

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/257 (24%), Positives = 112/257 (43%), Gaps = 36/257 (14%)
Query: 249 DHEDFLPLAIWRRTSYLDIQRATDEFNECNLLGTSSFGSVYKGTISD-GTDVAIKVFNLQ 307
           + + F     W+    L+I    ++F+   ++G   FG VY    +D G   A+K  + +
Sbjct: 167 ESDKFTRFCQWKNVE-LNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKK 225
Query: 308 LERAFRSFDSECEVLRNVRHRNLIKILS------------SYSNPDFKALVLEFMPNGSL 355
                R    + E L  +  R ++ ++S            ++  PD  + +L+ M  G L
Sbjct: 226 -----RIKMKQGETL-ALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDL 279
Query: 356 EKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVS 415
              L  H  F +   R     ++   LE++HN      +++ DLKP NILLDE+    +S
Sbjct: 280 HYHLSQHGVFSEADMRF-YAAEIILGLEHMHNRF----VVYRDLKPANILLDEHGHVRIS 334
Query: 416 DFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIV-SAKCDVYSYGVLLME------T 468
           D G+     + +       ++ T GYMAPE   +G+   +  D +S G +L +       
Sbjct: 335 DLGLACDFSKKKPHA----SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
Query: 469 FTRKRPTDEMFIGEMSL 485
           F + +  D+  I  M+L
Sbjct: 391 FRQHKTKDKHEIDRMTL 407

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/257 (24%), Positives = 112/257 (43%), Gaps = 36/257 (14%)
Query: 249 DHEDFLPLAIWRRTSYLDIQRATDEFNECNLLGTSSFGSVYKGTISD-GTDVAIKVFNLQ 307
           + + F     W+    L+I    ++F+   ++G   FG VY    +D G   A+K  + +
Sbjct: 167 ESDKFTRFCQWKNVE-LNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKK 225
Query: 308 LERAFRSFDSECEVLRNVRHRNLIKILS------------SYSNPDFKALVLEFMPNGSL 355
                R    + E L  +  R ++ ++S            ++  PD  + +L+ M  G L
Sbjct: 226 -----RIKMKQGETL-ALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDL 279
Query: 356 EKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVS 415
              L  H  F +   R     ++   LE++HN      +++ DLKP NILLDE+    +S
Sbjct: 280 HYHLSQHGVFSEADMRF-YAAEIILGLEHMHNRF----VVYRDLKPANILLDEHGHVRIS 334
Query: 416 DFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIV-SAKCDVYSYGVLLME------T 468
           D G+     + +       ++ T GYMAPE   +G+   +  D +S G +L +       
Sbjct: 335 DLGLACDFSKKKPHA----SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
Query: 469 FTRKRPTDEMFIGEMSL 485
           F + +  D+  I  M+L
Sbjct: 391 FRQHKTKDKHEIDRMTL 407

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 106/207 (51%), Gaps = 14/207 (6%)
Query: 272 DEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRS-FDSECEVLRNVRHRN 329
           D+F + + LG  + G V+K +    G  +A K+ +L+++ A R+    E +VL       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 330 LIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLD-ILERLNIMIDVGSALEYLHNG 388
           ++    ++ +    ++ +E M  GSL++ L       + IL +++I +  G  L YL   
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG--LTYLREK 123
Query: 389 HSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGL 448
           H    I+H D+KP+NIL++      + DFG+    G+  DS+  +  + T  YM+PE  L
Sbjct: 124 HK---IMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSF-VGTRSYMSPER-L 175
Query: 449 EGI-VSAKCDVYSYGVLLMETFTRKRP 474
           +G   S + D++S G+ L+E    + P
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 102/206 (49%), Gaps = 24/206 (11%)
Query: 274 FNECNLLGTSSFGSVYKGTISD-GTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIK 332
           + +  ++G  SFG VY+  + D G  VAIK   LQ +R F+  + E +++R + H N+++
Sbjct: 60  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FK--NRELQIMRKLDHCNIVR 115
Query: 333 I----LSSYSNPD--FKALVLEFMPNG--SLEKWLYSHNYFLDILERLNIMIDVGSALEY 384
           +     SS    D  +  LVL+++P     + +        L ++     M  +  +L Y
Sbjct: 116 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 175
Query: 385 LHNGHSSVHIIHCDLKPTNILLD-ENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           +H    S  I H D+KP N+LLD +  V  + DFG  K L  GE +V     + +  Y A
Sbjct: 176 IH----SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRA 228
Query: 444 PE--YGLEGIVSAKCDVYSYGVLLME 467
           PE  +G     S+  DV+S G +L E
Sbjct: 229 PELIFGATDYTSS-IDVWSAGCVLAE 253

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 105/233 (45%), Gaps = 17/233 (7%)
Query: 240 CRNRNTKKSDHEDFLPLAIWRRTSYLDIQ----RATDEFNECNLLGTSSFGSVYKGT-IS 294
            R + T  S++++++   IW++     ++       D ++    LGT +FG V++ T  +
Sbjct: 122 VRGKGTVSSNYDNYV-FDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERA 180
Query: 295 DGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGS 354
            G + A K      E    +   E + +  +RH  L+ +  ++ + +   ++ EFM  G 
Sbjct: 181 TGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGE 240
Query: 355 L-EKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAH 413
           L EK    HN   +  E +  M  V   L ++H      + +H DLKP NI+        
Sbjct: 241 LFEKVADEHNKMSED-EAVEYMRQVCKGLCHMHEN----NYVHLDLKPENIMFTTKRSNE 295
Query: 414 VS--DFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVL 464
           +   DFG+   L + + SV+  +T  T  + APE      V    D++S GVL
Sbjct: 296 LKLIDFGLTAHL-DPKQSVK--VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVL 345

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 101/206 (49%), Gaps = 24/206 (11%)
Query: 274 FNECNLLGTSSFGSVYKGTISD-GTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIK 332
           + +  ++G  SFG VY+  + D G  VAIK   +  ++ F+  + E +++R + H N+++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFK--NRELQIMRKLDHCNIVR 77
Query: 333 I----LSSYSNPD--FKALVLEFMPNG--SLEKWLYSHNYFLDILERLNIMIDVGSALEY 384
           +     SS    D  +  LVL+++P     + +        L ++     M  +  +L Y
Sbjct: 78  LRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 385 LHNGHSSVHIIHCDLKPTNILLD-ENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           +H    S  I H D+KP N+LLD +  V  + DFG  K L  GE +V     + +  Y A
Sbjct: 138 IH----SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYRA 190
Query: 444 PE--YGLEGIVSAKCDVYSYGVLLME 467
           PE  +G     S+  DV+S G +L E
Sbjct: 191 PELIFGATDYTSS-IDVWSAGCVLAE 215

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 102/206 (49%), Gaps = 24/206 (11%)
Query: 274 FNECNLLGTSSFGSVYKGTISD-GTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIK 332
           + +  ++G  SFG VY+  + D G  VAIK   LQ +R F+  + E +++R + H N+++
Sbjct: 50  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FK--NRELQIMRKLDHCNIVR 105
Query: 333 I----LSSYSNPD--FKALVLEFMPNG--SLEKWLYSHNYFLDILERLNIMIDVGSALEY 384
           +     SS    D  +  LVL+++P     + +        L ++     M  +  +L Y
Sbjct: 106 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 165
Query: 385 LHNGHSSVHIIHCDLKPTNILLD-ENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           +H    S  I H D+KP N+LLD +  V  + DFG  K L  GE +V     + +  Y A
Sbjct: 166 IH----SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRA 218
Query: 444 PE--YGLEGIVSAKCDVYSYGVLLME 467
           PE  +G     S+  DV+S G +L E
Sbjct: 219 PELIFGATDYTSS-IDVWSAGCVLAE 243

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 101/206 (49%), Gaps = 24/206 (11%)
Query: 274 FNECNLLGTSSFGSVYKGTISD-GTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIK 332
           + +  ++G  SFG VY+  + D G  VAIK   +  ++ F+  + E +++R + H N+++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFK--NRELQIMRKLDHCNIVR 77
Query: 333 I----LSSYSNPD--FKALVLEFMPNG--SLEKWLYSHNYFLDILERLNIMIDVGSALEY 384
           +     SS    D  +  LVL+++P     + +        L ++     M  +  +L Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 385 LHNGHSSVHIIHCDLKPTNILLD-ENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           +H    S  I H D+KP N+LLD +  V  + DFG  K L  GE +V     + +  Y A
Sbjct: 138 IH----SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYRA 190
Query: 444 PE--YGLEGIVSAKCDVYSYGVLLME 467
           PE  +G     S+  DV+S G +L E
Sbjct: 191 PELIFGATDYTSS-IDVWSAGCVLAE 215

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 101/206 (49%), Gaps = 24/206 (11%)
Query: 274 FNECNLLGTSSFGSVYKGTISD-GTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIK 332
           + +  ++G  SFG VY+  + D G  VAIK   +  ++ F+  + E +++R + H N+++
Sbjct: 23  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFK--NRELQIMRKLDHCNIVR 78
Query: 333 I----LSSYSNPD--FKALVLEFMPNG--SLEKWLYSHNYFLDILERLNIMIDVGSALEY 384
           +     SS    D  +  LVL+++P     + +        L ++     M  +  +L Y
Sbjct: 79  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 138
Query: 385 LHNGHSSVHIIHCDLKPTNILLD-ENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           +H    S  I H D+KP N+LLD +  V  + DFG  K L  GE +V     + +  Y A
Sbjct: 139 IH----SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYRA 191
Query: 444 PE--YGLEGIVSAKCDVYSYGVLLME 467
           PE  +G     S+  DV+S G +L E
Sbjct: 192 PELIFGATDYTSS-IDVWSAGCVLAE 216

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 91/208 (43%), Gaps = 15/208 (7%)
Query: 266 DIQRATDEFNECNLLGTSSFGSVYKGTI----SDGTDVAIKVF-NLQLERAFRSFDSECE 320
           +IQR   E   C  +G   FG V++G      +    VAIK   N   +     F  E  
Sbjct: 6   EIQRERIELGRC--IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEAL 63
Query: 321 VLRNVRHRNLIKILSSYS-NPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVG 379
            +R   H +++K++   + NP +  +++E    G L  +L    + LD+   +     + 
Sbjct: 64  TMRQFDHPHIVKLIGVITENPVW--IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLS 121
Query: 380 SALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATI 439
           +AL YL     S   +H D+   N+L+  N    + DFG+ + + E     + +     I
Sbjct: 122 TALAYLE----SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTXXKASKGKLPI 176
Query: 440 GYMAPEYGLEGIVSAKCDVYSYGVLLME 467
            +MAPE       ++  DV+ +GV + E
Sbjct: 177 KWMAPESINFRRFTSASDVWMFGVCMWE 204

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 101/206 (49%), Gaps = 24/206 (11%)
Query: 274 FNECNLLGTSSFGSVYKGTISD-GTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIK 332
           + +  ++G  SFG VY+  + D G  VAIK   +  ++ F+  + E +++R + H N+++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFK--NRELQIMRKLDHCNIVR 77
Query: 333 I----LSSYSNPD--FKALVLEFMPNG--SLEKWLYSHNYFLDILERLNIMIDVGSALEY 384
           +     SS    D  +  LVL+++P     + +        L ++     M  +  +L Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 385 LHNGHSSVHIIHCDLKPTNILLD-ENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           +H    S  I H D+KP N+LLD +  V  + DFG  K L  GE +V     + +  Y A
Sbjct: 138 IH----SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYRA 190
Query: 444 PE--YGLEGIVSAKCDVYSYGVLLME 467
           PE  +G     S+  DV+S G +L E
Sbjct: 191 PELIFGATDYTSS-IDVWSAGCVLAE 215

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 101/206 (49%), Gaps = 24/206 (11%)
Query: 274 FNECNLLGTSSFGSVYKGTISD-GTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIK 332
           + +  ++G  SFG VY+  + D G  VAIK   +  ++ F+  + E +++R + H N+++
Sbjct: 26  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFK--NRELQIMRKLDHCNIVR 81
Query: 333 I----LSSYSNPD--FKALVLEFMPNG--SLEKWLYSHNYFLDILERLNIMIDVGSALEY 384
           +     SS    D  +  LVL+++P     + +        L ++     M  +  +L Y
Sbjct: 82  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 141
Query: 385 LHNGHSSVHIIHCDLKPTNILLD-ENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           +H    S  I H D+KP N+LLD +  V  + DFG  K L  GE +V     + +  Y A
Sbjct: 142 IH----SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYRA 194
Query: 444 PE--YGLEGIVSAKCDVYSYGVLLME 467
           PE  +G     S+  DV+S G +L E
Sbjct: 195 PELIFGATDYTSS-IDVWSAGCVLAE 219

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 102/206 (49%), Gaps = 24/206 (11%)
Query: 274 FNECNLLGTSSFGSVYKGTISD-GTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIK 332
           + +  ++G  SFG VY+  + D G  VAIK   LQ +R F+  + E +++R + H N+++
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FK--NRELQIMRKLDHCNIVR 156
Query: 333 I----LSSYSNPD--FKALVLEFMPNG--SLEKWLYSHNYFLDILERLNIMIDVGSALEY 384
           +     SS    D  +  LVL+++P     + +        L ++     M  +  +L Y
Sbjct: 157 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 216
Query: 385 LHNGHSSVHIIHCDLKPTNILLD-ENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           +H    S  I H D+KP N+LLD +  V  + DFG  K L  GE +V     + +  Y A
Sbjct: 217 IH----SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRA 269
Query: 444 PE--YGLEGIVSAKCDVYSYGVLLME 467
           PE  +G     S+  DV+S G +L E
Sbjct: 270 PELIFGATDYTSS-IDVWSAGCVLAE 294

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 99/208 (47%), Gaps = 10/208 (4%)
Query: 269 RATDEFNECNLLGTSSFG-SVYKGTISDGTDVAIKVFNLQLERAFRSFDS--ECEVLRNV 325
           ++ +++     +G  SFG ++   +  DG    IK  N+    +    +S  E  VL N+
Sbjct: 21  QSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANM 80
Query: 326 RHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILER-LNIMIDVGSALEY 384
           +H N+++   S+       +V+++   G L K + +    L   ++ L+  + +  AL++
Sbjct: 81  KHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKH 140
Query: 385 LHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAP 444
           +H+      I+H D+K  NI L ++    + DFGI ++L    +  R    + T  Y++P
Sbjct: 141 VHDRK----ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELAR--ACIGTPYYLSP 194
Query: 445 EYGLEGIVSAKCDVYSYGVLLMETFTRK 472
           E       + K D+++ G +L E  T K
Sbjct: 195 EICENKPYNNKSDIWALGCVLYELCTLK 222

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 106/207 (51%), Gaps = 14/207 (6%)
Query: 272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRS-FDSECEVLRNVRHRN 329
           D+F + + LG  + G V+K +    G  +A K+ +L+++ A R+    E +VL       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 330 LIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLD-ILERLNIMIDVGSALEYLHNG 388
           ++    ++ +    ++ +E M  GSL++ L       + IL +++I +  G  L YL   
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG--LTYLREK 123
Query: 389 HSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGL 448
           H    I+H D+KP+NIL++      + DFG+    G+  DS+  +  + T  YM+PE  L
Sbjct: 124 HK---IMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSF-VGTRSYMSPER-L 175
Query: 449 EGI-VSAKCDVYSYGVLLMETFTRKRP 474
           +G   S + D++S G+ L+E    + P
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 106/207 (51%), Gaps = 14/207 (6%)
Query: 272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRS-FDSECEVLRNVRHRN 329
           D+F + + LG  + G V+K +    G  +A K+ +L+++ A R+    E +VL       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 330 LIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLD-ILERLNIMIDVGSALEYLHNG 388
           ++    ++ +    ++ +E M  GSL++ L       + IL +++I +  G  L YL   
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG--LTYLREK 123
Query: 389 HSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGL 448
           H    I+H D+KP+NIL++      + DFG+    G+  DS+  +  + T  YM+PE  L
Sbjct: 124 HK---IMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSF-VGTRSYMSPER-L 175
Query: 449 EGI-VSAKCDVYSYGVLLMETFTRKRP 474
           +G   S + D++S G+ L+E    + P
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/197 (23%), Positives = 93/197 (47%), Gaps = 11/197 (5%)
Query: 279 LLGTSSFGSVYKGTISD--GTDVAIKVFNLQLERAF---RSFDSECEVLRNVRHRNLIKI 333
           +LG   FG VY+G  ++  G  + + V   + +        F SE  +++N+ H +++K+
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 334 LSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVH 393
           +      +   +++E  P G L  +L  +   L +L  +   + +  A+ YL     S++
Sbjct: 79  IGIIEE-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE----SIN 133
Query: 394 IIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVS 453
            +H D+   NIL+       + DFG+ + + E ED  + ++T   I +M+PE       +
Sbjct: 134 CVHRDIAVRNILVASPECVKLGDFGLSRYI-EDEDYYKASVTRLPIKWMSPESINFRRFT 192
Query: 454 AKCDVYSYGVLLMETFT 470
              DV+ + V + E  +
Sbjct: 193 TASDVWMFAVCMWEILS 209

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 102/206 (49%), Gaps = 24/206 (11%)
Query: 274 FNECNLLGTSSFGSVYKGTISD-GTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIK 332
           + +  ++G  SFG VY+  + D G  VAIK   LQ +R F+  + E +++R + H N+++
Sbjct: 27  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FK--NRELQIMRKLDHCNIVR 82
Query: 333 I----LSSYSNPD--FKALVLEFMPNG--SLEKWLYSHNYFLDILERLNIMIDVGSALEY 384
           +     SS    D  +  LVL+++P     + +        L ++     M  +  +L Y
Sbjct: 83  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 142
Query: 385 LHNGHSSVHIIHCDLKPTNILLD-ENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           +H    S  I H D+KP N+LLD +  V  + DFG  K L  GE +V     + +  Y A
Sbjct: 143 IH----SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRA 195
Query: 444 PE--YGLEGIVSAKCDVYSYGVLLME 467
           PE  +G     S+  DV+S G +L E
Sbjct: 196 PELIFGATDYTSS-IDVWSAGCVLAE 220

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 99/216 (45%), Gaps = 27/216 (12%)
Query: 278 NLLGTSSFGSVYKGTISDGTDV-AIKVFN-LQLERAFRSFDSECEVLRNVRHRNLIKILS 335
           ++LG  +  +V++G      D+ AIKVFN +   R       E EVL+ + H+N++K+ +
Sbjct: 15  DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFA 74
Query: 336 --SYSNPDFKALVLEFMPNGSLEKWLY--SHNYFLDILERLNIMIDVGSALEYL-HNGHS 390
               +    K L++EF P GSL   L   S+ Y L   E L ++ DV   + +L  NG  
Sbjct: 75  IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG-- 132
Query: 391 SVHIIHCDLKPTNILL----DENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEY 446
              I+H ++KP NI+     D   V  ++DFG  + L   ED  +      T  Y+ P+ 
Sbjct: 133 ---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL---EDDEQFVXLYGTEEYLHPDM 186
Query: 447 GLEGIV--------SAKCDVYSYGVLLMETFTRKRP 474
               ++         A  D++S GV      T   P
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 96/221 (43%), Gaps = 18/221 (8%)
Query: 251 EDFLPLAIWRRTSYLDIQRATDEFNECNLLGTSSFGSVYKGTISD-GTDVAIKVFNLQLE 309
           EDFL    W   S    Q   D+F+    LGT SFG V      + G   A+K+ + Q  
Sbjct: 24  EDFL--KKWETPSQNTAQ--LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV 79
Query: 310 RAFRSFD---SECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFL 366
              +  +   +E  +L+ V    L+K+  S+ +     +V+E++  G +   L     F 
Sbjct: 80  VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS 139
Query: 367 DILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG 426
           +   R      +    EYLH    S+ +I+ DLKP N+L+D+     V+DFG  K +   
Sbjct: 140 EPHARF-YAAQIVLTFEYLH----SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--- 191
Query: 427 EDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLME 467
               R      T  Y+AP   L    +   D ++ GVL+ E
Sbjct: 192 --KGRTWXLCGTPEYLAPAIILSKGYNKAVDWWALGVLIYE 230

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/197 (23%), Positives = 93/197 (47%), Gaps = 11/197 (5%)
Query: 279 LLGTSSFGSVYKGTISD--GTDVAIKVFNLQLERAF---RSFDSECEVLRNVRHRNLIKI 333
           +LG   FG VY+G  ++  G  + + V   + +        F SE  +++N+ H +++K+
Sbjct: 15  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 74
Query: 334 LSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVH 393
           +      +   +++E  P G L  +L  +   L +L  +   + +  A+ YL     S++
Sbjct: 75  IGIIEE-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE----SIN 129
Query: 394 IIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVS 453
            +H D+   NIL+       + DFG+ + + E ED  + ++T   I +M+PE       +
Sbjct: 130 CVHRDIAVRNILVASPECVKLGDFGLSRYI-EDEDYYKASVTRLPIKWMSPESINFRRFT 188
Query: 454 AKCDVYSYGVLLMETFT 470
              DV+ + V + E  +
Sbjct: 189 TASDVWMFAVCMWEILS 205

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 101/206 (49%), Gaps = 24/206 (11%)
Query: 274 FNECNLLGTSSFGSVYKGTISD-GTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIK 332
           + +  ++G  SFG VY+  + D G  VAIK   +  ++ F+  + E +++R + H N+++
Sbjct: 35  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFK--NRELQIMRKLDHCNIVR 90
Query: 333 I----LSSYSNPD--FKALVLEFMPNG--SLEKWLYSHNYFLDILERLNIMIDVGSALEY 384
           +     SS    D  +  LVL+++P     + +        L ++     M  +  +L Y
Sbjct: 91  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 150
Query: 385 LHNGHSSVHIIHCDLKPTNILLD-ENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           +H    S  I H D+KP N+LLD +  V  + DFG  K L  GE +V     + +  Y A
Sbjct: 151 IH----SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRA 203
Query: 444 PE--YGLEGIVSAKCDVYSYGVLLME 467
           PE  +G     S+  DV+S G +L E
Sbjct: 204 PELIFGATDYTSS-IDVWSAGCVLAE 228

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 12/205 (5%)
Query: 280 LGTSSFGSVYKGTISDGTDVAI-KVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYS 338
           LG  +FG VYK    + + +A  KV + + E     +  E ++L +  H N++K+L ++ 
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 339 NPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCD 398
             +   +++EF   G+++  +      L   +   +      AL YLH+      IIH D
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN----KIIHRD 160
Query: 399 LKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGL-----EGIVS 453
           LK  NIL   +    ++DFG+           R+   + T  +MAPE  +     +    
Sbjct: 161 LKAGNILFTLDGDIKLADFGVSA--KNTRXIQRRDXFIGTPYWMAPEVVMCETSKDRPYD 218
Query: 454 AKCDVYSYGVLLMETFTRKRPTDEM 478
            K DV+S G+ L+E    + P  E+
Sbjct: 219 YKADVWSLGITLIEMAEIEPPHHEL 243

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNL--QLERAFRSFDSECEVLRNVRHR 328
           + F +   +G  ++G VYK      G  VA+K   L  + E    +   E  +L+ + H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 329 NLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMID-VGSALEYLHN 387
           N++K+L      +   LV EF+ +  L+K       F+D      I +  + S L  L  
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKK-------FMDASALTGIPLPLIKSYLFQLLQ 114
Query: 388 GHSSVH---IIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQ-TMTMATIGYMA 443
           G S  H   ++H DLKP N+L++      ++DFG+ +  G     VR  T  + T+ Y A
Sbjct: 115 GLSFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV---PVRTYTHEVVTLWYRA 171
Query: 444 PEYGLE-GIVSAKCDVYSYGVLLMETFTRK 472
           PE  L     S   D++S G +  E  TR+
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 69/261 (26%), Positives = 115/261 (44%), Gaps = 45/261 (17%)
Query: 245 TKKSDHEDFLPLAIWRRTSY---LDIQRATDEFNECNLLGTSSFGSVYKGT---ISD--- 295
           T  SD+E F     +R   Y    +  R   EF +  +LG+ +FG V   T   IS    
Sbjct: 19  TGSSDNEYFY--VDFREYEYDLKWEFPRENLEFGK--VLGSGAFGKVMNATAYGISKTGV 74
Query: 296 GTDVAIKVFNLQLERAFR-SFDSECEVLRNV-RHRNLIKILSS--YSNPDFKALVLEFMP 351
              VA+K+   + + + R +  SE +++  +  H N++ +L +   S P +  L+ E+  
Sbjct: 75  SIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIY--LIFEYCC 132
Query: 352 NGSLEKWL-------------YSHNYFLDILERLNIMI---------DVGSALEYLHNGH 389
            G L  +L             Y +   L+  E LN++           V   +E+L    
Sbjct: 133 YGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS 192
Query: 390 SSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLE 449
                +H DL   N+L+    V  + DFG+ + +    + V +      + +MAPE   E
Sbjct: 193 C----VHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE 248
Query: 450 GIVSAKCDVYSYGVLLMETFT 470
           GI + K DV+SYG+LL E F+
Sbjct: 249 GIYTIKSDVWSYGILLWEIFS 269

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 95/212 (44%), Gaps = 26/212 (12%)
Query: 280 LGTSSFGSVYKGTISDGTDVAI-KVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYS 338
           LG  +FG VYK    + + +A  KV + + E     +  E ++L +  H N++K+L ++ 
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 339 NPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCD 398
             +   +++EF   G+++  +      L   +   +      AL YLH+      IIH D
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN----KIIHRD 160
Query: 399 LKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMT-------MATIGYMAPEYGL--- 448
           LK  NIL   +    ++DFG+         S + T T       + T  +MAPE  +   
Sbjct: 161 LKAGNILFTLDGDIKLADFGV---------SAKNTRTIQRRDSFIGTPYWMAPEVVMCET 211
Query: 449 --EGIVSAKCDVYSYGVLLMETFTRKRPTDEM 478
             +     K DV+S G+ L+E    + P  E+
Sbjct: 212 SKDRPYDYKADVWSLGITLIEMAEIEPPHHEL 243

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 105/233 (45%), Gaps = 17/233 (7%)
Query: 240 CRNRNTKKSDHEDFLPLAIWRRTSYLDIQ----RATDEFNECNLLGTSSFGSVYKGT-IS 294
            R + T  S++++++   IW++     ++       D ++    LGT +FG V++ T  +
Sbjct: 16  VRGKGTVSSNYDNYV-FDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERA 74
Query: 295 DGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGS 354
            G + A K      E    +   E + +  +RH  L+ +  ++ + +   ++ EFM  G 
Sbjct: 75  TGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGE 134
Query: 355 L-EKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAH 413
           L EK    HN   +  E +  M  V   L ++H      + +H DLKP NI+        
Sbjct: 135 LFEKVADEHNKMSED-EAVEYMRQVCKGLCHMHEN----NYVHLDLKPENIMFTTKRSNE 189
Query: 414 VS--DFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVL 464
           +   DFG+   L + + SV+  +T  T  + APE      V    D++S GVL
Sbjct: 190 LKLIDFGLTAHL-DPKQSVK--VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVL 239

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 101/206 (49%), Gaps = 24/206 (11%)
Query: 274 FNECNLLGTSSFGSVYKGTISD-GTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIK 332
           + +  ++G  SFG VY+  + D G  VAIK   +  ++ F+  + E +++R + H N+++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFK--NRELQIMRKLDHCNIVR 77
Query: 333 I----LSSYSNPD--FKALVLEFMPNG--SLEKWLYSHNYFLDILERLNIMIDVGSALEY 384
           +     SS    D  +  LVL+++P     + +        L ++     M  +  +L Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 385 LHNGHSSVHIIHCDLKPTNILLD-ENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           +H    S  I H D+KP N+LLD +  V  + DFG  K L  GE +V     + +  Y A
Sbjct: 138 IH----SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRA 190
Query: 444 PE--YGLEGIVSAKCDVYSYGVLLME 467
           PE  +G     S+  DV+S G +L E
Sbjct: 191 PELIFGATDYTSS-IDVWSAGCVLAE 215

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 96/215 (44%), Gaps = 18/215 (8%)
Query: 265 LDIQRATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLE------RAFRSFDSE 318
           L  Q   +++ +   +G  ++G VYK   S G  VA+K   L  E       A R    E
Sbjct: 14  LYFQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIR----E 69
Query: 319 CEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDV 378
             +L+ + H N++ ++    +     LV EFM    L+K L  +   L   +   I I +
Sbjct: 70  ISLLKELHHPNIVSLIDVIHSERCLTLVFEFM-EKDLKKVLDENKTGL---QDSQIKIYL 125
Query: 379 GSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMAT 438
              L  + + H    I+H DLKP N+L++ +    ++DFG+ +  G    S   T  + T
Sbjct: 126 YQLLRGVAHCHQH-RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY--THEVVT 182
Query: 439 IGYMAPEYGL-EGIVSAKCDVYSYGVLLMETFTRK 472
           + Y AP+  +     S   D++S G +  E  T K
Sbjct: 183 LWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 95/209 (45%), Gaps = 18/209 (8%)
Query: 265 LDIQRATDEFNECNLLGTSSFGSVY--KGTISDGTDVAIKVF---NLQLERAFRSFDSEC 319
           L  Q  +D +     LG+ ++G V   K  ++ G + AIK+    ++       +   E 
Sbjct: 14  LYFQGLSDRYQRVKKLGSGAYGEVLLCKDKLT-GAERAIKIIKKSSVTTTSNSGALLDEV 72
Query: 320 EVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVG 379
            VL+ + H N++K+   + +     LV+E    G L   +     F ++ +   IM  V 
Sbjct: 73  AVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEV-DAAVIMKQVL 131
Query: 380 SALEYLHNGHSSVHIIHCDLKPTNILLD---ENMVAHVSDFGIYKLLGEGEDSVRQTMTM 436
           S   YLH  +    I+H DLKP N+LL+    + +  + DFG   L    E   +    +
Sbjct: 132 SGTTYLHKHN----IVHRDLKPENLLLESKSRDALIKIVDFG---LSAHFEVGGKMKERL 184
Query: 437 ATIGYMAPEYGLEGIVSAKCDVYSYGVLL 465
            T  Y+APE  L      KCDV+S GV+L
Sbjct: 185 GTAYYIAPEV-LRKKYDEKCDVWSCGVIL 212

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 96/215 (44%), Gaps = 18/215 (8%)
Query: 265 LDIQRATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLE------RAFRSFDSE 318
           L  Q   +++ +   +G  ++G VYK   S G  VA+K   L  E       A R    E
Sbjct: 14  LYFQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIR----E 69
Query: 319 CEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDV 378
             +L+ + H N++ ++    +     LV EFM    L+K L  +   L   +   I I +
Sbjct: 70  ISLLKELHHPNIVSLIDVIHSERCLTLVFEFM-EKDLKKVLDENKTGL---QDSQIKIYL 125
Query: 379 GSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMAT 438
              L  + + H    I+H DLKP N+L++ +    ++DFG+ +  G    S   T  + T
Sbjct: 126 YQLLRGVAHCHQH-RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY--THEVVT 182
Query: 439 IGYMAPEYGL-EGIVSAKCDVYSYGVLLMETFTRK 472
           + Y AP+  +     S   D++S G +  E  T K
Sbjct: 183 LWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 12/205 (5%)
Query: 280 LGTSSFGSVYKGTISDGTDVAI-KVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYS 338
           LG  +FG VYK    + + +A  KV + + E     +  E ++L +  H N++K+L ++ 
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 339 NPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCD 398
             +   +++EF   G+++  +      L   +   +      AL YLH+      IIH D
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN----KIIHRD 160
Query: 399 LKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGL-----EGIVS 453
           LK  NIL   +    ++DFG+           R+   + T  +MAPE  +     +    
Sbjct: 161 LKAGNILFTLDGDIKLADFGVSA--KNTRXIQRRDSFIGTPYWMAPEVVMCETSKDRPYD 218
Query: 454 AKCDVYSYGVLLMETFTRKRPTDEM 478
            K DV+S G+ L+E    + P  E+
Sbjct: 219 YKADVWSLGITLIEMAEIEPPHHEL 243

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNL--QLERAFRSFDSECEVLRNVRHR 328
           + F +   +G  ++G VYK      G  VA+K   L  + E    +   E  +L+ + H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 329 NLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMID-VGSALEYLHN 387
           N++K+L      +   LV EF+ +  L+K       F+D      I +  + S L  L  
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFL-HQDLKK-------FMDASALTGIPLPLIKSYLFQLLQ 121
Query: 388 GHSSVH---IIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQ-TMTMATIGYMA 443
           G +  H   ++H DLKP N+L++      ++DFG+ +  G     VR  T  + T+ Y A
Sbjct: 122 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV---PVRTYTHEVVTLWYRA 178
Query: 444 PEYGL-EGIVSAKCDVYSYGVLLMETFTRK 472
           PE  L     S   D++S G +  E  TR+
Sbjct: 179 PEILLGXKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 35/106 (33%), Positives = 55/106 (51%), Gaps = 4/106 (3%)
Query: 365 FLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG 424
           FL +   +     V   +E+L    +S   IH DL   NILL E  V  + DFG+ + + 
Sbjct: 189 FLTLEHLICYSFQVAKGMEFL----ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY 244
Query: 425 EGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
           +  D VR+      + +MAPE   + + + + DV+S+GVLL E F+
Sbjct: 245 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 35/106 (33%), Positives = 55/106 (51%), Gaps = 4/106 (3%)
Query: 365 FLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG 424
           FL +   +     V   +E+L    +S   IH DL   NILL E  V  + DFG+ + + 
Sbjct: 187 FLTLEHLICYSFQVAKGMEFL----ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY 242
Query: 425 EGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
           +  D VR+      + +MAPE   + + + + DV+S+GVLL E F+
Sbjct: 243 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 288

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNL--QLERAFRSFDSECEVLRNVRHR 328
           + F +   +G  ++G VYK      G  VA+K   L  + E    +   E  +L+ + H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 329 NLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMID-VGSALEYLHN 387
           N++K+L      +   LV EF+ +  L+K       F+D      I +  + S L  L  
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKK-------FMDASALTGIPLPLIKSYLFQLLQ 114
Query: 388 GHSSVH---IIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQ-TMTMATIGYMA 443
           G +  H   ++H DLKP N+L++      ++DFG+ +  G     VR  T  + T+ Y A
Sbjct: 115 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV---PVRTYTHEVVTLWYRA 171
Query: 444 PEYGL-EGIVSAKCDVYSYGVLLMETFTRK 472
           PE  L     S   D++S G +  E  TR+
Sbjct: 172 PEILLGXKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 35/106 (33%), Positives = 55/106 (51%), Gaps = 4/106 (3%)
Query: 365 FLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG 424
           FL +   +     V   +E+L    +S   IH DL   NILL E  V  + DFG+ + + 
Sbjct: 196 FLTLEHLICYSFQVAKGMEFL----ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY 251
Query: 425 EGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
           +  D VR+      + +MAPE   + + + + DV+S+GVLL E F+
Sbjct: 252 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 297

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 35/106 (33%), Positives = 55/106 (51%), Gaps = 4/106 (3%)
Query: 365 FLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG 424
           FL +   +     V   +E+L    +S   IH DL   NILL E  V  + DFG+ + + 
Sbjct: 194 FLTLEHLICYSFQVAKGMEFL----ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY 249
Query: 425 EGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
           +  D VR+      + +MAPE   + + + + DV+S+GVLL E F+
Sbjct: 250 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 295

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 94/201 (46%), Gaps = 14/201 (6%)
Query: 273 EFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQL---ERAFRSFDSECEVL-RNVRH 327
           +F+   ++G  SFG V      ++    A+KV   +    ++  +   SE  VL +NV+H
Sbjct: 39  DFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKH 98
Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
             L+ +  S+   D    VL+++  G L   L     FL+   R     ++ SAL YLH 
Sbjct: 99  PFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYLH- 156
Query: 388 GHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTM-ATIGYMAPEY 446
              S++I++ DLKP NILLD      ++DFG+ K   E  +    T T   T  Y+APE 
Sbjct: 157 ---SLNIVYRDLKPENILLDSQGHIVLTDFGLCK---ENIEHNSTTSTFCGTPEYLAPEV 210
Query: 447 GLEGIVSAKCDVYSYGVLLME 467
             +       D +  G +L E
Sbjct: 211 LHKQPYDRTVDWWCLGAVLYE 231

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 47/199 (23%), Positives = 90/199 (45%), Gaps = 10/199 (5%)
Query: 271 TDEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRH 327
           +D ++    LG  +F  V +    + G + A K+ N +    R F+  + E  + R ++H
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH- 386
            N++++  S     F  LV + +  G L + + +  ++ +  +  + +  +  ++ Y H 
Sbjct: 88  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEA-DASHCIQQILESIAYCHS 146
Query: 387 NGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEY 446
           NG     I+H +LKP N+LL             + L  E  DS        T GY++PE 
Sbjct: 147 NG-----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEV 201
Query: 447 GLEGIVSAKCDVYSYGVLL 465
             +   S   D+++ GV+L
Sbjct: 202 LKKDPYSKPVDIWACGVIL 220

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 96/215 (44%), Gaps = 12/215 (5%)
Query: 265 LDIQRATDEFNECNLLGTSSFGSV-YKGTISDGTDVAIKVFNLQLERAFRSFD---SECE 320
           +D +   +EF    LLG  +FG V      + G   A+K+   ++  A        +E  
Sbjct: 3   MDPRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENR 62
Query: 321 VLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGS 380
           VL+N RH  L  +  S+   D    V+E+   G L   L     F +   R     ++ S
Sbjct: 63  VLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVS 121
Query: 381 ALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG-EDSVRQTMTMATI 439
           AL+YLH   S  ++++ DLK  N++LD++    ++DFG+ K   EG +D         T 
Sbjct: 122 ALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKXFCGTP 175
Query: 440 GYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
            Y+APE   +       D +  GV++ E    + P
Sbjct: 176 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 210

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 99/217 (45%), Gaps = 27/217 (12%)
Query: 277 CNLLGTSSFGSVYKGTISDGTDV-AIKVFN-LQLERAFRSFDSECEVLRNVRHRNLIKIL 334
            ++LG  +  +V++G      D+ AIKVFN +   R       E EVL+ + H+N++K+ 
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73
Query: 335 S--SYSNPDFKALVLEFMPNGSLEKWLY--SHNYFLDILERLNIMIDVGSALEYL-HNGH 389
           +    +    K L++EF P GSL   L   S+ Y L   E L ++ DV   + +L  NG 
Sbjct: 74  AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG- 132
Query: 390 SSVHIIHCDLKPTNILL----DENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPE 445
               I+H ++KP NI+     D   V  ++DFG  + L   ED  +      T  Y+ P+
Sbjct: 133 ----IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL---EDDEQFVSLYGTEEYLHPD 185
Query: 446 YGLEGIV--------SAKCDVYSYGVLLMETFTRKRP 474
                ++         A  D++S GV      T   P
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 105/216 (48%), Gaps = 36/216 (16%)
Query: 272 DEFNECNLLGTSSFGSVYKGTISDGT--DVAIKVFNLQLERAFR-----------SFDSE 318
           DE+     LG+ + G V K      T   VAIK+ +   +R F            + ++E
Sbjct: 10  DEYIMSKTLGSGACGEV-KLAFERKTCKKVAIKIIS---KRKFAIGSAREADPALNVETE 65
Query: 319 CEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDV 378
            E+L+ + H  +IKI + +   D+  +VLE M  G L   +  +    +   +L     +
Sbjct: 66  IEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKL-YFYQM 123
Query: 379 GSALEYLH-NGHSSVHIIHCDLKPTNILL---DENMVAHVSDFGIYKLLGEGEDSVRQTM 434
             A++YLH NG     IIH DLKP N+LL   +E+ +  ++DFG  K+L  GE S+ +T+
Sbjct: 124 LLAVQYLHENG-----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTL 176
Query: 435 TMATIGYMAPE----YGLEGIVSAKCDVYSYGVLLM 466
              T  Y+APE     G  G   A  D +S GV+L 
Sbjct: 177 C-GTPTYLAPEVLVSVGTAGYNRA-VDCWSLGVILF 210

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 96/221 (43%), Gaps = 18/221 (8%)
Query: 251 EDFLPLAIWRRTSYLDIQRATDEFNECNLLGTSSFGSVYKGTISD-GTDVAIKVFNLQLE 309
           EDFL    W   S    Q   D+F+    LGT SFG V      + G   A+K+ + Q  
Sbjct: 24  EDFL--KKWETPSQNTAQ--LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV 79
Query: 310 RAFRSFD---SECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFL 366
              +  +   +E  +L+ V    L+K+  S+ +     +V+E++  G +   L     F 
Sbjct: 80  VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS 139
Query: 367 DILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG 426
           +   R      +    EYLH    S+ +I+ DLKP N+L+D+     V+DFG  K +   
Sbjct: 140 EPHARF-YAAQIVLTFEYLH----SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--- 191
Query: 427 EDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLME 467
               R      T   +APE  L    +   D ++ GVL+ E
Sbjct: 192 --KGRTWXLCGTPEALAPEIILSKGYNKAVDWWALGVLIYE 230

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 105/216 (48%), Gaps = 36/216 (16%)
Query: 272 DEFNECNLLGTSSFGSVYKGTISDGT--DVAIKVFNLQLERAFR-----------SFDSE 318
           DE+     LG+ + G V K      T   VAIK+ +   +R F            + ++E
Sbjct: 10  DEYIMSKTLGSGACGEV-KLAFERKTCKKVAIKIIS---KRKFAIGSAREADPALNVETE 65
Query: 319 CEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDV 378
            E+L+ + H  +IKI + +   D+  +VLE M  G L   +  +    +   +L     +
Sbjct: 66  IEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKL-YFYQM 123
Query: 379 GSALEYLH-NGHSSVHIIHCDLKPTNILL---DENMVAHVSDFGIYKLLGEGEDSVRQTM 434
             A++YLH NG     IIH DLKP N+LL   +E+ +  ++DFG  K+L  GE S+ +T+
Sbjct: 124 LLAVQYLHENG-----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTL 176
Query: 435 TMATIGYMAPE----YGLEGIVSAKCDVYSYGVLLM 466
              T  Y+APE     G  G   A  D +S GV+L 
Sbjct: 177 C-GTPTYLAPEVLVSVGTAGYNRA-VDCWSLGVILF 210

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 103/207 (49%), Gaps = 14/207 (6%)
Query: 272 DEFNECNLLGTSSFGSVYK-GTISDGTDVAIKVFNLQLERAFRS-FDSECEVLRNVRHRN 329
           D+F   + LG  + G V K      G  +A K+ +L+++ A R+    E +VL       
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 75
Query: 330 LIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLD-ILERLNIMIDVGSALEYLHNG 388
           ++    ++ +    ++ +E M  GSL++ L       + IL +++I +  G  L YL   
Sbjct: 76  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRG--LAYLREK 133
Query: 389 HSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGL 448
           H    I+H D+KP+NIL++      + DFG+    G+  DS+  +  + T  YMAPE  L
Sbjct: 134 H---QIMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSF-VGTRSYMAPER-L 185
Query: 449 EGI-VSAKCDVYSYGVLLMETFTRKRP 474
           +G   S + D++S G+ L+E    + P
Sbjct: 186 QGTHYSVQSDIWSMGLSLVELAVGRYP 212

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNL--QLERAFRSFDSECEVLRNVRHR 328
           + F +   +G  ++G VYK      G  VA+K   L  + E    +   E  +L+ + H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 329 NLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMID-VGSALEYLHN 387
           N++K+L      +   LV EF+ +  L+K       F+D      I +  + S L  L  
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFL-HQDLKK-------FMDASALTGIPLPLIKSYLFQLLQ 121
Query: 388 GHSSVH---IIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQ-TMTMATIGYMA 443
           G +  H   ++H DLKP N+L++      ++DFG+ +  G     VR  T  + T+ Y A
Sbjct: 122 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV---PVRTYTHEVVTLWYRA 178
Query: 444 PEYGLE-GIVSAKCDVYSYGVLLMETFTRK 472
           PE  L     S   D++S G +  E  TR+
Sbjct: 179 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 105/216 (48%), Gaps = 36/216 (16%)
Query: 272 DEFNECNLLGTSSFGSVYKGTISDGT--DVAIKVFNLQLERAFR-----------SFDSE 318
           DE+     LG+ + G V K      T   VAIK+ +   +R F            + ++E
Sbjct: 16  DEYIMSKTLGSGACGEV-KLAFERKTCKKVAIKIIS---KRKFAIGSAREADPALNVETE 71
Query: 319 CEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDV 378
            E+L+ + H  +IKI + +   D+  +VLE M  G L   +  +    +   +L     +
Sbjct: 72  IEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKL-YFYQM 129
Query: 379 GSALEYLH-NGHSSVHIIHCDLKPTNILL---DENMVAHVSDFGIYKLLGEGEDSVRQTM 434
             A++YLH NG     IIH DLKP N+LL   +E+ +  ++DFG  K+L  GE S+ +T+
Sbjct: 130 LLAVQYLHENG-----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTL 182
Query: 435 TMATIGYMAPE----YGLEGIVSAKCDVYSYGVLLM 466
              T  Y+APE     G  G   A  D +S GV+L 
Sbjct: 183 C-GTPTYLAPEVLVSVGTAGYNRA-VDCWSLGVILF 216

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNL--QLERAFRSFDSECEVLRNVRHR 328
           + F +   +G  ++G VYK      G  VA+K   L  + E    +   E  +L+ + H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 329 NLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMID-VGSALEYLHN 387
           N++K+L      +   LV EF+ +  L+K       F+D      I +  + S L  L  
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKK-------FMDASALTGIPLPLIKSYLFQLLQ 113
Query: 388 GHSSVH---IIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQ-TMTMATIGYMA 443
           G +  H   ++H DLKP N+L++      ++DFG+ +  G     VR  T  + T+ Y A
Sbjct: 114 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV---PVRTYTHEVVTLWYRA 170
Query: 444 PEYGLE-GIVSAKCDVYSYGVLLMETFTRK 472
           PE  L     S   D++S G +  E  TR+
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 105/216 (48%), Gaps = 36/216 (16%)
Query: 272 DEFNECNLLGTSSFGSVYKGTISDGT--DVAIKVFNLQLERAFR-----------SFDSE 318
           DE+     LG+ + G V K      T   VAIK+ +   +R F            + ++E
Sbjct: 10  DEYIMSKTLGSGACGEV-KLAFERKTCKKVAIKIIS---KRKFAIGSAREADPALNVETE 65
Query: 319 CEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDV 378
            E+L+ + H  +IKI + +   D+  +VLE M  G L   +  +    +   +L     +
Sbjct: 66  IEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKL-YFYQM 123
Query: 379 GSALEYLH-NGHSSVHIIHCDLKPTNILL---DENMVAHVSDFGIYKLLGEGEDSVRQTM 434
             A++YLH NG     IIH DLKP N+LL   +E+ +  ++DFG  K+L  GE S+ +T+
Sbjct: 124 LLAVQYLHENG-----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTL 176
Query: 435 TMATIGYMAPE----YGLEGIVSAKCDVYSYGVLLM 466
              T  Y+APE     G  G   A  D +S GV+L 
Sbjct: 177 C-GTPTYLAPEVLVSVGTAGYNRA-VDCWSLGVILF 210

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 44/179 (24%), Positives = 91/179 (50%), Gaps = 8/179 (4%)
Query: 296 GTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSL 355
           G  VA+K+ +L+ ++      +E  ++R+ +H N++++  SY   +   +++EF+  G+L
Sbjct: 70  GRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGAL 129
Query: 356 EKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVS 415
              +      L+  +   +   V  AL YLH    +  +IH D+K  +ILL  +    +S
Sbjct: 130 TDIV--SQVRLNEEQIATVCEAVLQALAYLH----AQGVIHRDIKSDSILLTLDGRVKLS 183
Query: 416 DFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
           DFG    +   +D  ++   + T  +MAPE     + + + D++S G++++E    + P
Sbjct: 184 DFGFCAQI--SKDVPKRKXLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP 240

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 105/216 (48%), Gaps = 36/216 (16%)
Query: 272 DEFNECNLLGTSSFGSVYKGTISDGT--DVAIKVFNLQLERAFR-----------SFDSE 318
           DE+     LG+ + G V K      T   VAIK+ +   +R F            + ++E
Sbjct: 9   DEYIMSKTLGSGACGEV-KLAFERKTCKKVAIKIIS---KRKFAIGSAREADPALNVETE 64
Query: 319 CEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDV 378
            E+L+ + H  +IKI + +   D+  +VLE M  G L   +  +    +   +L     +
Sbjct: 65  IEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKL-YFYQM 122
Query: 379 GSALEYLH-NGHSSVHIIHCDLKPTNILL---DENMVAHVSDFGIYKLLGEGEDSVRQTM 434
             A++YLH NG     IIH DLKP N+LL   +E+ +  ++DFG  K+L  GE S+ +T+
Sbjct: 123 LLAVQYLHENG-----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTL 175
Query: 435 TMATIGYMAPE----YGLEGIVSAKCDVYSYGVLLM 466
              T  Y+APE     G  G   A  D +S GV+L 
Sbjct: 176 C-GTPTYLAPEVLVSVGTAGYNRA-VDCWSLGVILF 209

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 99/233 (42%), Gaps = 20/233 (8%)
Query: 262 TSYLDIQRATDEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFN------LQLERAFRS 314
           TS  D Q     +     +G  +F  V     +  G +VA+K+ +        L++ FR 
Sbjct: 5   TSATDEQPHIGNYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFR- 63
Query: 315 FDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNI 374
              E  +++ + H N++K+           LV+E+   G +  +L +H    +   R   
Sbjct: 64  ---EVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF 120
Query: 375 MIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTM 434
              + SA++Y H  +    I+H DLK  N+LLD +M   ++DFG       G    +   
Sbjct: 121 R-QIVSAVQYCHQKY----IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGN---KLDT 172
Query: 435 TMATIGYMAPE-YGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLR 486
              +  Y APE +  +     + DV+S GV+L    +   P D   + E+  R
Sbjct: 173 FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRER 225

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/173 (30%), Positives = 84/173 (48%), Gaps = 16/173 (9%)
Query: 298 DVAIKVFNLQLERAFRSFDSECEVL-RNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLE 356
           + A+KV    ++++ R    E E+L R  +H N+I +   Y +     LV E M  G L 
Sbjct: 54  EYAVKV----IDKSKRDPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELL 109
Query: 357 KWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNIL-LDEN---MVA 412
             +    +F +  E   ++  +G  +EYLH    S  ++H DLKP+NIL +DE+      
Sbjct: 110 DKILRQKFFSE-REASFVLHTIGKTVEYLH----SQGVVHRDLKPSNILYVDESGNPECL 164
Query: 413 HVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLL 465
            + DFG  K L   E+ +  T    T  ++APE          CD++S G+LL
Sbjct: 165 RICDFGFAKQL-RAENGLLMT-PCYTANFVAPEVLKRQGYDEGCDIWSLGILL 215

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNL--QLERAFRSFDSECEVLRNVRHR 328
           + F +   +G  ++G VYK      G  VA+K   L  + E    +   E  +L+ + H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 329 NLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMID-VGSALEYLHN 387
           N++K+L      +   LV EF+ +  L+K       F+D      I +  + S L  L  
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKK-------FMDASALTGIPLPLIKSYLFQLLQ 114
Query: 388 GHSSVH---IIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQ-TMTMATIGYMA 443
           G +  H   ++H DLKP N+L++      ++DFG+ +  G     VR  T  + T+ Y A
Sbjct: 115 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV---PVRTYTHEVVTLWYRA 171
Query: 444 PEYGLE-GIVSAKCDVYSYGVLLMETFTRK 472
           PE  L     S   D++S G +  E  TR+
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNL--QLERAFRSFDSECEVLRNVRHR 328
           + F +   +G  ++G VYK      G  VA+K   L  + E    +   E  +L+ + H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 329 NLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMID-VGSALEYLHN 387
           N++K+L      +   LV EF+ +  L+K       F+D      I +  + S L  L  
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKK-------FMDASALTGIPLPLIKSYLFQLLQ 113
Query: 388 GHSSVH---IIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQ-TMTMATIGYMA 443
           G +  H   ++H DLKP N+L++      ++DFG+ +  G     VR  T  + T+ Y A
Sbjct: 114 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV---PVRTYTHEVVTLWYRA 170
Query: 444 PEYGLE-GIVSAKCDVYSYGVLLMETFTRK 472
           PE  L     S   D++S G +  E  TR+
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 20/212 (9%)
Query: 270 ATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNL--QLERAFRSFDSECEVLRNVR 326
           + + F +   +G  ++G VYK      G  VA+K   L  + E    +   E  +L+ + 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 327 HRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMID-VGSALEYL 385
           H N++K+L      +   LV EF+ +  L+K       F+D      I +  + S L  L
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKK-------FMDASALTGIPLPLIKSYLFQL 113
Query: 386 HNGHSSVH---IIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQ-TMTMATIGY 441
             G +  H   ++H DLKP N+L++      ++DFG+ +  G     VR  T  + T+ Y
Sbjct: 114 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV---PVRTYTHEVVTLWY 170
Query: 442 MAPEYGLE-GIVSAKCDVYSYGVLLMETFTRK 472
            APE  L     S   D++S G +  E  TR+
Sbjct: 171 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNL--QLERAFRSFDSECEVLRNVRHR 328
           + F +   +G  ++G VYK      G  VA+K   L  + E    +   E  +L+ + H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 329 NLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMID-VGSALEYLHN 387
           N++K+L      +   LV EF+ +  L+K       F+D      I +  + S L  L  
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKK-------FMDASALTGIPLPLIKSYLFQLLQ 114
Query: 388 GHSSVH---IIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQ-TMTMATIGYMA 443
           G +  H   ++H DLKP N+L++      ++DFG+ +  G     VR  T  + T+ Y A
Sbjct: 115 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV---PVRTYTHEVVTLWYRA 171
Query: 444 PEYGLE-GIVSAKCDVYSYGVLLMETFTRK 472
           PE  L     S   D++S G +  E  TR+
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNL--QLERAFRSFDSECEVLRNVRHR 328
           + F +   +G  ++G VYK      G  VA+K   L  + E    +   E  +L+ + H 
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 66
Query: 329 NLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMID-VGSALEYLHN 387
           N++K+L      +   LV EF+ +  L+K       F+D      I +  + S L  L  
Sbjct: 67  NIVKLLDVIHTENKLYLVFEFL-HQDLKK-------FMDASALTGIPLPLIKSYLFQLLQ 118
Query: 388 GHSSVH---IIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQ-TMTMATIGYMA 443
           G +  H   ++H DLKP N+L++      ++DFG+ +  G     VR  T  + T+ Y A
Sbjct: 119 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV---PVRTYTHEVVTLWYRA 175
Query: 444 PEYGLE-GIVSAKCDVYSYGVLLMETFTRK 472
           PE  L     S   D++S G +  E  TR+
Sbjct: 176 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 103/222 (46%), Gaps = 27/222 (12%)
Query: 267 IQRATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAF----RS----FDSE 318
           +Q   ++++   ++G  +FG V           + KV+ ++L   F    RS    F  E
Sbjct: 70  LQMKAEDYDVVKVIGRGAFGEVQLVR----HKASQKVYAMKLLSKFEMIKRSDSAFFWEE 125
Query: 319 CEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLN--IMI 376
            +++       ++++  ++ +  +  +V+E+MP G L   +   NY  D+ E+       
Sbjct: 126 RDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLM--SNY--DVPEKWAKFYTA 181
Query: 377 DVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTM 436
           +V  AL+ +H    S+ +IH D+KP N+LLD++    ++DFG    + E    V     +
Sbjct: 182 EVVLALDAIH----SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE-TGMVHCDTAV 236
Query: 437 ATIGYMAPE----YGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
            T  Y++PE     G +G    +CD +S GV L E      P
Sbjct: 237 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 278

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 95/202 (47%), Gaps = 16/202 (7%)
Query: 271 TDEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRH 327
           +D ++    LG  +F  V +    + G + A K+ N +    R F+  + E  + R ++H
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 63
Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH- 386
            N++++  S     F  LV + +  G L + + +  ++ +  +  + +  +  ++ Y H 
Sbjct: 64  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEA-DASHCIQQILESIAYCHS 122
Query: 387 NGHSSVHIIHCDLKPTNILL---DENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           NG     I+H +LKP N+LL    +     ++DFG   L  E  DS        T GY++
Sbjct: 123 NG-----IVHRNLKPENLLLASKAKGAAVKLADFG---LAIEVNDSEAWHGFAGTPGYLS 174
Query: 444 PEYGLEGIVSAKCDVYSYGVLL 465
           PE   +   S   D+++ GV+L
Sbjct: 175 PEVLKKDPYSKPVDIWACGVIL 196

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 47/199 (23%), Positives = 90/199 (45%), Gaps = 10/199 (5%)
Query: 271 TDEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRH 327
           +D ++    LG  +F  V +    + G + A K+ N +    R F+  + E  + R ++H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH- 386
            N++++  S     F  LV + +  G L + + +  ++ +  +  + +  +  ++ Y H 
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEA-DASHCIQQILESIAYCHS 123
Query: 387 NGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEY 446
           NG     I+H +LKP N+LL             + L  E  DS        T GY++PE 
Sbjct: 124 NG-----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEV 178
Query: 447 GLEGIVSAKCDVYSYGVLL 465
             +   S   D+++ GV+L
Sbjct: 179 LKKDPYSKPVDIWACGVIL 197

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 94/215 (43%), Gaps = 20/215 (9%)
Query: 280 LGTSSFGSVYKGT-ISDGTDVAIKVFNL------QLERAFRSFDSECEVLRNVRHRNLIK 332
           +G  +F  V     I  G +VA+K+ +        L++ FR    E  +++ + H N++K
Sbjct: 15  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR----EVRIMKVLNHPNIVK 70
Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSV 392
           +           LV+E+   G +  +L +H +  +   R      + SA++Y H      
Sbjct: 71  LFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFR-QIVSAVQYCHQKF--- 126
Query: 393 HIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPE-YGLEGI 451
            I+H DLK  N+LLD +M   ++DFG       G    +      +  Y APE +  +  
Sbjct: 127 -IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGN---KLDTFCGSPPYAAPELFQGKKY 182
Query: 452 VSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLR 486
              + DV+S GV+L    +   P D   + E+  R
Sbjct: 183 DGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRER 217

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 95/202 (47%), Gaps = 16/202 (7%)
Query: 271 TDEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRH 327
           +D ++    LG  +F  V +    + G + A K+ N +    R F+  + E  + R ++H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH- 386
            N++++  S     F  LV + +  G L + + +  ++ +  +  + +  +  ++ Y H 
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEA-DASHCIQQILESIAYCHS 123
Query: 387 NGHSSVHIIHCDLKPTNILL---DENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           NG     I+H +LKP N+LL    +     ++DFG   L  E  DS        T GY++
Sbjct: 124 NG-----IVHRNLKPENLLLASKAKGAAVKLADFG---LAIEVNDSEAWHGFAGTPGYLS 175
Query: 444 PEYGLEGIVSAKCDVYSYGVLL 465
           PE   +   S   D+++ GV+L
Sbjct: 176 PEVLKKDPYSKPVDIWACGVIL 197

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 94/211 (44%), Gaps = 18/211 (8%)
Query: 272 DEFNECNLLGTSSFGSV-YKGTISDGTDVAIKVFNLQLERAFRSFD---SECEVLRNVRH 327
           +EF    LLG  +FG V      + G   A+K+   ++  A        +E  VL+N RH
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
             L  +  S+   D    V+E+   G L   L     F +   R     ++ SAL+YLH 
Sbjct: 208 PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDYLH- 265
Query: 388 GHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATI----GYMA 443
             S  ++++ DLK  N++LD++    ++DFG+ K      + ++   TM T      Y+A
Sbjct: 266 --SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK------EGIKDGATMKTFCGTPEYLA 317
Query: 444 PEYGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
           PE   +       D +  GV++ E    + P
Sbjct: 318 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/173 (30%), Positives = 84/173 (48%), Gaps = 16/173 (9%)
Query: 298 DVAIKVFNLQLERAFRSFDSECEVL-RNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLE 356
           + A+KV    ++++ R    E E+L R  +H N+I +   Y +     LV E M  G L 
Sbjct: 54  EYAVKV----IDKSKRDPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELL 109
Query: 357 KWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNIL-LDEN---MVA 412
             +    +F +  E   ++  +G  +EYLH    S  ++H DLKP+NIL +DE+      
Sbjct: 110 DKILRQKFFSE-REASFVLHTIGKTVEYLH----SQGVVHRDLKPSNILYVDESGNPECL 164
Query: 413 HVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLL 465
            + DFG  K L   E+ +  T    T  ++APE          CD++S G+LL
Sbjct: 165 RICDFGFAKQL-RAENGLLMT-PCYTANFVAPEVLKRQGYDEGCDIWSLGILL 215

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 94/211 (44%), Gaps = 18/211 (8%)
Query: 272 DEFNECNLLGTSSFGSV-YKGTISDGTDVAIKVFNLQLERAFRSFD---SECEVLRNVRH 327
           +EF    LLG  +FG V      + G   A+K+   ++  A        +E  VL+N RH
Sbjct: 151 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 210
Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
             L  +  S+   D    V+E+   G L   L     F +   R     ++ SAL+YLH 
Sbjct: 211 PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDYLH- 268
Query: 388 GHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATI----GYMA 443
             S  ++++ DLK  N++LD++    ++DFG+ K      + ++   TM T      Y+A
Sbjct: 269 --SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK------EGIKDGATMKTFCGTPEYLA 320
Query: 444 PEYGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
           PE   +       D +  GV++ E    + P
Sbjct: 321 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 351

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 52/220 (23%), Positives = 100/220 (45%), Gaps = 22/220 (10%)
Query: 273 EFNECNL-----LGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRSFD------SECE 320
           EF   NL     LG  +FG V + T    G + A+    +++ ++    D      SE +
Sbjct: 42  EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 101
Query: 321 VLRNV-RHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVG 379
           ++ ++ +H N++ +L + ++     ++ E+   G L  +L   +  L+      I     
Sbjct: 102 IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTA 161
Query: 380 SALEYLHNGH---------SSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSV 430
           S  + LH            +S + IH D+   N+LL    VA + DFG+ + +    + +
Sbjct: 162 STRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI 221
Query: 431 RQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
            +      + +MAPE   + + + + DV+SYG+LL E F+
Sbjct: 222 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/159 (33%), Positives = 84/159 (52%), Gaps = 19/159 (11%)
Query: 316 DSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIM 375
           ++E E+L+ + H  +IKI + +   D+  +VLE M  G L   +  +    +   +L   
Sbjct: 202 ETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKL-YF 259
Query: 376 IDVGSALEYLH-NGHSSVHIIHCDLKPTNILL---DENMVAHVSDFGIYKLLGEGEDSVR 431
             +  A++YLH NG     IIH DLKP N+LL   +E+ +  ++DFG  K+LGE   S+ 
Sbjct: 260 YQMLLAVQYLHENG-----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET--SLM 312
Query: 432 QTMTMATIGYMAPE----YGLEGIVSAKCDVYSYGVLLM 466
           +T+   T  Y+APE     G  G   A  D +S GV+L 
Sbjct: 313 RTLC-GTPTYLAPEVLVSVGTAGYNRA-VDCWSLGVILF 349

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/159 (33%), Positives = 84/159 (52%), Gaps = 19/159 (11%)
Query: 316 DSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIM 375
           ++E E+L+ + H  +IKI + +   D+  +VLE M  G L   +  +    +   +L   
Sbjct: 188 ETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKL-YF 245
Query: 376 IDVGSALEYLH-NGHSSVHIIHCDLKPTNILL---DENMVAHVSDFGIYKLLGEGEDSVR 431
             +  A++YLH NG     IIH DLKP N+LL   +E+ +  ++DFG  K+LGE   S+ 
Sbjct: 246 YQMLLAVQYLHENG-----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET--SLM 298
Query: 432 QTMTMATIGYMAPE----YGLEGIVSAKCDVYSYGVLLM 466
           +T+   T  Y+APE     G  G   A  D +S GV+L 
Sbjct: 299 RTLC-GTPTYLAPEVLVSVGTAGYNRA-VDCWSLGVILF 335

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 93/214 (43%), Gaps = 19/214 (8%)
Query: 262 TSYLDIQRATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVF-----NLQLERAFRSFD 316
           T   +IQR   E   C  +G   FG V++G      + A+ V      N   +     F 
Sbjct: 382 TRDYEIQRERIELGRC--IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFL 439
Query: 317 SECEVLRNVRHRNLIKILSSYS-NPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIM 375
            E   +R   H +++K++   + NP +  +++E    G L  +L    + LD+   +   
Sbjct: 440 QEALTMRQFDHPHIVKLIGVITENPVW--IIMELCTLGELRSFLQVRKFSLDLASLILYA 497
Query: 376 IDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSV--RQT 433
             + +AL YL     S   +H D+   N+L+  N    + DFG+ + +   EDS   + +
Sbjct: 498 YQLSTALAYLE----SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM---EDSTYYKAS 550
Query: 434 MTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLME 467
                I +MAPE       ++  DV+ +GV + E
Sbjct: 551 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWE 584

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 56/189 (29%), Positives = 86/189 (45%), Gaps = 17/189 (8%)
Query: 317 SECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIM- 375
           +E ++L  V  R ++ +  +Y   D   LVL  M  G L+  +Y H       E   +  
Sbjct: 233 NEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIY-HMGQAGFPEARAVFY 291
Query: 376 -IDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTM 434
             ++   LE LH       I++ DLKP NILLD++    +SD G+   + EG     QT+
Sbjct: 292 AAEICCGLEDLHR----ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG-----QTI 342
Query: 435 T--MATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDE--MFIGEMSLRRWVK 490
              + T+GYMAPE       +   D ++ G LL E    + P  +    I    + R VK
Sbjct: 343 KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK 402
Query: 491 ESLPHGLTE 499
           E +P   +E
Sbjct: 403 E-VPEEYSE 410

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 93/208 (44%), Gaps = 12/208 (5%)
Query: 272 DEFNECNLLGTSSFGSV-YKGTISDGTDVAIKVFNLQLERAFRSFD---SECEVLRNVRH 327
           +EF    LLG  +FG V      + G   A+K+   ++  A        +E  VL+N RH
Sbjct: 9   NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 68
Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
             L  +  S+   D    V+E+   G L   L     F +   R     ++ SAL+YLH 
Sbjct: 69  PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDYLH- 126
Query: 388 GHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG-EDSVRQTMTMATIGYMAPEY 446
             S  ++++ DLK  N++LD++    ++DFG+ K   EG +D         T  Y+APE 
Sbjct: 127 --SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKXFCGTPEYLAPEV 181
Query: 447 GLEGIVSAKCDVYSYGVLLMETFTRKRP 474
             +       D +  GV++ E    + P
Sbjct: 182 LEDNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 93/227 (40%), Gaps = 34/227 (14%)
Query: 269 RATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNVRH 327
           R   +F E  +LG  +FG V K   + D    AIK      E    +  SE  +L ++ H
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVXLLASLNH 61
Query: 328 -------------RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNI 374
                        RN +K  ++        +  E+  N +L   ++S N      E   +
Sbjct: 62  QYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRL 121
Query: 375 MIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVR--- 431
              +  AL Y+H    S  IIH +LKP NI +DE+    + DFG+ K +    D ++   
Sbjct: 122 FRQILEALSYIH----SQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 432 ---------QTMTMATIGYMAPEYGLEGI--VSAKCDVYSYGVLLME 467
                     T  + T  Y+A E  L+G    + K D YS G++  E
Sbjct: 178 QNLPGSSDNLTSAIGTAXYVATEV-LDGTGHYNEKIDXYSLGIIFFE 223

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/187 (33%), Positives = 95/187 (50%), Gaps = 27/187 (14%)
Query: 297 TDVAIKVFNLQ----LERAFRSFDSECEVLRNVR-HRNLIKILSSYSNPDFKALVLEFMP 351
            + A+K+   Q      R FR    E E+L   + HRN+++++  +   D   LV E M 
Sbjct: 39  QEYAVKIIEKQPGHIRSRVFR----EVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMR 94
Query: 352 NGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDE-NM 410
            GS+   ++   +F + LE   ++ DV SAL++LHN      I H DLKP NIL +  N 
Sbjct: 95  GGSILSHIHKRRHFNE-LEASVVVQDVASALDFLHNK----GIAHRDLKPENILCEHPNQ 149
Query: 411 VAHVS--DFGI---YKLLGEGED-SVRQTMT-MATIGYMAPE----YGLEG-IVSAKCDV 458
           V+ V   DFG+    KL G+    S  + +T   +  YMAPE    +  E  I   +CD+
Sbjct: 150 VSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDL 209
Query: 459 YSYGVLL 465
           +S GV+L
Sbjct: 210 WSLGVIL 216

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 93/208 (44%), Gaps = 12/208 (5%)
Query: 272 DEFNECNLLGTSSFGSV-YKGTISDGTDVAIKVFNLQLERAFRSFD---SECEVLRNVRH 327
           +EF    LLG  +FG V      + G   A+K+   ++  A        +E  VL+N RH
Sbjct: 8   NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 67
Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
             L  +  S+   D    V+E+   G L   L     F +   R     ++ SAL+YLH 
Sbjct: 68  PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDYLH- 125
Query: 388 GHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG-EDSVRQTMTMATIGYMAPEY 446
             S  ++++ DLK  N++LD++    ++DFG+ K   EG +D         T  Y+APE 
Sbjct: 126 --SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKXFCGTPEYLAPEV 180
Query: 447 GLEGIVSAKCDVYSYGVLLMETFTRKRP 474
             +       D +  GV++ E    + P
Sbjct: 181 LEDNDYGRAVDWWGLGVVMYEMMCGRLP 208

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/189 (29%), Positives = 86/189 (45%), Gaps = 17/189 (8%)
Query: 317 SECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIM- 375
           +E ++L  V  R ++ +  +Y   D   LVL  M  G L+  +Y H       E   +  
Sbjct: 233 NEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIY-HMGQAGFPEARAVFY 291
Query: 376 -IDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTM 434
             ++   LE LH       I++ DLKP NILLD++    +SD G+   + EG     QT+
Sbjct: 292 AAEICCGLEDLHR----ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG-----QTI 342
Query: 435 T--MATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDE--MFIGEMSLRRWVK 490
              + T+GYMAPE       +   D ++ G LL E    + P  +    I    + R VK
Sbjct: 343 KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK 402
Query: 491 ESLPHGLTE 499
           E +P   +E
Sbjct: 403 E-VPEEYSE 410

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 95/202 (47%), Gaps = 15/202 (7%)
Query: 271 TDEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRH 327
           TDE+     LG  +F  V +   I  G + A K+ N +    R  +  + E  + R ++H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH- 386
            N++++  S S   F  LV + +  G L + + +  Y+ +  +  + +  +  ++ + H 
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEA-DASHCIQQILESVNHCHL 121
Query: 387 NGHSSVHIIHCDLKPTNILL---DENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           NG     I+H DLKP N+LL    +     ++DFG+  +  +G+          T GY++
Sbjct: 122 NG-----IVHRDLKPENLLLASKSKGAAVKLADFGL-AIEVQGDQQAWFGFA-GTPGYLS 174
Query: 444 PEYGLEGIVSAKCDVYSYGVLL 465
           PE   +       D+++ GV+L
Sbjct: 175 PEVLRKDPYGKPVDMWACGVIL 196

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 95/202 (47%), Gaps = 15/202 (7%)
Query: 271 TDEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRH 327
           TDE+     LG  +F  V +   I  G + A K+ N +    R  +  + E  + R ++H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH- 386
            N++++  S S   F  LV + +  G L + + +  Y+ +  +  + +  +  ++ + H 
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEA-DASHCIQQILESVNHCHL 121
Query: 387 NGHSSVHIIHCDLKPTNILL---DENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           NG     I+H DLKP N+LL    +     ++DFG+  +  +G+          T GY++
Sbjct: 122 NG-----IVHRDLKPENLLLASKSKGAAVKLADFGL-AIEVQGDQQAWFGFA-GTPGYLS 174
Query: 444 PEYGLEGIVSAKCDVYSYGVLL 465
           PE   +       D+++ GV+L
Sbjct: 175 PEVLRKDPYGKPVDMWACGVIL 196

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 93/203 (45%), Gaps = 18/203 (8%)
Query: 271 TDEFNECNLLGTSSFGSVY--KGTISDGTDVAIKVF---NLQLERAFRSFDSECEVLRNV 325
           +D +     LG+ ++G V   K  ++ G + AIK+    ++       +   E  VL+ +
Sbjct: 3   SDRYQRVKKLGSGAYGEVLLCKDKLT-GAERAIKIIKKSSVTTTSNSGALLDEVAVLKQL 61
Query: 326 RHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYL 385
            H N++K+   + +     LV+E    G L   +     F ++ +   IM  V S   YL
Sbjct: 62  DHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEV-DAAVIMKQVLSGTTYL 120
Query: 386 HNGHSSVHIIHCDLKPTNILLD---ENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYM 442
           H  +    I+H DLKP N+LL+    + +  + DFG   L    E   +    + T  Y+
Sbjct: 121 HKHN----IVHRDLKPENLLLESKSRDALIKIVDFG---LSAHFEVGGKMKERLGTAYYI 173
Query: 443 APEYGLEGIVSAKCDVYSYGVLL 465
           APE  L      KCDV+S GV+L
Sbjct: 174 APEV-LRKKYDEKCDVWSCGVIL 195

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 106/220 (48%), Gaps = 27/220 (12%)
Query: 271 TDEFNECNLLGTSSFGSVYKGTISD-GTDVAIK---VFNLQLERAFRSFDSECEVLRNVR 326
           + +F   +LLG  ++G V   T    G  VAIK    F+  L  A R+   E ++L++ +
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPL-FALRTL-REIKILKHFK 67
Query: 327 HRNLIKILS-----SYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSA 381
           H N+I I +     S+ N +   ++ E M    L + + +     D ++    +     A
Sbjct: 68  HENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVISTQMLSDDHIQYF--IYQTLRA 124
Query: 382 LEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGE-----GEDSVRQ---T 433
           ++ LH  +    +IH DLKP+N+L++ N    V DFG+ +++ E      E + +Q   T
Sbjct: 125 VKVLHGSN----VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMT 180
Query: 434 MTMATIGYMAPEYGL-EGIVSAKCDVYSYGVLLMETFTRK 472
             +AT  Y APE  L     S   DV+S G +L E F R+
Sbjct: 181 EXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 90/208 (43%), Gaps = 12/208 (5%)
Query: 269 RATDEFNECNLLGTSSFGSVYK-GTISDGTDVAIKVFNL--QLERAFRSFDSECEVLRNV 325
           RA D +     +GT S+G   K    SDG  +  K  +     E   +   SE  +LR +
Sbjct: 4   RAED-YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 62
Query: 326 RHRNLIKILSSYSNPDFKAL--VLEFMPNGSLEKWLYS---HNYFLDILERLNIMIDVGS 380
           +H N+++      +     L  V+E+   G L   +        +LD    L +M  +  
Sbjct: 63  KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122
Query: 381 ALEYLHNGHSSVH-IIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATI 439
           AL+  H      H ++H DLKP N+ LD      + DFG+ ++L    D+      + T 
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDTSFAKAFVGTP 180
Query: 440 GYMAPEYGLEGIVSAKCDVYSYGVLLME 467
            YM+PE       + K D++S G LL E
Sbjct: 181 YYMSPEQMNRMSYNEKSDIWSLGCLLYE 208

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/221 (23%), Positives = 91/221 (41%), Gaps = 34/221 (15%)
Query: 280 LGTSSFGSVYKG------TISDGTDVAIKVFNLQLERAFRS-FDSECEVLRNVRHRNLIK 332
           +G  +FG V++            T VA+K+   +     ++ F  E  ++    + N++K
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYF-----------------------LDIL 369
           +L   +      L+ E+M  G L ++L S +                         L   
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 370 ERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDS 429
           E+L I   V + + YL    S    +H DL   N L+ ENMV  ++DFG+ + +   +  
Sbjct: 175 EQLCIARQVAAGMAYL----SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 230
Query: 430 VRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
                    I +M PE       + + DV++YGV+L E F+
Sbjct: 231 KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 90/208 (43%), Gaps = 12/208 (5%)
Query: 269 RATDEFNECNLLGTSSFGSVYK-GTISDGTDVAIKVFNL--QLERAFRSFDSECEVLRNV 325
           RA D +     +GT S+G   K    SDG  +  K  +     E   +   SE  +LR +
Sbjct: 4   RAED-YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 62
Query: 326 RHRNLIKILSSYSNPDFKAL--VLEFMPNGSLEKWLYS---HNYFLDILERLNIMIDVGS 380
           +H N+++      +     L  V+E+   G L   +        +LD    L +M  +  
Sbjct: 63  KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122
Query: 381 ALEYLHNGHSSVH-IIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATI 439
           AL+  H      H ++H DLKP N+ LD      + DFG+ ++L    D+      + T 
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDTSFAKTFVGTP 180
Query: 440 GYMAPEYGLEGIVSAKCDVYSYGVLLME 467
            YM+PE       + K D++S G LL E
Sbjct: 181 YYMSPEQMNRMSYNEKSDIWSLGCLLYE 208

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 96/218 (44%), Gaps = 19/218 (8%)
Query: 265 LDIQRATDEFNECNLLGTSSFGSVY----KGTISDGTDVAIKVFNLQLERAFRSFD---S 317
           +D +   ++F+   LLG  +FG V     K T   G   A+K+   ++  A        +
Sbjct: 3   MDPKVTMNDFDYLKLLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVT 59
Query: 318 ECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMID 377
           E  VL+N RH  L  +  ++   D    V+E+   G L   L     F +   R     +
Sbjct: 60  ESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAE 118
Query: 378 VGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG-EDSVRQTMTM 436
           + SALEYLH    S  +++ D+K  N++LD++    ++DFG+ K   EG  D        
Sbjct: 119 IVSALEYLH----SRDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKXFC 171
Query: 437 ATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
            T  Y+APE   +       D +  GV++ E    + P
Sbjct: 172 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/145 (31%), Positives = 71/145 (48%), Gaps = 14/145 (9%)
Query: 367 DILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG 426
           DIL +  I + +  ALE+LH   S + +IH D+KP+N+L++      + DFGI   L   
Sbjct: 153 DILGK--IAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL--- 204
Query: 427 EDSVRQTMTMATIGYMA-----PEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIG 481
            DSV +T+      YMA     PE   +G  S K D++S G+ ++E    + P D     
Sbjct: 205 VDSVAKTIDAGCKPYMAPERINPELNQKG-YSVKSDIWSLGITMIELAILRFPYDSWGTP 263
Query: 482 EMSLRRWVKESLPHGLTEVVDANLV 506
              L++ V+E  P    +   A  V
Sbjct: 264 FQQLKQVVEEPSPQLPADKFSAEFV 288

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/162 (32%), Positives = 77/162 (47%), Gaps = 27/162 (16%)
Query: 317 SECEVLRNVR-HRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIM 375
            E ++LR V  H N+I++  +Y    F  LV + M  G L  +L +    L   E   IM
Sbjct: 59  KEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVTLSEKETRKIM 117
Query: 376 IDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMT 435
             +   +  LH     ++I+H DLKP NILLD++M   ++DFG    L  GE  +R+   
Sbjct: 118 RALLEVICALHK----LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE-KLRE--V 170
Query: 436 MATIGYMAPE------------YGLEGIVSAKCDVYSYGVLL 465
             T  Y+APE            YG E       D++S GV++
Sbjct: 171 CGTPSYLAPEIIECSMNDNHPGYGKE------VDMWSTGVIM 206

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 95/211 (45%), Gaps = 18/211 (8%)
Query: 270 ATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNL--QLERAFRSFDSECEVLRNVR 326
           + + F +   +G  ++G VYK      G  VA+K   L  + E    +   E  +L+ + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 327 HRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMID-VGSALEYL 385
           H N++K+L      +   LV EF+ +  L+K       F+D      I +  + S L  L
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKK-------FMDASALTGIPLPLIKSYLFQL 115
Query: 386 HNGHSSVH---IIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYM 442
             G +  H   ++H DLKP N+L++      ++DFG+ +  G    +    +   T+ Y 
Sbjct: 116 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYR 173
Query: 443 APEYGLE-GIVSAKCDVYSYGVLLMETFTRK 472
           APE  L     S   D++S G +  E  TR+
Sbjct: 174 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 95/211 (45%), Gaps = 18/211 (8%)
Query: 270 ATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNL--QLERAFRSFDSECEVLRNVR 326
           + + F +   +G  ++G VYK      G  VA+K   L  + E    +   E  +L+ + 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 327 HRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMID-VGSALEYL 385
           H N++K+L      +   LV EF+ +  L+K       F+D      I +  + S L  L
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKK-------FMDASALTGIPLPLIKSYLFQL 112
Query: 386 HNGHSSVH---IIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYM 442
             G +  H   ++H DLKP N+L++      ++DFG+ +  G    +    +   T+ Y 
Sbjct: 113 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYR 170
Query: 443 APEYGLE-GIVSAKCDVYSYGVLLMETFTRK 472
           APE  L     S   D++S G +  E  TR+
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/252 (25%), Positives = 118/252 (46%), Gaps = 21/252 (8%)
Query: 236 MYIRCRNRNTKKSDHEDFLPLAIWRR--TSYLDIQR-ATDEFNECNLLGTSSFGSVYKGT 292
           +Y  C N   ++   ++ L    W +  TS +   R   ++F    ++G  +FG V    
Sbjct: 37  LYDECNNSPLRRE--KNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVK 94
Query: 293 ISDGTDV-AIKVFNL--QLERAFRS-FDSECEVLRNVRHRNLIKILSSYSNPDFKALVLE 348
           + +   V A+K+ N    L+RA  + F  E +VL N   + +  +  ++ + +   LV++
Sbjct: 95  LKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMD 154
Query: 349 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDE 408
           +   G L   L      L        + ++  A++ +H     +H +H D+KP NIL+D 
Sbjct: 155 YYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQ----LHYVHRDIKPDNILMDM 210
Query: 409 NMVAHVSDFG-IYKLLGEGEDSVRQTMTMATIGYMAPEY-----GLEGIVSAKCDVYSYG 462
           N    ++DFG   KL+ +G  +V+ ++ + T  Y++PE      G +G    +CD +S G
Sbjct: 211 NGHIRLADFGSCLKLMEDG--TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLG 268
Query: 463 VLLMETFTRKRP 474
           V + E    + P
Sbjct: 269 VCMYEMLYGETP 280

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 95/211 (45%), Gaps = 18/211 (8%)
Query: 270 ATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNL--QLERAFRSFDSECEVLRNVR 326
           + + F +   +G  ++G VYK      G  VA+K   L  + E    +   E  +L+ + 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 327 HRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMID-VGSALEYL 385
           H N++K+L      +   LV EF+ +  L+K       F+D      I +  + S L  L
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKK-------FMDASALTGIPLPLIKSYLFQL 114
Query: 386 HNGHSSVH---IIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYM 442
             G +  H   ++H DLKP N+L++      ++DFG+ +  G    +    +   T+ Y 
Sbjct: 115 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYR 172
Query: 443 APEYGLE-GIVSAKCDVYSYGVLLMETFTRK 472
           APE  L     S   D++S G +  E  TR+
Sbjct: 173 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 95/211 (45%), Gaps = 18/211 (8%)
Query: 270 ATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNL--QLERAFRSFDSECEVLRNVR 326
           + + F +   +G  ++G VYK      G  VA+K   L  + E    +   E  +L+ + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 327 HRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMID-VGSALEYL 385
           H N++K+L      +   LV EF+ +  L+K       F+D      I +  + S L  L
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKK-------FMDASALTGIPLPLIKSYLFQL 115
Query: 386 HNGHSSVH---IIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYM 442
             G +  H   ++H DLKP N+L++      ++DFG+ +  G    +    +   T+ Y 
Sbjct: 116 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYR 173
Query: 443 APEYGLE-GIVSAKCDVYSYGVLLMETFTRK 472
           APE  L     S   D++S G +  E  TR+
Sbjct: 174 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 95/211 (45%), Gaps = 18/211 (8%)
Query: 270 ATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNL--QLERAFRSFDSECEVLRNVR 326
           + + F +   +G  ++G VYK      G  VA+K   L  + E    +   E  +L+ + 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 327 HRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMID-VGSALEYL 385
           H N++K+L      +   LV EF+ +  L+K       F+D      I +  + S L  L
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKK-------FMDASALTGIPLPLIKSYLFQL 114
Query: 386 HNGHSSVH---IIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYM 442
             G +  H   ++H DLKP N+L++      ++DFG+ +  G    +    +   T+ Y 
Sbjct: 115 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYR 172
Query: 443 APEYGLE-GIVSAKCDVYSYGVLLMETFTRK 472
           APE  L     S   D++S G +  E  TR+
Sbjct: 173 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 95/211 (45%), Gaps = 18/211 (8%)
Query: 270 ATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNL--QLERAFRSFDSECEVLRNVR 326
           + + F +   +G  ++G VYK      G  VA+K   L  + E    +   E  +L+ + 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 327 HRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMID-VGSALEYL 385
           H N++K+L      +   LV EF+ +  L+K       F+D      I +  + S L  L
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKK-------FMDASALTGIPLPLIKSYLFQL 112
Query: 386 HNGHSSVH---IIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYM 442
             G +  H   ++H DLKP N+L++      ++DFG+ +  G    +    +   T+ Y 
Sbjct: 113 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYR 170
Query: 443 APEYGLE-GIVSAKCDVYSYGVLLMETFTRK 472
           APE  L     S   D++S G +  E  TR+
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 92/210 (43%), Gaps = 19/210 (9%)
Query: 266 DIQRATDEFNECNLLGTSSFGSVYKGTI----SDGTDVAIKVF-NLQLERAFRSFDSECE 320
           +IQR   E   C  +G   FG V++G      +    VAIK   N   +     F  E  
Sbjct: 6   EIQRERIELGRC--IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEAL 63
Query: 321 VLRNVRHRNLIKILSSYS-NPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVG 379
            +R   H +++K++   + NP +  +++E    G L  +L    + LD+   +     + 
Sbjct: 64  TMRQFDHPHIVKLIGVITENPVW--IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLS 121
Query: 380 SALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSV--RQTMTMA 437
           +AL YL     S   +H D+   N+L+       + DFG+ + +   EDS   + +    
Sbjct: 122 TALAYLE----SKRFVHRDIAARNVLVSATDCVKLGDFGLSRYM---EDSTYYKASKGKL 174
Query: 438 TIGYMAPEYGLEGIVSAKCDVYSYGVLLME 467
            I +MAPE       ++  DV+ +GV + E
Sbjct: 175 PIKWMAPESINFRRFTSASDVWMFGVCMWE 204

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 95/211 (45%), Gaps = 18/211 (8%)
Query: 270 ATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNL--QLERAFRSFDSECEVLRNVR 326
           + + F +   +G  ++G VYK      G  VA+K   L  + E    +   E  +L+ + 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 327 HRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMID-VGSALEYL 385
           H N++K+L      +   LV EF+ +  L+K       F+D      I +  + S L  L
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKK-------FMDASALTGIPLPLIKSYLFQL 113
Query: 386 HNGHSSVH---IIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYM 442
             G +  H   ++H DLKP N+L++      ++DFG+ +  G    +    +   T+ Y 
Sbjct: 114 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYR 171
Query: 443 APEYGLE-GIVSAKCDVYSYGVLLMETFTRK 472
           APE  L     S   D++S G +  E  TR+
Sbjct: 172 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/162 (32%), Positives = 77/162 (47%), Gaps = 27/162 (16%)
Query: 317 SECEVLRNVR-HRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIM 375
            E ++LR V  H N+I++  +Y    F  LV + M  G L  +L +    L   E   IM
Sbjct: 72  KEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVTLSEKETRKIM 130
Query: 376 IDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMT 435
             +   +  LH     ++I+H DLKP NILLD++M   ++DFG    L  GE  +R+   
Sbjct: 131 RALLEVICALHK----LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE-KLRE--V 183
Query: 436 MATIGYMAPE------------YGLEGIVSAKCDVYSYGVLL 465
             T  Y+APE            YG E       D++S GV++
Sbjct: 184 CGTPSYLAPEIIECSMNDNHPGYGKE------VDMWSTGVIM 219

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 95/211 (45%), Gaps = 18/211 (8%)
Query: 270 ATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNL--QLERAFRSFDSECEVLRNVR 326
           + + F +   +G  ++G VYK      G  VA+K   L  + E    +   E  +L+ + 
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 64
Query: 327 HRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMID-VGSALEYL 385
           H N++K+L      +   LV EF+ +  L+K       F+D      I +  + S L  L
Sbjct: 65  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKK-------FMDASALTGIPLPLIKSYLFQL 116
Query: 386 HNGHSSVH---IIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYM 442
             G +  H   ++H DLKP N+L++      ++DFG+ +  G    +    +   T+ Y 
Sbjct: 117 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYR 174
Query: 443 APEYGLE-GIVSAKCDVYSYGVLLMETFTRK 472
           APE  L     S   D++S G +  E  TR+
Sbjct: 175 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 94/209 (44%), Gaps = 18/209 (8%)
Query: 272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNL--QLERAFRSFDSECEVLRNVRHR 328
           + F +   +G  ++G VYK      G  VA+K   L  + E    +   E  +L+ + H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 329 NLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMID-VGSALEYLHN 387
           N++K+L      +   LV EF+ +  L+K       F+D      I +  + S L  L  
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKK-------FMDASALTGIPLPLIKSYLFQLLQ 113
Query: 388 GHSSVH---IIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAP 444
           G +  H   ++H DLKP N+L++      ++DFG+ +  G    +    +   T+ Y AP
Sbjct: 114 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 171
Query: 445 EYGLE-GIVSAKCDVYSYGVLLMETFTRK 472
           E  L     S   D++S G +  E  TR+
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 93/215 (43%), Gaps = 20/215 (9%)
Query: 280 LGTSSFGSVYKGT-ISDGTDVAIKVFNL------QLERAFRSFDSECEVLRNVRHRNLIK 332
           +G  +F  V     I  G +VA+K+ +        L++ FR    E  +++ + H N++K
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR----EVRIMKVLNHPNIVK 77
Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSV 392
           +           LV+E+   G +  +L +H    +   R      + SA++Y H      
Sbjct: 78  LFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKF--- 133
Query: 393 HIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPE-YGLEGI 451
            I+H DLK  N+LLD +M   ++DFG       G    +      +  Y APE +  +  
Sbjct: 134 -IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGN---KLDTFCGSPPYAAPELFQGKKY 189
Query: 452 VSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLR 486
              + DV+S GV+L    +   P D   + E+  R
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRER 224

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 95/211 (45%), Gaps = 18/211 (8%)
Query: 270 ATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNL--QLERAFRSFDSECEVLRNVR 326
           + + F +   +G  ++G VYK      G  VA+K   L  + E    +   E  +L+ + 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 327 HRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMID-VGSALEYL 385
           H N++K+L      +   LV EF+ +  L+K       F+D      I +  + S L  L
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKK-------FMDASALTGIPLPLIKSYLFQL 112
Query: 386 HNGHSSVH---IIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYM 442
             G +  H   ++H DLKP N+L++      ++DFG+ +  G    +    +   T+ Y 
Sbjct: 113 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYR 170
Query: 443 APEYGLE-GIVSAKCDVYSYGVLLMETFTRK 472
           APE  L     S   D++S G +  E  TR+
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 105/234 (44%), Gaps = 39/234 (16%)
Query: 255 PLAIWRRTSYLDIQRATDEFNECNLLGTSSFGSVYKGTI---------------SDGTDV 299
           P  I  +  YLD +  T E  E   LG+ +FG+V KG                 ++  D 
Sbjct: 355 PEEIRPKEVYLDRKLLTLEDKE---LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDP 411
Query: 300 AIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWL 359
           A+K   L          +E  V++ + +  +++++       +  LV+E    G L K+L
Sbjct: 412 ALKDELL----------AEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYL 460
Query: 360 YSHNYFLD--ILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDF 417
             + +  D  I+E   ++  V   ++YL   +     +H DL   N+LL     A +SDF
Sbjct: 461 QQNRHVKDKNIIE---LVHQVSMGMKYLEESN----FVHRDLAARNVLLVTQHYAKISDF 513
Query: 418 GIYKLLGEGEDSVR-QTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
           G+ K L   E+  + QT     + + APE       S+K DV+S+GVL+ E F+
Sbjct: 514 GLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 567

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 94/209 (44%), Gaps = 18/209 (8%)
Query: 272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNL--QLERAFRSFDSECEVLRNVRHR 328
           + F +   +G  ++G VYK      G  VA+K   L  + E    +   E  +L+ + H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 329 NLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMID-VGSALEYLHN 387
           N++K+L      +   LV EF+ +  L+K       F+D      I +  + S L  L  
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKK-------FMDASALTGIPLPLIKSYLFQLLQ 113
Query: 388 GHSSVH---IIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAP 444
           G +  H   ++H DLKP N+L++      ++DFG+ +  G    +    +   T+ Y AP
Sbjct: 114 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 171
Query: 445 EYGLE-GIVSAKCDVYSYGVLLMETFTRK 472
           E  L     S   D++S G +  E  TR+
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 93/211 (44%), Gaps = 19/211 (9%)
Query: 272 DEFNECNLLGTSSFGSVY----KGTISDGTDVAIKVFNLQLERAFRSFD---SECEVLRN 324
           ++F+   LLG  +FG V     K T   G   A+K+   ++  A        +E  VL+N
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 325 VRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEY 384
            RH  L  +  ++   D    V+E+   G L   L     F +   R     ++ SALEY
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEY 120
Query: 385 LHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG-EDSVRQTMTMATIGYMA 443
           LH    S  +++ D+K  N++LD++    ++DFG+ K   EG  D         T  Y+A
Sbjct: 121 LH----SRDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLA 173
Query: 444 PEYGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
           PE   +       D +  GV++ E    + P
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 93/215 (43%), Gaps = 20/215 (9%)
Query: 280 LGTSSFGSVYKGT-ISDGTDVAIKVFNL------QLERAFRSFDSECEVLRNVRHRNLIK 332
           +G  +F  V     I  G +VA+K+ +        L++ FR    E  +++ + H N++K
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR----EVRIMKVLNHPNIVK 77
Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSV 392
           +           LV+E+   G +  +L +H    +   R      + SA++Y H      
Sbjct: 78  LFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKF--- 133
Query: 393 HIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPE-YGLEGI 451
            I+H DLK  N+LLD +M   ++DFG       G    +      +  Y APE +  +  
Sbjct: 134 -IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGN---KLDTFCGSPPYAAPELFQGKKY 189
Query: 452 VSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLR 486
              + DV+S GV+L    +   P D   + E+  R
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRER 224

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 105/234 (44%), Gaps = 39/234 (16%)
Query: 255 PLAIWRRTSYLDIQRATDEFNECNLLGTSSFGSVYKGTI---------------SDGTDV 299
           P  I  +  YLD +  T E  E   LG+ +FG+V KG                 ++  D 
Sbjct: 356 PEEIRPKEVYLDRKLLTLEDKE---LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDP 412
Query: 300 AIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWL 359
           A+K   L          +E  V++ + +  +++++       +  LV+E    G L K+L
Sbjct: 413 ALKDELL----------AEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYL 461
Query: 360 YSHNYFLD--ILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDF 417
             + +  D  I+E   ++  V   ++YL   +     +H DL   N+LL     A +SDF
Sbjct: 462 QQNRHVKDKNIIE---LVHQVSMGMKYLEESN----FVHRDLAARNVLLVTQHYAKISDF 514
Query: 418 GIYKLLGEGEDSVR-QTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
           G+ K L   E+  + QT     + + APE       S+K DV+S+GVL+ E F+
Sbjct: 515 GLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 568

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 106/220 (48%), Gaps = 27/220 (12%)
Query: 271 TDEFNECNLLGTSSFGSVYKGTISD-GTDVAIK---VFNLQLERAFRSFDSECEVLRNVR 326
           + +F   +LLG  ++G V   T    G  VAIK    F+  L  A R+   E ++L++ +
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPL-FALRTL-REIKILKHFK 67
Query: 327 HRNLIKILS-----SYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSA 381
           H N+I I +     S+ N +   ++ E M    L + + +     D ++    +     A
Sbjct: 68  HENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVISTQMLSDDHIQYF--IYQTLRA 124
Query: 382 LEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGE-----GEDSVRQ---T 433
           ++ LH  +    +IH DLKP+N+L++ N    V DFG+ +++ E      E + +Q   T
Sbjct: 125 VKVLHGSN----VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMT 180
Query: 434 MTMATIGYMAPEYGL-EGIVSAKCDVYSYGVLLMETFTRK 472
             +AT  Y APE  L     S   DV+S G +L E F R+
Sbjct: 181 EYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 93/211 (44%), Gaps = 19/211 (9%)
Query: 272 DEFNECNLLGTSSFGSVY----KGTISDGTDVAIKVFNLQLERAFRSFD---SECEVLRN 324
           ++F+   LLG  +FG V     K T   G   A+K+   ++  A        +E  VL+N
Sbjct: 8   NDFDYLKLLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 64
Query: 325 VRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEY 384
            RH  L  +  ++   D    V+E+   G L   L     F +   R     ++ SALEY
Sbjct: 65  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEY 123
Query: 385 LHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG-EDSVRQTMTMATIGYMA 443
           LH    S  +++ D+K  N++LD++    ++DFG+ K   EG  D         T  Y+A
Sbjct: 124 LH----SRDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLA 176
Query: 444 PEYGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
           PE   +       D +  GV++ E    + P
Sbjct: 177 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 207

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 93/211 (44%), Gaps = 19/211 (9%)
Query: 272 DEFNECNLLGTSSFGSVY----KGTISDGTDVAIKVFNLQLERAFRSFD---SECEVLRN 324
           ++F+   LLG  +FG V     K T   G   A+K+   ++  A        +E  VL+N
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 325 VRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEY 384
            RH  L  +  ++   D    V+E+   G L   L     F +   R     ++ SALEY
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEY 120
Query: 385 LHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG-EDSVRQTMTMATIGYMA 443
           LH    S  +++ D+K  N++LD++    ++DFG+ K   EG  D         T  Y+A
Sbjct: 121 LH----SRDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLA 173
Query: 444 PEYGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
           PE   +       D +  GV++ E    + P
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 75/161 (46%), Gaps = 27/161 (16%)
Query: 318 ECEVLRNVR-HRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMI 376
           E ++LR V  H N+I++  +Y    F  LV + M  G L  +L +    L   E   IM 
Sbjct: 73  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVTLSEKETRKIMR 131
Query: 377 DVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTM 436
            +   +  LH     ++I+H DLKP NILLD++M   ++DFG    L  GE   +     
Sbjct: 132 ALLEVICALHK----LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLRSVC 184
Query: 437 ATIGYMAPE------------YGLEGIVSAKCDVYSYGVLL 465
            T  Y+APE            YG E       D++S GV++
Sbjct: 185 GTPSYLAPEIIECSMNDNHPGYGKE------VDMWSTGVIM 219

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 102/224 (45%), Gaps = 38/224 (16%)
Query: 272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIK----VFNLQLERAFRSFDSECEVLRNVR 326
           DE+     +G  ++G V        G  VAIK     F++ +  A R+   E ++L++ +
Sbjct: 55  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDV-VTNAKRTL-RELKILKHFK 112
Query: 327 HRNLIKI----LSSYSNPDFKAL--VLEFMPNGSLEKWLYSHN--------YFLDILERL 372
           H N+I I      +    +FK++  VL+ M    L + ++S          YFL  L R 
Sbjct: 113 HDNIIAIKDILRPTVPYGEFKSVYVVLDLM-ESDLHQIIHSSQPLTLEHVRYFLYQLLR- 170
Query: 373 NIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLL--GEGEDSV 430
                    L+Y+H    S  +IH DLKP+N+L++EN    + DFG+ + L     E   
Sbjct: 171 --------GLKYMH----SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQY 218
Query: 431 RQTMTMATIGYMAPEYGLE-GIVSAKCDVYSYGVLLMETFTRKR 473
             T  +AT  Y APE  L     +   D++S G +  E   R++
Sbjct: 219 FMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 95/211 (45%), Gaps = 18/211 (8%)
Query: 270 ATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNL--QLERAFRSFDSECEVLRNVR 326
           + + F +   +G  ++G VYK      G  VA+K   L  + E    +   E  +L+ + 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 327 HRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMID-VGSALEYL 385
           H N++K+L      +   LV EF+ +  L+K       F+D      I +  + S L  L
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKK-------FMDASALTGIPLPLIKSYLFQL 112
Query: 386 HNGHSSVH---IIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYM 442
             G +  H   ++H DLKP N+L++      ++DFG+ +  G    +    +   T+ Y 
Sbjct: 113 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYR 170
Query: 443 APEYGLE-GIVSAKCDVYSYGVLLMETFTRK 472
           APE  L     S   D++S G +  E  TR+
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 95/211 (45%), Gaps = 18/211 (8%)
Query: 270 ATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNL--QLERAFRSFDSECEVLRNVR 326
           + + F +   +G  ++G VYK      G  VA+K   L  + E    +   E  +L+ + 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 327 HRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMID-VGSALEYL 385
           H N++K+L      +   LV EF+ +  L+K       F+D      I +  + S L  L
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKK-------FMDASALTGIPLPLIKSYLFQL 114
Query: 386 HNGHSSVH---IIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYM 442
             G +  H   ++H DLKP N+L++      ++DFG+ +  G    +    +   T+ Y 
Sbjct: 115 LQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYR 172
Query: 443 APEYGLE-GIVSAKCDVYSYGVLLMETFTRK 472
           APE  L     S   D++S G +  E  TR+
Sbjct: 173 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 93/211 (44%), Gaps = 19/211 (9%)
Query: 272 DEFNECNLLGTSSFGSVY----KGTISDGTDVAIKVFNLQLERAFRSFD---SECEVLRN 324
           ++F+   LLG  +FG V     K T   G   A+K+   ++  A        +E  VL+N
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 325 VRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEY 384
            RH  L  +  ++   D    V+E+   G L   L     F +   R     ++ SALEY
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEY 120
Query: 385 LHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG-EDSVRQTMTMATIGYMA 443
           LH    S  +++ D+K  N++LD++    ++DFG+ K   EG  D         T  Y+A
Sbjct: 121 LH----SRDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKXFCGTPEYLA 173
Query: 444 PEYGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
           PE   +       D +  GV++ E    + P
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 94/209 (44%), Gaps = 18/209 (8%)
Query: 272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNL--QLERAFRSFDSECEVLRNVRHR 328
           + F +   +G  ++G VYK      G  VA+K   L  + E    +   E  +L+ + H 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 329 NLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMID-VGSALEYLHN 387
           N++K+L      +   LV EF+ +  L+K       F+D      I +  + S L  L  
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFL-HQDLKK-------FMDASALTGIPLPLIKSYLFQLLQ 115
Query: 388 GHSSVH---IIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAP 444
           G +  H   ++H DLKP N+L++      ++DFG+ +  G    +    +   T+ Y AP
Sbjct: 116 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 173
Query: 445 EYGLE-GIVSAKCDVYSYGVLLMETFTRK 472
           E  L     S   D++S G +  E  TR+
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 93/211 (44%), Gaps = 19/211 (9%)
Query: 272 DEFNECNLLGTSSFGSVY----KGTISDGTDVAIKVFNLQLERAFRSFD---SECEVLRN 324
           ++F+   LLG  +FG V     K T   G   A+K+   ++  A        +E  VL+N
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 325 VRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEY 384
            RH  L  +  ++   D    V+E+   G L   L     F +   R     ++ SALEY
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEY 120
Query: 385 LHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG-EDSVRQTMTMATIGYMA 443
           LH    S  +++ D+K  N++LD++    ++DFG+ K   EG  D         T  Y+A
Sbjct: 121 LH----SRDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKXFCGTPEYLA 173
Query: 444 PEYGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
           PE   +       D +  GV++ E    + P
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/220 (23%), Positives = 100/220 (45%), Gaps = 22/220 (10%)
Query: 273 EFNECNL-----LGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRSFD------SECE 320
           EF   NL     LG  +FG V + T    G + A+    +++ ++    D      SE +
Sbjct: 42  EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 101
Query: 321 VLRNV-RHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVG 379
           ++ ++ +H N++ +L + ++     ++ E+   G L  +L   +  L+      I     
Sbjct: 102 IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTL 161
Query: 380 SALEYLHNGH---------SSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSV 430
           S  + LH            +S + IH D+   N+LL    VA + DFG+ + +    + +
Sbjct: 162 STRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI 221
Query: 431 RQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
            +      + +MAPE   + + + + DV+SYG+LL E F+
Sbjct: 222 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 95/211 (45%), Gaps = 18/211 (8%)
Query: 270 ATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNL--QLERAFRSFDSECEVLRNVR 326
           + + F +   +G  ++G VYK      G  VA+K   L  + E    +   E  +L+ + 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 327 HRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMID-VGSALEYL 385
           H N++K+L      +   LV EF+ +  L+K       F+D      I +  + S L  L
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKK-------FMDASALTGIPLPLIKSYLFQL 113
Query: 386 HNGHSSVH---IIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYM 442
             G +  H   ++H DLKP N+L++      ++DFG+ +  G    +    +   T+ Y 
Sbjct: 114 LQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYR 171
Query: 443 APEYGLE-GIVSAKCDVYSYGVLLMETFTRK 472
           APE  L     S   D++S G +  E  TR+
Sbjct: 172 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 94/218 (43%), Gaps = 21/218 (9%)
Query: 274 FNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQ-LERAF--------RSFDSECEVLRN 324
           F    +LG   +G V++     G +   K+F ++ L++A             +E  +L  
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTG-KIFAMKVLKKAMIVRNAKDTAHTKAERNILEE 77
Query: 325 VRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEY 384
           V+H  ++ ++ ++       L+LE++  G L   L     F++       + ++  AL +
Sbjct: 78  VKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACF-YLAEISMALGH 136
Query: 385 LHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAP 444
           LH       II+ DLKP NI+L+      ++DFG+ K      D         TI YMAP
Sbjct: 137 LHQKG----IIYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTVTHXFCGTIEYMAP 190
Query: 445 EYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGE 482
           E  +    +   D +S G L+ +  T   P    F GE
Sbjct: 191 EILMRSGHNRAVDWWSLGALMYDMLTGAPP----FTGE 224

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 95/210 (45%), Gaps = 20/210 (9%)
Query: 272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNL--QLERAFRSFDSECEVLRNVRHR 328
           + F +   +G  ++G VYK      G  VA+    L  + E    +   E  +L+ + H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 329 NLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMID-VGSALEYLHN 387
           N++K+L      +   LV EF+ +  L+K       F+D      I +  + S L  L  
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKK-------FMDASALTGIPLPLIKSYLFQLLQ 114
Query: 388 GHSSVH---IIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQ-TMTMATIGYMA 443
           G +  H   ++H DLKP N+L++      ++DFG+ +  G     VR  T  + T+ Y A
Sbjct: 115 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV---PVRTYTHEVVTLWYRA 171
Query: 444 PEYGLE-GIVSAKCDVYSYGVLLMETFTRK 472
           PE  L     S   D++S G +  E  TR+
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 95/210 (45%), Gaps = 20/210 (9%)
Query: 272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNL--QLERAFRSFDSECEVLRNVRHR 328
           + F +   +G  ++G VYK      G  VA+    L  + E    +   E  +L+ + H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 329 NLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMID-VGSALEYLHN 387
           N++K+L      +   LV EF+ +  L+K       F+D      I +  + S L  L  
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKK-------FMDASALTGIPLPLIKSYLFQLLQ 113
Query: 388 GHSSVH---IIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQ-TMTMATIGYMA 443
           G +  H   ++H DLKP N+L++      ++DFG+ +  G     VR  T  + T+ Y A
Sbjct: 114 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV---PVRTYTHEVVTLWYRA 170
Query: 444 PEYGLE-GIVSAKCDVYSYGVLLMETFTRK 472
           PE  L     S   D++S G +  E  TR+
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 96/217 (44%), Gaps = 23/217 (10%)
Query: 272 DEFNECNLLGTSSFGSVYKGTISDGTDV----AIKVFN----LQLERAFRSFDSECEVLR 323
           + F    +LGT ++G V+      G D     A+KV      +Q  +      +E +VL 
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 324 NVRHRNLIKILSSYSNPDFK-ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGS-- 380
           ++R    +  L      + K  L+L+++  G L   L     F +      + I VG   
Sbjct: 114 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTE----HEVQIYVGEIV 169
Query: 381 -ALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATI 439
            ALE+LH     + II+ D+K  NILLD N    ++DFG+ K     +++ R      TI
Sbjct: 170 LALEHLHK----LGIIYRDIKLENILLDSNGHVVLTDFGLSKEF-VADETERAYDFCGTI 224
Query: 440 GYMAPEY--GLEGIVSAKCDVYSYGVLLMETFTRKRP 474
            YMAP+   G +       D +S GVL+ E  T   P
Sbjct: 225 EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 92/215 (42%), Gaps = 20/215 (9%)
Query: 280 LGTSSFGSVYKGT-ISDGTDVAIKVFNL------QLERAFRSFDSECEVLRNVRHRNLIK 332
           +G  +F  V     I  G +VA+K+ +        L++ FR    E  +++ + H N++K
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR----EVRIMKVLNHPNIVK 77
Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSV 392
           +           LV+E+   G +  +L +H    +   R      + SA++Y H      
Sbjct: 78  LFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKF--- 133
Query: 393 HIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPE-YGLEGI 451
            I+H DLK  N+LLD +M   ++DFG       G    +         Y APE +  +  
Sbjct: 134 -IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGN---KLDAFCGAPPYAAPELFQGKKY 189
Query: 452 VSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLR 486
              + DV+S GV+L    +   P D   + E+  R
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRER 224

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 94/218 (43%), Gaps = 21/218 (9%)
Query: 274 FNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQ-LERAF--------RSFDSECEVLRN 324
           F    +LG   +G V++     G +   K+F ++ L++A             +E  +L  
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTG-KIFAMKVLKKAMIVRNAKDTAHTKAERNILEE 77
Query: 325 VRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEY 384
           V+H  ++ ++ ++       L+LE++  G L   L     F++       + ++  AL +
Sbjct: 78  VKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACF-YLAEISMALGH 136
Query: 385 LHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAP 444
           LH       II+ DLKP NI+L+      ++DFG+ K      D         TI YMAP
Sbjct: 137 LHQKG----IIYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTVTHTFCGTIEYMAP 190
Query: 445 EYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGE 482
           E  +    +   D +S G L+ +  T   P    F GE
Sbjct: 191 EILMRSGHNRAVDWWSLGALMYDMLTGAPP----FTGE 224

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 69/244 (28%), Positives = 108/244 (44%), Gaps = 36/244 (14%)
Query: 252 DFLPLA--IWRRTSYLDIQRATDEFNECNLLGTSSFGSVYKGTISD-GTDVAIKVFNL-- 306
           DFL  A  I  R   + +QR  D+F    ++G  +F  V    +   G   A+K+ N   
Sbjct: 41  DFLQWAEPIVVRLKEVRLQR--DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWD 98
Query: 307 QLERAFRS-FDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYF 365
            L+R   S F  E +VL N   R + ++  ++ + ++  LV+E+   G L          
Sbjct: 99  MLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDL---------- 148
Query: 366 LDILERLNIMIDVGSALEYLHN---GHSSVH---IIHCDLKPTNILLDENMVAHVSDFG- 418
           L +L +    I    A  YL        SVH    +H D+KP NILLD      ++DFG 
Sbjct: 149 LTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGS 208
Query: 419 IYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSA--------KCDVYSYGVLLMETFT 470
             KL  +G  +VR  + + T  Y++PE  L+ +           +CD ++ GV   E F 
Sbjct: 209 CLKLRADG--TVRSLVAVGTPDYLSPEI-LQAVGGGPGTGSYGPECDWWALGVFAYEMFY 265
Query: 471 RKRP 474
            + P
Sbjct: 266 GQTP 269

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 95/211 (45%), Gaps = 18/211 (8%)
Query: 270 ATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNL--QLERAFRSFDSECEVLRNVR 326
           + + F +   +G  ++G VYK      G  VA+K   L  + E    +   E  +L+ + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 327 HRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMID-VGSALEYL 385
           H N++K+L      +   LV EF+ +  L+K       F+D      I +  + S L  L
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-SMDLKK-------FMDASALTGIPLPLIKSYLFQL 115
Query: 386 HNGHSSVH---IIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYM 442
             G +  H   ++H DLKP N+L++      ++DFG+ +  G    +    +   T+ Y 
Sbjct: 116 LQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYR 173
Query: 443 APEYGLE-GIVSAKCDVYSYGVLLMETFTRK 472
           APE  L     S   D++S G +  E  TR+
Sbjct: 174 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 93/215 (43%), Gaps = 20/215 (9%)
Query: 280 LGTSSFGSVYKGT-ISDGTDVAIKVFN------LQLERAFRSFDSECEVLRNVRHRNLIK 332
           +G  +F  V     I  G +VAIK+ +        L++ FR    E  +++ + H N++K
Sbjct: 20  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR----EVRIMKILNHPNIVK 75
Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSV 392
           +           L++E+   G +  +L +H    +   R      + SA++Y H      
Sbjct: 76  LFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR-QIVSAVQYCHQKR--- 131
Query: 393 HIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPE-YGLEGI 451
            I+H DLK  N+LLD +M   ++DFG       G    +      +  Y APE +  +  
Sbjct: 132 -IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG---KLDTFCGSPPYAAPELFQGKKY 187
Query: 452 VSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLR 486
              + DV+S GV+L    +   P D   + E+  R
Sbjct: 188 DGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRER 222

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 92/215 (42%), Gaps = 20/215 (9%)
Query: 280 LGTSSFGSVYKGT-ISDGTDVAIKVFN------LQLERAFRSFDSECEVLRNVRHRNLIK 332
           +G  +F  V     I  G +VAIK+ +        L++ FR    E  +++ + H N++K
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR----EVRIMKILNHPNIVK 78
Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSV 392
           +           L++E+   G +  +L +H    +   R      + SA++Y H      
Sbjct: 79  LFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR-QIVSAVQYCHQKR--- 134
Query: 393 HIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPE-YGLEGI 451
            I+H DLK  N+LLD +M   ++DFG       G    +         Y APE +  +  
Sbjct: 135 -IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG---KLDAFCGAPPYAAPELFQGKKY 190
Query: 452 VSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLR 486
              + DV+S GV+L    +   P D   + E+  R
Sbjct: 191 DGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRER 225

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 95/211 (45%), Gaps = 18/211 (8%)
Query: 270 ATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNL--QLERAFRSFDSECEVLRNVR 326
           + + F +   +G  ++G VYK      G  VA+K   L  + E    +   E  +L+ + 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 327 HRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMID-VGSALEYL 385
           H N++K+L      +   LV EF+ +  L+K       F+D      I +  + S L  L
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-SMDLKK-------FMDASALTGIPLPLIKSYLFQL 113
Query: 386 HNGHSSVH---IIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYM 442
             G +  H   ++H DLKP N+L++      ++DFG+ +  G    +    +   T+ Y 
Sbjct: 114 LQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYR 171
Query: 443 APEYGLE-GIVSAKCDVYSYGVLLMETFTRK 472
           APE  L     S   D++S G +  E  TR+
Sbjct: 172 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 93/211 (44%), Gaps = 19/211 (9%)
Query: 272 DEFNECNLLGTSSFGSVY----KGTISDGTDVAIKVFNLQLERAFRSFD---SECEVLRN 324
           ++F+   LLG  +FG V     K T   G   A+K+   ++  A        +E  VL+N
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 325 VRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEY 384
            RH  L  +  ++   D    V+E+   G L   L     F +   R     ++ SALEY
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEY 120
Query: 385 LHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG-EDSVRQTMTMATIGYMA 443
           LH    S  +++ D+K  N++LD++    ++DFG+ K   EG  D         T  Y+A
Sbjct: 121 LH----SRDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKXFCGTPEYLA 173
Query: 444 PEYGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
           PE   +       D +  GV++ E    + P
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 96/218 (44%), Gaps = 18/218 (8%)
Query: 265 LDIQRATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRN 324
           L I+   ++F    +LG  SFG V+       T+    +  L+ +      D EC ++  
Sbjct: 11  LQIKLKIEDFELHKMLGKGSFGKVFLAEFK-KTNQFFAIKALKKDVVLMDDDVECTMVEK 69
Query: 325 ------VRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDV 378
                   H  L  +  ++   +    V+E++  G L   + S + F D+        ++
Sbjct: 70  RVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKF-DLSRATFYAAEI 128
Query: 379 GSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYK--LLGEGEDSVRQTMTM 436
              L++LH    S  I++ DLK  NILLD++    ++DFG+ K  +LG+     +     
Sbjct: 129 ILGLQFLH----SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA----KTNEFC 180
Query: 437 ATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
            T  Y+APE  L    +   D +S+GVLL E    + P
Sbjct: 181 GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 218

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 102/224 (45%), Gaps = 38/224 (16%)
Query: 272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIK----VFNLQLERAFRSFDSECEVLRNVR 326
           DE+     +G  ++G V        G  VAIK     F++ +  A R+   E ++L++ +
Sbjct: 54  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDV-VTNAKRTL-RELKILKHFK 111
Query: 327 HRNLIKI----LSSYSNPDFKAL--VLEFMPNGSLEKWLYSHN--------YFLDILERL 372
           H N+I I      +    +FK++  VL+ M    L + ++S          YFL  L R 
Sbjct: 112 HDNIIAIKDILRPTVPYGEFKSVYVVLDLM-ESDLHQIIHSSQPLTLEHVRYFLYQLLR- 169
Query: 373 NIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLL--GEGEDSV 430
                    L+Y+H    S  +IH DLKP+N+L++EN    + DFG+ + L     E   
Sbjct: 170 --------GLKYMH----SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQY 217
Query: 431 RQTMTMATIGYMAPEYGLE-GIVSAKCDVYSYGVLLMETFTRKR 473
             T  +AT  Y APE  L     +   D++S G +  E   R++
Sbjct: 218 FMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 62/234 (26%), Positives = 104/234 (44%), Gaps = 39/234 (16%)
Query: 255 PLAIWRRTSYLDIQRATDEFNECNLLGTSSFGSVYKGTI---------------SDGTDV 299
           P  I  +  YLD +  T E  E   LG+ +FG+V KG                 ++  D 
Sbjct: 11  PEEIRPKEVYLDRKLLTLEDKE---LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDP 67
Query: 300 AIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWL 359
           A+K              +E  V++ + +  +++++       +  LV+E    G L K+L
Sbjct: 68  ALK----------DELLAEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYL 116
Query: 360 YSHNYFLD--ILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDF 417
             + +  D  I+E   ++  V   ++YL   +     +H DL   N+LL     A +SDF
Sbjct: 117 QQNRHVKDKNIIE---LVHQVSMGMKYLEESN----FVHRDLAARNVLLVTQHYAKISDF 169
Query: 418 GIYKLLGEGEDSVR-QTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
           G+ K L   E+  + QT     + + APE       S+K DV+S+GVL+ E F+
Sbjct: 170 GLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 223

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 95/205 (46%), Gaps = 22/205 (10%)
Query: 272 DEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDS----ECEVLRNVRH 327
           ++++    +G  ++G VYK   + G   A+K   ++LE+      S    E  +L+ ++H
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALK--KIRLEKEDEGIPSTTIREISILKELKH 59
Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
            N++K+           LV E + +  L+K        LD+ E     +   S L  L N
Sbjct: 60  SNIVKLYDVIHTKKRLVLVFEHL-DQDLKK-------LLDVCEGGLESVTAKSFLLQLLN 111
Query: 388 GHSSVH---IIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQ-TMTMATIGYMA 443
           G +  H   ++H DLKP N+L++      ++DFG+ +  G     VR+ T  + T+ Y A
Sbjct: 112 GIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFG---IPVRKYTHEIVTLWYRA 168
Query: 444 PEYGL-EGIVSAKCDVYSYGVLLME 467
           P+  +     S   D++S G +  E
Sbjct: 169 PDVLMGSKKYSTTIDIWSVGCIFAE 193

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 62/234 (26%), Positives = 104/234 (44%), Gaps = 39/234 (16%)
Query: 255 PLAIWRRTSYLDIQRATDEFNECNLLGTSSFGSVYKGTI---------------SDGTDV 299
           P  I  +  YLD +  T E  E   LG+ +FG+V KG                 ++  D 
Sbjct: 13  PEEIRPKEVYLDRKLLTLEDKE---LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDP 69
Query: 300 AIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWL 359
           A+K              +E  V++ + +  +++++       +  LV+E    G L K+L
Sbjct: 70  ALK----------DELLAEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYL 118
Query: 360 YSHNYFLD--ILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDF 417
             + +  D  I+E   ++  V   ++YL   +     +H DL   N+LL     A +SDF
Sbjct: 119 QQNRHVKDKNIIE---LVHQVSMGMKYLEESN----FVHRDLAARNVLLVTQHYAKISDF 171
Query: 418 GIYKLLGEGEDSVR-QTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
           G+ K L   E+  + QT     + + APE       S+K DV+S+GVL+ E F+
Sbjct: 172 GLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 225

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 62/234 (26%), Positives = 104/234 (44%), Gaps = 39/234 (16%)
Query: 255 PLAIWRRTSYLDIQRATDEFNECNLLGTSSFGSVYKGTI---------------SDGTDV 299
           P  I  +  YLD +  T E  E   LG+ +FG+V KG                 ++  D 
Sbjct: 13  PEEIRPKEVYLDRKLLTLEDKE---LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDP 69
Query: 300 AIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWL 359
           A+K              +E  V++ + +  +++++       +  LV+E    G L K+L
Sbjct: 70  ALK----------DELLAEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYL 118
Query: 360 YSHNYFLD--ILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDF 417
             + +  D  I+E   ++  V   ++YL   +     +H DL   N+LL     A +SDF
Sbjct: 119 QQNRHVKDKNIIE---LVHQVSMGMKYLEESN----FVHRDLAARNVLLVTQHYAKISDF 171
Query: 418 GIYKLLGEGEDSVR-QTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
           G+ K L   E+  + QT     + + APE       S+K DV+S+GVL+ E F+
Sbjct: 172 GLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 225

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 76/160 (47%), Gaps = 28/160 (17%)
Query: 317 SECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLN--- 373
            E  VL+ + H N++K+   + +     LV+E    G L         F +I+ R+    
Sbjct: 85  EEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGEL---------FDEIIHRMKFNE 135
Query: 374 -----IMIDVGSALEYLHNGHSSVHIIHCDLKPTNILL---DENMVAHVSDFGIYKLLGE 425
                I+  V S + YLH  +    I+H DLKP N+LL   +++ +  + DFG+  +   
Sbjct: 136 VDAAVIIKQVLSGVTYLHKHN----IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF-- 189
Query: 426 GEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLL 465
            E+  +    + T  Y+APE  L      KCDV+S GV+L
Sbjct: 190 -ENQKKMKERLGTAYYIAPEV-LRKKYDEKCDVWSIGVIL 227

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 99/226 (43%), Gaps = 34/226 (15%)
Query: 271 TDEFNECNLLGTSSFGSVYKGTISDGTD--VAIKVFNLQLERAFRSFDSECEVLRNVRHR 328
           +D F   + LG  +   VY+     GT    A+KV    +++  +   +E  VL  + H 
Sbjct: 52  SDFFEVESELGRGATSIVYRCK-QKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHP 108
Query: 329 NLIKILSSYSNPDFKALVLEFMPNGSL-----EKWLYSHNYFLDILERLNIMIDVGSALE 383
           N+IK+   +  P   +LVLE +  G L     EK  YS     D +++      +  A+ 
Sbjct: 109 NIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQ------ILEAVA 162
Query: 384 YLH-NGHSSVHIIHCDLKPTNILLDE---NMVAHVSDFGIYKLLGEGEDSVRQTMTMATI 439
           YLH NG     I+H DLKP N+L      +    ++DFG+ K++   E  V       T 
Sbjct: 163 YLHENG-----IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV---EHQVLMKTVCGTP 214
Query: 440 GYMAPEYGLEGIVSAKCDVYSYGVLL------METFTRKRPTDEMF 479
           GY APE         + D++S G++        E F  +R    MF
Sbjct: 215 GYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMF 260

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 95/205 (46%), Gaps = 22/205 (10%)
Query: 272 DEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDS----ECEVLRNVRH 327
           ++++    +G  ++G VYK   + G   A+K   ++LE+      S    E  +L+ ++H
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALK--KIRLEKEDEGIPSTTIREISILKELKH 59
Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
            N++K+           LV E + +  L+K        LD+ E     +   S L  L N
Sbjct: 60  SNIVKLYDVIHTKKRLVLVFEHL-DQDLKK-------LLDVCEGGLESVTAKSFLLQLLN 111
Query: 388 GHSSVH---IIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQ-TMTMATIGYMA 443
           G +  H   ++H DLKP N+L++      ++DFG+ +  G     VR+ T  + T+ Y A
Sbjct: 112 GIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFG---IPVRKYTHEVVTLWYRA 168
Query: 444 PEYGL-EGIVSAKCDVYSYGVLLME 467
           P+  +     S   D++S G +  E
Sbjct: 169 PDVLMGSKKYSTTIDIWSVGCIFAE 193

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 95/205 (46%), Gaps = 22/205 (10%)
Query: 272 DEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDS----ECEVLRNVRH 327
           ++++    +G  ++G VYK   + G   A+K   ++LE+      S    E  +L+ ++H
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALK--KIRLEKEDEGIPSTTIREISILKELKH 59
Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
            N++K+           LV E + +  L+K        LD+ E     +   S L  L N
Sbjct: 60  SNIVKLYDVIHTKKRLVLVFEHL-DQDLKK-------LLDVCEGGLESVTAKSFLLQLLN 111
Query: 388 GHSSVH---IIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQ-TMTMATIGYMA 443
           G +  H   ++H DLKP N+L++      ++DFG+ +  G     VR+ T  + T+ Y A
Sbjct: 112 GIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFG---IPVRKYTHEVVTLWYRA 168
Query: 444 PEYGL-EGIVSAKCDVYSYGVLLME 467
           P+  +     S   D++S G +  E
Sbjct: 169 PDVLMGSKKYSTTIDIWSVGCIFAE 193

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 102/228 (44%), Gaps = 39/228 (17%)
Query: 261 RTSYLDIQRATDEFNECNLLGTSSFGSVYKGTI---------------SDGTDVAIKVFN 305
           +  YLD +  T E  E   LG+ +FG+V KG                 ++  D A+K   
Sbjct: 3   KEVYLDRKLLTLEDKE---LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALK--- 56
Query: 306 LQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYF 365
                      +E  V++ + +  +++++       +  LV+E    G L K+L  + + 
Sbjct: 57  -------DELLAEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHV 108
Query: 366 LD--ILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLL 423
            D  I+E   ++  V   ++YL   +     +H DL   N+LL     A +SDFG+ K L
Sbjct: 109 KDKNIIE---LVHQVSMGMKYLEESN----FVHRDLAARNVLLVTQHYAKISDFGLSKAL 161
Query: 424 GEGEDSVR-QTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
              E+  + QT     + + APE       S+K DV+S+GVL+ E F+
Sbjct: 162 RADENXYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 209

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/203 (23%), Positives = 94/203 (46%), Gaps = 13/203 (6%)
Query: 269 RATDEFNECNLLGTSSFGSVYKGTISDGT-DVAIKVFNLQL--ERAFRSFDSECEVLRNV 325
           R TD++     LG  +F  V +      T + A K+ N +    R  +  + E  + R +
Sbjct: 28  RFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLL 87
Query: 326 RHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYL 385
           +H N++++  S S   F  LV + +  G L + + +  Y+ +  +  + +  +  ++ ++
Sbjct: 88  KHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEA-DASHCIHQILESVNHI 146
Query: 386 HNGHSSVHIIHCDLKPTNILLD---ENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYM 442
           H       I+H DLKP N+LL    +     ++DFG+  +  +GE          T GY+
Sbjct: 147 HQH----DIVHRDLKPENLLLASKCKGAAVKLADFGL-AIEVQGEQQAWFGFA-GTPGYL 200
Query: 443 APEYGLEGIVSAKCDVYSYGVLL 465
           +PE   +       D+++ GV+L
Sbjct: 201 SPEVLRKDPYGKPVDIWACGVIL 223

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 93/215 (43%), Gaps = 20/215 (9%)
Query: 280 LGTSSFGSVYKGT-ISDGTDVAIKVFNL------QLERAFRSFDSECEVLRNVRHRNLIK 332
           +G  +F  V     I  G +VA+++ +        L++ FR    E  +++ + H N++K
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFR----EVRIMKVLNHPNIVK 77
Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSV 392
           +           LV+E+   G +  +L +H    +   R      + SA++Y H      
Sbjct: 78  LFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKF--- 133
Query: 393 HIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPE-YGLEGI 451
            I+H DLK  N+LLD +M   ++DFG       G    +      +  Y APE +  +  
Sbjct: 134 -IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGN---KLDTFCGSPPYAAPELFQGKKY 189
Query: 452 VSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLR 486
              + DV+S GV+L    +   P D   + E+  R
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRER 224

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 76/155 (49%), Gaps = 13/155 (8%)
Query: 269 RATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNV-- 325
           R T EF+E   +G+  FGSV+K     DG   AIK     L  +    ++  EV  +   
Sbjct: 8   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 67
Query: 326 -RHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNY----FLDILERLNIMIDVGS 380
            +H ++++  S+++  D   +  E+   GSL   + S NY    +    E  ++++ VG 
Sbjct: 68  GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAI-SENYRIMSYFKEAELKDLLLQVGR 126
Query: 381 ALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVS 415
            L Y+H    S+ ++H D+KP+NI +    + + +
Sbjct: 127 GLRYIH----SMSLVHMDIKPSNIFISRTSIPNAA 157

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 105/226 (46%), Gaps = 32/226 (14%)
Query: 273 EFNECNL-----LGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRSFD------SECE 320
           EF   NL     LG  +FG V + T    G + A+    +++ ++    D      SE +
Sbjct: 42  EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 101
Query: 321 VLRNV-RHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWL---------YSHNYFLDILE 370
           ++ ++ +H N++ +L + ++     ++ E+   G L  +L         YS+N   +  E
Sbjct: 102 IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEE 161
Query: 371 RL------NIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG 424
           +L      +    V   + +L    +S + IH D+   N+LL    VA + DFG+ + + 
Sbjct: 162 QLSSRDLLHFSSQVAQGMAFL----ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIM 217
Query: 425 EGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
              + + +      + +MAPE   + + + + DV+SYG+LL E F+
Sbjct: 218 NDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 263

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 76/155 (49%), Gaps = 13/155 (8%)
Query: 269 RATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNV-- 325
           R T EF+E   +G+  FGSV+K     DG   AIK     L  +    ++  EV  +   
Sbjct: 6   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 65
Query: 326 -RHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNY----FLDILERLNIMIDVGS 380
            +H ++++  S+++  D   +  E+   GSL   + S NY    +    E  ++++ VG 
Sbjct: 66  GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAI-SENYRIMSYFKEAELKDLLLQVGR 124
Query: 381 ALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVS 415
            L Y+H    S+ ++H D+KP+NI +    + + +
Sbjct: 125 GLRYIH----SMSLVHMDIKPSNIFISRTSIPNAA 155

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 51/220 (23%), Positives = 102/220 (46%), Gaps = 26/220 (11%)
Query: 273 EFNECNL-----LGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRSFD------SECE 320
           EF   NL     LG  +FG V + T    G + A+    +++ ++    D      SE +
Sbjct: 34  EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 93
Query: 321 VLRNV-RHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYF---------LDILE 370
           ++ ++ +H N++ +L + ++     ++ E+   G L  +L               L++ +
Sbjct: 94  IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRD 153
Query: 371 RLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSV 430
            L+    V   + +L    +S + IH D+   N+LL    VA + DFG+ + +    + +
Sbjct: 154 LLHFSSQVAQGMAFL----ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI 209
Query: 431 RQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
            +      + +MAPE   + + + + DV+SYG+LL E F+
Sbjct: 210 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 249

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 96/218 (44%), Gaps = 18/218 (8%)
Query: 265 LDIQRATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRN 324
           L I+   ++F    +LG  SFG V+       T+    +  L+ +      D EC ++  
Sbjct: 10  LQIKLKIEDFILHKMLGKGSFGKVFLAEFK-KTNQFFAIKALKKDVVLMDDDVECTMVEK 68
Query: 325 ------VRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDV 378
                   H  L  +  ++   +    V+E++  G L   + S + F D+        ++
Sbjct: 69  RVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKF-DLSRATFYAAEI 127
Query: 379 GSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYK--LLGEGEDSVRQTMTM 436
              L++LH    S  I++ DLK  NILLD++    ++DFG+ K  +LG+     +     
Sbjct: 128 ILGLQFLH----SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA----KTNXFC 179
Query: 437 ATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
            T  Y+APE  L    +   D +S+GVLL E    + P
Sbjct: 180 GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/245 (24%), Positives = 104/245 (42%), Gaps = 14/245 (5%)
Query: 269 RATDEFNECNLLGTSSFGSVYKGTISDGTDV-AIKVFNLQL---ERAFRSFDSECEVLRN 324
           R    +     LG   F   Y+ T  D  +V A KV    +           +E  + ++
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 98
Query: 325 VRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEY 384
           + + +++     + + DF  +VLE     SL + L+     +   E    M      ++Y
Sbjct: 99  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTIQGVQY 157
Query: 385 LHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIY-KLLGEGEDSVRQTMTMATIGYMA 443
           LHN      +IH DLK  N+ L+++M   + DFG+  K+  +GE   R+     T  Y+A
Sbjct: 158 LHNNR----VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGE---RKKXLCGTPNYIA 210
Query: 444 PEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKE-SLPHGLTEVVD 502
           PE   +   S + D++S G +L      K P +   + E  +R    E S+P  +  V  
Sbjct: 211 PEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVAS 270
Query: 503 ANLVR 507
           A + R
Sbjct: 271 ALIRR 275

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 109/234 (46%), Gaps = 41/234 (17%)
Query: 270 ATDEFNECNLLGTSSFGSVYKG--TISDGTDVAIKVFNLQLER------AFRSFDSECEV 321
           + D +     LG  ++G VYK   T+++ T VAIK   L+ E       A R    E  +
Sbjct: 32  SIDRYRRITKLGEGTYGEVYKAIDTVTNET-VAIKRIRLEHEEEGVPGTAIR----EVSL 86
Query: 322 LRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSA 381
           L+ ++HRN+I++ S   +     L+ E+  N  L+K++  +    D+  R+     + S 
Sbjct: 87  LKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNP---DVSMRV-----IKSF 137
Query: 382 LEYLHNGHSSVH---IIHCDLKPTNILL-----DENMVAHVSDFGIYKLLGEGEDSVRQ- 432
           L  L NG +  H    +H DLKP N+LL      E  V  + DFG+ +  G     +RQ 
Sbjct: 138 LYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG---IPIRQF 194
Query: 433 TMTMATIGYMAPEYGLEGI-VSAKCDVYS----YGVLLMET--FTRKRPTDEMF 479
           T  + T+ Y  PE  L     S   D++S    +  +LM+T  F      D++F
Sbjct: 195 THEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLF 248

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 73/146 (50%), Gaps = 13/146 (8%)
Query: 269 RATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNV-- 325
           R T EF+E   +G+  FGSV+K     DG   AIK     L  +    ++  EV  +   
Sbjct: 6   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 65
Query: 326 -RHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNY----FLDILERLNIMIDVGS 380
            +H ++++  S+++  D   +  E+   GSL   + S NY    +    E  ++++ VG 
Sbjct: 66  GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAI-SENYRIMSYFKEAELKDLLLQVGR 124
Query: 381 ALEYLHNGHSSVHIIHCDLKPTNILL 406
            L Y+H    S+ ++H D+KP+NI +
Sbjct: 125 GLRYIH----SMSLVHMDIKPSNIFI 146

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/245 (24%), Positives = 104/245 (42%), Gaps = 14/245 (5%)
Query: 269 RATDEFNECNLLGTSSFGSVYKGTISDGTDV-AIKVFNLQL---ERAFRSFDSECEVLRN 324
           R    +     LG   F   Y+ T  D  +V A KV    +           +E  + ++
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 98
Query: 325 VRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEY 384
           + + +++     + + DF  +VLE     SL + L+     +   E    M      ++Y
Sbjct: 99  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTIQGVQY 157
Query: 385 LHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIY-KLLGEGEDSVRQTMTMATIGYMA 443
           LHN      +IH DLK  N+ L+++M   + DFG+  K+  +GE   R+     T  Y+A
Sbjct: 158 LHNNR----VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGE---RKKTLCGTPNYIA 210
Query: 444 PEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKE-SLPHGLTEVVD 502
           PE   +   S + D++S G +L      K P +   + E  +R    E S+P  +  V  
Sbjct: 211 PEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVAS 270
Query: 503 ANLVR 507
           A + R
Sbjct: 271 ALIRR 275

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 92/214 (42%), Gaps = 19/214 (8%)
Query: 262 TSYLDIQRATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVF-----NLQLERAFRSFD 316
           T   +IQR   E   C  +G   FG V++G      + A+ V      N   +     F 
Sbjct: 382 TRDYEIQRERIELGRC--IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFL 439
Query: 317 SECEVLRNVRHRNLIKILSSYS-NPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIM 375
            E   +R   H +++K++   + NP +  +++E    G L  +L    + LD+   +   
Sbjct: 440 QEALTMRQFDHPHIVKLIGVITENPVW--IIMELCTLGELRSFLQVRKFSLDLASLILYA 497
Query: 376 IDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSV--RQT 433
             + +AL YL     S   +H D+   N+L+       + DFG+ + +   EDS   + +
Sbjct: 498 YQLSTALAYLE----SKRFVHRDIAARNVLVSATDCVKLGDFGLSRYM---EDSTYYKAS 550
Query: 434 MTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLME 467
                I +MAPE       ++  DV+ +GV + E
Sbjct: 551 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWE 584

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 73/146 (50%), Gaps = 13/146 (8%)
Query: 269 RATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNV-- 325
           R T EF+E   +G+  FGSV+K     DG   AIK     L  +    ++  EV  +   
Sbjct: 4   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 63
Query: 326 -RHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNY----FLDILERLNIMIDVGS 380
            +H ++++  S+++  D   +  E+   GSL   + S NY    +    E  ++++ VG 
Sbjct: 64  GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAI-SENYRIMSYFKEAELKDLLLQVGR 122
Query: 381 ALEYLHNGHSSVHIIHCDLKPTNILL 406
            L Y+H    S+ ++H D+KP+NI +
Sbjct: 123 GLRYIH----SMSLVHMDIKPSNIFI 144

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 102/228 (44%), Gaps = 39/228 (17%)
Query: 261 RTSYLDIQRATDEFNECNLLGTSSFGSVYKGTI---------------SDGTDVAIKVFN 305
           +  YLD +  T E  E   LG+ +FG+V KG                 ++  D A+K   
Sbjct: 3   KEVYLDRKLLTLEDKE---LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALK--- 56
Query: 306 LQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYF 365
                      +E  V++ + +  +++++       +  LV+E    G L K+L  + + 
Sbjct: 57  -------DELLAEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHV 108
Query: 366 LD--ILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLL 423
            D  I+E   ++  V   ++YL   +     +H DL   N+LL     A +SDFG+ K L
Sbjct: 109 KDKNIIE---LVHQVSMGMKYLEESN----FVHRDLAARNVLLVTQHYAKISDFGLSKAL 161
Query: 424 GEGEDSVR-QTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
              E+  + QT     + + APE       S+K DV+S+GVL+ E F+
Sbjct: 162 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 209

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 51/220 (23%), Positives = 102/220 (46%), Gaps = 26/220 (11%)
Query: 273 EFNECNL-----LGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRSFD------SECE 320
           EF   NL     LG  +FG V + T    G + A+    +++ ++    D      SE +
Sbjct: 42  EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 101
Query: 321 VLRNV-RHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYF---------LDILE 370
           ++ ++ +H N++ +L + ++     ++ E+   G L  +L               L++ +
Sbjct: 102 IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRD 161
Query: 371 RLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSV 430
            L+    V   + +L    +S + IH D+   N+LL    VA + DFG+ + +    + +
Sbjct: 162 LLHFSSQVAQGMAFL----ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI 217
Query: 431 RQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
            +      + +MAPE   + + + + DV+SYG+LL E F+
Sbjct: 218 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 257

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 106/220 (48%), Gaps = 27/220 (12%)
Query: 271 TDEFNECNLLGTSSFGSVYKGTISD-GTDVAIK---VFNLQLERAFRSFDSECEVLRNVR 326
           + +F   +LLG  ++G V   T    G  VAIK    F+  L  A R+   E ++L++ +
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPL-FALRTL-REIKILKHFK 67
Query: 327 HRNLIKILS-----SYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSA 381
           H N+I I +     S+ N +   ++ E M    L + + +     D ++    +     A
Sbjct: 68  HENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVISTQMLSDDHIQYF--IYQTLRA 124
Query: 382 LEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGE-----GEDSVRQTMT- 435
           ++ LH  +    +IH DLKP+N+L++ N    V DFG+ +++ E      E + +Q+   
Sbjct: 125 VKVLHGSN----VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMV 180
Query: 436 --MATIGYMAPEYGL-EGIVSAKCDVYSYGVLLMETFTRK 472
             +AT  Y APE  L     S   DV+S G +L E F R+
Sbjct: 181 EFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 102/228 (44%), Gaps = 39/228 (17%)
Query: 261 RTSYLDIQRATDEFNECNLLGTSSFGSVYKGTI---------------SDGTDVAIKVFN 305
           +  YLD +  T E  E   LG+ +FG+V KG                 ++  D A+K   
Sbjct: 9   KEVYLDRKLLTLEDKE---LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALK--- 62
Query: 306 LQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYF 365
                      +E  V++ + +  +++++       +  LV+E    G L K+L  + + 
Sbjct: 63  -------DELLAEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHV 114
Query: 366 LD--ILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLL 423
            D  I+E   ++  V   ++YL   +     +H DL   N+LL     A +SDFG+ K L
Sbjct: 115 KDKNIIE---LVHQVSMGMKYLEESN----FVHRDLAARNVLLVTQHYAKISDFGLSKAL 167
Query: 424 GEGEDSVR-QTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
              E+  + QT     + + APE       S+K DV+S+GVL+ E F+
Sbjct: 168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 215

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 93/215 (43%), Gaps = 20/215 (9%)
Query: 280 LGTSSFGSVYKGT-ISDGTDVAIKVFNL------QLERAFRSFDSECEVLRNVRHRNLIK 332
           +G  +F  V     I  G +VA+++ +        L++ FR    E  +++ + H N++K
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFR----EVRIMKVLNHPNIVK 77
Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSV 392
           +           LV+E+   G +  +L +H    +   R      + SA++Y H      
Sbjct: 78  LFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKF--- 133
Query: 393 HIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPE-YGLEGI 451
            I+H DLK  N+LLD +M   ++DFG       G    +      +  Y APE +  +  
Sbjct: 134 -IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGN---KLDEFCGSPPYAAPELFQGKKY 189
Query: 452 VSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLR 486
              + DV+S GV+L    +   P D   + E+  R
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRER 224

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 59/234 (25%), Positives = 98/234 (41%), Gaps = 17/234 (7%)
Query: 249 DHEDFLPLAIWRRTSYLDIQ-RATDEFNECNLLGTSSFGSVY----KGTISDGTDVAIKV 303
           D + FL    W+   +L+ Q    D F +  +LG   FG V+    K T        +  
Sbjct: 164 DSKYFLRFLQWK---WLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNK 220
Query: 304 FNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYS-- 361
             L+  + ++    E ++L  V  R ++ +  ++       LV+  M  G +   +Y+  
Sbjct: 221 KRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVD 280
Query: 362 -HNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIY 420
             N        +     + S LE+LH      +II+ DLKP N+LLD++    +SD G+ 
Sbjct: 281 EDNPGFQEPRAIFYTAQIVSGLEHLHQ----RNIIYRDLKPENVLLDDDGNVRISDLGLA 336
Query: 421 KLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
             L  G+   +      T G+MAPE  L        D ++ GV L E    + P
Sbjct: 337 VELKAGQTKTKG--YAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 101/225 (44%), Gaps = 39/225 (17%)
Query: 264 YLDIQRATDEFNECNLLGTSSFGSVYKGTI---------------SDGTDVAIKVFNLQL 308
           YLD +  T E  E   LG+ +FG+V KG                 ++  D A+K      
Sbjct: 2   YLDRKLLTLEDKE---LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALK------ 52
Query: 309 ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLD- 367
                   +E  V++ + +  +++++       +  LV+E    G L K+L  + +  D 
Sbjct: 53  ----DELLAEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK 107
Query: 368 -ILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG 426
            I+E   ++  V   ++YL   +     +H DL   N+LL     A +SDFG+ K L   
Sbjct: 108 NIIE---LVHQVSMGMKYLEESN----FVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 160
Query: 427 EDSVR-QTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
           E+  + QT     + + APE       S+K DV+S+GVL+ E F+
Sbjct: 161 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 205

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 46/201 (22%), Positives = 94/201 (46%), Gaps = 13/201 (6%)
Query: 271 TDEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRH 327
           TDE+     +G  +F  V +   +  G + A K+ N +    R  +  + E  + R ++H
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
            N++++  S S   F  LV + +  G L + + +  Y+ +  +  + +  +  A+ + H 
Sbjct: 63  SNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEA-DASHCIQQILEAVLHCHQ 121
Query: 388 GHSSVHIIHCDLKPTNILLD---ENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAP 444
               + ++H DLKP N+LL    +     ++DFG+  +  +G+          T GY++P
Sbjct: 122 ----MGVVHRDLKPENLLLASKCKGAAVKLADFGL-AIEVQGDQQAWFGFA-GTPGYLSP 175
Query: 445 EYGLEGIVSAKCDVYSYGVLL 465
           E   +       D+++ GV+L
Sbjct: 176 EVLRKEAYGKPVDIWACGVIL 196

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 62/187 (33%), Positives = 94/187 (50%), Gaps = 27/187 (14%)
Query: 297 TDVAIKVFNLQ----LERAFRSFDSECEVLRNVR-HRNLIKILSSYSNPDFKALVLEFMP 351
            + A+K+   Q      R FR    E E+L   + HRN+++++  +   D   LV E M 
Sbjct: 39  QEYAVKIIEKQPGHIRSRVFR----EVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMR 94
Query: 352 NGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDE-NM 410
            GS+   ++   +F + LE   ++ DV SAL++LHN      I H DLKP NIL +  N 
Sbjct: 95  GGSILSHIHKRRHFNE-LEASVVVQDVASALDFLHNK----GIAHRDLKPENILCEHPNQ 149
Query: 411 VAHVS--DFGI---YKLLGEGED-SVRQTMT-MATIGYMAPE----YGLEG-IVSAKCDV 458
           V+ V   DF +    KL G+    S  + +T   +  YMAPE    +  E  I   +CD+
Sbjct: 150 VSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDL 209
Query: 459 YSYGVLL 465
           +S GV+L
Sbjct: 210 WSLGVIL 216

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 94/211 (44%), Gaps = 18/211 (8%)
Query: 270 ATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNL--QLERAFRSFDSECEVLRNVR 326
           + + F +   +G  ++G VYK      G  VA+K   L  + E    +   E  +L+ + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 327 HRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMID-VGSALEYL 385
           H N++K+L      +   LV EF+ +  L+        F+D      I +  + S L  L
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKT-------FMDASALTGIPLPLIKSYLFQL 115
Query: 386 HNGHSSVH---IIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYM 442
             G +  H   ++H DLKP N+L++      ++DFG+ +  G    +    +   T+ Y 
Sbjct: 116 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYR 173
Query: 443 APEYGLE-GIVSAKCDVYSYGVLLMETFTRK 472
           APE  L     S   D++S G +  E  TR+
Sbjct: 174 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 92/211 (43%), Gaps = 18/211 (8%)
Query: 270 ATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNL--QLERAFRSFDSECEVLRNVR 326
           + + F +   +G  ++G VYK      G  VA+K   L  + E    +   E  +L+ + 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 327 HRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMID-VGSALEYL 385
           H N++K+L      +   LV EF+     +        F+D      I +  + S L  L
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKD--------FMDASALTGIPLPLIKSYLFQL 112
Query: 386 HNGHSSVH---IIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYM 442
             G +  H   ++H DLKP N+L++      ++DFG+ +  G    +    +   T+ Y 
Sbjct: 113 LQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYR 170
Query: 443 APEYGLE-GIVSAKCDVYSYGVLLMETFTRK 472
           APE  L     S   D++S G +  E  TR+
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/245 (24%), Positives = 104/245 (42%), Gaps = 14/245 (5%)
Query: 269 RATDEFNECNLLGTSSFGSVYKGTISDGTDV-AIKVFNLQL---ERAFRSFDSECEVLRN 324
           R    +     LG   F   Y+ T  D  +V A KV    +           +E  + ++
Sbjct: 23  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 82
Query: 325 VRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEY 384
           + + +++     + + DF  +VLE     SL + L+     +   E    M      ++Y
Sbjct: 83  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTIQGVQY 141
Query: 385 LHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIY-KLLGEGEDSVRQTMTMATIGYMA 443
           LHN      +IH DLK  N+ L+++M   + DFG+  K+  +GE   R+     T  Y+A
Sbjct: 142 LHNNR----VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGE---RKKDLCGTPNYIA 194
Query: 444 PEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKE-SLPHGLTEVVD 502
           PE   +   S + D++S G +L      K P +   + E  +R    E S+P  +  V  
Sbjct: 195 PEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVAS 254
Query: 503 ANLVR 507
           A + R
Sbjct: 255 ALIRR 259

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/245 (24%), Positives = 104/245 (42%), Gaps = 14/245 (5%)
Query: 269 RATDEFNECNLLGTSSFGSVYKGTISDGTDV-AIKVFNLQL---ERAFRSFDSECEVLRN 324
           R    +     LG   F   Y+ T  D  +V A KV    +           +E  + ++
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 98
Query: 325 VRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEY 384
           + + +++     + + DF  +VLE     SL + L+     +   E    M      ++Y
Sbjct: 99  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTIQGVQY 157
Query: 385 LHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIY-KLLGEGEDSVRQTMTMATIGYMA 443
           LHN      +IH DLK  N+ L+++M   + DFG+  K+  +GE   R+     T  Y+A
Sbjct: 158 LHNNR----VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGE---RKKDLCGTPNYIA 210
Query: 444 PEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKE-SLPHGLTEVVD 502
           PE   +   S + D++S G +L      K P +   + E  +R    E S+P  +  V  
Sbjct: 211 PEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVAS 270
Query: 503 ANLVR 507
           A + R
Sbjct: 271 ALIRR 275

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/250 (24%), Positives = 117/250 (46%), Gaps = 17/250 (6%)
Query: 236 MYIRCRNRNTKKSDH-EDFLPLAIWRRTSYLDIQRATDEFNECNLLGTSSFGSVYKGTIS 294
           +Y  C +   ++  +  +FL  A        ++Q   ++F    ++G  +FG V    + 
Sbjct: 53  LYTECSHSALRRDKYVAEFLEWAKPFTQLVKEMQLHREDFEIIKVIGRGAFGEVAVVKMK 112
Query: 295 DGTDV-AIKVFNL--QLERAFRS-FDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFM 350
           +   + A+K+ N    L+RA  + F  E +VL N   + +  +  ++ + +   LV+++ 
Sbjct: 113 NTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQWITALHYAFQDENHLYLVMDYY 172
Query: 351 PNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENM 410
             G L   L   + F D L        +G  +  + + H  +H +H D+KP N+LLD N 
Sbjct: 173 VGGDLLTLL---SKFEDKLPEDMARFYIGEMVLAIDSIHQ-LHYVHRDIKPDNVLLDVNG 228
Query: 411 VAHVSDFG-IYKLLGEGEDSVRQTMTMATIGYMAPE--YGLE---GIVSAKCDVYSYGVL 464
              ++DFG   K+  +G  +V+ ++ + T  Y++PE    +E   G    +CD +S GV 
Sbjct: 229 HIRLADFGSCLKMNDDG--TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVC 286
Query: 465 LMETFTRKRP 474
           + E    + P
Sbjct: 287 MYEMLYGETP 296

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 86/180 (47%), Gaps = 20/180 (11%)
Query: 306 LQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKW-----LY 360
           + ++  +  F +E +++ ++++   +      +N D   ++ E+M N S+ K+     + 
Sbjct: 81  ISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVL 140
Query: 361 SHNY--FLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFG 418
             NY  F+ I     I+  V ++  Y+HN     +I H D+KP+NIL+D+N    +SDF 
Sbjct: 141 DKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNILMDKNGRVKLSDF- 196
Query: 419 IYKLLGEGEDSVRQTM--TMATIGYMAPEY--GLEGIVSAKCDVYSYGVLLMETFTRKRP 474
                GE E  V + +  +  T  +M PE+         AK D++S G+ L   F    P
Sbjct: 197 -----GESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/250 (24%), Positives = 117/250 (46%), Gaps = 17/250 (6%)
Query: 236 MYIRCRNRNTKKSDH-EDFLPLAIWRRTSYLDIQRATDEFNECNLLGTSSFGSVYKGTIS 294
           +Y  C +   ++  +  +FL  A        ++Q   ++F    ++G  +FG V    + 
Sbjct: 37  LYTECSHSALRRDKYVAEFLEWAKPFTQLVKEMQLHREDFEIIKVIGRGAFGEVAVVKMK 96
Query: 295 DGTDV-AIKVFNL--QLERAFRS-FDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFM 350
           +   + A+K+ N    L+RA  + F  E +VL N   + +  +  ++ + +   LV+++ 
Sbjct: 97  NTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQWITALHYAFQDENHLYLVMDYY 156
Query: 351 PNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENM 410
             G L   L   + F D L        +G  +  + + H  +H +H D+KP N+LLD N 
Sbjct: 157 VGGDLLTLL---SKFEDKLPEDMARFYIGEMVLAIDSIHQ-LHYVHRDIKPDNVLLDVNG 212
Query: 411 VAHVSDFG-IYKLLGEGEDSVRQTMTMATIGYMAPE--YGLE---GIVSAKCDVYSYGVL 464
              ++DFG   K+  +G  +V+ ++ + T  Y++PE    +E   G    +CD +S GV 
Sbjct: 213 HIRLADFGSCLKMNDDG--TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVC 270
Query: 465 LMETFTRKRP 474
           + E    + P
Sbjct: 271 MYEMLYGETP 280

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 96/230 (41%), Gaps = 17/230 (7%)
Query: 253 FLPLAIWRRTSYLDIQ-RATDEFNECNLLGTSSFGSVY----KGTISDGTDVAIKVFNLQ 307
           FL    W+   +L+ Q    D F +  +LG   FG V+    K T        +    L+
Sbjct: 168 FLRFLQWK---WLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLK 224
Query: 308 LERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYS---HNY 364
             + ++    E ++L  V  R ++ +  ++       LV+  M  G +   +Y+    N 
Sbjct: 225 KRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNP 284
Query: 365 FLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG 424
                  +     + S LE+LH      +II+ DLKP N+LLD++    +SD G+   L 
Sbjct: 285 GFQEPRAIFYTAQIVSGLEHLHQ----RNIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340
Query: 425 EGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
            G+   +      T G+MAPE  L        D ++ GV L E    + P
Sbjct: 341 AGQTKTKG--YAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 96/230 (41%), Gaps = 17/230 (7%)
Query: 253 FLPLAIWRRTSYLDIQ-RATDEFNECNLLGTSSFGSVY----KGTISDGTDVAIKVFNLQ 307
           FL    W+   +L+ Q    D F +  +LG   FG V+    K T        +    L+
Sbjct: 168 FLRFLQWK---WLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLK 224
Query: 308 LERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYS---HNY 364
             + ++    E ++L  V  R ++ +  ++       LV+  M  G +   +Y+    N 
Sbjct: 225 KRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNP 284
Query: 365 FLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG 424
                  +     + S LE+LH      +II+ DLKP N+LLD++    +SD G+   L 
Sbjct: 285 GFQEPRAIFYTAQIVSGLEHLHQ----RNIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340
Query: 425 EGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
            G+   +      T G+MAPE  L        D ++ GV L E    + P
Sbjct: 341 AGQTKTKG--YAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 92/211 (43%), Gaps = 18/211 (8%)
Query: 270 ATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNL--QLERAFRSFDSECEVLRNVR 326
           + + F +   +G  ++G VYK      G  VA+K   L  + E    +   E  +L+ + 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 327 HRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMID-VGSALEYL 385
           H N++K+L      +   LV EF+     +        F+D      I +  + S L  L
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLSMDLKD--------FMDASALTGIPLPLIKSYLFQL 114
Query: 386 HNGHSSVH---IIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYM 442
             G +  H   ++H DLKP N+L++      ++DFG+ +  G    +    +   T+ Y 
Sbjct: 115 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYR 172
Query: 443 APEYGLE-GIVSAKCDVYSYGVLLMETFTRK 472
           APE  L     S   D++S G +  E  TR+
Sbjct: 173 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 98/228 (42%), Gaps = 33/228 (14%)
Query: 267 IQRA-TDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNV 325
           +QR    +      +G   +G V+ G    G  VA+KVF    E A  S+  E E+ + V
Sbjct: 31  VQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVF-FTTEEA--SWFRETEIYQTV 86
Query: 326 --RHRNLIKILSSYSNPDFKA--------LVLEFMPNGSLEKWLYSHNYFLDILERLNIM 375
             RH N++  +++    D K         L+ ++  NGSL  +L S    LD    L + 
Sbjct: 87  LMRHENILGFIAA----DIKGTGSWTQLYLITDYHENGSLYDYLKSTT--LDAKSMLKLA 140
Query: 376 IDVGSALEYLHNGHSSVH----IIHCDLKPTNILLDENMVAHVSDFGI-YKLLGE-GEDS 429
               S L +LH    S      I H DLK  NIL+ +N    ++D G+  K + +  E  
Sbjct: 141 YSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVD 200
Query: 430 VRQTMTMATIGYMAPEYGLEGIVSAK------CDVYSYGVLLMETFTR 471
           +     + T  YM PE   E +           D+YS+G++L E   R
Sbjct: 201 IPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARR 248

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 96/230 (41%), Gaps = 17/230 (7%)
Query: 253 FLPLAIWRRTSYLDIQ-RATDEFNECNLLGTSSFGSVY----KGTISDGTDVAIKVFNLQ 307
           FL    W+   +L+ Q    D F +  +LG   FG V+    K T        +    L+
Sbjct: 168 FLRFLQWK---WLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLK 224
Query: 308 LERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYS---HNY 364
             + ++    E ++L  V  R ++ +  ++       LV+  M  G +   +Y+    N 
Sbjct: 225 KRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNP 284
Query: 365 FLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG 424
                  +     + S LE+LH      +II+ DLKP N+LLD++    +SD G+   L 
Sbjct: 285 GFQEPRAIFYTAQIVSGLEHLHQ----RNIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340
Query: 425 EGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
            G+   +      T G+MAPE  L        D ++ GV L E    + P
Sbjct: 341 AGQTKTKG--YAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 92/211 (43%), Gaps = 18/211 (8%)
Query: 270 ATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNL--QLERAFRSFDSECEVLRNVR 326
           + + F +   +G  ++G VYK      G  VA+K   L  + E    +   E  +L+ + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 327 HRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMID-VGSALEYL 385
           H N++K+L      +   LV EF+     +        F+D      I +  + S L  L
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLSMDLKD--------FMDASALTGIPLPLIKSYLFQL 115
Query: 386 HNGHSSVH---IIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYM 442
             G +  H   ++H DLKP N+L++      ++DFG+ +  G    +    +   T+ Y 
Sbjct: 116 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYR 173
Query: 443 APEYGLE-GIVSAKCDVYSYGVLLMETFTRK 472
           APE  L     S   D++S G +  E  TR+
Sbjct: 174 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 94/211 (44%), Gaps = 18/211 (8%)
Query: 270 ATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNL--QLERAFRSFDSECEVLRNVR 326
           + + F +   +G  ++G VYK      G  VA+K   L  + E    +   E  +L+ + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 327 HRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMID-VGSALEYL 385
           H N++K+L      +   LV E + +  L+K       F+D      I +  + S L  L
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEHV-DQDLKK-------FMDASALTGIPLPLIKSYLFQL 115
Query: 386 HNGHSSVH---IIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYM 442
             G +  H   ++H DLKP N+L++      ++DFG+ +  G    +    +   T+ Y 
Sbjct: 116 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYR 173
Query: 443 APEYGLE-GIVSAKCDVYSYGVLLMETFTRK 472
           APE  L     S   D++S G +  E  TR+
Sbjct: 174 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 94/209 (44%), Gaps = 36/209 (17%)
Query: 280 LGTSSFGSVYKGTI---------------SDGTDVAIKVFNLQLERAFRSFDSECEVLRN 324
           LG+ +FG+V KG                 ++  D A+K              +E  V++ 
Sbjct: 13  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALK----------DELLAEANVMQQ 62
Query: 325 VRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLD--ILERLNIMIDVGSAL 382
           + +  +++++       +  LV+E    G L K+L  + +  D  I+E   ++  V   +
Sbjct: 63  LDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNIIE---LVHQVSMGM 118
Query: 383 EYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVR-QTMTMATIGY 441
           +YL   +     +H DL   N+LL     A +SDFG+ K L   E+  + QT     + +
Sbjct: 119 KYLEESN----FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKW 174
Query: 442 MAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
            APE       S+K DV+S+GVL+ E F+
Sbjct: 175 YAPECINYYKFSSKSDVWSFGVLMWEAFS 203

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 74/151 (49%), Gaps = 10/151 (6%)
Query: 327 HRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH 386
           H N++K+   + +     LV+E +  G L + +    +F +  E   IM  + SA+ ++H
Sbjct: 65  HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSET-EASYIMRKLVSAVSHMH 123
Query: 387 NGHSSVHIIHCDLKPTNILL---DENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           +    V ++H DLKP N+L    ++N+   + DFG  +L  +  D+        T+ Y A
Sbjct: 124 D----VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARL--KPPDNQPLKTPCFTLHYAA 177
Query: 444 PEYGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
           PE   +      CD++S GV+L    + + P
Sbjct: 178 PELLNQNGYDESCDLWSLGVILYTMLSGQVP 208

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 106/236 (44%), Gaps = 15/236 (6%)
Query: 279 LLGTSSFGSVYKGTISDGTDV-AIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLIKIL 334
            LG   F   ++ + +D  +V A K+    L            E  + R++ H++++   
Sbjct: 46  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 105
Query: 335 SSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHI 394
             + + DF  +VLE     SL + L+     L   E    +  +    +YLH       +
Sbjct: 106 GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLHRNR----V 160
Query: 395 IHCDLKPTNILLDENMVAHVSDFGIY-KLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVS 453
           IH DLK  N+ L+E++   + DFG+  K+  +GE   R+ +   T  Y+APE   +   S
Sbjct: 161 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE---RKKVLCGTPNYIAPEVLSKKGHS 217
Query: 454 AKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKE-SLPHGLTEVVDANLVRE 508
            + DV+S G ++      K P +   + E  LR    E S+P  +  V  A+L+++
Sbjct: 218 FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVA-ASLIQK 272

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 106/236 (44%), Gaps = 15/236 (6%)
Query: 279 LLGTSSFGSVYKGTISDGTDV-AIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLIKIL 334
            LG   F   ++ + +D  +V A K+    L            E  + R++ H++++   
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 335 SSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHI 394
             + + DF  +VLE     SL + L+     L   E    +  +    +YLH       +
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLHRNR----V 162
Query: 395 IHCDLKPTNILLDENMVAHVSDFGIY-KLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVS 453
           IH DLK  N+ L+E++   + DFG+  K+  +GE   R+ +   T  Y+APE   +   S
Sbjct: 163 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE---RKKVLCGTPNYIAPEVLSKKGHS 219
Query: 454 AKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKE-SLPHGLTEVVDANLVRE 508
            + DV+S G ++      K P +   + E  LR    E S+P  +  V  A+L+++
Sbjct: 220 FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVA-ASLIQK 274

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 100/208 (48%), Gaps = 15/208 (7%)
Query: 273 EFNECNLLGTSSFGSVYKGTISDGTD-VAIKVFNLQL--ERAFRSFDSECEVLRNVRHRN 329
           ++ +   +G  ++G+V+K    +  + VA+K   L    E    S   E  +L+ ++H+N
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 330 LIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGH 389
           ++++     +     LV EF  +  L+K+  S N  LD     + +  +   L + H   
Sbjct: 63  IVRLHDVLHSDKKLTLVFEFC-DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH--- 118
Query: 390 SSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVR-QTMTMATIGYMAPE--Y 446
            S +++H DLKP N+L++ N    ++DFG+ +  G     VR  +  + T+ Y  P+  +
Sbjct: 119 -SRNVLHRDLKPQNLLINRNGELKLADFGLARAFGI---PVRCYSAEVVTLWYRPPDVLF 174
Query: 447 GLEGIVSAKCDVYSYGVLLMETFTRKRP 474
           G + + S   D++S G +  E     RP
Sbjct: 175 GAK-LYSTSIDMWSAGCIFAELANAARP 201

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 67/256 (26%), Positives = 104/256 (40%), Gaps = 22/256 (8%)
Query: 239 RCRNRNTKKSDHEDFLPLAIWRRTSYL---DIQRATDEFNECNLLGTSSFGSVYK-GTIS 294
           R R  + K  D+E  L     +   Y    ++  AT +      LG  SFG V++     
Sbjct: 42  RSREPSPKTEDNEGVLLTEKLKPVDYEYREEVHWATHQLR----LGRGSFGEVHRMEDKQ 97
Query: 295 DGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGS 354
            G   A+K   L++ RA       C  L + R   ++ +  +     +  + +E +  GS
Sbjct: 98  TGFQCAVKKVRLEVFRAEELM--ACAGLTSPR---IVPLYGAVREGPWVNIFMELLEGGS 152
Query: 355 LEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLD-ENMVAH 413
           L + L      L     L  +      LEYLH    S  I+H D+K  N+LL  +   A 
Sbjct: 153 LGQ-LVKEQGCLPEDRALYYLGQALEGLEYLH----SRRILHGDVKADNVLLSSDGSHAA 207
Query: 414 VSDFGIYKLL---GEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
           + DFG    L   G G+D +       T  +MAPE  L     AK DV+S   +++    
Sbjct: 208 LCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLN 267
Query: 471 RKRPTDEMFIGEMSLR 486
              P  + F G + L+
Sbjct: 268 GCHPWTQFFRGPLCLK 283

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 105/236 (44%), Gaps = 15/236 (6%)
Query: 279 LLGTSSFGSVYKGTISDGTDV-AIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLIKIL 334
            LG   F   ++ + +D  +V A K+    L            E  + R++ H++++   
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 83
Query: 335 SSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHI 394
             + + DF  +VLE     SL + L+     L   E    +  +    +YLH       +
Sbjct: 84  GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLHRNR----V 138
Query: 395 IHCDLKPTNILLDENMVAHVSDFGIY-KLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVS 453
           IH DLK  N+ L+E++   + DFG+  K+  +GE   R+     T  Y+APE   +   S
Sbjct: 139 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE---RKKTLCGTPNYIAPEVLSKKGHS 195
Query: 454 AKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKE-SLPHGLTEVVDANLVRE 508
            + DV+S G ++      K P +   + E  LR    E S+P  +  V  A+L+++
Sbjct: 196 FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVA-ASLIQK 250

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 106/236 (44%), Gaps = 15/236 (6%)
Query: 279 LLGTSSFGSVYKGTISDGTDV-AIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLIKIL 334
            LG   F   ++ + +D  +V A K+    L            E  + R++ H++++   
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 335 SSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHI 394
             + + DF  +VLE     SL + L+     L   E    +  +    +YLH       +
Sbjct: 82  GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLHRNR----V 136
Query: 395 IHCDLKPTNILLDENMVAHVSDFGIY-KLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVS 453
           IH DLK  N+ L+E++   + DFG+  K+  +GE   R+ +   T  Y+APE   +   S
Sbjct: 137 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE---RKKVLCGTPNYIAPEVLSKKGHS 193
Query: 454 AKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKE-SLPHGLTEVVDANLVRE 508
            + DV+S G ++      K P +   + E  LR    E S+P  +  V  A+L+++
Sbjct: 194 FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVA-ASLIQK 248

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 105/236 (44%), Gaps = 15/236 (6%)
Query: 279 LLGTSSFGSVYKGTISDGTDV-AIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLIKIL 334
            LG   F   ++ + +D  +V A K+    L            E  + R++ H++++   
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 83
Query: 335 SSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHI 394
             + + DF  +VLE     SL + L+     L   E    +  +    +YLH       +
Sbjct: 84  GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLHRNR----V 138
Query: 395 IHCDLKPTNILLDENMVAHVSDFGIY-KLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVS 453
           IH DLK  N+ L+E++   + DFG+  K+  +GE   R+     T  Y+APE   +   S
Sbjct: 139 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE---RKKTLCGTPNYIAPEVLSKKGHS 195
Query: 454 AKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKE-SLPHGLTEVVDANLVRE 508
            + DV+S G ++      K P +   + E  LR    E S+P  +  V  A+L+++
Sbjct: 196 FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVA-ASLIQK 250

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 94/210 (44%), Gaps = 20/210 (9%)
Query: 272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNL--QLERAFRSFDSECEVLRNVRHR 328
           + F +   +G  ++G VYK      G  VA+K   L  + E    +   E  +L+ + H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 329 NLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMID-VGSALEYLHN 387
           N++K+L      +   LV E + +  L+        F+D      I +  + S L  L  
Sbjct: 62  NIVKLLDVIHTENKLYLVFEHV-HQDLKT-------FMDASALTGIPLPLIKSYLFQLLQ 113
Query: 388 GHSSVH---IIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQ-TMTMATIGYMA 443
           G +  H   ++H DLKP N+L++      ++DFG+ +  G     VR  T  + T+ Y A
Sbjct: 114 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV---PVRTYTHEVVTLWYRA 170
Query: 444 PEYGLE-GIVSAKCDVYSYGVLLMETFTRK 472
           PE  L     S   D++S G +  E  TR+
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 105/236 (44%), Gaps = 15/236 (6%)
Query: 279 LLGTSSFGSVYKGTISDGTDV-AIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLIKIL 334
            LG   F   ++ + +D  +V A K+    L            E  + R++ H++++   
Sbjct: 28  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 87
Query: 335 SSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHI 394
             + + DF  +VLE     SL + L+     L   E    +  +    +YLH       +
Sbjct: 88  GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLHRNR----V 142
Query: 395 IHCDLKPTNILLDENMVAHVSDFGIY-KLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVS 453
           IH DLK  N+ L+E++   + DFG+  K+  +GE   R+     T  Y+APE   +   S
Sbjct: 143 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE---RKKTLCGTPNYIAPEVLSKKGHS 199
Query: 454 AKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKE-SLPHGLTEVVDANLVRE 508
            + DV+S G ++      K P +   + E  LR    E S+P  +  V  A+L+++
Sbjct: 200 FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVA-ASLIQK 254

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 93/217 (42%), Gaps = 22/217 (10%)
Query: 271 TDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAF---RSFDSECEVLRNVRH 327
            ++++    LG  ++G V +  ++  T+ A+ V  + ++RA     +   E  + + + H
Sbjct: 6   VEDWDLVQTLGEGAYGEV-QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNH 64
Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
            N++K        + + L LE+   G L           D +E  +I +    A  + H 
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGEL----------FDRIEP-DIGMPEPDAQRFFHQ 113
Query: 388 ---GHSSVH---IIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGY 441
              G   +H   I H D+KP N+LLDE     +SDFG+  +               T+ Y
Sbjct: 114 LMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPY 173
Query: 442 MAPEYGLEGIVSAK-CDVYSYGVLLMETFTRKRPTDE 477
           +APE        A+  DV+S G++L      + P D+
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 29/105 (27%), Positives = 55/105 (52%), Gaps = 4/105 (3%)
Query: 366 LDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGE 425
           L++ + L+    V   + +L    +S + IH D+   N+LL    VA + DFG+ + +  
Sbjct: 155 LELRDLLHFSSQVAQGMAFL----ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMN 210
Query: 426 GEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
             + + +      + +MAPE   + + + + DV+SYG+LL E F+
Sbjct: 211 DSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 255

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 93/217 (42%), Gaps = 22/217 (10%)
Query: 271 TDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAF---RSFDSECEVLRNVRH 327
            ++++    LG  ++G V +  ++  T+ A+ V  + ++RA     +   E  + + + H
Sbjct: 5   VEDWDLVQTLGEGAYGEV-QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNH 63
Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
            N++K        + + L LE+   G L           D +E  +I +    A  + H 
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGEL----------FDRIEP-DIGMPEPDAQRFFHQ 112
Query: 388 ---GHSSVH---IIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGY 441
              G   +H   I H D+KP N+LLDE     +SDFG+  +               T+ Y
Sbjct: 113 LMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPY 172
Query: 442 MAPEYGLEGIVSAK-CDVYSYGVLLMETFTRKRPTDE 477
           +APE        A+  DV+S G++L      + P D+
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 90/217 (41%), Gaps = 38/217 (17%)
Query: 272 DEFNECNLLGTSSFGSVYKGTISD-GTDVAIKV-----FNLQLERAFRSFDSECEVLRNV 325
           D +  C ++G  +F  V +    + G   A+K+     F      +      E  +   +
Sbjct: 24  DVYELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 326 RHRNLIKILSSYSNPDFKALVLEFMPNGSL---------EKWLYSH----NYFLDILERL 372
           +H +++++L +YS+     +V EFM    L           ++YS     +Y   ILE  
Sbjct: 84  KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILE-- 141
Query: 373 NIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILL---DENMVAHVSDFGIYKLLGEGEDS 429
                   AL Y H+     +IIH D+KP N+LL   + +    + DFG+   LGE    
Sbjct: 142 --------ALRYCHDN----NIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGES--G 187
Query: 430 VRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLM 466
           +     + T  +MAPE           DV+  GV+L 
Sbjct: 188 LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILF 224

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 93/217 (42%), Gaps = 22/217 (10%)
Query: 271 TDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAF---RSFDSECEVLRNVRH 327
            ++++    LG  ++G V +  ++  T+ A+ V  + ++RA     +   E  + + + H
Sbjct: 5   VEDWDLVQTLGEGAYGEV-QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNH 63
Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
            N++K        + + L LE+   G L           D +E  +I +    A  + H 
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGEL----------FDRIEP-DIGMPEPDAQRFFHQ 112
Query: 388 ---GHSSVH---IIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGY 441
              G   +H   I H D+KP N+LLDE     +SDFG+  +               T+ Y
Sbjct: 113 LMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 442 MAPEYGLEGIVSAK-CDVYSYGVLLMETFTRKRPTDE 477
           +APE        A+  DV+S G++L      + P D+
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 69/145 (47%), Gaps = 14/145 (9%)
Query: 367 DILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG 426
           DIL +  I + +  ALE+LH   S + +IH D+KP+N+L++      + DFGI   L   
Sbjct: 109 DILGK--IAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL--- 160
Query: 427 EDSVRQTMTMATIGYMA-----PEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIG 481
            D V + +      YMA     PE   +G  S K D++S G+ ++E    + P D     
Sbjct: 161 VDDVAKDIDAGCKPYMAPERINPELNQKG-YSVKSDIWSLGITMIELAILRFPYDSWGTP 219
Query: 482 EMSLRRWVKESLPHGLTEVVDANLV 506
              L++ V+E  P    +   A  V
Sbjct: 220 FQQLKQVVEEPSPQLPADKFSAEFV 244

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 110/283 (38%), Gaps = 35/283 (12%)
Query: 272 DEFNECNLLGTSSFGSV----YKGTISDGTDVAIKVFNLQLER---AFRSFDSECEVLRN 324
           D +     LG+  F  V     KGT  +     IK   L   R   +    + E  +LR 
Sbjct: 5   DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 325 VRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEY 384
           +RH N+I +   + N     L+LE +  G L  +L       +  E    +  +   + Y
Sbjct: 65  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTED-EATQFLKQILDGVHY 123
Query: 385 LHNGHSSVHIIHCDLKPTNI-LLDENM---VAHVSDFGIYKLLGEGEDSVRQTMTMATIG 440
           LH    S  I H DLKP NI LLD+N+      + DFGI   +  G +         T  
Sbjct: 124 LH----SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNIFGTPE 176
Query: 441 YMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEV 500
           ++APE      +  + D++S GV+     +   P    F+GE              LT +
Sbjct: 177 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASP----FLGETK---------QETLTNI 223
Query: 501 VDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDA 543
              N   +E+ FS   +      DF     ++ P  R+ +  +
Sbjct: 224 SAVNYDFDEEYFSNTSEL---AKDFIRRLLVKDPKRRMTIAQS 263

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 39/147 (26%), Positives = 60/147 (40%), Gaps = 39/147 (26%)
Query: 372 LNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVR 431
           L+I I +  A+E+LH    S  ++H DLKP+NI    + V  V DFG+   + + E+   
Sbjct: 167 LHIFIQIAEAVEFLH----SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQT 222
Query: 432 QTMTMATIG----------YMAPEYGLEGIVSAKCDVYSYGVLLME-------------- 467
               M              YM+PE       S K D++S G++L E              
Sbjct: 223 VLTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRI 282
Query: 468 -----------TFTRKRPTDEMFIGEM 483
                       FT+K P + M + +M
Sbjct: 283 ITDVRNLKFPLLFTQKYPQEHMMVQDM 309

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 103/227 (45%), Gaps = 48/227 (21%)
Query: 267 IQRATDEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLERAFRSF------DSEC 319
           I    + +   + +G+ ++GSV        G  VA+K    +L R F+S         E 
Sbjct: 22  IWEVPERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 77
Query: 320 EVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEK----WLYSHNYFLDI-----LE 370
            +L++++H N+I +L              F P  SLE+    +L +H    D+      +
Sbjct: 78  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 125
Query: 371 RLN------IMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG 424
           +L       ++  +   L+Y+H    S  IIH DLKP+N+ ++E+    + DFG+ +   
Sbjct: 126 KLTDDHVQFLIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDXELKILDFGLAR--- 178
Query: 425 EGEDSVRQTMTMATIGYMAPEYGLEGI-VSAKCDVYSYGVLLMETFT 470
             +D +  T  +AT  Y APE  L  +  +   D++S G ++ E  T
Sbjct: 179 HTDDEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 223

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 101/227 (44%), Gaps = 48/227 (21%)
Query: 267 IQRATDEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLERAFRSF------DSEC 319
           I    + +   + +G+ ++GSV        G  VA+K    +L R F+S         E 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 72
Query: 320 EVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEK----WLYSHNYFLDI-----LE 370
            +L++++H N+I +L              F P  SLE+    +L +H    D+      +
Sbjct: 73  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 371 RLN------IMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG 424
           +L       ++  +   L+Y+H    S  IIH DLKP+N+ ++E+    + DFG+ +   
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 176
Query: 425 EGEDSVRQTMTMATIGYMAPEYGLEGI-VSAKCDVYSYGVLLMETFT 470
           +       T  +AT  Y APE  L  +  +   D++S G ++ E  T
Sbjct: 177 D-----EMTGYVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLT 218

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 101/227 (44%), Gaps = 48/227 (21%)
Query: 267 IQRATDEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLERAFRSF------DSEC 319
           I    + +   + +G+ ++GSV        G  VA+K    +L R F+S         E 
Sbjct: 24  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 79
Query: 320 EVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEK----WLYSHNYFLDI-----LE 370
            +L++++H N+I +L              F P  SLE+    +L +H    D+      +
Sbjct: 80  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 127
Query: 371 RLN------IMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG 424
           +L       ++  +   L+Y+H    S  IIH DLKP+N+ ++E+    + DFG+ +   
Sbjct: 128 KLTDDHVQFLIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTA 183
Query: 425 EGEDSVRQTMTMATIGYMAPEYGLEGI-VSAKCDVYSYGVLLMETFT 470
           +       T  +AT  Y APE  L  +  +   D++S G ++ E  T
Sbjct: 184 D-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 225

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 103/227 (45%), Gaps = 48/227 (21%)
Query: 267 IQRATDEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLERAFRSF------DSEC 319
           I    + +   + +G+ ++GSV        G  VA+K    +L R F+S         E 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 72
Query: 320 EVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEK----WLYSHNYFLDI-----LE 370
            +L++++H N+I +L              F P  SLE+    +L +H    D+      +
Sbjct: 73  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKXQ 120
Query: 371 RLN------IMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG 424
           +L       ++  +   L+Y+H    S  IIH DLKP+N+ ++E+    + DFG+ +   
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDXELKILDFGLAR--- 173
Query: 425 EGEDSVRQTMTMATIGYMAPEYGLEGI-VSAKCDVYSYGVLLMETFT 470
             +D +  T  +AT  Y APE  L  +  +   D++S G ++ E  T
Sbjct: 174 HTDDEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 101/227 (44%), Gaps = 48/227 (21%)
Query: 267 IQRATDEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLERAFRSF------DSEC 319
           I    + +   + +G+ ++GSV        G  VA+K    +L R F+S         E 
Sbjct: 24  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 79
Query: 320 EVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEK----WLYSHNYFLDI-----LE 370
            +L++++H N+I +L              F P  SLE+    +L +H    D+      +
Sbjct: 80  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 127
Query: 371 RLN------IMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG 424
           +L       ++  +   L+Y+H    S  IIH DLKP+N+ ++E+    + DFG+ +   
Sbjct: 128 KLTDDHVQFLIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTA 183
Query: 425 EGEDSVRQTMTMATIGYMAPEYGLEGI-VSAKCDVYSYGVLLMETFT 470
           +       T  +AT  Y APE  L  +  +   D++S G ++ E  T
Sbjct: 184 D-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 225

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 101/227 (44%), Gaps = 48/227 (21%)
Query: 267 IQRATDEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLERAFRSF------DSEC 319
           I    + +   + +G+ ++GSV        G  VA+K    +L R F+S         E 
Sbjct: 24  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 79
Query: 320 EVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEK----WLYSHNYFLDI-----LE 370
            +L++++H N+I +L              F P  SLE+    +L +H    D+      +
Sbjct: 80  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 127
Query: 371 RLN------IMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG 424
           +L       ++  +   L+Y+H    S  IIH DLKP+N+ ++E+    + DFG+ +   
Sbjct: 128 KLTDDHVQFLIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTA 183
Query: 425 EGEDSVRQTMTMATIGYMAPEYGLEGI-VSAKCDVYSYGVLLMETFT 470
           +       T  +AT  Y APE  L  +  +   D++S G ++ E  T
Sbjct: 184 D-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 225

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 50/223 (22%), Positives = 95/223 (42%), Gaps = 33/223 (14%)
Query: 269 RATDEFNECNLLGTSSFGSVYKGT--ISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVR 326
           RA  ++     +G  ++G V+K     + G  VA+K   +Q          E   L  +R
Sbjct: 8   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT-------GEEGMPLSTIR 60
Query: 327 HRNLIKILSSYSNPD----FKALVLEFMPNGSLEKWLYSH-----NYFLDILER------ 371
              +++ L ++ +P+    F    +      +    ++ H       +LD +        
Sbjct: 61  EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTE 120
Query: 372 --LNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDS 429
              ++M  +   L++LH    S  ++H DLKP NIL+  +    ++DFG+ ++       
Sbjct: 121 TIKDMMFQLLRGLDFLH----SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---Q 173
Query: 430 VRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRK 472
           +  T  + T+ Y APE  L+   +   D++S G +  E F RK
Sbjct: 174 MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 103/227 (45%), Gaps = 48/227 (21%)
Query: 267 IQRATDEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLERAFRSF------DSEC 319
           I    + +   + +G+ ++GSV        G  VA+K    +L R F+S         E 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 72
Query: 320 EVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEK----WLYSHNYFLDI-----LE 370
            +L++++H N+I +L              F P  SLE+    +L +H    D+      +
Sbjct: 73  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 371 RLN------IMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG 424
           +L       ++  +   L+Y+H    S  IIH DLKP+N+ ++E+    + DFG+ +   
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLAR--- 173
Query: 425 EGEDSVRQTMTMATIGYMAPEYGLEGI-VSAKCDVYSYGVLLMETFT 470
             +D +  T  +AT  Y APE  L  +  +   D++S G ++ E  T
Sbjct: 174 HTDDEM--TGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 89/215 (41%), Gaps = 20/215 (9%)
Query: 280 LGTSSFGSVYKGT-ISDGTDVAIKVFNL------QLERAFRSFDSECEVLRNVRHRNLIK 332
           +G  +F  V     I  G +VA+K+ +        L++ FR    E  + + + H N++K
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR----EVRIXKVLNHPNIVK 77
Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSV 392
           +           LV E+   G +  +L +H    +   R      + SA++Y H      
Sbjct: 78  LFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFR-QIVSAVQYCHQKF--- 133
Query: 393 HIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPE-YGLEGI 451
            I+H DLK  N+LLD +    ++DFG       G    +         Y APE +  +  
Sbjct: 134 -IVHRDLKAENLLLDADXNIKIADFGFSNEFTFGN---KLDAFCGAPPYAAPELFQGKKY 189
Query: 452 VSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLR 486
              + DV+S GV+L    +   P D   + E+  R
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRER 224

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 50/223 (22%), Positives = 95/223 (42%), Gaps = 33/223 (14%)
Query: 269 RATDEFNECNLLGTSSFGSVYKGT--ISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVR 326
           RA  ++     +G  ++G V+K     + G  VA+K   +Q          E   L  +R
Sbjct: 8   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT-------GEEGMPLSTIR 60
Query: 327 HRNLIKILSSYSNPD----FKALVLEFMPNGSLEKWLYSH-----NYFLDILER------ 371
              +++ L ++ +P+    F    +      +    ++ H       +LD +        
Sbjct: 61  EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTE 120
Query: 372 --LNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDS 429
              ++M  +   L++LH    S  ++H DLKP NIL+  +    ++DFG+ ++       
Sbjct: 121 TIKDMMFQLLRGLDFLH----SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---Q 173
Query: 430 VRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRK 472
           +  T  + T+ Y APE  L+   +   D++S G +  E F RK
Sbjct: 174 MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 50/223 (22%), Positives = 95/223 (42%), Gaps = 33/223 (14%)
Query: 269 RATDEFNECNLLGTSSFGSVYKGT--ISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVR 326
           RA  ++     +G  ++G V+K     + G  VA+K   +Q          E   L  +R
Sbjct: 8   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT-------GEEGMPLSTIR 60
Query: 327 HRNLIKILSSYSNPD----FKALVLEFMPNGSLEKWLYSH-----NYFLDILER------ 371
              +++ L ++ +P+    F    +      +    ++ H       +LD +        
Sbjct: 61  EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTE 120
Query: 372 --LNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDS 429
              ++M  +   L++LH    S  ++H DLKP NIL+  +    ++DFG+ ++       
Sbjct: 121 TIKDMMFQLLRGLDFLH----SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---Q 173
Query: 430 VRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRK 472
           +  T  + T+ Y APE  L+   +   D++S G +  E F RK
Sbjct: 174 MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 51/228 (22%), Positives = 102/228 (44%), Gaps = 25/228 (10%)
Query: 318 ECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMID 377
           E  +L   RHRN++ +  S+ + +   ++ EF+    + + + +  + L+  E ++ +  
Sbjct: 51  EISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQ 110
Query: 378 VGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVS--DFGIYKLLGEGEDSVRQTMT 435
           V  AL++LH    S +I H D++P NI+      + +   +FG  + L  G D+ R   T
Sbjct: 111 VCEALQFLH----SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-DNFRLLFT 165
Query: 436 MATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPH 495
                Y APE     +VS   D++S G L+    +   P             ++ E+   
Sbjct: 166 APE--YYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP-------------FLAETNQQ 210
Query: 496 GLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDA 543
            +  +++A    +E+AF    +  +  MDF     ++    R+  ++A
Sbjct: 211 IIENIMNAEYTFDEEAFK---EISIEAMDFVDRLLVKERKSRMTASEA 255

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 103/227 (45%), Gaps = 48/227 (21%)
Query: 267 IQRATDEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLERAFRSF------DSEC 319
           I    + +   + +G+ ++GSV        G  VA+K    +L R F+S         E 
Sbjct: 22  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 77
Query: 320 EVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEK----WLYSHNYFLDI-----LE 370
            +L++++H N+I +L              F P  SLE+    +L +H    D+      +
Sbjct: 78  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 125
Query: 371 RLN------IMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG 424
           +L       ++  +   L+Y+H    S  IIH DLKP+N+ ++E+    + DFG+ +   
Sbjct: 126 KLTDDHVQFLIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDXELKILDFGLAR--- 178
Query: 425 EGEDSVRQTMTMATIGYMAPEYGLEGI-VSAKCDVYSYGVLLMETFT 470
             +D +  T  +AT  Y APE  L  +  +   D++S G ++ E  T
Sbjct: 179 HTDDEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 223

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 103/227 (45%), Gaps = 48/227 (21%)
Query: 267 IQRATDEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLERAFRSF------DSEC 319
           I    + +   + +G+ ++GSV        G  VA+K    +L R F+S         E 
Sbjct: 28  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 83
Query: 320 EVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEK----WLYSHNYFLDI-----LE 370
            +L++++H N+I +L              F P  SLE+    +L +H    D+      +
Sbjct: 84  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 131
Query: 371 RLN------IMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG 424
           +L       ++  +   L+Y+H    S  IIH DLKP+N+ ++E+    + DFG+ +   
Sbjct: 132 KLTDDHVQFLIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDXELKILDFGLAR--- 184
Query: 425 EGEDSVRQTMTMATIGYMAPEYGLEGI-VSAKCDVYSYGVLLMETFT 470
             +D +  T  +AT  Y APE  L  +  +   D++S G ++ E  T
Sbjct: 185 HTDDEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 229

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 93/217 (42%), Gaps = 22/217 (10%)
Query: 271 TDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAF---RSFDSECEVLRNVRH 327
            ++++    LG  ++G V +  ++  T+ A+ V  + ++RA     +   E  + + + H
Sbjct: 5   VEDWDLVQTLGEGAYGEV-QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 63
Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
            N++K        + + L LE+   G L           D +E  +I +    A  + H 
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGEL----------FDRIEP-DIGMPEPDAQRFFHQ 112
Query: 388 ---GHSSVH---IIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGY 441
              G   +H   I H D+KP N+LLDE     +SDFG+  +               T+ Y
Sbjct: 113 LMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPY 172
Query: 442 MAPEYGLEGIVSAK-CDVYSYGVLLMETFTRKRPTDE 477
           +APE        A+  DV+S G++L      + P D+
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 78/331 (23%), Positives = 128/331 (38%), Gaps = 53/331 (16%)
Query: 272 DEFNECNLLGTSSFGSVYK-GTISDGTDVAIKVFNLQLERAFR------SFDSECEVLRN 324
           D ++    LG+  F  V K    S G   A K    +  ++ R        + E  +L+ 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 325 VRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEY 384
           ++H N+I +   Y N     L+LE +  G L  +L +    L   E    +  + + + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYY 129
Query: 385 LHNGHSSVHIIHCDLKPTNI-LLDENMVA---HVSDFGIYKLLGEGEDSVRQTMTMATIG 440
           LH    S+ I H DLKP NI LLD N+      + DFG+   +  G +         T  
Sbjct: 130 LH----SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPA 182
Query: 441 YMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEV 500
           ++APE      +  + D++S GV+     +   P    F+G+              L  V
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASP----FLGDTK---------QETLANV 229
Query: 501 VDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAA----KLKKIKVKFLD 556
              N   E++ FS   +      DF     ++ P  R+ + D+      K K  +     
Sbjct: 230 SAVNYEFEDEYFS---NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSR 286
Query: 557 DAAATN------------WRNFHCVSLLTLC 575
            A+A N            W+    V L++LC
Sbjct: 287 KASAVNMEKFKKFAARKKWK--QSVRLISLC 315

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 102/227 (44%), Gaps = 48/227 (21%)
Query: 267 IQRATDEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLERAFRSF------DSEC 319
           I    + +   + +G+ ++GSV     +  G  +A+K    +L R F+S         E 
Sbjct: 46  IWEVPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVK----KLSRPFQSIIHAKRTYREL 101
Query: 320 EVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEK----WLYSHNYFLDI-----LE 370
            +L++++H N+I +L              F P  SLE+    +L +H    D+      +
Sbjct: 102 RLLKHMKHENVIGLLDV------------FTPATSLEEFNDVYLVTHLMGADLNNIVKCQ 149
Query: 371 RLN------IMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG 424
           +L       ++  +   L+Y+H    S  IIH DLKP+N+ ++E+    + DFG+ +   
Sbjct: 150 KLTDDHVQFLIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 205
Query: 425 EGEDSVRQTMTMATIGYMAPEYGLEGI-VSAKCDVYSYGVLLMETFT 470
           +       T  +AT  Y APE  L  +  +   D++S G ++ E  T
Sbjct: 206 D-----EMTGYVATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLT 247

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 110/283 (38%), Gaps = 35/283 (12%)
Query: 272 DEFNECNLLGTSSFGSV----YKGTISDGTDVAIKVFNLQLER---AFRSFDSECEVLRN 324
           D +     LG+  F  V     KGT  +     IK   L   R   +    + E  +LR 
Sbjct: 26  DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILRE 85
Query: 325 VRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEY 384
           +RH N+I +   + N     L+LE +  G L  +L       +  E    +  +   + Y
Sbjct: 86  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTED-EATQFLKQILDGVHY 144
Query: 385 LHNGHSSVHIIHCDLKPTNI-LLDENM---VAHVSDFGIYKLLGEGEDSVRQTMTMATIG 440
           LH    S  I H DLKP NI LLD+N+      + DFGI   +  G +         T  
Sbjct: 145 LH----SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNIFGTPE 197
Query: 441 YMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEV 500
           ++APE      +  + D++S GV+     +   P    F+GE              LT +
Sbjct: 198 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASP----FLGETK---------QETLTNI 244
Query: 501 VDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDA 543
              N   +E+ FS   +      DF     ++ P  R+ +  +
Sbjct: 245 SAVNYDFDEEYFSNTSEL---AKDFIRRLLVKDPKRRMXIAQS 284

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 110/283 (38%), Gaps = 35/283 (12%)
Query: 272 DEFNECNLLGTSSFGSV----YKGTISDGTDVAIKVFNLQLER---AFRSFDSECEVLRN 324
           D +     LG+  F  V     KGT  +     IK   L   R   +    + E  +LR 
Sbjct: 12  DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 71
Query: 325 VRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEY 384
           +RH N+I +   + N     L+LE +  G L  +L       +  E    +  +   + Y
Sbjct: 72  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTED-EATQFLKQILDGVHY 130
Query: 385 LHNGHSSVHIIHCDLKPTNI-LLDENM---VAHVSDFGIYKLLGEGEDSVRQTMTMATIG 440
           LH    S  I H DLKP NI LLD+N+      + DFGI   +  G +         T  
Sbjct: 131 LH----SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNIFGTPE 183
Query: 441 YMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEV 500
           ++APE      +  + D++S GV+     +   P    F+GE              LT +
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASP----FLGETK---------QETLTNI 230
Query: 501 VDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDA 543
              N   +E+ FS   +      DF     ++ P  R+ +  +
Sbjct: 231 SAVNYDFDEEYFSNTSEL---AKDFIRRLLVKDPKRRMXIAQS 270

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 103/227 (45%), Gaps = 48/227 (21%)
Query: 267 IQRATDEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLERAFRSF------DSEC 319
           I    + +   + +G+ ++GSV        G  VA+K    +L R F+S         E 
Sbjct: 13  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 68
Query: 320 EVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEK----WLYSHNYFLDI-----LE 370
            +L++++H N+I +L              F P  SLE+    +L +H    D+      +
Sbjct: 69  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 116
Query: 371 RLN------IMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG 424
           +L       ++  +   L+Y+H    S  IIH DLKP+N+ ++E+    + DFG+ +   
Sbjct: 117 KLTDDHVQFLIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLAR--- 169
Query: 425 EGEDSVRQTMTMATIGYMAPEYGLEGI-VSAKCDVYSYGVLLMETFT 470
             +D +  T  +AT  Y APE  L  +  +   D++S G ++ E  T
Sbjct: 170 HTDDEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 214

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 103/227 (45%), Gaps = 48/227 (21%)
Query: 267 IQRATDEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLERAFRSF------DSEC 319
           I    + +   + +G+ ++GSV        G  VA+K    +L R F+S         E 
Sbjct: 15  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 70
Query: 320 EVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEK----WLYSHNYFLDI-----LE 370
            +L++++H N+I +L              F P  SLE+    +L +H    D+      +
Sbjct: 71  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 118
Query: 371 RLN------IMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG 424
           +L       ++  +   L+Y+H    S  IIH DLKP+N+ ++E+    + DFG+ +   
Sbjct: 119 KLTDDHVQFLIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLAR--- 171
Query: 425 EGEDSVRQTMTMATIGYMAPEYGLEGI-VSAKCDVYSYGVLLMETFT 470
             +D +  T  +AT  Y APE  L  +  +   D++S G ++ E  T
Sbjct: 172 HTDDEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 216

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 95/218 (43%), Gaps = 23/218 (10%)
Query: 270 ATDEFNECNLLGTSSFGSVYKGT-ISDGTDVAIK---VFNLQLERAFRSFDSECEV---- 321
           AT  +     +G  ++G+VYK      G  VA+K   V N           +  EV    
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 322 -LRNVRHRNLIKIL----SSYSNPDFKA-LVLEFMPNGSLEKWL-YSHNYFLDILERLNI 374
            L    H N+++++    +S ++ + K  LV E + +  L  +L  +    L      ++
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDL 125
Query: 375 MIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTM 434
           M      L++LH       I+H DLKP NIL+       ++DFG+ ++       +  T 
Sbjct: 126 MRQFLRGLDFLHANC----IVHRDLKPENILVTSGGTVKLADFGLARIYSY---QMALTP 178
Query: 435 TMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRK 472
            + T+ Y APE  L+   +   D++S G +  E F RK
Sbjct: 179 VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 103/227 (45%), Gaps = 48/227 (21%)
Query: 267 IQRATDEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLERAFRSF------DSEC 319
           I    + +   + +G+ ++GSV        G  VA+K    +L R F+S         E 
Sbjct: 13  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK----KLSRPFQSIIHAKRTYREL 68
Query: 320 EVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEK----WLYSHNYFLDI-----LE 370
            +L++++H N+I +L              F P  SLE+    +L +H    D+      +
Sbjct: 69  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 116
Query: 371 RLN------IMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG 424
           +L       ++  +   L+Y+H    S  IIH DLKP+N+ ++E+    + DFG+ +   
Sbjct: 117 KLTDDHVQFLIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLAR--- 169
Query: 425 EGEDSVRQTMTMATIGYMAPEYGLEGI-VSAKCDVYSYGVLLMETFT 470
             +D +  T  +AT  Y APE  L  +  +   D++S G ++ E  T
Sbjct: 170 HTDDEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 214

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 103/227 (45%), Gaps = 48/227 (21%)
Query: 267 IQRATDEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLERAFRSF------DSEC 319
           I    + +   + +G+ ++GSV        G  VA+K    +L R F+S         E 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 72
Query: 320 EVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEK----WLYSHNYFLDI-----LE 370
            +L++++H N+I +L              F P  SLE+    +L +H    D+      +
Sbjct: 73  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 371 RLN------IMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG 424
           +L       ++  +   L+Y+H    S  IIH DLKP+N+ ++E+    + DFG+ +   
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLAR--- 173
Query: 425 EGEDSVRQTMTMATIGYMAPEYGLEGI-VSAKCDVYSYGVLLMETFT 470
             +D +  T  +AT  Y APE  L  +  +   D++S G ++ E  T
Sbjct: 174 HTDDEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 103/227 (45%), Gaps = 48/227 (21%)
Query: 267 IQRATDEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLERAFRSF------DSEC 319
           I    + +   + +G+ ++GSV        G  VA+K    +L R F+S         E 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 72
Query: 320 EVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEK----WLYSHNYFLDI-----LE 370
            +L++++H N+I +L              F P  SLE+    +L +H    D+      +
Sbjct: 73  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKXQ 120
Query: 371 RLN------IMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG 424
           +L       ++  +   L+Y+H    S  IIH DLKP+N+ ++E+    + DFG+ +   
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLAR--- 173
Query: 425 EGEDSVRQTMTMATIGYMAPEYGLEGI-VSAKCDVYSYGVLLMETFT 470
             +D +  T  +AT  Y APE  L  +  +   D++S G ++ E  T
Sbjct: 174 HTDDEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 101/227 (44%), Gaps = 48/227 (21%)
Query: 267 IQRATDEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLERAFRSF------DSEC 319
           I    + +   + +G+ ++GSV        G  VA+K    +L R F+S         E 
Sbjct: 19  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 74
Query: 320 EVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEK----WLYSHNYFLDI-----LE 370
            +L++++H N+I +L              F P  SLE+    +L +H    D+      +
Sbjct: 75  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 122
Query: 371 RLN------IMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG 424
           +L       ++  +   L+Y+H    S  IIH DLKP+N+ ++E+    + DFG+ +   
Sbjct: 123 KLTDDHVQFLIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 178
Query: 425 EGEDSVRQTMTMATIGYMAPEYGLEGI-VSAKCDVYSYGVLLMETFT 470
           +       T  +AT  Y APE  L  +  +   D++S G ++ E  T
Sbjct: 179 D-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 220

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 93/217 (42%), Gaps = 22/217 (10%)
Query: 271 TDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAF---RSFDSECEVLRNVRH 327
            ++++    LG  ++G V +  ++  T+ A+ V  + ++RA     +   E  + + + H
Sbjct: 5   VEDWDLVQTLGEGAYGEV-QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 63
Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
            N++K        + + L LE+   G L           D +E  +I +    A  + H 
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGEL----------FDRIEP-DIGMPEPDAQRFFHQ 112
Query: 388 ---GHSSVH---IIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGY 441
              G   +H   I H D+KP N+LLDE     +SDFG+  +               T+ Y
Sbjct: 113 LMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPY 172
Query: 442 MAPEYGLEGIVSAK-CDVYSYGVLLMETFTRKRPTDE 477
           +APE        A+  DV+S G++L      + P D+
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 103/227 (45%), Gaps = 48/227 (21%)
Query: 267 IQRATDEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLERAFRSF------DSEC 319
           I    + +   + +G+ ++GSV        G  VA+K    +L R F+S         E 
Sbjct: 14  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 69
Query: 320 EVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEK----WLYSHNYFLDI-----LE 370
            +L++++H N+I +L              F P  SLE+    +L +H    D+      +
Sbjct: 70  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 117
Query: 371 RLN------IMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG 424
           +L       ++  +   L+Y+H    S  IIH DLKP+N+ ++E+    + DFG+ +   
Sbjct: 118 KLTDDHVQFLIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLAR--- 170
Query: 425 EGEDSVRQTMTMATIGYMAPEYGLEGI-VSAKCDVYSYGVLLMETFT 470
             +D +  T  +AT  Y APE  L  +  +   D++S G ++ E  T
Sbjct: 171 HTDDEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 215

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 103/227 (45%), Gaps = 48/227 (21%)
Query: 267 IQRATDEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLERAFRSF------DSEC 319
           I    + +   + +G+ ++GSV        G  VA+K    +L R F+S         E 
Sbjct: 14  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 69
Query: 320 EVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEK----WLYSHNYFLDI-----LE 370
            +L++++H N+I +L              F P  SLE+    +L +H    D+      +
Sbjct: 70  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 117
Query: 371 RLN------IMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG 424
           +L       ++  +   L+Y+H    S  IIH DLKP+N+ ++E+    + DFG+ +   
Sbjct: 118 KLTDDHVQFLIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLAR--- 170
Query: 425 EGEDSVRQTMTMATIGYMAPEYGLEGI-VSAKCDVYSYGVLLMETFT 470
             +D +  T  +AT  Y APE  L  +  +   D++S G ++ E  T
Sbjct: 171 HTDDEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 215

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 73/303 (24%), Positives = 121/303 (39%), Gaps = 36/303 (11%)
Query: 272 DEFNECNLLGTSSFGSVYK-GTISDGTDVAIKVFNLQLERAFR------SFDSECEVLRN 324
           D ++    LG+  F  V K    S G   A K    +  ++ R        + E  +L+ 
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 325 VRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEY 384
           ++H N+I +   Y N     L+LE +  G L  +L +    L   E    +  + + + Y
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYY 128
Query: 385 LHNGHSSVHIIHCDLKPTNI-LLDENMVA---HVSDFGIYKLLGEGEDSVRQTMTMATIG 440
           LH    S+ I H DLKP NI LLD N+      + DFG+   +  G +         T  
Sbjct: 129 LH----SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPE 181
Query: 441 YMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEV 500
           ++APE      +  + D++S GV+     +   P    F+G+              L  V
Sbjct: 182 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASP----FLGDTK---------QETLANV 228
Query: 501 VDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKFLDDAAA 560
              N   E++ FS   +      DF     ++ P  R+ + D + +   IK K    A +
Sbjct: 229 SAVNYEFEDEYFS---NTSALAKDFIRRLLVKDPKKRMTIQD-SLQHPWIKPKDTQQALS 284
Query: 561 TNW 563
           + W
Sbjct: 285 SAW 287

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 103/227 (45%), Gaps = 48/227 (21%)
Query: 267 IQRATDEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLERAFRSF------DSEC 319
           I    + +   + +G+ ++GSV        G  VA+K    +L R F+S         E 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 72
Query: 320 EVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEK----WLYSHNYFLDI-----LE 370
            +L++++H N+I +L              F P  SLE+    +L +H    D+      +
Sbjct: 73  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 371 RLN------IMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG 424
           +L       ++  +   L+Y+H    S  IIH DLKP+N+ ++E+    + DFG+ +   
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLAR--- 173
Query: 425 EGEDSVRQTMTMATIGYMAPEYGLEGI-VSAKCDVYSYGVLLMETFT 470
             +D +  T  +AT  Y APE  L  +  +   D++S G ++ E  T
Sbjct: 174 HTDDEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 101/227 (44%), Gaps = 48/227 (21%)
Query: 267 IQRATDEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLERAFRSF------DSEC 319
           I    + +   + +G+ ++GSV        G  VA+K    +L R F+S         E 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 72
Query: 320 EVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEK----WLYSHNYFLDI-----LE 370
            +L++++H N+I +L              F P  SLE+    +L +H    D+      +
Sbjct: 73  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 371 RLN------IMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG 424
           +L       ++  +   L+Y+H    S  IIH DLKP+N+ ++E+    + DFG+ +   
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 176
Query: 425 EGEDSVRQTMTMATIGYMAPEYGLEGI-VSAKCDVYSYGVLLMETFT 470
           +       T  +AT  Y APE  L  +  +   D++S G ++ E  T
Sbjct: 177 D-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 93/217 (42%), Gaps = 22/217 (10%)
Query: 271 TDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAF---RSFDSECEVLRNVRH 327
            ++++    LG  ++G V +  ++  T+ A+ V  + ++RA     +   E  + + + H
Sbjct: 5   VEDWDLVQTLGEGAYGEV-QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 63
Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
            N++K        + + L LE+   G L           D +E  +I +    A  + H 
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGEL----------FDRIEP-DIGMPEPDAQRFFHQ 112
Query: 388 ---GHSSVH---IIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGY 441
              G   +H   I H D+KP N+LLDE     +SDFG+  +               T+ Y
Sbjct: 113 LMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPY 172
Query: 442 MAPEYGLEGIVSAK-CDVYSYGVLLMETFTRKRPTDE 477
           +APE        A+  DV+S G++L      + P D+
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 93/217 (42%), Gaps = 22/217 (10%)
Query: 271 TDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAF---RSFDSECEVLRNVRH 327
            ++++    LG  ++G V +  ++  T+ A+ V  + ++RA     +   E  + + + H
Sbjct: 5   VEDWDLVQTLGEGAYGEV-QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 63
Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
            N++K        + + L LE+   G L           D +E  +I +    A  + H 
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGEL----------FDRIEP-DIGMPEPDAQRFFHQ 112
Query: 388 ---GHSSVH---IIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGY 441
              G   +H   I H D+KP N+LLDE     +SDFG+  +               T+ Y
Sbjct: 113 LMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 442 MAPEYGLEGIVSAK-CDVYSYGVLLMETFTRKRPTDE 477
           +APE        A+  DV+S G++L      + P D+
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 103/227 (45%), Gaps = 48/227 (21%)
Query: 267 IQRATDEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLERAFRSF------DSEC 319
           I    + +   + +G+ ++GSV        G  VA+K    +L R F+S         E 
Sbjct: 28  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 83
Query: 320 EVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEK----WLYSHNYFLDI-----LE 370
            +L++++H N+I +L              F P  SLE+    +L +H    D+      +
Sbjct: 84  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 131
Query: 371 RLN------IMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG 424
           +L       ++  +   L+Y+H    S  IIH DLKP+N+ ++E+    + DFG+ +   
Sbjct: 132 KLTDDHVQFLIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLAR--- 184
Query: 425 EGEDSVRQTMTMATIGYMAPEYGLEGI-VSAKCDVYSYGVLLMETFT 470
             +D +  T  +AT  Y APE  L  +  +   D++S G ++ E  T
Sbjct: 185 HTDDEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 229

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 92/217 (42%), Gaps = 22/217 (10%)
Query: 271 TDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAF---RSFDSECEVLRNVRH 327
            ++++    LG  ++G V +  ++  T+ A+ V  + ++RA     +   E  + + + H
Sbjct: 4   VEDWDLVQTLGEGAYGEV-QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 62
Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
            N++K        + + L LE+   G L           D +E  +I +    A  + H 
Sbjct: 63  ENVVKFYGHRREGNIQYLFLEYCSGGEL----------FDRIEP-DIGMPEPDAQRFFHQ 111
Query: 388 GHSSV------HIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGY 441
             + V       I H D+KP N+LLDE     +SDFG+  +               T+ Y
Sbjct: 112 LMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 171
Query: 442 MAPEYGLEGIVSAK-CDVYSYGVLLMETFTRKRPTDE 477
           +APE        A+  DV+S G++L      + P D+
Sbjct: 172 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 208

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 103/227 (45%), Gaps = 48/227 (21%)
Query: 267 IQRATDEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLERAFRSF------DSEC 319
           I    + +   + +G+ ++GSV        G  VA+K    +L R F+S         E 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 72
Query: 320 EVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEK----WLYSHNYFLDI-----LE 370
            +L++++H N+I +L              F P  SLE+    +L +H    D+      +
Sbjct: 73  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 371 RLN------IMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG 424
           +L       ++  +   L+Y+H    S  IIH DLKP+N+ ++E+    + DFG+ +   
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLAR--- 173
Query: 425 EGEDSVRQTMTMATIGYMAPEYGLEGI-VSAKCDVYSYGVLLMETFT 470
             +D +  T  +AT  Y APE  L  +  +   D++S G ++ E  T
Sbjct: 174 HTDDEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 91/226 (40%), Gaps = 57/226 (25%)
Query: 274 FNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRSFDSECEVLRNV------- 325
           F    L+G  ++G VYKG  +  G   AIKV ++       + D E E+ + +       
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV-------TGDEEEEIKQEINMLKKYS 78
Query: 326 RHRNLIKILSSY--SNP----DFKALVLEFMPNGSL-------------EKWLYSHNYFL 366
            HRN+     ++   NP    D   LV+EF   GS+             E+W+       
Sbjct: 79  HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWI------- 131
Query: 367 DILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG 426
                  I  ++   L +LH       +IH D+K  N+LL EN    + DFG+   L   
Sbjct: 132 -----AYICREILRGLSHLHQHK----VIHRDIKGQNVLLTENAEVKLVDFGVSAQL--D 180
Query: 427 EDSVRQTMTMATIGYMAPEY-----GLEGIVSAKCDVYSYGVLLME 467
               R+   + T  +MAPE        +     K D++S G+  +E
Sbjct: 181 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIE 226

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 103/227 (45%), Gaps = 48/227 (21%)
Query: 267 IQRATDEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLERAFRSF------DSEC 319
           I    + +   + +G+ ++GSV        G  VA+K    +L R F+S         E 
Sbjct: 40  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 95
Query: 320 EVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEK----WLYSHNYFLDI-----LE 370
            +L++++H N+I +L              F P  SLE+    +L +H    D+      +
Sbjct: 96  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 143
Query: 371 RLN------IMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG 424
           +L       ++  +   L+Y+H    S  IIH DLKP+N+ ++E+    + DFG+ +   
Sbjct: 144 KLTDDHVQFLIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLAR--- 196
Query: 425 EGEDSVRQTMTMATIGYMAPEYGLEGI-VSAKCDVYSYGVLLMETFT 470
             +D +  T  +AT  Y APE  L  +  +   D++S G ++ E  T
Sbjct: 197 HTDDEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 241

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 103/227 (45%), Gaps = 48/227 (21%)
Query: 267 IQRATDEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLERAFRSF------DSEC 319
           I    + +   + +G+ ++GSV        G  VA+K    +L R F+S         E 
Sbjct: 22  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 77
Query: 320 EVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEK----WLYSHNYFLDI-----LE 370
            +L++++H N+I +L              F P  SLE+    +L +H    D+      +
Sbjct: 78  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 125
Query: 371 RLN------IMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG 424
           +L       ++  +   L+Y+H    S  IIH DLKP+N+ ++E+    + DFG+ +   
Sbjct: 126 KLTDDHVQFLIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLAR--- 178
Query: 425 EGEDSVRQTMTMATIGYMAPEYGLEGI-VSAKCDVYSYGVLLMETFT 470
             +D +  T  +AT  Y APE  L  +  +   D++S G ++ E  T
Sbjct: 179 HTDDEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 223

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 103/227 (45%), Gaps = 48/227 (21%)
Query: 267 IQRATDEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLERAFRSF------DSEC 319
           I    + +   + +G+ ++GSV        G  VA+K    +L R F+S         E 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 72
Query: 320 EVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEK----WLYSHNYFLDI-----LE 370
            +L++++H N+I +L              F P  SLE+    +L +H    D+      +
Sbjct: 73  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 371 RLN------IMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG 424
           +L       ++  +   L+Y+H    S  IIH DLKP+N+ ++E+    + DFG+ +   
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLAR--- 173
Query: 425 EGEDSVRQTMTMATIGYMAPEYGLEGI-VSAKCDVYSYGVLLMETFT 470
             +D +  T  +AT  Y APE  L  +  +   D++S G ++ E  T
Sbjct: 174 HTDDEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 103/227 (45%), Gaps = 48/227 (21%)
Query: 267 IQRATDEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLERAFRSF------DSEC 319
           I    + +   + +G+ ++GSV        G  VA+K    +L R F+S         E 
Sbjct: 37  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 92
Query: 320 EVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEK----WLYSHNYFLDI-----LE 370
            +L++++H N+I +L              F P  SLE+    +L +H    D+      +
Sbjct: 93  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 140
Query: 371 RLN------IMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG 424
           +L       ++  +   L+Y+H    S  IIH DLKP+N+ ++E+    + DFG+ +   
Sbjct: 141 KLTDDHVQFLIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLAR--- 193
Query: 425 EGEDSVRQTMTMATIGYMAPEYGLEGI-VSAKCDVYSYGVLLMETFT 470
             +D +  T  +AT  Y APE  L  +  +   D++S G ++ E  T
Sbjct: 194 HTDDEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 238

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 93/217 (42%), Gaps = 22/217 (10%)
Query: 271 TDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAF---RSFDSECEVLRNVRH 327
            ++++    LG  ++G V +  ++  T+ A+ V  + ++RA     +   E  + + + H
Sbjct: 5   VEDWDLVQTLGEGAYGEV-QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 63
Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
            N++K        + + L LE+   G L           D +E  +I +    A  + H 
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGEL----------FDRIEP-DIGMPEPDAQRFFHQ 112
Query: 388 ---GHSSVH---IIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGY 441
              G   +H   I H D+KP N+LLDE     +SDFG+  +               T+ Y
Sbjct: 113 LMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 442 MAPEYGLEGIVSAK-CDVYSYGVLLMETFTRKRPTDE 477
           +APE        A+  DV+S G++L      + P D+
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 93/217 (42%), Gaps = 22/217 (10%)
Query: 271 TDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAF---RSFDSECEVLRNVRH 327
            ++++    LG  ++G V +  ++  T+ A+ V  + ++RA     +   E  + + + H
Sbjct: 5   VEDWDLVQTLGEGAYGEV-QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 63
Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
            N++K        + + L LE+   G L           D +E  +I +    A  + H 
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGEL----------FDRIEP-DIGMPEPDAQRFFHQ 112
Query: 388 ---GHSSVH---IIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGY 441
              G   +H   I H D+KP N+LLDE     +SDFG+  +               T+ Y
Sbjct: 113 LMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 442 MAPEYGLEGIVSAK-CDVYSYGVLLMETFTRKRPTDE 477
           +APE        A+  DV+S G++L      + P D+
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 100/208 (48%), Gaps = 15/208 (7%)
Query: 273 EFNECNLLGTSSFGSVYKGTISDGTD-VAIKVFNLQL--ERAFRSFDSECEVLRNVRHRN 329
           ++ +   +G  ++G+V+K    +  + VA+K   L    E    S   E  +L+ ++H+N
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 330 LIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGH 389
           ++++     +     LV EF  +  L+K+  S N  LD     + +  +   L + H   
Sbjct: 63  IVRLHDVLHSDKKLTLVFEFC-DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH--- 118
Query: 390 SSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVR-QTMTMATIGYMAPE--Y 446
            S +++H DLKP N+L++ N    +++FG+ +  G     VR  +  + T+ Y  P+  +
Sbjct: 119 -SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI---PVRCYSAEVVTLWYRPPDVLF 174
Query: 447 GLEGIVSAKCDVYSYGVLLMETFTRKRP 474
           G + + S   D++S G +  E     RP
Sbjct: 175 GAK-LYSTSIDMWSAGCIFAELANAGRP 201

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 103/227 (45%), Gaps = 48/227 (21%)
Query: 267 IQRATDEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLERAFRSF------DSEC 319
           I    + +   + +G+ ++GSV        G  VA+K    +L R F+S         E 
Sbjct: 29  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 84
Query: 320 EVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEK----WLYSHNYFLDI-----LE 370
            +L++++H N+I +L              F P  SLE+    +L +H    D+      +
Sbjct: 85  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 132
Query: 371 RLN------IMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG 424
           +L       ++  +   L+Y+H    S  IIH DLKP+N+ ++E+    + DFG+ +   
Sbjct: 133 KLTDDHVQFLIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLAR--- 185
Query: 425 EGEDSVRQTMTMATIGYMAPEYGLEGI-VSAKCDVYSYGVLLMETFT 470
             +D +  T  +AT  Y APE  L  +  +   D++S G ++ E  T
Sbjct: 186 HTDDEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 230

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 93/217 (42%), Gaps = 22/217 (10%)
Query: 271 TDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAF---RSFDSECEVLRNVRH 327
            ++++    LG  ++G V +  ++  T+ A+ V  + ++RA     +   E  + + + H
Sbjct: 5   VEDWDLVQTLGEGAYGEV-QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 63
Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
            N++K        + + L LE+   G L           D +E  +I +    A  + H 
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGEL----------FDRIEP-DIGMPEPDAQRFFHQ 112
Query: 388 ---GHSSVH---IIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGY 441
              G   +H   I H D+KP N+LLDE     +SDFG+  +               T+ Y
Sbjct: 113 LMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 442 MAPEYGLEGIVSAK-CDVYSYGVLLMETFTRKRPTDE 477
           +APE        A+  DV+S G++L      + P D+
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 103/227 (45%), Gaps = 48/227 (21%)
Query: 267 IQRATDEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLERAFRSF------DSEC 319
           I    + +   + +G+ ++GSV        G  VA+K    +L R F+S         E 
Sbjct: 29  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 84
Query: 320 EVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEK----WLYSHNYFLDI-----LE 370
            +L++++H N+I +L              F P  SLE+    +L +H    D+      +
Sbjct: 85  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 132
Query: 371 RLN------IMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG 424
           +L       ++  +   L+Y+H    S  IIH DLKP+N+ ++E+    + DFG+ +   
Sbjct: 133 KLTDDHVQFLIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLAR--- 185
Query: 425 EGEDSVRQTMTMATIGYMAPEYGLEGI-VSAKCDVYSYGVLLMETFT 470
             +D +  T  +AT  Y APE  L  +  +   D++S G ++ E  T
Sbjct: 186 HTDDEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 230

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 103/227 (45%), Gaps = 48/227 (21%)
Query: 267 IQRATDEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLERAFRSF------DSEC 319
           I    + +   + +G+ ++GSV        G  VA+K    +L R F+S         E 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 72
Query: 320 EVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEK----WLYSHNYFLDI-----LE 370
            +L++++H N+I +L              F P  SLE+    +L +H    D+      +
Sbjct: 73  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 371 RLN------IMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG 424
           +L       ++  +   L+Y+H    S  IIH DLKP+N+ ++E+    + DFG+ +   
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLAR--- 173
Query: 425 EGEDSVRQTMTMATIGYMAPEYGLEGI-VSAKCDVYSYGVLLMETFT 470
             +D +  T  +AT  Y APE  L  +  +   D++S G ++ E  T
Sbjct: 174 HTDDEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 101/227 (44%), Gaps = 48/227 (21%)
Query: 267 IQRATDEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLERAFRSF------DSEC 319
           I    + +   + +G+ ++GSV        G  VA+K    +L R F+S         E 
Sbjct: 19  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 74
Query: 320 EVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEK----WLYSHNYFLDI-----LE 370
            +L++++H N+I +L              F P  SLE+    +L +H    D+      +
Sbjct: 75  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 122
Query: 371 RLN------IMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG 424
           +L       ++  +   L+Y+H    S  IIH DLKP+N+ ++E+    + DFG+ +   
Sbjct: 123 KLTDDHVQFLIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 178
Query: 425 EGEDSVRQTMTMATIGYMAPEYGLEGI-VSAKCDVYSYGVLLMETFT 470
           +       T  +AT  Y APE  L  +  +   D++S G ++ E  T
Sbjct: 179 D-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 220

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 103/227 (45%), Gaps = 48/227 (21%)
Query: 267 IQRATDEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLERAFRSF------DSEC 319
           I    + +   + +G+ ++GSV        G  VA+K    +L R F+S         E 
Sbjct: 24  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 79
Query: 320 EVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEK----WLYSHNYFLDI-----LE 370
            +L++++H N+I +L              F P  SLE+    +L +H    D+      +
Sbjct: 80  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 127
Query: 371 RLN------IMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG 424
           +L       ++  +   L+Y+H    S  IIH DLKP+N+ ++E+    + DFG+ +   
Sbjct: 128 KLTDDHVQFLIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLAR--- 180
Query: 425 EGEDSVRQTMTMATIGYMAPEYGLEGI-VSAKCDVYSYGVLLMETFT 470
             +D +  T  +AT  Y APE  L  +  +   D++S G ++ E  T
Sbjct: 181 HTDDEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 225

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 101/227 (44%), Gaps = 48/227 (21%)
Query: 267 IQRATDEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLERAFRSF------DSEC 319
           I    + +   + +G+ ++GSV        G  VA+K    +L R F+S         E 
Sbjct: 36  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 91
Query: 320 EVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEK----WLYSHNYFLDI-----LE 370
            +L++++H N+I +L              F P  SLE+    +L +H    D+      +
Sbjct: 92  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 139
Query: 371 RLN------IMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG 424
           +L       ++  +   L+Y+H    S  IIH DLKP+N+ ++E+    + DFG+ +   
Sbjct: 140 KLTDDHVQFLIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 195
Query: 425 EGEDSVRQTMTMATIGYMAPEYGLEGI-VSAKCDVYSYGVLLMETFT 470
           +       T  +AT  Y APE  L  +  +   D++S G ++ E  T
Sbjct: 196 D-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 237

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 103/227 (45%), Gaps = 48/227 (21%)
Query: 267 IQRATDEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLERAFRSF------DSEC 319
           I    + +   + +G+ ++GSV        G  VA+K    +L R F+S         E 
Sbjct: 22  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 77
Query: 320 EVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEK----WLYSHNYFLDI-----LE 370
            +L++++H N+I +L              F P  SLE+    +L +H    D+      +
Sbjct: 78  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 125
Query: 371 RLN------IMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG 424
           +L       ++  +   L+Y+H    S  IIH DLKP+N+ ++E+    + DFG+ +   
Sbjct: 126 KLTDDHVQFLIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLAR--- 178
Query: 425 EGEDSVRQTMTMATIGYMAPEYGLEGI-VSAKCDVYSYGVLLMETFT 470
             +D +  T  +AT  Y APE  L  +  +   D++S G ++ E  T
Sbjct: 179 HTDDEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 223

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 103/227 (45%), Gaps = 48/227 (21%)
Query: 267 IQRATDEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLERAFRSF------DSEC 319
           I    + +   + +G+ ++GSV        G  VA+K    +L R F+S         E 
Sbjct: 16  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 71
Query: 320 EVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEK----WLYSHNYFLDI-----LE 370
            +L++++H N+I +L              F P  SLE+    +L +H    D+      +
Sbjct: 72  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 119
Query: 371 RLN------IMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG 424
           +L       ++  +   L+Y+H    S  IIH DLKP+N+ ++E+    + DFG+ +   
Sbjct: 120 KLTDDHVQFLIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLAR--- 172
Query: 425 EGEDSVRQTMTMATIGYMAPEYGLEGI-VSAKCDVYSYGVLLMETFT 470
             +D +  T  +AT  Y APE  L  +  +   D++S G ++ E  T
Sbjct: 173 HTDDEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 217

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 103/227 (45%), Gaps = 48/227 (21%)
Query: 267 IQRATDEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLERAFRSF------DSEC 319
           I    + +   + +G+ ++GSV        G  VA+K    +L R F+S         E 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 72
Query: 320 EVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEK----WLYSHNYFLDI-----LE 370
            +L++++H N+I +L              F P  SLE+    +L +H    D+      +
Sbjct: 73  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 371 RLN------IMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG 424
           +L       ++  +   L+Y+H    S  IIH DLKP+N+ ++E+    + DFG+ +   
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLAR--- 173
Query: 425 EGEDSVRQTMTMATIGYMAPEYGLEGI-VSAKCDVYSYGVLLMETFT 470
             +D +  T  +AT  Y APE  L  +  +   D++S G ++ E  T
Sbjct: 174 HTDDEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 92/217 (42%), Gaps = 22/217 (10%)
Query: 271 TDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAF---RSFDSECEVLRNVRH 327
            ++++    LG  ++G V +  ++  T+ A+ V  + ++RA     +   E  + + + H
Sbjct: 6   VEDWDLVQTLGEGAYGEV-QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 64
Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
            N++K        + + L LE+   G L           D +E  +I +    A  + H 
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGEL----------FDRIEP-DIGMPEPDAQRFFHQ 113
Query: 388 GHSSV------HIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGY 441
             + V       I H D+KP N+LLDE     +SDFG+  +               T+ Y
Sbjct: 114 LMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 442 MAPEYGLEGIVSAK-CDVYSYGVLLMETFTRKRPTDE 477
           +APE        A+  DV+S G++L      + P D+
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 103/227 (45%), Gaps = 48/227 (21%)
Query: 267 IQRATDEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLERAFRSF------DSEC 319
           I    + +   + +G+ ++GSV        G  VA+K    +L R F+S         E 
Sbjct: 23  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 78
Query: 320 EVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEK----WLYSHNYFLDI-----LE 370
            +L++++H N+I +L              F P  SLE+    +L +H    D+      +
Sbjct: 79  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 126
Query: 371 RLN------IMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG 424
           +L       ++  +   L+Y+H    S  IIH DLKP+N+ ++E+    + DFG+ +   
Sbjct: 127 KLTDDHVQFLIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDSELKILDFGLAR--- 179
Query: 425 EGEDSVRQTMTMATIGYMAPEYGLEGI-VSAKCDVYSYGVLLMETFT 470
             +D +  T  +AT  Y APE  L  +  +   D++S G ++ E  T
Sbjct: 180 HTDDEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 224

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 92/217 (42%), Gaps = 22/217 (10%)
Query: 271 TDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAF---RSFDSECEVLRNVRH 327
            ++++    LG  ++G V +  ++  T+ A+ V  + ++RA     +   E  + + + H
Sbjct: 5   VEDWDLVQTLGEGAYGEV-QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 63
Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
            N++K        + + L LE+   G L           D +E  +I +    A  + H 
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGEL----------FDRIEP-DIGMPEPDAQRFFHQ 112
Query: 388 GHSSV------HIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGY 441
             + V       I H D+KP N+LLDE     +SDFG+  +               T+ Y
Sbjct: 113 LMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 442 MAPEYGLEGIVSAK-CDVYSYGVLLMETFTRKRPTDE 477
           +APE        A+  DV+S G++L      + P D+
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 101/227 (44%), Gaps = 48/227 (21%)
Query: 267 IQRATDEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLERAFRSF------DSEC 319
           I    + +   + +G+ ++GSV        G  VA+K    +L R F+S         E 
Sbjct: 19  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 74
Query: 320 EVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEK----WLYSHNYFLDI-----LE 370
            +L++++H N+I +L              F P  SLE+    +L +H    D+      +
Sbjct: 75  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 122
Query: 371 RLN------IMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG 424
           +L       ++  +   L+Y+H    S  IIH DLKP+N+ ++E+    + DFG+ +   
Sbjct: 123 KLTDDHVQFLIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDSELKILDFGLARHTD 178
Query: 425 EGEDSVRQTMTMATIGYMAPEYGLEGI-VSAKCDVYSYGVLLMETFT 470
           +       T  +AT  Y APE  L  +  +   D++S G ++ E  T
Sbjct: 179 D-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 220

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 92/217 (42%), Gaps = 22/217 (10%)
Query: 271 TDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAF---RSFDSECEVLRNVRH 327
            ++++    LG  ++G V +  ++  T+ A+ V  + ++RA     +   E  + + + H
Sbjct: 6   VEDWDLVQTLGEGAYGEV-QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 64
Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
            N++K        + + L LE+   G L           D +E  +I +    A  + H 
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGEL----------FDRIEP-DIGMPEPDAQRFFHQ 113
Query: 388 GHSSV------HIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGY 441
             + V       I H D+KP N+LLDE     +SDFG+  +               T+ Y
Sbjct: 114 LMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 442 MAPEYGLEGIVSAK-CDVYSYGVLLMETFTRKRPTDE 477
           +APE        A+  DV+S G++L      + P D+
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 101/227 (44%), Gaps = 48/227 (21%)
Query: 267 IQRATDEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLERAFRSF------DSEC 319
           I    + +   + +G+ ++GSV        G  VA+K    +L R F+S         E 
Sbjct: 36  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK----KLSRPFQSIIHAKRTYREL 91
Query: 320 EVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEK----WLYSHNYFLDI-----LE 370
            +L++++H N+I +L              F P  SLE+    +L +H    D+      +
Sbjct: 92  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 139
Query: 371 RLN------IMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG 424
           +L       ++  +   L+Y+H    S  IIH DLKP+N+ ++E+    + DFG+ +   
Sbjct: 140 KLTDDHVQFLIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 195
Query: 425 EGEDSVRQTMTMATIGYMAPEYGLEGI-VSAKCDVYSYGVLLMETFT 470
           +       T  +AT  Y APE  L  +  +   D++S G ++ E  T
Sbjct: 196 D-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 237

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 73/303 (24%), Positives = 121/303 (39%), Gaps = 36/303 (11%)
Query: 272 DEFNECNLLGTSSFGSVYK-GTISDGTDVAIKVFNLQLERAFR------SFDSECEVLRN 324
           D ++    LG+  F  V K    S G   A K    +  ++ R        + E  +L+ 
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 325 VRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEY 384
           ++H N+I +   Y N     L+LE +  G L  +L +    L   E    +  + + + Y
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYY 128
Query: 385 LHNGHSSVHIIHCDLKPTNI-LLDENMVA---HVSDFGIYKLLGEGEDSVRQTMTMATIG 440
           LH    S+ I H DLKP NI LLD N+      + DFG+   +  G +         T  
Sbjct: 129 LH----SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPE 181
Query: 441 YMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEV 500
           ++APE      +  + D++S GV+     +   P    F+G+              L  V
Sbjct: 182 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASP----FLGDTK---------QETLANV 228
Query: 501 VDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKFLDDAAA 560
              N   E++ FS   +      DF     ++ P  R+ + D + +   IK K    A +
Sbjct: 229 SAVNYEFEDEYFS---NTSALAKDFIRRLLVKDPKKRMTIQD-SLQHPWIKPKDTQQALS 284
Query: 561 TNW 563
           + W
Sbjct: 285 SAW 287

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 101/227 (44%), Gaps = 48/227 (21%)
Query: 267 IQRATDEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLERAFRSF------DSEC 319
           I    + +   + +G+ ++GSV        G  VA+K    +L R F+S         E 
Sbjct: 37  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK----KLSRPFQSIIHAKRTYREL 92
Query: 320 EVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEK----WLYSHNYFLDI-----LE 370
            +L++++H N+I +L              F P  SLE+    +L +H    D+      +
Sbjct: 93  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 140
Query: 371 RLN------IMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG 424
           +L       ++  +   L+Y+H    S  IIH DLKP+N+ ++E+    + DFG+ +   
Sbjct: 141 KLTDDHVQFLIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 196
Query: 425 EGEDSVRQTMTMATIGYMAPEYGLEGI-VSAKCDVYSYGVLLMETFT 470
           +       T  +AT  Y APE  L  +  +   D++S G ++ E  T
Sbjct: 197 D-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 238

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 101/227 (44%), Gaps = 48/227 (21%)
Query: 267 IQRATDEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLERAFRSF------DSEC 319
           I    + +   + +G+ ++GSV        G  VA+K    +L R F+S         E 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK----KLSRPFQSIIHAKRTYREL 72
Query: 320 EVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEK----WLYSHNYFLDI-----LE 370
            +L++++H N+I +L              F P  SLE+    +L +H    D+      +
Sbjct: 73  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 371 RLN------IMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG 424
           +L       ++  +   L+Y+H    S  IIH DLKP+N+ ++E+    + DFG+ +   
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 176
Query: 425 EGEDSVRQTMTMATIGYMAPEYGLEGI-VSAKCDVYSYGVLLMETFT 470
           +       T  +AT  Y APE  L  +  +   D++S G ++ E  T
Sbjct: 177 D-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 92/217 (42%), Gaps = 22/217 (10%)
Query: 271 TDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAF---RSFDSECEVLRNVRH 327
            ++++    LG  ++G V +  ++  T+ A+ V  + ++RA     +   E  + + + H
Sbjct: 6   VEDWDLVQTLGEGAYGEV-QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 64
Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
            N++K        + + L LE+   G L           D +E  +I +    A  + H 
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGEL----------FDRIEP-DIGMPEPDAQRFFHQ 113
Query: 388 GHSSV------HIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGY 441
             + V       I H D+KP N+LLDE     +SDFG+  +               T+ Y
Sbjct: 114 LMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 442 MAPEYGLEGIVSAK-CDVYSYGVLLMETFTRKRPTDE 477
           +APE        A+  DV+S G++L      + P D+
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 92/217 (42%), Gaps = 22/217 (10%)
Query: 271 TDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAF---RSFDSECEVLRNVRH 327
            ++++    LG  ++G V +  ++  T+ A+ V  + ++RA     +   E  + + + H
Sbjct: 6   VEDWDLVQTLGEGAYGEV-QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 64
Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
            N++K        + + L LE+   G L           D +E  +I +    A  + H 
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGEL----------FDRIEP-DIGMPEPDAQRFFHQ 113
Query: 388 GHSSV------HIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGY 441
             + V       I H D+KP N+LLDE     +SDFG+  +               T+ Y
Sbjct: 114 LMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 442 MAPEYGLEGIVSAK-CDVYSYGVLLMETFTRKRPTDE 477
           +APE        A+  DV+S G++L      + P D+
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 73/303 (24%), Positives = 121/303 (39%), Gaps = 36/303 (11%)
Query: 272 DEFNECNLLGTSSFGSVYK-GTISDGTDVAIKVFNLQLERAFR------SFDSECEVLRN 324
           D ++    LG+  F  V K    S G   A K    +  ++ R        + E  +L+ 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 325 VRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEY 384
           ++H N+I +   Y N     L+LE +  G L  +L +    L   E    +  + + + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYY 129
Query: 385 LHNGHSSVHIIHCDLKPTNI-LLDENMVA---HVSDFGIYKLLGEGEDSVRQTMTMATIG 440
           LH    S+ I H DLKP NI LLD N+      + DFG+   +  G +         T  
Sbjct: 130 LH----SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPE 182
Query: 441 YMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEV 500
           ++APE      +  + D++S GV+     +   P    F+G+              L  V
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASP----FLGDTK---------QETLANV 229
Query: 501 VDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKFLDDAAA 560
              N   E++ FS   +      DF     ++ P  R+ + D + +   IK K    A +
Sbjct: 230 SAVNYEFEDEYFS---NTSALAKDFIRRLLVKDPKKRMTIQD-SLQHPWIKPKDTQQALS 285
Query: 561 TNW 563
           + W
Sbjct: 286 SAW 288

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 92/217 (42%), Gaps = 22/217 (10%)
Query: 271 TDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAF---RSFDSECEVLRNVRH 327
            ++++    LG  ++G V +  ++  T+ A+ V  + ++RA     +   E  + + + H
Sbjct: 6   VEDWDLVQTLGEGAYGEV-QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 64
Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
            N++K        + + L LE+   G L           D +E  +I +    A  + H 
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGEL----------FDRIEP-DIGMPEPDAQRFFHQ 113
Query: 388 GHSSV------HIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGY 441
             + V       I H D+KP N+LLDE     +SDFG+  +               T+ Y
Sbjct: 114 LMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 442 MAPEYGLEGIVSAK-CDVYSYGVLLMETFTRKRPTDE 477
           +APE        A+  DV+S G++L      + P D+
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 66/256 (25%), Positives = 103/256 (40%), Gaps = 22/256 (8%)
Query: 239 RCRNRNTKKSDHEDFLPLAIWRRTSYL---DIQRATDEFNECNLLGTSSFGSVYK-GTIS 294
           R R  + K  D+E  L     +   Y    ++  AT +      LG  SFG V++     
Sbjct: 61  RSREPSPKTEDNEGVLLTEKLKPVDYEYREEVHWATHQLR----LGRGSFGEVHRMEDKQ 116
Query: 295 DGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGS 354
            G   A+K   L++ RA       C  L + R   ++ +  +     +  + +E +  GS
Sbjct: 117 TGFQCAVKKVRLEVFRAEELM--ACAGLTSPR---IVPLYGAVREGPWVNIFMELLEGGS 171
Query: 355 LEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLD-ENMVAH 413
           L + L      L     L  +      LEYLH    S  I+H D+K  N+LL  +   A 
Sbjct: 172 LGQ-LVKEQGCLPEDRALYYLGQALEGLEYLH----SRRILHGDVKADNVLLSSDGSHAA 226
Query: 414 VSDFGIYKLL---GEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
           + DFG    L   G G+  +       T  +MAPE  L     AK DV+S   +++    
Sbjct: 227 LCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLN 286
Query: 471 RKRPTDEMFIGEMSLR 486
              P  + F G + L+
Sbjct: 287 GCHPWTQFFRGPLCLK 302

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 103/227 (45%), Gaps = 48/227 (21%)
Query: 267 IQRATDEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLERAFRSF------DSEC 319
           I    + +   + +G+ ++GSV        G  VA+K    +L R F+S         E 
Sbjct: 23  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 78
Query: 320 EVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEK----WLYSHNYFLDI-----LE 370
            +L++++H N+I +L              F P  SLE+    +L +H    D+      +
Sbjct: 79  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 126
Query: 371 RLN------IMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG 424
           +L       ++  +   L+Y+H    S  IIH DLKP+N+ ++E+    + DFG+ +   
Sbjct: 127 KLTDDHVQFLIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLAR--- 179
Query: 425 EGEDSVRQTMTMATIGYMAPEYGLEGI-VSAKCDVYSYGVLLMETFT 470
             +D +  T  +AT  Y APE  L  +  +   D++S G ++ E  T
Sbjct: 180 HTDDEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 224

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 101/227 (44%), Gaps = 48/227 (21%)
Query: 267 IQRATDEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLERAFRSF------DSEC 319
           I    + +   + +G+ ++GSV        G  VA+K    +L R F+S         E 
Sbjct: 19  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 74
Query: 320 EVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEK----WLYSHNYFLDI-----LE 370
            +L++++H N+I +L              F P  SLE+    +L +H    D+      +
Sbjct: 75  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 122
Query: 371 RLN------IMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG 424
           +L       ++  +   L+Y+H    S  IIH DLKP+N+ ++E+    + DFG+ +   
Sbjct: 123 KLTDDHVQFLIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 178
Query: 425 EGEDSVRQTMTMATIGYMAPEYGLEGI-VSAKCDVYSYGVLLMETFT 470
           +       T  +AT  Y APE  L  +  +   D++S G ++ E  T
Sbjct: 179 D-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 220

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 100/214 (46%), Gaps = 32/214 (14%)
Query: 274 FNECNLLGTSSFGSVYKGTIS-DGTDVAIKV----FNLQL--ERAFRSFDSECEVLRNVR 326
           + +   +G+ ++G+V        G  VAIK     F  +L  +RA+R    E  +L+++R
Sbjct: 27  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR----ELRLLKHMR 82
Query: 327 HRNLIKILSSYSNP----DFKA--LVLEFMPNGSLEKWLYSHNYFLDILERLNIMI-DVG 379
           H N+I +L  ++      DF    LV+ FM  G+    L  H    +  +R+  ++  + 
Sbjct: 83  HENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGE--DRIQFLVYQML 138
Query: 380 SALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATI 439
             L Y+H    +  IIH DLKP N+ ++E+    + DFG    L    DS      + T 
Sbjct: 139 KGLRYIH----AAGIIHRDLKPGNLAVNEDCELKILDFG----LARQADS-EMXGXVVTR 189
Query: 440 GYMAPEYGLEGI-VSAKCDVYSYGVLLMETFTRK 472
            Y APE  L  +  +   D++S G ++ E  T K
Sbjct: 190 WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 73/303 (24%), Positives = 121/303 (39%), Gaps = 36/303 (11%)
Query: 272 DEFNECNLLGTSSFGSVYK-GTISDGTDVAIKVFNLQLERAFR------SFDSECEVLRN 324
           D ++    LG+  F  V K    S G   A K    +  ++ R        + E  +L+ 
Sbjct: 11  DYYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 325 VRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEY 384
           ++H N+I +   Y N     L+LE +  G L  +L +    L   E    +  + + + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYY 129
Query: 385 LHNGHSSVHIIHCDLKPTNI-LLDENMVA---HVSDFGIYKLLGEGEDSVRQTMTMATIG 440
           LH    S+ I H DLKP NI LLD N+      + DFG+   +  G +         T  
Sbjct: 130 LH----SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPE 182
Query: 441 YMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEV 500
           ++APE      +  + D++S GV+     +   P    F+G+              L  V
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASP----FLGDTK---------QETLANV 229
Query: 501 VDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKFLDDAAA 560
              N   E++ FS   +      DF     ++ P  R+ + D + +   IK K    A +
Sbjct: 230 SAVNYEFEDEYFS---NTSALAKDFIRRLLVKDPKKRMTIQD-SLQHPWIKPKDTQQALS 285
Query: 561 TNW 563
           + W
Sbjct: 286 SAW 288

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 92/217 (42%), Gaps = 22/217 (10%)
Query: 271 TDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAF---RSFDSECEVLRNVRH 327
            ++++    LG  ++G V +  ++  T+ A+ V  + ++RA     +   E  + + + H
Sbjct: 5   VEDWDLVQTLGEGAYGEV-QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 63
Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
            N++K        + + L LE+   G L           D +E  +I +    A  + H 
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGEL----------FDRIEP-DIGMPEPDAQRFFHQ 112
Query: 388 GHSSV------HIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGY 441
             + V       I H D+KP N+LLDE     +SDFG+  +               T+ Y
Sbjct: 113 LMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 442 MAPEYGLEGIVSAK-CDVYSYGVLLMETFTRKRPTDE 477
           +APE        A+  DV+S G++L      + P D+
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 92/217 (42%), Gaps = 22/217 (10%)
Query: 271 TDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAF---RSFDSECEVLRNVRH 327
            ++++    LG  ++G V +  ++  T+ A+ V  + ++RA     +   E  + + + H
Sbjct: 6   VEDWDLVQTLGEGAYGEV-QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 64
Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
            N++K        + + L LE+   G L           D +E  +I +    A  + H 
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGEL----------FDRIEP-DIGMPEPDAQRFFHQ 113
Query: 388 GHSSV------HIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGY 441
             + V       I H D+KP N+LLDE     +SDFG+  +               T+ Y
Sbjct: 114 LMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 442 MAPEYGLEGIVSAK-CDVYSYGVLLMETFTRKRPTDE 477
           +APE        A+  DV+S G++L      + P D+
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 103/227 (45%), Gaps = 48/227 (21%)
Query: 267 IQRATDEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLERAFRSF------DSEC 319
           I    + +   + +G+ ++GSV        G  VA+K    +L R F+S         E 
Sbjct: 23  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 78
Query: 320 EVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEK----WLYSHNYFLDI-----LE 370
            +L++++H N+I +L              F P  SLE+    +L +H    D+      +
Sbjct: 79  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 126
Query: 371 RLN------IMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG 424
           +L       ++  +   L+Y+H    S  IIH DLKP+N+ ++E+    + DFG+ +   
Sbjct: 127 KLTDDHVQFLIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLAR--- 179
Query: 425 EGEDSVRQTMTMATIGYMAPEYGLEGI-VSAKCDVYSYGVLLMETFT 470
             +D +  T  +AT  Y APE  L  +  +   D++S G ++ E  T
Sbjct: 180 HTDDEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 224

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 78/331 (23%), Positives = 128/331 (38%), Gaps = 53/331 (16%)
Query: 272 DEFNECNLLGTSSFGSVYK-GTISDGTDVAIKVFNLQLERAFR------SFDSECEVLRN 324
           D ++    LG+  F  V K    S G   A K    +  ++ R        + E  +L+ 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 325 VRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEY 384
           ++H N+I +   Y N     L+LE +  G L  +L +    L   E    +  + + + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYY 129
Query: 385 LHNGHSSVHIIHCDLKPTNI-LLDENMVA---HVSDFGIYKLLGEGEDSVRQTMTMATIG 440
           LH    S+ I H DLKP NI LLD N+      + DFG+   +  G +         T  
Sbjct: 130 LH----SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPE 182
Query: 441 YMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEV 500
           ++APE      +  + D++S GV+     +   P    F+G+              L  V
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASP----FLGDTK---------QETLANV 229
Query: 501 VDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAA----KLKKIKVKFLD 556
              N   E++ FS   +      DF     ++ P  R+ + D+      K K  +     
Sbjct: 230 SAVNYEFEDEYFS---NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSR 286
Query: 557 DAAATN------------WRNFHCVSLLTLC 575
            A+A N            W+    V L++LC
Sbjct: 287 KASAVNMEKFKKFAARKKWK--QSVRLISLC 315

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 101/227 (44%), Gaps = 48/227 (21%)
Query: 267 IQRATDEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLERAFRSF------DSEC 319
           I    + +   + +G+ ++GSV        G  VA+K    +L R F+S         E 
Sbjct: 23  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK----KLSRPFQSIIHAKRTYREL 78
Query: 320 EVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEK----WLYSHNYFLDI-----LE 370
            +L++++H N+I +L              F P  SLE+    +L +H    D+      +
Sbjct: 79  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 126
Query: 371 RLN------IMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG 424
           +L       ++  +   L+Y+H    S  IIH DLKP+N+ ++E+    + DFG+ +   
Sbjct: 127 KLTDDHVQFLIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 182
Query: 425 EGEDSVRQTMTMATIGYMAPEYGLEGI-VSAKCDVYSYGVLLMETFT 470
           +       T  +AT  Y APE  L  +  +   D++S G ++ E  T
Sbjct: 183 D-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 224

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 77/174 (44%), Gaps = 32/174 (18%)
Query: 317 SECEVLRNVRHRNLIKILSSYSNPDFKAL--VLEFMPNGSLE----------KWLYSHNY 364
            E ++LR +RH+N+I+++    N + + +  V+E+   G  E              +H Y
Sbjct: 55  KEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGY 114
Query: 365 FLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG 424
           F  +++           LEYLH    S  I+H D+KP N+LL       +S  G+ + L 
Sbjct: 115 FCQLID----------GLEYLH----SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALH 160
Query: 425 --EGEDSVRQTMTMATIGYMAPEY--GLEGIVSAKCDVYSYGVLLMETFTRKRP 474
               +D+ R   +  +  +  PE   GL+     K D++S GV L    T   P
Sbjct: 161 PFAADDTCR--TSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 74/310 (23%), Positives = 121/310 (39%), Gaps = 39/310 (12%)
Query: 272 DEFNECNLLGTSSFGSVYK-GTISDGTDVAIKVFNLQLERAFR------SFDSECEVLRN 324
           D ++    LG+  F  V K    S G   A K    +  ++ R        + E  +L+ 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 325 VRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEY 384
           ++H N+I +   Y N     L+LE +  G L  +L +    L   E    +  + + + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYY 129
Query: 385 LHNGHSSVHIIHCDLKPTNI-LLDENMVA---HVSDFGIYKLLGEGEDSVRQTMTMATIG 440
           LH    S+ I H DLKP NI LLD N+      + DFG+   +  G +         T  
Sbjct: 130 LH----SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPE 182
Query: 441 YMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEV 500
           ++APE      +  + D++S GV+     +   P    F+G+              L  V
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASP----FLGDTK---------QETLANV 229
Query: 501 VDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAA----KLKKIKVKFLD 556
              N   E++ FS   +      DF     ++ P  R+ + D+      K K  +     
Sbjct: 230 SAVNYEFEDEYFS---NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSR 286
Query: 557 DAAATNWRNF 566
            A+A N   F
Sbjct: 287 KASAVNMEKF 296

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 68/283 (24%), Positives = 113/283 (39%), Gaps = 35/283 (12%)
Query: 272 DEFNECNLLGTSSFGSVYK-GTISDGTDVAIKVFNLQLERAFR------SFDSECEVLRN 324
           D ++    LG+  F  V K    S G   A K    +  ++ R        + E  +L+ 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 325 VRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEY 384
           ++H N+I +   Y N     L+LE +  G L  +L +    L   E    +  + + + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYY 129
Query: 385 LHNGHSSVHIIHCDLKPTNI-LLDENMVA---HVSDFGIYKLLGEGEDSVRQTMTMATIG 440
           LH    S+ I H DLKP NI LLD N+      + DFG+   +  G +         T  
Sbjct: 130 LH----SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPE 182
Query: 441 YMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEV 500
           ++APE      +  + D++S GV+     +   P    F+G+              L  V
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASP----FLGDTK---------QETLANV 229
Query: 501 VDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDA 543
              N   E++ FS   +      DF     ++ P  R+ + D+
Sbjct: 230 SAVNYEFEDEYFS---NTSALAKDFIRRLLVKDPKKRMTIQDS 269

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 101/227 (44%), Gaps = 48/227 (21%)
Query: 267 IQRATDEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFN------LQLERAFRSFDSEC 319
           I    + +   + +G+ ++GSV        G  VA+K  +      +  +R +R    E 
Sbjct: 29  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYR----EL 84
Query: 320 EVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEK----WLYSHNYFLDI-----LE 370
            +L++++H N+I +L              F P  SLE+    +L +H    D+      +
Sbjct: 85  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 132
Query: 371 RLN------IMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG 424
           +L       ++  +   L+Y+H    S  IIH DLKP+N+ ++E+    + DFG+ +   
Sbjct: 133 KLTDDHVQFLIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 188
Query: 425 EGEDSVRQTMTMATIGYMAPEYGLEGI-VSAKCDVYSYGVLLMETFT 470
           +       T  +AT  Y APE  L  +  +   D++S G ++ E  T
Sbjct: 189 D-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 230

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 100/227 (44%), Gaps = 48/227 (21%)
Query: 267 IQRATDEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLERAFRSF------DSEC 319
           I    + +     +G+ ++GSV        G  VA+K    +L R F+S         E 
Sbjct: 27  IWEVPERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVK----KLSRPFQSIIHAKRTYREL 82
Query: 320 EVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEK----WLYSHNYFLDI-----LE 370
            +L++++H N+I +L              F P  SLE+    +L +H    D+      +
Sbjct: 83  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 130
Query: 371 RLN------IMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG 424
           +L       ++  +   L+Y+H    S  IIH DLKP+N+ ++E+    + DFG+ +   
Sbjct: 131 KLTDDHVQFLIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 186
Query: 425 EGEDSVRQTMTMATIGYMAPEYGLEGI-VSAKCDVYSYGVLLMETFT 470
           +       T  +AT  Y APE  L  +  +   D++S G ++ E  T
Sbjct: 187 D-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 228

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 101/227 (44%), Gaps = 48/227 (21%)
Query: 267 IQRATDEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLERAFRSF------DSEC 319
           I    + +   + +G+ ++GSV        G  VA+K    +L R F+S         E 
Sbjct: 13  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK----KLSRPFQSIIHAKRTYREL 68
Query: 320 EVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEK----WLYSHNYFLDILERLN-- 373
            +L++++H N+I +L              F P  SLE+    +L +H    D+   +   
Sbjct: 69  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCA 116
Query: 374 ---------IMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG 424
                    ++  +   L+Y+H    S  IIH DLKP+N+ ++E+    + DFG+ +   
Sbjct: 117 KLTDDHVQFLIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLAR--- 169
Query: 425 EGEDSVRQTMTMATIGYMAPEYGLEGI-VSAKCDVYSYGVLLMETFT 470
             +D +  T  +AT  Y APE  L  +  +   D++S G ++ E  T
Sbjct: 170 HTDDEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 214

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 101/227 (44%), Gaps = 48/227 (21%)
Query: 267 IQRATDEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLERAFRSF------DSEC 319
           I    + +   + +G+ ++GSV        G  VA+K    +L R F+S         E 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 72
Query: 320 EVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEK----WLYSHNYFLDI-----LE 370
            +L++++H N+I +L              F P  SLE+    +L +H    D+      +
Sbjct: 73  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKSQ 120
Query: 371 RLN------IMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG 424
           +L       ++  +   L+Y+H    S  IIH DLKP+N+ ++E+    + DFG+ +   
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDSELKILDFGLCRHTD 176
Query: 425 EGEDSVRQTMTMATIGYMAPEYGLEGI-VSAKCDVYSYGVLLMETFT 470
           +       T  +AT  Y APE  L  +  +   D++S G ++ E  T
Sbjct: 177 D-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 68/287 (23%), Positives = 114/287 (39%), Gaps = 35/287 (12%)
Query: 268 QRATDEFNECNLLGTSSFGSVYK-GTISDGTDVAIKVFNLQLERAFR------SFDSECE 320
           +   D ++    LG+  F  V K    S G   A K    +  ++ R        + E  
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 321 VLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGS 380
           +L+ ++H N+I +   Y N     L+LE +  G L  +L +    L   E    +  + +
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILN 125
Query: 381 ALEYLHNGHSSVHIIHCDLKPTNI-LLDENMVA---HVSDFGIYKLLGEGEDSVRQTMTM 436
            + YLH    S+ I H DLKP NI LLD N+      + DFG+   +  G +        
Sbjct: 126 GVYYLH----SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIF 178
Query: 437 ATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHG 496
            T  ++APE      +  + D++S GV+     +   P    F+G+              
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP----FLGDTK---------QET 225
Query: 497 LTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDA 543
           L  V   N   E++ FS   +      DF     ++ P  R+ + D+
Sbjct: 226 LANVSAVNYEFEDEYFS---NTSALAKDFIRRLLVKDPKKRMTIQDS 269

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 68/287 (23%), Positives = 114/287 (39%), Gaps = 35/287 (12%)
Query: 268 QRATDEFNECNLLGTSSFGSVYK-GTISDGTDVAIKVFNLQLERAFR------SFDSECE 320
           +   D ++    LG+  F  V K    S G   A K    +  ++ R        + E  
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 321 VLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGS 380
           +L+ ++H N+I +   Y N     L+LE +  G L  +L +    L   E    +  + +
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILN 125
Query: 381 ALEYLHNGHSSVHIIHCDLKPTNI-LLDENMVA---HVSDFGIYKLLGEGEDSVRQTMTM 436
            + YLH    S+ I H DLKP NI LLD N+      + DFG+   +  G +        
Sbjct: 126 GVYYLH----SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIF 178
Query: 437 ATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHG 496
            T  ++APE      +  + D++S GV+     +   P    F+G+              
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP----FLGDTK---------QET 225
Query: 497 LTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDA 543
           L  V   N   E++ FS   +      DF     ++ P  R+ + D+
Sbjct: 226 LANVSAVNYEFEDEYFS---NTSALAKDFIRRLLVKDPKKRMTIQDS 269

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 73/303 (24%), Positives = 121/303 (39%), Gaps = 36/303 (11%)
Query: 272 DEFNECNLLGTSSFGSVYK-GTISDGTDVAIKVFNLQLERAFR------SFDSECEVLRN 324
           D ++    LG+  F  V K    S G   A K    +  ++ R        + E  +L+ 
Sbjct: 11  DYYDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 325 VRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEY 384
           ++H N+I +   Y N     L+LE +  G L  +L +    L   E    +  + + + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYY 129
Query: 385 LHNGHSSVHIIHCDLKPTNI-LLDENMVA---HVSDFGIYKLLGEGEDSVRQTMTMATIG 440
           LH    S+ I H DLKP NI LLD N+      + DFG+   +  G +         T  
Sbjct: 130 LH----SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPE 182
Query: 441 YMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEV 500
           ++APE      +  + D++S GV+     +   P    F+G+              L  V
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASP----FLGDTK---------QETLANV 229
Query: 501 VDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKFLDDAAA 560
              N   E++ FS   +      DF     ++ P  R+ + D + +   IK K    A +
Sbjct: 230 SAVNYEFEDEYFS---NTSALAKDFIRRLLVKDPKKRMTIQD-SLQHPWIKPKDTQQALS 285
Query: 561 TNW 563
           + W
Sbjct: 286 SAW 288

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/192 (22%), Positives = 89/192 (46%), Gaps = 13/192 (6%)
Query: 280 LGTSSFGSVYKGT-ISDGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSS 336
           LG  +F  V +   +  G + A K+ N +    R  +  + E  + R ++H N++++  S
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 89
Query: 337 YSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIH 396
            S      L+ + +  G L + + +  Y+ +  +  + +  +  A+ + H     + ++H
Sbjct: 90  ISEEGHHYLIFDLVTGGELFEDIVAREYYSEA-DASHCIQQILEAVLHCHQ----MGVVH 144
Query: 397 CDLKPTNILLDENM---VAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVS 453
            DLKP N+LL   +      ++DFG+  +  EGE          T GY++PE   +    
Sbjct: 145 RDLKPENLLLASKLKGAAVKLADFGL-AIEVEGEQQAWFGFA-GTPGYLSPEVLRKDPYG 202
Query: 454 AKCDVYSYGVLL 465
              D+++ GV+L
Sbjct: 203 KPVDLWACGVIL 214

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 68/287 (23%), Positives = 114/287 (39%), Gaps = 35/287 (12%)
Query: 268 QRATDEFNECNLLGTSSFGSVYK-GTISDGTDVAIKVFNLQLERAFR------SFDSECE 320
           +   D ++    LG+  F  V K    S G   A K    +  ++ R        + E  
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 321 VLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGS 380
           +L+ ++H N+I +   Y N     L+LE +  G L  +L +    L   E    +  + +
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILN 125
Query: 381 ALEYLHNGHSSVHIIHCDLKPTNI-LLDENMVA---HVSDFGIYKLLGEGEDSVRQTMTM 436
            + YLH    S+ I H DLKP NI LLD N+      + DFG+   +  G +        
Sbjct: 126 GVYYLH----SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIF 178
Query: 437 ATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHG 496
            T  ++APE      +  + D++S GV+     +   P    F+G+              
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP----FLGDTK---------QET 225
Query: 497 LTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDA 543
           L  V   N   E++ FS   +      DF     ++ P  R+ + D+
Sbjct: 226 LANVSAVNYEFEDEYFS---NTSALAKDFIRRLLVKDPKKRMTIQDS 269

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 68/287 (23%), Positives = 114/287 (39%), Gaps = 35/287 (12%)
Query: 268 QRATDEFNECNLLGTSSFGSVYK-GTISDGTDVAIKVFNLQLERAFR------SFDSECE 320
           +   D ++    LG+  F  V K    S G   A K    +  ++ R        + E  
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 321 VLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGS 380
           +L+ ++H N+I +   Y N     L+LE +  G L  +L +    L   E    +  + +
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILN 125
Query: 381 ALEYLHNGHSSVHIIHCDLKPTNI-LLDENMVA---HVSDFGIYKLLGEGEDSVRQTMTM 436
            + YLH    S+ I H DLKP NI LLD N+      + DFG+   +  G +        
Sbjct: 126 GVYYLH----SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIF 178
Query: 437 ATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHG 496
            T  ++APE      +  + D++S GV+     +   P    F+G+              
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP----FLGDTK---------QET 225
Query: 497 LTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDA 543
           L  V   N   E++ FS   +      DF     ++ P  R+ + D+
Sbjct: 226 LANVSAVNYEFEDEYFS---NTSALAKDFIRRLLVKDPKKRMTIQDS 269

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 78/162 (48%), Gaps = 29/162 (17%)
Query: 317 SECEVLRNVRHRNLIKILSSYSNP--DFKALVLEFMPNGSLEKWL--------YSHNYFL 366
            E  +L+ + H N++K++    +P  D   +V E +  G + +           +  YF 
Sbjct: 85  QEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQ 144
Query: 367 DILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG 426
           D+++           +EYLH       IIH D+KP+N+L+ E+    ++DFG+     +G
Sbjct: 145 DLIK----------GIEYLHYQK----IIHRDIKPSNLLVGEDGHIKIADFGVSNEF-KG 189
Query: 427 EDSVRQTMTMATIGYMAPEYGLE--GIVSAKC-DVYSYGVLL 465
            D++    T+ T  +MAPE   E   I S K  DV++ GV L
Sbjct: 190 SDALLSN-TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 92/208 (44%), Gaps = 30/208 (14%)
Query: 278 NLLGTSSFGSVYKGTIS--DGTDVAIKVFNLQLERAFRSFDSECEVLRNVR-HRNLIKIL 334
            LLG  ++  V +G +S  +G + A+K+   Q   +      E E L   + ++N+++++
Sbjct: 19  ELLGEGAYAKV-QGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELI 77
Query: 335 SSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHI 394
             + +     LV E +  GS+   +    +F +  E   ++ DV +AL++LH    +  I
Sbjct: 78  EFFEDDTRFYLVFEKLQGGSILAHIQKQKHF-NEREASRVVRDVAAALDFLH----TKGI 132
Query: 395 IHCDLKPTNILL---DENMVAHVSDFGIYKLLGEGED---------SVRQTMTMATIGYM 442
            H DLKP NIL    ++     + DF     LG G           +   T    +  YM
Sbjct: 133 AHRDLKPENILCESPEKVSPVKICDFD----LGSGMKLNNSCTPITTPELTTPCGSAEYM 188
Query: 443 APEY-----GLEGIVSAKCDVYSYGVLL 465
           APE              +CD++S GV+L
Sbjct: 189 APEVVEVFTDQATFYDKRCDLWSLGVVL 216

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 96/215 (44%), Gaps = 20/215 (9%)
Query: 270 ATDEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQ--LERAFRSFDSECEVLRNVR 326
           AT  +     +G  ++G+VYK      G  VA+K   +    E    S   E  +LR + 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 327 ---HRNLIKIL----SSYSNPDFK-ALVLEFMPNGSLEKWL-YSHNYFLDILERLNIMID 377
              H N+++++    +S ++ + K  LV E + +  L  +L  +    L      ++M  
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 378 VGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMA 437
               L++LH       I+H DLKP NIL+       ++DFG+ ++       +     + 
Sbjct: 121 FLRGLDFLHANC----IVHRDLKPENILVTSGGTVKLADFGLARIYSY---QMALAPVVV 173
Query: 438 TIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRK 472
           T+ Y APE  L+   +   D++S G +  E F RK
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/203 (22%), Positives = 93/203 (45%), Gaps = 13/203 (6%)
Query: 269 RATDEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQL--ERAFRSFDSECEVLRNV 325
           R T+E+     LG  +F  V +   +  G + A  + N +    R  +  + E  + R +
Sbjct: 8   RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL 67
Query: 326 RHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYL 385
           +H N++++  S S      L+ + +  G L + + +  Y+ +  +  + +  +  A+ + 
Sbjct: 68  KHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEA-DASHCIQQILEAVLHC 126
Query: 386 HNGHSSVHIIHCDLKPTNILLDENM---VAHVSDFGIYKLLGEGEDSVRQTMTMATIGYM 442
           H     + ++H +LKP N+LL   +      ++DFG+  +  EGE          T GY+
Sbjct: 127 HQ----MGVVHRNLKPENLLLASKLKGAAVKLADFGL-AIEVEGEQQAWFGFA-GTPGYL 180
Query: 443 APEYGLEGIVSAKCDVYSYGVLL 465
           +PE   +       D+++ GV+L
Sbjct: 181 SPEVLRKDPYGKPVDLWACGVIL 203

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 103/227 (45%), Gaps = 48/227 (21%)
Query: 267 IQRATDEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLERAFRSF------DSEC 319
           I    + +   + +G+ ++GSV        G  VA+K    +L R F+S         E 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 72
Query: 320 EVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEK----WLYSHNYFLDI-----LE 370
            +L++++H N+I +L              F P  SLE+    +L +H    D+      +
Sbjct: 73  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 371 RLN------IMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG 424
           +L       ++  +   L+Y+H    S  IIH DLKP+N+ ++E+    + D+G+ +   
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDYGLAR--- 173
Query: 425 EGEDSVRQTMTMATIGYMAPEYGLEGI-VSAKCDVYSYGVLLMETFT 470
             +D +  T  +AT  Y APE  L  +  +   D++S G ++ E  T
Sbjct: 174 HTDDEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 92/217 (42%), Gaps = 22/217 (10%)
Query: 271 TDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAF---RSFDSECEVLRNVRH 327
            ++++    LG  ++G V +  ++  T+ A+ V  + ++RA     +   E  +   + H
Sbjct: 6   VEDWDLVQTLGEGAYGEV-QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNH 64
Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
            N++K        + + L LE+   G L           D +E  +I +    A  + H 
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGEL----------FDRIEP-DIGMPEPDAQRFFHQ 113
Query: 388 ---GHSSVH---IIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGY 441
              G   +H   I H D+KP N+LLDE     +SDFG+  +               T+ Y
Sbjct: 114 LMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 442 MAPEYGLEGIVSAK-CDVYSYGVLLMETFTRKRPTDE 477
           +APE        A+  DV+S G++L      + P D+
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 100/227 (44%), Gaps = 48/227 (21%)
Query: 267 IQRATDEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLERAFRSF------DSEC 319
           I    + +   + +G+ ++GSV        G  VA+K    +L R F+S         E 
Sbjct: 37  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK----KLSRPFQSIIHAKRTYREL 92
Query: 320 EVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEK----WLYSHNYFLDI-----LE 370
            +L++++H N+I +L              F P  SLE+    +L +H    D+      +
Sbjct: 93  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 140
Query: 371 RLN------IMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG 424
           +L       ++  +   L+Y+H    S  IIH DLKP+N+ ++E+    + DFG+ +   
Sbjct: 141 KLTDDHVQFLIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 196
Query: 425 EGEDSVRQTMTMATIGYMAPEYGLEGI-VSAKCDVYSYGVLLMETFT 470
           +          +AT  Y APE  L  +  +   D++S G ++ E  T
Sbjct: 197 D-----EMXGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 238

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 96/215 (44%), Gaps = 20/215 (9%)
Query: 270 ATDEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQ--LERAFRSFDSECEVLRNVR 326
           AT  +     +G  ++G+VYK      G  VA+K   +    E    S   E  +LR + 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 327 ---HRNLIKIL----SSYSNPDFK-ALVLEFMPNGSLEKWL-YSHNYFLDILERLNIMID 377
              H N+++++    +S ++ + K  LV E + +  L  +L  +    L      ++M  
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 378 VGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMA 437
               L++LH       I+H DLKP NIL+       ++DFG+ ++       +     + 
Sbjct: 121 FLRGLDFLHANC----IVHRDLKPENILVTSGGTVKLADFGLARIYSY---QMALDPVVV 173
Query: 438 TIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRK 472
           T+ Y APE  L+   +   D++S G +  E F RK
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 66/145 (45%), Gaps = 14/145 (9%)
Query: 367 DILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG 426
           DIL +  I + +  ALE+LH   S + +IH D+KP+N+L++        DFGI   L   
Sbjct: 136 DILGK--IAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKXCDFGISGYL--- 187
Query: 427 EDSVRQTMTMATIGYMA-----PEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIG 481
            D V + +      Y A     PE   +G  S K D++S G+  +E    + P D     
Sbjct: 188 VDDVAKDIDAGCKPYXAPERINPELNQKG-YSVKSDIWSLGITXIELAILRFPYDSWGTP 246
Query: 482 EMSLRRWVKESLPHGLTEVVDANLV 506
              L++ V+E  P    +   A  V
Sbjct: 247 FQQLKQVVEEPSPQLPADKFSAEFV 271

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 102/227 (44%), Gaps = 48/227 (21%)
Query: 267 IQRATDEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLERAFRSF------DSEC 319
           I    + +   + +G+ ++GSV        G  VA+K    +L R F+S         E 
Sbjct: 13  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK----KLSRPFQSIIHAKRTYREL 68
Query: 320 EVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEK----WLYSHNYFLDI-----LE 370
            +L++++H N+I +L              F P  SLE+    +L +H    D+      +
Sbjct: 69  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 116
Query: 371 RLN------IMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG 424
           +L       ++  +   L+Y+H    S  IIH DLKP+N+ ++E+    + DFG+ +   
Sbjct: 117 KLTDDHVQFLIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLAR--- 169
Query: 425 EGEDSVRQTMTMATIGYMAPEYGLEGI-VSAKCDVYSYGVLLMETFT 470
             +D +     +AT  Y APE  L  +  +   D++S G ++ E  T
Sbjct: 170 HTDDEM--AGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 214

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 91/217 (41%), Gaps = 22/217 (10%)
Query: 271 TDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAF---RSFDSECEVLRNVRH 327
            ++++    LG  + G V +  ++  T+ A+ V  + ++RA     +   E  + + + H
Sbjct: 5   VEDWDLVQTLGEGAAGEV-QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 63
Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
            N++K        + + L LE+   G L           D +E  +I +    A  + H 
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGEL----------FDRIEP-DIGMPEPDAQRFFHQ 112
Query: 388 GHSSV------HIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGY 441
             + V       I H D+KP N+LLDE     +SDFG+  +               T+ Y
Sbjct: 113 LMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 442 MAPEYGLEGIVSAK-CDVYSYGVLLMETFTRKRPTDE 477
           +APE        A+  DV+S G++L      + P D+
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 25/81 (30%), Positives = 42/81 (51%)
Query: 390 SSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLE 449
           +S + IH DL   NILL    +  + DFG+ + +    + V +      + +MAPE    
Sbjct: 185 ASKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGNARLPVKWMAPESIFN 244
Query: 450 GIVSAKCDVYSYGVLLMETFT 470
            + + + DV+SYG+ L E F+
Sbjct: 245 CVYTFESDVWSYGIFLWELFS 265

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 98/217 (45%), Gaps = 24/217 (11%)
Query: 270 ATDEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQ--LERAFRSFDSECEVLRNVR 326
           AT  +     +G  ++G+VYK      G  VA+K   +    E    S   E  +LR + 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 327 ---HRNLIKIL----SSYSNPDFKA-LVLEFMPNGSLEKWL-YSHNYFLDILERLNIMID 377
              H N+++++    +S ++ + K  LV E + +  L  +L  +    L      ++M  
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 378 VGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTM--T 435
               L++LH       I+H DLKP NIL+       ++DFG+ ++      S +  +   
Sbjct: 121 FLRGLDFLHANC----IVHRDLKPENILVTSGGTVKLADFGLARIY-----SYQMALFPV 171
Query: 436 MATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRK 472
           + T+ Y APE  L+   +   D++S G +  E F RK
Sbjct: 172 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 102/227 (44%), Gaps = 48/227 (21%)
Query: 267 IQRATDEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLERAFRSF------DSEC 319
           I    + +   + +G+ ++GSV        G  VA+K    +L R F+S         E 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK----KLSRPFQSIIHAKRTYREL 72
Query: 320 EVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEK----WLYSHNYFLDI-----LE 370
            +L++++H N+I +L              F P  SLE+    +L +H    D+      +
Sbjct: 73  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 371 RLN------IMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG 424
           +L       ++  +   L+Y+H    S  IIH DLKP+N+ ++E+    + DFG+ +   
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLAR--- 173
Query: 425 EGEDSVRQTMTMATIGYMAPEYGLEGI-VSAKCDVYSYGVLLMETFT 470
             +D +     +AT  Y APE  L  +  +   D++S G ++ E  T
Sbjct: 174 HTDDEM--AGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 102/227 (44%), Gaps = 48/227 (21%)
Query: 267 IQRATDEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLERAFRSF------DSEC 319
           I    + +   + +G+ ++GSV        G  VA+K    +L R F+S         E 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK----KLSRPFQSIIHAKRTYREL 72
Query: 320 EVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEK----WLYSHNYFLDI-----LE 370
            +L++++H N+I +L              F P  SLE+    +L +H    D+      +
Sbjct: 73  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 371 RLN------IMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG 424
           +L       ++  +   L+Y+H    S  IIH DLKP+N+ ++E+    + DFG+ +   
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLAR--- 173
Query: 425 EGEDSVRQTMTMATIGYMAPEYGLEGI-VSAKCDVYSYGVLLMETFT 470
             +D +     +AT  Y APE  L  +  +   D++S G ++ E  T
Sbjct: 174 HTDDEM--AGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 100/227 (44%), Gaps = 48/227 (21%)
Query: 267 IQRATDEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLERAFRSF------DSEC 319
           I    + +   + +G+ ++GSV        G  VA+K    +L R F+S         E 
Sbjct: 40  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 95
Query: 320 EVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEK----WLYSHNYFLDI-----LE 370
            +L++++H N+I +L              F P  SLE+    +L +H    D+      +
Sbjct: 96  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 143
Query: 371 RLN------IMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG 424
           +L       ++  +   L+Y+H    S  IIH DLKP+N+ ++E+    + DFG+ +   
Sbjct: 144 KLTDDHVQFLIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 199
Query: 425 EGEDSVRQTMTMATIGYMAPEYGLEGI-VSAKCDVYSYGVLLMETFT 470
           +          +AT  Y APE  L  +  +   D++S G ++ E  T
Sbjct: 200 D-----EMXGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 241

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 25/81 (30%), Positives = 42/81 (51%)
Query: 390 SSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLE 449
           +S + IH DL   NILL    +  + DFG+ + +    + V +      + +MAPE    
Sbjct: 178 ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN 237
Query: 450 GIVSAKCDVYSYGVLLMETFT 470
            + + + DV+SYG+ L E F+
Sbjct: 238 CVYTFESDVWSYGIFLWELFS 258

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 25/81 (30%), Positives = 42/81 (51%)
Query: 390 SSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLE 449
           +S + IH DL   NILL    +  + DFG+ + +    + V +      + +MAPE    
Sbjct: 162 ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN 221
Query: 450 GIVSAKCDVYSYGVLLMETFT 470
            + + + DV+SYG+ L E F+
Sbjct: 222 CVYTFESDVWSYGIFLWELFS 242

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 25/81 (30%), Positives = 42/81 (51%)
Query: 390 SSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLE 449
           +S + IH DL   NILL    +  + DFG+ + +    + V +      + +MAPE    
Sbjct: 180 ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN 239
Query: 450 GIVSAKCDVYSYGVLLMETFT 470
            + + + DV+SYG+ L E F+
Sbjct: 240 CVYTFESDVWSYGIFLWELFS 260

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 25/81 (30%), Positives = 42/81 (51%)
Query: 390 SSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLE 449
           +S + IH DL   NILL    +  + DFG+ + +    + V +      + +MAPE    
Sbjct: 185 ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN 244
Query: 450 GIVSAKCDVYSYGVLLMETFT 470
            + + + DV+SYG+ L E F+
Sbjct: 245 CVYTFESDVWSYGIFLWELFS 265

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 92/221 (41%), Gaps = 49/221 (22%)
Query: 278 NLLGTSSFGSVYKGTISDGTDVAI--KVFNLQLERAFRSF------DSECEVLRNVRHRN 329
            L G    GS   G++    D  +  KV   +L R F+S         E  +L++++H N
Sbjct: 21  RLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHEN 80
Query: 330 LIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDIL----------------ERLN 373
           +I +L              F P  S+E   +S  Y +  L                E + 
Sbjct: 81  VIGLLDV------------FTPATSIED--FSEVYLVTTLMGADLNNIVKCQALSDEHVQ 126
Query: 374 IMI-DVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQ 432
            ++  +   L+Y+H    S  IIH DLKP+N+ ++E+    + DFG+ +   E       
Sbjct: 127 FLVYQLLRGLKYIH----SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADE-----EM 177
Query: 433 TMTMATIGYMAPEYGLEGI-VSAKCDVYSYGVLLMETFTRK 472
           T  +AT  Y APE  L  +  +   D++S G ++ E    K
Sbjct: 178 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 92/221 (41%), Gaps = 49/221 (22%)
Query: 278 NLLGTSSFGSVYKGTISDGTDVAI--KVFNLQLERAFRSF------DSECEVLRNVRHRN 329
            L G    GS   G++    D  +  KV   +L R F+S         E  +L++++H N
Sbjct: 29  RLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHEN 88
Query: 330 LIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDIL----------------ERLN 373
           +I +L              F P  S+E   +S  Y +  L                E + 
Sbjct: 89  VIGLLDV------------FTPATSIED--FSEVYLVTTLMGADLNNIVKCQALSDEHVQ 134
Query: 374 IMI-DVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQ 432
            ++  +   L+Y+H    S  IIH DLKP+N+ ++E+    + DFG+ +   E       
Sbjct: 135 FLVYQLLRGLKYIH----SAGIIHRDLKPSNVAVNEDSELRILDFGLARQADE-----EM 185
Query: 433 TMTMATIGYMAPEYGLEGI-VSAKCDVYSYGVLLMETFTRK 472
           T  +AT  Y APE  L  +  +   D++S G ++ E    K
Sbjct: 186 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 92/209 (44%), Gaps = 25/209 (11%)
Query: 278 NLLGTSSFGSVYKGTISDGTDVAI--KVFNLQLERAFRSF------DSECEVLRNVRHRN 329
            L G    GS   G++    D  +  KV   +L R F+S         E  +L++++H N
Sbjct: 29  RLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHEN 88
Query: 330 LIKILSSY----SNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMI-DVGSALEY 384
           +I +L  +    S  DF  + L     G+    +       D  E +  ++  +   L+Y
Sbjct: 89  VIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSD--EHVQFLVYQLLRGLKY 146
Query: 385 LHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAP 444
           +H    S  IIH DLKP+N+ ++E+    + DFG+ +   E       T  +AT  Y AP
Sbjct: 147 IH----SAGIIHRDLKPSNVAVNEDSELRILDFGLARQADE-----EMTGYVATRWYRAP 197
Query: 445 EYGLEGI-VSAKCDVYSYGVLLMETFTRK 472
           E  L  +  +   D++S G ++ E    K
Sbjct: 198 EIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 38/114 (33%), Positives = 54/114 (47%), Gaps = 13/114 (11%)
Query: 368 ILERL--NIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGE 425
           I ER+   + + +  AL YL   H    +IH D+KP+NILLDE     + DFGI    G 
Sbjct: 121 IPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGIS---GR 174
Query: 426 GEDSVRQTMTMATIGYMAPEY-----GLEGIVSAKCDVYSYGVLLMETFTRKRP 474
             D   +  +     YMAPE        +     + DV+S G+ L+E  T + P
Sbjct: 175 LVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 53/100 (53%), Gaps = 9/100 (9%)
Query: 380 SALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATI 439
           + ++ L++   ++ IIH D+KP+NILLD +    + DFGI    G+  DS+ +T      
Sbjct: 133 ATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGIS---GQLVDSIAKTRDAGCR 189
Query: 440 GYMAPE-----YGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
            YMAPE        +G    + DV+S G+ L E  T + P
Sbjct: 190 PYMAPERIDPSASRQG-YDVRSDVWSLGITLYELATGRFP 228

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 93/210 (44%), Gaps = 25/210 (11%)
Query: 272 DEFNECNLLGTSSFGSVYKGTISD-GTDVAIKVFNLQLER-------AFRSFDSECEVLR 323
           +++ +   +G  S+G V+K    D G  VAIK F L+ E        A R    E  +L+
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF-LESEDDPVIKKIALR----EIRMLK 57
Query: 324 NVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERL--NIMIDVGSA 381
            ++H NL+ +L  +       LV E+  +  L +      Y   + E L  +I      A
Sbjct: 58  QLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHEL---DRYQRGVPEHLVKSITWQTLQA 114
Query: 382 LEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGY 441
           + + H  +     IH D+KP NIL+ ++ V  + DFG  +LL    D       +AT  Y
Sbjct: 115 VNFCHKHNC----IHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDD--EVATRWY 168
Query: 442 MAPEYGL-EGIVSAKCDVYSYGVLLMETFT 470
            +PE  + +       DV++ G +  E  +
Sbjct: 169 RSPELLVGDTQYGPPVDVWAIGCVFAELLS 198

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 102/227 (44%), Gaps = 48/227 (21%)
Query: 267 IQRATDEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLERAFRSF------DSEC 319
           I    + +   + +G+ ++GSV        G  VA+K    +L R F+S         E 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 72
Query: 320 EVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEK----WLYSHNYFLDI-----LE 370
            +L++++H N+I +L              F P  SLE+    +L +H    D+      +
Sbjct: 73  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 371 RLN------IMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG 424
           +L       ++  +   L+Y+H    S  IIH DLKP+N+ ++E+    +  FG+ +   
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILGFGLAR--- 173
Query: 425 EGEDSVRQTMTMATIGYMAPEYGLEGI-VSAKCDVYSYGVLLMETFT 470
             +D +  T  +AT  Y APE  L  +  +   D++S G ++ E  T
Sbjct: 174 HTDDEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 72/303 (23%), Positives = 120/303 (39%), Gaps = 36/303 (11%)
Query: 272 DEFNECNLLGTSSFGSVYK-GTISDGTDVAIKVFNLQLERAFR------SFDSECEVLRN 324
           D ++    LG+  F  V K    S G   A K    +  ++ R        + E  +L+ 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 325 VRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEY 384
           ++H N+I +   Y N     L+ E +  G L  +L +    L   E    +  + + + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILIGELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYY 129
Query: 385 LHNGHSSVHIIHCDLKPTNI-LLDENMVA---HVSDFGIYKLLGEGEDSVRQTMTMATIG 440
           LH    S+ I H DLKP NI LLD N+      + DFG+   +  G +         T  
Sbjct: 130 LH----SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPE 182
Query: 441 YMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEV 500
           ++APE      +  + D++S GV+     +   P    F+G+              L  V
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASP----FLGDTK---------QETLANV 229
Query: 501 VDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKFLDDAAA 560
              N   E++ FS   +      DF     ++ P  R+ + D + +   IK K    A +
Sbjct: 230 SAVNYEFEDEYFS---NTSALAKDFIRRLLVKDPKKRMTIQD-SLQHPWIKPKDTQQALS 285
Query: 561 TNW 563
           + W
Sbjct: 286 SAW 288

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 90/218 (41%), Gaps = 15/218 (6%)
Query: 265 LDIQRATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRN 324
           LD  + TD FN   +LG  SFG V       GT+    +  L+ +   +  D EC ++  
Sbjct: 13  LDRVKLTD-FNFLMVLGKGSFGKVMLAD-RKGTEELYAIKILKKDVVIQDDDVECTMVEK 70
Query: 325 V------RHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDV 378
                  +   L ++ S +   D    V+E++  G L   +     F +  + +    ++
Sbjct: 71  RVLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEP-QAVFYAAEI 129
Query: 379 GSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMAT 438
              L +LH       II+ DLK  N++LD      ++DFG+ K      D V       T
Sbjct: 130 SIGLFFLHKRG----IIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMMDGVTTREFCGT 183
Query: 439 IGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTD 476
             Y+APE           D ++YGVLL E    + P D
Sbjct: 184 PDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 221

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 102/227 (44%), Gaps = 48/227 (21%)
Query: 267 IQRATDEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLERAFRSF------DSEC 319
           I    + +   + +G+ ++GSV        G  VA+K    +L R F+S         E 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 72
Query: 320 EVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEK----WLYSHNYFLDI-----LE 370
            +L++++H N+I +L              F P  SLE+    +L +H    D+      +
Sbjct: 73  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 371 RLN------IMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG 424
           +L       ++  +   L+Y+H    S  IIH DLKP+N+ ++E+    + D G+ +   
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDAGLAR--- 173
Query: 425 EGEDSVRQTMTMATIGYMAPEYGLEGI-VSAKCDVYSYGVLLMETFT 470
             +D +  T  +AT  Y APE  L  +  +   D++S G ++ E  T
Sbjct: 174 HTDDEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 91/196 (46%), Gaps = 25/196 (12%)
Query: 286 GSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKAL 345
           GS  +G +    D AI   N+ +++  R F ++    R  R   L+K+++   + +   L
Sbjct: 33  GSGAQGIVCAAYD-AILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVN---HKNIIGL 88
Query: 346 VLEFMPNGSLEKW--LYSHNYFLDI-----------LERLNIMI-DVGSALEYLHNGHSS 391
           +  F P  SLE++  +Y     +D             ER++ ++  +   +++LH    S
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIKHLH----S 144
Query: 392 VHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGI 451
             IIH DLKP+NI++  +    + DFG+ +  G    S   T  + T  Y APE  L   
Sbjct: 145 AGIIHRDLKPSNIVVKSDATLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEVILGMG 201
Query: 452 VSAKCDVYSYGVLLME 467
                D++S GV++ E
Sbjct: 202 YKENVDIWSVGVIMGE 217

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 91/196 (46%), Gaps = 25/196 (12%)
Query: 286 GSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKAL 345
           GS  +G +    D AI   N+ +++  R F ++    R  R   L+K+++   + +   L
Sbjct: 33  GSGAQGIVVAAYD-AILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVN---HKNIIGL 88
Query: 346 VLEFMPNGSLEKW--LYSHNYFLDI-----------LERLNIMI-DVGSALEYLHNGHSS 391
           +  F P  SLE++  +Y     +D             ER++ ++  +   +++LH    S
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIKHLH----S 144
Query: 392 VHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGI 451
             IIH DLKP+NI++  +    + DFG+ +  G    S   T  + T  Y APE  L   
Sbjct: 145 AGIIHRDLKPSNIVVKSDATLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEVILGMG 201
Query: 452 VSAKCDVYSYGVLLME 467
                D++S GV++ E
Sbjct: 202 YKENVDIWSVGVIMGE 217

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 102/227 (44%), Gaps = 48/227 (21%)
Query: 267 IQRATDEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLERAFRSF------DSEC 319
           I    + +   + +G+ ++GSV        G  VA+K    +L R F+S         E 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 72
Query: 320 EVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEK----WLYSHNYFLDI-----LE 370
            +L++++H N+I +L              F P  SLE+    +L +H    D+      +
Sbjct: 73  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 371 RLN------IMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG 424
           +L       ++  +   L+Y+H    S  IIH DLKP+N+ ++E+    + D G+ +   
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDRGLAR--- 173
Query: 425 EGEDSVRQTMTMATIGYMAPEYGLEGI-VSAKCDVYSYGVLLMETFT 470
             +D +  T  +AT  Y APE  L  +  +   D++S G ++ E  T
Sbjct: 174 HTDDEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 102/227 (44%), Gaps = 48/227 (21%)
Query: 267 IQRATDEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLERAFRSF------DSEC 319
           I    + +   + +G+ ++GSV        G  VA+K    +L R F+S         E 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK----KLSRPFQSIIHAKRTYREL 72
Query: 320 EVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEK----WLYSHNYFLDI-----LE 370
            +L++++H N+I +L              F P  SLE+    +L +H    D+      +
Sbjct: 73  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 371 RLN------IMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG 424
           +L       ++  +   L+Y+H    S  IIH DLKP+N+ ++E+    + DF + +   
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFYLAR--- 173
Query: 425 EGEDSVRQTMTMATIGYMAPEYGLEGI-VSAKCDVYSYGVLLMETFT 470
             +D +  T  +AT  Y APE  L  +  +   D++S G ++ E  T
Sbjct: 174 HTDDEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 89/188 (47%), Gaps = 25/188 (13%)
Query: 309 ERAFRSFDSECEVLRNVRHRNLIKILSSYSNP----DFK--ALVLEFMPNGSLEKWLYSH 362
           +RA+R    E  +++ V H+N+I +L+ ++      +F+   LV+E M + +L + +   
Sbjct: 68  KRAYR----ELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLXQVIQME 122
Query: 363 NYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKL 422
              LD      ++  +   +++LH    S  IIH DLKP+NI++  +    + DFG+ + 
Sbjct: 123 ---LDHERMSYLLYQMLXGIKHLH----SAGIIHRDLKPSNIVVKSDXTLKILDFGLART 175
Query: 423 LGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGE 482
            G    S   T  + T  Y APE  L        D++S G ++ E    K     +F G 
Sbjct: 176 AGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI----LFPGR 228
Query: 483 MSLRRWVK 490
             + +W K
Sbjct: 229 DYIDQWNK 236

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 102/227 (44%), Gaps = 48/227 (21%)
Query: 267 IQRATDEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLERAFRSF------DSEC 319
           I    + +   + +G+ ++GSV        G  VA+K    +L R F+S         E 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 72
Query: 320 EVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEK----WLYSHNYFLDI-----LE 370
            +L++++H N+I +L              F P  SLE+    +L +H    D+      +
Sbjct: 73  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 371 RLN------IMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG 424
           +L       ++  +   L+Y+H    S  IIH DLKP+N+ ++E+    + D G+ +   
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDGGLAR--- 173
Query: 425 EGEDSVRQTMTMATIGYMAPEYGLEGI-VSAKCDVYSYGVLLMETFT 470
             +D +  T  +AT  Y APE  L  +  +   D++S G ++ E  T
Sbjct: 174 HTDDEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 51/101 (50%), Gaps = 14/101 (13%)
Query: 370 ERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDE---NMVAHVSDFGIYKLLGEG 426
           E   IM  +G A++YLH    S++I H D+KP N+L      N +  ++DFG  K     
Sbjct: 162 EASEIMKSIGEAIQYLH----SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK----- 212
Query: 427 EDSVRQTMTMA--TIGYMAPEYGLEGIVSAKCDVYSYGVLL 465
           E +   ++T    T  Y+APE          CD++S GV++
Sbjct: 213 ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 97/208 (46%), Gaps = 33/208 (15%)
Query: 280 LGTSSFGSVYKGTIS-DGTDVAIKVFNLQLE------RAFRSFDSECEVLRNVRHRNLIK 332
           +G+ ++GSV        G  VAIK  +   +      RA+R    E  +L++++H N+I 
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR----ELLLLKHMQHENVIG 105
Query: 333 ILSSYSNP-------DFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYL 385
           +L  ++         DF  LV+ FM    L+K +    +  + ++ L   +  G  L+Y+
Sbjct: 106 LLDVFTPASSLRNFYDF-YLVMPFM-QTDLQK-IMGMEFSEEKIQYLVYQMLKG--LKYI 160
Query: 386 HNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPE 445
           H    S  ++H DLKP N+ ++E+    + DFG+ +           T  + T  Y APE
Sbjct: 161 H----SAGVVHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVVTRWYRAPE 211
Query: 446 YGLEGI-VSAKCDVYSYGVLLMETFTRK 472
             L  +  +   D++S G ++ E  T K
Sbjct: 212 VILSWMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 51/101 (50%), Gaps = 14/101 (13%)
Query: 370 ERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDE---NMVAHVSDFGIYKLLGEG 426
           E   IM  +G A++YLH    S++I H D+KP N+L      N +  ++DFG  K     
Sbjct: 124 EASEIMKSIGEAIQYLH----SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK----- 174
Query: 427 EDSVRQTMTMA--TIGYMAPEYGLEGIVSAKCDVYSYGVLL 465
           E +   ++T    T  Y+APE          CD++S GV++
Sbjct: 175 ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 215

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 51/101 (50%), Gaps = 14/101 (13%)
Query: 370 ERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDE---NMVAHVSDFGIYKLLGEG 426
           E   IM  +G A++YLH    S++I H D+KP N+L      N +  ++DFG  K     
Sbjct: 122 EASEIMKSIGEAIQYLH----SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK----- 172
Query: 427 EDSVRQTMTMA--TIGYMAPEYGLEGIVSAKCDVYSYGVLL 465
           E +   ++T    T  Y+APE          CD++S GV++
Sbjct: 173 ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 213

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 51/101 (50%), Gaps = 14/101 (13%)
Query: 370 ERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDE---NMVAHVSDFGIYKLLGEG 426
           E   IM  +G A++YLH    S++I H D+KP N+L      N +  ++DFG  K     
Sbjct: 123 EASEIMKSIGEAIQYLH----SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK----- 173
Query: 427 EDSVRQTMTMA--TIGYMAPEYGLEGIVSAKCDVYSYGVLL 465
           E +   ++T    T  Y+APE          CD++S GV++
Sbjct: 174 ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 214

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 51/101 (50%), Gaps = 14/101 (13%)
Query: 370 ERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDE---NMVAHVSDFGIYKLLGEG 426
           E   IM  +G A++YLH    S++I H D+KP N+L      N +  ++DFG  K     
Sbjct: 168 EASEIMKSIGEAIQYLH----SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK----- 218
Query: 427 EDSVRQTMTMA--TIGYMAPEYGLEGIVSAKCDVYSYGVLL 465
           E +   ++T    T  Y+APE          CD++S GV++
Sbjct: 219 ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 259

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 51/101 (50%), Gaps = 14/101 (13%)
Query: 370 ERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDE---NMVAHVSDFGIYKLLGEG 426
           E   IM  +G A++YLH    S++I H D+KP N+L      N +  ++DFG  K     
Sbjct: 132 EASEIMKSIGEAIQYLH----SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK----- 182
Query: 427 EDSVRQTMTMA--TIGYMAPEYGLEGIVSAKCDVYSYGVLL 465
           E +   ++T    T  Y+APE          CD++S GV++
Sbjct: 183 ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 223

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 91/211 (43%), Gaps = 22/211 (10%)
Query: 274 FNECNLLGTSSFGSVYKGTIS-DGTDVAIK---VFNLQL--ERAFRSFDSECEVLRNVRH 327
           + +   +G  ++G V         T VAIK    F  Q   +R  R    E ++L   RH
Sbjct: 45  YTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLR----EIQILLRFRH 100
Query: 328 RNLIKILSSYSNPDFKAL----VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALE 383
            N+I I         +A+    +++ +    L K L S     D +     +  +   L+
Sbjct: 101 ENVIGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHI--CYFLYQILRGLK 158
Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVR-QTMTMATIGYM 442
           Y+H    S +++H DLKP+N+L++      + DFG+ ++     D     T  +AT  Y 
Sbjct: 159 YIH----SANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYR 214
Query: 443 APEYGLEGIVSAKC-DVYSYGVLLMETFTRK 472
           APE  L      K  D++S G +L E  + +
Sbjct: 215 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 89/188 (47%), Gaps = 25/188 (13%)
Query: 309 ERAFRSFDSECEVLRNVRHRNLIKILSSYSNP----DFK--ALVLEFMPNGSLEKWLYSH 362
           +RA+R    E  +++ V H+N+I +L+ ++      +F+   LV+E M + +L + +   
Sbjct: 68  KRAYR----ELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLXQVIQME 122
Query: 363 NYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKL 422
              LD      ++  +   +++LH    S  IIH DLKP+NI++  +    + DFG+ + 
Sbjct: 123 ---LDHERMSYLLYQMLCGIKHLH----SAGIIHRDLKPSNIVVKSDXTLKILDFGLART 175
Query: 423 LGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGE 482
            G    S   T  + T  Y APE  L        D++S G ++ E    K     +F G 
Sbjct: 176 AGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI----LFPGR 228
Query: 483 MSLRRWVK 490
             + +W K
Sbjct: 229 DYIDQWNK 236

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 65/245 (26%), Positives = 91/245 (37%), Gaps = 71/245 (28%)
Query: 280 LGTSSFGSVYKGTISDGTDV--AIKVFNLQLERAFRSFD-----SECEVLRNVRHRNLIK 332
           +G  S+G V +  I + T    AIK+ N    R     D     +E  +++ + H N+ +
Sbjct: 34  IGQGSYG-VVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIAR 92
Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWL--------------------------------- 359
           +   Y +  +  LV+E    G L   L                                 
Sbjct: 93  LYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAING 152
Query: 360 --YSHNYFLDILER----LNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAH 413
             +     LD ++R     NIM  + SAL YLHN      I H D+KP N L   N    
Sbjct: 153 SIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ----GICHRDIKPENFLFSTNKSFE 208
Query: 414 VS--DFGIYK---LLGEGEDSVRQTMTMATIGYMAPE--------YGLEGIVSAKCDVYS 460
           +   DFG+ K    L  GE     T    T  ++APE        YG       KCD +S
Sbjct: 209 IKLVDFGLSKEFYKLNNGE-YYGMTTKAGTPYFVAPEVLNTTNESYG------PKCDAWS 261
Query: 461 YGVLL 465
            GVLL
Sbjct: 262 AGVLL 266

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 51/101 (50%), Gaps = 14/101 (13%)
Query: 370 ERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDE---NMVAHVSDFGIYKLLGEG 426
           E   IM  +G A++YLH    S++I H D+KP N+L      N +  ++DFG  K     
Sbjct: 118 EASEIMKSIGEAIQYLH----SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK----- 168
Query: 427 EDSVRQTMTMA--TIGYMAPEYGLEGIVSAKCDVYSYGVLL 465
           E +   ++T    T  Y+APE          CD++S GV++
Sbjct: 169 ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 209

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 51/101 (50%), Gaps = 14/101 (13%)
Query: 370 ERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDE---NMVAHVSDFGIYKLLGEG 426
           E   IM  +G A++YLH    S++I H D+KP N+L      N +  ++DFG  K     
Sbjct: 117 EASEIMKSIGEAIQYLH----SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK----- 167
Query: 427 EDSVRQTMTMA--TIGYMAPEYGLEGIVSAKCDVYSYGVLL 465
           E +   ++T    T  Y+APE          CD++S GV++
Sbjct: 168 ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 208

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 51/101 (50%), Gaps = 14/101 (13%)
Query: 370 ERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDE---NMVAHVSDFGIYKLLGEG 426
           E   IM  +G A++YLH    S++I H D+KP N+L      N +  ++DFG  K     
Sbjct: 116 EASEIMKSIGEAIQYLH----SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK----- 166
Query: 427 EDSVRQTMTMA--TIGYMAPEYGLEGIVSAKCDVYSYGVLL 465
           E +   ++T    T  Y+APE          CD++S GV++
Sbjct: 167 ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 207

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 51/101 (50%), Gaps = 14/101 (13%)
Query: 370 ERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDE---NMVAHVSDFGIYKLLGEG 426
           E   IM  +G A++YLH    S++I H D+KP N+L      N +  ++DFG  K     
Sbjct: 118 EASEIMKSIGEAIQYLH----SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK----- 168
Query: 427 EDSVRQTMTMA--TIGYMAPEYGLEGIVSAKCDVYSYGVLL 465
           E +   ++T    T  Y+APE          CD++S GV++
Sbjct: 169 ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 209

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 53/99 (53%), Gaps = 11/99 (11%)
Query: 370 ERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILL---DENMVAHVSDFGIYKLLGEG 426
           E   IM D+G+A+++LH    S +I H D+KP N+L    +++ V  ++DFG  K   E 
Sbjct: 129 EAAEIMRDIGTAIQFLH----SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK---ET 181
Query: 427 EDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLL 465
             +  QT    T  Y+APE          CD++S GV++
Sbjct: 182 TQNALQT-PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 89/188 (47%), Gaps = 25/188 (13%)
Query: 309 ERAFRSFDSECEVLRNVRHRNLIKILSSYSNP----DFK--ALVLEFMPNGSLEKWLYSH 362
           +RA+R    E  +++ V H+N+I +L+ ++      +F+   LV+E M + +L + +   
Sbjct: 68  KRAYR----ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLXQVIQME 122
Query: 363 NYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKL 422
              LD      ++  +   +++LH    S  IIH DLKP+NI++  +    + DFG+ + 
Sbjct: 123 ---LDHERMSYLLYQMLXGIKHLH----SAGIIHRDLKPSNIVVKSDXTLKILDFGLART 175
Query: 423 LGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGE 482
            G    S   T  + T  Y APE  L        D++S G ++ E    K     +F G 
Sbjct: 176 AGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI----LFPGR 228
Query: 483 MSLRRWVK 490
             + +W K
Sbjct: 229 DYIDQWNK 236

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 70/159 (44%), Gaps = 8/159 (5%)
Query: 318 ECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYS--HNYFLDILERLNIM 375
           E ++L   RH N+I I      P  + +   ++    +E  LY       L        +
Sbjct: 75  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 134
Query: 376 IDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVR-QTM 434
             +   L+Y+H    S +++H DLKP+N+LL+      + DFG+ ++     D     T 
Sbjct: 135 YQILRGLKYIH----SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTE 190
Query: 435 TMATIGYMAPEYGLEGIVSAKC-DVYSYGVLLMETFTRK 472
            +AT  Y APE  L      K  D++S G +L E  + +
Sbjct: 191 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 41/212 (19%)
Query: 280 LGTSSFGSVYKGTIS-DGTDVAIKVFNLQLE------RAFRSFDSECEVLRNVRHRNLIK 332
           +G+ ++GSV        G  VAIK  +   +      RA+R    E  +L++++H N+I 
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR----ELLLLKHMQHENVIG 87
Query: 333 ILSSYSNP-------DFKALVLEFMPNGSLEKWL---YSHNYFLDILERLNIMI-DVGSA 381
           +L  ++         DF  LV+ FM    L+K +   +S        E++  ++  +   
Sbjct: 88  LLDVFTPASSLRNFYDF-YLVMPFM-QTDLQKIMGLKFSE-------EKIQYLVYQMLKG 138
Query: 382 LEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGY 441
           L+Y+H    S  ++H DLKP N+ ++E+    + DFG+ +           T  + T  Y
Sbjct: 139 LKYIH----SAGVVHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVVTRWY 189
Query: 442 MAPEYGLEGI-VSAKCDVYSYGVLLMETFTRK 472
            APE  L  +  +   D++S G ++ E  T K
Sbjct: 190 RAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 53/99 (53%), Gaps = 11/99 (11%)
Query: 370 ERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILL---DENMVAHVSDFGIYKLLGEG 426
           E   IM D+G+A+++LH    S +I H D+KP N+L    +++ V  ++DFG  K   E 
Sbjct: 110 EAAEIMRDIGTAIQFLH----SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK---ET 162
Query: 427 EDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLL 465
             +  QT    T  Y+APE          CD++S GV++
Sbjct: 163 TQNALQT-PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 200

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 89/188 (47%), Gaps = 25/188 (13%)
Query: 309 ERAFRSFDSECEVLRNVRHRNLIKILSSYSNP----DFK--ALVLEFMPNGSLEKWLYSH 362
           +RA+R    E  +++ V H+N+I +L+ ++      +F+   LV+E M + +L + +   
Sbjct: 61  KRAYR----ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLXQVIQME 115
Query: 363 NYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKL 422
              LD      ++  +   +++LH    S  IIH DLKP+NI++  +    + DFG+ + 
Sbjct: 116 ---LDHERMSYLLYQMLXGIKHLH----SAGIIHRDLKPSNIVVKSDXTLKILDFGLART 168
Query: 423 LGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGE 482
            G    S   T  + T  Y APE  L        D++S G ++ E    K     +F G 
Sbjct: 169 AGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI----LFPGR 221
Query: 483 MSLRRWVK 490
             + +W K
Sbjct: 222 DYIDQWNK 229

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 70/159 (44%), Gaps = 8/159 (5%)
Query: 318 ECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYS--HNYFLDILERLNIM 375
           E ++L   RH N+I I      P  + +   ++    +E  LY       L        +
Sbjct: 71  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 130
Query: 376 IDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVR-QTM 434
             +   L+Y+H    S +++H DLKP+N+LL+      + DFG+ ++     D     T 
Sbjct: 131 YQILRGLKYIH----SANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTE 186
Query: 435 TMATIGYMAPEYGLEGIVSAKC-DVYSYGVLLMETFTRK 472
            +AT  Y APE  L      K  D++S G +L E  + +
Sbjct: 187 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 70/159 (44%), Gaps = 8/159 (5%)
Query: 318 ECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYS--HNYFLDILERLNIM 375
           E ++L   RH N+I I      P  + +   ++    +E  LY       L        +
Sbjct: 75  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 134
Query: 376 IDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVR-QTM 434
             +   L+Y+H    S +++H DLKP+N+LL+      + DFG+ ++     D     T 
Sbjct: 135 YQILRGLKYIH----SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTE 190
Query: 435 TMATIGYMAPEYGLEGIVSAKC-DVYSYGVLLMETFTRK 472
            +AT  Y APE  L      K  D++S G +L E  + +
Sbjct: 191 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 70/159 (44%), Gaps = 8/159 (5%)
Query: 318 ECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYS--HNYFLDILERLNIM 375
           E ++L   RH N+I I      P  + +   ++    +E  LY       L        +
Sbjct: 71  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 130
Query: 376 IDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVR-QTM 434
             +   L+Y+H    S +++H DLKP+N+LL+      + DFG+ ++     D     T 
Sbjct: 131 YQILRGLKYIH----SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTE 186
Query: 435 TMATIGYMAPEYGLEGIVSAKC-DVYSYGVLLMETFTRK 472
            +AT  Y APE  L      K  D++S G +L E  + +
Sbjct: 187 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 70/159 (44%), Gaps = 8/159 (5%)
Query: 318 ECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYS--HNYFLDILERLNIM 375
           E ++L   RH N+I I      P  + +   ++    +E  LY       L        +
Sbjct: 71  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 130
Query: 376 IDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVR-QTM 434
             +   L+Y+H    S +++H DLKP+N+LL+      + DFG+ ++     D     T 
Sbjct: 131 YQILRGLKYIH----SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTE 186
Query: 435 TMATIGYMAPEYGLEGIVSAKC-DVYSYGVLLMETFTRK 472
            +AT  Y APE  L      K  D++S G +L E  + +
Sbjct: 187 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 51/101 (50%), Gaps = 14/101 (13%)
Query: 370 ERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDE---NMVAHVSDFGIYKLLGEG 426
           E   IM  +G A++YLH    S++I H D+KP N+L      N +  ++DFG  K     
Sbjct: 116 EASEIMKSIGEAIQYLH----SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK----- 166
Query: 427 EDSVRQTMTMA--TIGYMAPEYGLEGIVSAKCDVYSYGVLL 465
           E +   ++T    T  Y+APE          CD++S GV++
Sbjct: 167 ETTSHNSLTEPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 207

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 70/159 (44%), Gaps = 8/159 (5%)
Query: 318 ECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYS--HNYFLDILERLNIM 375
           E ++L   RH N+I I      P  + +   ++    +E  LY       L        +
Sbjct: 79  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 138
Query: 376 IDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVR-QTM 434
             +   L+Y+H    S +++H DLKP+N+LL+      + DFG+ ++     D     T 
Sbjct: 139 YQILRGLKYIH----SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 194
Query: 435 TMATIGYMAPEYGLEGIVSAKC-DVYSYGVLLMETFTRK 472
            +AT  Y APE  L      K  D++S G +L E  + +
Sbjct: 195 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 70/159 (44%), Gaps = 8/159 (5%)
Query: 318 ECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYS--HNYFLDILERLNIM 375
           E ++L   RH N+I I      P  + +   ++    +E  LY       L        +
Sbjct: 71  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 130
Query: 376 IDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVR-QTM 434
             +   L+Y+H    S +++H DLKP+N+LL+      + DFG+ ++     D     T 
Sbjct: 131 YQILRGLKYIH----SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 186
Query: 435 TMATIGYMAPEYGLEGIVSAKC-DVYSYGVLLMETFTRK 472
            +AT  Y APE  L      K  D++S G +L E  + +
Sbjct: 187 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/188 (26%), Positives = 86/188 (45%), Gaps = 30/188 (15%)
Query: 327 HRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILE------RLNIMIDVGS 380
           H N+I+   S +   F  + LE + N +L+  + S N   + L+       ++++  + S
Sbjct: 86  HPNVIRYYCSETTDRFLYIALE-LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 144
Query: 381 ALEYLHNGHSSVHIIHCDLKPTNILLD-------------ENMVAHVSDFGIYKLLGEGE 427
            + +LH    S+ IIH DLKP NIL+              EN+   +SDFG+ K L  G+
Sbjct: 145 GVAHLH----SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 200
Query: 428 DSVRQTMT--MATIGYMAPEYGLEGI---VSAKCDVYSYGVLLMETFTR-KRPTDEMFIG 481
              R  +     T G+ APE   E     ++   D++S G +     ++ K P  + +  
Sbjct: 201 XXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 260
Query: 482 EMSLRRWV 489
           E ++ R +
Sbjct: 261 ESNIIRGI 268

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 70/159 (44%), Gaps = 8/159 (5%)
Query: 318 ECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYS--HNYFLDILERLNIM 375
           E ++L   RH N+I I      P  + +   ++    +E  LY       L        +
Sbjct: 73  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 132
Query: 376 IDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVR-QTM 434
             +   L+Y+H    S +++H DLKP+N+LL+      + DFG+ ++     D     T 
Sbjct: 133 YQILRGLKYIH----SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 188
Query: 435 TMATIGYMAPEYGLEGIVSAKC-DVYSYGVLLMETFTRK 472
            +AT  Y APE  L      K  D++S G +L E  + +
Sbjct: 189 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 70/159 (44%), Gaps = 8/159 (5%)
Query: 318 ECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYS--HNYFLDILERLNIM 375
           E ++L   RH N+I I      P  + +   ++    +E  LY       L        +
Sbjct: 75  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 134
Query: 376 IDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVR-QTM 434
             +   L+Y+H    S +++H DLKP+N+LL+      + DFG+ ++     D     T 
Sbjct: 135 YQILRGLKYIH----SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 190
Query: 435 TMATIGYMAPEYGLEGIVSAKC-DVYSYGVLLMETFTRK 472
            +AT  Y APE  L      K  D++S G +L E  + +
Sbjct: 191 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 70/159 (44%), Gaps = 8/159 (5%)
Query: 318 ECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYS--HNYFLDILERLNIM 375
           E ++L   RH N+I I      P  + +   ++    +E  LY       L        +
Sbjct: 91  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 150
Query: 376 IDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVR-QTM 434
             +   L+Y+H    S +++H DLKP+N+LL+      + DFG+ ++     D     T 
Sbjct: 151 YQILRGLKYIH----SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 206
Query: 435 TMATIGYMAPEYGLEGIVSAKC-DVYSYGVLLMETFTRK 472
            +AT  Y APE  L      K  D++S G +L E  + +
Sbjct: 207 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 70/159 (44%), Gaps = 8/159 (5%)
Query: 318 ECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYS--HNYFLDILERLNIM 375
           E ++L   RH N+I I      P  + +   ++    +E  LY       L        +
Sbjct: 76  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 135
Query: 376 IDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVR-QTM 434
             +   L+Y+H    S +++H DLKP+N+LL+      + DFG+ ++     D     T 
Sbjct: 136 YQILRGLKYIH----SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 191
Query: 435 TMATIGYMAPEYGLEGIVSAKC-DVYSYGVLLMETFTRK 472
            +AT  Y APE  L      K  D++S G +L E  + +
Sbjct: 192 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 70/159 (44%), Gaps = 8/159 (5%)
Query: 318 ECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYS--HNYFLDILERLNIM 375
           E ++L   RH N+I I      P  + +   ++    +E  LY       L        +
Sbjct: 77  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 136
Query: 376 IDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVR-QTM 434
             +   L+Y+H    S +++H DLKP+N+LL+      + DFG+ ++     D     T 
Sbjct: 137 YQILRGLKYIH----SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 192
Query: 435 TMATIGYMAPEYGLEGIVSAKC-DVYSYGVLLMETFTRK 472
            +AT  Y APE  L      K  D++S G +L E  + +
Sbjct: 193 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 70/159 (44%), Gaps = 8/159 (5%)
Query: 318 ECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYS--HNYFLDILERLNIM 375
           E ++L   RH N+I I      P  + +   ++    +E  LY       L        +
Sbjct: 68  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 127
Query: 376 IDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVR-QTM 434
             +   L+Y+H    S +++H DLKP+N+LL+      + DFG+ ++     D     T 
Sbjct: 128 YQILRGLKYIH----SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 183
Query: 435 TMATIGYMAPEYGLEGIVSAKC-DVYSYGVLLMETFTRK 472
            +AT  Y APE  L      K  D++S G +L E  + +
Sbjct: 184 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 70/159 (44%), Gaps = 8/159 (5%)
Query: 318 ECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYS--HNYFLDILERLNIM 375
           E ++L   RH N+I I      P  + +   ++    +E  LY       L        +
Sbjct: 75  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 134
Query: 376 IDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVR-QTM 434
             +   L+Y+H    S +++H DLKP+N+LL+      + DFG+ ++     D     T 
Sbjct: 135 YQILRGLKYIH----SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 190
Query: 435 TMATIGYMAPEYGLEGIVSAKC-DVYSYGVLLMETFTRK 472
            +AT  Y APE  L      K  D++S G +L E  + +
Sbjct: 191 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 70/159 (44%), Gaps = 8/159 (5%)
Query: 318 ECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYS--HNYFLDILERLNIM 375
           E ++L   RH N+I I      P  + +   ++    +E  LY       L        +
Sbjct: 69  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 128
Query: 376 IDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVR-QTM 434
             +   L+Y+H    S +++H DLKP+N+LL+      + DFG+ ++     D     T 
Sbjct: 129 YQILRGLKYIH----SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 184
Query: 435 TMATIGYMAPEYGLEGIVSAKC-DVYSYGVLLMETFTRK 472
            +AT  Y APE  L      K  D++S G +L E  + +
Sbjct: 185 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/188 (26%), Positives = 86/188 (45%), Gaps = 30/188 (15%)
Query: 327 HRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILE------RLNIMIDVGS 380
           H N+I+   S +   F  + LE + N +L+  + S N   + L+       ++++  + S
Sbjct: 86  HPNVIRYYCSETTDRFLYIALE-LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 144
Query: 381 ALEYLHNGHSSVHIIHCDLKPTNILLD-------------ENMVAHVSDFGIYKLLGEGE 427
            + +LH    S+ IIH DLKP NIL+              EN+   +SDFG+ K L  G+
Sbjct: 145 GVAHLH----SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 200
Query: 428 DSVRQTMT--MATIGYMAPEYGLEGI---VSAKCDVYSYGVLLMETFTR-KRPTDEMFIG 481
              R  +     T G+ APE   E     ++   D++S G +     ++ K P  + +  
Sbjct: 201 XXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 260
Query: 482 EMSLRRWV 489
           E ++ R +
Sbjct: 261 ESNIIRGI 268

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 70/159 (44%), Gaps = 8/159 (5%)
Query: 318 ECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYS--HNYFLDILERLNIM 375
           E ++L   RH N+I I      P  + +   ++    +E  LY       L        +
Sbjct: 69  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 128
Query: 376 IDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVR-QTM 434
             +   L+Y+H    S +++H DLKP+N+LL+      + DFG+ ++     D     T 
Sbjct: 129 YQILRGLKYIH----SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 184
Query: 435 TMATIGYMAPEYGLEGIVSAKC-DVYSYGVLLMETFTRK 472
            +AT  Y APE  L      K  D++S G +L E  + +
Sbjct: 185 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 70/159 (44%), Gaps = 8/159 (5%)
Query: 318 ECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYS--HNYFLDILERLNIM 375
           E ++L   RH N+I I      P  + +   ++    +E  LY       L        +
Sbjct: 71  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 130
Query: 376 IDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVR-QTM 434
             +   L+Y+H    S +++H DLKP+N+LL+      + DFG+ ++     D     T 
Sbjct: 131 YQILRGLKYIH----SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 186
Query: 435 TMATIGYMAPEYGLEGIVSAKC-DVYSYGVLLMETFTRK 472
            +AT  Y APE  L      K  D++S G +L E  + +
Sbjct: 187 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 83/203 (40%), Gaps = 23/203 (11%)
Query: 274 FNECNLLGTSSFGSVYK-GTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNV------- 325
           F   + LG  S+G V+K  +  DG   A+K    +    FR        L  V       
Sbjct: 59  FQRLSRLGHGSYGEVFKVRSKEDGRLYAVK----RSMSPFRGPKDRARKLAEVGSHEKVG 114
Query: 326 RHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYL 385
           +H   +++  ++       L  E     SL++   +    L   +    + D   AL +L
Sbjct: 115 QHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHL 173
Query: 386 HNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG-EGEDSVRQTMTMATIGYMAP 444
           H    S  ++H D+KP NI L       + DFG+   LG  G   V++        YMAP
Sbjct: 174 H----SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE----GDPRYMAP 225
Query: 445 EYGLEGIVSAKCDVYSYGVLLME 467
           E  L+G      DV+S G+ ++E
Sbjct: 226 EL-LQGSYGTAADVFSLGLTILE 247

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 101/216 (46%), Gaps = 25/216 (11%)
Query: 273 EFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRSFDS--ECEVLRNVRHRN 329
           ++ +   +G  +FG V+K      G  VA+K   ++ E+      +  E ++L+ ++H N
Sbjct: 19  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 78
Query: 330 ---LIKILSSYSNPDFKA-----LVLEFMPN---GSLEKWLYSHNYFLDILERLNIMIDV 378
              LI+I  + ++P  +      LV +F  +   G L   L    + L  ++R+  M+  
Sbjct: 79  VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK--FTLSEIKRVMQMLLN 136
Query: 379 GSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSV--RQTMTM 436
           G  L Y+H       I+H D+K  N+L+  + V  ++DFG+ +     ++S   R    +
Sbjct: 137 G--LYYIHRNK----ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRV 190
Query: 437 ATIGYMAPEYGL-EGIVSAKCDVYSYGVLLMETFTR 471
            T+ Y  PE  L E       D++  G ++ E +TR
Sbjct: 191 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR 226

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 101/216 (46%), Gaps = 25/216 (11%)
Query: 273 EFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRSFDS--ECEVLRNVRHRN 329
           ++ +   +G  +FG V+K      G  VA+K   ++ E+      +  E ++L+ ++H N
Sbjct: 18  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 77
Query: 330 ---LIKILSSYSNPDFKA-----LVLEFMPN---GSLEKWLYSHNYFLDILERLNIMIDV 378
              LI+I  + ++P  +      LV +F  +   G L   L    + L  ++R+  M+  
Sbjct: 78  VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK--FTLSEIKRVMQMLLN 135
Query: 379 GSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSV--RQTMTM 436
           G  L Y+H       I+H D+K  N+L+  + V  ++DFG+ +     ++S   R    +
Sbjct: 136 G--LYYIHRNK----ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRV 189
Query: 437 ATIGYMAPEYGL-EGIVSAKCDVYSYGVLLMETFTR 471
            T+ Y  PE  L E       D++  G ++ E +TR
Sbjct: 190 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR 225

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 97/219 (44%), Gaps = 29/219 (13%)
Query: 286 GSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKAL 345
           GS  +G +    D AI   N+ +++  R F ++    R  R   L+K ++   + +   L
Sbjct: 38  GSGAQGIVCAAYD-AILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN---HKNIIGL 93
Query: 346 VLEFMPNGSLEKW--LYSHNYFLDI-----------LERLNIMI-DVGSALEYLHNGHSS 391
           +  F P  SLE++  +Y     +D             ER++ ++  +   +++LH    S
Sbjct: 94  LNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH----S 149
Query: 392 VHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGI 451
             IIH DLKP+NI++  +    + DFG+ +  G    S   T  + T  Y APE  L   
Sbjct: 150 AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEVILGMG 206
Query: 452 VSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVK 490
                D++S G ++ E    K     +F G   + +W K
Sbjct: 207 YKENVDLWSVGCIMGEMVCHKI----LFPGRDYIDQWNK 241

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 87/217 (40%), Gaps = 38/217 (17%)
Query: 272 DEFNECNLLGTSSFGSVYKGTISD-GTDVAIKV-----FNLQLERAFRSFDSECEVLRNV 325
           D +  C ++G   F  V +    + G   A+K+     F      +      E  +   +
Sbjct: 26  DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 85
Query: 326 RHRNLIKILSSYSNPDFKALVLEFMPNGSL---------EKWLYSH----NYFLDILERL 372
           +H +++++L +YS+     +V EFM    L           ++YS     +Y   ILE  
Sbjct: 86  KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILE-- 143
Query: 373 NIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILL---DENMVAHVSDFGIYKLLGEGEDS 429
                   AL Y H+     +IIH D+KP  +LL   + +    +  FG+   L  GE  
Sbjct: 144 --------ALRYCHDN----NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL--GESG 189
Query: 430 VRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLM 466
           +     + T  +MAPE           DV+  GV+L 
Sbjct: 190 LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILF 226

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 70/159 (44%), Gaps = 8/159 (5%)
Query: 318 ECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYS--HNYFLDILERLNIM 375
           E ++L   RH N+I I      P  + +   ++    +E  LY       L        +
Sbjct: 73  EIKILLAFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 132
Query: 376 IDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVR-QTM 434
             +   L+Y+H    S +++H DLKP+N+LL+      + DFG+ ++     D     T 
Sbjct: 133 YQILRGLKYIH----SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 188
Query: 435 TMATIGYMAPEYGLEGIVSAKC-DVYSYGVLLMETFTRK 472
            +AT  Y APE  L      K  D++S G +L E  + +
Sbjct: 189 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 90/196 (45%), Gaps = 25/196 (12%)
Query: 286 GSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKAL 345
           GS  +G +    D AI   N+ +++  R F ++    R  R   L+K+++   + +   L
Sbjct: 33  GSGAQGIVCAAYD-AILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVN---HKNIIGL 88
Query: 346 VLEFMPNGSLEKW--LYSHNYFLDI-----------LERLNIMI-DVGSALEYLHNGHSS 391
           +  F P  SLE++  +Y     +D             ER++ ++  +   +++LH    S
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHLH----S 144
Query: 392 VHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGI 451
             IIH DLKP+NI++  +    + DFG+ +  G    S   T  + T  Y APE  L   
Sbjct: 145 AGIIHRDLKPSNIVVKSDATLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEVILGMG 201
Query: 452 VSAKCDVYSYGVLLME 467
                D++S G ++ E
Sbjct: 202 YKENVDIWSVGCIMGE 217

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 89/188 (47%), Gaps = 25/188 (13%)
Query: 309 ERAFRSFDSECEVLRNVRHRNLIKILSSYSNP----DFK--ALVLEFMPNGSLEKWLYSH 362
           +RA+R    E  +++ V H+N+I +L+ ++      +F+   LV+E M + +L + +   
Sbjct: 106 KRAYR----ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME 160
Query: 363 NYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKL 422
              LD      ++  +   +++LH    S  IIH DLKP+NI++  +    + DFG+ + 
Sbjct: 161 ---LDHERMSYLLYQMLCGIKHLH----SAGIIHRDLKPSNIVVKSDCTLKILDFGLART 213
Query: 423 LGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGE 482
            G    S   T  + T  Y APE  L        D++S G ++ E    K     +F G 
Sbjct: 214 AGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI----LFPGR 266
Query: 483 MSLRRWVK 490
             + +W K
Sbjct: 267 DYIDQWNK 274

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 70/159 (44%), Gaps = 8/159 (5%)
Query: 318 ECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYS--HNYFLDILERLNIM 375
           E ++L   RH N+I I      P  + +   ++    +E  LY       L        +
Sbjct: 73  EIKILLAFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 132
Query: 376 IDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVR-QTM 434
             +   L+Y+H    S +++H DLKP+N+LL+      + DFG+ ++     D     T 
Sbjct: 133 YQILRGLKYIH----SANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTE 188
Query: 435 TMATIGYMAPEYGLEGIVSAKC-DVYSYGVLLMETFTRK 472
            +AT  Y APE  L      K  D++S G +L E  + +
Sbjct: 189 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 101/216 (46%), Gaps = 25/216 (11%)
Query: 273 EFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRSFDS--ECEVLRNVRHRN 329
           ++ +   +G  +FG V+K      G  VA+K   ++ E+      +  E ++L+ ++H N
Sbjct: 19  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 78
Query: 330 ---LIKILSSYSNPDFKA-----LVLEFMPN---GSLEKWLYSHNYFLDILERLNIMIDV 378
              LI+I  + ++P  +      LV +F  +   G L   L    + L  ++R+  M+  
Sbjct: 79  VVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVK--FTLSEIKRVMQMLLN 136
Query: 379 GSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSV--RQTMTM 436
           G  L Y+H       I+H D+K  N+L+  + V  ++DFG+ +     ++S   R    +
Sbjct: 137 G--LYYIHRNK----ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRV 190
Query: 437 ATIGYMAPEYGL-EGIVSAKCDVYSYGVLLMETFTR 471
            T+ Y  PE  L E       D++  G ++ E +TR
Sbjct: 191 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR 226

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 87/192 (45%), Gaps = 34/192 (17%)
Query: 327 HRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILE------RLNIMIDVGS 380
           H N+I+   S +   F  + LE + N +L+  + S N   + L+       ++++  + S
Sbjct: 68  HPNVIRYYCSETTDRFLYIALE-LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 126
Query: 381 ALEYLHNGHSSVHIIHCDLKPTNILLD-------------ENMVAHVSDFGIYKLLGEGE 427
            + +LH    S+ IIH DLKP NIL+              EN+   +SDFG+ K L  G+
Sbjct: 127 GVAHLH----SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 182
Query: 428 DSVRQTMT--MATIGYMAPEYGLEG-------IVSAKCDVYSYGVLLMETFTR-KRPTDE 477
            S R  +     T G+ APE   E         ++   D++S G +     ++ K P  +
Sbjct: 183 SSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 242
Query: 478 MFIGEMSLRRWV 489
            +  E ++ R +
Sbjct: 243 KYSRESNIIRGI 254

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 103/226 (45%), Gaps = 20/226 (8%)
Query: 255 PLAIWRRTSYLDIQRATDEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFNLQLERAFR 313
           P   W   S++      D++     LG   +  V++   I++   V +K+     +   +
Sbjct: 20  PREYWDYASHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKNKIK 79
Query: 314 SFDSECEVLRNVRH-RNLIKILSSYSNPDFK--ALVLEFMPNGSLEKWLYSHNYFLDILE 370
               E ++L N+R   N+I +     +P  +  ALV E + N   ++ LY      DI  
Sbjct: 80  R---EIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ-LYQTLTDYDI-- 133
Query: 371 RLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLD-ENMVAHVSDFGIYKLLGEGEDS 429
           R   M ++  AL+Y H    S+ I+H D+KP N+++D E+    + D+G+ +    G++ 
Sbjct: 134 RF-YMYEILKALDYCH----SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY 188
Query: 430 VRQTMTMATIGYMAPEYGLE-GIVSAKCDVYSYGVLLMETFTRKRP 474
               + +A+  +  PE  ++  +     D++S G +L     RK P
Sbjct: 189 ---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 231

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 67/149 (44%), Gaps = 17/149 (11%)
Query: 323 RNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSAL 382
           R++RH N+++       P   A+++E+   G L + + +   F +   R      + S +
Sbjct: 71  RSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARF-FFQQLLSGV 129
Query: 383 EYLHNGHSSVHIIHCDLKPTNILLDENMVAH--VSDFGIYKLLGEGEDSVRQTMTMATIG 440
            Y H    S+ I H DLK  N LLD +      + DFG  K       SV  +   +T+G
Sbjct: 130 SYCH----SMQICHRDLKLENTLLDGSPAPRLKICDFGYSK------SSVLHSQPKSTVG 179
Query: 441 ---YMAPEYGLEGIVSAK-CDVYSYGVLL 465
              Y+APE  L      K  DV+S GV L
Sbjct: 180 TPAYIAPEVLLRQEYDGKIADVWSCGVTL 208

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 101/216 (46%), Gaps = 25/216 (11%)
Query: 273 EFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRSFDS--ECEVLRNVRHRN 329
           ++ +   +G  +FG V+K      G  VA+K   ++ E+      +  E ++L+ ++H N
Sbjct: 19  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 78
Query: 330 ---LIKILSSYSNPDFKA-----LVLEFMPN---GSLEKWLYSHNYFLDILERLNIMIDV 378
              LI+I  + ++P  +      LV +F  +   G L   L    + L  ++R+  M+  
Sbjct: 79  VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK--FTLSEIKRVMQMLLN 136
Query: 379 GSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSV--RQTMTM 436
           G  L Y+H       I+H D+K  N+L+  + V  ++DFG+ +     ++S   R    +
Sbjct: 137 G--LYYIHRNK----ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRV 190
Query: 437 ATIGYMAPEYGL-EGIVSAKCDVYSYGVLLMETFTR 471
            T+ Y  PE  L E       D++  G ++ E +TR
Sbjct: 191 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR 226

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 89/189 (47%), Gaps = 27/189 (14%)
Query: 309 ERAFRSFDSECEVLRNVRHRNLIKILSSYSNP----DFK--ALVLEFMPNGSLEKWLYSH 362
           +RA+R    E  +++ V H+N+I +L+ ++      +F+   LV+E M     +      
Sbjct: 68  KRAYR----ELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL 123
Query: 363 NYFLDILERLNIMI-DVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYK 421
           ++     ER++ ++  +   +++LH    S  IIH DLKP+NI++  +    + DFG+ +
Sbjct: 124 DH-----ERMSYLLYQMLCGIKHLH----SAGIIHRDLKPSNIVVKSDXTLKILDFGLAR 174
Query: 422 LLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIG 481
             G    S   T  + T  Y APE  L        D++S G ++ E    K     +F G
Sbjct: 175 TAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI----LFPG 227
Query: 482 EMSLRRWVK 490
              + +W K
Sbjct: 228 RDYIDQWNK 236

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 71/162 (43%), Gaps = 14/162 (8%)
Query: 318 ECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLN---- 373
           E ++L   RH N+I I      P  + +   ++    +E  LY     L      N    
Sbjct: 75  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYK---LLKCQHLSNDHIC 131
Query: 374 -IMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVR- 431
             +  +   L+Y+H    S +++H DLKP+N+LL+      + DFG+ ++     D    
Sbjct: 132 YFLYQILRGLKYIH----SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 187
Query: 432 QTMTMATIGYMAPEYGLEGIVSAKC-DVYSYGVLLMETFTRK 472
            T  +AT  Y APE  L      K  D++S G +L E  + +
Sbjct: 188 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 90/196 (45%), Gaps = 25/196 (12%)
Query: 286 GSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKAL 345
           GS  +G +    D AI   N+ +++  R F ++    R  R   L+K+++   + +   L
Sbjct: 33  GSGAQGIVCAAYD-AILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVN---HKNIIGL 88
Query: 346 VLEFMPNGSLEKW--LYSHNYFLDI-----------LERLNIMI-DVGSALEYLHNGHSS 391
           +  F P  SLE++  +Y     +D             ER++ ++  +   +++LH    S
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIKHLH----S 144
Query: 392 VHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGI 451
             IIH DLKP+NI++  +    + DFG+ +  G    S   T  + T  Y APE  L   
Sbjct: 145 AGIIHRDLKPSNIVVKSDATLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEVILGMG 201
Query: 452 VSAKCDVYSYGVLLME 467
                D++S G ++ E
Sbjct: 202 YKENVDIWSVGCIMGE 217

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 97/219 (44%), Gaps = 29/219 (13%)
Query: 286 GSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKAL 345
           GS  +G +    D AI   N+ +++  R F ++    R  R   L+K ++   + +   L
Sbjct: 27  GSGAQGIVCAAYD-AILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN---HKNIIGL 82
Query: 346 VLEFMPNGSLEKW--LYSHNYFLDI-----------LERLNIMI-DVGSALEYLHNGHSS 391
           +  F P  SLE++  +Y     +D             ER++ ++  +   +++LH    S
Sbjct: 83  LNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH----S 138
Query: 392 VHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGI 451
             IIH DLKP+NI++  +    + DFG+ +  G    S   T  + T  Y APE  L   
Sbjct: 139 AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEVILGMG 195
Query: 452 VSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVK 490
                D++S G ++ E    K     +F G   + +W K
Sbjct: 196 YKENVDLWSVGCIMGEMVCHKI----LFPGRDYIDQWNK 230

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 87/217 (40%), Gaps = 38/217 (17%)
Query: 272 DEFNECNLLGTSSFGSVYKGTISD-GTDVAIKV-----FNLQLERAFRSFDSECEVLRNV 325
           D +  C ++G   F  V +    + G   A+K+     F      +      E  +   +
Sbjct: 24  DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 326 RHRNLIKILSSYSNPDFKALVLEFMPNGSL---------EKWLYSH----NYFLDILERL 372
           +H +++++L +YS+     +V EFM    L           ++YS     +Y   ILE  
Sbjct: 84  KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILE-- 141
Query: 373 NIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILL---DENMVAHVSDFGIYKLLGEGEDS 429
                   AL Y H+     +IIH D+KP  +LL   + +    +  FG+   LGE    
Sbjct: 142 --------ALRYCHDN----NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES--G 187
Query: 430 VRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLM 466
           +     + T  +MAPE           DV+  GV+L 
Sbjct: 188 LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILF 224

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 73/161 (45%), Gaps = 12/161 (7%)
Query: 318 ECEVLRNVRHRNLIKILSSYSNPDFKAL----VLEFMPNGSLEKWLYSHNYFLDILERLN 373
           E ++L   RH N+I I      P  + +    ++  +    L K L + +   D +    
Sbjct: 91  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHI--CY 148
Query: 374 IMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVR-Q 432
            +  +   L+Y+H    S +++H DLKP+N+LL+      + DFG+ ++     D     
Sbjct: 149 FLYQILRGLKYIH----SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFL 204
Query: 433 TMTMATIGYMAPEYGLEGIVSAKC-DVYSYGVLLMETFTRK 472
           T  +AT  Y APE  L      K  D++S G +L E  + +
Sbjct: 205 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 80/194 (41%), Gaps = 20/194 (10%)
Query: 266 DIQRATDEFNEC-----------NLLGTSSFGSVYKGTISDGTDVAIKVFNLQL--ERAF 312
           D  +A+   NEC             +G+     V++         AIK  NL+    +  
Sbjct: 39  DDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTL 98
Query: 313 RSFDSECEVLRNVR-HRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILER 371
            S+ +E   L  ++ H + I  L  Y   D    ++    N  L  WL      +D  ER
Sbjct: 99  DSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKK-SIDPWER 157
Query: 372 LNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVR 431
            +   ++  A+  +H  H    I+H DLKP N L+ + M+  + DFGI   +     SV 
Sbjct: 158 KSYWKNMLEAVHTIHQ-HG---IVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVV 212
Query: 432 QTMTMATIGYMAPE 445
           +   + T+ YM PE
Sbjct: 213 KDSQVGTVNYMPPE 226

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 58/240 (24%), Positives = 97/240 (40%), Gaps = 33/240 (13%)
Query: 266 DIQRATDEFNEC-----------NLLGTSSFGSVYKGTISDGTDVAIKVFNLQL--ERAF 312
           D  +A+   NEC             +G+     V++         AIK  NL+    +  
Sbjct: 39  DDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTL 98
Query: 313 RSFDSECEVLRNVR-HRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILER 371
            S+ +E   L  ++ H + I  L  Y   D    ++    N  L  WL      +D  ER
Sbjct: 99  DSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKK-SIDPWER 157
Query: 372 LNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVR 431
            +   ++  A+  +H  H    I+H DLKP N L+ + M+  + DFGI   +     SV 
Sbjct: 158 KSYWKNMLEAVHTIHQ-HG---IVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVV 212
Query: 432 QTMTMATIGYMAPEYGLEGIVSAK------------CDVYSYGVLLMETFTRKRPTDEMF 479
           +   + T+ YM PE  ++ + S++             DV+S G +L      K P  ++ 
Sbjct: 213 KDSQVGTVNYMPPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 271

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 89/188 (47%), Gaps = 25/188 (13%)
Query: 309 ERAFRSFDSECEVLRNVRHRNLIKILSSYSNP----DFK--ALVLEFMPNGSLEKWLYSH 362
           +RA+R    E  +++ V H+N+I +L+ ++      +F+   LV+E M + +L + +   
Sbjct: 106 KRAYR----ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME 160
Query: 363 NYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKL 422
              LD      ++  +   +++LH    S  IIH DLKP+NI++  +    + DFG+ + 
Sbjct: 161 ---LDHERMSYLLYQMLCGIKHLH----SAGIIHRDLKPSNIVVKSDCTLKILDFGLART 213
Query: 423 LGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGE 482
            G    S   T  + T  Y APE  L        D++S G ++ E    K     +F G 
Sbjct: 214 AGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI----LFPGR 266
Query: 483 MSLRRWVK 490
             + +W K
Sbjct: 267 DYIDQWNK 274

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 89/196 (45%), Gaps = 25/196 (12%)
Query: 286 GSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKAL 345
           GS  +G +    D AI   N+ +++  R F ++    R  R   L+K ++   + +   L
Sbjct: 33  GSGAQGIVCAAYD-AILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN---HKNIIGL 88
Query: 346 VLEFMPNGSLEKW--LYSHNYFLDI-----------LERLNIMI-DVGSALEYLHNGHSS 391
           +  F P  SLE++  +Y     +D             ER++ ++  +   +++LH    S
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH----S 144
Query: 392 VHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGI 451
             IIH DLKP+NI++  +    + DFG+ +  G    S   T  + T  Y APE  L   
Sbjct: 145 AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPEVVTRYYRAPEVILGMG 201
Query: 452 VSAKCDVYSYGVLLME 467
                D++S G ++ E
Sbjct: 202 YKENVDIWSVGCIMGE 217

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 89/188 (47%), Gaps = 25/188 (13%)
Query: 309 ERAFRSFDSECEVLRNVRHRNLIKILSSYSNP----DFK--ALVLEFMPNGSLEKWLYSH 362
           +RA+R    E  +++ V H+N+I +L+ ++      +F+   LV+E M + +L + +   
Sbjct: 68  KRAYR----ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME 122
Query: 363 NYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKL 422
              LD      ++  +   +++LH    S  IIH DLKP+NI++  +    + DFG+ + 
Sbjct: 123 ---LDHERMSYLLYQMLCGIKHLH----SAGIIHRDLKPSNIVVKSDCTLKILDFGLART 175
Query: 423 LGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGE 482
            G    S   T  + T  Y APE  L        D++S G ++ E    K     +F G 
Sbjct: 176 AGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI----LFPGR 228
Query: 483 MSLRRWVK 490
             + +W K
Sbjct: 229 DYIDQWNK 236

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 89/188 (47%), Gaps = 25/188 (13%)
Query: 309 ERAFRSFDSECEVLRNVRHRNLIKILSSYSNP----DFK--ALVLEFMPNGSLEKWLYSH 362
           +RA+R    E  +++ V H+N+I +L+ ++      +F+   LV+E M + +L + +   
Sbjct: 67  KRAYR----ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME 121
Query: 363 NYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKL 422
              LD      ++  +   +++LH    S  IIH DLKP+NI++  +    + DFG+ + 
Sbjct: 122 ---LDHERMSYLLYQMLCGIKHLH----SAGIIHRDLKPSNIVVKSDCTLKILDFGLART 174
Query: 423 LGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGE 482
            G    S   T  + T  Y APE  L        D++S G ++ E    K     +F G 
Sbjct: 175 AGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI----LFPGR 227
Query: 483 MSLRRWVK 490
             + +W K
Sbjct: 228 DYIDQWNK 235

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 66/262 (25%), Positives = 109/262 (41%), Gaps = 41/262 (15%)
Query: 300 AIKVFNLQL--ERAFRSFDSECEVLRNVR-HRNLIKILSSYSNPDFKALVLEFMPNGSLE 356
           AIK  NL+    +   S+ +E   L  ++ H + I  L  Y   D    ++    N  L 
Sbjct: 40  AIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLN 99
Query: 357 KWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSD 416
            WL      +D  ER +   ++  A+  +H  H    I+H DLKP N L+ + M+  + D
Sbjct: 100 SWLKKKK-SIDPWERKSYWKNMLEAVHTIHQ-HG---IVHSDLKPANFLIVDGMLKLI-D 153
Query: 417 FGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAK------------CDVYSYGVL 464
           FGI   +     SV +   + T+ YM PE  ++ + S++             DV+S G +
Sbjct: 154 FGIANQMQPDTTSVVKDSQVGTVNYMPPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCI 212
Query: 465 LMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMD 524
           L      K P  ++ I ++S            L  ++D N    E  F    D     + 
Sbjct: 213 LYYMTYGKTPFQQI-INQIS-----------KLHAIIDPN---HEIEFP---DIPEKDLQ 254
Query: 525 FALDCCME-SPDMRINMTDAAA 545
             L CC++  P  RI++ +  A
Sbjct: 255 DVLKCCLKRDPKQRISIPELLA 276

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 47/195 (24%), Positives = 90/195 (46%), Gaps = 12/195 (6%)
Query: 280 LGTSSFGSVYKGTISDGTD--VAIKVFNLQLER-AFRSFDSECEVLRNVRHRNLIKILSS 336
           LG  ++ +VYKG  S  TD  VA+K   L+ E  A  +   E  +L++++H N++ +   
Sbjct: 10  LGEGTYATVYKGK-SKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 68
Query: 337 YSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIH 396
                   LV E++ +  L+++L      +++      +  +   L Y H       ++H
Sbjct: 69  IHTEKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK----VLH 123
Query: 397 CDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGI-VSAK 455
            DLKP N+L++E     ++DFG+ +   +   +      + T+ Y  P+  L     S +
Sbjct: 124 RDLKPQNLLINERGELKLADFGLAR--AKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQ 181
Query: 456 CDVYSYGVLLMETFT 470
            D++  G +  E  T
Sbjct: 182 IDMWGVGCIFYEMAT 196

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 89/188 (47%), Gaps = 25/188 (13%)
Query: 309 ERAFRSFDSECEVLRNVRHRNLIKILSSYSNP----DFK--ALVLEFMPNGSLEKWLYSH 362
           +RA+R    E  +++ V H+N+I +L+ ++      +F+   LV+E M + +L + +   
Sbjct: 69  KRAYR----ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME 123
Query: 363 NYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKL 422
              LD      ++  +   +++LH    S  IIH DLKP+NI++  +    + DFG+ + 
Sbjct: 124 ---LDHERMSYLLYQMLCGIKHLH----SAGIIHRDLKPSNIVVKSDCTLKILDFGLART 176
Query: 423 LGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGE 482
            G    S   T  + T  Y APE  L        D++S G ++ E    K     +F G 
Sbjct: 177 AGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI----LFPGR 229
Query: 483 MSLRRWVK 490
             + +W K
Sbjct: 230 DYIDQWNK 237

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 89/188 (47%), Gaps = 25/188 (13%)
Query: 309 ERAFRSFDSECEVLRNVRHRNLIKILSSYSNP----DFK--ALVLEFMPNGSLEKWLYSH 362
           +RA+R    E  +++ V H+N+I +L+ ++      +F+   LV+E M + +L + +   
Sbjct: 62  KRAYR----ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME 116
Query: 363 NYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKL 422
              LD      ++  +   +++LH    S  IIH DLKP+NI++  +    + DFG+ + 
Sbjct: 117 ---LDHERMSYLLYQMLCGIKHLH----SAGIIHRDLKPSNIVVKSDCTLKILDFGLART 169
Query: 423 LGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGE 482
            G    S   T  + T  Y APE  L        D++S G ++ E    K     +F G 
Sbjct: 170 AGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI----LFPGR 222
Query: 483 MSLRRWVK 490
             + +W K
Sbjct: 223 DYIDQWNK 230

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 89/188 (47%), Gaps = 25/188 (13%)
Query: 309 ERAFRSFDSECEVLRNVRHRNLIKILSSYSNP----DFK--ALVLEFMPNGSLEKWLYSH 362
           +RA+R    E  +++ V H+N+I +L+ ++      +F+   LV+E M + +L + +   
Sbjct: 61  KRAYR----ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME 115
Query: 363 NYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKL 422
              LD      ++  +   +++LH    S  IIH DLKP+NI++  +    + DFG+ + 
Sbjct: 116 ---LDHERMSYLLYQMLCGIKHLH----SAGIIHRDLKPSNIVVKSDCTLKILDFGLART 168
Query: 423 LGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGE 482
            G    S   T  + T  Y APE  L        D++S G ++ E    K     +F G 
Sbjct: 169 AGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI----LFPGR 221
Query: 483 MSLRRWVK 490
             + +W K
Sbjct: 222 DYIDQWNK 229

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 89/188 (47%), Gaps = 25/188 (13%)
Query: 309 ERAFRSFDSECEVLRNVRHRNLIKILSSYSNP----DFK--ALVLEFMPNGSLEKWLYSH 362
           +RA+R    E  +++ V H+N+I +L+ ++      +F+   LV+E M + +L + +   
Sbjct: 62  KRAYR----ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME 116
Query: 363 NYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKL 422
              LD      ++  +   +++LH    S  IIH DLKP+NI++  +    + DFG+ + 
Sbjct: 117 ---LDHERMSYLLYQMLCGIKHLH----SAGIIHRDLKPSNIVVKSDCTLKILDFGLART 169
Query: 423 LGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGE 482
            G    S   T  + T  Y APE  L        D++S G ++ E    K     +F G 
Sbjct: 170 AGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI----LFPGR 222
Query: 483 MSLRRWVK 490
             + +W K
Sbjct: 223 DYIDQWNK 230

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 89/188 (47%), Gaps = 25/188 (13%)
Query: 309 ERAFRSFDSECEVLRNVRHRNLIKILSSYSNP----DFK--ALVLEFMPNGSLEKWLYSH 362
           +RA+R    E  +++ V H+N+I +L+ ++      +F+   LV+E M + +L + +   
Sbjct: 69  KRAYR----ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME 123
Query: 363 NYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKL 422
              LD      ++  +   +++LH    S  IIH DLKP+NI++  +    + DFG+ + 
Sbjct: 124 ---LDHERMSYLLYQMLCGIKHLH----SAGIIHRDLKPSNIVVKSDCTLKILDFGLART 176
Query: 423 LGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGE 482
            G    S   T  + T  Y APE  L        D++S G ++ E    K     +F G 
Sbjct: 177 AGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI----LFPGR 229
Query: 483 MSLRRWVK 490
             + +W K
Sbjct: 230 DYIDQWNK 237

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 87/207 (42%), Gaps = 17/207 (8%)
Query: 265 LDIQRATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRN 324
           L I   +D +     +G+ +FG           ++    +  + E+   +   E    R+
Sbjct: 12  LPIMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIAANVKREIINHRS 71
Query: 325 VRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEY 384
           +RH N+++       P   A+V+E+   G L + + +   F +   R      + S + Y
Sbjct: 72  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF-FFQQLISGVSY 130
Query: 385 LHNGHSSVHIIHCDLKPTNILLDENMVAH--VSDFGIYKLLGEGEDSVRQTMTMATIG-- 440
            H    ++ + H DLK  N LLD +      + DFG  K       SV  +   +T+G  
Sbjct: 131 CH----AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK------SSVLHSQPKSTVGTP 180
Query: 441 -YMAPEYGLEGIVSAK-CDVYSYGVLL 465
            Y+APE  L+     K  DV+S GV L
Sbjct: 181 AYIAPEVLLKKEYDGKVADVWSCGVTL 207

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 89/188 (47%), Gaps = 25/188 (13%)
Query: 309 ERAFRSFDSECEVLRNVRHRNLIKILSSYSNP----DFK--ALVLEFMPNGSLEKWLYSH 362
           +RA+R    E  +++ V H+N+I +L+ ++      +F+   LV+E M + +L + +   
Sbjct: 68  KRAYR----ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME 122
Query: 363 NYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKL 422
              LD      ++  +   +++LH    S  IIH DLKP+NI++  +    + DFG+ + 
Sbjct: 123 ---LDHERMSYLLYQMLCGIKHLH----SAGIIHRDLKPSNIVVKSDCTLKILDFGLART 175
Query: 423 LGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGE 482
            G    S   T  + T  Y APE  L        D++S G ++ E    K     +F G 
Sbjct: 176 AGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI----LFPGR 228
Query: 483 MSLRRWVK 490
             + +W K
Sbjct: 229 DYIDQWNK 236

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 96/219 (43%), Gaps = 29/219 (13%)
Query: 286 GSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKAL 345
           GS  +G +    D AI   N+ +++  R F ++    R  R   L+K ++   + +   L
Sbjct: 33  GSGAQGIVCAAYD-AILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN---HKNIIGL 88
Query: 346 VLEFMPNGSLEKW--LYSHNYFLDI-----------LERLNIMI-DVGSALEYLHNGHSS 391
           +  F P  SLE++  +Y     +D             ER++ ++  +   +++LH    S
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH----S 144
Query: 392 VHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGI 451
             IIH DLKP+NI++  +    + DFG+ +  G    S      + T  Y APE  L   
Sbjct: 145 AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMEPEVVTRYYRAPEVILGMG 201
Query: 452 VSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVK 490
                D++S G ++ E    K     +F G   + +W K
Sbjct: 202 YKENVDIWSVGCIMGEMVCHKI----LFPGRDYIDQWNK 236

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 66/262 (25%), Positives = 109/262 (41%), Gaps = 41/262 (15%)
Query: 300 AIKVFNLQL--ERAFRSFDSECEVLRNVR-HRNLIKILSSYSNPDFKALVLEFMPNGSLE 356
           AIK  NL+    +   S+ +E   L  ++ H + I  L  Y   D    ++    N  L 
Sbjct: 36  AIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLN 95
Query: 357 KWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSD 416
            WL      +D  ER +   ++  A+  +H  H    I+H DLKP N L+ + M+  + D
Sbjct: 96  SWLKKKK-SIDPWERKSYWKNMLEAVHTIHQ-HG---IVHSDLKPANFLIVDGMLKLI-D 149
Query: 417 FGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAK------------CDVYSYGVL 464
           FGI   +     SV +   + T+ YM PE  ++ + S++             DV+S G +
Sbjct: 150 FGIANQMQPDTTSVVKDSQVGTVNYMPPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCI 208
Query: 465 LMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMD 524
           L      K P  ++ I ++S            L  ++D N    E  F    D     + 
Sbjct: 209 LYYMTYGKTPFQQI-INQIS-----------KLHAIIDPN---HEIEFP---DIPEKDLQ 250
Query: 525 FALDCCME-SPDMRINMTDAAA 545
             L CC++  P  RI++ +  A
Sbjct: 251 DVLKCCLKRDPKQRISIPELLA 272

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 69/159 (43%), Gaps = 8/159 (5%)
Query: 318 ECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYS--HNYFLDILERLNIM 375
           E ++L   RH N+I I      P  + +   ++    +E  LY       L        +
Sbjct: 75  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 134
Query: 376 IDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVR-QTM 434
             +   L+Y+H    S +++H DLKP+N+LL+      + DFG+ ++     D       
Sbjct: 135 YQILRGLKYIH----SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXE 190
Query: 435 TMATIGYMAPEYGLEGIVSAKC-DVYSYGVLLMETFTRK 472
            +AT  Y APE  L      K  D++S G +L E  + +
Sbjct: 191 XVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 69/159 (43%), Gaps = 8/159 (5%)
Query: 318 ECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYS--HNYFLDILERLNIM 375
           E ++L   RH N+I I      P  + +   ++    +E  LY       L        +
Sbjct: 76  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 135
Query: 376 IDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVR-QTM 434
             +   L+Y+H    S +++H DLKP+N+LL+      + DFG+ ++     D       
Sbjct: 136 YQILRGLKYIH----SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXE 191
Query: 435 TMATIGYMAPEYGLEGIVSAKC-DVYSYGVLLMETFTRK 472
            +AT  Y APE  L      K  D++S G +L E  + +
Sbjct: 192 XVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 91/225 (40%), Gaps = 20/225 (8%)
Query: 266 DIQRATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNV 325
           D  + TD FN   +LG  SFG V       GTD    V  L+ +   +  D EC ++   
Sbjct: 15  DRMKLTD-FNFLMVLGKGSFGKVMLSE-RKGTDELYAVKILKKDVVIQDDDVECTMVEKR 72
Query: 326 ------RHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVG 379
                 +   L ++ S +   D    V+E++  G L   +     F +    +    ++ 
Sbjct: 73  VLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP-HAVFYAAEIA 131
Query: 380 SALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATI 439
             L +L     S  II+ DLK  N++LD      ++DFG+ K      D V       T 
Sbjct: 132 IGLFFLQ----SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKXFCGTP 185
Query: 440 GYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRP-----TDEMF 479
            Y+APE           D +++GVLL E    + P      DE+F
Sbjct: 186 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF 230

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 66/262 (25%), Positives = 109/262 (41%), Gaps = 41/262 (15%)
Query: 300 AIKVFNLQL--ERAFRSFDSECEVLRNVR-HRNLIKILSSYSNPDFKALVLEFMPNGSLE 356
           AIK  NL+    +   S+ +E   L  ++ H + I  L  Y   D    ++    N  L 
Sbjct: 37  AIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLN 96
Query: 357 KWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSD 416
            WL      +D  ER +   ++  A+  +H  H    I+H DLKP N L+ + M+  + D
Sbjct: 97  SWLKKKK-SIDPWERKSYWKNMLEAVHTIHQ-HG---IVHSDLKPANFLIVDGMLKLI-D 150
Query: 417 FGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAK------------CDVYSYGVL 464
           FGI   +     SV +   + T+ YM PE  ++ + S++             DV+S G +
Sbjct: 151 FGIANQMQPDTTSVVKDSQVGTVNYMPPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCI 209
Query: 465 LMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMD 524
           L      K P  ++ I ++S            L  ++D N    E  F    D     + 
Sbjct: 210 LYYMTYGKTPFQQI-INQIS-----------KLHAIIDPN---HEIEFP---DIPEKDLQ 251
Query: 525 FALDCCME-SPDMRINMTDAAA 545
             L CC++  P  RI++ +  A
Sbjct: 252 DVLKCCLKRDPKQRISIPELLA 273

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 89/196 (45%), Gaps = 25/196 (12%)
Query: 286 GSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKAL 345
           GS  +G +    D AI   N+ +++  R F ++    R  R   L+K ++   + +   L
Sbjct: 33  GSGAQGIVCAAYD-AILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN---HKNIIGL 88
Query: 346 VLEFMPNGSLEKW--LYSHNYFLDI-----------LERLNIMI-DVGSALEYLHNGHSS 391
           +  F P  SLE++  +Y     +D             ER++ ++  +   +++LH    S
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH----S 144
Query: 392 VHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGI 451
             IIH DLKP+NI++  +    + DFG+ +  G    S   T  + T  Y APE  L   
Sbjct: 145 AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEVILGMG 201
Query: 452 VSAKCDVYSYGVLLME 467
                D++S G ++ E
Sbjct: 202 YKENVDIWSVGCIMGE 217

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 89/197 (45%), Gaps = 25/197 (12%)
Query: 285 FGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKA 344
            GS  +G +    D AI   N+ +++  R F ++    R  R   L+K ++   + +   
Sbjct: 33  IGSGAQGIVCAAYD-AILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN---HKNIIG 88
Query: 345 LVLEFMPNGSLEKW--LYSHNYFLDI-----------LERLNIMI-DVGSALEYLHNGHS 390
           L+  F P  SLE++  +Y     +D             ER++ ++  +   +++LH    
Sbjct: 89  LLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH---- 144
Query: 391 SVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEG 450
           S  IIH DLKP+NI++  +    + DFG+ +  G    S   T  + T  Y APE  L  
Sbjct: 145 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEVILGM 201
Query: 451 IVSAKCDVYSYGVLLME 467
                 D++S G ++ E
Sbjct: 202 GYKENVDIWSVGCIMGE 218

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 87/207 (42%), Gaps = 17/207 (8%)
Query: 265 LDIQRATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRN 324
           L I   +D +     +G+ +FG           ++    +  + E+   +   E    R+
Sbjct: 11  LPIMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRS 70
Query: 325 VRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEY 384
           +RH N+++       P   A+V+E+   G L + + +   F +   R      + S + Y
Sbjct: 71  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF-FFQQLISGVSY 129
Query: 385 LHNGHSSVHIIHCDLKPTNILLDENMVAH--VSDFGIYKLLGEGEDSVRQTMTMATIG-- 440
            H    ++ + H DLK  N LLD +      + DFG  K       SV  +   +T+G  
Sbjct: 130 CH----AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK------SSVLHSQPKSTVGTP 179
Query: 441 -YMAPEYGLEGIVSAK-CDVYSYGVLL 465
            Y+APE  L+     K  DV+S GV L
Sbjct: 180 AYIAPEVLLKKEYDGKVADVWSCGVTL 206

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 91/225 (40%), Gaps = 20/225 (8%)
Query: 266 DIQRATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNV 325
           D  + TD FN   +LG  SFG V       GTD    V  L+ +   +  D EC ++   
Sbjct: 336 DRMKLTD-FNFLMVLGKGSFGKVMLSE-RKGTDELYAVKILKKDVVIQDDDVECTMVEKR 393
Query: 326 ------RHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVG 379
                 +   L ++ S +   D    V+E++  G L   +     F +    +    ++ 
Sbjct: 394 VLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP-HAVFYAAEIA 452
Query: 380 SALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATI 439
             L +L     S  II+ DLK  N++LD      ++DFG+ K      D V       T 
Sbjct: 453 IGLFFLQ----SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKXFCGTP 506
Query: 440 GYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRP-----TDEMF 479
            Y+APE           D +++GVLL E    + P      DE+F
Sbjct: 507 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF 551

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 91/213 (42%), Gaps = 17/213 (7%)
Query: 280 LGTSSFGSVYK-GTISDGTDVAIKVFNLQLERAFRSFD-SECEVLRNVRHRNLIKILSSY 337
           LG  SFG V++      G   A+K   L++   FR  +   C  L + R   ++ +  + 
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKVRLEV---FRVEELVACAGLSSPR---IVPLYGAV 133
Query: 338 SNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHC 397
               +  + +E +  GSL + +      +  L     +  +G ALE L   H+   I+H 
Sbjct: 134 REGPWVNIFMELLEGGSLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLHTR-RILHG 188
Query: 398 DLKPTNILLD-ENMVAHVSDFGIYKLL---GEGEDSVRQTMTMATIGYMAPEYGLEGIVS 453
           D+K  N+LL  +   A + DFG    L   G G+  +       T  +MAPE  +     
Sbjct: 189 DVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCD 248
Query: 454 AKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLR 486
           AK D++S   +++       P  + F G + L+
Sbjct: 249 AKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK 281

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 66/262 (25%), Positives = 109/262 (41%), Gaps = 41/262 (15%)
Query: 300 AIKVFNLQL--ERAFRSFDSECEVLRNVR-HRNLIKILSSYSNPDFKALVLEFMPNGSLE 356
           AIK  NL+    +   S+ +E   L  ++ H + I  L  Y   D    ++    N  L 
Sbjct: 56  AIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLN 115
Query: 357 KWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSD 416
            WL      +D  ER +   ++  A+  +H  H    I+H DLKP N L+ + M+  + D
Sbjct: 116 SWLKKKK-SIDPWERKSYWKNMLEAVHTIHQ-HG---IVHSDLKPANFLIVDGMLKLI-D 169
Query: 417 FGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAK------------CDVYSYGVL 464
           FGI   +     SV +   + T+ YM PE  ++ + S++             DV+S G +
Sbjct: 170 FGIANQMQPDTTSVVKDSQVGTVNYMPPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCI 228
Query: 465 LMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMD 524
           L      K P  ++ I ++S            L  ++D N    E  F    D     + 
Sbjct: 229 LYYMTYGKTPFQQI-INQIS-----------KLHAIIDPN---HEIEFP---DIPEKDLQ 270
Query: 525 FALDCCME-SPDMRINMTDAAA 545
             L CC++  P  RI++ +  A
Sbjct: 271 DVLKCCLKRDPKQRISIPELLA 292

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 89/196 (45%), Gaps = 25/196 (12%)
Query: 286 GSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKAL 345
           GS  +G +    D AI   N+ +++  R F ++    R  R   L+K ++   + +   L
Sbjct: 33  GSGAQGIVCAAYD-AILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN---HKNIIGL 88
Query: 346 VLEFMPNGSLEKW--LYSHNYFLDI-----------LERLNIMI-DVGSALEYLHNGHSS 391
           +  F P  SLE++  +Y     +D             ER++ ++  +   +++LH    S
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHLH----S 144
Query: 392 VHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGI 451
             IIH DLKP+NI++  +    + DFG+ +  G    S   T  + T  Y APE  L   
Sbjct: 145 AGIIHRDLKPSNIVVKSDATLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEVILGMG 201
Query: 452 VSAKCDVYSYGVLLME 467
                D++S G ++ E
Sbjct: 202 YKENVDIWSVGCIMGE 217

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 89/196 (45%), Gaps = 25/196 (12%)
Query: 286 GSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKAL 345
           GS  +G +    D AI   N+ +++  R F ++    R  R   L+K ++   + +   L
Sbjct: 33  GSGAQGIVCAAYD-AILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN---HKNIIGL 88
Query: 346 VLEFMPNGSLEKW--LYSHNYFLDI-----------LERLNIMI-DVGSALEYLHNGHSS 391
           +  F P  SLE++  +Y     +D             ER++ ++  +   +++LH    S
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH----S 144
Query: 392 VHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGI 451
             IIH DLKP+NI++  +    + DFG+ +  G    S   T  + T  Y APE  L   
Sbjct: 145 AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEVILGMG 201
Query: 452 VSAKCDVYSYGVLLME 467
                D++S G ++ E
Sbjct: 202 YKENVDIWSVGCIMGE 217

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 86/211 (40%), Gaps = 25/211 (11%)
Query: 279 LLGTSSFGSVYKGTISDGTDVAIK-VFNLQ--------LERAF--RSFDSECEVLRNVRH 327
            + + S+G+V  G  S+G  VAIK VFN          L  +F  +    E  +L +  H
Sbjct: 29  FISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88
Query: 328 RNLI---KILSSYSNPDFKALVL--EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSAL 382
            N++    I   +  P    L L  E M    L + ++     +        M  +   L
Sbjct: 89  PNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQYFMYHILLGL 147
Query: 383 EYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYM 442
             LH       ++H DL P NILL +N    + DF + +   E      +T  +    Y 
Sbjct: 148 HVLHEAG----VVHRDLHPGNILLADNNDITICDFNLAR---EDTADANKTHYVTHRWYR 200
Query: 443 APEYGLEGIVSAK-CDVYSYGVLLMETFTRK 472
           APE  ++     K  D++S G ++ E F RK
Sbjct: 201 APELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 89/196 (45%), Gaps = 25/196 (12%)
Query: 286 GSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKAL 345
           GS  +G +    D AI   N+ +++  R F ++    R  R   L+K ++   + +   L
Sbjct: 33  GSGAQGIVCAAYD-AILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN---HKNIIGL 88
Query: 346 VLEFMPNGSLEKW--LYSHNYFLDI-----------LERLNIMI-DVGSALEYLHNGHSS 391
           +  F P  SLE++  +Y     +D             ER++ ++  +   +++LH    S
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHLH----S 144
Query: 392 VHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGI 451
             IIH DLKP+NI++  +    + DFG+ +  G    S   T  + T  Y APE  L   
Sbjct: 145 AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEVILGMG 201
Query: 452 VSAKCDVYSYGVLLME 467
                D++S G ++ E
Sbjct: 202 YKENVDIWSVGCIMGE 217

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 93/219 (42%), Gaps = 28/219 (12%)
Query: 281 GTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKI----LSS 336
           G  S+  + +G + DG   A+K      ++       E ++ R   H N++++    L  
Sbjct: 40  GGFSYVDLVEG-LHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRE 98
Query: 337 YSNPDFKALVLEFMPNGSLEKW-----LYSHNYFLDILERLNIMIDVGSALEYLH-NGHS 390
                   L+L F   G+L  W     L     FL   + L +++ +   LE +H  G++
Sbjct: 99  RGAKHEAWLLLPFFKRGTL--WNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYA 156
Query: 391 SVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMA-------TIGYMA 443
                H DLKPTNILL +     + D G         +  RQ +T+        TI Y A
Sbjct: 157 -----HRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRA 211
Query: 444 PE-YGLEG--IVSAKCDVYSYGVLLMETFTRKRPTDEMF 479
           PE + ++   ++  + DV+S G +L      + P D +F
Sbjct: 212 PELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVF 250

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 86/211 (40%), Gaps = 25/211 (11%)
Query: 279 LLGTSSFGSVYKGTISDGTDVAIK-VFNLQ--------LERAF--RSFDSECEVLRNVRH 327
            + + S+G+V  G  S+G  VAIK VFN          L  +F  +    E  +L +  H
Sbjct: 29  FISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88
Query: 328 RNLI---KILSSYSNPDFKALVL--EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSAL 382
            N++    I   +  P    L L  E M    L + ++     +        M  +   L
Sbjct: 89  PNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQYFMYHILLGL 147
Query: 383 EYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYM 442
             LH       ++H DL P NILL +N    + DF + +   E      +T  +    Y 
Sbjct: 148 HVLHEAG----VVHRDLHPGNILLADNNDITICDFNLAR---EDTADANKTHYVTHRWYR 200
Query: 443 APEYGLEGIVSAK-CDVYSYGVLLMETFTRK 472
           APE  ++     K  D++S G ++ E F RK
Sbjct: 201 APELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 86/207 (41%), Gaps = 17/207 (8%)
Query: 265 LDIQRATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRN 324
           L I   +D +     +G  +FG           ++    +  + E+   +   E    R+
Sbjct: 12  LPIMHDSDRYELVKDIGAGNFGVARLMRDKQANELVAVKYIERGEKIDENVKREIINHRS 71
Query: 325 VRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEY 384
           +RH N+++       P   A+V+E+   G L + + +   F +   R      + S + Y
Sbjct: 72  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF-FFQQLISGVSY 130
Query: 385 LHNGHSSVHIIHCDLKPTNILLDENMVAH--VSDFGIYKLLGEGEDSVRQTMTMATIG-- 440
            H    ++ + H DLK  N LLD +      ++DFG  K       SV  +   + +G  
Sbjct: 131 AH----AMQVAHRDLKLENTLLDGSPAPRLKIADFGYSKA------SVLHSQPKSAVGTP 180
Query: 441 -YMAPEYGLEGIVSAK-CDVYSYGVLL 465
            Y+APE  L+     K  DV+S GV L
Sbjct: 181 AYIAPEVLLKKEYDGKVADVWSCGVTL 207

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 48/100 (48%), Gaps = 14/100 (14%)
Query: 370 ERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDE---NMVAHVSDFGIYKLLGEG 426
           E   I   +G A++YLH    S++I H D+KP N+L      N +  ++DFG  K     
Sbjct: 162 EASEIXKSIGEAIQYLH----SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK----- 212
Query: 427 EDSVRQTMTMA--TIGYMAPEYGLEGIVSAKCDVYSYGVL 464
           E +   ++T    T  Y+APE          CD +S GV+
Sbjct: 213 ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDXWSLGVI 252

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/192 (25%), Positives = 86/192 (44%), Gaps = 34/192 (17%)
Query: 327 HRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILE------RLNIMIDVGS 380
           H N+I+   S +   F  + LE + N +L+  + S N   + L+       ++++  + S
Sbjct: 68  HPNVIRYYCSETTDRFLYIALE-LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 126
Query: 381 ALEYLHNGHSSVHIIHCDLKPTNILLD-------------ENMVAHVSDFGIYKLLGEGE 427
            + +LH    S+ IIH DLKP NIL+              EN+   +SDFG+ K L  G+
Sbjct: 127 GVAHLH----SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 182
Query: 428 DSVRQTMT--MATIGYMAPEYGLEG-------IVSAKCDVYSYGVLLMETFTR-KRPTDE 477
              R  +     T G+ APE   E         ++   D++S G +     ++ K P  +
Sbjct: 183 XXFRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 242
Query: 478 MFIGEMSLRRWV 489
            +  E ++ R +
Sbjct: 243 KYSRESNIIRGI 254

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 96/219 (43%), Gaps = 29/219 (13%)
Query: 286 GSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKAL 345
           GS  +G +    D AI   N+ +++  R F ++    R  R   L+K ++   + +   L
Sbjct: 33  GSGAQGIVCAAYD-AILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN---HKNIIGL 88
Query: 346 VLEFMPNGSLEKW--LYSHNYFLDI-----------LERLNIMI-DVGSALEYLHNGHSS 391
           +  F P  SLE++  +Y     +D             ER++ ++  +   +++LH    S
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH----S 144
Query: 392 VHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGI 451
             IIH DLKP+NI++  +    + DFG+ +  G    S      + T  Y APE  L   
Sbjct: 145 AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMEPEVVTRYYRAPEVILGMG 201
Query: 452 VSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVK 490
                D++S G ++ E    K     +F G   + +W K
Sbjct: 202 YKENVDLWSVGCIMGEMVCHKI----LFPGRDYIDQWNK 236

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 98/233 (42%), Gaps = 26/233 (11%)
Query: 279 LLGTSSFGSVYKGT-ISDGTDVAIKVFNL-------QLERAFRSFDSECEVLRNVRH--R 328
           LLG+  FGSVY G  +SD   VAIK           +L    R    E  +L+ V     
Sbjct: 15  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VPMEVVLLKKVSSGFS 73
Query: 329 NLIKILSSYSNPDFKALVLEFM-PNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
            +I++L  +  PD   L+LE M P   L  ++       + L R +    V  A+ + HN
Sbjct: 74  GVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHN 132
Query: 388 GHSSVHIIHCDLKPTNILLDENMVA-HVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEY 446
                 ++H D+K  NIL+D N     + DFG   LL   +D+V        + Y  PE+
Sbjct: 133 ----CGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRV-YSPPEW 184
Query: 447 -GLEGIVSAKCDVYSYGVLLMETFTRKRP---TDEMFIGEMSLRRWVKESLPH 495
                       V+S G+LL +      P    +E+  G++  R+ V     H
Sbjct: 185 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQH 237

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 57/240 (23%), Positives = 96/240 (40%), Gaps = 33/240 (13%)
Query: 266 DIQRATDEFNEC-----------NLLGTSSFGSVYKGTISDGTDVAIKVFNLQL--ERAF 312
           D  +A+   NEC             +G+     V++         AIK  NL+    +  
Sbjct: 39  DDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTL 98
Query: 313 RSFDSECEVLRNVR-HRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILER 371
            S+ +E   L  ++ H + I  L  Y   D    ++    N  L  WL      +D  ER
Sbjct: 99  DSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKK-SIDPWER 157
Query: 372 LNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVR 431
            +   ++  A+  +H  H    I+H DLKP N L+ + M+  + DFGI   +     SV 
Sbjct: 158 KSYWKNMLEAVHTIHQ-HG---IVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVV 212
Query: 432 QTMTMATIGYMAPEYGLEGIVSAK------------CDVYSYGVLLMETFTRKRPTDEMF 479
           +   +  + YM PE  ++ + S++             DV+S G +L      K P  ++ 
Sbjct: 213 KDSQVGAVNYMPPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 271

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 91/213 (42%), Gaps = 17/213 (7%)
Query: 280 LGTSSFGSVYK-GTISDGTDVAIKVFNLQLERAFRSFD-SECEVLRNVRHRNLIKILSSY 337
           +G  SFG V++      G   A+K   L++   FR  +   C  L + R   ++ +  + 
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKVRLEV---FRVEELVACAGLSSPR---IVPLYGAV 119
Query: 338 SNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHC 397
               +  + +E +  GSL + +      +  L     +  +G ALE L   H+   I+H 
Sbjct: 120 REGPWVNIFMELLEGGSLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLHTR-RILHG 174
Query: 398 DLKPTNILLD-ENMVAHVSDFGIYKLL---GEGEDSVRQTMTMATIGYMAPEYGLEGIVS 453
           D+K  N+LL  +   A + DFG    L   G G+  +       T  +MAPE  +     
Sbjct: 175 DVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCD 234
Query: 454 AKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLR 486
           AK D++S   +++       P  + F G + L+
Sbjct: 235 AKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK 267

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 49/184 (26%), Positives = 90/184 (48%), Gaps = 27/184 (14%)
Query: 296 GTDVAIKVFNLQLE------RAFRSFDSECEVLRNVRHRNLIKILSSYSNP----DFK-- 343
           G +VA+K  +   +      RA+R    E  +L+ V H+N+I +L+ ++      +F+  
Sbjct: 49  GINVAVKKLSRPFQNQTHAKRAYR----ELVLLKCVNHKNIISLLNVFTPQKTLEEFQDV 104
Query: 344 ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTN 403
            LV+E M + +L + ++     LD      ++  +   +++LH    S  IIH DLKP+N
Sbjct: 105 YLVMELM-DANLCQVIHME---LDHERMSYLLYQMLCGIKHLH----SAGIIHRDLKPSN 156
Query: 404 ILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGV 463
           I++  +    + DFG+ +       +   T  + T  Y APE  L    +A  D++S G 
Sbjct: 157 IVVKSDCTLKILDFGLART---ACTNFMMTPYVVTRYYRAPEVILGMGYAANVDIWSVGC 213
Query: 464 LLME 467
           ++ E
Sbjct: 214 IMGE 217

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 91/213 (42%), Gaps = 17/213 (7%)
Query: 280 LGTSSFGSVYK-GTISDGTDVAIKVFNLQLERAFRSFD-SECEVLRNVRHRNLIKILSSY 337
           +G  SFG V++      G   A+K   L++   FR  +   C  L + R   ++ +  + 
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKVRLEV---FRVEELVACAGLSSPR---IVPLYGAV 135
Query: 338 SNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHC 397
               +  + +E +  GSL + +      +  L     +  +G ALE L   H+   I+H 
Sbjct: 136 REGPWVNIFMELLEGGSLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLHTR-RILHG 190
Query: 398 DLKPTNILLD-ENMVAHVSDFGIYKLL---GEGEDSVRQTMTMATIGYMAPEYGLEGIVS 453
           D+K  N+LL  +   A + DFG    L   G G+  +       T  +MAPE  +     
Sbjct: 191 DVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCD 250
Query: 454 AKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLR 486
           AK D++S   +++       P  + F G + L+
Sbjct: 251 AKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK 283

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 88/197 (44%), Gaps = 25/197 (12%)
Query: 285 FGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKA 344
            GS  +G +    D AI   N+ +++  R F ++    R  R   L+K ++   + +   
Sbjct: 34  IGSGAQGIVCAAYD-AILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN---HKNIIG 89
Query: 345 LVLEFMPNGSLEKW--LYSHNYFLDI-----------LERLNIMI-DVGSALEYLHNGHS 390
           L+  F P  SLE++  +Y     +D             ER++ ++  +   +++LH    
Sbjct: 90  LLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH---- 145
Query: 391 SVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEG 450
           S  IIH DLKP+NI++  +    + DFG+ +  G    S      + T  Y APE  L  
Sbjct: 146 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMVPFVVTRYYRAPEVILGM 202
Query: 451 IVSAKCDVYSYGVLLME 467
                 D++S G ++ E
Sbjct: 203 GYKENVDIWSVGCIMGE 219

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 65/262 (24%), Positives = 108/262 (41%), Gaps = 41/262 (15%)
Query: 300 AIKVFNLQL--ERAFRSFDSECEVLRNVR-HRNLIKILSSYSNPDFKALVLEFMPNGSLE 356
           AIK  NL+    +   S+ +E   L  ++ H + I  L  Y   D    ++    N  L 
Sbjct: 56  AIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLN 115
Query: 357 KWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSD 416
            WL      +D  ER +   ++  A+  +H  H    I+H DLKP N L+ + M+  + D
Sbjct: 116 SWLKKKK-SIDPWERKSYWKNMLEAVHTIHQ-HG---IVHSDLKPANFLIVDGMLKLI-D 169
Query: 417 FGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAK------------CDVYSYGVL 464
           FGI   +      V +   + T+ YM PE  ++ + S++             DV+S G +
Sbjct: 170 FGIANQMQPDXXXVVKDSQVGTVNYMPPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCI 228
Query: 465 LMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMD 524
           L      K P  ++ I ++S            L  ++D N    E  F    D     + 
Sbjct: 229 LYYMTYGKTPFQQI-INQIS-----------KLHAIIDPN---HEIEFP---DIPEKDLQ 270
Query: 525 FALDCCME-SPDMRINMTDAAA 545
             L CC++  P  RI++ +  A
Sbjct: 271 DVLKCCLKRDPKQRISIPELLA 292

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 38/151 (25%), Positives = 70/151 (46%), Gaps = 20/151 (13%)
Query: 320 EVLRNVRHRNLIKILSSYSNPDFKA-----LVLEFMPNGSLEKWLYSHNYFLDILERLNI 374
           + L  V H ++++I +   + D        +V+E++   SL++   S    L + E +  
Sbjct: 131 QFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKR---SKGQKLPVAEAIAY 187
Query: 375 MIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTM 434
           ++++  AL YLH    S+ +++ DLKP NI+L E  +  +    + ++   G        
Sbjct: 188 LLEILPALSYLH----SIGLVYNDLKPENIMLTEEQLKLIDLGAVSRINSFG-------Y 236
Query: 435 TMATIGYMAPEYGLEGIVSAKCDVYSYGVLL 465
              T G+ APE    G   A  D+Y+ G  L
Sbjct: 237 LYGTPGFQAPEIVRTGPTVA-TDIYTVGRTL 266

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 106/219 (48%), Gaps = 32/219 (14%)
Query: 268 QRATDEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRSFDSECEVLRNV- 325
           ++  D F    + G  +FG+V  G   S G  VAIK   +Q  R FR  + E ++++++ 
Sbjct: 19  RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV-IQDPR-FR--NRELQIMQDLA 74
Query: 326 --RHRNLIKILSSY-------SNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMI 376
              H N++++ S +           +  +V+E++P+ +L +     NY+   +    I+I
Sbjct: 75  VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRC--CRNYYRRQVAPPPILI 131
Query: 377 DVG-----SALEYLHNGHSSVHIIHCDLKPTNILLDE-NMVAHVSDFGIYKLLGEGEDSV 430
            V       ++  LH    SV++ H D+KP N+L++E +    + DFG  K L   E +V
Sbjct: 132 KVFLFQLIRSIGCLH--LPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNV 189
Query: 431 RQTMTMATIGYMAPE--YGLEGIVSAKCDVYSYGVLLME 467
                + +  Y APE  +G +   +A  D++S G +  E
Sbjct: 190 ---AYICSRYYRAPELIFGNQHYTTA-VDIWSVGCIFAE 224

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 101/243 (41%), Gaps = 46/243 (18%)
Query: 279 LLGTSSFGSVYKGT-ISDGTDVAIKVFNL-------QLERAFRSFDSECEVLRNVRH--R 328
           LLG+  FGSVY G  +SD   VAIK           +L    R    E  +L+ V     
Sbjct: 50  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VPMEVVLLKKVSSGFS 108
Query: 329 NLIKILSSYSNPDFKALVLE-----------FMPNGSLEKWLYSHNYFLDILERLNIMID 377
            +I++L  +  PD   L+LE               G+L++ L + ++F  +LE       
Sbjct: 109 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-ARSFFWQVLE------- 160
Query: 378 VGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVA-HVSDFGIYKLLGEGEDSVRQTMTM 436
              A+ + HN      ++H D+K  NIL+D N     + DFG   LL   +D+V      
Sbjct: 161 ---AVRHCHN----CGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDG 210
Query: 437 ATIGYMAPEY-GLEGIVSAKCDVYSYGVLLMETFTRKRP---TDEMFIGEMSLRRWVKES 492
             + Y  PE+            V+S G+LL +      P    +E+  G++  R+ V   
Sbjct: 211 TRV-YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSE 269
Query: 493 LPH 495
             H
Sbjct: 270 CQH 272

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 101/243 (41%), Gaps = 46/243 (18%)
Query: 279 LLGTSSFGSVYKGT-ISDGTDVAIKVFNL-------QLERAFRSFDSECEVLRNVRH--R 328
           LLG+  FGSVY G  +SD   VAIK           +L    R    E  +L+ V     
Sbjct: 31  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VPMEVVLLKKVSSGFS 89
Query: 329 NLIKILSSYSNPDFKALVLE-----------FMPNGSLEKWLYSHNYFLDILERLNIMID 377
            +I++L  +  PD   L+LE               G+L++ L + ++F  +LE       
Sbjct: 90  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-ARSFFWQVLE------- 141
Query: 378 VGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVA-HVSDFGIYKLLGEGEDSVRQTMTM 436
              A+ + HN      ++H D+K  NIL+D N     + DFG   LL   +D+V      
Sbjct: 142 ---AVRHCHN----CGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDG 191
Query: 437 ATIGYMAPEY-GLEGIVSAKCDVYSYGVLLMETFTRKRP---TDEMFIGEMSLRRWVKES 492
             + Y  PE+            V+S G+LL +      P    +E+  G++  R+ V   
Sbjct: 192 TRV-YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSE 250
Query: 493 LPH 495
             H
Sbjct: 251 CQH 253

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 101/243 (41%), Gaps = 46/243 (18%)
Query: 279 LLGTSSFGSVYKGT-ISDGTDVAIKVFNL-------QLERAFRSFDSECEVLRNVRH--R 328
           LLG+  FGSVY G  +SD   VAIK           +L    R    E  +L+ V     
Sbjct: 30  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VPMEVVLLKKVSSGFS 88
Query: 329 NLIKILSSYSNPDFKALVLE-----------FMPNGSLEKWLYSHNYFLDILERLNIMID 377
            +I++L  +  PD   L+LE               G+L++ L + ++F  +LE       
Sbjct: 89  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-ARSFFWQVLE------- 140
Query: 378 VGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVA-HVSDFGIYKLLGEGEDSVRQTMTM 436
              A+ + HN      ++H D+K  NIL+D N     + DFG   LL   +D+V      
Sbjct: 141 ---AVRHCHN----CGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDG 190
Query: 437 ATIGYMAPEY-GLEGIVSAKCDVYSYGVLLMETFTRKRP---TDEMFIGEMSLRRWVKES 492
             + Y  PE+            V+S G+LL +      P    +E+  G++  R+ V   
Sbjct: 191 TRV-YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSE 249
Query: 493 LPH 495
             H
Sbjct: 250 CQH 252

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 101/243 (41%), Gaps = 46/243 (18%)
Query: 279 LLGTSSFGSVYKGT-ISDGTDVAIKVFNL-------QLERAFRSFDSECEVLRNVRH--R 328
           LLG+  FGSVY G  +SD   VAIK           +L    R    E  +L+ V     
Sbjct: 58  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VPMEVVLLKKVSSGFS 116
Query: 329 NLIKILSSYSNPDFKALVLE-----------FMPNGSLEKWLYSHNYFLDILERLNIMID 377
            +I++L  +  PD   L+LE               G+L++ L + ++F  +LE       
Sbjct: 117 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-ARSFFWQVLE------- 168
Query: 378 VGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVA-HVSDFGIYKLLGEGEDSVRQTMTM 436
              A+ + HN      ++H D+K  NIL+D N     + DFG   LL   +D+V      
Sbjct: 169 ---AVRHCHN----CGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDG 218
Query: 437 ATIGYMAPEY-GLEGIVSAKCDVYSYGVLLMETFTRKRP---TDEMFIGEMSLRRWVKES 492
             + Y  PE+            V+S G+LL +      P    +E+  G++  R+ V   
Sbjct: 219 TRV-YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSE 277
Query: 493 LPH 495
             H
Sbjct: 278 CQH 280

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 101/243 (41%), Gaps = 46/243 (18%)
Query: 279 LLGTSSFGSVYKGT-ISDGTDVAIKVFNL-------QLERAFRSFDSECEVLRNVRH--R 328
           LLG+  FGSVY G  +SD   VAIK           +L    R    E  +L+ V     
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VPMEVVLLKKVSSGFS 102
Query: 329 NLIKILSSYSNPDFKALVLE-----------FMPNGSLEKWLYSHNYFLDILERLNIMID 377
            +I++L  +  PD   L+LE               G+L++ L + ++F  +LE       
Sbjct: 103 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-ARSFFWQVLE------- 154
Query: 378 VGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVA-HVSDFGIYKLLGEGEDSVRQTMTM 436
              A+ + HN      ++H D+K  NIL+D N     + DFG   LL   +D+V      
Sbjct: 155 ---AVRHCHN----CGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDG 204
Query: 437 ATIGYMAPEY-GLEGIVSAKCDVYSYGVLLMETFTRKRP---TDEMFIGEMSLRRWVKES 492
             + Y  PE+            V+S G+LL +      P    +E+  G++  R+ V   
Sbjct: 205 TRV-YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSE 263
Query: 493 LPH 495
             H
Sbjct: 264 CQH 266

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 103/249 (41%), Gaps = 46/249 (18%)
Query: 273 EFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNL-------QLERAFRSFDSECEVLRN 324
           ++    LLG+  FGSVY G  +SD   VAIK           +L    R    E  +L+ 
Sbjct: 57  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VPMEVVLLKK 115
Query: 325 VRH--RNLIKILSSYSNPDFKALVLE-----------FMPNGSLEKWLYSHNYFLDILER 371
           V      +I++L  +  PD   L+LE               G+L++ L + ++F  +LE 
Sbjct: 116 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-ARSFFWQVLE- 173
Query: 372 LNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVA-HVSDFGIYKLLGEGEDSV 430
                    A+ + HN      ++H D+K  NIL+D N     + DFG   LL   +D+V
Sbjct: 174 ---------AVRHCHN----CGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTV 217
Query: 431 RQTMTMATIGYMAPEY-GLEGIVSAKCDVYSYGVLLMETFTRKRP---TDEMFIGEMSLR 486
                   + Y  PE+            V+S G+LL +      P    +E+  G++  R
Sbjct: 218 YTDFDGTRV-YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 276
Query: 487 RWVKESLPH 495
           + V     H
Sbjct: 277 QRVSXECQH 285

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 82/204 (40%), Gaps = 23/204 (11%)
Query: 278 NLLGTSSFGSVYKGTISD-GTDVAIKVFNLQLERAFRSFDSECEVLRNVRHR------NL 330
            ++G  SFG V K         VA+K+   + +R  R    E  +L ++R +      N+
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNV 161
Query: 331 IKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERL--NIMIDVGSALEYLHNG 388
           I +L +++  +   +  E +     E  L   N F      L       +   L+ LH  
Sbjct: 162 IHMLENFTFRNHICMTFELLSMNLYE--LIKKNKFQGFSLPLVRKFAHSILQCLDALHKN 219
Query: 389 HSSVHIIHCDLKPTNILLDENMVA--HVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEY 446
                IIHCDLKP NILL +   +   V DFG         +  R    + +  Y APE 
Sbjct: 220 R----IIHCDLKPENILLKQQGRSGIKVIDFG-----SSCYEHQRVYTXIQSRFYRAPEV 270
Query: 447 GLEGIVSAKCDVYSYGVLLMETFT 470
            L        D++S G +L E  T
Sbjct: 271 ILGARYGMPIDMWSLGCILAELLT 294

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 82/204 (40%), Gaps = 23/204 (11%)
Query: 278 NLLGTSSFGSVYKGTISD-GTDVAIKVFNLQLERAFRSFDSECEVLRNVRHR------NL 330
            ++G  SFG V K         VA+K+   + +R  R    E  +L ++R +      N+
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNV 161
Query: 331 IKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERL--NIMIDVGSALEYLHNG 388
           I +L +++  +   +  E +     E  L   N F      L       +   L+ LH  
Sbjct: 162 IHMLENFTFRNHICMTFELLSMNLYE--LIKKNKFQGFSLPLVRKFAHSILQCLDALHKN 219
Query: 389 HSSVHIIHCDLKPTNILLDENMVA--HVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEY 446
                IIHCDLKP NILL +   +   V DFG         +  R    + +  Y APE 
Sbjct: 220 R----IIHCDLKPENILLKQQGRSGIKVIDFG-----SSCYEHQRVYTXIQSRFYRAPEV 270
Query: 447 GLEGIVSAKCDVYSYGVLLMETFT 470
            L        D++S G +L E  T
Sbjct: 271 ILGARYGMPIDMWSLGCILAELLT 294

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 101/243 (41%), Gaps = 46/243 (18%)
Query: 279 LLGTSSFGSVYKGT-ISDGTDVAIKVFNL-------QLERAFRSFDSECEVLRNVRH--R 328
           LLG+  FGSVY G  +SD   VAIK           +L    R    E  +L+ V     
Sbjct: 31  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VPMEVVLLKKVSSGFS 89
Query: 329 NLIKILSSYSNPDFKALVLE-----------FMPNGSLEKWLYSHNYFLDILERLNIMID 377
            +I++L  +  PD   L+LE               G+L++ L + ++F  +LE       
Sbjct: 90  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-ARSFFWQVLE------- 141
Query: 378 VGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVA-HVSDFGIYKLLGEGEDSVRQTMTM 436
              A+ + HN      ++H D+K  NIL+D N     + DFG   LL   +D+V      
Sbjct: 142 ---AVRHCHN----CGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDG 191
Query: 437 ATIGYMAPEY-GLEGIVSAKCDVYSYGVLLMETFTRKRP---TDEMFIGEMSLRRWVKES 492
             + Y  PE+            V+S G+LL +      P    +E+  G++  R+ V   
Sbjct: 192 TRV-YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSXE 250
Query: 493 LPH 495
             H
Sbjct: 251 CQH 253
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	593
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	7e-79
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	8e-78
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	5e-68
3soc_A	322	Activin receptor type-2A; structural genomics cons	6e-60
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	3e-58
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-35
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	2e-24
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-54
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	9e-54
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-53
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	3e-53
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-52
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-51
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	7e-51
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-46
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-46
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	5e-46
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	5e-38
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	6e-38
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	8e-35
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	7e-34
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	9e-26
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	7e-21
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	9e-06
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-50
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	3e-50
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	4e-50
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	7e-50
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-47
3q4u_A	301	Activin receptor type-1; structural genomics conso	3e-45
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-44
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	5e-43
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	7e-39
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-36
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	4e-36
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-35
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	3e-35
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	3e-35
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	5e-35
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	6e-35
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-34
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-34
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-34
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	3e-34
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	4e-34
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	7e-34
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	7e-34
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	7e-34
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	8e-34
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	9e-34
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	9e-34
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-33
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-33
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-33
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	4e-33
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	5e-33
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	5e-33
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	6e-33
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	8e-33
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	8e-33
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	8e-33
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	8e-33
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-32
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-32
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-32
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-32
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-32
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-32
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-32
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	4e-32
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	5e-32
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	6e-32
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-31
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-31
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-31
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-31
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-31
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-29
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-29
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	8e-27
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	5e-26
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-23
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-23
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-23
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	6e-23
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	9e-12
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-07
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	3e-31
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	3e-31
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	4e-31
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	4e-31
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	8e-31
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	4e-30
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-28
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-26
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-25
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-21
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	4e-20
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-18
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-17
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	5e-17
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-13
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	7e-12
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	9e-31
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-30
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-30
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	3e-30
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	5e-30
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	6e-30
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	8e-30
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-29
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-29
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-29
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-29
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-29
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-28
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	4e-26
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	5e-26
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	8e-26
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-24
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	4e-24
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	4e-24
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-23
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-21
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	4e-29
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-28
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	4e-28
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	5e-28
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	3e-24
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-13
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	6e-28
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	7e-28
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	7e-28
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	8e-28
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-27
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-27
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-27
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-27
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	3e-27
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	5e-27
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	5e-27
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	5e-27
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	5e-27
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	6e-27
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	7e-27
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	8e-27
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-26
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-26
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-22
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	4e-21
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	5e-21
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	3e-20
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	5e-19
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	8e-19
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-10
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-07
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-26
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-26
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-26
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	3e-26
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	4e-26
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	7e-26
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	8e-26
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	9e-26
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-25
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-25
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-23
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-19
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	5e-19
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	7e-19
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-16
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	4e-15
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-25
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-25
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	1e-25
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-25
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-25
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-25
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	3e-25
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	3e-25
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	3e-25
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	3e-25
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	4e-25
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	7e-25
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	9e-25
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-24
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-24
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-24
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-24
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	6e-23
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	4e-22
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-21
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	4e-21
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-20
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	5e-20
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	6e-20
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	8e-13
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	4e-11
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	8e-09
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	3e-24
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	5e-24
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	5e-24
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	5e-24
3an0_A	340	Dual specificity mitogen-activated protein kinase;	5e-24
3aln_A	327	Dual specificity mitogen-activated protein kinase;	6e-24
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	7e-24
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-23
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-23
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-23
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-23
3fme_A	290	Dual specificity mitogen-activated protein kinase;	3e-23
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	3e-23
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	5e-23
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-21
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	6e-13
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-11
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	3e-08
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	5e-23
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	6e-23
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	7e-23
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	7e-23
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	2e-22
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	3e-22
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	8e-21
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	8e-13
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	5e-11
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	6e-11
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-08
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-07
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	3e-22
2dyl_A	318	Dual specificity mitogen-activated protein kinase	3e-22
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	3e-22
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	3e-22
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	5e-22
3bhy_A	283	Death-associated protein kinase 3; death associate	8e-22
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-21
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-21
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-21
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-21
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-21
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-21
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	3e-21
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	7e-21
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	8e-21
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	8e-18
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	6e-14
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-09
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	3e-20
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	5e-20
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	6e-20
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	3e-17
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	1e-08
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	5e-06
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-19
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-19
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-19
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	3e-19
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	5e-19
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	1e-17
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	6e-10
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	2e-06
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	5e-19
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	6e-19
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	7e-19
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	4e-18
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-16
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-16
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-13
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-18
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-18
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	3e-18
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	6e-18
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-13
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	3e-13
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	3e-12
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	4e-11
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-09
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-08
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-18
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-18
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-18
1o6v_A	466	Internalin A; bacterial infection, extracellular r	5e-18
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-14
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-13
1o6v_A	466	Internalin A; bacterial infection, extracellular r	4e-13
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-10
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	5e-18
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	6e-18
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	8e-18
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	8e-18
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-17
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-17
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-17
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-17
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	5e-17
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	7e-16
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	8e-14
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	6e-13
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-12
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	4e-10
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-17
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-17
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-17
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	3e-17
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	3e-17
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	4e-17
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	5e-17
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	6e-17
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	3e-14
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	8e-14
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-13
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	4e-13
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	9e-17
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-16
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-16
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-16
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-06
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-16
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	4e-16
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	9e-15
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	2e-13
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	3e-10
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	5e-16
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	8e-16
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-15
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-14
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	8e-13
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	9e-16
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-15
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-15
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-15
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-15
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-15
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-15
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	7e-13
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	1e-15
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	7e-15
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	6e-14
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	6e-13
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-09
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-15
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-15
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-15
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-15
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-14
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-13
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	9e-12
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	6e-09
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-08
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-15
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	9e-12
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-15
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-15
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	3e-15
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	3e-15
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	4e-15
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	1e-14
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-13
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-13
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-08
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	5e-15
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	6e-15
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	4e-13
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	6e-13
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	8e-04
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	5e-15
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	1e-13
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	3e-13
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	4e-13
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	6e-15
3uqc_A	286	Probable conserved transmembrane protein; structur	6e-15
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	7e-15
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	7e-15
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	5e-14
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	2e-13
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	8e-15
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	8e-15
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	9e-15
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	9e-15
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-14
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-14
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	2e-14
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-14
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-13
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-10
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	5e-05
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	3e-14
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	3e-13
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	5e-08
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	6e-06
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	3e-05
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	7e-04
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	3e-14
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	3e-14
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	1e-13
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-07
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	3e-14
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	3e-14
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	4e-14
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	4e-14
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	8e-14
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	9e-13
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	2e-12
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	8e-14
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	8e-14
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	9e-14
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-13
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-13
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-13
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-13
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	3e-13
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	1e-12
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-10
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	9e-10
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	3e-08
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	3e-13
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	5e-13
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	5e-13
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	6e-13
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	6e-13
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	8e-13
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-12
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-12
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-11
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	1e-12
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	6e-11
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	9e-09
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	7e-05
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	1e-12
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	2e-12
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	4e-12
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	1e-10
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	3e-12
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	5e-12
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	2e-10
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	3e-08
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	9e-12
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	9e-12
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	3e-11
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	8e-11
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-10
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	2e-10
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	2e-08
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	2e-05
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	3e-10
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	3e-10
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	9e-10
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-09
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	6e-09
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	7e-07
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	4e-10
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	5e-10
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	6e-10
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	7e-10
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	6e-09
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	1e-08
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	1e-08
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	9e-10
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	3e-09
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	4e-09
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	8e-09
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-08
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-07
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	1e-09
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	2e-09
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	7e-07
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	1e-06
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	2e-09
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	3e-08
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	5e-09
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	8e-09
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	8e-09
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-08
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	1e-08
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	8e-08
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	2e-04
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	2e-08
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	2e-08
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	1e-07
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-08
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	6e-07
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	4e-08
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	8e-07
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	1e-05
3m19_A	251	Variable lymphocyte receptor A diversity region; a	6e-08
3m19_A	251	Variable lymphocyte receptor A diversity region; a	2e-07
3m19_A	251	Variable lymphocyte receptor A diversity region; a	4e-06
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	9e-08
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	1e-07
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	4e-07
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	2e-06
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	3e-06
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	2e-05
3e6j_A	229	Variable lymphocyte receptor diversity region; var	4e-06
3e6j_A	229	Variable lymphocyte receptor diversity region; var	5e-06
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	6e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	7e-06
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	1e-05
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	7e-05
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	5e-04
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-05
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	2e-04
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-04
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	2e-04
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	3e-04
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	8e-04
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	7e-04
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	7e-04

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  250 bits (642), Expect = 7e-79
 Identities = 95/294 (32%), Positives = 149/294 (50%), Gaps = 14/294 (4%)

Query: 260 RRTSYLDIQRATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSEC 319
            R   +D++ AT+ F+   L+G   FG VYKG + DG  VA+K    +  +    F++E 
Sbjct: 27  YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEI 86

Query: 320 EVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLY---SHNYFLDILERLNIMI 376
           E L   RH +L+ ++      +   L+ ++M NG+L++ LY        +   +RL I I
Sbjct: 87  ETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICI 146

Query: 377 DVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTM 436
                L YLH       IIH D+K  NILLDEN V  ++DFGI K   E + +   T+  
Sbjct: 147 GAARGLHYLHTR----AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVK 202

Query: 437 ATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMF-IGEMSLRRWVKESLPH 495
            T+GY+ PEY ++G ++ K DVYS+GV+L E    +    +      ++L  W  ES  +
Sbjct: 203 GTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNN 262

Query: 496 G-LTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLK 548
           G L ++VD NL  +      + + +    D A+ C   S + R +M D   KL+
Sbjct: 263 GQLEQIVDPNLADK-----IRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  248 bits (636), Expect = 8e-78
 Identities = 103/303 (33%), Positives = 151/303 (49%), Gaps = 25/303 (8%)

Query: 259 WRRTSYLDIQRATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAF-----R 313
            +R S  ++Q A+D F+  N+LG   FG VYKG ++DGT VA+K    +L+         
Sbjct: 17  LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVK----RLKEERTQGGEL 72

Query: 314 SFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLY---SHNYFLDILE 370
            F +E E++    HRNL+++      P  + LV  +M NGS+   L         LD  +
Sbjct: 73  QFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPK 132

Query: 371 RLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSV 430
           R  I +     L YLH+ H    IIH D+K  NILLDE   A V DFG+ KL+   +  V
Sbjct: 133 RQRIALGSARGLAYLHD-HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 191

Query: 431 RQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGE---MSLRR 487
             T    TIG++APEY   G  S K DV+ YGV+L+E  T +R  D   +     + L  
Sbjct: 192 T-TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 250

Query: 488 WVKESLPHG-LTEVVDANLVREEQAFSAK-MDCILSIMDFALDCCMESPDMRINMTDAAA 545
           WVK  L    L  +VD +L   +  +  + ++ ++ +   AL C   SP  R  M++   
Sbjct: 251 WVKGLLKEKKLEALVDVDL---QGNYKDEEVEQLIQV---ALLCTQSSPMERPKMSEVVR 304

Query: 546 KLK 548
            L+
Sbjct: 305 MLE 307

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  222 bits (568), Expect = 5e-68
 Identities = 87/302 (28%), Positives = 141/302 (46%), Gaps = 27/302 (8%)

Query: 263 SYLDIQRATDEFNE------CNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERA----F 312
           S+ +++  T+ F+E       N +G   FG VYKG + + T VA+K     ++       
Sbjct: 16  SFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELK 74

Query: 313 RSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYF--LDILE 370
           + FD E +V+   +H NL+++L   S+ D   LV  +MPNGSL   L   +    L    
Sbjct: 75  QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHM 134

Query: 371 RLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSV 430
           R  I     + + +LH  H     IH D+K  NILLDE   A +SDFG+ +   +   +V
Sbjct: 135 RCKIAQGAANGINFLHENH----HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190

Query: 431 RQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVK 490
             +  + T  YMAPE  L G ++ K D+YS+GV+L+E  T     DE       L    +
Sbjct: 191 MTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHR-EPQLLLDIKE 248

Query: 491 ESL--PHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLK 548
           E       + + +D  +     A S  ++ + S+   A  C  E  + R ++      L+
Sbjct: 249 EIEDEEKTIEDYIDKKM---NDADSTSVEAMYSV---ASQCLHEKKNKRPDIKKVQQLLQ 302

Query: 549 KI 550
           ++
Sbjct: 303 EM 304

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  201 bits (513), Expect = 6e-60
 Identities = 60/306 (19%), Positives = 117/306 (38%), Gaps = 22/306 (7%)

Query: 263 SYLDIQRATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVL 322
              ++   +       +     FG V+K  +     VA+K+F +Q +++++  + E   L
Sbjct: 15  GTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSWQ-NEYEVYSL 72

Query: 323 RNVRHRNLIKILSSYSNPDFKA----LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDV 378
             ++H N+++ + +            L+  F   GSL  +L      +   E  +I   +
Sbjct: 73  PGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL--KANVVSWNELCHIAETM 130

Query: 379 GSALEYLH------NGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQ 432
              L YLH             I H D+K  N+LL  N+ A ++DFG+      G+ +   
Sbjct: 131 ARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDT 190

Query: 433 TMTMATIGYMAPEY-----GLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRR 487
              + T  YMAPE        +     + D+Y+ G++L E  +R    D      M    
Sbjct: 191 HGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFE 250

Query: 488 WVKESLP--HGLTEVVDANLVREE-QAFSAKMDCILSIMDFALDCCMESPDMRINMTDAA 544
                 P    + EVV     R   + +  K   +  + +   +C     + R++     
Sbjct: 251 EEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVG 310

Query: 545 AKLKKI 550
            ++ ++
Sbjct: 311 ERITQM 316

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  196 bits (501), Expect = 3e-58
 Identities = 60/246 (24%), Positives = 102/246 (41%), Gaps = 58/246 (23%)

Query: 2   RILTLEG-NQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSF 60
             L + G N L G +P  I   L  + YL +T  N++G IP+ ++    L+ LD  +N+ 
Sbjct: 79  NFLYIGGINNLVGPIPPAIA-KLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNAL 137

Query: 61  SGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCL-----VLTVLDVSRNQLSGDI 115
           SG +  +  +L +L  ++         GN++ G IP        + T + +SRN+L+G I
Sbjct: 138 SGTLPPSISSLPNLVGIT-------FDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKI 190

Query: 116 PSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIP----------- 164
           P T    ++L  + L+ N  +G      GS  + + + L+ N+L+  +            
Sbjct: 191 PPTF-ANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGL 249

Query: 165 -----------------------------KLEGEIPVKGSFKNFSTESFFGNYALCGPPK 195
                                         L GEIP  G+ + F   ++  N  LCG P 
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP- 308

Query: 196 LRVPPC 201
             +P C
Sbjct: 309 --LPAC 312

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  135 bits (342), Expect = 1e-35
 Identities = 42/162 (25%), Positives = 65/162 (40%), Gaps = 30/162 (18%)

Query: 34  NNLTGTIPNSITNATKLIVLDLGFNSFSG--HILNTFGNLRHLSVLSLLMFGIRLTGNKL 91
               G + ++ T   ++  LDL   +      I ++  NL +L+ L +         N L
Sbjct: 36  RTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGI------NNL 89

Query: 92  YGRIPPCLV----LTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLI 147
            G IPP +     L  L ++   +SG IP  +     L TL  + N   G +P S+ SL 
Sbjct: 90  VGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLP 149

Query: 148 SLESLDLSGNNLSGKIPK------------------LEGEIP 171
           +L  +   GN +SG IP                   L G+IP
Sbjct: 150 NLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIP 191

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  102 bits (258), Expect = 2e-24
 Identities = 42/169 (24%), Positives = 62/169 (36%), Gaps = 37/169 (21%)

Query: 40  IPNSITNATKL----IVLDLGFNSFSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGR- 94
           I   + N T L       D    ++ G + +T      ++ L        L+G  L    
Sbjct: 14  IKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLD-------LSGLNLPKPY 66

Query: 95  -IPPCL----VLTVLDVS-RNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLIS 148
            IP  L     L  L +   N L G IP  I     L  L +      G IP+ +  + +
Sbjct: 67  PIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKT 126

Query: 149 LESLDLSGNNLSGKIP-----------------KLEGEIPVKGSFKNFS 180
           L +LD S N LSG +P                 ++ G IP   S+ +FS
Sbjct: 127 LVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPD--SYGSFS 173

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  185 bits (472), Expect = 2e-54
 Identities = 70/301 (23%), Positives = 123/301 (40%), Gaps = 54/301 (17%)

Query: 272 DEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQ-------LERAFRSFDSECEVLR 323
           +E      +G   FG V+KG  + D + VAIK   L        +   F+ F  E  ++ 
Sbjct: 19  NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78

Query: 324 NVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALE 383
           N+ H N++K+     NP    +V+EF+P G L   L    + +    +L +M+D+   +E
Sbjct: 79  NLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIE 136

Query: 384 YLHNGHSSVHIIHCDLKPTNILLDE-----NMVAHVSDFGIYKLLGEGEDSVRQTMTMA- 437
           Y+ N   +  I+H DL+  NI L        + A V+DFG+ +           +++   
Sbjct: 137 YMQN--QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-------SVHSVSGLL 187

Query: 438 -TIGYMAPE--YGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKE--- 491
               +MAPE     E   + K D YS+ ++L    T + P DE   G++     ++E   
Sbjct: 188 GNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL 247

Query: 492 --SLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKK 549
             ++P                      DC   + +    C    P  R + +    +L +
Sbjct: 248 RPTIPE---------------------DCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286

Query: 550 I 550
           +
Sbjct: 287 L 287

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  184 bits (469), Expect = 9e-54
 Identities = 72/303 (23%), Positives = 128/303 (42%), Gaps = 43/303 (14%)

Query: 272 DEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQ--LERAFRSFDSECEVLRNVRHRN 329
            + N    +G  SFG+V++     G+DVA+K+   Q         F  E  +++ +RH N
Sbjct: 37  CDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPN 95

Query: 330 LIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHN--YFLDILERLNIMIDVGSALEYLHN 387
           ++  + + + P   ++V E++  GSL + L+       LD   RL++  DV   + YLHN
Sbjct: 96  IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN 155

Query: 388 GHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMA-TIGYMAPEY 446
              +  I+H +LK  N+L+D+     V DFG+ +L      S   + + A T  +MAPE 
Sbjct: 156 --RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS---SKSAAGTPEWMAPEV 210

Query: 447 GLEGIVSAKCDVYSYGVLLMETFTRKRPTDEM-------FIGEMSLRRWVKESLPHGLTE 499
             +   + K DVYS+GV+L E  T ++P   +        +G    R  +  +L   +  
Sbjct: 211 LRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQV-- 268

Query: 500 VVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKFLDDAA 559
              A ++                      C    P  R +       L+ +    +    
Sbjct: 269 ---AAIIE--------------------GCWTNEPWKRPSFATIMDLLRPLIKSAVPPPN 305

Query: 560 ATN 562
            ++
Sbjct: 306 RSD 308

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  182 bits (465), Expect = 2e-53
 Identities = 66/287 (22%), Positives = 125/287 (43%), Gaps = 26/287 (9%)

Query: 272 DEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRN 329
            +      +G+ SFG+VYKG      DVA+K+ N+     +  ++F +E  VLR  RH N
Sbjct: 24  GQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 81

Query: 330 LIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGH 389
           ++  +   + P   A+V ++    SL   L++     ++ + ++I       ++YLH   
Sbjct: 82  ILLFMGYSTAPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH--- 137

Query: 390 SSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPE---Y 446
            +  IIH DLK  NI L E+    + DFG+         S +      +I +MAPE    
Sbjct: 138 -AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 196

Query: 447 GLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLV 506
                 S + DVY++G++L E  T + P   +             +    + E+V    +
Sbjct: 197 QDSNPYSFQSDVYAFGIVLYELMTGQLPYSNI-------------NNRDQIIEMVGRGSL 243

Query: 507 REEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVK 553
             + +   + +C   +     +C  +  D R +     A+++++  +
Sbjct: 244 SPDLS-KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELARE 289

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  183 bits (466), Expect = 3e-53
 Identities = 74/292 (25%), Positives = 117/292 (40%), Gaps = 43/292 (14%)

Query: 272 DEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLI 331
            E     ++G  +FG V K       DVAIK    + ER  ++F  E   L  V H N++
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIV 64

Query: 332 KILSSYSNPDFKALVLEFMPNGSLEKWLYSHN--YFLDILERLNIMIDVGSALEYLHNGH 389
           K+  +  NP    LV+E+   GSL   L+      +      ++  +     + YLH+  
Sbjct: 65  KLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHS-M 121

Query: 390 SSVHIIHCDLKPTNILLDENM-VAHVSDFGIYKLLGEGEDSVRQTMTMA--TIGYMAPEY 446
               +IH DLKP N+LL     V  + DFG           ++  MT    +  +MAPE 
Sbjct: 122 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD-------IQTHMTNNKGSAAWMAPEV 174

Query: 447 GLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKE----SLPHGLTEVVD 502
                 S KCDV+S+G++L E  TR++P DE+      +   V       L   L + + 
Sbjct: 175 FEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPI- 233

Query: 503 ANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKF 554
            +L+                      C  + P  R +M +    +  +   F
Sbjct: 234 ESLMT--------------------RCWSKDPSQRPSMEEIVKIMTHLMRYF 265

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  180 bits (458), Expect = 1e-52
 Identities = 64/297 (21%), Positives = 115/297 (38%), Gaps = 50/297 (16%)

Query: 272 DEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRN 329
            + N    L  +  G ++KG    G D+ +KV  ++    R  R F+ EC  LR   H N
Sbjct: 10  KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPN 68

Query: 330 LIKILSSYSNPDFK--ALVLEFMPNGSLEKWLYSH-NYFLDILERLNIMIDVGSALEYLH 386
           ++ +L +  +P      L+  +MP GSL   L+   N+ +D  + +   +D+   + +LH
Sbjct: 69  VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH 128

Query: 387 NGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPE- 445
                  I    L   ++++DE+M A +S   +         S +    M    ++APE 
Sbjct: 129 T--LEPLIPRHALNSRSVMIDEDMTARISMADVKF-------SFQSPGRMYAPAWVAPEA 179

Query: 446 --YGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEM-------FIGEMSLRRWVKESLPHG 496
                E       D++S+ VLL E  TR+ P  ++        +    LR  +   +   
Sbjct: 180 LQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPH 239

Query: 497 LTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVK 553
           +     + L++                     C  E P  R         L+K++ K
Sbjct: 240 V-----SKLMK--------------------ICMNEDPAKRPKFDMIVPILEKMQDK 271

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  186 bits (474), Expect = 7e-51
 Identities = 65/233 (27%), Positives = 83/233 (35%), Gaps = 38/233 (16%)

Query: 1   MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFN-- 58
           +  L L  N  +G +P+ +           + AN + G     I N           N  
Sbjct: 540 LIWLDLNTNLFNGTIPAAMFKQS-----GKIAANFIAGKRYVYIKNDGMKKECHGAGNLL 594

Query: 59  SFSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCL----VLTVLDVSRNQLSGD 114
            F G        L   +  ++       T     G   P       +  LD+S N LSG 
Sbjct: 595 EFQGIRSEQLNRLSTRNPCNI-------TSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGY 647

Query: 115 IPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIP---------- 164
           IP  IG    L  L+L  N   G IP+ VG L  L  LDLS N L G+IP          
Sbjct: 648 IPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLT 707

Query: 165 -------KLEGEIPVKGSFKNFSTESFFGNYALCGPPKLRVPPCKPDNSKRTK 210
                   L G IP  G F+ F    F  N  LCG P   +P C P N+    
Sbjct: 708 EIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYP---LPRCDPSNADGYA 757

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  174 bits (443), Expect = 1e-46
 Identities = 58/169 (34%), Positives = 86/169 (50%), Gaps = 12/169 (7%)

Query: 1   MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSF 60
           ++ L L+ N  +G++P T+  +   +  L L+ N L+GTIP+S+ + +KL  L L  N  
Sbjct: 396 LQELYLQNNGFTGKIPPTLS-NCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNML 454

Query: 61  SGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLV----LTVLDVSRNQLSGDIP 116
            G I      ++ L  L L         N L G IP  L     L  + +S N+L+G+IP
Sbjct: 455 EGEIPQELMYVKTLETLIL-------DFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIP 507

Query: 117 STIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPK 165
             IG   +L  L L++N F G IP  +G   SL  LDL+ N  +G IP 
Sbjct: 508 KWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPA 556

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  173 bits (442), Expect = 2e-46
 Identities = 60/196 (30%), Positives = 90/196 (45%), Gaps = 32/196 (16%)

Query: 1   MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSF 60
           ++ L+L  N+ +G +P  +  +   +  L L+ N+  G +P    + + L  L L  N+F
Sbjct: 271 LQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNF 330

Query: 61  SGHI-LNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLV-----LTVLDVSRNQLSGD 114
           SG + ++T   +R L VL        L+ N+  G +P  L      L  LD+S N  SG 
Sbjct: 331 SGELPMDTLLKMRGLKVLD-------LSFNEFSGELPESLTNLSASLLTLDLSSNNFSGP 383

Query: 115 IPSTIGG--RVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIP-------- 164
           I   +    +  L+ L L +N F G IP ++ +   L SL LS N LSG IP        
Sbjct: 384 ILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSK 443

Query: 165 ---------KLEGEIP 171
                     LEGEIP
Sbjct: 444 LRDLKLWLNMLEGEIP 459

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  172 bits (438), Expect = 5e-46
 Identities = 60/202 (29%), Positives = 88/202 (43%), Gaps = 31/202 (15%)

Query: 1   MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATK--LIVLDLGFN 58
           +++L L  N+ SG LP ++ +   ++  L L++NN +G I  ++    K  L  L L  N
Sbjct: 345 LKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNN 404

Query: 59  SFSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLV----LTVLDVSRNQLSGD 114
            F+G I  T  N   L  L L       + N L G IP  L     L  L +  N L G+
Sbjct: 405 GFTGKIPPTLSNCSELVSLHL-------SFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGE 457

Query: 115 IPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIP---------- 164
           IP  +     LETL L  N   G IP  + +  +L  + LS N L+G+IP          
Sbjct: 458 IPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLA 517

Query: 165 -------KLEGEIPVK-GSFKN 178
                     G IP + G  ++
Sbjct: 518 ILKLSNNSFSGNIPAELGDCRS 539

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  148 bits (377), Expect = 5e-38
 Identities = 52/193 (26%), Positives = 78/193 (40%), Gaps = 32/193 (16%)

Query: 2   RILTLEGNQLSGRLPS--TIGHSLPNIEYLLLTANNLTGTIPNSI-TNATKLIVLDLGFN 58
             L L  N LSG + +  ++G     +++L +++N L      S       L VLDL  N
Sbjct: 103 TSLDLSRNSLSGPVTTLTSLGS-CSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSAN 161

Query: 59  SFSGHI---LNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLV--LTVLDVSRNQLSG 113
           S SG              L  L++       +GNK+ G +       L  LDVS N  S 
Sbjct: 162 SISGANVVGWVLSDGCGELKHLAI-------SGNKISGDVDVSRCVNLEFLDVSSNNFST 214

Query: 114 DIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIP--------- 164
            IP  +G    L+ L ++ N+  G    ++ +   L+ L++S N   G IP         
Sbjct: 215 GIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQY 273

Query: 165 ------KLEGEIP 171
                 K  GEIP
Sbjct: 274 LSLAENKFTGEIP 286

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  148 bits (377), Expect = 6e-38
 Identities = 46/176 (26%), Positives = 76/176 (43%), Gaps = 18/176 (10%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFS 61
           R L L  N L G +P  +   +  +E L+L  N+LTG IP+ ++N T L  + L  N  +
Sbjct: 445 RDLKLWLNMLEGEIPQELM-YVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLT 503

Query: 62  GHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCL----VLTVLDVSRNQLSGDIPS 117
           G I    G L +L++L L       + N   G IP  L     L  LD++ N  +G IP+
Sbjct: 504 GEIPKWIGRLENLAILKL-------SNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPA 556

Query: 118 TIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGN--NLSGKIPKLEGEIP 171
            +  +    +  +A+N   G     + +    +    +GN     G   +    + 
Sbjct: 557 AMFKQ----SGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLS 608

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  139 bits (352), Expect = 8e-35
 Identities = 49/197 (24%), Positives = 82/197 (41%), Gaps = 39/197 (19%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIP--NSITNATKLIVLDLGFNS 59
             L L  + ++G +         ++  L L+ N+L+G +    S+ + + L  L++  N+
Sbjct: 80  ESLFLSNSHINGSVSG-FK-CSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNT 137

Query: 60  FSGHI-LNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLV-------LTVLDVSRNQL 111
                 ++    L  L VL        L+ N + G      V       L  L +S N++
Sbjct: 138 LDFPGKVSGGLKLNSLEVLD-------LSANSISGANVVGWVLSDGCGELKHLAISGNKI 190

Query: 112 SGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIP------- 164
           SGD+   +   V+LE L ++SN F   IP  +G   +L+ LD+SGN LSG          
Sbjct: 191 SGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCT 247

Query: 165 ----------KLEGEIP 171
                     +  G IP
Sbjct: 248 ELKLLNISSNQFVGPIP 264

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  136 bits (345), Expect = 7e-34
 Identities = 50/197 (25%), Positives = 82/197 (41%), Gaps = 40/197 (20%)

Query: 4   LTLEGNQLS---GRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSF 60
           + L    L+     + S++  SL  +E L L+ +++ G++      +  L  LDL  NS 
Sbjct: 55  IDLSSKPLNVGFSAVSSSLL-SLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRNSL 112

Query: 61  SGHI--LNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLV-----LTVLDVSRNQLSG 113
           SG +  L + G+   L  L+       ++ N L              L VLD+S N +SG
Sbjct: 113 SGPVTTLTSLGSCSGLKFLN-------VSSNTLDFPGKVSGGLKLNSLEVLDLSANSISG 165

Query: 114 DIPSTI---GGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIP------ 164
                     G  +L+ L+++ N+  G +   V   ++LE LD+S NN S  IP      
Sbjct: 166 ANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPFLGDCS 223

Query: 165 ----------KLEGEIP 171
                     KL G+  
Sbjct: 224 ALQHLDISGNKLSGDFS 240

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  111 bits (280), Expect = 9e-26
 Identities = 39/178 (21%), Positives = 61/178 (34%), Gaps = 36/178 (20%)

Query: 29  LLLTANNLT---GTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLMFGIR 85
           + L++  L      + +S+ + T L  L L  +  +G +   F     L+ L        
Sbjct: 55  IDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSG-FKCSASLTSLD------- 106

Query: 86  LTGNKLYGRIPP------CLVLTVLDVSRNQLSGDIPSTIGGR-VDLETLSLASNQFQGP 138
           L+ N L G +        C  L  L+VS N L      + G +   LE L L++N   G 
Sbjct: 107 LSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGA 166

Query: 139 IPESV---GSLISLESLDLSGNNLSGKIP---------------KLEGEIPVKGSFKN 178
                        L+ L +SGN +SG +                     IP  G    
Sbjct: 167 NVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSNNFSTGIPFLGDCSA 224

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 96.1 bits (240), Expect = 7e-21
 Identities = 42/162 (25%), Positives = 66/162 (40%), Gaps = 37/162 (22%)

Query: 46  NATKLIVLDL---GFNSFSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPP---CL 99
              K+  +DL     N     + ++  +L  L  L        L+ + + G +       
Sbjct: 48  RDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLF-------LSNSHINGSVSGFKCSA 100

Query: 100 VLTVLDVSRNQLSGDIPS--TIGGRVDLETLSLASNQFQGPIPESVG-SLISLESLDLSG 156
            LT LD+SRN LSG + +  ++G    L+ L+++SN    P   S G  L SLE LDLS 
Sbjct: 101 SLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSA 160

Query: 157 NNLSGKIP--------------------KLEGEIPVKGSFKN 178
           N++SG                       K+ G++ V     N
Sbjct: 161 NSISGANVVGWVLSDGCGELKHLAISGNKISGDVDV-SRCVN 201

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 47.6 bits (114), Expect = 9e-06
 Identities = 17/79 (21%), Positives = 30/79 (37%), Gaps = 21/79 (26%)

Query: 121 GRVDLETLSLASNQFQ---GPIPESVGSLISLESLDLSGNNLSGKIPK------------ 165
            +V   ++ L+S         +  S+ SL  LESL LS ++++G +              
Sbjct: 50  DKV--TSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDL 107

Query: 166 ----LEGEIPVKGSFKNFS 180
               L G +    S  + S
Sbjct: 108 SRNSLSGPVTTLTSLGSCS 126

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  174 bits (443), Expect = 2e-50
 Identities = 59/227 (25%), Positives = 97/227 (42%), Gaps = 24/227 (10%)

Query: 265 LDIQRATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQ----LERAFRSFDSECE 320
           L+I     E     ++G   FG VY+     G +VA+K         + +   +   E +
Sbjct: 2   LEIDF--AELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAK 58

Query: 321 VLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGS 380
           +   ++H N+I +           LV+EF   G L + L      +     +N  + +  
Sbjct: 59  LFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL--SGKRIPPDILVNWAVQIAR 116

Query: 381 ALEYLHNGHSSVHIIHCDLKPTNILLDE--------NMVAHVSDFGIYKLLGEGEDSVRQ 432
            + YLH+  + V IIH DLK +NIL+ +        N +  ++DFG+ +           
Sbjct: 117 GMNYLHD-EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT----- 170

Query: 433 TMTMA-TIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEM 478
            M+ A    +MAPE     + S   DV+SYGVLL E  T + P   +
Sbjct: 171 KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI 217

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  175 bits (446), Expect = 3e-50
 Identities = 57/294 (19%), Positives = 109/294 (37%), Gaps = 39/294 (13%)

Query: 272 DEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRN 329
           ++     L+G   FG VY G      +VAI++ +++   E   ++F  E    R  RH N
Sbjct: 33  EQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHEN 90

Query: 330 LIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGH 389
           ++  + +  +P   A++       +L   +      LD+ +   I  ++   + YLH   
Sbjct: 91  VVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH--- 147

Query: 390 SSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMA---TIGYMAPE- 445
            +  I+H DLK  N+  D   V  ++DFG++ + G  +   R+         + ++APE 
Sbjct: 148 -AKGILHKDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEI 205

Query: 446 --------YGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGL 497
                      +   S   DV++ G +  E   R+ P                      +
Sbjct: 206 IRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ--------------PAEAI 251

Query: 498 TEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIK 551
              +   +        +++     I D  L C     + R   T     L+K+ 
Sbjct: 252 IWQMGTGMKPNL----SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLP 301

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  175 bits (446), Expect = 4e-50
 Identities = 77/321 (23%), Positives = 136/321 (42%), Gaps = 39/321 (12%)

Query: 262 TSYLDIQRATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEV 321
            +  +     D      L+G   +G+VYKG++ D   VA+KVF+    +   +F +E  +
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNI 58

Query: 322 --LRNVRHRNLIKIL-----SSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNI 374
             +  + H N+ + +      +        LV+E+ PNGSL K+L  H    D +    +
Sbjct: 59  YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT--SDWVSSCRL 116

Query: 375 MIDVGSALEYLHN-----GHSSVHIIHCDLKPTNILLDENMVAHVSDFGI------YKLL 423
              V   L YLH       H    I H DL   N+L+  +    +SDFG+       +L+
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176

Query: 424 GEGEDSVRQTMTMATIGYMAPEYGLEGIVS--------AKCDVYSYGVLLMETFTRK--- 472
             GE+       + TI YMAPE  LEG V+         + D+Y+ G++  E F R    
Sbjct: 177 RPGEEDNAAISEVGTIRYMAPEV-LEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235

Query: 473 RPTDEMFIGEMSLRRWVKESLP-HGLTEVVDANLVREE--QAFSAKMDCILSIMDFALDC 529
            P + +   +M+ +  V        +  +V     R +  +A+      + S+ +   DC
Sbjct: 236 FPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDC 295

Query: 530 CMESPDMRINMTDAAAKLKKI 550
             +  + R+    A  ++ ++
Sbjct: 296 WDQDAEARLTAQXAEERMAEL 316

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  174 bits (442), Expect = 7e-50
 Identities = 63/293 (21%), Positives = 110/293 (37%), Gaps = 34/293 (11%)

Query: 272 DEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNL 330
            +     +LG   FG   K T    G  + +K      E   R+F  E +V+R + H N+
Sbjct: 10  SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNV 69

Query: 331 IKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHS 390
           +K +           + E++  G+L   + S +      +R++   D+ S + YLH    
Sbjct: 70  LKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---- 125

Query: 391 SVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMA------------T 438
           S++IIH DL   N L+ EN    V+DFG+ +L+ + +       ++              
Sbjct: 126 SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGN 185

Query: 439 IGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLT 498
             +MAPE         K DV+S+G++L E   R     +                     
Sbjct: 186 PYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDY-----------------LPR 228

Query: 499 EVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIK 551
            +     VR         +C  S     + CC   P+ R +       L+ ++
Sbjct: 229 TMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR 281

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  168 bits (428), Expect = 1e-47
 Identities = 68/322 (21%), Positives = 117/322 (36%), Gaps = 42/322 (13%)

Query: 254 LPLAIWRRTSYLDIQRATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFR 313
           LPL + R T    IQ           +G   +G V+ G    G  VA+KVF         
Sbjct: 27  LPLLVQR-TIAKQIQ-------MVKQIGKGRYGEVWMGKW-RGEKVAVKVFF---TTEEA 74

Query: 314 SFDSECEV--LRNVRHRNLIKILSSYSNPDFK----ALVLEFMPNGSLEKWLYSHNYFLD 367
           S+  E E+     +RH N++  +++            L+ ++  NGSL  +L   +  LD
Sbjct: 75  SWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL--KSTTLD 132

Query: 368 ILERLNIMIDVGSALEYLHN----GHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLL 423
               L +     S L +LH           I H DLK  NIL+ +N    ++D G+    
Sbjct: 133 AKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKF 192

Query: 424 GEGEDSVRQTMTMA--TIGYMAPEYGLEGIVSA-------KCDVYSYGVLLMETFTRKRP 474
               + V         T  YM PE  L+  ++          D+YS+G++L E   R   
Sbjct: 193 ISDTNEVDIPPNTRVGTKRYMPPEV-LDESLNRNHFQSYIMADMYSFGLILWEVARRCVS 251

Query: 475 TDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQ-----AFSAKMDCILSIMDFALDC 529
              +   ++    +          E +   +  ++         +  +C+  +     +C
Sbjct: 252 GGIVEEYQLP---YHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTEC 308

Query: 530 CMESPDMRINMTDAAAKLKKIK 551
              +P  R+        L K+ 
Sbjct: 309 WAHNPASRLTALRVKKTLAKMS 330

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  161 bits (409), Expect = 3e-45
 Identities = 62/296 (20%), Positives = 115/296 (38%), Gaps = 32/296 (10%)

Query: 278 NLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEV--LRNVRHRNLIKILS 335
             +G   +G V++G+   G +VA+K+F+ + E+   S+  E E+     +RH N++  ++
Sbjct: 14  ECVGKGRYGEVWRGSW-QGENVAVKIFSSRDEK---SWFRETELYNTVMLRHENILGFIA 69

Query: 336 SYSNPDFKA----LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSS 391
           S       +    L+  +   GSL  +L      LD +  L I++ + S L +LH     
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIASGLAHLHIEIFG 127

Query: 392 VH----IIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMA--TIGYMAPE 445
                 I H DLK  NIL+ +N    ++D G+  +  +  + +         T  YMAPE
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE 187

Query: 446 ------YGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKE--SLPHGL 497
                          + D++++G++L E   R      +   +      V    S     
Sbjct: 188 VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMR 247

Query: 498 TEVVDANL---VREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKI 550
             V        +         +  +  +M    +C  ++P  R+        L KI
Sbjct: 248 KVVCVDQQRPNIPNRWFSDPTLTSLAKLMK---ECWYQNPSARLTALRIKKTLTKI 300

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  156 bits (396), Expect = 5e-43
 Identities = 68/322 (21%), Positives = 125/322 (38%), Gaps = 42/322 (13%)

Query: 254 LPLAIWRRTSYLDIQRATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFR 313
           LPL + R T    I            +G   FG V++G    G +VA+K+F+ + ER   
Sbjct: 32  LPLLVQR-TIARTIVLQ-------ESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER--- 79

Query: 314 SFDSECEV--LRNVRHRNLIKILSSYSNPDFKA----LVLEFMPNGSLEKWLYSHNYFLD 367
           S+  E E+     +RH N++  +++ +  +       LV ++  +GSL  +L  + Y + 
Sbjct: 80  SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVT 137

Query: 368 ILERLNIMIDVGSALEYLHNGHSSVH----IIHCDLKPTNILLDENMVAHVSDFGIYKLL 423
           +   + + +   S L +LH           I H DLK  NIL+ +N    ++D G+    
Sbjct: 138 VEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 197

Query: 424 GEGEDSVRQTMTMA--TIGYMAPEYGLEGIVSA-------KCDVYSYGVLLMETFTRKRP 474
               D++         T  YMAPE  L+  ++        + D+Y+ G++  E   R   
Sbjct: 198 DSATDTIDIAPNHRVGTKRYMAPEV-LDDSINMKHFESFKRADIYAMGLVFWEIARRCSI 256

Query: 475 TDEMFIGEMSLRRWVKE--SLPHGLTEVVDANL---VREEQAFSAKMDCILSIMDFALDC 529
                  ++     V    S+      V +  L   +         +  +  IM    +C
Sbjct: 257 GGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMR---EC 313

Query: 530 CMESPDMRINMTDAAAKLKKIK 551
              +   R+        L ++ 
Sbjct: 314 WYANGAARLTALRIKKTLSQLS 335

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  145 bits (369), Expect = 7e-39
 Identities = 65/292 (22%), Positives = 120/292 (41%), Gaps = 44/292 (15%)

Query: 272 DEFNECNLLGTSSFGSVYKGTI-SDGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRN 329
           ++      +G  +FG V+ G + +D T VA+K     L       F  E  +L+   H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173

Query: 330 LIKIL--SSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
           +++++   +   P +  +V+E +  G    +L +    L +   L ++ D  + +EYL  
Sbjct: 174 IVRLIGVCTQKQPIY--IVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE- 230

Query: 388 GHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYG 447
              S   IH DL   N L+ E  V  +SDFG+ +   +G  +    +    + + APE  
Sbjct: 231 ---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEAL 287

Query: 448 LEGIVSAKCDVYSYGVLLMETFTR-KRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLV 506
             G  S++ DV+S+G+LL ETF+    P   +   +       +E +  G          
Sbjct: 288 NYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ------TREFVEKGG--------- 332

Query: 507 REEQAFSAKMDC-------ILSIMDFALDCCMESPDMRINMTDAAAKLKKIK 551
                   ++ C       +  +M     C    P  R + +    +L+ I+
Sbjct: 333 --------RLPCPELCPDAVFRLM---EQCWAYEPGQRPSFSTIYQELQSIR 373

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  137 bits (346), Expect = 2e-36
 Identities = 75/299 (25%), Positives = 130/299 (43%), Gaps = 36/299 (12%)

Query: 273 EFNECNL-----LGTSSFGSVYKGTI-----SDGTDVAIKVFNLQLERAFRSFDSECEVL 322
           +F E +L     LG  +FGSV          + G  VA+K      E   R F+ E E+L
Sbjct: 6   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 65

Query: 323 RNVRHRNLIKIL----SSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDV 378
           ++++H N++K      S+        L++E++P GSL  +L  H   +D ++ L     +
Sbjct: 66  KSLQHDNIVKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 123

Query: 379 GSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDS-VRQTMTMA 437
              +EYL     +   IH DL   NIL++      + DFG+ K+L + ++    +    +
Sbjct: 124 CKGMEYL----GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGES 179

Query: 438 TIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHG- 496
            I + APE   E   S   DV+S+GV+L E FT    +       M +      +   G 
Sbjct: 180 PIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRM----IGNDKQGQ 235

Query: 497 --LTEVVDANLVREEQAFSAKMDC---ILSIMDFALDCCMESPDMRINMTDAAAKLKKI 550
             +  +++  L++          C   I  IM    +C   + + R +  D A ++ +I
Sbjct: 236 MIVFHLIE--LLKNNGRLPRPDGCPDEIYMIM---TECWNNNVNQRPSFRDLALRVDQI 289

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  137 bits (346), Expect = 4e-36
 Identities = 75/299 (25%), Positives = 130/299 (43%), Gaps = 36/299 (12%)

Query: 273 EFNECNL-----LGTSSFGSVYKGTI-----SDGTDVAIKVFNLQLERAFRSFDSECEVL 322
           +F E +L     LG  +FGSV          + G  VA+K      E   R F+ E E+L
Sbjct: 37  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 96

Query: 323 RNVRHRNLIKIL----SSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDV 378
           ++++H N++K      S+        L++E++P GSL  +L  H   +D ++ L     +
Sbjct: 97  KSLQHDNIVKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 154

Query: 379 GSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDS-VRQTMTMA 437
              +EYL     +   IH DL   NIL++      + DFG+ K+L + ++    +    +
Sbjct: 155 CKGMEYL----GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGES 210

Query: 438 TIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHG- 496
            I + APE   E   S   DV+S+GV+L E FT    +       M +      +   G 
Sbjct: 211 PIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRM----IGNDKQGQ 266

Query: 497 --LTEVVDANLVREEQAFSAKMDC---ILSIMDFALDCCMESPDMRINMTDAAAKLKKI 550
             +  +++  L++          C   I  IM    +C   + + R +  D A ++ +I
Sbjct: 267 MIVFHLIE--LLKNNGRLPRPDGCPDEIYMIM---TECWNNNVNQRPSFRDLALRVDQI 320

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  134 bits (339), Expect = 2e-35
 Identities = 58/285 (20%), Positives = 113/285 (39%), Gaps = 27/285 (9%)

Query: 280 LGTSSFGSVYKGT-----ISDGTDVAIKVF-NLQLERAFRSFDSECEVLRNVRHRNLIKI 333
           LG   FG V          + G  VA+K                E E+LRN+ H N++K 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88

Query: 334 L----SSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGH 389
                    N     L++EF+P+GSL+++L  +   +++ ++L   + +   ++YL    
Sbjct: 89  KGICTEDGGNGIK--LIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYL---- 142

Query: 390 SSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVR-QTMTMATIGYMAPEYGL 448
            S   +H DL   N+L++      + DFG+ K +   ++    +    + + + APE  +
Sbjct: 143 GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLM 202

Query: 449 EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVRE 508
           +       DV+S+GV L E  T            + +       +    T +V+   ++E
Sbjct: 203 QSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTV--TRLVN--TLKE 258

Query: 509 EQAFSAKMDC---ILSIMDFALDCCMESPDMRINMTDAAAKLKKI 550
            +      +C   +  +M     C    P  R +  +     + +
Sbjct: 259 GKRLPCPPNCPDEVYQLM---RKCWEFQPSNRTSFQNLIEGFEAL 300

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  133 bits (338), Expect = 3e-35
 Identities = 58/232 (25%), Positives = 92/232 (39%), Gaps = 44/232 (18%)

Query: 269 RATDEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRH 327
           R   +F E  +LG  +FG V K     D    AIK      E    +  SE  +L ++ H
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNH 61

Query: 328 RNLIKILSSYSNPDFKA-------------LVLEFMPNGSLEKWLYSHNYFLDILERLNI 374
           + +++  +++                    + +E+  NG+L   ++S N      E   +
Sbjct: 62  QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121

Query: 375 MIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTM 434
              +  AL Y+H    S  IIH DLKP NI +DE+    + DFG+ K +    D ++   
Sbjct: 122 FRQILEALSYIH----SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177

Query: 435 TMAT---------IG---YMAPE-------YGLEGIVSAKCDVYSYGVLLME 467
                        IG   Y+A E       Y        K D+YS G++  E
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEVLDGTGHYN------EKIDMYSLGIIFFE 223

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  134 bits (339), Expect = 3e-35
 Identities = 77/297 (25%), Positives = 121/297 (40%), Gaps = 33/297 (11%)

Query: 273 EFNECNL-----LGTSSFGSVYKGTI-----SDGTDVAIKVFNLQLERAFRSFDSECEVL 322
            F E +L     LG  +FGSV          + G  VA+K          R F  E ++L
Sbjct: 19  IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQIL 78

Query: 323 RNVRHRNLIKIL----SSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDV 378
           + +    ++K                LV+E++P+G L  +L  H   LD    L     +
Sbjct: 79  KALHSDFIVKYRGVSYGPGRQSLR--LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQI 136

Query: 379 GSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDS-VRQTMTMA 437
              +EYL     S   +H DL   NIL++      ++DFG+ KLL   +D  V +    +
Sbjct: 137 CKGMEYL----GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQS 192

Query: 438 TIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTR-KRPTDEMFIGEMSLRRWVKESLPHG 496
            I + APE   + I S + DV+S+GV+L E FT   +           LR    E     
Sbjct: 193 PIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKS---CSPSAEFLRMMGCERDVPA 249

Query: 497 LTEVVDANLVREEQAFSAKMDC---ILSIMDFALDCCMESPDMRINMTDAAAKLKKI 550
           L+ +++  L+ E Q   A   C   +  +M     C   SP  R + +    +L  +
Sbjct: 250 LSRLLE--LLEEGQRLPAPPACPAEVHELM---KLCWAPSPQDRPSFSALGPQLDML 301

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  136 bits (343), Expect = 5e-35
 Identities = 53/212 (25%), Positives = 98/212 (46%), Gaps = 18/212 (8%)

Query: 273 EFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNV-RHRNLI 331
            F   ++LG  + G++    + D  DVA+K    +    F   D E ++LR    H N+I
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPE---CFSFADREVQLLRESDEHPNVI 81

Query: 332 KILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSS 391
           +   +  +  F+ + +E     +L++++   ++    LE + ++    S L +LH    S
Sbjct: 82  RYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH----S 136

Query: 392 VHIIHCDLKPTNILLDE-----NMVAHVSDFGIYKLLGEGEDSVRQTMTMA-TIGYMAPE 445
           ++I+H DLKP NIL+        + A +SDFG+ K L  G  S  +   +  T G++APE
Sbjct: 137 LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE 196

Query: 446 Y---GLEGIVSAKCDVYSYGVLLMETFTRKRP 474
                 +   +   D++S G +     +    
Sbjct: 197 MLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  133 bits (337), Expect = 6e-35
 Identities = 62/208 (29%), Positives = 101/208 (48%), Gaps = 15/208 (7%)

Query: 280 LGTSSFGSVYKGTI----SDGTDVAIKVFNL-QLERAFRSFDSECEVLRNVRHRNLIKIL 334
           +G+   G V  G +         VAIK       ER  R F SE  ++    H N+I++ 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116

Query: 335 --SSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSV 392
              +        +V E+M NGSL+ +L +H+    I++ + ++  VG+ + YL    S +
Sbjct: 117 GVVTRGRLAM--IVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYL----SDL 170

Query: 393 HIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTM-TMATIGYMAPEYGLEGI 451
             +H DL   N+L+D N+V  VSDFG+ ++L +  D+   T      I + APE      
Sbjct: 171 GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRT 230

Query: 452 VSAKCDVYSYGVLLMETFTR-KRPTDEM 478
            S+  DV+S+GV++ E     +RP   M
Sbjct: 231 FSSASDVWSFGVVMWEVLAYGERPYWNM 258

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  131 bits (333), Expect = 1e-34
 Identities = 51/206 (24%), Positives = 91/206 (44%), Gaps = 13/206 (6%)

Query: 280 LGTSSFGSVYKGT---ISDGTDVAIKVF-NLQLERAFRSFDSECEVLRNVRHRNLIKILS 335
           LG  +FGSV +G         DVAIKV      +        E +++  + +  +++++ 
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77

Query: 336 -SYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHI 394
              +      LV+E    G L K+L      + +     ++  V   ++YL       + 
Sbjct: 78  VCQAEALM--LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL----EEKNF 131

Query: 395 IHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVR-QTMTMATIGYMAPEYGLEGIVS 453
           +H DL   N+LL     A +SDFG+ K LG  +     ++     + + APE       S
Sbjct: 132 VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 191

Query: 454 AKCDVYSYGVLLMETFTR-KRPTDEM 478
           ++ DV+SYGV + E  +  ++P  +M
Sbjct: 192 SRSDVWSYGVTMWEALSYGQKPYKKM 217

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  133 bits (337), Expect = 2e-34
 Identities = 74/283 (26%), Positives = 126/283 (44%), Gaps = 40/283 (14%)

Query: 280 LGTSSFGSVYKGTI----SDGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKIL 334
           +G   FG V  G +         VAIK   +   E+  R F  E  ++    H N+I++ 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112

Query: 335 --SSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSV 392
              + S P    +V E+M NGSL+ +L  H+    +++ + ++  + S ++YL    S +
Sbjct: 113 GVVTKSKPVM--IVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL----SDM 166

Query: 393 HIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTM-TMATIGYMAPEYGLEGI 451
             +H DL   NIL++ N+V  VSDFG+ ++L +  ++   T      I + +PE      
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226

Query: 452 VSAKCDVYSYGVLLMETFTR-KRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQ 510
            ++  DV+SYG++L E  +  +RP  EM                    +V+ A  V E  
Sbjct: 227 FTSASDVWSYGIVLWEVMSYGERPYWEM-----------------SNQDVIKA--VDEGY 267

Query: 511 AFSAKMDC---ILSIMDFALDCCMESPDMRINMTDAAAKLKKI 550
                MDC   +  +M   LDC  +  + R       + L K+
Sbjct: 268 RLPPPMDCPAALYQLM---LDCWQKDRNNRPKFEQIVSILDKL 307

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  130 bits (328), Expect = 3e-34
 Identities = 60/204 (29%), Positives = 90/204 (44%), Gaps = 15/204 (7%)

Query: 280 LGTSSFGSVYKGTISDGTDVAIKVF--NLQLERAFRSFDSECEVLRNVRHRNLIKIL--S 335
           +G+  FG V+ G   +   VAIK        E  F     E EV+  + H  L+++    
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIE---EAEVMMKLSHPKLVQLYGVC 72

Query: 336 SYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHII 395
               P    LV EFM +G L  +L +          L + +DV   + YL        +I
Sbjct: 73  LEQAPIC--LVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL----EEACVI 126

Query: 396 HCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAK 455
           H DL   N L+ EN V  VSDFG+ + +   +     T T   + + +PE       S+K
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFV-LDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 185

Query: 456 CDVYSYGVLLMETFTR-KRPTDEM 478
            DV+S+GVL+ E F+  K P +  
Sbjct: 186 SDVWSFGVLMWEVFSEGKIPYENR 209

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  131 bits (333), Expect = 3e-34
 Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 14/207 (6%)

Query: 280 LGTSSFGSVYKGTISDG-----TDVAIKVFNL-QLERAFRSFDSECEVLRNVRHRNLIKI 333
           LG+ +FG+VYKG            VAIK        +A +    E  V+ +V + ++ ++
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82

Query: 334 LS-SYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSV 392
           L    ++     L+ + MP G L  ++  H   +     LN  + +   + YL       
Sbjct: 83  LGICLTSTVQ--LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL----EDR 136

Query: 393 HIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIV 452
            ++H DL   N+L+       ++DFG+ KLLG  E           I +MA E  L  I 
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 196

Query: 453 SAKCDVYSYGVLLMETFTR-KRPTDEM 478
           + + DV+SYGV + E  T   +P D +
Sbjct: 197 THQSDVWSYGVTVWELMTFGSKPYDGI 223

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  134 bits (338), Expect = 4e-34
 Identities = 63/210 (30%), Positives = 107/210 (50%), Gaps = 11/210 (5%)

Query: 272 DEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLI 331
           +       LG   FG V+ GT +  T VAIK           +F  E +V++ +RH  L+
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLV 242

Query: 332 KILS-SYSNPDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHNGH 389
           ++ +     P +  +V E+M  GSL  +L      +L + + +++   + S + Y+    
Sbjct: 243 QLYAVVSEEPIY--IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV---- 296

Query: 390 SSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLE 449
             ++ +H DL+  NIL+ EN+V  V+DFG+ +L+ + E + RQ      I + APE  L 
Sbjct: 297 ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALY 355

Query: 450 GIVSAKCDVYSYGVLLMETFTR-KRPTDEM 478
           G  + K DV+S+G+LL E  T+ + P   M
Sbjct: 356 GRFTIKSDVWSFGILLTELTTKGRVPYPGM 385

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  129 bits (327), Expect = 7e-34
 Identities = 57/211 (27%), Positives = 81/211 (38%), Gaps = 20/211 (9%)

Query: 280 LGTSSFGSVYKGT----ISDGTDVAIKVFN---LQLERAFRSFDSECEVLRNVRHRNLIK 332
           LG  SFG V +G           VA+K      L    A   F  E   + ++ HRNLI+
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85

Query: 333 ILS-SYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSS 391
           +     + P    +V E  P GSL   L  H     +       + V   + YL     S
Sbjct: 86  LYGVVLTPPMK--MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL----ES 139

Query: 392 VHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMAT---IGYMAPEYGL 448
              IH DL   N+LL    +  + DFG+ + L + +D     M         + APE   
Sbjct: 140 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHY--VMQEHRKVPFAWCAPESLK 197

Query: 449 EGIVSAKCDVYSYGVLLMETFTR-KRPTDEM 478
               S   D + +GV L E FT  + P   +
Sbjct: 198 TRTFSHASDTWMFGVTLWEMFTYGQEPWIGL 228

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  134 bits (339), Expect = 7e-34
 Identities = 63/210 (30%), Positives = 107/210 (50%), Gaps = 11/210 (5%)

Query: 272 DEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLI 331
           +       LG   FG V+ GT +  T VAIK           +F  E +V++ +RH  L+
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLV 325

Query: 332 KILS-SYSNPDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHNGH 389
           ++ +     P +  +V E+M  GSL  +L      +L + + +++   + S + Y+    
Sbjct: 326 QLYAVVSEEPIY--IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV---- 379

Query: 390 SSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLE 449
             ++ +H DL+  NIL+ EN+V  V+DFG+ +L+ + E + RQ      I + APE  L 
Sbjct: 380 ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALY 438

Query: 450 GIVSAKCDVYSYGVLLMETFTR-KRPTDEM 478
           G  + K DV+S+G+LL E  T+ + P   M
Sbjct: 439 GRFTIKSDVWSFGILLTELTTKGRVPYPGM 468

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  129 bits (326), Expect = 7e-34
 Identities = 56/202 (27%), Positives = 95/202 (47%), Gaps = 11/202 (5%)

Query: 280 LGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKIL--SSY 337
           LGT  FG V  G      DVAIK+       +   F  E +V+ N+ H  L+++    + 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90

Query: 338 SNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHC 397
             P F  ++ E+M NG L  +L    +     + L +  DV  A+EYL     S   +H 
Sbjct: 91  QRPIF--IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL----ESKQFLHR 144

Query: 398 DLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCD 457
           DL   N L+++  V  VSDFG+ + +   ++      +   + +  PE  +    S+K D
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLSRYV-LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSD 203

Query: 458 VYSYGVLLMETFTR-KRPTDEM 478
           ++++GVL+ E ++  K P +  
Sbjct: 204 IWAFGVLMWEIYSLGKMPYERF 225

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  130 bits (329), Expect = 8e-34
 Identities = 57/209 (27%), Positives = 105/209 (50%), Gaps = 16/209 (7%)

Query: 280 LGTSSFGSVYKG-----TISDGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKI 333
           +G   FG VYKG     +      VAIK       E+    F  E  ++    H N+I++
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111

Query: 334 L--SSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSS 391
               S   P    ++ E+M NG+L+K+L   +    +L+ + ++  + + ++YL    ++
Sbjct: 112 EGVISKYKPMM--IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL----AN 165

Query: 392 VHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTM-TMATIGYMAPEYGLEG 450
           ++ +H DL   NIL++ N+V  VSDFG+ ++L +  ++   T      I + APE     
Sbjct: 166 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR 225

Query: 451 IVSAKCDVYSYGVLLMETFTR-KRPTDEM 478
             ++  DV+S+G+++ E  T  +RP  E+
Sbjct: 226 KFTSASDVWSFGIVMWEVMTYGERPYWEL 254

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  128 bits (325), Expect = 9e-34
 Identities = 59/202 (29%), Positives = 94/202 (46%), Gaps = 11/202 (5%)

Query: 280 LGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKIL--SSY 337
           LG+  FG V  G      DVA+K+   +   +   F  E + +  + H  L+K     S 
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIK-EGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74

Query: 338 SNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHC 397
             P +  +V E++ NG L  +L SH   L+  + L +  DV   + +L     S   IH 
Sbjct: 75  EYPIY--IVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFL----ESHQFIHR 128

Query: 398 DLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCD 457
           DL   N L+D ++   VSDFG+ + +   +  V    T   + + APE       S+K D
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMTRYV-LDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSD 187

Query: 458 VYSYGVLLMETFTR-KRPTDEM 478
           V+++G+L+ E F+  K P D  
Sbjct: 188 VWAFGILMWEVFSLGKMPYDLY 209

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  132 bits (335), Expect = 9e-34
 Identities = 53/201 (26%), Positives = 98/201 (48%), Gaps = 10/201 (4%)

Query: 272 DEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLI 331
           +       LG   FG V+  T +  T VA+K        +  +F +E  V++ ++H  L+
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLV 246

Query: 332 KILS-SYSNPDFKALVLEFMPNGSLEKWLYSHNY-FLDILERLNIMIDVGSALEYLHNGH 389
           K+ +     P +  ++ EFM  GSL  +L S       + + ++    +   + ++    
Sbjct: 247 KLHAVVTKEPIY--IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI---- 300

Query: 390 SSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLE 449
              + IH DL+  NIL+  ++V  ++DFG+ +++ + E + R+      I + APE    
Sbjct: 301 EQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFP-IKWTAPEAINF 359

Query: 450 GIVSAKCDVYSYGVLLMETFT 470
           G  + K DV+S+G+LLME  T
Sbjct: 360 GSFTIKSDVWSFGILLMEIVT 380

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  128 bits (325), Expect = 2e-33
 Identities = 52/214 (24%), Positives = 93/214 (43%), Gaps = 14/214 (6%)

Query: 267 IQRATDEFNECNLLGTSSFGSVYKGTISDG----TDVAIKVFN-LQLERAFRSFDSECEV 321
           I       +   ++G   FG VY G   D        AIK  + +   +   +F  E  +
Sbjct: 16  IPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLL 75

Query: 322 LRNVRHRNLIKIL--SSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVG 379
           +R + H N++ ++            ++L +M +G L +++ S      + + ++  + V 
Sbjct: 76  MRGLNHPNVLALIGIMLPPEG-LPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVA 134

Query: 380 SALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMAT- 438
             +EYL    +    +H DL   N +LDE+    V+DFG+ + + + E    Q    A  
Sbjct: 135 RGMEYL----AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARL 190

Query: 439 -IGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTR 471
            + + A E       + K DV+S+GVLL E  TR
Sbjct: 191 PVKWTALESLQTYRFTTKSDVWSFGVLLWELLTR 224

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  128 bits (323), Expect = 2e-33
 Identities = 58/230 (25%), Positives = 95/230 (41%), Gaps = 31/230 (13%)

Query: 268 QRATDEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVR 326
           +R   +F E  L+G+  FG V+K     DG    IK      E+A R    E + L  + 
Sbjct: 7   KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLD 62

Query: 327 HRNLIKILSSYSNPDFKA----------------LVLEFMPNGSLEKWLYSHN-YFLDIL 369
           H N++     +   D+                  + +EF   G+LE+W+       LD +
Sbjct: 63  HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKV 122

Query: 370 ERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDS 429
             L +   +   ++Y+H    S  +I+ DLKP+NI L +     + DFG+   L    D 
Sbjct: 123 LALELFEQITKGVDYIH----SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSL--KNDG 176

Query: 430 VRQTMTMATIGYMAPEYGLEGIV-SAKCDVYSYGVLLMETFTRKRPTDEM 478
            R      T+ YM+PE  +       + D+Y+ G++L E         E 
Sbjct: 177 KRTRSK-GTLRYMSPEQ-ISSQDYGKEVDLYALGLILAELLHVCDTAFET 224

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  128 bits (324), Expect = 3e-33
 Identities = 58/223 (26%), Positives = 97/223 (43%), Gaps = 29/223 (13%)

Query: 272 DEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFN-LQLERAFRSFDSECEVLRNVRHRN 329
             +   ++LG  +  +V++G     G   AIKVFN +   R       E EVL+ + H+N
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68

Query: 330 LIKILSSYSNPDFKA--LVLEFMPNGSLEKWLYSHNYFLDILER--LNIMIDVGSALEYL 385
           ++K+ +       +   L++EF P GSL   L   +    + E   L ++ DV   + +L
Sbjct: 69  IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128

Query: 386 HNGHSSVHIIHCDLKPTNILL----DENMVAHVSDFGIYKLLGEGEDSVRQTMTMA-TIG 440
                   I+H ++KP NI+     D   V  ++DFG  + L + E    Q +++  T  
Sbjct: 129 R----ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE----QFVSLYGTEE 180

Query: 441 YMAPEYGLEGIV---------SAKCDVYSYGVLLMETFTRKRP 474
           Y+ P+   E  V          A  D++S GV      T   P
Sbjct: 181 YLHPDM-YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  128 bits (323), Expect = 4e-33
 Identities = 51/209 (24%), Positives = 95/209 (45%), Gaps = 21/209 (10%)

Query: 280 LGTSSFGSVYKGTISDG----TDVAIKVF--NLQLERAFRSFDSECEVLRNVRHRNLIKI 333
           LG   FGSV +  +         VA+K+   ++        F  E   ++   H ++ K+
Sbjct: 31  LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90

Query: 334 L--SSYSNPDFKA----LVLEFMPNGSLEKWLYSH-----NYFLDILERLNIMIDVGSAL 382
           +  S  S    +     ++L FM +G L  +L +       + L +   +  M+D+   +
Sbjct: 91  VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150

Query: 383 EYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYM 442
           EYL    SS + IH DL   N +L E+M   V+DFG+ + +  G+   +   +   + ++
Sbjct: 151 EYL----SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWL 206

Query: 443 APEYGLEGIVSAKCDVYSYGVLLMETFTR 471
           A E   + + +   DV+++GV + E  TR
Sbjct: 207 ALESLADNLYTVHSDVWAFGVTMWEIMTR 235

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  128 bits (323), Expect = 5e-33
 Identities = 67/299 (22%), Positives = 117/299 (39%), Gaps = 38/299 (12%)

Query: 273 EFNECNL-----LGTSSFGSVYKGTI-----SDGTDVAIKVFNLQ---LERAFRSFDSEC 319
            F++  L     LG   FG V            G  VA+K   L+     +    +  E 
Sbjct: 27  VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKA--LKADAGPQHRSGWKQEI 84

Query: 320 EVLRNVRHRNLIKIL----SSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIM 375
           ++LR + H ++IK       + +      LV+E++P GSL  +L  H+  + + + L   
Sbjct: 85  DILRTLYHEHIIKYKGCCEDAGAASLQ--LVMEYVPLGSLRDYLPRHS--IGLAQLLLFA 140

Query: 376 IDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVR-QTM 434
             +   + YLH    + H IH DL   N+LLD + +  + DFG+ K + EG +  R +  
Sbjct: 141 QQICEGMAYLH----AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRED 196

Query: 435 TMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLP 494
             + + + APE   E       DV+S+GV L E  T    +       + L    +  + 
Sbjct: 197 GDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMT 256

Query: 495 HGLTEVVDANLVREEQAFSAKMDC---ILSIMDFALDCCMESPDMRINMTDAAAKLKKI 550
                + +  L+   +       C   +  +M    +C       R    +    LK +
Sbjct: 257 V--LRLTE--LLERGERLPRPDKCPAEVYHLM---KNCWETEASFRPTFENLIPILKTV 308

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  127 bits (321), Expect = 5e-33
 Identities = 53/207 (25%), Positives = 95/207 (45%), Gaps = 15/207 (7%)

Query: 280 LGTSSFGSVYKGTI---SDGTDVAIKVF--NLQLERAFRSFDSECEVLRNVRHRNLIKIL 334
           LG+ +FG+V KG          VA+K+               +E  V++ + +  +++++
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84

Query: 335 S-SYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVH 393
               +      LV+E    G L K+L  + + +     + ++  V   ++YL       +
Sbjct: 85  GICEAESWM--LVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYL----EESN 137

Query: 394 IIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVR-QTMTMATIGYMAPEYGLEGIV 452
            +H DL   N+LL     A +SDFG+ K L   E+  + QT     + + APE       
Sbjct: 138 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 197

Query: 453 SAKCDVYSYGVLLMETFTR-KRPTDEM 478
           S+K DV+S+GVL+ E F+  ++P   M
Sbjct: 198 SSKSDVWSFGVLMWEAFSYGQKPYRGM 224

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  131 bits (331), Expect = 6e-33
 Identities = 56/203 (27%), Positives = 92/203 (45%), Gaps = 12/203 (5%)

Query: 272 DEFNECNLLGTSSFGSVYKGTI-SDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNL 330
            +    + LG   +G VY+G        VA+K            F  E  V++ ++H NL
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNL 278

Query: 331 IKIL--SSYSNPDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHN 387
           +++L   +   P +  ++ EFM  G+L  +L   N   +  +  L +   + SA+EYL  
Sbjct: 279 VQLLGVCTREPPFY--IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL-- 334

Query: 388 GHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYG 447
                + IH +L   N L+ EN +  V+DFG+ +L+     +         I + APE  
Sbjct: 335 --EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP-IKWTAPESL 391

Query: 448 LEGIVSAKCDVYSYGVLLMETFT 470
                S K DV+++GVLL E  T
Sbjct: 392 AYNKFSIKSDVWAFGVLLWEIAT 414

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  127 bits (321), Expect = 8e-33
 Identities = 51/207 (24%), Positives = 90/207 (43%), Gaps = 14/207 (6%)

Query: 280 LGTSSFGSVYKGTISDG-----TDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKI 333
           LG+  FG+V+KG            V IKV   +   ++F++       + ++ H +++++
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80

Query: 334 LS-SYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSV 392
           L     +     LV +++P GSL   +  H   L     LN  + +   + YL       
Sbjct: 81  LGLCPGSSLQ--LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYL----EEH 134

Query: 393 HIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIV 452
            ++H +L   N+LL       V+DFG+  LL   +  +  +     I +MA E    G  
Sbjct: 135 GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKY 194

Query: 453 SAKCDVYSYGVLLMETFTR-KRPTDEM 478
           + + DV+SYGV + E  T    P   +
Sbjct: 195 THQSDVWSYGVTVWELMTFGAEPYAGL 221

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  126 bits (320), Expect = 8e-33
 Identities = 61/287 (21%), Positives = 115/287 (40%), Gaps = 42/287 (14%)

Query: 278 NLLGTSSFGSVYKGTISDG----TDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIK 332
            ++G   FG VY GT+ D        A+K  N          F +E  ++++  H N++ 
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90

Query: 333 IL---SSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGH 389
           +L             +VL +M +G L  ++ +  +   + + +   + V   ++YL    
Sbjct: 91  LLGICLRSEGSPL--VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---- 144

Query: 390 SSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMAT--IGYMAPEYG 447
           +S   +H DL   N +LDE     V+DFG+ + + + E       T A   + +MA E  
Sbjct: 145 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 204

Query: 448 LEGIVSAKCDVYSYGVLLMETFTR-KRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLV 506
                + K DV+S+GVLL E  TR   P  ++                    ++     +
Sbjct: 205 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-----------------NTFDIT--VYL 245

Query: 507 REEQAFSAKMDC---ILSIMDFALDCCMESPDMRINMTDAAAKLKKI 550
            + +       C   +  +M   L C     +MR + ++  +++  I
Sbjct: 246 LQGRRLLQPEYCPDPLYEVM---LKCWHPKAEMRPSFSELVSRISAI 289

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  130 bits (328), Expect = 8e-33
 Identities = 61/198 (30%), Positives = 92/198 (46%), Gaps = 24/198 (12%)

Query: 280 LGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKIL--SSY 337
           +G   FG V  G    G  VA+K   ++ +   ++F +E  V+  +RH NL+++L     
Sbjct: 201 IGKGEFGDVMLGDYR-GNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 257

Query: 338 SNPDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHNGHSSVHIIH 396
                  +V E+M  GSL  +L S     L     L   +DV  A+EYL       + +H
Sbjct: 258 EKGGL-YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL----EGNNFVH 312

Query: 397 CDLKPTNILLDENMVAHVSDFG----IYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIV 452
            DL   N+L+ E+ VA VSDFG           G+  V+         + APE   E   
Sbjct: 313 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK---------WTAPEALREKKF 363

Query: 453 SAKCDVYSYGVLLMETFT 470
           S K DV+S+G+LL E ++
Sbjct: 364 STKSDVWSFGILLWEIYS 381

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  132 bits (333), Expect = 8e-33
 Identities = 50/206 (24%), Positives = 91/206 (44%), Gaps = 13/206 (6%)

Query: 280 LGTSSFGSVYKGTISDG---TDVAIKVF-NLQLERAFRSFDSECEVLRNVRHRNLIKILS 335
           LG  +FGSV +G         DVAIKV      +        E +++  + +  +++++ 
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403

Query: 336 -SYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHI 394
              +      LV+E    G L K+L      + +     ++  V   ++YL       + 
Sbjct: 404 VCQAEALM--LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL----EEKNF 457

Query: 395 IHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVR-QTMTMATIGYMAPEYGLEGIVS 453
           +H +L   N+LL     A +SDFG+ K LG  +     ++     + + APE       S
Sbjct: 458 VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 517

Query: 454 AKCDVYSYGVLLMETFTR-KRPTDEM 478
           ++ DV+SYGV + E  +  ++P  +M
Sbjct: 518 SRSDVWSYGVTMWEALSYGQKPYKKM 543

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  127 bits (320), Expect = 1e-32
 Identities = 54/208 (25%), Positives = 96/208 (46%), Gaps = 20/208 (9%)

Query: 280 LGTSSFGSVYKGTISDG----TDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKI 333
           LG   FGSV +G +         VA+K   L    +R    F SE   +++  H N+I++
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101

Query: 334 L--SSYSNPDFKA---LVLEFMPNGSLEKWLYSH-----NYFLDILERLNIMIDVGSALE 383
           L      +        ++L FM  G L  +L           + +   L  M+D+   +E
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161

Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           YL    S+ + +H DL   N +L ++M   V+DFG+ K +  G+   +  +    + ++A
Sbjct: 162 YL----SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA 217

Query: 444 PEYGLEGIVSAKCDVYSYGVLLMETFTR 471
            E   + + ++K DV+++GV + E  TR
Sbjct: 218 IESLADRVYTSKSDVWAFGVTMWEIATR 245

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  125 bits (317), Expect = 1e-32
 Identities = 48/206 (23%), Positives = 86/206 (41%), Gaps = 14/206 (6%)

Query: 280 LGTSSFGSVYKGTISDG----TDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKIL 334
           +G   FG V++G           VAIK       +     F  E   +R   H +++K++
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82

Query: 335 SSYS-NPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVH 393
              + NP +  +++E    G L  +L    Y LD+   +     + +AL YL     S  
Sbjct: 83  GVITENPVW--IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL----ESKR 136

Query: 394 IIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVS 453
            +H D+   N+L+  N    + DFG+ + + E     + +     I +MAPE       +
Sbjct: 137 FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFRRFT 195

Query: 454 AKCDVYSYGVLLMETFTR-KRPTDEM 478
           +  DV+ +GV + E      +P   +
Sbjct: 196 SASDVWMFGVCMWEILMHGVKPFQGV 221

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  126 bits (319), Expect = 1e-32
 Identities = 51/212 (24%), Positives = 85/212 (40%), Gaps = 22/212 (10%)

Query: 278 NLLGTSSFGSVYKGTISDGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNL--IKI 333
             +G+     V++         AIK  NL+    +   S+ +E   L  ++  +   I++
Sbjct: 34  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93

Query: 334 LSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVH 393
                   +  +V+E   N  L  WL       D  ER +   ++  A+  +H       
Sbjct: 94  YDYEITDQYIYMVMECG-NIDLNSWLKKKKSI-DPWERKSYWKNMLEAVHTIH----QHG 147

Query: 394 IIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPE-------- 445
           I+H DLKP N L+ + M+  + DFGI   +     SV +   + T+ YM PE        
Sbjct: 148 IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 206

Query: 446 ---YGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
                 +  +S K DV+S G +L      K P
Sbjct: 207 RENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  127 bits (322), Expect = 1e-32
 Identities = 58/299 (19%), Positives = 113/299 (37%), Gaps = 28/299 (9%)

Query: 198 VPPCKPDNSKRTKKVPLIVLKYILPPIVST-----VLVVITIIMYIRCRNRNTKKSDHED 252
           + P    +    ++   +    ++P           +  ++  +Y +  + N        
Sbjct: 4   IDPMGHHHHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANT 63

Query: 253 FLPLAIWRRTSYL-DIQRATDEFNECNL-----LGTSSFGSVYKGTISDG----TDVAIK 302
                       +  +Q      +   +     +G   FG VY GT+ D        A+K
Sbjct: 64  VHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVK 123

Query: 303 VFNLQL-ERAFRSFDSECEVLRNVRHRNLIKIL---SSYSNPDFKALVLEFMPNGSLEKW 358
             N          F +E  ++++  H N++ +L             +VL +M +G L  +
Sbjct: 124 SLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL--VVLPYMKHGDLRNF 181

Query: 359 LYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFG 418
           + +  +   + + +   + V   +++L    +S   +H DL   N +LDE     V+DFG
Sbjct: 182 IRNETHNPTVKDLIGFGLQVAKGMKFL----ASKKFVHRDLAARNCMLDEKFTVKVADFG 237

Query: 419 IYKLLGEGEDSVRQTMTMAT--IGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTR-KRP 474
           + + + + E       T A   + +MA E       + K DV+S+GVLL E  TR   P
Sbjct: 238 LARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  128 bits (323), Expect = 1e-32
 Identities = 59/223 (26%), Positives = 98/223 (43%), Gaps = 29/223 (13%)

Query: 272 DEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFN-LQLERAFRSFDSECEVLRNVRHRN 329
             +   ++LG  +  +V++G     G   AIKVFN +   R       E EVL+ + H+N
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68

Query: 330 LIKILSSY--SNPDFKALVLEFMPNGSLEKWLYSHNYFLDILER--LNIMIDVGSALEYL 385
           ++K+ +    +    K L++EF P GSL   L   +    + E   L ++ DV   + +L
Sbjct: 69  IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128

Query: 386 HNGHSSVHIIHCDLKPTNILL----DENMVAHVSDFGIYKLLGEGEDSVRQTMTMA-TIG 440
                   I+H ++KP NI+     D   V  ++DFG  + L + E    Q +++  T  
Sbjct: 129 R----ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE----QFVSLYGTEE 180

Query: 441 YMAPEYGLEGIV---------SAKCDVYSYGVLLMETFTRKRP 474
           Y+ P+   E  V          A  D++S GV      T   P
Sbjct: 181 YLHPDM-YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  126 bits (319), Expect = 2e-32
 Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 14/207 (6%)

Query: 280 LGTSSFGSVYKGTISDG-----TDVAIKVFNL-QLERAFRSFDSECEVLRNVRHRNLIKI 333
           LG+ +FG+VYKG            VAIK        +A +    E  V+ +V + ++ ++
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82

Query: 334 LS-SYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSV 392
           L    ++     L+ + MP G L  ++  H   +     LN  + +   + YL       
Sbjct: 83  LGICLTSTVQ--LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL----EDR 136

Query: 393 HIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIV 452
            ++H DL   N+L+       ++DFG+ KLLG  E           I +MA E  L  I 
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 196

Query: 453 SAKCDVYSYGVLLMETFTR-KRPTDEM 478
           + + DV+SYGV + E  T   +P D +
Sbjct: 197 THQSDVWSYGVTVWELMTFGSKPYDGI 223

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  126 bits (319), Expect = 2e-32
 Identities = 51/212 (24%), Positives = 85/212 (40%), Gaps = 22/212 (10%)

Query: 278 NLLGTSSFGSVYKGTISDGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNL--IKI 333
             +G+     V++         AIK  NL+    +   S+ +E   L  ++  +   I++
Sbjct: 15  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74

Query: 334 LSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVH 393
                   +  +V+E   N  L  WL       D  ER +   ++  A+  +H       
Sbjct: 75  YDYEITDQYIYMVMEC-GNIDLNSWLKKKKSI-DPWERKSYWKNMLEAVHTIH----QHG 128

Query: 394 IIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPE-------- 445
           I+H DLKP N L+ + M+  + DFGI   +     SV +   + T+ YM PE        
Sbjct: 129 IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 187

Query: 446 ---YGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
                 +  +S K DV+S G +L      K P
Sbjct: 188 RENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  124 bits (313), Expect = 4e-32
 Identities = 52/201 (25%), Positives = 101/201 (50%), Gaps = 10/201 (4%)

Query: 272 DEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLI 331
           +       LG   FG V+ G  +  T VA+K           +F +E  +++ ++H+ L+
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLV 71

Query: 332 KILSSYS-NPDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHNGH 389
           ++ +  +  P +  ++ E+M NGSL  +L + +   L I + L++   +   + ++    
Sbjct: 72  RLYAVVTQEPIY--IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI---- 125

Query: 390 SSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLE 449
              + IH DL+  NIL+ + +   ++DFG+ +L+ + E + R+      I + APE    
Sbjct: 126 EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG-AKFPIKWTAPEAINY 184

Query: 450 GIVSAKCDVYSYGVLLMETFT 470
           G  + K DV+S+G+LL E  T
Sbjct: 185 GTFTIKSDVWSFGILLTEIVT 205

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  126 bits (319), Expect = 5e-32
 Identities = 50/212 (23%), Positives = 84/212 (39%), Gaps = 22/212 (10%)

Query: 278 NLLGTSSFGSVYKGTISDGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNL--IKI 333
             +G+     V++         AIK  NL+    +   S+ +E   L  ++  +   I++
Sbjct: 62  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121

Query: 334 LSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVH 393
                   +  +V+E   N  L  WL       D  ER +   ++  A+  +H       
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKSI-DPWERKSYWKNMLEAVHTIH----QHG 175

Query: 394 IIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPE-------- 445
           I+H DLKP N L+ + M+  + DFGI   +     SV +   +  + YM PE        
Sbjct: 176 IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSS 234

Query: 446 ---YGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
                 +  +S K DV+S G +L      K P
Sbjct: 235 RENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  123 bits (312), Expect = 6e-32
 Identities = 50/206 (24%), Positives = 95/206 (46%), Gaps = 14/206 (6%)

Query: 280 LGTSSFGSVYKGT----ISDGTDVAIKVFNL-QLERAFRSFDSECEVLRNVRHRNLIKIL 334
           LG   FG VY+G       +  +VA+K             F SE  +++N+ H +++K++
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79

Query: 335 S-SYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVH 393
                 P +  +++E  P G L  +L  +   L +L  +   + +  A+ YL     S++
Sbjct: 80  GIIEEEPTW--IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYL----ESIN 133

Query: 394 IIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVS 453
            +H D+   NIL+       + DFG+ + + E ED  + ++T   I +M+PE       +
Sbjct: 134 CVHRDIAVRNILVASPECVKLGDFGLSRYI-EDEDYYKASVTRLPIKWMSPESINFRRFT 192

Query: 454 AKCDVYSYGVLLMETFTR-KRPTDEM 478
              DV+ + V + E  +  K+P   +
Sbjct: 193 TASDVWMFAVCMWEILSFGKQPFFWL 218

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  123 bits (310), Expect = 1e-31
 Identities = 56/219 (25%), Positives = 89/219 (40%), Gaps = 25/219 (11%)

Query: 272 DEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHR 328
           +++     +GT S+G   K    SDG  +  K  +     E   +   SE  +LR ++H 
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65

Query: 329 NLIKILSSYSNPDFKAL--VLEFMPNGSLEKWLYSH---NYFLDILERLNIMIDVGSALE 383
           N+++      +     L  V+E+   G L   +        +LD    L +M  +  AL+
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125

Query: 384 YLHNGHSSVH-IIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMA-TIGY 441
             H      H ++H DLKP N+ LD      + DFG+ ++L           T   T  Y
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS---FAKTFVGTPYY 182

Query: 442 MAPE------YGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
           M+PE      Y      + K D++S G LL E      P
Sbjct: 183 MSPEQMNRMSY------NEKSDIWSLGCLLYELCALMPP 215

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  123 bits (311), Expect = 1e-31
 Identities = 62/221 (28%), Positives = 101/221 (45%), Gaps = 12/221 (5%)

Query: 260 RRTSYLDIQRATDEFNECNLLGTSSFGSVYKGTISD-GTDVAIKVFNLQLERAFRSFDSE 318
             +  L+     DE  +  +LG  ++G VY G        +AIK    +  R  +    E
Sbjct: 10  CESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEE 69

Query: 319 CEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERL--NIMI 376
             + ++++H+N+++ L S+S   F  + +E +P GSL   L S    L   E+       
Sbjct: 70  IALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTK 129

Query: 377 DVGSALEYLHNGHSSVHIIHCDLKPTNILLD-ENMVAHVSDFGIYKLLGEGEDSVRQTMT 435
            +   L+YLH       I+H D+K  N+L++  + V  +SDFG  K L  G +   +T T
Sbjct: 130 QILEGLKYLH----DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRL-AGINPCTETFT 184

Query: 436 MATIGYMAPE--YGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
             T+ YMAPE             D++S G  ++E  T K P
Sbjct: 185 -GTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  123 bits (310), Expect = 1e-31
 Identities = 52/204 (25%), Positives = 89/204 (43%), Gaps = 16/204 (7%)

Query: 279 LLGTSSFGSVYKGT-ISDGTDVAIKVFNL--QLERAFRSFDSECEVLRNVRHRNLIKILS 335
            +G  SF +VYKG       +VA          +   + F  E E+L+ ++H N+++   
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 336 SYSNPDFKA----LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSS 391
           S+ +         LV E M +G+L+ +L         + R +    +   L++LH    +
Sbjct: 93  SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLR-SWCRQILKGLQFLHT--RT 149

Query: 392 VHIIHCDLKPTNILLD-ENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEG 450
             IIH DLK  NI +        + D G+  L      S  + + + T  +MAPE   E 
Sbjct: 150 PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKAV-IGTPEFMAPEMYEEK 205

Query: 451 IVSAKCDVYSYGVLLMETFTRKRP 474
                 DVY++G+ ++E  T + P
Sbjct: 206 -YDESVDVYAFGMCMLEMATSEYP 228

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  122 bits (309), Expect = 2e-31
 Identities = 58/200 (29%), Positives = 91/200 (45%), Gaps = 13/200 (6%)

Query: 280 LGTSSFGSVYKGTISDG-TDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKIL--SS 336
           LG   +G VY+G        VA+K            F  E  V++ ++H NL+++L   +
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT 79

Query: 337 YSNPDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHNGHSSVHII 395
              P +  ++ EFM  G+L  +L   N   +  +  L +   + SA+EYL       + I
Sbjct: 80  REPPFY--IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL----EKKNFI 133

Query: 396 HCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAK 455
           H DL   N L+ EN +  V+DFG+ +L+     +         I + APE       S K
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP-IKWTAPESLAYNKFSIK 192

Query: 456 CDVYSYGVLLMETFTR-KRP 474
            DV+++GVLL E  T    P
Sbjct: 193 SDVWAFGVLLWEIATYGMSP 212

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  127 bits (322), Expect = 3e-31
 Identities = 37/184 (20%), Positives = 73/184 (39%), Gaps = 24/184 (13%)

Query: 2   RILTLEGNQL-SGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSF 60
           +I+ +  N L +  + +++   +  +  L    N L G +P +  +  KL  L+L +N  
Sbjct: 308 QIIYIGYNNLKTFPVETSLQK-MKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQI 365

Query: 61  SGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCL------VLTVLDVSRNQLSG- 113
           +    N  G    +  LS          NKL   IP         V++ +D S N++   
Sbjct: 366 TEIPANFCGFTEQVENLSF-------AHNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGSV 417

Query: 114 ------DIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKLE 167
                  +  T    +++ +++L++NQ      E   +   L S++L GN L+       
Sbjct: 418 DGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSL 477

Query: 168 GEIP 171
            +  
Sbjct: 478 KDEN 481

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  122 bits (308), Expect = 2e-29
 Identities = 30/185 (16%), Positives = 69/185 (37%), Gaps = 23/185 (12%)

Query: 1   MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLT--------GTIPNSITNATKLIV 52
           +  + +       +LP+ +  +LP ++ + +  N                      K+ +
Sbjct: 251 LTDVEVYNCPNLTKLPTFLK-ALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQI 309

Query: 53  LDLGFNSF-SGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLV----LTVLDVS 107
           + +G+N+  +  +  +   ++ L +L           N+L G   P       L  L+++
Sbjct: 310 IYIGYNNLKTFPVETSLQKMKKLGMLE-------CLYNQLEG-KLPAFGSEIKLASLNLA 361

Query: 108 RNQLSGDIPSTIGGRVDLETLSLASNQFQG-PIPESVGSLISLESLDLSGNNLSGKIPKL 166
            NQ++    +  G    +E LS A N+ +  P      S+  + ++D S N +     K 
Sbjct: 362 YNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKN 421

Query: 167 EGEIP 171
              + 
Sbjct: 422 FDPLD 426

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  121 bits (306), Expect = 3e-29
 Identities = 31/191 (16%), Positives = 60/191 (31%), Gaps = 37/191 (19%)

Query: 1   MRILTLEGNQLSG-------RLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVL 53
           M  +    N++          L  T      N+  + L+ N ++       +  + L  +
Sbjct: 404 MSAIDFSYNEIGSVDGKNFDPLDPTPF-KGINVSSINLSNNQISKFPKELFSTGSPLSSI 462

Query: 54  DLGFNSFSG-------HILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLV------ 100
           +L  N  +             F N   L+ + L         NKL  ++           
Sbjct: 463 NLMGNMLTEIPKNSLKDENENFKNTYLLTSIDL-------RFNKL-TKLSDDFRATTLPY 514

Query: 101 LTVLDVSRNQLSGDIPSTIGGRVDLETLSL------ASNQFQGPIPESVGSLISLESLDL 154
           L  +D+S N  S   P+       L+   +        N+     PE +    SL  L +
Sbjct: 515 LVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQI 573

Query: 155 SGNNLSGKIPK 165
             N++   + +
Sbjct: 574 GSNDIRK-VNE 583

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  114 bits (287), Expect = 8e-27
 Identities = 31/192 (16%), Positives = 59/192 (30%), Gaps = 37/192 (19%)

Query: 1   MRILTLEGNQLSGRLPSTIGH-SLPNIEYLLLTANNLTG-------TIPNSITNATKLIV 52
           +  L+   N+L   +P+     S+  +  +  + N +          +  +      +  
Sbjct: 379 VENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSS 437

Query: 53  LDLGFNSFSGHILNTFGNLRHLSVLSLLMFGIRLTGNKL-------YGRIPPCLV----L 101
           ++L  N  S      F     LS +        L GN L                    L
Sbjct: 438 INLSNNQISKFPKELFSTGSPLSSI-------NLMGNMLTEIPKNSLKDENENFKNTYLL 490

Query: 102 TVLDVSRNQLSGDIPSTIGGR--VDLETLSLASNQFQGPIPESVGSLISLESL------D 153
           T +D+  N+L+  +           L  + L+ N F    P    +  +L+        D
Sbjct: 491 TSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRD 548

Query: 154 LSGNNLSGKIPK 165
             GN    + P+
Sbjct: 549 AQGNRTLREWPE 560

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  111 bits (280), Expect = 5e-26
 Identities = 26/191 (13%), Positives = 52/191 (27%), Gaps = 34/191 (17%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTG----TIPNSITNATKLIVLDLGF 57
             L+LEG   SGR+P  IG  L  +E L L ++          P  I+            
Sbjct: 84  TGLSLEGFGASGRVPDAIGQ-LTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMR 142

Query: 58  NSFSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPP----CLVLTVLDVSRNQLSG 113
             +    ++         ++        +  +     I       L  T +    N ++ 
Sbjct: 143 MHYQKTFVDYDPREDFSDLIKDC-----INSDPQQKSIKKSSRITLKDTQIGQLSNNITF 197

Query: 114 DIPSTIGGRVDLETLSLASNQFQGP-------------------IPESVGSLISLESLDL 154
            +   +     L    + ++ F                            +L  L  +++
Sbjct: 198 -VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEV 256

Query: 155 SGNNLSGKIPK 165
                  K+P 
Sbjct: 257 YNCPNLTKLPT 267

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  104 bits (261), Expect = 1e-23
 Identities = 32/172 (18%), Positives = 51/172 (29%), Gaps = 20/172 (11%)

Query: 2   RILTLEGNQLSG-------RLPSTIGHSLPNIEYLLLTANNLTGTIPNSI--TNATKLIV 52
             + L GN L+                +   +  + L  N LT  + +    T    L+ 
Sbjct: 460 SSINLMGNMLTEIPKNSLKDENENFK-NTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVG 517

Query: 53  LDLGFNSFSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPP----CLVLTVLDVSR 108
           +DL +NSFS        N   L    +        GN+     P     C  LT L +  
Sbjct: 518 IDLSYNSFSK-FPTQPLNSSTLKGFGIRNQ-RDAQGNRTLREWPEGITLCPSLTQLQIGS 575

Query: 109 NQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLS 160
           N +   +   I    ++  L +  N         V   I      L  +   
Sbjct: 576 NDIRK-VNEKIT--PNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ 624

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  103 bits (260), Expect = 2e-23
 Identities = 13/180 (7%), Positives = 41/180 (22%), Gaps = 11/180 (6%)

Query: 2   RILTLEGNQLSGRLPSTIGH-SLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSF 60
                                   ++    + ++    +I  S     K   +    N+ 
Sbjct: 136 EQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNI 195

Query: 61  SGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLVLTVLDVSRNQLSGDIPSTIG 120
           +  +      L  L    +         +               +    Q          
Sbjct: 196 TF-VSKAVMRLTKLRQFYM-------GNSPFVAENICEA-WENENSEYAQQYKTEDLKWD 246

Query: 121 GRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKLEGEIPVKGSFKNFS 180
              DL  + + +      +P  + +L  ++ ++++ N       +L+ +           
Sbjct: 247 NLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGIS-GEQLKDDWQALADAPVGE 305

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  103 bits (259), Expect = 3e-23
 Identities = 18/174 (10%), Positives = 51/174 (29%), Gaps = 27/174 (15%)

Query: 4   LTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGH 63
             +  +     +  +   +L     +   +NN+T  +  ++   TKL    +G + F   
Sbjct: 164 DCINSDPQQKSIKKSSRITL-KDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAE 221

Query: 64  ILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLV----LTVLDVSRNQLSGDIPSTI 119
            +       +                               LT ++V        +P+ +
Sbjct: 222 NICEAWENENSEYAQQY------------KTEDLKWDNLKDLTDVEVYNCPNLTKLPTFL 269

Query: 120 GGRVDLETLSLASNQF--------QGPIPESVGSLISLESLDLSGNNL-SGKIP 164
               +++ +++A N+                      ++ + +  NNL +  + 
Sbjct: 270 KALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVE 323

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  102 bits (255), Expect = 6e-23
 Identities = 22/166 (13%), Positives = 46/166 (27%), Gaps = 12/166 (7%)

Query: 11  LSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTF-G 69
           + G  P    +S   +  L L     +G +P++I   T+L VL LG +    +       
Sbjct: 68  MWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPK 127

Query: 70  NLRHLSVLSLLMFGIRLTGNKLYGRIPP------CLVLTVLDVSRNQLSGDIPSTIGGRV 123
            +             +                     L    ++ +     I  +    +
Sbjct: 128 GISANMSDEQK----QKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITL 183

Query: 124 DLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKLEGE 169
               +   SN     + ++V  L  L    +  +    +      E
Sbjct: 184 KDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWE 228

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 67.0 bits (164), Expect = 9e-12
 Identities = 18/101 (17%), Positives = 34/101 (33%), Gaps = 8/101 (7%)

Query: 101 LTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGP----IPESVGSLISLESLDLSG 156
           +T L +     SG +P  IG   +LE L+L S+  +       P+ + + +S E      
Sbjct: 83  VTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMR 142

Query: 157 NNLSGKIPKLEGEIPVKGSFKNFSTESFFGNYALCGPPKLR 197
            +            P +  F +   +    +       K  
Sbjct: 143 MHYQKTFV---DYDP-REDFSDLIKDCINSDPQQKSIKKSS 179

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 52.4 bits (126), Expect = 3e-07
 Identities = 12/72 (16%), Positives = 22/72 (30%)

Query: 90  KLYGRIPPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISL 149
              G           +   +        ++     +  LSL      G +P+++G L  L
Sbjct: 48  SQQGFGTQPGANWNFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTEL 107

Query: 150 ESLDLSGNNLSG 161
           E L L  +    
Sbjct: 108 EVLALGSHGEKV 119

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  125 bits (315), Expect = 3e-31
 Identities = 60/238 (25%), Positives = 99/238 (41%), Gaps = 41/238 (17%)

Query: 268 QRATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQ-LERAFRSFDSECEVLR-NV 325
           Q   +      +LG  S G+V       G  VA+K   +   + A      E ++L  + 
Sbjct: 11  QSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALM----EIKLLTESD 66

Query: 326 RHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERL------NIMIDVG 379
            H N+I+   S +   F  + LE   N +L+  + S N   + L+        +++  + 
Sbjct: 67  DHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIA 125

Query: 380 SALEYLHNGHSSVHIIHCDLKPTNILLD-------------ENMVAHVSDFGIYKLLGEG 426
           S + +LH    S+ IIH DLKP NIL+              EN+   +SDFG+ K L  G
Sbjct: 126 SGVAHLH----SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG 181

Query: 427 EDSVRQTMTMA--TIGYMAPEYGLEGIVSA--------KCDVYSYGVLLMETFTRKRP 474
           + S R  +     T G+ APE  LE   +           D++S G +     ++ + 
Sbjct: 182 QSSFRTNLNNPSGTSGWRAPEL-LEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  121 bits (306), Expect = 3e-31
 Identities = 61/200 (30%), Positives = 92/200 (46%), Gaps = 24/200 (12%)

Query: 278 NLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILS-- 335
             +G   FG V  G    G  VA+K   ++ +   ++F +E  V+  +RH NL+++L   
Sbjct: 27  QTIGKGEFGDVMLGDY-RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 83

Query: 336 SYSNPDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHNGHSSVHI 394
                    +V E+M  GSL  +L S     L     L   +DV  A+EYL       + 
Sbjct: 84  VEEKGGL-YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL----EGNNF 138

Query: 395 IHCDLKPTNILLDENMVAHVSDFG----IYKLLGEGEDSVRQTMTMATIGYMAPEYGLEG 450
           +H DL   N+L+ E+ VA VSDFG           G+  V+         + APE   E 
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK---------WTAPEALREK 189

Query: 451 IVSAKCDVYSYGVLLMETFT 470
             S K DV+S+G+LL E ++
Sbjct: 190 KFSTKSDVWSFGILLWEIYS 209

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  127 bits (321), Expect = 4e-31
 Identities = 46/197 (23%), Positives = 83/197 (42%), Gaps = 13/197 (6%)

Query: 280 LGTSSFGSVYKGTISDG----TDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKIL 334
           +G   FG V++G           VAIK       +     F  E   +R   H +++K++
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457

Query: 335 SSYS-NPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVH 393
              + NP +  +++E    G L  +L    + LD+   +     + +AL YL     S  
Sbjct: 458 GVITENPVW--IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYL----ESKR 511

Query: 394 IIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVS 453
            +H D+   N+L+  N    + DFG+ + + E     + +     I +MAPE       +
Sbjct: 512 FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFRRFT 570

Query: 454 AKCDVYSYGVLLMETFT 470
           +  DV+ +GV + E   
Sbjct: 571 SASDVWMFGVCMWEILM 587

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  123 bits (310), Expect = 4e-31
 Identities = 48/208 (23%), Positives = 90/208 (43%), Gaps = 12/208 (5%)

Query: 272 DEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHR 328
           +++     +G  SFG         DG    IK  N+     +       E  VL N++H 
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83

Query: 329 NLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSH-NYFLDILERLNIMIDVGSALEYLHN 387
           N+++   S+       +V+++   G L K + +         + L+  + +  AL+++H 
Sbjct: 84  NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH- 142

Query: 388 GHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYG 447
                 I+H D+K  NI L ++    + DFGI ++L    + + +     T  Y++PE  
Sbjct: 143 ---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE-LARACI-GTPYYLSPEI- 196

Query: 448 LEGI-VSAKCDVYSYGVLLMETFTRKRP 474
            E    + K D+++ G +L E  T K  
Sbjct: 197 CENKPYNNKSDIWALGCVLYELCTLKHA 224

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  126 bits (318), Expect = 8e-31
 Identities = 41/170 (24%), Positives = 64/170 (37%), Gaps = 15/170 (8%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSI-TNATKLIVLDLGFNSF 60
           + L L  N +     + +G  L  +E+L    +NL      S+  +   LI LD+     
Sbjct: 376 KYLDLSFNGVITMSSNFLG--LEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHT 433

Query: 61  SGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLV-----LTVLDVSRNQLSGDI 115
                  F  L  L VL +        GN       P +      LT LD+S+ QL    
Sbjct: 434 RVAFNGIFNGLSSLEVLKM-------AGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLS 486

Query: 116 PSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPK 165
           P+       L+ L+++ N F          L SL+ LD S N++     +
Sbjct: 487 PTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQ 536

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  123 bits (312), Expect = 4e-30
 Identities = 35/169 (20%), Positives = 61/169 (36%), Gaps = 13/169 (7%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFS 61
             L  + + L      ++  SL N+ YL ++  +            + L VL +  NSF 
Sbjct: 399 EHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQ 458

Query: 62  GHIL-NTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLV----LTVLDVSRNQLSGDIP 116
            + L + F  LR+L+ L L       +  +L    P        L VL++S N       
Sbjct: 459 ENFLPDIFTELRNLTFLDL-------SQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDT 511

Query: 117 STIGGRVDLETLSLASNQFQGPIPESVGSLI-SLESLDLSGNNLSGKIP 164
                   L+ L  + N       + +     SL  L+L+ N+ +    
Sbjct: 512 FPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 560

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  119 bits (300), Expect = 1e-28
 Identities = 41/191 (21%), Positives = 63/191 (32%), Gaps = 26/191 (13%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFS 61
           + L L  N L      +     P ++ L L+   +      +  + + L  L L  N   
Sbjct: 31  KNLDLSFNPLRHLGSYSFFS-FPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89

Query: 62  GHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLV----LTVLDVSRNQL-SGDIP 116
              L  F  L  L  L             L       +     L  L+V+ N + S  +P
Sbjct: 90  SLALGAFSGLSSLQKLVA-------VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLP 142

Query: 117 STIGGRVDLETLSLASNQFQGPIPESVGSLISLE----SLDLSGNNLSGKIPKLEGEIPV 172
                  +LE L L+SN+ Q      +  L  +     SLDLS N ++   P        
Sbjct: 143 EYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQP-------- 194

Query: 173 KGSFKNFSTES 183
            G+FK      
Sbjct: 195 -GAFKEIRLHK 204

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  112 bits (283), Expect = 2e-26
 Identities = 31/173 (17%), Positives = 58/173 (33%), Gaps = 18/173 (10%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFS 61
           ++L L   ++           L ++  L+LT N +      + +  + L  L     + +
Sbjct: 55  QVLDLSRCEIQTIEDGAYQS-LSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLA 113

Query: 62  GHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLV-----LTVLDVSRNQLSGDIP 116
                  G+L+ L  L++         N +     P        L  LD+S N++     
Sbjct: 114 SLENFPIGHLKTLKELNV-------AHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYC 166

Query: 117 STIGG----RVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPK 165
           + +       +   +L L+ N     I       I L  L L  N  S  + K
Sbjct: 167 TDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMK 218

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  109 bits (274), Expect = 3e-25
 Identities = 45/174 (25%), Positives = 61/174 (35%), Gaps = 19/174 (10%)

Query: 1   MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLT--GTIPNSITNATKLIVLDLGFN 58
           ++ LT   N+            LP++E+L L+ N L+  G    S    T L  LDL FN
Sbjct: 327 LKRLTFTSNKGGNAFSEV---DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFN 383

Query: 59  SFSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLV-----LTVLDVSRNQLSG 113
                + + F  L  L  L           + L       +      L  LD+S      
Sbjct: 384 GVIT-MSSNFLGLEQLEHL-------DFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRV 435

Query: 114 DIPSTIGGRVDLETLSLASNQFQGPI-PESVGSLISLESLDLSGNNLSGKIPKL 166
                  G   LE L +A N FQ    P+    L +L  LDLS   L    P  
Sbjct: 436 AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTA 489

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 98.2 bits (245), Expect = 1e-21
 Identities = 28/143 (19%), Positives = 47/143 (32%), Gaps = 28/143 (19%)

Query: 24  PNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLMFG 83
            + + L L+ N L      S  +  +L VLDL            + +L HLS L L    
Sbjct: 28  FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLIL---- 83

Query: 84  IRLTGNKLYGRIPPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESV 143
                                  + N +         G   L+ L              +
Sbjct: 84  -----------------------TGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPI 120

Query: 144 GSLISLESLDLSGNNL-SGKIPK 165
           G L +L+ L+++ N + S K+P+
Sbjct: 121 GHLKTLKELNVAHNLIQSFKLPE 143

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 93.2 bits (232), Expect = 4e-20
 Identities = 33/185 (17%), Positives = 53/185 (28%), Gaps = 22/185 (11%)

Query: 1   MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSF 60
           +    L            + + L N+    L +  +      S         L+L    F
Sbjct: 259 IEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFS--YNFGWQHLELVNCKF 316

Query: 61  SGHILNTFGNLRHLSVLSLLMFGI------------RLTGNKLY--GRIPPCLV----LT 102
                    +L+ L+  S                   L+ N L   G           L 
Sbjct: 317 GQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLK 376

Query: 103 VLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESV-GSLISLESLDLSGNNLSG 161
            LD+S N +   + S   G   LE L    +  +     SV  SL +L  LD+S  +   
Sbjct: 377 YLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRV 435

Query: 162 KIPKL 166
               +
Sbjct: 436 AFNGI 440

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 87.8 bits (218), Expect = 2e-18
 Identities = 32/170 (18%), Positives = 56/170 (32%), Gaps = 13/170 (7%)

Query: 2   RILTLEGNQLSGRLPSTIG--HSLPNIEYLL-LTANNLTGTIPNSITNATKLIVLDLGFN 58
             L L  N++     + +   H +P +   L L+ N +    P +     +L  L L  N
Sbjct: 152 EHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE-IRLHKLTLRNN 210

Query: 59  SFSGHIL-NTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLVLTVLDVSRNQLS----- 112
             S +++      L  L V  L++   R  GN           L  L +   +L+     
Sbjct: 211 FDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYY 270

Query: 113 -GDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSG 161
             DI        ++ + SL S   +     S       + L+L       
Sbjct: 271 LDDIIDLFNCLTNVSSFSLVSVTIERVKDFS--YNFGWQHLELVNCKFGQ 318

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 85.5 bits (212), Expect = 1e-17
 Identities = 39/193 (20%), Positives = 65/193 (33%), Gaps = 27/193 (13%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTAN------NLTGTIPNSITNATKLIVLDL 55
             LTL  N  S  +  T    L  +E   L         NL     +++     L + + 
Sbjct: 203 HKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEF 262

Query: 56  GFNS---FSGHILNTFGNLRHLSVLSLL---------------MFGIRLTGNKLYGRIPP 97
                  +   I++ F  L ++S  SL+                  + L   K  G+ P 
Sbjct: 263 RLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKF-GQFPT 321

Query: 98  CLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQ--FQGPIPESVGSLISLESLDLS 155
             + ++  ++     G    +      LE L L+ N   F+G   +S     SL+ LDLS
Sbjct: 322 LKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLS 381

Query: 156 GNNLSGKIPKLEG 168
            N +        G
Sbjct: 382 FNGVITMSSNFLG 394

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 83.5 bits (207), Expect = 5e-17
 Identities = 31/143 (21%), Positives = 44/143 (30%), Gaps = 31/143 (21%)

Query: 22  SLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLM 81
            +PNI Y  +   N    IP+++        LDL FN        +F +   L       
Sbjct: 6   VVPNITYQCM-ELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPEL------- 54

Query: 82  FGIRLTGNKLYGRIPPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPE 141
                                VLD+SR ++             L TL L  N  Q     
Sbjct: 55  --------------------QVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALG 94

Query: 142 SVGSLISLESLDLSGNNLSGKIP 164
           +   L SL+ L     NL+    
Sbjct: 95  AFSGLSSLQKLVAVETNLASLEN 117

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 72.8 bits (179), Expect = 1e-13
 Identities = 22/157 (14%), Positives = 44/157 (28%), Gaps = 30/157 (19%)

Query: 1   MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSF 60
           +  L L   QL    P+     L +++ L ++ NN              L VLD   N  
Sbjct: 472 LTFLDLSQCQLEQLSPTAFNS-LSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHI 530

Query: 61  SGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLVLTVLDVSRNQLSGDIPST-- 118
                    +                              L  L++++N  +        
Sbjct: 531 MTSKKQELQHFPSS--------------------------LAFLNLTQNDFACTCEHQSF 564

Query: 119 IGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLS 155
           +    D   L +   + +   P     +  + SL+++
Sbjct: 565 LQWIKDQRQLLVEVERMECATPSDKQGM-PVLSLNIT 600

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 67.4 bits (165), Expect = 7e-12
 Identities = 20/83 (24%), Positives = 31/83 (37%), Gaps = 3/83 (3%)

Query: 86  LTGNKLYGRIPPCL--VLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESV 143
                 Y +IP  L      LD+S N L      +     +L+ L L+  + Q     + 
Sbjct: 14  CMELNFY-KIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAY 72

Query: 144 GSLISLESLDLSGNNLSGKIPKL 166
            SL  L +L L+GN +       
Sbjct: 73  QSLSHLSTLILTGNPIQSLALGA 95

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  121 bits (305), Expect = 9e-31
 Identities = 53/210 (25%), Positives = 93/210 (44%), Gaps = 13/210 (6%)

Query: 272 DEFNECNLLGTSSFGSVYKGT-ISDGTDVAIK---VFNLQLERAFRSFDSECEVLRNVRH 327
             F     +G   F  VY+   + DG  VA+K   +F+L   +A      E ++L+ + H
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSH---NYFLDILERLNIMIDVGSALEY 384
            N+IK  +S+   +   +VLE    G L + +         +         + + SALE+
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151

Query: 385 LHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAP 444
           +H    S  ++H D+KP N+ +    V  + D G+ +     + +   ++   T  YM+P
Sbjct: 152 MH----SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF-SSKTTAAHSLV-GTPYYMSP 205

Query: 445 EYGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
           E   E   + K D++S G LL E    + P
Sbjct: 206 ERIHENGYNFKSDIWSLGCLLYEMAALQSP 235

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  121 bits (305), Expect = 1e-30
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 24/209 (11%)

Query: 280 LGTSSFGSVYKGTISDG------TDVAIKVFN-LQLERAFRSFDSECEVLRNVRHRNLIK 332
           LG  +FG VY+G +S          VA+K    +  E+    F  E  ++    H+N+++
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97

Query: 333 IL--SSYSNPDFKALVLEFMPNGSLEKWLYSH------NYFLDILERLNIMIDVGSALEY 384
            +  S  S P F  +++E M  G L+ +L            L +L+ L++  D+    +Y
Sbjct: 98  CIGVSLQSLPRF--ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155

Query: 385 LHNGHSSVHIIHCDLKPTNILLD---ENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGY 441
           L       H IH D+   N LL       VA + DFG+ + +       +    M  + +
Sbjct: 156 L----EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 211

Query: 442 MAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
           M PE  +EGI ++K D +S+GVLL E F+
Sbjct: 212 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  120 bits (304), Expect = 2e-30
 Identities = 45/241 (18%), Positives = 83/241 (34%), Gaps = 16/241 (6%)

Query: 239 RCRNRNTKKSDHEDFLPLAIWRRTSYLDIQRATDEFNECNLLGTSSFGSVYKGT-ISDGT 297
           + +    +  D+E  L     +   Y + +           +G  SFG V++      G 
Sbjct: 26  KLQRLGPETEDNEGVLLTEKLKPVDY-EYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGF 84

Query: 298 DVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEK 357
             A+K   L+          E      +    ++ +  +     +  + +E +  GSL +
Sbjct: 85  QCAVKKVRLE-----VFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQ 139

Query: 358 WLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDEN-MVAHVSD 416
            +       +       +      LEYLH    +  I+H D+K  N+LL  +   A + D
Sbjct: 140 LIKQMGCLPEDRAL-YYLGQALEGLEYLH----TRRILHGDVKADNVLLSSDGSRAALCD 194

Query: 417 FGIYKLLGEGEDSVRQTMTMATIG---YMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKR 473
           FG    L                G   +MAPE  +     AK D++S   +++       
Sbjct: 195 FGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCH 254

Query: 474 P 474
           P
Sbjct: 255 P 255

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  119 bits (301), Expect = 3e-30
 Identities = 49/210 (23%), Positives = 78/210 (37%), Gaps = 13/210 (6%)

Query: 269 RATDEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQL--ERAFRSFDSECEVLRNV 325
                F   + LG  S+G V+K     DG   A+K         +      +E      V
Sbjct: 54  FFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKV 113

Query: 326 -RHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEY 384
            +H   +++  ++       L  E     SL++   +    L   +    + D   AL +
Sbjct: 114 GQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAH 172

Query: 385 LHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAP 444
           LH    S  ++H D+KP NI L       + DFG+   L  G     +        YMAP
Sbjct: 173 LH----SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVEL--GTAGAGEVQE-GDPRYMAP 225

Query: 445 EYGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
           E  L+G      DV+S G+ ++E       
Sbjct: 226 EL-LQGSYGTAADVFSLGLTILEVACNMEL 254

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  118 bits (299), Expect = 5e-30
 Identities = 58/214 (27%), Positives = 96/214 (44%), Gaps = 29/214 (13%)

Query: 280 LGTSSFGSVYKGTI------SDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKI 333
           LG  +FG V+           D   VA+K        A + F  E E+L N++H +++K 
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82

Query: 334 L--SSYSNPDFKALVLEFMPNGSLEKWLYSH---------------NYFLDILERLNIMI 376
                  +P    +V E+M +G L K+L +H                  L + + L+I  
Sbjct: 83  YGVCGDGDPLI--MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140

Query: 377 DVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTM 436
            + S + YL    +S H +H DL   N L+  N++  + DFG+ + +   +       TM
Sbjct: 141 QIASGMVYL----ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 196

Query: 437 ATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
             I +M PE  +    + + DV+S+GV+L E FT
Sbjct: 197 LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  120 bits (302), Expect = 6e-30
 Identities = 60/209 (28%), Positives = 97/209 (46%), Gaps = 24/209 (11%)

Query: 280 LGTSSFGSVYKGTISDG------TDVAIKVFN-LQLERAFRSFDSECEVLRNVRHRNLIK 332
           LG  +FG VY+G +S          VA+K    +  E+    F  E  ++    H+N+++
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138

Query: 333 IL--SSYSNPDFKALVLEFMPNGSLEKWLYSH------NYFLDILERLNIMIDVGSALEY 384
            +  S  S P F  ++LE M  G L+ +L            L +L+ L++  D+    +Y
Sbjct: 139 CIGVSLQSLPRF--ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196

Query: 385 LHNGHSSVHIIHCDLKPTNILLD---ENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGY 441
           L       H IH D+   N LL       VA + DFG+ + +       +    M  + +
Sbjct: 197 L----EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKW 252

Query: 442 MAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
           M PE  +EGI ++K D +S+GVLL E F+
Sbjct: 253 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  118 bits (299), Expect = 8e-30
 Identities = 50/210 (23%), Positives = 93/210 (44%), Gaps = 24/210 (11%)

Query: 280 LGTSSFGSVYKGTISDG------TDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIK 332
           LG  SFG VY+G           T VAIK  N     R    F +E  V++     ++++
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92

Query: 333 IL--SSYSNPDFKALVLEFMPNGSLEKWLYSH---------NYFLDILERLNIMIDVGSA 381
           +L   S   P    +++E M  G L+ +L S               + + + +  ++   
Sbjct: 93  LLGVVSQGQPTL--VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150

Query: 382 LEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGY 441
           + YL    ++   +H DL   N ++ E+    + DFG+ + + E +   +    +  + +
Sbjct: 151 MAYL----NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 206

Query: 442 MAPEYGLEGIVSAKCDVYSYGVLLMETFTR 471
           M+PE   +G+ +   DV+S+GV+L E  T 
Sbjct: 207 MSPESLKDGVFTTYSDVWSFGVVLWEIATL 236

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  118 bits (299), Expect = 1e-29
 Identities = 69/299 (23%), Positives = 123/299 (41%), Gaps = 58/299 (19%)

Query: 280 LGTSSFGSVYKGTISDG------TDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKI 333
           LG  +FG V+     +         VA+K      E A + F  E E+L  ++H+++++ 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108

Query: 334 L--SSYSNPDFKALVLEFMPNGSLEKWLYSHNYF--------------LDILERLNIMID 377
               +   P    +V E+M +G L ++L SH                 L + + L +   
Sbjct: 109 FGVCTEGRPLL--MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166

Query: 378 VGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMA 437
           V + + YL    + +H +H DL   N L+ + +V  + DFG+ + +   +       TM 
Sbjct: 167 VAAGMVYL----AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 222

Query: 438 TIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPH-G 496
            I +M PE  L    + + DV+S+GV+L E FT          G+           P   
Sbjct: 223 PIRWMPPESILYRKFTTESDVWSFGVVLWEIFT---------YGKQ----------PWYQ 263

Query: 497 LT--EVVDANLVREEQAFSAKMDC---ILSIMDFALDCCMESPDMRINMTDAAAKLKKI 550
           L+  E +D   + + +       C   + +IM     C    P  R ++ D  A+L+ +
Sbjct: 264 LSNTEAID--CITQGRELERPRACPPEVYAIM---RGCWQREPQQRHSIKDVHARLQAL 317

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  118 bits (298), Expect = 1e-29
 Identities = 62/292 (21%), Positives = 109/292 (37%), Gaps = 41/292 (14%)

Query: 279 LLGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSY 337
            LG   F  V     + DG   A+K      ++       E ++ R   H N++++++  
Sbjct: 36  KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95

Query: 338 SNPDFKA----LVLEFMPNGSLEKWLYSH---NYFLDILERLNIMIDVGSALEYLHNGHS 390
                      L+L F   G+L   +        FL   + L +++ +   LE +H    
Sbjct: 96  LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---- 151

Query: 391 SVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMA-------TIGYMA 443
           +    H DLKPTNILL +     + D G         +  RQ +T+        TI Y A
Sbjct: 152 AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRA 211

Query: 444 PE----YGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTE 499
           PE         I   + DV+S G +L      + P D +F    S+   V+  L      
Sbjct: 212 PELFSVQSHCVI-DERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLS----- 265

Query: 500 VVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIK 551
                 + +    S+ +  +L+ M          P  R ++    ++L+ ++
Sbjct: 266 ------IPQSPRHSSALWQLLNSM------MTVDPHQRPHIPLLLSQLEALQ 305

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  117 bits (296), Expect = 1e-29
 Identities = 45/217 (20%), Positives = 86/217 (39%), Gaps = 36/217 (16%)

Query: 280 LGTSSFGSVYKGT--------ISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLI 331
           LG  +F  ++KG             T+V +KV +        SF     ++  + H++L+
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75

Query: 332 KIL--SSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGH 389
                    + +   LV EF+  GSL+ +L  +   ++IL +L +   + +A+ +L    
Sbjct: 76  LNYGVCVCGDENI--LVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFL---- 129

Query: 390 SSVHIIHCDLKPTNILLD--------ENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGY 441
               +IH ++   NILL               +SD GI   +   +      +    I +
Sbjct: 130 EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD------ILQERIPW 183

Query: 442 MAPE---YGLEGIVSAKCDVYSYGVLLMETFTR-KRP 474
           + PE         ++   D +S+G  L E  +   +P
Sbjct: 184 VPPECIENP--KNLNLATDKWSFGTTLWEICSGGDKP 218

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  117 bits (295), Expect = 2e-29
 Identities = 53/226 (23%), Positives = 91/226 (40%), Gaps = 32/226 (14%)

Query: 269 RATDEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNL-QLERAFRSFDSECEVLRNVR 326
           R   +F     LG   FG V++     D  + AIK   L   E A      E + L  + 
Sbjct: 2   RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 61

Query: 327 HRNLIKILSSY----------SNPDFKAL--VLEFMPNGSLEKWLYSHNYFLDILER--L 372
           H  +++  +++           +     L   ++     +L+ W+       +      L
Sbjct: 62  HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121

Query: 373 NIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQ 432
           +I + +  A+E+LH    S  ++H DLKP+NI    + V  V DFG+   + + E+    
Sbjct: 122 HIFLQIAEAVEFLH----SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177

Query: 433 TMTMATIG----------YMAPEYGLEGIV-SAKCDVYSYGVLLME 467
              M              YM+PE  + G   S K D++S G++L E
Sbjct: 178 LTPMPAYARHTGQVGTKLYMSPEQ-IHGNSYSHKVDIFSLGLILFE 222

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  122 bits (307), Expect = 3e-29
 Identities = 43/179 (24%), Positives = 64/179 (35%), Gaps = 21/179 (11%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFS 61
            +L L  N++   L       L NI  + L+ N       NS      L  L L   +  
Sbjct: 408 EVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALK 467

Query: 62  G--HILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLV----LTVLDVSRNQLS--- 112
                 + F  LR+L++L        L+ N +       L     L +LD+  N L+   
Sbjct: 468 NVDSSPSPFQPLRNLTILD-------LSNNNIANINDDMLEGLEKLEILDLQHNNLARLW 520

Query: 113 -----GDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKL 166
                G     + G   L  L+L SN F     E    L  L+ +DL  NNL+     +
Sbjct: 521 KHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASV 579

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  119 bits (300), Expect = 2e-28
 Identities = 39/169 (23%), Positives = 63/169 (37%), Gaps = 15/169 (8%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFS 61
            +      +L+ ++P  +     NI  L LT N L      + T  ++L  LD+GFN+ S
Sbjct: 7   EVADCSHLKLT-QVPDDL---PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTIS 62

Query: 62  GHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLV----LTVLDVSRNQLSGDIPS 117
                    L  L VL+L         N+L             LT L +  N +     +
Sbjct: 63  KLEPELCQKLPMLKVLNL-------QHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNN 115

Query: 118 TIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKL 166
               + +L TL L+ N        +   L +L+ L LS N +     + 
Sbjct: 116 PFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEE 164

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  112 bits (282), Expect = 4e-26
 Identities = 28/170 (16%), Positives = 58/170 (34%), Gaps = 8/170 (4%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTG--TIPNSITNATKLIVLDLGFNS 59
             + L  N+      ++    +P+++ L+L    L    + P+       L +LDL  N+
Sbjct: 433 FEIYLSYNKYLQLTRNSFAL-VPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNN 491

Query: 60  FSGHILNTFGNLRHLSVL-----SLLMFGIRLTGNKLYGRIPPCLVLTVLDVSRNQLSGD 114
            +    +    L  L +L     +L               +     L +L++  N     
Sbjct: 492 IANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEI 551

Query: 115 IPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIP 164
                    +L+ + L  N           + +SL+SL+L  N ++    
Sbjct: 552 PVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEK 601

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  112 bits (281), Expect = 5e-26
 Identities = 36/172 (20%), Positives = 59/172 (34%), Gaps = 15/172 (8%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFS 61
             L L  N +     +       N+  L L+ N L+ T   +      L  L L  N   
Sbjct: 100 TELHLMSNSIQKIKNNPFVK-QKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQ 158

Query: 62  GHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLV----LTVLDVSRNQLSGDIPS 117
                      + S+  L      L+ N++    P C      L  L ++  QL   +  
Sbjct: 159 ALKSEELDIFANSSLKKL-----ELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTE 213

Query: 118 TIGGRVD---LETLSLASNQFQGPIPESVGSL--ISLESLDLSGNNLSGKIP 164
            +   +    +  LSL+++Q       +   L   +L  LDLS NNL+    
Sbjct: 214 KLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGN 265

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  111 bits (279), Expect = 8e-26
 Identities = 32/187 (17%), Positives = 62/187 (33%), Gaps = 11/187 (5%)

Query: 1   MRILTLEGNQLSGRLPSTIGH-SLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNS 59
           ++ L L  N++       +   +  +++ L L++N +    P       +L  L L    
Sbjct: 147 LQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQ 206

Query: 60  FSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLV------LTVLDVSRNQLSG 113
               +          + +  L     L+ ++L        +      LT+LD+S N L+ 
Sbjct: 207 LGPSLTEKLCLELANTSIRNL----SLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNV 262

Query: 114 DIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKLEGEIPVK 173
               +      LE   L  N  Q     S+  L ++  L+L  +     I          
Sbjct: 263 VGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDD 322

Query: 174 GSFKNFS 180
            SF+   
Sbjct: 323 FSFQWLK 329

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  107 bits (268), Expect = 2e-24
 Identities = 36/181 (19%), Positives = 62/181 (34%), Gaps = 25/181 (13%)

Query: 1   MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLG---- 56
           + +L L  N L+     +    LP +EY  L  NN+     +S+     +  L+L     
Sbjct: 250 LTMLDLSYNNLNVVGNDSFAW-LPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFT 308

Query: 57  -----FNSFSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLV----LTVLDVS 107
                  S       +F  L+ L  L++         N + G           L  L +S
Sbjct: 309 KQSISLASLPKIDDFSFQWLKCLEHLNM-------EDNDIPGIKSNMFTGLINLKYLSLS 361

Query: 108 RNQLS-GDIPSTIG---GRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKI 163
            +  S   + +          L  L+L  N+      ++   L  LE LDL  N +  ++
Sbjct: 362 NSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQEL 421

Query: 164 P 164
            
Sbjct: 422 T 422

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  105 bits (265), Expect = 4e-24
 Identities = 37/180 (20%), Positives = 59/180 (32%), Gaps = 24/180 (13%)

Query: 2   RILTLEGNQLSGRLPSTIGH--SLPNIEYLLLTANNLTGTIPNSITN--ATKLIVLDLGF 57
             L L   QL   L   +    +  +I  L L+ + L+ T   +      T L +LDL +
Sbjct: 198 FGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSY 257

Query: 58  NSFSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLV-------------LTVL 104
           N+ +    ++F  L  L    L         N +       L               T  
Sbjct: 258 NNLNVVGNDSFAWLPQLEYFFL-------EYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQ 310

Query: 105 DVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIP 164
            +S   L      +      LE L++  N   G        LI+L+ L LS +  S +  
Sbjct: 311 SISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTL 370

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  105 bits (265), Expect = 4e-24
 Identities = 37/176 (21%), Positives = 58/176 (32%), Gaps = 16/176 (9%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLL---------TANNLTGTIPNSITNATKLIV 52
               LE N +      ++ H L N+ YL L         +  +L      S      L  
Sbjct: 275 EYFFLEYNNIQHLFSHSL-HGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEH 333

Query: 53  LDLGFNSFSGHILNTFGNLRHLSVLSL---LMFGIRLTGNKLYGRIPPCLVLTVLDVSRN 109
           L++  N   G   N F  L +L  LSL         LT           L   +L++++N
Sbjct: 334 LNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPL--HILNLTKN 391

Query: 110 QLSGDIPSTIGGRVDLETLSLASNQFQGPIPESV-GSLISLESLDLSGNNLSGKIP 164
           ++S            LE L L  N+    +       L ++  + LS N       
Sbjct: 392 KISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTR 447

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  104 bits (261), Expect = 1e-23
 Identities = 39/181 (21%), Positives = 64/181 (35%), Gaps = 23/181 (12%)

Query: 2   RILTLEGNQLSG--RLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNS 59
           + L L    L      PS     L N+  L L+ NN+     + +    KL +LDL  N+
Sbjct: 457 QRLMLRRVALKNVDSSPSPF-QPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNN 515

Query: 60  FS--------GHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIP----PCLVLTVLDVS 107
            +        G  +     L HL +L+L         N               L ++D+ 
Sbjct: 516 LARLWKHANPGGPIYFLKGLSHLHILNL-------ESNGFDEIPVEVFKDLFELKIIDLG 568

Query: 108 RNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVG-SLISLESLDLSGNNLSGKIPKL 166
            N L+    S    +V L++L+L  N       +  G +  +L  LD+  N        +
Sbjct: 569 LNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESI 628

Query: 167 E 167
            
Sbjct: 629 A 629

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 97.4 bits (243), Expect = 2e-21
 Identities = 35/144 (24%), Positives = 51/144 (35%), Gaps = 14/144 (9%)

Query: 25  NIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLMFGI 84
           + E    +   LT  +P+ +   T + VL+L  N         F     L+ L       
Sbjct: 5   SHEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSL------- 54

Query: 85  RLTGNKLYGRIPPCLV----LTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIP 140
            +  N +    P        L VL++  N+LS     T     +L  L L SN  Q    
Sbjct: 55  DVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKN 114

Query: 141 ESVGSLISLESLDLSGNNLSGKIP 164
                  +L +LDLS N LS    
Sbjct: 115 NPFVKQKNLITLDLSHNGLSSTKL 138

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  121 bits (304), Expect = 4e-29
 Identities = 59/230 (25%), Positives = 88/230 (38%), Gaps = 40/230 (17%)

Query: 268 QRATDEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQL-ERAFRSFDSECEVLRNV 325
            +    +     LGT  FG V +      G  VAIK    +L  +    +  E ++++ +
Sbjct: 10  TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL 69

Query: 326 RHRNLIKIL------SSYSNPDFKALVLEFMPNGSLEKWLYSH--NYFLDILERLNIMID 377
            H N++            +  D   L +E+   G L K+L        L       ++ D
Sbjct: 70  NHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSD 129

Query: 378 VGSALEYLHNGHSSVHIIHCDLKPTNILLD---ENMVAHVSDFGIYKLLGEGEDSVRQTM 434
           + SAL YLH       IIH DLKP NI+L    + ++  + D G  K L +GE       
Sbjct: 130 ISSALRYLH----ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE------- 178

Query: 435 TMATI----GYMAPE------YGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
                     Y+APE      Y          D +S+G L  E  T  RP
Sbjct: 179 LCTEFVGTLQYLAPELLEQKKYT------VTVDYWSFGTLAFECITGFRP 222

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  114 bits (287), Expect = 2e-28
 Identities = 51/215 (23%), Positives = 95/215 (44%), Gaps = 30/215 (13%)

Query: 280 LGTSSFGSVYKGTISDG------TDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIK 332
           LG   FG VYKG +           VAIK    +        F  E  +   ++H N++ 
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76

Query: 333 IL--SSYSNPDFKALVLEFMPNGSLEKWLYSH---------------NYFLDILERLNIM 375
           +L   +   P    ++  +  +G L ++L                     L+  + ++++
Sbjct: 77  LLGVVTKDQPLS--MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134

Query: 376 IDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMT 435
             + + +EYL    SS H++H DL   N+L+ + +   +SD G+++ +   +       +
Sbjct: 135 AQIAAGMEYL----SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNS 190

Query: 436 MATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
           +  I +MAPE  + G  S   D++SYGV+L E F+
Sbjct: 191 LLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  114 bits (287), Expect = 4e-28
 Identities = 64/215 (29%), Positives = 94/215 (43%), Gaps = 31/215 (14%)

Query: 278 NLLGTSSFGSVYKGTISDG---TDVAIKVFNLQL-ERAFRSFDSECEVLRNV-RHRNLIK 332
           +++G  +FG V K  I       D AIK       +   R F  E EVL  +  H N+I 
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90

Query: 333 IL--SSYSNPDFKALVLEFMPNGSLEKWLYSHNYF---------------LDILERLNIM 375
           +L    +    +  L +E+ P+G+L  +L                     L   + L+  
Sbjct: 91  LLGACEHRGYLY--LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148

Query: 376 IDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMT 435
            DV   ++YL    S    IH DL   NIL+ EN VA ++DFG   L    E  V++TM 
Sbjct: 149 ADVARGMDYL----SQKQFIHRDLAARNILVGENYVAKIADFG---LSRGQEVYVKKTMG 201

Query: 436 MATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
              + +MA E     + +   DV+SYGVLL E  +
Sbjct: 202 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  114 bits (287), Expect = 6e-28
 Identities = 41/248 (16%), Positives = 74/248 (29%), Gaps = 25/248 (10%)

Query: 265 LDIQRATDEFNECNLLGTSSFGSVYKGTISDGTD------VAIKVFNLQLERAFRSFDSE 318
            + Q  +      +LLG  +F  VY+ T  D  D        +KV        F      
Sbjct: 58  TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQL 117

Query: 319 CEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSL----EKWLYSHNYFLDILERLNI 374
            E L+       +K  S++   +   LV E    G+L      +  +    +     ++ 
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177

Query: 375 MIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAH-----------VSDFGIYKLL 423
            + +   +E +H       IIH D+KP N +L    +             + D G    +
Sbjct: 178 AMRMLYMIEQVH----DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDM 233

Query: 424 GEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEM 483
                    T    T G+   E       + + D +     +           +   GE 
Sbjct: 234 KLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC 293

Query: 484 SLRRWVKE 491
                 + 
Sbjct: 294 KPEGLFRR 301

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  117 bits (295), Expect = 7e-28
 Identities = 43/213 (20%), Positives = 83/213 (38%), Gaps = 29/213 (13%)

Query: 279 LLGTSSFGSVYKG--TISDGTDVAIKVFNLQLERAFRS-FDSECEVLRNVRHRNLIKILS 335
            +     G +Y       +G  V +K      +   ++   +E + L  V H ++++I +
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146

Query: 336 SYSNPDFKA-----LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHS 390
              + D        +V+E++   SL++        L + E +  ++++  AL YLH    
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK---LPVAEAIAYLLEILPALSYLH---- 199

Query: 391 SVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQT-MTMATIGYMAPEYGLE 449
           S+ +++ DLKP NI+L E  +  + D G    +               T G+ APE  + 
Sbjct: 200 SIGLVYNDLKPENIMLTEEQLK-LIDLGAVSRIN-------SFGYLYGTPGFQAPEI-VR 250

Query: 450 GIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGE 482
              +   D+Y+ G  L               G 
Sbjct: 251 TGPTVATDIYTVGRTLAALTLDLPT----RNGR 279

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  113 bits (284), Expect = 7e-28
 Identities = 57/223 (25%), Positives = 94/223 (42%), Gaps = 38/223 (17%)

Query: 280 LGTSSFGSVYKGTISDG------TDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIK 332
           LG   FG V K T          T VA+K+          R   SE  VL+ V H ++IK
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90

Query: 333 IL--SSYSNPDFKALVLEFMPNGSLEKWLYSH-----------------------NYFLD 367
           +    S   P    L++E+   GSL  +L                             L 
Sbjct: 91  LYGACSQDGPLL--LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148

Query: 368 ILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGE 427
           + + ++    +   ++YL    + + ++H DL   NIL+ E     +SDFG+ + + E +
Sbjct: 149 MGDLISFAWQISQGMQYL----AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204

Query: 428 DSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
             V+++     + +MA E   + I + + DV+S+GVLL E  T
Sbjct: 205 SYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  113 bits (284), Expect = 8e-28
 Identities = 57/217 (26%), Positives = 96/217 (44%), Gaps = 32/217 (14%)

Query: 280 LGTSSFGSVYKGTI------SDGTDVAIKVFNLQL-ERAFRSFDSECEVLRNV-RHRNLI 331
           LG  +FG V +         +    VA+K+          R+  SE ++L ++  H N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94

Query: 332 KIL---SSYSNPDFKALVLEFMPNGSLEKWLYSH---------------NYFLDILERLN 373
            +L   +    P    +++EF   G+L  +L S                  FL +   + 
Sbjct: 95  NLLGACTKPGGPLM--VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152

Query: 374 IMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQT 433
               V   +E+L    +S   IH DL   NILL E  V  + DFG+ + + +  D VR+ 
Sbjct: 153 YSFQVAKGMEFL----ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 208

Query: 434 MTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
                + +MAPE   + + + + DV+S+GVLL E F+
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  113 bits (284), Expect = 1e-27
 Identities = 51/218 (23%), Positives = 98/218 (44%), Gaps = 33/218 (15%)

Query: 280 LGTSSFGSVYKGTISD--------GTDVAIKVFN-LQLERAFRSFDSECEVLRNV-RHRN 329
           LG  +FG V                  VA+K+      E+      SE E+++ + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102

Query: 330 LIKIL--SSYSNPDFKALVLEFMPNGSLEKWLYSH---------------NYFLDILERL 372
           +I +L   +   P +  +++E+   G+L ++L +                   +   + +
Sbjct: 103 IINLLGACTQDGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160

Query: 373 NIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQ 432
           +    +   +EYL    +S   IH DL   N+L+ EN V  ++DFG+ + +   +   + 
Sbjct: 161 SCTYQLARGMEYL----ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216

Query: 433 TMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
           T     + +MAPE   + + + + DV+S+GVL+ E FT
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  112 bits (283), Expect = 1e-27
 Identities = 48/216 (22%), Positives = 92/216 (42%), Gaps = 29/216 (13%)

Query: 278 NLLGTSSFGSVYKGTISD------GTDVAIKVFNLQ-LERAFRSFDSECEVLRNV-RHRN 329
             LG  +FG V + T            VA+K+           +  SE +++ ++ +H N
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111

Query: 330 LIKIL--SSYSNPDFKALVLEFMPNGSLEKWLYSH-------------NYFLDILERLNI 374
           ++ +L   ++  P    ++ E+   G L  +L                N      + L+ 
Sbjct: 112 IVNLLGACTHGGPVL--VITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169

Query: 375 MIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTM 434
              V   + +L    +S + IH D+   N+LL    VA + DFG+ + +    + + +  
Sbjct: 170 SSQVAQGMAFL----ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN 225

Query: 435 TMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
               + +MAPE   + + + + DV+SYG+LL E F+
Sbjct: 226 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  111 bits (281), Expect = 2e-27
 Identities = 51/218 (23%), Positives = 88/218 (40%), Gaps = 33/218 (15%)

Query: 280 LGTSSFGSVYKGTISD------GTDVAIKVFNLQ-LERAFRSFDSECEVLRNV-RHRNLI 331
           LG  +FG V + T            VA+K+           +  SE +VL  +  H N++
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90

Query: 332 KIL--SSYSNPDFKALVLEFMPNGSLEKWLYSH-----------------NYFLDILERL 372
            +L   +   P    ++ E+   G L  +L                       LD+ + L
Sbjct: 91  NLLGACTIGGPTL--VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148

Query: 373 NIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQ 432
           +    V   + +L    +S + IH DL   NILL    +  + DFG+ + +    + V +
Sbjct: 149 SFSYQVAKGMAFL----ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 204

Query: 433 TMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
                 + +MAPE     + + + DV+SYG+ L E F+
Sbjct: 205 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  111 bits (279), Expect = 2e-27
 Identities = 52/208 (25%), Positives = 89/208 (42%), Gaps = 29/208 (13%)

Query: 272 DEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFN---LQLERAFRSFDSECEVLRNVRH 327
           ++F     LG   FG+VY          +A+KV     L+          E E+  ++RH
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68

Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
            N++++   + +     L+LE+ P G++ + L   + F +       + ++ +AL Y H 
Sbjct: 69  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA-TYITELANALSYCH- 126

Query: 388 GHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTM--TMATIGYMAPE 445
              S  +IH D+KP N+LL       ++DFG          S R  +  T+    Y+ PE
Sbjct: 127 ---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHA---PSSRRTDLCGTLD---YLPPE 177

Query: 446 ------YGLEGIVSAKCDVYSYGVLLME 467
                 +        K D++S GVL  E
Sbjct: 178 MIEGRMHD------EKVDLWSLGVLCYE 199

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  112 bits (282), Expect = 3e-27
 Identities = 53/223 (23%), Positives = 88/223 (39%), Gaps = 38/223 (17%)

Query: 280 LGTSSFGSVYKGTISDG------TDVAIKVFN-LQLERAFRSFDSECEVLRNVRHRNLIK 332
           +G  +FG V++            T VA+K+            F  E  ++    + N++K
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114

Query: 333 IL--SSYSNPDFKALVLEFMPNGSLEKWLYSH-----------------------NYFLD 367
           +L   +   P    L+ E+M  G L ++L S                           L 
Sbjct: 115 LLGVCAVGKPMC--LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172

Query: 368 ILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGE 427
             E+L I   V + + YL    S    +H DL   N L+ ENMV  ++DFG+ + +   +
Sbjct: 173 CAEQLCIARQVAAGMAYL----SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 228

Query: 428 DSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
                      I +M PE       + + DV++YGV+L E F+
Sbjct: 229 YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  112 bits (281), Expect = 5e-27
 Identities = 55/218 (25%), Positives = 100/218 (45%), Gaps = 33/218 (15%)

Query: 280 LGTSSFGSVYKGTI--------SDGTDVAIKVFN-LQLERAFRSFDSECEVLRNV-RHRN 329
           LG  +FG V             +  T VA+K+      E+      SE E+++ + +H+N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136

Query: 330 LIKIL--SSYSNPDFKALVLEFMPNGSLEKWLYSH---------------NYFLDILERL 372
           +I +L   +   P +  +++E+   G+L ++L +                   L   + +
Sbjct: 137 IINLLGACTQDGPLY--VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194

Query: 373 NIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQ 432
           +    V   +EYL    +S   IH DL   N+L+ E+ V  ++DFG+ + +   +   + 
Sbjct: 195 SCAYQVARGMEYL----ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 250

Query: 433 TMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
           T     + +MAPE   + I + + DV+S+GVLL E FT
Sbjct: 251 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  110 bits (277), Expect = 5e-27
 Identities = 61/241 (25%), Positives = 98/241 (40%), Gaps = 59/241 (24%)

Query: 261 RTSYLDIQRATDEFNE----CNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRSF 315
           R + L    +T  F E      +LG      V +        + A+K+ ++    +F + 
Sbjct: 2   RDAALPGSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAE 61

Query: 316 D---------SECEVLRNV-RHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYF 365
           +          E ++LR V  H N+I++  +Y    F  LV + M  G L         F
Sbjct: 62  EVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL---------F 112

Query: 366 LDILER--------LNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDF 417
             + E+          IM  +   +  LH     ++I+H DLKP NILLD++M   ++DF
Sbjct: 113 DYLTEKVTLSEKETRKIMRALLEVICALH----KLNIVHRDLKPENILLDDDMNIKLTDF 168

Query: 418 GIYKLLGEGEDSVRQTMTMA-TIGYMAPE------------YGLEGIVSAKCDVYSYGVL 464
           G    L  GE    +   +  T  Y+APE            YG E       D++S GV+
Sbjct: 169 GFSCQLDPGE----KLREVCGTPSYLAPEIIECSMNDNHPGYGKE------VDMWSTGVI 218

Query: 465 L 465
           +
Sbjct: 219 M 219

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  110 bits (277), Expect = 5e-27
 Identities = 51/211 (24%), Positives = 86/211 (40%), Gaps = 20/211 (9%)

Query: 279 LLGTSSFGSVYKGTISD---GTDVAIKVFNLQLER--AFRS-FDSECEVLRNVRHRNLIK 332
           L+G    G VY+    D      VA+K+ +  L     FR+    E      ++  +++ 
Sbjct: 41  LVGRGGMGDVYEAE--DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98

Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSV 392
           I           + +  +    L   L      L     + I+  +GSAL+  H    + 
Sbjct: 99  IHDFGEIDGQLYVDMRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAH----AA 153

Query: 393 HIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQT-MTMATIGYMAPEYGLEGI 451
              H D+KP NIL+  +  A++ DFGI     +    + Q   T+ T+ YMAPE   E  
Sbjct: 154 GATHRDVKPENILVSADDFAYLVDFGIASATTDE--KLTQLGNTVGTLYYMAPERFSESH 211

Query: 452 VSAKCDVYSYGVLLMETFTRKRPTDEMFIGE 482
            + + D+Y+   +L E  T   P    + G+
Sbjct: 212 ATYRADIYALTCVLYECLTGSPP----YQGD 238

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  110 bits (276), Expect = 5e-27
 Identities = 57/209 (27%), Positives = 93/209 (44%), Gaps = 16/209 (7%)

Query: 279 LLGTSSFGSVYKGT-ISDGTDVAIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLIKIL 334
            LG     +VY          VAIK   +     E   + F+ E      + H+N++ ++
Sbjct: 18  KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77

Query: 335 SSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHI 394
                 D   LV+E++   +L +++ SH   L +   +N    +   +++ H     + I
Sbjct: 78  DVDEEDDCYYLVMEYIEGPTLSEYIESHGP-LSVDTAINFTNQILDGIKHAH----DMRI 132

Query: 395 IHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQT-MTMATIGYMAPEYGLEGIVS 453
           +H D+KP NIL+D N    + DFGI K L   E S+ QT   + T+ Y +PE        
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKAL--SETSLTQTNHVLGTVQYFSPEQAKGEATD 190

Query: 454 AKCDVYSYGVLLMETFTRKRPTDEMFIGE 482
              D+YS G++L E    + P    F GE
Sbjct: 191 ECTDIYSIGIVLYEMLVGEPP----FNGE 215

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  111 bits (280), Expect = 6e-27
 Identities = 51/218 (23%), Positives = 97/218 (44%), Gaps = 33/218 (15%)

Query: 280 LGTSSFGSVYKGTISD--------GTDVAIKVFN-LQLERAFRSFDSECEVLRNV-RHRN 329
           LG   FG V                  VA+K+      E+      SE E+++ + +H+N
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148

Query: 330 LIKIL--SSYSNPDFKALVLEFMPNGSLEKWLYSH---------------NYFLDILERL 372
           +I +L   +   P +  +++E+   G+L ++L +                   +   + +
Sbjct: 149 IINLLGACTQDGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206

Query: 373 NIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQ 432
           +    +   +EYL    +S   IH DL   N+L+ EN V  ++DFG+ + +   +   + 
Sbjct: 207 SCTYQLARGMEYL----ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 262

Query: 433 TMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
           T     + +MAPE   + + + + DV+S+GVL+ E FT
Sbjct: 263 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  109 bits (276), Expect = 7e-27
 Identities = 57/214 (26%), Positives = 88/214 (41%), Gaps = 43/214 (20%)

Query: 271 TDEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRN 329
              F    +LG+ +F  V+       G   A+K           S ++E  VL+ ++H N
Sbjct: 8   RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67

Query: 330 LIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILER--------LNIMIDVGSA 381
           ++ +   Y +     LV++ +  G L         F  ILER          ++  V SA
Sbjct: 68  IVTLEDIYESTTHYYLVMQLVSGGEL---------FDRILERGVYTEKDASLVIQQVLSA 118

Query: 382 LEYLHNGHSSVHIIHCDLKPTNILL---DENMVAHVSDFGIYKLLGEGEDSVRQTMTMA- 437
           ++YLH       I+H DLKP N+L    +EN    ++DFG+ K+   G        T   
Sbjct: 119 VKYLH----ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-----IMSTACG 169

Query: 438 TIGYMAPE------YGLEGIVSAKCDVYSYGVLL 465
           T GY+APE      Y          D +S GV+ 
Sbjct: 170 TPGYVAPEVLAQKPYSKA------VDCWSIGVIT 197

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  109 bits (274), Expect = 8e-27
 Identities = 51/199 (25%), Positives = 94/199 (47%), Gaps = 26/199 (13%)

Query: 279 LLGTSSFGSVYKGT-ISDGTDVAIKVFN---LQLERAFRSFDSECEVLRNVRHRNLIKIL 334
           LLG  SF  VY+   I  G +VAIK+ +   +      +   +E ++   ++H +++++ 
Sbjct: 18  LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77

Query: 335 SSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHI 394
           + + + ++  LVLE   NG + ++L +        E  + M  + + + YLH    S  I
Sbjct: 78  NYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH----SHGI 133

Query: 395 IHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTM--TMATIGYMAPE------Y 446
           +H DL  +N+LL  NM   ++DFG+   L +       T+  T     Y++PE      +
Sbjct: 134 LHRDLTLSNLLLTRNMNIKIADFGLATQL-KMPHEKHYTLCGTPN---YISPEIATRSAH 189

Query: 447 GLEGIVSAKCDVYSYGVLL 465
           G       + DV+S G + 
Sbjct: 190 G------LESDVWSLGCMF 202

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  110 bits (277), Expect = 1e-26
 Identities = 64/266 (24%), Positives = 112/266 (42%), Gaps = 12/266 (4%)

Query: 272 DEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRSF-DSECEVLRNVRHRN 329
           D+F + + LG  + G V+K +    G  +A K+ +L+++ A R+    E +VL       
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92

Query: 330 LIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFL-DILERLNIMIDVGSALEYLHNG 388
           ++    ++ +    ++ +E M  GSL++ L         IL +  + I V   L YL   
Sbjct: 93  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK--VSIAVIKGLTYLREK 150

Query: 389 HSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGL 448
           H    I+H D+KP+NIL++      + DFG+    G+  DS+  +    T  YM+PE   
Sbjct: 151 H---KIMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSFV-GTRSYMSPERLQ 203

Query: 449 EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVRE 508
               S + D++S G+ L+E    + P       E+ L    +       T        R 
Sbjct: 204 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 263

Query: 509 EQAFSAKMDCILSIMDFALDCCMESP 534
              F       ++I +       E P
Sbjct: 264 LNKFGMDSRPPMAIFELLDYIVNEPP 289

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  114 bits (286), Expect = 1e-26
 Identities = 30/188 (15%), Positives = 57/188 (30%), Gaps = 35/188 (18%)

Query: 1   MRILTLEGNQLSGRLPSTIGHSLP-----NIEYLLLTANNLTGTIPNSITNATKLIVLDL 55
           M  +    N++       I  S+      N   + L+ N +           + +  + L
Sbjct: 646 MGSVDFSYNKIGS-EGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIIL 704

Query: 56  GFNSFS-------GHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLV------LT 102
             N  +             + N   L+ + L         NKL   +           L+
Sbjct: 705 SNNLMTSIPENSLKPKDGNYKNTYLLTTIDL-------RFNKL-TSLSDDFRATTLPYLS 756

Query: 103 VLDVSRNQLSGDIPSTIGGRVDLETLSL------ASNQFQGPIPESVGSLISLESLDLSG 156
            +DVS N  S   P+       L+   +        N+     P  + +  SL  L +  
Sbjct: 757 NMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGS 815

Query: 157 NNLSGKIP 164
           N++  K+ 
Sbjct: 816 NDIR-KVD 822

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  100 bits (251), Expect = 2e-22
 Identities = 37/189 (19%), Positives = 66/189 (34%), Gaps = 25/189 (13%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFS 61
           +I  +  N L     S     +  +  L    N +   +  +     KL  L L +N   
Sbjct: 551 QIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE 608

Query: 62  GHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPP------CLVLTVLDVSRNQLSGDI 115
               +       +  L         + NKL   IP         V+  +D S N++    
Sbjct: 609 EIPEDFCAFTDQVEGLGF-------SHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIGS-E 659

Query: 116 PSTIGGRVD------LETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKLEGE 169
              I   +D        T++L+ N+ Q    E   +   + ++ LS N ++  IP+    
Sbjct: 660 GRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT-SIPE-NSL 717

Query: 170 IPVKGSFKN 178
            P  G++KN
Sbjct: 718 KPKDGNYKN 726

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 96.9 bits (241), Expect = 4e-21
 Identities = 34/216 (15%), Positives = 69/216 (31%), Gaps = 38/216 (17%)

Query: 1   MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLT-------GTIPNSITNATKLIVL 53
              +TL  N++    P+ +  +   I  ++L+ N +T            +  N   L  +
Sbjct: 675 ASTVTLSYNEIQK-FPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTI 733

Query: 54  DLGFNSFSGHILN-TFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLV----LTVLDVSR 108
           DL FN  +    +     L +LS + +       + N      P   +    L    +  
Sbjct: 734 DLRFNKLTSLSDDFRATTLPYLSNMDV-------SYNCF-SSFPTQPLNSSQLKAFGIRH 785

Query: 109 ------NQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGK 162
                 N++    P+ I     L  L + SN  +  + E +     L  LD++ N     
Sbjct: 786 QRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRK-VDEKL--TPQLYILDIADNPN--- 839

Query: 163 IPKLEGEIPVKGSFKNFSTESFFGNY--ALCGPPKL 196
              +  ++     +          +    + G   L
Sbjct: 840 ---ISIDVTSVCPYIEAGMYVLLYDKTQDIRGCDAL 872

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 96.9 bits (241), Expect = 5e-21
 Identities = 28/191 (14%), Positives = 57/191 (29%), Gaps = 34/191 (17%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFS 61
             L+L G    GR+P  IG  L  ++ L    ++ T +            + +   +   
Sbjct: 326 TGLSLAGFGAKGRVPDAIGQ-LTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIR 384

Query: 62  GHI-----------------------LNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPC 98
            H                              ++  S +SL    I    N++   I   
Sbjct: 385 MHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRI-TFISKA 443

Query: 99  LV----LTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDL 154
           +     L ++  + +  + D  +     VD E  +    +       S  +L  L  ++L
Sbjct: 444 IQRLTKLQIIYFANSPFTYDNIA-----VDWEDANSDYAKQYENEELSWSNLKDLTDVEL 498

Query: 155 SGNNLSGKIPK 165
                  ++P 
Sbjct: 499 YNCPNMTQLPD 509

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 94.2 bits (234), Expect = 3e-20
 Identities = 15/184 (8%), Positives = 42/184 (22%), Gaps = 16/184 (8%)

Query: 3   ILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSG 62
           +     +++              +    L  + +       +    K   + L       
Sbjct: 375 MSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRN--PEMKPIKKDSRISLKDTQIGN 432

Query: 63  H------ILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLVLTVLDVSRNQLSGDIP 116
                  I      L  L ++           +         +     +    +   +  
Sbjct: 433 LTNRITFISKAIQRLTKLQIIYF-------ANSPFTY-DNIAVDWEDANSDYAKQYENEE 484

Query: 117 STIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKLEGEIPVKGSF 176
            +     DL  + L +      +P+ +  L  L+SL+++ N              +    
Sbjct: 485 LSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDE 544

Query: 177 KNFS 180
               
Sbjct: 545 DTGP 548

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 90.3 bits (224), Expect = 5e-19
 Identities = 24/164 (14%), Positives = 57/164 (34%), Gaps = 8/164 (4%)

Query: 11  LSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGN 70
           + G  P     +   +  L L      G +P++I   T+L VL  G +S +         
Sbjct: 310 MWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDE 369

Query: 71  LRHLSVLSLLMFGIRLTGNKLYGRIPPCLVLTVLDVSRNQLS-----GDIPSTIGGRVDL 125
                +       IR+   K++        L + D+ ++ ++       I       +  
Sbjct: 370 ELTPDMSEERKHRIRMHYKKMFLDYDQ--RLNLSDLLQDAINRNPEMKPIKKDSRISLKD 427

Query: 126 ETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKLEGE 169
             +   +N+    I +++  L  L+ +  + +  +     ++ E
Sbjct: 428 TQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWE 470

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 89.5 bits (222), Expect = 8e-19
 Identities = 26/186 (13%), Positives = 55/186 (29%), Gaps = 35/186 (18%)

Query: 6   LEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHIL 65
           +  N     +      SL + +   L   N    I  +I   TKL ++    + F+   +
Sbjct: 408 INRNPEMKPIKKDSRISLKDTQIGNL--TNRITFISKAIQRLTKLQIIYFANSPFTYDNI 465

Query: 66  NTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLV----LTVLDVSRNQLSGDIPSTIGG 121
                  +                K Y            LT +++        +P  +  
Sbjct: 466 AVDWEDANSD------------YAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYD 513

Query: 122 RVDLETLSLASNQFQGP---------IPESVGSLISLESLDLSGNNLSGKIPKLEGEIPV 172
             +L++L++A N+             + +   +   ++   +  NNL         E P 
Sbjct: 514 LPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE--------EFPA 565

Query: 173 KGSFKN 178
             S + 
Sbjct: 566 SASLQK 571

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 63.7 bits (155), Expect = 1e-10
 Identities = 12/97 (12%), Positives = 34/97 (35%)

Query: 101 LTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLS 160
           +T L ++     G +P  IG   +L+ LS  ++             ++ +  +   + + 
Sbjct: 325 VTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIR 384

Query: 161 GKIPKLEGEIPVKGSFKNFSTESFFGNYALCGPPKLR 197
               K+  +   + +  +   ++   N  +    K  
Sbjct: 385 MHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDS 421

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 54.1 bits (130), Expect = 1e-07
 Identities = 14/97 (14%), Positives = 31/97 (31%), Gaps = 2/97 (2%)

Query: 104 LDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKI 163
            +   +         +     +  LSLA    +G +P+++G L  L+ L    ++ +   
Sbjct: 304 FNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSG 363

Query: 164 PKLEGE--IPVKGSFKNFSTESFFGNYALCGPPKLRV 198
                E   P     +       +    L    +L +
Sbjct: 364 RLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNL 400

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  109 bits (275), Expect = 2e-26
 Identities = 51/233 (21%), Positives = 94/233 (40%), Gaps = 38/233 (16%)

Query: 280 LGTSSFGSVYKGTISDGTDVAIKVFN---LQLERAFRSFDS--------------ECEVL 322
           L    F  +      D    A+K +    L+ +R F   ++              E +++
Sbjct: 39  LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97

Query: 323 RNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYF-------LDILERLNIM 375
            ++++   +      +N D   ++ E+M N S+ K+              + I     I+
Sbjct: 98  TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157

Query: 376 IDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMT 435
             V ++  Y+H   +  +I H D+KP+NIL+D+N    +SDFG  + +    D   +  +
Sbjct: 158 KSVLNSFSYIH---NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYM---VDKKIKG-S 210

Query: 436 MATIGYMAPE--YGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLR 486
             T  +M PE          AK D++S G+ L   F    P    F  ++SL 
Sbjct: 211 RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP----FSLKISLV 259

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  108 bits (272), Expect = 2e-26
 Identities = 57/208 (27%), Positives = 90/208 (43%), Gaps = 29/208 (13%)

Query: 272 DEFNECNLLGTSSFGSVYKG-TISDGTDVAIKVFN---LQLERAFRSFDSECEVLRNVRH 327
           D+F+    LG   FG+VY      +   +A+KV     L+ E        E E+  ++RH
Sbjct: 14  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73

Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
            N++++ + + +     L+LEF P G L K L  H  F +       M ++  AL Y H 
Sbjct: 74  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSA-TFMEELADALHYCH- 131

Query: 388 GHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTM--TMATIGYMAPE 445
                 +IH D+KP N+L+       ++DFG            R+TM  T+    Y+ PE
Sbjct: 132 ---ERKVIHRDIKPENLLMGYKGELKIADFG---WSVHAPSLRRRTMCGTLD---YLPPE 182

Query: 446 ------YGLEGIVSAKCDVYSYGVLLME 467
                 +        K D++  GVL  E
Sbjct: 183 MIEGKTHD------EKVDLWCAGVLCYE 204

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  108 bits (273), Expect = 2e-26
 Identities = 56/213 (26%), Positives = 94/213 (44%), Gaps = 18/213 (8%)

Query: 279 LLGTSSFGSVYKGT-ISDGTDVAIKVFNLQLER--AFRS-FDSECEVLRNVRHRNLIKIL 334
           +LG      V+    + D  DVA+KV    L R  +F   F  E +    + H  ++ + 
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78

Query: 335 ----SSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHS 390
               +         +V+E++   +L   +++    +     + ++ D   AL + H    
Sbjct: 79  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQALNFSHQ--- 134

Query: 391 SVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQT-MTMATIGYMAPEYGLE 449
              IIH D+KP NI++       V DFGI + + +  +SV QT   + T  Y++PE    
Sbjct: 135 -NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193

Query: 450 GIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGE 482
             V A+ DVYS G +L E  T + P    F G+
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEPP----FTGD 222

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  109 bits (274), Expect = 3e-26
 Identities = 55/227 (24%), Positives = 89/227 (39%), Gaps = 46/227 (20%)

Query: 280 LGTSSFGSVYKGTISDG------TDVAIKVFNLQL-----ERAFRSFDSECEVLRNV-RH 327
           LG+ +FG V   T            VA+K     L          +  SE +++  +  H
Sbjct: 53  LGSGAFGKVMNATAYGISKTGVSIQVAVK----MLKEKADSSEREALMSELKMMTQLGSH 108

Query: 328 RNLIKIL--SSYSNPDFKALVLEFMPNGSLEKWLYSH----------------------N 363
            N++ +L   + S P +  L+ E+   G L  +L S                        
Sbjct: 109 ENIVNLLGACTLSGPIY--LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 166

Query: 364 YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLL 423
             L   + L     V   +E+L         +H DL   N+L+    V  + DFG+ + +
Sbjct: 167 NVLTFEDLLCFAYQVAKGMEFL----EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDI 222

Query: 424 GEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
               + V +      + +MAPE   EGI + K DV+SYG+LL E F+
Sbjct: 223 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  107 bits (269), Expect = 4e-26
 Identities = 51/216 (23%), Positives = 92/216 (42%), Gaps = 44/216 (20%)

Query: 271 TDEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRH 327
           +D ++    LG  +F  V +    + G + A K+ N +    R F+  + E  + R ++H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64

Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILER--------LNIMIDVG 379
            N++++  S     F  LV + +  G L         F DI+ R         + +  + 
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGEL---------FEDIVAREFYSEADASHCIQQIL 115

Query: 380 SALEYLHNGHSSVHIIHCDLKPTNILL---DENMVAHVSDFGIYKLLGEGEDSVRQTMTM 436
            ++ Y H    S  I+H +LKP N+LL    +     ++DFG+   + + E         
Sbjct: 116 ESIAYCH----SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE----AWHGF 167

Query: 437 A-TIGYMAPE------YGLEGIVSAKCDVYSYGVLL 465
           A T GY++PE      Y          D+++ GV+L
Sbjct: 168 AGTPGYLSPEVLKKDPYSKP------VDIWACGVIL 197

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  110 bits (276), Expect = 7e-26
 Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 20/204 (9%)

Query: 271 TDEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFN---LQLERAFRSFDSECEVLRNVR 326
           +D +    +LG  SFG V        G + A+KV +   ++ +    S   E ++L+ + 
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84

Query: 327 HRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERL--NIMIDVGSALEY 384
           H N++K+   + +  +  LV E    G L   + S   F    E     I+  V S + Y
Sbjct: 85  HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRF---SEVDAARIIRQVLSGITY 141

Query: 385 LHNGHSSVHIIHCDLKPTNILL---DENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGY 441
           +H       I+H DLKP N+LL    ++    + DFG+       +   +    + T  Y
Sbjct: 142 MH----KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK---KMKDKIGTAYY 194

Query: 442 MAPEYGLEGIVSAKCDVYSYGVLL 465
           +APE  L G    KCDV+S GV+L
Sbjct: 195 IAPEV-LHGTYDEKCDVWSTGVIL 217

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  108 bits (271), Expect = 8e-26
 Identities = 35/260 (13%), Positives = 79/260 (30%), Gaps = 60/260 (23%)

Query: 279 LLGTSSFGSVYKGT-ISDGTDVAIKVFNL----------------QLERAFRSFDSECEV 321
           +LG     +  + T    G    + V                      R  R   ++ + 
Sbjct: 80  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139

Query: 322 LRNVR------------HRNLIKILSSYSNPDFKALVLEFM----PNGSLEKWLYSH--- 362
             ++R             + +I++     +    +    +        +  + L SH   
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199

Query: 363 NYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKL 422
           +  L    RL + + V   L  LH       ++H  L+P +I+LD+     ++ F     
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLH----HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 255

Query: 423 LGEGEDSVRQTMTMATIGYMAPEY-----------GLEGIVSAKCDVYSYGVLLMETFTR 471
            G       + ++  + G+  PE                +++   D ++ G+++   +  
Sbjct: 256 DGA------RVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA 309

Query: 472 KRP---TDEMFIGEMSLRRW 488
             P      +   E   R  
Sbjct: 310 DLPITKDAALGGSEWIFRSC 329

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  107 bits (269), Expect = 9e-26
 Identities = 42/199 (21%), Positives = 78/199 (39%), Gaps = 27/199 (13%)

Query: 279 LLGTSSFGSVYKGT-ISDGTDVAIKVFN---LQLERAFRSFDSECEVLRNVRHRNLIKIL 334
            LG   F   ++ +        A K+     L           E  + R++ H++++   
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107

Query: 335 SSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHI 394
             + + DF  +VLE     SL +         +   R   +  +    +YLH       +
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQIVLGCQYLH----RNRV 162

Query: 395 IHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTM--TMATIGYMAPE------Y 446
           IH DLK  N+ L+E++   + DFG+   + E +   ++ +  T     Y+APE      +
Sbjct: 163 IHRDLKLGNLFLNEDLEVKIGDFGLATKV-EYDGERKKVLCGTPN---YIAPEVLSKKGH 218

Query: 447 GLEGIVSAKCDVYSYGVLL 465
             E       DV+S G ++
Sbjct: 219 SFE------VDVWSIGCIM 231

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  107 bits (270), Expect = 1e-25
 Identities = 52/224 (23%), Positives = 95/224 (42%), Gaps = 48/224 (21%)

Query: 267 IQRATDEFNE----CNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQL--ERAFRSFDSEC 319
           +  A+ +F++       LG  +F  V +    + G + A K+ N +    R F+  + E 
Sbjct: 20  MMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREA 79

Query: 320 EVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILER-------- 371
            + R ++H N++++  S     F  LV + +  G L         F DI+ R        
Sbjct: 80  RICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL---------FEDIVAREFYSEADA 130

Query: 372 LNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILL---DENMVAHVSDFGIYKLLGEGED 428
            + +  +  ++ Y H    S  I+H +LKP N+LL    +     ++DFG+   + + E 
Sbjct: 131 SHCIQQILESIAYCH----SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE- 185

Query: 429 SVRQTMTMA-TIGYMAPE------YGLEGIVSAKCDVYSYGVLL 465
                   A T GY++PE      Y          D+++ GV+L
Sbjct: 186 ---AWHGFAGTPGYLSPEVLKKDPYSKP------VDIWACGVIL 220

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  110 bits (277), Expect = 1e-25
 Identities = 37/166 (22%), Positives = 62/166 (37%), Gaps = 14/166 (8%)

Query: 1   MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSF 60
           ++ L  + + L      +   SL  + YL ++  N            T L  L +  NSF
Sbjct: 401 LQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSF 460

Query: 61  SGHIL-NTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPP----CLV-LTVLDVSRNQLSGD 114
             + L N F N  +L+ L L       +  +L   I       L  L +L++S N L   
Sbjct: 461 KDNTLSNVFANTTNLTFLDL-------SKCQLEQ-ISWGVFDTLHRLQLLNMSHNNLLFL 512

Query: 115 IPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLS 160
             S       L TL  + N+ +           SL   +L+ N+++
Sbjct: 513 DSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  102 bits (257), Expect = 3e-23
 Identities = 37/171 (21%), Positives = 58/171 (33%), Gaps = 15/171 (8%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNS-ITNATKLIVLDLGFNSF 60
           R L L  N     + S     L  +++L    + L      S   +  KL+ LD+ + + 
Sbjct: 379 RHLDLSFNGAI--IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNT 436

Query: 61  SGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLV-----LTVLDVSRNQLSGDI 115
                  F  L  L+ L +        GN         +      LT LD+S+ QL    
Sbjct: 437 KIDFDGIFLGLTSLNTLKM-------AGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQIS 489

Query: 116 PSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKL 166
                    L+ L+++ N            L SL +LD S N +      L
Sbjct: 490 WGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGIL 540

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 91.2 bits (227), Expect = 2e-19
 Identities = 33/177 (18%), Positives = 57/177 (32%), Gaps = 39/177 (22%)

Query: 4   LTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGH 63
                 +LS ++P  I     + + + L+ N L      S +N ++L  LDL        
Sbjct: 16  YQCMDQKLS-KVPDDIP---SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETI 71

Query: 64  ILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLVLTVLDVSRNQLSGDIPSTIGGRV 123
               +  L HLS L L                           + N +    P +  G  
Sbjct: 72  EDKAWHGLHHLSNLIL---------------------------TGNPIQSFSPGSFSGLT 104

Query: 124 DLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKLEGEIPVKGSFKNFS 180
            LE L     +        +G LI+L+ L+++ N +            +   F N +
Sbjct: 105 SLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHS--------CKLPAYFSNLT 153

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 89.7 bits (223), Expect = 5e-19
 Identities = 40/184 (21%), Positives = 60/184 (32%), Gaps = 30/184 (16%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFS 61
           + L++   QL    P+     LP ++ L LT N  +  I         L  LDL  N+ S
Sbjct: 310 QSLSIIRCQLKQ-FPTL---DLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALS 363

Query: 62  GHILNTFGNLRHLSVLSLLMFGIRLT------------------GNKLYGRIPP-----C 98
                ++ +L   S+  L +                         + L            
Sbjct: 364 FSGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSL 423

Query: 99  LVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESV-GSLISLESLDLSGN 157
             L  LD+S      D      G   L TL +A N F+     +V  +  +L  LDLS  
Sbjct: 424 EKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKC 483

Query: 158 NLSG 161
            L  
Sbjct: 484 QLEQ 487

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 89.3 bits (222), Expect = 7e-19
 Identities = 34/171 (19%), Positives = 52/171 (30%), Gaps = 21/171 (12%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFS 61
             L L GN +    P +    L ++E L+     L       I     L  L++  N   
Sbjct: 83  SNLILTGNPIQSFSPGSFSG-LTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIH 141

Query: 62  G-HILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPC---------LVLTVLDVSRNQL 111
              +   F NL +L  +        L+ N +   I             V   LD+S N +
Sbjct: 142 SCKLPAYFSNLTNLVHVD-------LSYNYIQT-ITVNDLQFLRENPQVNLSLDMSLNPI 193

Query: 112 SGDIPSTIGGRVDLETLSLASNQFQGPIPESVGS-LISLESLDLSGNNLSG 161
              I       + L  L+L  N     I ++    L  L    L       
Sbjct: 194 DF-IQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKD 243

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 81.6 bits (202), Expect = 2e-16
 Identities = 31/177 (17%), Positives = 60/177 (33%), Gaps = 19/177 (10%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTG-TIPNSITNATKLIVLDLGFNSF 60
             L     +L+      IG  L  ++ L +  N +    +P   +N T L+ +DL +N  
Sbjct: 107 ENLVAVETKLASLESFPIGQ-LITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYI 165

Query: 61  SGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPP----CLVLTVLDVSRNQLSGDIP 116
               +N    LR    ++L    + ++ N +   I       + L  L +  N  S +I 
Sbjct: 166 QTITVNDLQFLRENPQVNL---SLDMSLNPI-DFIQDQAFQGIKLHELTLRGNFNSSNIM 221

Query: 117 STIGGR-VDLETLSLASNQFQGPIPESVGSL--------ISLESLDLSGNNLSGKIP 164
            T       L    L   +F+      +           ++++   L+  N      
Sbjct: 222 KTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDI 278

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 77.4 bits (191), Expect = 4e-15
 Identities = 27/183 (14%), Positives = 47/183 (25%), Gaps = 23/183 (12%)

Query: 1   MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSF 60
           +    L                L N+  + L   ++       +    K   L +     
Sbjct: 263 IDEFRLTYTNDFSDDIVKFHC-LANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQL 319

Query: 61  SGHILNTFGNLRHLSV-----LSLLMFG-------IRLTGNKLYGRIP------PCLVLT 102
                     L+ L++                   + L+ N L               L 
Sbjct: 320 KQFPTLDLPFLKSLTLTMNKGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLR 379

Query: 103 VLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESV-GSLISLESLDLSGNNLSG 161
            LD+S N     + +   G  +L+ L    +  +     S   SL  L  LD+S  N   
Sbjct: 380 HLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKI 438

Query: 162 KIP 164
              
Sbjct: 439 DFD 441

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  106 bits (266), Expect = 1e-25
 Identities = 42/199 (21%), Positives = 78/199 (39%), Gaps = 27/199 (13%)

Query: 279 LLGTSSFGSVYKGT-ISDGTDVAIKVFN---LQLERAFRSFDSECEVLRNVRHRNLIKIL 334
            LG   F   ++ +        A K+     L           E  + R++ H++++   
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81

Query: 335 SSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHI 394
             + + DF  +VLE     SL +         +   R   +  +    +YLH       +
Sbjct: 82  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQIVLGCQYLH----RNRV 136

Query: 395 IHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTM--TMATIGYMAPE------Y 446
           IH DLK  N+ L+E++   + DFG+   + E +   ++ +  T     Y+APE      +
Sbjct: 137 IHRDLKLGNLFLNEDLEVKIGDFGLATKV-EYDGERKKVLCGTPN---YIAPEVLSKKGH 192

Query: 447 GLEGIVSAKCDVYSYGVLL 465
             E       DV+S G ++
Sbjct: 193 SFE------VDVWSIGCIM 205

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  105 bits (265), Expect = 1e-25
 Identities = 49/202 (24%), Positives = 82/202 (40%), Gaps = 37/202 (18%)

Query: 280 LGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYS 338
           +G  S+G V            A K            F  E E+++++ H N+I++  ++ 
Sbjct: 17  IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76

Query: 339 NPDFKALVLEFMPNGSLEKWLYSHNYFLDILER--------LNIMIDVGSALEYLHNGHS 390
           +     LV+E    G L         F  ++ +          IM DV SA+ Y H    
Sbjct: 77  DNTDIYLVMELCTGGEL---------FERVVHKRVFRESDAARIMKDVLSAVAYCH---- 123

Query: 391 SVHIIHCDLKPTNILL---DENMVAHVSDFGIYKLLGEGEDSVRQTMTMATI----GYMA 443
            +++ H DLKP N L      +    + DFG+      G+        M T      Y++
Sbjct: 124 KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK-------MMRTKVGTPYYVS 176

Query: 444 PEYGLEGIVSAKCDVYSYGVLL 465
           P+  LEG+   +CD +S GV++
Sbjct: 177 PQV-LEGLYGPECDEWSAGVMM 197

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  106 bits (267), Expect = 1e-25
 Identities = 51/209 (24%), Positives = 99/209 (47%), Gaps = 31/209 (14%)

Query: 271 TDEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRN 329
               +    +G  S G V        G  VA+K+ +L+ ++      +E  ++R+ +H N
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103

Query: 330 LIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILE--RLN------IMIDVGSA 381
           ++++  SY   +   +++EF+  G+L           DI+   RLN      +   V  A
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGAL----------TDIVSQVRLNEEQIATVCEAVLQA 153

Query: 382 LEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIG- 440
           L YLH    +  +IH D+K  +ILL  +    +SDFG    + + +   R+++    +G 
Sbjct: 154 LAYLH----AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK-DVPKRKSL----VGT 204

Query: 441 --YMAPEYGLEGIVSAKCDVYSYGVLLME 467
             +MAPE     + + + D++S G++++E
Sbjct: 205 PYWMAPEVISRSLYATEVDIWSLGIMVIE 233

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  105 bits (265), Expect = 2e-25
 Identities = 57/209 (27%), Positives = 97/209 (46%), Gaps = 31/209 (14%)

Query: 271 TDEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRN 329
             ++     +G  + G+VY    ++ G +VAI+  NLQ +       +E  V+R  ++ N
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 330 LIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILE--RLN------IMIDVGSA 381
           ++  L SY   D   +V+E++  GSL           D++    ++      +  +   A
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSL----------TDVVTETCMDEGQIAAVCRECLQA 128

Query: 382 LEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIG- 440
           LE+LH    S  +IH D+K  NILL  +    ++DFG    +   E S R TM    +G 
Sbjct: 129 LEFLH----SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP-EQSKRSTM----VGT 179

Query: 441 --YMAPEYGLEGIVSAKCDVYSYGVLLME 467
             +MAPE         K D++S G++ +E
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIE 208

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  107 bits (269), Expect = 2e-25
 Identities = 36/265 (13%), Positives = 82/265 (30%), Gaps = 62/265 (23%)

Query: 279 LLGTSSFGSVYKGT-ISDGTDVAIKVFNL----------------QLERAFR-------- 313
           +LG     +  + T    G    + V                      R  R        
Sbjct: 85  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144

Query: 314 ----SFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFM-PNGSLE---KWLYSH--- 362
                F    +++++ + + +I++     +    +    +     +L+   + L SH   
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204

Query: 363 NYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKL 422
           +  L    RL + + V   L  LH       ++H  L+P +I+LD+     ++ F     
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLH----HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 260

Query: 423 LGEGEDSVRQTMTMATIGYMAPEY----------GLEGIVSAKCDVYSYGVLLMETFTRK 472
            G         ++    G+  PE               +++   D ++ G+ +   +   
Sbjct: 261 DGAS------AVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314

Query: 473 RPTDEMFIGE--MSLRRWVKESLPH 495
            P       +  +    W+  S  +
Sbjct: 315 LP----NTDDAALGGSEWIFRSCKN 335

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  107 bits (270), Expect = 2e-25
 Identities = 56/210 (26%), Positives = 89/210 (42%), Gaps = 42/210 (20%)

Query: 280 LGTSSFGSVYKGT-ISDGTDVAIKVFN--------LQLERAFRSFDSECEVLRNVRHRNL 330
           LG+ + G V           VAI++ +         +      + ++E E+L+ + H  +
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202

Query: 331 IKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERL--NIMIDVGSALEYLHNG 388
           IKI + +   D+  +VLE M  G L   +  +       E         +  A++YLH  
Sbjct: 203 IKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLK---EATCKLYFYQMLLAVQYLH-- 256

Query: 389 HSSVHIIHCDLKPTNILL---DENMVAHVSDFGIYKLLGEGEDSVRQTMTMA-TIGYMAP 444
                IIH DLKP N+LL   +E+ +  ++DFG  K+LGE         T+  T  Y+AP
Sbjct: 257 --ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS----LMRTLCGTPTYLAP 310

Query: 445 E---------YGLEGIVSAKCDVYSYGVLL 465
           E         Y          D +S GV+L
Sbjct: 311 EVLVSVGTAGYNRA------VDCWSLGVIL 334

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  104 bits (262), Expect = 3e-25
 Identities = 57/204 (27%), Positives = 86/204 (42%), Gaps = 39/204 (19%)

Query: 280 LGTSSFGSVYKGT-ISDGTDVAIKVFN--LQLERAFRSFDSECEVLRNVRHRNLIKILSS 336
           LG  SFG V K        + A+KV N      +   +   E E+L+ + H N++K+   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89

Query: 337 YSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILER--------LNIMIDVGSALEYLHNG 388
             +     +V E    G L         F +I++R          I+  V S + Y+H  
Sbjct: 90  LEDSSSFYIVGELYTGGEL---------FDEIIKRKRFSEHDAARIIKQVFSGITYMH-- 138

Query: 389 HSSVHIIHCDLKPTNILL---DENMVAHVSDFGIYKLLGEGEDSVRQTMTMATI----GY 441
               +I+H DLKP NILL   +++    + DFG+     +          M        Y
Sbjct: 139 --KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT-------KMKDRIGTAYY 189

Query: 442 MAPEYGLEGIVSAKCDVYSYGVLL 465
           +APE  L G    KCDV+S GV+L
Sbjct: 190 IAPEV-LRGTYDEKCDVWSAGVIL 212

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  108 bits (271), Expect = 3e-25
 Identities = 54/211 (25%), Positives = 88/211 (41%), Gaps = 23/211 (10%)

Query: 267 IQRATDEFNEC----NLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQ--LERAFRSFDSEC 319
           I       +E       LG+ ++G V          + AIK+         +      E 
Sbjct: 28  ITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEV 87

Query: 320 EVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILER--LNIMID 377
            VL+ + H N++K+   + +     LV+E    G L   +     F    E     I+  
Sbjct: 88  AVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKF---NEVDAAVIIKQ 144

Query: 378 VGSALEYLHNGHSSVHIIHCDLKPTNILL---DENMVAHVSDFGIYKLLGEGEDSVRQTM 434
           V S + YLH      +I+H DLKP N+LL   +++ +  + DFG+  +    +   +   
Sbjct: 145 VLSGVTYLH----KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK---KMKE 197

Query: 435 TMATIGYMAPEYGLEGIVSAKCDVYSYGVLL 465
            + T  Y+APE  L      KCDV+S GV+L
Sbjct: 198 RLGTAYYIAPEV-LRKKYDEKCDVWSIGVIL 227

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  105 bits (264), Expect = 3e-25
 Identities = 57/210 (27%), Positives = 89/210 (42%), Gaps = 42/210 (20%)

Query: 280 LGTSSFGSVYKGT-ISDGTDVAIKVFN--------LQLERAFRSFDSECEVLRNVRHRNL 330
           LG+ + G V           VAIK+ +         +      + ++E E+L+ + H  +
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77

Query: 331 IKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERL--NIMIDVGSALEYLHNG 388
           IKI + +   D+  +VLE M  G L   +  +       E         +  A++YLH  
Sbjct: 78  IKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLK---EATCKLYFYQMLLAVQYLH-- 131

Query: 389 HSSVHIIHCDLKPTNILL---DENMVAHVSDFGIYKLLGEGEDSVRQTMTMA-TIGYMAP 444
                IIH DLKP N+LL   +E+ +  ++DFG  K+LGE         T+  T  Y+AP
Sbjct: 132 --ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS----LMRTLCGTPTYLAP 185

Query: 445 E---------YGLEGIVSAKCDVYSYGVLL 465
           E         Y          D +S GV+L
Sbjct: 186 EVLVSVGTAGYNRA------VDCWSLGVIL 209

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  106 bits (266), Expect = 3e-25
 Identities = 61/220 (27%), Positives = 95/220 (43%), Gaps = 60/220 (27%)

Query: 280 LGTSSFGSVYKGT-ISDGTDVAIKVFNL--------QLERAFRSFDSECEVLRNVR-HRN 329
           +G      V +    + G + A+K+  +        QLE    +   E  +LR V  H +
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161

Query: 330 LIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERL--------NIMIDVGSA 381
           +I ++ SY +  F  LV + M  G L         F  + E++        +IM  +  A
Sbjct: 162 IITLIDSYESSSFMFLVFDLMRKGEL---------FDYLTEKVALSEKETRSIMRSLLEA 212

Query: 382 LEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATI-- 439
           + +LH    + +I+H DLKP NILLD+NM   +SDFG    L  GE        +  +  
Sbjct: 213 VSFLH----ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE-------KLRELCG 261

Query: 440 --GYMAPE------------YGLEGIVSAKCDVYSYGVLL 465
             GY+APE            YG E       D+++ GV+L
Sbjct: 262 TPGYLAPEILKCSMDETHPGYGKE------VDLWACGVIL 295

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  107 bits (270), Expect = 4e-25
 Identities = 57/203 (28%), Positives = 89/203 (43%), Gaps = 19/203 (9%)

Query: 271 TDEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQ--LERAFRSFDSECEVLRNVRH 327
            + +N   +LG  SFG V K        + A+KV N      +   +   E E+L+ + H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80

Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILER--LNIMIDVGSALEYL 385
            N++K+     +     +V E    G L   +     F    E     I+  V S + Y+
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRF---SEHDAARIIKQVFSGITYM 137

Query: 386 HNGHSSVHIIHCDLKPTNILL---DENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYM 442
           H      +I+H DLKP NILL   +++    + DFG+     +     +    + T  Y+
Sbjct: 138 H----KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT---KMKDRIGTAYYI 190

Query: 443 APEYGLEGIVSAKCDVYSYGVLL 465
           APE  L G    KCDV+S GV+L
Sbjct: 191 APEV-LRGTYDEKCDVWSAGVIL 212

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  103 bits (260), Expect = 7e-25
 Identities = 45/227 (19%), Positives = 91/227 (40%), Gaps = 25/227 (11%)

Query: 269 RATDEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQL--ERAFRSFDSECEVLRNV 325
           R T EF+E   +G+  FGSV+K     DG   AIK     L      ++   E      +
Sbjct: 8   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 67

Query: 326 -RHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDIL---ERLNIMIDVGSA 381
            +H ++++  S+++  D   +  E+   GSL   +  +   +      E  ++++ VG  
Sbjct: 68  GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127

Query: 382 LEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSV----------R 431
           L Y+H    S+ ++H D+KP+NI +    + + +     +        +          R
Sbjct: 128 LRYIH----SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR 183

Query: 432 QTMTMATIG---YMAPEYGLEGIV-SAKCDVYSYGVLLMETFTRKRP 474
            +      G   ++A E   E      K D+++  + ++     +  
Sbjct: 184 ISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  103 bits (259), Expect = 9e-25
 Identities = 58/200 (29%), Positives = 90/200 (45%), Gaps = 28/200 (14%)

Query: 280 LGTSSFGSVYKGT-ISDGTDVAIKVFN-LQLERAFRSFDSECEVLRNVRHRNLIKILSSY 337
           LG+ +FG V+     S G +  IK  N  + +      ++E EVL+++ H N+IKI   +
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89

Query: 338 SNPDFKALVLEFMPNGSL-----EKWLYSHNYFLDILER--LNIMIDVGSALEYLHNGHS 390
            +     +V+E    G L                   E     +M  + +AL Y H    
Sbjct: 90  EDYHNMYIVMETCEGGELLERIVSAQARGKAL----SEGYVAELMKQMMNALAYFH---- 141

Query: 391 SVHIIHCDLKPTNILL---DENMVAHVSDFGIYKLLGEGEDSVRQTMTMA--TIGYMAPE 445
           S H++H DLKP NIL      +    + DFG+ +L         +  T A  T  YMAPE
Sbjct: 142 SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD-----EHSTNAAGTALYMAPE 196

Query: 446 YGLEGIVSAKCDVYSYGVLL 465
              +  V+ KCD++S GV++
Sbjct: 197 V-FKRDVTFKCDIWSAGVVM 215

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  104 bits (262), Expect = 2e-24
 Identities = 54/235 (22%), Positives = 99/235 (42%), Gaps = 15/235 (6%)

Query: 238 IRCRNRNTKKSDHEDFLPLAIWRRTSYLDIQRATDEFNE----CNLLGTSSFGSVYKGT- 292
           +R +    K +D++ F    IW++     ++       +       LG+ +FG V++   
Sbjct: 14  VRGKYDGPKINDYDKFYE-DIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVE 72

Query: 293 ISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPN 352
            + G     K  N        +  +E  ++  + H  LI +  ++ +     L+LEF+  
Sbjct: 73  KATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG 132

Query: 353 GSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVA 412
           G L   + + +Y +   E +N M      L+++H       I+H D+KP NI+ +    +
Sbjct: 133 GELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH----EHSIVHLDIKPENIMCETKKAS 188

Query: 413 HV--SDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLL 465
            V   DFG+   L   E      +T AT  + APE      V    D+++ GVL 
Sbjct: 189 SVKIIDFGLATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLG 240

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  106 bits (266), Expect = 2e-24
 Identities = 57/222 (25%), Positives = 101/222 (45%), Gaps = 34/222 (15%)

Query: 267 IQRATDEFNEC----NLLGTSSFGSVYKGT-ISDGTDVAIKV-------------FNLQL 308
           +++   +  E       LG+ ++G V      +  ++ AIKV              N  +
Sbjct: 27  VRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNI 86

Query: 309 ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDI 368
           E+      +E  +L+++ H N+IK+   + +  +  LV EF   G L + + + + F   
Sbjct: 87  EKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKF--- 143

Query: 369 LER--LNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILL---DENMVAHVSDFGIYKLL 423
            E    NIM  + S + YLH      +I+H D+KP NILL   +  +   + DFG+    
Sbjct: 144 DECDAANIMKQILSGICYLH----KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFF 199

Query: 424 GEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLL 465
            +     +    + T  Y+APE  L+   + KCDV+S GV++
Sbjct: 200 SKDY---KLRDRLGTAYYIAPEV-LKKKYNEKCDVWSCGVIM 237

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  102 bits (257), Expect = 2e-24
 Identities = 54/216 (25%), Positives = 88/216 (40%), Gaps = 38/216 (17%)

Query: 271 TDEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRN 329
            + +     LG  +FG VYK      G   A KV   + E     +  E E+L    H  
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77

Query: 330 LIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLN----------IMIDVG 379
           ++K+L +Y +     +++EF P G++            I+  L+          +   + 
Sbjct: 78  IVKLLGAYYHDGKLWIMIEFCPGGAV----------DAIMLELDRGLTEPQIQVVCRQML 127

Query: 380 SALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATI 439
            AL +LH    S  IIH DLK  N+L+       ++DFG+     +     R +     I
Sbjct: 128 EALNFLH----SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK-TLQKRDSF----I 178

Query: 440 G---YMAPE-----YGLEGIVSAKCDVYSYGVLLME 467
           G   +MAPE        +     K D++S G+ L+E
Sbjct: 179 GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIE 214

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  106 bits (266), Expect = 3e-24
 Identities = 34/164 (20%), Positives = 51/164 (31%), Gaps = 15/164 (9%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFS 61
           +    E   L+  +P T+     + E L  + N L      + +    L  LDL      
Sbjct: 15  KTYNCENLGLN-EIPGTL---PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIY 70

Query: 62  GHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLV----LTVLDVSRNQLSGDIPS 117
               +TF +   L  L        LT N L       L     L  L   +  +S     
Sbjct: 71  WIHEDTFQSQHRLDTL-------VLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFI 123

Query: 118 TIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSG 161
            +  +  LE+L L SN               L+ LD   N +  
Sbjct: 124 PLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHY 167

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  102 bits (256), Expect = 6e-23
 Identities = 32/167 (19%), Positives = 59/167 (35%), Gaps = 15/167 (8%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFS 61
            +L L   +L  +   +   +L  ++ L L+ + L  +          L  L+L  N F 
Sbjct: 403 ELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFP 462

Query: 62  GHI---LNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLV----LTVLDVSRNQLSGD 114
                  N+   L  L +L        L+   L             +  +D+S N+L+  
Sbjct: 463 KGNIQKTNSLQTLGRLEILV-------LSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSS 515

Query: 115 IPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSG 161
               +   +    L+LASN     +P  +  L    +++L  N L  
Sbjct: 516 SIEALSH-LKGIYLNLASNHISIILPSLLPILSQQRTINLRQNPLDC 561

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 99.7 bits (249), Expect = 4e-22
 Identities = 35/176 (19%), Positives = 63/176 (35%), Gaps = 18/176 (10%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTI-PNSITNATKLIVLDLGFN-- 58
           + L L  N+       +  +  P++ +L +  N     +    + N   L  LDL  +  
Sbjct: 304 KKLVLSANKFENLCQISASN-FPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDI 362

Query: 59  SFSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPP-----CLVLTVLDVSRNQLSG 113
             S        NL HL  L        L+ N+    +       C  L +LD++  +L  
Sbjct: 363 ETSDCCNLQLRNLSHLQSL-------NLSYNEP-LSLKTEAFKECPQLELLDLAFTRLKV 414

Query: 114 -DIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKLEG 168
            D  S       L+ L+L+ +       +    L +L+ L+L GN+      +   
Sbjct: 415 KDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTN 470

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 98.2 bits (245), Expect = 1e-21
 Identities = 38/174 (21%), Positives = 62/174 (35%), Gaps = 17/174 (9%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLT--GTIPNSITNATKLIVLDLGFNS 59
             L+++GN     L +    +L N+  L L+ +++         + N + L  L+L +N 
Sbjct: 328 THLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNE 387

Query: 60  FSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLV-----LTVLDVSRNQLSGD 114
                   F     L +L L          +L  +           L VL++S + L   
Sbjct: 388 PLSLKTEAFKECPQLELLDL-------AFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDIS 440

Query: 115 IPSTIGGRVDLETLSLASNQFQGPIPESVGS---LISLESLDLSGNNLSGKIPK 165
                 G   L+ L+L  N F     +   S   L  LE L LS  +LS     
Sbjct: 441 SEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQH 494

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 96.6 bits (241), Expect = 4e-21
 Identities = 35/174 (20%), Positives = 57/174 (32%), Gaps = 18/174 (10%)

Query: 1   MRILTLEGNQLSG-RLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNS 59
           +R L L  + +      +    +L +++ L L+ N        +     +L +LDL F  
Sbjct: 352 LRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTR 411

Query: 60  FSG-HILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLV-----LTVLDVSRNQLSG 113
                  + F NL  L VL        L+ + L       L      L  L++  N    
Sbjct: 412 LKVKDAQSPFQNLHLLKVL-------NLSHSLLDI-SSEQLFDGLPALQHLNLQGNHFPK 463

Query: 114 DIPSTIGGRVD---LETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIP 164
                         LE L L+          +  SL  +  +DLS N L+    
Sbjct: 464 GNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSI 517

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 93.5 bits (233), Expect = 3e-20
 Identities = 37/173 (21%), Positives = 58/173 (33%), Gaps = 17/173 (9%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSI-TNATKLIVLDLGFNSF 60
           + L L  N+    L +      P +E L L    L      S   N   L VL+L  +  
Sbjct: 379 QSLNLSYNEPLS-LKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLL 437

Query: 61  SGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLV-------LTVLDVSRNQLSG 113
                  F  L  L  L+L        GN                  L +L +S   LS 
Sbjct: 438 DISSEQLFDGLPALQHLNL-------QGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSS 490

Query: 114 DIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKL 166
                      +  + L+ N+      E++  L  +  L+L+ N++S  +P L
Sbjct: 491 IDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHISIILPSL 542

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 93.2 bits (232), Expect = 5e-20
 Identities = 36/187 (19%), Positives = 60/187 (32%), Gaps = 24/187 (12%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFS 61
           + L      +S      + +    +E L L +N+++           KL VLD   N+  
Sbjct: 108 KHLFFIQTGISSIDFIPLHN-QKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIH 166

Query: 62  GHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPP----CLVLTVLDVSRNQLSGDIPS 117
                   +L+  + LSL      L GN + G I P      V   L+    Q    I  
Sbjct: 167 YLSKEDMSSLQQATNLSL-----NLNGNDIAG-IEPGAFDSAVFQSLNFGGTQNLLVIFK 220

Query: 118 TIGGR--VDLETLSLASNQFQGPIPESVGSL--ISLESLDLSGNNLSGKIPKLEGEIPVK 173
            +       L   +      +   P     L  +S+ES++L  +                
Sbjct: 221 GLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISS--------- 271

Query: 174 GSFKNFS 180
            +F  FS
Sbjct: 272 NTFHCFS 278

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 92.8 bits (231), Expect = 6e-20
 Identities = 35/167 (20%), Positives = 60/167 (35%), Gaps = 14/167 (8%)

Query: 4   LTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNAT--KLIVLDLGFNSFS 61
           L L GN ++G +           + L          I   + N+T   L +         
Sbjct: 184 LNLNGNDIAG-IEPGAFD-SAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDE 241

Query: 62  GHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIP----PCLVLTVLDVSRNQLSGDIPS 117
                 F  L  +SV S+      L  +  +            L  LD++   LS ++PS
Sbjct: 242 DISPAVFEGLCEMSVESI-----NLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPS 295

Query: 118 TIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIP 164
            + G   L+ L L++N+F+     S  +  SL  L + GN    ++ 
Sbjct: 296 GLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELG 342

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 70.0 bits (172), Expect = 8e-13
 Identities = 26/136 (19%), Positives = 43/136 (31%), Gaps = 30/136 (22%)

Query: 29  LLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLMFGIRLTG 88
                  L   IP ++ N+T+   L+  FN        TF  L +L              
Sbjct: 17  YNCENLGLN-EIPGTLPNSTE--CLEFSFNVLPTIQNTTFSRLINL-------------- 59

Query: 89  NKLYGRIPPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLIS 148
                        T LD++R Q+      T   +  L+TL L +N        ++    +
Sbjct: 60  -------------TFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKA 106

Query: 149 LESLDLSGNNLSGKIP 164
           L+ L      +S    
Sbjct: 107 LKHLFFIQTGISSIDF 122

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 64.7 bits (158), Expect = 4e-11
 Identities = 26/166 (15%), Positives = 56/166 (33%), Gaps = 20/166 (12%)

Query: 2   RILTLEGNQLSGRLPSTIG--HSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNS 59
           + L L+GN              +L  +E L+L+  +L+    ++ T+   +  +DL  N 
Sbjct: 452 QHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNR 511

Query: 60  FSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLV----LTVLDVSRNQLSGDI 115
            +   +    +L+ +         + L  N +   +P  L        +++ +N L    
Sbjct: 512 LTSSSIEALSHLKGIY--------LNLASNHISIILPSLLPILSQQRTINLRQNPLDCTC 563

Query: 116 PSTIGGRVDL-ETLSLASNQFQGPIPESVGSLISLESLDLSGNNLS 160
            +         E       + +        +   L  + LS   LS
Sbjct: 564 SNI-----YFLEWYKENMQKLEDTEDTLCENPPLLRGVRLSDVTLS 604

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 57.3 bits (139), Expect = 8e-09
 Identities = 19/83 (22%), Positives = 28/83 (33%), Gaps = 3/83 (3%)

Query: 86  LTGNKLYGRIPPCL--VLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESV 143
                L   IP  L      L+ S N L     +T    ++L  L L   Q      ++ 
Sbjct: 19  CENLGLN-EIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTF 77

Query: 144 GSLISLESLDLSGNNLSGKIPKL 166
            S   L++L L+ N L       
Sbjct: 78  QSQHRLDTLVLTANPLIFMAETA 100

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  103 bits (258), Expect = 3e-24
 Identities = 27/254 (10%), Positives = 60/254 (23%), Gaps = 46/254 (18%)

Query: 279 LLGTSSFGSVYKGT-ISDGTDVAIKVFN---LQLERAFRSFDSECEVLRNVRHRN----- 329
            L       V+    +    D A+KVF                       +   +     
Sbjct: 69  PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128

Query: 330 -------------------LIKILSSYSNPDFKALVLEFM-PNGSLE------KWLYSHN 363
                                ++     +      +L     +  LE       ++Y   
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188

Query: 364 YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLL 423
               IL    +   +      L     S  ++H    P N+ +  +    + D      +
Sbjct: 189 GDEGILALHILTAQLIRLAANLQ----SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKV 244

Query: 424 GEGEDSVRQTMTMATIGYMAPEY--GLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIG 481
           G      R   +   + Y   E+        +   + +  G+ +   +    P   +  G
Sbjct: 245 GT-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPG 299

Query: 482 EMSLRRWVKESLPH 495
                +     +P 
Sbjct: 300 IKGSWKRPSLRVPG 313

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  102 bits (255), Expect = 5e-24
 Identities = 58/201 (28%), Positives = 90/201 (44%), Gaps = 15/201 (7%)

Query: 271 TDEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRN 329
            + F+    LG  S+GSVYK      G  VAIK   +  E   +    E  +++     +
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPV--ESDLQEIIKEISIMQQCDSPH 85

Query: 330 LIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGH 389
           ++K   SY       +V+E+   GS+   +   N  L   E   I+      LEYLH   
Sbjct: 86  VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH--- 142

Query: 390 SSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIG---YMAPEY 446
             +  IH D+K  NILL+    A ++DFG+   L +   + R T+    IG   +MAPE 
Sbjct: 143 -FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD-TMAKRNTV----IGTPFWMAPEV 196

Query: 447 GLEGIVSAKCDVYSYGVLLME 467
             E   +   D++S G+  +E
Sbjct: 197 IQEIGYNCVADIWSLGITAIE 217

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  104 bits (261), Expect = 5e-24
 Identities = 47/219 (21%), Positives = 90/219 (41%), Gaps = 49/219 (22%)

Query: 271 TDEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRSFD-----SECEVLRN 324
           T+E+     LG  +F  V +   +  G + A  + N    +   + D      E  + R 
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIIN---TKKLSARDHQKLEREARICRL 66

Query: 325 VRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILER--------LNIMI 376
           ++H N++++  S S      L+ + +  G L         F DI+ R         + + 
Sbjct: 67  LKHPNIVRLHDSISEEGHHYLIFDLVTGGEL---------FEDIVAREYYSEADASHCIQ 117

Query: 377 DVGSALEYLHNGHSSVHIIHCDLKPTNILL---DENMVAHVSDFGIYKLLGEGEDSVRQT 433
            +  A+ + H     + ++H +LKP N+LL    +     ++DFG+   +   + +    
Sbjct: 118 QILEAVLHCH----QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWF-- 171

Query: 434 MTMA-TIGYMAPE------YGLEGIVSAKCDVYSYGVLL 465
              A T GY++PE      YG         D+++ GV+L
Sbjct: 172 -GFAGTPGYLSPEVLRKDPYGKP------VDLWACGVIL 203

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  105 bits (263), Expect = 5e-24
 Identities = 52/234 (22%), Positives = 93/234 (39%), Gaps = 14/234 (5%)

Query: 239 RCRNRNTKKSDHEDFLPLAIWRRTSYLDIQRATDEFNE----CNLLGTSSFGSVYKGT-I 293
           +        S + D     IW++     ++   D   +       LGT +FG V++ T  
Sbjct: 120 KIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTER 179

Query: 294 SDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNG 353
           + G + A K      E    +   E + +  +RH  L+ +  ++ + +   ++ EFM  G
Sbjct: 180 ATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGG 239

Query: 354 SLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAH 413
            L + +   +  +   E +  M  V   L ++H      + +H DLKP NI+        
Sbjct: 240 ELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH----ENNYVHLDLKPENIMFTTKRSNE 295

Query: 414 V--SDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLL 465
           +   DFG+   L   +      +T  T  + APE      V    D++S GVL 
Sbjct: 296 LKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  102 bits (255), Expect = 6e-24
 Identities = 53/208 (25%), Positives = 91/208 (43%), Gaps = 20/208 (9%)

Query: 272 DEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQL-ERAFRSFDSECEV-LRNVRHR 328
           ++  +   +G  ++GSV K      G  +A+K     + E+  +    + +V +R+    
Sbjct: 22  EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81

Query: 329 NLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLD---ILERL--NIMIDVGSALE 383
            +++   +        + +E M + S +K  Y + Y +    I E +   I +    AL 
Sbjct: 82  YIVQFYGALFREGDCWICMELM-STSFDK-FYKYVYSVLDDVIPEEILGKITLATVKALN 139

Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           +L        IIH D+KP+NILLD +    + DFGI    G+  DS+ +T       YMA
Sbjct: 140 HLKENL---KIIHRDIKPSNILLDRSGNIKLCDFGI---SGQLVDSIAKTRDAGCRPYMA 193

Query: 444 PE----YGLEGIVSAKCDVYSYGVLLME 467
           PE             + DV+S G+ L E
Sbjct: 194 PERIDPSASRQGYDVRSDVWSLGITLYE 221

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  102 bits (256), Expect = 7e-24
 Identities = 50/223 (22%), Positives = 85/223 (38%), Gaps = 50/223 (22%)

Query: 271 TDEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRSFD-----SECEVLRN 324
            D +  C ++G   F  V +      G   A+K+ ++    +           E  +   
Sbjct: 23  EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82

Query: 325 VRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLN----------- 373
           ++H +++++L +YS+     +V EFM    L           +I++R +           
Sbjct: 83  LKHPHIVELLETYSSDGMLYMVFEFMDGADL---------CFEIVKRADAGFVYSEAVAS 133

Query: 374 -IMIDVGSALEYLHNGHSSVHIIHCDLKPTNILL---DENMVAHVSDFGIYKLLGEGEDS 429
             M  +  AL Y H      +IIH D+KP  +LL   + +    +  FG+   LGE    
Sbjct: 134 HYMRQILEALRYCH----DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLV 189

Query: 430 VRQTMTMA-TIGYMAPE------YGLEGIVSAKCDVYSYGVLL 465
                    T  +MAPE      YG         DV+  GV+L
Sbjct: 190 AG---GRVGTPHFMAPEVVKREPYGKP------VDVWGCGVIL 223

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  101 bits (254), Expect = 1e-23
 Identities = 53/216 (24%), Positives = 85/216 (39%), Gaps = 47/216 (21%)

Query: 271 TDEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRSFDSECEVL-RNVRHR 328
           TD +     +G  S+    +    +   + A+K+ +            E E+L R  +H 
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE----EIEILLRYGQHP 76

Query: 329 NLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLN--------IMIDVGS 380
           N+I +   Y +  +  +V E M  G L            IL +          ++  +  
Sbjct: 77  NIITLKDVYDDGKYVYVVTELMKGGEL---------LDKILRQKFFSEREASAVLFTITK 127

Query: 381 ALEYLHNGHSSVHIIHCDLKPTNILL----DENMVAHVSDFGIYKLLGEGEDSVRQTMTM 436
            +EYLH    +  ++H DLKP+NIL            + DFG  K L   E+ +   MT 
Sbjct: 128 TVEYLH----AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL-RAENGL--LMTP 180

Query: 437 A-TIGYMAPE------YGLEGIVSAKCDVYSYGVLL 465
             T  ++APE      Y         CD++S GVLL
Sbjct: 181 CYTANFVAPEVLERQGYDAA------CDIWSLGVLL 210

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  102 bits (255), Expect = 1e-23
 Identities = 38/199 (19%), Positives = 75/199 (37%), Gaps = 17/199 (8%)

Query: 281 GTSSFGSVYKGT-ISDGTDVAIKVFNL--QLERAFRSFDSECEVLRNVRHRNLIKILSSY 337
           G     +V        G  V ++  NL             E  V +   H N++   +++
Sbjct: 36  GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95

Query: 338 SNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERL--NIMIDVGSALEYLHNGHSSVHII 395
              +   +V  FM  GS +  L   ++   + E     I+  V  AL+Y+H     +  +
Sbjct: 96  IADNELWVVTSFMAYGSAKD-LICTHFMDGMNELAIAYILQGVLKALDYIH----HMGYV 150

Query: 396 HCDLKPTNILLDENMVAHVSDFGIYKLLGEGED--SVRQTMTMATIG---YMAPEYGLEG 450
           H  +K ++IL+  +   ++S       +        V       ++    +++PE   + 
Sbjct: 151 HRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQN 210

Query: 451 IV--SAKCDVYSYGVLLME 467
           +    AK D+YS G+   E
Sbjct: 211 LQGYDAKSDIYSVGITACE 229

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  101 bits (254), Expect = 1e-23
 Identities = 53/206 (25%), Positives = 85/206 (41%), Gaps = 44/206 (21%)

Query: 279 LLGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSY 337
            LG  +   VY+          A+KV    +++      +E  VL  + H N+IK+   +
Sbjct: 60  ELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKK--IVRTEIGVLLRLSHPNIIKLKEIF 117

Query: 338 SNPDFKALVLEFMPNGSLEKWLYSHNYFLDILER--------LNIMIDVGSALEYLHNGH 389
             P   +LVLE +  G L         F  I+E+         + +  +  A+ YLH   
Sbjct: 118 ETPTEISLVLELVTGGEL---------FDRIVEKGYYSERDAADAVKQILEAVAYLH--- 165

Query: 390 SSVHIIHCDLKPTNILL---DENMVAHVSDFGIYKLLGEGEDSVRQTMTMA-TIGYMAPE 445
               I+H DLKP N+L      +    ++DFG+ K++           T+  T GY APE
Sbjct: 166 -ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV----LMKTVCGTPGYCAPE 220

Query: 446 ------YGLEGIVSAKCDVYSYGVLL 465
                 YG E       D++S G++ 
Sbjct: 221 ILRGCAYGPE------VDMWSVGIIT 240

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  100 bits (250), Expect = 2e-23
 Identities = 55/211 (26%), Positives = 88/211 (41%), Gaps = 38/211 (18%)

Query: 279 LLGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVR-HRNLIKILSS 336
           +LG  +   V     +    + A+K+   Q          E E+L   + HRN+++++  
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79

Query: 337 YSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLN--------IMIDVGSALEYLHNG 388
           +   D   LV E M  GS+            I +R +        ++ DV SAL++LH  
Sbjct: 80  FEEEDRFYLVFEKMRGGSI---------LSHIHKRRHFNELEASVVVQDVASALDFLH-- 128

Query: 389 HSSVHIIHCDLKPTNILL---DENMVAHVSDFGIYKLLGEGED-SVRQTMTMATI----G 440
             +  I H DLKP NIL    ++     + DF +   +    D S   T  + T      
Sbjct: 129 --NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAE 186

Query: 441 YMAPEYGLEGIVSA------KCDVYSYGVLL 465
           YMAPE  +E           +CD++S GV+L
Sbjct: 187 YMAPEV-VEAFSEEASIYDKRCDLWSLGVIL 216

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 99.2 bits (248), Expect = 3e-23
 Identities = 50/207 (24%), Positives = 88/207 (42%), Gaps = 19/207 (9%)

Query: 272 DEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERA-FRSFDSECEV-LRNVRHR 328
           D+      LG  ++G V K   +  G  +A+K     +     +    + ++ +R V   
Sbjct: 7   DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66

Query: 329 NLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLD--ILERL--NIMIDVGSALEY 384
             +    +        + +E M + SL+K  Y         I E +   I + +  ALE+
Sbjct: 67  FTVTFYGALFREGDVWICMELM-DTSLDK-FYKQVIDKGQTIPEDILGKIAVSIVKALEH 124

Query: 385 LHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAP 444
           LH+      +IH D+KP+N+L++      + DFGI    G   D V + +      YMAP
Sbjct: 125 LHSKL---SVIHRDVKPSNVLINALGQVKMCDFGI---SGYLVDDVAKDIDAGCKPYMAP 178

Query: 445 E----YGLEGIVSAKCDVYSYGVLLME 467
           E       +   S K D++S G+ ++E
Sbjct: 179 ERINPELNQKGYSVKSDIWSLGITMIE 205

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  100 bits (251), Expect = 3e-23
 Identities = 49/197 (24%), Positives = 92/197 (46%), Gaps = 12/197 (6%)

Query: 273 EFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLI 331
             ++  +LG   FG V+K    + G  +A K+   +  +      +E  V+  + H NLI
Sbjct: 90  TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149

Query: 332 KILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSS 391
           ++  ++ + +   LV+E++  G L   +   +Y L  L+ +  M  +   + ++H     
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMH----Q 205

Query: 392 VHIIHCDLKPTNILL---DENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGL 448
           ++I+H DLKP NIL    D   +  + DFG+ +     E   +  +   T  ++APE   
Sbjct: 206 MYILHLDLKPENILCVNRDAKQIK-IIDFGLARRYKPRE---KLKVNFGTPEFLAPEVVN 261

Query: 449 EGIVSAKCDVYSYGVLL 465
              VS   D++S GV+ 
Sbjct: 262 YDFVSFPTDMWSVGVIA 278

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 99.3 bits (248), Expect = 5e-23
 Identities = 31/159 (19%), Positives = 60/159 (37%), Gaps = 14/159 (8%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFS 61
           +I  +  + L  +  +++  S  N++ L L+ N L+      +   TKL +L+L  N   
Sbjct: 13  KIEKVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY 71

Query: 62  GHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLVLTVLDVSRNQLSGDIPSTIGG 121
                   +L  L  L        L  N +   +     +  L  + N +S  +  + G 
Sbjct: 72  E--TLDLESLSTLRTLD-------LNNNYV-QELLVGPSIETLHAANNNIS-RVSCSRG- 119

Query: 122 RVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLS 160
               + + LA+N+         G    ++ LDL  N + 
Sbjct: 120 -QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID 157

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 95.1 bits (237), Expect = 1e-21
 Identities = 33/163 (20%), Positives = 60/163 (36%), Gaps = 18/163 (11%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFS 61
             L    N +S R+  + G      + + L  N +T          +++  LDL  N   
Sbjct: 102 ETLHAANNNIS-RVSCSRGQGK---KNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID 157

Query: 62  G-HILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLVLT---VLDVSRNQLSGDIPS 117
             +      +   L  L+L         N +Y  +   +V      LD+S N+L+  +  
Sbjct: 158 TVNFAELAASSDTLEHLNL-------QYNFIY-DVKGQVVFAKLKTLDLSSNKLA-FMGP 208

Query: 118 TIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLS 160
                  +  +SL +N+    I +++    +LE  DL GN   
Sbjct: 209 EFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFH 250

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 68.9 bits (169), Expect = 6e-13
 Identities = 31/191 (16%), Positives = 63/191 (32%), Gaps = 32/191 (16%)

Query: 1   MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSF 60
           ++ L L+ N++     + +  S   +E+L L  N +   +   +    KL  LDL  N  
Sbjct: 146 VQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKL 203

Query: 61  SGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLVLTVLDVSRNQLSGDIPSTIG 120
           +  +   F +   ++ +SL                             N+L   I   + 
Sbjct: 204 A-FMGPEFQSAAGVTWISL---------------------------RNNKLV-LIEKALR 234

Query: 121 GRVDLETLSLASNQFQ-GPIPESVGSLISLESLDLSGNNLSGKIPKLEGEIPVKGSFKNF 179
              +LE   L  N F  G + +       ++++            + E  +P  G +  +
Sbjct: 235 FSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAY 294

Query: 180 STESFFGNYAL 190
             E     +A 
Sbjct: 295 CCEDLPAPFAD 305

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 64.2 bits (157), Expect = 2e-11
 Identities = 26/126 (20%), Positives = 49/126 (38%), Gaps = 20/126 (15%)

Query: 40  IPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCL 99
           I     N  +  +  +  +S    + +   +  ++  L        L+GN L  +I    
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELD-------LSGNPL-SQISAAD 53

Query: 100 V-----LTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDL 154
           +     L +L++S N L  +    +     L TL L +N  Q      +    S+E+L  
Sbjct: 54  LAPFTKLELLNLSSNVLY-ETLD-LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHA 106

Query: 155 SGNNLS 160
           + NN+S
Sbjct: 107 ANNNIS 112

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 54.6 bits (132), Expect = 3e-08
 Identities = 15/68 (22%), Positives = 26/68 (38%), Gaps = 1/68 (1%)

Query: 101 LTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLS 160
             +  V+ + L   + S      +++ L L+ N         +     LE L+LS N L 
Sbjct: 12  YKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY 71

Query: 161 GKIPKLEG 168
            +   LE 
Sbjct: 72  -ETLDLES 78

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 98.5 bits (246), Expect = 5e-23
 Identities = 58/210 (27%), Positives = 93/210 (44%), Gaps = 32/210 (15%)

Query: 271 TDEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNL-QLERAFRSFDSECEVLRNVRHR 328
            + F +   +G  SFG V+KG        VAIK+ +L + E        E  VL      
Sbjct: 21  EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80

Query: 329 NLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILE--RLN------IMIDVGS 380
            + K   SY       +++E++  GS           LD+LE   L+      I+ ++  
Sbjct: 81  YVTKYYGSYLKDTKLWIIMEYLGGGSA----------LDLLEPGPLDETQIATILREILK 130

Query: 381 ALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIG 440
            L+YLH    S   IH D+K  N+LL E+    ++DFG+   L + +   R T     +G
Sbjct: 131 GLDYLH----SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IKRNTF----VG 181

Query: 441 ---YMAPEYGLEGIVSAKCDVYSYGVLLME 467
              +MAPE   +    +K D++S G+  +E
Sbjct: 182 TPFWMAPEVIKQSAYDSKADIWSLGITAIE 211

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 99.3 bits (248), Expect = 6e-23
 Identities = 51/206 (24%), Positives = 85/206 (41%), Gaps = 45/206 (21%)

Query: 280 LGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVR-HRNLIKILSSY 337
           LG  SF    K          A+K+ + ++E   +    E   L+    H N++K+   +
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLHEVF 75

Query: 338 SNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLN--------IMIDVGSALEYLHNGH 389
            +     LV+E +  G L         F  I ++ +        IM  + SA+ ++H   
Sbjct: 76  HDQLHTFLVMELLNGGEL---------FERIKKKKHFSETEASYIMRKLVSAVSHMH--- 123

Query: 390 SSVHIIHCDLKPTNILL---DENMVAHVSDFGIYKLLGEGEDSVRQTMTMA-TIGYMAPE 445
             V ++H DLKP N+L    ++N+   + DFG  +L       +    T   T+ Y APE
Sbjct: 124 -DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL---KTPCFTLHYAAPE 179

Query: 446 ------YGLEGIVSAKCDVYSYGVLL 465
                 Y         CD++S GV+L
Sbjct: 180 LLNQNGYDES------CDLWSLGVIL 199

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 99.1 bits (247), Expect = 7e-23
 Identities = 50/224 (22%), Positives = 82/224 (36%), Gaps = 28/224 (12%)

Query: 279 LLGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVR-HRNLIKILSS 336
           +L    F  VY+   +  G + A+K      E   R+   E   ++ +  H N+++  S+
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94

Query: 337 YS-------NPDFKALVLEFMPNGSLEKWL--YSHNYFLDILERLNIMIDVGSALEYLHN 387
            S           + L+L  +  G L ++L        L     L I      A++++H 
Sbjct: 95  ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH- 153

Query: 388 GHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMA---------- 437
                 IIH DLK  N+LL       + DFG    +    D        A          
Sbjct: 154 -RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNT 212

Query: 438 TIGYMAPE----YGLEGIVSAKCDVYSYGVLLMETFTRKRPTDE 477
           T  Y  PE    Y    I   K D+++ G +L     R+ P ++
Sbjct: 213 TPMYRTPEIIDLYSNFPI-GEKQDIWALGCILYLLCFRQHPFED 255

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 99.1 bits (247), Expect = 7e-23
 Identities = 55/246 (22%), Positives = 88/246 (35%), Gaps = 55/246 (22%)

Query: 271 TDEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRSFD-----SECEVLRN 324
             +++    +G  S+G V            AIK+ N    R     D     +E  +++ 
Sbjct: 25  QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84

Query: 325 VRHRNLIKILSSYSNPDFKALVLEFMPNGSL----------------------------- 355
           + H N+ ++   Y +  +  LV+E    G L                             
Sbjct: 85  LHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPE 144

Query: 356 --------EKWLYSHNYFLDILERL--NIMIDVGSALEYLHNGHSSVHIIHCDLKPTNIL 405
                       +  +      E+L  NIM  + SAL YLH    +  I H D+KP N L
Sbjct: 145 CNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH----NQGICHRDIKPENFL 200

Query: 406 L--DENMVAHVSDFGIYKLLGEGEDSVRQTMTMA--TIGYMAPE--YGLEGIVSAKCDVY 459
              +++    + DFG+ K   +  +     MT    T  ++APE           KCD +
Sbjct: 201 FSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAW 260

Query: 460 SYGVLL 465
           S GVLL
Sbjct: 261 SAGVLL 266

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 98.2 bits (245), Expect = 2e-22
 Identities = 52/214 (24%), Positives = 82/214 (38%), Gaps = 35/214 (16%)

Query: 271 TDEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRSFD------SECEVLR 323
            D ++    LG+  F  V K    S G + A K    +  RA R          E  +LR
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70

Query: 324 NVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILER--------LNIM 375
            V H N+I +   Y N     L+LE +  G L         F  + ++         + +
Sbjct: 71  QVLHPNIITLHDVYENRTDVVLILELVSGGEL---------FDFLAQKESLSEEEATSFI 121

Query: 376 IDVGSALEYLHNGHSSVHIIHCDLKPTNILL----DENMVAHVSDFGIYKLLGEGEDSVR 431
             +   + YLH    +  I H DLKP NI+L           + DFG+   + +G     
Sbjct: 122 KQILDGVNYLH----TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---E 174

Query: 432 QTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLL 465
                 T  ++APE      +  + D++S GV+ 
Sbjct: 175 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 99.5 bits (248), Expect = 3e-22
 Identities = 31/159 (19%), Positives = 60/159 (37%), Gaps = 14/159 (8%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFS 61
           +I  +  + L  +  +++  S  N++ L L+ N L+      +   TKL +L+L  N   
Sbjct: 13  KIEKVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY 71

Query: 62  GHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLVLTVLDVSRNQLSGDIPSTIGG 121
                   +L  L  L        L  N +   +     +  L  + N +S  +  + G 
Sbjct: 72  E--TLDLESLSTLRTLD-------LNNNYV-QELLVGPSIETLHAANNNIS-RVSCSRG- 119

Query: 122 RVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLS 160
               + + LA+N+         G    ++ LDL  N + 
Sbjct: 120 -QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID 157

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 94.9 bits (236), Expect = 8e-21
 Identities = 33/163 (20%), Positives = 60/163 (36%), Gaps = 18/163 (11%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFS 61
             L    N +S R+  + G      + + L  N +T          +++  LDL  N   
Sbjct: 102 ETLHAANNNIS-RVSCSRGQGK---KNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID 157

Query: 62  G-HILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLVLT---VLDVSRNQLSGDIPS 117
             +      +   L  L+L         N +Y  +   +V      LD+S N+L+  +  
Sbjct: 158 TVNFAELAASSDTLEHLNL-------QYNFIY-DVKGQVVFAKLKTLDLSSNKLA-FMGP 208

Query: 118 TIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLS 160
                  +  +SL +N+    I +++    +LE  DL GN   
Sbjct: 209 EFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFH 250

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 69.9 bits (171), Expect = 8e-13
 Identities = 26/164 (15%), Positives = 52/164 (31%), Gaps = 16/164 (9%)

Query: 1   MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSF 60
           ++ L L+ N++     + +  S   +E+L L  N +   +   +    KL  LDL  N  
Sbjct: 146 VQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKL 203

Query: 61  SGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLV----LTVLDVSRNQLSGDIP 116
           +  +   F +   ++ +S       L  NKL   I   L     L   D+  N       
Sbjct: 204 A-FMGPEFQSAAGVTWIS-------LRNNKL-VLIEKALRFSQNLEHFDLRGNGFHCGTL 254

Query: 117 STIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLS 160
                + +    ++A    +    ++                  
Sbjct: 255 RDFFSK-NQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCE 297

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 64.1 bits (156), Expect = 5e-11
 Identities = 26/125 (20%), Positives = 46/125 (36%), Gaps = 18/125 (14%)

Query: 40  IPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCL 99
           I     N  +  +  +  +S    + +   +  ++  L        L+GN L       L
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELD-------LSGNPLSQISAADL 54

Query: 100 V----LTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLS 155
                L +L++S N L       +     L TL L +N  Q      +    S+E+L  +
Sbjct: 55  APFTKLELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAA 107

Query: 156 GNNLS 160
            NN+S
Sbjct: 108 NNNIS 112

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 63.7 bits (155), Expect = 6e-11
 Identities = 27/184 (14%), Positives = 55/184 (29%), Gaps = 29/184 (15%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFS 61
           + L L  N+L+  +          + ++ L  N L   I  ++  +  L   DL  N F 
Sbjct: 194 KTLDLSSNKLA-FMGPEFQS-AAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFH 250

Query: 62  -GHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLV-----------------LTV 103
            G + + F   + +  ++      +LTG        P L                  L  
Sbjct: 251 CGTLRDFFSKNQRVQTVAKQTVK-KLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIA 309

Query: 104 LDVSRNQL-------SGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSG 156
           L    + L       +  +      +     +     Q++  I +      +  +L+   
Sbjct: 310 LKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKK 369

Query: 157 NNLS 160
             L 
Sbjct: 370 KALD 373

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 56.4 bits (136), Expect = 2e-08
 Identities = 13/61 (21%), Positives = 23/61 (37%)

Query: 101 LTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLS 160
             +  V+ + L   + S      +++ L L+ N         +     LE L+LS N L 
Sbjct: 12  YKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY 71

Query: 161 G 161
            
Sbjct: 72  E 72

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 52.5 bits (126), Expect = 2e-07
 Identities = 15/162 (9%), Positives = 32/162 (19%), Gaps = 9/162 (5%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFS 61
               L GN                ++ +      +      +    T   +   G     
Sbjct: 240 EHFDLRGNGFHCGTLRDFFSKNQRVQTVAK--QTVKKLTGQNEEECTVPTLGHYGAYCCE 297

Query: 62  GHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLV----LTVLDVSRNQLSGDIPS 117
                    L  L      +  +   G++   R+            +D  + Q    I  
Sbjct: 298 DLPAPFADRLIALKRKEHAL--LSGQGSET-ERLECERENQARQREIDALKEQYRTVIDQ 354

Query: 118 TIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNL 159
               +    TL          +     +   L+         
Sbjct: 355 VTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQ 396

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 96.9 bits (242), Expect = 3e-22
 Identities = 53/210 (25%), Positives = 95/210 (45%), Gaps = 29/210 (13%)

Query: 272 DEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFN-------LQLERAFRSFDSECEVLR 323
           ++F    +LG  SF +V     ++   + AIK+          ++         E +V+ 
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVT----RERDVMS 85

Query: 324 NVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALE 383
            + H   +K+  ++ + +     L +  NG L K++     F +   R     ++ SALE
Sbjct: 86  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALE 144

Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTM-ATIGYM 442
           YLH       IIH DLKP NILL+E+M   ++DFG  K+L       R   +   T  Y+
Sbjct: 145 YLH----GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR-ANSFVGTAQYV 199

Query: 443 APEYGLEGIVSAK-----CDVYSYGVLLME 467
           +PE     +++ K      D+++ G ++ +
Sbjct: 200 SPE-----LLTEKSACKSSDLWALGCIIYQ 224

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 97.1 bits (242), Expect = 3e-22
 Identities = 50/221 (22%), Positives = 89/221 (40%), Gaps = 20/221 (9%)

Query: 260 RRTSYLDI-----QRATDEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQL-ERAF 312
           ++T YL I     Q   ++      +G+ + G V+K      G  +A+K       +   
Sbjct: 8   KQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEEN 67

Query: 313 RSFDSECEVL-RNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILER 371
           +    + +V+ ++     +++   ++       + +E M     EK        +     
Sbjct: 68  KRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERIL 126

Query: 372 LNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVR 431
             + + +  AL YL   H    +IH D+KP+NILLDE     + DFGI    G   D   
Sbjct: 127 GKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGI---SGRLVDDKA 180

Query: 432 QTMTMATIGYMAPE-----YGLEGIVSAKCDVYSYGVLLME 467
           +  +     YMAPE        +     + DV+S G+ L+E
Sbjct: 181 KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVE 221

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 96.9 bits (242), Expect = 3e-22
 Identities = 52/214 (24%), Positives = 82/214 (38%), Gaps = 35/214 (16%)

Query: 271 TDEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRSFD------SECEVLR 323
            D ++    LG+  F  V K    S G + A K    +  RA R          E  +LR
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70

Query: 324 NVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILER--------LNIM 375
            V H N+I +   Y N     L+LE +  G L         F  + ++         + +
Sbjct: 71  QVLHHNVITLHDVYENRTDVVLILELVSGGEL---------FDFLAQKESLSEEEATSFI 121

Query: 376 IDVGSALEYLHNGHSSVHIIHCDLKPTNILL----DENMVAHVSDFGIYKLLGEGEDSVR 431
             +   + YLH    +  I H DLKP NI+L           + DFG+   + +G     
Sbjct: 122 KQILDGVNYLH----TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---E 174

Query: 432 QTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLL 465
                 T  ++APE      +  + D++S GV+ 
Sbjct: 175 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 97.1 bits (242), Expect = 3e-22
 Identities = 57/207 (27%), Positives = 88/207 (42%), Gaps = 24/207 (11%)

Query: 271 TDEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRSFDS---ECEVLRNVR 326
              F++   +G  SFG+VY    + +   VAIK  +   +++   +     E   L+ +R
Sbjct: 53  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112

Query: 327 HRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH 386
           H N I+    Y       LV+E+   GS    L  H   L  +E   +       L YLH
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 171

Query: 387 NGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIG---YMA 443
               S ++IH D+K  NILL E  +  + DFG   ++         +     +G   +MA
Sbjct: 172 ----SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-----ANSF----VGTPYWMA 218

Query: 444 PE---YGLEGIVSAKCDVYSYGVLLME 467
           PE      EG    K DV+S G+  +E
Sbjct: 219 PEVILAMDEGQYDGKVDVWSLGITCIE 245

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 95.9 bits (239), Expect = 5e-22
 Identities = 56/221 (25%), Positives = 92/221 (41%), Gaps = 41/221 (18%)

Query: 272 DEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRSFDS---ECEVLRNVRH 327
           D++    ++G+ +   V           VAIK  NL  E+   S D    E + +    H
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINL--EKCQTSMDELLKEIQAMSQCHH 72

Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLE---KWLYSHNYFLD-ILERLNIMI---DVGS 380
            N++   +S+   D   LV++ +  GS+    K + +       +L+   I     +V  
Sbjct: 73  PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 132

Query: 381 ALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFG----IYKLLGEGEDSVRQTMTM 436
            LEYLH        IH D+K  NILL E+    ++DFG    +        + VR+T   
Sbjct: 133 GLEYLH----KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF-- 186

Query: 437 ATIG---YMAPE-------YGLEGIVSAKCDVYSYGVLLME 467
             +G   +MAPE       Y        K D++S+G+  +E
Sbjct: 187 --VGTPCWMAPEVMEQVRGYD------FKADIWSFGITAIE 219

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 94.9 bits (237), Expect = 8e-22
 Identities = 55/211 (26%), Positives = 79/211 (37%), Gaps = 47/211 (22%)

Query: 280 LGTSSFGSVYKGT-ISDGTDVAIKVFNL-QLERAFRSFD-----SECEVLRNVRHRNLIK 332
           LG+  F  V K      G + A K     +L  + R         E  +LR +RH N+I 
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72

Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILER--------LNIMIDVGSALEY 384
           +   + N     L+LE +  G L         F  + E+           +  +   + Y
Sbjct: 73  LHDIFENKTDVVLILELVSGGEL---------FDFLAEKESLTEDEATQFLKQILDGVHY 123

Query: 385 LHNGHSSVHIIHCDLKPTNILL----DENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIG 440
           LH    S  I H DLKP NI+L      N    + DFGI   +  G           T  
Sbjct: 124 LH----SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN---EFKNIFGTPE 176

Query: 441 YMAPE------YGLEGIVSAKCDVYSYGVLL 465
           ++APE       GLE       D++S GV+ 
Sbjct: 177 FVAPEIVNYEPLGLE------ADMWSIGVIT 201

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 95.1 bits (237), Expect = 1e-21
 Identities = 58/239 (24%), Positives = 92/239 (38%), Gaps = 50/239 (20%)

Query: 259 WRRTSYLDIQRATD---EFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRS 314
            R    +D+    D    F    L+G  ++G VYKG  +  G   AIKV ++  +     
Sbjct: 8   ARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEE 66

Query: 315 FDSECEVLRNV-RHRNLIKILSSYSNPDFKA------LVLEFMPNGSLEKWLYSHNYFLD 367
              E  +L+    HRN+     ++   +         LV+EF   GS+           D
Sbjct: 67  IKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSV----------TD 116

Query: 368 ILERLN-----------IMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSD 416
           +++              I  ++   L +LH       +IH D+K  N+LL EN    + D
Sbjct: 117 LIKNTKGNTLKEEWIAYICREILRGLSHLH----QHKVIHRDIKGQNVLLTENAEVKLVD 172

Query: 417 FGIYKLLGEGEDSVRQTMTMATIG---YMAPE-----YGLEGIVSAKCDVYSYGVLLME 467
           FG+   L       R T     IG   +MAPE        +     K D++S G+  +E
Sbjct: 173 FGVSAQLDR-TVGRRNTF----IGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIE 226

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 95.0 bits (237), Expect = 1e-21
 Identities = 42/207 (20%), Positives = 84/207 (40%), Gaps = 23/207 (11%)

Query: 268 QRATDEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVR 326
           +   +++     LG   FG V++    S       K   ++          E  +L   R
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ-VLVKKEISILNIAR 59

Query: 327 HRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH 386
           HRN++ +  S+ + +   ++ EF+    + + + +  + L+  E ++ +  V  AL++LH
Sbjct: 60  HRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH 119

Query: 387 NGHSSVHIIHCDLKPTNILL--DENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAP 444
               S +I H D++P NI+     +    + +FG  + L  G+      +      Y AP
Sbjct: 120 ----SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAP 172

Query: 445 E------YGLEGIVSAKCDVYSYGVLL 465
           E                 D++S G L+
Sbjct: 173 EVHQHDVVSTA------TDMWSLGTLV 193

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 95.0 bits (237), Expect = 1e-21
 Identities = 52/211 (24%), Positives = 80/211 (37%), Gaps = 47/211 (22%)

Query: 280 LGTSSFGSVYKGT-ISDGTDVAIKVFN-LQLERAFRSFD-----SECEVLRNVRHRNLIK 332
           LG+  F  V K    S G   A K     + + + R         E  +L+ ++H N+I 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78

Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILER--------LNIMIDVGSALEY 384
           +   Y N     L+LE +  G L         F  + E+           +  + + + Y
Sbjct: 79  LHEVYENKTDVILILELVAGGEL---------FDFLAEKESLTEEEATEFLKQILNGVYY 129

Query: 385 LHNGHSSVHIIHCDLKPTNILL----DENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIG 440
           LH    S+ I H DLKP NI+L           + DFG+   +  G           T  
Sbjct: 130 LH----SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN---EFKNIFGTPE 182

Query: 441 YMAPE------YGLEGIVSAKCDVYSYGVLL 465
           ++APE       GLE       D++S GV+ 
Sbjct: 183 FVAPEIVNYEPLGLE------ADMWSIGVIT 207

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 95.9 bits (239), Expect = 2e-21
 Identities = 63/219 (28%), Positives = 98/219 (44%), Gaps = 33/219 (15%)

Query: 272 DEFNECNLLGTSSFGSVY----KGTISDGTDVAIKVFNLQL---ERAFRSFDSECEVLRN 324
           D F     +G  SFG V       T       A+K  N Q        R+   E ++++ 
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDT---KKMYAMKYMNKQKCVERNEVRNVFKELQIMQG 71

Query: 325 VRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEY 384
           + H  L+ +  S+ + +   +V++ +  G L   L  + +F +   +L I  ++  AL+Y
Sbjct: 72  LEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFIC-ELVMALDY 130

Query: 385 LHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMA-TIGYMA 443
           L     +  IIH D+KP NILLDE+   H++DF I  +L        Q  TMA T  YMA
Sbjct: 131 LQ----NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET----QITTMAGTKPYMA 182

Query: 444 PEYGLEGIVSAKC--------DVYSYGVLLMETFTRKRP 474
           PE     + S++         D +S GV   E    +RP
Sbjct: 183 PE-----MFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 94.7 bits (236), Expect = 2e-21
 Identities = 53/213 (24%), Positives = 87/213 (40%), Gaps = 55/213 (25%)

Query: 279 LLGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRSFDSECEVL-RNVRHRNLIKILSS 336
           +LG    G V +      G   A+K+      +A +    E +   +     +++ IL  
Sbjct: 36  VLGLGVNGKVLECFHRRTGQKCALKLLY-DSPKARQ----EVDHHWQASGGPHIVCILDV 90

Query: 337 YSNPDFKA----LVLEFMPNGSLEKWLYSHNYFLDILERLN----------IMIDVGSAL 382
           Y N         +++E M  G L         F  I ER +          IM D+G+A+
Sbjct: 91  YENMHHGKRCLLIIMECMEGGEL---------FSRIQERGDQAFTEREAAEIMRDIGTAI 141

Query: 383 EYLHNGHSSVHIIHCDLKPTNILL---DENMVAHVSDFGIYKLLGEGEDSVRQTMTMA-T 438
           ++LH    S +I H D+KP N+L    +++ V  ++DFG  K   +         T   T
Sbjct: 142 QFLH----SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA-----LQTPCYT 192

Query: 439 IGYMAPE------YGLEGIVSAKCDVYSYGVLL 465
             Y+APE      Y         CD++S GV++
Sbjct: 193 PYYVAPEVLGPEKYDKS------CDMWSLGVIM 219

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 94.2 bits (235), Expect = 2e-21
 Identities = 46/209 (22%), Positives = 72/209 (34%), Gaps = 45/209 (21%)

Query: 280 LGTSSFGSVYKGT-ISDGTDVAIKVFN--LQLERAFRSFDSECEVLRNVRHR-NLIKILS 335
           LG   F  V +    S G + A K      + +        E  VL   +    +I +  
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96

Query: 336 SYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERL----------NIMIDVGSALEYL 385
            Y N     L+LE+   G +         F   L  L           ++  +   + YL
Sbjct: 97  VYENTSEIILILEYAAGGEI---------FSLCLPELAEMVSENDVIRLIKQILEGVYYL 147

Query: 386 HNGHSSVHIIHCDLKPTNILL---DENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYM 442
           H      +I+H DLKP NILL          + DFG+ + +G           M T  Y+
Sbjct: 148 H----QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC---ELREIMGTPEYL 200

Query: 443 APE------YGLEGIVSAKCDVYSYGVLL 465
           APE                 D+++ G++ 
Sbjct: 201 APEILNYDPITTA------TDMWNIGIIA 223

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 93.5 bits (233), Expect = 3e-21
 Identities = 51/210 (24%), Positives = 81/210 (38%), Gaps = 41/210 (19%)

Query: 279 LLGTSSFGSVYKGT-ISDGTDVAIKVFN----LQLERAFRSFDSECEVLRNVRHRNLIKI 333
           LLG  S+G V +          A+K+       ++     +   E ++LR +RH+N+I++
Sbjct: 12  LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71

Query: 334 LS--SYSNPDFKALVLEFMPNGSLEKWLY----------SHNYFLDILERLNIMIDVGSA 381
           +            +V+E+   G  E              +H YF  ++            
Sbjct: 72  VDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLI----------DG 121

Query: 382 LEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATI-- 439
           LEYLH    S  I+H D+KP N+LL       +S  G    + E         T  T   
Sbjct: 122 LEYLH----SQGIVHKDIKPGNLLLTTGGTLKISALG----VAEALHPFAADDTCRTSQG 173

Query: 440 --GYMAPE--YGLEGIVSAKCDVYSYGVLL 465
              +  PE   GL+     K D++S GV L
Sbjct: 174 SPAFQPPEIANGLDTFSGFKVDIWSAGVTL 203

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 93.0 bits (231), Expect = 7e-21
 Identities = 55/281 (19%), Positives = 91/281 (32%), Gaps = 75/281 (26%)

Query: 269 RATDEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNL-QLERAFRSFDSECEVLRNVR 326
           R   +F     +G   FG V++     D  + AIK   L   E A      E + L  + 
Sbjct: 3   RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 62

Query: 327 HRNLIKILSSY-----------------------------------------SNPDFKAL 345
           H  +++  +++                                          +P     
Sbjct: 63  HPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKN 122

Query: 346 VLEFMPNGSLEKWLY------------------SHNYFLDILERLNIMIDVGSALEYLHN 387
            +  +   S + +LY                        +    L+I I +  A+E+LH 
Sbjct: 123 TVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH- 181

Query: 388 GHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMA---------- 437
              S  ++H DLKP+NI    + V  V DFG+   + + E+       M           
Sbjct: 182 ---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG 238

Query: 438 TIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEM 478
           T  YM+PE       S K D++S G++L E         E 
Sbjct: 239 TKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER 279

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 92.7 bits (231), Expect = 8e-21
 Identities = 31/164 (18%), Positives = 57/164 (34%), Gaps = 23/164 (14%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFS 61
           + +T++   L   LP T+      +E L L  N L   +P SI +  +L  L +      
Sbjct: 107 QHMTIDAAGLM-ELPDTMQQ-FAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPEL 163

Query: 62  GHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLVLTVLDVSRNQLSGDIPSTIGG 121
             +     +         L        N           L  L +    +   +P++I  
Sbjct: 164 TELPEPLASTDASGEHQGL-------VN-----------LQSLRLEWTGIR-SLPASIAN 204

Query: 122 RVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPK 165
             +L++L + ++     +  ++  L  LE LDL G       P 
Sbjct: 205 LQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPP 247

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 83.8 bits (208), Expect = 8e-18
 Identities = 34/183 (18%), Positives = 56/183 (30%), Gaps = 23/183 (12%)

Query: 2   RILTLEGNQLSGRLPSTIG--------HSLPNIEYLLLTANNLTGTIPNSITNATKLIVL 53
           R L++        LP  +           L N++ L L    +  ++P SI N   L  L
Sbjct: 153 RELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSL 211

Query: 54  DLGFNSFSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLV----LTVLDVS-R 108
            +  +  S  +     +L  L  L L        G       PP       L  L +   
Sbjct: 212 KIRNSPLS-ALGPAIHHLPKLEELDL-------RGCTALRNYPPIFGGRAPLKRLILKDC 263

Query: 109 NQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKLEG 168
           + L   +P  I     LE L L        +P  +  L +   + +  +  +        
Sbjct: 264 SNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPV 322

Query: 169 EIP 171
             P
Sbjct: 323 ARP 325

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 72.3 bits (178), Expect = 6e-14
 Identities = 26/168 (15%), Positives = 51/168 (30%), Gaps = 18/168 (10%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFS 61
             L  +G+         +       +       N          N+    +      +  
Sbjct: 15  ENLYFQGSTALRPYHDVLS----QWQRHYNADRNRW-HSAWRQANSNNPQIETRTGRALK 69

Query: 62  GHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLV----LTVLDVSRNQLSGDIPS 117
               +   +      ++L      L    L  + P        L  + +    L  ++P 
Sbjct: 70  -ATADLLEDATQPGRVALE-----LRSVPL-PQFPDQAFRLSHLQHMTIDAAGLM-ELPD 121

Query: 118 TIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPK 165
           T+     LETL+LA N  +  +P S+ SL  L  L +       ++P+
Sbjct: 122 TMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELTELPE 168

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 58.4 bits (142), Expect = 2e-09
 Identities = 17/142 (11%), Positives = 39/142 (27%), Gaps = 22/142 (15%)

Query: 38  GTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSL-------------LMFGI 84
           G+  +   +++    L    ++      +     +                         
Sbjct: 2   GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIE 61

Query: 85  RLTGNKLYGRIPPCL------VLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGP 138
             TG  L       L          L++    L    P        L+ +++ +      
Sbjct: 62  TRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLME- 118

Query: 139 IPESVGSLISLESLDLSGNNLS 160
           +P+++     LE+L L+ N L 
Sbjct: 119 LPDTMQQFAGLETLTLARNPLR 140

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 92.5 bits (230), Expect = 3e-20
 Identities = 51/215 (23%), Positives = 84/215 (39%), Gaps = 60/215 (27%)

Query: 280 LGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRSFDSECEVLRNV-RHRNLIKILSSY 337
           LG    G V +          A+K+      +A R    E E+     +  ++++I+  Y
Sbjct: 70  LGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARR----EVELHWRASQCPHIVRIVDVY 124

Query: 338 SNPDFKA----LVLEFMPNGSLEKWLYSHNYFLDILERLN----------IMIDVGSALE 383
            N         +V+E +  G L         F  I +R +          IM  +G A++
Sbjct: 125 ENLYAGRKCLLIVMECLDGGEL---------FSRIQDRGDQAFTEREASEIMKSIGEAIQ 175

Query: 384 YLHNGHSSVHIIHCDLKPTNILL---DENMVAHVSDFGIYKLLGEGEDSVRQTMTMATI- 439
           YLH    S++I H D+KP N+L      N +  ++DFG  K             ++ T  
Sbjct: 176 YLH----SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-------SLTTPC 224

Query: 440 ---GYMAPE------YGLEGIVSAKCDVYSYGVLL 465
               Y+APE      Y         CD++S GV++
Sbjct: 225 YTPYYVAPEVLGPEKYDKS------CDMWSLGVIM 253

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 89.2 bits (222), Expect = 5e-20
 Identities = 48/233 (20%), Positives = 86/233 (36%), Gaps = 44/233 (18%)

Query: 279 LLGTSSFGSVYKGT-ISDGTDVAIKVFNLQ-----LERAFRSFDSECEVLRNVRHRNLIK 332
            LG  ++G V           VA+K+ +++      E   +    E  + + + H N++K
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK----EICINKMLNHENVVK 69

Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWLYSH---------NYFLDILERLNIMIDVGSALE 383
                   + + L LE+   G L   +             +F  ++          + + 
Sbjct: 70  FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----------AGVV 119

Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           YLH     + I H D+KP N+LLDE     +SDFG+  +               T+ Y+A
Sbjct: 120 YLH----GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175

Query: 444 PEYGLEGIVS------AKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVK 490
           PE     ++          DV+S G++L      + P D+          W +
Sbjct: 176 PE-----LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE 223

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 93.0 bits (231), Expect = 6e-20
 Identities = 42/161 (26%), Positives = 67/161 (41%), Gaps = 27/161 (16%)

Query: 1   MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSF 60
           +  L    NQL+  LP         ++ L ++ N L  ++P   +   KL   +    S 
Sbjct: 163 LCKLWAYNNQLT-SLPMLPS----GLQELSVSDNQLA-SLPTLPSELYKLWAYNNRLTSL 216

Query: 61  SGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLV-LTVLDVSRNQLSGDIPSTI 119
                     L+ L           ++GN+L   +P     L  L VS N+L+  +P   
Sbjct: 217 PALP----SGLKELI----------VSGNRL-TSLPVLPSELKELMVSGNRLT-SLPMLP 260

Query: 120 GGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLS 160
            G   L +LS+  NQ    +PES+  L S  +++L GN LS
Sbjct: 261 SG---LLSLSVYRNQLTR-LPESLIHLSSETTVNLEGNPLS 297

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 84.6 bits (209), Expect = 3e-17
 Identities = 39/175 (22%), Positives = 67/175 (38%), Gaps = 23/175 (13%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFS 61
             L +  N L+  LP+        +  L ++ N LT ++P       +L +         
Sbjct: 64  TTLVIPDNNLT-SLPALPP----ELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLP 117

Query: 62  GHI-----LNTFGNLRHLSVLSLLMFGIR---LTGNKLYGRIPPCLV-LTVLDVSRNQLS 112
                   L  FGN   L+ L +L  G++   ++ N+L   +P     L  L    NQL+
Sbjct: 118 ALPSGLCKLWIFGN--QLTSLPVLPPGLQELSVSDNQL-ASLPALPSELCKLWAYNNQLT 174

Query: 113 GDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKLE 167
             +P    G   L+ LS++ NQ    +P     L  L + +    +L      L+
Sbjct: 175 -SLPMLPSG---LQELSVSDNQLAS-LPTLPSELYKLWAYNNRLTSLPALPSGLK 224

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 57.2 bits (138), Expect = 1e-08
 Identities = 19/84 (22%), Positives = 32/84 (38%), Gaps = 8/84 (9%)

Query: 86  LTGNKLYGRIPPCLV--LTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESV 143
           +  + L   +P CL   +T L +  N L+  +P+       L TL ++ NQ    +P   
Sbjct: 47  VGESGL-TTLPDCLPAHITTLVIPDNNLT-SLPALPPE---LRTLEVSGNQLTS-LPVLP 100

Query: 144 GSLISLESLDLSGNNLSGKIPKLE 167
             L+ L        +L      L 
Sbjct: 101 PGLLELSIFSNPLTHLPALPSGLC 124

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 48.4 bits (115), Expect = 5e-06
 Identities = 21/138 (15%), Positives = 46/138 (33%), Gaps = 10/138 (7%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFS 61
           + L + GN+L+  LP         +  L +  N LT  +P S+ + +    ++L  N  S
Sbjct: 244 KELMVSGNRLT-SLPMLPS----GLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLS 297

Query: 62  GHILNTFGNLRHLSVLS---LLMFGIRLTGNKLYGRIPPCLVLTVLDVSRNQLSG-DIPS 117
              L     +      S   +       +  +    +       ++     + +  D   
Sbjct: 298 ERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEPAPADRWH 357

Query: 118 TIGGRVDLETLSLASNQF 135
             G   + +  SL  ++ 
Sbjct: 358 MFGQEDNADAFSLFLDRL 375

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 89.3 bits (222), Expect = 1e-19
 Identities = 48/233 (20%), Positives = 86/233 (36%), Gaps = 44/233 (18%)

Query: 279 LLGTSSFGSVYKGT-ISDGTDVAIKVFNLQ-----LERAFRSFDSECEVLRNVRHRNLIK 332
            LG  ++G V           VA+K+ +++      E   +    E  + + + H N++K
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK----EICINKMLNHENVVK 69

Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWLYSH---------NYFLDILERLNIMIDVGSALE 383
                   + + L LE+   G L   +             +F  ++          + + 
Sbjct: 70  FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----------AGVV 119

Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           YLH     + I H D+KP N+LLDE     +SDFG+  +               T+ Y+A
Sbjct: 120 YLH----GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175

Query: 444 PEYGLEGIVS------AKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVK 490
           PE     ++          DV+S G++L      + P D+          W +
Sbjct: 176 PE-----LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE 223

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 91.0 bits (226), Expect = 2e-19
 Identities = 59/230 (25%), Positives = 91/230 (39%), Gaps = 37/230 (16%)

Query: 272 DEFNECNLLGTSSFGSVY----KGTISDGTDVAIKVFNLQLERAFRSFDSEC-----EVL 322
           + F +  +LG   FG V     + T   G   A K   L+ +R  +           ++L
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRAT---GKMYACKK--LEKKRIKKRKGEAMALNEKQIL 238

Query: 323 RNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMI-DVGSA 381
             V  R ++ +  +Y   D   LVL  M  G L+  +Y          R      ++   
Sbjct: 239 EKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCG 298

Query: 382 LEYLHNGHSSVHIIHCDLKPTNILLDENMVAHV--SDFGIYKLLGEGEDSVRQTMTMA-T 438
           LE LH       I++ DLKP NILLD++   H+  SD G+   + EG+           T
Sbjct: 299 LEDLH----RERIVYRDLKPENILLDDH--GHIRISDLGLAVHVPEGQ----TIKGRVGT 348

Query: 439 IGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT---------RKRPTDEMF 479
           +GYMAPE       +   D ++ G LL E            +K   +E+ 
Sbjct: 349 VGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE 398

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 87.7 bits (218), Expect = 2e-19
 Identities = 56/229 (24%), Positives = 92/229 (40%), Gaps = 60/229 (26%)

Query: 279 LLGTSSFGSVYKGT-ISDGTDVAIKVFN---LQLERAFRSFDS----------------- 317
            +G  S+G V      +D T  A+KV +   L  +  F                      
Sbjct: 20  EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79

Query: 318 ------ECEVLRNVRHRNLIKILSSYSNPDFKAL--VLEFMPNGSL----------EKWL 359
                 E  +L+ + H N++K++    +P+   L  V E +  G +          E   
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSED-- 137

Query: 360 YSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGI 419
            +  YF D++            +EYLH       IIH D+KP+N+L+ E+    ++DFG+
Sbjct: 138 QARFYFQDLI----------KGIEYLH----YQKIIHRDIKPSNLLVGEDGHIKIADFGV 183

Query: 420 YKLLGEGEDSVRQTMTMATIGYMAPE--YGLEGIVS-AKCDVYSYGVLL 465
                +G D++    T+ T  +MAPE       I S    DV++ GV L
Sbjct: 184 SNEF-KGSDALLSN-TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 90.7 bits (225), Expect = 3e-19
 Identities = 54/232 (23%), Positives = 90/232 (38%), Gaps = 41/232 (17%)

Query: 272 DEFNECNLLGTSSFGSVY----KGTISDGTDVAIKVFNLQLERAFRSFDSEC-------- 319
           ++F+   ++G   FG VY      T   G   A+K   L  +R                 
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADT---GKMYAMKC--LDKKRIKMKQGETLALNERIML 243

Query: 320 EVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVG 379
            ++       ++ +  ++  PD  + +L+ M  G L   L  H  F +   R     ++ 
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAA-EII 302

Query: 380 SALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHV--SDFGIYKLLGEGEDSVRQTMTMA 437
             LE++H    +  +++ DLKP NILLDE+   HV  SD G+     +      +     
Sbjct: 303 LGLEHMH----NRFVVYRDLKPANILLDEH--GHVRISDLGLACDFSKK-----KPHASV 351

Query: 438 -TIGYMAPEYGLEGIVSAKC-DVYSYGVLLMETFTRKRP--------TDEMF 479
            T GYMAPE   +G+      D +S G +L +      P          E+ 
Sbjct: 352 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 403

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 89.6 bits (222), Expect = 5e-19
 Identities = 38/165 (23%), Positives = 61/165 (36%), Gaps = 28/165 (16%)

Query: 1   MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSF 60
           +  L    N+LS  LP        ++++L +  N LT  +P        L  ++   N  
Sbjct: 102 LEYLDACDNRLS-TLPELPA----SLKHLDVDNNQLT-MLPELPAL---LEYINADNNQL 152

Query: 61  SGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLV-LTVLDVSRNQLSGDIPSTI 119
           +  +     +L  LS          +  N+L   +P     L  LDVS N L   +P+  
Sbjct: 153 T-MLPELPTSLEVLS----------VRNNQL-TFLPELPESLEALDVSTNLLE-SLPAVP 199

Query: 120 GGRVDLET----LSLASNQFQGPIPESVGSLISLESLDLSGNNLS 160
                 E          N+    IPE++ SL    ++ L  N LS
Sbjct: 200 VRNHHSEETEIFFRCRENRITH-IPENILSLDPTCTIILEDNPLS 243

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 85.4 bits (211), Expect = 1e-17
 Identities = 42/174 (24%), Positives = 63/174 (36%), Gaps = 30/174 (17%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFS 61
             L L    LS  LP  +    P I  L +T N L  ++P    +   L  LD   N  S
Sbjct: 62  SELQLNRLNLS-SLPDNLP---PQITVLEITQNALI-SLPELPAS---LEYLDACDNRLS 113

Query: 62  GHILNTFGNLRHLSV----LSLLMFGI------RLTGNKLYGRIPPCLV-LTVLDVSRNQ 110
             +     +L+HL V    L++L              N+L   +P     L VL V  NQ
Sbjct: 114 -TLPELPASLKHLDVDNNQLTMLPELPALLEYINADNNQL-TMLPELPTSLEVLSVRNNQ 171

Query: 111 LSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLES----LDLSGNNLS 160
           L+  +P        LE L +++N  +  +P         E          N ++
Sbjct: 172 LT-FLPELPES---LEALDVSTNLLES-LPAVPVRNHHSEETEIFFRCRENRIT 220

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 61.1 bits (148), Expect = 6e-10
 Identities = 29/140 (20%), Positives = 48/140 (34%), Gaps = 26/140 (18%)

Query: 29  LLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLMFGIRLTG 88
           ++L  NN      NS  N       D           + +      ++            
Sbjct: 3   IMLPINNNFSLSQNSFYNTISGTYADY---------FSAWDKWEKQALPGEN-------R 46

Query: 89  NKLYGRIPPCLV--LTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSL 146
           N+    +  CL+   + L ++R  LS  +P  +     +  L +  N     +PE   SL
Sbjct: 47  NEAVSLLKECLINQFSELQLNRLNLS-SLPDNLP--PQITVLEITQNALI-SLPELPASL 102

Query: 147 ISLESLDLSGNNLSGKIPKL 166
              E LD   N LS  +P+L
Sbjct: 103 ---EYLDACDNRLS-TLPEL 118

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 49.6 bits (118), Expect = 2e-06
 Identities = 26/170 (15%), Positives = 49/170 (28%), Gaps = 11/170 (6%)

Query: 1   MRILTLEGNQLSGRLPSTIG---HSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGF 57
           +  L +  N L   LP+      HS     +     N +T  IP +I +      + L  
Sbjct: 182 LEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILED 239

Query: 58  NSFSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLVLTVLDVSRNQLSGDIPS 117
           N  S  I  +               G R+  +   G+        + D        +  S
Sbjct: 240 NPLSSRIRESLSQQTAQP----DYHGPRIYFSMSDGQQNTL-HRPLADAVTAWFPENKQS 294

Query: 118 TIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKLE 167
            +            +N F     + +   +S  +       ++  + KL 
Sbjct: 295 DVSQIWHAFEHEEHANTFSA-FLDRLSDTVSARNTSGFREQVAAWLEKLS 343

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 87.5 bits (217), Expect = 5e-19
 Identities = 56/202 (27%), Positives = 86/202 (42%), Gaps = 29/202 (14%)

Query: 280 LGTSSFGSVYKGT-ISDGTDVAIKVFN------------LQLERAFRSFDSECEVLRNVR 326
           LG+ +FG V+         +V +K                +L +       E  +L  V 
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTL----EIAILSRVE 87

Query: 327 HRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLY-SHNYFLDILERLNIMIDVGSALEYL 385
           H N+IK+L  + N  F  LV+E   +G L+ + +   +  LD      I   + SA+ YL
Sbjct: 88  HANIIKVLDIFENQGFFQLVMEKHGSG-LDLFAFIDRHPRLDEPLASYIFRQLVSAVGYL 146

Query: 386 HNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPE 445
                   IIH D+K  NI++ E+    + DFG    L  G+  +  T    TI Y APE
Sbjct: 147 R----LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK--LFYT-FCGTIEYCAPE 199

Query: 446 YGLEGI--VSAKCDVYSYGVLL 465
             L G      + +++S GV L
Sbjct: 200 V-LMGNPYRGPELEMWSLGVTL 220

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 86.1 bits (214), Expect = 6e-19
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 55/213 (25%)

Query: 279 LLGTSSFGSVYKGT-ISDGTDVAIKVFNLQ-------LERAFRSFDSECEVLRNVRHRNL 330
            LG  +FG V  G     G  VA+K+ N Q       + +  R    E + L+  RH ++
Sbjct: 18  TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKR----EIQNLKLFRHPHI 73

Query: 331 IKILSSYSNPDFKALVLEFMPNGSLEKWLYSH---------NYFLDILERLNIMIDVGSA 381
           IK+    S P    +V+E++  G L  ++  H           F  IL          SA
Sbjct: 74  IKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQIL----------SA 123

Query: 382 LEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIG- 440
           ++Y H       ++H DLKP N+LLD +M A ++DFG+  ++ +GE          + G 
Sbjct: 124 VDYCH----RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE------FLRTSCGS 173

Query: 441 --YMAPEYGLEGIVS------AKCDVYSYGVLL 465
             Y APE     ++S       + D++S GV+L
Sbjct: 174 PNYAAPE-----VISGRLYAGPEVDIWSCGVIL 201

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 87.2 bits (217), Expect = 7e-19
 Identities = 44/167 (26%), Positives = 72/167 (43%), Gaps = 20/167 (11%)

Query: 1   MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSF 60
           +  L+L  NQ+     S +   L ++ Y     N +T   P  + N T+L  L +G N  
Sbjct: 179 LYSLSLNYNQIED--ISPLAS-LTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKI 233

Query: 61  SGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPP---CLVLTVLDVSRNQLSGDIPS 117
           +   L+   NL  L+ L +         N++   I        L +L+V  NQ+S    S
Sbjct: 234 TD--LSPLANLSQLTWLEI-------GTNQI-SDINAVKDLTKLKMLNVGSNQISD--IS 281

Query: 118 TIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIP 164
            +     L +L L +NQ      E +G L +L +L LS N+++   P
Sbjct: 282 VLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP 328

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 85.3 bits (212), Expect = 4e-18
 Identities = 37/162 (22%), Positives = 68/162 (41%), Gaps = 20/162 (12%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFS 61
              T   NQ++    + + + +  +  L +  N +T   P  + N ++L  L++G N  S
Sbjct: 202 HYFTAYVNQITD--ITPVAN-MTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQIS 256

Query: 62  GHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPP---CLVLTVLDVSRNQLSGDIPST 118
              +N   +L  L +L++         N++   I        L  L ++ NQL  +    
Sbjct: 257 D--INAVKDLTKLKMLNV-------GSNQISD-ISVLNNLSQLNSLFLNNNQLGNEDMEV 306

Query: 119 IGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLS 160
           IGG  +L TL L+ N      P  + SL  ++S D +   + 
Sbjct: 307 IGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 80.7 bits (200), Expect = 1e-16
 Identities = 29/171 (16%), Positives = 62/171 (36%), Gaps = 24/171 (14%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFS 61
               L+   ++     T    L +I  L++    +  +I   I   T L  L+L  N  +
Sbjct: 25  IRAVLQKASVTD--VVTQEE-LESITKLVVAGEKVA-SIQG-IEYLTNLEYLNLNGNQIT 79

Query: 62  GHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLV----LTVLDVSRNQLSGDIPS 117
              ++   NL  L+ L +         NK+       L     L  L ++ + +S DI  
Sbjct: 80  D--ISPLSNLVKLTNLYI-------GTNKI--TDISALQNLTNLRELYLNEDNIS-DISP 127

Query: 118 TIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKLEG 168
            +     + +L+L +N         + ++  L  L ++ + +   +  +  
Sbjct: 128 -LANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESKVK-DVTPIAN 175

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 79.9 bits (198), Expect = 2e-16
 Identities = 35/167 (20%), Positives = 66/167 (39%), Gaps = 22/167 (13%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFS 61
             LT+  +++     + I + L ++  L L  N +    P  + + T L       N  +
Sbjct: 158 NYLTVTESKVKD--VTPIAN-LTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQIT 212

Query: 62  GHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPP---CLVLTVLDVSRNQLSGDIPST 118
              +    N+  L+ L +         NK+   + P      LT L++  NQ+S    + 
Sbjct: 213 D--ITPVANMTRLNSLKI-------GNNKITD-LSPLANLSQLTWLEIGTNQISD--INA 260

Query: 119 IGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPK 165
           +     L+ L++ SNQ        + +L  L SL L+ N L  +  +
Sbjct: 261 VKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDME 305

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 71.0 bits (175), Expect = 2e-13
 Identities = 29/168 (17%), Positives = 57/168 (33%), Gaps = 22/168 (13%)

Query: 4   LTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGH 63
           L      ++   P      L      +L   ++T  +         +  L +     +  
Sbjct: 5   LATLPAPINQIFPDA---DLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVAS- 58

Query: 64  ILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPP---CLVLTVLDVSRNQLSGDIPSTIG 120
            +     L +L  L+L        GN++   I P    + LT L +  N+++    S + 
Sbjct: 59  -IQGIEYLTNLEYLNL-------NGNQITD-ISPLSNLVKLTNLYIGTNKIT--DISALQ 107

Query: 121 GRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKLEG 168
              +L  L L  +      P  + +L  + SL+L  N+    +  L  
Sbjct: 108 NLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLSPLSN 153

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 88.3 bits (219), Expect = 1e-18
 Identities = 60/232 (25%), Positives = 92/232 (39%), Gaps = 38/232 (16%)

Query: 272 DEFNECNLLGTSSFGSVY----KGTISDGTDVAIKVFNLQLERAFRSFDSEC-----EVL 322
           D F +  +LG   FG V+    K T   G   A K   L  +R  +    +      ++L
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKAT---GKLYACKK--LNKKRLKKRKGYQGAMVEKKIL 239

Query: 323 RNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDIL--ERLNIMI-DVG 379
             V  R ++ +  ++       LV+  M  G +   +Y+ +         R       + 
Sbjct: 240 AKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIV 299

Query: 380 SALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHV--SDFGIYKLLGEGEDSVRQTMTMA 437
           S LE+LH      +II+ DLKP N+LLD++   +V  SD G+   L  G+     T   A
Sbjct: 300 SGLEHLH----QRNIIYRDLKPENVLLDDD--GNVRISDLGLAVELKAGQTK---TKGYA 350

Query: 438 -TIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT---------RKRPTDEMF 479
            T G+MAPE  L        D ++ GV L E             K    E+ 
Sbjct: 351 GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK 402

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 88.2 bits (219), Expect = 1e-18
 Identities = 41/165 (24%), Positives = 61/165 (36%), Gaps = 15/165 (9%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSI-TNATKLIVLDLGFNSF 60
           + L L  N +   + S     L  +E+L    +NL      S+  +   LI LD+     
Sbjct: 376 KYLDLSFNGVI-TMSSNF-LGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHT 433

Query: 61  SGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCL-----VLTVLDVSRNQLSGDI 115
                  F  L  L VL +        GN       P +      LT LD+S+ QL    
Sbjct: 434 RVAFNGIFNGLSSLEVLKM-------AGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLS 486

Query: 116 PSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLS 160
           P+       L+ L++ASNQ +         L SL+ + L  N   
Sbjct: 487 PTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 531

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 87.1 bits (216), Expect = 3e-18
 Identities = 44/192 (22%), Positives = 66/192 (34%), Gaps = 28/192 (14%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFS 61
           + L L  N L   L S    S P ++ L L+   +      +  + + L  L L  N   
Sbjct: 31  KNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89

Query: 62  GHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLV-----LTVLDVSRNQL-SGDI 115
              L  F  L  L  L             L   +    +     L  L+V+ N + S  +
Sbjct: 90  SLALGAFSGLSSLQKL-------VAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKL 141

Query: 116 PSTIGGRVDLETLSLASNQFQGPIPESVGSLISLE----SLDLSGNNLSGKIPKLEGEIP 171
           P       +LE L L+SN+ Q      +  L  +     SLDLS N ++         I 
Sbjct: 142 PEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN--------FIQ 193

Query: 172 VKGSFKNFSTES 183
             G+FK      
Sbjct: 194 -PGAFKEIRLHK 204

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 86.3 bits (214), Expect = 6e-18
 Identities = 31/174 (17%), Positives = 59/174 (33%), Gaps = 20/174 (11%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFS 61
           ++L L   ++   +      SL ++  L+LT N +      + +  + L  L     + +
Sbjct: 55  QVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLA 113

Query: 62  GHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLV------LTVLDVSRNQLSGDI 115
                  G+L+ L  L++         N +               L  LD+S N++    
Sbjct: 114 SLENFPIGHLKTLKELNV-------AHNLI-QSFKLPEYFSNLTNLEHLDLSSNKIQSIY 165

Query: 116 PSTIGG----RVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPK 165
            + +       +   +L L+ N     I       I L  L L  N  S  + K
Sbjct: 166 CTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMK 218

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 72.1 bits (177), Expect = 2e-13
 Identities = 34/171 (19%), Positives = 56/171 (32%), Gaps = 21/171 (12%)

Query: 1   MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFN-- 58
            + L L   +   + P+     L +++ L  T+N        S  +   L  LDL  N  
Sbjct: 306 WQHLELVNCKFG-QFPT---LKLKSLKRLTFTSNKGGN--AFSEVDLPSLEFLDLSRNGL 359

Query: 59  SFSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLV----LTVLDVSRNQLSG- 113
           SF G    +      L  L        L+ N +   +    +    L  LD   + L   
Sbjct: 360 SFKGCCSQSDFGTTSLKYL-------DLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQM 411

Query: 114 DIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIP 164
              S      +L  L ++    +         L SLE L ++GN+      
Sbjct: 412 SEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFL 462

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 71.7 bits (176), Expect = 3e-13
 Identities = 28/135 (20%), Positives = 49/135 (36%), Gaps = 16/135 (11%)

Query: 31  LTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLMFGIRLTGNK 90
               N    IP+++  +TK   LDL FN        +F +   L VL L       +  +
Sbjct: 14  CMELNFY-KIPDNLPFSTK--NLDLSFNPLRHLGSYSFFSFPELQVLDL-------SRCE 63

Query: 91  LYGRIPP----CLV-LTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGS 145
           +   I       L  L+ L ++ N +         G   L+ L              +G 
Sbjct: 64  I-QTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGH 122

Query: 146 LISLESLDLSGNNLS 160
           L +L+ L+++ N + 
Sbjct: 123 LKTLKELNVAHNLIQ 137

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 68.6 bits (168), Expect = 3e-12
 Identities = 31/167 (18%), Positives = 49/167 (29%), Gaps = 23/167 (13%)

Query: 1   MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSF 60
           +   +L    +      +      ++E +             S      L  L    N  
Sbjct: 284 VSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKS------LKRLTFTSNKG 337

Query: 61  SGHILNTFGNLRHLSVLSLLMFGIRLTGNKLY--GRIPPCLV----LTVLDVSRNQLSGD 114
                 +  +L  L  L        L+ N L   G           L  LD+S N +   
Sbjct: 338 GN--AFSEVDLPSLEFLD-------LSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-T 387

Query: 115 IPSTIGGRVDLETLSLASNQFQGPIPESV-GSLISLESLDLSGNNLS 160
           + S   G   LE L    +  +     SV  SL +L  LD+S  +  
Sbjct: 388 MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR 434

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 64.7 bits (158), Expect = 4e-11
 Identities = 38/186 (20%), Positives = 62/186 (33%), Gaps = 29/186 (15%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLT------ANNLTGTIPNSITNATKLIVLDL 55
             LTL  N  S  +  T    L  +E   L         NL     +++     L + + 
Sbjct: 203 HKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEF 262

Query: 56  ---GFNSFSGHILNTFGNLRHLSVLSL----------LMFGIRLTGNKLYGRIPPCL--- 99
                + +   I++ F  L ++S  SL            +       +L           
Sbjct: 263 RLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTL 322

Query: 100 ---VLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQ--FQGPIPESVGSLISLESLDL 154
               L  L  + N+   +  S +     LE L L+ N   F+G   +S     SL+ LDL
Sbjct: 323 KLKSLKRLTFTSNKGG-NAFSEVDLP-SLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDL 380

Query: 155 SGNNLS 160
           S N + 
Sbjct: 381 SFNGVI 386

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 59.3 bits (144), Expect = 2e-09
 Identities = 27/139 (19%), Positives = 48/139 (34%), Gaps = 24/139 (17%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFS 61
             L  + + L      ++  SL N+ YL ++  +            + L VL +  NSF 
Sbjct: 399 EHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQ 458

Query: 62  GHIL-NTFGNLRHLSVLSL----------LMFG-------IRLTGNKLYGRIPPCLV--- 100
            + L + F  LR+L+ L L            F        + +  N+L   +P  +    
Sbjct: 459 ENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLK-SVPDGIFDRL 517

Query: 101 --LTVLDVSRNQLSGDIPS 117
             L  + +  N      P 
Sbjct: 518 TSLQKIWLHTNPWDCSCPR 536

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 56.6 bits (137), Expect = 1e-08
 Identities = 31/168 (18%), Positives = 54/168 (32%), Gaps = 13/168 (7%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLT---ANNLTGTIPNSITNATKLIVLDLGFN 58
             L L  N++   +  T    L  +  L L+   + N    I        +L  L L  N
Sbjct: 152 EHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNN 210

Query: 59  SFSGHIL-NTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLVLTVLDVSRNQLSG---- 113
             S +++      L  L V  L++   R  GN           L  L +   +L+     
Sbjct: 211 FDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYY 270

Query: 114 --DIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNL 159
             DI        ++ + SL S   +  + +        + L+L     
Sbjct: 271 LDDIIDLFNCLTNVSSFSLVSVTIER-VKDFSY-NFGWQHLELVNCKF 316

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 87.9 bits (218), Expect = 1e-18
 Identities = 58/214 (27%), Positives = 94/214 (43%), Gaps = 57/214 (26%)

Query: 279 LLGTSSFGSVYKGT-ISDGTDVAIKVFNLQ-------LERAFRSFDSECEVLRNVRHRNL 330
            LG  +FG V  G     G  VA+K+ N Q       + +  R    E + L+  RH ++
Sbjct: 23  TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRR----EIQNLKLFRHPHI 78

Query: 331 IKILSSYSNPDFKALVLEFMPNGSLEKWLYSH---------NYFLDILERLNIMIDVGSA 381
           IK+    S P    +V+E++  G L  ++  +           F  IL          S 
Sbjct: 79  IKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQIL----------SG 128

Query: 382 LEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATI-- 439
           ++Y H       ++H DLKP N+LLD +M A ++DFG+  ++ +GE        + T   
Sbjct: 129 VDYCH----RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-------FLRTSCG 177

Query: 440 --GYMAPEYGLEGIVS------AKCDVYSYGVLL 465
              Y APE     ++S       + D++S GV+L
Sbjct: 178 SPNYAAPE-----VISGRLYAGPEVDIWSSGVIL 206

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 87.1 bits (216), Expect = 2e-18
 Identities = 62/270 (22%), Positives = 108/270 (40%), Gaps = 63/270 (23%)

Query: 232 ITIIMYIRCRNRNTKKSDH-EDFLPLAIWRRTSYLDIQRATDEFNECNLLGTSSFGSVY- 289
           I I +Y  C N   ++  +  ++L  A    +    ++   ++F    ++G  +FG V  
Sbjct: 33  ILICLYDECNNSPLRREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAV 92

Query: 290 ---KGTISDGTDVAIKVFN----LQL-ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPD 341
              K         A+K+ N    L+  E A   F  E +VL N   + +  +  ++ + +
Sbjct: 93  VKLKNA---DKVFAMKILNKWEMLKRAETAC--FREERDVLVNGDSKWITTLHYAFQDDN 147

Query: 342 FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMID----------VGSALEYLHNGHSS 391
              LV+++   G L     +       L +    +           +  A++ +H     
Sbjct: 148 NLYLVMDYYVGGDL----LTL------LSKFEDRLPEEMARFYLAEMVIAIDSVH----Q 193

Query: 392 VHIIHCDLKPTNILLDENMVAHV--SDFGIYKLLGEGEDSVRQTMTM-ATIGYMAPE--- 445
           +H +H D+KP NIL+D N   H+  +DFG    L   ED   Q+     T  Y++PE   
Sbjct: 194 LHYVHRDIKPDNILMDMN--GHIRLADFGSCLKL--MEDGTVQSSVAVGTPDYISPEILQ 249

Query: 446 --------YGLEGIVSAKCDVYSYGVLLME 467
                   YG E      CD +S GV + E
Sbjct: 250 AMEGGKGRYGPE------CDWWSLGVCMYE 273

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 85.4 bits (212), Expect = 2e-18
 Identities = 54/207 (26%), Positives = 87/207 (42%), Gaps = 46/207 (22%)

Query: 280 LGTSSFGSVYKGT-ISDGTDVAIKVFN------LQLERAFRSFDSECEVLRNVRHRNLIK 332
           +G  +F  V     I  G +VAIK+ +        L++ FR    E  +++ + H N++K
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR----EVRIMKILNHPNIVK 78

Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWLYSH---------NYFLDILERLNIMIDVGSALE 383
           +           L++E+   G +  +L +H         + F  I+          SA++
Sbjct: 79  LFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIV----------SAVQ 128

Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIG--- 440
           Y H       I+H DLK  N+LLD +M   ++DFG       G          A  G   
Sbjct: 129 YCH----QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG------KLDAFCGAPP 178

Query: 441 YMAPEYGLEGI--VSAKCDVYSYGVLL 465
           Y APE   +G      + DV+S GV+L
Sbjct: 179 YAAPEL-FQGKKYDGPEVDVWSLGVIL 204

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 86.2 bits (214), Expect = 5e-18
 Identities = 44/166 (26%), Positives = 66/166 (39%), Gaps = 22/166 (13%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFS 61
             L+L GNQL      T+   L N+  L L  N ++   P  ++  TKL  L LG N  S
Sbjct: 224 DELSLNGNQLKD--IGTLAS-LTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQIS 278

Query: 62  GHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPP---CLVLTVLDVSRNQLSGDIPST 118
              ++    L  L+ L L         N+L   I P      LT L +  N +S   P  
Sbjct: 279 N--ISPLAGLTALTNLEL-------NENQLED-ISPISNLKNLTYLTLYFNNISDISP-- 326

Query: 119 IGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIP 164
           +     L+ L   +N+       S+ +L ++  L    N +S   P
Sbjct: 327 VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP 370

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 75.0 bits (185), Expect = 2e-14
 Identities = 44/166 (26%), Positives = 71/166 (42%), Gaps = 23/166 (13%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFS 61
             LTL  NQ++      + + L N+  L L++N ++    ++++  T L  L  G     
Sbjct: 115 TGLTLFNNQITD--IDPLKN-LTNLNRLELSSNTISD--ISALSGLTSLQQLSFGNQVTD 169

Query: 62  GHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPP---CLVLTVLDVSRNQLSGDIPST 118
              L    NL  L  L +       + NK+   I        L  L  + NQ+S   P  
Sbjct: 170 ---LKPLANLTTLERLDI-------SSNKVSD-ISVLAKLTNLESLIATNNQISDITP-- 216

Query: 119 IGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIP 164
           +G   +L+ LSL  NQ +     ++ SL +L  LDL+ N +S   P
Sbjct: 217 LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP 260

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 72.3 bits (178), Expect = 1e-13
 Identities = 34/150 (22%), Positives = 63/150 (42%), Gaps = 20/150 (13%)

Query: 22  SLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLM 81
           +L      +L   N+T T+    T+  ++  L           ++    L +L+ ++   
Sbjct: 22  ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK--SIDGVEYLNNLTQIN--- 74

Query: 82  FGIRLTGNKLYGRIPP--CLV-LTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGP 138
                + N+L   I P   L  L  + ++ NQ++   P  +    +L  L+L +NQ    
Sbjct: 75  ----FSNNQLTD-ITPLKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDI 127

Query: 139 IPESVGSLISLESLDLSGNNLSGKIPKLEG 168
            P  + +L +L  L+LS N +S  I  L G
Sbjct: 128 DP--LKNLTNLNRLELSSNTISD-ISALSG 154

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 70.8 bits (174), Expect = 4e-13
 Identities = 36/164 (21%), Positives = 63/164 (38%), Gaps = 20/164 (12%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFS 61
             L L  NQL     S I + L N+ YL L  NN++   P  +++ TKL  L    N  S
Sbjct: 290 TNLELNENQLED--ISPISN-LKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVS 344

Query: 62  GHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIP--PCLVLTVLDVSRNQLSGDIPSTI 119
              +++  NL +++ LS          N++    P      +T L ++    +    +  
Sbjct: 345 D--VSSLANLTNINWLSA-------GHNQISDLTPLANLTRITQLGLNDQAWTNAPVNYK 395

Query: 120 GGRVDLETLSLASNQFQGPI-PESVGSLISLESLDLSGNNLSGK 162
               ++   +   N     I P ++    S    D++ N  S  
Sbjct: 396 A---NVSIPNTVKNVTGALIAPATISDGGSYTEPDITWNLPSYT 436

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 62.7 bits (153), Expect = 1e-10
 Identities = 27/137 (19%), Positives = 52/137 (37%), Gaps = 14/137 (10%)

Query: 29  LLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLMFGIR-LT 87
             +T +     I    T   + +   LG  + +     +  +L  ++ L     GI+ + 
Sbjct: 6   ATITQDTPINQIFT-DTALAEKMKTVLGKTNVTD--TVSQTDLDQVTTLQADRLGIKSID 62

Query: 88  GNKLYGRIPPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLI 147
           G      +     LT ++ S NQL+   P  +     L  + + +NQ     P  + +L 
Sbjct: 63  G------VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLT 112

Query: 148 SLESLDLSGNNLSGKIP 164
           +L  L L  N ++   P
Sbjct: 113 NLTGLTLFNNQITDIDP 129

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 85.1 bits (211), Expect = 5e-18
 Identities = 49/211 (23%), Positives = 77/211 (36%), Gaps = 53/211 (25%)

Query: 279 LLGTSSFGSVYKGT-ISDGTDVAIKVFN---LQLERAFRSFDSECEVLRNVRHRNLIKIL 334
            +G+ +FG             VA+K         E   R    E    R++RH N+++  
Sbjct: 27  DIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQR----EIINHRSLRHPNIVRFK 82

Query: 335 SSYSNPDFKALVLEFMPNGSLEKWLYSH---------NYFLDILERLNIMIDVGSALEYL 385
                P   A+++E+   G L + + +           +F  +L          S + Y 
Sbjct: 83  EVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLL----------SGVSYC 132

Query: 386 HNGHSSVHIIHCDLKPTNILLDENMVAH--VSDFGIYKLLGEGEDSVRQTMTMATIG--- 440
           H    S+ I H DLK  N LLD +      + DFG  K               +T+G   
Sbjct: 133 H----SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS------QPKSTVGTPA 182

Query: 441 YMAPEYGLEGIVS------AKCDVYSYGVLL 465
           Y+APE     ++          DV+S GV L
Sbjct: 183 YIAPE-----VLLRQEYDGKIADVWSCGVTL 208

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 85.5 bits (212), Expect = 6e-18
 Identities = 56/248 (22%), Positives = 113/248 (45%), Gaps = 26/248 (10%)

Query: 234 IIMYIRCRNRNTKKSDH-EDFLPLAIWRRTSYLDIQRATDEFNECNLLGTSSFGSVY--- 289
             +         +K+ + ++FL           D++   +++    ++G  +FG V    
Sbjct: 30  DALVYDLDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVR 89

Query: 290 -KGTISDGTDVAIKVFNLQ--LERA-FRSFDSECEVLRNVRHRNLIKILSSYSNPDFKAL 345
            K T       A+K+ +    ++R+    F  E +++       ++++  ++ +  +  +
Sbjct: 90  HKST---RKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM 146

Query: 346 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNIL 405
           V+E+MP G L   + +++   +   R     +V  AL+ +H    S+  IH D+KP N+L
Sbjct: 147 VMEYMPGGDLVNLMSNYD-VPEKWARFYTA-EVVLALDAIH----SMGFIHRDVKPDNML 200

Query: 406 LDENMVAHV--SDFGIYKLLGEGEDSVRQTMTMATIGYMAPE----YGLEGIVSAKCDVY 459
           LD++   H+  +DFG    + + E  VR    + T  Y++PE     G +G    +CD +
Sbjct: 201 LDKS--GHLKLADFGTCMKMNK-EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWW 257

Query: 460 SYGVLLME 467
           S GV L E
Sbjct: 258 SVGVFLYE 265

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 83.9 bits (208), Expect = 8e-18
 Identities = 56/204 (27%), Positives = 82/204 (40%), Gaps = 31/204 (15%)

Query: 279 LLGTSSFGSVYKGT-ISDGTDVAIKVFN----------LQLERAFRSFDSECEVLRNVRH 327
           LLG+  FGSVY G  +SD   VAIK                 R       E  +L+ V  
Sbjct: 50  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM----EVVLLKKVSS 105

Query: 328 R--NLIKILSSYSNPDFKALVLEF-MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEY 384
               +I++L  +  PD   L+LE   P   L  ++      L      +    V  A+ +
Sbjct: 106 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRH 164

Query: 385 LHNGHSSVHIIHCDLKPTNILLDEN-MVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
            H    +  ++H D+K  NIL+D N     + DFG   LL   +D+V       T  Y  
Sbjct: 165 CH----NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTD-FDGTRVYSP 216

Query: 444 PEYGLEGI--VSAKCDVYSYGVLL 465
           PE+ +           V+S G+LL
Sbjct: 217 PEW-IRYHRYHGRSAAVWSLGILL 239

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 83.7 bits (208), Expect = 8e-18
 Identities = 64/213 (30%), Positives = 99/213 (46%), Gaps = 40/213 (18%)

Query: 272 DEFNECNLLGTSSFGSVY----KGTISDGTDVAIKVFNLQLERAFRSFDSEC-----EVL 322
            +F     LGT SFG V+    +     G   A+KV  L+ E   R    E       +L
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSRHN---GRYYAMKV--LKKEIVVRLKQVEHTNDERLML 60

Query: 323 RNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSAL 382
             V H  +I++  ++ +     ++++++  G L   L     F + + +     +V  AL
Sbjct: 61  SIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAA-EVCLAL 119

Query: 383 EYLHNGHSSVHIIHCDLKPTNILLDENMVAHV--SDFGIYKLLGEGEDSVRQTMTM-ATI 439
           EYLH    S  II+ DLKP NILLD+N   H+  +DFG  K + +       T T+  T 
Sbjct: 120 EYLH----SKDIIYRDLKPENILLDKN--GHIKITDFGFAKYVPD------VTYTLCGTP 167

Query: 440 GYMAPEYGLEGIVSAK-----CDVYSYGVLLME 467
            Y+APE     +VS K      D +S+G+L+ E
Sbjct: 168 DYIAPE-----VVSTKPYNKSIDWWSFGILIYE 195

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 83.9 bits (208), Expect = 1e-17
 Identities = 56/257 (21%), Positives = 93/257 (36%), Gaps = 51/257 (19%)

Query: 280 LGTSSFGSVYKGTISDGTDVAIK--VFNLQLERAFRSFDS---------ECEVLRNVRHR 328
           + + S+G+V  G  S+G  VAIK     +   R                E  +L +  H 
Sbjct: 30  ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89

Query: 329 NLIKIL---SSYSNPDFKA--LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALE 383
           N++ +      +  P      LV E M    L + ++     +        M  +   L 
Sbjct: 90  NILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLGLH 148

Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMT--MATIGY 441
            LH       ++H DL P NILL +N    + DF + +     ED+     T  +    Y
Sbjct: 149 VLH----EAGVVHRDLHPGNILLADNNDITICDFNLAR-----EDTADANKTHYVTHRWY 199

Query: 442 MAPEYGLE-GIVSAKCDVYSYGVLLMETFTRK--------------------RPTDE--M 478
            APE  ++    +   D++S G ++ E F RK                     P  E  +
Sbjct: 200 RAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVV 259

Query: 479 FIGEMSLRRWVKESLPH 495
                S R +++ SL +
Sbjct: 260 MFSSPSARDYLRNSLSN 276

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 84.3 bits (209), Expect = 1e-17
 Identities = 56/224 (25%), Positives = 97/224 (43%), Gaps = 39/224 (17%)

Query: 268 QRATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRH 327
           ++    +  C ++G  SFG V++  + +  +VAIK          R    E +++R V+H
Sbjct: 36  EQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR----ELQIMRIVKH 91

Query: 328 RNLIKIL----SSYSNPDFKA--LVLEFMPNGSLEKWLYSHNYFLDILERLNI---MIDV 378
            N++ +     S+    D     LVLE++P  ++ +    +      +  L I   M  +
Sbjct: 92  PNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQL 150

Query: 379 GSALEYLHNGHSSVHIIHCDLKPTNILLDENM-VAHVSDFGIYKLLGEGEDSVRQTMT-- 435
             +L Y+H    S+ I H D+KP N+LLD    V  + DFG  K+L  GE          
Sbjct: 151 LRSLAYIH----SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE-----PNVSY 201

Query: 436 MATIGYMAPE-------YGLEGIVSAKCDVYSYGVLLMETFTRK 472
           + +  Y APE       Y      +   D++S G ++ E    +
Sbjct: 202 ICSRYYRAPELIFGATNY------TTNIDIWSTGCVMAELMQGQ 239

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 83.5 bits (207), Expect = 1e-17
 Identities = 58/213 (27%), Positives = 95/213 (44%), Gaps = 40/213 (18%)

Query: 272 DEFNECNLLGTSSFGSVY----KGTISDGTDVAIKVFNL-------QLERAFRSFDSECE 320
           D+F+    LGT SFG V     K +   G   A+K+ +        Q+E       +E  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKES---GNHYAMKILDKQKVVKLKQIEHTL----NEKR 93

Query: 321 VLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGS 380
           +L+ V    L+K+  S+ +     +V+E++  G +   L     F +   R      +  
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA-QIVL 152

Query: 381 ALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTM-ATI 439
             EYLH    S+ +I+ DLKP N+L+D+     V+DFG  K +        +T T+  T 
Sbjct: 153 TFEYLH----SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWTLCGTP 202

Query: 440 GYMAPEYGLEGIVSAK-----CDVYSYGVLLME 467
             +APE     I+ +K      D ++ GVL+ E
Sbjct: 203 EALAPE-----IILSKGYNKAVDWWALGVLIYE 230

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 86.0 bits (213), Expect = 1e-17
 Identities = 44/188 (23%), Positives = 74/188 (39%), Gaps = 10/188 (5%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTI-PNSITNATKLIVLDLGFNSF 60
             L L  N +   + ++    L  ++ L L +     TI   +  N   L +LDLG +  
Sbjct: 27  ERLLLSFNYIR-TVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKI 85

Query: 61  SGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLV-LTVLDVSRNQLSG-DIPST 118
                + F  L HL  L L  +   L+   L       L  LT LD+S+NQ+    +  +
Sbjct: 86  YFLHPDAFQGLFHLFELRL--YFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPS 143

Query: 119 IGGRVDLETLSLASNQFQGPIPESVGSL--ISLESLDLSGNNLSGKIPKLEGEIPVKGSF 176
            G    L+++  +SNQ        +  L   +L    L+ N+L  ++    G+      F
Sbjct: 144 FGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCM--NPF 201

Query: 177 KNFSTESF 184
           +N   E  
Sbjct: 202 RNMVLEIL 209

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 83.7 bits (207), Expect = 5e-17
 Identities = 43/168 (25%), Positives = 65/168 (38%), Gaps = 22/168 (13%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFS 61
           RI       L+ ++P      L   E LLL+ N +     +S     +L +L+LG     
Sbjct: 7   RIAFYRFCNLT-QVPQ----VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTP 61

Query: 62  GHI-LNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPP-----CLVLTVLDVSRNQLSGDI 115
             I    F NL +L +L        L  +K+Y  + P        L  L +    LS  +
Sbjct: 62  LTIDKEAFRNLPNLRIL-------DLGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAV 113

Query: 116 --PSTIGGRVDLETLSLASNQFQG-PIPESVGSLISLESLDLSGNNLS 160
                      L  L L+ NQ +   +  S G L SL+S+D S N + 
Sbjct: 114 LKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIF 161

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 80.2 bits (198), Expect = 7e-16
 Identities = 40/181 (22%), Positives = 65/181 (35%), Gaps = 24/181 (13%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFS 61
           ++L L        +      +LPN+  L L ++ +    P++      L  L L F   S
Sbjct: 51  QLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLS 110

Query: 62  GHIL--NTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLV------LTVLDVSRNQLSG 113
             +L    F NL+ L+ L        L+ N++   +           L  +D S NQ+  
Sbjct: 111 DAVLKDGYFRNLKALTRLD-------LSKNQIR-SLYLHPSFGKLNSLKSIDFSSNQIFL 162

Query: 114 DIPSTIGG--RVDLETLSLASNQFQGPIPESVGSL------ISLESLDLSGNNLSGKIPK 165
                +       L   SLA+N     +    G        + LE LD+SGN  +  I  
Sbjct: 163 VCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITG 222

Query: 166 L 166
            
Sbjct: 223 N 223

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 73.7 bits (181), Expect = 8e-14
 Identities = 34/185 (18%), Positives = 61/185 (32%), Gaps = 34/185 (18%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFN--- 58
             + L+ N ++  +       L  ++ L L  N LT     +I     +  + L  N   
Sbjct: 341 AYIDLQKNHIA-IIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLV 394

Query: 59  -----SFSGHILNTFGNLRHLSVLSLLMFGIRLT--------GNKLYGRIPPCL-----V 100
                + + ++++   N   L  L +L F +R+          N+               
Sbjct: 395 TLPKINLTANLIHLSEN--RLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPS 452

Query: 101 LTVLDVSRNQLSGDIPSTIGGRV-----DLETLSLASNQFQGPIPESVGSLISLESLDLS 155
           L  L +  N L     + +   V      L+ L L  N      P     L +L  L L+
Sbjct: 453 LEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLN 512

Query: 156 GNNLS 160
            N L+
Sbjct: 513 SNRLT 517

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 71.0 bits (174), Expect = 6e-13
 Identities = 32/180 (17%), Positives = 60/180 (33%), Gaps = 30/180 (16%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFS 61
           R L L    +   L S +  +L +++ L L  N +      +      L VL+L +N   
Sbjct: 269 RHLDLSHGFVF-SLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLG 327

Query: 62  GHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLV-----LTVLDVSRNQLSG--- 113
               + F  L  ++ +        L  N +   I          L  LD+  N L+    
Sbjct: 328 ELYSSNFYGLPKVAYID-------LQKNHIA-IIQDQTFKFLEKLQTLDLRDNALTTIHF 379

Query: 114 ------------DIPSTIGGRVDLETLSLASNQFQG-PIPESVGSLISLESLDLSGNNLS 160
                        + +     +    + L+ N+ +   I   +  +  L+ L L+ N  S
Sbjct: 380 IPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFS 439

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 69.4 bits (170), Expect = 2e-12
 Identities = 33/178 (18%), Positives = 60/178 (33%), Gaps = 20/178 (11%)

Query: 2   RILTLEGNQLSGRLPSTIGH-SLPNIEYLLLTANNLTGTIPNSITNATK------LIVLD 54
           + +    NQ+       +       + +  L AN+L   +               L +LD
Sbjct: 151 KSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILD 210

Query: 55  LGFNSFSGHILNTFGN-LRHLSVLSLLM----FGIRLTGNKLYGRIPP-------CLVLT 102
           +  N ++  I   F N +      SL++     G     + +                + 
Sbjct: 211 VSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIK-DPDQNTFAGLARSSVR 269

Query: 103 VLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLS 160
            LD+S   +            DL+ L+LA N+      E+   L +L+ L+LS N L 
Sbjct: 270 HLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLG 327

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 61.7 bits (150), Expect = 4e-10
 Identities = 45/191 (23%), Positives = 63/191 (32%), Gaps = 46/191 (24%)

Query: 1   MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTG---------------------T 39
           ++ L L  N L+     TI H +P+I  + L+ N L                        
Sbjct: 364 LQTLDLRDNALT-----TI-HFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLD 417

Query: 40  IPNSITNATKLIVLDLGFNSFSGHILN-TFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPC 98
           I   +     L +L L  N FS    + T      L  L        L  N L       
Sbjct: 418 ILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQL-------FLGENMLQLAWETE 470

Query: 99  LV---------LTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISL 149
           L          L VL ++ N L+   P        L  LSL SN+    +  +     +L
Sbjct: 471 LCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTV-LSHND-LPANL 528

Query: 150 ESLDLSGNNLS 160
           E LD+S N L 
Sbjct: 529 EILDISRNQLL 539

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 84.4 bits (209), Expect = 1e-17
 Identities = 64/278 (23%), Positives = 112/278 (40%), Gaps = 52/278 (18%)

Query: 234 IIMYIRCRNRNTKKSDH-EDFLPLAIWRRTSYLDIQRAT---DEFNECNLLGTSSFGSVY 289
           + ++         +  +  DFL    W     + ++      D+F    ++G  +F  V 
Sbjct: 22  LGVHQELGASELAQDKYVADFLQ---WAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVA 78

Query: 290 ----KGTISDGTDVAIKVFNLQ--LERA-FRSFDSECEVLRNVRHRNLIKILSSYSNPDF 342
               K T   G   A+K+ N    L+R     F  E +VL N   R + ++  ++ + ++
Sbjct: 79  VVKMKQT---GQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENY 135

Query: 343 KALVLEFMPNGSLEKWLYSHNYFLDILERLNIMI-DVGSALEYLHNGHSSVHIIHCDLKP 401
             LV+E+   G L   L      +   E     + ++  A++ +H     +  +H D+KP
Sbjct: 136 LYLVMEYYVGGDLLTLLSKFGERIP-AEMARFYLAEIVMAIDSVH----RLGYVHRDIKP 190

Query: 402 TNILLDENMVAHV--SDFGIYKLLGEGEDSVRQTMTMATIGYMAPE-------------Y 446
            NILLD     H+  +DFG    L   + +VR  + + T  Y++PE             Y
Sbjct: 191 DNILLDRC--GHIRLADFGSCLKLRA-DGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSY 247

Query: 447 GLEGIVSAKCDVYSYGVLLMETFTRKRP-----TDEMF 479
           G E      CD ++ GV   E F  + P     T E +
Sbjct: 248 GPE------CDWWALGVFAYEMFYGQTPFYADSTAETY 279

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 83.1 bits (206), Expect = 2e-17
 Identities = 48/225 (21%), Positives = 91/225 (40%), Gaps = 34/225 (15%)

Query: 268 QRATDEFNECNLLGTSSFGSVYKGTISD-GTDVAIK-VFNLQLERAFRSFDSECEVLRNV 325
           ++  D F    + G  +FG+V  G     G  VAIK V         R      + L  +
Sbjct: 19  RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVI-QDPRFRNREL-QIMQDLAVL 76

Query: 326 RHRNLIKILSSYSNPDFKA-------LVLEFMPNGSLEKWLYSHNYFLDILERLNI---M 375
            H N++++ S +     +        +V+E++P+ +L +   ++         + I   +
Sbjct: 77  HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFL 135

Query: 376 IDVGSALEYLHNGHSSVHIIHCDLKPTNILLD-ENMVAHVSDFGIYKLLGEGEDSVRQTM 434
             +  ++  LH    SV++ H D+KP N+L++  +    + DFG  K L   E +     
Sbjct: 136 FQLIRSIGCLH--LPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN---VA 190

Query: 435 TMATIGYMAPE-------YGLEGIVSAKCDVYSYGVLLMETFTRK 472
            + +  Y APE       Y      +   D++S G +  E    +
Sbjct: 191 YICSRYYRAPELIFGNQHY------TTAVDIWSVGCIFAEMMLGE 229

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 83.2 bits (206), Expect = 2e-17
 Identities = 54/223 (24%), Positives = 91/223 (40%), Gaps = 44/223 (19%)

Query: 271 TDEFNECNLLGTSSFGSVYKGTISD-GTDVAIK----VFNLQLE--RAFRSFDSECEVLR 323
              +     +G+ + G V     +    +VAIK     F  Q    RA+R    E  +++
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR----ELVLMK 79

Query: 324 NVRHRNLIKIL----SSYSNPDFKA--LVLEFMPNGSLEKWLYS------HNYFLDILER 371
            V H+N+I +L       S  +F+   +V+E M   +L + +         +Y L  +  
Sbjct: 80  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHERMSYLLYQMLC 138

Query: 372 LNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVR 431
                     +++LH    S  IIH DLKP+NI++  +    + DFG+ +  G       
Sbjct: 139 ---------GIKHLH----SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS----- 180

Query: 432 QTMT--MATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRK 472
             MT  + T  Y APE  L        D++S G ++ E     
Sbjct: 181 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 83.6 bits (207), Expect = 3e-17
 Identities = 59/220 (26%), Positives = 98/220 (44%), Gaps = 36/220 (16%)

Query: 271 TDEFNECNLLGTSSFGSVYKGTISD-GTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRN 329
              + +  ++G  SFG VY+  + D G  VAIK          R    E +++R + H N
Sbjct: 53  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCN 108

Query: 330 LIKIL----SSYSNPDFKAL--VLEFMPNGSLEKWLYSHNYFLDILERLNI---MIDVGS 380
           ++++     SS    D   L  VL+++P  ++ +    ++     L  + +   M  +  
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFR 167

Query: 381 ALEYLHNGHSSVHIIHCDLKPTNILLDENM-VAHVSDFGIYKLLGEGEDSVRQTMTMATI 439
           +L Y+H    S  I H D+KP N+LLD +  V  + DFG  K L  GE +V     + + 
Sbjct: 168 SLAYIH----SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSR 220

Query: 440 GYMAPE-------YGLEGIVSAKCDVYSYGVLLMETFTRK 472
            Y APE       Y      ++  DV+S G +L E    +
Sbjct: 221 YYRAPELIFGATDY------TSSIDVWSAGCVLAELLLGQ 254

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 83.6 bits (207), Expect = 3e-17
 Identities = 60/223 (26%), Positives = 96/223 (43%), Gaps = 27/223 (12%)

Query: 272 DEFNECNLLGTSSFGSVY----KGTISDGTDVAIKVFNLQLERAFRSFDSEC-----EVL 322
           +EF    LLG  +FG V     K T   G   A+K+  L+ E      +         VL
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKAT---GRYYAMKI--LKKEVIVAKDEVAHTLTENRVL 202

Query: 323 RNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSAL 382
           +N RH  L  +  S+   D    V+E+   G L   L     F +   R     ++ SAL
Sbjct: 203 QNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA-EIVSAL 261

Query: 383 EYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTM-ATIGY 441
           +YLH+  +   +++ DLK  N++LD++    ++DFG+ K   EG        T   T  Y
Sbjct: 262 DYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKTFCGTPEY 315

Query: 442 MAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRP-----TDEMF 479
           +APE   +       D +  GV++ E    + P      +++F
Sbjct: 316 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF 358

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 81.6 bits (202), Expect = 4e-17
 Identities = 53/206 (25%), Positives = 81/206 (39%), Gaps = 33/206 (16%)

Query: 279 LLGTSSFGSVYKGT-ISDGTDVAIKVFN----------LQLERAFRSFDSECEVLRNVR- 326
           LLG   FG+V+ G  ++D   VAIKV                        E  +L  V  
Sbjct: 38  LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL----EVALLWKVGA 93

Query: 327 ---HRNLIKILSSYSNPDFKALVLEF-MPNGSLEKWLYSHNYFLDILERLNIMIDVGSAL 382
              H  +I++L  +   +   LVLE  +P   L  ++       +   R      V +A+
Sbjct: 94  GGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSR-CFFGQVVAAI 152

Query: 383 EYLHNGHSSVHIIHCDLKPTNILLD-ENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGY 441
           ++ H    S  ++H D+K  NIL+D     A + DFG   LL    D         T  Y
Sbjct: 153 QHCH----SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL---HDEPYTD-FDGTRVY 204

Query: 442 MAPEYGLEGI--VSAKCDVYSYGVLL 465
             PE+ +      +    V+S G+LL
Sbjct: 205 SPPEW-ISRHQYHALPATVWSLGILL 229

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 82.4 bits (204), Expect = 6e-17
 Identities = 32/148 (21%), Positives = 53/148 (35%), Gaps = 24/148 (16%)

Query: 22  SLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLM 81
           S   ++  L  ++NLT  +P    N          ++ +  +     G  R ++V     
Sbjct: 9   SNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVS---- 63

Query: 82  FGIRLTGNKLYGRIPPCLV--LTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPI 139
                       R+  CL      L+++   LS  +P        LE+L  + N     +
Sbjct: 64  ------------RLRDCLDRQAHELELNNLGLS-SLPELPP---HLESLVASCNSLT-EL 106

Query: 140 PESVGSLISLESLDLSGNNLSGKIPKLE 167
           PE   SL SL   + +   LS   P LE
Sbjct: 107 PELPQSLKSLLVDNNNLKALSDLPPLLE 134

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 74.3 bits (183), Expect = 3e-14
 Identities = 39/183 (21%), Positives = 63/183 (34%), Gaps = 33/183 (18%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFS 61
             L +  NQL  +LP  + +    ++ + +  N+L   +P+   +   L  +  G N   
Sbjct: 134 EYLGVSNNQLE-KLPE-LQN-SSFLKIIDVDNNSLK-KLPDLPPS---LEFIAAGNNQLE 186

Query: 62  GHILNTFGNLRHLSVLSL----------LMFGIR---LTGNKLYGRIPPCLV----LTVL 104
              L    NL  L+ +            L   +       N L     P L     LT +
Sbjct: 187 --ELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNIL--EELPELQNLPFLTTI 242

Query: 105 DVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIP 164
               N L   +P        LE L++  N     +PE   SL  L+  +   + LS   P
Sbjct: 243 YADNNLLK-TLPDLPPS---LEALNVRDNYLTD-LPELPQSLTFLDVSENIFSGLSELPP 297

Query: 165 KLE 167
            L 
Sbjct: 298 NLY 300

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 73.1 bits (180), Expect = 8e-14
 Identities = 32/169 (18%), Positives = 54/169 (31%), Gaps = 23/169 (13%)

Query: 1   MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSF 60
           +  L    N++   L        P++E L ++ N L   +P        L  L   FN  
Sbjct: 299 LYYLNASSNEIR-SLCD----LPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHL 349

Query: 61  SGHILNTFGNLRHLSV-------LSLLMFGIR-LTGNKLYGRIPPCLV-LTVLDVSRNQL 111
           +  +     NL+ L V          +   +  L  N     +P     L  L V  N L
Sbjct: 350 A-EVPELPQNLKQLHVEYNPLREFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPL 408

Query: 112 SGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLS 160
             + P        +E L + S +   P   +  +   LE      ++  
Sbjct: 409 R-EFPDIPES---VEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 72.0 bits (177), Expect = 2e-13
 Identities = 36/186 (19%), Positives = 64/186 (34%), Gaps = 43/186 (23%)

Query: 4   LTLEGNQLSGRLPSTIGH----------------SLPNIEYLLLTANNLTGTIPNSITNA 47
           L    N L+  LP                       P +EYL ++ N L   +P  + N+
Sbjct: 96  LVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLE-KLP-ELQNS 152

Query: 48  TKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPP---CLVLTVL 104
           + L ++D+  NS    + +   +L  ++             N+L   +P       LT +
Sbjct: 153 SFLKIIDVDNNSLK-KLPDLPPSLEFIA----------AGNNQL-EELPELQNLPFLTAI 200

Query: 105 DVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLS---G 161
               N L   +P        LE++   +N  +      + +L  L ++    N L     
Sbjct: 201 YADNNSLK-KLPDLPLS---LESIVAGNNILE--ELPELQNLPFLTTIYADNNLLKTLPD 254

Query: 162 KIPKLE 167
             P LE
Sbjct: 255 LPPSLE 260

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 70.8 bits (174), Expect = 4e-13
 Identities = 39/167 (23%), Positives = 60/167 (35%), Gaps = 23/167 (13%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFS 61
             +    NQL   LP     +LP +  +    N+L   +P+   +   L  +  G N   
Sbjct: 176 EFIAAGNNQLE-ELPELQ--NLPFLTAIYADNNSLK-KLPDLPLS---LESIVAGNNILE 228

Query: 62  GHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLV-LTVLDVSRNQLSGDIPSTIG 120
              L    NL  L+ +           N L   +P     L  L+V  N L+ D+P    
Sbjct: 229 --ELPELQNLPFLTTIYA-------DNNLL-KTLPDLPPSLEALNVRDNYLT-DLPELPQ 277

Query: 121 GRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKLE 167
               L  L ++ N F G + E   +L  L +      +L    P LE
Sbjct: 278 S---LTFLDVSENIFSG-LSELPPNLYYLNASSNEIRSLCDLPPSLE 320

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 80.8 bits (200), Expect = 9e-17
 Identities = 55/213 (25%), Positives = 89/213 (41%), Gaps = 56/213 (26%)

Query: 279 LLGTSSFGSVYKGT-ISDGTDVAIKVFNLQ-------LERAFRSFDSECEVLRNVRHRNL 330
            LG  SFG V   T       VA+K  + Q         R  R    E   L+ +RH ++
Sbjct: 16  TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVER----EISYLKLLRHPHI 71

Query: 331 IKILSSYSNPDFKALVLEFMPNGSLEKWLYSH---------NYFLDILERLNIMIDVGSA 381
           IK+    + P    +V+E+   G L  ++             +F  I+           A
Sbjct: 72  IKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQII----------CA 120

Query: 382 LEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIG- 440
           +EY H       I+H DLKP N+LLD+N+   ++DFG+  ++ +G           + G 
Sbjct: 121 IEYCH----RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN------FLKTSCGS 170

Query: 441 --YMAPEYGLEGIVS------AKCDVYSYGVLL 465
             Y APE     +++       + DV+S G++L
Sbjct: 171 PNYAAPE-----VINGKLYAGPEVDVWSCGIVL 198

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 80.3 bits (199), Expect = 1e-16
 Identities = 56/220 (25%), Positives = 95/220 (43%), Gaps = 34/220 (15%)

Query: 268 QRATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLER------AFRSFDSECEV 321
           Q   +++ +   +G  ++G VYK   S G  VA+K   L  E       A R    E  +
Sbjct: 17  QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIR----EISL 72

Query: 322 LRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSA 381
           L+ + H N++ ++    +     LV EFM    L+K L  +   L   +    +  +   
Sbjct: 73  LKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRG 131

Query: 382 LEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMT--MATI 439
           + + H       I+H DLKP N+L++ +    ++DFG+ +  G     VR + T  + T+
Sbjct: 132 VAHCH----QHRILHRDLKPQNLLINSDGALKLADFGLARAFG---IPVR-SYTHEVVTL 183

Query: 440 GYMAPE-------YGLEGIVSAKCDVYSYGVLLMETFTRK 472
            Y AP+       Y      S   D++S G +  E  T K
Sbjct: 184 WYRAPDVLMGSKKY------STSVDIWSIGCIFAEMITGK 217

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 79.5 bits (197), Expect = 1e-16
 Identities = 51/219 (23%), Positives = 95/219 (43%), Gaps = 35/219 (15%)

Query: 272 DEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQLER------AFRSFDSECEVLRN 324
            ++ +   +G  ++G+V+K         VA+K   L  +       A R    E  +L+ 
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR----EICLLKE 57

Query: 325 VRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEY 384
           ++H+N++++     +     LV EF     L+K+  S N  LD     + +  +   L +
Sbjct: 58  LKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGF 116

Query: 385 LHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMT--MATIGYM 442
            H    S +++H DLKP N+L++ N    +++FG+ +  G     VR   +  + T+ Y 
Sbjct: 117 CH----SRNVLHRDLKPQNLLINRNGELKLANFGLARAFG---IPVR-CYSAEVVTLWYR 168

Query: 443 APE-------YGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
            P+       Y      S   D++S G +  E     RP
Sbjct: 169 PPDVLFGAKLY------STSIDMWSAGCIFAELANAGRP 201

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 80.7 bits (199), Expect = 1e-16
 Identities = 36/122 (29%), Positives = 57/122 (46%), Gaps = 4/122 (3%)

Query: 349 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDE 408
                  E     +  FL +   +     V   +E+L    +S   IH DL   NILL E
Sbjct: 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL----ASRKCIHRDLAARNILLSE 228

Query: 409 NMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMET 468
             V  + DFG+ + + +  D VR+      + +MAPE   + + + + DV+S+GVLL E 
Sbjct: 229 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 288

Query: 469 FT 470
           F+
Sbjct: 289 FS 290

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 48.8 bits (116), Expect = 3e-06
 Identities = 46/213 (21%), Positives = 83/213 (38%), Gaps = 29/213 (13%)

Query: 280 LGTSSFGSVYKGTI------SDGTDVAIKVFNLQL-ERAFRSFDSECEVLRNV-RHRNLI 331
           LG  +FG V +         +    VA+K+          R+  SE ++L ++  H N++
Sbjct: 30  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89

Query: 332 KILSSYSNPDFKALV-LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHS 390
            +L + + P    +V +EF   G+L  +L S           N  +   +       G  
Sbjct: 90  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKR---------NEFVPYKTKGARFRQGKD 140

Query: 391 SVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSV------RQTMTMATIGYMAP 444
            V  I  DLK     +  +  +  S F   K L + E+        +  +T+  +   + 
Sbjct: 141 YVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSF 200

Query: 445 E--YGLEGIVSAKC---DVYSYGVLLMETFTRK 472
           +   G+E + S KC   D+ +  +LL E    K
Sbjct: 201 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVK 233

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 79.9 bits (198), Expect = 2e-16
 Identities = 65/223 (29%), Positives = 100/223 (44%), Gaps = 30/223 (13%)

Query: 265 LDIQRATDEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFR-SFDS----E 318
           LD++     + + + LG   F +VYK    +    VAIK   L      +   +     E
Sbjct: 3   LDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALRE 62

Query: 319 CEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDV 378
            ++L+ + H N+I +L ++ +    +LV +FM    LE  +  ++  L        M+  
Sbjct: 63  IKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMT 121

Query: 379 GSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMT--M 436
              LEYLH       I+H DLKP N+LLDEN V  ++DFG+ K  G      R   T  +
Sbjct: 122 LQGLEYLH----QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFG---SPNR-AYTHQV 173

Query: 437 ATIGYMAPE-------YGLEGIVSAKCDVYSYGVLLMETFTRK 472
            T  Y APE       YG  G+     D+++ G +L E   R 
Sbjct: 174 VTRWYRAPELLFGARMYG-VGV-----DMWAVGCILAELLLRV 210

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 80.1 bits (198), Expect = 4e-16
 Identities = 36/163 (22%), Positives = 62/163 (38%), Gaps = 12/163 (7%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFS 61
           + L +  N L   +       L ++E L L   NLT     ++++   LIVL L   + +
Sbjct: 131 KSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNIN 189

Query: 62  GHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPP----CLVLTVLDVSRNQLSGDIPS 117
                +F  L  L VL        ++       + P     L LT L ++   L+     
Sbjct: 190 AIRDYSFKRLYRLKVL-------EISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYL 242

Query: 118 TIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLS 160
            +   V L  L+L+ N         +  L+ L+ + L G  L+
Sbjct: 243 AVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLA 285

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 75.9 bits (187), Expect = 9e-15
 Identities = 33/164 (20%), Positives = 58/164 (35%), Gaps = 14/164 (8%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFS 61
             L +  N++   L   +   L N++ L +  N+L      + +    L  L L   + +
Sbjct: 107 TKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLT 165

Query: 62  GHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCL-----VLTVLDVSRNQLSGDIP 116
                   +L  L VL       RL    +   I          L VL++S       + 
Sbjct: 166 SIPTEALSHLHGLIVL-------RLRHLNIN-AIRDYSFKRLYRLKVLEISHWPYLDTMT 217

Query: 117 STIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLS 160
                 ++L +LS+           +V  L+ L  L+LS N +S
Sbjct: 218 PNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPIS 261

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 72.1 bits (177), Expect = 2e-13
 Identities = 32/165 (19%), Positives = 62/165 (37%), Gaps = 16/165 (9%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFS 61
            +L L    ++  +       L  ++ L ++      T+  +      L  L +   + +
Sbjct: 179 IVLRLRHLNIN-AIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT 237

Query: 62  GHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCL-----VLTVLDVSRNQLSGDIP 116
                   +L +L  L+L       + N +   I   +      L  + +   QL+   P
Sbjct: 238 AVPYLAVRHLVYLRFLNL-------SYNPI-STIEGSMLHELLRLQEIQLVGGQLAVVEP 289

Query: 117 STIGGRVDLETLSLASNQFQGPIPESV-GSLISLESLDLSGNNLS 160
               G   L  L+++ NQ    + ESV  S+ +LE+L L  N L+
Sbjct: 290 YAFRGLNYLRVLNVSGNQLTT-LEESVFHSVGNLETLILDSNPLA 333

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 62.0 bits (151), Expect = 3e-10
 Identities = 36/164 (21%), Positives = 54/164 (32%), Gaps = 41/164 (25%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFS 61
           R +     +    +P  I         L L  N +     +   +   L  L+L  N  S
Sbjct: 14  RAVLCHRKRFV-AVPEGI---PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS 69

Query: 62  GHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCL-----VLTVLDVSRNQLSGDIP 116
                 F NL +L  L        L  N+L   IP  +      LT LD+S N++     
Sbjct: 70  AVEPGAFNNLFNLRTL-------GLRSNRL-KLIPLGVFTGLSNLTKLDISENKIV---- 117

Query: 117 STIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLS 160
                        L    FQ         L +L+SL++  N+L 
Sbjct: 118 ------------ILLDYMFQD--------LYNLKSLEVGDNDLV 141

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 79.3 bits (196), Expect = 5e-16
 Identities = 40/164 (24%), Positives = 67/164 (40%), Gaps = 17/164 (10%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFS 61
           +I+T + + +  +LP+ +  S   +E L L    +      +   A  +  L +GFN+  
Sbjct: 48  KIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR 106

Query: 62  GHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCL-----VLTVLDVSRNQLSGDIP 116
               + F N+  L+VL        L  N L   +P  +      LT L +S N L     
Sbjct: 107 YLPPHVFQNVPLLTVLV-------LERNDL-SSLPRGIFHNTPKLTTLSMSNNNLERIED 158

Query: 117 STIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLS 160
            T      L+ L L+SN+    +      + SL   ++S N LS
Sbjct: 159 DTFQATTSLQNLQLSSNRLTH-VDL--SLIPSLFHANVSYNLLS 199

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 78.5 bits (194), Expect = 8e-16
 Identities = 43/170 (25%), Positives = 70/170 (41%), Gaps = 15/170 (8%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFS 61
            +L LE N LS  LP  I H+ P +  L ++ NNL     ++    T L  L L  N  +
Sbjct: 120 TVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT 178

Query: 62  GHILNTFGNLRHLSV----LSLLMFGIRLT-----GNKLYGRIPP--CLVLTVLDVSRNQ 110
              L+   +L H +V    LS L   I +       N +   +     + LT+L +  N 
Sbjct: 179 HVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSI-NVVRGPVNVELTILKLQHNN 237

Query: 111 LSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLS 160
           L+    + +     L  + L+ N+ +  +      +  LE L +S N L 
Sbjct: 238 LTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV 285

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 78.2 bits (193), Expect = 1e-15
 Identities = 36/163 (22%), Positives = 60/163 (36%), Gaps = 20/163 (12%)

Query: 1   MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSF 60
           +  L    N ++  +          +  L L  NNLT      + N   L+ +DL +N  
Sbjct: 207 VEELDASHNSIN-VVRG---PVNVELTILKLQHNNLT-DTA-WLLNYPGLVEVDLSYNEL 260

Query: 61  SGHILNTFGNLRHLSVLSLLMFGIRLTGNKLY---GRIPPCLVLTVLDVSRNQLSGDIPS 117
              + + F  ++ L  L        ++ N+L        P   L VLD+S N L   +  
Sbjct: 261 EKIMYHPFVKMQRLERL-------YISNNRLVALNLYGQPIPTLKVLDLSHNHLL-HVER 312

Query: 118 TIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLS 160
                  LE L L  N     +     +  +L++L LS N+  
Sbjct: 313 NQPQFDRLENLYLDHNSIV-TLKL--STHHTLKNLTLSHNDWD 352

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 73.9 bits (182), Expect = 2e-14
 Identities = 31/164 (18%), Positives = 56/164 (34%), Gaps = 26/164 (15%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFS 61
               +  N LS  L          +E L  + N++   +   +    +L +L L  N+ +
Sbjct: 189 FHANVSYNLLS-TLAI-----PIAVEELDASHNSIN-VVRGPVN--VELTILKLQHNNLT 239

Query: 62  GHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPP-----CLVLTVLDVSRNQLSGDIP 116
                   N   L  + L       + N+L  +I          L  L +S N+L   + 
Sbjct: 240 D--TAWLLNYPGLVEVDL-------SYNEL-EKIMYHPFVKMQRLERLYISNNRLV-ALN 288

Query: 117 STIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLS 160
                   L+ L L+ N     +  +      LE+L L  N++ 
Sbjct: 289 LYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIV 331

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 69.3 bits (170), Expect = 8e-13
 Identities = 32/146 (21%), Positives = 59/146 (40%), Gaps = 17/146 (11%)

Query: 22  SLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLM 81
           +L N + +    + +       + +  ++ +L+L            F     +  L    
Sbjct: 43  TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKL---- 98

Query: 82  FGIRLTGNKLYGRIPPCLV-----LTVLDVSRNQLSGDIPSTI-GGRVDLETLSLASNQF 135
               +  N +   +PP +      LTVL + RN LS  +P  I      L TLS+++N  
Sbjct: 99  ---YMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNL 153

Query: 136 QGPIPESV-GSLISLESLDLSGNNLS 160
           +  I +    +  SL++L LS N L+
Sbjct: 154 ER-IEDDTFQATTSLQNLQLSSNRLT 178

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 77.2 bits (191), Expect = 9e-16
 Identities = 49/216 (22%), Positives = 91/216 (42%), Gaps = 34/216 (15%)

Query: 272 DEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLER------AFRSFDSECEVLRNV 325
           ++++    +G  ++G VYK   + G   A+K   L+ E         R    E  +L+ +
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR----EISILKEL 57

Query: 326 RHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYL 385
           +H N++K+           LV E +    L+K L      L+ +   + ++ + + + Y 
Sbjct: 58  KHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC 116

Query: 386 HNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMT--MATIGYMA 443
           H       ++H DLKP N+L++      ++DFG+ +  G     VR   T  + T+ Y A
Sbjct: 117 H----DRRVLHRDLKPQNLLINREGELKIADFGLARAFG---IPVR-KYTHEIVTLWYRA 168

Query: 444 PE-------YGLEGIVSAKCDVYSYGVLLMETFTRK 472
           P+       Y      S   D++S G +  E     
Sbjct: 169 PDVLMGSKKY------STTIDIWSVGCIFAEMVNGT 198

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 77.7 bits (192), Expect = 1e-15
 Identities = 53/228 (23%), Positives = 99/228 (43%), Gaps = 39/228 (17%)

Query: 269 RATDEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQLER------AFRSFDSECEV 321
               ++ +   +G  +FG V+K      G  VA+K   ++ E+      A R    E ++
Sbjct: 14  DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR----EIKI 69

Query: 322 LRNVRHRN---LIKILSSYSNPDFKA-----LVLEFMPNGSLEKWLYSHNYFLDILERLN 373
           L+ ++H N   LI+I  + ++P  +      LV +F  +  L   L +      + E   
Sbjct: 70  LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKR 128

Query: 374 IMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQT 433
           +M  + + L Y+H       I+H D+K  N+L+  + V  ++DFG+ +     ++S    
Sbjct: 129 VMQMLLNGLYYIH----RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 184

Query: 434 MT--MATIGYMAPE-------YGLEGIVSAKCDVYSYGVLLMETFTRK 472
            T  + T+ Y  PE       YG         D++  G ++ E +TR 
Sbjct: 185 YTNRVVTLWYRPPELLLGERDYG------PPIDLWGAGCIMAEMWTRS 226

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 77.6 bits (192), Expect = 1e-15
 Identities = 60/225 (26%), Positives = 96/225 (42%), Gaps = 32/225 (14%)

Query: 272 DEFNECNLLGTSSFGSV----YKGTISDGTDVAIKVFNLQLERAFRSFDSEC-----EVL 322
           ++F+   LLG  +FG V     K T   G   A+K+  L+ E      +         VL
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKAT---GRYYAMKI--LRKEVIIAKDEVAHTVTESRVL 59

Query: 323 RNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSAL 382
           +N RH  L  +  ++   D    V+E+   G L   L     F +   R     ++ SAL
Sbjct: 60  QNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGA-EIVSAL 118

Query: 383 EYLHNGHSSVHIIHCDLKPTNILLDENMVAHV--SDFGIYKLLGEGEDSVRQTMTM-ATI 439
           EYLH    S  +++ D+K  N++LD++   H+  +DFG+ K   EG        T   T 
Sbjct: 119 EYLH----SRDVVYRDIKLENLMLDKD--GHIKITDFGLCK---EGISDGATMKTFCGTP 169

Query: 440 GYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRP-----TDEMF 479
            Y+APE   +       D +  GV++ E    + P      + +F
Sbjct: 170 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF 214

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 79.2 bits (195), Expect = 1e-15
 Identities = 44/170 (25%), Positives = 70/170 (41%), Gaps = 15/170 (8%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFS 61
            +L LE N LS  LP  I H+ P +  L ++ NNL     ++    T L  L L  N  +
Sbjct: 126 TVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT 184

Query: 62  GHILNTFGNLRHLSV----LSLLMFGIRLT-----GNKLYGRIPP--CLVLTVLDVSRNQ 110
              L+   +L H +V    LS L   I +       N +   +     + LT+L +  N 
Sbjct: 185 HVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSI-NVVRGPVNVELTILKLQHNN 243

Query: 111 LSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLS 160
           L+ D    +     L  + L+ N+ +  +      +  LE L +S N L 
Sbjct: 244 LT-DTA-WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV 291

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 79.2 bits (195), Expect = 1e-15
 Identities = 40/164 (24%), Positives = 67/164 (40%), Gaps = 17/164 (10%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFS 61
           +I+T + + +  +LP+ +  S   +E L L    +      +   A  +  L +GFN+  
Sbjct: 54  KIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR 112

Query: 62  GHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCL-----VLTVLDVSRNQLSGDIP 116
               + F N+  L+VL        L  N L   +P  +      LT L +S N L     
Sbjct: 113 YLPPHVFQNVPLLTVLV-------LERNDL-SSLPRGIFHNTPKLTTLSMSNNNLERIED 164

Query: 117 STIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLS 160
            T      L+ L L+SN+    +      + SL   ++S N LS
Sbjct: 165 DTFQATTSLQNLQLSSNRLTH-VDL--SLIPSLFHANVSYNLLS 205

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 78.4 bits (193), Expect = 2e-15
 Identities = 36/193 (18%), Positives = 66/193 (34%), Gaps = 39/193 (20%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLT----GTIPN------------SIT 45
             L++  N L  R+      +  +++ L L++N LT      IP+            ++ 
Sbjct: 150 TTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLSTLA 208

Query: 46  NATKLIVLDLGFNSFSGHILNTFGNLRHLSV-------------LSLLMFGIRLTGNKLY 92
               +  LD   NS +         L  L +                L+  + L+ N+L 
Sbjct: 209 IPIAVEELDASHNSINVVRGPVNVELTILKLQHNNLTDTAWLLNYPGLVE-VDLSYNEL- 266

Query: 93  GRIPP-----CLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLI 147
            +I          L  L +S N+L   +         L+ L L+ N     +  +     
Sbjct: 267 EKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFD 324

Query: 148 SLESLDLSGNNLS 160
            LE+L L  N++ 
Sbjct: 325 RLENLYLDHNSIV 337

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 78.4 bits (193), Expect = 2e-15
 Identities = 35/164 (21%), Positives = 60/164 (36%), Gaps = 22/164 (13%)

Query: 1   MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSF 60
           +  L    N ++  +          +  L L  NNLT      + N   L+ +DL +N  
Sbjct: 213 VEELDASHNSIN-VVRG---PVNVELTILKLQHNNLT-DTA-WLLNYPGLVEVDLSYNEL 266

Query: 61  SGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLV----LTVLDVSRNQLSGDIP 116
              + + F  ++ L  L        ++ N+L   +         L VLD+S N L   + 
Sbjct: 267 EKIMYHPFVKMQRLERL-------YISNNRL-VALNLYGQPIPTLKVLDLSHNHLL-HVE 317

Query: 117 STIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLS 160
                   LE L L  N     +     +  +L++L LS N+  
Sbjct: 318 RNQPQFDRLENLYLDHNSIV-TLKL--STHHTLKNLTLSHNDWD 358

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 70.3 bits (172), Expect = 7e-13
 Identities = 32/168 (19%), Positives = 62/168 (36%), Gaps = 21/168 (12%)

Query: 4   LTLEGNQLSGRLPSTIGH----SLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNS 59
                  +  +           +L N + +    + +       + +  ++ +L+L    
Sbjct: 27  CVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQ 86

Query: 60  FSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCL-----VLTVLDVSRNQLSGD 114
                   F     +  L        +  N +   +PP +     +LTVL + RN LS  
Sbjct: 87  IEEIDTYAFAYAHTIQKL-------YMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS-S 137

Query: 115 IPSTI-GGRVDLETLSLASNQFQGPIPESV-GSLISLESLDLSGNNLS 160
           +P  I      L TLS+++N  +  I +    +  SL++L LS N L+
Sbjct: 138 LPRGIFHNTPKLTTLSMSNNNLER-IEDDTFQATTSLQNLQLSSNRLT 184

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 78.2 bits (193), Expect = 1e-15
 Identities = 42/165 (25%), Positives = 65/165 (39%), Gaps = 15/165 (9%)

Query: 1   MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSI-TNATKLIVLDLG-FN 58
           +  L L  N L+  +PS     L  +  L L  N +  +IP+        L+ LDLG   
Sbjct: 125 LNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELK 182

Query: 59  SFSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIP---PCLVLTVLDVSRNQLSGDI 115
                    F  L +L  L+L           +   +P   P + L  L++S N      
Sbjct: 183 KLEYISEGAFEGLFNLKYLNL-------GMCNIK-DMPNLTPLVGLEELEMSGNHFPEIR 234

Query: 116 PSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLS 160
           P +  G   L+ L + ++Q       +   L SL  L+L+ NNLS
Sbjct: 235 PGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS 279

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 75.9 bits (187), Expect = 7e-15
 Identities = 38/164 (23%), Positives = 59/164 (35%), Gaps = 15/164 (9%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFS 61
            +L L  N +  ++     + L ++  L L  N LT     +    +KL  L L  N   
Sbjct: 102 EVLQLGRNSIR-QIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE 160

Query: 62  GHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPP-----CLVLTVLDVSRNQLSGDIP 116
                 F  +  L  L L          KL   I          L  L++    +  D+P
Sbjct: 161 SIPSYAFNRVPSLMRLDLG------ELKKL-EYISEGAFEGLFNLKYLNLGMCNIK-DMP 212

Query: 117 STIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLS 160
             +   V LE L ++ N F    P S   L SL+ L +  + +S
Sbjct: 213 -NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVS 255

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 73.2 bits (180), Expect = 6e-14
 Identities = 38/164 (23%), Positives = 54/164 (32%), Gaps = 17/164 (10%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSI-TNATKLIVLDLGFNSF 60
           R L L  N +   +PS   + +P++  L L        I          L  L+LG  + 
Sbjct: 150 RELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNI 208

Query: 61  SGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPP----CLV-LTVLDVSRNQLSGDI 115
               +     L  L  L +       +GN     I P     L  L  L V  +Q+S   
Sbjct: 209 KD--MPNLTPLVGLEELEM-------SGNHF-PEIRPGSFHGLSSLKKLWVMNSQVSLIE 258

Query: 116 PSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNL 159
            +   G   L  L+LA N       +    L  L  L L  N  
Sbjct: 259 RNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPW 302

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 70.2 bits (172), Expect = 6e-13
 Identities = 37/165 (22%), Positives = 59/165 (35%), Gaps = 17/165 (10%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFS 61
           R L L  N +   + +     L ++E L L  N++      +      L  L+L  N  +
Sbjct: 78  RYLNLMENNIQ-MIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLT 136

Query: 62  GHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPP-----CLVLTVLDVSR-NQLSGDI 115
                 F  L  L  L        L  N +   IP         L  LD+    +L    
Sbjct: 137 VIPSGAFEYLSKLREL-------WLRNNPI-ESIPSYAFNRVPSLMRLDLGELKKLEYIS 188

Query: 116 PSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLS 160
                G  +L+ L+L     +  +P     L+ LE L++SGN+  
Sbjct: 189 EGAFEGLFNLKYLNLGMCNIKD-MPNLTP-LVGLEELEMSGNHFP 231

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 59.0 bits (143), Expect = 2e-09
 Identities = 42/172 (24%), Positives = 60/172 (34%), Gaps = 21/172 (12%)

Query: 4   LTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGH 63
           +      LS  +P  I     N  YL L  NN+     ++  +   L VL LG NS    
Sbjct: 59  VVCTRRGLS-EVPQGI---PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQI 114

Query: 64  ILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCL-----VLTVLDVSRNQLSGDIPST 118
            +  F  L  L+ L        L  N L   IP         L  L +  N +   IPS 
Sbjct: 115 EVGAFNGLASLNTL-------ELFDNWL-TVIPSGAFEYLSKLRELWLRNNPIE-SIPSY 165

Query: 119 I-GGRVDLETLSLAS-NQFQGPIPESVGSLISLESLDLSGNNLSGKIPKLEG 168
                  L  L L    + +     +   L +L+ L+L   N+   +P L  
Sbjct: 166 AFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPNLTP 216

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 79.0 bits (195), Expect = 1e-15
 Identities = 31/166 (18%), Positives = 67/166 (40%), Gaps = 14/166 (8%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFS 61
           ++L L+ ++++  +     +SL ++E+L L+ N+L+    +     + L  L+L  N + 
Sbjct: 53  QVLILKSSRIN-TIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQ 111

Query: 62  GHILN-TFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLV-----LTVLDVSRNQLSGDI 115
              +   F NL +L  L        +   + +  I          L  L++    L    
Sbjct: 112 TLGVTSLFPNLTNLQTLR-------IGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQ 164

Query: 116 PSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSG 161
             ++    D+  L+L  ++    +      L S+  L+L   NL+ 
Sbjct: 165 SQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLAR 210

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 78.2 bits (193), Expect = 2e-15
 Identities = 33/165 (20%), Positives = 63/165 (38%), Gaps = 21/165 (12%)

Query: 2   RILTLEGNQLS--GRLPSTIGHSLPNIEYLLLTANNLT--GTIPNSITNATKLIVLDLGF 57
             L L  N +       S    + P+++ L+L+ N+L         +     L  LD+  
Sbjct: 337 EFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISR 396

Query: 58  NSFSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLV--LTVLDVSRNQLSGDI 115
           N+F   + ++      +  L        L+   +   +  C+   L VLDVS N L    
Sbjct: 397 NTFH-PMPDSCQWPEKMRFL-------NLSSTGI-RVVKTCIPQTLEVLDVSNNNLD-SF 446

Query: 116 PSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLS 160
              +     L+ L ++ N+ +  +P++      L  + +S N L 
Sbjct: 447 SLFL---PRLQELYISRNKLKT-LPDAS-LFPVLLVMKISRNQLK 486

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 77.8 bits (192), Expect = 3e-15
 Identities = 35/161 (21%), Positives = 56/161 (34%), Gaps = 18/161 (11%)

Query: 2   RILTLEGNQLSGRLPSTIG--HSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNS 59
           + L L  N L   +  T     +L N+  L ++ N     +P+S     K+  L+L    
Sbjct: 364 QTLVLSQNHLR-SMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTG 421

Query: 60  FSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLV-LTVLDVSRNQLSGDIPST 118
                      L  L           ++ N L       L  L  L +SRN+L   +P  
Sbjct: 422 IRVVKTCIPQTLEVLD----------VSNNNL-DSFSLFLPRLQELYISRNKLK-TLPDA 469

Query: 119 IGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNL 159
               V L  + ++ NQ +         L SL+ + L  N  
Sbjct: 470 SLFPV-LLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 77.8 bits (192), Expect = 3e-15
 Identities = 30/165 (18%), Positives = 56/165 (33%), Gaps = 19/165 (11%)

Query: 3   ILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSG 62
           +        +  +PS +      ++ L L+ N +T      +     L VL L  +  + 
Sbjct: 9   VCDGRSRSFT-SIPSGL---TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINT 64

Query: 63  HILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLV-----LTVLDVSRNQLSG-DIP 116
              + F +L  L  L        L+ N L   +          L  L++  N      + 
Sbjct: 65  IEGDAFYSLGSLEHL-------DLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGVT 116

Query: 117 STIGGRVDLETLSLASNQFQGPIPESV-GSLISLESLDLSGNNLS 160
           S      +L+TL + + +    I       L SL  L++   +L 
Sbjct: 117 SLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR 161

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 75.1 bits (185), Expect = 2e-14
 Identities = 36/166 (21%), Positives = 58/166 (34%), Gaps = 17/166 (10%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFS 61
           R L +    L   L +     L  ++ + +  + +     +   +   L  LDL  N   
Sbjct: 289 RRLHIPQFYLFYDLSTVYSL-LEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMV 347

Query: 62  GHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPP------CLV-LTVLDVSRNQLSGD 114
              L           L  L     L+ N L   +         L  LT LD+SRN     
Sbjct: 348 EEYLKNSACKGAWPSLQTL----VLSQNHLR-SMQKTGEILLTLKNLTSLDISRNTFH-P 401

Query: 115 IPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLS 160
           +P +      +  L+L+S   +  +        +LE LD+S NNL 
Sbjct: 402 MPDSCQWPEKMRFLNLSSTGIRV-VKT--CIPQTLEVLDVSNNNLD 444

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 71.3 bits (175), Expect = 3e-13
 Identities = 30/169 (17%), Positives = 61/169 (36%), Gaps = 25/169 (14%)

Query: 1   MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTI---PNSITNATKLIVLDLGF 57
           ++ +T+E +++   +P +    L ++E+L L+ N +                L  L L  
Sbjct: 312 VKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQ 370

Query: 58  NSFS--GHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLV----LTVLDVSRNQL 111
           N              L++L+ L        ++ N     +P        +  L++S   +
Sbjct: 371 NHLRSMQKTGEILLTLKNLTSL-------DISRNTF-HPMPDSCQWPEKMRFLNLSSTGI 422

Query: 112 SGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLS 160
              + + I     LE L +++N            L  L+ L +S N L 
Sbjct: 423 R-VVKTCIPQT--LEVLDVSNNNLDS-FSLF---LPRLQELYISRNKLK 464

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 66.7 bits (163), Expect = 9e-12
 Identities = 30/175 (17%), Positives = 57/175 (32%), Gaps = 16/175 (9%)

Query: 1   MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSF 60
           +  LTL  ++ +  L       L ++ YL L   NL     + +        +       
Sbjct: 174 IHHLTLHLSESA-FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRG 232

Query: 61  SGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYG--RIPP-------------CLVLTVLD 105
           S     +F  L  L    L +  +      L G     P              + +  L 
Sbjct: 233 SVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLH 292

Query: 106 VSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLS 160
           + +  L  D+ +       ++ +++ +++           L SLE LDLS N + 
Sbjct: 293 IPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMV 347

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 57.8 bits (140), Expect = 6e-09
 Identities = 22/198 (11%), Positives = 51/198 (25%), Gaps = 39/198 (19%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFS 61
           + L +   +    +       L ++  L + A +L      S+ +   +  L L  +  +
Sbjct: 126 QTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA 185

Query: 62  GHILNTFGNLRHLSVLSL-----------------LMFGIRLTGN--------------K 90
             +      L  +  L L                 +   ++                  K
Sbjct: 186 FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLK 245

Query: 91  LYGRIPPCLVLTVLDVSRNQLSGDIPSTIG--------GRVDLETLSLASNQFQGPIPES 142
           L   I     +   D + N L    PS             V +  L +        +   
Sbjct: 246 LLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTV 305

Query: 143 VGSLISLESLDLSGNNLS 160
              L  ++ + +  + + 
Sbjct: 306 YSLLEKVKRITVENSKVF 323

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 56.3 bits (136), Expect = 2e-08
 Identities = 30/148 (20%), Positives = 46/148 (31%), Gaps = 38/148 (25%)

Query: 31  LTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLMFGIRLTGNK 90
             + + T +IP+ +T A K   LDL FN  +           +L                
Sbjct: 12  GRSRSFT-SIPSGLTAAMK--SLDLSFNKITYIGHGDLRACANL---------------- 52

Query: 91  LYGRIPPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLE 150
                       VL +  ++++            LE L L+ N          G L SL+
Sbjct: 53  -----------QVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLK 101

Query: 151 SLDLSGNNLSGKIPKLEGEIPVKGSFKN 178
            L+L GN            + V   F N
Sbjct: 102 YLNLMGNPYQ--------TLGVTSLFPN 121

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 76.6 bits (189), Expect = 2e-15
 Identities = 38/168 (22%), Positives = 65/168 (38%), Gaps = 19/168 (11%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSI-TNATKLIVLDLGFNSF 60
             L  + + L      ++  SL N+ YL ++  +      N I    + L VL +  NSF
Sbjct: 104 EHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSF 162

Query: 61  SGHIL-NTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPP----CLV-LTVLDVSRNQLSGD 114
             + L + F  LR+L+ L        L+  +L  ++ P     L  L VL++S N     
Sbjct: 163 QENFLPDIFTELRNLTFLD-------LSQCQL-EQLSPTAFNSLSSLQVLNMSHNNFFSL 214

Query: 115 IPSTIGGRVDLETLSLASNQFQGPIPESV--GSLISLESLDLSGNNLS 160
                     L+ L  + N       +        SL  L+L+ N+ +
Sbjct: 215 DTFPYKCLNSLQVLDYSLNHIMT-SKKQELQHFPSSLAFLNLTQNDFA 261

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 65.4 bits (160), Expect = 9e-12
 Identities = 31/170 (18%), Positives = 53/170 (31%), Gaps = 23/170 (13%)

Query: 4   LTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGH 63
           +      L+  +P+ I     +   L L +N L           T+L  L L  N  S  
Sbjct: 12  IRCNSKGLT-SVPTGI---PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFK 67

Query: 64  ILN--TFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLV----LTVLDVSRNQLSGDIP- 116
                +      L  L L       + N +   +    +    L  LD   + L   +  
Sbjct: 68  GCCSQSDFGTTSLKYLDL-------SFNGV-ITMSSNFLGLEQLEHLDFQHSNLK-QMSE 118

Query: 117 -STIGGRVDLETLSLASNQFQGPIPESV-GSLISLESLDLSGNNLSGKIP 164
            S      +L  L ++    +      +   L SLE L ++GN+      
Sbjct: 119 FSVFLSLRNLIYLDISHTHTRV-AFNGIFNGLSSLEVLKMAGNSFQENFL 167

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 76.2 bits (188), Expect = 2e-15
 Identities = 46/212 (21%), Positives = 75/212 (35%), Gaps = 75/212 (35%)

Query: 280 LGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRSFDSECEV---LRNVRHRNLIKILS 335
           LG    G V +          A+K+             +  EV    R  +  ++++I+ 
Sbjct: 26  LGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQCPHIVRIVD 78

Query: 336 SYSNPDFKA----LVLEFMPNGSLEKWLYSHNYFLDILERLN----------IMIDVGSA 381
            Y N         +V+E +  G L         F  I +R +          IM  +G A
Sbjct: 79  VYENLYAGRKCLLIVMECLDGGEL---------FSRIQDRGDQAFTEREASEIMKSIGEA 129

Query: 382 LEYLHNGHSSVHIIHCDLKPTNILL---DENMVAHVSDFGIYKLLGEGEDSVRQTMTMAT 438
           ++YLH    S++I H D+KP N+L      N +  ++DFG                    
Sbjct: 130 IQYLH----SINIAHRDVKPENLLYTSKRPNAILKLTDFGF------------------- 166

Query: 439 IGYMAPE-----YGLEGIVSAKCDVYSYGVLL 465
               A E     Y         CD++S GV++
Sbjct: 167 ----AKETTGEKYDKS------CDMWSLGVIM 188

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 78.0 bits (192), Expect = 2e-15
 Identities = 55/217 (25%), Positives = 93/217 (42%), Gaps = 32/217 (14%)

Query: 271 TDEFNECNLLGTSSFGSVYKGTISD-GTDVAIK----VFNLQLE--RAFRSFDSECEVLR 323
              +     +G+ + G V     +    +VAIK     F  Q    RA+R    E  +++
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR----ELVLMK 116

Query: 324 NVRHRNLIKIL----SSYSNPDFKA--LVLEFMPNGSLEKWLYSHNYFLDILERLNIMID 377
            V H+N+I +L       +  +F+   LV+E M   +L + +      LD      ++  
Sbjct: 117 CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQME---LDHERMSYLLYQ 172

Query: 378 VGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMT-- 435
           +   +++LH    S  IIH DLKP+NI++  +    + DFG+ +  G         MT  
Sbjct: 173 MLCGIKHLH----SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-----FMMTPY 223

Query: 436 MATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRK 472
           + T  Y APE  L        D++S G ++ E    K
Sbjct: 224 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 76.4 bits (189), Expect = 3e-15
 Identities = 57/229 (24%), Positives = 96/229 (41%), Gaps = 36/229 (15%)

Query: 272 DEFNECNLLGTSSFGSVY---KGTISDGTDV-AIKVFN----LQLERAFRSFDSECEVLR 323
           + F    +LG   +G V+   K T ++   + A+KV      ++  +      +E  +L 
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76

Query: 324 NVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALE 383
            V+H  ++ ++ ++       L+LE++  G L   L     F++      +  ++  AL 
Sbjct: 77  EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLA-EISMALG 135

Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHV--SDFGIYKLLGEGEDSVRQTMTMA-TIG 440
           +LH       II+ DLKP NI+L+     HV  +DFG+ K   E       T T   TI 
Sbjct: 136 HLH----QKGIIYRDLKPENIMLNHQ--GHVKLTDFGLCK---ESIHDGTVTHTFCGTIE 186

Query: 441 YMAPEYGLEGIVSAK-----CDVYSYGVLLMETFTRKRP-----TDEMF 479
           YMAPE     I+         D +S G L+ +  T   P       +  
Sbjct: 187 YMAPE-----ILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTI 230

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 76.0 bits (188), Expect = 3e-15
 Identities = 66/231 (28%), Positives = 105/231 (45%), Gaps = 42/231 (18%)

Query: 272 DEFNECNLLGTSSFGSVY---KGTISDGTDV-AIKVFNLQLERAFRSFDSECE------V 321
            +F    +LG  SFG V+   K + SD   + A+KV    L++A               +
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKV----LKKATLKVRDRVRTKMERDI 79

Query: 322 LRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSA 381
           L  V H  ++K+  ++       L+L+F+  G L   L     F +   +  +  ++  A
Sbjct: 80  LVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-ELALA 138

Query: 382 LEYLHNGHSSVHIIHCDLKPTNILLDENMVAHV--SDFGIYKLLGEGEDSVRQTMTM-AT 438
           L++LH    S+ II+ DLKP NILLDE    H+  +DFG+ K   E  D  ++  +   T
Sbjct: 139 LDHLH----SLGIIYRDLKPENILLDEE--GHIKLTDFGLSK---ESIDHEKKAYSFCGT 189

Query: 439 IGYMAPEYGLEGIVSAK-----CDVYSYGVLLMETFTRKRP-----TDEMF 479
           + YMAPE     +V+ +      D +S+GVL+ E  T   P       E  
Sbjct: 190 VEYMAPE-----VVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETM 235

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 75.7 bits (186), Expect = 4e-15
 Identities = 36/179 (20%), Positives = 59/179 (32%), Gaps = 18/179 (10%)

Query: 1   MRILTLEGNQLSGR---LPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGF 57
           + IL L     + R   L        P ++ L +   +        +     L  LDL  
Sbjct: 123 LNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSD 182

Query: 58  NSFSGHI-------LNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLVLTVLDVSRNQ 110
           N   G            F  L+ L++ +  M       + L         L  LD+S N 
Sbjct: 183 NPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQ---LQGLDLSHNS 239

Query: 111 LSGDIPSTIGGRVD-LETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKLEG 168
           L     +        L +L+L+    +  +P+ + +   L  LDLS N L    P  + 
Sbjct: 240 LRDAAGAPSCDWPSQLNSLNLSFTGLKQ-VPKGLPA--KLSVLDLSYNRLDR-NPSPDE 294

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 74.2 bits (182), Expect = 1e-14
 Identities = 33/173 (19%), Positives = 53/173 (30%), Gaps = 25/173 (14%)

Query: 1   MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTI-------PNSITNATKLIVL 53
           +++L++                 P +  L L+ N   G         P        L + 
Sbjct: 151 LKVLSIAQAHSL-NFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALR 209

Query: 54  DLGFNSFSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPP--CLV---LTVLDVSR 108
           + G  + SG           L  L L       + N L        C     L  L++S 
Sbjct: 210 NAGMETPSGVCSALAAARVQLQGLDL-------SHNSLRDAAGAPSCDWPSQLNSLNLSF 262

Query: 109 NQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSG 161
             L   +P  +  +  L  L L+ N+     P S   L  + +L L GN    
Sbjct: 263 TGLKQ-VPKGLPAK--LSVLDLSYNRLDR-NP-SPDELPQVGNLSLKGNPFLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 70.7 bits (173), Expect = 2e-13
 Identities = 33/182 (18%), Positives = 63/182 (34%), Gaps = 16/182 (8%)

Query: 4   LTLEGNQLSGRLPSTIGH--SLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFS 61
           LT+   ++  R+         +  ++ L L    +TGT P  +  AT   +  L   + S
Sbjct: 73  LTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVS 132

Query: 62  GHILNTF-GNLRHLSVLSLLMFGIRLTGNKLYGRIPPCL----VLTVLDVSRNQLSGDIP 116
               + +   L+      L +  + +            +     L+ LD+S N   G+  
Sbjct: 133 WATRDAWLAELQQWLKPGLKV--LSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERG 190

Query: 117 STI----GGRVDLETLSLASNQFQ---GPIPESVGSLISLESLDLSGNNLSGKIPKLEGE 169
                       L+ L+L +   +   G       + + L+ LDLS N+L         +
Sbjct: 191 LISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCD 250

Query: 170 IP 171
            P
Sbjct: 251 WP 252

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 70.3 bits (172), Expect = 2e-13
 Identities = 34/146 (23%), Positives = 49/146 (33%), Gaps = 19/146 (13%)

Query: 2   RILTLEGNQLSGRLP---STIGHSLPNIEYLLLTANNLT---GTIPNSITNATKLIVLDL 55
             L L  N   G      +      P ++ L L    +    G          +L  LDL
Sbjct: 176 STLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDL 235

Query: 56  GFNSFSGHI-LNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLV--LTVLDVSRNQLS 112
             NS        +      L+ L+L       +   L  ++P  L   L+VLD+S N+L 
Sbjct: 236 SHNSLRDAAGAPSCDWPSQLNSLNL-------SFTGLK-QVPKGLPAKLSVLDLSYNRLD 287

Query: 113 GDIPSTIGGRVDLETLSLASNQFQGP 138
              PS       +  LSL  N F   
Sbjct: 288 R-NPS-PDELPQVGNLSLKGNPFLDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 54.9 bits (132), Expect = 2e-08
 Identities = 33/158 (20%), Positives = 56/158 (35%), Gaps = 15/158 (9%)

Query: 25  NIEYLLLTANNLTGTIP-NSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLMFG 83
           ++EYLL   +          I  +  L  L +        IL     +  +S L  L   
Sbjct: 44  SLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQEL--- 100

Query: 84  IRLTGNKLYGRIPPCLV------LTVLDVSRNQLSG--DIPSTIGGRV--DLETLSLASN 133
             L   ++ G  PP L+      L +L++     +      + +   +   L+ LS+A  
Sbjct: 101 -TLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQA 159

Query: 134 QFQGPIPESVGSLISLESLDLSGNNLSGKIPKLEGEIP 171
                  E V    +L +LDLS N   G+   +    P
Sbjct: 160 HSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCP 197

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 75.0 bits (185), Expect = 5e-15
 Identities = 42/167 (25%), Positives = 63/167 (37%), Gaps = 19/167 (11%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFS 61
           + + L GN++S  +P+    +  N+  L L +N L      + T    L  LDL  N+  
Sbjct: 35  QRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93

Query: 62  GHI-LNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCL-----VLTVLDVSRNQLSGDI 115
             +   TF  L  L  L        L    L   + P L      L  L +  N L   +
Sbjct: 94  RSVDPATFHGLGRLHTL-------HLDRCGL-QELGPGLFRGLAALQYLYLQDNALQ-AL 144

Query: 116 PSTI-GGRVDLETLSLASNQFQGPIPESV-GSLISLESLDLSGNNLS 160
           P        +L  L L  N+    +PE     L SL+ L L  N ++
Sbjct: 145 PDDTFRDLGNLTHLFLHGNRISS-VPERAFRGLHSLDRLLLHQNRVA 190

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 74.6 bits (184), Expect = 6e-15
 Identities = 40/168 (23%), Positives = 59/168 (35%), Gaps = 19/168 (11%)

Query: 1   MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSI-TNATKLIVLDLGFNS 59
           + IL L  N L+ R+ +     L  +E L L+ N    ++  +      +L  L L    
Sbjct: 58  LTILWLHSNVLA-RIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCG 116

Query: 60  FSGHI-LNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLV-----LTVLDVSRNQLSG 113
               +    F  L  L  L        L  N L   +P         LT L +  N++S 
Sbjct: 117 LQ-ELGPGLFRGLAALQYL-------YLQDNAL-QALPDDTFRDLGNLTHLFLHGNRISS 167

Query: 114 DIPSTIGGRVDLETLSLASNQFQGPIPESV-GSLISLESLDLSGNNLS 160
                  G   L+ L L  N+    +       L  L +L L  NNLS
Sbjct: 168 VPERAFRGLHSLDRLLLHQNRVAH-VHPHAFRDLGRLMTLYLFANNLS 214

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 69.3 bits (170), Expect = 4e-13
 Identities = 35/161 (21%), Positives = 53/161 (32%), Gaps = 20/161 (12%)

Query: 7   EGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILN 66
               L   +P  I       + + L  N ++     S      L +L L  N  +     
Sbjct: 19  PQQGLQ-AVPVGI---PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAA 74

Query: 67  TFGNLRHLSVLSLLMFGIRLTGNKLYGRIPP-----CLVLTVLDVSRNQLSGDIPSTI-G 120
            F  L  L  L        L+ N     + P        L  L + R  L  ++   +  
Sbjct: 75  AFTGLALLEQLD-------LSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFR 126

Query: 121 GRVDLETLSLASNQFQGPIPESV-GSLISLESLDLSGNNLS 160
           G   L+ L L  N  Q  +P+     L +L  L L GN +S
Sbjct: 127 GLAALQYLYLQDNALQA-LPDDTFRDLGNLTHLFLHGNRIS 166

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 68.5 bits (168), Expect = 6e-13
 Identities = 36/165 (21%), Positives = 60/165 (36%), Gaps = 17/165 (10%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSI-TNATKLIVLDLGFNSF 60
             L L  N     +     H L  +  L L    L   +   +      L  L L  N+ 
Sbjct: 83  EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNAL 141

Query: 61  SGHI-LNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPP-----CLVLTVLDVSRNQLSGD 114
              +  +TF +L +L+ L L        GN++   +P         L  L + +N+++  
Sbjct: 142 Q-ALPDDTFRDLGNLTHLFL-------HGNRI-SSVPERAFRGLHSLDRLLLHQNRVAHV 192

Query: 115 IPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNL 159
            P        L TL L +N       E++  L +L+ L L+ N  
Sbjct: 193 HPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPW 237

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 40.7 bits (96), Expect = 8e-04
 Identities = 15/64 (23%), Positives = 24/64 (37%)

Query: 101 LTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLS 160
              + +  N++S    ++     +L  L L SN        +   L  LE LDLS N   
Sbjct: 34  SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93

Query: 161 GKIP 164
             + 
Sbjct: 94  RSVD 97

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 75.4 bits (186), Expect = 5e-15
 Identities = 37/181 (20%), Positives = 69/181 (38%), Gaps = 29/181 (16%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSI-TNATKLIVLDLGFNSF 60
             L L  NQL   LP         ++ L +  N +T  +  S+     ++IV++LG N  
Sbjct: 103 ERLYLSKNQLK-ELPE---KMPKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPL 157

Query: 61  SGHIL--NTFGNLRHLSVLSL----------LMFG----IRLTGNKLYGRIPPCL----- 99
               +    F  ++ LS + +           +      + L GNK+  ++         
Sbjct: 158 KSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELHLDGNKI-TKVDAASLKGLN 216

Query: 100 VLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNL 159
            L  L +S N +S     ++     L  L L +N+    +P  +     ++ + L  NN+
Sbjct: 217 NLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNI 275

Query: 160 S 160
           S
Sbjct: 276 S 276

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 71.2 bits (175), Expect = 1e-13
 Identities = 34/169 (20%), Positives = 62/169 (36%), Gaps = 19/169 (11%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFS 61
           R++      L  ++P  +    P+   L L  N +T        N   L  L L  N  S
Sbjct: 34  RVVQCSDLGLE-KVPKDLP---PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS 89

Query: 62  GHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCL--VLTVLDVSRNQLSGDIPSTI 119
                 F  L  L  L        L+ N+L   +P  +   L  L V  N+++  +  ++
Sbjct: 90  KISPGAFAPLVKLERL-------YLSKNQLK-ELPEKMPKTLQELRVHENEIT-KVRKSV 140

Query: 120 -GGRVDLETLSLASNQFQ-GPIPESV-GSLISLESLDLSGNNLSGKIPK 165
             G   +  + L +N  +   I       +  L  + ++  N++  IP+
Sbjct: 141 FNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ 188

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 70.4 bits (173), Expect = 3e-13
 Identities = 31/172 (18%), Positives = 59/172 (34%), Gaps = 24/172 (13%)

Query: 1   MRILTLEGNQL-SGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNS 59
           M ++ L  N L S  + +     +  + Y+ +   N+T TIP  +     L  L L  N 
Sbjct: 147 MIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLP--PSLTELHLDGNK 203

Query: 60  FSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPP-----CLVLTVLDVSRNQLSGD 114
            +     +   L +L+ L        L+ N +   +          L  L ++ N+L   
Sbjct: 204 ITKVDAASLKGLNNLAKL-------GLSFNSI-SAVDNGSLANTPHLRELHLNNNKLV-K 254

Query: 115 IPSTIGGRVDLETLSLASNQFQG------PIPESVGSLISLESLDLSGNNLS 160
           +P  +     ++ + L +N            P       S   + L  N + 
Sbjct: 255 VPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 306

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 69.6 bits (171), Expect = 4e-13
 Identities = 36/168 (21%), Positives = 57/168 (33%), Gaps = 24/168 (14%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFS 61
             + +    ++  +P       P++  L L  N +T     S+     L  L L FNS S
Sbjct: 174 SYIRIADTNIT-TIPQ---GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSIS 229

Query: 62  GHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLV----LTVLDVSRNQLSG---- 113
                +  N  HL  L        L  NKL  ++P  L     + V+ +  N +S     
Sbjct: 230 AVDNGSLANTPHLRELH-------LNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSN 281

Query: 114 --DIPSTIGGRVDLETLSLASNQFQ-GPIPESV-GSLISLESLDLSGN 157
               P     +     +SL SN  Q   I  S    +    ++ L   
Sbjct: 282 DFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 75.8 bits (187), Expect = 6e-15
 Identities = 57/224 (25%), Positives = 92/224 (41%), Gaps = 42/224 (18%)

Query: 271 TDEFNECNLLGTSSFGSVYKGT-ISDGTDVAIK---VFNLQLE--RAFRSFDSECEVLRN 324
              +   + +G  ++G V       +   VAIK    F  Q    R  R    E ++L  
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLR 81

Query: 325 VRHRNLIKILSSYSNPDFKA-----LVLEFMPNGSLEKWLYS-------HNYFL-DILER 371
            RH N+I I      P  +      +V + M    L K L +         YFL  IL  
Sbjct: 82  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQIL-- 138

Query: 372 LNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVR 431
                     L+Y+H    S +++H DLKP+N+LL+      + DFG+ ++  + +    
Sbjct: 139 --------RGLKYIH----SANVLHRDLKPSNLLLNTTCDLKICDFGLARVA-DPDHDHT 185

Query: 432 QTMT--MATIGYMAPEYGLE-GIVSAKCDVYSYGVLLMETFTRK 472
             +T  +AT  Y APE  L     +   D++S G +L E  + +
Sbjct: 186 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 74.8 bits (184), Expect = 6e-15
 Identities = 33/255 (12%), Positives = 68/255 (26%), Gaps = 58/255 (22%)

Query: 279 LLGTSSFGSVYKGTISD---GTDVAIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLIK 332
             G       ++    D      VA+   + Q    +   +   S    L  +    + +
Sbjct: 38  FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95

Query: 333 ILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSV 392
           +L          +V E++  GSL++   +       +  +  M  + +A +  H      
Sbjct: 96  VLDVVHTRAGGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAH----RA 148

Query: 393 HIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIV 452
            +      P+ +         VS  G   L              A    M          
Sbjct: 149 GVALSIDHPSRVR--------VSIDGDVVL--------------AYPATMPD-------A 179

Query: 453 SAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLR-------------RWVKESLPHGLTE 499
           + + D+   G  L      + P  E       L                +   +P  ++ 
Sbjct: 180 NPQDDIRGIGASLYALLVNRWPLPEA-GVRSGLAPAERDTAGQPIEPADIDRDIPFQISA 238

Query: 500 VVDANLVREEQAFSA 514
           V   ++  +    SA
Sbjct: 239 VAARSVQGDGGIRSA 253

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 75.9 bits (187), Expect = 7e-15
 Identities = 36/164 (21%), Positives = 57/164 (34%), Gaps = 15/164 (9%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFS 61
            IL L  N +   +     + L N+  L L  N LT     +    +KL  L L  N   
Sbjct: 91  EILQLSRNHIR-TIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE 149

Query: 62  GHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPP-----CLVLTVLDVSRNQLSGDIP 116
                 F  +  L  L L          +L   I          L  L+++   L  +IP
Sbjct: 150 SIPSYAFNRIPSLRRLDLG------ELKRL-SYISEGAFEGLSNLRYLNLAMCNLR-EIP 201

Query: 117 STIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLS 160
             +   + L+ L L+ N      P S   L+ L+ L +  + + 
Sbjct: 202 -NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQ 244

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 75.9 bits (187), Expect = 7e-15
 Identities = 46/165 (27%), Positives = 71/165 (43%), Gaps = 15/165 (9%)

Query: 1   MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSI-TNATKLIVLDLG-FN 58
           +  L L  N+L+  +P+     L  ++ L L  N +  +IP+        L  LDLG   
Sbjct: 114 LNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELK 171

Query: 59  SFSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIP---PCLVLTVLDVSRNQLSGDI 115
             S      F  L +L  L+L           L   IP   P + L  LD+S N LS   
Sbjct: 172 RLSYISEGAFEGLSNLRYLNL-------AMCNLR-EIPNLTPLIKLDELDLSGNHLSAIR 223

Query: 116 PSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLS 160
           P +  G + L+ L +  +Q Q     +  +L SL  ++L+ NNL+
Sbjct: 224 PGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT 268

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 73.2 bits (180), Expect = 5e-14
 Identities = 33/164 (20%), Positives = 56/164 (34%), Gaps = 17/164 (10%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIP-NSITNATKLIVLDLGFNSF 60
           + L L  N +   +PS   + +P++  L L        I   +    + L  L+L   + 
Sbjct: 139 KELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNL 197

Query: 61  SGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPP-----CLVLTVLDVSRNQLSGDI 115
               +     L  L  L L       +GN L   I P      + L  L + ++Q+    
Sbjct: 198 RE--IPNLTPLIKLDELDL-------SGNHL-SAIRPGSFQGLMHLQKLWMIQSQIQVIE 247

Query: 116 PSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNL 159
            +       L  ++LA N       +    L  LE + L  N  
Sbjct: 248 RNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPW 291

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 71.7 bits (176), Expect = 2e-13
 Identities = 45/165 (27%), Positives = 66/165 (40%), Gaps = 17/165 (10%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFS 61
           R+L L  NQ+   +       L ++E L L+ N++      +      L  L+L  N  +
Sbjct: 67  RLLNLHENQIQ-IIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLT 125

Query: 62  GHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPP-----CLVLTVLDVSR-NQLSGDI 115
                 F  L  L  L        L  N +   IP         L  LD+    +LS   
Sbjct: 126 TIPNGAFVYLSKLKEL-------WLRNNPI-ESIPSYAFNRIPSLRRLDLGELKRLSYIS 177

Query: 116 PSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLS 160
                G  +L  L+LA    +  IP ++  LI L+ LDLSGN+LS
Sbjct: 178 EGAFEGLSNLRYLNLAMCNLRE-IP-NLTPLIKLDELDLSGNHLS 220

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 74.6 bits (184), Expect = 8e-15
 Identities = 54/240 (22%), Positives = 100/240 (41%), Gaps = 52/240 (21%)

Query: 260 RRTSYLDIQRATDEFNE------CNLLGTSSFGSVYKGT-ISDGTDVAIKVFNL-QLERA 311
           R   Y D +    E+           LG   +  V++   I++   V +K+    + ++ 
Sbjct: 18  RPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKI 77

Query: 312 FRSFDSECEVLRNVR-HRNLIKILSSYSNPDFK--ALVLEFMPNGSLEKWLYSHN----- 363
            R    E ++L N+R   N+I +     +P  +  ALV E + N   ++   +       
Sbjct: 78  KR----EIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIR 133

Query: 364 YFL-DILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLD-ENMVAHVSDFGIYK 421
           +++ +IL+          AL+Y H    S+ I+H D+KP N+++D E+    + D+G   
Sbjct: 134 FYMYEILK----------ALDYCH----SMGIMHRDVKPHNVMIDHEHRKLRLIDWG--- 176

Query: 422 LLGEGEDSVRQTMT--MATIGYMAPEYGLEGIVSAKC-----DVYSYGVLLMETFTRKRP 474
            L E      Q     +A+  +  PE     +V  +      D++S G +L     RK P
Sbjct: 177 -LAEFYHPG-QEYNVRVASRYFKGPEL----LVDYQMYDYSLDMWSLGCMLASMIFRKEP 230

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 75.0 bits (185), Expect = 8e-15
 Identities = 58/224 (25%), Positives = 97/224 (43%), Gaps = 47/224 (20%)

Query: 271 TDEFNECNLLGTSSFGSVYKGT-ISDGTDVAIK----VFNLQLE--RAFRSFDSECEVLR 323
              +     +G+ ++GSV        G  VAIK     F  ++   RA+R    E  +L+
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR----ELLLLK 78

Query: 324 NVRHRNLIKIL----SSYSNPDFKA--LVLEFMPNGSLEKWLYS------HNYFLDILER 371
           +++H N+I +L     + S  +F    LV+ FM    L+K +          Y +  + +
Sbjct: 79  HMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFSEEKIQYLVYQMLK 137

Query: 372 LNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVR 431
                     L+Y+H    S  ++H DLKP N+ ++E+    + DFG    L    D+  
Sbjct: 138 ---------GLKYIH----SAGVVHRDLKPGNLAVNEDCELKILDFG----LARHADA-- 178

Query: 432 QTMT--MATIGYMAPEYGLE-GIVSAKCDVYSYGVLLMETFTRK 472
             MT  + T  Y APE  L     +   D++S G ++ E  T K
Sbjct: 179 -EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 76.6 bits (188), Expect = 9e-15
 Identities = 61/226 (26%), Positives = 92/226 (40%), Gaps = 33/226 (14%)

Query: 272 DEFNECNLLGTSSFGSV----YKGTISDGTDVAIKVFNLQLERAFRSFDSEC-----EVL 322
            +FN   +LG  SFG V     KGT       A+K+  L+ +   +  D EC      VL
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGT---DELYAVKI--LKKDVVIQDDDVECTMVEKRVL 395

Query: 323 -RNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSA 381
               +   L ++ S +   D    V+E++  G L   +     F +         ++   
Sbjct: 396 ALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAA-EIAIG 454

Query: 382 LEYLHNGHSSVHIIHCDLKPTNILLDENMVAHV--SDFGIYKLLGEGEDSVRQTMTMA-T 438
           L +L     S  II+ DLK  N++LD     H+  +DFG+ K   E       T T   T
Sbjct: 455 LFFLQ----SKGIIYRDLKLDNVMLDSE--GHIKIADFGMCK---ENIWDGVTTKTFCGT 505

Query: 439 IGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRP-----TDEMF 479
             Y+APE           D +++GVLL E    + P      DE+F
Sbjct: 506 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF 551

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 74.6 bits (184), Expect = 9e-15
 Identities = 46/216 (21%), Positives = 91/216 (42%), Gaps = 34/216 (15%)

Query: 272 DEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQLE-----RAFRSFDSECEVLRNV 325
           + + + + LG  ++ +VYKG        VA+K   L+ E      A R    E  +L+++
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR----EVSLLKDL 57

Query: 326 RHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYL 385
           +H N++ +           LV E++    L+++L      +++      +  +   L Y 
Sbjct: 58  KHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYC 116

Query: 386 HNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMT--MATIGYMA 443
           H       ++H DLKP N+L++E     ++DFG+ +         + T    + T+ Y  
Sbjct: 117 H----RQKVLHRDLKPQNLLINERGELKLADFGLARAKS---IPTK-TYDNEVVTLWYRP 168

Query: 444 PE-------YGLEGIVSAKCDVYSYGVLLMETFTRK 472
           P+       Y      S + D++  G +  E  T +
Sbjct: 169 PDILLGSTDY------STQIDMWGVGCIFYEMATGR 198

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 74.1 bits (183), Expect = 1e-14
 Identities = 51/217 (23%), Positives = 89/217 (41%), Gaps = 35/217 (16%)

Query: 272 DEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQLER------AFRSFDSECEVLRN 324
           +++ +   +G  S+G V+K      G  VAIK F    +       A R    E  +L+ 
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR----EIRMLKQ 58

Query: 325 VRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEY 384
           ++H NL+ +L  +       LV E+  + ++   L  +   +      +I      A+ +
Sbjct: 59  LKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNF 117

Query: 385 LHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMT--MATIGYM 442
            H      + IH D+KP NIL+ ++ V  + DFG  +LL              +AT  Y 
Sbjct: 118 CH----KHNCIHRDVKPENILITKHSVIKLCDFGFARLLT----GPSDYYDDEVATRWYR 169

Query: 443 APE-------YGLEGIVSAKCDVYSYGVLLMETFTRK 472
           +PE       YG   +     DV++ G +  E  +  
Sbjct: 170 SPELLVGDTQYG-PPV-----DVWAIGCVFAELLSGV 200

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 74.3 bits (183), Expect = 2e-14
 Identities = 54/216 (25%), Positives = 92/216 (42%), Gaps = 48/216 (22%)

Query: 280 LGTSSFGSVYKGTISD-GTDVAIK----VFNLQLE--RAFRSFDSECEVLRNVRHRNLIK 332
           +G+ ++GSV     +  G  VA+K     F   +   R +R    E  +L++++H N+I 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 92

Query: 333 IL----SSYSNPDFKA--LVLEFMPNGSLEKWLYS-------HNYFLDILERLNIMIDVG 379
           +L     + S  +F    LV   M    L   +           + +  + R        
Sbjct: 93  LLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQILR-------- 143

Query: 380 SALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMT--MA 437
             L+Y+H    S  IIH DLKP+N+ ++E+    + DFG+ +            MT  +A
Sbjct: 144 -GLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTADEMTGYVA 191

Query: 438 TIGYMAPEYGLE-GIVSAKCDVYSYGVLLMETFTRK 472
           T  Y APE  L     +   D++S G ++ E  T +
Sbjct: 192 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 74.9 bits (184), Expect = 2e-14
 Identities = 41/165 (24%), Positives = 63/165 (38%), Gaps = 18/165 (10%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSI---TNATKLIVLDLGFN 58
             L    N L+          L  +E L+L  N L   +       T    L  LD+  N
Sbjct: 327 LHLDFSNNLLT-DTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQN 384

Query: 59  SFSGHIL-NTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLV--LTVLDVSRNQLSGDI 115
           S S           + L  L        ++ N L   I  CL   + VLD+  N++   I
Sbjct: 385 SVSYDEKKGDCSWTKSLLSL-------NMSSNILTDTIFRCLPPRIKVLDLHSNKIK-SI 436

Query: 116 PSTIGGRVDLETLSLASNQFQGPIPESV-GSLISLESLDLSGNNL 159
           P  +     L+ L++ASNQ +  +P+ +   L SL+ + L  N  
Sbjct: 437 PKQVVKLEALQELNVASNQLKS-VPDGIFDRLTSLQKIWLHTNPW 480

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 71.8 bits (176), Expect = 2e-13
 Identities = 36/185 (19%), Positives = 66/185 (35%), Gaps = 23/185 (12%)

Query: 1   MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSF 60
           M I     +     +       +    +L  + N LT T+  +  + T+L  L L  N  
Sbjct: 302 MNIKNFTVSGTR-MVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQL 360

Query: 61  SGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLV-----LTVLDVSRNQLSGDI 115
              +         +  L  L     ++ N +              L  L++S N L+  I
Sbjct: 361 K-ELSKIAEMTTQMKSLQQLD----ISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTI 415

Query: 116 PSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKLEGEIPVKGS 175
              +     ++ L L SN+ +  IP+ V  L +L+ L+++ N L          +P  G 
Sbjct: 416 FRCLP--PRIKVLDLHSNKIKS-IPKQVVKLEALQELNVASNQLK--------SVP-DGI 463

Query: 176 FKNFS 180
           F   +
Sbjct: 464 FDRLT 468

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 62.6 bits (152), Expect = 1e-10
 Identities = 51/318 (16%), Positives = 98/318 (30%), Gaps = 27/318 (8%)

Query: 3   ILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSG 62
           ++    N L   +P  +         L ++ N ++    + I + +KL +L +  N    
Sbjct: 4   LVDRSKNGLI-HVPKDLS---QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQY 59

Query: 63  HILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLV-LTVLDVSRNQL-SGDIPSTIG 120
             ++ F   + L  L        L+ NKL        V L  LD+S N   +  I    G
Sbjct: 60  LDISVFKFNQELEYL-------DLSHNKLVKISCHPTVNLKHLDLSFNAFDALPICKEFG 112

Query: 121 GRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKLEGEIPVKGSFKNFS 180
               L+ L L++   +      +  L   + L + G     K              ++F+
Sbjct: 113 NMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKED--------PEGLQDFN 164

Query: 181 TESFFGNYALCGPPKLRVPPC-KPDNSKRTKKVPLIVLKYILPPIVSTVLVVITIIMYIR 239
           TES    +         +    K   +     +  ++        +S +  + T      
Sbjct: 165 TESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSN 224

Query: 240 CRNRNTKKSDHEDFLPLAIWRRTS--YLDIQRATDEFNECNLLGTSSFGSVYKGTISDGT 297
               N + + +     L +   T+  Y  I     +          S  S+   +I    
Sbjct: 225 LTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIH--- 281

Query: 298 DVAIKVFNLQLERAFRSF 315
            V   VF       +  F
Sbjct: 282 QVVSDVFGFPQSYIYEIF 299

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 44.9 bits (106), Expect = 5e-05
 Identities = 25/136 (18%), Positives = 47/136 (34%), Gaps = 32/136 (23%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFS 61
           + L +  N +S            ++  L +++N LT TI   +    ++ VLDL  N   
Sbjct: 377 QQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSN--- 431

Query: 62  GHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLVLTVLDVSRNQLSGDIP-STIG 120
                       +  +   +   +L              L  L+V+ NQL   +P     
Sbjct: 432 -----------KIKSIPKQVV--KLEA------------LQELNVASNQLK-SVPDGIFD 465

Query: 121 GRVDLETLSLASNQFQ 136
               L+ + L +N + 
Sbjct: 466 RLTSLQKIWLHTNPWD 481

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 74.9 bits (184), Expect = 3e-14
 Identities = 42/164 (25%), Positives = 65/164 (39%), Gaps = 18/164 (10%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPN---SITNATKLIVLDLGFN 58
             L    N  +         +L  ++ L+L  N L            N + L  LD+  N
Sbjct: 356 TFLNFTQNVFT-DSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLN 413

Query: 59  SF-SGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLV--LTVLDVSRNQLSGDI 115
           S  S     T      + VL        L+ N L G +  CL   + VLD+  N++   I
Sbjct: 414 SLNSHAYDRTCAWAESILVL-------NLSSNMLTGSVFRCLPPKVKVLDLHNNRIM-SI 465

Query: 116 PSTIGGRVDLETLSLASNQFQGPIPESV-GSLISLESLDLSGNN 158
           P  +     L+ L++ASNQ +  +P+ V   L SL+ + L  N 
Sbjct: 466 PKDVTHLQALQELNVASNQLKS-VPDGVFDRLTSLQYIWLHDNP 508

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 71.4 bits (175), Expect = 3e-13
 Identities = 37/185 (20%), Positives = 70/185 (37%), Gaps = 23/185 (12%)

Query: 1   MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSF 60
           M I  L  +     +      S  +  +L  T N  T ++    +   +L  L L  N  
Sbjct: 331 MNIKMLSISDTP-FIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGL 389

Query: 61  SGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLV-----LTVLDVSRNQLSGDI 115
             +        +++S L  L     ++ N L              + VL++S N L+G +
Sbjct: 390 K-NFFKVALMTKNMSSLETL----DVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSV 444

Query: 116 PSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKLEGEIPVKGS 175
              +  +  ++ L L +N+    IP+ V  L +L+ L+++ N L          +P  G 
Sbjct: 445 FRCLPPK--VKVLDLHNNRIMS-IPKDVTHLQALQELNVASNQLK--------SVP-DGV 492

Query: 176 FKNFS 180
           F   +
Sbjct: 493 FDRLT 497

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 54.9 bits (132), Expect = 5e-08
 Identities = 38/166 (22%), Positives = 62/166 (37%), Gaps = 20/166 (12%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSF- 60
           R+L L  N++   L   +     ++EYL ++ N L   I         L  LDL FN F 
Sbjct: 79  RVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLDLSFNDFD 134

Query: 61  SGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPC------LVLTVLDVSRNQLSGD 114
              +   FGNL  L+ L        L+  K   ++         L   +LD+    + G 
Sbjct: 135 VLPVCKEFGNLTKLTFL-------GLSAAKFR-QLDLLPVAHLHLSCILLDLVSYHIKGG 186

Query: 115 IPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLS 160
              ++    +   L L  +       +   S+ +L  L LS   L+
Sbjct: 187 ETESLQI-PNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLN 231

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 48.3 bits (115), Expect = 6e-06
 Identities = 50/324 (15%), Positives = 95/324 (29%), Gaps = 42/324 (12%)

Query: 101 LTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESV-GSLISLESLDLSGNNL 159
              L +S+N +S      I    +L  L L+ N+ +  +   V      LE LD+S N L
Sbjct: 54  TKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRS-LDFHVFLFNQDLEYLDVSHNRL 112

Query: 160 S----GKIPKLE---------GEIPVKGSFKNFSTESFFGNYALCGPPKLRVPPCKPDNS 206
                  +  L            +PV   F N +  +F G  A     K R     P   
Sbjct: 113 QNISCCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSA----AKFRQLDLLPVAH 168

Query: 207 KRTKKVPLIVLKYILPPIVSTVLVVITIIMYIRCRNRNTKKSDHEDFLPLAIWRRTSYLD 266
                + L ++ Y +    +  L +    +     + N+  S   +          S   
Sbjct: 169 LHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVN---------MSVNA 219

Query: 267 IQRATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVR 326
           +        + N        +               + N+ L+    ++    ++ +   
Sbjct: 220 LGHLQLSNIKLNDENCQRLMTFLSELTRG-----PTLLNVTLQHIETTWKCSVKLFQFFW 274

Query: 327 HRNL----IKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSAL 382
            R +    I  L+     D +          +L+  +  H      L     +  V + +
Sbjct: 275 PRPVEYLNIYNLTITERIDREEFTYS---ETALKSLMIEHVKNQVFLFSKEALYSVFAEM 331

Query: 383 EYLHNGHSSVHIIH--CDLKPTNI 404
                  S    IH  C   P++ 
Sbjct: 332 NIKMLSISDTPFIHMVCPPSPSSF 355

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 46.0 bits (109), Expect = 3e-05
 Identities = 31/138 (22%), Positives = 46/138 (33%), Gaps = 31/138 (22%)

Query: 24  PNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLMFG 83
           P  + L L+ N+++      I+  ++L VL L  N       + F   +           
Sbjct: 52  PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQD---------- 101

Query: 84  IRLTGNKLYGRIPPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQG-PIPES 142
                            L  LDVS N+L   I         L  L L+ N F   P+ + 
Sbjct: 102 -----------------LEYLDVSHNRLQN-ISC--CPMASLRHLDLSFNDFDVLPVCKE 141

Query: 143 VGSLISLESLDLSGNNLS 160
            G+L  L  L LS     
Sbjct: 142 FGNLTKLTFLGLSAAKFR 159

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 41.4 bits (97), Expect = 7e-04
 Identities = 22/171 (12%), Positives = 49/171 (28%), Gaps = 15/171 (8%)

Query: 3   ILTLEGNQLS----GRLPSTIGHSLPNIEYLLLTANNLTGTIPN-----SITNATKLIVL 53
            L L   +L+     RL + +         L +T  ++  T               +  L
Sbjct: 222 HLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYL 281

Query: 54  DLGFNSFSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPP----CLVLTVLDVSRN 109
           ++   + +  I          ++ SL++    +                  + +  +S +
Sbjct: 282 NIYNLTITERIDREEFTYSETALKSLMIE--HVKNQVFLFSKEALYSVFAEMNIKMLSIS 339

Query: 110 QLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLS 160
                             L+   N F   + +   +L  L++L L  N L 
Sbjct: 340 DTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK 390

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 73.4 bits (181), Expect = 3e-14
 Identities = 62/227 (27%), Positives = 93/227 (40%), Gaps = 59/227 (25%)

Query: 280 LGTSSFGSVYKGT-ISDGTDVAIK---VFNLQLE--RAFRSFDSECEVLRNVRHRNLIKI 333
           LG  ++G V   T    G  VAIK    F+  L   R  R    E ++L++ +H N+I I
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR----EIKILKHFKHENIITI 74

Query: 334 LSSYSNPDFKA-----LVLEFMPNGSLEKWLYS-------HNYFL-DILERLNIMIDVGS 380
            +      F+      ++ E M    L + + +         YF+   L           
Sbjct: 75  FNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQMLSDDHIQYFIYQTL----------R 123

Query: 381 ALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFG----IYKLLGEGEDSVRQTMTM 436
           A++ LH      ++IH DLKP+N+L++ N    V DFG    I +   +  +   Q   M
Sbjct: 124 AVKVLH----GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179

Query: 437 ----ATIGYMAPE-------YGLEGIVSAKCDVYSYGVLLMETFTRK 472
               AT  Y APE       Y      S   DV+S G +L E F R+
Sbjct: 180 VEFVATRWYRAPEVMLTSAKY------SRAMDVWSCGCILAELFLRR 220

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 73.1 bits (180), Expect = 3e-14
 Identities = 31/165 (18%), Positives = 58/165 (35%), Gaps = 19/165 (11%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGT-IPNSITNATKLIVLDLGFNSF 60
             L +  N++  ++P  +   L N+  + +  N L  +       +  KL  L +     
Sbjct: 126 VELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKL 184

Query: 61  SGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPP-----CLVLTVLDVSRNQLSGDI 115
           +G   +    L  L           L  NK+   I          L  L +  NQ+    
Sbjct: 185 TGIPKDLPETLNEL----------HLDHNKI-QAIELEDLLRYSKLYRLGLGHNQIRMIE 233

Query: 116 PSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLS 160
             ++     L  L L +N+    +P  +  L  L+ + L  NN++
Sbjct: 234 NGSLSFLPTLRELHLDNNKLSR-VPAGLPDLKLLQVVYLHTNNIT 277

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 71.2 bits (175), Expect = 1e-13
 Identities = 36/167 (21%), Positives = 57/167 (34%), Gaps = 16/167 (9%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFS 61
           R++      L   +P  I    P+   L L  N+++    +       L  L L  N  S
Sbjct: 36  RVVQCSDLGLK-AVPKEIS---PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS 91

Query: 62  GHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLV--LTVLDVSRNQLSGDIPSTI 119
                 F  LR L  L        ++ N L   IPP L   L  L +  N++        
Sbjct: 92  KIHEKAFSPLRKLQKL-------YISKNHLV-EIPPNLPSSLVELRIHDNRIRKVPKGVF 143

Query: 120 GGRVDLETLSLASNQFQ-GPIPESVGSLISLESLDLSGNNLSGKIPK 165
            G  ++  + +  N  +           + L  L +S   L+  IPK
Sbjct: 144 SGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPK 189

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 52.7 bits (127), Expect = 2e-07
 Identities = 22/158 (13%), Positives = 44/158 (27%), Gaps = 25/158 (15%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFS 61
             L L+ N++   +          +  L L  N +      S++    L  L L  N  S
Sbjct: 196 NELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS 254

Query: 62  GHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLVLTVLDVSRNQLSGDIPSTIGG 121
             +     +L+ L V+        L  N +  ++             N            
Sbjct: 255 -RVPAGLPDLKLLQVV-------YLHTNNI-TKVGV-----------NDFCP--VGFGVK 292

Query: 122 RVDLETLSLASNQFQ-GPIPESV-GSLISLESLDLSGN 157
           R     +SL +N      +  +    +    ++     
Sbjct: 293 RAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 73.0 bits (180), Expect = 3e-14
 Identities = 63/226 (27%), Positives = 97/226 (42%), Gaps = 33/226 (14%)

Query: 272 DEFNECNLLGTSSFGSV----YKGTISDGTDVAIKVFNLQLERAFRSFDSEC-----EVL 322
           ++F    +LG  SFG V    +K T       AIK   L+ +      D EC      VL
Sbjct: 17  EDFILHKMLGKGSFGKVFLAEFKKT---NQFFAIKA--LKKDVVLMDDDVECTMVEKRVL 71

Query: 323 -RNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSA 381
                H  L  +  ++   +    V+E++  G L   + S + F           ++   
Sbjct: 72  SLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAA-EIILG 130

Query: 382 LEYLHNGHSSVHIIHCDLKPTNILLDENMVAHV--SDFGIYKLLGEGEDSVRQTMTM-AT 438
           L++LH    S  I++ DLK  NILLD++   H+  +DFG+ K   E      +T T   T
Sbjct: 131 LQFLH----SKGIVYRDLKLDNILLDKD--GHIKIADFGMCK---ENMLGDAKTNTFCGT 181

Query: 439 IGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRP-----TDEMF 479
             Y+APE  L    +   D +S+GVLL E    + P      +E+F
Sbjct: 182 PDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF 227

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 73.5 bits (181), Expect = 3e-14
 Identities = 60/216 (27%), Positives = 93/216 (43%), Gaps = 48/216 (22%)

Query: 280 LGTSSFGSVYKGTISD-GTDVAIK----VFNLQLE--RAFRSFDSECEVLRNVRHRNLIK 332
           +G+ ++G+V        G  VAIK     F  +L   RA+R    E  +L+++RH N+I 
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR----ELRLLKHMRHENVIG 88

Query: 333 IL----SSYSNPDFKA--LVLEFMPNGSLEKWLYS-------HNYFLDILERLNIMIDVG 379
           +L       +  DF    LV+ FM    L K +           + +  + +        
Sbjct: 89  LLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEKLGEDRIQFLVYQMLK-------- 139

Query: 380 SALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMT--MA 437
             L Y+H    +  IIH DLKP N+ ++E+    + DFG    L    DS    MT  + 
Sbjct: 140 -GLRYIH----AAGIIHRDLKPGNLAVNEDCELKILDFG----LARQADS---EMTGYVV 187

Query: 438 TIGYMAPEYGLE-GIVSAKCDVYSYGVLLMETFTRK 472
           T  Y APE  L     +   D++S G ++ E  T K
Sbjct: 188 TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 73.4 bits (181), Expect = 4e-14
 Identities = 66/231 (28%), Positives = 101/231 (43%), Gaps = 43/231 (18%)

Query: 272 DEFNECNLLGTSSFGSVY----KGTISDGTDVAIKVFNLQLERAFRSFDSEC-----EVL 322
            +F+   ++G  SFG V     K         A+KV  LQ +   +  + +       VL
Sbjct: 38  SDFHFLKVIGKGSFGKVLLARHKAE---EVFYAVKV--LQKKAILKKKEEKHIMSERNVL 92

Query: 323 -RNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSA 381
            +NV+H  L+ +  S+   D    VL+++  G L   L     FL+   R     ++ SA
Sbjct: 93  LKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAA-EIASA 151

Query: 382 LEYLHNGHSSVHIIHCDLKPTNILLDENMVAHV--SDFGIYKLLGEGEDSVRQTMTM-AT 438
           L YLH    S++I++ DLKP NILLD     H+  +DFG+ K   E  +    T T   T
Sbjct: 152 LGYLH----SLNIVYRDLKPENILLDSQ--GHIVLTDFGLCK---ENIEHNSTTSTFCGT 202

Query: 439 IGYMAPEYGLEGIVSAK-----CDVYSYGVLLMETFTRKRP-----TDEMF 479
             Y+APE     ++  +      D +  G +L E      P     T EM+
Sbjct: 203 PEYLAPE-----VLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY 248

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 73.1 bits (180), Expect = 4e-14
 Identities = 62/232 (26%), Positives = 100/232 (43%), Gaps = 34/232 (14%)

Query: 272 DEFNECNLLGTSSFGSVY---KGTISDGTDV-AIKVFN----LQLERAFRSFDSECEVLR 323
           + F    +LGT ++G V+   K +  D   + A+KV      +Q  +      +E +VL 
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113

Query: 324 NVRHRN-LIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSAL 382
           ++R    L+ +  ++       L+L+++  G L   L     F +   ++ +  ++  AL
Sbjct: 114 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVG-EIVLAL 172

Query: 383 EYLHNGHSSVHIIHCDLKPTNILLDENMVAHV--SDFGIYKLLGEGEDSVRQTMTMA-TI 439
           E+LH     + II+ D+K  NILLD N   HV  +DFG+ K     E           TI
Sbjct: 173 EHLH----KLGIIYRDIKLENILLDSN--GHVVLTDFGLSKEFVADETER--AYDFCGTI 224

Query: 440 GYMAPE---YGLEGIVSAKCDVYSYGVLLME---------TFTRKRPTDEMF 479
            YMAP+    G  G   A  D +S GVL+ E             K    E+ 
Sbjct: 225 EYMAPDIVRGGDSGHDKA-VDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS 275

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 71.3 bits (175), Expect = 8e-14
 Identities = 41/166 (24%), Positives = 60/166 (36%), Gaps = 21/166 (12%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFS 61
            IL L  N L              +  L L    LT  +         L  LDL  N   
Sbjct: 34  TILHLSENLLY-TFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLSHNQLQ 90

Query: 62  GHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPP----CLV-LTVLDVSRNQLSGDIP 116
             +      L  L+VL +       + N+L   +P      L  L  L +  N+L   +P
Sbjct: 91  -SLPLLGQTLPALTVLDV-------SFNRL-TSLPLGALRGLGELQELYLKGNELK-TLP 140

Query: 117 STI-GGRVDLETLSLASNQFQGPIPESV-GSLISLESLDLSGNNLS 160
             +      LE LSLA+N     +P  +   L +L++L L  N+L 
Sbjct: 141 PGLLTPTPKLEKLSLANNNLTE-LPAGLLNGLENLDTLLLQENSLY 185

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 68.2 bits (167), Expect = 9e-13
 Identities = 44/162 (27%), Positives = 68/162 (41%), Gaps = 20/162 (12%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFS 61
             L L+  +L+ +L   +  +LP +  L L+ N L  ++P        L VLD+ FN  +
Sbjct: 58  TQLNLDRAELT-KLQ--VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT 113

Query: 62  GHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPP----CLV-LTVLDVSRNQLSGDIP 116
              L     L  L  L L        GN+L   +PP        L  L ++ N L+ ++P
Sbjct: 114 SLPLGALRGLGELQELYL-------KGNEL-KTLPPGLLTPTPKLEKLSLANNNLT-ELP 164

Query: 117 STI-GGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGN 157
           + +  G  +L+TL L  N     IP+       L    L GN
Sbjct: 165 AGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 67.4 bits (165), Expect = 2e-12
 Identities = 43/161 (26%), Positives = 67/161 (41%), Gaps = 22/161 (13%)

Query: 6   LEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHIL 65
            +   L+  LP  +     +   L L+ N L      ++   T+L  L+L     +   L
Sbjct: 17  CDKRNLT-ALPPDL---PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT--KL 70

Query: 66  NTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLV----LTVLDVSRNQLSGDIPSTI-G 120
              G L  L  L        L+ N+L   +P        LTVLDVS N+L+  +P     
Sbjct: 71  QVDGTLPVLGTL-------DLSHNQL-QSLPLLGQTLPALTVLDVSFNRLT-SLPLGALR 121

Query: 121 GRVDLETLSLASNQFQGPIPESV-GSLISLESLDLSGNNLS 160
           G  +L+ L L  N+ +  +P  +      LE L L+ NNL+
Sbjct: 122 GLGELQELYLKGNELKT-LPPGLLTPTPKLEKLSLANNNLT 161

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 72.3 bits (178), Expect = 8e-14
 Identities = 69/232 (29%), Positives = 95/232 (40%), Gaps = 45/232 (19%)

Query: 272 DEFNECNLLGTSSFGSVY----KGTISDGTDVAIKVFNLQLERAFRSFDSEC-----EVL 322
           D F    +LG  SFG V     K T   G   A+KV  L+ +   +  D EC      +L
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKET---GDLYAVKV--LKKDVILQDDDVECTMTEKRIL 77

Query: 323 RNV-RHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSA 381
                H  L ++   +  PD    V+EF+  G L   +     F +   R     ++ SA
Sbjct: 78  SLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF-YAAEIISA 136

Query: 382 LEYLHNGHSSVHIIHCDLKPTNILLDENMVAHV--SDFGIYKLLGEGEDSVRQTMTM-AT 438
           L +LH       II+ DLK  N+LLD     H   +DFG+ K   EG  +   T T   T
Sbjct: 137 LMFLH----DKGIIYRDLKLDNVLLDHE--GHCKLADFGMCK---EGICNGVTTATFCGT 187

Query: 439 IGYMAPE------YGLEGIVSAKCDVYSYGVLLMETFTRKRP-----TDEMF 479
             Y+APE      YG         D ++ GVLL E      P      D++F
Sbjct: 188 PDYIAPEILQEMLYGPA------VDWWAMGVLLYEMLCGHAPFEAENEDDLF 233

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 71.9 bits (177), Expect = 8e-14
 Identities = 58/220 (26%), Positives = 96/220 (43%), Gaps = 35/220 (15%)

Query: 269 RATDEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQLER------AFRSFDSECEV 321
           ++ +++    L+G  S+G V K      G  VAIK F    +       A R    E ++
Sbjct: 22  QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR----EIKL 77

Query: 322 LRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSA 381
           L+ +RH NL+ +L          LV EF+ + ++   L      LD       +  + + 
Sbjct: 78  LKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIING 136

Query: 382 LEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMT--MATI 439
           + + H    S +IIH D+KP NIL+ ++ V  + DFG  + L    +         +AT 
Sbjct: 137 IGFCH----SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE----VYDDEVATR 188

Query: 440 GYMAPE-------YGLEGIVSAKCDVYSYGVLLMETFTRK 472
            Y APE       YG + +     DV++ G L+ E F  +
Sbjct: 189 WYRAPELLVGDVKYG-KAV-----DVWAIGCLVTEMFMGE 222

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 71.5 bits (176), Expect = 9e-14
 Identities = 50/223 (22%), Positives = 88/223 (39%), Gaps = 49/223 (21%)

Query: 280 LGTSSFGSVYKGT-ISDGTDVAIK--VFNLQLE--RAFRSFDSECEVLRNVRHRNLIKIL 334
           LG    G V+          VAIK  V         A R    E +++R + H N++K+ 
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR----EIKIIRRLDHDNIVKVF 74

Query: 335 ------------SSYSNPDFKA--LVLEFMPNGSLEKWLYSHN-------YFLDILERLN 373
                          S  +  +  +V E+M    L   L            F+  L R  
Sbjct: 75  EILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQGPLLEEHARLFMYQLLR-- 131

Query: 374 IMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLD-ENMVAHVSDFGIYKLLGEGEDSVRQ 432
                   L+Y+H    S +++H DLKP N+ ++ E++V  + DFG+ +++     S + 
Sbjct: 132 -------GLKYIH----SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDP-HYSHKG 179

Query: 433 TMT--MATIGYMAPEYGLEGIV-SAKCDVYSYGVLLMETFTRK 472
            ++  + T  Y +P   L     +   D+++ G +  E  T K
Sbjct: 180 HLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 72.5 bits (178), Expect = 1e-13
 Identities = 41/160 (25%), Positives = 74/160 (46%), Gaps = 22/160 (13%)

Query: 271 TDEFNECNLLGTSSFGSVYKGT-ISDGTDVAIK----VFNLQLE--RAFRSFDSECEVLR 323
            D +   +L+GT S+G V +     +   VAIK    VF   ++  R  R    E  +L 
Sbjct: 52  PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILR----EIAILN 107

Query: 324 NVRHRNLIK---ILSSYSNPDFKA--LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDV 378
            + H +++K   I+       F    +VLE   +   +K   +  Y  ++  +  ++ ++
Sbjct: 108 RLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKT-LLYNL 165

Query: 379 GSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFG 418
              ++Y+H    S  I+H DLKP N L++++    V DFG
Sbjct: 166 LVGVKYVH----SAGILHRDLKPANCLVNQDCSVKVCDFG 201

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 71.1 bits (175), Expect = 1e-13
 Identities = 55/225 (24%), Positives = 93/225 (41%), Gaps = 35/225 (15%)

Query: 269 RATDEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQLER---------AFRSFDSE 318
            AT  +     +G  ++G+VYK      G  VA+K   +               R     
Sbjct: 6   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVR----- 60

Query: 319 CEV-----LRNVRHRNLIKIL----SSYSNPDFKA-LVLEFMPNGSLEKWLYSHN-YFLD 367
            EV     L    H N+++++    +S ++ + K  LV E +    L  +L       L 
Sbjct: 61  -EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLP 118

Query: 368 ILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGE 427
                ++M      L++LH    +  I+H DLKP NIL+       ++DFG+ ++     
Sbjct: 119 AETIKDLMRQFLRGLDFLH----ANCIVHRDLKPENILVTSGGTVKLADFGLARIYS--- 171

Query: 428 DSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRK 472
             +  T  + T+ Y APE  L+   +   D++S G +  E F RK
Sbjct: 172 YQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 71.5 bits (176), Expect = 1e-13
 Identities = 61/226 (26%), Positives = 92/226 (40%), Gaps = 33/226 (14%)

Query: 272 DEFNECNLLGTSSFGSV----YKGTISDGTDVAIKVFNLQLERAFRSFDSEC-----EVL 322
            +FN   +LG  SFG V     KGT       A+K+  L+ +   +  D EC      VL
Sbjct: 20  TDFNFLMVLGKGSFGKVMLSERKGT---DELYAVKI--LKKDVVIQDDDVECTMVEKRVL 74

Query: 323 -RNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSA 381
               +   L ++ S +   D    V+E++  G L   +     F +         ++   
Sbjct: 75  ALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAA-EIAIG 133

Query: 382 LEYLHNGHSSVHIIHCDLKPTNILLDENMVAHV--SDFGIYKLLGEGEDSVRQTMTM-AT 438
           L +L     S  II+ DLK  N++LD     H+  +DFG+ K   E       T T   T
Sbjct: 134 LFFLQ----SKGIIYRDLKLDNVMLDSE--GHIKIADFGMCK---ENIWDGVTTKTFCGT 184

Query: 439 IGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRP-----TDEMF 479
             Y+APE           D +++GVLL E    + P      DE+F
Sbjct: 185 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF 230

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 71.1 bits (175), Expect = 1e-13
 Identities = 53/223 (23%), Positives = 93/223 (41%), Gaps = 33/223 (14%)

Query: 269 RATDEFNECNLLGTSSFGSVYKGTISDGTD--VAIKVFNLQLER------AFRSFDSECE 320
           RA  ++     +G  ++G V+K          VA+K   +Q           R      E
Sbjct: 8   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR------E 61

Query: 321 V-----LRNVRHRNLIKIL----SSYSNPDFKA-LVLEFMPNGSLEKWLYSH-NYFLDIL 369
           V     L    H N++++      S ++ + K  LV E +    L  +L       +   
Sbjct: 62  VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTE 120

Query: 370 ERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDS 429
              ++M  +   L++LH    S  ++H DLKP NIL+  +    ++DFG+ ++       
Sbjct: 121 TIKDMMFQLLRGLDFLH----SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS---FQ 173

Query: 430 VRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRK 472
           +  T  + T+ Y APE  L+   +   D++S G +  E F RK
Sbjct: 174 MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 71.3 bits (175), Expect = 3e-13
 Identities = 30/146 (20%), Positives = 53/146 (36%), Gaps = 17/146 (11%)

Query: 24  PNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHI-LNTFGNLRHLSVLSLLMF 82
            ++ Y+ L+ N++      S +    L  L +   +    I  NTF  L  L +L     
Sbjct: 30  AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIIL----- 84

Query: 83  GIRLTGNKLYGRIPP-----CLVLTVLDVSRNQL-SGDIPSTI-GGRVDLETLSLASNQF 135
             +L  N+   ++          L VL +++  L    +          LE L L  N  
Sbjct: 85  --KLDYNQF-LQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNI 141

Query: 136 QGPIPESV-GSLISLESLDLSGNNLS 160
           +   P S   ++     LDL+ N + 
Sbjct: 142 KKIQPASFFLNMRRFHVLDLTFNKVK 167

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 69.4 bits (170), Expect = 1e-12
 Identities = 36/183 (19%), Positives = 57/183 (31%), Gaps = 30/183 (16%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSI-TNATKLIVLDLGFNSF 60
           + L +E       + +     L ++  L L  N     +          L VL L   + 
Sbjct: 57  QFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNL 115

Query: 61  SGHIL--NTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLV------LTVLDVSRNQLS 112
            G +L  N F  L  L +L        L  N +  +I P           VLD++ N++ 
Sbjct: 116 DGAVLSGNFFKPLTSLEMLV-------LRDNNI-KKIQPASFFLNMRRFHVLDLTFNKVK 167

Query: 113 GDIPSTI---GGRVDLETLSLASNQ--------FQGPIPESVGSLISLESLDLSGNNLSG 161
             I               L L+S                 +     S+ +LDLSGN    
Sbjct: 168 -SICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKE 226

Query: 162 KIP 164
            + 
Sbjct: 227 SMA 229

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 62.1 bits (151), Expect = 2e-10
 Identities = 34/181 (18%), Positives = 63/181 (34%), Gaps = 31/181 (17%)

Query: 1   MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANN----LTGTIPNSITN---------- 46
           +  L L GN     +      ++   +   L  +N     +     +  +          
Sbjct: 214 ITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLE 273

Query: 47  ATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPP----CLV-L 101
           A+ +   DL  +     + + F +   L  L+L         N++  +I       L  L
Sbjct: 274 ASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTL-------AQNEI-NKIDDNAFWGLTHL 325

Query: 102 TVLDVSRNQLSGDIPSTI-GGRVDLETLSLASNQFQGPIPESV-GSLISLESLDLSGNNL 159
             L++S+N L   I S +      LE L L+ N  +  + +     L +L+ L L  N L
Sbjct: 326 LKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIRA-LGDQSFLGLPNLKELALDTNQL 383

Query: 160 S 160
            
Sbjct: 384 K 384

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 60.1 bits (146), Expect = 9e-10
 Identities = 33/159 (20%), Positives = 58/159 (36%), Gaps = 30/159 (18%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFS 61
           +   L  +++   L  ++     ++E L L  N +     N+    T L+ L+L  N   
Sbjct: 278 KTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLG 336

Query: 62  GHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLVLTVLDVSRNQLSGDIPSTIGG 121
                 F NL                             L VLD+S N +      +  G
Sbjct: 337 SIDSRMFENLDK---------------------------LEVLDLSYNHIRALGDQSFLG 369

Query: 122 RVDLETLSLASNQFQGPIPESV-GSLISLESLDLSGNNL 159
             +L+ L+L +NQ +  +P+ +   L SL+ + L  N  
Sbjct: 370 LPNLKELALDTNQLKS-VPDGIFDRLTSLQKIWLHTNPW 407

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 55.1 bits (133), Expect = 3e-08
 Identities = 39/188 (20%), Positives = 61/188 (32%), Gaps = 25/188 (13%)

Query: 2   RILTLEGNQL-SGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSI-TNATKLIVLDLGFNS 59
            +LTL    L    L       L ++E L+L  NN+    P S   N  +  VLDL FN 
Sbjct: 106 EVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNK 165

Query: 60  FSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLVLTVLDVSRNQLSGDIPSTI 119
                     N +      L     RL+   L             D++   L  +     
Sbjct: 166 VKSICEEDLLNFQGKHFTLL-----RLSSITL------------QDMNEYWLGWEKCGNP 208

Query: 120 GGRVDLETLSLASNQFQGPIPESVGSLISLESL-DLSGNNLSGKIPKLEGEIPVKGSFKN 178
                + TL L+ N F+  + +     I+   +  L  +N                +FK+
Sbjct: 209 FKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSF-----GHTNFKD 263

Query: 179 FSTESFFG 186
               +F G
Sbjct: 264 PDNFTFKG 271

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 70.5 bits (173), Expect = 3e-13
 Identities = 55/246 (22%), Positives = 92/246 (37%), Gaps = 69/246 (28%)

Query: 271 TDEFNECNLLGTSSFGSVYKGT-ISDGTDVAIK----VFNLQLE--RAFRSFDSECEVLR 323
             ++     LG  ++G V+K      G  VA+K     F    +  R FR    E  +L 
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR----EIMILT 63

Query: 324 NVR-HRNLIKILSSYSNPDFKA--LVLEFMPNGSLEKWLYS-------HNYFL-DILERL 372
            +  H N++ +L+     + +   LV ++M    L   + +         Y +  ++   
Sbjct: 64  ELSGHENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRANILEPVHKQYVVYQLI--- 119

Query: 373 NIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFG-------------- 418
                    ++YLH    S  ++H D+KP+NILL+      V+DFG              
Sbjct: 120 -------KVIKYLH----SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNN 168

Query: 419 ---IYKLLGEGEDSVRQTMT--MATIGYMAPE-------YGLEGIVSAKCDVYSYGVLLM 466
                    E  D  +  +T  +AT  Y APE       Y      +   D++S G +L 
Sbjct: 169 IPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKY------TKGIDMWSLGCILG 222

Query: 467 ETFTRK 472
           E    K
Sbjct: 223 EILCGK 228

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 69.6 bits (171), Expect = 5e-13
 Identities = 52/209 (24%), Positives = 82/209 (39%), Gaps = 28/209 (13%)

Query: 272 DEFNECNLLGTSSFGSVY----KGTISDGTDVAIKVFNLQLERAFRSFDSEC-----EVL 322
            +F+   ++G  S+  V     K T       A+KV  ++ E      D +       V 
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKT---DRIYAMKV--VKKELVNDDEDIDWVQTEKHVF 63

Query: 323 -RNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSA 381
            +   H  L+ + S +        V+E++  G L   +       +   R     ++  A
Sbjct: 64  EQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLA 122

Query: 382 LEYLHNGHSSVHIIHCDLKPTNILLDENMVAHV--SDFGIYKLLGEGEDSVRQTMTM-AT 438
           L YLH       II+ DLK  N+LLD     H+  +D+G+ K   EG      T T   T
Sbjct: 123 LNYLH----ERGIIYRDLKLDNVLLDSE--GHIKLTDYGMCK---EGLRPGDTTSTFCGT 173

Query: 439 IGYMAPEYGLEGIVSAKCDVYSYGVLLME 467
             Y+APE           D ++ GVL+ E
Sbjct: 174 PNYIAPEILRGEDYGFSVDWWALGVLMFE 202

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 70.1 bits (172), Expect = 5e-13
 Identities = 51/209 (24%), Positives = 82/209 (39%), Gaps = 28/209 (13%)

Query: 272 DEFNECNLLGTSSFGSVY----KGTISDGTDVAIKVFNLQLERAFRSFDSEC-----EVL 322
            +F+   ++G  S+  V     K T       A++V  ++ E      D +       V 
Sbjct: 52  QDFDLLRVIGRGSYAKVLLVRLKKT---DRIYAMRV--VKKELVNDDEDIDWVQTEKHVF 106

Query: 323 -RNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSA 381
            +   H  L+ + S +        V+E++  G L   +       +   R     ++  A
Sbjct: 107 EQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLA 165

Query: 382 LEYLHNGHSSVHIIHCDLKPTNILLDENMVAHV--SDFGIYKLLGEGEDSVRQTMTM-AT 438
           L YLH       II+ DLK  N+LLD     H+  +D+G+ K   EG      T T   T
Sbjct: 166 LNYLH----ERGIIYRDLKLDNVLLDSE--GHIKLTDYGMCK---EGLRPGDTTSTFCGT 216

Query: 439 IGYMAPEYGLEGIVSAKCDVYSYGVLLME 467
             Y+APE           D ++ GVL+ E
Sbjct: 217 PNYIAPEILRGEDYGFSVDWWALGVLMFE 245

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 69.8 bits (171), Expect = 6e-13
 Identities = 50/252 (19%), Positives = 94/252 (37%), Gaps = 68/252 (26%)

Query: 271 TDEFNECNLLGTSSFGSVYKGTISD-GTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRN 329
           + +++    LGT SFG V +    + G   A+K          R    E ++++ + H N
Sbjct: 6   SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNR----ELDIMKVLDHVN 61

Query: 330 LIKILSSYSNPDFKA--------------------------------------LVLEFMP 351
           +IK++  +     +                                       +++E++P
Sbjct: 62  IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121

Query: 352 NGSLEKWLYSHNYFLDILERLNI---MIDVGSALEYLHNGHSSVHIIHCDLKPTNILLD- 407
           + +L K L S       +    I   +  +  A+ ++H    S+ I H D+KP N+L++ 
Sbjct: 122 D-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH----SLGICHRDIKPQNLLVNS 176

Query: 408 ENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPE-------YGLEGIVSAKCDVYS 460
           ++    + DFG  K L   E S      + +  Y APE       Y      +   D++S
Sbjct: 177 KDNTLKLCDFGSAKKLIPSEPS---VAYICSRFYRAPELMLGATEY------TPSIDLWS 227

Query: 461 YGVLLMETFTRK 472
            G +  E    K
Sbjct: 228 IGCVFGELILGK 239

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 69.2 bits (170), Expect = 6e-13
 Identities = 53/224 (23%), Positives = 94/224 (41%), Gaps = 39/224 (17%)

Query: 269 RATDEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQLER------AFRSFDSECEV 321
            + D +     LG  ++G VYK         VAIK   L+ E       A R    E  +
Sbjct: 31  TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR----EVSL 86

Query: 322 LRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSA 381
           L+ ++HRN+I++ S   +     L+ E+  N  L+K++  +      + + + +  + + 
Sbjct: 87  LKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIK-SFLYQLING 144

Query: 382 LEYLHNGHSSVHIIHCDLKPTNILLDENMVAH-----VSDFGIYKLLGEGEDSVRQ-TMT 435
           + + H    S   +H DLKP N+LL  +  +      + DFG+ +  G     +RQ T  
Sbjct: 145 VNFCH----SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG---IPIRQFTHE 197

Query: 436 MATIGYMAPE-------YGLEGIVSAKCDVYSYGVLLMETFTRK 472
           + T+ Y  PE       Y      S   D++S   +  E   + 
Sbjct: 198 IITLWYRPPEILLGSRHY------STSVDIWSIACIWAEMLMKT 235

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 69.4 bits (170), Expect = 8e-13
 Identities = 45/207 (21%), Positives = 76/207 (36%), Gaps = 60/207 (28%)

Query: 280 LGTSSFGSVYKGT-ISDGTDVAIK----VFNLQLE--RAFRSFDSECEVLRNVRHRNLIK 332
           +G  S+G VY     +   +VAIK    +F   ++  R  R    E  +L  ++   +I+
Sbjct: 34  IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILR----EITILNRLKSDYIIR 89

Query: 333 IL---SSYSNPDFKA--LVLEFMPNGSLEKWLYSHN--------YFL-DILERLNIMIDV 378
           +           F    +VLE   +  L+K   +            L ++L         
Sbjct: 90  LYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLL--------- 139

Query: 379 GSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFG------------------IY 420
                ++H       IIH DLKP N LL+++    V DFG                    
Sbjct: 140 -LGENFIH----ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEEN 194

Query: 421 KLLGEGEDSVRQTMT--MATIGYMAPE 445
           +  G    ++++ +T  + T  Y APE
Sbjct: 195 EEPGPHNKNLKKQLTSHVVTRWYRAPE 221

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 68.0 bits (167), Expect = 1e-12
 Identities = 57/223 (25%), Positives = 98/223 (43%), Gaps = 39/223 (17%)

Query: 270 ATDEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQLER-----AFRSFDSECEVLR 323
           ++ +F +   LG  ++ +VYKG   + G  VA+K   L  E      A R    E  +++
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR----EISLMK 58

Query: 324 NVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYF-----LDILERLNIMIDV 378
            ++H N++++       +   LV EFM N  L+K++ S         L++         +
Sbjct: 59  ELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQL 117

Query: 379 GSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMT--M 436
              L + H       I+H DLKP N+L+++     + DFG+ +  G     V  T +  +
Sbjct: 118 LQGLAFCH----ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG---IPVN-TFSSEV 169

Query: 437 ATIGYMAPE-------YGLEGIVSAKCDVYSYGVLLMETFTRK 472
            T+ Y AP+       Y      S   D++S G +L E  T K
Sbjct: 170 VTLWYRAPDVLMGSRTY------STSIDIWSCGCILAEMITGK 206

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 66.1 bits (162), Expect = 1e-12
 Identities = 22/143 (15%), Positives = 48/143 (33%), Gaps = 16/143 (11%)

Query: 23  LPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLMF 82
             NI+ L +   + T   P  I+  + L  L +     +   +     L  L++L     
Sbjct: 65  AHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLD---- 118

Query: 83  GIRLTGNKLYGRIPPCLV----LTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGP 138
              ++ +     I   +     +  +D+S N    DI   +    +L++L++  +     
Sbjct: 119 ---ISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDY 174

Query: 139 IPESVGSLISLESLDLSGNNLSG 161
               +     L  L      + G
Sbjct: 175 RG--IEDFPKLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 63.1 bits (154), Expect = 1e-11
 Identities = 23/147 (15%), Positives = 45/147 (30%), Gaps = 11/147 (7%)

Query: 24  PNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLMFG 83
              +  L      + T   +      L  + L   + +   L       ++  L++    
Sbjct: 20  STFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTD--LTGIEYAHNIKDLTI---- 73

Query: 84  IRLTGNKL--YGRIPPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPE 141
                     Y  I     L  L +    ++ D    + G   L  L ++ +     I  
Sbjct: 74  ---NNIHATNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILT 130

Query: 142 SVGSLISLESLDLSGNNLSGKIPKLEG 168
            + +L  + S+DLS N     I  L+ 
Sbjct: 131 KINTLPKVNSIDLSYNGAITDIMPLKT 157

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 67.3 bits (165), Expect = 1e-12
 Identities = 50/167 (29%), Positives = 71/167 (42%), Gaps = 20/167 (11%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSI-TNATKLIVLDLGFNSF 60
           + L L+ N+LS  LPS   H L  +  L L  N L  T+P  I      L  L +  N  
Sbjct: 40  KKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKL 97

Query: 61  SGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPP----CLV-LTVLDVSRNQLSGDI 115
               +  F  L +L+ L       RL  N+L   +PP     L  LT L +  N+L   +
Sbjct: 98  QALPIGVFDQLVNLAEL-------RLDRNQL-KSLPPRVFDSLTKLTYLSLGYNELQ-SL 148

Query: 116 PSTI-GGRVDLETLSLASNQFQGPIPESV-GSLISLESLDLSGNNLS 160
           P  +      L+ L L +NQ +  +PE     L  L++L L  N L 
Sbjct: 149 PKGVFDKLTSLKELRLYNNQLKR-VPEGAFDKLTELKTLKLDNNQLK 194

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 62.3 bits (152), Expect = 6e-11
 Identities = 46/160 (28%), Positives = 63/160 (39%), Gaps = 16/160 (10%)

Query: 4   LTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSI-TNATKLIVLDLGFNSFSG 62
           L L  N+L   LP+ I   L N+E L +T N L   +P  +      L  L L  N    
Sbjct: 66  LYLNDNKLQT-LPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKS 123

Query: 63  HILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPP----CLV-LTVLDVSRNQLSGDIPS 117
                F +L  L+ LS       L  N+L   +P      L  L  L +  NQL      
Sbjct: 124 LPPRVFDSLTKLTYLS-------LGYNEL-QSLPKGVFDKLTSLKELRLYNNQLKRVPEG 175

Query: 118 TIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGN 157
                 +L+TL L +NQ +     +  SL  L+ L L  N
Sbjct: 176 AFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 55.8 bits (135), Expect = 9e-09
 Identities = 43/143 (30%), Positives = 60/143 (41%), Gaps = 17/143 (11%)

Query: 25  NIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLMFGI 84
           + + L L +N L+     +    TKL +L L  N         F  L++L  L       
Sbjct: 38  DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLW------ 91

Query: 85  RLTGNKLYGRIPP----CLV-LTVLDVSRNQLSGDIPSTI-GGRVDLETLSLASNQFQGP 138
            +T NKL   +P      LV L  L + RNQL   +P  +      L  LSL  N+ Q  
Sbjct: 92  -VTDNKL-QALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQS- 147

Query: 139 IPESV-GSLISLESLDLSGNNLS 160
           +P+ V   L SL+ L L  N L 
Sbjct: 148 LPKGVFDKLTSLKELRLYNNQLK 170

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 43.8 bits (104), Expect = 7e-05
 Identities = 21/78 (26%), Positives = 31/78 (39%), Gaps = 1/78 (1%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFS 61
             L+L  N+L   LP  +   L +++ L L  N L      +    T+L  L L  N   
Sbjct: 136 TYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK 194

Query: 62  GHILNTFGNLRHLSVLSL 79
                 F +L  L +L L
Sbjct: 195 RVPEGAFDSLEKLKMLQL 212

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 67.3 bits (165), Expect = 1e-12
 Identities = 39/166 (23%), Positives = 61/166 (36%), Gaps = 20/166 (12%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFS 61
             L L GN +   L       L +++ L+    NL       I +   L  L++  N   
Sbjct: 79  STLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ 137

Query: 62  GHIL-NTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPC---------LVLTVLDVSRNQL 111
              L   F NL +L  L        L+ NK+   I            L+   LD+S N +
Sbjct: 138 SFKLPEYFSNLTNLEHLD-------LSSNKI-QSIYCTDLRVLHQMPLLNLSLDLSLNPM 189

Query: 112 SGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGN 157
           +  I       + L+ L+L +NQ +         L SL+ + L  N
Sbjct: 190 N-FIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 66.5 bits (163), Expect = 2e-12
 Identities = 42/170 (24%), Positives = 63/170 (37%), Gaps = 21/170 (12%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSI-TNATKLIVLDLGFNSF 60
           + L L  N L   L S    S P ++ L L+   +  TI +    + + L  L L  N  
Sbjct: 31  KNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPI 88

Query: 61  SGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLV-----LTVLDVSRNQL-SGD 114
               L  F  L  L  L             L   +    +     L  L+V+ N + S  
Sbjct: 89  QSLALGAFSGLSSLQKL-------VAVETNL-ASLENFPIGHLKTLKELNVAHNLIQSFK 140

Query: 115 IPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLE----SLDLSGNNLS 160
           +P       +LE L L+SN+ Q      +  L  +     SLDLS N ++
Sbjct: 141 LPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN 190

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 65.8 bits (161), Expect = 4e-12
 Identities = 31/170 (18%), Positives = 59/170 (34%), Gaps = 22/170 (12%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSI-TNATKLIVLDLGFNSF 60
           ++L L   ++   +      SL ++  L+LT N +  ++     +  + L  L     + 
Sbjct: 55  QVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNL 112

Query: 61  SGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLV------LTVLDVSRNQLS-- 112
           +       G+L+ L  L++         N +               L  LD+S N++   
Sbjct: 113 ASLENFPIGHLKTLKELNV-------AHNLI-QSFKLPEYFSNLTNLEHLDLSSNKIQSI 164

Query: 113 --GDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLS 160
              D+       +   +L L+ N     I       I L+ L L  N L 
Sbjct: 165 YCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLKELALDTNQLK 213

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 61.9 bits (151), Expect = 1e-10
 Identities = 39/144 (27%), Positives = 58/144 (40%), Gaps = 16/144 (11%)

Query: 24  PNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLMFG 83
            + + L L+ N L      S  +  +L VLDL            + +L HLS L      
Sbjct: 28  FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTL------ 81

Query: 84  IRLTGNKLYGRIPPCL-----VLTVLDVSRNQLSGDIPS-TIGGRVDLETLSLASNQFQG 137
             LTGN +   +          L  L      L+  + +  IG    L+ L++A N  Q 
Sbjct: 82  -ILTGNPI-QSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQS 138

Query: 138 -PIPESVGSLISLESLDLSGNNLS 160
             +PE   +L +LE LDLS N + 
Sbjct: 139 FKLPEYFSNLTNLEHLDLSSNKIQ 162

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 67.5 bits (165), Expect = 3e-12
 Identities = 25/167 (14%), Positives = 52/167 (31%), Gaps = 12/167 (7%)

Query: 1   MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSF 60
           ++IL +       ++       L  +E L + A++L    P S+ +   +  L L     
Sbjct: 151 LQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQH 210

Query: 61  SGHILNTFGNLRHLSVLSLLMFGIRLTGNKL-------YGRIPPCLVLTVLDVSRNQLSG 113
              +         +  L L      L               +        + ++   L  
Sbjct: 211 ILLLEIFVDVTSSVECLEL--RDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF- 267

Query: 114 DIPSTIGGRVDLETLSLASNQFQGPIPESV-GSLISLESLDLSGNNL 159
            +   +     L  L  + NQ +  +P+ +   L SL+ + L  N  
Sbjct: 268 QVMKLLNQISGLLELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTNPW 313

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 66.7 bits (163), Expect = 5e-12
 Identities = 36/166 (21%), Positives = 65/166 (39%), Gaps = 16/166 (9%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFS 61
           + L L  N+++  + ++      N++ L+LT+N +     +S ++   L  LDL +N  S
Sbjct: 55  KSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLS 113

Query: 62  GHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLV------LTVLDVSRNQLSGDI 115
               + F  L  L+ L        L GN     +    +      L +L V        I
Sbjct: 114 NLSSSWFKPLSSLTFL-------NLLGNPY-KTLGETSLFSHLTKLQILRVGNMDTFTKI 165

Query: 116 PS-TIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLS 160
                 G   LE L + ++  Q   P+S+ S+ ++  L L      
Sbjct: 166 QRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI 211

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 61.7 bits (150), Expect = 2e-10
 Identities = 21/174 (12%), Positives = 52/174 (29%), Gaps = 23/174 (13%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSI-TNATKLIVLDLGFNSF 60
             L L GN       +++   L  ++ L +   +    I        T L  L++  +  
Sbjct: 127 TFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDL 186

Query: 61  SGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCL-----VLTVLDVSRNQLSGDI 115
             +   +  +++++S L        L   +    +          +  L++    L    
Sbjct: 187 QSYEPKSLKSIQNVSHL-------ILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFH 238

Query: 116 PSTI--------GGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSG 161
            S +          +     + +        + + +  +  L  L+ S N L  
Sbjct: 239 FSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKS 291

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 54.7 bits (132), Expect = 3e-08
 Identities = 28/145 (19%), Positives = 50/145 (34%), Gaps = 17/145 (11%)

Query: 24  PNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLMFG 83
             ++ L L+ N +T    + +     L  L L  N  +    ++F +L  L  L      
Sbjct: 52  EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHL------ 105

Query: 84  IRLTGNKLYGRIPPCL-----VLTVLDVSRNQLSGDIP--STIGGRVDLETLSLASNQFQ 136
             L+ N L   +          LT L++  N     +   S       L+ L + +    
Sbjct: 106 -DLSYNYL-SNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTF 162

Query: 137 GPIPESV-GSLISLESLDLSGNNLS 160
             I       L  LE L++  ++L 
Sbjct: 163 TKIQRKDFAGLTFLEELEIDASDLQ 187

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 65.9 bits (161), Expect = 9e-12
 Identities = 44/219 (20%), Positives = 85/219 (38%), Gaps = 37/219 (16%)

Query: 279 LLGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVR----------- 326
            LG   F +V+    + + T VA+K+     +    + + E ++L+ V            
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMG 84

Query: 327 HRNLIKILSS--YSNPDFK--ALVLEFMPNGSLEKWLYSHNYF---LDILERLNIMIDVG 379
             +++K+L    +  P+     +V E +   +L   +  + +    L  +++  I   + 
Sbjct: 85  ANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQ--ISKQLL 141

Query: 380 SALEYLHNGHSSVHIIHCDLKPTNILLDENMVAH------VSDFGIYKLLGEGEDSVRQT 433
             L+Y+H       IIH D+KP N+L++            ++D G      E   +  QT
Sbjct: 142 LGLDYMH---RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQT 198

Query: 434 MTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRK 472
                  Y +PE  L        D++S   L+ E  T  
Sbjct: 199 RE-----YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 66.0 bits (161), Expect = 9e-12
 Identities = 42/170 (24%), Positives = 60/170 (35%), Gaps = 20/170 (11%)

Query: 1   MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSI-TNATKLIVLDLGFNS 59
             +L L  N LS          L N+  LLL+ N+L   I +        L  LDL  N 
Sbjct: 41  TALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNH 99

Query: 60  FSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPC----LV-LTVLDVSRNQLSGD 114
                   F +L+ L VL        L  N +   +       +  L  L +S+NQ+S  
Sbjct: 100 LHTLDEFLFSDLQALEVL-------LLYNNHI-VVVDRNAFEDMAQLQKLYLSQNQISRF 151

Query: 115 IPSTIGGRV---DLETLSLASNQFQGPIPESVGSLISL--ESLDLSGNNL 159
               I        L  L L+SN+ +      +  L +     L L  N L
Sbjct: 152 PVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPL 201

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 64.1 bits (155), Expect = 3e-11
 Identities = 47/322 (14%), Positives = 94/322 (29%), Gaps = 69/322 (21%)

Query: 270 ATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKV--------FNLQLERAFRSFDSECEV 321
            T++   C  +G   FG V++  I+D T VAIK+         N   ++ F     E  +
Sbjct: 18  PTEKLQRCEKIGEGVFGEVFQT-IADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76

Query: 322 LRNV---------RHRNLIKILSSY------------------------------SNPDF 342
            + +         R    I + S +                                 D 
Sbjct: 77  SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136

Query: 343 KALVLEFMPNG-SLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKP 401
             +VLEF   G  LE+          +    +I+  + ++L             H DL  
Sbjct: 137 LFIVLEFEFGGIDLEQMRTK---LSSLATAKSILHQLTASLAVAEASL---RFEHRDLHW 190

Query: 402 TNILLDENMVAHVSDFGIYKLLG---------EGEDSVRQTMTMATIGYM---APEYGLE 449
            N+LL +  +  +      K              + ++ +      + +      E    
Sbjct: 191 GNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFT 250

Query: 450 GIVSAKCDVYSY-GVLLMETFTRKRP-TDEMFIGEMSLRRWVKESLPHGLTEVVDANLVR 507
           G    + D+Y          +    P ++ +++  ++ +   + +            + R
Sbjct: 251 GDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKR 310

Query: 508 EEQAFSAKMDCILSIMDFALDC 529
           + Q F   M    S  D     
Sbjct: 311 KIQEFHRTMLNFSSATDLLCQH 332

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 62.8 bits (153), Expect = 8e-11
 Identities = 36/151 (23%), Positives = 66/151 (43%), Gaps = 18/151 (11%)

Query: 280 LGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLI-KILSSY 337
           +G  +FG +  G  +     VAIK+    ++        E    + +   + I ++    
Sbjct: 17  IGCGNFGELRLGKNLYTNEYVAIKL--EPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFG 74

Query: 338 SNPDFKALVLEFMPNG-SLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIH 396
               + A+VLE +  G SLE      +    +   L I I + S +EY+H    S ++I+
Sbjct: 75  PCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH----SKNLIY 128

Query: 397 CDLKPTNILL------DENMVAHVSDFGIYK 421
            D+KP N L+       + ++ H+ DF + K
Sbjct: 129 RDVKPENFLIGRPGNKTQQVI-HIIDFALAK 158

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 62.4 bits (152), Expect = 2e-10
 Identities = 53/215 (24%), Positives = 84/215 (39%), Gaps = 47/215 (21%)

Query: 279 LLGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHR------NLI 331
           ++G  SFG V K         VA+K+     +R  R    E  +L ++R +      N+I
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVR-NEKRFHRQAAEEIRILEHLRKQDKDNTMNVI 162

Query: 332 KILSSYSNPDFKA---LVLEFMPNGSLEKWLYSHNYFLDILERLN-----------IMID 377
            +L ++    F+    +  E          L S N + +++++                 
Sbjct: 163 HMLENF---TFRNHICMTFE----------LLSMNLY-ELIKKNKFQGFSLPLVRKFAHS 208

Query: 378 VGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAH--VSDFGIYKLLGEGEDSVRQTMT 435
           +   L+ LH       IIHCDLKP NILL +   +   V DFG      +   +  Q+  
Sbjct: 209 ILQCLDALH----KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRF 264

Query: 436 MATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
                Y APE  L        D++S G +L E  T
Sbjct: 265 -----YRAPEVILGARYGMPIDMWSLGCILAELLT 294

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 61.8 bits (150), Expect = 2e-10
 Identities = 34/173 (19%), Positives = 61/173 (35%), Gaps = 19/173 (10%)

Query: 1   MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSI-TNATKLIVLDL-GFN 58
              L     +L   +         ++E + ++ N++   I   + +N  KL  + +   N
Sbjct: 32  AIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKAN 90

Query: 59  SFSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPP-----CLVLTVLDVSRNQLSG 113
           +        F NL +L  L +       +   +   +P       L   +LD+  N    
Sbjct: 91  NLLYINPEAFQNLPNLQYLLI-------SNTGI-KHLPDVHKIHSLQKVLLDIQDNINIH 142

Query: 114 DIPSTI--GGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIP 164
            I      G   +   L L  N  Q  I  S  +   L+ L+LS NN   ++P
Sbjct: 143 TIERNSFVGLSFESVILWLNKNGIQE-IHNSAFNGTQLDELNLSDNNNLEELP 194

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 55.6 bits (134), Expect = 2e-08
 Identities = 26/168 (15%), Positives = 53/168 (31%), Gaps = 18/168 (10%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYL-LLTANNLTGTIPNSITNATKLIVLDLGFNSF 60
             + +  N +   + + +  +LP +  + +  ANNL    P +  N   L  L +     
Sbjct: 57  EKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGI 116

Query: 61  SGHILN-TFGNLRHLSVLSLLMFGIRLTGNKLYGRIPP------CLVLTVLDVSRNQLSG 113
             H+ +    +     +L +         N     I             +L +++N +  
Sbjct: 117 K-HLPDVHKIHSLQKVLLDIQ-------DNINIHTIERNSFVGLSFESVILWLNKNGIQE 168

Query: 114 DIPSTIGGRVDLETLSLASNQFQGPIPESV-GSLISLESLDLSGNNLS 160
              S   G    E     +N  +  +P  V         LD+S   + 
Sbjct: 169 IHNSAFNGTQLDELNLSDNNNLEE-LPNDVFHGASGPVILDISRTRIH 215

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 46.4 bits (110), Expect = 2e-05
 Identities = 16/78 (20%), Positives = 27/78 (34%), Gaps = 1/78 (1%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFS 61
            IL L  N +   + ++  +     E  L   NNL     +    A+  ++LD+      
Sbjct: 157 VILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH 215

Query: 62  GHILNTFGNLRHLSVLSL 79
                   NL+ L   S 
Sbjct: 216 SLPSYGLENLKKLRARST 233

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 60.9 bits (148), Expect = 3e-10
 Identities = 37/162 (22%), Positives = 61/162 (37%), Gaps = 22/162 (13%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFS 61
             L L+ NQ++    + + + L  I  L L+ N L   +   I     +  LDL     +
Sbjct: 66  IGLELKDNQITD--LAPLKN-LTKITELELSGNPLK-NVSA-IAGLQSIKTLDLTSTQIT 120

Query: 62  GHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPP---CLVLTVLDVSRNQLSGDIPST 118
              +     L +L VL L         N++   I P      L  L +   Q+S D+ + 
Sbjct: 121 D--VTPLAGLSNLQVLYL-------DLNQI-TNISPLAGLTNLQYLSIGNAQVS-DL-TP 168

Query: 119 IGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLS 160
           +     L TL    N+        + SL +L  + L  N +S
Sbjct: 169 LANLSKLTTLKADDNKISDI--SPLASLPNLIEVHLKNNQIS 208

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 60.5 bits (147), Expect = 3e-10
 Identities = 35/168 (20%), Positives = 62/168 (36%), Gaps = 23/168 (13%)

Query: 4   LTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGH 63
           +    + ++     T    L  I  L      +T TI   +     LI L+L  N  +  
Sbjct: 24  IAAGKSNVTD--TVTQAD-LDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDNQITD- 77

Query: 64  ILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPP---CLVLTVLDVSRNQLSGDIPSTIG 120
            L    NL  ++ L L       +GN L   +        +  LD++  Q++ D+   + 
Sbjct: 78  -LAPLKNLTKITELEL-------SGNPL-KNVSAIAGLQSIKTLDLTSTQIT-DVTP-LA 126

Query: 121 GRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKLEG 168
           G  +L+ L L  NQ        +  L +L+ L +    +S  +  L  
Sbjct: 127 GLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVS-DLTPLAN 171

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 59.3 bits (144), Expect = 9e-10
 Identities = 38/170 (22%), Positives = 69/170 (40%), Gaps = 23/170 (13%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFS 61
             L+  G  ++      + + L N+  L L  N +T  +   + N TK+  L+L  N   
Sbjct: 44  TTLSAFGTGVTT--IEGVQY-LNNLIGLELKDNQIT-DLAP-LKNLTKITELELSGNPLK 98

Query: 62  GHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPC--LV-LTVLDVSRNQLSGDIPST 118
              ++    L+ +  L L       T  ++   + P   L  L VL +  NQ++ +I   
Sbjct: 99  --NVSAIAGLQSIKTLDL-------TSTQITD-VTPLAGLSNLQVLYLDLNQIT-NISP- 146

Query: 119 IGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKLEG 168
           + G  +L+ LS+ + Q        + +L  L +L    N +S  I  L  
Sbjct: 147 LAGLTNLQYLSIGNAQVSDL--TPLANLSKLTTLKADDNKIS-DISPLAS 193

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 58.2 bits (141), Expect = 2e-09
 Identities = 39/181 (21%), Positives = 69/181 (38%), Gaps = 22/181 (12%)

Query: 1   MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSF 60
           +  L L GN L     S I   L +I+ L LT+  +T   P  +   + L VL L  N  
Sbjct: 87  ITELELSGNPLKN--VSAIAG-LQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQI 141

Query: 61  SGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPP---CLVLTVLDVSRNQLSGDIPS 117
           +   ++    L +L  LS+          ++   + P      LT L    N++S DI  
Sbjct: 142 TN--ISPLAGLTNLQYLSI-------GNAQVSD-LTPLANLSKLTTLKADDNKIS-DISP 190

Query: 118 TIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKLEGEIPVKGSFK 177
            +    +L  + L +NQ        + +  +L  + L+   ++ +       + V    K
Sbjct: 191 -LASLPNLIEVHLKNNQISDV--SPLANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVK 247

Query: 178 N 178
            
Sbjct: 248 G 248

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 56.6 bits (137), Expect = 6e-09
 Identities = 35/150 (23%), Positives = 59/150 (39%), Gaps = 20/150 (13%)

Query: 22  SLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLM 81
           +L N   +    +N+T T+     +   +  L       +   +     L +L  L    
Sbjct: 17  ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTT--IEGVQYLNNLIGLE--- 69

Query: 82  FGIRLTGNKLYGRIPPCLVLT---VLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGP 138
               L  N++   + P   LT    L++S N L  ++ S I G   ++TL L S Q    
Sbjct: 70  ----LKDNQI-TDLAPLKNLTKITELELSGNPLK-NV-SAIAGLQSIKTLDLTSTQITDV 122

Query: 139 IPESVGSLISLESLDLSGNNLSGKIPKLEG 168
            P  +  L +L+ L L  N ++  I  L G
Sbjct: 123 TP--LAGLSNLQVLYLDLNQIT-NISPLAG 149

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 50.5 bits (121), Expect = 7e-07
 Identities = 34/163 (20%), Positives = 60/163 (36%), Gaps = 21/163 (12%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFS 61
           + L L   Q++    + +   L N++ L L  N +T   P  +   T L  L +G    S
Sbjct: 110 KTLDLTSTQITD--VTPLAG-LSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVS 164

Query: 62  GHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPP---CLVLTVLDVSRNQLSGDIPST 118
              L    NL  L+ L           NK+   I P      L  + +  NQ+S D+   
Sbjct: 165 D--LTPLANLSKLTTLKA-------DDNKI-SDISPLASLPNLIEVHLKNNQIS-DVSP- 212

Query: 119 IGGRVDLETLSLASNQFQGPIPESVGSLISLESL-DLSGNNLS 160
           +    +L  ++L +            +L+    +   SG  ++
Sbjct: 213 LANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAPIA 255

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 60.4 bits (147), Expect = 4e-10
 Identities = 32/151 (21%), Positives = 61/151 (40%), Gaps = 18/151 (11%)

Query: 280 LGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLI-KILSSY 337
           +G  SFG +++GT + +   VAIK    + +        E    + +     I  +    
Sbjct: 18  IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFG 75

Query: 338 SNPDFKALVLEFMPNG-SLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIH 396
                  LV++ +  G SLE  L        +         + + ++ +H       +++
Sbjct: 76  QEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH----EKSLVY 129

Query: 397 CDLKPTNILL------DENMVAHVSDFGIYK 421
            D+KP N L+      + NM+ +V DFG+ K
Sbjct: 130 RDIKPDNFLIGRPNSKNANMI-YVVDFGMVK 159

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 60.6 bits (147), Expect = 5e-10
 Identities = 54/257 (21%), Positives = 97/257 (37%), Gaps = 60/257 (23%)

Query: 249 DHEDFLPLAIWRRTSYLDIQRATDEFNECNL-LGTSSFGSVYKG---TISDGTDVAIKVF 304
           D++  + L+  R        R  D F      +G  ++G VYK       D  D A+K  
Sbjct: 4   DYDFKVKLSSERE-------RVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALK-- 54

Query: 305 NLQLERAFRSFDSECEV--LRNVRHRN---LIKILSSYSNPDFKALVLEFMPNGSLEKWL 359
             Q+E    S  +  E+  LR ++H N   L K+  S+++     L+ ++  +  L   +
Sbjct: 55  --QIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKV-WLLFDYAEH-DLWHII 110

Query: 360 YSHNYFLDILERLNI--------MIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMV 411
             H       + + +        +  +   + YLH    +  ++H DLKP NIL+     
Sbjct: 111 KFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH----ANWVLHRDLKPANILVMGEGP 166

Query: 412 AH----VSDFGIYKLLGEGEDSVRQTMTMA-----TIGYMAPE-------YGLEGIVSAK 455
                 ++D G  +L      S  + +        T  Y APE       Y      +  
Sbjct: 167 ERGRVKIADMGFARLFN----SPLKPLADLDPVVVTFWYRAPELLLGARHY------TKA 216

Query: 456 CDVYSYGVLLMETFTRK 472
            D+++ G +  E  T +
Sbjct: 217 IDIWAIGCIFAELLTSE 233

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 60.9 bits (147), Expect = 6e-10
 Identities = 43/142 (30%), Positives = 62/142 (43%), Gaps = 19/142 (13%)

Query: 22  SLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLM 81
            LPN+  L L  N LT  I   +TN   L  L L  N      L++  +L+ L  LSL  
Sbjct: 63  YLPNVTKLFLNGNKLT-DIKP-LTNLKNLGWLFLDENKIK--DLSSLKDLKKLKSLSL-- 116

Query: 82  FGIRLTGNKLYGRIPP---CLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGP 138
                  N +   I        L  L +  N+++ DI + +     L+TLSL  NQ    
Sbjct: 117 -----EHNGI-SDINGLVHLPQLESLYLGNNKIT-DI-TVLSRLTKLDTLSLEDNQISD- 167

Query: 139 IPESVGSLISLESLDLSGNNLS 160
           I   +  L  L++L LS N++S
Sbjct: 168 I-VPLAGLTKLQNLYLSKNHIS 188

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 60.9 bits (147), Expect = 7e-10
 Identities = 35/168 (20%), Positives = 65/168 (38%), Gaps = 23/168 (13%)

Query: 4   LTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGH 63
             L+   ++     T    L +I+ ++   +++  ++   I     +  L L  N  +  
Sbjct: 26  DNLKKKSVTD--AVTQNE-LNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFLNGNKLTD- 79

Query: 64  ILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPP---CLVLTVLDVSRNQLSGDIPSTIG 120
            +    NL++L  L L         NK+   +        L  L +  N +S DI + + 
Sbjct: 80  -IKPLTNLKNLGWLFL-------DENKI-KDLSSLKDLKKLKSLSLEHNGIS-DI-NGLV 128

Query: 121 GRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKLEG 168
               LE+L L +N+        +  L  L++L L  N +S  I  L G
Sbjct: 129 HLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQIS-DIVPLAG 173

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 57.8 bits (139), Expect = 6e-09
 Identities = 43/166 (25%), Positives = 66/166 (39%), Gaps = 22/166 (13%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFS 61
             L L GN+L+   P T   +L N+ +L L  N +   + + + +  KL  L L  N  S
Sbjct: 68  TKLFLNGNKLTDIKPLT---NLKNLGWLFLDENKIK-DLSS-LKDLKKLKSLSLEHNGIS 122

Query: 62  GHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPP---CLVLTVLDVSRNQLSGDIPST 118
              +N   +L  L  L L         NK+   I        L  L +  NQ+S DI   
Sbjct: 123 --DINGLVHLPQLESLYL-------GNNKIT-DITVLSRLTKLDTLSLEDNQIS-DIVP- 170

Query: 119 IGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIP 164
           + G   L+ L L+ N        ++  L +L+ L+L       K  
Sbjct: 171 LAGLTKLQNLYLSKNHIS--DLRALAGLKNLDVLELFSQECLNKPI 214

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 57.0 bits (137), Expect = 1e-08
 Identities = 31/150 (20%), Positives = 53/150 (35%), Gaps = 20/150 (13%)

Query: 22  SLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLM 81
           +        L   ++T  +         +  +    +      +     L +++ L    
Sbjct: 19  AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK--SVQGIQYLPNVTKLF--- 71

Query: 82  FGIRLTGNKLYGRIPP--CLV-LTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGP 138
               L GNKL   I P   L  L  L +  N++  D+ S++     L++LSL  N     
Sbjct: 72  ----LNGNKL-TDIKPLTNLKNLGWLFLDENKIK-DL-SSLKDLKKLKSLSLEHNGIS-- 122

Query: 139 IPESVGSLISLESLDLSGNNLSGKIPKLEG 168
               +  L  LESL L  N ++  I  L  
Sbjct: 123 DINGLVHLPQLESLYLGNNKIT-DITVLSR 151

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 56.7 bits (136), Expect = 1e-08
 Identities = 34/163 (20%), Positives = 63/163 (38%), Gaps = 24/163 (14%)

Query: 2   RILTLEGNQLSGRLPSTIG--HSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNS 59
             L L+ N++       +     L  ++ L L  N ++  I   + +  +L  L LG N 
Sbjct: 90  GWLFLDENKIK-----DLSSLKDLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNK 142

Query: 60  FSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPP---CLVLTVLDVSRNQLSGDIP 116
            +   +     L  L  LSL         N++   I P      L  L +S+N +S D+ 
Sbjct: 143 IT--DITVLSRLTKLDTLSL-------EDNQIS-DIVPLAGLTKLQNLYLSKNHIS-DL- 190

Query: 117 STIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNL 159
             + G  +L+ L L S +          +L+   ++  +  +L
Sbjct: 191 RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 233

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 60.1 bits (146), Expect = 9e-10
 Identities = 30/160 (18%), Positives = 53/160 (33%), Gaps = 23/160 (14%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFS 61
             L    N L+  +  +       +  L    N     +   +T  T+L  LD  FN  +
Sbjct: 130 TYLNCARNTLT-EIDVS---HNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKIT 183

Query: 62  GHILNTFGNLRHLSVLSLLMFGIRLTGNKLYG-RIPPCLVLTVLDVSRNQLSGDIPSTIG 120
              ++    L  L+             N +    +   + LT LD S N+L+ +I   + 
Sbjct: 184 ELDVSQNKLLNRLN----------CDTNNITKLDLNQNIQLTFLDCSSNKLT-EID--VT 230

Query: 121 GRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLS 160
               L     + N     +  S  +L  L +L     +L 
Sbjct: 231 PLTQLTYFDCSVNPLT-ELDVS--TLSKLTTLHCIQTDLL 267

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 58.5 bits (142), Expect = 3e-09
 Identities = 26/139 (18%), Positives = 46/139 (33%), Gaps = 18/139 (12%)

Query: 24  PNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLMFG 83
            N    +  A  +  T   S      L  LD   +S +   +     L  L+ L      
Sbjct: 18  DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITD--MTGIEKLTGLTKLI----- 70

Query: 84  IRLTGNKLYGRIPP--CLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPE 141
              T N +   +       LT L    N+L+ ++   +     L  L+  +N+    +  
Sbjct: 71  --CTSNNI-TTLDLSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT-KLDV 123

Query: 142 SVGSLISLESLDLSGNNLS 160
           S      L  L+ + N L+
Sbjct: 124 S--QNPLLTYLNCARNTLT 140

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 58.2 bits (141), Expect = 4e-09
 Identities = 35/184 (19%), Positives = 63/184 (34%), Gaps = 31/184 (16%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFS 61
             L  + N ++ +L          + +L  ++N LT  I   +T  T+L   D   N  +
Sbjct: 194 NRLNCDTNNIT-KLDLN---QNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLT 246

Query: 62  GHILNTFGNLRHLSVLSLLMFGIRLTGN----KLYGR---------IPPCLVLTVLDVSR 108
              ++T   L  L  +   +  I LT N                  +     L +LD   
Sbjct: 247 ELDVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQA 306

Query: 109 NQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLS-----GKI 163
             ++ ++   +     L  L L + +    +   V     L+SL     ++      GKI
Sbjct: 307 AGIT-ELD--LSQNPKLVYLYLNNTELTE-LD--VSHNTKLKSLSCVNAHIQDFSSVGKI 360

Query: 164 PKLE 167
           P L 
Sbjct: 361 PALN 364

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 57.0 bits (138), Expect = 8e-09
 Identities = 31/164 (18%), Positives = 52/164 (31%), Gaps = 20/164 (12%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFS 61
                   ++      +    L  +  L    +++T  +   I   T L  L    N+ +
Sbjct: 21  ASEVAAAFEMQATDTISEEQ-LATLTSLDCHNSSIT-DMTG-IEKLTGLTKLICTSNNIT 77

Query: 62  GHILNTFGNLRHLSVLSLLMFGIRLTGNKLYG-RIPPCLVLTVLDVSRNQLSGDIPSTIG 120
              L+   NL +L+             NKL    + P   LT L+   N+L+  +   + 
Sbjct: 78  TLDLSQNTNLTYLA----------CDSNKLTNLDVTPLTKLTYLNCDTNKLT-KLD--VS 124

Query: 121 GRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIP 164
               L  L+ A N         V     L  LD   N    K+ 
Sbjct: 125 QNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKLD 165

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 56.2 bits (136), Expect = 2e-08
 Identities = 23/160 (14%), Positives = 50/160 (31%), Gaps = 22/160 (13%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFS 61
                  N L+  L  +   +L  +  L     +L   I   +T+ T+LI          
Sbjct: 236 TYFDCSVNPLT-ELDVS---TLSKLTTLHCIQTDLL-EID--LTHNTQLIYFQAEGCRKI 288

Query: 62  GHILNTFGNLRHLSVLSLLMFGIRLTGNKL-YGRIPPCLVLTVLDVSRNQLSGDIPSTIG 120
             +     +   L +L             +    +     L  L ++  +L+ ++   + 
Sbjct: 289 KEL--DVTHNTQLYLLDC-------QAAGITELDLSQNPKLVYLYLNNTELT-ELD--VS 336

Query: 121 GRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLS 160
               L++LS  +   Q      VG + +L +   +     
Sbjct: 337 HNTKLKSLSCVNAHIQD-FSS-VGKIPALNNNFEAEGQTI 374

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 52.8 bits (127), Expect = 2e-07
 Identities = 28/168 (16%), Positives = 49/168 (29%), Gaps = 28/168 (16%)

Query: 1   MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSF 60
           +  L      L   +  T       + Y           +   +T+ T+L +LD      
Sbjct: 256 LTTLHCIQTDLL-EIDLT---HNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGI 309

Query: 61  SGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPP--CLVLTVLDVSRNQLSGDIPST 118
           +   L+       L  L L          +L   +       L  L      +  D  S 
Sbjct: 310 TE--LD-LSQNPKLVYLYL-------NNTELT-ELDVSHNTKLKSLSCVNAHIQ-DFSS- 356

Query: 119 IGGRVDLETLSLASNQFQGPIPESVGSL------ISLESLDLSGNNLS 160
           +G    L     A  Q    +P+   +       +S + LD  GN ++
Sbjct: 357 VGKIPALNNNFEAEGQTIT-MPKETLTNNSLTIAVSPDLLDQFGNPMN 403

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 58.5 bits (142), Expect = 1e-09
 Identities = 42/149 (28%), Positives = 74/149 (49%), Gaps = 16/149 (10%)

Query: 280 LGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLI-KILSSY 337
           +G+ SFG +Y GT I+ G +VAIK+  ++ +        E ++ + ++    I  I    
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCG 74

Query: 338 SNPDFKALVLEFMPNG-SLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIH 396
           +  D+  +V+E +  G SLE      +    +   L +   + S +EY+H    S + IH
Sbjct: 75  AEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH----SKNFIH 128

Query: 397 CDLKPTNILL----DENMVAHVSDFGIYK 421
            D+KP N L+      N+V ++ DFG+ K
Sbjct: 129 RDVKPDNFLMGLGKKGNLV-YIIDFGLAK 156

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 58.1 bits (141), Expect = 2e-09
 Identities = 35/159 (22%), Positives = 63/159 (39%), Gaps = 21/159 (13%)

Query: 4   LTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGH 63
             L    ++     +    L  ++      +N+  ++   +   T L  L L  N  S  
Sbjct: 24  QNLGKQSVTD--LVSQKE-LSGVQNFNGDNSNIQ-SLAG-MQFFTNLKELHLSHNQISD- 77

Query: 64  ILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPP--CLVLTVLDVSRNQLSGDIPSTIGG 121
            L+   +L  L  LS+         N+L   +       L+ L +  N+L  D   ++  
Sbjct: 78  -LSPLKDLTKLEELSV-------NRNRL-KNLNGIPSACLSRLFLDNNELR-DT-DSLIH 126

Query: 122 RVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLS 160
             +LE LS+ +N+ +      +G L  LE LDL GN ++
Sbjct: 127 LKNLEILSIRNNKLKSI--VMLGFLSKLEVLDLHGNEIT 163

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 50.0 bits (120), Expect = 7e-07
 Identities = 30/152 (19%), Positives = 56/152 (36%), Gaps = 25/152 (16%)

Query: 22  SLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHI--LNTFGNLRHLSVLSL 79
            L N     L   ++T  +       + +   +   ++    +  +  F NL+ L     
Sbjct: 17  GLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SLAGMQFFTNLKELH---- 69

Query: 80  LMFGIRLTGNKLYGRIPP---CLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQ 136
                 L+ N++   + P      L  L V+RN+L  ++         L  L L +N+ +
Sbjct: 70  ------LSHNQI-SDLSPLKDLTKLEELSVNRNRLK-NLNG--IPSACLSRLFLDNNELR 119

Query: 137 GPIPESVGSLISLESLDLSGNNLSGKIPKLEG 168
               +S+  L +LE L +  N L   I  L  
Sbjct: 120 DT--DSLIHLKNLEILSIRNNKLK-SIVMLGF 148

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 49.6 bits (119), Expect = 1e-06
 Identities = 29/164 (17%), Positives = 56/164 (34%), Gaps = 27/164 (16%)

Query: 2   RILTLEGNQLSGRLPSTIG--HSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNS 59
           +    + + +      ++       N++ L L+ N ++  +   + + TKL  L +  N 
Sbjct: 44  QNFNGDNSNIQ-----SLAGMQFFTNLKELHLSHNQIS-DLSP-LKDLTKLEELSVNRNR 96

Query: 60  FSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPP---CLVLTVLDVSRNQLSGDIP 116
                L     +    +  L      L  N+L            L +L +  N+L   I 
Sbjct: 97  -----LKNLNGIPSACLSRL-----FLDNNELR-DTDSLIHLKNLEILSIRNNKLK-SIV 144

Query: 117 STIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLS 160
             +G    LE L L  N+        +  L  +  +DL+G    
Sbjct: 145 M-LGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCV 185

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 57.3 bits (139), Expect = 2e-09
 Identities = 22/168 (13%), Positives = 50/168 (29%), Gaps = 16/168 (9%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSI-TNATKLIVLDLGFNSF 60
             + +  +    +L S   ++L  + ++ +        I          L  L +     
Sbjct: 58  SRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGL 117

Query: 61  SGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPP------CLVLTVLDVSRNQLSGD 114
              +      +    +  +L     +T N     IP       C     L +  N  +  
Sbjct: 118 K--MFPDLTKVYSTDIFFIL----EITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-S 170

Query: 115 IPSTIGGRVDLETLSLASNQFQGPIPESV--GSLISLESLDLSGNNLS 160
           +         L+ + L  N++   I +    G       LD+S  +++
Sbjct: 171 VQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT 218

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 53.9 bits (130), Expect = 3e-08
 Identities = 27/170 (15%), Positives = 61/170 (35%), Gaps = 29/170 (17%)

Query: 23  LPNIEYLLLTANNLTGTIP-NSITNATKLIVLDLGFNSFSGHI-LNTFGNLRHLSVLSLL 80
            P+ + L L   +L  TIP ++ +N   +  + +  +     +  ++F NL  ++ + + 
Sbjct: 30  PPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIR 88

Query: 81  -----------MFG-------IRLTGNKL-----YGRIPPCLVLTVLDVSRNQLSGDIPS 117
                                + +    L       ++    +  +L+++ N     IP 
Sbjct: 89  NTRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPV 148

Query: 118 TI--GGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPK 165
               G   +  TL L +N F   +     +   L+++ L+ N     I K
Sbjct: 149 NAFQGLCNETLTLKLYNNGFTS-VQGYAFNGTKLDAVYLNKNKYLTVIDK 197

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 57.7 bits (139), Expect = 5e-09
 Identities = 40/149 (26%), Positives = 71/149 (47%), Gaps = 16/149 (10%)

Query: 280 LGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLI-KILSSY 337
           +G+ SFG +Y GT I    +VAIK+ N++ +        E ++ R ++    I  +    
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFG 72

Query: 338 SNPDFKALVLEFMPNG-SLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIH 396
              D+  LV++ +  G SLE      +  L +   L +   + + +E++H    S   +H
Sbjct: 73  VEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH----SKSFLH 126

Query: 397 CDLKPTNILL----DENMVAHVSDFGIYK 421
            D+KP N L+      N V ++ DFG+ K
Sbjct: 127 RDIKPDNFLMGLGRRANQV-YIIDFGLAK 154

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 56.7 bits (137), Expect = 8e-09
 Identities = 28/168 (16%), Positives = 61/168 (36%), Gaps = 32/168 (19%)

Query: 279 LLGTSSFGSVYKGTISDGTDVAIKVFN-----------LQLERAFRSFDSECEVLRNVRH 327
            +G   FG +Y   ++    V                 L  E  F    ++ E ++    
Sbjct: 42  PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101

Query: 328 RNLIKIL----------SSYSNPDFKALVLEFMPNG-SLEKWLYSHNYFLDILERLNIMI 376
              +K L             +   ++ ++++    G  L+K   ++         L + +
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKRFSRKTVLQLSL 159

Query: 377 DVGSALEYLHNGHSSVHIIHCDLKPTNILL---DENMVAHVSDFGIYK 421
            +   LEY+H        +H D+K +N+LL   + + V ++ D+G+  
Sbjct: 160 RILDILEYIH----EHEYVHGDIKASNLLLNYKNPDQV-YLVDYGLAY 202

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 56.7 bits (137), Expect = 8e-09
 Identities = 30/166 (18%), Positives = 65/166 (39%), Gaps = 31/166 (18%)

Query: 279 LLGTSSFGSVYKGT-ISDGTDVAIKVFNL------QLERAFRSF---DSECEVLRNVRHR 328
            +G+  FG +Y     +     A  V  +       L    + +     +  + + +  +
Sbjct: 44  KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103

Query: 329 NLIKI---------LSSYSNPDFKALVLEFMPNG-SLEKWLYSHNYFLDILERLNIMIDV 378
            L  +         L+ +    ++ +V+E +  G  L+K +   N        L + I +
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQK-ISGQNGTFKKSTVLQLGIRM 160

Query: 379 GSALEYLHNGHSSVHIIHCDLKPTNILL---DENMVAHVSDFGIYK 421
              LEY+H        +H D+K  N+LL   + + V +++D+G+  
Sbjct: 161 LDVLEYIH----ENEYVHGDIKAANLLLGYKNPDQV-YLADYGLSY 201

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 56.6 bits (137), Expect = 1e-08
 Identities = 51/206 (24%), Positives = 84/206 (40%), Gaps = 25/206 (12%)

Query: 278 NLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHR------NL 330
           +L+G  SFG V K     +   VAIK+   + +        E  +L  +          +
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYI 118

Query: 331 IKILSSYSNPDFKA---LVLEFMPNGSLEKWLYSHNYF-LDILERLNIMIDVGSALEYLH 386
           + +   +    F+    LV E + + +L   L + N+  + +         + +AL +L 
Sbjct: 119 VHLKRHF---MFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLA 174

Query: 387 NGHSSVHIIHCDLKPTNILL--DENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAP 444
                + IIHCDLKP NILL   +     + DFG    LG+      Q+       Y +P
Sbjct: 175 TPE--LSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF-----YRSP 227

Query: 445 EYGLEGIVSAKCDVYSYGVLLMETFT 470
           E  L        D++S G +L+E  T
Sbjct: 228 EVLLGMPYDLAIDMWSLGCILVEMHT 253

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 55.0 bits (133), Expect = 1e-08
 Identities = 33/139 (23%), Positives = 57/139 (41%), Gaps = 13/139 (9%)

Query: 24  PNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLMFG 83
             I  + L  N +    P + +   KL  +DL  N  S    + F  LR L+ L      
Sbjct: 32  ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSL------ 85

Query: 84  IRLTGNKLYGRIPPCL-----VLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGP 138
             L GNK+   +P  L      L +L ++ N+++           +L  LSL  N+ Q  
Sbjct: 86  -VLYGNKI-TELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTI 143

Query: 139 IPESVGSLISLESLDLSGN 157
              +   L +++++ L+ N
Sbjct: 144 AKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 52.3 bits (126), Expect = 8e-08
 Identities = 25/129 (19%), Positives = 48/129 (37%), Gaps = 19/129 (14%)

Query: 39  TIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPP- 97
            IP ++        + L  N+        F   + L  + L       + N++   + P 
Sbjct: 25  EIPTNLPETIT--EIRLEQNTIKVIPPGAFSPYKKLRRIDL-------SNNQI-SELAPD 74

Query: 98  ---CLV-LTVLDVSRNQLSGDIPSTI-GGRVDLETLSLASNQFQGPIPESV-GSLISLES 151
               L  L  L +  N+++ ++P ++  G   L+ L L +N+    +       L +L  
Sbjct: 75  AFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINC-LRVDAFQDLHNLNL 132

Query: 152 LDLSGNNLS 160
           L L  N L 
Sbjct: 133 LSLYDNKLQ 141

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 41.9 bits (99), Expect = 2e-04
 Identities = 26/89 (29%), Positives = 42/89 (47%), Gaps = 11/89 (12%)

Query: 84  IRLTGNKLYGRIPP----CLV-LTVLDVSRNQLSGDIPSTI-GGRVDLETLSLASNQFQG 137
           IRL  N +   IPP        L  +D+S NQ+S ++      G   L +L L  N+   
Sbjct: 37  IRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKITE 94

Query: 138 PIPESV-GSLISLESLDLSGNNLSGKIPK 165
            +P+S+   L SL+ L L+ N ++  +  
Sbjct: 95  -LPKSLFEGLFSLQLLLLNANKIN-CLRV 121

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 55.8 bits (135), Expect = 2e-08
 Identities = 53/224 (23%), Positives = 87/224 (38%), Gaps = 43/224 (19%)

Query: 279 LLGTSSFGSVYKGT-ISDGTDVAIKVF-NLQLERAFRSFDSECEVLRNVRHR-----NLI 331
            +G  +FG V     I +    A+KV  N++  +  RS   E ++L+ +++      N++
Sbjct: 42  KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK--KYTRSAKIEADILKKIQNDDINNNNIV 99

Query: 332 KILSSYSNPDFKA---LVLEFMPNGSLEKWLYSHNY--FLDILERLNIMIDVGSALEYLH 386
           K    +    +     L+ E +   SL + +  +NY  F     +    I++  AL YL 
Sbjct: 100 KYHGKF---MYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIK-LYCIEILKALNYLR 154

Query: 387 NGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTM--------AT 438
                + + H DLKP NILLD+               G+     R   T         AT
Sbjct: 155 ----KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCAT 210

Query: 439 IG------------YMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
                         Y APE  L        D++S+G +L E +T
Sbjct: 211 FKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYT 254

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 55.1 bits (133), Expect = 2e-08
 Identities = 35/168 (20%), Positives = 61/168 (36%), Gaps = 23/168 (13%)

Query: 4   LTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGH 63
             L+   ++     T    L +I+ ++   +++  ++   I     +  L L  N     
Sbjct: 29  DNLKKKSVTD--AVTQNE-LNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFLNGNK---- 79

Query: 64  ILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPP---CLVLTVLDVSRNQLSGDIPSTIG 120
            L     L +L  L  L        NK+   +        L  L +  N +S DI   + 
Sbjct: 80  -LTDIKPLANLKNLGWLFLD----ENKV-KDLSSLKDLKKLKSLSLEHNGIS-DING-LV 131

Query: 121 GRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKLEG 168
               LE+L L +N+        +  L  L++L L  N +S  I  L G
Sbjct: 132 HLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQIS-DIVPLAG 176

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 52.7 bits (127), Expect = 1e-07
 Identities = 30/150 (20%), Positives = 52/150 (34%), Gaps = 20/150 (13%)

Query: 22  SLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLM 81
           +        L   ++T  +         +  +    +      +     L +++ L    
Sbjct: 22  AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK--SVQGIQYLPNVTKLF--- 74

Query: 82  FGIRLTGNKLYGRIPP---CLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGP 138
               L GNKL   I P      L  L +  N++  D+ S++     L++LSL  N     
Sbjct: 75  ----LNGNKL-TDIKPLANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSLEHNGIS-- 125

Query: 139 IPESVGSLISLESLDLSGNNLSGKIPKLEG 168
               +  L  LESL L  N ++  I  L  
Sbjct: 126 DINGLVHLPQLESLYLGNNKIT-DITVLSR 154

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 53.9 bits (130), Expect = 2e-08
 Identities = 30/157 (19%), Positives = 52/157 (33%), Gaps = 29/157 (18%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFS 61
             L L  N+ +    + I   LP +  +  + N +T     +   A+ +  + L  N   
Sbjct: 35  AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN--- 91

Query: 62  GHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLVLTVLDVSRNQLSGDIPSTIGG 121
                       L  +   MF   L              L  L +  N+++     +  G
Sbjct: 92  -----------RLENVQHKMFK-GLES------------LKTLMLRSNRITCVGNDSFIG 127

Query: 122 RVDLETLSLASNQFQGPIPESV-GSLISLESLDLSGN 157
              +  LSL  NQ    +      +L SL +L+L  N
Sbjct: 128 LSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 49.7 bits (119), Expect = 6e-07
 Identities = 29/129 (22%), Positives = 49/129 (37%), Gaps = 18/129 (13%)

Query: 39  TIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPP- 97
            IP  I   T    L L  N F+  +L   G  + L  L  +      + NK+   I   
Sbjct: 25  KIPEHIPQYTA--ELRLNNNEFT--VLEATGIFKKLPQLRKIN----FSNNKI-TDIEEG 75

Query: 98  ---CLV-LTVLDVSRNQLSGDIPSTI-GGRVDLETLSLASNQFQGPIPESV-GSLISLES 151
                  +  + ++ N+L  ++   +  G   L+TL L SN+    +       L S+  
Sbjct: 76  AFEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRITC-VGNDSFIGLSSVRL 133

Query: 152 LDLSGNNLS 160
           L L  N ++
Sbjct: 134 LSLYDNQIT 142

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 55.1 bits (132), Expect = 4e-08
 Identities = 28/151 (18%), Positives = 50/151 (33%), Gaps = 34/151 (22%)

Query: 21  HSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLL 80
               ++  L L   +LT  + + +     +  LDL  N     +      LR L      
Sbjct: 438 MEYADVRVLHLAHKDLT-VLCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCL------ 488

Query: 81  MFGIRLTGNKLYGRIPPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQG-PI 139
                                 VL  S N L  ++   +     L+ L L +N+ Q    
Sbjct: 489 ---------------------EVLQASDNALE-NVDG-VANLPRLQELLLCNNRLQQSAA 525

Query: 140 PESVGSLISLESLDLSGNNLSGKIPKLEGEI 170
            + + S   L  L+L GN+L  +   ++  +
Sbjct: 526 IQPLVSCPRLVLLNLQGNSLC-QEEGIQERL 555

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 50.9 bits (121), Expect = 8e-07
 Identities = 29/156 (18%), Positives = 52/156 (33%), Gaps = 10/156 (6%)

Query: 9   NQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLD-LGFNSFSGHILNT 67
            +L    P      L  I  +   A +       ++   + L  +D +            
Sbjct: 372 KELQELEPENKWCLLTIILLMR--ALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKF 429

Query: 68  FGNLRHLSVLSLLMFGIRLTGNKLYGRIPP---CLVLTVLDVSRNQLSGDIPSTIGGRVD 124
                 L +    +  + L    L   +      L++T LD+S N+L   +P  +     
Sbjct: 430 LLENSVLKMEYADVRVLHLAHKDL-TVLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRC 487

Query: 125 LETLSLASNQFQGPIPESVGSLISLESLDLSGNNLS 160
           LE L  + N  +  +   V +L  L+ L L  N L 
Sbjct: 488 LEVLQASDNALEN-VDG-VANLPRLQELLLCNNRLQ 521

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 47.1 bits (111), Expect = 1e-05
 Identities = 22/151 (14%), Positives = 50/151 (33%), Gaps = 8/151 (5%)

Query: 21  HSLPNIEYLLLTANNLTGTIPNSITNATKLIV--LDLGFNSFSGHILNTFGNLRHLSVLS 78
                ++  L +   L    P +      +I+    L    +    L  F  L+ +  + 
Sbjct: 359 EKSTVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMR 418

Query: 79  LLMFGIR--LTGNKLYGRIPPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQ 136
                        +          + VL ++   L+  +   +   + +  L L+ N+ +
Sbjct: 419 AAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLCH-LEQLLLVTHLDLSHNRLR 476

Query: 137 GPIPESVGSLISLESLDLSGNNLSGKIPKLE 167
             +P ++ +L  LE L  S N L   +  + 
Sbjct: 477 A-LPPALAALRCLEVLQASDNALE-NVDGVA 505

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 53.2 bits (128), Expect = 6e-08
 Identities = 41/139 (29%), Positives = 56/139 (40%), Gaps = 15/139 (10%)

Query: 27  EYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLMFGIRL 86
           E L L +  L      +    TKL  L+L +N         F +L  L  L        L
Sbjct: 38  EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTL-------GL 90

Query: 87  TGNKLY---GRIPPCLV-LTVLDVSRNQLSGDIPSTIGGR-VDLETLSLASNQFQGPIPE 141
             N+L      +   L  L  L +  NQL   +PS +  R   L+ L L +NQ Q  IP 
Sbjct: 91  ANNQLASLPLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQS-IPA 148

Query: 142 SV-GSLISLESLDLSGNNL 159
                L +L++L LS N L
Sbjct: 149 GAFDKLTNLQTLSLSTNQL 167

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 51.6 bits (124), Expect = 2e-07
 Identities = 46/161 (28%), Positives = 70/161 (43%), Gaps = 18/161 (11%)

Query: 4   LTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNA-TKLIVLDLGFNSFSG 62
           L L+   L+  L       L  + +L L  N L  T+   + +  T+L  L L  N  + 
Sbjct: 40  LDLQSTGLA-TLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLAS 97

Query: 63  HILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPP----CLV-LTVLDVSRNQLSGDIPS 117
             L  F +L  L  L L        GN+L   +P      L  L  L ++ NQL   IP+
Sbjct: 98  LPLGVFDHLTQLDKLYL-------GGNQL-KSLPSGVFDRLTKLKELRLNTNQLQ-SIPA 148

Query: 118 TIGGR-VDLETLSLASNQFQGPIPESVGSLISLESLDLSGN 157
               +  +L+TLSL++NQ Q     +   L  L+++ L GN
Sbjct: 149 GAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 47.4 bits (113), Expect = 4e-06
 Identities = 34/129 (26%), Positives = 53/129 (41%), Gaps = 19/129 (14%)

Query: 39  TIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPP- 97
           ++P+ I   T+   LDL     +     TF  L  L+ L+L         N+L   +   
Sbjct: 28  SVPSGIPADTE--KLDLQSTGLATLSDATFRGLTKLTWLNL-------DYNQL-QTLSAG 77

Query: 98  ---CLV-LTVLDVSRNQLSGDIPSTI-GGRVDLETLSLASNQFQGPIPESV-GSLISLES 151
               L  L  L ++ NQL+  +P  +      L+ L L  NQ +  +P  V   L  L+ 
Sbjct: 78  VFDDLTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKE 135

Query: 152 LDLSGNNLS 160
           L L+ N L 
Sbjct: 136 LRLNTNQLQ 144

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 53.5 bits (129), Expect = 9e-08
 Identities = 43/219 (19%), Positives = 84/219 (38%), Gaps = 37/219 (16%)

Query: 279 LLGTSSFGSVYKG--TISDGTDVAIKVF-NLQLERAFRSFDSECEVLRNVRHR------N 329
            LG  +FG V +        + VA+K+  N+   +   +   E  VL+ ++ +       
Sbjct: 26  NLGEGTFGKVVECLDHARGKSQVALKIIRNV--GKYREAARLEINVLKKIKEKDKENKFL 83

Query: 330 LIKILSSYSNPDFKA---LVLEFMPNGSLEKWLYSHNYF-LDILERLNIMIDVGSALEYL 385
            + +   +   +F     +  E +   +  ++L  +N+    +    ++   +  AL +L
Sbjct: 84  CVLMSDWF---NFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFL 139

Query: 386 HNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDS------------VRQT 433
           H       + H DLKP NIL   +    + +          +++              + 
Sbjct: 140 H----ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH 195

Query: 434 MT--MATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
            T  +AT  Y  PE  LE   +  CDV+S G +L E + 
Sbjct: 196 HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYR 234

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 52.8 bits (127), Expect = 1e-07
 Identities = 26/167 (15%), Positives = 56/167 (33%), Gaps = 32/167 (19%)

Query: 280 LGTSSFGSVYKGT---------ISDGTDVAIKV--FNLQLERAFRSFDSECEV------- 321
               + G +Y+                  ++K+   + +L      F    +        
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109

Query: 322 -LRNVRHRNLIKILSSYSN-PDFKALVLEFMPNG-SLEK-WLYSHNYFLDILERLNIMID 377
            L +     +   +    +   ++ LVL  +  G SL+     S  + L     L +   
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERSVLQVACR 167

Query: 378 VGSALEYLHNGHSSVHIIHCDLKPTNILL---DENMVAHVSDFGIYK 421
           +  ALE+LH        +H ++   NI +   D++ V  ++ +G   
Sbjct: 168 LLDALEFLH----ENEYVHGNVTAENIFVDPEDQSQV-TLAGYGFAF 209

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 51.1 bits (123), Expect = 4e-07
 Identities = 45/219 (20%), Positives = 87/219 (39%), Gaps = 37/219 (16%)

Query: 279 LLGTSSFGSVYKG--TISDGTDVAIKVF-NLQLERAFRSFDSECEVLRNVRHR------N 329
            LG  +FG V +     + G  VA+K+  N+  +R   +  SE +VL ++          
Sbjct: 21  TLGEGAFGKVVECIDHKAGGRHVAVKIVKNV--DRYCEAARSEIQVLEHLNTTDPNSTFR 78

Query: 330 LIKILSSYSNPDFKA---LVLEFMPNGSLEKWLYSHNYF-LDILERLNIMIDVGSALEYL 385
            +++L  +   +      +V E +   S   ++  + +    +     +   +  ++ +L
Sbjct: 79  CVQMLEWF---EHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFL 134

Query: 386 HNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDS-VR---------QTMT 435
           H    S  + H DLKP NIL  ++      +  I +      +  ++             
Sbjct: 135 H----SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH 190

Query: 436 MATI----GYMAPEYGLEGIVSAKCDVYSYGVLLMETFT 470
            +T+     Y APE  L    S  CDV+S G +L+E + 
Sbjct: 191 HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYL 229

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 48.9 bits (117), Expect = 2e-06
 Identities = 52/166 (31%), Positives = 73/166 (43%), Gaps = 26/166 (15%)

Query: 2   RILTLEGNQLSGRLPSTIG--HSLPNIEYLLLTANNLTGTIPNSITNA-TKLIVLDLGFN 58
           R L L GN+L       I     L N+ YL+LT N L  ++PN + +  T L  L L  N
Sbjct: 66  RYLALGGNKLH-----DISALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVEN 119

Query: 59  SFSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPP----CLV-LTVLDVSRNQLSG 113
                    F  L +L+ L        L  N+L   +P      L  LT LD+S NQL  
Sbjct: 120 QLQSLPDGVFDKLTNLTYL-------NLAHNQL-QSLPKGVFDKLTNLTELDLSYNQLQS 171

Query: 114 DIPSTIGGR-VDLETLSLASNQFQGPIPESV-GSLISLESLDLSGN 157
            +P  +  +   L+ L L  NQ +  +P+ V   L SL+ + L  N
Sbjct: 172 -LPEGVFDKLTQLKDLRLYQNQLKS-VPDGVFDRLTSLQYIWLHDN 215

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 48.5 bits (116), Expect = 3e-06
 Identities = 41/163 (25%), Positives = 71/163 (43%), Gaps = 24/163 (14%)

Query: 4   LTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGH 63
             L+   ++    +   + L +I+ ++   +++  ++   I     +  L LG N     
Sbjct: 24  ANLKKKSVT-DAVT--QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVRYLALGGNKLHD- 77

Query: 64  ILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPP----CLV-LTVLDVSRNQLSGDIPST 118
            ++    L +L+ L        LTGN+L   +P      L  L  L +  NQL   +P  
Sbjct: 78  -ISALKELTNLTYL-------ILTGNQL-QSLPNGVFDKLTNLKELVLVENQLQ-SLPDG 127

Query: 119 IGGR-VDLETLSLASNQFQGPIPESV-GSLISLESLDLSGNNL 159
           +  +  +L  L+LA NQ Q  +P+ V   L +L  LDLS N L
Sbjct: 128 VFDKLTNLTYLNLAHNQLQS-LPKGVFDKLTNLTELDLSYNQL 169

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 45.4 bits (108), Expect = 2e-05
 Identities = 45/161 (27%), Positives = 64/161 (39%), Gaps = 18/161 (11%)

Query: 4   LTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIP--NSITNATKLIVLDLGFNSFS 61
           +    + +   +       LPN+ YL L  N L   I     +TN T L    L  N   
Sbjct: 46  IIANNSDIK-SVQGI--QYLPNVRYLALGGNKLH-DISALKELTNLTYL---ILTGNQLQ 98

Query: 62  GHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLV-LTVLDVSRNQLSGDIPSTIG 120
                 F  L +L  L L     +L    L   +   L  LT L+++ NQL   +P  + 
Sbjct: 99  SLPNGVFDKLTNLKELVL--VENQLQ--SLPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVF 153

Query: 121 GR-VDLETLSLASNQFQGPIPESV-GSLISLESLDLSGNNL 159
            +  +L  L L+ NQ Q  +PE V   L  L+ L L  N L
Sbjct: 154 DKLTNLTELDLSYNQLQS-LPEGVFDKLTQLKDLRLYQNQL 193

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 47.4 bits (113), Expect = 4e-06
 Identities = 47/158 (29%), Positives = 68/158 (43%), Gaps = 33/158 (20%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNA-TKLIVLDLGFNSF 60
           +IL L  NQ++ +L   +  SL N++ L L +N L   +P  + ++ T+L VLDLG N  
Sbjct: 43  QILYLHDNQIT-KLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTN-- 98

Query: 61  SGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLVLTVLDVSRNQLSGDIPSTIG 120
                        L+VL   +F  RL              L  L +  N+L+  +P  I 
Sbjct: 99  ------------QLTVLPSAVFD-RLVH------------LKELFMCCNKLTE-LPRGIE 132

Query: 121 GRVDLETLSLASNQFQGPIPESV-GSLISLESLDLSGN 157
               L  L+L  NQ +  IP      L SL    L GN
Sbjct: 133 RLTHLTHLALDQNQLKS-IPHGAFDRLSSLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 47.0 bits (112), Expect = 5e-06
 Identities = 37/126 (29%), Positives = 54/126 (42%), Gaps = 18/126 (14%)

Query: 40  IPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPP-- 97
           +P  I    +  +L L  N  +      F +L +L  L L         N+L G +P   
Sbjct: 34  VPAGIPTNAQ--ILYLHDNQITKLEPGVFDSLINLKELYL-------GSNQL-GALPVGV 83

Query: 98  --CLV-LTVLDVSRNQLSGDIPSTIGGR-VDLETLSLASNQFQGPIPESVGSLISLESLD 153
              L  LTVLD+  NQL+  +PS +  R V L+ L +  N+    +P  +  L  L  L 
Sbjct: 84  FDSLTQLTVLDLGTNQLTV-LPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLA 141

Query: 154 LSGNNL 159
           L  N L
Sbjct: 142 LDQNQL 147

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 48.0 bits (114), Expect = 6e-06
 Identities = 51/254 (20%), Positives = 84/254 (33%), Gaps = 65/254 (25%)

Query: 280 LGTSSFGSVYKG-TISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVR--------HRNL 330
           LG   F +V+    I     VA+KV     E    +   E  +L++VR           +
Sbjct: 45  LGWGHFSTVWLSWDIQGKKFVAMKVVK-SAEHYTETALDEIRLLKSVRNSDPNDPNREMV 103

Query: 331 IKILSS--YSNPDFK--ALVLEFMPNG-SLEKWLYSHNYFLDILERL-NIMIDVGSALEY 384
           +++L     S  +     +V E +  G  L KW+   NY    L  +  I+  V   L+Y
Sbjct: 104 VQLLDDFKISGVNGTHICMVFEVL--GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDY 161

Query: 385 LHNGHSSVHIIHCDLKPTNILL---DENMVAHVSDFGIYKLLGEGEDSVRQTMTMA---- 437
           LH   +   IIH D+KP NILL   ++ +    ++   ++  G    S     T      
Sbjct: 162 LH---TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAG 218

Query: 438 -------------------------------------TIGYMAPEYGLEGIVSAKCDVYS 460
                                                T  Y + E  +    +   D++S
Sbjct: 219 NFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPADIWS 278

Query: 461 YGVLLMETFTRKRP 474
              +  E  T    
Sbjct: 279 TACMAFELATGDYL 292

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 48.3 bits (114), Expect = 7e-06
 Identities = 81/573 (14%), Positives = 153/573 (26%), Gaps = 216/573 (37%)

Query: 139 IPESVGSLISLESLD---LSGNNLSGKIPKLEGEIPVKGS--FKNFSTESFFGNY----- 188
           + +   S++S E +D   +S + +SG   +L   +  K     + F  E    NY     
Sbjct: 38  VQDMPKSILSKEEIDHIIMSKDAVSG-TLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMS 96

Query: 189 ---ALCGPPKLR--------------VPPCKPDNSKRTKKVPLI--VLKYILP-PIVS-- 226
                   P +                      N  R +    +   L  + P   V   
Sbjct: 97  PIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLID 156

Query: 227 -------TVLVVITI------------IMYIRCRNRNTKKS------------------- 248
                  T + +               I ++  +N N+ ++                   
Sbjct: 157 GVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSR 216

Query: 249 -DHEDFLPLAI----------WRRTSY------LD-IQRAT--DEFN-ECNLLGTSSFGS 287
            DH   + L I           +   Y      L  +Q A   + FN  C +L T+ F  
Sbjct: 217 SDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQ 276

Query: 288 VYKGTISDGTDV--AIKVFNLQLERAFRSFDSE---------------------C----- 319
           V        TD   A    ++ L+    +   +                           
Sbjct: 277 V--------TDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPR 328

Query: 320 ------EVLR-------NVRHRNLIK----ILSSYSN--PD-----FKALVLEFM----- 350
                 E +R       N +H N  K    I SS +   P      F  L + F      
Sbjct: 329 RLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSV-FPPSAHI 387

Query: 351 PNGSLEK-WLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDEN 409
           P   L   W        D++  +N +       +       S+  I+ +LK     L+  
Sbjct: 388 PTILLSLIWFDVIKS--DVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVK---LENE 442

Query: 410 MVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPE-YGLEGIVSAKCDVYSYGVL---L 465
              H        ++                 Y  P+ +  + ++    D Y Y  +   L
Sbjct: 443 YALHR------SIVDH---------------YNIPKTFDSDDLIPPYLDQYFYSHIGHHL 481

Query: 466 METFTRKRPTDEMFIGEMSLR--RWVKESLPHG----------LTEVVDANLVRE----- 508
                     + M +  M     R++++ + H           L  +      +      
Sbjct: 482 KNI----EHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDN 537

Query: 509 EQAFSAKMDCILSIMDFALDC---CMESPDMRI 538
           +  +   ++   +I+DF        + S    +
Sbjct: 538 DPKYERLVN---AILDFLPKIEENLICSKYTDL 567

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 46.9 bits (112), Expect = 1e-05
 Identities = 32/177 (18%), Positives = 58/177 (32%), Gaps = 21/177 (11%)

Query: 4   LTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGT----IPNSITNATKLIVLDLGFNS 59
           L ++  +LS    + +   L   + + L    LT      I +++     L  L+L  N 
Sbjct: 8   LDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNE 67

Query: 60  FSG----HILNTFGNLRHLSVLSLLMFGIRLTG---NKLYGRIPPCLVLTVLDVSRNQLS 112
                   +L          +  L +    LTG     L   +     L  L +S N L 
Sbjct: 68  LGDVGVHCVLQGLQTP-SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLG 126

Query: 113 GDIPSTIGGRV-----DLETLSLASNQFQGPIPESVGSLI----SLESLDLSGNNLS 160
                 +   +      LE L L          E + S++      + L +S N+++
Sbjct: 127 DAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDIN 183

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 44.6 bits (106), Expect = 7e-05
 Identities = 29/184 (15%), Positives = 52/184 (28%), Gaps = 27/184 (14%)

Query: 2   RILTLEGNQLSGR----LPSTIGHSLPNIEYLLLTANNLTGTIPNSITNA----TKLIVL 53
           + L L  N L       L   +      +E L L   +L+      + +          L
Sbjct: 116 QELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKEL 175

Query: 54  DLGFNSFSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGR--------IPPCLVLTVLD 105
            +  N  +   +         S   L    ++L    +           +     L  L 
Sbjct: 176 TVSNNDINEAGVRVLCQGLKDSPCQLEA--LKLESCGVTSDNCRDLCGIVASKASLRELA 233

Query: 106 VSRNQLSGD-----IPSTIGGRVDLETLSLASNQFQGP----IPESVGSLISLESLDLSG 156
           +  N+L         P  +     L TL +            +   + +  SL+ L L+G
Sbjct: 234 LGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAG 293

Query: 157 NNLS 160
           N L 
Sbjct: 294 NELG 297

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 41.9 bits (99), Expect = 5e-04
 Identities = 33/182 (18%), Positives = 51/182 (28%), Gaps = 23/182 (12%)

Query: 2   RILTLEGNQLSGR----LPSTIGHSLPNIEYLLLTANNLT----GTIPNSITNATKLIVL 53
           R L L  N+L       L   + H    +  L +    +T    G +   +     L  L
Sbjct: 230 RELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKEL 289

Query: 54  DLGFNSFSGHILNTFGNL-----RHLSVLSLLMFGIRLTG-NKLYGRIPPCLVLTVLDVS 107
            L  N                    L  L +          +     +     L  L +S
Sbjct: 290 SLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQIS 349

Query: 108 RNQLSGDIPSTIGGRVD-----LETLSLASNQFQ----GPIPESVGSLISLESLDLSGNN 158
            N+L       +   +      L  L LA           +  ++ +  SL  LDLS N 
Sbjct: 350 NNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNC 409

Query: 159 LS 160
           L 
Sbjct: 410 LG 411

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 43.2 bits (102), Expect = 4e-05
 Identities = 30/113 (26%), Positives = 48/113 (42%), Gaps = 7/113 (6%)

Query: 46  NATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLVLTVLD 105
            A + +VLD    S  G I        +L  LSL+  G+    N     +P    L  L+
Sbjct: 24  AAVRELVLDN-CKSNDGKIEGLTAEFVNLEFLSLINVGLISVSN-----LPKLPKLKKLE 77

Query: 106 VSRNQLSGDIPSTIGGRVDLETLSLASNQFQGP-IPESVGSLISLESLDLSGN 157
           +S N++ G +        +L  L+L+ N+ +     E +  L  L+SLDL   
Sbjct: 78  LSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 43.0 bits (100), Expect = 2e-04
 Identities = 17/128 (13%), Positives = 39/128 (30%), Gaps = 15/128 (11%)

Query: 48  TKLIVLDLGFNSFSGHILNTFG--NLRHLSVLSLLMFGIRLTGNKLYGRIPPCLV----- 100
             L  L++        ++      +L +L  L L +       +       P        
Sbjct: 193 PNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFP 252

Query: 101 -LTVLDVSRNQLSGDIPSTIGGRV---DLETLSLASNQFQG----PIPESVGSLISLESL 152
            L  L +   +    +            LET+ +++          + + V  +  L+ +
Sbjct: 253 NLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFI 312

Query: 153 DLSGNNLS 160
           ++  N LS
Sbjct: 313 NMKYNYLS 320

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 43.2 bits (101), Expect = 2e-04
 Identities = 15/67 (22%), Positives = 27/67 (40%), Gaps = 1/67 (1%)

Query: 95  IPPCLVLTVLDVSRNQLSGDIPS-TIGGRVDLETLSLASNQFQGPIPESVGSLISLESLD 153
           +P    LT L +   Q    +    + G  +L  L++  +  +   P++      L  L+
Sbjct: 27  LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLN 86

Query: 154 LSGNNLS 160
           LS N L 
Sbjct: 87  LSFNALE 93

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 41.6 bits (98), Expect = 2e-04
 Identities = 38/138 (27%), Positives = 54/138 (39%), Gaps = 17/138 (12%)

Query: 27  EYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLMFGIRL 86
            YL L  N+L           T L  L LG N         F  L  L+ L        L
Sbjct: 31  TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYL-------NL 83

Query: 87  TGNKLYGRIPP----CLV-LTVLDVSRNQLSGDIPSTIGGR-VDLETLSLASNQFQGPIP 140
           + N+L   +P      L  L  L ++ NQL   +P  +  +   L+ L L  NQ +  +P
Sbjct: 84  STNQL-QSLPNGVFDKLTQLKELALNTNQLQS-LPDGVFDKLTQLKDLRLYQNQLKS-VP 140

Query: 141 ESV-GSLISLESLDLSGN 157
           + V   L SL+ + L  N
Sbjct: 141 DGVFDRLTSLQYIWLHDN 158

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 41.6 bits (98), Expect = 3e-04
 Identities = 23/117 (19%), Positives = 43/117 (36%), Gaps = 19/117 (16%)

Query: 49  KLIVLDLGFNSFSG--HILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRI---PPCLVLTV 103
           + + L             L+T    +HL+          L+ N +  +I        L +
Sbjct: 26  EKVELHGMIPPIEKMDATLSTLKACKHLA----------LSTNNI-EKISSLSGMENLRI 74

Query: 104 LDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLS 160
           L + RN +   I +       LE L ++ NQ        +  L++L  L +S N ++
Sbjct: 75  LSLGRNLIK-KIENLDAVADTLEELWISYNQIA--SLSGIEKLVNLRVLYMSNNKIT 128

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 40.1 bits (94), Expect = 8e-04
 Identities = 33/148 (22%), Positives = 56/148 (37%), Gaps = 22/148 (14%)

Query: 29  LLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHI--LNTFGNLRHLSVLSLLMFGIRL 86
           L      +   +  +++       L L  N+    I  L+   NLR LS          L
Sbjct: 30  LHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-KISSLSGMENLRILS----------L 77

Query: 87  TGNKLYGRIPP----CLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIP-E 141
             N +  +I         L  L +S NQ++  + S I   V+L  L +++N+       +
Sbjct: 78  GRNLIK-KIENLDAVADTLEELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKITNWGEID 134

Query: 142 SVGSLISLESLDLSGNNLSGKIPKLEGE 169
            + +L  LE L L+GN L     +    
Sbjct: 135 KLAALDKLEDLLLAGNPLYNDYKENNAT 162

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 39.3 bits (92), Expect = 7e-04
 Identities = 21/100 (21%), Positives = 35/100 (35%), Gaps = 11/100 (11%)

Query: 63  HILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLVLTVLDVSRNQLS--GDIPSTIG 120
               T  +++ L +        R    KL G       L  L      L+   ++P    
Sbjct: 11  LRNRTPSDVKELVLD-----NSRSNEGKLEGLTDEFEELEFLSTINVGLTSIANLPKLN- 64

Query: 121 GRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLS 160
               L+ L L+ N+  G +        +L  L+LSGN + 
Sbjct: 65  ---KLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIK 101

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 40.0 bits (94), Expect = 7e-04
 Identities = 24/79 (30%), Positives = 39/79 (49%), Gaps = 11/79 (13%)

Query: 101 LTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESV-GSLISLESLDLSGNNL 159
           LT++D+S N++S     +      L TL L+ N+ +  IP      L SL  L L GN++
Sbjct: 56  LTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRC-IPPRTFDGLKSLRLLSLHGNDI 114

Query: 160 SGKIPKLEGEIPVKGSFKN 178
           S         +P +G+F +
Sbjct: 115 S--------VVP-EGAFND 124

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	593
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.96
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.93
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	99.92
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	99.91
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.89
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.88
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	99.87
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.87
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	99.87
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.87
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.86
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.85
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.85
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.85
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.84
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.84
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.84
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.84
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.83
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.83
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.83
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.83
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.83
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.82
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.82
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	99.82
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	99.82
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.82
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.82
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	99.81
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.81
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	99.81
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.81
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.81
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	99.8
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.8
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.8
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	99.8
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	99.79
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	99.79
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	99.79
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.79
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.79
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	99.79
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.79
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	99.79
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.78
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.78
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	99.78
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.77
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	99.77
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	99.77
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.77
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	99.77
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	99.76
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	99.76
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	99.76
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.76
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.76
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	99.76
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	99.76
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.76
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	99.75
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	99.75
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.75
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	99.75
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	99.74
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	99.74
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.74
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	99.74
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.74
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.73
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	99.73
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.73
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	99.73
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	99.73
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.73
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.73
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.73
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	99.73
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	99.73
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	99.72
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.72
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.72
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	99.72
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.72
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.72
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.72
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	99.72
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.71
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.71
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.71
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.7
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.7
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.69
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.68
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.68
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	99.67
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	99.67
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.66
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.66
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.66
1o6v_A	466	Internalin A; bacterial infection, extracellular r	99.64
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.64
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.64
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	99.64
1o6v_A	466	Internalin A; bacterial infection, extracellular r	99.63
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.63
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.63
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	99.62
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.6
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.6
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.59
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.59
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.59
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.58
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.58
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.57
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.57
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	99.57
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.57
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.57
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.56
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.55
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.55
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.55
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.54
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.54
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	99.53
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.53
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.53
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.52
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.51
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.51
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.5
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.49
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.41
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.39
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	99.39
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.38
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.36
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	99.36
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.33
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.25
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.24
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.2
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.1
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.05
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.04
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.02
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.0
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.97
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	98.95
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	98.83
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.72
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.65
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	98.64
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.52
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.44
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.44
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.4
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.37
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.33
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.32
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.29
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.26
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.26
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.05
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.95
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.95
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	97.84
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	97.82
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.81
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	97.78
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	97.76
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	97.68
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.64
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.56
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	97.53
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.52
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	97.51
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.47
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.33
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.27
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.2
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.18
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.07
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	97.04
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.01
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.0
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	97.0
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.82
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	96.73
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.68
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.48
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.34
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	92.59
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	88.88
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	84.81

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=7e-56  Score=445.11  Aligned_cols=260  Identities=26%  Similarity=0.411  Sum_probs=217.1

Q ss_pred             hhccccccccCccCcccEEEEEeC------CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS------DGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKA  344 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  344 (593)
                      .++|.+.+.||+|+||.||+|++.      +++.||||+++.......+.|.+|++++++++|||||+++|++.+++..+
T Consensus        12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~   91 (299)
T 4asz_A           12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   91 (299)
T ss_dssp             GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence            367899999999999999999863      47789999998776667788999999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhhCC------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcE
Q 007680          345 LVLEFMPNGSLEKWLYSHN------------YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVA  412 (593)
Q Consensus       345 lv~e~~~~gsL~~~l~~~~------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~  412 (593)
                      +|||||++|+|.+++...+            ..+++.++..++.||++||+|||+++    |+||||||+|||+++++.+
T Consensus        92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~----iiHRDlKp~NILl~~~~~~  167 (299)
T 4asz_A           92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH----FVHRDLATRNCLVGENLLV  167 (299)
T ss_dssp             EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCSGGGEEECGGGCE
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC----cccCccCHhhEEECCCCcE
Confidence            9999999999999997643            35999999999999999999999654    9999999999999999999


Q ss_pred             EEEeeccceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHH
Q 007680          413 HVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKE  491 (593)
Q Consensus       413 kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~  491 (593)
                      ||+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |+.||.+....  .....+..
T Consensus       168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~--~~~~~i~~  245 (299)
T 4asz_A          168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN--EVIECITQ  245 (299)
T ss_dssp             EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--HHHHHHHH
T ss_pred             EECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHc
Confidence            9999999987654433333344568999999999999999999999999999999999 89999774321  12222211


Q ss_pred             hcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhh
Q 007680          492 SLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVK  553 (593)
Q Consensus       492 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  553 (593)
                      ..                 ..+.+..+++++.+++.+||+.||++|||++|+.+.|+++...
T Consensus       246 ~~-----------------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~  290 (299)
T 4asz_A          246 GR-----------------VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA  290 (299)
T ss_dssp             TC-----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CC-----------------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence            11                 1112234677899999999999999999999999999988654

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=3.5e-55  Score=446.06  Aligned_cols=260  Identities=25%  Similarity=0.383  Sum_probs=210.5

Q ss_pred             hhccccccccCccCcccEEEEEeC------CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS------DGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKA  344 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  344 (593)
                      .++|.+.++||+|+||.||+|++.      +++.||||+++.......+.|.+|++++++++|||||+++|+|.+++..+
T Consensus        40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~  119 (329)
T 4aoj_A           40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL  119 (329)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            357888899999999999999864      47889999998776667788999999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhhCC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC
Q 007680          345 LVLEFMPNGSLEKWLYSHN--------------YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENM  410 (593)
Q Consensus       345 lv~e~~~~gsL~~~l~~~~--------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~  410 (593)
                      +|||||++|+|.+++....              ..+++.++..|+.||++||+|||++    +|+||||||+|||+++++
T Consensus       120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~----~iiHRDLKp~NILl~~~~  195 (329)
T 4aoj_A          120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL----HFVHRDLATRNCLVGQGL  195 (329)
T ss_dssp             EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEEETTT
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC----CeecccccHhhEEECCCC
Confidence            9999999999999997643              2589999999999999999999965    499999999999999999


Q ss_pred             cEEEEeeccceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHH
Q 007680          411 VAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWV  489 (593)
Q Consensus       411 ~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~  489 (593)
                      .+||+|||+|+...............||+.|||||++.+..++.++|||||||++|||+| |+.||.+....  .....+
T Consensus       196 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~--~~~~~i  273 (329)
T 4aoj_A          196 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT--EAIDCI  273 (329)
T ss_dssp             EEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH--HHHHHH
T ss_pred             cEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH--HHHHHH
Confidence            999999999987655443333445679999999999999999999999999999999999 89999774321  112222


Q ss_pred             HHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhh
Q 007680          490 KESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVK  553 (593)
Q Consensus       490 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  553 (593)
                      ....                 ..+.+..+++++.+++.+||+.||++|||++||+++|+.+...
T Consensus       274 ~~g~-----------------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~  320 (329)
T 4aoj_A          274 TQGR-----------------ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA  320 (329)
T ss_dssp             HHTC-----------------CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             HcCC-----------------CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence            1111                 1122334677899999999999999999999999999998654

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=6.6e-55  Score=438.12  Aligned_cols=265  Identities=25%  Similarity=0.408  Sum_probs=209.7

Q ss_pred             hhhccccccccCccCcccEEEEEeCCCCeEEEEEeehh--hHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEE
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQ--LERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVL  347 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  347 (593)
                      ..+++++.++||+|+||+||+|+++  ..||||+++..  .....+.|.+|++++++++|||||++++++.+ +..++||
T Consensus        34 ~~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVm  110 (307)
T 3omv_A           34 EASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVT  110 (307)
T ss_dssp             CTTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             cHHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEE
Confidence            3567888999999999999999875  36999998753  24456789999999999999999999998865 5689999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCC
Q 007680          348 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGE  427 (593)
Q Consensus       348 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~  427 (593)
                      |||++|+|.+++......+++.++..|+.||++||+|||++    +|+||||||+|||+++++.+||+|||+|+......
T Consensus       111 Ey~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~----~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~  186 (307)
T 3omv_A          111 QWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAK----NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS  186 (307)
T ss_dssp             ECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT----TCBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred             EcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC----CccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence            99999999999988776799999999999999999999965    49999999999999999999999999998765443


Q ss_pred             CccccccccCCccccCccccCC---CCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhh
Q 007680          428 DSVRQTMTMATIGYMAPEYGLE---GIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDAN  504 (593)
Q Consensus       428 ~~~~~~~~~gt~~y~aPE~~~~---~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  504 (593)
                      .........||+.|||||++.+   +.|+.++|||||||++|||+||+.||.+..... .....+......       + 
T Consensus       187 ~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~-~~~~~~~~~~~~-------p-  257 (307)
T 3omv_A          187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD-QIIFMVGRGYAS-------P-  257 (307)
T ss_dssp             -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-HHHHHHHTTCCC-------C-
T ss_pred             cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH-HHHHHHhcCCCC-------C-
Confidence            3333455679999999999853   468999999999999999999999997643221 111111111100       0 


Q ss_pred             hhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhhhc
Q 007680          505 LVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKFL  555 (593)
Q Consensus       505 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~  555 (593)
                           .....+.++++++.+++.+||+.||++|||+.||+++|+.++..+.
T Consensus       258 -----~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lp  303 (307)
T 3omv_A          258 -----DLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLP  303 (307)
T ss_dssp             -----CSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCC
T ss_pred             -----CcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCC
Confidence                 0001123456789999999999999999999999999999876653

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.1e-54  Score=441.87  Aligned_cols=250  Identities=22%  Similarity=0.321  Sum_probs=212.3

Q ss_pred             hccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEecc
Q 007680          272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFM  350 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  350 (593)
                      +.|+..++||+|+||.||+|+++ +|+.||||+++.......+.+.+|+++|++++|||||+++++|.+++..|+|||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            56999999999999999999976 79999999998765555667889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCcc
Q 007680          351 PNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSV  430 (593)
Q Consensus       351 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~  430 (593)
                      +||+|.+++...+  +++.++..++.||+.||+|||+++    |+||||||+|||++.++.+||+|||+|+.+.....  
T Consensus       154 ~gg~L~~~l~~~~--l~e~~~~~~~~qi~~aL~ylH~~~----IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~--  225 (346)
T 4fih_A          154 EGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLHAQG----VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--  225 (346)
T ss_dssp             TTEEHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHTT----EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--
T ss_pred             CCCcHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCC----cccccCCHHHEEECCCCCEEEecCcCceecCCCCC--
Confidence            9999999998754  999999999999999999999655    99999999999999999999999999998754332  


Q ss_pred             ccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhhh
Q 007680          431 RQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQ  510 (593)
Q Consensus       431 ~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  510 (593)
                      .....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+..  .......+....+..              
T Consensus       226 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~--~~~~~~~i~~~~~~~--------------  289 (346)
T 4fih_A          226 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP--PLKAMKMIRDNLPPR--------------  289 (346)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--HHHHHHHHHHSSCCC--------------
T ss_pred             cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--HHHHHHHHHcCCCCC--------------
Confidence            2345689999999999999999999999999999999999999997632  112222222221111              


Q ss_pred             hhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          511 AFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       511 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                       ......+++++.+|+.+||+.||++|||++|+++|
T Consensus       290 -~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H  324 (346)
T 4fih_A          290 -LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  324 (346)
T ss_dssp             -CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             -CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence             11122346688999999999999999999999876

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=7.1e-55  Score=439.68  Aligned_cols=256  Identities=23%  Similarity=0.406  Sum_probs=212.5

Q ss_pred             hccccccccCccCcccEEEEEeC------CCCeEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceE
Q 007680          272 DEFNECNLLGTSSFGSVYKGTIS------DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKA  344 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  344 (593)
                      +++++.++||+|+||.||+|++.      +++.||||+++... ....+.|.+|+.++++++|||||+++|+|.+++..+
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~  105 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS  105 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence            45778899999999999999863      46789999997543 334578999999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCC
Q 007680          345 LVLEFMPNGSLEKWLYSHN---------------YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDEN  409 (593)
Q Consensus       345 lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~  409 (593)
                      +|||||++|+|.+++....               ..+++.++..|+.||++||+|||+++    |+||||||+|||++++
T Consensus       106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~----iiHRDLK~~NILl~~~  181 (308)
T 4gt4_A          106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH----VVHKDLATRNVLVYDK  181 (308)
T ss_dssp             EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCSGGGEEECGG
T ss_pred             EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC----CCCCCccccceEECCC
Confidence            9999999999999996532               25899999999999999999999654    9999999999999999


Q ss_pred             CcEEEEeeccceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHH
Q 007680          410 MVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRW  488 (593)
Q Consensus       410 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~  488 (593)
                      +.+||+|||+|+...............||+.|||||++.++.|+.++|||||||++|||+| |+.||.+....  .+...
T Consensus       182 ~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~--~~~~~  259 (308)
T 4gt4_A          182 LNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ--DVVEM  259 (308)
T ss_dssp             GCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH--HHHHH
T ss_pred             CCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH--HHHHH
Confidence            9999999999987654433333445679999999999999999999999999999999999 89999774321  22222


Q ss_pred             HHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHh
Q 007680          489 VKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKI  550 (593)
Q Consensus       489 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  550 (593)
                      +...                 ...+.+.++++++.+++.+||+.||++|||++||+++|+..
T Consensus       260 i~~~-----------------~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          260 IRNR-----------------QVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             HHTT-----------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             HHcC-----------------CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            2111                 11122345678899999999999999999999999999864

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=2.3e-54  Score=440.33  Aligned_cols=251  Identities=21%  Similarity=0.334  Sum_probs=204.5

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehh--hHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQ--LERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVL  347 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  347 (593)
                      .++|++++.||+|+||.||+|++. +|+.||||+++..  .....+.+.+|++++++++|||||++++++++++..|+||
T Consensus        23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm  102 (350)
T 4b9d_A           23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM  102 (350)
T ss_dssp             CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence            368999999999999999999975 7999999999764  2445678999999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCC
Q 007680          348 EFMPNGSLEKWLYSHNY-FLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG  426 (593)
Q Consensus       348 e~~~~gsL~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  426 (593)
                      |||+||+|.+++...+. .+++.++..++.||+.||+|||+++    |+||||||+|||++.++.+||+|||+|+.+...
T Consensus       103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~----IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  178 (350)
T 4b9d_A          103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK----ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST  178 (350)
T ss_dssp             ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT----CEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred             eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC----eeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence            99999999999976544 5799999999999999999999655    999999999999999999999999999876432


Q ss_pred             CCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhh
Q 007680          427 EDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLV  506 (593)
Q Consensus       427 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  506 (593)
                      .  ......+||+.|||||++.+..|+.++|||||||++|||+||+.||......+ .+.+......+            
T Consensus       179 ~--~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~-~~~~i~~~~~~------------  243 (350)
T 4b9d_A          179 V--ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN-LVLKIISGSFP------------  243 (350)
T ss_dssp             H--HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHTCCC------------
T ss_pred             c--ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-HHHHHHcCCCC------------
Confidence            1  12234579999999999999999999999999999999999999997632111 11111111111            


Q ss_pred             hhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          507 REEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                            +.+..+++++.+|+.+||+.||++|||++|+++|
T Consensus       244 ------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  277 (350)
T 4b9d_A          244 ------PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK  277 (350)
T ss_dssp             ------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                  1112345688999999999999999999999986

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=3.3e-54  Score=432.04  Aligned_cols=251  Identities=22%  Similarity=0.299  Sum_probs=212.3

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALV  346 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  346 (593)
                      .++|++.+.||+|+||+||+|+.. +|+.||||++++..   ....+.+.+|++++++++|||||++++++++.+..|+|
T Consensus        31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv  110 (311)
T 4aw0_A           31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG  110 (311)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            367999999999999999999975 79999999998653   33456789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCC
Q 007680          347 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG  426 (593)
Q Consensus       347 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  426 (593)
                      ||||+||+|.+++.+.+. +++.++..++.||+.||+|||+++    |+||||||+|||++.++.+||+|||+|+.+...
T Consensus       111 mEy~~gG~L~~~i~~~~~-l~e~~~~~~~~qi~~al~ylH~~~----IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~  185 (311)
T 4aw0_A          111 LSYAKNGELLKYIRKIGS-FDETCTRFYTAEIVSALEYLHGKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  185 (311)
T ss_dssp             ECCCTTEEHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHHHTT----EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EecCCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHCC----CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence            999999999999987654 999999999999999999999655    999999999999999999999999999987654


Q ss_pred             CCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhh
Q 007680          427 EDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLV  506 (593)
Q Consensus       427 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  506 (593)
                      .........+||+.|||||++.+..|+.++||||+||++|||+||+.||.....  ......+....             
T Consensus       186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--~~~~~~i~~~~-------------  250 (311)
T 4aw0_A          186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE--GLIFAKIIKLE-------------  250 (311)
T ss_dssp             TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHTC-------------
T ss_pred             CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHcCC-------------
Confidence            444444567899999999999999999999999999999999999999976321  11111111110             


Q ss_pred             hhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          507 REEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                         .  ..+..+++++.+|+.+||+.||++|||++|++.+
T Consensus       251 ---~--~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~  285 (311)
T 4aw0_A          251 ---Y--DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY  285 (311)
T ss_dssp             ---C--CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCH
T ss_pred             ---C--CCCcccCHHHHHHHHHHccCCHhHCcChHHHcCC
Confidence               0  0112345678999999999999999999998654

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=7.7e-54  Score=434.50  Aligned_cols=257  Identities=20%  Similarity=0.235  Sum_probs=210.2

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEec
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEF  349 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  349 (593)
                      .+.|++.++||+|+||.||+|+++ +|+.||||+++....     ..+|+.++++++|||||++++++.+++..|+||||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  131 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL  131 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            457889999999999999999975 799999999986532     24699999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC-cEEEEeeccceecCCCCC
Q 007680          350 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENM-VAHVSDFGIYKLLGEGED  428 (593)
Q Consensus       350 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~-~~kL~Dfg~a~~~~~~~~  428 (593)
                      |+||+|.+++.+.+. +++.++..++.||+.||+|||++    +|+||||||+|||++.++ .+||+|||+|+.+.....
T Consensus       132 ~~gg~L~~~l~~~~~-l~e~~~~~~~~qi~~aL~ylH~~----~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~  206 (336)
T 4g3f_A          132 LEGGSLGQLIKQMGC-LPEDRALYYLGQALEGLEYLHTR----RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL  206 (336)
T ss_dssp             CTTCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHHTT----TEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred             cCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHC----CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence            999999999987654 99999999999999999999954    599999999999999987 699999999998764332


Q ss_pred             c---cccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhh
Q 007680          429 S---VRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANL  505 (593)
Q Consensus       429 ~---~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  505 (593)
                      .   ......+||+.|||||++.+..|+.++|||||||++|||+||+.||.+....+. +..... ..+           
T Consensus       207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-~~~i~~-~~~-----------  273 (336)
T 4g3f_A          207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL-CLKIAS-EPP-----------  273 (336)
T ss_dssp             -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC-HHHHHH-SCC-----------
T ss_pred             ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH-HHHHHc-CCC-----------
Confidence            1   122345799999999999999999999999999999999999999976433221 111111 000           


Q ss_pred             hhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhhh
Q 007680          506 VREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKF  554 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  554 (593)
                          .....+..+++++.+++.+||+.||++|||+.|++++|.......
T Consensus       274 ----~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~  318 (336)
T 4g3f_A          274 ----PIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEV  318 (336)
T ss_dssp             ----GGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             ----CchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhh
Confidence                001112345678899999999999999999999999998876554

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2.2e-53  Score=442.88  Aligned_cols=250  Identities=22%  Similarity=0.321  Sum_probs=211.9

Q ss_pred             hccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEecc
Q 007680          272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFM  350 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  350 (593)
                      +.|++.++||+|+||.||+|+++ +|+.||||++........+.+.+|+.+|++++|||||+++++|.+++..|+|||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~  230 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  230 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence            56999999999999999999975 79999999998765555567899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCcc
Q 007680          351 PNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSV  430 (593)
Q Consensus       351 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~  430 (593)
                      +||+|.+++...+  +++.++..++.||+.||+|||+++    |+||||||+|||++.+|.+||+|||+|+.+.....  
T Consensus       231 ~gG~L~~~i~~~~--l~e~~~~~~~~qil~aL~ylH~~~----IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~--  302 (423)
T 4fie_A          231 EGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLHAQG----VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--  302 (423)
T ss_dssp             TTEEHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHTT----EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC--
T ss_pred             CCCcHHHHHhccC--CCHHHHHHHHHHHHHHHHHHHHCC----eecccCCHHHEEEcCCCCEEEecCccceECCCCCc--
Confidence            9999999997654  999999999999999999999655    99999999999999999999999999998754332  


Q ss_pred             ccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhhh
Q 007680          431 RQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQ  510 (593)
Q Consensus       431 ~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  510 (593)
                      .....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+..  .......+....+..              
T Consensus       303 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~--~~~~~~~i~~~~~~~--------------  366 (423)
T 4fie_A          303 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP--PLKAMKMIRDNLPPR--------------  366 (423)
T ss_dssp             CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--HHHHHHHHHHSCCCC--------------
T ss_pred             cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--HHHHHHHHHcCCCCC--------------
Confidence            2345679999999999999999999999999999999999999997632  122222222221111              


Q ss_pred             hhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          511 AFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       511 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                       ......+++++.+|+.+||..||++|||+.|+++|
T Consensus       367 -~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H  401 (423)
T 4fie_A          367 -LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  401 (423)
T ss_dssp             -CSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             -CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence             11112345688999999999999999999999876

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.4e-52  Score=418.22  Aligned_cols=247  Identities=24%  Similarity=0.348  Sum_probs=198.8

Q ss_pred             ccccccCccCcccEEEEEeC-CCCeEEEEEeehhh--HHHHHHHHHHHHHHhhcCCCCcceeeeeeec----CCceEEEE
Q 007680          275 NECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSYSN----PDFKALVL  347 (593)
Q Consensus       275 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~  347 (593)
                      ++.++||+|+||+||+|.+. +++.||+|++....  ....+.+.+|++++++++|||||+++++|.+    .+..|+||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            56678999999999999975 68999999997642  4456789999999999999999999999865    34689999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC-CCcEEEEeeccceecCCC
Q 007680          348 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDE-NMVAHVSDFGIYKLLGEG  426 (593)
Q Consensus       348 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~-~~~~kL~Dfg~a~~~~~~  426 (593)
                      |||+||+|.+++.+... +++..+..++.||+.||+|||+++  .+|+||||||+|||++. ++.+||+|||+|+.....
T Consensus       109 Ey~~gg~L~~~l~~~~~-l~~~~~~~~~~qi~~aL~ylH~~~--~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~  185 (290)
T 3fpq_A          109 ELMTSGTLKTYLKRFKV-MKIKVLRSWCRQILKGLQFLHTRT--PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS  185 (290)
T ss_dssp             ECCCSCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHHTSS--SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred             eCCCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCC--CCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC
Confidence            99999999999987654 999999999999999999999643  24999999999999984 789999999999864322


Q ss_pred             CCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhh
Q 007680          427 EDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLV  506 (593)
Q Consensus       427 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  506 (593)
                          .....+||+.|||||++.+ .|+.++|||||||++|||+||+.||.+..... .+...+.....            
T Consensus       186 ----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~-~~~~~i~~~~~------------  247 (290)
T 3fpq_A          186 ----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-QIYRRVTSGVK------------  247 (290)
T ss_dssp             ----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-HHHHHHTTTCC------------
T ss_pred             ----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH-HHHHHHHcCCC------------
Confidence                2344679999999998865 69999999999999999999999997532211 11111111100            


Q ss_pred             hhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          507 REEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                          ....+..+++++.+|+.+||+.||++|||++|+++|
T Consensus       248 ----~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H  283 (290)
T 3fpq_A          248 ----PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             ----CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ----CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                001112234578999999999999999999999875

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.4e-52  Score=414.55  Aligned_cols=246  Identities=25%  Similarity=0.384  Sum_probs=193.2

Q ss_pred             hccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEE
Q 007680          272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVL  347 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  347 (593)
                      ++|++.+.||+|+||.||+|+.. +|+.||+|+++...   ......+.+|++++++++||||+++++++.+++..|+||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            68999999999999999999965 79999999997542   334567899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCC
Q 007680          348 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGE  427 (593)
Q Consensus       348 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~  427 (593)
                      ||+ +|+|.+++.+.+. +++.++..++.||+.||+|||+++    |+||||||+|||+++++.+||+|||+|+......
T Consensus        93 Ey~-~g~L~~~l~~~~~-l~e~~~~~~~~qi~~al~ylH~~~----IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~  166 (275)
T 3hyh_A           93 EYA-GNELFDYIVQRDK-MSEQEARRFFQQIISAVEYCHRHK----IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN  166 (275)
T ss_dssp             ECC-CEEHHHHHHHSCS-CCHHHHHHHHHHHHHHHHHHHHTT----CCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred             eCC-CCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHCC----cccccCChHHeEECCCCCEEEeecCCCeecCCCC
Confidence            999 6899999987665 999999999999999999999655    9999999999999999999999999998765432


Q ss_pred             CccccccccCCccccCccccCCCCC-CccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhh
Q 007680          428 DSVRQTMTMATIGYMAPEYGLEGIV-SAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLV  506 (593)
Q Consensus       428 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  506 (593)
                         ......||+.|||||++.+..+ +.++||||+||++|||+||+.||.+...  ....+.+....+            
T Consensus       167 ---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~--~~~~~~i~~~~~------------  229 (275)
T 3hyh_A          167 ---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI--PVLFKNISNGVY------------  229 (275)
T ss_dssp             -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHTCC------------
T ss_pred             ---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHHcCCC------------
Confidence               2234679999999999988876 6899999999999999999999976321  111111111110            


Q ss_pred             hhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          507 REEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                            ..+..+++++.+++.+||+.||++|||++|+++|
T Consensus       230 ------~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  263 (275)
T 3hyh_A          230 ------TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD  263 (275)
T ss_dssp             ------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred             ------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence                  0112245678999999999999999999999986

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1e-52  Score=431.31  Aligned_cols=267  Identities=26%  Similarity=0.403  Sum_probs=219.4

Q ss_pred             HHHHHhhhccccccccCccCcccEEEEEeCC------CCeEEEEEeehhh-HHHHHHHHHHHHHHhhcCC-CCcceeeee
Q 007680          265 LDIQRATDEFNECNLLGTSSFGSVYKGTISD------GTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRH-RNLIKILSS  336 (593)
Q Consensus       265 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h-~niv~l~~~  336 (593)
                      .+++...++|++.+.||+|+||.||+|++..      ++.||||.++... ....+.+.+|++++.+++| ||||+++|+
T Consensus        57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~  136 (353)
T 4ase_A           57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA  136 (353)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence            4455567899999999999999999998642      3579999997653 3445779999999999965 899999999


Q ss_pred             eecC-CceEEEEeccCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCC
Q 007680          337 YSNP-DFKALVLEFMPNGSLEKWLYSHN---------------YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLK  400 (593)
Q Consensus       337 ~~~~-~~~~lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlk  400 (593)
                      |.+. +..++|||||++|+|.++++...               ..+++.++..++.||++||+|||+++    |+|||||
T Consensus       137 ~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~----iiHRDLK  212 (353)
T 4ase_A          137 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK----CIHRDLA  212 (353)
T ss_dssp             ECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCS
T ss_pred             EEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC----eecCccC
Confidence            8764 56899999999999999997642               24899999999999999999999654    9999999


Q ss_pred             CCCeeeCCCCcEEEEeeccceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccc
Q 007680          401 PTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMF  479 (593)
Q Consensus       401 p~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~  479 (593)
                      |+|||+++++.+||+|||+|+.+.............||+.|||||++.+..|+.++|||||||++|||+| |+.||.+..
T Consensus       213 ~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~  292 (353)
T 4ase_A          213 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK  292 (353)
T ss_dssp             GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             ccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCC
Confidence            9999999999999999999998766554444555679999999999999999999999999999999998 999997743


Q ss_pred             cccchHHHHHHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhh
Q 007680          480 IGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVK  553 (593)
Q Consensus       480 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  553 (593)
                      ..+ .+.+.+....                 ..+.+..+++++.+++.+||+.||++|||++|++++|+++...
T Consensus       293 ~~~-~~~~~i~~g~-----------------~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~  348 (353)
T 4ase_A          293 IDE-EFCRRLKEGT-----------------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  348 (353)
T ss_dssp             CSH-HHHHHHHHTC-----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHH-HHHHHHHcCC-----------------CCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence            222 1222222111                 1122234567899999999999999999999999999998654

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.4e-52  Score=423.67  Aligned_cols=275  Identities=20%  Similarity=0.282  Sum_probs=204.9

Q ss_pred             hccccccccCccCcccEEEEEeCCCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCC----ceEEEE
Q 007680          272 DEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPD----FKALVL  347 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~  347 (593)
                      .+|.+.++||+|+||+||+|++ +|+.||||+++..... ....+.|+..+.+++|||||++++++.+++    ..++||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~   80 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence            4688889999999999999998 5899999999765432 223345677777899999999999997654    579999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcC----CCCCeEecCCCCCCeeeCCCCcEEEEeeccceec
Q 007680          348 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGH----SSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLL  423 (593)
Q Consensus       348 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~----~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~  423 (593)
                      |||++|+|.++++...  +++..+.+++.|+++||+|||++.    .+.+|+||||||+|||+++++.+||+|||+|+..
T Consensus        81 Ey~~~gsL~~~l~~~~--l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~  158 (303)
T 3hmm_A           81 DYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH  158 (303)
T ss_dssp             ECCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred             cCCCCCcHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccc
Confidence            9999999999998765  899999999999999999999651    1347999999999999999999999999999887


Q ss_pred             CCCCCcc--ccccccCCccccCccccCCC------CCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCC
Q 007680          424 GEGEDSV--RQTMTMATIGYMAPEYGLEG------IVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPH  495 (593)
Q Consensus       424 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~  495 (593)
                      .......  ......||+.|||||++.+.      .++.++|||||||++|||+||.+||.........+..+...  ..
T Consensus       159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~--~~  236 (303)
T 3hmm_A          159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS--DP  236 (303)
T ss_dssp             ETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS--SC
T ss_pred             cCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccc--cc
Confidence            5543322  22345799999999998754      46789999999999999999988875432211111000000  00


Q ss_pred             chhh----hhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhh
Q 007680          496 GLTE----VVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKV  552 (593)
Q Consensus       496 ~~~~----~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~  552 (593)
                      ...+    +.+..+...........+++..+.+++.+||+.||++|||+.||++.|+++..
T Consensus       237 ~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~  297 (303)
T 3hmm_A          237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  297 (303)
T ss_dssp             CHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence            0000    01111111111111223456788999999999999999999999999998864

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.2e-52  Score=420.65  Aligned_cols=248  Identities=24%  Similarity=0.260  Sum_probs=197.9

Q ss_pred             hccccccccCccCcccEEEEEeC----CCCeEEEEEeehhh--HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEE
Q 007680          272 DEFNECNLLGTSSFGSVYKGTIS----DGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKAL  345 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  345 (593)
                      ++|++.+.||+|+||+||+|+..    +++.||+|+++...  ......+.+|++++++++|||||++++++.+++..|+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            67999999999999999999863    47889999997542  2223467889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCC
Q 007680          346 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGE  425 (593)
Q Consensus       346 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~  425 (593)
                      |||||+||+|.+++.+.+. +++.++..++.|++.||+|||+++    |+||||||+|||++.++.+||+|||+|+....
T Consensus       104 vmEy~~gg~L~~~l~~~~~-l~e~~~~~~~~qi~~aL~ylH~~~----IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~  178 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKEVM-FTEEDVKFYLAELALALDHLHSLG----IIYRDLKPENILLDEEGHIKLTDFGLSKESID  178 (304)
T ss_dssp             EECCCTTCEEHHHHHHHCC-CCHHHHHHHHHHHHHHHHHHHHTT----CCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred             EEEcCCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCC----CcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence            9999999999999987664 999999999999999999999655    99999999999999999999999999986543


Q ss_pred             CCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhh
Q 007680          426 GEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANL  505 (593)
Q Consensus       426 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  505 (593)
                      ...  .....+||+.|||||++.+..|+.++||||+||++|||+||+.||.+....  .....+....+           
T Consensus       179 ~~~--~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~--~~~~~i~~~~~-----------  243 (304)
T 3ubd_A          179 HEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK--ETMTMILKAKL-----------  243 (304)
T ss_dssp             --C--CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHCCC-----------
T ss_pred             CCc--cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH--HHHHHHHcCCC-----------
Confidence            322  234467999999999999999999999999999999999999999763211  11111111100           


Q ss_pred             hhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCH-----HHHHHH
Q 007680          506 VREEQAFSAKMDCILSIMDFALDCCMESPDMRINM-----TDAAAK  546 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~~  546 (593)
                             ..+..+++++.+|+.+||+.||++|||+     +|+++|
T Consensus       244 -------~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H  282 (304)
T 3ubd_A          244 -------GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH  282 (304)
T ss_dssp             -------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred             -------CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence                   1112346688999999999999999985     566654

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=8.9e-51  Score=408.63  Aligned_cols=251  Identities=23%  Similarity=0.360  Sum_probs=191.1

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCC-------
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPD-------  341 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-------  341 (593)
                      .++|++++.||+|+||.||+|+++ +|+.||||+++... ....+.+.+|++++++++|||||+++++|.+.+       
T Consensus         4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~   83 (299)
T 4g31_A            4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP   83 (299)
T ss_dssp             HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred             chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence            457999999999999999999975 79999999997543 344567899999999999999999999987544       


Q ss_pred             -----ceEEEEeccCCCCHHHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEE
Q 007680          342 -----FKALVLEFMPNGSLEKWLYSHNY--FLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHV  414 (593)
Q Consensus       342 -----~~~lv~e~~~~gsL~~~l~~~~~--~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL  414 (593)
                           ..|+|||||++|+|.+++.....  ..++..+..++.||++||+|||+++    |+||||||+|||++.++.+||
T Consensus        84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~----IiHRDlKp~NILl~~~~~vKl  159 (299)
T 4g31_A           84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG----LMHRDLKPSNIFFTMDDVVKV  159 (299)
T ss_dssp             ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT----CCCCCCCGGGEEECTTCCEEE
T ss_pred             cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc----CccccCcHHHeEECCCCcEEE
Confidence                 36899999999999999987654  3566778999999999999999655    999999999999999999999


Q ss_pred             EeeccceecCCCCCc----------cccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccch
Q 007680          415 SDFGIYKLLGEGEDS----------VRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMS  484 (593)
Q Consensus       415 ~Dfg~a~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~  484 (593)
                      +|||+|+.+......          ...+..+||+.|||||++.+..|+.++|||||||++|||++   ||.....    
T Consensus       160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~----  232 (299)
T 4g31_A          160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME----  232 (299)
T ss_dssp             CCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH----
T ss_pred             ccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH----
Confidence            999999887543321          11234579999999999999999999999999999999996   7754211    


Q ss_pred             HHHHHHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          485 LRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       485 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      .......        +.....      .+.....++...+|+.+||+.||++|||+.|+++|
T Consensus       233 ~~~~~~~--------~~~~~~------p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  280 (299)
T 4g31_A          233 RVRTLTD--------VRNLKF------PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN  280 (299)
T ss_dssp             HHHHHHH--------HHTTCC------CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HHHHHHH--------HhcCCC------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            1111100        000000      01122334567889999999999999999999875

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.7e-48  Score=405.27  Aligned_cols=267  Identities=23%  Similarity=0.290  Sum_probs=203.1

Q ss_pred             hccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh--HHHHHHHHHHHHHHhhcCCCCcceeeeeeec------CCc
Q 007680          272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSYSN------PDF  342 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~  342 (593)
                      ++|++++.||+|+||+||+|++. +|+.||||+++...  ....+.+.+|+++|++++|||||++++++..      .+.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            57999999999999999999975 79999999997542  3445678899999999999999999998754      367


Q ss_pred             eEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeecccee
Q 007680          343 KALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKL  422 (593)
Q Consensus       343 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~  422 (593)
                      .|+|||||+ |+|.+++...+ .+++.++..++.||+.||+|||+++    |+||||||+|||++.++.+||+|||+|+.
T Consensus       134 ~~ivmE~~~-g~L~~~i~~~~-~l~~~~~~~~~~qil~al~ylH~~~----iiHRDlKP~NIl~~~~~~~Ki~DFGla~~  207 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHSSQ-PLTLEHVRYFLYQLLRGLKYMHSAQ----VIHRDLKPSNLLVNENCELKIGDFGMARG  207 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTSSS-CCCHHHHHHHHHHHHHHHHHHHHTT----CBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred             EEEEEeCCC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCc----CcCCCcCccccccCCCCCEEEeecceeee
Confidence            899999995 68999998765 4999999999999999999999655    99999999999999999999999999987


Q ss_pred             cCCCCC--ccccccccCCccccCccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhc--CC-c
Q 007680          423 LGEGED--SVRQTMTMATIGYMAPEYGLEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESL--PH-G  496 (593)
Q Consensus       423 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~--~~-~  496 (593)
                      +.....  .......+||+.|||||++.+. .++.++||||+||++|||++|++||.+...  ......+....  +. .
T Consensus       208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~--~~~l~~I~~~~g~p~~~  285 (398)
T 4b99_A          208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNY--VHQLQLIMMVLGTPSPA  285 (398)
T ss_dssp             C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSH--HHHHHHHHHHHCCCCGG
T ss_pred             cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCH--HHHHHHHHHhcCCCChH
Confidence            654321  1223456899999999998775 579999999999999999999999976322  11111111111  11 0


Q ss_pred             hhhhhhhhhhhh---------hhh-hhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          497 LTEVVDANLVRE---------EQA-FSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       497 ~~~~~~~~~~~~---------~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      ....+.......         ... .......++++.+|+.+||..||++|||+.|+++|
T Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  345 (398)
T 4b99_A          286 VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH  345 (398)
T ss_dssp             GTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             HhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            000000000000         000 00011235678999999999999999999999987

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=4.7e-48  Score=399.26  Aligned_cols=267  Identities=19%  Similarity=0.240  Sum_probs=201.5

Q ss_pred             hhhccccccccCccCcccEEEEEeC----CCCeEEEEEeehhhHHHHHHHHHHHHHHhhc-CCCCcceeeeeeecCCceE
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTIS----DGTDVAIKVFNLQLERAFRSFDSECEVLRNV-RHRNLIKILSSYSNPDFKA  344 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  344 (593)
                      ..++|++.++||+|+||+||+|+.+    +++.||+|.+.....  ...+.+|+++++.+ +||||+++++++.+.++.|
T Consensus        19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~--~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~   96 (361)
T 4f9c_A           19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH--PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV   96 (361)
T ss_dssp             GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC--HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred             ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC--HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence            4678999999999999999999853    478899999876532  34678899999998 6999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCC-CcEEEEeeccceec
Q 007680          345 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDEN-MVAHVSDFGIYKLL  423 (593)
Q Consensus       345 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~-~~~kL~Dfg~a~~~  423 (593)
                      +||||+++|+|.+++..    +++.++..++.|++.||+|||+++    |+||||||+|||++.+ +.+||+|||+|+..
T Consensus        97 lvmE~~~g~~L~~~~~~----l~~~~~~~~~~qll~al~ylH~~g----IiHRDiKPeNiLl~~~~~~~kl~DFGla~~~  168 (361)
T 4f9c_A           97 IAMPYLEHESFLDILNS----LSFQEVREYMLNLFKALKRIHQFG----IVHRDVKPSNFLYNRRLKKYALVDFGLAQGT  168 (361)
T ss_dssp             EEEECCCCCCHHHHHTT----CCHHHHHHHHHHHHHHHHHHHHTT----EECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             EEEeCCCcccHHHHHcC----CCHHHHHHHHHHHHHHHHHHHHCC----eEeCcCCHHHeEEeCCCCeEEECcCCCCccc
Confidence            99999999999999842    899999999999999999999655    9999999999999876 79999999999876


Q ss_pred             CCCCCc--------------------------cccccccCCccccCccccCCC-CCCccchHHHHHHHHHHHHhCCCCCC
Q 007680          424 GEGEDS--------------------------VRQTMTMATIGYMAPEYGLEG-IVSAKCDVYSYGVLLMETFTRKRPTD  476 (593)
Q Consensus       424 ~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlGvvl~elltg~~pf~  476 (593)
                      ......                          ......+||+.|+|||++.+. .|+.++||||+||++|||++|+.||.
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~  248 (361)
T 4f9c_A          169 HDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFY  248 (361)
T ss_dssp             TTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred             CCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCC
Confidence            433211                          012335799999999998775 48999999999999999999999996


Q ss_pred             ccccccchHHHHHHHh---------------------cCCc-hhhhhhhh-------------hhhhhhhhhhhHHHHHH
Q 007680          477 EMFIGEMSLRRWVKES---------------------LPHG-LTEVVDAN-------------LVREEQAFSAKMDCILS  521 (593)
Q Consensus       477 ~~~~~~~~~~~~~~~~---------------------~~~~-~~~~~~~~-------------~~~~~~~~~~~~~~~~~  521 (593)
                      ....+...+.....-.                     .+.. ........             ........+.....+++
T Consensus       249 ~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~  328 (361)
T 4f9c_A          249 KASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDE  328 (361)
T ss_dssp             CCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHH
T ss_pred             CCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHH
Confidence            5433222222111100                     0000 00000000             00000011112234567


Q ss_pred             HHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          522 IMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       522 l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      +.+|+.+||+.||++|||++|+++|
T Consensus       329 a~DLl~~lL~~dP~~R~ta~eaL~H  353 (361)
T 4f9c_A          329 AYDLLDKLLDLNPASRITAEEALLH  353 (361)
T ss_dssp             HHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred             HHHHHHHHCcCChhHCcCHHHHhcC
Confidence            8999999999999999999999876

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=2.9e-47  Score=416.64  Aligned_cols=253  Identities=23%  Similarity=0.276  Sum_probs=212.5

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEec
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEF  349 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  349 (593)
                      .++|++.+.||+|+||.||+|+.+ +|+.||+|++........+.+.+|+++|+.++||||++++++|.+.+..|+||||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~  235 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  235 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence            468999999999999999999975 7999999999876656667889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCC--CcEEEEeeccceecCCCC
Q 007680          350 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDEN--MVAHVSDFGIYKLLGEGE  427 (593)
Q Consensus       350 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~--~~~kL~Dfg~a~~~~~~~  427 (593)
                      |+||+|.+++......+++.++..++.||+.||+|||+++    |+||||||+|||++.+  +.+||+|||+|+.+....
T Consensus       236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~----iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~  311 (573)
T 3uto_A          236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN----YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ  311 (573)
T ss_dssp             CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTT----EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred             cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC----eeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence            9999999999776666999999999999999999999655    9999999999999854  899999999999876443


Q ss_pred             CccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhh
Q 007680          428 DSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVR  507 (593)
Q Consensus       428 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  507 (593)
                         .....+||+.|||||++.+..|+.++||||+||++|||++|+.||.+....  .....+......           .
T Consensus       312 ---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~--~~~~~i~~~~~~-----------~  375 (573)
T 3uto_A          312 ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD--ETLRNVKSCDWN-----------M  375 (573)
T ss_dssp             ---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHHHHHHTTCCC-----------C
T ss_pred             ---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--HHHHHHHhCCCC-----------C
Confidence               233457999999999999999999999999999999999999999763221  111111111000           0


Q ss_pred             hhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          508 EEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       508 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                         .......+++++.+|+.+||..||++|||+.|+++|
T Consensus       376 ---~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H  411 (573)
T 3uto_A          376 ---DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  411 (573)
T ss_dssp             ---CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ---CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence               001112345678999999999999999999999986

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.5e-46  Score=408.62  Aligned_cols=249  Identities=19%  Similarity=0.281  Sum_probs=202.6

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHH---HHHHHHHhhcCCCCcceeeeeeecCCce
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSF---DSECEVLRNVRHRNLIKILSSYSNPDFK  343 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~---~~E~~~l~~l~h~niv~l~~~~~~~~~~  343 (593)
                      .++|++.+.||+|+||.||+|+.+ +|+.||||++++..   .......   ..++.+++.++|||||+++++|.+.+..
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l  267 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL  267 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence            478999999999999999999976 79999999997643   1112223   3446777788999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceec
Q 007680          344 ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLL  423 (593)
Q Consensus       344 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~  423 (593)
                      |+|||||+||+|.+++.+.+. +++..+..++.||+.||+|||++    ||+||||||+|||++.+|.+||+|||+|+.+
T Consensus       268 ylVmEy~~GGdL~~~l~~~~~-l~E~~a~~y~~qIl~aL~yLH~~----gIiHRDLKPeNILld~~G~vKL~DFGlA~~~  342 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLSQHGV-FSEADMRFYAAEIILGLEHMHNR----FVVYRDLKPANILLDEHGHVRISDLGLACDF  342 (689)
T ss_dssp             EEEECCCCSCBHHHHHHHHCC-CCHHHHHHHHHHHHHHHHHHHTT----TEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEecCCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHC----CccccCCchHHeEEeCCCCEEecccceeeec
Confidence            999999999999999987654 99999999999999999999954    5999999999999999999999999999987


Q ss_pred             CCCCCccccccccCCccccCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCccccccc-hHHHHHHHhcCCchhhhh
Q 007680          424 GEGEDSVRQTMTMATIGYMAPEYGLE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEM-SLRRWVKESLPHGLTEVV  501 (593)
Q Consensus       424 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~  501 (593)
                      ....    ....+||+.|||||++.+ ..|+.++||||+||++|||++|++||.+...... .........         
T Consensus       343 ~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~---------  409 (689)
T 3v5w_A          343 SKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM---------  409 (689)
T ss_dssp             SSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHC---------
T ss_pred             CCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCC---------
Confidence            5433    234679999999999865 5799999999999999999999999976432211 111111100         


Q ss_pred             hhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCC-----HHHHHHH
Q 007680          502 DANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRIN-----MTDAAAK  546 (593)
Q Consensus       502 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~  546 (593)
                             .  ...+..+++++.+|+.+||..||++|++     ++|+++|
T Consensus       410 -------~--~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H  450 (689)
T 3v5w_A          410 -------A--VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  450 (689)
T ss_dssp             -------C--CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred             -------C--CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence                   0  0111234568899999999999999998     6888876

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1e-45  Score=377.78  Aligned_cols=283  Identities=33%  Similarity=0.540  Sum_probs=229.4

Q ss_pred             CCHHHHHHhhhccccccccCccCcccEEEEEeCCCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCC
Q 007680          262 TSYLDIQRATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPD  341 (593)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  341 (593)
                      .++.++...+++|++.+.||+|+||.||+|++++++.||+|++........+.+.+|++++++++||||+++++++.+.+
T Consensus        29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  108 (321)
T 2qkw_B           29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN  108 (321)
T ss_dssp             -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred             ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence            34455566788999999999999999999998889999999987765556678999999999999999999999999999


Q ss_pred             ceEEEEeccCCCCHHHHHhhCCC---CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeec
Q 007680          342 FKALVLEFMPNGSLEKWLYSHNY---FLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFG  418 (593)
Q Consensus       342 ~~~lv~e~~~~gsL~~~l~~~~~---~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg  418 (593)
                      ..++||||+++|+|.+++.....   .+++.++..++.|++.||+|||+++    |+||||||+||+++.++.+||+|||
T Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~----ivH~dlkp~Nil~~~~~~~kl~Dfg  184 (321)
T 2qkw_B          109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA----IIHRDVKSINILLDENFVPKITDFG  184 (321)
T ss_dssp             CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT----EECSCCCSTTEEECTTCCEEECCCT
T ss_pred             eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC----eecCCCCHHHEEECCCCCEEEeecc
Confidence            99999999999999999876542   5899999999999999999999654    9999999999999999999999999


Q ss_pred             cceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCcccccc-chHHHHHHHhcC-Cc
Q 007680          419 IYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGE-MSLRRWVKESLP-HG  496 (593)
Q Consensus       419 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~-~~~~~~~~~~~~-~~  496 (593)
                      +++...............||+.|+|||++.+..++.++||||||+++|||++|+.||......+ .....|...... ..
T Consensus       185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  264 (321)
T 2qkw_B          185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ  264 (321)
T ss_dssp             TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTC
T ss_pred             cccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccccc
Confidence            9987654333323344568999999999988899999999999999999999999997643322 233333322211 11


Q ss_pred             hhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhh
Q 007680          497 LTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVK  553 (593)
Q Consensus       497 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  553 (593)
                      ....+++....     ....+++..+.+++.+||+.||++|||+.|++++|+.+...
T Consensus       265 ~~~~~~~~~~~-----~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~  316 (321)
T 2qkw_B          265 LEQIVDPNLAD-----KIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL  316 (321)
T ss_dssp             CCSSSSSSCTT-----CSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             HHHhcChhhcc-----ccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence            22222222211     12235677899999999999999999999999999988653

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=8.9e-45  Score=368.92  Aligned_cols=263  Identities=24%  Similarity=0.383  Sum_probs=217.7

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEec
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEF  349 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  349 (593)
                      .++|.+.+.||+|+||.||+|.+. +++.||+|++........+.+.+|++++++++||||+++++++.+++..++||||
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   88 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY   88 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence            468999999999999999999975 6899999998766666778899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCc
Q 007680          350 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDS  429 (593)
Q Consensus       350 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~  429 (593)
                      +++++|.+++......+++.++..++.|++.||+|||+++    |+||||||+||+++.++.+||+|||+++........
T Consensus        89 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~----ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  164 (310)
T 3s95_A           89 IKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN----IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ  164 (310)
T ss_dssp             CTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTT----EECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred             cCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC----ccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence            9999999999986667999999999999999999999654    999999999999999999999999999876543321


Q ss_pred             c------------ccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCch
Q 007680          430 V------------RQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGL  497 (593)
Q Consensus       430 ~------------~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  497 (593)
                      .            ......||+.|+|||++.+..++.++||||||+++|||++|..||...........        ...
T Consensus       165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~--------~~~  236 (310)
T 3s95_A          165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG--------LNV  236 (310)
T ss_dssp             ---------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSS--------BCH
T ss_pred             ccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHh--------hhh
Confidence            1            11145699999999999999999999999999999999999999866322211000        000


Q ss_pred             hhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhhh
Q 007680          498 TEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKF  554 (593)
Q Consensus       498 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  554 (593)
                      ....+         ...+..+++.+.+++.+||+.||++|||+.|+++.|++++...
T Consensus       237 ~~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~  284 (310)
T 3s95_A          237 RGFLD---------RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL  284 (310)
T ss_dssp             HHHHH---------HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             hcccc---------ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence            00000         0112234567899999999999999999999999999998765

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=4.6e-45  Score=368.77  Aligned_cols=251  Identities=23%  Similarity=0.327  Sum_probs=210.6

Q ss_pred             hhccccccccCccCcccEEEEEe-CCCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEec
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTI-SDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEF  349 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  349 (593)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++........+.+.+|+.++++++||||+++++++..++..++||||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   98 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence            46899999999999999999996 47999999999876655567789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCc
Q 007680          350 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDS  429 (593)
Q Consensus       350 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~  429 (593)
                      +++|+|.+++....  +++.++..++.|++.||+|||+++    |+||||||+||+++.++.+||+|||++........ 
T Consensus        99 ~~~~~L~~~~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~----i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  171 (297)
T 3fxz_A           99 LAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLHSNQ----VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-  171 (297)
T ss_dssp             CTTCBHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHTT----EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred             CCCCCHHHHHhhcC--CCHHHHHHHHHHHHHHHHHHHhCC----ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-
Confidence            99999999998764  899999999999999999999654    99999999999999999999999999987654432 


Q ss_pred             cccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhh
Q 007680          430 VRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREE  509 (593)
Q Consensus       430 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  509 (593)
                       ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ .........+               
T Consensus       172 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~---------------  234 (297)
T 3fxz_A          172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-LYLIATNGTP---------------  234 (297)
T ss_dssp             -CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHHHCSC---------------
T ss_pred             -ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhCCCC---------------
Confidence             23445799999999999999999999999999999999999999976322111 1111111100               


Q ss_pred             hhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          510 QAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       510 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                       ....+..++..+.+++.+||+.||++|||+.|+++|
T Consensus       235 -~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  270 (297)
T 3fxz_A          235 -ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  270 (297)
T ss_dssp             -CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             -CCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence             011122345678999999999999999999999875

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=5.9e-45  Score=372.39  Aligned_cols=278  Identities=21%  Similarity=0.289  Sum_probs=212.9

Q ss_pred             hhhccccccccCccCcccEEEEEeCCCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCC----ceEE
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPD----FKAL  345 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~l  345 (593)
                      ..++|++.+.||+|+||.||+|++. ++.||||+++.... .......|+.++++++||||+++++++....    ..++
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l   99 (322)
T 3soc_A           22 QSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL   99 (322)
T ss_dssp             TTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             chhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence            3578999999999999999999985 79999999976543 3345567999999999999999999998754    3699


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcC------CCCCeEecCCCCCCeeeCCCCcEEEEeecc
Q 007680          346 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGH------SSVHIIHCDLKPTNILLDENMVAHVSDFGI  419 (593)
Q Consensus       346 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~------~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~  419 (593)
                      ||||+++|+|.+++....  +++..+..++.|++.||+|||+..      .+.+|+||||||+||+++.++.+||+|||+
T Consensus       100 v~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~  177 (322)
T 3soc_A          100 ITAFHEKGSLSDFLKANV--VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL  177 (322)
T ss_dssp             EEECCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             EEecCCCCCHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCc
Confidence            999999999999998755  899999999999999999999540      011699999999999999999999999999


Q ss_pred             ceecCCCCCccccccccCCccccCccccCC-----CCCCccchHHHHHHHHHHHHhCCCCCCccccccch-HHHHHHHhc
Q 007680          420 YKLLGEGEDSVRQTMTMATIGYMAPEYGLE-----GIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMS-LRRWVKESL  493 (593)
Q Consensus       420 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~-~~~~~~~~~  493 (593)
                      ++...............||+.|+|||++.+     ..++.++|||||||++|||+||+.||......... +.... ...
T Consensus       178 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~-~~~  256 (322)
T 3soc_A          178 ALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI-GQH  256 (322)
T ss_dssp             CEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH-CSS
T ss_pred             ccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh-ccC
Confidence            988765544333444679999999999876     35677899999999999999999999764322111 11100 000


Q ss_pred             CCchhhhhh----hhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhh
Q 007680          494 PHGLTEVVD----ANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVK  553 (593)
Q Consensus       494 ~~~~~~~~~----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  553 (593)
                      + ...+..+    ...............++.++.+++.+||+.||++|||+.|+++.|+++...
T Consensus       257 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~  319 (322)
T 3soc_A          257 P-SLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL  319 (322)
T ss_dssp             C-CHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             C-chhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence            0 0111110    000000111112224566799999999999999999999999999998764

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=7.5e-45  Score=372.14  Aligned_cols=286  Identities=35%  Similarity=0.504  Sum_probs=233.2

Q ss_pred             hcccCCHHHHHHhhhccccccccCccCcccEEEEEeCCCCeEEEEEeehhhH-HHHHHHHHHHHHHhhcCCCCcceeeee
Q 007680          258 IWRRTSYLDIQRATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLE-RAFRSFDSECEVLRNVRHRNLIKILSS  336 (593)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~  336 (593)
                      ..+.+++.++....++|++.+.||+|+||.||+|+..+|+.||+|++..... .....+.+|++++++++||||++++++
T Consensus        16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~   95 (326)
T 3uim_A           16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF   95 (326)
T ss_dssp             CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred             ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence            3467889999999999999999999999999999988899999999976532 223368899999999999999999999


Q ss_pred             eecCCceEEEEeccCCCCHHHHHhhCCC---CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEE
Q 007680          337 YSNPDFKALVLEFMPNGSLEKWLYSHNY---FLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAH  413 (593)
Q Consensus       337 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~---~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~k  413 (593)
                      +...+..++||||+++|+|.+++.....   .+++..+..++.|++.||+|||++. ..+|+||||||+||+++.++.+|
T Consensus        96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~-~~~ivH~Dlkp~Nil~~~~~~~k  174 (326)
T 3uim_A           96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHC-DPKIIHRDVKAANILLDEEFEAV  174 (326)
T ss_dssp             ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSS-SSCEECCCCSGGGEEECTTCCEE
T ss_pred             EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCC-CCCeEeCCCchhhEEECCCCCEE
Confidence            9999999999999999999999987543   4899999999999999999999762 23699999999999999999999


Q ss_pred             EEeeccceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCcc---ccccchHHHHHH
Q 007680          414 VSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEM---FIGEMSLRRWVK  490 (593)
Q Consensus       414 L~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~---~~~~~~~~~~~~  490 (593)
                      |+|||++......... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...   .........|+.
T Consensus       175 l~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  253 (326)
T 3uim_A          175 VGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK  253 (326)
T ss_dssp             ECCCSSCEECCSSSSC-EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT
T ss_pred             eccCccccccCccccc-ccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH
Confidence            9999999877543322 233456999999999998888999999999999999999999999743   122334445554


Q ss_pred             HhcCCc-hhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHh
Q 007680          491 ESLPHG-LTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKI  550 (593)
Q Consensus       491 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  550 (593)
                      ...... .....+.....     ....+.+..+.+++.+||+.||++|||+.|++++|++.
T Consensus       254 ~~~~~~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  309 (326)
T 3uim_A          254 GLLKEKKLEALVDVDLQG-----NYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD  309 (326)
T ss_dssp             TTTSSCCSTTSSCTTCTT-----SCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred             HHhhchhhhhhcChhhcc-----ccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence            443332 23333322211     12235577899999999999999999999999999874

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.9e-44  Score=375.69  Aligned_cols=261  Identities=23%  Similarity=0.413  Sum_probs=216.1

Q ss_pred             hhccccccccCccCcccEEEEEeC--------CCCeEEEEEeehhh-HHHHHHHHHHHHHHhhc-CCCCcceeeeeeecC
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS--------DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNV-RHRNLIKILSSYSNP  340 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  340 (593)
                      .++|++.+.||+|+||.||+|++.        ++..||+|+++... ....+.+.+|+++++++ +||||+++++++.+.
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            578999999999999999999852        35579999997653 34567899999999999 899999999999999


Q ss_pred             CceEEEEeccCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCee
Q 007680          341 DFKALVLEFMPNGSLEKWLYSHN---------------YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNIL  405 (593)
Q Consensus       341 ~~~~lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIl  405 (593)
                      +..++||||+++|+|.+++....               ..+++.++..++.||+.||+|||+++    |+||||||+||+
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~----ivHrDlkp~NIl  235 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK----CIHRDLAARNVL  235 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT----EECSCCCGGGEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC----eeccccchhhEE
Confidence            99999999999999999998754               24789999999999999999999654    999999999999


Q ss_pred             eCCCCcEEEEeeccceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccch
Q 007680          406 LDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMS  484 (593)
Q Consensus       406 l~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~  484 (593)
                      ++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||......  .
T Consensus       236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~--~  313 (370)
T 2psq_A          236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE--E  313 (370)
T ss_dssp             ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--G
T ss_pred             ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH--H
Confidence            99999999999999987765443333344567889999999999999999999999999999999 99999764221  1


Q ss_pred             HHHHHHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhhh
Q 007680          485 LRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKF  554 (593)
Q Consensus       485 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  554 (593)
                      ....+.....                 ...+..++.++.+++.+||+.||++|||+.|++++|+++....
T Consensus       314 ~~~~~~~~~~-----------------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~  366 (370)
T 2psq_A          314 LFKLLKEGHR-----------------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT  366 (370)
T ss_dssp             HHHHHHTTCC-----------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHhcCCC-----------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence            1121111110                 1112234668899999999999999999999999999987654

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=2.3e-44  Score=365.65  Aligned_cols=262  Identities=26%  Similarity=0.381  Sum_probs=206.3

Q ss_pred             HHhhhccccccccCccCcccEEEEEeCCCCeEEEEEeehhh--HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEE
Q 007680          268 QRATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKAL  345 (593)
Q Consensus       268 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  345 (593)
                      ....++|++.+.||+|+||.||+|+. +|+.||+|++....  ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus        33 ~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l  111 (309)
T 3p86_A           33 DIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSI  111 (309)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEE
T ss_pred             cCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEE
Confidence            34467899999999999999999987 58899999987543  3445678999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCC--eEecCCCCCCeeeCCCCcEEEEeeccce
Q 007680          346 VLEFMPNGSLEKWLYSHNY--FLDILERLNIMIDVGSALEYLHNGHSSVH--IIHCDLKPTNILLDENMVAHVSDFGIYK  421 (593)
Q Consensus       346 v~e~~~~gsL~~~l~~~~~--~l~~~~~~~i~~~i~~~L~~LH~~~~~~~--ivH~Dlkp~NIll~~~~~~kL~Dfg~a~  421 (593)
                      ||||+++|+|.+++.....  .+++..+..++.|++.||+|||+    .+  |+||||||+||+++.++.+||+|||+++
T Consensus       112 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~----~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~  187 (309)
T 3p86_A          112 VTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN----RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR  187 (309)
T ss_dssp             EEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHT----SSSCCCCTTCCGGGEEECTTCCEEECCCC---
T ss_pred             EEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHc----CCCCEECCCCChhhEEEeCCCcEEECCCCCCc
Confidence            9999999999999987543  48999999999999999999994    55  9999999999999999999999999997


Q ss_pred             ecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhh
Q 007680          422 LLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVV  501 (593)
Q Consensus       422 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  501 (593)
                      ......  .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+  ....+....        
T Consensus       188 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~--~~~~~~~~~--------  255 (309)
T 3p86_A          188 LKASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ--VVAAVGFKC--------  255 (309)
T ss_dssp             ----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH--HHHHHHHSC--------
T ss_pred             cccccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhcC--------
Confidence            654322  12234568999999999999999999999999999999999999997642211  111111000        


Q ss_pred             hhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhhh
Q 007680          502 DANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKF  554 (593)
Q Consensus       502 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  554 (593)
                              .....+..+++++.+++.+||+.||++|||+.|+++.|+.+....
T Consensus       256 --------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~  300 (309)
T 3p86_A          256 --------KRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA  300 (309)
T ss_dssp             --------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred             --------CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence                    001111234567899999999999999999999999999887654

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1e-44  Score=365.78  Aligned_cols=276  Identities=24%  Similarity=0.369  Sum_probs=213.2

Q ss_pred             hhccccccccCccCcccEEEEEe-----CCCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC--Cce
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTI-----SDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNP--DFK  343 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  343 (593)
                      .++|++.+.||+|+||.||+|++     .+++.||+|++........+.+.+|++++++++||||+++++++...  ...
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            46899999999999999999984     26889999999877666677899999999999999999999988653  568


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceec
Q 007680          344 ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLL  423 (593)
Q Consensus       344 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~  423 (593)
                      ++||||+++++|.+++......+++.++..++.|++.||+|||+++    |+||||||+||+++.++.+||+|||++...
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~----ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~  164 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR----YIHRDLATRNILVENENRVKIGDFGLTKVL  164 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCSGGGEEEEETTEEEECCCCSCC--
T ss_pred             EEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCC----cccCCCCHhhEEEcCCCeEEEccCcccccc
Confidence            9999999999999999887767999999999999999999999654    999999999999999999999999999876


Q ss_pred             CCCCCcc-ccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchh-hhh
Q 007680          424 GEGEDSV-RQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLT-EVV  501 (593)
Q Consensus       424 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~  501 (593)
                      ....... ......++..|+|||++.+..++.++||||||+++|||+||..|+......   .............. ...
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~~  241 (295)
T 3ugc_A          165 PQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE---FMRMIGNDKQGQMIVFHL  241 (295)
T ss_dssp             -----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH---HHHHHCTTCCTHHHHHHH
T ss_pred             cCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH---HHhhhcCccccchhHHHH
Confidence            5443221 123345777899999999999999999999999999999999998763211   11111110000000 000


Q ss_pred             hhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhhh
Q 007680          502 DANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKF  554 (593)
Q Consensus       502 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  554 (593)
                      ... .......+.+..+++++.+++.+||+.||++|||+.|+++.|+++....
T Consensus       242 ~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l  293 (295)
T 3ugc_A          242 IEL-LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM  293 (295)
T ss_dssp             HHH-HHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             HHH-HhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence            000 0111112223456778999999999999999999999999999987654

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=8.1e-44  Score=363.70  Aligned_cols=262  Identities=21%  Similarity=0.294  Sum_probs=215.5

Q ss_pred             ccCCHHHHHHhhhc----------cccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCC
Q 007680          260 RRTSYLDIQRATDE----------FNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHR  328 (593)
Q Consensus       260 ~~~~~~~~~~~~~~----------~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  328 (593)
                      ..+++.++..+++.          |+..+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++||
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  102 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF  102 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence            34667777776653          777889999999999999976 7999999999876555567789999999999999


Q ss_pred             CcceeeeeeecCCceEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC
Q 007680          329 NLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDE  408 (593)
Q Consensus       329 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~  408 (593)
                      ||+++++++...+..++||||+++++|.+++...  .+++..+..++.|++.||+|||+++    |+||||||+||+++.
T Consensus       103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~l~~~~~~~i~~qi~~~L~~LH~~~----ivH~Dlkp~NIll~~  176 (321)
T 2c30_A          103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV--RLNEEQIATVCEAVLQALAYLHAQG----VIHRDIKSDSILLTL  176 (321)
T ss_dssp             TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHTT----EECCCCSGGGEEECT
T ss_pred             CcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC----eecCCCCHHHEEECC
Confidence            9999999999999999999999999999998754  3899999999999999999999654    999999999999999


Q ss_pred             CCcEEEEeeccceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHH
Q 007680          409 NMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRW  488 (593)
Q Consensus       409 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~  488 (593)
                      ++.+||+|||++........  ......||+.|+|||++.+..++.++||||||+++|||++|+.||.....  ......
T Consensus       177 ~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~--~~~~~~  252 (321)
T 2c30_A          177 DGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP--VQAMKR  252 (321)
T ss_dssp             TCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHH
T ss_pred             CCcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHH
Confidence            99999999999987654322  22345799999999999999999999999999999999999999976321  111122


Q ss_pred             HHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          489 VKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       489 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      +....+..               ......+++.+.+++.+||+.||++|||+.|+++|
T Consensus       253 ~~~~~~~~---------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  295 (321)
T 2c30_A          253 LRDSPPPK---------------LKNSHKVSPVLRDFLERMLVRDPQERATAQELLDH  295 (321)
T ss_dssp             HHHSSCCC---------------CTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HhcCCCCC---------------cCccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            22111111               01112235678999999999999999999999986

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=2.9e-44  Score=367.79  Aligned_cols=249  Identities=21%  Similarity=0.323  Sum_probs=208.2

Q ss_pred             hhhccccccccCccCcccEEEEEe-CCCCeEEEEEeehhh--HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEE
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTI-SDGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALV  346 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  346 (593)
                      ..++|++.+.||+|+||.||+|++ .+|+.||||++....  ....+.+.+|+++++.++||||+++++++...+..++|
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   92 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI   92 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence            356899999999999999999997 489999999997652  34556788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCC
Q 007680          347 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG  426 (593)
Q Consensus       347 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  426 (593)
                      |||+++|+|.+++...+. +++.++..++.|++.||+|||+++    |+||||||+||+++.++.+||+|||++......
T Consensus        93 ~e~~~~~~L~~~l~~~~~-l~~~~~~~~~~qi~~al~~lH~~~----ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  167 (328)
T 3fe3_A           93 MEYASGGEVFDYLVAHGR-MKEKEARSKFRQIVSAVQYCHQKR----IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG  167 (328)
T ss_dssp             ECCCTTCBHHHHHHHHCC-CCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred             EECCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHCC----EeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence            999999999999977654 999999999999999999999655    999999999999999999999999999876543


Q ss_pred             CCccccccccCCccccCccccCCCCCC-ccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhh
Q 007680          427 EDSVRQTMTMATIGYMAPEYGLEGIVS-AKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANL  505 (593)
Q Consensus       427 ~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  505 (593)
                      .   ......||+.|+|||++.+..++ .++||||+||++|||++|+.||......  .....+....            
T Consensus       168 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~i~~~~------------  230 (328)
T 3fe3_A          168 G---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK--ELRERVLRGK------------  230 (328)
T ss_dssp             C---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHCC------------
T ss_pred             C---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH--HHHHHHHhCC------------
Confidence            3   23445799999999999887764 8999999999999999999999763211  1111111100            


Q ss_pred             hhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          506 VREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                            ...+..+++++.+++.+||..||++|||++|+++|
T Consensus       231 ------~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          231 ------YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             ------CCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred             ------CCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                  00111235678999999999999999999999987

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=3.5e-44  Score=367.12  Aligned_cols=262  Identities=27%  Similarity=0.434  Sum_probs=213.7

Q ss_pred             hhccccccccCccCcccEEEEEeC----CCCeEEEEEeehh-hHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS----DGTDVAIKVFNLQ-LERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKAL  345 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  345 (593)
                      .++|++.+.||+|+||.||+|.+.    .+..||||+++.. .....+.+.+|+.++++++||||+++++++.+++..++
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  127 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI  127 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence            468999999999999999999974    3445999999865 34455789999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCC
Q 007680          346 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGE  425 (593)
Q Consensus       346 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~  425 (593)
                      ||||+++++|.+++......+++.++..++.|++.||+|||+++    |+||||||+||+++.++.+||+|||+++....
T Consensus       128 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~----ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  203 (325)
T 3kul_A          128 VTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG----YVHRDLAARNVLVDSNLVCKVSDFGLSRVLED  203 (325)
T ss_dssp             EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT----EECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred             EeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC----eeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence            99999999999999877667999999999999999999999654    99999999999999999999999999998755


Q ss_pred             CCCcc-ccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhhhh
Q 007680          426 GEDSV-RQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDA  503 (593)
Q Consensus       426 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  503 (593)
                      ..... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......  .....+....          
T Consensus       204 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--~~~~~~~~~~----------  271 (325)
T 3kul_A          204 DPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR--DVISSVEEGY----------  271 (325)
T ss_dssp             ---CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH--HHHHHHHTTC----------
T ss_pred             CccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH--HHHHHHHcCC----------
Confidence            43221 2233346778999999988899999999999999999999 99999763221  1111111110          


Q ss_pred             hhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhhhc
Q 007680          504 NLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKFL  555 (593)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~  555 (593)
                             ..+.+..++..+.+++.+||+.||++|||+.|+++.|+.+.....
T Consensus       272 -------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~  316 (325)
T 3kul_A          272 -------RLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE  316 (325)
T ss_dssp             -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred             -------CCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence                   111122456688999999999999999999999999999876653

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=9.7e-45  Score=378.95  Aligned_cols=261  Identities=24%  Similarity=0.394  Sum_probs=215.0

Q ss_pred             hhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEE
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVL  347 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  347 (593)
                      ..++|++.+.||+|+||.||+|++. +++.||||+++... ....+.+.+|++++++++||||+++++++...+..++||
T Consensus       112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  191 (377)
T 3cbl_A          112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM  191 (377)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence            3578999999999999999999986 78999999987643 334457889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCC
Q 007680          348 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGE  427 (593)
Q Consensus       348 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~  427 (593)
                      ||+++|+|.+++...+..+++..+..++.|++.||+|||+++    |+||||||+||+++.++.+||+|||+++......
T Consensus       192 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~----ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~  267 (377)
T 3cbl_A          192 ELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC----CIHRDLAARNCLVTEKNVLKISDFGMSREEADGV  267 (377)
T ss_dssp             ECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT----EECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred             EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC----cCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence            999999999999876666999999999999999999999655    9999999999999999999999999998754332


Q ss_pred             CccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhhhhhhh
Q 007680          428 DSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLV  506 (593)
Q Consensus       428 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  506 (593)
                      .........++..|+|||++.++.++.++|||||||++|||+| |..||......  .....+....             
T Consensus       268 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~--~~~~~~~~~~-------------  332 (377)
T 3cbl_A          268 YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ--QTREFVEKGG-------------  332 (377)
T ss_dssp             EECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH--HHHHHHHTTC-------------
T ss_pred             eeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCC-------------
Confidence            1111122235678999999988899999999999999999998 99999764221  1111111110             


Q ss_pred             hhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhh
Q 007680          507 REEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVK  553 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  553 (593)
                          ..+.+..++.++.+++.+||+.||++|||+.++++.|++++..
T Consensus       333 ----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~  375 (377)
T 3cbl_A          333 ----RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR  375 (377)
T ss_dssp             ----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence                1111223566889999999999999999999999999998764

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=4.1e-43  Score=355.96  Aligned_cols=281  Identities=30%  Similarity=0.469  Sum_probs=226.7

Q ss_pred             cccCCHHHHHHhhhccccc------cccCccCcccEEEEEeCCCCeEEEEEeehhh----HHHHHHHHHHHHHHhhcCCC
Q 007680          259 WRRTSYLDIQRATDEFNEC------NLLGTSSFGSVYKGTISDGTDVAIKVFNLQL----ERAFRSFDSECEVLRNVRHR  328 (593)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~------~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~  328 (593)
                      ...+++.++..++++|...      +.||+|+||.||+|.. +++.||+|++....    ....+.+.+|+.++++++||
T Consensus        12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~   90 (307)
T 2nru_A           12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE   90 (307)
T ss_dssp             CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred             CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence            4568899999999998877      8999999999999987 58899999986532    33457789999999999999


Q ss_pred             CcceeeeeeecCCceEEEEeccCCCCHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeee
Q 007680          329 NLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHN--YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILL  406 (593)
Q Consensus       329 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll  406 (593)
                      ||+++++++.+.+..++||||+++++|.+++....  ..+++..+..++.|++.||+|||+++    |+||||||+||++
T Consensus        91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~----i~H~dlkp~Nili  166 (307)
T 2nru_A           91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH----HIHRDIKSANILL  166 (307)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT----EECSCCCGGGEEE
T ss_pred             CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC----eecCCCCHHHEEE
Confidence            99999999999999999999999999999987532  35899999999999999999999654    9999999999999


Q ss_pred             CCCCcEEEEeeccceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHH
Q 007680          407 DENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLR  486 (593)
Q Consensus       407 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~  486 (593)
                      +.++.+||+|||++................||+.|+|||++.+ .++.++||||||+++|+|++|..||........ ..
T Consensus       167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~  244 (307)
T 2nru_A          167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL-LL  244 (307)
T ss_dssp             CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB-TT
T ss_pred             cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH-HH
Confidence            9999999999999987765443333344578999999998765 589999999999999999999999977433221 11


Q ss_pred             HHHHH--hcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhh
Q 007680          487 RWVKE--SLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKV  552 (593)
Q Consensus       487 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~  552 (593)
                      .+...  .....+.+.++..+..      ....++..+.+++.+||+.||++|||+.+++++|+++..
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~  306 (307)
T 2nru_A          245 DIKEEIEDEEKTIEDYIDKKMND------ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA  306 (307)
T ss_dssp             HHHHHHHTTSCCHHHHSCSSCSC------CCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred             HHHHHhhhhhhhhhhhccccccc------cchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence            11111  1111233333332211      123456789999999999999999999999999999854

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=7.5e-44  Score=354.42  Aligned_cols=258  Identities=25%  Similarity=0.347  Sum_probs=214.4

Q ss_pred             hhccccccccCccCcccEEEEEeCCCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEecc
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFM  350 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  350 (593)
                      .++|++.+.||+|+||.||+|.+.+++.||+|++..... ..+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   87 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence            468999999999999999999998889999999986532 2357899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCcc
Q 007680          351 PNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSV  430 (593)
Q Consensus       351 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~  430 (593)
                      ++++|.+++......+++..+..++.|++.||+|||+++    |+||||||+||+++.++.+||+|||++........ .
T Consensus        88 ~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~----i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~  162 (269)
T 4hcu_A           88 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC----VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-T  162 (269)
T ss_dssp             TTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH-H
T ss_pred             CCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCC----eecCCcchheEEEcCCCCEEecccccccccccccc-c
Confidence            999999999887777999999999999999999999655    99999999999999999999999999986543221 1


Q ss_pred             ccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhh
Q 007680          431 RQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREE  509 (593)
Q Consensus       431 ~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  509 (593)
                      ......+++.|+|||++.+..++.++||||+|+++|+|++ |+.||......  .....+......              
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~--~~~~~~~~~~~~--------------  226 (269)
T 4hcu_A          163 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--EVVEDISTGFRL--------------  226 (269)
T ss_dssp             STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHTTCCC--------------
T ss_pred             cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH--HHHHHHhcCccC--------------
Confidence            2233456788999999988899999999999999999999 99999763221  111111111100              


Q ss_pred             hhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhh
Q 007680          510 QAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVK  553 (593)
Q Consensus       510 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  553 (593)
                         ..+..+++.+.+++.+||+.||++|||+.|++++|+++.+.
T Consensus       227 ---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~  267 (269)
T 4hcu_A          227 ---YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  267 (269)
T ss_dssp             ---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             ---CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence               01112345789999999999999999999999999998754

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.4e-43  Score=357.44  Aligned_cols=272  Identities=21%  Similarity=0.365  Sum_probs=212.7

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehh---hHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQ---LERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALV  346 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  346 (593)
                      .++|++.+.||+|+||.||+|++. +++.||+|++...   .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            467999999999999999999965 7899999998543   234557889999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCC
Q 007680          347 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG  426 (593)
Q Consensus       347 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  426 (593)
                      |||+++++|.+++...+. +++.++..++.|++.||+|||+++    |+||||||+||+++.++.+||+|||++......
T Consensus        90 ~e~~~g~~L~~~l~~~~~-~~~~~~~~~~~qi~~~l~~lH~~~----i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  164 (294)
T 4eqm_A           90 MEYIEGPTLSEYIESHGP-LSVDTAINFTNQILDGIKHAHDMR----IVHRDIKPQNILIDSNKTLKIFDFGIAKALSET  164 (294)
T ss_dssp             EECCCSCBHHHHHHHHCS-CCHHHHHHHHHHHHHHHHHHHHTT----CCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred             EeCCCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCC----cccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence            999999999999987654 999999999999999999999655    999999999999999999999999999876433


Q ss_pred             CCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhh
Q 007680          427 EDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLV  506 (593)
Q Consensus       427 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  506 (593)
                      .. .......||+.|+|||++.+..++.++||||||+++|||++|+.||......... .+......+. .         
T Consensus       165 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~-~~~~~~~~~~-~---------  232 (294)
T 4eqm_A          165 SL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIA-IKHIQDSVPN-V---------  232 (294)
T ss_dssp             -----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHH-HHHHSSCCCC-H---------
T ss_pred             cc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHhhccCCC-c---------
Confidence            22 1223456899999999999999999999999999999999999999763221110 0111100000 0         


Q ss_pred             hhhhhhhhhHHHHHHHHHHHhhcccCCCCCCC-CHHHHHHHHHHhhhhhcchhhccCC
Q 007680          507 REEQAFSAKMDCILSIMDFALDCCMESPDMRI-NMTDAAAKLKKIKVKFLDDAAATNW  563 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~i~~~~~~~~~~~~~  563 (593)
                          ......++++.+.+++.+||+.||++|| +++++.+.|+.+............+
T Consensus       233 ----~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~~~~~~~~  286 (294)
T 4eqm_A          233 ----TTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRANEDVYEL  286 (294)
T ss_dssp             ----HHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSSTTCCCCC-
T ss_pred             ----chhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccCCcchhhh
Confidence                0111123467889999999999999999 8999999999876554433333333

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=3.4e-43  Score=357.45  Aligned_cols=268  Identities=23%  Similarity=0.296  Sum_probs=207.6

Q ss_pred             hhccccccccCccCcccEEEEEeCCCCeEEEEEeehhh--HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEe
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLE  348 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  348 (593)
                      .++|++.+.||+|+||.||+|++.+|+.||+|+++...  ......+.+|++++++++||||+++++++.+++..++|||
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   99 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE   99 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence            57899999999999999999999889999999997543  2234678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCC
Q 007680          349 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGED  428 (593)
Q Consensus       349 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  428 (593)
                      |++ ++|.+++......+++..+..++.|++.||+|||+++    |+||||||+||+++.++.+||+|||+++.......
T Consensus       100 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~----ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~  174 (311)
T 3niz_A          100 FME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR----ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR  174 (311)
T ss_dssp             CCS-EEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT----EECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC
T ss_pred             CCC-CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC----cccCCCchHhEEECCCCCEEEccCcCceecCCCcc
Confidence            997 4899988877767999999999999999999999654    99999999999999999999999999987654322


Q ss_pred             ccccccccCCccccCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHh---cCCchhhhhhhh
Q 007680          429 SVRQTMTMATIGYMAPEYGLE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKES---LPHGLTEVVDAN  504 (593)
Q Consensus       429 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~  504 (593)
                        ......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+ .........   .+.......+..
T Consensus       175 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~  251 (311)
T 3niz_A          175 --SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD-QLPKIFSILGTPNPREWPQVQELP  251 (311)
T ss_dssp             -----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT-HHHHHHHHHCCCCTTTSGGGTTSH
T ss_pred             --cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHHCCCChHHhhhhhccc
Confidence              2234568999999998876 568999999999999999999999997743322 122221111   111111111000


Q ss_pred             hh--------hhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          505 LV--------REEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       505 ~~--------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      ..        ...........+++++.+++.+||+.||++|||++|+++|
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  301 (311)
T 3niz_A          252 LWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH  301 (311)
T ss_dssp             HHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             hhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            00        0000011112345678999999999999999999999975

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=3.7e-44  Score=371.97  Aligned_cols=269  Identities=26%  Similarity=0.403  Sum_probs=218.3

Q ss_pred             CHHHHHHhhhccccccccCccCcccEEEEEe------CCCCeEEEEEeehhh-HHHHHHHHHHHHHHhhc-CCCCcceee
Q 007680          263 SYLDIQRATDEFNECNLLGTSSFGSVYKGTI------SDGTDVAIKVFNLQL-ERAFRSFDSECEVLRNV-RHRNLIKIL  334 (593)
Q Consensus       263 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~  334 (593)
                      ...++....++|++.+.||+|+||.||+|++      .+++.||||+++... ....+.+.+|++++.++ +||||++++
T Consensus        13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~   92 (359)
T 3vhe_A           13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL   92 (359)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence            4455566788999999999999999999973      246889999997643 34456799999999999 789999999


Q ss_pred             eeeecCC-ceEEEEeccCCCCHHHHHhhCCC-------------------------------------------------
Q 007680          335 SSYSNPD-FKALVLEFMPNGSLEKWLYSHNY-------------------------------------------------  364 (593)
Q Consensus       335 ~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~-------------------------------------------------  364 (593)
                      +++.+.+ ..++||||+++|+|.+++.....                                                 
T Consensus        93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (359)
T 3vhe_A           93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS  172 (359)
T ss_dssp             EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred             eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence            9988765 48999999999999999976532                                                 


Q ss_pred             ----------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCC
Q 007680          365 ----------------FLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGED  428 (593)
Q Consensus       365 ----------------~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  428 (593)
                                      .+++..+..++.|++.||+|||+++    |+||||||+||+++.++.+||+|||+++.......
T Consensus       173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~----ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~  248 (359)
T 3vhe_A          173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK----CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD  248 (359)
T ss_dssp             -----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred             cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC----cccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence                            2899999999999999999999654    99999999999999999999999999987755544


Q ss_pred             ccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhh
Q 007680          429 SVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVR  507 (593)
Q Consensus       429 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  507 (593)
                      ........+|+.|+|||++.+..++.++|||||||++|||+| |+.||......+. ..........             
T Consensus       249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-~~~~~~~~~~-------------  314 (359)
T 3vhe_A          249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-FCRRLKEGTR-------------  314 (359)
T ss_dssp             CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH-HHHHHHHTCC-------------
T ss_pred             chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH-HHHHHHcCCC-------------
Confidence            444455668899999999999999999999999999999998 9999976432221 1111111111             


Q ss_pred             hhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhh
Q 007680          508 EEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVK  553 (593)
Q Consensus       508 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  553 (593)
                          ...+..+++++.+++.+||+.||++|||+.|++++|+++...
T Consensus       315 ----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  356 (359)
T 3vhe_A          315 ----MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  356 (359)
T ss_dssp             ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence                011122456789999999999999999999999999998754

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=2.7e-43  Score=361.62  Aligned_cols=249  Identities=21%  Similarity=0.257  Sum_probs=207.5

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALV  346 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  346 (593)
                      .++|++.+.||+|+||.||+|+.+ +|+.||+|+++...   ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            468999999999999999999976 79999999998753   23456788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCC
Q 007680          347 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG  426 (593)
Q Consensus       347 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  426 (593)
                      |||+++|+|.+++...+. +++..+..++.||+.||+|||+++    |+||||||+||+++.++.+||+|||+++.....
T Consensus        84 ~E~~~gg~L~~~l~~~~~-~~~~~~~~~~~qi~~aL~~LH~~~----ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  158 (337)
T 1o6l_A           84 MEYANGGELFFHLSRERV-FTEERARFYGAEIVSALEYLHSRD----VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD  158 (337)
T ss_dssp             EECCTTCBHHHHHHHHSC-CCHHHHHHHHHHHHHHHHHHHHTT----CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred             EeCCCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCC----eecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence            999999999999987654 899999999999999999999654    999999999999999999999999999864332


Q ss_pred             CCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhh
Q 007680          427 EDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLV  506 (593)
Q Consensus       427 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  506 (593)
                      ..  ......||+.|+|||++.+..++.++|||||||++|||++|+.||......  .....+...           .  
T Consensus       159 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~~i~~~-----------~--  221 (337)
T 1o6l_A          159 GA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--RLFELILME-----------E--  221 (337)
T ss_dssp             TC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHC-----------C--
T ss_pred             CC--cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH--HHHHHHHcC-----------C--
Confidence            21  233457999999999999999999999999999999999999999763211  111111110           0  


Q ss_pred             hhhhhhhhhHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHHH
Q 007680          507 REEQAFSAKMDCILSIMDFALDCCMESPDMRI-----NMTDAAAK  546 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  546 (593)
                         .  ..+..+++++.+++.+||+.||++||     +++|+++|
T Consensus       222 ---~--~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          222 ---I--RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             ---C--CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             ---C--CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence               0  01112456789999999999999999     89999886

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.7e-43  Score=358.68  Aligned_cols=252  Identities=19%  Similarity=0.284  Sum_probs=209.4

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEec
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEF  349 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  349 (593)
                      .++|++.+.||+|+||.||+|... +++.||+|.++... .....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   82 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence            468999999999999999999976 68899999987543 3345688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC--CCcEEEEeeccceecCCCC
Q 007680          350 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDE--NMVAHVSDFGIYKLLGEGE  427 (593)
Q Consensus       350 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~--~~~~kL~Dfg~a~~~~~~~  427 (593)
                      +++++|.+++......+++.++..++.|++.||+|||+++    |+||||||+||+++.  ++.+||+|||++.......
T Consensus        83 ~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g----ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~  158 (321)
T 1tki_A           83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN----IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD  158 (321)
T ss_dssp             CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT----EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC----CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC
Confidence            9999999999877666999999999999999999999654    999999999999987  7899999999998875433


Q ss_pred             CccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhh
Q 007680          428 DSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVR  507 (593)
Q Consensus       428 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  507 (593)
                         ......||+.|+|||++.+..++.++|||||||++|+|++|..||......  .....+......           .
T Consensus       159 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i~~~~~~-----------~  222 (321)
T 1tki_A          159 ---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ--QIIENIMNAEYT-----------F  222 (321)
T ss_dssp             ---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHHTCCC-----------C
T ss_pred             ---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH--HHHHHHHcCCCC-----------C
Confidence               223456899999999999888999999999999999999999999763221  111111111100           0


Q ss_pred             hhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          508 EEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       508 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                         .......++.++.+++.+||..||++|||+.|+++|
T Consensus       223 ---~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h  258 (321)
T 1tki_A          223 ---DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             ---CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ---ChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence               011122346688999999999999999999999986

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.9e-43  Score=351.16  Aligned_cols=259  Identities=25%  Similarity=0.344  Sum_probs=214.4

Q ss_pred             hhhccccccccCccCcccEEEEEeCCCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEec
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEF  349 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  349 (593)
                      ..++|++.+.||+|+||.||+|+.+++..||+|+++.... ..+.+.+|++++.+++||||+++++++.+.+..++||||
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (268)
T 3sxs_A            6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY   84 (268)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence            3578999999999999999999998888999999976532 235688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCc
Q 007680          350 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDS  429 (593)
Q Consensus       350 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~  429 (593)
                      +++++|.+++......+++.++..++.|++.||+|||+++    |+||||||+||+++.++.+||+|||.+........ 
T Consensus        85 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~----i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-  159 (268)
T 3sxs_A           85 ISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ----FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY-  159 (268)
T ss_dssp             CTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT----EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE-
T ss_pred             cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC----eecCCcCcceEEECCCCCEEEccCccceecchhhh-
Confidence            9999999999887666999999999999999999999654    99999999999999999999999999987654432 


Q ss_pred             cccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhh
Q 007680          430 VRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVRE  508 (593)
Q Consensus       430 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  508 (593)
                      .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||.......  ..........              
T Consensus       160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~~~~~~~--------------  223 (268)
T 3sxs_A          160 VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE--VVLKVSQGHR--------------  223 (268)
T ss_dssp             EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH--HHHHHHTTCC--------------
T ss_pred             hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH--HHHHHHcCCC--------------
Confidence            12233456778999999988889999999999999999999 999997642211  1111111100              


Q ss_pred             hhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhh
Q 007680          509 EQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVK  553 (593)
Q Consensus       509 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  553 (593)
                         ...+..+++.+.+++.+||+.||++|||+.|++++|+.++.+
T Consensus       224 ---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (268)
T 3sxs_A          224 ---LYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK  265 (268)
T ss_dssp             ---CCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred             ---CCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence               001112345789999999999999999999999999998654

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=2.7e-43  Score=364.93  Aligned_cols=252  Identities=22%  Similarity=0.273  Sum_probs=207.9

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHH------HHHHHHHHHHHHhhcCCCCcceeeeeeecCCce
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLER------AFRSFDSECEVLRNVRHRNLIKILSSYSNPDFK  343 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  343 (593)
                      .++|++.+.||+|+||.||+|+.+ +|+.||+|+++.....      ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            567999999999999999999976 6899999999764321      246789999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC----cEEEEeecc
Q 007680          344 ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENM----VAHVSDFGI  419 (593)
Q Consensus       344 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~----~~kL~Dfg~  419 (593)
                      ++||||+++|+|.+++.... .+++.++..++.||+.||+|||+++    |+||||||+||++++++    .+||+|||+
T Consensus        91 ~lv~e~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~g----ivHrDlkp~NIll~~~~~~~~~vkl~DFG~  165 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLHTKK----IAHFDLKPENIMLLDKNIPIPHIKLIDFGL  165 (361)
T ss_dssp             EEEEECCCSCBHHHHHTTCS-CCBHHHHHHHHHHHHHHHHHHHHTT----EECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred             EEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC----cccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence            99999999999999997655 4999999999999999999999654    99999999999998877    799999999


Q ss_pred             ceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhh
Q 007680          420 YKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTE  499 (593)
Q Consensus       420 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  499 (593)
                      +........   .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+....  .....+....      
T Consensus       166 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~--~~~~~i~~~~------  234 (361)
T 2yab_A          166 AHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--ETLANITAVS------  234 (361)
T ss_dssp             CEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHHHHHHTTC------
T ss_pred             ceEcCCCCc---cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhcC------
Confidence            987754322   23456999999999999999999999999999999999999999763211  1111111100      


Q ss_pred             hhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          500 VVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       500 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                           ...   .......++..+.+++.+||..||++|||+.|+++|
T Consensus       235 -----~~~---~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  273 (361)
T 2yab_A          235 -----YDF---DEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (361)
T ss_dssp             -----CCC---CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             -----CCC---CchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                 000   001122345678999999999999999999999975

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=9.5e-44  Score=363.48  Aligned_cols=254  Identities=20%  Similarity=0.302  Sum_probs=207.7

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEe
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLE  348 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  348 (593)
                      .++|++.+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            468999999999999999999976 78999999997543 2334568899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCC
Q 007680          349 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGED  428 (593)
Q Consensus       349 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  428 (593)
                      |+++++|.+++..... +++.++..++.|++.||+|||+++    |+||||||+||+++.++.+||+|||++..+.....
T Consensus        86 ~~~~~~L~~~l~~~~~-~~~~~~~~i~~qi~~aL~~LH~~g----ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  160 (323)
T 3tki_A           86 YCSGGELFDRIEPDIG-MPEPDAQRFFHQLMAGVVYLHGIG----ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  160 (323)
T ss_dssp             CCTTEEGGGGSBTTTB-CCHHHHHHHHHHHHHHHHHHHHTT----EECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             cCCCCcHHHHHhhcCC-CCHHHHHHHHHHHHHHHHHHHHCC----ccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence            9999999999976654 999999999999999999999654    99999999999999999999999999987654333


Q ss_pred             ccccccccCCccccCccccCCCCC-CccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhh
Q 007680          429 SVRQTMTMATIGYMAPEYGLEGIV-SAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVR  507 (593)
Q Consensus       429 ~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  507 (593)
                      ........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||............+.....              
T Consensus       161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~--------------  226 (323)
T 3tki_A          161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT--------------  226 (323)
T ss_dssp             ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCT--------------
T ss_pred             ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccc--------------
Confidence            323345679999999999887765 78999999999999999999999775433332222221110              


Q ss_pred             hhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          508 EEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       508 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                         .......++..+.+++.+||+.||++|||+.|++++
T Consensus       227 ---~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          227 ---YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             ---TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ---cCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence               011112345678999999999999999999999876

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=6.1e-44  Score=378.19  Aligned_cols=263  Identities=21%  Similarity=0.271  Sum_probs=212.2

Q ss_pred             CHHHHHHhhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhH---HHHHHHHHHHHHHhhcCCCCcceeeeeee
Q 007680          263 SYLDIQRATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLE---RAFRSFDSECEVLRNVRHRNLIKILSSYS  338 (593)
Q Consensus       263 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~  338 (593)
                      .+.++....++|++.++||+|+||.||+|+.+ +++.||+|+++....   .....+.+|..++..++||||+++++++.
T Consensus        65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~  144 (437)
T 4aw2_A           65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ  144 (437)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred             hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence            34555667789999999999999999999976 588999999986432   22334889999999999999999999999


Q ss_pred             cCCceEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeec
Q 007680          339 NPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFG  418 (593)
Q Consensus       339 ~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg  418 (593)
                      +.+..++||||+++|+|.+++......+++..+..++.|++.||+|||+++    |+||||||+|||++.++.+||+|||
T Consensus       145 ~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g----iiHrDLKp~NILl~~~g~vkL~DFG  220 (437)
T 4aw2_A          145 DDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH----YVHRDIKPDNILMDMNGHIRLADFG  220 (437)
T ss_dssp             CSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT----EECCCCSGGGEEECTTSCEEECCCT
T ss_pred             eCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCC----eEecccCHHHeeEcCCCCEEEcchh
Confidence            999999999999999999999886556999999999999999999999654    9999999999999999999999999


Q ss_pred             cceecCCCCCccccccccCCccccCccccC-----CCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhc
Q 007680          419 IYKLLGEGEDSVRQTMTMATIGYMAPEYGL-----EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESL  493 (593)
Q Consensus       419 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~  493 (593)
                      +++....... .......||+.|+|||++.     ...++.++|||||||++|||++|+.||......+ .+.....   
T Consensus       221 la~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~-~~~~i~~---  295 (437)
T 4aw2_A          221 SCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE-TYGKIMN---  295 (437)
T ss_dssp             TCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHT---
T ss_pred             hhhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhH-HHHhhhh---
Confidence            9987654432 2234457999999999986     5679999999999999999999999997632111 1111110   


Q ss_pred             CCchhhhhhhhhhhhhhhhh-hhHHHHHHHHHHHhhcccCCCCC--CCCHHHHHHH
Q 007680          494 PHGLTEVVDANLVREEQAFS-AKMDCILSIMDFALDCCMESPDM--RINMTDAAAK  546 (593)
Q Consensus       494 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~  546 (593)
                               ...   ....+ ....+++++.+|+.+||..+|++  ||+++|+++|
T Consensus       296 ---------~~~---~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H  339 (437)
T 4aw2_A          296 ---------HKE---RFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH  339 (437)
T ss_dssp             ---------HHH---HCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred             ---------ccc---cccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence                     000   00000 00124567899999999998888  9999999987

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.7e-43  Score=368.68  Aligned_cols=261  Identities=26%  Similarity=0.446  Sum_probs=203.4

Q ss_pred             hhccccccccCccCcccEEEEEeC----CCCeEEEEEeehh-hHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS----DGTDVAIKVFNLQ-LERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKAL  345 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  345 (593)
                      .++|++.+.||+|+||.||+|++.    ++..||||+++.. .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI  123 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence            468999999999999999999864    5778999999765 34455789999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCC
Q 007680          346 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGE  425 (593)
Q Consensus       346 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~  425 (593)
                      ||||+++|+|.+++......+++.++..++.|++.||+|||+++    |+||||||+||+++.++.+||+|||+++....
T Consensus       124 v~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~----ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  199 (373)
T 2qol_A          124 VTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG----YVHRDLAARNILINSNLVCKVSDFGLGRVLED  199 (373)
T ss_dssp             EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC----eeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence            99999999999999887667999999999999999999999654    99999999999999999999999999987654


Q ss_pred             CCCcc-ccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhhhh
Q 007680          426 GEDSV-RQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDA  503 (593)
Q Consensus       426 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  503 (593)
                      ..... ......++..|+|||++.+..++.++|||||||++|||++ |+.||......  .....+...           
T Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~--~~~~~i~~~-----------  266 (373)
T 2qol_A          200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ--DVIKAVDEG-----------  266 (373)
T ss_dssp             --------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH--HHHHHHHTT-----------
T ss_pred             CCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcC-----------
Confidence            32211 1122235778999999998999999999999999999998 99999764221  111111110           


Q ss_pred             hhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhhh
Q 007680          504 NLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKF  554 (593)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  554 (593)
                            ...+....++.++.+++.+||+.||++||++.|+++.|+++....
T Consensus       267 ------~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~  311 (373)
T 2qol_A          267 ------YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP  311 (373)
T ss_dssp             ------EECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred             ------CCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence                  011112245668899999999999999999999999999987543

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.5e-43  Score=369.03  Aligned_cols=264  Identities=25%  Similarity=0.398  Sum_probs=217.6

Q ss_pred             hhccccccccCccCcccEEEEEeC--------CCCeEEEEEeehhh-HHHHHHHHHHHHHHhhc-CCCCcceeeeeeecC
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS--------DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNV-RHRNLIKILSSYSNP  340 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  340 (593)
                      .++|.+.+.||+|+||.||+|++.        ++..||+|+++... ....+.+.+|+++++++ +||||+++++++...
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  147 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD  147 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence            578999999999999999999852        23579999997653 34557889999999999 999999999999999


Q ss_pred             CceEEEEeccCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCee
Q 007680          341 DFKALVLEFMPNGSLEKWLYSHN---------------YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNIL  405 (593)
Q Consensus       341 ~~~~lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIl  405 (593)
                      +..++||||+++|+|.+++....               ..+++.++..++.|++.||+|||+++    |+||||||+||+
T Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~----ivH~Dlkp~NIl  223 (382)
T 3tt0_A          148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK----CIHRDLAARNVL  223 (382)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCCGGGEE
T ss_pred             CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC----EecCCCCcceEE
Confidence            99999999999999999998754               24899999999999999999999654    999999999999


Q ss_pred             eCCCCcEEEEeeccceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccch
Q 007680          406 LDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMS  484 (593)
Q Consensus       406 l~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~  484 (593)
                      ++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |..||......  .
T Consensus       224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~--~  301 (382)
T 3tt0_A          224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--E  301 (382)
T ss_dssp             ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--H
T ss_pred             EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--H
Confidence            99999999999999987755433333344567889999999999999999999999999999999 99999763211  1


Q ss_pred             HHHHHHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhhhcch
Q 007680          485 LRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKFLDD  557 (593)
Q Consensus       485 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~  557 (593)
                      ....+.....                 ...+..++.++.+++.+||+.||++|||+.|++++|+++.......
T Consensus       302 ~~~~~~~~~~-----------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~  357 (382)
T 3tt0_A          302 LFKLLKEGHR-----------------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQ  357 (382)
T ss_dssp             HHHHHHTTCC-----------------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSC
T ss_pred             HHHHHHcCCC-----------------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcC
Confidence            1122211110                 1111234568899999999999999999999999999998765333

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=7.9e-43  Score=362.87  Aligned_cols=282  Identities=13%  Similarity=0.124  Sum_probs=215.7

Q ss_pred             hhhccccccccCccCcccEEEEEeCC------CCeEEEEEeehhhHHH-----------HHHHHHHHHHHhhcCCCCcce
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTISD------GTDVAIKVFNLQLERA-----------FRSFDSECEVLRNVRHRNLIK  332 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~  332 (593)
                      ..++|++.+.||+|+||.||+|.+.+      ++.||||++.......           ...+..|+..+..++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            35689999999999999999998754      4789999987643211           122445666778889999999


Q ss_pred             eeeeeecC----CceEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeC-
Q 007680          333 ILSSYSNP----DFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLD-  407 (593)
Q Consensus       333 l~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~-  407 (593)
                      +++++...    ...++||||+ +++|.+++......+++.++..++.|++.||+|||++    +|+||||||+||+++ 
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~----~iiHrDlkp~Nill~~  187 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEH----EYVHGDIKASNLLLNY  187 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEEES
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC----CeEEecCCHHHEEEec
Confidence            99998764    4589999999 9999999988766799999999999999999999965    499999999999999 


Q ss_pred             -CCCcEEEEeeccceecCCCCCcc-----ccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccc
Q 007680          408 -ENMVAHVSDFGIYKLLGEGEDSV-----RQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIG  481 (593)
Q Consensus       408 -~~~~~kL~Dfg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~  481 (593)
                       .++.+||+|||+++.+.......     ......||+.|+|||++.+..++.++|||||||++|||+||+.||......
T Consensus       188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~  267 (364)
T 3op5_A          188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD  267 (364)
T ss_dssp             SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred             CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence             88999999999998765432211     112345999999999999999999999999999999999999999864322


Q ss_pred             cchHHHHHHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhhhc-chhhc
Q 007680          482 EMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKFL-DDAAA  560 (593)
Q Consensus       482 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~-~~~~~  560 (593)
                      . ...............+.++..+.        ...++.++.+++.+||+.||++||++.++++.|+++..... .....
T Consensus       268 ~-~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~  338 (364)
T 3op5_A          268 P-KYVRDSKIRYRENIASLMDKCFP--------AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGK  338 (364)
T ss_dssp             H-HHHHHHHHHHHHCHHHHHHHHSC--------TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCC
T ss_pred             H-HHHHHHHHHhhhhHHHHHHHhcc--------cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCc
Confidence            2 22222222211222222222211        12346789999999999999999999999999999887652 33345


Q ss_pred             cCCcc
Q 007680          561 TNWRN  565 (593)
Q Consensus       561 ~~~~~  565 (593)
                      .+|..
T Consensus       339 ~dw~~  343 (364)
T 3op5_A          339 LDLSV  343 (364)
T ss_dssp             CCC--
T ss_pred             cceEe
Confidence            66654

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=2.9e-43  Score=358.07  Aligned_cols=261  Identities=27%  Similarity=0.403  Sum_probs=216.2

Q ss_pred             hhhccccccccCccCcccEEEEEe------CCCCeEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCc
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTI------SDGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDF  342 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  342 (593)
                      ..++|.+.+.||+|+||.||+|..      .+++.||+|+++... ....+.+.+|++++++++||||+++++++.+.+.
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  100 (314)
T 2ivs_A           21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP  100 (314)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence            357899999999999999999985      245789999997643 4455788999999999999999999999999999


Q ss_pred             eEEEEeccCCCCHHHHHhhCCC-----------------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCC
Q 007680          343 KALVLEFMPNGSLEKWLYSHNY-----------------------FLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDL  399 (593)
Q Consensus       343 ~~lv~e~~~~gsL~~~l~~~~~-----------------------~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dl  399 (593)
                      .++||||+++++|.+++.....                       .+++.++..++.|+++||+|||+++    |+||||
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~----ivH~di  176 (314)
T 2ivs_A          101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK----LVHRDL  176 (314)
T ss_dssp             CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT----EECCCC
T ss_pred             eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC----Cccccc
Confidence            9999999999999999987532                       3889999999999999999999655    999999


Q ss_pred             CCCCeeeCCCCcEEEEeeccceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCcc
Q 007680          400 KPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEM  478 (593)
Q Consensus       400 kp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~  478 (593)
                      ||+||+++.++.+||+|||++................+++.|+|||++.+..++.++||||||+++|||++ |..||...
T Consensus       177 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  256 (314)
T 2ivs_A          177 AARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI  256 (314)
T ss_dssp             SGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             chheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999999987765443333344567889999999988889999999999999999999 99999764


Q ss_pred             ccccchHHHHHHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhh
Q 007680          479 FIGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVK  553 (593)
Q Consensus       479 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  553 (593)
                      ...  .....+.....                 ...+..+++++.+++.+||+.||++|||+.|++++|+++..+
T Consensus       257 ~~~--~~~~~~~~~~~-----------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  312 (314)
T 2ivs_A          257 PPE--RLFNLLKTGHR-----------------MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK  312 (314)
T ss_dssp             CGG--GHHHHHHTTCC-----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CHH--HHHHHhhcCCc-----------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence            322  12222211110                 011123456889999999999999999999999999998654

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.1e-42  Score=351.09  Aligned_cols=274  Identities=15%  Similarity=0.151  Sum_probs=219.7

Q ss_pred             hhccccccccCccCcccEEEEEe-CCCCeEEEEEeehhhHHHHHHHHHHHHHHhhc-CCCCcceeeeeeecCCceEEEEe
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTI-SDGTDVAIKVFNLQLERAFRSFDSECEVLRNV-RHRNLIKILSSYSNPDFKALVLE  348 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  348 (593)
                      .++|++.+.||+|+||.||+|+. .+++.||+|++....  ..+.+.+|+.+++++ +|+|++++++++.+....++|||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e   86 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   86 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence            46799999999999999999996 479999999987543  234678899999999 79999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCc-----EEEEeeccceec
Q 007680          349 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMV-----AHVSDFGIYKLL  423 (593)
Q Consensus       349 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~-----~kL~Dfg~a~~~  423 (593)
                      |+ +++|.+++...+..+++.++..++.|++.||+|||++    +|+||||||+||+++.++.     +||+|||++...
T Consensus        87 ~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~  161 (298)
T 1csn_A           87 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK----SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  161 (298)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             ec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC----CEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence            99 9999999988766799999999999999999999954    5999999999999987775     999999999887


Q ss_pred             CCCCCc-----cccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccc-hHHHHHHHhcCCch
Q 007680          424 GEGEDS-----VRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEM-SLRRWVKESLPHGL  497 (593)
Q Consensus       424 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~-~~~~~~~~~~~~~~  497 (593)
                      ......     .......||+.|+|||++.+..++.++||||||+++|||++|+.||........ .....+..      
T Consensus       162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~------  235 (298)
T 1csn_A          162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE------  235 (298)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHH------
T ss_pred             ccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHh------
Confidence            654321     122445699999999999999999999999999999999999999977432211 11010000      


Q ss_pred             hhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhhhcc-hhhccCCc
Q 007680          498 TEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKFLD-DAAATNWR  564 (593)
Q Consensus       498 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~-~~~~~~~~  564 (593)
                           ...  ..........+++++.+++.+||+.||++||+++++++.|+++...... ...+.+|.
T Consensus       236 -----~~~--~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~  296 (298)
T 1csn_A          236 -----KKQ--STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWN  296 (298)
T ss_dssp             -----HHH--HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGGG
T ss_pred             -----hcc--CccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCCccccC
Confidence                 000  0000011123567899999999999999999999999999999877643 34456665

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.2e-43  Score=357.97  Aligned_cols=252  Identities=22%  Similarity=0.278  Sum_probs=207.4

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhH------HHHHHHHHHHHHHhhcCCCCcceeeeeeecCCce
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLE------RAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFK  343 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  343 (593)
                      .++|++.+.||+|+||.||+|... +|+.||+|+++....      ...+.+.+|+.++++++||||+++++++.+.+..
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            467999999999999999999976 689999999976431      1356789999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC----cEEEEeecc
Q 007680          344 ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENM----VAHVSDFGI  419 (593)
Q Consensus       344 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~----~~kL~Dfg~  419 (593)
                      ++||||+++++|.+++.... .+++.++..++.|++.||+|||+++    |+||||||+||+++.++    .+||+|||+
T Consensus        90 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~~~----ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~  164 (326)
T 2y0a_A           90 ILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLHSLQ----IAHFDLKPENIMLLDRNVPKPRIKIIDFGL  164 (326)
T ss_dssp             EEEEECCCSCBHHHHHTTSS-CCBHHHHHHHHHHHHHHHHHHHHTT----EECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEEEcCCCCCHHHHHHhcC-CcCHHHHHHHHHHHHHHHHHHHHCC----eEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence            99999999999999997654 4999999999999999999999654    99999999999999887    899999999


Q ss_pred             ceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhh
Q 007680          420 YKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTE  499 (593)
Q Consensus       420 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  499 (593)
                      ++.......   .....||+.|+|||++.+..++.++|||||||++|+|++|+.||......+  ....+......    
T Consensus       165 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~~~~~~~~----  235 (326)
T 2y0a_A          165 AHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE--TLANVSAVNYE----  235 (326)
T ss_dssp             CEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH--HHHHHHHTCCC----
T ss_pred             CeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH--HHHHHHhcCCC----
Confidence            987754332   234569999999999998999999999999999999999999997632111  11111110000    


Q ss_pred             hhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          500 VVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       500 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                                ........++..+.+++.+||+.||++|||+.|+++|
T Consensus       236 ----------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  272 (326)
T 2y0a_A          236 ----------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  272 (326)
T ss_dssp             ----------CCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             ----------cCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                      0001112345678999999999999999999999986

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=4.5e-43  Score=351.38  Aligned_cols=259  Identities=23%  Similarity=0.337  Sum_probs=211.0

Q ss_pred             hhhccccccccCccCcccEEEEEeCCCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEec
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEF  349 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  349 (593)
                      ..++|++.+.||+|+||.||++.+.++..||+|+++.... ..+.+.+|++++.+++||||+++++++.+.+..++||||
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  100 (283)
T 3gen_A           22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY  100 (283)
T ss_dssp             CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred             CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence            4678999999999999999999998888999999986532 235688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCc
Q 007680          350 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDS  429 (593)
Q Consensus       350 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~  429 (593)
                      +++++|.+++......+++.++..++.|++.||+|||+++    |+||||||+||+++.++.+||+|||++........ 
T Consensus       101 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~----i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~-  175 (283)
T 3gen_A          101 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ----FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-  175 (283)
T ss_dssp             CTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTT----CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH-
T ss_pred             cCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC----ccCCCCccceEEEcCCCCEEEcccccccccccccc-
Confidence            9999999999875556999999999999999999999655    99999999999999999999999999986643221 


Q ss_pred             cccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhh
Q 007680          430 VRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVRE  508 (593)
Q Consensus       430 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  508 (593)
                      .......+|+.|+|||++.+..++.++||||||+++|||+| |+.||......  .....+......             
T Consensus       176 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~--~~~~~~~~~~~~-------------  240 (283)
T 3gen_A          176 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--ETAEHIAQGLRL-------------  240 (283)
T ss_dssp             HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--HHHHHHHTTCCC-------------
T ss_pred             ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh--HHHHHHhcccCC-------------
Confidence            12233456788999999998899999999999999999998 99999764221  111111111100             


Q ss_pred             hhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhh
Q 007680          509 EQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVK  553 (593)
Q Consensus       509 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  553 (593)
                          ..+..+++.+.+++.+||+.||++|||++|++++|+++..+
T Consensus       241 ----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~  281 (283)
T 3gen_A          241 ----YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE  281 (283)
T ss_dssp             ----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence                01112345789999999999999999999999999988643

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=8.6e-43  Score=352.38  Aligned_cols=266  Identities=24%  Similarity=0.362  Sum_probs=204.1

Q ss_pred             hhccccccccCccCcccEEEEEeCCCCeEEEEEeehhhHHHHHHHHHHHHHHhh--cCCCCcceeeeeeec----CCceE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRN--VRHRNLIKILSSYSN----PDFKA  344 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~----~~~~~  344 (593)
                      .++|++.+.||+|+||.||+|++ +++.||||++.....   ..+..|.+++..  ++||||+++++++..    ....+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~---~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~   82 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRDE---KSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW   82 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGGH---HHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccccc---hhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence            57899999999999999999998 689999999976532   345556666666  799999999998654    34689


Q ss_pred             EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcC----CCCCeEecCCCCCCeeeCCCCcEEEEeeccc
Q 007680          345 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGH----SSVHIIHCDLKPTNILLDENMVAHVSDFGIY  420 (593)
Q Consensus       345 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~----~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a  420 (593)
                      +||||+++|+|.+++...  .+++..+..++.|++.||+|||...    .+.+|+||||||+||+++.++.+||+|||++
T Consensus        83 lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  160 (301)
T 3q4u_A           83 LITHYHEMGSLYDYLQLT--TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA  160 (301)
T ss_dssp             EEECCCTTCBHHHHHTTC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EehhhccCCCHHHHHhhc--ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCe
Confidence            999999999999999654  3999999999999999999999210    0235999999999999999999999999999


Q ss_pred             eecCCCCCcc--ccccccCCccccCccccCCC------CCCccchHHHHHHHHHHHHhC----------CCCCCcccccc
Q 007680          421 KLLGEGEDSV--RQTMTMATIGYMAPEYGLEG------IVSAKCDVYSYGVLLMETFTR----------KRPTDEMFIGE  482 (593)
Q Consensus       421 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~s~~~DvwSlGvvl~elltg----------~~pf~~~~~~~  482 (593)
                      +.........  ......||+.|+|||++.+.      .++.++|||||||++|||+||          +.||.......
T Consensus       161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~  240 (301)
T 3q4u_A          161 VMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND  240 (301)
T ss_dssp             EEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             eecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCC
Confidence            8765443221  12334799999999998876      456799999999999999999          88886644333


Q ss_pred             chHHHHHHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHh
Q 007680          483 MSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKI  550 (593)
Q Consensus       483 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  550 (593)
                      ................        ...........++.++.+++.+||+.||++|||+.|+++.|+++
T Consensus       241 ~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          241 PSFEDMRKVVCVDQQR--------PNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             CCHHHHHHHHTTSCCC--------CCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             cchhhhhHHHhccCCC--------CCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            3322222111110000        00000111234567899999999999999999999999999986

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-43  Score=369.14  Aligned_cols=261  Identities=24%  Similarity=0.377  Sum_probs=212.2

Q ss_pred             hhccccccccCccCcccEEEEEeC------CCCeEEEEEeehh-hHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCce
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS------DGTDVAIKVFNLQ-LERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFK  343 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  343 (593)
                      .++|++.+.||+|+||.||+|++.      +++.||||+++.. .......+.+|+.++++++||||+++++++.+.+..
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  149 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  149 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            468999999999999999999843      4678999999654 234456788999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhCC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC---cEEE
Q 007680          344 ALVLEFMPNGSLEKWLYSHN------YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENM---VAHV  414 (593)
Q Consensus       344 ~lv~e~~~~gsL~~~l~~~~------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~---~~kL  414 (593)
                      ++||||+++|+|.+++...+      ..+++.+++.++.|++.||+|||+++    |+||||||+||+++.++   .+||
T Consensus       150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~----ivHrDlkp~NIll~~~~~~~~~kL  225 (367)
T 3l9p_A          150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH----FIHRDIAARNCLLTCPGPGRVAKI  225 (367)
T ss_dssp             EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC----eeCCCCChhhEEEecCCCCceEEE
Confidence            99999999999999998643      25899999999999999999999655    99999999999999554   5999


Q ss_pred             EeeccceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhc
Q 007680          415 SDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESL  493 (593)
Q Consensus       415 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~  493 (593)
                      +|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |..||.....  ......+....
T Consensus       226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~--~~~~~~i~~~~  303 (367)
T 3l9p_A          226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--QEVLEFVTSGG  303 (367)
T ss_dssp             CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHHHHHHHTTC
T ss_pred             CCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHcCC
Confidence            99999986543322223344567899999999988999999999999999999998 9999976321  11112111111


Q ss_pred             CCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhhh
Q 007680          494 PHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKF  554 (593)
Q Consensus       494 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  554 (593)
                                       ....+..++..+.+++.+||+.||++|||+.|++++|+.+....
T Consensus       304 -----------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~  347 (367)
T 3l9p_A          304 -----------------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP  347 (367)
T ss_dssp             -----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred             -----------------CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence                             01112234567899999999999999999999999999987654

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.3e-42  Score=356.20  Aligned_cols=274  Identities=17%  Similarity=0.164  Sum_probs=216.6

Q ss_pred             hhccccccccCccCcccEEEEEe-CCCCeEEEEEeehhhHHHHHHHHHHHHHHhhc-CCCCcceeeeeeecCCceEEEEe
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTI-SDGTDVAIKVFNLQLERAFRSFDSECEVLRNV-RHRNLIKILSSYSNPDFKALVLE  348 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  348 (593)
                      .++|++.+.||+|+||.||+|+. .+|+.||||++.....  .+.+.+|+++++++ +||||+++++++...+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e   85 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE   85 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence            46799999999999999999996 4789999999876532  24688999999999 99999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCc-----EEEEeeccceec
Q 007680          349 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMV-----AHVSDFGIYKLL  423 (593)
Q Consensus       349 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~-----~kL~Dfg~a~~~  423 (593)
                      |+ +++|.+++......+++..+..++.|++.||+|||+++    |+||||||+||+++.++.     +||+|||+++.+
T Consensus        86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~----iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~  160 (330)
T 2izr_A           86 LL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN----LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY  160 (330)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT----EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred             eC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC----eeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence            99 99999999876666999999999999999999999654    999999999999998887     999999999976


Q ss_pred             CCCCCcc-----ccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchh
Q 007680          424 GEGEDSV-----RQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLT  498 (593)
Q Consensus       424 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  498 (593)
                      .......     ......||+.|+|||++.+..++.++|||||||++|||++|+.||........  ......       
T Consensus       161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~--~~~~~~-------  231 (330)
T 2izr_A          161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTL--KERYQK-------  231 (330)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSH--HHHHHH-------
T ss_pred             ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccH--HHHHHH-------
Confidence            5433211     12345799999999999999999999999999999999999999987432211  111000       


Q ss_pred             hhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhhhc-chhhccCCc
Q 007680          499 EVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKFL-DDAAATNWR  564 (593)
Q Consensus       499 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~-~~~~~~~~~  564 (593)
                       +......  .........++ ++.+++.+||+.||.+||+++++.+.|+++..... ......+|.
T Consensus       232 -i~~~~~~--~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~  294 (330)
T 2izr_A          232 -IGDTKRA--TPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDWI  294 (330)
T ss_dssp             -HHHHHHH--SCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCSCCCTTT
T ss_pred             -HHhhhcc--CCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCCCCccCC
Confidence             0000000  00000011234 89999999999999999999999999998876642 223345665

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.5e-43  Score=362.76  Aligned_cols=259  Identities=25%  Similarity=0.422  Sum_probs=205.8

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCe----EEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTD----VAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKA  344 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  344 (593)
                      .++|++.+.||+|+||.||+|++. +++.    ||+|.++... ....+.+.+|+.++++++||||+++++++..++ .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~   92 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence            467999999999999999999964 4444    5888775433 344568999999999999999999999998765 78


Q ss_pred             EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecC
Q 007680          345 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG  424 (593)
Q Consensus       345 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~  424 (593)
                      +|+||+++|+|.+++......+++..+..++.|++.||+|||+++    |+||||||+||+++.++.+||+|||+++...
T Consensus        93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~----ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~  168 (327)
T 3poz_A           93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             EEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC----eeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence            999999999999999987777999999999999999999999654    9999999999999999999999999998876


Q ss_pred             CCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhhhh
Q 007680          425 EGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDA  503 (593)
Q Consensus       425 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  503 (593)
                      ............+|..|+|||++.+..++.++|||||||++|||+| |+.||......  .....+.....         
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~~~~~~~---------  237 (327)
T 3poz_A          169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSILEKGER---------  237 (327)
T ss_dssp             TTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHHHTTCC---------
T ss_pred             CCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH--HHHHHHHcCCC---------
Confidence            5544333444567889999999999999999999999999999999 99999764322  12222211110         


Q ss_pred             hhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhh
Q 007680          504 NLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVK  553 (593)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  553 (593)
                              ...+..++.++.+++.+||+.||++|||+.|++++|+.+...
T Consensus       238 --------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~  279 (327)
T 3poz_A          238 --------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             --------CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred             --------CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence                    111123456789999999999999999999999999998754

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=4.8e-43  Score=361.17  Aligned_cols=263  Identities=23%  Similarity=0.366  Sum_probs=214.3

Q ss_pred             HhhhccccccccCccCcccEEEEEeC------CCCeEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCC
Q 007680          269 RATDEFNECNLLGTSSFGSVYKGTIS------DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPD  341 (593)
Q Consensus       269 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  341 (593)
                      ...++|++.+.||+|+||.||+|++.      +++.||+|+++... ....+.+.+|+.++++++||||+++++++.+.+
T Consensus        44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~  123 (343)
T 1luf_A           44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK  123 (343)
T ss_dssp             CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence            34678999999999999999999974      34789999998653 344578999999999999999999999999999


Q ss_pred             ceEEEEeccCCCCHHHHHhhCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecC
Q 007680          342 FKALVLEFMPNGSLEKWLYSHN-----------------------YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCD  398 (593)
Q Consensus       342 ~~~lv~e~~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~D  398 (593)
                      ..++||||+++|+|.+++....                       ..+++.+++.++.|+++||+|||+++    |+|||
T Consensus       124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~----ivH~D  199 (343)
T 1luf_A          124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK----FVHRD  199 (343)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT----CCCSC
T ss_pred             ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC----eecCC
Confidence            9999999999999999998742                       35899999999999999999999654    99999


Q ss_pred             CCCCCeeeCCCCcEEEEeeccceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCc
Q 007680          399 LKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDE  477 (593)
Q Consensus       399 lkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~  477 (593)
                      |||+||+++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |..||..
T Consensus       200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  279 (343)
T 1luf_A          200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG  279 (343)
T ss_dssp             CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence            999999999999999999999987654332222344567899999999988899999999999999999999 9999976


Q ss_pred             cccccchHHHHHHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhhh
Q 007680          478 MFIGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKF  554 (593)
Q Consensus       478 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  554 (593)
                      ....  .....+.....                 ...+..++.++.+++.+||+.||++|||+.+++++|+++....
T Consensus       280 ~~~~--~~~~~~~~~~~-----------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~  337 (343)
T 1luf_A          280 MAHE--EVIYYVRDGNI-----------------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA  337 (343)
T ss_dssp             SCHH--HHHHHHHTTCC-----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred             CChH--HHHHHHhCCCc-----------------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence            3221  11111111100                 0111234568899999999999999999999999999987665

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=9.1e-43  Score=370.49  Aligned_cols=255  Identities=20%  Similarity=0.266  Sum_probs=208.2

Q ss_pred             HhhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh--HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEE
Q 007680          269 RATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKAL  345 (593)
Q Consensus       269 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  345 (593)
                      ...++|++.+.||+|+||.||+|... +|+.||+|++....  ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus         8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l   87 (444)
T 3soa_A            8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL   87 (444)
T ss_dssp             HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred             cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence            35678999999999999999999865 78999999997642  3445678999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeC---CCCcEEEEeecccee
Q 007680          346 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLD---ENMVAHVSDFGIYKL  422 (593)
Q Consensus       346 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~---~~~~~kL~Dfg~a~~  422 (593)
                      ||||+++|+|.+++..... +++.++..++.|++.||+|||+++    |+||||||+||+++   .++.+||+|||++..
T Consensus        88 v~E~~~gg~L~~~i~~~~~-~~e~~~~~i~~qil~aL~~lH~~g----ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~  162 (444)
T 3soa_A           88 IFDLVTGGELFEDIVAREY-YSEADASHCIQQILEAVLHCHQMG----VVHRNLKPENLLLASKLKGAAVKLADFGLAIE  162 (444)
T ss_dssp             EECCCBCCBHHHHHHHCSC-CCHHHHHHHHHHHHHHHHHHHHTT----CBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred             EEEeCCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHCC----ccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence            9999999999999987654 999999999999999999999654    99999999999998   467899999999987


Q ss_pred             cCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhh
Q 007680          423 LGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVD  502 (593)
Q Consensus       423 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  502 (593)
                      ......  ......||+.|+|||++.+..++.++||||+||++|+|++|..||.....  ......+.......      
T Consensus       163 ~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~--~~~~~~i~~~~~~~------  232 (444)
T 3soa_A          163 VEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ--HRLYQQIKAGAYDF------  232 (444)
T ss_dssp             CCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHTCCCC------
T ss_pred             ecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH--HHHHHHHHhCCCCC------
Confidence            654332  22345799999999999999999999999999999999999999976321  11111111111000      


Q ss_pred             hhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          503 ANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                              ..+....+++++.+++.+||+.||++|||+.|+++|
T Consensus       233 --------~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h  268 (444)
T 3soa_A          233 --------PSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH  268 (444)
T ss_dssp             --------CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             --------CccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence                    001112345678999999999999999999999986

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.6e-42  Score=353.77  Aligned_cols=274  Identities=23%  Similarity=0.277  Sum_probs=213.2

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCC--ceEEE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPD--FKALV  346 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv  346 (593)
                      .++|++.+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|++++++++||||+++++++...+  ..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence            467999999999999999999976 58999999998643 334567789999999999999999999988765  78999


Q ss_pred             EeccCCCCHHHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeee----CCCCcEEEEeeccc
Q 007680          347 LEFMPNGSLEKWLYSHNY--FLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILL----DENMVAHVSDFGIY  420 (593)
Q Consensus       347 ~e~~~~gsL~~~l~~~~~--~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll----~~~~~~kL~Dfg~a  420 (593)
                      |||+++++|.+++.....  .+++.++..++.|++.||+|||+++    |+||||||+||++    +.++.+||+|||++
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~----ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a  163 (319)
T 4euu_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG----IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (319)
T ss_dssp             EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT----EECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred             EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC----EecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence            999999999999986543  3899999999999999999999654    9999999999999    78888999999999


Q ss_pred             eecCCCCCccccccccCCccccCccccC--------CCCCCccchHHHHHHHHHHHHhCCCCCCccccccc--hHHHHHH
Q 007680          421 KLLGEGEDSVRQTMTMATIGYMAPEYGL--------EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEM--SLRRWVK  490 (593)
Q Consensus       421 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~--~~~~~~~  490 (593)
                      +.......   .....||+.|+|||++.        +..++.++|||||||++|||++|+.||........  .....+.
T Consensus       164 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  240 (319)
T 4euu_A          164 RELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII  240 (319)
T ss_dssp             EECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHH
T ss_pred             eecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHh
Confidence            87755432   23356899999999875        57799999999999999999999999975332221  1111222


Q ss_pred             HhcCCc-hhhhh---hhhhhh---hhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhh
Q 007680          491 ESLPHG-LTEVV---DANLVR---EEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIK  551 (593)
Q Consensus       491 ~~~~~~-~~~~~---~~~~~~---~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~  551 (593)
                      ...+.. .....   ...+..   ...........+..+.+++.+||+.||++|||++|++++.++..
T Consensus       241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~  308 (319)
T 4euu_A          241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL  308 (319)
T ss_dssp             HHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred             cCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence            222211 11100   000000   00011122456778999999999999999999999999998754

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=2.6e-43  Score=350.71  Aligned_cols=254  Identities=26%  Similarity=0.383  Sum_probs=197.1

Q ss_pred             hhccccccccCccCcccEEEEEeCCCCeEEEEEeehhhH----HHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLE----RAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALV  346 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  346 (593)
                      .++|++.+.||+|+||.||+|.+. ++.||+|+++....    ...+.+.+|+++++.++||||+++++++.+++..++|
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV   84 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence            468999999999999999999985 88999999876432    2346788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC--------CCcEEEEeec
Q 007680          347 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDE--------NMVAHVSDFG  418 (593)
Q Consensus       347 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~--------~~~~kL~Dfg  418 (593)
                      |||+++++|.+++...  .+++..+..++.|++.||+|||+++ ..+|+||||||+||+++.        ++.+||+|||
T Consensus        85 ~e~~~~~~L~~~~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~-~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg  161 (271)
T 3dtc_A           85 MEFARGGPLNRVLSGK--RIPPDILVNWAVQIARGMNYLHDEA-IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG  161 (271)
T ss_dssp             EECCTTEEHHHHHTSS--CCCHHHHHHHHHHHHHHHHHHHHSS-SSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred             EEcCCCCCHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCC-CCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence            9999999999998654  4899999999999999999999765 344999999999999986        7789999999


Q ss_pred             cceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchh
Q 007680          419 IYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLT  498 (593)
Q Consensus       419 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  498 (593)
                      .+.......    .....||+.|+|||++.+..++.++||||||+++|+|++|+.||........  .......      
T Consensus       162 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--~~~~~~~------  229 (271)
T 3dtc_A          162 LAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV--AYGVAMN------  229 (271)
T ss_dssp             C-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHH--HHHHHTS------
T ss_pred             ccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHhhhcC------
Confidence            998654332    2234689999999999888999999999999999999999999976322111  0000000      


Q ss_pred             hhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHh
Q 007680          499 EVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKI  550 (593)
Q Consensus       499 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  550 (593)
                                ....+.+..+++.+.+++.+||+.||++|||+.|++++|+++
T Consensus       230 ----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          230 ----------KLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             ----------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             ----------CCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence                      000111123456789999999999999999999999999864

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-43  Score=363.89  Aligned_cols=266  Identities=21%  Similarity=0.340  Sum_probs=213.1

Q ss_pred             HhhhccccccccCccCcccEEEEEe------CCCCeEEEEEeehhh-HHHHHHHHHHHHHHhhc-CCCCcceeeeeeecC
Q 007680          269 RATDEFNECNLLGTSSFGSVYKGTI------SDGTDVAIKVFNLQL-ERAFRSFDSECEVLRNV-RHRNLIKILSSYSNP  340 (593)
Q Consensus       269 ~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  340 (593)
                      ...++|++.+.||+|+||.||+|++      .+++.||+|+++... ....+.+.+|+.++.++ +||||+++++++...
T Consensus        42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  121 (344)
T 1rjb_A           42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS  121 (344)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence            3467899999999999999999986      245689999997543 34456789999999999 899999999999999


Q ss_pred             CceEEEEeccCCCCHHHHHhhCCC----------------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecC
Q 007680          341 DFKALVLEFMPNGSLEKWLYSHNY----------------------FLDILERLNIMIDVGSALEYLHNGHSSVHIIHCD  398 (593)
Q Consensus       341 ~~~~lv~e~~~~gsL~~~l~~~~~----------------------~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~D  398 (593)
                      +..++||||+++|+|.+++.....                      .+++..+..++.|++.||+|||+++    |+|||
T Consensus       122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~----ivH~D  197 (344)
T 1rjb_A          122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS----CVHRD  197 (344)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT----EEETT
T ss_pred             CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC----cccCC
Confidence            999999999999999999987543                      2789999999999999999999654    99999


Q ss_pred             CCCCCeeeCCCCcEEEEeeccceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCc
Q 007680          399 LKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDE  477 (593)
Q Consensus       399 lkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~  477 (593)
                      |||+||+++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|||+| |..||..
T Consensus       198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  277 (344)
T 1rjb_A          198 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG  277 (344)
T ss_dssp             CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             CChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCccc
Confidence            999999999999999999999987755443333344567889999999988899999999999999999998 9999976


Q ss_pred             cccccchHHHHHHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhhhcc
Q 007680          478 MFIGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKFLD  556 (593)
Q Consensus       478 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~  556 (593)
                      ..... ...........                 ...+..+++++.+++.+||+.||++|||+.|++++|+.+.....+
T Consensus       278 ~~~~~-~~~~~~~~~~~-----------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~  338 (344)
T 1rjb_A          278 IPVDA-NFYKLIQNGFK-----------------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEE  338 (344)
T ss_dssp             CCCSH-HHHHHHHTTCC-----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-----
T ss_pred             CCcHH-HHHHHHhcCCC-----------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHHH
Confidence            43221 12222221111                 011122356789999999999999999999999999998766533

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=7.3e-43  Score=361.15  Aligned_cols=253  Identities=22%  Similarity=0.305  Sum_probs=206.1

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHH-----HHHHHHHHHHHHhhcCCCCcceeeeeeecCCceE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLER-----AFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKA  344 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  344 (593)
                      .++|++.+.||+|+||.||+|... +|+.||+|++......     ..+.+.+|+.++++++||||+++++++.+.+..+
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            468999999999999999999975 7899999999764321     3567899999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCc---EEEEeec
Q 007680          345 LVLEFMPNGSLEKWLYSH---NYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMV---AHVSDFG  418 (593)
Q Consensus       345 lv~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~---~kL~Dfg  418 (593)
                      +||||+++++|.+++...   ...+++..+..++.|++.||+|||+++    |+||||||+||+++.++.   +||+|||
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~----ivHrDlkp~NIl~~~~~~~~~vkl~Dfg  178 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN----IIHRDVKPHCVLLASKENSAPVKLGGFG  178 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT----EECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC----ceeccCChHHeEEecCCCCCcEEEecCc
Confidence            999999999999887643   235899999999999999999999654    999999999999986654   9999999


Q ss_pred             cceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchh
Q 007680          419 IYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLT  498 (593)
Q Consensus       419 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  498 (593)
                      ++........  ......||+.|+|||++.+..++.++|||||||++|+|++|+.||....  . .....+...      
T Consensus       179 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--~-~~~~~i~~~------  247 (351)
T 3c0i_A          179 VAIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK--E-RLFEGIIKG------  247 (351)
T ss_dssp             TCEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH--H-HHHHHHHHT------
T ss_pred             ceeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH--H-HHHHHHHcC------
Confidence            9988754332  2234579999999999999999999999999999999999999997631  1 111111110      


Q ss_pred             hhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          499 EVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       499 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                           .....   ......++.++.+++.+||+.||++|||+.|+++|
T Consensus       248 -----~~~~~---~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  287 (351)
T 3c0i_A          248 -----KYKMN---PRQWSHISESAKDLVRRMLMLDPAERITVYEALNH  287 (351)
T ss_dssp             -----CCCCC---HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             -----CCCCC---ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                 00000   01112345688999999999999999999999976

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=6e-43  Score=365.64  Aligned_cols=253  Identities=23%  Similarity=0.284  Sum_probs=209.9

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEec
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEF  349 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  349 (593)
                      .++|++.+.||+|+||.||+|... +|+.||+|++..........+.+|++++++++||||+++++++.+.+..++||||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            468999999999999999999975 7899999999876555556889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC--CCcEEEEeeccceecCCCC
Q 007680          350 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDE--NMVAHVSDFGIYKLLGEGE  427 (593)
Q Consensus       350 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~--~~~~kL~Dfg~a~~~~~~~  427 (593)
                      +++|+|.+++......+++.++..++.|++.||+|||+++    |+||||||+||+++.  ++.+||+|||++.......
T Consensus       130 ~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g----ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~  205 (387)
T 1kob_A          130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS----IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE  205 (387)
T ss_dssp             CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT----EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred             CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC----eeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence            9999999999877656999999999999999999999654    999999999999974  4789999999998875433


Q ss_pred             CccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhh
Q 007680          428 DSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVR  507 (593)
Q Consensus       428 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  507 (593)
                      .   .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....  ......+......           .
T Consensus       206 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~--~~~~~~i~~~~~~-----------~  269 (387)
T 1kob_A          206 I---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD--LETLQNVKRCDWE-----------F  269 (387)
T ss_dssp             C---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--HHHHHHHHHCCCC-----------C
T ss_pred             c---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH--HHHHHHHHhCCCC-----------C
Confidence            2   2334689999999999999999999999999999999999999976321  1111111111000           0


Q ss_pred             hhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          508 EEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       508 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                         .......+++++.+++.+||+.||++|||+.|+++|
T Consensus       270 ---~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          270 ---DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             ---CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             ---CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence               000112345678999999999999999999999986

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.9e-42  Score=359.26  Aligned_cols=253  Identities=21%  Similarity=0.313  Sum_probs=208.3

Q ss_pred             hhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh--HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEE
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALV  346 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  346 (593)
                      ..++|++.+.||+|+||.||+|..+ +|+.||+|+++...  ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  106 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV  106 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            4578999999999999999999975 68999999997642  34556789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC---cEEEEeeccceec
Q 007680          347 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENM---VAHVSDFGIYKLL  423 (593)
Q Consensus       347 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~---~~kL~Dfg~a~~~  423 (593)
                      |||+++|+|.+++.... .+++.++..++.|++.||+|||+++    |+||||||+||+++.++   .+||+|||++...
T Consensus       107 ~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~~----ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~  181 (362)
T 2bdw_A          107 FDLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV  181 (362)
T ss_dssp             ECCCCSCBHHHHHTTCS-CCCHHHHHHHHHHHHHHHHHHHHTT----CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred             EecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC----eEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence            99999999999997665 4899999999999999999999655    99999999999998654   5999999999876


Q ss_pred             CCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhh
Q 007680          424 GEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDA  503 (593)
Q Consensus       424 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  503 (593)
                      .....   .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.....  ......+.......       
T Consensus       182 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~--~~~~~~i~~~~~~~-------  249 (362)
T 2bdw_A          182 NDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--HRLYAQIKAGAYDY-------  249 (362)
T ss_dssp             TTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHTCCCC-------
T ss_pred             cCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHHhCCCCC-------
Confidence            54322   2345799999999999998999999999999999999999999976321  11111111111000       


Q ss_pred             hhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          504 NLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                             .......+++++.+++.+||+.||++|||+.|+++|
T Consensus       250 -------~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          250 -------PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             -------CTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             -------CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                   001112345678999999999999999999999987

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=9.9e-43  Score=350.72  Aligned_cols=268  Identities=20%  Similarity=0.259  Sum_probs=205.4

Q ss_pred             hccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh--HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEe
Q 007680          272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLE  348 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  348 (593)
                      ++|++.+.||+|+||.||+|+.. +++.||+|+++...  ......+.+|+.++++++||||+++++++.+++..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            57999999999999999999975 68999999997543  3344678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCC
Q 007680          349 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGED  428 (593)
Q Consensus       349 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  428 (593)
                      |+++ ++.+.+......+++..+..++.|++.||+|||+++    |+||||||+||+++.++.+||+|||+++.......
T Consensus        82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~----ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  156 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN----VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR  156 (292)
T ss_dssp             CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT----EECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS
T ss_pred             cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC----eecCCCCHHHEEEcCCCCEEEeecccceecCCccc
Confidence            9965 777777665566999999999999999999999654    99999999999999999999999999987654322


Q ss_pred             ccccccccCCccccCccccCCCC-CCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCC---chhhhhhh-
Q 007680          429 SVRQTMTMATIGYMAPEYGLEGI-VSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPH---GLTEVVDA-  503 (593)
Q Consensus       429 ~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~---~~~~~~~~-  503 (593)
                        ......+|+.|+|||++.+.. ++.++|||||||++|||++|..||....................   ........ 
T Consensus       157 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  234 (292)
T 3o0g_A          157 --CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP  234 (292)
T ss_dssp             --CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred             --cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccc
Confidence              233456899999999987765 89999999999999999998888644322222222222211110   01000000 


Q ss_pred             hhh------hhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          504 NLV------REEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       504 ~~~------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      ...      ...........++.++.+++.+||+.||++|||++|+++|
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  283 (292)
T 3o0g_A          235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             cccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            000      0000001112345678999999999999999999999875

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=5.2e-43  Score=356.02  Aligned_cols=263  Identities=22%  Similarity=0.344  Sum_probs=216.9

Q ss_pred             hhhccccccccCccCcccEEEEEe------CCCCeEEEEEeehhh-HHHHHHHHHHHHHHhhc-CCCCcceeeeeeecCC
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTI------SDGTDVAIKVFNLQL-ERAFRSFDSECEVLRNV-RHRNLIKILSSYSNPD  341 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  341 (593)
                      ..++|++.+.||+|+||.||+|++      .+++.||+|+++... ....+.+.+|+.+++++ +||||+++++++..++
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~  100 (313)
T 1t46_A           21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG  100 (313)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence            457899999999999999999985      257889999997653 34457889999999999 9999999999999999


Q ss_pred             ceEEEEeccCCCCHHHHHhhCCC-----------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCe
Q 007680          342 FKALVLEFMPNGSLEKWLYSHNY-----------------FLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNI  404 (593)
Q Consensus       342 ~~~lv~e~~~~gsL~~~l~~~~~-----------------~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NI  404 (593)
                      ..++||||+++|+|.+++.....                 .+++.++..++.|++.||+|||+++    |+||||||+||
T Consensus       101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~----i~H~dlkp~Ni  176 (313)
T 1t46_A          101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN----CIHRDLAARNI  176 (313)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCSGGGE
T ss_pred             CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC----eecCCCccceE
Confidence            99999999999999999987543                 3899999999999999999999654    99999999999


Q ss_pred             eeCCCCcEEEEeeccceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccc
Q 007680          405 LLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEM  483 (593)
Q Consensus       405 ll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~  483 (593)
                      +++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|||+| |+.||....... 
T Consensus       177 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-  255 (313)
T 1t46_A          177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS-  255 (313)
T ss_dssp             EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH-
T ss_pred             EEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh-
Confidence            999999999999999987765543333344557889999999988899999999999999999999 999997643221 


Q ss_pred             hHHHHHHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhhh
Q 007680          484 SLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKF  554 (593)
Q Consensus       484 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  554 (593)
                      ............                 ..+..++.++.+++.+||+.||++|||+.|++++|+++....
T Consensus       256 ~~~~~~~~~~~~-----------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  309 (313)
T 1t46_A          256 KFYKMIKEGFRM-----------------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES  309 (313)
T ss_dssp             HHHHHHHHTCCC-----------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             HHHHHhccCCCC-----------------CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence            111212111110                 011233567899999999999999999999999999987654

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=3.3e-43  Score=363.38  Aligned_cols=250  Identities=24%  Similarity=0.292  Sum_probs=202.1

Q ss_pred             hhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhc-CCCCcceeeeeeecCCceE
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNV-RHRNLIKILSSYSNPDFKA  344 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  344 (593)
                      ..++|++.+.||+|+||.||+|+.+ +|+.||+|+++...   ....+.+.+|..+++.+ +||||+++++++.+.+..+
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  100 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF  100 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence            3578999999999999999999976 68999999998652   33456688999999988 7999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecC
Q 007680          345 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG  424 (593)
Q Consensus       345 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~  424 (593)
                      +||||+++|+|.+++...+. +++..+..++.||+.||+|||+++    |+||||||+||+++.++.+||+|||+++...
T Consensus       101 lv~E~~~gg~L~~~l~~~~~-~~~~~~~~~~~qi~~aL~~LH~~g----ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~  175 (353)
T 3txo_A          101 FVMEFVNGGDLMFHIQKSRR-FDEARARFYAAEIISALMFLHDKG----IIYRDLKLDNVLLDHEGHCKLADFGMCKEGI  175 (353)
T ss_dssp             EEEECCCSCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHHHTT----CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             EEEeCCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHCC----CcccCCCHHHEEECCCCCEEEccccceeecc
Confidence            99999999999999987654 999999999999999999999654    9999999999999999999999999998543


Q ss_pred             CCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhh
Q 007680          425 EGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDAN  504 (593)
Q Consensus       425 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  504 (593)
                      ...  .......||+.|+|||++.+..++.++|||||||++|||++|+.||......  .....+...           .
T Consensus       176 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~--~~~~~i~~~-----------~  240 (353)
T 3txo_A          176 CNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED--DLFEAILND-----------E  240 (353)
T ss_dssp             C-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHC-----------C
T ss_pred             cCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH--HHHHHHHcC-----------C
Confidence            222  1234457999999999998889999999999999999999999999763221  111111110           0


Q ss_pred             hhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCH------HHHHHH
Q 007680          505 LVREEQAFSAKMDCILSIMDFALDCCMESPDMRINM------TDAAAK  546 (593)
Q Consensus       505 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~~  546 (593)
                      .       ..+..++.++.+++.+||+.||++||++      .|+++|
T Consensus       241 ~-------~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h  281 (353)
T 3txo_A          241 V-------VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH  281 (353)
T ss_dssp             C-------CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred             C-------CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence            0       0011235578999999999999999998      777765

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.5e-42  Score=355.40  Aligned_cols=252  Identities=23%  Similarity=0.327  Sum_probs=200.7

Q ss_pred             hhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCC------
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPD------  341 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  341 (593)
                      ..++|++.+.||+|+||.||+|++. +|+.||||+++... ....+.+.+|++++++++||||+++++++.+.+      
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~   83 (332)
T 3qd2_B            4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE   83 (332)
T ss_dssp             HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred             hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence            4578999999999999999999976 79999999997543 334578899999999999999999999886543      


Q ss_pred             ---------------------------------------------------ceEEEEeccCCCCHHHHHhhCCC--CCCH
Q 007680          342 ---------------------------------------------------FKALVLEFMPNGSLEKWLYSHNY--FLDI  368 (593)
Q Consensus       342 ---------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~--~l~~  368 (593)
                                                                         ..++||||+++++|.+++.....  ..++
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~  163 (332)
T 3qd2_B           84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH  163 (332)
T ss_dssp             HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred             hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence                                                               27999999999999999987654  4567


Q ss_pred             HHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCc----------cccccccCC
Q 007680          369 LERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDS----------VRQTMTMAT  438 (593)
Q Consensus       369 ~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~----------~~~~~~~gt  438 (593)
                      ..+..++.|++.||+|||+++    |+||||||+||+++.++.+||+|||+++........          .......||
T Consensus       164 ~~~~~i~~qi~~aL~~LH~~~----ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt  239 (332)
T 3qd2_B          164 GVCLHIFIQIAEAVEFLHSKG----LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT  239 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT----EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-C
T ss_pred             HHHHHHHHHHHHHHHHHHhCC----eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCC
Confidence            778999999999999999654    999999999999999999999999999987654321          122345699


Q ss_pred             ccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhhhhhhhhHHH
Q 007680          439 IGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDC  518 (593)
Q Consensus       439 ~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  518 (593)
                      +.|+|||++.+..++.++|||||||++|||++|..|+....    ........           .      .........
T Consensus       240 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~----~~~~~~~~-----------~------~~~~~~~~~  298 (332)
T 3qd2_B          240 KLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV----RIITDVRN-----------L------KFPLLFTQK  298 (332)
T ss_dssp             GGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH----HHHHHHHT-----------T------CCCHHHHHH
T ss_pred             cCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH----HHHHHhhc-----------c------CCCcccccC
Confidence            99999999999999999999999999999999987753311    00000000           0      001112233


Q ss_pred             HHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          519 ILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       519 ~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      ++++.+++.+||+.||++|||+.|+++|
T Consensus       299 ~~~~~~li~~~l~~~p~~Rps~~~~l~~  326 (332)
T 3qd2_B          299 YPQEHMMVQDMLSPSPTERPEATDIIEN  326 (332)
T ss_dssp             CHHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred             ChhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence            5577999999999999999999999875

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.9e-43  Score=354.78  Aligned_cols=250  Identities=24%  Similarity=0.315  Sum_probs=197.7

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhH--------------------------HHHHHHHHHHHHHh
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLE--------------------------RAFRSFDSECEVLR  323 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~  323 (593)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++.....                          ...+.+.+|+++++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            468999999999999999999965 689999999975421                          12356889999999


Q ss_pred             hcCCCCcceeeeeeec--CCceEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCC
Q 007680          324 NVRHRNLIKILSSYSN--PDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKP  401 (593)
Q Consensus       324 ~l~h~niv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp  401 (593)
                      +++||||+++++++.+  .+..++||||+++++|.+++...  .+++.++..++.|++.||+|||+++    |+||||||
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~----ivH~Dlkp  165 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK--PLSEDQARFYFQDLIKGIEYLHYQK----IIHRDIKP  165 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSS--CCCHHHHHHHHHHHHHHHHHHHHTT----EECCCCCG
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCC----eeccCCCH
Confidence            9999999999999986  56889999999999998865433  4999999999999999999999655    99999999


Q ss_pred             CCeeeCCCCcEEEEeeccceecCCCCCccccccccCCccccCccccCCCC---CCccchHHHHHHHHHHHHhCCCCCCcc
Q 007680          402 TNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGI---VSAKCDVYSYGVLLMETFTRKRPTDEM  478 (593)
Q Consensus       402 ~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~~~DvwSlGvvl~elltg~~pf~~~  478 (593)
                      +||+++.++.+||+|||++........  ......||+.|+|||++.+..   ++.++|||||||++|||++|+.||...
T Consensus       166 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~  243 (298)
T 2zv2_A          166 SNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE  243 (298)
T ss_dssp             GGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             HHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence            999999999999999999987654332  223457999999999987765   478899999999999999999999763


Q ss_pred             ccccchHHHHHHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          479 FIGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       479 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      ..  ......+....                ...+....+++++.+++.+||+.||++|||+.|+++|
T Consensus       244 ~~--~~~~~~~~~~~----------------~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h  293 (298)
T 2zv2_A          244 RI--MCLHSKIKSQA----------------LEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH  293 (298)
T ss_dssp             SH--HHHHHHHHHCC----------------CCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred             cH--HHHHHHHhccc----------------CCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence            21  11111111100                0001112345678999999999999999999999865

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.4e-42  Score=348.49  Aligned_cols=253  Identities=27%  Similarity=0.434  Sum_probs=206.1

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhH-------HHHHHHHHHHHHHhhcCCCCcceeeeeeecCCc
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLE-------RAFRSFDSECEVLRNVRHRNLIKILSSYSNPDF  342 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  342 (593)
                      .++|++.+.||+|+||.||+|++. +++.||+|++.....       ...+.+.+|+.++++++||||+++++++.+.. 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            468999999999999999999975 789999999865321       11267899999999999999999999987665 


Q ss_pred             eEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCC--eEecCCCCCCeeeCCCCc-----EEEE
Q 007680          343 KALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVH--IIHCDLKPTNILLDENMV-----AHVS  415 (593)
Q Consensus       343 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~--ivH~Dlkp~NIll~~~~~-----~kL~  415 (593)
                       ++||||+++++|.+++......+++..+..++.|++.||+|||+    .+  |+||||||+||+++.++.     +||+
T Consensus        97 -~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~----~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~  171 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQN----QNPPIVHRDLRSPNIFLQSLDENAPVCAKVA  171 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHT----SSSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred             -eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHh----CCCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence             79999999999999998777779999999999999999999994    55  999999999999988776     9999


Q ss_pred             eeccceecCCCCCccccccccCCccccCccccC--CCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhc
Q 007680          416 DFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGL--EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESL  493 (593)
Q Consensus       416 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~  493 (593)
                      |||+++....     ......||+.|+|||++.  ...++.++|||||||++|||++|+.||..................
T Consensus       172 Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~  246 (287)
T 4f0f_A          172 DFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEG  246 (287)
T ss_dssp             CCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSC
T ss_pred             CCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccC
Confidence            9999875432     223456899999999984  456889999999999999999999999775433322222222111


Q ss_pred             CCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHh
Q 007680          494 PHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKI  550 (593)
Q Consensus       494 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  550 (593)
                      .                ....+..+++++.+++.+||+.||++|||+.|+++.|+++
T Consensus       247 ~----------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          247 L----------------RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             C----------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             C----------------CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence            0                0011123456889999999999999999999999999864

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.7e-42  Score=350.18  Aligned_cols=265  Identities=25%  Similarity=0.357  Sum_probs=208.2

Q ss_pred             hhccccccccCccCcccEEEEEeCCCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEecc
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFM  350 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  350 (593)
                      .++|++.+.||+|+||.||+|++. ++.||+|++....  ..+.+.+|++++++++||||+++++++.+  ..++||||+
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~   81 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESES--ERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYA   81 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSSTT--HHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECC
T ss_pred             HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecChh--HHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcC
Confidence            467999999999999999999985 7899999987543  34678999999999999999999998874  479999999


Q ss_pred             CCCCHHHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCc-EEEEeeccceecCCCC
Q 007680          351 PNGSLEKWLYSHNY--FLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMV-AHVSDFGIYKLLGEGE  427 (593)
Q Consensus       351 ~~gsL~~~l~~~~~--~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~-~kL~Dfg~a~~~~~~~  427 (593)
                      ++++|.+++.....  .+++..+..++.|+++||+|||+.+ ..+|+||||||+||+++.++. +||+|||++...... 
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~-~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-  159 (307)
T 2eva_A           82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ-PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-  159 (307)
T ss_dssp             TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCS-SSCCCCCCCSGGGEEEETTTTEEEECCCCC--------
T ss_pred             CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCC-CCCeecCCCChhHEEEeCCCCEEEEcccccccccccc-
Confidence            99999999987654  4789999999999999999999733 256999999999999998886 799999998765432 


Q ss_pred             CccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhh
Q 007680          428 DSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVR  507 (593)
Q Consensus       428 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  507 (593)
                          .....||+.|+|||++.+..++.++||||||+++|||++|+.||...................             
T Consensus       160 ----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~-------------  222 (307)
T 2eva_A          160 ----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTR-------------  222 (307)
T ss_dssp             ---------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCC-------------
T ss_pred             ----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCC-------------
Confidence                123458999999999999999999999999999999999999997643222111111111100             


Q ss_pred             hhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhhhcchhhccCC
Q 007680          508 EEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKFLDDAAATNW  563 (593)
Q Consensus       508 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~~~~~  563 (593)
                          ......++..+.+++.+||+.||++|||+.|++++|+.+...+.....+..|
T Consensus       223 ----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~~~~  274 (307)
T 2eva_A          223 ----PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQY  274 (307)
T ss_dssp             ----CCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTSCCCC
T ss_pred             ----CCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCCcccc
Confidence                0111234567899999999999999999999999999998887555444433

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=4.4e-43  Score=359.74  Aligned_cols=247  Identities=24%  Similarity=0.390  Sum_probs=204.6

Q ss_pred             hhccccccccCccCcccEEEEEe-CCCCeEEEEEeehhhH---HHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTI-SDGTDVAIKVFNLQLE---RAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALV  346 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  346 (593)
                      .++|.+.+.||+|+||.||+|.+ .+++.||+|++.....   .....+.+|+.+++.++||||+++++++..++..++|
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            46899999999999999999997 4789999999986532   2245788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCC
Q 007680          347 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG  426 (593)
Q Consensus       347 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  426 (593)
                      |||+ +|+|.+++...+. +++.++..++.|++.||+|||+++    |+||||||+||++++++.+||+|||++......
T Consensus        88 ~E~~-~g~l~~~l~~~~~-l~~~~~~~i~~qi~~aL~~LH~~g----ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~  161 (336)
T 3h4j_B           88 IEYA-GGELFDYIVEKKR-MTEDEGRRFFQQIICAIEYCHRHK----IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG  161 (336)
T ss_dssp             ECCC-CEEHHHHHHHHCS-CCHHHHHHHHHHHHHHHHHHHHHT----CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred             EECC-CCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHCC----eEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence            9999 7899999877654 999999999999999999999665    999999999999999999999999999876543


Q ss_pred             CCccccccccCCccccCccccCCCCC-CccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhh
Q 007680          427 EDSVRQTMTMATIGYMAPEYGLEGIV-SAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANL  505 (593)
Q Consensus       427 ~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  505 (593)
                      .   ......||+.|+|||++.+..+ ++++|||||||++|+|++|+.||........             ... +... 
T Consensus       162 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~-------------~~~-i~~~-  223 (336)
T 3h4j_B          162 N---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL-------------FKK-VNSC-  223 (336)
T ss_dssp             B---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC-------------BCC-CCSS-
T ss_pred             c---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH-------------HHH-HHcC-
Confidence            2   2234569999999999988776 7899999999999999999999976321110             000 0000 


Q ss_pred             hhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          506 VREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                           ....+..+++++.+++.+||+.||++|||++|+++|
T Consensus       224 -----~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  259 (336)
T 3h4j_B          224 -----VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD  259 (336)
T ss_dssp             -----CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred             -----CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence                 001112245678999999999999999999999986

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=4.7e-43  Score=352.40  Aligned_cols=267  Identities=22%  Similarity=0.311  Sum_probs=203.6

Q ss_pred             hccccccccCccCcccEEEEEeCCCCeEEEEEeehhh--HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEec
Q 007680          272 DEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEF  349 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  349 (593)
                      ++|++.+.||+|+||.||+|+..+|+.||+|+++...  ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            5799999999999999999999889999999996543  22346788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCc
Q 007680          350 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDS  429 (593)
Q Consensus       350 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~  429 (593)
                      +++ +|.+++......+++..+..++.|++.||+|||+++    |+||||||+||+++.++.+||+|||++........ 
T Consensus        82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~----i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  155 (288)
T 1ob3_A           82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR----VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-  155 (288)
T ss_dssp             CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred             cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC----eecCCCCHHHEEEcCCCCEEEeECccccccCcccc-
Confidence            975 999999877667999999999999999999999654    99999999999999999999999999987643221 


Q ss_pred             cccccccCCccccCccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHh-cC--Cchhhhh----
Q 007680          430 VRQTMTMATIGYMAPEYGLEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKES-LP--HGLTEVV----  501 (593)
Q Consensus       430 ~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~-~~--~~~~~~~----  501 (593)
                       ......+|+.|+|||++.+. .++.++|||||||++|||++|+.||......+ ......... .+  .......    
T Consensus       156 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T 1ob3_A          156 -KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD-QLMRIFRILGTPNSKNWPNVTELPK  233 (288)
T ss_dssp             -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             -ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHHCCCChhhchhhhcccc
Confidence             22334689999999998764 58999999999999999999999997643221 111111111 00  0010000    


Q ss_pred             -hhhhhhh--hhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          502 -DANLVRE--EQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       502 -~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                       +......  .........+++++.+++.+||+.||++|||++|+++|
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  281 (288)
T 1ob3_A          234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (288)
T ss_dssp             CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence             0000000  00000112345678999999999999999999999875

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=4.5e-42  Score=357.99  Aligned_cols=250  Identities=24%  Similarity=0.311  Sum_probs=205.2

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALV  346 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  346 (593)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++....   ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   93 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV   93 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            478999999999999999999976 68899999997653   23456788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCC
Q 007680          347 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG  426 (593)
Q Consensus       347 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  426 (593)
                      |||+++|+|.+++..... +++..+..++.|++.||+|||+++    |+||||||+||+++.++.+||+|||++..+...
T Consensus        94 ~e~~~gg~L~~~l~~~~~-l~~~~~~~~~~qi~~aL~~LH~~g----ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  168 (384)
T 4fr4_A           94 VDLLLGGDLRYHLQQNVH-FKEETVKLFICELVMALDYLQNQR----IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE  168 (384)
T ss_dssp             ECCCTTEEHHHHHHTTCC-CCHHHHHHHHHHHHHHHHHHHHTT----EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EecCCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCC----ceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence            999999999999987654 999999999999999999999655    999999999999999999999999999876543


Q ss_pred             CCccccccccCCccccCccccCC---CCCCccchHHHHHHHHHHHHhCCCCCCccccccc-hHHHHHHHhcCCchhhhhh
Q 007680          427 EDSVRQTMTMATIGYMAPEYGLE---GIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEM-SLRRWVKESLPHGLTEVVD  502 (593)
Q Consensus       427 ~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~  502 (593)
                      .   ......||+.|+|||++.+   ..++.++|||||||++|||++|+.||........ ..........         
T Consensus       169 ~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~---------  236 (384)
T 4fr4_A          169 T---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTV---------  236 (384)
T ss_dssp             C---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCC---------
T ss_pred             C---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcc---------
Confidence            2   2344679999999999864   4589999999999999999999999975322111 1111111000         


Q ss_pred             hhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCC-HHHHHHH
Q 007680          503 ANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRIN-MTDAAAK  546 (593)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~  546 (593)
                               ...+..++.++.+++.+||+.||++||+ ++++++|
T Consensus       237 ---------~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~h  272 (384)
T 4fr4_A          237 ---------VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNF  272 (384)
T ss_dssp             ---------CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTS
T ss_pred             ---------cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcC
Confidence                     0111234567899999999999999998 6766653

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-42  Score=353.32  Aligned_cols=246  Identities=24%  Similarity=0.294  Sum_probs=206.2

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhH---HHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLE---RAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALV  346 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  346 (593)
                      .++|++.+.||+|+||.||+|+.+ +|+.||+|+++....   ...+.+.+|..+++.++||||+++++++.+.+..++|
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            468999999999999999999976 799999999987532   3456788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCC
Q 007680          347 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG  426 (593)
Q Consensus       347 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  426 (593)
                      |||+++|+|.+++..... +++..+..++.|++.||+|||++    +|+||||||+||+++.++.+||+|||+++.....
T Consensus        85 ~e~~~gg~L~~~l~~~~~-~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~  159 (318)
T 1fot_A           85 MDYIEGGELFSLLRKSQR-FPNPVAKFYAAEVCLALEYLHSK----DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV  159 (318)
T ss_dssp             ECCCCSCBHHHHHHHTSS-CCHHHHHHHHHHHHHHHHHHHTT----TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred             EeCCCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHC----CccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence            999999999999987654 89999999999999999999954    5999999999999999999999999999876432


Q ss_pred             CCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhh
Q 007680          427 EDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLV  506 (593)
Q Consensus       427 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  506 (593)
                           .....||+.|+|||++.+..++.++|||||||++|||++|+.||......  .....+..           ... 
T Consensus       160 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~i~~-----------~~~-  220 (318)
T 1fot_A          160 -----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM--KTYEKILN-----------AEL-  220 (318)
T ss_dssp             -----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHH-----------CCC-
T ss_pred             -----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--HHHHHHHh-----------CCC-
Confidence                 23357999999999999999999999999999999999999999763211  11111110           000 


Q ss_pred             hhhhhhhhhHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHHH
Q 007680          507 REEQAFSAKMDCILSIMDFALDCCMESPDMRI-----NMTDAAAK  546 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  546 (593)
                            ..+..++.++.+++.+||..||++||     +++|+++|
T Consensus       221 ------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h  259 (318)
T 1fot_A          221 ------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  259 (318)
T ss_dssp             ------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             ------CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence                  00112355789999999999999999     88998876

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.7e-42  Score=361.13  Aligned_cols=250  Identities=22%  Similarity=0.305  Sum_probs=201.5

Q ss_pred             cccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEeccCC
Q 007680          274 FNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPN  352 (593)
Q Consensus       274 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  352 (593)
                      +...+.||+|+||.||+|... +|+.||+|+++.......+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus        91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~  170 (373)
T 2x4f_A           91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDG  170 (373)
T ss_dssp             EEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred             eecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCC
Confidence            334678999999999999965 7899999999876555667899999999999999999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeee--CCCCcEEEEeeccceecCCCCCcc
Q 007680          353 GSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILL--DENMVAHVSDFGIYKLLGEGEDSV  430 (593)
Q Consensus       353 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll--~~~~~~kL~Dfg~a~~~~~~~~~~  430 (593)
                      ++|.+++......+++..+..++.|++.||+|||+++    |+||||||+||++  +.++.+||+|||+++.......  
T Consensus       171 ~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~----ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--  244 (373)
T 2x4f_A          171 GELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY----ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--  244 (373)
T ss_dssp             CEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT----EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--
T ss_pred             CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC----cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--
Confidence            9999999877666999999999999999999999654    9999999999999  5678999999999988754332  


Q ss_pred             ccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhhh
Q 007680          431 RQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQ  510 (593)
Q Consensus       431 ~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  510 (593)
                       .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..+..........               
T Consensus       245 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-~~~~~i~~~~~~~---------------  307 (373)
T 2x4f_A          245 -LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA-ETLNNILACRWDL---------------  307 (373)
T ss_dssp             -CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHHTCCCS---------------
T ss_pred             -cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhccCCC---------------
Confidence             23346999999999999999999999999999999999999999763221 1111111111100               


Q ss_pred             hhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          511 AFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       511 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      .......+++++.+++.+||+.||++|||+.|+++|
T Consensus       308 ~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h  343 (373)
T 2x4f_A          308 EDEEFQDISEEAKEFISKLLIKEKSWRISASEALKH  343 (373)
T ss_dssp             CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            001112345688999999999999999999999985

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.1e-42  Score=349.93  Aligned_cols=261  Identities=25%  Similarity=0.412  Sum_probs=198.7

Q ss_pred             hhhccccccccCccCcccEEEEEeCCCCeEEEEEeehhh--HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEE
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVL  347 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  347 (593)
                      ..++|++.+.||+|+||.||+|++.  ..||+|+++...  ....+.+.+|++++++++||||++++++. ..+..++||
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~   98 (289)
T 3og7_A           22 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT   98 (289)
T ss_dssp             CTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred             CccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence            3568999999999999999999864  469999987542  44557899999999999999999999965 556689999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCC
Q 007680          348 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGE  427 (593)
Q Consensus       348 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~  427 (593)
                      ||+++++|.+++......+++.++..++.|++.||+|||+++    |+||||||+||+++.++.+||+|||++.......
T Consensus        99 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~----i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  174 (289)
T 3og7_A           99 QWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS----IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS  174 (289)
T ss_dssp             ECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred             EecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC----cccccCccceEEECCCCCEEEccceecccccccc
Confidence            999999999999877667999999999999999999999654    9999999999999999999999999998665433


Q ss_pred             CccccccccCCccccCccccC---CCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHh-cCCchhhhhhh
Q 007680          428 DSVRQTMTMATIGYMAPEYGL---EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKES-LPHGLTEVVDA  503 (593)
Q Consensus       428 ~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  503 (593)
                      .........||+.|+|||++.   +..++.++||||||+++|||++|+.||......+ .....+... ......     
T Consensus       175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~-----  248 (289)
T 3og7_A          175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD-QIIEMVGRGSLSPDLS-----  248 (289)
T ss_dssp             ---------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH-HHHHHHHHTSCCCCTT-----
T ss_pred             ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH-HHHHHhcccccCcchh-----
Confidence            332334456899999999886   5678999999999999999999999997643222 122222111 111000     


Q ss_pred             hhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhh
Q 007680          504 NLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKV  552 (593)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~  552 (593)
                               .....+++++.+++.+||+.||++|||+.|+++.|+++..
T Consensus       249 ---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          249 ---------KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             ---------SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             ---------hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence                     0112345688999999999999999999999999998753

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=2.5e-42  Score=362.35  Aligned_cols=276  Identities=18%  Similarity=0.238  Sum_probs=209.3

Q ss_pred             hhccccccccCcc--CcccEEEEEeC-CCCeEEEEEeehhh--HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEE
Q 007680          271 TDEFNECNLLGTS--SFGSVYKGTIS-DGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKAL  345 (593)
Q Consensus       271 ~~~~~~~~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  345 (593)
                      .++|++.+.||+|  +||.||+|+.. +|+.||||+++...  ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            5789999999999  99999999976 79999999998653  4455778899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecC
Q 007680          346 VLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG  424 (593)
Q Consensus       346 v~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~  424 (593)
                      ||||+++|+|.+++.... ..+++..+..++.|++.||+|||+++    |+||||||+||+++.++.+||+|||.+....
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~----ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~  179 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG----YVHRSVKASHILISVDGKVYLSGLRSNLSMI  179 (389)
T ss_dssp             EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT----EECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred             EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC----eecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence            999999999999998753 35999999999999999999999654    9999999999999999999999999887653


Q ss_pred             CCCCc-----cccccccCCccccCccccCC--CCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCch
Q 007680          425 EGEDS-----VRQTMTMATIGYMAPEYGLE--GIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGL  497 (593)
Q Consensus       425 ~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  497 (593)
                      .....     .......||+.|+|||++.+  ..++.++|||||||++|||++|+.||.+....... ........+...
T Consensus       180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-~~~~~~~~~~~~  258 (389)
T 3gni_B          180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML-LEKLNGTVPCLL  258 (389)
T ss_dssp             ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHH-HHC---------
T ss_pred             cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHH-HHHhcCCCCccc
Confidence            22111     11223468999999999887  57999999999999999999999999764322211 111111100000


Q ss_pred             -----------------------hhhhhhh----hhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH--HH
Q 007680          498 -----------------------TEVVDAN----LVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK--LK  548 (593)
Q Consensus       498 -----------------------~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~  548 (593)
                                             .+.....    ........+....+++++.+|+.+||+.||++|||+.|+++|  ++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~  338 (389)
T 3gni_B          259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFK  338 (389)
T ss_dssp             -----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGG
T ss_pred             cccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHH
Confidence                                   0000000    000000111233456789999999999999999999999987  55


Q ss_pred             Hhh
Q 007680          549 KIK  551 (593)
Q Consensus       549 ~i~  551 (593)
                      ++.
T Consensus       339 ~~~  341 (389)
T 3gni_B          339 QIK  341 (389)
T ss_dssp             GC-
T ss_pred             HHh
Confidence            544

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.4e-42  Score=363.08  Aligned_cols=259  Identities=19%  Similarity=0.253  Sum_probs=204.1

Q ss_pred             hhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhc-CCCCcceeeeeeecCCceE
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNV-RHRNLIKILSSYSNPDFKA  344 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  344 (593)
                      ..++|++.+.||+|+||.||+|+.+ +++.||+|++++..   ....+.+..|..++.++ +||||+++++++.+.+..+
T Consensus        50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  129 (396)
T 4dc2_A           50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF  129 (396)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred             ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence            3578999999999999999999976 68899999998653   23345678899999887 8999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecC
Q 007680          345 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG  424 (593)
Q Consensus       345 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~  424 (593)
                      +||||+++|+|.+++...+. +++..+..++.||+.||+|||+++    |+||||||+||+++.++.+||+|||+++...
T Consensus       130 lV~E~~~gg~L~~~l~~~~~-l~~~~~~~~~~qi~~aL~~LH~~g----ivHrDLKp~NILl~~~g~ikL~DFGla~~~~  204 (396)
T 4dc2_A          130 FVIEYVNGGDLMFHMQRQRK-LPEEHARFYSAEISLALNYLHERG----IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  204 (396)
T ss_dssp             EEEECCTTCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHHHTT----CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEEEcCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHCC----EEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence            99999999999999987654 999999999999999999999654    9999999999999999999999999998633


Q ss_pred             CCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhh
Q 007680          425 EGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDAN  504 (593)
Q Consensus       425 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  504 (593)
                      ....  ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+...         ....+.+...
T Consensus       205 ~~~~--~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~---------~~~~~~~~~~  273 (396)
T 4dc2_A          205 RPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD---------QNTEDYLFQV  273 (396)
T ss_dssp             CTTC--CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC---------------CCHHHHHHH
T ss_pred             cCCC--ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccc---------hhhHHHHHHH
Confidence            2221  2344679999999999999999999999999999999999999996532111000         0000000000


Q ss_pred             hhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCH------HHHHHH
Q 007680          505 LVREEQAFSAKMDCILSIMDFALDCCMESPDMRINM------TDAAAK  546 (593)
Q Consensus       505 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~~  546 (593)
                      +....  ...+..++.++.+++.+||+.||++||++      .|+++|
T Consensus       274 i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H  319 (396)
T 4dc2_A          274 ILEKQ--IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  319 (396)
T ss_dssp             HHHCC--CCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred             Hhccc--cCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence            10000  01112345678999999999999999985      567665

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=5.7e-43  Score=357.69  Aligned_cols=263  Identities=22%  Similarity=0.412  Sum_probs=197.5

Q ss_pred             HhhhccccccccCccCcccEEEEEeCC-C---CeEEEEEeehh--hHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCc
Q 007680          269 RATDEFNECNLLGTSSFGSVYKGTISD-G---TDVAIKVFNLQ--LERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDF  342 (593)
Q Consensus       269 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  342 (593)
                      ...++|++.+.||+|+||.||+|++.. +   ..||+|+++..  .....+.+.+|++++++++||||+++++++...+.
T Consensus        20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   99 (323)
T 3qup_A           20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA   99 (323)
T ss_dssp             CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred             cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence            346789999999999999999998653 3   27999999765  33456789999999999999999999999987765


Q ss_pred             e------EEEEeccCCCCHHHHHhhCC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCc
Q 007680          343 K------ALVLEFMPNGSLEKWLYSHN-----YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMV  411 (593)
Q Consensus       343 ~------~lv~e~~~~gsL~~~l~~~~-----~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~  411 (593)
                      .      ++||||+++|+|.+++....     ..+++.++..++.|++.||+|||+++    |+||||||+||+++.++.
T Consensus       100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~----ivH~Dikp~NIli~~~~~  175 (323)
T 3qup_A          100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN----FIHRDLAARNCMLAEDMT  175 (323)
T ss_dssp             -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCSGGGEEECTTSC
T ss_pred             ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC----cccCCCCcceEEEcCCCC
Confidence            5      99999999999999986532     14899999999999999999999654    999999999999999999


Q ss_pred             EEEEeeccceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHH
Q 007680          412 AHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVK  490 (593)
Q Consensus       412 ~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~  490 (593)
                      +||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |+.||......  .......
T Consensus       176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--~~~~~~~  253 (323)
T 3qup_A          176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA--EIYNYLI  253 (323)
T ss_dssp             EEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHHH
T ss_pred             EEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH--HHHHHHh
Confidence            99999999987655443333344557889999999999999999999999999999999 99999764322  1111111


Q ss_pred             HhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhhh
Q 007680          491 ESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKF  554 (593)
Q Consensus       491 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  554 (593)
                      ...                 ....+..++.++.+++.+||+.||++|||+.++++.|+++....
T Consensus       254 ~~~-----------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~  300 (323)
T 3qup_A          254 GGN-----------------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL  300 (323)
T ss_dssp             TTC-----------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             cCC-----------------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence            110                 01111234567899999999999999999999999999998664

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=9.9e-43  Score=352.24  Aligned_cols=270  Identities=21%  Similarity=0.358  Sum_probs=210.7

Q ss_pred             hhccccccccCccCcccEEEEEe-----CCCCeEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceeeeeeecC--Cc
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTI-----SDGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSYSNP--DF  342 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~  342 (593)
                      .+.|++.+.||+|+||.||+|++     .+++.||+|+++... ....+.+.+|++++++++||||+++++++...  ..
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   99 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG   99 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence            35689999999999999999983     368999999997553 23456789999999999999999999999876  66


Q ss_pred             eEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeecccee
Q 007680          343 KALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKL  422 (593)
Q Consensus       343 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~  422 (593)
                      .++||||+++++|.+++......+++.++..++.|++.||+|||+++    |+||||||+||+++.++.+||+|||++..
T Consensus       100 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~----i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  175 (302)
T 4e5w_A          100 IKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ----YVHRDLAARNVLVESEHQVKIGDFGLTKA  175 (302)
T ss_dssp             EEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT----EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCC----cccCCCchheEEEcCCCCEEECccccccc
Confidence            89999999999999999776666999999999999999999999655    99999999999999999999999999988


Q ss_pred             cCCCCCc-cccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCc---hh
Q 007680          423 LGEGEDS-VRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHG---LT  498 (593)
Q Consensus       423 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~---~~  498 (593)
                      ....... .......+|..|+|||++.+..++.++||||||+++|||++|..|+.....      .......+..   ..
T Consensus       176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~~~~  249 (302)
T 4e5w_A          176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMA------LFLKMIGPTHGQMTV  249 (302)
T ss_dssp             CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH------HHHHHHCSCCGGGHH
T ss_pred             ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhh------HHhhccCCcccccCH
Confidence            7654332 123345688889999999888999999999999999999999998754211      1111000100   00


Q ss_pred             hhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhh
Q 007680          499 EVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIK  551 (593)
Q Consensus       499 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~  551 (593)
                      ..+...+ ......+.+..+++++.+++.+||+.||++|||+.|+++.|+++.
T Consensus       250 ~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          250 TRLVNTL-KEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             HHHHHHH-HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHH-hccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            0000000 011111122345678999999999999999999999999999874

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=8.1e-43  Score=359.15  Aligned_cols=252  Identities=23%  Similarity=0.311  Sum_probs=206.0

Q ss_pred             HHhhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhc-CCCCcceeeeeeecCCc
Q 007680          268 QRATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNV-RHRNLIKILSSYSNPDF  342 (593)
Q Consensus       268 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  342 (593)
                      ....++|++.+.||+|+||.||+|+.+ +|+.||+|+++...   ....+.+..|..++..+ +||||+++++++.+.+.
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~   92 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN   92 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence            445789999999999999999999976 68999999998753   23456678899999887 99999999999999999


Q ss_pred             eEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeecccee
Q 007680          343 KALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKL  422 (593)
Q Consensus       343 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~  422 (593)
                      .++||||+++|+|.+++..... +++.++..++.|++.||+|||+++    |+||||||+||+++.++.+||+|||+++.
T Consensus        93 ~~lv~E~~~gg~L~~~l~~~~~-~~~~~~~~~~~qi~~aL~~LH~~~----ivHrDlkp~NIll~~~g~vkL~DFG~a~~  167 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQSCHK-FDLSRATFYAAEIILGLQFLHSKG----IVYRDLKLDNILLDKDGHIKIADFGMCKE  167 (345)
T ss_dssp             EEEEEECCTTCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHHHTT----CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEEEeCCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHCC----eEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence            9999999999999999987554 999999999999999999999654    99999999999999999999999999986


Q ss_pred             cCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhh
Q 007680          423 LGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVD  502 (593)
Q Consensus       423 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  502 (593)
                      ......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||......  .....+....+        
T Consensus       168 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~~i~~~~~--------  235 (345)
T 1xjd_A          168 NMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE--ELFHSIRMDNP--------  235 (345)
T ss_dssp             CCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHCCC--------
T ss_pred             cccCCC--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHHhCCC--------
Confidence            433221  234467999999999999999999999999999999999999999763211  11111111100        


Q ss_pred             hhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHH-HHHHH
Q 007680          503 ANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMT-DAAAK  546 (593)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~~  546 (593)
                              .  .+..++.++.+++.+||..||++||++. |+++|
T Consensus       236 --------~--~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~h  270 (345)
T 1xjd_A          236 --------F--YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH  270 (345)
T ss_dssp             --------C--CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred             --------C--CCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence                    0  0112356789999999999999999997 77654

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.8e-42  Score=343.85  Aligned_cols=257  Identities=25%  Similarity=0.345  Sum_probs=213.3

Q ss_pred             hhccccccccCccCcccEEEEEeCCCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEecc
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFM  350 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  350 (593)
                      .++|++.+.||+|+||.||+|.+.+++.||+|+++.... ..+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM   85 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred             hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence            468999999999999999999998889999999986532 2357899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCcc
Q 007680          351 PNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSV  430 (593)
Q Consensus       351 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~  430 (593)
                      ++++|.+++......+++..+..++.|++.||+|||+++    ++||||||+||+++.++.+||+|||.+....... ..
T Consensus        86 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~----i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-~~  160 (267)
T 3t9t_A           86 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC----VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YT  160 (267)
T ss_dssp             TTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT----CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-HH
T ss_pred             CCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCC----cccCCCchheEEECCCCCEEEccccccccccccc-cc
Confidence            999999999887667999999999999999999999655    9999999999999999999999999988654321 11


Q ss_pred             ccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhh
Q 007680          431 RQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREE  509 (593)
Q Consensus       431 ~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  509 (593)
                      ......++..|+|||++.+..++.++||||||+++|+|++ |+.||......  .....+......              
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~i~~~~~~--------------  224 (267)
T 3t9t_A          161 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--EVVEDISTGFRL--------------  224 (267)
T ss_dssp             STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHTTCCC--------------
T ss_pred             ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH--HHHHHHhcCCcC--------------
Confidence            1233457788999999988889999999999999999999 89999763211  111111111100              


Q ss_pred             hhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhh
Q 007680          510 QAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKV  552 (593)
Q Consensus       510 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~  552 (593)
                         ..+..++..+.+++.+||+.||++|||+.|++++|+++.+
T Consensus       225 ---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (267)
T 3t9t_A          225 ---YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  264 (267)
T ss_dssp             ---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence               0011234578999999999999999999999999999865

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=5.8e-42  Score=352.01  Aligned_cols=263  Identities=23%  Similarity=0.409  Sum_probs=215.8

Q ss_pred             hhhccccccccCccCcccEEEEEeC--------CCCeEEEEEeehhh-HHHHHHHHHHHHHHhhc-CCCCcceeeeeeec
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTIS--------DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNV-RHRNLIKILSSYSN  339 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  339 (593)
                      ..++|++.+.||+|+||.||+|++.        +++.||+|+++... ....+.+.+|+++++++ +||||+++++++..
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  112 (334)
T 2pvf_A           33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  112 (334)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence            3578999999999999999999863        46789999997653 34567789999999999 89999999999999


Q ss_pred             CCceEEEEeccCCCCHHHHHhhCCC---------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCe
Q 007680          340 PDFKALVLEFMPNGSLEKWLYSHNY---------------FLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNI  404 (593)
Q Consensus       340 ~~~~~lv~e~~~~gsL~~~l~~~~~---------------~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NI  404 (593)
                      .+..++||||+++|+|.+++.....               .+++.++..++.|++.||+|||+++    |+||||||+||
T Consensus       113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~----ivH~Dlkp~NI  188 (334)
T 2pvf_A          113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK----CIHRDLAARNV  188 (334)
T ss_dssp             SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT----EECSCCSGGGE
T ss_pred             CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC----eeCCCCccceE
Confidence            9999999999999999999986542               3889999999999999999999654    99999999999


Q ss_pred             eeCCCCcEEEEeeccceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccc
Q 007680          405 LLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEM  483 (593)
Q Consensus       405 ll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~  483 (593)
                      +++.++.+||+|||++................+++.|+|||++.+..++.++||||||+++|||++ |+.||......  
T Consensus       189 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--  266 (334)
T 2pvf_A          189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE--  266 (334)
T ss_dssp             EECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--
T ss_pred             EEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH--
Confidence            999999999999999987765443333344457889999999988889999999999999999999 99999763211  


Q ss_pred             hHHHHHHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhhhc
Q 007680          484 SLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKFL  555 (593)
Q Consensus       484 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~  555 (593)
                      .....+.....                 ...+..++.++.+++.+||+.||++|||+.|++++|+++.....
T Consensus       267 ~~~~~~~~~~~-----------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~  321 (334)
T 2pvf_A          267 ELFKLLKEGHR-----------------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT  321 (334)
T ss_dssp             HHHHHHHHTCC-----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             HHHHHHhcCCC-----------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence            11111111110                 01112345678999999999999999999999999999977653

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-41  Score=348.88  Aligned_cols=274  Identities=24%  Similarity=0.345  Sum_probs=207.6

Q ss_pred             HHHhhhccccccccCccCcccEEEEEeCCCCeEEEEEeehhhHHHHHHHHHHHHHHhhc--CCCCcceeeeeeecC----
Q 007680          267 IQRATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNV--RHRNLIKILSSYSNP----  340 (593)
Q Consensus       267 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~----  340 (593)
                      .....++|++.+.||+|+||.||+|++. ++.||||++.....   ..+..|.+++...  +||||+++++++...    
T Consensus        32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~  107 (337)
T 3mdy_A           32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEE---ASWFRETEIYQTVLMRHENILGFIAADIKGTGSW  107 (337)
T ss_dssp             HTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred             ccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecccc---chhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence            3445679999999999999999999985 89999999975532   3344555555554  899999999999877    


Q ss_pred             CceEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcC----CCCCeEecCCCCCCeeeCCCCcEEEEe
Q 007680          341 DFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGH----SSVHIIHCDLKPTNILLDENMVAHVSD  416 (593)
Q Consensus       341 ~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~----~~~~ivH~Dlkp~NIll~~~~~~kL~D  416 (593)
                      ...++||||+++|+|.+++....  +++..+..++.|++.||+|||++.    ...+|+||||||+||+++.++.+||+|
T Consensus       108 ~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~D  185 (337)
T 3mdy_A          108 TQLYLITDYHENGSLYDYLKSTT--LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIAD  185 (337)
T ss_dssp             CEEEEEECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred             CceEEEEeccCCCcHHHHhhccC--CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEe
Confidence            68899999999999999997764  899999999999999999999650    012699999999999999999999999


Q ss_pred             eccceecCCCCCcc--ccccccCCccccCccccCCCCCCcc------chHHHHHHHHHHHHhC----------CCCCCcc
Q 007680          417 FGIYKLLGEGEDSV--RQTMTMATIGYMAPEYGLEGIVSAK------CDVYSYGVLLMETFTR----------KRPTDEM  478 (593)
Q Consensus       417 fg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~------~DvwSlGvvl~elltg----------~~pf~~~  478 (593)
                      ||++..+.......  ......||+.|+|||++.+..++.+      +|||||||++|||+||          +.||...
T Consensus       186 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~  265 (337)
T 3mdy_A          186 LGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL  265 (337)
T ss_dssp             CTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred             CCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhh
Confidence            99998765433221  1224579999999999887776665      9999999999999999          6666554


Q ss_pred             ccccchHHHHHHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhhh
Q 007680          479 FIGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKF  554 (593)
Q Consensus       479 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  554 (593)
                      ..................        ............+++.++.+++.+||+.||++|||+.|++++|+++....
T Consensus       266 ~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~  333 (337)
T 3mdy_A          266 VPSDPSYEDMREIVCIKK--------LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ  333 (337)
T ss_dssp             SCSSCCHHHHHHHHTTSC--------CCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             cCCCCchhhhHHHHhhhc--------cCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence            333222222211111000        00011111122356788999999999999999999999999999987654

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=6.5e-43  Score=367.54  Aligned_cols=260  Identities=18%  Similarity=0.264  Sum_probs=210.3

Q ss_pred             HHHHHHhhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhH---HHHHHHHHHHHHHhhcCCCCcceeeeeeec
Q 007680          264 YLDIQRATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLE---RAFRSFDSECEVLRNVRHRNLIKILSSYSN  339 (593)
Q Consensus       264 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  339 (593)
                      ..++....++|++.+.||+|+||.||+|+.+ +++.||+|+++....   ...+.+.+|+.+++.++||||+++++++.+
T Consensus        61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~  140 (410)
T 3v8s_A           61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  140 (410)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence            3445556789999999999999999999976 689999999986432   223457899999999999999999999999


Q ss_pred             CCceEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeecc
Q 007680          340 PDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGI  419 (593)
Q Consensus       340 ~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~  419 (593)
                      .+..++||||+++|+|.+++....  +++..+..++.|++.||+|||+++    |+||||||+||+++.++.+||+|||+
T Consensus       141 ~~~~~lV~E~~~gg~L~~~l~~~~--~~e~~~~~~~~qi~~aL~~LH~~g----ivHrDLKp~NILl~~~g~ikL~DFG~  214 (410)
T 3v8s_A          141 DRYLYMVMEYMPGGDLVNLMSNYD--VPEKWARFYTAEVVLALDAIHSMG----FIHRDVKPDNMLLDKSGHLKLADFGT  214 (410)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHHTT----EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             CCEEEEEEeCCCCCcHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCC----eEeccCCHHHeeECCCCCEEEeccce
Confidence            999999999999999999998754  899999999999999999999654    99999999999999999999999999


Q ss_pred             ceecCCCCCccccccccCCccccCccccCCCC----CCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCC
Q 007680          420 YKLLGEGEDSVRQTMTMATIGYMAPEYGLEGI----VSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPH  495 (593)
Q Consensus       420 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~  495 (593)
                      ++....... .......||+.|+|||++.+..    ++.++|||||||++|||++|+.||......+ .+.....     
T Consensus       215 a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-~~~~i~~-----  287 (410)
T 3v8s_A          215 CMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-TYSKIMN-----  287 (410)
T ss_dssp             CEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHT-----
T ss_pred             eEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhh-HHHHHHh-----
Confidence            987654332 2234567999999999987655    8899999999999999999999997632111 1111110     


Q ss_pred             chhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCC--CCCHHHHHHH
Q 007680          496 GLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDM--RINMTDAAAK  546 (593)
Q Consensus       496 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~  546 (593)
                             ..   .....+....++.++.+++.+||..+|.+  ||+++|+++|
T Consensus       288 -------~~---~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H  330 (410)
T 3v8s_A          288 -------HK---NSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  330 (410)
T ss_dssp             -------HH---HHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred             -------cc---ccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence                   00   00011111234568899999999999988  9999999987

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=9.6e-43  Score=356.46  Aligned_cols=259  Identities=22%  Similarity=0.383  Sum_probs=207.1

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCe----EEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTD----VAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKA  344 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  344 (593)
                      .++|++.+.||+|+||.||+|++. +++.    ||+|.+.... ......+.+|+.++++++||||+++++++. .+..+
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~   90 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ   90 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence            457999999999999999999965 4554    7777775432 223356778999999999999999999886 45689


Q ss_pred             EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecC
Q 007680          345 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG  424 (593)
Q Consensus       345 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~  424 (593)
                      +||||+++|+|.+++......+++..+..++.|++.||+|||+++    |+||||||+||+++.++.+||+|||+++...
T Consensus        91 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~----ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  166 (325)
T 3kex_A           91 LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG----MVHRNLAARNVLLKSPSQVQVADFGVADLLP  166 (325)
T ss_dssp             EEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTT----CCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred             EEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCC----CCCCccchheEEECCCCeEEECCCCcccccC
Confidence            999999999999999887666999999999999999999999655    9999999999999999999999999999876


Q ss_pred             CCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhhhh
Q 007680          425 EGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDA  503 (593)
Q Consensus       425 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  503 (593)
                      ............++..|+|||++.+..++.++|||||||++|||+| |+.||......  .....+....          
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~~----------  234 (325)
T 3kex_A          167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA--EVPDLLEKGE----------  234 (325)
T ss_dssp             CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT--HHHHHHHTTC----------
T ss_pred             cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH--HHHHHHHcCC----------
Confidence            5544434455568889999999998999999999999999999999 99999764222  1111111110          


Q ss_pred             hhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhh
Q 007680          504 NLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVK  553 (593)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  553 (593)
                             ....+..++.++.+++.+||+.||++|||+.|++++|+.+...
T Consensus       235 -------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~  277 (325)
T 3kex_A          235 -------RLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD  277 (325)
T ss_dssp             -------BCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred             -------CCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence                   0011112345678999999999999999999999999998654

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.4e-42  Score=365.20  Aligned_cols=261  Identities=22%  Similarity=0.309  Sum_probs=210.2

Q ss_pred             HHHHHHhhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhcCCCCcceeeeeeec
Q 007680          264 YLDIQRATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSYSN  339 (593)
Q Consensus       264 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  339 (593)
                      +.+.....++|++.+.||+|+||.||+|+.+ +|+.||+|++++..   ....+.+.+|..++..++||||+++++++.+
T Consensus        53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  132 (412)
T 2vd5_A           53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD  132 (412)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence            4445556789999999999999999999975 79999999998643   2234458899999999999999999999999


Q ss_pred             CCceEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeecc
Q 007680          340 PDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGI  419 (593)
Q Consensus       340 ~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~  419 (593)
                      .+..|+||||+++|+|.+++.+.+..+++..+..++.||+.||+|||+++    |+||||||+||+++.++.+||+|||+
T Consensus       133 ~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g----iiHrDLKp~NILld~~g~vkL~DFGl  208 (412)
T 2vd5_A          133 ENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG----YVHRDIKPDNILLDRCGHIRLADFGS  208 (412)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTT----EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             CCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC----eeecccCHHHeeecCCCCEEEeechh
Confidence            99999999999999999999876556999999999999999999999654    99999999999999999999999999


Q ss_pred             ceecCCCCCccccccccCCccccCccccC-------CCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHh
Q 007680          420 YKLLGEGEDSVRQTMTMATIGYMAPEYGL-------EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKES  492 (593)
Q Consensus       420 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~  492 (593)
                      ++....... .......||+.|+|||++.       +..++.++|||||||++|||++|+.||......+ .+...... 
T Consensus       209 a~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-~~~~i~~~-  285 (412)
T 2vd5_A          209 CLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE-TYGKIVHY-  285 (412)
T ss_dssp             CEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHTH-
T ss_pred             heeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHH-HHHHHHhc-
Confidence            987654332 1233457999999999886       4578999999999999999999999997632111 11111100 


Q ss_pred             cCCchhhhhhhhhhhhhhhhh-hhHHHHHHHHHHHhhcccCCCCCC---CCHHHHHHH
Q 007680          493 LPHGLTEVVDANLVREEQAFS-AKMDCILSIMDFALDCCMESPDMR---INMTDAAAK  546 (593)
Q Consensus       493 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~R---Ps~~evl~~  546 (593)
                                 .   .....+ ....++.++.+++.+||. +|++|   |+++|+++|
T Consensus       286 -----------~---~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H  328 (412)
T 2vd5_A          286 -----------K---EHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH  328 (412)
T ss_dssp             -----------H---HHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred             -----------c---cCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence                       0   000000 012346688999999999 99998   589999876

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=5.3e-43  Score=359.45  Aligned_cols=266  Identities=21%  Similarity=0.341  Sum_probs=215.9

Q ss_pred             HHHhhhccccccccCccCcccEEEEEeC-CC-----CeEEEEEeehhh-HHHHHHHHHHHHHHhhc-CCCCcceeeeeee
Q 007680          267 IQRATDEFNECNLLGTSSFGSVYKGTIS-DG-----TDVAIKVFNLQL-ERAFRSFDSECEVLRNV-RHRNLIKILSSYS  338 (593)
Q Consensus       267 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  338 (593)
                      +....++|++.+.||+|+||.||+|... ++     ..||+|.++... ....+.+.+|+.+++++ +||||+++++++.
T Consensus        41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  120 (333)
T 2i1m_A           41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT  120 (333)
T ss_dssp             GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence            4445678999999999999999999964 23     479999997653 34456789999999999 8999999999999


Q ss_pred             cCCceEEEEeccCCCCHHHHHhhC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCee
Q 007680          339 NPDFKALVLEFMPNGSLEKWLYSH-------------NYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNIL  405 (593)
Q Consensus       339 ~~~~~~lv~e~~~~gsL~~~l~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIl  405 (593)
                      +.+..++||||+++|+|.+++...             ...+++..+..++.|++.||+|||+++    |+||||||+||+
T Consensus       121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~----ivH~Dlkp~NIl  196 (333)
T 2i1m_A          121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN----CIHRDVAARNVL  196 (333)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT----EECSCCSGGGCE
T ss_pred             cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC----cccCCcccceEE
Confidence            999999999999999999998753             224799999999999999999999654    999999999999


Q ss_pred             eCCCCcEEEEeeccceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccch
Q 007680          406 LDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMS  484 (593)
Q Consensus       406 l~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~  484 (593)
                      ++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|||+| |..||....... .
T Consensus       197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-~  275 (333)
T 2i1m_A          197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS-K  275 (333)
T ss_dssp             EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH-H
T ss_pred             ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH-H
Confidence            99999999999999987654443333344557889999999988899999999999999999999 999997643221 1


Q ss_pred             HHHHHHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhhh
Q 007680          485 LRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKF  554 (593)
Q Consensus       485 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  554 (593)
                      ...........                 ..+..++..+.+++.+||+.||++|||+.|++++|+++....
T Consensus       276 ~~~~~~~~~~~-----------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~  328 (333)
T 2i1m_A          276 FYKLVKDGYQM-----------------AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQED  328 (333)
T ss_dssp             HHHHHHHTCCC-----------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHhcCCCC-----------------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhh
Confidence            12222211110                 011123557899999999999999999999999999987654

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=2.5e-42  Score=356.45  Aligned_cols=246  Identities=22%  Similarity=0.250  Sum_probs=206.7

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALV  346 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  346 (593)
                      .++|++.+.||+|+||.||+|+.. +|+.||+|+++...   ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  119 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence            468999999999999999999976 79999999998653   23456788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCC
Q 007680          347 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG  426 (593)
Q Consensus       347 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  426 (593)
                      |||+++|+|.+++...+. +++..+..++.|++.||+|||+++    |+||||||+||+++.++.+||+|||+++.....
T Consensus       120 ~e~~~gg~L~~~l~~~~~-~~~~~~~~~~~qi~~aL~~LH~~~----ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~  194 (350)
T 1rdq_E          120 MEYVAGGEMFSHLRRIGR-FSEPHARFYAAQIVLTFEYLHSLD----LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             EECCTTCBHHHHHHHHCC-CCHHHHHHHHHHHHHHHHHHHHTT----EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             EcCCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHCC----cccccCccceEEECCCCCEEEcccccceeccCC
Confidence            999999999999987654 999999999999999999999655    999999999999999999999999999876432


Q ss_pred             CCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhh
Q 007680          427 EDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLV  506 (593)
Q Consensus       427 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  506 (593)
                           .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....  ......+....           . 
T Consensus       195 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~~~~~~i~~~~-----------~-  255 (350)
T 1rdq_E          195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP--IQIYEKIVSGK-----------V-  255 (350)
T ss_dssp             -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHCC-----------C-
T ss_pred             -----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH--HHHHHHHHcCC-----------C-
Confidence                 2335689999999999999999999999999999999999999976321  11111111100           0 


Q ss_pred             hhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCC-----HHHHHHH
Q 007680          507 REEQAFSAKMDCILSIMDFALDCCMESPDMRIN-----MTDAAAK  546 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~  546 (593)
                            ..+..++.++.+++.+||+.||++||+     ++|+++|
T Consensus       256 ------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h  294 (350)
T 1rdq_E          256 ------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             ------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             ------CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence                  011224567899999999999999998     8888875

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=4e-42  Score=344.29  Aligned_cols=259  Identities=20%  Similarity=0.340  Sum_probs=201.2

Q ss_pred             hhhccccccccCccCcccEEEEEeCC----CCeEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceE
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTISD----GTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKA  344 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  344 (593)
                      ..++|++.+.||+|+||.||+|.+..    +..||+|+++... ....+.+.+|+.++++++||||+++++++. .+..+
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~   91 (281)
T 1mp8_A           13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW   91 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred             ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence            45789999999999999999998642    4569999987542 345567899999999999999999999984 46789


Q ss_pred             EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecC
Q 007680          345 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG  424 (593)
Q Consensus       345 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~  424 (593)
                      +||||+++++|.+++......+++..+..++.|++.||+|||+++    |+||||||+||+++.++.+||+|||+++...
T Consensus        92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~----i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  167 (281)
T 1mp8_A           92 IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR----FVHRDIAARNVLVSSNDCVKLGDFGLSRYME  167 (281)
T ss_dssp             EEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC----eecccccHHHEEECCCCCEEECccccccccC
Confidence            999999999999999887667999999999999999999999654    9999999999999999999999999998765


Q ss_pred             CCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhhhh
Q 007680          425 EGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDA  503 (593)
Q Consensus       425 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  503 (593)
                      .... .......+++.|+|||++.+..++.++||||||+++|||++ |..||......  .....+.....         
T Consensus       168 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~--~~~~~i~~~~~---------  235 (281)
T 1mp8_A          168 DSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIGRIENGER---------  235 (281)
T ss_dssp             ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHHHTTCC---------
T ss_pred             cccc-cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH--HHHHHHHcCCC---------
Confidence            4322 12233456788999999988899999999999999999997 99999764322  11111111100         


Q ss_pred             hhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhh
Q 007680          504 NLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVK  553 (593)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  553 (593)
                              .+.+..+++.+.+++.+||+.||++|||+.|++++|+++...
T Consensus       236 --------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  277 (281)
T 1mp8_A          236 --------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  277 (281)
T ss_dssp             --------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence                    011123466889999999999999999999999999998654

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.3e-42  Score=355.81  Aligned_cols=276  Identities=25%  Similarity=0.317  Sum_probs=215.2

Q ss_pred             hhccccccccCccCcccEEEEEe-----CCCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeee--cCCce
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTI-----SDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYS--NPDFK  343 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~  343 (593)
                      .++|++.+.||+|+||.||+|++     .+++.||+|++........+.+.+|++++++++||||+++++++.  +.+..
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  101 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL  101 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence            46899999999999999999984     368899999998776666778999999999999999999999886  45568


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceec
Q 007680          344 ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLL  423 (593)
Q Consensus       344 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~  423 (593)
                      ++||||+++++|.+++......+++..+..++.|++.||+|||+++    |+||||||+||+++.++.+||+|||++...
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~----ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  177 (327)
T 3lxl_A          102 RLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR----CVHRDLAARNILVESEAHVKIADFGLAKLL  177 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT----EECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred             EEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC----ccCCCCChhhEEECCCCCEEEcccccceec
Confidence            9999999999999999876556999999999999999999999654    999999999999999999999999999987


Q ss_pred             CCCCCcc-ccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhh
Q 007680          424 GEGEDSV-RQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVD  502 (593)
Q Consensus       424 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  502 (593)
                      ....... ......+|..|+|||++.+..++.++||||||+++|+|++|..||.........  .+.............+
T Consensus       178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~  255 (327)
T 3lxl_A          178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLR--MMGCERDVPALSRLLE  255 (327)
T ss_dssp             CTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH--HCC----CCHHHHHHH
T ss_pred             ccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhh--hcccccccccHHHHHH
Confidence            5443321 223446888899999998888999999999999999999999998663211100  0000000000111111


Q ss_pred             hhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhhh
Q 007680          503 ANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKF  554 (593)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  554 (593)
                      ..  ........+..+++.+.+++.+||+.||++|||+.|++++|+.+....
T Consensus       256 ~~--~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  305 (327)
T 3lxl_A          256 LL--EEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS  305 (327)
T ss_dssp             HH--HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred             Hh--hcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence            00  011111222345678999999999999999999999999999987655

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.7e-42  Score=357.26  Aligned_cols=252  Identities=23%  Similarity=0.330  Sum_probs=198.0

Q ss_pred             hhccccccccCccCcccEEEEEeCCCCeEEEEEeehh--hHHHHHHHHHHHHHHhhcCC--CCcceeeeeeecCCceEEE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQ--LERAFRSFDSECEVLRNVRH--RNLIKILSSYSNPDFKALV  346 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv  346 (593)
                      .++|++.+.||+|+||.||++...+++.||||++...  .....+.+.+|+.++.+++|  |||+++++++...+..++|
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv   87 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV   87 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence            4679999999999999999999888999999999754  23455788999999999976  9999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCC
Q 007680          347 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG  426 (593)
Q Consensus       347 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  426 (593)
                      ||+ .+++|.+++..... +++.++..++.|++.||+|||+++    |+||||||+||+++ ++.+||+|||+++.....
T Consensus        88 ~e~-~~~~L~~~l~~~~~-~~~~~~~~i~~qi~~al~~lH~~~----iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~  160 (343)
T 3dbq_A           88 MEC-GNIDLNSWLKKKKS-IDPWERKSYWKNMLEAVHTIHQHG----IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD  160 (343)
T ss_dssp             ECC-CSEEHHHHHHHSCC-CCHHHHHHHHHHHHHHHHHHHHTT----CCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred             EeC-CCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCC----eecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence            995 58899999988654 899999999999999999999655    99999999999997 578999999999877554


Q ss_pred             CCccccccccCCccccCccccCC-----------CCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCC
Q 007680          427 EDSVRQTMTMATIGYMAPEYGLE-----------GIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPH  495 (593)
Q Consensus       427 ~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~  495 (593)
                      ..........||+.|+|||++.+           ..++.++|||||||++|||++|+.||..............      
T Consensus       161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~------  234 (343)
T 3dbq_A          161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII------  234 (343)
T ss_dssp             ---------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH------
T ss_pred             cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHh------
Confidence            43333345679999999998754           6789999999999999999999999976322211111111      


Q ss_pred             chhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          496 GLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       496 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                            +....     ...+...+.++.+++.+||+.||++|||+.|+++|
T Consensus       235 ------~~~~~-----~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          235 ------DPNHE-----IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             ------CTTSC-----CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ------cCCcc-----cCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence                  10000     00011123468999999999999999999999987

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.2e-42  Score=353.97  Aligned_cols=270  Identities=26%  Similarity=0.398  Sum_probs=218.6

Q ss_pred             CHHHHHHhhhccccccccCccCcccEEEEEe------CCCCeEEEEEeehhh-HHHHHHHHHHHHHHhhc-CCCCcceee
Q 007680          263 SYLDIQRATDEFNECNLLGTSSFGSVYKGTI------SDGTDVAIKVFNLQL-ERAFRSFDSECEVLRNV-RHRNLIKIL  334 (593)
Q Consensus       263 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~  334 (593)
                      ...+.....++|++.+.||+|+||.||+|++      .+++.||+|+++... ....+.+.+|+.++.++ +||||++++
T Consensus        18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~   97 (316)
T 2xir_A           18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL   97 (316)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence            3445555678999999999999999999984      256889999997653 33456789999999999 799999999


Q ss_pred             eeeecCC-ceEEEEeccCCCCHHHHHhhCCC---------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecC
Q 007680          335 SSYSNPD-FKALVLEFMPNGSLEKWLYSHNY---------------FLDILERLNIMIDVGSALEYLHNGHSSVHIIHCD  398 (593)
Q Consensus       335 ~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~---------------~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~D  398 (593)
                      +++...+ ..++||||+++++|.+++.....               .+++..+..++.|++.||+|||+++    |+|||
T Consensus        98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~----i~H~d  173 (316)
T 2xir_A           98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK----CIHRD  173 (316)
T ss_dssp             EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT----CCCSC
T ss_pred             EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC----ccccc
Confidence            9987755 58999999999999999987653               2789999999999999999999654    99999


Q ss_pred             CCCCCeeeCCCCcEEEEeeccceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCc
Q 007680          399 LKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDE  477 (593)
Q Consensus       399 lkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~  477 (593)
                      |||+||+++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||+| |+.||..
T Consensus       174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~  253 (316)
T 2xir_A          174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  253 (316)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence            999999999999999999999987755444333444567889999999988999999999999999999998 9999976


Q ss_pred             cccccchHHHHHHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhhh
Q 007680          478 MFIGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKF  554 (593)
Q Consensus       478 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  554 (593)
                      ...... ..........                 ...+..+++++.+++.+||+.||++|||+.|++++|+.+....
T Consensus       254 ~~~~~~-~~~~~~~~~~-----------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  312 (316)
T 2xir_A          254 VKIDEE-FCRRLKEGTR-----------------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  312 (316)
T ss_dssp             CCCSHH-HHHHHHHTCC-----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             cchhHH-HHHHhccCcc-----------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence            432221 1111111110                 0011123567899999999999999999999999999987654

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=4.1e-42  Score=349.56  Aligned_cols=246  Identities=20%  Similarity=0.226  Sum_probs=196.2

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh--HHHHHHHHHHHHHHhhc-CCCCcceeeeeeecCCceEEE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL--ERAFRSFDSECEVLRNV-RHRNLIKILSSYSNPDFKALV  346 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  346 (593)
                      .++|++.++||+|+||+||+|++. +|+.||||++....  .........|+..+.++ +||||+++++++.+++..++|
T Consensus        56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv  135 (311)
T 3p1a_A           56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ  135 (311)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence            468999999999999999999976 79999999986532  23334455566666555 899999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCC
Q 007680          347 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG  426 (593)
Q Consensus       347 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  426 (593)
                      |||+ +++|.+++...+..+++..+..++.|++.||+|||+++    |+||||||+||+++.++.+||+|||++......
T Consensus       136 ~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~----ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~  210 (311)
T 3p1a_A          136 TELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG----LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA  210 (311)
T ss_dssp             EECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT----EECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred             Eecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC----EecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence            9999 77999999887767999999999999999999999654    999999999999999999999999999876543


Q ss_pred             CCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhh
Q 007680          427 EDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLV  506 (593)
Q Consensus       427 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  506 (593)
                      .   ......||+.|+|||++.+ .++.++|||||||++|||++|..|+....    .... +           ..... 
T Consensus       211 ~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~----~~~~-~-----------~~~~~-  269 (311)
T 3p1a_A          211 G---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE----GWQQ-L-----------RQGYL-  269 (311)
T ss_dssp             -------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH----HHHH-H-----------TTTCC-
T ss_pred             C---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc----HHHH-H-----------hccCC-
Confidence            2   2234568999999998875 79999999999999999999977664411    0000 0           00000 


Q ss_pred             hhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          507 REEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                          .......+++++.+++.+||+.||++|||+.|++++
T Consensus       270 ----~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  305 (311)
T 3p1a_A          270 ----PPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL  305 (311)
T ss_dssp             ----CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             ----CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence                001122346688999999999999999999999874

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=3.1e-42  Score=355.24  Aligned_cols=258  Identities=20%  Similarity=0.250  Sum_probs=204.9

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhc-CCCCcceeeeeeecCCceEE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNV-RHRNLIKILSSYSNPDFKAL  345 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  345 (593)
                      .++|++.+.||+|+||.||+|+.+ +++.||+|+++...   ....+.+.+|..++.++ +||||+++++++.+.+..++
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   87 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF   87 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence            468999999999999999999976 68999999998652   34456788999999988 89999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCC
Q 007680          346 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGE  425 (593)
Q Consensus       346 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~  425 (593)
                      ||||+++|+|.+++...+. +++..+..++.|++.||+|||+++    |+||||||+||+++.++.+||+|||+++....
T Consensus        88 v~e~~~gg~L~~~l~~~~~-l~~~~~~~~~~qi~~aL~~LH~~~----ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~  162 (345)
T 3a8x_A           88 VIEYVNGGDLMFHMQRQRK-LPEEHARFYSAEISLALNYLHERG----IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  162 (345)
T ss_dssp             EECCCCSCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHHHTT----CBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred             EEeCCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHCC----ceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence            9999999999999987654 999999999999999999999654    99999999999999999999999999986432


Q ss_pred             CCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhh
Q 007680          426 GEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANL  505 (593)
Q Consensus       426 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  505 (593)
                      ...  ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........         .....+...+
T Consensus       163 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~---------~~~~~~~~~i  231 (345)
T 3a8x_A          163 PGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ---------NTEDYLFQVI  231 (345)
T ss_dssp             TTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC----------------CHHHHHHHH
T ss_pred             CCC--cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCccccccccc---------ccHHHHHHHH
Confidence            221  23445799999999999999999999999999999999999999965321110000         0000000000


Q ss_pred             hhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCH------HHHHHH
Q 007680          506 VREEQAFSAKMDCILSIMDFALDCCMESPDMRINM------TDAAAK  546 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~~  546 (593)
                      .....  ..+..++.++.+++.+||+.||++||++      .|+++|
T Consensus       232 ~~~~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h  276 (345)
T 3a8x_A          232 LEKQI--RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  276 (345)
T ss_dssp             HHCCC--CCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred             HcCCC--CCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence            00000  0112345678999999999999999996      677665

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=5.1e-42  Score=342.60  Aligned_cols=252  Identities=21%  Similarity=0.259  Sum_probs=207.7

Q ss_pred             hhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEe
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLE  348 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  348 (593)
                      ..++|++.+.||+|+||.||+|... ++..||+|++........+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (277)
T 3f3z_A            7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME   86 (277)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence            3578999999999999999999976 578899999987665566789999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeee---CCCCcEEEEeeccceecCC
Q 007680          349 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILL---DENMVAHVSDFGIYKLLGE  425 (593)
Q Consensus       349 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll---~~~~~~kL~Dfg~a~~~~~  425 (593)
                      |+++++|.+++..... +++.++..++.|++.||+|||+++    |+||||||+||++   +.++.+||+|||.+.....
T Consensus        87 ~~~~~~L~~~~~~~~~-~~~~~~~~i~~~i~~~l~~lH~~~----i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~  161 (277)
T 3f3z_A           87 LCTGGELFERVVHKRV-FRESDAARIMKDVLSAVAYCHKLN----VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP  161 (277)
T ss_dssp             CCCSCBHHHHHHHHCS-CCHHHHHHHHHHHHHHHHHHHHTT----EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred             ccCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHCC----ccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence            9999999999877654 899999999999999999999655    9999999999999   7889999999999987654


Q ss_pred             CCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhh
Q 007680          426 GEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANL  505 (593)
Q Consensus       426 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  505 (593)
                      ..   ......+|+.|+|||++.+. ++.++||||||+++|||++|+.||......  .....+.......         
T Consensus       162 ~~---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~---------  226 (277)
T 3f3z_A          162 GK---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDS--EVMLKIREGTFTF---------  226 (277)
T ss_dssp             TS---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHCCCCC---------
T ss_pred             cc---chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHH--HHHHHHHhCCCCC---------
Confidence            33   22345689999999987654 999999999999999999999999763221  1111111110000         


Q ss_pred             hhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          506 VREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                           .......+++.+.+++.+||+.||++|||+.|+++|
T Consensus       227 -----~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  262 (277)
T 3f3z_A          227 -----PEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH  262 (277)
T ss_dssp             -----CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             -----CchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                 000111345688999999999999999999999875

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=3.3e-42  Score=351.16  Aligned_cols=269  Identities=24%  Similarity=0.345  Sum_probs=192.0

Q ss_pred             hhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEE
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVL  347 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  347 (593)
                      ..++|++.+.||+|+||.||+|... +|+.||+|+++... ....+.+.+|++++++++||||+++++++..++..++||
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   82 (317)
T 2pmi_A            3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF   82 (317)
T ss_dssp             ----------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred             cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence            3568999999999999999999965 68999999997643 223467889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeecccee
Q 007680          348 EFMPNGSLEKWLYSHN-----YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKL  422 (593)
Q Consensus       348 e~~~~gsL~~~l~~~~-----~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~  422 (593)
                      ||++ ++|.+++....     ..+++..+..++.|++.||+|||+++    |+||||||+||+++.++.+||+|||++..
T Consensus        83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~----ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~  157 (317)
T 2pmi_A           83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK----ILHRDLKPQNLLINKRGQLKLGDFGLARA  157 (317)
T ss_dssp             ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT----EECCCCCGGGEEECTTCCEEECCCSSCEE
T ss_pred             EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC----eeeCCCChHHeEEcCCCCEEECcCcccee
Confidence            9997 59999987532     24899999999999999999999654    99999999999999999999999999987


Q ss_pred             cCCCCCccccccccCCccccCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHh--cCCc-hh
Q 007680          423 LGEGEDSVRQTMTMATIGYMAPEYGLE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKES--LPHG-LT  498 (593)
Q Consensus       423 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~--~~~~-~~  498 (593)
                      ......  ......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||......+ .........  .+.. ..
T Consensus       158 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~  234 (317)
T 2pmi_A          158 FGIPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE-QLKLIFDIMGTPNESLWP  234 (317)
T ss_dssp             TTSCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCSCCTTTCG
T ss_pred             cCCCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCChhHhh
Confidence            654322  2234568999999999876 468999999999999999999999997643221 111111110  0111 00


Q ss_pred             hhhh-----hhhh-------hhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          499 EVVD-----ANLV-------REEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       499 ~~~~-----~~~~-------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      ....     ..+.       ...........++.++.+++.+||+.||++|||+.|+++|
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h  294 (317)
T 2pmi_A          235 SVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH  294 (317)
T ss_dssp             GGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence            0000     0000       0000000111345688999999999999999999999876

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.8e-42  Score=354.58  Aligned_cols=276  Identities=25%  Similarity=0.379  Sum_probs=216.0

Q ss_pred             hhccccccccCccCcccEEEEEe-----CCCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCC--ce
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTI-----SDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPD--FK  343 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~  343 (593)
                      .++|++.+.||+|+||.||+|++     .+++.||+|++........+.+.+|++++++++||||+++++++...+  ..
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            46799999999999999999984     368899999998766666778999999999999999999999887654  78


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceec
Q 007680          344 ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLL  423 (593)
Q Consensus       344 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~  423 (593)
                      ++||||+++++|.+++......+++.++..++.|++.||+|||+++    |+||||||+||+++.++.+||+|||++...
T Consensus       120 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~----ivH~dikp~NIli~~~~~~kL~Dfg~~~~~  195 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR----YIHRDLATRNILVENENRVKIGDFGLTKVL  195 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTT----EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC----EeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence            9999999999999999987767999999999999999999999654    999999999999999999999999999887


Q ss_pred             CCCCCccc-cccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCc-hhhhh
Q 007680          424 GEGEDSVR-QTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHG-LTEVV  501 (593)
Q Consensus       424 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~  501 (593)
                      ........ .....++..|+|||++.+..++.++||||||+++|||+||..||......   +.+......... ....+
T Consensus       196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~---~~~~~~~~~~~~~~~~~~  272 (326)
T 2w1i_A          196 PQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE---FMRMIGNDKQGQMIVFHL  272 (326)
T ss_dssp             CSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHH---HHHHHCTTCCTHHHHHHH
T ss_pred             cccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHH---HHHhhccccchhhhHHHH
Confidence            65432211 22345778899999998888999999999999999999999998652111   111100000000 00000


Q ss_pred             hhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhhh
Q 007680          502 DANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKF  554 (593)
Q Consensus       502 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  554 (593)
                      ...+ ......+.+..++.++.+++.+||+.||++|||+.|+++.|++++..+
T Consensus       273 ~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l  324 (326)
T 2w1i_A          273 IELL-KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM  324 (326)
T ss_dssp             HHHH-HTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHh-hcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence            0000 000111122345678999999999999999999999999999998764

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=3.6e-42  Score=357.25  Aligned_cols=274  Identities=21%  Similarity=0.217  Sum_probs=211.1

Q ss_pred             ccCCHHHHHHhhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcC-----CCCccee
Q 007680          260 RRTSYLDIQRATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNVR-----HRNLIKI  333 (593)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l  333 (593)
                      ..+++.+.....++|++.++||+|+||.||+|++. +++.||||+++... ...+.+..|+.+++.++     ||||+++
T Consensus        23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~h~~iv~~  101 (360)
T 3llt_A           23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK-KYTRSAKIEADILKKIQNDDINNNNIVKY  101 (360)
T ss_dssp             GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH-HHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred             eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch-hhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence            34455556666889999999999999999999974 78999999997532 33456778999999996     9999999


Q ss_pred             eeeeecCCceEEEEeccCCCCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC----
Q 007680          334 LSSYSNPDFKALVLEFMPNGSLEKWLYSHNY-FLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDE----  408 (593)
Q Consensus       334 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~----  408 (593)
                      ++++...+..++||||+ +++|.+++..... .+++.++..++.|++.||+|||+++    |+||||||+||+++.    
T Consensus       102 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~----ivHrDlkp~NIll~~~~~~  176 (360)
T 3llt_A          102 HGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS----LTHTDLKPENILLDDPYFE  176 (360)
T ss_dssp             EEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT----EECSCCSGGGEEESCTTCC
T ss_pred             cceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC----eeeCCCCcccEEEcccccc
Confidence            99999999999999999 8999999987653 5899999999999999999999654    999999999999975    


Q ss_pred             ---------------------CCcEEEEeeccceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHH
Q 007680          409 ---------------------NMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLME  467 (593)
Q Consensus       409 ---------------------~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~e  467 (593)
                                           ++.+||+|||++.......     ....||+.|+|||++.+..++.++|||||||++||
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e  251 (360)
T 3llt_A          177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAE  251 (360)
T ss_dssp             EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHH
T ss_pred             ccccchhcccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCCCCCCccchHHHHHHHHH
Confidence                                 7899999999998754322     33568999999999999999999999999999999


Q ss_pred             HHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhh-----------------h---h--------hhhhHHHH
Q 007680          468 TFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREE-----------------Q---A--------FSAKMDCI  519 (593)
Q Consensus       468 lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~---~--------~~~~~~~~  519 (593)
                      |++|+.||......  .....+....................                 .   .        ........
T Consensus       252 ll~g~~pf~~~~~~--~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~  329 (360)
T 3llt_A          252 LYTGSLLFRTHEHM--EHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKH  329 (360)
T ss_dssp             HHHSSCSCCCSSHH--HHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCC
T ss_pred             HHHCCCCCCCCcHH--HHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchH
Confidence            99999999764221  12222222111111111000000000                 0   0        00001112


Q ss_pred             HHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          520 LSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       520 ~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      +.+.+++.+||+.||++|||++|+++|
T Consensus       330 ~~l~~li~~~L~~dP~~Rpta~elL~h  356 (360)
T 3llt_A          330 ELFCDFLYSILQIDPTLRPSPAELLKH  356 (360)
T ss_dssp             HHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             HHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence            578899999999999999999999865

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.9e-42  Score=344.13  Aligned_cols=254  Identities=24%  Similarity=0.342  Sum_probs=206.9

Q ss_pred             hhccccccccCccCcccEEEEEeCCCCeEEEEEeehhh--HHHHHHHHHHHHHHhhcCCCCcceeeeeeecC--CceEEE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSYSNP--DFKALV  346 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv  346 (593)
                      .++|++.+.||+|+||.||+|++. ++.||+|+++...  ....+.+.+|+.++++++||||+++++++.+.  +..++|
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI   87 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred             HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence            468999999999999999999985 8899999997643  34556799999999999999999999999887  788999


Q ss_pred             EeccCCCCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCC
Q 007680          347 LEFMPNGSLEKWLYSHNY-FLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGE  425 (593)
Q Consensus       347 ~e~~~~gsL~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~  425 (593)
                      |||+++|+|.+++..... .+++.++..++.|++.||+|||+++  ..++||||||+||+++.++.++++|||++.....
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~  165 (271)
T 3kmu_A           88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLE--PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS  165 (271)
T ss_dssp             EECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSS--SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred             ecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCC--CceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence            999999999999987654 5899999999999999999999432  2299999999999999999999999998654322


Q ss_pred             CCCccccccccCCccccCccccCCCCCCc---cchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhh
Q 007680          426 GEDSVRQTMTMATIGYMAPEYGLEGIVSA---KCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVD  502 (593)
Q Consensus       426 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~---~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  502 (593)
                             ....+|+.|+|||++.+..++.   ++||||||+++|||++|+.||........ ..........        
T Consensus       166 -------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~~~~~~--------  229 (271)
T 3kmu_A          166 -------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI-GMKVALEGLR--------  229 (271)
T ss_dssp             -------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH-HHHHHHSCCC--------
T ss_pred             -------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH-HHHHHhcCCC--------
Confidence                   2346899999999988765544   79999999999999999999976432211 1111111100        


Q ss_pred             hhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhh
Q 007680          503 ANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKV  552 (593)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~  552 (593)
                               ...+..+++++.+++.+||+.||++|||++|+++.|+++..
T Consensus       230 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          230 ---------PTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             ---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             ---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence                     01112345678999999999999999999999999999854

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=5.9e-42  Score=349.48  Aligned_cols=273  Identities=24%  Similarity=0.379  Sum_probs=213.2

Q ss_pred             cccccccCccCcccEEEEEeC-----CCCeEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceeeeeeecC--CceEE
Q 007680          274 FNECNLLGTSSFGSVYKGTIS-----DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSYSNP--DFKAL  345 (593)
Q Consensus       274 ~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  345 (593)
                      |++.+.||+|+||.||++.+.     +++.||+|+++... ....+.+.+|++++++++||||+++++++.+.  ...++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            499999999999999998643     68899999998653 34567789999999999999999999999874  57899


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCC
Q 007680          346 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGE  425 (593)
Q Consensus       346 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~  425 (593)
                      ||||+++++|.+++....  +++.++..++.|++.||+|||+++    |+||||||+||+++.++.+||+|||++.....
T Consensus       113 v~e~~~~~~L~~~l~~~~--~~~~~~~~i~~~l~~~l~~LH~~~----ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~  186 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLHAQH----YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE  186 (318)
T ss_dssp             EECCCTTCBHHHHGGGSC--CCHHHHHHHHHHHHHHHHHHHHTT----EECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred             EEecccCCcHHHHHhhCC--CCHHHHHHHHHHHHHHHHHHHhCC----ccCCCCchheEEEcCCCCEEECCccccccccc
Confidence            999999999999998765  899999999999999999999655    99999999999999999999999999998765


Q ss_pred             CCCcc-ccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhh-hh
Q 007680          426 GEDSV-RQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVV-DA  503 (593)
Q Consensus       426 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  503 (593)
                      ..... ......++..|+|||++.+..++.++||||||+++|||++|..||...........     .......... ..
T Consensus       187 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~-----~~~~~~~~~~~~~  261 (318)
T 3lxp_A          187 GHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELI-----GIAQGQMTVLRLT  261 (318)
T ss_dssp             TCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHH-----CSCCHHHHHHHHH
T ss_pred             cccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhh-----cccccchhHHHHH
Confidence            43321 12344578889999999988999999999999999999999999876321110000     0000000000 00


Q ss_pred             hhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhhhcch
Q 007680          504 NLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKFLDD  557 (593)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~  557 (593)
                      .........+.+..++.++.+++.+||+.||++|||+.|+++.|+++...+...
T Consensus       262 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~  315 (318)
T 3lxp_A          262 ELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQ  315 (318)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC-
T ss_pred             HHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccC
Confidence            000011111222345678999999999999999999999999999998887543

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=2.9e-42  Score=368.55  Aligned_cols=253  Identities=28%  Similarity=0.427  Sum_probs=209.7

Q ss_pred             hhhccccccccCccCcccEEEEEeCCCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCC-ceEEEEe
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPD-FKALVLE  348 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e  348 (593)
                      ..++|++.+.||+|+||.||+|.+. |+.||||+++...  ..+.+.+|++++++++||||+++++++...+ ..++|||
T Consensus       191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e  267 (450)
T 1k9a_A          191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE  267 (450)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred             ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence            4578999999999999999999985 7899999997653  4567899999999999999999999987665 7899999


Q ss_pred             ccCCCCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCC
Q 007680          349 FMPNGSLEKWLYSHNY-FLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGE  427 (593)
Q Consensus       349 ~~~~gsL~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~  427 (593)
                      |+++|+|.+++...+. .+++..+..++.|++.||+|||+++    |+||||||+||+++.++.+||+|||+++......
T Consensus       268 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~----ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  343 (450)
T 1k9a_A          268 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN----FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ  343 (450)
T ss_dssp             CCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT----EECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC----eeCCCCCHhhEEECCCCCEEEeeCCCcccccccc
Confidence            9999999999987654 4799999999999999999999655    9999999999999999999999999998643221


Q ss_pred             CccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhhhhhhh
Q 007680          428 DSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLV  506 (593)
Q Consensus       428 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  506 (593)
                           ....++..|+|||++.+..++.++|||||||++|||+| |+.||......+  ....+...              
T Consensus       344 -----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--~~~~i~~~--------------  402 (450)
T 1k9a_A          344 -----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPRVEKG--------------  402 (450)
T ss_dssp             --------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT--HHHHHHTT--------------
T ss_pred             -----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcC--------------
Confidence                 22356889999999999999999999999999999998 999997643221  11111111              


Q ss_pred             hhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhh
Q 007680          507 REEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVK  553 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  553 (593)
                         .....+..+++++.+++.+||+.||++|||+.++++.|+.+...
T Consensus       403 ---~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~  446 (450)
T 1k9a_A          403 ---YKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH  446 (450)
T ss_dssp             ---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             ---CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence               01112234567899999999999999999999999999998653

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.2e-42  Score=352.20  Aligned_cols=270  Identities=24%  Similarity=0.424  Sum_probs=211.0

Q ss_pred             hhccccccccCccCcccEEEEEeCC-----CCeEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTISD-----GTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKA  344 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  344 (593)
                      .++|++.+.||+|+||.||+|....     +..||+|+++... ......+.+|+.++++++||||+++++++...+..+
T Consensus        43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  122 (333)
T 1mqb_A           43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM  122 (333)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence            3578889999999999999998642     2359999997643 344567899999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecC
Q 007680          345 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG  424 (593)
Q Consensus       345 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~  424 (593)
                      +||||+++++|.+++......+++.++..++.|++.||+|||+++    |+||||||+||+++.++.+||+|||++....
T Consensus       123 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~----ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~  198 (333)
T 1mqb_A          123 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN----YVHRDLAARNILVNSNLVCKVSDFGLSRVLE  198 (333)
T ss_dssp             EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             EEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC----eeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence            999999999999999887667999999999999999999999654    9999999999999999999999999998765


Q ss_pred             CCCCcc-ccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhhh
Q 007680          425 EGEDSV-RQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVD  502 (593)
Q Consensus       425 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  502 (593)
                      ...... ......+++.|+|||++.+..++.++||||||+++|||++ |+.||......  .....+....         
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~--~~~~~~~~~~---------  267 (333)
T 1mqb_A          199 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH--EVMKAINDGF---------  267 (333)
T ss_dssp             ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHTTC---------
T ss_pred             cccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH--HHHHHHHCCC---------
Confidence            432211 1223346788999999998999999999999999999999 99999763221  1111111110         


Q ss_pred             hhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhhhcchhhccCC
Q 007680          503 ANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKFLDDAAATNW  563 (593)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~~~~~  563 (593)
                              ..+.+..++..+.+++.+||+.||++||++.|++++|+++.......+....|
T Consensus       268 --------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~~~~~~~~  320 (333)
T 1mqb_A          268 --------RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLADF  320 (333)
T ss_dssp             --------CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGGGGSBCCC
T ss_pred             --------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchhhhhhcCC
Confidence                    01112234567899999999999999999999999999988766544444433

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=6.3e-42  Score=341.57  Aligned_cols=255  Identities=20%  Similarity=0.296  Sum_probs=209.6

Q ss_pred             hhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEE
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVL  347 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  347 (593)
                      ..++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   84 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence            3578999999999999999999976 78999999997653 334567899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCC
Q 007680          348 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGE  427 (593)
Q Consensus       348 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~  427 (593)
                      ||+++++|.+++.... .+++.++..++.|++.||+|||+++    ++||||||+||+++.++.+||+|||.+.......
T Consensus        85 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~----i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  159 (276)
T 2yex_A           85 EYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLHGIG----ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (276)
T ss_dssp             ECCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHHHTT----EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             EecCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHhCC----eeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence            9999999999987654 4899999999999999999999654    9999999999999999999999999998765433


Q ss_pred             CccccccccCCccccCccccCCCCC-CccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhh
Q 007680          428 DSVRQTMTMATIGYMAPEYGLEGIV-SAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLV  506 (593)
Q Consensus       428 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  506 (593)
                      .........|++.|+|||++.+..+ +.++||||||+++|||++|+.||............+.....             
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------------  226 (276)
T 2yex_A          160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT-------------  226 (276)
T ss_dssp             EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCT-------------
T ss_pred             chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhccc-------------
Confidence            2222344568999999999887765 78999999999999999999999774433222222221100             


Q ss_pred             hhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          507 REEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                          .......++..+.+++.+||+.||++|||+.|+++|
T Consensus       227 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (276)
T 2yex_A          227 ----YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (276)
T ss_dssp             ----TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ----ccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence                001112345678999999999999999999999875

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1e-41  Score=342.38  Aligned_cols=266  Identities=21%  Similarity=0.366  Sum_probs=216.1

Q ss_pred             hhcccccc-ccCccCcccEEEEEeC---CCCeEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEE
Q 007680          271 TDEFNECN-LLGTSSFGSVYKGTIS---DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKAL  345 (593)
Q Consensus       271 ~~~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  345 (593)
                      .++|.+.+ .||+|+||.||+|.+.   +++.||+|+++... ....+.+.+|++++++++||||+++++++ ..+..++
T Consensus         8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l   86 (287)
T 1u59_A            8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML   86 (287)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred             HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence            45677777 9999999999999853   57889999998642 34567889999999999999999999999 4567899


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCC
Q 007680          346 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGE  425 (593)
Q Consensus       346 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~  425 (593)
                      ||||+++++|.+++......+++..+..++.|++.||+|||+++    |+||||||+||+++.++.+||+|||++.....
T Consensus        87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~----i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~  162 (287)
T 1u59_A           87 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN----FVHRDLAARNVLLVNRHYAKISDFGLSKALGA  162 (287)
T ss_dssp             EEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT----EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             EEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCC----EeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence            99999999999999876667999999999999999999999654    99999999999999999999999999988754


Q ss_pred             CCCcc-ccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhhhh
Q 007680          426 GEDSV-RQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDA  503 (593)
Q Consensus       426 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  503 (593)
                      ..... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......  .....+.....         
T Consensus       163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~i~~~~~---------  231 (287)
T 1u59_A          163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVMAFIEQGKR---------  231 (287)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--HHHHHHHTTCC---------
T ss_pred             CcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH--HHHHHHhcCCc---------
Confidence            43221 1233456889999999988889999999999999999999 99999764321  12222211110         


Q ss_pred             hhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhhhcchhhc
Q 007680          504 NLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKFLDDAAA  560 (593)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~~  560 (593)
                              ...+..+++++.+++.+||+.||++||++.|++++|+++........+.
T Consensus       232 --------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~~  280 (287)
T 1u59_A          232 --------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEG  280 (287)
T ss_dssp             --------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCSS
T ss_pred             --------CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcccC
Confidence                    0111234668899999999999999999999999999998776444443

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=4.4e-42  Score=354.95  Aligned_cols=252  Identities=23%  Similarity=0.296  Sum_probs=191.7

Q ss_pred             hhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEe
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLE  348 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  348 (593)
                      ..++|++.+.||+|+||.||+|+.. +++.||+|+++...  ..+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  128 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE  128 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence            3568999999999999999999976 68899999998653  33568899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC---CCcEEEEeeccceecCC
Q 007680          349 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDE---NMVAHVSDFGIYKLLGE  425 (593)
Q Consensus       349 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~---~~~~kL~Dfg~a~~~~~  425 (593)
                      |+++++|.+++..... +++.++..++.|++.||+|||+++    |+||||||+||+++.   ++.+||+|||+++....
T Consensus       129 ~~~~~~L~~~l~~~~~-~~~~~~~~i~~qi~~~L~~LH~~~----ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~  203 (349)
T 2w4o_A          129 LVTGGELFDRIVEKGY-YSERDAADAVKQILEAVAYLHENG----IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH  203 (349)
T ss_dssp             CCCSCBHHHHHTTCSS-CCHHHHHHHHHHHHHHHHHHHHTT----CCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred             eCCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCC----eEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence            9999999999987654 899999999999999999999654    999999999999975   88999999999986543


Q ss_pred             CCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhh
Q 007680          426 GEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANL  505 (593)
Q Consensus       426 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  505 (593)
                      ..   ......||+.|+|||++.+..++.++|||||||++|||++|+.||.........+......... .         
T Consensus       204 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~-~---------  270 (349)
T 2w4o_A          204 QV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYY-F---------  270 (349)
T ss_dssp             ------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCC-C---------
T ss_pred             cc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCc-c---------
Confidence            22   1234568999999999999999999999999999999999999997643222111111110000 0         


Q ss_pred             hhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          506 VREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                           ..+....++.++.+++.+||+.||++|||+.|+++|
T Consensus       271 -----~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  306 (349)
T 2w4o_A          271 -----ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH  306 (349)
T ss_dssp             -----CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             -----CCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                 000112345678999999999999999999999985

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=2.1e-42  Score=351.89  Aligned_cols=268  Identities=23%  Similarity=0.395  Sum_probs=203.7

Q ss_pred             HHHHHhhhccccccccCccCcccEEEEEeC----CCCeEEEEEeehh--hHHHHHHHHHHHHHHhhcCCCCcceeeeeee
Q 007680          265 LDIQRATDEFNECNLLGTSSFGSVYKGTIS----DGTDVAIKVFNLQ--LERAFRSFDSECEVLRNVRHRNLIKILSSYS  338 (593)
Q Consensus       265 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  338 (593)
                      .++....++|.+.+.||+|+||.||+|...    +++.||+|+++..  .....+.+.+|+.++++++||||+++++++.
T Consensus        27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~  106 (313)
T 3brb_A           27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI  106 (313)
T ss_dssp             TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred             HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence            334445678999999999999999999854    3458999998754  2345577899999999999999999999998


Q ss_pred             cCC-----ceEEEEeccCCCCHHHHHhhC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC
Q 007680          339 NPD-----FKALVLEFMPNGSLEKWLYSH-----NYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDE  408 (593)
Q Consensus       339 ~~~-----~~~lv~e~~~~gsL~~~l~~~-----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~  408 (593)
                      +.+     ..++||||+++++|.+++...     ...+++..++.++.|++.||.|||++    +|+||||||+||+++.
T Consensus       107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~dikp~NIli~~  182 (313)
T 3brb_A          107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR----NFLHRDLAARNCMLRD  182 (313)
T ss_dssp             C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT----TCCCCCCSGGGEEECT
T ss_pred             eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCcceEEEcC
Confidence            765     359999999999999998532     23599999999999999999999954    5999999999999999


Q ss_pred             CCcEEEEeeccceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHH
Q 007680          409 NMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRR  487 (593)
Q Consensus       409 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~  487 (593)
                      ++.+||+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||......  ....
T Consensus       183 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~  260 (313)
T 3brb_A          183 DMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH--EMYD  260 (313)
T ss_dssp             TSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHHH
T ss_pred             CCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH--HHHH
Confidence            99999999999987654433223344567889999999999999999999999999999999 88998764222  1111


Q ss_pred             HHHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhhhc
Q 007680          488 WVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKFL  555 (593)
Q Consensus       488 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~  555 (593)
                      .......                 ...+..++.++.+++.+||+.||++|||+.+++++|+++.....
T Consensus       261 ~~~~~~~-----------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp  311 (313)
T 3brb_A          261 YLLHGHR-----------------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP  311 (313)
T ss_dssp             HHHTTCC-----------------CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred             HHHcCCC-----------------CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence            1111110                 01112345678999999999999999999999999999987653

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=2.3e-42  Score=358.60  Aligned_cols=253  Identities=21%  Similarity=0.269  Sum_probs=195.7

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEec
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEF  349 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  349 (593)
                      .++|++.+.||+|+||.||+++.. +++.||+|++..... ..+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   97 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY   97 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence            568999999999999999999976 789999999976432 235688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCc--EEEEeeccceecCCCC
Q 007680          350 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMV--AHVSDFGIYKLLGEGE  427 (593)
Q Consensus       350 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~--~kL~Dfg~a~~~~~~~  427 (593)
                      +++|+|.+++...+. +++..+..++.|++.||+|||+++    |+||||||+||+++.++.  +||+|||+++......
T Consensus        98 ~~~~~L~~~l~~~~~-~~~~~~~~i~~ql~~~L~~LH~~~----ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~  172 (361)
T 3uc3_A           98 ASGGELYERICNAGR-FSEDEARFFFQQLLSGVSYCHSMQ----ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS  172 (361)
T ss_dssp             CCSCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHHHTT----CCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred             CCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCC----cccCCCCHHHEEEcCCCCceEEEeecCccccccccC
Confidence            999999999977554 999999999999999999999655    999999999999987765  9999999987533222


Q ss_pred             CccccccccCCccccCccccCCCCCCcc-chHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhh
Q 007680          428 DSVRQTMTMATIGYMAPEYGLEGIVSAK-CDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLV  506 (593)
Q Consensus       428 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~-~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  506 (593)
                         ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||....... .+.........            
T Consensus       173 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-~~~~~~~~~~~------------  236 (361)
T 3uc3_A          173 ---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR-DYRKTIQRILS------------  236 (361)
T ss_dssp             -----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC-CHHHHHHHHHT------------
T ss_pred             ---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH-HHHHHHHHHhc------------
Confidence               2234569999999999888877655 899999999999999999997643221 11111111100            


Q ss_pred             hhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          507 REEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                       .....+....+++++.+++.+||+.||++|||+.|+++|
T Consensus       237 -~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          237 -VKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             -TCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             -CCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence             000111111235678999999999999999999999987

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=5.6e-43  Score=351.74  Aligned_cols=252  Identities=21%  Similarity=0.316  Sum_probs=205.4

Q ss_pred             hhccccccccCccCcccEEEEEeC-CC-------CeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCc
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DG-------TDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDF  342 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  342 (593)
                      .++|++.+.||+|+||.||+|+.. ++       ..||+|++........+.+.+|++++++++||||+++++++.+++.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            468999999999999999999865 33       4699999987766667889999999999999999999999999999


Q ss_pred             eEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCc--------EEE
Q 007680          343 KALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMV--------AHV  414 (593)
Q Consensus       343 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~--------~kL  414 (593)
                      .++||||+++++|.+++......+++..+..++.|++.||+|||+++    |+||||||+||+++.++.        +||
T Consensus        87 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~----ivH~Dlkp~NIll~~~~~~~~~~~~~~kl  162 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT----LIHGNVCAKNILLIREEDRKTGNPPFIKL  162 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT----CCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred             CEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCC----eECCCcCcceEEEecCCcccccccceeee
Confidence            99999999999999999887767999999999999999999999655    999999999999998887        999


Q ss_pred             EeeccceecCCCCCccccccccCCccccCccccCC-CCCCccchHHHHHHHHHHHHhCCC-CCCccccccchHHHHHHHh
Q 007680          415 SDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLE-GIVSAKCDVYSYGVLLMETFTRKR-PTDEMFIGEMSLRRWVKES  492 (593)
Q Consensus       415 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlGvvl~elltg~~-pf~~~~~~~~~~~~~~~~~  492 (593)
                      +|||.+.....      .....+++.|+|||++.+ ..++.++||||||+++|||++|.. ||.... ... ........
T Consensus       163 ~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~-~~~-~~~~~~~~  234 (289)
T 4fvq_A          163 SDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD-SQR-KLQFYEDR  234 (289)
T ss_dssp             CCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC-HHH-HHHHHHTT
T ss_pred             ccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccc-hHH-HHHHhhcc
Confidence            99999865432      122357889999999887 679999999999999999999654 443321 111 11111100


Q ss_pred             cCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhh
Q 007680          493 LPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVK  553 (593)
Q Consensus       493 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  553 (593)
                        .                 ..+...+.++.+++.+||+.||++|||+.|++++|+++...
T Consensus       235 --~-----------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p  276 (289)
T 4fvq_A          235 --H-----------------QLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP  276 (289)
T ss_dssp             --C-----------------CCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred             --C-----------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence              0                 00011234678999999999999999999999999998653

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.6e-42  Score=356.30  Aligned_cols=285  Identities=23%  Similarity=0.321  Sum_probs=202.0

Q ss_pred             hhccccccccCccCcccEEEEEeCCCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeee-----cCCceEE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYS-----NPDFKAL  345 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-----~~~~~~l  345 (593)
                      .++|++.+.||+|+||.||+|+. +++.||||+++...... .....|+..+..++||||+++++.+.     .....++
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~-~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~l   89 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQN-FINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLL   89 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGHHH-HHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccchhh-HHHHHHHHHHHhccCcchhhheecccccccCCCceEEE
Confidence            57899999999999999999987 68999999997653321 12233444455689999999997543     2336789


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-----CCCeEecCCCCCCeeeCCCCcEEEEeeccc
Q 007680          346 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHS-----SVHIIHCDLKPTNILLDENMVAHVSDFGIY  420 (593)
Q Consensus       346 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-----~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a  420 (593)
                      ||||+++|+|.+++....  .++..+..++.|++.||+|||++..     ..+|+||||||+||+++.++.+||+|||++
T Consensus        90 v~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a  167 (336)
T 3g2f_A           90 VMEYYPNGSLXKYLSLHT--SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLS  167 (336)
T ss_dssp             EECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTC
T ss_pred             EEecCCCCcHHHHHhhcc--cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccce
Confidence            999999999999998765  6899999999999999999996400     116999999999999999999999999999


Q ss_pred             eecCCCCC------ccccccccCCccccCccccCC-------CCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHH
Q 007680          421 KLLGEGED------SVRQTMTMATIGYMAPEYGLE-------GIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRR  487 (593)
Q Consensus       421 ~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~  487 (593)
                      +.+.....      ........||+.|+|||++.+       ..++.++|||||||++|||++|..||............
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~  247 (336)
T 3g2f_A          168 MRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMA  247 (336)
T ss_dssp             EECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCT
T ss_pred             eecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHh
Confidence            87654321      112234469999999999876       45678999999999999999997776432111100000


Q ss_pred             HHHHhc-CCchhh---hhhhhhhh--hhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhhhcchhh
Q 007680          488 WVKESL-PHGLTE---VVDANLVR--EEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKFLDDAA  559 (593)
Q Consensus       488 ~~~~~~-~~~~~~---~~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~  559 (593)
                      +..... .....+   .+......  ..........+++++.+++.+||+.||++|||++|+++.|+++...+.....
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~~~  325 (336)
T 3g2f_A          248 FQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKS  325 (336)
T ss_dssp             THHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC---
T ss_pred             hhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhccc
Confidence            000000 000000   00000000  0001111234567899999999999999999999999999999887755443

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.1e-42  Score=349.36  Aligned_cols=262  Identities=23%  Similarity=0.364  Sum_probs=216.8

Q ss_pred             HHhhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEE
Q 007680          268 QRATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALV  346 (593)
Q Consensus       268 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  346 (593)
                      ....++|++.+.||+|+||.||+|.+. +++.||+|+++... ...+.+.+|++++++++||||+++++++.+.+..++|
T Consensus         9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v   87 (288)
T 3kfa_A            9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII   87 (288)
T ss_dssp             BCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred             cccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEE
Confidence            345778999999999999999999976 58899999997543 3456788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCC
Q 007680          347 LEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGE  425 (593)
Q Consensus       347 ~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~  425 (593)
                      |||+++++|.+++.... ..+++..+..++.|++.||+|||+++    |+||||||+||+++.++.+||+|||.+.....
T Consensus        88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~----i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~  163 (288)
T 3kfa_A           88 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN----FIHRDLAARNCLVGENHLVKVADFGLSRLMTG  163 (288)
T ss_dssp             EECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT----CCCSCCSGGGEEECGGGCEEECCCCGGGTSCS
T ss_pred             EEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC----ccCCCCCcceEEEcCCCCEEEccCccceeccC
Confidence            99999999999998744 35899999999999999999999765    99999999999999999999999999987654


Q ss_pred             CCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhhhhh
Q 007680          426 GEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDAN  504 (593)
Q Consensus       426 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  504 (593)
                      ... .......+++.|+|||++.+..++.++||||||+++|+|++ |..||......  ...........          
T Consensus       164 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~--~~~~~~~~~~~----------  230 (288)
T 3kfa_A          164 DTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVYELLEKDYR----------  230 (288)
T ss_dssp             SSS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHHHHHHTTCC----------
T ss_pred             Ccc-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHhccCC----------
Confidence            332 22233457888999999988899999999999999999999 99999764221  11221111110          


Q ss_pred             hhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhhh
Q 007680          505 LVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKF  554 (593)
Q Consensus       505 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  554 (593)
                             ...+..+++.+.+++.+||+.||++|||+.|+++.|+.+....
T Consensus       231 -------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~  273 (288)
T 3kfa_A          231 -------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES  273 (288)
T ss_dssp             -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             -------CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence                   1111234568899999999999999999999999999887654

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=8.7e-42  Score=342.12  Aligned_cols=252  Identities=21%  Similarity=0.312  Sum_probs=207.4

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh--HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVL  347 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  347 (593)
                      .++|++.+.||+|+||.||+|.+. +++.||+|++....  ....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            578999999999999999999975 68999999997653  345577889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCc---EEEEeeccceecC
Q 007680          348 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMV---AHVSDFGIYKLLG  424 (593)
Q Consensus       348 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~---~kL~Dfg~a~~~~  424 (593)
                      ||+++++|.+.+..... +++..+..++.|++.||+|||+++    |+||||||+||+++.++.   +||+|||.+....
T Consensus        85 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~i~~~l~~lH~~~----i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~  159 (284)
T 3kk8_A           85 DLVTGGELFEDIVAREF-YSEADASHCIQQILESIAYCHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN  159 (284)
T ss_dssp             CCCCSCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHHHTT----EECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             ecCCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCC----cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence            99999999998877654 899999999999999999999655    999999999999986655   9999999998765


Q ss_pred             CCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhh
Q 007680          425 EGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDAN  504 (593)
Q Consensus       425 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  504 (593)
                      ....   .....||+.|+|||++.+..++.++||||||+++|+|++|+.||......  .....+.......        
T Consensus       160 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~--------  226 (284)
T 3kk8_A          160 DSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH--RLYAQIKAGAYDY--------  226 (284)
T ss_dssp             SSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHTCCCC--------
T ss_pred             cCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh--HHHHHHHhccccC--------
Confidence            4332   23456899999999999999999999999999999999999999763211  1111111111000        


Q ss_pred             hhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          505 LVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       505 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                            ..+....+++++.+++.+||+.||++|||+.|+++|
T Consensus       227 ------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (284)
T 3kk8_A          227 ------PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  262 (284)
T ss_dssp             ------CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             ------CchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence                  001112345678999999999999999999999986

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=9.6e-43  Score=354.18  Aligned_cols=260  Identities=22%  Similarity=0.353  Sum_probs=199.0

Q ss_pred             hhccccccccCccCcccEEEEEe-CCCCeEEEEEeehhh---HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCc----
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTI-SDGTDVAIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDF----  342 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----  342 (593)
                      .++|++.+.||+|+||.||+|++ .+++.||+|+++...   ......+.+|+.++++++||||+++++++...+.    
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            46899999999999999999996 478999999997642   3445678999999999999999999999876553    


Q ss_pred             eEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeecccee
Q 007680          343 KALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKL  422 (593)
Q Consensus       343 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~  422 (593)
                      .++||||+++++|.+++...+. +++.++..++.|++.||+|||+++    |+||||||+||+++.++.+||+|||++..
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~~~-~~~~~~~~~~~qi~~~l~~lH~~~----ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  165 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQALNFSHQNG----IIHRDVKPANIMISATNAVKVMDFGIARA  165 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHHCS-CCHHHHHHHHHHHHHHHHHHHHTT----CCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred             cEEEEecCCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCC----CCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence            4999999999999999987654 899999999999999999999655    99999999999999999999999999987


Q ss_pred             cCCCCCc-cccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhh
Q 007680          423 LGEGEDS-VRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVV  501 (593)
Q Consensus       423 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  501 (593)
                      +...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......... ........        
T Consensus       166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~-~~~~~~~~--------  236 (311)
T 3ork_A          166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA-YQHVREDP--------  236 (311)
T ss_dssp             ----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HHHHHCCC--------
T ss_pred             ccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHhcCCC--------
Confidence            6543322 1223456899999999999999999999999999999999999999764221110 11111000        


Q ss_pred             hhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH-HHHHhh
Q 007680          502 DANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAA-KLKKIK  551 (593)
Q Consensus       502 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~-~L~~i~  551 (593)
                          .   ........++.++.+++.+||+.||++||++.+++. .+..+.
T Consensus       237 ----~---~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  280 (311)
T 3ork_A          237 ----I---PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  280 (311)
T ss_dssp             ----C---CHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             ----C---CcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence                0   000111234668899999999999999997666554 455544

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=8.2e-43  Score=373.33  Aligned_cols=261  Identities=23%  Similarity=0.385  Sum_probs=213.9

Q ss_pred             HHhhhccccccccCccCcccEEEEEeCCCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEE
Q 007680          268 QRATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVL  347 (593)
Q Consensus       268 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  347 (593)
                      ....++|++.+.||+|+||.||+|.++++..||||+++... ...+.+.+|+.++++++||||+++++++. .+..++||
T Consensus       184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~  261 (454)
T 1qcf_A          184 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIIT  261 (454)
T ss_dssp             BCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred             eechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEE
Confidence            34567899999999999999999999888999999998653 24568999999999999999999999986 56789999


Q ss_pred             eccCCCCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCC
Q 007680          348 EFMPNGSLEKWLYSHNY-FLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG  426 (593)
Q Consensus       348 e~~~~gsL~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  426 (593)
                      ||+++|+|.+++..... .+++..+..++.|++.||+|||+++    |+||||||+|||++.++.+||+|||+++.....
T Consensus       262 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~----ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~  337 (454)
T 1qcf_A          262 EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN----YIHRDLRAANILVSASLVCKIADFGLARVIEDN  337 (454)
T ss_dssp             CCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT----CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH
T ss_pred             eecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC----ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC
Confidence            99999999999975432 5889999999999999999999654    999999999999999999999999999876432


Q ss_pred             CCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhhhhhh
Q 007680          427 EDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANL  505 (593)
Q Consensus       427 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  505 (593)
                      .. .......++..|+|||++.+..++.++|||||||++|||+| |+.||......  .....+....            
T Consensus       338 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~--~~~~~i~~~~------------  402 (454)
T 1qcf_A          338 EY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--EVIRALERGY------------  402 (454)
T ss_dssp             HH-HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHHHHHHHTC------------
T ss_pred             ce-eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCC------------
Confidence            11 11223346788999999988899999999999999999999 99999764221  1111111110            


Q ss_pred             hhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhhh
Q 007680          506 VREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKF  554 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  554 (593)
                           ..+.+..+++++.+++.+||+.||++|||+.++++.|+++....
T Consensus       403 -----~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~  446 (454)
T 1qcf_A          403 -----RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT  446 (454)
T ss_dssp             -----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred             -----CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence                 11112345678999999999999999999999999999986543

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.1e-41  Score=357.46  Aligned_cols=274  Identities=22%  Similarity=0.297  Sum_probs=197.8

Q ss_pred             HhhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehh--hHHHHHHHHHHHHHHhhcC-CCCcceeeeeeecCC--c
Q 007680          269 RATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQ--LERAFRSFDSECEVLRNVR-HRNLIKILSSYSNPD--F  342 (593)
Q Consensus       269 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~  342 (593)
                      ...++|++.+.||+|+||.||+|.+. +|+.||||++...  .......+.+|+.++.++. ||||+++++++...+  .
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~   85 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD   85 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence            34678999999999999999999965 7899999998643  2345567889999999997 999999999997544  7


Q ss_pred             eEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeecccee
Q 007680          343 KALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKL  422 (593)
Q Consensus       343 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~  422 (593)
                      .|+||||++ ++|.+++....  +++..+..++.|++.||+|||+++    |+||||||+||+++.++.+||+|||+++.
T Consensus        86 ~~lv~e~~~-~~L~~~~~~~~--~~~~~~~~i~~qi~~~L~~LH~~~----ivHrDlkp~NIll~~~~~~kl~DFG~a~~  158 (388)
T 3oz6_A           86 VYLVFDYME-TDLHAVIRANI--LEPVHKQYVVYQLIKVIKYLHSGG----LLHRDMKPSNILLNAECHVKVADFGLSRS  158 (388)
T ss_dssp             EEEEEECCS-EEHHHHHHHTC--CCHHHHHHHHHHHHHHHHHHHHTT----EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEecccC-cCHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhCC----EEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence            899999996 69999998753  899999999999999999999654    99999999999999999999999999987


Q ss_pred             cCCCCC-------------------ccccccccCCccccCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCcccccc
Q 007680          423 LGEGED-------------------SVRQTMTMATIGYMAPEYGLE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGE  482 (593)
Q Consensus       423 ~~~~~~-------------------~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~  482 (593)
                      +.....                   ........||+.|+|||++.+ ..++.++||||+||++|||++|++||.+.....
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~  238 (388)
T 3oz6_A          159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN  238 (388)
T ss_dssp             SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            643111                   111234579999999999876 679999999999999999999999997642211


Q ss_pred             chHHHHHHHh-cCCc----------hhhhhhhhh-----------------hhhhhhhhhhHHHHHHHHHHHhhcccCCC
Q 007680          483 MSLRRWVKES-LPHG----------LTEVVDANL-----------------VREEQAFSAKMDCILSIMDFALDCCMESP  534 (593)
Q Consensus       483 ~~~~~~~~~~-~~~~----------~~~~~~~~~-----------------~~~~~~~~~~~~~~~~l~~li~~cl~~dP  534 (593)
                       .+....... .|..          ....+....                 ............+++++.+|+.+||+.||
T Consensus       239 -~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP  317 (388)
T 3oz6_A          239 -QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNP  317 (388)
T ss_dssp             -HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSG
T ss_pred             -HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCc
Confidence             111111110 0100          000000000                 00000000111345688999999999999


Q ss_pred             CCCCCHHHHHHH--HHHh
Q 007680          535 DMRINMTDAAAK--LKKI  550 (593)
Q Consensus       535 ~~RPs~~evl~~--L~~i  550 (593)
                      ++|||++|+++|  ++..
T Consensus       318 ~~R~t~~e~l~Hp~~~~~  335 (388)
T 3oz6_A          318 NKRISANDALKHPFVSIF  335 (388)
T ss_dssp             GGSCCHHHHTTSTTTTTT
T ss_pred             ccCCCHHHHhCCHHHHHh
Confidence            999999999988  5544

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.3e-42  Score=355.69  Aligned_cols=259  Identities=25%  Similarity=0.421  Sum_probs=203.1

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeE----EEEEeehh-hHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDV----AIKVFNLQ-LERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKA  344 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~v----avK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  344 (593)
                      .++|++.+.||+|+||.||+|++. +++.+    |+|.+... .....+.+.+|+.++++++||||+++++++.... .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~   92 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence            468999999999999999999964 55554    66666433 2334567899999999999999999999998765 78


Q ss_pred             EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecC
Q 007680          345 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG  424 (593)
Q Consensus       345 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~  424 (593)
                      +|+||+.+|+|.+++......+++..+..++.|++.||+|||+++    |+||||||+||+++.++.+||+|||+++...
T Consensus        93 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~----ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~  168 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             EEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC----CcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence            999999999999999887777999999999999999999999655    9999999999999999999999999998775


Q ss_pred             CCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhhhh
Q 007680          425 EGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDA  503 (593)
Q Consensus       425 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  503 (593)
                      ............+|+.|+|||++.+..++.++|||||||++|||++ |+.||.......  ....+....          
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--~~~~~~~~~----------  236 (327)
T 3lzb_A          169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSILEKGE----------  236 (327)
T ss_dssp             -----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHHHHTTC----------
T ss_pred             CccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--HHHHHHcCC----------
Confidence            5443333344557889999999999999999999999999999999 999997743222  222221111          


Q ss_pred             hhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhh
Q 007680          504 NLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVK  553 (593)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  553 (593)
                             ..+.+..++.++.+++.+||+.||++|||+.|+++.|+++...
T Consensus       237 -------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  279 (327)
T 3lzb_A          237 -------RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             -------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred             -------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence                   0111123456789999999999999999999999999998744

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=8.9e-43  Score=356.00  Aligned_cols=267  Identities=23%  Similarity=0.376  Sum_probs=216.0

Q ss_pred             HHHHHHhhhccccccccCccCcccEEEEEeC------CCCeEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceeeee
Q 007680          264 YLDIQRATDEFNECNLLGTSSFGSVYKGTIS------DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSS  336 (593)
Q Consensus       264 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~  336 (593)
                      ..++....++|++.+.||+|+||.||+|.+.      +++.||+|++.... ......+.+|+.++++++||||++++++
T Consensus        17 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~   96 (322)
T 1p4o_A           17 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGV   96 (322)
T ss_dssp             CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred             hhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEE
Confidence            3444556789999999999999999999854      36789999997543 3445678999999999999999999999


Q ss_pred             eecCCceEEEEeccCCCCHHHHHhhCC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeC
Q 007680          337 YSNPDFKALVLEFMPNGSLEKWLYSHN---------YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLD  407 (593)
Q Consensus       337 ~~~~~~~~lv~e~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~  407 (593)
                      +.+.+..++||||+++|+|.+++...+         ..+++..+..++.|++.||+|||+++    |+||||||+||+++
T Consensus        97 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~----i~H~dikp~NIli~  172 (322)
T 1p4o_A           97 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK----FVHRDLAARNCMVA  172 (322)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT----CBCSCCSGGGEEEC
T ss_pred             EccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC----CccCCCccceEEEc
Confidence            999999999999999999999987632         24789999999999999999999655    99999999999999


Q ss_pred             CCCcEEEEeeccceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHH
Q 007680          408 ENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLR  486 (593)
Q Consensus       408 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~  486 (593)
                      .++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|||++ |+.||......  ...
T Consensus       173 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~  250 (322)
T 1p4o_A          173 EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE--QVL  250 (322)
T ss_dssp             TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH--HHH
T ss_pred             CCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH--HHH
Confidence            999999999999986654332222334457889999999988899999999999999999999 89999763221  111


Q ss_pred             HHHHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhh
Q 007680          487 RWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVK  553 (593)
Q Consensus       487 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  553 (593)
                      ..+....           .      ......++..+.+++.+||+.||++|||+.|++++|+++...
T Consensus       251 ~~~~~~~-----------~------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~  300 (322)
T 1p4o_A          251 RFVMEGG-----------L------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP  300 (322)
T ss_dssp             HHHHTTC-----------C------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred             HHHHcCC-----------c------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence            1111110           0      011123456789999999999999999999999999887543

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.3e-41  Score=342.77  Aligned_cols=275  Identities=18%  Similarity=0.221  Sum_probs=213.7

Q ss_pred             hhhccccccccCccCcccEEEEEe-CCCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeee-ecCCceEEEE
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTI-SDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSY-SNPDFKALVL  347 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~  347 (593)
                      ..++|++.+.||+|+||.||+|+. .+++.||+|++.....  ...+.+|+.+++.++|++++..+..+ ...+..++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence            457899999999999999999996 4789999998765432  24578899999999988877766655 6677889999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeee---CCCCcEEEEeeccceecC
Q 007680          348 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILL---DENMVAHVSDFGIYKLLG  424 (593)
Q Consensus       348 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll---~~~~~~kL~Dfg~a~~~~  424 (593)
                      ||+ +++|.+++......+++.++..++.|++.||+|||+++    |+||||||+||++   +.++.+||+|||+++...
T Consensus        85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~----ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~  159 (296)
T 4hgt_A           85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN----FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             ECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT----EECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             Ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC----eecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence            999 99999999876667999999999999999999999655    9999999999999   788999999999998876


Q ss_pred             CCCCcc-----ccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccc--hHHHHHHHhcCCch
Q 007680          425 EGEDSV-----RQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEM--SLRRWVKESLPHGL  497 (593)
Q Consensus       425 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~--~~~~~~~~~~~~~~  497 (593)
                      ......     ......||+.|+|||++.+..++.++|||||||++|||++|+.||........  ........      
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~------  233 (296)
T 4hgt_A          160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK------  233 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHH------
T ss_pred             CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcc------
Confidence            543211     22345789999999999999999999999999999999999999976432211  11111110      


Q ss_pred             hhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhhhcch-hhccCCcc
Q 007680          498 TEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKFLDD-AAATNWRN  565 (593)
Q Consensus       498 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~-~~~~~~~~  565 (593)
                            .....  .......+++++.+++.+||+.||++|||++++++.|+++......+ ....+|..
T Consensus       234 ------~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~~~~dw~~  294 (296)
T 4hgt_A          234 ------KMSTP--IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNM  294 (296)
T ss_dssp             ------HHHSC--HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTTCCCGGGG
T ss_pred             ------cccch--hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCccCccchhh
Confidence                  00000  00011234668999999999999999999999999999998876433 34567765

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=3.3e-42  Score=352.70  Aligned_cols=249  Identities=21%  Similarity=0.270  Sum_probs=195.9

Q ss_pred             hhccccccccCccCcccEEEEEe----CCCCeEEEEEeehhh----HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCc
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTI----SDGTDVAIKVFNLQL----ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDF  342 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  342 (593)
                      .++|++.+.||+|+||.||+|+.    .+|+.||+|+++...    ......+.+|+.++++++||||+++++++...+.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            57899999999999999999986    478999999997642    2334567889999999999999999999999999


Q ss_pred             eEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeecccee
Q 007680          343 KALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKL  422 (593)
Q Consensus       343 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~  422 (593)
                      .++||||+++++|.+++..... +++..+..++.|++.||+|||+++    |+||||||+||+++.++.+||+|||+++.
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~qi~~al~~lH~~~----ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~  170 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLEREGI-FMEDTACFYLAEISMALGHLHQKG----IIYRDLKPENIMLNHQGHVKLTDFGLCKE  170 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHHHTT----CCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred             EEEEEeCCCCCcHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCC----EEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence            9999999999999999987654 899999999999999999999655    99999999999999999999999999876


Q ss_pred             cCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhh
Q 007680          423 LGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVD  502 (593)
Q Consensus       423 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  502 (593)
                      ......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||......  .....+....         
T Consensus       171 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~i~~~~---------  237 (327)
T 3a62_A          171 SIHDGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK--KTIDKILKCK---------  237 (327)
T ss_dssp             ----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHTC---------
T ss_pred             cccCCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH--HHHHHHHhCC---------
Confidence            433221  223456899999999999999999999999999999999999999763211  1111111100         


Q ss_pred             hhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHHH
Q 007680          503 ANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRI-----NMTDAAAK  546 (593)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  546 (593)
                        .       ..+..++.++.+++.+||+.||++||     ++.|+++|
T Consensus       238 --~-------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h  277 (327)
T 3a62_A          238 --L-------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH  277 (327)
T ss_dssp             --C-------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred             --C-------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence              0       00112356789999999999999999     77888876

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.8e-42  Score=343.72  Aligned_cols=250  Identities=23%  Similarity=0.393  Sum_probs=187.0

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhH---HHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLE---RAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALV  346 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  346 (593)
                      .++|++.+.||+|+||.||+|+.. +|+.||+|++.....   ...+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            468999999999999999999974 799999999976532   2346789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCC
Q 007680          347 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG  426 (593)
Q Consensus       347 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  426 (593)
                      |||+++++|.+++......+++.++..++.|+++||+|||+++    |+||||||+||+++.++.+||+|||.+......
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~----i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~  165 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG----ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP  165 (278)
T ss_dssp             EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTT----EECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred             EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC----eecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence            9999999999999887667999999999999999999999654    999999999999999999999999999876533


Q ss_pred             CCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhh
Q 007680          427 EDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLV  506 (593)
Q Consensus       427 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  506 (593)
                      ..  ......+|+.|+|||++.+..++.++||||||+++|||++|+.||........     ..        ....... 
T Consensus       166 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~~--------~~~~~~~-  229 (278)
T 3cok_A          166 HE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT-----LN--------KVVLADY-  229 (278)
T ss_dssp             ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------------------CCSSCC-
T ss_pred             CC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH-----HH--------HHhhccc-
Confidence            22  12335689999999999988999999999999999999999999976321110     00        0000000 


Q ss_pred             hhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          507 REEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                            ..+..++.++.+++.+||+.||++|||++|+++|
T Consensus       230 ------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  263 (278)
T 3cok_A          230 ------EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH  263 (278)
T ss_dssp             ------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             ------CCccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence                  0111235578999999999999999999999875

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=6e-42  Score=353.35  Aligned_cols=261  Identities=23%  Similarity=0.287  Sum_probs=204.9

Q ss_pred             HHHHhhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh-----HHHHHHHHHHHHHHhhcCCCCcceeeeeeec
Q 007680          266 DIQRATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL-----ERAFRSFDSECEVLRNVRHRNLIKILSSYSN  339 (593)
Q Consensus       266 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  339 (593)
                      ++....++|++.+.||+|+||.||+|... +++.||+|++....     ....+.+.+|++++++++||||+++++++.+
T Consensus        20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   99 (345)
T 3hko_A           20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED   99 (345)
T ss_dssp             CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence            35566789999999999999999999975 78899999997652     3445788999999999999999999999999


Q ss_pred             CCceEEEEeccCCCCHHHHHhhC---------------------------------------CCCCCHHHHHHHHHHHHH
Q 007680          340 PDFKALVLEFMPNGSLEKWLYSH---------------------------------------NYFLDILERLNIMIDVGS  380 (593)
Q Consensus       340 ~~~~~lv~e~~~~gsL~~~l~~~---------------------------------------~~~l~~~~~~~i~~~i~~  380 (593)
                      .+..++||||+++|+|.+++...                                       ...+++..+..++.|++.
T Consensus       100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~  179 (345)
T 3hko_A          100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS  179 (345)
T ss_dssp             SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence            99999999999999999998521                                       112457788899999999


Q ss_pred             HHHHHHhcCCCCCeEecCCCCCCeeeCCCC--cEEEEeeccceecCCCCCc--cccccccCCccccCccccCC--CCCCc
Q 007680          381 ALEYLHNGHSSVHIIHCDLKPTNILLDENM--VAHVSDFGIYKLLGEGEDS--VRQTMTMATIGYMAPEYGLE--GIVSA  454 (593)
Q Consensus       381 ~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~--~~kL~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~s~  454 (593)
                      ||+|||+++    |+||||||+||+++.++  .+||+|||++..+......  .......||+.|+|||++.+  ..++.
T Consensus       180 ~l~~LH~~~----ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~  255 (345)
T 3hko_A          180 ALHYLHNQG----ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGP  255 (345)
T ss_dssp             HHHHHHHTT----EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCT
T ss_pred             HHHHHHHCC----ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCc
Confidence            999999654    99999999999998776  8999999999876432221  12344569999999999865  67899


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCC
Q 007680          455 KCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESP  534 (593)
Q Consensus       455 ~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP  534 (593)
                      ++|||||||++|||++|+.||......+ .........            ...   ..+....+++++.+++.+||+.||
T Consensus       256 ~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~------------~~~---~~~~~~~~~~~~~~li~~~l~~~p  319 (345)
T 3hko_A          256 KCDAWSAGVLLHLLLMGAVPFPGVNDAD-TISQVLNKK------------LCF---ENPNYNVLSPLARDLLSNLLNRNV  319 (345)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCC------------CCT---TSGGGGGSCHHHHHHHHHHSCSCT
T ss_pred             HHHHHHHHHHHHHHHHCCCCCCCCChHH-HHHHHHhcc------------ccc---CCcccccCCHHHHHHHHHHcCCCh
Confidence            9999999999999999999997643221 111111110            000   001112345688999999999999


Q ss_pred             CCCCCHHHHHHH
Q 007680          535 DMRINMTDAAAK  546 (593)
Q Consensus       535 ~~RPs~~evl~~  546 (593)
                      ++|||+.|+++|
T Consensus       320 ~~Rps~~~~l~h  331 (345)
T 3hko_A          320 DERFDAMRALQH  331 (345)
T ss_dssp             TTSCCHHHHHHS
T ss_pred             hHCCCHHHHhcC
Confidence            999999999986

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=3.6e-42  Score=355.39  Aligned_cols=250  Identities=21%  Similarity=0.231  Sum_probs=205.4

Q ss_pred             hhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhc-CCCCcceeeeeeecCCceE
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNV-RHRNLIKILSSYSNPDFKA  344 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  344 (593)
                      ..++|++.+.||+|+||.||+|+.+ +|+.||+|+++...   ....+.+..|..++..+ +||||+++++++.+.+..|
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   97 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY   97 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence            4578999999999999999999976 58899999998753   23456788899999988 8999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecC
Q 007680          345 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG  424 (593)
Q Consensus       345 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~  424 (593)
                      +||||++||+|.+++...+. +++..+..++.|++.||+|||+++    |+||||||+||+++.++.+||+|||+++...
T Consensus        98 lv~E~~~gg~L~~~l~~~~~-~~~~~~~~~~~qi~~aL~~LH~~g----ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  172 (353)
T 2i0e_A           98 FVMEYVNGGDLMYHIQQVGR-FKEPHAVFYAAEIAIGLFFLQSKG----IIYRDLKLDNVMLDSEGHIKIADFGMCKENI  172 (353)
T ss_dssp             EEEECCCSCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHHHTT----CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEEeCCCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCC----EEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence            99999999999999987654 999999999999999999999654    9999999999999999999999999998643


Q ss_pred             CCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhh
Q 007680          425 EGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDAN  504 (593)
Q Consensus       425 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  504 (593)
                      ....  ......||+.|+|||++.+..++.++|||||||++|||++|+.||......  .....+...           .
T Consensus       173 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~--~~~~~i~~~-----------~  237 (353)
T 2i0e_A          173 WDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--ELFQSIMEH-----------N  237 (353)
T ss_dssp             CTTC--CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHC-----------C
T ss_pred             cCCc--ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH--HHHHHHHhC-----------C
Confidence            2221  234457999999999999999999999999999999999999999763211  111111110           0


Q ss_pred             hhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCC-----HHHHHHH
Q 007680          505 LVREEQAFSAKMDCILSIMDFALDCCMESPDMRIN-----MTDAAAK  546 (593)
Q Consensus       505 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~  546 (593)
                      .       ..+..++.++.+++.+||..||++||+     ++|+++|
T Consensus       238 ~-------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h  277 (353)
T 2i0e_A          238 V-------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  277 (353)
T ss_dssp             C-------CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred             C-------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence            0       011134567899999999999999995     5777765

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=2.2e-42  Score=355.19  Aligned_cols=243  Identities=25%  Similarity=0.341  Sum_probs=204.3

Q ss_pred             hhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhH--------HHHHHHHHHHHHHhhcCCCCcceeeeeeecC
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLE--------RAFRSFDSECEVLRNVRHRNLIKILSSYSNP  340 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  340 (593)
                      ..++|++.+.||+|+||.||+|+.. +++.||||+++....        ...+.+.+|+.++++++||||+++++++.+.
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            4678999999999999999999964 789999999976531        1234577899999999999999999999999


Q ss_pred             CceEEEEeccCCC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeecc
Q 007680          341 DFKALVLEFMPNG-SLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGI  419 (593)
Q Consensus       341 ~~~~lv~e~~~~g-sL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~  419 (593)
                      +..++||||+.+| +|.+++..... +++..+..++.|++.||+|||+++    |+||||||+||+++.++.+||+|||+
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~~~~-l~~~~~~~i~~qi~~~L~~LH~~~----ivH~Dlkp~NIll~~~~~~kL~Dfg~  176 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDRHPR-LDEPLASYIFRQLVSAVGYLRLKD----IIHRDIKDENIVIAEDFTIKLIDFGS  176 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHTCCC-CCHHHHHHHHHHHHHHHHHHHHTT----EECSCCSGGGEEECTTSCEEECCCTT
T ss_pred             CEEEEEEEeCCCCccHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCC----eEEeccCHHHEEEcCCCcEEEeeccc
Confidence            9999999999776 99999987654 999999999999999999999654    99999999999999999999999999


Q ss_pred             ceecCCCCCccccccccCCccccCccccCCCCC-CccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchh
Q 007680          420 YKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIV-SAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLT  498 (593)
Q Consensus       420 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  498 (593)
                      +........   .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||......                 
T Consensus       177 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----------------  236 (335)
T 3dls_A          177 AAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET-----------------  236 (335)
T ss_dssp             CEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-----------------
T ss_pred             ceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-----------------
Confidence            987754432   233568999999999888776 88999999999999999999999762110                 


Q ss_pred             hhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          499 EVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       499 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                        .....       ..+..+++++.+++.+||+.||++|||+.|++++
T Consensus       237 --~~~~~-------~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          237 --VEAAI-------HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             --TTTCC-------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             --Hhhcc-------CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              00000       0011235678999999999999999999999987

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=5.1e-42  Score=343.10  Aligned_cols=248  Identities=23%  Similarity=0.323  Sum_probs=203.3

Q ss_pred             hhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEE
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKAL  345 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  345 (593)
                      +.++|++.+.||+|+||.||+|... +++.||+|++....   ......+.+|+.++++++||||+++++++.+.+..++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   86 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL   86 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence            3578999999999999999999876 67899999997653   2234678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCC
Q 007680          346 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGE  425 (593)
Q Consensus       346 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~  425 (593)
                      ||||+++++|.+++..... +++..+..++.|++.||+|||++    +|+||||||+||+++.++.+||+|||++.....
T Consensus        87 v~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~qi~~~l~~LH~~----~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~  161 (279)
T 3fdn_A           87 ILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSK----RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS  161 (279)
T ss_dssp             EECCCTTEEHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHHTT----TCEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred             EEecCCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhC----CEecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence            9999999999999987654 89999999999999999999954    599999999999999999999999998865433


Q ss_pred             CCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhh
Q 007680          426 GEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANL  505 (593)
Q Consensus       426 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  505 (593)
                      ..    .....+++.|+|||++.+..++.++||||||+++|+|++|+.||......  .....+....            
T Consensus       162 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~------------  223 (279)
T 3fdn_A          162 SR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ--ETYKRISRVE------------  223 (279)
T ss_dssp             ----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHHTC------------
T ss_pred             cc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH--HHHHHHHhCC------------
Confidence            22    23456899999999999999999999999999999999999999763211  1111111100            


Q ss_pred             hhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          506 VREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                            ...+..++..+.+++.+||+.||++|||+.|+++|
T Consensus       224 ------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          224 ------FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH  258 (279)
T ss_dssp             ------CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred             ------CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence                  00111235578999999999999999999999987

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=9.3e-42  Score=348.49  Aligned_cols=253  Identities=22%  Similarity=0.280  Sum_probs=207.9

Q ss_pred             hhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHH------HHHHHHHHHHHHhhcCCCCcceeeeeeecCCc
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLER------AFRSFDSECEVLRNVRHRNLIKILSSYSNPDF  342 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  342 (593)
                      ..++|++.+.||+|+||.||+|+.. +|+.||+|+++.....      ..+.+.+|+.++++++||||+++++++.+.+.
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   89 (321)
T 2a2a_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD   89 (321)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence            3578999999999999999999976 6899999999764321      35678999999999999999999999999999


Q ss_pred             eEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC----cEEEEeec
Q 007680          343 KALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENM----VAHVSDFG  418 (593)
Q Consensus       343 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~----~~kL~Dfg  418 (593)
                      .++||||+++++|.+++.... .+++..+..++.|++.||+|||+++    |+||||||+||+++.++    .+||+|||
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~~~----ivH~dikp~NIl~~~~~~~~~~~kl~Dfg  164 (321)
T 2a2a_A           90 VVLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLHTKK----IAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (321)
T ss_dssp             EEEEECCCCSCBHHHHHHTCS-CEEHHHHHHHHHHHHHHHHHHHHTT----EECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred             EEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC----eecCCCChHHEEEecCCCCcCCEEEccCc
Confidence            999999999999999998754 4899999999999999999999654    99999999999999888    79999999


Q ss_pred             cceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchh
Q 007680          419 IYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLT  498 (593)
Q Consensus       419 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  498 (593)
                      ++........   .....||+.|+|||++.+..++.++||||||+++|+|++|+.||......  .....+...... . 
T Consensus       165 ~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~i~~~~~~-~-  237 (321)
T 2a2a_A          165 LAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--ETLANITSVSYD-F-  237 (321)
T ss_dssp             TCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHHHHHHTTCCC-C-
T ss_pred             cceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHhcccc-c-
Confidence            9987654322   23456899999999999999999999999999999999999999763211  111111111000 0 


Q ss_pred             hhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          499 EVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       499 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                                  .......++..+.+++.+||+.||++|||+.|+++|
T Consensus       238 ------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h  273 (321)
T 2a2a_A          238 ------------DEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (321)
T ss_dssp             ------------CHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred             ------------ChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                        001112345678999999999999999999999986

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=7.2e-42  Score=365.98  Aligned_cols=248  Identities=25%  Similarity=0.408  Sum_probs=206.9

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhH---HHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLE---RAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALV  346 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  346 (593)
                      .++|.+.+.||+|+||.||+|++. +|+.||||+++....   .....+.+|+.+++.++||||+++++++...+..++|
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv   94 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV   94 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            467999999999999999999976 799999999986532   2346789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCC
Q 007680          347 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG  426 (593)
Q Consensus       347 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  426 (593)
                      |||+++|+|.+++...+ .+++.++..++.|++.||+|||++    +|+||||||+||+++.++.+||+|||++......
T Consensus        95 ~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~----givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~  169 (476)
T 2y94_A           95 MEYVSGGELFDYICKNG-RLDEKESRRLFQQILSGVDYCHRH----MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG  169 (476)
T ss_dssp             EECCSSEEHHHHTTSSS-SCCHHHHHHHHHHHHHHHHHHHTT----TEECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred             EeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC----CCCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence            99999999999998655 499999999999999999999954    5999999999999999999999999999876543


Q ss_pred             CCccccccccCCccccCccccCCCCC-CccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhh
Q 007680          427 EDSVRQTMTMATIGYMAPEYGLEGIV-SAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANL  505 (593)
Q Consensus       427 ~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  505 (593)
                      .   ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||.+....  .....+....            
T Consensus       170 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~--~~~~~i~~~~------------  232 (476)
T 2y94_A          170 E---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP--TLFKKICDGI------------  232 (476)
T ss_dssp             C---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH--HHHHHHHTTC------------
T ss_pred             c---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH--HHHHHHhcCC------------
Confidence            2   2234579999999999888765 78999999999999999999999763211  1111111110            


Q ss_pred             hhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          506 VREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                            ...+..+++++.+++.+||+.||++|||+.|+++|
T Consensus       233 ------~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h  267 (476)
T 2y94_A          233 ------FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH  267 (476)
T ss_dssp             ------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             ------cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence                  00111235578999999999999999999999986

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=6.2e-42  Score=359.10  Aligned_cols=251  Identities=23%  Similarity=0.324  Sum_probs=198.2

Q ss_pred             hccccccccCccCcccEEEEEeCCCCeEEEEEeehhh--HHHHHHHHHHHHHHhhcC--CCCcceeeeeeecCCceEEEE
Q 007680          272 DEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVR--HRNLIKILSSYSNPDFKALVL  347 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~  347 (593)
                      ++|++.+.||+|+||.||+|...+++.||||++....  ....+.+.+|+.++.+++  ||||+++++++...+..++||
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  135 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  135 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence            4699999999999999999998889999999997542  445678999999999996  599999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCC
Q 007680          348 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGE  427 (593)
Q Consensus       348 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~  427 (593)
                      | +.+++|.+++.... .+++.++..++.||+.||+|||++    +|+||||||+|||++ ++.+||+|||+++.+....
T Consensus       136 E-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~~----~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~  208 (390)
T 2zmd_A          136 E-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQH----GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  208 (390)
T ss_dssp             E-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHHTT----TCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred             e-cCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence            9 56889999998766 489999999999999999999954    599999999999995 5799999999998775443


Q ss_pred             CccccccccCCccccCccccCC-----------CCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCc
Q 007680          428 DSVRQTMTMATIGYMAPEYGLE-----------GIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHG  496 (593)
Q Consensus       428 ~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  496 (593)
                      .........||+.|+|||++.+           ..++.++|||||||++|||++|+.||.........+...        
T Consensus       209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~--------  280 (390)
T 2zmd_A          209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI--------  280 (390)
T ss_dssp             -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHH--------
T ss_pred             ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHH--------
Confidence            3323344579999999998764           468999999999999999999999997632211111111        


Q ss_pred             hhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          497 LTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       497 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                          ++.....     ..+...+.++.+++.+||+.||++|||+.|+++|
T Consensus       281 ----~~~~~~~-----~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          281 ----IDPNHEI-----EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             ----HCTTSCC-----CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ----hCccccC-----CCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence                1111000     0011123578999999999999999999999987

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1.6e-41  Score=344.90  Aligned_cols=265  Identities=22%  Similarity=0.295  Sum_probs=203.2

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehh---hHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQ---LERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALV  346 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  346 (593)
                      .++|++.+.||+|+||.||+|... +|+.||+|+++..   .......+.+|+.++++++||||+++++++...+..++|
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  110 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV  110 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence            467999999999999999999964 7899999999753   244567789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceec
Q 007680          347 LEFMPNGSLEKWLYS---HNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLL  423 (593)
Q Consensus       347 ~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~  423 (593)
                      |||+++++|.+++..   ....+++..+..++.|++.||+|||+++    ++||||||+||+++.++.+||+|||++...
T Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~----i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~  186 (310)
T 2wqm_A          111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR----VMHRDIKPANVFITATGVVKLGDLGLGRFF  186 (310)
T ss_dssp             EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT----CCCCCCCGGGEEECTTSCEEECCC------
T ss_pred             EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC----eeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence            999999999999865   3345899999999999999999999654    999999999999999999999999998866


Q ss_pred             CCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhh
Q 007680          424 GEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDA  503 (593)
Q Consensus       424 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  503 (593)
                      .....  ......+++.|+|||++.+..++.++||||||+++|+|++|+.||.............+......        
T Consensus       187 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--------  256 (310)
T 2wqm_A          187 SSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYP--------  256 (310)
T ss_dssp             --------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSC--------
T ss_pred             cCCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCC--------
Confidence            43322  12334689999999999999999999999999999999999999976322221221111111000        


Q ss_pred             hhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhhhcch
Q 007680          504 NLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKFLDD  557 (593)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~  557 (593)
                              ......++.++.+++.+||+.||++|||+.++++.|+++++...+.
T Consensus       257 --------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~  302 (310)
T 2wqm_A          257 --------PLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASS  302 (310)
T ss_dssp             --------CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC--
T ss_pred             --------CCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhh
Confidence                    0001234567899999999999999999999999999998876443

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=5.7e-42  Score=350.61  Aligned_cols=254  Identities=21%  Similarity=0.281  Sum_probs=184.1

Q ss_pred             hccccc---cccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcC-CCCcceeeeeeecCCceEEE
Q 007680          272 DEFNEC---NLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNVR-HRNLIKILSSYSNPDFKALV  346 (593)
Q Consensus       272 ~~~~~~---~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv  346 (593)
                      ++|++.   +.||+|+||.||+|.+. +++.||||++....   ...+.+|+.+++.+. ||||+++++++.+.+..++|
T Consensus         8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv   84 (325)
T 3kn6_A            8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM---EANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLV   84 (325)
T ss_dssp             HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG---HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhh---hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEE
Confidence            455554   78999999999999975 68999999997653   356778999999997 99999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC---cEEEEeeccceec
Q 007680          347 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENM---VAHVSDFGIYKLL  423 (593)
Q Consensus       347 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~---~~kL~Dfg~a~~~  423 (593)
                      |||+++|+|.+++..... +++.++..++.|++.||+|||+++    |+||||||+||+++.++   .+||+|||+++..
T Consensus        85 ~e~~~~~~L~~~l~~~~~-~~~~~~~~i~~qi~~~l~~LH~~~----ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~  159 (325)
T 3kn6_A           85 MELLNGGELFERIKKKKH-FSETEASYIMRKLVSAVSHMHDVG----VVHRDLKPENLLFTDENDNLEIKIIDFGFARLK  159 (325)
T ss_dssp             ECCCCSCBHHHHHHHCSC-CCHHHHHHHHHHHHHHHHHHHHTT----EECCCCCGGGEEEEC----CEEEECCCTTCEEC
T ss_pred             EEccCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCC----CeecCCCHHHEEEecCCCcccEEEeccccceec
Confidence            999999999999987654 999999999999999999999654    99999999999998765   8999999999876


Q ss_pred             CCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCcccccc--chHHHHHHHhcCCchhhhh
Q 007680          424 GEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGE--MSLRRWVKESLPHGLTEVV  501 (593)
Q Consensus       424 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~  501 (593)
                      .....  ......+|+.|+|||++.+..++.++|||||||++|+|++|+.||.......  ...........        
T Consensus       160 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~--------  229 (325)
T 3kn6_A          160 PPDNQ--PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIK--------  229 (325)
T ss_dssp             CC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHT--------
T ss_pred             CCCCC--cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHH--------
Confidence            54322  2234568999999999999999999999999999999999999997642211  01111111100        


Q ss_pred             hhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          502 DANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       502 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      ....   ....+....+++++.+++.+||+.||++|||++|+++|
T Consensus       230 ~~~~---~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  271 (325)
T 3kn6_A          230 KGDF---SFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN  271 (325)
T ss_dssp             TTCC---CCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred             cCCC---CCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence            0000   00111123356788999999999999999999999865

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=3.2e-42  Score=372.33  Aligned_cols=259  Identities=23%  Similarity=0.366  Sum_probs=214.5

Q ss_pred             HhhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEE
Q 007680          269 RATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVL  347 (593)
Q Consensus       269 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  347 (593)
                      ...++|++.+.||+|+||.||+|.++ ++..||||+++... ...+.+.+|+.++++++||||+++++++...+..++||
T Consensus       217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~  295 (495)
T 1opk_A          217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT  295 (495)
T ss_dssp             CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEE
Confidence            34678999999999999999999976 48899999997653 23567899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCC
Q 007680          348 EFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG  426 (593)
Q Consensus       348 e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  426 (593)
                      ||+++|+|.+++.... ..+++..+..++.|++.||+|||+++    |+||||||+|||++.++.+||+|||+++.....
T Consensus       296 E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~----ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  371 (495)
T 1opk_A          296 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN----FIHRNLAARNCLVGENHLVKVADFGLSRLMTGD  371 (495)
T ss_dssp             ECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT----EECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred             EccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC----cccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence            9999999999998744 35899999999999999999999654    999999999999999999999999999876543


Q ss_pred             CCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhhhhhh
Q 007680          427 EDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANL  505 (593)
Q Consensus       427 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  505 (593)
                      .. .......++..|+|||++.+..++.++|||||||++|||+| |..||......  .....+....            
T Consensus       372 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~--~~~~~~~~~~------------  436 (495)
T 1opk_A          372 TY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVYELLEKDY------------  436 (495)
T ss_dssp             CE-ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHHHHHHTTC------------
T ss_pred             ce-eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCC------------
Confidence            21 12233446788999999988899999999999999999999 99999764322  1122211111            


Q ss_pred             hhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhh
Q 007680          506 VREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKV  552 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~  552 (593)
                           ....+..++.++.+++.+||+.||++|||+.++++.|+.+..
T Consensus       437 -----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~  478 (495)
T 1opk_A          437 -----RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  478 (495)
T ss_dssp             -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred             -----CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence                 111123456788999999999999999999999999998753

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=3.3e-41  Score=347.31  Aligned_cols=276  Identities=21%  Similarity=0.320  Sum_probs=214.2

Q ss_pred             HHHHHhhhccccccccCccCcccEEEEEeCCCCeEEEEEeehhhHHHHHHHHHHHHHHhh--cCCCCcceeeeeeecCC-
Q 007680          265 LDIQRATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRN--VRHRNLIKILSSYSNPD-  341 (593)
Q Consensus       265 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~-  341 (593)
                      .......++|++.+.||+|+||.||+|++ +|+.||+|+++...   ...+.+|.+++..  ++||||+++++++...+ 
T Consensus        35 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~  110 (342)
T 1b6c_B           35 LVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNG  110 (342)
T ss_dssp             HHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCS
T ss_pred             eecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCchh---HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCC
Confidence            33455678999999999999999999998 58999999997553   3467788888887  68999999999998876 


Q ss_pred             ---ceEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcC----CCCCeEecCCCCCCeeeCCCCcEEE
Q 007680          342 ---FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGH----SSVHIIHCDLKPTNILLDENMVAHV  414 (593)
Q Consensus       342 ---~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~----~~~~ivH~Dlkp~NIll~~~~~~kL  414 (593)
                         ..++||||+++|+|.+++....  +++.++..++.|++.||+|||...    .+.+|+||||||+||+++.++.+||
T Consensus       111 ~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL  188 (342)
T 1b6c_B          111 TWTQLWLVSDYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI  188 (342)
T ss_dssp             SCCCEEEEECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEE
T ss_pred             ccceeEEEEeecCCCcHHHHHhccC--ccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEE
Confidence               7899999999999999998754  899999999999999999999210    0235999999999999999999999


Q ss_pred             EeeccceecCCCCCcc--ccccccCCccccCccccCCC------CCCccchHHHHHHHHHHHHhC----------CCCCC
Q 007680          415 SDFGIYKLLGEGEDSV--RQTMTMATIGYMAPEYGLEG------IVSAKCDVYSYGVLLMETFTR----------KRPTD  476 (593)
Q Consensus       415 ~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~s~~~DvwSlGvvl~elltg----------~~pf~  476 (593)
                      +|||++..........  ......||+.|+|||++.+.      .++.++|||||||++|||+||          ..||.
T Consensus       189 ~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~  268 (342)
T 1b6c_B          189 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY  268 (342)
T ss_dssp             CCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred             EECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcc
Confidence            9999998765543221  22345699999999998765      234789999999999999999          77886


Q ss_pred             ccccccchHHHHHHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhhh
Q 007680          477 EMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKF  554 (593)
Q Consensus       477 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  554 (593)
                      ...........+..........        ..........+++..+.+++.+||+.||++|||+.|++++|+++....
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~  338 (342)
T 1b6c_B          269 DLVPSDPSVEEMRKVVCEQKLR--------PNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE  338 (342)
T ss_dssp             TTSCSSCCHHHHHHHHTTSCCC--------CCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             ccCcCcccHHHHHHHHHHHHhC--------CCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHh
Confidence            6543333332222211111100        000001112345678999999999999999999999999999987653

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=2.1e-41  Score=341.32  Aligned_cols=274  Identities=18%  Similarity=0.218  Sum_probs=216.3

Q ss_pred             hhccccccccCccCcccEEEEEe-CCCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeee-ecCCceEEEEe
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTI-SDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSY-SNPDFKALVLE  348 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~e  348 (593)
                      .++|++.+.||+|+||.||+|+. .+|+.||+|++.....  .+.+.+|+.+++.++|++++..+.++ ...+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence            56899999999999999999996 4799999999875432  24688999999999988877666655 56678899999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeC---CCCcEEEEeeccceecCC
Q 007680          349 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLD---ENMVAHVSDFGIYKLLGE  425 (593)
Q Consensus       349 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~---~~~~~kL~Dfg~a~~~~~  425 (593)
                      |+ +++|.+++......+++.++..++.|++.||+|||+++    |+||||||+||+++   .++.+||+|||++.....
T Consensus        86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~----ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~  160 (296)
T 3uzp_A           86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN----FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  160 (296)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT----EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             ec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC----eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence            99 89999999866667999999999999999999999655    99999999999994   888999999999988765


Q ss_pred             CCCcc-----ccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCcccccc--chHHHHHHHhcCCchh
Q 007680          426 GEDSV-----RQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGE--MSLRRWVKESLPHGLT  498 (593)
Q Consensus       426 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~--~~~~~~~~~~~~~~~~  498 (593)
                      .....     ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......  ..+......       
T Consensus       161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-------  233 (296)
T 3uzp_A          161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK-------  233 (296)
T ss_dssp             TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHH-------
T ss_pred             cccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccc-------
Confidence            43211     1234579999999999999999999999999999999999999998642211  111111110       


Q ss_pred             hhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhhhcc-hhhccCCcc
Q 007680          499 EVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKFLD-DAAATNWRN  565 (593)
Q Consensus       499 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~-~~~~~~~~~  565 (593)
                           .....  .......+++++.+++.+||+.||++|||+.++++.|+++...... .....+|+.
T Consensus       234 -----~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~~~~dw~~  294 (296)
T 3uzp_A          234 -----KMSTP--IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNM  294 (296)
T ss_dssp             -----HHHSC--HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSSCCCGGGG
T ss_pred             -----ccCCc--hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCcccccccccc
Confidence                 00000  0011123467899999999999999999999999999999877533 344566764

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.1e-41  Score=347.07  Aligned_cols=263  Identities=21%  Similarity=0.224  Sum_probs=209.2

Q ss_pred             hhccccccccCccCcccEEEEEe-CCCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeee----cCCceEE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTI-SDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYS----NPDFKAL  345 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----~~~~~~l  345 (593)
                      .++|++.+.||+|+||.||+++. .+++.||+|++........+.+.+|++++++++||||+++++++.    .....++
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  107 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL  107 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence            46899999999999999999997 479999999997766666778999999999999999999999986    3347899


Q ss_pred             EEeccCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeecccee
Q 007680          346 VLEFMPNGSLEKWLYS---HNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKL  422 (593)
Q Consensus       346 v~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~  422 (593)
                      ||||+++|+|.+++..   ....+++.++..++.|++.||+|||+++    |+||||||+||+++.++.+||+|||.+..
T Consensus       108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~----ivH~dlkp~NIl~~~~~~~kl~dfg~~~~  183 (317)
T 2buj_A          108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG----YAHRDLKPTNILLGDEGQPVLMDLGSMNQ  183 (317)
T ss_dssp             EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT----EECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred             EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC----cccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence            9999999999999876   3446999999999999999999999654    99999999999999999999999999876


Q ss_pred             cCCCCCcc-------ccccccCCccccCccccCCCC---CCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHh
Q 007680          423 LGEGEDSV-------RQTMTMATIGYMAPEYGLEGI---VSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKES  492 (593)
Q Consensus       423 ~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~  492 (593)
                      ........       ......||+.|+|||++.+..   ++.++||||||+++|||++|+.||.................
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~  263 (317)
T 2buj_A          184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQ  263 (317)
T ss_dssp             SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC
T ss_pred             cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhcc
Confidence            54221110       112235799999999987654   78999999999999999999999965322222211111110


Q ss_pred             cCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhhh
Q 007680          493 LPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKF  554 (593)
Q Consensus       493 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  554 (593)
                                       ...+....++.++.+++.+||+.||++|||+.|++++|+.+....
T Consensus       264 -----------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~  308 (317)
T 2buj_A          264 -----------------LSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPA  308 (317)
T ss_dssp             -------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCC
T ss_pred             -----------------CCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCC
Confidence                             001111234567899999999999999999999999999986543

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=2e-41  Score=339.16  Aligned_cols=260  Identities=20%  Similarity=0.318  Sum_probs=208.6

Q ss_pred             hhhccccccccCccCcccEEEEEeCC----CCeEEEEEeehh-hHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceE
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTISD----GTDVAIKVFNLQ-LERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKA  344 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  344 (593)
                      ..++|++.+.||+|+||.||+|++.+    +..||+|+++.. .....+.+.+|+.++++++||||+++++++.++ ..+
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~   88 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTW   88 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCE
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCE
Confidence            35789999999999999999998542    345999999765 234557899999999999999999999998654 568


Q ss_pred             EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecC
Q 007680          345 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG  424 (593)
Q Consensus       345 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~  424 (593)
                      +||||+++++|.+++......+++..+..++.|++.||+|||+++    |+||||||+||+++.++.+||+|||++....
T Consensus        89 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~----i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  164 (281)
T 3cc6_A           89 IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN----CVHRDIAVRNILVASPECVKLGDFGLSRYIE  164 (281)
T ss_dssp             EEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT----CCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred             EEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCC----cccCCCccceEEECCCCcEEeCccCCCcccc
Confidence            999999999999999877667999999999999999999999655    9999999999999999999999999998765


Q ss_pred             CCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhhhh
Q 007680          425 EGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDA  503 (593)
Q Consensus       425 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  503 (593)
                      .... .......+++.|+|||++.+..++.++||||||+++|||++ |+.||......  .....+.....         
T Consensus       165 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~--~~~~~~~~~~~---------  232 (281)
T 3cc6_A          165 DEDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK--DVIGVLEKGDR---------  232 (281)
T ss_dssp             ---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG--GHHHHHHHTCC---------
T ss_pred             cccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH--HHHHHHhcCCC---------
Confidence            4322 12233457889999999988899999999999999999998 99999753222  11121111110         


Q ss_pred             hhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhhh
Q 007680          504 NLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKF  554 (593)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  554 (593)
                              ...+..+++.+.+++.+||+.||++|||+.|++++|+++...-
T Consensus       233 --------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~  275 (281)
T 3cc6_A          233 --------LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQME  275 (281)
T ss_dssp             --------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             --------CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhh
Confidence                    0111224567899999999999999999999999999987654

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.5e-41  Score=345.20  Aligned_cols=267  Identities=21%  Similarity=0.236  Sum_probs=201.9

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh--HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVL  347 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  347 (593)
                      .++|++.+.||+|+||.||+|++. +|+.||+|++....  ....+.+.+|++++++++||||+++++++...+..++||
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF   81 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence            367999999999999999999976 68999999986542  334567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCC
Q 007680          348 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGE  427 (593)
Q Consensus       348 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~  427 (593)
                      ||+++++|.+++..... +++..+..++.|++.||+|||+++    |+||||||+||+++.++.+||+|||.+.......
T Consensus        82 e~~~~~~l~~~~~~~~~-~~~~~~~~i~~~l~~~l~~lH~~~----ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  156 (311)
T 4agu_A           82 EYCDHTVLHELDRYQRG-VPEHLVKSITWQTLQAVNFCHKHN----CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS  156 (311)
T ss_dssp             ECCSEEHHHHHHHTSSC-CCHHHHHHHHHHHHHHHHHHHHTT----EECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             EeCCCchHHHHHhhhcC-CCHHHHHHHHHHHHHHHHHHHHCC----CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence            99999999998876554 999999999999999999999654    9999999999999999999999999998765433


Q ss_pred             CccccccccCCccccCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCc---hhhhhhh
Q 007680          428 DSVRQTMTMATIGYMAPEYGLE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHG---LTEVVDA  503 (593)
Q Consensus       428 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~---~~~~~~~  503 (593)
                      .  ......+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||......+  ....+.......   .......
T Consensus       157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  232 (311)
T 4agu_A          157 D--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVD--QLYLIRKTLGDLIPRHQQVFST  232 (311)
T ss_dssp             -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCSCCHHHHHHHHT
T ss_pred             c--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhccccccccccccc
Confidence            2  2234568999999998876 668999999999999999999999997643221  111111111110   0000000


Q ss_pred             hhh------h----hhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          504 NLV------R----EEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       504 ~~~------~----~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      ...      .    ..........++.++.+++.+||+.||++|||++|+++|
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  285 (311)
T 4agu_A          233 NQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH  285 (311)
T ss_dssp             CGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred             ccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            000      0    000001112356678999999999999999999999986

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.3e-42  Score=352.35  Aligned_cols=271  Identities=20%  Similarity=0.282  Sum_probs=202.5

Q ss_pred             hccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHH-HHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEec
Q 007680          272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLER-AFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEF  349 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  349 (593)
                      ++|++.+.||+|+||.||+|+.. +++.||+|+++..... ....+.+|++++++++||||+++++++...+..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            57999999999999999999976 7899999999754322 222455799999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCc
Q 007680          350 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDS  429 (593)
Q Consensus       350 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~  429 (593)
                      ++ |+|.+++......+++..+..++.|++.||+|||+++    |+||||||+||+++.++.+||+|||++........ 
T Consensus        82 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~----ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~-  155 (324)
T 3mtl_A           82 LD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK----VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-  155 (324)
T ss_dssp             CS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT----EEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred             cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC----ccCCCcCHHHEEECCCCCEEEccCcccccccCCcc-
Confidence            96 5999999887777999999999999999999999654    99999999999999999999999999986543322 


Q ss_pred             cccccccCCccccCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcC----Cchhhhhhhh
Q 007680          430 VRQTMTMATIGYMAPEYGLE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLP----HGLTEVVDAN  504 (593)
Q Consensus       430 ~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~  504 (593)
                       ......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||......+  ....+.....    ..+.......
T Consensus       156 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~i~~~~~~~~~~~~~~~~~~~  232 (324)
T 3mtl_A          156 -TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE--QLHFIFRILGTPTEETWPGILSNE  232 (324)
T ss_dssp             --------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCCCTTTSTTGGGCH
T ss_pred             -ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCChHhchhhhcch
Confidence             2233468999999998876 568999999999999999999999997743221  2222211111    1111111110


Q ss_pred             hhh--------hhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH--HHHhh
Q 007680          505 LVR--------EEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK--LKKIK  551 (593)
Q Consensus       505 ~~~--------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~i~  551 (593)
                      ...        ..........+++++.+++.+||+.||++|||++|+++|  +.++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  289 (324)
T 3mtl_A          233 EFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG  289 (324)
T ss_dssp             HHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred             hhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcc
Confidence            000        000011122345678999999999999999999999986  44443

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=6.5e-42  Score=342.81  Aligned_cols=253  Identities=22%  Similarity=0.346  Sum_probs=206.3

Q ss_pred             hhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec---------
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSN---------  339 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---------  339 (593)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|+++...    +.+.+|++++++++||||+++++++..         
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   84 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS   84 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence            4578999999999999999999976 79999999997653    346789999999999999999998854         


Q ss_pred             -------CCceEEEEeccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCc
Q 007680          340 -------PDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMV  411 (593)
Q Consensus       340 -------~~~~~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~  411 (593)
                             ....++||||+++++|.+++.... ..+++..+..++.|++.||.|||+++    |+||||||+||+++.++.
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~----i~H~dlkp~Nil~~~~~~  160 (284)
T 2a19_B           85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK----LINRDLKPSNIFLVDTKQ  160 (284)
T ss_dssp             ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT----EECSCCSGGGEEEEETTE
T ss_pred             ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC----eeeccCCHHHEEEcCCCC
Confidence                   345799999999999999997653 35899999999999999999999654    999999999999999999


Q ss_pred             EEEEeeccceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHH
Q 007680          412 AHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKE  491 (593)
Q Consensus       412 ~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~  491 (593)
                      +||+|||++........   .....+++.|+|||++.+..++.++||||||+++|||++|..|+....    ........
T Consensus       161 ~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~----~~~~~~~~  233 (284)
T 2a19_B          161 VKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS----KFFTDLRD  233 (284)
T ss_dssp             EEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH----HHHHHHHT
T ss_pred             EEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH----HHHHHhhc
Confidence            99999999987754432   233468999999999999999999999999999999999999874311    00000000


Q ss_pred             hcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhhhcch
Q 007680          492 SLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKFLDD  557 (593)
Q Consensus       492 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~  557 (593)
                                 ..+         ...++..+.+++.+||+.||++|||+.|++++|+.++...+..
T Consensus       234 -----------~~~---------~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~~  279 (284)
T 2a19_B          234 -----------GII---------SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKN  279 (284)
T ss_dssp             -----------TCC---------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-----
T ss_pred             -----------ccc---------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCcc
Confidence                       000         0123456899999999999999999999999999987665443

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1e-41  Score=346.03  Aligned_cols=268  Identities=24%  Similarity=0.298  Sum_probs=201.1

Q ss_pred             hhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh-----HHHHHHHHHHHHHHhhc---CCCCcceeeeeeecC
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL-----ERAFRSFDSECEVLRNV---RHRNLIKILSSYSNP  340 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~  340 (593)
                      ..++|++.+.||+|+||.||+|++. +++.||+|+++...     ......+.+|+.+++++   +||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            4678999999999999999999964 78999999997432     11124566777777766   499999999999776


Q ss_pred             C-----ceEEEEeccCCCCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEE
Q 007680          341 D-----FKALVLEFMPNGSLEKWLYSHNY-FLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHV  414 (593)
Q Consensus       341 ~-----~~~lv~e~~~~gsL~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL  414 (593)
                      .     ..++||||++ ++|.+++..... .+++.++..++.|++.||+|||+++    |+||||||+||+++.++.+||
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~----ivH~Dlkp~Nil~~~~~~~kl  161 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC----IVHRDLKPENILVTSGGTVKL  161 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCCTTTEEECTTSCEEE
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC----cccCCCCHHHEEEcCCCCEEE
Confidence            5     5799999996 599999987654 4899999999999999999999655    999999999999999999999


Q ss_pred             EeeccceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHh-c
Q 007680          415 SDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKES-L  493 (593)
Q Consensus       415 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~-~  493 (593)
                      +|||+++......   ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ......... .
T Consensus       162 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~~  237 (308)
T 3g33_A          162 ADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD-QLGKIFDLIGL  237 (308)
T ss_dssp             CSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH-HHHHHHHHHCC
T ss_pred             eeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCC
Confidence            9999998664332   2244568999999999999999999999999999999999999997643221 111111111 0


Q ss_pred             CC-c-hhhhh---hhhhhhh--hhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          494 PH-G-LTEVV---DANLVRE--EQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       494 ~~-~-~~~~~---~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      +. . +....   .......  ........+++.++.+++.+||+.||++|||+.|+++|
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  297 (308)
T 3g33_A          238 PPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH  297 (308)
T ss_dssp             CCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence            00 0 00000   0000000  00011112345688999999999999999999999975

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.4e-41  Score=345.24  Aligned_cols=261  Identities=20%  Similarity=0.244  Sum_probs=202.4

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALV  346 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  346 (593)
                      .++|++.+.||+|+||.||+|... +++.||+|++....   ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            578999999999999999999975 78999999997653   23457789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCC
Q 007680          347 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG  426 (593)
Q Consensus       347 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  426 (593)
                      |||+++++|.+++..... +++.++..++.|++.||+|||+++    |+||||||+||+++.++.+||+|||++......
T Consensus       113 ~e~~~~~~L~~~l~~~~~-~~~~~~~~i~~qi~~~l~~lH~~~----i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  187 (309)
T 2h34_A          113 MRLINGVDLAAMLRRQGP-LAPPRAVAIVRQIGSALDAAHAAG----ATHRDVKPENILVSADDFAYLVDFGIASATTDE  187 (309)
T ss_dssp             EECCCCEEHHHHHHHHCS-CCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred             EEecCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCc----CCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence            999999999999987654 899999999999999999999654    999999999999999999999999998866443


Q ss_pred             CCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhh
Q 007680          427 EDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLV  506 (593)
Q Consensus       427 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  506 (593)
                      .. .......+++.|+|||++.+..++.++||||||+++|||++|+.||......  ..........+.           
T Consensus       188 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~-----------  253 (309)
T 2h34_A          188 KL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS--VMGAHINQAIPR-----------  253 (309)
T ss_dssp             ----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH--HHHHHHHSCCCC-----------
T ss_pred             cc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH--HHHHHhccCCCC-----------
Confidence            21 1223456899999999999999999999999999999999999999763211  111111111100           


Q ss_pred             hhhhhhhhhHHHHHHHHHHHhhcccCCCCCCC-CHHHHHHHHHHhhhhh
Q 007680          507 REEQAFSAKMDCILSIMDFALDCCMESPDMRI-NMTDAAAKLKKIKVKF  554 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~i~~~~  554 (593)
                          .......++.++.+++.+||+.||++|| +++++++.|++.....
T Consensus       254 ----~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~  298 (309)
T 2h34_A          254 ----PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA  298 (309)
T ss_dssp             ----GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred             ----ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence                0011123456789999999999999999 9999999999876554

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=7.3e-42  Score=352.91  Aligned_cols=268  Identities=16%  Similarity=0.161  Sum_probs=203.6

Q ss_pred             hhccccccccCccCcccEEEEEeC----CCCeEEEEEeehhhHH-----------HHHHHHHHHHHHhhcCCCCcceeee
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS----DGTDVAIKVFNLQLER-----------AFRSFDSECEVLRNVRHRNLIKILS  335 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~l~~  335 (593)
                      .++|++.+.||+|+||.||+|...    ++..||+|++......           ....+.+|+..+..++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            468999999999999999999975    5788999998754211           1234667889999999999999999


Q ss_pred             eeec----CCceEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC-
Q 007680          336 SYSN----PDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENM-  410 (593)
Q Consensus       336 ~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~-  410 (593)
                      ++..    ....++||||+ +++|.+++...+ .+++.++..++.|++.||+|||+++    |+||||||+||+++.++ 
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~----ivH~Dlkp~NIll~~~~~  189 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHENE----YVHGDIKAANLLLGYKNP  189 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHHTT----EECSCCSGGGEEEESSST
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC----eeCCCcCHHHEEEccCCC
Confidence            9887    67899999999 999999998766 5999999999999999999999654    99999999999999887 


Q ss_pred             -cEEEEeeccceecCCCCCc-----cccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccch
Q 007680          411 -VAHVSDFGIYKLLGEGEDS-----VRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMS  484 (593)
Q Consensus       411 -~~kL~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~  484 (593)
                       .+||+|||+++.+......     .......||+.|+|||++.+..++.++|||||||++|||++|+.||.........
T Consensus       190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~  269 (345)
T 2v62_A          190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA  269 (345)
T ss_dssp             TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred             CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence             9999999999877543211     1123457999999999999999999999999999999999999999653222221


Q ss_pred             HHHHHHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhh
Q 007680          485 LRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVK  553 (593)
Q Consensus       485 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  553 (593)
                      ......... ......+.        .......++.++.+++.+||+.||++|||+.++++.|+++...
T Consensus       270 ~~~~~~~~~-~~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~  329 (345)
T 2v62_A          270 VQTAKTNLL-DELPQSVL--------KWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIP  329 (345)
T ss_dssp             HHHHHHHHH-HTTTHHHH--------HHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCC
T ss_pred             HHHHHHhhc-ccccHHHH--------hhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCc
Confidence            111111100 00000000        0000113466899999999999999999999999999987543

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=7.6e-42  Score=343.06  Aligned_cols=251  Identities=26%  Similarity=0.335  Sum_probs=198.8

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEe
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLE  348 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  348 (593)
                      .++|.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  100 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME  100 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence            468999999999999999999975 68999999998754 2345678999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeee---CCCCcEEEEeecccee
Q 007680          349 FMPNGSLEKWLYSH---NYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILL---DENMVAHVSDFGIYKL  422 (593)
Q Consensus       349 ~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll---~~~~~~kL~Dfg~a~~  422 (593)
                      |+++++|.+++...   ...+++..+..++.|++.||+|||+++    |+||||||+||++   +.++.+||+|||++..
T Consensus       101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~----ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~  176 (285)
T 3is5_A          101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH----VVHKDLKPENILFQDTSPHSPIKIIDFGLAEL  176 (285)
T ss_dssp             CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT----CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred             eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC----EEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence            99999999988643   245999999999999999999999654    9999999999999   4567899999999987


Q ss_pred             cCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhh
Q 007680          423 LGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVD  502 (593)
Q Consensus       423 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  502 (593)
                      .....   ......+|+.|+|||++. +.++.++||||||+++|||++|+.||......+  .........+..      
T Consensus       177 ~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~--~~~~~~~~~~~~------  244 (285)
T 3is5_A          177 FKSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE--VQQKATYKEPNY------  244 (285)
T ss_dssp             -------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHCCCCC------
T ss_pred             cCCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHH--HHhhhccCCccc------
Confidence            65432   223456899999999875 568999999999999999999999997642211  111111110000      


Q ss_pred             hhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          503 ANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                               .......++++.+++.+||+.||++|||+.|+++|
T Consensus       245 ---------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  279 (285)
T 3is5_A          245 ---------AVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH  279 (285)
T ss_dssp             ---------CC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred             ---------ccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                     00001134578999999999999999999999864

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=6e-42  Score=353.63  Aligned_cols=248  Identities=27%  Similarity=0.339  Sum_probs=202.9

Q ss_pred             hhccccccccCccCcccEEEEEe-CCCCeEEEEEeehh---hHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTI-SDGTDVAIKVFNLQ---LERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALV  346 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  346 (593)
                      .+.|+..+.||+|+||.||+|+. .+|+.||||++...   .....+.+.+|++++++++||||+++++++...+..++|
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  132 (348)
T 1u5q_A           53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV  132 (348)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence            45699999999999999999996 47899999999753   234456789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCC
Q 007680          347 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG  426 (593)
Q Consensus       347 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  426 (593)
                      |||+. |+|.+++......+++.++..++.|++.||+|||+++    |+||||||+||+++.++.+||+|||++......
T Consensus       133 ~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~----ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~  207 (348)
T 1u5q_A          133 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN----MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  207 (348)
T ss_dssp             EECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT----CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred             EecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC----eeeCCCCHHHEEECCCCCEEEeeccCceecCCC
Confidence            99996 6898888766666999999999999999999999655    999999999999999999999999999865432


Q ss_pred             CCccccccccCCccccCccccC---CCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhh
Q 007680          427 EDSVRQTMTMATIGYMAPEYGL---EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDA  503 (593)
Q Consensus       427 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  503 (593)
                            ....||+.|+|||++.   +..++.++|||||||++|||++|+.||....... ..........+.        
T Consensus       208 ------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~-~~~~~~~~~~~~--------  272 (348)
T 1u5q_A          208 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQNESPA--------  272 (348)
T ss_dssp             ------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHSCCCC--------
T ss_pred             ------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhcCCCC--------
Confidence                  2346899999999874   5678999999999999999999999997632111 111111111000        


Q ss_pred             hhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 007680          504 NLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKL  547 (593)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  547 (593)
                               .....++..+.+++.+||+.||++|||+.+++++-
T Consensus       273 ---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~  307 (348)
T 1u5q_A          273 ---------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR  307 (348)
T ss_dssp             ---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred             ---------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence                     00112355789999999999999999999999763

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-41  Score=343.71  Aligned_cols=263  Identities=22%  Similarity=0.358  Sum_probs=209.4

Q ss_pred             ccccccccCccCcccEEEEEeC-CC---CeEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCce-EEE
Q 007680          273 EFNECNLLGTSSFGSVYKGTIS-DG---TDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFK-ALV  346 (593)
Q Consensus       273 ~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-~lv  346 (593)
                      .|...+.||+|+||.||+|.+. ++   ..||+|++.... ....+.+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            5666789999999999999853 22   369999987543 34567889999999999999999999999876655 999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCC
Q 007680          347 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG  426 (593)
Q Consensus       347 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  426 (593)
                      |||+.+++|.+++......+++.++..++.|++.||+|||+++    |+||||||+||+++.++.+||+|||+++.....
T Consensus       102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~----i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~  177 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK----FVHRDLAARNCMLDESFTVKVADFGLARDILDR  177 (298)
T ss_dssp             ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT----CCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred             EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC----cccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence            9999999999999886667999999999999999999999655    999999999999999999999999999865433


Q ss_pred             CC--ccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhh
Q 007680          427 ED--SVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDAN  504 (593)
Q Consensus       427 ~~--~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  504 (593)
                      ..  ........+++.|+|||.+.+..++.++||||||+++|+|++|..|+..... .............          
T Consensus       178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~-~~~~~~~~~~~~~----------  246 (298)
T 3pls_A          178 EYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID-PFDLTHFLAQGRR----------  246 (298)
T ss_dssp             GGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC-GGGHHHHHHTTCC----------
T ss_pred             cccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCC-HHHHHHHhhcCCC----------
Confidence            21  1122334678899999999999999999999999999999996555433211 1122222221111          


Q ss_pred             hhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhhhcch
Q 007680          505 LVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKFLDD  557 (593)
Q Consensus       505 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~  557 (593)
                             ...+..++..+.+++.+||+.||++|||+.++++.|+++...+..+
T Consensus       247 -------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~  292 (298)
T 3pls_A          247 -------LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGD  292 (298)
T ss_dssp             -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSC
T ss_pred             -------CCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhcc
Confidence                   1111234567899999999999999999999999999998876443

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.7e-41  Score=345.55  Aligned_cols=268  Identities=22%  Similarity=0.287  Sum_probs=200.0

Q ss_pred             hhccccc-cccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhc-CCCCcceeeeeeecCCceEEEE
Q 007680          271 TDEFNEC-NLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNV-RHRNLIKILSSYSNPDFKALVL  347 (593)
Q Consensus       271 ~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  347 (593)
                      .+.|++. +.||+|+||.||+|... +++.||||++........+.+.+|++++.++ +||||+++++++.+.+..++||
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~   90 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF   90 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence            4578885 78999999999999964 7899999999876545567889999999985 7999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCc---EEEEeeccceecC
Q 007680          348 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMV---AHVSDFGIYKLLG  424 (593)
Q Consensus       348 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~---~kL~Dfg~a~~~~  424 (593)
                      ||+++++|.+++..... +++.++..++.|++.||+|||+++    |+||||||+||+++.++.   +||+|||++....
T Consensus        91 e~~~~~~L~~~l~~~~~-~~~~~~~~i~~qi~~~l~~lH~~~----ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~  165 (316)
T 2ac3_A           91 EKMRGGSILSHIHKRRH-FNELEASVVVQDVASALDFLHNKG----IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK  165 (316)
T ss_dssp             ECCTTCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHHHTT----CCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred             EcCCCCcHHHHHhccCC-CCHHHHHHHHHHHHHHHHHHHhCC----ceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence            99999999999987654 899999999999999999999654    999999999999998776   9999999987654


Q ss_pred             CCCC-----ccccccccCCccccCccccCC-----CCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcC
Q 007680          425 EGED-----SVRQTMTMATIGYMAPEYGLE-----GIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLP  494 (593)
Q Consensus       425 ~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~  494 (593)
                      ....     ........||+.|+|||++.+     ..++.++|||||||++|||++|+.||......+.....   ....
T Consensus       166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~---~~~~  242 (316)
T 2ac3_A          166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDR---GEAC  242 (316)
T ss_dssp             ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC-------CC
T ss_pred             cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccc---cccc
Confidence            3221     111223458999999999865     56899999999999999999999999764322210000   0000


Q ss_pred             Cchhhhhhhhhhhhhhhh--hhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          495 HGLTEVVDANLVREEQAF--SAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       495 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      ......+...+.......  .....++.++.+++.+||+.||++|||+.|+++|
T Consensus       243 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  296 (316)
T 2ac3_A          243 PACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH  296 (316)
T ss_dssp             HHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            000000000000000000  0112345688999999999999999999999986

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.4e-42  Score=358.66  Aligned_cols=263  Identities=22%  Similarity=0.361  Sum_probs=202.0

Q ss_pred             hccccccccCccCcccEEEEEeC--C--CCeEEEEEeehh-hHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CCceEE
Q 007680          272 DEFNECNLLGTSSFGSVYKGTIS--D--GTDVAIKVFNLQ-LERAFRSFDSECEVLRNVRHRNLIKILSSYSN-PDFKAL  345 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~--~--~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~l  345 (593)
                      ..|++.+.||+|+||.||+|++.  +  +..||+|.++.. .....+.+.+|+.++++++||||+++++++.. .+..++
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l  168 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  168 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence            45778899999999999999864  2  246899998653 23456789999999999999999999998654 567899


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCC
Q 007680          346 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGE  425 (593)
Q Consensus       346 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~  425 (593)
                      ||||+++|+|.+++......+++.++..++.|+++||+|||+++    |+||||||+||+++.++.+||+|||+++....
T Consensus       169 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~----ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~  244 (373)
T 3c1x_A          169 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK----FVHRDLAARNCMLDEKFTVKVADFGLARDMYD  244 (373)
T ss_dssp             EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT----CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCC----EecCccchheEEECCCCCEEEeeccccccccc
Confidence            99999999999999887767899999999999999999999654    99999999999999999999999999986643


Q ss_pred             CCCc--cccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhhh
Q 007680          426 GEDS--VRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVD  502 (593)
Q Consensus       426 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  502 (593)
                      ....  .......+++.|+|||++.+..++.++|||||||++|||+| |.+||......+  ....+....         
T Consensus       245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~--~~~~~~~~~---------  313 (373)
T 3c1x_A          245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--ITVYLLQGR---------  313 (373)
T ss_dssp             -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC--HHHHHHTTC---------
T ss_pred             cccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH--HHHHHHcCC---------
Confidence            3211  11233457789999999999999999999999999999999 677886632221  111111110         


Q ss_pred             hhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhhhcch
Q 007680          503 ANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKFLDD  557 (593)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~  557 (593)
                              ....+..++..+.+++.+||+.||++|||+.|++++|+++...+..+
T Consensus       314 --------~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~  360 (373)
T 3c1x_A          314 --------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE  360 (373)
T ss_dssp             --------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred             --------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcccc
Confidence                    00111234567899999999999999999999999999998877543

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.7e-41  Score=347.37  Aligned_cols=261  Identities=23%  Similarity=0.378  Sum_probs=207.7

Q ss_pred             hhccccccccCccCcccEEEEEe------CCCCeEEEEEeehh-hHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCce
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTI------SDGTDVAIKVFNLQ-LERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFK  343 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  343 (593)
                      .++|++.+.||+|+||.||+|++      .+++.||+|++... .......+.+|+.++++++||||+++++++.+.+..
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            57899999999999999999984      25778999999644 234556788999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhCC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC---CCcEEE
Q 007680          344 ALVLEFMPNGSLEKWLYSHN------YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDE---NMVAHV  414 (593)
Q Consensus       344 ~lv~e~~~~gsL~~~l~~~~------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~---~~~~kL  414 (593)
                      ++||||+++++|.+++....      ..+++.++..++.|++.||.|||+++    |+||||||+||+++.   +..+||
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~----i~H~dlkp~NIli~~~~~~~~~kl  184 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH----FIHRDIAARNCLLTCPGPGRVAKI  184 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC----eecCcCCHhHEEEecCCCcceEEE
Confidence            99999999999999998764      24899999999999999999999654    999999999999984   456999


Q ss_pred             EeeccceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhc
Q 007680          415 SDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESL  493 (593)
Q Consensus       415 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~  493 (593)
                      +|||++................+++.|+|||++.+..++.++||||||+++|+|+| |+.||.....  ......+....
T Consensus       185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--~~~~~~~~~~~  262 (327)
T 2yfx_A          185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--QEVLEFVTSGG  262 (327)
T ss_dssp             CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHHHHHHHTTC
T ss_pred             CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH--HHHHHHHhcCC
Confidence            99999886544332223344567899999999988899999999999999999998 9999976321  11112211111


Q ss_pred             CCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhhh
Q 007680          494 PHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKF  554 (593)
Q Consensus       494 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  554 (593)
                      .                 ......++..+.+++.+||+.||++||++.|++++|+.+....
T Consensus       263 ~-----------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~  306 (327)
T 2yfx_A          263 R-----------------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP  306 (327)
T ss_dssp             C-----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred             C-----------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence            0                 0111234567899999999999999999999999999987654

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.1e-42  Score=356.74  Aligned_cols=276  Identities=11%  Similarity=0.100  Sum_probs=214.7

Q ss_pred             hhccccccccCccCcccEEEEEeCC---------CCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcce---------
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTISD---------GTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIK---------  332 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---------  332 (593)
                      .++|++.+.||+|+||.||+|+...         ++.||+|++...     +.+.+|++++++++||||++         
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            3689999999999999999999763         789999998754     35788999999999999988         


Q ss_pred             ------eeeeeec-CCceEEEEeccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCe
Q 007680          333 ------ILSSYSN-PDFKALVLEFMPNGSLEKWLYSH-NYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNI  404 (593)
Q Consensus       333 ------l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NI  404 (593)
                            +++++.. .+..++||||+ +++|.+++... ...+++.++..++.|++.||+|||+++    |+||||||+||
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~----ivH~Dikp~NI  190 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE----YVHGNVTAENI  190 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT----CBCSCCCGGGE
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC----ccCCCCCHHHE
Confidence                  5666655 67889999999 99999999876 235999999999999999999999654    99999999999


Q ss_pred             eeCCCC--cEEEEeeccceecCCCCCcc-----ccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCc
Q 007680          405 LLDENM--VAHVSDFGIYKLLGEGEDSV-----RQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDE  477 (593)
Q Consensus       405 ll~~~~--~~kL~Dfg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~  477 (593)
                      +++.++  .+||+|||+++.+.......     ......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  270 (352)
T 2jii_A          191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN  270 (352)
T ss_dssp             EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred             EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            999998  99999999998765432211     12334799999999999999999999999999999999999999987


Q ss_pred             cccccchHHHHHHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhhhcch
Q 007680          478 MFIGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKFLDD  557 (593)
Q Consensus       478 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~  557 (593)
                      ................. ......+.        ......++.++.+++.+||+.||++|||++++++.|+++.......
T Consensus       271 ~~~~~~~~~~~~~~~~~-~~~~~~~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~  341 (352)
T 2jii_A          271 CLPNTEDIMKQKQKFVD-KPGPFVGP--------CGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVS  341 (352)
T ss_dssp             GTTCHHHHHHHHHHHHH-SCCCEECT--------TSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred             CCcCHHHHHHHHHhccC-Chhhhhhh--------ccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCC
Confidence            54222222222111000 00000000        0000123568899999999999999999999999999998776433


Q ss_pred             -hhccCCcc
Q 007680          558 -AAATNWRN  565 (593)
Q Consensus       558 -~~~~~~~~  565 (593)
                       ..+.+|+.
T Consensus       342 ~~~~~dw~~  350 (352)
T 2jii_A          342 PYDPIGLPM  350 (352)
T ss_dssp             TTSCCCCCC
T ss_pred             cCccccCcC
Confidence             56677765

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=3.5e-42  Score=367.76  Aligned_cols=250  Identities=22%  Similarity=0.242  Sum_probs=197.6

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALV  346 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  346 (593)
                      .++|++.+.||+|+||.||+|+.. +|+.||+|+++...   ......+.+|+.+++.++||||+++++++...+..++|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            578999999999999999999965 78999999998652   33445678899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCC
Q 007680          347 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG  426 (593)
Q Consensus       347 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  426 (593)
                      |||+++|+|.+++..... +++..+..++.|++.||+|||+.   .+|+||||||+|||++.++.+||+|||+++.....
T Consensus       227 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~qi~~aL~~LH~~---~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  302 (446)
T 4ejn_A          227 MEYANGGELFFHLSRERV-FSEDRARFYGAEIVSALDYLHSE---KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD  302 (446)
T ss_dssp             ECCCSSCBHHHHHHHHSC-CCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred             EeeCCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHhhc---CCEEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence            999999999999977654 89999999999999999999951   34999999999999999999999999999854332


Q ss_pred             CCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhh
Q 007680          427 EDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLV  506 (593)
Q Consensus       427 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  506 (593)
                      ..  ......||+.|+|||++.+..++.++|||||||++|||++|+.||......  .....+....             
T Consensus       303 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~~i~~~~-------------  365 (446)
T 4ejn_A          303 GA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KLFELILMEE-------------  365 (446)
T ss_dssp             ------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHCC-------------
T ss_pred             Cc--ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH--HHHHHHHhCC-------------
Confidence            22  234467999999999999999999999999999999999999999763211  1111111100             


Q ss_pred             hhhhhhhhhHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHHH
Q 007680          507 REEQAFSAKMDCILSIMDFALDCCMESPDMRI-----NMTDAAAK  546 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  546 (593)
                         .  ..+..+++++.+++.+||+.||++||     +++|+++|
T Consensus       366 ---~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h  405 (446)
T 4ejn_A          366 ---I--RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH  405 (446)
T ss_dssp             ---C--CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             ---C--CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence               0  01112356789999999999999999     99999976

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=2.7e-41  Score=341.14  Aligned_cols=262  Identities=22%  Similarity=0.363  Sum_probs=208.0

Q ss_pred             hhccccccccCccCcccEEEEEeCC----CCeEEEEEeehh-hHHHHHHHHHHHHHHhhcCCCCcceeeeee-ecCCceE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTISD----GTDVAIKVFNLQ-LERAFRSFDSECEVLRNVRHRNLIKILSSY-SNPDFKA  344 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~  344 (593)
                      ..+|++.+.||+|+||.||+|++.+    +..||+|.++.. .....+.+.+|+.++++++||||+++++++ ...+..+
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  103 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence            4578999999999999999998642    235899998753 234557789999999999999999999985 4556889


Q ss_pred             EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecC
Q 007680          345 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG  424 (593)
Q Consensus       345 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~  424 (593)
                      +||||+++++|.+++......+++.++..++.|++.||+|||+++    |+||||||+||+++.++.+||+|||+++...
T Consensus       104 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~----i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~  179 (298)
T 3f66_A          104 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK----FVHRDLAARNCMLDEKFTVKVADFGLARDMY  179 (298)
T ss_dssp             EEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred             EEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC----ccCCCCchheEEECCCCCEEECccccccccc
Confidence            999999999999999877667899999999999999999999655    9999999999999999999999999998765


Q ss_pred             CCCCc--cccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhh
Q 007680          425 EGEDS--VRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVV  501 (593)
Q Consensus       425 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  501 (593)
                      .....  .......+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||......  ...........       
T Consensus       180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~--~~~~~~~~~~~-------  250 (298)
T 3f66_A          180 DKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVYLLQGRR-------  250 (298)
T ss_dssp             CGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTT--THHHHHHTTCC-------
T ss_pred             ccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHH--HHHHHHhcCCC-------
Confidence            43221  12233457889999999988899999999999999999999 55666553221  11111111110       


Q ss_pred             hhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhhhc
Q 007680          502 DANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKFL  555 (593)
Q Consensus       502 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~  555 (593)
                                ...+..++..+.+++.+||+.||++|||+.|+++.|+++...+.
T Consensus       251 ----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~  294 (298)
T 3f66_A          251 ----------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  294 (298)
T ss_dssp             ----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred             ----------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence                      00112235678999999999999999999999999999987664

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=2.9e-42  Score=368.78  Aligned_cols=260  Identities=27%  Similarity=0.434  Sum_probs=207.6

Q ss_pred             HhhhccccccccCccCcccEEEEEeCCCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEe
Q 007680          269 RATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLE  348 (593)
Q Consensus       269 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  348 (593)
                      ...++|++.+.||+|+||.||+|.+.++..||||+++.... ..+.+.+|++++++++||||+++++++.+ +..++|||
T Consensus       181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e  258 (452)
T 1fmk_A          181 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE  258 (452)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred             cChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEeh
Confidence            34678999999999999999999998778899999986532 34678999999999999999999999876 67899999


Q ss_pred             ccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCC
Q 007680          349 FMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGE  427 (593)
Q Consensus       349 ~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~  427 (593)
                      |+++|+|.+++.... ..+++.++..++.|++.||+|||+++    |+||||||+||+++.++.+||+|||+++......
T Consensus       259 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~----ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  334 (452)
T 1fmk_A          259 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN----YVHRDLRAANILVGENLVCKVADFGLARLIEDNE  334 (452)
T ss_dssp             CCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred             hhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC----eeCCCCChhhEEECCCCCEEECCCccceecCCCc
Confidence            999999999997532 35899999999999999999999654    9999999999999999999999999998765432


Q ss_pred             CccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhhhhhhh
Q 007680          428 DSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLV  506 (593)
Q Consensus       428 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  506 (593)
                      .. ......++..|+|||++.+..++.++|||||||++|||++ |+.||......+  ....+....             
T Consensus       335 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--~~~~i~~~~-------------  398 (452)
T 1fmk_A          335 YT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLDQVERGY-------------  398 (452)
T ss_dssp             ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHHHTTC-------------
T ss_pred             ee-cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCC-------------
Confidence            11 1223456788999999988899999999999999999999 999997642211  111111110             


Q ss_pred             hhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhhh
Q 007680          507 REEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKF  554 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  554 (593)
                          ..+.+..++..+.+++.+||+.||++|||++++++.|+++....
T Consensus       399 ----~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~  442 (452)
T 1fmk_A          399 ----RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  442 (452)
T ss_dssp             ----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             ----CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence                11112345678899999999999999999999999999986543

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=2.3e-41  Score=362.28  Aligned_cols=263  Identities=22%  Similarity=0.237  Sum_probs=197.1

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehh--hHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC------C
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQ--LERAFRSFDSECEVLRNVRHRNLIKILSSYSNP------D  341 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~  341 (593)
                      .++|++.+.||+|+||.||+|.+. +|+.||||++...  .....+.+.+|+.+++.++||||+++++++...      .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            578999999999999999999865 6899999999754  334556788999999999999999999998654      3


Q ss_pred             ceEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccce
Q 007680          342 FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYK  421 (593)
Q Consensus       342 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~  421 (593)
                      ..++||||+++ +|.+.+..   .+++.++..++.|++.||+|||+++    |+||||||+||+++.++.+||+|||+++
T Consensus       141 ~~~lv~E~~~~-~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH~~~----iiHrDlkp~NIll~~~~~~kl~DFG~a~  212 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAG----IIHRDLKPSNIVVKSDCTLKILDFGLAR  212 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTT----CCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred             eEEEEEeCCCC-CHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCC----cccCCCChHhEEEeCCCCEEEEEEEeee
Confidence            57999999965 57776643   2899999999999999999999654    9999999999999999999999999998


Q ss_pred             ecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhh-
Q 007680          422 LLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEV-  500 (593)
Q Consensus       422 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-  500 (593)
                      ......   ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+ .+...+ ........+. 
T Consensus       213 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~-~~~~i~-~~lg~p~~~~~  287 (464)
T 3ttj_A          213 TAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID-QWNKVI-EQLGTPCPEFM  287 (464)
T ss_dssp             ----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHH-HHHCSCCHHHH
T ss_pred             ecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHH-HhcCCCCHHHH
Confidence            765432   2344579999999999999999999999999999999999999997642111 111111 1110000000 


Q ss_pred             ----------hhhhhh----------hh---hhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          501 ----------VDANLV----------RE---EQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       501 ----------~~~~~~----------~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                                +.....          ..   ..........++++.+|+.+||..||++|||++|+++|
T Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  356 (464)
T 3ttj_A          288 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  356 (464)
T ss_dssp             TTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                      000000          00   00001112236678999999999999999999999987

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=2.6e-41  Score=338.51  Aligned_cols=257  Identities=22%  Similarity=0.296  Sum_probs=206.4

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhH------HHHHHHHHHHHHHhhcCCCCcceeeeeeecCCce
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLE------RAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFK  343 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  343 (593)
                      .++|++.+.||+|+||.||+|+.. +++.||+|+++....      ...+.+.+|+.++++++||||+++++++.+.+..
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV   83 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence            467999999999999999999976 689999999976421      1356789999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC----cEEEEeecc
Q 007680          344 ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENM----VAHVSDFGI  419 (593)
Q Consensus       344 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~----~~kL~Dfg~  419 (593)
                      ++||||+++++|.+++..... +++.++..++.|++.||+|||+++    ++||||||+||+++.++    .+||+|||.
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~l~~lH~~~----i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~  158 (283)
T 3bhy_A           84 VLILELVSGGELFDFLAEKES-LTEDEATQFLKQILDGVHYLHSKR----IAHFDLKPENIMLLDKNVPNPRIKLIDFGI  158 (283)
T ss_dssp             EEEEECCCSCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHHHTT----EECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEEeecCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCC----ccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence            999999999999999976544 899999999999999999999654    99999999999998877    899999999


Q ss_pred             ceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhh
Q 007680          420 YKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTE  499 (593)
Q Consensus       420 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  499 (593)
                      +........   .....+++.|+|||++.+..++.++||||||+++|+|++|+.||......  .....+......    
T Consensus       159 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~----  229 (283)
T 3bhy_A          159 AHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ--ETLTNISAVNYD----  229 (283)
T ss_dssp             CEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHTTCCC----
T ss_pred             ceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH--HHHHHhHhcccC----
Confidence            987654322   23346899999999999899999999999999999999999999763211  111111100000    


Q ss_pred             hhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH--HHHhh
Q 007680          500 VVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK--LKKIK  551 (593)
Q Consensus       500 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~i~  551 (593)
                                ........++..+.+++.+||+.||++|||+.|+++|  ++.+.
T Consensus       230 ----------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  273 (283)
T 3bhy_A          230 ----------FDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR  273 (283)
T ss_dssp             ----------CCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred             ----------CcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence                      0011112345678999999999999999999999986  45543

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.2e-41  Score=340.37  Aligned_cols=259  Identities=22%  Similarity=0.385  Sum_probs=211.9

Q ss_pred             hhhccccccccCccCcccEEEEEeCCCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEec
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEF  349 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  349 (593)
                      ..++|++.+.||+|+||.||+|...+++.||+|+++... ...+.+.+|++++++++||||+++++++.. +..++||||
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~   88 (279)
T 1qpc_A           11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY   88 (279)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEec
Confidence            457899999999999999999998888899999997643 234678999999999999999999998864 568999999


Q ss_pred             cCCCCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCC
Q 007680          350 MPNGSLEKWLYSHNY-FLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGED  428 (593)
Q Consensus       350 ~~~gsL~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  428 (593)
                      +++++|.+++..... .+++.++..++.|++.||+|||+++    |+||||||+||++++++.+||+|||.+........
T Consensus        89 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~----i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  164 (279)
T 1qpc_A           89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN----YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY  164 (279)
T ss_dssp             CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT----EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred             CCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC----eeccCCCHhhEEEcCCCCEEECCCcccccccCccc
Confidence            999999999976432 5899999999999999999999654    99999999999999999999999999987754332


Q ss_pred             ccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhh
Q 007680          429 SVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVR  507 (593)
Q Consensus       429 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  507 (593)
                      . ......++..|+|||++.+..++.++||||||+++|||++ |+.||......  .....+.....             
T Consensus       165 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~~~~~~~~-------------  228 (279)
T 1qpc_A          165 T-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP--EVIQNLERGYR-------------  228 (279)
T ss_dssp             E-CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHHTTCC-------------
T ss_pred             c-cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH--HHHHHHhcccC-------------
Confidence            1 2233456788999999988889999999999999999999 99999763221  11111111100             


Q ss_pred             hhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhhh
Q 007680          508 EEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKF  554 (593)
Q Consensus       508 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  554 (593)
                          ...+..++.++.+++.+||+.||++|||+.++++.|+++....
T Consensus       229 ----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  271 (279)
T 1qpc_A          229 ----MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT  271 (279)
T ss_dssp             ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             ----CCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence                0111234568899999999999999999999999999987654

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=4.5e-41  Score=360.52  Aligned_cols=274  Identities=22%  Similarity=0.261  Sum_probs=190.1

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehh--hHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-----CCc
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQ--LERAFRSFDSECEVLRNVRHRNLIKILSSYSN-----PDF  342 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~~  342 (593)
                      .++|++.+.||+|+||.||+|++. +++.||||++...  .....+.+.+|++++++++||||+++++++..     .+.
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            468999999999999999999865 7899999998653  23455678999999999999999999999843     357


Q ss_pred             eEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeecccee
Q 007680          343 KALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKL  422 (593)
Q Consensus       343 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~  422 (593)
                      .|+||||+ +++|.+++.... .+++..+..++.||+.||+|||+++    |+||||||+|||++.++.+||+|||+++.
T Consensus       132 ~~lv~e~~-~~~L~~~~~~~~-~l~~~~~~~~~~qi~~aL~~LH~~~----iiHrDlKp~NILl~~~~~~kl~DFGla~~  205 (458)
T 3rp9_A          132 LYVVLEIA-DSDFKKLFRTPV-YLTELHIKTLLYNLLVGVKYVHSAG----ILHRDLKPANCLVNQDCSVKVCDFGLART  205 (458)
T ss_dssp             EEEEECCC-SEEHHHHHHSSC-CCCHHHHHHHHHHHHHHHHHHHHTT----CBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred             EEEEEecc-ccchhhhcccCC-CCCHHHHHHHHHHHHHHHHHHHhCC----cCCCCCChhhEEECCCCCEeecccccchh
Confidence            89999998 579999997665 4999999999999999999999654    99999999999999999999999999987


Q ss_pred             cCCCCCc-------------------------cccccccCCccccCcccc-CCCCCCccchHHHHHHHHHHHHh------
Q 007680          423 LGEGEDS-------------------------VRQTMTMATIGYMAPEYG-LEGIVSAKCDVYSYGVLLMETFT------  470 (593)
Q Consensus       423 ~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~s~~~DvwSlGvvl~ellt------  470 (593)
                      .......                         .......||+.|+|||++ .+..++.++|||||||++|||++      
T Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~  285 (458)
T 3rp9_A          206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENV  285 (458)
T ss_dssp             TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTC
T ss_pred             ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccc
Confidence            6533211                         112345689999999975 56679999999999999999999      


Q ss_pred             -----CCCCCCcccccc------------------chHHHHHHHhcCCchhhhhhhhhhhhh-------------hhhhh
Q 007680          471 -----RKRPTDEMFIGE------------------MSLRRWVKESLPHGLTEVVDANLVREE-------------QAFSA  514 (593)
Q Consensus       471 -----g~~pf~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~  514 (593)
                           |+++|.+...-.                  ......+.........+.+........             .....
T Consensus       286 ~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  365 (458)
T 3rp9_A          286 AYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAER  365 (458)
T ss_dssp             SSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGG
T ss_pred             cccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHH
Confidence                 555554421000                  000000110000000000000000000             00001


Q ss_pred             hHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH--HHHh
Q 007680          515 KMDCILSIMDFALDCCMESPDMRINMTDAAAK--LKKI  550 (593)
Q Consensus       515 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~i  550 (593)
                      ....++++.+|+.+||..||++|||++|+++|  ++++
T Consensus       366 ~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~  403 (458)
T 3rp9_A          366 FPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV  403 (458)
T ss_dssp             STTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             CCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhc
Confidence            12335678999999999999999999999997  4444

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.1e-41  Score=354.32  Aligned_cols=247  Identities=24%  Similarity=0.277  Sum_probs=193.6

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHH-HhhcCCCCcceeeeeeecCCceEE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEV-LRNVRHRNLIKILSSYSNPDFKAL  345 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~l  345 (593)
                      .++|++.+.||+|+||.||+|+.+ +++.||+|+++...   ......+..|..+ ++.++||||+++++++.+.+..|+
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            468999999999999999999976 68899999998653   2334456677776 567899999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCC
Q 007680          346 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGE  425 (593)
Q Consensus       346 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~  425 (593)
                      ||||+++|+|.+++...+. +++..+..++.||+.||+|||+++    |+||||||+||+++.++.+||+|||+++....
T Consensus       117 v~E~~~gg~L~~~l~~~~~-~~~~~~~~~~~qi~~aL~~LH~~g----ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~  191 (373)
T 2r5t_A          117 VLDYINGGELFYHLQRERC-FLEPRARFYAAEIASALGYLHSLN----IVYRDLKPENILLDSQGHIVLTDFGLCKENIE  191 (373)
T ss_dssp             EEECCCSCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHHHTT----CCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred             EEeCCCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCC----ceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence            9999999999999987654 899999999999999999999654    99999999999999999999999999986433


Q ss_pred             CCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhh
Q 007680          426 GEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANL  505 (593)
Q Consensus       426 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  505 (593)
                      ...  ......||+.|+|||++.+..++.++|||||||++|||++|+.||......  .....+..           ...
T Consensus       192 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~--~~~~~i~~-----------~~~  256 (373)
T 2r5t_A          192 HNS--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA--EMYDNILN-----------KPL  256 (373)
T ss_dssp             CCC--CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH--HHHHHHHH-----------SCC
T ss_pred             CCC--ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH--HHHHHHHh-----------ccc
Confidence            221  234457999999999999999999999999999999999999999763211  11111110           000


Q ss_pred             hhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHH
Q 007680          506 VREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAA  544 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl  544 (593)
                             ..+..++.++.+++.+||+.||++||++.+.+
T Consensus       257 -------~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~  288 (373)
T 2r5t_A          257 -------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDF  288 (373)
T ss_dssp             -------CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred             -------CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCH
Confidence                   00112356789999999999999999985433

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.2e-41  Score=350.38  Aligned_cols=252  Identities=21%  Similarity=0.276  Sum_probs=202.1

Q ss_pred             hhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhc-CCCCcceeeeeeecCCceEEEE
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNV-RHRNLIKILSSYSNPDFKALVL  347 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  347 (593)
                      ..++|++.+.||+|+||.||+|..+ +|+.||+|+++....    ...+|++++.++ +||||+++++++.+++..++||
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   95 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT   95 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence            4678999999999999999999976 689999999976532    245688888888 7999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCC----CcEEEEeeccceec
Q 007680          348 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDEN----MVAHVSDFGIYKLL  423 (593)
Q Consensus       348 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~----~~~kL~Dfg~a~~~  423 (593)
                      ||+++|+|.+++...+. +++.++..++.|++.||+|||+++    |+||||||+||++.++    +.+||+|||+++..
T Consensus        96 E~~~gg~L~~~i~~~~~-~~~~~~~~~~~qi~~al~~lH~~g----ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~  170 (342)
T 2qr7_A           96 ELMKGGELLDKILRQKF-FSEREASAVLFTITKTVEYLHAQG----VVHRDLKPSNILYVDESGNPESIRICDFGFAKQL  170 (342)
T ss_dssp             CCCCSCBHHHHHHTCTT-CCHHHHHHHHHHHHHHHHHHHHTT----EECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred             eCCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHCC----cEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence            99999999999987654 999999999999999999999654    9999999999998543    35999999999876


Q ss_pred             CCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccc-cchHHHHHHHhcCCchhhhhh
Q 007680          424 GEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIG-EMSLRRWVKESLPHGLTEVVD  502 (593)
Q Consensus       424 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~  502 (593)
                      .....  ......||+.|+|||++.+..++.++|||||||++|||++|..||...... .......+.......      
T Consensus       171 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~------  242 (342)
T 2qr7_A          171 RAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSL------  242 (342)
T ss_dssp             BCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCC------
T ss_pred             cCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCccc------
Confidence            54332  223456899999999998888999999999999999999999999753211 111111111110000      


Q ss_pred             hhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          503 ANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                              .......++.++.+++.+||..||++|||+.|+++|
T Consensus       243 --------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  278 (342)
T 2qr7_A          243 --------SGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH  278 (342)
T ss_dssp             --------CSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             --------CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                    000112345678999999999999999999999986

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=6.6e-42  Score=346.19  Aligned_cols=253  Identities=23%  Similarity=0.322  Sum_probs=201.5

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEec
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEF  349 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  349 (593)
                      .++|++.+.||+|+||.||+|++. +++.||+|++........+.+.+|++++++++||||+++++++...+..++||||
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   97 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF   97 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence            578999999999999999999976 6899999999876655667899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCc
Q 007680          350 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDS  429 (593)
Q Consensus       350 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~  429 (593)
                      +++++|.+++......+++..+..++.|++.||.|||+++    ++||||||+||+++.++.+||+|||++.......  
T Consensus        98 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~----i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--  171 (302)
T 2j7t_A           98 CPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR----IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL--  171 (302)
T ss_dssp             CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT----CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH--
T ss_pred             CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCC----cccCCCCHHHEEECCCCCEEEEECCCCccccccc--
Confidence            9999999998876566999999999999999999999654    9999999999999999999999999875432111  


Q ss_pred             cccccccCCccccCcccc-----CCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhh
Q 007680          430 VRQTMTMATIGYMAPEYG-----LEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDAN  504 (593)
Q Consensus       430 ~~~~~~~gt~~y~aPE~~-----~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  504 (593)
                      .......|++.|+|||++     .+..++.++||||||+++|+|++|+.||....... ..........+          
T Consensus       172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~----------  240 (302)
T 2j7t_A          172 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-VLLKIAKSDPP----------  240 (302)
T ss_dssp             HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHSCCC----------
T ss_pred             cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH-HHHHHhccCCc----------
Confidence            112234689999999987     46778999999999999999999999997642211 11111111100          


Q ss_pred             hhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          505 LVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       505 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                            ....+..++.++.+++.+||+.||++|||+.|+++|
T Consensus       241 ------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  276 (302)
T 2j7t_A          241 ------TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH  276 (302)
T ss_dssp             ------CCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred             ------ccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence                  001112345678999999999999999999999875

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=4.2e-41  Score=344.77  Aligned_cols=262  Identities=20%  Similarity=0.281  Sum_probs=203.1

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcC-CCCcceeeeeeec--CCceEEE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNVR-HRNLIKILSSYSN--PDFKALV  346 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lv  346 (593)
                      .++|++.+.||+|+||.||+|+.. +++.||+|+++...   .+.+.+|++++++++ ||||+++++++.+  ....++|
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv  111 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  111 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence            478999999999999999999864 78999999997543   356889999999997 9999999999987  5678999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC-cEEEEeeccceecCC
Q 007680          347 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENM-VAHVSDFGIYKLLGE  425 (593)
Q Consensus       347 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~-~~kL~Dfg~a~~~~~  425 (593)
                      |||+++++|.+++..    +++.++..++.|++.||+|||+++    |+||||||+||+++.++ .+||+|||+++....
T Consensus       112 ~e~~~~~~l~~~~~~----~~~~~~~~~~~qi~~~l~~lH~~~----ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~  183 (330)
T 3nsz_A          112 FEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHSMG----IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  183 (330)
T ss_dssp             EECCCCCCHHHHGGG----CCHHHHHHHHHHHHHHHHHHHHTT----EECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred             EeccCchhHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCC----eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence            999999999999854    889999999999999999999654    99999999999999776 899999999987654


Q ss_pred             CCCccccccccCCccccCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhh
Q 007680          426 GEDSVRQTMTMATIGYMAPEYGLE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDAN  504 (593)
Q Consensus       426 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  504 (593)
                      ...   .....++..|+|||++.+ ..++.++|||||||++|||++|+.||.........+.............+.++..
T Consensus       184 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  260 (330)
T 3nsz_A          184 GQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY  260 (330)
T ss_dssp             TCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred             CCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHh
Confidence            332   234568999999999877 6799999999999999999999999965332222222211111100011111000


Q ss_pred             h---------------hh---hhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          505 L---------------VR---EEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       505 ~---------------~~---~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      .               ..   ..........+++++.+++.+||+.||++|||++|+++|
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h  320 (330)
T 3nsz_A          261 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  320 (330)
T ss_dssp             TCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             ccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            0               00   000001112246789999999999999999999999976

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=9.9e-42  Score=342.88  Aligned_cols=261  Identities=24%  Similarity=0.375  Sum_probs=200.6

Q ss_pred             hhccccccccCccCcccEEEEEeC--CCC--eEEEEEeehhh---HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCce
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS--DGT--DVAIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFK  343 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~--~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  343 (593)
                      .++|++.+.||+|+||.||+|++.  +++  .||+|+++...   ....+.+.+|++++++++||||+++++++...+ .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            468999999999999999999853  333  68999987642   345678899999999999999999999998765 8


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceec
Q 007680          344 ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLL  423 (593)
Q Consensus       344 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~  423 (593)
                      ++||||+++++|.+++......+++..+..++.|++.||+|||+++    |+||||||+||+++.++.+||+|||++...
T Consensus        96 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~----i~H~dikp~Nili~~~~~~kl~Dfg~~~~~  171 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR----FIHRDLAARNLLLATRDLVKIGDFGLMRAL  171 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT----EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             eeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCC----cccCCCchheEEEcCCCCEEEccccccccc
Confidence            8999999999999999876566999999999999999999999654    999999999999999999999999999887


Q ss_pred             CCCCCcc-ccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhh
Q 007680          424 GEGEDSV-RQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVV  501 (593)
Q Consensus       424 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  501 (593)
                      ....... ......++..|+|||++.+..++.++||||||+++|+|++ |+.||......  .....+...         
T Consensus       172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~~~~---------  240 (291)
T 1u46_A          172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS--QILHKIDKE---------  240 (291)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHTS---------
T ss_pred             cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH--HHHHHHHcc---------
Confidence            5543221 1233457888999999988889999999999999999999 99999764221  111111100         


Q ss_pred             hhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhhh
Q 007680          502 DANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKF  554 (593)
Q Consensus       502 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  554 (593)
                             ....+....++.++.+++.+||+.||++|||+.+++++|+++....
T Consensus       241 -------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  286 (291)
T 1u46_A          241 -------GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTD  286 (291)
T ss_dssp             -------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred             -------CCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccc
Confidence                   0001111234668899999999999999999999999999886543

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=6.7e-41  Score=348.26  Aligned_cols=258  Identities=26%  Similarity=0.359  Sum_probs=209.0

Q ss_pred             HHHHHhhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh--------HHHHHHHHHHHHHHhhc-CCCCcceee
Q 007680          265 LDIQRATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL--------ERAFRSFDSECEVLRNV-RHRNLIKIL  334 (593)
Q Consensus       265 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l-~h~niv~l~  334 (593)
                      .......++|++.+.||+|+||.||+|++. +|+.||||+++...        ....+.+.+|+.++.++ +||||++++
T Consensus        87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~  166 (365)
T 2y7j_A           87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI  166 (365)
T ss_dssp             HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred             hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence            344556788999999999999999999976 79999999987542        22356788999999999 799999999


Q ss_pred             eeeecCCceEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEE
Q 007680          335 SSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHV  414 (593)
Q Consensus       335 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL  414 (593)
                      +++...+..++||||+++++|.+++..... +++..+..++.|++.||+|||+++    |+||||||+||+++.++.+||
T Consensus       167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~-l~~~~~~~i~~qi~~~L~~LH~~g----i~H~Dlkp~NIl~~~~~~ikl  241 (365)
T 2y7j_A          167 DSYESSSFMFLVFDLMRKGELFDYLTEKVA-LSEKETRSIMRSLLEAVSFLHANN----IVHRDLKPENILLDDNMQIRL  241 (365)
T ss_dssp             EEEEBSSEEEEEECCCTTCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHHHTT----EECSCCSGGGEEECTTCCEEE
T ss_pred             EEEeeCCEEEEEEEeCCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCC----eecCCCCHHHEEECCCCCEEE
Confidence            999999999999999999999999986544 999999999999999999999654    999999999999999999999


Q ss_pred             EeeccceecCCCCCccccccccCCccccCccccCC------CCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHH
Q 007680          415 SDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLE------GIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRW  488 (593)
Q Consensus       415 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~  488 (593)
                      +|||++..+.....   .....||+.|+|||++.+      ..++.++|||||||++|||++|+.||.....  ......
T Consensus       242 ~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~--~~~~~~  316 (365)
T 2y7j_A          242 SDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ--ILMLRM  316 (365)
T ss_dssp             CCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHH
T ss_pred             EecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH--HHHHHH
Confidence            99999987754332   234579999999998753      3588999999999999999999999976321  111111


Q ss_pred             HHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          489 VKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       489 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      +.......              ..+....++..+.+++.+||+.||++|||+.|+++|
T Consensus       317 i~~~~~~~--------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  360 (365)
T 2y7j_A          317 IMEGQYQF--------------SSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQH  360 (365)
T ss_dssp             HHHTCCCC--------------CHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHhCCCCC--------------CCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            11111000              011112345678999999999999999999999875

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=8.8e-42  Score=354.38  Aligned_cols=267  Identities=22%  Similarity=0.290  Sum_probs=207.6

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehh-hHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEe
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQ-LERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLE  348 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  348 (593)
                      .++|++.+.||+|+||.||+|.+. +++.||+|+++.. .....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  111 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME  111 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence            468999999999999999999976 7899999999765 23445778999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCC
Q 007680          349 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGED  428 (593)
Q Consensus       349 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  428 (593)
                      |+++++|.+++..... +++..+..++.|++.||+|||++   .+|+||||||+||+++.++.+||+|||++......  
T Consensus       112 ~~~~~~L~~~l~~~~~-~~~~~~~~i~~~i~~~l~~lh~~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--  185 (360)
T 3eqc_A          112 HMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLREK---HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  185 (360)
T ss_dssp             CCTTCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHHHH---HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred             CCCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHh---CCEEcCCccHHHEEECCCCCEEEEECCCCcccccc--
Confidence            9999999999987654 89999999999999999999964   14999999999999999999999999998755321  


Q ss_pred             ccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHH--------------------
Q 007680          429 SVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRW--------------------  488 (593)
Q Consensus       429 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~--------------------  488 (593)
                        ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.............                    
T Consensus       186 --~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (360)
T 3eqc_A          186 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP  263 (360)
T ss_dssp             --C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------------
T ss_pred             --cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCc
Confidence              1233468999999999999999999999999999999999999997643221110000                    


Q ss_pred             ----HHH-hcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          489 ----VKE-SLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       489 ----~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                          ... ..+....+..+....... .......++.++.+++.+||+.||++|||++|+++|
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  325 (360)
T 3eqc_A          264 LNKFGMDSRPPMAIFELLDYIVNEPP-PKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  325 (360)
T ss_dssp             ----------CCCHHHHHHHHHHSCC-CCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             ccccccCCCCcccchhhhhHHhccCC-CCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence                000 000001111111110000 000111245688999999999999999999999987

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=2.8e-41  Score=340.34  Aligned_cols=249  Identities=20%  Similarity=0.286  Sum_probs=207.3

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALV  346 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  346 (593)
                      .++|.+.+.||+|+||.||+|... +++.||+|++....   ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            468999999999999999999976 68899999997652   34556788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCC
Q 007680          347 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG  426 (593)
Q Consensus       347 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  426 (593)
                      |||+++++|.+++..... +++.++..++.|++.||+|||+++    |+||||||+||+++.++.+||+|||.+......
T Consensus        94 ~e~~~~~~L~~~~~~~~~-~~~~~~~~i~~qi~~~l~~lH~~~----i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  168 (294)
T 2rku_A           94 LELCRRRSLLELHKRRKA-LTEPEARYYLRQIVLGCQYLHRNR----VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD  168 (294)
T ss_dssp             EECCTTCBHHHHHHHHCS-CCHHHHHHHHHHHHHHHHHHHHTT----EECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             EecCCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCC----ccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence            999999999999877554 899999999999999999999654    999999999999999999999999999876533


Q ss_pred             CCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhh
Q 007680          427 EDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLV  506 (593)
Q Consensus       427 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  506 (593)
                      ..  ......|++.|+|||++.+..++.++||||||+++|+|++|+.||......+  ....+...           .  
T Consensus       169 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~~~~~~-----------~--  231 (294)
T 2rku_A          169 GE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE--TYLRIKKN-----------E--  231 (294)
T ss_dssp             TC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH--HHHHHHTT-----------C--
T ss_pred             cc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHhhc-----------c--
Confidence            22  2234568999999999998899999999999999999999999997632211  00001000           0  


Q ss_pred             hhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          507 REEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                           ...+..++..+.+++.+||+.||++|||+.|++++
T Consensus       232 -----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          232 -----YSIPKHINPVAASLIQKMLQTDPTARPTINELLND  266 (294)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             -----CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence                 00111234578999999999999999999999986

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.1e-41  Score=349.13  Aligned_cols=268  Identities=22%  Similarity=0.288  Sum_probs=197.1

Q ss_pred             hhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh--HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEE
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALV  346 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  346 (593)
                      ..++|++.+.||+|+||.||+|+.. +++.||+|+++...  ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  111 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI  111 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred             chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence            4678999999999999999999865 78999999997543  23345678999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeee-----CCCCcEEEEeeccce
Q 007680          347 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILL-----DENMVAHVSDFGIYK  421 (593)
Q Consensus       347 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll-----~~~~~~kL~Dfg~a~  421 (593)
                      |||++ |+|.+++..... +++..+..++.|++.||+|||+++    |+||||||+||++     +.++.+||+|||++.
T Consensus       112 ~e~~~-~~L~~~~~~~~~-~~~~~~~~i~~ql~~~l~~LH~~~----ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~  185 (329)
T 3gbz_A          112 FEYAE-NDLKKYMDKNPD-VSMRVIKSFLYQLINGVNFCHSRR----CLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR  185 (329)
T ss_dssp             EECCS-EEHHHHHHHCTT-CCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred             EecCC-CCHHHHHhhcCC-CCHHHHHHHHHHHHHHHHHHHhCC----EECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence            99997 599999987765 999999999999999999999654    9999999999999     455569999999998


Q ss_pred             ecCCCCCccccccccCCccccCccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHH-hcCCc--h
Q 007680          422 LLGEGEDSVRQTMTMATIGYMAPEYGLEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKE-SLPHG--L  497 (593)
Q Consensus       422 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~-~~~~~--~  497 (593)
                      .......  ......+|+.|+|||++.+. .++.++|||||||++|||++|+.||......+ ........ ..+..  .
T Consensus       186 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~  262 (329)
T 3gbz_A          186 AFGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID-QLFKIFEVLGLPDDTTW  262 (329)
T ss_dssp             HHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCTTTS
T ss_pred             ccCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH-HHHHHHHHhCCCchhhh
Confidence            7653322  22345689999999998775 48999999999999999999999997643221 11111111 11110  0


Q ss_pred             hhhhh--------hhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          498 TEVVD--------ANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       498 ~~~~~--------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      .....        +..............++.++.+++.+||+.||++|||+.|+++|
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  319 (329)
T 3gbz_A          263 PGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH  319 (329)
T ss_dssp             TTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             hhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence            00000        00000000011112245688999999999999999999999875

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.9e-41  Score=356.47  Aligned_cols=250  Identities=20%  Similarity=0.268  Sum_probs=193.3

Q ss_pred             hhccccc-cccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhc-CCCCcceeeeeeec----CCce
Q 007680          271 TDEFNEC-NLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNV-RHRNLIKILSSYSN----PDFK  343 (593)
Q Consensus       271 ~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~~  343 (593)
                      .++|.+. +.||+|+||.||+|.+. +|+.||||+++..     ..+.+|+.++.++ +||||+++++++..    .+..
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~  134 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL  134 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence            4567776 68999999999999976 7899999999743     3466788887544 89999999998875    5678


Q ss_pred             EEEEeccCCCCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC---CCcEEEEeecc
Q 007680          344 ALVLEFMPNGSLEKWLYSHNY-FLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDE---NMVAHVSDFGI  419 (593)
Q Consensus       344 ~lv~e~~~~gsL~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~---~~~~kL~Dfg~  419 (593)
                      ++||||+++|+|.+++..... .+++.++..++.||+.||+|||+++    |+||||||+||+++.   ++.+||+|||+
T Consensus       135 ~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~----ivHrDlkp~Nill~~~~~~~~~kl~DFG~  210 (400)
T 1nxk_A          135 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN----IAHRDVKPENLLYTSKRPNAILKLTDFGF  210 (400)
T ss_dssp             EEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT----EECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred             EEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC----ccccCcCcceEEEecCCCCccEEEEeccc
Confidence            999999999999999987543 5899999999999999999999654    999999999999997   78999999999


Q ss_pred             ceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccc--hHHHHHHHhcCCch
Q 007680          420 YKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEM--SLRRWVKESLPHGL  497 (593)
Q Consensus       420 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~--~~~~~~~~~~~~~~  497 (593)
                      ++......   ......||+.|+|||++.+..++.++|||||||++|||++|+.||........  .....+......  
T Consensus       211 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~--  285 (400)
T 1nxk_A          211 AKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE--  285 (400)
T ss_dssp             CEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCC--
T ss_pred             ccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCccc--
Confidence            98764322   22345689999999999999999999999999999999999999976432111  111111110000  


Q ss_pred             hhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          498 TEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       498 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                                  ........++.++.+++.+||+.||++|||+.|+++|
T Consensus       286 ------------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          286 ------------FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             ------------CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ------------CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                        0001112346688999999999999999999999987

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=2.2e-41  Score=367.23  Aligned_cols=252  Identities=24%  Similarity=0.334  Sum_probs=209.0

Q ss_pred             hhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEE
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKAL  345 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  345 (593)
                      ..++|++.+.||+|+||.||+|+.. +|+.||+|++....   ......+.+|++++++++||||+++++++.+.+..++
T Consensus       182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l  261 (576)
T 2acx_A          182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL  261 (576)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence            3568999999999999999999975 79999999998653   2334568899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecC
Q 007680          346 VLEFMPNGSLEKWLYSHNY-FLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG  424 (593)
Q Consensus       346 v~e~~~~gsL~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~  424 (593)
                      ||||++||+|.+++..... .+++..+..++.||+.||+|||+++    |+||||||+||+++.++.+||+|||+++...
T Consensus       262 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g----IvHrDLKPeNILld~~g~vKL~DFGla~~~~  337 (576)
T 2acx_A          262 VLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER----IVYRDLKPENILLDDHGHIRISDLGLAVHVP  337 (576)
T ss_dssp             EECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT----EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC----EeccCCchheEEEeCCCCeEEEecccceecc
Confidence            9999999999999977543 5899999999999999999999654    9999999999999999999999999998775


Q ss_pred             CCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCcccccc--chHHHHHHHhcCCchhhhhh
Q 007680          425 EGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGE--MSLRRWVKESLPHGLTEVVD  502 (593)
Q Consensus       425 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~  502 (593)
                      ....   .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......  ......+.. .+..      
T Consensus       338 ~~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~-~~~~------  407 (576)
T 2acx_A          338 EGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE-VPEE------  407 (576)
T ss_dssp             TTCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHH-CCCC------
T ss_pred             cCcc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhc-cccc------
Confidence            4332   233579999999999999899999999999999999999999997642211  111111111 0100      


Q ss_pred             hhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHHH
Q 007680          503 ANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRI-----NMTDAAAK  546 (593)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  546 (593)
                                 .+..+++++.+++.+||+.||++||     +++|+++|
T Consensus       408 -----------~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H  445 (576)
T 2acx_A          408 -----------YSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH  445 (576)
T ss_dssp             -----------CCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred             -----------CCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence                       0122456789999999999999999     78999876

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=2.3e-41  Score=342.70  Aligned_cols=251  Identities=25%  Similarity=0.320  Sum_probs=204.1

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEec
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEF  349 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  349 (593)
                      .++|.+.+.||+|+||.||+|+.. +|+.||+|+++.......+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL   87 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence            568999999999999999999975 7999999999866544456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeee---CCCCcEEEEeeccceecCCC
Q 007680          350 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILL---DENMVAHVSDFGIYKLLGEG  426 (593)
Q Consensus       350 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll---~~~~~~kL~Dfg~a~~~~~~  426 (593)
                      +++++|.+++...+. +++..+..++.|++.||+|||+++    |+||||||+||++   +.++.+||+|||++......
T Consensus        88 ~~~~~L~~~l~~~~~-~~~~~~~~~~~qi~~~l~~lH~~~----i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~  162 (304)
T 2jam_A           88 VSGGELFDRILERGV-YTEKDASLVIQQVLSAVKYLHENG----IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG  162 (304)
T ss_dssp             CCSCBHHHHHHHHSC-CCHHHHHHHHHHHHHHHHHHHHTT----CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB
T ss_pred             CCCccHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHCC----ccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC
Confidence            999999999876554 899999999999999999999654    9999999999999   78899999999998754322


Q ss_pred             CCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhh
Q 007680          427 EDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLV  506 (593)
Q Consensus       427 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  506 (593)
                          ......|++.|+|||++.+..++.++||||||+++|+|++|+.||......  .....+.......          
T Consensus       163 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~i~~~~~~~----------  226 (304)
T 2jam_A          163 ----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES--KLFEKIKEGYYEF----------  226 (304)
T ss_dssp             ----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHHCCCCC----------
T ss_pred             ----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHcCCCCC----------
Confidence                123346899999999999999999999999999999999999999763211  1111111111000          


Q ss_pred             hhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          507 REEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                          ..+....++.++.+++.+||+.||++|||+.|+++|
T Consensus       227 ----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (304)
T 2jam_A          227 ----ESPFWDDISESAKDFICHLLEKDPNERYTCEKALSH  262 (304)
T ss_dssp             ----CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             ----CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence                001112345678999999999999999999999985

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8e-41  Score=347.85  Aligned_cols=262  Identities=22%  Similarity=0.267  Sum_probs=197.3

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehh--hHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCC------
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQ--LERAFRSFDSECEVLRNVRHRNLIKILSSYSNPD------  341 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  341 (593)
                      .++|++.+.||+|+||.||+|.+. +|+.||||++...  .....+.+.+|++++++++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            467999999999999999999975 7999999998543  2344567889999999999999999999987653      


Q ss_pred             ceEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccce
Q 007680          342 FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYK  421 (593)
Q Consensus       342 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~  421 (593)
                      ..++||||+ +++|.+++....  +++..+..++.|++.||+|||+++    |+||||||+||+++.++.+||+|||+++
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~~~--l~~~~~~~~~~qi~~~L~~LH~~~----ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  176 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKHEK--LGEDRIQFLVYQMLKGLRYIHAAG----IIHRDLKPGNLAVNEDCELKILDFGLAR  176 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHHTT----EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             eEEEEEecC-CCCHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCC----ccccCcCHHHEEEcCCCCEEEEeeeccc
Confidence            469999999 889999998743  899999999999999999999655    9999999999999999999999999998


Q ss_pred             ecCCCCCccccccccCCccccCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhh
Q 007680          422 LLGEGEDSVRQTMTMATIGYMAPEYGLE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEV  500 (593)
Q Consensus       422 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  500 (593)
                      .....     .....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||.+....  .....+.........+.
T Consensus       177 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~l~~i~~~~g~~~~~~  249 (367)
T 1cm8_A          177 QADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL--DQLKEIMKVTGTPPAEF  249 (367)
T ss_dssp             ECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCCCCHHH
T ss_pred             ccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHhcCCCCHHH
Confidence            75432     233568999999998877 67999999999999999999999999763221  11111111111000010


Q ss_pred             hhh---hhhhh---------hhh-hhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          501 VDA---NLVRE---------EQA-FSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       501 ~~~---~~~~~---------~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      ...   .....         ... .......++.+.+++.+||..||++|||+.|+++|
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h  308 (367)
T 1cm8_A          250 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  308 (367)
T ss_dssp             HHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence            000   00000         000 00112345688999999999999999999999986

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=3.9e-41  Score=337.55  Aligned_cols=247  Identities=24%  Similarity=0.319  Sum_probs=205.7

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhH---HHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLE---RAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALV  346 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  346 (593)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++.....   ...+.+.+|++++++++||||+++++++.+.+..++|
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   92 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM   92 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence            468999999999999999999976 678999999976532   2346788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCC
Q 007680          347 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG  426 (593)
Q Consensus       347 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  426 (593)
                      |||+++++|.+++...+. +++..+..++.|++.||+|||++    +|+||||||+||+++.++.+||+|||++......
T Consensus        93 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~  167 (284)
T 2vgo_A           93 LEFAPRGELYKELQKHGR-FDEQRSATFMEELADALHYCHER----KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL  167 (284)
T ss_dssp             ECCCTTEEHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHHTT----TEECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred             EEeCCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHC----CceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence            999999999999987654 89999999999999999999954    5999999999999999999999999998765432


Q ss_pred             CCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhh
Q 007680          427 EDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLV  506 (593)
Q Consensus       427 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  506 (593)
                      .    .....|++.|+|||++.+..++.++||||||+++|+|++|+.||......+  ....+...           .. 
T Consensus       168 ~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~~-----------~~-  229 (284)
T 2vgo_A          168 R----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE--THRRIVNV-----------DL-  229 (284)
T ss_dssp             C----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH--HHHHHHTT-----------CC-
T ss_pred             c----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH--HHHHHhcc-----------cc-
Confidence            2    233568999999999999999999999999999999999999997632111  11111100           00 


Q ss_pred             hhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          507 REEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                            ..+..++.++.+++.+||+.||++|||+.|+++|
T Consensus       230 ------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  263 (284)
T 2vgo_A          230 ------KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH  263 (284)
T ss_dssp             ------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred             ------CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence                  0011235578999999999999999999999986

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=2.3e-41  Score=347.16  Aligned_cols=268  Identities=24%  Similarity=0.279  Sum_probs=202.5

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh--HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVL  347 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  347 (593)
                      .++|++.+.||+|+||.||+|+.. +|+.||+|++....  ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            568999999999999999999976 58999999986542  334566889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCC
Q 007680          348 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGE  427 (593)
Q Consensus       348 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~  427 (593)
                      ||+++++|.+++.... .+++..+..++.|++.||+|||+++    |+||||||+||+++.++.+||+|||++.......
T Consensus       104 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~----ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  178 (331)
T 4aaa_A          104 EFVDHTILDDLELFPN-GLDYQVVQKYLFQIINGIGFCHSHN----IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG  178 (331)
T ss_dssp             ECCSEEHHHHHHHSTT-CCCHHHHHHHHHHHHHHHHHHHHTT----CCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred             ecCCcchHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHCC----EEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence            9999988888866554 4999999999999999999999654    9999999999999999999999999998765432


Q ss_pred             CccccccccCCccccCccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHh--cCCchhhhhhh-
Q 007680          428 DSVRQTMTMATIGYMAPEYGLEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKES--LPHGLTEVVDA-  503 (593)
Q Consensus       428 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~-  503 (593)
                      .  ......+++.|+|||++.+. .++.++|||||||++|+|++|+.||......+ .........  ........... 
T Consensus       179 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  255 (331)
T 4aaa_A          179 E--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDID-QLYHIMMCLGNLIPRHQELFNKN  255 (331)
T ss_dssp             -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCSCCHHHHHHHHHC
T ss_pred             c--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCCCChhhhhHhhhc
Confidence            2  22345689999999998775 78999999999999999999999997643221 111111100  00000000000 


Q ss_pred             ---------hhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          504 ---------NLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       504 ---------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                               ..............+++.+.+++.+||+.||++|||+.|+++|
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  307 (331)
T 4aaa_A          256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH  307 (331)
T ss_dssp             GGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             cccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence                     0000000111112356789999999999999999999999986

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=4.6e-41  Score=342.06  Aligned_cols=252  Identities=26%  Similarity=0.328  Sum_probs=202.7

Q ss_pred             hhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEe
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLE  348 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  348 (593)
                      ..++|++.+.||+|+||.||+|... +|+.||+|++....  ..+.+.+|+.++++++||||+++++++...+..++|||
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  104 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME  104 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence            4578999999999999999999976 68999999997653  34678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCC
Q 007680          349 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGED  428 (593)
Q Consensus       349 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  428 (593)
                      |+++++|.+++......+++..+..++.|++.||.|||+++    ++|+||||+||+++.++.+||+|||.+........
T Consensus       105 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~----i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~  180 (314)
T 3com_A          105 YCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR----KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA  180 (314)
T ss_dssp             CCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT----EECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS
T ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC----CcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc
Confidence            99999999999865556999999999999999999999654    99999999999999999999999999987654322


Q ss_pred             ccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhh
Q 007680          429 SVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVRE  508 (593)
Q Consensus       429 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  508 (593)
                        ......|++.|+|||++.+..++.++||||||+++|+|++|+.||.......  .........+.             
T Consensus       181 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~-------------  243 (314)
T 3com_A          181 --KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR--AIFMIPTNPPP-------------  243 (314)
T ss_dssp             --CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHHHHSCCC-------------
T ss_pred             --ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHhcCCCc-------------
Confidence              2234568999999999999999999999999999999999999997632211  11111111100             


Q ss_pred             hhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          509 EQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       509 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                        ....+..++..+.+++.+||+.||++|||+.++++|
T Consensus       244 --~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~  279 (314)
T 3com_A          244 --TFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH  279 (314)
T ss_dssp             --CCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             --ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence              001112235678999999999999999999999875

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=2.8e-41  Score=347.06  Aligned_cols=249  Identities=20%  Similarity=0.281  Sum_probs=207.2

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALV  346 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  346 (593)
                      .++|.+.+.||+|+||.||++.+. +++.||+|++....   ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            468999999999999999999976 58899999997652   34556789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCC
Q 007680          347 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG  426 (593)
Q Consensus       347 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  426 (593)
                      |||+++++|.+++..... +++.++..++.|++.||+|||+++    |+||||||+||+++.++.+||+|||++......
T Consensus       120 ~e~~~~~~L~~~~~~~~~-l~~~~~~~i~~qi~~aL~~LH~~~----ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  194 (335)
T 2owb_A          120 LELCRRRSLLELHKRRKA-LTEPEARYYLRQIVLGCQYLHRNR----VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD  194 (335)
T ss_dssp             ECCCTTCBHHHHHHHHCS-CCHHHHHHHHHHHHHHHHHHHHTT----EECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             EecCCCCCHHHHHhccCC-CCHHHHHHHHHHHHHHHHHHHHCC----CEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence            999999999999877554 899999999999999999999654    999999999999999999999999999876533


Q ss_pred             CCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhh
Q 007680          427 EDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLV  506 (593)
Q Consensus       427 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  506 (593)
                      ..  ......|++.|+|||++.+..++.++||||||+++|||++|+.||......+  ....+....             
T Consensus       195 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~-------------  257 (335)
T 2owb_A          195 GE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE--TYLRIKKNE-------------  257 (335)
T ss_dssp             TC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH--HHHHHHHTC-------------
T ss_pred             cc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH--HHHHHhcCC-------------
Confidence            22  2234568999999999999899999999999999999999999997632111  111111000             


Q ss_pred             hhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          507 REEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                           ...+..++..+.+++.+||+.||++|||+.|++++
T Consensus       258 -----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~  292 (335)
T 2owb_A          258 -----YSIPKHINPVAASLIQKMLQTDPTARPTINELLND  292 (335)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             -----CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                 00111234578999999999999999999999986

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.8e-41  Score=356.62  Aligned_cols=276  Identities=23%  Similarity=0.278  Sum_probs=213.4

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCC--ceEEE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPD--FKALV  346 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv  346 (593)
                      .++|++.+.||+|+||.||+|++. +|+.||||+++... ....+.+.+|++++++++||||+++++++...+  ..++|
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv   87 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence            467999999999999999999976 58999999998643 234567789999999999999999999988765  77999


Q ss_pred             EeccCCCCHHHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeee----CCCCcEEEEeeccc
Q 007680          347 LEFMPNGSLEKWLYSHNY--FLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILL----DENMVAHVSDFGIY  420 (593)
Q Consensus       347 ~e~~~~gsL~~~l~~~~~--~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll----~~~~~~kL~Dfg~a  420 (593)
                      |||+++|+|.+++.....  .+++..+..++.|++.||+|||+++    |+||||||+||++    +.++.+||+|||++
T Consensus        88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~----ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a  163 (396)
T 4eut_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG----IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (396)
T ss_dssp             ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT----EECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred             EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC----EEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence            999999999999976543  3899999999999999999999654    9999999999999    77888999999999


Q ss_pred             eecCCCCCccccccccCCccccCccccCC--------CCCCccchHHHHHHHHHHHHhCCCCCCccccccc--hHHHHHH
Q 007680          421 KLLGEGEDSVRQTMTMATIGYMAPEYGLE--------GIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEM--SLRRWVK  490 (593)
Q Consensus       421 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~--~~~~~~~  490 (593)
                      +......   ......||+.|+|||++.+        ..++.++|||||||++|||++|+.||........  .....+.
T Consensus       164 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~  240 (396)
T 4eut_A          164 RELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII  240 (396)
T ss_dssp             EECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHH
T ss_pred             eEccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHh
Confidence            8765432   2234568999999998764        5678899999999999999999999975432221  1111122


Q ss_pred             HhcCCc-hhhhh---hhhhhhh---hhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhh
Q 007680          491 ESLPHG-LTEVV---DANLVRE---EQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVK  553 (593)
Q Consensus       491 ~~~~~~-~~~~~---~~~~~~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  553 (593)
                      ...+.. .....   ...+...   .........++..+.+++.+||+.||++||++.|+++.++++...
T Consensus       241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~  310 (396)
T 4eut_A          241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (396)
T ss_dssp             HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred             cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence            222211 11000   0000000   001112245677899999999999999999999999999888654

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=8.6e-41  Score=355.33  Aligned_cols=275  Identities=21%  Similarity=0.257  Sum_probs=201.4

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehh--hHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-----Cc
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQ--LERAFRSFDSECEVLRNVRHRNLIKILSSYSNP-----DF  342 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~  342 (593)
                      .++|++.+.||+|+||.||+|++. +++.||||+++..  .....+.+.+|++++++++||||+++++++...     +.
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            568999999999999999999975 6889999999753  234556889999999999999999999999766     57


Q ss_pred             eEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeecccee
Q 007680          343 KALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKL  422 (593)
Q Consensus       343 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~  422 (593)
                      .|+||||++ ++|.+++.... .+++..+..++.||+.||+|||+++    |+||||||+||+++.++.+||+|||+++.
T Consensus       105 ~~lv~e~~~-~~L~~~~~~~~-~l~~~~~~~i~~qil~aL~~LH~~g----ivHrDlkp~NILl~~~~~~kL~DFGla~~  178 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKTPI-FLTEEHIKTILYNLLLGENFIHESG----IIHRDLKPANCLLNQDCSVKVCDFGLART  178 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHSSC-CCCHHHHHHHHHHHHHHHHHHHHTT----EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEEecCC-cCHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCC----CCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence            899999995 59999997754 4999999999999999999999654    99999999999999999999999999998


Q ss_pred             cCCCCCc--------------------cccccccCCccccCcccc-CCCCCCccchHHHHHHHHHHHHhCCCCCCccccc
Q 007680          423 LGEGEDS--------------------VRQTMTMATIGYMAPEYG-LEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIG  481 (593)
Q Consensus       423 ~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~  481 (593)
                      .......                    .......||+.|+|||++ .+..++.++||||+||++|||++|..||.....+
T Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~  258 (432)
T 3n9x_A          179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTN  258 (432)
T ss_dssp             C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGG
T ss_pred             ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccc
Confidence            7543221                    112456789999999985 5667999999999999999999866555432110


Q ss_pred             c--------------------------chHHHHHHHhcCCchhhhh----hhhhhhh--------h-hhhhhhHHHHHHH
Q 007680          482 E--------------------------MSLRRWVKESLPHGLTEVV----DANLVRE--------E-QAFSAKMDCILSI  522 (593)
Q Consensus       482 ~--------------------------~~~~~~~~~~~~~~~~~~~----~~~~~~~--------~-~~~~~~~~~~~~l  522 (593)
                      .                          ......+.........+.+    .......        . ........+++++
T Consensus       259 ~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  338 (432)
T 3n9x_A          259 RFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDG  338 (432)
T ss_dssp             CCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHH
T ss_pred             ccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHH
Confidence            0                          0000001110000000000    0000000        0 0000112346788


Q ss_pred             HHHHhhcccCCCCCCCCHHHHHHH--HHHhh
Q 007680          523 MDFALDCCMESPDMRINMTDAAAK--LKKIK  551 (593)
Q Consensus       523 ~~li~~cl~~dP~~RPs~~evl~~--L~~i~  551 (593)
                      .+|+.+||+.||++|||++|+++|  ++++.
T Consensus       339 ~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~  369 (432)
T 3n9x_A          339 INLLESMLKFNPNKRITIDQALDHPYLKDVR  369 (432)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHHTCGGGTTTC
T ss_pred             HHHHHHHhcCCcccCCCHHHHhcChhhhhcc
Confidence            999999999999999999999987  55543

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=3.1e-41  Score=351.01  Aligned_cols=255  Identities=16%  Similarity=0.113  Sum_probs=206.4

Q ss_pred             HhhhccccccccCccCcccEEEEE------eCCCCeEEEEEeehhhHHHHHHHHHHHHHHhhcC---CCCcceeeeeeec
Q 007680          269 RATDEFNECNLLGTSSFGSVYKGT------ISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVR---HRNLIKILSSYSN  339 (593)
Q Consensus       269 ~~~~~~~~~~~lg~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~  339 (593)
                      ...++|.+.+.||+|+||.||+|.      ..+++.||+|+++....   ..+..|+++++.++   |+||+++++++..
T Consensus        62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~  138 (365)
T 3e7e_A           62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP---WEFYIGTQLMERLKPSMQHMFMKFYSAHLF  138 (365)
T ss_dssp             CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCH---HHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred             ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCCh---hHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence            345789999999999999999994      34789999999976533   35677777777775   9999999999999


Q ss_pred             CCceEEEEeccCCCCHHHHHhh----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC-------
Q 007680          340 PDFKALVLEFMPNGSLEKWLYS----HNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDE-------  408 (593)
Q Consensus       340 ~~~~~lv~e~~~~gsL~~~l~~----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~-------  408 (593)
                      .+..++||||+++|+|.+++..    ....+++..+..++.|++.||+|||++    +|+||||||+|||++.       
T Consensus       139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~----~ivHrDiKp~NIll~~~~~~~~~  214 (365)
T 3e7e_A          139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC----EIIHGDIKPDNFILGNGFLEQDD  214 (365)
T ss_dssp             SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCSGGGEEECGGGTCC--
T ss_pred             CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC----CeecCCCCHHHEEecccccCccc
Confidence            9999999999999999999975    234599999999999999999999954    5999999999999998       


Q ss_pred             ----CCcEEEEeeccceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccch
Q 007680          409 ----NMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMS  484 (593)
Q Consensus       409 ----~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~  484 (593)
                          ++.+||+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||+||+.||.....+...
T Consensus       215 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~  294 (365)
T 3e7e_A          215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK  294 (365)
T ss_dssp             ----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE
T ss_pred             cccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee
Confidence                8999999999998765433333445567999999999999999999999999999999999999999653221110


Q ss_pred             HHHHHHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCC-CCHHHHHHHHHHhhhhh
Q 007680          485 LRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMR-INMTDAAAKLKKIKVKF  554 (593)
Q Consensus       485 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R-Ps~~evl~~L~~i~~~~  554 (593)
                                      +.......        ..++.+.+++..|++.+|.+| |+++++.+.|+++....
T Consensus       295 ----------------~~~~~~~~--------~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~  341 (365)
T 3e7e_A          295 ----------------PEGLFRRL--------PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH  341 (365)
T ss_dssp             ----------------ECSCCTTC--------SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             ----------------echhcccc--------CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence                            00000000        113467889999999999999 57888888888876553

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.9e-41  Score=347.09  Aligned_cols=258  Identities=28%  Similarity=0.429  Sum_probs=206.6

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeE--EEEEeehhh-HHHHHHHHHHHHHHhhc-CCCCcceeeeeeecCCceEE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDV--AIKVFNLQL-ERAFRSFDSECEVLRNV-RHRNLIKILSSYSNPDFKAL  345 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~v--avK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  345 (593)
                      .++|++.+.||+|+||.||+|+.. ++..+  |+|.++... ....+.+.+|+++++++ +||||+++++++.+.+..++
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l  103 (327)
T 1fvr_A           24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL  103 (327)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred             HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence            468999999999999999999965 56644  999987532 33456789999999999 89999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC
Q 007680          346 VLEFMPNGSLEKWLYSHN---------------YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENM  410 (593)
Q Consensus       346 v~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~  410 (593)
                      ||||+++++|.+++....               ..+++.++..++.|++.||+|||+++    |+||||||+||+++.++
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~----ivH~dlkp~NIl~~~~~  179 (327)
T 1fvr_A          104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ----FIHRDLAARNILVGENY  179 (327)
T ss_dssp             EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT----EECSCCSGGGEEECGGG
T ss_pred             EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC----ccCCCCccceEEEcCCC
Confidence            999999999999998754               35899999999999999999999654    99999999999999999


Q ss_pred             cEEEEeeccceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHH
Q 007680          411 VAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWV  489 (593)
Q Consensus       411 ~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~  489 (593)
                      .+||+|||+++......   ......+++.|+|||++.+..++.++||||||+++|||++ |+.||......+  ....+
T Consensus       180 ~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~--~~~~~  254 (327)
T 1fvr_A          180 VAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--LYEKL  254 (327)
T ss_dssp             CEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHG
T ss_pred             eEEEcccCcCccccccc---cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH--HHHHh
Confidence            99999999987432211   2233456889999999988889999999999999999998 999997632111  11110


Q ss_pred             HHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhhh
Q 007680          490 KESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKF  554 (593)
Q Consensus       490 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  554 (593)
                      ...                 .....+..+++++.+++.+||+.||++|||+.|++++|+++....
T Consensus       255 ~~~-----------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  302 (327)
T 1fvr_A          255 PQG-----------------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  302 (327)
T ss_dssp             GGT-----------------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             hcC-----------------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence            000                 001111234567899999999999999999999999999987664

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=5.4e-41  Score=362.53  Aligned_cols=252  Identities=24%  Similarity=0.322  Sum_probs=205.3

Q ss_pred             hhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh--HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEE
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALV  346 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  346 (593)
                      ..++|++.+.||+|+||.||+|+.. +++.||+|++....  ......+.+|++++++++||||+++++++.+.+..++|
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   99 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence            3578999999999999999999976 78999999997653  23456789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeC---CCCcEEEEeeccceec
Q 007680          347 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLD---ENMVAHVSDFGIYKLL  423 (593)
Q Consensus       347 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~---~~~~~kL~Dfg~a~~~  423 (593)
                      |||+++|+|.+++..... +++.++..++.|++.||.|||+++    |+||||||+||+++   .++.+||+|||+++..
T Consensus       100 ~e~~~~~~L~~~~~~~~~-~~~~~~~~i~~qi~~al~~lH~~~----ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~  174 (486)
T 3mwu_A          100 GELYTGGELFDEIIKRKR-FSEHDAARIIKQVFSGITYMHKHN----IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF  174 (486)
T ss_dssp             ECCCCSCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred             EEcCCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCC----eEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence            999999999999877654 999999999999999999999654    99999999999995   4567999999999866


Q ss_pred             CCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhh
Q 007680          424 GEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDA  503 (593)
Q Consensus       424 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  503 (593)
                      ....   ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||......  .....+......        
T Consensus       175 ~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i~~~~~~--------  240 (486)
T 3mwu_A          175 QQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY--DILKRVETGKYA--------  240 (486)
T ss_dssp             CCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHTCCC--------
T ss_pred             CCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhCCCC--------
Confidence            5432   2234569999999999865 5999999999999999999999999763211  111111111000        


Q ss_pred             hhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          504 NLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                            ...+....+++++.+++.+||+.||++|||+.|+++|
T Consensus       241 ------~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          241 ------FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             ------SCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             ------CCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                  0011122346688999999999999999999999987

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=6e-41  Score=337.48  Aligned_cols=263  Identities=22%  Similarity=0.344  Sum_probs=210.6

Q ss_pred             hhhcccccc-ccCccCcccEEEEEeC---CCCeEEEEEeehhh--HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCce
Q 007680          270 ATDEFNECN-LLGTSSFGSVYKGTIS---DGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFK  343 (593)
Q Consensus       270 ~~~~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  343 (593)
                      ..++|++.+ .||+|+||.||+|.+.   +++.||+|+++...  ....+.+.+|++++++++||||+++++++ ..+..
T Consensus        14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~   92 (291)
T 1xbb_A           14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW   92 (291)
T ss_dssp             CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred             cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence            356788888 9999999999999642   47889999997653  23456799999999999999999999998 56678


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceec
Q 007680          344 ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLL  423 (593)
Q Consensus       344 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~  423 (593)
                      ++||||+++++|.+++..... +++.++..++.|++.||+|||+++    |+||||||+||+++.++.+||+|||++...
T Consensus        93 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~i~~qi~~~l~~LH~~~----i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  167 (291)
T 1xbb_A           93 MLVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYLEESN----FVHRDLAARNVLLVTQHYAKISDFGLSKAL  167 (291)
T ss_dssp             EEEEECCTTEEHHHHHHHCTT-CCHHHHHHHHHHHHHHHHHHHHTT----EECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEEeCCCCCHHHHHHhCcC-CCHHHHHHHHHHHHHHHHHHHhCC----eEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence            999999999999999987654 999999999999999999999654    999999999999999999999999999877


Q ss_pred             CCCCCccc-cccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhh
Q 007680          424 GEGEDSVR-QTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVV  501 (593)
Q Consensus       424 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  501 (593)
                      ........ .....+++.|+|||++.+..++.++||||||+++|||++ |+.||......  .....+.....       
T Consensus       168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~~~~~~-------  238 (291)
T 1xbb_A          168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVTAMLEKGER-------  238 (291)
T ss_dssp             CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHHTTCC-------
T ss_pred             ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHHcCCC-------
Confidence            55433221 223346788999999988889999999999999999999 99999764221  11121111110       


Q ss_pred             hhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhhhcch
Q 007680          502 DANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKFLDD  557 (593)
Q Consensus       502 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~  557 (593)
                                ...+..++..+.+++.+||+.||++||++.++++.|+++......+
T Consensus       239 ----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~  284 (291)
T 1xbb_A          239 ----------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNE  284 (291)
T ss_dssp             ----------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHHH
T ss_pred             ----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhhc
Confidence                      0111234568899999999999999999999999999987665433

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-41  Score=349.91  Aligned_cols=271  Identities=26%  Similarity=0.333  Sum_probs=201.4

Q ss_pred             HHhhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhH-----HHHHHHHHHHHHHhhcCCCCcceeeeeeecCC
Q 007680          268 QRATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLE-----RAFRSFDSECEVLRNVRHRNLIKILSSYSNPD  341 (593)
Q Consensus       268 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  341 (593)
                      ....++|++.+.||+|+||.||+|+.. +|+.||+|+++....     ...+.+.+|++++++++||||+++++++.+.+
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   85 (346)
T 1ua2_A            6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS   85 (346)
T ss_dssp             -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred             HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence            344678999999999999999999975 689999999975421     12346789999999999999999999999999


Q ss_pred             ceEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccce
Q 007680          342 FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYK  421 (593)
Q Consensus       342 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~  421 (593)
                      ..++||||+++ +|.+++......+++.++..++.|+++||+|||+++    |+||||||+||+++.++.+||+|||+++
T Consensus        86 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~----ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  160 (346)
T 1ua2_A           86 NISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW----ILHRDLKPNNLLLDENGVLKLADFGLAK  160 (346)
T ss_dssp             CCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT----CCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred             ceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC----EECCCCCHHHEEEcCCCCEEEEecccce
Confidence            99999999975 899999877667899999999999999999999655    9999999999999999999999999998


Q ss_pred             ecCCCCCccccccccCCccccCccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHh-cCC--ch
Q 007680          422 LLGEGEDSVRQTMTMATIGYMAPEYGLEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKES-LPH--GL  497 (593)
Q Consensus       422 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~-~~~--~~  497 (593)
                      .......  ......+|+.|+|||++.+. .++.++|||||||++|||++|.+||......+ .+....... .+.  .+
T Consensus       161 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~-~~~~i~~~~~~~~~~~~  237 (346)
T 1ua2_A          161 SFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD-QLTRIFETLGTPTEEQW  237 (346)
T ss_dssp             TTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCTTTS
T ss_pred             eccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHcCCCChhhh
Confidence            7654322  22345689999999998664 58999999999999999999999997643211 122222111 110  00


Q ss_pred             hhhh---hh---hhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          498 TEVV---DA---NLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       498 ~~~~---~~---~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      ....   +.   ..............++.++.+++.+||+.||++|||+.|+++|
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          238 PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             SSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             hhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            0000   00   0000000001112345689999999999999999999999986

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=2.9e-41  Score=357.38  Aligned_cols=254  Identities=24%  Similarity=0.316  Sum_probs=195.4

Q ss_pred             HhhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh--------HHHHHHHHHHHHHHhhcCCCCcceeeeeeec
Q 007680          269 RATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL--------ERAFRSFDSECEVLRNVRHRNLIKILSSYSN  339 (593)
Q Consensus       269 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  339 (593)
                      ...++|.+.+.||+|+||.||+|... +++.||+|++....        ......+.+|+.++++++||||+++++++..
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  211 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA  211 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            34678999999999999999999865 68999999997642        1122357899999999999999999999754


Q ss_pred             CCceEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC---cEEEEe
Q 007680          340 PDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENM---VAHVSD  416 (593)
Q Consensus       340 ~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~---~~kL~D  416 (593)
                       +..++||||+++|+|.+++..... +++.++..++.|++.||+|||+++    |+||||||+||+++.++   .+||+|
T Consensus       212 -~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~i~~qi~~~l~~LH~~~----ivHrDlkp~NIll~~~~~~~~~kl~D  285 (419)
T 3i6u_A          212 -EDYYIVLELMEGGELFDKVVGNKR-LKEATCKLYFYQMLLAVQYLHENG----IIHRDLKPENVLLSSQEEDCLIKITD  285 (419)
T ss_dssp             -SEEEEEEECCTTCBGGGGTSSSCC-CCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred             -CceEEEEEcCCCCcHHHHHhccCC-CCHHHHHHHHHHHHHHHHHHHHCC----ccccCCChHhEEEecCCCcceEEEee
Confidence             557999999999999998876654 999999999999999999999654    99999999999997544   599999


Q ss_pred             eccceecCCCCCccccccccCCccccCccccCC---CCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhc
Q 007680          417 FGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLE---GIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESL  493 (593)
Q Consensus       417 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~  493 (593)
                      ||+++......   ......||+.|+|||++.+   ..++.++|||||||++|+|++|+.||....... .....+....
T Consensus       286 FG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~-~~~~~i~~~~  361 (419)
T 3i6u_A          286 FGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV-SLKDQITSGK  361 (419)
T ss_dssp             SSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC-CHHHHHHTTC
T ss_pred             cccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH-HHHHHHhcCC
Confidence            99998765432   2234568999999999753   568899999999999999999999997642221 1222221111


Q ss_pred             CCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          494 PHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       494 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      ....              ......+++.+.+++.+||+.||++|||+.|+++|
T Consensus       362 ~~~~--------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  400 (419)
T 3i6u_A          362 YNFI--------------PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH  400 (419)
T ss_dssp             CCCC--------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CCCC--------------chhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            1000              01112345688999999999999999999999986

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=3.4e-41  Score=346.14  Aligned_cols=259  Identities=20%  Similarity=0.237  Sum_probs=191.5

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcC-CCCcceeeeeee--------cC
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNVR-HRNLIKILSSYS--------NP  340 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~--------~~  340 (593)
                      ..+|++.+.||+|+||.||+|++. +++.||+|++........+.+.+|+.++.++. ||||+++++++.        ..
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~  106 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ  106 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence            458999999999999999999975 78999999997766666678899999999996 999999999984        33


Q ss_pred             CceEEEEeccCCCCHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeec
Q 007680          341 DFKALVLEFMPNGSLEKWLYS--HNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFG  418 (593)
Q Consensus       341 ~~~~lv~e~~~~gsL~~~l~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg  418 (593)
                      ...++||||++ |+|.+++..  ....+++.++..++.|++.||+|||+++  .+|+||||||+||+++.++.+||+|||
T Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--~~ivH~Dikp~NIl~~~~~~~kl~Dfg  183 (337)
T 3ll6_A          107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK--PPIIHRDLKVENLLLSNQGTIKLCDFG  183 (337)
T ss_dssp             EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS--SCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred             ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC--CCEEEccCCcccEEECCCCCEEEecCc
Confidence            45799999995 799998865  3345999999999999999999999432  239999999999999999999999999


Q ss_pred             cceecCCCCCcc----------ccccccCCccccCcccc---CCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchH
Q 007680          419 IYKLLGEGEDSV----------RQTMTMATIGYMAPEYG---LEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSL  485 (593)
Q Consensus       419 ~a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~  485 (593)
                      ++..........          ......+|+.|+|||++   .+..++.++|||||||++|||++|+.||......    
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~----  259 (337)
T 3ll6_A          184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL----  259 (337)
T ss_dssp             TCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------
T ss_pred             cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH----
Confidence            998765432211          11134589999999998   5667899999999999999999999999653211    


Q ss_pred             HHHHHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhhh
Q 007680          486 RRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKF  554 (593)
Q Consensus       486 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  554 (593)
                       ........                 .......+..+.+++.+||+.||++|||+.|++++|+.+....
T Consensus       260 -~~~~~~~~-----------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~  310 (337)
T 3ll6_A          260 -RIVNGKYS-----------------IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR  310 (337)
T ss_dssp             -------CC-----------------CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             -HhhcCccc-----------------CCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence             01110000                 0001112335789999999999999999999999999997654

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.3e-41  Score=339.83  Aligned_cols=252  Identities=28%  Similarity=0.433  Sum_probs=201.1

Q ss_pred             hhccccccccCccCcccEEEEEeCCCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-CceEEEEec
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNP-DFKALVLEF  349 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~  349 (593)
                      .++|++.+.||+|+||.||+|+.. |+.||+|+++...  ..+.+.+|++++++++||||+++++++... +..++||||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   96 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   96 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence            578999999999999999999884 8899999997543  346789999999999999999999986554 578999999


Q ss_pred             cCCCCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCC
Q 007680          350 MPNGSLEKWLYSHNY-FLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGED  428 (593)
Q Consensus       350 ~~~gsL~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  428 (593)
                      +++++|.+++..... .+++..+..++.|++.||+|||+++    ++||||||+||+++.++.+||+|||++....... 
T Consensus        97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~----i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  171 (278)
T 1byg_A           97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN----FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-  171 (278)
T ss_dssp             CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred             CCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC----ccccCCCcceEEEeCCCcEEEeeccccccccccc-
Confidence            999999999976543 3789999999999999999999655    9999999999999999999999999987654322 


Q ss_pred             ccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhh
Q 007680          429 SVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVR  507 (593)
Q Consensus       429 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  507 (593)
                          ....+++.|+|||++.+..++.++||||||+++|||++ |+.||......  .....+....              
T Consensus       172 ----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--~~~~~~~~~~--------------  231 (278)
T 1byg_A          172 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPRVEKGY--------------  231 (278)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG--GHHHHHTTTC--------------
T ss_pred             ----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHhcCC--------------
Confidence                22357889999999988899999999999999999998 99999764221  1111111100              


Q ss_pred             hhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhh
Q 007680          508 EEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVK  553 (593)
Q Consensus       508 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  553 (593)
                         ....+..+++.+.+++.+||+.||++|||+.|+++.|++++..
T Consensus       232 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~  274 (278)
T 1byg_A          232 ---KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH  274 (278)
T ss_dssp             ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence               0111123466889999999999999999999999999998754

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.4e-40  Score=344.06  Aligned_cols=269  Identities=21%  Similarity=0.278  Sum_probs=204.6

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh--HHHHHHHHHHHHHHhhcCCCCcceeeeeeec--------
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSYSN--------  339 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------  339 (593)
                      .++|++.+.||+|+||.||+|+.. +|+.||+|++....  ......+.+|++++++++||||+++++++..        
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            468999999999999999999974 79999999986543  2234567899999999999999999999876        


Q ss_pred             CCceEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeecc
Q 007680          340 PDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGI  419 (593)
Q Consensus       340 ~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~  419 (593)
                      .+..++||||+++ +|.+.+......+++.++..++.|++.||+|||+++    |+||||||+||+++.++.+||+|||+
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~----ivH~Dlkp~NIl~~~~~~~kl~Dfg~  170 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK----ILHRDMKAANVLITRDGVLKLADFGL  170 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT----EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             CceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC----eeCCCCCHHHEEEcCCCCEEEccchh
Confidence            3468999999965 888888776667999999999999999999999655    99999999999999999999999999


Q ss_pred             ceecCCCCCc--cccccccCCccccCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHH---hc
Q 007680          420 YKLLGEGEDS--VRQTMTMATIGYMAPEYGLE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKE---SL  493 (593)
Q Consensus       420 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~---~~  493 (593)
                      ++.+......  .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......  ....+..   ..
T Consensus       171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~i~~~~~~~  248 (351)
T 3mi9_A          171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH--QLALISQLCGSI  248 (351)
T ss_dssp             CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCC
T ss_pred             cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCC
Confidence            9876533221  22344568999999998876 458999999999999999999999998743221  1111111   11


Q ss_pred             CCc-hhhhhhhhhhh----------hhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          494 PHG-LTEVVDANLVR----------EEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       494 ~~~-~~~~~~~~~~~----------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      +.. ...........          ...........++.+.+++.+||+.||++|||++|+++|
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  312 (351)
T 3mi9_A          249 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  312 (351)
T ss_dssp             CTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence            111 11110000000          000000011124578999999999999999999999986

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.4e-40  Score=334.50  Aligned_cols=250  Identities=24%  Similarity=0.329  Sum_probs=199.6

Q ss_pred             hccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh--HHHHHHHHHHHHHHhhcCCCCcceeeeeeec----CCceE
Q 007680          272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSYSN----PDFKA  344 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~  344 (593)
                      ..|.+.+.||+|+||.||+|.+. ++..||+|++....  ....+.+.+|+.++++++||||+++++++..    ....+
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  105 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV  105 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence            35788889999999999999975 68899999997643  4456788999999999999999999998865    35689


Q ss_pred             EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeC-CCCcEEEEeeccceec
Q 007680          345 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLD-ENMVAHVSDFGIYKLL  423 (593)
Q Consensus       345 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~-~~~~~kL~Dfg~a~~~  423 (593)
                      +||||+++++|.+++..... +++..+..++.|++.||+|||+++  .+|+||||||+||+++ .++.+||+|||++...
T Consensus       106 lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~qi~~~l~~lH~~~--~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~  182 (290)
T 1t4h_A          106 LVTELMTSGTLKTYLKRFKV-MKIKVLRSWCRQILKGLQFLHTRT--PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  182 (290)
T ss_dssp             EEEECCCSCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHHTSS--SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             EEEEecCCCCHHHHHHHccC-CCHHHHHHHHHHHHHHHHHHHcCC--CCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence            99999999999999987544 899999999999999999999532  2399999999999998 7899999999999754


Q ss_pred             CCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhh
Q 007680          424 GEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDA  503 (593)
Q Consensus       424 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  503 (593)
                      ....    .....||+.|+|||++. +.++.++||||||+++|+|++|+.||.......... ........         
T Consensus       183 ~~~~----~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-~~~~~~~~---------  247 (290)
T 1t4h_A          183 RASF----AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY-RRVTSGVK---------  247 (290)
T ss_dssp             CTTS----BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHH-HHHTTTCC---------
T ss_pred             cccc----cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHH-HHHhccCC---------
Confidence            4322    23356899999999876 459999999999999999999999997632221111 11110000         


Q ss_pred             hhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          504 NLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                             ........++++.+++.+||+.||++|||+.|+++|
T Consensus       248 -------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  283 (290)
T 1t4h_A          248 -------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             -------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             -------ccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence                   001111224578999999999999999999999875

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.3e-40  Score=336.89  Aligned_cols=250  Identities=24%  Similarity=0.357  Sum_probs=207.9

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEe
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLE  348 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  348 (593)
                      .+.|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  100 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME  100 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence            456999999999999999999865 78999999997653 3345788999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCC
Q 007680          349 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGED  428 (593)
Q Consensus       349 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  428 (593)
                      |+++++|.+++...  .+++..+..++.|++.||.|||+++    |+||||||+||+++.++.+||+|||.+........
T Consensus       101 ~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~----i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~  174 (303)
T 3a7i_A          101 YLGGGSALDLLEPG--PLDETQIATILREILKGLDYLHSEK----KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI  174 (303)
T ss_dssp             CCTTEEHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHTT----EECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC
T ss_pred             eCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC----CccCCCChheEEECCCCCEEEeecccceecCcccc
Confidence            99999999999764  4899999999999999999999654    99999999999999999999999999987654322


Q ss_pred             ccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhh
Q 007680          429 SVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVRE  508 (593)
Q Consensus       429 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  508 (593)
                        ......|++.|+|||++.+..++.++||||||+++|+|++|+.||......  .....+....+..            
T Consensus       175 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~------------  238 (303)
T 3a7i_A          175 --KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM--KVLFLIPKNNPPT------------  238 (303)
T ss_dssp             --CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHHSCCCC------------
T ss_pred             --ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH--HHHHHhhcCCCCC------------
Confidence              223456899999999999999999999999999999999999999763221  1111111111100            


Q ss_pred             hhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 007680          509 EQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKL  547 (593)
Q Consensus       509 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  547 (593)
                           ....++..+.+++.+||+.||++|||+.|++++.
T Consensus       239 -----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~  272 (303)
T 3a7i_A          239 -----LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHK  272 (303)
T ss_dssp             -----CCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred             -----CccccCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence                 0112355789999999999999999999999874

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1e-40  Score=361.23  Aligned_cols=254  Identities=22%  Similarity=0.312  Sum_probs=207.0

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhH---HHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLE---RAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALV  346 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  346 (593)
                      .++|++.+.||+|+||.||+|+.+ +|+.||+|+++....   .....+.+|++++++++||||+++++++.+.+..|+|
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  263 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV  263 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence            478999999999999999999975 799999999986532   2346788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceec
Q 007680          347 LEFMPNGSLEKWLYSHN---YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLL  423 (593)
Q Consensus       347 ~e~~~~gsL~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~  423 (593)
                      |||++||+|.+++....   ..+++..+..++.||+.||+|||+++    |+||||||+||+++.++.+||+|||+++.+
T Consensus       264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g----IvHrDLKP~NILl~~~g~vkL~DFGla~~~  339 (543)
T 3c4z_A          264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN----IIYRDLKPENVLLDDDGNVRISDLGLAVEL  339 (543)
T ss_dssp             ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT----EECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC----CcccCCChHHEEEeCCCCEEEeecceeeec
Confidence            99999999999997643   35999999999999999999999654    999999999999999999999999999876


Q ss_pred             CCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhh
Q 007680          424 GEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDA  503 (593)
Q Consensus       424 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  503 (593)
                      .....  ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .........        ...
T Consensus       340 ~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~-~~~~~~~~i--------~~~  408 (543)
T 3c4z_A          340 KAGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-ENKELKQRV--------LEQ  408 (543)
T ss_dssp             CTTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC-CHHHHHHHH--------HHC
T ss_pred             cCCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch-hHHHHHHHH--------hhc
Confidence            54332  2233579999999999999999999999999999999999999997642211 111111100        000


Q ss_pred             hhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCH-----HHHHHH
Q 007680          504 NLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINM-----TDAAAK  546 (593)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~~  546 (593)
                      .       ...+..++.++.+++.+||+.||++||++     .++++|
T Consensus       409 ~-------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H  449 (543)
T 3c4z_A          409 A-------VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH  449 (543)
T ss_dssp             C-------CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred             c-------cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence            0       00112345688999999999999999965     667654

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=6.5e-41  Score=336.73  Aligned_cols=253  Identities=22%  Similarity=0.264  Sum_probs=190.1

Q ss_pred             hhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh--HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEE
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALV  346 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  346 (593)
                      ..++|++.+.||+|+||.||+|+.. +|+.||+|+++...  ....+.+.++...++.++||||+++++++.+++..++|
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv   84 (290)
T 3fme_A            5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC   84 (290)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred             cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence            3578999999999999999999974 78999999997642  22334455566668888999999999999999999999


Q ss_pred             EeccCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceec
Q 007680          347 LEFMPNGSLEKWLYS---HNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLL  423 (593)
Q Consensus       347 ~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~  423 (593)
                      |||++ |+|.+++..   ....+++..+..++.|++.||+|||++   .+|+||||||+||+++.++.+||+|||++...
T Consensus        85 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  160 (290)
T 3fme_A           85 MELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK---LSVIHRDVKPSNVLINALGQVKMCDFGISGYL  160 (290)
T ss_dssp             EECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---SCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred             Eehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhc---CCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            99997 588887754   344699999999999999999999975   14999999999999999999999999999876


Q ss_pred             CCCCCccccccccCCccccCcccc----CCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhh
Q 007680          424 GEGEDSVRQTMTMATIGYMAPEYG----LEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTE  499 (593)
Q Consensus       424 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  499 (593)
                      ....   ......||+.|+|||++    .+..++.++||||||+++|+|++|+.||..................+..   
T Consensus       161 ~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---  234 (290)
T 3fme_A          161 VDDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQL---  234 (290)
T ss_dssp             ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCC---
T ss_pred             cccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCc---
Confidence            5432   22334689999999995    5667899999999999999999999999753222222222222111110   


Q ss_pred             hhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          500 VVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       500 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                                    ....++.++.+++.+||+.||++|||+.|+++|
T Consensus       235 --------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h  267 (290)
T 3fme_A          235 --------------PADKFSAEFVDFTSQCLKKNSKERPTYPELMQH  267 (290)
T ss_dssp             --------------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             --------------ccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence                          011235678999999999999999999999985

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.1e-40  Score=335.93  Aligned_cols=251  Identities=25%  Similarity=0.332  Sum_probs=199.7

Q ss_pred             ccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEeccC
Q 007680          273 EFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMP  351 (593)
Q Consensus       273 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  351 (593)
                      +|.....||+|+||.||+|.+. +++.||+|.+........+.+.+|+.++++++||||+++++++...+..++||||++
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  102 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP  102 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence            4455569999999999999964 688999999987655566789999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC-CCcEEEEeeccceecCCCCC
Q 007680          352 NGSLEKWLYSHNY--FLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDE-NMVAHVSDFGIYKLLGEGED  428 (593)
Q Consensus       352 ~gsL~~~l~~~~~--~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~-~~~~kL~Dfg~a~~~~~~~~  428 (593)
                      +++|.+++.....  .+++..+..++.|++.||+|||+++    |+||||||+||+++. ++.+||+|||.+........
T Consensus       103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~----i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~  178 (295)
T 2clq_A          103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ----IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP  178 (295)
T ss_dssp             EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT----EECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred             CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC----EEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence            9999999987643  4678899999999999999999654    999999999999987 89999999999987654321


Q ss_pred             ccccccccCCccccCccccCCCC--CCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhh
Q 007680          429 SVRQTMTMATIGYMAPEYGLEGI--VSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLV  506 (593)
Q Consensus       429 ~~~~~~~~gt~~y~aPE~~~~~~--~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  506 (593)
                        ......|++.|+|||++.+..  ++.++||||||+++|+|++|+.||....................           
T Consensus       179 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-----------  245 (295)
T 2clq_A          179 --CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHP-----------  245 (295)
T ss_dssp             ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCC-----------
T ss_pred             --cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccc-----------
Confidence              123456899999999987653  88999999999999999999999976322211111110000000           


Q ss_pred             hhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          507 REEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                            ..+..++.++.+++.+||+.||++|||+.|++++
T Consensus       246 ------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  279 (295)
T 2clq_A          246 ------EIPESMSAEAKAFILKCFEPDPDKRACANDLLVD  279 (295)
T ss_dssp             ------CCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred             ------cccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                  0112345678999999999999999999999875

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=8.9e-41  Score=361.50  Aligned_cols=255  Identities=22%  Similarity=0.309  Sum_probs=203.3

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh--HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVL  347 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  347 (593)
                      .++|++.+.||+|+||.||+|+.+ +++.||+|+++...  ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  115 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM  115 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            568999999999999999999976 78999999997653  233567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCC---CcEEEEeeccceecC
Q 007680          348 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDEN---MVAHVSDFGIYKLLG  424 (593)
Q Consensus       348 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~---~~~kL~Dfg~a~~~~  424 (593)
                      ||+++|+|.+++..... +++..+..++.|++.||+|||+++    |+||||||+||+++..   +.+||+|||++....
T Consensus       116 e~~~~g~L~~~~~~~~~-~~~~~~~~i~~qi~~~l~~lH~~~----ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~  190 (494)
T 3lij_A          116 ECYKGGELFDEIIHRMK-FNEVDAAVIIKQVLSGVTYLHKHN----IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE  190 (494)
T ss_dssp             ECCCSCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHHHTT----EECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred             ecCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHCC----ceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence            99999999998877654 899999999999999999999654    9999999999999764   559999999998765


Q ss_pred             CCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhh
Q 007680          425 EGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDAN  504 (593)
Q Consensus       425 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  504 (593)
                      ...   ......||+.|+|||++. +.++.++||||+||++|+|++|..||......  .....+.......        
T Consensus       191 ~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i~~~~~~~--------  256 (494)
T 3lij_A          191 NQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ--EILRKVEKGKYTF--------  256 (494)
T ss_dssp             TTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHTCCCC--------
T ss_pred             CCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhCCCCC--------
Confidence            433   223456999999999875 56999999999999999999999999764221  1111111111000        


Q ss_pred             hhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH--HHHh
Q 007680          505 LVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK--LKKI  550 (593)
Q Consensus       505 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~i  550 (593)
                            ..+....+++.+.+++.+||+.||++|||+.|+++|  +++.
T Consensus       257 ------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~  298 (494)
T 3lij_A          257 ------DSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM  298 (494)
T ss_dssp             ------CSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred             ------CchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence                  001112345678999999999999999999999987  5544

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=8.4e-41  Score=333.54  Aligned_cols=248  Identities=25%  Similarity=0.406  Sum_probs=198.3

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhH---HHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLE---RAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALV  346 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  346 (593)
                      .++|++.+.||+|+||.||+|.+. +|+.||+|++.....   ...+.+.+|+.++++++||||+++++++...+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV   89 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence            468999999999999999999976 799999999976532   2356788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCC
Q 007680          347 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG  426 (593)
Q Consensus       347 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  426 (593)
                      |||+++++|.+++..... +++..+..++.|++.||+|||+++    ++||||||+||+++.++.+||+|||++......
T Consensus        90 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~qi~~~l~~lH~~~----i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  164 (276)
T 2h6d_A           90 MEYVSGGELFDYICKHGR-VEEMEARRLFQQILSAVDYCHRHM----VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG  164 (276)
T ss_dssp             EECCCSCBHHHHHHHHCS-CCHHHHHHHHHHHHHHHHHHHHHC----SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred             EeccCCCcHHHHHhccCC-CCHHHHHHHHHHHHHHHHHHHHCC----CccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence            999999999999987654 899999999999999999999765    999999999999999999999999999876543


Q ss_pred             CCccccccccCCccccCccccCCCCC-CccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhh
Q 007680          427 EDSVRQTMTMATIGYMAPEYGLEGIV-SAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANL  505 (593)
Q Consensus       427 ~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  505 (593)
                      .   ......+++.|+|||.+.+..+ +.++||||||+++|+|++|+.||......  .....+.....           
T Consensus       165 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~-----------  228 (276)
T 2h6d_A          165 E---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP--TLFKKIRGGVF-----------  228 (276)
T ss_dssp             ---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHCCC-----------
T ss_pred             c---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH--HHHHHhhcCcc-----------
Confidence            2   1233468999999999887765 68999999999999999999999763211  11111111100           


Q ss_pred             hhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          506 VREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                             ..+..++..+.+++.+||+.||++|||+.|+++|
T Consensus       229 -------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          229 -------YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             -------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             -------cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                   0011234578999999999999999999999986

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.7e-41  Score=373.70  Aligned_cols=260  Identities=21%  Similarity=0.368  Sum_probs=207.2

Q ss_pred             hcccccc-ccCccCcccEEEEEeC---CCCeEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEE
Q 007680          272 DEFNECN-LLGTSSFGSVYKGTIS---DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALV  346 (593)
Q Consensus       272 ~~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  346 (593)
                      +++.+.+ .||+|+||.||+|.+.   ++..||||+++... ....+.+.+|++++++++||||+++++++.. +..++|
T Consensus       335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv  413 (613)
T 2ozo_A          335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV  413 (613)
T ss_dssp             TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence            4455555 7999999999999864   46679999997643 3345789999999999999999999999976 568999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCC
Q 007680          347 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG  426 (593)
Q Consensus       347 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  426 (593)
                      |||+++|+|.+++......+++..+..++.||+.||+|||+++    |+||||||+|||++.++.+||+|||+++.+...
T Consensus       414 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~----iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~  489 (613)
T 2ozo_A          414 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN----FVHRNLAARNVLLVNRHYAKISDFGLSKALGAD  489 (613)
T ss_dssp             EECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCSGGGEEEEETTEEEECCCSTTTTCC--
T ss_pred             EEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC----EEcCcCCHHHEEEcCCCcEEEeeccCcccccCC
Confidence            9999999999999877667999999999999999999999654    999999999999999999999999999876543


Q ss_pred             CCcc-ccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhhhhh
Q 007680          427 EDSV-RQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDAN  504 (593)
Q Consensus       427 ~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  504 (593)
                      .... ......+++.|+|||++.+..++.++|||||||++|||++ |+.||......  .....+....           
T Consensus       490 ~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--~~~~~i~~~~-----------  556 (613)
T 2ozo_A          490 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVMAFIEQGK-----------  556 (613)
T ss_dssp             ------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH--HHHHHHHTTC-----------
T ss_pred             CceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH--HHHHHHHcCC-----------
Confidence            3211 1122345688999999998999999999999999999998 99999774322  1222221110           


Q ss_pred             hhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhhhc
Q 007680          505 LVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKFL  555 (593)
Q Consensus       505 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~  555 (593)
                            ....+..+++++.+++.+||+.||++||++.++++.|+.+.....
T Consensus       557 ------~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~  601 (613)
T 2ozo_A          557 ------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA  601 (613)
T ss_dssp             ------CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHS
T ss_pred             ------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhc
Confidence                  111123456789999999999999999999999999999876653

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=3.3e-41  Score=364.14  Aligned_cols=251  Identities=25%  Similarity=0.362  Sum_probs=207.2

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALV  346 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  346 (593)
                      .++|++.+.||+|+||.||+|+.. +|+.||||++....   ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  104 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV  104 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            568999999999999999999976 79999999997542   23456789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeee---CCCCcEEEEeeccceec
Q 007680          347 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILL---DENMVAHVSDFGIYKLL  423 (593)
Q Consensus       347 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll---~~~~~~kL~Dfg~a~~~  423 (593)
                      |||+.+|+|.+++..... +++..+..++.|++.||+|||+++    |+||||||+||++   +.++.+||+|||++...
T Consensus       105 ~e~~~~~~L~~~~~~~~~-~~~~~~~~i~~qi~~~l~~lH~~~----ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~  179 (484)
T 3nyv_A          105 GEVYTGGELFDEIISRKR-FSEVDAARIIRQVLSGITYMHKNK----IVHRDLKPENLLLESKSKDANIRIIDFGLSTHF  179 (484)
T ss_dssp             ECCCCSCBHHHHHHTCSC-CBHHHHHHHHHHHHHHHHHHHHTT----CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred             EecCCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCC----eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence            999999999999977654 999999999999999999999655    9999999999999   56789999999999876


Q ss_pred             CCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhh
Q 007680          424 GEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDA  503 (593)
Q Consensus       424 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  503 (593)
                      .....   .....||+.|+|||++.+ .++.++||||+||++|+|++|+.||.....  ......+......        
T Consensus       180 ~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~i~~~~~~--------  245 (484)
T 3nyv_A          180 EASKK---MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE--YDILKKVEKGKYT--------  245 (484)
T ss_dssp             CCCCS---HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHCCCC--------
T ss_pred             ccccc---cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHHcCCCC--------
Confidence            54332   234569999999999865 699999999999999999999999976321  1111211111100        


Q ss_pred             hhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          504 NLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                            ...+....+++++.+++.+||+.||++|||+.|+++|
T Consensus       246 ------~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  282 (484)
T 3nyv_A          246 ------FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH  282 (484)
T ss_dssp             ------CCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ------CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence                  0011222346688999999999999999999999986

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.5e-40  Score=360.59  Aligned_cols=251  Identities=23%  Similarity=0.320  Sum_probs=203.3

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhH-------------HHHHHHHHHHHHHhhcCCCCcceeeee
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLE-------------RAFRSFDSECEVLRNVRHRNLIKILSS  336 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~l~~~  336 (593)
                      .++|++.+.||+|+||.||+|+.. +++.||+|+++....             ...+.+.+|+.++++++||||++++++
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  114 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV  114 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            578999999999999999999976 688999999975421             234678899999999999999999999


Q ss_pred             eecCCceEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC---cEE
Q 007680          337 YSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENM---VAH  413 (593)
Q Consensus       337 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~---~~k  413 (593)
                      +.+++..++||||+++|+|.+++..... +++..+..++.|++.||+|||+++    |+||||||+||+++.++   .+|
T Consensus       115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~-~~~~~~~~i~~qi~~~l~~lH~~~----ivH~Dlkp~Nil~~~~~~~~~~k  189 (504)
T 3q5i_A          115 FEDKKYFYLVTEFYEGGELFEQIINRHK-FDECDAANIMKQILSGICYLHKHN----IVHRDIKPENILLENKNSLLNIK  189 (504)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHHHSC-CCHHHHHHHHHHHHHHHHHHHHTT----EECSCCSGGGEEESSTTCCSSEE
T ss_pred             EEcCCEEEEEEecCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHCC----eEeCCCcHHHEEEecCCCCccEE
Confidence            9999999999999999999999877654 999999999999999999999654    99999999999998776   699


Q ss_pred             EEeeccceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhc
Q 007680          414 VSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESL  493 (593)
Q Consensus       414 L~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~  493 (593)
                      |+|||++.......   ......||+.|+|||++. +.++.++||||+||++|+|++|..||......  .....+....
T Consensus       190 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i~~~~  263 (504)
T 3q5i_A          190 IVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ--DIIKKVEKGK  263 (504)
T ss_dssp             ECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHCC
T ss_pred             EEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHcCC
Confidence            99999998775433   223456999999999876 56999999999999999999999999763221  1111111110


Q ss_pred             CCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          494 PHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       494 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      ..              ...+....+++++.+++.+||+.||++|||+.|+++|
T Consensus       264 ~~--------------~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h  302 (504)
T 3q5i_A          264 YY--------------FDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS  302 (504)
T ss_dssp             CC--------------CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CC--------------CCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            00              0111122346788999999999999999999999986

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.7e-40  Score=336.25  Aligned_cols=251  Identities=22%  Similarity=0.271  Sum_probs=200.2

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh----HHHHHHHHHHHHHHhhcCCCCcceeeeeee--cCCce
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL----ERAFRSFDSECEVLRNVRHRNLIKILSSYS--NPDFK  343 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~  343 (593)
                      .++|++.+.||+|+||.||+|... +++.||+|+++...    ....+.+.+|++++++++||||+++++++.  +.+..
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            468999999999999999999975 78999999998653    234567899999999999999999999984  45688


Q ss_pred             EEEEeccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeecccee
Q 007680          344 ALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKL  422 (593)
Q Consensus       344 ~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~  422 (593)
                      ++||||++++ |.+++.... ..+++..+..++.|++.||+|||+++    |+||||||+||+++.++.+||+|||.+..
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~----i~H~dlkp~NIl~~~~~~~kl~dfg~~~~  158 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG----IVHKDIKPGNLLLTTGGTLKISALGVAEA  158 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT----EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC----eeecCCCcccEEEcCCCcEEeeccccccc
Confidence            9999999876 777776533 36999999999999999999999655    99999999999999999999999999987


Q ss_pred             cCCCCCccccccccCCccccCccccCCCC--CCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhh
Q 007680          423 LGEGEDSVRQTMTMATIGYMAPEYGLEGI--VSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEV  500 (593)
Q Consensus       423 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  500 (593)
                      ..............|++.|+|||++.+..  ++.++||||||+++|||++|+.||......  .....+....       
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~i~~~~-------  229 (305)
T 2wtk_C          159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY--KLFENIGKGS-------  229 (305)
T ss_dssp             CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHCC-------
T ss_pred             cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH--HHHHHHhcCC-------
Confidence            75433333334456899999999987644  478999999999999999999999763211  1111111100       


Q ss_pred             hhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          501 VDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       501 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                                 ...+..++..+.+++.+||+.||++|||+.|+++|
T Consensus       230 -----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          230 -----------YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             -----------CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             -----------CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                       01112345678999999999999999999999987

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=4e-41  Score=344.76  Aligned_cols=262  Identities=19%  Similarity=0.235  Sum_probs=207.7

Q ss_pred             CCHHHHHHhhhccccc-cccCccCcccEEEEEeC-CCCeEEEEEeehhh--HHHHHHHHHHHHHHhhc-CCCCcceeeee
Q 007680          262 TSYLDIQRATDEFNEC-NLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL--ERAFRSFDSECEVLRNV-RHRNLIKILSS  336 (593)
Q Consensus       262 ~~~~~~~~~~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~  336 (593)
                      ..+.......++|.+. +.||+|+||.||+|... +++.||+|+++...  ......+.+|+.++.++ .||||++++++
T Consensus        18 ~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~   97 (327)
T 3lm5_A           18 LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV   97 (327)
T ss_dssp             CCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred             hHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence            3445566778888888 89999999999999976 69999999997643  22356788999999999 56999999999


Q ss_pred             eecCCceEEEEeccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC---CCcE
Q 007680          337 YSNPDFKALVLEFMPNGSLEKWLYSH-NYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDE---NMVA  412 (593)
Q Consensus       337 ~~~~~~~~lv~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~---~~~~  412 (593)
                      +.+.+..++||||+++|+|.+++... ...+++.++..++.|++.||+|||+++    |+||||||+||+++.   ++.+
T Consensus        98 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g----ivH~Dikp~NIl~~~~~~~~~~  173 (327)
T 3lm5_A           98 YENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN----IVHLDLKPQNILLSSIYPLGDI  173 (327)
T ss_dssp             EECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT----EECSCCCGGGEEESCBTTBCCE
T ss_pred             EEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC----eecCcCChHHEEEecCCCCCcE
Confidence            99999999999999999999998654 236899999999999999999999654    999999999999998   7899


Q ss_pred             EEEeeccceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHh
Q 007680          413 HVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKES  492 (593)
Q Consensus       413 kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~  492 (593)
                      ||+|||+++.......   .....||+.|+|||++.+..++.++||||||+++|||++|+.||......+  ....+...
T Consensus       174 kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~i~~~  248 (327)
T 3lm5_A          174 KIVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE--TYLNISQV  248 (327)
T ss_dssp             EECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHT
T ss_pred             EEeeCccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH--HHHHHHhc
Confidence            9999999987654322   233568999999999999999999999999999999999999997632211  11111111


Q ss_pred             cCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          493 LPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       493 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      ...              ........++..+.+++.+||+.||++|||++|+++|
T Consensus       249 ~~~--------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          249 NVD--------------YSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             CCC--------------CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred             ccc--------------cCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence            000              0001112345678999999999999999999999876

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=2.4e-40  Score=344.11  Aligned_cols=267  Identities=21%  Similarity=0.249  Sum_probs=204.3

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-----Cce
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSYSNP-----DFK  343 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~  343 (593)
                      .++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++.+++||||+++++++...     ...
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            468999999999999999999965 78899999997533 34457789999999999999999999998665     368


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceec
Q 007680          344 ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLL  423 (593)
Q Consensus       344 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~  423 (593)
                      ++||||++ ++|.+++....  +++.++..++.|++.||+|||+++    |+||||||+||+++.++.+||+|||++...
T Consensus       106 ~iv~e~~~-~~L~~~l~~~~--~~~~~~~~i~~qi~~aL~~LH~~~----ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~  178 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLKTQH--LSNDHICYFLYQILRGLKYIHSAN----VLHRDLKPSNLLLNTTCDLKICDFGLARVA  178 (364)
T ss_dssp             EEEEECCS-EEHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHHTT----EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEcccC-cCHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHHCC----eecCCCChHhEEECCCCCEEEEeCcceEec
Confidence            99999996 59999997754  899999999999999999999654    999999999999999999999999999876


Q ss_pred             CCCCCcc-ccccccCCccccCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhh
Q 007680          424 GEGEDSV-RQTMTMATIGYMAPEYGLE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVV  501 (593)
Q Consensus       424 ~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  501 (593)
                      ....... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+  ....+.........+..
T Consensus       179 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~i~~~~~~~~~~~~  256 (364)
T 3qyz_A          179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD--QLNHILGILGSPSQEDL  256 (364)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG--HHHHHHHHHCSCCHHHH
T ss_pred             CCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH--HHHHHHHHhCCCCHHHH
Confidence            5433221 1234579999999998654 458999999999999999999999997643222  11111111111111100


Q ss_pred             hhhh----hh--------h-hhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          502 DANL----VR--------E-EQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       502 ~~~~----~~--------~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      ....    ..        . .........++.++.+++.+||+.||++|||+.|+++|
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  314 (364)
T 3qyz_A          257 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  314 (364)
T ss_dssp             HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            0000    00        0 00000112345678999999999999999999999986

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.8e-40  Score=344.68  Aligned_cols=276  Identities=20%  Similarity=0.237  Sum_probs=204.7

Q ss_pred             CCHHHHHHhhhccccccccCccCcccEEEEEeCCCCeEEEEEeehhh-----------HHHHHHHHHHHHHHhhcCCCCc
Q 007680          262 TSYLDIQRATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQL-----------ERAFRSFDSECEVLRNVRHRNL  330 (593)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-----------~~~~~~~~~E~~~l~~l~h~ni  330 (593)
                      ....++....++|++.+.||+|+||.||+|...+|+.||||++....           ....+.+.+|++++++++||||
T Consensus        12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i   91 (362)
T 3pg1_A           12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI   91 (362)
T ss_dssp             HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence            34567888899999999999999999999998889999999985431           2234778999999999999999


Q ss_pred             ceeeeeeec-----CCceEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCee
Q 007680          331 IKILSSYSN-----PDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNIL  405 (593)
Q Consensus       331 v~l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIl  405 (593)
                      +++++++..     ....++||||++ |+|.+++......+++..+..++.|++.||+|||+++    |+||||||+||+
T Consensus        92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~----ivH~Dlkp~NIl  166 (362)
T 3pg1_A           92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG----VVHRDLHPGNIL  166 (362)
T ss_dssp             CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT----CCCCCCCGGGEE
T ss_pred             cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCc----CEecCCChHHEE
Confidence            999999843     336799999997 6999998877667999999999999999999999655    999999999999


Q ss_pred             eCCCCcEEEEeeccceecCCCCCccccccccCCccccCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCccccccch
Q 007680          406 LDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMS  484 (593)
Q Consensus       406 l~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~  484 (593)
                      ++.++.+||+|||++.......   ......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+ .
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~  242 (362)
T 3pg1_A          167 LADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN-Q  242 (362)
T ss_dssp             ECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-H
T ss_pred             EcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHH-H
Confidence            9999999999999997544332   2234568999999998876 679999999999999999999999997642211 1


Q ss_pred             HHHHHHHhcCCchhhh-----------hhhhhhhh--hhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          485 LRRWVKESLPHGLTEV-----------VDANLVRE--EQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       485 ~~~~~~~~~~~~~~~~-----------~~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      ..............+.           +.......  ..........++.+.+++.+||+.||++|||+.|+++|
T Consensus       243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  317 (362)
T 3pg1_A          243 LNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH  317 (362)
T ss_dssp             HHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence            1111111111111110           00000000  00011112335678999999999999999999999986

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=3.4e-40  Score=343.82  Aligned_cols=263  Identities=20%  Similarity=0.196  Sum_probs=194.5

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehh--hHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCC------
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQ--LERAFRSFDSECEVLRNVRHRNLIKILSSYSNPD------  341 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  341 (593)
                      .++|++.+.||+|+||.||+|... +++.||||++...  .....+.+.+|+.+++.++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            468999999999999999999865 6899999999753  2344567889999999999999999999987665      


Q ss_pred             ceEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccce
Q 007680          342 FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYK  421 (593)
Q Consensus       342 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~  421 (593)
                      ..++||||++ ++|.+++..   .+++..+..++.|++.||+|||+++    |+||||||+||+++.++.+||+|||+++
T Consensus       104 ~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~~----ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~  175 (371)
T 2xrw_A          104 DVYIVMELMD-ANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAG----IIHRDLKPSNIVVKSDCTLKILDFGLAR  175 (371)
T ss_dssp             EEEEEEECCS-EEHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred             ceEEEEEcCC-CCHHHHHhh---ccCHHHHHHHHHHHHHHHHHHHHCC----eecccCCHHHEEEcCCCCEEEEEeeccc
Confidence            7899999996 588888853   3899999999999999999999654    9999999999999999999999999998


Q ss_pred             ecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhh
Q 007680          422 LLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVV  501 (593)
Q Consensus       422 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  501 (593)
                      ......   ......||+.|+|||++.+..++.++|||||||++|||++|+.||......  .....+.........+..
T Consensus       176 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~  250 (371)
T 2xrw_A          176 TAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI--DQWNKVIEQLGTPCPEFM  250 (371)
T ss_dssp             -----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHC-CCCCCHHHH
T ss_pred             cccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCCHHHH
Confidence            654322   223456899999999999999999999999999999999999999764221  111111111110000000


Q ss_pred             h---hhhh------------------h---hhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          502 D---ANLV------------------R---EEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       502 ~---~~~~------------------~---~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      .   ....                  .   ...........+.++.+|+.+||..||++|||++|+++|
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  319 (371)
T 2xrw_A          251 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  319 (371)
T ss_dssp             TTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             HHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence            0   0000                  0   000011122346789999999999999999999999987

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=5.6e-42  Score=358.17  Aligned_cols=247  Identities=15%  Similarity=0.207  Sum_probs=193.2

Q ss_pred             hhccccccccCccCcccEEEEEe-CCCCeEEEEEeehh---hHHHHHHHHHHH---HHHhhcCCCCcceee-------ee
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTI-SDGTDVAIKVFNLQ---LERAFRSFDSEC---EVLRNVRHRNLIKIL-------SS  336 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~---~~l~~l~h~niv~l~-------~~  336 (593)
                      .++|++.+.||+|+||.||+|++ .+|+.||||++...   .....+.+.+|+   +++++++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            46899999999999999999996 47999999999743   234557889999   455555899999998       55


Q ss_pred             eecCC-----------------ceEEEEeccCCCCHHHHHhhCCC------CCCHHHHHHHHHHHHHHHHHHHhcCCCCC
Q 007680          337 YSNPD-----------------FKALVLEFMPNGSLEKWLYSHNY------FLDILERLNIMIDVGSALEYLHNGHSSVH  393 (593)
Q Consensus       337 ~~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~~------~l~~~~~~~i~~~i~~~L~~LH~~~~~~~  393 (593)
                      +.+++                 ..++||||+ +|+|.+++...+.      .+++..+..++.|++.||+|||+++    
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~----  226 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG----  226 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT----
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC----
Confidence            55543                 278999999 6899999986433      2335888899999999999999654    


Q ss_pred             eEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCccccccccCCccccCccccCCC-----------CCCccchHHHHH
Q 007680          394 IIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEG-----------IVSAKCDVYSYG  462 (593)
Q Consensus       394 ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~~~DvwSlG  462 (593)
                      |+||||||+|||++.++.+||+|||+++....     ......| +.|+|||++.+.           .++.++||||||
T Consensus       227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG  300 (377)
T 3byv_A          227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALG  300 (377)
T ss_dssp             EECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHH
T ss_pred             eecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHH
Confidence            99999999999999999999999999986432     2234457 999999998877           899999999999


Q ss_pred             HHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHH
Q 007680          463 VLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTD  542 (593)
Q Consensus       463 vvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e  542 (593)
                      |++|||++|+.||.......             .......           ....+++++.+++.+||+.||++|||+.|
T Consensus       301 ~il~elltg~~Pf~~~~~~~-------------~~~~~~~-----------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e  356 (377)
T 3byv_A          301 LVIYWIWCADLPITKDAALG-------------GSEWIFR-----------SCKNIPQPVRALLEGFLRYPKEDRLLPLQ  356 (377)
T ss_dssp             HHHHHHHHSSCCC------C-------------CSGGGGS-----------SCCCCCHHHHHHHHHHTCSSGGGCCCHHH
T ss_pred             HHHHHHHHCCCCCccccccc-------------chhhhhh-----------hccCCCHHHHHHHHHHcCCCchhCCCHHH
Confidence            99999999999996632111             0001100           01133567899999999999999999999


Q ss_pred             HHHH--HHHhhh
Q 007680          543 AAAK--LKKIKV  552 (593)
Q Consensus       543 vl~~--L~~i~~  552 (593)
                      +++|  ++++..
T Consensus       357 ~l~hp~f~~~~~  368 (377)
T 3byv_A          357 AMETPEYEQLRT  368 (377)
T ss_dssp             HHTSHHHHHHHH
T ss_pred             HhhChHHHHHHH
Confidence            9975  455443

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.4e-40  Score=337.28  Aligned_cols=267  Identities=20%  Similarity=0.269  Sum_probs=197.8

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeee-----------
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYS-----------  338 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-----------  338 (593)
                      .++|++.+.||+|+||.||+|... +++.||+|++........+.+.+|++++++++||||+++++++.           
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            468999999999999999999976 58999999998766666778999999999999999999999874           


Q ss_pred             ---cCCceEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeC-CCCcEEE
Q 007680          339 ---NPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLD-ENMVAHV  414 (593)
Q Consensus       339 ---~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~-~~~~~kL  414 (593)
                         +.+..++||||++ |+|.+++...  .+++..+..++.|++.||+|||+++    |+||||||+||+++ +++.+||
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~----i~H~dlkp~Nil~~~~~~~~kl  162 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLEQG--PLLEEHARLFMYQLLRGLKYIHSAN----VLHRDLKPANLFINTEDLVLKI  162 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHTT----CBCCCCSGGGEEEETTTTEEEE
T ss_pred             cccccCceeEEeeccC-CCHHHHhhcC--CccHHHHHHHHHHHHHHHHHHHhCC----EecCCCCHHHEEEcCCCCeEEE
Confidence               3467899999997 6999999754  3899999999999999999999655    99999999999997 5679999


Q ss_pred             EeeccceecCCCCCc-cccccccCCccccCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHh
Q 007680          415 SDFGIYKLLGEGEDS-VRQTMTMATIGYMAPEYGLE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKES  492 (593)
Q Consensus       415 ~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~  492 (593)
                      +|||+++........ .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......  .....+...
T Consensus       163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--~~~~~~~~~  240 (320)
T 2i6l_A          163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL--EQMQLILES  240 (320)
T ss_dssp             CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHH
T ss_pred             ccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHh
Confidence            999999876432211 11233457899999998765 67899999999999999999999999764321  112222222


Q ss_pred             cCCchhhh-----------hhhhhhhh-hhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          493 LPHGLTEV-----------VDANLVRE-EQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       493 ~~~~~~~~-----------~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      .+....+.           +....... .........++.++.+++.+||+.||++|||++|+++|
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (320)
T 2i6l_A          241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH  306 (320)
T ss_dssp             SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence            22110000           00000000 00001112356789999999999999999999999975

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=4.9e-41  Score=346.91  Aligned_cols=265  Identities=21%  Similarity=0.283  Sum_probs=206.8

Q ss_pred             hhccccccccCccCcccEEEEEeCCCCeEEEEEeehhhHHH-----------------HHHHHHHHHHHhhcCCCCccee
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERA-----------------FRSFDSECEVLRNVRHRNLIKI  333 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~h~niv~l  333 (593)
                      .++|++.+.||+|+||.||+|+. +|+.||+|++.......                 .+.+.+|+.++++++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            46899999999999999999999 89999999998654321                 1789999999999999999999


Q ss_pred             eeeeecCCceEEEEeccCCCCHHHH------HhhC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeee
Q 007680          334 LSSYSNPDFKALVLEFMPNGSLEKW------LYSH-NYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILL  406 (593)
Q Consensus       334 ~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll  406 (593)
                      ++++.+.+..++||||+++++|.++      +... ...+++..+..++.|++.||+|||+   ..+|+||||||+||++
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~i~H~dl~p~Nil~  185 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN---EKNICHRDVKPSNILM  185 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHH---TSCEECCCCCGGGEEE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhc---cCCEeecCCChHhEEE
Confidence            9999999999999999999999998      5542 3469999999999999999999996   1359999999999999


Q ss_pred             CCCCcEEEEeeccceecCCCCCccccccccCCccccCccccCCC-CCCc-cchHHHHHHHHHHHHhCCCCCCccccccch
Q 007680          407 DENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEG-IVSA-KCDVYSYGVLLMETFTRKRPTDEMFIGEMS  484 (593)
Q Consensus       407 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~-~~DvwSlGvvl~elltg~~pf~~~~~~~~~  484 (593)
                      +.++.+||+|||.+......    ......++..|+|||++.+. .++. ++||||||+++|||++|+.||....... .
T Consensus       186 ~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~  260 (348)
T 2pml_X          186 DKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV-E  260 (348)
T ss_dssp             CTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH-H
T ss_pred             cCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH-H
Confidence            99999999999999876443    23345689999999998877 6666 9999999999999999999997643321 1


Q ss_pred             HHHHHHHhcCC---chhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          485 LRRWVKESLPH---GLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       485 ~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      ....+......   .......... . .........++.++.+++.+||+.||++|||+.|+++|
T Consensus       261 ~~~~i~~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h  323 (348)
T 2pml_X          261 LFNNIRTKNIEYPLDRNHFLYPLT-N-KKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH  323 (348)
T ss_dssp             HHHHHTSCCCCCCCSSSSSTTTTC-C---------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             HHHHHhccCcCCccchhhhhcccc-c-cccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            22222111100   0000000000 0 00001112346688999999999999999999999985

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=2.3e-40  Score=332.02  Aligned_cols=245  Identities=18%  Similarity=0.265  Sum_probs=199.8

Q ss_pred             hhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehh--hHHHHHHHHHHHHHHhhc-CCCCcceeeeeeecCCceEE
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQ--LERAFRSFDSECEVLRNV-RHRNLIKILSSYSNPDFKAL  345 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  345 (593)
                      ..++|++.+.||+|+||.||+|... +++.||+|+++..  .......+.+|+..+.++ +||||+++++++.+.+..++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l   88 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI   88 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            4678999999999999999999976 7999999999753  233456788999999999 99999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCC-------------
Q 007680          346 VLEFMPNGSLEKWLYSHN---YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDEN-------------  409 (593)
Q Consensus       346 v~e~~~~gsL~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~-------------  409 (593)
                      ||||+++++|.+++....   ..+++.++..++.|++.||+|||+++    |+||||||+||+++.+             
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~----ivH~Dikp~NIl~~~~~~~~~~~~~~~~~  164 (289)
T 1x8b_A           89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS----LVHMDIKPSNIFISRTSIPNAASEEGDED  164 (289)
T ss_dssp             EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT----EECSCCSGGGEEEC---------------
T ss_pred             EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC----EeecCCCHHHEEEcCCCCCcccccccccc
Confidence            999999999999997642   34899999999999999999999655    9999999999999844             


Q ss_pred             ------CcEEEEeeccceecCCCCCccccccccCCccccCccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCcccccc
Q 007680          410 ------MVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFIGE  482 (593)
Q Consensus       410 ------~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~  482 (593)
                            ..+||+|||.+.......      ...||+.|+|||++.+. .+++++|||||||++|+|++|.+|+....   
T Consensus       165 ~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---  235 (289)
T 1x8b_A          165 DWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---  235 (289)
T ss_dssp             -----CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---
T ss_pred             cccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---
Confidence                  479999999998765432      23589999999998766 56789999999999999999998764421   


Q ss_pred             chHHHHHHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          483 MSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       483 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                       .... +......                 ..+..+++++.+++.+||+.||++|||+.|+++|
T Consensus       236 -~~~~-~~~~~~~-----------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  280 (289)
T 1x8b_A          236 -QWHE-IRQGRLP-----------------RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH  280 (289)
T ss_dssp             -HHHH-HHTTCCC-----------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             -HHHH-HHcCCCC-----------------CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence             1111 1111000                 0111235678999999999999999999999875

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=4.8e-41  Score=335.83  Aligned_cols=258  Identities=21%  Similarity=0.266  Sum_probs=204.4

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh--HHHHHHHHHHHHHHhhcCCCCcceeeeeee--cCCceEE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSYS--NPDFKAL  345 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~l  345 (593)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++....  ....+.+.+|++++++++||||+++++++.  ..+..++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            578999999999999999999976 78999999997542  345677899999999999999999999874  4568899


Q ss_pred             EEeccCCCCHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHhcCC-CCCeEecCCCCCCeeeCCCCcEEEEeeccce
Q 007680          346 VLEFMPNGSLEKWLYSHN---YFLDILERLNIMIDVGSALEYLHNGHS-SVHIIHCDLKPTNILLDENMVAHVSDFGIYK  421 (593)
Q Consensus       346 v~e~~~~gsL~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~  421 (593)
                      ||||+++++|.+++....   ..+++..+..++.|++.||+|||+++. ..+|+||||||+||+++.++.+||+|||.+.
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~  164 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  164 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence            999999999999997532   348999999999999999999996431 1239999999999999999999999999988


Q ss_pred             ecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhh
Q 007680          422 LLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVV  501 (593)
Q Consensus       422 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  501 (593)
                      .......  ......+++.|+|||++.+..++.++||||||+++|+|++|+.||.....  ......+......      
T Consensus       165 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~i~~~~~~------  234 (279)
T 2w5a_A          165 ILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ--KELAGKIREGKFR------  234 (279)
T ss_dssp             HC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHTCCC------
T ss_pred             eeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH--HHHHHHHhhcccc------
Confidence            7643321  12234689999999999988999999999999999999999999976421  1111111111110      


Q ss_pred             hhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHH
Q 007680          502 DANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKK  549 (593)
Q Consensus       502 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  549 (593)
                                 ..+..++.++.+++.+||+.||++|||+.|+++++..
T Consensus       235 -----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~  271 (279)
T 2w5a_A          235 -----------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  271 (279)
T ss_dssp             -----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             -----------cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence                       0111245678999999999999999999999987644

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.2e-41  Score=371.20  Aligned_cols=261  Identities=27%  Similarity=0.429  Sum_probs=212.4

Q ss_pred             HHHhhhccccccccCccCcccEEEEEeCCCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEE
Q 007680          267 IQRATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALV  346 (593)
Q Consensus       267 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  346 (593)
                      +....++|++.+.||+|+||.||+|.+.++..||||+++.... ..+.+.+|++++++++||||+++++++.+ +..++|
T Consensus       262 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv  339 (535)
T 2h8h_A          262 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV  339 (535)
T ss_dssp             SBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred             eecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEe
Confidence            3345678999999999999999999998788899999986532 34678999999999999999999999876 678999


Q ss_pred             EeccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCC
Q 007680          347 LEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGE  425 (593)
Q Consensus       347 ~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~  425 (593)
                      |||+++|+|.+++.... ..+++.++..++.||+.||+|||+++    |+||||||+|||++.++.+||+|||+++....
T Consensus       340 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~----ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  415 (535)
T 2h8h_A          340 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN----YVHRDLRAANILVGENLVCKVADFGLARLIED  415 (535)
T ss_dssp             ECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred             eehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC----eeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence            99999999999997532 35899999999999999999999654    99999999999999999999999999986543


Q ss_pred             CCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhhhhh
Q 007680          426 GEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDAN  504 (593)
Q Consensus       426 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  504 (593)
                      ... .......++..|+|||++.+..++.++|||||||++|||++ |+.||......  .....+....           
T Consensus       416 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~--~~~~~i~~~~-----------  481 (535)
T 2h8h_A          416 NEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--EVLDQVERGY-----------  481 (535)
T ss_dssp             HHH-HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH--HHHHHHHTTC-----------
T ss_pred             Cce-ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCC-----------
Confidence            211 11223346788999999988899999999999999999999 99999764221  1111111110           


Q ss_pred             hhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhh
Q 007680          505 LVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVK  553 (593)
Q Consensus       505 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  553 (593)
                            ..+.+..++..+.++|.+||+.||++|||+.++++.|+.+...
T Consensus       482 ------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  524 (535)
T 2h8h_A          482 ------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  524 (535)
T ss_dssp             ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred             ------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence                  0111224567889999999999999999999999999987544

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=2.2e-40  Score=334.33  Aligned_cols=253  Identities=25%  Similarity=0.308  Sum_probs=205.9

Q ss_pred             hhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh---------HHHHHHHHHHHHHHhhcC-CCCcceeeeeee
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---------ERAFRSFDSECEVLRNVR-HRNLIKILSSYS  338 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~  338 (593)
                      ..++|++.+.||+|+||.||+|... +|+.||+|+++...         ....+.+.+|+++++++. ||||+++++++.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            4678999999999999999999975 68999999997532         234567889999999995 999999999999


Q ss_pred             cCCceEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeec
Q 007680          339 NPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFG  418 (593)
Q Consensus       339 ~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg  418 (593)
                      ..+..++||||+++++|.+++.... .+++..+..++.|++.||+|||+++    ++||||||+||+++.++.+||+|||
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~----i~H~dl~p~Nil~~~~~~~kl~dfg  169 (298)
T 1phk_A           95 TNTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALHKLN----IVHRDLKPENILLDDDMNIKLTDFG  169 (298)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT----EECSCCSGGGEEECTTCCEEECCCT
T ss_pred             cCCeEEEEEeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCC----cccCCCCcceEEEcCCCcEEEeccc
Confidence            9999999999999999999998754 3899999999999999999999654    9999999999999999999999999


Q ss_pred             cceecCCCCCccccccccCCccccCccccC------CCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHh
Q 007680          419 IYKLLGEGEDSVRQTMTMATIGYMAPEYGL------EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKES  492 (593)
Q Consensus       419 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~  492 (593)
                      .+........   .....+++.|+|||++.      ...++.++||||||+++|+|++|+.||.....  ......+...
T Consensus       170 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~  244 (298)
T 1phk_A          170 FSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ--MLMLRMIMSG  244 (298)
T ss_dssp             TCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHT
T ss_pred             chhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH--HHHHHHHhcC
Confidence            9987654332   23356899999999874      45689999999999999999999999976321  1111111111


Q ss_pred             cCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          493 LPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       493 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      ....              ..+....++..+.+++.+||+.||++|||+.|+++|
T Consensus       245 ~~~~--------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (298)
T 1phk_A          245 NYQF--------------GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  284 (298)
T ss_dssp             CCCC--------------CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             Cccc--------------CcccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence            0000              001112345678999999999999999999999874

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=2.2e-40  Score=369.83  Aligned_cols=251  Identities=21%  Similarity=0.229  Sum_probs=206.6

Q ss_pred             HhhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhc-CCCCcceeeeeeecCCce
Q 007680          269 RATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNV-RHRNLIKILSSYSNPDFK  343 (593)
Q Consensus       269 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  343 (593)
                      ...++|++.+.||+|+||.||+|+.+ +++.||||+++...   ....+.+..|..++..+ +||+|+++++++.+.+..
T Consensus       338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~  417 (674)
T 3pfq_A          338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL  417 (674)
T ss_dssp             --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred             ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence            34678999999999999999999976 68899999998652   33456778899999988 799999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceec
Q 007680          344 ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLL  423 (593)
Q Consensus       344 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~  423 (593)
                      |+||||+++|+|.+++...+. +++..+..++.||+.||+|||+++    |+||||||+|||++.++.+||+|||+++..
T Consensus       418 ~lV~E~~~gg~L~~~l~~~~~-~~~~~~~~~~~qi~~aL~~LH~~g----IiHrDLKp~NILl~~~g~ikL~DFGla~~~  492 (674)
T 3pfq_A          418 YFVMEYVNGGDLMYHIQQVGR-FKEPHAVFYAAEIAIGLFFLQSKG----IIYRDLKLDNVMLDSEGHIKIADFGMCKEN  492 (674)
T ss_dssp             EEEEECCCSCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHHHTS----EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred             EEEEeCcCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCC----eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence            999999999999999987654 999999999999999999999654    999999999999999999999999999864


Q ss_pred             CCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhh
Q 007680          424 GEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDA  503 (593)
Q Consensus       424 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  503 (593)
                      .....  ......||+.|+|||++.+..++.++|||||||++|||++|+.||......  .....+...           
T Consensus       493 ~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~--~~~~~i~~~-----------  557 (674)
T 3pfq_A          493 IWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--ELFQSIMEH-----------  557 (674)
T ss_dssp             CCTTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHSS-----------
T ss_pred             ccCCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH--HHHHHHHhC-----------
Confidence            33322  234467999999999999999999999999999999999999999763211  111111110           


Q ss_pred             hhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCH-----HHHHHH
Q 007680          504 NLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINM-----TDAAAK  546 (593)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~~  546 (593)
                      ..       ..+..+++++.+|+.+||+.||++||++     +|+++|
T Consensus       558 ~~-------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h  598 (674)
T 3pfq_A          558 NV-------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  598 (674)
T ss_dssp             CC-------CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred             CC-------CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence            00       0112345688999999999999999997     677654

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.4e-40  Score=345.93  Aligned_cols=262  Identities=21%  Similarity=0.281  Sum_probs=185.4

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehh--hHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC------C
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQ--LERAFRSFDSECEVLRNVRHRNLIKILSSYSNP------D  341 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~  341 (593)
                      .++|++.+.||+|+||.||+|... +|+.||||++...  .....+.+.+|+++++.++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            468999999999999999999864 7899999998653  234456788999999999999999999998654      5


Q ss_pred             ceEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccce
Q 007680          342 FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYK  421 (593)
Q Consensus       342 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~  421 (593)
                      ..++|+|++ +++|.+++...  .+++..+..++.|+++||+|||+++    |+||||||+||+++.++.+||+|||+++
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~g----ivH~Dlkp~NIll~~~~~~kL~DFG~a~  180 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHSAD----IIHRDLKPSNLAVNEDCELKILDFGLAR  180 (367)
T ss_dssp             CCEEEEECC-CEECC-----C--CCCHHHHHHHHHHHHHHHHHHHHTT----CCCCCCCGGGEEECTTCCEEECC-----
T ss_pred             eEEEEeccc-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC----eeeCCCCHhhEEECCCCCEEEeeccccc
Confidence            679999999 78999998763  3999999999999999999999654    9999999999999999999999999998


Q ss_pred             ecCCCCCccccccccCCccccCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhh
Q 007680          422 LLGEGEDSVRQTMTMATIGYMAPEYGLE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEV  500 (593)
Q Consensus       422 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  500 (593)
                      .....     .....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||.+...  ......+.........+.
T Consensus       181 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~l~~i~~~~g~p~~~~  253 (367)
T 2fst_X          181 HTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH--IDQLKLILRLVGTPGAEL  253 (367)
T ss_dssp             ---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCSCCHHH
T ss_pred             ccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCCCHHH
Confidence            65432     233568999999999876 6799999999999999999999999976422  111111111111100000


Q ss_pred             hhh-----------hhhh-hhhh-hhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          501 VDA-----------NLVR-EEQA-FSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       501 ~~~-----------~~~~-~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      ...           .+.. .... .......++.+.+|+.+||..||++|||+.|+++|
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          254 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  312 (367)
T ss_dssp             HTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence            000           0000 0000 00111335678999999999999999999999987

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=5.5e-41  Score=339.35  Aligned_cols=264  Identities=23%  Similarity=0.297  Sum_probs=188.3

Q ss_pred             HhhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEE
Q 007680          269 RATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALV  346 (593)
Q Consensus       269 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  346 (593)
                      ...++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus        12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   91 (303)
T 2vwi_A           12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV   91 (303)
T ss_dssp             -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred             cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence            34678999999999999999999864 78999999987543 33456788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhh-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeecc
Q 007680          347 LEFMPNGSLEKWLYS-------HNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGI  419 (593)
Q Consensus       347 ~e~~~~gsL~~~l~~-------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~  419 (593)
                      |||+++++|.+++..       ....+++..+..++.|++.||+|||+++    |+||||||+||+++.++.+||+|||.
T Consensus        92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~----i~H~dl~p~Nil~~~~~~~kl~dfg~  167 (303)
T 2vwi_A           92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG----QIHRDVKAGNILLGEDGSVQIADFGV  167 (303)
T ss_dssp             EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT----CCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred             ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC----CCCCCCChhhEEEcCCCCEEEEeccc
Confidence            999999999999874       2335899999999999999999999654    99999999999999999999999999


Q ss_pred             ceecCCCCCc---cccccccCCccccCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCC
Q 007680          420 YKLLGEGEDS---VRQTMTMATIGYMAPEYGLE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPH  495 (593)
Q Consensus       420 a~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~  495 (593)
                      +.........   .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||........  ........+.
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~  245 (303)
T 2vwi_A          168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV--LMLTLQNDPP  245 (303)
T ss_dssp             HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH--HHHHHTSSCC
T ss_pred             hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH--HHHHhccCCC
Confidence            8766543211   11233468999999998865 5689999999999999999999999977432221  1111111111


Q ss_pred             chhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          496 GLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       496 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      ......        ........++.++.+++.+||+.||++|||+.|+++|
T Consensus       246 ~~~~~~--------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  288 (303)
T 2vwi_A          246 SLETGV--------QDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH  288 (303)
T ss_dssp             CTTC-------------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             cccccc--------ccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence            110000        0000111235678999999999999999999999975

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=3.2e-40  Score=350.39  Aligned_cols=197  Identities=24%  Similarity=0.325  Sum_probs=172.4

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhc------CCCCcceeeeeeecCCce
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNV------RHRNLIKILSSYSNPDFK  343 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~~~~  343 (593)
                      ..+|++.+.||+|+||.||+|... +++.||||+++... ...+.+.+|+++++.+      +|+||+++++++...+..
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  174 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI  174 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence            457999999999999999999865 68999999997643 3345677888888887      577999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCc--EEEEeeccc
Q 007680          344 ALVLEFMPNGSLEKWLYSHNY-FLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMV--AHVSDFGIY  420 (593)
Q Consensus       344 ~lv~e~~~~gsL~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~--~kL~Dfg~a  420 (593)
                      ++||||+. ++|.+++..... .+++..+..++.||+.||+|||+++    |+||||||+|||++.++.  +||+|||++
T Consensus       175 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~----ivHrDlKp~NILl~~~~~~~vkL~DFG~a  249 (429)
T 3kvw_A          175 CMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR----IIHCDLKPENILLKQQGRSGIKVIDFGSS  249 (429)
T ss_dssp             EEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT----EECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             EEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC----eecCCCCHHHeEEccCCCcceEEeecccc
Confidence            99999995 699999887653 5899999999999999999999665    999999999999999887  999999999


Q ss_pred             eecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCcc
Q 007680          421 KLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEM  478 (593)
Q Consensus       421 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~  478 (593)
                      ......     .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       250 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~  302 (429)
T 3kvw_A          250 CYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE  302 (429)
T ss_dssp             EETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             eecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence            765432     23356899999999999999999999999999999999999999764

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.8e-40  Score=339.01  Aligned_cols=253  Identities=25%  Similarity=0.320  Sum_probs=199.3

Q ss_pred             hhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh--------HHHHHHHHHHHHHHhhcCCCCcceeeeeeecC
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL--------ERAFRSFDSECEVLRNVRHRNLIKILSSYSNP  340 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  340 (593)
                      ..++|++.+.||+|+||.||+|... +++.||||++....        ......+.+|++++++++||||+++++++...
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence            4578999999999999999999975 68999999986532        12234578999999999999999999998766


Q ss_pred             CceEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCc---EEEEee
Q 007680          341 DFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMV---AHVSDF  417 (593)
Q Consensus       341 ~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~---~kL~Df  417 (593)
                      + .++||||+++++|.+++.... .+++..+..++.|++.||+|||+++    |+||||||+||+++.++.   +||+||
T Consensus        88 ~-~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~----ivH~dlkp~NIl~~~~~~~~~~kl~Df  161 (322)
T 2ycf_A           88 D-YYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLHENG----IIHRDLKPENVLLSSQEEDCLIKITDF  161 (322)
T ss_dssp             S-EEEEEECCTTEETHHHHSTTC-CCCHHHHHHHHHHHHHHHHHHHHTT----EECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred             c-eEEEEecCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCC----eeccCCCHHHEEEecCCCCCeEEEccC
Confidence            5 899999999999999987655 4999999999999999999999654    999999999999987654   999999


Q ss_pred             ccceecCCCCCccccccccCCccccCccccC---CCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcC
Q 007680          418 GIYKLLGEGEDSVRQTMTMATIGYMAPEYGL---EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLP  494 (593)
Q Consensus       418 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~  494 (593)
                      |++.......   ......||+.|+|||++.   ...++.++|||||||++|+|++|+.||....... .....+.....
T Consensus       162 g~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~  237 (322)
T 2ycf_A          162 GHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV-SLKDQITSGKY  237 (322)
T ss_dssp             TTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS-CHHHHHHHTCC
T ss_pred             ccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH-HHHHHHHhCcc
Confidence            9998765332   123346899999999863   5678999999999999999999999997643221 12222211111


Q ss_pred             CchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          495 HGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       495 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      ...              ......++.++.+++.+||+.||++|||+.|+++|
T Consensus       238 ~~~--------------~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h  275 (322)
T 2ycf_A          238 NFI--------------PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH  275 (322)
T ss_dssp             CCC--------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             ccC--------------chhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence            000              01112345688999999999999999999999975

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.2e-41  Score=354.98  Aligned_cols=260  Identities=10%  Similarity=0.054  Sum_probs=187.2

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhc--CCCCcceee-------eee
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNV--RHRNLIKIL-------SSY  337 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l--~h~niv~l~-------~~~  337 (593)
                      ..+|++.+.||+|+||.||+|++. +|+.||+|+++...   ....+.+.+|+.+++.+  +||||++++       +++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            446999999999999999999975 78999999998743   34456778885555544  699988855       333


Q ss_pred             ecC-----------------CceEEEEeccCCCCHHHHHhhCCCCCCHHHH------HHHHHHHHHHHHHHHhcCCCCCe
Q 007680          338 SNP-----------------DFKALVLEFMPNGSLEKWLYSHNYFLDILER------LNIMIDVGSALEYLHNGHSSVHI  394 (593)
Q Consensus       338 ~~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~------~~i~~~i~~~L~~LH~~~~~~~i  394 (593)
                      ...                 ...++||||++ |+|.+++...+..+++..+      ..++.|++.||+|||+++    |
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~----i  215 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG----L  215 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT----E
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC----C
Confidence            322                 23799999998 8999999875444555566      788899999999999655    9


Q ss_pred             EecCCCCCCeeeCCCCcEEEEeeccceecCCCCCccccccccCCccccCccccCC--CCCCccchHHHHHHHHHHHHhCC
Q 007680          395 IHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLE--GIVSAKCDVYSYGVLLMETFTRK  472 (593)
Q Consensus       395 vH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~~DvwSlGvvl~elltg~  472 (593)
                      +||||||+|||++.++.+||+|||+++.....     .....+|+.|+|||++.+  ..++.++|||||||++|||++|+
T Consensus       216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~  290 (371)
T 3q60_A          216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF  290 (371)
T ss_dssp             EETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred             ccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence            99999999999999999999999999876432     113456799999999987  67999999999999999999999


Q ss_pred             CCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH--HHHh
Q 007680          473 RPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK--LKKI  550 (593)
Q Consensus       473 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~i  550 (593)
                      .||.........           .................+....+++.+.+++.+||+.||++|||+.|+++|  ++++
T Consensus       291 ~Pf~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  359 (371)
T 3q60_A          291 LPFGLVTPGIKG-----------SWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQL  359 (371)
T ss_dssp             CSTTBCCTTCTT-----------CCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHH
T ss_pred             CCCCCcCccccc-----------chhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHH
Confidence            999874322110           000000000000011111112446788999999999999999999999875  4444


Q ss_pred             h
Q 007680          551 K  551 (593)
Q Consensus       551 ~  551 (593)
                      .
T Consensus       360 ~  360 (371)
T 3q60_A          360 Q  360 (371)
T ss_dssp             H
T ss_pred             H
Confidence            3

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.9e-41  Score=348.72  Aligned_cols=255  Identities=24%  Similarity=0.280  Sum_probs=202.7

Q ss_pred             hhccccccccCccCcccEEEEEe----CCCCeEEEEEeehhh----HHHHHHHHHHHHHHhhc-CCCCcceeeeeeecCC
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTI----SDGTDVAIKVFNLQL----ERAFRSFDSECEVLRNV-RHRNLIKILSSYSNPD  341 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  341 (593)
                      .++|++.+.||+|+||.||+|+.    .+++.||||+++...    ....+.+.+|+++++++ +||||+++++++...+
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            46899999999999999999997    378999999986532    22335577899999999 6999999999999999


Q ss_pred             ceEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccce
Q 007680          342 FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYK  421 (593)
Q Consensus       342 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~  421 (593)
                      ..++||||+++++|.+++..... +++.++..++.|++.||+|||+++    |+||||||+||+++.++.+||+|||+++
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~qi~~aL~~LH~~~----ivH~Dlkp~NIll~~~~~~kl~DfG~a~  207 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQRER-FTEHEVQIYVGEIVLALEHLHKLG----IIYRDIKLENILLDSNGHVVLTDFGLSK  207 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHSC-CCHHHHHHHHHHHHHHHHHHHHTT----CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             eEEEEeecCCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHCC----cccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence            99999999999999999987654 899999999999999999999654    9999999999999999999999999998


Q ss_pred             ecCCCCCccccccccCCccccCccccCC--CCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhh
Q 007680          422 LLGEGEDSVRQTMTMATIGYMAPEYGLE--GIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTE  499 (593)
Q Consensus       422 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  499 (593)
                      ....... .......||+.|+|||++.+  ..++.++|||||||++|||++|+.||....... .........       
T Consensus       208 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-~~~~~~~~~-------  278 (355)
T 1vzo_A          208 EFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN-SQAEISRRI-------  278 (355)
T ss_dssp             ECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC-CHHHHHHHH-------
T ss_pred             ecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc-hHHHHHHHH-------
Confidence            7643322 12234569999999999875  347899999999999999999999997532211 111111100       


Q ss_pred             hhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHHHH
Q 007680          500 VVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRI-----NMTDAAAKL  547 (593)
Q Consensus       500 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~L  547 (593)
                           . ..  ....+..++..+.+++.+||..||++||     +++|+++|.
T Consensus       279 -----~-~~--~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          279 -----L-KS--EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             -----H-HC--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             -----h-cc--CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence                 0 00  0011123456789999999999999999     999999874

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=2.3e-40  Score=336.79  Aligned_cols=256  Identities=23%  Similarity=0.324  Sum_probs=198.8

Q ss_pred             HHHhhhccccccccCccCcccEEEEEeCCCCeEEEEEeehh--hHHHHHHHHHHHHHHhhcC--CCCcceeeeeeecCCc
Q 007680          267 IQRATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQ--LERAFRSFDSECEVLRNVR--HRNLIKILSSYSNPDF  342 (593)
Q Consensus       267 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~  342 (593)
                      +....++|++.+.||+|+||.||++...+++.||+|++...  .....+.+.+|++++.+++  ||||+++++++...+.
T Consensus        23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~  102 (313)
T 3cek_A           23 MSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY  102 (313)
T ss_dssp             EEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSE
T ss_pred             eeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCE
Confidence            33446789999999999999999999888999999999754  2445678899999999997  5999999999999999


Q ss_pred             eEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeecccee
Q 007680          343 KALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKL  422 (593)
Q Consensus       343 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~  422 (593)
                      .++||| +.+++|.+++..... +++.++..++.|+++||+|||+++    |+||||||+||++++ +.+||+|||++..
T Consensus       103 ~~lv~e-~~~~~L~~~l~~~~~-~~~~~~~~i~~qi~~aL~~LH~~~----ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~  175 (313)
T 3cek_A          103 IYMVME-CGNIDLNSWLKKKKS-IDPWERKSYWKNMLEAVHTIHQHG----IVHSDLKPANFLIVD-GMLKLIDFGIANQ  175 (313)
T ss_dssp             EEEEEC-CCSEEHHHHHHHCSS-CCHHHHHHHHHHHHHHHHHHHHTT----CCCCCCCGGGEEEET-TEEEECCCSSSCC
T ss_pred             EEEEEe-cCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCC----ceecCCCcccEEEEC-CeEEEeecccccc
Confidence            999999 558899999987654 899999999999999999999654    999999999999965 8999999999987


Q ss_pred             cCCCCCccccccccCCccccCccccCC-----------CCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHH
Q 007680          423 LGEGEDSVRQTMTMATIGYMAPEYGLE-----------GIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKE  491 (593)
Q Consensus       423 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~  491 (593)
                      ..............|++.|+|||++.+           ..++.++||||||+++|||++|+.||..............  
T Consensus       176 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~--  253 (313)
T 3cek_A          176 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII--  253 (313)
T ss_dssp             --------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH--
T ss_pred             ccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHH--
Confidence            654433222334568999999998765           4688999999999999999999999976432211111111  


Q ss_pred             hcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          492 SLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       492 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                                +....     ...+...+.++.+++.+||+.||++|||+.|++++
T Consensus       254 ----------~~~~~-----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  293 (313)
T 3cek_A          254 ----------DPNHE-----IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  293 (313)
T ss_dssp             ----------CTTSC-----CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ----------hcccc-----cCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence                      11000     00011124578999999999999999999999986

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=9.7e-41  Score=370.27  Aligned_cols=252  Identities=23%  Similarity=0.350  Sum_probs=201.8

Q ss_pred             cccCccCcccEEEEEeC---CCCeEEEEEeehhh--HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEeccCC
Q 007680          278 NLLGTSSFGSVYKGTIS---DGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPN  352 (593)
Q Consensus       278 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  352 (593)
                      +.||+|+||.||+|.+.   +++.||||+++...  ....+.+.+|++++++++||||+++++++.. +..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            47999999999999653   46789999998653  2345789999999999999999999999865 558899999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCcc-c
Q 007680          353 GSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSV-R  431 (593)
Q Consensus       353 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~-~  431 (593)
                      |+|.+++..... +++.++..++.||+.||+|||+++    |+||||||+||+++.++.+||+|||+++.+....... .
T Consensus       454 g~L~~~l~~~~~-l~~~~~~~i~~qi~~~L~yLH~~~----iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  528 (635)
T 4fl3_A          454 GPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYLEESN----FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA  528 (635)
T ss_dssp             EEHHHHHHHCTT-CCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred             CCHHHHHhhCCC-CCHHHHHHHHHHHHHHHHHHHHCC----EeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccc
Confidence            999999987654 999999999999999999999655    9999999999999999999999999998775443221 1


Q ss_pred             cccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhhh
Q 007680          432 QTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQ  510 (593)
Q Consensus       432 ~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  510 (593)
                      .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||......  .....+....                 
T Consensus       529 ~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--~~~~~i~~~~-----------------  589 (635)
T 4fl3_A          529 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVTAMLEKGE-----------------  589 (635)
T ss_dssp             ------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHHTTC-----------------
T ss_pred             ccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCC-----------------
Confidence            233456788999999999999999999999999999998 99999774321  1111111110                 


Q ss_pred             hhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhhh
Q 007680          511 AFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKF  554 (593)
Q Consensus       511 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  554 (593)
                      ....+..++.++.+++.+||+.||++||++.++++.|+++..+.
T Consensus       590 ~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l  633 (635)
T 4fl3_A          590 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV  633 (635)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence            11112245678999999999999999999999999999886554

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2e-40  Score=347.05  Aligned_cols=272  Identities=21%  Similarity=0.265  Sum_probs=200.5

Q ss_pred             HHhhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC------
Q 007680          268 QRATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNP------  340 (593)
Q Consensus       268 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  340 (593)
                      ....++|++.+.||+|+||.||+|+.. +|+.||+|++.....    ...+|+++++.++||||+++++++...      
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~   78 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK   78 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence            345678999999999999999999864 799999999875432    234699999999999999999998443      


Q ss_pred             --------------------------------CceEEEEeccCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHH
Q 007680          341 --------------------------------DFKALVLEFMPNGSLEKWLYS---HNYFLDILERLNIMIDVGSALEYL  385 (593)
Q Consensus       341 --------------------------------~~~~lv~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~L  385 (593)
                                                      ...++||||++ ++|.+.+..   ....+++..+..++.|+++||+||
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L  157 (383)
T 3eb0_A           79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI  157 (383)
T ss_dssp             -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence                                            34889999997 588777653   334599999999999999999999


Q ss_pred             HhcCCCCCeEecCCCCCCeeeC-CCCcEEEEeeccceecCCCCCccccccccCCccccCccccCCC-CCCccchHHHHHH
Q 007680          386 HNGHSSVHIIHCDLKPTNILLD-ENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEG-IVSAKCDVYSYGV  463 (593)
Q Consensus       386 H~~~~~~~ivH~Dlkp~NIll~-~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlGv  463 (593)
                      |+    .||+||||||+||+++ .++.+||+|||+++.+.....   .....+|+.|+|||++.+. .++.++||||+||
T Consensus       158 H~----~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~  230 (383)
T 3eb0_A          158 HS----LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLWSIGC  230 (383)
T ss_dssp             HT----TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred             HH----CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhhhHHH
Confidence            95    4599999999999997 688999999999987654432   2345689999999988765 4899999999999


Q ss_pred             HHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhh--hh--------hhhhhhhhhhhHHHHHHHHHHHhhcccCC
Q 007680          464 LLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVD--AN--------LVREEQAFSAKMDCILSIMDFALDCCMES  533 (593)
Q Consensus       464 vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~--------~~~~~~~~~~~~~~~~~l~~li~~cl~~d  533 (593)
                      ++|||++|+.||...... ..+...+...-......+..  +.        ..........+..++.++.+++.+||+.|
T Consensus       231 il~ell~g~~pf~~~~~~-~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d  309 (383)
T 3eb0_A          231 VFGELILGKPLFSGETSI-DQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYE  309 (383)
T ss_dssp             HHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSS
T ss_pred             HHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCC
Confidence            999999999999764222 12222221111111111100  00        00000001111234667899999999999


Q ss_pred             CCCCCCHHHHHHH--HHHhhh
Q 007680          534 PDMRINMTDAAAK--LKKIKV  552 (593)
Q Consensus       534 P~~RPs~~evl~~--L~~i~~  552 (593)
                      |++|||+.|+++|  +++++.
T Consensus       310 P~~R~t~~e~l~hp~f~~~~~  330 (383)
T 3eb0_A          310 PDLRINPYEAMAHPFFDHLRN  330 (383)
T ss_dssp             GGGSCCHHHHHTSGGGHHHHH
T ss_pred             hhhCCCHHHHhcCHHHHHHHh
Confidence            9999999999976  555543

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=2.2e-40  Score=348.08  Aligned_cols=266  Identities=21%  Similarity=0.239  Sum_probs=202.4

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcC--------CCCcceeeeeee---
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNVR--------HRNLIKILSSYS---  338 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~---  338 (593)
                      .++|++.+.||+|+||.||+|+.. +++.||+|+++... ...+.+.+|+.++++++        |+||+++++++.   
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE-HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC-cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            468999999999999999999865 68899999997542 34567889999999995        788999999987   


Q ss_pred             -cCCceEEEEeccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC------
Q 007680          339 -NPDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENM------  410 (593)
Q Consensus       339 -~~~~~~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~------  410 (593)
                       .....++||||+ +++|.+++.... ..+++..+..++.||+.||+|||++   .+|+||||||+|||++.++      
T Consensus       115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~givHrDikp~NIll~~~~~~~~~~  190 (397)
T 1wak_A          115 VNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTK---CRIIHTDIKPENILLSVNEQYIRRL  190 (397)
T ss_dssp             TTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT---TCEECCCCSGGGEEECCCHHHHHHH
T ss_pred             CCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHeeEeccchhhhhh
Confidence             556899999999 566766665543 4699999999999999999999965   1599999999999999775      


Q ss_pred             -------------------------------------------cEEEEeeccceecCCCCCccccccccCCccccCcccc
Q 007680          411 -------------------------------------------VAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYG  447 (593)
Q Consensus       411 -------------------------------------------~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~  447 (593)
                                                                 .+||+|||.+......     .....||+.|+|||++
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~~  265 (397)
T 1wak_A          191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEVL  265 (397)
T ss_dssp             HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHHH
T ss_pred             hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChhh
Confidence                                                       7999999999876532     2334689999999999


Q ss_pred             CCCCCCccchHHHHHHHHHHHHhCCCCCCccccccc----hHHHHHHHhcCCchhhhh-hhhhh----------------
Q 007680          448 LEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEM----SLRRWVKESLPHGLTEVV-DANLV----------------  506 (593)
Q Consensus       448 ~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~----~~~~~~~~~~~~~~~~~~-~~~~~----------------  506 (593)
                      .+..++.++|||||||++|||++|+.||........    .................+ .....                
T Consensus       266 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (397)
T 1wak_A          266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKL  345 (397)
T ss_dssp             HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCC
T ss_pred             cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccccc
Confidence            999999999999999999999999999976432221    111111111100000000 00000                


Q ss_pred             -------hhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          507 -------REEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       507 -------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                             ............+..+.+|+.+||+.||++|||+.|+++|
T Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  392 (397)
T 1wak_A          346 KPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH  392 (397)
T ss_dssp             CCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred             CCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence                   0000111234567789999999999999999999999975

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1e-39  Score=350.04  Aligned_cols=263  Identities=18%  Similarity=0.233  Sum_probs=210.3

Q ss_pred             hhccccccccCccCcccEEEEEe-CCCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCC-CCcceeeeeeecCCceEEEEe
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTI-SDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRH-RNLIKILSSYSNPDFKALVLE  348 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e  348 (593)
                      .++|++.+.||+|+||.||+|++ .+++.||||++.....  ...+..|+++++.++| +++..+..++...+..++|||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            46899999999999999999996 4799999999876532  2357889999999987 556666667778888999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeee---CCCCcEEEEeeccceecCC
Q 007680          349 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILL---DENMVAHVSDFGIYKLLGE  425 (593)
Q Consensus       349 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll---~~~~~~kL~Dfg~a~~~~~  425 (593)
                      |+ +++|.+++......+++.+++.++.||+.||+|||+++    |+||||||+|||+   +.++.+||+|||+++.+..
T Consensus        84 ~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g----IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~  158 (483)
T 3sv0_A           84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS----FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD  158 (483)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT----EECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             CC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC----EeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence            99 99999999876667999999999999999999999654    9999999999999   5889999999999998765


Q ss_pred             CCCcc-----ccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccc--hHHHHHHHhcCCchh
Q 007680          426 GEDSV-----RQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEM--SLRRWVKESLPHGLT  498 (593)
Q Consensus       426 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~--~~~~~~~~~~~~~~~  498 (593)
                      .....     ......||..|+|||++.+..++.++|||||||++|||++|+.||........  .+......       
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~-------  231 (483)
T 3sv0_A          159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK-------  231 (483)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHH-------
T ss_pred             CccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhc-------
Confidence            43221     12245799999999999999999999999999999999999999987432211  11111110       


Q ss_pred             hhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhhh
Q 007680          499 EVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKF  554 (593)
Q Consensus       499 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  554 (593)
                           ....  ........++.++.+++.+||+.||++||++.++++.|+++....
T Consensus       232 -----~~~~--~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~  280 (483)
T 3sv0_A          232 -----KVAT--SIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE  280 (483)
T ss_dssp             -----HHHS--CHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             -----cccc--cHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence                 0000  000111234678999999999999999999999999999986543

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.8e-41  Score=343.80  Aligned_cols=259  Identities=23%  Similarity=0.302  Sum_probs=199.9

Q ss_pred             CHHHHHHhhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhc-CCCCcceeeeeeec-
Q 007680          263 SYLDIQRATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNV-RHRNLIKILSSYSN-  339 (593)
Q Consensus       263 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-  339 (593)
                      .+.++....++|++.+.||+|+||.||+|++. +|+.||+|++.... ...+.+.+|+.+++++ +||||+++++++.. 
T Consensus        15 ~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   93 (326)
T 2x7f_A           15 DLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKK   93 (326)
T ss_dssp             -CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred             cchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence            33444556789999999999999999999974 78999999987543 2346788999999999 89999999999976 


Q ss_pred             -----CCceEEEEeccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEE
Q 007680          340 -----PDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAH  413 (593)
Q Consensus       340 -----~~~~~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~k  413 (593)
                           .+..++||||+++++|.+++.... ..+++..+..++.|++.||+|||+++    |+||||||+||+++.++.+|
T Consensus        94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~----ivH~dlkp~NIl~~~~~~~k  169 (326)
T 2x7f_A           94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK----VIHRDIKGQNVLLTENAEVK  169 (326)
T ss_dssp             C--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT----CCCCCCSGGGEEECTTCCEE
T ss_pred             cCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC----ccccCCcHHHEEEcCCCCEE
Confidence                 467899999999999999998753 35899999999999999999999655    99999999999999999999


Q ss_pred             EEeeccceecCCCCCccccccccCCccccCccccC-----CCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHH
Q 007680          414 VSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGL-----EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRW  488 (593)
Q Consensus       414 L~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~  488 (593)
                      |+|||++........  ......|++.|+|||++.     +..++.++|||||||++|+|++|+.||.......  ....
T Consensus       170 l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~  245 (326)
T 2x7f_A          170 LVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR--ALFL  245 (326)
T ss_dssp             ECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHH
T ss_pred             EeeCcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH--HHHH
Confidence            999999887643221  223346899999999986     5678999999999999999999999997632211  1111


Q ss_pred             HHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          489 VKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       489 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      ........                .....++..+.+++.+||..||++||++.|+++|
T Consensus       246 ~~~~~~~~----------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  287 (326)
T 2x7f_A          246 IPRNPAPR----------------LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH  287 (326)
T ss_dssp             HHHSCCCC----------------CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             hhcCcccc----------------CCccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            11100000                0011234578999999999999999999999985

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=9.6e-40  Score=335.40  Aligned_cols=263  Identities=21%  Similarity=0.282  Sum_probs=204.3

Q ss_pred             hhccccccccCccCcccEEEEEe-C-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCC------CcceeeeeeecCCc
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTI-S-DGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHR------NLIKILSSYSNPDF  342 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~-~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~------niv~l~~~~~~~~~  342 (593)
                      .++|++.+.||+|+||.||+|.. . +++.||+|+++... ...+.+.+|+++++.++|+      +++++++++...+.
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~   91 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH   91 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence            46899999999999999999986 3 68899999997543 3456788999999998765      49999999999999


Q ss_pred             eEEEEeccCCCCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC-------------
Q 007680          343 KALVLEFMPNGSLEKWLYSHNY-FLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDE-------------  408 (593)
Q Consensus       343 ~~lv~e~~~~gsL~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~-------------  408 (593)
                      .++||||+ +++|.+++..... .+++.++..++.|++.||+|||+++    |+||||||+||+++.             
T Consensus        92 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~----ivH~Dlkp~Nil~~~~~~~~~~~~~~~~  166 (339)
T 1z57_A           92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK----LTHTDLKPENILFVQSDYTEAYNPKIKR  166 (339)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT----EECCCCCGGGEEESCCCEEEEEC----C
T ss_pred             EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC----CcCCCCCHHHEEEeccccccccCCcccc
Confidence            99999999 8899999987653 5899999999999999999999654    999999999999987             


Q ss_pred             ------CCcEEEEeeccceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCcccccc
Q 007680          409 ------NMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGE  482 (593)
Q Consensus       409 ------~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~  482 (593)
                            ++.+||+|||++......     .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+
T Consensus       167 ~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~  241 (339)
T 1z57_A          167 DERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE  241 (339)
T ss_dssp             EEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred             ccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence                  668999999999875432     233468999999999999999999999999999999999999997643221


Q ss_pred             chHHHHHHHh---cCCchhhhh-----------------------hhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCC
Q 007680          483 MSLRRWVKES---LPHGLTEVV-----------------------DANLVREEQAFSAKMDCILSIMDFALDCCMESPDM  536 (593)
Q Consensus       483 ~~~~~~~~~~---~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~  536 (593)
                        ....+...   .+..+....                       .................++++.+++.+||+.||++
T Consensus       242 --~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~  319 (339)
T 1z57_A          242 --HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK  319 (339)
T ss_dssp             --HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred             --HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccc
Confidence              11111111   111000000                       00000000001112245678999999999999999


Q ss_pred             CCCHHHHHHH
Q 007680          537 RINMTDAAAK  546 (593)
Q Consensus       537 RPs~~evl~~  546 (593)
                      |||+.|+++|
T Consensus       320 Rpt~~ell~h  329 (339)
T 1z57_A          320 RITLREALKH  329 (339)
T ss_dssp             SCCHHHHTTS
T ss_pred             ccCHHHHhcC
Confidence            9999999876

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.9e-41  Score=345.65  Aligned_cols=266  Identities=21%  Similarity=0.342  Sum_probs=203.2

Q ss_pred             HHHHhhhccccccccCccCcccEEEEEeCCCCeEEEEEeehhh--HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCce
Q 007680          266 DIQRATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFK  343 (593)
Q Consensus       266 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  343 (593)
                      +.....++|++.+.||+|+||.||+|++.  ..||+|+++...  ....+.+.+|+.++++++||||+++++++.+.+..
T Consensus        27 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~--~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  104 (319)
T 2y4i_B           27 EWDIPFEQLEIGELIGKGRFGQVYHGRWH--GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHL  104 (319)
T ss_dssp             GSSSCCSCEECCCBCCCSSSSEEEEEEES--SSEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCE
T ss_pred             cccCCHHHeEEeeEeccCCceEEEEEEEc--CeEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCce
Confidence            33345678999999999999999999975  359999987542  22334577899999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceec
Q 007680          344 ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLL  423 (593)
Q Consensus       344 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~  423 (593)
                      ++||||+++++|.+++...+..+++..+..++.|++.||+|||+++    |+||||||+||+++ ++.+||+|||++...
T Consensus       105 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~----i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~  179 (319)
T 2y4i_B          105 AIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG----ILHKDLKSKNVFYD-NGKVVITDFGLFSIS  179 (319)
T ss_dssp             EEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTT----CCCCCCCSTTEEEC---CCEECCCSCCC--
T ss_pred             EEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC----ccccCCChhhEEEe-CCCEEEeecCCcccc
Confidence            9999999999999999887767999999999999999999999655    99999999999998 679999999998765


Q ss_pred             CCCCC---ccccccccCCccccCccccCC---------CCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHH
Q 007680          424 GEGED---SVRQTMTMATIGYMAPEYGLE---------GIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKE  491 (593)
Q Consensus       424 ~~~~~---~~~~~~~~gt~~y~aPE~~~~---------~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~  491 (593)
                      .....   ........|++.|+|||++.+         ..++.++||||||+++|||++|+.||.......  .......
T Consensus       180 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~~~~  257 (319)
T 2y4i_B          180 GVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA--IIWQMGT  257 (319)
T ss_dssp             --------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH--HHHHHHT
T ss_pred             ccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHhcc
Confidence            32211   112233458999999998764         457899999999999999999999997642211  1111111


Q ss_pred             hcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhhhcc
Q 007680          492 SLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKFLD  556 (593)
Q Consensus       492 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~  556 (593)
                      .....        .        ....++.++.+++.+||+.||++|||+.++++.|+++......
T Consensus       258 ~~~~~--------~--------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~  306 (319)
T 2y4i_B          258 GMKPN--------L--------SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRR  306 (319)
T ss_dssp             TCCCC--------C--------CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC------
T ss_pred             CCCCC--------C--------CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhcc
Confidence            10000        0        0012345689999999999999999999999999999877533

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.2e-39  Score=329.35  Aligned_cols=254  Identities=23%  Similarity=0.290  Sum_probs=195.2

Q ss_pred             hhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec---------
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSN---------  339 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---------  339 (593)
                      ..++|++.+.||+|+||.||+|+.. +++.||+|+++... ...+.+.+|+.++++++||||+++++++.+         
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE-EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT   82 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccH-HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence            4678999999999999999999975 79999999997543 345778999999999999999999998754         


Q ss_pred             ----CCceEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEE
Q 007680          340 ----PDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVS  415 (593)
Q Consensus       340 ----~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~  415 (593)
                          .+..++||||+++++|.+++......+++..+..++.|++.||+|||+++    |+||||||+||+++.++.+||+
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~----i~H~dlkp~Nil~~~~~~~kl~  158 (303)
T 1zy4_A           83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG----IIHRDLKPMNIFIDESRNVKIG  158 (303)
T ss_dssp             ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCCGGGEEECTTSCEEEC
T ss_pred             ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCC----eecccCCHHhEEEcCCCCEEEe
Confidence                35679999999999999999877767889999999999999999999655    9999999999999999999999


Q ss_pred             eeccceecCCCCC------------ccccccccCCccccCccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCcccccc
Q 007680          416 DFGIYKLLGEGED------------SVRQTMTMATIGYMAPEYGLEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFIGE  482 (593)
Q Consensus       416 Dfg~a~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~  482 (593)
                      |||.+........            ........|++.|+|||++.+. .++.++|||||||++|||++   ||...... 
T Consensus       159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~-  234 (303)
T 1zy4_A          159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMER-  234 (303)
T ss_dssp             CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHH-
T ss_pred             eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhH-
Confidence            9999987643211            1112345689999999998764 68999999999999999998   55432111 


Q ss_pred             chHHHHHHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          483 MSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       483 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      ......+..... ...             .......+..+.+++.+||+.||++|||+.|+++|
T Consensus       235 ~~~~~~~~~~~~-~~~-------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  284 (303)
T 1zy4_A          235 VNILKKLRSVSI-EFP-------------PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS  284 (303)
T ss_dssp             HHHHHHHHSTTC-CCC-------------TTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             HHHHHhcccccc-ccC-------------ccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence            111111111000 000             00112234568999999999999999999999985

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.1e-39  Score=337.48  Aligned_cols=268  Identities=24%  Similarity=0.264  Sum_probs=201.7

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-----Cce
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSYSNP-----DFK  343 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~  343 (593)
                      .++|++.+.||+|+||.||+|++. +|+.||||+++... ......+.+|++++++++||||+++++++...     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            568999999999999999999976 68999999996532 34456788999999999999999999987654     678


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceec
Q 007680          344 ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLL  423 (593)
Q Consensus       344 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~  423 (593)
                      ++||||++ ++|.+++....  +++..+..++.|++.||+|||+++    |+||||||+||+++.++.+||+|||++...
T Consensus        90 ~lv~e~~~-~~L~~~~~~~~--~~~~~~~~~~~qi~~~L~~LH~~~----ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  162 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVISTQM--LSDDHIQYFIYQTLRAVKVLHGSN----VIHRDLKPSNLLINSNCDLKVCDFGLARII  162 (353)
T ss_dssp             EEEECCCS-EEHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHHTT----EECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEeccC-ccHHHHHhhcC--CCHHHHHHHHHHHHHHHHHHHHCC----eecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence            99999996 69999998753  899999999999999999999654    999999999999999999999999999876


Q ss_pred             CCCCCcc--------ccccccCCccccCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHH-hc
Q 007680          424 GEGEDSV--------RQTMTMATIGYMAPEYGLE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKE-SL  493 (593)
Q Consensus       424 ~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~-~~  493 (593)
                      .......        ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ........ ..
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~  241 (353)
T 2b9h_A          163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH-QLLLIFGIIGT  241 (353)
T ss_dssp             C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCC
T ss_pred             ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCC
Confidence            5432111        1123468999999998654 679999999999999999999999997643211 11111110 00


Q ss_pred             CC--c-hhhhhhhhhhh---------hhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          494 PH--G-LTEVVDANLVR---------EEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       494 ~~--~-~~~~~~~~~~~---------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      +.  . ...........         ..........+++++.+++.+||+.||++|||+.|+++|
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (353)
T 2b9h_A          242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH  306 (353)
T ss_dssp             CCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            00  0 00000000000         000001112456788999999999999999999999986

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=9.5e-40  Score=338.90  Aligned_cols=279  Identities=19%  Similarity=0.221  Sum_probs=193.8

Q ss_pred             HHHHHhhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCc-
Q 007680          265 LDIQRATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDF-  342 (593)
Q Consensus       265 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-  342 (593)
                      .+.....++|++.+.||+|+||.||+|++. +|+.||||++.... .......+|++.+..++||||+++++++...+. 
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            445667889999999999999999999975 78999999986542 223456678888899999999999999865433 


Q ss_pred             ------eEEEEeccCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC-CCcE
Q 007680          343 ------KALVLEFMPNGSLEKWLYS---HNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDE-NMVA  412 (593)
Q Consensus       343 ------~~lv~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~-~~~~  412 (593)
                            .++||||+++ +|.+.+..   ....+++..+..++.|++.||.|||.+  +.+|+||||||+||+++. ++.+
T Consensus        95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~--~~~ivH~Dlkp~NIll~~~~~~~  171 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLP--SVNVCHRDIKPHNVLVNEADGTL  171 (360)
T ss_dssp             CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTST--TTCCBCSCCCGGGEEEETTTTEE
T ss_pred             cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCC--CCCeecCcCCHHHEEEeCCCCcE
Confidence                  7899999976 55554432   333589999999999999999999921  234999999999999996 8999


Q ss_pred             EEEeeccceecCCCCCccccccccCCccccCccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHH
Q 007680          413 HVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKE  491 (593)
Q Consensus       413 kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~  491 (593)
                      ||+|||++........   .....||+.|+|||++.+. .++.++|||||||++|||++|+.||....... .+......
T Consensus       172 kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~-~~~~~~~~  247 (360)
T 3e3p_A          172 KLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAG-QLHEIVRV  247 (360)
T ss_dssp             EECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHH
T ss_pred             EEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHH-HHHHHHHH
Confidence            9999999987654332   2345689999999988665 48999999999999999999999997743221 12222211


Q ss_pred             hcCCc--hhhhhhhhhh-----------hhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH--HHHhh
Q 007680          492 SLPHG--LTEVVDANLV-----------REEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK--LKKIK  551 (593)
Q Consensus       492 ~~~~~--~~~~~~~~~~-----------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~i~  551 (593)
                      .....  ....+++...           ............++++.+++.+||+.||++|||+.|+++|  ++++.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~  322 (360)
T 3e3p_A          248 LGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH  322 (360)
T ss_dssp             HCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGG
T ss_pred             cCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccC
Confidence            11100  1011100000           0000000111246789999999999999999999999987  44443

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.8e-39  Score=338.37  Aligned_cols=266  Identities=21%  Similarity=0.269  Sum_probs=200.3

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehh--hHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCce----
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQ--LERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFK----  343 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~----  343 (593)
                      .++|.+.+.||+|+||.||+|.+. +|+.||+|++...  .....+.+.+|+.+++.++||||+++++++...+..    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            468999999999999999999965 7899999999764  234457788999999999999999999999877654    


Q ss_pred             --EEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccce
Q 007680          344 --ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYK  421 (593)
Q Consensus       344 --~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~  421 (593)
                        ++||||++ ++|.+++..   .+++..+..++.|++.||+|||+++    |+||||||+||+++.++.+||+|||+++
T Consensus       121 ~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~----ivH~Dikp~NIll~~~~~~kL~Dfg~a~  192 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMGM---EFSEEKIQYLVYQMLKGLKYIHSAG----VVHRDLKPGNLAVNEDCELKILDFGLAR  192 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCCGGGEEECTTCCEEECSTTCC-
T ss_pred             eEEEEEcccc-ccHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCC----CcCCCcCHHHeEECCCCCEEEEecCccc
Confidence              99999996 688888743   3899999999999999999999654    9999999999999999999999999998


Q ss_pred             ecCCCCCccccccccCCccccCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHh-cCC-chh
Q 007680          422 LLGEGEDSVRQTMTMATIGYMAPEYGLE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKES-LPH-GLT  498 (593)
Q Consensus       422 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~-~~~-~~~  498 (593)
                      .....     .....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+ .+....... .+. ...
T Consensus       193 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~  266 (371)
T 4exu_A          193 HADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKVTGVPGTEFV  266 (371)
T ss_dssp             ------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCHHHH
T ss_pred             ccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCcHHHH
Confidence            65432     233568999999999877 679999999999999999999999997642211 111111111 010 000


Q ss_pred             hhhhhhhhh--------h--hhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH--HHHh
Q 007680          499 EVVDANLVR--------E--EQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK--LKKI  550 (593)
Q Consensus       499 ~~~~~~~~~--------~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~i  550 (593)
                      ..+......        .  .........+++.+.+|+.+||+.||++|||+.|+++|  ++.+
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  330 (371)
T 4exu_A          267 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF  330 (371)
T ss_dssp             TTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred             HHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccC
Confidence            000000000        0  00001112346789999999999999999999999987  4444

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1e-39  Score=327.90  Aligned_cols=253  Identities=24%  Similarity=0.314  Sum_probs=204.5

Q ss_pred             HhhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh--HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEE
Q 007680          269 RATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKAL  345 (593)
Q Consensus       269 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  345 (593)
                      ...++|++.+.||+|+||.||+|+.. +++.||+|++....  ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus        19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   98 (287)
T 2wei_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI   98 (287)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence            34678999999999999999999976 78999999997653  2345678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCC---CcEEEEeecccee
Q 007680          346 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDEN---MVAHVSDFGIYKL  422 (593)
Q Consensus       346 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~---~~~kL~Dfg~a~~  422 (593)
                      ||||+++++|.+++..... +++.++..++.|++.||+|||+++    ++||||||+||+++.+   +.+||+|||++..
T Consensus        99 v~e~~~~~~L~~~l~~~~~-~~~~~~~~i~~qi~~~l~~LH~~~----i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~  173 (287)
T 2wei_A           99 VGELYTGGELFDEIIKRKR-FSEHDAARIIKQVFSGITYMHKHN----IVHRDLKPENILLESKEKDCDIKIIDFGLSTC  173 (287)
T ss_dssp             EECCCCSCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred             EEEccCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCC----eeccCCChhhEEEecCCCcccEEEeccCccee
Confidence            9999999999998876554 899999999999999999999654    9999999999999754   4799999999886


Q ss_pred             cCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhh
Q 007680          423 LGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVD  502 (593)
Q Consensus       423 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  502 (593)
                      ......   .....+++.|+|||++.+ .++.++||||||+++|+|++|+.||......  .....+......       
T Consensus       174 ~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~-------  240 (287)
T 2wei_A          174 FQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY--DILKRVETGKYA-------  240 (287)
T ss_dssp             BCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHCCCC-------
T ss_pred             ecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH--HHHHHHHcCCCC-------
Confidence            654322   223357889999998765 4899999999999999999999999763221  111111111000       


Q ss_pred             hhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          503 ANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                             ...+....++.++.+++.+||+.||++|||+.|++++
T Consensus       241 -------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  277 (287)
T 2wei_A          241 -------FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (287)
T ss_dssp             -------CCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             -------CCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence                   0011112345678999999999999999999999985

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=4.4e-39  Score=336.85  Aligned_cols=201  Identities=25%  Similarity=0.320  Sum_probs=173.1

Q ss_pred             HhhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcC-CC-----CcceeeeeeecCC
Q 007680          269 RATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNVR-HR-----NLIKILSSYSNPD  341 (593)
Q Consensus       269 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~~~  341 (593)
                      ...++|++.+.||+|+||.||+|... +++.||||+++... .....+..|+.+++.++ |+     +|+++++++...+
T Consensus        51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~  129 (382)
T 2vx3_A           51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN  129 (382)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred             EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence            34678999999999999999999975 68899999997543 33466788999988885 55     4999999999999


Q ss_pred             ceEEEEeccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeC--CCCcEEEEeec
Q 007680          342 FKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLD--ENMVAHVSDFG  418 (593)
Q Consensus       342 ~~~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~--~~~~~kL~Dfg  418 (593)
                      ..++||||++ ++|.+++.... ..+++..+..++.|++.||.|||.+  ..+|+||||||+||+++  .++.+||+|||
T Consensus       130 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~--~~~ivHrDlkp~NIll~~~~~~~~kL~DFG  206 (382)
T 2vx3_A          130 HLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP--ELSIIHCDLKPENILLCNPKRSAIKIVDFG  206 (382)
T ss_dssp             EEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST--TTCEECCCCSGGGEEESSTTSCCEEECCCT
T ss_pred             ceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC--CCCEEcCCCCcccEEEecCCCCcEEEEecc
Confidence            9999999995 59999998764 3589999999999999999999953  24699999999999995  47789999999


Q ss_pred             cceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCcc
Q 007680          419 IYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEM  478 (593)
Q Consensus       419 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~  478 (593)
                      +++.....     .....+|+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       207 ~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~  261 (382)
T 2vx3_A          207 SSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA  261 (382)
T ss_dssp             TCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             Cceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            99876432     23356899999999999999999999999999999999999999864

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=8.6e-40  Score=343.38  Aligned_cols=269  Identities=22%  Similarity=0.298  Sum_probs=197.3

Q ss_pred             hhccccccccCccCcccEEEEEeCCCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCC------ceE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPD------FKA  344 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~  344 (593)
                      ..+|++.+.||+|+||.||+|+..++..||+|++.....    ...+|+++++.++||||+++++++...+      ..+
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~  114 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN  114 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence            457999999999999999999987777799998865422    2246999999999999999999986543      378


Q ss_pred             EEEeccCCCCHHHHHh--hCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeC-CCCcEEEEeeccce
Q 007680          345 LVLEFMPNGSLEKWLY--SHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLD-ENMVAHVSDFGIYK  421 (593)
Q Consensus       345 lv~e~~~~gsL~~~l~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~-~~~~~kL~Dfg~a~  421 (593)
                      +||||++++.+.....  .....+++..+..++.|++.||+|||+++    |+||||||+||+++ .++.+||+|||+++
T Consensus       115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~----ivHrDlkp~Nill~~~~~~~kL~DFG~a~  190 (394)
T 4e7w_A          115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG----ICHRDIKPQNLLLDPPSGVLKLIDFGSAK  190 (394)
T ss_dssp             EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT----EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC----ccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence            9999997643333221  22345999999999999999999999654    99999999999999 79999999999998


Q ss_pred             ecCCCCCccccccccCCccccCccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchh--
Q 007680          422 LLGEGEDSVRQTMTMATIGYMAPEYGLEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLT--  498 (593)
Q Consensus       422 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~--  498 (593)
                      .......   .....+|+.|+|||++.+. .++.++||||+||++|||++|+.||.+.... ..+.......-.....  
T Consensus       191 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~l~~i~~~~g~p~~~~~  266 (394)
T 4e7w_A          191 ILIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGI-DQLVEIIKVLGTPSREQI  266 (394)
T ss_dssp             ECCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCHHHH
T ss_pred             cccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHH
Confidence            7654332   2345689999999988765 5999999999999999999999999774321 1122222111111000  


Q ss_pred             hhhhhhhh--------hhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH--HHHhh
Q 007680          499 EVVDANLV--------REEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK--LKKIK  551 (593)
Q Consensus       499 ~~~~~~~~--------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~i~  551 (593)
                      ...+....        ............++++.+++.+||+.||++|||+.|+++|  +++++
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  329 (394)
T 4e7w_A          267 KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELR  329 (394)
T ss_dssp             HHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTT
T ss_pred             HhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhc
Confidence            00000000        0000001111245689999999999999999999999987  55443

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.2e-39  Score=332.01  Aligned_cols=253  Identities=22%  Similarity=0.267  Sum_probs=184.9

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh--HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVL  347 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  347 (593)
                      .++|++.+.||+|+||.||+|.+. +|+.||||++....  ....+.+.++..+++.++||||+++++++.+.+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            578999999999999999999975 78999999997643  223344555566788889999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCC
Q 007680          348 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGE  427 (593)
Q Consensus       348 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~  427 (593)
                      ||+ ++.+..+.......+++..+..++.|++.||+|||++   .+|+||||||+||+++.++.+||+|||++.......
T Consensus       104 e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  179 (318)
T 2dyl_A          104 ELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK---HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK  179 (318)
T ss_dssp             CCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHH---HCCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred             ecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhh---CCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc
Confidence            999 5667666665455699999999999999999999963   149999999999999999999999999987664432


Q ss_pred             CccccccccCCccccCccccC-----CCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhh
Q 007680          428 DSVRQTMTMATIGYMAPEYGL-----EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVD  502 (593)
Q Consensus       428 ~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  502 (593)
                      .   .....+++.|+|||++.     +..++.++||||||+++|||++|+.||................ .+.       
T Consensus       180 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~-------  248 (318)
T 2dyl_A          180 A---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQE-EPP-------  248 (318)
T ss_dssp             ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHS-CCC-------
T ss_pred             c---ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhcc-CCC-------
Confidence            1   23346899999999984     4568999999999999999999999997632222111111111 110       


Q ss_pred             hhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          503 ANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                              ..+....++.++.+++.+||+.||++||++.|+++|
T Consensus       249 --------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (318)
T 2dyl_A          249 --------LLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH  284 (318)
T ss_dssp             --------CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             --------CCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence                    001111235678999999999999999999999986

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=2.9e-39  Score=359.78  Aligned_cols=263  Identities=20%  Similarity=0.335  Sum_probs=209.6

Q ss_pred             HHHHhhhccccccccCccCcccEEEEEeC----CCCeEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceeeeeeecC
Q 007680          266 DIQRATDEFNECNLLGTSSFGSVYKGTIS----DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSYSNP  340 (593)
Q Consensus       266 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  340 (593)
                      +.....++|++.+.||+|+||.||+|.+.    .+..||+|.++... ....+.+.+|+.++++++||||+++++++. .
T Consensus       384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~  462 (656)
T 2j0j_A          384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E  462 (656)
T ss_dssp             GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred             ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-c
Confidence            33444578999999999999999999864    24579999987543 344578899999999999999999999985 4


Q ss_pred             CceEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccc
Q 007680          341 DFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIY  420 (593)
Q Consensus       341 ~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a  420 (593)
                      +..++||||+++|+|.+++......+++..+..++.|++.||+|||+++    |+||||||+||+++.++.+||+|||++
T Consensus       463 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g----ivHrDikp~NILl~~~~~vkL~DFG~a  538 (656)
T 2j0j_A          463 NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR----FVHRDIAARNVLVSSNDCVKLGDFGLS  538 (656)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCSGGGEEEEETTEEEECCCCCC
T ss_pred             CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC----ccccccchHhEEEeCCCCEEEEecCCC
Confidence            5689999999999999999877667999999999999999999999654    999999999999999999999999999


Q ss_pred             eecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhh
Q 007680          421 KLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTE  499 (593)
Q Consensus       421 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  499 (593)
                      +....... .......+++.|+|||++.+..++.++|||||||++|||++ |..||.+....  .....+.....     
T Consensus       539 ~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~--~~~~~i~~~~~-----  610 (656)
T 2j0j_A          539 RYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIGRIENGER-----  610 (656)
T ss_dssp             CSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHHTCC-----
T ss_pred             eecCCCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH--HHHHHHHcCCC-----
Confidence            87654322 12233456789999999988899999999999999999997 99999764221  11111111110     


Q ss_pred             hhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhh
Q 007680          500 VVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVK  553 (593)
Q Consensus       500 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  553 (593)
                                  .+.+..+++.+.+++.+||+.||++|||+.|+++.|+++...
T Consensus       611 ------------~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~  652 (656)
T 2j0j_A          611 ------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  652 (656)
T ss_dssp             ------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ------------CCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence                        011223466889999999999999999999999999998643

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.6e-39  Score=342.79  Aligned_cols=269  Identities=21%  Similarity=0.251  Sum_probs=184.8

Q ss_pred             hhcccc-ccccCccCcccEEEEEeC---CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeee--cCCceE
Q 007680          271 TDEFNE-CNLLGTSSFGSVYKGTIS---DGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYS--NPDFKA  344 (593)
Q Consensus       271 ~~~~~~-~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~  344 (593)
                      .+.|++ .++||+|+||.||+|+++   +++.||+|++....  ....+.+|+.++++++||||+++++++.  .....+
T Consensus        19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~   96 (405)
T 3rgf_A           19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVW   96 (405)
T ss_dssp             HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred             hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence            455776 458999999999999965   57899999997542  2346788999999999999999999995  467899


Q ss_pred             EEEeccCCCCHHHHHhhCC--------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeee----CCCCcE
Q 007680          345 LVLEFMPNGSLEKWLYSHN--------YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILL----DENMVA  412 (593)
Q Consensus       345 lv~e~~~~gsL~~~l~~~~--------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll----~~~~~~  412 (593)
                      +||||++ ++|.+++....        ..+++..+..++.||+.||+|||+++    |+||||||+||++    +.++.+
T Consensus        97 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~----ivH~Dlkp~NIll~~~~~~~~~~  171 (405)
T 3rgf_A           97 LLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW----VLHRDLKPANILVMGEGPERGRV  171 (405)
T ss_dssp             EEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT----CCCCCCCGGGEEECCSSTTTTCE
T ss_pred             EEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC----EeCCCcCHHHeEEecCCCCCCcE
Confidence            9999996 58888875321        14899999999999999999999655    9999999999999    677899


Q ss_pred             EEEeeccceecCCCCCc-cccccccCCccccCccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCcccccc--------
Q 007680          413 HVSDFGIYKLLGEGEDS-VRQTMTMATIGYMAPEYGLEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFIGE--------  482 (593)
Q Consensus       413 kL~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~--------  482 (593)
                      ||+|||+++........ .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.......        
T Consensus       172 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~  251 (405)
T 3rgf_A          172 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH  251 (405)
T ss_dssp             EECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCH
T ss_pred             EEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchH
Confidence            99999999876543221 123345789999999998774 59999999999999999999999997542210        


Q ss_pred             chHHHHHHHh-cCCc--hhhhhh--------hhhhhhhhh--------hhhhHHHHHHHHHHHhhcccCCCCCCCCHHHH
Q 007680          483 MSLRRWVKES-LPHG--LTEVVD--------ANLVREEQA--------FSAKMDCILSIMDFALDCCMESPDMRINMTDA  543 (593)
Q Consensus       483 ~~~~~~~~~~-~~~~--~~~~~~--------~~~~~~~~~--------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev  543 (593)
                      ..+....... .+..  +.....        .........        .......+..+.+|+.+||+.||++|||++|+
T Consensus       252 ~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~  331 (405)
T 3rgf_A          252 DQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQA  331 (405)
T ss_dssp             HHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             HHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence            1111111110 0100  110000        000000000        00000114578899999999999999999999


Q ss_pred             HHH
Q 007680          544 AAK  546 (593)
Q Consensus       544 l~~  546 (593)
                      ++|
T Consensus       332 L~h  334 (405)
T 3rgf_A          332 MQD  334 (405)
T ss_dssp             HTS
T ss_pred             hcC
Confidence            986

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=9.9e-40  Score=345.76  Aligned_cols=263  Identities=22%  Similarity=0.286  Sum_probs=194.8

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC------Cce
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNP------DFK  343 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~  343 (593)
                      ..+|++.+.||+|+||.||+|++. +|+.||||++....    ....+|++++++++||||+++++++...      ...
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~  128 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL  128 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred             cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence            347999999999999999999975 69999999986542    2234699999999999999999988532      236


Q ss_pred             EEEEeccCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCC-CcEEEEeecc
Q 007680          344 ALVLEFMPNGSLEKWLYS---HNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDEN-MVAHVSDFGI  419 (593)
Q Consensus       344 ~lv~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~-~~~kL~Dfg~  419 (593)
                      ++||||+++ ++.+.+..   ....+++..+..++.||++||+|||++    +|+||||||+|||++.+ +.+||+|||+
T Consensus       129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~NILl~~~~~~~kl~DFG~  203 (420)
T 1j1b_A          129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF----GICHRDIKPQNLLLDPDTAVLKLCDFGS  203 (420)
T ss_dssp             EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT----TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCChhhEEEeCCCCeEEeccchh
Confidence            799999975 67666542   344699999999999999999999954    59999999999999955 6789999999


Q ss_pred             ceecCCCCCccccccccCCccccCccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchh
Q 007680          420 YKLLGEGEDSVRQTMTMATIGYMAPEYGLEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLT  498 (593)
Q Consensus       420 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  498 (593)
                      ++.+.....   .....+|+.|+|||++.+. .++.++|||||||++|||++|+.||.+.... ..+.+.+...-.....
T Consensus       204 a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~-~~l~~i~~~lg~p~~~  279 (420)
T 1j1b_A          204 AKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-DQLVEIIKVLGTPTRE  279 (420)
T ss_dssp             CEECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCSCCHH
T ss_pred             hhhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHH
Confidence            987654332   2335689999999998765 7999999999999999999999999764221 1222222211111000


Q ss_pred             hh--hhhhh--------hhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          499 EV--VDANL--------VREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       499 ~~--~~~~~--------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      .+  .++..        ....-........++++.+|+.+||..||++|||+.|+++|
T Consensus       280 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h  337 (420)
T 1j1b_A          280 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  337 (420)
T ss_dssp             HHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence            00  00000        00000000011235688999999999999999999999986

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.4e-39  Score=332.78  Aligned_cols=268  Identities=24%  Similarity=0.302  Sum_probs=202.1

Q ss_pred             hhhccccccccCccCcccEEEEEe--CCCCeEEEEEeehhhH--HHHHHHHHHHHHHhhc---CCCCcceeeeeee----
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTI--SDGTDVAIKVFNLQLE--RAFRSFDSECEVLRNV---RHRNLIKILSSYS----  338 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~----  338 (593)
                      ..++|++.+.||+|+||.||+|+.  .+|+.||+|+++....  .....+.+|+.+++.+   +||||+++++++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            467899999999999999999997  3688999999875421  1223566777777766   8999999999987    


Q ss_pred             -cCCceEEEEeccCCCCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEe
Q 007680          339 -NPDFKALVLEFMPNGSLEKWLYSHNY-FLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSD  416 (593)
Q Consensus       339 -~~~~~~lv~e~~~~gsL~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~D  416 (593)
                       .....++||||++ |+|.+++..... .+++..+..++.|++.||+|||+++    |+||||||+||+++.++.+||+|
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g----i~H~dlkp~Nili~~~~~~kl~D  163 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR----VVHRDLKPQNILVTSSGQIKLAD  163 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT----CCCCCCCGGGEEECTTCCEEECS
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC----ceeccCCHHHeEEcCCCCEEEec
Confidence             5567899999997 699999987543 5899999999999999999999654    99999999999999999999999


Q ss_pred             eccceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHh-cCC
Q 007680          417 FGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKES-LPH  495 (593)
Q Consensus       417 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~-~~~  495 (593)
                      ||.+.......   ......+++.|+|||++.+..++.++||||||+++|+|++|+.||....... ......... .+.
T Consensus       164 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~~~~  239 (326)
T 1blx_A          164 FGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILDVIGLPG  239 (326)
T ss_dssp             CCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCC
T ss_pred             CcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHHHcCCCC
Confidence            99998654322   2234568999999999999999999999999999999999999997643211 111111110 000


Q ss_pred             c--hhhhhh---hhhh--hhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          496 G--LTEVVD---ANLV--REEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       496 ~--~~~~~~---~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      .  +.....   ....  ...........++..+.+++.+||+.||++|||+.|+++|
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  297 (326)
T 1blx_A          240 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  297 (326)
T ss_dssp             GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             cccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            0  000000   0000  0000001112346688999999999999999999999975

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=4.7e-39  Score=332.61  Aligned_cols=263  Identities=21%  Similarity=0.277  Sum_probs=201.1

Q ss_pred             hhccccccccCccCcccEEEEEeC-CC-CeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCC------cceeeeeeecCCc
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DG-TDVAIKVFNLQLERAFRSFDSECEVLRNVRHRN------LIKILSSYSNPDF  342 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~  342 (593)
                      .++|++.+.||+|+||.||+|... ++ +.||+|+++... ...+.+.+|+.++++++|++      ++.+++++...+.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~   96 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH   96 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence            468999999999999999999975 44 689999997543 34567888999999997655      8999999999999


Q ss_pred             eEEEEeccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeee---------------
Q 007680          343 KALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILL---------------  406 (593)
Q Consensus       343 ~~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll---------------  406 (593)
                      .++||||+ ++++.+++.... ..+++.++..++.|++.||+|||++    +|+||||||+||++               
T Consensus        97 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~----~ivH~Dlkp~NIll~~~~~~~~~~~~~~~  171 (355)
T 2eu9_A           97 MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN----QLTHTDLKPENILFVNSEFETLYNEHKSC  171 (355)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred             EEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEEecccccccccccccc
Confidence            99999999 667777776654 3699999999999999999999954    59999999999999               


Q ss_pred             ----CCCCcEEEEeeccceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCcccccc
Q 007680          407 ----DENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGE  482 (593)
Q Consensus       407 ----~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~  482 (593)
                          +.++.+||+|||+++......     ....||+.|+|||++.+..++.++|||||||++|||++|+.||......+
T Consensus       172 ~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~  246 (355)
T 2eu9_A          172 EEKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE  246 (355)
T ss_dssp             CEEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             cccccCCCcEEEeecCccccccccc-----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence                567899999999998754322     33568999999999999999999999999999999999999997643221


Q ss_pred             chHHHHHHHh---cCCchhhhh-----------------------hhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCC
Q 007680          483 MSLRRWVKES---LPHGLTEVV-----------------------DANLVREEQAFSAKMDCILSIMDFALDCCMESPDM  536 (593)
Q Consensus       483 ~~~~~~~~~~---~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~  536 (593)
                        ....+...   .+.......                       .................+.++.+++.+||+.||++
T Consensus       247 --~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~  324 (355)
T 2eu9_A          247 --HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQ  324 (355)
T ss_dssp             --HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred             --HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhh
Confidence              11111111   111100000                       00000000000111234568899999999999999


Q ss_pred             CCCHHHHHHH
Q 007680          537 RINMTDAAAK  546 (593)
Q Consensus       537 RPs~~evl~~  546 (593)
                      |||+.|+++|
T Consensus       325 Rpt~~e~l~h  334 (355)
T 2eu9_A          325 RITLAEALLH  334 (355)
T ss_dssp             SCCHHHHTTS
T ss_pred             CcCHHHHhcC
Confidence            9999999976

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=4e-39  Score=335.80  Aligned_cols=265  Identities=19%  Similarity=0.228  Sum_probs=200.2

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcC-----------CCCcceeeeeee
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNVR-----------HRNLIKILSSYS  338 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~  338 (593)
                      .++|++.+.||+|+||.||+|+.. +++.||||++.... ...+.+.+|+.++++++           ||||+++++++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            468999999999999999999964 78999999997543 33466788999999886           899999999987


Q ss_pred             cCC----ceEEEEeccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeC------
Q 007680          339 NPD----FKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLD------  407 (593)
Q Consensus       339 ~~~----~~~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~------  407 (593)
                      ..+    ..++||||+ +++|.+++.... ..+++..+..++.||+.||+|||++   .+|+||||||+||+++      
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~~ivH~Dikp~NIll~~~~~~~  172 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR---CGIIHTDIKPENVLMEIVDSPE  172 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT---TCEECSCCSGGGEEEEEEETTT
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhc---CCEEecCCChHHeEEeccCCCc
Confidence            654    789999999 889999998743 3589999999999999999999964   1499999999999994      


Q ss_pred             CCCcEEEEeeccceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCcccccc-----
Q 007680          408 ENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGE-----  482 (593)
Q Consensus       408 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~-----  482 (593)
                      ..+.+||+|||++......     .....+|+.|+|||++.+..++.++|||||||++|||++|+.||.......     
T Consensus       173 ~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~  247 (373)
T 1q8y_A          173 NLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD  247 (373)
T ss_dssp             TEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred             CcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence            4458999999999876532     233468999999999999999999999999999999999999997642211     


Q ss_pred             chHHHHHHHhcCCchhhhhhh-hh-----------------------hhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCC
Q 007680          483 MSLRRWVKESLPHGLTEVVDA-NL-----------------------VREEQAFSAKMDCILSIMDFALDCCMESPDMRI  538 (593)
Q Consensus       483 ~~~~~~~~~~~~~~~~~~~~~-~~-----------------------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP  538 (593)
                      ....... ............. ..                       ............++.++.+|+.+||+.||++||
T Consensus       248 ~~~~~~~-~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp  326 (373)
T 1q8y_A          248 DHIAQII-ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA  326 (373)
T ss_dssp             HHHHHHH-HHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred             HHHHHHH-HhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence            1111111 1100000000000 00                       000001112245678899999999999999999


Q ss_pred             CHHHHHHH
Q 007680          539 NMTDAAAK  546 (593)
Q Consensus       539 s~~evl~~  546 (593)
                      |+.|+++|
T Consensus       327 t~~ell~h  334 (373)
T 1q8y_A          327 DAGGLVNH  334 (373)
T ss_dssp             CHHHHHTC
T ss_pred             CHHHHhhC
Confidence            99999986

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=6.1e-40  Score=334.87  Aligned_cols=243  Identities=23%  Similarity=0.259  Sum_probs=200.5

Q ss_pred             HhhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHH------HHHHHHHHHHHHhhcC--CCCcceeeeeeec
Q 007680          269 RATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLER------AFRSFDSECEVLRNVR--HRNLIKILSSYSN  339 (593)
Q Consensus       269 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~niv~l~~~~~~  339 (593)
                      ...++|++.+.||+|+||.||+|+.. +++.||||+++.....      ..+.+.+|+.++++++  ||||+++++++..
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~  119 (320)
T 3a99_A           40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER  119 (320)
T ss_dssp             CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred             CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence            34678999999999999999999864 7899999999765321      2245678999999996  5999999999999


Q ss_pred             CCceEEEEeccCC-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeC-CCCcEEEEee
Q 007680          340 PDFKALVLEFMPN-GSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLD-ENMVAHVSDF  417 (593)
Q Consensus       340 ~~~~~lv~e~~~~-gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~-~~~~~kL~Df  417 (593)
                      ++..++|||++.+ ++|.+++..... +++..+..++.|++.||+|||+++    |+||||||+||+++ +++.+||+||
T Consensus       120 ~~~~~lv~e~~~~~~~L~~~l~~~~~-l~~~~~~~i~~qi~~~L~~LH~~~----ivH~Dlkp~NIll~~~~~~~kL~Df  194 (320)
T 3a99_A          120 PDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCHNCG----VLHRDIKDENILIDLNRGELKLIDF  194 (320)
T ss_dssp             SSEEEEEEECCSSEEEHHHHHHHHCS-CCHHHHHHHHHHHHHHHHHHHHTT----EECCCCSGGGEEEETTTTEEEECCC
T ss_pred             CCcEEEEEEcCCCCccHHHHHhccCC-CCHHHHHHHHHHHHHHHHHHHHCC----cEeCCCCHHHEEEeCCCCCEEEeeC
Confidence            9999999999976 899999987554 899999999999999999999654    99999999999999 7899999999


Q ss_pred             ccceecCCCCCccccccccCCccccCccccCCCCC-CccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCc
Q 007680          418 GIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIV-SAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHG  496 (593)
Q Consensus       418 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  496 (593)
                      |++.......    .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||....       ......    
T Consensus       195 g~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-------~~~~~~----  259 (320)
T 3a99_A          195 GSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------EIIRGQ----  259 (320)
T ss_dssp             TTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------HHHHCC----
T ss_pred             cccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-------hhhccc----
Confidence            9998765432    233468999999999877665 788999999999999999999996521       001000    


Q ss_pred             hhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          497 LTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       497 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                              .       .....++.++.+++.+||+.||++|||+.|++++
T Consensus       260 --------~-------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  294 (320)
T 3a99_A          260 --------V-------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH  294 (320)
T ss_dssp             --------C-------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             --------c-------cccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                    0       0011235678999999999999999999999875

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=3.2e-39  Score=343.31  Aligned_cols=251  Identities=24%  Similarity=0.295  Sum_probs=187.8

Q ss_pred             ccccccccCccCcccEEEEEeCCCCeEEEEEeehhhHHHHHHHHHHHHHHhhc-CCCCcceeeeeeecCCceEEEEeccC
Q 007680          273 EFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNV-RHRNLIKILSSYSNPDFKALVLEFMP  351 (593)
Q Consensus       273 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~  351 (593)
                      .|...+.||+|+||+||.+...+|+.||||++....   .+.+.+|+.+++++ +||||+++++++.+.+..++||||++
T Consensus        16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~   92 (434)
T 2rio_A           16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN   92 (434)
T ss_dssp             CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred             eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence            455668899999999987766689999999987653   34578899999887 89999999999999999999999995


Q ss_pred             CCCHHHHHhhCCCC------CCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCC-------------CcE
Q 007680          352 NGSLEKWLYSHNYF------LDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDEN-------------MVA  412 (593)
Q Consensus       352 ~gsL~~~l~~~~~~------l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~-------------~~~  412 (593)
                       |+|.+++......      .++..+..++.||+.||+|||+++    |+||||||+||+++.+             +.+
T Consensus        93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~----ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~  167 (434)
T 2rio_A           93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK----IIHRDLKPQNILVSTSSRFTADQQTGAENLRI  167 (434)
T ss_dssp             -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT----EECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred             -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC----ccccCCChHhEEEecCcccccccccCCCceEE
Confidence             6999999875431      123345789999999999999654    9999999999999754             489


Q ss_pred             EEEeeccceecCCCCCcc--ccccccCCccccCccccCC-------CCCCccchHHHHHHHHHHHHh-CCCCCCcccccc
Q 007680          413 HVSDFGIYKLLGEGEDSV--RQTMTMATIGYMAPEYGLE-------GIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGE  482 (593)
Q Consensus       413 kL~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~  482 (593)
                      ||+|||+++.........  ......||+.|+|||++.+       ..++.++|||||||++|||+| |+.||.......
T Consensus       168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~  247 (434)
T 2rio_A          168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE  247 (434)
T ss_dssp             EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred             EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence            999999999876543221  1234579999999999865       568999999999999999999 999997643221


Q ss_pred             chHHHHHHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          483 MSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       483 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                         ...........            .........++.++.+++.+||+.||++|||+.|+++|
T Consensus       248 ---~~i~~~~~~~~------------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  296 (434)
T 2rio_A          248 ---SNIIRGIFSLD------------EMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH  296 (434)
T ss_dssp             ---HHHHHTCCCCC------------CCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ---HHHhcCCCCcc------------cccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence               11111111000            00001112456788999999999999999999999874

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.8e-40  Score=332.70  Aligned_cols=245  Identities=24%  Similarity=0.286  Sum_probs=192.3

Q ss_pred             HHHhhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhH------HHHHHHHHHHHHHhhc----CCCCcceeee
Q 007680          267 IQRATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLE------RAFRSFDSECEVLRNV----RHRNLIKILS  335 (593)
Q Consensus       267 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l----~h~niv~l~~  335 (593)
                      .....++|++.+.||+|+||.||+|+.. +++.||+|+++....      .....+.+|+.++.++    +||||+++++
T Consensus        26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~  105 (312)
T 2iwi_A           26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD  105 (312)
T ss_dssp             -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred             hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence            3445678999999999999999999864 789999999975431      1223456799999998    8999999999


Q ss_pred             eeecCCceEEEEec-cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeC-CCCcEE
Q 007680          336 SYSNPDFKALVLEF-MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLD-ENMVAH  413 (593)
Q Consensus       336 ~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~-~~~~~k  413 (593)
                      ++...+..++|||+ +.+++|.+++..... +++..+..++.|++.||+|||+++    |+||||||+||+++ .++.+|
T Consensus       106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~-~~~~~~~~~~~qi~~~l~~lH~~~----i~H~dlkp~Nil~~~~~~~~k  180 (312)
T 2iwi_A          106 WFETQEGFMLVLERPLPAQDLFDYITEKGP-LGEGPSRCFFGQVVAAIQHCHSRG----VVHRDIKDENILIDLRRGCAK  180 (312)
T ss_dssp             EC-----CEEEEECCSSEEEHHHHHHHHCS-CCHHHHHHHHHHHHHHHHHHHHHT----EECCCCSGGGEEEETTTTEEE
T ss_pred             EEecCCeEEEEEEecCCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCC----eeecCCChhhEEEeCCCCeEE
Confidence            99999999999999 789999999987654 899999999999999999999765    99999999999999 889999


Q ss_pred             EEeeccceecCCCCCccccccccCCccccCccccCCCCC-CccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHh
Q 007680          414 VSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIV-SAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKES  492 (593)
Q Consensus       414 L~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~  492 (593)
                      |+|||++.......    .....|+..|+|||++.+..+ +.++||||||+++|||++|+.||....       ....  
T Consensus       181 l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-------~~~~--  247 (312)
T 2iwi_A          181 LIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-------EILE--  247 (312)
T ss_dssp             ECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------HHHH--
T ss_pred             EEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-------HHhh--
Confidence            99999998765432    233568999999998877665 458999999999999999999997521       0000  


Q ss_pred             cCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          493 LPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       493 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                                ...       .....++.++.+++.+||+.||++|||+.|++++
T Consensus       248 ----------~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  284 (312)
T 2iwi_A          248 ----------AEL-------HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD  284 (312)
T ss_dssp             ----------TCC-------CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             ----------hcc-------CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                      000       0011235578999999999999999999999985

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=5.4e-39  Score=332.49  Aligned_cols=262  Identities=21%  Similarity=0.272  Sum_probs=197.4

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehh--hHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCc-----
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQ--LERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDF-----  342 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  342 (593)
                      .++|.+.+.||+|+||.||+|.+. +|+.||||++...  .....+.+.+|+.++++++||||+++++++...+.     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            467999999999999999999975 7899999999653  23445678899999999999999999999987654     


Q ss_pred             -eEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccce
Q 007680          343 -KALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYK  421 (593)
Q Consensus       343 -~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~  421 (593)
                       .++||||++ ++|.+++..   .+++.++..++.|++.||+|||+++    |+||||||+||+++.++.+||+|||++.
T Consensus       103 ~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~LH~~~----ivH~dlkp~NIl~~~~~~~kl~Dfg~~~  174 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMGL---KFSEEKIQYLVYQMLKGLKYIHSAG----VVHRDLKPGNLAVNEDCELKILDFGLAR  174 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTTS---CCCHHHHHHHHHHHHHHHHHHHHTT----CCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred             eEEEEecccc-CCHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC----cccCCCCHHHEeECCCCcEEEeeccccc
Confidence             499999996 588887643   3899999999999999999999655    9999999999999999999999999987


Q ss_pred             ecCCCCCccccccccCCccccCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHh-cCC-chh
Q 007680          422 LLGEGEDSVRQTMTMATIGYMAPEYGLE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKES-LPH-GLT  498 (593)
Q Consensus       422 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~-~~~-~~~  498 (593)
                      .....     .....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+ .+....... .+. ...
T Consensus       175 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~  248 (353)
T 3coi_A          175 HADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKVTGVPGTEFV  248 (353)
T ss_dssp             C-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH-HHHHHHHHHCBCCHHHH
T ss_pred             CCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHH
Confidence            65432     233468999999998876 678999999999999999999999997643211 111111100 000 000


Q ss_pred             hhhhhh--------hhhh-hhh-hhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          499 EVVDAN--------LVRE-EQA-FSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       499 ~~~~~~--------~~~~-~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      ..+...        +... ... ......+++++.+++.+||+.||++|||+.|+++|
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  306 (353)
T 3coi_A          249 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  306 (353)
T ss_dssp             TTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            000000        0000 000 00112346789999999999999999999999986

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=2.1e-39  Score=331.86  Aligned_cols=255  Identities=22%  Similarity=0.270  Sum_probs=179.2

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh-HHHHHHHHHHHH-HHhhcCCCCcceeeeeeecCCceEEEE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL-ERAFRSFDSECE-VLRNVRHRNLIKILSSYSNPDFKALVL  347 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~  347 (593)
                      .++|++.+.||+|+||.||+|... +|+.||||+++... ......+..|+. +++.++||||+++++++...+..++||
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~  100 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM  100 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence            478999999999999999999975 78999999997642 233345555655 777789999999999999999999999


Q ss_pred             eccCCCCHHHHHhh----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceec
Q 007680          348 EFMPNGSLEKWLYS----HNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLL  423 (593)
Q Consensus       348 e~~~~gsL~~~l~~----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~  423 (593)
                      ||+++ +|.+++..    ....+++..+..++.|++.||.|||++   .+|+||||||+||+++.++.+||+|||++...
T Consensus       101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~  176 (327)
T 3aln_A          101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN---LKIIHRDIKPSNILLDRSGNIKLCDFGISGQL  176 (327)
T ss_dssp             CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH---HSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred             eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc---CCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence            99975 88887763    234589999999999999999999975   14999999999999999999999999999876


Q ss_pred             CCCCCccccccccCCccccCcccc----CCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhh
Q 007680          424 GEGEDSVRQTMTMATIGYMAPEYG----LEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTE  499 (593)
Q Consensus       424 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  499 (593)
                      ....   ......||+.|+|||++    .+..++.++||||||+++|+|++|+.||........    ...        .
T Consensus       177 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~~~--------~  241 (327)
T 3aln_A          177 VDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD----QLT--------Q  241 (327)
T ss_dssp             --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-----------C--------C
T ss_pred             cccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH----HHH--------H
Confidence            4332   12334689999999998    456789999999999999999999999976321100    000        0


Q ss_pred             hhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          500 VVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       500 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      ........  ........+++++.+++.+||+.||++|||+.|++++
T Consensus       242 ~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  286 (327)
T 3aln_A          242 VVKGDPPQ--LSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH  286 (327)
T ss_dssp             CCCSCCCC--CCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             HhcCCCCC--CCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence            00000000  0000011245678999999999999999999999886

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=5.2e-39  Score=330.22  Aligned_cols=252  Identities=21%  Similarity=0.251  Sum_probs=174.4

Q ss_pred             hhcccccc-ccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec----CCceE
Q 007680          271 TDEFNECN-LLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSN----PDFKA  344 (593)
Q Consensus       271 ~~~~~~~~-~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~  344 (593)
                      .++|.+.+ .||+|+||.||+|.+. +|+.||+|++.....    ...+....++.++||||+++++++..    ....+
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~  102 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK----ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL  102 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH----HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH----HHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence            67899865 6999999999999976 799999999975422    11222334566799999999999876    44589


Q ss_pred             EEEeccCCCCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC---CCcEEEEeeccc
Q 007680          345 LVLEFMPNGSLEKWLYSHNY-FLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDE---NMVAHVSDFGIY  420 (593)
Q Consensus       345 lv~e~~~~gsL~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~---~~~~kL~Dfg~a  420 (593)
                      +||||+++|+|.+++..... .+++.++..++.|++.||+|||+++    |+||||||+||+++.   ++.+||+|||++
T Consensus       103 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~----ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~  178 (336)
T 3fhr_A          103 IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN----IAHRDVKPENLLYTSKEKDAVLKLTDFGFA  178 (336)
T ss_dssp             EEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT----EECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC----eecCCCCHHHEEEEecCCCceEEEeccccc
Confidence            99999999999999987643 6999999999999999999999655    999999999999986   456999999999


Q ss_pred             eecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhh
Q 007680          421 KLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEV  500 (593)
Q Consensus       421 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  500 (593)
                      .......    .....+|+.|+|||++.+..++.++||||||+++|+|++|+.||..........  ......       
T Consensus       179 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~--~~~~~~-------  245 (336)
T 3fhr_A          179 KETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP--GMKRRI-------  245 (336)
T ss_dssp             EEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------
T ss_pred             eeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh--hHHHhh-------
Confidence            8754322    233568999999999988889999999999999999999999997643221100  000000       


Q ss_pred             hhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          501 VDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       501 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      .....   ....+....++.++.+++.+||+.||++|||+.|+++|
T Consensus       246 ~~~~~---~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  288 (336)
T 3fhr_A          246 RLGQY---GFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH  288 (336)
T ss_dssp             --------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             hcccc---ccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            00000   00001112346688999999999999999999999986

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.3e-39  Score=340.86  Aligned_cols=251  Identities=22%  Similarity=0.322  Sum_probs=189.6

Q ss_pred             hhccccccccCccCcccEEEEEeCCCCeEEEEEeehhhHHHHHHHHHHHHHHhhc-CCCCcceeeeeeecCCceEEEEec
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNV-RHRNLIKILSSYSNPDFKALVLEF  349 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~  349 (593)
                      ..+|++.+.||+|+||+||.....+|+.||||++.....   ..+.+|+++++++ +||||+++++++.+.+..++||||
T Consensus        23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~   99 (432)
T 3p23_A           23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL   99 (432)
T ss_dssp             TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence            457899999999999997665566799999999975432   2356799999999 799999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC-----CCcEEEEeeccceecC
Q 007680          350 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDE-----NMVAHVSDFGIYKLLG  424 (593)
Q Consensus       350 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~-----~~~~kL~Dfg~a~~~~  424 (593)
                      ++ |+|.+++..........++..++.||+.||+|||+++    |+||||||+||+++.     ...+||+|||+++...
T Consensus       100 ~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~----ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~  174 (432)
T 3p23_A          100 CA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN----IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA  174 (432)
T ss_dssp             CS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTT----CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred             CC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCc----CEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence            95 6999999877655666677899999999999999654    999999999999953     3368899999998775


Q ss_pred             CCCCc-cccccccCCccccCccccC---CCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhh
Q 007680          425 EGEDS-VRQTMTMATIGYMAPEYGL---EGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTE  499 (593)
Q Consensus       425 ~~~~~-~~~~~~~gt~~y~aPE~~~---~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  499 (593)
                      ..... .......||+.|+|||++.   ...++.++|||||||++|||++ |..||.......   .........   ..
T Consensus       175 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~---~~~~~~~~~---~~  248 (432)
T 3p23_A          175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ---ANILLGACS---LD  248 (432)
T ss_dssp             -----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH---HHHHTTCCC---CT
T ss_pred             CCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH---HHHHhccCC---cc
Confidence            43321 1234457999999999987   4567889999999999999999 999996532111   111000000   00


Q ss_pred             hhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          500 VVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       500 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                                 ........+..+.+++.+||+.||++|||+.|+++|
T Consensus       249 -----------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h  284 (432)
T 3p23_A          249 -----------CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH  284 (432)
T ss_dssp             -----------TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             -----------ccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence                       000111234567899999999999999999999964

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.2e-38  Score=349.14  Aligned_cols=263  Identities=24%  Similarity=0.287  Sum_probs=197.7

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehh-hHHHHHHHHHHHHHHhhcCCCCcceeeeeeec------CCc
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQ-LERAFRSFDSECEVLRNVRHRNLIKILSSYSN------PDF  342 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~  342 (593)
                      .++|++.+.||+|+||.||+|.+. +|+.||||+++.. .....+.+.+|++++++++||||+++++++..      .+.
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            478999999999999999999974 6899999998754 34456778999999999999999999998765      667


Q ss_pred             eEEEEeccCCCCHHHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCc---EEEEee
Q 007680          343 KALVLEFMPNGSLEKWLYSHNY--FLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMV---AHVSDF  417 (593)
Q Consensus       343 ~~lv~e~~~~gsL~~~l~~~~~--~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~---~kL~Df  417 (593)
                      .++||||+++|+|.+++.....  .+++..+..++.|++.||+|||+++    |+||||||+||+++.++.   +||+||
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g----IVHrDLKP~NILl~~~g~~~~vKL~DF  168 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR----IIHRDLKPENIVLQPGPQRLIHKIIDL  168 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT----BCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred             EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC----CccCCCCHHHeEeecCCCceeEEEccc
Confidence            8999999999999999987543  5889999999999999999999654    999999999999997664   999999


Q ss_pred             ccceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCc-
Q 007680          418 GIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHG-  496 (593)
Q Consensus       418 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-  496 (593)
                      |.+........   .....||+.|+|||++.+..++.++||||||+++|+|++|..||......    ..|........ 
T Consensus       169 G~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~----~~~~~~i~~~~~  241 (676)
T 3qa8_A          169 GYAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP----VQWHGKVREKSN  241 (676)
T ss_dssp             CCCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH----HHSSTTCC----
T ss_pred             ccccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch----hhhhhhhhcccc
Confidence            99987654332   23457899999999999999999999999999999999999999653111    11100000000 


Q ss_pred             ----hhhhhhhhhhhh---hhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHH
Q 007680          497 ----LTEVVDANLVRE---EQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAA  544 (593)
Q Consensus       497 ----~~~~~~~~~~~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl  544 (593)
                          ..+.........   .........++..+.+++.+||..||++|||+.|++
T Consensus       242 ~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL  296 (676)
T 3qa8_A          242 EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP  296 (676)
T ss_dssp             --CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCC
T ss_pred             hhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHh
Confidence                000000000000   000011223567899999999999999999998854

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.4e-37  Score=312.12  Aligned_cols=234  Identities=11%  Similarity=0.070  Sum_probs=186.2

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALV  346 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  346 (593)
                      .++|++.+.||+|+||.||+|++. +++.||+|+++...   ....+.+.+|+.++.+++||||+++++++.+.+..|+|
T Consensus        30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  109 (286)
T 3uqc_A           30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV  109 (286)
T ss_dssp             TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence            367999999999999999999976 58999999997652   34457889999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCC
Q 007680          347 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG  426 (593)
Q Consensus       347 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  426 (593)
                      |||++|++|.+++...   ....++..++.|++.||+|||+++    |+||||||+||+++.++.+||+++|        
T Consensus       110 ~e~~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~lH~~g----ivH~Dikp~NIll~~~g~~kl~~~~--------  174 (286)
T 3uqc_A          110 AEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAHRAG----VALSIDHPSRVRVSIDGDVVLAYPA--------  174 (286)
T ss_dssp             EECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT----CCCCCCSGGGEEEETTSCEEECSCC--------
T ss_pred             EEecCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHHHHCC----CccCCCCcccEEEcCCCCEEEEecc--------
Confidence            9999999999999543   466678999999999999999655    9999999999999999999998543        


Q ss_pred             CCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhh
Q 007680          427 EDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLV  506 (593)
Q Consensus       427 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  506 (593)
                                    |++       .++.++|||||||++|||+||+.||..........          .....+.... 
T Consensus       175 --------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~----------~~~~~~~~~~-  222 (286)
T 3uqc_A          175 --------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA----------PAERDTAGQP-  222 (286)
T ss_dssp             --------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE----------ECCBCTTSCB-
T ss_pred             --------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH----------HHHHHhccCC-
Confidence                          233       36889999999999999999999997642211000          0000000000 


Q ss_pred             hhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhhh
Q 007680          507 REEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKF  554 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  554 (593)
                        .........+++++.+++.+||+.||++| |+.|+++.|+++....
T Consensus       223 --~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~  267 (286)
T 3uqc_A          223 --IEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA  267 (286)
T ss_dssp             --CCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred             --CChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence              00001112356789999999999999999 9999999999987654

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.4e-37  Score=349.25  Aligned_cols=241  Identities=20%  Similarity=0.276  Sum_probs=194.8

Q ss_pred             hhccccccccCccCcccEEEEEeC--CCCeEEEEEeehh-hHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCc-----
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS--DGTDVAIKVFNLQ-LERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDF-----  342 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  342 (593)
                      .++|++.+.||+|+||.||+|.+.  +|+.||||++... .......+.+|++++++++||||+++++++...+.     
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            478999999999999999999975  6899999998643 23455678899999999999999999999987665     


Q ss_pred             eEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeecccee
Q 007680          343 KALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKL  422 (593)
Q Consensus       343 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~  422 (593)
                      .|+||||+++++|.+++..   .+++.++..++.||+.||+|||+++    |+||||||+||+++.+ .+||+|||+++.
T Consensus       159 ~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~g----iiHrDlkp~NIll~~~-~~kl~DFG~a~~  230 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSIG----LVYNDLKPENIMLTEE-QLKLIDLGAVSR  230 (681)
T ss_dssp             EEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHTT----EECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred             eEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCC----CeecccChHHeEEeCC-cEEEEecccchh
Confidence            7999999999999998765   4999999999999999999999654    9999999999999986 899999999987


Q ss_pred             cCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhh
Q 007680          423 LGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVD  502 (593)
Q Consensus       423 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  502 (593)
                      ....      ....||+.|+|||++.+.. +.++|||||||++|+|++|..||........          +.       
T Consensus       231 ~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~----------~~-------  286 (681)
T 2pzi_A          231 INSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL----------PE-------  286 (681)
T ss_dssp             TTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC----------CT-------
T ss_pred             cccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc----------cc-------
Confidence            6433      3356899999999886654 8999999999999999999998865321110          00       


Q ss_pred             hhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCC-HHHHHHHHHHhhh
Q 007680          503 ANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRIN-MTDAAAKLKKIKV  552 (593)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~L~~i~~  552 (593)
                               .......++.+.+++.+||+.||++||+ ++++...|..+..
T Consensus       287 ---------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~  328 (681)
T 2pzi_A          287 ---------DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR  328 (681)
T ss_dssp             ---------TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred             ---------cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence                     0011123457899999999999999995 5666666766543

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=6.1e-37  Score=309.53  Aligned_cols=231  Identities=20%  Similarity=0.289  Sum_probs=180.5

Q ss_pred             hhccccc-cccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHH-hhcCCCCcceeeeeeec----CCce
Q 007680          271 TDEFNEC-NLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVL-RNVRHRNLIKILSSYSN----PDFK  343 (593)
Q Consensus       271 ~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~~~  343 (593)
                      .++|.+. +.||+|+||.||+|... +++.||+|+++..     ..+.+|+.++ +..+||||+++++++..    ....
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   90 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   90 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence            4678777 78999999999999974 7899999999743     3566788888 55589999999999876    6678


Q ss_pred             EEEEeccCCCCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC---CCcEEEEeecc
Q 007680          344 ALVLEFMPNGSLEKWLYSHNY-FLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDE---NMVAHVSDFGI  419 (593)
Q Consensus       344 ~lv~e~~~~gsL~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~---~~~~kL~Dfg~  419 (593)
                      ++||||+++++|.+++..... .+++.++..++.|++.||+|||+++    |+||||||+||+++.   ++.+||+|||+
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~----i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~  166 (299)
T 3m2w_A           91 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN----IAHRDVKPENLLYTSKRPNAILKLTDFGF  166 (299)
T ss_dssp             EEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT----EECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred             EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC----cccCCCCHHHEEEecCCCCCcEEEecccc
Confidence            999999999999999987653 6999999999999999999999654    999999999999998   78999999998


Q ss_pred             ceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhh
Q 007680          420 YKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTE  499 (593)
Q Consensus       420 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  499 (593)
                      +....                        +..++.++|||||||++|||++|+.||........      ......   .
T Consensus       167 a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~------~~~~~~---~  213 (299)
T 3m2w_A          167 AKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI------SPGMKT---R  213 (299)
T ss_dssp             CEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------------CCSCC---S
T ss_pred             ccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh------hHHHHH---H
Confidence            86432                        24567899999999999999999999976321110      000000   0


Q ss_pred             hhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          500 VVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       500 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      ......   .........+++++.+++.+||+.||++|||+.|+++|
T Consensus       214 ~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h  257 (299)
T 3m2w_A          214 IRMGQY---EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  257 (299)
T ss_dssp             SCTTCC---SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             Hhhccc---cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence            000000   00011112356789999999999999999999999986

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.4e-37  Score=328.47  Aligned_cols=247  Identities=15%  Similarity=0.152  Sum_probs=184.7

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhcCC-CCcceee-----------
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNVRH-RNLIKIL-----------  334 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h-~niv~l~-----------  334 (593)
                      ...|...+.||+|+||.||+|++. +|+.||||+++...   ....+.+.+|+.+++.++| +|.....           
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence            456888899999999999999964 79999999987432   2335778999999999977 3221111           


Q ss_pred             ----------eeeec-----CCceEEEEeccCCCCHHHHHh------hCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCC
Q 007680          335 ----------SSYSN-----PDFKALVLEFMPNGSLEKWLY------SHNYFLDILERLNIMIDVGSALEYLHNGHSSVH  393 (593)
Q Consensus       335 ----------~~~~~-----~~~~~lv~e~~~~gsL~~~l~------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~  393 (593)
                                .++..     ....+++|+++ +++|.+++.      .....+++..+..++.|+++||+|||+++    
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~----  231 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG----  231 (413)
T ss_dssp             EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT----
T ss_pred             cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC----
Confidence                      11111     12456777766 689999884      22335788899999999999999999654    


Q ss_pred             eEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCccccccccCCccccCcccc----------CCCCCCccchHHHHHH
Q 007680          394 IIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYG----------LEGIVSAKCDVYSYGV  463 (593)
Q Consensus       394 ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~s~~~DvwSlGv  463 (593)
                      |+||||||+|||++.++.+||+|||+++.....     .....| +.|+|||++          .+..++.++|||||||
T Consensus       232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGv  305 (413)
T 3dzo_A          232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGL  305 (413)
T ss_dssp             EECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHH
T ss_pred             cccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHH
Confidence            999999999999999999999999998875432     233457 999999998          5566899999999999


Q ss_pred             HHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHH
Q 007680          464 LLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDA  543 (593)
Q Consensus       464 vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev  543 (593)
                      ++|||++|+.||......+.             ....+.           ....+++++.+++.+||+.||++||++.|+
T Consensus       306 il~elltg~~Pf~~~~~~~~-------------~~~~~~-----------~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~  361 (413)
T 3dzo_A          306 AIYWIWCADLPNTDDAALGG-------------SEWIFR-----------SCKNIPQPVRALLEGFLRYPKEDRLLPLQA  361 (413)
T ss_dssp             HHHHHHHSSCCCCTTGGGSC-------------SGGGGS-----------SCCCCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHHHHHHCCCCCCCcchhhh-------------HHHHHh-----------hcccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence            99999999999976321110             000000           011235678999999999999999999888


Q ss_pred             HHH--HHHhhh
Q 007680          544 AAK--LKKIKV  552 (593)
Q Consensus       544 l~~--L~~i~~  552 (593)
                      +++  ++++..
T Consensus       362 l~~~~~~~~~~  372 (413)
T 3dzo_A          362 METPEYEQLRT  372 (413)
T ss_dssp             TTSHHHHHHHH
T ss_pred             HhCHHHHHHHH
Confidence            765  444443

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=8.1e-38  Score=321.40  Aligned_cols=244  Identities=18%  Similarity=0.248  Sum_probs=185.3

Q ss_pred             hhccccccccCccCcccEEEEEeCCCCeEEEEEeehhh--------HHHHHHHHHHHHHHhhcC---------CCCccee
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQL--------ERAFRSFDSECEVLRNVR---------HRNLIKI  333 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------h~niv~l  333 (593)
                      .++|++.+.||+|+||.||+|++ +|+.||||+++...        ....+.+.+|+.+++.++         ||||+++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            57899999999999999999998 68999999998652        123367888999998886         6666655


Q ss_pred             eee-----------------eec-------------CCceEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHH
Q 007680          334 LSS-----------------YSN-------------PDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALE  383 (593)
Q Consensus       334 ~~~-----------------~~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~  383 (593)
                      .+.                 +.+             .+..++||||+++|++.+.+.+  ..+++.++..++.||+.||+
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL~  175 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASLA  175 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHHH
Confidence            554                 333             6789999999999977666644  34899999999999999999


Q ss_pred             HHH-hcCCCCCeEecCCCCCCeeeCCCC--------------------cEEEEeeccceecCCCCCccccccccCCcccc
Q 007680          384 YLH-NGHSSVHIIHCDLKPTNILLDENM--------------------VAHVSDFGIYKLLGEGEDSVRQTMTMATIGYM  442 (593)
Q Consensus       384 ~LH-~~~~~~~ivH~Dlkp~NIll~~~~--------------------~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~  442 (593)
                      ||| +++    |+||||||+|||++.++                    .+||+|||+|+.....       ...||+.|+
T Consensus       176 ~lH~~~~----ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y~  244 (336)
T 2vuw_A          176 VAEASLR----FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVSM  244 (336)
T ss_dssp             HHHHHHC----CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCTT
T ss_pred             HHHHhCC----EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeeccc
Confidence            999 766    99999999999999887                    8999999999876432       346999999


Q ss_pred             CccccCCCCCCccchHHHHHHH-HHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHH
Q 007680          443 APEYGLEGIVSAKCDVYSYGVL-LMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILS  521 (593)
Q Consensus       443 aPE~~~~~~~s~~~DvwSlGvv-l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  521 (593)
                      |||++.+.. +.++||||+|++ .+++++|..||....        |....    ...+.................++++
T Consensus       245 aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~--------~~~~~----~~~~~~~~~~~~~~~~~~~~~~s~~  311 (336)
T 2vuw_A          245 DEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVL--------WLHYL----TDKMLKQMTFKTKCNTPAMKQIKRK  311 (336)
T ss_dssp             CSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHH--------HHHHH----HHHHHHTCCCSSCCCSHHHHHHHHH
T ss_pred             ChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchh--------hhhHH----HHhhhhhhccCcccchhhhhhcCHH
Confidence            999988766 899999998777 778899999985411        10000    0000000000001111223456789


Q ss_pred             HHHHHhhcccCCCCCCCCHHHHH-HH
Q 007680          522 IMDFALDCCMESPDMRINMTDAA-AK  546 (593)
Q Consensus       522 l~~li~~cl~~dP~~RPs~~evl-~~  546 (593)
                      +.+|+.+||+.|     |++|++ +|
T Consensus       312 ~~dli~~~L~~d-----sa~e~l~~H  332 (336)
T 2vuw_A          312 IQEFHRTMLNFS-----SATDLLCQH  332 (336)
T ss_dssp             HHHHHHHGGGSS-----SHHHHHHHC
T ss_pred             HHHHHHHHhccC-----CHHHHHhcC
Confidence            999999999976     999988 54

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.96  E-value=2.7e-30  Score=282.45  Aligned_cols=185  Identities=18%  Similarity=0.075  Sum_probs=131.8

Q ss_pred             ccCccCcccEEEEE-eCCCCeEEEEEeehh----------hHHHHHHHHHHHHHHhhc-CCCCcceeeeeeecCCceEEE
Q 007680          279 LLGTSSFGSVYKGT-ISDGTDVAIKVFNLQ----------LERAFRSFDSECEVLRNV-RHRNLIKILSSYSNPDFKALV  346 (593)
Q Consensus       279 ~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  346 (593)
                      ..+.|+.|.+..++ .-.|+.+|+|++...          .+...+++.+|+++|+++ .|+||+++++++++.+..|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            46677777766665 336899999999753          234456799999999999 799999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCC
Q 007680          347 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG  426 (593)
Q Consensus       347 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  426 (593)
                      |||++|++|.+++...+. ++..   +|+.||+.||+|+|++|    |+||||||+|||++++|.+||+|||+|+.....
T Consensus       321 MEyv~G~~L~d~i~~~~~-l~~~---~I~~QIl~AL~ylH~~G----IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~  392 (569)
T 4azs_A          321 MEKLPGRLLSDMLAAGEE-IDRE---KILGSLLRSLAALEKQG----FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD  392 (569)
T ss_dssp             EECCCSEEHHHHHHTTCC-CCHH---HHHHHHHHHHHHHHHTT----CEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred             EecCCCCcHHHHHHhCCC-CCHH---HHHHHHHHHHHHHHHCC----ceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence            999999999999987654 6654   58899999999999665    999999999999999999999999999876543


Q ss_pred             CCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCC
Q 007680          427 EDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRP  474 (593)
Q Consensus       427 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~p  474 (593)
                      ..  .....+||+.|+|||++.+ .+..++|+||+|++++++.++..+
T Consensus       393 ~~--~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          393 CS--WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             -C--CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             Cc--cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence            32  2344679999999999865 467789999999998887666544

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.93  E-value=1.6e-26  Score=251.16  Aligned_cols=186  Identities=18%  Similarity=0.167  Sum_probs=146.0

Q ss_pred             ccccccCccCcccEEEEEeCCCCeEEEEEeehhh--------HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEE
Q 007680          275 NECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQL--------ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALV  346 (593)
Q Consensus       275 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  346 (593)
                      ...+.||+|+||.||+|.. .++.+++|......        ....+.+.+|++++++++||||+++..++...+..++|
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            3457899999999999965 47889999864321        12345689999999999999999666666677788999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCC
Q 007680          347 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG  426 (593)
Q Consensus       347 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  426 (593)
                      |||+++++|.+++..         +..++.|+++||+|||+++    |+||||||+||+++.  .+||+|||+++.....
T Consensus       418 mE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~g----IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~  482 (540)
T 3en9_A          418 MSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKND----VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD  482 (540)
T ss_dssp             EECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTT----EECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred             EECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCc----CccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence            999999999999876         5689999999999999655    999999999999999  9999999999987543


Q ss_pred             CCcc-----ccccccCCccccCccccCC--CCCCccchHHHHHHHHHHHHhCCCCCC
Q 007680          427 EDSV-----RQTMTMATIGYMAPEYGLE--GIVSAKCDVYSYGVLLMETFTRKRPTD  476 (593)
Q Consensus       427 ~~~~-----~~~~~~gt~~y~aPE~~~~--~~~s~~~DvwSlGvvl~elltg~~pf~  476 (593)
                      ....     ......||+.|+|||++..  ..|+..+|+||..+-..+-+.++.+|.
T Consensus       483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            2211     1134579999999999887  568888999999999998888877764

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=99.92  E-value=1.2e-25  Score=255.80  Aligned_cols=195  Identities=41%  Similarity=0.655  Sum_probs=125.0

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLL   80 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~   80 (593)
                      |+.|+|++|++++.+|..+.. +++|++|+|++|+|++.+|..|+++++|+.|+|++|++++.+|..|+.+++|+.|+|+
T Consensus       468 L~~L~L~~N~l~~~~p~~l~~-l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls  546 (768)
T 3rgz_A          468 LETLILDFNDLTGEIPSGLSN-CTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLN  546 (768)
T ss_dssp             CCEEECCSSCCCSCCCGGGGG-CTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECC
T ss_pred             ceEEEecCCcccCcCCHHHhc-CCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECC
Confidence            456666666666666666554 6666777777777666666666666777777777777766666667777777766554


Q ss_pred             cceeeccCCcccccCCC---------------------------------------------------------------
Q 007680           81 MFGIRLTGNKLYGRIPP---------------------------------------------------------------   97 (593)
Q Consensus        81 ~n~l~l~~n~l~~~~~~---------------------------------------------------------------   97 (593)
                      +|       ++.|.+|.                                                               
T Consensus       547 ~N-------~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~  619 (768)
T 3rgz_A          547 TN-------LFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRV  619 (768)
T ss_dssp             SS-------EEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCE
T ss_pred             CC-------ccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccce
Confidence            43       33322221                                                               


Q ss_pred             -----------cccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCccccCCccccccccccccccCCCCCC
Q 007680           98 -----------CLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKL  166 (593)
Q Consensus        98 -----------~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~~N~l~~~~p~~  166 (593)
                                 +..|++|+|++|+++|.+|..|+++++|+.|+|++|+++|.+|..++++++|+.|||++|+++|.+|..
T Consensus       620 ~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~  699 (768)
T 3rgz_A          620 YGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQA  699 (768)
T ss_dssp             EEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGG
T ss_pred             ecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChH
Confidence                       123566666666666666666666666666666666666666666666666666666666666666654


Q ss_pred             CCC-----------------CCCCCCccCCCcccccCCccCCCCCCCCCCCCCCCCC
Q 007680          167 EGE-----------------IPVKGSFKNFSTESFFGNYALCGPPKLRVPPCKPDNS  206 (593)
Q Consensus       167 ~~~-----------------~~~~~~~~~~~~~~~~~n~~~c~~~~~~~~~~~~~~~  206 (593)
                      +..                 +|..+.+..+...+|.||+.+||.|.   ++|.....
T Consensus       700 l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l---~~C~~~~~  753 (768)
T 3rgz_A          700 MSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPL---PRCDPSNA  753 (768)
T ss_dssp             GGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTS---CCCCSCC-
T ss_pred             HhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchhcCCCC---cCCCCCcc
Confidence            332                 34445677788889999999999863   37765444

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=99.91  E-value=1.8e-24  Score=219.57  Aligned_cols=186  Identities=27%  Similarity=0.477  Sum_probs=137.1

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCC-Cchhhhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLR-HLSVLSL   79 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~l   79 (593)
                      |++|+|++|++++.+|..+.. +++|++|+|++|+|++.+|..|.++++|+.|+|++|++++.+|..|+.++ +|++|+|
T Consensus       103 L~~L~Ls~n~l~~~~p~~~~~-l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L  181 (313)
T 1ogq_A          103 LHYLYITHTNVSGAIPDFLSQ-IKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTI  181 (313)
T ss_dssp             CSEEEEEEECCEEECCGGGGG-CTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEEC
T ss_pred             CCEEECcCCeeCCcCCHHHhC-CCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEEC
Confidence            567777777777667776664 77777777777777777777777777777777777777777777777777 7777766


Q ss_pred             hccee----------------eccCCcccccCC----CcccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCC
Q 007680           80 LMFGI----------------RLTGNKLYGRIP----PCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPI  139 (593)
Q Consensus        80 ~~n~l----------------~l~~n~l~~~~~----~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~  139 (593)
                      ++|.+                ++++|++.+.+|    .+..|++|++++|++++.+|. +..+++|++|+|++|+|++.+
T Consensus       182 ~~N~l~~~~~~~~~~l~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~  260 (313)
T 1ogq_A          182 SRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTL  260 (313)
T ss_dssp             CSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECC
T ss_pred             cCCeeeccCChHHhCCcccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcC
Confidence            65543                356666654333    334577777777777765554 777788888888888888778


Q ss_pred             CccccCCccccccccccccccCCCCCCCCCCCCCCCccCCCcccccCCccCCCCCC
Q 007680          140 PESVGSLISLESLDLSGNNLSGKIPKLEGEIPVKGSFKNFSTESFFGNYALCGPPK  195 (593)
Q Consensus       140 p~~l~~~~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~n~~~c~~~~  195 (593)
                      |..+..+++|+.|++++|+++|.+|..       ..+.++....+.+|+.+|+.|.
T Consensus       261 p~~l~~l~~L~~L~Ls~N~l~~~ip~~-------~~l~~L~~l~l~~N~~lc~~p~  309 (313)
T 1ogq_A          261 PQGLTQLKFLHSLNVSFNNLCGEIPQG-------GNLQRFDVSAYANNKCLCGSPL  309 (313)
T ss_dssp             CGGGGGCTTCCEEECCSSEEEEECCCS-------TTGGGSCGGGTCSSSEEESTTS
T ss_pred             ChHHhcCcCCCEEECcCCcccccCCCC-------ccccccChHHhcCCCCccCCCC
Confidence            888888888888888888888877664       3455666778999999999753

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.89  E-value=1.9e-23  Score=208.27  Aligned_cols=149  Identities=15%  Similarity=0.121  Sum_probs=119.0

Q ss_pred             HHhhhccccccccCccCcccEEEEEeCCCCeEEEEEeehhhH------------------HHHHHHHHHHHHHhhcCCCC
Q 007680          268 QRATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLE------------------RAFRSFDSECEVLRNVRHRN  329 (593)
Q Consensus       268 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~n  329 (593)
                      ......|++.+.||+|+||.||+|.+.+|+.||+|+++....                  .....+.+|++++++++  |
T Consensus        86 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~  163 (282)
T 1zar_A           86 VRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G  163 (282)
T ss_dssp             HHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T
T ss_pred             HhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C
Confidence            334455677799999999999999997799999999964321                  23567899999999999  4


Q ss_pred             cceeeeeeecCCceEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCC
Q 007680          330 LIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDEN  409 (593)
Q Consensus       330 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~  409 (593)
                       +++.+++.. +..++||||++|++|.+ +..       .+...++.|++.||+|||+++    |+||||||+||+++ +
T Consensus       164 -~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH~~g----iiHrDlkp~NILl~-~  228 (282)
T 1zar_A          164 -LAVPKVYAW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFYHRG----IVHGDLSQYNVLVS-E  228 (282)
T ss_dssp             -SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHHHTT----EECSCCSTTSEEEE-T
T ss_pred             -CCcCeEEec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHHHCC----CEeCCCCHHHEEEE-C
Confidence             666665543 56699999999999998 422       234579999999999999654    99999999999999 9


Q ss_pred             CcEEEEeeccceecCCCCCccccccccCCccccCccccC
Q 007680          410 MVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGL  448 (593)
Q Consensus       410 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~  448 (593)
                      +.+||+|||+++.               +..|+|||++.
T Consensus       229 ~~vkl~DFG~a~~---------------~~~~~a~e~l~  252 (282)
T 1zar_A          229 EGIWIIDFPQSVE---------------VGEEGWREILE  252 (282)
T ss_dssp             TEEEECCCTTCEE---------------TTSTTHHHHHH
T ss_pred             CcEEEEECCCCeE---------------CCCCCHHHHHH
Confidence            9999999999874               23467888764

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.88  E-value=8.2e-22  Score=195.49  Aligned_cols=178  Identities=24%  Similarity=0.245  Sum_probs=125.3

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLL   80 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~   80 (593)
                      |+.|+|++|+++ .+|...+..+++|++|+|++|+|+...+..|.++++|++|+|++|++++..+..|..+++|++|   
T Consensus        39 l~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L---  114 (270)
T 2o6q_A           39 TKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAEL---  114 (270)
T ss_dssp             CSEEECCSSCCS-CCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEE---
T ss_pred             CCEEECcCCCCC-eeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEE---
Confidence            467777777777 5665444457777777777777775555556777777777777777776666667777777777   


Q ss_pred             cceeeccCCcccccC----CCcccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCccccCCcccccccccc
Q 007680           81 MFGIRLTGNKLYGRI----PPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSG  156 (593)
Q Consensus        81 ~n~l~l~~n~l~~~~----~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~~  156 (593)
                          ++++|++++..    ..+..|++|+|++|+|++..+..|..+++|+.|+|++|++++..+..|..+++|+.|++++
T Consensus       115 ----~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~  190 (270)
T 2o6q_A          115 ----RLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDN  190 (270)
T ss_dssp             ----ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCS
T ss_pred             ----ECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCC
Confidence                66667666432    3344588888888888765566677888888888888888866666677888888888888


Q ss_pred             ccccCCCCCCCCCCCCCCCccCCCcccccCCccCCC
Q 007680          157 NNLSGKIPKLEGEIPVKGSFKNFSTESFFGNYALCG  192 (593)
Q Consensus       157 N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~n~~~c~  192 (593)
                      |++++.++..+..++      .+....+.+|++.|.
T Consensus       191 N~l~~~~~~~~~~l~------~L~~L~l~~N~~~c~  220 (270)
T 2o6q_A          191 NQLKRVPEGAFDSLE------KLKMLQLQENPWDCT  220 (270)
T ss_dssp             SCCSCCCTTTTTTCT------TCCEEECCSSCBCCS
T ss_pred             CcCCcCCHHHhcccc------CCCEEEecCCCeeCC
Confidence            888876666555444      344556778887664

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=99.87  E-value=2.3e-22  Score=228.72  Aligned_cols=166  Identities=33%  Similarity=0.518  Sum_probs=113.4

Q ss_pred             cEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhhc
Q 007680            2 RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLM   81 (593)
Q Consensus         2 ~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~   81 (593)
                      +.|+|++|.+++.+|..+.. +++|++|+|++|++++.+|..|.++++|+.|+|++|++++.+|..|+.+++|++|    
T Consensus       445 ~~L~L~~n~l~~~~p~~~~~-l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L----  519 (768)
T 3rgz_A          445 RDLKLWLNMLEGEIPQELMY-VKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAIL----  519 (768)
T ss_dssp             CEEECCSSCCCSCCCGGGGG-CTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEE----
T ss_pred             CEEECCCCcccCcCCHHHcC-CCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEE----
Confidence            34444444444444444432 4445555555555544445455555555555555555554555555555555554    


Q ss_pred             ceeeccCCcccccCCCc----ccccEEEccCCcccCcCCCC---------------------------------------
Q 007680           82 FGIRLTGNKLYGRIPPC----LVLTVLDVSRNQLSGDIPST---------------------------------------  118 (593)
Q Consensus        82 n~l~l~~n~l~~~~~~~----~~L~~L~l~~N~l~~~~p~~---------------------------------------  118 (593)
                         ++++|++.+.+|..    ..|++|++++|+++|.+|..                                       
T Consensus       520 ---~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  596 (768)
T 3rgz_A          520 ---KLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEF  596 (768)
T ss_dssp             ---ECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEEC
T ss_pred             ---ECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhcccccccccccccccccccccccccccc
Confidence               78888888777653    45999999999998777743                                       


Q ss_pred             -------------------------------CCCCCCCCEecCCCccCCCCCCccccCCccccccccccccccCCCCCCC
Q 007680          119 -------------------------------IGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKLE  167 (593)
Q Consensus       119 -------------------------------~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~~N~l~~~~p~~~  167 (593)
                                                     ++.+++|+.|+|++|+++|.+|..++++++|+.|+|++|+++|.+|..+
T Consensus       597 ~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l  676 (768)
T 3rgz_A          597 QGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEV  676 (768)
T ss_dssp             TTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGG
T ss_pred             ccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHH
Confidence                                           3446789999999999999999999999999999999999999999987


Q ss_pred             CCCCCCCC
Q 007680          168 GEIPVKGS  175 (593)
Q Consensus       168 ~~~~~~~~  175 (593)
                      ..++.+..
T Consensus       677 ~~L~~L~~  684 (768)
T 3rgz_A          677 GDLRGLNI  684 (768)
T ss_dssp             GGCTTCCE
T ss_pred             hCCCCCCE
Confidence            77665433

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.87  E-value=7.5e-22  Score=209.98  Aligned_cols=183  Identities=26%  Similarity=0.261  Sum_probs=111.7

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLL   80 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~   80 (593)
                      |++|+|++|+|+ .++...+.++++|++|+|++|+|++..+..|.++++|+.|+|++|+|+...+..|..+++|++|+|+
T Consensus        90 L~~L~Ls~n~i~-~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~  168 (440)
T 3zyj_A           90 LEILQLSRNHIR-TIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLG  168 (440)
T ss_dssp             CCEEECCSSCCC-EECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECC
T ss_pred             CCEEECCCCcCC-ccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCC
Confidence            455555555555 3443333345556666666665554444455555666666666666554444455555555555444


Q ss_pred             cc------------------eeeccCCcccccCC---CcccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCC
Q 007680           81 MF------------------GIRLTGNKLYGRIP---PCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPI  139 (593)
Q Consensus        81 ~n------------------~l~l~~n~l~~~~~---~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~  139 (593)
                      +|                  .+++++|+++ .+|   .+..|++|+|++|+|++..|..|.++++|+.|+|++|+|++..
T Consensus       169 ~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~  247 (440)
T 3zyj_A          169 ELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIE  247 (440)
T ss_dssp             CCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCCCCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEEC
T ss_pred             CCCCcceeCcchhhcccccCeecCCCCcCc-cccccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEC
Confidence            31                  1345555554 222   2334777777777777666777777777777777777777666


Q ss_pred             CccccCCccccccccccccccCCCCCCCCCCCCCCCccCCCcccccCCccCC
Q 007680          140 PESVGSLISLESLDLSGNNLSGKIPKLEGEIPVKGSFKNFSTESFFGNYALC  191 (593)
Q Consensus       140 p~~l~~~~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~n~~~c  191 (593)
                      +..|.++++|+.|+|++|++++.++..+..++      ++....+.+||+.|
T Consensus       248 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~------~L~~L~L~~Np~~C  293 (440)
T 3zyj_A          248 RNAFDNLQSLVEINLAHNNLTLLPHDLFTPLH------HLERIHLHHNPWNC  293 (440)
T ss_dssp             TTSSTTCTTCCEEECTTSCCCCCCTTTTSSCT------TCCEEECCSSCEEC
T ss_pred             hhhhcCCCCCCEEECCCCCCCccChhHhcccc------CCCEEEcCCCCccC
Confidence            77777777777788888877777666655444      34445677888776

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=99.87  E-value=1.3e-22  Score=205.73  Aligned_cols=156  Identities=30%  Similarity=0.564  Sum_probs=102.5

Q ss_pred             CcEEEeeC-ccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhh
Q 007680            1 MRILTLEG-NQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSL   79 (593)
Q Consensus         1 L~~L~Ls~-n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l   79 (593)
                      |++|+|++ |++.+.+|..+.. +++|++|+|++|+|++.+|+.|.++++|++|+|++|++++.+|..|..+++|++|  
T Consensus        78 L~~L~L~~~n~l~~~~p~~l~~-l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L--  154 (313)
T 1ogq_A           78 LNFLYIGGINNLVGPIPPAIAK-LTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGI--  154 (313)
T ss_dssp             CSEEEEEEETTEESCCCGGGGG-CTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEE--
T ss_pred             CCeeeCCCCCcccccCChhHhc-CCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeE--
Confidence            45666663 6666666666654 6677777777777766666667777777777777777766666667777777766  


Q ss_pred             hcceeeccCCcccccCCC----cc-cccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCccccCCcccccccc
Q 007680           80 LMFGIRLTGNKLYGRIPP----CL-VLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDL  154 (593)
Q Consensus        80 ~~n~l~l~~n~l~~~~~~----~~-~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l  154 (593)
                           ++++|++++.+|.    +. .|++|++++|++++.+|..+..+. |+.|++++|++++.+|..+..+++|+.|++
T Consensus       155 -----~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  228 (313)
T 1ogq_A          155 -----TFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHL  228 (313)
T ss_dssp             -----ECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEEC
T ss_pred             -----ECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEEC
Confidence                 5666666654443    22 467777777777666666666665 666777777666666666666666666666


Q ss_pred             ccccccCCCCC
Q 007680          155 SGNNLSGKIPK  165 (593)
Q Consensus       155 ~~N~l~~~~p~  165 (593)
                      ++|++++.+|.
T Consensus       229 ~~N~l~~~~~~  239 (313)
T 1ogq_A          229 AKNSLAFDLGK  239 (313)
T ss_dssp             CSSEECCBGGG
T ss_pred             CCCceeeecCc
Confidence            66666655544

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.87  E-value=1.6e-21  Score=191.27  Aligned_cols=174  Identities=26%  Similarity=0.307  Sum_probs=150.1

Q ss_pred             cEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhhc
Q 007680            2 RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLM   81 (593)
Q Consensus         2 ~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~   81 (593)
                      +.+++++|+++ .+|..+.   ++|+.|+|++|+|++..+..|.++++|+.|+|++|+|++..|..|..+++|++|    
T Consensus        17 ~~l~~~~~~l~-~~p~~~~---~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L----   88 (251)
T 3m19_A           17 KEVDCQGKSLD-SVPSGIP---ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTL----   88 (251)
T ss_dssp             TEEECTTCCCS-SCCSCCC---TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEE----
T ss_pred             eEEecCCCCcc-ccCCCCC---CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEE----
Confidence            57999999999 8998765   589999999999998888899999999999999999998888889999999999    


Q ss_pred             ceeeccCCcccccC----CCcccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCccccCCccccccccccc
Q 007680           82 FGIRLTGNKLYGRI----PPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGN  157 (593)
Q Consensus        82 n~l~l~~n~l~~~~----~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~~N  157 (593)
                         ++++|++.+..    ..+..|++|+|++|+|++..+..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|
T Consensus        89 ---~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N  165 (251)
T 3m19_A           89 ---GLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTN  165 (251)
T ss_dssp             ---ECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             ---ECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCC
Confidence               77788877433    34556999999999999777777899999999999999999777778999999999999999


Q ss_pred             cccCCCCCCCCCCCCCCCccCCCcccccCCccCCC
Q 007680          158 NLSGKIPKLEGEIPVKGSFKNFSTESFFGNYALCG  192 (593)
Q Consensus       158 ~l~~~~p~~~~~~~~~~~~~~~~~~~~~~n~~~c~  192 (593)
                      ++++.++..+..++      ++....+.+|+..|.
T Consensus       166 ~l~~~~~~~~~~l~------~L~~L~l~~N~~~c~  194 (251)
T 3m19_A          166 QLQSVPHGAFDRLG------KLQTITLFGNQFDCS  194 (251)
T ss_dssp             CCSCCCTTTTTTCT------TCCEEECCSCCBCTT
T ss_pred             cCCccCHHHHhCCC------CCCEEEeeCCceeCC
Confidence            99998887666554      444567888888764

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.86  E-value=9.3e-22  Score=210.03  Aligned_cols=184  Identities=22%  Similarity=0.189  Sum_probs=99.7

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLL   80 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~   80 (593)
                      |+.|+|++|+|+ .++...+..+++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..+..|..+++|++|+|+
T Consensus        77 l~~L~L~~n~i~-~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  155 (452)
T 3zyi_A           77 TRYLNLMENNIQ-MIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLR  155 (452)
T ss_dssp             CSEEECCSSCCC-EECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEECC
T ss_pred             ccEEECcCCcCc-eECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEECC
Confidence            456666666666 3333222336666666666666665555666666666666666666665555556666666666554


Q ss_pred             cce------------------------------------------eeccCCcccc--cCCCcccccEEEccCCcccCcCC
Q 007680           81 MFG------------------------------------------IRLTGNKLYG--RIPPCLVLTVLDVSRNQLSGDIP  116 (593)
Q Consensus        81 ~n~------------------------------------------l~l~~n~l~~--~~~~~~~L~~L~l~~N~l~~~~p  116 (593)
                      +|.                                          +++++|++.+  .+..+..|++|+|++|++++..|
T Consensus       156 ~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~  235 (452)
T 3zyi_A          156 NNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDMPNLTPLVGLEELEMSGNHFPEIRP  235 (452)
T ss_dssp             SCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSCCCCTTCTTCCEEECTTSCCSEECG
T ss_pred             CCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccccccccccccccEEECcCCcCcccCc
Confidence            433                                          2233333331  11112235555555555554445


Q ss_pred             CCCCCCCCCCEecCCCccCCCCCCccccCCccccccccccccccCCCCCCCCCCCCCCCccCCCcccccCCccCC
Q 007680          117 STIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKLEGEIPVKGSFKNFSTESFFGNYALC  191 (593)
Q Consensus       117 ~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~n~~~c  191 (593)
                      ..|.++++|+.|+|++|++++..|..|.++++|+.|+|++|++++.++..+..++      ++....+.+|++.|
T Consensus       236 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~------~L~~L~L~~Np~~C  304 (452)
T 3zyi_A          236 GSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLR------YLVELHLHHNPWNC  304 (452)
T ss_dssp             GGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCT------TCCEEECCSSCEEC
T ss_pred             ccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhcccc------CCCEEEccCCCcCC
Confidence            5555555555555555555555555555555666666666666555555444333      33445666777665

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.85  E-value=4.1e-21  Score=191.96  Aligned_cols=165  Identities=24%  Similarity=0.201  Sum_probs=122.9

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCc-ccccccccccCCCCchhhhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNS-FSGHILNTFGNLRHLSVLSL   79 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~l   79 (593)
                      |+.|+|++|+++ .+|...+..+++|++|+|++|+|++..|..|.++++|+.|+|++|. ++...|..|..+++|++|  
T Consensus        34 l~~L~l~~n~i~-~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L--  110 (285)
T 1ozn_A           34 SQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTL--  110 (285)
T ss_dssp             CSEEECTTSCCC-EECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEE--
T ss_pred             ceEEEeeCCcCC-ccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEE--
Confidence            577888888888 5665544458888888888888887778888888888888888886 776667778888888888  


Q ss_pred             hcceeeccCCccccc----CCCcccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCccccCCccccccccc
Q 007680           80 LMFGIRLTGNKLYGR----IPPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLS  155 (593)
Q Consensus        80 ~~n~l~l~~n~l~~~----~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~  155 (593)
                           ++++|++.+.    +..+..|++|++++|++++..+..|.++++|+.|++++|++++..+..+..+++|+.|+++
T Consensus       111 -----~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~  185 (285)
T 1ozn_A          111 -----HLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLH  185 (285)
T ss_dssp             -----ECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred             -----ECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECC
Confidence                 6666666643    3334558888888888876666667778888888888888875555567778888888888


Q ss_pred             cccccCCCCCCCCCCCCC
Q 007680          156 GNNLSGKIPKLEGEIPVK  173 (593)
Q Consensus       156 ~N~l~~~~p~~~~~~~~~  173 (593)
                      +|++++..|..+..++.+
T Consensus       186 ~n~l~~~~~~~~~~l~~L  203 (285)
T 1ozn_A          186 QNRVAHVHPHAFRDLGRL  203 (285)
T ss_dssp             SSCCCEECTTTTTTCTTC
T ss_pred             CCcccccCHhHccCcccc
Confidence            888887777766555443

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.85  E-value=5.5e-21  Score=187.39  Aligned_cols=156  Identities=26%  Similarity=0.285  Sum_probs=138.0

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLL   80 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~   80 (593)
                      |+.|+|++|+++ .++...+..+++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..+..|..+++|++|   
T Consensus        37 l~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L---  112 (251)
T 3m19_A           37 TEKLDLQSTGLA-TLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKL---  112 (251)
T ss_dssp             CCEEECTTSCCC-CCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEE---
T ss_pred             CCEEEccCCCcC-ccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEE---
Confidence            678999999999 5665544469999999999999998888889999999999999999998888889999999999   


Q ss_pred             cceeeccCCcccccC----CCcccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCccccCCcccccccccc
Q 007680           81 MFGIRLTGNKLYGRI----PPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSG  156 (593)
Q Consensus        81 ~n~l~l~~n~l~~~~----~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~~  156 (593)
                          ++++|++++..    ..+..|++|+|++|+|++..+..|.++++|+.|+|++|+|++..+..+..+++|+.|++++
T Consensus       113 ----~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~  188 (251)
T 3m19_A          113 ----YLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFG  188 (251)
T ss_dssp             ----ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCS
T ss_pred             ----EcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeC
Confidence                78888887433    3455699999999999977777899999999999999999988788899999999999999


Q ss_pred             ccccCCCC
Q 007680          157 NNLSGKIP  164 (593)
Q Consensus       157 N~l~~~~p  164 (593)
                      |+++....
T Consensus       189 N~~~c~~~  196 (251)
T 3m19_A          189 NQFDCSRC  196 (251)
T ss_dssp             CCBCTTST
T ss_pred             CceeCCcc
Confidence            99988643

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.85  E-value=2e-21  Score=198.32  Aligned_cols=159  Identities=22%  Similarity=0.267  Sum_probs=104.9

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccC---------C
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGN---------L   71 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~---------l   71 (593)
                      |++|+|++|+++ .+|..+.. +++|++|+|++|+|+ .+|..|.++++|+.|+|++|++.+.+|..+..         +
T Consensus       106 L~~L~L~~n~l~-~lp~~~~~-l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l  182 (328)
T 4fcg_A          106 LQHMTIDAAGLM-ELPDTMQQ-FAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGL  182 (328)
T ss_dssp             CSEEEEESSCCC-CCCSCGGG-GTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEES
T ss_pred             CCEEECCCCCcc-chhHHHhc-cCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhhccC
Confidence            678888888888 78877765 888888888888888 67888888888888888887777777776554         7


Q ss_pred             CCchhhhhhcceeeccCCcccccCC----CcccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCccccCCc
Q 007680           72 RHLSVLSLLMFGIRLTGNKLYGRIP----PCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLI  147 (593)
Q Consensus        72 ~~L~~L~l~~n~l~l~~n~l~~~~~----~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~  147 (593)
                      ++|++|+|       ++|+++ .+|    .+..|++|+|++|++++ +|..++.+++|+.|++++|++.+.+|..+..++
T Consensus       183 ~~L~~L~L-------~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~  253 (328)
T 4fcg_A          183 VNLQSLRL-------EWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRA  253 (328)
T ss_dssp             TTCCEEEE-------EEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCC
T ss_pred             CCCCEEEC-------cCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEECcCCcchhhhHHHhcCCC
Confidence            78888844       444443 222    23346666666666653 444455566666666666665555666666666


Q ss_pred             cccccccccccccCCCCCCCCCCC
Q 007680          148 SLESLDLSGNNLSGKIPKLEGEIP  171 (593)
Q Consensus       148 ~L~~L~l~~N~l~~~~p~~~~~~~  171 (593)
                      +|+.|++++|++.+.+|..+..++
T Consensus       254 ~L~~L~L~~n~~~~~~p~~~~~l~  277 (328)
T 4fcg_A          254 PLKRLILKDCSNLLTLPLDIHRLT  277 (328)
T ss_dssp             CCCEEECTTCTTCCBCCTTGGGCT
T ss_pred             CCCEEECCCCCchhhcchhhhcCC
Confidence            666666666666655555444433

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.84  E-value=1.4e-20  Score=188.44  Aligned_cols=157  Identities=27%  Similarity=0.294  Sum_probs=88.3

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLL   80 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~   80 (593)
                      |+.|++++|+|+ .+|..++   ++|+.|+|++|+|++..|..|.++++|+.|+|++|.|++..+  .+.+++|++|   
T Consensus        12 l~~l~~~~~~l~-~ip~~~~---~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L---   82 (290)
T 1p9a_G           12 HLEVNCDKRNLT-ALPPDLP---KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV--DGTLPVLGTL---   82 (290)
T ss_dssp             CCEEECTTSCCS-SCCSCCC---TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC--CSCCTTCCEE---
T ss_pred             ccEEECCCCCCC-cCCCCCC---CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccC--CCCCCcCCEE---
Confidence            355666666666 6665543   366666666666665556666666666666666666663322  2556666666   


Q ss_pred             cceeeccCCcccccCC----CcccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCccccCCcccccccccc
Q 007680           81 MFGIRLTGNKLYGRIP----PCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSG  156 (593)
Q Consensus        81 ~n~l~l~~n~l~~~~~----~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~~  156 (593)
                          ++++|++. .+|    .+..|++|++++|+|++..|..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++
T Consensus        83 ----~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  157 (290)
T 1p9a_G           83 ----DLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLAN  157 (290)
T ss_dssp             ----ECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTT
T ss_pred             ----ECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCC
Confidence                44444443 222    223355666666666544445555556666666666666544444455555566666666


Q ss_pred             ccccCCCCCCCCCCC
Q 007680          157 NNLSGKIPKLEGEIP  171 (593)
Q Consensus       157 N~l~~~~p~~~~~~~  171 (593)
                      |++++.++..+..++
T Consensus       158 N~l~~l~~~~~~~l~  172 (290)
T 1p9a_G          158 NNLTELPAGLLNGLE  172 (290)
T ss_dssp             SCCSCCCTTTTTTCT
T ss_pred             CcCCccCHHHhcCcC
Confidence            666555544444333

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.84  E-value=2.5e-21  Score=197.61  Aligned_cols=162  Identities=19%  Similarity=0.311  Sum_probs=146.9

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLL   80 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~   80 (593)
                      ++.|+|++|+++ .+|..++. +++|++|+|++|+|+ .+|..|+++++|++|+|++|+++ .+|..|+.+++|++|   
T Consensus        83 l~~L~L~~n~l~-~lp~~l~~-l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L---  155 (328)
T 4fcg_A           83 RVALELRSVPLP-QFPDQAFR-LSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLREL---  155 (328)
T ss_dssp             CCEEEEESSCCS-SCCSCGGG-GTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEE---
T ss_pred             eeEEEccCCCch-hcChhhhh-CCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEE---
Confidence            578999999999 99999987 999999999999999 89999999999999999999999 789999999999999   


Q ss_pred             cceeeccCCcccccCCC-------------cccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCccccCCc
Q 007680           81 MFGIRLTGNKLYGRIPP-------------CLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLI  147 (593)
Q Consensus        81 ~n~l~l~~n~l~~~~~~-------------~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~  147 (593)
                          ++++|++.+.+|.             +..|++|+|++|+++ .+|..++++++|+.|+|++|+++ .+|..+..++
T Consensus       156 ----~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~-~l~~~l~~l~  229 (328)
T 4fcg_A          156 ----SIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLP  229 (328)
T ss_dssp             ----EEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCC-CCCGGGGGCT
T ss_pred             ----ECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCC-cCchhhccCC
Confidence                7777777766665             557999999999999 78888999999999999999999 5777899999


Q ss_pred             cccccccccccccCCCCCCCCCCCCCCC
Q 007680          148 SLESLDLSGNNLSGKIPKLEGEIPVKGS  175 (593)
Q Consensus       148 ~L~~L~l~~N~l~~~~p~~~~~~~~~~~  175 (593)
                      +|+.|++++|++.+.+|..+..++.+..
T Consensus       230 ~L~~L~Ls~n~~~~~~p~~~~~l~~L~~  257 (328)
T 4fcg_A          230 KLEELDLRGCTALRNYPPIFGGRAPLKR  257 (328)
T ss_dssp             TCCEEECTTCTTCCBCCCCTTCCCCCCE
T ss_pred             CCCEEECcCCcchhhhHHHhcCCCCCCE
Confidence            9999999999999999988776665443

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.84  E-value=2.8e-20  Score=184.59  Aligned_cols=175  Identities=24%  Similarity=0.249  Sum_probs=146.7

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLL   80 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~   80 (593)
                      |+.|++++|.+. .++. +.. +++|++|+|++|+|++ + +.+..+++|++|+|++|.+++..+..|+.+++|++|   
T Consensus        43 L~~L~l~~~~i~-~~~~-l~~-l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L---  114 (272)
T 3rfs_A           43 IDQIIANNSDIK-SVQG-IQY-LPNVRYLALGGNKLHD-I-SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKEL---  114 (272)
T ss_dssp             CCEEECTTSCCC-CCTT-GGG-CTTCCEEECTTSCCCC-C-GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEE---
T ss_pred             eeeeeeCCCCcc-cccc-ccc-CCCCcEEECCCCCCCC-c-hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEE---
Confidence            678999999998 6764 554 9999999999999995 3 478999999999999999998888889999999999   


Q ss_pred             cceeeccCCcccccC----CCcccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCccccCCcccccccccc
Q 007680           81 MFGIRLTGNKLYGRI----PPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSG  156 (593)
Q Consensus        81 ~n~l~l~~n~l~~~~----~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~~  156 (593)
                          ++++|++.+..    ..+..|++|++++|++++..+..|+++++|+.|++++|++++..+..+..+++|+.|++++
T Consensus       115 ----~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~  190 (272)
T 3rfs_A          115 ----VLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQ  190 (272)
T ss_dssp             ----ECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             ----ECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCC
Confidence                77788877543    3445699999999999977777789999999999999999987777789999999999999


Q ss_pred             ccccCCCCCCCCCCCCCCCccCCCcccccCCccCCCC
Q 007680          157 NNLSGKIPKLEGEIPVKGSFKNFSTESFFGNYALCGP  193 (593)
Q Consensus       157 N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~n~~~c~~  193 (593)
                      |++++.+|..+..++.      +....+.+|+..|..
T Consensus       191 N~l~~~~~~~~~~l~~------L~~L~l~~N~~~~~~  221 (272)
T 3rfs_A          191 NQLKSVPDGVFDRLTS------LQYIWLHDNPWDCTC  221 (272)
T ss_dssp             SCCSCCCTTTTTTCTT------CCEEECCSSCBCCCT
T ss_pred             CcCCccCHHHHhCCcC------CCEEEccCCCccccC
Confidence            9999988876665554      445577888876643

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.84  E-value=7.2e-21  Score=192.20  Aligned_cols=176  Identities=24%  Similarity=0.253  Sum_probs=90.4

Q ss_pred             cEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCC-ccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhh
Q 007680            2 RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIP-NSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLL   80 (593)
Q Consensus         2 ~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~   80 (593)
                      ++|+|++|++. .+|..+.. +++|++|+|++|+|++..+ ..|.++++|+.|+|++|.+++..|..|..+++|++|   
T Consensus        81 ~~L~Ls~n~i~-~l~~~~~~-l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L---  155 (306)
T 2z66_A           81 KYLDLSFNGVI-TMSSNFLG-LEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVL---  155 (306)
T ss_dssp             CEEECCSCSEE-EEEEEEET-CTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEE---
T ss_pred             CEEECCCCccc-cChhhcCC-CCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEE---
Confidence            44444444444 34444332 4455555555555543322 344455555555555555554444445555555555   


Q ss_pred             cceeeccCCcccc-----cCCCcccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCccccCCccccccccc
Q 007680           81 MFGIRLTGNKLYG-----RIPPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLS  155 (593)
Q Consensus        81 ~n~l~l~~n~l~~-----~~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~  155 (593)
                          ++++|.+.+     .+..+..|++|++++|++++..|..|.++++|+.|++++|++++..+..+..+++|+.|+++
T Consensus       156 ----~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  231 (306)
T 2z66_A          156 ----KMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYS  231 (306)
T ss_dssp             ----ECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECT
T ss_pred             ----ECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECC
Confidence                444444443     12223346666666666665555566666666666666666665444456666666666666


Q ss_pred             cccccCCCCCCCCCCCCCCCccCCCcccccCCccCC
Q 007680          156 GNNLSGKIPKLEGEIPVKGSFKNFSTESFFGNYALC  191 (593)
Q Consensus       156 ~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~n~~~c  191 (593)
                      +|++++..|..+..+|.     .+......+|+..|
T Consensus       232 ~N~l~~~~~~~~~~~~~-----~L~~L~L~~N~~~~  262 (306)
T 2z66_A          232 LNHIMTSKKQELQHFPS-----SLAFLNLTQNDFAC  262 (306)
T ss_dssp             TSCCCBCSSSSCCCCCT-----TCCEEECTTCCEEC
T ss_pred             CCCCcccCHHHHHhhhc-----cCCEEEccCCCeec
Confidence            66666655555444431     23334455555544

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.83  E-value=1.7e-20  Score=180.08  Aligned_cols=149  Identities=23%  Similarity=0.306  Sum_probs=132.0

Q ss_pred             cEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhhc
Q 007680            2 RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLM   81 (593)
Q Consensus         2 ~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~   81 (593)
                      +.+++++|+++ .+|..+.   ++|+.|+|++|+|++..+..|.++++|+.|+|++|+|++..|+.|..+++|++|    
T Consensus        14 ~~v~c~~~~l~-~iP~~l~---~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L----   85 (220)
T 2v9t_B           14 NIVDCRGKGLT-EIPTNLP---ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSL----   85 (220)
T ss_dssp             TEEECTTSCCS-SCCSSCC---TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEE----
T ss_pred             CEEEcCCCCcC-cCCCccC---cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEE----
Confidence            46899999999 8998765   589999999999998777899999999999999999998889999999999999    


Q ss_pred             ceeeccCCccccc----CCCcccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCccccCCccccccccccc
Q 007680           82 FGIRLTGNKLYGR----IPPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGN  157 (593)
Q Consensus        82 n~l~l~~n~l~~~----~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~~N  157 (593)
                         ++++|+++..    +..+..|++|+|++|+|++..|..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|
T Consensus        86 ---~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  162 (220)
T 2v9t_B           86 ---VLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN  162 (220)
T ss_dssp             ---ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSS
T ss_pred             ---ECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCC
Confidence               7778887732    234556999999999999888889999999999999999999877778999999999999999


Q ss_pred             cccC
Q 007680          158 NLSG  161 (593)
Q Consensus       158 ~l~~  161 (593)
                      ++..
T Consensus       163 ~~~c  166 (220)
T 2v9t_B          163 PFIC  166 (220)
T ss_dssp             CEEC
T ss_pred             CcCC
Confidence            9874

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.83  E-value=1.3e-20  Score=188.30  Aligned_cols=178  Identities=24%  Similarity=0.199  Sum_probs=152.9

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCc-CcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANN-LTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSL   79 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l   79 (593)
                      |++|+|++|++++..|..+. .+++|++|+|++|. ++...|..|.++++|+.|+|++|.+++..|..|..+++|++|  
T Consensus        58 L~~L~l~~n~l~~~~~~~~~-~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L--  134 (285)
T 1ozn_A           58 LTILWLHSNVLARIDAAAFT-GLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYL--  134 (285)
T ss_dssp             CCEEECCSSCCCEECTTTTT-TCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEE--
T ss_pred             CCEEECCCCccceeCHhhcC-CccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEE--
Confidence            68999999999944455565 59999999999997 887778899999999999999999998888899999999999  


Q ss_pred             hcceeeccCCccccc----CCCcccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCccccCCccccccccc
Q 007680           80 LMFGIRLTGNKLYGR----IPPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLS  155 (593)
Q Consensus        80 ~~n~l~l~~n~l~~~----~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~  155 (593)
                           ++++|++.+.    +..+..|++|++++|++++..+..|.++++|+.|++++|++++..|..+..+++|+.|+++
T Consensus       135 -----~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~  209 (285)
T 1ozn_A          135 -----YLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLF  209 (285)
T ss_dssp             -----ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred             -----ECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCC
Confidence                 7778887743    3345569999999999997777779999999999999999998889999999999999999


Q ss_pred             cccccCCCCCCCCCCCCCCCccCCCcccccCCccCCC
Q 007680          156 GNNLSGKIPKLEGEIPVKGSFKNFSTESFFGNYALCG  192 (593)
Q Consensus       156 ~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~n~~~c~  192 (593)
                      +|++++.++..+..++.      +....+.+|+..|.
T Consensus       210 ~n~l~~~~~~~~~~l~~------L~~L~l~~N~~~c~  240 (285)
T 1ozn_A          210 ANNLSALPTEALAPLRA------LQYLRLNDNPWVCD  240 (285)
T ss_dssp             SSCCSCCCHHHHTTCTT------CCEEECCSSCEECS
T ss_pred             CCcCCcCCHHHcccCcc------cCEEeccCCCccCC
Confidence            99999977776655543      44567888888764

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.83  E-value=4e-20  Score=183.47  Aligned_cols=155  Identities=29%  Similarity=0.308  Sum_probs=137.8

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLL   80 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~   80 (593)
                      |++|+|++|+++ .++ .+. .+++|++|+|++|+|++..+..|.++++|+.|+|++|++++..+..|+.+++|++|   
T Consensus        65 L~~L~l~~n~l~-~~~-~l~-~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L---  138 (272)
T 3rfs_A           65 VRYLALGGNKLH-DIS-ALK-ELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYL---  138 (272)
T ss_dssp             CCEEECTTSCCC-CCG-GGT-TCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEE---
T ss_pred             CcEEECCCCCCC-Cch-hhc-CCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEE---
Confidence            689999999999 565 555 49999999999999998878889999999999999999998888889999999999   


Q ss_pred             cceeeccCCcccccC----CCcccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCccccCCcccccccccc
Q 007680           81 MFGIRLTGNKLYGRI----PPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSG  156 (593)
Q Consensus        81 ~n~l~l~~n~l~~~~----~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~~  156 (593)
                          ++++|++++..    ..+..|++|++++|++++..+..|+.+++|+.|++++|++++..|..+..+++|+.|++++
T Consensus       139 ----~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~  214 (272)
T 3rfs_A          139 ----NLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHD  214 (272)
T ss_dssp             ----ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCS
T ss_pred             ----ECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccC
Confidence                78888887543    3455699999999999987788889999999999999999988888899999999999999


Q ss_pred             ccccCCCCC
Q 007680          157 NNLSGKIPK  165 (593)
Q Consensus       157 N~l~~~~p~  165 (593)
                      |++++..|.
T Consensus       215 N~~~~~~~~  223 (272)
T 3rfs_A          215 NPWDCTCPG  223 (272)
T ss_dssp             SCBCCCTTT
T ss_pred             CCccccCcH
Confidence            999987664

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.83  E-value=1.6e-20  Score=180.21  Aligned_cols=150  Identities=20%  Similarity=0.216  Sum_probs=133.9

Q ss_pred             cEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCC-ccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhh
Q 007680            2 RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIP-NSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLL   80 (593)
Q Consensus         2 ~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~   80 (593)
                      +.+++++|+++ .+|..++   +.+++|+|++|+|++..| ..|.++++|+.|+|++|+|++..+..|..+++|++|   
T Consensus        14 ~~l~~s~n~l~-~iP~~~~---~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L---   86 (220)
T 2v70_A           14 TTVDCSNQKLN-KIPEHIP---QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEI---   86 (220)
T ss_dssp             TEEECCSSCCS-SCCSCCC---TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEE---
T ss_pred             CEeEeCCCCcc-cCccCCC---CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEE---
Confidence            57999999999 8998765   367999999999997755 458999999999999999998888899999999999   


Q ss_pred             cceeeccCCccccc----CCCcccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCccccCCcccccccccc
Q 007680           81 MFGIRLTGNKLYGR----IPPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSG  156 (593)
Q Consensus        81 ~n~l~l~~n~l~~~----~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~~  156 (593)
                          ++++|++++.    +..+..|++|+|++|+|++..|..|.++++|+.|+|++|+|++..|..|..+++|+.|++++
T Consensus        87 ----~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  162 (220)
T 2v70_A           87 ----LLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLA  162 (220)
T ss_dssp             ----ECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             ----ECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecC
Confidence                8888888754    34456799999999999988899999999999999999999988899999999999999999


Q ss_pred             ccccCC
Q 007680          157 NNLSGK  162 (593)
Q Consensus       157 N~l~~~  162 (593)
                      |+++..
T Consensus       163 N~l~c~  168 (220)
T 2v70_A          163 NPFNCN  168 (220)
T ss_dssp             CCEECS
T ss_pred             cCCcCC
Confidence            999864

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.83  E-value=4.6e-20  Score=182.84  Aligned_cols=155  Identities=28%  Similarity=0.291  Sum_probs=138.6

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLL   80 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~   80 (593)
                      |++|+|++|+++ .+|..++..+++|++|+|++|+|++..+..|.++++|+.|+|++|++++..|..|..+++|++|   
T Consensus        63 L~~L~l~~n~l~-~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L---  138 (270)
T 2o6q_A           63 LRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYL---  138 (270)
T ss_dssp             CCEEECCSSCCS-CCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEE---
T ss_pred             CCEEECCCCccC-eeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEE---
Confidence            789999999999 8998887779999999999999997777789999999999999999998888889999999999   


Q ss_pred             cceeeccCCccccc----CCCcccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCccccCCcccccccccc
Q 007680           81 MFGIRLTGNKLYGR----IPPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSG  156 (593)
Q Consensus        81 ~n~l~l~~n~l~~~----~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~~  156 (593)
                          ++++|++.+.    +..+..|++|+|++|++++..+..|.++++|+.|+|++|+|++..+..+..+++|+.|++++
T Consensus       139 ----~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~  214 (270)
T 2o6q_A          139 ----SLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQE  214 (270)
T ss_dssp             ----ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCS
T ss_pred             ----ECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecC
Confidence                7788887743    34456799999999999987777899999999999999999977777799999999999999


Q ss_pred             ccccCCC
Q 007680          157 NNLSGKI  163 (593)
Q Consensus       157 N~l~~~~  163 (593)
                      |++...-
T Consensus       215 N~~~c~c  221 (270)
T 2o6q_A          215 NPWDCTC  221 (270)
T ss_dssp             SCBCCSS
T ss_pred             CCeeCCC
Confidence            9997643

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.82  E-value=5.1e-20  Score=175.04  Aligned_cols=153  Identities=24%  Similarity=0.230  Sum_probs=116.4

Q ss_pred             cEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhhc
Q 007680            2 RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLM   81 (593)
Q Consensus         2 ~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~   81 (593)
                      +.+++++++++ .+|..+.   ++|++|+|++|+|++..+..|.++++|+.|+|++|++++..+..|..+++|++|    
T Consensus        10 ~~v~c~~~~l~-~~p~~~~---~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L----   81 (208)
T 2o6s_A           10 TTVECYSQGRT-SVPTGIP---AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYL----   81 (208)
T ss_dssp             TEEECCSSCCS-SCCSCCC---TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEE----
T ss_pred             CEEEecCCCcc-CCCCCCC---CCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEE----
Confidence            45778888887 7886653   478888888888886666667888888888888888886666667888888888    


Q ss_pred             ceeeccCCccccc----CCCcccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCccccCCccccccccccc
Q 007680           82 FGIRLTGNKLYGR----IPPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGN  157 (593)
Q Consensus        82 n~l~l~~n~l~~~----~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~~N  157 (593)
                         ++++|++++.    +..+..|++|++++|++++..+..|..+++|+.|++++|++++..+..+..+++|+.|++++|
T Consensus        82 ---~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N  158 (208)
T 2o6s_A           82 ---NLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDN  158 (208)
T ss_dssp             ---ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSC
T ss_pred             ---ECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCC
Confidence               6677776633    233446888888888888666666788888888888888888666666788888888888888


Q ss_pred             cccCCCCC
Q 007680          158 NLSGKIPK  165 (593)
Q Consensus       158 ~l~~~~p~  165 (593)
                      ++.+..|.
T Consensus       159 ~~~~~~~~  166 (208)
T 2o6s_A          159 PWDCTCPG  166 (208)
T ss_dssp             CBCCCTTT
T ss_pred             CeecCCCC
Confidence            88775553

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.82  E-value=1.9e-20  Score=182.06  Aligned_cols=163  Identities=19%  Similarity=0.212  Sum_probs=132.3

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCc-CcccCCccCCCCCCCcEEEccC-CcccccccccccCCCCchhhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANN-LTGTIPNSITNATKLIVLDLGF-NSFSGHILNTFGNLRHLSVLS   78 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~   78 (593)
                      |+.|+|++|+++ .+|...+..+++|++|+|++|+ |++..+.+|.++++|+.|+|++ |++++..+..|..+++|++| 
T Consensus        33 l~~L~l~~n~l~-~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L-  110 (239)
T 2xwt_C           33 TQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFL-  110 (239)
T ss_dssp             CCEEEEESCCCS-EECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEE-
T ss_pred             ccEEEEeCCcce-EECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEE-
Confidence            689999999999 7887655569999999999997 9977777899999999999999 99997777889999999999 


Q ss_pred             hhcceeeccCCcccccCC---Cccccc---EEEccCC-cccCcCCCCCCCCCCCC-EecCCCccCCCCCCccccCCcccc
Q 007680           79 LLMFGIRLTGNKLYGRIP---PCLVLT---VLDVSRN-QLSGDIPSTIGGRVDLE-TLSLASNQFQGPIPESVGSLISLE  150 (593)
Q Consensus        79 l~~n~l~l~~n~l~~~~~---~~~~L~---~L~l~~N-~l~~~~p~~~~~l~~L~-~L~l~~N~l~~~~p~~l~~~~~L~  150 (593)
                            ++++|++.+ +|   .+..|+   +|++++| ++++..+..|.++++|+ .|++++|+++ .+|......++|+
T Consensus       111 ------~l~~n~l~~-lp~~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~~~~~~L~  182 (239)
T 2xwt_C          111 ------GIFNTGLKM-FPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLD  182 (239)
T ss_dssp             ------EEEEECCCS-CCCCTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTTTTTTCEEE
T ss_pred             ------eCCCCCCcc-ccccccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHhhcCCCCCC
Confidence                  666666653 33   333466   9999999 88876677788899999 9999999998 5555444448899


Q ss_pred             cccccccc-ccCCCCCCCCCC-CCC
Q 007680          151 SLDLSGNN-LSGKIPKLEGEI-PVK  173 (593)
Q Consensus       151 ~L~l~~N~-l~~~~p~~~~~~-~~~  173 (593)
                      .|++++|+ ++++.+..+..+ +.+
T Consensus       183 ~L~L~~n~~l~~i~~~~~~~l~~~L  207 (239)
T 2xwt_C          183 AVYLNKNKYLTVIDKDAFGGVYSGP  207 (239)
T ss_dssp             EEECTTCTTCCEECTTTTTTCSBCC
T ss_pred             EEEcCCCCCcccCCHHHhhccccCC
Confidence            99999995 888777777665 443

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=99.82  E-value=7.4e-20  Score=186.88  Aligned_cols=155  Identities=24%  Similarity=0.321  Sum_probs=81.4

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLL   80 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~   80 (593)
                      |++|+|++|++++..|..+. .+++|++|+|++|+|+ .+|..+.  ++|+.|+|++|++++..+..|..+++|+.|+|+
T Consensus        78 L~~L~L~~n~l~~~~~~~~~-~l~~L~~L~Ls~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~  153 (330)
T 1xku_A           78 LHTLILINNKISKISPGAFA-PLVKLERLYLSKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELG  153 (330)
T ss_dssp             CCEEECCSSCCCCBCTTTTT-TCTTCCEEECCSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECC
T ss_pred             CCEEECCCCcCCeeCHHHhc-CCCCCCEEECCCCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECC
Confidence            56778888888733355554 3777777777777777 4554433  455555555555554444444444444444443


Q ss_pred             ccee-------------------eccCCcccccCCCc--ccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCC
Q 007680           81 MFGI-------------------RLTGNKLYGRIPPC--LVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPI  139 (593)
Q Consensus        81 ~n~l-------------------~l~~n~l~~~~~~~--~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~  139 (593)
                      +|.+                   ++++|.+.. +|..  ..|++|++++|++++..|..|.++++|+.|++++|++++..
T Consensus       154 ~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~-l~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~  232 (330)
T 1xku_A          154 TNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVD  232 (330)
T ss_dssp             SSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS-CCSSCCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEEC
T ss_pred             CCcCCccCcChhhccCCCCcCEEECCCCcccc-CCccccccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeC
Confidence            3321                   233443331 2211  12555555555555444445555555555555555555444


Q ss_pred             CccccCCcccccccccccccc
Q 007680          140 PESVGSLISLESLDLSGNNLS  160 (593)
Q Consensus       140 p~~l~~~~~L~~L~l~~N~l~  160 (593)
                      +..+..+++|+.|++++|+++
T Consensus       233 ~~~~~~l~~L~~L~L~~N~l~  253 (330)
T 1xku_A          233 NGSLANTPHLRELHLNNNKLV  253 (330)
T ss_dssp             TTTGGGSTTCCEEECCSSCCS
T ss_pred             hhhccCCCCCCEEECCCCcCc
Confidence            444555555555555555555

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=99.82  E-value=3.7e-20  Score=198.99  Aligned_cols=80  Identities=24%  Similarity=0.292  Sum_probs=42.3

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLL   80 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~   80 (593)
                      |++|+|++|+++ .+|...+..+++|++|+|++|+|++..|..|.++++|+.|+|++|.+++..|..|..+++|++|+|+
T Consensus        82 L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~  160 (477)
T 2id5_A           82 LRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLE  160 (477)
T ss_dssp             CCEEECCSSCCC-SCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEE
T ss_pred             CCEEECCCCcCC-ccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECC
Confidence            455555555555 4554443345555555555555555555555555555555555555554444455555555555444


Q ss_pred             c
Q 007680           81 M   81 (593)
Q Consensus        81 ~   81 (593)
                      +
T Consensus       161 ~  161 (477)
T 2id5_A          161 K  161 (477)
T ss_dssp             S
T ss_pred             C
Confidence            3

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.82  E-value=1.9e-20  Score=193.81  Aligned_cols=176  Identities=24%  Similarity=0.187  Sum_probs=145.6

Q ss_pred             cEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCC-CCCCCcEEEccCCcccccccccccCCCCchhhhhh
Q 007680            2 RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSIT-NATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLL   80 (593)
Q Consensus         2 ~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~   80 (593)
                      +++++++|+|+ .+|..++   +.++.|+|++|+|++..+..|. ++++|+.|+|++|+|++..|+.|..+++|++|   
T Consensus        21 ~~l~c~~~~l~-~iP~~~~---~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L---   93 (361)
T 2xot_A           21 NILSCSKQQLP-NVPQSLP---SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYL---   93 (361)
T ss_dssp             TEEECCSSCCS-SCCSSCC---TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEE---
T ss_pred             CEEEeCCCCcC-ccCccCC---CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEE---
Confidence            57899999999 8998765   4799999999999987778887 99999999999999998888899999999999   


Q ss_pred             cceeeccCCccccc----CCCcccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCccc---cCCccccccc
Q 007680           81 MFGIRLTGNKLYGR----IPPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESV---GSLISLESLD  153 (593)
Q Consensus        81 ~n~l~l~~n~l~~~----~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l---~~~~~L~~L~  153 (593)
                          +|++|+|.+.    +..+..|++|+|++|+|++..|..|.++++|+.|+|++|+|++..+..|   ..+++|+.|+
T Consensus        94 ----~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~  169 (361)
T 2xot_A           94 ----DLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLD  169 (361)
T ss_dssp             ----ECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEE
T ss_pred             ----ECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEE
Confidence                8888888743    4455679999999999998889999999999999999999995444444   5789999999


Q ss_pred             cccccccCCCCCCCCCCCCCCCccCCCcccccCCccCCC
Q 007680          154 LSGNNLSGKIPKLEGEIPVKGSFKNFSTESFFGNYALCG  192 (593)
Q Consensus       154 l~~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~n~~~c~  192 (593)
                      |++|+|+++++..+..++..    .+....+.+|++.|.
T Consensus       170 L~~N~l~~l~~~~~~~l~~~----~l~~l~l~~N~~~C~  204 (361)
T 2xot_A          170 LSSNKLKKLPLTDLQKLPAW----VKNGLYLHNNPLECD  204 (361)
T ss_dssp             CCSSCCCCCCHHHHHHSCHH----HHTTEECCSSCEECC
T ss_pred             CCCCCCCccCHHHhhhccHh----hcceEEecCCCccCC
Confidence            99999998776655554421    013457788888773

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.82  E-value=2.8e-20  Score=184.99  Aligned_cols=158  Identities=26%  Similarity=0.243  Sum_probs=123.0

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLL   80 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~   80 (593)
                      |++|+|++|+++ .+|...+..+++|++|+|++|+|++..+..|.++++|+.|+|++|++++..|+.|..+++|++|   
T Consensus        30 l~~L~ls~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L---  105 (276)
T 2z62_A           30 TKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKL---  105 (276)
T ss_dssp             CCEEECTTCCCC-EECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEE---
T ss_pred             ccEEECCCCccc-ccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEE---
Confidence            678999999999 6666444459999999999999997777789999999999999999998888889999999999   


Q ss_pred             cceeeccCCccccc----CCCcccccEEEccCCcccCc-CCCCCCCCCCCCEecCCCccCCCCCCccccCCcccc----c
Q 007680           81 MFGIRLTGNKLYGR----IPPCLVLTVLDVSRNQLSGD-IPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLE----S  151 (593)
Q Consensus        81 ~n~l~l~~n~l~~~----~~~~~~L~~L~l~~N~l~~~-~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~----~  151 (593)
                          ++++|++.+.    +..+..|++|++++|++++. +|..|.++++|+.|++++|++++..+..+..+.+|+    .
T Consensus       106 ----~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~  181 (276)
T 2z62_A          106 ----VAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLS  181 (276)
T ss_dssp             ----ECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEE
T ss_pred             ----ECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhcccccee
Confidence                6667766632    33455688888888888753 577788888888888888888866666666655555    5


Q ss_pred             cccccccccCCCCCC
Q 007680          152 LDLSGNNLSGKIPKL  166 (593)
Q Consensus       152 L~l~~N~l~~~~p~~  166 (593)
                      |++++|++++..+..
T Consensus       182 L~ls~n~l~~~~~~~  196 (276)
T 2z62_A          182 LDLSLNPMNFIQPGA  196 (276)
T ss_dssp             EECCSSCCCEECTTS
T ss_pred             eecCCCcccccCccc
Confidence            566666666555443

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=99.81  E-value=1e-19  Score=185.95  Aligned_cols=180  Identities=22%  Similarity=0.245  Sum_probs=116.1

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCccc-------------------
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFS-------------------   61 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-------------------   61 (593)
                      |+.|+|++|+++ .++...+..+++|++|+|++|+|++..|.+|.++++|+.|+|++|+++                   
T Consensus        56 l~~L~l~~n~i~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~L~~L~l~~n~  134 (332)
T 2ft3_A           56 TTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLVEIPPNLPSSLVELRIHDNR  134 (332)
T ss_dssp             CCEEECCSSCCC-EECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCCSCCSSCCTTCCEEECCSSC
T ss_pred             CeEEECCCCcCC-ccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCCccCccccccCCEEECCCCc
Confidence            455666666666 343322233666666666666666555566666666666666555554                   


Q ss_pred             --ccccccccCCCCchhhhhhccee------------------eccCCcccccCCCc--ccccEEEccCCcccCcCCCCC
Q 007680           62 --GHILNTFGNLRHLSVLSLLMFGI------------------RLTGNKLYGRIPPC--LVLTVLDVSRNQLSGDIPSTI  119 (593)
Q Consensus        62 --~~~p~~~~~l~~L~~L~l~~n~l------------------~l~~n~l~~~~~~~--~~L~~L~l~~N~l~~~~p~~~  119 (593)
                        +..+..|..+++|+.|++++|.+                  ++++|++++ +|..  ..|++|++++|++++..+..|
T Consensus       135 i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~L~~L~l~~n~l~~-l~~~~~~~L~~L~l~~n~i~~~~~~~l  213 (332)
T 2ft3_A          135 IRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTG-IPKDLPETLNELHLDHNKIQAIELEDL  213 (332)
T ss_dssp             CCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSCCCSCCBCCSSBCSS-CCSSSCSSCSCCBCCSSCCCCCCTTSS
T ss_pred             cCccCHhHhCCCccCCEEECCCCccccCCCCcccccCCccCEEECcCCCCCc-cCccccCCCCEEECCCCcCCccCHHHh
Confidence              33334577777788776665543                  344555542 3322  248888888888887777788


Q ss_pred             CCCCCCCEecCCCccCCCCCCccccCCccccccccccccccCCCCCCCCCCCCCCCccCCCcccccCCcc
Q 007680          120 GGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKLEGEIPVKGSFKNFSTESFFGNYA  189 (593)
Q Consensus       120 ~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~n~~  189 (593)
                      .++++|+.|++++|++++..|..+..+++|+.|++++|+++. +|..+..++.      +....+.+|..
T Consensus       214 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-lp~~l~~l~~------L~~L~l~~N~l  276 (332)
T 2ft3_A          214 LRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSR-VPAGLPDLKL------LQVVYLHTNNI  276 (332)
T ss_dssp             TTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCCB-CCTTGGGCTT------CCEEECCSSCC
T ss_pred             cCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCee-cChhhhcCcc------CCEEECCCCCC
Confidence            888899999999999987777788888899999999998884 4544444443      33344555543

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.81  E-value=1.1e-19  Score=175.35  Aligned_cols=151  Identities=25%  Similarity=0.291  Sum_probs=132.7

Q ss_pred             cEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhhc
Q 007680            2 RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLM   81 (593)
Q Consensus         2 ~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~   81 (593)
                      +.+++++++++ .+|.++.   ++|++|+|++|+|++..|..|.++++|+.|+|++|+|+...+..|..+++|+.|    
T Consensus        22 ~~v~c~~~~l~-~ip~~~~---~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L----   93 (229)
T 3e6j_A           22 TTVDCRSKRHA-SVPAGIP---TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVL----   93 (229)
T ss_dssp             TEEECTTSCCS-SCCSCCC---TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE----
T ss_pred             CEeEccCCCcC-ccCCCCC---CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEE----
Confidence            57899999998 8998764   699999999999998889999999999999999999997777788999999999    


Q ss_pred             ceeeccCCccccc----CCCcccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCccccCCccccccccccc
Q 007680           82 FGIRLTGNKLYGR----IPPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGN  157 (593)
Q Consensus        82 n~l~l~~n~l~~~----~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~~N  157 (593)
                         ++++|++++.    +..+..|++|+|++|+|+ .+|..+..+++|+.|+|++|+|++..+..|..+++|+.|++++|
T Consensus        94 ---~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N  169 (229)
T 3e6j_A           94 ---DLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGN  169 (229)
T ss_dssp             ---ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTS
T ss_pred             ---ECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCC
Confidence               7788887743    334556999999999999 78888999999999999999999776778999999999999999


Q ss_pred             cccCCCC
Q 007680          158 NLSGKIP  164 (593)
Q Consensus       158 ~l~~~~p  164 (593)
                      +++...+
T Consensus       170 ~~~c~c~  176 (229)
T 3e6j_A          170 PWDCECR  176 (229)
T ss_dssp             CBCTTBG
T ss_pred             CccCCcc
Confidence            9987543

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=99.81  E-value=9.4e-20  Score=194.49  Aligned_cols=172  Identities=26%  Similarity=0.287  Sum_probs=124.8

Q ss_pred             CcEEEeeCccccccCChh-hhhCCCCCcEEECCCCcCcccCCcc-CCCCCCCcEEEccCCcccccccccccCC-------
Q 007680            1 MRILTLEGNQLSGRLPST-IGHSLPNIEYLLLTANNLTGTIPNS-ITNATKLIVLDLGFNSFSGHILNTFGNL-------   71 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~-~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~~~~p~~~~~l-------   71 (593)
                      |++|+|++|++++.+|.. .+..+++|++|+|++|+|++..|.. |.++++|+.|+|++|++++..|..+..+       
T Consensus       105 L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~  184 (455)
T 3v47_A          105 LEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTL  184 (455)
T ss_dssp             CCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEE
T ss_pred             CCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhhhccccccccc
Confidence            577888888887544443 2234778888888888887666665 6778888888888888777666655443       


Q ss_pred             ---------------------------CCchhhhhhcce-----------------------------------------
Q 007680           72 ---------------------------RHLSVLSLLMFG-----------------------------------------   83 (593)
Q Consensus        72 ---------------------------~~L~~L~l~~n~-----------------------------------------   83 (593)
                                                 ++|++|+|++|.                                         
T Consensus       185 L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~  264 (455)
T 3v47_A          185 LRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDP  264 (455)
T ss_dssp             EECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCTTCCSSCCC
T ss_pred             cccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccccchhhhccC
Confidence                                       556666666552                                         


Q ss_pred             ---------------eeccCCcccccCC----CcccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCcccc
Q 007680           84 ---------------IRLTGNKLYGRIP----PCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVG  144 (593)
Q Consensus        84 ---------------l~l~~n~l~~~~~----~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~  144 (593)
                                     +++++|++.+.+|    .+..|++|++++|++++..|..|.++++|+.|+|++|++++..|..+.
T Consensus       265 ~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~  344 (455)
T 3v47_A          265 DNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFE  344 (455)
T ss_dssp             CTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGT
T ss_pred             cccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhc
Confidence                           4677888775443    344588888888888877777888888888888888888876777788


Q ss_pred             CCccccccccccccccCCCCCCCCCCCC
Q 007680          145 SLISLESLDLSGNNLSGKIPKLEGEIPV  172 (593)
Q Consensus       145 ~~~~L~~L~l~~N~l~~~~p~~~~~~~~  172 (593)
                      ++++|+.|++++|++++..|..+..++.
T Consensus       345 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~  372 (455)
T 3v47_A          345 NLDKLEVLDLSYNHIRALGDQSFLGLPN  372 (455)
T ss_dssp             TCTTCCEEECCSSCCCEECTTTTTTCTT
T ss_pred             CcccCCEEECCCCcccccChhhcccccc
Confidence            8888888888888888877776655554

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.81  E-value=1.3e-19  Score=181.40  Aligned_cols=174  Identities=24%  Similarity=0.179  Sum_probs=144.8

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLL   80 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~   80 (593)
                      |+.|+|++|+++ .++...+..+++|++|+|++|+|++. +.. ..+++|+.|+|++|+|+ .+|..+..+++|++|   
T Consensus        33 l~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~-~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L---  105 (290)
T 1p9a_G           33 TTILHLSENLLY-TFSLATLMPYTRLTQLNLDRAELTKL-QVD-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVL---  105 (290)
T ss_dssp             CCEEECTTSCCS-EEEGGGGTTCTTCCEEECTTSCCCEE-ECC-SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEE---
T ss_pred             CCEEEcCCCcCC-ccCHHHhhcCCCCCEEECCCCccCcc-cCC-CCCCcCCEEECCCCcCC-cCchhhccCCCCCEE---
Confidence            679999999999 55544444699999999999999954 433 79999999999999999 788889999999999   


Q ss_pred             cceeeccCCccccc----CCCcccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCccccCCcccccccccc
Q 007680           81 MFGIRLTGNKLYGR----IPPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSG  156 (593)
Q Consensus        81 ~n~l~l~~n~l~~~----~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~~  156 (593)
                          ++++|++++.    +..+..|++|+|++|+|++.++..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++
T Consensus       106 ----~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~  181 (290)
T 1p9a_G          106 ----DVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQE  181 (290)
T ss_dssp             ----ECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCS
T ss_pred             ----ECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCC
Confidence                8888888743    44556799999999999987778889999999999999999976666788999999999999


Q ss_pred             ccccCCCCCCCCCCCCCCCccCCCcccccCCccCCC
Q 007680          157 NNLSGKIPKLEGEIPVKGSFKNFSTESFFGNYALCG  192 (593)
Q Consensus       157 N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~n~~~c~  192 (593)
                      |+++.+++..+ ..+      .+....+.+||+.|.
T Consensus       182 N~l~~ip~~~~-~~~------~L~~l~L~~Np~~C~  210 (290)
T 1p9a_G          182 NSLYTIPKGFF-GSH------LLPFAFLHGNPWLCN  210 (290)
T ss_dssp             SCCCCCCTTTT-TTC------CCSEEECCSCCBCCS
T ss_pred             CcCCccChhhc-ccc------cCCeEEeCCCCccCc
Confidence            99996554433 222      455667889999873

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.81  E-value=1.1e-19  Score=193.90  Aligned_cols=165  Identities=25%  Similarity=0.318  Sum_probs=114.2

Q ss_pred             cEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhhc
Q 007680            2 RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLM   81 (593)
Q Consensus         2 ~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~   81 (593)
                      ..+++++++++ .+|.++.   ++|++|+|++|+|++..|+.|.++++|+.|+|++|+|++..|..|.++++|++|+|++
T Consensus        57 ~~v~c~~~~l~-~iP~~~~---~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~  132 (452)
T 3zyi_A           57 SKVVCTRRGLS-EVPQGIP---SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFD  132 (452)
T ss_dssp             CEEECCSSCCS-SCCSCCC---TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             cEEEECCCCcC-ccCCCCC---CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCC
Confidence            46889999999 8998765   5999999999999988899999999999999999999988889999999999996654


Q ss_pred             ce-----------------eeccCCccccc----CCCcccccEEEccC-CcccCcCCCCCCCCCCCCEecCCCccCCCCC
Q 007680           82 FG-----------------IRLTGNKLYGR----IPPCLVLTVLDVSR-NQLSGDIPSTIGGRVDLETLSLASNQFQGPI  139 (593)
Q Consensus        82 n~-----------------l~l~~n~l~~~----~~~~~~L~~L~l~~-N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~  139 (593)
                      |.                 +++++|++...    +..+..|++|++++ |.+....+..|.++++|+.|+|++|+|++ +
T Consensus       133 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~  211 (452)
T 3zyi_A          133 NWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-M  211 (452)
T ss_dssp             SCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSS-C
T ss_pred             CcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccc-c
Confidence            43                 33444444311    11122233333333 12221122245666777777777777763 4


Q ss_pred             CccccCCccccccccccccccCCCCCCCCCCCC
Q 007680          140 PESVGSLISLESLDLSGNNLSGKIPKLEGEIPV  172 (593)
Q Consensus       140 p~~l~~~~~L~~L~l~~N~l~~~~p~~~~~~~~  172 (593)
                      | .+..+++|+.|+|++|++++..|..+..++.
T Consensus       212 ~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~  243 (452)
T 3zyi_A          212 P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSS  243 (452)
T ss_dssp             C-CCTTCTTCCEEECTTSCCSEECGGGGTTCTT
T ss_pred             c-cccccccccEEECcCCcCcccCcccccCccC
Confidence            4 3566667777777777777666665555443

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=99.80  E-value=3.9e-20  Score=212.54  Aligned_cols=190  Identities=24%  Similarity=0.248  Sum_probs=132.6

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLL   80 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~   80 (593)
                      |+.|+|++|++++..|..+ .++++|++|+|++|+|++..|..|.++++|+.|+|++|.+++..+..|..+++|+.|+|+
T Consensus       292 L~~L~L~~n~i~~~~~~~~-~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls  370 (844)
T 3j0a_A          292 LKVLNLAYNKINKIADEAF-YGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLR  370 (844)
T ss_dssp             CCEEEEESCCCCEECTTTT-TTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEE
T ss_pred             CCEEECCCCcCCCCChHHh-cCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECC
Confidence            6788888888884444444 458899999999999987778888899999999999999987777788888889888887


Q ss_pred             ccee------------eccCCccc--------------------cc-----CCCcccccEEEccCCcccC----------
Q 007680           81 MFGI------------RLTGNKLY--------------------GR-----IPPCLVLTVLDVSRNQLSG----------  113 (593)
Q Consensus        81 ~n~l------------~l~~n~l~--------------------~~-----~~~~~~L~~L~l~~N~l~~----------  113 (593)
                      +|.+            ++++|++.                    +.     +..+..|++|+|++|++++          
T Consensus       371 ~N~l~~i~~~~~L~~L~l~~N~l~~l~~~~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~  450 (844)
T 3j0a_A          371 DNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSEN  450 (844)
T ss_dssp             TCCSCCCSSCCSCSEEEEESCCCCCCCCCCTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSC
T ss_pred             CCCCCcccCCCCcchhccCCCCcccccccccccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccC
Confidence            6652            23333332                    10     0022234455555544442          


Q ss_pred             --------------------cCCCCCCCCCCCCEecCCCccCCCCCCccccCCccccccccccccccCCCCCCCC-CC--
Q 007680          114 --------------------DIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKLEG-EI--  170 (593)
Q Consensus       114 --------------------~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~~N~l~~~~p~~~~-~~--  170 (593)
                                          ..+..|.++++|+.|+|++|+|++.+|..|.++++|+.|+|++|++++.+|..+. .+  
T Consensus       451 ~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~~L~~  530 (844)
T 3j0a_A          451 PSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLPANLEI  530 (844)
T ss_dssp             TTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCCSCCCE
T ss_pred             CccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhhccccE
Confidence                                2234567788888888888888887888888888888888888888887766442 00  


Q ss_pred             ----------CCCCCccCCCcccccCCccCC
Q 007680          171 ----------PVKGSFKNFSTESFFGNYALC  191 (593)
Q Consensus       171 ----------~~~~~~~~~~~~~~~~n~~~c  191 (593)
                                +....+..+....+.+||+.|
T Consensus       531 L~Ls~N~l~~~~~~~~~~L~~l~l~~Np~~C  561 (844)
T 3j0a_A          531 LDISRNQLLAPNPDVFVSLSVLDITHNKFIC  561 (844)
T ss_dssp             EEEEEECCCCCCSCCCSSCCEEEEEEECCCC
T ss_pred             EECCCCcCCCCChhHhCCcCEEEecCCCccc
Confidence                      001234455667788888887

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.80  E-value=1.5e-19  Score=192.26  Aligned_cols=168  Identities=21%  Similarity=0.208  Sum_probs=110.6

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLL   80 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~   80 (593)
                      |+.|+|++|+|+ .++...+..+++|++|+|++|+|++..+.+|.++++|+.|+|++|+|+...++.|..+++|++|+|+
T Consensus        66 l~~L~L~~n~i~-~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  144 (440)
T 3zyj_A           66 TRLLNLHENQIQ-IIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLR  144 (440)
T ss_dssp             CSEEECCSCCCC-EECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEECC
T ss_pred             CcEEEccCCcCC-eeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeCC
Confidence            578999999999 5665555569999999999999998888899999999999999999997777789999999999555


Q ss_pred             ccee-----------------eccCCcccc-----cCCCcccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCC
Q 007680           81 MFGI-----------------RLTGNKLYG-----RIPPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGP  138 (593)
Q Consensus        81 ~n~l-----------------~l~~n~l~~-----~~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~  138 (593)
                      +|.+                 ++++|+..+     .+..+.+|++|+|++|+++ .+| .+..+++|+.|+|++|+|++.
T Consensus       145 ~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~  222 (440)
T 3zyj_A          145 NNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAI  222 (440)
T ss_dssp             SCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCC-CCTTCSSCCEEECTTSCCCEE
T ss_pred             CCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-ccc-ccCCCcccCEEECCCCccCcc
Confidence            4432                 122211111     1222333555555555554 333 244555555555555555544


Q ss_pred             CCccccCCccccccccccccccCCCCCCCCCCC
Q 007680          139 IPESVGSLISLESLDLSGNNLSGKIPKLEGEIP  171 (593)
Q Consensus       139 ~p~~l~~~~~L~~L~l~~N~l~~~~p~~~~~~~  171 (593)
                      .|..|.++++|+.|++++|++++..+..+..++
T Consensus       223 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~  255 (440)
T 3zyj_A          223 RPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQ  255 (440)
T ss_dssp             CTTTTTTCTTCCEEECTTCCCCEECTTSSTTCT
T ss_pred             ChhhhccCccCCEEECCCCceeEEChhhhcCCC
Confidence            455555555555555555555555554444333

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.80  E-value=4.1e-19  Score=168.74  Aligned_cols=157  Identities=24%  Similarity=0.240  Sum_probs=136.3

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLL   80 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~   80 (593)
                      |+.|+|++|+++ .+|...+..+++|++|+|++|+|++..+..|.++++|++|+|++|++++..+..|..+++|++|   
T Consensus        30 l~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L---  105 (208)
T 2o6s_A           30 TTYLDLETNSLK-SLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKEL---  105 (208)
T ss_dssp             CSEEECCSSCCC-CCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE---
T ss_pred             CcEEEcCCCccC-cCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEE---
Confidence            689999999999 7887766669999999999999997767778999999999999999997777779999999999   


Q ss_pred             cceeeccCCcccccC----CCcccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCccccCCcccccccccc
Q 007680           81 MFGIRLTGNKLYGRI----PPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSG  156 (593)
Q Consensus        81 ~n~l~l~~n~l~~~~----~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~~  156 (593)
                          ++++|++.+..    ..+..|++|++++|++++..+..|..+++|+.|++++|++.+       .+++|+.|+++.
T Consensus       106 ----~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~-------~~~~l~~L~~~~  174 (208)
T 2o6s_A          106 ----ALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC-------TCPGIRYLSEWI  174 (208)
T ss_dssp             ----ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC-------CTTTTHHHHHHH
T ss_pred             ----EcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec-------CCCCHHHHHHHH
Confidence                77888887433    345569999999999997777778999999999999999874       456899999999


Q ss_pred             ccccCCCCCCCCCCCC
Q 007680          157 NNLSGKIPKLEGEIPV  172 (593)
Q Consensus       157 N~l~~~~p~~~~~~~~  172 (593)
                      |+++|.+|..+..++.
T Consensus       175 n~~~g~ip~~~~~l~~  190 (208)
T 2o6s_A          175 NKHSGVVRNSAGSVAP  190 (208)
T ss_dssp             HHCTTTBBCTTSSBCT
T ss_pred             HhCCceeeccCccccC
Confidence            9999999987766553

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=99.80  E-value=1e-19  Score=201.56  Aligned_cols=178  Identities=21%  Similarity=0.202  Sum_probs=106.9

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCC-ccCCCCCCCcEEEccCCcccccccccccCCCCchhhhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIP-NSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSL   79 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l   79 (593)
                      |+.|+|++|.+. .+|..+.. +++|+.|+|++|++++..| ..|.++++|+.|+|++|.+++..|..|+.+++|++|  
T Consensus       378 L~~L~L~~n~l~-~~~~~~~~-l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L--  453 (606)
T 3vq2_A          378 LRHLDLSFNGAI-IMSANFMG-LEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTL--  453 (606)
T ss_dssp             CCEEECCSCSEE-EECCCCTT-CTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEE--
T ss_pred             ccEeECCCCccc-cchhhccC-CCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEE--
Confidence            344555555554 34433332 5555555555555554444 345555555555555555555555555555555555  


Q ss_pred             hcceeeccCCccccc-----CCCcccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCccccCCcccccccc
Q 007680           80 LMFGIRLTGNKLYGR-----IPPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDL  154 (593)
Q Consensus        80 ~~n~l~l~~n~l~~~-----~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l  154 (593)
                           ++++|++.+.     +..+..|++|++++|++++.+|..|.++++|+.|++++|++++..|..+.++++|+.|++
T Consensus       454 -----~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l  528 (606)
T 3vq2_A          454 -----KMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDC  528 (606)
T ss_dssp             -----ECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEEC
T ss_pred             -----ECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEEC
Confidence                 5666666542     233445777777777777766777777777777777777777666777777777777777


Q ss_pred             ccccccCCCCCCCCCCCCCCCccCCCcccccCCccCCCC
Q 007680          155 SGNNLSGKIPKLEGEIPVKGSFKNFSTESFFGNYALCGP  193 (593)
Q Consensus       155 ~~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~n~~~c~~  193 (593)
                      ++|+++.+++. +..++.     .+....+.+|+..|.-
T Consensus       529 ~~N~l~~~p~~-~~~l~~-----~L~~l~l~~N~~~c~c  561 (606)
T 3vq2_A          529 SFNRIETSKGI-LQHFPK-----SLAFFNLTNNSVACIC  561 (606)
T ss_dssp             TTSCCCCEESC-GGGSCT-----TCCEEECCSCCCCCSS
T ss_pred             CCCcCcccCHh-Hhhhcc-----cCcEEEccCCCcccCC
Confidence            77777753333 444331     2445567788877743

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.79  E-value=1.7e-19  Score=199.40  Aligned_cols=158  Identities=23%  Similarity=0.258  Sum_probs=87.9

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLL   80 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~   80 (593)
                      |+.|+|++|.|+ .+|+..+..+++|++|+|++|.|++..+..|.++++|+.|+|++|.+++..|..|+.+++|++|+|+
T Consensus       101 L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~  179 (597)
T 3oja_B          101 IQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLS  179 (597)
T ss_dssp             CCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECT
T ss_pred             CCEEECCCCcCC-CCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECc
Confidence            566777777776 4554443447777777777777775444456777777777777777776666677777777777665


Q ss_pred             ccee--------------eccCCcccc-------------------cCCC-cccccEEEccCCcccCcCCCCCCCCCCCC
Q 007680           81 MFGI--------------RLTGNKLYG-------------------RIPP-CLVLTVLDVSRNQLSGDIPSTIGGRVDLE  126 (593)
Q Consensus        81 ~n~l--------------~l~~n~l~~-------------------~~~~-~~~L~~L~l~~N~l~~~~p~~~~~l~~L~  126 (593)
                      +|.+              ++++|.+.+                   ..+. ...|+.|+|++|.+++  +..+..+++|+
T Consensus       180 ~N~l~~~~~~~l~~L~~L~l~~n~l~~l~~~~~L~~L~ls~n~l~~~~~~~~~~L~~L~L~~n~l~~--~~~l~~l~~L~  257 (597)
T 3oja_B          180 SNRLTHVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVRGPVNVELTILKLQHNNLTD--TAWLLNYPGLV  257 (597)
T ss_dssp             TSCCSBCCGGGCTTCSEEECCSSCCSEEECCTTCSEEECCSSCCCEEECSCCSCCCEEECCSSCCCC--CGGGGGCTTCS
T ss_pred             CCCCCCcChhhhhhhhhhhcccCccccccCCchhheeeccCCcccccccccCCCCCEEECCCCCCCC--ChhhccCCCCC
Confidence            5432              122222211                   0000 0113444444444432  12345555555


Q ss_pred             EecCCCccCCCCCCccccCCccccccccccccccC
Q 007680          127 TLSLASNQFQGPIPESVGSLISLESLDLSGNNLSG  161 (593)
Q Consensus       127 ~L~l~~N~l~~~~p~~l~~~~~L~~L~l~~N~l~~  161 (593)
                      .|+|++|.|++.+|..|..+++|+.|+|++|++++
T Consensus       258 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  292 (597)
T 3oja_B          258 EVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA  292 (597)
T ss_dssp             EEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE
T ss_pred             EEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC
Confidence            55555555555555555555555555555555555

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=99.79  E-value=2e-19  Score=188.07  Aligned_cols=158  Identities=22%  Similarity=0.237  Sum_probs=82.9

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLL   80 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~   80 (593)
                      |++|+|++|+++ .+|...+..+++|++|+|++|+|+...+..|.++++|+.|+|++|.+++..|..|..+++|++|+|+
T Consensus        95 L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~  173 (390)
T 3o6n_A           95 IQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLS  173 (390)
T ss_dssp             CCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECC
T ss_pred             cCEEECCCCCCC-cCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECC
Confidence            456666666666 4444433346666666666666663333345666677777777777666556666666677766555


Q ss_pred             ccee--------------eccCCcccc-------------------cCC-CcccccEEEccCCcccCcCCCCCCCCCCCC
Q 007680           81 MFGI--------------RLTGNKLYG-------------------RIP-PCLVLTVLDVSRNQLSGDIPSTIGGRVDLE  126 (593)
Q Consensus        81 ~n~l--------------~l~~n~l~~-------------------~~~-~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~  126 (593)
                      +|.+              ++++|.+.+                   .-. ....|++|++++|.+++ + ..+..+++|+
T Consensus       174 ~n~l~~~~~~~l~~L~~L~l~~n~l~~~~~~~~L~~L~l~~n~l~~~~~~~~~~L~~L~l~~n~l~~-~-~~l~~l~~L~  251 (390)
T 3o6n_A          174 SNRLTHVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVRGPVNVELTILKLQHNNLTD-T-AWLLNYPGLV  251 (390)
T ss_dssp             SSCCSBCCGGGCTTCSEEECCSSCCSEEECCSSCSEEECCSSCCCEEECCCCSSCCEEECCSSCCCC-C-GGGGGCTTCS
T ss_pred             CCcCCccccccccccceeecccccccccCCCCcceEEECCCCeeeeccccccccccEEECCCCCCcc-c-HHHcCCCCcc
Confidence            4432              112221110                   000 00123444444444432 1 2344555566


Q ss_pred             EecCCCccCCCCCCccccCCccccccccccccccC
Q 007680          127 TLSLASNQFQGPIPESVGSLISLESLDLSGNNLSG  161 (593)
Q Consensus       127 ~L~l~~N~l~~~~p~~l~~~~~L~~L~l~~N~l~~  161 (593)
                      +|++++|++++..|..+..+++|+.|++++|++++
T Consensus       252 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~  286 (390)
T 3o6n_A          252 EVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA  286 (390)
T ss_dssp             EEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE
T ss_pred             EEECCCCcCCCcChhHccccccCCEEECCCCcCcc
Confidence            66666665555455555555555555555555554

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=99.79  E-value=2.2e-19  Score=201.65  Aligned_cols=180  Identities=22%  Similarity=0.252  Sum_probs=101.8

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccC--------------------------CccCCCCCCCcEEE
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTI--------------------------PNSITNATKLIVLD   54 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~--------------------------p~~~~~l~~L~~L~   54 (593)
                      |+.|+|++|.+++.+|...+.++++|++|+|++|++++..                          |..|.++++|+.|+
T Consensus       407 L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~  486 (680)
T 1ziw_A          407 LEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILD  486 (680)
T ss_dssp             CCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEE
T ss_pred             CCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEE
Confidence            4566666666665555444444666666666666655433                          33444444455555


Q ss_pred             ccCCcccccccccccCCCCchhhhhhcceeeccCCccccc------------CCCcccccEEEccCCcccCcCCCCCCCC
Q 007680           55 LGFNSFSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGR------------IPPCLVLTVLDVSRNQLSGDIPSTIGGR  122 (593)
Q Consensus        55 L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~l~~n~l~~~------------~~~~~~L~~L~l~~N~l~~~~p~~~~~l  122 (593)
                      |++|+|++..|..|..+++|++|       ++++|++++.            +..+..|++|+|++|+++...+..|.++
T Consensus       487 Ls~N~l~~i~~~~~~~l~~L~~L-------~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l  559 (680)
T 1ziw_A          487 LSNNNIANINDDMLEGLEKLEIL-------DLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDL  559 (680)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCCEE-------ECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTC
T ss_pred             CCCCCCCcCChhhhccccccCEE-------eCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccc
Confidence            55555544444444445555544       4555555421            2333446666666666664333456666


Q ss_pred             CCCCEecCCCccCCCCCCccccCCccccccccccccccCCCCCCCCCCCCCCCccCCCcccccCCccCCC
Q 007680          123 VDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKLEGEIPVKGSFKNFSTESFFGNYALCG  192 (593)
Q Consensus       123 ~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~n~~~c~  192 (593)
                      ++|+.|+|++|+|++..+..|.++++|+.|++++|++++..|..+.     ..+.++....+.+||+.|.
T Consensus       560 ~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-----~~~~~L~~l~l~~N~~~c~  624 (680)
T 1ziw_A          560 FELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFG-----PAFRNLTELDMRFNPFDCT  624 (680)
T ss_dssp             TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHH-----HHHTTCSEEECTTCCCCBC
T ss_pred             cCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhc-----ccccccCEEEccCCCcccC
Confidence            6666666666666655555556666666666666666665554332     0233455677889999885

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.79  E-value=2.1e-19  Score=182.07  Aligned_cols=158  Identities=22%  Similarity=0.235  Sum_probs=92.2

Q ss_pred             CcEEEeeCccccccCChhhh-hCCCCCcEEECCCCcCcccCCccCCCC-----CCCcEEEccCCcccccccccccCCCCc
Q 007680            1 MRILTLEGNQLSGRLPSTIG-HSLPNIEYLLLTANNLTGTIPNSITNA-----TKLIVLDLGFNSFSGHILNTFGNLRHL   74 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~-~~l~~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~~p~~~~~l~~L   74 (593)
                      |++|+|++|++++.+|..++ ..+++|++|+|++|+|++. |..+.++     ++|++|+|++|++++..|+.|+.+++|
T Consensus        97 L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L  175 (312)
T 1wwl_A           97 LQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPAL  175 (312)
T ss_dssp             CCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSC
T ss_pred             ccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCC
Confidence            45666777766666666552 3466666666666666654 5555554     666666666666665555666666666


Q ss_pred             hhhhhhcce---------------------eeccCCcccc--cCC-----CcccccEEEccCCcccCcCC-CCCCCCCCC
Q 007680           75 SVLSLLMFG---------------------IRLTGNKLYG--RIP-----PCLVLTVLDVSRNQLSGDIP-STIGGRVDL  125 (593)
Q Consensus        75 ~~L~l~~n~---------------------l~l~~n~l~~--~~~-----~~~~L~~L~l~~N~l~~~~p-~~~~~l~~L  125 (593)
                      ++|+|++|.                     +++++|++.+  .++     .+..|++|++++|++++.+| ..+..+++|
T Consensus       176 ~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L  255 (312)
T 1wwl_A          176 STLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQL  255 (312)
T ss_dssp             CEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTC
T ss_pred             CEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCC
Confidence            666333222                     1445555541  111     22346666666666665443 344556666


Q ss_pred             CEecCCCccCCCCCCccccCCccccccccccccccCC
Q 007680          126 ETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGK  162 (593)
Q Consensus       126 ~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~~N~l~~~  162 (593)
                      +.|+|++|+|+ .+|..+.  ++|+.||+++|++++.
T Consensus       256 ~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~  289 (312)
T 1wwl_A          256 NSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN  289 (312)
T ss_dssp             CEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC
T ss_pred             CEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC
Confidence            66666666666 5555554  5666666666666654

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.79  E-value=1.1e-19  Score=183.61  Aligned_cols=163  Identities=28%  Similarity=0.319  Sum_probs=118.3

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCccc--CCccCCCCCCCcEEEccCCcccccccccccCCCCchhhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGT--IPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLS   78 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~   78 (593)
                      |+.|+|++|+++ .+|..++..+++|++|+|++|+|+..  .|..+..+++|++|+|++|.++ .+|..|..+++|++| 
T Consensus        30 l~~L~L~~n~l~-~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L-  106 (306)
T 2z66_A           30 ATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHL-  106 (306)
T ss_dssp             CCEEECCSSCCC-CCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCSCSEE-EEEEEEETCTTCCEE-
T ss_pred             CCEEECCCCccC-ccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECCCCccc-cChhhcCCCCCCCEE-
Confidence            578888888888 78877665688888888888888732  2566667888888888888888 566678888888888 


Q ss_pred             hhcceeeccCCcccc-----cCCCcccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCC-CCCccccCCcccccc
Q 007680           79 LLMFGIRLTGNKLYG-----RIPPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQG-PIPESVGSLISLESL  152 (593)
Q Consensus        79 l~~n~l~l~~n~l~~-----~~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~-~~p~~l~~~~~L~~L  152 (593)
                            ++++|++.+     .+..+..|++|++++|.+++..|..|.++++|+.|++++|++++ .+|..+..+++|+.|
T Consensus       107 ------~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L  180 (306)
T 2z66_A          107 ------DFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFL  180 (306)
T ss_dssp             ------ECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEE
T ss_pred             ------ECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEE
Confidence                  555555553     23334457777777777776677777777777777777777764 466777777777777


Q ss_pred             ccccccccCCCCCCCCCCCC
Q 007680          153 DLSGNNLSGKIPKLEGEIPV  172 (593)
Q Consensus       153 ~l~~N~l~~~~p~~~~~~~~  172 (593)
                      ++++|++++..|..+..++.
T Consensus       181 ~Ls~n~l~~~~~~~~~~l~~  200 (306)
T 2z66_A          181 DLSQCQLEQLSPTAFNSLSS  200 (306)
T ss_dssp             ECTTSCCCEECTTTTTTCTT
T ss_pred             ECCCCCcCCcCHHHhcCCCC
Confidence            77777777776666655543

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=99.79  E-value=2.2e-19  Score=192.97  Aligned_cols=166  Identities=24%  Similarity=0.219  Sum_probs=131.5

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLL   80 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~   80 (593)
                      |+.|+|++|+|+ .++...+..+++|++|+|++|+|++..|.+|.++++|+.|+|++|++++..+..|..+++|++|   
T Consensus        34 l~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L---  109 (477)
T 2id5_A           34 TRLLDLGKNRIK-TLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKL---  109 (477)
T ss_dssp             CSEEECCSSCCC-EECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEE---
T ss_pred             CcEEECCCCccc-eECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEE---
Confidence            578888888888 5544434458888888888888888778888888888888888888886666678888888888   


Q ss_pred             cceeeccCCccccc----CCCcccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCccccCCcccccccccc
Q 007680           81 MFGIRLTGNKLYGR----IPPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSG  156 (593)
Q Consensus        81 ~n~l~l~~n~l~~~----~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~~  156 (593)
                          ++++|++.+.    +..+..|++|++++|.+++..|..|.++++|+.|++++|++++..+..+..+++|+.|++++
T Consensus       110 ----~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~  185 (477)
T 2id5_A          110 ----DISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRH  185 (477)
T ss_dssp             ----ECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEES
T ss_pred             ----ECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCC
Confidence                7777777643    34455688899999988877788888888899999999988866666788888899999999


Q ss_pred             ccccCCCCCCCCCCCCCC
Q 007680          157 NNLSGKIPKLEGEIPVKG  174 (593)
Q Consensus       157 N~l~~~~p~~~~~~~~~~  174 (593)
                      |++++..+..+..++.+.
T Consensus       186 n~i~~~~~~~~~~l~~L~  203 (477)
T 2id5_A          186 LNINAIRDYSFKRLYRLK  203 (477)
T ss_dssp             CCCCEECTTCSCSCTTCC
T ss_pred             CcCcEeChhhcccCcccc
Confidence            888887777666655443

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.79  E-value=2e-19  Score=178.74  Aligned_cols=158  Identities=25%  Similarity=0.218  Sum_probs=128.6

Q ss_pred             EEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhhcc
Q 007680            3 ILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLMF   82 (593)
Q Consensus         3 ~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n   82 (593)
                      .++.++.++. .+|..+.   ++|++|+|++|+|++..+..|.++++|+.|+|++|++++..+..|..+++|++|     
T Consensus        11 ~~~c~~~~l~-~ip~~l~---~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L-----   81 (276)
T 2z62_A           11 TYQCMELNFY-KIPDNLP---FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTL-----   81 (276)
T ss_dssp             EEECTTSCCS-SCCSSSC---TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEE-----
T ss_pred             eEEecCCCcc-ccCCCCC---CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEE-----
Confidence            4677788887 7887654   478999999999997777788999999999999999987777789999999998     


Q ss_pred             eeeccCCccccc----CCCcccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCC-CCccccCCccccccccccc
Q 007680           83 GIRLTGNKLYGR----IPPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGP-IPESVGSLISLESLDLSGN  157 (593)
Q Consensus        83 ~l~l~~n~l~~~----~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~-~p~~l~~~~~L~~L~l~~N  157 (593)
                        ++++|++.+.    +..+..|++|++++|++++..+..++++++|+.|++++|++++. +|..+..+++|+.|++++|
T Consensus        82 --~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N  159 (276)
T 2z62_A           82 --ILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSN  159 (276)
T ss_dssp             --ECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSS
T ss_pred             --ECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCC
Confidence              7777777643    44455699999999999876666788999999999999999853 5888999999999999999


Q ss_pred             cccCCCCCCCCCCC
Q 007680          158 NLSGKIPKLEGEIP  171 (593)
Q Consensus       158 ~l~~~~p~~~~~~~  171 (593)
                      ++++..+..+..++
T Consensus       160 ~l~~~~~~~~~~l~  173 (276)
T 2z62_A          160 KIQSIYCTDLRVLH  173 (276)
T ss_dssp             CCCEECGGGGHHHH
T ss_pred             CCCcCCHHHhhhhh
Confidence            99887776554444

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=99.79  E-value=1.7e-19  Score=199.65  Aligned_cols=175  Identities=22%  Similarity=0.202  Sum_probs=98.2

Q ss_pred             cEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCcc-CCCCCCCcEEEccCCcccccccccccCCCCchhhhhh
Q 007680            2 RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNS-ITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLL   80 (593)
Q Consensus         2 ~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~   80 (593)
                      ++|+|++|++.+..|..+. .+++|++|+|++|++++..|.. |.++++|+.|+|++|.+++..|..|+.+++|++|   
T Consensus       379 ~~L~l~~n~l~~~~~~~~~-~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L---  454 (606)
T 3t6q_A          379 QSLNLSYNEPLSLKTEAFK-ECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHL---  454 (606)
T ss_dssp             CEEECCSCSCEEECTTTTT-TCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEE---
T ss_pred             CEEECCCCcCCcCCHHHhc-CCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEE---
Confidence            3444444444422222222 2444444444444444333322 4444444444444444444444444444555544   


Q ss_pred             cceeeccCCcccc-------cCCCcccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCccccCCccccccc
Q 007680           81 MFGIRLTGNKLYG-------RIPPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLD  153 (593)
Q Consensus        81 ~n~l~l~~n~l~~-------~~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~  153 (593)
                          ++++|++.+       .+..+..|++|++++|++++..|..|.++++|+.|+|++|++++..|..+..++.| .|+
T Consensus       455 ----~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~  529 (606)
T 3t6q_A          455 ----NLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLN  529 (606)
T ss_dssp             ----ECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEE
T ss_pred             ----ECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEE
Confidence                555665543       12233457777777777776666777777777777777777776667777777777 777


Q ss_pred             cccccccCCCCCCCCCCCCCCCccCCCcccccCCccCC
Q 007680          154 LSGNNLSGKIPKLEGEIPVKGSFKNFSTESFFGNYALC  191 (593)
Q Consensus       154 l~~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~n~~~c  191 (593)
                      +++|++++.+|..+..++      .+....+.+|+..|
T Consensus       530 L~~N~l~~~~~~~~~~l~------~L~~L~l~~N~~~c  561 (606)
T 3t6q_A          530 LASNHISIILPSLLPILS------QQRTINLRQNPLDC  561 (606)
T ss_dssp             CCSSCCCCCCGGGHHHHH------TSSEEECTTCCEEC
T ss_pred             CcCCcccccCHhhcccCC------CCCEEeCCCCCccc
Confidence            777777766666544333      34456677887766

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.78  E-value=1.7e-19  Score=177.33  Aligned_cols=137  Identities=20%  Similarity=0.250  Sum_probs=107.7

Q ss_pred             ccccccccCccCcccEEEEEe-CCCCe--EEEEEeehhhH------------------------HHHHHHHHHHHHHhhc
Q 007680          273 EFNECNLLGTSSFGSVYKGTI-SDGTD--VAIKVFNLQLE------------------------RAFRSFDSECEVLRNV  325 (593)
Q Consensus       273 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~------------------------~~~~~~~~E~~~l~~l  325 (593)
                      -|++.+.||+|+||.||+|.. .+|+.  ||||+++....                        .....+.+|+.++.++
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            367889999999999999997 68889  99998754311                        1123678999999999


Q ss_pred             CCCCc--ceeeeeeecCCceEEEEeccCC-C----CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCCeEec
Q 007680          326 RHRNL--IKILSSYSNPDFKALVLEFMPN-G----SLEKWLYSHNYFLDILERLNIMIDVGSALEYLH-NGHSSVHIIHC  397 (593)
Q Consensus       326 ~h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH-~~~~~~~ivH~  397 (593)
                      .|+++  ..+++.    +..++||||+.+ |    +|.++...    .++..+..++.|++.||.||| +.+    |+||
T Consensus       128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~g----ivHr  195 (258)
T 1zth_A          128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEAE----LVHA  195 (258)
T ss_dssp             HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTSC----EECS
T ss_pred             HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHCC----EEeC
Confidence            88764  334432    356899999942 3    77776543    234567889999999999999 655    9999


Q ss_pred             CCCCCCeeeCCCCcEEEEeeccceec
Q 007680          398 DLKPTNILLDENMVAHVSDFGIYKLL  423 (593)
Q Consensus       398 Dlkp~NIll~~~~~~kL~Dfg~a~~~  423 (593)
                      ||||+|||+++  .++|+|||+|...
T Consensus       196 Dlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          196 DLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             SCSTTSEEESS--SEEECCCTTCEET
T ss_pred             CCCHHHEEEcC--cEEEEECcccccC
Confidence            99999999998  9999999999764

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.78  E-value=3.2e-19  Score=180.55  Aligned_cols=159  Identities=19%  Similarity=0.174  Sum_probs=84.0

Q ss_pred             CcEEEeeCccccccCChhhh-hCCCCCcEEECCCCcCcccCC----ccCCCCCCCcEEEccCCcccccccccccCCCCch
Q 007680            1 MRILTLEGNQLSGRLPSTIG-HSLPNIEYLLLTANNLTGTIP----NSITNATKLIVLDLGFNSFSGHILNTFGNLRHLS   75 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~-~~l~~L~~L~L~~N~l~~~~p----~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~   75 (593)
                      |+.|+|++|++.+.+|..++ ..+++|++|+|++|+|++..|    ..+..+++|+.|+|++|++++..|..|+.+++|+
T Consensus        93 L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~  172 (310)
T 4glp_A           93 LKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALT  172 (310)
T ss_dssp             CCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCC
T ss_pred             eeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCCC
Confidence            45666666666655555442 235555555555555554333    2234455555555555555544445555555555


Q ss_pred             hhhhhccee---------------------eccCCcccc--c-----CCCcccccEEEccCCcccCcCCCCCCCC---CC
Q 007680           76 VLSLLMFGI---------------------RLTGNKLYG--R-----IPPCLVLTVLDVSRNQLSGDIPSTIGGR---VD  124 (593)
Q Consensus        76 ~L~l~~n~l---------------------~l~~n~l~~--~-----~~~~~~L~~L~l~~N~l~~~~p~~~~~l---~~  124 (593)
                      +|+|++|.+                     ++++|+++.  .     +..+..|++|+|++|+|++..|..+..+   ++
T Consensus       173 ~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~  252 (310)
T 4glp_A          173 SLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSA  252 (310)
T ss_dssp             EEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTT
T ss_pred             EEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCc
Confidence            552222210                     444555531  1     1122346666666666665555555554   46


Q ss_pred             CCEecCCCccCCCCCCccccCCccccccccccccccCC
Q 007680          125 LETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGK  162 (593)
Q Consensus       125 L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~~N~l~~~  162 (593)
                      |+.|+|++|+|+ .+|..+.  ++|+.|++++|++++.
T Consensus       253 L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~  287 (310)
T 4glp_A          253 LNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA  287 (310)
T ss_dssp             CCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC
T ss_pred             CCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC
Confidence            666666666666 4555543  5666666666666653

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=99.78  E-value=5.3e-19  Score=188.65  Aligned_cols=157  Identities=24%  Similarity=0.226  Sum_probs=107.5

Q ss_pred             CcEEEeeCccccccCChhhhhC--------------------------------------CCCCcEEECCCCcCcccCCc
Q 007680            1 MRILTLEGNQLSGRLPSTIGHS--------------------------------------LPNIEYLLLTANNLTGTIPN   42 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~--------------------------------------l~~L~~L~L~~N~l~~~~p~   42 (593)
                      |+.|+|++|++++.+|..+...                                      .++|+.|+|++|+|++..|.
T Consensus       214 L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~  293 (455)
T 3v47_A          214 ITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKS  293 (455)
T ss_dssp             EEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTT
T ss_pred             eeeEecCCCcccccchhhhhccccccceeeEeeccccccccccchhhhccCcccccccccccCceEEEecCccccccchh
Confidence            5788999999887777666531                                      14677777777777766677


Q ss_pred             cCCCCCCCcEEEccCCcccccccccccCCCCchhhhhhcceeeccCCccccc----CCCcccccEEEccCCcccCcCCCC
Q 007680           43 SITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGR----IPPCLVLTVLDVSRNQLSGDIPST  118 (593)
Q Consensus        43 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~l~~n~l~~~----~~~~~~L~~L~l~~N~l~~~~p~~  118 (593)
                      .|..+++|+.|+|++|++++..|..|..+++|++|       ++++|++.+.    +..+..|++|+|++|++++..|..
T Consensus       294 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L-------~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~  366 (455)
T 3v47_A          294 VFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKL-------NLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQS  366 (455)
T ss_dssp             TTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE-------ECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTT
T ss_pred             hcccCCCCCEEECCCCcccccChhHhcCcccCCEE-------ECCCCccCCcChhHhcCcccCCEEECCCCcccccChhh
Confidence            77777777777777777776666677777777777       5566665533    233445777777777777666667


Q ss_pred             CCCCCCCCEecCCCccCCCCCCccccCCccccccccccccccCCCC
Q 007680          119 IGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIP  164 (593)
Q Consensus       119 ~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~~N~l~~~~p  164 (593)
                      |.++++|++|++++|+|++..+..+..+++|+.|++++|++++..|
T Consensus       367 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~  412 (455)
T 3v47_A          367 FLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  412 (455)
T ss_dssp             TTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred             ccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence            7777777777777777775555556677777777777777776555

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.77  E-value=3.4e-19  Score=184.29  Aligned_cols=153  Identities=28%  Similarity=0.249  Sum_probs=130.6

Q ss_pred             CcEEEeeCccccccCChhhhh-CCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGH-SLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSL   79 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l   79 (593)
                      |+.|+|++|+|+ .+|...+. .+++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..+..|..+++|+.|  
T Consensus        41 l~~L~Ls~N~l~-~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L--  117 (361)
T 2xot_A           41 TALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVL--  117 (361)
T ss_dssp             CSEEECCSSCCC-EECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEE--
T ss_pred             CCEEECCCCCCC-ccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEE--
Confidence            578999999999 78777664 69999999999999998888899999999999999999998778889999999999  


Q ss_pred             hcceeeccCCcccc----cCCCcccccEEEccCCcccCcCCCCC---CCCCCCCEecCCCccCCCCCCccccCCcc--cc
Q 007680           80 LMFGIRLTGNKLYG----RIPPCLVLTVLDVSRNQLSGDIPSTI---GGRVDLETLSLASNQFQGPIPESVGSLIS--LE  150 (593)
Q Consensus        80 ~~n~l~l~~n~l~~----~~~~~~~L~~L~l~~N~l~~~~p~~~---~~l~~L~~L~l~~N~l~~~~p~~l~~~~~--L~  150 (593)
                           +|++|++.+    .+..+..|++|+|++|+|++..+..|   ..+++|+.|+|++|+|++..+..+..++.  |+
T Consensus       118 -----~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~  192 (361)
T 2xot_A          118 -----LLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKN  192 (361)
T ss_dssp             -----ECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHT
T ss_pred             -----ECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcc
Confidence                 778888774    34456679999999999996544445   57999999999999999666677888887  48


Q ss_pred             ccccccccccC
Q 007680          151 SLDLSGNNLSG  161 (593)
Q Consensus       151 ~L~l~~N~l~~  161 (593)
                      .|+|++|++.-
T Consensus       193 ~l~l~~N~~~C  203 (361)
T 2xot_A          193 GLYLHNNPLEC  203 (361)
T ss_dssp             TEECCSSCEEC
T ss_pred             eEEecCCCccC
Confidence            99999999973

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=99.77  E-value=1.2e-18  Score=191.22  Aligned_cols=156  Identities=21%  Similarity=0.265  Sum_probs=129.5

Q ss_pred             hCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCccccc--ccccccCCCCchhhhhhcceeeccCCcccccCCC-
Q 007680           21 HSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGH--ILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPP-   97 (593)
Q Consensus        21 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~l~~n~l~l~~n~l~~~~~~-   97 (593)
                      ..+++|++|+|++|+|++..|..|.++++|+.|+|++|++++.  +|..|..+++|++|       ++++|++.+.+|. 
T Consensus       350 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L-------~l~~N~l~~~~~~~  422 (562)
T 3a79_B          350 PSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETL-------DVSLNSLNSHAYDR  422 (562)
T ss_dssp             SSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEE-------ECTTSCCBSCCSSC
T ss_pred             cCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEE-------ECCCCcCCCccChh
Confidence            3478999999999999988999999999999999999999963  35679999999999       8888888764443 


Q ss_pred             ----cccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCccccCCccccccccccccccCCCCCCCCCCCCC
Q 007680           98 ----CLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKLEGEIPVK  173 (593)
Q Consensus        98 ----~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~~N~l~~~~p~~~~~~~~~  173 (593)
                          +..|++|++++|++++.+|..+.  ++|+.|++++|+|+ .+|..+..+++|+.|++++|+++++++..+..++  
T Consensus       423 ~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~--  497 (562)
T 3a79_B          423 TCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLT--  497 (562)
T ss_dssp             CCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCCCCTTSTTTCT--
T ss_pred             hhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCCCCHHHHhcCC--
Confidence                45699999999999888877664  78999999999998 7888888999999999999999976655455444  


Q ss_pred             CCccCCCcccccCCccCCC
Q 007680          174 GSFKNFSTESFFGNYALCG  192 (593)
Q Consensus       174 ~~~~~~~~~~~~~n~~~c~  192 (593)
                          .+......+|++.|.
T Consensus       498 ----~L~~L~l~~N~~~c~  512 (562)
T 3a79_B          498 ----SLQYIWLHDNPWDCT  512 (562)
T ss_dssp             ----TCCCEECCSCCBCCC
T ss_pred             ----CCCEEEecCCCcCCC
Confidence                444567888888763

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=99.77  E-value=1.2e-18  Score=189.42  Aligned_cols=155  Identities=22%  Similarity=0.234  Sum_probs=128.2

Q ss_pred             CCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccc--cccccccCCCCchhhhhhcceeeccCCcccccCC---
Q 007680           22 SLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSG--HILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIP---   96 (593)
Q Consensus        22 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~l~~n~l~l~~n~l~~~~~---   96 (593)
                      .+++|++|+|++|+|++..|..|.++++|+.|+|++|++++  .+|..|+.+++|++|       ++++|++.+.+|   
T Consensus       322 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L-------~Ls~N~l~~~l~~~~  394 (520)
T 2z7x_B          322 KISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQL-------DISQNSVSYDEKKGD  394 (520)
T ss_dssp             SCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEE-------ECCSSCCBCCGGGCS
T ss_pred             hCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEE-------ECCCCcCCcccccch
Confidence            57899999999999998889999999999999999999996  456789999999999       888888876444   


Q ss_pred             --CcccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCccccCCccccccccccccccCCCCCCCCCCCCCC
Q 007680           97 --PCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKLEGEIPVKG  174 (593)
Q Consensus        97 --~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~~N~l~~~~p~~~~~~~~~~  174 (593)
                        .+..|++|++++|++++..|..+.  ++|+.|++++|+|+ .+|..+..+++|+.|++++|+++++++..+..++   
T Consensus       395 ~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~---  468 (520)
T 2z7x_B          395 CSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLT---  468 (520)
T ss_dssp             CCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCT---
T ss_pred             hccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccCHHHhccCC---
Confidence              345699999999999888887664  78999999999998 7888888999999999999999976555444443   


Q ss_pred             CccCCCcccccCCccCCC
Q 007680          175 SFKNFSTESFFGNYALCG  192 (593)
Q Consensus       175 ~~~~~~~~~~~~n~~~c~  192 (593)
                         ++......+|+..|.
T Consensus       469 ---~L~~L~l~~N~~~c~  483 (520)
T 2z7x_B          469 ---SLQKIWLHTNPWDCS  483 (520)
T ss_dssp             ---TCCEEECCSSCBCCC
T ss_pred             ---cccEEECcCCCCccc
Confidence               445567888888763

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.77  E-value=1.5e-19  Score=183.02  Aligned_cols=156  Identities=24%  Similarity=0.314  Sum_probs=122.4

Q ss_pred             CcEEEeeCcccc-ccCChhhh------hCCCCCcEEECCCCcCcccCCccC--CCCCCCcEEEccCCcccccccccccCC
Q 007680            1 MRILTLEGNQLS-GRLPSTIG------HSLPNIEYLLLTANNLTGTIPNSI--TNATKLIVLDLGFNSFSGHILNTFGNL   71 (593)
Q Consensus         1 L~~L~Ls~n~l~-~~lp~~~~------~~l~~L~~L~L~~N~l~~~~p~~~--~~l~~L~~L~L~~N~l~~~~p~~~~~l   71 (593)
                      |+.|+|++|++. +.+|..++      ..+++|++|+|++|+|++.+|..+  ..+++|+.|+|++|++++. |..|+.+
T Consensus        65 L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l  143 (312)
T 1wwl_A           65 IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAEL  143 (312)
T ss_dssp             HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHH
T ss_pred             HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHH
Confidence            467899999994 56787765      138999999999999999999986  8999999999999999976 8888887


Q ss_pred             -----CCchhhhhhcceeeccCCcccccC----CCcccccEEEccCCcccCc--CCCCC--CCCCCCCEecCCCccCCCC
Q 007680           72 -----RHLSVLSLLMFGIRLTGNKLYGRI----PPCLVLTVLDVSRNQLSGD--IPSTI--GGRVDLETLSLASNQFQGP  138 (593)
Q Consensus        72 -----~~L~~L~l~~n~l~l~~n~l~~~~----~~~~~L~~L~l~~N~l~~~--~p~~~--~~l~~L~~L~l~~N~l~~~  138 (593)
                           ++|++|       ++++|++.+..    ..+..|++|++++|++.+.  .|..+  .++++|++|+|++|+|++.
T Consensus       144 ~~~~~~~L~~L-------~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~  216 (312)
T 1wwl_A          144 QQWLKPGLKVL-------SIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETP  216 (312)
T ss_dssp             HTTCCTTCCEE-------EEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCH
T ss_pred             HHhhcCCCcEE-------EeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcch
Confidence                 899999       77777776433    3445689999999987754  23233  7888888888888888731


Q ss_pred             --CC-ccccCCccccccccccccccCCCC
Q 007680          139 --IP-ESVGSLISLESLDLSGNNLSGKIP  164 (593)
Q Consensus       139 --~p-~~l~~~~~L~~L~l~~N~l~~~~p  164 (593)
                        ++ ..+..+++|+.|++++|++++.+|
T Consensus       217 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~  245 (312)
T 1wwl_A          217 SGVCSALAAARVQLQGLDLSHNSLRDAAG  245 (312)
T ss_dssp             HHHHHHHHHTTCCCSEEECTTSCCCSSCC
T ss_pred             HHHHHHHHhcCCCCCEEECCCCcCCcccc
Confidence              12 334567888888888888888664

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=99.77  E-value=2.3e-18  Score=180.06  Aligned_cols=130  Identities=25%  Similarity=0.312  Sum_probs=112.6

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLL   80 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~   80 (593)
                      |+.|++++|.++ .+|..++..+++|++|+|++|+|++..+..|.++++|+.|+|++|.+++..|..|+.+++|++|   
T Consensus        47 l~~l~l~~~~l~-~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L---  122 (390)
T 3o6n_A           47 QKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL---  122 (390)
T ss_dssp             CSEEEEESCEES-EECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE---
T ss_pred             ceEEEecCCchh-hCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEE---
Confidence            578999999998 8998877679999999999999998777899999999999999999998888889999999999   


Q ss_pred             cceeeccCCccccc----CCCcccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCC
Q 007680           81 MFGIRLTGNKLYGR----IPPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGP  138 (593)
Q Consensus        81 ~n~l~l~~n~l~~~----~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~  138 (593)
                          ++++|++...    +..+..|++|++++|++++..|..|.++++|+.|++++|++++.
T Consensus       123 ----~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~  180 (390)
T 3o6n_A          123 ----VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV  180 (390)
T ss_dssp             ----ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC
T ss_pred             ----ECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc
Confidence                7777777632    23445699999999999987788899999999999999998854

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=99.76  E-value=2e-18  Score=176.15  Aligned_cols=166  Identities=21%  Similarity=0.249  Sum_probs=132.7

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLL   80 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~   80 (593)
                      |+.|+|++|+++ .+|...+..+++|++|+|++|+|++..|..|.++++|++|+|++|+++ .+|..+.  ++|++|+++
T Consensus        54 l~~L~L~~n~i~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~--~~L~~L~l~  129 (330)
T 1xku_A           54 TALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMP--KTLQELRVH  129 (330)
T ss_dssp             CCEEECCSSCCC-CBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSCC--TTCCEEECC
T ss_pred             CeEEECCCCcCC-EeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCC-ccChhhc--ccccEEECC
Confidence            578999999999 677654446999999999999999888999999999999999999999 5665554  688999776


Q ss_pred             cce-----------------eeccCCcccc------cCCCcccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCC
Q 007680           81 MFG-----------------IRLTGNKLYG------RIPPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQG  137 (593)
Q Consensus        81 ~n~-----------------l~l~~n~l~~------~~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~  137 (593)
                      +|.                 +++++|.+..      .+..+..|++|++++|.++ .+|..+.  ++|+.|++++|++++
T Consensus       130 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~-~l~~~~~--~~L~~L~l~~n~l~~  206 (330)
T 1xku_A          130 ENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLP--PSLTELHLDGNKITK  206 (330)
T ss_dssp             SSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSCC--TTCSEEECTTSCCCE
T ss_pred             CCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc-cCCcccc--ccCCEEECCCCcCCc
Confidence            554                 4566666642      2233445888888888888 4665553  789999999999998


Q ss_pred             CCCccccCCccccccccccccccCCCCCCCCCCCCC
Q 007680          138 PIPESVGSLISLESLDLSGNNLSGKIPKLEGEIPVK  173 (593)
Q Consensus       138 ~~p~~l~~~~~L~~L~l~~N~l~~~~p~~~~~~~~~  173 (593)
                      ..|..+..+++|+.|++++|++++..+..+..++.+
T Consensus       207 ~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L  242 (330)
T 1xku_A          207 VDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHL  242 (330)
T ss_dssp             ECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTC
T ss_pred             cCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCC
Confidence            778899999999999999999999888766655543

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=99.76  E-value=7.6e-19  Score=195.14  Aligned_cols=157  Identities=25%  Similarity=0.231  Sum_probs=129.0

Q ss_pred             EEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhhcc
Q 007680            3 ILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLMF   82 (593)
Q Consensus         3 ~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n   82 (593)
                      +.+.++.+|+ .+|.++.   +++++|+|++|+|+++.|.+|.++++|++|+|++|+|+++.|++|.+|++|++|     
T Consensus        35 ~~~c~~~~l~-~vP~~lp---~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L-----  105 (635)
T 4g8a_A           35 TYQCMELNFY-KIPDNLP---FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTL-----  105 (635)
T ss_dssp             EEECTTSCCS-SCCSSSC---TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEE-----
T ss_pred             EEECCCCCcC-ccCCCCC---cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEE-----
Confidence            4577788888 8887654   378999999999997777789999999999999999997778889999999999     


Q ss_pred             eeeccCCcccc----cCCCcccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCC-CCCccccCCccccccccccc
Q 007680           83 GIRLTGNKLYG----RIPPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQG-PIPESVGSLISLESLDLSGN  157 (593)
Q Consensus        83 ~l~l~~n~l~~----~~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~-~~p~~l~~~~~L~~L~l~~N  157 (593)
                        +|++|+|++    .+.++.+|++|+|++|+|++..+..|+++++|++|+|++|++++ .+|..+..+++|+.|++++|
T Consensus       106 --~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N  183 (635)
T 4g8a_A          106 --ILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSN  183 (635)
T ss_dssp             --ECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSS
T ss_pred             --EccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCc
Confidence              777777763    34456679999999999987777778999999999999999875 35778888999999999999


Q ss_pred             cccCCCCCCCCCC
Q 007680          158 NLSGKIPKLEGEI  170 (593)
Q Consensus       158 ~l~~~~p~~~~~~  170 (593)
                      ++++..|..+..+
T Consensus       184 ~l~~~~~~~l~~L  196 (635)
T 4g8a_A          184 KIQSIYCTDLRVL  196 (635)
T ss_dssp             CCCEECGGGGHHH
T ss_pred             cccccccccccch
Confidence            9988877755433

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=99.76  E-value=9.8e-19  Score=194.26  Aligned_cols=161  Identities=26%  Similarity=0.239  Sum_probs=139.2

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLL   80 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~   80 (593)
                      +++|||++|+|+ .+|+..+.++++|++|+|++|+|+++.|++|.+|++|++|+|++|+|++..++.|.+|++|++|   
T Consensus        54 ~~~LdLs~N~i~-~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L---  129 (635)
T 4g8a_A           54 TKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKL---  129 (635)
T ss_dssp             CCEEECTTSCCC-EECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEE---
T ss_pred             CCEEEeeCCCCC-CCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEE---
Confidence            579999999999 7887666679999999999999998778899999999999999999998778889999999999   


Q ss_pred             cceeeccCCcccc----cCCCcccccEEEccCCcccCc-CCCCCCCCCCCCEecCCCccCCCCCCccccCCcccc----c
Q 007680           81 MFGIRLTGNKLYG----RIPPCLVLTVLDVSRNQLSGD-IPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLE----S  151 (593)
Q Consensus        81 ~n~l~l~~n~l~~----~~~~~~~L~~L~l~~N~l~~~-~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~----~  151 (593)
                          ++++|++++    .+..+..|++|+|++|.+++. +|..++.+++|+.|++++|+|++..|..+..+.+++    .
T Consensus       130 ----~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~  205 (635)
T 4g8a_A          130 ----VAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLS  205 (635)
T ss_dssp             ----ECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCE
T ss_pred             ----ECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhh
Confidence                778888774    244566799999999999753 577889999999999999999988888887776654    5


Q ss_pred             cccccccccCCCCCCCCC
Q 007680          152 LDLSGNNLSGKIPKLEGE  169 (593)
Q Consensus       152 L~l~~N~l~~~~p~~~~~  169 (593)
                      ++++.|+++.+.+..+..
T Consensus       206 ~~ls~n~l~~i~~~~~~~  223 (635)
T 4g8a_A          206 LDLSLNPMNFIQPGAFKE  223 (635)
T ss_dssp             EECTTCCCCEECTTTTTT
T ss_pred             hhcccCcccccCcccccc
Confidence            789999999887776543

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.76  E-value=1.7e-18  Score=162.98  Aligned_cols=145  Identities=18%  Similarity=0.236  Sum_probs=120.3

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLL   80 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~   80 (593)
                      |+.|+|++|+++ .+| ++.. +++|++|+|++|.++ . +..+..+++|++|+|++|++++..|..|+.+++|++|   
T Consensus        46 L~~L~l~~n~i~-~l~-~l~~-l~~L~~L~l~~n~~~-~-~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L---  117 (197)
T 4ezg_A           46 LTYITLANINVT-DLT-GIEY-AHNIKDLTINNIHAT-N-YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLL---  117 (197)
T ss_dssp             CCEEEEESSCCS-CCT-TGGG-CTTCSEEEEESCCCS-C-CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEE---
T ss_pred             ccEEeccCCCcc-ChH-HHhc-CCCCCEEEccCCCCC-c-chhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEE---
Confidence            678999999999 888 6664 999999999999887 3 3478899999999999999998788889999999999   


Q ss_pred             cceeeccCCccccc----CCCcccccEEEccCCc-ccCcCCCCCCCCCCCCEecCCCccCCCCCCccccCCccccccccc
Q 007680           81 MFGIRLTGNKLYGR----IPPCLVLTVLDVSRNQ-LSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLS  155 (593)
Q Consensus        81 ~n~l~l~~n~l~~~----~~~~~~L~~L~l~~N~-l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~  155 (593)
                          ++++|++++.    +..+..|++|++++|+ ++ .+| .+..+++|+.|++++|++++ ++ .+..+++|+.|+++
T Consensus       118 ----~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~  189 (197)
T 4ezg_A          118 ----DISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAF  189 (197)
T ss_dssp             ----ECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEEC
T ss_pred             ----EecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEee
Confidence                7788888752    4455679999999998 66 566 68899999999999999984 55 78899999999999


Q ss_pred             cccccC
Q 007680          156 GNNLSG  161 (593)
Q Consensus       156 ~N~l~~  161 (593)
                      +|++.+
T Consensus       190 ~N~i~~  195 (197)
T 4ezg_A          190 SQTIGG  195 (197)
T ss_dssp             BC----
T ss_pred             CcccCC
Confidence            999865

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.76  E-value=1.8e-19  Score=185.82  Aligned_cols=157  Identities=22%  Similarity=0.223  Sum_probs=84.6

Q ss_pred             EEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhhcce
Q 007680            4 LTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLMFG   83 (593)
Q Consensus         4 L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~   83 (593)
                      .++++|+++ .+|..++   ++|++|+|++|+|++..++.|.++++|+.|+|++|++++..|..|+.+++|++|      
T Consensus        36 c~~~~~~l~-~iP~~~~---~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L------  105 (353)
T 2z80_A           36 CKGSSGSLN-SIPSGLT---EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHL------  105 (353)
T ss_dssp             EECCSTTCS-SCCTTCC---TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE------
T ss_pred             eeCCCCCcc-ccccccc---ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEE------
Confidence            455556665 5555443   355666666666664444455666666666666666655555556666666655      


Q ss_pred             eeccCCccccc----CCCcccccEEEccCCcccCcCC-CCCCCCCCCCEecCCCc-cCCCCCCccccCCccccccccccc
Q 007680           84 IRLTGNKLYGR----IPPCLVLTVLDVSRNQLSGDIP-STIGGRVDLETLSLASN-QFQGPIPESVGSLISLESLDLSGN  157 (593)
Q Consensus        84 l~l~~n~l~~~----~~~~~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~L~l~~N-~l~~~~p~~l~~~~~L~~L~l~~N  157 (593)
                       ++++|++++.    +..+..|++|++++|++++..+ ..|.++++|+.|++++| .+++..|..+.++++|+.|++++|
T Consensus       106 -~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n  184 (353)
T 2z80_A          106 -DLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDAS  184 (353)
T ss_dssp             -ECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEET
T ss_pred             -ECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCC
Confidence             4455554421    2223345666666666553222 24555666666666655 344344455555566666666666


Q ss_pred             cccCCCCCCCCCCC
Q 007680          158 NLSGKIPKLEGEIP  171 (593)
Q Consensus       158 ~l~~~~p~~~~~~~  171 (593)
                      ++++..|..+..++
T Consensus       185 ~l~~~~~~~l~~l~  198 (353)
T 2z80_A          185 DLQSYEPKSLKSIQ  198 (353)
T ss_dssp             TCCEECTTTTTTCS
T ss_pred             CcCccCHHHHhccc
Confidence            66555555444433

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=99.76  E-value=2.7e-19  Score=198.95  Aligned_cols=150  Identities=17%  Similarity=0.279  Sum_probs=107.1

Q ss_pred             cccccCChhhhhCCCCCcEEECCCCcCccc-----------------CCccCC--CCCCCcEEEccCCcccccccccccC
Q 007680           10 QLSGRLPSTIGHSLPNIEYLLLTANNLTGT-----------------IPNSIT--NATKLIVLDLGFNSFSGHILNTFGN   70 (593)
Q Consensus        10 ~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~-----------------~p~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~   70 (593)
                      +++| +|..+++ +++|++|+|++|+|++.                 +|+.++  ++++|++|+|++|++.+.+|..|+.
T Consensus       194 ~l~~-ip~~l~~-l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~  271 (636)
T 4eco_A          194 NITF-VSKAVMR-LTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKA  271 (636)
T ss_dssp             EEEE-ECGGGGG-CTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTT
T ss_pred             CCcc-CCHHHhc-ccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhc
Confidence            4454 7777765 78888888888888864                 777777  8888888888888887788888888


Q ss_pred             CCCchhhhhhcceeeccCCc-ccc-cCCC----c------ccccEEEccCCcccCcCCC--CCCCCCCCCEecCCCccCC
Q 007680           71 LRHLSVLSLLMFGIRLTGNK-LYG-RIPP----C------LVLTVLDVSRNQLSGDIPS--TIGGRVDLETLSLASNQFQ  136 (593)
Q Consensus        71 l~~L~~L~l~~n~l~l~~n~-l~~-~~~~----~------~~L~~L~l~~N~l~~~~p~--~~~~l~~L~~L~l~~N~l~  136 (593)
                      +++|++|       ++++|+ +++ .+|.    +      ..|++|++++|+++ .+|.  .++++++|+.|++++|+++
T Consensus       272 l~~L~~L-------~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~  343 (636)
T 4eco_A          272 LPEMQLI-------NVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLE  343 (636)
T ss_dssp             CSSCCEE-------ECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCE
T ss_pred             CCCCCEE-------ECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCc
Confidence            8888888       666666 655 4442    1      45777777777777 6666  6777777777777777777


Q ss_pred             CCCCccccCCccccccccccccccCCCCCCCCCCC
Q 007680          137 GPIPESVGSLISLESLDLSGNNLSGKIPKLEGEIP  171 (593)
Q Consensus       137 ~~~p~~l~~~~~L~~L~l~~N~l~~~~p~~~~~~~  171 (593)
                      |.+| .+..+++|+.|++++|+++ .+|..+..++
T Consensus       344 g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~  376 (636)
T 4eco_A          344 GKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFT  376 (636)
T ss_dssp             EECC-CCEEEEEESEEECCSSEEE-ECCTTSEEEC
T ss_pred             cchh-hhCCCCCCCEEECCCCccc-cccHhhhhhc
Confidence            6677 6777777777777777777 4444444433

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.76  E-value=2.6e-18  Score=189.85  Aligned_cols=130  Identities=25%  Similarity=0.303  Sum_probs=108.1

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLL   80 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~   80 (593)
                      |+.|++++|.+. .+|..++..+++|++|+|++|.|++..|..|..+++|+.|+|++|.|++.+|..|+.+++|++|   
T Consensus        53 l~~l~l~~~~l~-~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L---  128 (597)
T 3oja_B           53 QKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL---  128 (597)
T ss_dssp             CSEEEESSCEES-EECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE---
T ss_pred             ceEEEeeCCCCC-CcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEE---
Confidence            467899999998 7888877678999999999999998777889999999999999999998888888999999999   


Q ss_pred             cceeeccCCcccccC----CCcccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCC
Q 007680           81 MFGIRLTGNKLYGRI----PPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGP  138 (593)
Q Consensus        81 ~n~l~l~~n~l~~~~----~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~  138 (593)
                          ++++|.+.+..    ..+..|++|+|++|.+++.+|..|+++++|+.|+|++|++++.
T Consensus       129 ----~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  186 (597)
T 3oja_B          129 ----VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV  186 (597)
T ss_dssp             ----ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBC
T ss_pred             ----EeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCc
Confidence                77777776332    3344688999999998887888888888888888888888754

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.76  E-value=1.4e-18  Score=162.93  Aligned_cols=129  Identities=28%  Similarity=0.344  Sum_probs=92.6

Q ss_pred             cEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCc-cCCCCCCCcEEEccCCcccccccccccCCCCchhhhhh
Q 007680            2 RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPN-SITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLL   80 (593)
Q Consensus         2 ~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~   80 (593)
                      ++|++++|+++ .+|..++.   +|++|+|++|+|++..+. .|.++++|+.|+|++|+|++..|..|..+++|++|   
T Consensus        11 ~~l~~s~~~l~-~ip~~~~~---~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L---   83 (192)
T 1w8a_A           11 TTVDCTGRGLK-EIPRDIPL---HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQEL---   83 (192)
T ss_dssp             TEEECTTSCCS-SCCSCCCT---TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEE---
T ss_pred             CEEEcCCCCcC-cCccCCCC---CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEE---
Confidence            57899999998 89987653   899999999999966664 48899999999999999998888888888887766   


Q ss_pred             cceeeccCCcccccCCCcccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCccccCCcccccccccccccc
Q 007680           81 MFGIRLTGNKLYGRIPPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLS  160 (593)
Q Consensus        81 ~n~l~l~~n~l~~~~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~~N~l~  160 (593)
                          ++++|                    +|++..|..|.++++|+.|+|++|+|++..|..+..+++|+.|++++|+|+
T Consensus        84 ----~Ls~N--------------------~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  139 (192)
T 1w8a_A           84 ----QLGEN--------------------KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFN  139 (192)
T ss_dssp             ----ECCSC--------------------CCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBC
T ss_pred             ----ECCCC--------------------cCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCcc
Confidence                44444                    444444444555555555555555555555555555555555555555555


Q ss_pred             C
Q 007680          161 G  161 (593)
Q Consensus       161 ~  161 (593)
                      +
T Consensus       140 c  140 (192)
T 1w8a_A          140 C  140 (192)
T ss_dssp             C
T ss_pred             C
Confidence            4

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=99.75  E-value=2.1e-18  Score=189.44  Aligned_cols=178  Identities=20%  Similarity=0.208  Sum_probs=132.5

Q ss_pred             CcEEEeeCccccccC--ChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCccccccc-ccccCCCCchhh
Q 007680            1 MRILTLEGNQLSGRL--PSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHIL-NTFGNLRHLSVL   77 (593)
Q Consensus         1 L~~L~Ls~n~l~~~l--p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L   77 (593)
                      |+.|+|++|++++..  |..+.. +++|++|+|++|++++. |..|.++++|+.|+|++|.+++..| ..|..+++|++|
T Consensus       349 L~~L~l~~n~l~~~~~~~~~~~~-~~~L~~L~l~~n~l~~~-~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L  426 (570)
T 2z63_A          349 LEFLDLSRNGLSFKGCCSQSDFG-TTSLKYLDLSFNGVITM-SSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYL  426 (570)
T ss_dssp             CCEEECCSSCCBEEEEEEHHHHT-CSCCCEEECCSCSEEEE-EEEEETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEE
T ss_pred             CCEEeCcCCccCccccccccccc-cCccCEEECCCCccccc-cccccccCCCCEEEccCCccccccchhhhhcCCCCCEE
Confidence            567777777776321  455553 77888888888887744 4447778888888888888876655 467778888887


Q ss_pred             hhhcceeeccCCcccccCC----CcccccEEEccCCccc-CcCCCCCCCCCCCCEecCCCccCCCCCCccccCCcccccc
Q 007680           78 SLLMFGIRLTGNKLYGRIP----PCLVLTVLDVSRNQLS-GDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESL  152 (593)
Q Consensus        78 ~l~~n~l~l~~n~l~~~~~----~~~~L~~L~l~~N~l~-~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L  152 (593)
                             ++++|.+.+.++    .+..|++|++++|.++ +.+|..+..+++|+.|++++|++++..|..+..+++|+.|
T Consensus       427 -------~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L  499 (570)
T 2z63_A          427 -------DISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVL  499 (570)
T ss_dssp             -------ECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred             -------eCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEE
Confidence                   667777665433    3456889999999887 5688888889999999999999987778888888999999


Q ss_pred             ccccccccCCCCCCCCCCCCCCCccCCCcccccCCccCCCC
Q 007680          153 DLSGNNLSGKIPKLEGEIPVKGSFKNFSTESFFGNYALCGP  193 (593)
Q Consensus       153 ~l~~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~n~~~c~~  193 (593)
                      ++++|++++.+|..+..++.      +....+.+|+..|.-
T Consensus       500 ~l~~n~l~~~~~~~~~~l~~------L~~L~l~~N~~~~~~  534 (570)
T 2z63_A          500 NMASNQLKSVPDGIFDRLTS------LQKIWLHTNPWDCSC  534 (570)
T ss_dssp             ECCSSCCSCCCTTTTTTCTT------CCEEECCSSCBCCCT
T ss_pred             eCCCCcCCCCCHHHhhcccC------CcEEEecCCcccCCC
Confidence            99999998887776655543      445577888877643

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=99.75  E-value=6.2e-18  Score=172.74  Aligned_cols=165  Identities=20%  Similarity=0.261  Sum_probs=111.1

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLL   80 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~   80 (593)
                      |+.+++++|+++ .+|..++   ++|+.|+|++|+|++..|+.|.++++|+.|+|++|++++..|..|+.+++|++|+|+
T Consensus        35 l~~l~~~~~~l~-~ip~~~~---~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  110 (332)
T 2ft3_A           35 LRVVQCSDLGLK-AVPKEIS---PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYIS  110 (332)
T ss_dssp             TTEEECCSSCCS-SCCSCCC---TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECC
T ss_pred             CCEEECCCCCcc-ccCCCCC---CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECC
Confidence            578999999999 8998764   599999999999998878899999999999999999998889999999999999555


Q ss_pred             cce--------------eeccCCccccc----CCCcccccEEEccCCccc--CcCCCCCCCCCCCCEecCCCccCCCCCC
Q 007680           81 MFG--------------IRLTGNKLYGR----IPPCLVLTVLDVSRNQLS--GDIPSTIGGRVDLETLSLASNQFQGPIP  140 (593)
Q Consensus        81 ~n~--------------l~l~~n~l~~~----~~~~~~L~~L~l~~N~l~--~~~p~~~~~l~~L~~L~l~~N~l~~~~p  140 (593)
                      +|.              +++++|++.+.    +..+..|++|++++|.++  +..|..+..+ +|+.|++++|+++ .+|
T Consensus       111 ~n~l~~l~~~~~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~-~l~  188 (332)
T 2ft3_A          111 KNHLVEIPPNLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLT-GIP  188 (332)
T ss_dssp             SSCCCSCCSSCCTTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCS-SCC
T ss_pred             CCcCCccCccccccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCC-ccC
Confidence            443              22334444321    112223455555555443  2334444443 3444444444443 233


Q ss_pred             ccccCCccccccccccccccCCCCCCCCCCCCC
Q 007680          141 ESVGSLISLESLDLSGNNLSGKIPKLEGEIPVK  173 (593)
Q Consensus       141 ~~l~~~~~L~~L~l~~N~l~~~~p~~~~~~~~~  173 (593)
                      ..+.  ++|+.|++++|++++..|..+..++.+
T Consensus       189 ~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L  219 (332)
T 2ft3_A          189 KDLP--ETLNELHLDHNKIQAIELEDLLRYSKL  219 (332)
T ss_dssp             SSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTC
T ss_pred             cccc--CCCCEEECCCCcCCccCHHHhcCCCCC
Confidence            3222  467777777777777766666555443

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.75  E-value=9.2e-18  Score=160.87  Aligned_cols=150  Identities=19%  Similarity=0.190  Sum_probs=129.8

Q ss_pred             CcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhhcceeeccCCccccc----CCCcccc
Q 007680           26 IEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGR----IPPCLVL  101 (593)
Q Consensus        26 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~l~~n~l~~~----~~~~~~L  101 (593)
                      -+.+++++|.|+ .+|..+.  ++|+.|+|++|+|++..+..|..+++|+.|       ++++|++.+.    +..+..|
T Consensus        13 ~~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L-------~Ls~N~i~~~~~~~~~~l~~L   82 (220)
T 2v9t_B           13 NNIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRI-------DLSNNQISELAPDAFQGLRSL   82 (220)
T ss_dssp             TTEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEE-------ECCSSCCCEECTTTTTTCSSC
T ss_pred             CCEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEE-------ECCCCcCCCcCHHHhhCCcCC
Confidence            368999999999 6787765  789999999999998778899999999999       7888888743    4455679


Q ss_pred             cEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCccccCCccccccccccccccCCCCCCCCCCCCCCCccCCCc
Q 007680          102 TVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKLEGEIPVKGSFKNFST  181 (593)
Q Consensus       102 ~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~~~  181 (593)
                      ++|+|++|+|++..+..|.++++|+.|+|++|+|++..|..|..+++|+.|+|++|++++..+..+..++.      +..
T Consensus        83 ~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~------L~~  156 (220)
T 2v9t_B           83 NSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRA------IQT  156 (220)
T ss_dssp             CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTT------CCE
T ss_pred             CEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCC------CCE
Confidence            99999999999766677899999999999999999888999999999999999999999988887765543      445


Q ss_pred             ccccCCccCC
Q 007680          182 ESFFGNYALC  191 (593)
Q Consensus       182 ~~~~~n~~~c  191 (593)
                      ..+.+|++.|
T Consensus       157 L~L~~N~~~c  166 (220)
T 2v9t_B          157 MHLAQNPFIC  166 (220)
T ss_dssp             EECCSSCEEC
T ss_pred             EEeCCCCcCC
Confidence            6788998877

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=99.75  E-value=5.6e-19  Score=196.45  Aligned_cols=173  Identities=20%  Similarity=0.344  Sum_probs=146.4

Q ss_pred             CcEEEeeCcccccc-----------------CChhhh--hCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCc-c
Q 007680            1 MRILTLEGNQLSGR-----------------LPSTIG--HSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNS-F   60 (593)
Q Consensus         1 L~~L~Ls~n~l~~~-----------------lp~~~~--~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~-l   60 (593)
                      |++|+|++|++++.                 +|..++  . +++|++|+|++|++.+.+|+.|+++++|+.|+|++|+ +
T Consensus       208 L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~-l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l  286 (636)
T 4eco_A          208 LRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDN-LKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGI  286 (636)
T ss_dssp             CCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGG-CTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTS
T ss_pred             CCEEECcCCccccccccccccccccchhcccCchhhhhcc-cCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCC
Confidence            78999999999964                 999987  6 9999999999999999999999999999999999999 9


Q ss_pred             cc-cccccccCC------CCchhhhhhcceeeccCCcccccCCC------cccccEEEccCCcccCcCCCCCCCCCCCCE
Q 007680           61 SG-HILNTFGNL------RHLSVLSLLMFGIRLTGNKLYGRIPP------CLVLTVLDVSRNQLSGDIPSTIGGRVDLET  127 (593)
Q Consensus        61 ~~-~~p~~~~~l------~~L~~L~l~~n~l~l~~n~l~~~~~~------~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~  127 (593)
                      ++ .+|..++.+      ++|++|       ++++|+++ .+|.      +..|++|++++|+++|.+| .|+++++|+.
T Consensus       287 ~~~~lp~~~~~L~~~~~l~~L~~L-------~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~  357 (636)
T 4eco_A          287 SGEQLKDDWQALADAPVGEKIQII-------YIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLAS  357 (636)
T ss_dssp             CHHHHHHHHHHHHHSGGGGTCCEE-------ECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESE
T ss_pred             ccccchHHHHhhhccccCCCCCEE-------ECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCE
Confidence            98 899988886      899999       77888887 5554      4459999999999998899 8999999999


Q ss_pred             ecCCCccCCCCCCccccCCcc-ccccccccccccCCCCCCCCCCCCCCCccCCCcccccCCcc
Q 007680          128 LSLASNQFQGPIPESVGSLIS-LESLDLSGNNLSGKIPKLEGEIPVKGSFKNFSTESFFGNYA  189 (593)
Q Consensus       128 L~l~~N~l~~~~p~~l~~~~~-L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~n~~  189 (593)
                      |++++|+++ .+|..+..+++ |+.|++++|+++ .+|..+....    +.++....+.+|..
T Consensus       358 L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~----l~~L~~L~Ls~N~l  414 (636)
T 4eco_A          358 LNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKS----VSVMSAIDFSYNEI  414 (636)
T ss_dssp             EECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTC----SSCEEEEECCSSCT
T ss_pred             EECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcc----cCccCEEECcCCcC
Confidence            999999998 78888999999 999999999999 5566543322    22344445555543

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=99.74  E-value=2.5e-18  Score=190.35  Aligned_cols=174  Identities=18%  Similarity=0.104  Sum_probs=143.1

Q ss_pred             CcEEEeeCcccccc--CChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCccccccc-ccccCCCCchhh
Q 007680            1 MRILTLEGNQLSGR--LPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHIL-NTFGNLRHLSVL   77 (593)
Q Consensus         1 L~~L~Ls~n~l~~~--lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L   77 (593)
                      |+.|+|++|++++.  +|..+.. +++|++|+|++|.++ .+|..|.++++|+.|+|++|++++..| ..|..+++|++|
T Consensus       352 L~~L~ls~n~l~~~~~~~~~~~~-~~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L  429 (606)
T 3vq2_A          352 LSYLDLSRNALSFSGCCSYSDLG-TNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYL  429 (606)
T ss_dssp             CCEEECCSSCEEEEEECCHHHHC-CSCCCEEECCSCSEE-EECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEE
T ss_pred             CCEEECcCCccCCCcchhhhhcc-CCcccEeECCCCccc-cchhhccCCCCCCeeECCCCccCCccChhhhhccccCCEE
Confidence            67888999988843  2666664 899999999999998 477889999999999999999997777 678899999999


Q ss_pred             hhhcceeeccCCcccccCC----CcccccEEEccCCcccC-cCCCCCCCCCCCCEecCCCccCCCCCCccccCCcccccc
Q 007680           78 SLLMFGIRLTGNKLYGRIP----PCLVLTVLDVSRNQLSG-DIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESL  152 (593)
Q Consensus        78 ~l~~n~l~l~~n~l~~~~~----~~~~L~~L~l~~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L  152 (593)
                             ++++|++.+.+|    .+.+|++|++++|++++ .+|..|+++++|+.|++++|++++..|..+.++++|+.|
T Consensus       430 -------~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L  502 (606)
T 3vq2_A          430 -------DISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLL  502 (606)
T ss_dssp             -------ECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred             -------ECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEE
Confidence                   777888775444    44569999999999987 478889999999999999999998888899999999999


Q ss_pred             ccccccccCCCCCCCCCCCCCCCccCCCcccccCCcc
Q 007680          153 DLSGNNLSGKIPKLEGEIPVKGSFKNFSTESFFGNYA  189 (593)
Q Consensus       153 ~l~~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~n~~  189 (593)
                      ++++|++++..|..+..++.+.      .....+|..
T Consensus       503 ~Ls~N~l~~~~~~~~~~l~~L~------~L~l~~N~l  533 (606)
T 3vq2_A          503 NMSHNNLLFLDSSHYNQLYSLS------TLDCSFNRI  533 (606)
T ss_dssp             ECCSSCCSCEEGGGTTTCTTCC------EEECTTSCC
T ss_pred             ECCCCcCCCcCHHHccCCCcCC------EEECCCCcC
Confidence            9999999998888777665443      345556643

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=99.74  E-value=3.1e-18  Score=194.71  Aligned_cols=144  Identities=17%  Similarity=0.268  Sum_probs=93.4

Q ss_pred             CChhhhhCCCCCcEEECCCCcCcc-----------------cCCccCC--CCCCCcEEEccCCcccccccccccCCCCch
Q 007680           15 LPSTIGHSLPNIEYLLLTANNLTG-----------------TIPNSIT--NATKLIVLDLGFNSFSGHILNTFGNLRHLS   75 (593)
Q Consensus        15 lp~~~~~~l~~L~~L~L~~N~l~~-----------------~~p~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~   75 (593)
                      +|..+.. +++|++|+|++|+|++                 .+|+.++  ++++|+.|+|++|++.+.+|..|++|++|+
T Consensus       440 IP~~l~~-L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~  518 (876)
T 4ecn_A          440 ISKAIQR-LTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQ  518 (876)
T ss_dssp             ECGGGGG-CTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCC
T ss_pred             hhHHHhc-CCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCC
Confidence            6666664 7777777777777776                 3677766  777777777777777777777777777777


Q ss_pred             hhhhhcceeeccCCc-ccc-cCCC-----------cccccEEEccCCcccCcCCC--CCCCCCCCCEecCCCccCCCCCC
Q 007680           76 VLSLLMFGIRLTGNK-LYG-RIPP-----------CLVLTVLDVSRNQLSGDIPS--TIGGRVDLETLSLASNQFQGPIP  140 (593)
Q Consensus        76 ~L~l~~n~l~l~~n~-l~~-~~~~-----------~~~L~~L~l~~N~l~~~~p~--~~~~l~~L~~L~l~~N~l~~~~p  140 (593)
                      .|       ++++|+ +++ .+|.           +..|++|+|++|+++ .+|.  .|+++++|+.|+|++|+++ .+|
T Consensus       519 ~L-------~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp  589 (876)
T 4ecn_A          519 SL-------NIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE  589 (876)
T ss_dssp             EE-------ECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC
T ss_pred             EE-------ECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch
Confidence            77       555555 444 2321           124666666666666 5665  5666666666666666666 555


Q ss_pred             ccccCCccccccccccccccCCCCCCCCCC
Q 007680          141 ESVGSLISLESLDLSGNNLSGKIPKLEGEI  170 (593)
Q Consensus       141 ~~l~~~~~L~~L~l~~N~l~~~~p~~~~~~  170 (593)
                       .|..+++|+.|+|++|+++ .+|..+..+
T Consensus       590 -~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l  617 (876)
T 4ecn_A          590 -AFGTNVKLTDLKLDYNQIE-EIPEDFCAF  617 (876)
T ss_dssp             -CCCTTSEESEEECCSSCCS-CCCTTSCEE
T ss_pred             -hhcCCCcceEEECcCCccc-cchHHHhhc
Confidence             6666666666666666666 444434333

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.74  E-value=3.3e-18  Score=183.91  Aligned_cols=155  Identities=25%  Similarity=0.238  Sum_probs=104.6

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLL   80 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~   80 (593)
                      |+.|+|++|.++ .+|+..+..+++|++|+|++|.|++..|  |..+++|+.|+|++|.|++..+.     ++|++|+|+
T Consensus        36 L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~~-----~~L~~L~L~  107 (487)
T 3oja_A           36 VKELDLSGNPLS-QISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLVG-----PSIETLHAA  107 (487)
T ss_dssp             CCEEECCSSCCC-CCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEEC-----TTCCEEECC
T ss_pred             ccEEEeeCCcCC-CCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCCC-----CCcCEEECc
Confidence            678999999999 4554433459999999999999997665  88999999998888888753321     445555544


Q ss_pred             cce--------------eeccCCcccccCCC----cccccEEEccCCcccCcCCCCCC-CCCCCCEecCCCccCCCCCCc
Q 007680           81 MFG--------------IRLTGNKLYGRIPP----CLVLTVLDVSRNQLSGDIPSTIG-GRVDLETLSLASNQFQGPIPE  141 (593)
Q Consensus        81 ~n~--------------l~l~~n~l~~~~~~----~~~L~~L~l~~N~l~~~~p~~~~-~l~~L~~L~l~~N~l~~~~p~  141 (593)
                      +|.              +++++|.+++..|.    +..|++|+|++|.+++.+|..+. .+++|+.|+|++|+|++. |.
T Consensus       108 ~N~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~~  186 (487)
T 3oja_A          108 NNNISRVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG  186 (487)
T ss_dssp             SSCCCCEEECCCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC
T ss_pred             CCcCCCCCccccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc-cc
Confidence            332              35667776654332    33477777777777766666664 566777777777777643 22


Q ss_pred             cccCCccccccccccccccCCCCC
Q 007680          142 SVGSLISLESLDLSGNNLSGKIPK  165 (593)
Q Consensus       142 ~l~~~~~L~~L~l~~N~l~~~~p~  165 (593)
                       +..+++|+.|+|++|++++.+|.
T Consensus       187 -~~~l~~L~~L~Ls~N~l~~~~~~  209 (487)
T 3oja_A          187 -QVVFAKLKTLDLSSNKLAFMGPE  209 (487)
T ss_dssp             -CCCCTTCCEEECCSSCCCEECGG
T ss_pred             -cccCCCCCEEECCCCCCCCCCHh
Confidence             23466677777777777665544

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=99.74  E-value=6.7e-18  Score=186.89  Aligned_cols=153  Identities=21%  Similarity=0.276  Sum_probs=86.4

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCcc-CCCCCCCcEEEccCCcccccc--cccccCCCCchhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNS-ITNATKLIVLDLGFNSFSGHI--LNTFGNLRHLSVL   77 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L   77 (593)
                      |++|+|++|++.+..|..+. .+++|++|+|++|.+.+.+|.. |.++++|+.|+|++|.+++..  |..+..+++|++|
T Consensus       303 L~~L~l~~n~l~~~~~~~~~-~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L  381 (606)
T 3t6q_A          303 LKKLVLSANKFENLCQISAS-NFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSL  381 (606)
T ss_dssp             CCEEECTTCCCSBGGGGCGG-GCTTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEE
T ss_pred             CCEEECccCCcCcCchhhhh-ccCcCCEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEE
Confidence            56777777777733344444 3777777777777776555543 667777777777777776544  5566677777776


Q ss_pred             hhhcceeeccCCccccc----CCCcccccEEEccCCcccCcCCCC-CCCCCCCCEecCCCccCCCCCCccccCCcccccc
Q 007680           78 SLLMFGIRLTGNKLYGR----IPPCLVLTVLDVSRNQLSGDIPST-IGGRVDLETLSLASNQFQGPIPESVGSLISLESL  152 (593)
Q Consensus        78 ~l~~n~l~l~~n~l~~~----~~~~~~L~~L~l~~N~l~~~~p~~-~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L  152 (593)
                             ++++|++.+.    +..+..|++|++++|++++..|.. +.++++|+.|++++|++++..|..+..+++|+.|
T Consensus       382 -------~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L  454 (606)
T 3t6q_A          382 -------NLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHL  454 (606)
T ss_dssp             -------ECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEE
T ss_pred             -------ECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEE
Confidence                   4444444322    222233555555555554443322 4455555555555555554445555555555555


Q ss_pred             ccccccccC
Q 007680          153 DLSGNNLSG  161 (593)
Q Consensus       153 ~l~~N~l~~  161 (593)
                      ++++|++++
T Consensus       455 ~L~~n~l~~  463 (606)
T 3t6q_A          455 NLQGNHFPK  463 (606)
T ss_dssp             ECTTCBCGG
T ss_pred             ECCCCCCCc
Confidence            555555544

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.74  E-value=6.4e-18  Score=158.47  Aligned_cols=128  Identities=27%  Similarity=0.349  Sum_probs=106.7

Q ss_pred             cEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhhc
Q 007680            2 RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLM   81 (593)
Q Consensus         2 ~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~   81 (593)
                      +++++++|+|+ .+|..++   ++|++|+|++|+|+ .+|..|.++++|+.|+|++|+|++..+..|..+++|+      
T Consensus        13 ~~l~~~~~~l~-~ip~~~~---~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~------   81 (193)
T 2wfh_A           13 TVVRCSNKGLK-VLPKGIP---RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLL------   81 (193)
T ss_dssp             TEEECTTSCCS-SCCSCCC---TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCC------
T ss_pred             CEEEcCCCCCC-cCCCCCC---CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCC------
Confidence            46889999998 8887654   58899999999998 7788899999999999999999977777777766665      


Q ss_pred             ceeeccCCcccccCCCcccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCccccCCccccccccccccccC
Q 007680           82 FGIRLTGNKLYGRIPPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSG  161 (593)
Q Consensus        82 n~l~l~~n~l~~~~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~~N~l~~  161 (593)
                                           +|+|++|+|++..|..|.++++|+.|+|++|+|++..+..|..+++|+.|++++|++..
T Consensus        82 ---------------------~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C  140 (193)
T 2wfh_A           82 ---------------------TLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYC  140 (193)
T ss_dssp             ---------------------EEECCSSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred             ---------------------EEECCCCccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeec
Confidence                                 45777777877777789999999999999999986666678889999999999999874

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.73  E-value=1.1e-17  Score=160.43  Aligned_cols=131  Identities=21%  Similarity=0.217  Sum_probs=115.7

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLL   80 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~   80 (593)
                      ++.|+|++|+|++..|...+..+++|++|+|++|+|++..+..|.++++|+.|+|++|+|++..|..|..+++|++|   
T Consensus        34 ~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L---  110 (220)
T 2v70_A           34 TAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTL---  110 (220)
T ss_dssp             CSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEE---
T ss_pred             CCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEE---
Confidence            47899999999944355655569999999999999998888899999999999999999998888889999999999   


Q ss_pred             cceeeccCCcccccC----CCcccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCC
Q 007680           81 MFGIRLTGNKLYGRI----PPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGP  138 (593)
Q Consensus        81 ~n~l~l~~n~l~~~~----~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~  138 (593)
                          ++++|++.+..    ..+..|++|+|++|+|++..|..|..+++|+.|+|++|++...
T Consensus       111 ----~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~  168 (220)
T 2v70_A          111 ----MLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCN  168 (220)
T ss_dssp             ----ECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECS
T ss_pred             ----ECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCC
Confidence                88888887543    3455699999999999988899999999999999999999853

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=99.73  E-value=1.1e-17  Score=182.93  Aligned_cols=178  Identities=20%  Similarity=0.249  Sum_probs=122.4

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCC---ccCCCCCCCcEEEccCCccccccc--ccccCCCCch
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIP---NSITNATKLIVLDLGFNSFSGHIL--NTFGNLRHLS   75 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p---~~~~~l~~L~~L~L~~N~l~~~~p--~~~~~l~~L~   75 (593)
                      |+.|+|++|++. .+|..++..+++|++|+|++|+|++..|   ..++.+++|+.|+|++|++++..+  ..+..+++|+
T Consensus       312 L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~  390 (549)
T 2z81_A          312 VKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLT  390 (549)
T ss_dssp             CCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCC
T ss_pred             ceEEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCC
Confidence            567888888887 7888876558888888888888887664   346778888888888888875433  4577788888


Q ss_pred             hhhhhcce----------------eeccCCcccccCCCc--ccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCC
Q 007680           76 VLSLLMFG----------------IRLTGNKLYGRIPPC--LVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQG  137 (593)
Q Consensus        76 ~L~l~~n~----------------l~l~~n~l~~~~~~~--~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~  137 (593)
                      +|+|++|.                +++++|++. .++..  ..|++|++++|+|++.+    .++++|++|+|++|+|+ 
T Consensus       391 ~L~Ls~N~l~~lp~~~~~~~~L~~L~Ls~N~l~-~l~~~~~~~L~~L~Ls~N~l~~~~----~~l~~L~~L~Ls~N~l~-  464 (549)
T 2z81_A          391 SLDISRNTFHPMPDSCQWPEKMRFLNLSSTGIR-VVKTCIPQTLEVLDVSNNNLDSFS----LFLPRLQELYISRNKLK-  464 (549)
T ss_dssp             EEECTTCCCCCCCSCCCCCTTCCEEECTTSCCS-CCCTTSCTTCSEEECCSSCCSCCC----CCCTTCCEEECCSSCCS-
T ss_pred             EEECCCCCCccCChhhcccccccEEECCCCCcc-cccchhcCCceEEECCCCChhhhc----ccCChhcEEECCCCccC-
Confidence            88444432                234444443 12221  23566666666665422    46788888889999888 


Q ss_pred             CCCccccCCccccccccccccccCCCCCCCCCCCCCCCccCCCcccccCCccCCC
Q 007680          138 PIPESVGSLISLESLDLSGNNLSGKIPKLEGEIPVKGSFKNFSTESFFGNYALCG  192 (593)
Q Consensus       138 ~~p~~l~~~~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~n~~~c~  192 (593)
                      .+|. ...+++|+.|++++|++++.+|..+..++      .+......+|++.|.
T Consensus       465 ~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~------~L~~L~l~~N~~~~~  512 (549)
T 2z81_A          465 TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLT------SLQKIWLHTNPWDCS  512 (549)
T ss_dssp             SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCT------TCCEEECCSSCBCCC
T ss_pred             cCCC-cccCccCCEEecCCCccCCcCHHHHhcCc------ccCEEEecCCCccCC
Confidence            6675 46788889999999999888877665554      344557778877663

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.73  E-value=1.1e-17  Score=169.10  Aligned_cols=145  Identities=23%  Similarity=0.333  Sum_probs=83.6

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLL   80 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~   80 (593)
                      |+.|+|++|++. .+| .+.. +++|++|+|++|+|++. +. +.++++|+.|+|++|++++ ++ .+..+++|++|   
T Consensus        43 L~~L~l~~~~i~-~l~-~~~~-l~~L~~L~L~~n~i~~~-~~-~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L---  112 (308)
T 1h6u_A           43 ITTLSAFGTGVT-TIE-GVQY-LNNLIGLELKDNQITDL-AP-LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTL---  112 (308)
T ss_dssp             CCEEECTTSCCC-CCT-TGGG-CTTCCEEECCSSCCCCC-GG-GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEE---
T ss_pred             cCEEEeeCCCcc-Cch-hhhc-cCCCCEEEccCCcCCCC-hh-HccCCCCCEEEccCCcCCC-ch-hhcCCCCCCEE---
Confidence            466777777776 565 3443 67777777777777743 33 6677777777777777764 33 46667777776   


Q ss_pred             cceeeccCCcccc--cCCCcccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCccccCCcccccccccccc
Q 007680           81 MFGIRLTGNKLYG--RIPPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNN  158 (593)
Q Consensus        81 ~n~l~l~~n~l~~--~~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~~N~  158 (593)
                          ++++|++.+  .+..+..|++|++++|++++..+  +..+++|+.|++++|++++ ++. +..+++|+.|++++|+
T Consensus       113 ----~l~~n~l~~~~~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~  184 (308)
T 1h6u_A          113 ----DLTSTQITDVTPLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSD-LTP-LANLSKLTTLKADDNK  184 (308)
T ss_dssp             ----ECTTSCCCCCGGGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSC
T ss_pred             ----ECCCCCCCCchhhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCC-Chh-hcCCCCCCEEECCCCc
Confidence                444444442  12333345566666665553222  5555555566666655553 332 5555555555555555


Q ss_pred             ccCCC
Q 007680          159 LSGKI  163 (593)
Q Consensus       159 l~~~~  163 (593)
                      +++..
T Consensus       185 l~~~~  189 (308)
T 1h6u_A          185 ISDIS  189 (308)
T ss_dssp             CCCCG
T ss_pred             cCcCh
Confidence            55443

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=99.73  E-value=4.7e-18  Score=190.80  Aligned_cols=164  Identities=27%  Similarity=0.258  Sum_probs=119.7

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLL   80 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~   80 (593)
                      |++|+|++|+++ .+|...+..+++|++|+|++|+|++..|+.|.++++|+.|+|++|++++..+..|+.+++|++|   
T Consensus        27 l~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L---  102 (680)
T 1ziw_A           27 ITVLNLTHNQLR-RLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTEL---  102 (680)
T ss_dssp             CSEEECCSSCCC-CCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEE---
T ss_pred             CcEEECCCCCCC-CcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEE---
Confidence            567888888887 5665544457888888888888887777778888888888888888875555568888888888   


Q ss_pred             cceeeccCCccccc----CCCcccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCcccc--CCcccccccc
Q 007680           81 MFGIRLTGNKLYGR----IPPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVG--SLISLESLDL  154 (593)
Q Consensus        81 ~n~l~l~~n~l~~~----~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~--~~~~L~~L~l  154 (593)
                          ++++|++.+.    +..+..|++|++++|.+++..|..++++++|+.|++++|++++..+..+.  .+++|+.|++
T Consensus       103 ----~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L  178 (680)
T 1ziw_A          103 ----HLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLEL  178 (680)
T ss_dssp             ----ECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEEC
T ss_pred             ----ECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEEC
Confidence                6666666532    33445688888888888877777788888888888888888766555543  4577888888


Q ss_pred             ccccccCCCCCCCCCCCC
Q 007680          155 SGNNLSGKIPKLEGEIPV  172 (593)
Q Consensus       155 ~~N~l~~~~p~~~~~~~~  172 (593)
                      ++|++++..|..+..++.
T Consensus       179 ~~n~l~~~~~~~~~~l~~  196 (680)
T 1ziw_A          179 SSNQIKEFSPGCFHAIGR  196 (680)
T ss_dssp             TTCCCCCBCTTGGGGSSE
T ss_pred             CCCcccccChhhhhhhhh
Confidence            888888877776655543

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=99.73  E-value=3.5e-18  Score=194.28  Aligned_cols=172  Identities=21%  Similarity=0.326  Sum_probs=145.0

Q ss_pred             CcEEEeeCccccc-----------------cCChhhh-hCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCc-cc
Q 007680            1 MRILTLEGNQLSG-----------------RLPSTIG-HSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNS-FS   61 (593)
Q Consensus         1 L~~L~Ls~n~l~~-----------------~lp~~~~-~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~   61 (593)
                      |+.|+|++|+|++                 .+|..++ ..+++|++|+|++|++.+.+|..|.++++|+.|+|++|+ ++
T Consensus       450 L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~ls  529 (876)
T 4ecn_A          450 LQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGIS  529 (876)
T ss_dssp             CCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSC
T ss_pred             CCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcc
Confidence            7899999999996                 3999885 239999999999999999999999999999999999998 99


Q ss_pred             c-cccccccCCC-------CchhhhhhcceeeccCCcccccCCC------cccccEEEccCCcccCcCCCCCCCCCCCCE
Q 007680           62 G-HILNTFGNLR-------HLSVLSLLMFGIRLTGNKLYGRIPP------CLVLTVLDVSRNQLSGDIPSTIGGRVDLET  127 (593)
Q Consensus        62 ~-~~p~~~~~l~-------~L~~L~l~~n~l~l~~n~l~~~~~~------~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~  127 (593)
                      + .+|..++.++       +|+.|       ++++|++. .+|.      +.+|++|+|++|+++ .+| .|+.+++|+.
T Consensus       530 g~~iP~~i~~L~~~~~~l~~L~~L-------~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~  599 (876)
T 4ecn_A          530 AAQLKADWTRLADDEDTGPKIQIF-------YMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTD  599 (876)
T ss_dssp             HHHHHHHHHHHHHCTTTTTTCCEE-------ECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESE
T ss_pred             cccchHHHHhhhhcccccCCccEE-------EeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceE
Confidence            8 7888777666       99999       77888877 5554      456999999999999 888 8999999999


Q ss_pred             ecCCCccCCCCCCccccCCcc-ccccccccccccCCCCCCCCCCCCCCCccCCCcccccCCc
Q 007680          128 LSLASNQFQGPIPESVGSLIS-LESLDLSGNNLSGKIPKLEGEIPVKGSFKNFSTESFFGNY  188 (593)
Q Consensus       128 L~l~~N~l~~~~p~~l~~~~~-L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~n~  188 (593)
                      |+|++|+|+ .+|..+..+++ |+.|+|++|+++ .+|..+..++.    ..+....+.+|.
T Consensus       600 L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~----~~L~~L~Ls~N~  655 (876)
T 4ecn_A          600 LKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSV----YVMGSVDFSYNK  655 (876)
T ss_dssp             EECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCS----SCEEEEECCSSC
T ss_pred             EECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhcccc----CCCCEEECcCCc
Confidence            999999999 89999999999 999999999999 56665543321    123344555554

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.73  E-value=2.5e-17  Score=158.83  Aligned_cols=151  Identities=24%  Similarity=0.266  Sum_probs=129.4

Q ss_pred             CCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhhcceeeccCCccccc----CCCccc
Q 007680           25 NIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGR----IPPCLV  100 (593)
Q Consensus        25 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~l~~n~l~~~----~~~~~~  100 (593)
                      +.+.+++++|.++ .+|..+.  ++|+.|+|++|+|++..|..|..+++|++|       ++++|++...    +..+..
T Consensus        20 s~~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L-------~L~~N~l~~i~~~~~~~l~~   89 (229)
T 3e6j_A           20 SGTTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKEL-------YLGSNQLGALPVGVFDSLTQ   89 (229)
T ss_dssp             ETTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEE-------ECCSSCCCCCCTTTTTTCTT
T ss_pred             eCCEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEE-------ECCCCCCCCcChhhcccCCC
Confidence            3578999999999 7887665  899999999999998889999999999999       7778887632    344556


Q ss_pred             ccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCccccCCccccccccccccccCCCCCCCCCCCCCCCccCCC
Q 007680          101 LTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKLEGEIPVKGSFKNFS  180 (593)
Q Consensus       101 L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~~  180 (593)
                      |++|+|++|+|++..+..|..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|++++..+..+..++      ++.
T Consensus        90 L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~------~L~  162 (229)
T 3e6j_A           90 LTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLS------SLT  162 (229)
T ss_dssp             CCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCT------TCC
T ss_pred             cCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCC------CCC
Confidence            999999999999777777899999999999999999 7899999999999999999999988877666554      444


Q ss_pred             cccccCCccCCC
Q 007680          181 TESFFGNYALCG  192 (593)
Q Consensus       181 ~~~~~~n~~~c~  192 (593)
                      ...+.+|+..|.
T Consensus       163 ~L~l~~N~~~c~  174 (229)
T 3e6j_A          163 HAYLFGNPWDCE  174 (229)
T ss_dssp             EEECTTSCBCTT
T ss_pred             EEEeeCCCccCC
Confidence            567889988774

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.73  E-value=9.7e-18  Score=169.57  Aligned_cols=155  Identities=21%  Similarity=0.271  Sum_probs=114.3

Q ss_pred             CcEEEeeCccccccCC----hhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCccccc--cc--ccccCCC
Q 007680            1 MRILTLEGNQLSGRLP----STIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGH--IL--NTFGNLR   72 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp----~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~p--~~~~~l~   72 (593)
                      |++|+|++|++++..|    ..+. .+++|++|+|++|+|++..|..|.++++|++|+|++|++.+.  ++  ..++.++
T Consensus       119 L~~L~Ls~n~i~~~~~~~~~~~~~-~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~  197 (310)
T 4glp_A          119 LSSLRLRNVSWATGRSWLAELQQW-LKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFP  197 (310)
T ss_dssp             CSSCEEESCCCSSTTSSHHHHHTT-BCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSC
T ss_pred             CCEEEeecccccchhhhhHHHHhh-hccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCC
Confidence            5667777777775444    2233 377777777777777766667777777777777777776542  21  1235667


Q ss_pred             Cchhhhhhcce--------------------eeccCCcccccCC----Cc---ccccEEEccCCcccCcCCCCCCCCCCC
Q 007680           73 HLSVLSLLMFG--------------------IRLTGNKLYGRIP----PC---LVLTVLDVSRNQLSGDIPSTIGGRVDL  125 (593)
Q Consensus        73 ~L~~L~l~~n~--------------------l~l~~n~l~~~~~----~~---~~L~~L~l~~N~l~~~~p~~~~~l~~L  125 (593)
                      +|++|+|++|.                    +++++|++.+..|    .+   ..|++|+|++|+|+ .+|..+.  ++|
T Consensus       198 ~L~~L~Ls~N~l~~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L  274 (310)
T 4glp_A          198 AIQNLALRNTGMETPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKL  274 (310)
T ss_dssp             CCCSCBCCSSCCCCHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCC
T ss_pred             CCCEEECCCCCCCchHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCC
Confidence            77777776544                    4789999987643    33   36999999999999 6787774  799


Q ss_pred             CEecCCCccCCCCCCccccCCccccccccccccccC
Q 007680          126 ETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSG  161 (593)
Q Consensus       126 ~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~~N~l~~  161 (593)
                      +.|+|++|+|++ +|. +..+++|+.|++++|+|+.
T Consensus       275 ~~L~Ls~N~l~~-~~~-~~~l~~L~~L~L~~N~l~~  308 (310)
T 4glp_A          275 RVLDLSSNRLNR-APQ-PDELPEVDNLTLDGNPFLV  308 (310)
T ss_dssp             SCEECCSCCCCS-CCC-TTSCCCCSCEECSSTTTSC
T ss_pred             CEEECCCCcCCC-Cch-hhhCCCccEEECcCCCCCC
Confidence            999999999995 454 6888999999999999985

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.73  E-value=4.6e-18  Score=175.21  Aligned_cols=157  Identities=22%  Similarity=0.245  Sum_probs=136.8

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLL   80 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~   80 (593)
                      |+.|+|++|+++ .+|...+..+++|++|+|++|+|++..|..|.++++|++|+|++|++++..+..|+.+++|++|   
T Consensus        54 L~~L~l~~n~i~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L---  129 (353)
T 2z80_A           54 VKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFL---  129 (353)
T ss_dssp             CCEEECTTSCCC-EECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEE---
T ss_pred             CcEEECCCCcCc-ccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEE---
Confidence            689999999999 6777544569999999999999998888899999999999999999997666679999999999   


Q ss_pred             cceeeccCCcccc-----cCCCcccccEEEccCC-cccCcCCCCCCCCCCCCEecCCCccCCCCCCccccCCcccccccc
Q 007680           81 MFGIRLTGNKLYG-----RIPPCLVLTVLDVSRN-QLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDL  154 (593)
Q Consensus        81 ~n~l~l~~n~l~~-----~~~~~~~L~~L~l~~N-~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l  154 (593)
                          ++++|++.+     .+..+..|++|++++| .+.+..|..|.++++|+.|++++|++++..|..+..+++|+.|++
T Consensus       130 ----~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l  205 (353)
T 2z80_A          130 ----NLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLIL  205 (353)
T ss_dssp             ----ECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEE
T ss_pred             ----ECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecC
Confidence                777777763     2334557999999999 577667788999999999999999999888999999999999999


Q ss_pred             ccccccCCCCC
Q 007680          155 SGNNLSGKIPK  165 (593)
Q Consensus       155 ~~N~l~~~~p~  165 (593)
                      ++|+++..++.
T Consensus       206 ~~n~l~~~~~~  216 (353)
T 2z80_A          206 HMKQHILLLEI  216 (353)
T ss_dssp             ECSCSTTHHHH
T ss_pred             CCCccccchhh
Confidence            99999765443

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=99.73  E-value=1.2e-17  Score=191.88  Aligned_cols=163  Identities=25%  Similarity=0.220  Sum_probs=130.7

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccC-CccCCCCCCCcEEEccCCcccccccccccCCCCchhhhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTI-PNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSL   79 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l   79 (593)
                      |+.|||++|.|++..|..+. .+++|++|+|++|.+.+.+ |++|.++++|++|+|++|.+++..|+.|+++++|++|  
T Consensus        26 l~~LdLs~N~i~~i~~~~~~-~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L--  102 (844)
T 3j0a_A           26 TERLLLSFNYIRTVTASSFP-FLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFEL--  102 (844)
T ss_dssp             CCEEEEESCCCCEECSSSCS-SCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCE--
T ss_pred             cCEEECCCCcCCccChhHCc-ccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEe--
Confidence            57899999999844455554 5899999999999655455 7789999999999999999998888899999999998  


Q ss_pred             hcceeeccCCccccc------CCCcccccEEEccCCcccCcCC-CCCCCCCCCCEecCCCccCCCCCCccccCC--cccc
Q 007680           80 LMFGIRLTGNKLYGR------IPPCLVLTVLDVSRNQLSGDIP-STIGGRVDLETLSLASNQFQGPIPESVGSL--ISLE  150 (593)
Q Consensus        80 ~~n~l~l~~n~l~~~------~~~~~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~--~~L~  150 (593)
                           ++++|.+.+.      +..+.+|++|+|++|.+++..+ ..|+++++|+.|+|++|++++..|..+..+  ++|+
T Consensus       103 -----~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~  177 (844)
T 3j0a_A          103 -----RLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLS  177 (844)
T ss_dssp             -----ECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSC
T ss_pred             -----eCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccc
Confidence                 7777777653      3345569999999999986654 468889999999999999988888888877  7889


Q ss_pred             ccccccccccCCCCCCCCCCC
Q 007680          151 SLDLSGNNLSGKIPKLEGEIP  171 (593)
Q Consensus       151 ~L~l~~N~l~~~~p~~~~~~~  171 (593)
                      .|++++|++++..|..+..++
T Consensus       178 ~L~L~~n~l~~~~~~~~~~~~  198 (844)
T 3j0a_A          178 FFSLAANSLYSRVSVDWGKCM  198 (844)
T ss_dssp             CCEECCSBSCCCCCCCCCSSS
T ss_pred             eEECCCCccccccccchhhcC
Confidence            999999998887776555443

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=99.73  E-value=1e-17  Score=183.82  Aligned_cols=156  Identities=26%  Similarity=0.321  Sum_probs=139.4

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCC-ccCCCCCCCcEEEccCCcccccccccccCCCCchhhhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIP-NSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSL   79 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l   79 (593)
                      |+.|+|++|.+. .+|..+. .+++|++|+|++|++++..| ..|.++++|+.|+|++|.+++..|..|..+++|++|  
T Consensus       375 L~~L~l~~n~l~-~~~~~~~-~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L--  450 (570)
T 2z63_A          375 LKYLDLSFNGVI-TMSSNFL-GLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVL--  450 (570)
T ss_dssp             CCEEECCSCSEE-EEEEEEE-TCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEE--
T ss_pred             cCEEECCCCccc-ccccccc-ccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEE--
Confidence            689999999999 6777755 59999999999999997766 578999999999999999998899999999999999  


Q ss_pred             hcceeeccCCccc-ccCC----CcccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCccccCCcccccccc
Q 007680           80 LMFGIRLTGNKLY-GRIP----PCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDL  154 (593)
Q Consensus        80 ~~n~l~l~~n~l~-~~~~----~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l  154 (593)
                           ++++|++. +.+|    .+..|++|++++|++++..|..|.++++|+.|++++|++++.+|..+..+++|+.|++
T Consensus       451 -----~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l  525 (570)
T 2z63_A          451 -----KMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWL  525 (570)
T ss_dssp             -----ECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEEC
T ss_pred             -----ECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEe
Confidence                 77777776 3344    4556999999999999888999999999999999999999888888999999999999


Q ss_pred             ccccccCCCCC
Q 007680          155 SGNNLSGKIPK  165 (593)
Q Consensus       155 ~~N~l~~~~p~  165 (593)
                      ++|++++..|.
T Consensus       526 ~~N~~~~~~~~  536 (570)
T 2z63_A          526 HTNPWDCSCPR  536 (570)
T ss_dssp             CSSCBCCCTTT
T ss_pred             cCCcccCCCcc
Confidence            99999987664

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=99.72  E-value=1.3e-17  Score=182.91  Aligned_cols=153  Identities=26%  Similarity=0.386  Sum_probs=133.2

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCccc--CCccCCCCCCCcEEEccCCccccccc-ccccCCCCchhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGT--IPNSITNATKLIVLDLGFNSFSGHIL-NTFGNLRHLSVL   77 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L   77 (593)
                      |++|+|++|++++.+|..+.. +++|++|+|++|+|++.  +|..|.++++|+.|+|++|++++.+| ..|..+++|++|
T Consensus       355 L~~L~l~~n~l~~~~~~~~~~-l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L  433 (562)
T 3a79_B          355 FTFLNFTQNVFTDSVFQGCST-LKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVL  433 (562)
T ss_dssp             CCEEECCSSCCCTTTTTTCCS-CSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEE
T ss_pred             ceEEECCCCccccchhhhhcc-cCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEE
Confidence            689999999999778887764 99999999999999963  35679999999999999999998455 468899999999


Q ss_pred             hhhcceeeccCCcccccCCCc--ccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCcc-ccCCcccccccc
Q 007680           78 SLLMFGIRLTGNKLYGRIPPC--LVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPES-VGSLISLESLDL  154 (593)
Q Consensus        78 ~l~~n~l~l~~n~l~~~~~~~--~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-l~~~~~L~~L~l  154 (593)
                             ++++|++++.++..  ..|++|+|++|+|+ .+|..+.++++|+.|+|++|+|+ .+|.. +..+++|+.|++
T Consensus       434 -------~l~~n~l~~~~~~~l~~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l  504 (562)
T 3a79_B          434 -------NLSSNMLTGSVFRCLPPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWL  504 (562)
T ss_dssp             -------ECCSSCCCGGGGSSCCTTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCC-CCCTTSTTTCTTCCCEEC
T ss_pred             -------ECCCCCCCcchhhhhcCcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCC-CCCHHHHhcCCCCCEEEe
Confidence                   88889888766654  36999999999999 68877779999999999999999 56655 999999999999


Q ss_pred             ccccccCCC
Q 007680          155 SGNNLSGKI  163 (593)
Q Consensus       155 ~~N~l~~~~  163 (593)
                      ++|++++..
T Consensus       505 ~~N~~~c~c  513 (562)
T 3a79_B          505 HDNPWDCTC  513 (562)
T ss_dssp             CSCCBCCCH
T ss_pred             cCCCcCCCc
Confidence            999998743

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.72  E-value=6.1e-18  Score=171.64  Aligned_cols=154  Identities=25%  Similarity=0.235  Sum_probs=92.9

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLL   80 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~   80 (593)
                      |+.|+|++|+++ .++...+..+++|++|+|++|+|++..|  |..+++|++|+|++|++++..+     +++|++|+++
T Consensus        36 L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~l~~-----~~~L~~L~l~  107 (317)
T 3o53_A           36 VKELDLSGNPLS-QISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETLHAA  107 (317)
T ss_dssp             CSEEECTTSCCC-CCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEEEEEE-----CTTCCEEECC
T ss_pred             CCEEECcCCccC-cCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCccccccC-----CCCcCEEECC
Confidence            678899999998 5654444458899999999999886554  8888888888888888874321     2444444444


Q ss_pred             cce--------------eeccCCcccccCC----CcccccEEEccCCcccCcCCCCCC-CCCCCCEecCCCccCCCCCCc
Q 007680           81 MFG--------------IRLTGNKLYGRIP----PCLVLTVLDVSRNQLSGDIPSTIG-GRVDLETLSLASNQFQGPIPE  141 (593)
Q Consensus        81 ~n~--------------l~l~~n~l~~~~~----~~~~L~~L~l~~N~l~~~~p~~~~-~l~~L~~L~l~~N~l~~~~p~  141 (593)
                      +|.              +++++|++++..+    .+..|++|++++|.+++..+..+. .+++|+.|+|++|+|++ +|.
T Consensus       108 ~n~l~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~  186 (317)
T 3o53_A          108 NNNISRVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-VKG  186 (317)
T ss_dssp             SSCCSEEEECCCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCE-EEC
T ss_pred             CCccCCcCccccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCcc-ccc
Confidence            332              2455555553222    223466666666666654444442 45556666666666653 222


Q ss_pred             cccCCccccccccccccccCCCC
Q 007680          142 SVGSLISLESLDLSGNNLSGKIP  164 (593)
Q Consensus       142 ~l~~~~~L~~L~l~~N~l~~~~p  164 (593)
                       ...+++|+.|++++|++++.++
T Consensus       187 -~~~l~~L~~L~Ls~N~l~~l~~  208 (317)
T 3o53_A          187 -QVVFAKLKTLDLSSNKLAFMGP  208 (317)
T ss_dssp             -CCCCTTCCEEECCSSCCCEECG
T ss_pred             -ccccccCCEEECCCCcCCcchh
Confidence             2235556666666666655433

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.72  E-value=1.5e-17  Score=166.64  Aligned_cols=163  Identities=25%  Similarity=0.349  Sum_probs=131.0

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLL   80 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~   80 (593)
                      |+.|++++|.+. .+|. +.. +++|++|+|++|+|++..+  +.++++|+.|+|++|++++ +| .+..+++|++|   
T Consensus        48 L~~L~l~~~~i~-~~~~-~~~-l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L---  117 (291)
T 1h6t_A           48 IDQIIANNSDIK-SVQG-IQY-LPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSL---  117 (291)
T ss_dssp             CCEEECTTSCCC-CCTT-GGG-CTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEE---
T ss_pred             ccEEEccCCCcc-cChh-Hhc-CCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEE---
Confidence            688999999998 7874 554 9999999999999996544  9999999999999999995 44 39999999999   


Q ss_pred             cceeeccCCcccc--cCCCcccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCccccCCcccccccccccc
Q 007680           81 MFGIRLTGNKLYG--RIPPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNN  158 (593)
Q Consensus        81 ~n~l~l~~n~l~~--~~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~~N~  158 (593)
                          ++++|++.+  .+..+..|++|++++|++++.  ..+..+++|+.|++++|++++..|  +..+++|+.|++++|+
T Consensus       118 ----~L~~n~i~~~~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~  189 (291)
T 1h6t_A          118 ----SLEHNGISDINGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNH  189 (291)
T ss_dssp             ----ECTTSCCCCCGGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSC
T ss_pred             ----ECCCCcCCCChhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCc
Confidence                777777763  234455699999999999854  468899999999999999996444  8999999999999999


Q ss_pred             ccCCCCCCCCCCCCCCCccCCCcccccCCcc
Q 007680          159 LSGKIPKLEGEIPVKGSFKNFSTESFFGNYA  189 (593)
Q Consensus       159 l~~~~p~~~~~~~~~~~~~~~~~~~~~~n~~  189 (593)
                      +++.. . +.      .+.++......+|+.
T Consensus       190 i~~l~-~-l~------~l~~L~~L~l~~n~i  212 (291)
T 1h6t_A          190 ISDLR-A-LA------GLKNLDVLELFSQEC  212 (291)
T ss_dssp             CCBCG-G-GT------TCTTCSEEEEEEEEE
T ss_pred             CCCCh-h-hc------cCCCCCEEECcCCcc
Confidence            98742 2 33      334445556666654

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=99.72  E-value=7.5e-18  Score=182.97  Aligned_cols=152  Identities=28%  Similarity=0.369  Sum_probs=134.1

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcc--cCCccCCCCCCCcEEEccCCcccccccc-cccCCCCchhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTG--TIPNSITNATKLIVLDLGFNSFSGHILN-TFGNLRHLSVL   77 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L   77 (593)
                      |++|+|++|++++.+|..+.. +++|++|+|++|+|++  .+|..|.++++|+.|+|++|++++.+|. .|..+++|++|
T Consensus       326 L~~L~Ls~n~l~~~~~~~~~~-l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L  404 (520)
T 2z7x_B          326 FLHLDFSNNLLTDTVFENCGH-LTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSL  404 (520)
T ss_dssp             CCEEECCSSCCCTTTTTTCCC-CSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEE
T ss_pred             ccEEEeECCccChhhhhhhcc-CCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEE
Confidence            689999999999778888865 9999999999999996  5567899999999999999999974665 58899999999


Q ss_pred             hhhcceeeccCCcccccCCCc--ccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCcc-ccCCcccccccc
Q 007680           78 SLLMFGIRLTGNKLYGRIPPC--LVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPES-VGSLISLESLDL  154 (593)
Q Consensus        78 ~l~~n~l~l~~n~l~~~~~~~--~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-l~~~~~L~~L~l  154 (593)
                             ++++|++++.+|..  ..|++|++++|+|+ .+|..+..+++|+.|+|++|+|+ .+|.. +..+++|+.|++
T Consensus       405 -------~Ls~N~l~~~~~~~l~~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l  475 (520)
T 2z7x_B          405 -------NMSSNILTDTIFRCLPPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWL  475 (520)
T ss_dssp             -------ECCSSCCCGGGGGSCCTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEEC
T ss_pred             -------ECcCCCCCcchhhhhcccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCC-ccCHHHhccCCcccEEEC
Confidence                   88889888766554  36999999999999 78887889999999999999999 56655 999999999999


Q ss_pred             ccccccCC
Q 007680          155 SGNNLSGK  162 (593)
Q Consensus       155 ~~N~l~~~  162 (593)
                      ++|++++.
T Consensus       476 ~~N~~~c~  483 (520)
T 2z7x_B          476 HTNPWDCS  483 (520)
T ss_dssp             CSSCBCCC
T ss_pred             cCCCCccc
Confidence            99999874

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.72  E-value=1.3e-17  Score=167.10  Aligned_cols=147  Identities=27%  Similarity=0.414  Sum_probs=125.6

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLL   80 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~   80 (593)
                      |+.|+|++|+++ .++. +. .+++|++|+|++|+|++ +| .+..+++|+.|+|++|++++.  +.+..+++|+.|   
T Consensus        70 L~~L~L~~n~l~-~~~~-l~-~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L---  139 (291)
T 1h6t_A           70 VTKLFLNGNKLT-DIKP-LA-NLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESL---  139 (291)
T ss_dssp             CCEEECCSSCCC-CCGG-GT-TCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEE---
T ss_pred             CCEEEccCCccC-CCcc-cc-cCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEE---
Confidence            689999999999 6776 55 59999999999999995 44 499999999999999999954  469999999999   


Q ss_pred             cceeeccCCcccc--cCCCcccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCccccCCcccccccccccc
Q 007680           81 MFGIRLTGNKLYG--RIPPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNN  158 (593)
Q Consensus        81 ~n~l~l~~n~l~~--~~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~~N~  158 (593)
                          ++++|++.+  .+..+..|++|++++|++++..|  +..+++|+.|++++|+|++ +| .+..+++|+.|++++|+
T Consensus       140 ----~l~~n~l~~~~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~-l~-~l~~l~~L~~L~l~~n~  211 (291)
T 1h6t_A          140 ----YLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFSQE  211 (291)
T ss_dssp             ----ECCSSCCCCCGGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEEEE
T ss_pred             ----EccCCcCCcchhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCCC-Ch-hhccCCCCCEEECcCCc
Confidence                777777774  34455679999999999996555  9999999999999999984 55 48999999999999999


Q ss_pred             ccCCCCC
Q 007680          159 LSGKIPK  165 (593)
Q Consensus       159 l~~~~p~  165 (593)
                      ++..+..
T Consensus       212 i~~~~~~  218 (291)
T 1h6t_A          212 CLNKPIN  218 (291)
T ss_dssp             EECCCEE
T ss_pred             ccCCccc
Confidence            9875443

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.72  E-value=1.6e-17  Score=163.66  Aligned_cols=140  Identities=26%  Similarity=0.346  Sum_probs=77.8

Q ss_pred             EEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhhcce
Q 007680            4 LTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLMFG   83 (593)
Q Consensus         4 L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~   83 (593)
                      ++|++|.++ .++ .+.. +++|++|+|++|.|+ .+| ++..+++|+.|+|++|+|++..|  |..+++|++|      
T Consensus        24 l~l~~~~i~-~~~-~~~~-l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L------   90 (263)
T 1xeu_A           24 QNLGKQSVT-DLV-SQKE-LSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEEL------   90 (263)
T ss_dssp             HHHTCSCTT-SEE-CHHH-HTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEE------
T ss_pred             HHhcCCCcc-ccc-chhh-cCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEE------
Confidence            345556665 444 2332 566666666666666 344 45566666666666666664333  6666666666      


Q ss_pred             eeccCCcccc--cCCCcccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCccccCCccccccccccccccC
Q 007680           84 IRLTGNKLYG--RIPPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSG  161 (593)
Q Consensus        84 l~l~~n~l~~--~~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~~N~l~~  161 (593)
                       ++++|++.+  .++. ..|++|++++|++++ ++ .+..+++|+.|++++|+|++ +| .+..+++|+.|++++|++++
T Consensus        91 -~L~~N~l~~l~~~~~-~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~-~~-~l~~l~~L~~L~L~~N~i~~  164 (263)
T 1xeu_A           91 -SVNRNRLKNLNGIPS-ACLSRLFLDNNELRD-TD-SLIHLKNLEILSIRNNKLKS-IV-MLGFLSKLEVLDLHGNEITN  164 (263)
T ss_dssp             -ECCSSCCSCCTTCCC-SSCCEEECCSSCCSB-SG-GGTTCTTCCEEECTTSCCCB-CG-GGGGCTTCCEEECTTSCCCB
T ss_pred             -ECCCCccCCcCcccc-CcccEEEccCCccCC-Ch-hhcCcccccEEECCCCcCCC-Ch-HHccCCCCCEEECCCCcCcc
Confidence             555555542  1112 346666666666653 33 35566666666666666653 33 45566666666666666665


Q ss_pred             C
Q 007680          162 K  162 (593)
Q Consensus       162 ~  162 (593)
                      .
T Consensus       165 ~  165 (263)
T 1xeu_A          165 T  165 (263)
T ss_dssp             C
T ss_pred             h
Confidence            4

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.72  E-value=2.6e-17  Score=166.22  Aligned_cols=163  Identities=23%  Similarity=0.304  Sum_probs=134.1

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLL   80 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~   80 (593)
                      |+.|+|++|+++ .+|. +. .+++|++|+|++|+|++ +| .+..+++|+.|+|++|++++. |. +..+++|++|   
T Consensus        65 L~~L~L~~n~i~-~~~~-~~-~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~l~~n~l~~~-~~-l~~l~~L~~L---  134 (308)
T 1h6u_A           65 LIGLELKDNQIT-DLAP-LK-NLTKITELELSGNPLKN-VS-AIAGLQSIKTLDLTSTQITDV-TP-LAGLSNLQVL---  134 (308)
T ss_dssp             CCEEECCSSCCC-CCGG-GT-TCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEECTTSCCCCC-GG-GTTCTTCCEE---
T ss_pred             CCEEEccCCcCC-CChh-Hc-cCCCCCEEEccCCcCCC-ch-hhcCCCCCCEEECCCCCCCCc-hh-hcCCCCCCEE---
Confidence            689999999999 7877 55 59999999999999995 44 699999999999999999964 43 9999999999   


Q ss_pred             cceeeccCCccccc--CCCcccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCccccCCcccccccccccc
Q 007680           81 MFGIRLTGNKLYGR--IPPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNN  158 (593)
Q Consensus        81 ~n~l~l~~n~l~~~--~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~~N~  158 (593)
                          ++++|++.+.  +..+..|++|++++|++++ ++. +..+++|+.|++++|++++ ++. +..+++|+.|++++|+
T Consensus       135 ----~l~~n~l~~~~~l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~L~~N~  206 (308)
T 1h6u_A          135 ----YLDLNQITNISPLAGLTNLQYLSIGNAQVSD-LTP-LANLSKLTTLKADDNKISD-ISP-LASLPNLIEVHLKNNQ  206 (308)
T ss_dssp             ----ECCSSCCCCCGGGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCC-CGG-GGGCTTCCEEECTTSC
T ss_pred             ----ECCCCccCcCccccCCCCccEEEccCCcCCC-Chh-hcCCCCCCEEECCCCccCc-Chh-hcCCCCCCEEEccCCc
Confidence                7778887743  3455569999999999995 444 8999999999999999985 443 8999999999999999


Q ss_pred             ccCCCCCCCCCCCCCCCccCCCcccccCCcc
Q 007680          159 LSGKIPKLEGEIPVKGSFKNFSTESFFGNYA  189 (593)
Q Consensus       159 l~~~~p~~~~~~~~~~~~~~~~~~~~~~n~~  189 (593)
                      +++..|  +..+      .++....+.+|+.
T Consensus       207 l~~~~~--l~~l------~~L~~L~l~~N~i  229 (308)
T 1h6u_A          207 ISDVSP--LANT------SNLFIVTLTNQTI  229 (308)
T ss_dssp             CCBCGG--GTTC------TTCCEEEEEEEEE
T ss_pred             cCcccc--ccCC------CCCCEEEccCCee
Confidence            998663  3333      3444556667765

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=99.72  E-value=2.6e-18  Score=187.82  Aligned_cols=153  Identities=20%  Similarity=0.202  Sum_probs=71.2

Q ss_pred             EeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhhccee
Q 007680            5 TLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLMFGI   84 (593)
Q Consensus         5 ~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l   84 (593)
                      |+++|+++ .+|..++   ++|++|+|++|+|++..|.+|.++++|++|+|++|++++..|+.|+.+++|++|       
T Consensus        11 ~~~~~~l~-~ip~~~~---~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L-------   79 (549)
T 2z81_A           11 DGRSRSFT-SIPSGLT---AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHL-------   79 (549)
T ss_dssp             ECTTSCCS-SCCSCCC---TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEE-------
T ss_pred             ECCCCccc-cccccCC---CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEE-------
Confidence            44445554 4554432   345555555555554444445555555555555555554444445555555555       


Q ss_pred             eccCCccccc----CCCcccccEEEccCCcccC-cCCCCCCCCCCCCEecCCCccCCCCCC-ccccCCcccccccccccc
Q 007680           85 RLTGNKLYGR----IPPCLVLTVLDVSRNQLSG-DIPSTIGGRVDLETLSLASNQFQGPIP-ESVGSLISLESLDLSGNN  158 (593)
Q Consensus        85 ~l~~n~l~~~----~~~~~~L~~L~l~~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~~p-~~l~~~~~L~~L~l~~N~  158 (593)
                      ++++|++.+.    +..+..|++|++++|++++ ..|..++++++|++|++++|++.+.+| ..+.++++|+.|++++|+
T Consensus        80 ~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~  159 (549)
T 2z81_A           80 DLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALS  159 (549)
T ss_dssp             ECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETT
T ss_pred             ECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCc
Confidence            4444444422    1223335555555555543 123344455555555555554222222 344455555555555555


Q ss_pred             ccCCCCCCCC
Q 007680          159 LSGKIPKLEG  168 (593)
Q Consensus       159 l~~~~p~~~~  168 (593)
                      +++..|..+.
T Consensus       160 l~~~~~~~l~  169 (549)
T 2z81_A          160 LRNYQSQSLK  169 (549)
T ss_dssp             CCEECTTTTT
T ss_pred             ccccChhhhh
Confidence            5544444433

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.71  E-value=3.8e-17  Score=150.90  Aligned_cols=132  Identities=22%  Similarity=0.249  Sum_probs=105.9

Q ss_pred             cEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhhc
Q 007680            2 RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLM   81 (593)
Q Consensus         2 ~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~   81 (593)
                      +.+++++|+++ .+|..++   ++|++|+|++|+|++..+..|.++++|+.|+|++|+|++..+..|..+++|+      
T Consensus        10 ~~l~~~~~~l~-~~p~~~~---~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~------   79 (177)
T 2o6r_A           10 TEIRCNSKGLT-SVPTGIP---SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLT------   79 (177)
T ss_dssp             TEEECCSSCCS-SCCTTCC---TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCC------
T ss_pred             CEEEecCCCCc-cCCCCCC---CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccC------
Confidence            57899999998 8886654   5899999999999977677788999999999999999966666666666654      


Q ss_pred             ceeeccCCcccccCCCcccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCccccCCccccccccccccccC
Q 007680           82 FGIRLTGNKLYGRIPPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSG  161 (593)
Q Consensus        82 n~l~l~~n~l~~~~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~~N~l~~  161 (593)
                                           +|++++|+|++.++..|.++++|+.|++++|+|++..+..+..+++|+.|++++|++++
T Consensus        80 ---------------------~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~  138 (177)
T 2o6r_A           80 ---------------------ILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDC  138 (177)
T ss_dssp             ---------------------EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred             ---------------------EEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeec
Confidence                                 55777777776666667888889999999999986666667888889999999998887


Q ss_pred             CCC
Q 007680          162 KIP  164 (593)
Q Consensus       162 ~~p  164 (593)
                      ..|
T Consensus       139 ~~~  141 (177)
T 2o6r_A          139 SCP  141 (177)
T ss_dssp             CHH
T ss_pred             cCc
Confidence            554

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.71  E-value=3.1e-18  Score=173.78  Aligned_cols=165  Identities=21%  Similarity=0.107  Sum_probs=109.6

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLL   80 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~   80 (593)
                      |++|+|++|+++ .+|.     .++|++|++++|+|++..+..   +++|+.|+|++|++++..|..|+.+++|++|   
T Consensus        82 L~~L~Ls~n~l~-~l~~-----~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L---  149 (317)
T 3o53_A           82 LRTLDLNNNYVQ-ELLV-----GPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYL---  149 (317)
T ss_dssp             CCEEECCSSEEE-EEEE-----CTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEE---
T ss_pred             CCEEECcCCccc-cccC-----CCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEE---
Confidence            678888888887 5552     467888888888887554443   4667888888888876666677777788777   


Q ss_pred             cceeeccCCcccccCC-----CcccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCccccCCccccccccc
Q 007680           81 MFGIRLTGNKLYGRIP-----PCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLS  155 (593)
Q Consensus        81 ~n~l~l~~n~l~~~~~-----~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~  155 (593)
                          ++++|++.+..+     .+..|++|++++|++++. |. ...+++|+.|+|++|+|++ +|..+..+++|+.|+++
T Consensus       150 ----~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~L~  222 (317)
T 3o53_A          150 ----DLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLR  222 (317)
T ss_dssp             ----ECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECT
T ss_pred             ----ECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-cc-ccccccCCEEECCCCcCCc-chhhhcccCcccEEECc
Confidence                666666664322     234577788888877743 32 3347777788888887773 45557777777888888


Q ss_pred             cccccCCCCCCCCCCCCCCCccCCCcccccCCccCC
Q 007680          156 GNNLSGKIPKLEGEIPVKGSFKNFSTESFFGNYALC  191 (593)
Q Consensus       156 ~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~n~~~c  191 (593)
                      +|+++++ |..+..++      .+......+|+..|
T Consensus       223 ~N~l~~l-~~~~~~l~------~L~~L~l~~N~~~~  251 (317)
T 3o53_A          223 NNKLVLI-EKALRFSQ------NLEHFDLRGNGFHC  251 (317)
T ss_dssp             TSCCCEE-CTTCCCCT------TCCEEECTTCCCBH
T ss_pred             CCcccch-hhHhhcCC------CCCEEEccCCCccC
Confidence            8877753 33333333      34445566666654

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.71  E-value=3.7e-18  Score=183.57  Aligned_cols=166  Identities=22%  Similarity=0.121  Sum_probs=130.2

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLL   80 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~   80 (593)
                      |++|+|++|.|+ .+|.     .++|++|+|++|+|++..+.   .+++|+.|+|++|.|++..|..|+.+++|+.|   
T Consensus        82 L~~L~Ls~N~l~-~l~~-----~~~L~~L~L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L---  149 (487)
T 3oja_A           82 LRTLDLNNNYVQ-ELLV-----GPSIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYL---  149 (487)
T ss_dssp             CCEEECCSSEEE-EEEE-----CTTCCEEECCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEE---
T ss_pred             CCEEEecCCcCC-CCCC-----CCCcCEEECcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEE---
Confidence            688999999998 5663     37899999999999976654   35789999999999998888889999999999   


Q ss_pred             cceeeccCCcccccCC-----CcccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCccccCCccccccccc
Q 007680           81 MFGIRLTGNKLYGRIP-----PCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLS  155 (593)
Q Consensus        81 ~n~l~l~~n~l~~~~~-----~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~  155 (593)
                          ++++|.+++..|     .+..|++|+|++|.|++. |. +..+++|+.|+|++|+|++ +|..+..+++|+.|+++
T Consensus       150 ----~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~Ls  222 (487)
T 3oja_A          150 ----DLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLR  222 (487)
T ss_dssp             ----ECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECT
T ss_pred             ----ECCCCCCCCcChHHHhhhCCcccEEecCCCccccc-cc-cccCCCCCEEECCCCCCCC-CCHhHcCCCCccEEEec
Confidence                778888776433     345699999999999865 33 4468899999999999985 55558889999999999


Q ss_pred             cccccCCCCCCCCCCCCCCCccCCCcccccCCccCCC
Q 007680          156 GNNLSGKIPKLEGEIPVKGSFKNFSTESFFGNYALCG  192 (593)
Q Consensus       156 ~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~n~~~c~  192 (593)
                      +|+++++ |..+..++      .+...++.+|+..|+
T Consensus       223 ~N~l~~l-p~~l~~l~------~L~~L~l~~N~l~c~  252 (487)
T 3oja_A          223 NNKLVLI-EKALRFSQ------NLEHFDLRGNGFHCG  252 (487)
T ss_dssp             TSCCCEE-CTTCCCCT------TCCEEECTTCCBCHH
T ss_pred             CCcCccc-chhhccCC------CCCEEEcCCCCCcCc
Confidence            9999974 44344333      445567788888765

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.70  E-value=2e-17  Score=170.24  Aligned_cols=170  Identities=15%  Similarity=0.102  Sum_probs=129.7

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCC-ccCCCCCCCcE-EEccCCcccccccccccCCCCchhhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIP-NSITNATKLIV-LDLGFNSFSGHILNTFGNLRHLSVLS   78 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~-L~L~~N~l~~~~p~~~~~l~~L~~L~   78 (593)
                      |+.|+|++|+|+ .||.+.+.++++|++|+|++|+|.+.+| .+|.++++|+. +.+++|+|+...|+.|..+++|++|+
T Consensus        32 l~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~  110 (350)
T 4ay9_X           32 AIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLL  110 (350)
T ss_dssp             CSEEEEESCCCS-EECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEE
T ss_pred             CCEEEccCCcCC-CcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhcccccccc
Confidence            578999999999 8998877679999999999999876665 46889988775 66778999988888999999999998


Q ss_pred             hhcceee-----------------ccC-Ccccc----cCCCcc-cccEEEccCCcccCcCCCCCCCCCCCCEecCCC-cc
Q 007680           79 LLMFGIR-----------------LTG-NKLYG----RIPPCL-VLTVLDVSRNQLSGDIPSTIGGRVDLETLSLAS-NQ  134 (593)
Q Consensus        79 l~~n~l~-----------------l~~-n~l~~----~~~~~~-~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~-N~  134 (593)
                      +++|.+.                 +.+ |++..    .+..+. .|+.|+|++|+|+. +|.......+|++|++.+ |.
T Consensus       111 l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~-i~~~~f~~~~L~~l~l~~~n~  189 (350)
T 4ay9_X          111 ISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE-IHNSAFNGTQLDELNLSDNNN  189 (350)
T ss_dssp             EEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCE-ECTTSSTTEEEEEEECTTCTT
T ss_pred             ccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccccC-CChhhccccchhHHhhccCCc
Confidence            8776643                 222 33331    112222 37889999999984 554554567899999974 67


Q ss_pred             CCCCCCccccCCccccccccccccccCCCCCCCCCCCC
Q 007680          135 FQGPIPESVGSLISLESLDLSGNNLSGKIPKLEGEIPV  172 (593)
Q Consensus       135 l~~~~p~~l~~~~~L~~L~l~~N~l~~~~p~~~~~~~~  172 (593)
                      ++...++.|.++++|+.||+++|+|+.+++..+..+..
T Consensus       190 l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~L~~  227 (350)
T 4ay9_X          190 LEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKK  227 (350)
T ss_dssp             CCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCTTCCE
T ss_pred             ccCCCHHHhccCcccchhhcCCCCcCccChhhhccchH
Confidence            77444567899999999999999999887776655543

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.70  E-value=7.9e-17  Score=176.92  Aligned_cols=151  Identities=28%  Similarity=0.382  Sum_probs=68.6

Q ss_pred             cEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhhc
Q 007680            2 RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLM   81 (593)
Q Consensus         2 ~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~   81 (593)
                      +.|+|++|.|. .+| .+.. +++|+.|+|++|+|++..|  |..+++|+.|+|++|+|++ +| .|..|++|+.|+|++
T Consensus        46 ~~L~l~~n~i~-~l~-~l~~-l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~  118 (605)
T 1m9s_A           46 DQIIANNSDIK-SVQ-GIQY-LPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSLSLEH  118 (605)
T ss_dssp             CCCBCTTCCCC-CCT-TGGG-CTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEEECTT
T ss_pred             CEEECcCCCCC-CCh-HHcc-CCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEEEecC
Confidence            44555555554 444 2332 5555555555555553322  4455555555555555552 22 345555555551111


Q ss_pred             cee---------------eccCCcccc--cCCCcccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCcccc
Q 007680           82 FGI---------------RLTGNKLYG--RIPPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVG  144 (593)
Q Consensus        82 n~l---------------~l~~n~l~~--~~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~  144 (593)
                      |.+               +|++|++.+  .+..+..|+.|+|++|+|++..|  +..+++|+.|+|++|+|++ +| .+.
T Consensus       119 N~l~~l~~l~~l~~L~~L~Ls~N~l~~l~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~-l~-~l~  194 (605)
T 1m9s_A          119 NGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD-LR-ALA  194 (605)
T ss_dssp             SCCCCCGGGGGCTTCSEEECCSSCCCCCGGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB-CG-GGT
T ss_pred             CCCCCCccccCCCccCEEECCCCccCCchhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCC-Ch-HHc
Confidence            110               334444432  12223335555555555553333  4455555555555555542 22 345


Q ss_pred             CCccccccccccccccCCC
Q 007680          145 SLISLESLDLSGNNLSGKI  163 (593)
Q Consensus       145 ~~~~L~~L~l~~N~l~~~~  163 (593)
                      .+++|+.|+|++|++++.+
T Consensus       195 ~l~~L~~L~L~~N~l~~~p  213 (605)
T 1m9s_A          195 GLKNLDVLELFSQECLNKP  213 (605)
T ss_dssp             TCTTCSEEECCSEEEECCC
T ss_pred             cCCCCCEEEccCCcCcCCc
Confidence            5555555555555555433

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.69  E-value=1.9e-17  Score=163.20  Aligned_cols=146  Identities=23%  Similarity=0.311  Sum_probs=124.5

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLL   80 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~   80 (593)
                      |+.|+|++|+++ .+| .+.. +++|++|+|++|+|++..|  |.++++|+.|+|++|++++ +|. +.. ++|+.|   
T Consensus        43 L~~L~l~~n~i~-~l~-~l~~-l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N~l~~-l~~-~~~-~~L~~L---  111 (263)
T 1xeu_A           43 VQNFNGDNSNIQ-SLA-GMQF-FTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLKN-LNG-IPS-ACLSRL---  111 (263)
T ss_dssp             CSEEECTTSCCC-CCT-TGGG-CTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSCCSC-CTT-CCC-SSCCEE---
T ss_pred             CcEEECcCCCcc-cch-HHhh-CCCCCEEECCCCccCCChh--hccCCCCCEEECCCCccCC-cCc-ccc-CcccEE---
Confidence            689999999999 898 5664 9999999999999996544  9999999999999999995 444 333 899999   


Q ss_pred             cceeeccCCcccc--cCCCcccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCccccCCcccccccccccc
Q 007680           81 MFGIRLTGNKLYG--RIPPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNN  158 (593)
Q Consensus        81 ~n~l~l~~n~l~~--~~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~~N~  158 (593)
                          ++++|++++  .+..+.+|++|++++|+|++ +| .+..+++|+.|++++|++++.  ..+..+++|+.|++++|+
T Consensus       112 ----~L~~N~l~~~~~l~~l~~L~~L~Ls~N~i~~-~~-~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~  183 (263)
T 1xeu_A          112 ----FLDNNELRDTDSLIHLKNLEILSIRNNKLKS-IV-MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQK  183 (263)
T ss_dssp             ----ECCSSCCSBSGGGTTCTTCCEEECTTSCCCB-CG-GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEE
T ss_pred             ----EccCCccCCChhhcCcccccEEECCCCcCCC-Ch-HHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCc
Confidence                778888774  34556679999999999995 45 689999999999999999965  678999999999999999


Q ss_pred             ccCCCCC
Q 007680          159 LSGKIPK  165 (593)
Q Consensus       159 l~~~~p~  165 (593)
                      +++.+..
T Consensus       184 ~~~~~~~  190 (263)
T 1xeu_A          184 CVNEPVK  190 (263)
T ss_dssp             EECCCEE
T ss_pred             ccCCccc
Confidence            9986444

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.68  E-value=4.2e-17  Score=149.22  Aligned_cols=132  Identities=20%  Similarity=0.152  Sum_probs=110.0

Q ss_pred             CCCCcEEECCCCcCc-ccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhhcceeeccCCcccccCCC----
Q 007680           23 LPNIEYLLLTANNLT-GTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPP----   97 (593)
Q Consensus        23 l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~l~~n~l~~~~~~----   97 (593)
                      .++|+.|+|++|+|+ +.+|..+..+++|+.|+|++|.+++.  ..|..+++|++|       ++++|++.+.+|.    
T Consensus        23 ~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L-------~Ls~N~l~~~~~~~~~~   93 (168)
T 2ell_A           23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKL-------ELSENRIFGGLDMLAEK   93 (168)
T ss_dssp             TTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEE-------EEESCCCCSCCCHHHHH
T ss_pred             cccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEE-------ECcCCcCchHHHHHHhh
Confidence            578999999999998 67888888899999999999999855  678889999988       7788888765554    


Q ss_pred             cccccEEEccCCcccCcCC-CCCCCCCCCCEecCCCccCCCCCC---ccccCCccccccccccccccCCC
Q 007680           98 CLVLTVLDVSRNQLSGDIP-STIGGRVDLETLSLASNQFQGPIP---ESVGSLISLESLDLSGNNLSGKI  163 (593)
Q Consensus        98 ~~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~p---~~l~~~~~L~~L~l~~N~l~~~~  163 (593)
                      +..|++|++++|++++..+ ..+..+++|+.|++++|++++..+   ..+..+++|+.|++++|.+...+
T Consensus        94 l~~L~~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~  163 (168)
T 2ell_A           94 LPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQEAP  163 (168)
T ss_dssp             CTTCCEEECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCBCC
T ss_pred             CCCCCEEeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChhhcc
Confidence            3459999999999985432 678999999999999999995444   48999999999999999998644

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.68  E-value=6e-17  Score=177.86  Aligned_cols=143  Identities=22%  Similarity=0.301  Sum_probs=102.6

Q ss_pred             EEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhhcce
Q 007680            4 LTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLMFG   83 (593)
Q Consensus         4 L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~   83 (593)
                      +.|+.+.+.+.++  +.. |++|+.|+|++|.|+ .+| .|..+++|+.|+|++|+|++..|  |..|++|+.|      
T Consensus        26 l~l~~~~i~~~~~--~~~-L~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L------   92 (605)
T 1m9s_A           26 DNLKKKSVTDAVT--QNE-LNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWL------   92 (605)
T ss_dssp             HHTTCSCTTSEEC--HHH-HTTCCCCBCTTCCCC-CCT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEE------
T ss_pred             HhccCCCcccccc--hhc-CCCCCEEECcCCCCC-CCh-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEE------
Confidence            3466777773333  333 889999999999999 455 68999999999999999996655  9999999999      


Q ss_pred             eeccCCcccc--cCCCcccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCccccCCccccccccccccccC
Q 007680           84 IRLTGNKLYG--RIPPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSG  161 (593)
Q Consensus        84 l~l~~n~l~~--~~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~~N~l~~  161 (593)
                       +|++|++.+  .+..+..|++|+|++|+|++ ++ .+..+++|+.|+|++|+|++.  ..+..+++|+.|+|++|++++
T Consensus        93 -~Ls~N~l~~l~~l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~  167 (605)
T 1m9s_A           93 -FLDENKIKDLSSLKDLKKLKSLSLEHNGISD-IN-GLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISD  167 (605)
T ss_dssp             -ECCSSCCCCCTTSTTCTTCCEEECTTSCCCC-CG-GGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCC
T ss_pred             -ECcCCCCCCChhhccCCCCCEEEecCCCCCC-Cc-cccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCC
Confidence             555665553  23444457777777777763 33 366677777777777777643  456667777777777777766


Q ss_pred             CCC
Q 007680          162 KIP  164 (593)
Q Consensus       162 ~~p  164 (593)
                      ..|
T Consensus       168 ~~~  170 (605)
T 1m9s_A          168 IVP  170 (605)
T ss_dssp             CGG
T ss_pred             chh
Confidence            554

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=99.67  E-value=8.7e-17  Score=165.11  Aligned_cols=153  Identities=24%  Similarity=0.328  Sum_probs=95.2

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLL   80 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~   80 (593)
                      |+.|++++|.+. .++. +. .+++|++|++++|.+++. +. +..+++|+.|++++|.+++..+  +..+++|++|   
T Consensus       157 L~~L~l~~~~~~-~~~~-~~-~l~~L~~L~l~~n~l~~~-~~-~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L---  226 (347)
T 4fmz_A          157 LNYLTVTESKVK-DVTP-IA-NLTDLYSLSLNYNQIEDI-SP-LASLTSLHYFTAYVNQITDITP--VANMTRLNSL---  226 (347)
T ss_dssp             CCEEECCSSCCC-CCGG-GG-GCTTCSEEECTTSCCCCC-GG-GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEE---
T ss_pred             CcEEEecCCCcC-Cchh-hc-cCCCCCEEEccCCccccc-cc-ccCCCccceeecccCCCCCCch--hhcCCcCCEE---
Confidence            567777777777 5554 43 377777777777777743 33 6677777777777777774443  6667777777   


Q ss_pred             cceeeccCCccccc--CCCcccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCccccCCcccccccccccc
Q 007680           81 MFGIRLTGNKLYGR--IPPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNN  158 (593)
Q Consensus        81 ~n~l~l~~n~l~~~--~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~~N~  158 (593)
                          ++++|++++.  +..+..|++|++++|.+++ ++ .+..+++|+.|++++|++++ + ..+..+++|+.|++++|+
T Consensus       227 ----~l~~n~l~~~~~~~~l~~L~~L~l~~n~l~~-~~-~~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~L~~n~  298 (347)
T 4fmz_A          227 ----KIGNNKITDLSPLANLSQLTWLEIGTNQISD-IN-AVKDLTKLKMLNVGSNQISD-I-SVLNNLSQLNSLFLNNNQ  298 (347)
T ss_dssp             ----ECCSSCCCCCGGGTTCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSC
T ss_pred             ----EccCCccCCCcchhcCCCCCEEECCCCccCC-Ch-hHhcCCCcCEEEccCCccCC-C-hhhcCCCCCCEEECcCCc
Confidence                5555555522  2334456666666666663 32 46666666666666666663 3 245666666666666666


Q ss_pred             ccCCCCCCCCCCC
Q 007680          159 LSGKIPKLEGEIP  171 (593)
Q Consensus       159 l~~~~p~~~~~~~  171 (593)
                      +++..|..+..++
T Consensus       299 l~~~~~~~l~~l~  311 (347)
T 4fmz_A          299 LGNEDMEVIGGLT  311 (347)
T ss_dssp             CCGGGHHHHHTCT
T ss_pred             CCCcChhHhhccc
Confidence            6665555444433

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=99.67  E-value=5.5e-16  Score=165.18  Aligned_cols=145  Identities=25%  Similarity=0.282  Sum_probs=90.0

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLL   80 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~   80 (593)
                      |++|+|++|+++ .+|  +. .+++|++|+|++|+|++. |  |+++++|+.|+|++|++++ +|  ++.+++|++|+++
T Consensus        66 L~~L~Ls~n~l~-~~~--~~-~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l~  135 (457)
T 3bz5_A           66 LTKLICTSNNIT-TLD--LS-QNTNLTYLACDSNKLTNL-D--VTPLTKLTYLNCDTNKLTK-LD--VSQNPLLTYLNCA  135 (457)
T ss_dssp             CSEEECCSSCCS-CCC--CT-TCTTCSEEECCSSCCSCC-C--CTTCTTCCEEECCSSCCSC-CC--CTTCTTCCEEECT
T ss_pred             CCEEEccCCcCC-eEc--cc-cCCCCCEEECcCCCCcee-e--cCCCCcCCEEECCCCcCCe-ec--CCCCCcCCEEECC
Confidence            566777777776 455  43 366777777777777643 3  6666777777777777664 33  6666666666554


Q ss_pred             ccee--------------eccCCccccc--CCCcccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCcccc
Q 007680           81 MFGI--------------RLTGNKLYGR--IPPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVG  144 (593)
Q Consensus        81 ~n~l--------------~l~~n~l~~~--~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~  144 (593)
                      +|.+              ++++|+..+.  +..+..|++|++++|++++ +|  +..+++|+.|++++|++++.   .+.
T Consensus       136 ~N~l~~l~l~~l~~L~~L~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~---~l~  209 (457)
T 3bz5_A          136 RNTLTEIDVSHNTQLTELDCHLNKKITKLDVTPQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL---DLN  209 (457)
T ss_dssp             TSCCSCCCCTTCTTCCEEECTTCSCCCCCCCTTCTTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC---CCT
T ss_pred             CCccceeccccCCcCCEEECCCCCcccccccccCCcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee---ccc
Confidence            4432              3444433322  2234457777777777774 44  66677777777777777643   266


Q ss_pred             CCccccccccccccccC
Q 007680          145 SLISLESLDLSGNNLSG  161 (593)
Q Consensus       145 ~~~~L~~L~l~~N~l~~  161 (593)
                      .+++|+.|++++|++++
T Consensus       210 ~l~~L~~L~Ls~N~l~~  226 (457)
T 3bz5_A          210 QNIQLTFLDCSSNKLTE  226 (457)
T ss_dssp             TCTTCSEEECCSSCCSC
T ss_pred             cCCCCCEEECcCCcccc
Confidence            66777777777777776

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.66  E-value=1.8e-17  Score=169.60  Aligned_cols=136  Identities=13%  Similarity=0.169  Sum_probs=99.8

Q ss_pred             cccccccCccCcccEEEEEeCCCCeEEEEEeehhhH--------------H--------HHHHHHHHHHHHhhcCCCCcc
Q 007680          274 FNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLE--------------R--------AFRSFDSECEVLRNVRHRNLI  331 (593)
Q Consensus       274 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------------~--------~~~~~~~E~~~l~~l~h~niv  331 (593)
                      |++.+.||+|++|.||+|...+|+.||||+++....              .        ......+|...|.++.+.++.
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~  176 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP  176 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred             EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence            899999999999999999998999999998754210              0        001123566666666444332


Q ss_pred             --eeeeeeecCCceEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCC
Q 007680          332 --KILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDEN  409 (593)
Q Consensus       332 --~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~  409 (593)
                        ..++.    ...++||||++|++|.++..       ......++.|++.+|.+||++|    ||||||||.|||++++
T Consensus       177 vp~p~~~----~~~~LVME~i~G~~L~~l~~-------~~~~~~l~~qll~~l~~lH~~g----IVHrDLKp~NILl~~d  241 (397)
T 4gyi_A          177 VPEPIAQ----SRHTIVMSLVDALPMRQVSS-------VPDPASLYADLIALILRLAKHG----LIHGDFNEFNILIREE  241 (397)
T ss_dssp             CCCEEEE----ETTEEEEECCSCEEGGGCCC-------CSCHHHHHHHHHHHHHHHHHTT----EECSCCSTTSEEEEEE
T ss_pred             CCeeeec----cCceEEEEecCCccHhhhcc-------cHHHHHHHHHHHHHHHHHHHCC----CcCCCCCHHHEEEeCC
Confidence              22221    22379999999988866432       1234578899999999999655    9999999999999877


Q ss_pred             C----------cEEEEeeccceecC
Q 007680          410 M----------VAHVSDFGIYKLLG  424 (593)
Q Consensus       410 ~----------~~kL~Dfg~a~~~~  424 (593)
                      +          .+.|+||+-+....
T Consensus       242 gd~~d~~~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          242 KDAEDPSSITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             ECSSCTTSEEEEEEECCCTTCEETT
T ss_pred             CCcccccccccceEEEEeCCcccCC
Confidence            6          38999999877543

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.66  E-value=1.9e-16  Score=153.74  Aligned_cols=156  Identities=16%  Similarity=0.152  Sum_probs=131.6

Q ss_pred             CcEEEeeCcc-ccccCChhhhhCCCCCcEEECCC-CcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCch---
Q 007680            1 MRILTLEGNQ-LSGRLPSTIGHSLPNIEYLLLTA-NNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLS---   75 (593)
Q Consensus         1 L~~L~Ls~n~-l~~~lp~~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~---   75 (593)
                      |++|+|++|+ ++ .+|...+..+++|++|+|++ |+|++..+..|.++++|+.|+|++|++++ +|+ |..+++|+   
T Consensus        57 L~~L~l~~n~~l~-~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~  133 (239)
T 2xwt_C           57 ISRIYVSIDVTLQ-QLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFF  133 (239)
T ss_dssp             CCEEEEECCSSCC-EECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEE
T ss_pred             CcEEeCCCCCCcc-eeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-ccccccccccc
Confidence            6899999997 88 78876666799999999999 99997777889999999999999999995 666 88888888   


Q ss_pred             hhhhhcceeeccCC-cccc----cCCCccccc-EEEccCCcccCcCCCCCCCCCCCCEecCCCcc-CCCCCCccccCC-c
Q 007680           76 VLSLLMFGIRLTGN-KLYG----RIPPCLVLT-VLDVSRNQLSGDIPSTIGGRVDLETLSLASNQ-FQGPIPESVGSL-I  147 (593)
Q Consensus        76 ~L~l~~n~l~l~~n-~l~~----~~~~~~~L~-~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~-l~~~~p~~l~~~-~  147 (593)
                      +|       ++++| ++.+    .+..+..|+ +|++++|+++...+..|.. ++|+.|++++|+ +++..+..|.++ +
T Consensus       134 ~L-------~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~  205 (239)
T 2xwt_C          134 IL-------EITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG-TKLDAVYLNKNKYLTVIDKDAFGGVYS  205 (239)
T ss_dssp             EE-------EEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTT-CEEEEEECTTCTTCCEECTTTTTTCSB
T ss_pred             EE-------ECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCC-CCCCEEEcCCCCCcccCCHHHhhcccc
Confidence            88       78888 7763    244566799 9999999999444444555 899999999995 987667889999 9


Q ss_pred             cccccccccccccCCCCCCC
Q 007680          148 SLESLDLSGNNLSGKIPKLE  167 (593)
Q Consensus       148 ~L~~L~l~~N~l~~~~p~~~  167 (593)
                      +|+.|++++|++++.++..+
T Consensus       206 ~L~~L~l~~N~l~~l~~~~~  225 (239)
T 2xwt_C          206 GPSLLDVSQTSVTALPSKGL  225 (239)
T ss_dssp             CCSEEECTTCCCCCCCCTTC
T ss_pred             CCcEEECCCCccccCChhHh
Confidence            99999999999998766643

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.66  E-value=3.8e-16  Score=169.76  Aligned_cols=65  Identities=31%  Similarity=0.378  Sum_probs=38.4

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVL   77 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L   77 (593)
                      |+.|+|++|+|+ .+|..++   ++|++|+|++|+|+ .+|   ..+++|+.|+|++|+|++ +|. |.+  +|++|
T Consensus        61 L~~L~Ls~n~L~-~lp~~l~---~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L  125 (571)
T 3cvr_A           61 FSELQLNRLNLS-SLPDNLP---PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHL  125 (571)
T ss_dssp             CSEEECCSSCCS-CCCSCCC---TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEE
T ss_pred             ccEEEeCCCCCC-ccCHhHc---CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEE
Confidence            456666666666 4665543   46666666666666 455   335666666666666664 444 443  55555

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=99.64  E-value=6.7e-16  Score=165.25  Aligned_cols=153  Identities=27%  Similarity=0.338  Sum_probs=79.9

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLL   80 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~   80 (593)
                      |+.|+|++|++. .++. +. .+++|+.|+|++|++++ + +.+..+++|+.|+|++|.+++..|  +..+++|+.|+++
T Consensus       201 L~~L~l~~n~l~-~~~~-~~-~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~  273 (466)
T 1o6v_A          201 LESLIATNNQIS-DITP-LG-ILTNLDELSLNGNQLKD-I-GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLG  273 (466)
T ss_dssp             CSEEECCSSCCC-CCGG-GG-GCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECC
T ss_pred             CCEEEecCCccc-cccc-cc-ccCCCCEEECCCCCccc-c-hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECC
Confidence            455566666655 2332 22 25555555555555553 2 234455555555555555553332  4445555555222


Q ss_pred             cce---------------eeccCCccccc--CCCcccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCccc
Q 007680           81 MFG---------------IRLTGNKLYGR--IPPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESV  143 (593)
Q Consensus        81 ~n~---------------l~l~~n~l~~~--~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l  143 (593)
                      +|.               +++++|++.+.  +..+..|++|++++|++++..|  +..+++|+.|++++|++++.  ..+
T Consensus       274 ~n~l~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l  349 (466)
T 1o6v_A          274 ANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSL  349 (466)
T ss_dssp             SSCCCCCGGGTTCTTCSEEECCSSCCSCCGGGGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGG
T ss_pred             CCccCccccccCCCccCeEEcCCCcccCchhhcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhh
Confidence            111               14555555432  2233346666666666665444  55666666666666666642  356


Q ss_pred             cCCccccccccccccccCCCC
Q 007680          144 GSLISLESLDLSGNNLSGKIP  164 (593)
Q Consensus       144 ~~~~~L~~L~l~~N~l~~~~p  164 (593)
                      ..+++|+.|++++|++++..|
T Consensus       350 ~~l~~L~~L~l~~n~l~~~~~  370 (466)
T 1o6v_A          350 ANLTNINWLSAGHNQISDLTP  370 (466)
T ss_dssp             TTCTTCCEEECCSSCCCBCGG
T ss_pred             ccCCCCCEEeCCCCccCccch
Confidence            666666666666666666554

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.64  E-value=1e-16  Score=143.45  Aligned_cols=125  Identities=19%  Similarity=0.209  Sum_probs=90.9

Q ss_pred             CCCCcEEECCCCcCc-ccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhhcceeeccCCcccccCCC----
Q 007680           23 LPNIEYLLLTANNLT-GTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPP----   97 (593)
Q Consensus        23 l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~l~~n~l~~~~~~----   97 (593)
                      .++|+.|++++|.|+ +.+|..+..+++|+.|+|++|.+++.  ..|+.+++|++|       ++++|++++.+|.    
T Consensus        16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L-------~Ls~n~i~~~~~~~~~~   86 (149)
T 2je0_A           16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKL-------ELSDNRVSGGLEVLAEK   86 (149)
T ss_dssp             GGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEE-------ECCSSCCCSCTHHHHHH
T ss_pred             CccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEE-------ECCCCcccchHHHHhhh
Confidence            457888888888887 67777778888888888888888754  567777777777       6666666654433    


Q ss_pred             cccccEEEccCCcccCc-CCCCCCCCCCCCEecCCCccCCCCCC---ccccCCcccccccccc
Q 007680           98 CLVLTVLDVSRNQLSGD-IPSTIGGRVDLETLSLASNQFQGPIP---ESVGSLISLESLDLSG  156 (593)
Q Consensus        98 ~~~L~~L~l~~N~l~~~-~p~~~~~l~~L~~L~l~~N~l~~~~p---~~l~~~~~L~~L~l~~  156 (593)
                      +..|++|++++|++++. .+..++.+++|+.|++++|++++..+   ..+..+++|+.||+++
T Consensus        87 l~~L~~L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d  149 (149)
T 2je0_A           87 CPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD  149 (149)
T ss_dssp             CTTCCEEECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred             CCCCCEEECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence            33477778888888753 23677888888888888888885444   4677888888888763

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.64  E-value=3.2e-16  Score=170.29  Aligned_cols=153  Identities=24%  Similarity=0.298  Sum_probs=111.3

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLL   80 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~   80 (593)
                      |++|+|++|+|+ .+| .   .+++|++|+|++|+|++ +|. |.+  +|+.|+|++|+|++ +|.   .+++|+.|   
T Consensus        82 L~~L~Ls~N~l~-~ip-~---~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L---  145 (571)
T 3cvr_A           82 ITVLEITQNALI-SLP-E---LPASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYI---  145 (571)
T ss_dssp             CSEEECCSSCCS-CCC-C---CCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEE---
T ss_pred             CCEEECcCCCCc-ccc-c---ccCCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEE---
Confidence            688999999999 899 2   37899999999999996 777 766  89999999999996 665   67888888   


Q ss_pred             cceeeccCCcccccCCCc-ccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCccccCCccc-------ccc
Q 007680           81 MFGIRLTGNKLYGRIPPC-LVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISL-------ESL  152 (593)
Q Consensus        81 ~n~l~l~~n~l~~~~~~~-~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L-------~~L  152 (593)
                          ++++|++++ +|.. .+|++|+|++|+|++ +|. |.  ++|+.|+|++|+|+ .+|. +..  +|       +.|
T Consensus       146 ----~Ls~N~l~~-lp~~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L  212 (571)
T 3cvr_A          146 ----NADNNQLTM-LPELPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFF  212 (571)
T ss_dssp             ----ECCSSCCSC-CCCCCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SCCC-CC----------CCEEE
T ss_pred             ----eCCCCccCc-CCCcCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEE
Confidence                777777774 4443 358888888888875 665 65  77888888888887 5666 554  66       888


Q ss_pred             ccccccccCCCCCCCCCCCCCCCccCCCcccccCCcc
Q 007680          153 DLSGNNLSGKIPKLEGEIPVKGSFKNFSTESFFGNYA  189 (593)
Q Consensus       153 ~l~~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~n~~  189 (593)
                      +|++|+|+.+ |..+..++      ++....+.+|+.
T Consensus       213 ~Ls~N~l~~l-p~~l~~l~------~L~~L~L~~N~l  242 (571)
T 3cvr_A          213 RCRENRITHI-PENILSLD------PTCTIILEDNPL  242 (571)
T ss_dssp             ECCSSCCCCC-CGGGGGSC------TTEEEECCSSSC
T ss_pred             ecCCCcceec-CHHHhcCC------CCCEEEeeCCcC
Confidence            8888888854 43332333      333445566654

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=99.64  E-value=3.1e-16  Score=160.96  Aligned_cols=164  Identities=26%  Similarity=0.400  Sum_probs=136.1

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLL   80 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~   80 (593)
                      |+.|+|++|++. .++. +. .+++|+.|++++|.+++..+  +..+++|+.|+|++|.+++..+  +..+++|++|   
T Consensus       179 L~~L~l~~n~l~-~~~~-~~-~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L---  248 (347)
T 4fmz_A          179 LYSLSLNYNQIE-DISP-LA-SLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWL---  248 (347)
T ss_dssp             CSEEECTTSCCC-CCGG-GG-GCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEE---
T ss_pred             CCEEEccCCccc-cccc-cc-CCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEE---
Confidence            689999999999 6776 54 49999999999999996544  8899999999999999996544  9999999999   


Q ss_pred             cceeeccCCcccc--cCCCcccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCccccCCcccccccccccc
Q 007680           81 MFGIRLTGNKLYG--RIPPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNN  158 (593)
Q Consensus        81 ~n~l~l~~n~l~~--~~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~~N~  158 (593)
                          ++++|.+.+  .+..+..|++|++++|++++ +| .+..+++|+.|++++|++++..|..+..+++|+.|++++|+
T Consensus       249 ----~l~~n~l~~~~~~~~l~~L~~L~l~~n~l~~-~~-~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~  322 (347)
T 4fmz_A          249 ----EIGTNQISDINAVKDLTKLKMLNVGSNQISD-IS-VLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNH  322 (347)
T ss_dssp             ----ECCSSCCCCCGGGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSS
T ss_pred             ----ECCCCccCCChhHhcCCCcCEEEccCCccCC-Ch-hhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCc
Confidence                777777763  34556679999999999985 44 58899999999999999998888889999999999999999


Q ss_pred             ccCCCCCCCCCCCCCCCccCCCcccccCCc
Q 007680          159 LSGKIPKLEGEIPVKGSFKNFSTESFFGNY  188 (593)
Q Consensus       159 l~~~~p~~~~~~~~~~~~~~~~~~~~~~n~  188 (593)
                      +++..|  +..++      ++....+.+|+
T Consensus       323 l~~~~~--~~~l~------~L~~L~l~~N~  344 (347)
T 4fmz_A          323 ITDIRP--LASLS------KMDSADFANQV  344 (347)
T ss_dssp             CCCCGG--GGGCT------TCSEESSSCC-
T ss_pred             cccccC--hhhhh------ccceeehhhhc
Confidence            998776  33333      44445566664

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=99.63  E-value=7.8e-16  Score=164.70  Aligned_cols=146  Identities=24%  Similarity=0.289  Sum_probs=97.3

Q ss_pred             cEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhhc
Q 007680            2 RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLM   81 (593)
Q Consensus         2 ~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~   81 (593)
                      +.|+|++|.++ .++. +. .+++|+.|+|++|++++..+  +..+++|+.|+|++|++++..|  ++.+++|+.|    
T Consensus       246 ~~L~l~~n~l~-~~~~-~~-~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L----  314 (466)
T 1o6v_A          246 TDLDLANNQIS-NLAP-LS-GLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYL----  314 (466)
T ss_dssp             SEEECCSSCCC-CCGG-GT-TCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEE----
T ss_pred             CEEECCCCccc-cchh-hh-cCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEE----
Confidence            44444444444 2322 22 24455555555555543222  4455555555555555553332  4555555555    


Q ss_pred             ceeeccCCcccccC--CCcccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCccccCCccccccccccccc
Q 007680           82 FGIRLTGNKLYGRI--PPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNL  159 (593)
Q Consensus        82 n~l~l~~n~l~~~~--~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~~N~l  159 (593)
                         ++++|++.+..  ..+..|++|++++|++++. + .+.++++|+.|++++|++++..|  +..+++|+.|++++|++
T Consensus       315 ---~L~~n~l~~~~~~~~l~~L~~L~l~~n~l~~~-~-~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~  387 (466)
T 1o6v_A          315 ---TLYFNNISDISPVSSLTKLQRLFFYNNKVSDV-S-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAW  387 (466)
T ss_dssp             ---ECCSSCCSCCGGGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEE
T ss_pred             ---ECcCCcCCCchhhccCccCCEeECCCCccCCc-h-hhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCcc
Confidence               78889888643  3455699999999999964 4 68999999999999999997766  89999999999999999


Q ss_pred             cCCCCC
Q 007680          160 SGKIPK  165 (593)
Q Consensus       160 ~~~~p~  165 (593)
                      ++.+..
T Consensus       388 ~~~p~~  393 (466)
T 1o6v_A          388 TNAPVN  393 (466)
T ss_dssp             ECCCBC
T ss_pred             cCCchh
Confidence            985433

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.63  E-value=7.3e-17  Score=181.46  Aligned_cols=139  Identities=22%  Similarity=0.216  Sum_probs=91.7

Q ss_pred             hCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhhcceeeccCCcccccCCC---
Q 007680           21 HSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPP---   97 (593)
Q Consensus        21 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~l~~n~l~~~~~~---   97 (593)
                      ..+++|+.|+|++|+|+ .+|..+.++++|+.|+|++|.|+ .+|..|+.|++|++|       +|++|+|+ .+|.   
T Consensus       221 ~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L-------~Ls~N~l~-~lp~~~~  290 (727)
T 4b8c_D          221 YDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVL-------DLSHNRLT-SLPAELG  290 (727)
T ss_dssp             -CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEE-------ECTTSCCS-SCCSSGG
T ss_pred             ccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEE-------eCcCCcCC-ccChhhc
Confidence            34777777777777777 56666667777777777777777 667777777777777       66666665 3443   


Q ss_pred             -cccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCccccCCcc-ccccccccccccCCCCCCCCCC
Q 007680           98 -CLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLIS-LESLDLSGNNLSGKIPKLEGEI  170 (593)
Q Consensus        98 -~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~-L~~L~l~~N~l~~~~p~~~~~~  170 (593)
                       +..|++|+|++|.|+ .+|..|+++++|+.|+|++|+|++.+|..+..+.. +..|+|++|.+++.+|..+..+
T Consensus       291 ~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~l~~l  364 (727)
T 4b8c_D          291 SCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHERRFI  364 (727)
T ss_dssp             GGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC----
T ss_pred             CCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcccccee
Confidence             334777777777776 56666777777777777777777666666655432 2346777777777776654433

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.63  E-value=1e-15  Score=143.31  Aligned_cols=112  Identities=32%  Similarity=0.398  Sum_probs=96.5

Q ss_pred             CcEEEeeCccccccCCh-hhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhh
Q 007680            1 MRILTLEGNQLSGRLPS-TIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSL   79 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l   79 (593)
                      |+.|+|++|+|+ .+|. ..+..+++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..|..|..+++|+    
T Consensus        31 l~~L~l~~n~i~-~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~----  105 (192)
T 1w8a_A           31 TTELLLNDNELG-RISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLK----  105 (192)
T ss_dssp             CSEEECCSCCCC-SBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCC----
T ss_pred             CCEEECCCCcCC-ccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCC----
Confidence            689999999999 6665 3344599999999999999998899999999999999999999988777777766654    


Q ss_pred             hcceeeccCCcccccCCCcccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCC
Q 007680           80 LMFGIRLTGNKLYGRIPPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIP  140 (593)
Q Consensus        80 ~~n~l~l~~n~l~~~~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p  140 (593)
                                             +|+|++|+|++.+|..|..+++|+.|+|++|++++..+
T Consensus       106 -----------------------~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~  143 (192)
T 1w8a_A          106 -----------------------TLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH  143 (192)
T ss_dssp             -----------------------EEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred             -----------------------EEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence                                   55777888888888899999999999999999986543

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=99.62  E-value=3.8e-15  Score=158.65  Aligned_cols=141  Identities=24%  Similarity=0.285  Sum_probs=108.4

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLL   80 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~   80 (593)
                      |++|+|++|+++ .+| ++.. +++|++|+|++|+|++. |  ++.+++|+.|+|++|+|++. |  |+.+++|++|   
T Consensus        44 L~~L~Ls~n~l~-~~~-~l~~-l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L---  111 (457)
T 3bz5_A           44 LTSLDCHNSSIT-DMT-GIEK-LTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D--VTPLTKLTYL---  111 (457)
T ss_dssp             CCEEECCSSCCC-CCT-TGGG-CTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--CTTCTTCCEE---
T ss_pred             CCEEEccCCCcc-cCh-hhcc-cCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--cCCCCcCCEE---
Confidence            689999999999 677 5664 99999999999999964 4  99999999999999999964 4  9999999999   


Q ss_pred             cceeeccCCccccc-CCCcccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCccccCCccccccccccccc
Q 007680           81 MFGIRLTGNKLYGR-IPPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNL  159 (593)
Q Consensus        81 ~n~l~l~~n~l~~~-~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~~N~l  159 (593)
                          ++++|++++. +..+..|++|++++|++++ ++  ++++++|+.|++++|+..+.+  .+..+++|+.|++++|++
T Consensus       112 ----~L~~N~l~~l~~~~l~~L~~L~l~~N~l~~-l~--l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l  182 (457)
T 3bz5_A          112 ----NCDTNKLTKLDVSQNPLLTYLNCARNTLTE-ID--VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKI  182 (457)
T ss_dssp             ----ECCSSCCSCCCCTTCTTCCEEECTTSCCSC-CC--CTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCC
T ss_pred             ----ECCCCcCCeecCCCCCcCCEEECCCCccce-ec--cccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCcc
Confidence                6666666642 3344558888888888875 33  666777777777777544444  356666777777777776


Q ss_pred             cCC
Q 007680          160 SGK  162 (593)
Q Consensus       160 ~~~  162 (593)
                      ++.
T Consensus       183 ~~l  185 (457)
T 3bz5_A          183 TEL  185 (457)
T ss_dssp             CCC
T ss_pred             cee
Confidence            663

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.60  E-value=1e-17  Score=182.83  Aligned_cols=150  Identities=21%  Similarity=0.212  Sum_probs=81.4

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCc-------------CcccCCccCCCCC-------------------
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANN-------------LTGTIPNSITNAT-------------------   48 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~-------------l~~~~p~~~~~l~-------------------   48 (593)
                      |+.|+|++|+|+ .||.+++. +++|+.|++++|.             +.+..|+.+++++                   
T Consensus       351 L~~L~Ls~n~L~-~Lp~~i~~-l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~~L~~l  428 (567)
T 1dce_A          351 LFRCELSVEKST-VLQSELES-CKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSK  428 (567)
T ss_dssp             SSSCCCCHHHHH-HHHHHHHH-HHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHHHHHHH
T ss_pred             ceeccCChhhHH-hhHHHHHH-HHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccchhhhh
Confidence            345677777776 67777765 7777777776654             3334444333222                   


Q ss_pred             -------------CCcEEEccCCcccccccccccCCCCchhhhhhcceeeccCCcccccCC----CcccccEEEccCCcc
Q 007680           49 -------------KLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIP----PCLVLTVLDVSRNQL  111 (593)
Q Consensus        49 -------------~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~l~~n~l~~~~~----~~~~L~~L~l~~N~l  111 (593)
                                   .|+.|+|++|+|++ +|. |+.+++|+.|       ++++|+|+ .+|    .+.+|+.|+|++|+|
T Consensus       429 ~l~~n~i~~l~~~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L-------~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l  498 (567)
T 1dce_A          429 FLLENSVLKMEYADVRVLHLAHKDLTV-LCH-LEQLLLVTHL-------DLSHNRLR-ALPPALAALRCLEVLQASDNAL  498 (567)
T ss_dssp             HHHHHHHHHHHHTTCSEEECTTSCCSS-CCC-GGGGTTCCEE-------ECCSSCCC-CCCGGGGGCTTCCEEECCSSCC
T ss_pred             hhhcccccccCccCceEEEecCCCCCC-CcC-ccccccCcEe-------ecCccccc-ccchhhhcCCCCCEEECCCCCC
Confidence                         34455555555553 343 5555555555       44444444 222    223355555555555


Q ss_pred             cCcCCCCCCCCCCCCEecCCCccCCCCC-CccccCCccccccccccccccCCCC
Q 007680          112 SGDIPSTIGGRVDLETLSLASNQFQGPI-PESVGSLISLESLDLSGNNLSGKIP  164 (593)
Q Consensus       112 ~~~~p~~~~~l~~L~~L~l~~N~l~~~~-p~~l~~~~~L~~L~l~~N~l~~~~p  164 (593)
                      ++ +| .++++++|+.|+|++|+|++.. |..+..+++|+.|+|++|++++.+|
T Consensus       499 ~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~  550 (567)
T 1dce_A          499 EN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEG  550 (567)
T ss_dssp             CC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSS
T ss_pred             CC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCcc
Confidence            53 44 4555555555555555555443 5555555555555555555555444

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.60  E-value=3.5e-15  Score=139.74  Aligned_cols=130  Identities=25%  Similarity=0.315  Sum_probs=108.5

Q ss_pred             CcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhhcceeeccCCcccccCCCcccccEEE
Q 007680           26 IEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLVLTVLD  105 (593)
Q Consensus        26 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~l~~n~l~~~~~~~~~L~~L~  105 (593)
                      -+.+++++|.|+ .+|..+.  ++|+.|+|++|+|+ .+|..|..+++|                           ++|+
T Consensus        12 ~~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L---------------------------~~L~   60 (193)
T 2wfh_A           12 DTVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHL---------------------------TLID   60 (193)
T ss_dssp             TTEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTC---------------------------CEEE
T ss_pred             CCEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCC---------------------------CEEE
Confidence            368999999999 6787664  68999999999999 677777666655                           4557


Q ss_pred             ccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCccccCCccccccccccccccCCCCCCCCCCCCCCCccCCCccccc
Q 007680          106 VSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKLEGEIPVKGSFKNFSTESFF  185 (593)
Q Consensus       106 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~  185 (593)
                      |++|+|++..+..|.++++|+.|+|++|+|++..|..|.++++|+.|+|++|++++.++..+..++.      +....+.
T Consensus        61 Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~------L~~L~L~  134 (193)
T 2wfh_A           61 LSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSA------LSHLAIG  134 (193)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTT------CCEEECC
T ss_pred             CCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCcc------ccEEEeC
Confidence            7888888777888999999999999999999888889999999999999999999988877765554      4456788


Q ss_pred             CCccCCC
Q 007680          186 GNYALCG  192 (593)
Q Consensus       186 ~n~~~c~  192 (593)
                      +|++.|.
T Consensus       135 ~N~~~C~  141 (193)
T 2wfh_A          135 ANPLYCD  141 (193)
T ss_dssp             SSCEECS
T ss_pred             CCCeecC
Confidence            9988773

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.59  E-value=2.4e-15  Score=141.31  Aligned_cols=125  Identities=20%  Similarity=0.261  Sum_probs=105.3

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLL   80 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~   80 (593)
                      |++|+|++|.+. .++ .+. .+++|++|+|++|+|++..|..|.++++|+.|+|++|++++..|..|+.+++|++|   
T Consensus        68 L~~L~l~~n~~~-~~~-~l~-~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L---  141 (197)
T 4ezg_A           68 IKDLTINNIHAT-NYN-PIS-GLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSI---  141 (197)
T ss_dssp             CSEEEEESCCCS-CCG-GGT-TCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEE---
T ss_pred             CCEEEccCCCCC-cch-hhh-cCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEE---
Confidence            689999999887 555 565 49999999999999998889999999999999999999998889999999999999   


Q ss_pred             cceeeccCCcccccCC---CcccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCC
Q 007680           81 MFGIRLTGNKLYGRIP---PCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQG  137 (593)
Q Consensus        81 ~n~l~l~~n~l~~~~~---~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~  137 (593)
                          ++++|++.+.++   .+..|++|++++|++++ ++ .+..+++|+.|++++|++.+
T Consensus       142 ----~L~~n~~i~~~~~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N~i~~  195 (197)
T 4ezg_A          142 ----DLSYNGAITDIMPLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQTIGG  195 (197)
T ss_dssp             ----ECCSCTBCCCCGGGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECBC----
T ss_pred             ----EccCCCCccccHhhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeCcccCC
Confidence                777887222333   44569999999999995 55 78999999999999999863

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.59  E-value=7.3e-16  Score=142.11  Aligned_cols=126  Identities=18%  Similarity=0.177  Sum_probs=95.8

Q ss_pred             CCCCcEEECCCCcCcccCCccCCCCC-CCcEEEccCCcccccccccccCCCCchhhhhhcceeeccCCcccccCC----C
Q 007680           23 LPNIEYLLLTANNLTGTIPNSITNAT-KLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIP----P   97 (593)
Q Consensus        23 l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~l~~n~l~~~~~----~   97 (593)
                      +++|++|+|++|+|+ .+|. +..+. +|+.|+|++|.|++.  ..|+.+++|++|       ++++|++++..+    .
T Consensus        18 ~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L-------~Ls~N~l~~~~~~~~~~   86 (176)
T 1a9n_A           18 AVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTL-------LVNNNRICRIGEGLDQA   86 (176)
T ss_dssp             TTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEE-------ECCSSCCCEECSCHHHH
T ss_pred             cCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEE-------ECCCCcccccCcchhhc
Confidence            677888888888888 4454 44444 788888888888754  567778888877       666777663322    2


Q ss_pred             cccccEEEccCCcccCcCCC--CCCCCCCCCEecCCCccCCCCCCcc----ccCCccccccccccccccC
Q 007680           98 CLVLTVLDVSRNQLSGDIPS--TIGGRVDLETLSLASNQFQGPIPES----VGSLISLESLDLSGNNLSG  161 (593)
Q Consensus        98 ~~~L~~L~l~~N~l~~~~p~--~~~~l~~L~~L~l~~N~l~~~~p~~----l~~~~~L~~L~l~~N~l~~  161 (593)
                      +..|++|++++|+|+ .+|.  .+..+++|+.|++++|+++ .+|..    +..+++|+.||+++|....
T Consensus        87 l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~~  154 (176)
T 1a9n_A           87 LPDLTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLKE  154 (176)
T ss_dssp             CTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHHH
T ss_pred             CCCCCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHHH
Confidence            345888899999997 5665  7888999999999999998 56764    8899999999999998864

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.59  E-value=8.2e-15  Score=161.17  Aligned_cols=32  Identities=41%  Similarity=0.581  Sum_probs=17.7

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCc
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLT   37 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~   37 (593)
                      |++|+|++|+|+ .+|.    .+++|++|+|++|+|+
T Consensus        83 L~~L~Ls~N~l~-~lp~----~l~~L~~L~Ls~N~l~  114 (622)
T 3g06_A           83 LRTLEVSGNQLT-SLPV----LPPGLLELSIFSNPLT  114 (622)
T ss_dssp             CCEEEECSCCCS-CCCC----CCTTCCEEEECSCCCC
T ss_pred             CCEEEcCCCcCC-cCCC----CCCCCCEEECcCCcCC
Confidence            455666666665 4554    2455555555555555

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.58  E-value=4.3e-15  Score=152.73  Aligned_cols=154  Identities=15%  Similarity=0.083  Sum_probs=118.7

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcE-EECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEY-LLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSL   79 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~-L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l   79 (593)
                      |++|+|++|++.+.+|.+.+.++++|++ +.+++|+|+...|+.|.++++|+.|++++|+|+...+..+....++..|++
T Consensus        56 L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l  135 (350)
T 4ay9_X           56 LEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDI  135 (350)
T ss_dssp             CCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEE
T ss_pred             CCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhh
Confidence            7899999999976899888777988775 677889999888899999999999999999999766666666666666665


Q ss_pred             hcc-------------------eeeccCCcccccCCC---cccccEEEccC-CcccCcCCCCCCCCCCCCEecCCCccCC
Q 007680           80 LMF-------------------GIRLTGNKLYGRIPP---CLVLTVLDVSR-NQLSGDIPSTIGGRVDLETLSLASNQFQ  136 (593)
Q Consensus        80 ~~n-------------------~l~l~~n~l~~~~~~---~~~L~~L~l~~-N~l~~~~p~~~~~l~~L~~L~l~~N~l~  136 (593)
                      .++                   .+++++|+++..-+.   ...|++|++++ |.++...++.|.++++|+.|+|++|+|+
T Consensus       136 ~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~  215 (350)
T 4ay9_X          136 QDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH  215 (350)
T ss_dssp             ESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCC
T ss_pred             ccccccccccccchhhcchhhhhhccccccccCCChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcC
Confidence            321                   157889998743222   23599999985 7777545567899999999999999999


Q ss_pred             CCCCccccCCcccccccc
Q 007680          137 GPIPESVGSLISLESLDL  154 (593)
Q Consensus       137 ~~~p~~l~~~~~L~~L~l  154 (593)
                      ...+..+.++.+|+.+++
T Consensus       216 ~lp~~~~~~L~~L~~l~~  233 (350)
T 4ay9_X          216 SLPSYGLENLKKLRARST  233 (350)
T ss_dssp             CCCSSSCTTCCEEECTTC
T ss_pred             ccChhhhccchHhhhccC
Confidence            555555666555555544

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.58  E-value=2.1e-15  Score=165.87  Aligned_cols=152  Identities=24%  Similarity=0.263  Sum_probs=85.4

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccC----------
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGN----------   70 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~----------   70 (593)
                      |++|+|++|+|+ .+|.    .+++|+.|+|++|+|+ .+|..   +++|+.|+|++|+|++ +|..+.+          
T Consensus       103 L~~L~Ls~N~l~-~l~~----~l~~L~~L~L~~N~l~-~lp~~---l~~L~~L~Ls~N~l~~-l~~~~~~L~~L~L~~N~  172 (622)
T 3g06_A          103 LLELSIFSNPLT-HLPA----LPSGLCKLWIFGNQLT-SLPVL---PPGLQELSVSDNQLAS-LPALPSELCKLWAYNNQ  172 (622)
T ss_dssp             CCEEEECSCCCC-CCCC----CCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCSC-CCCCCTTCCEEECCSSC
T ss_pred             CCEEECcCCcCC-CCCC----CCCCcCEEECCCCCCC-cCCCC---CCCCCEEECcCCcCCC-cCCccCCCCEEECCCCC
Confidence            566777777776 5665    2455666666666665 24432   2555555555555553 2222211          


Q ss_pred             -------CCCchhhhhhcce-------------eeccCCcccccCCCc-ccccEEEccCCcccCcCCCCCCCCCCCCEec
Q 007680           71 -------LRHLSVLSLLMFG-------------IRLTGNKLYGRIPPC-LVLTVLDVSRNQLSGDIPSTIGGRVDLETLS  129 (593)
Q Consensus        71 -------l~~L~~L~l~~n~-------------l~l~~n~l~~~~~~~-~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~  129 (593)
                             +++|+.|+|++|.             +++++|.++ .+|.. .+|++|+|++|+|++ +|   ..+++|+.|+
T Consensus       173 l~~l~~~~~~L~~L~Ls~N~l~~l~~~~~~L~~L~L~~N~l~-~l~~~~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~  247 (622)
T 3g06_A          173 LTSLPMLPSGLQELSVSDNQLASLPTLPSELYKLWAYNNRLT-SLPALPSGLKELIVSGNRLTS-LP---VLPSELKELM  247 (622)
T ss_dssp             CSCCCCCCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCS-SCCCCCTTCCEEECCSSCCSC-CC---CCCTTCCEEE
T ss_pred             CCCCcccCCCCcEEECCCCCCCCCCCccchhhEEECcCCccc-ccCCCCCCCCEEEccCCccCc-CC---CCCCcCcEEE
Confidence                   1455555444433             244555554 22222 347777777777774 55   3456777777


Q ss_pred             CCCccCCCCCCccccCCccccccccccccccCCCCCCCCCCCC
Q 007680          130 LASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKLEGEIPV  172 (593)
Q Consensus       130 l~~N~l~~~~p~~l~~~~~L~~L~l~~N~l~~~~p~~~~~~~~  172 (593)
                      |++|+|+ .+|.   .+++|+.|+|++|+++. +|..+..++.
T Consensus       248 Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~~-lp~~l~~l~~  285 (622)
T 3g06_A          248 VSGNRLT-SLPM---LPSGLLSLSVYRNQLTR-LPESLIHLSS  285 (622)
T ss_dssp             CCSSCCS-CCCC---CCTTCCEEECCSSCCCS-CCGGGGGSCT
T ss_pred             CCCCCCC-cCCc---ccccCcEEeCCCCCCCc-CCHHHhhccc
Confidence            7777777 4554   45677777777777773 3544444443

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.57  E-value=1.1e-15  Score=171.80  Aligned_cols=152  Identities=23%  Similarity=0.272  Sum_probs=100.0

Q ss_pred             cEEEeeCccccccCChhhhhCCCCC-----cEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchh
Q 007680            2 RILTLEGNQLSGRLPSTIGHSLPNI-----EYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSV   76 (593)
Q Consensus         2 ~~L~Ls~n~l~~~lp~~~~~~l~~L-----~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~   76 (593)
                      +.|+|++|.+. .+|..+.. ...|     ..++++.|++. ..|+.|..+++|+.|+|++|.+. .+|..+..+++|++
T Consensus       176 ~~l~L~~n~~~-~~~~~~l~-~l~Ls~~~i~~~~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~  251 (727)
T 4b8c_D          176 PKIELFANGKD-EANQALLQ-HKKLSQYSIDEDDDIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTR  251 (727)
T ss_dssp             -------------------------------------------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSC
T ss_pred             ceEEeeCCCCC-cchhhHhh-cCccCcccccCcccccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCE
Confidence            56889999998 56665543 2233     33445556666 66888999999999999999999 67777889999999


Q ss_pred             hhhhcceeeccCCcccccCCC----cccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCccccCCcccccc
Q 007680           77 LSLLMFGIRLTGNKLYGRIPP----CLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESL  152 (593)
Q Consensus        77 L~l~~n~l~l~~n~l~~~~~~----~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L  152 (593)
                      |       +|++|+|+ .+|.    +..|++|+|++|+|+ .+|..|+++++|+.|+|++|.|+ .+|..|..+++|+.|
T Consensus       252 L-------~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L  321 (727)
T 4b8c_D          252 L-------YLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFL  321 (727)
T ss_dssp             C-------BCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCE
T ss_pred             E-------EeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEE
Confidence            9       77777777 5553    456999999999999 78999999999999999999998 789889999999999


Q ss_pred             ccccccccCCCCCCC
Q 007680          153 DLSGNNLSGKIPKLE  167 (593)
Q Consensus       153 ~l~~N~l~~~~p~~~  167 (593)
                      +|++|+|++.+|..+
T Consensus       322 ~L~~N~l~~~~p~~~  336 (727)
T 4b8c_D          322 GVEGNPLEKQFLKIL  336 (727)
T ss_dssp             ECTTSCCCSHHHHHH
T ss_pred             eCCCCccCCCChHHH
Confidence            999999999888754

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.57  E-value=1.2e-16  Score=163.27  Aligned_cols=162  Identities=17%  Similarity=0.159  Sum_probs=107.5

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCccc-CCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGT-IPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSL   79 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l   79 (593)
                      |+.|+|++|.+.+ .+..++. +++|++|+|++|.+++. +|..+..+++|+.|+|++|.+++..|..|+.+++|++|  
T Consensus        72 l~~L~l~~n~l~~-~~~~~~~-~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L--  147 (336)
T 2ast_B           72 VIAFRCPRSFMDQ-PLAEHFS-PFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRL--  147 (336)
T ss_dssp             CSEEECTTCEECS-CCCSCCC-CBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEE--
T ss_pred             ceEEEcCCccccc-cchhhcc-CCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEE--
Confidence            4677888888874 4444554 78888888888887755 67777788888888888888877777778888888888  


Q ss_pred             hcceeeccCC-cccc-----cCCCcccccEEEccCC-cccCc-CCCCCCCCC-CCCEecCCCc--cCC-CCCCccccCCc
Q 007680           80 LMFGIRLTGN-KLYG-----RIPPCLVLTVLDVSRN-QLSGD-IPSTIGGRV-DLETLSLASN--QFQ-GPIPESVGSLI  147 (593)
Q Consensus        80 ~~n~l~l~~n-~l~~-----~~~~~~~L~~L~l~~N-~l~~~-~p~~~~~l~-~L~~L~l~~N--~l~-~~~p~~l~~~~  147 (593)
                           ++++| .+++     .+..+..|++|++++| .+++. ++..+..++ +|++|++++|  .++ +.+|..+..++
T Consensus       148 -----~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~  222 (336)
T 2ast_B          148 -----NLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCP  222 (336)
T ss_dssp             -----ECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCT
T ss_pred             -----ECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCC
Confidence                 55555 4442     1223445777777777 66643 455556666 7777777777  343 23455566677


Q ss_pred             ccccccccccc-ccCCCCCCCCCCC
Q 007680          148 SLESLDLSGNN-LSGKIPKLEGEIP  171 (593)
Q Consensus       148 ~L~~L~l~~N~-l~~~~p~~~~~~~  171 (593)
                      +|+.|++++|. +++..+..+..++
T Consensus       223 ~L~~L~l~~~~~l~~~~~~~l~~l~  247 (336)
T 2ast_B          223 NLVHLDLSDSVMLKNDCFQEFFQLN  247 (336)
T ss_dssp             TCSEEECTTCTTCCGGGGGGGGGCT
T ss_pred             CCCEEeCCCCCcCCHHHHHHHhCCC
Confidence            77777777777 5554444444443

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=99.57  E-value=1.8e-14  Score=153.36  Aligned_cols=119  Identities=24%  Similarity=0.371  Sum_probs=59.6

Q ss_pred             CCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhhcceeeccCCcccc--cCCCcccc
Q 007680           24 PNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYG--RIPPCLVL  101 (593)
Q Consensus        24 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~l~~n~l~~--~~~~~~~L  101 (593)
                      ++|++|+|++|+|++ +| +|.++++|++|++++|++++ +|..+   .+|++|       ++++|++.+  .+..+..|
T Consensus       131 ~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L-------~L~~n~l~~l~~~~~l~~L  197 (454)
T 1jl5_A          131 PLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFI-------AAGNNQLEELPELQNLPFL  197 (454)
T ss_dssp             TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEE-------ECCSSCCSSCCCCTTCTTC
T ss_pred             CCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEE-------ECcCCcCCcCccccCCCCC
Confidence            466666666666664 55 46666666666666666663 44322   355555       444444442  11222235


Q ss_pred             cEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCccccCCccccccccccccccC
Q 007680          102 TVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSG  161 (593)
Q Consensus       102 ~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~~N~l~~  161 (593)
                      ++|++++|++++ +|...   ++|+.|++++|+++ .+|. +..+++|+.|++++|++++
T Consensus       198 ~~L~l~~N~l~~-l~~~~---~~L~~L~l~~n~l~-~lp~-~~~l~~L~~L~l~~N~l~~  251 (454)
T 1jl5_A          198 TAIYADNNSLKK-LPDLP---LSLESIVAGNNILE-ELPE-LQNLPFLTTIYADNNLLKT  251 (454)
T ss_dssp             CEEECCSSCCSS-CCCCC---TTCCEEECCSSCCS-SCCC-CTTCTTCCEEECCSSCCSS
T ss_pred             CEEECCCCcCCc-CCCCc---CcccEEECcCCcCC-cccc-cCCCCCCCEEECCCCcCCc
Confidence            555555555543 33221   34555555555554 3442 4455555555555555544

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.57  E-value=3.9e-17  Score=170.38  Aligned_cols=155  Identities=19%  Similarity=0.262  Sum_probs=109.0

Q ss_pred             CcEEEeeCc---cccccCChhhh------hCCCCCcEEECCCCcCcc----cCCccCCCCCCCcEEEccCCccccccccc
Q 007680            1 MRILTLEGN---QLSGRLPSTIG------HSLPNIEYLLLTANNLTG----TIPNSITNATKLIVLDLGFNSFSGHILNT   67 (593)
Q Consensus         1 L~~L~Ls~n---~l~~~lp~~~~------~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~   67 (593)
                      |++|+|++|   ++++.+|.++.      ..+++|++|+|++|+|++    .+|..+..+++|+.|+|++|.++...+..
T Consensus        62 L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~  141 (386)
T 2ca6_A           62 LEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAK  141 (386)
T ss_dssp             CCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHH
T ss_pred             ccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHH
Confidence            678888885   45556666652      347889999999999886    46777888889999999999887544444


Q ss_pred             ccC----C---------CCchhhhhhcceeeccCCccc-ccCC-------CcccccEEEccCCccc--C---cCCCCCCC
Q 007680           68 FGN----L---------RHLSVLSLLMFGIRLTGNKLY-GRIP-------PCLVLTVLDVSRNQLS--G---DIPSTIGG  121 (593)
Q Consensus        68 ~~~----l---------~~L~~L~l~~n~l~l~~n~l~-~~~~-------~~~~L~~L~l~~N~l~--~---~~p~~~~~  121 (593)
                      +..    +         ++|++|       ++++|+++ +.++       .+..|++|++++|+++  |   ..|..+..
T Consensus       142 l~~~l~~l~~~~~~~~~~~L~~L-------~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~  214 (386)
T 2ca6_A          142 IARALQELAVNKKAKNAPPLRSI-------ICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAY  214 (386)
T ss_dssp             HHHHHHHHHHHHHHHTCCCCCEE-------ECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGG
T ss_pred             HHHHHHHHhhhhhcccCCCCcEE-------ECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhc
Confidence            433    3         788888       66666665 2222       3445777888877776  2   34446777


Q ss_pred             CCCCCEecCCCccCC----CCCCccccCCccccccccccccccCC
Q 007680          122 RVDLETLSLASNQFQ----GPIPESVGSLISLESLDLSGNNLSGK  162 (593)
Q Consensus       122 l~~L~~L~l~~N~l~----~~~p~~l~~~~~L~~L~l~~N~l~~~  162 (593)
                      +++|+.|+|++|+|+    +.+|..+..+++|+.|+|++|++++.
T Consensus       215 ~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~  259 (386)
T 2ca6_A          215 CQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSAR  259 (386)
T ss_dssp             CTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHH
T ss_pred             CCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchh
Confidence            777777777777774    35666777777777777777777654

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.57  E-value=6.7e-17  Score=165.11  Aligned_cols=150  Identities=19%  Similarity=0.248  Sum_probs=75.2

Q ss_pred             CcEEEeeCcccccc-CChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCC-cccc-cccccccCCCCchhh
Q 007680            1 MRILTLEGNQLSGR-LPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFN-SFSG-HILNTFGNLRHLSVL   77 (593)
Q Consensus         1 L~~L~Ls~n~l~~~-lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~-~~p~~~~~l~~L~~L   77 (593)
                      |+.|+|++|.+++. +|..+. .+++|++|+|++|.+++..|..|..+++|+.|+|++| .+++ .++..+..+++|++|
T Consensus        95 L~~L~L~~~~l~~~~~~~~~~-~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L  173 (336)
T 2ast_B           95 VQHMDLSNSVIEVSTLHGILS-QCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDEL  173 (336)
T ss_dssp             CCEEECTTCEECHHHHHHHHT-TBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEE
T ss_pred             CCEEEccCCCcCHHHHHHHHh-hCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEE
Confidence            34555555555533 444333 2555555555555555555555555555555555555 4443 134445555555555


Q ss_pred             hhhcceeeccCC-ccccc-----CCCcc-cccEEEccCCc--cc-CcCCCCCCCCCCCCEecCCCcc-CCCCCCccccCC
Q 007680           78 SLLMFGIRLTGN-KLYGR-----IPPCL-VLTVLDVSRNQ--LS-GDIPSTIGGRVDLETLSLASNQ-FQGPIPESVGSL  146 (593)
Q Consensus        78 ~l~~n~l~l~~n-~l~~~-----~~~~~-~L~~L~l~~N~--l~-~~~p~~~~~l~~L~~L~l~~N~-l~~~~p~~l~~~  146 (593)
                             ++++| .+++.     +..+. +|++|++++|.  ++ +.+|..+..+++|+.|++++|. +++..+..+..+
T Consensus       174 -------~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l  246 (336)
T 2ast_B          174 -------NLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQL  246 (336)
T ss_dssp             -------ECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGC
T ss_pred             -------cCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCC
Confidence                   44444 44321     22233 45555555552  32 2334444455555555555555 443444455555


Q ss_pred             cccccccccccc
Q 007680          147 ISLESLDLSGNN  158 (593)
Q Consensus       147 ~~L~~L~l~~N~  158 (593)
                      ++|+.|++++|.
T Consensus       247 ~~L~~L~l~~~~  258 (336)
T 2ast_B          247 NYLQHLSLSRCY  258 (336)
T ss_dssp             TTCCEEECTTCT
T ss_pred             CCCCEeeCCCCC
Confidence            555555555554

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.56  E-value=8.7e-15  Score=134.03  Aligned_cols=104  Identities=24%  Similarity=0.316  Sum_probs=65.2

Q ss_pred             cEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhhc
Q 007680            2 RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLM   81 (593)
Q Consensus         2 ~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~   81 (593)
                      +.|++++|+|+ .+|..++   ++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..+..|..+++|+      
T Consensus        12 ~~l~~s~n~l~-~ip~~~~---~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~------   81 (170)
T 3g39_A           12 TTVDCSGKSLA-SVPTGIP---TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLT------   81 (170)
T ss_dssp             TEEECTTSCCS-SCCSCCC---TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCC------
T ss_pred             CEEEeCCCCcC-ccCccCC---CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCC------
Confidence            45667777776 5665543   4666677777777665566666666677777777666655554455444443      


Q ss_pred             ceeeccCCcccccCCCcccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCC
Q 007680           82 FGIRLTGNKLYGRIPPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQ  136 (593)
Q Consensus        82 n~l~l~~n~l~~~~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~  136 (593)
                                           +|+|++|+|++..+..|.++++|+.|+|++|+++
T Consensus        82 ---------------------~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~  115 (170)
T 3g39_A           82 ---------------------QLSLNDNQLKSIPRGAFDNLKSLTHIWLLNNPWD  115 (170)
T ss_dssp             ---------------------EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred             ---------------------EEECCCCccCEeCHHHhcCCCCCCEEEeCCCCCC
Confidence                                 3455566666545555666777777777777766

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.55  E-value=7.2e-15  Score=135.11  Aligned_cols=103  Identities=21%  Similarity=0.297  Sum_probs=63.4

Q ss_pred             EEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhhcc
Q 007680            3 ILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLMF   82 (593)
Q Consensus         3 ~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n   82 (593)
                      .+++++|+++ .+|..++   ++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..+..|..+++|        
T Consensus        16 ~l~~~~n~l~-~iP~~~~---~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L--------   83 (174)
T 2r9u_A           16 LVNCQNIRLA-SVPAGIP---TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQL--------   83 (174)
T ss_dssp             EEECCSSCCS-SCCSCCC---TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC--------
T ss_pred             EEEeCCCCCC-ccCCCcC---CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchh--------
Confidence            5666666665 6666543   466666666666666556666666666666666666665444444444444        


Q ss_pred             eeeccCCcccccCCCcccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCC
Q 007680           83 GIRLTGNKLYGRIPPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQ  136 (593)
Q Consensus        83 ~l~l~~n~l~~~~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~  136 (593)
                                         ++|+|++|+|++..+..|..+++|+.|+|++|++.
T Consensus        84 -------------------~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~~~  118 (174)
T 2r9u_A           84 -------------------TQLDLNDNHLKSIPRGAFDNLKSLTHIYLYNNPWD  118 (174)
T ss_dssp             -------------------CEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred             -------------------hEEECCCCccceeCHHHhccccCCCEEEeCCCCcc
Confidence                               34455666666444445667777777777777776

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.55  E-value=7.2e-17  Score=168.38  Aligned_cols=166  Identities=21%  Similarity=0.287  Sum_probs=128.4

Q ss_pred             CcEEEeeCccccccCChhhh---hCCCCCcEEECCCC---cCcccCCccC-------CCCCCCcEEEccCCcccc----c
Q 007680            1 MRILTLEGNQLSGRLPSTIG---HSLPNIEYLLLTAN---NLTGTIPNSI-------TNATKLIVLDLGFNSFSG----H   63 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~---~~l~~L~~L~L~~N---~l~~~~p~~~-------~~l~~L~~L~L~~N~l~~----~   63 (593)
                      |+.|+|++|++++..+..+.   ..+++|++|+|++|   ++++.+|..+       ..+++|+.|+|++|.+++    .
T Consensus        34 L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~  113 (386)
T 2ca6_A           34 VKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEP  113 (386)
T ss_dssp             CCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHHH
T ss_pred             ccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCHHHHHH
Confidence            68999999999865444432   24899999999996   4555666655       789999999999999997    4


Q ss_pred             ccccccCCCCchhhhhhcceeeccCCcccc----cCCC----c---------ccccEEEccCCccc-CcCC---CCCCCC
Q 007680           64 ILNTFGNLRHLSVLSLLMFGIRLTGNKLYG----RIPP----C---------LVLTVLDVSRNQLS-GDIP---STIGGR  122 (593)
Q Consensus        64 ~p~~~~~l~~L~~L~l~~n~l~l~~n~l~~----~~~~----~---------~~L~~L~l~~N~l~-~~~p---~~~~~l  122 (593)
                      +|..|..+++|++|       ++++|.+.+    .++.    +         ..|++|+|++|+++ +.+|   ..+..+
T Consensus       114 l~~~l~~~~~L~~L-------~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~  186 (386)
T 2ca6_A          114 LIDFLSKHTPLEHL-------YLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSH  186 (386)
T ss_dssp             HHHHHHHCTTCCEE-------ECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHC
T ss_pred             HHHHHHhCCCCCEE-------ECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhC
Confidence            78889999999999       777777752    2222    2         57999999999997 3445   456788


Q ss_pred             CCCCEecCCCccCC--C---CCCccccCCcccccccccccccc----CCCCCCCCCCCCC
Q 007680          123 VDLETLSLASNQFQ--G---PIPESVGSLISLESLDLSGNNLS----GKIPKLEGEIPVK  173 (593)
Q Consensus       123 ~~L~~L~l~~N~l~--~---~~p~~l~~~~~L~~L~l~~N~l~----~~~p~~~~~~~~~  173 (593)
                      ++|+.|+|++|+|+  |   ..|..+..+++|+.|+|++|.++    +.+|..+..++.+
T Consensus       187 ~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L  246 (386)
T 2ca6_A          187 RLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNL  246 (386)
T ss_dssp             TTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTC
T ss_pred             CCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCc
Confidence            89999999999997  2   34557889999999999999996    5555555555443

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.55  E-value=1.5e-14  Score=133.32  Aligned_cols=111  Identities=24%  Similarity=0.281  Sum_probs=93.5

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLL   80 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~   80 (593)
                      |+.|+|++|+++ .+|...+..+++|++|+|++|+|++..+..|.++++|+.|+|++|+|++..+..|..+++|+     
T Consensus        30 l~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~-----  103 (177)
T 2o6r_A           30 ATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLK-----  103 (177)
T ss_dssp             CSEEECCSSCCC-CCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCC-----
T ss_pred             CcEEEeCCCccc-EeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccC-----
Confidence            689999999999 78877665699999999999999977777789999999999999999977666666666654     


Q ss_pred             cceeeccCCcccccCCCcccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCC
Q 007680           81 MFGIRLTGNKLYGRIPPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPI  139 (593)
Q Consensus        81 ~n~l~l~~n~l~~~~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~  139 (593)
                                            +|++++|++++..+..|..+++|+.|++++|++++..
T Consensus       104 ----------------------~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~  140 (177)
T 2o6r_A          104 ----------------------ELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC  140 (177)
T ss_dssp             ----------------------EEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred             ----------------------EEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccC
Confidence                                  5577788888666666788999999999999998543

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.54  E-value=4.4e-16  Score=160.93  Aligned_cols=153  Identities=22%  Similarity=0.220  Sum_probs=67.3

Q ss_pred             CcEEEeeCccccccCCh----hhhhCCC-CCcEEECCCCcCcccCCccCCCC-----CCCcEEEccCCcccccccccccC
Q 007680            1 MRILTLEGNQLSGRLPS----TIGHSLP-NIEYLLLTANNLTGTIPNSITNA-----TKLIVLDLGFNSFSGHILNTFGN   70 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~----~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~~p~~~~~   70 (593)
                      |+.|||++|+++ .++.    ..+..++ +|++|+|++|+|++..+..|..+     ++|+.|+|++|++++..+..+..
T Consensus        24 L~~L~Ls~n~l~-~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~  102 (362)
T 3goz_A           24 VTSLDLSLNNLY-SISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVK  102 (362)
T ss_dssp             CCEEECTTSCGG-GSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHH
T ss_pred             ceEEEccCCCCC-hHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHH
Confidence            345555555554 3332    1222244 45555555555554444444433     55555555555555444432222


Q ss_pred             ----C-CCchhhhhhcceeeccCCcccccCC--------C-cccccEEEccCCcccCcC----CCCCCCCC-CCCEecCC
Q 007680           71 ----L-RHLSVLSLLMFGIRLTGNKLYGRIP--------P-CLVLTVLDVSRNQLSGDI----PSTIGGRV-DLETLSLA  131 (593)
Q Consensus        71 ----l-~~L~~L~l~~n~l~l~~n~l~~~~~--------~-~~~L~~L~l~~N~l~~~~----p~~~~~l~-~L~~L~l~  131 (593)
                          + ++|++|       ++++|++++..+        . ...|++|+|++|++++..    +..+..++ +|++|+|+
T Consensus       103 ~l~~~~~~L~~L-------~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls  175 (362)
T 3goz_A          103 TLAAIPFTITVL-------DLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLR  175 (362)
T ss_dssp             HHHTSCTTCCEE-------ECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECT
T ss_pred             HHHhCCCCccEE-------ECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeec
Confidence                2 455555       444444432111        1 123555555555554221    11222232 45555555


Q ss_pred             CccCCCCCCcccc----CC-ccccccccccccccC
Q 007680          132 SNQFQGPIPESVG----SL-ISLESLDLSGNNLSG  161 (593)
Q Consensus       132 ~N~l~~~~p~~l~----~~-~~L~~L~l~~N~l~~  161 (593)
                      +|+|++..+..+.    .+ ++|+.|||++|++++
T Consensus       176 ~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~  210 (362)
T 3goz_A          176 GNNLASKNCAELAKFLASIPASVTSLDLSANLLGL  210 (362)
T ss_dssp             TSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGG
T ss_pred             CCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCCh
Confidence            5555543332222    22 355555555555554

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.54  E-value=2e-15  Score=135.07  Aligned_cols=123  Identities=20%  Similarity=0.219  Sum_probs=102.8

Q ss_pred             CCCCCcEEEccCCccc-ccccccccCCCCchhhhhhcceeeccCCcccc--cCCCcccccEEEccCCcccCcCCCCCCCC
Q 007680           46 NATKLIVLDLGFNSFS-GHILNTFGNLRHLSVLSLLMFGIRLTGNKLYG--RIPPCLVLTVLDVSRNQLSGDIPSTIGGR  122 (593)
Q Consensus        46 ~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~l~~n~l~l~~n~l~~--~~~~~~~L~~L~l~~N~l~~~~p~~~~~l  122 (593)
                      ..++|+.|++++|.++ +.+|..+..+++|+.|       ++++|++.+  .+..+..|++|++++|++++.+|..+..+
T Consensus        15 ~~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L-------~l~~n~l~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l   87 (149)
T 2je0_A           15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFL-------STINVGLTSIANLPKLNKLKKLELSDNRVSGGLEVLAEKC   87 (149)
T ss_dssp             CGGGCSEEECTTCBCBTTBCCSCCTTCTTCCEE-------ECTTSCCCCCTTCCCCTTCCEEECCSSCCCSCTHHHHHHC
T ss_pred             CCccCeEEEccCCcCChhHHHHHHhhcCCCcEE-------ECcCCCCCCchhhhcCCCCCEEECCCCcccchHHHHhhhC
Confidence            3478999999999998 7888889999999999       677777764  45556679999999999997788888889


Q ss_pred             CCCCEecCCCccCCCC-CCccccCCccccccccccccccCCCC---CCCCCCCCCCC
Q 007680          123 VDLETLSLASNQFQGP-IPESVGSLISLESLDLSGNNLSGKIP---KLEGEIPVKGS  175 (593)
Q Consensus       123 ~~L~~L~l~~N~l~~~-~p~~l~~~~~L~~L~l~~N~l~~~~p---~~~~~~~~~~~  175 (593)
                      ++|+.|++++|++++. .+..+..+++|+.|++++|++++.++   ..+..++.+..
T Consensus        88 ~~L~~L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~  144 (149)
T 2je0_A           88 PNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTY  144 (149)
T ss_dssp             TTCCEEECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCE
T ss_pred             CCCCEEECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCccc
Confidence            9999999999999853 34889999999999999999998776   45555555443

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=99.53  E-value=4.9e-14  Score=149.93  Aligned_cols=136  Identities=24%  Similarity=0.344  Sum_probs=89.1

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLL   80 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~   80 (593)
                      |+.|+|++|+++ .+|..    +++|++|++++|+|++ +|..   .++|++|+|++|++++ +| .|+.+++|++|   
T Consensus        93 L~~L~l~~n~l~-~lp~~----~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L---  158 (454)
T 1jl5_A           93 LESLVASCNSLT-ELPEL----PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEK-LP-ELQNSSFLKII---  158 (454)
T ss_dssp             CSEEECCSSCCS-SCCCC----CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCEE---
T ss_pred             CCEEEccCCcCC-ccccc----cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEE---
Confidence            344555555555 34421    3455555555555553 2221   1577888888888874 56 47888888887   


Q ss_pred             cceeeccCCcccccCCCc-ccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCccccCCccccccccccccc
Q 007680           81 MFGIRLTGNKLYGRIPPC-LVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNL  159 (593)
Q Consensus        81 ~n~l~l~~n~l~~~~~~~-~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~~N~l  159 (593)
                          ++++|++.+ +|.. ..|++|++++|++++ +| .++++++|+.|++++|++++ +|...   ++|+.|++++|++
T Consensus       159 ----~l~~N~l~~-lp~~~~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~~---~~L~~L~l~~n~l  227 (454)
T 1jl5_A          159 ----DVDNNSLKK-LPDLPPSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDLP---LSLESIVAGNNIL  227 (454)
T ss_dssp             ----ECCSSCCSC-CCCCCTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCCC---TTCCEEECCSSCC
T ss_pred             ----ECCCCcCcc-cCCCcccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCCc---CcccEEECcCCcC
Confidence                777777764 4433 358888888888875 56 57888888888888888874 55432   4788888888888


Q ss_pred             cC
Q 007680          160 SG  161 (593)
Q Consensus       160 ~~  161 (593)
                      +.
T Consensus       228 ~~  229 (454)
T 1jl5_A          228 EE  229 (454)
T ss_dssp             SS
T ss_pred             Cc
Confidence            74

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.53  E-value=2.6e-14  Score=130.88  Aligned_cols=110  Identities=25%  Similarity=0.216  Sum_probs=94.3

Q ss_pred             CCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhhcceeeccCCcccccCCCcccccEE
Q 007680           25 NIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLVLTVL  104 (593)
Q Consensus        25 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~l~~n~l~~~~~~~~~L~~L  104 (593)
                      ..+.|++++|+|+ .+|..+.  ++|+.|+|++|+|++..|..|..+++|+                           +|
T Consensus        10 ~~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~---------------------------~L   59 (170)
T 3g39_A           10 SGTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLT---------------------------RL   59 (170)
T ss_dssp             ETTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCS---------------------------EE
T ss_pred             CCCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCC---------------------------EE
Confidence            3578999999999 6787764  8899999999999988788787777665                           45


Q ss_pred             EccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCccccCCccccccccccccccCCCC
Q 007680          105 DVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIP  164 (593)
Q Consensus       105 ~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~~N~l~~~~p  164 (593)
                      +|++|+|++..+..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|+++...+
T Consensus        60 ~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~  119 (170)
T 3g39_A           60 DLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWLLNNPWDCACS  119 (170)
T ss_dssp             ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred             ECCCCCcCccChhhccCCCCCCEEECCCCccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence            778888887777778999999999999999997777789999999999999999987554

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.53  E-value=4.4e-15  Score=135.66  Aligned_cols=122  Identities=22%  Similarity=0.244  Sum_probs=102.1

Q ss_pred             CCCCCcEEEccCCccc-ccccccccCCCCchhhhhhcceeeccCCcccc--cCCCcccccEEEccCCcccCcCCCCCCCC
Q 007680           46 NATKLIVLDLGFNSFS-GHILNTFGNLRHLSVLSLLMFGIRLTGNKLYG--RIPPCLVLTVLDVSRNQLSGDIPSTIGGR  122 (593)
Q Consensus        46 ~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~l~~n~l~l~~n~l~~--~~~~~~~L~~L~l~~N~l~~~~p~~~~~l  122 (593)
                      ..++|+.|+|++|.++ +.+|..+..+++|+.|       ++++|.+.+  .+..+..|++|++++|++++.+|..+..+
T Consensus        22 ~~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L-------~l~~n~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l   94 (168)
T 2ell_A           22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFL-------SLINVGLISVSNLPKLPKLKKLELSENRIFGGLDMLAEKL   94 (168)
T ss_dssp             CTTSCSEEECCSCBCBTTBCSSCCGGGGGCCEE-------EEESSCCCCCSSCCCCSSCCEEEEESCCCCSCCCHHHHHC
T ss_pred             CcccCCEEECCCCCCChhhHHHHHHhCCCCCEE-------eCcCCCCCChhhhccCCCCCEEECcCCcCchHHHHHHhhC
Confidence            3478999999999998 7788889999999999       667777664  45556679999999999997788777789


Q ss_pred             CCCCEecCCCccCCCCCC--ccccCCccccccccccccccCCCC---CCCCCCCCCCC
Q 007680          123 VDLETLSLASNQFQGPIP--ESVGSLISLESLDLSGNNLSGKIP---KLEGEIPVKGS  175 (593)
Q Consensus       123 ~~L~~L~l~~N~l~~~~p--~~l~~~~~L~~L~l~~N~l~~~~p---~~~~~~~~~~~  175 (593)
                      ++|+.|++++|+|++ +|  ..+..+++|+.|++++|++++.++   ..+..++.+..
T Consensus        95 ~~L~~L~Ls~N~l~~-~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~  151 (168)
T 2ell_A           95 PNLTHLNLSGNKLKD-ISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTY  151 (168)
T ss_dssp             TTCCEEECBSSSCCS-SGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCE
T ss_pred             CCCCEEeccCCccCc-chhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcE
Confidence            999999999999985 44  789999999999999999998776   45655654433

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.52  E-value=3.7e-17  Score=153.92  Aligned_cols=128  Identities=24%  Similarity=0.304  Sum_probs=58.4

Q ss_pred             CCCcEEECCCCcCcccCCc------cCCCCCCCcEEEccCCcccccccccccCCCCchhhhhhcceeeccCCcccccCCC
Q 007680           24 PNIEYLLLTANNLTGTIPN------SITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPP   97 (593)
Q Consensus        24 ~~L~~L~L~~N~l~~~~p~------~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~l~~n~l~~~~~~   97 (593)
                      ..++.++++.|.+++..|.      .|..+++|+.|+|++|++++ +| .+..+++|+.|       ++++|++. .+|.
T Consensus        18 ~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L-------~l~~n~l~-~l~~   87 (198)
T 1ds9_A           18 KSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRIL-------SLGRNLIK-KIEN   87 (198)
T ss_dssp             TCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEE-------EEEEEEEC-SCSS
T ss_pred             ccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEE-------ECCCCCcc-cccc
Confidence            3444444444444444443      44444444444444444443 33 44444444444       33333333 2222


Q ss_pred             c----ccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCC--ccccCCccccccccccccccCCCC
Q 007680           98 C----LVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIP--ESVGSLISLESLDLSGNNLSGKIP  164 (593)
Q Consensus        98 ~----~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p--~~l~~~~~L~~L~l~~N~l~~~~p  164 (593)
                      .    ..|++|++++|++++ +| .+..+++|+.|++++|++++ +|  ..+..+++|+.|++++|++++..|
T Consensus        88 ~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~-~~~~~~l~~l~~L~~L~l~~N~l~~~~~  157 (198)
T 1ds9_A           88 LDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITN-WGEIDKLAALDKLEDLLLAGNPLYNDYK  157 (198)
T ss_dssp             HHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCC-HHHHHHHTTTTTCSEEEECSCHHHHHHH
T ss_pred             hhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCc-hhHHHHHhcCCCCCEEEecCCccccccc
Confidence            1    125555555555553 33 34455555555555555542 22  244555555555555555554433

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.51  E-value=4.9e-14  Score=129.53  Aligned_cols=109  Identities=20%  Similarity=0.176  Sum_probs=92.6

Q ss_pred             CcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhhcceeeccCCcccccCCCcccccEEE
Q 007680           26 IEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLVLTVLD  105 (593)
Q Consensus        26 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~l~~n~l~~~~~~~~~L~~L~  105 (593)
                      -+.+++++|+|+ .+|..+.  ++|+.|+|++|+|++..|..|..+++|+.                           |+
T Consensus        14 ~~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~---------------------------L~   63 (174)
T 2r9u_A           14 QTLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQ---------------------------LY   63 (174)
T ss_dssp             SSEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCE---------------------------EE
T ss_pred             CcEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCE---------------------------EE
Confidence            478999999998 7888775  89999999999999888888877776654                           57


Q ss_pred             ccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCccccCCccccccccccccccCCCC
Q 007680          106 VSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIP  164 (593)
Q Consensus       106 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~~N~l~~~~p  164 (593)
                      |++|+|++.++..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|+|....+
T Consensus        64 Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~~  122 (174)
T 2r9u_A           64 FNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYLYNNPWDCECR  122 (174)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCBCTTBG
T ss_pred             CCCCCCCccChhHhCCcchhhEEECCCCccceeCHHHhccccCCCEEEeCCCCcccccc
Confidence            77788886666678999999999999999997666679999999999999999986543

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.51  E-value=6.9e-16  Score=159.48  Aligned_cols=157  Identities=24%  Similarity=0.299  Sum_probs=118.1

Q ss_pred             CcEEEeeCccccccCChhhhhCC-----CCCcEEECCCCcCcccCCccCC----CC-CCCcEEEccCCccccccccccc-
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSL-----PNIEYLLLTANNLTGTIPNSIT----NA-TKLIVLDLGFNSFSGHILNTFG-   69 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l-----~~L~~L~L~~N~l~~~~p~~~~----~l-~~L~~L~L~~N~l~~~~p~~~~-   69 (593)
                      |+.|+|++|++++..+..+.. +     ++|++|+|++|+|++..+..+.    .+ ++|+.|+|++|+|++..+..+. 
T Consensus        53 L~~L~Ls~N~l~~~~~~~l~~-~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~  131 (362)
T 3goz_A           53 VTSLNLSGNSLGFKNSDELVQ-ILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQ  131 (362)
T ss_dssp             CCEEECCSSCGGGSCHHHHHH-HHHTSCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHH
T ss_pred             eeEEECcCCCCCHHHHHHHHH-HHhccCCCccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHH
Confidence            689999999999555666654 4     8999999999999977666444    44 8999999999999977665544 


Q ss_pred             ---C-CCCchhhhhhcceeeccCCcccc----cC----CCcc-cccEEEccCCcccCcCCCCC----CCC-CCCCEecCC
Q 007680           70 ---N-LRHLSVLSLLMFGIRLTGNKLYG----RI----PPCL-VLTVLDVSRNQLSGDIPSTI----GGR-VDLETLSLA  131 (593)
Q Consensus        70 ---~-l~~L~~L~l~~n~l~l~~n~l~~----~~----~~~~-~L~~L~l~~N~l~~~~p~~~----~~l-~~L~~L~l~  131 (593)
                         . .++|++|       ++++|++.+    .+    .... .|++|+|++|++++..+..+    ..+ ++|+.|+|+
T Consensus       132 ~l~~~~~~L~~L-------~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls  204 (362)
T 3goz_A          132 AFSNLPASITSL-------NLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLS  204 (362)
T ss_dssp             HHTTSCTTCCEE-------ECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECT
T ss_pred             HHHhCCCceeEE-------EccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECC
Confidence               3 3689999       777777763    11    2222 69999999999986655433    344 589999999


Q ss_pred             CccCCCC----CCccccC-CccccccccccccccCCCCC
Q 007680          132 SNQFQGP----IPESVGS-LISLESLDLSGNNLSGKIPK  165 (593)
Q Consensus       132 ~N~l~~~----~p~~l~~-~~~L~~L~l~~N~l~~~~p~  165 (593)
                      +|+|++.    ++..+.. .++|+.|+|++|++++..+.
T Consensus       205 ~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~  243 (362)
T 3goz_A          205 ANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLE  243 (362)
T ss_dssp             TSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCCHH
T ss_pred             CCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHHHH
Confidence            9999852    4555655 35899999999999886653

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.50  E-value=2.3e-14  Score=156.38  Aligned_cols=120  Identities=22%  Similarity=0.200  Sum_probs=97.8

Q ss_pred             CCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhhcceeeccCCcccc--cCCCccccc
Q 007680           25 NIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYG--RIPPCLVLT  102 (593)
Q Consensus        25 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~l~~n~l~~--~~~~~~~L~  102 (593)
                      .|+.|+|++|+|++ +|. |+++++|+.|+|++|+|+ .+|..|+.|++|+.|       +|++|++++  .+..+.+|+
T Consensus       442 ~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L-------~Ls~N~l~~lp~l~~l~~L~  511 (567)
T 1dce_A          442 DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVL-------QASDNALENVDGVANLPRLQ  511 (567)
T ss_dssp             TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEE-------ECCSSCCCCCGGGTTCSSCC
T ss_pred             CceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEE-------ECCCCCCCCCcccCCCCCCc
Confidence            68899999999985 676 889999999999999999 778889999999998       777777764  233445699


Q ss_pred             EEEccCCcccCcC-CCCCCCCCCCCEecCCCccCCCCCCcc---ccCCcccccccc
Q 007680          103 VLDVSRNQLSGDI-PSTIGGRVDLETLSLASNQFQGPIPES---VGSLISLESLDL  154 (593)
Q Consensus       103 ~L~l~~N~l~~~~-p~~~~~l~~L~~L~l~~N~l~~~~p~~---l~~~~~L~~L~l  154 (593)
                      +|+|++|+|++.. |..|+++++|+.|+|++|+|++.+|..   +..+++|+.|++
T Consensus       512 ~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~~L~l  567 (567)
T 1dce_A          512 ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSILT  567 (567)
T ss_dssp             EEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEEEC
T ss_pred             EEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCcccCccCC
Confidence            9999999999776 899999999999999999999654422   233778888864

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.49  E-value=5.5e-14  Score=143.14  Aligned_cols=172  Identities=11%  Similarity=0.083  Sum_probs=129.8

Q ss_pred             CcEEEeeCcccc----------c---------cCChhhhhC--------CCCCcEEECCCCcCcccCCccCCCCCCCcEE
Q 007680            1 MRILTLEGNQLS----------G---------RLPSTIGHS--------LPNIEYLLLTANNLTGTIPNSITNATKLIVL   53 (593)
Q Consensus         1 L~~L~Ls~n~l~----------~---------~lp~~~~~~--------l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L   53 (593)
                      |+.|||++|+|.          +         .||...|.+        +++|+.|+|.+ +|+.+.+.+|.++++|+.|
T Consensus        51 L~~LdLs~n~i~~~~~~~~~~~~~~~~~~~~~~I~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l  129 (329)
T 3sb4_A           51 LKVLDISNAEIKMYSGKAGTYPNGKFYIYMANFVPAYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAFKGCDNLKIC  129 (329)
T ss_dssp             CCEEEEEEEEECCEEESSSSSGGGCCEEECTTEECTTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTTTTCTTCCEE
T ss_pred             CeEEecCcceeEEecCccccccccccccccccccCHHHhcccccccccccCCCcEEECCc-cccchhHHHhhcCcccceE
Confidence            789999999987          1         477788888        99999999999 8997777789999999999


Q ss_pred             EccCCcccccccccccCCCCchhhhhhcceeeccCCccc-----------------------------------------
Q 007680           54 DLGFNSFSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLY-----------------------------------------   92 (593)
Q Consensus        54 ~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~l~~n~l~-----------------------------------------   92 (593)
                      +|++|.+..+.+.+|.++.+|..+.+..+......+.+.                                         
T Consensus       130 ~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~  209 (329)
T 3sb4_A          130 QIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLETTIQVGAMGKLEDEIMKAGLQPRDINFLTI  209 (329)
T ss_dssp             EBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCEEEEEECTTCCHHHHHHHTTCCGGGCSEEEE
T ss_pred             EcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccccceeEEecCCCcHHHHHhhcccCccccceEEE
Confidence            999999987778889988888777544311100000000                                         


Q ss_pred             -ccC--------C-CcccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCccccCCcccc-ccccccccccC
Q 007680           93 -GRI--------P-PCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLE-SLDLSGNNLSG  161 (593)
Q Consensus        93 -~~~--------~-~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~-~L~l~~N~l~~  161 (593)
                       +.+        . .+..|+.|+|++|+++.+.+.+|.++.+|+.|++.+| ++...+.+|.++.+|+ .|++.+ +++.
T Consensus       210 ~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~  287 (329)
T 3sb4_A          210 EGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTA  287 (329)
T ss_dssp             EECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCE
T ss_pred             eeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceE
Confidence             000        0 1456889999998888666778889999999999888 7766677888888898 888887 7887


Q ss_pred             CCCCCCCCCCCCCC
Q 007680          162 KIPKLEGEIPVKGS  175 (593)
Q Consensus       162 ~~p~~~~~~~~~~~  175 (593)
                      +.+..|..++.+..
T Consensus       288 I~~~aF~~c~~L~~  301 (329)
T 3sb4_A          288 IEFGAFMGCDNLRY  301 (329)
T ss_dssp             ECTTTTTTCTTEEE
T ss_pred             EchhhhhCCccCCE
Confidence            77787777665443

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.41  E-value=1e-13  Score=127.59  Aligned_cols=122  Identities=23%  Similarity=0.197  Sum_probs=97.1

Q ss_pred             ccCCCCCCCcEEEccCCcccccccccccCCC-CchhhhhhcceeeccCCcccc--cCCCcccccEEEccCCcccCcCCCC
Q 007680           42 NSITNATKLIVLDLGFNSFSGHILNTFGNLR-HLSVLSLLMFGIRLTGNKLYG--RIPPCLVLTVLDVSRNQLSGDIPST  118 (593)
Q Consensus        42 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~l~~n~l~l~~n~l~~--~~~~~~~L~~L~l~~N~l~~~~p~~  118 (593)
                      ..+.++.+|+.|+|++|+++. +|. +..+. +|++|       ++++|.+++  .+..+..|++|++++|+|++..+..
T Consensus        13 ~~~~~~~~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L-------~Ls~N~l~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~   83 (176)
T 1a9n_A           13 AQYTNAVRDRELDLRGYKIPV-IEN-LGATLDQFDAI-------DFSDNEIRKLDGFPLLRRLKTLLVNNNRICRIGEGL   83 (176)
T ss_dssp             CEEECTTSCEEEECTTSCCCS-CCC-GGGGTTCCSEE-------ECCSSCCCEECCCCCCSSCCEEECCSSCCCEECSCH
T ss_pred             HhcCCcCCceEEEeeCCCCch-hHH-hhhcCCCCCEE-------ECCCCCCCcccccccCCCCCEEECCCCcccccCcch
Confidence            356788999999999999994 555 55555 99999       777777764  4556667999999999999655555


Q ss_pred             CCCCCCCCEecCCCccCCCCCCc--cccCCccccccccccccccCCCCC---CCCCCCCC
Q 007680          119 IGGRVDLETLSLASNQFQGPIPE--SVGSLISLESLDLSGNNLSGKIPK---LEGEIPVK  173 (593)
Q Consensus       119 ~~~l~~L~~L~l~~N~l~~~~p~--~l~~~~~L~~L~l~~N~l~~~~p~---~~~~~~~~  173 (593)
                      |..+++|+.|++++|+|+ .+|.  .+..+++|+.|++++|+++..++.   .+..+|.+
T Consensus        84 ~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~~~~~~~~~~~~l~~L  142 (176)
T 1a9n_A           84 DQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQV  142 (176)
T ss_dssp             HHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTC
T ss_pred             hhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCCCcHhHHHHHHHHCCcc
Confidence            589999999999999997 6776  899999999999999999865332   24455543

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.39  E-value=5e-13  Score=137.04  Aligned_cols=103  Identities=20%  Similarity=0.159  Sum_probs=78.5

Q ss_pred             EEEeeCc-cccccCChhhhhCCCCCcEEECCC-CcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhh
Q 007680            3 ILTLEGN-QLSGRLPSTIGHSLPNIEYLLLTA-NNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLL   80 (593)
Q Consensus         3 ~L~Ls~n-~l~~~lp~~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~   80 (593)
                      .++++++ +|+ .+|. +.. +++|++|+|++ |+|++..|..|.+|++|+.|+|++|+|++.+|+.|..|++|+.|   
T Consensus        12 ~v~~~~~n~l~-~ip~-l~~-~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L---   85 (347)
T 2ifg_A           12 GLRCTRDGALD-SLHH-LPG-AENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRL---   85 (347)
T ss_dssp             CEECCSSCCCT-TTTT-SCS-CSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEE---
T ss_pred             EEEcCCCCCCC-ccCC-CCC-CCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEE---
Confidence            4678887 888 7888 654 88888888885 88887777788888888888888888887777777777766554   


Q ss_pred             cceeeccCCcccccCCCcccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCC
Q 007680           81 MFGIRLTGNKLYGRIPPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQ  136 (593)
Q Consensus        81 ~n~l~l~~n~l~~~~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~  136 (593)
                                              +|++|+|++.++..|..+. |+.|+|.+|++.
T Consensus        86 ------------------------~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~  116 (347)
T 2ifg_A           86 ------------------------NLSFNALESLSWKTVQGLS-LQELVLSGNPLH  116 (347)
T ss_dssp             ------------------------ECCSSCCSCCCSTTTCSCC-CCEEECCSSCCC
T ss_pred             ------------------------eCCCCccceeCHHHcccCC-ceEEEeeCCCcc
Confidence                                    6666667655555555555 888888888887

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=99.39  E-value=5.7e-15  Score=157.55  Aligned_cols=163  Identities=18%  Similarity=0.166  Sum_probs=117.5

Q ss_pred             CcEEEeeCcccccc----CChhhhhCCCCCcEEECCCCcCcccC-----CccCCCCCCCcEEEccCCccccc----cccc
Q 007680            1 MRILTLEGNQLSGR----LPSTIGHSLPNIEYLLLTANNLTGTI-----PNSITNATKLIVLDLGFNSFSGH----ILNT   67 (593)
Q Consensus         1 L~~L~Ls~n~l~~~----lp~~~~~~l~~L~~L~L~~N~l~~~~-----p~~~~~l~~L~~L~L~~N~l~~~----~p~~   67 (593)
                      |+.|+|++|++++.    ++..+.. +++|++|+|++|+|++..     +..+..+++|+.|+|++|+++..    ++..
T Consensus       201 L~~L~L~~n~l~~~~~~~l~~~l~~-~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~  279 (461)
T 1z7x_W          201 LEALKLESCGVTSDNCRDLCGIVAS-KASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRV  279 (461)
T ss_dssp             CCEEECTTSCCBTTHHHHHHHHHHH-CTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHH
T ss_pred             ceEEEccCCCCcHHHHHHHHHHHHh-CCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHH
Confidence            68999999999842    5766665 899999999999998542     33345689999999999999854    6777


Q ss_pred             ccCCCCchhhhhhcceeeccCCccccc----CC-----CcccccEEEccCCcccCc----CCCCCCCCCCCCEecCCCcc
Q 007680           68 FGNLRHLSVLSLLMFGIRLTGNKLYGR----IP-----PCLVLTVLDVSRNQLSGD----IPSTIGGRVDLETLSLASNQ  134 (593)
Q Consensus        68 ~~~l~~L~~L~l~~n~l~l~~n~l~~~----~~-----~~~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~  134 (593)
                      +..+++|++|       ++++|.+.+.    +.     ....|++|++++|.+++.    ++..+..+++|++|++++|+
T Consensus       280 l~~~~~L~~L-------~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~  352 (461)
T 1z7x_W          280 LRAKESLKEL-------SLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNR  352 (461)
T ss_dssp             HHHCTTCCEE-------ECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSB
T ss_pred             HhhCCCcceE-------ECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCc
Confidence            8889999999       6666666421    11     113588888888888754    34556667888888888888


Q ss_pred             CCCCCCccccC-----CccccccccccccccC----CCCCCCCCCC
Q 007680          135 FQGPIPESVGS-----LISLESLDLSGNNLSG----KIPKLEGEIP  171 (593)
Q Consensus       135 l~~~~p~~l~~-----~~~L~~L~l~~N~l~~----~~p~~~~~~~  171 (593)
                      +++..+..+..     .++|+.|++++|++++    .+|..+..++
T Consensus       353 i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~  398 (461)
T 1z7x_W          353 LEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANH  398 (461)
T ss_dssp             CHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCC
T ss_pred             cccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCC
Confidence            87544444432     5688888888888875    4454444333

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.38  E-value=1.2e-15  Score=143.57  Aligned_cols=147  Identities=28%  Similarity=0.308  Sum_probs=119.6

Q ss_pred             cEEEeeCccccccCCh------hhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCch
Q 007680            2 RILTLEGNQLSGRLPS------TIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLS   75 (593)
Q Consensus         2 ~~L~Ls~n~l~~~lp~------~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~   75 (593)
                      +.++|+.|.+.|.+|.      .+.. +++|++|+|++|+|++ +| .+.++++|+.|+|++|.++ .+|..+..+++|+
T Consensus        21 ~~l~l~~~~l~~~~~~l~~l~~~~~~-l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~   96 (198)
T 1ds9_A           21 VATEAEKVELHGMIPPIEKMDATLST-LKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLE   96 (198)
T ss_dssp             CCTTCSEEECCBCCTTCCCCHHHHHH-TTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCS
T ss_pred             cCcchheeEeccccCcHhhhhHHHhc-CCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCC
Confidence            4456777777766665      7775 9999999999999995 77 8999999999999999999 6788888889999


Q ss_pred             hhhhhcceeeccCCcccc--cCCCcccccEEEccCCcccCcCC-CCCCCCCCCCEecCCCccCCCCCCcc----------
Q 007680           76 VLSLLMFGIRLTGNKLYG--RIPPCLVLTVLDVSRNQLSGDIP-STIGGRVDLETLSLASNQFQGPIPES----------  142 (593)
Q Consensus        76 ~L~l~~n~l~l~~n~l~~--~~~~~~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~p~~----------  142 (593)
                      +|       ++++|++++  .+..+..|++|++++|++++..+ ..+..+++|+.|++++|++++.+|..          
T Consensus        97 ~L-------~L~~N~l~~l~~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~  169 (198)
T 1ds9_A           97 EL-------WISYNQIASLSGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEV  169 (198)
T ss_dssp             EE-------EEEEEECCCHHHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHH
T ss_pred             EE-------ECcCCcCCcCCccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHH
Confidence            99       777777764  12234459999999999985332 46889999999999999998765553          


Q ss_pred             ccCCccccccccccccccC
Q 007680          143 VGSLISLESLDLSGNNLSG  161 (593)
Q Consensus       143 l~~~~~L~~L~l~~N~l~~  161 (593)
                      +..+++|+.||  +|+++.
T Consensus       170 ~~~l~~L~~Ld--~~~i~~  186 (198)
T 1ds9_A          170 VKRLPNLKKLD--GMPVDV  186 (198)
T ss_dssp             HHHCSSCSEEC--CGGGTT
T ss_pred             HHhCCCcEEEC--CcccCH
Confidence            78889999887  787764

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.36  E-value=2.5e-12  Score=126.30  Aligned_cols=148  Identities=14%  Similarity=0.134  Sum_probs=116.6

Q ss_pred             HHHhhhccccccccCccCcccEEEEEeCCCCeEEEEEeehhhHHHHHHHHHHHHHHhhcC-CCCcceeeeeeecCCceEE
Q 007680          267 IQRATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVR-HRNLIKILSSYSNPDFKAL  345 (593)
Q Consensus       267 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l  345 (593)
                      +....++|++...++.|+.+.||++... ++.+++|+...........+.+|+.+++.+. +..+.++++++...+..++
T Consensus         9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l   87 (263)
T 3tm0_A            9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL   87 (263)
T ss_dssp             HHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred             HHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence            3445567988899999999999999864 6899999987542223346888999999984 6778889999988889999


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------
Q 007680          346 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGH------------------------------------  389 (593)
Q Consensus       346 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~------------------------------------  389 (593)
                      ||||++|.+|.+...      +......++.+++++|+.||+-.                                    
T Consensus        88 v~e~i~G~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (263)
T 3tm0_A           88 LMSEADGVLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED  161 (263)
T ss_dssp             EEECCSSEEHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred             EEEecCCeehhhccC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence            999999999987632      11234578899999999999710                                    


Q ss_pred             -------------------CCCCeEecCCCCCCeeeCCCCcEEEEeeccce
Q 007680          390 -------------------SSVHIIHCDLKPTNILLDENMVAHVSDFGIYK  421 (593)
Q Consensus       390 -------------------~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~  421 (593)
                                         ....++|+|++|.||+++++..+.|+||+.+.
T Consensus       162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                               01458999999999999876667799999765

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=99.36  E-value=3e-14  Score=151.95  Aligned_cols=154  Identities=21%  Similarity=0.270  Sum_probs=108.6

Q ss_pred             CcEEEeeCccccc----cCChhhhhCCCCCcEEECCCCcCcccCCccCC-CCC----CCcEEEccCCcccc----ccccc
Q 007680            1 MRILTLEGNQLSG----RLPSTIGHSLPNIEYLLLTANNLTGTIPNSIT-NAT----KLIVLDLGFNSFSG----HILNT   67 (593)
Q Consensus         1 L~~L~Ls~n~l~~----~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~----~L~~L~L~~N~l~~----~~p~~   67 (593)
                      |++|+|++|++++    .+|..+.. +++|++|+|++|.|+...+..+. .++    +|+.|+|++|+++.    .+|..
T Consensus        30 L~~L~L~~~~l~~~~~~~l~~~l~~-~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~  108 (461)
T 1z7x_W           30 CQVVRLDDCGLTEARCKDISSALRV-NPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSST  108 (461)
T ss_dssp             CSEEEEESSCCCHHHHHHHHHHHHT-CTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHH
T ss_pred             ccEEEccCCCCCHHHHHHHHHHHHh-CCCcCEEeCCCCcCChHHHHHHHHHHhhCCCceeEEEccCCCCCHHHHHHHHHH
Confidence            6789999999873    34555554 88999999999998864444332 344    69999999999884    55788


Q ss_pred             ccCCCCchhhhhhcceeeccCCccccc---------CCCcccccEEEccCCcccCcC----CCCCCCCCCCCEecCCCcc
Q 007680           68 FGNLRHLSVLSLLMFGIRLTGNKLYGR---------IPPCLVLTVLDVSRNQLSGDI----PSTIGGRVDLETLSLASNQ  134 (593)
Q Consensus        68 ~~~l~~L~~L~l~~n~l~l~~n~l~~~---------~~~~~~L~~L~l~~N~l~~~~----p~~~~~l~~L~~L~l~~N~  134 (593)
                      |..+++|++|       ++++|.+.+.         ......|++|++++|++++..    +..+..+++|++|++++|+
T Consensus       109 l~~~~~L~~L-------~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~  181 (461)
T 1z7x_W          109 LRTLPTLQEL-------HLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNND  181 (461)
T ss_dssp             TTSCTTCCEE-------ECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSB
T ss_pred             HccCCceeEE-------ECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCC
Confidence            8899999998       6667766521         112335888888888887532    4455667788888888888


Q ss_pred             CCCCCCcccc-----CCccccccccccccccCC
Q 007680          135 FQGPIPESVG-----SLISLESLDLSGNNLSGK  162 (593)
Q Consensus       135 l~~~~p~~l~-----~~~~L~~L~l~~N~l~~~  162 (593)
                      +++..+..+.     ..++|+.|++++|.+++.
T Consensus       182 i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~  214 (461)
T 1z7x_W          182 INEAGVRVLCQGLKDSPCQLEALKLESCGVTSD  214 (461)
T ss_dssp             CHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTT
T ss_pred             cchHHHHHHHHHHhcCCCCceEEEccCCCCcHH
Confidence            7644333333     245788888888887763

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.33  E-value=1.7e-12  Score=133.02  Aligned_cols=105  Identities=24%  Similarity=0.226  Sum_probs=89.7

Q ss_pred             cEEECCCC-cCcccCCccCCCCCCCcEEEccC-CcccccccccccCCCCchhhhhhcceeeccCCcccccCCCcccccEE
Q 007680           27 EYLLLTAN-NLTGTIPNSITNATKLIVLDLGF-NSFSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLVLTVL  104 (593)
Q Consensus        27 ~~L~L~~N-~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~l~~n~l~l~~n~l~~~~~~~~~L~~L  104 (593)
                      ..+++++| +|+ .+|. |..+++|+.|+|++ |+|++..|+.|+.|++|+.                           |
T Consensus        11 ~~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~---------------------------L   61 (347)
T 2ifg_A           11 SGLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRN---------------------------L   61 (347)
T ss_dssp             SCEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSE---------------------------E
T ss_pred             CEEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCE---------------------------E
Confidence            45799998 899 5888 99999999999996 9999877788887777654                           5


Q ss_pred             EccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCccccCCccccccccccccccC
Q 007680          105 DVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSG  161 (593)
Q Consensus       105 ~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~~N~l~~  161 (593)
                      +|++|+|++.+|..|.++++|+.|+|++|+|++..+..+..+. |+.|+|++|+|..
T Consensus        62 ~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c  117 (347)
T 2ifg_A           62 TIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLHC  117 (347)
T ss_dssp             ECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSCC-CCEEECCSSCCCC
T ss_pred             ECCCCccceeCHHHhcCCcCCCEEeCCCCccceeCHHHcccCC-ceEEEeeCCCccC
Confidence            7788888888888999999999999999999976666666665 9999999999985

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.25  E-value=1e-13  Score=143.27  Aligned_cols=158  Identities=19%  Similarity=0.210  Sum_probs=113.7

Q ss_pred             CcEEEeeCccccccCChhhhh----CCCCCcEEECCCCcCcccCCccCC-CCCCCcEEEccCCcccccccccc-----cC
Q 007680            1 MRILTLEGNQLSGRLPSTIGH----SLPNIEYLLLTANNLTGTIPNSIT-NATKLIVLDLGFNSFSGHILNTF-----GN   70 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~----~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~-----~~   70 (593)
                      |+.|+|++|.|++.-...+..    ..++|++|+|++|.|+......+. .+++|+.|+|++|.|+......+     ..
T Consensus        74 L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~  153 (372)
T 3un9_A           74 LRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHD  153 (372)
T ss_dssp             CCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHST
T ss_pred             CCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhc
Confidence            678999999998433333332    236899999999999754444443 46789999999999986544444     34


Q ss_pred             CCCchhhhhhcceeeccCCcccc--------cCCCcccccEEEccCCcccCc----CCCCCCCCCCCCEecCCCccCCCC
Q 007680           71 LRHLSVLSLLMFGIRLTGNKLYG--------RIPPCLVLTVLDVSRNQLSGD----IPSTIGGRVDLETLSLASNQFQGP  138 (593)
Q Consensus        71 l~~L~~L~l~~n~l~l~~n~l~~--------~~~~~~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~  138 (593)
                      .++|++|       +|++|.++.        .+....+|++|+|++|.|+..    ++..+...++|+.|+|++|+|+..
T Consensus       154 ~~~L~~L-------~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~  226 (372)
T 3un9_A          154 QCQITTL-------RLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDT  226 (372)
T ss_dssp             TCCCCEE-------ECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHH
T ss_pred             CCcccee-------eCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHH
Confidence            6789998       777777752        223455699999999998742    245566778899999999999742


Q ss_pred             ----CCccccCCccccccccccccccCCCCC
Q 007680          139 ----IPESVGSLISLESLDLSGNNLSGKIPK  165 (593)
Q Consensus       139 ----~p~~l~~~~~L~~L~l~~N~l~~~~p~  165 (593)
                          ++..+..+++|++|||++|++++....
T Consensus       227 g~~~l~~~L~~~~~L~~L~Ls~N~i~~~g~~  257 (372)
T 3un9_A          227 AALALARAAREHPSLELLHLYFNELSSEGRQ  257 (372)
T ss_dssp             HHHHHHHHHHHCSSCCEEECTTSSCCHHHHH
T ss_pred             HHHHHHHHHHhCCCCCEEeccCCCCCHHHHH
Confidence                344556678899999999999864433

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.24  E-value=1.2e-11  Score=125.75  Aligned_cols=164  Identities=12%  Similarity=0.087  Sum_probs=132.1

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcc----ccccccccc-------
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSF----SGHILNTFG-------   69 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l----~~~~p~~~~-------   69 (593)
                      |+.|+|.+ +++ .|+...|.++++|+.|+|++|.++...+.+|.++.++..+.+..+..    .......|.       
T Consensus       103 L~~l~L~~-~i~-~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~~  180 (329)
T 3sb4_A          103 LEKVILSE-KIK-NIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLET  180 (329)
T ss_dssp             CCC-CBCT-TCC-EECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCEE
T ss_pred             CcEEECCc-ccc-chhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccccce
Confidence            67889998 898 89999888899999999999999877788899988888888776332    111111111       


Q ss_pred             -------------------------------------------CCCCchhhhhhcceeeccCCccc----ccCCCccccc
Q 007680           70 -------------------------------------------NLRHLSVLSLLMFGIRLTGNKLY----GRIPPCLVLT  102 (593)
Q Consensus        70 -------------------------------------------~l~~L~~L~l~~n~l~l~~n~l~----~~~~~~~~L~  102 (593)
                                                                 .+++|+.|       ++++|+++    +++..+..|+
T Consensus       181 ~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l-------~L~~n~i~~I~~~aF~~~~~L~  253 (329)
T 3sb4_A          181 TIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSL-------DISKTNATTIPDFTFAQKKYLL  253 (329)
T ss_dssp             EEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEE-------ECTTBCCCEECTTTTTTCTTCC
T ss_pred             eEEecCCCcHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEE-------ECCCCCcceecHhhhhCCCCCC
Confidence                                                       26677777       77777776    3566677899


Q ss_pred             EEEccCCcccCcCCCCCCCCCCCC-EecCCCccCCCCCCccccCCccccccccccccccCCCCCCCCCCCCCCC
Q 007680          103 VLDVSRNQLSGDIPSTIGGRVDLE-TLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKLEGEIPVKGS  175 (593)
Q Consensus       103 ~L~l~~N~l~~~~p~~~~~l~~L~-~L~l~~N~l~~~~p~~l~~~~~L~~L~l~~N~l~~~~p~~~~~~~~~~~  175 (593)
                      .|+|++| ++.+.+.+|.++.+|+ .|++.+ +++...+.+|.+|++|+.|++++|+++.+.+..|..++.++.
T Consensus       254 ~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~  325 (329)
T 3sb4_A          254 KIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKL  325 (329)
T ss_dssp             EEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCE
T ss_pred             EEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhh
Confidence            9999999 8867788999999999 999999 777677899999999999999999999999998888776543

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.20  E-value=2.6e-11  Score=118.60  Aligned_cols=140  Identities=15%  Similarity=0.113  Sum_probs=103.0

Q ss_pred             hhccccccccCccCcccEEEEEeCCCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCC--cceeeeeeecCCceEEEEe
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRN--LIKILSSYSNPDFKALVLE  348 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e  348 (593)
                      ..++.+....+.|..+.||++...+|+.+++|+....   ....+..|+.+++.+.+.+  +.+++++...++..++|||
T Consensus        19 ~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e   95 (264)
T 1nd4_A           19 LFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLG   95 (264)
T ss_dssp             TTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEE
T ss_pred             cCCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEE
Confidence            3455554444466679999998777888999997653   2245778999999985444  5568888888888999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCC--------------------------------------
Q 007680          349 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHS--------------------------------------  390 (593)
Q Consensus       349 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~--------------------------------------  390 (593)
                      |++|.++.  ...    .+   ...++.++++.|..||+...                                      
T Consensus        96 ~i~G~~l~--~~~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (264)
T 1nd4_A           96 EVPGQDLL--SSH----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA  166 (264)
T ss_dssp             CCSSEETT--TSC----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred             ecCCcccC--cCc----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCcc
Confidence            99998884  211    11   23567888888888885320                                      


Q ss_pred             ----------------CCCeEecCCCCCCeeeCCCCcEEEEeecccee
Q 007680          391 ----------------SVHIIHCDLKPTNILLDENMVAHVSDFGIYKL  422 (593)
Q Consensus       391 ----------------~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~  422 (593)
                                      ...++|+|++|.||++++++.+.|+|||.+..
T Consensus       167 ~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          167 PAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                            12399999999999998876677999998653

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.10  E-value=1.2e-12  Score=135.20  Aligned_cols=137  Identities=17%  Similarity=0.143  Sum_probs=103.5

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccC-----CCCCCCcEEEccCCcccc----cccccccCC
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSI-----TNATKLIVLDLGFNSFSG----HILNTFGNL   71 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~-----~~l~~L~~L~L~~N~l~~----~~p~~~~~l   71 (593)
                      |+.|+|++|.|++.-...+...+++|+.|+|++|+|+......+     ...++|+.|+|++|.|+.    .++..+..+
T Consensus       103 L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~  182 (372)
T 3un9_A          103 LDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGN  182 (372)
T ss_dssp             EEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTC
T ss_pred             ceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhcC
Confidence            57899999999855455555567899999999999985544444     357899999999999975    345556889


Q ss_pred             CCchhhhhhcceeeccCCcccc--------cCCCcccccEEEccCCcccCc----CCCCCCCCCCCCEecCCCccCCCCC
Q 007680           72 RHLSVLSLLMFGIRLTGNKLYG--------RIPPCLVLTVLDVSRNQLSGD----IPSTIGGRVDLETLSLASNQFQGPI  139 (593)
Q Consensus        72 ~~L~~L~l~~n~l~l~~n~l~~--------~~~~~~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~  139 (593)
                      ++|++|       +|++|.+.+        .+....+|++|+|++|.|+..    ++..+...++|++|+|++|.|+...
T Consensus       183 ~~L~~L-------~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~g  255 (372)
T 3un9_A          183 TSVTHL-------SLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEG  255 (372)
T ss_dssp             SSCCEE-------ECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHHH
T ss_pred             CCcCEE-------eCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHHH
Confidence            999999       777777762        344455799999999999743    3334556789999999999998543


Q ss_pred             Ccccc
Q 007680          140 PESVG  144 (593)
Q Consensus       140 p~~l~  144 (593)
                      ...+.
T Consensus       256 ~~~L~  260 (372)
T 3un9_A          256 RQVLR  260 (372)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            33343

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.05  E-value=6.6e-10  Score=115.82  Aligned_cols=163  Identities=12%  Similarity=0.063  Sum_probs=115.5

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLL   80 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~   80 (593)
                      |+.++|.. .+. .|+...|.++++|+.++|++|+++.+.+.+|. ..+|+.+.|.+| ++.+...+|.+|++|+.+++.
T Consensus       159 L~~i~lp~-~l~-~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~  234 (401)
T 4fdw_A          159 VQEIVFPS-TLE-QLKEDIFYYCYNLKKADLSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIP  234 (401)
T ss_dssp             CCEEECCT-TCC-EECSSTTTTCTTCCEEECTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECC
T ss_pred             ceEEEeCC-Ccc-EehHHHhhCcccCCeeecCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecC
Confidence            45666664 666 67777676777888888888777744444555 577777777744 664556677777777777664


Q ss_pred             cce---------------eeccCCccc----ccCCCcccccEEEccCCccc-----CcCCCCCCCCCCCCEecCCCccCC
Q 007680           81 MFG---------------IRLTGNKLY----GRIPPCLVLTVLDVSRNQLS-----GDIPSTIGGRVDLETLSLASNQFQ  136 (593)
Q Consensus        81 ~n~---------------l~l~~n~l~----~~~~~~~~L~~L~l~~N~l~-----~~~p~~~~~l~~L~~L~l~~N~l~  136 (593)
                      .|-               +.+ .|.+.    +++..|..|+.+++.+|.+.     .+.+.+|.+|++|+.+++. |.++
T Consensus       235 ~~l~~I~~~aF~~~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~  312 (401)
T 4fdw_A          235 ENVSTIGQEAFRESGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIR  312 (401)
T ss_dssp             TTCCEECTTTTTTCCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCC
T ss_pred             CCccCccccccccCCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceE
Confidence            322               122 12222    35566778999999998775     4567889999999999999 4577


Q ss_pred             CCCCccccCCccccccccccccccCCCCCCCCCC
Q 007680          137 GPIPESVGSLISLESLDLSGNNLSGKIPKLEGEI  170 (593)
Q Consensus       137 ~~~p~~l~~~~~L~~L~l~~N~l~~~~p~~~~~~  170 (593)
                      .....+|.+|.+|+.|+|..| ++.+.+..|..+
T Consensus       313 ~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~  345 (401)
T 4fdw_A          313 ILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT  345 (401)
T ss_dssp             EECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS
T ss_pred             EEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC
Confidence            667788999999999999655 777777777655

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.04  E-value=3.7e-12  Score=140.21  Aligned_cols=156  Identities=17%  Similarity=0.127  Sum_probs=98.7

Q ss_pred             CcEEEee-----------CccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCC-CCCCcEEEcc----CCccccc-
Q 007680            1 MRILTLE-----------GNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITN-ATKLIVLDLG----FNSFSGH-   63 (593)
Q Consensus         1 L~~L~Ls-----------~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-l~~L~~L~L~----~N~l~~~-   63 (593)
                      |+.|+|+           .|.+++.-...+...+++|++|+|+.|++++..+..+.. +++|+.|+|+    .|.+++. 
T Consensus       344 L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p  423 (592)
T 3ogk_B          344 LKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLP  423 (592)
T ss_dssp             CCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCC
T ss_pred             CCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCch
Confidence            5667777           355653322333334777777777777777665555554 7777777775    6677643 


Q ss_pred             ----ccccccCCCCchhhhhhcceeeccC--Cccccc----C-CCcccccEEEccCCcccC-cCCCCCCCCCCCCEecCC
Q 007680           64 ----ILNTFGNLRHLSVLSLLMFGIRLTG--NKLYGR----I-PPCLVLTVLDVSRNQLSG-DIPSTIGGRVDLETLSLA  131 (593)
Q Consensus        64 ----~p~~~~~l~~L~~L~l~~n~l~l~~--n~l~~~----~-~~~~~L~~L~l~~N~l~~-~~p~~~~~l~~L~~L~l~  131 (593)
                          ++..+..+++|+.|       +++.  |.+++.    + ..+..|++|++++|++++ .++..+.++++|+.|+|+
T Consensus       424 ~~~~~~~~~~~~~~L~~L-------~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~  496 (592)
T 3ogk_B          424 LDNGVRSLLIGCKKLRRF-------AFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMR  496 (592)
T ss_dssp             CHHHHHHHHHHCTTCCEE-------EEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEE
T ss_pred             HHHHHHHHHHhCCCCCEE-------EEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeecc
Confidence                33335667777777       4432  123311    1 124458888888888875 244445678888888888


Q ss_pred             CccCCCC-CCccccCCccccccccccccccCCC
Q 007680          132 SNQFQGP-IPESVGSLISLESLDLSGNNLSGKI  163 (593)
Q Consensus       132 ~N~l~~~-~p~~l~~~~~L~~L~l~~N~l~~~~  163 (593)
                      +|++++. ++..+..+++|+.|++++|++++..
T Consensus       497 ~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~~  529 (592)
T 3ogk_B          497 GCCFSERAIAAAVTKLPSLRYLWVQGYRASMTG  529 (592)
T ss_dssp             SCCCBHHHHHHHHHHCSSCCEEEEESCBCCTTC
T ss_pred             CCCCcHHHHHHHHHhcCccCeeECcCCcCCHHH
Confidence            8887643 3444556788888888888887653

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.02  E-value=1.1e-11  Score=136.43  Aligned_cols=152  Identities=16%  Similarity=0.118  Sum_probs=87.9

Q ss_pred             CcEEEeeCcc-ccc-cCChhhhhCCCCCcEEECCCCcCccc----CCccCCCCCCCcEEEccCCccc----ccccccccC
Q 007680            1 MRILTLEGNQ-LSG-RLPSTIGHSLPNIEYLLLTANNLTGT----IPNSITNATKLIVLDLGFNSFS----GHILNTFGN   70 (593)
Q Consensus         1 L~~L~Ls~n~-l~~-~lp~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~----~~~p~~~~~   70 (593)
                      |+.|+|++|. ++. .++.-. ..+++|++|+|++|.+++.    ++..+.++++|+.|+|++|.++    +.++..+..
T Consensus       140 L~~L~L~~~~~~~~~~l~~~~-~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~  218 (592)
T 3ogk_B          140 LETLKLDKCSGFTTDGLLSIV-THCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARN  218 (592)
T ss_dssp             CCEEEEESCEEEEHHHHHHHH-HHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHH
T ss_pred             CcEEECcCCCCcCHHHHHHHH-hhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhh
Confidence            5777887776 221 122222 2377888888888877654    2333456777788888887776    233444566


Q ss_pred             CCCchhhhhhcceeeccCCcccc---cCCCcccccEEEccCCccc---CcCCCCCCCCCCCCEecCCCccCCCCCCcccc
Q 007680           71 LRHLSVLSLLMFGIRLTGNKLYG---RIPPCLVLTVLDVSRNQLS---GDIPSTIGGRVDLETLSLASNQFQGPIPESVG  144 (593)
Q Consensus        71 l~~L~~L~l~~n~l~l~~n~l~~---~~~~~~~L~~L~l~~N~l~---~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~  144 (593)
                      +++|++|       ++++|.+.+   .+..+.+|++|+++.+...   +..+..+..+++|+.|+++++... .+|..+.
T Consensus       219 ~~~L~~L-------~L~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~-~l~~~~~  290 (592)
T 3ogk_B          219 CRSLVSV-------KVGDFEILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPN-EMPILFP  290 (592)
T ss_dssp             CTTCCEE-------ECSSCBGGGGHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCTT-TGGGGGG
T ss_pred             CCCCcEE-------eccCccHHHHHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCccccchh-HHHHHHh
Confidence            7777777       555555543   1222334667776643322   123344555666666666665443 4566666


Q ss_pred             CCccccccccccccccC
Q 007680          145 SLISLESLDLSGNNLSG  161 (593)
Q Consensus       145 ~~~~L~~L~l~~N~l~~  161 (593)
                      .+++|+.|++++|.+++
T Consensus       291 ~~~~L~~L~Ls~~~l~~  307 (592)
T 3ogk_B          291 FAAQIRKLDLLYALLET  307 (592)
T ss_dssp             GGGGCCEEEETTCCCCH
T ss_pred             hcCCCcEEecCCCcCCH
Confidence            66666666666666543

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.00  E-value=1.1e-09  Score=112.74  Aligned_cols=143  Identities=13%  Similarity=0.152  Sum_probs=107.3

Q ss_pred             cccccCccCcccEEEEEeCCCCeEEEEEee--hhh-HHHHHHHHHHHHHHhhcC--CCCcceeeeeeecC---CceEEEE
Q 007680          276 ECNLLGTSSFGSVYKGTISDGTDVAIKVFN--LQL-ERAFRSFDSECEVLRNVR--HRNLIKILSSYSNP---DFKALVL  347 (593)
Q Consensus       276 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---~~~~lv~  347 (593)
                      ..+.++.|.++.||++... +..+++|+..  ... ......+.+|..+++.+.  +..+.+++.++.+.   +..++||
T Consensus        42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm  120 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM  120 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred             eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence            4568999999999999875 4678899876  332 123356788999999996  45678888888776   4589999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-------------------------------------
Q 007680          348 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHS-------------------------------------  390 (593)
Q Consensus       348 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-------------------------------------  390 (593)
                      ||++|.++.+..   ...++..+...++.++++.|..||+...                                     
T Consensus       121 e~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (359)
T 3dxp_A          121 EFVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAM  197 (359)
T ss_dssp             ECCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHH
T ss_pred             EecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHH
Confidence            999998775421   1136788889999999999999997310                                     


Q ss_pred             -----------------CCCeEecCCCCCCeeeCCCCc--EEEEeecccee
Q 007680          391 -----------------SVHIIHCDLKPTNILLDENMV--AHVSDFGIYKL  422 (593)
Q Consensus       391 -----------------~~~ivH~Dlkp~NIll~~~~~--~kL~Dfg~a~~  422 (593)
                                       ...++|||++|.||+++.++.  +.|+||+.+..
T Consensus       198 ~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          198 DSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                             246999999999999997753  68999998875

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.97  E-value=2.9e-10  Score=114.06  Aligned_cols=188  Identities=15%  Similarity=0.127  Sum_probs=124.4

Q ss_pred             ccccCccCcccEEEEEeCCCCeEEEEEeehhhHHHHHHHHHHHHHHhhcC-CCC--cceeeeeeecCC---ceEEEEecc
Q 007680          277 CNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVR-HRN--LIKILSSYSNPD---FKALVLEFM  350 (593)
Q Consensus       277 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lv~e~~  350 (593)
                      .+.++.|.+..||++.    ..+++|+....  .....+.+|.++++.+. +..  +.+++......+   ..|+|||++
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            4568999999999863    56899986543  33467889999998883 332  344555443333   358899999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------------
Q 007680          351 PNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGH-----------------------------------------  389 (593)
Q Consensus       351 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-----------------------------------------  389 (593)
                      +|.++.+....   .++..++..++.++++.++.||+..                                         
T Consensus        99 ~G~~l~~~~~~---~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  175 (304)
T 3sg8_A           99 KGVPLTPLLLN---NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD  175 (304)
T ss_dssp             CCEECCHHHHH---TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred             CCeECCccccc---cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence            99888764332   2677888889999999999998611                                         


Q ss_pred             -------------CCCCeEecCCCCCCeeeCC--CCcEEEEeeccceecCCCCCccccccccCCccccCccccCC-----
Q 007680          390 -------------SSVHIIHCDLKPTNILLDE--NMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLE-----  449 (593)
Q Consensus       390 -------------~~~~ivH~Dlkp~NIll~~--~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----  449 (593)
                                   ....++|+|++|.||++++  ...+.++||+.+..-....+.......  . .-..|+....     
T Consensus       176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~--~-~~~~~~~~~~~l~~Y  252 (304)
T 3sg8_A          176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMED--D-EEYGMEFVSKILNHY  252 (304)
T ss_dssp             HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCT--T-TSCCHHHHHHHHHHH
T ss_pred             HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhh--c-cccCHHHHHHHHHHc
Confidence                         0135899999999999998  556889999988754221110000000  0 0012221110     


Q ss_pred             CC---------CCccchHHHHHHHHHHHHhCCCCCC
Q 007680          450 GI---------VSAKCDVYSYGVLLMETFTRKRPTD  476 (593)
Q Consensus       450 ~~---------~s~~~DvwSlGvvl~elltg~~pf~  476 (593)
                      +.         .....+.|++|.++|.+.+|..+|.
T Consensus       253 ~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~  288 (304)
T 3sg8_A          253 KHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY  288 (304)
T ss_dssp             TCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred             CCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence            00         1123689999999999999988763

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=98.95  E-value=2.3e-09  Score=111.68  Aligned_cols=148  Identities=11%  Similarity=0.088  Sum_probs=95.7

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLL   80 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~   80 (593)
                      |+.++|..| +. .|+...|.+ .+|+.+.|.+ .++.+.+.+|.++++|+.++|++|.++.+....|. +.+|+.+.|.
T Consensus       137 L~~i~l~~~-i~-~I~~~aF~~-~~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~-~~~L~~l~lp  211 (401)
T 4fdw_A          137 IAKVVLNEG-LK-SIGDMAFFN-STVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPASTFV-YAGIEEVLLP  211 (401)
T ss_dssp             CSEEECCTT-CC-EECTTTTTT-CCCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECTTTTT-TCCCSEEECC
T ss_pred             ccEEEeCCC-cc-EECHHhcCC-CCceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceEechhhEe-ecccCEEEeC
Confidence            567888776 87 899888875 5899999996 77867778999999999999999999966566676 6899998443


Q ss_pred             cceeeccCCcccccCCCcccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCccccCCcccccccccccccc
Q 007680           81 MFGIRLTGNKLYGRIPPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLS  160 (593)
Q Consensus        81 ~n~l~l~~n~l~~~~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~~N~l~  160 (593)
                      .+--.+..    +++..+..|+.+++..| ++.+-..+|.+ .+|+.+.+ .|.++...+.+|.+|++|+.+++.+|.+.
T Consensus       212 ~~l~~I~~----~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~  284 (401)
T 4fdw_A          212 VTLKEIGS----QAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFN  284 (401)
T ss_dssp             TTCCEECT----TTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCC
T ss_pred             Cchheehh----hHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCcccc
Confidence            22111111    24445555666666654 33333444444 44555555 23343333445555555555555554443

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=98.83  E-value=1.5e-10  Score=127.35  Aligned_cols=55  Identities=22%  Similarity=0.165  Sum_probs=27.0

Q ss_pred             CCCCcEEECCCCcCcccCCccCC-CCCCCcEEEccCC-ccccc-ccccccCCCCchhh
Q 007680           23 LPNIEYLLLTANNLTGTIPNSIT-NATKLIVLDLGFN-SFSGH-ILNTFGNLRHLSVL   77 (593)
Q Consensus        23 l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~~N-~l~~~-~p~~~~~l~~L~~L   77 (593)
                      +++|++|+|++|.+++..+..+. .+++|+.|+|++| .++.. ++..+..+++|++|
T Consensus       104 ~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L  161 (594)
T 2p1m_B          104 YTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKEL  161 (594)
T ss_dssp             CTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEE
T ss_pred             CCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEE
Confidence            55555555555555544444443 3555555555555 33321 22333345555555

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.65  E-value=4.2e-09  Score=107.86  Aligned_cols=156  Identities=15%  Similarity=0.157  Sum_probs=93.0

Q ss_pred             CcEEEeeCcccc---------ccCChhhhhCCCCCcEEECCCCc-CcccCCccCCCCCCCcEEEccCCccccccccccc-
Q 007680            1 MRILTLEGNQLS---------GRLPSTIGHSLPNIEYLLLTANN-LTGTIPNSITNATKLIVLDLGFNSFSGHILNTFG-   69 (593)
Q Consensus         1 L~~L~Ls~n~l~---------~~lp~~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~-   69 (593)
                      |+.|.+..+...         +.++.-+ ..+|+|+.|+|++|. ++  ++. +. +++|+.|+|..|.++......+. 
T Consensus       141 L~~L~l~~~~~e~~~is~~~~~~L~~ll-~~~P~L~~L~L~g~~~l~--l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~  215 (362)
T 2ra8_A          141 FEGLFWGDIDFEEQEISWIEQVDLSPVL-DAMPLLNNLKIKGTNNLS--IGK-KP-RPNLKSLEIISGGLPDSVVEDILG  215 (362)
T ss_dssp             CSEEEECCCCTTTCCGGGCBCCBCHHHH-HTCTTCCEEEEECCBTCB--CCS-CB-CTTCSEEEEECSBCCHHHHHHHHH
T ss_pred             hhheeecCcchhhcccccccccCHHHHH-hcCCCCcEEEEeCCCCce--ecc-cc-CCCCcEEEEecCCCChHHHHHHHH
Confidence            566777654321         1233333 347888888888873 32  333 43 78888888888887654444454 


Q ss_pred             -CCCCchhhhhhcceeeccCC-cc---cccCC--CcccccEEEccCCcccCcCCCCC---CCCCCCCEecCCCccCCCC-
Q 007680           70 -NLRHLSVLSLLMFGIRLTGN-KL---YGRIP--PCLVLTVLDVSRNQLSGDIPSTI---GGRVDLETLSLASNQFQGP-  138 (593)
Q Consensus        70 -~l~~L~~L~l~~n~l~l~~n-~l---~~~~~--~~~~L~~L~l~~N~l~~~~p~~~---~~l~~L~~L~l~~N~l~~~-  138 (593)
                       .+++|++|+|+.+.-...++ .+   ...+.  .+.+|++|+|++|.+....+..+   ..+++|+.|+|+.|.|++. 
T Consensus       216 ~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G  295 (362)
T 2ra8_A          216 SDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEG  295 (362)
T ss_dssp             SBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHH
T ss_pred             ccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHH
Confidence             67888888553110000011 01   11111  23468888888888764322112   2467888888888888743 


Q ss_pred             ---CCccccCCccccccccccccccC
Q 007680          139 ---IPESVGSLISLESLDLSGNNLSG  161 (593)
Q Consensus       139 ---~p~~l~~~~~L~~L~l~~N~l~~  161 (593)
                         ++..+..+++|+.|++++|.++.
T Consensus       296 ~~~L~~~L~~l~~L~~L~L~~n~i~d  321 (362)
T 2ra8_A          296 ARLLLDHVDKIKHLKFINMKYNYLSD  321 (362)
T ss_dssp             HHHHHTTHHHHTTCSEEECCSBBCCH
T ss_pred             HHHHHhhcccCCcceEEECCCCcCCH
Confidence               33444567888888888888764

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=98.64  E-value=5.2e-10  Score=122.96  Aligned_cols=157  Identities=17%  Similarity=0.121  Sum_probs=75.7

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEEC---------CCCcCcccCCccCC-CCCCCcEEEccCCccccccccccc-
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLL---------TANNLTGTIPNSIT-NATKLIVLDLGFNSFSGHILNTFG-   69 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L---------~~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~-   69 (593)
                      |+.|+|++| +.+.....+...+++|++|+|         +.|.+++.....+. ++++|+.|+++.|.+++..+..+. 
T Consensus       316 L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~  394 (594)
T 2p1m_B          316 LQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIAR  394 (594)
T ss_dssp             CCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHH
T ss_pred             cCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHh
Confidence            567777777 442222233334677777776         33455533222232 366677777777777655544444 


Q ss_pred             CCCCchhhhhhcceeeccCCcccc---------cCCCcccccEEEccCCcccCcCCCCCCC-CCCCCEecCCCccCCCCC
Q 007680           70 NLRHLSVLSLLMFGIRLTGNKLYG---------RIPPCLVLTVLDVSRNQLSGDIPSTIGG-RVDLETLSLASNQFQGPI  139 (593)
Q Consensus        70 ~l~~L~~L~l~~n~l~l~~n~l~~---------~~~~~~~L~~L~l~~N~l~~~~p~~~~~-l~~L~~L~l~~N~l~~~~  139 (593)
                      .+++|+.|+|+.+..+ .-|.+++         .+..+..|+.|++++ .+++..+..++. +++|+.|+|++|.+++..
T Consensus       395 ~~~~L~~L~L~~~~~~-~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~  472 (594)
T 2p1m_B          395 NRPNMTRFRLCIIEPK-APDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLG  472 (594)
T ss_dssp             HCTTCCEEEEEESSTT-CCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHH
T ss_pred             hCCCcceeEeecccCC-CcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHH
Confidence            3666766633310000 0022321         011223466666654 343332223332 455666666666554332


Q ss_pred             Cccc-cCCcccccccccccccc
Q 007680          140 PESV-GSLISLESLDLSGNNLS  160 (593)
Q Consensus       140 p~~l-~~~~~L~~L~l~~N~l~  160 (593)
                      +..+ ..+++|+.|++++|+++
T Consensus       473 ~~~l~~~~~~L~~L~L~~n~~~  494 (594)
T 2p1m_B          473 MHHVLSGCDSLRKLEIRDCPFG  494 (594)
T ss_dssp             HHHHHHHCTTCCEEEEESCSCC
T ss_pred             HHHHHhcCCCcCEEECcCCCCc
Confidence            2222 34555666666666654

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.52  E-value=6.7e-07  Score=89.50  Aligned_cols=137  Identities=14%  Similarity=0.078  Sum_probs=97.5

Q ss_pred             ccccCccCcccEEEEEeCCCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCC---Ccceeeeeee-cCCceEEEEeccCC
Q 007680          277 CNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHR---NLIKILSSYS-NPDFKALVLEFMPN  352 (593)
Q Consensus       277 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~~~~  352 (593)
                      .+.++.|....||+.    |..+++|+....  .....+.+|.++++.+.+.   .+.+++.+.. ..+..++|||+++|
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~~~--~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPKSQ--QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEESSH--HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecCCc--hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            456788888899988    577899985432  3346788999999999642   3556666664 44567899999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcC-------------------------------------------
Q 007680          353 GSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGH-------------------------------------------  389 (593)
Q Consensus       353 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-------------------------------------------  389 (593)
                      .++.+....   .++..+...++.++++.|..||+-.                                           
T Consensus        98 ~~l~~~~~~---~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~  174 (306)
T 3tdw_A           98 QILGEDGMA---VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTL  174 (306)
T ss_dssp             EECHHHHHT---TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHH
T ss_pred             eECchhhhh---hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHH
Confidence            888764221   1455566666666666666666422                                           


Q ss_pred             -------------CCCCeEecCCCCCCeeeCC---CCc-EEEEeecccee
Q 007680          390 -------------SSVHIIHCDLKPTNILLDE---NMV-AHVSDFGIYKL  422 (593)
Q Consensus       390 -------------~~~~ivH~Dlkp~NIll~~---~~~-~kL~Dfg~a~~  422 (593)
                                   ....++|+|++|.||+++.   ++. +.|+||+.+..
T Consensus       175 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          175 RFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                         1234799999999999987   455 58999997764

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.44  E-value=4.5e-08  Score=95.25  Aligned_cols=17  Identities=29%  Similarity=0.399  Sum_probs=9.0

Q ss_pred             CCCCCcEEEccCCcccc
Q 007680           46 NATKLIVLDLGFNSFSG   62 (593)
Q Consensus        46 ~l~~L~~L~L~~N~l~~   62 (593)
                      ++++|+.|+|++|+|++
T Consensus       168 ~l~~L~~L~Ls~N~l~~  184 (267)
T 3rw6_A          168 NIPELLSLNLSNNRLYR  184 (267)
T ss_dssp             HCTTCCEEECTTSCCCC
T ss_pred             hCCCCCEEECCCCCCCC
Confidence            34555555555555553

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.44  E-value=2.3e-06  Score=83.71  Aligned_cols=136  Identities=18%  Similarity=0.128  Sum_probs=99.1

Q ss_pred             ccCccCcc-cEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcC-CCCcceeeeeeecCCceEEEEeccCCCCH
Q 007680          279 LLGTSSFG-SVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNVR-HRNLIKILSSYSNPDFKALVLEFMPNGSL  355 (593)
Q Consensus       279 ~lg~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL  355 (593)
                      .+..|..+ .||+.... ++..+++|+-....   ...+.+|...|+.+. +-.+.++++++.+.+..++|||+++|.++
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~---~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~  107 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGSV---ANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA  107 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETHH---HHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCCC---HhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence            45556665 58988765 56789999876542   346788999998884 33467788899899999999999999888


Q ss_pred             HHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------------------
Q 007680          356 EKWLYSHNYFLDILERLNIMIDVGSALEYLHNGH----------------------------------------------  389 (593)
Q Consensus       356 ~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~----------------------------------------------  389 (593)
                      .+......     .....+..+++..|..||.-.                                              
T Consensus       108 ~~~~~~~~-----~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  182 (272)
T 4gkh_A          108 FQVLEEYP-----DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKE  182 (272)
T ss_dssp             HHHHHHCG-----GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHH
T ss_pred             cccccCCH-----HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHH
Confidence            87654321     233456666777777777310                                              


Q ss_pred             --------CCCCeEecCCCCCCeeeCCCCcEEEEeecccee
Q 007680          390 --------SSVHIIHCDLKPTNILLDENMVAHVSDFGIYKL  422 (593)
Q Consensus       390 --------~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~  422 (593)
                              ....++|+|+.+.||++++++.+-|+||+.+..
T Consensus       183 l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          183 MHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                    011278999999999999887778999997653

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.33  E-value=9.3e-08  Score=88.23  Aligned_cols=108  Identities=14%  Similarity=0.145  Sum_probs=80.9

Q ss_pred             CCCCCcEEECCCC-cCcc----cCCccCCCCCCCcEEEccCCccccc----ccccccCCCCchhhhhhcceeeccCCccc
Q 007680           22 SLPNIEYLLLTAN-NLTG----TIPNSITNATKLIVLDLGFNSFSGH----ILNTFGNLRHLSVLSLLMFGIRLTGNKLY   92 (593)
Q Consensus        22 ~l~~L~~L~L~~N-~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~l~~n~l~l~~n~l~   92 (593)
                      ..++|++|+|++| .|+.    .+.+.+...++|+.|+|++|.|...    +...+...++|++|       +|++|.+.
T Consensus        34 ~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L-------~L~~N~i~  106 (185)
T 1io0_A           34 NDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSL-------NVESNFIS  106 (185)
T ss_dssp             TCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEE-------ECCSSCCC
T ss_pred             cCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEE-------ECcCCcCC
Confidence            3788999999999 8874    2455677788999999999999743    34456666789988       77777776


Q ss_pred             c--------cCCCcccccEEEc--cCCcccCc----CCCCCCCCCCCCEecCCCccCC
Q 007680           93 G--------RIPPCLVLTVLDV--SRNQLSGD----IPSTIGGRVDLETLSLASNQFQ  136 (593)
Q Consensus        93 ~--------~~~~~~~L~~L~l--~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~  136 (593)
                      .        .+....+|++|+|  ++|.|...    +...+...++|++|+|++|.+.
T Consensus       107 ~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~  164 (185)
T 1io0_A          107 GSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG  164 (185)
T ss_dssp             HHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred             HHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence            2        3444556999999  88998743    2334555688999999999986

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.32  E-value=3.1e-07  Score=89.31  Aligned_cols=83  Identities=24%  Similarity=0.370  Sum_probs=60.9

Q ss_pred             EEeeCccccccCChh---hhhCCCCCcEEECCCCcCcc--cCCccCCCCCCCcEEEccCCcccccccccccCCC--Cchh
Q 007680            4 LTLEGNQLSGRLPST---IGHSLPNIEYLLLTANNLTG--TIPNSITNATKLIVLDLGFNSFSGHILNTFGNLR--HLSV   76 (593)
Q Consensus         4 L~Ls~n~l~~~lp~~---~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~--~L~~   76 (593)
                      ++++.|+.. .++..   +...+++|+.|+|++|+|++  .+|+.+..+++|+.|+|++|+|++.  ..+..+.  +|++
T Consensus       148 l~l~~N~~~-~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~  224 (267)
T 3rw6_A          148 IDVVLNRRS-CMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEE  224 (267)
T ss_dssp             CCCCTTSHH-HHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSE
T ss_pred             ccccCCHHH-HHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcce
Confidence            567778655 44432   22348999999999999997  4456677899999999999999964  3344444  8888


Q ss_pred             hhhhcceeeccCCcccccCC
Q 007680           77 LSLLMFGIRLTGNKLYGRIP   96 (593)
Q Consensus        77 L~l~~n~l~l~~n~l~~~~~   96 (593)
                      |       +|++|.+.+.+|
T Consensus       225 L-------~L~~Npl~~~~~  237 (267)
T 3rw6_A          225 L-------WLDGNSLCDTFR  237 (267)
T ss_dssp             E-------ECTTSTTGGGCS
T ss_pred             E-------EccCCcCccccC
Confidence            8       788888876554

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.29  E-value=9.4e-08  Score=88.20  Aligned_cols=116  Identities=14%  Similarity=0.137  Sum_probs=88.5

Q ss_pred             cCCccCCCCCCCcEEEccCC-ccccc----ccccccCCCCchhhhhhcceeeccCCcccc--------cCCCcccccEEE
Q 007680           39 TIPNSITNATKLIVLDLGFN-SFSGH----ILNTFGNLRHLSVLSLLMFGIRLTGNKLYG--------RIPPCLVLTVLD  105 (593)
Q Consensus        39 ~~p~~~~~l~~L~~L~L~~N-~l~~~----~p~~~~~l~~L~~L~l~~n~l~l~~n~l~~--------~~~~~~~L~~L~  105 (593)
                      .+...+...++|+.|+|++| .|...    +...+...++|++|       +|++|.+..        .+....+|++|+
T Consensus        27 ~l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L-------~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~   99 (185)
T 1io0_A           27 TLKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKF-------SIVGTRSNDPVAFALAEMLKVNNTLKSLN   99 (185)
T ss_dssp             HHHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEE-------ECTTSCCCHHHHHHHHHHHHHCSSCCEEE
T ss_pred             HHHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEE-------ECcCCCCChHHHHHHHHHHHhCCCcCEEE
Confidence            44556778899999999999 88742    44567778899999       777777752        233345699999


Q ss_pred             ccCCcccCc----CCCCCCCCCCCCEecC--CCccCCCC----CCccccCCccccccccccccccC
Q 007680          106 VSRNQLSGD----IPSTIGGRVDLETLSL--ASNQFQGP----IPESVGSLISLESLDLSGNNLSG  161 (593)
Q Consensus       106 l~~N~l~~~----~p~~~~~l~~L~~L~l--~~N~l~~~----~p~~l~~~~~L~~L~l~~N~l~~  161 (593)
                      |++|.|...    +...+...++|++|+|  ++|.|...    +...+...++|+.|+|++|.+..
T Consensus       100 L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~~  165 (185)
T 1io0_A          100 VESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQGP  165 (185)
T ss_dssp             CCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHHH
T ss_pred             CcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCCh
Confidence            999999743    3456777889999999  88999743    34456667899999999999863

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.26  E-value=8.9e-07  Score=90.60  Aligned_cols=81  Identities=10%  Similarity=-0.021  Sum_probs=56.8

Q ss_pred             ccccc-CccCcccEEEEEeC-------CCCeEEEEEeehhhH---HHHHHHHHHHHHHhhcC-C--CCcceeeeeeecC-
Q 007680          276 ECNLL-GTSSFGSVYKGTIS-------DGTDVAIKVFNLQLE---RAFRSFDSECEVLRNVR-H--RNLIKILSSYSNP-  340 (593)
Q Consensus       276 ~~~~l-g~G~~g~Vy~~~~~-------~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~-  340 (593)
                      ..+.| +.|....+|+....       +++.+++|+......   .....+.+|+.+++.+. +  -.+.+++.+..+. 
T Consensus        24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~  103 (357)
T 3ats_A           24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD  103 (357)
T ss_dssp             EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST
T ss_pred             EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC
Confidence            34677 88889999998764       267899998654320   01245778889888884 2  3567788877655 


Q ss_pred             --CceEEEEeccCCCCHH
Q 007680          341 --DFKALVLEFMPNGSLE  356 (593)
Q Consensus       341 --~~~~lv~e~~~~gsL~  356 (593)
                        +..++||||++|.++.
T Consensus       104 ~~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          104 VLGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             TTSSCEEEEECCCCBCCC
T ss_pred             ccCCceEEEEecCCCChh
Confidence              3578999999887654

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.26  E-value=1e-07  Score=97.55  Aligned_cols=144  Identities=16%  Similarity=0.212  Sum_probs=97.4

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCC--CCCCCcEEEccC--Cccccc-----cccccc--
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSIT--NATKLIVLDLGF--NSFSGH-----ILNTFG--   69 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~--~l~~L~~L~L~~--N~l~~~-----~p~~~~--   69 (593)
                      |+.|+|++|.-. .+|. + . +++|+.|+|..|.|+......+.  .+++|+.|+|+.  |...+.     +...+.  
T Consensus       174 L~~L~L~g~~~l-~l~~-~-~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~  249 (362)
T 2ra8_A          174 LNNLKIKGTNNL-SIGK-K-P-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKD  249 (362)
T ss_dssp             CCEEEEECCBTC-BCCS-C-B-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTT
T ss_pred             CcEEEEeCCCCc-eecc-c-c-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcC
Confidence            789999998422 4555 3 3 78999999999998754334443  789999999963  332211     112232  


Q ss_pred             CCCCchhhhhhcceeeccCCccccc-------CCCcccccEEEccCCcccCc----CCCCCCCCCCCCEecCCCccCCCC
Q 007680           70 NLRHLSVLSLLMFGIRLTGNKLYGR-------IPPCLVLTVLDVSRNQLSGD----IPSTIGGRVDLETLSLASNQFQGP  138 (593)
Q Consensus        70 ~l~~L~~L~l~~n~l~l~~n~l~~~-------~~~~~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~  138 (593)
                      .+++|+.|       ++.+|.+.+.       .+.+..|++|+|+.|.|.+.    ++..+..+++|+.|+|++|.|+..
T Consensus       250 ~~p~Lr~L-------~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~  322 (362)
T 2ra8_A          250 RFPNLKWL-------GIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDE  322 (362)
T ss_dssp             TCTTCCEE-------EEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHH
T ss_pred             CCCCcCEE-------eCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHH
Confidence            47899999       6666666521       13455799999999999853    344456689999999999998732


Q ss_pred             CCccccCCcc-c-ccccccccc
Q 007680          139 IPESVGSLIS-L-ESLDLSGNN  158 (593)
Q Consensus       139 ~p~~l~~~~~-L-~~L~l~~N~  158 (593)
                      .   ...+.. | ..+++++|+
T Consensus       323 ~---~~~l~~alg~~~~~~~~~  341 (362)
T 2ra8_A          323 M---KKELQKSLPMKIDVSDSQ  341 (362)
T ss_dssp             H---HHHHHHHCCSEEECCSBC
T ss_pred             H---HHHHHHHcCCEEEecCCc
Confidence            2   222222 2 457888877

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.05  E-value=1.6e-05  Score=80.41  Aligned_cols=140  Identities=17%  Similarity=0.139  Sum_probs=79.7

Q ss_pred             ccccCccCcccEEEEEeCCCCeEEEEEeehhhHHHHHHHHHHHHHHhhcC--CCCcceeee------eeecCCceEEEEe
Q 007680          277 CNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVR--HRNLIKILS------SYSNPDFKALVLE  348 (593)
Q Consensus       277 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~------~~~~~~~~~lv~e  348 (593)
                      .+.|+.|..+.||++...+| .+++|+.....    ..+..|..+++.+.  .-.+.+++.      +....+..+++||
T Consensus        37 ~~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~~----~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~  111 (346)
T 2q83_A           37 IDVIQGNQMALVWKVHTDSG-AVCLKRIHRPE----KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD  111 (346)
T ss_dssp             EEECC----CEEEEEEETTE-EEEEEEECSCH----HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred             eeeccccccCcEEEEEeCCC-CEEEEecCCCH----HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence            34566678899999987654 58999987532    23344555555552  112333332      1234567889999


Q ss_pred             ccCCCCHH-----H---------HHhh--CCC-----------CCCHHHH------------------------------
Q 007680          349 FMPNGSLE-----K---------WLYS--HNY-----------FLDILER------------------------------  371 (593)
Q Consensus       349 ~~~~gsL~-----~---------~l~~--~~~-----------~l~~~~~------------------------------  371 (593)
                      |++|.++.     +         .++.  ...           ...|...                              
T Consensus       112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  191 (346)
T 2q83_A          112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE  191 (346)
T ss_dssp             CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred             eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence            99986542     0         1111  000           0122111                              


Q ss_pred             -HHHHHHHHHHHHHHHh--------c-CCCCCeEecCCCCCCeeeCCCCcEEEEeeccce
Q 007680          372 -LNIMIDVGSALEYLHN--------G-HSSVHIIHCDLKPTNILLDENMVAHVSDFGIYK  421 (593)
Q Consensus       372 -~~i~~~i~~~L~~LH~--------~-~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~  421 (593)
                       ..+..++..++++|++        . .....++|+|+++.||+++.++.+.++||+.+.
T Consensus       192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence             0111223445666653        1 014679999999999999888899999999764

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.95  E-value=4.6e-05  Score=76.00  Aligned_cols=138  Identities=13%  Similarity=0.056  Sum_probs=92.7

Q ss_pred             cccccCccCcccEEEEEeCCCCeEEEEEeehhhHHHHHHHHHHHHHHhhcC---CCCcceeeeeeecCCceEEEEeccCC
Q 007680          276 ECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVR---HRNLIKILSSYSNPDFKALVLEFMPN  352 (593)
Q Consensus       276 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~  352 (593)
                      ..+.|+.|....+|+... +++.+++|+....   ....+..|...|+.+.   ...+.+++++....+..++||||+++
T Consensus        40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G  115 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK  115 (312)
T ss_dssp             EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred             eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence            356789999999999986 4678899987644   2456888999998883   35688888888888889999999998


Q ss_pred             CCHH--------H---HHhhCCC---------------------CCCHHHHH---HHH----------------HHHHHH
Q 007680          353 GSLE--------K---WLYSHNY---------------------FLDILERL---NIM----------------IDVGSA  381 (593)
Q Consensus       353 gsL~--------~---~l~~~~~---------------------~l~~~~~~---~i~----------------~~i~~~  381 (593)
                      .++.        +   .++....                     .-+|.+..   ++.                ..+...
T Consensus       116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~  195 (312)
T 3jr1_A          116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI  195 (312)
T ss_dssp             CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred             CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence            7542        1   1222110                     01343321   111                112222


Q ss_pred             H-HHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeec
Q 007680          382 L-EYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFG  418 (593)
Q Consensus       382 L-~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg  418 (593)
                      + ..|........++|+|+.+.|++++.++ +.++|+.
T Consensus       196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            2 2343222256799999999999999887 8899974

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.95  E-value=1.9e-05  Score=81.91  Aligned_cols=75  Identities=13%  Similarity=0.154  Sum_probs=49.7

Q ss_pred             ccccCccCcccEEEEEeC-CCCeEEEEEeehhhH-------HHHHHHHHHHHHHhhcCC--CC-cceeeeeeecCCceEE
Q 007680          277 CNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLE-------RAFRSFDSECEVLRNVRH--RN-LIKILSSYSNPDFKAL  345 (593)
Q Consensus       277 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~n-iv~l~~~~~~~~~~~l  345 (593)
                      .+.+|.|..+.||++... +++.+++|.......       ...+.+..|.++++.+..  +. +.+++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            468999999999999754 468899998653211       122456778888888742  33 3345543  3455689


Q ss_pred             EEeccCCC
Q 007680          346 VLEFMPNG  353 (593)
Q Consensus       346 v~e~~~~g  353 (593)
                      |||++++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999764

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=97.84  E-value=5.1e-05  Score=78.59  Aligned_cols=161  Identities=12%  Similarity=-0.033  Sum_probs=93.3

Q ss_pred             cEEEeeCccccccCChhhhhCCCCCcEEECCCCcCc---------------------ccCCccCCCCCCCcEEEccCCcc
Q 007680            2 RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLT---------------------GTIPNSITNATKLIVLDLGFNSF   60 (593)
Q Consensus         2 ~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~---------------------~~~p~~~~~l~~L~~L~L~~N~l   60 (593)
                      +.+++..| +. .++...+.....|+.+.+.++...                     .....+|.++.+|+.+.+..|..
T Consensus       188 ~~i~l~~~-~~-~I~~~~F~~~~~L~~i~~~~~~~~i~~~~~~~~~l~~i~ip~~~~~i~~~~f~~~~~l~~~~~~~~~~  265 (394)
T 4fs7_A          188 KSIKLPRN-LK-IIRDYCFAECILLENMEFPNSLYYLGDFALSKTGVKNIIIPDSFTELGKSVFYGCTDLESISIQNNKL  265 (394)
T ss_dssp             CBCCCCTT-CC-EECTTTTTTCTTCCBCCCCTTCCEECTTTTTTCCCCEEEECTTCCEECSSTTTTCSSCCEEEECCTTC
T ss_pred             eEEEcCCC-ce-EeCchhhccccccceeecCCCceEeehhhcccCCCceEEECCCceecccccccccccceeEEcCCCcc
Confidence            33444443 44 455555555666666655554332                     12223444555555555555443


Q ss_pred             cccccccccCCCCchhhhhhcceeeccCCccc-ccCCCcccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCC
Q 007680           61 SGHILNTFGNLRHLSVLSLLMFGIRLTGNKLY-GRIPPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPI  139 (593)
Q Consensus        61 ~~~~p~~~~~l~~L~~L~l~~n~l~l~~n~l~-~~~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~  139 (593)
                      . .....|..+..|+.+       ....+.+. ..+..+..|+.+.+.++ ++.+-+.+|.++.+|+.+++.++ ++...
T Consensus       266 ~-i~~~~F~~~~~l~~~-------~~~~~~i~~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~  335 (394)
T 4fs7_A          266 R-IGGSLFYNCSGLKKV-------IYGSVIVPEKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIG  335 (394)
T ss_dssp             E-ECSCTTTTCTTCCEE-------EECSSEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEEC
T ss_pred             e-eecccccccccccee-------ccCceeeccccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEh
Confidence            3 344445555555444       22233222 23455666888888765 65455677888888888888754 66455


Q ss_pred             CccccCCccccccccccccccCCCCCCCCCCCCCCC
Q 007680          140 PESVGSLISLESLDLSGNNLSGKIPKLEGEIPVKGS  175 (593)
Q Consensus       140 p~~l~~~~~L~~L~l~~N~l~~~~p~~~~~~~~~~~  175 (593)
                      ..+|.+|.+|+.+++..| ++.+....|..++.+..
T Consensus       336 ~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~  370 (394)
T 4fs7_A          336 KRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKK  370 (394)
T ss_dssp             TTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCE
T ss_pred             HHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCE
Confidence            677888888888888766 77666666666554433

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=97.82  E-value=9.9e-05  Score=76.37  Aligned_cols=151  Identities=12%  Similarity=0.026  Sum_probs=94.4

Q ss_pred             ccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhhcceeeccCCc
Q 007680           11 LSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLMFGIRLTGNK   90 (593)
Q Consensus        11 l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~l~~n~   90 (593)
                      ++ .|+...|.++.+|+.+.|.++ ++.+-..+|.++++|+.++|.+| ++.+...+|.++.+|+.+.+..+-..+... 
T Consensus        59 Vt-sIg~~AF~~c~~L~~i~lp~~-i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~l~~i~~~-  134 (394)
T 4fs7_A           59 VV-SIGYAAFQGCRKVTEIKIPST-VREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLMLKSIGVE-  134 (394)
T ss_dssp             EE-EECTTTTTTCTTEEEEECCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTTCCEECTT-
T ss_pred             Ee-EhHHHHhhCCCCceEEEeCCC-ccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCceeeecce-
Confidence            44 566677777899999999854 77566778999999999999866 664566789999999887443221122221 


Q ss_pred             ccccCCCcccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCccccCCccccccccccccccCCCCCCCCCC
Q 007680           91 LYGRIPPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKLEGEI  170 (593)
Q Consensus        91 l~~~~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~~N~l~~~~p~~~~~~  170 (593)
                         ++..+. +..+.+..+ +...-..+|.++.+|+.+.+.++..+ ....+|.++.+|+.+++..| ++.+....+...
T Consensus       135 ---aF~~~~-~~~~~~~~~-~~~i~~~aF~~c~~L~~i~l~~~~~~-I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~  207 (394)
T 4fs7_A          135 ---AFKGCD-FKEITIPEG-VTVIGDEAFATCESLEYVSLPDSMET-LHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAEC  207 (394)
T ss_dssp             ---TTTTCC-CSEEECCTT-CCEECTTTTTTCTTCCEEECCTTCCE-ECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTC
T ss_pred             ---eeeccc-ccccccCcc-ccccchhhhcccCCCcEEecCCccce-eccccccCCCCceEEEcCCC-ceEeCchhhccc
Confidence               222222 222222222 22134556777777887777765443 55666777777777777655 444444444444


Q ss_pred             CC
Q 007680          171 PV  172 (593)
Q Consensus       171 ~~  172 (593)
                      ..
T Consensus       208 ~~  209 (394)
T 4fs7_A          208 IL  209 (394)
T ss_dssp             TT
T ss_pred             cc
Confidence            33

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.81  E-value=4.8e-05  Score=75.09  Aligned_cols=79  Identities=18%  Similarity=0.171  Sum_probs=57.8

Q ss_pred             ccccccccCccCcccEEEEEeCCCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCC---CCcceeeeeeecCCceEEEEec
Q 007680          273 EFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRH---RNLIKILSSYSNPDFKALVLEF  349 (593)
Q Consensus       273 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~~~~~lv~e~  349 (593)
                      +...++.+|.|..+.||+.+..+|+.|++|+...........+..|+..|+.+..   -.+.+++++    +..++||||
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~   91 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEW   91 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEEC
T ss_pred             CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEe
Confidence            4555678999999999999999999999998765433333467889999998842   234455554    234789999


Q ss_pred             cCCCCH
Q 007680          350 MPNGSL  355 (593)
Q Consensus       350 ~~~gsL  355 (593)
                      ++++..
T Consensus        92 l~~~~~   97 (288)
T 3f7w_A           92 VDERPP   97 (288)
T ss_dssp             CCCCCC
T ss_pred             ecccCC
Confidence            987643

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=97.78  E-value=0.00012  Score=75.18  Aligned_cols=134  Identities=12%  Similarity=0.049  Sum_probs=86.0

Q ss_pred             CCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhhcceeeccCCccc----ccCCC
Q 007680           22 SLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLY----GRIPP   97 (593)
Q Consensus        22 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~l~~n~l~----~~~~~   97 (593)
                      ...+|+.+.+..+ ++.....+|.++.+|+.+.+..+ ++.+....|.++.+|+.+       .+..+ +.    +.+..
T Consensus       215 ~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i-------~l~~~-i~~i~~~aF~~  284 (379)
T 4h09_A          215 YGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTL-------NFYAK-VKTVPYLLCSG  284 (379)
T ss_dssp             TCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEE-------EECCC-CSEECTTTTTT
T ss_pred             cccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhccc-------ccccc-ceecccccccc
Confidence            3566777777655 34355566777777888877766 554555667777777776       33222 21    24555


Q ss_pred             cccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCccccCCccccccccccccccCCCCCCC
Q 007680           98 CLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKLE  167 (593)
Q Consensus        98 ~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~~N~l~~~~p~~~  167 (593)
                      +.+|+.+.+.+|.++.+-+.+|.++.+|+.+.|..+ ++.....+|.+|.+|+.+.+..+ ++.+....|
T Consensus       285 c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~-v~~I~~~aF  352 (379)
T 4h09_A          285 CSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS-ITLIESGAF  352 (379)
T ss_dssp             CTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTT
T ss_pred             ccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc-cCEEchhHh
Confidence            666888888777777555677788888888888654 55445567778888888777543 444444433

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=97.76  E-value=3.4e-05  Score=79.87  Aligned_cols=124  Identities=12%  Similarity=0.210  Sum_probs=76.4

Q ss_pred             CCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhhcceeeccCCccc----ccCCCccc
Q 007680           25 NIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLY----GRIPPCLV  100 (593)
Q Consensus        25 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~l~~n~l~----~~~~~~~~  100 (593)
                      .+..+.+.+ .++..-..+|.++++|+.+.+.++..+ +....|.++.+|+.+       .+. +.+.    +++.+|.+
T Consensus       243 ~~~~~~ip~-~v~~i~~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i-------~l~-~~i~~I~~~aF~~c~~  312 (394)
T 4gt6_A          243 EDPAFKIPN-GVARIETHAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDI-------EFS-SRITELPESVFAGCIS  312 (394)
T ss_dssp             CCSEEECCT-TEEEECTTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEE-------ECC-TTCCEECTTTTTTCTT
T ss_pred             ccceEEcCC-cceEcccceeeecccccEEecccccce-ecCcccccccccccc-------cCC-CcccccCceeecCCCC
Confidence            344444432 233344556777777777777665544 555567777777766       332 1221    24555666


Q ss_pred             ccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCccccCCcccccccccccccc
Q 007680          101 LTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLS  160 (593)
Q Consensus       101 L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~~N~l~  160 (593)
                      |+.++|..| ++.+-..+|.++.+|+.+.+..+ ++.....+|.+|.+|+.+++.+|...
T Consensus       313 L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~  370 (394)
T 4gt6_A          313 LKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQ  370 (394)
T ss_dssp             CCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHH
T ss_pred             cCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceee
Confidence            777777655 55455667888888888888654 55455667888888888888776543

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=97.68  E-value=0.00015  Score=74.47  Aligned_cols=126  Identities=11%  Similarity=0.053  Sum_probs=97.3

Q ss_pred             ccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhhcceeeccCCc
Q 007680           11 LSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLMFGIRLTGNK   90 (593)
Q Consensus        11 l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~l~~n~   90 (593)
                      +. .++...+.+..+|+.+.+..+ ++..-..+|.++.+|+.+.+..+ +.......|.+|.+|+.+       .+.++.
T Consensus       228 ~~-~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i-------~l~~~~  297 (379)
T 4h09_A          228 VT-TLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKV-------VMDNSA  297 (379)
T ss_dssp             CC-EECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEE-------EECCTT
T ss_pred             ee-EEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccc-------cccccc
Confidence            44 566666666899999999877 66566778999999999999765 654666689999999998       666665


Q ss_pred             cc----ccCCCcccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCccccCCcc
Q 007680           91 LY----GRIPPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLIS  148 (593)
Q Consensus        91 l~----~~~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~  148 (593)
                      +.    +++.+|.+|+.+.|..+ ++.+-..+|.++.+|+.+.+..+ ++..-..+|.++..
T Consensus       298 i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~-v~~I~~~aF~~c~~  357 (379)
T 4h09_A          298 IETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS-ITLIESGAFEGSSI  357 (379)
T ss_dssp             CCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTSSC
T ss_pred             cceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc-cCEEchhHhhCCCC
Confidence            54    46677888999999866 76566788999999999999765 65455667777643

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.64  E-value=0.00016  Score=75.50  Aligned_cols=80  Identities=14%  Similarity=0.076  Sum_probs=48.1

Q ss_pred             CCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCccccccccCCccccCccccCCC---CCCccchHHHHHHHHHH
Q 007680          391 SVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEG---IVSAKCDVYSYGVLLME  467 (593)
Q Consensus       391 ~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~~~DvwSlGvvl~e  467 (593)
                      ...++|+|++|.||+++.++ ++++||+.+..-....+-.. ....-...|.+|+.....   ......++.+....+|+
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGA-YLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN  308 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHH-HHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHH-HHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence            45699999999999998876 99999998875321111000 000011346666654311   11223556677888888


Q ss_pred             HHhCC
Q 007680          468 TFTRK  472 (593)
Q Consensus       468 lltg~  472 (593)
                      .++++
T Consensus       309 ~y~~~  313 (420)
T 2pyw_A          309 LFNKR  313 (420)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            77653

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.56  E-value=0.00018  Score=71.97  Aligned_cols=157  Identities=10%  Similarity=0.103  Sum_probs=87.6

Q ss_pred             CCHHHHHHhhhcccc-----ccccCccCcccEEEEEeCCCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCC--cceee
Q 007680          262 TSYLDIQRATDEFNE-----CNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRN--LIKIL  334 (593)
Q Consensus       262 ~~~~~~~~~~~~~~~-----~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~  334 (593)
                      .+..++......|..     .+.|+.|....+|+....+| .+++|+.....  ....+..|..+++.+....  +.+++
T Consensus         7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~   83 (322)
T 2ppq_A            7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL   83 (322)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCccc
Confidence            344555555555544     34677788889999987655 68899887531  2234566777777773212  23333


Q ss_pred             ee------eecCCceEEEEeccCCCCHHH--------------HHhhC--C--CC----C---CHHHHHH----------
Q 007680          335 SS------YSNPDFKALVLEFMPNGSLEK--------------WLYSH--N--YF----L---DILERLN----------  373 (593)
Q Consensus       335 ~~------~~~~~~~~lv~e~~~~gsL~~--------------~l~~~--~--~~----l---~~~~~~~----------  373 (593)
                      ..      ....+..+++|+|++|..+..              .++..  .  ..    .   .|.....          
T Consensus        84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~  163 (322)
T 2ppq_A           84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  163 (322)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence            21      123356789999998864311              01111  0  00    1   1211100          


Q ss_pred             --HHHHHHHHHHHHHhcC---CCCCeEecCCCCCCeeeCCCCcEEEEeeccce
Q 007680          374 --IMIDVGSALEYLHNGH---SSVHIIHCDLKPTNILLDENMVAHVSDFGIYK  421 (593)
Q Consensus       374 --i~~~i~~~L~~LH~~~---~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~  421 (593)
                        +...+...++++++..   ...+++|+|+.+.||+++++..+.++||+.+.
T Consensus       164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence              0112344555555321   13469999999999999987666899999765

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=97.53  E-value=0.00039  Score=71.81  Aligned_cols=161  Identities=11%  Similarity=0.162  Sum_probs=109.4

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCc---------------------
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNS---------------------   59 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~---------------------   59 (593)
                      |+.+.+..+ +. .+....|. -.+|+.+.+..+-.. ....+|.++.+|.......+.                     
T Consensus       162 L~~i~~~~~-~~-~I~~~aF~-~~~l~~i~ip~~~~~-i~~~af~~c~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (394)
T 4gt6_A          162 LHTVTLPDS-VT-AIEERAFT-GTALTQIHIPAKVTR-IGTNAFSECFALSTITSDSESYPAIDNVLYEKSANGDYALIR  237 (394)
T ss_dssp             CCEEECCTT-CC-EECTTTTT-TCCCSEEEECTTCCE-ECTTTTTTCTTCCEEEECCSSSCBSSSCEEEECTTSCEEEEE
T ss_pred             cccccccce-ee-Eecccccc-ccceeEEEECCcccc-cccchhhhccccceecccccccccccceeecccccccccccc
Confidence            344555433 55 57777775 467888888766544 556677777777666544322                     


Q ss_pred             ---------------ccccccccccCCCCchhhhhhcceeeccCCccc---ccCCCcccccEEEccCCcccCcCCCCCCC
Q 007680           60 ---------------FSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLY---GRIPPCLVLTVLDVSRNQLSGDIPSTIGG  121 (593)
Q Consensus        60 ---------------l~~~~p~~~~~l~~L~~L~l~~n~l~l~~n~l~---~~~~~~~~L~~L~l~~N~l~~~~p~~~~~  121 (593)
                                     ++..-..+|.++.+|+.+       .+.++...   +++..+..|+.+.+. +.++.+...+|.+
T Consensus       238 ~~~~~~~~~~~ip~~v~~i~~~aF~~c~~L~~i-------~lp~~~~~I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~  309 (394)
T 4gt6_A          238 YPSQREDPAFKIPNGVARIETHAFDSCAYLASV-------KMPDSVVSIGTGAFMNCPALQDIEFS-SRITELPESVFAG  309 (394)
T ss_dssp             CCTTCCCSEEECCTTEEEECTTTTTTCSSCCEE-------ECCTTCCEECTTTTTTCTTCCEEECC-TTCCEECTTTTTT
T ss_pred             cccccccceEEcCCcceEcccceeeecccccEE-------ecccccceecCcccccccccccccCC-CcccccCceeecC
Confidence                           221223468888999888       44433222   355667779999997 4566566788999


Q ss_pred             CCCCCEecCCCccCCCCCCccccCCccccccccccccccCCCCCCCCCCCCCCC
Q 007680          122 RVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKLEGEIPVKGS  175 (593)
Q Consensus       122 l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~~N~l~~~~p~~~~~~~~~~~  175 (593)
                      +.+|+.+.+..| ++.....+|.+|.+|+.+.+..+ ++.+....|..+..++.
T Consensus       310 c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~  361 (394)
T 4gt6_A          310 CISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNN  361 (394)
T ss_dssp             CTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCE
T ss_pred             CCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCE
Confidence            999999999865 66456778999999999999654 77777777776665443

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.52  E-value=0.00035  Score=70.37  Aligned_cols=141  Identities=12%  Similarity=0.070  Sum_probs=74.3

Q ss_pred             ccccCccCccc-EEEEEeCCCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCC--CCcceeeeeeecCCceEEEEeccCCC
Q 007680          277 CNLLGTSSFGS-VYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRH--RNLIKILSSYSNPDFKALVLEFMPNG  353 (593)
Q Consensus       277 ~~~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g  353 (593)
                      .+.|+.|.... +|+....+|+.+++|.......   ..+..|+.+++.+..  -.+.+++.+....+  +++||++.+.
T Consensus        23 ~~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~   97 (333)
T 3csv_A           23 RTPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDA   97 (333)
T ss_dssp             ECC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSC
T ss_pred             eeECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCc
Confidence            35676665554 7787654467788886544321   234556777776632  23555666533333  7899999776


Q ss_pred             CHHHHHhhCC-------------------------CCCCHHHHH-------HH-------------HHHHHHHHHHHHh-
Q 007680          354 SLEKWLYSHN-------------------------YFLDILERL-------NI-------------MIDVGSALEYLHN-  387 (593)
Q Consensus       354 sL~~~l~~~~-------------------------~~l~~~~~~-------~i-------------~~~i~~~L~~LH~-  387 (593)
                      ++.+++....                         ..++.....       .+             ...+...++.+.+ 
T Consensus        98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~  177 (333)
T 3csv_A           98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA  177 (333)
T ss_dssp             BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred             chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence            7655443210                         001111100       00             0011112222211 


Q ss_pred             -cCCCCCeEecCCCCCCeeeCCC----CcEEEEeecccee
Q 007680          388 -GHSSVHIIHCDLKPTNILLDEN----MVAHVSDFGIYKL  422 (593)
Q Consensus       388 -~~~~~~ivH~Dlkp~NIll~~~----~~~kL~Dfg~a~~  422 (593)
                       ......++|||+.+.||+++.+    +.+.++||+.+..
T Consensus       178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence             0113469999999999999874    6899999998764

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=97.51  E-value=9e-05  Score=63.63  Aligned_cols=56  Identities=27%  Similarity=0.380  Sum_probs=37.1

Q ss_pred             EEEeeCcccc-ccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCccc
Q 007680            3 ILTLEGNQLS-GRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFS   61 (593)
Q Consensus         3 ~L~Ls~n~l~-~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~   61 (593)
                      .++.++++|+ ..+|..+.   ++|+.|+|++|+|+.+.++.|..+++|+.|+|++|.+.
T Consensus        12 ~v~Cs~~~L~~~~vP~~lp---~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~   68 (130)
T 3rfe_A           12 LVDCGRRGLTWASLPTAFP---VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR   68 (130)
T ss_dssp             EEECCSSCCCTTTSCSCCC---TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred             EEEeCCCCCccccCCCCCC---cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence            5677777774 24665543   36777777777777555556677777777777777654

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.47  E-value=0.00017  Score=71.65  Aligned_cols=129  Identities=16%  Similarity=0.200  Sum_probs=76.0

Q ss_pred             ccccCccCcccEEEEEeCCCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCc-ceeeeeeecCCceEEEEecc-CCCC
Q 007680          277 CNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNL-IKILSSYSNPDFKALVLEFM-PNGS  354 (593)
Q Consensus       277 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~-~~gs  354 (593)
                      .+.|+.|....+|+.     +.+++|+....... .....+|..+++.+....+ .+++++  +.+.-++++||+ +|.+
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~   94 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT   94 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence            678999999999998     56889987653221 1123568888877743223 455554  344457899999 6654


Q ss_pred             HHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------------------
Q 007680          355 LEKWLYSHNYFLDILERLNIMIDVGSALEYLHN-----------------------------------------------  387 (593)
Q Consensus       355 L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~-----------------------------------------------  387 (593)
                      +...-...        ...++.++++.|+-||+                                               
T Consensus        95 l~~~~~~~--------~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l  166 (301)
T 3dxq_A           95 MSPEKFKT--------RPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSAL  166 (301)
T ss_dssp             CCHHHHHH--------STTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHH
T ss_pred             CCHhhHhh--------hHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHH
Confidence            43210000        00011222222222221                                               


Q ss_pred             --cCCCCCeEecCCCCCCeeeCCCCcEEEEeecccee
Q 007680          388 --GHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKL  422 (593)
Q Consensus       388 --~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~  422 (593)
                        ......++|+|+.+.||+ ..++.+.++||..+..
T Consensus       167 ~~~~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          167 AAHPLPLAACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             HSSCCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             HhcCCCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence              122345899999999999 5666789999998764

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.33  E-value=0.0011  Score=61.31  Aligned_cols=103  Identities=12%  Similarity=0.027  Sum_probs=68.9

Q ss_pred             CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCccccc
Q 007680          354 SLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQT  433 (593)
Q Consensus       354 sL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~  433 (593)
                      +|.+.+...+.++++++++.++.|.+.+|.-+-.+.  . -..+=+.|..|++..+|.|...+ +.+.            
T Consensus        34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~--~-~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------   97 (229)
T 2yle_A           34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRR--Q-PRHRVRSAAQIRVWRDGAVTLAP-AADD------------   97 (229)
T ss_dssp             EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--C-CCCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred             cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcc--c-CCceecCCcceEEecCCceeccc-cccc------------
Confidence            899999999999999999999999999987762110  0 11233456889999999887653 1110            


Q ss_pred             cccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCC
Q 007680          434 MTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPT  475 (593)
Q Consensus       434 ~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf  475 (593)
                        .....+.|||... ...+.+.=|||+|+++|..+--..|-
T Consensus        98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e  136 (229)
T 2yle_A           98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKE  136 (229)
T ss_dssp             -----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCc
Confidence              1223466888753 45677889999999999998755443

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.27  E-value=0.0033  Score=62.90  Aligned_cols=157  Identities=13%  Similarity=0.051  Sum_probs=87.6

Q ss_pred             CCHHHHHHhhhcccc-----ccccCccCcccEEEEEeCCCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCC--CCcceee
Q 007680          262 TSYLDIQRATDEFNE-----CNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRH--RNLIKIL  334 (593)
Q Consensus       262 ~~~~~~~~~~~~~~~-----~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~  334 (593)
                      .+..++....+.|.+     ...++ |....||++...+|+.+++|+.+... .....+..|..+++.+..  -.+.+++
T Consensus        11 l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~   88 (328)
T 1zyl_A           11 LHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPV   88 (328)
T ss_dssp             CCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCC
T ss_pred             CCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeeccee
Confidence            444555555454432     23466 78889999887777789999987431 123456678888877742  1234444


Q ss_pred             ee-----eecCCceEEEEeccCCCCHH-----HH---------Hhh----CC----CCCCHHHH----HHH---------
Q 007680          335 SS-----YSNPDFKALVLEFMPNGSLE-----KW---------LYS----HN----YFLDILER----LNI---------  374 (593)
Q Consensus       335 ~~-----~~~~~~~~lv~e~~~~gsL~-----~~---------l~~----~~----~~l~~~~~----~~i---------  374 (593)
                      ..     ....+..+++||+++|.++.     .+         ++.    ..    ...++...    ..+         
T Consensus        89 ~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  168 (328)
T 1zyl_A           89 AFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPS  168 (328)
T ss_dssp             CBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCT
T ss_pred             ecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCH
Confidence            32     12245567899999875431     11         111    00    01222111    000         


Q ss_pred             ------HHHHHHHHHHHHhcC---CCCCeEecCCCCCCeeeCCCCcEEEEeecccee
Q 007680          375 ------MIDVGSALEYLHNGH---SSVHIIHCDLKPTNILLDENMVAHVSDFGIYKL  422 (593)
Q Consensus       375 ------~~~i~~~L~~LH~~~---~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~  422 (593)
                            ...+...++.+.+..   ....++|+|+++.||+++ + .+.++||+.+..
T Consensus       169 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          169 GLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             TTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             HHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence                  011111223332211   134589999999999999 4 899999987654

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.20  E-value=0.00033  Score=73.23  Aligned_cols=73  Identities=14%  Similarity=0.203  Sum_probs=49.5

Q ss_pred             ccccCccCcccEEEEEeCC--------CCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCC-cceeeeeeecCCceEEEE
Q 007680          277 CNLLGTSSFGSVYKGTISD--------GTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRN-LIKILSSYSNPDFKALVL  347 (593)
Q Consensus       277 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~  347 (593)
                      .+.|+.|....+|++...+        ++.+++|+.....  ....+..|..+++.+...+ ..++++.+.+    .+|+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~  151 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  151 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence            4678889999999998653        5789999884321  1134457888888884333 3566765543    3899


Q ss_pred             eccCCCCH
Q 007680          348 EFMPNGSL  355 (593)
Q Consensus       348 e~~~~gsL  355 (593)
                      ||++|.++
T Consensus       152 e~l~G~~l  159 (429)
T 1nw1_A          152 EYIPSRPL  159 (429)
T ss_dssp             CCCCEEEC
T ss_pred             EEeCCccc
Confidence            99986433

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.18  E-value=0.0015  Score=66.75  Aligned_cols=141  Identities=12%  Similarity=0.159  Sum_probs=83.8

Q ss_pred             ccccCccCcccEEEEEeC--------CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcC-CCCcceeeeeeecCCceEEEE
Q 007680          277 CNLLGTSSFGSVYKGTIS--------DGTDVAIKVFNLQLERAFRSFDSECEVLRNVR-HRNLIKILSSYSNPDFKALVL  347 (593)
Q Consensus       277 ~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  347 (593)
                      .+.+..|-...+|++...        +++.+++|+..... .......+|..+++.+. +.-..++++.+.+    .+||
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~-~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~  129 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL-QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE  129 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc-chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence            457888989999999864        24789999864321 22345668999998884 3334566766544    2899


Q ss_pred             eccCCCCHHH--------------H---HhhCC----CCCC--HHHHHHHHHHHHH-------------------HHHHH
Q 007680          348 EFMPNGSLEK--------------W---LYSHN----YFLD--ILERLNIMIDVGS-------------------ALEYL  385 (593)
Q Consensus       348 e~~~~gsL~~--------------~---l~~~~----~~l~--~~~~~~i~~~i~~-------------------~L~~L  385 (593)
                      ||++|.+|..              .   ++...    ....  +.++.++..++..                   .++.|
T Consensus       130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L  209 (379)
T 3feg_A          130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL  209 (379)
T ss_dssp             ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred             EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence            9998765431              1   11111    1122  3445555444321                   23333


Q ss_pred             ----HhcCCCCCeEecCCCCCCeeeCCC----CcEEEEeecccee
Q 007680          386 ----HNGHSSVHIIHCDLKPTNILLDEN----MVAHVSDFGIYKL  422 (593)
Q Consensus       386 ----H~~~~~~~ivH~Dlkp~NIll~~~----~~~kL~Dfg~a~~  422 (593)
                          ........++|+|+.+.||+++.+    +.+.++||..+..
T Consensus       210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence                222224569999999999999876    7899999998753

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.07  E-value=0.0001  Score=66.37  Aligned_cols=89  Identities=11%  Similarity=0.034  Sum_probs=63.6

Q ss_pred             cCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCc-ccccccccccCC----CCchhhhhhcceeeccC
Q 007680           14 RLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNS-FSGHILNTFGNL----RHLSVLSLLMFGIRLTG   88 (593)
Q Consensus        14 ~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l----~~L~~L~l~~n~l~l~~   88 (593)
                      .+|..... --+|+.|+|+++.|+..-=..+.++++|+.|+|+++. ++..--..++.+    ++|++|       ++++
T Consensus        52 ~LP~~~~~-~~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L-------~Ls~  123 (176)
T 3e4g_A           52 HLPTGPLD-KYKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEM-------EIIS  123 (176)
T ss_dssp             GSCCCSTT-CCCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEE-------EEES
T ss_pred             cCCcccCC-CceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEE-------EcCC
Confidence            35543322 2479999999999886555567899999999999985 765444456664    468888       7777


Q ss_pred             Cc-ccc----cCCCcccccEEEccCCc
Q 007680           89 NK-LYG----RIPPCLVLTVLDVSRNQ  110 (593)
Q Consensus        89 n~-l~~----~~~~~~~L~~L~l~~N~  110 (593)
                      +. ++.    .+..+.+|++|+|+++.
T Consensus       124 C~~ITD~Gl~~L~~~~~L~~L~L~~c~  150 (176)
T 3e4g_A          124 CGNVTDKGIIALHHFRNLKYLFLSDLP  150 (176)
T ss_dssp             CTTCCHHHHHHGGGCTTCCEEEEESCT
T ss_pred             CCcCCHHHHHHHhcCCCCCEEECCCCC
Confidence            54 662    35567779999999985

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=97.04  E-value=9.5e-05  Score=67.93  Aligned_cols=114  Identities=11%  Similarity=0.091  Sum_probs=61.1

Q ss_pred             CCCCcEEECCCC-cCcc----cCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhhcceeeccCCcccccCCC
Q 007680           23 LPNIEYLLLTAN-NLTG----TIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPP   97 (593)
Q Consensus        23 l~~L~~L~L~~N-~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~l~~n~l~~~~~~   97 (593)
                      -+.|++|+|++| +|..    .+.+++..-+.|+.|+|++|+|...-...|+.                       .+..
T Consensus        40 n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~-----------------------aL~~   96 (197)
T 1pgv_A           40 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIE-----------------------LIET   96 (197)
T ss_dssp             CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHH-----------------------HHHH
T ss_pred             CCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHH-----------------------HHhc
Confidence            456888888875 7753    23455666677888888888877433222221                       0111


Q ss_pred             cccccEEEccCCcccCc----CCCCCCCCCCCCEecCCCccC---CC----CCCccccCCccccccccccccc
Q 007680           98 CLVLTVLDVSRNQLSGD----IPSTIGGRVDLETLSLASNQF---QG----PIPESVGSLISLESLDLSGNNL  159 (593)
Q Consensus        98 ~~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l---~~----~~p~~l~~~~~L~~L~l~~N~l  159 (593)
                      ...|++|+|++|.|...    +-.++..-..|++|+|++|..   ..    .+..++..-+.|+.|+++.|.+
T Consensus        97 N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~  169 (197)
T 1pgv_A           97 SPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM  169 (197)
T ss_dssp             CSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred             CCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCc
Confidence            12356666666665421    112344445577777765432   21    1223445556677777765544

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.01  E-value=0.00047  Score=70.54  Aligned_cols=74  Identities=12%  Similarity=0.256  Sum_probs=45.4

Q ss_pred             ccccCccCcccEEEEEeCC---------CCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCC-cceeeeeeecCCceEEE
Q 007680          277 CNLLGTSSFGSVYKGTISD---------GTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRN-LIKILSSYSNPDFKALV  346 (593)
Q Consensus       277 ~~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv  346 (593)
                      .+.++.|....+|++...+         ++.+++|+....... ......|..+++.+...+ +.++++..  .  -++|
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v  112 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI  112 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence            4578888889999998653         268899987653221 112357888888874333 44666544  2  3689


Q ss_pred             EeccCCCCH
Q 007680          347 LEFMPNGSL  355 (593)
Q Consensus       347 ~e~~~~gsL  355 (593)
                      |||++|.++
T Consensus       113 ~e~i~G~~l  121 (369)
T 3c5i_A          113 EEWLYGDPL  121 (369)
T ss_dssp             EECCCSEEC
T ss_pred             EEEecCCcC
Confidence            999987543

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.00  E-value=0.00024  Score=64.03  Aligned_cols=88  Identities=11%  Similarity=0.116  Sum_probs=64.3

Q ss_pred             CCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhhcceeeccCCc-ccc----cCCCc----ccccEEEccCCc
Q 007680           40 IPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLMFGIRLTGNK-LYG----RIPPC----LVLTVLDVSRNQ  110 (593)
Q Consensus        40 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~l~~n~-l~~----~~~~~----~~L~~L~l~~N~  110 (593)
                      +|.....-.+|+.|||+++.++..--..+.+|++|++|       +|+++. +++    .+...    .+|++|+|++|.
T Consensus        53 LP~~~~~~~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L-------~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~  125 (176)
T 3e4g_A           53 LPTGPLDKYKIQAIDATDSCIMSIGFDHMEGLQYVEKI-------RLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCG  125 (176)
T ss_dssp             SCCCSTTCCCEEEEEEESCCCCGGGGGGGTTCSCCCEE-------EEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCT
T ss_pred             CCcccCCCceEeEEeCcCCCccHHHHHHhcCCCCCCEE-------EeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCC
Confidence            35444344579999999999986555678899999999       777774 552    24442    359999999985


Q ss_pred             -ccCcCCCCCCCCCCCCEecCCCcc
Q 007680          111 -LSGDIPSTIGGRVDLETLSLASNQ  134 (593)
Q Consensus       111 -l~~~~p~~~~~l~~L~~L~l~~N~  134 (593)
                       |+..-=..+..+++|+.|+|+++.
T Consensus       126 ~ITD~Gl~~L~~~~~L~~L~L~~c~  150 (176)
T 3e4g_A          126 NVTDKGIIALHHFRNLKYLFLSDLP  150 (176)
T ss_dssp             TCCHHHHHHGGGCTTCCEEEEESCT
T ss_pred             cCCHHHHHHHhcCCCCCEEECCCCC
Confidence             663322346678999999999986

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=97.00  E-value=0.00094  Score=57.17  Aligned_cols=57  Identities=26%  Similarity=0.425  Sum_probs=35.1

Q ss_pred             cEEEccCCccc-CcCCCCCCCCCCCCEecCCCccCCCCCCccccCCcccccccccccccc
Q 007680          102 TVLDVSRNQLS-GDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLS  160 (593)
Q Consensus       102 ~~L~l~~N~l~-~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~~N~l~  160 (593)
                      ..++.+++.|+ ..+|..+.  .+|+.|+|++|+|+...++.|..+++|+.|+|++|++.
T Consensus        11 ~~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~   68 (130)
T 3rfe_A           11 TLVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR   68 (130)
T ss_dssp             TEEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred             CEEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence            35666666665 23443321  34677777777777555556666777777777777764

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.82  E-value=0.0012  Score=69.42  Aligned_cols=74  Identities=14%  Similarity=0.177  Sum_probs=48.0

Q ss_pred             ccccCccCcccEEEEEeCC-CCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCc-ceeeeeeecCCceEEEEeccCCCC
Q 007680          277 CNLLGTSSFGSVYKGTISD-GTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNL-IKILSSYSNPDFKALVLEFMPNGS  354 (593)
Q Consensus       277 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~gs  354 (593)
                      .+.|+.|-...+|++...+ +..+++|+........ -...+|..+++.+...++ .++++.+.  +  .+||||++|.+
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~  187 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA  187 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence            4678889999999998764 4788999875432111 112578888988864444 46777663  2  35999998754


Q ss_pred             H
Q 007680          355 L  355 (593)
Q Consensus       355 L  355 (593)
                      |
T Consensus       188 l  188 (458)
T 2qg7_A          188 L  188 (458)
T ss_dssp             C
T ss_pred             C
Confidence            3

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=96.73  E-value=0.00032  Score=64.44  Aligned_cols=62  Identities=16%  Similarity=0.209  Sum_probs=45.9

Q ss_pred             CcEEEeeCc-ccccc----CChhhhhCCCCCcEEECCCCcCcccC----CccCCCCCCCcEEEccCCccccc
Q 007680            1 MRILTLEGN-QLSGR----LPSTIGHSLPNIEYLLLTANNLTGTI----PNSITNATKLIVLDLGFNSFSGH   63 (593)
Q Consensus         1 L~~L~Ls~n-~l~~~----lp~~~~~~l~~L~~L~L~~N~l~~~~----p~~~~~l~~L~~L~L~~N~l~~~   63 (593)
                      |+.|+|++| +|...    |-+.+.. -+.|+.|+|++|+|+..-    .+++..-+.|+.|+|++|+|...
T Consensus        43 L~~L~L~~nn~igd~ga~~la~aL~~-N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~  113 (197)
T 1pgv_A           43 LKEVNINNMKRVSKERIRSLIEAACN-SKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPE  113 (197)
T ss_dssp             CCEEECTTCCSSCHHHHHHHHHHHTT-CSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHH
T ss_pred             ccEEECCCCCCCCHHHHHHHHHHHhh-CCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHH
Confidence            688999986 88632    3333433 578999999999998433    33455668899999999999843

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.68  E-value=0.0059  Score=61.51  Aligned_cols=68  Identities=13%  Similarity=0.172  Sum_probs=43.8

Q ss_pred             CccCcccEEEEEeCCCCeEEEEEeehhhHHHHHHHHHHHHHHhhcC---CCCcceeeee------eecCCceEEEEeccC
Q 007680          281 GTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVR---HRNLIKILSS------YSNPDFKALVLEFMP  351 (593)
Q Consensus       281 g~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~------~~~~~~~~lv~e~~~  351 (593)
                      |.|....||+....+| .+++|+......      ..|+.+++.+.   -|.+.+++..      ....+..+++|+|++
T Consensus        32 G~g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~  104 (339)
T 3i1a_A           32 GADTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIH  104 (339)
T ss_dssp             TSCSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCC
T ss_pred             cCccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccC
Confidence            3444689999987766 899998765431      34666666552   1224454432      234567889999999


Q ss_pred             CCCH
Q 007680          352 NGSL  355 (593)
Q Consensus       352 ~gsL  355 (593)
                      |..+
T Consensus       105 G~~~  108 (339)
T 3i1a_A          105 APNG  108 (339)
T ss_dssp             CCBT
T ss_pred             CCcC
Confidence            8755

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.34  E-value=0.026  Score=58.42  Aligned_cols=74  Identities=12%  Similarity=0.267  Sum_probs=48.8

Q ss_pred             ccccCccCcccEEEEEeCC--------CCeEEEEEeehhhHHHHHHHHHHHHHHhhcC-CCCcceeeeeeecCCceEEEE
Q 007680          277 CNLLGTSSFGSVYKGTISD--------GTDVAIKVFNLQLERAFRSFDSECEVLRNVR-HRNLIKILSSYSNPDFKALVL  347 (593)
Q Consensus       277 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  347 (593)
                      ++.+..|-...+|+....+        ++.+++|+....... .-...+|..+++.+. +.-..++++.+.    -+.||
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~  149 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADFP----EGRIE  149 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence            4577888889999998753        578999986543211 122357888888874 333445565332    27899


Q ss_pred             eccCCCCH
Q 007680          348 EFMPNGSL  355 (593)
Q Consensus       348 e~~~~gsL  355 (593)
                      ||++|.+|
T Consensus       150 efI~G~~l  157 (424)
T 3mes_A          150 EFIDGEPL  157 (424)
T ss_dssp             ECCCSEEC
T ss_pred             EEeCCccC
Confidence            99998653

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=92.59  E-value=0.071  Score=54.84  Aligned_cols=30  Identities=30%  Similarity=0.325  Sum_probs=25.2

Q ss_pred             CeEecCCCCCCeee------CCCCcEEEEeecccee
Q 007680          393 HIIHCDLKPTNILL------DENMVAHVSDFGIYKL  422 (593)
Q Consensus       393 ~ivH~Dlkp~NIll------~~~~~~kL~Dfg~a~~  422 (593)
                      .++|+|+.+.||++      +++..++++||..|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            36799999999999      4567899999998764

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=88.88  E-value=0.67  Score=42.61  Aligned_cols=117  Identities=15%  Similarity=0.206  Sum_probs=79.6

Q ss_pred             CCCCcceeeeeeecCCceEEEEeccCCC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCe
Q 007680          326 RHRNLIKILSSYSNPDFKALVLEFMPNG-SLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNI  404 (593)
Q Consensus       326 ~h~niv~l~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NI  404 (593)
                      .||+.+.. .+-.+.+...+.++.-+.+ ++.. +..    .+..++++++.+|+...++++.      -+|--+.|+|+
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik~----~~~~eKlr~l~ni~~l~~~~~~------r~tf~L~P~NL  110 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IKS----FTKNEKLRYLLNIKNLEEVNRT------RYTFVLAPDEL  110 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GGG----SCHHHHHHHHHHGGGGGGGGGS------SEECCCSGGGE
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HHh----cCHHHHHHHHHHHHHHHHHhcC------ceEEEEecceE
Confidence            58888866 4556666666666554322 2322 332    7789999999999988866663      47889999999


Q ss_pred             eeCCCCcEEEEeeccceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCcc
Q 007680          405 LLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEM  478 (593)
Q Consensus       405 ll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~  478 (593)
                      +++.++.+++.-.|+-..+                   +|.     ..+...=.-.+=+++..+++++..|+..
T Consensus       111 ~f~~~~~p~i~~RGik~~l-------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe~l  160 (215)
T 4ann_A          111 FFTRDGLPIAKTRGLQNVV-------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFDAL  160 (215)
T ss_dssp             EECTTSCEEESCCEETTTB-------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHHHH
T ss_pred             EEcCCCCEEEEEccCccCC-------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHHHH
Confidence            9999999999887753221                   121     1111122335778889999999998764

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=84.81  E-value=2  Score=39.62  Aligned_cols=115  Identities=10%  Similarity=0.078  Sum_probs=78.5

Q ss_pred             CCCCcceeeeeeecCCceEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHH-HHHhcCCCCCeEecCCCCCCe
Q 007680          326 RHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALE-YLHNGHSSVHIIHCDLKPTNI  404 (593)
Q Consensus       326 ~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~-~LH~~~~~~~ivH~Dlkp~NI  404 (593)
                      .||+.  -...-.+.+...+.++.-+++.=...+..    .+..++++++.+++.... +++.      -+|--+.|+||
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~~----~~~~eKlrll~nl~~L~~~~~~~------r~tf~l~P~NL  115 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIRK----TTLLSRIRAAIHLVSKVKHHSAR------RLIFIVCPENL  115 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHHT----SCHHHHHHHHHHHHHHHSSCCSS------SEECCCCGGGE
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHHh----cCHHHHHHHHHHHHHHHHHhhhC------ceeEEEeCceE
Confidence            57887  44455677777777776544332333433    788999999999888766 5553      67889999999


Q ss_pred             eeCCCCcEEEEeeccceecCCCCCccccccccCCccccCccccCCCCCCccchHH-HHHHHHHHHHhCCCCCCc
Q 007680          405 LLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVY-SYGVLLMETFTRKRPTDE  477 (593)
Q Consensus       405 ll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvw-SlGvvl~elltg~~pf~~  477 (593)
                      +++.++.+++.-.|+-..                   ++|.-     .+ ..|.| .+=+++..++.++..|+.
T Consensus       116 ~f~~~~~p~i~hRGi~~~-------------------lpP~e-----~~-ee~fl~qyKali~all~~K~~Fe~  164 (219)
T 4ano_A          116 MFNRALEPFFLHVGVKES-------------------LPPDE-----WD-DERLLREVKATVLALTEGEYRFDE  164 (219)
T ss_dssp             EECTTCCEEESCCEETTT-------------------BSSCS-----CC-HHHHHHHHHHHHHHHTTCSSCHHH
T ss_pred             EEeCCCcEEEEEcCCccc-------------------CCCCC-----CC-HHHHHHHHHHHHHHHHcCCCCHHH
Confidence            999999999988886322                   22221     11 22333 577888888999888765

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	593
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-61
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	5e-54
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	3e-53
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	6e-53
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	7e-53
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	3e-52
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	5e-52
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-51
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-51
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	6e-51
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	5e-50
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-49
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-49
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	4e-49
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-48
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	4e-48
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	5e-48
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	6e-48
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-47
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-47
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	7e-47
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	9e-47
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-46
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-46
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	7e-46
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-45
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-45
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	4e-45
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	4e-45
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-44
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	4e-44
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	4e-44
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-42
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-40
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	4e-40
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-39
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-39
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	5e-39
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	4e-37
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	7e-37
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	1e-36
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-36
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-35
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	3e-35
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	8e-35
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-34
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-34
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	3e-34
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-33
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	4e-33
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	6e-33
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-32
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	4e-32
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	5e-32
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	3e-31
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	3e-31
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	4e-29
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	3e-27
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-26
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-25
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	3e-25
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	8e-24
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	7e-16
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	8e-14
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	8e-16
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	4e-15
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	7e-11
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	1e-09
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	2e-10
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	2e-07
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	5e-07
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	5e-06
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	8e-09
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	2e-05
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	2e-05
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	0.001
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	3e-07
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	5e-04
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	7e-07
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	5e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	5e-05
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	7e-05
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	9e-05
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	6e-04
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	6e-04
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	0.003
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	0.002

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (517), Expect = 1e-61
 Identities = 68/285 (23%), Positives = 123/285 (43%), Gaps = 26/285 (9%)

Query: 272 DEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRN 329
            +      +G+ SFG+VYKG      DVA+K+ N+     +  ++F +E  VLR  RH N
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65

Query: 330 LIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGH 389
           ++  +  YS     A+V ++    SL   L+      ++++ ++I       ++YLH   
Sbjct: 66  ILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS 124

Query: 390 SSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEY--- 446
               IIH DLK  NI L E++   + DFG+  +      S +      +I +MAPE    
Sbjct: 125 ----IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 180

Query: 447 GLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLV 506
             +   S + DVY++G++L E  T + P   +   +  +    +  L   L++V      
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRS---- 236

Query: 507 REEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIK 551
                     +C  ++     +C  +  D R       A ++ + 
Sbjct: 237 ----------NCPKAMKRLMAECLKKKRDERPLFPQILASIELLA 271

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  183 bits (466), Expect = 5e-54
 Identities = 67/305 (21%), Positives = 121/305 (39%), Gaps = 39/305 (12%)

Query: 263 SYLDIQRATDEFNEC---------NLLGTSSFGSVYKG----TISDGTDVAIKVFNLQL- 308
           ++ D   A  EF +           ++G   FG V  G           VAIK       
Sbjct: 8   TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67

Query: 309 ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDI 368
           E+  R F SE  ++    H N+I +    +      ++ EFM NGSL+ +L  ++    +
Sbjct: 68  EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTV 127

Query: 369 LERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGED 428
           ++ + ++  + + ++YL +    ++ +H DL   NIL++ N+V  VSDFG+ + L +   
Sbjct: 128 IQLVGMLRGIAAGMKYLAD----MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183

Query: 429 SVRQTMT---MATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSL 485
               T        I + APE       ++  DV+SYG+++ E  +               
Sbjct: 184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYW-------- 235

Query: 486 RRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAA 545
                      +T     N + ++      MDC  ++    LDC  +  + R        
Sbjct: 236 ----------DMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVN 285

Query: 546 KLKKI 550
            L K+
Sbjct: 286 TLDKM 290

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (457), Expect = 3e-53
 Identities = 62/279 (22%), Positives = 103/279 (36%), Gaps = 24/279 (8%)

Query: 272 DEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLI 331
            E      +G+  FG V+ G   +   VAIK            F  E EV+  + H  L+
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLV 63

Query: 332 KILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSS 391
           ++           LV EFM +G L  +L +          L + +DV   + YL      
Sbjct: 64  QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA--- 120

Query: 392 VHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGI 451
             +IH DL   N L+ EN V  VSDFG+ + + + + +         + + +PE      
Sbjct: 121 -CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT-KFPVKWASPEVFSFSR 178

Query: 452 VSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQA 511
            S+K DV+S+GVL+ E F+  +   E       +   +          +   ++      
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKIPYENR-SNSEVVEDISTGFRLYKPRLASTHVY----- 232

Query: 512 FSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKI 550
                            C  E P+ R   +    +L +I
Sbjct: 233 ------------QIMNHCWKERPEDRPAFSRLLRQLAEI 259

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (459), Expect = 6e-53
 Identities = 58/290 (20%), Positives = 115/290 (39%), Gaps = 22/290 (7%)

Query: 280 LGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSN 339
           +G   FG V++G    G +VA+K+F+ + ER++   ++E      +RH N++  +++ + 
Sbjct: 11  IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAADNK 68

Query: 340 PDFKA----LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNG----HSS 391
            +       LV ++  +GSL  +L  + Y + +   + + +   S L +LH         
Sbjct: 69  DNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 126

Query: 392 VHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMT--MATIGYMAPEYGLE 449
             I H DLK  NIL+ +N    ++D G+        D++       + T  YMAPE   +
Sbjct: 127 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 186

Query: 450 GI------VSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKE--SLPHGLTEVV 501
            I         + D+Y+ G++  E   R          ++     V    S+      V 
Sbjct: 187 SINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVC 246

Query: 502 DANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIK 551
           +  L           + +  +     +C   +   R+        L ++ 
Sbjct: 247 EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (460), Expect = 7e-53
 Identities = 64/303 (21%), Positives = 117/303 (38%), Gaps = 34/303 (11%)

Query: 267 IQRATDEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRS-FDSECEVLRN 324
           ++   D+F + + LG  + G V+K +    G  +A K+ +L+++ A R+    E +VL  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60

Query: 325 VRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEY 384
                ++    ++ +    ++ +E M  GSL++ L      +       + I V   L Y
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTY 119

Query: 385 LHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAP 444
           L   H    I+H D+KP+NIL++      + DFG+   L +          + T  YM+P
Sbjct: 120 LREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSP 172

Query: 445 EYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSL----------RRWVKESLP 494
           E       S + D++S G+ L+E    + P       E+ L                   
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232

Query: 495 HGLTEVVDANLVREEQAFSAKMDCILS--------------IMDFALDCCMESPDMRINM 540
            G          R   A    +D I++                DF   C +++P  R ++
Sbjct: 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADL 292

Query: 541 TDA 543
              
Sbjct: 293 KQL 295

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (452), Expect = 3e-52
 Identities = 60/280 (21%), Positives = 118/280 (42%), Gaps = 26/280 (9%)

Query: 272 DEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLI 331
           +       LG   FG V+ G  +  T VA+K        +  +F +E  +++ ++H+ L+
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLV 71

Query: 332 KILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYF-LDILERLNIMIDVGSALEYLHNGHS 390
           ++ +  +      ++ E+M NGSL  +L + +   L I + L++   +   + ++     
Sbjct: 72  RLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---- 126

Query: 391 SVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEG 450
             + IH DL+  NIL+ + +   ++DFG+ +L+ + E + R       I + APE    G
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR-EGAKFPIKWTAPEAINYG 185

Query: 451 IVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQ 510
             + K DV+S+G+LL E  T  R           ++   +              +VR + 
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER-----------GYRMVRPD- 233

Query: 511 AFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKI 550
                 +C   +      C  E P+ R       + L+  
Sbjct: 234 ------NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (449), Expect = 5e-52
 Identities = 75/282 (26%), Positives = 116/282 (41%), Gaps = 32/282 (11%)

Query: 272 DEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLI 331
            E      +G   FG V  G    G  VA+K   ++ +   ++F +E  V+  +RH NL+
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLV 63

Query: 332 KIL-SSYSNPDFKALVLEFMPNGSLEKWLYSHNY-FLDILERLNIMIDVGSALEYLHNGH 389
           ++L           +V E+M  GSL  +L S     L     L   +DV  A+EYL    
Sbjct: 64  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--- 120

Query: 390 SSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLE 449
              + +H DL   N+L+ E+ VA VSDFG+ K       S  Q      + + APE   E
Sbjct: 121 -GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA-----SSTQDTGKLPVKWTAPEALRE 174

Query: 450 GIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREE 509
              S K DV+S+G+LL E ++  R         + L+  V                V + 
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRV----PYPRIPLKDVVP--------------RVEKG 216

Query: 510 QAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIK 551
               A   C  ++ +   +C      MR +      +L+ IK
Sbjct: 217 YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (448), Expect = 1e-51
 Identities = 60/294 (20%), Positives = 112/294 (38%), Gaps = 33/294 (11%)

Query: 280 LGTSSFGSVYKGTI---SDGTDVAIKVFNLQLERAFR-SFDSECEVLRNVRHRNLIKILS 335
           LG  +FGSV +G         DVAIKV     E+A       E +++  + +  +++++ 
Sbjct: 17  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76

Query: 336 SYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHII 395
                    LV+E    G L K+L      + +     ++  V   ++YL       + +
Sbjct: 77  VCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE----KNFV 131

Query: 396 HCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMA-TIGYMAPEYGLEGIVSA 454
           H DL   N+LL     A +SDFG+ K LG  +            + + APE       S+
Sbjct: 132 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 191

Query: 455 KCDVYSYGVLLMETFTR-KRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQAFS 513
           + DV+SYGV + E  +  ++P  +M   E+                      + + +   
Sbjct: 192 RSDVWSYGVTMWEALSYGQKPYKKMKGPEV-------------------MAFIEQGKRME 232

Query: 514 AKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKFLDDAAATNWRNFH 567
              +C   +     DC +   + R +      +++     +   A+     + H
Sbjct: 233 CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC---YYSLASKVEGHHHH 283

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (445), Expect = 2e-51
 Identities = 59/279 (21%), Positives = 106/279 (37%), Gaps = 24/279 (8%)

Query: 272 DEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLI 331
            +      LGT  FG V  G      DVAIK+       +   F  E +V+ N+ H  L+
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLV 62

Query: 332 KILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSS 391
           ++    +      ++ E+M NG L  +L    +     + L +  DV  A+EYL +    
Sbjct: 63  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK--- 119

Query: 392 VHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGI 451
              +H DL   N L+++  V  VSDFG+ + + + E +     +   + +  PE  +   
Sbjct: 120 -QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLMYSK 177

Query: 452 VSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQA 511
            S+K D++++GVL+ E ++  +   E                    T    A  + +   
Sbjct: 178 FSSKSDIWAFGVLMWEIYSLGKMPYE------------------RFTNSETAEHIAQGLR 219

Query: 512 FSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKI 550
                     +      C  E  D R       + +  +
Sbjct: 220 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (444), Expect = 6e-51
 Identities = 72/280 (25%), Positives = 120/280 (42%), Gaps = 26/280 (9%)

Query: 272 DEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLI 331
           +       LG   FG V+ GT +  T VAIK        +  +F  E +V++ +RH  L+
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLV 75

Query: 332 KILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDIL-ERLNIMIDVGSALEYLHNGHS 390
           ++ +  S      +V E+M  GSL  +L         L + +++   + S + Y+     
Sbjct: 76  QLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER--- 131

Query: 391 SVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEG 450
            ++ +H DL+  NIL+ EN+V  V+DFG+ +L+ + E + RQ      I + APE  L G
Sbjct: 132 -MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA-KFPIKWTAPEAALYG 189

Query: 451 IVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQ 510
             + K DV+S+G+LL E  T+ R                      G+      + V    
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGRVPYP------------------GMVNREVLDQVERGY 231

Query: 511 AFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKI 550
                 +C  S+ D    C  + P+ R       A L+  
Sbjct: 232 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (436), Expect = 5e-50
 Identities = 66/286 (23%), Positives = 121/286 (42%), Gaps = 29/286 (10%)

Query: 272 DEFNECNLLGTSSFGSVYKGTISDGTD-----VAIKVFNLQL-ERAFRSFDSECEVLRNV 325
                  ++G   FG VYKG +   +      VAIK       E+    F  E  ++   
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66

Query: 326 RHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYL 385
            H N+I++    S      ++ E+M NG+L+K+L   +    +L+ + ++  + + ++YL
Sbjct: 67  SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 126

Query: 386 HNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMA-TIGYMAP 444
            N    ++ +H DL   NIL++ N+V  VSDFG+ ++L +  ++   T      I + AP
Sbjct: 127 AN----MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 182

Query: 445 EYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDAN 504
           E       ++  DV+S+G+++ E  T           E+S    +K              
Sbjct: 183 EAISYRKFTSASDVWSFGIVMWEVMTYGER----PYWELSNHEVMK-------------- 224

Query: 505 LVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKI 550
            + +       MDC  +I    + C  +    R    D  + L K+
Sbjct: 225 AINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  171 bits (434), Expect = 2e-49
 Identities = 61/318 (19%), Positives = 115/318 (36%), Gaps = 52/318 (16%)

Query: 263 SYLDIQRATDEFNECNLLGTSSFGSVYKGT------ISDGTDVAIKVFNLQLERAFRS-F 315
             L ++   +       +G  +FG V++            T VA+K+   +     ++ F
Sbjct: 4   KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63

Query: 316 DSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYF---------- 365
             E  ++    + N++K+L   +      L+ E+M  G L ++L S +            
Sbjct: 64  QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123

Query: 366 -------------LDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVA 412
                        L   E+L I   V + + YL         +H DL   N L+ ENMV 
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS----ERKFVHRDLATRNCLVGENMVV 179

Query: 413 HVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRK 472
            ++DFG+ + +   +           I +M PE       + + DV++YGV+L E F+  
Sbjct: 180 KIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 239

Query: 473 RPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCME 532
                                 +G+        VR+    +   +C L + +    C  +
Sbjct: 240 LQPY------------------YGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSK 281

Query: 533 SPDMRINMTDAAAKLKKI 550
            P  R +       L+++
Sbjct: 282 LPADRPSFCSIHRILQRM 299

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (435), Expect = 2e-49
 Identities = 60/308 (19%), Positives = 125/308 (40%), Gaps = 30/308 (9%)

Query: 258 IWRRTSYLDIQRATDEFNECNLLGTSSFGSVYKGTISD----GTDVAIKVFNLQLERAFR 313
           + +   ++ I  ++   +   ++G   FG VY GT+ D        A+K  N   +    
Sbjct: 13  LVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV 72

Query: 314 S-FDSECEVLRNVRHRNLIKILSSYSNPDFKA-LVLEFMPNGSLEKWLYSHNYFLDILER 371
           S F +E  ++++  H N++ +L      +    +VL +M +G L  ++ +  +   + + 
Sbjct: 73  SQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL 132

Query: 372 LNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVR 431
           +   + V   +++L +       +H DL   N +LDE     V+DFG+ + + + E    
Sbjct: 133 IGFGLQVAKGMKFLASKK----FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 188

Query: 432 QTMT--MATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWV 489
              T     + +MA E       + K DV+S+GVLL E  TR  P       +++     
Sbjct: 189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP----PYPDVNTFDIT 244

Query: 490 KESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKK 549
                           + + +       C   + +  L C     +MR + ++  +++  
Sbjct: 245 VY--------------LLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 290

Query: 550 IKVKFLDD 557
           I   F+ +
Sbjct: 291 IFSTFIGE 298

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (430), Expect = 4e-49
 Identities = 58/281 (20%), Positives = 101/281 (35%), Gaps = 30/281 (10%)

Query: 272 DEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHR 328
           +++     +GT S+G   K    SDG  +  K  +     E   +   SE  +LR ++H 
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63

Query: 329 NLIKILSSYSNPDFKAL--VLEFMPNGSLEKWLYSH---NYFLDILERLNIMIDVGSALE 383
           N+++      +     L  V+E+   G L   +        +LD    L +M  +  AL+
Sbjct: 64  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123

Query: 384 YLHN-GHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYM 442
             H        ++H DLKP N+ LD      + DFG+ ++L    D+      + T  YM
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH--DTSFAKAFVGTPYYM 181

Query: 443 APEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVD 502
           +PE       + K D++S G LL E      P       +  L   ++E     +     
Sbjct: 182 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF--SQKELAGKIREGKFRRIPYRYS 239

Query: 503 ANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDA 543
             L                  +            R ++ + 
Sbjct: 240 DELN-----------------EIITRMLNLKDYHRPSVEEI 263

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  169 bits (428), Expect = 2e-48
 Identities = 66/280 (23%), Positives = 100/280 (35%), Gaps = 36/280 (12%)

Query: 271 TDEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNL---QLERAFRSFDSECEVLRNVR 326
              F++   +G  SFG+VY    + +   VAIK  +    Q    ++    E   L+ +R
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73

Query: 327 HRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH 386
           H N I+    Y       LV+E+    + +     H   L  +E   +       L YLH
Sbjct: 74  HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYLH 132

Query: 387 NGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEY 446
               S ++IH D+K  NILL E  +  + DFG   ++            + T  +MAPE 
Sbjct: 133 ----SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NSFVGTPYWMAPEV 182

Query: 447 GL---EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDA 503
            L   EG    K DV+S G+  +E   RK P   M      L    +   P   +     
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIAQNESPALQSGHWSE 241

Query: 504 NLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDA 543
                               +F   C  + P  R      
Sbjct: 242 YFR-----------------NFVDSCLQKIPQDRPTSEVL 264

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  167 bits (424), Expect = 4e-48
 Identities = 63/281 (22%), Positives = 108/281 (38%), Gaps = 26/281 (9%)

Query: 272 DEFNECNLLGTSSFGSVYKGTISD-GTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNL 330
            +    + LG   +G VY+G        VA+K            F  E  V++ ++H NL
Sbjct: 17  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNL 75

Query: 331 IKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYF-LDILERLNIMIDVGSALEYLHNGH 389
           +++L   +      ++ EFM  G+L  +L   N   +  +  L +   + SA+EYL    
Sbjct: 76  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--- 132

Query: 390 SSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLE 449
              + IH DL   N L+ EN +  V+DFG+ +L+  G+           I + APE    
Sbjct: 133 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAY 190

Query: 450 GIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREE 509
              S K DV+++GVLL E  T                         G+       L+ ++
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGMSPYP------------------GIDLSQVYELLEKD 232

Query: 510 QAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKI 550
                   C   + +    C   +P  R +  +     + +
Sbjct: 233 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (426), Expect = 5e-48
 Identities = 67/293 (22%), Positives = 120/293 (40%), Gaps = 30/293 (10%)

Query: 265 LDIQRATDEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQL-----ERAFRSFDSE 318
           L I + T+ F +  +LG+ +FG+VYKG  I +G  V I V   +L      +A +    E
Sbjct: 3   LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 61

Query: 319 CEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDV 378
             V+ +V + ++ ++L        + L+ + MP G L  ++  H   +     LN  + +
Sbjct: 62  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 120

Query: 379 GSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMAT 438
              + YL +      ++H DL   N+L+       ++DFG+ KLLG  E           
Sbjct: 121 AKGMNYLEDRR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 176

Query: 439 IGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLT 498
           I +MA E  L  I + + DV+SYGV + E  T                         G+ 
Sbjct: 177 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK------------------PYDGIP 218

Query: 499 EVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIK 551
               ++++ + +       C + +    + C M   D R    +   +  K+ 
Sbjct: 219 ASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (423), Expect = 6e-48
 Identities = 64/289 (22%), Positives = 108/289 (37%), Gaps = 32/289 (11%)

Query: 264 YLDIQR---ATDEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRSFDSEC 319
           Y  + R     D +     LG  +FG VYK          A KV + + E     +  E 
Sbjct: 1   YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI 60

Query: 320 EVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVG 379
           ++L +  H N++K+L ++   +   +++EF   G+++  +      L   +   +     
Sbjct: 61  DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTL 120

Query: 380 SALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATI 439
            AL YLH       IIH DLK  NIL   +    ++DFG+           R+   + T 
Sbjct: 121 DALNYLH----DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--RRDSFIGTP 174

Query: 440 GYMAPEY-----GLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLP 494
            +MAPE        +     K DV+S G+ L+E    + P  E+    + L +  K   P
Sbjct: 175 YWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV-LLKIAKSEPP 233

Query: 495 HGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDA 543
                             +       +  DF   C  ++ D R   +  
Sbjct: 234 T----------------LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQL 266

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (422), Expect = 1e-47
 Identities = 58/304 (19%), Positives = 104/304 (34%), Gaps = 46/304 (15%)

Query: 272 DEFNECNLLGTSSFGSVYKGTI------SDGTDVAIKVFNLQLERAFR-SFDSECEVLRN 324
           +  +    LG  +FG V + T            VA+K+         R +  SE +VL  
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 325 V-RHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSH-----------------NYFL 366
           +  H N++ +L + +      ++ E+   G L  +L                       L
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 367 DILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG 426
           D+ + L+    V   + +L     S + IH DL   NILL    +  + DFG+ + +   
Sbjct: 143 DLEDLLSFSYQVAKGMAFLA----SKNCIHRDLAARNILLTHGRITKICDFGLARDIKND 198

Query: 427 EDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLR 486
            + V +      + +MAPE     + + + DV+SYG+ L E F+           +    
Sbjct: 199 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258

Query: 487 RWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK 546
           + +KE                      +       + D    C    P  R         
Sbjct: 259 KMIKEGFR-----------------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301

Query: 547 LKKI 550
           ++K 
Sbjct: 302 IEKQ 305

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (418), Expect = 2e-47
 Identities = 61/293 (20%), Positives = 113/293 (38%), Gaps = 33/293 (11%)

Query: 264 YLDIQRATDEFNECNLLGTSSFGSVYKGTISD---GTDVAIKVFNLQL--ERAFRSFDSE 318
           YLD +  T E  E   LG+ +FG+V KG          VA+K+   +           +E
Sbjct: 2   YLDRKLLTLEDKE---LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAE 58

Query: 319 CEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDV 378
             V++ + +  +++++       +  LV+E    G L K+L  + + +     + ++  V
Sbjct: 59  ANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQV 116

Query: 379 GSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMA- 437
              ++YL   +     +H DL   N+LL     A +SDFG+ K L   E+  +       
Sbjct: 117 SMGMKYLEESN----FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 172

Query: 438 TIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGL 497
            + + APE       S+K DV+S+GVL+ E F+  +                      G+
Sbjct: 173 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK------------------PYRGM 214

Query: 498 TEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKI 550
                  ++ + +       C   + D    C     + R        +L+  
Sbjct: 215 KGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (418), Expect = 7e-47
 Identities = 57/307 (18%), Positives = 105/307 (34%), Gaps = 51/307 (16%)

Query: 272 DEFNECNLLGTSSFGSVYKGT------ISDGTDVAIKVFNLQLERAFR-SFDSECEVLRN 324
           +      +LG+ +FG V   T            VA+K+   + + + R +  SE +++  
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96

Query: 325 V-RHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHN-------------------- 363
           +  H N++ +L + +      L+ E+   G L  +L S                      
Sbjct: 97  LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156

Query: 364 --YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYK 421
               L   + L     V   +E+L         +H DL   N+L+    V  + DFG+ +
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLE----FKSCVHRDLAARNVLVTHGKVVKICDFGLAR 212

Query: 422 LLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIG 481
            +    + V +      + +MAPE   EGI + K DV+SYG+LL E F+           
Sbjct: 213 DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272

Query: 482 EMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMT 541
           + +  + ++                               I      C       R +  
Sbjct: 273 DANFYKLIQNGFK-----------------MDQPFYATEEIYIIMQSCWAFDSRKRPSFP 315

Query: 542 DAAAKLK 548
           +  + L 
Sbjct: 316 NLTSFLG 322

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (413), Expect = 9e-47
 Identities = 65/288 (22%), Positives = 101/288 (35%), Gaps = 30/288 (10%)

Query: 272 DEFNECNLLGTSSFGSVYKGTI----SDGTDVAIKVFNLQL---ERAFRSFDSECEVLRN 324
            +      LG  SFG V +G           VA+K     +     A   F  E   + +
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 325 VRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEY 384
           + HRNLI++      P  K +V E  P GSL   L  H     +       + V   + Y
Sbjct: 68  LDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 126

Query: 385 LHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDS-VRQTMTMATIGYMA 443
           L     S   IH DL   N+LL    +  + DFG+ + L + +D  V Q        + A
Sbjct: 127 LE----SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182

Query: 444 PEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDA 503
           PE       S   D + +GV L E FT  +         ++  + +              
Sbjct: 183 PESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI----GLNGSQILH------------- 225

Query: 504 NLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIK 551
            + +E +      DC   I +  + C    P+ R         L + +
Sbjct: 226 KIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (416), Expect = 1e-46
 Identities = 70/299 (23%), Positives = 115/299 (38%), Gaps = 45/299 (15%)

Query: 272 DEFNECNLLGTSSFGSVYKGTISDG---TDVAIKVFNLQLER-AFRSFDSECEVLRNV-R 326
           ++    +++G  +FG V K  I       D AIK       +   R F  E EVL  +  
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 327 HRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYF---------------LDILER 371
           H N+I +L +  +  +  L +E+ P+G+L  +L                     L   + 
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 372 LNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVR 431
           L+   DV   ++YL         IH DL   NIL+ EN VA ++DFG+ +     E  V+
Sbjct: 130 LHFAADVARGMDYLS----QKQFIHRDLAARNILVGENYVAKIADFGLSRG---QEVYVK 182

Query: 432 QTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKE 491
           +TM    + +MA E     + +   DV+SYGVLL E  +            M+     + 
Sbjct: 183 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT----PYCGMTCAELYE- 237

Query: 492 SLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKI 550
                         + +       ++C   + D    C  E P  R +       L ++
Sbjct: 238 -------------KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 283

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (412), Expect = 1e-46
 Identities = 52/275 (18%), Positives = 100/275 (36%), Gaps = 25/275 (9%)

Query: 272 DEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNL-QLERAFRSFDSECEVLRNVRHRN 329
           ++++    LG  ++G V           VA+K+ ++ +      +   E  + + + H N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 330 LIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGH 389
           ++K        + + L LE+   G L   +          +       + + + YLH   
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGM-PEPDAQRFFHQLMAGVVYLH--- 120

Query: 390 SSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGL- 448
             + I H D+KP N+LLDE     +SDFG+  +               T+ Y+APE    
Sbjct: 121 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 179

Query: 449 EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVRE 508
               +   DV+S G++L      + P D+          W ++       + +D+  +  
Sbjct: 180 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL-- 237

Query: 509 EQAFSAKMDCILSIMDFALDCCMESPDMRINMTDA 543
                                 +E+P  RI + D 
Sbjct: 238 ---------------ALLHKILVENPSARITIPDI 257

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (407), Expect = 7e-46
 Identities = 60/272 (22%), Positives = 103/272 (37%), Gaps = 33/272 (12%)

Query: 280 LGTSSFGSVYKGT-ISDGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSS 336
           +G  SF +VYKG       +VA      +   +   + F  E E+L+ ++H N+++   S
Sbjct: 17  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76

Query: 337 Y----SNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSV 392
           +           LV E M +G+L+ +L      + I    +    +   L++LH    + 
Sbjct: 77  WESTVKGKKCIVLVTELMTSGTLKTYLKRFKV-MKIKVLRSWCRQILKGLQFLH--TRTP 133

Query: 393 HIIHCDLKPTNILL-DENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGI 451
            IIH DLK  NI +        + D G+  L      +      + T  +MAPE   E  
Sbjct: 134 PIIHRDLKCDNIFITGPTGSVKIGDLGLATLK----RASFAKAVIGTPEFMAPEM-YEEK 188

Query: 452 VSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQA 511
                DVY++G+ ++E  T + P  E        RR      P    +V    +      
Sbjct: 189 YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVK----- 243

Query: 512 FSAKMDCILSIMDFALDCCMESPDMRINMTDA 543
                       +    C  ++ D R ++ D 
Sbjct: 244 ------------EIIEGCIRQNKDERYSIKDL 263

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (405), Expect = 1e-45
 Identities = 65/277 (23%), Positives = 108/277 (38%), Gaps = 35/277 (12%)

Query: 272 DEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFN---LQLERAFRSFDSECEVLRNVRH 327
           ++F     LG   FG+VY          +A+KV     L+          E E+  ++RH
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
            N++++   + +     L+LE+ P G++ + L   + F D       + ++ +AL Y H 
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALSYCH- 123

Query: 388 GHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYG 447
              S  +IH D+KP N+LL       ++DFG          S R+T    T+ Y+ PE  
Sbjct: 124 ---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHA----PSSRRTTLCGTLDYLPPEMI 176

Query: 448 LEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLR-RWVKESLPHGLTEVVDANLV 506
              +   K D++S GVL  E    K P +     E   R   V+ + P  +TE       
Sbjct: 177 EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE------- 229

Query: 507 REEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDA 543
                            D        +P  R  + + 
Sbjct: 230 --------------GARDLISRLLKHNPSQRPMLREV 252

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (405), Expect = 2e-45
 Identities = 63/304 (20%), Positives = 113/304 (37%), Gaps = 32/304 (10%)

Query: 268 QRATDEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQL---ERAFRSFDSECEVLR 323
           ++  ++F    +LG  SF +V     ++   + AIK+   +    E        E +V+ 
Sbjct: 4   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63

Query: 324 NVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALE 383
            + H   +K+  ++ + +     L +  NG L K++     F D         ++ SALE
Sbjct: 64  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF-DETCTRFYTAEIVSALE 122

Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           YLH       IIH DLKP NILL+E+M   ++DFG  K+L       R    + T  Y++
Sbjct: 123 YLH----GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 178

Query: 444 PEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDA 503
           PE   E       D+++ G ++ +      P             +   +      +++  
Sbjct: 179 PELLTEKSACKSSDLWALGCIIYQLVAGLPP-------------FRAGNEYLIFQKIIKL 225

Query: 504 NLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKFLDDAAATNW 563
                E+ F    D +           +     R+   +           F +      W
Sbjct: 226 EYDFPEKFFPKARDLVEK-------LLVLDATKRLGCEEMEGYGPLKAHPFFES---VTW 275

Query: 564 RNFH 567
            N H
Sbjct: 276 ENLH 279

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (404), Expect = 4e-45
 Identities = 58/274 (21%), Positives = 107/274 (39%), Gaps = 26/274 (9%)

Query: 271 TDEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRN 329
             ++     +G  + G+VY    ++ G +VAI+  NLQ +       +E  V+R  ++ N
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 330 LIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGH 389
           ++  L SY   D   +V+E++  GSL   +          +   +  +   ALE+LH   
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG--QIAAVCRECLQALEFLH--- 133

Query: 390 SSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLE 449
            S  +IH D+K  NILL  +    ++DFG    +   +   +++  + T  +MAPE    
Sbjct: 134 -SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTR 190

Query: 450 GIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREE 509
                K D++S G++ +E    + P    ++ E  L               +        
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEPP----YLNENPL-------------RALYLIATNGT 233

Query: 510 QAFSAKMDCILSIMDFALDCCMESPDMRINMTDA 543
                         DF   C     + R +  + 
Sbjct: 234 PELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKEL 267

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  161 bits (407), Expect = 4e-45
 Identities = 60/275 (21%), Positives = 107/275 (38%), Gaps = 26/275 (9%)

Query: 272 DEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNL 330
           D ++    LGT +FG V++ T  + G + A K      E    +   E + +  +RH  L
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85

Query: 331 IKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHS 390
           + +  ++ + +   ++ EFM  G L + +   +  +   E +  M  V   L ++H    
Sbjct: 86  VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---- 141

Query: 391 SVHIIHCDLKPTNILL--DENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGL 448
             + +H DLKP NI+     +    + DFG+   L   +      +T  T  + APE   
Sbjct: 142 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAE 198

Query: 449 EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVRE 508
              V    D++S GVL     +   P             +  E+    L  V   +   +
Sbjct: 199 GKPVGYYTDMWSVGVLSYILLSGLSP-------------FGGENDDETLRNVKSCDWNMD 245

Query: 509 EQAFSAKMDCILSIMDFALDCCMESPDMRINMTDA 543
           + AFS          DF     +  P+ R+ +  A
Sbjct: 246 DSAFS---GISEDGKDFIRKLLLADPNTRMTIHQA 277

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  159 bits (404), Expect = 1e-44
 Identities = 63/275 (22%), Positives = 108/275 (39%), Gaps = 26/275 (9%)

Query: 272 DEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNL 330
           D ++    LG+ +FG V++    + G     K  N        +  +E  ++  + H  L
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88

Query: 331 IKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHS 390
           I +  ++ +     L+LEF+  G L   + + +Y +   E +N M      L+++H    
Sbjct: 89  INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---- 144

Query: 391 SVHIIHCDLKPTNILLDENMVAHV--SDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGL 448
              I+H D+KP NI+ +    + V   DFG+   L   E      +T AT  + APE   
Sbjct: 145 EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAPEIVD 201

Query: 449 EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVRE 508
              V    D+++ GVL     +   P             +  E     L  V   +   +
Sbjct: 202 REPVGFYTDMWAIGVLGYVLLSGLSP-------------FAGEDDLETLQNVKRCDWEFD 248

Query: 509 EQAFSAKMDCILSIMDFALDCCMESPDMRINMTDA 543
           E AFS          DF  +   + P  R+ + DA
Sbjct: 249 EDAFS---SVSPEAKDFIKNLLQKEPRKRLTVHDA 280

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (395), Expect = 4e-44
 Identities = 58/289 (20%), Positives = 104/289 (35%), Gaps = 31/289 (10%)

Query: 267 IQRATDEFNECNLLGTSSFGSVYKG----TISDGTDVAIKVFNLQLERAFRS-FDSECEV 321
           IQR  +       +G   FG V++G      +    VAIK        + R  F  E   
Sbjct: 4   IQR--ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALT 61

Query: 322 LRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSA 381
           +R   H +++K++   +  +   +++E    G L  +L    Y LD+   +     + +A
Sbjct: 62  MRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 120

Query: 382 LEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGY 441
           L YL     S   +H D+   N+L+  N    + DFG+ + + E     + +     I +
Sbjct: 121 LAYLE----SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKW 175

Query: 442 MAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVV 501
           MAPE       ++  DV+ +GV + E                            G+    
Sbjct: 176 MAPESINFRRFTSASDVWMFGVCMWEILMHGVK------------------PFQGVKNND 217

Query: 502 DANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKI 550
               +   +      +C  ++      C    P  R   T+  A+L  I
Sbjct: 218 VIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (397), Expect = 4e-44
 Identities = 59/296 (19%), Positives = 116/296 (39%), Gaps = 38/296 (12%)

Query: 272 DEFNECNLLGTSSFGSVYKGT------ISDGTDVAIKVFNL-QLERAFRSFDSECEVLRN 324
           ++      LG  SFG VY+G           T VAIK  N     R    F +E  V++ 
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 325 VRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYF---------LDILERLNIM 375
               +++++L   S      +++E M  G L+ +L S               + + + + 
Sbjct: 80  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139

Query: 376 IDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMT 435
            ++   + YL+    +   +H DL   N ++ E+    + DFG+ + + E +   +    
Sbjct: 140 GEIADGMAYLN----ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKG 195

Query: 436 MATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPH 495
           +  + +M+PE   +G+ +   DV+S+GV+L E  T      +    E  LR  ++  L  
Sbjct: 196 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL- 254

Query: 496 GLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIK 551
                                +C   + +    C   +P MR +  +  + +K+  
Sbjct: 255 -----------------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 2e-42
 Identities = 65/304 (21%), Positives = 115/304 (37%), Gaps = 47/304 (15%)

Query: 272 DEFNECNLLGTSSFGSVYKGT--------ISDGTDVAIKVFNLQL-ERAFRSFDSECEVL 322
           D       LG  +FG V             +  T VA+K+      E+      SE E++
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 323 RNV-RHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYF---------------L 366
           + + +H+N+I +L + +      +++E+   G+L ++L +                   L
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 367 DILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG 426
              + ++    V   +EYL     S   IH DL   N+L+ E+ V  ++DFG+ + +   
Sbjct: 133 SSKDLVSCAYQVARGMEYLA----SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 188

Query: 427 EDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLR 486
           +   + T     + +MAPE   + I + + DV+S+GVLL E FT                
Sbjct: 189 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP--------- 239

Query: 487 RWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK 546
                    G+       L++E        +C   +     DC    P  R         
Sbjct: 240 ---------GVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290

Query: 547 LKKI 550
           L +I
Sbjct: 291 LDRI 294

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (372), Expect = 1e-40
 Identities = 66/303 (21%), Positives = 108/303 (35%), Gaps = 45/303 (14%)

Query: 272 DEFNECNLLGTSSFGSVYKGT------ISDGTDVAIKVFNL-QLERAFRSFDSECEVLRN 324
           D       LG  +FG V +         +    VA+K+          R+  SE ++L +
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 325 VRHRNLIKIL--SSYSNPDFKALVLEFMPNGSLEKWLYSHNY---------------FLD 367
           + H   +  L  +         +++EF   G+L  +L S                  FL 
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 368 ILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGE 427
           +   +     V   +E+L     S   IH DL   NILL E  V  + DFG+ + + +  
Sbjct: 133 LEHLICYSFQVAKGMEFLA----SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 188

Query: 428 DSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRR 487
           D VR+      + +MAPE   + + + + DV+S+GVLL E F+           +    R
Sbjct: 189 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 248

Query: 488 WVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKL 547
            +KE                      A       +    LDC    P  R   ++    L
Sbjct: 249 RLKEGTR-----------------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 291

Query: 548 KKI 550
             +
Sbjct: 292 GNL 294

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  145 bits (366), Expect = 4e-40
 Identities = 61/290 (21%), Positives = 114/290 (39%), Gaps = 31/290 (10%)

Query: 271 TDEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQL---ERAFRSFDSECEVLRNVR 326
           +D +    +LG      V+    +    DVA+KV    L      +  F  E +    + 
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 327 HRNLIKILSSYSNPDFKA----LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSAL 382
           H  ++ +  +            +V+E++   +L   +++    +     + ++ D   AL
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQAL 124

Query: 383 EYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMA-TIGY 441
            + H       IIH D+KP NI++       V DFGI + + +  +SV QT  +  T  Y
Sbjct: 125 NFSH----QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 180

Query: 442 MAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVV 501
           ++PE      V A+ DVYS G +L E  T + P        ++ +   ++ +P       
Sbjct: 181 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP------- 233

Query: 502 DANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRI-NMTDAAAKLKKI 550
                   +  SA +D         L    ++P+ R     +  A L ++
Sbjct: 234 ---PSARHEGLSADLD------AVVLKALAKNPENRYQTAAEMRADLVRV 274

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (367), Expect = 1e-39
 Identities = 55/275 (20%), Positives = 114/275 (41%), Gaps = 27/275 (9%)

Query: 272 DEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNL 330
           +++     LG   FG V++    S       K   ++          E  +L   RHRN+
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL-VKKEISILNIARHRNI 63

Query: 331 IKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHS 390
           + +  S+ + +   ++ EF+    + + + +  + L+  E ++ +  V  AL++LH    
Sbjct: 64  LHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---- 119

Query: 391 SVHIIHCDLKPTNILLDENMVAHV--SDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGL 448
           S +I H D++P NI+      + +   +FG  + L  G+      +      Y APE   
Sbjct: 120 SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQ 176

Query: 449 EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVRE 508
             +VS   D++S G L+    +   P             ++ E+    +  +++A    +
Sbjct: 177 HDVVSTATDMWSLGTLVYVLLSGINP-------------FLAETNQQIIENIMNAEYTFD 223

Query: 509 EQAFSAKMDCILSIMDFALDCCMESPDMRINMTDA 543
           E+AF    +  +  MDF     ++    R+  ++A
Sbjct: 224 EEAFK---EISIEAMDFVDRLLVKERKSRMTASEA 255

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  145 bits (367), Expect = 2e-39
 Identities = 54/253 (21%), Positives = 105/253 (41%), Gaps = 25/253 (9%)

Query: 272 DEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNL------QLERAFRSFDSECEVLRN 324
           ++F+   ++G   FG VY       G   A+K  +       Q E    +      ++  
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 325 VRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEY 384
                ++ +  ++  PD  + +L+ M  G L   L  H  F +  +      ++   LE+
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSE-ADMRFYAAEIILGLEH 122

Query: 385 LHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAP 444
           +H    +  +++ DLKP NILLDE+    +SD G+     +     +   ++ T GYMAP
Sbjct: 123 MH----NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KPHASVGTHGYMAP 174

Query: 445 EYGLEGI-VSAKCDVYSYGVLLMETFTRKRPTD--------EMFIGEMSLRRWVKESLPH 495
           E   +G+   +  D +S G +L +      P          E+    +++   + +S   
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSP 234

Query: 496 GLTEVVDANLVRE 508
            L  +++  L R+
Sbjct: 235 ELRSLLEGLLQRD 247

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  143 bits (361), Expect = 5e-39
 Identities = 63/287 (21%), Positives = 109/287 (37%), Gaps = 28/287 (9%)

Query: 259 WRRTSYLDIQRATDEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQ-LERAFRSFD 316
           W++    DI+   D ++  ++LGT +F  V           VAIK    + LE    S +
Sbjct: 1   WKQAE--DIR---DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSME 55

Query: 317 SECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMI 376
           +E  VL  ++H N++ +   Y +     L+++ +  G L   +     F    +   ++ 
Sbjct: 56  NEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG-FYTERDASRLIF 114

Query: 377 DVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTM 436
            V  A++YLH+    VH            LDE+    +SDFG+ K+   G      +   
Sbjct: 115 QVLDAVKYLHD-LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTAC 170

Query: 437 ATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHG 496
            T GY+APE   +   S   D +S GV+         P             +  E+    
Sbjct: 171 GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP-------------FYDENDAKL 217

Query: 497 LTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDA 543
             +++ A    +   +    D   S  DF      + P+ R     A
Sbjct: 218 FEQILKAEYEFDSPYWD---DISDSAKDFIRHLMEKDPEKRFTCEQA 261

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  138 bits (348), Expect = 4e-37
 Identities = 54/207 (26%), Positives = 89/207 (42%), Gaps = 14/207 (6%)

Query: 272 DEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQL---ERAFRSFDSECEVLRNVRH 327
            +F     LGT SFG V+      +G   A+KV   ++    +     + E  +L  V H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
             +I++  ++ +     ++++++  G L       +             +V  ALEYLH 
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSL-LRKSQRFPNPVAKFYAAEVCLALEYLH- 121

Query: 388 GHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYG 447
              S  II+ DLKP NILLD+N    ++DFG  K + +            T  Y+APE  
Sbjct: 122 ---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYTLCGTPDYIAPEVV 173

Query: 448 LEGIVSAKCDVYSYGVLLMETFTRKRP 474
                +   D +S+G+L+ E      P
Sbjct: 174 STKPYNKSIDWWSFGILIYEMLAGYTP 200

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (346), Expect = 7e-37
 Identities = 62/258 (24%), Positives = 105/258 (40%), Gaps = 18/258 (6%)

Query: 272 DEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFN---LQLERAFRSFDSECEVL-RNVR 326
           ++F    +LG  SFG V+           AIK      + ++        E  VL     
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 327 HRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH 386
           H  L  +  ++   +    V+E++  G L   + S + F D+        ++   L++LH
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKF-DLSRATFYAAEIILGLQFLH 120

Query: 387 NGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEY 446
               S  I++ DLK  NILLD++    ++DFG+ K    G+   +      T  Y+APE 
Sbjct: 121 ----SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA--KTNTFCGTPDYIAPEI 174

Query: 447 GLEGIVSAKCDVYSYGVLLMETFTRKRP-----TDEMFIGEMSLRRWVKESLPHGLTEVV 501
            L    +   D +S+GVLL E    + P      +E+F        +    L     +++
Sbjct: 175 LLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLL 234

Query: 502 DANLVRE-EQAFSAKMDC 518
               VRE E+    + D 
Sbjct: 235 VKLFVREPEKRLGVRGDI 252

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (343), Expect = 1e-36
 Identities = 65/296 (21%), Positives = 113/296 (38%), Gaps = 26/296 (8%)

Query: 267 IQRATDEFNECNLLGTSSFGSVYKGT--ISDGTDVAIKVFNLQL--ERAFRSFDSECEVL 322
           + RA  ++     +G  ++G V+K     + G  VA+K   +Q   E    S   E  VL
Sbjct: 2   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 61

Query: 323 R---NVRHRNLIKILSSYSNPDFKA-----LVLEFMPNGSLEKWLYSHNYFLDILERLNI 374
           R      H N++++    +           LV E +               +      ++
Sbjct: 62  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM 121

Query: 375 MIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTM 434
           M  +   L++LH    S  ++H DLKP NIL+  +    ++DFG+ ++       +  T 
Sbjct: 122 MFQLLRGLDFLH----SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTS 174

Query: 435 TMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRP------TDEMFIGEMSLRRW 488
            + T+ Y APE  L+   +   D++S G +  E F RK         D++      +   
Sbjct: 175 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP 234

Query: 489 VKESLPHGLTEVVDANLVREEQAFSAKMDCI-LSIMDFALDCCMESPDMRINMTDA 543
            +E  P  +     A   +  Q     +  I     D  L C   +P  RI+   A
Sbjct: 235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  135 bits (341), Expect = 2e-36
 Identities = 61/289 (21%), Positives = 107/289 (37%), Gaps = 41/289 (14%)

Query: 272 DEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNL---------QLERAFRSFDSECEV 321
           + +    +LG      V +        + A+K+ ++         +++    +   E ++
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 322 LRNVR-HRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGS 380
           LR V  H N+I++  +Y    F  LV + M  G L  +L      L   E   IM  +  
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT-LSEKETRKIMRALLE 121

Query: 381 ALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIG 440
            +  LH     ++I+H DLKP NILLD++M   ++DFG    L  GE   +      T  
Sbjct: 122 VICALH----KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPS 174

Query: 441 YMAPEYGLEGIV------SAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLP 494
           Y+APE     +         + D++S GV++        P             +      
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP-------------FWHRKQM 221

Query: 495 HGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDA 543
             L  ++  N       +    D   ++ D      +  P  R    +A
Sbjct: 222 LMLRMIMSGNYQFGSPEWD---DYSDTVKDLVSRFLVVQPQKRYTAEEA 267

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (337), Expect = 2e-35
 Identities = 56/290 (19%), Positives = 100/290 (34%), Gaps = 21/290 (7%)

Query: 271 TDEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFN-LQLERAFRSFDSECEVLRNVRHR 328
              +   + +G  ++G V       +   VAIK  +  + +   +    E ++L   RH 
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66

Query: 329 NLIKILSSYSNPDFKALVLEFMPNGSLEKWLYS--HNYFLDILERLNIMIDVGSALEYLH 386
           N+I I      P  + +   ++    +   LY       L        +  +   L+Y+H
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126

Query: 387 NGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSV-RQTMTMATIGYMAPE 445
               S +++H DLKP+N+LL+      + DFG+ ++     D     T  +AT  Y APE
Sbjct: 127 ----SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182

Query: 446 YGLEGIV-SAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDAN 504
             L     +   D++S G +L E  + +         +           P         N
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242

Query: 505 LVREEQAFSAKMDCILSI-----------MDFALDCCMESPDMRINMTDA 543
           L       S      +             +D        +P  RI +  A
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (333), Expect = 3e-35
 Identities = 68/281 (24%), Positives = 110/281 (39%), Gaps = 22/281 (7%)

Query: 278 NLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQL-----ERAFRSFDSECEVLRNVRHRNLI 331
           + LG   F +VYK    +    VAIK   L       +   R+   E ++L+ + H N+I
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 332 KILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSS 391
            +L ++ +    +LV +FM        +  ++  L        M+     LEYLH     
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLE-VIIKDNSLVLTPSHIKAYMLMTLQGLEYLH----Q 118

Query: 392 VHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLE-G 450
             I+H DLKP N+LLDEN V  ++DFG+ K  G    +   T  + T  Y APE      
Sbjct: 119 HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA--YTHQVVTRWYRAPELLFGAR 176

Query: 451 IVSAKCDVYSYGVLLMETFTRKRP------TDEMFIGEMSLRRWVKESLPHGLTEVVDAN 504
           +     D+++ G +L E   R          D++     +L    +E  P   +      
Sbjct: 177 MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236

Query: 505 LVREEQAFSAKMDCILS--IMDFALDCCMESPDMRINMTDA 543
                      +       ++D      + +P  RI  T A
Sbjct: 237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (333), Expect = 8e-35
 Identities = 56/276 (20%), Positives = 99/276 (35%), Gaps = 36/276 (13%)

Query: 279 LLGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSY 337
           +LG    G V +          A+K+      +A R  +      R  +  ++++I+  Y
Sbjct: 19  VLGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARREVELH---WRASQCPHIVRIVDVY 74

Query: 338 SNPDFKA----LVLEFMPNGSLEKWLYSH-NYFLDILERLNIMIDVGSALEYLHNGHSSV 392
            N         +V+E +  G L   +    +      E   IM  +G A++YLH    S+
Sbjct: 75  ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH----SI 130

Query: 393 HIIHCDLKPTNILLD---ENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLE 449
           +I H D+KP N+L      N +  ++DFG  K           T    T  Y+APE    
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGP 187

Query: 450 GIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREE 509
                 CD++S GV++        P    F     L           ++  +   +   +
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGYPP----FYSNHGLA----------ISPGMKTRIRMGQ 233

Query: 510 QAFSAKMDCILS--IMDFALDCCMESPDMRINMTDA 543
             F       +S  +     +     P  R+ +T+ 
Sbjct: 234 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF 269

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  131 bits (329), Expect = 1e-34
 Identities = 50/294 (17%), Positives = 104/294 (35%), Gaps = 33/294 (11%)

Query: 269 RATDEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRH 327
           R  + +     +G+ SFG +Y GT I+ G +VAIK+  ++ +        E ++ + ++ 
Sbjct: 4   RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQG 61

Query: 328 RNLIKIL-SSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH 386
              I  +    +  D+  +V+E +     + + +    F  +   L +   + S +EY+H
Sbjct: 62  GVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKF-SLKTVLLLADQMISRIEYIH 120

Query: 387 NGHSSVHIIHCDLKPTNIL---LDENMVAHVSDFGIYKLLGEGEDSVRQTMTMA-----T 438
               S + IH D+KP N L     +  + ++ DFG+ K   +                 T
Sbjct: 121 ----SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 176

Query: 439 IGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGE--MSLRRWVKESLPHG 496
             Y +    L    S + D+ S G +LM       P   +          R  ++ +   
Sbjct: 177 ARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 236

Query: 497 LTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKI 550
           +  +                        +   C     D + + +      + +
Sbjct: 237 IEVLCK--------------GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (327), Expect = 2e-34
 Identities = 58/285 (20%), Positives = 104/285 (36%), Gaps = 19/285 (6%)

Query: 272 DEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHR 328
           + F +   +G  ++G VYK      G  VA+K   L    E    +   E  +L+ + H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61

Query: 329 NLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNG 388
           N++K+L      +   LV EF+     +    S    + +    + +  +   L + H  
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 119

Query: 389 HSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPE-YG 447
             S  ++H DLKP N+L++      ++DFG+ +  G        T  + T+ Y APE   
Sbjct: 120 --SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILL 175

Query: 448 LEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVR 507
                S   D++S G +  E  TR+         +   R +     P  +      ++  
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235

Query: 508 EEQAFSAKMDCILS---------IMDFALDCCMESPDMRINMTDA 543
            + +F        S                     P+ RI+   A
Sbjct: 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  129 bits (324), Expect = 3e-34
 Identities = 55/286 (19%), Positives = 111/286 (38%), Gaps = 23/286 (8%)

Query: 272 DEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRN 329
           ++++    +G  ++G VYK   + G   A+K   L+   E    +   E  +L+ ++H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 330 LIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGH 389
           ++K+           LV E + +  L+K L      L+ +   + ++ + + + Y H   
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH--- 117

Query: 390 SSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGL- 448
               ++H DLKP N+L++      ++DFG+ +    G    + T  + T+ Y AP+  + 
Sbjct: 118 -DRRVLHRDLKPQNLLINREGELKIADFGLARAF--GIPVRKYTHEIVTLWYRAPDVLMG 174

Query: 449 EGIVSAKCDVYSYGVLLMETFTRKRPTDEM-----------FIGEMSLRRWVKESLPHGL 497
               S   D++S G +  E          +            +G  + + W   +     
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234

Query: 498 TEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDA 543
                       ++F   +D   S +D         P+ RI    A
Sbjct: 235 DPNFTVYEPLPWESFLKGLD--ESGIDLLSKMLKLDPNQRITAKQA 278

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (319), Expect = 2e-33
 Identities = 62/283 (21%), Positives = 108/283 (38%), Gaps = 35/283 (12%)

Query: 272 DEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQL------ERAFRSFDSECEVLRN 324
           D ++    LG+  F  V K    S G   A K    +         +    + E  +L+ 
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69

Query: 325 VRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEY 384
           ++H N+I +   Y N     L+LE +  G L  +L       +  E    +  + + + Y
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYY 128

Query: 385 LHNGHSSVHIIHCDLKPTNILLDENMVA----HVSDFGIYKLLGEGEDSVRQTMTMATIG 440
           LH    S+ I H DLKP NI+L +  V      + DFG+   +  G           T  
Sbjct: 129 LH----SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN---EFKNIFGTPE 181

Query: 441 YMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEV 500
           ++APE      +  + D++S GV+     +   P             ++ ++    L  V
Sbjct: 182 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASP-------------FLGDTKQETLANV 228

Query: 501 VDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDA 543
              N   E++ FS   +      DF     ++ P  R+ + D+
Sbjct: 229 SAVNYEFEDEYFS---NTSALAKDFIRRLLVKDPKKRMTIQDS 268

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (316), Expect = 4e-33
 Identities = 57/229 (24%), Positives = 87/229 (37%), Gaps = 22/229 (9%)

Query: 279 LLGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRS------FDSECEVLRNVR--HRN 329
           LLG+  FGSVY G  +SD   VAIK         +           E  +L+ V      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 330 LIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGH 389
           +I++L  +  PD   L+LE            +    L      +    V  A+ + H   
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH--- 127

Query: 390 SSVHIIHCDLKPTNILLDEN-MVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGL 448
            +  ++H D+K  NIL+D N     + DFG   LL +       T    T  Y  PE+  
Sbjct: 128 -NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIR 182

Query: 449 -EGIVSAKCDVYSYGVLLMETFTRKRP---TDEMFIGEMSLRRWVKESL 493
                     V+S G+LL +      P    +E+  G++  R+ V    
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSEC 231

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (319), Expect = 6e-33
 Identities = 58/290 (20%), Positives = 108/290 (37%), Gaps = 31/290 (10%)

Query: 274 FNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIK 332
           + +  ++G  SFG VY+      G  VAIK             + E +++R + H N+++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVR 77

Query: 333 ILSSYSNPD------FKALVLEFMPNGSLEKWLY--SHNYFLDILERLNIMIDVGSALEY 384
           +   + +        +  LVL+++P        +       L ++     M  +  +L Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137

Query: 385 LHNGHSSVHIIHCDLKPTNILLD-ENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           +H    S  I H D+KP N+LLD +  V  + DFG  K L  GE        + +  Y A
Sbjct: 138 IH----SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE---PNVSYICSRYYRA 190

Query: 444 PEYGLEGI-VSAKCDVYSYGVLLMETFTRKRP------TDEMFIGEMSLRRWVKESLPHG 496
           PE        ++  DV+S G +L E    +         D++      L    +E +   
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250

Query: 497 LTEVVDANLVR-EEQAFSAKMDCILS--IMDFALDCCMESPDMRINMTDA 543
                +    + +   ++           +         +P  R+   +A
Sbjct: 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  124 bits (313), Expect = 1e-32
 Identities = 41/293 (13%), Positives = 85/293 (29%), Gaps = 33/293 (11%)

Query: 279 LLGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSY 337
            +G  SFG +++GT + +   VAIK    + +        E    + +     I  +  +
Sbjct: 12  RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYF 69

Query: 338 SNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHC 397
                  +++  +   SLE  L        +         + + ++ +H       +++ 
Sbjct: 70  GQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH----EKSLVYR 125

Query: 398 DLKPTNILLDENMVAH-----VSDFGIYKLLGEGEDSVRQTMTMA-----TIGYMAPEYG 447
           D+KP N L+      +     V DFG+ K   +                 T  YM+    
Sbjct: 126 DIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTH 185

Query: 448 LEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLV 506
           L    S + D+ + G + M                       + E         + A   
Sbjct: 186 LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFP 245

Query: 507 REEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKI--KVKFLDD 557
            E                +       + D   +         K+  ++   +D
Sbjct: 246 EE-------------FYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTED 285

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (309), Expect = 4e-32
 Identities = 52/286 (18%), Positives = 111/286 (38%), Gaps = 21/286 (7%)

Query: 272 DEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHR 328
            ++ +   +G  ++G+V+K         VA+K   L    E    S   E  +L+ ++H+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 329 NLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNG 388
           N++++     +     LV EF      + +   +          + +  +   L + H+ 
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPE-IVKSFLFQLLKGLGFCHS- 119

Query: 389 HSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGL 448
               +++H DLKP N+L++ N    +++FG+ +  G        +  + T+ Y  P+   
Sbjct: 120 ---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR--CYSAEVVTLWYRPPDVLF 174

Query: 449 -EGIVSAKCDVYSYGVLLMETFTRKRP------TDEMFIGEMSLRRWVKESLPHGLTEVV 501
              + S   D++S G +  E     RP       D+       L     E     +T++ 
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234

Query: 502 DANLVREEQAFSAKMDCILSIMDFALD----CCMESPDMRINMTDA 543
           D        A ++ ++ +  +     D        +P  RI+  +A
Sbjct: 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  124 bits (313), Expect = 5e-32
 Identities = 54/207 (26%), Positives = 85/207 (41%), Gaps = 14/207 (6%)

Query: 272 DEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQL---ERAFRSFDSECEVLRNVRH 327
           D+F+    LGT SFG V        G   A+K+ + Q     +      +E  +L+ V  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
             L+K+  S+ +     +V+E++  G +   L     F            +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRF-SEPHARFYAAQIVLTFEYLH- 158

Query: 388 GHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYG 447
              S+ +I+ DLKP N+L+D+     V+DFG  K         R      T   +APE  
Sbjct: 159 ---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALAPEII 210

Query: 448 LEGIVSAKCDVYSYGVLLMETFTRKRP 474
           L    +   D ++ GVL+ E      P
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPP 237

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (304), Expect = 3e-31
 Identities = 57/301 (18%), Positives = 113/301 (37%), Gaps = 31/301 (10%)

Query: 269 RATDEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQL--ERAFRSFDSECEVLRNV 325
               ++ +   +G  +FG V+K      G  VA+K   ++   E    +   E ++L+ +
Sbjct: 7   DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL 66

Query: 326 RHRNLIKILSSYSNPDFKA--------LVLEFMPNGSLEKWLYSHNYFLDILERLNIMID 377
           +H N++ ++                  LV +F  +            F  + E   +M  
Sbjct: 67  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKF-TLSEIKRVMQM 125

Query: 378 VGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMT-- 435
           + + L Y+H       I+H D+K  N+L+  + V  ++DFG+ +     ++S     T  
Sbjct: 126 LLNGLYYIH----RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNR 181

Query: 436 MATIGYMAPEYGL-EGIVSAKCDVYSYGVLLMETFTRKRP-TDEMFIGEMSLRRWVKESL 493
           + T+ Y  PE  L E       D++  G ++ E +TR           +++L   +  S+
Sbjct: 182 VVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 241

Query: 494 PHGLTEVVDANLVREEQAFSAKMDCILS-----------IMDFALDCCMESPDMRINMTD 542
              +   VD   + E+          +             +D      +  P  RI+  D
Sbjct: 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDD 301

Query: 543 A 543
           A
Sbjct: 302 A 302

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (306), Expect = 3e-31
 Identities = 52/207 (25%), Positives = 89/207 (42%), Gaps = 11/207 (5%)

Query: 272 DEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQL---ERAFRSFDSECEVLRNVRH 327
           ++F+   LLG  +FG V      + G   A+K+   ++   +       +E  VL+N RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 328 RNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
             L  +  ++   D    V+E+   G L   L     F +         ++ SALEYLH 
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE-RARFYGAEIVSALEYLH- 122

Query: 388 GHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYG 447
              S  +++ D+K  N++LD++    ++DFG+ K      D         T  Y+APE  
Sbjct: 123 ---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG--ISDGATMKTFCGTPEYLAPEVL 177

Query: 448 LEGIVSAKCDVYSYGVLLMETFTRKRP 474
            +       D +  GV++ E    + P
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  115 bits (289), Expect = 4e-29
 Identities = 47/209 (22%), Positives = 96/209 (45%), Gaps = 20/209 (9%)

Query: 272 DEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVR-HRN 329
           D++     LG   +  V++   I++   V +K+     ++  +    E ++L N+R   N
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIK---REIKILENLRGGPN 91

Query: 330 LIKILSSYSNPDFK--ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHN 387
           +I +     +P  +  ALV E + N   ++   +    L   +    M ++  AL+Y H 
Sbjct: 92  IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCH- 146

Query: 388 GHSSVHIIHCDLKPTNILLD-ENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEY 446
              S+ I+H D+KP N+++D E+    + D+G+ +    G+      + +A+  +  PE 
Sbjct: 147 ---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFKGPEL 200

Query: 447 GLE-GIVSAKCDVYSYGVLLMETFTRKRP 474
            ++  +     D++S G +L     RK P
Sbjct: 201 LVDYQMYDYSLDMWSLGCMLASMIFRKEP 229

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (277), Expect = 3e-27
 Identities = 55/300 (18%), Positives = 106/300 (35%), Gaps = 31/300 (10%)

Query: 266 DIQRATDEFNE----CNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQL--ERAFRSFDSE 318
           ++ +   E          +G+ ++G+V        G  VAIK        E   +    E
Sbjct: 8   EVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRE 67

Query: 319 CEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSH---NYFLDILERLNIM 375
             +L+++RH N+I +L  ++  +      +F                +  L       ++
Sbjct: 68  LRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLV 127

Query: 376 IDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMT 435
             +   L Y+H    +  IIH DLKP N+ ++E+    + DFG+ +           T  
Sbjct: 128 YQMLKGLRYIH----AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS-----EMTGY 178

Query: 436 MATIGYMAPEYGLEGI-VSAKCDVYSYGVLLMETFTRKRP---------TDEMFIGEMSL 485
           + T  Y APE  L  +  +   D++S G ++ E  T K             E+     + 
Sbjct: 179 VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTP 238

Query: 486 RRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILS--IMDFALDCCMESPDMRINMTDA 543
                + L     +     L   E+   A +    S   ++      +   + R+   +A
Sbjct: 239 PAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (271), Expect = 1e-26
 Identities = 58/214 (27%), Positives = 93/214 (43%), Gaps = 17/214 (7%)

Query: 272 DEFNECNLLGTSSFGSVYKG----TISDGTDVAIKVFN----LQLERAFRSFDSECEVLR 323
           + F    +LGT ++G V+          G   A+KV      +Q  +      +E +VL 
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 324 NVRHR-NLIKILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSAL 382
           ++R    L+ +  ++       L+L+++  G L   L     F +  E    + ++  AL
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTE-HEVQIYVGEIVLAL 142

Query: 383 EYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYM 442
           E+LH     + II+ D+K  NILLD N    ++DFG+ K     E          TI YM
Sbjct: 143 EHLH----KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAY-DFCGTIEYM 197

Query: 443 APE--YGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
           AP+   G +       D +S GVL+ E  T   P
Sbjct: 198 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 231

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (263), Expect = 2e-25
 Identities = 59/292 (20%), Positives = 115/292 (39%), Gaps = 29/292 (9%)

Query: 271 TDEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRH 327
            + +   + +G+ ++GSV        G  VA+K  +         +    E  +L++++H
Sbjct: 17  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76

Query: 328 RNLIKILSSYSNP----DFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALE 383
            N+I +L  ++      +F  + L     G+    +       D      ++  +   L+
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD-HVQFLIYQILRGLK 135

Query: 384 YLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMA 443
           Y+H    S  IIH DLKP+N+ ++E+    + DFG+ +   +       T  +AT  Y A
Sbjct: 136 YIH----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRWYRA 186

Query: 444 PEYGLEGI-VSAKCDVYSYGVLLMETFTRKRP---TDEMFIGEMSLRRWVK--ESLPHGL 497
           PE  L  +  +   D++S G ++ E  T +     TD +   ++ LR        L   +
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 246

Query: 498 TEVVDANLVREEQAFSAK--MDCILSIMDFALD----CCMESPDMRINMTDA 543
           +     N ++           +  +     A+D      +   D RI    A
Sbjct: 247 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (261), Expect = 3e-25
 Identities = 56/303 (18%), Positives = 102/303 (33%), Gaps = 42/303 (13%)

Query: 272 DEFNECNLLGTSSFGSVYKGT-ISDGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHR 328
             +     +G+ + G V          +VAIK  +     +   +    E  +++ V H+
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76

Query: 329 NLIKILSSYSNPDFK------ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSAL 382
           N+I +L+ ++            LV+E M     +          D      ++  +   +
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL----DHERMSYLLYQMLCGI 132

Query: 383 EYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYM 442
           ++LH    S  IIH DLKP+NI++  +    + DFG+ +  G        T  + T  Y 
Sbjct: 133 KHLH----SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYR 185

Query: 443 APEYGLEGIVSAKCDVYSYGVLLMETFTRKRP--------------------TDEMFIGE 482
           APE  L        D++S G ++ E    K                        E     
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245

Query: 483 MSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILS--IMDFALDCCMESPDMRINM 540
               R   E+ P                   ++ + + +    D      +  P  RI++
Sbjct: 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 305

Query: 541 TDA 543
            DA
Sbjct: 306 DDA 308

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  101 bits (251), Expect = 8e-24
 Identities = 43/213 (20%), Positives = 79/213 (37%), Gaps = 21/213 (9%)

Query: 279 LLGTSSFGSVYKGT-ISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSY 337
            LG   F +V+    + + T VA+K+     +    + + E ++L+ V   +  K  S  
Sbjct: 20  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMG 78

Query: 338 SNPDFK---------------ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSAL 382
           +N   K                +V E +    L       +  + ++    I   +   L
Sbjct: 79  ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138

Query: 383 EYLHNGHSSVHIIHCDLKPTNILLD-ENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGY 441
           +Y+H       IIH D+KP N+L++  +   ++    I  L          T ++ T  Y
Sbjct: 139 DYMHRRCG---IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREY 195

Query: 442 MAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRP 474
            +PE  L        D++S   L+ E  T    
Sbjct: 196 RSPEVLLGAPWGCGADIWSTACLIFELITGDFL 228

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 77.3 bits (189), Expect = 7e-16
 Identities = 40/181 (22%), Positives = 60/181 (33%), Gaps = 28/181 (15%)

Query: 1   MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSF 60
           +  L    NQ+S   P  I  +L   + L L  N L      ++ + T L  LDL  N  
Sbjct: 199 LESLIATNNQISDITPLGILTNL---DELSLNGNQLKD--IGTLASLTNLTDLDLANNQI 253

Query: 61  SGHILNTFGNLRHLSVLSLLMFGIR-----------------LTGNKLYGRIPPCLVLTV 103
           S         L  L+ L L    I                      +    I     LT 
Sbjct: 254 SNLA--PLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTY 311

Query: 104 LDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKI 163
           L +  N +S   P  +     L+ L  A+N+       S+ +L ++  L    N +S   
Sbjct: 312 LTLYFNNISDISP--VSSLTKLQRLFFANNKVSDV--SSLANLTNINWLSAGHNQISDLT 367

Query: 164 P 164
           P
Sbjct: 368 P 368

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 71.2 bits (173), Expect = 8e-14
 Identities = 42/173 (24%), Positives = 67/173 (38%), Gaps = 26/173 (15%)

Query: 1   MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSF 60
           +  L+L GNQL      T+  SL N+  L L  N ++   P  ++  TKL  L LG N  
Sbjct: 221 LDELSLNGNQLKD--IGTLA-SLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQI 275

Query: 61  SG--------------HILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIP--PCLVLTVL 104
           S                  N   ++  +S L  L + + L  N +    P      L  L
Sbjct: 276 SNISPLAGLTALTNLELNENQLEDISPISNLKNLTY-LTLYFNNISDISPVSSLTKLQRL 334

Query: 105 DVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGN 157
             + N++S    S++    ++  LS   NQ     P  + +L  +  L L+  
Sbjct: 335 FFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 74.0 bits (181), Expect = 8e-16
 Identities = 23/154 (14%), Positives = 48/154 (31%), Gaps = 11/154 (7%)

Query: 278 NLLGTSSFGSVYKGTISDGTDVAIKVFNL------QLERAFRSFDSECEVLRNVRHRNLI 331
            L+G     +V+        +  +K   +      +++      D    VL     RN  
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 332 KILSSYSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSS 391
           + L          +         +E       Y + +     ++  +   +   +     
Sbjct: 66  RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY----H 121

Query: 392 VHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGE 425
             I+H DL   N+L+ E  +  + DF     +GE
Sbjct: 122 RGIVHGDLSQYNVLVSEEGI-WIIDFPQSVEVGE 154

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 74.4 bits (181), Expect = 4e-15
 Identities = 24/72 (33%), Positives = 38/72 (52%), Gaps = 10/72 (13%)

Query: 130 LASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKLEGEIPVKGSFKNFSTESFFGNYA 189
           L +N+  G +P+ +  L  L SL++S NNL G+IP+        G+ + F   ++  N  
Sbjct: 251 LRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-------GNLQRFDVSAYANNKC 303

Query: 190 LCGPPKLRVPPC 201
           LCG P   +P C
Sbjct: 304 LCGSP---LPAC 312

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 61.3 bits (147), Expect = 7e-11
 Identities = 32/164 (19%), Positives = 63/164 (38%), Gaps = 6/164 (3%)

Query: 1   MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSF 60
           +  +T +GN++SG +P + G        + ++ N LTG IP +  N     V        
Sbjct: 151 LVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLE 210

Query: 61  SGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLVLTVLDVSRNQLSGDIPSTIG 120
               +    +          +   + +     G++     L  LD+  N++ G +P  + 
Sbjct: 211 GDASVLFGSDKNTQ-----KIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLT 265

Query: 121 GRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIP 164
               L +L+++ N   G IP+  G+L   +    + N      P
Sbjct: 266 QLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKCLCGSP 308

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 57.5 bits (137), Expect = 1e-09
 Identities = 24/77 (31%), Positives = 34/77 (44%), Gaps = 10/77 (12%)

Query: 24  PNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLMFG 83
            N+  L L  N + GT+P  +T    L  L++ FN+  G I    GNL+   V +     
Sbjct: 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI-PQGGNLQRFDVSA----- 297

Query: 84  IRLTGNK-LYGR-IPPC 98
                NK L G  +P C
Sbjct: 298 --YANNKCLCGSPLPAC 312

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 60.1 bits (144), Expect = 2e-10
 Identities = 34/171 (19%), Positives = 50/171 (29%), Gaps = 26/171 (15%)

Query: 14  RLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRH 73
           ++P  +    P+   L L  N +T        N   L  L L  N  S      F  L  
Sbjct: 24  KVPKDLP---PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVK 80

Query: 74  LSVLSL-----------------LMFGIRLTGNKLYGRIPPCLVLTV---LDVSRNQLSG 113
           L  L L                  +        K+   +   L   +   L  +  + SG
Sbjct: 81  LERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSG 140

Query: 114 DIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIP 164
                  G   L  + +A       IP+  G   SL  L L GN ++    
Sbjct: 141 IENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVDA 188

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 50.4 bits (119), Expect = 2e-07
 Identities = 28/163 (17%), Positives = 51/163 (31%), Gaps = 14/163 (8%)

Query: 4   LTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGH 63
           L     + SG         +  + Y+ +   N+T TIP  +     L  L L  N  +  
Sbjct: 131 LGTNPLKSSGIENGAFQG-MKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKV 186

Query: 64  ILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLVLTVLDVSRNQLSGDIPSTIGGRV 123
              +   L +L+ L               G +     L  L ++ N+L   +P  +    
Sbjct: 187 DAASLKGLNNLAKL---GLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHK 242

Query: 124 DLETLSLASNQFQG------PIPESVGSLISLESLDLSGNNLS 160
            ++ + L +N            P       S   + L  N + 
Sbjct: 243 YIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 49.7 bits (117), Expect = 5e-07
 Identities = 36/228 (15%), Positives = 67/228 (29%), Gaps = 43/228 (18%)

Query: 1   MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSF 60
           +  L L  N++S   P      L  +E L L+ N L            +L V +      
Sbjct: 57  LHTLILINNKISKISPGAFAP-LVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKV 115

Query: 61  SGHILNTFGNLRHLSVLSLLMFGI----------------RLTGNKLYGRIPPCLV--LT 102
              + N    +  + + +  +                   R+    +   IP  L   LT
Sbjct: 116 RKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNI-TTIPQGLPPSLT 174

Query: 103 VLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPI----------------------- 139
            L +  N+++    +++ G  +L  L L+ N                             
Sbjct: 175 ELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKV 234

Query: 140 PESVGSLISLESLDLSGNNLSGKIPKLEGEIPVKGSFKNFSTESFFGN 187
           P  +     ++ + L  NN+S                 ++S  S F N
Sbjct: 235 PGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSN 282

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 46.6 bits (109), Expect = 5e-06
 Identities = 31/162 (19%), Positives = 54/162 (33%), Gaps = 16/162 (9%)

Query: 1   MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSF 60
           +  + +    ++  +P  +    P++  L L  N +T     S+     L  L L FNS 
Sbjct: 152 LSYIRIADTNIT-TIPQGL---PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSI 207

Query: 61  SGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLVLTVLDVSRNQLSG------D 114
           S     +  N  HL  L L    +      L         + V+ +  N +S        
Sbjct: 208 SAVDNGSLANTPHLRELHLNNNKLVKVPGGLAD----HKYIQVVYLHNNNISAIGSNDFC 263

Query: 115 IPSTIGGRVDLETLSLASNQFQ--GPIPESVGSLISLESLDL 154
            P     +     +SL SN  Q     P +   +    ++ L
Sbjct: 264 PPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 54.8 bits (130), Expect = 8e-09
 Identities = 31/156 (19%), Positives = 54/156 (34%), Gaps = 8/156 (5%)

Query: 6   LEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHIL 65
           L+ N L      T    L N+ +L L  N ++     +      L  L L  N  +    
Sbjct: 136 LQDNALQALPDDTF-RDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHP 194

Query: 66  NTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLVLTVLDVSRNQLSGDIPSTIGGRVDL 125
           + F +L  L  L L    +          + P   L  L ++ N    D  +       L
Sbjct: 195 HAFRDLGRLMTLYLFANNL---SALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWL 250

Query: 126 ETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSG 161
           +    +S++    +P+    L   +   L+ N+L G
Sbjct: 251 QKFRGSSSEVPCSLPQ---RLAGRDLKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.4 bits (103), Expect = 2e-05
 Identities = 33/140 (23%), Positives = 55/140 (39%), Gaps = 14/140 (10%)

Query: 1   MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSF 60
           +  L L GN++S  +P      L +++ LLL  N +    P++  +  +L+ L L  N+ 
Sbjct: 155 LTHLFLHGNRISS-VPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNL 213

Query: 61  SGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLV---LTVLDVSRNQLSGDIPS 117
           S         LR L  L L         N          +   L     S +++   +P 
Sbjct: 214 SALPTEALAPLRALQYLRL-------NDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQ 266

Query: 118 TIGGRVDLETLSLASNQFQG 137
            + GR   +   LA+N  QG
Sbjct: 267 RLAGR---DLKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.0 bits (102), Expect = 2e-05
 Identities = 31/150 (20%), Positives = 46/150 (30%), Gaps = 5/150 (3%)

Query: 15  LPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHL 74
           +P  I       + + L  N ++     S      L +L L  N  +      F  L  L
Sbjct: 26  VPVGIP---AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82

Query: 75  SVLSLLMFGIRLTGNKLYGRIPPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQ 134
             L   +       +           L  L + R  L    P    G   L+ L L  N 
Sbjct: 83  EQLD--LSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNA 140

Query: 135 FQGPIPESVGSLISLESLDLSGNNLSGKIP 164
            Q    ++   L +L  L L GN +S    
Sbjct: 141 LQALPDDTFRDLGNLTHLFLHGNRISSVPE 170

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.0 bits (89), Expect = 0.001
 Identities = 31/175 (17%), Positives = 50/175 (28%), Gaps = 35/175 (20%)

Query: 24  PNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLMFG 83
             ++YL L  N L     ++  +   L  L L  N  S      F  L  L  L L    
Sbjct: 129 AALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQ-- 186

Query: 84  IRLTGNKLYGRIPPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESV 143
                                    N+++   P        L TL L +N       E++
Sbjct: 187 -------------------------NRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEAL 221

Query: 144 GSLISLESLDLSGNNLSGKIPKLEGEIPVKGSFKNFSTESFFGNYALC-GPPKLR 197
             L +L+ L L+ N           +   +  +          +   C  P +L 
Sbjct: 222 APLRALQYLRLNDNPWV-------CDCRARPLWAWLQKFRGSSSEVPCSLPQRLA 269

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 47.4 bits (112), Expect = 3e-07
 Identities = 25/121 (20%), Positives = 45/121 (37%), Gaps = 12/121 (9%)

Query: 52  VLDLGFNSFSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLVLTVLDVSRNQL 111
           VL L     +  +L     L  ++ L L       + N+L    P    L  L+V +   
Sbjct: 2   VLHLAHKDLT--VLCHLEQLLLVTHLDL-------SHNRLRALPPALAALRCLEVLQASD 52

Query: 112 SGDI-PSTIGGRVDLETLSLASNQFQG-PIPESVGSLISLESLDLSGNNLSGKIPKLEGE 169
           +       +     L+ L L +N+ Q     + + S   L  L+L GN+L      ++  
Sbjct: 53  NALENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQER 111

Query: 170 I 170
           +
Sbjct: 112 L 112

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 38.2 bits (88), Expect = 5e-04
 Identities = 23/113 (20%), Positives = 41/113 (36%), Gaps = 8/113 (7%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFS 61
           R+L L    L+      +   L  + +L L+ N L    P ++     L V      +  
Sbjct: 1   RVLHLAHKDLTV--LCHLEQ-LLLVTHLDLSHNRLRALPP-ALAALRCLEV----LQASD 52

Query: 62  GHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLVLTVLDVSRNQLSGD 114
             + N  G      +  LL+   RL  +     +  C  L +L++  N L  +
Sbjct: 53  NALENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 49.4 bits (116), Expect = 7e-07
 Identities = 19/84 (22%), Positives = 34/84 (40%), Gaps = 9/84 (10%)

Query: 88  GNKLYGRIPPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLI 147
            N++         L  L+VS N+L  ++P+       LE L  + N     +PE   +L 
Sbjct: 273 SNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLAE-VPELPQNL- 326

Query: 148 SLESLDLSGNNLSGKIPKLEGEIP 171
             + L +  N L  + P +   + 
Sbjct: 327 --KQLHVEYNPLR-EFPDIPESVE 347

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 43.7 bits (101), Expect = 5e-05
 Identities = 14/76 (18%), Positives = 29/76 (38%), Gaps = 10/76 (13%)

Query: 1   MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSF 60
           +  L +  N+L       +    P +E L+ + N+L   +P    N   L  L + +N  
Sbjct: 286 LEELNVSNNKLI-----ELPALPPRLERLIASFNHLA-EVPELPQN---LKQLHVEYNPL 336

Query: 61  SGHILNTFGNLRHLSV 76
                +   ++  L +
Sbjct: 337 RE-FPDIPESVEDLRM 351

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.8 bits (114), Expect = 1e-06
 Identities = 11/70 (15%), Positives = 23/70 (32%), Gaps = 5/70 (7%)

Query: 101 LTVLDVSRNQLSGDIPSTIGGRV-DLETLSLASNQFQG----PIPESVGSLISLESLDLS 155
           +  LD+   +LS    + +   +   + + L            I  ++    +L  L+L 
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 156 GNNLSGKIPK 165
            N L      
Sbjct: 64  SNELGDVGVH 73

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.4 bits (105), Expect = 1e-05
 Identities = 17/83 (20%), Positives = 29/83 (34%), Gaps = 9/83 (10%)

Query: 93  GRIPPCLVLTVLDVSRNQLSGD----IPSTIGGRVDLETLSLASNQFQGPIPESVGSLI- 147
           G   P  VL VL ++   +S      + +T+     L  L L++N         +   + 
Sbjct: 363 GLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVR 422

Query: 148 ----SLESLDLSGNNLSGKIPKL 166
                LE L L     S ++   
Sbjct: 423 QPGCLLEQLVLYDIYWSEEMEDR 445

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.6 bits (103), Expect = 3e-05
 Identities = 12/80 (15%), Positives = 26/80 (32%), Gaps = 4/80 (5%)

Query: 4  LTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTG----TIPNSITNATKLIVLDLGFNS 59
          L ++  +LS    + +   L   + + L    LT      I +++     L  L+L  N 
Sbjct: 7  LDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNE 66

Query: 60 FSGHILNTFGNLRHLSVLSL 79
               ++            +
Sbjct: 67 LGDVGVHCVLQGLQTPSCKI 86

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.4 bits (100), Expect = 5e-05
 Identities = 18/90 (20%), Positives = 33/90 (36%), Gaps = 12/90 (13%)

Query: 1   MRILTLEGNQLSGRLPSTIGHSL---PNIEYLLLTANNLTGTIPNSITNA-----TKLIV 52
           +R+L L    +S    S++  +L    ++  L L+ N L       +  +       L  
Sbjct: 371 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQ 430

Query: 53  LDLGFNSFSGHILNTFGNLR----HLSVLS 78
           L L    +S  + +    L      L V+S
Sbjct: 431 LVLYDIYWSEEMEDRLQALEKDKPSLRVIS 460

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.8 bits (99), Expect = 7e-05
 Identities = 31/176 (17%), Positives = 51/176 (28%), Gaps = 20/176 (11%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPN-------SITNATKLIVLD 54
            IL L  N L     +T+      +  L L    LT    +       ++  +   +   
Sbjct: 34  TILHLSENLLYTFSLATLMP-YTRLTQLNLDRAELTKLQVDGTLPVLGTLDLSHNQLQSL 92

Query: 55  LGFNSFSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLVLT-----------V 103
                    +     +   L+ L L          +LY +      L             
Sbjct: 93  PLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEK 152

Query: 104 LDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNL 159
           L ++ N L+      + G  +L+TL L  N     IP+       L    L GN  
Sbjct: 153 LSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.4 bits (98), Expect = 9e-05
 Identities = 34/175 (19%), Positives = 57/175 (32%), Gaps = 26/175 (14%)

Query: 4   LTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGH 63
           +  +   L+  LP  +     +   L L+ N L      ++   T+L  L+L  +     
Sbjct: 15  VNCDKRNLT-ALPPDLP---KDTTILHLSENLLYTFSLATLMPYTRLTQLNL--DRAELT 68

Query: 64  ILNTFGNLRHLSVLSLLMFGIRLTGNKLYG--------------------RIPPCLVLTV 103
            L   G L  L  L L    ++                             +     L  
Sbjct: 69  KLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQE 128

Query: 104 LDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNN 158
           L +  N+L    P  +     LE LSLA+N         +  L +L++L L  N+
Sbjct: 129 LYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENS 183

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.7 bits (91), Expect = 6e-04
 Identities = 9/58 (15%), Positives = 19/58 (32%), Gaps = 3/58 (5%)

Query: 101 LTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNN 158
              ++  +  L+  +P  +    D   L L+ N        ++     L  L+L    
Sbjct: 12  HLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAE 66

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.7 bits (91), Expect = 6e-04
 Identities = 10/61 (16%), Positives = 23/61 (37%), Gaps = 2/61 (3%)

Query: 102 TVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSG 161
             LD++   L  D+   +  +  +       +    P+ E   S   ++ +DLS + +  
Sbjct: 3   QTLDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEH-FSPFRVQHMDLSNSVIEV 60

Query: 162 K 162
            
Sbjct: 61  S 61

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.8 bits (86), Expect = 0.003
 Identities = 29/201 (14%), Positives = 61/201 (30%), Gaps = 31/201 (15%)

Query: 2   RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFN--- 58
           + + L  + +       I      ++ L L    L+  I N++   + L+ L+L      
Sbjct: 49  QHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGF 108

Query: 59  --SFSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLVLTVLDVSRN------- 109
                  +L++   L  L++     F  +     +         L +    +N       
Sbjct: 109 SEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLS 168

Query: 110 ------------------QLSGDIPSTIGGRVDLETLSLAS-NQFQGPIPESVGSLISLE 150
                              L  D          L+ LSL+            +G + +L+
Sbjct: 169 TLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLK 228

Query: 151 SLDLSGNNLSGKIPKLEGEIP 171
           +L + G    G +  L+  +P
Sbjct: 229 TLQVFGIVPDGTLQLLKEALP 249

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 37.7 bits (86), Expect = 0.002
 Identities = 13/64 (20%), Positives = 25/64 (39%), Gaps = 4/64 (6%)

Query: 92  YGRIPPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLES 151
              +     LT L    N++S   P  +    +L  + L +NQ     P  + +  +L  
Sbjct: 166 LTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFI 221

Query: 152 LDLS 155
           + L+
Sbjct: 222 VTLT 225

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	593
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.89
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.88
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.85
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.81
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.79
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.77
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.77
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.76
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.69
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.68
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.67
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.66
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.65
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.64
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.61
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.59
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.57
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.56
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.55
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.54
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.53
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.44
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.44
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.42
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.4
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.4
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.35
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.32
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.25
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.24
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.16
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.04
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	98.82
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	98.76
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	98.75
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.61
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	98.33
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	98.3
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.29
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.28
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.04
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.67
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.65
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.37
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.27
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.97
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	96.86
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.72
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	96.7

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-53  Score=420.77  Aligned_cols=250  Identities=23%  Similarity=0.326  Sum_probs=211.0

Q ss_pred             hccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEecc
Q 007680          272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFM  350 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  350 (593)
                      ++|++.+.||+|+||+||+|+.. +|+.||||+++.......+.+.+|++++++++||||+++++++.+++..|+||||+
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            47999999999999999999964 79999999998766555678999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCcc
Q 007680          351 PNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSV  430 (593)
Q Consensus       351 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~  430 (593)
                      ++|+|.+++....  +++.++..++.||+.||+|||+++    |+||||||+|||++.++.+||+|||+|+.+.....  
T Consensus       100 ~gg~L~~~~~~~~--l~~~~~~~i~~qi~~aL~yLH~~~----iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~--  171 (293)
T d1yhwa1         100 AGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLHSNQ----VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--  171 (293)
T ss_dssp             TTCBHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHTT----EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--
T ss_pred             CCCcHHHHhhccC--CCHHHHHHHHHHHHHHHHHHHHCC----CcccCCcHHHeEECCCCcEeeccchhheeeccccc--
Confidence            9999999887654  999999999999999999999654    99999999999999999999999999998754332  


Q ss_pred             ccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhhh
Q 007680          431 RQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQ  510 (593)
Q Consensus       431 ~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  510 (593)
                      ......||+.|+|||++.+..++.++||||+||++|||+||+.||.+..... ..........+                
T Consensus       172 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~~~~~~~~~----------------  234 (293)
T d1yhwa1         172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-ALYLIATNGTP----------------  234 (293)
T ss_dssp             CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHHCSC----------------
T ss_pred             cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH-HHHHHHhCCCC----------------
Confidence            2345679999999999999999999999999999999999999997632211 11111111111                


Q ss_pred             hhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          511 AFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       511 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      ....+..+++++.+++.+||+.||++|||++|+++|
T Consensus       235 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H  270 (293)
T d1yhwa1         235 ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (293)
T ss_dssp             CCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred             CCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            111123346688999999999999999999999876

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-53  Score=422.55  Aligned_cols=263  Identities=24%  Similarity=0.390  Sum_probs=208.6

Q ss_pred             hhccccccccCccCcccEEEEEeCCCCeEEEEEeehh--hHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEe
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQ--LERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLE  348 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  348 (593)
                      .++|++.+.||+|+||+||+|+++  ..||||+++..  .....+.+.+|++++++++||||+++++++.+ +..++|||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E   83 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ   83 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence            568999999999999999999864  36999998754  24456789999999999999999999998755 56899999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCC
Q 007680          349 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGED  428 (593)
Q Consensus       349 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  428 (593)
                      |+++|+|.+++...+..+++.++..++.||++||+|||++    +|+||||||+|||++.++.+||+|||+|+.......
T Consensus        84 y~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~----~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~  159 (276)
T d1uwha_          84 WCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK----SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG  159 (276)
T ss_dssp             CCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred             cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcC----CEeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence            9999999999987766799999999999999999999965    499999999999999999999999999987765443


Q ss_pred             ccccccccCCccccCccccCC---CCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhh
Q 007680          429 SVRQTMTMATIGYMAPEYGLE---GIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANL  505 (593)
Q Consensus       429 ~~~~~~~~gt~~y~aPE~~~~---~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  505 (593)
                      ........||+.|+|||++.+   ..++.++|||||||++|||+||+.||.+..... .....+.......         
T Consensus       160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~-~~~~~~~~~~~~p---------  229 (276)
T d1uwha_         160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD-QIIFMVGRGYLSP---------  229 (276)
T ss_dssp             ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-HHHHHHHHTSCCC---------
T ss_pred             cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH-HHHHHHhcCCCCC---------
Confidence            334455679999999999864   358999999999999999999999997643222 1111111111100         


Q ss_pred             hhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhhh
Q 007680          506 VREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKF  554 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  554 (593)
                          .......++++++.+++.+||+.||++|||++|++++|+.++...
T Consensus       230 ----~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~  274 (276)
T d1uwha_         230 ----DLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL  274 (276)
T ss_dssp             ----CGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred             ----cchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence                001112345678999999999999999999999999999987654

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-53  Score=419.16  Aligned_cols=254  Identities=20%  Similarity=0.302  Sum_probs=208.2

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEe
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLE  348 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  348 (593)
                      .++|++.+.||+|+||+||+|+++ +|+.||||+++... ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence            468999999999999999999975 79999999997653 3344678999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCC
Q 007680          349 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGED  428 (593)
Q Consensus       349 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  428 (593)
                      |+++|+|.+++.... .+++.++..++.|+++||+|||+++    |+||||||+|||+++++.+||+|||+|+.......
T Consensus        84 y~~gg~L~~~l~~~~-~l~e~~~~~i~~qi~~al~ylH~~~----IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~  158 (271)
T d1nvra_          84 YCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLHGIG----ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  158 (271)
T ss_dssp             CCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHHHTT----EECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             ccCCCcHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHcC----CccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence            999999999997655 4999999999999999999999654    99999999999999999999999999998765443


Q ss_pred             ccccccccCCccccCccccCCCCC-CccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhh
Q 007680          429 SVRQTMTMATIGYMAPEYGLEGIV-SAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVR  507 (593)
Q Consensus       429 ~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  507 (593)
                      ........||+.|+|||++.+..+ +.++||||+||++|||+||+.||.........+..+....               
T Consensus       159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~---------------  223 (271)
T d1nvra_         159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK---------------  223 (271)
T ss_dssp             ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTC---------------
T ss_pred             cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC---------------
Confidence            333455679999999999988775 6789999999999999999999976433322222211110               


Q ss_pred             hhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          508 EEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       508 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                        ........+++++.+|+.+||+.||++|||++|+++|
T Consensus       224 --~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  260 (271)
T d1nvra_         224 --TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  260 (271)
T ss_dssp             --TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             --CCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence              0011122345678999999999999999999999764

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-52  Score=411.64  Aligned_cols=258  Identities=25%  Similarity=0.359  Sum_probs=205.1

Q ss_pred             hhccccccccCccCcccEEEEEeCCCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEecc
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFM  350 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  350 (593)
                      .++|++.+.||+|+||.||+|++.+++.||||+++... ...+++.+|++++++++||||++++|++..++..++||||+
T Consensus         4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~   82 (263)
T d1sm2a_           4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   82 (263)
T ss_dssp             CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence            35799999999999999999999888899999997643 23467999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCcc
Q 007680          351 PNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSV  430 (593)
Q Consensus       351 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~  430 (593)
                      ++|+|.+++......+++..+..++.|++.||+|||+++    |+||||||+||++++++.+||+|||+++........ 
T Consensus        83 ~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~----iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~-  157 (263)
T d1sm2a_          83 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC----VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-  157 (263)
T ss_dssp             TTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT----CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred             CCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccc----eeecccchhheeecCCCCeEecccchheeccCCCce-
Confidence            999999999887777999999999999999999999655    999999999999999999999999999876543322 


Q ss_pred             ccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhC-CCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhh
Q 007680          431 RQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTR-KRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREE  509 (593)
Q Consensus       431 ~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  509 (593)
                      ......||+.|+|||++.+..++.++|||||||++|||+|+ ++||....  .......+.....               
T Consensus       158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~--~~~~~~~i~~~~~---------------  220 (263)
T d1sm2a_         158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS--NSEVVEDISTGFR---------------  220 (263)
T ss_dssp             -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC--HHHHHHHHHHTCC---------------
T ss_pred             eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC--HHHHHHHHHhcCC---------------
Confidence            22345689999999999999999999999999999999995 55554421  1122222222111               


Q ss_pred             hhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhh
Q 007680          510 QAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVK  553 (593)
Q Consensus       510 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  553 (593)
                        ...+..+++++.+++.+||+.||++|||++|++++|+++.+.
T Consensus       221 --~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es  262 (263)
T d1sm2a_         221 --LYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES  262 (263)
T ss_dssp             --CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --CCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence              111123456789999999999999999999999999998753

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-53  Score=420.55  Aligned_cols=252  Identities=25%  Similarity=0.341  Sum_probs=209.7

Q ss_pred             hccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEecc
Q 007680          272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFM  350 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  350 (593)
                      +.|++.+.||+|+||.||+|++. +|+.||||+++.......+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            56899999999999999999975 78999999998766566678999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCcc
Q 007680          351 PNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSV  430 (593)
Q Consensus       351 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~  430 (593)
                      ++|+|.+++.+....+++.++..++.||+.||+|||+++    |+||||||+|||++.++.+||+|||+|+......  .
T Consensus        92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~----ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~--~  165 (288)
T d2jfla1          92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK----IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--Q  165 (288)
T ss_dssp             TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT----EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--H
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC----EEEeecChhheeECCCCCEEEEechhhhccCCCc--c
Confidence            999999998776666999999999999999999999655    9999999999999999999999999997653221  1


Q ss_pred             ccccccCCccccCccccC-----CCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhh
Q 007680          431 RQTMTMATIGYMAPEYGL-----EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANL  505 (593)
Q Consensus       431 ~~~~~~gt~~y~aPE~~~-----~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  505 (593)
                      ......||+.|+|||++.     +..|+.++|||||||++|||+||+.||.+....+ .+..... ..+           
T Consensus       166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~-~~~~i~~-~~~-----------  232 (288)
T d2jfla1         166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR-VLLKIAK-SEP-----------  232 (288)
T ss_dssp             HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG-HHHHHHH-SCC-----------
T ss_pred             cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH-HHHHHHc-CCC-----------
Confidence            233467999999999874     4568999999999999999999999997643221 1111111 111           


Q ss_pred             hhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          506 VREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                          .....+..+++++.+|+.+||+.||++|||++|+++|
T Consensus       233 ----~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h  269 (288)
T d2jfla1         233 ----PTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH  269 (288)
T ss_dssp             ----CCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             ----CCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                1111223446688999999999999999999999875

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-52  Score=411.11  Aligned_cols=246  Identities=22%  Similarity=0.327  Sum_probs=208.0

Q ss_pred             hccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEE
Q 007680          272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVL  347 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  347 (593)
                      ++|++.+.||+|+||.||+|+++ +++.||+|++....   ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            68999999999999999999975 78999999997643   234567899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCC
Q 007680          348 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGE  427 (593)
Q Consensus       348 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~  427 (593)
                      ||+++|+|.+++...+. +++.++..++.||++||+|||+++    |+||||||+|||++.++.+||+|||+|+......
T Consensus        86 Ey~~~g~L~~~l~~~~~-l~e~~~~~i~~qi~~al~~lH~~~----ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~  160 (263)
T d2j4za1          86 EYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSKR----VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR  160 (263)
T ss_dssp             ECCTTCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHHHTT----CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC
T ss_pred             eecCCCcHHHHHhhcCC-CCHHHHHHHHHHHHHHHHHHHHCC----eeeeeeccccceecCCCCEeecccceeeecCCCc
Confidence            99999999999987654 999999999999999999999654    9999999999999999999999999998664332


Q ss_pred             CccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhh
Q 007680          428 DSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVR  507 (593)
Q Consensus       428 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  507 (593)
                          .....||+.|+|||++.+..++.++|||||||++|||++|+.||......  .....+....              
T Consensus       161 ----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--~~~~~i~~~~--------------  220 (263)
T d2j4za1         161 ----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ--ETYKRISRVE--------------  220 (263)
T ss_dssp             ----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHTTC--------------
T ss_pred             ----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH--HHHHHHHcCC--------------
Confidence                23457999999999999999999999999999999999999999763211  1111111100              


Q ss_pred             hhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          508 EEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       508 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                          ...+..+++++.+++.+||+.||++|||++|+++|
T Consensus       221 ----~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h  255 (263)
T d2j4za1         221 ----FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH  255 (263)
T ss_dssp             ----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             ----CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence                00112345688999999999999999999999875

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-52  Score=406.26  Aligned_cols=255  Identities=24%  Similarity=0.358  Sum_probs=215.6

Q ss_pred             hhccccccccCccCcccEEEEEeCCCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEecc
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFM  350 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  350 (593)
                      .++|++.++||+|+||+||+|++++++.||||+++.... ..+.+.+|++++++++||||++++|++.+.+..++||||+
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~   81 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM   81 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred             hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence            368999999999999999999998888999999986532 3467999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCcc
Q 007680          351 PNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSV  430 (593)
Q Consensus       351 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~  430 (593)
                      ++|+|.+++......+++..+.+++.|+++||+|||+++    |+||||||+||++++++.+||+|||+++........ 
T Consensus        82 ~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~----iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~-  156 (258)
T d1k2pa_          82 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ----FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-  156 (258)
T ss_dssp             TTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT----BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-
T ss_pred             CCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcC----cccccccceeEEEcCCCcEEECcchhheeccCCCce-
Confidence            999999998877777999999999999999999999654    999999999999999999999999999876554322 


Q ss_pred             ccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhh
Q 007680          431 RQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREE  509 (593)
Q Consensus       431 ~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  509 (593)
                      ......+|+.|+|||++.+..++.++|||||||++|||+| |+.||......+  ....+....                
T Consensus       157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~--~~~~i~~~~----------------  218 (258)
T d1k2pa_         157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE--TAEHIAQGL----------------  218 (258)
T ss_dssp             CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH--HHHHHHTTC----------------
T ss_pred             eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH--HHHHHHhCC----------------
Confidence            3344568999999999999999999999999999999998 899998753221  112121111                


Q ss_pred             hhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHh
Q 007680          510 QAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKI  550 (593)
Q Consensus       510 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  550 (593)
                       ....+..+++++.+++.+||+.||++|||++|++++|.+|
T Consensus       219 -~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         219 -RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             -CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             -CCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence             1111223456889999999999999999999999999764

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.7e-52  Score=415.84  Aligned_cols=262  Identities=23%  Similarity=0.340  Sum_probs=215.2

Q ss_pred             HHHhhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEE
Q 007680          267 IQRATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKAL  345 (593)
Q Consensus       267 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  345 (593)
                      ++...++|++.+.||+|+||+||+|+++ +|+.||||+++... ...+++.+|++++++++|||||++++++.+++..++
T Consensus        12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i   90 (287)
T d1opja_          12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI   90 (287)
T ss_dssp             TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             cEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEE
Confidence            3445678999999999999999999976 68899999997653 335679999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecC
Q 007680          346 VLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG  424 (593)
Q Consensus       346 v~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~  424 (593)
                      ||||+++|+|.+++.... ..+++..+..++.|+++||+|||+++    |+||||||+|||+++++.+||+|||+|+...
T Consensus        91 v~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~----iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~  166 (287)
T d1opja_          91 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN----FIHRDLAARNCLVGENHLVKVADFGLSRLMT  166 (287)
T ss_dssp             EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCSGGGEEECGGGCEEECCCCCTTTCC
T ss_pred             EeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC----cccCccccCeEEECCCCcEEEccccceeecC
Confidence            999999999999997643 36899999999999999999999655    9999999999999999999999999998765


Q ss_pred             CCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhh
Q 007680          425 EGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDAN  504 (593)
Q Consensus       425 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  504 (593)
                      ..... ......|++.|+|||++.+..++.++|||||||++|||++|..||..... .....+.+....           
T Consensus       167 ~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~-~~~~~~~i~~~~-----------  233 (287)
T d1opja_         167 GDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDY-----------  233 (287)
T ss_dssp             SSSSE-EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC-HHHHHHHHHTTC-----------
T ss_pred             CCCce-eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch-HHHHHHHHhcCC-----------
Confidence            44322 23345688999999999999999999999999999999997776643211 111112221111           


Q ss_pred             hhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhh
Q 007680          505 LVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKV  552 (593)
Q Consensus       505 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~  552 (593)
                            ..+.+..+++++.+|+.+||+.||++|||++|+++.|+.+..
T Consensus       234 ------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~  275 (287)
T d1opja_         234 ------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  275 (287)
T ss_dssp             ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred             ------CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence                  111122456789999999999999999999999999988743

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.3e-51  Score=413.39  Aligned_cols=259  Identities=25%  Similarity=0.428  Sum_probs=202.7

Q ss_pred             hccccccccCccCcccEEEEEeC-CCC---eEEEEEeehh-hHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEE
Q 007680          272 DEFNECNLLGTSSFGSVYKGTIS-DGT---DVAIKVFNLQ-LERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALV  346 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~---~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  346 (593)
                      ++|++.+.||+|+||+||+|+++ +++   .||||.+... .....+.|.+|++++++++|||||+++|++.+++..++|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            56777899999999999999975 332   5889988654 344567899999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCC
Q 007680          347 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG  426 (593)
Q Consensus       347 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  426 (593)
                      |||+++|+|.+++......+++.++..++.||++||+|||+++    |+||||||+|||++.++.+||+|||+++.+...
T Consensus       106 ~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~----iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~  181 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN----YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD  181 (299)
T ss_dssp             EECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             EEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCC----CccCccccceEEECCCCcEEECCcccceEccCC
Confidence            9999999999999887767999999999999999999999654    999999999999999999999999999877544


Q ss_pred             CCccc---cccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhhh
Q 007680          427 EDSVR---QTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVD  502 (593)
Q Consensus       427 ~~~~~---~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  502 (593)
                      .....   .....+|+.|+|||++.++.++.++|||||||++|||+| |+.||.+....  .....+....         
T Consensus       182 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~--~~~~~i~~~~---------  250 (299)
T d1jpaa_         182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ--DVINAIEQDY---------  250 (299)
T ss_dssp             --------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHTTC---------
T ss_pred             CCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCC---------
Confidence            32211   122457899999999999999999999999999999998 89999764321  2222222111         


Q ss_pred             hhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhh
Q 007680          503 ANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVK  553 (593)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  553 (593)
                              ..+.+.+++.++.+++.+||+.||++|||+.|+++.|+++...
T Consensus       251 --------~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~  293 (299)
T d1jpaa_         251 --------RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN  293 (299)
T ss_dssp             --------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             --------CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence                    1112234567899999999999999999999999999987653

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-52  Score=411.96  Aligned_cols=252  Identities=22%  Similarity=0.304  Sum_probs=207.0

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALV  346 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  346 (593)
                      .++|++.+.||+|+||.||+|++. +|+.||||+++...   ....+.+.+|++++++++||||+++++++.+.+..|+|
T Consensus         7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv   86 (288)
T d1uu3a_           7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG   86 (288)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEE
T ss_pred             CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEE
Confidence            368999999999999999999975 79999999998643   23456789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCC
Q 007680          347 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG  426 (593)
Q Consensus       347 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  426 (593)
                      |||+++|+|.+++...+. +++..+..++.|++.||+|||+++    |+||||||+||++++++.+||+|||+|+.+...
T Consensus        87 mEy~~gg~L~~~~~~~~~-l~e~~~~~~~~qi~~al~ylH~~~----iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~  161 (288)
T d1uu3a_          87 LSYAKNGELLKYIRKIGS-FDETCTRFYTAEIVSALEYLHGKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  161 (288)
T ss_dssp             ECCCTTEEHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHHHTT----EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EEccCCCCHHHhhhccCC-CCHHHHHHHHHHHHHHHHhhcccc----EEcCcCCccccccCCCceEEecccccceecccC
Confidence            999999999999887654 999999999999999999999655    999999999999999999999999999987654


Q ss_pred             CCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhh
Q 007680          427 EDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLV  506 (593)
Q Consensus       427 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  506 (593)
                      ..........||+.|+|||++.+..++.++||||+||++|||++|+.||.....  ......+...           .  
T Consensus       162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--~~~~~~i~~~-----------~--  226 (288)
T d1uu3a_         162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE--YLIFQKIIKL-----------E--  226 (288)
T ss_dssp             --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHTT-----------C--
T ss_pred             CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH--HHHHHHHHcC-----------C--
Confidence            433344456799999999999999999999999999999999999999976321  1111111110           0  


Q ss_pred             hhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 007680          507 REEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKL  547 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  547 (593)
                         .  ..+..+++++.+|+.+||+.||++|||++|++++-
T Consensus       227 ---~--~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~  262 (288)
T d1uu3a_         227 ---Y--DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYG  262 (288)
T ss_dssp             ---C--CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHH
T ss_pred             ---C--CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCH
Confidence               0  01123456789999999999999999999987653

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-51  Score=405.47  Aligned_cols=255  Identities=21%  Similarity=0.279  Sum_probs=197.2

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh--HHHHHHHHHHHHHHhhcCCCCcceeeeeeec--CCceEE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSYSN--PDFKAL  345 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l  345 (593)
                      .++|++.+.||+|+||.||+|+.+ +|+.||+|+++...  +...+.+.+|++++++++||||+++++++.+  .+..|+
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i   82 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   82 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence            478999999999999999999975 78999999997642  4456678999999999999999999999865  456899


Q ss_pred             EEeccCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCCeEecCCCCCCeeeCCCCcEEEEeeccce
Q 007680          346 VLEFMPNGSLEKWLYSH---NYFLDILERLNIMIDVGSALEYLHNGHS-SVHIIHCDLKPTNILLDENMVAHVSDFGIYK  421 (593)
Q Consensus       346 v~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~  421 (593)
                      ||||+++|+|.+++.+.   +..+++..++.++.|++.||+|||+++. ..+|+||||||+|||++.++.+||+|||+|+
T Consensus        83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~  162 (269)
T d2java1          83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  162 (269)
T ss_dssp             EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred             EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence            99999999999998642   3359999999999999999999997541 2359999999999999999999999999998


Q ss_pred             ecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhh
Q 007680          422 LLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVV  501 (593)
Q Consensus       422 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  501 (593)
                      .+.....  ......||+.|+|||++.+..++.++|||||||++|||+||+.||.....  ......+......      
T Consensus       163 ~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~--~~~~~~i~~~~~~------  232 (269)
T d2java1         163 ILNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ--KELAGKIREGKFR------  232 (269)
T ss_dssp             HC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHTCCC------
T ss_pred             ecccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH--HHHHHHHHcCCCC------
Confidence            8754332  22346799999999999999999999999999999999999999976322  1121211111100      


Q ss_pred             hhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          502 DANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       502 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                                 ..+..+++++.+++.+||+.||++|||++|+++|
T Consensus       233 -----------~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h  266 (269)
T d2java1         233 -----------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN  266 (269)
T ss_dssp             -----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             -----------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence                       0112345688999999999999999999999875

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-51  Score=406.56  Aligned_cols=260  Identities=22%  Similarity=0.380  Sum_probs=214.0

Q ss_pred             hhccccccc-cCccCcccEEEEEeC---CCCeEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEE
Q 007680          271 TDEFNECNL-LGTSSFGSVYKGTIS---DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKAL  345 (593)
Q Consensus       271 ~~~~~~~~~-lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  345 (593)
                      .++|.+.+. ||+|+||.||+|.++   ++..||||+++... ....+.+.+|++++++++|||||++++++.. +..++
T Consensus         7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l   85 (285)
T d1u59a_           7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML   85 (285)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred             ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence            456777774 999999999999864   35579999997543 4456789999999999999999999999875 46899


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCC
Q 007680          346 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGE  425 (593)
Q Consensus       346 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~  425 (593)
                      ||||+++|+|.+++...+..+++.++..++.|+++||+|||+++    |+||||||+||+++.++.+||+|||+++.+..
T Consensus        86 vmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~----iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~  161 (285)
T d1u59a_          86 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN----FVHRDLAARNVLLVNRHYAKISDFGLSKALGA  161 (285)
T ss_dssp             EEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT----EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             EEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCC----eecCcCchhheeeccCCceeeccchhhhcccc
Confidence            99999999999998877667999999999999999999999654    99999999999999999999999999998765


Q ss_pred             CCCcc-ccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhhhh
Q 007680          426 GEDSV-RQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDA  503 (593)
Q Consensus       426 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  503 (593)
                      ..... ......||+.|+|||++.++.++.++|||||||++|||+| |+.||.+....  .....+....          
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~--~~~~~i~~~~----------  229 (285)
T d1u59a_         162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVMAFIEQGK----------  229 (285)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--HHHHHHHTTC----------
T ss_pred             cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCC----------
Confidence            44322 2234568999999999999999999999999999999998 99999874322  2222222111          


Q ss_pred             hhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhhh
Q 007680          504 NLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKF  554 (593)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  554 (593)
                             ..+.+..+++++.+++.+||+.||++|||+.+|.+.|+......
T Consensus       230 -------~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~  273 (285)
T d1u59a_         230 -------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL  273 (285)
T ss_dssp             -------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             -------CCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence                   11122345678999999999999999999999999998876554

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-52  Score=421.28  Aligned_cols=268  Identities=22%  Similarity=0.297  Sum_probs=208.7

Q ss_pred             hhhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEE
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVL  347 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  347 (593)
                      ..++|++.+.||+|+||+||+|++. +|+.||+|+++... ....+.+.+|+.++++++|||||+++++|.++++.++||
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm   83 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   83 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            4678999999999999999999975 78999999997642 334567899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCC
Q 007680          348 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGE  427 (593)
Q Consensus       348 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~  427 (593)
                      ||+++|+|.+++.+.+. +++..+..++.|+++||+|||++   .+|+||||||+|||+++++.+||+|||+|+.+... 
T Consensus        84 Ey~~gg~L~~~l~~~~~-l~~~~~~~~~~qil~aL~yLH~~---~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-  158 (322)
T d1s9ja_          84 EHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLREK---HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  158 (322)
T ss_dssp             ECCTTEEHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHHHH---HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred             EcCCCCcHHHHHhhcCC-CCHHHHHHHHHHHHHHHHHHHHh---CCEEccccCHHHeeECCCCCEEEeeCCCccccCCC-
Confidence            99999999999987654 99999999999999999999963   14999999999999999999999999999876432 


Q ss_pred             CccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHH--HHh-------------
Q 007680          428 DSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWV--KES-------------  492 (593)
Q Consensus       428 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~--~~~-------------  492 (593)
                         ......||+.|+|||++.+..|+.++||||+||++|||++|+.||..............  ...             
T Consensus       159 ---~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (322)
T d1s9ja_         159 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR  235 (322)
T ss_dssp             ---TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------
T ss_pred             ---ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccc
Confidence               12345799999999999999999999999999999999999999976432211110000  000             


Q ss_pred             ----------cCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          493 ----------LPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       493 ----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                                .+....+..+........ .......+.++.+++.+||..||++|||++|+++|
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H  298 (322)
T d1s9ja_         236 PLSSYGMDSRPPMAIFELLDYIVNEPPP-KLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  298 (322)
T ss_dssp             ----------CCCCHHHHHHHHHTSCCC-CCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cccccccccccchhHHHHHhhhhccCCc-cCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence                      000000000000000000 00001235678999999999999999999999987

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.8e-52  Score=408.93  Aligned_cols=257  Identities=22%  Similarity=0.380  Sum_probs=209.4

Q ss_pred             hhhccccccccCccCcccEEEEEeCCCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEec
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEF  349 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  349 (593)
                      ..++|++.+.||+|+||.||+|++++++.||||+++... ...+.+.+|++++++++|||||++++++.+ +..++||||
T Consensus        11 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey   88 (272)
T d1qpca_          11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY   88 (272)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             CHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEe
Confidence            357899999999999999999999888999999997643 234679999999999999999999998755 567999999


Q ss_pred             cCCCCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCC
Q 007680          350 MPNGSLEKWLYSHNY-FLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGED  428 (593)
Q Consensus       350 ~~~gsL~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  428 (593)
                      +++|+|.+++..... .+++.++..++.||++||+|||+++    |+||||||+||++++++.+||+|||+|+.+.....
T Consensus        89 ~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~----ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~  164 (272)
T d1qpca_          89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN----YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY  164 (272)
T ss_dssp             CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT----EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred             CCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC----cccCccchhheeeecccceeeccccceEEccCCcc
Confidence            999999998765433 5899999999999999999999654    99999999999999999999999999998765432


Q ss_pred             ccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhh
Q 007680          429 SVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVRE  508 (593)
Q Consensus       429 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  508 (593)
                       .......||+.|+|||++.++.++.++|||||||++|||+||..|+...... ......+....               
T Consensus       165 -~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~-~~~~~~i~~~~---------------  227 (272)
T d1qpca_         165 -TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-PEVIQNLERGY---------------  227 (272)
T ss_dssp             -ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH-HHHHHHHHTTC---------------
T ss_pred             -ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH-HHHHHHHHhcC---------------
Confidence             2234456899999999999899999999999999999999966554332111 11112221111               


Q ss_pred             hhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhh
Q 007680          509 EQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIK  551 (593)
Q Consensus       509 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~  551 (593)
                        ....+..+++++.+++.+||+.||++|||++|+++.|+++-
T Consensus       228 --~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f  268 (272)
T d1qpca_         228 --RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF  268 (272)
T ss_dssp             --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --CCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence              11112245668899999999999999999999999998863

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-50  Score=399.27  Aligned_cols=248  Identities=24%  Similarity=0.350  Sum_probs=198.9

Q ss_pred             cccccccCccCcccEEEEEeC-CCCeEEEEEeehhh--HHHHHHHHHHHHHHhhcCCCCcceeeeeeec----CCceEEE
Q 007680          274 FNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSYSN----PDFKALV  346 (593)
Q Consensus       274 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv  346 (593)
                      |+..++||+|+||+||+|++. +++.||+|++....  ....+.+.+|++++++++||||+++++++.+    ....++|
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv   90 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV   90 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence            356678999999999999975 68899999997653  4456779999999999999999999999865    3467999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeC-CCCcEEEEeeccceecCC
Q 007680          347 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLD-ENMVAHVSDFGIYKLLGE  425 (593)
Q Consensus       347 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~-~~~~~kL~Dfg~a~~~~~  425 (593)
                      |||+++|+|.+++.+... +++.++..++.||++||+|||+++  .+|+||||||+|||++ +++.+||+|||+|+....
T Consensus        91 mE~~~~g~L~~~l~~~~~-~~~~~~~~~~~qi~~gl~yLH~~~--~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~  167 (270)
T d1t4ha_          91 TELMTSGTLKTYLKRFKV-MKIKVLRSWCRQILKGLQFLHTRT--PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  167 (270)
T ss_dssp             EECCCSCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHHTSS--SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             EeCCCCCcHHHHHhcccc-ccHHHHHHHHHHHHHHHHHHHHCC--CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence            999999999999987654 999999999999999999999643  3499999999999997 578999999999986433


Q ss_pred             CCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhh
Q 007680          426 GEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANL  505 (593)
Q Consensus       426 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  505 (593)
                      .    ......||+.|+|||++.+ .++.++|||||||++|||++|+.||.+..... ...+.+....+           
T Consensus       168 ~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~-~~~~~i~~~~~-----------  230 (270)
T d1t4ha_         168 S----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-QIYRRVTSGVK-----------  230 (270)
T ss_dssp             T----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-HHHHHHTTTCC-----------
T ss_pred             C----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH-HHHHHHHcCCC-----------
Confidence            2    2234579999999998865 69999999999999999999999997532211 11111111100           


Q ss_pred             hhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          506 VREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                           .......+++++.+++.+||+.||++|||++|+++|
T Consensus       231 -----~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H  266 (270)
T d1t4ha_         231 -----PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  266 (270)
T ss_dssp             -----CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             -----CcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence                 001112235578999999999999999999999875

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-50  Score=403.83  Aligned_cols=262  Identities=24%  Similarity=0.417  Sum_probs=206.2

Q ss_pred             hhccccccccCccCcccEEEEEeCC-C----CeEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTISD-G----TDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKA  344 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  344 (593)
                      .++|++.+.||+|+||.||+|.+++ +    ..||||+++... ......+.+|++++++++|||||+++|++.+.+..+
T Consensus         6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~   85 (283)
T d1mqba_           6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM   85 (283)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence            3578899999999999999998653 2    469999997643 344567899999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecC
Q 007680          345 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG  424 (593)
Q Consensus       345 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~  424 (593)
                      +||||+.++++.+++......+++.++..++.|++.||+|||+++    |+||||||+|||++.++.+||+|||+++.+.
T Consensus        86 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~----iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  161 (283)
T d1mqba_          86 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN----YVHRDLAARNILVNSNLVCKVSDFGLSRVLE  161 (283)
T ss_dssp             EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             EEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccc----cccCccccceEEECCCCeEEEcccchhhccc
Confidence            999999999999999887777999999999999999999999654    9999999999999999999999999998775


Q ss_pred             CCCCc-cccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhh
Q 007680          425 EGEDS-VRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDA  503 (593)
Q Consensus       425 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  503 (593)
                      ..... .......||+.|+|||++.++.++.++|||||||++|||++|..|+...... ....+.+....          
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~-~~~~~~i~~~~----------  230 (283)
T d1mqba_         162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-HEVMKAINDGF----------  230 (283)
T ss_dssp             ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-HHHHHHHHTTC----------
T ss_pred             CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH-HHHHHHHhccC----------
Confidence            44322 1223456899999999999999999999999999999999976665432111 11222222111          


Q ss_pred             hhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhhh
Q 007680          504 NLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKF  554 (593)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  554 (593)
                             ..+.+.+++.++.+++.+||+.||++|||+.||++.|+++....
T Consensus       231 -------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p  274 (283)
T d1mqba_         231 -------RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP  274 (283)
T ss_dssp             -------CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             -------CCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCc
Confidence                   11122345678899999999999999999999999999887643

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1e-50  Score=407.92  Aligned_cols=252  Identities=24%  Similarity=0.304  Sum_probs=192.7

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEe
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLE  348 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  348 (593)
                      .+.|++.+.||+|+||+||+|+++ +|+.||||++.... ......+.+|++++++++||||+++++++.+++..|+|||
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE   87 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ   87 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            467999999999999999999975 78999999997653 2334568899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeC---CCCcEEEEeeccceecCC
Q 007680          349 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLD---ENMVAHVSDFGIYKLLGE  425 (593)
Q Consensus       349 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~---~~~~~kL~Dfg~a~~~~~  425 (593)
                      |++||+|.+++...+. +++.++..++.||+.||+|||+++    |+||||||+||++.   +++.+||+|||+|+....
T Consensus        88 ~~~gg~L~~~l~~~~~-l~e~~~~~~~~qi~~al~ylH~~~----iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~  162 (307)
T d1a06a_          88 LVSGGELFDRIVEKGF-YTERDASRLIFQVLDAVKYLHDLG----IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP  162 (307)
T ss_dssp             CCCSCBHHHHHHTCSC-CCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred             ccCCCcHHHhhhcccC-CCHHHHHHHHHHHHHHHHhhhhce----eeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence            9999999999987554 999999999999999999999655    99999999999995   578999999999987654


Q ss_pred             CCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhh
Q 007680          426 GEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANL  505 (593)
Q Consensus       426 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  505 (593)
                      ..   ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....  .....+......          
T Consensus       163 ~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~--~~~~~i~~~~~~----------  227 (307)
T d1a06a_         163 GS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA--KLFEQILKAEYE----------  227 (307)
T ss_dssp             -------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHTTCCC----------
T ss_pred             CC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH--HHHHHHhccCCC----------
Confidence            32   223457999999999999999999999999999999999999999763221  111111111000          


Q ss_pred             hhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          506 VREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                          ...+....+++++.+|+.+||+.||++|||++|+++|
T Consensus       228 ----~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  264 (307)
T d1a06a_         228 ----FDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH  264 (307)
T ss_dssp             ----CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             ----CCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence                0011112346688999999999999999999999986

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.6e-50  Score=413.51  Aligned_cols=253  Identities=23%  Similarity=0.273  Sum_probs=211.6

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEec
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEF  349 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  349 (593)
                      .++|++.+.||+|+||.||+|+.. +|+.||||++........+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            468999999999999999999975 7999999999876656667899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC--CCcEEEEeeccceecCCCC
Q 007680          350 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDE--NMVAHVSDFGIYKLLGEGE  427 (593)
Q Consensus       350 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~--~~~~kL~Dfg~a~~~~~~~  427 (593)
                      |+||+|.+++......+++.++..++.||+.||+|||+++    |+||||||+|||++.  ++.+||+|||+++.+....
T Consensus       105 ~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~----iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~  180 (350)
T d1koaa2         105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN----YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ  180 (350)
T ss_dssp             CCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTT----EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred             CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC----CeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence            9999999999766666999999999999999999999655    999999999999964  6789999999999875443


Q ss_pred             CccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhh
Q 007680          428 DSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVR  507 (593)
Q Consensus       428 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  507 (593)
                      .   .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+...  ......+......           .
T Consensus       181 ~---~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--~~~~~~i~~~~~~-----------~  244 (350)
T d1koaa2         181 S---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND--DETLRNVKSCDWN-----------M  244 (350)
T ss_dssp             C---EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHTCCC-----------S
T ss_pred             c---cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH--HHHHHHHHhCCCC-----------C
Confidence            2   3345799999999999999999999999999999999999999976321  1111111111000           0


Q ss_pred             hhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          508 EEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       508 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                         .......+++++.+|+.+||+.||++|||++|+++|
T Consensus       245 ---~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         245 ---DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             ---CCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             ---CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence               001112345678999999999999999999999987

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-51  Score=413.27  Aligned_cols=258  Identities=22%  Similarity=0.360  Sum_probs=210.6

Q ss_pred             hhhccccccccCccCcccEEEEEeCC-C-----CeEEEEEeehh-hHHHHHHHHHHHHHHhhc-CCCCcceeeeeeecCC
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTISD-G-----TDVAIKVFNLQ-LERAFRSFDSECEVLRNV-RHRNLIKILSSYSNPD  341 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  341 (593)
                      ..++|++.+.||+|+||+||+|++.. +     ..||+|.+... .......+.+|+.++.++ +|||||++++++.+.+
T Consensus        35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~  114 (325)
T d1rjba_          35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  114 (325)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence            34789999999999999999998642 2     36999998654 334456789999999998 8999999999999999


Q ss_pred             ceEEEEeccCCCCHHHHHhhCCC----------------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCC
Q 007680          342 FKALVLEFMPNGSLEKWLYSHNY----------------------FLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDL  399 (593)
Q Consensus       342 ~~~lv~e~~~~gsL~~~l~~~~~----------------------~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dl  399 (593)
                      ..++||||+++|+|.+++.....                      .+++.+++.++.||++||+|||+++    |+||||
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~----IiHRDl  190 (325)
T d1rjba_         115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS----CVHRDL  190 (325)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT----EEETTC
T ss_pred             eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC----eeeccC
Confidence            99999999999999999976532                      4789999999999999999999654    999999


Q ss_pred             CCCCeeeCCCCcEEEEeeccceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCcc
Q 007680          400 KPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEM  478 (593)
Q Consensus       400 kp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~  478 (593)
                      ||+||+++.++.+||+|||+|+...............||+.|+|||++.++.++.++|||||||++|||+| |+.||.+.
T Consensus       191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~  270 (325)
T d1rjba_         191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI  270 (325)
T ss_dssp             SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             chhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCC
Confidence            99999999999999999999987765544434445668999999999999999999999999999999998 89999764


Q ss_pred             ccccchHHHHHHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHH
Q 007680          479 FIGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKK  549 (593)
Q Consensus       479 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  549 (593)
                      .... .+.+.+....                 ..+.+..+++++.+|+.+||+.||++|||++||+++|..
T Consensus       271 ~~~~-~~~~~~~~~~-----------------~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~  323 (325)
T d1rjba_         271 PVDA-NFYKLIQNGF-----------------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC  323 (325)
T ss_dssp             CCSH-HHHHHHHTTC-----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CHHH-HHHHHHhcCC-----------------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence            3221 2222222111                 111223456789999999999999999999999999963

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=2.5e-50  Score=412.39  Aligned_cols=253  Identities=23%  Similarity=0.273  Sum_probs=212.1

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEec
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEF  349 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  349 (593)
                      .++|++.+.||+|+||.||+|+.. +|+.||||+++.........+.+|++++++++||||+++++++.+++..|+||||
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  107 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  107 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            467999999999999999999975 7999999999876555567889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeC--CCCcEEEEeeccceecCCCC
Q 007680          350 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLD--ENMVAHVSDFGIYKLLGEGE  427 (593)
Q Consensus       350 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~--~~~~~kL~Dfg~a~~~~~~~  427 (593)
                      |+||+|.+++......+++.++..++.||+.||+|||+++    |+||||||+|||++  .++.+||+|||+|+.+....
T Consensus       108 ~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~----iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~  183 (352)
T d1koba_         108 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS----IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE  183 (352)
T ss_dssp             CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT----EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred             CCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC----eeecccccccccccccCCCeEEEeecccceecCCCC
Confidence            9999999998877667999999999999999999999655    99999999999998  67899999999999876543


Q ss_pred             CccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhh
Q 007680          428 DSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVR  507 (593)
Q Consensus       428 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  507 (593)
                      .   .....||+.|+|||++.+..++.++||||+||++|||+||+.||.+....  .....+.......           
T Consensus       184 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--~~~~~i~~~~~~~-----------  247 (352)
T d1koba_         184 I---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL--ETLQNVKRCDWEF-----------  247 (352)
T ss_dssp             C---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHHHHHHHCCCCC-----------
T ss_pred             c---eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhCCCCC-----------
Confidence            2   34457899999999999999999999999999999999999999763221  1111111110000           


Q ss_pred             hhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          508 EEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       508 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                         .......+++++.+|+.+||+.||++|||++|+++|
T Consensus       248 ---~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H  283 (352)
T d1koba_         248 ---DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  283 (352)
T ss_dssp             ---CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             ---CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence               001112345688999999999999999999999986

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.5e-50  Score=406.80  Aligned_cols=246  Identities=25%  Similarity=0.318  Sum_probs=202.6

Q ss_pred             hccccccccCccCcccEEEEEeC-CCCeEEEEEeehh---hHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEE
Q 007680          272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQ---LERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVL  347 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  347 (593)
                      +.|+.++.||+|+||.||+|++. +|+.||||+++..   .....+.+.+|++++++++|||||++++++.+++..++||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            45999999999999999999965 7899999999754   2344567899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCC
Q 007680          348 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGE  427 (593)
Q Consensus       348 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~  427 (593)
                      |||++|+|..++.... .+++.++..++.||+.||.|||+++    |+||||||+|||+++++.+||+|||+|+..... 
T Consensus        95 E~~~~g~l~~~~~~~~-~l~e~~~~~i~~qi~~aL~yLH~~~----iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~-  168 (309)
T d1u5ra_          95 EYCLGSASDLLEVHKK-PLQEVEIAAVTHGALQGLAYLHSHN----MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-  168 (309)
T ss_dssp             ECCSEEHHHHHHHHTS-CCCHHHHHHHHHHHHHHHHHHHHTT----CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-
T ss_pred             EecCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCC----EeccCCCcceEEECCCCCEEEeecccccccCCC-
Confidence            9999999987766554 4999999999999999999999655    999999999999999999999999999865432 


Q ss_pred             CccccccccCCccccCccccCC---CCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhh
Q 007680          428 DSVRQTMTMATIGYMAPEYGLE---GIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDAN  504 (593)
Q Consensus       428 ~~~~~~~~~gt~~y~aPE~~~~---~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  504 (593)
                           ....||+.|+|||++.+   +.|+.++|||||||++|||++|+.||.+....+ .+........+.         
T Consensus       169 -----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~-~~~~i~~~~~~~---------  233 (309)
T d1u5ra_         169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQNESPA---------  233 (309)
T ss_dssp             -----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHSCCCC---------
T ss_pred             -----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHhCCCCC---------
Confidence                 33569999999998754   468999999999999999999999997632211 111111111100         


Q ss_pred             hhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          505 LVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       505 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                              .....+++++.+|+.+||+.||++|||++|+++|
T Consensus       234 --------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H  267 (309)
T d1u5ra_         234 --------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (309)
T ss_dssp             --------CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             --------CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence                    0112245678999999999999999999999874

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-50  Score=400.27  Aligned_cols=249  Identities=23%  Similarity=0.355  Sum_probs=202.1

Q ss_pred             cccCccCcccEEEEEeC---CCCeEEEEEeehhh--HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEeccCC
Q 007680          278 NLLGTSSFGSVYKGTIS---DGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFMPN  352 (593)
Q Consensus       278 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  352 (593)
                      ++||+|+||.||+|.++   +++.||||+++...  ....+.+.+|++++++++||||+++++++.. +..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            47999999999999864   35689999997542  3345689999999999999999999999865 457899999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCcc-c
Q 007680          353 GSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSV-R  431 (593)
Q Consensus       353 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~-~  431 (593)
                      |+|.+++..... +++.++..++.||+.||+|||+++    |+||||||+||+++.++.+||+|||+++.+....... .
T Consensus        92 g~L~~~l~~~~~-l~~~~~~~i~~qi~~gl~ylH~~~----iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~  166 (277)
T d1xbba_          92 GPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYLEESN----FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA  166 (277)
T ss_dssp             EEHHHHHHHCTT-CCHHHHHHHHHHHHHHHHHHHHTT----EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred             CcHHHHHhhccC-CCHHHHHHHHHHHHHHHhhHHhCC----cccCCCcchhhcccccCcccccchhhhhhcccccccccc
Confidence            999999987664 999999999999999999999654    9999999999999999999999999999876543322 2


Q ss_pred             cccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhhh
Q 007680          432 QTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQ  510 (593)
Q Consensus       432 ~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  510 (593)
                      .....||+.|+|||++.+..++.++|||||||++|||+| |+.||.+....  .....+....                 
T Consensus       167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~--~~~~~i~~~~-----------------  227 (277)
T d1xbba_         167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVTAMLEKGE-----------------  227 (277)
T ss_dssp             ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHHTTC-----------------
T ss_pred             ccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH--HHHHHHHcCC-----------------
Confidence            234568999999999999999999999999999999998 89999764321  1222222111                 


Q ss_pred             hhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhh
Q 007680          511 AFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIK  551 (593)
Q Consensus       511 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~  551 (593)
                      ..+.+..+++++.+++.+||+.||++|||+++|.+.|+..-
T Consensus       228 ~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~  268 (277)
T d1xbba_         228 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY  268 (277)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             CCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence            11122345678999999999999999999999999888764

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-49  Score=398.94  Aligned_cols=252  Identities=22%  Similarity=0.273  Sum_probs=208.2

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh------HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCce
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL------ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFK  343 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  343 (593)
                      .++|++.+.||+|+||+||+|+++ +|+.||||+++...      ....+.+.+|++++++++||||+++++++.+++..
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            467999999999999999999975 79999999997542      12356799999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC----cEEEEeecc
Q 007680          344 ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENM----VAHVSDFGI  419 (593)
Q Consensus       344 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~----~~kL~Dfg~  419 (593)
                      ++|||||++|+|.+++...+. +++.++..++.|++.||+|||+++    |+||||||+||+++.++    .+|++|||+
T Consensus        89 ~iv~E~~~gg~L~~~i~~~~~-l~~~~~~~~~~qi~~al~yLH~~~----ivHrDiKp~Nill~~~~~~~~~vkl~DfG~  163 (293)
T d1jksa_          89 ILILELVAGGELFDFLAEKES-LTEEEATEFLKQILNGVYYLHSLQ----IAHFDLKPENIMLLDRNVPKPRIKIIDFGL  163 (293)
T ss_dssp             EEEEECCCSCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHHHTT----EECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEEEcCCCccccchhccccc-cchhHHHHHHHHHHHHHHhhhhcc----eeecccccceEEEecCCCcccceEecchhh
Confidence            999999999999999987654 999999999999999999999655    99999999999998776    599999999


Q ss_pred             ceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhh
Q 007680          420 YKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTE  499 (593)
Q Consensus       420 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  499 (593)
                      |........   .....||+.|+|||++.+..++.++||||+||++|||++|+.||.+....  .....+......    
T Consensus       164 a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~--~~~~~i~~~~~~----  234 (293)
T d1jksa_         164 AHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--ETLANVSAVNYE----  234 (293)
T ss_dssp             CEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHTTCCC----
T ss_pred             hhhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH--HHHHHHHhcCCC----
Confidence            988754332   33456899999999999999999999999999999999999999763211  111111111000    


Q ss_pred             hhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          500 VVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       500 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                                ........+++++.+|+.+||+.||++|||++|+++|
T Consensus       235 ----------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  271 (293)
T d1jksa_         235 ----------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  271 (293)
T ss_dssp             ----------CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ----------CCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                      0011122346688999999999999999999999875

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.4e-50  Score=404.14  Aligned_cols=258  Identities=25%  Similarity=0.419  Sum_probs=208.1

Q ss_pred             hccccccccCccCcccEEEEEeC-CCC----eEEEEEeehh-hHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEE
Q 007680          272 DEFNECNLLGTSSFGSVYKGTIS-DGT----DVAIKVFNLQ-LERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKAL  345 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  345 (593)
                      ++|++++.||+|+||+||+|.+. +|+    +||+|.++.. .....+.+.+|++++++++|||||++++++.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            47999999999999999999865 444    5888888654 334567899999999999999999999999875 5678


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCC
Q 007680          346 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGE  425 (593)
Q Consensus       346 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~  425 (593)
                      ++||+.+|+|.+++......+++..+..++.||++||+|||+++    |+||||||+||+++.++.+||+|||+|+....
T Consensus        88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~----iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~  163 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  163 (317)
T ss_dssp             EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred             EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcC----cccCcchhhcceeCCCCCeEeeccccceeccc
Confidence            89999999999999888778999999999999999999999654    99999999999999999999999999998765


Q ss_pred             CCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhhhhh
Q 007680          426 GEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDAN  504 (593)
Q Consensus       426 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  504 (593)
                      ...........||+.|+|||++.++.++.++|||||||++|||+| |++||.+....  .+...+....           
T Consensus       164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~--~~~~~i~~~~-----------  230 (317)
T d1xkka_         164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSILEKGE-----------  230 (317)
T ss_dssp             TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG--GHHHHHHHTC-----------
T ss_pred             ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH--HHHHHHHcCC-----------
Confidence            544444445568999999999999999999999999999999999 88998764322  1222222111           


Q ss_pred             hhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhh
Q 007680          505 LVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVK  553 (593)
Q Consensus       505 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  553 (593)
                            ..+.+..+++++.+++.+||+.||++|||+.|++++|+.+...
T Consensus       231 ------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~  273 (317)
T d1xkka_         231 ------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  273 (317)
T ss_dssp             ------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             ------CCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence                  1112234567889999999999999999999999999988654

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-49  Score=401.69  Aligned_cols=249  Identities=21%  Similarity=0.254  Sum_probs=209.6

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALV  346 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  346 (593)
                      .++|++++.||+|+||.||+|+.+ +|+.||||++++..   ....+.+.+|+.++++++||||+++++++.+.+..|+|
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence            478999999999999999999975 79999999998653   23456788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCC
Q 007680          347 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG  426 (593)
Q Consensus       347 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  426 (593)
                      |||++||+|.+++...+. +++..+..++.|++.||+|||+++    |+||||||+|||++.+|.+||+|||+|+.....
T Consensus        84 ~ey~~gg~L~~~~~~~~~-~~e~~~~~~~~qil~al~ylH~~~----iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~  158 (337)
T d1o6la_          84 MEYANGGELFFHLSRERV-FTEERARFYGAEIVSALEYLHSRD----VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD  158 (337)
T ss_dssp             EECCTTCBHHHHHHHHSC-CCHHHHHHHHHHHHHHHHHHHHTT----CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred             eeccCCCchhhhhhcccC-CcHHHHHHHHHHHhhhhhhhhhcC----ccccccCHHHeEecCCCCEEEeecccccccccC
Confidence            999999999999988665 899999999999999999999654    999999999999999999999999999876433


Q ss_pred             CCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhh
Q 007680          427 EDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLV  506 (593)
Q Consensus       427 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  506 (593)
                      ..  .....+||+.|+|||++.+..|+.++||||+||++|||++|++||......  .+.+......             
T Consensus       159 ~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~--~~~~~i~~~~-------------  221 (337)
T d1o6la_         159 GA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--RLFELILMEE-------------  221 (337)
T ss_dssp             TC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHCC-------------
T ss_pred             Cc--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH--HHHHHHhcCC-------------
Confidence            22  234467999999999999999999999999999999999999999774221  1111111110             


Q ss_pred             hhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCC-----HHHHHHH
Q 007680          507 REEQAFSAKMDCILSIMDFALDCCMESPDMRIN-----MTDAAAK  546 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~  546 (593)
                           ...+..+++++.+|+.+||++||++||+     ++|+++|
T Consensus       222 -----~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H  261 (337)
T d1o6la_         222 -----IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             -----CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence                 0111234567899999999999999995     8888876

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.4e-50  Score=402.64  Aligned_cols=263  Identities=23%  Similarity=0.377  Sum_probs=214.8

Q ss_pred             HHHHhhhccccccccCccCcccEEEEEeC------CCCeEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceeeeeee
Q 007680          266 DIQRATDEFNECNLLGTSSFGSVYKGTIS------DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSYS  338 (593)
Q Consensus       266 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  338 (593)
                      +++...++|++.+.||+|+||+||+|+++      +++.||||+++... ....+.+.+|++++++++||||+++++++.
T Consensus         7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~   86 (301)
T d1lufa_           7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA   86 (301)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence            34445678999999999999999999864      35789999997653 334567999999999999999999999999


Q ss_pred             cCCceEEEEeccCCCCHHHHHhhCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeE
Q 007680          339 NPDFKALVLEFMPNGSLEKWLYSHN-----------------------YFLDILERLNIMIDVGSALEYLHNGHSSVHII  395 (593)
Q Consensus       339 ~~~~~~lv~e~~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~iv  395 (593)
                      ..+..++||||+++|+|.+++....                       ..+++.++..++.|++.||+|||+++    |+
T Consensus        87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~----iv  162 (301)
T d1lufa_          87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK----FV  162 (301)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT----CC
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC----eE
Confidence            9999999999999999999997532                       14789999999999999999999654    99


Q ss_pred             ecCCCCCCeeeCCCCcEEEEeeccceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCC-CC
Q 007680          396 HCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRK-RP  474 (593)
Q Consensus       396 H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~-~p  474 (593)
                      ||||||+|||++.++.+||+|||+|+.+.............+++.|+|||++.+..++.++|||||||++|||++|. +|
T Consensus       163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p  242 (301)
T d1lufa_         163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP  242 (301)
T ss_dssp             CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             eeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCC
Confidence            99999999999999999999999998775544433445567899999999999999999999999999999999985 56


Q ss_pred             CCccccccchHHHHHHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhh
Q 007680          475 TDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIK  551 (593)
Q Consensus       475 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~  551 (593)
                      |......  .....+....                 ..+.+..+++++.+++.+||+.||++||||.||++.|++|.
T Consensus       243 ~~~~~~~--e~~~~v~~~~-----------------~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         243 YYGMAHE--EVIYYVRDGN-----------------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             TTTSCHH--HHHHHHHTTC-----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCCCCHH--HHHHHHHcCC-----------------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            7653221  1112222111                 11112345668899999999999999999999999999985

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-50  Score=395.78  Aligned_cols=258  Identities=20%  Similarity=0.343  Sum_probs=202.6

Q ss_pred             hhccccccccCccCcccEEEEEeCC----CCeEEEEEeehh-hHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTISD----GTDVAIKVFNLQ-LERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKAL  345 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  345 (593)
                      .++|++.+.||+|+||.||+|++..    +..||||.++.. .....+.+.+|++++++++||||+++++++.+ +..++
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~i   84 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWI   84 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEE
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEE
Confidence            4689999999999999999998642    356889988654 34456789999999999999999999999864 67899


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCC
Q 007680          346 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGE  425 (593)
Q Consensus       346 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~  425 (593)
                      ||||+++|+|.+++......+++..+..++.||++||+|||+++    |+||||||+||++++++.+||+|||+|+.+..
T Consensus        85 v~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~----iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~  160 (273)
T d1mp8a_          85 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR----FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  160 (273)
T ss_dssp             EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCSGGGEEEEETTEEEECC---------
T ss_pred             EEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccC----eeccccchhheeecCCCcEEEccchhheeccC
Confidence            99999999999998887777999999999999999999999655    99999999999999999999999999987654


Q ss_pred             CCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhhhhh
Q 007680          426 GEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDAN  504 (593)
Q Consensus       426 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  504 (593)
                      ... .......||+.|+|||++.+..++.++|||||||++|||+| |.+||......  .....+....           
T Consensus       161 ~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~--~~~~~i~~~~-----------  226 (273)
T d1mp8a_         161 STY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIGRIENGE-----------  226 (273)
T ss_dssp             -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHHHTTC-----------
T ss_pred             Ccc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH--HHHHHHHcCC-----------
Confidence            322 22344568999999999999999999999999999999998 89999774322  2222222111           


Q ss_pred             hhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhh
Q 007680          505 LVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVK  553 (593)
Q Consensus       505 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  553 (593)
                            ..+.+..+++++.+++.+||+.||++|||++|++++|+++.+.
T Consensus       227 ------~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  269 (273)
T d1mp8a_         227 ------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  269 (273)
T ss_dssp             ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ------CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence                  1112234567899999999999999999999999999998654

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-49  Score=393.12  Aligned_cols=257  Identities=25%  Similarity=0.387  Sum_probs=201.1

Q ss_pred             hhccccccccCccCcccEEEEEeC--CC--CeEEEEEeehhh---HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCce
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS--DG--TDVAIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFK  343 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~--~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  343 (593)
                      .++|++.+.||+|+||.||+|++.  ++  ..||||+++...   ....+.|.+|++++++++||||++++|++.++ ..
T Consensus         7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~   85 (273)
T d1u46a_           7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PM   85 (273)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SC
T ss_pred             hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-ch
Confidence            367999999999999999999853  22  368999987642   34456899999999999999999999999764 67


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceec
Q 007680          344 ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLL  423 (593)
Q Consensus       344 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~  423 (593)
                      ++||||+++|++.+++......+++..+..++.|++.||+|||+++    |+||||||+||+++.++.+||+|||+++..
T Consensus        86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~----iiHrDikp~NIll~~~~~vkl~DfGl~~~~  161 (273)
T d1u46a_          86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR----FIHRDLAARNLLLATRDLVKIGDFGLMRAL  161 (273)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT----EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             heeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCC----EeeeeecHHHhccccccceeeccchhhhhc
Confidence            8999999999999998877667999999999999999999999654    999999999999999999999999999987


Q ss_pred             CCCCCcc-ccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhh
Q 007680          424 GEGEDSV-RQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVV  501 (593)
Q Consensus       424 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  501 (593)
                      ....... ......++..|+|||++.+..++.++|||||||++|||+| |+.||.+....  .....+..          
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~--~~~~~i~~----------  229 (273)
T d1u46a_         162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS--QILHKIDK----------  229 (273)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHT----------
T ss_pred             ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH--HHHHHHHh----------
Confidence            6544322 2334567889999999999999999999999999999998 89999764222  11111111          


Q ss_pred             hhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHh
Q 007680          502 DANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKI  550 (593)
Q Consensus       502 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  550 (593)
                            .....+.+..++.++.+++.+||+.||++|||+.||.+.|++.
T Consensus       230 ------~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         230 ------EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             ------SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ------CCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence                  1111122234567899999999999999999999999998875

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=6.6e-49  Score=396.27  Aligned_cols=246  Identities=23%  Similarity=0.282  Sum_probs=207.5

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALV  346 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  346 (593)
                      .++|++.+.||+|+||+||+|+++ +|+.||||+++...   ....+.+.+|+.++++++||||+++++++.+++..|+|
T Consensus         3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv   82 (316)
T d1fota_           3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   82 (316)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence            368999999999999999999975 79999999998653   23456789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCC
Q 007680          347 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG  426 (593)
Q Consensus       347 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  426 (593)
                      |||++||+|.+++..... +++..+..++.||+.||+|||+    .+|+||||||+|||++.++.+||+|||+|+.....
T Consensus        83 mE~~~gg~l~~~~~~~~~-~~~~~~~~~~~qi~~al~~lH~----~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~  157 (316)
T d1fota_          83 MDYIEGGELFSLLRKSQR-FPNPVAKFYAAEVCLALEYLHS----KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV  157 (316)
T ss_dssp             ECCCCSCBHHHHHHHTSS-CCHHHHHHHHHHHHHHHHHHHT----TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred             eeecCCcccccccccccc-ccccHHHHHHHHHHHhhhhhcc----CcEEccccCchheeEcCCCCEEEecCccceEeccc
Confidence            999999999999887765 8899999999999999999995    45999999999999999999999999999986543


Q ss_pred             CCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhh
Q 007680          427 EDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLV  506 (593)
Q Consensus       427 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  506 (593)
                      .     ....||+.|+|||++.+..++.++||||+||++|||+||+.||.+....  .....+....             
T Consensus       158 ~-----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~--~~~~~i~~~~-------------  217 (316)
T d1fota_         158 T-----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM--KTYEKILNAE-------------  217 (316)
T ss_dssp             B-----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHHCC-------------
T ss_pred             c-----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH--HHHHHHHcCC-------------
Confidence            2     3457999999999999999999999999999999999999999763211  1111111100             


Q ss_pred             hhhhhhhhhHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHHH
Q 007680          507 REEQAFSAKMDCILSIMDFALDCCMESPDMRI-----NMTDAAAK  546 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  546 (593)
                           ...+..+++++.+++.+||..||.+||     |++|+++|
T Consensus       218 -----~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H  257 (316)
T d1fota_         218 -----LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  257 (316)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             -----CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence                 001122456789999999999999996     89999886

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-49  Score=394.38  Aligned_cols=258  Identities=27%  Similarity=0.435  Sum_probs=204.2

Q ss_pred             hhccccccccCccCcccEEEEEeCCCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEecc
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEFM  350 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  350 (593)
                      .++|++.+.||+|+||.||+|++++++.||||+++... ...+.|.+|+.++++++|||||++++++.+ +..++||||+
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~   93 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM   93 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence            47899999999999999999999888899999997553 234679999999999999999999999855 5678999999


Q ss_pred             CCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCc
Q 007680          351 PNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDS  429 (593)
Q Consensus       351 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~  429 (593)
                      ++|+|.+++.... ..+++.++..++.||+.||+|||+++    |+||||||+|||+++++.+||+|||+++........
T Consensus        94 ~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~----ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~  169 (285)
T d1fmka3          94 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN----YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT  169 (285)
T ss_dssp             TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred             CCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh----eecccccceEEEECCCCcEEEcccchhhhccCCCce
Confidence            9999999887543 35899999999999999999999655    999999999999999999999999999876543322


Q ss_pred             cccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhhh
Q 007680          430 VRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVREE  509 (593)
Q Consensus       430 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  509 (593)
                       ......||+.|+|||++.++.++.++|||||||++|||++|..|+...... ......+....                
T Consensus       170 -~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~-~~~~~~i~~~~----------------  231 (285)
T d1fmka3         170 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGY----------------  231 (285)
T ss_dssp             -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-HHHHHHHHTTC----------------
T ss_pred             -eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH-HHHHHHHHhcC----------------
Confidence             233456899999999999999999999999999999999976665442221 11222222111                


Q ss_pred             hhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhh
Q 007680          510 QAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVK  553 (593)
Q Consensus       510 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  553 (593)
                       ..+.+..+++++.+++.+||+.||++|||+++|++.|++....
T Consensus       232 -~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~  274 (285)
T d1fmka3         232 -RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  274 (285)
T ss_dssp             -CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             -CCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence             1112234566889999999999999999999999988886433

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-49  Score=387.10  Aligned_cols=251  Identities=28%  Similarity=0.434  Sum_probs=201.3

Q ss_pred             hhccccccccCccCcccEEEEEeCCCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CCceEEEEec
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSN-PDFKALVLEF  349 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~  349 (593)
                      .++|++.+.||+|+||.||+|+++ |+.||||+++...  ..+.+.+|++++++++||||++++|++.+ .+..++||||
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey   82 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   82 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             HHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence            468999999999999999999985 7899999997543  34678999999999999999999998865 4568999999


Q ss_pred             cCCCCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCC
Q 007680          350 MPNGSLEKWLYSHNY-FLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGED  428 (593)
Q Consensus       350 ~~~gsL~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  428 (593)
                      +++|+|.+++..... .+++..++.++.||+.||+|||+.    +|+||||||+||+++.++.+|++|||+++...... 
T Consensus        83 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~----~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~-  157 (262)
T d1byga_          83 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN----NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-  157 (262)
T ss_dssp             CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred             cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC----ceeccccchHhheecCCCCEeecccccceecCCCC-
Confidence            999999999976542 589999999999999999999965    49999999999999999999999999998654322 


Q ss_pred             ccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhh
Q 007680          429 SVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVR  507 (593)
Q Consensus       429 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  507 (593)
                          ....++..|+|||++.++.+++++|||||||++|||+| |++||.....  ......+....              
T Consensus       158 ----~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~--~~~~~~i~~~~--------------  217 (262)
T d1byga_         158 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPRVEKGY--------------  217 (262)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG--GGHHHHHTTTC--------------
T ss_pred             ----ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH--HHHHHHHHcCC--------------
Confidence                23457889999999999999999999999999999998 7888866322  22222222111              


Q ss_pred             hhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhh
Q 007680          508 EEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKV  552 (593)
Q Consensus       508 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~  552 (593)
                         ..+.+..+++++.+++.+||+.||++|||+.|++++|++++.
T Consensus       218 ---~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~  259 (262)
T d1byga_         218 ---KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  259 (262)
T ss_dssp             ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---CCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence               111122345688999999999999999999999999999865

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-48  Score=392.48  Aligned_cols=262  Identities=26%  Similarity=0.405  Sum_probs=203.4

Q ss_pred             HhhhccccccccCccCcccEEEEEeC------CCCeEEEEEeehhh-HHHHHHHHHHHHHHhhc-CCCCcceeeeeeecC
Q 007680          269 RATDEFNECNLLGTSSFGSVYKGTIS------DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNV-RHRNLIKILSSYSNP  340 (593)
Q Consensus       269 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  340 (593)
                      ...++|++.+.||+|+||.||+|++.      +++.||||+++... ....+.+.+|..++.++ +|+||+.+++++...
T Consensus        10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~   89 (299)
T d1ywna1          10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP   89 (299)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred             ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence            34578999999999999999999853      34689999997543 34456778888888887 689999999987654


Q ss_pred             -CceEEEEeccCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCe
Q 007680          341 -DFKALVLEFMPNGSLEKWLYSHN---------------YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNI  404 (593)
Q Consensus       341 -~~~~lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NI  404 (593)
                       +..++|||||++|+|.+++....               ..+++.++..++.||++||+|||+++    |+||||||+||
T Consensus        90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~----ivHrDlKp~NI  165 (299)
T d1ywna1          90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK----CIHRDLAARNI  165 (299)
T ss_dssp             TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCCGGGE
T ss_pred             CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC----CcCCcCCccce
Confidence             46899999999999999997542               24889999999999999999999654    99999999999


Q ss_pred             eeCCCCcEEEEeeccceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCC-CCCCccccccc
Q 007680          405 LLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRK-RPTDEMFIGEM  483 (593)
Q Consensus       405 ll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~-~pf~~~~~~~~  483 (593)
                      |+++++.+||+|||+|+...............||+.|+|||++.++.++.++|||||||++|||+||. +||...... .
T Consensus       166 Ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~-~  244 (299)
T d1ywna1         166 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-E  244 (299)
T ss_dssp             EECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS-H
T ss_pred             eECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH-H
Confidence            99999999999999998776555444455567999999999999999999999999999999999964 577653222 1


Q ss_pred             hHHHHHHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhh
Q 007680          484 SLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKV  552 (593)
Q Consensus       484 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~  552 (593)
                      .+...+.....                 ...+..+++++.+++.+||+.||++|||++|+++||+++.+
T Consensus       245 ~~~~~~~~~~~-----------------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq  296 (299)
T d1ywna1         245 EFCRRLKEGTR-----------------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  296 (299)
T ss_dssp             HHHHHHHHTCC-----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHhcCCC-----------------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            22222222111                 11122346688999999999999999999999999998854

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.8e-48  Score=385.67  Aligned_cols=252  Identities=24%  Similarity=0.300  Sum_probs=207.4

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh---------HHHHHHHHHHHHHHhhcC-CCCcceeeeeeec
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---------ERAFRSFDSECEVLRNVR-HRNLIKILSSYSN  339 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~  339 (593)
                      .++|++.+.||+|+||+||+|+.. +|+.||||+++...         ....+.+.+|+.++++++ ||||+++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            468999999999999999999975 78999999997542         223456889999999997 9999999999999


Q ss_pred             CCceEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeecc
Q 007680          340 PDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGI  419 (593)
Q Consensus       340 ~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~  419 (593)
                      ++..|+||||+++|+|.+++...+ .+++.++..++.||++||+|||+++    |+||||||+||+++.++.+||+|||+
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~~lH~~~----ivHrDlkp~Nill~~~~~~kl~DFG~  156 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALHKLN----IVHRDLKPENILLDDDMNIKLTDFGF  156 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT----EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             CcceEEEEEcCCCchHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcC----CcccccccceEEEcCCCCeEEccchh
Confidence            999999999999999999998765 4999999999999999999999655    99999999999999999999999999


Q ss_pred             ceecCCCCCccccccccCCccccCccccCC------CCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhc
Q 007680          420 YKLLGEGEDSVRQTMTMATIGYMAPEYGLE------GIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESL  493 (593)
Q Consensus       420 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~  493 (593)
                      ++.+.....   .....||+.|+|||++.+      ..++.++||||+||++|||++|+.||.+.....  ....+....
T Consensus       157 a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~--~~~~i~~~~  231 (277)
T d1phka_         157 SCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML--MLRMIMSGN  231 (277)
T ss_dssp             CEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHTC
T ss_pred             eeEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH--HHHHHHhCC
Confidence            998765332   344679999999998753      357889999999999999999999998743211  111111110


Q ss_pred             CCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          494 PHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       494 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      ..              ...+....+++++.+++.+||+.||++|||++|+++|
T Consensus       232 ~~--------------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h  270 (277)
T d1phka_         232 YQ--------------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  270 (277)
T ss_dssp             CC--------------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             CC--------------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            00              0111222456789999999999999999999999875

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-48  Score=394.61  Aligned_cols=252  Identities=19%  Similarity=0.292  Sum_probs=208.4

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEec
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEF  349 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  349 (593)
                      .++|++.+.||+|+||+||+|.++ +|+.||||+++.... ....+.+|+++|++++||||+++++++.+.+..|+||||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~   82 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence            468999999999999999999976 789999999986543 235688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCC--CcEEEEeeccceecCCCC
Q 007680          350 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDEN--MVAHVSDFGIYKLLGEGE  427 (593)
Q Consensus       350 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~--~~~kL~Dfg~a~~~~~~~  427 (593)
                      |+||+|.+++...+..+++.++..++.||++||+|||+++    |+||||||+||+++.+  ..+||+|||+++......
T Consensus        83 ~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~----iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~  158 (321)
T d1tkia_          83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN----IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD  158 (321)
T ss_dssp             CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT----EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred             CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC----CCcccccccceeecCCCceEEEEcccchhhccccCC
Confidence            9999999999877666999999999999999999999654    9999999999999854  589999999998765433


Q ss_pred             CccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhh
Q 007680          428 DSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVR  507 (593)
Q Consensus       428 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  507 (593)
                         ......+|+.|+|||...+..++.++||||+||++|+|++|+.||......  .....+...           ....
T Consensus       159 ---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~--~~~~~i~~~-----------~~~~  222 (321)
T d1tkia_         159 ---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ--QIIENIMNA-----------EYTF  222 (321)
T ss_dssp             ---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHHT-----------CCCC
T ss_pred             ---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhC-----------CCCC
Confidence               233456899999999999999999999999999999999999999763221  111111111           0000


Q ss_pred             hhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          508 EEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       508 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                         .......+++++.+|+.+||..||++|||++|+++|
T Consensus       223 ---~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h  258 (321)
T d1tkia_         223 ---DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             ---CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ---ChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence               011112345678999999999999999999999986

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.3e-48  Score=387.98  Aligned_cols=260  Identities=22%  Similarity=0.337  Sum_probs=204.1

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCC----c
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPD----F  342 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~  342 (593)
                      .++|++.+.||+|+||.||+|++. +|+.||||+++...   ....+.+.+|++++++++||||+++++++...+    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            467999999999999999999964 79999999997542   344567999999999999999999999987654    3


Q ss_pred             eEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeecccee
Q 007680          343 KALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKL  422 (593)
Q Consensus       343 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~  422 (593)
                      .|+||||++|++|.+++...+. +++.++..++.||+.||+|||+++    |+||||||+||+++.++..+++|||.+..
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~~~-l~~~~~~~i~~qi~~al~~lH~~~----iiHrDiKP~NIll~~~~~~~l~d~~~~~~  160 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQALNFSHQNG----IIHRDVKPANIMISATNAVKVMDFGIARA  160 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHHCS-CCHHHHHHHHHHHHHHHHHHHHTT----EECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred             EEEEEECCCCCEehhhhcccCC-CCHHHHHHHHHHHHHHHHHHHhCC----ccCccccCcccccCccccceeehhhhhhh
Confidence            7899999999999999877664 999999999999999999999655    99999999999999999999999999876


Q ss_pred             cCCCCCc-cccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhh
Q 007680          423 LGEGEDS-VRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVV  501 (593)
Q Consensus       423 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  501 (593)
                      ....... .......||+.|+|||++.+..+++++|||||||++|||+||+.||......+ ...+.......  .    
T Consensus       161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-~~~~~~~~~~~--~----  233 (277)
T d1o6ya_         161 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS-VAYQHVREDPI--P----  233 (277)
T ss_dssp             CC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHCCCC--C----
T ss_pred             hccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHH-HHHHHHhcCCC--C----
Confidence            6443322 22344579999999999999999999999999999999999999997632211 11111111000  0    


Q ss_pred             hhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCC-CHHHHHHHHHHhh
Q 007680          502 DANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRI-NMTDAAAKLKKIK  551 (593)
Q Consensus       502 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~i~  551 (593)
                               ......++++++.+++.+||+.||++|| |++++++.|.+++
T Consensus       234 ---------~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         234 ---------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             ---------GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             ---------CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence                     0011123467889999999999999999 8999999888764

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.2e-48  Score=397.80  Aligned_cols=245  Identities=22%  Similarity=0.250  Sum_probs=207.4

Q ss_pred             hccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEE
Q 007680          272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVL  347 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  347 (593)
                      ++|++++.||+|+||.||+|+++ +|+.||||+++...   ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            68999999999999999999975 79999999997643   234567899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCC
Q 007680          348 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGE  427 (593)
Q Consensus       348 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~  427 (593)
                      ||+.+|+|.+++...+. +++.++..++.||+.||.|||+++    |+||||||+|||++.++.+||+|||+|+.+....
T Consensus       121 e~~~~g~l~~~l~~~~~-l~e~~~~~i~~qi~~aL~yLH~~~----iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~  195 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRIGR-FSEPHARFYAAQIVLTFEYLHSLD----LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT  195 (350)
T ss_dssp             ECCTTCBHHHHHHHHCC-CCHHHHHHHHHHHHHHHHHHHHTT----EECCCCSGGGEEECTTSCEEECCCTTCEECSSCB
T ss_pred             ccccccchhhhHhhcCC-CCHHHHHHHHHHHHHHHHHHHhCC----EecCcCCHHHcccCCCCCEEeeeceeeeeccccc
Confidence            99999999999987664 999999999999999999999654    9999999999999999999999999999865332


Q ss_pred             CccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhh
Q 007680          428 DSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVR  507 (593)
Q Consensus       428 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  507 (593)
                           ....||+.|||||++.+..++.++|||||||++|||+||+.||.+..  .......+....+             
T Consensus       196 -----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~--~~~~~~~i~~~~~-------------  255 (350)
T d1rdqe_         196 -----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ--PIQIYEKIVSGKV-------------  255 (350)
T ss_dssp             -----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHCCC-------------
T ss_pred             -----ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC--HHHHHHHHhcCCC-------------
Confidence                 33579999999999999999999999999999999999999997632  1111111111100             


Q ss_pred             hhhhhhhhHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHHH
Q 007680          508 EEQAFSAKMDCILSIMDFALDCCMESPDMRI-----NMTDAAAK  546 (593)
Q Consensus       508 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  546 (593)
                           ..+..+++++.+++.+||..||++|+     |++|+++|
T Consensus       256 -----~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H  294 (350)
T d1rdqe_         256 -----RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             -----CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             -----CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence                 11123456889999999999999994     89999875

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-48  Score=390.46  Aligned_cols=277  Identities=20%  Similarity=0.281  Sum_probs=205.1

Q ss_pred             hhccccccccCccCcccEEEEEeCCCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCC----ceEEE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNPD----FKALV  346 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv  346 (593)
                      .++|...+.||+|+||.||+|++ +|+.||||+++..... ....+.|+..+.+++||||+++++++.+.+    ..++|
T Consensus         2 ~~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv   79 (303)
T d1vjya_           2 ARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence            35788889999999999999997 5899999999765332 222344666667789999999999987654    57999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcC----CCCCeEecCCCCCCeeeCCCCcEEEEeecccee
Q 007680          347 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGH----SSVHIIHCDLKPTNILLDENMVAHVSDFGIYKL  422 (593)
Q Consensus       347 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~----~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~  422 (593)
                      |||+++|+|.+++++..  +++.++.+++.|++.||+|+|+..    .+.+|+||||||+|||++.++.+||+|||+++.
T Consensus        80 ~Ey~~~g~L~~~l~~~~--l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~  157 (303)
T d1vjya_          80 SDYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR  157 (303)
T ss_dssp             EECCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             EecccCCCHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence            99999999999998764  899999999999999999999631    135799999999999999999999999999998


Q ss_pred             cCCCCCcc--ccccccCCccccCccccCCCC------CCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcC
Q 007680          423 LGEGEDSV--RQTMTMATIGYMAPEYGLEGI------VSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLP  494 (593)
Q Consensus       423 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~  494 (593)
                      ........  ......||+.|+|||++.+..      ++.++|||||||++|||+||..||...............  ..
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~--~~  235 (303)
T d1vjya_         158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP--SD  235 (303)
T ss_dssp             EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC--SS
T ss_pred             ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccc--cc
Confidence            76543322  234567999999999877542      677999999999999999999887653222111100000  00


Q ss_pred             Cchh----hhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhh
Q 007680          495 HGLT----EVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVK  553 (593)
Q Consensus       495 ~~~~----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  553 (593)
                      ....    ...+....+.........+.+..+.+++.+||+.||++|||+.||+++|+++...
T Consensus       236 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  298 (303)
T d1vjya_         236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             CCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             chHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence            0000    0011111111111122234566799999999999999999999999999988643

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=8.2e-48  Score=395.71  Aligned_cols=250  Identities=20%  Similarity=0.281  Sum_probs=202.0

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHH---HHHHHHHhhcCCCCcceeeeeeecCCce
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSF---DSECEVLRNVRHRNLIKILSSYSNPDFK  343 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~---~~E~~~l~~l~h~niv~l~~~~~~~~~~  343 (593)
                      .++|++.+.||+|+||.||+|+.. +|+.||||++....   ......+   ..|+++++.++||||+++++++.+.+..
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~   82 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL   82 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence            468999999999999999999975 79999999997542   1112233   3457777788899999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceec
Q 007680          344 ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLL  423 (593)
Q Consensus       344 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~  423 (593)
                      |+||||+++|+|.+++..... +++.++..++.||+.||+|||+++    |+||||||+|||++.++.+||+|||+|+.+
T Consensus        83 ~ivmE~~~gg~L~~~l~~~~~-~~e~~~~~~~~qi~~aL~ylH~~~----iiHrDlKP~NILl~~~g~iKl~DFGla~~~  157 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQHGV-FSEADMRFYAAEIILGLEHMHNRF----VVYRDLKPANILLDEHGHVRISDLGLACDF  157 (364)
T ss_dssp             EEEECCCCSCBHHHHHHHHCS-CCHHHHHHHHHHHHHHHHHHHHTT----EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred             EEEEEecCCCcHHHHHHhccc-ccHHHHHHHHHHHHHHHHHHHHCC----ccceeeccceeEEcCCCcEEEeeeceeeec
Confidence            999999999999999987654 899999999999999999999655    999999999999999999999999999977


Q ss_pred             CCCCCccccccccCCccccCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhh
Q 007680          424 GEGEDSVRQTMTMATIGYMAPEYGLE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVD  502 (593)
Q Consensus       424 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  502 (593)
                      ....    .....||+.|+|||++.+ ..++.++|||||||++|||+||+.||........  ..........       
T Consensus       158 ~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~--~~~~~~~~~~-------  224 (364)
T d1omwa3         158 SKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDRMTLTM-------  224 (364)
T ss_dssp             SSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH--HHHHHHSSSC-------
T ss_pred             CCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhcccC-------
Confidence            5432    234579999999999865 5689999999999999999999999976432211  1111111100       


Q ss_pred             hhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCC-----HHHHHHH
Q 007680          503 ANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRIN-----MTDAAAK  546 (593)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~  546 (593)
                              ....+..+++++.+|+.+||+.||++|||     ++|+++|
T Consensus       225 --------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H  265 (364)
T d1omwa3         225 --------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  265 (364)
T ss_dssp             --------CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred             --------CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence                    00111234567899999999999999999     6888875

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-48  Score=389.08  Aligned_cols=260  Identities=25%  Similarity=0.409  Sum_probs=210.6

Q ss_pred             hhhccccccccCccCcccEEEEEeCC--------CCeEEEEEeehhh-HHHHHHHHHHHHHHhhc-CCCCcceeeeeeec
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTISD--------GTDVAIKVFNLQL-ERAFRSFDSECEVLRNV-RHRNLIKILSSYSN  339 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  339 (593)
                      ..++|++.+.||+|+||.||+|+..+        +..||||+++... ......+.+|...+.++ +||||+++++++.+
T Consensus        11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~   90 (299)
T d1fgka_          11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ   90 (299)
T ss_dssp             CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence            35789999999999999999998532        2479999997754 34457788999999888 89999999999999


Q ss_pred             CCceEEEEeccCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCe
Q 007680          340 PDFKALVLEFMPNGSLEKWLYSHN---------------YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNI  404 (593)
Q Consensus       340 ~~~~~lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NI  404 (593)
                      ++..++||||+++|+|.+++....               ..+++.+++.++.||+.||+|||+++    |+||||||+||
T Consensus        91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~----ivHrDiKp~Ni  166 (299)
T d1fgka_          91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK----CIHRDLAARNV  166 (299)
T ss_dssp             SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCSGGGE
T ss_pred             CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC----EEeeeecccce
Confidence            999999999999999999997653               24899999999999999999999655    99999999999


Q ss_pred             eeCCCCcEEEEeeccceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccc
Q 007680          405 LLDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFIGEM  483 (593)
Q Consensus       405 ll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-g~~pf~~~~~~~~  483 (593)
                      |++.++.+||+|||+++...............+++.|+|||.+.++.|+.++|||||||++|||++ |.+||.+....  
T Consensus       167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~--  244 (299)
T d1fgka_         167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--  244 (299)
T ss_dssp             EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--
T ss_pred             eecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH--
Confidence            999999999999999998766554444555678999999999999999999999999999999998 78888663221  


Q ss_pred             hHHHHHHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhh
Q 007680          484 SLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKV  552 (593)
Q Consensus       484 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~  552 (593)
                      .....+....                 ..+.+..+++++.+++.+||+.||++|||+.||++.|+++.+
T Consensus       245 ~~~~~i~~~~-----------------~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a  296 (299)
T d1fgka_         245 ELFKLLKEGH-----------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA  296 (299)
T ss_dssp             HHHHHHHTTC-----------------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHcCC-----------------CCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence            1222222111                 111122346688999999999999999999999999998853

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-48  Score=392.15  Aligned_cols=248  Identities=23%  Similarity=0.317  Sum_probs=205.1

Q ss_pred             hccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh---HHHHHHHHHHHHHHh-hcCCCCcceeeeeeecCCceEEE
Q 007680          272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL---ERAFRSFDSECEVLR-NVRHRNLIKILSSYSNPDFKALV  346 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lv  346 (593)
                      ++|++.+.||+|+||+||+|+++ +|+.||||+++...   ....+.+..|..++. .++||||+++++++.+++..|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            68999999999999999999975 79999999998643   233456677777765 68999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCC
Q 007680          347 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEG  426 (593)
Q Consensus       347 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  426 (593)
                      |||+++|+|.+++..... +++.++..++.||+.||+|||+++    |+||||||+|||+++++.+||+|||+++.....
T Consensus        82 mEy~~~g~L~~~i~~~~~-~~e~~~~~~~~qi~~al~ylH~~~----iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~  156 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCHK-FDLSRATFYAAEIILGLQFLHSKG----IVYRDLKLDNILLDKDGHIKIADFGMCKENMLG  156 (320)
T ss_dssp             EECCTTCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHHHTT----CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EeecCCCcHHHHhhccCC-CCHHHHHHHHHHHHHHHHHHHhCC----eeeccCcccceeecCCCceeccccchhhhcccc
Confidence            999999999999987665 899999999999999999999654    999999999999999999999999999876543


Q ss_pred             CCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhh
Q 007680          427 EDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLV  506 (593)
Q Consensus       427 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  506 (593)
                      ..  ......||+.|+|||++.+..++.++||||+||++|||+||+.||.+....  .+...+....+            
T Consensus       157 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~--~~~~~i~~~~~------------  220 (320)
T d1xjda_         157 DA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE--ELFHSIRMDNP------------  220 (320)
T ss_dssp             TC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHCCC------------
T ss_pred             cc--cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH--HHHHHHHcCCC------------
Confidence            32  234467999999999999999999999999999999999999999763221  11111111111            


Q ss_pred             hhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHH-HHHHH
Q 007680          507 REEQAFSAKMDCILSIMDFALDCCMESPDMRINMT-DAAAK  546 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~~  546 (593)
                            ..+..+++++.+|+.+||+.||++|||+. |+++|
T Consensus       221 ------~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~h  255 (320)
T d1xjda_         221 ------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH  255 (320)
T ss_dssp             ------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred             ------CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhC
Confidence                  11123456789999999999999999995 77654

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-48  Score=388.49  Aligned_cols=258  Identities=22%  Similarity=0.380  Sum_probs=208.5

Q ss_pred             ccccCccCcccEEEEEeCC----CCeEEEEEeehh-hHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CCceEEEEecc
Q 007680          277 CNLLGTSSFGSVYKGTISD----GTDVAIKVFNLQ-LERAFRSFDSECEVLRNVRHRNLIKILSSYSN-PDFKALVLEFM  350 (593)
Q Consensus       277 ~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~  350 (593)
                      .++||+|+||+||+|++.+    ...||||+++.. .....+.+.+|++++++++||||++++|++.. ++..++||||+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            4689999999999999753    235899999743 44556789999999999999999999999865 46889999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCcc
Q 007680          351 PNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDSV  430 (593)
Q Consensus       351 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~  430 (593)
                      ++|+|.+++.......++..+..++.|++.||.|||+.    +|+||||||+|||+++++.+||+|||+++.........
T Consensus       112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~----~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~  187 (311)
T d1r0pa_         112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK----KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS  187 (311)
T ss_dssp             TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred             ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhccc----CcccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence            99999999988777788999999999999999999965    49999999999999999999999999998775443221


Q ss_pred             --ccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhhhhhhhh
Q 007680          431 --RQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVDANLVRE  508 (593)
Q Consensus       431 --~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  508 (593)
                        ......||+.|+|||.+.++.++.++||||||+++|||+||..||...... .....++.....              
T Consensus       188 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~-~~~~~~i~~g~~--------------  252 (311)
T d1r0pa_         188 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FDITVYLLQGRR--------------  252 (311)
T ss_dssp             TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHHHHTTCC--------------
T ss_pred             ceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH-HHHHHHHHcCCC--------------
Confidence              223456899999999999999999999999999999999988887653211 111122211110              


Q ss_pred             hhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhhhcc
Q 007680          509 EQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKFLD  556 (593)
Q Consensus       509 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~  556 (593)
                         ...+..+++++.+++.+||+.||++|||+.||+++|+++...+..
T Consensus       253 ---~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~  297 (311)
T d1r0pa_         253 ---LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG  297 (311)
T ss_dssp             ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred             ---CCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhh
Confidence               111223456889999999999999999999999999999877644

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-48  Score=391.29  Aligned_cols=252  Identities=21%  Similarity=0.278  Sum_probs=200.4

Q ss_pred             hhcccccc-ccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhc-CCCCcceeeeeeec----CCce
Q 007680          271 TDEFNECN-LLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNV-RHRNLIKILSSYSN----PDFK  343 (593)
Q Consensus       271 ~~~~~~~~-~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~~  343 (593)
                      .++|++.+ .||+|+||.||+|++. +++.||||+++..     ..+.+|++++.++ +||||++++++|++    ....
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~   84 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   84 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence            46898875 5999999999999974 7999999999743     3567899987665 89999999999875    4578


Q ss_pred             EEEEeccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC---CCcEEEEeecc
Q 007680          344 ALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDE---NMVAHVSDFGI  419 (593)
Q Consensus       344 ~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~---~~~~kL~Dfg~  419 (593)
                      |+|||||+||+|.+++...+ ..+++.++..++.|++.||+|||+++    |+||||||+||++++   ++.+||+|||+
T Consensus        85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~----iiHRDiKp~NIll~~~~~~~~~Kl~DFG~  160 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN----IAHRDVKPENLLYTSKRPNAILKLTDFGF  160 (335)
T ss_dssp             EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT----EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC----Cccccccccccccccccccccccccccce
Confidence            99999999999999998754 36999999999999999999999655    999999999999985   56799999999


Q ss_pred             ceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhh
Q 007680          420 YKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTE  499 (593)
Q Consensus       420 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  499 (593)
                      |+.......   .....||+.|+|||++.+..|+.++|||||||++|+|+||+.||.+.....  ............   
T Consensus       161 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~--~~~~~~~~i~~~---  232 (335)
T d2ozaa1         161 AKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA--ISPGMKTRIRMG---  232 (335)
T ss_dssp             CEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------CCCSC---
T ss_pred             eeeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHH--HHHHHHHHHhcC---
Confidence            987654332   344579999999999999999999999999999999999999997632211  111111110000   


Q ss_pred             hhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          500 VVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       500 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                          ..   ....+....+++++.+|+.+||+.||++|||+.|+++|
T Consensus       233 ----~~---~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  272 (335)
T d2ozaa1         233 ----QY---EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  272 (335)
T ss_dssp             ----SS---SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             ----CC---CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence                00   00011223457789999999999999999999999986

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-47  Score=386.37  Aligned_cols=261  Identities=22%  Similarity=0.340  Sum_probs=215.5

Q ss_pred             hhccccccccCccCcccEEEEEeC------CCCeEEEEEeehhh-HHHHHHHHHHHHHHhhc-CCCCcceeeeeeecCCc
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS------DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNV-RHRNLIKILSSYSNPDF  342 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  342 (593)
                      .++|++.++||+|+||.||+|++.      +++.||||+++... ......+.+|+.+++++ +|||||++++++.+++.
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~  101 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence            478999999999999999999852      46789999997643 34456789999999999 69999999999999999


Q ss_pred             eEEEEeccCCCCHHHHHhhCCC-----------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCee
Q 007680          343 KALVLEFMPNGSLEKWLYSHNY-----------------FLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNIL  405 (593)
Q Consensus       343 ~~lv~e~~~~gsL~~~l~~~~~-----------------~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIl  405 (593)
                      .++||||+++|+|.+++.....                 .+++..+..++.||++||+|||+++    ++||||||+||+
T Consensus       102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~----ivHrDLKp~NIl  177 (311)
T d1t46a_         102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN----CIHRDLAARNIL  177 (311)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCSGGGEE
T ss_pred             EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC----eeeccccccccc
Confidence            9999999999999999976432                 5889999999999999999999655    999999999999


Q ss_pred             eCCCCcEEEEeeccceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhC-CCCCCccccccch
Q 007680          406 LDENMVAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTR-KRPTDEMFIGEMS  484 (593)
Q Consensus       406 l~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg-~~pf~~~~~~~~~  484 (593)
                      ++.++.+|++|||.++...............||+.|+|||++.++.++.++|||||||++|||+|+ .+||... .....
T Consensus       178 ~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~-~~~~~  256 (311)
T d1t46a_         178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM-PVDSK  256 (311)
T ss_dssp             EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC-CSSHH
T ss_pred             ccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCC-CHHHH
Confidence            999999999999999987765555555567899999999999999999999999999999999995 5555442 22222


Q ss_pred             HHHHHHHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhh
Q 007680          485 LRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVK  553 (593)
Q Consensus       485 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  553 (593)
                      +.+.+....+.                 ..+..++.++.+|+.+||+.||++|||+.|+++.|+++..+
T Consensus       257 ~~~~i~~~~~~-----------------~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~  308 (311)
T d1t46a_         257 FYKMIKEGFRM-----------------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE  308 (311)
T ss_dssp             HHHHHHHTCCC-----------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHhcCCCC-----------------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence            33333322211                 11123456789999999999999999999999999886543

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9e-48  Score=385.96  Aligned_cols=268  Identities=22%  Similarity=0.272  Sum_probs=203.2

Q ss_pred             hccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh--HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEe
Q 007680          272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLE  348 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  348 (593)
                      ++|++++.||+|+||.||+|++. +|+.||||+++...  ....+.+.+|++++++++||||+++++++.+++..|+|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            68999999999999999999974 79999999997643  2345688999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCC
Q 007680          349 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGED  428 (593)
Q Consensus       349 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  428 (593)
                      |+.++.+..........+++.++..++.|++.||+|||+++    |+||||||+|||++.++.+||+|||.|+.......
T Consensus        82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~----IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~  157 (298)
T d1gz8a_          82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR  157 (298)
T ss_dssp             CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB
T ss_pred             ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC----EEccccCchheeecccCcceeccCCcceeccCCcc
Confidence            99664444443444556999999999999999999999655    99999999999999999999999999987654332


Q ss_pred             ccccccccCCccccCccccCCCC-CCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHH-hcCCc--hhhhhhh-
Q 007680          429 SVRQTMTMATIGYMAPEYGLEGI-VSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKE-SLPHG--LTEVVDA-  503 (593)
Q Consensus       429 ~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~-  503 (593)
                        ......||+.|+|||++.... ++.++||||+||++|+|++|+.||.+....+ .+...... ..+..  ....... 
T Consensus       158 --~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~  234 (298)
T d1gz8a_         158 --TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID-QLFRIFRTLGTPDEVVWPGVTSMP  234 (298)
T ss_dssp             --CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCTTTSTTGGGST
T ss_pred             --cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH-HHHHHHHhcCCCchhhcccccccc
Confidence              234457999999999876655 5889999999999999999999997643222 11121111 11111  1110000 


Q ss_pred             hhhhh------hhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          504 NLVRE------EQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       504 ~~~~~------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      .....      .........+++++.+|+.+||..||++|||++|+++|
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            00000      00011112345678999999999999999999999987

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.6e-48  Score=387.52  Aligned_cols=258  Identities=28%  Similarity=0.424  Sum_probs=206.0

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCC--eEEEEEeehh-hHHHHHHHHHHHHHHhhc-CCCCcceeeeeeecCCceEE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGT--DVAIKVFNLQ-LERAFRSFDSECEVLRNV-RHRNLIKILSSYSNPDFKAL  345 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  345 (593)
                      .++|++.++||+|+||.||+|+++ +|.  .||||.++.. .....+.+.+|+++++++ +||||+++++++.+.+..++
T Consensus         9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i   88 (309)
T d1fvra_           9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   88 (309)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred             HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEE
Confidence            378999999999999999999975 444  4778887643 334556799999999999 79999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC
Q 007680          346 VLEFMPNGSLEKWLYSH---------------NYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENM  410 (593)
Q Consensus       346 v~e~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~  410 (593)
                      ||||+++|+|.+++...               ...+++.++..++.||+.||.|||++    +|+||||||+|||++.++
T Consensus        89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~----~iiHrDlkp~NIL~~~~~  164 (309)
T d1fvra_          89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK----QFIHRDLAARNILVGENY  164 (309)
T ss_dssp             EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECGGG
T ss_pred             EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC----CccccccccceEEEcCCC
Confidence            99999999999999754               23689999999999999999999965    499999999999999999


Q ss_pred             cEEEEeeccceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCC-CCCCccccccchHHHHH
Q 007680          411 VAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRK-RPTDEMFIGEMSLRRWV  489 (593)
Q Consensus       411 ~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~-~pf~~~~~~~~~~~~~~  489 (593)
                      .+||+|||+++......   ......||..|+|||.+.++.++.++|||||||++|||++|. +||......  .+...+
T Consensus       165 ~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~--~~~~~i  239 (309)
T d1fvra_         165 VAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--ELYEKL  239 (309)
T ss_dssp             CEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHG
T ss_pred             ceEEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHH--HHHHHH
Confidence            99999999998654322   223446899999999999999999999999999999999976 466553211  111111


Q ss_pred             HHhcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhhh
Q 007680          490 KESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKF  554 (593)
Q Consensus       490 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  554 (593)
                      ..                 ....+.+..+++++.+|+.+||+.||++|||++|++++|+++....
T Consensus       240 ~~-----------------~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~  287 (309)
T d1fvra_         240 PQ-----------------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  287 (309)
T ss_dssp             GG-----------------TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             Hh-----------------cCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence            11                 0111222345678999999999999999999999999999987543

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-47  Score=384.41  Aligned_cols=262  Identities=26%  Similarity=0.300  Sum_probs=196.3

Q ss_pred             cccccCccCcccEEEEEeC-CCCeEEEEEeehhhH-----HHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEec
Q 007680          276 ECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLE-----RAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEF  349 (593)
Q Consensus       276 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  349 (593)
                      .++.||+|+||+||+|+++ +|+.||||+++....     ...+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            4678999999999999975 799999999975432     1234688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCc
Q 007680          350 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDS  429 (593)
Q Consensus       350 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~  429 (593)
                      +.++++..+.. .+..+++.++..++.||+.||+|||+++    |+||||||+||+++.++.+||+|||+|+....... 
T Consensus        82 ~~~~~~~~~~~-~~~~l~~~~~~~~~~qil~aL~~lH~~~----iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~-  155 (299)
T d1ua2a_          82 METDLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLHQHW----ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR-  155 (299)
T ss_dssp             CSEEHHHHHTT-CCSSCCSSHHHHHHHHHHHHHHHHHHTT----CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-
T ss_pred             hcchHHhhhhh-cccCCCHHHHHHHHHHHHHHHHHhhccc----eecccCCcceEEecCCCccccccCccccccCCCcc-
Confidence            98877666554 3445899999999999999999999655    99999999999999999999999999987654332 


Q ss_pred             cccccccCCccccCccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhc--CC--chhhhhhh-
Q 007680          430 VRQTMTMATIGYMAPEYGLEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESL--PH--GLTEVVDA-  503 (593)
Q Consensus       430 ~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~--~~--~~~~~~~~-  503 (593)
                       ......||+.|+|||++.+. .++.++||||+||++|||+||.+||......  +....+....  +.  ........ 
T Consensus       156 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~--~~l~~i~~~~~~~~~~~~~~~~~~~  232 (299)
T d1ua2a_         156 -AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL--DQLTRIFETLGTPTEEQWPDMCSLP  232 (299)
T ss_dssp             -CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCCCCTTTSSSTTSST
T ss_pred             -cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHH--HHHHHHHHhcCCCChhhccchhccc
Confidence             22345799999999987654 5899999999999999999999999764221  1111111110  00  00000000 


Q ss_pred             ---hhh--hhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          504 ---NLV--REEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       504 ---~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                         ...  ............++++.+|+.+||+.||++|||++|+++|
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H  280 (299)
T d1ua2a_         233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  280 (299)
T ss_dssp             TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             hhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence               000  0000001112335678999999999999999999999875

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-47  Score=386.67  Aligned_cols=262  Identities=23%  Similarity=0.384  Sum_probs=214.4

Q ss_pred             HhhhccccccccCccCcccEEEEEeC------CCCeEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCC
Q 007680          269 RATDEFNECNLLGTSSFGSVYKGTIS------DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPD  341 (593)
Q Consensus       269 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  341 (593)
                      ...++|++.+.||+|+||.||+|.+.      +++.||||+++... ......+.+|++++++++||||+++++++...+
T Consensus        17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~   96 (308)
T d1p4oa_          17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ   96 (308)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred             ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCC
Confidence            34578999999999999999999863      35789999997543 345567899999999999999999999999999


Q ss_pred             ceEEEEeccCCCCHHHHHhhCC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcE
Q 007680          342 FKALVLEFMPNGSLEKWLYSHN---------YFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVA  412 (593)
Q Consensus       342 ~~~lv~e~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~  412 (593)
                      ..++||||+++|+|.+++....         ..+++..+..++.|+++||.|||+++    |+||||||+|||++.++++
T Consensus        97 ~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~----ivHrDlk~~NiLld~~~~~  172 (308)
T d1p4oa_          97 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK----FVHRDLAARNCMVAEDFTV  172 (308)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT----CBCSCCSGGGEEECTTCCE
T ss_pred             ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC----eeeceEcCCceeecCCceE
Confidence            9999999999999999986532         24789999999999999999999654    9999999999999999999


Q ss_pred             EEEeeccceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCC-CCCCccccccchHHHHHHH
Q 007680          413 HVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRK-RPTDEMFIGEMSLRRWVKE  491 (593)
Q Consensus       413 kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~-~pf~~~~~~~~~~~~~~~~  491 (593)
                      ||+|||+++.+.............+|+.|+|||.+.+..++.++||||||+++|||+||. .||......+  ....+..
T Consensus       173 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~--~~~~i~~  250 (308)
T d1p4oa_         173 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ--VLRFVME  250 (308)
T ss_dssp             EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH--HHHHHHT
T ss_pred             EEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHh
Confidence            999999998776554444445557899999999999999999999999999999999985 6775532111  1111111


Q ss_pred             hcCCchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhh
Q 007680          492 SLPHGLTEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVK  553 (593)
Q Consensus       492 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  553 (593)
                                 .      ...+.+..++..+.+++.+||+.||++|||+.||+++|++..+.
T Consensus       251 -----------~------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~  295 (308)
T d1p4oa_         251 -----------G------GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP  295 (308)
T ss_dssp             -----------T------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred             -----------C------CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence                       0      01111234566899999999999999999999999999887543

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-48  Score=380.58  Aligned_cols=241  Identities=23%  Similarity=0.258  Sum_probs=198.1

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhH------HHHHHHHHHHHHHhhcC--CCCcceeeeeeecCC
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLE------RAFRSFDSECEVLRNVR--HRNLIKILSSYSNPD  341 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~  341 (593)
                      .++|++.+.||+|+||+||+|+.. +|+.||||+++....      .....+.+|+.++++++  ||||+++++++.+++
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            357999999999999999999975 799999999976421      11234678999999996  899999999999999


Q ss_pred             ceEEEEeccCC-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC-CCcEEEEeecc
Q 007680          342 FKALVLEFMPN-GSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDE-NMVAHVSDFGI  419 (593)
Q Consensus       342 ~~~lv~e~~~~-gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~-~~~~kL~Dfg~  419 (593)
                      ..++||||+.+ +++.+++..... +++.++..++.|+++||+|||+++    |+||||||+||+++. ++.+||+|||+
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~~~~-l~e~~~~~~~~qi~~al~~lH~~~----iiHrDiKp~NIll~~~~~~vkl~DFG~  157 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCHNCG----VLHRDIKDENILIDLNRGELKLIDFGS  157 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHHHCS-CCHHHHHHHHHHHHHHHHHHHHTT----EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             eEEEEEEeccCcchHHHHHhccCC-CCHHHHHHHHHHHHHHHHHHHHCC----CccccCcccceEEecCCCeEEECcccc
Confidence            99999999976 678888876554 999999999999999999999654    999999999999985 57999999999


Q ss_pred             ceecCCCCCccccccccCCccccCccccCCCCC-CccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchh
Q 007680          420 YKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIV-SAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLT  498 (593)
Q Consensus       420 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  498 (593)
                      |+......    .....||+.|+|||++.+..+ +.++||||+||++|||+||+.||....       .....       
T Consensus       158 a~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-------~i~~~-------  219 (273)
T d1xwsa_         158 GALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------EIIRG-------  219 (273)
T ss_dssp             CEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------HHHHC-------
T ss_pred             ceeccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-------HHhhc-------
Confidence            98754332    234579999999999887665 678999999999999999999997621       00110       


Q ss_pred             hhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          499 EVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       499 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                           ..       ..+..+++++.+++.+||+.||++|||++|+++|
T Consensus       220 -----~~-------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h  255 (273)
T d1xwsa_         220 -----QV-------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH  255 (273)
T ss_dssp             -----CC-------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             -----cc-------CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence                 00       0011235678999999999999999999999886

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=6.5e-47  Score=377.68  Aligned_cols=267  Identities=21%  Similarity=0.292  Sum_probs=202.3

Q ss_pred             hccccccccCccCcccEEEEEeCCCCeEEEEEeehhh--HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEec
Q 007680          272 DEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLEF  349 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  349 (593)
                      ++|+++++||+|+||+||+|++++|+.||||+++...  ....+.+.+|+.++++++||||+++++++.+.+..+++|||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            6899999999999999999999999999999997642  33357899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCCc
Q 007680          350 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGEDS  429 (593)
Q Consensus       350 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~  429 (593)
                      +.++.+..+.... ..+++.++..++.||+.||+|||+++    |+||||||+|||++.++.+|++|||.+........ 
T Consensus        82 ~~~~~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~----IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~-  155 (286)
T d1ob3a_          82 LDQDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRR----VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-  155 (286)
T ss_dssp             CSEEHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred             ehhhhHHHHHhhc-CCcchhhhHHHHHHHHHHHHHhccCc----EEecCCCCceeeEcCCCCEEecccccceecccCcc-
Confidence            9776666655444 45999999999999999999999654    99999999999999999999999999987654332 


Q ss_pred             cccccccCCccccCccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHh-cCC--chhhhhhh--
Q 007680          430 VRQTMTMATIGYMAPEYGLEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKES-LPH--GLTEVVDA--  503 (593)
Q Consensus       430 ~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~--  503 (593)
                       ......+++.|+|||.+.+. .++.++||||+||++|||++|+.||.+....+. +.+..... .+.  ........  
T Consensus       156 -~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~  233 (286)
T d1ob3a_         156 -KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ-LMRIFRILGTPNSKNWPNVTELPK  233 (286)
T ss_dssp             -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             -ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHH-HHHHHHhhCCCChhhccchhhhhh
Confidence             23344689999999988654 579999999999999999999999976432221 11111111 110  01110000  


Q ss_pred             ---hhh-hh-hhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          504 ---NLV-RE-EQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       504 ---~~~-~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                         ... .. ..........++++.+|+.+||+.||++|||++|+++|
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H  281 (286)
T d1ob3a_         234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (286)
T ss_dssp             CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence               000 00 00011112345678999999999999999999999875

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-46  Score=377.56  Aligned_cols=269  Identities=23%  Similarity=0.268  Sum_probs=201.3

Q ss_pred             hhhccccccccCccCcccEEEEEeC-C-CCeEEEEEeehhh--HHHHHHHHHHHHHHhhc---CCCCcceeeeeeec---
Q 007680          270 ATDEFNECNLLGTSSFGSVYKGTIS-D-GTDVAIKVFNLQL--ERAFRSFDSECEVLRNV---RHRNLIKILSSYSN---  339 (593)
Q Consensus       270 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~---  339 (593)
                      +.++|++++.||+|+||+||+|++. + ++.||||+++...  ......+.+|+.+++.+   +||||++++++|..   
T Consensus         5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~   84 (305)
T d1blxa_           5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   84 (305)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence            3578999999999999999999974 4 6679999997542  22233466777777766   79999999998853   


Q ss_pred             --CCceEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEee
Q 007680          340 --PDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDF  417 (593)
Q Consensus       340 --~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df  417 (593)
                        ....+++|||++++++..........+++..+..++.|++.||+|||+++    |+||||||+|||+++++.+||+||
T Consensus        85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~----ivHrDiKp~NILi~~~~~~kl~df  160 (305)
T d1blxa_          85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR----VVHRDLKPQNILVTSSGQIKLADF  160 (305)
T ss_dssp             SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT----CCCCCCCGGGEEECTTCCEEECSC
T ss_pred             ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC----EEecCCCccEEEEcCCCCeeecch
Confidence              34789999999888777666666667999999999999999999999655    999999999999999999999999


Q ss_pred             ccceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhc-CCc
Q 007680          418 GIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESL-PHG  496 (593)
Q Consensus       418 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~-~~~  496 (593)
                      |+++......   ......||+.|+|||++.+..|+.++||||+||++|||++|+.||......+ .+........ +..
T Consensus       161 g~~~~~~~~~---~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~  236 (305)
T d1blxa_         161 GLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILDVIGLPGE  236 (305)
T ss_dssp             CSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCG
T ss_pred             hhhhhhcccc---cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHH-HHHHHHHhhCCCch
Confidence            9987653322   3345679999999999999999999999999999999999999997643221 1111111110 000


Q ss_pred             --hhhhhh---hhhh--hhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          497 --LTEVVD---ANLV--REEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       497 --~~~~~~---~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                        ......   ....  ............++.+.+|+.+||+.||++|||++|+++|
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H  293 (305)
T d1blxa_         237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  293 (305)
T ss_dssp             GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence              000000   0000  0000011112345678999999999999999999999986

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-44  Score=370.34  Aligned_cols=272  Identities=21%  Similarity=0.250  Sum_probs=200.8

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh-HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCC----ceE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPD----FKA  344 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~  344 (593)
                      .++|++++.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|+++|++++||||+++++++....    ..+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            457999999999999999999864 89999999997543 445667899999999999999999999987653    234


Q ss_pred             EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecC
Q 007680          345 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLG  424 (593)
Q Consensus       345 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~  424 (593)
                      ++++|+.+|+|.+++....  +++..+..++.|++.||+|||+++    |+||||||+|||++.++.+||+|||+++...
T Consensus        87 ~l~~~~~~g~L~~~l~~~~--l~~~~i~~i~~qil~al~yLH~~~----iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~  160 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKTQH--LSNDHICYFLYQILRGLKYIHSAN----VLHRDLKPSNLLLNTTCDLKICDFGLARVAD  160 (345)
T ss_dssp             EEEEECCCEEHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHHTT----EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEeecCCchhhhhhcCC--CCHHHHHHHHHHHHHHHHHHHHCC----CcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence            4555667999999997654  999999999999999999999655    9999999999999999999999999998765


Q ss_pred             CCCCcc-ccccccCCccccCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhhh
Q 007680          425 EGEDSV-RQTMTMATIGYMAPEYGLE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVVD  502 (593)
Q Consensus       425 ~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  502 (593)
                      ...... ......||+.|+|||++.. ..++.++||||+||++|||++|+.||......+.  .................
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~  238 (345)
T d1pmea_         161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ--LNHILGILGSPSQEDLN  238 (345)
T ss_dssp             GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCSCCHHHHH
T ss_pred             CCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHH--HHHHhhhccCCChhhhh
Confidence            433221 2345679999999998854 5678999999999999999999999976432211  11111111100000000


Q ss_pred             hhh----hh--------h-hhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH--HHHh
Q 007680          503 ANL----VR--------E-EQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK--LKKI  550 (593)
Q Consensus       503 ~~~----~~--------~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~i  550 (593)
                      ...    ..        . ..........+.++.+|+.+||+.||++|||++|+++|  ++..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~  301 (345)
T d1pmea_         239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY  301 (345)
T ss_dssp             TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred             hhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence            000    00        0 00000111234578999999999999999999999987  5443

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-44  Score=369.26  Aligned_cols=268  Identities=22%  Similarity=0.283  Sum_probs=199.4

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehh--hHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCC------
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQ--LERAFRSFDSECEVLRNVRHRNLIKILSSYSNPD------  341 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  341 (593)
                      .++|++++.||+|+||+||+|.+. +|+.||||+++..  .....+.+.+|+++|++++|||||+++++|...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            468999999999999999999975 7999999999753  2345667899999999999999999999997654      


Q ss_pred             ceEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccce
Q 007680          342 FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYK  421 (593)
Q Consensus       342 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~  421 (593)
                      +.|+||||+ +.+|..+.....  +++..+..++.|++.||+|||+++    |+||||||+|||++.++.+|++|||.|+
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~~~--l~~~~~~~~~~qi~~aL~~LH~~~----IiHrDiKp~NIL~~~~~~~kl~Dfg~a~  169 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKHEK--LGEDRIQFLVYQMLKGLRYIHAAG----IIHRDLKPGNLAVNEDCELKILDFGLAR  169 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHHTT----EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             eEEEEEecc-cccHHHHHHhcc--ccHHHHHHHHHHHHHHHHHHHhCC----CcccccCcchhhccccccccccccccee
Confidence            579999999 668888876554  999999999999999999999655    9999999999999999999999999998


Q ss_pred             ecCCCCCccccccccCCccccCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhc--CCchh
Q 007680          422 LLGEGEDSVRQTMTMATIGYMAPEYGLE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESL--PHGLT  498 (593)
Q Consensus       422 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~--~~~~~  498 (593)
                      .....     .+...||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... ..+........  +....
T Consensus       170 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~  243 (346)
T d1cm8a_         170 QADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL-DQLKEIMKVTGTPPAEFV  243 (346)
T ss_dssp             ECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCHHHH
T ss_pred             ccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChH-HHHHHHHhccCCCcHHHH
Confidence            76432     234579999999998876 45799999999999999999999999764221 11111111110  00000


Q ss_pred             hhhhh--------hhhhh-h-hhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH--HHHhh
Q 007680          499 EVVDA--------NLVRE-E-QAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK--LKKIK  551 (593)
Q Consensus       499 ~~~~~--------~~~~~-~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~i~  551 (593)
                      .....        ..... . .........++++.+|+.+||..||++|||++|+++|  ++++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         244 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             hhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence            00000        00000 0 0000112345678999999999999999999999997  65543

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.6e-44  Score=362.71  Aligned_cols=273  Identities=19%  Similarity=0.219  Sum_probs=207.6

Q ss_pred             hccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcc-eeeeeeecCCceEEEEec
Q 007680          272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLI-KILSSYSNPDFKALVLEF  349 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~  349 (593)
                      ++|++.+.||+|+||.||+|++. +|+.||||++.....  ...+..|++++++++|+|++ .+.+++.+.+..++||||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~   84 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   84 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence            57999999999999999999974 789999999876532  24578899999999877655 455666778889999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC---CCcEEEEeeccceecCCC
Q 007680          350 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDE---NMVAHVSDFGIYKLLGEG  426 (593)
Q Consensus       350 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~---~~~~kL~Dfg~a~~~~~~  426 (593)
                      + ++++.+.+......+++..+..++.|++.||+|||+++    |+||||||+||+++.   +..+||+|||+|+.+...
T Consensus        85 ~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~----iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~  159 (299)
T d1ckia_          85 L-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN----FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  159 (299)
T ss_dssp             C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT----EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred             c-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCC----eeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence            9 66787877776667999999999999999999999655    999999999999864   557999999999987654


Q ss_pred             CCc-----cccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchH--HHHHHHhcCCchhh
Q 007680          427 EDS-----VRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSL--RRWVKESLPHGLTE  499 (593)
Q Consensus       427 ~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~--~~~~~~~~~~~~~~  499 (593)
                      ...     .......||+.|+|||++.+..++.++|||||||++|||+||+.||..........  ......        
T Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~--------  231 (299)
T d1ckia_         160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK--------  231 (299)
T ss_dssp             TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHH--------
T ss_pred             ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcc--------
Confidence            321     12234579999999999999999999999999999999999999997643221110  011000        


Q ss_pred             hhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhhh-cchhhccCCcc
Q 007680          500 VVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKF-LDDAAATNWRN  565 (593)
Q Consensus       500 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~-~~~~~~~~~~~  565 (593)
                          ...  .........+++++.+++.+||+.||++||+++++.+.|+.+.... .......+|..
T Consensus       232 ----~~~--~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~~~~~~Dw~~  292 (299)
T d1ckia_         232 ----KMS--TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNM  292 (299)
T ss_dssp             ----HHH--SCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCCCSCCCHHHH
T ss_pred             ----cCC--CChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCCCCCCCcCchh
Confidence                000  0001112245678999999999999999999999998888764332 22233445543

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-44  Score=361.87  Aligned_cols=268  Identities=19%  Similarity=0.238  Sum_probs=207.3

Q ss_pred             hccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh--HHHHHHHHHHHHHHhhcCCCCcceeeeeeecCCceEEEEe
Q 007680          272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSYSNPDFKALVLE  348 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  348 (593)
                      ++|+++++||+|+||+||+|++. +|+.||||+++...  ......+.+|+.++++++||||+++++++.+.+..++|+|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            57999999999999999999975 78999999997543  3456788999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccceecCCCCC
Q 007680          349 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKLLGEGED  428 (593)
Q Consensus       349 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  428 (593)
                      ++.++++..++...+ .+++..+..++.|++.||+|||+++    |+||||||+||+++.++.+||+|||.++.......
T Consensus        82 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~q~~~aL~~lH~~~----IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~  156 (292)
T d1unla_          82 FCDQDLKKYFDSCNG-DLDPEIVKSFLFQLLKGLGFCHSRN----VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR  156 (292)
T ss_dssp             CCSEEHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHTT----EECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred             ecccccccccccccc-ccchhHHHHHHHHHHHHHHHhhcCC----EeeecccCcccccccCCceeeeecchhhcccCCCc
Confidence            999998888876655 4899999999999999999999655    99999999999999999999999999998765432


Q ss_pred             ccccccccCCccccCccccCCCC-CCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCC--c-hh---hhh
Q 007680          429 SVRQTMTMATIGYMAPEYGLEGI-VSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPH--G-LT---EVV  501 (593)
Q Consensus       429 ~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~--~-~~---~~~  501 (593)
                        ......++..|+|||++.+.. ++.++||||+||++|||++|+.||..................+.  . ..   ...
T Consensus       157 --~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (292)
T d1unla_         157 --CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP  234 (292)
T ss_dssp             --CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred             --cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcc
Confidence              223345788999999887665 69999999999999999999999754322222222211111110  0 00   000


Q ss_pred             hhh----hhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          502 DAN----LVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       502 ~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      +..    ..............++.+.+|+.+||+.||++|||++|+++|
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H  283 (292)
T d1unla_         235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             cccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            000    000000111112345678999999999999999999999876

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=4.3e-44  Score=357.88  Aligned_cols=275  Identities=15%  Similarity=0.153  Sum_probs=215.5

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCC-CCcceeeeeeecCCceEEEEe
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNVRH-RNLIKILSSYSNPDFKALVLE  348 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e  348 (593)
                      .++|++.+.||+|+||+||+|++. +|+.||||+++....  ...+.+|++.++.++| +|++.+++++..+...++|||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme   81 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   81 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence            357999999999999999999975 789999999865432  2457789999999965 899999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC-----CCcEEEEeeccceec
Q 007680          349 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDE-----NMVAHVSDFGIYKLL  423 (593)
Q Consensus       349 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~-----~~~~kL~Dfg~a~~~  423 (593)
                      |+ +++|.+++......+++.++..++.|++.||+|||+    .||+||||||+||+++.     ++.+||+|||+|+.+
T Consensus        82 ~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~----~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~  156 (293)
T d1csna_          82 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE----KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  156 (293)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHT----TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             ec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHH----CCceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence            99 789999998877779999999999999999999995    45999999999999974     578999999999987


Q ss_pred             CCCCCc-----cccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchH-HHHHHHhcCCch
Q 007680          424 GEGEDS-----VRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSL-RRWVKESLPHGL  497 (593)
Q Consensus       424 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~-~~~~~~~~~~~~  497 (593)
                      ......     .......||+.|+|||++.+..+++++|||||||++|||+||+.||.......... ...+..      
T Consensus       157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~------  230 (293)
T d1csna_         157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE------  230 (293)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHH------
T ss_pred             ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHh------
Confidence            543221     12234579999999999999999999999999999999999999997643221110 010100      


Q ss_pred             hhhhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHhhhhhc-chhhccCCcc
Q 007680          498 TEVVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAKLKKIKVKFL-DDAAATNWRN  565 (593)
Q Consensus       498 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~-~~~~~~~~~~  565 (593)
                           ....  .........+|+++.+++..|++.+|++||+++.+.+.|+++..... ......+|..
T Consensus       231 -----~~~~--~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~~~~~~Dw~~  292 (293)
T d1csna_         231 -----KKQS--TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWNL  292 (293)
T ss_dssp             -----HHHH--SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGGGC
T ss_pred             -----ccCC--CChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCCCCCCCCCCc
Confidence                 0000  00011112356789999999999999999999999999988765542 2233456653

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-44  Score=364.13  Aligned_cols=269  Identities=20%  Similarity=0.270  Sum_probs=197.4

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh--HHHHHHHHHHHHHHhhcCCCCcceeeeeeec--------
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSYSN--------  339 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------  339 (593)
                      .++|+++++||+|+||+||+|++. +|+.||||++....  ......+.+|++++++++||||+++++++..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            478999999999999999999975 79999999986542  3345678899999999999999999998755        


Q ss_pred             CCceEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeecc
Q 007680          340 PDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGI  419 (593)
Q Consensus       340 ~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~  419 (593)
                      .+..++||||++++++.... .....+++..+..++.|++.||.|||+++    |+||||||+|||++.++.+||+|||+
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~-~~~~~~~~~~~~~i~~qil~~l~~lH~~~----ivHrDlKp~NILl~~~~~~kl~dfg~  163 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLS-NVLVKFTLSEIKRVMQMLLNGLYYIHRNK----ILHRDMKAANVLITRDGVLKLADFGL  163 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHT-CTTCCCCHHHHHHHHHHHHHHHHHHHHTT----EECCCCCGGGEEECTTSCEEECCCTT
T ss_pred             CceEEEEEeccCCCccchhh-hcccccccHHHHHHHHHHHHHHHHhccCC----EEecCcCchheeecCCCcEEeeecce
Confidence            34689999999776655444 44445999999999999999999999654    99999999999999999999999999


Q ss_pred             ceecCCCCCcc--ccccccCCccccCccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHH---hc
Q 007680          420 YKLLGEGEDSV--RQTMTMATIGYMAPEYGLEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKE---SL  493 (593)
Q Consensus       420 a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~---~~  493 (593)
                      ++.........  ......||+.|+|||++.+. .+++++||||+||++|||++|+.||.+....  ........   ..
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~--~~~~~i~~~~~~~  241 (318)
T d3blha1         164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ--HQLALISQLCGSI  241 (318)
T ss_dssp             CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCC
T ss_pred             eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHH--HHHHHHHHhcCCC
Confidence            98765433221  22335699999999998765 6899999999999999999999999763221  11111111   11


Q ss_pred             CCch-hhhhhhhhh----------hhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          494 PHGL-TEVVDANLV----------REEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       494 ~~~~-~~~~~~~~~----------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      +... .........          .............+.+.+|+.+||+.||++|||++|+++|
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H  305 (318)
T d3blha1         242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  305 (318)
T ss_dssp             CTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             ChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence            1110 010000000          0000011112234577899999999999999999999976

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=2.7e-44  Score=365.79  Aligned_cols=262  Identities=19%  Similarity=0.278  Sum_probs=198.9

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcC-CCCcceeeeeeecC--CceEEE
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNVR-HRNLIKILSSYSNP--DFKALV  346 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv  346 (593)
                      .++|+++++||+|+||+||+|+.. +|+.||||+++...   .+.+.+|+++|++++ ||||+++++++...  ...++|
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v  110 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  110 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred             CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence            368999999999999999999974 79999999997543   356889999999995 99999999998754  568999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC-cEEEEeeccceecCC
Q 007680          347 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENM-VAHVSDFGIYKLLGE  425 (593)
Q Consensus       347 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~-~~kL~Dfg~a~~~~~  425 (593)
                      |||+++++|.++..    .+++.++..++.||+.||+|||+++    |+||||||+|||++.++ .+||+|||+|+....
T Consensus       111 ~e~~~~~~L~~~~~----~l~e~~i~~i~~qil~aL~~LH~~g----IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~  182 (328)
T d3bqca1         111 FEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMG----IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  182 (328)
T ss_dssp             EECCCSCBGGGTTT----SCCHHHHHHHHHHHHHHHHHHHHTT----EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred             EeecCCCcHHHHhc----CCCHHHHHHHHHHHHHHHHHHhhcc----cccccccccceEEcCCCCeeeecccccceeccC
Confidence            99999999877532    3899999999999999999999655    99999999999998655 699999999987754


Q ss_pred             CCCccccccccCCccccCccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHH------------HHHh
Q 007680          426 GEDSVRQTMTMATIGYMAPEYGLEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRW------------VKES  492 (593)
Q Consensus       426 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~------------~~~~  492 (593)
                      ...   .....+|+.|+|||.+.+. .++.++||||+||++|||++|+.||.............            ....
T Consensus       183 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~  259 (328)
T d3bqca1         183 GQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY  259 (328)
T ss_dssp             TCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred             CCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhc
Confidence            432   3445789999999997765 47999999999999999999999997643221111111            1000


Q ss_pred             cCCc---hhhhhhhhhh---hhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          493 LPHG---LTEVVDANLV---REEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       493 ~~~~---~~~~~~~~~~---~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      ....   ..........   ...........+++++.+|+.+||..||++|||++|+++|
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H  319 (328)
T d3bqca1         260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  319 (328)
T ss_dssp             TCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0000   0000000000   0000111122345688999999999999999999999874

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-44  Score=369.00  Aligned_cols=266  Identities=22%  Similarity=0.289  Sum_probs=196.2

Q ss_pred             ccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC------CceEE
Q 007680          273 EFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSYSNP------DFKAL  345 (593)
Q Consensus       273 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~l  345 (593)
                      +|+..++||+|+||+||+|++. +|+.||||+++....    ...+|++++++++||||++++++|...      .+.++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            6889999999999999999975 799999999976432    234799999999999999999998543      35789


Q ss_pred             EEeccCCCCHHHHHh--hCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC-cEEEEeecccee
Q 007680          346 VLEFMPNGSLEKWLY--SHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENM-VAHVSDFGIYKL  422 (593)
Q Consensus       346 v~e~~~~gsL~~~l~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~-~~kL~Dfg~a~~  422 (593)
                      ||||++++.+..+..  .....+++.++..++.||+.||+|||+    .||+||||||+|||++.++ .+||+|||+++.
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~----~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~  172 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS----FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ  172 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT----TTEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred             EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh----cCCcccCCCcceEEEecCCCceeEecccchhh
Confidence            999997654333322  233459999999999999999999995    4599999999999999775 899999999987


Q ss_pred             cCCCCCccccccccCCccccCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhh
Q 007680          423 LGEGEDSVRQTMTMATIGYMAPEYGLE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVV  501 (593)
Q Consensus       423 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  501 (593)
                      ......   .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||......+ .+....... .....+..
T Consensus       173 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~-~l~~i~~~~-g~~~~~~~  247 (350)
T d1q5ka_         173 LVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD-QLVEIIKVL-GTPTREQI  247 (350)
T ss_dssp             CCTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH-HHHHHHHHH-CCCCHHHH
T ss_pred             ccCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHH-HHHHHHHHh-CCChHHhh
Confidence            754432   234579999999998765 568999999999999999999999997643211 111111110 00000000


Q ss_pred             hhh-----------hhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH--HHHhh
Q 007680          502 DAN-----------LVREEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK--LKKIK  551 (593)
Q Consensus       502 ~~~-----------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~i~  551 (593)
                      ...           ..............++++.+|+.+||..||++|||+.|+++|  +++++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~  310 (350)
T d1q5ka_         248 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR  310 (350)
T ss_dssp             HHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred             hhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence            000           000000000111345678999999999999999999999986  55554

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-43  Score=362.16  Aligned_cols=263  Identities=21%  Similarity=0.213  Sum_probs=191.6

Q ss_pred             hccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh--HHHHHHHHHHHHHHhhcCCCCcceeeeeeec------CCc
Q 007680          272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSYSN------PDF  342 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~  342 (593)
                      ++|+++++||+|+||+||+|++. +|+.||||+++...  ......+.+|+.++++++||||++++++|..      ..+
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            67999999999999999999976 79999999997542  3445678999999999999999999999864      367


Q ss_pred             eEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeecccee
Q 007680          343 KALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKL  422 (593)
Q Consensus       343 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~  422 (593)
                      .|+||||+.++ +.+.+..   .+++..+..++.|++.||+|||+++    |+||||||+|||++.++.+|++|||.++.
T Consensus        97 ~~iv~Ey~~~~-l~~~~~~---~~~~~~i~~~~~qil~gl~~LH~~g----iiHrDlKP~Nil~~~~~~~kl~df~~~~~  168 (355)
T d2b1pa1          97 VYLVMELMDAN-LCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAG----IIHRDLKPSNIVVKSDCTLKILDFGLART  168 (355)
T ss_dssp             EEEEEECCSEE-HHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             eEEEEeccchH-HHHhhhc---CCCHHHHHHHHHHHHHHHHHhhhcc----cccccCCccccccccccceeeechhhhhc
Confidence            89999999665 4444432   3899999999999999999999654    99999999999999999999999999886


Q ss_pred             cCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCC-------
Q 007680          423 LGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPH-------  495 (593)
Q Consensus       423 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~-------  495 (593)
                      .....   ......+|+.|+|||++.+..+++++||||+||++|||++|+.||.+.... .............       
T Consensus       169 ~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~-~~~~~i~~~~~~~~~~~~~~  244 (355)
T d2b1pa1         169 AGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI-DQWNKVIEQLGTPCPEFMKK  244 (355)
T ss_dssp             ---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCHHHHTT
T ss_pred             ccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHH-HHHHHHHHhccCCCHHHHHH
Confidence            54432   234457899999999999999999999999999999999999999653211 1111111100000       


Q ss_pred             ---chhhhhhhhh----------hh---hhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          496 ---GLTEVVDANL----------VR---EEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       496 ---~~~~~~~~~~----------~~---~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                         ..........          ..   ...........++++.+|+.+||..||++|||++|+++|
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence               0000000000          00   000112233457789999999999999999999999987

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-44  Score=363.83  Aligned_cols=254  Identities=24%  Similarity=0.285  Sum_probs=203.1

Q ss_pred             hhccccccccCccCcccEEEEEeC----CCCeEEEEEeehhh----HHHHHHHHHHHHHHhhcCC-CCcceeeeeeecCC
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS----DGTDVAIKVFNLQL----ERAFRSFDSECEVLRNVRH-RNLIKILSSYSNPD  341 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~  341 (593)
                      .++|++.+.||+|+||+||+|+..    +|+.||||+++...    ....+.+.+|++++++++| |||+++++++.+..
T Consensus        23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~  102 (322)
T d1vzoa_          23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  102 (322)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence            377999999999999999999852    58899999986532    2334568899999999976 89999999999999


Q ss_pred             ceEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccce
Q 007680          342 FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYK  421 (593)
Q Consensus       342 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~  421 (593)
                      ..+++|||+.+|+|.+++...+. +++..+..++.|++.||+|+|+++    |+||||||+||+++.++.+||+|||+++
T Consensus       103 ~~~~v~e~~~~~~L~~~i~~~~~-~~e~~~~~~~~Qi~~al~~lH~~~----ivHrDiKp~Nill~~~~~vkL~DFG~a~  177 (322)
T d1vzoa_         103 KLHLILDYINGGELFTHLSQRER-FTEHEVQIYVGEIVLALEHLHKLG----IIYRDIKLENILLDSNGHVVLTDFGLSK  177 (322)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHSC-CCHHHHHHHHHHHHHHHHHHHHTT----CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             ceeeeeecccccHHHHHHHhccc-ccHHHHHHHHHHHHHHHHHhhcCC----EEeccCCccceeecCCCCEEEeeccchh
Confidence            99999999999999999987765 788999999999999999999654    9999999999999999999999999998


Q ss_pred             ecCCCCCccccccccCCccccCccccCCC--CCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhh
Q 007680          422 LLGEGEDSVRQTMTMATIGYMAPEYGLEG--IVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTE  499 (593)
Q Consensus       422 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  499 (593)
                      .+...... ......|++.|+|||.+.+.  .++.++||||+||++|||++|+.||......... .......       
T Consensus       178 ~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~-~~i~~~~-------  248 (322)
T d1vzoa_         178 EFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ-AEISRRI-------  248 (322)
T ss_dssp             ECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH-HHHHHHH-------
T ss_pred             hhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHhc-------
Confidence            76543322 23445799999999988654  4788999999999999999999999764322211 1111100       


Q ss_pred             hhhhhhhhhhhhhhhhHHHHHHHHHHHhhcccCCCCCCCC-----HHHHHHH
Q 007680          500 VVDANLVREEQAFSAKMDCILSIMDFALDCCMESPDMRIN-----MTDAAAK  546 (593)
Q Consensus       500 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~  546 (593)
                           . ..  ..+.+..+++++.+++.+||++||++|||     ++|+++|
T Consensus       249 -----~-~~--~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H  292 (322)
T d1vzoa_         249 -----L-KS--EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  292 (322)
T ss_dssp             -----H-HC--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             -----c-cC--CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence                 0 00  00111235678999999999999999994     7888865

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-43  Score=360.64  Aligned_cols=263  Identities=20%  Similarity=0.267  Sum_probs=196.5

Q ss_pred             hhccccccccCccCcccEEEEEeC-CCCeEEEEEeehhh--HHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-----Cc
Q 007680          271 TDEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSYSNP-----DF  342 (593)
Q Consensus       271 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~  342 (593)
                      .++|+++++||+|+||+||+|++. +|+.||||+++...  ....+.+.+|++++++++||||+++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            578999999999999999999964 79999999997542  34456788999999999999999999998643     33


Q ss_pred             eEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeecccee
Q 007680          343 KALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYKL  422 (593)
Q Consensus       343 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~  422 (593)
                      .+++++|+.+|+|.+++...+  +++.++..++.||+.||+|||+++    |+||||||+||+++.++.+|++|||.+..
T Consensus        97 ~~~i~~~~~gg~L~~~~~~~~--l~e~~~~~i~~qil~aL~~LH~~g----iiHrDiKp~NILi~~~~~~kl~dfg~a~~  170 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIHSAD----IIHRDLKPSNLAVNEDCELKILDFGLARH  170 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTTCC--CCHHHHHHHHHHHHHHHHHHHHTT----CCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred             eEEEEEeecCCchhhhccccc--ccHHHHHHHHHHHHHHHHHHHhCC----CcccccCCccccccccccccccccchhcc
Confidence            466677788999999996543  999999999999999999999655    99999999999999999999999999876


Q ss_pred             cCCCCCccccccccCCccccCccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhh
Q 007680          423 LGEGEDSVRQTMTMATIGYMAPEYGLEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFIGEMSLRRWVKESLPHGLTEVV  501 (593)
Q Consensus       423 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  501 (593)
                      ...     ......|++.|+|||...+. .++.++||||+||++|+|++|+.||.+....  .....+.........+..
T Consensus       171 ~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~--~~~~~i~~~~~~~~~~~~  243 (348)
T d2gfsa1         171 TDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI--DQLKLILRLVGTPGAELL  243 (348)
T ss_dssp             CTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCCHHHH
T ss_pred             cCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHH--HHHHHHHHhcCCCChHHh
Confidence            432     23345689999999986665 4689999999999999999999999763211  111111111110000000


Q ss_pred             hh-----------hhhh--hhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007680          502 DA-----------NLVR--EEQAFSAKMDCILSIMDFALDCCMESPDMRINMTDAAAK  546 (593)
Q Consensus       502 ~~-----------~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  546 (593)
                      ..           ....  ...........++++.+|+.+||..||++|||++|+++|
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H  301 (348)
T d2gfsa1         244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  301 (348)
T ss_dssp             TTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence            00           0000  000000112345678999999999999999999999986

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=7.1e-38  Score=322.78  Aligned_cols=266  Identities=20%  Similarity=0.227  Sum_probs=189.5

Q ss_pred             hccccccccCccCcccEEEEEeC-CCCeEEEEEeehhhHHHHHHHHHHHHHHhhcC-----------CCCcceeeeeeec
Q 007680          272 DEFNECNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQLERAFRSFDSECEVLRNVR-----------HRNLIKILSSYSN  339 (593)
Q Consensus       272 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~  339 (593)
                      ++|+++++||+|+||+||+|+.. +|+.||||+++.... ..+.+.+|+++++.++           |+||+++++++..
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            35999999999999999999974 799999999986532 3456788999888875           5789999988764


Q ss_pred             C--CceEEEEeccCCCCH-HHH-HhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC-----
Q 007680          340 P--DFKALVLEFMPNGSL-EKW-LYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENM-----  410 (593)
Q Consensus       340 ~--~~~~lv~e~~~~gsL-~~~-l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~-----  410 (593)
                      .  ...+++++++..+.. ... .......+++..+..++.|++.||+|||+   ..||+||||||+|||++.++     
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~---~~~IvHrDlKp~NIll~~~~~~~~~  168 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEIVDSPENL  168 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEEEETTTTE
T ss_pred             ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh---hcCcccccCChhHeeeeccCccccc
Confidence            3  456666666554432 222 23333468999999999999999999996   24699999999999998655     


Q ss_pred             -cEEEEeeccceecCCCCCccccccccCCccccCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCcccccc-----ch
Q 007680          411 -VAHVSDFGIYKLLGEGEDSVRQTMTMATIGYMAPEYGLEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFIGE-----MS  484 (593)
Q Consensus       411 -~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlGvvl~elltg~~pf~~~~~~~-----~~  484 (593)
                       .++++|||.+......     .....||+.|+|||++.+..++.++||||+||++++|++|+.||.......     ..
T Consensus       169 ~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~  243 (362)
T d1q8ya_         169 IQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH  243 (362)
T ss_dssp             EEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred             ceeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence             4999999998865432     234569999999999999999999999999999999999999997532111     01


Q ss_pred             HHHHHH--HhcCCchh-------hhhhh-----h--------hhh-hhhhhhhhHHHHHHHHHHHhhcccCCCCCCCCHH
Q 007680          485 LRRWVK--ESLPHGLT-------EVVDA-----N--------LVR-EEQAFSAKMDCILSIMDFALDCCMESPDMRINMT  541 (593)
Q Consensus       485 ~~~~~~--~~~~~~~~-------~~~~~-----~--------~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  541 (593)
                      ......  ...+....       ...+.     .        ... ...........++++.+|+.+||+.||.+|||++
T Consensus       244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~  323 (362)
T d1q8ya_         244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG  323 (362)
T ss_dssp             HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred             HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence            111110  00000000       00000     0        000 0001112235677899999999999999999999


Q ss_pred             HHHHH
Q 007680          542 DAAAK  546 (593)
Q Consensus       542 evl~~  546 (593)
                      |+++|
T Consensus       324 e~L~H  328 (362)
T d1q8ya_         324 GLVNH  328 (362)
T ss_dssp             HHHTC
T ss_pred             HHhcC
Confidence            99986

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.89  E-value=1.1e-23  Score=195.29  Aligned_cols=163  Identities=17%  Similarity=0.167  Sum_probs=121.1

Q ss_pred             ccccccCccCcccEEEEEeCCCCeEEEEEeehhh------------------HHHHHHHHHHHHHHhhcCCCCcceeeee
Q 007680          275 NECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQL------------------ERAFRSFDSECEVLRNVRHRNLIKILSS  336 (593)
Q Consensus       275 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~------------------~~~~~~~~~E~~~l~~l~h~niv~l~~~  336 (593)
                      .+.++||+|+||+||+|+..+|+.||||+++...                  .........|...+.++.|++++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            4678999999999999998899999999875321                  1112345678899999999999988765


Q ss_pred             eecCCceEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEe
Q 007680          337 YSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSD  416 (593)
Q Consensus       337 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~D  416 (593)
                      .    ..+++|||+++..+.+        ++......++.|++++++|||+++    |+||||||+|||++++ .++|+|
T Consensus        83 ~----~~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH~~g----iiHrDiKP~NILv~~~-~~~liD  145 (191)
T d1zara2          83 E----GNAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFYHRG----IVHGDLSQYNVLVSEE-GIWIID  145 (191)
T ss_dssp             E----TTEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHHHTT----EECSCCSTTSEEEETT-EEEECC
T ss_pred             c----CCEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHhhCC----EEEccCChhheeeeCC-CEEEEE
Confidence            3    2379999998765533        444556789999999999999655    9999999999999966 489999


Q ss_pred             eccceecCCCCCccccccccCCccccC------ccccCCCCCCccchHHHHHHHH
Q 007680          417 FGIYKLLGEGEDSVRQTMTMATIGYMA------PEYGLEGIVSAKCDVYSYGVLL  465 (593)
Q Consensus       417 fg~a~~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~s~~~DvwSlGvvl  465 (593)
                      ||.|.........          .|..      .|. ....|+.++|+||..--+
T Consensus       146 FG~a~~~~~~~~~----------~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         146 FPQSVEVGEEGWR----------EILERDVRNIITY-FSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             CTTCEETTSTTHH----------HHHHHHHHHHHHH-HHHHHCCCCCHHHHHHHH
T ss_pred             CCCcccCCCCCcH----------HHHHHHHHHHHHH-HcCCCCCcccHHHHHHHH
Confidence            9999865432210          1111      011 135678899999976443

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.88  E-value=1.6e-23  Score=210.07  Aligned_cols=91  Identities=33%  Similarity=0.651  Sum_probs=76.1

Q ss_pred             ccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCccccCCccccccccccccccCCCCCCCCCCCCCCCccCCC
Q 007680          101 LTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKLEGEIPVKGSFKNFS  180 (593)
Q Consensus       101 L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~~  180 (593)
                      |+.|++++|.+.+.+| .++.+++|+.|+|++|+|+|.+|..|+++++|+.|+|++|+|+|.+|.       .+.+.++.
T Consensus       223 l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-------~~~L~~L~  294 (313)
T d1ogqa_         223 TQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-------GGNLQRFD  294 (313)
T ss_dssp             CSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-------STTGGGSC
T ss_pred             cccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC-------cccCCCCC
Confidence            6777788888776555 578889999999999999999999999999999999999999997775       24566777


Q ss_pred             cccccCCccCCCCCCCCCCCCC
Q 007680          181 TESFFGNYALCGPPKLRVPPCK  202 (593)
Q Consensus       181 ~~~~~~n~~~c~~~~~~~~~~~  202 (593)
                      ..++.+|+.+||.|   .|+|.
T Consensus       295 ~l~l~~N~~l~g~p---lp~c~  313 (313)
T d1ogqa_         295 VSAYANNKCLCGSP---LPACT  313 (313)
T ss_dssp             GGGTCSSSEEESTT---SSCCC
T ss_pred             HHHhCCCccccCCC---CCCCC
Confidence            88999999999976   35663

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.85  E-value=4.2e-21  Score=187.52  Aligned_cols=174  Identities=26%  Similarity=0.195  Sum_probs=126.4

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLL   80 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~   80 (593)
                      |++|||++|+|+ .+|...+..+++|++|+|++|+|+ .+| .++.+++|+.|+|++|+++ ..+..+..+++|+.|   
T Consensus        33 l~~L~Ls~N~i~-~l~~~~f~~l~~L~~L~L~~N~l~-~l~-~~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L---  105 (266)
T d1p9ag_          33 TTILHLSENLLY-TFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVL---  105 (266)
T ss_dssp             CCEEECTTSCCS-EEEGGGGTTCTTCCEEECTTSCCC-EEE-CCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEE---
T ss_pred             CCEEECcCCcCC-CcCHHHhhcccccccccccccccc-ccc-ccccccccccccccccccc-ccccccccccccccc---
Confidence            466777777776 566555445777777777777776 333 3456777777777777776 445566777777777   


Q ss_pred             cceeeccCCcccccC----CCcccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCccccCCcccccccccc
Q 007680           81 MFGIRLTGNKLYGRI----PPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSG  156 (593)
Q Consensus        81 ~n~l~l~~n~l~~~~----~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~~  156 (593)
                          ++++|.+.+..    ..+..|++|++++|.++...+..+..+++|+.|++++|+|++..++.|..+++|+.|+|++
T Consensus       106 ----~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~  181 (266)
T d1p9ag_         106 ----DVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQE  181 (266)
T ss_dssp             ----ECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCS
T ss_pred             ----cccccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCccccccccccceeeccc
Confidence                66666665322    2334589999999999977777788899999999999999987888899999999999999


Q ss_pred             ccccCCCCCCCCCCCCCCCccCCCcccccCCccCCC
Q 007680          157 NNLSGKIPKLEGEIPVKGSFKNFSTESFFGNYALCG  192 (593)
Q Consensus       157 N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~n~~~c~  192 (593)
                      |+|+. +|+.+..+      ..+......+||+.|.
T Consensus       182 N~L~~-lp~~~~~~------~~L~~L~L~~Np~~Cd  210 (266)
T d1p9ag_         182 NSLYT-IPKGFFGS------HLLPFAFLHGNPWLCN  210 (266)
T ss_dssp             SCCCC-CCTTTTTT------CCCSEEECCSCCBCCS
T ss_pred             CCCcc-cChhHCCC------CCCCEEEecCCCCCCC
Confidence            99995 44433333      3445678899999883

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.81  E-value=3e-20  Score=183.24  Aligned_cols=184  Identities=25%  Similarity=0.218  Sum_probs=113.3

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEcc-CCcccccccccccCCCCchhhhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLG-FNSFSGHILNTFGNLRHLSVLSL   79 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~-~N~l~~~~p~~~~~l~~L~~L~l   79 (593)
                      +++|+|++|+|+ .+|...+.++++|++|++++|+|....+..+.++..++.++.. .|.++...|..|.++++|++|++
T Consensus        34 ~~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l  112 (284)
T d1ozna_          34 SQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHL  112 (284)
T ss_dssp             CSEEECTTSCCC-EECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCEEECcCCcCC-CCCHHHhhccccccccccccccccccccccccccccccccccccccccccccchhhcccccCCEEec
Confidence            478899999998 7887766678899999999998886666666666666666553 55566555666777777777744


Q ss_pred             hcce-----------------eeccCCcccccCC----CcccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCC
Q 007680           80 LMFG-----------------IRLTGNKLYGRIP----PCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGP  138 (593)
Q Consensus        80 ~~n~-----------------l~l~~n~l~~~~~----~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~  138 (593)
                      +.|.                 +++++|++++..+    ....|+.|++++|++++..+..|.++++|+.+++++|++++.
T Consensus       113 ~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i  192 (284)
T d1ozna_         113 DRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHV  192 (284)
T ss_dssp             TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEE
T ss_pred             CCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhcccccc
Confidence            4322                 2455555542211    222355666666666555555555666666666666666555


Q ss_pred             CCccccCCccccccccccccccCCCCCCCCCCCCCCCccCCCcccccCCccCC
Q 007680          139 IPESVGSLISLESLDLSGNNLSGKIPKLEGEIPVKGSFKNFSTESFFGNYALC  191 (593)
Q Consensus       139 ~p~~l~~~~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~n~~~c  191 (593)
                      .|..|..+++|+.||+++|++++..|..+..++.      +....+.+|+..|
T Consensus       193 ~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~------L~~L~l~~N~l~C  239 (284)
T d1ozna_         193 HPHAFRDLGRLMTLYLFANNLSALPTEALAPLRA------LQYLRLNDNPWVC  239 (284)
T ss_dssp             CTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTT------CCEEECCSSCEEC
T ss_pred             ChhHhhhhhhcccccccccccccccccccccccc------cCEEEecCCCCCC
Confidence            5555666666666666666666555554444332      2334556666655

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.79  E-value=4.5e-19  Score=176.49  Aligned_cols=189  Identities=20%  Similarity=0.212  Sum_probs=120.6

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccc------------
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTF------------   68 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~------------   68 (593)
                      |++|+|++|+|+ .+|+..+..+++|++|++++|.++...|..|.++++|+.|+|++|+|+......+            
T Consensus        33 l~~L~Ls~N~i~-~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l~~l~~~~~~~l~~L~~~~n~  111 (305)
T d1xkua_          33 TALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENE  111 (305)
T ss_dssp             CCEEECCSSCCC-CBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCSBCCSSCCTTCCEEECCSSC
T ss_pred             CCEEECcCCcCC-CcChhHhhccccccccccccccccccchhhhhCCCccCEecccCCccCcCccchhhhhhhhhccccc
Confidence            567888888887 7877555558888888888888887667778888888888888887763222111            


Q ss_pred             -----------------------------------cCCCCchhhhhhcce--------------eeccCCccccc----C
Q 007680           69 -----------------------------------GNLRHLSVLSLLMFG--------------IRLTGNKLYGR----I   95 (593)
Q Consensus        69 -----------------------------------~~l~~L~~L~l~~n~--------------l~l~~n~l~~~----~   95 (593)
                                                         ..+++|+.+++++|.              +++++|...+.    +
T Consensus       112 l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~l~~~~~~~L~~L~l~~n~~~~~~~~~~  191 (305)
T d1xkua_         112 ITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELHLDGNKITKVDAASL  191 (305)
T ss_dssp             CCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSCCSSCCTTCSEEECTTSCCCEECTGGG
T ss_pred             hhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCccccCcccCCccCEEECCCCcCCCCChhHh
Confidence                                               112222222221111              22333332211    2


Q ss_pred             CCcccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCccccCCccccccccccccccCCCCCCCCCCCCCCC
Q 007680           96 PPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKLEGEIPVKGS  175 (593)
Q Consensus        96 ~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~~N~l~~~~p~~~~~~~~~~~  175 (593)
                      ..+..+++|++++|.+++..+..|.++++|++|+|++|+|+ .+|..|..+++|+.|+|++|+++.+....|........
T Consensus       192 ~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~  270 (305)
T d1xkua_         192 KGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTK  270 (305)
T ss_dssp             TTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTT
T ss_pred             hccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEECCCCccCccChhhccCcchhcc
Confidence            22233677777777777666677777778888888888887 56777777888888888888887766666655444445


Q ss_pred             ccCCCcccccCCccCC
Q 007680          176 FKNFSTESFFGNYALC  191 (593)
Q Consensus       176 ~~~~~~~~~~~n~~~c  191 (593)
                      ...+....+.+|++.+
T Consensus       271 ~~~L~~L~L~~N~~~~  286 (305)
T d1xkua_         271 KASYSGVSLFSNPVQY  286 (305)
T ss_dssp             SCCCSEEECCSSSSCG
T ss_pred             cCCCCEEECCCCcCcc
Confidence            5556666777777654

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.77  E-value=1.5e-19  Score=180.74  Aligned_cols=172  Identities=30%  Similarity=0.490  Sum_probs=118.8

Q ss_pred             cEEEeeCccccc--cCChhhhhCCCCCcEEECCC-CcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhh
Q 007680            2 RILTLEGNQLSG--RLPSTIGHSLPNIEYLLLTA-NNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLS   78 (593)
Q Consensus         2 ~~L~Ls~n~l~~--~lp~~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~   78 (593)
                      +.|||++|+++|  .+|..++. |++|++|+|++ |+++|.+|++|++|++|++|+|++|++.+..|..+..+.+|+.|+
T Consensus        53 ~~L~L~~~~l~g~~~lp~~l~~-L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~  131 (313)
T d1ogqa_          53 NNLDLSGLNLPKPYPIPSSLAN-LPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLD  131 (313)
T ss_dssp             EEEEEECCCCSSCEECCGGGGG-CTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEE
T ss_pred             EEEECCCCCCCCCCCCChHHhc-Cccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcccc
Confidence            457777777765  46777765 77777777775 677777777777777777777777777766666666666666665


Q ss_pred             hhcce-----------------eeccCCcccccCCCcc----c-ccEEEccCCc-----------------------ccC
Q 007680           79 LLMFG-----------------IRLTGNKLYGRIPPCL----V-LTVLDVSRNQ-----------------------LSG  113 (593)
Q Consensus        79 l~~n~-----------------l~l~~n~l~~~~~~~~----~-L~~L~l~~N~-----------------------l~~  113 (593)
                      ++.|.                 +++++|.+.+.+|...    . ++.+++++|+                       +.+
T Consensus       132 l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~~  211 (313)
T d1ogqa_         132 FSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEG  211 (313)
T ss_dssp             CCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEE
T ss_pred             cccccccccCchhhccCcccceeecccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            55432                 3566666665555322    1 2444444444                       444


Q ss_pred             cCCCCCCCCCCCCEecCCCccCCCCCCccccCCccccccccccccccCCCCCCCCCCCCCCC
Q 007680          114 DIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKLEGEIPVKGS  175 (593)
Q Consensus       114 ~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~~N~l~~~~p~~~~~~~~~~~  175 (593)
                      .+|..+..+++|+.+++++|.+++.+ ..+..+++|+.|+|++|+++|.+|..+..++.+..
T Consensus       212 ~~~~~~~~~~~l~~l~~~~~~l~~~~-~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~  272 (313)
T d1ogqa_         212 DASVLFGSDKNTQKIHLAKNSLAFDL-GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHS  272 (313)
T ss_dssp             CCGGGCCTTSCCSEEECCSSEECCBG-GGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCE
T ss_pred             cccccccccccccccccccccccccc-cccccccccccccCccCeecccCChHHhCCCCCCE
Confidence            45555667788899999999998654 46888899999999999999989987777665443

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.77  E-value=8.7e-19  Score=162.05  Aligned_cols=153  Identities=25%  Similarity=0.256  Sum_probs=120.5

Q ss_pred             cEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccC-CccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhh
Q 007680            2 RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTI-PNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLL   80 (593)
Q Consensus         2 ~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~   80 (593)
                      +++++++|+|+ .||.+++   +++++|+|++|+|++.+ +..|.++++|+.|+|++|.+....++.|..+++|++|   
T Consensus        11 ~~v~Cs~~~L~-~iP~~lp---~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L---   83 (192)
T d1w8aa_          11 TTVDCTGRGLK-EIPRDIP---LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQEL---   83 (192)
T ss_dssp             TEEECTTSCCS-SCCSCCC---TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEE---
T ss_pred             CEEEEeCCCcC-ccCCCCC---CCCCEEEeCCCCCcccccccccCCCceEeeeecccccccccccccccccccccee---
Confidence            57899999999 9998775   58999999999998645 5678999999999999999998888999999999998   


Q ss_pred             cceeeccCCcccc----cCCCcccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCccccCCcccccccccc
Q 007680           81 MFGIRLTGNKLYG----RIPPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSG  156 (593)
Q Consensus        81 ~n~l~l~~n~l~~----~~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~~  156 (593)
                          ++++|++..    .+.++..|++|+|++|+|++..|++|.++++|++|+|++|++.. ......-...++.+.+..
T Consensus        84 ----~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~-~~~~~~~~~~l~~~~l~~  158 (192)
T d1w8aa_          84 ----QLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC-NCHLAWFAEWLRKKSLNG  158 (192)
T ss_dssp             ----ECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCC-SGGGHHHHHHHHHHCCSG
T ss_pred             ----eeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCccccccccccccccc-ccchHHHhhhhhhhcccC
Confidence                777887773    34445568888888888887777888888888888888888874 332211223466677777


Q ss_pred             ccccCCCCCC
Q 007680          157 NNLSGKIPKL  166 (593)
Q Consensus       157 N~l~~~~p~~  166 (593)
                      |.++...|..
T Consensus       159 ~~~~c~~p~~  168 (192)
T d1w8aa_         159 GAARCGAPSK  168 (192)
T ss_dssp             GGCBBCSSTT
T ss_pred             CCeEeCCChh
Confidence            7777655543

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.76  E-value=2e-18  Score=168.23  Aligned_cols=169  Identities=25%  Similarity=0.238  Sum_probs=142.4

Q ss_pred             cEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhhc
Q 007680            2 RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLM   81 (593)
Q Consensus         2 ~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~   81 (593)
                      ..+|+++++|+ .+|++++   ++|++|+|++|+|++..+.+|.++++|+.|+|++|+|+ .+| .++.+++|++|    
T Consensus        13 ~~v~C~~~~L~-~iP~~lp---~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~-~~~~l~~L~~L----   82 (266)
T d1p9ag_          13 LEVNCDKRNLT-ALPPDLP---KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTL----   82 (266)
T ss_dssp             CEEECTTSCCS-SCCSCCC---TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEE-CCSCCTTCCEE----
T ss_pred             eEEEccCCCCC-eeCcCcC---cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-ccc-ccccccccccc----
Confidence            45799999999 8998765   48999999999999777788999999999999999999 455 36889999999    


Q ss_pred             ceeeccCCcccc---cCCCcccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCccccCCcccccccccccc
Q 007680           82 FGIRLTGNKLYG---RIPPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNN  158 (593)
Q Consensus        82 n~l~l~~n~l~~---~~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~~N~  158 (593)
                         ++++|++.+   .+..+..|++|++++|.+.+..+..+..+.+|..|++++|.+++..+..+..+++|+.|++++|+
T Consensus        83 ---~Ls~N~l~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~  159 (266)
T d1p9ag_          83 ---DLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNN  159 (266)
T ss_dssp             ---ECCSSCCSSCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred             ---ccccccccccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhccccccc
Confidence               777787763   23345569999999999998788888999999999999999997778888899999999999999


Q ss_pred             ccCCCCCCCCCCCCCCCccCCCcccccCCcc
Q 007680          159 LSGKIPKLEGEIPVKGSFKNFSTESFFGNYA  189 (593)
Q Consensus       159 l~~~~p~~~~~~~~~~~~~~~~~~~~~~n~~  189 (593)
                      +++..+..+..++.+.      .....+|..
T Consensus       160 l~~~~~~~~~~l~~L~------~L~Ls~N~L  184 (266)
T d1p9ag_         160 LTELPAGLLNGLENLD------TLLLQENSL  184 (266)
T ss_dssp             CSCCCTTTTTTCTTCC------EEECCSSCC
T ss_pred             ccccCccccccccccc------eeecccCCC
Confidence            9999888776665443      345566643

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.69  E-value=7.8e-17  Score=149.58  Aligned_cols=144  Identities=27%  Similarity=0.399  Sum_probs=119.4

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLL   80 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~   80 (593)
                      |+.|++++|++. .++ ++. .+++|++|+|++|+|++. ++ |.++++|+.|++++|.+. .++ .+..+++|+.|   
T Consensus        42 l~~L~l~~~~i~-~l~-~l~-~l~nL~~L~Ls~N~l~~~-~~-l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L---  111 (199)
T d2omxa2          42 VTTLQADRLGIK-SID-GVE-YLNNLTQINFSNNQLTDI-TP-LKNLTKLVDILMNNNQIA-DIT-PLANLTNLTGL---  111 (199)
T ss_dssp             CCEEECTTSCCC-CCT-TGG-GCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEE---
T ss_pred             CCEEECCCCCCC-Ccc-ccc-cCCCcCcCccccccccCc-cc-ccCCcccccccccccccc-ccc-ccccccccccc---
Confidence            578999999998 775 465 499999999999999954 33 899999999999999998 444 38899999999   


Q ss_pred             cceeeccCCcccc--cCCCcccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCccccCCcccccccccccc
Q 007680           81 MFGIRLTGNKLYG--RIPPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNN  158 (593)
Q Consensus        81 ~n~l~l~~n~l~~--~~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~~N~  158 (593)
                          ++++|.+..  .+..+..|+.|++++|++. .++ .+..+++|+.|++.+|++++ ++ .+.++++|+.|++++|+
T Consensus       112 ----~l~~~~~~~~~~~~~l~~L~~L~l~~n~l~-~~~-~l~~~~~L~~L~l~~n~l~~-l~-~l~~l~~L~~L~ls~N~  183 (199)
T d2omxa2         112 ----TLFNNQITDIDPLKNLTNLNRLELSSNTIS-DIS-ALSGLTSLQQLNFSSNQVTD-LK-PLANLTTLERLDISSNK  183 (199)
T ss_dssp             ----ECCSSCCCCCGGGTTCTTCSEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCC-CG-GGTTCTTCCEEECCSSC
T ss_pred             ----cccccccccccccchhhhhHHhhhhhhhhc-ccc-cccccccccccccccccccC-Cc-cccCCCCCCEEECCCCC
Confidence                666666653  3455667999999999998 455 58899999999999999985 44 48899999999999999


Q ss_pred             ccCC
Q 007680          159 LSGK  162 (593)
Q Consensus       159 l~~~  162 (593)
                      ++++
T Consensus       184 i~~i  187 (199)
T d2omxa2         184 VSDI  187 (199)
T ss_dssp             CCCC
T ss_pred             CCCC
Confidence            9874

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.68  E-value=7e-17  Score=160.38  Aligned_cols=167  Identities=22%  Similarity=0.231  Sum_probs=117.0

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLL   80 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~   80 (593)
                      ++++|.++++++ .+|.+++   ++|++|+|++|+|+...+.+|.++++|+.|++++|.+....|..|..+++|+.|+++
T Consensus        12 ~~~~~C~~~~L~-~lP~~l~---~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~   87 (305)
T d1xkua_          12 LRVVQCSDLGLE-KVPKDLP---PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS   87 (305)
T ss_dssp             TTEEECTTSCCC-SCCCSCC---TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred             CCEEEecCCCCC-ccCCCCC---CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEeccc
Confidence            467899999999 9998875   589999999999996555689999999999999999998888899999999999887


Q ss_pred             cce--------------eeccCCcccc------------------------------cCCCcc-----------------
Q 007680           81 MFG--------------IRLTGNKLYG------------------------------RIPPCL-----------------   99 (593)
Q Consensus        81 ~n~--------------l~l~~n~l~~------------------------------~~~~~~-----------------   99 (593)
                      +|.              +++.+|.+.+                              .+..+.                 
T Consensus        88 ~n~l~~l~~~~~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~l~~  167 (305)
T d1xkua_          88 KNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQ  167 (305)
T ss_dssp             SSCCSBCCSSCCTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSCCS
T ss_pred             CCccCcCccchhhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCccccCc
Confidence            654              2223333321                              001111                 


Q ss_pred             ----cccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCccccCCccccccccccccccCCCCCCCCCCCC
Q 007680          100 ----VLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKLEGEIPV  172 (593)
Q Consensus       100 ----~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~~N~l~~~~p~~~~~~~~  172 (593)
                          +|+.|++++|.+++..+..|.+++.++.|++++|.+++..+..+.++++|++|+|++|+|+.+ |..+..++.
T Consensus       168 ~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~~l-p~~l~~l~~  243 (305)
T d1xkua_         168 GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKV-PGGLADHKY  243 (305)
T ss_dssp             SCCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSC-CTTTTTCSS
T ss_pred             ccCCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccccc-ccccccccC
Confidence                145555555555555555566666667777777777665566666677777777777777654 334444443

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.67  E-value=1.1e-16  Score=157.23  Aligned_cols=142  Identities=23%  Similarity=0.213  Sum_probs=123.1

Q ss_pred             cCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhhcceeeccCCcccc
Q 007680           14 RLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYG   93 (593)
Q Consensus        14 ~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~l~~n~l~~   93 (593)
                      .++...+..+++|++|+|++|.+....+..+..+++|+.+++++|+|+++.++.|..+++|+.|       ++++|++.+
T Consensus        95 ~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L-------~l~~N~l~~  167 (284)
T d1ozna_          95 SVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHL-------FLHGNRISS  167 (284)
T ss_dssp             CCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE-------ECCSSCCCE
T ss_pred             cccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhc-------ccccCcccc
Confidence            4444444558899999999999987777788889999999999999997777889999999998       778888763


Q ss_pred             ----cCCCcccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCccccCCccccccccccccccCC
Q 007680           94 ----RIPPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGK  162 (593)
Q Consensus        94 ----~~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~~N~l~~~  162 (593)
                          .+..+..|++|++++|++++..|..|.++++|+.|++++|++++..|..|.++++|+.|++++|++...
T Consensus       168 l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~  240 (284)
T d1ozna_         168 VPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCD  240 (284)
T ss_dssp             ECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECS
T ss_pred             cchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCC
Confidence                445566799999999999998899999999999999999999988888999999999999999999863

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.66  E-value=1.4e-16  Score=146.91  Aligned_cols=128  Identities=28%  Similarity=0.272  Sum_probs=111.0

Q ss_pred             CcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccc-cccccCCCCchhhhhhcceeeccCCcccccC----CCccc
Q 007680           26 IEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHI-LNTFGNLRHLSVLSLLMFGIRLTGNKLYGRI----PPCLV  100 (593)
Q Consensus        26 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~l~~n~l~l~~n~l~~~~----~~~~~  100 (593)
                      .+.++.++|+|+ .+|..+.  +++++|+|++|+|+..+ +..|..+++|+.|       ++++|++....    .....
T Consensus        10 ~~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L-------~L~~N~i~~~~~~~~~~~~~   79 (192)
T d1w8aa_          10 GTTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKL-------ELKRNQLTGIEPNAFEGASH   79 (192)
T ss_dssp             TTEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEE-------ECCSSCCCCBCTTTTTTCTT
T ss_pred             CCEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeee-------eccccccccccccccccccc
Confidence            468999999999 7888774  68999999999998644 6678999999999       78888877433    34456


Q ss_pred             ccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCccccCCccccccccccccccCCC
Q 007680          101 LTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKI  163 (593)
Q Consensus       101 L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~~N~l~~~~  163 (593)
                      |++|+|++|+|++..|++|.++++|++|+|++|+|++..|++|..+++|++|+|++|++....
T Consensus        80 L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~  142 (192)
T d1w8aa_          80 IQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNC  142 (192)
T ss_dssp             CCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSG
T ss_pred             cceeeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCccccccccccccccccc
Confidence            999999999999888888999999999999999999888888999999999999999998643

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.65  E-value=3.2e-16  Score=146.61  Aligned_cols=144  Identities=27%  Similarity=0.362  Sum_probs=119.0

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLL   80 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~   80 (593)
                      |+.|++++|.++ .++ ++.. +++|++|+|++|+|++ ++ .++.+++|+.|++++|+|++ +| .+..+++|+.|   
T Consensus        48 L~~L~l~~~~i~-~l~-~l~~-l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L---  117 (210)
T d1h6ta2          48 IDQIIANNSDIK-SVQ-GIQY-LPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSL---  117 (210)
T ss_dssp             CCEEECTTSCCC-CCT-TGGG-CTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEE---
T ss_pred             ccEEECcCCCCC-Cch-hHhh-CCCCCEEeCCCccccC-cc-ccccCccccccccccccccc-cc-ccccccccccc---
Confidence            678999999998 676 4654 9999999999999996 44 37899999999999999994 55 48999999999   


Q ss_pred             cceeeccCCcccc--cCCCcccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCccccCCcccccccccccc
Q 007680           81 MFGIRLTGNKLYG--RIPPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNN  158 (593)
Q Consensus        81 ~n~l~l~~n~l~~--~~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~~N~  158 (593)
                          ++++|.+..  .+..+..|+.+++++|.+++ ++ .+..+++|+.+++++|++++ ++ .+.++++|+.|++++|+
T Consensus       118 ----~l~~~~~~~~~~l~~l~~l~~l~~~~n~l~~-~~-~~~~l~~L~~l~l~~n~l~~-i~-~l~~l~~L~~L~Ls~N~  189 (210)
T d1h6ta2         118 ----SLEHNGISDINGLVHLPQLESLYLGNNKITD-IT-VLSRLTKLDTLSLEDNQISD-IV-PLAGLTKLQNLYLSKNH  189 (210)
T ss_dssp             ----ECTTSCCCCCGGGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCSEEECCSSCCCC-CG-GGTTCTTCCEEECCSSC
T ss_pred             ----ccccccccccccccccccccccccccccccc-cc-cccccccccccccccccccc-cc-cccCCCCCCEEECCCCC
Confidence                666666552  34445569999999999984 33 57789999999999999985 44 38899999999999999


Q ss_pred             ccCC
Q 007680          159 LSGK  162 (593)
Q Consensus       159 l~~~  162 (593)
                      ++.+
T Consensus       190 i~~l  193 (210)
T d1h6ta2         190 ISDL  193 (210)
T ss_dssp             CCBC
T ss_pred             CCCC
Confidence            9864

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.64  E-value=6.1e-16  Score=146.60  Aligned_cols=153  Identities=24%  Similarity=0.326  Sum_probs=117.2

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLL   80 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~   80 (593)
                      |+.|++++|+|+ .++ ++.+ +++|++|+|++|+|++..|  |..+++|+.|++++|.++ .++ .|..+++|+.|+++
T Consensus        43 L~~L~l~~~~i~-~l~-~l~~-l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~-~i~-~l~~l~~L~~l~l~  115 (227)
T d1h6ua2          43 ITTLSAFGTGVT-TIE-GVQY-LNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLDLT  115 (227)
T ss_dssp             CCEEECTTSCCC-CCT-TGGG-CTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCS-CCG-GGTTCTTCCEEECT
T ss_pred             cCEEECCCCCCC-cch-hHhc-CCCCcEeecCCceeecccc--cccccccccccccccccc-ccc-cccccccccccccc
Confidence            689999999999 785 6765 9999999999999996443  899999999999999998 444 48899999999766


Q ss_pred             cce---------------eeccCCcccc--cCCCcccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCccc
Q 007680           81 MFG---------------IRLTGNKLYG--RIPPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESV  143 (593)
Q Consensus        81 ~n~---------------l~l~~n~l~~--~~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l  143 (593)
                      .+.               +.++.+.+..  .+....+|++|++++|.+.. .+ .++++++|++|+|++|++++ ++ .+
T Consensus       116 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~~~~-~~-~l~~l~~L~~L~Ls~n~l~~-l~-~l  191 (227)
T d1h6ua2         116 STQITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSD-LT-PLANLSKLTTLKADDNKISD-IS-PL  191 (227)
T ss_dssp             TSCCCCCGGGTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCC-CG-GG
T ss_pred             cccccccchhccccchhhhhchhhhhchhhhhcccccccccccccccccc-ch-hhcccccceecccCCCccCC-Ch-hh
Confidence            433               2233443332  12233348889998888874 33 37888889999999999884 44 37


Q ss_pred             cCCccccccccccccccCCCC
Q 007680          144 GSLISLESLDLSGNNLSGKIP  164 (593)
Q Consensus       144 ~~~~~L~~L~l~~N~l~~~~p  164 (593)
                      .++++|+.|++++|+++++.|
T Consensus       192 ~~l~~L~~L~Ls~N~lt~i~~  212 (227)
T d1h6ua2         192 ASLPNLIEVHLKNNQISDVSP  212 (227)
T ss_dssp             GGCTTCCEEECTTSCCCBCGG
T ss_pred             cCCCCCCEEECcCCcCCCCcc
Confidence            888899999999998887543

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.61  E-value=8.3e-16  Score=147.02  Aligned_cols=171  Identities=13%  Similarity=0.074  Sum_probs=121.9

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccC-CccCCCCCCCcEEEcc-CCcccccccccccCCCCchhhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTI-PNSITNATKLIVLDLG-FNSFSGHILNTFGNLRHLSVLS   78 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L~-~N~l~~~~p~~~~~l~~L~~L~   78 (593)
                      ++.|||++|+|+ .+|...+.++++|++|+|++|.+...+ +.+|.++++++.|++. .|++....+..|.++++|++|+
T Consensus        31 l~~L~Ls~n~i~-~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~  109 (242)
T d1xwdc1          31 AIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLL  109 (242)
T ss_dssp             CSEEEEESCCCC-EECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEE
T ss_pred             CCEEECcCCcCC-ccChhHhhccchhhhhhhccccccceeeccccccccccccccccccccccccccccccccccccccc
Confidence            578899999998 788876667889999999999887654 4467888888888876 4677767777889999999997


Q ss_pred             hhcceee------------------ccCCcccc----cCCCcc-cccEEEccCCcccCcCCCCCCCCCCCC-EecCCCcc
Q 007680           79 LLMFGIR------------------LTGNKLYG----RIPPCL-VLTVLDVSRNQLSGDIPSTIGGRVDLE-TLSLASNQ  134 (593)
Q Consensus        79 l~~n~l~------------------l~~n~l~~----~~~~~~-~L~~L~l~~N~l~~~~p~~~~~l~~L~-~L~l~~N~  134 (593)
                      +.+|.+.                  ..++.+..    .+..+. .++.|++++|+++...+..| ...++. .+++++|+
T Consensus       110 l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~-~~~~l~~~~~l~~n~  188 (242)
T d1xwdc1         110 ISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAF-NGTQLDELNLSDNNN  188 (242)
T ss_dssp             EESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTTT-TTCCEEEEECTTCTT
T ss_pred             cchhhhcccccccccccccccccccccccccccccccccccccccceeeecccccccccccccc-cchhhhccccccccc
Confidence            7655432                  11111211    111111 37789999999985444444 445544 44678889


Q ss_pred             CCCCCCccccCCccccccccccccccCCCCCCCCCCCCC
Q 007680          135 FQGPIPESVGSLISLESLDLSGNNLSGKIPKLEGEIPVK  173 (593)
Q Consensus       135 l~~~~p~~l~~~~~L~~L~l~~N~l~~~~p~~~~~~~~~  173 (593)
                      |+...+..|.++++|+.|++++|+++.+++..+..++.+
T Consensus       189 l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L  227 (242)
T d1xwdc1         189 LEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKL  227 (242)
T ss_dssp             CCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEE
T ss_pred             cccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCccc
Confidence            985555668999999999999999998777766666544

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.59  E-value=2.2e-15  Score=140.81  Aligned_cols=138  Identities=28%  Similarity=0.434  Sum_probs=116.3

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLL   80 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~   80 (593)
                      |+.|+|++|.|+ .++. +. .+++|++|++++|+|++ +| .+.++++|+.|++++|.+.. ++ .+..+++|+.+   
T Consensus        70 L~~L~L~~n~i~-~l~~-~~-~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~~~~~~~-~~-~l~~l~~l~~l---  139 (210)
T d1h6ta2          70 VTKLFLNGNKLT-DIKP-LA-NLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISD-IN-GLVHLPQLESL---  139 (210)
T ss_dssp             CCEEECCSSCCC-CCGG-GT-TCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCC-CG-GGGGCTTCCEE---
T ss_pred             CCEEeCCCcccc-Cccc-cc-cCccccccccccccccc-cc-cccccccccccccccccccc-cc-ccccccccccc---
Confidence            789999999999 6774 44 49999999999999994 55 58999999999999999983 43 58889999999   


Q ss_pred             cceeeccCCcccc--cCCCcccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCccccCCcccccccccc
Q 007680           81 MFGIRLTGNKLYG--RIPPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSG  156 (593)
Q Consensus        81 ~n~l~l~~n~l~~--~~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~~  156 (593)
                          +++.|.+++  .+..+..|+++++++|++++ +++ +.++++|++|+|++|+|+ .+| .+.++++|+.|+|++
T Consensus       140 ----~~~~n~l~~~~~~~~l~~L~~l~l~~n~l~~-i~~-l~~l~~L~~L~Ls~N~i~-~l~-~l~~l~~L~~L~Ls~  209 (210)
T d1h6ta2         140 ----YLGNNKITDITVLSRLTKLDTLSLEDNQISD-IVP-LAGLTKLQNLYLSKNHIS-DLR-ALAGLKNLDVLELFS  209 (210)
T ss_dssp             ----ECCSSCCCCCGGGGGCTTCSEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCC-BCG-GGTTCTTCSEEEEEE
T ss_pred             ----ccccccccccccccccccccccccccccccc-ccc-ccCCCCCCEEECCCCCCC-CCh-hhcCCCCCCEEEccC
Confidence                777777763  23345569999999999985 443 889999999999999998 566 589999999999975

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.57  E-value=1.5e-15  Score=129.11  Aligned_cols=102  Identities=25%  Similarity=0.282  Sum_probs=62.9

Q ss_pred             cEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhhc
Q 007680            2 RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLM   81 (593)
Q Consensus         2 ~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~   81 (593)
                      |+|||++|+|+ .+|. +.+ +++|++|+|++|+|+ .+|++|+.+++|+.|++++|+|++ +| .|+.+++|++|    
T Consensus         1 R~L~Ls~n~l~-~l~~-l~~-l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L----   70 (124)
T d1dcea3           1 RVLHLAHKDLT-VLCH-LEQ-LLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQEL----   70 (124)
T ss_dssp             SEEECTTSCCS-SCCC-GGG-GTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEE----
T ss_pred             CEEEcCCCCCC-CCcc-ccc-CCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeE----
Confidence            46777777777 6663 543 777777777777777 566677777777777777777773 33 25555544433    


Q ss_pred             ceeeccCCcccccCCCcccccEEEccCCcccCcCC-CCCCCCCCCCEecCCCccCC
Q 007680           82 FGIRLTGNKLYGRIPPCLVLTVLDVSRNQLSGDIP-STIGGRVDLETLSLASNQFQ  136 (593)
Q Consensus        82 n~l~l~~n~l~~~~~~~~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~  136 (593)
                                             ++++|+|+.... ..+..+++|+.|++++|+++
T Consensus        71 -----------------------~l~~N~i~~~~~~~~l~~~~~L~~L~l~~N~i~  103 (124)
T d1dcea3          71 -----------------------LLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC  103 (124)
T ss_dssp             -----------------------ECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred             -----------------------ECCCCccCCCCCchhhcCCCCCCEEECCCCcCC
Confidence                                   444555542211 23455566666666666665

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.56  E-value=6.5e-15  Score=150.42  Aligned_cols=158  Identities=27%  Similarity=0.323  Sum_probs=98.3

Q ss_pred             cEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhhc
Q 007680            2 RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLM   81 (593)
Q Consensus         2 ~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~   81 (593)
                      +.|++++|.++ .++.. . ..++|++|++++|+++. + +.+..+++|+.|++++|.+++..+  ++.+++|+.|++++
T Consensus       200 ~~l~l~~n~i~-~~~~~-~-~~~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~  272 (384)
T d2omza2         200 ESLIATNNQIS-DITPL-G-ILTNLDELSLNGNQLKD-I-GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGA  272 (384)
T ss_dssp             SEEECCSSCCC-CCGGG-G-GCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCS
T ss_pred             ceeeccCCccC-CCCcc-c-ccCCCCEEECCCCCCCC-c-chhhcccccchhccccCccCCCCc--ccccccCCEeeccC
Confidence            45566666665 33321 1 24556666666666552 2 245555666666666666653332  55555555554433


Q ss_pred             ce---------------eeccCCcccc--cCCCcccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCcccc
Q 007680           82 FG---------------IRLTGNKLYG--RIPPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVG  144 (593)
Q Consensus        82 n~---------------l~l~~n~l~~--~~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~  144 (593)
                      |.               +++..|.+.+  .+..+..++.|++++|++++. + .+..+++|++|++++|+|+ .++ .+.
T Consensus       273 ~~l~~~~~~~~~~~l~~l~~~~n~l~~~~~~~~~~~l~~L~ls~n~l~~l-~-~l~~l~~L~~L~L~~n~l~-~l~-~l~  348 (384)
T d2omza2         273 NQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDI-S-PVSSLTKLQRLFFANNKVS-DVS-SLA  348 (384)
T ss_dssp             SCCCCCGGGTTCTTCSEEECCSSCCSCCGGGGGCTTCSEEECCSSCCSCC-G-GGGGCTTCCEEECCSSCCC-CCG-GGG
T ss_pred             cccCCCCccccccccccccccccccccccccchhcccCeEECCCCCCCCC-c-ccccCCCCCEEECCCCCCC-CCh-hHc
Confidence            22               1455555553  133344589999999999854 3 2788899999999999998 455 588


Q ss_pred             CCccccccccccccccCCCCCCCCCCCC
Q 007680          145 SLISLESLDLSGNNLSGKIPKLEGEIPV  172 (593)
Q Consensus       145 ~~~~L~~L~l~~N~l~~~~p~~~~~~~~  172 (593)
                      ++++|+.|++++|++++..|  +..++.
T Consensus       349 ~l~~L~~L~l~~N~l~~l~~--l~~l~~  374 (384)
T d2omza2         349 NLTNINWLSAGHNQISDLTP--LANLTR  374 (384)
T ss_dssp             GCTTCCEEECCSSCCCBCGG--GTTCTT
T ss_pred             CCCCCCEEECCCCcCCCChh--hccCCC
Confidence            89999999999999988654  444443

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.55  E-value=1.1e-14  Score=134.66  Aligned_cols=134  Identities=26%  Similarity=0.390  Sum_probs=111.4

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLL   80 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~   80 (593)
                      |++|+|++|+++ .++. +. .+++|++|++++|.+. .++ .+.++++|+.|++++|.+....  .+..+++|+.|   
T Consensus        64 L~~L~Ls~N~l~-~~~~-l~-~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~l~~~~~~~~~--~~~~l~~L~~L---  133 (199)
T d2omxa2          64 LTQINFSNNQLT-DITP-LK-NLTKLVDILMNNNQIA-DIT-PLANLTNLTGLTLFNNQITDID--PLKNLTNLNRL---  133 (199)
T ss_dssp             CCEEECCSSCCC-CCGG-GT-TCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEE---
T ss_pred             cCcCcccccccc-Cccc-cc-CCcccccccccccccc-ccc-cccccccccccccccccccccc--ccchhhhhHHh---
Confidence            689999999999 6764 55 4999999999999998 444 4899999999999999998533  48899999999   


Q ss_pred             cceeeccCCcccc--cCCCcccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCccccCCcccccc
Q 007680           81 MFGIRLTGNKLYG--RIPPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESL  152 (593)
Q Consensus        81 ~n~l~l~~n~l~~--~~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L  152 (593)
                          ++++|++..  .+..+..|++|++++|++++ ++ .++++++|+.|++++|++++ ++ .+..+++|++|
T Consensus       134 ----~l~~n~l~~~~~l~~~~~L~~L~l~~n~l~~-l~-~l~~l~~L~~L~ls~N~i~~-i~-~l~~L~~L~~L  199 (199)
T d2omxa2         134 ----ELSSNTISDISALSGLTSLQQLNFSSNQVTD-LK-PLANLTTLERLDISSNKVSD-IS-VLAKLTNLESL  199 (199)
T ss_dssp             ----ECCSSCCCCCGGGTTCTTCSEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEE
T ss_pred             ----hhhhhhhcccccccccccccccccccccccC-Cc-cccCCCCCCEEECCCCCCCC-Cc-cccCCCCCCcC
Confidence                777777763  34555679999999999985 54 38999999999999999984 54 57888888865

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.54  E-value=2e-15  Score=134.73  Aligned_cols=119  Identities=18%  Similarity=0.161  Sum_probs=74.2

Q ss_pred             CCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhhcceeeccCCcccccCC----Cc
Q 007680           23 LPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIP----PC   98 (593)
Q Consensus        23 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~l~~n~l~~~~~----~~   98 (593)
                      ..+|++|+|++|+|+ .+|..+..+++|+.|+|++|+|+ .++ .|..+++|++|       ++++|+++...+    .+
T Consensus        17 ~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L-------~ls~N~i~~l~~~~~~~l   86 (162)
T d1a9na_          17 AVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTL-------LVNNNRICRIGEGLDQAL   86 (162)
T ss_dssp             TTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEE-------ECCSSCCCEECSCHHHHC
T ss_pred             cCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhh-------hcccccccCCCccccccc
Confidence            667888888888888 55666677888888888888888 343 36667777666       555555542211    12


Q ss_pred             ccccEEEccCCcccCcCC--CCCCCCCCCCEecCCCccCCCCCCc----cccCCccccccc
Q 007680           99 LVLTVLDVSRNQLSGDIP--STIGGRVDLETLSLASNQFQGPIPE----SVGSLISLESLD  153 (593)
Q Consensus        99 ~~L~~L~l~~N~l~~~~p--~~~~~l~~L~~L~l~~N~l~~~~p~----~l~~~~~L~~L~  153 (593)
                      ..|++|++++|+|+ .++  ..+..+++|+.|++++|+++ ..|.    .+..+++|+.||
T Consensus        87 ~~L~~L~L~~N~i~-~~~~l~~l~~l~~L~~L~l~~N~i~-~~~~~r~~~i~~lp~L~~LD  145 (162)
T d1a9na_          87 PDLTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLD  145 (162)
T ss_dssp             TTCCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEET
T ss_pred             cccccceecccccc-ccccccccccccccchhhcCCCccc-cccchHHHHHHHCCCcCeeC
Confidence            33566666666665 232  23555666666666666665 3332    355556666655

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.53  E-value=7.4e-15  Score=124.65  Aligned_cols=104  Identities=27%  Similarity=0.349  Sum_probs=85.5

Q ss_pred             cEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhhcceeeccCCcccccCCCcccccEEEc
Q 007680           27 EYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLVLTVLDV  106 (593)
Q Consensus        27 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~l~~n~l~~~~~~~~~L~~L~l  106 (593)
                      ++|+|++|+|+ .++ .+.++++|++|+|++|+|+ .+|+.|+.+++|+.|                           ++
T Consensus         1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L---------------------------~l   50 (124)
T d1dcea3           1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVL---------------------------QA   50 (124)
T ss_dssp             SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEE---------------------------EC
T ss_pred             CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccc---------------------------cc
Confidence            57999999999 555 4899999999999999999 567677777766554                           67


Q ss_pred             cCCcccCcCCCCCCCCCCCCEecCCCccCCCCC-CccccCCccccccccccccccCC
Q 007680          107 SRNQLSGDIPSTIGGRVDLETLSLASNQFQGPI-PESVGSLISLESLDLSGNNLSGK  162 (593)
Q Consensus       107 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~-p~~l~~~~~L~~L~l~~N~l~~~  162 (593)
                      ++|+|+ .+| .++.+++|+.|++++|+|+... ...+..+++|+.|++++|+++..
T Consensus        51 ~~N~i~-~l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~~~~L~~L~l~~N~i~~~  105 (124)
T d1dcea3          51 SDNALE-NVD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE  105 (124)
T ss_dssp             CSSCCC-CCG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGS
T ss_pred             cccccc-ccC-ccccccccCeEECCCCccCCCCCchhhcCCCCCCEEECCCCcCCcC
Confidence            777777 455 4889999999999999998433 25689999999999999999864

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.44  E-value=1.2e-13  Score=140.90  Aligned_cols=147  Identities=27%  Similarity=0.350  Sum_probs=114.1

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLL   80 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~   80 (593)
                      |+.|++++|+++ .+| .+. .+++|+.|++++|++++..  .+..+++|+.|++++|.+++..+  +..++.++.+++.
T Consensus       221 L~~L~l~~n~l~-~~~-~l~-~l~~L~~L~l~~n~l~~~~--~~~~~~~L~~L~l~~~~l~~~~~--~~~~~~l~~l~~~  293 (384)
T d2omza2         221 LDELSLNGNQLK-DIG-TLA-SLTNLTDLDLANNQISNLA--PLSGLTKLTELKLGANQISNISP--LAGLTALTNLELN  293 (384)
T ss_dssp             CCEEECCSSCCC-CCG-GGG-GCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECC
T ss_pred             CCEEECCCCCCC-Ccc-hhh-cccccchhccccCccCCCC--cccccccCCEeeccCcccCCCCc--ccccccccccccc
Confidence            578999999998 665 454 4889999999999998544  37788899999999998885433  4444444444443


Q ss_pred             cce---------------eeccCCccccc--CCCcccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCccc
Q 007680           81 MFG---------------IRLTGNKLYGR--IPPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESV  143 (593)
Q Consensus        81 ~n~---------------l~l~~n~l~~~--~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l  143 (593)
                      .|.               +++++|++++.  +..+.+|++|++++|+|+ .++ .+.++++|++|++++|+|++..|  +
T Consensus       294 ~n~l~~~~~~~~~~~l~~L~ls~n~l~~l~~l~~l~~L~~L~L~~n~l~-~l~-~l~~l~~L~~L~l~~N~l~~l~~--l  369 (384)
T d2omza2         294 ENQLEDISPISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFANNKVS-DVS-SLANLTNINWLSAGHNQISDLTP--L  369 (384)
T ss_dssp             SSCCSCCGGGGGCTTCSEEECCSSCCSCCGGGGGCTTCCEEECCSSCCC-CCG-GGGGCTTCCEEECCSSCCCBCGG--G
T ss_pred             ccccccccccchhcccCeEECCCCCCCCCcccccCCCCCEEECCCCCCC-CCh-hHcCCCCCCEEECCCCcCCCChh--h
Confidence            322               37888988853  455667999999999998 466 59999999999999999996544  8


Q ss_pred             cCCcccccccccccc
Q 007680          144 GSLISLESLDLSGNN  158 (593)
Q Consensus       144 ~~~~~L~~L~l~~N~  158 (593)
                      .++++|+.|+|++|.
T Consensus       370 ~~l~~L~~L~L~~Na  384 (384)
T d2omza2         370 ANLTRITQLGLNDQA  384 (384)
T ss_dssp             TTCTTCSEEECCCEE
T ss_pred             ccCCCCCEeeCCCCc
Confidence            999999999999983

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.44  E-value=1.9e-14  Score=128.27  Aligned_cols=112  Identities=24%  Similarity=0.202  Sum_probs=93.8

Q ss_pred             cCCCCCCCcEEEccCCcccccccccccCCCCchhhhhhcceeeccCCccc--ccCCCcccccEEEccCCcccCcCCCCCC
Q 007680           43 SITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLY--GRIPPCLVLTVLDVSRNQLSGDIPSTIG  120 (593)
Q Consensus        43 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~l~~n~l~--~~~~~~~~L~~L~l~~N~l~~~~p~~~~  120 (593)
                      .|.++.+|+.|+|++|+|+ .+|+.+..+++|+.|       ++++|++.  ..++.+..|++|++++|+++...+..+.
T Consensus        13 ~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L-------~Ls~N~i~~l~~~~~l~~L~~L~ls~N~i~~l~~~~~~   84 (162)
T d1a9na_          13 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAI-------DFSDNEIRKLDGFPLLRRLKTLLVNNNRICRIGEGLDQ   84 (162)
T ss_dssp             EEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEE-------ECCSSCCCEECCCCCCSSCCEEECCSSCCCEECSCHHH
T ss_pred             hccCcCcCcEEECCCCCCC-ccCccccccccCCEE-------ECCCCCCCccCCcccCcchhhhhcccccccCCCccccc
Confidence            4668889999999999999 567777889999999       77778776  2456667799999999999965555567


Q ss_pred             CCCCCCEecCCCccCCCCCC--ccccCCccccccccccccccCCC
Q 007680          121 GRVDLETLSLASNQFQGPIP--ESVGSLISLESLDLSGNNLSGKI  163 (593)
Q Consensus       121 ~l~~L~~L~l~~N~l~~~~p--~~l~~~~~L~~L~l~~N~l~~~~  163 (593)
                      .+++|+.|++++|+|+ .++  ..+..+++|+.|++++|+++...
T Consensus        85 ~l~~L~~L~L~~N~i~-~~~~l~~l~~l~~L~~L~l~~N~i~~~~  128 (162)
T d1a9na_          85 ALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTNKK  128 (162)
T ss_dssp             HCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGGST
T ss_pred             cccccccceecccccc-ccccccccccccccchhhcCCCcccccc
Confidence            8999999999999998 455  46889999999999999998643

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.42  E-value=3.1e-13  Score=127.55  Aligned_cols=140  Identities=21%  Similarity=0.310  Sum_probs=109.9

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCccccccc---------------
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHIL---------------   65 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p---------------   65 (593)
                      |++|+|++|+++ .++. +. .+++|+.|++++|.++ .++ +|.++++|+.|++++|...+..+               
T Consensus        65 L~~L~ls~n~i~-~~~~-l~-~l~~l~~l~~~~n~~~-~i~-~l~~l~~L~~l~l~~~~~~~~~~~~~~~~~~~l~~~~~  139 (227)
T d1h6ua2          65 LIGLELKDNQIT-DLAP-LK-NLTKITELELSGNPLK-NVS-AIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLN  139 (227)
T ss_dssp             CCEEECCSSCCC-CCGG-GT-TCCSCCEEECCSCCCS-CCG-GGTTCTTCCEEECTTSCCCCCGGGTTCTTCCEEECCSS
T ss_pred             CcEeecCCceee-cccc-cc-cccccccccccccccc-ccc-cccccccccccccccccccccchhccccchhhhhchhh
Confidence            789999999998 5653 54 4999999999999998 444 58889999999999988774332               


Q ss_pred             -----ccccCCCCchhhhhhcceeeccCCcccc--cCCCcccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCC
Q 007680           66 -----NTFGNLRHLSVLSLLMFGIRLTGNKLYG--RIPPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGP  138 (593)
Q Consensus        66 -----~~~~~l~~L~~L~l~~n~l~l~~n~l~~--~~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~  138 (593)
                           ..+..+++|++|       ++++|.+.+  .+..+..|++|+|++|++++ ++. ++++++|++|+|++|+|++ 
T Consensus       140 ~~~~~~~~~~~~~L~~L-------~l~~n~~~~~~~l~~l~~L~~L~Ls~n~l~~-l~~-l~~l~~L~~L~Ls~N~lt~-  209 (227)
T d1h6ua2         140 QITNISPLAGLTNLQYL-------SIGNAQVSDLTPLANLSKLTTLKADDNKISD-ISP-LASLPNLIEVHLKNNQISD-  209 (227)
T ss_dssp             CCCCCGGGGGCTTCCEE-------ECCSSCCCCCGGGTTCTTCCEEECCSSCCCC-CGG-GGGCTTCCEEECTTSCCCB-
T ss_pred             hhchhhhhccccccccc-------cccccccccchhhcccccceecccCCCccCC-Chh-hcCCCCCCEEECcCCcCCC-
Confidence                 123444555555       677777763  35566779999999999985 553 8899999999999999994 


Q ss_pred             CCccccCCcccccccccc
Q 007680          139 IPESVGSLISLESLDLSG  156 (593)
Q Consensus       139 ~p~~l~~~~~L~~L~l~~  156 (593)
                      ++ .+.++++|+.|++++
T Consensus       210 i~-~l~~l~~L~~L~lsn  226 (227)
T d1h6ua2         210 VS-PLANTSNLFIVTLTN  226 (227)
T ss_dssp             CG-GGTTCTTCCEEEEEE
T ss_pred             Cc-ccccCCCCCEEEeeC
Confidence            55 389999999999974

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.40  E-value=9.2e-16  Score=141.80  Aligned_cols=116  Identities=28%  Similarity=0.364  Sum_probs=58.9

Q ss_pred             cCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhhcceeeccCCcccc
Q 007680           14 RLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYG   93 (593)
Q Consensus        14 ~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~l~~n~l~~   93 (593)
                      .+|..+.. |++|++|+|++|+|+ .++ .|.++++|+.|+|++|+|+ .+|+.+..+++                    
T Consensus        39 ~l~~sl~~-L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~--------------------   94 (198)
T d1m9la_          39 KMDATLST-LKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADT--------------------   94 (198)
T ss_dssp             CCHHHHHH-TTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHH--------------------
T ss_pred             hhhhHHhc-ccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-ccccccccccc--------------------
Confidence            34445543 666666666666666 333 3555666666666666665 33333333334                    


Q ss_pred             cCCCcccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCC--ccccCCccccccccccccccCCC
Q 007680           94 RIPPCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIP--ESVGSLISLESLDLSGNNLSGKI  163 (593)
Q Consensus        94 ~~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p--~~l~~~~~L~~L~l~~N~l~~~~  163 (593)
                             |++|++++|+|+. ++ .+..+++|+.|++++|+|+ .++  ..+..+++|+.|++++|+++...
T Consensus        95 -------L~~L~l~~N~i~~-l~-~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~L~~N~l~~~~  156 (198)
T d1m9la_          95 -------LEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKIT-NWGEIDKLAALDKLEDLLLAGNPLYNDY  156 (198)
T ss_dssp             -------CCEEECSEEECCC-HH-HHHHHHHSSEEEESEEECC-CHHHHHHHTTTTTCSEEEECSSHHHHHH
T ss_pred             -------ccccccccccccc-cc-cccccccccccccccchhc-cccccccccCCCccceeecCCCccccCc
Confidence                   4455555555542 22 2444555555555555554 222  23455555555555555554433

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.40  E-value=3.2e-13  Score=119.31  Aligned_cols=69  Identities=12%  Similarity=0.018  Sum_probs=33.6

Q ss_pred             EEeeCccccccCChhhhhCCCCCcEEECCCC-cCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCc
Q 007680            4 LTLEGNQLSGRLPSTIGHSLPNIEYLLLTAN-NLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHL   74 (593)
Q Consensus         4 L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L   74 (593)
                      ++++++++. .+|..+.. +++|++|+|++| .|+.+.+++|.++++|+.|+|++|+|+.+.|++|..+++|
T Consensus        13 l~c~~~~~~-~~p~~l~~-l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L   82 (156)
T d2ifga3          13 LRCTRDGAL-DSLHHLPG-AENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL   82 (156)
T ss_dssp             EECCSSCCC-TTTTTSCS-CSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCC
T ss_pred             EEecCCCCc-cCcccccC-ccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccc
Confidence            445555554 44544442 555555555433 3553334445555555555555555554444444444443

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.35  E-value=1.1e-12  Score=124.87  Aligned_cols=154  Identities=16%  Similarity=0.098  Sum_probs=106.8

Q ss_pred             cEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccc-cccccCCCCchhhhhh
Q 007680            2 RILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHI-LNTFGNLRHLSVLSLL   80 (593)
Q Consensus         2 ~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~l~   80 (593)
                      +++++++++++ .+|.+++   +++++|+|++|+|+...+.+|.++++|++|+|++|.+...+ +..|..++++++|   
T Consensus        11 ~~i~c~~~~l~-~iP~~l~---~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l---   83 (242)
T d1xwdc1          11 RVFLCQESKVT-EIPSDLP---RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEI---   83 (242)
T ss_dssp             SEEEEESCSCS-SCCSCSC---SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEE---
T ss_pred             CEEEEeCCCCC-CcCCCCC---CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccc---
Confidence            57899999999 9998775   48999999999999666668999999999999999997654 4579999999988   


Q ss_pred             cceeecc-CCcccc----cCCCcccccEEEccCCcccCcCCC-CCCCCCCCCEecCCCccCCCCCCccccCCc-cccccc
Q 007680           81 MFGIRLT-GNKLYG----RIPPCLVLTVLDVSRNQLSGDIPS-TIGGRVDLETLSLASNQFQGPIPESVGSLI-SLESLD  153 (593)
Q Consensus        81 ~n~l~l~-~n~l~~----~~~~~~~L~~L~l~~N~l~~~~p~-~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~-~L~~L~  153 (593)
                          .+. .|++..    .+..+..|++|++++|++....+. .+..+..|..+..+++++....+..+.+++ .++.|+
T Consensus        84 ----~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~  159 (242)
T d1xwdc1          84 ----RIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILW  159 (242)
T ss_dssp             ----EEECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEE
T ss_pred             ----cccccccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeee
Confidence                433 345542    233445688888888888743222 223344455555556666544444455443 456666


Q ss_pred             cccccccCCCCCC
Q 007680          154 LSGNNLSGKIPKL  166 (593)
Q Consensus       154 l~~N~l~~~~p~~  166 (593)
                      +++|+++.+.+..
T Consensus       160 l~~n~l~~i~~~~  172 (242)
T d1xwdc1         160 LNKNGIQEIHNCA  172 (242)
T ss_dssp             CCSSCCCEECTTT
T ss_pred             ccccccccccccc
Confidence            6666666544443

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.32  E-value=1.9e-12  Score=114.17  Aligned_cols=109  Identities=21%  Similarity=0.162  Sum_probs=83.9

Q ss_pred             CCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCC-cccccccccccCCCCchhhhhhcceeeccCCcccccCCCcccc
Q 007680           23 LPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFN-SFSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLVL  101 (593)
Q Consensus        23 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~l~~n~l~l~~n~l~~~~~~~~~L  101 (593)
                      ....+.++++++.++ ..|..+..+++|+.|+|++| .|+.+.+++|.++++|+.|                        
T Consensus         7 c~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L------------------------   61 (156)
T d2ifga3           7 PHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNL------------------------   61 (156)
T ss_dssp             CSSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEE------------------------
T ss_pred             cCCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcc------------------------
Confidence            345677999999998 67888999999999999866 4886667778877776555                        


Q ss_pred             cEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCccccCCcccccccccccccc
Q 007680          102 TVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLS  160 (593)
Q Consensus       102 ~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~~N~l~  160 (593)
                         +|++|+|+.+.|.+|.++++|+.|+|++|+|+ .+|..+.....|+.|+|++|+|.
T Consensus        62 ---~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~-~l~~~~~~~~~l~~L~L~~Np~~  116 (156)
T d2ifga3          62 ---TIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH  116 (156)
T ss_dssp             ---ECCSSCCCEECTTGGGSCSCCCEEECCSSCCS-CCCSTTTCSCCCCEEECCSSCCC
T ss_pred             ---eeeccccCCcccccccccccccceeccCCCCc-ccChhhhccccccccccCCCccc
Confidence               66777777666777888888888888888888 44444444457888888888884

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.25  E-value=2.7e-14  Score=131.79  Aligned_cols=127  Identities=18%  Similarity=0.235  Sum_probs=88.5

Q ss_pred             CCCcEEECCCC--cCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhhcceeeccCCcccccCCCcccc
Q 007680           24 PNIEYLLLTAN--NLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLVL  101 (593)
Q Consensus        24 ~~L~~L~L~~N--~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~l~~n~l~~~~~~~~~L  101 (593)
                      ..++.+.++++  .|+ .+|..|..+++|+.|+|++|+|+. ++ .|..|++                           |
T Consensus        23 ~~~~~~~l~~~~~~i~-~l~~sl~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~---------------------------L   72 (198)
T d1m9la_          23 TEAEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIEK-IS-SLSGMEN---------------------------L   72 (198)
T ss_dssp             TTCSCEECCBCCTTCC-CCHHHHHHTTTCCEEECSEEEESC-CC-CHHHHTT---------------------------C
T ss_pred             cccceeeeecccCchh-hhhhHHhcccccceeECcccCCCC-cc-cccCCcc---------------------------c
Confidence            34566677654  355 566778888888888888888883 33 2544444                           4


Q ss_pred             cEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCccccCCccccccccccccccCCCC-CCCCCCCCCCCccCCC
Q 007680          102 TVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIP-KLEGEIPVKGSFKNFS  180 (593)
Q Consensus       102 ~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~~N~l~~~~p-~~~~~~~~~~~~~~~~  180 (593)
                      ++|+|++|+|+ .+|..+..+++|+.|++++|+|+ .++ .+..+++|+.|++++|+++.... ..+..      +.++.
T Consensus        73 ~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~L~~N~i~~~~~~~~l~~------l~~L~  143 (198)
T d1m9la_          73 RILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SLS-GIEKLVNLRVLYMSNNKITNWGEIDKLAA------LDKLE  143 (198)
T ss_dssp             CEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECC-CHH-HHHHHHHSSEEEESEEECCCHHHHHHHTT------TTTCS
T ss_pred             cChhhcccccc-ccccccccccccccccccccccc-ccc-cccccccccccccccchhccccccccccC------CCccc
Confidence            56677777776 56654555678999999999998 454 58889999999999999986432 22333      34455


Q ss_pred             cccccCCcc
Q 007680          181 TESFFGNYA  189 (593)
Q Consensus       181 ~~~~~~n~~  189 (593)
                      ...+.+|+.
T Consensus       144 ~L~L~~N~l  152 (198)
T d1m9la_         144 DLLLAGNPL  152 (198)
T ss_dssp             EEEECSSHH
T ss_pred             eeecCCCcc
Confidence            567777764

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.24  E-value=3.5e-11  Score=120.34  Aligned_cols=54  Identities=28%  Similarity=0.287  Sum_probs=39.3

Q ss_pred             CCCCCEecCCCccCCCCCCccccCCccccccccccccccCCCCCCCCCCCCCCCccCCCcccccCCcc
Q 007680          122 RVDLETLSLASNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKLEGEIPVKGSFKNFSTESFFGNYA  189 (593)
Q Consensus       122 l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~n~~  189 (593)
                      +++|++|+|++|+|+ .+|..   +++|+.|++++|+|+. +|+..         .++......+|+-
T Consensus       283 ~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~~-l~~~~---------~~L~~L~L~~N~L  336 (353)
T d1jl5a_         283 PPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLAE-VPELP---------QNLKQLHVEYNPL  336 (353)
T ss_dssp             CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCSC-CCCCC---------TTCCEEECCSSCC
T ss_pred             CCCCCEEECCCCccC-ccccc---cCCCCEEECCCCcCCc-ccccc---------CCCCEEECcCCcC
Confidence            368999999999998 67754   5689999999999985 44422         2334456677764

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.16  E-value=7e-13  Score=129.54  Aligned_cols=166  Identities=19%  Similarity=0.217  Sum_probs=103.6

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccC-Cccccc-ccccccCCCCchhhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGF-NSFSGH-ILNTFGNLRHLSVLS   78 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~-~p~~~~~l~~L~~L~   78 (593)
                      |++|||++|.+++.....++..+++|++|+|++|.+++..+..+..+++|+.|+|++ +.++.. +..-+..+++|++| 
T Consensus        48 L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L-  126 (284)
T d2astb2          48 VQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDEL-  126 (284)
T ss_dssp             CCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEE-
T ss_pred             CCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhcccc-
Confidence            689999999987554455666799999999999999888888899999999999998 466632 22334568899999 


Q ss_pred             hhcceeeccCC-cccc-----cCCC-cccccEEEccCCc--ccCc-CCCCCCCCCCCCEecCCCc-cCCCCCCccccCCc
Q 007680           79 LLMFGIRLTGN-KLYG-----RIPP-CLVLTVLDVSRNQ--LSGD-IPSTIGGRVDLETLSLASN-QFQGPIPESVGSLI  147 (593)
Q Consensus        79 l~~n~l~l~~n-~l~~-----~~~~-~~~L~~L~l~~N~--l~~~-~p~~~~~l~~L~~L~l~~N-~l~~~~p~~l~~~~  147 (593)
                            +++++ +++.     .+.. +..|+.|+++++.  ++.. +...+.++++|++|++++| .+++.....+..++
T Consensus       127 ------~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~  200 (284)
T d2astb2         127 ------NLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLN  200 (284)
T ss_dssp             ------ECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCT
T ss_pred             ------ccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccC
Confidence                  44442 2221     1111 1236666666542  2211 1112234566777777664 35544555566666


Q ss_pred             ccccccccc-ccccCCCCCCCCCCCCC
Q 007680          148 SLESLDLSG-NNLSGKIPKLEGEIPVK  173 (593)
Q Consensus       148 ~L~~L~l~~-N~l~~~~p~~~~~~~~~  173 (593)
                      +|++|++++ +.+++.....+..+|.+
T Consensus       201 ~L~~L~L~~C~~i~~~~l~~L~~~~~L  227 (284)
T d2astb2         201 YLQHLSLSRCYDIIPETLLELGEIPTL  227 (284)
T ss_dssp             TCCEEECTTCTTCCGGGGGGGGGCTTC
T ss_pred             cCCEEECCCCCCCChHHHHHHhcCCCC
Confidence            677777766 34554433333344433

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.04  E-value=1.1e-09  Score=109.18  Aligned_cols=136  Identities=26%  Similarity=0.352  Sum_probs=100.9

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhh
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLL   80 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~   80 (593)
                      |+.|||++|+|+ .+|+.    +++|++|+|++|+|+ .+|+.+   .+|+.|++++|+++ .+++ +.  +.|++|   
T Consensus        40 l~~LdLs~~~L~-~lp~~----~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~-lp--~~L~~L---  103 (353)
T d1jl5a_          40 AHELELNNLGLS-SLPEL----PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSD-LP--PLLEYL---  103 (353)
T ss_dssp             CSEEECTTSCCS-CCCSC----CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCS-CC--TTCCEE---
T ss_pred             CCEEEeCCCCCC-CCCCC----CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhh-hc--cccccc---
Confidence            578999999999 89952    579999999999999 778764   57999999999998 4443 21  358888   


Q ss_pred             cceeeccCCcccccCC---CcccccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCccccCCccccccccccc
Q 007680           81 MFGIRLTGNKLYGRIP---PCLVLTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPESVGSLISLESLDLSGN  157 (593)
Q Consensus        81 ~n~l~l~~n~l~~~~~---~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~l~~N  157 (593)
                          ++++|.+. .+|   .+..|+.|++++|.+.. .+..   ...+..+.+.++...  .+..+..++.++.|++++|
T Consensus       104 ----~L~~n~l~-~lp~~~~l~~L~~L~l~~~~~~~-~~~~---~~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~~n  172 (353)
T d1jl5a_         104 ----GVSNNQLE-KLPELQNSSFLKIIDVDNNSLKK-LPDL---PPSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNN  172 (353)
T ss_dssp             ----ECCSSCCS-SCCCCTTCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS--SCCCCTTCTTCCEEECCSS
T ss_pred             ----cccccccc-cccchhhhccceeeccccccccc-cccc---cccccchhhcccccc--ccccccccccceecccccc
Confidence                77888876 333   34569999999999874 4433   345667777766665  3445677777888888888


Q ss_pred             cccCCC
Q 007680          158 NLSGKI  163 (593)
Q Consensus       158 ~l~~~~  163 (593)
                      .+....
T Consensus       173 ~~~~~~  178 (353)
T d1jl5a_         173 SLKKLP  178 (353)
T ss_dssp             CCSSCC
T ss_pred             cccccc
Confidence            776543

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=98.82  E-value=2.4e-10  Score=114.39  Aligned_cols=82  Identities=16%  Similarity=0.191  Sum_probs=54.3

Q ss_pred             CcEEEeeCccccccCChhhhh---CCCCCcEEECCCCcCccc----------CCccCCCCCCCcEEEccCCccccc----
Q 007680            1 MRILTLEGNQLSGRLPSTIGH---SLPNIEYLLLTANNLTGT----------IPNSITNATKLIVLDLGFNSFSGH----   63 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~---~l~~L~~L~L~~N~l~~~----------~p~~~~~l~~L~~L~L~~N~l~~~----   63 (593)
                      |+.|+|++|.+...-...+..   ..++|+.|++++|.+...          +.+.+...++|+.|+|++|.++..    
T Consensus        33 l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~  112 (344)
T d2ca6a1          33 VKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEP  112 (344)
T ss_dssp             CCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHHH
T ss_pred             CCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccccccccccccc
Confidence            578899999886432233322   367889999988765422          123356678899999999988753    


Q ss_pred             ccccccCCCCchhhhhhcc
Q 007680           64 ILNTFGNLRHLSVLSLLMF   82 (593)
Q Consensus        64 ~p~~~~~l~~L~~L~l~~n   82 (593)
                      +...+..+++|++|++++|
T Consensus       113 l~~~l~~~~~L~~L~l~~n  131 (344)
T d2ca6a1         113 LIDFLSKHTPLEHLYLHNN  131 (344)
T ss_dssp             HHHHHHHCTTCCEEECCSS
T ss_pred             hhhhhcccccchheecccc
Confidence            3344566788888855433

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=98.76  E-value=4.1e-10  Score=112.67  Aligned_cols=154  Identities=18%  Similarity=0.205  Sum_probs=89.8

Q ss_pred             CcEEEeeCcccc---ccCChhh---h---hCCCCCcEEECCCCcCccc----CCccCCCCCCCcEEEccCCccccccccc
Q 007680            1 MRILTLEGNQLS---GRLPSTI---G---HSLPNIEYLLLTANNLTGT----IPNSITNATKLIVLDLGFNSFSGHILNT   67 (593)
Q Consensus         1 L~~L~Ls~n~l~---~~lp~~~---~---~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~   67 (593)
                      |+.|+++++.+.   ...|..+   .   ...++|+.|+|++|.|+..    +...+...++|+.|+|++|.+...-...
T Consensus        61 L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~  140 (344)
T d2ca6a1          61 LEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAK  140 (344)
T ss_dssp             CCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHH
T ss_pred             CCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccccccccccccchhhhhcccccchheeccccccccccccc
Confidence            467777776553   1112211   1   1257788888888887743    2334456778888888888775211111


Q ss_pred             c-------------cCCCCchhhhhhcceeeccCCcccc--------cCCCcccccEEEccCCcccCc-----CCCCCCC
Q 007680           68 F-------------GNLRHLSVLSLLMFGIRLTGNKLYG--------RIPPCLVLTVLDVSRNQLSGD-----IPSTIGG  121 (593)
Q Consensus        68 ~-------------~~l~~L~~L~l~~n~l~l~~n~l~~--------~~~~~~~L~~L~l~~N~l~~~-----~p~~~~~  121 (593)
                      +             ...+.|+.|       .++.|++..        .++....|++|+|++|+++..     +...+..
T Consensus       141 l~~~l~~~~~~~~~~~~~~L~~l-------~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~  213 (344)
T d2ca6a1         141 IARALQELAVNKKAKNAPPLRSI-------ICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAY  213 (344)
T ss_dssp             HHHHHHHHHHHHHHHTCCCCCEE-------ECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGG
T ss_pred             ccccccccccccccccCccccee-------ecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcc
Confidence            1             234455555       555555541        123334577777777776521     3344566


Q ss_pred             CCCCCEecCCCccCCCC----CCccccCCccccccccccccccC
Q 007680          122 RVDLETLSLASNQFQGP----IPESVGSLISLESLDLSGNNLSG  161 (593)
Q Consensus       122 l~~L~~L~l~~N~l~~~----~p~~l~~~~~L~~L~l~~N~l~~  161 (593)
                      +++|+.|+|++|+++..    +...+..+++|+.|+|++|++++
T Consensus       214 ~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~  257 (344)
T d2ca6a1         214 CQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSA  257 (344)
T ss_dssp             CTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCH
T ss_pred             hhhhcccccccccccccccccccccccccccchhhhhhcCccCc
Confidence            77777777777776521    33445667777777777777764

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.75  E-value=5.1e-10  Score=108.73  Aligned_cols=146  Identities=18%  Similarity=0.201  Sum_probs=102.1

Q ss_pred             CCCCcEEECCCCcCccc-CCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhhcceeeccC-Ccccc-----cC
Q 007680           23 LPNIEYLLLTANNLTGT-IPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLMFGIRLTG-NKLYG-----RI   95 (593)
Q Consensus        23 l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~l~~-n~l~~-----~~   95 (593)
                      ..+|++|+|++|.+++. ++..+.++++|+.|+|++|.+++..+..++.+++|++|       ++++ +.++.     ..
T Consensus        45 ~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L-------~Ls~c~~itd~~l~~l~  117 (284)
T d2astb2          45 PFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRL-------NLSGCSGFSEFALQTLL  117 (284)
T ss_dssp             CBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEE-------ECTTCBSCCHHHHHHHH
T ss_pred             CCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCc-------cccccccccccccchhh
Confidence            56799999999998743 34457889999999999999988788889999999999       6666 34542     12


Q ss_pred             CCcccccEEEccCC-cccCc-CCCCCC-CCCCCCEecCCCcc--CCCC-CCccccCCcccccccccccc-ccCCCCCCCC
Q 007680           96 PPCLVLTVLDVSRN-QLSGD-IPSTIG-GRVDLETLSLASNQ--FQGP-IPESVGSLISLESLDLSGNN-LSGKIPKLEG  168 (593)
Q Consensus        96 ~~~~~L~~L~l~~N-~l~~~-~p~~~~-~l~~L~~L~l~~N~--l~~~-~p~~l~~~~~L~~L~l~~N~-l~~~~p~~~~  168 (593)
                      ..+..|++|+++++ .++.. +...+. ..++|+.|+++++.  ++.. +...+..+++|++|++++|. +++.....+.
T Consensus       118 ~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~  197 (284)
T d2astb2         118 SSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFF  197 (284)
T ss_dssp             HHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGG
T ss_pred             HHHHhccccccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhc
Confidence            24566999999986 44311 122222 34689999999753  4321 23334568999999999864 7766555555


Q ss_pred             CCCCCCC
Q 007680          169 EIPVKGS  175 (593)
Q Consensus       169 ~~~~~~~  175 (593)
                      .++.+..
T Consensus       198 ~~~~L~~  204 (284)
T d2astb2         198 QLNYLQH  204 (284)
T ss_dssp             GCTTCCE
T ss_pred             ccCcCCE
Confidence            5554433

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.61  E-value=8.2e-08  Score=91.37  Aligned_cols=150  Identities=13%  Similarity=0.142  Sum_probs=105.7

Q ss_pred             HHHHHhhhccccccccCccCcccEEEEEeCCCCeEEEEEeehhhHHHHHHHHHHHHHHhhcC-CCCcceeeeeeecCCce
Q 007680          265 LDIQRATDEFNECNLLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVR-HRNLIKILSSYSNPDFK  343 (593)
Q Consensus       265 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~  343 (593)
                      .++....+.|+..+..+.++.+.||+... +++.+++|+...........+.+|...+..+. +--+.+++++..+++..
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~   85 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS   85 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred             HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence            35666677888777766666678999875 46678889887654444445778888888774 43467788888888899


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------
Q 007680          344 ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHNGH----------------------------------  389 (593)
Q Consensus       344 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~----------------------------------  389 (593)
                      ++||++++|.++.+......      ....++.++++.++.||+..                                  
T Consensus        86 ~lv~~~l~G~~~~~~~~~~~------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (263)
T d1j7la_          86 NLLMSEADGVLCSEEYEDEQ------SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE  159 (263)
T ss_dssp             EEEEECCSSEEHHHHTTTCS------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred             EEEEEecccccccccccccc------cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccc
Confidence            99999999988866543211      12334555556666666311                                  


Q ss_pred             ---------------------CCCCeEecCCCCCCeeeCCCCcEEEEeeccce
Q 007680          390 ---------------------SSVHIIHCDLKPTNILLDENMVAHVSDFGIYK  421 (593)
Q Consensus       390 ---------------------~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~  421 (593)
                                           ....++|+|+.|.||++++++.+.|+||+.+.
T Consensus       160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             ccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                 01227899999999999987777799999765

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.33  E-value=1.7e-08  Score=103.99  Aligned_cols=153  Identities=22%  Similarity=0.187  Sum_probs=81.6

Q ss_pred             cEEEeeCcccccc----CChhhhhCCCCCcEEECCCCcCcccC----CccCCCCCCCcEEEccCCcccccccccc----c
Q 007680            2 RILTLEGNQLSGR----LPSTIGHSLPNIEYLLLTANNLTGTI----PNSITNATKLIVLDLGFNSFSGHILNTF----G   69 (593)
Q Consensus         2 ~~L~Ls~n~l~~~----lp~~~~~~l~~L~~L~L~~N~l~~~~----p~~~~~l~~L~~L~L~~N~l~~~~p~~~----~   69 (593)
                      +.+++++|++...    ..........+|+.|++++|.+....    ...+...+.++.+++++|.++......+    .
T Consensus       229 ~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~  308 (460)
T d1z7xw1         229 RELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLL  308 (460)
T ss_dssp             CEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHT
T ss_pred             cccchhhccccccccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhcccc
Confidence            4566777765421    11122223556777777777765321    2234456677777777777753222211    1


Q ss_pred             -CCCCchhhhhhcceeeccCCccccc--------CCCcccccEEEccCCcccCc----CCCCCC-CCCCCCEecCCCccC
Q 007680           70 -NLRHLSVLSLLMFGIRLTGNKLYGR--------IPPCLVLTVLDVSRNQLSGD----IPSTIG-GRVDLETLSLASNQF  135 (593)
Q Consensus        70 -~l~~L~~L~l~~n~l~l~~n~l~~~--------~~~~~~L~~L~l~~N~l~~~----~p~~~~-~l~~L~~L~l~~N~l  135 (593)
                       ....|+.+       ++++|.++..        +....+|++|+|++|+|+..    ++..+. ..+.|+.|+|++|+|
T Consensus       309 ~~~~~L~~l-------~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i  381 (460)
T d1z7xw1         309 EPGCQLESL-------WVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDV  381 (460)
T ss_dssp             STTCCCCEE-------ECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCC
T ss_pred             ccccccccc-------cccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCC
Confidence             23456666       4455544421        11222477777777776531    222222 345577777777777


Q ss_pred             CCC----CCccccCCccccccccccccccC
Q 007680          136 QGP----IPESVGSLISLESLDLSGNNLSG  161 (593)
Q Consensus       136 ~~~----~p~~l~~~~~L~~L~l~~N~l~~  161 (593)
                      +..    ++..+..+++|++|||++|+++.
T Consensus       382 ~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~  411 (460)
T d1z7xw1         382 SDSSCSSLAATLLANHSLRELDLSNNCLGD  411 (460)
T ss_dssp             CHHHHHHHHHHHHHCCCCCEEECCSSSCCH
T ss_pred             ChHHHHHHHHHHhcCCCCCEEECCCCcCCH
Confidence            521    33445556677777777777764

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.30  E-value=4.1e-08  Score=100.98  Aligned_cols=61  Identities=20%  Similarity=0.209  Sum_probs=44.0

Q ss_pred             CcEEEeeCccccccCChhhhhCCCCCcEEECCCCcCcc----cCCccCCCCCCCcEEEccCCccc
Q 007680            1 MRILTLEGNQLSGRLPSTIGHSLPNIEYLLLTANNLTG----TIPNSITNATKLIVLDLGFNSFS   61 (593)
Q Consensus         1 L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~   61 (593)
                      |+.||+++|++++.-=..+...++++++|+|++|.|+.    .++.++..+++|+.|||++|.|+
T Consensus         4 l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~   68 (460)
T d1z7xw1           4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELG   68 (460)
T ss_dssp             EEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCH
T ss_pred             CCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCC
Confidence            57889999999832112223347888999999998873    33455677888888888888886

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.29  E-value=5.8e-09  Score=91.97  Aligned_cols=107  Identities=22%  Similarity=0.199  Sum_probs=54.6

Q ss_pred             CCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccccccccCCCCchhhhhhcceeeccCCcccccCCCcccccEE
Q 007680           25 NIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHILNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLVLTVL  104 (593)
Q Consensus        25 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~l~~n~l~~~~~~~~~L~~L  104 (593)
                      +.+.|+++++...    ..+..+..+..|++.+|... .++..+..+++|++|                           
T Consensus        23 ~~~~Ldls~l~~~----~~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L---------------------------   70 (162)
T d1koha1          23 SQQALDLKGLRSD----PDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSL---------------------------   70 (162)
T ss_dssp             SSCCBCCCCCSSC----TTTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCC---------------------------
T ss_pred             hhCeeecccCCCC----chhhhccchhhcchhhhHhh-hhHHHHHhCCCCCEe---------------------------
Confidence            4566666655432    13444444555555555444 444444455555555                           


Q ss_pred             EccCCcccCc--CCCCCCCCCCCCEecCCCccCCCCCCc-cccCCccccccccccccccCCCC
Q 007680          105 DVSRNQLSGD--IPSTIGGRVDLETLSLASNQFQGPIPE-SVGSLISLESLDLSGNNLSGKIP  164 (593)
Q Consensus       105 ~l~~N~l~~~--~p~~~~~l~~L~~L~l~~N~l~~~~p~-~l~~~~~L~~L~l~~N~l~~~~p  164 (593)
                      +|++|+|+..  ++..+..+++|+.|+|++|+|+. +++ .......|+.|++++|+++....
T Consensus        71 ~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~-l~~l~~l~~~~L~~L~L~~Npl~~~~~  132 (162)
T d1koha1          71 NLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKS-ERELDKIKGLKLEELWLDGNSLSDTFR  132 (162)
T ss_dssp             CCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCC-GGGHHHHTTCCCSSCCCTTSTTSSSSS
T ss_pred             eCCCccccCCchhHHHHhhCCcccccccccCcccc-chhhhhhhccccceeecCCCCcCcCcc
Confidence            4444444421  12234456666666666666663 332 22233456666666666665443

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.28  E-value=8.1e-09  Score=91.00  Aligned_cols=107  Identities=21%  Similarity=0.189  Sum_probs=62.5

Q ss_pred             CCCCcEEECCCCcCcccCCccCCCCCCCcEEEccCCcccccc--cccccCCCCchhhhhhcceeeccCCcccccCCCccc
Q 007680           23 LPNIEYLLLTANNLTGTIPNSITNATKLIVLDLGFNSFSGHI--LNTFGNLRHLSVLSLLMFGIRLTGNKLYGRIPPCLV  100 (593)
Q Consensus        23 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~l~~n~l~l~~n~l~~~~~~~~~  100 (593)
                      +..+..|++.+|.++ .++..+..+++|++|+|++|+|+...  +..+..+++|+.|       ++++            
T Consensus        41 ~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L-------~Ls~------------  100 (162)
T d1koha1          41 QNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKIL-------NLSG------------  100 (162)
T ss_dssp             TTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCC-------CCTT------------
T ss_pred             ccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCccccc-------cccc------------
Confidence            455556666666655 55555667889999999999998543  2345556666666       4444            


Q ss_pred             ccEEEccCCcccCcCCCCCCCCCCCCEecCCCccCCCCCCcc-------ccCCccccccccccccc
Q 007680          101 LTVLDVSRNQLSGDIPSTIGGRVDLETLSLASNQFQGPIPES-------VGSLISLESLDLSGNNL  159 (593)
Q Consensus       101 L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-------l~~~~~L~~L~l~~N~l  159 (593)
                              |+|+...+-.+....+|+.|++++|++.......       +..+++|+.||  ++.+
T Consensus       101 --------N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD--g~~v  156 (162)
T d1koha1         101 --------NELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD--GHEL  156 (162)
T ss_dssp             --------SCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET--TEEC
T ss_pred             --------CccccchhhhhhhccccceeecCCCCcCcCcccchhHHHHHHHHCCCCCEEC--cCCC
Confidence                    4444211111222335677777777776433321       45567777665  4443

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.04  E-value=2.5e-06  Score=80.22  Aligned_cols=140  Identities=13%  Similarity=0.091  Sum_probs=85.7

Q ss_pred             ccCccCc-ccEEEEEeCCCCeEEEEEeehhhHHHHHHHHHHHHHHhhcC--CCCcceeeeeeecCCceEEEEeccCCCCH
Q 007680          279 LLGTSSF-GSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVR--HRNLIKILSSYSNPDFKALVLEFMPNGSL  355 (593)
Q Consensus       279 ~lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~gsL  355 (593)
                      .+..|.. +.||+....++..+++|.......   ..+..|...++.+.  .-.+.+++++..+++..++||++++|.++
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            4555554 578999988888899998765432   34677888887774  33466778888888889999999987655


Q ss_pred             HHH--------------Hhh-CCC-----C--CCHHHHHHHH--------------------HHHHHHHHHHHhcCC---
Q 007680          356 EKW--------------LYS-HNY-----F--LDILERLNIM--------------------IDVGSALEYLHNGHS---  390 (593)
Q Consensus       356 ~~~--------------l~~-~~~-----~--l~~~~~~~i~--------------------~~i~~~L~~LH~~~~---  390 (593)
                      .+.              +.+ +..     .  ........-.                    ......+..+.+..+   
T Consensus        94 ~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  173 (255)
T d1nd4a_          94 LSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGE  173 (255)
T ss_dssp             TTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSC
T ss_pred             ccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCccC
Confidence            321              000 000     0  0000000000                    001112233332211   


Q ss_pred             CCCeEecCCCCCCeeeCCCCcEEEEeeccce
Q 007680          391 SVHIIHCDLKPTNILLDENMVAHVSDFGIYK  421 (593)
Q Consensus       391 ~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~  421 (593)
                      ...++|+|+.|.||+++++..+-|+||+.+.
T Consensus       174 ~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         174 DLVVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             CEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             CceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence            2238999999999999988777899999765

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.67  E-value=6.2e-05  Score=75.35  Aligned_cols=76  Identities=14%  Similarity=0.157  Sum_probs=48.8

Q ss_pred             ccccCccCcccEEEEEeC-CCCeEEEEEeehhh-------HHHHHHHHHHHHHHhhcC-C--CCcceeeeeeecCCceEE
Q 007680          277 CNLLGTSSFGSVYKGTIS-DGTDVAIKVFNLQL-------ERAFRSFDSECEVLRNVR-H--RNLIKILSSYSNPDFKAL  345 (593)
Q Consensus       277 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~l  345 (593)
                      .+.||.|....||++... +++.+++|.-....       .....+...|.+.++.+. +  ..+.+++.+  +++..++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            457899999999999865 46789999754321       112234556888887762 3  234555544  4556689


Q ss_pred             EEeccCCCC
Q 007680          346 VLEFMPNGS  354 (593)
Q Consensus       346 v~e~~~~gs  354 (593)
                      |||++++..
T Consensus       109 vmE~L~~~~  117 (392)
T d2pula1         109 VMEDLSHLK  117 (392)
T ss_dssp             EECCCTTSE
T ss_pred             EEeccCCcc
Confidence            999997654

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.65  E-value=6.9e-06  Score=71.97  Aligned_cols=41  Identities=7%  Similarity=0.131  Sum_probs=30.1

Q ss_pred             CCCCCcEEECCCC-cCccc----CCccCCCCCCCcEEEccCCcccc
Q 007680           22 SLPNIEYLLLTAN-NLTGT----IPNSITNATKLIVLDLGFNSFSG   62 (593)
Q Consensus        22 ~l~~L~~L~L~~N-~l~~~----~p~~~~~l~~L~~L~L~~N~l~~   62 (593)
                      ..++|++|+|+++ .|+..    +..++...++|+.|+|++|.+..
T Consensus        13 n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~   58 (167)
T d1pgva_          13 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISD   58 (167)
T ss_dssp             TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBH
T ss_pred             CCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccch
Confidence            4678999999874 56532    33456777889999999998873

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.37  E-value=1.4e-05  Score=69.98  Aligned_cols=107  Identities=15%  Similarity=0.138  Sum_probs=68.9

Q ss_pred             CCCCCCcEEEccCC-ccccc----ccccccCCCCchhhhhhcceeeccCCcccc--------cCCCcccccEEEccCCcc
Q 007680           45 TNATKLIVLDLGFN-SFSGH----ILNTFGNLRHLSVLSLLMFGIRLTGNKLYG--------RIPPCLVLTVLDVSRNQL  111 (593)
Q Consensus        45 ~~l~~L~~L~L~~N-~l~~~----~p~~~~~l~~L~~L~l~~n~l~l~~n~l~~--------~~~~~~~L~~L~l~~N~l  111 (593)
                      .+.++|+.|+|+++ .++..    +...+...+.|++|       ++++|.+..        .+....+|++|+|++|.|
T Consensus        12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L-------~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i   84 (167)
T d1pgva_          12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKF-------SLANTAISDSEARGLIELIETSPSLRVLNVESNFL   84 (167)
T ss_dssp             TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEE-------ECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBC
T ss_pred             hCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCcccee-------eccccccchhHHHHHhhhhhhcccccceeeehhhc
Confidence            35688999999974 56532    23456677788888       666666652        233334588888888887


Q ss_pred             cCc----CCCCCCCCCCCCEecCCCccCCCC-------CCccccCCcccccccccccc
Q 007680          112 SGD----IPSTIGGRVDLETLSLASNQFQGP-------IPESVGSLISLESLDLSGNN  158 (593)
Q Consensus       112 ~~~----~p~~~~~l~~L~~L~l~~N~l~~~-------~p~~l~~~~~L~~L~l~~N~  158 (593)
                      +..    +-.++...+.|++|++++|++...       +...+...++|+.|+++.+.
T Consensus        85 ~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~  142 (167)
T d1pgva_          85 TPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS  142 (167)
T ss_dssp             CHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred             chHHHHHHHHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCC
Confidence            632    123456667788888888876522       23334456677777776554

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.27  E-value=0.00058  Score=66.16  Aligned_cols=134  Identities=13%  Similarity=0.103  Sum_probs=77.2

Q ss_pred             ccEEEEEeCCCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCCCC--cceee-----eeeecCCceEEEEeccCCCCH---
Q 007680          286 GSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRHRN--LIKIL-----SSYSNPDFKALVLEFMPNGSL---  355 (593)
Q Consensus       286 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~-----~~~~~~~~~~lv~e~~~~gsL---  355 (593)
                      -.||+++.++|+.|++|+.+... ...+++..|...+..|....  ++..+     ..+...+..+.++++++|..+   
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~  114 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD  114 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred             ceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence            58999999999999999987642 23356778888888874222  12111     123445667889999876422   


Q ss_pred             --HHH------H---hh----C----CCCCCHH----------------------HHHHHHHHHHHHHHHHHhcCCCCCe
Q 007680          356 --EKW------L---YS----H----NYFLDIL----------------------ERLNIMIDVGSALEYLHNGHSSVHI  394 (593)
Q Consensus       356 --~~~------l---~~----~----~~~l~~~----------------------~~~~i~~~i~~~L~~LH~~~~~~~i  394 (593)
                        ..+      +   +.    .    +...+..                      .....+.++...+.-.-......++
T Consensus       115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l  194 (325)
T d1zyla1         115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR  194 (325)
T ss_dssp             CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred             CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence              111      0   00    0    0011111                      1122233333333222112224579


Q ss_pred             EecCCCCCCeeeCCCCcEEEEeecccee
Q 007680          395 IHCDLKPTNILLDENMVAHVSDFGIYKL  422 (593)
Q Consensus       395 vH~Dlkp~NIll~~~~~~kL~Dfg~a~~  422 (593)
                      +|+|+.+.||+++++  ..++||+-+..
T Consensus       195 iHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         195 LHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             ecCCCCcccEEEeCC--ceEEechhccc
Confidence            999999999999754  45899997763

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.97  E-value=0.00096  Score=64.14  Aligned_cols=157  Identities=8%  Similarity=-0.014  Sum_probs=86.3

Q ss_pred             CCHHHHHHhhhcccccc-----ccCccCcccEEEEEeCCCCeEEEEEeehhhHHHHHHHHHHHHHHhhcCC-----CCcc
Q 007680          262 TSYLDIQRATDEFNECN-----LLGTSSFGSVYKGTISDGTDVAIKVFNLQLERAFRSFDSECEVLRNVRH-----RNLI  331 (593)
Q Consensus       262 ~~~~~~~~~~~~~~~~~-----~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-----~niv  331 (593)
                      .+..|+.....+|.+.+     .|..|---+.|+.+..+| .+++|++....  ..+.+..|++++..+..     |..+
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi   79 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL   79 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccc
Confidence            34567777777887643     345666678899987655 58999986532  22345567777777732     2222


Q ss_pred             eeee---eeecCCceEEEEeccCCCCHH-----H------H---Hhh----CC--C--C------------------CCH
Q 007680          332 KILS---SYSNPDFKALVLEFMPNGSLE-----K------W---LYS----HN--Y--F------------------LDI  368 (593)
Q Consensus       332 ~l~~---~~~~~~~~~lv~e~~~~gsL~-----~------~---l~~----~~--~--~------------------l~~  368 (593)
                      ...+   +....+....++.+..+....     .      .   ++.    ..  .  .                  ...
T Consensus        80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (316)
T d2ppqa1          80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  159 (316)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence            1111   112234556667766553221     0      0   000    00  0  0                  001


Q ss_pred             HHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEEeeccce
Q 007680          369 LERLNIMIDVGSALEYLHNGHSSVHIIHCDLKPTNILLDENMVAHVSDFGIYK  421 (593)
Q Consensus       369 ~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~  421 (593)
                      ......+......+...+......|++|+|+.++||+++.+...-++||+.+.
T Consensus       160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence            11122233334444444433335679999999999999998877899999875

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=96.86  E-value=0.00012  Score=63.64  Aligned_cols=107  Identities=13%  Similarity=0.129  Sum_probs=69.7

Q ss_pred             CCCCCcEEECCC-CcCccc----CCccCCCCCCCcEEEccCCcccccc----cccccCCCCchhhhhhcceeeccCCccc
Q 007680           22 SLPNIEYLLLTA-NNLTGT----IPNSITNATKLIVLDLGFNSFSGHI----LNTFGNLRHLSVLSLLMFGIRLTGNKLY   92 (593)
Q Consensus        22 ~l~~L~~L~L~~-N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~----p~~~~~l~~L~~L~l~~n~l~l~~n~l~   92 (593)
                      ..++|++|+|++ |.|+..    +..++...++|+.|+|++|.++...    ...+...++|+.|       ++++|.+.
T Consensus        15 ~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l-------~l~~~~~~   87 (166)
T d1io0a_          15 NDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSL-------NVESNFIS   87 (166)
T ss_dssp             TCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEE-------ECCSSCCC
T ss_pred             cCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhh-------hhcccccc
Confidence            467888888887 556521    2345667888889999988886432    2345556778777       66666654


Q ss_pred             --------ccCCCcccccEEEc--cCCcccC----cCCCCCCCCCCCCEecCCCccC
Q 007680           93 --------GRIPPCLVLTVLDV--SRNQLSG----DIPSTIGGRVDLETLSLASNQF  135 (593)
Q Consensus        93 --------~~~~~~~~L~~L~l--~~N~l~~----~~p~~~~~l~~L~~L~l~~N~l  135 (593)
                              ..+....+|+.++|  ++|.+..    .+...+...++|+.|+++.|..
T Consensus        88 ~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~  144 (166)
T d1io0a_          88 GSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ  144 (166)
T ss_dssp             HHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred             chhHHHHHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCC
Confidence                    23445556776555  4566642    1333455678899999987765

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.72  E-value=0.001  Score=66.19  Aligned_cols=73  Identities=14%  Similarity=0.195  Sum_probs=49.3

Q ss_pred             ccccCccCcccEEEEEeCC--------CCeEEEEEeehhhHHHHHHHHHHHHHHhhcC-CCCcceeeeeeecCCceEEEE
Q 007680          277 CNLLGTSSFGSVYKGTISD--------GTDVAIKVFNLQLERAFRSFDSECEVLRNVR-HRNLIKILSSYSNPDFKALVL  347 (593)
Q Consensus       277 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  347 (593)
                      ++.|+.|-.-.+|++...+        .+.|++++.... . ......+|..+++.+. +.-..++++++.+    .+|+
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~  120 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-E-TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  120 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-C-CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc-c-hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence            4678889999999998653        345777776522 1 2234567888888884 4334567777643    6899


Q ss_pred             eccCCCCH
Q 007680          348 EFMPNGSL  355 (593)
Q Consensus       348 e~~~~gsL  355 (593)
                      ||++|.++
T Consensus       121 efi~g~~l  128 (395)
T d1nw1a_         121 EYIPSRPL  128 (395)
T ss_dssp             CCCCEEEC
T ss_pred             EEeccccC
Confidence            99987543

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=96.70  E-value=0.0001  Score=64.04  Aligned_cols=108  Identities=14%  Similarity=0.149  Sum_probs=64.9

Q ss_pred             CCCCCCcEEEccC-Cccccc----ccccccCCCCchhhhhhcceeeccCCcccc--------cCCCcccccEEEccCCcc
Q 007680           45 TNATKLIVLDLGF-NSFSGH----ILNTFGNLRHLSVLSLLMFGIRLTGNKLYG--------RIPPCLVLTVLDVSRNQL  111 (593)
Q Consensus        45 ~~l~~L~~L~L~~-N~l~~~----~p~~~~~l~~L~~L~l~~n~l~l~~n~l~~--------~~~~~~~L~~L~l~~N~l  111 (593)
                      .+.++|+.|+|++ |.++..    +...+...++|++|       ++++|.++.        .+.....|+.|++++|.+
T Consensus        14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L-------~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~   86 (166)
T d1io0a_          14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKF-------SIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFI   86 (166)
T ss_dssp             TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEE-------ECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCC
T ss_pred             hcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCee-------eccCCcccHHHHHHHHHHHhhcccchhhhhccccc
Confidence            4567788888876 456532    23345567778877       666666542        223334578888888877


Q ss_pred             cCc----CCCCCCCCCCCCEecC--CCccCCC----CCCccccCCccccccccccccc
Q 007680          112 SGD----IPSTIGGRVDLETLSL--ASNQFQG----PIPESVGSLISLESLDLSGNNL  159 (593)
Q Consensus       112 ~~~----~p~~~~~l~~L~~L~l--~~N~l~~----~~p~~l~~~~~L~~L~l~~N~l  159 (593)
                      ...    +-..+...++|+.++|  ++|.+..    .+...+...+.|+.|+++.|..
T Consensus        87 ~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~  144 (166)
T d1io0a_          87 SGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ  144 (166)
T ss_dssp             CHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred             cchhHHHHHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCC
Confidence            522    1234556677776444  4566642    2344455677788888776654